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Abstracts of Original Contributions: 43rd Annual Scientific Session 
The American College of Cardiology is pleased to announce that 
5,915 abstracts of original contributions were submitted to the 
Program Committee of the 43rd Annual Scientific Session, includ· 
ing computer applications submissions. Space and time consider· 
ations this year allowed the selection of 1,900. 
Each abstract was peer reviewed by a panel of graders; chosen 
abstracts are presented in either oral, poster or computer format. 
The American College of Cardiology thanks the thousands of 
abstract participants and the hundreds of category graders and 
990 Signal and Image Analysis 
Monday, March 14, 1994 9:00 AM-12:30 PM 
Georgia World Congress Center, Hall G Booth 4629 
990·1 
Automatic Detection of Arterial Lumen IIDd Medio-ad'fentitiaI 
Bouoclaries in Intra'fascular IDtruouod Images Using Textural 
Operators IIDd Mathematical Morphology 
A1eksandra Mojsilovic. Neoad Amodaj. Miodug Popovic. Rade Babic·. 
Miodrag Ostojic·. Faculty of Electrical Eogineering; ·Iostitute for 
Cardiovascular DiIle8SC8, Belgrade, Yugoslavia. 
Intravascular u1traaoUDd (IVUS) is echo tolDOgraphic technique providing 
valuable information on vessel pometry. wall Ihlckness, exte:ol of 
atheroaclerotic di_ and plaque morphology. By outliDin& the two cootoUIS: 
original 1_ and free 1_, • clinically important determiDaDts of luminal 
narrowing can be computed. Each of the tIuee vessel wall layers is 
characterized by the specific texture pattern and by the dominant gray level 
intensity. Oa the basis of textural and tooaI features, our method performs 
UDSUperVised segmentation of IVUS images in the way that matches the hUDIaD 
visual system. 
To partition images into different tissue regions. segmentation method 
based on thresholding in texture feature space was employed. In the lint step. 
• set of spatial texture and tooaIlII08S\IreS are computed for each iDlage pixel. 
The measures were extracted from l5xl5 pixel neighborhood of a given pixel. 
Festure space thresholds for tissue discrimination are determined from the 
JI)eaSUre histograms. By application of thresholds to festure iDlages. two binary 
objects are obtained: free lumen and actual lumen regions. Boundary 
irregularities in extracted regions, caused by catheter artifacts. noise. acoustic 
shadowing and segmentation errors are removed in the final step. using 
mathematical morpbology. In order to efficiently implement all operations, a 
knowledge about blood vessel anatomy and IVUS iDlages is taken into 
consideration as well. 
The method is implemented as a PC-based program written in the C 
langusge. In clinical testing, we compared the boundaries obtained by automatic 
segmentation with the manually traced ones in 20 intracoronary images. The 
correlation coefficients for detected areas and diameters were 0.98 and 0.99, 
respectively. The average matcb ratio was 89%. We conclude that the method 
based on textural operators can be utilized efficiently for automatic 
segmentation of IVUS images into different tissue layers. 
chairmen for their efforts. 
Richard O. Russell, Jr., MD, FACC 
Chairman 
1994 Annual Scientific Session Program Committee 
R. Joe Noble, MD, F ACC 
Co-Chairman 
1994 Annual Scientific Session Program Committee 
990·2 
An Interactiva, UHr Friendly Computer Program for Hean Rate 
Veriebility Anelysis 
Zhixing Li, Franc;ois Sestier, Robert LeBlanc. Benoit Coutu, Pierre 
Lacombe, Claude Guimond, Cardiology Research, Notre-Dame 
Hospital, Montreal, Quebec, Canada. 
Heart rate variability (HRV) from ambulatory electrocardiography can 
provide important data relating to the prognosis of patients recovering 
from myocardial infarction or congestive heart failure. Components 
of HRV can also provide valuable infonnation about the functioning of 
the autonomic nervous system. Many commerCially available systems 
for Holter analysis do provide HRV analysis. but most implementations 
have been limited by a lack of accuracy since spectral analysis is 
sensitive to signal quality. We developed a program, written in an 
object oriented programming language (C+ +1, on an IBM-PCIAT 
compatible system, which reads the annotated RR interval files 
downloaded from a Marquette 8000 Holter analysis system. It 
provides an integrated environment and is equipped with a user 
friendly interlace. The program pennits a user to visualize RR 
intervallheart rate versus time. to choose andlor edit segments from 
.the downloaded QRSDK file for HRV analysis. The chosen segments 
are stored as objects in a sorted collection file. Each segment is 
keyed with the hook-up date and segment time. Segment length is at 
the user's choice. From the collection file, one may visualize and edit 
signals andlor do an HRV analYSis. Plots of tachogram andlor spectra 
in a user selected fonnat may be produced on a laser printer or 
exported in HPGL-fonnat or as PCX files which in tum may be 
imported by many word processing or graphics programs. Time 
domain measurements for each segment are expressed as mRR, sdRR 
and pNNSO; frequency domain as absolute and nonnalized power at 
very low frequency (VLF:O.OOS-O.OS HZ), low frequency (LF:O.OS· 
0.15 Hz), high frequency (HF:0.15-0.4 Hz), total power and center of 
gravity of the power spectra. These parameters and the segment key 
are stored in an ASCII file, which may be imported into any 
commerCially available spreadsheet Of statistics packages for analysis. 
or they may be incorporated as part of a report. 
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990·3 
A Windows Software AppHcatlon to Assess Arterial Dynamic Behavior: a 
Useful Tool In Laboratory and Non invasive CIlnIcaI Research. 
"Marcelo R. Risk, Ricardo L. Annentano, Juan G. Barra, Carlos A. Perazzo, 
Ricardo H. Pichel, from the Teaching and Reaearch Department, Favaloro 
Foundation, Buenos Aires, Argentina. 
To fully characterize the cardiovascular system it is necessary to know In detail 
the dynamic behavior of the hydraulic load. The pwpose of this work was to 
assess the parameters that characterize the arterial biodynamics obtaIned both 
from animal investigation (invasive) and patients (non invasive) studied in 
clinical centers of aneriaI hypertension. To this aim a software written In C++ 
for Windows enabling off line visualization and analysis of previously acquired 
signals was developed. 
This software was designed to read ASCII file fonnat to avoid Incompatibility 
with the acquisition system, and it was divided into four blocks: 1) 
Identification, averaging and evaluation of hemodynamic signals of aneriaI 
pressure and diameter (beat to beat analysis) showing Instantaneous temporal 
tnlCings and pressure-diameter loops, and calculation of purely elastic pressure•
diameter relationship by elimination of the hysteresis loop enabling calculus of 
isobaric arterial compliance by means of three different theoretical models of the 
aneriaI wall. 2) VisuaIization of blood flow velocity obtaIned step by step at 
different depth into the arterial lumen, showing blood flow velocity profiles, the 
time variation of the velocity profile (obtaIned from a pulsed Doppler device) 
during the cardiac cycle, and the theoretical reconsuuction of blood flow 
velocity assuming several models. 3) Calculation of arterial blood flow (from 
arterial diameter and cross sectional blood flow velocity) and analysis of arterial 
pressure and blood flow waveforms, showing beat to beat and averaged 
spectrum of arterial impedance. 4) Obtention and visualization of forward and 
backward waves of arterial pressure and flow from its original signals. In all 
cases printing output of graphics and data, as well as ASCII files of output data 
compatible with standard software, are enabled at any moment. 
In conclusion, this software allows immediate analysis after basic and clinical 
research studies, independently of the signal sources, and taking into account 
elaborated mathematical models, therefore constituting a useful tool for the 
interpretation of the dynamic of the arterial behavior. 
990·4 
Automatic Accurate Analysis or Monophasic Action Potential 
Recordings 
Micbael R. Franz, C. Lariasa Fabritz, Paulus F. Kln:bboC, Bellina S. Koller, MaItus 
Zabel. 
DivisiOllS of Canliology and CtiD. PIIannacology, Gelqetown UDiw:nity aod 
VA MedicIl Centtr, Wasbingtoo, DC. 
Monopbasic dOO poIeDliaI (MAP) reaJnlings are widely used In clinical and 
experimeaIal studies but Ibelr III8IIIIIlmeasuremeot is QllDbenome, espedaIly wben 
hundred 01" dIousaDds ofbeals must be amalyzed 10 mooilCr the exact lime c:oune of 
acdOD poICnIial dunIIioD (API» c:bImges. We devdqJed a MacinI06b-based IXJIIIIlIIIrZ 
pogram whidl ....... V'BJly execuIeS JII08IIIIIIIIed eIecIriaII stimulalioo with up 10 3 
exttastimuJi, sIreams 1 kHz· MAP RIIXlRIings 10 disk (up to 6 dIanneIs sim"ltlJlM'015-
Iy), Iben 8DaIyzes API> 81 ft:pOIarizaIjcI levels fran 101090% In 10% cII:aancoIs IDI 
outputs numerical daIa aJtomaIicaIIy Into spreadsbeets 01" grapbical displays. The 
a1gorilbm "lntelligendy" reproduces the MAP amalysis aiteria developed In our 
laboratory: it identifies the fastest point 00 the upstroke pbase, detennines the 
maximum amplitude c:l die MAP pa&tau (mI8ffecIed by vDtioos ill "spilco-lIKHkme" 
appearance 01" afterdcpoIariz.), RItUIDS the pacOO cycle IeIIgth and caJcu\aIes die 
elecIricaJ diasIOIic iDI5vaI bttwem MAPD-9O% and the oext upstroke. Validalim was 
pedooned by canparIng manual anaIysis by 2 indepeDdeDtobsemn (paperspeed 100 
mmlsec) with caDpUtel" gcnaaIed daIa fOl" a IOtaI of 608 MAP recmlings. The table 
sbows die resuJts far API> 813 repoIarizIIioo levels as mean diffeaeoce (millisec:mds) ± 
standard deviaIioo. 
APD 20% API> 50% API> 90% 
Computtr minus observer 1 ·2.0 ± 8.8 -0.7 ± 7.9 -0.2 ± 8.5 
Coolputer minus observer 2 ·12.2 ± 8.3 ·5.8 ± 7.5 ·1.4 ± 10.1 
Observer 1 minus observer 2 ·10.3 ± 11.1 ·5.1 ± 9.0 ·1.2± 7.8 
Paced cycle length VI. canputtr rep«rted cycle length: ezror <0.2 ± 0.7 msec. 
Analysis of 100 MAP signals took approximaIely 2 boors by manuaI analysis and 1 
min by COIIIjlUtI2". This pogram povides IICCUt"8Ie, CX1rC:IIldy efIicieDt anaIysis of API> 
and cycle length. 
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701 Local Drug Delivery-Experimental 
Adjuncts to Angioplasty 
Monday, March 14, 1994 10:30 AM-Noon 
Georgia World Congress Center, Room 257W 
701·1 10:30 
Local Arterial Wall Drug Delivery from a Polymer Coated Removablt 
Metallic Stent: Kinetics, Distribution, and Bioaetivity of Forskolin 
·Neal L. Eigler, Thomas L.l.ambert, Visbva Dev, Joel Kupfer, Ken Mahrer, 
James S. Forrester, ·Frank Utvack, Cedars·Sinai Medical Center, Los 
Angeles,CA 
We have developed a polyurethane coated removable metallic stent which 
incorporates milligram quantities of lipophilic drugs. Forskolin was chosen 
as the model drug because it is a small nonpolar molecule that can be 
Incorporated into the coating and has antiplatelet and vasodilator properties. 
Our goal was to evaluate tbe kinetics, distribution, and bioaetivity of local 
arterial delivery of forskolin. Stents (n= IS) were deployed In the rahbit 
carotid for up to 24 hours. The quantity of forskolin bound to the stent 
decreased exponentially from l58O±550 mg initially to 75 ±6 mg at 24 hours 
(half·life of 5.8 hours). Blood concentrations peaked at 140±39 PwuL at 4 
hours and remained elevated at 68±18 PwuL at 24 hours. The arterial flux 
of forskolin, initially 6.9±1.9 uwmin decreased exponentially with a half-life 
of 1.2 hours. The adjacent arterial media contained 60±39 nwmg which was 
380 and 460 times greater than the contralateral carotid media and the 
blood, respectiveiy(p<O.OOOI). Mediaforskolin concentrations declined over 
time with a tissue half·life of 5.0 hours. Drug distributed throughout the 
vessel waD with a decreasing gradient in tbe radial and axial dimensions, 
consistent with a diffusion process. Removal of the stent was associated with 
a loo-fold decline in media forskolin concentration within 2 hours. Forskolin 
release was associated with a sustained 74% increase in carotid flow al d a 
56% decrease in resistance (p<O.OI).ln another set of rabbits (n= 14) using 
a carotid crush injury, low flow model, forskolin prolonged the time to flow 
variation and occlusion by 12x compared to bare metal stents and 5x 
compared to polyurethane coated stents (p<O.OOOI). Conclusions: A 
polymer coated stent can deliver forskolin to the arterial waD in high 
concentrations relative to the blood or other tissues. Local tissue and bl"lOd 
kinetics can be modeled as a simple diffusion process. Tissue forskolin levels 
are proportional to the drug remaining on the stent and are dependent on 
maintaining stent to tissue drug gradients. The delivered drug is biologically 
active demonstrating vasodilating and antiplatelet properties. 
701·2 10:45 
Local Delivery of Heparin with a PTCA hlfuaiOll Balloon Inhibits 
P1atelet-dependent TIuombo8is 
Clifford N. Thomas,*James J. Barry, Spencer B. King ill, Neal A. 
Scott. Division of Cardiology, Emory University Medical School, 
Atlanta,GA 
Thrombosis is a major component of acute coronary syndromes and 
is associated with acute closure during PTCA. To assess the 
feasibility of local heparin delivery during PTCA, we compared the 
efficacy of systemic heparin administration and local delivery of 
heparin using a specially-designed PTCA balloon catheter with 
intramural channels for site-specific drug delivery. ThrombogeniC 
Dacron graft segments were inserted into chronic arteriovenous 
shunts in pigs. Autologous platelets were labeled with ll1lndium. 
Platelet deposition was quantitated with gamma camera imaging 
over a two hour period. The Dacron graft was exposed to flowing 
blood for 15 minutes in order to allow for mural thrombus 
formation. The infusion balloon was then deployed at the site of the 
thrombus, and heparin was infused over a five minute period. The 
balloon was then deflated and removed, and flow was re•
established. 
Platelet Deposition (x10-8) 
Saline 
Heparin (500 U) 
Heparin (SOOl U) 
··p<o.05 
45 min 
S.O± 1.0 
1.4 ±0.4· 
0.8 ± 0.4· 
60 min 
S.2± 1.1 
1.9 ± 0.9" 
0.5 ± 0.7' 
100 min 
5.8 ± 1.3 
1.6 ± 1.0" 
0.8±0.9" 
Local delivery of 500 U of heparin provided significantly more 
inhibition of platelet deposition than the 3000U systemic dose. We 
conclude that local delivery of heparin with a specia11y-designed 
infusion balloon catheter inhibits thrombosis at doses that are at least 
several fold less than the dose of heparin given systemically. 
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701·3 11:00 
Effect of Local Delivery of Urokinase on Platelet Deposition During In•
Vivo Balloon Aogioplasty Usiog Hydrogel-Coated BalIooDS 
Joseph F. Mitchel, Michael A. Azrin, Lisa A. Pearsall, Timothy M. 
Curley, Too V. A1berghini, Hans Bauer, David D. Waters, Raymond G. 
McKay 
Hartford Hospital, University of Connecticut, Hartford, CT 
Previous work by our laboratory has demonstrated the efficacy of local 
urokinase delivery using hydrogel-coated bailooDS in the treatment of 
intracoronary thrombus and abrupt thrombotic closure following 
conventional PTCA. To determine the effect of this technique on platelet 
deposition following in-vivo balloon angioplasty, II1In-labelled platelet 
deposition was measured in 13 porcine carotid or iliac arteries which had 
been dilated with urokinase-coated balloons. Hydrogel loading of urokinase 
was achieved by • dipping" inflated balloons in a concentrated Abbokinase 
solution for I minute (50,000 u/rnl). All balloon inflations were performed 
at 4 atm for 5 minutes with a balloon-artery ration of 1.3: I as determined 
by intravascular ultrasound. Contralateral vessels were dilated with the 
same-size uncoated balloons and served as study controls. One hour 
following local urokinase delivery, all dilated arterial segments were 
surgically removed and '"In platelet deposition was determined by gamma 
counting. 
RESULTS: In 10 out of 13 vessel pairs, there was less platelet deposition 
on urokinase-treated vessels than control vessels. Local urokinase delivery 
decreased platelet deposition by 47%, with 2.54 ± 3.93 x 10' in control 
vessels and 1.34 ± 1.66 x 10' in urokinase-treated vessels (p=0.03). 
CONCLUSION: Localized urokinase delivery using urokinase-coated 
balloons reduces platelet deposition after balloon-induced vascular injury 
and may decrease intracoronary thrombus formation following balloon 
angioplasty. 
701·4 
Transfer of Mitropartic1es to Balloon·injured Swine Coronary 
Arteries Usm& the Mitroporous Infusion Catheter 
11:15 
Keith A. Robinson, Roo Waksrnan, Clifford Thomas, Steven R. Sigman, 
Gustavo D. Cipolla, *steve Rowland, "Melissa Jones, Neal A. Scott, 
Spencer B. King m, Emory University School of Medicine, Atlanta, GA 
Attempts to inhibit forrnatioo of neointima after balloon catheter injury in 
anirnaI models, using local delivery of biologically active compounds from 
modified balloon catheters, may be thwarted by inadequate retentioo and 
sustained release of simple aqueous solutions. The use of microparticles 
as drug carriers bas potential to provide sustained release. We 
investigated the capacity of a novel microporous infusioo catheter (Cordis 
Corp.) to transfer 30 nrn colloidal gold particles in aqueous suspension, to 
the sites of balloon injury in swine coronary arteries. Four arteries (LAD 
and LCX) were injured and infused with 2 rnI gold suspeosioo in vivo at 5 
atrn driving pressure, then pressure-perfusioo fixed with buffered forrna1in 
or glutara1dehyde after 10·15 min. Two arteries (RCA) were fixed after 
injury and infusioo with similar volume and pressure in vitro. 
Deposition of gold microparticles was restricted to the luminal surface, 
with uniform circumferential distributioo observed in silver-enhanced 
thick sections by light microscopy. By transrnissioo electroo microscopy, 
microparticles were found associated with the cytoplasm of damaged 
endothelial cells, at the luminal aspect of the internal elastic lamina, and 
within platelet·fibrin microthrornbi. Use of the infusioo catheter did not 
induce further damage to arteries than balloon injury alone. 
Conclusion: Acute transfer and shan·term reteotioo of dense 
rnicroparticles to coronary arteries after balloon overstretch injury, is 
feasible using the rnicroporous infusioo catheter. This strategy bas 
potential for sustained release activity of anti-thrornbotic or anti-resteootic 
cornpouods at the site of angioplasty. 
ABSTRACTS 
701·5 11:30 
A Biocompatible Phosphotidylcholine Coating 
Applied to Metallic stents 
Jan E. Nordrehaug, Nicolas Chronos, Ulrich 
Sigwart. Invasive Cardiology, Royal Brompton 
National Heart and Lung Hospital, London, UK. 
Metal stents are thrombogenic and do not 
eliminate restenosis. Polymeric stents and 
coatings have been found to cause profound 
vessel wall reaction with significant smooth 
muscle cell proliferation. We have examined 
the thrombogenicity and vessel wall reaction 
to a biocompatible phosphotidylcholine stent 
coating. Ten anaesthetized New Zealand 
rabbitts (3-5 kg) underwent trans catheter 
placement via the right carotid artery of 
balloon-expandable slotted tube stents. One 
coated and one none-coated stainless steel 
stent were placed in opposite iliac arteries 
in a randomised fashion under fluoroscopic 
imaging. The histological and morphometric 
appearances of the gluteraldehyde fixed and 
hardened vessel walls were compared in rab•
bitts sacrificed at 24 hours, 1 week, and 24 
hours. There were no thrombotic occlusions in 
either group and the degree of fibrous tissue 
reaction and smooth muscle recruitment and 
proliferation was no different in the coated 
versus the uncoated stents. 
We conclude that the phosphotidylcholine coat•
ing offers a biocompatible alternative to 
polymeric co?tings and does not cause the 
intense vessel wall reaction seen with the 
polymeric coatings. Phosphotidylcholine coat•
ings may constitute an ideal substrate for 
local drug delivery via intracoronary stents. 
701·6 11:45 
Thin Hydrogel Barriers For Prevention of Thrombosis 
and Intimal Thickening after Balloon Injury 
Jennifer L. Hill· West, Sanghamitra M. Chowdhury, "'Marvin J. 
Slepian, "'Jeffrey A. Hubbell, University of Texas, Austin, TX. 
Prevention of thrombosis and resulting intimal thickening was 
achieved by nonpharrnacological means with the use of mechanical 
barriers. Conformal hydrogel barriers were formed by the conversion 
of a water soluble precursor, a diacrylated poly (ethylene glycol)-Iactic 
acid block copolymer, to a hydrogel on the surface of the vessel wall 
using an interfachl polymerization technique. 
Male New Zealand rabbits (2.5-3.5 kg) underwent balloon 
angioplasty of the left common carotid performed by a researcher who 
was blind to treatment groups. The hydrogel barrier was applied by 
adsorbing a photoinitiator onto the lumen surface, filling the artery 
with the precursor solution, and exposing the artery to a xenon arc 
lamp to convert the liquid precursor to a gel at the lumen surface. 
Imaging of hydrogel films containing fluorescent beads determined 
that this process created coatings which were 10-15 flITl thick. The 
thickness of the coating could be controlled by light IDtensity and the 
duration of exposure to light. The barrier degrades via hydrolysis 
over a period of several days into non-toxic, non-inflammatory 
products. 
The efficacy of the hydrogel barrier was assessed in the rabbit 
angioplasty model at two time points: 2 hours and 2 weeks. The first 
time point provided a measurement of thromboprotection. Video 
image processing of histological sections of tissue taken after 2 hours 
showed a thrombusllumen area ratio of 0.87 ± 0.1 (mean ± SD) for 
the control group (n = 4) and 0.Q3 ± 0.03 for the hydrogel treatment 
group (n = 4, P = 0.02). Macroscopic visualization of excised vessels 
showed that control vessels displayed red thrombus across the entire 
injured region, while hydrogel treated vessels appeared free of 
thrombus formation. Analysis of histological sections of tissue taken 
at the 2 week time point displayed an intima/media area ratio of 1.6 ± 
0.6 for the control group (n = 7) and 0.32 ± 0.08 for the hydrogel 
treatment group (n = 6, P = 0.002). 
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702 Chronic Ischemia in Women: 
Detection, Sequellae, and Treatment 
Monday, March 14, 1994 10:30 AM-Noon 
Georgia World Congress Center, Room 364W 
702-1 10:30 
Gender Differences in Circadian Pattern of Transient Ischemic Episodes 
in Asymptomatic and Minimally Symptomatic Patients With CAD 
Prakash C. Deedwania, Carl Pepine, Udho Thadani, Ron Marks, Eileen 
Handberg for the ASIST Study Group, VAMC/UCSF, Fresno, CA 
Although it is known that transient ischemic episodes (TIEsl have a 
definite circadian pattern with a morning increase, little information is 
available regarding the gender differences in the circadian pattern of 
TIEs. In this prospective study we evaluated the prevalence and pattern 
of TIEs during daily life in 1368 patients with evidence of CAD andlor 
ischemia on exercise stress testing. Ambulatory ECG monitoring (AEMI 
for 48 hours was performed with a digital real time system while 
patients were off all antianginal drugs except NTG. A total of 306 
patients had ;;. 2 TIEs or ;;. 5 min of silent ischemia (51) during AEM; 
266 were males and 40 were females. The average hourly number and 
duration of TIEs were evaluated using time series analysis. Whereas 
men had the usual surge in TIEs during the morning hours, the women 
had two primary peaks at 4 AM and noon. Unlike men the women had 
a definite secondary peak at 9 PM. In general women also tended to 
have longer average duration at all times throughout the day. 
I.' •• , " ' •• UD"WUI"I ••• IlDD .. --... 
Conclusion: These findings showing multiple peaks in women could have 
significant clinical implications as potential triggers of acute MI and 
sudden death. 
702-2 10:45 
Factors Limit~ the Enrolllnent of Wallen in RanXmized 
Coronary Artery Disease Trials. 
Richard M. st:eirgart, San:ira F'onIiIn, Hiltrud K.leller, 
Rd:bin M:lisa, MaIyEllen Coglianese, William Frishman, 
Anthony Ga!lbirXl, George Williams, Vera Bittner, Gina 
Vita, Eileen Han:D:lerg, Midlael Horan and C. Richard 
Conti for the ACIP Investigators, Wint:hrcp-University 
Hospital, Health Sciences Center, SUNY stalyBrook. 
Because 1iaDell have previQlSly been urrder-:t:eptese.1ted 
in CAD treatJDent trials, emolllnent was pu::sp ... :tively 
tracked in the NHIBI AsyuptaDatic ca:t:diac IsdIemia(lICI) 
pilot (ACIP). pts with ischemic :en; stress tests loIere 
identified and asked to 1rIeIIr the ACIP anb.llato:t:y :en; 
(AEXXi) • pts with AEXXi lICI and significant CAD suitable 
for revaso.Il.arizatioo cruld be rarmnized into ACIP. 
~ at ACIP centers identified 1953 pts with 
ischemi.c :en; stress tests; CB1l y 341/1953 (17%) pts loIere 
1iaDell. Mean age for 1iaDell was 60 yrs, and for men 61 
yrs (NS). AEXXi lICI was present in 176/341 (52%) wanen 
and 806/1612 (50%) men (NS). pts with AEXXi lICI loIere 
potentially eligible for ran:1anizatioo. '!he table 
carpares major reasons for exclusioo fran ran:1anizatioo 
for these men and1iaDell with AEXXi lICI. 
ACI No CAD Unsuitable CAD Refusal Randanized 
MEN 806 82(10%) 47(6%) 87(11%) 525(65%) 
WOMEN 176 46(26%) 14(8%) 10 (6%) 93(53%) 
P <0.001 NS 0.04 <0.01 
wanen make up a SIIBll p:t:qlOrtioo of pts ran:1anized 
(93/618 or 15%) in lICIP largely because fewer 1iaDell than 
men loIere identified with ischemic :en; stress tests. 
wanen with ischemi.c :en; stress tests loIere as likely as 
men to have AEXXi lICI, and more likely than men to 
participate in the study. '!he lCl\VeI" prevalence of 
significant CAD at ~iognqily despite AEXXi lICI also 
limited the enrolllnent of 1iaDell. 
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702-3 11:00 
Congestive Heart Failure and Left Ventricular Ejection 
Fraction: The Gender Paradox 
Lisa A. Mendes, Ravin Davidoff, Thomas J. Ryan, Alice 
K. Jacobs, Boston University Medical Center, Boston, MA 
Previous studies evaluating gender differences in 
patients presenting for coronary revascularization have 
consistently shown an increased incidence of congestive 
heart failure(CHF) despite higher LVEF in women(V) in 
comparison to men(H). To assess the impact of LV 
diastolic dysfunction on this "gender paradox", we 
compared LVEF, LV end-diastolic pressure(LVEDP), and LV 
end-diastolic volume(LVEDV) in 1673 consecutive 
patients without valvular disease undergoing coronary 
angiography between 1989-91. 
V (n=589) M (n=1084) l 
Age(years) 62.7±0.S 60.2±0.4 0.0001 
CBF(%) 13.9 9.8 0.01 
Diabetes(%) 17.6 12.1 0.002 
Bypertension(%) 40.3 31.1 0.0001 
3-vessel CAD(%) 17.5 32.2 0.0001 
LVEF(%) 60.9±0.6 S6.S±0.S 0.0001 
LVEDP(amBg) 1S.6±0.3 lS.S±0.2 NS 
LVEDV(al/a Z) 73.S±1.1 79.2±0.9 0.0001 
To further assess the LV pressure-volume relationship, 
LVEDV was compared at similar LVEDP in V and M. 
V:LVEDV(al/a Z) M:LVEDV(al/a Z) l 
LVEDP < 10 (aaBg) 69.0±2.4 72.4±1.7 0.23 
LVEDP 10-17 (aaBg) 74.S±1.7 77.S±1.2 0.15 
LVEDP > 18 (aaHg) 7S.0±2.0 8S.4±1.6 0.0001 
Gender-differences in LVEDV increased at higher LVEDP, 
suggesting a steeper LV pressure-volume relationship in 
V. Conclusion: These data suggest that the paradox of 
more frequent CHF despite better LVEF in V in 
comparison to M may be due to LV diastolic dysfunction, 
perhaps on the basis of hypertension and diabetes. 
702-4 11:15 
Symptomatic Response to I 78-Estradiol in Women with 
Syndrome X 
Giuseppe M. C. Rosano, David C. Lefroy, Nicholas S. Peters, David 
C. Lindsay, Philip M. Sarrel, Peter Collins, Philip A. Poole-Wilson. 
Royal Brompton Hospital and National Heart & Lung Institute, 
London, UK. 
Syndrome X is the triad of anginal chest pain, a positive exercise 
ECG, and angiographically normal coronary arteries. The syndrome 
is associated with abnormal vasomotion of the coronary 
microvasculature in some patients, occurs more commonly in women, 
and the onset is frequently around the time of the menopause. 
Estrogens modulate vascular reactivity. We have tested the 
hypothesis that estrogen deficiency may contribute to the 
pathophysiology of syndrome X in women. A double-blind, 
randomised, placebo-controlled, crossover trial was undertaken in 25 
women (aged 57±6 years, mean±S.D.) with syndrome X. All 
cardiovascularly active medication was stopped, and after an initial 
run·in period of 4 weeks all subjects underwent two 8 week treatment 
periods with either placebo or transdermal 176-estradiol. Symptoms 
were recorded and maximal exercise testing was performed initially 
and at the end of each treatment period. The levels of circulating 
176-estradiol during the active treatment period compared to the 
placebo period were 386±223 and 53±51 pmollL respectively. 176· 
estradiol compared with placebo caused a significant reduction in the 
reported frequency of chest pain (·3.6 episodes per lO days, 95% Cl 
0.0 to -6.6, P=0.045). There was no significant difference in the 
maximum exercise duration on treatment with 176-estradiol (6.6±2.8 
min) compared with placebo (6.8±2.4 min). 
These results indicate that 176-estradiol reduces the frequency of 
chest pain but does not increase maximal exercise capacity in 
menopausal women with syndrome X. The mechanism could relate 
to a differential effect of estrogen replacement on structural and 
functional coronary microvascular abnormalities in syndrome X or to 
systemic effects of estrogens. 
lACC February 1994:1A-484A 
702-5 11:30 
Coronary Arterial Acetylcholine-Induced Vasoconstriction Is Reversed 
by Intracoronary Administration or Estradiol-176 In Menopausal 
Women with Coronary Artery Disease 
Peter Collins, Giuseppe M.C. Rosano, Stamatis AdamopouJos, John 
McNeil, Lian Ulrich, Philip M. Sanel, Philip A. Poole-Wilson, National 
Heart & Lung Institute, London, UK 
Estradiol-176 (E) relaxes rabbit coronary arteries and improves 
myocardial ischemia in female patients with coronary artery disease 
(CAD). Ethinyl-estradiol causes endothelium.iJependent coronary 
vasodilation in monkeys, In vivo. To test this latter effect in humans we 
studied the effect of intracoronary administration of E (2.5 mcg) in 9 
female patients with proven CAD (mean age 59 years). Patients underwent 
measurements of coronary artery diameter and coronary blood flow after 
infusion of acetylcholine (ACh) 1.6 and 16 ,.,.g per min, before and 20 min 
after intracoronary E. Coronary artery diameter was measured by 
quantitative angiography and changes in coronary blood flow were 
measured with an intracoronary Doppler catheter. ACh increased coronary 
blood flow before and after the infusion ofE. However, the mean (±SE) 
ACh-induced increases in coronary flow were significantly greater 
(P<O.OO9) after the administration of E (2S0±47 and 390±83% 
respectively) than before its administration (149± 17 and 225±51 % 
respectively). Compared with control, ACh (1.6 and 16 ,.,.g per min) 
caused constriction before the administration of E (-<i ± 2 and -8± 5 %, 
respectively). This constrictor response was converted to dilatation after 
intracoronary administration of E (+8±2 and +9±3%, respectively; 
P<O.OI, before vs after E). Isosorbide dinitrate (Img) caused dilatation 
of the coronary arteries by II ±2% (p<0.01). E alone had no significant 
effect on coronary diameter (P=0.48). 
Estradiol-17 is appears to enhance endothelium.iJependent coronary 
vasodilation induced by acetylcholine in humans in vivo. Endothelium•
dependent coronary vasodilation may account for some of the improvement 
of exercise-induced myocardial ischemia observed after administration of 
sublingual estradiol-l7iS. 
702-6 11:45 
Estrogen Replacement Therapy After Coronary Artery 
Bypass Surgery: Effect on Survival 
Jay M. Sullivan, Faten EI-Zeky, Roger Vander Zwaag, K. B. 
Ramanathan, Baptist Memorial Hospital and the University of 
Tennessee, Memphis. 
We examined the relationship between postmenopausal estrogen 
use and survival in 1091 women who underwent coronary artery 
bypass surgery. Patients were selected for the study if their age 
was 55 years or more at the time of preoperative coronary 
angiography or if they had previously undergone bilateral 
oophorectomy. Life-table analysis was used to compare survival 
after surgery in 92 women who received estrogen replacement 
therapy and 999 women who did not. Five year survival was 
98.8% in the estrogen users and 80.7% in the non-users. Ten year 
survival was 69.3% in the users and 46.3% in the nonusers 
(p=O.OOOI by Lee Desu test). The women who did not use 
estrogen were significantly older, (p<O.OOI), had more vessels 
with significant stenosis (p=0.033), lower ejection fractions 
(p=0.05I) and more prior myocardial infarctions (p=O.054). 
However, a Cox Proportional Hazards Model selected the number 
of vessels diseased, estrogen use, left main, coronary stenosis and 
diabetes mellitus as the significant independent predictors of 
survival. 
Stepwise Logistic Regression 
Variable Relative Risk P Value 
Number of Diseased Vessels 1.43 <.0001 
Estrogen Use 0.34 0.001 
Left Main Stenosis 1.83 0.001 
Diabetes Mellitus 1.57 0.003 
We conclude that estrogen replacement therapy improves survival 
significantly after coronary bypass surgery in postmenopausal 
women with coronary artery disease. 
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Indications for Aortic Valve Replacement In Children with Severe Aortic 
Regurgitation 
fhristine Boutin, Brian W. McCrindle, ·Stephen P. Sanders, ·Steven o. Colan. 
Children's Hospital, Boston, MA, and The Hospital for Sick Children, 
Toronto, Canada. 
ID adult patients with severe aortic regurgition (AR), aortic valve replacement 
(AVR) has been recommended for patients with an absolute end-diastolic 
dimension (EOO) of 6.5 CDI. This value is 3 standard deviations above the normal 
mean value for an adult male. Application of this criterion to children is 
problematic due to the need to adjust for body size and potential age-related 
differences in tolerance for severe volume overload. To explore this issue, we 
reviewed serial echocardiographic evaluation of ventricular mechanics in 23 
children witb moderate or severe AR, mild stenosis (gradient=31±19 mmHg), 
and no other Significant cardiac abnormalities, who have not undergone A VR. 
To account for differences in age and body size, all measurements were evaluated 
as z-sc:ores relative to the distribution of measurements in normals. The mean age 
at first exam was l4± 7 yrs, and follow-up was 4±2 yrs (1-7 yrs). The EOO z•
score was markedly elevated (3.4±1.9 SO, p<O.OOOJ) and did not change 
significantly over the period of observation, indicating marked but stable 
dilatation. End-systolic dimension, wall thickness, and mass were also markedly 
elevated. Peak systolic wall stress z-score (PSSz) was normal throughout the 
period of observation and did not rise over the period of observation. implying 
adequate compensatory hypertrophy. Similarly, end-systolic wall stress was not 
elevated and did not rise witb time, implying that afterload mismatch did not 
develop. Systolic function was normal in all and did not deteriorate with time. 
The stress-adjusted velocity of shortening (SVI), a load independent index of 
contractility, fell somewhat with time but was not different from normal at last 
exam (SVI=O.04±2.0, normal=O.O±l.O). 
Conclusion: These children with moderate or severe AR had LV dilatation 
equivalent to that which has been suggested as an indication for A VR in adults, 
but did not manifest progressive dilatation, inadequate hypertrophy, afterload 
mismatch. or onset of contractile dysfunction during up to 7 years of 
observation. Therefore, some patients who could otherwise expect years of stable 
ventricular mechanics would undergo valve replacement if this decision were 
based on LV dilatation alone. 
703-2 10:45 
Single-Stage Repair of Aortic Arch Obstruction and Associated 
Intracardiac Defects Using the Anterior Approach in Infants 
Satinder K. Sandhu, Robert H. Beekman, Ralph S. Mosca, Edward 
L. Bove. Divisions of Pediatric Cardiothoracic Surgery and Pediatric 
Cardiology, C.S. Mott Children's Hospital, The University Of 
Michigan, Ann Arbor, MI 
The effectiveness of a single-stage anterior approach for repair of 
aortic arch obstruction and associated intracardiac defects has not 
been well evaluated. We therefore reviewed our experience with 73 
infants (median age 10 days; range 1-303 days) who underwent a 
single-stage repair via median sternotomy at our institution between 
1986-1993. Only 12 patients were over 1 month of age. Twenty-five 
(34%) had coarctation (CoA) with VSD, 17 (23%) had interrupted 
arch (IAA) with VSD, 27 (36%) had CoA fIAA with complex 
intracardiac anatomy, and 4 (6%) had isolated CoA with transverse 
arch hypoplasia. The arch obstruction was repaired using primary 
anastomosis (n= 63), patch aortoplasty (n=4), gortex graft (n=2), or 
subclavian flap (n=4). Total circulatory arrest time was 44 ± 2 mins 
(mean ± SEM). There were 11 early post-operative deaths (15%; 
70% CL:II-20%). The 62 survivors have been followed for a mean 
of 24 mo (2-78 mo), total of 1488 patient-months. Recurrent arch 
obstruction ~ 20 mm Hg has occured in 3/62 patients (5%; 70% 
CL:4-9%); all 3 underwent successful balloon angioplasty. There 
were 2 late deaths, one non-cardiac. We conclude that repair of aortic 
arch obstruction and intracardiac defects by a single-stage approach 
through median sternotomy can be accomplished with low mortality 
in infancy even with associated complex intracardiac anatomy. 
Recurrent coarctation is relatively uncommon (5%) and can be 
managed successfully with balloon angioplasty. 
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703·4 11:15 
Primary Bidirectional Glenn In Patients Between One and Four Months 
of Age. 
V. Mobao Reddy, John R. Liddicoat, Frank L. Hanley. Division of 
Cardiothoracic Surgery, University of California San Francisco, 
San Francisco, CA 
Primary Sidirectional Glenn (pSG) in early infancy is attractive 
because it minimizes the number of operations prior to Fontan procedure, 
avoids ventricular volume overload, and eliminates pulmonary artery (PA) 
distortion. However, concerns over elevated or labile pulmonary vascular 
resistance (PVR) have limited its use in the first rew months of life. Seven 
patients aged I to 4 months (5 pts less than 2 months) have undergone PSG 
between 10/92 and 7/93. Primary diagnoses were tricuspid atresia (3), asplenia 
syndmme (2), polysplenia syndrome (I), and double outlet right ventricle. The 
associated lesions of immediate surgical importance were severe pulmonary 
stenosis (5), and patent ductus arteriosus (2). Surgery included unilateral (2) 
or bilateral PSG (5) and correetion of associated lesions. There were no early 
or late deaths on follow up from I to 10 months. Of significance, 4/5 pts 
under 2 months of age were hypoxic (paO,:21-26 mmHg) despite low PA 
pressures (9-14 mmHg) immediately after cardiopulmonary bypass (CPS). In 
these four patients a very limited additional source of pulmonary blood flow 
was provided. PaO, significantly improved by the second post-operative day 
in all cases. The fifth patient in whom a bilateral PSG (interrupted IVC•
Kawashima) was performed without the use of CPS had excellent oxygenation. 
In conclusion, PSG is possible in very young infants as the primary 
procedure. The presumption that elevated or labile PVR precludes PSG in 
these patients was found not to be true as evidenced by the lack of elevated 
PA pressures. The relative hypoxia in the immediate post-operative period 
with rapid resolution of the same suggests that this may be a CPS related 
pulmonary parencbymal insult. A surgical approacb avoiding CPS may be 
beneficial in these young infants. 
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703·5 11:30 
Complex Foruu or Double Outlet RV: 'FoutD' VI 'Blwatricular Repair' 
James Wilkinson, Sabine Kleinert, Tetsuo Sano, Tom Karl, Roger Moe 
Royal Children's Hospital, Melbourne, Australia. 
193 consecutive patients with Double Outlet Right Ventricle, 
presenting for palliation or repair between Jan 1978 and July 1993, bave 
been reviewed. Those with "univentricular A V connections" were excluded. 
Patients with concordant A V connections, a single VSD and two adequate 
sized ventricles were classified as "DOn complex", while those with isomeric 
atria. an A V septal defect. multiple VSDs, hypoplasia of one ventricle, 
straddling of an A V valve, pulmonary atresia or other major complicating 
defects were categorised as "complex".On this basis 120 patients were 
regarded as "DOn complex" and 73 as "complex". 
Complicating anomalies included "atrial isomerism"(l8), discordant 
A V connection (8), hypoplasia of one ventricle, with hypop\asialsteDOSis or 
straddling of an AV valve (19), supero-inferior ventricles (3) with criss 
cross AV connection in 2, complete AV septal defect (18), pulmonary 
atresia (5) and aortic arch interruption (5). 
To date 142 patients have bad biventricular repairs - intraventricular 
baftle in 102, Senning in 10 and Arterial Switch in 30. Of these 142 
patients 106 were in the 'non complex' category and 3 died (hospital 
mortality 2.8% ; 70"10 CI 1.2 - 5.5%). By contrast 35 were 'complex' with 8 
deaths (hospital mortality 23%; 70"10 CI 15-32%). 
22 patients bave had Fontan operations with I death and 8 additional 
patients are presently palliated with bidirectional cava-pulmonary shunts 
(no deaths). Amongst the 30 patients having Fontan or cava-pulmonary 
shunts all but 2 were 'complex'. 
Thus the adoption of a Fontan or cavo-pulmonary sbunt, in complex 
cases (28), bas been associated with an early mortality of 3.6% (70"10 CI 0.6 
- 12%). This figure is similar to the hospital mortality (2.8%) of those with 
'non complex' forms baving biventricular repairs (CI 1.2-5.5%). By contrast, 
attempts to achieve a biventricular correction in 'complex' cases have been 
associated with an early mortality of 23% (p= 0.03). Thus in patients with 
complex forms of Double Outlet RV, who are suitable for a Fontan or cava•
pulmonary shunt, the option of biventricular repajr should only be adopted 
when the complicating factors are likely to be repairable with low risk. 
703·6 11:45 
Heart Transplantation for Congenital Heart Diseases 
Abbas Ardehali, Hillel Laks, Davis Drinkwater, Peter Grant, Barbara 
George, Alvaro Galindo, UCLA Medical Center, Los Angeles, CA 
Orthotopic hean transplantation in pediatric patients with congenital 
hean disease (CHD) has been associated with a high monality. The 
purposes of this study were i) to compare the survival following hean 
transplantation of children with CHD versus idiopathic 
cardiomyopathy (CM), and ii) to identify the preoperative risk 
faetor(s) for early death in the CHD group. Between 2/84 and 11/92, 
40 children underwent hean transplantation at our institution. Of 
these, 20 (50%) had CHD (age range: 5 mos-17 yrs), and 20 (50%) 
had CM (age range: 8 mos-17.5 yrs). In CUD group, diagnoses were: 
single ventricle physiology (12), TGAlVSD (2), congenital valve 
disease (2), AV canal (1), hypoplastic left hean (1), pulmonary 
atresia/intact septum (1), and tetralogy of Fallot (1). All of children 
with CHD had undergone at least one prior palliative cardiac 
operation; 8 of the 12 children with single ventricle physiology had 
previously undergone Fontan procedure. Reconstruction of 
pulmonary anery was required in 60% of the CHD patients. 
Actuarial survival fOllowi~an transplantation in children 
ThOi1ii ~ 
CHD 83%", 64%. 54%. 
"'P<O.05 
CM 100% 94% 94% 
Multivariate analysis of several preoperative risk factors (including 
preoperative status, transpulmonary gradient, number of previous 
cardiac operations) identified single ventricle physiology (p<O.05) as 
the only risk factor for ~ death in children with CHD. All of the 
late deaths (between 30 days to 3 years post-transplant) in the CHD 
group were due to refractory cellular rejection. Conclusions: I) 
Pediatric patients with CM have excellent short and long term 
survival following hean transplantation. 2) High risk children with 
CHD can undergo hean transplantation with acceptable surgical risk 
and favorable outcome, however, children with complex anatomy 
due to single ventricle physiology appear to be at a high risk for ~ 
death following hean transplantation. 
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A Comprehensive Approach For Image Segmentation, Cutting Planes 
and Display Projections In Three-Dimensional Echr .:ardlography: 
Suggested Guidelines for Clinically Useful projections Based on 
Multicenter Experience In 300 Adult and Pediatric Patients 
Natesa Pandian, ai-Ling Cao, Rairrund Erbel, Frank Flachskamp, Gerald 
Marx, Navin Nanda, Ramdas Pai, Jos Roelandt, Nelson Schiller, Steven 
Schwartz, Pravin Shah, Michael Vogel and Mani Vannan. 
Tufts-New Engl Medical Clr, Boston, MA, on behaH of collaborating centers. 
Recent studies have shown the clinical feasibiltty of dynamic 3-D echocar•
diography (30E) both transesophageally and transthoracically. The ability 
of 30E to display dynamic cardiac anatomy in many new views, while a 
unique strength, also presents a problem because of the countless ways in 
which a 3D data could be cut. We explored the various ways in which 30E 
image projections can be derived in 25 in vttro hearts, and in vivo in 300 pts 
(infants, children and adutts w~h a variety of cardiac disorders) acquiring 
data transesophageally or transthoracically using a tomographic (1 mm in•
terval slices) or rotational approach (slices at every 2, 3 or 5 degrees) with 
ECG and respiration gating. Dynamic 30E reconstructions were then cut in 
various planes to ident~y projections that would aid in diagnostic appraisal 
and surgical planning. ~: 30E depicted the dynamic cardiac anatomy 
in a rrutt~ude of views. Projections found to be useful fell in two categories: 
(A) 30E yjews jn conyentional 20E orientations; and (B) New Projections: 
1) Mitral Valve (V) Disorders: From above via -left atriotomy", and from 
below from LV body and outflow; 2) Similar views in the right heart for 
tricuspid V disorders; 3) Aortic V disorders: From above the valve and from 
below from the LVOF; 4) LVOF disorders: Fr~m above across the aortic 
valve and from below from the LV body 5) Views for pulmonic V and RVOF 
disorders: from the PA and from RV body and apex; 6) Pulm Artery: Views 
from Main PA and also long~udinal cuts; 7) Atrial and ventricular septal 
disorders: From the RA and LA, and RV and LV respectively; 8) LV dis•
orders: Cylindrical views looking from above and below; 9) Pulm veins: 
From LA looking up at all veins; 10) Similar views from RA for vena cavae 
and coronary sinus; 11) Aortic disorders: Longttudinal and cylindrical cuts. 
30E projections in conventional 2DE orientations provided a global spatial 
perspective; New region-oriented and lesion-oriented 30E projections dis•
played the functional morphology of various structures and also simulated 
surgical views. We conclude that this structured approach to 30E could aid 
valuably in the diagnostic assessment of various cardiac disorders and also 
provide a practical approach to use 30E as a clinical tool. 
704-2 10:45 
Ultrasound Holography of the Heart and Great Vessels and True 
Three-Dimensional Delineation of cardiac Structures: (1) Validation of 
the Technique In identifying Pathology In In Vitro Hearts and (2) 
Clinical Application In Displaying cardiac Abnormalities In Patients 
Mani Vannan, Natesa Pandian, Michael OaHon, Steven Schwartz, 
Bemhard Mumm, Gary Geil, Alan WoHe, Stephen Hart and ai-Ling Cao. 
Tufts-New England Medical Center, Boston, Massachusetts. 
We have previously demonstrated the feasibiltty of the concept of 
uttrasound holography, a new method capable of projecting the heart in a 
lnIIx 3-dimensional (3~) manner. The rationale behind exploring this 
concept was that in conventional 3D echo, visualization of cardiac struc•
tures in 3D requires various processing techniques to imply the depth but 
still the display is in a flat 20 videotape mode. The previous study employ•
ed normal sheep hearts imaged in vttro. The aim of the present study was 
to assess whether uHrasound holography could ident~y cardiac pathology 
and whether tt could be applied in pts wtth heart disease. In Vttro study: 
We first imaged 11 hearts of various sizes (pig, dog, calf) wtth experimen•
tally created atrial and ventricular septal defects and ventricular deforma•
tions in a water-bath and obIained parallel slices at 1 mm intervals wtth the 
use of a computer-driven 5 MHz transducer. The images, recorded digttally, 
were registered in sequence onto a holographic film using Inverse tomogra•
phy concept, retaining true 3D spatial relationships and maintaining correct 
linear translation. Oispersion-compensatEid white-light transmission was 
used to display 30E images. Clinjcal study: Using a computer-driven tomo•
graphic TEE probe, gated cardiac images were obtained in 5 pts (mttral 
stenosis, aortic valve disease and abnormal LV) at 1 mm intervals and this 
data were processed using the tachnique described above to develop 
holograms. ~: Both in in vttro and clinical studies, we were able to 
obtain high qualtty holograms (with intact gray scale) which depicted the 
whole heart. Sectioning of the heart in transverse, sag mal, and coronal 
orientations or the use of region-specKic windows displayed the atrial and 
ventricular septal defects and the deformed LV of the animal hearts. In the 
patient studies, the stenotic mttral valve, the abnormal aortic valve and 
enlarged cardiac chambers (LA, LV) could be recognized in true 3D projec•
tions. The relative depths and diameters could be measured. One could 
Itterally place one's finger inside the chambers. We conclude that uttra•
sound holography could be applied to humans and has promising clinical 
potential in demonstrating cardiac pathology in a unique 3-~ manner. 
ABSTRACTS 
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Atturacy or Three-Dimensional Echocardlographlc Reconstruction by 
E1edromagnetlc Positional Location: A Fnrther Step Toward Practical 
implementation or the Technique 
LengJiang, Robert A. Levine, Arthur E. Weyman, Mark O. Handschumacher 
Massachusetts General Hospital, Boston, MA ' 
Three-dimensional echocardiography (30E) has been validated in a variety of 
controlled settings for measuring ventricular volume and function. Several 
features of current technology, however, limit its ease of practical application 
in routine patient studies. In particular, the acoustic spark gap locating 
devices typically used, although accurate, are cumbersome, requiring a large 
external microphone array with UDimpeded line of sight to the transducer, and 
cannot combine views from two windows with perpendicu1ar transducer axis 
orientation, such as parasternal and subcostal. The purpose of this study, 
therefore, was to incorporate into a 30 system an electromagnetic (EM) 
positional seosor that is smaIl and does not require UDimpeded acoustic 
access. A 0.8 in3 device (Ascension Bird) attached to the transducer senses 
the EM field created by a set of OC coils at the bedside at rates of l00/s. 
Spatial locating data are then automatically integrated with 2D echo images 
in real time by a portable computer. As an initial test, this system was applied 
to reconstruct the left ventricle in five sheep hearts and the cavity of five heart 
phantoms from intersecting scans (adjusting for EM field inhomogeneities) 
compared with spark gap reconstructions. RESULTS: Cavity volumes 
measured with the EM locator agreed well with actual values (r = .99), with no 
significant difference in accuracy compared with spark gap data (F-test NS). 
Phantom~ versus actual (mean 294 ccl: 
EM y = 1.Ox + 7.9 
Spark gap y = 1.Ox - 1.3 
Hearts versus actual (mean 23 eel: 
~ 
4.4 
3.3 
Mean Error (cc) 
7.5 (2.8%) 
6.8 (2.2%) 
EM y = 1.Ox + 0.4 0.56 0.5 (2.3%) 
Spark gap y = l.Ox - 0.14 0.96 0.8 (3.7%) 
CONCLUSIONS: An electromagnetic positional locating system can 
reconstruct cavity volumes with the same accuracy as conventional spark-gap 
techniques but without requiring an UDimpeded acoustic line of sight to the 
transducer and with a smaIl additional bulk that does not impair scanning. 
This promising method should therefore facilitate practical implementation of 
three-dimensional echocardiographic reconstruction. 
704-4 11:15 
Left Ventricular Ejection Fraction: Three-dlmenalonal 
Echocardlography va. Two-dlmenalonal Echocardlographic 
Visual Estimation With Comparison to Multlgated Acquisition 
Radlonucllde Angiography 
Aasha S. Gopal, Zhanqlng Shen, Peter M. Sapln, Andrew M, 
Keller, Matthew J, Schnellbascher, David W, Leibowitz, 
Donald L. King, Columbia Unlveralty, New York, NY 
Subjective two-dimensional echocardiographlc (20E) visual estimation of 
left ventricular ejection fraction (EF) is widely used and thought to be 
sufficiently accurate for clinical use. We have previously validated three•
dimensional echocardiographic (3D E) volume computation and shown that 
30E EF is not significantly different from Tc 99m multigated radionuclide 
angiography (MUGA) for the EF range 30 - 65%. The purpose of this study 
was to compare subjective 20E visual estimation by observers with a range 
of echocardiographic experience to 30E computation of EF using MUGA as 
a standard of comparison. 44 unselected patients undergoing MUGA had 
20E and 3DE examinations within 1 hour. 20E EF was visuaUy estimated by 
2 experienced (>2 yrs) observers (exp) and 2 inexperienced (3 mol 
observers (inexp). 30E EFs were computed by 2 observers from diastolic 
and systolic volumes obtained by a 30E system using an acoustic spatial 
locater, an interactive line of intersection display to guide image plane 
posttioning and a polyhedral surface reconstruction algOrithm. 
EF 9 • 75% 
20E (inexp) 
2DE(exp) 
3DE 
EF30-65% 
n 
44 
44 
44 
Observer 1 Observer 2 Inter observer 
r SEE r SEE Vaiability 
0.85 10.1 % 0.83 7.5 % 23.5 % 
0.91 9.4 % 0.86 8.9 % 33.8 % 
0.94 5.5 % 0.98 3.4 % 10.3 % 
20E(inexp) 28 0.52 11.6% 0.48 7.8% 23.7% 
2DE(exp) 28 0.7811.1% 0.6710.0% 32.4% 
3DE 28 0.90 4.4 % 0.95 3.3 % 7.8 % 
Conclusion:1) 30E achieves a 2-3 fold improvement in SEE and 
interobserver variability over 20E visual estimation regardless of observer 
experience. 2) Greatest improvement of 30E over 20E is shown for the 
middle range of EFs (30 - 65%). Implication: 30E may be used in place of 
MUGA for serial evaluation of left ventricular function particularly in the most 
clinically relevant range of 30-65%. 
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Dynamic Multidimensional Visualization of Acquired and Congenital 
Abnonnalltles of the Aortic Valve, Aortic Root and Related Structures 
In Children and Adults: Direct Depiction of the Pathomorphology by 
Transthoracic and Transesophageal 3-Dlmenslonal EChocardlography 
Natesa Pandian, Michael Vogel, ai-Ling Cao, Konrad Buhlmeyer, Jose 
Azevedo, Ramdas Pai, Steven Schwanz and Pravin Shah. 
German Heart Center, Munich, Gennany, Loma Linda Univ, CA, and 
Tufts-New England Medical Center, Boston, Massachusetts. 
Hemodynamic and angiographiC evaluation, and transthoracic and trans•
esophageal echocardiography have become valuable in assessing aortic 
valve (AoV) disorders. However they provide indirect or only 2-dimensional 
data on a 3-dimensional (3D) structure. In this study, we examined the 
clinical potential of a new method, 3-dimensional echocardiography (30E) 
in evaluating AoV abnormal~ies, in 30 pts (wHh a variety of Ao V disorders). 
We used a computerized tomographic u~rasound probe e~her transeso•
phageally (14 aduHs, age 30 - 70 yrs) or transthoracically (16 children, age 
1 wk - 11 yrs), and collected real-time parallel sector images of the heart 
from apex to base, gated to ECG and respiration, at 1 mm intervals (1 
cardiac cycle per mm). Oig~jzed, refonnatted and volume rendered, these 
yielded a 3D cubic data w"h tissue-depiction images. The 3D cubic data 
was segmented to examine either the whole heart or a desired region. 
Employing cutting planes in x, y, and z coordinates, we were able to vis•
ualize the AoV in muHiple dimensions in a dynamic mode. The AoV, LV 
outflow and Ao root were displayed in many longitudinal planes, and in 
addHion, we were able to visualize the Ao V in many novel projections as H 
a surgeon or a pathologist would view the valve from above (simulating 
aortotomy) or from below (simulating ventriculotomy). Besides recognizing 
pathology such as bicuspid valve, congenital and acquired stenoses of 
various degrees (measured as well), nodules and vegetations, we were 
also able to assess the functional morphology of AoV in real-time. Because 
gray-scale data are retained, we were able to ascertain the tissue structure 
as well (calcification, fibrosis, non-calcific vegetation, fenestration) in new 
3D cut-planes and in derived 20 views in any orientation. Abnormalities in 
adjacent regions (sub and supra aortic stenosis, interrupted aortic arch, 
diminished LV function) were recognized in 30E. We conclude that 
dynamic 30E, coupled to 20Echo and Doppler, displays the surgical and 
functional morphology of the aortic valve and related structures, and is 
likely to become the uHimate diagnostic tool in these disorders. 
704-6 11:45 
Evaluation of Aortic DIssection, Aneurysm, Coarctation, and 
Atheroma by Volume and Surface-Renclerecllhree-D1menslonal 
EchocCl'cliographlc Studies Using OmnIpiane Imaging Probe 
Usa Sugeng. QI-Ung Cao. Mani Vannan. Darryl Esakof, Steven 
Schwartz. Glen DeLoid. Mike Gordon and Notesa Pondlan. 
Tuft-New England Medical Center. Boston. Massachusetts. 
3-dimensional echocardiographic (30E) imaging of the aorta (Ao) has been 
shown to be feasible by graded wHhdrawl of a TEE probe in the past. This 
however required mechanical movement of the TEE probe using an outSide 
stepper motor w~h attendant accuracy problems in spatial registration of 
images. The current availability of omniplane probes with automated calib•
rated rotation of the imaging plane w~h a stable probe pos~ion provides an 
opportunity for wider application. In this in vitro study we evaluated the 
potential of30E in evaluating Ao from a rotational approach by deriving the 
basic 20 data set w~h an omniplane probe. In 28 pig Ao trees, the following 
35 lesions were experimentally created: Ao dissection (AD) of three types 
in 15, saccular aneurysms (AN) in 5, Ao coarctation (AC) in 5, thrombus 
(TH) in 5 and atheroma (AT) in 5. With the hearts in a water-bath, the 
omniplane transducer was placed behind at 3 different locations (simulating 
TEE) and from each site, 20E images were collected at every 3 degrees 
from 0 to 180. These were reformatted and segmented in a 30E image 
processing system and volume- and surface-rendered 30E reconstructions 
were performed. Various cutting and clipping planes were employed to 
examine the Ao pathology. ResuHs: High quality 30E was possible in all 
hearts and aortas. The Ao wall, lumen, its branches and all forms of Ao 
pathology were displayed in mu~iple projections. In long~udinal, cylindrical 
and oblique 30E cutplanes, the span of the intimal flap of AD, the size and 
shape of true and false lumens were clearly seen. The site and degree of 
narrowing in AC corresponded well to anatomic realities. The location, size 
and shape of ANs were well recognizable. Layered and protruding TH and 
AT were identified in the 30E in all instances. Besides visualizing these 
abnormalities in cut planes, transparent shading of aortic wall allowed 
visualization of interior abnormalities in intact 3D aortas without employing 
cutting planes. In addition, casts of lumens could be extracted and exami•
ned in muHiple 30E orientations. We conclude that excellent quality 30E 
could be performed with the rotational data collection approach using an 
omniplane probe and that volume and surlace-rendered 30E reconstruc•
tions could be very useful in the clinical evaluation of aortic diseases. 
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705-1 10:30 
Acute Evaluation Of DOD Versus DOOR Mode Predicts Additional 
Benefit Of Rate Adaptive Pacing In Hypertrophic Cardiomyopathy. 
Alistair KB Slade, Phillip J Keeling, Krishna Prasad, Carol Page, William 
J McKenna. Department of Cardiological Sciences, St George's Hospital 
Medical School, London, UK. 
Permanent dual chamber pacing in the DOD mode with short 
atrioventricular delay appears to be effective therapy in patients with 
hypertrophic cardiomyopathy refractory or intolerant to medication. It has 
been demonstrated that a significant proportion (37%) of a consecutive 
population with hypertrophic cardiomyopathy display chronotropic 
incompetence (CI) on exercise testing and that this is associated .with 
significantly worsened exercise capacity. We have evaluated the use of 
DOOR pacing to assess functional restoration of chronotripc response. 
12 patients were evaluated after insertion of temporary pacing wires into 
the right atrial appendage and right ventricular apex. Paced and sensed 
atrioventricular delays were adjusted independently to produce equivalent 
and maximal ventricular pre-excitation. Patients were then exercised 
blindly in either DOD or DOOR mode using an extemal Medtronic Elite II 
pacemaker generator strapped to the chest wall. 
6 patients with CI showed improved treadmill duration [sees] (773 v 666 
secs p < 0.05) and V02max [mls/kg/min](20.7 v 18.2 p < 0.05) in DOOR 
mode as compared to DOD mode. 6 patients without CI showed no 
significant difference between the modes. 7 patients have to date 
received permanent implanted pacemaker generators and have been 
followed out to 3 months where significant further improvements in 
exercise capacity were seen Mean treadmill time [sees]: follow-up 790 vs 
baseline 496, (p < 0.001), V02max [mis/kg/min]: follow-up 21.1 vs 
baseline 17.6, p < 0.02). 5 patients with left ventricular outflow tract 
gradients showed significant reduction with pacing (64 mmHg versus 25 
mmHg p < 0.05). All patients have shown improvements in NYHA class, 
angina and syncope. 
Conclusion. This study suggests that restoration of chronotropic 
incompetence may produce additional objective functional improvement 
over and above that produced by current approaches to pacing therapy in 
hypertrophic cardiomyopathy. 
705-2 10:45 
Acute Pacing Studies are Not Valuable in Predicting Long 
Term Benefits of DOD Pacing for LV Outflow Obstruction in 
Hypertrophic Cardiomyopathy. 
Dorothea McAreavey and Lameh Fananapazir, NIH, Bethesda MD 
We have shown recently that 3 months of dual chamber (DOD) 
pacing relieves drug-refractory symptoms and reduces LV outflow 
gradient (L VOG) in most pts with obstructive hypertrophic 
cardiomyopathy (HeM). We studied whether acute hemodynamic 
changes induced by A V pacing pre implantation of DOD could 
predict which pts would benefit long-term from pacing. 
Seventy-three pts (age 49.±16 yrs) were treated with DOD 
devices for obstructive HCM (L VOG > 30 mmHg at rest) and 
symptoms refractory to verapamil and 8-blockers. Hemodynamic 
indices were measured before and I yr after DOD insertion. 
NYHA functional class status was significantly improved at 
follow-up: 1.4.±0.6 versus 3.2.±O.5, p<O.OOOI. LVOG was 
reduced from 103.±48 mmHg at baseline in sinus rhythm (SR) to 
29.±34 mmHg in DOD (p<O.OOOl). Significant reduction also 
occurred in pulmonary artery (PA) capillary wedge pressure 
(14.±7 versus 16.±9 mmHg at baseline, p<0.05), and mean PA 
pressure (21.±.8 versus 24.±1O mmHg, p=O.02). There was no 
significant change in cardiac output or heart rate. The difference 
in L VOG between right atrial and A V pacing at 120 bpm at 
baseline was 39.±36 mmHg and correlated weakly (r=0.514, 
p<O.OOI) with the difference in LVOG recorded in SR at baseline 
and DOD pacing at follow up (70.±55 mmHg). There was no 
correlation between the acute bemodynamic changes recorded at 
baseline and alterations in other hemodynamic indices or 
improvement in functional status at follow-up. 
Conclusions: The long-term results of DOD pacing are excellent 
and are not satisfactorily predicted by baseline pacing studies. 
This poor predictive value suggests that factors other than 
paradoxical septal motion, eg cellular and molecular modification 
of the myocardium, account for the hemodynamic changes. 
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705·3 11:00 
Dual Chamber Pacing is Effective Therapy for Hypertrophic 
Cardiomyopathy Patients with Provocable LV Outflow Tract 
Obstruction and Symptoms Refractory to Medical Therapy 
Dorothea McAreavey, Neal D. Epstein, Lameh Fananapazir. 
NIH, Bethesda MD. 
We have recently shown that dual chamber {DDD) pacing 
relieves LV outflow obstruction in hypertrophic cardiomyoathy 
(HeM) patients with resting LV outflow tract gradients (L VOTG) 
>30 mmHg. We studied the effect ofDDD pacing on LVOTG 
and symptoms in 10 HCM patients without significant L VOTG at 
rest, but with provocable (Prov) obstruction. 
Patients (47,±IS years, 3 males) were evaluated by exercise test 
(ETT, Bruce protocol) and cardiac catheterization at baseline and 1 
year after receiving DDD pacemakers. Symptoms were improved 
or eliminated in all patients and NYHA functional class reduced 
from 3.1.±0.3 to 1.4.±0.S (p<O.OOOl). ETT duration increased 
from 337.±223 sec at baseline to 484.± 172 sec at follow-up 
(p < 0.02). The hemodynamic findings were: 
Rest LVOTG (mmHg) 
Prov. LVOTG (mmHg) 
Mean PA (mmHg) 
Capillary wedge (mmHg) 
Heart rate (bpm) 
*= p<O.OOOl 
JWd.iJIc 
13.±11 
132.±60 
2O.±8 
13.±8 
84.±22 
Follow-Up (DDD) 
6.±6 
56±46* 
18±10 
13.±8 
80±8 
There was no significant change in cardiac output or LV end 
diastolic pressure. 
Conclusions: Chronic DDD pacing results in significant 
symptomatic and hemodynamic improvement in HCM patients 
with provocable LV outflow obstruction but without resting 
LVOTG. 
705·4 11:15 
Safety of Defibrillator Implantation in Patients with 
Hypertrophic Cardiomyopathy 
Susan O'Donoghue, Edward Platia, Luis Mispireta, Steven Boyce, 
Julio Panza, Dorothy Tripodi, Dorothea McAreavey and 
Lameh Fananapazir, Washington Hospital Center, Washington 
DC, and NIH, MD. 
Patients with hypertrophic cardiomyopathy (HCM) are prone 
to ventricular tachycardia (VT) and sudden death (SD). The 
marked thickening of the LV may hamper ability to successfully 
defibrillate these patients. Extensive testing of defibriIlation 
thresholds is probably also inadvisable. We report on OUT 
experience with automatic defibrillators implanted in 20 HCM 
patients. Twelve were males and mean age was 28 yrs (range, 
14 to S7 years). Thirteen presented with cardiac arrest, 3 with 
syncope and 4 with presyncope. In all patients, a sustained VT 
was induced at electrophysiologic study. The mean LV mass was 
429.±120 gm by 2D and M-mode echocardiography. LV systolic 
function was preserved in all but one patient. No patient had 
coronary artery disease. 
Fifteen patients received an AICD, 3 via the subxiphoid 
approach and 12 via lateral thoracotomy. All patients were 
successfully defibrillated with ISJ at implant testing. Five 
patients received a PCD, 4 with a non-thoracotomy approach. 
All PCD recipients were successfully defibrillated with lSJ. 
There was no operative or hospital mortality. One patient had 
pericarditis requiring medical therapy. During a follow-up of 
29.±19 months (maximum, S years), there have been appropriate 
and successful defibrillator discharges in 4 patients: a 3-year 
cardiac event rate of 20% . 
Conclusions· DefibrilIator implantation can be performed 
safely, and is effective therapy in HCM patients at high risk for 
SD. Problems with elevated defibrilIation threshold, precluding 
use of a defibrillator device were not encountered in this series. 
ABSTRACTS 
705·5 11:30 
Atrio-Ventricular Pacing Relieves Obstruction but Impairs 
Diastolic Fnnction in Hypertrophic Cardiomyopathy 
Sandro Betocchi, Maria Angela Losi, Federico Piscione, Enrico 
Russolillo, Pasquale PerrOlle-Filardi, Leonardo Pace, Marco 
Boccalatte, Marco Salvatore, Massimo Chiariello. Federico II 
University, Naples, Italy. 
Atrio-ventricular pacing (A VP) reduces left ventricular (LV) 
outflow tract gradient (OTG) in hypertrophic cardiomyopathy. AVP, 
however, causes asynchrony (Asy) which may impair diastolic 
function. To test the effects of AVP on both LVOTG and diastolic 
function, we studied 9 patients with hypertrophic cardiomyopathy 
by simultaneous cardiac catheterization (high fidelity LV catheters) 
and high temporal resolution radionuc1ide angiography, during atrial 
pacing (AP) and A VP, at the same heart rate. We measured LV 
systolic pressure (L VSP, mm Hg), L VOTG (mm Hg), pulmonary 
wedge pressure (PWP, mm Hg), time constant of isovolumic 
relaxation (T, ms, variable asymptote method), and peak filling rate 
(PFR., end-diastolic counts/s). Systolic and diastolic Asy were 
computed as the coefficients of variation of time to end·systole and 
to PFR of 4 LV regions (SAsy and DAsy respectively, %). 
LVSP LVOTG PWP I. PFR SAsy DAsy 
AP 156±34 58±22 1l±6 59±34 3.8±1.9 9±4 5±4 
AVP 146±33 26±18 15±5 81±43 3.5±1.5 13±6 8±6 
p= 0.012 0.001 0.010 0.010 N.S. 0.039 0.008 
Conclusion: A VP relieves obstruction in HeM. However, SAsy and 
DAsy rise and are associated with impaired diastolic function, 
shown by the prolongation in T which occurs despite the decrease 
in L VSP, and by the trend to a decrease in PFR despite the 
elevation in PWP. 
705·6 11:45 
Obstructive Hypertrophic Cardiomyopathy Treated by DDD Pacing 
: The M~or Importance of AV Synchrony. 
Daniel Gras, Christian De Place, Christophe Leclercq, Herve Le 
Breton, Philippe Mabo, Claude Daubert. University Hospital, 
Rennes, France. 
DDD pacing has been reported as an effective primary treatment 
in pts with obstructive hypertrophic cardiomyopathy (OHCM). The 
aim of this study is to demonstrate that optimal benefit depends on 
the quality of AV synchrony. 19 pts, aged 2S to 80 years, with 
OHCM and drug refractory symptoms, underwent echodoppler 
studies fLV outflow tract gradient (LVOTG) and transmitral blood 
flow (TMBF») during sinus rhythm (SR) and temporary VDD pacing 
with the longest programmable AV delay (AVD) resulting in 
complete ventricular capture (CVC). 
In 10 pts LVOTGwas abolished (n = 6) or decreased~ 50 % (n -4). 
PR interval in SR was ranged from 120-180 ms, allowing to program 
AVD at 87:t 17 ms (60-140 ms). A wave was correctly synchronized 
at doppler TMBF. 
In the other 9 pts LVOTG was only decreased So 50 % (n • 2) or 
unmodified (n = 7). PR interval was short during SR in 8 (90-120 ms) 
necessitating to program very short AVD (20-50 ms) to achieve 
CVC. The last pt had major interatrial conduction block resulting in 
delayed left atrial activation. TMBF recorded no A wave or very 
delayed A wave during VDD pacing. The first 3 pts were treated by 
surgery but the 6 other by DDD pacing associated with optimization 
of AV synchrony. That was achieved by pharmacological 
prolongation of PR interval in 2 pts, induced complete AV block by 
RF ablation in 3 pts, and atrial resynchronization via simultaneous 
dual atrium pacing in I pt. With a resulting programmed AVD of 
150 ms LVOTG decreased> 70 % in all 6 pts and mitral regurgitation 
(grade II - III) also disappeared in 3. 
In conclusion most of OHCM pts may benefit from DDD pacing 
prOVided to preserve a fully effective left atrial contibution via 
optimal AV synchrony. 
llA 
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706·1 10:30 
Comparison of Single Versus Dual Pathway Biphasic 
Shocks for Defibrillation Using Non·thoracotomy Lead 
System in Pigs 
Zoltan Csanadi. Douglas L. Jones. G. Kim Wood. George J. 
Klein. Department of Medicine. University of Westem Ontario. 
London. Ontario. Canada 
Our group showed that addition of sequential pulses to a 
second pathway and blphasic shocks improved defibrillation 
efficacy using an orthogonal epicardial 4 electrode system. To 
test If similar results can be achieved using non-thoracotomy lead 
systems. we compared defibrillation efficacy of 2 electrode 
systems potentially used for implantable cardioverter defibrillators 
(ICD): a dual pathway system conSisting of superior vena cava 
(SVC). right ventricular (RV) and subcutaneous patch (SO) 
electrodes and sin~le pathway system consisting of RV and SO 
electrodes. Triplicate defibrillation thresholds (OFT) were 
obtained in 10 anaesthetized pigs in a randomized cross-over 
design using both the dual pathway biphaslc shocks (5 msec 
phases separated by 0.2 msec) delivered between RV (S cm2) 
and SO (52 cm2) then between RV and SVC (S cm2) electrodes 
and the single pathway blphasic shocks delivered between the 
RV and SO electrodes. Shocks were delivered from a 200 I1F 
capacitor bank. The mean ± SEM values of peak leading edge 
voltage and current at OFT were not different. The energy at OFT 
was significantly lower for single-biphasic shocks. 
Voltage (V) 
Current (A) 
Energy (J) 
Single-Siphasic 
484 ± 14 
B.l ±O.S 
21.7± 1.5 
Seq.-Siphaslc 
509± 17 
7.4±0.S 
2B.2±3.0 
P 
>0.05 
>0.05 
<0.05 
Conclusion: An additional pathway USing an SVC lead does not 
improve defibrillation efficacy in this biphasic non-thoracotomy 
lead system utilizing RV and SO electrodes. The Impact of 
waveform on OFT seems to be electrode system dependent. 
706·2 10:45 
Determination of Position Sensitivity of a New Subcutaneous 
Electrode for Implantable Defibrillator in Pigs 
John E. Heil. David K. Swanson. Roger W. Dahl. Stephen J. Hahn and 
Douglas J. Lang; Tachyarrhythmia Research. Cardiac Pacemakers. 
Inc .• SI. Paul. MN. 
Endocardial defibrillation (D) systems are commonly supplemented 
by a subcutaneous mesh patch. A new subcutaneous array electrode 
(SQA) has demonstrated better D efficacy. The objective of the study 
was to determine if the SQA was poSition sensitive. The SQA 
electrode. composed of three 15 cm ribbon wires. were applied in 6 
different left thoracic sites to determine the robustness of D efficacy. 
In 6 Isoflurane-anesthetized pigs (35-46 kg). acute D strength 
requirements curves were resolved for each position. Positions: (1) 
between 5th and 8th intercostal spaces (ICS) centered mid-axillary; 
(2) transversely starting on the left sternal margin. equally spaced 
between 3rd and 6th ICS; (3) same as 2. but elements on the right 
spinal margin; (4) placed longitudinally with 3 cm spacing. center 
placed mid-axillary; (5) same as 4. but anterior with 1st SQA element 
left of the sternal margin; (6) radially applied in a 900 fan centered. 8 
cm anterior of the mid-axillary on the 3rd ICS. In all cases the 
endocardial leads were comprised of RV and RA shOCking coils (3.9 
cm2) with RA and SQA cathodically common. D trials were latin 
squared sequenced using a fix tilt (80%) biphasic waveform. D dose•
response curves were fitted to data generated by an up/down protocol. 
50% probability of success values for delivered energy (E50). peak 
voltages (V50). and currents (150) were averaged and compared using 
paired Student -t tests. 
RESULTS; SQA Position 
(1) (2) (3) (4) (5) (6) 
E5O(]) 11.9±3 IO.2±2 II.1±4 11.6±3 11.7±4 12.2±5 
15O(A) 1O.4±1 IO.1±1 9.4±2 I0.4±2 IO.1±2 IO.6±3 
V50(V) 374±40 357±36 360±73 373±61 369±68 382±86 
CONCLUSION; Non-thoracotomy defibrillation efficacy with the 
SQA lead system was not sensitive to left thoracic locations or 
orientation. 
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706·3 11:00 
A Second Subcutaneous Patch Will Increase 
Implantation Rates For Honthoracotomy 
Defibrillators 
Allen J. Solomon, John F. Swartz, David J. 
Rodak, Hans J. Moore, Robert L. Hannan, Ross 
D. Fletcher, Cynthia M. Tracy 
Georgetown University, USUHS, and V.A. Medical 
Centers, Washington D.C. 
Defibrillation, using a nonthoracotomy lead 
system, may be unsuccessful in up to 20% of 
patients, with monophasic waveforms. This 
study prospectively examined the efficacy of a 
second subcutaneous patch in 14 consecutive 
patients (age 62±11 years, ejection fraction = 
0.29±0.12) with high defibrillation thresholds 
(DFT's), defined as ~ 24 Joules. The initial 
lead system consisted of a right ventricular 
(cathode) and superior vena cava lead, and a 
subscapular patch. The subscapular approach 
permits easy positioning of a second patch, 
when necessary. If the DFT was ~ 24 Joules, a 
second subcutaneous patch was added in the mid 
or anterior axillary line. The changes in 
impedance and OFT after the second patch were 
as follows; 
1 Patch 
Impedance (ohms) 72.3±13.3 
OFT (Joules) ~ 24 
2 Patches 
52.2±8.6 
l6.6±2.8 
P 
<0.001 
<0.001 
Conclusion: The second subcutaneous patch 
resulted in a lower impedance and OFT. This 
permitted a successful nonthoracotomy 
defibrillator implant in all patients studied. 
706·4 11:15 
The Effect of Polarity on Defibrillation Threshold Using a 
Non-Thoracotomy Lead System 
S. Adam Strickberger. John D. Hummel. Laura E. Horwood. John Jentzer. 
Emile Daoud. Mark Niebauer. Omar Bakr. K. Ching Man. Brian O. 
Williamson. Fred Morady. University of Michigan, Ann Arlx>r. MI 
Implantable cardiovener defibrillators may be implanted with a non•
thoracotomy lead system. Implantation is sometimes limited by inadequate 
defibrillation thresholds (OFf). The purpose of this study was to determine 
if polarity of a non-thoracotomy lead (N11..) system using monophasic 
shocks. with a proximal and distal shOCking coil (Cardiac Pacemakers. 
Inc.). affects DFf. In each of 16 consecutive patients. the OFf was 
determined twice in random order: with the distal coil as the anode and the 
proximal coil as the cathode. and with the polarity reversed. All shocks 
were monophasic. The DFf was performed using a step-<1own protocol 
(20.15.10.6.3. and 1 joule) and was defined as the lowest energy that 
convetted ventricular fibrillation to sinus rltythm. The impedance of each 
shock was measured and recorded. The mean age of the patients was 
62±14 years and their mean ejection fraction was 27±8%. Eleven patients 
had coronary disease and 4 had idiopathic cardiomyopathy. Ten patients 
presented with cardiac arrest and 5 patients presented with ventricular 
tachycardia or syncope. The results are as follows: 
Distal Cathode/Proximal Anode 
Proximal cathode/Distal Anode 
• p<O.OI (paired t-test) 
DEI. Impedance 
16.4±7.3 5O±6t 
11.7±5.7 5I±5 
t p=NS (paired t -test) 
There were 2 patients in whom the NTL lead system would have 
required a subcutaneous patch to obtain an adequate DFf for implant if the 
DFf had not also been determined with the proximal electrode as the 
cathode. In conclusion. these data suggest that electrode polarity of a NIL 
system can affect the DFf. Specifically. with the proximal electrode as the 
cathode the DFf was 29% lower than with the distal electrode as the 
cathode. The clinical use of these data may allow more frequent 
implantation of a N1L system without a subcutaneous patch. 
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706·5 11:30 
A Prospective Randomized Comparison In Humlns of 60 I'F VI 120 I'F 
85% TIlt Blphaslc Pul .. Defibrillation Using I Unlpollr Pectoral 
Transvlnous Defibrillation System. 
Gust H. Bardy,' Jeanne E. Poole, Peter J. Kudenchuk, G. Lee DoIack, Merrill H. 
Rail\, Gregory K. Jones, Rahul Mehra, Charles Troutman, Jill Anderson, George 
Johnson. University of Washington, Seattle, WA. 
Capacitance is known to influence defibrillation efficacy in animals. There are 
little data, however, identifying the optimal biphasic waveform capacitance in 
man. 
In an effort to inllrove defibrillation efficacy further for transvenous unipolar 
pectorai defibrillation systems, we examined the relative defibrillation efficacy of a 
60 ~ capacitor, 65% tilt asymmetric biphasic pulse compared to a 120 ~ 
capacitor, 65% tilt asyrrvnetric biphasic pulse In a prospective, randomized 
fashion in 38 consecutive cardiac arrest survivors undergoing defibrillator 
surgery. The transvenous unipolar pectoral defibrillation system employs a 
single endocardial RV anodal defibrillation coil and the shell of an 00 co volume 
pulse generator (Medtronic model 7219C PCD 'CAN') as the cathode: 
Rv+ ... CAN". The study showed the following defibrillation threshold findings: 
Capacitance Leading Edge Voltage Stored Energy 
60 I'F 517 :t 128 Volts 8.5 :t 3.4 Joules 
120 J.1F 382 :t 140 Volts 9.9 :t 7.3 JoUles 
p value <0.0001 0.18 
From the above results, we conclude that 60 ~, 65% tilt asymmetric biphasic 
pulses, used with unipolar pectoral defibrillation systems, require higher voltage 
than 120 I'F, 65% tilt pulses but have equivalent defibrillation efficacy with 
respect to stored energy. The slightly higher voltage requirements will not 
compromise existing circuit designs. Thus, use of lower capacitance is possible 
in present implantable defibrillators and creates an opportunity to decrease 
device size and improve ease of use without compromising defibrillation 
efficiency. 
706·6 11:45 
Comparilon or Tbree COIIlIIlerclaDy A.-liable Waveforms DSiDg the 
ENDOT AK Non·thoracotomy Lead System In Pigs 
'GregOl)' P Walcott, Robert G Walker, Eric N Prystowsky, William M 
Smith, Raymond E Ideker, Duke University Medical Center, Durham, 
N.C. and St. Vincent's Hospital, Indianapolis, Ind. 
Most patients can now be implanted with internal cardiovertor•
defibrillators using a transvenous lead system. With a growing number of 
device and lead systems available, choosing the most appropriate 
combination of waveform and lead configuration for a patients is becoming 
more difficult. This study compared three comercially available waveforms 
using single transvenous lead system in an animal model of defibrination. 
Six pigs underwent placement of an ENDOT AK catheter with the 
cathode in the RV apex and the anode at the junction of the RA and the 
SVC. A CPI Ventak model 2815 external defibrillator was used to deliver 
monophasic (MONO) and biphasic (BI-l) waveforms. MONO was a 65% 
fixed tilt lingle capacitor waveform.BI-l was a 60% fixed tilt PI and a 50% 
fixed tilt P2 single capacitor waveform. Average shock duration fOT the 
MONO was 8.0±.S ms and for BI-l was 11.8±0.8 ms. A Ventritex HVS-
02 was used to deliver a biphasic waveform (BI-2). Phase 1 (PI) was a 6 ms 
from a 150 ... f capacitor. Phase 2 (P2) was 6 ms from a 300 ... f capacitor. P2 
leading edge voltage (lev) was equal to 112 PI trailing edge voltage. 
Interleaved probability of success curves were determined using an up-down 
protocol. The DFf for each waveform, determined at the beginning of 
each experiment, was used as the starting point for each curve. 
MONO BI-1 BI-2 
LEV 615+78 V 441±40Vt 521±72 V 
I ave 9.4±1.9 A 7.4±1.6 A 8.5±1.5 A 
TDE 28.4+7.8 J 16.1 +2.9 J* 17.8±6.3 J * 
I ave. average current TOE e total delivered energy 
t sig. lower than BI·2 and MONO .• not sig. different BI-l vs BI-2 
Both biphasic waveforms were significantly better than the monophasic 
waveform in terms of LEV, I ave and TOE. LEV was lower for BI-I than 
for BI-2, though delivered energies were the same. This result is likely due 
to differences in phase 2 in the two devices leading to differences in the 
pha'lC 2 delivered energy. 
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The Mechanism of Reocclusion After Successful Coronary 
Thrombolysis as Validated by Percutaneous Angioscopy 
Kiyoshi Inoue, Hidenobu Ochiai and Keiichi Kuwaki. 
Cardiovascular Disease Center, Tokyo Metropolitan Police Hospital, 
TOKYO. 
A considerable number of patients with acute myocardial infarction 
(AMI) have recurrent ischemia shortly after initially successful 
thrombolysis due to reclasure ar stenosis re-augmentation at the same 
infarct related artery (IRA). In order to understand this in vivo etio•
pathology, percutaneous angioscopic examinations were performed at 
25 IRA sites in AMI patients in whom recurrent myocardial ischemia 
occurred within 48 hours of initially successful (~TIMI grade 2 flow) 
thrombolytic reperfusion by inttavenous toP A. 
Among 19 IRA sites successfully angioscoped, either newly apparent 
thrombus obliterating the lumen (II cases) or complex plaque partially 
covered by thrombus causing ~O% narrowing the lumen (8 cases), 
and thus causing recurrent ischemia was angioscopically witnessed. 
After second thrombolysis, large plaque with interplaque thrombus 
swelling out from its crevasse was observed in 6 cases of reocclusion 
and in 4 cases of stenosis reaugumentation. In 6 of these cases, plaque 
volume was larger than it was when observed immediately after initial 
thrombolysis. 
Our results indicate that both rethrombosis and plaque swelling, 
possibly due to an increase of interplaque thrombosis, are the primary 
causes of both reoccl usion and reaugmentation of residual stenosis 
within a few days of initially successful thrombolysis. 
In conclusion, deep injury which allows blood to enter, produce 
thrombus within the plaque, and increase plaque volume may have an 
impact on reocclusion after initially successful thrombolysis. 
707·2 10:45 
The Impact on Left Ventricular Function of Coronary Reocclusion 
After Successful Thrombolysis For Acute Myocardiat Infarction 
Jonathan S. Reiner, Conor F. Lundergan, James Smith, Steven 
Rohrbeck, V. Krishnaswami, M Castadot, Joseph Perry, David Brown, 
GIC Nelson, Allan M.Rass, for the GUSTO Investigators. The George 
Washington University, WashingtOn, DC 
Previous reports of reocclusion (R) following successful 
thrombolysis have shown a deleterious effect on mortality but no 
confirmation of mechanism. In the GUSTO Angiographic Trial, SS9 
pts had a patent (TIMI flow grade 2 or 3) infarct related artery (IRA) 
at 90 minutes and a follow-up (flu) angiogram S to 1 days later without 
interval PTeA. 33 pIS (5.9%) bad R (TIMI flow grade 0 or I) at flu. 
When pIS with R were compared with those with persistently patent (P) 
IRAs there were no differences in age (63 ± 13 vs. S9 ± 12 yrs). sex 
(70 vs. 81% male) or prior MI (15 vs. 12%) (aU p = NS). There were 
no differences in LV function at 90 min between the group with R vs. 
P [ejection fraction 60 ± 15 vs. 60 ± 14%, end systolic volume index 
(ESVI) 25 ±12 vs. 27 ± 14 ml/m2, mean waU motion in infarct zone -
2.4 ± 1.6 vs. -2.4 ± 1.5 SO/chord, mean number chords more than 2 
SO from normal in infarct zone 20 ± 16 vs. 21 ± 17 chords (aU p = 
NS)]. Compared with 90 min study. at flu the group with R had a 
significant decrease in LV function as measured by change in ESVI (~ 
ESVI) and change in number of abnormal chords (~ chords) 
compared with the P group whose ESVI did not significantly change 
and # abn chords decreased. 30-day mortality for the R group was 
12% vs. 1.1 % for the P p < 0.001. 
P .. < .001 P = :U4 
3.4 
R P R P R 
Conclusion: PIs who undergo R after initially successful thrombolysis 
have significantly increased LV volumes, number of abnormal chords, 
and 30 day mortality compared with pIS who remain patent. 
14A ABSTRACTS 
707·3 11:00 
Fibrinolytic Response of Cultured Vascular Endothelial 
Cells Induced by Addition of Thrombolytic Agents 
Toru Awaya, Akeo Nakazawa, Atsuhiko Hattori, Takuro Suzuki, 
*Fumihiko Miyake, * Asahi Kamogawa, *Haruto Kanda, *Katsuya 
Akashi, *Masahiro Murayama 
The First Department of Anatomy, *The Second Department of 
Internal Medicine, SI. Marianna University School of Medicine, 
Kawasaki, Japan 
Serum levels of plasminogen activator inhibitor· I (PAl-I) increase 
after coronary thrombolysis in patients with myocardial infarction. 
This increase of PAl-I might inhibit the desired effect of the 
thrombolytic therapy. The purpose of this study was to examine 
whether some thrombolytic agents (plasminogen activators) induce the 
release of PAl-I into a cultured medium of human vascular endothelial 
cells (HUVEC). t-PA, Urokinase (UK), pro-urokinase (pro-UK) 
and streptokinase (SK) were added to a cultured medium of HUVEC 
at different concentrations, and the levels of PAl-I antigen released in 
the media were measured. RESULTS: The addition oft·PA, UK or 
pro-UK increa~ed the level of PAJ-J in the medium and was dose 
dependent. The percent increase (vs. control) of PAl-I after addition 
of UK or pro-UK was smalJer than that oft-PA. However, addition 
of SK did not increase the level of PAl-I antigen at any concentration. 
The percentage ch:mge of PAl-I concentration after addition of these 
thrombolytic agents is shown below: 
concentration (ng/mI) 50 H)() 
t-PA +74% +86% 
UK +11% 
pro-UK 
SK 
+14% 
-18% 
500 
+174% 
+26% 
+25% 
-13% 
1000 
+50% 
+61% 
-2% 
Re-occlusion of coronary artery after SK thrombolytic therapy occurs 
less frequently th:m after t-PA therapy. The major reason for this may 
be that SK does not initiate the release of PAI-I from vascubr 
endothelial cells as seen with t-PA and other thrombolytic agents. 
707·4 11:15 
Late Infarct Related Artery Opening after Initially Failed 
Thrombolysis Is Common and Improves Left Ventricular 
Function 
Jonathan S. Reiner, Conor F. Lundergan, J Delean, Yuri A. 
Deychak, Shyuan Cho, Alan Blaker, James O'Toole, John 
Hodgson, Marcel van de Brand, Irwin Silverman, Christopher 
White, Allan M. Ross, for the GUSTO Investigators. The George 
Washington University, Washington, DC 
In the GUSTO Angiographic trial, 147 patients had a closed 
(I1MI flow grade 0 or 1) infarct related artery (IRA) 90 minutes after 
the start of thrombolytic therapy, no intervening angioplasty, and a 
protocol-driven follow-up (f/u) angiogram 5-7 days later. At flu 104 
(71%) had opened (TIMI flow grade 2 or 3) vessels and 43 (29%) 
remained closed. There were no differences in LV function assessed 
at 90 minutes between the late open vs. the persistently closed 
groups; ejection fraction (EF) (58 ± 15% vs. 57 ± 14%), end 
systolic volume index (ESVI) (31 ± 17 mVm2 vs. 32 ± 16 mVm2), 
number of chords in infarct zone less than 2 SO from mean (23 ± 17 
chords vs. 26 ± 18 chords) or % of patients with preserved LV 
function; i.e. no chords in infarct zone < -2 SO from norm (23% vs. 
24%) (all p == NS). At 5 - 7 day flu more patients in the group with 
late open lRAs had preserved LV function (29% vs. 13%, P == .03). 
Other indices of change (A) in LV function between initial cath and 
flu trended in favor of the late open vs. the persistently closed group; 
~EF (-0.79 ± 10% vs. -1.6 ± 11%), ~SVI (0.67 ± 12 vs. 2.3 ± 12 
mVm2), and ~umber of chords in infarct zone less than 2 SO from 
mean -2.9 ± 16 chords vs. -1.1 ± 15 chords). 
Conclusions: 1) A substantial majority (71 %) of infarct related 
arteries, occluded at 90 minutes after lytic therapy, will be open when 
restudied 5-7 days later. 2) There is a small but significant 
advantage in measures of LV function among patients with initially 
failed thrombolysis but subsequent IRA reopening. 
lACC February 1994:1A-484A 
707·5 11:30 
Non-invasive Prediction of Reperfl6ion and Coronary Palency by Continu•
ous ST -segment Monitoring in the GUSTO Trial. 
·Peter K1ootwijk, Mitchell W. Krucoff, Anatoly Lanser, Maarten L. SUnoons, 
Paul W. ArmstronS, for Ibe GUSTO ECG monitorinS substudy 
In Ibe GUSTO ECG ischemia monitoring substudy, 706 patients underwent 
continuous ST monitoring, using MIDA (304 pts), Mortara (237 pts) and Holter 
(165 pis) continuous ECG recordings. 353 patients had simultaneous angioglll•
pby at 90 minutes or ISO minutes following lytic Iberapy. Visual patency 
assessment was predicted from pre-angio ST trends. Presence of 50 % ST recov•
ery from peak ST level before angio wilbout recurrence of ST elevation was 
used to predict patency (angio TIM! 2-3). The absence of 50% ST recovery or 
recurrent ST elevation was used to predict occlusion (angio TIM! 0-1). 75 % of 
patients had 50% ST recovery within 90 minutes from start of Iytics. Median 
times from Iytics to 50% ST recovery were 44, 56 and 34 min. for MIDA, 
Mortara and Holter respectively and did not significantly differ between 
systems. Predictive values (%) for patency (PPV), occlusion (OPY) and overall 
acuracy (ACC) per device were: 
Angioglllphy at 90 or 180 min. I 
Mida Mortara Holter All 
(pts) (188) (88) (77) (353) 
PPV 77 
OPV 52 
ACC 71 
86 
50 
74 
70 
70 
70 
78 
55 
71 
Angiography I Angiography 
at 90 min. at 180 min. 
All All 
(263) (90) 
73 
59 
69 
81 
60 
78 
Pre-angio peak ST levels appeared stronSly related to accuracy of Ibe test. 
Overall accuracy was bigber if pre-angio peak ST levels were > 400 p. V. As 
95 % confidence limits of predictive values for eilber patency or occlusion oflbe 
3 recording devices were wide, no significant difference between systems could 
be demonstrated. We conclude that continuous ECG monitoring predicts 
reperfusion and patency. This non-invasive method may be used for selection of 
patients wilbout apparent reperfusion who may benefit from additional lytic 
Iberapy or rescue PTCA. As time from lytic Ibelllpy to 50 % ST recovery 
appeared short and accuracy of the test was related to preexisting peak ST 
levels, the use of on-line ECG monitoring devices on emergency wards and 
cardiac care units may be warranted. 
707·6 11:45 
Implct of Hospital Protocols on TIme to T .... tment WIth Thrombolytic 
Thel1lPY (Door to Drug TIme) 
'Costas T. Lambrew, W. Douglas Weaver, WilHam J.French, Laura Bowlby, 
Michael Rubison. for the National Registry of Myocardial Infarction (NRMI). 
Portland, ME 
A subset of 524 NRMI hospitals responded to a survey to evaluate existing 
protocols for identification and treatment of patients with ecute myocardial 
infarction (AMI). Median time to treatment with t-PA following hospital anivel 
in 17,646 patients was 53 min. A pre-hospital 12 lead ECG was evailable to 
only 5.2% of hospitals, but decreesed door-drug time from 53 to 48 min (p < 
.001). Door-drug time was slightly longer in the 25.3% of hospitals with a 
Chest Pain Emergency Department (ED)/Evaluation Center, 54 v 52 min. (p 
•. 018). Bedside consultation by a cardiologist prior to drug Initiation was 
required by 23.2% and prolonged door-drug time to 54 min compared to 
consultation by telephonelFAX, at 51 min (p < .001). Emergency physician 
initiation of drug without cardiologist involvement decreased door-drug time 
from 56 to 51 min. (p < .001). The longest delay was imposed by waiting to 
etart the drug in the CCU (75 min.) esopposedtothe ED (50.0 min.). Waiting 
for results of chest Xrey, echo and other laboratory work before initiation of 
drug each significantly delayed drug administration. ECG acquisition by a 
designated person who has to be paged decreased door-drug time (52 min.) 
es opposed to having the ECG done by an ED nurse or physician with other 
responsibilities (55 min.), P < .001. Evaluation of the ECG by the nurse prior 
to the physician decreased door-drug time from 60 to 52 min. Door-drug time 
in the 38% of hospitals that required written informed consent was 55 min. v 
52 min. in those who verbally informed patients (p •. 002). 
Surprisingly, protocols precluding use of a thrombolytic drug in patients with 
~ 6 hours of pain existed in 55% of respondent hospitals and in 30.4% for 
patients over 75 yrs. 
These findings suggest that many emergency department policies and 
protocols significantly impede appropriate, rapid initiation of thrombolytic 
therapy in patients with AMI. 
JACC February 1994:1A-484A 
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708·1 10:30 
Comparison of Exercise and Catecholamine Stress Agents in 
Producing Myocardial Ischemia 
Brian Guth and Kevin Mullane. Dept. of Medicine, University of 
California, San Diego, and Gensia, Inc. San Diego, CA 
Pharmacological stress test agents play an important role in the 
diagnosis of coronary artery disease. The new stress agent, 
arbutamine, was compared to dobutamine and exercise for 
induction of regional wall motion abnormalities (RWMA) measured 
by sonornicrometry in conscious instrumented dogs with a critical 
coronary artery stenosis. Dogs were trained to run on a treadmill 
(from 2·6.5 mph) and to lie quietly during graded infusions of 
arbutamine (0.3·0.82 Ilglkglmin) and dobutamine (5.8-43 
Ilglkglmin). Of 6 dogs tested, one failed to develop RWMA upon 
exercise and was excluded; the other 5 received all 3 tests. At 
matched heart·rates arbutamine and exercise produced 
quantitatively similar hemodynamic changes and RWMA (% 
control), with paradoxical systolic wall thinning of -25 ± 14% and-
30 ± 13% respectively. In contrast, dobutamine elicited larger 
inotropic (p < 0.03) and smaller chronotropic (p < 0.01) responses 
than either arbutamine or exercise, but failed at these doses to 
induce RWMA, instead enhancing function in the ischemic zone by 
35 ± 14%. Moreover, ischemic zone wall thickening (WT) was not 
significantly different to normal zone WT with dobutamine (p=0.1). 
Thus in this study: 1). arbutamine is similar to exercise for inducing 
ischemia; 2). dobutamine is ineffective despite greater inotropic 
aclivity; and 3). chronotropic activity apparently is the major 
determinant of ischemia. 
708·2 10:45 
Does Addition or Dobutamine to Dipyridamole Electrocardiograpbic 
Negative Tests Improve Diagnostic Accuracy of Pbanaacological Stresses 
to Match that Achieved by Routine Exercise Test? 
Milan Nedeljkovic, Miodrag Ostojic, Btanko Beleslin, Ivana Nedeljkovic, 
Rade Babic, Goran Stankovic, Sinisa Stojkovic, ADa Djordjevic-Dikic, Jeleoa 
Stepanovic, Zorisa Petrasinovic, Jovica Saponjski. iDstitute for Cardiovascular 
Disease, Belgrade, Yugoslavia 
The JIIIIPOSe of the study was to determine if Iddition of dobutamine to 
dipyridamole (DIPDOB) stress electrocardiographic Dellative testa could eabance 
the diqnostic value of dipyridamole (DIP) and dobutamine (DOB) stress 
electrocardiography, performed separately. We atudied 219 pts (83" male, mean 
age S2± II yean;) with normal baseline electrocardiogram (ECG). All patients 
UDd_ent coronary angiography and criterion for significant CAD was '" SO" 
diameter stenosis in at least one major coronary artery. There were 113 pts with 
CAD (98 pts single-vessel CAD) and 106 pts without CAD. All patients 
performed exercise stress test (EX), (maximal Bruce treadmill protocol), DIP (up 
to 0.84 IIIIllkg over 10 minutes), DOB (S-40 mcglkg/min) and combined 
DIPDOB (immediate continuation of DOB in DIP negative patients), in random 
order over 4 consecutive days. Criteria for an IhnormaI stress ECG included '" 
Imm of horizontal or downsloping ST -depression or '" hnm ST segment 
elevation at 0.08 sec after J point. Tbe mean maximum rate-pressure product 
during stress tests were 132±30, 179±4S, 186±S8and240±S4mmHg/min/100 
for DIP, DIPDOB, DOB, and EX, respectively (p<O.OS; except DIPDOB vs 
DOB, p-ns). Sensitivity was SO", 43", 70", and 72" for DIP, DOB, 
cumulative DIPDOB, and EX, respectively (DIP vs DIPDOB, p < 0.05; DOB vs 
DIPDOB, p<O.OS; EX va DIPDOB, p=ns). Specificity was 91", 8a, 83%, 
and 8a for DIP, DOB, cumulative DIPDOB, and EX respectively (p~ns). 
Feasibility was 100", 94", 93", and 93" for DIP, DOB, DIPDOB, and EX, 
respectively. 
We conclude that in patients with normal baseline ECG, comhined 
dipyridamole-dobutamine stress electrocardiography improves the diagnostic 
value of conventional pharmacolopcal stress testa for diagnosis of CAD. 
Furthermore, dipyridamole-dobutamine electrocardiography can be used as 
efficient option for diagnosing CAD in patients unable to exercise adequately. 
ABSTRACTS 
708·3 11:00 
Dobutamlne Echocardlograpby ill Single Vessel Coronary Artery Disease : 
Relatlooshlp with Fractional Flow Reserve ud Quaatltatlve Coronary 
Allgiography 
Jozef BartuDek, ADa Oara Rodrigues, "Nico HJ. Pijls, aDd Bernard De Bruyne. 
Cardiovascular Center, Aalsl, Belgium, 'Catharina Hospital, Eindhoven, The 
Netherlands. 
Ohjectives. The aims of the study were : I) to study the relationship between 
functional significance of coronary stenoses and dobutamille-induced wall 
motion abnormalities (WMA) and 2) to investipte the influence of the extent 
of the area at risk on the sensitivity of dobutamine echocardiography (DE). 
Methods. 47 patients with single vessel disease aDd normal left ventricular 
function were studied. Functional severity of coronary stenoses was assessed by 
myocardial fractional flow reserve (FFR,.y.,) calculated from simultaneously 
recorded mean aortic pressure (P..,), central venous pressure (P.) and 
transstenotic pressure gradient (4P, measured by O.OlSpressure monitoring 
guide wire) during maximal hyperemia by the equation: 
F'FR",y. = 1- 4P/(P",-P.). 
% area stenosis (AS), minimal luminal diameter (MID) and reference vessel 
diameter (RD) were determined by the CAAS system from at least two 
ortbogonal projections. RD was considered as aD index of the area at risk. 
ResUlts. DE sbowed overall sensitivity (Ss) of 76% and specificity (Sp) of 88 % 
in detecting AS '" 75%. Ss and Sp for detecting lesions with MID ~ 1 mm 
was n% and 95% respectively. 71% of patients with a F'F'R,... ~ 0.7 developed 
WMA during DE. The incidence (%) of abnormal DE as a-function of FFR,. • 
and RD of the diseased coronary artery is given: y 
RD",3mm RD<3mm 
FFR,.y.> 0.7 0 (0/1) 0 (0/5) 
F'FR",y.~0.7 93 (15/16) 52 (10/19)' 
·p<0.05 vs RD '" 3 mm 
CODeluslons. 1. A F'FR",y. >0.7 is not associated with inducible WMA during 
DE. 2. In functionally significant coronary stenoses (FFR,.y.~O.1) the extent of 
the area at risk greatly influences the accuracy of DE in detecting coronary 
artery disease (as estimated from reference diameter of the diseased artery). 
708·4 11:15 
Accuracy of Dobutamine Stress Electrocardiography in 
the Diagnosis of Suspected Coronary Artery Disease 
John P. Foran, Sandeep Gupta, Steven J. Hare, Ray J. 
Wainwright. Brook Cardiac Unit, London, UK. 
There are few reports and some controversy regarding the 
diagnostic value of 12 lead electrocardiographic recordings during 
dobutamine infusion (D1) in patients with suspected coronary artery 
disease (CAD). We perfonned dobutamine electrocardiography (0-
ECG) using D1, range 5-40 ~cglkgfmin, in a series of 56 male 
patients. mean age (±SD) 55.4±1O.5 (range 29-80) years, referred 
for investigation of CAD. All patients underwent Bruce protocol 
exercise treadmill testing (ElT) for comparison. The development 
of horizontal or down-sloping ST segment depression ",1.Omm at 
J+80 msec was considered positive for myocardial ischaemia. All 
patients underwent quantitative coronary arteriography on the same 
day as D-ECG. CAD (.,sQ% luminal narrowing) was present in 46 
(82%) patients; single-fmultivessel CAD was present in 14132 
patients, respectively. Rate pressure product increase was 
significantly greater during ElT than during D1; 14864±4625 vs. 
8003±4033 mmHg/min, p<O.OOl. D-ECG was positive in 16 
patients and negative in 40 patients. The overall sensitivity, 
specificity and accuracy of D-ECG was 30.4%, 80% and 87.5% 
respectively. The sensitivity was statistically similar in patients with 
single- (35.7%) and multivessel CAD (28.1%), p=NS. ElT was 
positive in 29 and negative in 27 patients. The sensitivity, 
specificity and accuracy of ElT was 54.3%, 60% and 86.2%. The 
sensitivity to detect patients with single- and multi vessel disease 
was 57.1 % and 53.1 % respectively (p=NS). 
In conclusion, D-ECG is insensitive as a diagnostic tool in 
patients with CAD. It is less sensitive than ElT 1p<0.05) in the 
provocation of electrocardiographically detectable ischaemia but 
possesses a higher specificity and diagnostic accuracy. These 
differences, despite significant increments in rate pressure product 
may relate to the different nature of the haemodynamic changes 
induced by these methods of cardiovascular stress. 
15A 
16A ABSTRACTS 
708·5 11:30 
Evidence ror Dift'erent Pathophysiological Mechanisms Underlying 
Dobutamine- and Exercise-Induced Wall Motion AbnonnaJities. 
Georaes H. Mairesse, Thomas H. Marwick, William Wijas, JeII!-Marie 
Detry, Jacques A. Melin, Jell! L. VlDoverscbelde. University of !.ouvain 
Medical School, Brussels, Belgiwn. 
In patients (pis) with coronary artery disease, the dobutamine test (Db) is 
thoueht to provoke myocardial ischemia hy increasing oxy&eo demand for 
extema1 cardiac woric. However, the increment in rate-pressure product (RPP) 
is UlllaiJy las durin, Db than durina classical exercise testina (Ex). This 
study aimed to compare the classical determinants of myocardial oxy,en 
COIISUIIIptioo i.e. heart rate (HR) and systolic blood pressure (SBP), durin, Ex 
and Db two-dimensiooal echocardiography (2DE). Of27 consecutive coronary 
pts, with stress-induced wall motion abnormalities (WMA) durina both Db (5 
to 40 DlCalka/min) IDd Ex (upright bicycle, lOW/min), we selected 13 pts 
with comparable MW A durine both tests (3 points lCaie WMScore in 16 
seemeots, 3.3 ± 1.9 durine Db VB 3.8 ± 1.6 during Ex, p=NS). The onset 
of WMA was determined from continuous tape-recorded 2DE monitoring. 
End-systolic (ESV) IDd end-diastolic (EDV) volumes were calculated at rest 
IDd onset using Simpson's method. ECG signals were computer-averaged 
every minute using the orthogooal lead system IDd the melD ST vector 80 
msec after the ] point (Sn was used to characterize ischemia. AI rest, there 
was no difference (p=NS) in HR, ESV, EDV or ST between Db IDd Ex, 
while SBP IDd RPP were slightly (p < 0.05) higher before Ex. The followin, 
table summarizes the onset characteristics: 
Db Ex tI vslue 
HR(bpm) 95 ± 26 116 ± 17 <om 
SBP(mmHg) 156 ± 22 203 ± 17 < 0.002 
RPP (xlO') 14.9 ± 4.3 23.5 ± 3.8 < 0.001 
ESV (mI) 20 ± 9 18 ± 8 NS 
EDV (mI) 79 ± 10 75 ± 12 NS 
ST (lO"'mV) 7.6 ± 4.4 8.7 ± 5.4 NS 
Thus, ischemia occurs at a lower external cardiac woric with Db than with 
Ex, SUllllesting thai other mechanisms, such as the oxygen-wasting effect of 
catecholamines, might also be involved in dobutamine-induced WMA. 
708·6 11:45 
Increasing Myocardial Oxygen Demand Adding 
Atropine to Dipyridamole Improves Diagnostic 
Accuracy of Dipyridamole Echo-Stress Test. 
Luca Lanzarinl, Raffaela Fetiveau, Arnaldo 
Poli, Antonio Mussini, Mario Previtali. Div. 
Cardiology, S.Matteo Hospital, pavia, Italy. 
Sensitivity of Dipyridamole Echo-Stress 
Test (DIP-E) (0.56 mg/kg+0.28 mg/kg over 10 
min) is unsatisfactory in pts with less severe 
extent of CAD. To improve sensitivity of DIP-E 
we studied 59 consecutive pts (56 m, mean age 
51+/-8 yrs) adding Atropine (ATRO) at the dose 
of 1 mg at the end of DIP infusion in those 
with a negative response to DIP. pts were 
evaluated for chest pain with or without 
previous myocardial infarction (MI) (57%) and 
in the early phase of a recent HI (43%). No 
CAD was present in 4 pts (7%), 1-vessel CAD in 
28/59 (47%), 2-vessel CAD in 16/59 (27%) and 
3-vessel CAD in 11/59 (19%) pts. The results 
are: DIP-E DIP-E+ATRO 
Sensitivity: overall 27/55(49%) 44/55(80%) 
1-vessel 13/28(46%) 21/28(75%) 
2-vessel 6/16(38%) 12/16(75%) 
3-vessel 8/11(73%) 11/11(100%) 
Specificity 4/4 (100%) 3/4 (75%) 
Diagnostic Accuracy 31/59(52%) 47/59(80%) 
Heart rate (HR) and double product (DP) were 
significantly increased by ATRO in pts with 
DIP-E+ATRO positive results (HR (bts/min) : 
65+/-10basal; 85+/-11DIP-E;102+/-17DIP-E+ATRO, 
p<.OOl) (DP (mmHg.bts/min) : 8370+/-1450basal; 
10400+/-2400 DIP-E; 13700+/-3580 DIP-E+ATRO, 
p<.OOl). No significant side effects were 
induced adding ATRO to DIP. 
In conclusion: ATRO may increase diagnostic 
accuracy of DIP-E particularly via an increase 
of sensitivity in 1 and 2-vessel CAD. 
JACC February 1994:1A-484A 
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Antiseme eDNA Transc:ription of lnsuUn·Uke Growth Factor I 
Receptor lnhJbits Vasc:ular Smooth MU8cle Cell Growth. 
Jie Du, Patrick Delafontaine, Division of Cardiology, Emory 
University, Atlanta, GA 
Insulin·UJre Growth Factor 1 (IGF I) Is an imponant mitogen for 
vascular smooth muscle cells (VSMC) and exerts ilS effects after 
binding to a speclflc cell·surface receptor (IGF IR). To characterize 
the role of the IGF IR in VSMC growth, we cloned a eDNA encoding 
the entire rat IGF IR precursor. A 1.1 kb eDNA probe generated 
using PCR was used to screen a Lambda gt 11 eDNA library from rat 
brain. Nine overlapping clones were obtained yielding a 5.2 kb 
eDNA which encompassed the full coding sequence of the rat IGF IR 
precursor. To study the effect ofIGF IR inhibition on VSMC growth, 
we subcloned a 1.0 kb antisense construct intO an Ebstein Barr virus 
based episomal vector with a cytomegalovirus promotor/enhancer. 
Early passage rat aonic smooth muscle cells (RASM) were stably 
transfected with this construct (AS) or with vector alone (C). 
Southern analysis of hygromycin-resistant clones conflnned the 
presence of vector sequence and Nonhem analysis indicated high. 
level expresSion of the 1.0 kb transcript in AS cells. 1l51_IGF I 
radioligand binding and ['HI·thymidine incorporation studies were 
perfonned in parallel in RASM grown in the presence of 10% calf 
serum. There was a 61% decrease in IGF IR number in AS (39.5 ± 
11.5 fmol/lO' cells) compared with C cells (102 ± 4.4 fmo1!IO' cells), 
whereas binding·affinity did not change (K., AS, 7.5 ± 2.9 nM, Ko C, 
10.2 ± 1.2 nM). The decrease in IGF 1 binding sites in AS cells 
correlated with a 56% inhibition in DNA synthesis - AS, 635 ± 93 
dpm/lO' cells, C, 1382 ± 240 dpm/IO' cells. Thus, antisense IGF IR 
eDNA transcription downregulated IGF IR number and markedly 
blunted the growth response ofRASM to 10% serum. These fmdings 
establish that the IGF IR is critically imponant for serum-induced 
growth of VSMC in vitro and suggest a key role for this receptor in 
proliferative responses ofVSMC in vivo. 
709-2 10:45 
Proliferative Response of Human Vascular Smooth 
Muscle Cells Incubated in Male Serum is Partially 
Inhibited by Estradiol 
Douglas W. Losordo, Elizabeth KIm, James Symes, Joseph Stetz, 
Jeffrey M. Isner, St Elizabeth's Medical Center, Boston MA 
We perfonned an investigation to test the hypothesis that the 
atheroprotective effect of circulating estradiol(Ez) is mediated in part 
by direct effects on cells of the arterial wall. Human vascular 
smooth muscle cells(hVSMC) derived from artery segments 
obtained at the time of coronary bypass surgery, were grown in cell 
culture. Subconfluent cells were exposed to serum·free medium 
supplemented with one of the following: pooled serum from male 
donors(E2 content 40 pglml ~ 1.5 x to-10M), pooled serum from 
pre-menopausal female donors(E2 content 270 pglml ~ to-9M), 
pooled serum from male donors supplemented with Ez(IO-7M). 
Tritiated thymidinerH-Thy) was added to the culture plates, 24 hrs 
H·1bymidiae 
lDcorpomiOD 
(cpm) 
0-6 
,..,-r="'I"":::;::::"'F'-' after the addition of the serum 
supplemented medium. 3H•
Thy incorporation was then 
assayed by scintillation 
counting 24 hours later. 
Human VSMC incubated in 
male serum demonstrated 
significantly greater 
proliferative activity, as 
ascertained by 3H-Thy 
incorporation, than incuba.ted in female serum. When Ez 
was added to the male serum and incubated with the hVSMC, 
however, the proliferative activity of the cells was significantly 
reduced. Cell counts of all treatment groups were equal 72 hrs later, 
consistent with a suppressive, rather than toxic effect of E2. 
Conclusion: E2 exerts a direct anti-proliferative effect on hVSMC. 
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709-3 11:00 
Presence of C-Type Natriuretic Peptide in Human Kidney 
and Urine 
Michael T. Mattingly. Roland R. Brandt. Denise M. Heublein. Chi•
Ming Wei. Amiram Nir. John C. Burnett. Ir. Mayo Clinic and 
Foundation. Rochester. MN 
Atrial natriuretic peptide (ANP). brain natriuretic peptide (BNP) and 
C-type natriuretic peptide (CNP) are a family of natriuretic peptides 
which mediate their biological actions through a family of paniculale 
guanylyl cyclase receptors in the regulation of cardiorenal function. 
CNP. the newest member of this natriuretic peptide system. shares 
structural homology with ANP and BNP and has been shown to be 
natriuretic in rats and vasoactive in multiple species. Recently. CNP 
immunoreactivity has been found in human plasma and vascular 
endothelial cells. In addition. studies from our laboratory and others 
suggest that CNP is produced in cultured renal epithelial cells of non•
human origin. To date. the presence of CNP in the human kidney and 
urine remains undefined. The current study was undenaken 10 
investigate the presence of CNP immunoreactivity in both human 
kidney and urine. Immunohistochemical staining with an indirect 
immunoperoxidase method utilizing an antibody which is 100% cross•
reactive to both CNP-S3 and CNP-22 was performed on five human 
kidney specimens (three biopsies of normal cadaveric donor kidneys 
and two of normal autopsy specimens). CNP immunoreactivity was 
positive in both proximal and distal tubular cells in a perinuclear and 
granular staining pattern. CNP immunoreactivity was also determined 
in the urine of five healthy volunteers utilizing a sensitive and specific 
double-antibody radioimmunoassay with a mean concentration of 
10.8 ± 2.1 pg/ml. With the utilization of high pressure liquid 
chromatography. this immunoreactivity proved to be consistent with 
CNP-S3. the probable pro-hormone of mature CNP-22 which was 
also present in urine in smaller amounts. 
This study demonstrates for the fim time the presence of CNP 
immunoreactivity in human kidney and suggests that renal tubular cells 
may be an additional non-vascular site of synthesis for this cardiorenal 
acting peptide. 
709-4 11:15 
Secretion of Atrial Natriuretic Peptide from Cultured 
Human Aortic Endothelial Cells 
Roland R. Brandt, Denise M. Heublein. Michael T. Mattingly. Mark 
R. Pittelkow. John C. Burnett. Jr. Mayo Clinic and Foundation. 
Rochester, MN 
Endothelial cells produce vasoactive factors which interact with 
vascular smooth muscle cells in the regulation of vascular tone and 
growth. Atrial n~triureti~ peptide (~) is a natriuretic. vasoactiye. 
and antimitogemc pepude synthesized and secreted from cardiaC 
myocytes. The present study was undenaken to investigate the 
presence and secretion of ANP immunoreactivity from human aortic 
endothelial cells (HAEC). HAEC were grown in culture flasks 
containing epidermal growth factor (10 ng/m!). hydrocortisone (1 
j.Lg/ml). fetal b9vine serum (2%). gentamicin (SO j.L~ml). and 
amphothericin-B (SO j.Lglml). HAEC reached confluence m 4-6 days. 
Cell extracts were obtained 24 hours after HAEC reached confluence 
by gently scraping the cells from the culture flask followed by 
sonication. The resulting suspension was centrifuged and the 
supernatant assayed for ANP immunoreactivity utilizing a sensitive 
and specific double-antibody radioimmunoassay without extraction. 
ANP immunoreactivity was present in the cell extracts with a mean 
concentration of 477.S±34.S pg/ml. ANP immunoreactivity was also 
detectable in the cell culture medium at a concentration of 92.S±3.S 
pg/ml and was significantly greater than any detectable 
immunoreactivity in buffer or culture medium without HAEC. 
These findings demonstrate for the first time that vascular 
endothelial cells in addition to cardiac myocytes secrete ANP. ANP 
production by endothelial cells may be consistent with ANP 
functioning as a paracrine factor in the regulation of vascular tone and 
smooth muscle cell growth. 
ABSTRACTS 
709-5 11:30 
Age-Related Decreases in Il, Receptor mRNA Abundance in Human Heart. 
Michael R. Bristow. Wayne A. Minobe, Mary V. Raynolds, Robert L. Roden, 
J. David POlt, Arthur M. Feldman, University of Colorado Health Sciences 
Center, Denver, CO 
We have previously reported that ~, adrenergic receptor density declines with 
age in the human heart. The purpose of the current study was to test the 
hypothesis that the decline in ~I receptors is related to a decrease in the steady•
state abundance of P, receptor mRNA. PI receptor mRNA was measured by 
quantitative PCR (QPCR) using reverse transcribed poly(A)+ -enriched RNA 
extracted from left ventricular aliquots obtained from 14 organ donors age 1-71 
years. Identity of the QPCR product was continued by direct PCR sequencing. 
Measurements of mRNA abundance by QPCR were in agreement with those 
measured by RNase protection using a riboprobe derived from the 3' untranslated 
region of the human P, receptor cDNA. PI and P2 receptor density was measured 
by CGP20712A112SI-ICYP competition curves. The relations between age and III 
receptor mRNA abundance or III receptor density are given below. (e=mRNA. 
.=receptors ) 
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112 receptor density and 112 receptor mRNA abundance measured in total RNA by 
QPCR did not correlate with age (both p=NS). 
Condusion. There is a statistically significant inverse correlation between age 
and ~I mRNA abundance, as well as between age and III receptor density. The 
age-related decline in III receptor density in the human heart is likely due to 
decreased steady-state abundance of III receptor mRNA. 
709-6 11:45 
Adrenomedullin (ADM): A novel vasodilator 
peptide. 
Albert L. Hyman, Jaw-Rang Chang, Qingzhong 
Hao, and Howard L. Lippton, Tulane and LSU 
Medical Schools, New Orleans, LA and Peninsula 
Laboratories, Belmont, CA. 
ADM is a 52 amino acid peptide released 
by pheochromocytoma tissue and is secreted by 
the human lung, kidney and adrenal gland. We 
studied the effects of ADM'.'2' ADM13•s2 , and ADM,.s2 
on the pulmonary (PUL) and systemic (SYS) 
vascular beds of the intact anesthetized cat. 
Since PUL blood flow and left atrial pressure 
were held constant, changes in lobar arterial 
pressure directly reflect changes in PUL 
vascular resistance. Under conditions of 
elevated PUL vasomotor tone induced by U46619 
(a thromboxane A2 mimic) intralobar arterial 
bolus injections of ADM,.s2 and ADM13•s2 (10-300 
nanog) produced similar, dose-dependent 
decreases in lobar arterial pressure. These 
injections also decreased SYS arterial 
pressure, mildly increased cardiac output, and 
markedly decreased SYS vascular resistance. 
ADM'.12 had no PUL or SYS vascular effect. The 
present data demonstrate ADM, a newly•
discovered peptide in man, is a potent 
vasodilator substance in the PUL and SYS 
vascular beds. The present data suggest that 
only a fragment of the ADM molecule excluding 
the amino-terminus is necessary for 
vasodilator activity. Results from these 
experiments suggest that ADM may represent a 
new vasodilator system in vivo. 
17A 
18A ABSTRACTS 
840 Local Drug Delivery for Prevention of 
Restenosis 
Monday, March 14, 1994 Noon-2:00 PM 
Georgia World Congress Center, Hall H 
Presenting Hour: Noon 
840·26 
Efficiency of Solute Transfer by a Microporous Balloon Catheter in the Porcine 
Coronary Model of Arterial Injury 
A. Michael Lincoff,Joseph G. Furst, Marc S. Penn, PhilmoLee,Andrew I. MacIsaac, 
Guy M. Chisolm, Eric J. Topol, Stephen G. Ellis. The Cleveland Clinic Foundation, 
Cleveland,OH 
A microporous balloon catheter (MPBC) has been developed to deliver high 
concentrations ofphannacologic agents to the arterial wall. To quantitatively assess 
the efficiency (EFF) of solute transfer by this device in the porcine coronary model 
of vascular injury, horseradish peroxidase (mw = 44 ill, 10 mglmJ) (HRP) was 
administered following balloon overexpansion injury in 2-3 arteries of each pig 
under 4 conditions: 1.5 cc locally at the coronary injury site during each of3 MPBC 
inflations (Group A, n = 9 vessels), 1.5 cc locally during I MPBC inflation (Group 
B, n = 5),4.5 cc infused subselectively without the MPBC into the coronary artery 
(lntracoronary Control- Group C, n = 6), and 4.5 cc infused intravenously (Systemic 
Control - Group D, n = 6). Vessels were fixed within II ± 3 min ofHRP delivery. 
Radial concentrations ofHRP reaction product in the arterial media were quantified 
against known standards by measurement of light transmission through the tissue 
section; EFF was calculated as the ratio of medial to infusate concentrations, 
corrected for the distribution coefficient ofHRP in arterial media (assumed 37.5%). 
HRP Uptake Efficiency ("10) 
1.5 ...--------------, 
Group A 
0.5 Gr~8 
Gr~C 
a Gr~D 
a 40 80 120 
Media Depth (microns) 
Thus, solute can be transported througbout the coronary media by the multiple 
infusions with the MBPC. Efficiency, although 20-40 fold superior to intravenous 
or intracoronary control infusions, is low (-I %). These findings have implications 
for optimizing delivery of agents to prevent restenosis. 
840·27 
Sustained Local Drug Delivery by a Novel Intravascular Eluting Stent til 
Prevent Restenosis in tbe Porcine Coronary Artery 
A. Michael Lincoff, Joseph G. Furst, Stephen G. Ellis, Eric J. Topol. Cleveland 
Clinic Foundation, Cleveland, Ohio 
Previous polymeric implants for local intravascular drug delivery have been 
limited by marked inflammation or poor release kinetics. To assess the feasibility 
of sustained drug delivery from anew eluting stem, the effect of local administration 
of dexamethasone (DEX) on neointimaI proliferation following arterial injury in the 
porcine coronary artery was evaluated. A tantalum wire coil stent was coated with 
a20-25 micron thick layer of DE X (mean 0.8 mg) suspended within a binder of poly -
I-lactic acid (PLLA) (m.w.= 321 ill). Uncoated stenls (CONTROL), PLLA coated 
stenls (polymer control), and DEX-PLLA coated stenls were overexpanded by 30-
50% to the normal coronary arterial diameter in 8, 4, and 5 animals, respectively. 
Serum DEX levels following deployment of 3 stenls per animal suggested 
sustainedin~release,decliningfrom 201 ±46to 105±54ngldI at I and 28 days 
post-implantation, respectively. Nevertheless, quantitative histology at 28 days 
follow-up demonstrated no difference between the 24 CONTROL, II PLLA, and 15 
DEX-PLLA treated vessels in the linear relationship between Mean Neointimal 
Thickness and "Injury Score" [0 = no internal elastic lamina(IEL) laceration, I = IEL 
laceration, 2 = media laceration, 3 = external elastic lamina laceration]. 
Mean Neolntlmal Thickness (mm) 
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Importantly, the tissue 
responses to coated (pLLA 
or DEX-PLLA) and 
uncoated (CONTROL) 
stents were identical: 
uniform smooth muscle 
cells in a homogeneous 
extracellularmatrix. PLLA 
polymer did not evoke an 
inflammatory reaction. 
Thus, although this current 
dosage of DE X did not limit neointimal proliferation in the stented porcine coronary 
injury model, the coated eluting stent proved to be an effective and well-tolerated 
means of intravascular sustained drug delivery. Studies are continuing to evaluate 
this novel drug delivery system. 
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840·28 
Delayed Re·exposure or Injured Arterial Sub·Intima to Blood 
Via Erodible Hydrogel Barriers Limits Neointimal Hyperplasia 
Marvin 1. Slepian and Stephen P. Massia. Univ Heart Center - Univ 
of Arizona-Tucson Veterans Affairs Medical Center. Tucson. A2 
Localized platelet deposition and thrombus fonnation at sites of 
arterial injury appear to be imponant contributory events leading to 
the development of neointimal hyperplasia. We recently 
demonstrated that bioerodible polyether hydro gels applied to 
injured arterial sub-intima fonn adherent transient physical 
barriers limiting arterial surface-blood contact and subsequent 
thrombus fonnation. In this study we examined whether these 
thromboprotective hydrogels. applied immediately following 
balloon abrasion. would alter the degree of neointimal hyperplasia 
development at 14 days in the rat. In II rats (male, 350g.) a 
segment of the carotid artery was isolated. washed free of blood. 
and balloon abraded (2fr Fogarty x3). In SIll rats blood flow 
was then immediately restored ( non-polymer coated controls). In 
6/11 rats a layer of polyether hydrogel was applied to the injured 
segment following which blood flow was restored (care was taken 
to prevent injured surface re·exposure to blood until after polymer 
was applied). No anti-platelet agents or anti-coagulants were 
utilized. At 14 days rats were sacrificed, carotid arteries pressure 
fixed and mean intima and media thickness detennined. ~
The mean intima/media ratio (11M) of control balloon abraded 
aneries was 2.09 ± 0.54. In abraded-polymer coated arteries 11M 
was 0.49 ± 0.08 (p<O.OOI). Polymer coating lead to a 77% 
reduction in the degree of neointimal hyperplasia development. 
There was no significant change in media thickness between the 
groups. ConclusjoD' The physical limitation of early contact 
between injured arterial sub-intima and blood, via the application 
of a bioerodible polyether hydrogel barrier coating, leads to 
reduced neointimal hyperplasia following injury. Further 
development of this approach may lead to viable prophylaxis 
against restenosis post PTCA. 
840·29 
Local Delivery of r-Hirudin by a Double Balloon Perfusion Catheter 
Inhibits Platelet Deposition Post Angioplasty. 
Beat Meyer, Antonio Femandez-Ortiz, Valentin Fuster, Alessandra 
Maiihac, Tony DonMichael, James Chesebro, Lina Badimon, Juan 
Badimon. Cardiac Unit,Massachusetts General Hospital,Boston, MA. 
The effects of local delivery (LO) of r-Hirudin (r-Hir) on acute platelet 
deposition on severely damaged vessel wall was studied in the porcine 
model. Deep arterial injury was induced by carotid balloon angioplasty. 
Local delivery (LO) was achieved through a newly developed (Cordis 
Corp) dual balloon perfusion catheter (OBPC). The device consists of two 
separately inflatable balloons creating a protected space where the drug 
is instilled through a central port, and of an internal perfusion conduit 
(flow: 55 m1/min). Bilateral angioplasty was performed with a 8 mm 
balloon in animals under perioperative systemic treatment with heparin 
(100 IU /Kg ± 100 IU /Kg/h) (Group I), or r-hir (0.3 mg/Kg :to.3 mg/Kg/h) 
(Group II). Immediately after angioplasty one carotid was locally 
treated through the DBPC with 0.3 mg/Kg r-Hir (volume 1 mI) for 1 
hour, while the contralateral carotid was the control (receiving only 
systemic treatment). Another group (Group ill) was treated with a high 
systemic concentration of r-hir (0.7 mg/Kg ± 0.7 mg/Kg/h) for comparison. 
Acute PO on angioplasty-induced deep injury (confirmed by histology) 
was evaluated by 111- In-labeled platelet one hour after reperfusion . 
Results are expressed as PDxl06/cm2 (X±SE). Levels of anticoagulation 
were measured by aPTT and expressed as ratios vs baseline. 
PD/OIrotjd Gmyp! GroupD Group ill 
With LO 15.1 ± 2.5 11.3 ± 2.5 
Witlxrut LD 7l.2 + 194 85.5 + 17 7 14 l± 2.3 
p< Q.(6 p<1lffi 
aPJT 26+ 0.5 19+ Q.2 22 + 0 6 
Local delivery of r-Hir with OBPC results in a Significant reduction of 
acute PO following balloon angioplasty with respect to systemiC 
treatments within therapeutic range drug regimes, reaching PO values 
obtained with higher systemic r-Hir administration. Therefore, LD is 
feasible and provides antithrombotic protection with a significantly 
lower blood drug concentration reducing the risk for potential side effects. 
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840·30 
In vivo Endothelial cell Seeding after Completa Vascular 
Denuding In a Porclna Modal 
Cari W. Chrislensen, Nelson E. Gencheff, C. Thomas Gaeckle, 
Michelle A. Rieder, Peter I. Lelkes, Dawn M. Chick, Eve L. 
Siiverslein, Donald H. Schmidt, University of Wisconsin, 
Cardiovascular Disease Section, Sinal Samaritan Medical Center, 
Milwaukee, WI. 
Restenosis (RS) after angloplasty or directional atherectomy occurs 
in 3a-..O% of the population. The pr1mary mechanism is thought to 
be due to the loss of functional endothelial cells (EC) with subsequent 
Intimal proliferation. We hypothesized that RS could be reduced or 
prevented by re-eslabllshment of the EC lining following complete 
denudation. In two porcine we completely denuded an Isolated 
segment In both iliac arteries using 0.2% collagenase incubated for 
15 minutes. We then attempted to reseed one iliac artery segment 
with porcine EC in vivo using percutaneous catheter placement. Two 
million EC derived from porcine pulmonary artery were labeled with a 
fluorescent DNA marker and incubated in vivo in the Isolated 
segment of the contralateral iliac artery. The animal was rotated 90· 
in each direction from dorsal recumbancy and reseeded every 1 S 
minutes for a total of 45 minutes. The non-seeded iliac artery served 
as a control. After seeding, complete blood flow was resumed for 60 
minutes after which both vessels were harvested for scanning 
electron microscopy and fluorescence microscopic analysis. 
The non·seeded segment exhibited significant (100%) thrombus 
tightly adhered to the denuded vessel wall. The seeded segment was 
thrombus free and exhibited M±5% seeding with the labeled EC after 
60 minutes reperfusion. EC were uniformly distributed over the major 
portion of the vessel with the dorsal area least seeded. The results 
suggest in vivo seeding may be easily achieved by the techniques 
used. This technique may have potential in the reduction of RS in 
vessels post angioplasty or atherectomy. 
840·31 
Locally Delivered Microspberes iD Atherosclerotic Arteries Via a New 
CbaDDeled Balloon PTCA Catbeter Are RetaiDed latramarally For At 
last .)4 HOUTS 
Mun K. Hong, Andrew Farb, S. Chiu Wong, Moshe D. Mehlman, Renu 
Vinnani, -James J. Barry, Martin B. Leon. Washington Hospital Center and 
Anned Forces Institute of Pathology, Washington, DC 
Using a new balloon PTCA catheter with intrtunlUal channels containing 100 
micron exterior pores for simultaneous local drug infusion at low pressure, we 
previously characterized in normaJ and atherosclerotic arteries the local drug 
delivery properties of small tracer agents (0.005 micron). ~ (I) To 
determine whether larger agents, such as microspheres that can be impregnated 
with drugs for prolonged local effects, can be delivered via the channeled 
balloon; and (2) To study inttamural retention of microspheres over time. 
~ 13 rabbits with balloon injury and diet-induced atherosclerosis 
underwent simultaneous PTCA at 6 81m with local infusion of I ml of Cel ' l -
labelled microspheres (15 micron; equivalent to I UCi) at 2 atm in one i1iac 
artery (infusion time=94 ± 13 seconds) and I mI of fluorescent microspheres (3 
micron) at 2 atm in the contraIateral iliac artery (infusion time: 167 ± 64 
seconds). Rabbits were sacrificed acutely (0=4), at 4 hours (0=5), or at 24 hours 
(n=4) after the procedure. The iliac arteries and lower aIx10minal ama (control 
segments) were harvested and immersion fixed (CeI41_labelled microspheres) or 
quickly frozen (fluorescent microspheres). BwIll6.:. PTCA "effect" (plaque 
dissection and intimal disruption) was seen in 17/1fJ arteries. Mean radioactivity 
in the Ce141_tteated segments (vs. control segments) was 3.3x acutely, 1.7x at 4· 
hours, and 2.9x at 24-hours. There was no detectable radioactivity in the blood 
at pre- or post-procedure and at the time of sacrifice in any of the animals. The 
fluorescent microspheres were equally distributed in both the plaque and 
adventitia in 12 of 13 treated arteries and were seen in PrCA dissection planes 
in 7/12 (58%) arteries. CollclgsiDlIs' Via the dual purpose (PTCA and drug 
infusion) channeled balloon catheter: (I) Microspheres (up to IS micron) with 
potential as drug carriers can be delivered with ttansmural penetration in 
atherosclerotic vessels; (2) InttamuraJ microsphere retention did not vary 
appreciably with time over the fU'St 24 hours; and (3) Local microsphere 
delivery may preferentially favor sites of greatest PTCA-induced injury (ie., 
dissection planes). 
ABSTRACTS 
840·32 
Mlcrospberes for Drug Delivery to the Arterial Wall: A Stody of KInetics, 
Toxicity aad ElTects of Corticosteroid Loaded Mlcrospberes 
Visbva Dev, Hao Zeng, James S. Forrester, Neal Eigler, Youqin Tian, 
Antbony J. Hickey, Michael C. Fisbbein, Joel KUpfer, Frank Litvack, 
Cedars-Sinai Medical Center, Los Angeles, CA and University of Dlinois, 
Cbicago 
Biodegradable microspberes (uS) are a potential vebicle for local drug 
delivery. This study was designed to evaluate: (1) kinetics of delivery and 
persistence of polylactic acid (PLA) uS (size 1-5u) using microporous 
balloon (2) tissue response to PLA uS (3) the effect of steroid loaded uS 
on tbe vascular wall. To evaluate efficiency of delivery and residence time, 
we delivered 2 mI of 2 mglml suspension of Rhodamine B (R) loaded micro•
spheres (R content 10%) to the rabbit carotid artery (n=14). R (4 mg) 
without uS was delivered into tbe contralateral artery as control. Animals 
were sacrificed at 0, 4, 24 and 72 bours and at 1, 2 and 4 weeks and 
fluorescent microscopy was performed. To study tissue response to PLA, 
unlabelled uS were delivered into the carotid arteries of 6 rabbits. Two mI 
normal saline under similar conditions was delivered to the contralateral 
carotid as control. To study effect of steroids, dexamethasone (0) loaded 
microspheres (D content 0.4 mg) were delivered to carotid arteries of 
another group of 3 rabbits. Histopathology studies were performed at 1, 2 
and 4 weeks. Results: Fluorescent microscopy showed circumferentially dis•
tributed uS throughout the vessel wall. Fluorescent uS persisted in the vessel 
wall for 4 weeks. In the arteries infused with R solution without uS, 
fluorescence disappeared at 72 hours. Serial histopathologic studies in 
arteries infused with unloaded uS showed mild inflammatory cell infiltrate 
around the uS with mainly polymorpbonuclear cells at 1 week and 
macrophages at 4 weeks. There were a few scattered inflammatory cells in 
the saline treated control arteries. Arteries infused with D loaded uS did not 
show any inflammatory cell infiltrate. Conclusions: PLA microsph -res 
delivered by porous balloon remain in the arterial wall slowly discharging 
lipophilic drugs for up to 4 weeks. The microspheres induce a mild 
inflammatory reaction which can be prevented by loading them with 
dexamethasone. 
840·33 
LoaU,. DeUvered Platelet Eacap.alated Doproat IIlblblta Carotid 
N_ IIltl_1 Hyperp ... l. loUowlal 1.1I00a Aactopluty III Pip. 
Adrian P Banning, Peter H Groves, Lesley Brewer", Malcolm J Lewis, Hi1ary 
Cbeadle, William J Penny, Neville Crawford". Department of Cardiology, 
University Hospital of Wales, Cardiff and Department of Biochemistry-, Royal 
Free Hospital, London. 
EIectroporation using high voltage discharge pulses, generates transient pores iD 
\be surface membranes of platelets. Eltposure of platelets 10 drugs followed by 
resealing at 37C leads 10 encapsulation of the drug within the p1ateIet cytosol. 
Targeting anli-p1ateIet, anlithrombotic &lor anti-proliferative drugs 10 vesaeI wall 
lesions can be achieved by exploiting the platelets naturaI haemostatic propetISity 
lIoprost (a stable prostaCyclin analogue) elevates intraeellular cAMP whicb 
inhibits smooth muscle cell proliferation in vitro. We studied the administratiOl 
of autologous i1oprost-loaded platelets using a new 4 lumen double ballOOl 
catheter (USCl) in a poo:ine model of carotid angioplasty. 30 pigs (mean weight 
3Okg) were randomised to receive either i10pr0st loaded or sbam (e1ectroporation 
alone) platelets. Pigs underwent biIateral carotid angioplasty using \be proximal 
angioplasty balloon. The site of injury was then isolaled by proximal movement 
of \be catheter and inflation of both balloons at low pressure. Each artery then 
received 0.8m1 of autologous platelets via the delivery ports. Carotid arteries 
were removed at 7 days (0=10, 5 sbam,5 i10pr0st) or 21 days (0=20,10 sham,10 
i1oprost) and sections taken for histology (n=6 eacb artery). Rupture of the 
internal elastic lamina ([EL) has been shown to promote intimal thickening and 
using pIanimetry, arteries were therefore classified as either superficially injured 
(intaCt IEL) or deeply injured (ruptured IEL). At 7 days no difference between the 
tteatment groups was observed. However at 21 days there was a significant 
reduction in the i1oprost group in both intimal area (O.lI±O.04 vs O.l6±O.01, 
p=<O.05) and intimallmedial ratio (0.029±O.01 vs O.04I±O.02, p<O.05) in the 
superficially iDjured arteries. No significant differences were observed belween 
treatment groups in the deeply injured arteries. Local delivery of iloprost to the 
lire of injury usin8 eIec1JqKnted p1ateIcu IDd a double ba1Ioon CIIheter system 
Is possible iD vivo, and by limiting the llimulus to prolifcratiOD II reduced 
aaecoosis iD IRCriea with aupcrficia1 iDjury. 
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840-34 
Smooth Muscle Cell Proliferation in Coronary Restenosis is 
Limited to a Few Generations: Cell Kinetic Model Implications 
Robert S. Schwartz, Sanjay S. Srivatsa, Allan R. Camrud, JejJ'rtry M. Isner. 
·St. Elizabeth's Hospital, Boston, MA; and Mayo Foundation, Rochester, 
MN 55905 
Medial smooth muscle cell proliferation is a major cause of 
neointimal thickening in restenosis. However, atherectomy 
specimens from restenotic lesions show low rates of proliferation. To 
better understand the cell kinetics of this problem, proliferation was 
modelled for a 3.0 rom coronary artery with a 90% restenotic 
neointimallesion. Growth fractions (GF) and labelling indices were 
taken from published data in arteries following injury. Cell densities 
per rom3 (media: 4xlOS, neointima:2xlOS) were measured directly. 
Assuming a GF of .4, kinetic equations showed that 4.15 generations 
resulted in a 90% restenotic lesion. Percent area stenosis was 
calculated vs. cell generation assuming different growth fractions 
(A=.4, B=.25, C=.l, D=.02) as shown in the figure. 
Conclusions: Proliferation in 
restenosis is highly controlled. Small 
kinetic proliferation differences can 
cause large variations in neointimal 
volume. These differences may be 
responsible for patients who develop 
restenosis compared to those who do 
not. 
840-35 
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M-CSF(macropbage corony stimnlating factor) 
Decreases Neolntlmal Formation after .. ascural Injury 
·Watanabe Ikuyoshi. Nagao Ken. Wang Dangyee. Satoh 
Kazuyoshi. Yamashita Makoto. Kikuchi Satoru. Shioiri 
Kimiyasu. Akutsu Naoko. Vagi Hiroshi. Kanmatsuse Katsuo. 
Surugadai Nihon Univ. Hosp .• Tokyo. Japan. 
The early atherosclerotic lession is characterized by the 
presence of macrophage-derived foam cells. M-CSF specifically 
stimulates the functions of the monocyte-macrophages and 
enhances both uptake and efflux of cholesterol in human 
monocyte-derived macrophage. In principle. the increased uptake 
and efflux of cholesterol as modified-LOL may induce tbe 
progression of atherosclerosis. Tbis study assesseed the effect of 
M-CSF on the neointimal formation in vivo after endotherial 
denudation of carotid artery in Sprague-Dawley rat. M-CSF (50 or 
200 milion units /kg/day) was injected intra-peritoneal from one 
day before to 4 days afrer the surgical procedure for vascura! 
injury and pathological examination were performed 2 weeks after 
the procedure. Neointima! formations were compared among M•
CSF treated and control group using the ratio of cross-sectional 
area of the neointiomal to the media of the injury arteries(N/M 
ratio). 
Result 
(n) control(9) M-CSF50(6) M- CSF200(7) 
N/M ratio(%) 86±9.2 6.6±4.9* 24.1±5.7* 
N/M ratio was significantly decreased by M-CSF 
treatment(·p<O.OI vs.control). We concluded that M-CSF may 
prevent the progression of atherosclerosis and be usefulness to 
prevent restenosis after coronary angioplasty. 
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840-36 
Effect of Antl.eD1S Adlte.lon Glycoprotein Monoclonal Antibody on 
Rcstenosls Following BalJooa AogIopJaty In the Rabbit AtheJ'OlClerotic Model. 
Luis A Guzman. Augusto E Villa. Farbad Forudi. Robert RllIhlcin. Eric J Topol. 
OeveJand Clinic Foundatioo. OeveJand. Ohio 
The purpose of this study was to determine if anti·eD18 adhesion glycoprotein 
moooclonal antibody inhibiting leukocytes adhesion to the vessel injured wall. could 
decrease neointlmal prolifcration following balloon angioplasty (BA) in 
athero5Clerotic rabbits. Each rabbit underwent bilaleral focal femoral artery injury 
by air desiccation. followed by an atherogenic diet (J % cholcsterol and 6% peanut 
oil) for 28 days. On day 28. 12 brs prior to BA, 2 mglkg body Wl of anti-eD18 (Ab 
group) or saline (placebo group) was randomly injected intravenously. Bilateral 
femoral BA was performed with a 2.S mm balloon catbeter. following a standard 
protocOl of 3 inflations at 6 aIDIospbcres cadl. during 60 sec. Aftct this procedure. 
the cholesterol diet was discontinUed. A second dose of anti-eD1S or placebo was 
injected 411 brs after BA procedure. Twcnty one days Jater a follow·up angiogram 
was performed immediately prior 10 sacrificc. In·vivo pressure fixation was done 
with 10% formaIdehyde. At the time of BA, toIaI peripheral white ccll count was 
16.4 ± 1.7 KIUL in Ab group and 6.9 ± 12 KIUL in placebo group (p< 0.001). with 
no differences in the differential formula At sacrifice. while cell count was similar 
in both groups. MJ!IIlbomebic results are sununarized in fillure: 
('01 
1 
f 
I 
i 
() liioi 
11M. intimalmedia ratio. All p valucs= NS 
Conclusions: inhibition of leukocyte adhesion with anti-CD 18 mooocional antibody 
did not decrease neointimaJ proliferation following balloon angioplasty in the 
atherosclerotic rabbit model. 
840-37 
Brier, Profound Inhibition of Thrombin Attenuates Stenosis 
Following Balloon-Induced Arterial Injury in Hyperlipidemic 
Miniswine 
Dana R. Abendschein, Dino Recchia, Yuan Meng, Luigi 
Oltrona, Samuel A Wickline, Paul R. Eisenberg 
Washington University, Sl Louis, Missouri 
Thrombin has been implicated as a mediator of restenosis 
after balloon angioplasty, but adjunctive administration of 
antithrombin agents has not consistently decreased the extent 
of stenosis. To oetermine whether brief, profound inhibition of 
thrombin limits stenosis after arterial inj~, we infused 
recombinant desulfatohirudin (COP 39393, hirudin, 2mg/kg 
bolus followed by 2 mg/kg/h, n=lO) or heparin (100 U/kg/h, 
n=6) intravenously beginrung 15 min before and for 3 h after 
balloon hyperinflation-induced injury in a carotid artery of 
miniswine with hypercholesterolemia induced by feeding 
atherogenic diet; a procedure we have shown rap-Idly yields 
complex, plaque-like lesions containing foam cells, smooth 
muscle cells, and hemorrhage. After 4 weeks, the lesioned 
vessels were perfusion fixed and examined histologically. 
Luminal stenosis was 26 ± 32(SD)% in hirudin·treated and 70 
± 35% in heparin-treated pigs (p<O.02). Plasma fibrinopeptide 
A levels were consistently but not significantly lower at the end 
of the infusion of hirudin (17 ± 22 ng/ml) compared with 
heparin (48 ± 54 ng/ml). Partial thromboplastin time was 3.3· 
ford baseline levels at the end of the infusion of hirudin and 
3.5-fold baseline at the end of the infusion of heparin. These 
results show that despite similar, marked anticoagulation, direct 
inhibition of thrombin with hirudin is more effective than 
heparin for limiting luminal stenosis. The data are consistent 
with thrombin pla~ a major role in restenosis and suggest 
that a relatively bnef interval of profound inhibition of 
thrombin may be effective to attenuate restenosis following 
balloon·induced arterial injury. 
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841·1 
Moaocloaal Antibody to eDllb Improves functional Recovery of the 
Immature Swine Heart Followiag 6 Houn of Hypotbermic Storage 
Joseph M. Fotbess, Takeshi Hiramatsu. Fumikazu Nomura, Takuya Miura, 
Karen Sokolowski, Mark Bree, Mark Cioffi, G. King Farrington, and 
John E. Mayer, Jr., Dept. of Cardiovascular Surgery, Children's Hospital. 
Boston. MA and Repligen Corp .. Cambridge. MA 
Myocardial dysfunction following prolonged hypotbermic storage contributes to 
the morbidity and mortality of pediatric heart transplant recipients. In an effort 
to define the role of neutrophil-endothelial interaction in this postischemic 
dysfunction. we examined the effects of a functionally blocking monoclonal 
anubody F(ab')2 fragment to the leukocyte adhesion molecule CDIIb(MlnO) 
given at reperfusion following 6 hrs of 4C cardioplegic ischemia in isolated, 
blood-perfused piglet(age 2wI<s) hearts. A total of 20 hearts were studied in 3 
experimental groups. Group MlnO(n=6) received ISug/mJ ofMlnO • group 
MBIO.6(n=8) received ISug/mJ ofa non-blocking F(ab')2 antibody fragment 
MB 10.6, and group Con(n=6) received saline vehicle only. At 30 and 60 min of 
reperfusion, maximal(Max) and volume-normalized(VIO) LV developed 
pressure(DP). +dP/dt. and -dP/dt were measured. as were coronary blood 
flow(CBF) and ox-ygen consurnption(V02).Results are given as %recovery of 
preischemicvalucs.(*=p<.OS vs. Con and MBIO.6."p<.OS vs. MBIO.6) 
Rep Group 
30min MI!70 
MBIO.6 
Con 
DP 
93.5" 
70.6 
74.4 
VIO 
+dP/dt 
99.4* 
68.33 
71.7 
Max 
-dP/dt DP +dP/dt -dP/dt 
87.8" 93.8* 92.7* 81.8" 
63 71.6 67.6 63.5 
67.4 7ti.8 72.7 71 
60min MlnO 94.4* 101* 89" 92.2* 92.3* 80.2** 
MBIO.6 68.1 66 58.7 67.7 65.2 61.4 
Con 73.9 72.8 65.8 76.4 74.6 69.4 
There were no intergroup differences in recovery of CBF or V02. These data 
demonstrate that pm·ention of neutrophil adhesion with M I no results in 
improved myocardial function after prolonged hypothermic ischemia in 
immature swine. M I no may be a useful agent to safely extend storage of the 
immature heart. 
841·2 
Is Left Ventricular Concentric Remodeling a Predictor of Left 
Ventricular Hypertrophy in Cardiac Transplant Recipients? 
Hector O. Ventura, Maria R. Costanzo. Carlos A. Tenorio. Carl J. 
Lavie. Frank W. Smart, Dagnovar A. Aristizabal. Franz H. Messerli, 
Maryl R. Johnson. Ochsner Medical Institutions. New Orleans. LA 
and Loyola University. Chicago. n.. 
Concentric remodeling (CR) of the left ventricle has been shown 
to predict the development of left ventricular hypertrophy (L VH) in 
patients with essential hypertension. To study the role of left ven•
tricular CR as a determinant of L VH in cardiac transplant recipients. 
we obtained body mass index (BMI) and serial echocardiographic 
indices [Le .• relative wall thickness (RWT) and left ventricular mass 
index (LVMI)] at baseline (1 month after transplant) and at 2 years 
follow-up in 34 cardiac transplant recipients. We defmed CR as a 
RWT >0.45 and a LVMI <131 g/m2 in males and <100 g/r02 in fe•
males and defined LVH as a LVMI>131 g/m2 in males and >100 
~m2 in females. Results as follows: 
Baseline 2 Years 
Echos Echos % TBMI 
Normal (NL) 7/34 (20%) NL=7n(lOO%) 15% 
LVH 6/34 (18%) CR .. 3/6 ( 50%) 25% 
LVH .. 3/6 ( 50%) 35%t 
CR 21/34 (62%)* CR ,,7/21 (33%) 13% 
NL = 3/21 ( 14%) 12% 
L VH= 11/21 ( 52%) 23%t 
* p=O.OOI versus NL; t p .. 0.02 versus CR and NL 
Of cardiac transplant recipients who had CR at baseline. 52% devel•
oped L VH. These patients. as opposed to patients with CR who did 
not develop LVH. showed significant increases in body mass index 
from baseline (p=O.02). Conclusions: 1) Concentric remodeling is 
the most common echocardiograpbic finding at baseline in cardiac 
transplant recipients. 2) Concentric remodeling predicts the devel•
opment of L VH in patients after cardiac transplantation. 3) A signif•
icant increase in body mass index correlates with the development of 
L VH after cardiac transplantation. 
ABSTRACTS 
841·3 
Endothelium-Dependent Contractloa or Canine Coronary Artery Is 
Enhanced by Cardiac Preservation Solution 
*Pyng Jing Lin. Chau·Hsiung Chang. Pei-Chin Yao, Hui-Ping Liu. Kuei·Ton 
Tsai, Chang Gung Memorial Hospital, Chang Gung Medical College, Taipei, 
Taiwan. R.O.C. 
In the past decade. it has become apparent that endothelium reguIa!e vasomotor 
tone by releasing a number of potent vasoactive compounds that act on the 
underlying vascular smooth muscle. Previous experiments showed that 
endothelium·dependent relaxation was impaired and endothelium-dependent 
contraction was found to be enhanced following extracorporeal circulation. 
Enhanced contraction and impaired relaxation could lead to vasospasm and 
thrombosis. Infusion of hyperkalemic crystallOid cardioplegic solution during 
cardiac surgery may be one of the causes of the coronary endothelium 
dysfunction. It has been reported that hyperkalemic crystalloid cardioplegic 
solution does not a11er endothelium-dependent relaxation of Ihe epicardial coronary 
aneries. However. little is lcnown about the effects of cardioplegic solutions on 
Ihe endolhelium-dependent contraction of Ihe coronary endolhelium. 
To determine whelher Ihese solutions enhances the production of endothelium, 
derived contracting factor. we investigaled the endolhelium-dependent contraction 
of canine coronary arteries (n=8 in each group) preserved in cold (4 o , 60 
minutes) SL Thomas No.2 solution (group I), University of Wisconsin solution 
(group 2 ), and physiological solution (group 3). Segments of preserved and 
control (group 4) coronary arteries wilh or wilhout endolhelium were suspended 
in organ chambers to measure isometric force. Perfusa!e hypoxia (pOz 35 ± 5 
mmHg) caused endothelium-dependent contraction in arteries of all 4 groups. 
However. vascular segments wilh endolhelium of group I and group 2 exhibiled 
hypoxic contraction (68.5 ± 15.3% and 55.5 ± 9.7% of Ihe initial !ension 
contracled by prostaglandin Fu. 2xl~ mole/L. p<0.05) that were significantly 
greater than those of the group 3 and group 4 segments with endothelium (26.6 ± 
5.6% and 20.6 ± 4.4%). The hypoxic contraction in aneries of group 1 and 
group 2 could be attenualed by NG-monomethyl,L·arginine (L-NMMA), the 
blocker of endolhelial cell synlhesis of Ihe nitric oxide from L-arginine. The 
action of L·NMMA could be reversed by L,arginine but not D-arginine. 
Thus, after preservation, augmenled production of endothelium-derived contracting 
factor occurs by L·arginine·dependent pathway. Augmenled production of 
endothelium-derived contracting factor by cardioplegic solution or preservation 
solution would favor coronary vasospasm after cardiac operation or 
transplantation. 
841·4 
Mitral Regurgitation by Echocardlography Predicts 18 Months 
Survival In Dilated Cardiomyopathy 
David L. Kemp. Ramon Castello. Steven H. Jennison. Leslie W. Miller. 
Arthur J. Labovitz, Saint Louis University Health Sciences Center. St. 
Louis. MO 
Echocardiographic (ECHO) indices predictive of clinical outcome 
have not yet been fully established for dilated cardiomyopathy. To 
evaluate their pmgnostic value. 103 patients (78m.25f; age 48.0 ±9.6; 
ejection fraction (EF) 20.0 ±7.3; functional class (NYHA) 3.2 ±O.4) 
were followed for 19.5 ±8.5 months (range 8-44) or until death (11=18) 
or tranSplant (n=40). Death and cardiac tranSplantation were considered 
as final endpoints. Univariate regression analysis identified (NYHA; 
(p=0.035). EF (p=O.017). left ventricular end diastolic (L YEO) size 
(p=(1.024) and mitral regurgitation (MR) (p=0.006) as prognostically 
significant parameters. By Cox multivariate regression analysis only MR 
(p-0.OO8) and EF (p=0.05) independently predicted outcome. 
Eighteen month actuarial survival progressively diminished with 
increasing MR from 64% (mild MR) to 25% (severe MR) p=O.OO5. 
When patients were stratified above and below the median EF. severe 
MR predicted 89% of deaths/transplants in the subgroup with EF <20% 
vs 0% for mild MR (p=O.OO6). There was no statistical difference in the 
subgroup with EF > 20% although 75% of endpoints in this subgroup 
occurred in patients with severe MR. When death alone was considered 
as the endpoint, MR was the only independent predictor of mortality 
(p=0.004) and predicted 83% of deaths. 
80~=ns 75% Il:: E~>20% 
! 20 
o Mild Moderate Severe 
21A 
Thus. MR independently predicts 18 month survival in dilated 
cardiomyopathy and is particularly powerful in those pts with relatively 
worse cardiac function. It adds important prognostic infonnation to the 
EF and should influence the timing of cardiac tranSplantation. 
22A ABSTRACTS 
841·5 
Sinus Node Dysfunction After Cardiac Transplantation 
Christopher D. Scott, John H. Dark, Janet M. McComb. Freeman 
Hospital, Newcastle upon Tyne, UK. 
Sinus node (SN) dysfunction is a frequent complication of 
orthotopic heart transplantation and is the commonest indication for 
permanent pacing. Previous electrophysiologic studies have shown a very 
high incidence of SN dysfunction (approximately 50'!') but the incidence 
of bradyarrbythmias attributable to SN dysfunction in several larger series 
without electropbysiologicaJ data has been much lower. Also serial 
electrophysiologic data have not been reported thus the natural history of 
SN dysfunction after transplantation has not been adequately described. 
40 recipients undecwent serial electrophysiologic testing of SN 
function 1,2,3 and 6 weeks, 3 and 6 months after cardiac transplantation. 
Corrected maximal SN recovery time (CSNRT) and sinoatrial conduction 
time (SACT) were measured using standard techniques. 
Seven subjects (17.5%) had abnormal CSNRT by standard criteria 
(>525 msec) on at least one occasion. CSNRT was abnormal at 1 week 
in 6 (early SN dysfunction) and was first abnormal at 3 months in 1 (late 
SN dysfunction). CSNRT decreased progressively from week 2 in all 
subjects with early SN dysfunction and bad returned to normal by week 6. 
SACT was abnormal (> 2SOmsec) in 5 subjects all of whom also had early 
SN dysfunction. In contrast with CSNRT an abnormal SACT developed 
late in two subjects with early SN dysfunction. Two subjects with 
abnormal CSNRT at 3 weeks received permanent pacemakers. 1 required 
long term pacing coincident with the measurement of an abnormal SACT 
despite a normal CSNRT. 
Thus the incidence of SN dysfunction after cardiac transplantation 
as defined by electropbysiologic testing is much lower than has been 
previously reported. Abnormalities of SN automaticity and sinoatrial 
conduction are usually associated. Whereas SN automaticity returns to 
normal in subjects with early SN dysfunction, abnormalities of sinoatrial 
conduction may develop late and necessitate long term pacing. 
841·6 
Dobutamine Stress Echocardiography in Orthotopic 
Heart Transplant Recipients. 
.Genevi~ve Derumeaux. Michel Redonnet, R~mi DouilIet, 
Dominique Mouton Schleifer, Jean P. Bessou, Robert Soyer, Alain 
Cribier. Brice Letac.University of ROUEN, (Vacomed). FRANCE. 
Coronary artery disease (CAD) is a major cause of morbity in heart 
transplant recipients (HTR). CAD is related to diffuse or focal 
intimal thickening as assessed by intracoronary ultrasound. 
However. clinical or angiographic diagnosis is difficult. The aim of 
this study was to determine whether dobutamine stress 
echocardiography (DSE) could accurately identify CAD. From our 
population of 99 HTR. we enrolled 18 consecutive HTR. 29 ± 14 
months after heart transplantation. at the time of their routine control 
coronary angiogram (CA). We excluded 2 HTR because of poor 
echogenicity. DSE was performed with graded infusions at 3 min 
intervals to a maximal dose of 35 mcg! kg I min. Standan parasternal 
long and short axis. apical 2 and 4 chamber views and ECG were 
acquired at baseline and each infusion levels. Regional wall motion 
was assessed using a 16-segment model. Systolic wall thickening 
was graded as I· normal. 2- hypokinetic. 3- akinetic, and 4-
dyskinetic. CA was performed 24 hours after DSE. Both DSE and 
CA were analysed in blinded fashion. 
~ In a first group of 8 HTR, CA was normal and DSE 
showed no abnormalities in both wall thickening and in ECG. In the 
remaining 8 HTR, CA was considered as abnormal: Focal stenosis 
less than 40% were found in 5 HTR: DSE correctly identified the 
corresponding hypoperfused segments in 4 HTR as being 
hypokinetic and was normal in I HTR. Diffuse coronary 
irregularities were found in 3 HTR and DSE showed hypokinesia in 
these 3 HTR. The respective sensitivity and specificity ofDSE were 
87% and 100%. 
Conclusjon. From these preliminary results, DSE is an accurate 
noninvasive and reproducible method for detecting CAD in HTR, 
even when CAD appears to be mild on CA. At the opposite, a 
____ 1 T"\.l"Ir" _'-~ _____________ ...1_ A_ _ _ _____ 1"''' 
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842·113 
Intravascular Echo Assists Datarmlnatlon of tha Anatomy 
and Position of Obstructions In Right Vantrlcular to 
Pulmonary Artary Conduits 
Takahiro Shiola, Antoinette Kenny, William Hellenbrand, Paul Droukas, 
Mary J. Rice, Mark D. Reller, Abraham Rothman, David J. Sahn. Oregon 
Health Sciences University, Portland, Oregon. 
Improvements in image quality, depth of penetration, and reliability have 
made intravascular echo studies easier to i"""ement for congen~al heart 
disease investigations and improved the quality of information 
obtainable. We studied 11 patients, aged 3.2 to 17 years, to report the 
results of investigations of right ventricular to pulmonary artery condu~ 
obstruction. Studies were accomplished by use of 12.5 to 15 mHz 
catheters from 6.2 to 8 French in size which were used for imaging 
during pullbacks from the PA to the RV after placement through 7-8 
French long Mullins sheaths with scanning performed on Diasonics, 
Hewlett Packard and Aloka intravascular systems. We studied 3 
valveless Dacron. 3 porcine valved condu~s. and 5 cryopraserved aortic 
homografts which had been in place from 23 months to 7.5 years. The 
narrowest area was easily localized by intravascular ultrasound often 
clarifying angiographic impressions and included stenosis at or just 
above the valve, at mid-level, associated with sternal compressive 
changes or at the insertion into the pulmonary artery bifurcation. 
Mechanisms and pethology of obstruction which were surgically verified 
included, severe calcific changes of valve and supravalve area, 
compressive elliptical profiles w~h secondary intimal fibrous proliferative 
'onion peel' or mixed proliferate and calcific changes. Conduits with 
significant calcium in valves or supravalve segments resulted in uniformly 
unsuccessful attempts at balloon dilation and obstruction with calcium 
depos~ion in the valve was viewed as a contraindication to stenting. A 
distal stenosis just at the bifurcation not well localized angiographically 
was clarified when intravascular imaging clearly demonstrated the 
narrowest area as a guide to a subsequent angiogram and ~s position 
was felt to be contraindication to balloon dilatation. Two conduits with 
only fibrous 'onion peel' changes, 1 localized and 1 diffuse, were 
successfully dilated with increase in implantation longevity for the 
patients of an add~ional 2.8 and 3.5 years respectively. In this study. 
intravascular scans were easy to accomplish and gave insights into the 
location and pathology of conduit obstruction which with larger 
experience may help to guide choices of available interventional 
catheter therapy or surgical strategies. 
842-114 
Transasophageal Echo for Predicting ResuUs for Repair of 
Tetrafogy of Fallot: Using New High Resolution Biplane 5·7,5 MHz 
Probes with CW Doppler Capability 
David Beltran, Abraham Rothman, Takahlro Shiota, David J. Sahn, 
Robert Weintraub, Mary J. Rice, Adnan Cobanoglu, Henry Casson; 
Oregon Hllh Sci Univ, Portland, OR 
To define the role of intraoperative transesophageal echo (TEE) with 
CW Doppler during surgical repairs of tetralogy of Fallot (TOF). we 
reviewed 29 pis: (2.S mo. to 8 yrs. of age): Group I: 17 pis studied 
during primary repair with subsequent good results of RVOT 
reconstruction (1") or valved conduit placement (3) who hed post-op 
transthoracic echo (TTE) data suggesting RV pressures < 30 mmHg; 
Group II: five pis who had post-op TTE which suggested RV pressure 
>35 mmHg andlor significant peripheral PA stenosis and have post-op 
precordial thrills and loud munnurs; and Group III: 7 other pis studied 
intraoperatively before undergoing a redo surgery for recurrent RVOT 
obstruction with catheterization documented RV pressures> 50mmHg. 
TEE study included biplane Imaging of the proximal and distal RVOT 
and CW Doppler interrogation when pis were off bypass and 
hemodynamically stable (or before bypass in Group III). TEE was 
performed with biplane SMHz and 12mm probes or using a new high 
resolution prototype element 7.SMHz biplane probe both with CW 
capability. In Group I, the highest RVOT velocity during intraoperative 
TEE was 1.8 mlsec despite the presence of PI and pts had smooth non•
turbulent PA flows. In Group II, TEE RVOT velocities were ~2.5 mlsec, 
and 3 pts had 20 or color Doppler evidence of stenOSis in the distal PA, 
a hypoplastic PA or significant subvalvular narrowing of the RVOT. In 
all Group III pts, TEE showed maximal RVOT velocities >2.95 mlsec 
and all pts had RVOT narrowing imaged. High resolution biplane TEE 
provides imaging of the entire RVOT after tetralogy repair. Doppler 
velocity >2.5 m/sec in pts after repair and still under anesthesia and/or 
imaging of stenotic segments indicate the need for obtaining pressures 
and may predict suboptimal results so as to suggest the need to 
consider revision of the repair. 
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842·115 
E.aJuatioD of lutl'llopenlti.e Tnusesopbageal EcbocanIiograpby During 
Cooaenital Heart SlII'Iery 
Howard M Il.-.feld, Thomas L Gentles, Gil Wemovslcy, Peter C LausseD, 
Ricbln:l A JOIIIS, John E Mayer Jr, Steven D Colan, Stepbeo P Suders, 
Mary E van derVeide. Cbildteat's Hospital, BosIoa, MA 
Despite the iDcreasing use of intraoperative tnnsesopbaeeal ecbocanIiograpby 
(lTEE) during congenital beart surgery, there is little informatioo correlating 
immediate post-bypass _t of residual lesiOllS with postoperative follow•
up. We examined the ability of ITEE to identify and grade residual lesiOllS after 
bypass by comparing ITEE tiDdings with intra/postoperative data 011 7S patients 
(pis), aged 4 days to 30.7 yrs (median=lS mos) weighing 2.9 to 61.6 kg 
(medianz8.9 kll)' Study pis were II risk for postoperative ventricular septsI 
defect (VSD D=60), rigbt or left ventriculu outflow IrIct obstructioo (RVOTO 
D=SI, LVOTO D-24), IOrtiC regurgitatioo (AR D-11), milrll steoosis (MS 
DE 8), or milrll regureitatioo (MR D=8). Follow-up data were analyzed for 
these 162 poIeDtiaJ postoperative lesioos: lrIDsIhoncic ecbocardiograms (81), 
direct surgical observation (3), LV or RV outflow lrIct cIIbeter pullback 
endient (25), pulmoaary artery oxygen saturatioo (26), or combined 
ecbocardiographic and bemodyaamic data (27). Lesioos were categorized as I) 
IbseDt or bemodyuamicaJJy insieaificant, 2) possibly sieaificant, or 3) 
sieaificant. 
ITEE results agreed with intra/postoperative data in 100"; of pis II risk for 
posl-operllive VSD, AR, MS, and MR; in 92"; ofpts at risk for RVOTO and 
in 96"; of those II risk for LVOTO. Residual RVOTO was overestimated in 
4 pis and LVOTO was UDderestimated in ODe. 
Sieaificant residual lesiOllS led to reinstitutioo of cudiopu\mODary bypass and 
sureical revisioo in 11 cases (6 RVOTO, 3 VSD, 2 LVOTO). Of these, ITEE 
coafirmed and quantified suspected residual lesioos in 7, identified UIISIISp<lCted 
lesiOllS in 3, and localized and guided resectiOD of residual LVOTO in ODe. 
Hemodyaamic improvement was achieved in 11112 pis. 
Immediate post-bypass ITEE is highly reliable for assessing residual VSDs, 
AR, MS, and MR. A1thougb accurate for assessmeat of the left and rigbt 
ventriculu outflow Inlet in most pis, ITEE may DOt reliably reflect the severity 
of obstructioo in all cases. 
842·116 
Transverse Versus Apical Assessment of Systolic and Diastolic 
Function in Children Using Automatic Border Detection 
Thomas R. Kimball, Sandra A. Witt, Betty J. Glascock, Charlene A. 
Schroder, Philip R. Khoury, Stephen R. Daniels, Richard A. Meyer. 
Children's Hospital Medical Center, Cincinnati, OH 
Automatic border detection provides on-line display of left 
ventricular area and its changes throughout the cardiac cycle. Previous 
studies have suggested that functional assesstuent using this technique 
may depend upon the ecbographic plane. To assess differences in area 
and its changes in the transverse versus the apical planes, automatic 
border detection was performed in 48 normal children (ages = 42 d.o. 
to 18 y.o.). Fractional area change, peak filling and emptying rates 
(normalized for end-diastolic area) and time to peak filling rates were 
obtained from 3 end-expiratory cardiac cycles in shon axis and apical 
views. 
Fractional area change was significantly higher in the shon axis view 
(6 I ± 9) vs the apical view (29 ± 9 %, p < 0.000 I). Likewise, peak ftlling 
and emptying rates were significantly different in the shon axis versus 
apical views (6.3± 1.5 vs 2.6±0.9sec·' , p<O.OOOI; 4.5± 1.0 vs 
2.2±0.8sec·' , p<O.OOOI, respectively). Time to peak ftlling rate was 
not statistically different (97±64 vs J05±45msec, p=0.3). Univariate 
analysis showed no significant correlations between the variables in the 
shon axis view versus those in the apical view. However, in each view 
peak ftlling rate was directly related to fractional area change (r = 0.61, 
P < 0.0001 in shon axis and r = 0.82, p < 0.0001 in apical view). 
. We conclude that significant differences in the automatic border 
detection assessment of systolic and diastolic function of the left 
ventricle exist between the transverse and apical planes. We speculate 
that these differences are due to normal regional differences in left 
ventricular wall motion from the apex to the mitral annulus. Separate 
standards may be needed in assessing function from the two views. 
These data may provide useful reference values for patients with 
diseased states. 
ABSTRACTS 
842·117 
Impact of Ventricular Septal Defect on Outflow Tract FluId uynamlcs: 
Finite Difference Solution of Navier·Stokes Equations 
Huaqiang U, Gerard J. Boyle, Tin-Kan Hung, Josl! A. Ettedgui, Edward G. 
Cape. Cardiac Dynamics Laboratory at Children's Hospital, University of 
Pittsburgh, PA. 
Previous studies have suggested that color Doppler flow mapping can be 
used to assess ventricular septal defect (VSD) flow and other outflow tract 
(aT) defects such as subaortic stenosis. While these methods are still 
being refined, ~ Is clear that a fluid dynamic understanding of the flow field 
in the vicinity of the OT is critical to the development of new techniques 
depending on velocity measurement modaltties. The purpose of this study 
was to address the hypothesis that VSD's impart a potential energy sink 
which affects the entire left ventricular OT and thus gradual closyre of the 
VSD myst be taken Into accoynt when Interpreting color flow maps. 
Methods: The OT flow field was modeled using the nonslmplHied Navier•
Stokes equations. Patankar's Semi·lmplicit Method for Pressure Unked 
Equations was used for solution. Results were displayed using vector plots 
(figure) and isovelocity maps. OT velocity ranged from a limiting case of 
zero up to 1.5 mls to simulate accelerating flow Into an aortic stenOSis. 
Maximum VSD velocities ranged from 0-3 mis, and OT dimension was 
varied up to an extreme case of 4 cm. Results: The energy sink created 
by the VSD had a profound and nonsymmetric effect on aT velocities for 
§!! conditions studied. Even for OT of exaggerated size (4 em), velocity 
vectors directed toward the aorta were shifted in the direction of the VSD. 
These shifts in velocity vector direction are further complicated when 
viewed in the 'Doppler domain' where angle of Incidence effects are added. 
Conclusions: Subtle chanaes in VSD LVOT 
flow due to pressure considerations or 
the natural history of the lesion imparts 
Important changes In flow throughout 
the OT region. These fundamental 
changes in the velocity field can be 
further distorted by the relatively 
unstandardized method of color 
Doppler flow mapping. 
842·118 
Magnetic Resonance Imawng of Ventricular Geometry 
and Performance in Patients with Functional Sin~le 
Ventricle Throughout Staged Fontan Reconstruction 
Mark A. Fogel, Paul M. Weinberg, Alvin 1. Chin, Eric A. Hoffmon 
The Children's Hospital of Philadelphia, Philadelphia, PA 
Ventricular end-diastolic volume (vol), mass, ejection fraction (EFl, stroke 
volume (SV) and ventricular output (VO [l/minlm2j), important parameters in 
studying cardiac geometry and perfonnance, can be ascertained in functional single 
ventricles by magnetic resonance imaging. This imaging modality can determine 
these indices in complex ventricular shapes with minimal geometric assumptions. 
Previous studies using other imaging modalities have shown that I week post 
hemiFontan, mass/vol ratio markedly increases. To test the hypothesis that Vol. 
mass, EF, SV and VO change as pIS progress through staged Fontan reconstruct•
ion, we performed multipbase, multislice, spin-echo (in 5) and cine (in 25) 
magnetic resonance imaging on 30 pts (I week·12 years old) with functional 
single ventricles at various stages of Fontan reconstruction to assess these indices 
(group 1: 12 pts pre hemiFoDtan, group II: 11 pts 6-9 months post hemiFoDtan 
and group 111: 7 pts 1-2 years post Fontan completion). Vol and mass were 
calculated by summing the ventricular areas on each slice multiplied by thickness 
at end·systole and end-diastole. VO was calculated by multiplying SV by HR. 
The results are summarized below' *p <0 0'\ . -
Group vol mass EF SV HR va 
(cclm2) (21m2) (%) (cclm2) (bpm) (I/min/m2) 
I. 117±21 175+59 69±12 82±26 123+22 9.7+1.8 
II. 96±21 172±38 66±9 63+14 111+10 7.0±1.6 
III. 65±23* 129±41* 49±14" 34±20* 87+14" 2.9±1.5* 
Prog~sston of the smgle ventricle from group I to II demoDstrates a smaIl (21 
cc/m ) decrease in vol and no decrease ~n mass or EF 6·9 months post 
hemiFontan. The VO decreased 2.7 I/minlm , but this was not significant. Pts 
who are 1·2 years post Fontan demonstrated a marked decrease in all indices. 
indicating the geometric change of significant vol unloading and decrease in mass. 
Ventricular performance deaeased as demonstrated by a diminution in EF and VO. 
Conclusjon: Major cardiac geometric and performance changes occur in 
functional single ventricles from pre hemiFontan to post Fontan, wbich are not 
present 6-9 months post bemiFontan. The dramatic changes in !be mass/vol ratio 
which have been previously seen I week post bemiFontan using other imaging 
modalities do not seem to persist at 6-9 months. Furthermore, diminution of both 
mass and vol are Jnsent at least 2 years post Fontan. 
23A 
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842-119 
Cine MRI ANe .. ment of Right Ventricular Function for Long Term 
Followup of Primary Repair of Tetralogy of Fallot In Infancy 
Gautam K. Singh, Yong S. Yap, David P. Delany, James L Monro, Barry 
R. Keeton, Anthony P. Salmon, Nanci R. Stauffer, S. Bruce Greenberg, 
Richard M. Donner, Lloyd A. Marks, Southampton General Hospital, 
Southampton, UK and Temple University, Philadelphia, PA, USA 
Primary repair 0/ TOF in inIancy has been performed with the hope 0/ 
preservation 0/ RV function. MRI has been shown to reliably measure RV 
and LV volume. The purpose 0/ our study was to evaluate RV function 
using cine MRI in adolescents who had primary repair 0/ TOF in infancy. 
Cine MRI 0/ the hean was performed on 10 adolescents who had primary 
repair of TOF with transannular patch in the first year of IHe and in 7 age 
and sex matched normal controls. Measurements of right and left 
ventricle volumes were performed throughout the cardiac cycle. The RV 
end-diastollc volume Index (RVEDVQ, RV end-systolic volume index 
(RVESVI), LV end-diastolic volume Index. and LV end-systolic volume 
index were measured. The RV stroke volume index (RVSVI), RV ejection 
fraction (RVEF) and RV regurgitant frection (RVRF) were calculated. The 
heart rate (HR) was recorded at the time of MRI to calculate the cardiac 
index (CI). The results are summarized in the table. The RVEDVI, 
RVESVI, and RVSVI were significantly greater and the RVEF was 
significantly smaller in the adolescents who had TOF repair than the 
control group. The RVEF of the study group was independent of RVRF. 
(mean+sem} Patients Controls 
CI(Vm/M2) 3.2±0.3 2.9±0.4 n.s. 
HR(/min) B2.3±4.2 78.7±4.3 n.s. 
RVEDVI(mI/M2) 122.3:t10.3 67.2±6.4 p<0.OO1 
RVESVI(mVM2) 78.7±8.3 3O.0:t1.8 p<0.OO1 
RVSVI(mI/M2) 43.9:t2.5 37.1±3.7 p<0.1 
RVEF(%) 35.4:t1.9 54.9±1.1 p<0.OO1 
In conclusion, RV functional impairment Is present despite early primary 
repair of TOF within the first year of life. Cine MR imaging is a useful tool 
for the assessment of RV function in the post-surgical evaluation of 
congenital heart disease. 
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843-9 
Attenuation Deforms Time-intensity Curves During Contrast Echo•
cardiography: Practical Implications. 
Ananda R. Javaweera, PhD, Suad Ismail, MD, Sanjiv Kaul, MD, FACC. 
University of Virginia. Charlottesville. Virginia 
Time-intensity curves during contrast echocardiography are used 
for the estimation of flow. Since the relation between microbubble 
concentration and videointensity is non-linear, we hypothesized that the 
shape of the time-intensity curves would be deformed at higher 
concentrations of microbubbles resulting in erroneous parameter 
estimates from such curves. Assuming that microbubble concentration 
varied with time t according to a gamma-variate function A.t.exp(-a.tl 
where A is a constant and a is the transit rate, computer simulations 
were performed to obtain curves of background subtracted time-intensity 
plots for increasing concentrations for the same value of a. Distortion of 
the curves increased with .. K;::-~:;:::75';~:t:!'~ 
increasing concentrations. Not 
on IV was peak intensity affected, " 
but a broadening of the time-, 
intensity curves was noted!" 
resulting in a decrease in transit ! 
rates when fitted to a gamma•
variate function (See Figure). 
To validate these data, 
experiments were performed in•
vitro where increasing concentrations of microbubbles were injected into 
a tube infused with saline at a constant rate. The end of the tube was 
attached to a piece of vein immersed in saline bath. Contrast 
echocardiography was performed on the vein "'10 obtain time-intensity 
curves. These curves closely resemble computer generated curves and 
the transit rate decreases with increasing concentrations (V = -0.39x + 
0.73. r = 0.84, SEE = 0.08, n = 10). 
We conclude that attenuation deforms the time-intensity curves 
obtained during contrast echocardiography. Not only is there an effect 
on peak intensity as would be expected, but the width of the curve is 
also broadened. These results have important bearing on using time•
intensity curves to measure flow in-vivo. 
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843-10 
Image Quality and Safety Following Intravenous BY 963, a New 
Transpulmonary Echo Contrast Medium In Man 
Gustav G. Belz, Kerstin Breithau~~ Raunhild Butzer. "Harald Bliesath. 
Christian de Mey. Center for Caraiovascular Pharmacology (ZeKaPha 
GmbH). Main: and "Byk Gulden Pharmaceuticals. Konstan:. Germany 
An ideal Iv. contrast agent for echocardiographic visualisation of the 
right and the left heait chambers should' give a conSistently sC?Od 
contrast. must be well tolerated and of low risk potentia (HIV•
contamination. anaphylaxiS, etc.). 
An aqueous solution containing sacharides, lipids and 0.2ml of air was 
mixed mechanically. (using a mix-chamber mounted between two 5 ml 
syringues) so that it became aerated with stable air bubbles of 3.8 :t 
1.4lJm diameter. This solution was tested for the first time in man in a 
placebo {NaCI-solutionl controlled single blind study with ascending 
volumes In order to evaluate Its capacitY to enhance echocardiographic 
visuali~tion. Its tolerance !lnd safety. Volumes of 0.5 to 15 ml were 
tested In seven consecutive steps. In 28 healthy males apical 4 
chamber ECHO-views were derived continuously before, during and up 
to 5 min alter iv. injection of the test volumes. Blood pressure heart 
rate and stroke volume equivalents (impedance cardiography) were 
monitored non-invaslvely throughout. ECGs and clinical laooratory 
profiles were obtained repeatedly up to 24h after injection. 
flight heart ECHO-contrast became evident alreaCly after 1 ml BY 963 
In '1/4 volunteers. Dual chamber visualisation was liighly prominent for 
all volumes ~ 5 ml (see table). 
Table 
BY 963 
dose 
TiiiI 
2.5ml 
5ml 
7.5ml 
10 ml 
15 ml 
Percentage of clear contrast 
ri~hbB,rt left heart 
o ---uT 
100% 25% 
100 % 92 % 
100 % 100 % 
100 % 100 % 
100% 100% 
Left ventricular contrast was evident within 5 to 10 sec. after iv. 
injection of 5ml and lasted up to 2min. As such, 5ml BY 963 might be 
aCiequate and sufficient to allow clear enhancemenl of 
echocardiographic imaging of both right and left cardiac chambers. 
Volumes up to 15 ml (optimized formulation) were clinically well 
tolerated. 
Conclusion: BY 963 is a well tolerated and effective contrast agent for 
the enhancement of echocardiographic visualisation of both tfie right 
and the left heart chambers. 
843-11 
Value of Contrast Transcranial Duplex Sonography (cTCD) as a 
Routine Test Additional to Transthoracic Echocardiograpby 
(cTIE) in Patients With Suspected Patent Foramen Ovale (PFO) 
Frank P. Job, Andreas Franke, Frank A. Flachskampf, Peter Hanrath, 
Medical Clinic I, RWTH Aachen, Germany 
Contrast transesophageai echocardiography as the gold standard for the 
detection of PFO is semiinvasive and time consuming. cTCD has been 
proven to be superior to cITE and of similar specificity and sensitivity as 
cTEE. However, it has been hypothesized, that pulmonary passage 
(PASS) of echo contrast may lead to false positive cTCD results. To 
clarify the influence of PASS, cTeD and cITE were combined in 207 pts 
with suspected PFO (mean age 57 ± 13.6 y). Contrast appearance times 
(CAT) after peripheral venous injection of 10 mI of agitated 
oxypolygelatine were assessed in the right upper pulmonary vein (PY) and 
middle cerebral artery (MCA) and cTCD results graded as "0" (negative), 
"1" (1 to 10 spikes within 40 s after end of injection) or "2" <2.. " spikes 
within 40 s). In 161 out of 207 pts (78%) sufficient PY flow patterns were 
obtained. In 92 % of the pIS the MCA could be insonated. The prevalence 
of PFO by ITE was 27 %. PASS (defined as spike like interruptions of 
PY flow patterns) was detected in 40 % of the non-PFO and in 44 % of 
the PFO group: 
PFO pos 
PFO neg 
PY 
16±S.3 
22±6.2 
eTCD (grade I) 
24±9.3 
eTCD (grade 2) 
9±6.1 
(all values are mean CATin seconds ± SD) 
Although PASS was documented in 55 % of pts without PFO all of them 
were grade "I" and signals were recorded late. In contrast, eTCD of all 
pts with PFO was massive (grade "2") and CAT significantly shorter 
(p<O.OOI). CAT could neither be correlated to heart rate, nor to left 
ventricular dysfunction (8%), to presence of atrial fibrillation (14%) nor 
to age. Conclusions: Positive cTCD caused by true PFO can be 
discriminated from "false" po(Jtive cTCD due to PASS by late CAT and 
the number of spikes. cTCD in addition to routine cITE serves as a 
precise, time-saving and non-invasive tool for the detection of PFO. 
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843-12 
Effect of Pulsatile Pressure on Echocardiographic Contrast 
Persistence: Is It Due to Peak or Duration of Pressure? 
Ming Hui Chen, Luis R Padial, Cedric Yuille, 
J Luis Guerrero, Arthur E Weyman, Michael H Picard. 
Massachusetts General Hospital, Boston, MA 
Characterization of physical factors influencing the 
intensity of echocardiographic contrast (EC) agents is 
necessary pri or to contrast use as a quant i tat i ve flow 
marker. Although EC intensity and its rate of decay are 
altered when exposed to pulsatile pressures, it is unclear 
whether the predominant influence on EC intensity decay is 
~ pressure or duration of time exposed to peak pres•
sure. To address this, sonicated albumin was examined in 
an in vitro model where pulse pressure ranged from a nadir 
of IS mmHg to a peak of 104 mmHg at rates from 30/min to 
120/min. Peak and nadir pressures were kept constant but 
the pressure wave forms were systematically modified by 
altering the rate (pulses/min) and the duration of peak 
pressure/pul se to regul ate the percent of time at peak 
pressure per minute (% Peak P/min). For each injection, 
2-D echocardiograms were recorded from initial injection 
until complete disappearance of contrast. Off-line 
measurements of contrast videointensity were made at peak 
and nadir of each pulse, and then time intensity curves 
constructed. For comparisons of differing pulse 
characteristics, each curve was fitted to an exponential 
function and the decay rate, ~, computed. 
~ Peak Plmin (%) -A-
120 SO 1.07±0.42 * 
60 51 0.36±0.IS 
30 46.5 0.35±0.1l 
* p<O.05 va. 60, 30 
CONCLUSIONS: The rate of disappearance of EC intensity of 
sonicated albumin when exposed to pulsatile pressure is 
affected predominantly by the duration of exposure to peak 
pressure rather than the pulse rate alone. 
843-13 
Transpulmonary Passage of Aerosomes'" a Pressure Stable, 
Lipid-Based Echocardiographlc Contrast Agent: Studies In 
Pigs 
Andrew Arai, Antoinette Kenny, Tekahiro Shiote, Evan Unger, David 
Yellowhair, Amaldo Passafini, Terry Matsunaga, Susan E. Grauer, George 
Pantely, David J. Sshn. Oregon Heshh Sciences University, Portland, 
Oregon. 
We studied the characteristics of a new echocsrdiographic contrast agent 
(approx. 8-10 micron air-filled deformable lipid micro-bubbles) in five 45-55 
kg anesthetized and ventilated domestic swine. For monitoring, a Swan•
Genz cathater and an arterial sheath were placed in the neck vessels. 
Echocardiography was performed transthoracically using a 5 mHz 
transducer (Toshiba 140). The Aerosornes"", as a flexible microbubble, 
transitted the lungs briskly and LV contrast persisted without the systolic 
disappearance often seen with other agants. As experienced with some 
other contrast agents in swine, intravenous injections resuhed in 
Significant pulmonary hypertension (with PA pressure rising from 20 
mmHg to 60 mmHg) but this effect was blocked effectively by aspirin or 
indomethacin (maximal rises in pressure to 27 mmHg). SVC injections of 
0.1-0.2 cclkg of contrast resulted in excellent, dense opacification of the 
LV cavity on transthoracic imaging; and subtle but definite videodensito•
metrically verifiable myocardial contrast enhancement (4% change) was 
seen in 3 animals after pseudocolor was applied to images. Aortic root 
and left ventricular injectionS did not adversely affect hemodynamics, but 
produced dense reproducible myocardial contrast with a prolonged slow 
wash-out and showed regional perfusion defects over appropriate wall 
segments when the left anterior descending coronary artery was 
occluded. This new agant produces dense transpulmonary contrast and 
myocardial opacification aftar right sided injections. It's long persistence 
precludes it's use as a flow tracer, but should make it more easily 
quantifiable. 
ABSTRACTS 
843-14 
Reported Loss of Contrast Intell'lity in the LV CavIty During Systole: 
Is It 111 Artifact of Microbubble Velocity? 
Susan Tiukinhoy, Jacqueline Winkelmann, Michael Kenner, Raj 
Chandwaney, Paul Harper, Steven Feinstein, Univ. of llIinois at 
Chicago. Chicago, Illinois 
It has been suggested that the observed systolic drop in video intensity 
in the LV cavity following IV administration of Albunex is related to 
microbubble instability. We propose that the phenomenon is a 
consequence of mismatch between the ultrasound imaging system and 
the microbubble velocity. To test this, we used an in vitro flowing 
tube model with the velocity of microbubbles varied at stable 
concentrations of Albunex in the reservoir tank. Funhermore, 
sampling rates and transducer frequencies were also varied. 2D-Echo 
signal was then analyzed off-line using videodensitometry data at high 
velocity (1.2 M/Sec), medium velocity (1.0 M/Sec), and low velocity 
(0.6 M/Sec). Results: The signal strength of contrast material varied 
inversely with microbubble velocity. 
Conclusioll'l: 
I. There is an inverse 
relationship between 
microbubble velocity 
and video intensity of 
the contrast material 
in vitro. 2. This 
relationship persisted 
at different Albunex 
concentrations, using 
different ultrasound 
843·15 
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Positive Echo-Contrast Does Not Correlate With Physiologic Shunt 
Studies In Patients With Severe Liver Disease 
Leonardo Rodriguez, Paul Lange, Mario Garcia, Helga Lombardo, 
James K. Stoller and James D. Thomas 
The Cleveland Clinic Foundation. Cleveland, Ohio 
Contrast echocardiography has been used for detection of intrapulmonary 
shunts in patients with severe liver disease. However, its relation with physi•
ologiC shunt studies has not been described. 
Methods: We studied 34 consecutive candidates (age 33-66 years, mean 50) 
for liver transplant. All patients had a physiologic shunt study breathing 
100% 02 and a complete transthoracic echocardiographic study including 
a hand-agitated saline injection. 
Results: 13 patients (38.2%) had a positive echo-contrast and 10 (29.4%) had 
a physiologic shunt> 5%. The magnitude of the shunt ranged from 5.8 to 18.9%. 
Contrast + Contrast -
Physiologic shunt + 4(11.7%) 6(17.6%) 
Physiologic shunt • 9 (26.4%) 15 (44.1%) 
Chi square p=O.08 
Pa02 in patients with positive contrast was 84 mmHg and 94.6 mmHg in those 
with negative contrast (p=O.055). 
Conclusion: 1) There is an important discrepancy between echo-contrast and 
physiologic shunt testing in patients with advanced liver disease. 2) Until the 
cause for this discrepancy is known. reliance on either test may lead to under 
detection of patients with hepatopulmonary syndrome. 
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843·16 
Frequency Dependent Ultra§ouncl TlWISducer Obsen'aliOIB With 
M1crobubbles: A Better Method to EnIuP:e Signals? 
Jacqueline Winkelmann, Susan Tiukinhoy, Maitreya Thakkar, Raj 
Chandwaney, Jose Saldivar, Antonio Fernandez, Solomon Aronson, Steven 
Feinstein, Univ. of Illinois at Chicago, Chicago, Illinois 
To enhance the recognition of micro bubbles in the myocardium, we explored 
the possibility that microbubble/frequency interactions may be utilized to 
enhance the detection rate. 
Hypotbesls: Frequency dependent changes associated with microbubbles and 
resonating transducers could be used to enhance reflected ultrasound signals. 
Methods: (I) Tissue phantom (panicle reflectors), (2) Various A1bunex· 
concemrations (microbubble reflectors), (3) In vivo animal studies. 
A commercial ultrasound system (HP-lSOO) with 2.0,2.5,2.7,3.5, and 5.0 
MHz frequency transducers were used. Settings were unchanged for eacb 
study. 
Resulls: The following graphs indicated a frequency response to microbubbles 
not observed with particle reflectors. 
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Conclusioll'l: (I) A frequency response exists with regard to microbubble 
reflectors (not seeD with particle reflectors). in vitro and in vivo, (2) Research 
needs to focus on additional acoustical effeclS in order to enhance microbubble 
sensitivity in tissue. 
843·17 
The Concentration, Ratio, and Bolus of Sonicated Dextro •• 
Albumin Required to Produc. Maximal Left Ventricular 
Opacification Following Intravenou. Injection in Human •. 
Thomas Porter, Feng Xie, Alan Kricsfeld, University of 
Nebraska Medical Center, Omaha, Nebraska 
Improved transpulmonary passage (TPP) of sonicated 
albumin (SA) microbubbles has occurred when the agent is 
mixed with dextrose{O) prior to sonication, and when the 
agent is given in higher concentration boluses. The 
objective of this study was to determine what ratio and 
concentrat ion of 0 to mix with albumin, and determine 
whether a higher concentration bolus of this mixture 
improves TPP in humans. Accordingly, we gave 15 patients 
(mean age 63±12 years) intravenous injections (IVI) of SA, 
as well as 3 and 4-fold dilutions of albumin with either 
5%D(1:305,1:405) or 50%D(1:3D50,1:4D50) prior to 
sonication. These agents were given initially as an 8.0 ml 
IVI (n=9). In the remaining 6 patients, the 8.0 ml sample 
of one 50% and one 5% dilution was also given as a 1.0 ml 
compact bolus by decanting the 7.0 ml clear layer prior to 
IVI. Ejection fraction of the patients ranged from 25-70%, 
and cardiac output ranged from 2.6-7.4 liters/minute. Peak 
videointensity (PVI) and area under the time intensity 
curve (AREA) from the mid-left ventricular (LV) cavity were 
assessed with each injection. Data for 8.0ml injections 
are below(*p<0.005 compared to SA): 
Agent SA 1'3D5 1·3D50 1·4D5 1·4D50 
PVI 9±10 15±l2* 18±10* 14±10* 21t14 * 
AREA 62+75 192+230* 208+187* 1B5+03* 220+212* 
All dilutions (whether with 5 or 50% D) significantly 
improved LV PVI compared to SA. When given as a 1.0 ml 
compact bolus, the 1: 4D50 (1: 4D50c) resulted in a 
significant increase in LV PVI when compared to the 8.0 ml 
1:4D50 injection (4.2±2.8 1:4D50 vs. 6.3±2.3 
1:4D50c;p=0.005). These data demonstrate that (l)multi•
fold dilutions of A with D significantly improve LV 
opacification; (2) since 5%D produces the same PVI as a 
50%0 dilution, the mechanism of improved TPP is not 
increased viscosity; and (3) a compact bolus of these 
dilutions further improves TPP in humans. Compact multi•
fold sonicated dilutions of A with D, therefore, may 
significantly improve the clinical utility of contrast 
echocardiography in humans with structural heart disease. 
JACC February 1994:1A-484A 
843·52 
Echocardiographic Identification of Spontaneously 
Occurring Feline Hypertrophic Cardiomyopathy: A 
Potential Animal Hodel of ~uman Diaease 
Philip R. Fox, Barry J. Maron, Animal Medical Center, 
New York, NY and Minneapolis Heart Institute 
Foundation, Minneapolis, KN 
Autopsy studies in domestic cats have suggested the 
occurrence of a primary cardiac disease resembling 
hypertrophic cardiomyopathy (HCM) in man. We have 
utilized two·dimensional echocardiography (echo) to 
define morphologic and functional features of HCM . 
during life in 46 domestic short-haired cats who were 
initially evaluated because of the suspicion of heart 
disease in a subspeCialty outpatient veterinary 
clinic. Cats were S months-14 years (mean 6 years) and 
had either congestive hesrt failure, arrhythmias, 
syncope, or thromboembolism; 10 died suddenly an 
average of 6 months after echo. Echo showed a variety 
of patterns of left ventricular (LV) hypertrophy 
associated with small LV cavity and outflow tract: 
diffuse (septum and free wall) 37 cats, SO% (including 
15 with concentric hypertrophy); and confined to 
anterior septum (9, 20%). In 31 cats (65%) marked 
mitral valve systolic anterior motion and mitral-septal 
contact produced LV outflow tract obstruction 
associated with a late peaking flow-velocity waveform 
typical of HCM (Doppler gradients, 30-1S0 mm Hg) . 
Conclusions: 1) a spontaneously occurring cardiac 
disease was identified by echo in domestic cats with or 
without LV outflow obstruction, which showed a 
phenotypic expression similar to HCM in humans; 2) a 
variety of patterns of LV hypertrophy occurred, usually 
diffuse, but also more segmental in some animals; 3) 
such cats with HCM may prove to be valuable as animal 
models of the human disease. 
843·53 
First Trimester Normal Human Cardiac Doppler 
Maria Leiva, Jorge Tolosa, Cristiane Binotto, Sharon Weil, 
James Huhta 
Perinatal Cardiology, Maternal-Fetal Medicine, 
Pennsylvania Hospital, Philadelphia, PA 
The changes in cardiac energetics dUring the time of 
cardiac development in the human fetus (4-8 weeks) were 
studied with standard 5MHz transvaginal probes and a 
biplane TEE 5-7 MHz probe (Accuson) to obtain 
information on the size and timing of cardiac events in 
the developing human heart in the first trimester after 
timed in vitro fertilization. Eighty-two studies were 
performed serially in 33 fetuses between 4.9 and 14 weeks 
of gestation (menstrual age) after obtaining informed 
consent. 
The heart size increased linearly from 1-10 millimeters in 
diameter from 5-14 weeks gestation (r=0.88) while peak 
outflow and descending aonic velocities increased from 
10-45 cmls (r=0.65) and 5-40 cmls (r=0.6) respectively. 
Fetal heart rate increased from 60 to 175/minute. 
Umbilical artery pUlsatility index was constant at 3.0. 
Peak inflow velocity ranged from 10-45 cmls and was 
monophasic before and biphasic after 10 weeks gestation. 
A novel observation was a period of isovolemic 
contraction present until 12 weeks gestation occupying as 
much as 20% of the cardiac cycle. Ventricular ejection 
increased from 25 to 50% of the cardiac cycle from 5-14 
weeks gestation. 
Conclusions: Cardiac functional changes occur in the 
normal human hean during the first trimester. High 
velocity monophasic inflow velocities due to atrial 
contraction and the presence of isovolemic ventricular 
systolic contraction delay characterize the early heart 
function. 
JACC February 1994:1A-484A 
843·54 
The Effect of Changes in Heart Rate and Loading on 
Color M·mode Doppler Filling Pattern in the Intact 
Ventricle 
Marie Stugaard, Cecilie RiS0e, Halfdan ThIen, Otto A. Smiseth, 
Institute for Surgical Research and Medical Department B, 
Rikshospitalet, Oslo, Norway 
Color M-mode Doppler (CMD) has recently been introduced for 
the assessment of diastolic dysfunction. An abnonna1 diastolic 
pattern with delayed apical filling of the left ventricle (LV) has been 
found during myocardial ischemia. We investigated the hypothesis 
that such abnonnai CMD pattern might be due to the hemodynamic 
changes which accompany myocardial ischemia. Thus, in 8 
anesthetized dogs we studied the effect on CMD pattern of each of 
the following interventions: 1) Atrial pacing at three different rates: 
120, 135 and 150 min-I; 2) Constriction of both venae cavae (n = 7) 
which caused a 25 % reduction in stroke volume; 3) Rapid 
intravenous infusion of saline to three different levels of L VEDP: 13, 
17 and 22 mmHg. To quantitate the change in the CMD pattern we 
calculated the time difference (TO) between occurrence of peak 
velocity in the apical region and at the mitral tip. TO was 18 ± 8 
(x ± SE) and 16 ± 6 ms at control and pacing at 150 min-I, 
respectively, while time constant of isovolumic relaxation (tau) was 
34 ± 2 and 32 ± 2 ms. TO increased nonsignificantly during caval 
constriction, from 24 ± 11 to 32 ± 18 ms, whereas tau was 
unchanged. During maximum volume loading, TO increased 
slightly, but not significantly, from 23 ± 12 to 33 ± 9 ms, and tau 
was again unchanged. 
In conclusion, changes in heart rate and loading had no major 
effect on the CMD filling pattern of the intact LV. Thus, the observed 
abnonna1 filling during myocardial ischemia cannot be attributed to 
changes in these hemodynamic variables. 
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844-93 
Early Angiographic Predictors of Excess Mortality Risk Following 
Lytic Therapy for Myocardial Infarction; Observations from GUSTO 
Allan M. Ross. Jonathan S. Reiner. Alec Vahanian, Paul Schmidt, John 
Kazmierski. CR Thompson. David Gossman. Joseph Dorchak. Conor F. 
Lundergan. for the GUSTO Investigators. The George Washington 
University. Washington, DC 
The GUSTO trial described the quantitative relationship between 
early coronary patency and survival in patients treated with 
th"?mbolytic .therapy for acute myocardial infarction. We now repon on 
a direct relationship observed between very early (90 minute) post-lytic 
therapy LV function and 30-day mortality. We analyzed the functional 
data on all patients undergoing catheterization at a mean of 97±12 min 
following initiation of lytic therapy in GUSTO. Groups were statified as 
follows: ejection fraction (EF) S 45% (N = 266) vs. > 45% (N = 811), 
end systolic volume index (ESVI) ~ 35 ml/m2 (N = 201) vs.< 35 ml/m2 
(N " 876). and mean infarct zone wall motion S -2.8 SO/chord (N" 
582) vs. > -2.8 SO/chord (N = 495). These divisions were empirically 
selected to divide the cohort into groups with minor vs. major LV 
functional deficits. The 30-day mortality rates for each of the groups 
above. stratified by whether the IRA was open or closed at 90 minutes, 
a,8!0wn below. 
EF ESVI Wall Motion D OpenIRA 
~ St=,.}---4------+---- _ Closed IRA 
S4S >45 >35 s 35 S-2.8 <!-2.8 
.p S .001 
(combining 
open and 
closed ve els) 
ConclUSion: In addition - to the- previously rePorted infarct anery 
patency - mortality relationship, LV function assessed 90 minutes 
following administration of thrombolytic therapy contributes 
substantially to the angiographic separation of 30-day survivors vs. non•
survivors. More precise identification of high-risk groups may help 
select patients who warrant aggressive post-lytic interventions. 
ABSTRACTS 
844·94 
Advantages or Patient-Specific Predictions Over Subgroup Analysis in 
DerIDing Differential Treatment Effects or tP A and Streptokinase From the 
GUSTO Trial 
Robert M. Califf, Maarten Simoons, Kerry L. Lee, Frank E. Harrell. Jr., Eric 1. 
Topol. Duke Coordinating Center, Durham NC 
In an era of constrained resources some societies and heallh care systems may 
choose to use streptokinase (SK) rather than t-PA when the potential benefit of t•
PA is marginal. In the GUSTO Trial the overall treaunent effect was a 14% 
relative reduction and a I % absolute reduction in 30-day mortality with 
accelerated t-PA compared with SK. When subgroups of patients were evaluated. 
the only true interaction between baseline characteristics and treaUnent effect was 
a greater effect of t-PA in pts treated earlier. With regard to all other baseline 
characteristics the treaUnent benefit of t-PA was directly rellUed to the severity of 
~ 0 r---------------------~ 
..; 
2l 
c: 0 ~ N ~ c 
02468 12 16 20 
Baseline (51<) Mortality (%), Quintiles 
the patient's illness (see 
figure) . 
When individual pts are 
assessed. a combination 
of higher risk and low 
risk characteristics may 
coexist. For example. a 
pt with anterior Ml 5 hrs 
out from symptom onset 
might be given t-PA 
because of the anterior 
location. but the time 
from onset might indicate 
equivalent benefit with SK. To deal with this issue we have developed statistical 
models estimating the risk of death. stroke and disabling stroke based on all 
measured baseline characteristics of each pI. Critical characteristics in the 
models include age, Killip Class, infarct location, blood pressure, hean rate. 
diabetes, prior infarction and prior peripheral vascular disease. By estimating the 
likelihood of death and nonfatal disabling stroke for the individual pt treated with 
either t-PA or SK. the clinician can avoid the problem of conflicting subgroup 
recommendations. 
844·95 
Importance or Clinical Findings During Post-Inrarction Angina in 
Determining Prognosis: Results rrom tbe GUSTO Trial 
Amadeo Betriu, Robert M Califf, Christopher Granger, for the GUSTO 
Investigators. GUSTO Coordinating Center, Durham, NC 
Post-infarction recurrent ischemia has been known to poRend an ominous 
prognosis, but the relevance of examination during recurrent ischemia has not 
been assessed in a large popuIation of patients. As pan of the GUSTO Trial 
comparing reperfusion regimens, we examined electrocardiographic ST segment 
deviation (ST) and hemodynamic fmdings (herno). including rales, S3 gallop and 
hypotension. during post-infarction ischemia and evaluated their relationship to 
eventual clinical outcomes. Five groups were developed: Group I-pts without 
post-infarction ischemia; Group 2-pts with recurrent ischemia but no ST or hemo 
findings: Group 3-pts with recurrent ischemia and ST but no bemo; Group 4-pts 
with recurrent ischemia and bemo but no ST; and Group 5-pts with recurrent 
ischemia and both ST and hemo. 
N 
30-day Death 
Reinfarction 
ShOke 
Shock 
CABG 
PTCA 
Hospital stay (days) 
Group I 
32717 
6.7 
1.6 
1.4 
5.4 
6.8 
23.7 
10.7 
Group 2 
4488 
5.6 
7.0 
1.5 
5.3 
13.7 
27.3 
12.3 
Group 3 
3021 
7.7 
21.8 
2.1 
7.6 
18.7 
37.2 
14.0 
Group 4 
337 
21.8 
13.1 
0.6 
28.6 
17.6 
32.6 
14.0 
Group 5 
285 
26.3 
29.6 
1.8 
32.3 
19.4 
45.6 
14.9 
Recurrenl ischemia after thrombolytic therapy is associated with an incremental 
risk of negative outcomes as a function of ST segment changes and 
hemodynamic deterioration. 
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844·96 
Higher Arterial Blood Pressure Is Associated With Lower Mortality But 
Higher Risk of Stroke: Results From the GUSTO Trial 
Philip Aylwanl, Robert Wilcox, Ouistopher Granger, 101m Horgan, for the 
GUSTO Investigators, f1inders Medical Centre, Adelaide, Australia 
Although patients with acute MI presenting with hypertension have been 
shown to benefit from thrombolytic therapy, the risk of stroke is known to 
increase. To determine the relationship of arterial blood pressure to oulCOO1e 
following thrombolytic therapy for acute MI, we examined the relationship of 
systolic blood pressure to 3<H1ay mortality, total stroke, and nonfatal 
disabling stroke in the 41,021 patients in the GUSTO Trial. 
1. 
14 -+-Uorl8l1ty 
12 _Slro1<8 
10 ......... ---1Ing atroke 
% • 
• 
4 
2 
0 
cl00 101- 1111- 117- 121- 130- 134- 141- 1511- >180 
1011 11. 120 1211 133 140 148 lSi 
8pIoIIc BP (mmHg,1n _1M) 
In spite of caution being advised for patients presenting with hypertension 
and the recoounendatioo that blood pressure be COOlrolled before initiating 
thnInbolytics, the relationship of stroke with 1st reconied blood pressure 
(before efforts to cootrol) and blood pressure at study entry was the same. 
This suggests that attempts to cootrol initial hypertension may not 
substantially reduce the risk of stroke. 
In cooclusion. patients presenting with hypertension treated with 
thrombolytic therapy have relatively low mortality rates, but higher stroke 
rates, and slightly higher rates of nonfataI. disabling stroke. 
844·97 
More Aggressive Tbrombolytic Treatment Increases Stroke Risk: Results 
From the GUSTO Trial 
Gabriel t. Barbash, Harvey D. White.1oel M Gore, Ouiswpher Granger. W. 
Douglas Weaver. MaanenL. Simoons. Phil Aylward. Frans Van de Werf. for the 
GUSTO Trial Investigators. GUSTO Coordinating Center. Durham, NC. 
41.021 patients enrolled in GUSTO were assigned 1 of 4 regimens: streptokinase 
with subcutaneous heparin (SK-SQ). streptokinase with N heparin (SK-IV). 
accelerated tPA with N heparin (tPA). and combined SK and tPA with N heparin 
tPA-SK. Of the 592 patients (1.44%) who suffered strokes. 549 (93%) had brain 
images available: 
SK:SQ SK:IY !fA 1fA:SK nuaI 
N (//Pts) 9.841 10.410 10.396 10.374 41.021 
HemOJThagic 0.46% 0.57% 0.70%" 0.88%· 0.65% 
Ischemic 0.56% 0.64% 0.66% 0.56% 0.60% 
Hemonbagic Conversion 0.07% 0.06% 0.10% 0.11% 0.08% 
Unknown 0.10% 0.12% 0.09% 0.12% 0.10% 
Total Stroke 1.19% 1.39% 1.55% 1.64% 1.44% 
·For SK anns vs tPA ann: Total Stroke p= 0.02. hemonbagic p < 0.001. 
Of the 268 patients with hemonbagic strokes. 12 (4.4%) had subdural hematoma 
and 47 (16.6%) underwent surgical evacuations. MortaJity was 34 % in 
hemorrhagic stroke with (versus 61 % without) surgical evacuation. 
Conclusion: Combined tPA + SK and accelerated tPA for myocardial infarction 
are associated with significantly higher risk of intracranial bleeding. 
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844·98 
Functional Status Following Stroke After Thrombolytic Therapy- Results 
From the GUSTO Trial 
Joel M. Gore, Gabriel J. Barbash, Harvey D. White, Christopher Granger, 
W. Douglas Weaver, Maarten L. Simoons, Phil Aylward, Frans Van de 
Werf, for the GUSTO Trial, University of Massachusetts, Worcester, MA 
In the GUSTO Trial there were 589 strokes (1.45%). Tomographic 
scans/autopsy findings were available in 94 % of patients to confirm the 
type of event: primary intracranial hemorrhage UCH) (0.68%), cerebral 
infarction with hemorrhagic conversion (CIHC) (0.06%), non-hemor•
rhagic stroke (non-HS) (0.59%) and unknown type (0.13%). Outcome 
and functional disabiiity by S type were assessed both from the patients 
themselves and from the treating physiCian. There was excellent 
correlation between patient and treating physician. Results were as 
follows: 
Fatal 
Disability 
IQli! 
41% 
1Q:I 
59% 
~ 
26% 
~ Unknown 
16% 70% 
severe 12% 8% 30% 16% 6% 
moderate 14% 11% 17% 21% 2% 
minor 16% 9% 9% 25% 11% 
no 5% 4% 4% 8% 0 
unknown 12% 10% 13% 14% 11% 
Univariate and multivariate analyses will be performed to identify 
factors associated with disability and recovery. 
The incidence of intracranial hemorrhage and non-hemorrhagic stroke 
is similar with thrombolytic therapy. Intracranial hemorrhage is most 
often associated with death, whereas non-hemorrhagic stroke is associ•
ated with disability. Functional status following stroke is important in 
assessing the net clinical benefit of thrombolytic strategies. 
844·99 
Is IV Heparin or Time·to·Treatment Responsible for Differences 
in GUSTO and ISIS-3 Results? 
Jeffrey L Anderson, Labros A Karagounis, University of Utah, LDS 
Hospital, Salt Lake City, Utah 
Failure of tissue plasminogen activator (tPA) to demonstrate a better 
survival outcome than streptokinase (SK) in ISIS-3 has been ascribed 
by some investigators to use of subcutaneous (SC) rather than intra•
venous (IV) heparin. The better performance of tPA than SK in 
GUSTO, which used IV heparin, appeared to substantiate that view. 
However, other differences in ISIS-3 and GUSTO are present, includ•
ing differing enuy criteria for admission ECG (+/-ST t vs+ST t ) and 
for time from symptom onset (<24h vs <6h), as well for average time•
to-treatment (>4h vs 2.Sh). Thus, we explored the hypothesis that 
time-to-treatment and ECG factors, rather than changes in heparin 
(hep) alone, might explain differences in study results. The published 
data bases were used. Odds ratios (OR) of 1 mo. mortality for therapy 
with tPA vs SK were computed and comparisons of results made for 
groups of interest (Table). 
Study/Group OR 
1. I I - (a ) . 7 
Overall results of ISIS-3 and GUSTO were indeed heterogeneous (X2 
homogeneity=4.2, p=O.04). However, comparisons of more compar•
able subgroups (lSIS-3 <6h. ST t vs GUSTO[all) or GUSTO>2h) were 
not significantly different Of note, even in GUSTO, no advantage of 
tPA vs SK was shown in pts treated after >4h. On the other hand, in 
the ISIS-3 <6h, ST t subgroup, a trend in favor of tPA was observed. 
Thus, differences between ISIS-3 and GUSTO may be explained by 
differences in time-to-therapy and EOO enuy criteria (ST t ) as well as 
by augmentation of the heparin regimen (IV vs SC). 
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844·100 
The Influence of Both Time to Therapy and Collaterals on the 
Emcacy of Reperfuslon Therapy In Acute Myocardial Infarction 
Dan W. Giebel, *Raymond J. Gibbons, Timothy F. Christian, David 
R. Holmes, Mayo Clinic, Rochester, MN 
The purpose of this study was to examine the effects of collaterals 
and time to treatment (TIME) on the efficacy of reperfusion therapy 
in acute infarction. Fifty-five patients with a first anterior infarct 
underwent successful thrombolysis (n=23) or direct angioplasty 
(n=32) at 320±285 min. after symptom onset. Tomographic imaging 
with Tc-99m sestamibi was performed acutely and before discharge. 
Using a previously published method, the perfusion defect size on the 
acute and discharge images was quantitated to determine myocardium 
at risk (RISK) and infarct size (INFARCT), respectively. Treatment 
efficacy was assessed by the salvage index, defined as [RISK•
INFARCT]IRlSK, which represents the proportion of RISK that is 
salvaged. Collateral flow to the infarct zone was noninvasively 
assessed with the nadir (NADIR) of the acute sestamibi count proftle 
curve. This parameter has been previously demonstrated to be highly 
associated with angiographic collateral grade in anterior infarcts. 
For all pts, the NADIR correlated significantly (p=.OOOl) with 
salvage index but TIME as a continuous variable did not (p=.34). 
When TIME was dichotomized at 2 hrs, therapy ~ hrs (10 pts) was 
associated with a significantly higher salvage index than therapy after 
2 hrs (mean .80±.26 vs .. 53±.34, p=.02). For therapy >2 hrs (45 pts), 
NADIR was significantly associated with salvage index (p=.OOOl), 
but TIME was not (p>.5). 
Conclusions: I) Reperfusion therapy very early (;5;2 hrs) in acute 
infarction is associated with greater myocardial salvage. 2) After 2 
hrs, the efficacy of therapy is more dependent on collaterals than the 
time to treatment. 
844·101 
Rescue Thrombolysis for Suspected Reinfarction Following 
Thrombolytic Therapy: Experience from the GUSTO Trial 
Gabriel!. Barbash, E. Magnus Ohman, Harvey D. White, Christopher 
Granger, Robert M. Califf, for the GUSTO Investigators, The Chaim 
Sheba Medical Center, Tel Hashomer, Israel 
The management of reinfarction early after initiating thrombolytic therapy 
remains to be established. To explore the experience with repeat 
administration of thrombolytic therapy <Tn to restore patency, patients 
with reinfarction in the GUSTO study were evaluated. Reinfarction 
occurred during the first 30 days in 1628 (4%) of 41,102 patients enrolled 
in the study. Of these, 46% received and 54% did not receive repeat· 
thrombolytic infusions. Patients receiving repeat thrombolytic therapy 
were significantly younger and bad less comorbidity. The time interval 
between the two thrombolytic infusions was 96±80 hours and the time 
from onset of reinfarction to receiving repeat thrombolysis was 1.6 ± 2.6 
hours. 
~ RescueTT No Rescue TT ~ 
Heart Failure 8.5% 13.4% 0.002 
IC Bleed 1.0% 0.2% 0.055 
Stroke 2.4% 1.2% 0.074 
Mortal ity (3Oday) 11.0% 24.0% <0.001 
The time to repeat thrombolytic therapy from onset of reinfarction 
symptoms was similar in patients who died (mean 99 mins) and those who 
survived (mean 109 mins). 
In conclusion, in spite of considerable delays in starting repeat infusions 
of thrombolytic therapy and a marginal higher risk of hemorrhagic stroke 
the use of repeat thrombolysis for reinfarction is associated with an 
improvement in morbidity and mortality. A more aggressive approach to 
patients with reinfarction by using repeat thrombolytic therapy is 
suggested and might be further enhanced with earlier initiation. 
ABSTRACTS 
844·102 
The Risk of Mortality FoUowing Thrombolytic Thenpy Is Cblefly lDf\uenred 
by BueIine CIiniclll Facton: ReIUIts from the GUSTO Trilll 
Kerry L. Lee, Lynn H. Woodlief, Christopher B. Granger, Eric 1. Topol, Roben 
M. Califf for the GUSTO Investigators, Duke University, Durham, NC 
To assess the prognostic relationsblps of baseline clinical characteristics and 
develop a risk model for predicting 30-day mortality following acute myocardial 
infarction and treatment with intravenous thrombolytic therapy (TI'), we 
analyzed data coUected on the 41,021 pIS enrolled in the GUSTO trial. Pts within 
6 bours of symptom onset having ST -segment elevation were randomly allocated 
to TT regimens involving streptokinase (SK), accelerated t·PA, and the 
combination of t-PA and SK. Risk modeling was performed using logistic 
regression and validated using bootstrapping techniques. Variables examined 
included demographics, histoty and risk 18ctors, blood pressure (BP), bean rate, 
Killip class, MI location, symptom duration, and treatment assignment 
Overall, 30-day mortality was 7.0"10. The multivariable analysis identified 
the 5 most significant predictors of 30-day mortality to be: 
~ Mu!tivariable)(2 f 
Age 886 < 0.0001 
Systolic BP 502 < 0.0001 
Killip Class 342 < 0.0001 
HeanRate 269 <0.0001 
MI location 142 < 0.0001 
Age was the most important factor influencing mortality. with rates of 1.2% 
in the youngest age decile (<45) and 20.6% in pts over age 75. Lower systolic BP 
(especially <1I0mmHg), elevated bean rate, higher Killip Class at entry, and an 
anterior infarction were all independently associated with increased mortality. 
Together these 5 characteristics contained approximately 90% of the total 
prognostic information available in the variables examined. Other important 
factors included previous MI, time·te-treatment, type of TT, female sex, diabetes. 
hypenension, previous CABG, and histoty of smoking, with smokers exhibiting a 
lower risk of mortality. 
Although accelerated t·PA produced a 14% relative reduction and a 1% 
absolute reduction in mortality compared to SI<, the Iikelibood of survival 
following TT is strongly affected by multiple other non-treatment factors whicb 
should be considered in the clinical decision process. 
844·103 
Delaying Thrombolytic Therapy Unbl Arrival at 8 Tertiary 
Center Increases Mortality 
Douglas J. Pearce, William J. Rogers, for the National Registry 
of Myocardial Infarction Registry Investigators, University of 
Alabama Medical Center, Birmingham, AL 
To determine whether delaying reperfusion therapy until 
arrival at a tertiary center results in an increase in mortality, 
we examined data from the National Registry of Myocardial 
Infarction. Of 44,339 patients treated with tPA, 11,847 were 
initially evaluated at one center and then transferred to a 
second center for tertiary care. Of these, tpA was initiated at 
the referring hospital in 10,697 patients and at the receiving 
hospital in 1,150. While Slightly fewer males (71.3%vs 74.4%, 
p=0.023) were treated at the receiving hospital, there was no 
difference in age, weight, or Mllocation between the groups. 
Initiating reperfusion therapy at the receiving hospital resulted 
in a median delay in the time from hospital arrival to tPA 
initiation of 105 minutes (165 vs 60, p< 0.001), and In the time 
from symptom onset to tPA initiation of 102 minutes (260 vs 
158, p< 0.001). Patients who had tPA initiated at the 
receiving hospital were more likely to suffer recurrent MI (5.2% 
vs 3.9%, p=O.038) and major bleeding (3.9% vs 2.7% p= 
0.024). Patients in whom tPA was initiated at the receiving 
hospital also had a higher mortality (6.4% vs 4.7%, p=O.OO9), 
not attributable to procedures. 
In summary, delaying reperfusion therapy until arrival at a 
tertiary center substantially increases the time from symptom 
onset to reperfusion and results in a higher incidence of 
complications and mortality. We conclude that to be optimally 
beneficial, thrombolytic therapy should be initiated at the 
primary hospital. 
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845·104 
Aspirin Enhances the Benefits of Late Reperfuslon on 
Infarct Shape: A Possible Mechanism of Aspirin's Beneficial 
Effects on Survival In Acute Myocardial Infarction 
Imad A. A1haddad, Kalhleen M. Sinner, Charles F. Saladino, Edward J. 
Brown, Jr .. Nassau County Medical Center, East Meadow, N.Y. 
Aspirin improves patient survival after acute myocardial inlarction by 
unknown mechanisms. In rats, late coronary artery reperfusion without 
infarct size reduction will prevent infarct expansion. However, the time 
window is limited and late reperfusion's benefits diminish after 8 hours of 
coronary occlusion and are gone after 16 hours. To test the ability 01 
aspirin to enhance the benefits 01 late reperfusion on infard shape, rats 
were randomized into two groups. Aspirin group: rats underwent left 
coronary artery occlusion, followed by treatment with aspirin (12mgJkg in 
O.Sml of 0.9 % saline intravenously). Control group: rats underwent left 
coronary artery occlusion, followed by treatment with placebo ( O.Sml of 
0.9 % saline intravenously). Eight hours after coronary occlusion, both 
groups were permanently reperfused. Rats in the aspirin group received 
aspirin 1211l9'kg daily in the drinking water. Two weeks after acute 
myocardial infardion, hearts were arrested and fixed at a constant end•
diastolic pressure, then sectioned and photographed for morphometric 
analysis. Resu~s follow with mean .±,SEM. 
Aspirin Control P 
(n=9) (n=11) 
Expansion Index 1.24±0.14 2.04 ±0.28 <O.OS 
Infarct Thickness (mm) 0.78±0.09 0.S4±0.OS <O.OS 
Septal Thickness(mm) 1.80 ±0.11 2.07 ±0.13 NS 
Thus, aspirin enhances the benefits of late reperfusion on infarct 
shape following 8 hours of coronary artery ligation. Aspirin may extend 
the time after infarction during which late reperfusion is beneficial. 
Enhancing the benefits of late reperfusion may explain the benefits on 
patient survival associated with aspirin therapy following acute myocardial 
infarction 
845·105 
Adenosine-Induced Improvement in Endocardial Metabolism is 
Mediated by an Increase in Regional Blood Flow 
Kenneth M. McDonald. Jianyi Zhang. Kamil Ugurbil, Jay N. 
Cohn, University of Minnesota. Minneapolis. MN 
We have shown that intravenous adenosine improves the 
reduced endocardial creatine phosphate: adenosine triphosphate 
ratio (CP:A lP) in remodeled viable myocardium in the canine model 
of transmyocardial direct current (DC) shock. To determine whether 
this improvement was due to a reduction in myocardial load or an 
improvement in myocardial blood flow. high energy phosphate 
metabolism was assessed (phosphorus spectroscopy) in viable left 
ventricular myocardium in 14 dogs IS±3 months following DC 
shock. Analysis was performed at baseline (BL) and during 
intracoronary adenosine (A: S()"IOO mcg/kglmin). Myocardial 
blood flow (BF; mVgmlmin: microspheres) and hemodynamics 
were assessed at these times 
ENDOCARDIUM (EN) EPICARDIUM (EP) 
mill m: Cf;AIf BE 
BL l.72iO.8 O.83iO.1 2.l4iO.7 O.82±O.12 
A 1.90iO.6* 3.33iO.6* 2.17iO.7 4.07±O.6* 
* £1<0 OJ with hasdinc 
Endocardial and epicardial CPI A TP at BL were significantly lower 
than in a group of 8 nllrmal dogs (normal EP 2.38±0.2. p=(l.04; 
normal EN 1.96iO.2. p=O.OS). Endocardial CP/ATP was 
significantly improved during adenosine infusion. Since adenosine 
did not produce a significant change in myocardial double product 
(-112±489. p::O.8), the adenosine-induced improvement in 
endocardial CP:ATP in remodeled myocardium appears to be 
mediated by increased blood !low to this region. Therefore. reduced 
subendocardial perfusion could conUihute to remodeling of the 
myocardium in a non-ischemic model of myocardial damage. 
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845·106 
Influence of Lisinopril on Long Tera Mortality 
in Rats With Chronic MI. Role of Blood Pressure 
Reduction and Tissue ACE-Inhibition 
Kai C. Wollert, Roland Studer, Han jOrg Just, 
nd Helmut Drexler. UniVersity of Freiburg, 
Dept. of Cardiology, Freiburg, Germany. 
We determined the relevance of blood pressure 
reduction, inhibition of tissue ACE and 
reduction of left ventricular (LV) hypertrophy 
on the beneficial effects of ACE-inhibitor 
therapy post MI in the rat. Rats underwent 
coronary artery ligation and were treated for 
1 year with vehicle, a low dose (0.3mgjkgjday) 
or a high dose of lisinopril (3mgjkgjday) (n=80 
per group). The 1 year mortality rates were as 
follows: vehicle:S6% low dose:S3% high dose:23% 
(p<O.OOOl high dose vs. vehicle and low dose). 
In another set of infarcted rats blood pressure 
(BP), left ventricular weight (LVW), left 
ventricular ANF-mRNA expression (Northern blot) 
and tissue ACE-activities (nmolHHLjminjmg) were 
measured after treatment for 6 weeks: 
Vehicle Low pose High pose 
BP(mmHg) lll±4 l07±S 91±3 *,§ 
LVW(g) 1.l±0.0 1.0±0.0 0.9±0.0 * 
LV-ANF(units) 2S09±S34 1962±478 973±288 * 
Plasma-ACE S7±S 27±2 * l3±2 * 
Pulmonary-ACE 128±18 4S±6 * 26±S * 
Renal-ACE 0.8±O.1 0.6±0.1 0.2±0.O .,§ 
LV-ACE O.S±O.O O.S±O.l 0.4±0.0 
(* p<O.OS vs. vehicle, § p<O.OS vs. low dose) 
In conclusion, only a high dose of lisinopril 
reduces long term mortality post HI in the rat. 
Reduction of long term mortality is associated 
with a reduction of BP and LV hypertrophy and a 
significant inhibition of renal ACE. 
845·107 
Bndothelins Protect the Ischeaic Myocardium. 
Carlos E. Velasco, Masashi Yanagisawa, 
Dallas VAMC, UT Southwestern Medical Center, 
and HHMI, Dallas, TX 
Our recent studies have demonstrated 
enhanced ET-1 mRNA expression in the 
ischemic tissue, as well as a marked 
increase on infarct size induced by an ETA 
receptor antagonist(AHA meeting). To confirm 
these data, we tested the effect of the non-
selective ET receptor antagonist 
PD14S06S(PD) on infarct size(IS). Dose-
ranging stUdies demonstrated its efficacy to 
prevent ET-l induced vasoconstriction(O.oS 
mg/kg/h). 
DogS(10 control, 9 PO) were subjected to 90 
minutes of LAD ischemia and S hours of 
reperfusion. The PO group received an 
intracoronary(IC) infusion of 0.1 mg/kg/h 
starting 30 minutes before occlusion and 
continued until sacrifice. Control received 
IC saline. Serial hemodynamics, myocardial 
blood flow (MBF), LAD flow, regional MV02 , 
and ET-1 levels were obtained. IS (%AN/AR) 
was determined with TTC. (*=p<0.05). 
MBF(ml/min/g) HRxBP %AN/AR 
Control 0.07+0.02 24,100 3S+4 
PO 0.OS+0.02 23,602 SO+6 * 
Administration of PO increased IS. This 
study confirms our preliminary data obtained 
with the ET~ receptor antagonist. The 
cardioprotect1ve action of ET could be 
related to a myocytic effect and/or to its 
vascular actions including interaction with 
other vasoactive factors. 
lACC February 1994:1A-484A 
845·108 
Relationship Between Heat Shock Treatment, Catalase 
Inhibition, and Infarct Size In Rat Hearts. 
Yanying Auyeung, Richard E Sievers, Vania Barbosa, Christopher L 
Wolle, for the University of Cel~omia, San Francisco, CA 
Recant studies have shown that improved myocardial salvage after heat 
shock pretreatment correlates with the amount of induced cardiac HSP72. 
However, heat shock also induces myocardial catalase activity, potentially 
reducing free radical mediated ischemic injury. To test tha hypothesis that 
heat shock pretreatment reduces infarct size independent of induced 
catalase activity, heat shocked (HS) and control (C) rats were treated with 
3-amino·1,2,4·triazole (3·AT) (1000 mglkg IP), an irreversible catalase 
inhibitor, or saline prior to being subjected to 35 min of left coronary artery 
occlusion and 120 min of reflow. Infarct size, determined by dual 
perfusion w~h triphenyltetrazolium chloride and phthalocyanine blue dye, 
was signifICantly reduced in heat shocked rats both treated and untreated 
with 3-AT. 
Ggp N Iii sjzw1.\I Aiik I!I!laA.\I 
Control 26 25.6±1.9 51.9±1.2 
C+3-AT 23 27.2±1.7 52.5±1.0 
HS 22 14.4±2.2· 49.9±1.6 
HS+3-AT 26 ".8±2.0* 50.8±1.2 
All values expressed as % (mean±SEM) 
*p<0.0001 vs both Control and C + 3-AT groups 
Inf size/Risk area 
48.6±3.25 
52.0±3.02 
28.2±4.0· 
22.5±3.7* 
These data suggest that infarct size reduction in heat shocked rats is not 
secondary to myocardial catalase activity but is more likely due to 
induction of cardiac HSP72. 
845·109 
Attenuation of Calcium Overload and Delay of Cell Death by 
Chlorpromazine and Trifluoperazine in Cardiomyocytes During 
Chemical Anoxia 
Douwe E. Atsma, Lars E.M. Bastiaanse, Lizet van der Valk, Arnoud 
van der Laarse, University Hospital, Leiden, The Netherlands 
Phospholipase A, (PLA,) is considered to play an important role in 
cell injury in cardiomyocytes during ischemia. We examined 
whether the PLA. inhibitors trifluoperazine (TFP) and 
chlorpromazine (CPZ) could influence the rise in intracellular 
calcium ion concentration ([Ca'·U, and the subsequent irreversible 
myocyte damage during chemical anoxia (CA). To this end, 
cultured neonatal rat ventricular myocytes were incubated with 5 
mM sodium cyanide and 10 mM 2-deoxyglucose, in the presence 
or absence of 5 pM TFP or 5 pM CPZ. [Ca'·I; and cell death were 
measured using dual probe fluorescence videomicroscopy, 
employing the fluorescent calcium indicator Fura-2. and the DNA 
indicator propidium iodide. respectively. A speCially constructed 
incubation chamber allowed the study of the effect of TFP or CPZ 
in one half of a culture, while using the other half as control, 
hereby circumventing the natural variability between different 
cultures. [Ca2+l; rose during CA from 0.08 ± 0.02pM to 3.85 ± 
0.37 pM (mean ± SO, n =4) in control, but TFP and CPZ limited 
calcium accumulation to 1.40 ± 0.16 pM (p<O.OOI, n=4) and 
1.38 ± 0.41 pM (p<O.OOI, n=5), respectively. Cell death, 
quantified by determining the time 50% of the cells were no longer 
viable. was delayed by TFP from the control value of 103 ± 6 min 
to 158 :t: 9 min (p<O.Ol, n=4), whereas this was 151 ± 10 min 
for CPZ (p<O.OI. n=5). In addition. cell blebbing was markedly 
limited by TFP and CPZ. We conclude that both TFP and CPZ exert 
protective effects on cardiac myocytes during chemical anoxia, 
confirming the important role of PLA, in the process of irreversible 
cardiomyocyte injury. 
ABSTRACTS 
845·110 
Magnesium Infusion Decreases Platelet Aggregabillty In 
Swine. 
William R. Herzog, Dan Atar. Morton R. Rinder, Paul A. Gurbel, 
Victor L. Serebruany, University of Maryland School of Medicine, 
Baltimore, Maryland 
Recent clinical trials show a beneficial effect of intravenous 
magnesium (IVMG) supplementation given as part of the 
treatment for acute myocardial Infarction (AMI). We hypothesize 
that the benefits of IVMG may be due to decreased platelet 
aggregability. possibly resulting In less coronary arterial reo 
occlusion following successful reperfusion. We observed the effect 
of IVMG on platelet aggregation in 11 female Yorkshire swine in 
platelet·rich plasma utilizing different agonists (ADP 5mM; ADP 
10mM and collagen lmg/ml). Each swine was 10·12 weeks of 
age, and the baseline serum magnesium level was 2.08 ± 0.13 
mg/dl. After sedation, the femoral vein was cannulated and 1 gram 
of MgS04 was continuously infused for 1 hour, resulting in 
elevation of serum magnesium level to 3.57 .t. 0.13 mg/dl. 
Platelet aggregation studies were performed before and 
immediately after the IVMG with a whole blood platelet 
aggregometer. Results are tabulated below. 
Platelet Aggregation(%) 
Before After 
~ Magnesium 
ADP 5mM 38.01 ± 3.13 
ADP 10mM 41.63 ± 3.20 
Collagen lmglml 59.27 ± 1.75 
Magnesium 
24.82 .t. 1.91 
30.64 ± 1.58 
45.36 ± 3.74 
p=0.0014 
p=0.0101 
p=O.0021 
Conclusion: Platelet aggregability significantly decreases in swine 
after IVMG. This may be one factor in the beneficial effect of 
magnesium supplementation in AMI. 
845·111 
Lys.Plasminogen, but not Glu·Plasminogen, Improves the 
Quality of Tissue·Plasminogen Activator·Induced 
Coronary Thrombolysis in Dogs 
Liying Chen, Wilmer W. Nichols, Tom G.P. Saldeen, Marie 
Johannsen, Claus Bregegard, Jawahar L. Mehta, University of 
Rorida, and the VA Medical Center, Gainesville, FL 
Tissue-plasminogen activator (t-PA) restores blood flow in the 
thrombosed coronary arteries, but the artery often reoccludes after 
initial thrombolysis. To examine the hypothesis that the limited 
availability of plasminogen relates to the short·lasting effects of t-PA, 
20 dogs with electrically·induced thrombus in the LAD coronary artery 
were treated with saline (n=IO), Iys-plasminogen (2 mg/kg, n=5) or 
glu·plasminogen (2 mg/kg, n=5) after the occlusive thrombus had 
been stable for 20 min. Neither lys-plasminogen nor glu-plasminogen 
induced reflow in any dog. Ten minutes later, t-PA (1 mg/kg) was 
infused over 20 min and blood flow characteristics including time to 
thrombus, time to restoration of flow, reperfusion rates and 
reocclusion rates were observed for 2 hrs. 
Repeffu- Reocclu- Tune to fimeto Reflow 
sion Rate sion Rate Thrombus Reflow Duration 
(%) (%) (min) (min) (min) 
Saline 
+t-PA 70 71 35:t5 24:t3 41:t5 
Lys-plas 
+I-PA 100· O· 37:t7 14:t4t >60t 
GJu-plas 
+t-PA 80 50 31::4 23:t3 50±S 
Abbreviations: /ys-plas - lys·plasminogen; glu-plas - glu-plasminogen. ·P<O.05 
vs saline +t-PA ; tP<O.02 vs saline +t·PA. 
These data show that treatment with Iys-plasminogen before t-PA 
reduces time to reflow and decreases coronary artery reocclusion rate. 
In contrast, glu-plasminogen has no such effect. Better efficacy of 
Iys-plasminogen may relate to more open structure and greater binding 
(than glu-plasminogen) to the thrombus. 
31A 
32A ABSTRACTS 
845-112 
Effects or Chronic Beta Adrenergic Blockade on 
Excitation-Contraction Coupling in Noninrarcted 
Myocardium. 
Sheldon E. Litwin and James P. Morgan. The Harvard·Thorndike LabcnIory of 
Beth Israel Hospital, BaSIon, MA. 
There is increasing inlrleSt in the use of beta adrenergic receptor (BAR) 
antagonists in die lrealment of heart failure. To detennine the effects of chronic 
BAR blockade 01\ exciratiolH:ontraction (e-c) coupling in failing m)'OC8ldium, we 
SIUdied sham-operated nus (n=13) and nus widllarge myocardial infarction (MI, 
n: 14). Rats were randomized to placebo or proJnIIOloI (Pro, 500 mg/L in drink· 
ing Wilier) I week after surgery. After 5·7 weeks of lrealment (12·18 hours after 
discontinuing propranolol) noninflllCted LV posterior papillary muscles were 
suspended in an organ bath 8I\d loaded widl die bioluminescent calcium indicator, 
aequorin. Conaactility and inaaceIluJar calcium [Ca]i transients were recorded 
during dose·responses to calcium (0.25·3.0 mM) and isoproterenol (InM·IJ.LM). 
Infarct size was not diferent between the two groups (54±2 vs 57±2 % LV), 
bowever, L VEDP was more elevated in Pro treated MI nus than untrcaIed MI nus 
(27 3 vs 21± 2 mmHg). Data are shown for maximally effective [isoproterenol] 
(I J.LM). Results are mean±SEM. DT=deveioped tension (gImmA2); 
dT/dt=g/mmA2Is); Tl/2R=time to 50% relaxation (ms); TPTztime to peak 
tension (ms); TPLztime to peak of aequorin light signal (ms); % fj. [Ca]=% 
change in peak [Ca]i transient after isoproterenol; * p < 0.05 vs sham. 
DT -+<IT1dt Tl/2R TPT TPL % fj. [Cal 
Sham 2.5±0.4 43±8 55±2 101±3 33±2 210±44 
Sham Pro 2.5±0.3 35±4 62±4 1l1±3 40±2 91±19* 
MI l.l±O.3* 15±3* 60±2 123±3* 49±S* 68±16' 
.MI Pro 1.3±O.2* 18±3' 62±63 I 24±4* 50±4* 143±27' 
Summary: I) Noninfarcted m)'OC8ldium in rats with heart failure exhibits: 
I) depressed contractility with prolongation of die time course of the isometric 
twitch and the [Ca]i transient, even during maximal BAR stimulation. 
2) Chronic lrealment with propranolol does not significandy improve 
contractility, e-c coupling, or l! responsiveness in postinfarction heart failure. 
Conclusion: Improved survival seen widl chronic BAR blockade after MI 
may accure by mechanisms other than prevention of myocardial dysfunction. 
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846·19 
Structural Abnonnallties of Connective Tissue In Floppy Mitral VaIve 
Koichi Tamura, 'Yuh Fukuda. *Nobuaki Yamanaka, Victor J. Ferrans 
National Hean, Luog, aod Blood Institute, NIH, Bethesda, MD, aod 
'Nippon Medical School, Tokyo, Japao, 
Accumulations of proteoglycans (PO) are widely recognized as a 
prominent histological fmding in floppy (prolapsed) mitral valves (FMV); 
however, little attention has been paid to the abnormalities of other connective 
tissue components of these valves. To evaluate these abnormalities, 
histological, immuoohistochemical aod ultrastructural studies were performed 
on 12 FMV (from patients with isolated disease, not associated with aoy 
systemic disorder of connective tissue), 5 mitral valves showing focal 
myxomatous chaoges without prolapse, aod 3 normal mitral valves. All FMV 
were thickened by deposits of PO, which corresponded ultrastructurally to star•
shaped graoules that gave a positive Thiery reaction for carbohydrate materials 
and often formed networks in myxomatous areas. The collagen fibrils in FMV 
had an irregular arrangement with poorly formed buodles; S 5 % of collagen 
fibrils had a spiraling substructure. The elastic fibers in FMV showed 
fragmentation, graoular appearance aod poor demarcation of amorphous 
(elastin) components, associated with occasional vacuoles and calcium deposits. 
Masses of microfibrils without amorphous components aod amorphous 
components without microfibrils were also observed. A diffuse positive 
reaction of some elastic fibers with aotielastin aotibody, which is indicative of 
greater penetration of the aotibody into the amorphous cores of elastic fibers 
(due to either degradation or decrease crosslinking of elastin), was a distinctive 
immuoohistochemical fmding in FMV. These alterations were rarely observed 
in nonfloppy, focally myxomatous valves aod absent in normal valves. 
We conclude that: I) the structure of all major connective tissue components 
in FMV is abnormal; 2) alterations in collagen aod PO accumulations are 
nonspecific chaoges that may be secondary to the abnormal mechanical forces 
to which FMV are subjected because of their excessively large surface area; 
3) PO accumulation may interfere with normal assembly of collagen and elastic 
fibers; 4) abnormalities of elastic fibers resemble those in emphysematous 
luogs aod aortic aneurysms, which are characterized by structural dilatation or 
expansion, and 5) alterations in elastin could result from either defective 
formation, increase degradation, or both, of this protein. 
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846-20 
Impact of Leaflet Geometry on the Severity of Mitral 
Regurgitation In Mitral Valve Prolapse: Insights From an In 
Vitro Model 
Ehud Schwammenthal, "ShenQqiu He, "Arnold A. Fontaine, Stephen 
M. Nidorf, Gus J. Vlahakes, "Alit P. Yoganathan, Arthur E. Weyman, 
Robert A Levine. Massachusetts General Hospital, Boston. MA; 
"Georgia Institute of Technology, Atlanta, GA. 
PathologiC reports have suggested that patients with mitrll valve 
prolapse (MVP) coming to surgery most commonly have asymmetric 
and predominantly posterior leaflet involvement. The purpose of this 
study was to address prospectively the hypothe~is that asymmetry 
inthed re ntrirvrs stri I flet I I mntriher 
n tie r f 1 I m nt i I t rmin t 
severity of M In V y Impairing e ective coaptation. itral va ve 
geometry was varied by surgical manipulation of excised porCine 
valves. ~or each geometry, the papillary muscles were displaced 
superiorly in 4 mm increments at a steady flow of 151lmin to produce 
different degrees of prolapse. Results: Symmetric elongation of both 
mitral leaflets (A) caused MR to increase only from 0.2 to 0.7 Ilmin 
with increasing bileaflet prolapse. Asymmetric anterior leaflet 
elongation (8) caused MR to increase from 0.1 to 1.9 Ilmin, and 
asymmetric posterior leaflet elongation (C) caused MR to increase 
from 0.2 to 2.3 lImin with increasing displacement (p < 0.05). 
A fio B ho C .ho ~ /E~ <;g0"1--: 
L;- _b" ==-~ 
The rate of increase in regurgitant flow with displacement was higher 
in posterior leaflet elongation. Conclusion: 1) Severe leaflet 
malcoaptation and MR in MVP result from disproportionate degrees of 
anterior and posterior leaflet displacement rather than from the 
absolute degree of prolapse itself. 2) Posterior leaflet elongation 
results more readily in significant regurgitation than comparable 
anterior leaflet elongation, presumably because of the shorter 
distance between papillary muscle tips and posterior leaflet 
attachment These results highlight the need to reduce asymmmetric 
coaptation in mitral valve repair. 
846·21 
Left Venbicular Function In Significant Mitral Stenosis: 
Echocardiographic and Hemodynamic Data 
Alex Sagie, Ehud Schwammenthal, Igor F Palacios, Nelmacy Freitas, 
Arthur E Weyman, Robert A Levine, Massachusetts General Hospital, 
Boston, MA 
Previous reports have suggested that left ventricular function (L VF) is 
impaired in approximately one· fourth of pts with pure mitral stenosis (MS). 
Those reports were based on cineangiography, in which the LV projection 
and apparent wall motion can be affected by displacement of the LV by an 
enlarged RV with foreshortening of its image. Therefore, to avoid such 
limitations, we analyzed regional and global LV wall motion by cross· 
sectional echocardiography (CSE) in 278 pts (age 55 015) with predominant 
MS who uoderwent balloon mitral valvotomy, in addition to collecting 
angiographic and hemodynamic data. PIs with coronary artery disease were 
excluded. Using CSE, global LV hypokinesia was fouod in only 2% and 
regional contraction abnormalities in 3% of pts (3 anterolateral, 2 
posterobasal and 3 apical). L VEDP was 11.8 0 6.6 mm Hg in the entire 
group. Pts with mild TR and an RA pressure s 8 mm Hg (n = 130) had an 
L VEDP of 10.4 0 4 mm Hg; in contrast pts "ith significant TR and an RA 
pressure> 8 mm Hg (n = 41) had an LVEDP of 13.904.9 mm Hg (p 
0.(01). Accordingly, mean LV chamber compliance was significantly lower 
in the latter group (4.0 + 3.5 versus 6.1 + 4.7 ml/mm Hg, p < 0.GU5). 
Mullivariate analysis of the entire study group revealed that only RA 
pressure and the severity of TR were significant determinants of L VEDP 
(unlike pulmonary artery pressure and resistance, cardiac output and mitral 
valve area. Conclusion: 1) LV systolic dysfunction is uncommon in pure MS, 
and occurs less frequently than previously reported by angiography. As 
suggested in the literature, this may relate to paradoxical septal motion 
causing apparent hypo- or dyskinesis on the angiogram (projection 
technique), but not on the echocardiogram (cross sectional technique). 
2) Increased L VEDP in pis with significant RV volume overload suggests 
an interventricular interaction caused by RV dilatation at the expense of the 
left ventricle. 
lACC February 1994:1A-484A 
846·22 
Postural Changes in Mitral Regurgitation in Patients 
with Mitral Valve Prolapse Echocardiographic 
Considerations on its Mechanism 
Nobuo Fukuda. TOIlIOISUgu TabaIa, Takashi Oki, Arata Iuthi. Kazuyo Manabe. 
Yoshirni Kageji. Miwa Sasaki. Minori Harna, Susumu 110. 
Tokushima University. Tokusbima. Japan. 
<Background and MethodS? It has been believed Ihat the auscultatOry changes 
occuring wilh upright posture in miuaJ valve prolapse (MVP) wilh IaIe sySlOlic 
murmur (LSM) are tdaIed 10 greater prolapse of 1he MV associaIed wilh a small 
left venricuJar (LV) volume in the upright position. To investigate the validity 
of this theory. 12 MVP patients wilh LSM and 7 normal controls (Gr-C) were 
studied by phooo-. echo- and Doppler ecbocardiography. Following parameters 
were compared between the supine position and die sitting position: heart !ale 
(HR); duration and intensity of die LSM; end-diaslOlic and end-syslOlic 
dimensions of the LV (L VDd. LVDs); LV posterior wall motion at Ihe levels 
just below Ihe miuaJ annulus and just above Ihe papillary muscle; extent and 
duration of color Doppler signal of miuaJ regurgitation (MR). 
~ The patients were divided inlO the two groups based on postural 
changes in LSM duration from die supine 10 sitting position: 7 patients wilh 
prolongation (Gr-P) and 5 wilh no change (Gr-N) of die murmur. In 4 of Ihe 7 
patients in Gr-P. die munnur was also intensified. In Ihe sitting position 
compared wilh the supine position. HR showed a significant increase in each 
group wilh similar degree. and LV dimensions (L VDd and L VDs) showed a 
significant decrease in each group, but the degree of decrease in dimensions was 
significantly greater in Gr-P (12.2%) than Ihat in Gr-N (6.5%) and Gr-C (4.1 %). 
In the supine position. all the nonnals and MVP patients showed normal LV 
posterior wall motion. When sitting. 3 of the 4 patients wilh intensification of 
Ihe munnur in Gr-P showed obvious dyskinesia of the LV posterior wall 
extending from die basal portion 10 die mid-ventricle, but only 1 of die 5 
patients in Gr-N showed mild posterior wall dyskinesia confmed 10 the basal 
portion. Postural changes in color Doppler signal of MR corresponded weD with 
those in the murmur with regard 10 1he duration in all MVP patients. 
<Conclusion> The postural changes in MR from die supine 10 sitting position 
in patients wilh MVP may be mainly detennined by the change in LV volume 
and additionally detennined by Ihe development of abnormal motion of the LV 
posterior wall. 
846·23 
Brain Magnetic Aesonance T2-Weighted Imaging (BMAI) 
Suggests High Frequency of Brain Embolism During 
Percutaneous Mitral Balloon Commissurotomy 
Paulo Rocha, Robert Mulot, Pascal Lacombe, Abdel Belarbi. 
Jacques Berland. Bernadelle Ralfestin, Jean Pierre Bourdarias. 
H6pital Ambroise Panl. Rene Descartes University of Paris. 
With the use of transoesophageal echocardiography before 
each procedure to rule out atrial thrombi. stroke frequency 
during percutaneous mitral balloon commissurotomy 
(PMBC) is reduced. The common finding of thrombi over the 
balloons when they are pulled back alter dilation. prompted 
us to look for evidence of minor brain embolisms by a 
sensitive technique such as BAM!. In each of the 23 patients 
(pt) studied, BMAI was performed 48 h before and after 
PMBC. Anticoagulation was stopped 48 h before PMBC and 
O.7mg/kg iv heparin was administered after transseptal 
catheterization. 
There was evidence of brain embolism (hyperintensity foci 
(HI)) in 19/23 pt belore and appearance of new HI in 9/23 
pt after the procedure. In these 9 pt. PMBC had been 
performed with Inoue's balloons (4pt) or bifoil balloons 
(5pt). 
Locations of the new HI were: in the white-matter of the 
left (L) parietal (1 pt). right (R) parietal (1 pt). L frontal 
(2pt) lobes. In the L cerebellum (2pt). the semiovale A 
centrum (1 pt). the body of the R caudate nucleus (1 pt). the 
corpus callosus(1pt). 
These new HI were always smaller than 1cm in diameter 
and asymptomatic. Since time interval between the 2 SMAI 
was short. new HI were most likely related to embolisms and 
not to other causes such as local degeneration of myelinated 
axons. gliosis etc.. In none of these pt. the procedure was 
complicated by a prolonged period of hypotension. 
Brain embolism is frequent during PMBC but in most of the 
cases. limited and free of clinical signs 
ABSTRACTS 
846·24 
Long-Term Results After Successful Percutaneous Mitral 
Commissurotomy in 523 Patients_ 
Bernard lung, Bertrand Cormier, Joseph Elias, Jean-Marc Porte, 
Pierre-Louis Michel, Alec Vahanian, Jean Acar - Cardiology 
Department - Tenon Hospital, Paris, France. 
The long-term efficacy of percutaneous mitral 
commissurotomy (PMC) was assessed in 523 patients (pts) who 
had undergone successful PMC, as defined by a fina1 valve area 
(V A) > 1.5cm2 without mitral regurgitation > 2/4. 
Before PMC, their mean age was 46±8 yrs (18-86). Eighty-two 
pts (16%) had had previous surgical commissurotomy; 385 (74%) 
were in NYHA class III or IV; and 312 (60%) were in atrial 
fibrillation. Echocardiographic examination showed that 84 pts 
(16 %) had pliable valves without severe subvalvular disease, 3 IO 
(59%) had extensive subvalvular disease, while 129 (25%) had 
calcified valves. PMC was performed using a single balloon in 13 
pts , 2 balloons in 346, and the Inoue balloon in 164. 
After PMC, VA increased from 1.1 ±.2 to 2_0± .3cm2 as 
assessed by 2D echo (p< .001). 
Clinical follow-up (FU) was carried out for 50s patients (97 % ). 
Mean FU was 32±18 months (1-74). The 5-year actuarial results 
were: survival in 93±4%; survival without operation in 83±6%; 
and survival without operation and with persistent good functional 
results (GFR) (NYHA class I or II) in 76±6%. 
A multivariate Cox model identified the following predictors of 
GFR: valve anatomy as assessed by echocardiograpby (p= .007), 
pre-PMC NYHA class (p=.05), pre-PMC cardiothoracic index 
(p=.004). and VA after PMC (p=.008). There was no 
significant relationship between the type of balloon used and late 
results (p = .54). 
We conclude that after successful PMC 1) Functional results are 
good at 5 years. 2) Continued GFR are related to valve anatomy, 
NYHA class, degree of cardiomegaly before PMC, and the 
quality of initial results. but not to procedural variables. 
846·25 
Superior Acute and 6 Month Results With Fewer Complications Using 
the Inoue Balloon Technique for Mitral Commissurotomy 
John S. Wilson. Steven E. Hearne. J. Kevin Harrison. Eric B. 
Lieberman. Frank D. Tice. Katherine B. Kisslo, Cynthia H. Pierce. 
Charles J. Davidson. Donald D. Glower. Thomas M. Bashore 
Duke University Medical Center. Durham. NC 
A consecutive series of 164 patients undergoing percutaneous balloon 
mitral commissurotomy (BMC) was analyzed to compare outcomes using 
the Inoue balloon method (n=101) with patients using standard single 
(n=12) and double balloon (n=51) (non-Inoue) commissurotomy. 
There were no differences in baseline demographics or hemodynamic 
measurements. including the hemodynamic mitral valve area (MYA), 
between the 2 groups. Serious complications were defined as death. 
emergent mitral valve replacement (MYR). stroke, or cardiac perfora•
tion. 
RESULTS (mean ± SD) 
EchQ Data 
Doppler MY A pre(cm2~ 
Doppler MY A post(cm ) 
Echo Score 
Echo Score> 8 
Cath Complications 
30 day - all 
30 day - serious 
MVR within 6 months 
1.1 ± 0.3 
1.9 ± 0.5 
7.6 ± 2.3 
35% 
Non-lnQue 
1.0 ± 0.3 
1.7 ± 0.5 
6.4 ± 2.3 
11% 
NS 
0.02 
0.002 
0.001 
22/101(22%) 24/63(38%) 0.02 
5/101(5%) 7/63(11%) 0.07 
4/79(5%) 12/63(19%) 0.009 
Thus, despite significantly higher chest wall echo scores and similar 
baseline hemodynamics, patients undergoing BMC using the Inoue 
method had a larger final MY A. fewer 30 day complications. and less 
need for mitral valve replacement (MYR) at six months compared with 
patients treated with standard single or double halloon methods. 
33A 
34A ABSTRACTS 
847 Ventricular Arrhythmias: Electrophysiology 
Monday, March 14, 1994 Noon-2:00 PM 
Georgia World Congress Center, Hall H 
Presenting Hour: Noon 
847·63 
Percutaneous Microwave Ablation of the Ventricular 
Myocardium Using a 4-mm Split-Tip Antenna Electrode: A 
Novel Method for Potential Ablation of Ventricular 
Tachycardia 
Shoei K. Stephen Huang, James C. Lin, Frank Mazzola, Luis A. 
Pires, Alan B. Wagshal, Robert S. Mittleman, Yu·Jin Wang, 
University of Massachusetts Medical Center, Worcester, MA. 
To evaluate the feasibility of ablating ventricular tachycardia 
using a custom·made 7F bipolar catheter with a 4-mm split·tip 
electrode capable of recording intracardiac electrograrns, and a 
coaxial microwave antenna designed to transmit the microwave 
energy (2450MHz) preferentially at the tip of the electrode, we 
performed c1osed-chest ablation in 10 mongrel dogs. Based on 
our data from the in·vitro experiment, each dog received a single 
pulsed ablation (30 watts for 30 sec) at 4 distinct LV and 2 RV 
(apex and outflow tract) endocardial sites except for I dog who 
died of intractable ventricular fibrillation after receiving 4 
ablations in the LV. There was no change in the arterial 
pressure during energy delivery. Animals were sacrificed 
immediately after the procedure. A total of 40 LV and 18 RV 
discrete lesions were created. Four of the LV and 12 of the RV 
lesions were transmural. The mean size of lesions was 10.4 x 
9.1 x 7.Omm (length x width x depth) or 379.0mm3 (volume) for 
LV ablation and 10.4 x 8.4 x 5.2mm or 249.3mm3 for RV 
ablation. Each hemielliptical or hemispherical lesion consisted 
of a central crater covered by a thin layer of thrombus, along 
with a pale necrotic and a hemorrhagic peripheral zone. We 
conclude that the lesion is discrete and the size is large enough 
that it is possible to ablate a ventricular tachycardia focus using 
this new microwave antenna/catheter ablation system. 
847·64 
Influence or Exerdse ud Sport AdiYity on Functlonll Symptoms 
and Ventricular Arrhythmias In Arrhythmogenlc Right Ventricular 
Disease. 
Claude Daubert, Martine Vauthier, Fran~ois Carre, Marcel 
Laurent, Christophe Leclercq, Philippe Mabo. Department of 
Cardiology, University Hospital, Rennes, FRANCE. 
Sport activity (SA), the circumstances In which functional 
symptoms (FS) occured, and the influence of exercise testiq (ET) 
on ventricular arrhythmias (VA) were analyzed in 74 consecutive 
pts, 5 I males and 23 females, referred to the same institution 
between 1981 and 1992 for arrhythmogenic right ventricular disease 
(ARVD). Mean age at symptom onset was 35 % 12.5 yrs. 
22 pts (29.7 ~) had intensive and regular SA (sport group), 
including competition in 13 (17.6 ~) (c:ycling : 8 ; running: 3 ; 
soccer: I ; triathlon: I). Compared to non sport group, mean age 
was Significantly lower (28.3 % 10.2 vs 36.5 % 13.3 yrs ; p < 0.02). FS 
(palpitations: 75 ~ ; presyncope : 52 ~ ; syncope : 30 ~ ; aborted 
sudden death: 2. 7 ~) were obviously related to exercise in 31 pts (42 
~), exclusively in 2S and preferentially in 6. This feature was 
significantly more frequent in sport group (14122 vs 17/52: p < 0.01). 
Considering all pts, there was no significant difference for age 
between pts with exercise related FS and others. VA were 
significantly worsened during ET in 33 pts (44.6 ~), Including 
exercise induced sustained VT in 13 and non sustained VT in 9. VA 
exercise worsening was more frequent in sport group (15122 = 68.2 
~) than in non sport group (18/52 = 34.8 ~ ; p < 0.01). 
(n conclusion, this study shows a surprising but obvious 
assOCiation between ARVD and SA. (n addition, the high 
prevalence of exercise related FS and of exercise induced VA 
indicates that the consequences of ARVD are very dependent on 
sympathetic tone, especially in athletes. This can suggest an 
important role for beta-blockers to treat those pts. 
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847·65 
Right Ventricular Dysplasia: A Need for Precise Pathological 
Defmition for Interpretation of Sudden Death 
Win K. Shen, William D. Edwards, Stephen C. Hammill, Bernard 1. 
Gersh, Mayo Clinic, Rochester, MN 
Right ventricular dysplasia (RVD) is commonly defmed as a 
partial absence of the RV myocardium with fatty infiltration. 
Considerable variation of the prevalence ofRVD in autopsy studies 
has been reported. One possible explanation is that fatty infiltration 
is a nonspecific marker. To examine this hypothesis, multiple 
histological sections of the RV were studied from 54 sudden death 
victims ages 20-40 yrs from Olmsted County, MN, between 1960-
1989. RVD was suspected histologically when adipose tissue 
infiltrated at least 75 % of the-free wall thickness. Histological 
features consistent with RVD were found in 9 subjects (17%). 
Among the 9 subjects, causes of death were established in 6 (mean 
age 36±2; all female): 1 had aortic dissection due to medial necrosis, 
2 had acute coronary syndromes, and 3 had seizures. Of the 
remaining three subjects (mean age, 27±6; 1 female and 2 males), 
causes of death were uncertain: I had presumed arrhythmias due to 
atrioventricular nodal artery stenosis, and 2 had undetermined causes 
of death with a history of cocaine abuse. Of the 6 subjects with an 
established causes of death, 1 was taking birth control pills, I was 
receiving estrogen replacement therapy, and 3 were taking 
anticonvulsive medication. Conclusions: 1) Pathological features 
suggestive of R VD are relatively common among young sudden 
death victims; 2) The role of R VD in cases of sudden death may be 
complex and variable. 3) Acquired conditions inducing changes 
mimicking RVD or inducing arrhythmias in pts with underlying 
RVD warrants further investigation; 4) A precise pathological 
definition of RVD is needed to distinguish this entity from normal 
variants. 
847·66 
Long-term Outcome of Patients with 
Arrhythmogenic Right Ventricular Dysplasia. 
Guillaume Canu, Gilbert Kirkorian, Jean·Philippe Claudel, 
Philippe Chevalier, Christian Bellon, Enrique Moncada, 
Paul ToubouI. H6pital Cardiologique, Lyon, France. 
From 1971 to 1989, 22 patients (pts), 3 women and 19 men, 
16 to 5S yrs (36H2) were hospitalized for a documented 
episode of ventricular tachycardia associated with features 
of arrhythmogenic right ventricular dysplasia (ARVD) on 
angiography. ventricular tachycardia related symptoms 
were palpitations in 7 pts, syncope or dizziness in 12 pts. 3 
pts had no symptoms. A familial history of ARVD or sudden 
death was present in 6 pIS. Treatment included empiric or 
electrophysiologically-guided antiarrhythmic medication 
in all pts, catheter ablation in S pts, heart transplantation 
due to intractable right ventricular failure in 2 pts, 
automatic implantable defibrillator in 1 pt. Patients were 
followed up for 1 to 42 yrs (11±9) from the first episode of 
ventricular tachycardia. Ventricular tachycardia could be 
controlled by antiarrhythmic medication in IS pts. Three 
pts had episodes of ventricular fibrillation that were 
successfully treated. Severe right ventricular failure 
developed in 4 pts requiring heart transplantation in 2. 
There were 3 sudden deaths at 7, 7 and 8 yrs respectively: 
2/3 pts had had prior ventricular fibrillation. Ten year 
actuarial survival rate was 7S %. In conclUSion, pts with 
ARVD have a less favorable outcome than generally 
aknowledged, even though ventricular tachycardia can be 
controlled by antiarrhytmic therapy in most cases. Sudden 
death can occur lately during the course of the disease. 
Occurrence of ventricular fibrillation is a predictor of 
poor prognosis. 
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847·67 
Does Microwave Heating in Saline Predict the 
3·Dimensional Heating Pattern in Myocardium? 
Amin Ahmad, N. A. Mark Estes m, Antonis S. Manolis, 
·Paul J. Wang. TuftslNew England Medical Center, Boston, MA 
Microwave (MW) energy has been proposed as an energy source 
for the catheter ablation of cardiac arrhythmias. MW acts via 
radiative heating and may result in deeper heating and larger 
lesions. MW temperature parterns may be rapidly studied using 
saline as a medium, but it is not known whether the change in 
temperature(TEMP)Itime in saline predicts the myocardial thermal 
panero. Thus, we delivered 15 wans of MW for 30 sec to 
excised ovine \eft ventricular tissue in a bath of circulating saline at 
37 degrees C. TEMP was monitored using fluoroptic probes at 
depths of 1.5, 3, 4.5, and 6 mm and along the antenna before and 
after MW delivery, creating a 3-dimensional(3-D) map. The 
TEMP-time curves were fit to 4th to 7th order polynomial 
functions. At the onset of MW, the derivative of this polynomial 
was determined. The change in TEMP/seconds in saline was 
compared to the change in TEMP/seconds in myocardium and to 
the myocardial thermal map at the end of MW. 
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The 3-D pattern of change in TEMP/sec in saline is comparable to 
the parterns of the change in TEMP/sec in myocardium and the 
myocardial thermal map. Thus, 3·D thermal maps in saline may be 
used to rapidly predict myocardial thermal patterns during ablation. 
847·68 
svi4ence of Kultifora Propagation in the 
Critical Zone of Slow Conduction in a.entrant 
Ventricular Tachycardia 
Morio Shc,da, Hiroshi Kasanuki, Satoshi Ohnishi. Jun 
Umemura, Saichi Hosoda, The Heart Institute of Japan, 
Tokyo Women's Medical College, Tokyo, Japan 
Electrophysiologic structures of the reentry circuit of 
ventricular tachycardia (VT) are still controversial. 
To clarify features of the propagation inside the 
critical zone of slow conduction (SC) of reentrant VT, 
the results of the electrophysiologic testing at sites 
where catheter ablation had been successful for 
elimination of VT were analyzed . Eleven reentrant VT 
patients (pts) with organic heart disease 
(arrhythrnogenic right ventricular dysplasia in 7 pts 
and myocardial infarction in 4 pts) were studied. The 
mean cycle length of VT was 359 ± 61 rnsec (range; 290-
425 msec). All intracardiac electrocardiograms at 
successfully ablated sites showed diastolic potentials 
during VT, and the overdrive stimulation at the sites 
revealed a perfect pacernap andlor concealed entrainment 
with the stimulus-QRS interval corresponding to the 
interval between a discrete diastolic potential and the 
onset of QRS. Although the pacing stimulus-QRS interval 
at this site stayed constant in 2 pts, the interval 
lengthened gradually from 92 ± 44 rnsec to 189 ± 32 rnsec 
with early extrastimulation as the result of 
decrementa1 conduction in 9 patients. There were abrupt 
changes in the paced QRS complex morphology with 
prolongation of stimulus-QRS interval indicating an 
existence of multiple exits in the zone of SC in 6 pts 
and there were not in 5 pts. In 2 pts , the "jump up" 
phenomenon of the stimulus-QRS interval without any 
change in the QRS morphology indicating an evidence of 
alternative pathways to the same exit in the zone of SC 
was observed. We conclude that the electrophysiologic 
structure of the zone of SC in the circuit of reentrant 
VT is complex and propagation of the excitation is 
multiform in some cases . 
ABSTRACTS 
847·69 
Bretyliwn Tosylate Is Ineffedlve for Ventricular Tachycardia. 
Steven L. Zeleokofske, Dwayne Siu, Patricia Van Etten, Edith Menchavez•
Tan. Fredrick Ehlen, Jonathan S. Steinberg. St, Luke's-Roosevelt Hospital 
Center and Columbia University. New York, NY. 
Bretylium tosylate (BT) is I of only 3 intravenous antiarrhythmic drugs thaI 
are currently FDA-approved for the trealIDent of VT and is pan of the 
preseO! ACLS protocol. While previous studies have demonstrated the 
usefulness of BT in the treaUnent of ventricular fibrillation, there is little 
clinical data to suppan the use of BT for VT. We therefore prospectively 
evaluated patiems with inducible VT to analyze the effectiveness of ST. 15 
patients were consecutively evaluated; age: 63.±13 years, sex 9M/6F, 
presenting arrhythmia: 13 VT/2 VF, bean disease: 13 CAD, I dilaled 
cardiomyopathy, I other, LVEF 39.±16%. All patients bad reproducibly 
inducible sustained monomorphic VT al baseline EPS. After baseline EPS, 
patients were loaded with BT at 10 mg/kg and maintained on 2 mg/min 
during repeal EPS. Results: 
~ .l!LS1wb: pValue 
Systolic BP 109.±14 88.±18 p=O.04 
AERP(600)(ms) 234.±28 227.±20 NS 
AVNERP(600)(ms) 297.±72 268.±61 NS 
VERP(400)(ms) 233.±21 231.±24 NS 
2 patients could not complete EPS due to severe hypotension during BT 
infusion. The remaining 13 patients were still inducible after BT with the same 
morphology of induced VT. The cycle length of VT before and after BT was 
similar: 277.±60 ms vs. 288.±55 ms,(p=NS). VT induction required fewer 
exttastimuli (1.6.±O.7) with BT than without BT (2.2.±0.7,p=0.03).6patients 
were induced with ~ I fewer exttastimulus with BT. VT was tenninated with 
DC cardioversion in 3 patients prior to BT and 5 after BT. 2 patients 
developed more hemodynamically unstable VT with BT requiring 
cardioversion whereas only I bad improved SBP but no change in symptoms. 
The remaining patients had no change in VT hemodynamics or sympwms 
with BT. CONCLUSION: BT was uniformly not useful in the trealIDem of 
inducible VT. These results warrant concerns regarding BT's efficacy against 
spontaneous VT and reconsideration of current ACLS reccommendations. 
847·70 
RADIOFREQUENCY CATHETER ABLATION FOR VENTRICULAR 
TACHYCARDIA NOT ASSOCIATED WITH CORONARY HEART 
DISEASE. 
Guiller'mo E. 5osa-Suarez, Tom G.Trouton, Sean S.O'Nunain, Stefan 
Osswald, Irving Perez, Brian A. McGovern, Jeremy N. Ruskin, Hasan Garan. 
Massachusetts General Hospnal, Boston, MA. 
Eighteen consecutive patients (ptS) wnh ventricular tachycardia (VT) not as•
sociated w~h coronaty artety disease (CAD) underwent transcatheter 
radiofrequency ablation (RFA). There were 9 men and 9 women. Mean age 
was 48y (32 to 77). Nine patients had normal hearts (NHD), 4 pts had arrhyth•
mogenic right ventricular dysplasia (ARVD), 4 pis had dilated cardiomyopa· 
thy(OCM) and one pi had scleroderma. Mean LV ejeclion fraction was 
60%7.9"/ •. A mean of 3.5 (1 to 6) antiarrhythmic drugs(AAD)/pt had failed to 
control VT. SYrT\'loms were syncope in 8 pts, pre-syncope in 7 and palpUa•
tions In 2 pis. Mean cycle length of VT was 349 ms(250 to 400). Pacemapping 
and the earliest local activation lime (LAT) recorded during VT mapping were 
used to guide RFA. RESULTS: VT origin was the RV outflow tract in 10, RV 
free wall in 1 , inferobasal RV in 2, RV septum in 2, anterolateral LV in 1 and ba•
sal lateral LV In 2. Mechanism of VT was reentty in 10 and triggered activUy in 
8 pts. A perfect surface ECG match w"h pacemapping was possible in 14/18 
pts. Mean LA T olthe site of earfiest depolarization was 68;t24 ms earlier than 
surface aRSonset. Mean number of RFapplications was 8 per pt (2to 16). 
There were no complications. RFAwas successful in eliminating inducible VT 
In the pt with scleroderma, in 719 pIS w"h NHD, in 314 pts wnh ARVD and in 1/4 
pts with OCM. Six pts were discharged on AAD and one patient received an 
iJr4)lantable defibrillator. No pt w~h a successful RFA was slarted on new 
AAO. Aller a mean follow up of 13.4 % 7.2 months VT recurred in 316 pts w"h 
unsuccessful RFA and in none of the 12 pts w"h successful RF A. 
CONCLUSION: 1) RFA of non-CAD ventricular tachycardia is feasible and 
safe. 2) In patients wllh structurally normal heans Ihe acute success rate 01 
VT-RFAwas high, as was the long term efficacy of the RF procedure in pre•
venting the recurrence of VT, off all antiarrhythmic drugs. 
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847·71 
Catheter Ablation for Successful Management of Left Posterior 
Fascicular Tachycardia. An Approach Guided by Recording of 
Fascicular Potentials. 
Demosthenes Katritsis, Arif Absan, MalIc H Anderson, A John Camm, David E 
Ward, Edward Rowland. DeparUDent of Cardiological Sciences, St George's 
Hospital Medical School, London, England. 
Five consecutive patients (mean age 27 years, range 16 to 39 years) with 
ventricular tachycardia originating from the left poSlerior fascicle (LPFT), 
undeIwent electropbysiology study and detailed mapping of endocardial activation. 
They were successfully treated with low-energy DC ClUTent ablation. The 
selection of ablation siles was based on !be recording, during LPFl' and sinus 
rhythm, of a descrete poIeDtial preceding !be earliest ventricuJar elecUogram and 
which was thought to represent conduction through the poSlerior fascicle. 
~ 
foe V Fe V4 ~ ----~ 
Fascicular potentials recorded during /QC/rycarditJ (left) and sinus rhythm (riglll). 
No patient had any change in intraventricular conduction. Tbe average 
fluoroscopy and procedure times were 21 min (range 6 to 32 min) and 116 min 
(range 50 to 176 min) respectively. In a follow-up period of 2 to 8 months, four 
of !be patients were asymptomatic and !be mnaining had minor symptoms. 
These data suggest a specific anatomical substrale in the mechanism of 
LPFl'. Fascicular poIentials can be reproducibly recorded in LPFl' and may save 
as a reliable marl!:er for successful ablation procedures. 
847·72 
Combination Therapy with Type Antiarrhythmic Drugs: 
Elactrophysiologic Predictors of Efficacy 
Malcolm Foster, Stephen R. Shorofsky, Robert W. Peters, Michael R. 
Gold. University of Maryland, Baltimore, MD 
Despite the increasing use of non-pharmacologic therapy for life•
threatening ventricular arrhythmias (VA), type 1 antiarrhythmic agents 
remain one of the first lines of treatment. To determine the factors 
predictive of success in the electrophysiology laboratory, we examined 
the results of drug testing in 100 consecutive patients receiving a 
combination of type 1 A and 1 B drugs. All pts had sustained ventricular 
arrhythmias inducible in the baseline state that were not suppressed 
with a type lA agent alone. Results are expressed as the difference (.) 
between the baseline and drug-treated (combination therapy with type 
lA and 1 B drugs) states. 
n NERP6 "VERP4 "PR "ORS "OTC 
R 24 47±41 50±28 5±43 -3±16 26±63 
NR 76 30±31* 33±35* 18±32 8±20** 25±58 
-responder, NR-non-responder; VERPti and VERP4-ventrlcular 
effective refractory periods at paced cycle lengths of 600 and 400 
msec., respectively; *p = .05; * *p = .02 
We conclude that lengthening of refractoriness without accompanying 
prolongation of repolarization is a key factor in the efficacy of combined 
type 1 A and 1 B therapy. In contrast, depression of intraventricular 
conduction, the prototypical type 1 antiarrhythmic electro physiOlogical 
effect, correlated negatively with outcome. This information may help 
to explain the success of type 3 antiarrhythmic agents in recent clinical 
trials and may be of use in designing future studies with type 1 drugs. 
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848·38 
aTc Prolongation in Hypothyroidism 
Cyril Nathaniel, Leila Caleb, Michael A. Azrin. 
University of Connecticut,Department of Cardiology, Farmington, CT 
Hypothyroidism may be associated with various cardiac 
manifestations including prolongation of the aRS and aT intervals 
and even torsades de pointes. The relationship of aT prolongation to 
the extent of hypothyroidism was characterized in this study. 
Methods: All patients admitted with a history of hypothyroidism 
were eligible. Those with confounding conditions were excluded. 
Controls consisted of patients receiving adequate thyroid hormone 
replacement. Study patients had elevated TSH levels. aTc intervals 
and TSH levels were determined in all patients. 
Results: 19 eligible patients were retrospectively identified: 
eleven with an elevated TSH (30.5 ± 22.4) and 8 controls with TSH 
levels in the normal range (0.9±1.1). The aTc was prolonged in the 
study patients (0.47±0.04) compared to controls (0.39 ± 0.05). 
p< 0.002. In the hypothyroid patients there was a direct relation•
ship between TSH level and aTc r=O.87, p=O.Ol. There were no 
significant differences in heart rate, age or serum electrolytes. 
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Discussion: SignifICant prolongation of the aTc intervals occurs 
in inadequately treated hypothyrOidism, and the degree of aTc 
prolongation is directly related to the severity of hypothyroidism. 
These findings may be important in diagnosis, therapy and 
interpretation of aTc prolongation. 
848·39 
aT DISPERSION IN NORMAL SUBJECTS AND PATIENTS WITH 
MYOCARDIAL INFARCTION 
Parveen Uppal, Param P. Sharma, Rafique Ahmed, Jonnalagedda S.M. 
Sarma, Mark Urman, Jack Farahi, Bramah N. Singh. West Los Angeles 
VA Medical Center, LA, CA 
Abnormal dispersion of aT interval is considered indicative of electrical 
instability, a predictor of arrhythmic events in patients with heart 
disease. Changes in OT/OTc dispersion in myocardial infarction (Mil are 
not well defined. We compared aT and OTc dispersion in patients with 
myocardial infarction and age-matched controls. 
Methods: From 12-lead ECG, paper speed 25 mm/sec, we compared 
aT dispersion (OTOI and OTc dispersion (OTcO) in 84 patients (mean 
age 64 ± 7.5yrl with remote MI to those in 40 normal (N) subjects 
(mean age 59.7 ± 7.3yrl. OTO and OTcO were calculated as 
differences between minimum and maximum OTc intervals for each 
subject. Results (mean ± SO) 
OTc 
OTD 
OTc s420 
OTc >420 
OTcO 
OTc s420 
OTc >420 
MI (msec) 
429.2±24.6 
54.4±17.8 
54.4±17.9J NS 
54.5± 18.8 
58.7±20.1 
54.5±18.6JNS 
62.1 ±20.9 
N (msec) P 
412.2±19.4 0.0001 
23.7±9.1 <0.0001 
22.8±9.9) NS 
25.3 ± 7.4 
29.9±14.4 <0.0001 
26.8±18.6] p=0.05 
36.2±12.0 
Conclusions: 1. Compared to controls, OTO & OTcO intervals are 
significantly prolonged in MI patients. The prognostic significance of 
abnormal OTO and OTc dispersion is unclear but may be predictive of 
arrhythmic events. 
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~ Modale""" AtIIaIII ....... """ CIIpuIr III LQ'!'II1Dd 
IfaaU: artJKrfe CUIICIII DIIIIDg .... ad ~.Jl!oo!mc!. 
L1Zhang. O. MIchael VIncent, Department ofMedlcIne, LOS IbpltallUntv. 
of Utah HaalIh Selena. Center. 5a1t Lake Cily. UT 
Sympathetic .tImulation and blockade ani Important In the genesis of 
lYJIIPIoma and Ueatment ~ of LQTS. We evaluated the ratio of 
QTpIQTe (_ diagram a) .. a markar ol8YJlqlathetic elfecla. 
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OTPIQTe decreued during Ell In LOTS and NIl. The decrease was 
attenuated during ElI+E. p<.oooa for LQTS &lid <.OS for NIl. OTPIQTe 
Increuecl .t r..t wkh E In LQTS bat IIOC NIl. 
Cqu:1geIrwc We have Ihown chang .. In QTp/QTe willi ~thetlc 
lIIOdulation. The dec_ of OTPIQTe during Ell Indlcat .. an Increase In 
the diapIrIIy of repoIu\zation. TIle Inc_ In QTp/QTe willi E at rest. 
&lid attenuation of QTp/QTe decnIue by ElI+E IInpIieI that p-adrenergic 
blockade dec_ the diapIrIIy. Th_ obeervatlons retlect on the 
pathophYlloloO'Y of LOTS and may have IIt1111y for predlctlng therapeutic 
decttven_. 
848·41 
Dynamic Behaviour of OTc measured in Holter Tapes in Different Groups 
of Postmyocardial Infarction Patients: Evidence of Circadian Variation of 
OTc Lengthening. 
"Eduard Homs, Vicens Marti, Pablo Laguna, Xavier Villolas, Jose Guindo, 
Pere Caminal. A.Bayes de Luna. Hospital Sant Pau, Barcelona, Spain. 
Sudden cardiac death (SCDI occurs more often during morning hours, and 
different markers of SCD show also I circadian variation. We 
automatically measured in Holter tapes the dynamic behaviour of OTc 
using a previously reported algorithm. We have previously demonstrated 
that postmyocardial infarction patients IPMIPI prone to develop malignant 
ventricular arrhythmias (MV A) exhibited more often peaks of OTc (defined 
as percent of measured beats with oTc > 500 ms), when compared to 
PMIP without arrhythmias or normal subjects . The aim of this study was 
to analyze the existence of circadian rhythm of the peaks of oTc. 
We studied 14 PMIP with clinically documented sustained VT (n = 8) or VF 
(n = 6) during follow·up (mean age:56 ± 16; mean ejection 
fraction c 42 ± 4 % I. We automatically measured oTc beat·to·beat from 
data recorded obtained using a Nihon·Kohden DMC 3000K system. 
Patients on drugs known to 
influence oTc were 
excluded. 
RESULTS: Mean peaks of 
aTe was 6.8% ± 4.7% (7 
pm to 6 am) compared to 
3.3%±1 .4% (7 am to 6 
pm) (p<0.05). 
(see figure) 
CONCLUSIONS: LJ~~~~==::~~lJ 1 . There is a significant 
incidence of beats with OTc 
> 500 ms from 7 pm to 6 am. 
2.·There is a circadian rhythm of aTc lengthening similar to the Circadian 
pattern of SCD. The clinical relevance and predictive value of these finding 
remains to be established. 
ABSTRACTS 
848·42 
Criteria for Delayed Repolarization in Patients with 
Wide QRS Complex 
Wojciech Zareba, Arthur I. Moss. and the LQTS Study Group. 
University of Rochester Medical Center. Rochester. NY 
Duration of QT interval in ECG of patients with a wide ~.12 sec) 
QRS complex. due to the presence of bundle branch block or 
venoicular pacing. frequently exceeds accepted nonnal values. 
Conoibution of the QRS duration to the duration of venoicular 
repolarization was evaluated in 28 pts with long QT syndrome 
(diagnosed on ECG with narrow QRS). in whom the QRS 
prolongation (by mean of 0.06 sec). due to new appearance of 
bundle branch block (BBB; n=11) or venoicular pacing (VP; n=17), 
was observed during follow·up. Repolarization measurements 
included QT, IT (QT·QRS). Bazett corrected QTc and ITc. The 
measured QRS and repolarization duration parameters were similar 
in BBB and VP pts. 
ECG NarrowQRS WideQRS p 
(0.08+0.02) (0.14+0.02) 
RR 0.89±0.22 0.82±0.14 ns 
QTc 0.49±0.05 0.54:tO.06 <0.0001 
ITc 0.41±D.06 0.39±0.06 ns 
QTc increased significantly. but ITc did not. despite the QRS 
prolongation caused by BBB or VP. Since there is no data on 
nonnal ITc values. ECGs of 417 healthy adults were assessed. 
Mean ± sd ITc were: in 218 males = 0.31±0.02 sec; and in 199 
females == 0.33:tO.02 sec. Upper limits of 95% confidence intervals 
were 0.34 sec and 0.36 sec. respectively. 
Conclusions: In patients with prolonged QRS duration, ITc is a 
more reliable measure for evaluation of repolarization duration than 
QTc. ITc values above 0.34 sec for males and above 0.36 sec for 
females can be considered as abnormal. 
84843 
DobUIaml..",OVOkId MyocIrdlalllChtmla Inc ..... BeaI·IO-BeaI QRS Amplituda 
Variability In Pallents willi Coronary Artery 01 ..... . 
Inger Hagennan, Jacek Nowak, OIof Nyquist, Jan Svedenhag, Christer Sylviln. 
Karolinska Institute al Departments of Medicine and Clinical Physiology, Huddinge 
Hospital, SlOCIdlOlm, Sweden. 
Signal variance ECG Is a recently developed high fidelity resting body surface ECG fhal 
measures beal·lo-beat phase-locked electrical mlcrofluclualions during myocardial 
depoIarisallon, which differs qualitatively from delayed activation fhat is stabie and fixed 
n time and meastJ8d by signal average ECG. Both ki1ds of electrical disorganisation 
have been demonstrated in myocarclal ischemia and in healed myocardal infarction. 
Recently, the diagnostic capacity of vartance ECG n a high prevalence population was 
reported 10 be al least as gOod as myocardial SCif1l9'aphy and belter than exen:lse IeSl 
AIm: To ~te If proVoked myocardial ischemia Increases beat-iHleal QRS 
amplitude varialiility, II patients wiIh ~y verified coronary artery disease. 
compared 10 healthy controls 
MethOd: Variance £CG was recorded before and dIr1ng Increasing concentrations of 
dobutamin InfutIon In 15 patients. age 62 (range 46·73) and 10 healthy controls. age 25 
(range 22-42). Total variabiUty from f2ieads were evaluated. 
_tts: Mean dobutamine iowdose was tor patienlS and controls 10.1t 0.07 and 9.8 
t 0.4 ~in, respectively and for high dose 30.6 t 1.9 and 37.6 t O.8l1Q11<glmln, 
respectively. 7/15 patienls developed Si depressions 2: 0.1 mV In 2: 2ieads'al ordinary 
12 lead ECG. 11115 patients developed chest pain 2: 3 accoroing 10 Borg CR·IO scale. 
With dobutamine, variabitity InCreased slgnificanUy In the patienl group but nolln the 
controls (see fig.). 
Conctuslon: Dobutamine1l'Ovoked myocardial Ischemia generales electrical nstability 
with ilcreased b8a1·10-bea1 QRS amplitude variability. Variance ECG is a sensilive 
methOd for deleclion of dynamic ischemia In patients with CAD. 
1500 Variability 
Patients 
~ 1000 d 
ANOVA 
p<0.01 
E 
..... 
Control. ~ 500 ANOVA 
p-0.48 
0 
Rest Low High 
Dobutamlne 
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848·44 
Electrocardiographic Predictors of High Defibrillation Thresholds with 
Nonthoracotomy C8rdloverter·Deflbrlllator Lead Systems 
Stefan Osswald, Tom G. Trouton, Sean S. O'Nunain, Marc Roelke, Guillermo 
E. Sosa-Suarez, BrianA. McGovem, Hasan Garan, Jeremy N. Ruskin, Ross 
Brooks. Massachusetts General Hospital, Boston MA. 
This study assesses the value of the surface ECG in predicting high defib•
rillation thresholds (OFT) in 130 consecutive patients (104 males, 26 females; 
age 61 ±[SO)12 years) undergoing implantation of a nonthoracotomy (NTL) 
cardioverter-defibrillatorleadsystem. Implantation of a NTLsystemwas suc•
cessful in 97/130 (7S"Io) pts. Despite testing multiple NTL configurations 
(monophasic pulse waves only), 331130 (2S"Io) pts (31 males, 2 females) re•
quired thoracotomy and insertion of one or more extrapericardial patches to 
acheive acceptable OFTs (S2S Joules). 
Univariate analysis revealed that male gender was associated with a sig· 
Micanfly higherNTLfailure rate (29.8"10 vs 7 .6%, P <O.OS). A ORSwidth~120 
ms and the presence of a left bundle branch block (LBBB) were both predic•
tive of NTL system failure and high OFTs as evidenced by the number of dif· 
ferent lead configurations tested and the total number of test shocks used 
(table; "p <0.01; 'p <O.OS). In male patients, LBBB predicted a NTL failure 
rateof58"1ocomparedt024"1ointheabsenceofLBBB(p<0.01).ORSvo~age, 
R-wave amplitudes, ORS-axis, OT-interval and other ECG abnormalities 
such as right bundle branch block, presence and extent of a O-wave infarct, 
left ventricular hypertrophy and ST-T-wave abnormalities were not asso•
ciated with a higher failure rate. 
Configurations (n) Total shocks (n) NTL failure ("10) 
OR~120vs 3.B±2.8vs2.7±2.1· 
ORS<120 
13.2±7.9 vs 9.6±6.7*' 36.2 vs 16.9' 
LBBBvs 
noLB8B 
4.4±3.1 vs 2.9±2.3" 1S.0±7.5 vs 10.3±7.2" 44.0 vs 21.9' 
In conclusion, male gender, a ORS width ~120ms and the presence of a 
LBBB are predictors of high OFTs and failure of a NTL system. In males, 
LBBB is associated with a very high failure rate (58"10). 
848·45 
Impaired Very Low Frequency Oscillations of Heart Rate in Patients 
With Life-Tbreateaing Arrhythmias 
Heikki V. Huikuri, M. Juhani Koistinen, Sinikka YJj·Mayry, K.E. Juhani 
Airaksinen, Markku J. Ikabeimo, Robert J. Myerburg. Division of 
Cardiology, Department of Medicine, University of 0uIu, 0u1u, Finland 
and Miami University Medical Ccmer, Miami, FLA. 
High-frequency (HF) (0.15 - 0.4 Hz), low frequency (LF) (0.04 - 0.15 
Hz) and very low frequency (VLF) (0.005 • 0.04 Hz) power spectra1 
components of heart rate variability (HRV) wen: compared in 32 paticnlS 
with coronary artery disease (CAD) and clinic:aI sustained ventricular 
tacl1yarrbytbmi (V1) and 32 control paticnlS matcbed with respect to 
age and severity of CAD but without clinical VT eveots. All VT paticnlS 
were inducible into sustained VT by programmed e1ectricaI stimulation 
(PES), but IIOIlC of the CXlIIIrol patients wen: inducible into VT during PES. 
Twenty·four hour VLF spectra wen: analyzed from the time epochs of 
1536 R·R intervaJs without detraIding the data. The results wen:: 
VLF 
LF 
HF 
(msec:2x 10) 
(msec:2x10) 
(msec2xIO) 
VT + VT - significance 
124 ± 92 23l± 180 p<O.OOI 
33 ± 30 59 ± 57 p<0.01 
32± 37 35 ± 45 NS 
On multiple regression analysis, including the measures of HR V and 
clinical and ansiographic variables, the VLF power of HRV was the 
strongest independent predictor of VT susceptibility (p<0.001). Thus, 
VLF oscil1ations of heart rate are reduced in CAD paticnlS who are 
susceptible to life-tbreatenin arrbyt1unias, suggesting that impaired 
autonomic and/or reoin-ansiotensin CXlIIIrol of heart rate is a specific 
marlcer ofVT risk in CAD. 
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849·77 
Quantitative coronary arteriograpby "ersus stress ecbocanIiograpby: 
WbidJ is the "best" lUJlliograplak cut4i? 
RIde Babic, Miodrag Ostojic, Gonm Stankovic, Branko BelesIin, Sinisa 
Stojkovic, Milan Nedeljkovic, Jeleoa Pantelic-Babic. Jeleoa Stepanovic, Ana 
Djordjevic-Dikic. Institute for Cardiovascular Diseases, Belgrade, Yugoslavia 
Stress ecbocardiography results are usually compared against coronary 
arteriography, IS a gold standard, allowing calculatioo of discriminative 
puameters such IS sensitivity (So), specificity (Sp) and diagnostic accuracy 
(Ace). However, coronary artery disease is oot an all or nothing condition: a 
binary classification requires arbitrary thtesbold criteria and creates artificial 
distinction in coronary artery disease that, in actuality, shows a continuous 
spectrum of severity. Most widely used cut-off criterion is a traditional 5091> 
diameter stenosis (OS); alternative thtesbold criterion, introduced by quantita•
tive coronary arteriography (QCA), is the minimal luminal diameter (MLD). 
To assess the relation between DS and MLD IS the sole quantitative 
measures of CS severity and the development of exercise induced regional wall 
motion abnormalities, 187 exercise (EX) stress echo tests were dooe in pts with 
single vessel coronary artery disease. All pts bad coronarography done within 
3 days. Coronary angiographies were analyzed by QCA system (MEDlS, 
Netherlands) utilizing interpolated refereoce diameter calculation with a catheter 
tip calibration. The relations between DS and MLD IS the single threshold 
criterioDS and EX stress echo tests' So, Sp and Ace are presented on graphs. 
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We conclude that both 5091> DS and 1.3mm MLD 00 QCA, IS the sole 
measured anatomic variables of stenotic coronary lesion, are providing the best 
trade-off between Sn and Sp of EX stress echo tests, correlating comparably 
with the functional severity. 
849·78 
ExerCise-Induced Prominent U·Wave .8 a Marker of Stenosis of the 
Left Circumflex or Right COronary Artery 
Taishiro Chikamori, Mitsutoshi Yamada, Jun Takata, Takashi Furuno, 
Fumiyasu Yamasaki, Toshikazu Yabe, Yoshinori Ooi, Kochi Medical School, 
Nankoku, Kochi, Japan 
Exercise-induced prominent U-wave can be assumed as reciprocal 
changes for U-wave inversion in inferoposterior ischemia, and may be useful 
in detecting left circumflex (LCx) or right coronary artery (RCA) stenosiS. 
To identify LCx or RCA stenosis, 311 consecutive patien1s suspected of 
having coronary artery disease underwent standard exercise testing with 
U-wave analysis. No patient with previous myocardial infarction was 
included. Prominent U-wave was defined if the magnitude of U-wave 
increased ~0.05 mV in association with decreased height of T-wave. 
Ninety-one patients (29"10) had prominent U-waves in the precordial leads on 
exercise. The incidence of prominent U-wave was higher in patients with 
LCx/RCA stenosis than in those without (70/135 vs 211176; peO.00D01). 
A severe stenosis of ~O% in LCX/RCA was observed in 70% of patients with 
prominent U-waves, and a LCx/RCA lesion was culprit in 59%. 
Prominent U-wave was superior to ischemic ST-segment depression in the 
inferior leads in specificity (88 vs 70%; peO.OD01) and positive predictive 
value (77 vs 61%; p=0.01) for identifying LCx/RCA stenOsis. Even in 
patients with negative exercise testing, prominent U-wave had a specificity 
of 92%. 
These resuHs indicate that prominent U-wave on standard exercise testing is 
a specific marker for stenosis of the left circumflex or right coronary artery. 
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849·79 
The Incremental Value of Thallium Lung·Heart Ratio Over 
Other Thallium Variables for the Presence and Extent of 
Coronary Disease 
Anthony P. Morise, West Virginia University, Morgantown, WV 
We evaluated the incremental value of thallium lung·heart ratio 
(LHR) over other thallium variables concerning the presence ~I 
vessel with a :::SOOIo stenosis) and extent (3 vessel/left main disease) 
of coronary disease. We performed logistic regression analysis on 
a prospectively derived cohort of 213 patients (SI % women) using 
thallium variables added to post-exercise ECG probability (based on 
age, sex, symptoms, risk factors, and exercise ECG data). Thallium 
variables were obtained using single photon emission tomographic 
imaging and included defect presence (Pres), reversibility (Rev), and 
intensity (Int). LHR was obtained using planar imaging. Accuracy 
was assessed by receiver operating characteristic (ROC) curve areas. 
RESULTS: The following table displays the change in ROC curve 
areas when the respective thallium variables were added to the 
analysis. 
Prevalence 
Post Exercise ECG 
Plus Pres, Rev, Int 
Plus LHR, Pres, Rev, Int 
Presence 
SO% 
0.80 
0.84· 
0.86· 
• p<0.03 vs Post Exercise ECG alone 
Extent 
IS% 
0.77 
0.77 
0.81** 
•• p<O.OS vs Post Exercise ECG Plus Pres, Rev, Int 
CONCLUSION: After consideration of clinical, exercise ECG, and 
other thallium data (Pres, Rev, Int), LHR had significant incremental 
diagnostic value concerning coronary disease extent but not coronary 
disease presence. 
849·80 
The Incremental Value of Thallium EIerciJe Testing for tbe Presence and 
EItent of Coronary Artery Obease 
Anthony P. Morise and George A. Diamond, West Virginia University, 
Morgantown, WV and Cedars·Sinai Medical Center, Los Angeles, CA 
We evaluated the incremental diagnostic accuracy of sequential exercise ECG and 
thallium scintigraphY concerning the presence ~ 1 vessel with a ~S()oA. stenosis) 
and extent ~2 vessel disease) of coronary disease using 722 patients. Using a 
training set of 213 patients from 1 center, we performed logistic regression 
analysis on various combinations of thallium variables when added to post•
exercise ECG probability (based on age, sex, symptoms, risk factors, and exercise 
ECG data). Thallium variables included defect presence (IDP), reversibility, and 
intensity (lDI). A separate test set of S09 patients (2 centers) was used to test the 
algorithms. Accuracy was assessed by receiver operating characteristic (ROC) 
curve areas. RESULTS: Displayed variables were all independent predictors and 
displayed algorithms had the highest ROC curve areas. The following table 
displays the ROC curve areas for the training set. 
Presence Extent 
Post Exercise ECG 0.80 0.79 
Plus lDl, lDP 0.84-- 0.83" 
The following table displays the ROC curve areas for the test set. 
Presence Extent 
Post Exercise ECG I :::- I 0.78"" 0.76 Plus lDl,lDP 
.. p<O.OI "p<O.03 vs Post EXercise ECd alone 
CONCLUSION: After consideration of available clinical and exercise ECG data, 
there was significant incremental value to the performance of an exercise thallium 
study for both the presence and extent of coronary artery disease. 
ABSTRACTS 
849·81 
Is low-Intensity Exercise Training Sumdent to Improve Aerobic Capacity of 
Patients With 8 Recent Myocardial Infarction? A Biopsy Study of Vastus 
Lateralis Muscle. 
Romualdo Belardinelli, 'Demetrios Georgiou, Auguslo Purcaro, Lancisi Heart 
Hospital, Ancona, Italy and 'Harbor-UCLA Medical Center and Saint John's 
Cardiovascular Research Center, Tonance, California. 
Previous studies have shown that exercise training(ET) improves aerobic capacity 
of patients with a recent myocardial infarction(MI). These results have been achieved 
with ET intensities abo"e the lactic anaerobic thresbold(LA T)(i.e. '7Q..8()I)t of maximal 
oxygen uptake-V02max).The purpose of the present study is 10 evaluate if low•
intensity ET (beloW the LA T)may improve the aerobic capacity of pts with a recent 
MI. We studied 14 males(mean age 45±9 years) w;tharecent MI(<3 months). MI was 
anterior in 9 pts and inferior in 5. Seven pts developed a left ventricular dysfunction 
(EF<409C) in the following 3 months(Group I). The other patients had a mean EF of 
63±11%(Group II). Training consisled of cycling for 30 min 3 days a week for8weeks 
at 40% of V02max. Before and after training pts underwent a cardiopulmonary 
exercise tesl(CPX) with hemodynamic measurements, a basal echocardiographic 
study and a percutaneous needle biopsy of vastus lateralis muscle. Blood lactate and 
catecbolamines were measured e"elj' min during CPX from antecubital vein samples. 
At baseline, Group I showed a reduced percentage ofType I fibers with an increase 
in Type II fibers, reduced capillary density, fibers atrophy and reduced volume 
density of milochondria(VVm) compared with Group II. In both Groups VVm was 
correlated with peak V02 before ET. After ET. peak V02 increased in both 
Groups(Group I +JO%;p<O.05; Group II +12%;p<O.05)as well as peak workload 
(Group I +15% ;p=O.OI ;Group II +20%;p=0.0!) . Cardiac outpul and stroke volume 
were both unchanged at rest and al submaximal exercise, with a modest increase al 
peak in both Groups. Ejection fraction was unchanged. The lactate threshold was 
delayed and increased(p=O. 00 I) whereas catecholamines were reduced al submaximal 
exercise in both Groups. In both Groups an increase in the diameter of both Type I 
and Type II muscle fibers with no change in their percentage distribution and 
capiJIalj' densily was observed. However, an increase in "olume density of 
mitochondria was observed in both Groups (Group I +20%;p=O.05; Group II 
+18%;p<O.05) which correlates with the changes in peak V02(r=O.80;p=O.OOOl). 
These results show that low-intensitv ET is a sufficient stimulus 10 improve aerobic 
capacity in patients with a recenl MI. We postulate that this fa"orable effect is relaled 
alieast in part 10 ET -induced improvements in intrinsic muscle properties. 
849·82 
Exercise-Induced ST Segment Elevation on Infarct-Related Leads is 
not Related to Myocardial Viability: Study OD I-Vessel Disease 
Patients. 
Antonio Ventosa, Vitor Gil, Miguel Mendes, Ricardo Seabra-Gomes. 
Hospital de Santa Cruz and Instituto do Cora~o, Camaxide, Portugal. 
Exercise-induced ST·segment elevation (ST-a) in leads with Q-waves, 
classically considered as representing dyskinesia associated with 
ventricular akinesia or aneurysm, has been recently reported as a marker of 
myocardial viability. To further assess this question, we studied with 
exercise test and with stress-(nitroglicerin)-reinjection thallium (TL) 
scintigraphy 53 patients with Q-wave myocardial infarction (MI) and 
single-vessel CAD on coronary arteriography. Infarct was anterior in 34 pi. 
and had been treated with thrombolytics in 22 pI. ST-a was defined as 
Imm greater than baseline at 40 ms. Perfusion was assessed at stress and 
reinjection images by a weighted score based on visual analysis of extent 
and intensity of thallium uptake, with results being expressed as 
percentage of myocardium considered as normal (%N) and with reversible 
(%R) or fixed defects (%F). We also considered the reversible fraction 
(Rf) of the stress defect area. 
%R 
55 5-10 10·20 ,20 
with ST-a (n=38)l..:I_I_8:....-_I..:.I __ 81-J1 ~;::;..+:::=::::::+.:~~~~ 
No ST-a (n=15) . 3 5 6 . 
P ns 
Similar trends were observed irrespective of thrombolytic use or 
infarct age or location. No differences in perfusion were observed when 
comparing patients with or without associated STD. In conclusion, in this 
study ST-a was not related to reversibility, but instead to a greater extent 
of non-reversible defects, suggesting that it is not related to viability. Both 
STfr and reversibility by TL are relatively frequent findings after MI and 
ST-a often coexists with reversibility. Its occurrence does not exclude the 
presence of a significant amount of viable myocardium or potential 
benefit with revascularization, but it should not be considered as a marker 
of viability. 
39A 
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849·83 
The Value of Exercise Testing in the Detection of 'SHent" 
Restenosis After Successful Coronary Angioplasty 
Walter J. Desmet. Ivan K. De Scheerder. Jan H. Piessens. 
University Hospital Gasthuisberg. leuven. Belgium 
We studied the diagnostic value of exercise electrocardiographic 
(ECG) testing in 191 patients who were completely asymptomatic 
6 months after a successful percutaneous transluminal coronary 
angioplasty (PTCA). All patients performed exercise ECG testing 
on the day a repeat coronary angiography was obtained. lesions 
were analyzed quantitatively by means of a computer-assisted 
system. 
The exercise ECG test was considered abnormal if a horizontal or 
downsloping ST -segment depression of ~ 0.1 mV occurred during 
exercise or early recuperation. When taking > 70 % diameter 
stenosis and > 50 % diameter stenosis at follow-up as restenosis 
criteria. sensitivities of exercise ECG testing were 29 % and 21 % 
respectively. specificities 89 % and 91 %. positive predictive 
values 20 % and 52 %. negative predictive values 93 % and 
70 %. accuracies 83 % and 68 %. and risk ratios 2.8 and 1.7 for 
prevalences of 9 % and 33 %. There were no significant 
differences in the diagnostic value of exercise ECG testing 
between men and women. patients taking and not taking beta•
blocking agents and in the presence or absence of pathological 
a-waves. Significant differences in maximal heart rate. maximal 
systolic blood pressure and maximal double product between 
various subgroups of patients with and without restenosis were 
found. In the individual patient however. no practical conclusions 
can be drawn from these values. 
Conclusion : The diagnostic value of exercise ECG testing for the 
detection of "silent" restenosis is rather low. and supplementation 
with other diagnostic techniques seems warranted. 
849·84 
Treadmill Exercise Stress Tests Early After 
uncomplicated Myocardial Infarctions. 
Avanindra Jain, Peter M. Sapin, Robert A. O'Rourke. 
The University of Texas Health Science Center-San 
Antonio. TX 
Risk stratification early after myocardial infarction 
(MI) is useful for identifying high risk patients with 
inducible ischemia who would benefit from aggressive 
invasive management and low risk pts who could be 
discharged early without invasive procedures. The 
optimal time for an exercise stress test has not been 
determined. We performed symptom limited ETTs 
(6.4z3.1 days) ~sing a modified Bruce protocol in 150 
consecutive pts (111 men and ~9 women). The mean age 
was 58z13 years. MI was Q-wave in 85 pts and non-Q•
wave in 65 pts. Thrombolytic therapy was given to 43 
pts (33%). The average exercise duration was 9.7±4.2 
min and the peak BR was 122±23 and the peak BP was 
158±31 rom Bg. There were no complications during 
exercise stress testing. positive exercise response 
with ST segment depression was obtained in 60 pts 
(40%). positive exercise response was observed in 
significantly more pts 34/65 (52%) who had the ETT 
before day 5 than those pts [26/85 (31%)1 who had the 
ETT after day 5 (p<0.05). 
Conclusions. Exercise stress tests can be performed 
safely very early after an MI and are more likely to 
be positive than tests performed 1 week after the MI. 
This llIay relate to a more significant residual 
stenosis in the infarct vessel early after HI which 
with time may decrease in severity as the superimposed 
thrombus and or spasm resolves. Further studies are 
required to define the optimum time for an ETT after 
an MI for appropriate risk stratification. 
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849·85 
Treadmill Exercise Test Parameters for Women Smokers Compared to 
Non-Smokers 
Arfan J. AI-Hani, Alice Furomoto-Dawson, Cherdkiat Sangkam, Raja P. 
Gowda, and Ricbard Cerceo. SI. James Hospital & Health Ctrs, Chicago 
Heights, n.. 
Smoking status, as well as other risk factors and demographics were assessed 
for the 5932 women in the Women Take Heart Project, a community study of 
cororuuy artery disease (CAD) in women with minimal or no cardiac 
symptoms, aged 35 years and older. For these analyses, current smokers (S; 
n=795) were compared to non-smokers (NS; n=2847) for mean exercise 
duration (sees) and peak heart rate achieved, adjusting for probable 
confounding by age and body mass index (BMI; kg/ro2) differences between 
smokers and non-smokers. Logistic regression was used to compare the 
likelihoods of significant ST segment depression (2:1.0 mm, 60 msec post J 
point) while adjusting for age and BMI. Ex-smokers were excluded from all 
analyses, and only women with measurable ST segments were included in the 
logistic regression analysis. 
S on average exercised 417 sees compared to 444 sees for NS and achieved a 
maximum heart rate of 156 vs. 161 beats/min (both p<.OOOOI) (adjusted for 
age and BMI). S were also less likely to develop significant ST depression 
(odds ratio .98; p=.OOOOI). 
Conclusion: Compared to non-smokers, women who smoke had much lower 
tolerance for exercise indicated by shorter mean exercise time and lower 
mean maximum heart rate. The lower exercise duration and peak heart rate 
of smokers may have affected their likelihood of developing significant ST 
segment depression. 
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850·55 
Moaoc:yte Tissue Factor Expression: A Rapid and Sensitive Flow· 
Cytometrlc Metllod for Assessing Cellular Procoallulanls 
Edward Leatham, Philip Bath, Jennifer Tooze. David Martint, Edward Tuddenhamt, 
A. John Camm, St George's Hospital Medical School,tNorthwick Park Hospital, 
London, UK 
IIII,oduction: Enhanced procoagulant activity (PCA) relaled to tissue factor (TF) 
expression on monocytes has been described in a numlx7 of diseases associated with 
blood hyper-coagulability, including septicaemia and unstable angina. Previous 
methods of assessing PCA have measured the thromboplastin activity of isolated 
lDOIIOCyte8 in a purified coagulation system. A new f1ow-cytometric technique is 
described which directly measures monocyte IF expression in whole blOO!L 
Methods: lOOjIJ of blood was incubated with 2j1g of polyclona1 rabbit anti-human 
TF antibody (raised against recombinant-human TF) for 30 min at 4OC. Red cells 
wen: lysed and the cells washed twice before incubating with f1uoroscein-<:ODjugated 
IWine anti-rabbit antibody. CelIs were re-washed and fixed in 1% paraformaldebyde. 
TF expression was measured using a Becton Dickinson flow cytometer (FACScan). 
Monocytes were identified by gating on fmward and side scatter and confumed with 
CDI4 labelling. TF expression was compared before and after separation of 
mononuclear cells on FicoU-Paque. FicoU-separated ceUs were incubated with 
plasma for 10 minutes at 40C to reduce non-specific binding. SepaIlI\ed cells were 
tested for PCA on a 96 weU plate. using a modification of a previously desaibed 
method: SO¢. of a Sxl()6 celI/L suspension were mixed with 20IiL of Chromogen 
S2222, 100jIL of culture medium (M199 without phenol red) and 100jIL of factor 
vn (I Unil/mL). Plates were incubated at 370C until optimum colour developed. A 
IIandard curve was prepared using a source of reference bovine thranboplastin. 
Results: Lipopolysaccharide (LPS) induced time and concenttation dependent 
expression of monocyte IF. Maximal tissue factor expression was found to occur 
after incubation for 3 hours at 370C with 10\1g/mL of LPS. Mononuclear cell PCA 
also showed a dose response to LPS. Whole blood TF expression was strongly 
correlated with Ficoll-separated, monocyte PCA (R2:0.96). When f1ow-cytometry 
was used to measure TF expression in LPS stimulated whole blood, consistently 
higher levels (44% versus 35% positive for TF) were seen compared with 
monocytes which had undergone FicoU separation first. Furtbamore. the minimum 
detectable level of monocyte 1F expression using whole blood analysis was one 
ICBth of the level obtained with separated mononuclear cells. 
COllclusion: Monocyte TF expression using fIow-cytometry ccm:laIes with in-vitro 
PCA. This whole blood method provides a highly IlenSitive IIId specific lSSay for 
IIIClIIOCyte TF expression. The method is well suited for iavestigation of lDOIIOCyte 
PCA in _te coronary syndromes. 
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850·56 
Moaocyte -mtmeat to the 8thel'OlClerotic plaque: tile role III LDL ad 
IIIIOOth mud cells 
Sara A Thome, David R Blake, Peter G Mills. RoyaJ London Hospital, London, 
UK 
hrtrodIu:tit»t: Oxidatively modified LDL is implicated in atherogenesis; it 
enhances monocyte adhesion to the endothelium of the vessel waJ.J. and 
subsequent foam cell formation. However, focal endothelial denudation occurs 
early in the atherogenic process, exposing intima1 smooth muscle cells (SMC) to 
the circuJation. Aims: To investigate (i) the ability of human ClOIOnary artcty 
(HCA) SMC to support monocyte adhesion, (ti) the role of LDL in inducing such 
adhesion, and (iii) the mcclIanisms involved in the adhesion of JIIOnocyteS to 
SMC. MdlltHIs: SMC were cultured from normal HCA LDL was isolated from 
bealthy volunteers by ulttacentrifugation in the JIRSCIlCC of hnM EDT A. The 
endotoxin content was less than 30pg1ml, ensuring no lipopolysaccharide 
stimulation of adhesion !l!eCbanisms LDL was used in its native state, or after 
c:oppcr oxidation, or minimal modification. Human peripheral blood monocytes 
were isolated and labeled with slchromium. Adhesion assay: SMC were 
preincubated in medium alone, or with inlCrJeukin·l (IL·l), tumour necrosis 
factor-a (TNFa) (both O.l·IOOulmI), native or modified LDL (O.1-2001L!1 LDL 
protein/mIl. SMC were then washed before incubating with 51Cr labeled 
monoeytes. Uoattached monocytes were mnoved. The SMC and adherent 
monocytes wen: lysed and counts determined using a gamma counter. Adhesion 
molecule EUSA: In parallel experiments, SMC wen: stimulated as above, and 
expression of ICAM·l and VCAM-l (intercellular and vascular cell adhesion 
molecule) qnantified by an ELISA <monoclonal antibodies provided by D 
Haskard, Royal PostgraduaIC Medical School, UK). RaM1ts: Monocyte adhesion 
to SMC stimulated by IL-l and TNFa and by modified, but not native LDL, was 
significantly enhanced (p<O.OI). IL-I and TNFa induced significant SMC 
expression of ICAM·l and VCAM·l (p<O.OI). Neither native or modified LDL 
induced SMC adhesion molecule expression. COIICbuioIu: HCA SMC stimulated 
by modified, but not native, LDL, and by cytokines support the adhesion of 
unstimulated monocytes. The mechanism by which cytokines induce this effect 
may involve the expression oflCAM-1 and VCAM-l. However, the expression of 
these adbcsion molecules is not involved in the monocyte-SMC adhesion induced 
by modified LDL. 'These studies suggest !bat SMC may not be solely passive 
effector cells in the atherogenic process, but an: capable of playing an active role 
in monocyte adhesion and recruitment to the intima. 
850·57 
The Effects of Iron, Free Radicals, and Antioxidants 
on the Development of Atherosclerosis 
Michael A. Weiner, Stephen B. Paige, Steven R. Bailey, University 
of Texas Health Science Center at San Antonio, TX 
Peroxidation of lipids by free oxygen radicals has been proposed 
as an initiating factor in atherosclerosis. This theory was tested 
in vivo in a rabbit model to determine if: (J) iron supplement 
accelerated atherosclerosis; (2) antioxidants that scavenge free 
oxygen radicals inhibited atherosclerosis; and (3) iron and 
antioxidants interacted. 
Nine New Zealand white rabbits were fed a high cholesterol diet 
(HF), iron (Fe) loading accelerated atherosclerosis compared to 
controls; in HF+Fe rabbit, lipid deposits covered up to 65% of 6 
aortic areas vs. 42% in HF rabbit controls (pz O.04), and 0% in 
normal diet (NO) controls. Antioxidants inhibited formation of 
aortic atherosclerosis in the experimentals given beta-carotene 
(bC) and fed the HF diet vs. the HF controls (p.O.OOI). In 
bC+Fe+HF, atherosclerosis was inhibited with no gross plaques 
and only !SmAl~.!!!i£!:Qlli1Qif~i!Q;!!L!k!lli~ __ ---, 
HI" "'+"c ..... c 
~!.'~~!!!!!'!!~!: !~~!"' 
..... 001 
~ .. 
Conclusioo: J) In this model iron therapy increases arterial plaque 
formation. 2) Antioxidant therapy significantly reduces arterial 
plaque formation. 
ABSTRACTS 41A 
850·58 
Mooocyte adbeslon molecules .nd tissue f.ctor expression In .cute 
coron.ry syndromes, 
Edward Learbam, Philip Bath. Jennifer Tooze, David Martint, Edward Tuddenhamt, 
A. John camm, St George's Hospital Medical School, tNorthwick Parle Hospital, 
London,UK 
Introducrion: Adhesion, migration, and transfoonation of monocytes into foam cells 
an: characteristic features of coronary atherosclerosis. Recent work suggests that 
abnormal expression of monocyte adhesion molecules and enhanced monocyte pro•
coagulant activity may occur in patients with acute coronary ischaemia. We bave 
used flow cytometry to measure JIIODOCyte expression of CDllb (the a1pha·subunit 
of the integrin receptor responsible for monocyte adhesion) and tissue factor ('IF) in 
patients presenting with acute coronary ischaemia. 
Methods: lOO!JL of blood was incubated with 10jIL of mouse anti·human CDllb 
monoclonal antibody pre-conjupted with fITC, or 2j1g of polycJonaJ rabbit anti•
human IF antibody (raised against recomhinant-buman TF), for 30 min at 4"C. Red 
cells were lysed and the cells washed twice. IF antibody samples and 1F negative 
conb'Ols wen: then incubated with fluoroscein-conjugated swine anti-rabbit antibody. 
Cells wen: re-washed and fIXed in 1% paraformaJdebyde. 1F and CDIlb expression 
wen: measured using a Becton Dickinson flow cytometer (FACScan). Monocytes 
were identified by gating on forward and side scatlCr. Fluorescence values wen: 
converted into molecules of equivalent soluble fluorochrome units (MESF) by 
comparison with standard calibration beads for each experiment Using the above 
technique, monocyte CD II b and IF expression was investigated in 13 patients with 
unstable angina (VA), 14 patients with myocanlial infarction (MI) and 14 normal 
subjects. 
Results: Mean CDllb MESF (xl03) showed a large variation within each group, 
conb'Ols (mean 5.13±SD 3.8), UA (6.7±3.1) and MI (5.86±I.9) and wen: not 
different between the groups. The proportion of W+ve monocytes in the circulation 
was increased in patients with MI and UA. The number of samples (%) positive roc 
1F were 1/14 (7%) in normal subjects, 6/14 (43%) in MI (Fishers exact test 
2p=(J.08) and 8115 (62%) in UA (2p=O.019). 
Conclusion: Increased monocyte expression of 1F in UA and MI may, in part, 
explain the syslCmic hypercoagulable stalC observed in these conditions. Since 
monocytes an: attracted and adhere to areas of atherosclerotic plaque, via inlCgrin 
expression, focal accumulalion of 1F may be the cause of a profound localised pro•
thrombotic environment in which occlusive coronary thrombus develops. Wide 
variation in the surface expression of monocyte CDllb exists. No significant 
pattern of altered CD II b expression was shown in acute coronary ischaemia in this 
preliminary study, but larger numbers an: required to confirm this. 
850·59 
aff.ct of a I.y.r. Itano.i. OD 'ibriD(og.n) Depo.itioD 
on Sey.r.ly Daaag.4 V •••• l Wall 1D Art.rial ~.i. 
Alessandra Mailhac, Juan Badimon, Beat Meyer, Antonio 
Fernandez-Ortiz, Valentin Fuster, Lina Badimon. Cardiac 
Unit. Massachusetts General Hospital, Boston, MA. 
We have studied the kinetics of fibrin (ogen) deposition 
(FO) on an eccentrically stenotic (80\) severely 
damaged vessel wall (SOVW). Autologous lllIn-platelet 
(P) and 125I-porcine fibrinogen (F) were injected into 
pigs instrumented for extracorporeal circulat ion and 
treated with low dose heparin (APTT ratio,l.S) not to 
affact P and/or F attachment. FO (mols x l012/cm2), its 
longitudinal axial dependence, and its relationship to 
platelet deposition (PO x l06/ cm2) were determined by 
ax vivo analysis of the substrates exposed in a 
perfusion chamber. FO and PO were both significantly 
higher (p=0.03) at the apex than either in the pra- or 
post-stenotic area, at all the studied perfusion times 
(1,5, and 10 min). However, FO showed a significantly 
smaller increase from the pre- stenotic to the stenotic 
area as well as a significantly smaller decrease from 
the latter one to the post-stenotic region comparad to 
PO (p=O.OOl). This pattern remained significant at all 
perfusion times. Interestingly, the FO/PO ratio showed 
a relatively smaller increase in FO over time that 
~:am:LS~.~~.~~i:~nt bet:lAen 5 and 10 min (P<O'O~,l •• 
i, - - .. I ,.: \ . 
i~ - ,M.. - ,,,,, '., -t"~\ .. D~ .,~,. Y tOMIN'-' ~.. r· ........ . . 
IINMUJQIT I'IEIlPEXIUT "ll1IIfX"" 
Thus, we have demonstrated that FO is shear dependant, 
though to •• ignificant I •••• r .xt.nt than PO and that 
this pattern is not tilDe d.p.nd.nt. Furthel"lllOre, PO 
.eems to be predOlllinant in the thrombus layer. adj~cant 
to an eccentrically stenotic SOVW. 
42A ABSTRACTS 
850·60 
INSULIN INCREASES ENDOTIIELIN-I RELEASE FROM HUMAN 
ENDOTIIELIAL CELLS. 
Claudio Ferri. Alfonso PicCOli. Valerio Pittoni. Cesare Bellini. Guido Valesini. 
Giuliana Properzi*. Anna Santucci*. Francesco Balsano. 
Institute of I Clinica Medica. University "La Sapienza". Rome and *Department of 
Internal Medicine. University ofL'Aquila - Italy. 
The ability of insulin to stimulate the endothelin-I (ET -I) release by the human 
endothelium was evaluated in cultured endothelial cells. isolated form human 
umbelical cord veins (HEC). and in a continuous human cell line (EA-hy926) 
derived from the fusion of human arterial endothelial cells and human tumoral 
cells (lung adenocarcinoma). HEC and EA-hy926 were incubated with various 
concentrations of human recombinant insulin (1(t9 M. 10'" M. 1(16 M). The 
supemantaDt of cultured cells was collected after 4. 8 and 24 h. The secretion of 
ET -I was evaluated in the supematans by reverse-phase. high-pressure liquid 
chromatography. using an acetonitrile gradient. As it shown in the table. human 
insulin Significantly increased ET-I release from HEC. The insulin-related ET-I 
release was observed for the entire 24 h period in a dose-dependent fashion. 
Blli: TIME OF INCUBATION (hours) *p<O.OOOI vs 0 
4 8 l4 
I OM I :H;I;8!t (llelmll 252;tH12 (llelmil * 1I~22 (PRimll * 
N 
Slll·9 M 12~;I;23 " * 1~:M;I;25 152~;I;fi8 " * E 
U T 
L 111.8 M 38~;I;12fi " * :H2Q;t2Ql ~5Q;t22fi " * 
I 
N 111.6 M ~52Q;t 128 " * ~8Q2;1;132 523Q;tH3 " * 
Genistein. a tyrosine kinase inhibitor. and actynomicin-D. a mRNA synthesis 
inhibitor. completely blocked the insulin-mediated ET-l secretion in BEe. 
demonstrating that insulin induces a de novo ET -I biosynthesis. The results 
obtained in EA-hy926 were identical to those observed in HEC. This study 
demonstrates for the fllSt time that insulin induces a significant ET -I release from 
HEC and EA-hy926. If occurring in vivo. the insulin-related ET-I release could 
play a role in inducing the vascular complications usually observed in 
hyperinsulinemic states. 
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851·7 
Poteat htifibrillatory Effect of eombiaed Blockade of Calcium 
Clwaaels ud SeratoDI. 5-HT2 Recepton With LU-.. "3. Duriag 
Myocardial ischemia ad Reperfasioala CaaiDes 
Bruce D. Nearing, Jon J. Hutter, Richard L. Verrier, Genraetown 
University School of Medicine, Washlnaton DC 
Few aaents are capahle of preuntina hotb Ischemla- and reperfuslon•
Induced VF hecause of the dlfferlna arrhythmoaenic mechanisms. We 
tested whether the novelaaent LU-49938, which has comhined calcium 
channel and serotonin S-HT 2 receptor hlocklnll properties, would he 
antlflbrlllatory durlna these two phases. To quantify the drull's 
antiflhrillatory action, we used complex demodulation of T -wave 
aiternans and monitored the spontaneous occurrence of VT and VF. 
The experiments were performed In 6 chloralose-anesthetized dogs 
durina fixed rate pacinI at 180 bpm. The drua (0.05 ma/kll, I.v.) was 
IDfused for 2 minutes. A/D recordinll of electrocardiollraphic and 
hemodynamic Ilgnals was commenced 25 minutes after the start of 
Infusion. The LAD corODary artery was occluded for 10 minutes aDd 
abruptly released. *p<0.05, values are means ± SEM. 
OcciusioD Reperfuslon 
VT/VF T-wave Ait VT/VF T-wave Ait 
(mVxmsec) (mVxmsec) 
No drull 5 of 6 14.62±3.96 5 of 6 20.60±8.84 
Drug 0 of 6* 1.39±0.34* 0 of 6* 2.34±0.77 
In 9 additional dogs, left stellate ganglion stimulation was carried out 
for 30 sec startina at 2 minutes of LAD occlusion. DuriDg com biDed 
stimulation and occlusion, the drug (0.025 me/kg, i.v.) reduced the 
VT /VF Incidence from 6 of 9 to 2 of' dogs and T -wave alternans from 
24.78±4.08 to 6.75±1.71 mVxmsec (p<0.005).· 
CONCLUSIONS: LU-49938 exerts a sianlficant antlfihrillatory effect 
durinE both coronary artery occlusion and release-reperfusion. This 
action prohahly results from Its comhined anti-sympathetic and anti•
ischemic Influences due to the drug's calcium chanDel hlocklng 
properties. ReperfusloD arrhythmias may he further averted because of 
serotonin 5-HT 2 receptor blockade, which inhibits the cyclic 
aallregatloD and disaggregation of platelets In stenosed coroDary 
arteries. 
JACC February 1994:1A-484A 
851·8 
Cocaine Associated Sudden Cardiac Death in Swine. Evidence for an 
Experimental Model of Acute Cardiac Death 
Michael A. Klein. Maria M. Nliiiez, Lin Miao. James S. Ross, Boris D. 
Nliiiez. James P. Morgaa. Boston V.A. Medical Ceater, Boston MA; 
Harvard-Thorndike Laboratory, Beth Israel Hospital, Boston MA; Tufts 
University School of Veterinary Medicine. North Grafton. MA. 
In order to study the phenomenon of cardiac death associated with cocaine. 
we examined the hearts of experimental animals wbo died following acute 
cocaine exposure. Forty-four Yucatan minipigs were given cocaine (0.1. O.S. 
3.0. aad 7.0 mglkg i.v.) followed by balloon-induced vascular injury (LAD•
aagioplasty aad LCX-denudation). Six control animals received angioplasty 
aad denudation without the drug. AmoDg the cocaine group. 13/44 (29%) 
pigs died spontaoeously: S perioperatively (EARLY) aad 8 from I to 6 days 
following the procedure (LATE). Pathologic examination of their hearts 
revealed subendocardial iscbemic changes in 13/13 (100%). Also, 4/8 LATE 
pigs had grossly evident nontransmural infarcts. all in a posterior apical 
location. The LAD and LCX showed severe vessel wall damage. including 
full-thickness Decrosis of the media. in 7113 (54%) animals. This degree of 
necrosis was not found in any of the coDtrols. Coronary thrombi were 
identified in OIS EARLY and 6/8 LATE animals but did Dot correlate with 
either the age or the location of the infarcts. and were considered secondary 
phenomena. Among the control group. there was 1 (17%) spontaoeous (early) 
death. from perforation of the left main coronary artery. The other S were 
sacrificied 2 days follOwing the procedure: there were no grossly evident 
infarcts amoDg aay of the 6. 
Conclusions: One - balloon injury aad cocaine act synergistically to produce 
severe vessel wall damage. possibly due to a vasoconstrictor effect of cocaine 
on the vasa vasorum. Two - cocaine in the presence of such coronary artery 
injury frequently produces infarction. particularly in the watershed areas of 
coronary circulation. Three - induced vascular injury may provide an 
experimental model for the study of cocaine-associated cardiac death. 
851·61 
Protective Effects of the Cardloselectlve ATP·sensltlve Potassium 
Channel Opener BM5-180448In Two Stunned Myocardium Models 
Gary J. Grover and Charles S. Parham. Bristol-Myers Squibb 
CO"1lany. Princeton. New Jersey 
A novel. cardioselective ATP-sensitive potassium channel (KATP) 
opener. BMS-180448 (BMS) has recently been developed. We 
determined if BMS enhances functional recovery (subendocardial 
shortening) after two types of ischemia in pentobarbital-anesthetized 
dogs. In the first model. recovery of function was determined during 
reperfusion following15 min of total LAD occlusion. BMS was given Lv. 
15 min pre-ischemia in doses of 0.5-4.2 mg!kg. At 1.4 and 4.2 mg!kg. 
BMS significantly (p<0.05) enhanced post-ischemic functional recovery 
(at 3 hr into reperfusion. shortening was 10±1% for BMS (4.2 mg/kg) 
vs. 0±1% for vehicle. In another model. dog hearts were subjected to 
15 min pacing-induced ischemia (pacing+LAD stenOSis) after which 
pacing and the LAD stenosis were ceased. Vehicle or BMS (3.5 
mg/kg, Lv.) were given 15 min before pacing-induced ischemia. In 
vehicle-treated hearts, contractile dysfunction was observed 
throughout the 3 hr recovery period and BMS significantly improved 
recovery of function (at 3 hr. shortening was 0.5±1.5% for vehicle and 
7.8±1.4% for BMS). No differences in hemodynamic status or 
myocardial blood flow were observed in either model. BMS is a 
cardioselective KATP opener which reduces post-ischemic stunning 
without hemodynamic effects. which is advantageous relative to 
existing KATP openers. 
JACC February 1994:1A-484A 
851·62 
Attenuation of Cyclosporine A·Induced Vascular Toxicity by Ramipril 
Guy Berkenboom, Dmitri Brekine, Philippe Unger, Beatrice Gulbis, Jeanine 
Fontaine, Universitc! Libre de Bruxelles, Brussels. Belgium 
ACE inbibitors attenuate the endothelial (E) dysfunction in experimental 
models of hypertension and bypercholesterolemia. In aortas isolated from rats 
treated with ramipril (10 mglkg p.o. for 4 weeks), the relaxations induced by 
acetylcholine (Acb, an cndothelium-dependent vasodilator) were potentiated, 
while the contractions induced by phenylephrine (phe) and angiotensin II 
(Ag II) were unchanged. Therefore, 3 groups of rats were studied in parallel. 
Group I received ramipriJ (10 mglkg p.o.) for 4 weeks and the 5th week, 
ramipril (10 mglkg p.o.) + cyclosporine (Cx : 20 mglkg I.M.); group 2 received 
Cx only (20 mglkg I.M.) and group 3 served as control. 
Results: mean (SEM) 
MAXIMAL RESPONSE (%) AREA UNDER CURVE 
GROUP 
I (n=9) 
2 (n= 9) 
3 (n= 10) 
Ach 
80 (5) 
62 (8)· 
88 (4) 
Phe Ag II 
99 (7) 90 (7) 
101 (7) 107 (13). 
82 (7) 76 (4) 
Ach Phe AG II 
296 (28) 434 (34) 392 (38) 
260 (32)· 491 (45)· 424 (28)· 
400 (34) 348 (38) 314 (49) 
• P < 0.05 vs control; % ofPhe (0.1 11M) - induced plateau for Acb and % of 
KCI (90 mM) for Phe and Ag II. 
Blood pressure and plasma creatinine level were similar in the 3 groups. 
Incubation \\ith indomethacin (3 )1M) did not alter these concentration•
response curves. After mechanical removal of E. the increased responsiveness 
to Phe and Ag II persisted in group 2 and was partially attenuated in group I. 
Thus, chronic administration of ramipril may attenuate E dysfunction and 
functional changes in smooth muscle induced by Cx. ACE inhibitors could 
delay the vascular complications of Cx treated patients. 
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852·18 
Altered Adhesion of Smooth Muscle Cells to 
Extracellular Matrix Protein: A Possible Mechanism 
for SMC Migration in Intimal Hyperplasia 
*Justin Bick-Forrester, Behrooz Sharifi, Cedars-Sinai 
Hedical Center, Los Angeles, California 
After vessel injury, quiescent smooth muscle cells 
(SHCs) develop the abi 1 ity to migrate and 
prol iferate. We hypothesi zed that thi s change 
results from altered adhesion to extracellular matrix 
(ECH). We compared the adhesion of quiescent and 
prol i ferat ing SHCs to the 5 major ECH proteins: 
elastin, fibronectin, collagen I and IV~ and laminin. 
Rat aortic SMCs were labeled with "H-thymidine. 
Adhesion was measured by adding the cells to 
precoated wells containing each ECM protein. Bovine 
serum albumin was used as control. Quiescent SMC's 
adhered most avidly to laminin (4-fold BSA) whereas 
adhesion to elastin was not different from control. 
In contrast adhesion of actively proliferating cells 
to ECM was reversed. Adhesion to laminin was not 
different from control, whereas adhesion to elastin 
was 5-fold control. Addition of 1 mg/ml RGD 
tripeptide completely blocked SMC adhesion to all ECM 
proteins. CONCLUSIONS: 1. Quiescent vascular SHC's 
adhere to ECH substrates, most notably laminin. 2. 
The profile of adhesion to ECM proteins is sharply 
reversed when SMC' s are prol i ferat i ng. 3. Adhes i on 
is mediated by RGD tripeptide. 4. Change in SMe 
adhesion to [CM protein may regulate cell migration 
following blood vessel injury. 
ABSTRACTS 
852·46 
IdentifIcation of Elastin Gene Deletions In Supravalvular 
Aortic Stenosis 
Timothy M. Olson, Virginia V. Michels, David J. Driscol, Charles D. Boyd, 
Stephen N. Thibodeau, Mayo Clinic/Foundation, Rochester, MN, and 
UMDNJ-Robert Wood Johnson Medical Center, New Brunswick, NJ 
Supravalvular aortiC stenoSiS (SVAS) is a congenital narrowing oflhe 
ascending aorta which may occur as an isolated sporadic or autosomal 
dominant familial defed, or in aSSOCiation with Wiltiams syndrome. We have 
recently localized the gene for SVAS by linkage analysis In a large 
pedigree. Identffying elastin as a candidate gene for this disorder. h this 
study, Southem blot analysis was utilized to Identify mutations within the 
elastin gene in this and 5 additional families without features of WiIiams 
syndrome. Genomic DNA from an affected individual in each family was 
digested with 3 restriction enzymes (Eco RI, Bam HI, Hind III) and 
hybridized to cDNA elastin probes. A deletion was Identffied in the safT1)le 
from 1 family on the basis of reduced band intensity and the presence of 2 
novel fragments. The deletion began several kilobases (kb) upstream of 
the initiation codon and extended beyond exon 27, eliminating 27 of 34 
exons. This 40-50 kb deletion, therefore, may result in a non•
transcribable elastin gene. Interestingly, there Is a wide range of 
phenotypic variability in this pedigree, ranging from subtle disease in an 
adult obligate carrier to severe SVAS with peripheral PA stenoses in a 
young Child. No dinically obvious abnormalities of other elastin-contalning 
tissues were apparent. In addition, preliminary resuHs suggest a smaller 5' 
elastin gene deletion in another sample. None of the other 4 samples, 
Including one from the family for which linkage to the elastin gene was 
established, had detectable gross deletions. Conclusions: 1) Mutations 
in the elastin gene have been documented in SVAS, supporting its 
primary pathogenetic role in this disorder. 2) The SVAS phenotype may 
be a resuH of a quantitative reduction in elastin protein synthesis, perhaps 
during a critical developmental period. Variability in phenotype may be due 
to additional genetic and/or environmental factors. 3) The absence of 
deletions not detected by Southern blot in the other SVAS families 
suggests other elastin gene abnormalities (e.g . • point mutations) 
andlor,less likely, other gene defects. 
852·47 
Angiotensin II Induced Collagen aRKA Expression in 
Cardiac Fibroblasts Depends on Autocrine Production 
of Transforaing Growth Factor-beta I 
'Kazushige Nagasawa, Rene Zimmermann, 
Doris Westernacher, Jutta Schaper, Max-Planck•
Institute, Bad Nauheim, F.R.G. 
AngiotenSin II(AII) has been implicated in collagen 
synthesis of cardiac fibroblasts, but the molecular 
mechanisms of this effect still remain uncertain. 
The aims of this study were to elucidate All effect 
on the expression of collagen ~l[I] ([I]) and 
~l[III]([III]) mRNA in cardiac fibroblasts derived 
from Wi star-Kyoto rats as a function of time and 
whether or not the All effect was mediated by 
autocrine production of transforming growth factor•
beta l(TGF-B). Northern blot analysis was used to 
determine levels of mRNA in total RNA extracted 
from cultured cardiac fibroblasts and quantified by 
densitometry. All data were normalized to 18S rRNA. 
AII(10- 7 M) increased the levels of mRNA for both 
collagens. This increase was detectable at 24 hours 
after addition of All to the cells and continued up 
to 72 hours (the highest expression at 48h, 
[1]:274.7:11.2%, [111]:279.1:10.2% vs. control, 
p<.OOl). On the other hand, All also upregu1ated 
TGF-B mRNA levels as early as 2 hours (194.9t7.4% 
vs. control, p<.OOI) and immunocytochemistry 
revealed strong positive staining with TGF-B 
antibody compared with control at 24 hours after 
addition of All. Adding a TGF-B neutralizing 
antibody reduced both collagen mRNA levels ([I]: 
5l.1t3.2%, [III]:45.0t5.4% vs. All, p<.OOl), 
whereas a non-specific antibody was ineffective. 
These results indicate a TGF-B mediated effect of 
All on collagen [I] and [Ill] mRNA synthesis via an 
autocrine/paracrine loop. 
43A 
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852-48 
Somatostatin Analogue Octreotide Reversibly Decreases 
Arterial Insulin-Like Growth Factor-I Gene Expression 
Koshi Yumi, James A. Fagin, Paul Dimayuga, Juliana 
Vano, James S. Forrester, Bojan Cercek, 
Cedars-Sinai Medical Center and UCLA School of 
Medicine, Los Angeles, CA 
We studied the effects of somatostatin analogue 
octreotide on vascular insulin-like growth factor-I 
(IGF-I), its receptor (R) gene expression and 
neointimal thickening after balloon injury of femoral 
arteries in rats. Octreotide, 100 ug/kg s.q for 2 days 
prior to and 5 days after injury, decreased IGF-I mRNA 
content and increased IGF - I receptor mRNA content 
(fold content in control arteries): 
mRNA Content: Day 0 Day 1 Day 7 Day 14 
IGF-I 1.0 5.0±2.8 3.0±1.4 1.5±0.2 
IGF-I (octreotide) 0.3±0.1 0.6±0.3 0.3±0.1 2.5±1.7 
IGF-IR 1.0 1.g±1.0 0.7±0.1 2.9±1.1 
IGF-IR (octreotide) 1.3±0.6 2.6±1.6 2.0±1.6 1.6±0.8 
Neointimal thickening measured as intimal/medial area 
at 14 days after denudation was also decreased in rats 
treated with octreotide, 0.41±0.2 vs 0.15.±0.1, 
p=O.OOOl. There was no difference in plasma IGF-I 
level between the two groups (525±21 vs 534±18 ng/ml). 
Conclusion: Octreotide, in doses given, reversibly 
decreases arterial IGF-I gene expression, with rebound 
above the IGF-I mRNA content in untreated animals. 
Octreotide does not prevent the transient upregulation 
of vascular IGF-I gene after balloon denudation and 
inverse regulation of IGF-I ligand and receptor gene. 
Octreotide induced decrease in arterial IGF-I gene 
expression and reduced neointimal thickening after 
balloon denudation appear to be caused by local 
effects on vascular tissue. 
852-49 
EvlDlation of Gene Transfer to Human Arterial Smooth Muscle Cells 
Using Adenovirul-transferriD-polylysineIDNA Complexes. 
Guoging Liu, Joban Tran, Neal Eigler, Frank Litvack, James Forrester and 
Joel M Kupfer Division of Cardiology, Cedars-Sinai Medical Center, Los 
Angeles,CA 
Transfer of DNA to vascular smooth muscles (SMCs) cells using chemical or 
physical means is inefficient and results in low levels of expression. The 
practical application of gene therapy requires that high efficiency gene 
transfer. Retroviruses have been used, but often lack predictable results, and 
are associated with neoplastic transformation. Adenoviruses, have recently 
gained widespread attention because they can he produced in high titer, do 
not require cell replication to achieve infection, and are not associated with 
neoplastic transformation in humans. It has recently been demonstrated that 
coupling of adenovirus to polylysinelDNA complexes results in high•
efficiency transfer of DNA into lung epithelial cells. In this system the 
adenovirus functions to disrupt the endosomes, freeing the DNA to he 
translocated to the nucleus. To evaluate whether similar levels of expression 
and efficiency can he obtained we used this method to transfect hSMCs with 
chloramphenicol acetyltransferase (CAT)or ~-galactosidase (~-gaI) reporter 
genes. Adenovirus was coupled to transferrin-polylysinelCA T complexes and 
exposed to cultured hSMCs for I hour. CAT assay was performed 24 hours 
later using phase-separation method. Levels of expression were compared to 
plasmid alone versus lipofectin-mediated transfection. Results were as 
follows: 
Transfection Method CAT ASSAY (CPMlUG cell protein) 
control 32.3±5.1 
plasmid a1o~e 27.7±2.4 
Iipofectin-mcdiated transfection 483±13 
AdenO\ irus-Mediated 12118± 110 
Using the ~-gaI reporter gene transfection efficiencies were determined. 
Lipofectin resulted in < 10% efficiency, where as adenovirus-mediated 
transfer (5x109 particles/mI) resulted in nearly 100% efficiency after I hour 
of exposure. We conclude that adenovirus-transferrin-polylysinelDNA 
complexes offer an artractive means of achieving high level expression in 
hSMCs. In. vivo studies are currently in progress. 
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Intracellular Disposition and Mechanisms of Oligonucleotide Transport in 
Vascular Smooth Muscle Cells. 
Joban Tran, Frank Litvack, Neill Eigler, James Forrester and Joel Kupfer. 
Cedars-Sinai Medical Center, Los Angeles 
Antisense Oligonucleotides are inhibitors of gene expression and have been 
used to block cellular responses to growth factors. As such they offer an 
artractive strategy for treatment of restenosis by local arterial delivery. 
Antisense bioefficacy is determined by several factors including, ability to enter 
the target cell, intracellular loca1ization and stahlity, and access to the target 
mRNA. Very little is known about the intracellular disposition and metabolism 
of oligos in vascular smooth muscle cells (VSMC). The kinetics of oligo 
accumulation and the effects of Na-azide, and chloroquine were studied in 
cultures of rat VSMCs using a fluorescein-Jahelled phosphorothioate 18-mer (f•
oligo), and quantitated by fluorescent-activated cell $Orting. Intracellular 
disposition was documented by fluorescent microscopy. Data are reported as 
aIbitrary intracellular fluorescence (mean ± se, n=3). In serum deprived cells 
uptake was time-dependent, reaching a plateau at 50 hours. Early uptake was 
identical in growing cells, but failed to saturate. At longer time periods growing 
cells accumulated greater oligos compared to quiescent cells(1287±43 vs 
831±23, at 50 hours, respectively). At 40C oligonucleotides adhered to the cell 
surface but were not transported intracellularly. Na-azide significantly reduced 
oligo uptake from 507±35 to 152±2 at 16 hours. In contrast, the 
Iysosomatropic agent chloroquine increased uptake from 507±35 to 2191±421. 
At low oligo concentrations «100M), cationic liposomes (lipofectin, BRL) 
enhanced uptake in a dose-dependent manner. The effects were greatest at luM 
(215±9.6 vs 887±36). Fluorescent microscopy revealed punctate cytoplasmic 
accumulation, consist with lysosomal location. No nuclear staining was 
observed. Intracellular distribution was not effected by chloroquine, or 
lipofcction. In conclusion, oligo uptake is relatively slow in VSMC, requiring 
at least 24 hours to reach half-maximal concentration. Uptake appears 
endosomal mediated and proceeds through the lysosomal degradation/recycling 
pathway. While Iiposome assisted delivery enhances uptake it does not lead to 
nuclear translocation, as reported for other cell types, suggesting cell-specific 
differences in oligonucleotide transport and metabolism. These results should 
aid in the design of strategies for enhancing oligonucleotide uptake in VSMC. 
852·51 
Programmed Cell Death (Apoptosis) in Vascular Smooth 
Muscle Cells. 
·Prakash R. Tirupattur, Prabodh M. Mehta, William C. Reeves, 
Atul Bedi , East Carolina University, Greenville, NC and Iohns 
Hopkins University, Baltimore, MD. 
Hematopoietic cells, fibroblasts and T -cells undergo 
apoptotic cell death by DNA fragmentation followed several hours 
later by morphologic cell death. The mechanism of cell death in 
vascular smooth muscle cells (VSMC) has not been previ~usly 
studied. We investigated this phenomenon using DNA 
fragmentation assays in cultured a7R5 cells (VSMC derived from 
embryonic rat thoracic aorta). Cells were grown to confluence in 
DMEM + 10% calf serum, incubated in DMEM + 0.5% calf 
serum, lysed at various time intervals and low molecular wt DNA 
extracted. Equal amounts of DNA were subjected to gel 
electrophoresis, and gels stained with ethidium bromide. 
Morphologic cell death was documented by cell staining with 
trypan blue and percent dead cell calculated. 
VSMC displayed DNA fragmentation as evidenced by 
ladder formation of electrophoresed DNA, while morphologic cell 
death occurred several hours later (n =6). This temporal sequence 
of DNA fragmentation followed by morphologic cell death is the 
hallmark of apoptosis and is the first study to demonstrate 
programmed cell death in VSMC. Understanding the mechanism 
of cell death in VSMC will further enhance our knowledge of cell 
biology in general and the pathophysiology of atherosclerosis in 
particular . 
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853·121 
Ra. and IGF·1 SIgnaling Pathway. In Cardiac Growth and 
Hypertrophy 
John J. Hunter, Giuseppe Lembo, Kenneth R. Chian. University of 
Califomla, San Diego, La Jolla, CA. 
Transgenic mice harboring an activated H·ras mutant targeted to 
the myocardium by 260 bp of the MLC2v promoter exhibit an 
Increase In left ventricular mass, suggesting that ras-dapendent 
pathways can mediate cardiac growth in vivo. The extracellular 
signal(s) which presumably act through the ras pathway, however, 
remain to be defined. Insulin-like growth factor-l (IGF-
1 )mediates the trophic effects of growth hormone on various 
tissues, end IGF·l signaling in other systems appears to be 
mediated through ras. Recent evidence has shown that IGF-l(10-7 
M) treatment of cul-tured cardiac myocytes induces modest cell 
enlargement, and in-creases mRNA for MLC2, a-skeletal ectin, and 
cardiac troponin I [Ito et al., Circulation 87: 1715). To 
characterize the cellular signaling pathways which mediate this 
response, we have cotranB-fected neonatal rat ventricular myocytes 
with dominant negative mutant forms of the IGFl receptor gene 
(kinase deficient, IGF1R-M2) or the H-ras gene (ala-15 mutation, 
HRGA), similarly driven by the MLC2v promoter. with an ANF•
luciferase repor1er. IGF·l treatment of cells cotransfected with an 
inactive vector(MLCSVOA) induced ANF·luciferase 1.5,±O.1 fold. 
when corrected for trans-fection efficiency. Cotransfection of 
MLC2v-IGF1R-M2 completely blocked the increase in corrected 
luciferase induced by IGF-l (O.8,±O.1 fold). as did the MLC2v· 
HRGA construct (O.7,±O.1 fold). suggesting that the effect of IGF·l 
is specifically mediated by the IGF-l receptor. via a ras-dependent 
signaling pathway. Prelimi-nary data suggest that phenylephrine 
induction of ANF·luciferase is partially antagonized by MLC2v· 
HRGA (consonant with previous results from our laboratory). but 
not by MLC2v-IGFl R·M2; the latter may thus be specific for the 
IGF·l signaling pathway. but ras may be involved in both pathways. 
Transgenic mice harboring these constructs are being generated. 
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853·123 
S._ial Diff_ Bxi8t :In tba DUtrllluticD of .............. te 
Pi~. IIDd Heat Sboc:k Prota:\n8 ~ IICaal cm:d1.ac ~
aDd tboea :In ca.. of ~ta1 IIMZt ~. 
susan D:xX!, IIuan-Xin~, Helena Qlrdiner. 
Departnents of It>rbid AnataT!i '!he Rl:¥al l.ald:rl Hospital, I<:n:bn E1 
IBB and Paediatric cardiolcgy, '!he Hospital for Sick Children, 
Great Omcnd Street, l.ald:rl w:lN 3JH, UK. 
45A 
Miocardial ~sfunction is seen under ocnditioos of increased velum> 
and/or pressure lead and nay w:>rsell follaolin; a sud:len red.icticn in 
load post--cperatively. Altere::l geatetry Il!ldoobteclly ccntribltes to 
the failure of a ventricle to adapt to these ch/Inges, rut we 
postulate::l that a Il'Ore fun<:Wrental prinary disorganisaticn of 
nuqcle cell function exists that might also be inp:%tant. '!he 
assE!llbly of the ccntractile ~tus of the cardiac l!fr'OCYte is 
facilitate::l I:1r the cytoskeletoo, certain elarents of 1otUch, the 
intennsdiate filaments, have been sh:lwn to be intinately associate::l 
with heat smck proteins (lISPs) 1otUc:h are essential for the oorrect 
Il'Olecular asserrt>ly of cellular proteins bing deve].cprent. We 
awlie::l antibodies to cytokeratins, v:irnentin, desnin, i!IIXl HSPs 60 
dlld 72 to paraffin - erri::ed:le::l left ventricular (LV) S8lTPles fran 60 
cases of fetal, neonatal and paediatric c:a>genital heart disease 
usin\l age and sex-natched c:ontrols (19 ....eks gestation-19 years). 
In viva hetr>:lynam:i ~s (catheter and ecOO data) were revi.........:i and 
rases divided into those witln.tt heIrodynamic dist~, i!IIXl those 
with ventr~cular VOlUIre (W) and pressure overload (VP). 
HS?3 h,d been frun:l in ah.mdance in the !l!{ocytes of early art:Jt:yooic 
hearts ta-crning undetectable I:1r the time heart m:xlelling was 
cxnplete, rut """re ""Pressed again I:1r the herrodynarnica1ly stresse::l 
!l!{ocyte. Slinilarly keratin and vimentin """re present in the LV of 
coose w-ith V\' and VP. Desmin was present in the coarse grarnllar 
cytcplasmi.c arrange:rent of early gestatioo, suggesting a disorderly 
disposition of intennsdiate fibres under stress. 
These findings all suggest deregulation of cytoskeletal and stress 
protein ""Pression under condi tioos of varie::l herrodynarnic 
intalance. nus nay represent an acEiptive respoose or nay be the 
result of failure of !l!{ocytes in the Il'OrpIx:>logically ablormal heart 
to ccnplete a develq:rrental cascade. Studies with a triSCIl!{ llO.ISe 
nodel are proceeding in an attEllpt to determine 10tUch is the case. 
853-124 
Lower Susceptibility to Aging of Myocardial Mitochondria 
Compared With Skeletal Muscle Mitochondria 
*Masaaki Takasawa, Satoru Sugiyama, Kazuki Hattori, Mika 
Hayakawa, Takayuki Ozawa, Division of Cardiology, Yachiyo 
Hospital, Aichi 446, Japan and Department of Biomedical 
Chemistry, Faculty of Medicine. University of Nagoya, Nagoya 
466, Japan 
The relationship between age-related decline in organ function 
and changes in mitochondria, responsible organellae for cellular 
energy production, has attracted much interest. In the present study, 
we detennined heart, skeletal muscle, and liver mitochondrial 
electron transpon activity in rats and dogs of various ages. In the 
skeletal muscle mitochondria, decrease in the activity of complex I 
was observed in rats aged 28 weeks (75% of age 7 w), and funher 
reduction of the activity was observed in rats aged 55 weeks (49% 
of age 7 w). A significant decrease in complex IV activity was 
observed in rats aged 55 weeks (75% of age 7 w). No significant 
reduction in complex II and III activities were observed in rats aged 
up to 100 weeks. Significant decreases in complex I and IV 
activities were observed in rats aged 100 weeks in heart muscle 
(70% and 79% of age 7 w, respectively), while no significant 
changes in the activity of complex I in liver mitochondria were 
observed in rats aged up to 100 weeks. Similar results, i.e., 
remarkable decrease in the activity of complex I in skeletal muscle 
mitochondria were observed in dogs aged 11 years (53% vs age 2 
years). Complex IV activity also decreased to 73% of that of age 2 
years. In left venoicle mitochondria. 23% and 9% reductions of the 
activities of complex I and IV, respectively, were observed in dogs 
aged 11 years compared with those aged 2 years. From our results, 
the susceptibility to aging differs among complexes, and it also 
differs from tissue to tissue. In addition, the rather late appearance 
of aging effect on heart mitochondria is emphasized. 
46A ABSTRACTS 
853-125 
Prolongation of the Monophasic Action Potential During Acidosis 
and Shortening During ischaemia 
Hugh W. L. Bethell, Jamie I. Vandenberg, Andrew A. Grace 
Department of Biochemistry, University of Cambridge CB2 lQW 
Activation of potassium-sensitive ATP (KATP) channels has been suggested 
to be one mechanism contributing to K + efflux and action potential 
shortening during ischaemia (Nichols and Lederer, Am. J. Physiol; 
261:HI675-1686, 1991). Acidosis causes activation ofKATP channels in 
cardiac myocyte membrane patches (Cuevas er al .. Am. J. Physiol; H755-
H761, 1991, Koyano er al., J. Physiol;I993 in press) and it has been 
suggested that acidosis, rather than a decline in A TP, may be responsible for 
the activation of these channels during ischaemia. In this study we 
investigated the effects of respiratory acidosis and ischaemia on monophasic 
action potentials (MAP), measured using suction electrodes, and pHi, 
measured using 31p nuclear magnetic resonance spectroscopy, in 
perfused ferret hearts. Increasing C02 from 5% to 15% (with or 
without correction of 
extracellular pH: 25mM HC03- 300 
, pH,,- 6.9; 60mM 
HC03-, pH,,= 7.4 ) 
caused pHi to fall to = 6.9 and 
led to ~ 18 % prolongation of 
MAP duration. Conversely, 280 
when pHi had fallen to 6.9 .Q 
after 10 minutes oflow-flow ~ 
ischaemia MAP duration E 
decreased by 15-18%(n=6). "260 
During low-flow ischaemia < 
bulk [A TPli decreased < 10% :E 
but contraction ceased. These 
results suggest that the 
reduction in action potential 
duration during ischaemia is 
not due to intracellular or 
extracellular acidosis but rather 
a fall in pH may limit the 
extent of shortening that 
occurs. 
853-126 
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Effect 01 Intraperlcardial Administration 01 Urokinase on Experimental 
Constrictive Pericarditis 
*Hul-Un Pan, Jlan Uu, Yong-Dong Zhang. Depts. of Internal Medicine & 
Pharmacology, Unyl College of Medicine, Unyl, Shandong, P.R. CHINA 
Mesothelial damage and subsquent hypoflbrlnolysls In perlcardlal space 
occurring during acute pericarditis have been Implicated In the 
pathogenesis of constrictive pericarditis. However, it Is not known whether 
exogenous augmentation of fibrinolytic activity can minimize the 
progression of perlcardlal constriction following acute pericarditis. An 
experimental model of acute pericarditis with progressive perlcardlal 
constriction was produced In dogs by injecting an Irritant mixture into the 
perlcardlal spaca through a surgically Implanted catheter. Urokinase (10,000 
units, treated group, n=10) or saline (control group, n=ll) was 
administered Into the perlcardlal cavity dally from the 3rd through 6th day 
after InstHlatlon of Intraperlcardiallrrltants. Nine animals In the control group 
demonstrated clinical features of constrictive pericarditis. Diffuse perlcardlal 
thickening and massive pericardlal adhesions were found In all 11 animals 
during a 6O-day observation period. The fibrinogen Influx Into perlcardlal 
exudate slgnHlcantly increased for the first 6 days after Intraperlcardial 
installation of the irritant mixture. In the treated group, 5 animals manifested 
clinical features of perlcardlal constriction and 2 of them were found to have 
only a single filmy adhesion in the perlcardlal cavity. The extent of 
perlcardial thickening In these 5 animals was signHicantly less than that of 
observed In the control group (3.StO.6 vs. 6.6±1.0 mm, p<O.OI). The other 
5 treated animals showed no clinical manifestation or pathological changes 
In the pericardium. Intraperlcardial Infusion of urokinase signifICantly 
reduced fibrinogen levels In the perlcardial exudate but did not change 
thrombin times, kaolin partial thromboplastin times or fibrinogen levels in 
plasma. These resuits suggest that Intraperlcardlal administration of 
urokinase, by means of restoring the local fibrinolytic activity, Is an effective 
and safe method to prevent acute pericarditis from progressing to 
constrictive pericarditis. 
JACC February 1994:1A-484A 
853-127 
Simpathetic denervation and reinnervation after myocardial infarction: 
a scinti&raphicJhistolo&ic correlation in man. 
Stefania L. Nori, Alessandro Giordano, Mario Gaudino, Francesco 
Alessandrini, Carlo Trani, Roberto Patrizi, Fulvio Bellocci,Pietro Santarelli. 
Institutes of Anatomy, Nuclear Medicine and Cardiology, Catholic 
University, Rome, Italy 
Transmural myocardial infarction (MI) produces necrosis of sympathetic 
nerves leading to viable but denervated myocardium. This partial 
denervation may produce imbalanced sympathetic innervation (SI) which 
predisposes to ventricular arrhythmias. 1-123 MIBG provides scintigraphic 
images of myocardial SI: however, its correlation with histologic features 
has been studied only in animals. A scintigraphiclhistologic study of 
myocardial SI was performed in 7 pts (6 males, mean age 59 ± 6 years) 
with previous (> 2 years) MI undergoing left ventricular aneurismectomy. 
METHODS: preoperatively, the distribution of SI using 1-123 MIBG was 
compared with the distribution of perfusion using thallium-20 I with the aid 
of color-coded computer functional map. Intraoperatively, tissue samples 
were removed from the areas showing reduced MIBG but nonna! thallium 
uptake (denervated areas) and normal MIBG but reduced thallium uptake 
(reinnervated areas). Samples were fixed and 10!1m thick serial sections 
were processed for immunohistochemistry by ABC method (Vector). 
Specific anibodies against SIOO (Dako) and tyrosine hydroxilase 
(Chemicon) were used to recognize sympathetic nerve endings. RESULTS: 
no histologic evidence of SI was found in areas with scintigraphic evidence 
of sympathetic denervation. Newly developed, scar associated 
catecholaminergic nerve fibers were observed in areas with scintigraphic 
evidence of sympathetic reinnervation. These newly developed fibers ranged 
from isolated fibers to fiber networks, and were thicker and of greater 
density than in normal tissue. CONCLUSION: in pts with previous MI, 
scintigraphic study (1-123 MIBG + thallium-201) of myocardial denervation 
and reinnervation well correlates with histologic evidence of sympathetic 
denervation and reinnervation. 
853-128 
Attenuated Sympathetic Responses to Cocaine 
Characterize Binge Use in Conscious Dogs 
Richard p, Shannon, Tadashi Ihara 
Cardiovascular Division, Beth Israel Hospital, Harvard Medical 
School and NERPRC, Southborough, MA 
To determine the mechanisms of the acute cardiovascular 
tolerance which develops to the effects of binge cocaine (COC) use, 
we studied 8 conscious dogs, chronically instrumented with LV 
pressure gauges (LV dP/dt), aortic (MAP) and coronary sinus (CS) 
catheters and left circumflex flowmeters. Dogs received 5 boluses 
of COC (lmg/kg) every 25 minutes to simulate binge use. Both 
resting MAP (before: 98:1:4 mmHg; after: 126:1:4 mmHg) and heart 
rate (HR) (before: 93:1:7 min·'; after: 118:1:11 min") were increased 
(p<O.05) while LV dP/dt was depressed (before: 2846:1:114 
mmHglsec; after: 2449:1:121 mmHglsec. p<0,05) following binge 
COC use. The peak MAP (lst dose:+45:1:4 mmHg; 3rd dose:+15:1:3 
mmHg; 5th dose: +8±2 mmHg), HR (lst dose:+39:t:3 min·' ; 3rd 
dose:+7:1:4 min"; 5th dose:-2±5 min") and LV dP/dt responses (1st 
dose:+613:1:133 mmHg/sec; 3rd dose:+156±128 mmHglsec; 5th 
dose:-123:1:236 mmHg/sec) were attenuated progressively (p<O,05) 
as was O. consumption (1st dose:+55±12% from 79l:t:57 ml 
O/min; 3rd dose:+12±8%; 5th dose:+4±1O%). The coronary 
vasoconstrictor response (CVR) was also attenuated (1st 
dose:+22:1:5% from l.69:1:0,57 mmHglmllmin; 3rd dose:+0.2:t:3%; 
5th dose:-5.3:1:5%, p<0.05), suggesting tolerance to the CVR effects 
of binge COC use. The plasma NE responses were progressively 
attenuated (lst dose:+253±36 pg/ml from 234±32 pglml; 3rd 
dose:+1l8±26 pg/ml; 5th dose:+47±43 pg/ml, p<0.05), while the LV 
dP/dt and HR responses to isoproterenol and forskolin were 
maintained. Thus, the cardiovascular tolerance which develops to 
binge coe use is due to decreased sympathetic stimulation, not 
end organ hyporesponsiveness. 
JACC February 1994:1A-484A 
853·129 
Enhanced Sympathetic Activity Identified by Heart 
Rate Variability Analysis in Hypertrophic 
Cardiomyopathy 
Stefano Guzzetti, Lubna Choudhury, ·Silvia Mezzetti, • Alberto 
Malliani, Paolo G. Camici. MRC Cyclotron Unit and RPMS, 
Hammersmith Hospital, London UK and ·Medicina Interna II, 
Ospedale L.Sacco, Universita' di Milano, Italy. 
It has been hypothesized that an interaction between 
sympathetic nervous activity and an abnormal myocardium plays 
a role in the development of hypertrophic cardiomyopathy 
(HCM). In the present study we investigated cardiac autonomic 
function by 24 hour spectral analysis of heart rate variability 
(HRV) in 18 patients (pts) with HCM, without evidence of 
systolic dysfunction, and 18 age·matched controls (C). In WI8 
pts myocardial beta adrenoceptor (B·AR) density was also 
measured with lIC·CGP-12177 and positron emission 
tomography. An echo-Doppler index of left ventricular diastolic 
function $ A ratio) was assessed in all pts. 
Total HRV was 15535±9109 msec2 in HCM vs 24721±12452 
msec2 in C (p<O.05). During the night hours (0-6 am), the low 
frequency (- ~.l Hz) to high frequency (- 0.25 Hz) spectral 
component rauo (LFIHF), a marker of sympathetic activity, was 
greater in HCM than in C (4.54±3.96 vs 2.13±l.OO, p<o.05). 
The day-night change of LFIHF was blunted in pts relative to C 
and showed a positive correlation with myocardial B-AR density 
(r=O.72, p<O.OO 1). In addition, a significant correlation 
(r=O.89; p<O.OOI) was found between myocardial B-AR density 
and the echo index of left ventricular diastolic function. 
In conclusjon, these data are consistent with an increased efferent 
sympathetic input to the heart in HCM as assessed by 24 hour 
spectral analysis of HRV. The HRV results are strengthened by 
the positive correlation of the day·night change of LFIHF with 
myocardial B-AR density measured by PET. 
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854·86 
Abnormal Transesophageal Doppler Coronary Flow 
Velocity Pattern in Hypertensive Patients With Angina 
Pectoris And Normal Coronary Angiogram 
Karl Isaaz, Jean F Bruntz, FaYez Zannad, Gerard Ethevenot. Etienne 
Aliot Division of Cardiology, University of Nancy, Nancy, France 
The pathogenesis of angina pectoris in hypertensive patients with LV 
hypertrophy (L VH) without evidence of coronary artery disease at 
the angiogram remains uncertain. In the present study we evaluated 
whether transesophageal Doppler echocardiography (TED) can detect 
altered characteristics of coronary blood flow velocity (CFV) in such 
patients. Nineteen hypertensive patients were studied: 8 pts were 
symptomatic (Hs, age 65±· 0 yrs) with exertional angina pectoris and 
angiographically normal coronary arteries; II pts were asymptomatic 
(~a! age 57±14.yrs, NS). Th.irteen age-matched subjects with no 
slgmficant cardIOvascular dIsease (N) were also studied. Peak 
diastolic and systolic CFV (Vd, Vs, cm/sec) were recorded in the 
proximal part of the left anterior descending artery with the use of 
pulsed Doppler guided by colour flow imaging. Results: BP= blood 
pressure (mmHg); L VMI = indexed LV mass (grams/m2); 
LVMI BPdiast BPsys Vs Vd Vd/LVMI EtA 
N 85±23 78±13 126±15 23±1l 44±1l .56±.25 l.I±.5 
Hs l20±21* 95±14* 171±31* 35±JO* 77±9* .67±.I4 .6±.I* 
Ha 132±46* JOl±15* l61±22* 20±4# 43±10# .37±.15*# l.I±.6# 
Peak Vd was inversely related to Doppler LV filling ratio E/A (r=-
0.40. p=O.Ol). Ih.u.s, hypertensive patients with angina pectoris and 
normal epicardial arteries at the coronary angiogram have abnormally 
high baseline CFV resulting in magnified intimal shear stress within 
t~e. vessel. High CFV are associated with impaired LV diastolic 
fllhng. As CFV= flow/vessel cross-sectional area, high CFV in 
symptomatic hypertensive pts may result from both augmented 
c~ronary flow and failure of the vessel to enlarge commensurately 
with the increase in LV mass ("relative coronary stenosis"). In 
hypertensive patients with L VH but no symptoms of ischemia an 
increase in coronary area may establish a constant blood flow velocity 
despite increased volume flow. (p<0.05 *vs N; #Vs Hs). 
ABSTRACTS 
854·87 
ECG CIwlaes ad CorOlW')' Flow Reserve Durin& Stress Testing in 
Hypertensive Patieots 
Joseph A. Diamond, Mileaa J. Henzlova, Josef Macbac, Kevin Martin, 
Adam Goldman, Maria Ardeljan, ArIeoe Travis, Robert A. Phillips, Mount 
Sinai Medical Center, New York, NY. 
ST -segment depression (ST·D) occurring with exercise stress testing in 
patients with hypertellsion but not corooary artery disease has been 
attributed to left ventricular hypertrophy. The specific role of coronary 
flow reserve (CFR) has not been defined. We examined the relationShip 
between CFR, LV mass and ST·D ~.5 mm in V5,V6) during symptom 
limited bicycle exercise in 33 WJtreated patients (20Ml13F, mean age 
47±8yrs.) with moderate to severe asymptomatic hyperteosion. Coronary 
perfusion was evaluated at rest and after i.v. adenosine (170 mcgIksfmin) 
using spJit-dose thallium·20l imaging. The ratio ofanterior or inferior wall 
counts (vasodilatation/rest) defined CFR. 
ST·D yes (N=17) 
ST·D no (N=16) 
anterior wall CPRt inferior wall CFRt 
1.40±0.25 l.37±O.27 
1.62±O.30 1.69±0.28 
tp<lJ.03 "<0.003 
Echo dmrmined LV mass and the hemodynamic response to exercise 
and vasodilatation were siIDilar among both groups. Thus, impaired CPR 
is an important factor in the development of ST·D during exercise. In 
addition to detecting obstructive coronary artery disease, ST-segment 
depression during exercise stress testing may reflect abnormal coronary 
flow reserve. 
854·88 
Superiority or Dobutamine Stress Ecbocardiography Over 
Electrocardiographic Treadmill Test in Diagnosis or Coronary Artery Disease 
in Hypertemive Patients 
Tomasz Pasierski. Hanna Szwed, Beata Malczewska, Bobdan Firek, Marek 
KoSmicki. Tomasz Antoniak. Zygmunt Sadowski 
National Institute of Cardiology, Wanzawa, Poland 
The specificity of electrocardiographic stress test in hypertensive patients is often 
low because of prevalent left ventricular hypertrophy. The study was designed to 
assess the value of dobutamine echocardiographY (DB) in diagnosis of coronary 
artery disease in hypertensive patients with angina. DB was performed in 65 (age 
50± 8 ys)(18 f, 47 m) symptomatic patients with pharmacologically controlled. 
mild to moderate hypertension. Dobutamine was given intravenously in 
incremental doses 5 to 50 mcglkg/min (mean peak dose 35 ± II mcglkg/min). 
Atropine 0.25- 0.5 mg iv was added in 24 patients. A positive DB was defined as 
an won;ening of wall motion abnormality during infusion. Patients underwent also 
symptom limited electrocardiographic exercise stress test (BEC) using Bruce 
protocol. Statistical significance of the difference between both tests was analyzed 
with a 95 % confidence intervals (CI). 
Mean baseline heart rate (HR) was 73 ± 16 beats/min, systolic blood pressure 
(SBP) 133 ± 16 mm Hg, diastolic blood pressure (DBP) 89 ± 9 mm Hg. At the 
peak dobutamine dose HR was 136 ± 23 beats/min, SBP 177 ± 30 mm Hg. DBP 
102 ± 13 mm Hg. Four patients became hypotensive (> 20 % fall in SBP) 
during infusion. In 4 patients systolic blood pressure increased above 240 mmHg 
but immediately returned to baseline after termination of the infusion. Diagnostic 
study (submaximal heart rate or a new wall motion abnormality) was obtained in 
7S % of patients. 
Significant coronary disease was defined as a diameter stenosis > 50 %. • 
Sensitivity of DE and BEC were respectively 72 % and 65 9Ii (CI -20 - + 34), 
specificity 95 % and 50 % (CI + 20 - + 70) and accuracy 83 % and 58 % (CI +6 
- +44). Dobutamine echocardiography may be safely used in patients with well 
controlled hypertension although major changes in systolic blood pressure during 
dobutamine infusion may be expected in few subjects. This test is significantly 
more accurate and specific for the noninvasive diagnosis of coronary artery 
disease in hypertensive patients than electrocardiographic exercise stress test. 
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854·89 
Exercise Ejection Fraction Responses During Upright III'Id Supln. Exercis. 
In Hypertansive. With Abnormal FDllng Rates 
John F. Tugaoen. Douglas S. Schulman. Angel R. Ror ... Donald J. 
Grandis. Judith E. Orie. Nathaniel Reichek. Medical College of 
Pennsylvania. Pittsburgh. PA 
During supine exercise. hypertensives with diastolic dysfunction. 
characterized by an abnormal peak filling (PFR). fail to increase left 
ventricular end-diastolic volume (LVEDV) or ejection fraction (EF). Whether 
similar abnormalities occur In the upright position. where In Increase In 
LVEDV during exercise is normally more prominent. ia unknown. Using 
exercise &rgometry. radionuclide angiography and a metabolic cart. we 
measured EF. LVEDV. cardiac output. heart rate. blood pressure and 0, 
consumption In 1 5 hypertensives with no evidenca of coronary disease 
(age 55.±.5 yrs. 8 men. 7 women). Patients performed upright and supine 
bicycle exercise on the same day. LV mass was measured by 2-D echo. 
Resting PFR was below normal in both upright Ind supine positions 
(2.5.±.0.5 and 2.5.±.0.4 EDV/s) but LV mass was normal. 99.±.29 gms/m'. 
For exercise data:·p<0.05. upright vs supine. +p<0.05. rest vs exercise 
~ ~ 
Rest Exercise Rest Exercise 
EF(%) 69.±.12 73.±.,0'+ 65.±.8 65.±.6 
LVEDV(ml) 119.±.27' 112.±.23' 140.±.29 132.±.26 
Cardiac Output(l/min) 6.±.2 14.±.3+ 6.±.2 14.±.3+ 
Systolic Pressure 164.±.20 221.±.25+ 165.±.24 220.±.24+ 
Heart Rate(min") 81.±.'0' 151.±.20'+ 71.±.9 139.±.13+ 
O. Consumption(mllkg/min) 19.±.6 20.±.5 
Despite similar exercise intensity. EF increased only in the upright position. 
Absolute L VEDV at rest and exercise were greater supine. but there was 
no significant change in LVEDV in either position from rest to exercise. 
There was no relation between resting PFR and the EF response to 
exercise (r=.o.06). Thus. in patients with hypertension. normal LV mass 
and abnormal resting PFR. EF increases during upright but not supine 
exercise. In both positions. LVEDV fails to increase appropriately with 
exercise. However. unlike patients with increased LV mass. PFR does not 
predict the EF response to exercise in this population. 
854·90 
ReiatioD at Left Ventricular MIa to IIuuIiD ResistaDce IDd Blood 
Preuure iD Noa-Obele Subjects 
tRobert A. Phillips, tLawreace R. Krakoll; tMaria Anleljan, tlADdrea 
Duaaif, 'tDiaDe T. Fincgood, :Seicchi Sbimabukw"o, tRichard Gorlin, 
tCraig WiIkeDfeId. tMount SiDai Medical Ceater, New Yor!<. NY, tlMiltoo 
S. Hershey Medical Ceater, Henhey, PA, 'IlIniversity of Alberta, Edmonton, 
Caaada, ptiraDo Hospital, Gifu, Japaa 
The separate CODIribution to left ventricular (LV) mass of daily arterial 
pressure and insulin resistance was determined iD 17 (age = 44±9. mean ± 
SO) non.ooese (bmi = 24±2 kglm2) non-diabetic, glucose tolerant subjects 
with normal or nntreatcd mild hypertension. Insu1in sensitivity index [(SI) x 
10-4 min·I/(ILU/m1» was determined from the frcquentIy-ampled 
intravenous glucose tolerance test (FSIGT) using the minimaJ model method 
of Bergman. Blood pressure was characlerizcd by ambulatory 24 boor blood 
pressure (SP) monitoring and LV mass was deIcrmined by 2·0 directed m· 
mode ecbocardiograpby and Indexed (L VMI) by body swface area I.S to 
adjust for the effects of variation in body size. Average 24 hour systolic BP 
was 133± 9 DUD Hg and average diastolic BP was 8S± 6 DUD Hg. Insulin 
sensitivity index was 3.9±1.9 (x 10-4 min -1'ILU/m1) and LVMI was 64±13 
gmlbsa1.3. L VMI was significantly relatcd to SBP (r=O.S6, p<O.OS) and OBP 
(r=O.S I, p<O.OS). L VMI was also significantly reIatcd to SI (r-O.S6, 
p<O.OS), and several other measnres of insulin resistance and carbobydr.ite 
metabolism, including fasting Insulin, fasting glucose, fasting insuIinIfasting 
glucose ratio and the insulin area under the curve of the FSIGT. SI was 
significantly relatcd to LV wall thickness (r ~.64, p<O.OI). In this non•
obese group, L VMI was not reIatcd to body mass index nor to age. In 
multiple regression analysis, after adjustment for the possible influence of 
gender and blood pressure, a significant relation remained between L VMI 
and SI (P <O.OS). In this model. for eacb unit decrease in SI, L VMI increases 
by 3.9 g/bsal.S. 
Thus, in the non.ooese, insulin sensitivity is related to LV mass 
independently of blood pressure and may be an important modulator of LV 
growth even in normotensives. Prevention of LV hypertrophy and optimal 
regression of LV mass may Rqnire improved insulin sensitivity in addition to 
reduction of blood pressure. 
JACC February 1994:1A-484A 
854·91 
Racial Differences in the Prevalence of Left Ventricular 
Hypertrophy Among Chronic Cocaine Abusers, 
DuWayne L. Willett, M. Elizabeth Brickner. Carlos O. OgllJT08, 
Christopher R. deFilippi. Eric 1. Eichhorn. Paul A. Grayburn. 
UT Southwestern and VA Medical Centers. Dallas. Texas. 
Previous studies have shown that left ventricular hypertrophy 
(LVH) is present in 43·54% of non·hypertensive chronic cocaine 
abusers. In essential hypertension. L VH is more prevalent in blacks 
than in whites at the same level of blood pressure elevation. To 
determine whether racial differences also exist in the prevalence of 
LVH among normotensive chronic cocaine users. we studied 107 
subjects recruited from an in-patient drug treatment program. All 
patients were S 45 years old and had nonnal casual blood pressures 
« 140/90) recorded three times daily for three weeks. Obesity. 
family history of hypertension. and weight or endurance training 
were specifically excluded. Tw<Hiimensionai echocardiography 
was performed in all patients and was interpreted in blinded fashion. 
L VH was prospectively defined as: 1) posterior wall thickness ~ 1.2 
em. and 2) LV mass index ~ 105 g/m2. The latter criteria represents 
2 standard deviations above the mean value for healthy age and race•
matched controls in our laboratory. Five subjects had technically 
difficult studies. leaving 79 blacks and 23 whites. There were no 
differences between groups in tenns of quantity and duration of 
cocaine use. age. height. weight. blood pressure. LV end-diastolic 
dimension. LV end· systolic dimension. or left atrial size. However. 
posterior wall thickness (1.13 ± 0.17 vs 1.05 ± 0.15 cm. p=O.03) 
and LV mass index (97 ± 22 vs 87 ± 12 g/m2, p=0.03) were 
significantly greater in blacks. L VH was present in 36 of 79 blacks 
(46%) and 3 of 23 whites (13%) (p=O.OI). Thus. chronic cocaine 
abuse is more likely to cause L VH in black men than in white men. 
854·92 
Regre •• ioa of Left Ventricul.r Bypertrophy ia 
Experiment.l Bypert.a8ioa: Iacr •••• d Di •• tolic stiffa ••• 
i. Mor. Dep.nd.Dt oa Myoc.rdi.l Coll.gen thaa MA ••• 
G.stOn R Dussaillant, Bernin Gonzalez, C.rlos Vio, RamOn 
corbalin, Jorge E Jalil. Departamentos de Enfermedades 
cardiovasculares y ciencias Fisio16qicas, Pontificia 
universidad Cat6lica de Chile. santiago. Chile. 
Factors responsible for diastolic dysfunction d~ring 
regression of hypertensive left ventricular hypertrophy 
(LVH) are not completely understood. we have eva;I.uated 
the potential roles of LV mass reduction and myocardial 
collagen on diastolic stiffness in the experimental 
model of hypertensive Goldblatt rats. 
Bypertensive rats (4 weeks) were started on either 
Losartan (38 mg/Kg/d, LOS), Enalapril (58 mg/L, ENA) or 
spironolactone (288 mg/Kg/week, SPI) for 8 w.ek •• 
systolic blood pressure (SBP, mm Bg), LV .... ss 
(LV*100/body weight, LV/BW) ,myocardial hydroxiproline 
concentration (OBP,' ug/g) and the slopes of the end 
diastolic stress-strain relationships in the isolated 
beating hearts (m, g/cm2 ) were compared with untreated 
(BT12W) and sham operated rats. Results were (mean t 
SEM) : 
Group SHAM BT12W 
n 9 11 
SBP 11S±3 189±3* 
LV/BW 189±6 328±l7* 
OBP 421±7 581±33* 
LOS ENA 
12 11 
103±4& 133±4&# 
204±8& 221±ll& 
602±33* 682±55* 
SPI 
9 
184±8* 
287±l4* 
578±40* 
m 120±2 130±2* 137±2* 126±2* 130±3* 
* p<.05 vs SHAM; • p<.001 vs LOS; & p<,005 vs BT12 and 
SPI 
Thus, although LVH was substantially reduced after LOS 
and ENA treatments. abnormal myocardial diastolic 
stiffness was still present as myocardial collagen 
concentration was increased. 
JACC February 1994:1A-484A 
854·120 
Atrial Natriuretic Peptide and Diastolic Function in Young 
Essential Hypertensives 
Hans·Michael Steffen, Ralf Muller, Gerhard Wambach, Reinhard 
Griebenow 
Med. Klinik II, University of Cologne, Germany 
Elevated plasma levels of ANP in essential hypertension have been 
attributed to LV hypertrophy and increased activity of the 
sympathetic nervous system. Since hemodynamic changes due to 
dereased distensibility of the hypertrophied LV may stimulate ANP 
secretion we used 2D guided M-mode and PW·Doppler echocardio•
graphy to evaluate diastoliC function in 15 hypertensive pts (mean 
age 3.2 :!:. 7.4 yrs). Plasma levels of ANP (RIA after plasma ex•
traction) and norepinephrine (NOR; HPLC) were measured during 
rest (r) and supine exercise (e; 6' SOW). Early and atrial flow velocity 
integrals (EI , AI) of the LV inflow were determined as well as end•
systolic and enddiastolic LV dimension (LVESD, LVEDD). LV muscle 
mass was calculated according to Devereux (LVMI). 15 normo•
tensive volunteers (30.4 :!:. 5.8 yrs) served as a control group. 
Hypertension Control 
ANPr (pg/ml) 49 :!:. 27 ns 43 :!:. 22 
ANPe (pg/ml) 88 :!:. 83 ns 56 :!:. 24 
NORr (pg/ml) 305 :!:. 133 P < .01 182 :!:. 90 
NORe (pg/ml) 465 + 261 p < .01 245 + 108 
EIIAI 2.48~1.05 p<.05 3.59~1.19 
LVEDD (mm) 51 + 6 ns 49 + 4 
LVESD (mm) 30 :;: 5 ns 30 :;: 3 
LVMI (g/m2) 134 ~ 28 p < .001 87 ~ 23 
In hypertensive pts the exercise induced increase in ANP correlated 
with EIIAI (r = -.70, p < .01) but not with NOR or LVMI. 
These data suggest that in essential hypertensive pts ANP secretion 
is stimulated as LA pressure rises to compensate for the decrease in 
early diastolic LV filling. Measurements of ANP may thus be useful to 
detect pathologic hypertrophy with decreased LV distensibility. 
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855-130 
Gastric or IV Administration of French Red Wine but not Whim Wine 
Inhibits In Vivo Platelet Activity and Thrombosis in SlBnosed Canine 
Coronary Arteries 
Heather S. Damrow and John D. Folts, University of Wisconsin Medical 
School, Cardiology, Madison, WI 
Moderate daily consumption of alcoholic beverages is a negative risk 
factor for the development of atherosclerosis and coronary artery disease 
(CAD), especially in France and areas where red wine is regularly 
consumed with meals. Platelets contribute to the development of 
atherosclerosis, CAD, and also acute arterial thrombus formation. A high 
dose of alcohol (A) (blood alcohol content (BAC) = 0.24 g/dl), in our 
established model, inhibits platelet activity and coronary thrombosis. 
Thirty anesthetized dogs (D) ware prapared with our model of 
mechanically stenosed coronary arteries and intimal damage. Periodic 
acute platelet mediated thrombus formation (APTF) occurred causing 
cyclic flow reductions (CFR's) in coronary blood flow. The CFR's caused 
by APTF can be abolished by platelet inhibitors such as aspirin (5 mg/kg) 
or pure A (BAC = 0.24 g/dl). In 13 D, French red wine (AW), 
1,74±1.16 mil kg diluted in saline and infused IV, abolished the CFR's and 
produced an average BAC of 0.0410.03 g/dl. In 5 D, intragastric (IG) 
edministration of the RW, 3.5810.89 ml/kg, eliminated the CFR's producing 
a SAC of 0.0410.01 g/dl. The template bleeding time (TBT) increased 
after RW with both the IV and gastric administration (p<O.03). In 7 D, 
French white wine CNWl, 2.2010.75 mil kg given IV, did not eliminate the 
CFR's (BAC = 0.0510.02 g/dl). Five D ware given the WN IG, 4.0 mllkg 
(BAC of 0.0410,02 g/dl), and the CFR's ware decreased but not 
significantly diminished. There was no significant change in the TBT of 
any 0 given WN. RW appears to have antiplatelet effects independent of 
the alcohol content as it inhibits the CFR's at one-sixth the BAC required 
when pure A is given. Thus, some of the many constituents in red wine 
besides the alcohol must inhibit platelet activity, or be synergistic with 
alcohol. The daily consumption of RW but not WW may chronically inhibit 
platelet activity and reduce the platelet contribution to the development of 
atherosclerosis, CAD, and APTF mediated myocardial infarction. 
ABSTRACTS 
855·131 
Progression of Coronary Artery Disease Following Cessation of 
Cigarette Smoking 
Ivo Amende, Paul WenzIaff, Medical University Hannover, 
Germany 
Cigarette (CIG) smoking is an established risk factor for the 
development of coronary artery disease (CAD), but whether 
cessation of heavy smoking influences progression of CAD is 
unclear. In 390 patients (359 men, 31 women; 52.4±6.7 SD 
years) with CAD, 2 coronary angiograms were performed in an 
interval of 62.4±23.5 months. Smoking habits were obtained 
by questionnaires. Progression of CAD was defined as the sum 
of new stenoses, progression of existing stenoses and new 
coronary occlusions. 
Multivariate classification analyses of risk factor profile 
revealed CIG smoking (amount per day and length of time) as 
the most relevant factor for progression of CAD. Non-smokers 
bad a progression score of 0.96 (95 % confidence interval, 0.63-
1.28) over the observation period. Former smokers (23.8±9.2 
CIG/day for 31.3±7.0 years) who quit at the time of the first 
angiogram showed a progression of 2.47 (95%; 1.97-2.97; 
P<O.OOI) compared to non-smokers. Current smokers 
(20.5±9.7 CIG/day for 34.8±8.5 years) bad a progression of 
3.17 (95%; 2.35-3.99; P<O.OOl). 
The data indicate that former heavy CIG smoking continues 
to act as a significant risk factor for progression of CAD even 
after cessation. This does not mean that current CIG smokers 
should not stop. On the contrary, continuing to smoke further 
increases progression of CAD. 
855-132 
Relationship of Short Stature to Traditional Coronary Risk 
Factors in the Incidence and Survival Among Patients with 
Angiographically Defined Coronary Artery Disease. 
"Kodangudi B. Ramanathan, Faten EI-Zeky, Roger Vander 
Zwaag, Jay M. Sullivan, Baptist Memorial Hospital, 
University of Tennessee, Memphis, Tennessee 
Short stature has been shown to be associated with 
cardiovascular disease. To determine its relationship to 
other coronary risk factors, we studied 14,767 patients 
with known coronary anatomy. Average height for men 
was defined as 5'7" to 5'10" and for women 5'1" to 5'4". 
Significant coronary disease was defined as >70% 
stenosis in anyone of the major epicardial vessels. The 
risk factors examined were age, smoking, hypertension, 
diabetes mellitus, cholesterol and body mass index in 
both males and females. Short stature was significantly 
associated with coronary disease in males (79% vs 71 % 
p<.0001) and females (53% vs 38% p<.0001). Risk 
factors significantly associated with short stature in males 
were age and body mass index while among females all 
major risk factors were significantly associated. Long-term 
survival for patients with coronary disease followed a 
similar pattern as incidence among men and women. 
Stature 10 Year Survival 
Men Women 
Tall 72.6 79.6 
Medium 72.3 78.1 " p<0.01 
Short 65.4" 69.6" 
Thus short stature is a risk factor not only for an increase 
in the incidence of coronary disease but also for a 
decrease in long-term survival. 
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855-133 
Lack of Patient Awareness and Physician Treatment of Hyper•
cholesterolemia in Patients Undergoing Coronary Angioplasty 
·Robert A. Vogel, Michael Miller, University of Maryland School 
of Medicine, Baltimore, MD 
Despite considerable medical and lay media attention to the import•
ance of hypercholesterolemia as a cardiac risk factor, it is not clear 
whether patients with coronary disease are aware andlor receive 
treatment for hypercholesterolemia. To test patient awareness, we 
surveyed 203 patients at the time of hospital admission (January, 
1991) for coronary artery diagnostic or therapeutic procedures. 
Only 22 % of patients were aware of the risk factor concept and 
only 12 % of hypercholesterolemic (total cholesterol> 240 mg/dl) 
patients knew it to be a risk factor for their coronary disease. 
To correct this, we established a nurse based, uniformly applied 
risk factor modification program. Hypercholesterolemia, hyper•
tension, smoking, obesity, diabetes and family history for coronary 
disease are identified on admission, and counseling is routinely 
provided. Physician education is also provided at 6 month inter•
vals. The effect of this program was monitored by comparing pre•
initiation cholesterol therapy to that given after initiation in 4S1 
patients, 87 of whom underwent coronary angioplasty. Hyper•
cholesterolemia was identified in 49 % of angioplasty patients, 24 % 
of whom were on drug therapy at baseline. One year later, the rate 
of treatment rose to 62 % (p < O.OS). Individual physician treat•
ment rates varied from 0% to 80%. These data confirm that 
hypercholesterolemia is unappreciated and undertreated in coronary 
disease patients, but suggests that an organized risk factor program 
increases the rate of clearly appropriate cholesterol management. 
855-134 
Effects of Cardiac Rehabilitation and Exercise Training on 
Exercise Capacity, Coronary Risk Factors and Quality of Life 
in Women 
Carl 1. Lavie, Richard V. Milani, Chris Boykin, Ochsner Medical 
Institutions, New Orleans, LA 
Despite the known benefits of cardiac rehabilitation and 
exercise training, women are frequently not referred for this 
therapy following major cardiac events. We compared the effects 
of cardiac rehabilitation and exercise training on exercise capacity, 
coronary heart disease risk factors, and quality of life in a large 
cohon of 83 women (63±10 years) with the effects of cardiac 
rehabilitation in 375 men (61±10 years). At baseline, women had 
higher total cholesterol (+7%, p<O.OOOI), LDL-C (+8%, p<O.02), 
HDL-C (+2S%, p<O.OOOI), and percentage fat (+16%, p<O.OOOI), 
but lower METs (-9%, p=O.09) and LDUHDL (-11%, p<O.OI) 
~an men; however, both genders showed similar results regarding 
trlglycerides, body mass index, and most quality of life parameters. 
After rehabilitation, women had significant improvements in 
METs (+32%, p<O.OOOI), percentage fat (-6%, p<O.OOI), 
LDUHDL (-14%, p=O.08), anxiety (4.3±4.9 to 3.0±4.0 units, 
p=O.05), somatization (6.1±4.4 to 4.8±4.0 units, p=O.03), energy 
(l3.6±4.1 to 16.1±4.4 units, p<O.OI), general health (20.7±3.S to 
23.2±4.2 units, p<O.OOI), pain (S.3±2.4 to 9.6±1.4 units, p<O.OI), 
function (32.6±7.4 to 38.9±6.9 units, p<O.OOOI), well being 
(45.3±S.4 to SO.O±S.7 units, p<O.OOI), and total quality of life 
(99±17 to 112±17 units, p<O.OOOl), but not in LDL-C (-4%), 
HD~~C (+3%), triglycerides (-S%), body mass index (-1%), 
hostlhty, or depression. However, improvements in all of these 
parameters following cardiac rehabilitation were statistically 
similar in both genders. 
Conclusions: 1) Following cardiac rehabilitation and exercise 
training programs, women significantly improve exercise capacity, 
body fat, and most quality of life parameters. 2) Greater emphasis 
is needed on improving lipids as well as reducing hostility and 
depression indices to further enhance secondary prevention of 
coronary heart disease in women. 
JACC February 1994:IA-484A 
855-135 
RegIonal and Ethnic Comparison of Total and Specific Cardiovascular 
Disease Mortality Rates In New York City, 1990. 
Anekwe Onwuanyi, David Hodges, Johnoy Makhoul, Jay Brown, Colin 
McCord. Harlem Hospital Center, Columbia University, New York. 
Although mortality from cardiovascular disease: (CVD) has been decfuUng, 
regional and ethnic differences in total and specific cardiovascular disease: 
mortality exist. In order to determine ethnic and regional CVD mortality 
differences in NYC, total and specific CVD mortality rates were analyzed 
for the year 1990. Data were generated from death certificates coded 
according to the International Classification of Disease - 9th revision and 
specific ICD-9 codes were used to generate mortality rates (MR) and 
mortality rate ratios (MRR). 
Total ethnic specific cardiovascular mortality rates per 100,000 in NYC 
were as follows: 
A&I; MAk 
Age White Black 
25-44 29.9 793 
45-64 412.4 635.9 
> 65 2968.4 2720.4 
Hispanic 
37.9 
323.9 
1513.6 
fulDk 
White Black Hispanic 
9.7 36.9 14.7 
1772 355.1 159.7 
2622.8 2212.7 1162.7 
Comparative CVD mortality rates per 100,000 for NYC, NYC (blacks) and 
Central Harlem (CH) are as follows: 
l::!Y.C t:m.:...!ID 
AgeM F M F 
25-44 43.4 18.7 793 36.9 
45-64 444.0 223.9 635.9 355.1 
> 65 282l.4 2420.9 2720.4 2212.7 
ill 
M 
95.9 
1021.1 
3076 
F 
53.8 
520.1 
2420.1 
Below tbe age of 65 years, CVD mortility is higher in NYC blacks 
compared to whites and Hispanics. Total CVD mortality rates are 
dramatically bigher in CH. Hypertension bad tbe bighest disease: specific 
MRR (4 for males and 4.9 for females) while the MRR for acute 
myocardial infarction was 0.5 for males and l.6 for females. 
855-136 
Cbaracteristics Predicting Improvement in Functional Capacity in a Cardiac 
Prevention and Rebabilitation Program 
Stuart E. Sheifer. Lisa Giannetto. Nancy Wildenrumn. Liane Navey. Kerry L. 
Lee, David J. Frid. Duke Center for Living, Duke Medical Center, Durham, NC. 
To determine characteristics that predict improvement in functional capacity 
(METS) in participants of a cardiac prevention and rehabilitation program. 396 
consecutive patients (pts) were examined. All pts had an Err at entry and at 
regular follow-up (mean=102 days) after beginning participation. 
Demographics. clinical history, cardiac risk factors. cardiac symptoms and ETI 
data were collected prospectively at entry and follow up (FU). The study group 
had a mean age of 60 yrs. 60% were male. 44% had a history of (11/0) a cardiac 
event (MI. PTCA. CABG) and 86% had ~3 cardiac risk factors. A mean 
improvement of 26% in functional capacity [(RJ METS-Entry METS)/Entry 
METS] was noted for the entire group. A multivariable linear regression model. 
controlling for entry METS and using entry characteristics to predict 
improvement in functional capacity, was developed; significant predictors are 
listed below: 
EntryMETS 
Body mass index (kg/m') 
Diabetes mellitus (YIN) 
hlo angina (YIN) 
hlo PTCA (YIN) 
hlo CABG (YIN) 
Male 
Age (10 yr intervals) 
%aMETS 
- 4.5 
-1.1 
- 20.6 
- 8.5 
17.2 
10.3 
10.3 
- 6.1 
p 
0.049 
0.0001 
0.0001 
0.0025 
0.0001 
0.0014 
0.0001 
0.0001 
These data reafftnn that improvements in functional capacity (METS) occur 
through participation in cardiac prevention and rehabilitation programs. In 
addition. young males. patients with previous revascularization procedures and 
those who are most deconditioned show the most improvement. Cenain groups 
of participants -women. diabetics. obese pts. a hlo of angina - do not derive the 
same benefit from participation in cardiac prevention and rehabilitation 
programs. and more research regarding benefits and outcomes from participation 
in these populations is indicated. 
JACC February 1994:1A-484A 
855·137 
Hormone Replacement After Menopause: Importance of Heart 
Disease in Women's Decision Making 
Louise Pilote, Mark Hlatky, 
Stanford University, Stanford, California 
Background: Hormone replacement therapy (HRT) may reduce 
coronary heart disease in women, but little is known about how women 
weigh factors that affect their decision to use HR T. 
Objective: To assess facton affecting women's decision about HRT. 
Methods: We sent surveys to 550 Stanford women alumnae who were 
randomly selected from 3,000 alumnae age 48·52. 
Results: Three hundred and thirty nine surveys were returned (62%). 
Most women were menopausal (75%), many of whom were taking 
HRT (36%). Among potential benefits considered in starting HRT, 
protecting against heart disease was ranked lowest (25% of women) 
while protecting against osteoporosis (35%) and alleviating menopausal 
symptoms (32%) were highest. In spite of their high educational level, 
most women (73%) perceived their heart disease risk as very low « = 
1%) even though most women die of heart disease, whereas 52% 
perceived their risk of breast cancer as high (>= 10%). The first 
concern of women was far more likely to be breast cancer than heart 
disease (65% vs 31 %). Indeed, 49% of women feared breast cancer 
more than heart disease while only 17% feared heart disease more than 
breast cancer. Sixty one percent were aware that HRT could decrease 
risk of heart disease, while 66% believed HRT could increase risk of 
breast cancer. 
Conclusion: We conclude that in this highly educated group of peri•
menopausal women, there is more concern about breast cancer than 
heart disease. These attitudes may lead to low acceptance of HRT as a 
means of preventing coronary heart disease. 
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856·82 
Echocardiographic Image Processing by Means of Methods of 
Mathematical Morphology 
*Evelin Lieback, Isabell Hardouin, Bertram Nickolay, Sabine 
Muller, Roland Hetzer, German Heart Institute Berin, Germany 
The aim of our study was to assess whether the mathematical mor•
phology can improve the diagnostic abilities of echocardiographic 
tissue characterization. The condition for winning remarkable 
features for tissue differentiation is an image amelioration by 
filtering processes followed by a segmentation. The filtering 
processes are based on methods of mathematical morphology. The 
principle of this method consists in the analysis of the environment 
of an image point and its comparison to the structering element. If 
both environment and structering element are identical certain 
image transformations are realized. The noise has to be removed 
from the image without erasing the textural details of importance. 
A second level of filtering may smooth the images to a higher 
degree before they undergo the segmentation stage by thresholding. 
Then the morphometric parameter (area, perimeter, center of 
gravity, ferret diameter, mean gray level) of the segmented objects 
are calculated. We analyzed the cyclic variation of echocardiogra•
phic texture by means of this mathematical morphology. For this 
pupose we obtained 1239 echocardiographic images frem 26 heart 
transplant recipients. The heart cycles of every patient were stored 
by using the cineloop function of echocardiographic machine. Then 
every second image were digitized into the matrix of the image 
processing system. Results: The morphological parameter area, 
perimeter and center of gravity showed a variability during the 
heart cycle. The area and perimeters were smaller at endsysto!ic 
phase compared to enddiastolic phase. This variability be:::ame 
smaller in patients with rejection episodes. Conclusion: Our study 
indicates that mathem~ti:;aJ morphology can improve the diagnostic 
abilities of echocardiographic tissue characterization. 
ABSTRACTS 
856·83 
Validation of 3·D Surface Area Measurement 
Algorithms: Necessity of Standardized Test Objects 
Valerie Desjardins, Thomas Behrenbeck, Marek Belohlavek, James 
F. Greenleaf, James B. Seward; Mayo Clinic, Rochester, MN 
Computer algorithms for surface area measurement (SAM) are 
complex. The use of neural networks, evolving knowledge base 
and inherent unpredictability of multiple decision nodes makes the 
resulting SAM potentially inconsistent. 
To test the behavior and assess the accuracy of SAM algorithms 
applied to 3-D volumes, reconstructed from 2-D echocardiographic 
data sets, we assembled a set of defmed computer-generated test 
objects. Extra surface pixels were systematically introduced to test 
the effect of imaging artefacts (noise, echo blooming). Corners·and 
angles were used to assess the influence of vector orientation. The 
importance of starting point and spatial sequencing of the program 
was assessed by objects that had axis or spatial symmetry with 
variable spatial orientation. 
Several SAMs were tested, i.e. surface picture element (pixel) or 
volume element (voxel) vs. pixel count of a skeleton or spine fit of 
the object. SAM was mostly influenced by two factors with a 
tendency for overestimation: 1) surface noise, and 2) 3-dimensional 
boundary detection. Gross misrepresentation and erroneous 
wraparound artefacts occurred when structural continuity was not 
present (simulating anatomic discontinuity or echo dropout) or when 
the surface was not defmed in all three axes. A 2-D matrix resulted 
in significant incoherence between slices of some complex shaped 
volumes, with gross unpredictable underestimation of SAM. 
Conclusion: A set of "standardized" test objects is mandatory to 
validate the accuracy of SAM algorithms. SAM algorithms need to 
be based on a 3-D rather than 2-D matrix to be effective. 
856·84 
On·line Computerized Body.Surface Pace Mapping: A Novel Method of 
Localizing the Origin of Ventricular Tachycardias 
Todd J. Cohen, Bruce Goldner, Ram Jadonath, Leora Horwitz, Weilun 
Quan, North Shore Univ. Hospital-Comell Univ. Medical College, 
Manhasset, NY 
The purpose of this study was to develop a simple computer-guided 
approach to localizing ventricular tachycardias (VT) during left 
ventricular (LV) mapping. Four patients with sustained monomorphic VT 
were connected to a 32-lead computer-processed body surface mapping 
system. lsoarea maps of induced VT were recorded. Then an LV pacing 
probe was placed via retrograde aortic approach and maps were 
generated from a variety of sites. Differences between VT and pace map 
extrema were utilized in catheter manipulation and localization. 
Results: In 4 of 4 patients this method provided a systematic approach to 
VT localization. The figure below shows isoarea maps during VT and 
during pace mapping distant and proximal to the VT focus. Computer 
generated correlations, as well as the (x,y) coordinates of extremas, were 
used to determine proximity to VT foci and to direct catheter 
manipulation. 
QRST Isoarea Maps: 
N.tive VT 
Percent Correlation of 
VTMap and 
Pace Maps: 
51A 
Cone/usion: On-line mapping can assist in 
localizing VT. Differences in extrema during pace maps and in-situ VTs 
can help with catheter manipulation as well as more precise 
identification of focal tachycardias. 
52A ABSTRACTS 
856·85 
Efficient Computation of Multivariate Receiver Operator and Predictive 
Cbaracteristics. 
Katerina Hnatkova, Jan Poloniecki, A Jobo Camm, Marek Malik, St George's 
Hospital Medical School, London, United Kingdom 
Retrospective risk: stratification as well as other efficiency studies are based on 
the evaluation of the values of sensitivity and specificity. As the paiIs of these 
indices are influenced by the selection of dichotomy points, the so-called Receiver 
Operator Cbaracteristics (ROC), i.e. functions that assign the maximum specificity 
to each value of sensitivity, are frequently used. Computation of ROC is simple 
providing the characteristics are based on univariate data. On the contrary, 
multivariate characteristics are difficult to compute as the complexity of their 
calculation increases exponentially with the dimension of data. 
We have developed a new algorithm designed for computation of multivariate 
ROC and derived functions (namely positive and negative predictive 
characteristics). The algorithm is based on several concepts which increase its 
computational efficiency. The most important of them is pre-sorting of the data in 
each dimension and the division of each dimension into groups in which the 
negative cases precede the positive ones. The algorithm was implemented as a 
special computer package and employed in a several practical studies. The package 
was written in Twbo Pascal (approximately 2800 lines of source text) and 
implemented on a IBM PC compatible computer. 
The performance of the package was tested in a risk stratification stndy that 
was aimed at identifying survivors of acute myocardial infarction who are at the risk 
of early death. The study stratified a cohort of 539 patients of who 37 died during 
the first two years of follow·up (positive group). For the stratification, the stndy 
employed (a) 3 time-domain indices, and (b) 6 spectral turbulence indices of signal 
averaged electrocardiogram. The computation of ROC and predictive accuracy 
characteristics based on the 3 time-domain indices required approximately 40 s, 
while the computation based on the 6 spectral turbulence indices took 
approximately 2 hours (i486 SOMHz powered computer). 
Thus the package makes computation of receiver operator and predictive 
accuracy characteristics feasible also for large sets of data, provided that the number 
of dimensions of the data is moderate. 
991 Computer.Aided Instruction I-Pediatric 
Cardiology 
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Georgia World Congress Center, Hall G 
991·1 
A Computer·Based Multimedia Learning 
Environment for Congenital Heart Disease 
Alan H. Friedman, Peter C. Jaffe, Patrick Lynch, Charles S. 
Kleinman, C. Carl Jaffe 
Yale University School of Medicine, New Haven, cr 
Accurate assessment of congenital heart disease can 
present a diagnostic challenge because its learning curve 
requires mastering several alternative mental models of 
normal and abnormal developmental anatomy. This 
requires extensive clinical experience acquired over a long 
period of time. Multimedia computer-aided instruction can 
facilitate more rapid understanding of the structural 
abnormalities visualized by real-time echocardiography 
because it offers immediate access to an extensive library of 
primary images and secondary learning tools such as 
graphics, three-dimensional illustrations, text files and 
embryological diagrams. 
A computer-based multimedia learning environment for 
congenital heart disease was devised containing digital 
QJJickTime'" echocardiographic sequences from more than 
fifteen congenital cardiac abnormalities. The user can 
point-and-click a computer mouse at on-screen menus that 
offer real-time display of "endless-loop" echocardiographic 
sequences. Help files, graphics, pointers, ECGs, X-rays and 
explanatory text are immediately available, allowing the 
user to become familiar with a broad range of congenital 
cardiac abnormalities in a relatively short time. A self•
administered quiz module allows the user to validate 
learning progress. 
The program runs on a conventional desktop personal 
computer (Macintosh) with 5 MB of RAM memory. 
Technical advances making affordable write-once CD ROM 
devices (Kodak PCD 200) available permit the 450 MB 
software program to be easily and inexpensively 
distributable. The program software will be demonstrated 
using a standard CD ROM as the access source. 
JACC February 1994:1A-484A 
991·2 
Iateractlve Computer Aided Instructioa for CardIae AuaJltalioa 1a PecIlatrk 
CardIology 
"Richard A Humes, linda Glowaz, James C. PoUock, Carolyn Gilbreath. 
Children's Hospital of Michigan, Wayne State University, Detroit, MI. 
Instruction in cardiac auscultation bas traditionally employed bedside 
teacbing. audiotapes or heart sound simulator devices. Each of these methods 
may be limiting and laborious for individual student training. As a result, 
pediatricians, family practice physicians and allied health workers are often 
uncomfortable in their clinical auscu1tatory skills in pediatric patients. 
The program which we have developed provides a non-linear, self-paced 
teaching program in cardiac auscultation with particular emphasis on congenital 
heart disease. Two levels of instruction are provided - comprehensive and 
individual concepts. A classic tutorial is available as a comprehensive study 
program with context sensitive help and glossary. Individual concept development 
may be user-selected, allowing for inductive instruction. The program allows both 
methodologies to be ·tracked" so that the pathway of instruction which is chosen 
may be analyzed against the results of testing. Instruction sequences are 
dynamically linked to provide the student with access to related areas of 
instruction within the program and between program modules. 
Sounds are recorded digitally into a . W A V file format from a 
Cardionics· Heart sound simulator and replayed through a commercially 
available 16-bit sound board. The student interacts with a menu-driven, mouse•
controUed interface developed on Assymetrics Toolbook. for the personal 
computer (386 or above). 
Instructional concepts may be evaluated by analysis of the pathways 
which students choose to achieve their educational goals. This information may 
then allow the program to be modified to better suit the needs of students at 
different levels of training. Pre- and post -testing of concepts and recognition of 
specific beart sounds are preformed to provide a traditional evaluation of 
performance. A case oriented, patient simulator allows the student to practice 
their skills in a simulated clinical setting. The development of this program will 
allow for self-paced instruction and evaluation in auscultation of congenital heart 
disease. 
991·3 
Multimedia InstnJctiooal System tor Congenital Heart 
Disease 
Allen D. Everett, Jack Wilson, for the University of Virginia, 
Charlottesville, VA 
Congenital heart disease has always been an area of 
conceptual difficulty due to complicated anatomy and 
physiology, presence of multiple defects and the rarity of some 
lesions. Therefore a Windows based multimedia computer 
program for the instruction of congenital heart disease for 
students, residents, fellows and primary care physicians is 
under development. The application includes a tutorial to 
instruct the novice in the interpretation of normal heart sounds 
and murmurs, pediatric electrocardiograms and 
roentgenograms. The second portion includes a large browsing 
library of graphic images of congenital heart defects, digitized 
electrocardiograms, roentgenograms, and realtime video images 
of echocardiograms and clneangiograms. Textual and 
graphical images are linked to a database and can be viewed by 
searching for the title of the defect or by a patients clinical 
findings. The combination of textual, graphical and video 
information in one easy to access source provides a powerful 
instructional tool in a difficult and underserved area of medical 
education, congenital heart disease. 
JACC February 1994:1A-484A 
991·4 
Fetal EcOO Expert Systan 
Krzysztof P. Wroblewski 
University of Pennsylvania, philadelphia, PA 
Zhi Yun Tian 
Children's Hospital of Philadelphia, philadelphia, PA 
An expert systan using Dempster-Shaffer theory of 
evidence has been designed to assist nedical students 
and residents with interpretation of fetal echo data. 
The systEm oontains koowledge of anatany, physiology 
and function of a heart. It contains also a library 
of congenital heart diseases. The user is guided step 
by step to obtain all necessary measuraren1;s and 
infonnation, to analyze four and five chambers' view 
and to read and evaluate Doppler data. Intelligent 
screen linking is provided, thus depending on the 
answers given, appropriate subsidiary questions would 
be asked. All infonnation provided is then used in 
conjunction with the facts and rules pIogranmed into 
the systEm. After the dialog bet\.leen the user and 
the oc:rtputer is oc:rtpleted the systan presents its 
conclusions. If it is necessary additional tests (not 
necessarily regarding the heart) are suggested. 
Abnonnali ties are divided into six groups: diseases 
ooncerned with atrioventricles, valves, great vessels, 
veins, arrhyttmias, and other cardiac abnonnalities. 
The shell of the expert systen is written in roRI'RAN 
and is dynamically linked to the graphics user 
interface written in Visual Basic for Windows. 
710 Therapy for Chronic Ischemia: Randomized 
Clinical Trials I 
Monday, March 14, 1994 2:00-3:30 PM 
Georgia World Congress Center, Room 254W 
710·1 2:00 
Amlodipine Reduces the Total Ischemic Burden of Patients 
with Coronary Disease: Double-Blind Circadian Anti•
Ischemia Program in Europe (CAPE) Trial 
John E. Deanfield, London, UK for the CAPE investigators 
The CAPE trial was a IO-week, international, double-blind 
study evaluating the anti-ischemic effect of a once-daily, long•
acting calcium blocker, Amlodipine (A) (t'n 35-50 hrs), versus 
placebo (P) in patients (pts) with chronic stable angina. After a 
2-week, Single-blind, placebo phase, during which stable doses 
of anti-anginal drugs were maintained (65 % of pts were 
receiving beta-blockers) pts with ~4 ambulatory ECG ischemic 
episodes (~I mm ST depression for ~ I min) and/or ~20 min 
total ischemia time/48 hrs began treatment with 5 mg/od of 
either A or P (2: I randomization). This was automatically 
increased to 10 mg/od after 4 weeks. During week 7 of 
treatment, 48-hr ECGs were repeated. All ECG tapes were read 
blinded in a central facility and independently overread by one 
physician. 315 of 1160 pts screened were eligible and 250 had 
completely evaluable data. Compared with P, A significantly 
reduced both total frequency of ST-segment episodes (A 60% vs 
P 44%; p=0.025) and the total ST-segment integral (mm x 
time)(A 61.6 mm-min vs P 49.5 mm-min; p=0.042). A was 
effective compared with baseline over 24 hrs but the circadian 
pattern was unchanged. In addition, diaries showed a significant 
reduction in angina attacks (A 69% vs P 41 %; p=O.OOOI) and 
GTN consumption (A 67% vs P 18%; p=0.OOO2). Overall safety 
profiles were similar (adverse events 17.3% for A and 13.3% for 
P: discontinuation rates 1.5% for A and 4.5% for Pl. Thus, 
once-daily A significantly reduced symptomatic and 
asymptomatic ischemic episodes during normal daily life in pts 
with chronic stable angina. 
ABSTRACTS 53A 
710·2 2:15 
Mechanism of I5cbemia Suppression by Amlodlplne and Atenolol on 
Exercise TreadmHl Testilli and Ambulatory Monitoring. 
Richard F. Davies, Habibullab Habibi, W. Peter Klinke, Claude Nadeau, Denis 
C. Phaneuf, Serge Lepage, Sankanmarayanan Raman, Margaret Herben, Kathy 
Foris, Pierre Dessain, Jennifer A. Buttars, and CASIS Investigators. University 
of Ottawa Heart Institute, Ottawa, Ontario, Canada. 
introduction: Cardiac 
drugs affect ischemia 
by changing 
myocardial 0, supply•
demand. To clarify 
mechanism, we studied 
the effects of 
amlodipine (AML), 
atenolol (ATE) and the 
combination (COMB) 
on cardiac demand and 
ischemic threshold 
during exercise 
treadmill testing (EIT) 
and ambulatory 
monitoring (AM). 
Metbods: 100 patients 
with stable CAD, 
IIftIIItI: MIL Crqup ATI GrouP 
196 of plllcebol AIIL COM! ATI COMI 
Time 109t 115ft 103 110U 
peak 
exercls OP 
me 
99 82U 82t 82t 
trime 130t 148t 103 122U 
1.0mm 
ST depr OP 102 88ft 82t 83t 
82 48t 49t 36t Episode 
freQuency 
MI Peak HR 103 83ft 83t 8St 
HR threshold 104t 83ft 82t 84t 
p < .01, t vs placebo, t vs simile drug 
positive ETTs and ischemia on baseline AM were randomized to AML 5-10 mg 
od (N=SI) or ATE 50-100 mg od (N=49) in a double-blind, placebo-controlled 
trial. ETTs and 48hr AMs were obtained after 3 weeks oftreatmcnt with AML, 
ATE, and COMB. Cardiac workload during ETT was estimated by the double 
product and ischemic threshold on AM by regression of HR on ST depression 
during episode onset. 
Conclusions: ATE lowered the threshold for ischemia on both ETT and AM, 
offsetting the anti-ischemic effects due to reduced DP. AML increased the 
amount of exercise required to produce a given DP, and did not alter ischemic 
thresholds. 
710-3 2:30 
Total Ischemic Burden. - Betablockade or Calcium Antagonism? 
Results of the TIBBS Trial 
Thomas v.Arnim, Red Cross Hospital, Munich. Germany, for the 
TIBBS Investigators 
In the Total Ischaemic Burden Bisoprolol Study (TIBBS) the effects 
of bisoprolol (B) and nWedipine (N) on transient ischemic episodes 
(TIE) were compared in a randomized double blind controlled study 
wkh two parallel groups. 
330 patients from 25 centers in 7 european countries were Included 
wkh stable angina pectoris. posttive E1T and more than two TIE on 
48 hours Holter monttoring. Holter tape evaluation was centralIZed. 
161 patients were randomized to B. 169 patients received N slow 
release. 
In phase I of the trial, 4 weeks of B o.d. reduced the number of TIE 
from 8.0 .±. 4.6/48 hours (x .±. SEM) to 3.2 .±. 0.4. N 2 x 20 mg 
reduced TIE from 8.3 + 0.5 to 5.9 + 0.4. Total duration of Ischemia 
was reduced from 99.3.±. 10.1 to 3i.9 .±. 5.4 minutes per 48 hours 
with B and from 101 + 9.1 to 72.6 + 8.1 wtth N. TIB was reduced 
from 193.7 + 27.1 to58.9 + 11.7 mTrix mmwtth B and from 194.7 
.±. 23.8 to 117.0 .±. 16.0-with N. Reductions were statistically 
significant for both drugs, the difference between Band N was also 
significant. B reduced the heart rate at onset of episodes from 
99.5 .±. 1.2 to 84.0 .±. 1.5/min. (p < 0.001). Heart rate was 
unchanged with N. 
Doubling of the dose for both drugs for further four weeks In phase 
II of the trial had only marginal addttive effects. Based on responder 
definitions from 25% to 100% decrease of TIE B had signWicantly 
higher responder rates than N. Only B showed a marked circadian 
effect by reducing the morning peak of TIE (from 0.4 episodes/h to 
0.13 episodes/h). 
Conclusions: In a large number of patients w~h stable angina 
pectoris and severe circadian ischemia. B and N showed signfficant 
decreases in number of episodes, duration and total ischemic 
burden. Bisoprolol was signWicantly more effective in both doses 
tested and reduced the morning peak of episodes wtth a single daily 
dose. 
54A ABSTRACTS 
710·4 2:45 
~\/II Effects of IiIIllupEl, llltaprolol tnI llimlipinl in 
Stabla AlCina. A ~ticent1lr, 1InIIaUzad, llaubla Blind, PlKeIIo 
Cant:rolled Study. 
SI"AP Study Group, Italy. 
Ail of the study was to ellaluate the effects of gallopliU (G), 
.. toprolol (") and nifedipine (H) in pts with IUd to .aderate stable 
angina pectoris. Accordingly, 16<1 pts with steble angina (CeS class 
I-II) and reproducible ST sellltnt depression in tllO consecutiw 
exercise tests were enrolled in a .ulticenter, randoaized, double 
blind, placebo (PL) controlled, parallel groups study (SIMP), 
Exercise tests and 24 hour Holter IOnitoring were perfornd under 
control conditions, after 4 weeks of single therapy with G (50 .. tid, 
"=46) or " (lOO11g bid, H=47> or H oOlig 5 tins/day, N=54) or PL 
(H=l7> and after 2 weeks of coabined therapy with open isosorbide 
.anoni trate (lSIIN 20 .. tid). Tile to 1 • ST depression increased 
after S (+23\) and " (+26\) (both p<. 05 liS PL) but did not change 
after II (+15\, lIS liS PL). The addition of IS"" did not result in 
further ilprOlltnnt in exercise duration but significantly decreased 
ischelic episodes and HTS consulption in the whole population 
(p< .01). Side effects requiring drop out froa the study were reported 
in 2\ of pts during G, 18\ during ", 10\ during Hand 11\ during PL 
therapy. 
In conclusion, G and " prowd to be affectille IOnotherapies in 
petients with IUd to lOderate engine pectoris. The addition of ISIIN 
reduced enginel SYiptOIS without further ilprollelent in exercise 
paranters. 
710·5 3:00 
Rebound IIchImIa DurIng N~"'" PeItocII wHh Intermment 
Cutaneous NnroglyCerin. 
Bipin V Oaxlnl, ~iana Noyce, Phlilipa Sobb, S. Ben Freedman. Hallstrom 
Instilule of Cardiology, Royal Prince Allred Hospital, Sydney, Australia. 
Rebound angina has been suggested to be a col1lllicatlon of the 
nltrate-lree period with ctvonlc cutaneous nltrate therapy wilen given 
intermittently to prevent tolerance. To determine whether rebound 
Ischemia occurs In patients on background anti·anginal therapy we 
studied 52 patients with stable effort angina taking either a &-blocker (25 
pis), cliltiazem (22 pis) or their combination (5 pis) In a double-blind 
placebo controlled randomized crosso()wr trial of nitroglycerin patches 
(SOmg). Active or placebo patches were 
worn for 1 week (applied at Sam and 
removed at 1Opm) to give a 10 hr nltrate- (or 
placebo-) lree period. During the last 48hr of 
each period a 2-c11annel ambulatory ST· 
Holter monltor was used to detect Ischemia. 
Duration of ischemia lmiootesl24hrl 
Active Placebo 
Total period 35.5±15.0 29.7±9.8 
Patch on 27.5±14.0 34.7±10.9 
Patch off' 46.9±17.9 22.5±9.2 
1p-O.07 active YS placebo. All values are 
rnean±SEM normalized to 24hr period. The 
diurnal distribution of Ischemic episodes 
=lliIili-~ _w" -: 
.....•.•... , 
;I-~ ... '=:trr1ll1WI 
......••.... .... "..,p ..... ....-..a 
during active and placebo phases (grouped In 2 hr periods from 8am-
8am, solid bars • patch-off nitrate-lree period) is shown above. The 
pattem of diurnal distribution of Ischemic episodes on active drug 
appeared different to placebo. Although there was an increased duration 
0/ Ischemia in the nitrate-tree period, this did not reach conventional 
statistical significance (p-O.07), and an identical proportion of patients 
(29%) experienced >5 min Ischemia during the patch-off period for both 
active drug and placebo. These results indicate that the potential for 
rebound Ischemia during nitrate-tree periods cannot be excluded, even in 
the presence of concomitant antI-anginal treatment with a 8-bIocker or 
diltiazem. 
JACC February 1994:1A-484A 
710·6 3:15 
Intermittent Transdermal Nitroglycerin. Effective in 
Angina Pectoris without Tolerance or Rebound. 
John O. Parker, *Mark H. Amies, *Ron W. Hawkinson, *Mark 
C. Vollmer, and the Minitran Study Group, Kingston, 
Ontario, Canada and St. Paul, Minnesota. 
The antianginal and anti-ischemic effects and safety 
of transdermal (TD) nitroglycerin (GTN) patches were 
studied in 262 patients with stable angina pectoris, a 
majority (61%) of whom were on stable dose of beta 
blockers. In a multicentre, placebo (PL) controlled, 
parallel study, 4 patient groups (TD-PL, TD-GTN 0.2, 
0.4 and 0.8 mg/h) applied patches 12 h daily. Tread•
mill walking time (TWT) to moderate angina (P2) was re•
corded before (Oh) and 4,8 and 12 h after TD-PL (Day 0) 
and after TD-GTN on days 1 and 30 and at Oh and 4h on 
days 7 and 14. In comparison to the changes with TD-PL 
on day 0, TWT to P2 increased with each GTN group with 
greater effects with 0.4 and 0.8 mg/h. On day 30, TWT 
to P2 was significantly (P 0.05) increased after 12h 
for each group. Time to 1 mm ST depression followed a 
similar pattern and on day 30, this was significantly 
prolonged for 12h in each GTN group. Tolerance did not 
develop as TWT at matched times during the study did not 
diminish. All groups showed progressive increases in 
TWT to P2 before patch application and the changes in 
the PL, 0.4 and 0.8 groups were similar. There was 
no increase in rest or exercise induced angina during 
the patch off period. These observations suggest that 
rebound phenomena do not occur during intermittent 
TD-GTN therapy. 
Conclusion: Intermittent TD-GTN therapy improves 
exercise performance in patients with angina pectoris 
and is not associated with tolerance or rebound 
phenomena. 
711 Dobutamine Stress Echocardiography 
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711·1 2:00 
Tbe Atropine Factor In Pbarmacologlcal Stress Ecbocardlollrapby 
Barbara Reisenhofer, Alessandro Pingitore, Guido Gigli, Massimo Quanacolosso, 
Alfonso Galati, Alessandro Salustri, Gabriella Greco, Maria J080 Andrade, 
Patrizia Landi, Mauro Raciti, Alessandro Vallebona. Wilson Mathias. Roberto 
MaItioli, Eugenio Picano on behalf of the EPIC·EOIC study group. 
ID the continuing quest of ideal diagnostic accuracy, pharmacological sUess 
echoc:ardiography quickly moved over the years from low dose to high dose 
regimens and is currently performed with atropine coadministration. ID order to 
compare head to head the 2 most popular pharmacological stress ecbo tests with 
"stale of the an" protoCOls, both dobutamine (up to 40 j.lg/kglmin) • atropine (up 
to 1 mg over 4') suess ecbo (DOBASE) and dipyridamole (up to .84 mg/kg/min 
over 10'). atropine (up to I mg over 4') sUess echo (DIPASE) were performed, on 
different days and in random order, in 201 pts with chest pain syndrome. Six 
different echo laboratories, all fulfilling quality control criteria for stress eclIo 
reading, conbibuled to the project. No major complications occurred during either 
test. The test was intenupled before the achievement of predetermined endpoints 
for limiting side effects in 23 DOBASE and in 3 DlPASE (feasibility: 89 vs 
99%, p <.05). In 68 pts undergoing coronary angiography independently of leSt 
results and within I week from IeSting, a significant CAD (~SO% reduction in at 
least 1 major coronary vessel) was found in 59. The sensitivity for CAD delection 
was SO/59 for DOBASE and 49/59 for DlPASE (85 vs 83%, pzns). The 
specificity was 819 for DOBASE and 919 for DIPASE (88 vs 100%, p=ns). 
In conclusion, both DOBASE and DlPASE are safe and feasible, although 
submaximal studies are more frequent with dobutamine. The 2 stresseS have 
comparable accuracy in the detection of angiographica1ly assessed CAD, albeit 
dobutamine is marginally more sensitive and dipyridamole marginally more 
specific. 
lACC February 1994:1A-484A 
711·2 2:15 
Tbe Incremental Diagnostic Value of Addition of Dobutamine to 
tbe Negative Dipyridamole Echocardiograpby Test 
Miodrag OslOjic, Eugenio Picano" , Branko Beleslin, Ana Djordje\'ic-Dikic, Jelena 
S&epanovic, RIde Babic, Sinisa Stojkovic, Milan Nedeljkovic, Goran Stankovic, 
Slavko Simeunovic, Valdimir Kanjuh. Institute for Cardiovascular Disease, 
Belgrade, YU; " CNR,lnstitute of Clinical Physiology, Pisa, lully. 
In a previous pilot study we have shown that immediate dobutamine addilion (up 
to 40 Ilg/kg/min) causes a further hemodynamic sttess to the myocardium already 
challenged by flow maldistribulion induced by dipyridamole infusion (up to 0.84 
mg/kg in 10 min). The test is wen IOlerated and safe and increases the accuracy of 
dipyridamole-echocardiography test (DEn or dobutamine-echocardiography test 
(DOBEn separately performed for the detection of coronary artery disease (CAD). 
A larger scale experience with the dipyridamole-dobutamine stress 
echocardiography (DIDOSE) protocol is needed at this point. One hundred and 
fifty patients (age 51± 11 years), referred for stress echo, were prospectively 
submitted 10 combined DIDOSE test. Ninety-five pts were slOpped during the 
dipyridamole step of the test for achievement of a predetermined endpoint (obvious 
dyssynergy, induced by the lower or higher DET dose); 55 pts progressed 10 the 
dobutamine arm of the stress. In all 150 pts also DOBET was performed on a 
separate day. CAD ~50% diameter stenosis in at least I major coronary vessel) 
was present in 131 pts and absent in 19. The feasibility was 100,98 and 96% for 
DET, OOBET and DIOOSE, respectively. The sensitivity was 71% for DET, 
75% for DOBET and 92% for DIOOSE (p<0.01 vs DET and OOBEn, while 
specificity was 89%, 79% and 89% for DET, DOBET and DlDOSE (p=ns) 
respectively. The 4 sequential stress steps identified progressively milder degrees 
of CAD: 
No of vessels (pts) 0 (n= 19) I (n= 115) 2 (n= I 0) 3 (0=6) 
Positive low dose DET 0 27 3 3 
Positive high dose DET 2 52 5 3 
Positive DlOOSE 0 25 2 0 
Negative DIDOSE 17 II 0 0 
We conclude that routine dobutamine addition to dipyridamole stress is clinically 
useful, does not significantly decrease feasibility, expands the spectrum of disease 
detectable by pharmacological stress echo and allows the documenlation of milder 
forms of CAD which can be missed by conventional DET or OOBET. 
711·3 2:30 
Comparison of Dobutamine Stress Echocardlogrsphy to Dobutamine 
SPECT Isonitrile Perfusion Imaging for Detection of Coronary Artery 
Disease 
Thomas R. Stoiber, Steven C. Sman, Roben S. Hellman, Robin Stan, John 
C. Wynsen, Klrsn B. Sagar, Medical College of Wisconsin, Milwaukee, WI 
To detennine the relative accuracy of dobutamlne stress echocardiography 
(DSE) and dobutamine stress SPECT Tc-99m sestamlbi SCintigraphy 
(DMIBI), 53 patients (age 57:1: 11 years, mean :I: SO) wtth suspected 
coronary anery disease (CAD) were prospectively evaluated. All patients 
underwent coronary angiography, graded DSE (5 minute stages 
dobutamlne, up to 50 PII/kg/mln) wtth simultaneous OMIBI (10 mCI at peak 
dose, 20 mCI at rest). Coronary luminal narrowing 01 ~ 50% was 
considered significant. OSE and OMISI Images were analyzed according 
to the standard 16 segment model. Peak dobutamlne dose was 28:1: 12 
pg/kg/mln and atropine was used In 24 patients. Peak hean rate and 
double product were 132:1: 15/mn and 17046:1: 4967, respectively. CAD was 
present In 27 patients, 18 patients had single vessel disease (SVO) and 9 
patients had multivessel disease (MVO). Sensttlvlty (SENS), specificity 
(SPEC) and accuracy (ACC) of two tests to detect CAD were as follows: 
SVO MVO OVERALL 
SENSITIVITY SENS SPEC ACC 
DSE 89% 89% 89% 88% 89% 
OMISI 83% 44%· 70%· 69%· 70%· 
p<.05 (vs DSE) 
A concordant result was obtained In 37/53 patients (agreement 70%). 01 
16 discordant cases, OSE was correct in 12. 
In conclusion, dobutamlne stress echocardiography Is superior to 
dobutamine stress isonttrile Imaging for the detection of coronary anery 
disease. 
ABSTRACTS 55A 
711·4 2:45 
Gender Specific Outcomes After Dobutamine Stress 
Ecbocardiograpby: Increased Incidence of Deatb and Myocardial 
Infarction in Women Witb an Iscbemic Response. 
Pamela Marcovitz, Viktoria Shayna, William F. Annstrong 
University of Michigan, Ann Arbor, MI 
Recent attention has been drawn 10 differential outcomes in cardiovascular testing 
based on gender. Prior studies have demonstrated an increased incidence of 
subsequent non-fallil myocardial infarction (NFMI) and cardiac death (CD) in patients 
with inducible ischemia during dobutamine stress echocardiography (DSE). The 
purpose of this study was to assess the impact of gender on clinical outcome 
following DSE in patients with known or suspected coronary artery disease. C1inical 
follow-up was available in 251 patients 14+/-5 months after DSE; of these 125 
(50%) were women. The mean age was 63 ± 12 years and did not differ between 
gender groups. The prevalence of cardiovascular risk factors was likewise similar in 
the two groups. Specific hard end-points (HE) were NFMI and CD. Soft end•
points of catheterization and revascularization (PTCA) were also tabulated. DSE 
responses were characterized as normal (NI), ischemic (Isc). fixed (Fx) or mixed 
(Mx). Event rates (%) for males (M), females (F) were as follows: 
DSE NI-M NI-F Isc-M (sc-F Fx-M Fx-F Mx-M 
n 27 43 14 20 32 29 54 
HE 0(0)+ 1(2.3)+ 0(0) 5(25)' 5(16) 2(7) 11(20)# 
Catb 5(19) 5(12) 5(35) 8(42) 7(22) 3(10) 20(37) 
PTCA 2(7) 3(7) 1(7) 1(5) 5(16) 2(7) 10(19) 
*p<.OO5; # P<.02; Compared to normal: +P<.OI Compared 10 abnormal. 
Mx-F 
33 
5(15) 
11(33) 
7(21) 
An ischemic response (normal rest with induced abnormality) was predictive of a hard 
endpoint only in females. No male with an ischemic response sustained a hard 
event. Within the male cohort a hard event was most likely after a mixed response 
(abnonnal rest with induced ischemia). Cath and PTCA were equally distributed in 
both genders suggesting a lack of gender bias in treatment. We conclude that DSE 
provides prognostic infonnation in both genders. however both the nature of the 
response and the type of clinical outcome may be gender specific and do not appear 
related to utilization of catheterization or interventional procedures. 
711-5 3:00 
Dobutamine Ecbocardiograpby Predicts Recovery of Hypoperfused 
Dysfunctional Myocardium in Patients witb Coronary Artery Disease. 
Pasquale Perrone-Filardi, Mariella Prastaro, "Leonardo Pace, Federico 
Piscionc, Sandra Betocchi, "Andrea Soricclli, "#Marco SaI\·atore, Massimo 
Chiariello. Divisions of Cardiology and "Nuclear Medicine, "Federico II" 
University, and #Istituto "Pascale", Naples, Italy 
In patients with coronary artery disease, dysfunctional bypoperfused 
myocardium at rest may represent either necrotic or viable myocardium. To 
assess the ability of dobutamine ecbocardiograpby to identify viable 
bypopetfused myocardium, 14 patients ",ith stable chronic coronary III1cIy 
disease underwent, wbile ofT drugs, quantitative 20Ithallium (TL) SPECT 20 
minutes following rest injection (2-3 mCi), and echocardiography at rest and 
during dobutamine (5-10 jlg/kgfmin, i.y.), within the same day. TL SPECT 
and ecbocardiograpby at rest "'ere repeated 28±ll days after successful 
coronary revascularization. Regional TL uptake was measured from short 
axis tomograms, and resting hypopetfusion ",as defined as TL uptake ~80% 
of maximal activity. Wall motion (WM) was scored from I (normal) to 4 
(dyskinesia), and WM improvement defmed as WM cbangc?1 grade. Of34 
dysfunctional bypoperfused segments, 24 improved WM after coron8l)' 
revascularization. In 21 (88%) of these segments WM bad improved during 
dobutamine. Conversely, WM after coronary revascularization did not 
improvc in 10 segments, and in 7(70%) of them it bad not improved during 
dobutamine. A WM improvement following coronary revascu1arization was 
observed in 19(86%) of 22 segments manifesting a WM improvement 
during dobutamine as opposed to 5(42%) of 12 segments that did not 
improvc during dobutaminc. Resting TL uptake (% of maximal actiyity) 
before revascularization was significantly greater in the segments wbere 
WM improved after revascularization than in those that did not (65±20 vs 
49±23%; p<O.OI), and significlll1t1y improved afterrevascu1arization in the 
formcr (74±24%; p<0.02) but not in the latter (52±25%; p=n.s.). Thus, 
dobutamine ecbocardiograph)' is a sensitive technique for identifying viable 
dysfunctional myocardium, and a WM improvement during dobutamine is 
highly predictive ofWM improvement following revascu1arization. 
56A ABSTRACfS 
711·6 3:15 
Dobutamlne Stress Ecbocardiograpby Correlates wltb Positron 
Emission Tomograpby In Predicting Tissue Viability In Patients 
wltb Cbronic Lert Ventricular Dysrunction but does not Predict 
Recovery or Function wit bin /I weeks Post Revascularlzatlon. 
Anne M. Hepner. Carolyn L. Donovan. David S. Bach. G. Michael Deeb, Sleven 
F. Bolling, Louis A. Brunsting, Kate Stafford, Victoria Shayna, Marcus 
Schwaiger, William F. ArmstrOng, University of Michigan Hospitals, Ann Arbor, 
MI. 
Patients (pts) with chronic coronary disease (CAD) and left ventricular (L VD) 
dysfunction are often refused coronary BrIery bypass surgery (CABS) due to 
increased risk. We evaluated 17 pIS with CAD and L YO with dobutamine stress 
echocardiography (DSE) and positron emission tomography (PET) prior to c.ABS 
(16 pts) or PTCA (Ipt). PIS were evalualed post rev8SCularization (RV) with 
echocardiography (2DE) early (1-2211) and late (29-116 d, average 48d). DSE was 
perfonned with incremental infusions of dobutamine (DB) at S or 10,20,30, 
4Omcg/kg/min in 3 minule stages. Images from par8Slernal long and sbon axis, 4 
and 2 chamber views were acquired at each stage. Wall motion scores (WM), left 
ventricular ejection ftaction (E.F) were measured at baseline (8), !.D, and peak (P) 
images. DSE and 2DE studies were scored in 13 segments. Viability by DSE 
(DV) was defined as hypokinetic or nonnal wall motion at rest or improvement in 
wall motion with LD DB. PET was perfonned within 20 days with 20mCi NI3 
Ammonia (N13) and IOmCi fluorodeoxyglucose (FOG) afler oral glucose loading 
or insulin therapy. A visual score of I (normal tracer uptake) to 4 (activity 
comparable to background) was given to each of 13 corresponding left ventricular 
segments (SG) by an observer blinded to results of the DSE study. Viability by 
PET (PV) was defmed as an N 13 score of S2, or an FOG score Sl. PIS were 
divided into 2 groups (GP); Group I (PIS with an improvement in EF by grealer 
than 5% on post RV 20E) and Group II (PIS with a <5% increase in EF post 
RV). 
GP n PV OV WM WM WM EF WM EF 
SG/pt SG/pt B !.D P B !ale tale 
9 II 9.1 2.41 2.38 2.44 28 2.23 38 
n 8 12 8 2.40 2.38 2.59 29 2.57 26 
Both PET and DSE agreed with respect to the presence of tissue viability 
(concordance was 70%). Neither PET nor DSE parameters were able to predict 
improvement in EF to an average of 4S days post RV (one-way Anova lest, p>.I). 
Six of 7 pts with> IO viable SEG by DSE showed an improvement in EF post 
RV We conclude DSE cannot predict improvement in objective echo parameters 
at 6 weeks post RV. 
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Hirulog In the Treatment of Unstable Angina: Results of the TIMI 7 Trial 
Joanna Fuchs, Carolyn H. McCabe, Elliott M. Antman, Steven Borzak, 
Donald Palisaitis, Steven Herson, Richard Daum, Sebastian Palmeri, Rafael 
Sequeira, G.V.R.K. Sharma, Daniel Diver, Wayne Warnica, Hiltrud Mueller, 
Raymond Magorien, Nieca Goldberg, Fred Leya, Christopher Thompson, 
David O. Williams, Michael Remetz, Simon Chakko, Timothy Henry, Judith 
Hochman, Bernard Chaitman, Christopher P. Cannon, "Kate Findlen, "Burt 
Adelman and Eugene Braunwald, for the TIMI 7 Investigators, Harvard 
Medical School, Brigham and Women's Hospital, Boston, MA 
Hirulog™ (HLOGI is a synthetic peptide that is a highly specific direct 
inhibitor of free and clot-bound thrombin. The TIMI 7 trial was a 
randomized, double-blind, dose-ranging study to compare the activity of 
4 doses of HLOG, given with aspirin, to 41 0 patients with unstable angina 
(UAI. Patients (Ptsl received a constant infusion of HLOG for 72 hours at 
1 of 4 doses: 0.02,n=160; 0.25,n=81; 0.5,n=88; and 1.0,n=81 
mgikglh. For purposes of analysis, comparisons were made between the 
lowest dose (Lo HLOG,I and the combination of the 3 higher doses 
(HLOG2 3 41. The primary endpoint was "unsatisfactory outcome" defined 
as any cif the following events by 72 hours: death, MI, recurrent ischemic 
pain at rest with ECG changes, and rapid clinical deterioration. 
Death or nonfatal MI was significantly reduced in pts treated with 
HLOG2,3,4 compared to Lo HLOG" at both hospital discharge (9/250, 
3.6% vs. 17/160, 10.6%; p< 0.0041 and at 6 weeks (14/250, 5.6% vs. 
20/160,12.5%; p< 0.0131. Unsatisfactory outcome was not different 
between dose groups. Only 0.2% (1/4101 of pts required HLOG to be 
prematurely discontinued due to maior hemorrhage. 
CONCLUSIONS: Hirulog appears to be well tolerated and HLOG 2,3,4 
significantly improves the outcome (Death or nonfatal Mil at hospital 
discharge and at 6 weeks in pts with UA compared to Lo HLOG,. 
Although prior studies of UA failed to definitively demonstrate that the 
addition of heparin to ASA improved outcome, HLOG 2,3 4 demonstrated 
substantial benefit when used in addition to aspirin. These favorable 
results will be tested further in TIMI 8, an international randomized, 
double-blind Phase 3 trial designed to compare hirulog with heparin in the 
management of unstable angina and non-Q wave MI. 
JACC February 1994:1A-484A 
712·2 2:15 
Hemostatic Markers Predict Clinical Events ID Patients Treated With rt·PA 
and Adjunctive Antltbrombotic Tberapy 
Jonathan S. Scbarfstein, Dorinda George, J.E.B. Burchenal, Christopher P. 
Cannon, Richard C. Becker, Paul R. Eisenberg, Dana R. Abendschein, Bunon E. 
Sobel, Eugene Braunwald, Joseph Loscalzo for the TIMI 5 IDvestigators, Boston, 
MA. 
The Thrombolysis in Myocardial infarction (TlM1)-5 study is a randomized, 
dose-ranging, pilot trial of hirudin versus heparin as adjunctive antithrombotic 
therapy with recombinant tissue-type plasminogen activator (n-PA) administered 
to patients with acute myocardial infarction. As an ancillary study to this trial, we 
measured several markers of thrombosis, (fibrinopeptide A (FPA), thrombin•
antithrombin III complexes (TAT), and prothrombin fragment 1.2 (F1.2)], and a 
marker of fibrino(geno)lysis [8,6 1-42 (B,6)], at baseline (TO), and one hour (Tl), 
12 hours (T12), and 24 bours (T24) after initiation of therapy. By repeated 
measures analysis of variance, there was a trend for a decrease in FPA levels over 
time in the heparin-treated patients (p=0.13) and a significant decrease in FPA 
levels over time in patients treated with hirudin (p <0.05). Both B,6 and F1.2 
levels initially increased, then decreased during the study period; these changes 
over time were significant (p<0.02), and were similar in both hirudin- and 
heparin-treated patients. Correlating clinical events with markers, we found that 
increased monaiity was associated with significantly higher levels of FPA 
(p<0.05) and TAT (p<0.01) at TI in all patients and higber B,6levels at Tl2 
(p=0.05) in beparin-treated patients. TIMI grade 0 or I flow at 90 minutes was 
associated with significantly higber levels of FPA (p <0.02) and B,6 (p <0.002) at 
Tl2, and F1.2 at TI (p<0.05) for all patients. The higber B,6 levels at Tl2 
remained significant (p < 0.05) when heparin- and hirudin-treated patient groups 
were analyzed individually. HemOrrhagic events were associated with higber FPA 
and F1.2 and lower TATieveis (p<0.05) at TI. These data suggest that: 1) at the 
doses used in this study, hirudin may be more potent than heparin as a thrombin 
inbibitor when administered adjunctively with n-PA; and 2) increased FPA and 
TAT levels at I hour and Btl values at 12 hours reflect a higber thrombus burden 
and are predictive of both deatb and failure to reperfuse the infarct-related artery. 
We conclude that thrombolytic therapy with n-PA is accompanied by enhanced 
thrombin activity, which may promote adverse thrombotic outcomes. These 
outcomes can be predicted by simple hemostatic markers. 
712·3 2:30 
Differential Effects of Heparin and of a Direct Thrombin Inhibitor 
on the Plasma Levels of Plasminogen Activator Inhibitor and 
TISsue Plasminogen Activator in Unstable Angina 
Rosa-Maria Lid6n, Pierre Theroux, Montreal, Canada 
Heparin modifies levels of tissue plasminogen activator (t-PA) and 
activator inhibitor (PAl), presumably by binding to the endothelial 
cells. This study compares plasma levels oft-PA, PAl and t-PA-PAl 
complex using sandwich enzyme immunoassays, in 78 pts with 
unstable angina enrolled in a randomized therapeutic trial of heparin 
(Hep) vs Hirulog (Hi), a direct bipolar thrombin inhibitor. Hep was 
titrated to an aP'IT 2 to 2.5 X control. Hi was administered at doses 
of 0.25 mg/kglh in 5 pts, 0.5 mg/kglh in 14 pts, and 1 mg/kg/h in 
21 pts and produced aP'IT prolongation ranging from 2 to 3.5 x 
control. Baseline values were similar in the 2 study groups. 
~ Values during treatment £h l! 
ID ID ru afw 
PAl (ng/ml) 
Hi 15.2±2 13.8±2 14.2±3 13.2±3 13.3±2 NS 
Hep 19.4±3 29.5±3 27.2±4 36.1±5 21±3 <.roll 
t-PA (ng/ml) 
Hi 8.9±.5 7.8±.5 9.3±.8 8.8±.6 8.6±.8 NS 
Hep 8.9±.5 29.5±3 18.9±1 20.3±2 24.2±4 <.roll 
t-PA-PAl complex (ng/ml) 
Hi 2.9±.3 2.7±.4 3.9±.3 2.8±.3 2.7±.4 NS 
Hep 2.5±.3 7.2±.7 9.6±1 9.6±1 11.5±3 <.ron 
Hep, but not Hi, consistently increased t-PA, PAl and t-PA-PAl 
complex plasma levels. This endothelial effect of Hep can promote 
thrombin inhibition and modulates plasminogen activation. The 
significance of its absence with the direct thrombin inhibitor is 
unknown. 
lACC February 1994:1A-484A 
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Can Aspirin Potentiate the Antithrombotic Effect of Heparin at 
Sites of Deep Vessel Injury and Vessel Stenosis? 
Joseph Hung, Jules Y.T. Lam, Lucie L·Lacoste, Montreal, Canada 
Unstable angina is usually caused by plaque rupture and 
subocclusive platelet thrombosis at the sites of coronary stenoses. 
Aspirin (ASA) and heparin have been found to favourably influence 
the clinical course of unstable angina but whether their combined 
antithrombotic efficacy is greater than either drug alone is uncertain. 
Thus, we compared the antithrombotic effects of high-dose heparin 
(200 IU/kg) in normal (control) pigs (n= 12) and normal pigs taking 
2 mg/kg/day ASA (n = 11). For platelet deposition, porcine aortic 
media (simulating deep vessel or type III injury associated with plaque 
rupture) were placed in cylindrical flow chambers maintained at 37"C 
and exposed ex vivo to circulating arterial blood from the pig. The 
flow chambers were designed with a 75 % diameter stenosis to 
examine the influence of high shear rate and turbulence typically seen 
at the site of plaque rupture and stenosis, on platelet thrombus 
formation. The results of Cr'-labelled platelet deposition on aortic 
media (xl06/cm2) are compared before and 20 min after heparin in 
both the control and AS A-treated pigs, and are shown below: 
Control pigs ASA-treated pigs 
Before heparin 260.8±33.9 158.3±30.9* 
After heparin 174.6±32.9t 90.2± 19.0*t 
tp < 0.05 versus before heparin; *p < 0.05 ASA-treated versus control 
pigs. 
Thus, in this model of deep arterial injury and severe vessel 
stenosis, the combination of aspirin and heparin has a greater 
antithrombotic efficacy than either drug alone. 
712·5 3:00 
A Prospective Study of the Value of MOnitoring Heparin 
Treatment After Thrombolysis With the Activated Clotting 
Time 
Giovanni Melandri, Angelo Branzi, Anna M. Traini, Maria L. 
Bacchi Reggiani, Valeria Mignatti, Bruno Magnani.Institute of 
Cardiology, University of Bologna, Italy 
Heparin (H) dosage requirements vary considerably among pts 
with AMI, due to increased plasma levels of procoagulants and H 
binding plasma proteins(Young,Thromb Res 1992;67:639). As a 
consequence,as many as 50% subtherapeutic APTIs are found 
when H is given after thrombolysis (fh) according to protocols 
such as those adopted in GUSTO. The activated clotting time 
(ACI')(Haemochron) on whole blood is more representative of the 
in vivo anticoagulant effect and gives a strong linear correlation 
with H concentration. In this study we prospectively used i.v. H 
after Th starting with 5000 U bolus + 1200 U/hr and aiming for an 
ACf ratio of 1.5 to 2.5. The ACf was measured 4-hourly and the 
infusion rate was increased by 200 U/hr if the ACf was 
subtherapeutic or stopped if supratherapeutic. Each adjustment 
was checked after 1 hr. A total of 1605 ACfs were obtained in 124 
pts. Remarkably steady levels were obtained over 4 days of H 
infusion. The ACf (S.D.) was, on average, 110(20)s at baseline, 
229(65)s at the end of Th, 200(41)s at 24 brs, 210(29)s at 48 brs 
and 228(25)s at 96 brs. Overall 18% of ACfs were sUbtherapeutic 
and 5% supratherapeutic over 4 days. There was a relationship 
between the recurrence of ischemia and presence of a 
subtherapeutic ACf (24% vs 4%; p<O.Ol),thus confrrming the 
dependence of H efficacy on adequate drug level. Only 3 pts 
required blood transfusion. 
We conclude that this algorithm for H infusion based on the ACf, 
measured at the bedside, results in remarkably stable drug level 
and provides an useful reference to compare new anticoagulant 
agents. 
ABSTRACTS 
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Should aPlT Assays Be Standardized In MultIcenter Clinical Trills 
DeSigned to Investigate the Benefits of Heparin? 
Richard Becker. Russell Tracy, Edwin Bovill. Bruce Thompson. NAY 
Randall. Christopher Cannon, Eugene Braunwald. Thrombosis Research 
Canter, University of Massachusetts Medical School. Worcester. MA 
In thromboembolic disorders treated with heparin, an association 
between recurrent events and suboptimal anticoagulation exists. Because 
the responsiveness of different aPTT reagents varies widely, a 
'therapeutic' aPTT may not represent a 'therapeutic' heparin 
concentration. In TIMI IIIB. heparin was titrated carefully to achieve an 
aPTT 1.5-2X control. Serial aPTTs were obtained at the Individual 
participating snes. 
TIMIIIIB PROTOCOL (N=I461) 
Heparin Concentration (u/ml)" 
aPlT (sec) 
Sampling Time Mean±SD <0.2 (%) Mean 
12 hour 0.29.;!:..20 40 
24 hour 0.26.;!:..21 46 78.4 
46 hour 0.24.;!:..22 53 70.3 
96 hour 0.13.;!:..17 76 57.4 
"Therapeutic heparin [0.2-0.4 u/mll 
This represents the largest patient cohort having direct heparin 
measurements In a clinical trial. The findings show that suboptimal 
heparin concentrations are common during treatment despite the 
presence of 'therapeutiC' aPTTs. Reference stsndards should be 
considered in multicenter clinical trials to compensate for the variable 
response of aPTT reagents to heparin. 
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Comparison of Excimer Laser Angioplasty and Rotational Atherectomy with 
Balloon Angioplasty for Complex Lesions: ERBAC Study Final Results 
*Michel Vandormael. Nicolaus Reifart. Wolfgang Preusler. Franz Schwarz. 
*Hans Storger, Manfred Hofmann, Johann W Klopper, Stefan Miiller, Red Cross 
Hospital. FrankfurtlMain. Germany 
Patients with type B or C lesions fail to achieve full benefits of PTCA due to 
poorer immediate and longterm results. Excimer laser angioplasty (ELCA) and 
rotational atherectomy (PTRA) bave several theoretical advantages in re•
establishing vessel patency which may improve outcomes in PTS with complex 
lesions. ERBAC is a single center randomized study comparing procedural and 
angiographic results of ELCA, PTRA and PTCA in PTS with native de novo 
type B or C lesions suitable to all 3 techniques. The primary endpoint is 
procedural success (PS) defined as residual stenosis < 50 % (assessed 
quantitatively) and the absence of in-hospital death, QMI and Em.CABG. 
Secondary parameters are 4-6 mo. clinical. angiographic (uo restenosis 2: 50 %) 
and economic outcomes. Patient enrollment began in Oct. '91 and was 
interrupted in June '92 because of Rotablator recall. Enrollment is to be 
completed (700 pts.) in Sept. '93. Results of the interim analysis is noted below: 
YfCA ELCA YfRA P 
No. of lesions 142 105 137 n.s. 
B2/C type (%) 54/9 5917 72/9 O.Olln.s. 
Eccentric/calcific. (%) 68/39 76/33 75/28 n.s./n.s. 
Ostial/bend 45°-60° (%) 5/11 6/12 8113 n.s./n.s. 
Length > 10 mm (%) 33 28 26 n.s. 
% Diam.stenosispre 75±11 74±12 76±1O n.s. 
% Diam.stenosisfinal 35±15 29±15 27±14 < 0.05 
Crossover/tech. fail. (%) 113 9113 112 0.0007/0.0001 
P.S.intention to treat (%j 84* 89 93* *<l.009 
P.S.beforecrosSQver(%) 84 77+ 93+ +0.0005 
Death. QMI. Em.CABG (%) 7.0* 5.7 1.5* *<l.02 
PTRA did result in better procedural outcomes as compared with PTCA and 
ELCA in pts. with selected type B or C lesions. Compared to PTCA. PTRA and 
ELCA led to greater initial gain in lumen size. Technical failure and crossover 
occured more frequently with ELCA. Final results will be presented. 
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Vie 01 PrQIoaaed PerfualOil W- IIIIIadou 0160 MiIIufeI .. a "T_porary 
Steat· to sma. IaitlaUy VasllCll!e8lflll ear-., ~ Aade ad 
I..oq-tena OuteGme 
John S. Wdsoa, E. Magnus Ohman, JoSe A Perez, Laura H. Oardner, 
Charlotte L. Nelson, ·Harry R. Phillip&, Michael H. Sketch, Jr, Duke 
UDiversity Mcdic:aI CcDtcr, Durham, N.C. 
An accepted method to sa1wge an initially unsuccessful coronary 
intc~ntiOll8l procedure is to USC a proloagcd perfusion baI100n iDfIatioo of 
1().15 minutes. A perccDtage of these attempts will remain lIIISIIa:CS5ful and it 
is unclear whether loDger infIaIioas as a meaDS of temporarily &tenting the 
artery can further improve the acute and long-term sa1wge rate in these 
patieDlS whose only options arc pcrm8IICIIt steDling or CABO. 
The present study examines the outcome of 49 eoasccutivc patieDlS (mean 
age 59; 65% male) who failed both coa-wooaI PTCA and at least a 15 
minute perfusion baUoon dilations, who then went 011 to get an inflation of at 
least 60 minutes with a perfusion baI1oon. The mean duratinn of the 10agest 
dilation prior to the 60 minute dilation was 25:29 ± 10:19 (minutes: &CCODds ± 
SD). The mean duration ofthe~ 60 minute dilation was 63:14± 12:20. 
After failure of at lcast a lS-minute inflation, a subsequent ~ 60 minute 
inIIation resulted in angiograpbic success (defined as S 50% residual stenosis 
without the need for further devices or emergency CABO) in 42/49 (86%) 
patients. In-hospital complications included: clcctM: CABO (8), myocardial 
infarction (6), repeat inte~ntion on same lesion (2), and death (1). 
Cumulative event-free survival (freedom from Ml, CABO, death, repeat 
inte~ntion) is shown below: 
Cumulative Event Free Survival 
• In-Hospital 
• 6 months Post-Di&charge 
Z7/49 (55%) 
23/49 (47%) 
Caadnaloa: The acute salvage rate is high and nearly baIf of these difficult 
patieDlS remain event -free at 6 months, susgesting that these prolonged 
inflations can be used as a temporary stent to improve salvage rate and reduce 
the need for permanent stent implantation or CABO. 
713-3 2:30 
Comparative Effects of Long (> 12 min) Versus Standard (S 3 
min) Sequential Balloon Innations In PTCA_ Preliminary 
Results of a Prospective Randomized Study: Immediate Results 
and Restenosls Rate. 
·Alain Cribier, H~~ne Eltcbaninoff, Cbarles Chan, Ren~ Koning, Neeraj Jolly, 
Brahim Baala. Milan Kbotari, Nadir Saoudi. Arthur Tan. Brice Letac, Singapore 
General Hospital, Singapore - Hlipital Cbarles Nicolle (Vacomed Group), 
University of Rouen, France. 
To assess the effects of long sequential (LS) balloon inflations (B INF) (II the 
short and mid-tenn results of PTCA, an ongoing prospective randomized study 
started in June 92. To date, 278 lesions in 259 PIs were randomly assigned to 
"standard" PTCA (3 B INF SI min eaCh. Group 1,0=145) or LS-PTCA (3 or 4 
B 1NF,4 to 5 min each. Group 2, n= 133). Baseline and immediate post-PTCA 
stenosis (% decrease in internal diameter) were calculated in 2 perpendicular 
views (Philips DCI computerization system). Angiograpbic success was defmed 
as S50% residual stenosis. Post-PTCA dissections were assessed by 2 
independent observers and graded from A to F using the NHLBI guidelines. 
Repeat catheterization W8.' perfonned 4 to 6 months after PTCA or earlier in 
case of recurrence of symptoms. Angiograpbic restenosis was defined as a 
stenosis ~ 50% al follow-up. Immediate angiographic results were assessed at 
the end of the randomly assigned B INF time. The 2 groups were comparable for 
demographic and angiograpbic data and other PTCA tecJmical aspects. 
~: Mean duration of total B INF was 201±50 sec in Group I vs 810±285 
sec in Group 2. PTCA success rate was 78% in Group 1 vs 91% in Group 2 
(p<.01). Dissections were more frequent (43 vs 19, p<.01) and more severe 
(C-F: 27 vs 10, p<.01) in Group I tban in Group 2. Dissections or suboptimal 
results led 10 complementary B INF in 29 PIs of Group 1 and in 12 of Group 2 
(p<.01). Stent implanl8lion was required in 6 PIs of each group. One Pt in eacb 
group underwent emergency surgery. Myocardial infarction developed in 3 PIs of 
Group I and 4 Pts of Group 2. There were no deaths. Repeat catheterization 
(systematic control: 66%. recurrence of symptoms: 34%) was obtained to date 
for 60% of PL. a mean of 140+-22 days after PTCA. Angiographic restenosis rate 
was similar in the 2 groups: 43% (41190) in Group 1 and 47% (36174) in Group 
2, (p=NS). Repeat PTCA was performed in 23 and 18 Pts in Group 1 and 2 
respectively, while 2 PIs in Group I and 7 PIs in Group 2 underwent CABG. 
Conclusjons: These preliminary results show that long sequential B INF 
improve the immediate results of PTCA and decrease the incidence of 
dissections. Repeat catbeterization shows no effect of long sequential B INF on 
restenosis rate as comJl8l'ed to "standard" B INF. 
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713-4 2:45 
n. 80.. Balloon: n. First 95 V .... l C!aaulath. 
Exp.ri.nc •• 
Christopher U. Cat.a. William D. Knopf. Nicholas J. 
Lembo. Caryn Bernatein. Robbie Moye. Jill Ryan. St. 
Joaeph's Hospital. Atlanta. GA 
Certain complex lesion types are difficult to 
approach utilizing standard balloon catheters. These 
include acute spiral dissections (D). long diffuee 
diseaBe (DD) greater than 40mm and diffuaely 
diseaBed aaphenous vein graft (SVG) lesions. We 
proBpectively evaluated the use of the 80mm balloon 
in the first 95 lesions to categorize ita uae and 
efficacy. 95 vessels were dilated in 93 patients 
(age mean 62. range 37-88). 72\ male. 28\ famale. 
Ve88ale dilated: Native 76 (80')1 RCA 55 (58'). 
Left circumflex (LCx) 7 (7'). LAD 14 (15'). 
Saphenous vein graft 19 (20\)1 (RCA 7. LCx 6. LAD 
6). Mean inflation time 4.1 (.33-37.1 minutes). 
Pressure (mean) 9 atms. 
Results: Overall success rate: PTCA stand alone 
80/95 (84\); PTCA plus adjunctive stent 88/95 (93\). 
Mean stenosis (pre) 92\. mean atenosia (post) 16\. 
Indication 
Spiral D 
DO 
SVG 
Ii 
29(31\) 
54(57\) 
12(13\) 
il!££!!.U 
PTCA PTCA/Stent 
21(73') 24(83') 
49(91\) 52(96\) 
10(83\) 12(100') 
~ 
5(17\) 
1(4\) 
0(0\) 
Conclusion: 1) The 80mm balloon is useful in 
treatment of complex lesions including spiral D. DD 
native coronary arteries and diffuse SVG lesions. 
2) Few complications are noted in using the 80mm 
balloon despite difficult lesion characteristics. 
3) Use of 80mm balloon allows for success in 
additional patients by converting long diffuse 
lesions to ahorter lesions amenable to stenting. 
713-5 3:00 
Vibrational Coronary Angioplasty for Chronic Total Occlusions. A Novel 
Approacb. 
Michael R. Rees, Lampros K Micbalis 
Department of Cardiovascular Inlervention, Killingbeck Hospital, Leeds, U.K. 
We present the first 12 cases of chronic total occlusions treated with a new 
angioplasty device. This offers a novel approacb to coronary intervention termed 
'vibrational angioplasty" in which lesions are subjected to vibrational energy. The 
device consists of two parts: a) a motor and gearing system producing a fine 
oscillation with a vibrational frequency of 100-500 Hz and b) a steerable guide 
wire. The tip of the wire is vibrated against the lesion for 1-2 minutes before slow 
passage through the lesion is attempted while vibration continues. Once the lesion 
is crossed with a wire coronary angioplasty (pTCA) is performed using the minimal 
pressure required for adequate vessel dilatation. Using -vibrational angioplasty" 
we treated 12 patients (8 males, 4 females, mean age: 61.8 yrs, age range: 49-73) 
with symptoms of slable angina and tolal coronary occlusions (left anterior 
descending:4, left circumflex:3, right coronary artery:5). In all 12 cases at least 
two conventional wires used without vibrational (high torque floppy, intermediate, 
Istandard, Magnum) had failed to cross the lesion. The mean duration of the 
occlusion been estimated either clinically or by sequential coronary angiograms, 
Was 14.8 months (range:7-{j0 months). In seven out of twelve cases the lesion was 
crossed by vibrating a blunt ended wire while in 5/12 cases additional wires, either 
a hydrophillic (4/5) or a high torque floppy (1/5) bad to be used. In 2112 cases 
where a hydrophillic wire used no balloon could subsequently cross the lesion. In 
10/12 the lesion was crossed successfully by a balloon and PTCA was performed 
with pressure ranging between 2.5-{j AIm. The post procedural result was: 
slJccessful in 7112 (mild dissection was seen only in I case), complicated by major 
dissection needed stenting in 1112, compromised by the evidence of severe diffuse 
disease distally in 2112 and failure in 2112. The total procedural and screening 
times (mean ± 50.17 and 43.2 ± 32.32 min respectively. In conclusion 
"vibrational angioplasty" appears to achieve bigb primary success rates in tbe 
recanalisation of totally occluded arteries. Further studies are needed to 
clarify tbe vessel wall changes due to vibrational energy and tbeir impact to 
restennsis. 
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CollSlDDer "Scorecard" for Interventional Cardiologists 
Stephen G. Ellis. John A. Biul. A. Michael Lincoff. Burt Adelman. Mark W. 
Wolfe. Patrick L. Whitlow. Eric J. Topol. Cleveland Clinic Foundation. 
Cleveland. OH. Brigham & Woroen's Hospital. Boston. MA. 
Constuntm of medical care and the media are increasingly demanding access to 
medical procedural results. but often lack the background and sophistication to 
understand the data. Outcome stratification for elective procedures based upon risk 
may be particularly important in understanding the results of operators willing to 
accept patients of differing complexities. Drawing upon a 1992193 10 center. multi· 
device. source documented quality controlled database (n=1754) and concurrent 
literature (n > 6000). we developed the following criteria and illustrate their 
application at one of our institutions. 
% SuccesslComplications 
Lesion: simple simple complex 
Patient: low risk high risk low risk 
Resultant class: I n ill 
complex 
high risk 
IV 
Superior 9810.5 9411 9412 8717 
Average 9712 9212 9215 80110 
Below average 9314 8315 8618 70115 
Criteria: superior=approximately 76·100th percentile; average = 26-75th percentile; 
below average = 0-25th percentile. Lesiog definitions: simple = modified ACCI AHA 
A or BI. complex=B2 or C. Patient defitions: low risk=age<75. LVEF>30%. 
no recent MI. 1-2 vessel disease; high risk = not low risk. Success=at least one 
target reduced to <50% (calipers) and no complications. CoDIPlications=death. 
emergency bypass. Q wave infarction. 
Class: 
Highest volume 
2nd highest 
3rd highest 
I 
9610 
9812 
9510 
n 
9013 
8915 
9310 
ill 
9512 
9511 
9015 
IV 
9015 
8816 
8419 
These criteria have the advantage of relative simplicity. wide applicability and 
relevance. hence may be useful for consumers and physicians. They should be 
validated with other quality-controlled datasets. 
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714·1 2:00 
Nitric Oxide Donors Reduce Restenosil After Coronary Angloplasty: 
the ACCORD Study. 
The ACCORD Study Investigators. University of L1l1e. Ulle. France. 
Nitrlc-Oxlde (NO) donors are a novel group of vasodilators that have 
potent antlprollferatlve effects in animal models of balloon angioplasty. We 
performed a randomized trial In 22 French centers to compare restenosis 
rates In patients treated with the NO-donors (SIN·1 and molsldomine) or 
with dlltiazem. before and for 6 months after PTeA. The effects of 
treatment were assessed by blinded core lab quantItative coronary 
angiography. The NO-donor treated group received linsldomlne 1 mg/hour 
IV for at least 3 hours before PTeA followed by moIsldomlne 12 mglday 
for six months. The diltiazem group received dilliazem 160 mglday for six 
months beginning before PTeA. All patients received aspirin 250 mglday. 
Inclusion criteria were age < 70. primary lesion. native coronary artery. 
TIMI grade 2 or 3. Exclusion criteria were: recent « 3 weeks) MI. recent « 
8 days) unstable angina. a contraindication to aspirin therapy and ejeclion 
fraction < 35%. Of 723 patients enrolled 700 patients were randomized and 
underwent PTCA: 629 patients were eligible for anglographlc follow-up 
which was performed In 521 (83% of eligible patients). Major In-hospital 
complications (death (n"'1). acute MI. emergent CABG) occured In 14 
patients In the NO-donor group. and In 13 patients In the dilliazem group (p 
a NS). 
Minimal lumen diameter (MLD. mm) pre-PTCA was not significantly 
different in the NO-donor group (0.78 +/. 0.33) and In the dilliazem group 
(0.76 +/. 0.32). Immediately after PTeA. the MLD was significantly (p .. 
0.004) greater In the NO-donor group (1.93 +/- 0.48) than in the dilliazem 
(1.81 +/- 0.43) group. Acute gain was signiflcently greater (p • 0.03) In the 
NO-donor group (1.17 +/. 0.50) than In the dilliazem group (1.07+/- 0.44). 
AI follow up. MLD In the NO-donor group (1.54 +/. 0.66) was significantly 
greater (p .. 0.009) than in the diHiazem group (1.38 +/- 0.67). The loss 
Index (late IoSSl acute gain) was less (p .. 0.053) in the NO-donor group 
(0.35 +/- 0.78) than In the diltiazem group (0.48 +/- 0.74). Late loss in MLD 
was slightly but not significantly (p .. 0.28) less In the NO-donor group 
(0.41 +/- 0.67) than in the dilliazem group (0.44 +/- 0.61). Restenosls. by 
binary classification (> 50% stenosis at follow up) occulTed less often (p = 
0.052) in the NO-donor group (38%) than in the dilliazem group (48.5%). 
Treatment with NO-donors Is associated with a better acute angiographic 
outcome after PTCA. This improvement Is maintained at 6 months. 
ABSTRACTS 
714·2 2:15 
The z.pact of Flsh 011 OD Jestanosls folloving Coronary 
Angloplasty: the Fish 011 lestenosis Trlal (FORT) 
Alice I. Jacobs, Bonnie H. Veiner, Al Raizner, David A. 
Schoenfeld, Judy Scheer, Peter Hahrer, Gilles Cote, John 
Slack, Hirle A. (ellett, Hichael Jorgensen, Alexander 
Leaf, Hassachusetts General Hospital, Boston, HA. 
The efficacy of fish oil (FO) ln preventing restenosis 
(RS) following coronary angioplasty (PTCA) reaains 
unclear. Previous studies have been criticized for lack 
of pretreatment or for using low doses of FO. Therefore, 
in a double-blind, placebo-controlled trial, patients 
were randomly assigned to high dose (8ga/day) oaega-3 
fatty acids (FA) or corn oil (CO) with pretreatment for 
a minimum of 12 days prior to PTCA. 470/503 (93X) 
patients had successful procedures and vere continued on 
treatment for 6 months. Baseline characteristics 
including age, gender, risk factors and the incidence of 
aultilesion PTCA as veIl as the incidence of major 
complications vere similar in both groups. Red blood 
cell oaega-3 FA vere increased significantly in the FO 
group. RS, defined as a loss of 1/2 the gain or >30X 
increase in post PTCA stenosis, vas no different betveen 
groups whether analyzed as a discrete or continuous 
variable. Results (mean + SEll 
10(n-226) CO(n-221) 
HLD pre PTCA (mo) 0.68+0.02 0.68+0.02 
HLD post PTCA (ma) 1.83+0.03 1.87+0.03 
HLD follow-up (mo) 1.34+0.05 1.39+0.05 
Stenosis pre PTCA (X) 74.6+0.6 74.9+0.6 
Stenosis post PTCA (X) 31.2+0.7 30.8+0.7 
Stenosis follov-up (X) 50.2+1.6 48.8!1.5 
Restenosis rate (X) 52- 46 
Therefore, pretreatment vith FO prior to PTCA and for 6 
months thereafter does not reduce the incidence of RS 
despite the expected biochemical and cellular changes 
induced by FO. These data suggest that other factors 
aay be more important in the RS process. 
714·3 2:30 
LoDg·term Effects or Allgiopeptio Treatment in Coronary Allgioplasty • 
Reduction or Clinical Events but not or Angiographic Restenosis. 
JWcan Emanuelsson. Jeos-Peder Bagger. Raphael Balcon. Kevin Bean, Marie 
Foegh. Jan Piesseos. Jeffery J. Popma. for the EW'Opean Angiopeptin Sbldy 
Group. Division of Cardiology. Sahlgrenska Hospital. (l(jtehorg. Sweden. 
Aogiopeptin. a somatostatin analogue. was studied in a placelJo.controlled. 
randomized trial on 554 patients for the prevention of restenosis and clinical 
events after coronary angioplasty (PTCA). Patients received either placebo 
infusion s.c. for 5 days or angiopeptin 3 mg/day beginning the day prior 10 PI'CA. 
and increased 10 6 mg/day at PI'CA. Quantirative coronary angiography (QCA) 
was performed pre-PI'CA. post-PTCA and at follow-up at 6 months. Clinical end•
points were death. non-fatal myocardial infarction and target lesion 
revascuIarization with coronary artery bypass surgery or repeat PI'CA during the 
follow-up period. Angiographic end-points were restenosis rate (>50% diameter 
stenosis). minimal luminal diameter (MLO). and percent diameter stenosis at 
follow-up. 
Results: PI'CA was initially successful in 89% in the angiopeptin group and 
86% in the placebo group. Follow-up angiography was performed in 210 (90%) 
and 215 (96%) patients. respectively (541 lesions). 
Clinical events Angiopeptio Placebo p-value 
(Intention 10 treat analysis) 
9 months follow-up 
Total events 22% 30% 0.03 
Target lesion PTCA 9% 16% 0.02 
QCA 
MLO(mm) 
Pre 0.94:W.38 0.95±O.39 0.96 
Post 1.83:W.43 1.8 I ±O.48 0.64 
Follow-up 1.52:W.64 1.51±O.65 0.89 
Restenosis rate 36.5% 37.4% 0.83 
Acute gain (mm) 0.89±O.47 0.87±O.48 0.62 
Late loss (mm) 0.32±O.59 0.3I±O.62 0.83 
Loss index O.34±O.64 0.38±O.68 0.95 
In conclusion. there was a signiftcant reduction of clinical events after 
angiopeptin treaunenL With the dose and mode of administration of the drug in 
this study. no effect could be demonstrated on angiographic parameterS. 
59A 
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Six·Month Follow·Up after Acute Phase Platelet Ublllla Integrin 
Blockade in the EPIC Trial: Reduction in Need for 
Revascularization Procedures 
Eric J. Topol, Robert M. Califf, Harlan F. Weisman, Keaven 
Anderson, Ann Wang, James T. Willerson,l..!or the EPIC Investigators, 
Cleveland Clinic Foundation, Cleveland, unio 
Our randomized, placebo-controlled trial of 2,099 patients 
undergoing high risk coronary intervention with c7E3 (a platelet 
Ilblllfa integrin antibody fragment) demonstrated a 37 % reduction of 
3O-day major events (death MI CABGr PTCA) for pts. receiving c7E3 bolus (0.25mg/kg) and a 12-hour infuSion (IOmcg/min) compared with 
the placebo group. Pts. receiving the bolus only (the third arm) had 
only a moderate (11%) reduction of events. We hypothesized that more 
profound inhibition of platelet aggregation acutely could reduce clinical 
restenosis1 as measured by repeat revascularization pro.s:edures. All pts. not expenencing a primary efficacy event in the firkt 30 days were 
prospectively followed with preserved blinding of treatment 
asssignment for 6 months and the events were as follows: 
Death 
MI 
CABG 
PTCA 
CABGIPTCA 
Com)lOsite • Death, 
MI,CABG,PTCA 
Composite from 
Baseline (inc 0-30 d) 
Placebo Bolus Only Bolus + p. 
(N=601) (N=611) Infusion Value 
1.8 
2.4 
5.9 
13.8 
18.4 
19.5 
34.8 
1.3 
2.5 
5.5 
14.8 
18.3 
19.6 
32.2 
(N=643) 
1.0 
2.2 
4.4 
10.7 
14.6 
15.4 
26.9 
0.38 
0.85 
0.24 
0.12 
0.077 
0.059 
0.001 
Thus, these data support a potential effect (21% reduction) of the acute 
phase administration of c7E3 bolus plus infusion for reduction of the 
need for repeat revascularization I?rocedures and indicates that more 
profound platelet suppression dunng coronary intervention may be 
linked to the reduction of restenosis. 
714·5 3:00 
Acute and Late Angiographic Results of the STent 
REStenosis Study (STRESS) 
David Fischman, Michael Savage, Martin Leon, Richard Schatz', 
Donald Baim, Ian Penn, Katherine Detre, Richard Heuser, Donald 
Ricci, David Fish, Randal Rake, Sharon Gebhardt. Sheldon 
Goldberg, for the STRESS Investigators. Jefferson Medical College, 
Philadelphia, PA 
The purpose of this study was to compare the acute and late 
angiographic outcome of coronary stent placement and conventional 
balloon angioplasty (PTCA) in the STent REStenosis Study 
(STRESS). 409 patients with de novo, native coronary lesions were 
randomized to either single Palmaz-Schatz stent implantation (n '" 
207) or PTCA (n '" 202). Quantitative analysis of the baseline, post•
procedural, and 6 mo. follow-up angiograms was performed by a 
core lab. Procedural success was defined as a final stenosis < 50% 
with the assigned therapy and the absence of major complications. 
Primary success was achieved in 191(93.2%) stent procedures vs. 
168 (83.2%) PTCA procedures, p =0.02. Compared to the acute 
results of PTCA, stent placement was associated with less elastic 
recoil (13% vs 24%, p<.0001) and a lower incidence of intimal 
dissection (6% vs 36%. p<.0001). Of patients eligible for late follow•
up, repeat angiography was performed at 6.4±2.0 mo. in 78% to 
date. The following compares the quantitative results: 
pre-mid proc mid flu mid acute gain late loss net gain 
PTCA .7S±.2S 1.91±.SI I.S2±.64 1.19±.46 .44±.S9 .76±.63 
Stent .77+.27 2.49±.43 1.78+.61 1.73+.42 .72±.S7 1.02±.61 
P value ns .0001 .0007 .0001 .0001 .0004 
proc = procedure; mid = minimal lumen diameter (mm); flu-follOW-UP 
Thus, stenting is aSSOCiated with a greater initial gain, but also a 
greater late loss at 6 mo. However, the overall net effect of stent 
implantation is a wider lumen at 10nQ term follow-up. In conclusion, 
(1) Elective stent placement results In improved acute angiographic 
outcome with a larger final lumen diameter, less elastic recoil, and 
fewer intimal dissections than balloon angioplasty, (2) the reduction 
in restenosis conferred by stenting is a function of the initial 
procedural gain rather than a reduction in late intimal hyperplasia. 
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AIIalysis or Early and Late CIiDIcal Eveuts from the STent REStenosis 
Study (STRESS) 
Martin B. Leon, David Fischman, Richard A. Schatz, Donald S. Bairn, Ian Penn, 
Masakiyo Nobuyoshi, Antonio Colombo, Michael W. Cleman, David Almond, 
Jeffrey Moses, Michael Savage, Sheldon Goldberg, Katherine Deue, for the 
S1RESS investigatorS, Washington Hospital Ceruer, Washington, DC 
In this repon. early and late clinical events are presented from the ongoing 
analysis of SlRESS, a randomized multicenter Irial (@ 20 sites) comparing 
PTCA (11'=202) vs. single Palmaz-Schatz stents (psS, n=207) in de novo lesions 
of native coronaries ~3.0 mm diameter. Baseline patient and lesion 
characteristics were similar for both groups. Clinical events examined included 
failure of intended therapy (failed Rx) usually due to crossover events, major 
complications (death, Q-wave MI, and urgent CABG), procedure success «50% 
diameter stenosis by QCA and no major complications), out-of-Iab abrupt 
closure, bleeding/vascular events (hemorrhage requiring transfusion and/or 
vascular repair), and late (between 30 and 180 days) symptom-driven target 
lesion revascularization (1LR = CABG or angioplasty) which was available in 
7S% of Jlts thus far. 
YI'CA PSS P 
11(%) 11(%) 
FailedRx 20(9.9) 9(4.4) .03 
Death / QMI / CABO 
in-hospital 012(1.0) /8(4.0) 0!2( 1.0) /4(2.0) allns 
@30days 3(1.S) /3(I.S) /8(4.0) I (O.S) /4(2.0) /7(3.8) allns 
Procedure success 168(83.2) 191(92.3) .OOS 
Abrupt closure 3(I.S) 7(3.S) ns 
Bleeding/vascular 6(3.0) 14(6.8) .08 
TI.R (0) 180 davs 24(15.8) 13{Ml .05 
All 10 out-of-Iab abrupt closures were due to subacute thromboSIS (SAT) of 
stents (7 randomized to PSS, 3 YI'CA crossovers to PSS); predictors of SAT 
were residual angiograpbic dissection post-stent (p<.OOOI) and stent use as 
"bailout" for failed PTCA (p<.OOOI). /n Conclusion: a randomized 
comparison of YI'CA vs PSS therapy indicated (I) higher failed Rx in YI'CA pts 
resulting in more frequent crossover events to PSS, (2) improved procedure 
success in PSS pts, (3) more frequent out-of-Iab abrupt closure due to 
thrombosis and more frequent bleeding/vascular events due to anticoagulation in 
PSS pts, (4) similar major complications in-hospital and during the first 30 days, 
and (5) reduced late TI.R (i.e. "clinical restenosis") in PSS pts. 
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715·1 2:00 
Inoue Balloon Mitral Valvotomy la Patients with Severe Valvular 
and Subvalvular Deformity 
James R. Post, Ted Feldman, Jeffrey M. Isner, Howard C. Hemnann, and the 
Nonh American Inoue InvesligalDlS 
University of Pennsylvania Medical Center, PIIiladelphia. PA 
1be results of Inoue pen:utaneous balloon mitral valvotomy in patients 
with severe valvular and subvalvular deformity has DOt been cbaracterized. We 
reviewed the pre-valvOlOlDy tranSthoracic echocardiograms of patients from the 
Inoue registry with total echo scores of ~IO (out of 16 using the MGH aiteria). 
Fifty-eight echocardiograms from nine centers were rescored by the same \wo 
investigalOrs using Slriet aiteria to eliminate inter-institutional variability. Only 
14 patients (24%) had identical total scores afIa' review, and 8 patients (14%) were 
eIiminaIed from f~ analysis after being rescored under 10. 
1be 50 remaining patients had a mean l\IIe of 64 ± 16 years and 78% were 
female. The mean total echo score was 11.8 ± 1.5. Scores for calcification and 
thickening were bigher than for mobility or subvalvuiar disease (p<O.OOI). 
Valvotomy was technically successful in 94% and mean mitral valve area 
increased from 0.8 ± 0.2 cm2 to 1.7 ± 0.5 cm2 (p<O.OOI). Seventy-two percent 
or patients had a successful result as defined by ~ inaease in mitral valve area 
or a fmal area ~1.S cm2. 1be severity of mitral regurgitation increased SI+ in 
88% of patients. 
Early and later follow-up (flu) is shown in the table. 1be indication for 
valve replacement (MVR) was mitral regurgitation in 4 of the S patients requiring 
early surgery. 
~ 
MVR 
NYHA Class lorn 
Early flu (3 months) 
Il....OO 
2 (4%) 
S (10%) 
34 (68%) 
Later flu 
II....W III.Wl1bl 
5 (10%) 7.2 ± 5.7 
12 (24%) 12.3 ± 10.5 
22 (44%) 15.5 ± 8.4 
Conclusions: I) There is substantial institutional variability in the 
grading of mitral valve deformity by echo score. 2) Immediate technical and 
hemodynamic success rates in patients with severe valvular and subvalvular 
deformity are good and similar 10 the results obtained in less deformed valves. 
3) However, in mean follow-up of 12.7 months, recurrent symptoms or the need 
for MVR occurred in the majority of patients. 
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Three V .. r Follow-up After Inoue Woon Mltrll Vllvotomy 
-Ted Feldman. John D. Carroll. Howard C. Herrmann. David R. 
Holme •• Donald A. Rothbaum. Jeffrey M. IaMr. Augusto D. Pichard, 
Jonathan M. Tobia. J. Kevin Harriaon. Steven R. Bailey, Robart C. 
Feldman and the North American Inoue Invutigators. University of 
Chicago. Chicago. IL. 
Long term follow up after Inoue balloon mitral valvotomy IBMV) hal 
not lIMn characterized in • North AmericIn population. We report 3 
yell' follow up In. group of 770 Pltienta. 85% were fern.le. the 
me.n .ge w .. 53:t14 YUfl •• nd mHn Echo score 7.3:t2.6162% 
with score :s 8). ThI populltion I. 75% Clucasian. 7% black. 8% 
HisPinic. and 5% Allan. 
The BMV procedure WlS completed aucceufully in 94%. Mitral 
v.lve.fII incr .. sed from 1.0:t0.3 em' to 1.8:t0.6 cm'lp<0.OO1). 
Mitr.1 regurgitation increlsed 1 + or .... IICIIe ()-4 +) in 89%. 
PRE POST 1 yr 2 yr. 3 yr. 
NYHA Clasa :s 2 
Asymptomatic 
MVAlcm2, 
27% 89% 
49% 
1.0 1.8 
770 
89% 79% 
55% 47% 
1.6 1.6 
278 107 
87% 
83% 
1.6 
23 
In follow up thl majority of Pltienta remained in NYHA class 2 or 
..... • bout half were 'symptomatic .nd over 80% remained improved 
by It least one NYHA cia .. It every follow up interval. Mitral valve 
replacement was performed in 4.6% within 30 days •• nd an 
edditionel 6.1 % batw"n 30 day. and 3 YHfI. 
Actuarial freadom from death. mitral valve replacement or repeat 
procedure was 86% after 1 v .. r. 80% after 2 YHra, and 77% after 
3 years. 
Conclusions: Threa year follow up Ifter Inoue balloon mitral 
valvotomy In I large. hlterogenous North ArneriCin populltion shows 
I majority of Pltienta with preserved mitral valve Irea Ind improved 
.ymptoms. Actuarial Ivent free survival.fter 3 year. is 77%. 
715-3 2:30 
Temporary Improvement After Balloon Mitral 
Commissurotomy: Incidence, Demographics, and Clinical 
Predictors 
Michael J. Attubato, James Slater. Frederick Feit, Fedor Bilyk, 
Mary Mickel, Itzhak Kronzon, for the NHLBI Balloon 
Valvuloplasty Registry, NY, NY and Seattle WA. 
Balloon mitral commissurotomy (BMC) frequently results in 
long-term improvement in pts with mitral stenosis. In some 
pts, however, improvement is only temporary. Using the 
balloon valvuloplasty registry, we sought to define the incidence 
and the clinical predictors of temporary improvement after 
BMC. 
Results: Of 646 pts, 570 (88%) were improved 30 days following 
BMC. By 2 years, 413 pts (64%) had sustained improvement 
(Group 1) while 157 pts (24%) had either returned to their pre•
BMC status or experienced an adverse event (death, mitral 
valve surgery, or repeat BMC) (Group 2). There were 
significant differences between the 2 groups which are shown 
in the table. 
Groupl Group 2 pValue 
N=413 N=l57 
W 52± 14 59± 13 <0.0001 HA III/IV pre-BMC 231(56%) 112 (71%) <0.001 
Prior MY Surgery 60(15%) 40(25%) <0.01 
Digitalis pre-BMC 263(64%) 118(75%) <0.01 
Diuretics pre-BMC 272 (66%) 126(80%) <0.001 
The sex of the pts, the incidence of atrial fibrillation, 
hypertension, diabetes, and embolic events, and the use of 
anticoagulants did not differ between the groups. 
Conclusions: 1. Approximately one-fourth of pts who initially 
improve following BMC return to their pre-BMC status or have 
an adverse event by 2 years. 2. Temp<>rary improvement only is 
associated with higher age, hi~her NYHA class pre-BMC, and 
higher incidence of prior mItral surgery and digitalis or 
diuretic use. 
ABSTRACTS 
715-4 2:45 
Efficacy and Safety or BaBoon Valvuloplasty III Elderly Patients wItb Severe 
Mitral Stenosis and Unfavorable Valve Morphology 
Augusto D. Pichard. Walter C. Brogan. Ann O. Greenberg, Steven Goldstein, 
Karen Nikonow, Lowell F. Saller, Kenneth M. Kent. Martin B. Leon. 
Washington Hospital Center, Washington. DC 
PerculaneOus transluminal mitral valvuloplasty (PTMV) is a beneficial therapy 
for patients with low echo scores, sinus rlJythm and mild symptoms. However, 
the safely and efficacy of PTMV in elderly patients with severe symptoms. 
advanced stenosis, and heavily calcified valves is unknown. Of 11 I patients 
with symplOmalic mitral stenoSis referred for PI'MV, 25 (23%) were ~ 70 years 
of age (mean 75, range 70-84 years; 80% female). Mean echo score for this 
subgroup was 12 ± 2, due largely to profound valvuJar calcification. decreased 
leaflet mobility, and valve and subvalve thickening. Atrial fibrillation was 
present in 84%. 
Pre-PTMV POSI-PTMV 
Mitral Valve Area (cm') J.O±O.3 2.I±O.S 
Mitral Valve Gradient (mm Hg) 12±6 3±2 
NYHA Class I/II (%) Oft) 18(78)/4( 17) 
riItIV (%) 16(M),A)(36) 1(5)ft) 
PTMV was successful (area> 1.5 cm2 or >50% increase in mitral valve area 
after PTMV) in 23 patients (92%). Early procedure failures (due to inability to 
cross calcified valves) resulted in frequent mortality within the first few weeks. 
Symptomatic improvement was maintained during 2 year follow-up in 21 
patients, despite documented restenosis in 6 (26%). Immediately post PI'MV • 
mitral regurgitation increased by one grade in 5 patients and 2 grades in 2, one 
requiring mitral valve replacement. We conclude: In elderly patients with 
severe mitral stenosis. (I) PTMV can usually be perfonned safely and 
effectively despite unfavorable valve morphology. (2) successful initial PI'MV 
usually results in sustained symptomatic benefit, and (3) failed PI'MV in this 
subgroup is associated with high subsequent morbidity and monaIity. Thus. 
PTMV is a viable treatment strategy in elderly patients with advanced mitral 
stenosis deemed unsuitable for surgical mitral valve replacement. 
715-5 3:00 
Risk Analysis or Increase or Mitral Regurgitation Arter Balloon Mitral 
Valvotomy 
He Ping Zhang, John W. Allen, Francis Y.K. Lau, Carlos E. Ruiz. Loma 
Linda University, Loma Linda, CA. 
The question whether or DOt increase of mittal regurgitation (MR t) after 
balloon mitral valvotomy (BMV) can be predicted is still uncertain. To 
investigate this, we retrospectively studied 474 consecutive pIS with severe 
mitral stenosis who underwent BMV by either Inoue single-balloon method 
(IB, n=83) or double balloon technique (DB, n=391). After BMV, there 
were 344 pIS with DO MR t (Group I) and 130 pIS baving MR t (Group 11). 
Fourteen pre-procedure variables-age. sex, NYHA functional class. cs(diac 
rhythm, mittal valve echo score. fluoroscopic Ca'·, MR, m-PAP, m-LAP, 
mean aortic pressure, CO, mittal valve gradient, mitral valve area (MVA) 
and balloon technique (IB or DB)-were used for analysis. The two groups 
were similar in all the variables except five that were found to differ 
significsntly between the groups: 
Echo score 
Pre m-PA (mm Hg) 
Pre CO (Llmin) 
Pre MVA (cm2) 
IB/DB 
~ 
6.9±2.6 
36±13 
3.8± 1.0 
0.9±0.2 
38/306 
~ 
7.6±2.5 
39±13 
3.6±0.9 
0.8±0.2 
45/85 
~ 
0.02 
0.02 
0.02 
<0.05 
<0.!XXl1 
When all the variables were used in the stepwise logistic regression 
analysis, balloon technique with IB (p=O.OOOl), higher m-PAP (p<O.OI), 
male sex (p<0.05), and anial fibrillation (AF) (p<O.05) were identified 
as the significsnt predictors for MR t . The odds ratio for MR t was 4-fold 
(95% CI: 2.~.8) greater by the IB than by the DB method. Importantly, 
if pIS had MR t , the likelihood of developing severe MR (MR t o! 2 + ) was 
only related to the IB technique (p<O.OS) and the odds ratio was 3-fold 
higher than by the DB method. Conclusions: (I) MR t after BMV may be 
influenced by poor valve morphology and severity of the disease; (2) It csn 
be predicted by the balloon technique, high mop AP, male sex and AF; and 
(3) IB technique is the strongest risk factor associated with MR t by at 
least 3-fold higher and is the only predictor for significsnt MR t . 
61A 
62A ABSTRACfS 
715·6 3:15 
Predictors of Long-Term Event-Free Survival After Percutaneous 
Balloon Mitral Commissurotomy 
Steven E. Hearne, John S. Wilson, J. Kevin Harrison, Charles J. 
Davidson, Katherine B. Kisslo, Cynthia H. Pierce, Karen S. Pieper, 
Thomas M. Bashore, Duke University Medical Center, Durham, NC 
Selection of patients appropriate for balloon commissurotomy (BMC) 
to treat rheumatic mitral stenosis continues to evolve. While variables 
related to acute procedural outcome have been studied, predictors of 
long-term event-free outcome bave not been defined. 
Tbe impact of clinical, bemodynamic, and echocardiographic variables 
on long-term outcome in 164 consecutive patients undergoing BMC 
were analyzed. Event-free survival was defined as the absence of 
mitral valve replacement, repeat BMC, or death. Followup was 99% 
complete and ranged from 0-68 months (mean of 20 months). 
Surprisingly, age, gender, LVEDP, mitral valve echo score and mitral 
valve area were not related to long-term event-free survival. 
Congestive heart failure (CHF) class, prior surgical mitral 
commissurotomy (prior surgery) and the degree of mitral regurgitation 
(MR), bowever, were strongly related to event-free survival. 
YAIiihlc 
CHF 
Prior Surgery 
MR 
Chi Square 
12.309 
6.159 
4.639 
~ 
.0005 
.013 
.031 
Variables predictive of long-term event-free outcome are dissimilar 
to variables previously found related to acute procedural success. 
Oinical variables, rather than echocardiographically defined mitral 
valve morphology or hemodynamically defined mitral stenosis sevcrity, 
were the most important determinants of long-term outcome. 
These data suggest that when one considers long-term outcome, 
patients with less severe CHF symptoms, minimal MR and without a 
prior surgical commissurotomy are most likely to benefit from balloon 
commissurotomy. 
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716·1 2:00 
Long-Term Prognosis in Relation to Adenosine TI-201 SPECT 
Scintigraphic Findings 
Timothy M. Bateman, James H. O'Keefe, Carrie Barnhart. 
Mid America Heart Institute, Kansas City, MO. 
The long-term prognostic Implications of findings during 
adenosine SPECT TI-201 scintigraphy have been 
Insufficiently studied. Of 659 consecutive pts evaluated 
between 3/90 and 6/92, 134 had PTCAICABC within 30 days, 
and 10 were lost to follow-up. The remaining 515 pts were 
followed for 22 :t 9.5 months. Mean age was 68 yrs; 57% were 
male; 362 (70%) had known CAD; and 318 (62%) had angina. 
Cardiac death (28 pts) and nonfatal myocardial infarction 
(MI) (9 pts) occurred in 37 pts. Cox regression Identified 
extent of Ischemia, abnormal lung uptake (LUj, and prior MI 
as independent predictors of events. We assigned equal 
weighting to ischemia In each coronary distribution (max of 
3 for 3,.vessel ischemia), LU, and prior MI. Events were 
distributed as follows: 
Score Pts Events ..!. 
-0- 185 -2- 1.1% 
1 143 6 4.2% 
2 117 12 10.3% 
3 53 " 20.8% 
4 17 6 35.3% 
Cardiac death or MI occurred in 4/222 pts (2%) with a 
nonlschemic SPECT vs 33/293 (11%) with an Ischemic SPECT. 
An additional 32 pts required PTCA or CABO 13 months 
(mean) after testing; of 69 total events, 8 (3.6%) were In pts 
with a nonischemic SPECT vs 61 (21%) with an ischemic 
SPECT. 
CONCLUSION: There Is considerable long-term prognostic 
Information provided by adenosine SPECT TI-201 findings. 
Pts with prior MI, abn. LU, and multivessel Ischemia are at 
particularly high risk for death or MI. Pts with a nonischemic 
SPECT scan are at low risk for any events. 
JACC February 1994:1A-484A 
716·2 2:15 
Additional Prognostic Value of Thallium·201 SPECT Perfusion 
Imaging According to the Results of the Exercise 
Electrocardiogram in Patients With Suspected Coronary Artery 
Disease. 
Longere P, Machecourt 1, Vanzetto G, Fagret D, Polidori C, Mansour P, 
Wolf JE, Comet M, Denis B. University Hospital· Grenoble - France. 
To examine the additional prognostic value of Thallium-201-SPECT 
perfusion imaging compared to exercise ECG in patients studied for angina 
pectoris, we have determined the long term cardiovascular mortality in 3193 
patients who undergone TI-SPECT, between 1987 and 1989. 
METHODS: After exclusion of patients i)with unstable angina, ii)who have 
suffered a myocardial infarction within the previous month, iii)who have 
undergone revascularization, or iiii)who have undergone Thallium SPECT 
under Dipyridamole infusion, 1121 patients were followed for 33±IO 
months after undergOing a stress I redistribution Thallium SPECT. The 
Thallium SPECT imaging was divided into 6 segments ; images were 
classified as normal, transient, or permanent uptake defects. 
RESULTS: 
Positive Negative 
Exercise ECG Exercise ECG 
~~ 
Abnormal Normal Abnormal Normal 
SPECT.TI SPECT.TI SPECT-T1 SPECT·TI 
(208) (30) (343) (293) 
I I I I 
2 deaths o death 2 deaths 1 death 
Non Diagnostic 
Exercise ECG 
~ 
Abnormal Normal 
SPECT-TI SPECT-TI 
(190) (57) 
I I 
12 deaths o death 
The main cause of non diagnostic exercise ECG was the inability of the 
patient to reach 85% of the maximal predicted heart rate. and these pts had a 
significantly worst prognosis (Logrank., p<O.OOOI). However no pt died 
after a normal SPECT following a non diagnostic exercice ECG. 
CONCLUSION: TI-SPECT perfusion imaging provides a high additional 
predictive value in pts with a non diagnostic exercice ECG. 
716·3 2:30 
Use of Exercise SPECT Thallium Imaging in liskAssessment 
in Women with Coronary Artery Disease 
Samir Pancholy, Alia Abdel Fattah, Abdalia Mostafa Kamal, 
Massroor Ghods, Jaekyeong Heo, Abdulmassih S. Iskandrian, 
Philadelphia Heart Institute, Presbyterian Medical 
Center, Philadelphia, PA 
This study examined the prognostic predictors in 212 
women who had exercise SPECT thallium imaging and 
coronary angiography, 75 patients (pts) had 0-, 65 had 
1·, 36 2-, and 36 3-vessel coronary artery disease (CAD) 
(~ 50\ stenosis of one or more vessels). During a mean 
follow-up of 36 months, 20 women had events (cardiac 
death or nonfatal infarction). None of the exercise 
treadmill data including ~ ST, heart rate, duration, and 
workload were predictive of events. Several exercise 
SPECT thallium data were predictive of events by 
univariate Cox survival analysis: reversible defects 
(X2_6, P < 0.01), t lung thallium uptake (X 2-3, P < 
0.07), extent perfusion abnormality (X 2 -8, (P < 0.004), 
extent reversible abnormality (X'-7, P < 0.007), and 
number of abnormal vascular territories (X2-10, P < 
0.002). The extent of CAD was also important (X 2-8, P 
<0.004). Multivariate survival analysis showed 2 
independent predictors of events: number of abnormal 
vascular territories (X2-10, P < 0.002), and multivessel 
disease (X 2-3, P < 0.08). Actuarial life-table analysis 
showed that pts with multivessel thallium abnormality had 
significantly worse prognosis (Mantel-Cox statistic - 14, 
P - 0.0002). Thus, exercise SPECT thallium imaging 
provides independent and incremental prognostic 
information to coronary angiography in women. Women with 
multivessel thallium abnormality are at high risk of 
cardiac events. 
JACC February 1994:1A-484A 
716·4 2:45 
Prognosis or 1044 Patients with Normal Exercise Tc:·99m 
Sestamlhi Myocardial Perfusion SPECT. 
Daniel S. Bennan. Hosen Kiat, Ishac Cohen, J. Arthur Cabico, Fan Ping Wang, 
John D. Friedman, George A. Diamond. Cedars-Sinai Medical Center, LA., CA 
The benign prognOSis of patients with nonna! exercise n-201 imaging is well 
recognized. To assess the prognostic implications of a normal Tc-99m sestamibi 
SPECT, we studied 1044 patients with nonnal studies who were followed up > I 
year (19.6±4.8 months) after perlonnance of separate acquisition rest n-20I/exercise 
Tc-99Jn sestamibi dual isotope myocardial perlusion SPBCT (DIMPS). Pre-scan 
Bayesian likelihood (ll) of coronary arteJy disease (.31 ± .33) was calculated from 
clinical and exercise data. Patients were stratified into 3 LIe groups: low (<.15, 
n=537), intennediate (.15 - .84, n=386) and bigh (>.84, n=121). DIMPS was 
visually evaluated in 20 segments with a 5 point score (O=nonnal to 4=absent 
uptake). Summed scores (S) were calculated by adding stress S (SSS=summed stress 
score) and rest stress minus rest S (SRS=summed reversibility score). SSS <4 was 
considered nonnal. Scans were subclassified as nmnal, probably nonnal (Prob NL) 
and equivocal (Equiv). At follow-up, bard events had occurred in 5 pts (0.5%) 
including 3 MIs and 2 cardiac deaths. Soft events bad occurred in II (I.I %) (7 
CABG and 4 PTCA). Eventl1lles as a function of pre-scan LIe and scan findings 
were as follows: 
u 0 
i i 
5
W 
5 
Il '.6 .Oa.IIo.MJ i luj1.3.3 i 2.5 ";' 2.5 
jIo. t 1 iJo> 1 1 
101' EiII CABGor 101 .5 
0.2 • PTe.. 0 • 
<15 U~14 ,.s. NL .... NL £qui .. 
LII Tc-MIBI 
Conclusion: In a very large patient cohort, the findings show that a nonnal or 
equivocal exercise Tc-99Jn sestamibi SPBCT study implies an excellent prognosis 
with respect to hard or soft cardiac events over a follow-up period of 19.6 months. 
The benign prognosis extends even to those patients with a bigh pre-test likelihood 
of CAD. 
716·5 3:00 
Prognosis In 484 Consecutive Patients Following 
Intravenous Dipyridamole Te·99m Sestemlbl SPECT Imaging 
Steven D. Hennan, Carol Ewing Garber, Mark I. Travin, Joseph R. 
McClellan, Donna J. Cloutier, John I. Baron, Pamela R. Rama, 
Gary V. Heller. Memorial and Roger Williams Hospitals, Brown University, 
Providence, R I 
To establish the prognostic value of intravenous dipyridamole Tc-99m 
aestamibi SPECT imaging, 484 consecutive patients (pts)(age 67±11, 
59% female) wera evaluated. The myocardial images of thesa pts were 
classified as demonstreting normal or abnormal perfusion. In addition, 
perfusion defects wera subclassified as fixed or ischemic, and the extent 
of each wes graded as mild, moderate or savera. All pts were evaluated for 
the occurrence of subsequent cardiac events. During a mean follow-up 
period of 6 months, 29 patients had cardiac events including 16 cardiac 
deaths and 13 nonfatal myocardial infarctions. 
rL ~ ~ ~ ~ ~ ~II 
1Il1ll i'~ ;!!S ~o Z~ E If Ql :E I!! ~ v 2 "§ ~ Jl.c. ~ - ~ 
PIs with abnormal perfusion had significantly more events than those 
with normal parfusion with trends suggesting more events with ischemic 
and extensive defects. In a subgroup of 365 pts with no prior history of 
myocardial infarction, significantly more avents occurred in thosa w~h 
abnormal (9.6%) and ischemic (10.6%) images than in thosa with normal 
images (1.4%). 
CONCLUSIONS: Patients with a normal dipyridamole Te-99m sestamibi 
SPECT study have an excellent short-term prognosis, while those with an 
abnormal study have an increased probability of subsequent cardiac death 
and nonfatal myocardial infarction. 
ABSTRACTS 63A 
716·6 3:15 
Prognosis in Patients With Spontaneous Chest Pain But Without 
Significant Resting Iscbemia on Tc99m Sestamibi Scintigrapby 
*Todd D. Miller, Mona R. Hopfenspirger, Mary F. Hauser, David O. 
Hodge, Timothy F. Christian, *Raymond 1. Gibbons, Mayo Clinic, 
Rochester, MN 
The purpose of this study was to evaluate the prognosis of patients 
with chest pain occurring at rest, who did not have a significant 
reversible perfusion abnonnality by quantitative Tc99m sestamibi 
(MffiI) imaging. One hundred-seven patients (62M, 45F, age 6O±14 
yrs), 56% with documented coronary artery disease, were injected 
with MIBI during an episode of rest pain. Tomographic imaging was 
perfonned 1-6 hours later and delayed injection and imaging were 
perfonned (when necessary) 24-48 hours later when the patient was 
pain free. MIBI uptake was quantitated by a program previously 
developed to measure infarct size. Ninety-two patients had nonnal 
images and 15 patients had fixed defects (ranging in size from 2% to 
39% of the left ventricle). Median duration offollow-up was 31 
months. During follow-up there were 7 initial hard cardiac events (1 
death, 6 myocardial infarctions) and 20 revascularizations (7 
perfonned "late" > 3 months after the MIBI study). 
Event-free survival was: 
Survival free of hard events 
Survival free of hard events or 
late revascularizations 
Wm 
94% 
92% 
~~ 
93% 91% 
85% 82% 
There was no association between the presence of fixed defects and 
events. Fifteen patients had possible mild redistribution by 
subjective interpretation of images. This fmding did not predict 
outcome. 
CONCLUSION: Patients with spontaneous chest pain who do not 
have significant reversibility on quantitative tomographic MffiI 
imaging are at low risk for future cardiac events. 
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717·1 2:00 
The Effect or 'l)l'ODlbill Receptor Activating Pepdde OD Platelet AaregatioD 
In PatieDlI UDdergoing Glyc:oproteiD IIbJIJIa Receptor BIoc:kade With 7E3 
-Neal S. Kleiman, -Robert Jordan, Bany Coller, -Daniel Norton, -Harlan 
Weisman, Coachita Mercado, Dale Roae, Kathlcea Trainor, Susan Johason, Lori 
Buschmann. Baylor College of Mediciae, The Methodist Hospital, Houston, Tx. 
Blockade of the platelet (PIt) g1ycoprotein receptor GPIIbIIIla with the 
monoclooa! anu"body 7E3 prevents ex vivo aggregation in response to a variety of 
agonists including thrombin, but its ewIuation is confounded by thrombin 
induced formation of fibrin. The thrombin receptor IICtivatiDg peptide 
SFLLRNPNDKY (fRAP) ovcrcomcs this problem by activaIing pits without 
forming fibrin > but bas DOl been studied ill patiealS (pis) tIeated with 8 GPIIbIIIIa 
antagonist ill 32 angioplasty pis retleiviag aspirin, bcparin, and an 0.25 mglkg 
bolus of 7E3, we oompared aggregatioD responses to the agonists OOIlageD S""mI, 
ADP 511M and 2011M, with respouses to TRAP 711M ill 14 pis and 14 11M ill 18 
pIS. GPIIbIIIIa receptor blockade was assayed usiag radiotabeUed 7E3. Receptor 
b lockade and percent inhibition {.,gD~ ofpre-7E3 aggre, ~on were: 
Time from Receptors ADP ADP Collagen TRAP 
bolus (brs) Blocked (%) 5 11M 20 11M Sl1IImI 7 11M 
2 73=12 86:10 72%13 87:1:3 57%27+ 
6 70%15 67=16 49:18 83:6 33:45+ 
24 39:36 29:18 26:1:33 62:27 43=46 
Time from Receptors ADP ADP CollageD TRAP 
bolus_~ Blocked~ 5~ 2Md SlI2ImI 14 11M 
2 85:7 84=12 81=17 83:14 38=19-
6 73=11 73=13 69:19 86:7 34:19-
24 42%32 46:25 33%21 70%20 13=34 
+ 0.05<P<O.1 vs ADP 2011M *P<O.OO4 vs. ADP 201lM. 
lahibitioD of 7 11M TRAP-induced aggregatiOD 5 minutes after the bolus, 
measured ill 8 pIS, was 73=16%. Thus, following a 7E3 bolus, inhibitioD of 
TRAP·induced aggregation appears to be only paniaI compared to that induced by 
ADP or collagen, with more rapid recovery at the higber COllCClltratiOn, posstbly 
due to additiooa! IIbIIIIa receptors from a1pba granules joining the plasma 
membrane. Thus ill patiealS receiving thrombolytic therapy ill whom thrombill is 
geoerated iatravascuIarIy, sustained infusiODS of 7E3 may be required to preveDt 
platelet-mediated rethrombosis. 
64A ABSTRACfS 
717-2 2:15 
Thrombus Contains Soluble Factors Wbicb Decrease Blood Flow In Swine 
Coronary Arteries Tbrougb a Nitrous Oxide- Dependent Pathway 
George Y. Paik. Ronald P. Caputo. Boris D. Nlinez. Donald S. Bairn. and Joseph 
P. Carrozza. Harvard- Thorndike Laboratory. Beth Israel Hospital. Boston. MA 
Decreases in coronary blood flow have been observed after successful PTCA of 
thrombotic lesions despite an angiographically patent epicardial vessel. 
Microvascular constriction mediated by soluble factors from thrombus has been 
hypothesized to cause "No- Reflow." To test this hypothesis. we administered a 
solution containing thrombus- derived soluble factors into the coronary arteries 
of to normal pigs. Supernatant (SN) obtained from whole blood thrombus was 
injected into the left coronary artery while the average peak coronary blood flow 
velocity (APV) was measured with a 0.018" Doppler- tipped flow wire 
positioned in the proximal left anterior descending artery. Coronary artery cross 
sectional area was determined by angiography. Coronary flow reserve (CFR) was 
assessed with adenosine (A). 
~: SN administration caused a dose-dependent increase in CBF (96 vs. 71 
mllmin; p=O.OOI Fig). Following pretreatment with N-Cl>-nitro-L-arginine methyl 
ester (L-NAME). an inhibitor of nitrous oxide (NO) production. however. SN 
caused a reduction in CBF (60 vs. 74 mllmin. p=O.OO2; Fig). Adenosine•
stimulated CFR was preserved after SN administration in the L-NAME treated 
animals (2.2 vs. 1.7. p= NS). Significant epicardial narrowing did not occur. 
175 
"- 125 • SN 
1:3 Ed SN &A 
.5 75 • L-NAME & SN 
<3 25 0 L-NAME. SN & A ~ f---~"""-I..-"'::: 
-25 -1-----=-----, 
• p<O.05 (compared with SN) 
Conclusions: I. Soluble factors from disrupted thrombus augment CBF when NO 
production is intact. 2. These same factors decrease CBP when NO production is 
inhibited by L-NAME. probably reflecting unopposed microvascular 
constriction. 3. Despite thrombus- induced vasoconstriction. endothelial•
independent microvascular dilatation to adenosine is preserved 
717-3 2:30 
Inhibition of the Progresaion of Thrombul Growth on Pre-exlatlng Mural 
Thrombus: Tugetlng Optimal Therapy 
Beat Meyer, Juan Badimon, Valentin Fuster, Alessandra MaUhac, 
Antonio Femandez-Ortiz, James Chesebro, Una Badimon. Cardiac 
Unit, Massachusetts General Hospital, Boston, MA 
Residual mural thrombus on severely damaged arterial wall is a highly 
reactive substrate for further thrombus growth. A primary mural 
thrombus was formed perfusing porcine blood over severely damaged 
arterial wall at a shear rate of 1700/5 ( corresponding to a moderate 
coronary stenosis) for 5 min In a well characterized porcine perfusion 
system. The average platelet deposition (PO) achieved in 5 minutes 
was 382±32 x106 platelets/cm2. The inhibition of the progression of 
thrombus growth triggered by the preformed mural thrombus was tested 
by perfusing labeled blood ( autologous 11IJn_ platelets) for an 
additional 5 minutes over the preformed mural thrombus, at the same 
flow conditions. Treatments Included r-hirudln (r-hir , 1 mg/kg/h, iv) 
aspirin (ASA, 5 mg/Kg, iv), heparin (Hep, 100 IU/Kg/h) plus ASA (5 
mg/Kg, iv), high-dose Hep (250 IU/Kg/h, iv), or placebo. 
Anticoagulation levels were measured by aPTT (sec). Results are 
expressed as PDxl06 / cm2 (X±SEM) and comparisons were performed by 
ANOVA (p< O.ffi, "vs Placebo; • vs Hep 250) 
PIal'f'ho 6-5.6 liI:p±AS6 liI:pZ5!l [·Hi[ 
n 23 8 4 8 8 
PO 1164:t85 1063±120 495±99" 206:t64" 3O±12". 
il£II 29;t5 3titi ~ ~ Zfl;j;~" 
Specific thrombin inhibition with r-hirudln significantly abolished the 
progression of thrombus growth on a pre-existing mural thrombus, at a 
shear rate typical of moderate coronary stenosis. r-hirudln has shown 
to be the most effective therapy In this model; thus, thrombin appears to 
be a key agonist for platelet activation on growing thrombus and should 
be the target for optimal pharmacological Intervention. 
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717-4 2:45 
Immunohistochemical Detection of Tissue Factor In Humen 
Coronary Atheroma 
Jonathan D. Mall1llr. Bllie Fyle. Samin K. Sharma. John A. Ambrose. Marc 
Habert, Sarah Eisenberg. Sabino R. Tone, Yale Nemerson. Mark B. 
Taubman. Mt. Sinal Medical Center. NY, NY. 
Tissue Faclor (TF) InHlates the predominant pathway of blood 
coagulation In vivo and has been detected In atherosclerotic plaque 
derived from carotid artery and saphenous vein grafts. To characterize the 
expression of TF In coronary atheroma. immunohistochemistry with a 
monoclonal antl-ruman TF antibody was pel10rmecl on frozen sections of 
24 lesions from 24 patients treated with directional coronary atherectomy. 
PosHlve staining for TF antigen was demonstrated In specimens derived 
from 8 (33%) of the lesions. TF antigen was distribUted In a norHiiftuse 
pattem. wtth small foci detectable PIedominantly In areas of acellular 
sclerotic plaque. Areas of Intimal hyperplasla were not associated with 
posHive TF staining. Differences between patients with posHive TF stain 
(TF+) versus patients with negative TF stain (TF-) were analyzed using 
Fishe~s exact test. Lesion morphology was defined as complex when an 
ulceration, Irregular borders. or a filling defect was present on baseline 
angiography. 
TF+ (n-s) 
unstable angina (rest or post-MI pain) 7 (88%) 
thrombus on histology (H & E staining) 6 (75%) • 
complex angiographic morphology 6 (75%) •• 
·p.O.08; -11"'0.03 (for TF+ vs TF-) 
TF. (n.16) 
14(88%) 
5(31%) 
4(25%) 
TF antigen was detected in a substantial portion of coronary lesions 
undergoing atherectomy (33%). The variability ollis expression In 
coronary atheroscleroSis may explain the variable thrombotic tendency 01 
lesions that ere disrupted by percutaneous Interventions. The association 
Of TF antigen wHh a complex anglographlc lesion morphology and the 
trend toward an association between TF antigen and histologic thrombus 
support a role for TF In the thrombotic events associated whh coronary 
atherosclerosis. 
717-5 3:00 
Effect of Low Dens 1 ty L1 poprote1 ns on Vascular 
Responses to Platelets 
*Sanjay Kaul, Barry J. Waack, Robert M. Brooks, and 
Donald D. Heistad, Univ of Iowa and VA Med Ctr, Iowa 
City, Iowa, and *Cedars-Sinai Medical Ctr, Los 
Angeles, CA 
We showed recently that vasodil ator responses to 
plate 1 ets (PL T I from hypercho 1 estero 1 emi c humans are 
profoundly impaired. It is not clear, however, 
whether these findings are due to an intrinsic 
platelet defect or are related to the platelet's 
lipid-rich plasma environment. In this study, we 
exami ned effects of exposure of normal human PL T to 
low density lipoproteins (LOLl on vasodilator 
responses to PL1. Rabbit carotid arteries were 
perfused in vitro, diameter was measured, and 
responses were expressed as % change in di ameter of 
preconstricted arteries. Baseline diameter of carotid 
arteries was 2.4±0.1 mm (mean±SEMI. Activation of PLT 
(108/ml, nEIOI increased arterial diameter by 44±4%. 
Vasodilator responses to PLT incubated with LDL were 
greatly impaired in a time and concentration-dependent 
fashion: diameter increased by 25±4%* and 20±7%* in 
response to PLT incubated with 50 mcg/ml LDL for 2 and 
4 hours, and 16±4%* and I2±3%* in response to PLT 
incubated with 100 mcg/ml LDL for 2 and 4 hours, 
respectively (*p<0.05 vs control I. Incubation with 
LDL for <5 minutes did not affect vasodilator 
responses to PL 1. Incubation wi th LDL augmented PL T 
aggregation induced by thrombin_ 
In summary, LDL augments platelet aggregation and 
impairs platelet-mediated vasodilation. Thus, 
a lterat i on of PL T by exposure to e 1 evat i on of LDL 
occurs rapidly, and may contribute to abnormal 
vascular responses in atherosclerosis. 
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717·6 3:15 
Detection and Quantification of TIsaue Factor Activity In 
Coronary Atherectomy Speclmena 
Jonathan D. Mal'llllr, ThiNvikraman V. Singanallore, Samin K. Sharma, 
Billie Fyfe, Arabinda Guha, John A. Ambrose, Yale Nemerson. Depts. of 
Medicine and Pathology, MI. Sinal Hosp., NY. 
Tissue lactor (TF) Is a mermrane-bound clotting lactor that InHiates the 
major pathway of coagulation in vivo by binding factor VII (FVII). The 
TF:FVII COl1lllex converts factor X (FX) to Hs active lonn, xa, activating the 
clotting cascade. We have detacted TF antigen in 33% of coronary 
atherectomy specimens using a monoclonal anti-TF antibody. To detect 
and quantity TF activity, IlIman coronary atherectomy specimens (na 15) 
were incubated with an assay mix (AM) containing FX (100nM), FVlla 
(lnM), and calcium (5mM) at 370C in microtlter plate wells. In these 
conditions, the amount of xa generation Is detennined by the quantity of 
bioavailable TF. To quantHy xa generation, a xa-sensltive chromogen 
(ILeu-Pro-Arg-pNA) was added to the wells that produces a color change 
measured at 405 nM in an ELISA counter. TF activity in wells containing 
AM alone, and AM and plaque (AM+P) were read after various periods of 
incubation. TF activity (mean±SD) is In optical density units (milli 00): 
TF Activity :1 iii (milIiOO) - -o -0.5 2.5 19 0.5 2.5 19 HRS 
AM AM+P 
Factor Xa generation is time-dependent and detectable at high levels 
in wells containing atherosclerotic plaque but not in wells containing 
AM alone. At 2.5 hrs, 13 of the 15 (87%) atherectomy specimens 
generated >3.0 milli 00. Procoagulant activity was eliminated by 
pre-incubation of the plaque with anti-TF antibody. Conclysion: TF 
activity is detectable and quantifiable in coronary atheroma. The 
activity assay appears to be more sensitive than 
immunohistochemistry for the detection of TF (87% versus 33%). 
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718·1 2:00 
The Predictive Power of Heart Rate Variability Index After Acute Myocardial 
Infan:tion is not Different in Patients Who Did and Did Not Receive an Early 
Tbrombolytic Treatment 
Marek Malik, Angus Turner, Katerina Hnatkova, Anne Staunton, A. John Carom, 
S1. George's Hospital Medical School, London, United Kingdom 
The evidence that reduced heart rate variability (HRV) is associated with an 
increased risk of mortality and arrhythmic complications after acute myocardial 
infarction (AMI) has been obtained from data accumulated before the era of the 
thrombolytic treatment. This study investigated whether there are any significant 
differences between the predictive power of reduced HRV in populations of AMI 
survivors who did and did not receive thrombolytic treatment. 
A population of 695 patients admitted to our hospital with AMI was 
investigated; 351 (51%) of these received thrombolytic treatment within the first 24 
hours after onset of symptoms (thrombolysed group - TO). There were no significant 
differences between the thrombolysed and non-thrombolysed group (42% vs 43% 
older than 60 years, 53% vs 58% male, 45% vs 49"A. anterior AMI, 67% vs 56% Q 
wave infarction; mean ejection fraction 44% vs 46%). The patients were followed up 
for I to 6 years; during the follow-up restricted to I year after admission they were 
55 pts died (20 in TO), 27 of these deaths were sudden (10 in TO), 25 patients 
suffered from a non-fatal arrhythmic event: 23 spontaneous symptomatic sustained 
ventricular tachycardia (VI) (II in TO), and 2 resuscitated from primary 
ventricular fibrillation (VF) (I in TO). A 24 hour Holter monitoring was carried out 
in each patient between days 5 - II after admission and the HR V index value was 
obtained for each tape. Receiver operator characteristics and positive predictive 
characteristics were computed for the prediction of I year mortality, and I year 
arrbythmic events based on the HRV values separately for the thrombolysed and 
non-thrombolysed population. 
In the non-thrombolysed and the thrombolysed group, I year mortality was 
predicted with a positive predictive accuracy (PPA) of 62% and 58% at 25% 
sensitivity, 37% and 49"A. at 40% sensitivity, and 37% and 39"A. at 50% sensitivity, 
respectively (all NS). In these groups, I year arrhythmic events (sudden death + vr 
+ VF) were predicted with a PPA of59"A.and 48% at 25% sensitivity, 47% and 39"/. 
at 40% sensitivity, and 37% and 39"A. at 50% sensitivity, respectively (all NS). 
The study shows that they are no significant differences in the predictive 
power of HR V in thrombolysed and non-thrombolysed populations of AMI survivors 
for the prediction of early mortality or early arrhythmic complications. 
ABSTRACTS 
718·2 2:15 
Residual Myocardial Ischemia, 24-Hour Heart Rate Variability and 
Cardiac Events After First Acute Myocardial Infarction. 
Anders Junker. Hans Mickley. Mogens Meller. Department of Cardiolo· 
gy. Odense University Hospital, Odense. Denmark. 
Twenty-four hour heart rate variability (HRV) is a predictor of sudden 
cardiac death after acute myocardial infarction (AMI). Residual 
myocardial ischemia after AMI is associated with an increased risk of 
future ischemic events. The purpose of the present study was twofold: 
First. to evaluate the relation between 24-hour HRV and the presence 
of residual myocardial ischemia in pts with a first AMI. Second. to asses 
the one-year prognostic significance of 24-hour HRV in the same 
population. . 
1 18 consecutive pts (55 ± 8 years) with a lirst AMI performed a 
predischarge exercise test and an early out-of-hospital ambulatory 
monitoring. A 24·hour HRV index was measured as an index of the 
width of the frequency distribution curve (a triangular index), and 
residual myocardial ischemia was defined as horizontal or descending 
ST-segment depression (ST j I of at least 1 mm measured 80 ms after 
the J-point detected during exercise ECG or ambulatory monitoring. 
No difference was found between the 1) 24-hour HRV index in the 63 
pts (53%) with exercise induced ischemia (30.5 ± 10.0). 21 the 23 pts 
with ambulatory ischemia (27.5 ± 9.5) or 3) the 53 pts without ischemia 
during any of the ECG methods (29.5± 10.2; all NS). 
Even in pts With more than 100 min of ischemia during ambulatory 
monitoring (10 pts) 24-hour HRV was not significantly different 
(27.2 ± 1 1 .8). 
During follow-up 6 pts had an arrhythmic event (SCDIVTIVF) and 16 
pts an ischemic endpoint (recurrent AMI or revascularization). Thirty· 
three % of pts (5/15) with a 24-hour HRV index s 20 had an arrhyth· 
mic event vs one % (1/103) of pts with a 24-hour HRV index> 20 (P 
< 0.01). Ischemic endpoints were not related to the 24-HRV index. 
Conclusion: 24·hour HRV is not related to residual myocardial 
ischemia following a first AMI. A low HRV is associated with an 
increased risk of arrhythmic events but does not predict recurrent ische· 
mic events. 
718·3 2:30 
Heart RaIc variability Before the Oasct of Parm:ysmal AIriaI FibriIIaIion 
Masataka Mitsuno, Ricbard B. Schuess1er, Phyllis K. Stein, John P. Boineau, 
James L. Cox, Washington University, St. Louis, MO 
Altered vagosympatbetic interaction is considered to be one possible condition 
that produces paroxysmal atrial fibrillation (PAP). To assess autonomic 
function before the onset of PAF, wc reviewed 24 hr Holter ECGs of 15 
patients who showed P AF during the monitoring. Forty-three out of 344 
episodes of P AF, which occurred following at least 20 minutes of sinus rhythm 
(SR), were used for this study. Episodes in which PAF occurred following SR 
with > 20% PACs wcre emuded. Onset time was divided into three groups 
(daytime (7:30-21:00, n=25], nighttime (0:00-5:00, n=10), and transition time 
(n=8)). Low frequeney (0.04-0.15 Hz:LF) and high frequeney (0.15'().4 Hz:HF) 
spectral power of heart rate variability (HR V) were computed in 1-hour 
segments for the 24-hour period and in 10 or 2 minute segments before the 
onset of P AF. Beats of P AF were labeled manually and emuded from the 
analysis. Tbe average power (Avg) was calculated from aU SR during the same 
period as tbe episode of P AF, except SR 1 hour prior to P AF. 
Results: 
min before PAF 10-20 8-10 6-8 4-6 2-4 0-2 Avg 
LF (ms) 19.10· 17.11 2OtU· 19.11· 22.13· 29.15·· 16>7 
HF (IDS) 14<6 u.s u.s U.7 U.7 17.90·· U.s 
('p<O.OO2 compare to Avg. "p<O.OO2 compare to an other penOdS) 
Conclusions· LF was already increased 20 min prior to P AF and in addition 
rapidly increased 2 min prior to P AF. HF showed rapid increase 2 min prior 
to PAF. This suggests that sympathetic tone increased first and after that vagal 
tone increased just prior to P AF. Tbe sudden increase in vagal tone could be 
a reflex response to the increasing sympathetic tone which exceeded a certain 
threshold, and tbereafter tbe combined effects of both created pro-arrbythmic 
conditioDS. 
65A 
66A ABSTRACfS 
718-4 2:45 
HEART RATE VARIABILITY AS AN ASSESSMENT OF BRAIN DEATH 
·J.Freitas, J.Puig, J.Telxeira, A.P. Rocha, P. Lago, M.Carvalho, O.Costa 
and A.F .Freitas. S. Cardiologia-Hospital de S. Jollo, Departamentos de 
Medicina e de Matematica Aplicada-Universidade do Porto. Portugal. 
Purpose: To evaluate the sensitivity of heart rate variability in the assessment 
of brain death in comatose patients with acute traumatic intracranial lesions. 
Material and Methods: We studied 18 patients aged 22 +1- 7 years, with 
universal accepted criteria of brain death, all of them has been organ donors 
(Group A), 18 comatose patients (Group B) with Glasgow scale score < 7 and 
18 subjects with normal clinical and cardiac noninvasive evaluation (Group 
C), age matched. The ECG was sampled at 650 Hz. The following indexes in 
time and frequency domain (FIT) were calculated: RR variance (var) and 
corrected standard deviation (cSD); RRmaxlRRmin ratio (Ell); variance of 
differences between adjacent RR intervals (var pNN); very low frequency 
(VLF, <.05 Hzeq): low frequency (LF .. 05 to .15 Hzeq); high frequency (HF. 
.15 to.40 Hzeq) and total power (TP, < .50 Hz). 
Results: Group C values are clearly greater than Group A and B. Group A 
values are significantly lower than in Group B. Four indexes had no overlap 
between Group A and B (var, cSD. Ell and TP). 
GROUP A CROUPB GRoupe 
nul %6+1-9 ~.OOOI 154+{-34 2790+1- !l~ 
VIIrDNN mol 14+1-! O.O39(l 20+1-' 887 +/··4%1 
TP mol 13 +1-' -«1.0001 109 +1-3~ 2286 +1- 420 
VLF mol '7+1-4 <0.0001 61 +1·39 585 +1-1l6 
LF nul 1 +1-1 <0.0001 13+1·8 368 +1-.7 
HF msl 8 +1-" <0.0001 2'7+/-15 1164+1-~ 
,SD (m. 7.0+1-1.0 <0.0001 11.3+1_!i.3 49.0 +1- 8." 
Ell 1.031 +{. 0.009 <0.0001 LIl9 +1. 0.044 1.442 +/.0.121 
Conclusions: These data indicated that heart rate variability analysis was a 
fully sensitive method for assessing brain death in potential organ donors 
patients with acute traumatic intracranial lesions. This fast bedside method 
seems very promising in the early diagnosis of brain death. which is very 
important for the success of the transplants procedures. 
718-5 3:00 
Heart rate variability for the assessment of autonomic function in patients 
with vasovagal syncope. 
Moro C, Madrid AH, Mestre JL, Marin E, Novo L. AlTbythmia Unit. Ramon 
y Cajal Hospital. Madrid, Spain. 
Autonomic nervous system activity plays an important role in the 
pathogenesis of vasovagal syncope. Head up tilt test (HUT) Is a useful tool to 
evaluate patients with neuromedialed syncope. However, the relationship 
betw1:en heart rate variability (HRV) aud tilt Induced syncope is not 
established. 
The purpose of this study was to assess the differences in HRV among 
patients with clinical suspicion of vasovagal syncope and HUT negative aud 
those with HUT positive. Fifty patients (mean age 33 ± 17 years, Z4 female, 
26 male) with syncope underwent HUT (20 min, 80" tilt and 20 min more with 
isoproterenol 1-6 p.gimin). Twenty-three patients have a negative HUT while 
It was positive in 27. There were not significant differences in age or sex. 
Inmediately after HUT,a Z4-hour ambulatory ECG was performed(Marquette). 
The measured parameters during Holter monitoring were: SDANN, SD,. 
rMSSD, pNNSO and frequency analysis of heart rate spectnun (low frequency 
0.04-O.1S Hz, higb frequency 0.15-0.4 Hz aud the relation lowlbigb). 
RESUL.~TS~:==~=====T====T=====r====F==~ 
HJr· 
p_o.ooe p_D.04 
pNNSO was 'significantly higber in HUT + patients, and the best predictor 
of the results of HUT. SDANN (which has shown to be a good predictor of 
deatb In patients with ischemic heart disease) was not a useful parameter. 
pNNSO :> 25% identify the patients with a positive HUT with a specificity of 
82.6% and a predictive positive value of 77%. In frequency analysis only tbe 
relation lowihigh (UH) was significantly dilTerent. HRV is a useful tool in the 
evaluation of patients with vasovagal syncope.1t may identify patients with 
chronically elevated vagal tone and thus may predict HUT results. 
JACC February 1994:1A-484A 
718-6 3:15 
TIle Very Law f'requeucy CcIIpoDeDt of Beart Rate 
Variability 18 incnaaed in Patienta with Chronic 
Beart ,.ailure prior to episodea of Hon-Suat.ainad 
Ventricular TachycarcU.a 
Elena Cerquetani, Maurizio Volterrani, Massimo 
Piepoli Piotre Ponikowski, Andrew Coats. Dept of 
Cardiac Medicine, National Heart , Lung Institute, 
London and John Radcliffe Hospital, OXford, UK. 
Abnormalities in autonomic control have t.een 
implicated in the genesis of ventricular arrhythmias 
(VA). Power spectral analysis (PSA) of ECG may detect 
changes in autonomic balance, but less attention ·has 
been payed to very low frequency (VLF) (0.008-0.04 
Hz) rhythms • We studied 13 episodes of non-sustained 
ventricular tachycardia (NSVT) in 8 patients with 
chronic ischemic heart failure (age 63t5). PSA was 
measured during a 30 minutes before and after each 
NSVT episode,(divided into 10 intervals of 6 minutes) 
and 30 minutes (without VA) one hour before. PSA was 
derived from 24 h ECG recordings of heart rate 
variability detecting high (HF K O. 15-0.4 Hz), low (IE 
= 0.04-0.15 Hz) and very low (VLF = 0.008-0.04 Hz) 
components (Marquette 8.000). VLF power was 
significantly increased in the 6 minutes immediately 
preceding NSVT (P<0.005) and also between 7 to 12 
minutes before (P<0.05). IE power was significantly 
increased (P<0.05) only between 6 to 12 minutes after 
the episode. HF power did not differ. These data 
confirm an association between alterations of the 
autonomic nervous system and episodes of NSVT in CHF 
and suggest that VLF power may be a specific precursor 
of these episodes. 
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719·1 2:00 
Two GI88888 of Red but not Whits Wine Inhibits Ex-Vivo Platslet 
Aggregation and Incraaaes Bleeding Time in Human VoluntBers 
John D. Folts, Heather S. Damrow, Peter R. Slane, University of Wisconsin, 
Cardiology Section, Madison, WI 
Moderate consumption of alcoholic beverages is considered a negative 
risk factor for coronary artery disease. The French red wine paradox 
suggests that drinking red wine daily appears to reverse the hannful effect 
01 some coronary risk factors and decreases heart attacks. We have 
previously shown that pure alcohol (blood alcohol content (BAC) 
0.2 gm/dl) and red wine (RW) (BAC 0.05) but not white wine CNNl (BAC 
0.05 gm/dl) inhibits in vivo platelet aggregation (PA) and prevents 
experimental coronary thrombosis in stenosed canine coronary arteries 
with intimal damage (Folts Model). In seven human subjects (HS) ex-vivo 
PA and template bleeding time (TBn were determined before and 30 
minutes after drinking 5 ml/kg of French RoN and one week later 5 ml/kg 
of French WtN. PA in response to collagen Sienco® aggregometer was 
decreased by 39 :I: 11% (p<.01) and TBTincreased 37 :1:8% (p<.01) after 
RoN but there were no significant changes in PA or TBT after WtN. The 
BAC averaged 0.06 :1:.02 g/dl after RoN and 0.06 :I: .01 g/dl after WtN. 
Previous studies in HS have shown that when using pure ethanol a BAC 
of 0.15 to 0.25 g/dl is required to significantly inhibit PA. There are many 
biologically active natural compounds such as Quercetin 120 I'Q/ml found 
in our RoN but only trace amounts in WtN that inhibit PA in vitro. Quercetin 
(50 II M) inhibits human PA in response to ADP, collagen and thrombin, in 
vitro. Thus, there are apparently substances in RoN that are absorbed from 
the GI tract and act either synergistically or independent of ethanol to 
inhibit platelet activity and prolong the bleeding time. Increased platelet 
activity enhances the development of atherosclerosis and coronary 
thrombosis. The daily consumption of RoN may inhibit platelet activity and 
reduce the development of atherosclerotic coronary artery disease and 
coronary thrombosis seen in some populations. 
JACC February 1994:1A-484A 
719·2 
Moderate Alcohol Consumption is Associated with a Beneficial Effect 
on Hemostasis: Analysis of the Framingham Offspring Study 
Praveen P. Jadhav, Otavio C.E. Gebara, Murray Mittleman, Patrice 
Sutherland, Travis H. Matheney, Ping Xu, Isabella Upinska, Daniel 
Levy, Peter Wilson, James E. Muller and Geoffrey H. Tofler. Institute 
for Prevention of Cardiovascular Disease, Cardiovascular Division, 
Deaconess Hospital and the Framingham Heart StudY, Boston, MA. 
Although moderate alcohol consumption is associated with a 
reduced risk of cardiovascular disease, the mechanism of its possible 
benefit is not well understood. Since thrombosis plays a major role in 
the onset of cardiovascular disease, and the effects of alcohol on 
hemostatic function have been controversial, we determined the 
relation between alcohol consumption and hemostatic factors in the 
Framingham Offspring Study. 
Of the 887 subjects studied, we identified 377 subjects (51 % 
females, mean age 54.±.9 years) who were non-drinkers or moderate 
drinkers (defined as 1-3 drinks of alcohol per day) and had no history 
of cardiovascular disease. We determined levels of the following 
hemostatic factors previously correlated with cardiovascular risk: 
fibrinogen, plasma viscosity, Factor VII antigen, von Willebrand Factor 
antigen (vWF), and Plasminogen Activator Inhibitor-I antigen (PAl-I). 
Values are mean.±. standard error of mean. 
Non-Drinkers Moderate Drinkers p vakJe 
(n) (234) (143) 
Fibrinogen (mg/dl) 307 .±. 3 283.±. 5 <0.001 
Viscosity(cps) 1.27 .±..001 1.24.±. .01 0.06 
Factor VII (%) 98.±. .06 91 .±. 1.1 <0.001 
vWF (%) 139 .±. 3 121 .±. 4 0.002 
PAl-I (ng/dl) 22 .±. 1.1 24.±. 1.8 0.18 
Moderate alcohol consumption was associated with lower 
levels of fibrinogen, plasma viscosity, Factor VII and vWF. The 
differences between the two groups remain significant after adjusting 
for age, gender, and smoking. Low levels of these parameters reduce 
thrombotic tendency, and may be responsible, in part, for the possible 
cardioprotective effect of moderate alcohol consumption. 
719·3 2:30 
Hemodynamic Changes During Exercise After Exposure to Low Level Carbon 
Monoxide in PatienlS with Ischemic Hean Disease 
Guy E. De Gent, Martha N. Ballenger, Kirlcwood F. Adams and David S. Sheps, 
University of North Carolina, Chapel Hill, NC 
We examined the cardiovascular efIeclS of cartxm monoxide (CO) exposure in 82 
patienlS with ischemic hean disease (IHD) during exercise. This study evaluated 
changes in left ventricular volumes as a sensitive marlcer for ischemia induced by 
exposure to CO to achieve 4% anti 6% carboxyhemoglobin (COHb), which are 
bklod levels often achieved in busy II1'ban environments. 
Patients with marlcers for e3fly or severe ischemia, as detennined by an early•
positive exercise u-eadmi11 test (time to positive test; TST<180sec) or maximum 
ST- depression> 2mm, showed significant increases in end- systolic volumes 
during maxim31 exercise (&MESV) on a supine exercise bicycle achieving levels of 
6% COHb, compared to patients with less severe IHD (cfr. f1l!ures). &MESY was 
measured by CO\!I1IS-based method without 811enuation correction ± SE. 
10 10 
8 ST>2mm * 
~ 6 > 6 4 ~ 4 
2 2 
0 0 
AIR ,,% 6% AIR 4% 6% 
·p=O.<i3vs. patients TST>I80s • P =0.02 vs. patienlS ST <2mm 
No d.!I~rences were noted in changes in *ction fraction during maximal (&MEF) 
or scl'rnl.'timal exerecise (~MEF) af·.er CO- exposL!l'C (dMEF during air exposure 
.-2.33%, &MEl' after 4% CO: -0.6% Imd MIEF after 6%= -2.17%; ANOYA: 
p>O.OS). 
Conclusion.: I) PatienlS with severe ischemic hean disease, as compared to those 
with lesser severity, b3ve m3lt.ed increases in end- systolic volume during maximal 
exmise after inhalation of CO. 2) Changes in left venticular end- systolic volume 
during exercise appear to be a more sensitive marlcer for ischemia after CO exposure 
then changes in EF. 
ABSTRACTS 
719·4 2:45 
Chest Pain With Nontal Coronary Arteriesl Do Atherogenic 
Risk Factors cause Syndroae %1 
Fernando L. Lapetina, Edward F. Philbin, Paul L. Jenkins, 
Thomas A. Pearson, The Guthrie Clinic, Sayre, PA and K.I. 
Bassett Research Institute, Cooperstown, NY 
Angiographically normal coronary arteries are found in 
a subset of patients with angina; the so-called syndrome 
X. The suggested underlying mechanism, endothelial 
dysfunction, may be caused by established coronary risk 
factors, but these associations have only been examined 
in small groups of patients. To study this, we examined 
the relationship of epidemiologically defined risk 
factors in patients with chest pain symptoms and 
angiographically normal coronaries. Risk factor 
information was collected by self-administered 
questionnaires, review of medical records, and analyses 
of blood samples for serum lipids and lipoproteins. A 
panel of three cardiologist reviewed 1000 consecutive 
coronary arteriograms, defining normal coronaries as 
those with less than 50' stenosis. The resulting 274 
patients (121 males, 153 females) were 8ubgrouped as 
having no chest pain (NO), atypical angina (ATYP) (one or 
fewer anginal symptoms), typical angina (TYP) (two or 
more angina symptoms). After adjusting for age, several 
differences were observed between groups: 
NO 
Hypertension >140/90(%) 19 
Mean LDL Chol_(mg/dl} 118 
Mean Quet.Index(kg/m) 25 
Kales 
ATYP TYP 
**30 
*138 
26 
**51 
*141 
26 
+Family History CAD(') 59 **67 **77 
* P < .05 ** P <.10 
NO 
23 
131 
23 
82 
Females 
ATYP TYP 
26 52 
*153 *151 
*27 *27 
76 86 
There were no differer.ces between chest pain groups in 
HDL Cholesterol, triglycerides, VLDL cholesterol, 
diabetes or smoking. The prevalence of elevated LDL 
cholesterol (>130 mg/dl) and obesity (Quetelet index 
>27:5) was high in patients with typical angina (59\ and 
18% in men; 65% and 46% in women, respectively. 
Chest pain and normal coronary arteries is associated 
with specific coronary risk factors, especially 
hypertension and hypercholesterolemia. If they cause 
endothelial dysfunction, modifications of these risk 
factors may play a role in the treatment of Syndrome X. 
719·5 3:00 
Increased Platelet Activation in Cigarette Smokers in the Framingham 
Offspring Study Demonstrated by Elevated P-Selectin Activity 
Ingo H. Stubbe, Jane Mitchell, Otavio C.E. Gebara, Murray Mittleman, 
Peter Wilson, Daniel Levy, Patrice Sutherland, Travis Matheney, James 
E. Muller, Kenneth A. Ault, Geoffrey H. Tofler. Institute for Prevention 
of Cardiovascular Disease, Deaconess Hospital, Harvard Medical School, 
Boston MA. The Framingham Heart Study, Framingham MA. Maine 
Medical Center Research Institute, South Portland ME. 
Cigarette smoking is associated with an increased risk of thrombotic 
cardiovascular disease but its effect on platelet function remains 
controversial. We assessed platelet activation in whole blood using a 
new flow cytometric method with potential application for population 
screening. The activity of P-Selectin, an adhesive glycoprotein released 
from platelet a-granUles, was measured in fixed blood samples 
(spontaneous activation: ACT -0, and after stimulation with 1 pM 
adenosine diphosphate: ACT-I) using a fluorescent anti-P-Selectin 
antibody. 
Studies were conducted in 806 subjects free of cardiovascular 
disease (382 men, 424 women, age 53.±.9 yrs) from the Framingham 
Offspring Study, of whom 640 (79%) were non-smokers, and 166 (80 
men, 86 women) were cigarette smokers. Values are mean .±.SEM. 
P-selectin ACT-O 
P-selectin ACT-I 
Fibrinogen (mg/dl) 
HDL-chol (mg/dl) 
Non-Smokers ~ ~ 
7.' .±. 0.2 8.6 .±. 0.5 0.001 
14.8.±. 0.4 17 .5.±. 1.1 0.022 
291 .±. 2 314.±. 5 <0.001 
51.0.±. 0.6 47.9.±. 1.2 0.005 
P-Selectin ACT -0 and ACT-I levels were significantly higher in 
smokers compared to non-smokers. Smokers also had higher fibrinogen 
and lower HDL levels, as reported in prior studies. Differences remained 
significant after adjustment for age, gender, and alcohol intake. 
These data indicate that smokers have increased platelet activation 
as assessed by the new method of P-Selectin determination. This 
increase in platelet activation may provide a further explanation for the 
increased risk of thrombotic cardiovascular disease in smokers. 
67A 
68A ABSTRACTS 
719·6 
Utility of the Framingham Risk Factor 
Profile in Predicting Late Events after 
Coronary Angioplasty. 
3:15 
Richard E. Shaw, Nanisoa Ravoninjatovo, Jean 
Chan, Mary C. Murphy, Colman Ryan. San 
Francisco Heart Institute, Seton Medical 
Center, Daly City, CA 
To assess the utility of the Framingham Risk 
Factor profile score in predicting late 
events after intervention in PTS with 
coronary disease, 2,207 consecutive PTS 
having coronary angioplasty between 1984 and 
1988 were studied. PT age, gender, LV 
function, history of diabetes, hypertension, 
smoking status and triglyceride level at the 
time of the initial procedure were used to 
calculate a modified risk factor score. 
Analyses showed that the mean risk factor 
score was significantly higher in PTS who 
died at followup (25.1 vs. 21.4; p<O.OOOl) 
and those having a late myocardial in•
farction (23.2 vs. 21.7; p<0.05). Higher 
risk factor scores were also correlated with 
shorter time to these late cardiac events 
(p<O.Ol). There was no relationship between 
risk factor scores and the need for repeat 
revascularization. These analyses suggest 
. that this modified risk factor score may 
provide information that is valuable in 
predicting late cardiac events for PTS 
undergoing intervention for coronary 
disease. 
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857·26 
Electrocardiographic Evidence of Myocardial 
Preconditioning In Patients Undergoing PTCA. 
Jo Ann S Daugherty, Barbara J Drew, Tony M Chou, Thomas M 
Amidon, Paul G Yock, Thomas A Ports, Christopher L Wolfe. 
University 01 California, San Francisco, CA 
Recent studies indicate that short repetitive episodes of myocardial 
ischemia and reperfusion enhance tolerance to subsequent iSChemic 
episodes, a phenomenon known as preconditioning. To evaluate for a 
potential preconditioning effect during PTCA, ST segment changes were 
measured on continuous 12·lead electrocardiographic recordings 
obtained during 3 repetitive balloon inflations in 10 patients undergoing 
elective PTCA of the LAD (n=4), LCx (n=4) and RCA (11=2). The inflation 
time ranged from 20 to 120 sec (mean 74±34 sec for first inflation). The 
ST segment score, calculated as the sum of the absolute values of ST 
segment deviation in all 12 leads, was measured at constant time intervals 
after onset 01 balloon inflation in each patient. There was a reduction in 
the ST segment score between the first balloon inflation and subsequent 
inflations in 7 of 10 patients studied that was statistically significant in the 
group as a whole: 
Inflation 
ST segment score (mm) 14.4±9.8 10.6±7.9· 10.3±8.0· 
mean±SD; ·p<0.05 vs ST segment score during 1 st inflation, n=10 
There was no relationship batween the duration of 1 st balloon inflation 
and the degree 01 reduction in ST segment score during the subsequent 
balloon inflation (r=O.55, p=NS). 
The reduction in magnitude 01 ST segment deviation during the 2nd and 
3rd balloon inflation suggests that ischemic preconditioning may occur in 
patients undergoing PTCA. 
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857·27 
Iaprov .. ent of Global and Regional Left Ventricular 
Function by Percutaneou. ~ran.luainal COronary 
Angiopla.ty After Myocardial Infarction 
Sinisa Miketic, J6rg Carl.son, AndreaB Kuhn, Ulrich 
Tebbe, Klinikum Lippe-Detmold, Detmold, Germany 
To aBBeBB the impact of percutaneouB tranBluminal 
coronary angioplaBty (PTCA) on left ventricular function 
(LVF) after myocardial infarction (MI) we prospectively 
evaluated patients (pts) with prior MI, poet-infarct 
ischemia (documented by recurrent angina, exercise 
.treBB testing or thallium-201 imaging) and high-grade 
etenosiB with TIMI flow S 2 in the infarct-related artery 
who underwent succesBful PTCA. So far we examined 50 pts 
(40 maleB, 10 femaleB, age 56.4:1: 7.9 years ) with an•
terior wall MI (n-24) or inferior wall MI (n-26). 
Angiographic infarct-region function (expressed aB area 
ejection fraction) and global ejection fraction (EF) was 
measured before PTCA (3.8± 1.9 weeks after MI) and at 
control angiography 5 ± 1 months after PTCA. RestenoBis 
with TIMI <3 flow occured in 16 pts (32\). In n=18 pts 
with anterior wall MI without reBtenoBis the global EF 
inc rea Bed from 54.5' to 67.4\ (p=0.012). The regional EF 
of the infarct area increased from 23.2\ to 38.1\ 
(p=0.017). In n-16 ptB with inferior wall MI without 
restenoBiB the global EF inc rea Bed from 54.6\ to 63.5\ 
(p=0.02). The regional EF of the infarct area increaBed 
from 20.2\ to 26.0\ (~0.02). In n-6 patients with 
anterior wall MI and reBtenosis the global EF did not 
change significantly from 48.3' to 51.0\ as did the 
regional EF of the infarct area. In n=lO ptB with 
inferior wall MI and restenoBiB the global EF decreaBed 
from .52.0\ to 43.6\ (p=0.015). The regional EF of the 
infarct zone decreased not Bignificantly from 19.8\ to 
14.0\. In concluBion, global and regional myocardial 
dysfunction due to poBt-infarct iBchemia significantly 
improveB after succeBsful PTCA of the infarct related 
coronary artery with long-term sUBtained TIMI 3 flow. In 
contraBt, reBtenosiB preventB long-term improvement of 
LVF. Reversible myocardial dYBfunction after MI seems to 
be related to hibernating myocardium. Further follow-up 
will Bhow whether .ucceBBful Re-PTCA in ptB with reBten•
oBiB is able to improve LVF monthB to years after MI. 
857·28 
False Aneurysm of Arterial Puncture Site 
After Coronary Angioplasty: Real Incidence 
and Therapy. 
Edoardo Camenzind, Alain Naimi, Philip Urban, Dominique 
Didier, Vincent Hoang, Damien Metz, Pascal Chatelain, 
Bernhard Meier, Wilhelm Rutishauser, University Hospital, 
Geneva, Switzerland 
Of 527 consecutive patients undergoing coronary angioplasty 
(PTCA), the arterial puncture site of 116 (group A) was 
evaluated prospectively both clinically and by Duplex 
sonography (DS) 24h after sheath removal. The other 411 
patients (group B) were examined clinically after 24h and OS 
was performed only if considered clinically indicated. All false 
aneurysms, defined by DS as a cavity linked to the arterial 
lumen with turbulent color flow pattern and a biphasic flow 
specter on pulsed Doppler analysis, were treated (TT) by 
local, dosed compression guided by color Doppler. 
Disappearance of local pain during guided compression 
proved a good clinical sign of success. 
N False aneurysm n Time of 
clinically 00 mean size by DS success compression 
(em) (min) 
A 116 0 7(6%)2.1x2.9 7717(100%) 16±9 
B 411 15 8(2%) 2.8x3.2 8 7/8(86%) 25±28· 
·[16±101 for successfully obliterated pseudo aneurysms only 
In conclusion, clinical evaluation alone has low sensitivity and 
specificity for the detection of false aneurysms at the arterial 
puncture site. Dosed compression guided by Duplex 
sonography is an effective, non-invasive therapy and an 
alternative to surgery. 
JACC February 1994:1A-484A 
857·29 
Predieton of Blood Loll and Bleeding Complications Mter Angioplasty. 
William B. Hillegass, Brigitta C. Brott, Craig R. Narins, Eric B. Haura, Harry R. 
Phillips, Richard S. Stack, Robert M Califf. Duke Hospital., Durham, NC. 
While blood loss and bleeding complications occur with angioplasty (PTCA) due 
to arterial puncture and anticoagulation, the rates and risk factors for these events 
are not well established. In 438 patients who underwent non-emergency PTCA, 
blood loss was measured with a pre-procedural hematocrit (HeI) and a nadir Het 
within 72 hours post-PTCA. Mean Ret decrease was 4.8±9.2% (95% CI). 
Patients also were followed prospectively for clinical bleeding complications, 
defined as (1) large femoral hematomas with at least >4 em firm hematoma mass 
(n=4I, 9.4±2.7%), (2) other bleeding sites (n=7, 1.6±1.2%), including 
gastrointestinal and retroperitoneal, or transfusions (n=3) for Het decrease 
without an identified bleeding site. Potential bleeding risk factors including age, 
female gender, weight, presenting diagnosis, creatinine, pre-procedura1 heparin 
use, in-lab bepain use, procedure length (Proc Length), sheath size, activated 
clotting times (ACT), and subsequent catheterization, bypass surgery (CABG), or 
repeat PTCA within 72 bours were prospectively collected. Univariate regression 
analysis was done followed by stepwise multivariate regression on significant 
urtivariate predictors. Significant predictors of blood loss and clinical bleeding 
complications during and within 72 bours of PTCA are displayed in the table. 
Predictor Blood Loss (Bet decline) Bleeding Complication 
Univariate Multivariate Univariate Multivariate 
ti' p ti' P ti' P ti' P 
ProcLength 6.52 <.001 6.14 <.001 1.92 0.06 1.63 0.10 
Age 4.92 <.001 3.32 <.001 5.33 <.001 4.60 <.001 
RepeatPTCA 4.64 <.001 4.62 <.001 4.64 <.001 0.50 ns 
Weight 4.51 <.001 2.60 0.011 3.68 <.001 1.46 0.16 
Female 3.66 <.001 2.80 0.005 4.45 <.001 3.26 <.001 
Sheath Size 2.65 0.008 0.71 ns 1.15 ns 
CABG 2.24 0.03 1.45 0.08 2.24 0.03 2.12 0.04 
High ACT 2.12 0.04 0.36 ns 2.93 0.003 2.76 0.004 
lnLabHcparin 1.97 0.05 0.33 ns 0.08 ns 'critical value 
In this population, the individual patient's risk of a bleeding complication can be 
stratified from <5% up to 40%. 
857-30 
Clinical Importance or Preprotedural Renal Dysrunction and Its 
Relation to Procedure-Induced Renal Failure in Patients Undergoing 
PTCA 
Alexandra J. Lansky, Lowell F. Satler. Ya Chien Chuang, Stefan Dosa. Alan J. 
Merritt, Jeffrey J. Popma, Martin B. Leon. Augusto D. Pichard. Kenneth M. 
Kent. and Chester E. Clark. WashinglOn Hospital Center, WashinglOn, DC 
To define the procedural risk in patients with renal dysfunction undergoing 
coronary angioplasty and to determine the effect of baseline renal dysfunction 
on the development of post-procedural acute renal failure, we reviewed the 
clinical course of 1547 patients undergoing balloon or new device coronary 
angioplasty. Acute renal failure (ARF) was defined as 2. 25% increase in 
baseline creatinine (Cr) level. Mild (Cr = 1.5-2.0 mg/d1) baseline renal 
insufficiency was present in 8.2% of patients; moderate-severe (Cr > 2.1 
mgldl) renal insufficiency was present in 3.1 % of patients. 
Baseline Creatinine Level Overall < I.S mg/d1 
Number of Patients 1547 1372 
Age (years)/Ejection Fraction (%) 62/47 61/48 
Diabetes!Hyper!enSion (%) 27/55 26/53 
MajlX' Complications 3.8 3.7 
DeathIMlICABG 1.1,1).812.6 0.8/0.9/2.7 
MinIX' Complications 18 16 
Pulmonary EdemalBalloon Pump 1.7f3.2 1.2/2.7 
Recurrent Chest Pain 21 21 
t p < 0.001 and * p < 0.05 compared with creatinine < 1.5 mg/d1 
~ 1.5 mg/d1 
175 
69t/44t 
39t/68t 
4.6 
3.4tlO.611.7 
28t 
5.7tn.5t 
27* 
Independent risk factors of ARF included advanced age (p<0.005), creatinine 
~ 1.5 mg/d1 (p < 0.05). diabetes (p < 0.05). hypertension (p < 0.05). smoking 
(p < 0.005), baseline and A hematocrit concentrations (p < 0.00 1) and minor 
complications (p < 0.001). We conclude that renal insufficiency 1) increases 
the periprocedural risk of morbidity and mortality in patients undergoing 
coronary angioplasty and 2) is associated with an independent risk of peri•
JI'OCedural acute renal failure. 
ABSTRACTS 
857·31 
Myoglobin and Creatine Kinase MB2 Release After Elective 
Percutaneous Transluminal Coronary Angioplasty 
W. Carter Grinstead, Neal S. Kleiman, Peter Puleo, Denise 
Meyer, Lori Buschmann, Albert E. Raizner. The Methodist 
Hospital/Baylor College of Medicine, Houston, Texas 
Myoglobin (MG) and creatine kinase (CK)-MB2 levels rise 
within 5 hrs of myocardial infarction (MI). However, the 
frequency and importance of MG and CK-MB2 rise after PTCA 
are not well characterized. Therefore, serum MG and CK-MB2 
levels were measured immediately pre and post and every 4 hrs 
for 24 hrs post elective PTCA In 101 patients (pts) aged 
62± 11 yrs (73% males). One hundred thirty-nine lesions 
(ACC/AHA Type A-24%, B1-43%, B2-26%, C-7%) within 113 
vessels (LAO-34%, RCA-33%, CX-29%, graft-4%) were 
dilated. Mean number of inflations, longest inflation, and total 
inflation time were 4.4±2.5, 125±98 sec and 6.1 ±5.6 min, 
respectively for 83 pts not requiring a perfusion balloon. Angina 
and ST-segment changes occurred during PTCA in 60% and 
46% of pts, respectively. MG rose from normal range «33 
ng/ml) to above normal in 15 (15%) pts (mean peak MG 68 
ng/ml; range 33-297). CK-MB2 rose ~0.5 lUll above baseline 
to ~0.7 lUll in 12 (12%) pts (mean peak CK-MB2 5.5 lUll; 
range 0.7-28.5). Five pts had rises in both MG and CK-MB2, 
including the only 3 pts with peak total CK > 120 lUll (range 
127-349). Twelve (12%1 pts had complications either during 
PTCA (4 occlusions, 1 CABG, 2 stents, 1 ventricular fibrillation, 
1 complete AV block, 1 severe dissection) or after PTCA (2 
emergent repeat PTCA): 
N 
Complications 12 
No Complications 89 
Total 101 
MG Rise 
Only 
o 
10 
10 
CK-MB2 
Rise Only 
1 
6 
7 
Rise in 
Both 
5 
o 
5 
No 
Rise 
6 
73 
79 
We conclude that a rise of MG or CK-MB2 after PTCA is 
frequent (1 5 % and 1 2 %, respectively). A rise of either MG or 
CK-MB2 alone is not indicative of a PTCA complication, but a 
rise of both is associated with complications, and usually with 
MI, in every case. Therefore, early determination of MG and 
CK-MB2 early after a complicated PTCA may be a useful 
technique to rapidly diagnose MI. 
857-32 
Exercise Induced ST.segment Depression In Patients 
Without Angiographic Restenosis Following Balloon 
Angioplasty 
*Hajime Kirigaya, Tadanori Aizawa, Ken Ogasawara, Hiroshi Sato, 
Kazuyuki Nagasbima, Akihisa Yabe, Tsuneo Mizogami, Hichiro Abe, 
Hisao Nakamura, Kazuzo Kato. The Cardiovascular Institute, Tokyo, 
Japan. 
To investigate the mechanism responsible for exercise induced ST•
segment depression in patients without angiographic restenosis after 
balloon angioplasty, we studied the vasomotion of coronary arteries 
subjected to balloon angioplasty with use of intracoronary 
acetylcholine(ACH) administtation. Nineteen consecutive pts who had 
successful initial angioplasty of the left anterior descending aneries and 
had no angiographic restenoses (luminal stenosis < 50%) at the 
follow-up study were enrolled in this studr. All pts had had single 
vessel coronary artery disease and had no hIStory of prior myocardial 
infarction. Follow-up angiographies were performed 112±19 days 
after the procedures. Incremental doses of ACH(25,50,lOO~g) were 
injected into the left coronary anery over 1 min., and then 5 mg of 
isosorbide-dinittate(lSDN) was injected into the same anery. Coronary 
anery diameter of the angioplasty-vessels were analyzed quantitatively. 
Exercise test was defmed as positive with ischemic ST-segment 
depression of more than 1 mm. Pts were divided into two groups 
based on the results of exercise tests. Group A consisted of 9 pts with 
a negative exercise test and Group B consisted 'of 10 pts with a 
positive test. The coronary artery diameters after ISDN were similar 
between Group A and B, 2.0±0.3mm and 2.1iO.4mm, respectively. 
However, the diameters after ACH were different between Group A 
and B, 1.5iO.5mm and 0.7iO.4mm, respectively (P<O.OI). Although 
8 of 10 pts in Group B showed severe vasoconstriction(>50% luminal 
narrowing) in response to ACH, only 1 of 9 pts in Group A showed 
severe vasoconstriction (P<O.Ol). Thus, the data suggest that 
abnonnal vasomotion exists in the coronary artery subjected to balloon 
angioplasty even in the absence of restenosis, and that this abnonnality 
of vasomotor tone might playa role for the cause of ST-segment 
depression in exercise tolerance tests. 
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857·33 
How Clinical Event Rates Relate to Angiograpbic Restudy 
Diameter Narrowing After Successful Alllioplasty 
WilJiam S. Weintraub Ziyad M.B. Ghazzal. Henry A. Liberman. 
Douglas C. Morris. Spencer B. King m. Emory University School of 
Medicine. Atlanta GA 
Luminal renarrowing after PTCA occurs to a variable extent. Thus to 
determine the clinical importance of restudy percent diameter s~sis 
("DS) at angiographic restudy after successful PTCA 3322 of 3363 
(99") restudy patients were followed for 6 years for 'clinical events. 
The patients were divided by the most severe recurrent "DS on the 
first followup angiogram: a)<20". b)20-29". c)30-39". d)40-49". 
e)50-50". ~". g)70-79". h)80-99". i)I00". The 1 and 6 
year survival (.99 and .94) did not vary across groups. The freedom 
from myocardial infarction (MI) and coronary surgery (CABG): 
1 1~~~~ 0.9 0.9 
0.8 0.8 
0.7 Freedom 
From MI 
0.7 
0.6 p<.OOOI 0.6 
0.5 0.5 -t--,--,'~"-r--r-""'; 
o 234 5 6 0 1 234 5 6 
The incidence of MI varied little until restudy "OS reached SO" but 
then rose in groups h) "OS 80-99" and i) "DS 1 00" . CABG 
increased consistently with "DS. 6 year freedom from repeat PTCA 
fell from 0.74 for "OS < 19" to 0.11 for "DS 80-99". but rose to 
0.47 for "OS 100". Some events may result in the restudy "DS 
(MI) whereas the restudy "OS may generate other events (CABG or 
PTCA). Cardiovascular events after successful PTCA vary with 
restudy "OS in different and complex ways for each type of event that 
may best be seen using multiple rather than dichotomous definitions of 
restenosis 
857·34 
Do V ..... Size and Balloon/Artery RatIo Intluance ReatanoIla after 
PTCA? 
Eddy Barasch, James M.WUson, James J.Ferguson and the MARCATOR 
INVESTIGATORS. St Luke', Episcopal HoapItaIfThe T8XIII Heart Institute, 
Houston. TX. 
To deI8rmIne whether vvasaI size and the baBoon arteIy ratio (BAR) 
may Inftuence the development 01 restenoaIa following PleA. we I'IIYIewed 
angIographic data from 1434 pIIIIenIa participating In the MARCATOR atudy. 
a rnUtk:arUr b1aI 01 the ACE-InhIbItor cIazaprI for restenoaIa. Minimal 
luminal diameter (MLD). reference v..a size (RVS) and BAR were 
measured pre. post PlCA and 81 eIx months following PleA. The varlablee 
analyzed were: initial gain (post-pre MLD). late loss (post-f/u MLD). net gain 
(f/U-pre MLD). galn/lOSl ratio (lnItIaI galn/late Iosa) and gain ratio (inIIlaI 
gain/net gain). Unear regression anaJysIs 1Ihowed: 1) a strong relationship 
between IntlaI gain and late Iosa; 2) a strong reIatIonshtp between initial gain 
and late gain; 3) no relationship between BAR and net gain, late Iosa, 
galn/lOSllosa ratio or gain ratio; 4) no relationship between RVS and net 
gain. galn/lOSl ratio or gain ratIo.There was a alight relationship of RVS with 
late loss; partial correlation using BAR showed this to be an lluaory 
assoclatlon; 5) A strong relationship between BAR and RVS, with undersized 
baBoons used In large veasels and oversized balloons used In amaH vessels. 
ConcIyslons: 
1.The larger the initial gain, the larger the late loss and the larger the net 
gain. 2.BaII00n artery ratios and reference vessel size do not Inftuence 
restenosIs foIICMlng PleA. 3.HIgher baBoon artery ratlos are not associated 
with more anglographlc Improvement. 
JACC February 1994:1A-484A 
857·35 
Comparison Of Coronary Luminal Area obtained from 
Intracoronary Ultrasound and both Edge Detection (ED) 
and Vldeodensltometrlc M Quantitative Angiography 
following PTCA and DCA. 
Yukio Ozaki, Carto dl Marto, Jose Baptista, David Keane, JOrgen Haase, 
Victor Umans, Plm de Feyter, Jos R.T.C. Roeland!, Patrick W. Serruys. 
Thoraxcenter, Erasmus University, Rotterdam, The Nethertands. 
WhUe the primary role of Intracoronary ultrasound (ICUS) may be the 
Imaging of coronary mural pathology, precise quantifICation of luminal cross 
sectional area (MCSA) would offer a signHicant advantage. The complex 
morphological changes Induced by coronary Interventlonal procedures might 
render luminal quantHication by angiography less reliable. Seventy-one 
patients who underwent successful balloon angioplasty (pTCA, n=57) or 
atherectomy (DCA, n=14) were examined by ICUS, and by both edge 
detection (ED) and vldeodensttometric M quantitative angiography. The 
results of the three quantitative techniques were compared by the mean (± 
standard error) of the signed differences and by linear regression. Mean 
MCSA was 5.18 ± 0.24 min2 derived by ICUS. 3.88 ± 0.28 mrif by ED and 
447 + 027 mm2 by V -
difference p r y SEE 
ICUS· ED + 1.30mm2 <.0001 0.57 0.40 + O.67x " 1.96 
ICUS·V + 0.71 mm2 <.001 0.75 0.15 + O.83x " 1.52 
V • ED + 0.SSmm2 <.01 0.83 1.40 + 0.79>< " 1.28 
"allowln I~ ana Uljl\, ICUS assessment of MCSA IS Sl nificant g g y larger 
than MeSA derived from ED and V. Thrombus formation, Intimal dissection 
and disruption of the Intemal elastic lamina may contribute to unreliable 
luminal quantification following coronary Intervention. Furthennore, 
Introduction of the nose cone of the ultrasound catheter may kself result In 
disruption of fresh thrombus, tacking back of dissections and stretching or 
dilatation of the vessel (Dotter effect). 
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858·36 
Timing of Stent OccluslonlThrombosis After Stent 
Placement 
David R. Holmes. Kirk N. Oman. Robert S. Schwartz, Christopher 
White for the Medtronic Wiktor Stent Investigators, Rochester. MN 
Stents are being used with increasing frequency for the treaunent of 
acute or threatened closure or suboptimal results after conventional 
PTCA. When placed in this setting. stents may themselves develop 
either thrombus or occlusion within the stent. The timing of stent 
thrombosis or occlusion remains poorly defined. Three hundred 
seventy·five patients have been treated with Medtronic Wiktor stents 
for acute or threatened closure or suboptimal results of PI'CA; IS2 in 
the United States and 273 in Europe. Pts being stented in the U.S. had 
a higher incidence of unstable angma prior to stent,a higher incidence 
of vein graft stenosis. and had more stents placed for threatened than 
acute closure than in Europe. Stent occlusion was subsequently 
documented in IS (3.7%) [2.6% in U.S. and 4.S% in Europe]. Stent 
thrombosis with angiographic documentation of thrombus was seen in 
30 (8.0%) [4.6% in U.S. and 10.3% in Europe]. The timing of stent 
occlusion or thrombosis was: 
N 
Tuning 
<24hrs N (%) 
1·9 days N (%) 
>9 days N(%) 
Stent Occlusion 
14 (3.7%) 
8 (2.1) 
S (1.3) 
1 (.04) 
Stent Thrombosis 
30 (8.0%) 
16 (4.2) 
10 (2.6) 
4 (1.2) 
The frequency of complete Slent occlusion after Slent placement for 
treaunent of failed or suboptimal dilatation is low at 3.7%. The 
frequency of stent thrombosis is somewhat higher at 8.0%. For both 
s~nt. occlusion and stent thrombosis. the majority of events occur 
wlthm the first 24 hours. After 9 days. stent occlusion or stent 
thrombosis is very infrequent 
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858·37 
Predkton of ~ After Glanturco-Roubin Coronary Steat 
Deploymeat. AllaIylil of 135 Couecuti\'e 'atieDts From a Single Center 
Nadir M Ali, Richard W. Lowry, CyriJ B. TaW&, JBDe Joseph, Jobn Abukbalil, 
Gary F. Marks, ClcmeDl DeFelice, Neal S. Kleiman, Albert E. Raimer, The 
Methodist Hospital and Baylor College ofMcdiciDc, Hooston TX 
The Gianturco Roubin SleDt (FlcxsIcnt) is a useful adjunct for procedurally 
complicated or suboptimal angioplasty. HO\Ve\'el, RStenosis after Slenting 
diminishes its clinical utility. We aougbt to determine RStenosis pnodictors io 
136 consecutive patients (pts) woo bad FlexstcDt deployed for tbmUcned closure 
(57%), abrupt closure (15%) or RStenosis (27%) from 10189 to 1193. Most pts 
(mean age 59 yrs) were nondiabetic (87%) men (74%) with multi~ disease 
(SO%) admitted for unstable angina (80".4). Pre stent lesions were clwacterized 
as ACCIAHA class B (74%) or C (9%) having thrombus (8%) or dissection 
and/or exIraIuminal contrast (54%) with TIMI flow ~ (22%) and ~ residual 
SIenoSis post PTCA (36%). Symptomatic iscbcmia and/or ST segment changes at 
Slenting occum:d io 23%. Stent diameten were 2.Smm (3S%), 3.Omm (41%), 
3.Smm (18%) and 4.Omm (6%) and were deployed io natM coronary arteries 
(88%) and \'eio grafts (12%). In.hospital e\'eDts occum:d io 17 pts: I death, 10 
MI and 10 thrombosed stents resulting io CABG (7) or repeat PTCA (3). 
Quantitative angiograpbic analysis was done io 113 of the remaining 119 pts 
(96%) 6.S ± 2 mos post SleDting. Minimallwnen diameter (MID io mm ± SO) 
increased from 0.72 ± 0.38 pre PTCA to 2.3 ± 0.48 post stent (acute luminal gain 
1.59 ± O.S) but fell to 1.42 ± 0.77 at 6 DIllS (late loss 0.91 ± 0.74) R.estenosis 
(>SO% diameter SIenoSis) occum:d io 47% pts at 6 mo angiogram. Neither the 
indication for SleDting nor the presence of unstable angina or diabetes affected 
restenosis rates. SimiJarly, angiograpbic variables like lesion class, thrombus, 
dissection, normal anery diameter and MLD post SleDt bad no predictive value. 
When analyzed as continuous variables only larger acute gain (p=.02) and pre 
PTCA MLD (p=.OS) pnodicted lower RStenosis rates. R.estenosis io pts with 2.S 
mm SleDts was 58".4 compared to 41% io pts with~3.0 (p=.1 by chi square). 
Conclusions I) AI:ute luminal gain is an important determinant of restenosis 
following F1exstent deployment 2) Stent diameter ~3.0 mm shows a trend 
toward lower restenosis. Therefore, maximizing initial gain and using larger 
stent sizes, manipulations wbich are technically possible with stents, should 
lower restenosis. 
858·38 
Emergent Stent Placement: Wonse Outcome In the 
Patients with a Recent Myocardial Infarction 
Quinn Capers IV, Clifford N. Thomas, William S. Weintraub, 
Spencer B. King III, John S. Douglas Jr, Neal A Scott. 
Division of Cardiology, Emory University School of 
Medicine, Atlanta, GA. 
Recent studies have shown that patients undergoing 
interventional coronary procedures in the setting of a recent 
myocardial infarction (RMI) have worse clinicel outcomes. 
We reviewed the charts of the first 170 patients (174 stented 
vessels) to receive the Gianturco-Roubin stent at Emory 
University Hospital; 161/174 (93%) for acute or threatened 
closure complicating PTCA Clinical success was defined as 
procedural success in the absence of in-hospital : death, Q•
wave MI, re-PTCA, or emergent CABG. Recent MI was 
defined as a documented MI up to seven (7) days prior to 
receiving the stent. 
Clinical Emergent re-PTCA Death 
Success CABG 
RMI 15129 7129 4/29 2129 
, (52%) (24%) (14%) (7%) 
noRMI 116/145 9/145 121145 7/145 
I (80o,{,) 1(7%) (9%) (5%) 
I pvalue 0.003 0.007 0.09 0.33 
Thus, patients undergoing bailout stenting in the setting of 
a RMI have a significantly higher incidence of clinical 
complications requiring further revascularisation. 
ABSTRACTS 
858·39 
Intracoronary Ultrasound Guidance of Stent Deployment Leads 
to an Increase of Luminal Gain not Discernible by Angiography 
Harald Mudra, Volker Klauss, Rudolf Blasini*, Johannes Rieber, 
Andreas Konig, Michael Kroetz, Karl Theisen. 
Med. Klinik, Klinikum Innenstadt, Univ. of Munich and Med. Klinik 
I, Technical Univ. of Munich*, FRG 
Quantitative coronary angiography (QCA) as a silhouette 
technique is limited in coronary stenting regarding the assessment of 
stent expansion patterns and true luminal dimensions. Since these 
factors may have impact on the clinical results intracoronary 
ultrasound (IVUS) was used for guidance of stent implantation by 
use of a combined imaging balloon catheter. 
Imaging was perfonned with an 3.5F electronical 64-element 
array (20 MHz) mounted proximal to the balloon of the combined 
catheter (Endosonics Corp.). 21 patients (pts) received I to 3 Palmaz•
Schatz stents (ballon diameter 3.0 to 4.0 mm) for treatment of de•
novo or restenoses (n=13) or symptomatic dissections (n=8) in a 
native coronary artery (n=15) or a vein graft (n=6). In 15 pts the 
combined catheter was also used for stent delivery. After each 
balloon inflation of the stented segment, starting with the nominal 
ballon pressure, IVUS and QCA were perfonned. Repeated balloon 
inflations with higher pressure or larger balloon size were carried out 
to gain a minimal stent diameter (MLD) of at least 80% of the 
reference segment diameter as assessed by IVUS. 
Results: No adverse effects occurred. Off·line analysis revealed a 
substantial overestimation of the MLD by QCA vs IVUS both 
initially (2.7±O.3 vs 2.0±0.3 mm, p<O.OI) and for the final result 
(2.9±OA vs 2.5±O.3 mm, p<O.OJ) mainly due to an eccentric luminal 
contour or an incomplete vessel wall attachment. The IVUS guided 
further stent dilation yielded to an increase of the MLD of 25% on 
average. No patient experienced subacute stent closure. 
Conclusion: QCA incurs a substantial overestimation of MLD 
after coronary stenting mainly due to the complex lesion morphology 
and stent vessel wall interaction. IVUS guided stent deployment 
leads to a significant increase of acute luminal gain and thus, should 
have impact on the clinical results. 
858·40 
Re.ult. With Elective Stentlng of the Protected 
Lett M.ln Coronary Artery 
Yaron Almagor, Antonio Coiombo, Luigi Maiello, Boutros Khlat, 
Patrick Hall, Leo Finci. Centro Cuore Columbus, Milano, Italy. 
Repeat CABG is associated with higher surgical risk and 
increased potential of damaging previously placed conduits. 
Results of protected left main angioplasty is not encouraging 
because of increased acute complications and high restenosis 
rate. We report our experience in 17 patients undergoing PTCA 
and subsequent implantation of Palmaz·Schatz coronary stents 
In protected left main coronary arteries (LMCA). The mean 
patient age was 56 years, and there were 16 males. The 
procedures were done electively for symptomatic coronary 
artery disease in all patients. Stenting was performed by 
brachial approach in 4 patients and by femoral approach in 13 
patients. In 12 patients, multiple stents were implanted for 
complex left main lesions. All stents were successfully depioyed. 
Prior to stenting the mean percent diameter stenosis was 
72±11%, and improved to 5±3% foliowing stenting. There were 
no major acute complications. Foliowing discharge, an improved 
stress test result was observed in 15 of 17 patients. Clinical 
foliow·up was available in all patients. Two patients died during 
follow·up. The causes of death were cardiac but not due to 
ciosure of the LMCA stent (emergency angiogram performed). 
Follow·up angiography performed within 6 months 
demonstrated restenosis in 2 of 11 eligible patients (18%). 
Conclusion: Stent implantation in protected LMCA is feasible in 
selected pts and is associated with good clinical and angiographic 
results. 
71A 
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858-41 
Bail-out Coronary Stenting for Failed Balloon 
Angioplasty Using 6 French Guiding Catheters 
Philip Urban, Ber~hard Meier, Damien Metz, Vincent Hoang, 
Edoardo Camenzlnd, Pascal Chatelain, Cardiology Center 
University Hospital, Geneva, Switzerland ' 
~etween July 92 and Augu.st 93, 28.patients underwent attempted 
ball-out PaImaz-Schatz stent ImplantatIOn through a 6 French guiding 
cathe~er after failed coronary angioplasty (9 cases (32%) with 
established abrupt vessel closure, and 19 cases (68%) with dissection 
or threatening closure). The stent(s) were implanted after manual 
crimping o~to the previously used angioplasty. balloon; a single stent 
was .used In 2? cases (79%), a half stent In 2 cases (7%), and 
multIple stents In 4 cases (14%). Mean stent diameter was 3.1 + 0.3 
mm (range 3.0-4.0). Technical implantation success was 26/28 
(93%), an~ none of the patients suffered in-hospital stent thrombosis. 
Three patIents (11 %) had non-Q myocardial infarction (2 because of 
late implantation and 1 due to distal thrombus emboli), and 1 patient 
(3%) with implantation failure underwent bypass surgery. There were 
no ~eath and no Q w~ve myocardial infarction, and no patient 
requITed blood transfUSIOn or surgery for groin complications. Two 
patients had a !emoral pseudoaneurysm, and both could be treated by 
ultrasound-gUided compression. Mean hospital stay duration after 
stent implantation was 6 ± 1 days. 
Stents can safely and effectively be delivered through 6 French 
gu~ding catheters after.failed balloon angioplasty. This may contribute 
to Improved hemostaSIs at the puncture site, and also makes 6 French 
guiding catheters a reasonable choice for a majority of routine 
coronary balloon procedures. 
858-42 
Predicting the Risk of Ischemic Complications After Bail•
out Stenting for Failed Angioplasty 
Damien Metz, Philip Urban, Vincent Hoang, Edoardo Camenzind, 
Pascal Chatelain, Cardiology Center, University Hospital, Geneva, 
Switzerland 
Stent implantation can be a valuable non surgical bail-out procedure 
to treat established or threatening abrupt closure (AC) following 
angioplasty. To identify predictors of in-hospital related ischemic 
events, we analysed clinical, angiographic and procedural variables of 
101 procedures (102 balloon-expandable and 21 self-expanding 
stents) of our single center experience of bail-out stenting for AC 
foHowing 3,041 angioplasty procedures (3.4%). 
Ischemic events occured in 28 patients (18 non Q and 7 Q wave 
myocardial infarctions, 7 coronary bypass operations, and 3 deaths). 
Among 27 evaluated parameters, univariate analysis identified the 
following predictors (odds ratio and 95% confidence intervals) 
1 )TIMI flow<3 prior to stenting 
2)dissection length>20mm 
3)deferred stent implantation 
4)dissection not entirely covered 
5)occluded side branch 
6)multiple stents implantation 
2.6 CI: 1.4-4 
3.6 CI:1.4-9.2 
5.2 CI: 1.7-15.2 
3.3 CI: 1.3-8.3 
10.4 CI:3.1-35 
6.8 CI:3.8-12 
p<O.05 
p<O.OI 
p<0.OO5 
p<0.OO5 
p<O.OOOI 
p<0.0005 
Only the variables 3, 5, and 6 were found to be independant ischemic 
predictors with multivariate analysis. 
Thus, these data suggest that bail-out stenting is less likely to be 
associated with ischemic complications when it is carried out early. A 
poor angiographic ~esult, particularly when multiple stents are used, 
should prompt conSideration of urgent or semi-elective surgery. 
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858-43 
Dilatation Prior to Stent Implantation Predisposes 10 Thrombotic 
Complications 
Joseph F. Mitchel, Michael A. Azrin, Thomas A. Aretz, Francis Kiernan, 
Jeffrey A. Hirst, Adel M. Eldin, David D. Waters, Raymond G. McKay 
Hartford Hospital, University of Connecticut, Hartford, CT 
Intracoronary stent implantation continues to be complicated by acute and 
subacute thrombosis. To determine whether the arterial trauma of balloon 
angioplasty prior to stent placement contributes to this problem, 24 Strecker 
tantulum stents sized 3 to 4 mm were implanted in the left anterior 
descending (LAD) and circumflex (CFX) arteries of 12 anesthesized, non•
atherosclerotic pigs. All animals received 200 U /Kg of heparin before stent 
placement, but no aspirin, dextran, or persantine. Before stent placement, 
a balloon dilation was performed in the LAD of 6 pigs and in the CFX of 
the other 6. Pre-dilation was performed with a balloon-artery ratio of 1.3: I, 
an inflation pressure of 8 atm, and an inflation time of 60 sees. Following 
stent placement, serial coronary angiography was performed at hourly 
intervals. All animals were subsequently sacrificed for post-mortem exam. 
In a subset of 2 pigs, IIlln-labelled platelet deposition at the stented sites 
was quantitated one hour following implantation. 
RESULTS: All stents placed without a preceeding dilatation remained 
patent with normal coronary flow. In the stented arteries with predilatation, 
acute stent closure occurred within I hour in 4 cases and thrombotic filling 
defects occurrred in an additional 2 cases. In each of the cases with stent 
closure at arteriography, complete stent thrombosis with myocardial 
infarction was confirmed at postmortem exam. In the 2 pigs with platelet 
labelling, predilated stent sites contained 64% more platelets than 
nondilated stent sites. 
CONCLUSIONS: Balloon angioplasty prior to stent placement may 
predispose to increased platelet deposition and subsequent thrombotic stent 
complications. This observation may partially explain a higher incidence of 
acute and subacute thrombosis in stents used as "bailout" devices following 
failed coronary angioplasty. 
858-94 
Qualitative Comparison of IntravllKUlar U1trlllOund and Angioscopy With 
Angiograpbic Assessment of Palmaz-Schatz (PS) Coronary StenD 
• Alexander Shaknovich, Scott M Liebennan, Edward M. Kreps, Cenap Undemir 
Jill E. Higgins, Nancy T. Cohen, .Jeffrey W. Moses, Lenox Hill Hospital, NY, NY 
Immediate outcomes of implantations of PS stents in 30pts were evaluated with 
angiOgraphy (ANGlO) and intravascular ultrasound (IVUS) (CIVS, Sunnyvale, 
CAl and/or angioscopy (SCOPE) (Baxter, Irvine, CAl. Results were quaJitatively 
graded as excellent (A), fair (B), and unsatisfactory (C) based on stent size, 
symmetry, and evidence of thrombus and dissection according to the following 
ANGlO, IVUS and SCOPE criteria: stent size was assessed as % stenosis by 
ANGlO and IVUS (A~%, B=>O%, <20%, C=~20";"), and as wall contact by 
SCOPE (A=complete, C-incomplete); sten! symmetry was assessed by the ratio 
of minimaJ stent diameters in 2 orthogonal views by ANGlO and the ratio of 
orthogonal diameters of the IIlIIIOWest stent cross-section by IVUS (A=~.9, 
B=~.7,<0.9, C=<0.7 for bath), and by stent strut crowding by SCOPE (A=none, 
B=minimaI, C=severe); thrombus was graded as abscotlpresent (AlC), and 
dissection as absentlsmal1llarge (AlBIC) by all 3 imaging modalities. Overall 
score was A for ~3As and no Cs; C for any Cs, and B for all other obsetVations. 
ANGlO lOpts IVUS 17pts SCOPE 8pts 
"1><.05 ABC ABC ABC 
Size 8 19 3 0 6 21 7 0 
Symmetry 20 6 0 7 13 7 4 2 1 
Thrombus 29 I 27 0 5 2 
Dissection 26 4 0 27 0 0 6 0 I 
Overall 16 IO 4 4 2 21 5 0 2 
When overall scores by IVUS and ANGlO were compared, they were same in 
7pts, worse by IVUS in ISpts, and better by IVUS in 2pts. Lower overall scores 
by IVUS were clue to smaller stent size and less circular sten! geometry by IVUS. 
When overall scores by SCOPE and ANGlO were compared, they were same in 
Spts, worse by SCOPE in 2pts, and better by SCOPE in Opt. Lower overall scores 
by SCOPE were due to detection of small thrombi by SCOPE. CONCLUSIONS: 
I)IVUS is superior to ANGlO in assessing stent size and geometry immediately 
after implantation, and may serve as a guide for optimizing immediate outcomes 
of PS stents. 2)SCOPE may have a limited role in evaluating immediate outcome 
of PS stenting, primarily in excluding thrombus. 3)Clinical correlation is required 
in order to define proper role for IVUS and SCOPE in conjunction with PS stent. 
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858-95 
STENT SIZING SHOULD MAKE ALLOWANCE FOR BOTH 
INHOMOGENOUS INFLATION AND RECOIL 
David Keane, Yukio Ozaki, Jose Baptista, Carlo di Mario, 
Peter de Jaegere, Patrick W. Serruys. Thoraxcenter, 
Erasmus University, Rotterdam, the Netherlands 
Twenty Gianturco Roubin Flexstents were implanted in 17 
patients for management of primary lesions (n = 2), restenotic 
lesions (n = 6) and bailout alter balloon angioplasty (n = 12). 
All lesions were predilated by balloon (B) angioplasty prior to 
stent (S) deployment. Computerised quantitative coronary 
angiography (CAAS II) was performed on the inflated B 
(infIB) and inflated S (infIS) as well as pre and post Band S 
dilatation. A mean nominal (manufacurer's) stent size of 
.57mm greater than the reference vessel diameter (RVD) was 
selected. Minimal luminal diameter (MLD) of inflB was .31mm 
smaller than mean inflB diameter with an inflB standard 
deviation of .18mm. In contrast, MLD of inflS was .43mm 
smaller than mean inflS diameter and the standard deviation 
of inflS was .21 mm. Elastic recoil of mean diameter post S 
was 27mm while elastic recoil of MLD post S was .40mm. 
RVD S MLD MLD MLD MLD MLD 
(mm) size preB inflB postB inflS postS 
2.96 3.63 1.07 2.85 1.73 3.00 2.60 
Inflation of the Gianturco Roubln stent IS not Un! orm whl ch 
may relate to the interstrut distance and use of a highly 
compliant premounted balloon. Despite a policy of oversizing 
(.57mm > RVD), a residual diameter stenosis of over 10% 
persists. This study supports the recent change in policy from 
matching stent size to vessel size to a policy of oversizing. 
858-96 
A Costing Study of Coronary Slanting in Failed Angioplasty 
Claude Pilon, J. Brendan Foley, Ian M. Penn, Robert loG. Brown. 
Victaia Hospital, London, Ontario, Canada. 
The objective of this study was to determine the cost implication of 
ooronary stenting in acute a threatened acute dosure afta- coronary 
angioplasty and to evaluate the potential cost reduction as compared 
to emergency CABG. 
Procedural, hospitalization and one year follow-up oosts were 
calculated fa 26 consecutive patients in whom coronary stenting was 
used in a situation of acute or threatened acute dosure, where the 
altemative would have been emergency CABG. Acute or threatened 
dosure was defined by: a) TIMI 0-2 flow in a vessel with initial TIMI 
3 flON (n=10), b) long dissection (>15mm) associated with mae 
than 50% residual stenosis, by quantitative coronary angiography 
(n=8), c) complex dissection in a proximal segment with mae than 
50% residual stenosis (n=8). 
Stenting was successful in all 26 patients. Complication rate (Q-wave 
MI n=2, emergency CABG n=2, death n=O) was low. Costs are 
expressed in Canadian dollars. With stenting, the total cost per 
patient was $18,864. Repeat PTCA (10/26) and late CABG (1/26) are 
induded in the castings. The average cost for emergengy CABG alta•
failed angioplasty is $22,959 per patient The use of coronary 
stenting instead of emergency CABG in this group resulted in a cost 
reduction a $4,095 pa- patient. Sensitivity analyses show that if 
~75% a these patients had emergency CABG, the use a coronary 
stenting would still result in cost savings. 
Even when accounting for reinterventions, ooronary stenting results 
in cast savings as compared to emergency CABG. 
ABSTRACTS 
858-97 
Multiple Gianturro-Roubin Stents for Long Dissections 
Causing Acute and Threatened Coronary Artery Oosure 
James B. Henniller, Edward T.A. Fry, Thomas F. Peters, 
Charles M. Orr, James W. Van Tassel, Cass A. Pinkerton, 
St. Vincent Hospital, Indianapolis, IN 
Vessel closure due to angioplasty-induced long, complex 
coronary dissections is associated with a high rate of myocardial 
infarction and bypass surgery (CABO). To examine the efficacy of 
multiple coronary stents for the treatment of abrupt and threatened 
closure, we studied 43 patients (23 male; 20 female; mean age 62) 
who underwent single vessel deployment of contiguous and multiple 
Gianturco-Roubin (OR) stents for long, complex dissections. Over the 
3.5 year study period, 7 patients (pts) had 3 stents inserted and 35 had 
two stents deployed. In one patient, multi-stent deployment failed. In•
hospital outcome and six month clinical follow-up were assessed. 
Results: There were no in-hospital deaths. Multiple stents were 
successfully deployed in 42143 pts. Because of an inadequate acute 
result, elective CABO was perfonned in four Pts' Two others suffered 
subacute stent thrombosis with Q-MI. One of these pts required 
emergent CABO. Three others had non-Q infarcts following the 
procedure. Thus, 77% (33/43) had successful multistent deployment 
without in-hospital moIbidity. Thirty two patients were eligible for six 
month follow-up. Of the 29 undergoing 6-month, relook catheterization, 
58% (17129) had > 50% stenosis at the stent site as assessed by digital 
calipers. Of those with restenosis, none died, 5 had elective CABO, 4 had 
repeat angioplasty, 2 had non-Q infarcts, and 4 developed angina treated 
medically. Those without restenosis, remained event free. 
Conclusion: Multiple OR stents are effective for the acute 
treatment of long dissections causing abrupt and threatened closure. 
Although angiographic restenosis is moderately high, the 6 month 
clinical outcome is encouraging. 
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859-1 
Aneury_ of the A8cen4iD9 '1'boracicr Aozta aDd Arch. 
Burgical "aulta in the CUrrent ara 
Yiannis Chloroyiannis and David A. ott 
St. Luke's Hospital - Texas Heart Institute, Houaton 
TX ' 
Forty-five consecutive operations for aneurysm 
(dissecting or saccular) of the ascending aorta or 
aortic arch were performed in 44 patients. Fourteen 
patients (31.1\) had emergent acute Type A di .. ection. 
Nine (20\) had chronic Type A dissection, eighteen 
(40\) had saccular aneurysms without dissection 
involving the ascending aorta with or without arch 
inVOlvement, and two (4.4\) had saccular aneurysme 
restricted to the aortic arch. Two patients (4.4') 
were referred for emergency redo aneurysm surgery (one 
for thrombosed prosthesis, one for hemolytiC anemia). 
Surgical techniques included either supracoronary 
graft interposition with (nz 8, 17.7\) or without 
(n=14, 31.1\) valve replacement or composite conduit 
interposition with coronary reimplantation (n-19, 
42.2\) or simple patch aortoplasty (n=3,6.6\). 
Moderate to deep hypothermia (18-26°c) was utilized in 
all patients with total circulatory arrest (mean 
10.8+-2.9 min) in 19 (42.2\) and without in 25 (57.8\) 
cases. There were no early deaths (0/29) in patients 
with chronic dissections or saccular nondie.ected 
aneurysms. Four early deaths (4/14,28.6\) occurred in 
patients requiring emergency surgery for acute 
dis.ection. Four late deaths (4/40,10\) were 
unrelated to the aneurysm surgery. Total one year 
actuarial survival was 91\ and five year 84.7\. 
Univariate and multivariate survival analysis 
demonstrated risk factors for early death to include 
acute dissection, coronary artery occlusive disease 
and hypertension (p<0.05). No Significant difference 
in mortality was noted among the various surgical 
techniques. The data demonstrate that surgery for 
saccular or chronic dissection of the ascending aorta 
with or without arch involvement can be performed at 
very low risk. Acute dissection requiring emergency 
repair continues to be a Burgical challange, 
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859-2 
flctorl Associated with Acute Hospital Mortality Following 
a latissimus Dorsi Cardiomyoplasty. 
The Phase II Dynamic Cardiomyoplasty Study Group, Maastricht, the 
Netherlands, and Minneapolis, MN 
A dynamic cardiomyoplasty was performed on 117 pts with dilated 
cardiomyopathy and congestive heart failure(CHF}. Mean EF was 
21t 7%, age 55± 1 0 yrs, and V02 15.4±4.9 ml/kg/min. Seventeen pts 
(15%) died during the initial hospitalization (DEAD) and 1.00.pts 
were discharged for outpatient follow-up (SURVIVOR). A univariate 
logistic regression analysis was performed on 41 variables to 
determine predictors of acute in-hospital mortality. Included were 
demographic, exercise, hemodynamic, drug utilization, and operative 
variables as well as NYHA class. The following variables were found to 
be associated (psO.l) with acute mortality in this analysis. 
12EAD SIIRVIVOR 
No. of patients 17 100 
Anaerobic Threshold (sec) 629±235 996±336 11=0.002 
PVR (dyne'sec/cm5) 274±212 162±99 11=0.004 
Peak METS 3.2± 1.4 4.4± 1.4 11=0.004 
Peak V02 {ml/kg/min} 11.S±4.9 15.9±4.7 II=O.OOS 
ACE inhibitor use 71% 92% 11=0.01 
Pulmonary artery mean {mmHg} 36±16 27±11 p~O.D1 
LV end diastolic pressure {mmHg} 2S± 15 21 ±S p~0.03 
Right atrial pressure {mmHg} S.5±4.S 6.3±3.9 p=0.06 
LV ejection fraction lS±6% 22± 7% 11=0.10 
Pulmonary capillary wedge (mmHg) 23± 1 0 19±9 p=0.10 
Multiple logistic regression analysiS on the above variables defined 
only peak V02 and LV end diastolic pressure as independent risk factors 
for hospital mortality. The exclusion of patients with a peak V02 < '0 
mI/kg/min and an LV end diastolic pressure of >35 mmHg is predicted 
to reduce hospital mortality from 15% to 8.5%. 
In summary, preoperative variables may identify p~tients who 
have a high risk of acute mortality following dynamic cardlomyoplasty. 
Patients with more advanced heart failure as evidenced by low peak 
V02 and high filling pressures should probably be considered for 
transplantation rather than dynamic cardiomyoplasty. 
859-3 
Doppler Echocardlographlc Demonstration of Improved 
Systolic Function After Dynamic CardiomyopJasty. 
Charles D Gottlieb, Jian-Fang Ren, Mariell Jessup, George W 
Lighty Jr, Diana Dimarzio, Kathleen M Leflar, and James D Sink. 
Philadelphia Heart Institute, Philadelphia, PA 
Prospectively evaluated were the effects of a left latissimus 
dorsi cardiomyoplasty (CM) on left ventricular function. Doppler 
echocardiography was performed immediately prior to and at 12 
wks following the CM in 7 patients (5 male and 2 female) with a 
mean age of 59 ± 11 yrs and ejection fraction (EF) of 14 ± 5%. 
The latissimus dorsi were all stimulated at 30 Hz with every other 
cardiac cycle at a voltage of twice the palpation threshold. Left 
ventricular EF was determined by the area-length method from 
the apical views. Stroke volume (SV) and cardiac output (CO) 
were derived from an average of the transvalvular flow velocity 
time integrals and orifice areas at the aortic, mitral, tricuspid, 
and/or pulmonic positions. 
EF (%) 
CO (Umin) 
SV(ml) 
fm:.QM 
14 ± 5 
3.3 ± 0.9 
38 ± 11 
fs2s1:QM 
26 ± 6 
4.1 ± 1.2 
49 ± 11 
~ 
+98% p<0.001 
+24% p<0.002 
+36% p=0.023 
Qualitative improvement in systolic function was most marked 
in the left ventricular posterior wall segments . 
In summary, an improvement in left ventricular systolic 
function was seen at three months after a left latissimus dorsi 
cardiomyoplasty. Whether or not this early hemodynamic 
improvement will translate into prolonged clinical benefit 
requires further investigation. 
JACC February 1994:1A-484A 
859-4 
Surgical Treatments of Non-dissecting Thoracic Aortic 
Aneurysms with Selective Organ Perfusion 
Masaya Kitamura, Akimasa . Hashimoto, Mizuho Imamaki, 
Shigeyuki Aomi, Hitoshi Koyanagi, The Heart Institute of Japan, 
Tokyo Women's Medical College, Tokyo, Japan 
The aim of this study is to evaluate the change of surgical results 
of non-dissecting thoracic aortic aneurysm (TAA) with recent organ 
perfusion techniques. Between January 1970 and June 1993, 208 
patients with TAA were treated surgically. One hundred ten cases 
had ascending TAA (AsA), 37 had arch TAA (ArA) and 61 had 
descending TAA (DsA). Fifty-six of 110 AsA patients showed 
Marfan's syndrome and 102 AsA patients received composite valve 
graft replacement. In AsA group, selective coronary perfusion was 
applied since May 1977. In ArA group, antegrade and retrograde 
cerebral perfusion was introduced in March 1985 and in November 
1990, respectively. In DsA group, low-heparinized left heart bypass 
v\1th lower body perfusion was used from April 1987. All groups 
were divided into two subgroups of before (period I) and after 
(period II) induction of the selective organ perfusion methods. 
Surgical results were compared among subgroups by Kaplan-Meier 
actuarial method. The lO-year actuarial survival was 36.7% in AsA•
I and 72.6% in AsA-II (p<O.Ol). In AsA-II, the 6-year survival 
increased from 76.2% to 97.4% after the introduction of interposed 
coronary graft technique in April 1986 (p<0.05). The 6-year 
survival was 20.0% in ArA-I and 71.6% in ArA-II (p<O.Ol). In 
ArA-II, there was no statistical difference between the 2-year 
survival of the patients v\1th antegrade perfusion (74.5%) and that of 
the patients with retrograde perfusion (70.0%). After DsA 
operation, the 5-year survival was 81.5% in DsA-I and 96.7% in 
DsA-II (p<0.05). We conclude that surgical results of non•
dissecting TAA improved with introduction of the selective organ 
perfusion techniques. 
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860-9 
Morphological Characteristics of Atrial 
aneurysms. A French Multicenter study 
Transesophageal Echocardiography in 
Patients. 
Septal 
Using 
259 
Raymond Roudaut, Marc Marazanof. Christophe 
Tribouilloy. Yvette Bernard. Ariel Cohen. Herve Lardoux. 
Jean F. Bruntz, Marie C. Malergue. Christine Halphen. 
Filiale d'Echocardiographie. Societe Fran~aise de 
Cardiologie. Paris. France. 
Transesophageal echocardiograpby (TEE) is a superior 
imaging technique for the detection of atrial septal 
aneurysm (ASA) during life. Furthermore. a strong 
association between ASA and stroke has recently lead 
many authors to consider ASA as a potential cardiac 
source of embolism. 
Morphological characteristics and main associations of 
ASA were analysed in a large cooperative study based on 
TEE - 259 ASA were studied in 134 men and 125 women 
with a mean age of 59 ±. 15. ASA was restricted to the fossa 
ovalis in 45% and involved the complete atrial septum in 
55%. ASA was protruding in the right atrium in 90% of 
the cases. It appears thin in 81 % of the patients and 
highly mobile in 79%. 
An history of systemic event (EE) was present in 59% of 
the patients. An atrial septal shunt was detected in 61 % of 
the pts. In pts with EE only the mobility of ASA was 
significantly higher than in pts without EE. In 9 cases a 
pulmonary embolism (emb) was associated with arterial 
emb. Furthermore. we reported three cases of paradoxical 
emb. However. the true demontration of a thrombus 
within the ASA is of very rare occurence. 
Conclusion : In pts with ASA and EE both the migration of 
a trombus constituted in situ or moving through the ASA 
may be suspected. 
JACC February 1994:1A-484A 
860·10 
Diagnosis of Patent Foramen Ovale by Contrast Versus Color Doppler 
Using TEE: Relationship to Left Atrial Size 
Jlag Ping Sun. William J. Stewart. Joseph Hanna and James D. Thomas 
Cleveland Clinic Foundation. Cleveland. Ohio 
To examine the diagnostic accuracy of saline contrast (C) and color Doppler 
(0) in the transesophageal echo (lEE) diagnosis of patent foramen ovale 
(PFO) and its relationship to left atrial (LA) size. we reviewed the 1EE 
records of 615 consecutive patients. Methods: All studies with a diagnosis 
ofPFO were reviewed for I) trans-septal contrast passage; 2) presence and 
width ofPFO color jet; 3) presence and width of septal defect by 2D echo; 4) 
size of right and left atria (from transthoracic echo). Results: 74 patients 
(46M/28F. 24 to 89 years. mean 54.0 years) had PFO identified by either 
C (n=62. 84%) or D (n=58. 78%). with 48 (61%) diagnosed by both 
modalities. 49/62 patients were positive by C only with Valsalva maneuver. 
Of the D+ patients. 48 had left-to-right flow. 8 had right-to-left flow. and 
2 had bidirectional flow. With atrial (A) enlargement. sensitivity by C was 
decreased (97% for normal A. 67"'" for enlarged A. p<0.()(J5). while sensi•
tivity ofD improved (58% for normal A. 98"'" for enlarged A. p<0.OO5). All 
patients with negative C studies had evidence for elevated LA pressure. PFO 
was directly visualized by 2D echo in 60 patients (8 I %). withcJoseagreement 
between 2D size of the PFO (x) and the jet width by D (y): y=0.96x + O.l16. 
r=O.88. p<O.OOI.a (y-x)=...{).OJ±O.5 mm (mean±SD). PFO size(y. mm) was 
strongly related to LA size (x. mm): y=O.04x + 2.0. r=O.73. p<0.01. 
Conclusions: 1) C and D are complementary in the diagnosis of PFO; 
2) PFO diagnosis by C is more reliable with normal atrial size, while 
diagnosis by Disenhanced by atrial enlargement; 3) PFO sizeis well assessed 
by either D jet width or 2D measurement; 4) PFO size is strongly and linearly 
related to LA size. 
860·11 
Transesophageal Echocardlographlc Diagnosis of Sinus Venosus 
Atrial Septal Defects. 
Roess D. Pascoe. James B. Seward, Carole A. Wames, Jae K. Oh, A. Jamil 
Tajik. Mayo Cfinic. Rochester, MN. 
Sinus venosus atrial septal defect (SV-ASD) is an uncommon condition in 
aduHs Bnd frequently missed by transthoracic echocardiography due to its 
unusual location. Transesophageal echocardiography (TEE) should be ideally 
suited for diagnosing SV-ASD because of the proximity of the transducer to 
the defect. however the reported experience is small. 
We identified 19 patients(pts) (8 males. mean age 42 yrs, range 10-78 yrs) 
between 1989 and 1992 with a diagnosis of SV-ASD who had undergone 
TEE. Prior transthoracic echo had defined the SV-ASD in only 4/19 pts 
(21%) and it was suspected in 7/19 pts (37%) by Colour Flow imaging. The 
remainder had unexplained right heart chamber dilation which prompted TEE 
examination. The average pulmonary artery systolic pressure by Doppler was 
44 mmHg (range 26-52 mmHg). 
The SV-ASD was visualised in all 19 pts by TEE. the majority of stUdies 
were biplane/multi plane examinations (15/19). The defects ranged in size 
from 0.5 cm to 3.0 cm (average diameter 1.5 cm). Associated findings 
included patent foramen ovale in 3 pts and persistent left superior vena cava 
in another 3 pts. 24 anomalous pulmonary veins (APVs) were visualised in 
17119 pts. The right upper pulmonary vein was the commonest anomaly 
(15/16 pts) followed by the right middle pulmonary vein (8/16 pts). The 
majority of these veins entered the superior vena cava directly (15124 veins) 
or at the cavo-atrial junction (8124 veins). No anomalous left sided pulmonary 
veins were seen. 
Anatomic confirmation of the SV-ASD anatomy was obtained in 15 surgical 
pts. A further 9 APVs (all arising from the right upper lobe) were identified in 
7 pts at surgery. Pre operative cardiac catheterisation was not deemed 
necessary in any pts. 
Conclusions: 1. TEE is accurate for the diagnosis of SV-ASD and should 
be undertaken in any pts with unexplained right heart dilatation. 
2. TEE can exclude left sided APVs but may miss APVs from the right upper 
lobe. 
3. Diagnostic cardiac catheterisation is not reQuired pre-operatively. 
ABSTRACTS 
860·12 
Value of Transesopbageal Echocardiography in the Evaluation 
of Persbtent Hypoxemia in an lCU Setting 
Michele Nanna, Antonio Palma, Jiajia Wu, Joshua Luce, Philip 
Rogers, Mark Goldberger, AECOM-Montefiore Medical Center, 
Bronx, NY 
Arterial hypoxemia (HPO) can result from a number of 
pathophysiologic mechanisms which may occur singly or in 
combination. We tested the value of ttansesophagea1 
echocardiography (TEE) in identifying the etiology of persistent 
HPO in an intensive care unit (ICU) setting. 54 consecutive 
patients (pts) with unexplained, and persistent (> 48 hrs) Pa02 
< 70mmHg were studied. Mono and biplane images were 
obtained using Hewlett Packard or Acuson equipment. A right 
sided contrast study (CS) using I. V. peripheral injection of 
agitated saline was obtained in all pts. In 18 pts no discemable 
cardiac etiology or contributing cause could be identified. In 9 
patients severe LV dysfunction (5 pts) andlor severe mitral 
insufficiency (7 pts) was identified. In 24 pts right sided chamber 
dilatation was noted along with tricuspid regurgitation and 
pulmonary hypertension (65±12mmHg) (m±SD). 15 of these 24 
pts showed evidence of R to L shunt by CS. The remaining 3 pts 
without evidence of right sided dilatation also showed evidence of 
R to L shunt. Of all pts with evidence of interatrial shunt, 14 pts 
had a morphologic type secundum atrial septal defect (2) or patent 
foramen ovale (12) and 4 pts had an atrial septal aneurysm and 
fenestrated septum. 
Conclusion: In ICU pts with persistent arterial hypoxemia, TEE 
is a useful technique for identifying the presence or combination 
of different pathophysiologic mechanisms. 
860·13 
Redundant Loops of Cbordae Tendineae: A New Potential 
Cardiac Source of Embolism Detected by Transesopbageal 
Echocardiograpby 
Scott L. Roth, Gary H. Friedman, Monty M. Bodenheimer. Harris 
Chasanoff Heart Institute, Long Island Jewish Medical Center, New 
Hyde Park, New York 
Transesophagea1 Echocardiography (TEE) is widely employed in the 
diagnosis of suspected cardiac source of embolism (CSOE). TEE 
flDdings which have been associated with potential CSOE have 
included: atrial thrombus, left ventricular thrombus, spontaneous echo 
contrast, patent foramen ovale, atrial septal aneurysm, and aortic 
atheroma. Several previous studies have also included mitral valve 
prolapse (MVP), with a weak association. Patients without any of the 
above fIDdings on TEE are considered to have a "low risk" TEE by 
many investigators. We have noted an interesting flDding in this group 
of patients with suspected CSOE and a "low risk" TEE. This fIDding 
consists of a redundant loop (or multiple loops) of mitral chordae 
tendineae. with no evidence of MVP (either by TEE or transthoracic 
echo), normal sized left atrium, and no significant mitral insufficiency. 
Of 72 consecutive patients examined by TEE for suspected CSOE at 
our institution, 28 patients (39 %) had a positive fIDding consistent with 
"high risk". 44 patients (61 %) were considered "low risk". Of these 
44 patients, 10 (23%) had one or more redundant loops of chordae. 
Thus. a significant percentage of patients referred for suspected CSOE. 
with no "high risk" positive fIDdings. were found to have redundant 
loop(s) of chordae. This finding has not been noted in any of our 
patients refelTed for diagnoses other than suspected CSOE. These 
redundant loops of chordae could serve as a nidus for the formation of 
platelet fibrin thrombi. thus providing a potential mechanism to explain 
the association with suspected CSOE. 
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860·14 
ADatomy 01 the Normal Left Atrial Appendage: A Quutltallve Study 
01 Age.Related Cbanges ID 500 Autopsy Hearts, witb 
Echocardiographic ImpUcatioll5 
"John P. Veinot, PhillipJ. Harrity, FedericoGenIile, KentR. Bailey, 
Jeffrey T. Eickholt, Bijoy K.. Khandberia. William D. Edwards, from the 
Division of AnaIomical PaIbology, Divisioo of Cardiovascular Diseases, 
Section of BiOSlatics, Mayo Clinic, RochesIer, MN. 
Tran~ edIocanIiography (TEE) is the modality of ehoice for 
imaging the left IIIriaJ appendage (LAA). No previous study bas defined 
morpho1ogic fcalUres of the LAA, such as size and lobes. 
Five bWldred oorma1l1111OpSy hearts w= reviewed (from 25 ma1es and 25' 
females from each decade, for ten decades). LAA length, width, orifice 
size, number of 1obes, and pectinate muscle size (< or ~ 1 mm) were 
recorded. Two-segment regression models,1inear from age zero to 20, and 
linear with a different s\ope from age 20 ooward, were fit with a variety of 
assumptions regarding equality betwoc:n genders. Models were aeleclcd by 
testing significance of additional terms in nested models. Gender 
differences were also assessed assuming equal growth or aging slopes for 
males and females. Number of 10bes was compared between genders by 
the rank-sum test, and regressed against age. 
Alllhree dimensions increased up 10 age 20 in both genders. Rates were 
. 024, .041, and .030 em/year for orifice size, length. and width respectively 
(p<.000 1). Rates of increase were significantly different between genders 
only for length; males have a signiflCllltly greater raIC (p=.0065). After 
age 20. in males only. orifice size, length. and width increased (.0026 
cm/year, p=.0003). decreased (.0072 cm/year, p=.0002) and increased 
(.0037 em{year. p=.0061), respectively. Assuming equal mtes of change 
between genders, there were gender differences in mean orifICe size (M > 
F. age > 20 •. 085 em, JIE.0055),1ength (M> F. age < 20 • .23 cm. p=.016). 
and width (M > F, age > 20 • .16 em. JIE.OO46). Fifty-five percent of LAA 
had two lobes (range 1-4), with no age or gendez differences. Sixty-nine 
percent of pectinate muscles smaUer 1han 1 mm were seen in the tint and 
last decades and only accounted for 2.6% of cases. 
Age and gender-related differences in LAA dimension and lobaIion exist 
These differences and the existence of muItilobed appendages with lobes in 
different 3-dimensional planes,lIOIlIC having prominent pectinate muscles, 
are important in the accuraIe evaIuaIion of the LAA by TEE. 
860-15 
The OMwmllllnta of Atrial Thlckneal end thickening: A 
TrellHlOp/lligeal EChocerdiogrephy Study 
Anthony C. Pearson, Ruiqlang Guo, Peter Gray, Mary Alton, DavId A. 
Orslnelli, The Ohio State University, Columbus, Ohio 
The factors which detennlne atrial wall thickness and function are 
unknown but may be important detennlnants of the overall cardiac 
response to pathologic or physiologic stress. in order to establish the 
detennlnants of atrial wall thickness (AST) and function we measured the 
atrial septum In a longitudinal plane during routine biplane transesophageal 
echocardlography In 103 patients (53 male, 50 female, aged 19-84 years, 
mean 56:1: 17 years) 48 of whom were hypertensive. AST did not 
significantly change between the end of ventricular systole (AST -T) and the 
peak of the p wave (ASTp) (7.2:1:2.8 mm to 7.1 :1:2.5 mm) respectively but 
significantly (p<O.OOI) Increased after atrial contraction (ASTO) to 9.7:1:3.5 
mm. Atrial thickening fraction (A TF) as a measure of atrial contractUIty was 
defined as (ASTO-ASTp)/ASTp and averaged 38:1:21% (range 1-104%). 
Relative AST (AST-T /left atrial diameter) averaged 0.23:1:0.012. ASTO and 
ASTp were significantly positively related to age (r=0.37, p<O.OOOl, 
r=0.37, p<O.OOOI respectively) but not to body slze,systollc or diastolic 
blood pressure, heart rate or left atrial size. Patients with a history of 
hypertension had significantly graater AST -T than those without 
hypertension (8.6:1:3.2 mm vs 5.9:1:1.7 mm, p<O.OOOl). Neither age nor 
history of hypertension had any association with ATF. Relative AST was 
significantly greater In hypertensives than nonnotensives (2.7:1: 1.4 vs 
2.0:1:0.07 mm, p<0.OO5). 
CONCLUSIONS: We conctude atrial wall thickness Is significantly 
increased with both aging and hypertension. Increased atrial thickness 
may serve to maintain systolic atrial function In the presence of Increased 
atrial afterioad associated with diastolic dysfunction. 
JACC February 1994:1A-484A 
860-16 
Quantification of Left Atrial Spontaneous Echo Contrast Using A New 
Approach of Integrated Backscatter 
Allan L. Klein, Richard A. Grimm, R. Daniel Murray, Annitta J. 
Morehead. Ian W. Black. Alwyn D'SA. Andreas Meyer, William J. 
Stewart, James D. Thomas, Cleveland Clinic Foundation, Cleveland, OH 
Spontaneous echo contrast (smoke) is dynamic smoke-like echos within 
the left atrium (LA) that is associated with embolic events. Assessment of 
the severity of smoke has been limited because the grading has been 
subjective and may be affected by gain settings. To develop a quantitative 
analysis of smoke, we used a prototype densitometry package to measure 
integrated backscatter (lBS) from the LA in 17 patients (mean age 62 ± 9 
yrs) undergoing transesophageal echo (TEE). Patients were divided into 
no smoke (n=3), mild smoke (n=7) and severe smoke (n=7) groups. 
based on a qual itative assessment. An independent observer measured the 
peak intensity (decibels; dB) and cyclic variation of the ms of the LA 
cavity and the LV cavity and interatrial septum (lAS) as reference 
markers. under normal transmit and high transmit settings. Data is 
presented as mean ± SO . 
NORMAL TRANSMIT HIGH TRANSMIT 
Peak Intensity (decibels) Peak Intensity (decibels) 
n J.A.. LY.. 1M I.A LV lAS 
NONE 3 7±0.4 6±0.4 40±2.2 8±1.7 6±1.3 41±1.0 
MILD 7 16±7.2 10±3.8 42±1.3 19±.4.1 1l±.2.S 42±.0.7 
SEVERE 7 21±.6.1 9±.2.6 41±.2.3 26±.S.0 1O±.3.8 42±.1.6 
P value 0.017 NS NS 0.001 NS NS 
ms of mild LA smoke was 7dB (1.6x) higher than the LV cavity, while it 
was 13 dB (2.4x) higher for the severe smoke group. High transmit 
tended to increase the ms of mild and severe LA smoke (p = 0.10). 
Cyclic variation did not differ in the smoke groups compared to normals. 
Conclusions: I) Integrated backscatter by TEE can quantify LA smoke, 
which correlates well with mild (7 decibels > LV) and severe (13 decibels 
> LV) qualitative assessments. 2) ms can be used to provide an objective 
measure of LA smoke which may be used to define embolic risk. 
860-17 
Direct Validation of the "Stasis Hypothesis" of 
Cardioembolism During Atrial Fibrillation or Flutter 
Bruce K. Shively, Erika A. Smith, Michael H. Crawford, 
University of New Mexico and VA Medical Center, 
Albuquerque, New Mexico 
Only indirect evidence favors the hypothesis that 
left atrial (LA) stasis causes cardioembolic stroke 
during atrial fibrillation/flutter (AF). To directly 
test this hypothesis, we performed transesophageal 
echocardiography (TEE) on 60 patients (pts) with AF of 
diverse etiologies. Blood flow velocity was .measured 
by pulsed wave Doppler in the posterior left atrium 
and appendage, mitral regurgitation was quantitated by 
color Doppler and the presence of pseudo contrast was 
noted. Recent cerebral ischemic events (elE) were 
documented during AF in 16 pts. 
eIE were related to the maximum diastolic 
posterior LA velocity: 
velocity (cm/sec) li % with eIE % 
< 10 15 47 
10-20 27 19 
20-25 13 11 
> 25 5 a 
(chi square p<.05) 
with MR > 2+ 
7 
19 
38 
100 
Only one pt of 20 with >2+ mitral regurgitation 
had eIE (p<.03. CIE occurred in 52% of pts with LA 
pseudocontrast and only 9% of pts without 
pseudocontrast (p<. 001). Similar trends for 
pseudocontrast and velocity were observed in the 
atrial appendage. 
These data show: 1) eIE during AF is associated 
with LA stasis, 2) CIE is unusual when posterior LA 
or appendage velocity is > 25cm/sec, and when MR is 
> 2+. LA velocity measurement can supplement LA 
pseudocontrast for identifying patients at risk for 
cardioembolism during AF. 
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861·52 
Powerful Prolnostic Value of Troponin T And C·Reactive Protein In 
Patients With Unstable Anlina 
Antonio G. Rebuzzi, Giovanna Liuzza, ·Edoardo Menini, ··Rita Grillo, 
Luigi M.Biasucci, fMaria A. Pala, §Nadia Aspromonte, §§Gabriele 
M.Giorgi, and Attilio Maseri 
Istituto di Cardiologia, ·Chimica Clinica, and ··Patologia Generale of 
Catholic Univenity, Rome; §Divisione Cardiologia, Ospedale S. Spirito, 
Rome; §§Divisione Medicina, Ospedale Civile Frascati. (ITALy) 
Troponin T (1T) is a highly sensitive and specific marker of myocardial•
cell injury. C·reactive protein (CRP) is an acute phase reactant that is 
elevated in case of acute coronary syndromes. 
Aim of the study was to assess the prognostic significance of IT and CRP 
plasma levels in a multicentric study, which recruited so far 66 patients 
(pts) with unstable angina (UA) without any evidence of previous 
myocardial infarction. Blood samples were taken immediately on admission 
to the hospital (To) and after 48 houn (T48). Patients were followed for 3 
months. 
Results: 10/66 pts (15%) had elevated IT values on admission (mean 
0.27, range 0.24-0.43 Ilg/l) [normal values <0.2 Ilg/l]. 5/10 (50%) pts with 
elevated IT developed myocardial infarction (MI), whereas only 3/56 pts 
(5%) with normal IT values on admission developed MI 
(p<O.OO I).Sensitivity of elevated IT level for MI was 62% and specificity 
91 % (positive predictive value=62%; negative predictive value=94%). 
CRP on admission was elevated in 55% ofpts(mean 17.2, range 3.1-82.5 
mgtl) [normal values <3mg/l]; 33% of pts with elevated CRP had MI. No 
pt with nomlal CRP value had MI. Sensitivity of elevated CRP for Ml was 
100% and specificity 54% (positive predictive value=33%; negative 
predictive value=IOO%). 
No significant difference was shown between the values of IT and CRP at 
To and T48 · 
In conclusion: our data suggest that IT and CRP provide a powerful 
prediction of risk ofMI in pts with UA without evidence of previous MI. 
861·53 
Development and Characterisation of an Improved Rapid Enzyme Immuno 
Assay Specific for Cardiac Troponin T 
Hugo A. Katus, Margit Miiller-Bard0rf, Klaus Hallermayr, Anneli .. e Borgya, 
Josef Maier, Fritz Mattusch, Andre .... Remppis, Thomas Scheffoid, Inllere 
Medizin III, University of Heidelberg and Boehringer Mannheim, Tutzing, FR•
Gennany 
The assay for cardiac rrojJcmin T (TilT) h{u improved thi' efficiency of 
diagnostic methods for thl~ deteCTion of myocanlial cell injury. However the 
quantitative measuremem,\' by thl' availabi(' te,\"t kit Illki~S 90 minutl'o\' alld the 
assay may give faLre posilive result.\" ill pal;ems with extremely severl' skletal 
muscle i"juIY. The goal of thi! pri~.\"ent work was to develop a rapid test system 
with essentially liD cross-reactivity. 
Out of 110 positive hybridomax 5 cell lilli',Ii secreting cardimpecific 
monoclonal amibodil~S (MAB) were si'lected. The affinity of the MABs and thl~ir 
utility for a sandwich assay was assessed ill a BiaCore l)'.\'tem. AccordillX to the 
predefined specificity, affinity, and epitop" bindilll: two MABs w,'re finally 
choosen. The first cardimpecific IIM7 MAB was labelled with biotin, the 
second cardio-specific I M7 MAB was conju/iatl'fi with peroxidase. These MABs 
were employed in a streptavidilJ micrOliter plme assay. The tum around timl~ of 
this assay war J 5 minUles wirh a sellsitil'ity of O. J IJ.gIL alld a variation 
coefficiem 0/5% ell IIJ.XIL. There was no cross-reactivity eithi'r by resting with 
skeletal muscle homogenates or purified sk('/etai muscle Tn T. In 48 serum 
samples of healthy volunteers after strenuous physical exercise (CK: 80-36.000 
lUlL, normal: 70 lUlL) mill 39 serum somples of patiellls with skeletal musele 
injuries (CK: 700-34.000 lUlL. n01,,/(/I: 701UlL) no false posiri\'(' r"sulrs w("re 
observed. /11 27 paricJllfs WiTh llCUle myocardial infarcrion the releas() killeric.\' 
and serum cOllcemrmiol1s observed by this (l\'.Wy ,.e.\·emhLe rhl'st' obll/;lIed by rhe 
TilT test kit. 
Thus a rapid and specific qUtllllilllliw' TnT assay has beell developed 
elimiliaTinR the limirfllioll.\" of the avaiLuhle TnT reST kir while mailllaillill~ ;1.\" high 
sensitivity. 
ABSTRACTS 
861·54 
Association between spontaneous coronary 
reperfuslon and altered haemostatlc activity In 
patients with acute myocardial Infarction 
Agha W Haider, Felicita Andreotti, David Hackett, Dimitri 
Tousoulis, Attilio Maserl, Graham J Davies. Department of 
Cardiology, Hammersmith Hospital, London, UK 
The association between spontaneous intermittent 
coronary reperfusion and endogenous haemostatic activity 
was investigated in 35 patients with acute myocardial 
infarction of less than 6 hours' duration_ Spontaneous 
intermittent reperfusion was defined at continuous ECG 
monitoring as ~2 episodes of transient resolution of 
elevated ST segment lasting ~1 min. Peripheral venous 
blood samples were taken before the administration of 
thrombolytic treatment. Haemostatic changes in blood 
were assessed by measuring the plasma concentration of 
t-PA antigen, prothrombin fragment F1 +2 and soluble 
fibrin. Spontaneous intermittent reperfusion in the first 
hours after admission was seen in 51.4 % (18/35) of 
patients and absent in 48.6%. Patients with intermittent 
reperfusion had significantly lower mean (± SEM) plasma 
t-PA antigen {16.8 (± 2.7) versus 28.7 ± (3.3) ug/L, 
p<O.008}, but higher prothrombin fragment F1 +2 {5.56 
(±2.06) versus 1.15 (±O.12) nmolll, p<O.002} and fibrin 
monomer {70.7 (±7.95) versus 43_2(±7.38} nmolll, 
p<O.007} compared to patients without coronary 
reperfusion. The results indicate that, in patients with acute 
myocardial infarction, spontaneous coronary reperfusion is 
associated with altered haemostatic activity. This may 
influence spontaneous reperfusion and re occlusion of 
infarct related coronary artery in these patients. 
861·55 
Elevated Troponin-T Levels in Relation to the ECG as an Indicator 
of Myocardial Damage in Unstable Angina. 
Jozef PMC Gorgels, Bob Van Vlies, Mark JW Koelemay. Andries J 
Bakker. Jan P Tijssen, Frans OM Haagen. Academic Medical Center. 
Amsterdam and KCL and MCL. Leeuwarden. the Netherlands. 
Assays for Troponin T have been reported to be elevated in a high 
percentage of patients with unstable angina (UA), which appears to 
be associated with a higher risk for subsequent major cardiac events. 
In order to assess the significance of the release of Troponin T (TnT) 
in VA, we studied the association of elevated marker levels with 
ECG changes at admission in 102 patients with VA and normal CK•
MB activity levels. 
During the first 24 hours TnT was elevated in 44 patients (43%). 
Baseline characteristics in patients with elevated TnT levels were not 
significantly different from those with normal levels. At admission. 
50 patients (49%) had a normal ECG, in 29 (28%) the ECG was 
inconclusive. and in 23 (23%) ST -changes suggestive for ischemia 
were observed. Association of elevated levels with ECG changes is 
given in the following table (nr elevated/nr pts (percentage»: 
ECG normal inconclusive ischemic 
TnT 17/50 (34%) 13/29 (45%) 14/23 (61%) 
Ischemic vs. normal: significantly different. P<0.05. 
We conclude that TnT elevations occur more frequently in patients 
with signs of ongoing ischemia at admission. despite negative CK•
Mil-activity. This may indicate more serious cardiac disease. Our 
observation contributes to the hypothesis that in some patients with 
VA cardiac myocyte damage occun during ischemia. 
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861·56 
Timing of Coronary Reperfusion Using Serial Determinations of 
Plasma Myoglobin in Early Evolving Myocardial Infarction 
Felix Perez-Villa, Pierre Theroux, B. Charles Solymoss, Rosa-Maria 
Lid6n, Pierre de Guise, Eva Wesolowska, Montreal, Canada 
Reperfusion therapy accelerates the plasma release of cardiac 
enzymes. In this study, we correlated enzyme elevation to coronary 
artery patency, determined by serial opacification of the culprit 
coronary lesion from 60 to 120 min after the initiation of thrombolytic 
therapy in 36 myocardial infarction pts. Coronary angioplasty was 
performed in 7 pts with persistent occluded arteries. Plasma creatine 
kinase activity (enzymatic method) and mass of creatine kinase-MB, 
troponin T and myoglobin (all three by immunoassay) were 
determined every 30 min for 150 min and every 4 h thereafter, until 
36 h. Thrombolysis was started 2.3 ±0.8 h (0.9-4 h) after onset of 
pain and all pts had, at that time, normal plasma values for the 4 
enzymes studied. 
All pts had an early and rapid increase in myoglobin following 
reperfusion and this increase was independent of the time elapsed 
from onset of pain to thrombolysis and from thrombolysis to 
reperfusion. The time from reperfusion to 1.5-fold increase was 
0.5±0.3 h for myoglobin, 0.7±0.5 h for creatine kinase-MB, 
1.5 ± 1.3 for creatine kinase and 1.7 ± 1.2 for troponin T. The rate of 
increase of myoglobin (plasma concentration 30± 13 min after 
reperfusionlbefore reperfusion) was significantly higher than that of 
creatine kinase, creatine kinase-MB and troponin T (p < 0.01). 
Thus, changes observed in myoglobin plasma levels can help to 
determine rapidly and noninvasively the success of thrombolysis in pts 
treated within 4 h after onset of myocardial infarction. 
861·57 
Troponin T r.1.... •• • Specific Mark.r of 
•• r1y Reperfu.ion aft.r Thrombo1y.ia in 
Acute Myoc.rdi.1 Inf.rction 
M.C. Iliou, M. Paris, G. Bayet, T. Lavergne, T 
Laperche*, J.L. Guermonprez, L. Guize. Department 
of Cardiology, Broussais Hospital. Beaujon 
Hospital*. Paris. France. 
Troponin T (TnT) is a specific cardiac 
antigen, used for assessing myocardial cells 
damage. The aim of this study was to assess the 
predictive value of TnT release for early 
reperfusion of acute myocardial infarction (AMI). 
Twenty consecutive patients (pts) presented 
within 6 hours after the onset of pain received 
intravenous (IV) thrombolytic therapy. TnT serum 
levels were determined with an immunologic method 
at TO, T60, T90, T120, T180 and T360 minutes 
after thrombolytic therapy. TnT release was 
considered effective if serum level ~ 0.2 ~g/L. 
All patients had coronary angiogram at 90 min. 
Infarct-related artery (IRA) patency was graded 
using the TIMI SCore. At TO, all patients had TnT 
value under 0.05 ~g/L. 
TnT Release 
TIMI 0-1 
TIMI 2 
TIMI 3 
(nb of pts) T60 
o 
3 
7 
T90 
o 
2 
3 
T120 
o 
1 
o 
T>180 
4 
o 
o 
TnT release at 90 min had a sensitivity 93%, 
specificity 100%, positive predictive value (PV) 
100% and negative PV 80% for IRA patency. 
Conclusions: 1/ Early TnT release was 
associated with high TIMI grade. 2/ No patient 
with persistent occluded IRA had TnT release 
before 120 minutes. 3/ TnT release at 90 min is a 
specific non invasive marker for early 
reperfusion after IV thrombolysis in AMI. 
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861·58 
Similar Sensitivities of Cardiac Troponin I and MB 
Creatine Kinase for Detection of Acute Myocardial 
Infarction 
Jesse E. Adams, *Jack H. Ladenson, and Allan S. Jaffe, 
Washington University, St. Louis, MO. 
The cardiac form of the regulatory protein troponin I (cTnl) is 
highly specific for myocardium. Thus, elevations do not occur in 
patients with skeletal muscle injury even if MB creatine kinase (MB 
CK) is elevated. However, whether ern! is as sensitive for the 
detection of acute myocardial injury as MBCK has not been defined. 
Accordingly, we prospectively evaluated MBCK and cTn! values in 
199 consecutive patients admitted to the coronary care unit at Barnes 
Hospital. Most patients (n=188) were admitted for evaluation of 
possible acute myocardial ischemia. Eleven were admitted due to 
hemodynamic instability associated with complex medical problems 
and these 11 were excluded from analysis. Total CK activity was 
determined by a kinetic enzymatic assay, and MBCK and cTnl mass 
were determined by immunoabsorbant assays using specific 
monoclonal antibodies. Of the 188 patients admitted with a suspicion 
of acute myocardial ischemia, 89 were diagnosed as having an acute 
myocardial infarction based on a rising and falling pattern of MBCK. 
Eighty-six had elevations of cTnl as well (concordance =96.6%), 
while 3 did not. One of these patients had a single sample obtained 
prior to urgent surgery, and 2 had only minor increases in MBCK of 
uncertain etiology. Five patients with unstable angina prior to admis•
sion had elevated levels of cTn!, a marker that persists in plasma, but 
not MBCK. These data document that elevations of cTn! have 
comparable sensitivity for the detection of acute myocardial injury to 
those of MBCK. The comparable acute sensitivity to MBCK 
combined with the previously documented superior specificity sup•
pon the use of cTnl to diagnose or to exclude the diagnosis of acute 
myocardial infarction in patients with chest discomfon. 
861·59 
Myoglobin Detects Acut. Myocardial Infarction More Rapidly Than 
Creatine Kin ... ·MB or Troponin·T Irrespective of D.y 
Electrocardiogram Diagnolil 
Paul A. Kelly, Paul Walker, Penelope S. Astridge, Adel A. Ismail, 
John I. Wilson and E. John Perrins. Pinderfields General Hospital, 
Wakefield and General Infirm.ry at Leeds, leeds, UK 
The benefits of thrombolytic therapy are greatest when it is given as 
soon as possible after the onset of symptoms of acute myocardial 
infarction (AMII. Cenain patients with AMI who have been shown to 
benefit from thrombolysis have In electrocardiogram (ECGI at the time 
of admission which is non-diagnostic of AMI. 
To investigate any difference in the mean time taken to diagnose AMI 
by a number of biochemical markers we studied 88 patients (62 males, 
mean age 63.4 years) admitted consecutively to a coronary care unit 
with symptoms suggestive of AMI. All patients had a diagnosis of AMI 
proven on the third day after admission by recognised (WHOI criteria. 
Blood samples and 12-lead ECG recordings were taken on admission, 
at 2 hourly intervals until 12 hours after symptom onset, and on days 2 
and 3. Biochemical analysis was performed on stored serum samples and 
ECG analysis was performed independently of all other data. Diagnostic 
cut-off levels for the 3 markers (myoglobin 2: 1 00 poll, creatine kinase•
MB 2:20 UII and troponin-T 2:0.20 ng/mll and for ECG (standard ECG 
criterial were determined prior to commencing the study. Patients were 
divided into 2 groups: Group l-Day 1 ECG diagnostic of AMI (n=50), 
Group 2-Day 1 ECG not diagnostic of AMI (n=38). 
fImIIll Time to diagnosis Ifter symptom onset (hours) (Mean ± S.E.M.I 
Myoglobin CK-MB Troponil-T 
Group 1 4.56 ± 0.31· 5.68 ± 0.34 5.58±0.35 
Group 2 4.03 ± 0.40· 6.18 ± 0.52 6.00±O.OO 
·p<0.05 for myoglobin compared to CK-MB or troponin-T 
Conclusions 
For all patients presenting with AMI, and especially in those without 
diagnostic ECG changes soon after the onset of symptoms, myoglobin 
detects infarction significantly earlier than CK-MB or troponin-T. This 
time saving is likely to be of clinical benefit. 
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861·60 
High Levels or PAI·1 and Low Levels or Lipoprotein(a) 
Deleterious in Thrombolysis ror Myocardial Infarction? 
Milos Savcicl , Jacques Hauert2, Pierre Vogtl , Lukas 
Kappenbergerl , Fedor Bachmann2. Divisions of Cardiology I and 
Haematology2, CHUV Lausanne, Switzerland. 
We evaluated whether high levels of lipoprotein(a) [Lp(a)] or 
plasminogen activator inhibitor type-I antigen (P AI-I :Ag) influence 
the outcome of thrombolytic therapy with streptokinase or APSAC 
in myocardial infarction. In a randomized swdy involving ·175 
patients (pts), the angiographically determined patency rate 3 hours 
post thrombolysis (t1) was 70%. The reocclusion rate was 15%. 
Before treatment (to), median±SD levels of PAI-I:Ag were higher 
(43±34 ng/mL) than in an age-matched control group and increased 
further to 72±49 ng/mL at t1 (p<O.OOOI by Wilcoxon rank sum 
test). The increase was 39±48 ng/mL in unsuccessful and 2I±51 
ng/mL in successful thrombolysis (p<O.Os). Pts with reocclusion 
presented at to higher PAI-I:Ag levels: 77±47 ng/mL than those 
without reocclusion: 42±31 ng/mL (p=O.OOI). 
High levels of Lp(a) were not associated with unfavourable course. 
Surprisingly the number of pts with levels >300 mg/L was greater in 
the group with successful: 21 % than unsuccessful thrombolysis: 
9.8% (p=0.07 by Pearson Chi-square). Morenver there was a 
correlation between Lp(a) and the increase of P AI-I:Ag levels after 
thrombolysis, which were higher in pts with Lp(a) <300 mg/L than 
in those with levels >300 mg/L at tl : sl±32 vs 82±51 ng/mL 
respectively (p=O.002). 
Thus high P AI-I levels are found in pts with recurrent ischemic 
events. Thrombolysis induces an increase of P AI-I, which is more 
marked in cases of failure of treatment High levels of Lp(a) do not 
influence negatively the outcome of thrombolysis but rather seem to 
favour a successful course. 
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862·18 
Do .. a Short·Lutlng Mild Epl.ode of Myocardial lachemla ReaIIH In 
Stunning In Patlenta with Coronary Artery DIaN .. ? 
Louis Bartels, Wlilem J. Remme, Martin van der Ent, AI:J van der Heuvel, 
Dick Kruijssen. Sticares Foundation, Rotterdam, The Nether1ands 
In animal models, 18Ver8 ischemia results in prolonged but """era•
Ible cardiac dysfunction after the ischemic event. Whether in man short•
lasting episodes of mild stress-induced ischemia may result in persisting 
cardiac dysfunction, Is unknown and was investigated In 54 nonnoten•
siva patients with left coronary artery disease during an Incremental atrial 
pacing test (10 bealS/2 min) until angina, AV block or maximal heart rate 
of 170 min". Paired arterial and coronary venous sampling for oxygen 
and lactate, ECG monitoring, hemodynamic determinations and nuclear 
angiography were carried out at control, maximal pacing, and at 2, 5 
and 30 min post pacing (p-p). Based on ST-segment depression (ST) 
during pacing, 2 groups were formed, one without ST (NI, n=11) and 
one with ST 2:1 mm (I, n=43). AI. baseline, both groups were c0m•
parable as to cardiac function, hemodynamics and metabolic param•
eters. Pacing resutted in a similar increase in oxygen demand in both 
groups, but myocardial O. consumption (MVO.J increased 50% mora in I 
than in NI. In I, pacing induced significant ST and lactate reiease, where•
as ejection fraction decreased by 7%. No such changes occurred in NI. 
Between 2 and 5 min p-p, metabolic and ECG parameters of ischemia 
normalized in I, and ramained at this level throughout the study. Also, 
angina disappeared shortiy after pacing. In contrast, ejection fraction and 
peak ejection rate were depressed by 6% and 6%, respectively, at 30 
min p-p. Moreover, time to peak filling increased significantly by 17 msec 
and peak filling rate had decreased by 10% at 30 minutes p-p. Although 
this was accompanied by a 13% decrease in MVO., and an 18% in•
crease in coronary resistance (all p< .05) coronary flow had returned to 
baseline levels. In NI, no changes occurred after pacing. 
Thus, follOwing shortlasting mild ischemia, systOliC and diastolic myocar•
dial function ramain depressed for at least 30 min after the event, long 
after angina and objective signs of ischemia have disappeared and car•
diac metabolism and coronary flow have normalized. 
ABSTRACTS 
862·19 
Do Persistent Regional Wall Motion 
Abnormalities After Exercise Represent 
Stunned Myocardium? 
Peter T. Katsiyiannis, James A. Arrighi, 
Arshed A. Quyyumi, Robert O. Bonow, 
Stephen L. Bacharach, John E. Stuhlmuller, 
Vasken Dilsizian, NHLBI, Bethesda, Maryland 
Whether stunned myocardium occurs after 
exercise (ex)-induced myocardial ischemia 
remains controversial. We studied 17 pts with 
angiographically proven coronary artery 
disease, all of whom had abnormal left . 
ventricular ejection fraction (EF) response 
from rest (48+16%) to ex (44+1S%) as assessed 
by radionuclice angiog~phy TRNA). Of the 17 
pts, 5 also underwent .~ myocardial blood 
flow study using pOSitron emissbon tomography. 
For each pt, 4 sets of RNA and Rb images were 
acquired at rest, during maximal supine 
bicycle ex, IS min and 30 min post-ex. 
Quantitative regional EF (rEF) was assessed by 
dividing the LV region of interest into 8 
annular sectors. In IS of 17 pts (88%), 
regions with abnormal ex-induced rEF had 
persistent or worsening of rEF at IS min post•
ex (ArEF -21+22%) and in 11 pts (65%) the 
abnormal response persisted at 3D min post-ex 
(ArEF -10+8%1' Among the 5 pts with rEF and 
myocardia! b ood flow studies, 8 regions 
showed decreased rEF during ex and 15 min 
post-ex associated with lower MBF compared to 
normal regions. At 30 min post-ex, myocardial 
blood flow continued to track rEF, with 4 
regions demonstrating concordant improvement 
in rEF and blood flow and 4 regions with 
persistent decrease in rEF and blood flow. The 
finding of decreased myocardial blood flow in 
regions with decreased rEF post-ex does not 
conform to the classic definition of stunned 
myocardium. 
862-20 
Adenosine Does Not Attenuate Myocardial Stunning Induced by 
Ezerclse Induced Ischemia 
Eric S Hockstad, Pam R Paulsen, Todd Pavek, Melanie Crampton, Sara K 
Henlinger, David C Homans. University of Minnesota, Minneapolis, MN 
To determine whether exogeuous adenosine administration attenuated mycx:ardial 
stunning, 6 mogrel dogs were instrumented with coronary flow probes, coronary 
artery occIuders, and sonomicromClers. Dogs exercised on a treadmill with a 
coronary stenosis for 10 minutes. Immediately following exercise, the stenosis 
was released. On an alternate day, the dogs were pretreated with intracoronary 
adenosine (40 micrograms/kg/min for 10 minutes). Approximately 5 minutes 
after the infusion, when coronary flow mumed 10 baseline, the dogs performed 
an identical period of exercise. During exercise with a stenosis, regional 
function declined approximately 65% from rest. Immediately following exercise 
after release of stenosis, function initially recovered, followed by a prolonged 
period of depressed myO<:ardial functioo (Fig 1). During adenosine infusion, 
mean coronary flow inaeased threefoid (p=O.OOO7). Mter the adenosine infusion 
was discontinued, flow returned to baseline within 5 minutes, and mean flow 
was no different from Ibe amtrol run througbout exercise, and recovery. During 
exercise without stenosis, the function improved by 22% in amtrols, and 5% in 
adenosine treated animals (p=O.04). There was no difference in the amount of 
myocardial srunning in the dogs after trealment with adenosine as compared to 
amtrol (Fig. I). 
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Exogenous adenosine administration does not allenuate post iscbemic 
dysfunction in this model of myocardial stunning. 
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862·21 
Cardiae Tozlelty or Interleukln·2 plus Alra·2 Interferon 
Chiara Lestuzzi, Gian Luigi Nicolosi, Mirella Viel, Gabriella Zouarel, 
Roberto Sorio, Giovanni Calzavara. Cardiologia-ARC, Pordenone and 
Uni~ di Cardiologia Sperimentale, Oncologia Medica, CRO, A viano. 
Italy. 
Interleukin-2 (11..2) and a1fa ·2 interferon (IFN) are successfully used 
against renal cancer (RC) and melanoma (M). Both drugs may 
however have cardiotoxic effects. We prospectively studied 47 patients 
(pts) (38 males, 9 females) with RC (42 pts) or M (5 pts) during 
treatment with 11..2 i.v. push plus IFN (group A, 12 pts) or 11..2 alone 
in continuous ( group B, 35 pts). All patients undClWent serial EKG, 
echocardiograms (ECHO) and CPK determinations. In group A, 7/12 
pts (58%) bad cardiac toxicity: 1 atrial fibrillation converted to sinus 
rhythm with digitalis, 1 stunned myocardium at ECHO with 
subsequent recovery of function, 2 transitory EKG Signs of ischemia, 
and 3 non Q myocardial infarction (l of them died, 2 recovered 
clinically and at ECHO). In group B 7/35 pts (20%) bad cardiotoxicity: 
angina (lpt) or supraventricolar arrhytmias (6 pts). There were no 
deaths in this group. After recovery all patients in both groups repeated 
the same chemotherapy without recurrence of significant cardiotoxic 
effects. CONCLUSIONS: 11..2 may cause arrhythmias and/or 
myocardial ischemia. When 11..2 is given in i.v. push and associated 
to IFN, the risk of cardiotoxicity significantly increases. After 
recovery from the acute phase, further chemotherapy seems at lower 
risk of complications. 
862·22 
Adaptation of Myocardial Iscbemla to Repetitive Prolonged 
Coronary Occlusions In PTCA: Clinical, ECG, 
Ecbocardiograpbic and Metabolic Assessment. 
• Alain Cribier, H~I~ne Eltchaninoff, Christophe Tron, Ren~ Koning, Genev~ve 
Dennneaux, Brahim BaaIa, Nasser Farid, Bernadette HecketSweiUer, Brice Letac, 
H/lrital Charles Nicolle. University of Rouen (Vacomed Group), France 
Myocardial ischemic threshold has been shown to increase with sequential 
coronary occlusions dwing PTCA, as a.sessed on chest pain and ECG changes. 
The aim of this study was to further evaluate the adaptation to ischemia using: 
1) intra-coronary ECG (lC-ECG) for ST segment elevation (ST,,; 2) 2D echo 
for left venlricular wall motion analysis and 3) arterial/coronary sinus blood 
sampling for lactate mea.urements. Nineteen patients (PIS) with single left 
anterior descending anery stenosis and normal left venlricular function were 
enrolled. PTCA consisted in 4 long balloon inflations of similar duration 
(210±1l3 sec) separated by 2 min deflation. Time to onset of chest pain was 
noted in each balloon inflation. ST l' (calculated .OS sec after] point) was 
measured at the end of each balloon inflation on IC-ECG. 2D echo was recorded 
continuously in 13/19 PIS (6 Pt.. were excluded for poor echogenicity): 
incidence and delay of hypokinesia, akinesia and dyskinesia were noted. Lactate 
metllbolism was assessed at 3 min into inflation I and inflation 4 in 12119 PIS. 
In order to evaluate an adaplation of the myocardium 10 repetitive epi!;()()es of 
ischemia, all paramelers were compared belween the first (inflation I) and the 
last inflation (inflation 4). 
~ When inflation 4 was compared to inflation I, onset of chest pain was 
delayed (90±57 sec vs 64£\2 sec, jK.05) and ST~was lessened (.S5 ±.S3 mY 
vs 1.20 ±54 m V, 1)<.05). The ischemia-related laclate production was decreased 
c- 2.5±16% vs -12±IS%, jK.05). Len venlricular wall motion analysis showed 
lesser and delayed onsel of systolic dysfunction during inflation 4: hypokinesia 
developed al 27±16 sec into inflation 4 vs 15±9 sec into inflation 1 (p=.07l, 
akinesia nOled in 10113 PIS during inflation I occured in 8/13 PIS during 
inflation 4 and dyskinesia observed in 5113 PIS during inflation I was seen in 
none during inflalion 4. 
CpncJusiPO' This sludy showed delayed chesl pain, less ST segment elevation, 
lessened wall mOl ion changes and less lactate production wilh sequential 
coronmy occlusions, tbus demonstrating a progressive adaptation of the 
myocardiwn 10 repetitive episodes of acule ischemia. 
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862·23 
Antiarrhythmic Effect of Ischemic Preconditioning In Patients 
with Variant Angina 
Hitoshi Takano, Yoshiki Kusama, Tsutomu Saito, Kazuo Munakata 
Hiroshi Kishida, Hirokazu Hayakawa, Department of Medicine ' 
Nippon Medical School, Tokyo, Japan ' 
Severe ventricular arrhythmias are known to occur during ischemic 
attacks in patients with variant angina (VA). Experimental studies 
have demonstrated that ischemic preconditioning by brief episodes 
of myocardial ischemia showed antiarrhythmic effect on ventricular 
arrhythmias during subsequent ischemia. To assess whether 
ischemic preconditioning is observed in patients with VA, the rela•
tion between degree of ventricular arrhythmias during ischemic at•
tack and interval from preceding attack was analyzed. Twenty-five 
patients with VA underwent 24hrs ambulatory ECG prior to the start 
of antianginal treatment and 50 episodes of ischemic attacks were 
used for the analYSis. As shown in tables, during ischemic attacks 
with shorter interval from preceding ischemic attack, both severity 
and incidence of ventricular arrhythmias were reduced. (VPC; ven•
tricular premature contraction. VT; ventricular tachycardia.) 
A. Severity of arrhythmias and interval from preceding attack (mean±SD). 
VPC ~ 10 beats VPC ~uplet VT 
(-) 2.6±2.5 hrs (-) 2.3±1.3 hrs (-) 2.7±2.6 hrs 
(+) 7.3±4.9 hrs (+) 7.2±4.8 hrs (+) 8.3±4.3 hrs 
p<O.OI p<O.OI p<O.OI 
B. Incidence of arrhythmias and interval from preceding attack. 
Interval VPC~10 beats VPC ~uplet VT 
Less than 5 hrs 18% 
5 hrs or more 56% 
p<O.05 
21% 
69% 
p<O.05 
9% 
56% 
p<O.05 
Thus, antiarrhythmic effects of ischemic preconditioning on ven•
tricular arrhythmias were observed in patients with VA. 
862·24 
Postischemic Left Ventricular Remodeling: Shape Alterations in 
Patients with Angina without Prior Myocardial Infarction. 
Giuseppe Barletta, Marisa Di Donato, Fabio Fantini, Anna Toso, 
·Maurizio Baroni. 
Dpt. of Cardiology, Institute of Internal Medicine, 
• Dpt. of Engineering, University of Florence, Italy. 
In order to assess whether LV shape is altered in patients (pts) with 
angina independently from prior myocardial infarction (MI) and 
wall motion abnonnalities, 58 patients (pts) with stable or unstable 
angina (A), aged 57±10 yrs, were studied. The study group was se•
lected according to these criteria: a) single·vessel disease involving 
either the left anterior descending artery (LAD=37 pts) or the right 
coronary (RC=21 pts); b) no prior MI and no wall motion 
abnonnalities (centerline method); c) LV volumes and LV ejection 
fraction within normal limits. Pts with hypertension or valvular 
diseases were excluded. 
Global LV shape was analyzed by calculating the circular shape 
index (CSI). Regional wall curvature (C) was measured at 90 points 
along the 30oRAO angiographic outlines (windowed Fourier's 
analysis). In respect to 16 normal subjects, A showed significant LV 
shape alterations, which were mainly present at end-diastole. Global 
shape took a more rounded aspect (CSI= 0.73±0.03 vs 0.68±0.03 in 
normal group; p < 0.01). C showed significant alterations at several 
points of the anterior, apical and inferior regions. The extent of 
shape alterations was greater in pts with long lasting angina (more 
than 6 months). The general pattern of shape alterations was similar 
in LAD and RC groups, i.e. both groups showed the involvement of 
regions subtended by angiographically normal arteries. 
In conclusion: LV remodeling occurred in A even in the absence of 
prior MI and wall motion abnormalities. These data support the 
hypothesis that repeated ischemic episodes bring about a damage of 
the collagen network, leading to widespread alterations of the 
viscous-elastic properties of LV wall. 
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862·25 
Hibernating Myocardium Shows Different Degrees of 
Structural Adaptation and Its Functional Downregulation 
Is not Sufficient to Prevent Structural Deterioration 
"Ernst R. Schwarz", Jutta Schaper +, Jurgen vom 
Dahl", Carsten Altehoefer", Friedrich Schoendube", 
Udalrich Buell", Bruno J. Messmer", Florence H. 
Sheehan + +, Wolfgang Schaper +, Peter Hanrath". 
"RWTH Aachen, +MPI Bad Nauheim, FRG, + + Dept. 
Cardiology Univ. Washington, Seattle, WA 
The morphology of suspected hibernating myocardium 
was studied in 12 patients (pts) with coronary multi•
vessel disease and regional wall motion abnormalities 
(WMA) in the anterior wall from transmural biopsies 
taken during CABG. WMA was measured using the 
centerline method, 18-FDG uptake was determined in 
PET as a predictor for preserved viability in all pts. WMA 
was preoperatively -2,21 ± 0,2150, EF was 46,1 ± 
3,3%, 6 months postoperatively WMA increased to 
-1,56 ± 0.4 SO, EF to 56,5 ± 3,1% (p<0.05, 
compared to preoperative data). Oespite the absence of 
transmural infarctions pts with suspected hibernating 
myocardium showed different degrees of degeneration 
with loss of sarcomeres and replacement of connective 
tissue, occurence of glycogen and slightly or moderately 
reduced contractile material, and hypertrophic as well as 
atrophic cells. Despite maintained 18-FOG uptake in PET 
these regional changes indicate a modest or severe 
structural adaptation, which was not prevented by a 
functional and metabolic downregulation. 
862·44 
Mechanism of Suhendocardial Ischemia Associated with Decreased 
Aortic CompliBDce 
• Hideki Waumabe. Sadanori Ohtsuka, Masaaki Kakihana. Yasuro Sugishita 
University of Tsukuba.lbaraId. Japan 
Aortic compliance (ACo) and systemic vascular resistance (SVR) are 
components of die afterload imposed on die left ventricle. We previously 
demonstrated that ACo was a determinant of the exm:ise capacity in patients widl 
stable angina. and. and that decreased ACo was a great additional risk for die 
development of subendocardial ischemia in cases of coronary stenosis. This study 
was designed 10 clarify mechanisms of subendocardial ischemia associated widl 
decreased ACo or increased SVR. 
Ten anesdletized open chest dogs willi coronary stenosis in die left circumflex 
coronary artery (LCx) were used. The level of die stenosis was adjusted 10 eliminate 
reactive hyperemia induced by a 10 seconds occlusion. To evaluate die blood flow 
of lIIe ischemic area. myocardial oxygen tension (p02) of die inner and outer layer 
were measured by membrane-covered oxygen electrodes (Inter Medical Co. Japan). 
After the measurements in die conuel stage. ACo was decreased by the bandage of 
thoracic aorta widl adjustable plastic rings lACo stage). SVR was increased by the 
inttavenous administtation (0.2 - 0.3 Ilg/kg/min) of norepinephrine (SVR stage) 
after the release of the bandage. Measurements were performed at rest and during 
rapid attiaI pacing (HR=200) in the each stage. 
ACo was significantly decreased by the bandage (0.63±0.14 vs. 0.18±0.02 
ml/mmHg; conuel vs. ACo stage. p<0.01). but SYR and mean blood pressure 
(MBP) were not changed. In the SVR stage. ACo was not changed. but SVR and 
MBP were significantly increased (SYR: 88±14 vs. 114±18 mmHg/L/min. 
p<O.OI; MBP: 84±12 vs. 128±18 mmHg. p<O.OI; conuel vs. NAd stage). In the 
LCx area. die ST level in subendocardial ECG was significantly elevated and 
myocardial segment shortening (%SS) were significantly decreased during pacing in 
the ACo and SYR stages. In the ACo stage. subendocardial p02 (End) was 
decreased and subepicardial p02 (Epi) was increased (End: 52±5 vs. 37±11 mmHg. 
p<O.05; Epi: 43±4 vs. 56±4 mmHg. p<O.05; rest vs. pacing). End/Epi ratio was 
significantly decreased (1.21±O.13 vs. 0.66±O.13. p<O.OI; rest vs. pacing). 
However. in die SVR stage. bodl End and Epi were significantly increased (End: 
59±.6 vs. 72±.6 mmHg. p<O.05; Epi: 39±9 vs. 46±.9 mmHg. p<O.05; rest vs. 
pacing). End/Epi ratio was not changed (1.5I±O.51 vs. 1.57±O.83. rest vs. pacing). 
Conclusion: These results indicate that decreased ACo induces the 
maldistribution of die inner and outer myocardial blood flow in die ischemic area. 
Thus decreased ACo may augment impaired subendocardial oxygen supply in the 
presence of coronary stenosis. 
ABSTRACTS 
862·45 
Pronounced Neurohumoral ActIvation following Acute Beta·blockade 
Affeeta Coronary R_rve and Umlta the Antllachemlc Efficacy of 
thla Intervention In Patlenta with Cardiac Dyafunctlon 
Ad F.M. van den Hewel. Edna H.G. V .... nek.... Willem J. Remme. 
Sticaras Foundation. Rotterdam. the Nethellands. 
81A 
Myocardial ischemia induces neurohumoral activation and suI>•
sequent vasoconstriction. particularty In patients with LY dysfunction. As 
this may negatively Influence antiischemic therapy. the efficacy of fJ•
blockade in this context in ralalion to neurohumoral activation was c0m•
pared in patients with coronary artery diaease. 8 with a normal (52:!:4%. 
gr N) and 6 with a low (33:!:8%. gr L) ejection fraction. PIs underwent 2 
identical incremental atrial pacing tests. 30 min before (Tl) and 15 min 
after (T2) Iv fJ-blockade (epanoloQ. Baseline neurohumoral and hemody•
namic parameters were comparable. Only stroke work index was 23% 
lower in L. Changes during T1 were similar In N .... L. During T2. myo•
cardial 0, demand was significantly less in both groups due to a reduc•
tion in LV systolic pressure (68% vs 83% In N. and 70% vs 91% In L. T2 
vs T1). Contractility was 18% and 22% lower in N and L _po during T2. 
Ischemia (ST -depression) was significantly less during T2 in N. whereas 
H was comparable in L (0.16:!:0.04 vs 0.25:!:0.06 mY in Nand 0.12:!:0.04 
vs 0.16:!:0.02 mY in L. Tl vs T2). In N. coronary flow increased by 37% 
and resistance decreased by 22"'" during T2. whereas they did not 
change in L. Also. during T2. coronary vascular _istance was signifi•
cantly higher and coronary blood flow lower in L compared to N. Norep~ 
nephrine (NE) and Epinephrine (E) increased in both groups during both 
tests. However. levels were 115% and 81% (NE and E. rasp.) higher In L 
during T2. Moreover. arterial angiotensin 11. although decreased follOwing 
epanolol, was still 52% higher in L than in N during T2. Thus. during 
pacing after epanolol. angiotensin 11. NE and E levels were significantly 
higher in L. and resutted in significantly less coronary vasodilatation 
during pacing. Consequently. in this group. the antiischernic effects of 
epanolol were absent. whereas they were clearly present In N. in which 
neurohumoral activation was less and coronary flow improved during 
pacing. It is concluded that pronounced neurohumoral activation and 
subsequent failure to improve coronary flow limH the antiischemic effica•
cy of p-blockade in pts with diminished. but not with normal LY function. 
862·46 
Exerct .. -Induced ST Elevation After Q Wave Infarction: Dltferance 
In Implications Between Recent and Old Infarctlon 
Tomoya Onodera, Akinori Takizawa, Kazuhiro Yamamoto, Terumoto 
Fukuchi. Masahiko Kimura, Hiroyuki Fukita, Tadashi Mikami. Masaharu 
Akao, Tsuyoshi Urushida. 
Shizuoka City Hospital. Shizuoka, Japan 
Exercise-induced ST segment elevation (ST t ) in leads with Q waves 
has been reported to represent ventricular aneurysm or ischemia in re•
sidual viable myocardium. Differences may arise from varying duration 
after myocardial infarction (MI). To test the hypothesis. 116 consecutive 
patients with anterior Q wave MI, who underwent exercise thallium 
SPECT and left ventriculography, were divided by duration after MI «3 
months, mean 1.2±0.4 months and 0;:3 months, mean 36.3±30.5 
months). Presence of ST t (0;:2mm) was compared with the incidence 
of redistributing thallium defect (Tl-RD), global left ventricular ejection 
fraction (L VEF) and anterior regional wall motion (RWM) by centerline 
method in left ventriculography. 
Duration after MI 
< 3 months (n=50) 0;: 3 months (n=66) 
ST t (+) ST t (-) ST t (+) ST t H 
(n=24) (n=26) P (n=27) (n=39) P 
Tl-RD(+I-) 19/5 5121 <0.01 
LVEF(%) 55±11 48±16 NS 
RWM(SD/chord)-2.1 ±1.3 -2.6±1.7 NS 
10/17 21/18 NS 
39±16 51 ±14 <0.01 
-2.8 ± 1.4 -2.0 ± 1.2 <0.05 
In a total of 116 patients, no differences were found in the incidence of 
Tl-RO, LVEF or RWM between those with ST t and those without. 
Thus, ST t in leads with a waves in recent MI was associated with 
ischemic viable myocardium and ST t in old MI was associated with 
impairment of left ventricular motion. It was suggested that implications 
of ST t differ with duration after MI. 
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862·47 
Influence of Sex and Simple Risk Stratification on Signs of 
Ischemia and Arrytbmias in an Angina Pectoris Population of 
790 Patients. A Report from APSIS. 
~ Forsl~d, loge BjOrkander, Ciaes Held, Paul Hjemdahl*, 
Nma Rehnqvlst. Dept. of Med. Danderyd Hospital and Dept. of Clin. 
Pharmacol.* Karolinska Hospital, Stockholm, Sweden. 
. In a single:center, prospective and randomized study (APSIS; AJi•
gma ftognOSIS S.tudy In S.tockholm), we have analyzed long-term 
ECG registrations (LTER) from 790 patients (31 % women). Mean 
age was 60± 7 years for both genders and the median duration of 
angina prior to inclusion was 2 years. The patients were stratified at 
inclusion to low, intermediate and high risk groups based on simple 
clinical characteristics (age> 60, clinical signs of left ventricular dys•
fu~ction and signs of multivessel disease during exercise testing). 
With none of these present, the patient was considered at low risk, 
with 2 or 3 at high risk, those with one were judge as intermediate 
risk patients. Patients with angina only at rest formed a separate 
group. Each risk stratum contained 30-35% women. LTER was re•
gistered with Oxford MediJog 4500 tape recorders and analyzed on 
an Oxford Excel computer. Numbers of premature ventricular comp•
lexesl24h (PVC) of Lown grade 2 or more occured in 313 of all pa•
tients (44%). There were 52% of the men and 26% of the women 
showing these types of PVC:s, the median numbers were 16 vs I re•
spectively (p<0.001). Total time of ST -depressionl24h was equal in 
men and women (median 6 vs 5 min; ns). When analyzed according 
to risk strata, there were significantly more PVC:s of Lown grade 2 
or more in the high risk group compared with the low risk group 
(52% vs 34%; p<0.(01). The high risk group had longer total time 
with ST-depressionl24h compared with the low risk group (median 
14 vs 1 min; p<0.05). 
Conclusion: In accordance with patients having suffered a pre•
vious myocardial infarction, high risk angina patients had higher fre•
quency of PVC:s than low risk patients and had more signs of ische•
mia. Interestingly enough, women had the same ischemic burden as 
men but significantly fewer PVC:s. 
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863·48 
Serial Echocardiography to Assess the Incidence and Clinical 
Course of Pericardial Effusion Following Radiofrequency Cath· 
eter Ablation of Accessory Pathways 
Afsaneh Khanedani, Michael SchlUter, Riccardo Cappato, Karl H. 
Kuck. University Hospital Eppendorf, Hamburg, Germany 
To assess conditions potentially predictive of pericardial effusion 
(PE) following radiofrequency (RF) current catheter ablation of an 
accessory pathway (AP), data of 334 consecutive pIS were retrospec•
tively analyzed using multivariate logistic regression analysis. All pIS 
were heparinized (100 IU/kg) during ablation. PE was diagnosed and 
graded by echocardiography, on the day after ablation and again 2-3 
days later. PE was found in 93 pts (28%), graded on repeat echo as 
minimal (n = 72), medium (:!> 1 cm; n = 15), large (> 1 cm; n = 4), 
and tamponade (n = 2). In 20 PIS, PE had aggravated between initial 
and repeat echo from minimal to medium in 15, from minimal (n = 
1) or medium to large in 3, and from large to tamponade in 2. Oral 
acetylsalicylic acid for antithrombotic prophylaxis was given if the 
repeat echo disclosed minimal or no PE. Pericardiocentesis was 
required in 2 pIS with large PE and the 2 pIS with tamponade. PE was 
not influenced by the site and conduction properties of the AP, the 
number of RF applications, cumulative energy, and incidence of 
impedance rises. Only age and gender were independent predictive 
factors. A significantly higher proportion of women were among pts 
wilh PE (43193) as compared to piS without PE (78/241, P < 0.05); 
statistically, pts with PE were older than pIS without PE (43 ± 16 vs 
36 ± 16 years, p < 0.(01). Conclusions: 1) In 28% of pIS undergoing 
RF ablation of an AP, PE is observed postablation. 2) PE is not influ•
enced by the number of RF applications and the site of the AP. 3) Pts 
with PE had a higher age and a larger proportion of women than pts 
without PE. 4) Aggravation of PE within 2-3 days was diagnosed by 
echo in 21 % of these pts. 5) Serial echocardiographic control of pts 
undergoing RF ablation of an AP is recommended. 
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863·49 
Use of A Newly·Designed Microwave Antenna for catheter 
Ablation of the Atrioventricular Juncfton 
Alan B. Wagshal, Shoel K. Stephen Huang, James C. Un, Henri F. 
Cuenoud, Yu-Jln Wang, Robert S. Mittleman, Frank Mazzola, Luis A. 
Pires. Unlv. of Massachusetts Medical Ctr, Worcester, MA. & Univ. 
of illinois, Chicago, IL. 
Microwave (MW) energy has been suggested as a possible 
altemative to radiofrequency (RF) energy for catheter ablation, 
particularly because of Its potential to produce larger lesion size. 
Most previous MW antenna designs have employed a helical coli 
configuration which results in a large catheter diameter and 
difficulty In precise lesion localization. We have developed a 7 
French MW catheter that uses a single 4 mm spllt-dlpole antenna at 
the tip, allowing for more preCise energy delivery and bipolar 
electrogram recording. To test the efficacy of this catheter in vivo, 
we attempted complete AV junction ablation In 9 anesthetized, 
closed-chest mongrel dogs. The catheter was advanced to the 
AV junction from the femoral vein under fluoroscopy, and energy 
was supplied using a 2450 MHz MW generator at an output of 30 
watts for 30 second pulses. We were able to record a His bundle 
potential in all animals, and complete heart block (CHB) was 
achieved in 8 of the 9 dogs (in the 9th dog only first degree AV block 
could be achieved) with a mean of 5±4 energy deliveries (range 2-
1A). In all cases there was a stable ventricular escape rhythm 
between 30 and AD bpm and CHB perSisted until sacrifice 2 hours 
later. Similar to human AV junction ablation with RF energy, 
successful sites showed a large atrial electrogram and a small His 
bundle potential. and AV block was heralded by flurries of 
junctional beats. Histology revealed discrete lesions with a surface 
dimension of 6-8 mm long by A~ mm wide, which involved the 
approaches to the AV node. the node, and the penetrating 
bundle. No complications resulted from any of the procedures. 
We conclude that this new MW antenna design allows for effective 
AV junction ablation and may be a suitable altemative to RF 
energy for catheter ablation. 
863·50 
The "Encircling" Mapping Technique. a Simplified Approach to 
Radio·frequency Current Ablation of Ectopic Atrial Tachycardia 
Christian Weiss, Roben Hatala, Riccardo Cappato, Michael SchlUter, 
Karl H. Kuck 
University Hospital EppendoIf, Hamburg, Germany 
Radiofrequency current (RFC) ablation of ectopic atrial tachycardia 
(EAT) was attempted in 10 pts. (6m, 4f, 9·52 (median 21) years) by 
using a simplified mapping approach. Two catheters (6-7 F) were ad•
vanced to the right atrium. During EAT, mapping was performed with 
one catheter in search for an atrial activation site simultaneous to or 
earlier than the onset of P·wave. Once such site was found, the cathe•
ter was kept in place while the second catheter was used 10 map tho 
atrium for an earlier activation sile. Thus, the two catheters were used 
;n an alternating way, "encircling" the focus, until no earlier atrial acti•
vation could be detected. At this site 2·27 (median 4) RFC pulses eli•
minated the atrial focus in 8/10 pIS. In 6 cases the successful site was 
in the right atrium (3 posterolateral, 1 posteroseptal, 1 anterolateral, 1 
lateral); ablation of lefl sided atrial foci was accomplished through a 
catheter located in the posteroseptal region of the coronary sinus (CS) 
in one pt, and via a transseptal approach in another pt, who also pre· 
sented with dextrocardia. In this pt, the mapping of the left atrium was 
performed with one mapping catheter and additional catheters in the 
CS and the right ventricular apex. During 2 • 18 (median 6) months of 
follow· up, 2 pIS had recurrences. In both cases a repeat ablation pr0-
cedure was successfully performed 
Conclusions' The "encircling" technique provides a valuable and pro•
mising approach for RFC ablation of EAT. 
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863-51 
Low Recurrence of Atrial Fibrillation Following Radiofrequency 
Catheter Ablation of Accessory AV Pathways 
Raed Sweidan, James H. McClelland, Karen J. Beckman, 
Xunzhang Wang, Mauricio S. Arruda, Michael P. Rome, Ishmaile 
Abdalla, Anantjit Singh, Bemard Thibault, Mario Gonzalez, Hiroshi 
Nakagawa, Lawrence E. Widman, Ralph Lazzara, Warren M. 
Jackman, University of Oklahoma, Oklahoma City, OK 
Previous studies have found a low recurrence of atrial 
fibrillation following surgical ablation of accessory AV pathways. 
The purpose of this study is to determine the incidence of atrial 
fibrillation following radiofrequency catheter ablation of accessory 
AV pathways in patients with documented atrial fibrillation prior to 
ablation. 
Among 460 patients (pts) who underwent successful 
radiofrequency catheter ablation of an accessory pathway between 
Nov. 1988 and Mar. 1993, 96 pts (20%) had at least one 
documented episode of atrial fibrillation prior to ablation. Clinical 
follow-up was obtained on 83 pts (mean age: 37±13 years) with 
total of 86 accessory pathways (42 left free wall, 38 septal, 4 right 
free wall, and 2 right atrio-fascicular). 9 pis (11 %) had structural 
heart disease (3 cardiomyopathy, 3 mitral valve prolapse, 1 
hypertensive heart disease, 1 moderate aortic regurgitation, and 1 
coronary artery disease with dilated right heart). During 6-58 (mean 
25±12) months of clinical follow-up, 6 pts (7%) had a recurrence of 
atrial fibrillation: 3 of 74 (4%) pts without structural heart disease 
compared to 3 of 9 (33%) pts with structural heart disease. In all 6 
pts, atrial fibrillation recurred within 13 months. 
Conclusions: Recurrence of atrial fibrillation is low following 
radiofrequency catheter ablation of accessory AV pathways and 
comparable to recurrence of atrial fibrillation following surgical 
ablation. 
863·86 
Radiofrequency Catheter Modification of the Sinus Node 
for Management of Sinus Tachyarrhythmias 
Charles H. Machell. New Mexico Heart Clinic, Albuquerque 
New Mexico 
Sinus node (SN) tachyarrhythmias represent an infrequent 
cause of supraventricular tachycardia (SVT), but often 
resist medical management. This is a report of three 
cases of SVT involving the SN node managed by radiofreq•
uency catheter modification of SN function. One patient 
had sinus node reentry (SNR) as the mechanism for SVT, 
and the other two had nonparoxysmal sinus tachycardia 
(NPST). Secondary causes for sinus tachycardia were ex•
cluded in all pt, including an analysis for hyperthy•
roidism and catecholamine excess. Electrophysiologic 
testing disclosed an intra-atrial mechanism for SVT with 
P wave morphology and intracardiac activation sequence 
indistinguishable from sinus rhythm. SVT was inducible 
with programmed stimulation in the pt with SNR and with 
infusion of isoproterenol in the two pt with NPST. Radio•
frequency (RF) current was applied to the earliest site 
of atrial activation in the high right atrium at the ex•
pected location of the SN. RF application was repeated 
until SVT was terminated and was no longer inducible by 
either programmed stimulation or isoproterenol infusion. 
All three procedures resulted in eradication of SVT. SN 
function was modified with a reduction in resting heart 
rate in two pt and development of junctional rhythm at 
res·t in the other. One pt developed asymptomatic epi•
sodes of sinus exit block one year following the proced•
ure. No pt has required permanent pacing and all three 
are asymptomatic with a followup of 9+3 months. No com-
pi ications occured in any pt. -
Conclusions: SN function can be successfully modified to 
eliminate SVT in pt with tachyarrhythmias involving this 
structure. The risk of requirement for permanent pacing 
is unknown but appears to be low. 
ABSTRACTS 
863·87 
Temperature Guided RadlOfrequency catheter Ablation: Comparison 
of Rapidly and Slowty Ascending Temperature Curves In Controlling 
the Growth of lesIOns. 
Kongsgaard E, Foerster A, Aass H, Madsen S, Amlie JP. Inst~ute for 
Surgical Research, Rikshosp~alet, Oslo, Norway. 
This study was designed to assess the feasibil~ of temperature guided 
RF ablation of different temperature profiles to modffy AV conduction and 
to correlate these data to localisation and size of the induced lesions. 
A 6 F custom-made bipolar catheter was posHioned in the AV nodal region 
(AV ratiO ~1 and wHh a small His bundle signal) in 16 closed-chest 
anaesthetised pigs. RF current was delivered unipolarly. In 8 pigs (group 
1) a software program designed to achieve the set temperature(80° C) 
rapidly was used, and in 8 pigs (group 2) the RF generator was manually 
adjusted to increase the temperature slowly. Each RF application was 
stopped after 30 sec or when AV-bIock(AVB) was induced. 
Incomplete AVB was produced in a majo~(75%) of pigs. The degree of 
AVB was similar in the two groups. 
Pig no No. applications Av node His RBB LBB 
1) 2 ++ ++ ++ 0 
2) 1 ++ ++ + 0 
3) 4 ++ ++ + + 
4) 3 ++ ++ 0 0 
5) 4 ++ ++ 0 0 
6) 2 ++ ++ 0 0 
7) 1 + ++ 0 + 
8) 1 ±t ±± 0 ±t 
9) 4 ++ ++ 0 0 
10) 1 + 0 0 0 
11) 1 ++ ++ 0 0 
12) 2 ++ 0 0 0 
13) 1 ++ 0 0 0 
14) 2 ++ 0 + 0 
15) 4 + + 0 0 
16) 4 + + 0 0 
Pig no 1)-8): groupl. Pig no 9)·16):group 2. 0: no necrosis. +: small necrotic 
area. ++: more extensive lesions. 
These data suggest that a slowly ascending temperature curve may 
provide a better control of the growth of the lesion than a rapidly curve. 
863·88 
Radiofrequency Transcatheter Ablation of Permanent Junctional Reciprocating 
Tachycardia. 
Fiorenzo Gaita, 1/ Michel Haissaguerre. § Carla Giustetto. 1/ Bruno Fisher. 
Riccardo Riccardi. 
Cardiology Departments of Ospedale Civile of Asti and § University of Torino 
(Italy); 1/ Hopital Saint-Andre, University of Bordeaux (France). 
Permanent junctional reciprocating tachycardia (pJRT) is an uncommOll form 
of reciprocating tachycardia, almost incessant from infancy and usually 
refractory to drug therapy. characterized by negative P waves in leads 
IIJII,aVF.Y4-V6 and RP'>P'R, with retrograde conduction through an accessory 
pathway (AP) with slow and decremental properties. This AP has been 
classically described in the posteroseptal zone, however other locations hive 
been recently reported. AP location and radiofrequency (RF) ablation efficacy 
and safety in a large group of PJRT patients (pts) are reported. 
The study includes 19 pts with PJRT (12M.7F). aged 29+-17 years. Six pts 
had a depressed systolic function of the left ventricle. RF ablation was performed 
at the site of the earliest retrograde atrial activation during tachycardia. n.is was 
observed at the coronary sinus (CS) os in 6 pts, in the midseptal zone in 3. below 
the CS os in 5. in the right posterior zone in 2 and inside the CS in 3 pts. In 1 pt 
with the AP in the midseptal zone, a transient 2nd degree A V block was 
observed. At a mean follow-up of 13+-9 months. all pts are asymptomatic 
without antiarrhythmic therapy. except one. successfully treated with 
propafenone, that was previously ineffective. 
Most of the AP were localized in the septal area and the majority very close to 
the CS os, in the midseptal region or inside the CS itself in some cases. All 
ablations were performed with a right approach. Pis requiring RF application 
inside the CS were characterized by slightly negative P waves in lead I. 
Depressed systolic function improved after successful ablation. Transcatheter RF 
ablation is an effective therapy for PJRT refractory to pharmacologic treatment. 
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863·89 
Catheter Ablation for Atrial Flutter Substrate Using Low Energy Direct 
Current: Results of Lons·Term FoIlow·Up 
Baiyan Xie, Francis D Murgatroyd, Spencer C Heald, Yaver Bashir, Edward 
Rowland, David E Ward. St. George's Hospital, London, UK. 
The effect and long-term follow-up results of catheter ablation for 
atrial flutter (AFL) substrate using low energy direct current (LEDC) is 
unknown. Sixteen patients (pts) with drug resistant symptomatic type I AFL 
(paroxysmal AFL in 10 pts and chronic sustained AFL in 6) were studied. 
Structural heart disease was present in 4 pts (1 hypertension, 2 
cardiomyopathy, 1 mitral regurgitation). Two pts had previously undergone 
atrioventricular nodal ablation but failed. In each pt, a series of LEDCs 
( < 35J) was delivered in the region of the triangle of Koch. 
Results immediately after ablation were: sinus rhythm (14 pts), atrial 
fibrillation (1 pt), junctional rhythm (1 pt). After mean 17±7 months follow•
up (range 6-31 months): 
-No clinical recurrence of AFL: 5 pts 
(no AFL on Holtor: 4 pts) 
(nonsustained « 10 seconds) AFL on Holtor: 1 pt) 
-Clinical improvement: 5 pts 
(without antiarrhythmic drugs: 3 pts) 
(improved with antiarrhythmic drugs: 2 pts) 
-No clinical improvement: 6 pts 
After ablation the time to fltst recurrent episode was varied from 1 day to 5 
months. No difference was observed between those patients with and without 
clinical recurrence of AFL in age, sex, duration of AFL, number of ablation 
sites and follow-up period. However, the number of shocks and the 
cumulative energy were greater in those without clinical recurrence (20 ± 4 vs 
15±S P=0.05; 3OS±77 vs 203±66 P=0.03). ,No significant complications 
occurred immediately after ablation or during follow-up. 
Conclusions: 1. LEDC ablation for resistant AFL is a safe technique of 
comparable efficacy to other methods. 2. There have been no recurrence after 
6 months follow-up. 
863·90 
Does AV Nodal Ablation Impair Long·Term Survival Compared with 
Medical Treatment of Atrial Fibrillation? 
Stephan Windecker, Vance 1. Plumb, Andrew E. Epstein, and G. Neal Kay. 
University of Alabama at Birmingham, Birmingham, Alabama. 
Catheter ablation of the A V node improves symptoms in pis with atrial 
fibrillation (AF) but is associated with a small incidence of sudden death. 
However, antiarrhythmic drugs may also negatively impact survival in these pis. 
We analyzed the long-term survival of 332 pis with AF treated with medications 
(Meds) (137 pIS) or A V nodal ablation with DC (63 pIS) or radiofrequency (RF) 
energy (132 pis). The characteristics of each group are shown in the table below: 
MW JK: R[ II 
~ge 64.50 61.00 64.90 NS 
Sex (M/F) 77/60 27135 56n6 NS 
LVEF 0.50 0.50 0.49 NS 
LA size (540/41-491>50 mm) 64145120 40/14/S 6414016 NS 
CAD 30% 25% 35% NS 
IcHF 16% 24% 13% NS 
Valvular Disease 2S% 26% 21% NS 
Cardiomyopathy S.S% 6.6% 9.S% NS 
~ypertension 4S% 41% 45% NS 
hroniclEpisodic AF 2S%/72% 36%/64% 23%177% NS 
iNumber of prior drugs 2.0 + \.I 4.3 + 1.6 4.0± 1.4 om 
The mean follow-up duratIon was 4S.S mos (Meds), 70.3 mos (DC), and 33.S 
mos (RF). Kaplan-Meier survival analysis demonstrated no difference in total 
survival at J year (0.93 Meds, 0.95 DC, 0.93 RF), 2 years (0.S7 vs 0.92 vs 0.S7), 
or 3 years (0.79 vs 0.S5 vs 0.S7) (p=O. 1 7). Analysis of freedom from 
cardiac-related mortality demonstrated no difference between the groups 
(p=O.7 J ). Sudden death occurred in 21\3 7 pis on Meds, 2/63 pis with DC 
ablation, and 3/132 pis with RF ablation (P=NS). 
Therefore, in similar pis with AF treated by medications or A V nodal 
ablation there is no difference in either cardiac-related mortality or total survival 
in long:term follow-up. These findings suggest that decisions regarding the 
advisability of A V nodal ablation should be based on the degree of symptoms 
rather than on the impact on long-term survival. 
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863-91 
Electrogral1l'i Recorded From the Ablation Site I&!:ini the 
Application of Radio Frequency Energy in Patients 
Undergoing Catheter Ablation 
Bruce N. Goldreyer, Kim Stephens. Serge A. Tobias. San Pedro 
Peninsula Hospital. San Pedro. CA. 
Standard electrophysiology catheters have not allowed 
simultaneous electrogram (EGM) recording from the ablation site 
during the application of radiofI:equenc.y ou:> ene!gy.. A 
specially designed catheter, employmg a distal sumulaung tip of 
2 or 4 mm2, in combination with orthogonal circumferential 
electrodes I mm proximal to the tip, was used to record local 
endocardial activation during bipolar stimulation and/or RF 
ablation in 45 patients. 
The timing of local endocardial activation, as sensed from 
the orthogonal electrodes, was identical to that recorded between 
the contacting tip electrode and ring. Orthogonal EGM's were 
more discrete signals with marked attenuation of far-field events. 
Fragmented near-field potentials w~re recorded. during 
stimulation in the relative refractory penod of local ussue and 
during pace-mapping prior to the onset of the propagating 
depolarization. Fragmented mid-diastolic potentials were clearly 
demonstrated on orthogonal EGM's during atrial flutter (AF) and 
ventricular tachycardia (VT). In 18 patients, orthogonal EGM's 
were recorded from the ablation site during RF ablation of A V 
nodal tissue (3), A V nodal slow-pathway conduction (2), AF (6), 
VT (3) and WPW pathways (4). During RF ablation, progressive 
diminution of local EGM amplitude and prolongation of 
conduction time was demonstrated. Diastolic potentials seen in 
VT and AF showed fragmentation prior to arrhythmia 
termination. Catheter movement during ablation could be clearly 
demonstrated by EGM alteration. 
A specially designed catheter with unique sensing 
capabilities may prove a useful tool by allowing local EGM 
recording during electrophysiological testing and while RF 
ablative energy is applied. 
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864·92 
Array Electrode Improves Defibrillation Emcacy of an Endocardlal•
Based Lead System Compared to Standard Subcutaneous Patch 
Bruce H. KenKnight, Roger W. Dahl, David K. Swanson, Stephen J. 
Hahn, John E. Heil, and Douglas J. Lang; Tachyarrhytbmia Research, 
Cardiac Pacemakers, Inc., St. Paul, MN. 
Endocardial leads systems are routinely augmented with a 
subcutaneous (SQ) mesh patch electrode. Such systems have been 
shown to have a very high rate of clinical success but the mesh patches 
are known to exhibit positional sensitivities. are sometimes 
cumbersome to implant and may cause some discomfort to the patient. 
We hypothesized that an SQ lead system composed of several long 
flexible conductors would improve defibrillation efficacy, be Simpler 
to implant, have less positional sensitivity and cause less patient 
discomfort. This new SQ array lead is now under clinical 
investigation. In six isofluorane anesthetized pigs an endocardial lead 
system consisting of two 3.9 cm2 catheter electrodes was positioned in 
the RV apex and SVC. SQ electrodes, poSitioned on the left lateral 
thorax consisted of either a 26 cm2 mesh patch or four 17 em long 
ribbon wires (array). In each animal, paired defibrillation strength 
comparisons were performed using a standard biphasic waveform and 
an up/down protocol in two lead configurations: 1) RV+SVC(-)---> 
SQ(+) and 2) RV(-)---> SVC+SQ(+). Conversion data from 15 
fibrillation/defibrillation episodes per SQ electrode and shock 
configuration were fit to sigmoidal probability of success curves. Data 
are reported as mean 50% probability of success ± SD. 
RESULTS: Paired Student's t-test showed energy and voltage 
requirements were significantly lower with the array in both shocking 
configurations. (*p<.05) 
Energy(J) Voltage(V) Current(A) Impedance(Q) 
Patch I 17.6±.8 559±109 11.0±4 49±6 
Array I 11.6±3* 488±62* 13.0±2 27±2* 
Patch 2 11.8±2 477±30 9.8±1 40±2 
Array 2 8.2±2* 402±38* 8.9±1 33±3* 
CONCLUSION: An array of long flexible conductors Significantly 
reduces defibrillation requirements of an endocardial lead system 
compared to a SQ patch electrode in two clinically relevant 
configurations in pigs. The array electrode was easier to implant and 
should reduce patient discomfort. 
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864·93 
Spatially Distributed Non·Cardlac Electrode Reduces Endocardial-based 
Defibrillation Ene'1)' Requirements Compared to Unipolar Configuration 
Bruce H. KenKnight, John E. Heil, Stephen J. Hahn, Yayun Lin, Roger W. Dahl 
and Douglas J. Lang; Department of Therapy Research, CPI, St. Paul, MN. 
The most beneficial endocardial-based implantable cardioverter defibrillator 
systems minimize both surgical invasiveness and therapeutic shock strength 
requirements. The weighted balance of these two factors has not yet been fully 
defined clinically. Recently, a "unipolar" electrode configuration (BC) has been 
introduced that requires prepectoral placement of the pulse generator shell which 
serves as an electrode. However, direct comparisons between defibrillation (OF) 
efficacy of the unipolar and other experimental ECs have not been reported. We 
tested the hypothesis that increasing the effective area of the non-cardiac electrode 
improves DF efficacy without significantly complicating the implantation 
procedure. DF shock strength requirements for endocardial-based ECs were 
determined in 6 isoflurane-anesthetized pigs (35-45 kg). Both configurations used 
a catheter-mounted coil electrode (3.9 em', cathode) located in the RV apex. The 
anode for configuration A consisted of electrically common coil electrodes in the 
SVC (3.9 em') and three parallel ribbon wires (0.5 mm x 2 mm x 20 em) in the 
left lateral subcutis centered on the mid-axillary line. For configuration B, the 
anode was formed by a simulated pulse generator shell (-60 em'). In each pig, DF 
probability curves were generated from shock strength data collected during 10 
episodes of VF using a modified up/down protocol. All internal shocks (biphasic, 
single capacitor, 80% fixed-tilt, phase I duration = 60% total duration) were used 
to fit sigmoidal curves relating DF probability to energy delivered, peak voltage 
and peak current. Additionally, electrical impedance to each shock was 
determined. Values corresponding to 50"10 DF probability were extracted and 
statistically compared. ESO, VSO and Z, but not ISO, were lower for A (* = P < 
0.05 compared to B). 
Configuration 
A 
B 
l2Q..ill 
IS.4±S.3' 
30.4±9.6 
VSO (V) 
464±78' 
624±82 
150 (A) 
10.9±2.3' 
IJ.2±J.6 
Z(o) 
43±6' 
56±4 
Electrode configurations incorporating spatially distributed thoracic electrodes 
.displayed superior DF efficacy compared to the unipolar configuration in pigs. 
Future clinical studies should define an appropriate balance between invasiveness 
and efficacy. 
864·113 
Innuence or a Rigbt Ventricular Foamed Electrode on Defibrillation Efficacy 
'-tasahiro Usui, Bruce H. KenKnight, Gregory P. Walcott, Dennis L. Rollins. 
Patrick D. Wolf. Williams M. Smith. Raymond E. Ideker. 
Duke University Medical Cenler, Durham. NC 
Endocardial lead systems require higher energy levels than epicardial lead 
systems. The area of the right ventricular (RV) electrode contacting the endocar•
dia! surface is so small that the high current density at the electrode may have a 
detrimental effect on defibrillation. The purpose of the study was to determine 
whClher defibriJ1alion shock strength requiremeDls were different for endocardial 
RV-superior vena cava lead systems having an RV electrode (I) intimately con•
tacting the RV free wall or (2) intentionally spaced away from the endocardium 
using a physical barrier that does not impact current flow. The physical. but not 
electrical. barrier was provided by 5-10 mm of an open cell foam. Each RV elec•
trode was positioned in the apex. Defibrillation waveforms were created by an 
arbitrary waveform generator. In 8 anesthetized pigs, ventricular fibrillation was 
induced by using a 6O-Hz a11erDating current and defibrillation was attempted using 
a 6 ms/6 ms biphasic, single capacilor waveform. An up/down protocol (0.4 A 
resolution) requiring fifteen shocks was used to determine the defibrillation proba•
bility of success curve. Peak voltage. mean current, and total energy at 50% 
probability of success were compared by a paired Student's t test. Data are ex•
pressed as means ± SD. 
Peak voltage (V) 
Mean current (A) 
Total energy (J) 
(I) No foam 
427±60 
5.68±0.77 
13.1 ± 3.4 
(2) Foamed electrode 
455 ±52 
6.19 ±0.88 
15.1 ±3.8 
p value 
0.035 
0.036 
0.022 
These results suggest that as little as 5 mm spacing between the RV electrode 
and the endocardium lowers defibrillation efficacy. This decrease is most likely 
due to the shunting of current preferentially away from the higher impedance myo•
cardium to the blood. These results also suggest that contact between the catheter 
and the myocardium does not hurt defibrillation efficacy and may help. 
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864-114 
All.cpuriml loIierB Def:llrll.l.atial 'l!Jresbllds 
w. ~ey Johnson, saed F. saedi, M. Laxman Kamath, 
ClIerie '!'auro, Robert Stawicki, Galen Van Wyhe, Joam 
Kiemen, and Imran K. Niazi, st. Mary's Hospital, 
Milwaukee, WI 
The effect of allopuriool (AILO) on internal 
defibrillation thresholds (DFl') was studied in 22 
patients undergoing implantation of CPI ventak 1600 
defibrillators for clinical ventricular tachycardia 
or ventricular fibrillation (VF). Q)ronary artery 
disease was present in 19 patients and cardianyopathy 
in 3. The mean age was 64:9.5 and mean LVEF 30.5:13. 
Transthoracic lead systens were implanted in 8 patients, 
and transvenous CPI Endotak leads in 14. DFl"s were 
determined after acininistering 1200 ng ALLO over 24 
hours (DFl'#1); and again, after allowing the drug to 
clear(DFl'#2), in all 22 patients. 9 of these patients 
were again loaded with AILO and had DFl" s 
determined(DFl'#3). In each case, OF'!"s were determined 
after 10 seconds of VF, in decrements of 2 to 5 joules, 
till threshold was reached. Drugs known to effect 
DFl" s were discontinued or kept constant during each 
set of DF'!"s. Intraoperative DFl"s were excluded fran 
the study, 
Results DFl'1I1 DFl'#2 DF1'II3 
(ALLO, N=22) (00 AILO, N=22) (AILO, N=9) 
DF'!' 14,3:7 21.3±9 16:6.8 
(J) --P<.001- --P=.03 ......... 
ALLO significantly and reproducibly lowers DFl"s; this 
may be due to its inhibition of free radicals generated 
as a result of ischemia, during VF. 
864·115 
aass m AntiantJytbmic Effects of LY·190147 on Defibrillation 
Thresbold 
Greg N. Beatch, David R. Dickenson, Randall H.Wood, Anthony S.L. 
Tang, U. of Ottawa Heart Institute, Ottawa, ONT, Canada 
8SA 
A cumulative dose-response study was perfonned to assess the effects 
ofL Y -190147 (L Y) on defibrillation threshold (DFT). DFT was detennined 
in II mongrel dogs (20-35 kg). In 7 of these dogs VERP and steady state 
epicardial monophasic action potential duration (APD) were recorded at 300 
ms pacing cycle length. Patch defibrillation electrodes were sutured to the 
epicardium after thoracotomy. DFT, VERP. and APD recordings made at 
pre-drug (PD); 0.03 (DI); OJ (D2); and after 3.0 mglkg, i.v. bolus (D3) 
with 1.5 hour dosing intervals. DFT -Volts (V .. .J, Current (I...J and 
Energy VERP & APD" were' , 
Dose DFT-V .... DFT- I",., DFT -Energy VERP APD" 
(Volts) (Amps) (Joules) (ms) (ms) 
PD 3S3±72 6.2±1.6 6.8±2.9 176±11 156±12 
DI 327±SS 6.1±1.2 6.0±1.9 179±IS 167±2S 
D2 286±41" S.S±J.3 4.7±1.4** 196±14** 178±21* 
D3 303±36* 6.2±1.6 S.4±I.S* 191±9** 18S±23* 
(Mean ± S.U., p<U: J),"°p<O.OI compared to P J) 
Class III anti-arrhythmic effect appeared to have reached its maximum 
effect at D2, with no additonal benefit seen with D3. 
ColIClusiom: L Y has potent Class III antiarrhythmic actions. L Y reduced 
DFT-V .. ox and Energy at doses associated with significant widening of 
VERP and APD. 
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864·116 
The Effect of Tilt on Defibrillation Efficacy 
Stephen R. Shorofsky, Andrew H. Foster, Michael R. Gold, 
University of Maryland, Baltimore, MO. 
Automatic implantable defibrillators (ICO) use truncated 
exponential waveforms for defibrillation. Depending on the device, 
the pulse width is either automatically or manually adjusted to 
achieve tilts of about 65%. This value was chosen based on 
theoretic and experimental animal data. To evaluate the effect of 
tilt on monophasic defibrillation thresholds (OFTs) in humans, we 
studied 17 consecutive patients undergoing ICO implantation (11 
patients with transvenous systems and 6 with conventional double 
patch systems). OFTs were measured using a step-down protocol 
at 35%, 50%, 65%, and 80% tilts by altering the defibrillation 
waveform pulse width (PW). Mean defibrillation impedance was 41 
± 60, and the capacitance of the external defibrillator was 
150pF. 
A tilt of 65% yielded the lowest OFT voltage in only 7 out of 17 
patients. Significantly lower OFTs (:o!:40V) were obtained using 
other tilts in 5 patients. We conclude that 1} OFTs in humans are 
relatively insensitive to varying tilts between 50% and 80%, and 2) 
the tilt necessary to optimize OFTs vary among patients suggesting 
that empirical testing is of value in the treatment of patients when 
high thresholds are observed. 
864·117 
Effect of Capacitor Size on Defibrillation Threshold In Humans 
Charles O. Swerdlow, Robert M. Kass, Sharo Raissi. Cedars-Sinai Medical 
Center, Los Angeles, CA. 
Background: For implantable-defibrillators, smaller output capacitors 
permit smaller pulse generators that deliver stored energy in shorter pulses. 
The effect of varying capacitor size on defibrillation threshold (OFf) in 
humans has not been reported. Methods: OFf was measured for standard 
120 microfarad (pF) capacitors and smaller 60 IlF capacitors at defibrillator 
implantation. We gaw simultaneous, bidirectional pulses using right 
ventricular, coronary sinus, and subcutaneous electrodes in 9 patients and 
single pulses between 2 epicardial electrodes in 7 patients. OFf was 
determined by a binary-search algorithm with constant-energy steps of 2.5 
joules after 10 sec of ventricular fibrillation. We used monophasic, 
truncated exponential pulses with 65% tilt. Rtsults: The table shows OFfs: 
Energy (jou les) 
Voltage (volts) 
Current (amps) 
Impedance (ohms 
Pulse width (ms) 
) 
Epicardial (n=7) 
1201lF 601J,F 
5.8 ± 5.0 6.9 ± 6.4 
323± 119 476± 194 
8.2±3.8 12.5 ± 6.3 
41±6.7 40±6.7 
5.0±0.9 2.7 ± 0.7 
P 
NS 
.002 
.004 
.02 
.001 
Transvenous (n-9) 
1201J,F 601J,F 
13.6±5.6 12.8±5.5 
465± 106 638± 145 
11.2±4.t 15.8±5.6 
5O±10 47±9.2 
6.2± 1.2 3.0±0.6 
P 
NS 
.001 
.001 
.002 
.001 
Conclusions: Voltage and current OFfs are higher for smaller capacitors, 
but energy OFf is not significantly different. Smaller capacitors may 
decrease the size of implanted pulse generators without compromising 
energy OFf. 
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864·118 
Double·Pulse Defibrillation Reduces Defibrillation 
Energy for Longer Duration Shocks 
° Robert J. Sweeney, ° Robert M. GiH, ° Philip R. Reid 
Ully Research Laboratories, Eli Ully and Company, Indianapolis, IN 
Increasing a shock's duration usually reduces the current required 
for defibrillation but increases the total energy. The double-pulse 
method of combining two shocks for defibrillation Is another method 
to effectively double the total shock duration. To test if these 
methods for increasing total shock duration had different effects on 
total energy, we compared defibrillation thresholds for single and 
double-pulse shocks with the same total duration In six 
pentobarbital anesthetized dogs. Single (5) shocks were rectangular 
current pulses with 4 to 24 msec duration. Double-pulse (DP) 
shocks had two rectangular pulses (each 2 to 12 msec iong) with 
leading edges separated by 85% of the fibrillation cycle length. 
Shocks were delivered under computer control according the cycle 
length of the VF episode being defibrillated. Animals were 
electrically induced into VF and shocked after 15 seconds across disk 
electrodes on the RV base and LV apex. The currents required for 
50% success at defibrillation and the ratios of DP total energy 
divided by S total energy were (mean ± SO): 
Total Duration 5 (amps) DP (amps) 
4 msec 3.92 ± 0.58 4.09 ± 0.74 
8 msec 2.84 ± 0.68 2.83 ± 0.61 
12 msec 2.72 ± 0.81 2.65 ± 0.67 
16 msec 2.54 ± 0.65 2.38 ± 0.65 
24 msec 2.33 ± 0.77 2.03 ± 0.59 
(0 Different from 1.00 by t-test, p So 0.02) 
Energy Ratio 
1.08 ± 0.13 
1.00 ± 0.11 
1.01 ± 0.37 
0.89 ± 0.16 
0.80 ± 0.18 • 
While increasing the total shock duration by both methods reduced 
the current and increased the total energy for defibrillation, the 
double-pulse method required up to 20% less energy at long 
durations. We conclude that delivering shocks as double-pulses is a 
more effective method of Increasing total shock duration (and 
reducing current) than Increasing the duration of a single shock. 
864·119 
Intravascular Guide Wire Current Shunting During 
Nonthoracotomy DelibriUator Implantation 
John F. Swartz, Pamela E. Karasik, John Donofrio, Ross D. Fletcher. 
Uniformed Services University, Bethesda, MD and Veterans 
Affairs/Georgetown Medical Centers, Washington, D.C. 
Nonthoracotomy defibrillator systems are implanted using 
techniques similar to those used for permanent pacemaker 
implantation. It is common practice to retain intravascular guide 
wires during pacemaker lead placement and testing to preserve 
vascular access sites. However, guide wires retained during 
placement and testing of nonthoracotomy defibri11ation lead systems 
may contact defibrillation electrodes positioned in the superior vena 
cava (SVC). The purpose of this study was to test the hypothesis that 
intravascular guide wires may cause cunent shunting during testing 
of nonthoracotomy lead systems that include an SVC electrode. 
Leading edge impedance of a 100 V, R-wave synchronous, truncated 
exponential monophasic waveform was measured before and after 
guide wire removal in 25 patients. 
The RV·SVC pathway impedance was falsely reduced 15.1±4.8 n 
(25%), from 59.9±7.9 n to 44.8±6.8 n (p<O.OOI) when the guide wire 
was retained. 
Conclusions: 1) An intravascular guide wire Significantly reduces 
RV-SVC pathway impedance due to SVC electrode contact and 
artificial electrode surface area increase. 2) Current shunting 
associated with guide wire use may cause erroneous defibrillation 
threshold results. 3) Intravascular guide wires should be removed 
prior to non thoracotomy defibrillation threshold testing. 
lACC February 1994:IA-484A 
864·120 
Inverse Relationship of Defibrillation Impedance and Delivered 
Energy 
Daniel N. Weiss. Zenaida Feliciano. Rangarao V. Tummala, Stephen R. 
Shorofsky. Andrew H. Foster. Michael R. Gold. UnivelSity of Maryland 
School of Medicine. Baltimore. MD 
Defibrillation impedance (R) is presumed to be independent of delivered 
energy (E). To test this. and to determine the relationship between E and 
R. we prospectively studied 30 consecutive patients who received 
implantable cardiovener-defibri1lator (lCD) systems. We compared those 
who received a transvenous coil and a patch (TV) with those who received 
traditional 2 epicardial patch systems (Epi). Mean age (63.1 ± 11.5 yr) and 
EF (.29 ± .12) did not differ statistically between the 2 groups. The'results 
are summarized in the ~ below. Note that R rises as E is reduced. The 
differences in R values WIthin groups are significant when E < 10 J. while 
differences in R values between groups is significant when E < 3 J. 
225 ~1V 
200 ~ Epi 
175 g ISO 
I 125 100 75 
SO 
25 
0 I : ., , ""., i "" .. i '''''., 
.01 .1 1 10 100 
Energy (1) 
In conclusion. R is not independent of E. and increases considerably at 
low energies. This relationship is even more marked for transvenous 
systems than for traditional epicardial patch systems. In ICD systems with 
programmable pulse widths. pulse width duration needs to be adjusted at 
low energies to account for the higher defibrillation impedance. 
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865·5 
Increased Electrophysiological Responsiveness of Cardiac 
Myocytes to Isoproterenol After Their Exposure to 
Acetylcholine 
Yejia Song, John C. Shryock, Luiz Belardinelli. University of Florida, 
Gainesville, FL. 
An adaptive increase in isoproterenol (lSOl-stimulated adenylyl 
cyclase activity in cardiac cells after termination of an exposure to 
cholinergic agonists has been reported. We tested the hypothesis 
that the electrophysiological responsiveness of guinea pig ventricular 
myocytes to ISO may also be increased after termination of the 
exposure to acetylcholine (ACh). Isolated myocytes were 
consecutively exposed to ISO (3- 8 min), ISO+ACh (2-4 min) and 
ISO + atropine (3 min). Either action potential duration (APD) or 
calcium current (Ie.) was measured during drug exposure. ISO 
increased APD and Ie. from 266±21 to 311 ±26 ms (n=12) and 
from 1.2±O.1 to 2.1 ±O.2 nA (n=9), respectively, and induced 
delayed afterdepolarization (DAD). The effects of ISO were 
effectively attenuated by ACh. However, immediately after 
termination of ACh exposure, the ISO-induced Ie. and prolongation 
of APD were transiently (lasted about 1 min) yet significantly 
increased by 94% and 187%, respectively, causing the APD and Ie. 
to ·rebound· to 395±37 ms and 3.0±O.3 nA. Moreover, the 
average amplitude of ISO-induced DADs was then increased by 4.5-
fold, and sustained triggered activity developed in some cells. Similar 
responses were seen when ISO was replaced by forskolin (a direct 
adenylyl cyclase activator) but not by Bay K 8644 (a calcium•
channel agonist). Our results thus demonstrate an increased 
electrophysiological responsiveness of the ventricular myocytes to 
ISO after termination of an exposure to ACh and suggest a role for 
an increased adenylyl cyclase activity in mediating the process. 
ABSTRACTS 87A 
865·6 
C .... dtrlzdon III Exc:llablt Gap In a Func:tionaly o..rmlned AniIoIropic 
RHnlnlnt CIn:uI 
Shinichi Niwano, Albert L. Waldo, CWRU, Cleveland, OH. 
Single premature beats were introduced in the reentrant circuit during stable 
atrial flutter (AFL) in the canine pericarditis model to test the hypotheses that: I) 
some, but not all areas of the reentrant circuit have a fully excitable gap; 2) the 
return cycle after a premature beat may be prolonged despite the presence of a fully 
excitable gap; 3) the slowing of conduction in the reentrant circuit caused by a 
premature stimulus results in a progressive increase in coupling interval (CI) 
throughout the reentrant circuit; and 4) the CI which terminates AFL is different 
than the effective refractory period (ERP) of the same area during sinus rhythm. 
Me ....... : A multiplexing system was used to record 190 unipolar electrograms from 
an electrode array placed on the right atrial free wall during 18 AFL episodes in 9 
dogs. During AFL, single premature stimuli at twice threshold strength were 
introduced (i.e. resetting) at 2 ms decrements from the AFL cycle length (CL) via 
bipolar tungsten electrodes placed in the reentrant circuit until either the local ERP 
or AFL termination was obtained. Conduction times across each area of slow 
conduction (ASC), the sulcus terminalis region and the pectinate muscle region were 
determined during resetting. When the AFL was terminated, the CI at the site just 
proximal to the block of the orthodromic wave front was considered the ERP of that 
area during AFL (ERP-AFL). This was compared with the ERP of the same area 
during overdrive pacing of sinus rhythm at the AFL CL (ERP-NSR). ReauJ .. : In all 
AFL episodes. each premature stimulus reset the AFL CL. With progressively 
shorter Cis of the premature stimulus: I) the return cycle progressively prolonged; 
2) conduction times in the ASCs progressively prolonged; and 3) conduction times 
in the other parts were constant (indicating fully excitable gap) until at a critically 
short CI, then it progressively prolonged. In 13/18 AFL episodes (mean CL 126%6 
ms), a premature stimulus (mean coupling interval 96%8 ms) tenninated AFL by 
causing block of the orthodromic wave front of the premature beat in an ASC. The 
ERP-AFL (mean 113:1:5 ms) was always longer than the ERP-NSR (mean 90:1:4 ms, 
p<O.OOI). Co_IUllo ... : In this functionally determined anisotropic AFL reentrant 
circuit in the canine sterile pericarditis model: I) there is a fully excitable gap 
despite the presence of a prolonged return cycle; 2) the CI of the premature stimulus 
does not reflect the CIs in other parts of the reentrant circuit; and 3) the ERP-AFL 
is different than the ERP-NSR in the ASC, suggesting that block of the premature 
beat may be due to factors other than refractoriness. 
865·7 
Pharmacological Profile of Two Human Cardiae Potassium 
Channels 
David J. Amold, William J. Crumb, Jr., Arthur M. Brown,Barbara Wible, 
Baylor College of Medicine, Houston TX 
The electrophysiologic characteristics of atrial and ventricular 
myocytes, either epicardial or endocardial, result in regionally specific 
phannacology and physiology. These differences in electrophysiology 
are detennined in part hy the specific ion channel composition of the 
cells. Cardiac myocytes have a number of different potassium currents 
and analysis is greatly facilitated by the study of individual cloned ion 
channels. A phannacological profile would be essential in correlating 
these channels with specific currents in human cardiac myocytes. 
Two rapidly activating delayed rectifier potassium channels DRK 1 
(Kv2.J) and fHK (Kv1.5 isoform) have been cloned from human cardiac 
tissue. We characterized the effects of the quaternary amine clofilium 
and some selected methanesulfonanilides (dofetilide, E-403 I and sotalol) 
on DRK J and fHK. These channels were cloned and stably expressed in 
a human cell line (HEK-293 cells) and studied by voltage clamp 
techniques using macropatches in the inside-out configuration. The 
DRK I clone used was isolated from rat brain and its conserved 
hydrophobic core is virtually identical to the core of a DRK 1 clone we 
have identified in human heart. DRK 1 was relatively insensitive to 
dofetilide, E-4031 and sotalol with 1CSO values of 31, 86 and 246 flM, 
respectively. fHK was insensitive to all selected methanesulfonanilides. 
DRK I and fHK were very sensitive to clofilium both having an 1CSO of 
68nM. 
This phannacological profile will permit the ready distinction of 
these two rapidly activating human cardiac potassium channels in human 
cardiac myocytes. Understanding the ion channel composition of cardiac 
myocytes allows correlation of molecular mechanisms to global 
physiology and pathophysiology. 
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865·8 
Effects of Class m Drugs on AV Node Functional Properties 
Moshen Nayebpour, Jacques Billette, Farid Amellal, Stanley Nattel, 
Montreal, Canada 
A V node refractoriness has traditionally been related to the 
recovery of calcium channels, and changes in action potential duration 
(APD) have been considered to playa minor role. However, there is 
some clinical evidence to suggest that class III drugs can terminate 
A V node reentry. To determine the ability of such agents to alter AV 
nodal function, we assessed selectively the functional properties of AV 
nodal refractoriness (A VERP) time-dependent recovery from 
premature activation (REC), the facilitating effect (F AC) of premature 
beats to reduce REC effects on subsequent beats, and the fatigue 
(FA T)-induced slowing of A V nodal conduction resulting from 
sustained rate increases. The specific II blockers E-4031 (E, dose I 
(dl)=O.l 11M; dose 2 (d2)=O.S 11M) and d-sotaIol (S, dl=l00 11M; 
d2=SOO 11M) were studied in 6 isolated rabbit AV node preparations. 
&mIti .Qmb:l!l E..Jl1 E.....G .Qmb:l!l s..JIl s....dl 
(ms) 
AVERP 121 ±9 17H38 2IS±30* 106±4 142±9*182±9** 
T... SS± 16 79±23 106± 18" S3±S 48±S SHS 
AFAC 23±3 31±S 29±l0 1S±3 23±3 23±3 
AFAT 12±3 17±4 21±4" 8±3 10±3* 16±2** 
T = time constant of AV recovery course, AFAC = left shift of 
r;;overy curve following early premature activation, AFAT = time•
dependent increase in AH interval upon rate increase. * p < O.OS, 
**p<O.OI. 
Conclusions: (1) Class III drugs increase AVERP and FAT-induced 
conduction slowing at rapid rates; (2) These changes in AV node 
function are attributable to APD prolongation. These results indicate 
an important role for Ix and APD in governing A V nodal function, 
and explain the beneficial effects of class III drugs in A V node 
reentry. 
865·61 
Intracoronary Arterial Embolization and Electrothrombosis: 
A Novel Technique Potentially Useful for Ablation of Cardiac 
Arrhythmias 
Ruey J. Sung, Tain-Yen Hsia, Gene Samson, Robert Kernoff, 
Margaret Billingham, Stanford University, Stanford, CA 
To develop a new technique for ablating arrhythmias by 
interrupting coronary perfusion to the myocardium, we studied. 8 
mongrel dogs, weighing 24-34 Kg. Under the angiographlc 
guidance a microcatheter (1.0 mm diameter) was introduced into a 
branch of the diagonal, obtuse marginal or posterior descending 
artery. A detachable platinum coil (PC) (0.026 mm diameter, 3 em 
length) soldered onto a stainless steel delivery wire (Guglielmi) 
was inserted through the microcatheter and advanced to occlude 
the selected arterial branch. A O.S-mA electric current applied to 
the proximal end of the delivery wire resulted in thrombosis due to 
attraction of negatively charged blood cells, platelets and 
fibrinogen to the positively charged PC. In 4.S min., as the 
thrombus was formed, electric current dissolved the soldering and 
detached the PC from the delivery wire. Electrocardiograms 
showed focal ST-T changes but no ventricular tachyarrythmias. 
Pathologic studies revealed thrombosis around the PC and 
demarcated focal ischemia/infarction correlated with elevation of 
cardiac enzymes. We conclude that intracoronary arterial 
embolization and electrothrombosis using an electrolytic PC can be 
selectively performed in a very small coronary arterial branch 
resulting in a limited area of myocardial damage. This technique is 
potentially useful for ablating cardiac arrhythmias and may be 
safer and more controllable than intracoronary alcohol infusion. 
lACC February 1994:1A-484A 
865·62 
Rapid Determination of Apparent Quinidine Binding Rates In 
In Vivo Canine Myocardium using Combined Analysis of 
Incremental and DeClining Conduction Velocities 
Frank N. HalJgland, Susan B. Johnson, Douglas L Packer, Mayo 
Foundation, ROchester, MN 
PreviOUS determinations of apparent rate constants describing 
quinidine binding to canine myocardium In vivo required anal),sls of 
either decllnlna normalized squared conduction velocity (92(N)) or 
Incremental 92(N) generated by multiple pulse trains coverl~g a 
wide range of Inters6mulus Intervals (ISiS). We therefore exarnuled 
whether complete quinidine binding rates could be extracted from a 
simplified analysiS combining Incremental and declining 92(N) 
recorded using a 56 bipolar electrode mapping system during a 
single 27s pulse train sweep (N - 14 dogs). A 12s step decrease 
In lSI from 1.0 to 0.3s followed by a 121 retum to lSI = 1.0s elicited 
a monoexponential decrease In 92(N) with an apparent drug uptake 
rate ),: followed by a monoexp<lnentlal Increase In 92(N) with an 
appWerit drug decline rate, R),.'. Exploiting the approximation that ),.' 
and R)'" are identical linear functions of the recovery Interval (t" 
where Ir .. ISI-APDeo) such that R)'" .. ),.' • Aeta + Arlr (where Ae Is the 
activated state drug uptake rate, Ar Is the resting state drug uptake 
rate. and 1. is the assumed mean channel open time of 1ms), the 
apparent rate constants for quinidine binding and unbindinp to 
activated (ka, lal and resting (k" I,) sodium channels were derived 
(Combined 92 method). Alternatively, step decreases In lSI tror.n 
1.0 to 0.75, 0.6, 0.45 or 0.3s elicited monoexponentlal decreases 111 
92(N), each quantified by),.·. From this fam!ly of curves! the 
quInidine binding rates constants were determined as previously 
described (Declining 92 method): 
ka(X106M-1s-l) 1.(S·I) k,(x103M-1s-l) I,(S·I) 
Combined 92: 8.7±3.9 72:1:29 10.6±8.9 0.54±O.24 
Declining 92: 10.214.7 84±42 14.6±13.6 0.48±O.22 
The combined approach yielded rate constants equivalent to those 
derived using multiple pacing interventions. This simplified 
approach allows quinidine binding rates to. be d~termined r.api?ly 
during acute experimental interventions which might alter qUinidine 
efficacy. These methods could also be applied to quantify 
antiantlythmic drug action In man. 
865·63 
Mediation of Mechanoelectrical Feedback by Ca1+. 
Activated Potassium Channels 
Erica D. Engelstein, John A. Zelano, Robert E. Helm, Karen 
Bennan, Ellen Kim, Bruce B. Lennan. Cornell University Medical 
College, New York, NY. 
We have previously shown that changes in preload can increase 
electrical excitability of the heart by shortening action potential 
duration. This was hypothesized to be mediated by Ca2+-activated 
potassium channels, IK(Ca). To test this hypothesis, we studied the 
effects of charybdotoxin (CHTX), a specific inhibitor of IK(Ca), and 
pinacidil, a potassium channel opener, on preload mediated changes 
in electrical excitability and action potential duration in 13 isolated 
canine hearts (modified Langendorff preparation). Monophasic 
action potential duration .at 90% repolarization (MAPD90) and 
excitability (strength-interval curves) were determined at low and 
high end-diastolic left ventricular filling volumes before and after 
pretreatment with CHTX (30 nM) and pinacidil (0.5-1.0 mM). 
Results: During control, an increase in end-diastolic volume from 
16±2 to 44±3 ml resulted in shortening of MAPD90 from 192±16 
ms (mean±SD) to 180±15, the relative refractory period (RRP) 
from 183±17 to 179±17 ms, and the absolute refractory period 
(ARP) from 162±IS to 154±17 ms (all P<0.05, n=7). Following 
CHTX, an identical increment in preload failed to shorten MAPD90, 
RRP or ARP. When in another 6 dogs MAPD90, RRP and ARP at 
low preload were significantly shortened (by 44±33, 28±27 
and28±16 ms respectively) by increasing K+ conductance with 
pinacidil (which likely overrides the effects of IK(Ca), changes in 
MAPD90 and excitability in response to increased preload were 
abolished. 
Conclusions: Mechanoelectrical feedback, defined as changes in 
mechanical state that precede and alter action potential duration and 
electrical excitability, appears to be mediated in part by Ca2+•
activated potassium channels. 
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866-77 
Magnetic Resonance Imaging of Left Vantrlcular Masi. Gaometry and 
Function In Elite Cyclists and Weightlifte,. 
Ernst E. van der Wall. Babette M. Pluim. Albert de Roos. Hans-Marc J. 
Siebelink. J.C. Chin. A. van der Laarse. A.V,G. Bruschke. Departments 
of Cardiology and Radiology. University Hospital Laiden. the Netherlands. 
The goal of the study was to accurately determine by cine magnetic 
resonance imaging (MRII whether selected groups of elite endurance- and 
strength-trained athletes show characteristic patterns of left ventricular 
hypertrophy (LVH' and functional cardiac changes in comparison to a 
nonsedentary control group. We studied 39 subjects consisting of 13 
cyclists and 14 weight-lifters. and 12 control subjects matched for age. 
sex and weight. Both the cyclists and weight-lifters were participants at 
national level competition. MRI was performed at a field strength of 1.5 
Tesla. The following parameters (mean ± SO. were obtained: left 
ventricular mass (LVMI. LVenddiastolic volume (LVEDV'. LV relative wall 
thickness (LVMIlVEDVI. stroke volume (SV'. fractional shortening (FS'. 
LV ejection fraction (LVEF'. and systolic wall stress (WS •. 
Controll Cyclists :'!i¥~t-lifter. p-yaJue 
n-12 n-13 
LVM 168.7±18.2 243.2 ± 19.2' 184.2±22.8 0.0001 
LVEOV 154.3% 22.0 207.9%22.4' 174.0±32.4 0.0001 
LVMILVEOV 1.1 ±0.1 I.UO.l 1.1 ±0.2 NS 
SV 98.7±15.9 133.4±21.3· 113.3±28.4 0.0014 
FS 0.4±0.1 0.4±0.1 0.4±0.1 NS 
LVEF 64.1 %8.7 64.0±5.8 64.h7.3 NS 
WS 31.4±3.0 32.0±2.8 34.5±6.4 NS 
'Significantly different from weight-lifters and controls 
Conclusion: our MRI data show eccentric LVH and increased volume 
parameters in cyclists. but fail to show the frequently assumed concentric 
LVH in weight-lifters. None of the endurance-trained athletes had 
abnormal LV function parameters. indicating that L VH in cyclists was 
functional rather than pathophysiological. 
866-78 
Usefulness of MRI for Diagnosis of Amyloidosis Cardiac Involvement: 
An Alternative to Endomyocardial Biopsy. 
A. Furber, J.J. Le Jeune, J. Laporte, P. Pezard, P. Geslin, A. Tadei. 
Cardiology and Nuclear Medicine departments. C.H.U. ANGERS - FRANCE. 
To assess the role of magnetic resonance imaging (MRI) in the 
detection of cardiac involvement in patients with amyloidosis, 
echocardiography and MRI were performed in 5 consecutive patients 
with rectal (n=5) and cardiac (n=3) biopsy-proved amyloidosis. All 
patients had typical er' .rliographic features of cardiac involvement. 
METHODS: The stu, was performed with a supraconducting magnet 
operating at 0.5 Tusing ECG gating (Gyroscan Philips T5). The 
protocol included T1 weighted images ( TE = 25 msec, 8 mm slice 
thickness, matrix size 256 X 154, 4 acquisitions) in axial and (".oronal 
or sagittal planes and n weighted sequence ( TEl = 30 msec, TE2 = 
90 rnsec, 8 mm slice thickness, matrix size 256 X 154, 4 acquisitions) 
in axial direction. Moreover, an gradient-echo sequence (TE = 9-11 
msec, flip angle 40 0) was used to visualize in cine-MRI the movement 
of the LV wall in the sagittal and coronal planes. 
RESULTS: The Tl weighted images identified abnormalities included 
thickened right and left ventricular walls, thickening of interatrial 
septum, thickened papillary muscles, thickened atrio-ventricular valve 
leaflets, left atrial enlargement, normal pericardial thickness and 
pericardial effusion. The T1 and n weighted spin-echo sequences 
showed an increased myocardial signal intensity that was higher than 
skeletal muscle signal intensity calculated in the same images. Cine•
MRI showed impaired global left ventricular function with reduced 
systolic wall thickening. 
CONCLUSION : Our preliminary results suggest that the tissue 
alterations caused by myocardial amyloid infiltration induce abnormal 
signal intensity of the myocardial walls detectable using specific 
sequences. This technique seems to be able to quantify the amyloid 
infiltration and thus to monitor disease progression 0)" response to 
treatment. If our results are confirmed, MRI will be a useful altermti.e 
to endomyocardial biopsy or at least will allow directed biopsy in the 
diagnosis of cardiac amyloidosis. Moreover, MRI can be used to 
exclude constrictive pericarditis. 
ABSTRACTS 
866·79 
Multi-Slice Magnetic Resonance Coronary Angiography 
Bob S. Hu, Craig H. Meyer, Albert Macovski and Dwight 
G. Nishimura Stanford University, Stanford, CA. 
Magnetic resonance coronary angiography holds promise 
for the routine noninvasive examination of coronary anatomy. 
Curnently, large coronary vessels as well as significant coronary 
lesions can be detected in selected patients. Single-slice 
breath held coronary angiographic techniques are now the most 
common methods. However, the need for multiple breathholds to 
obtained the necessary slices and the inconsistencies of the 
breathholds lead to excessive scan time. We have shown the 
feasibility of submillimeter coronary angiography with a fast 
spiral imaging technique. We have now tested a multi-slice 
version of our sequence on normals as well as 10 patients. 
The basic sequence consists of a spectral-spatial 
excitation for simultaneous slice-selection and fat suppression 
followed by a fast spiral k -space readout. The sequence is 
implemented on a standard GE 1.5T Signa imager. As a single 
spiral acquisition occurs over 17 ms with a excitation-readout 
cycle time of - 40 ms, 10 or more acquisitions can be obtained in 
a single breathhold during one diastolic period. Since cardiac 
motion continues throughout diastole, overlapping slices are used 
to cover the region of interest contiguously. Flip angles are 
reduced to avoid significant saturation. In our patients, the target 
coronary vessel is covered in 2-3 multi-slice sets--signiflcantly 
reduces the number of breathholds and scan time. Signal-to•
noise ratios appear adequate without significant losses from 
either saturation from overlapping slices or the increased 
saturation of ventricular blood. The thick multi-slice set reduces 
the need to accurately position individual slices as in the single 
slice approach and appears more immune to variations in 
breathholding. 
Conclusion: Multi-slice spiral magnetic resonance coronary 
angiography is a more time-efficient method at imaging coronary 
vessels compared with single-slice techniques. 
866·80 
Stroke Volume and Cardiac Output Assessment Using 
Fourier Velocity-Encoded Magnetic Resonance Imaging 
Elie Mousseaux, Jean-Pierre Tazu, Anne Tardivon, Franyois 
Brenot, Jacques Bittoun, Odile Jolivet, Jean-Claude Gaux, Pierre 
Peronneau, CIERM & INSERM (U256), Kremlin-Bicetre, France 
The purpose was to validate right and left ventricular stoke volume 
and cardiac output measurements using Fourier velocity-encoded 
MR Imaging (vMRI). On laminar flow phantom, using a 
continuously propelled solution of 50 % Glycerol in water, volume 
flow rate has been measured over a range of 1 to 7 II mn, which 
corresponds to a maximal velocity ranging from 0,2 to 3.5 mls. In 
order to compare vMRI flow rates (mVmin) to experimental flow 
rates, parabolic velocity maps were spatially integrated over the 
section of the phantom. In vivo: In 10 healthy volunteers (HV) 
blood flow rate was estimated at each time frame of the cardiac 
cycle using vMRI (TR=25ms) within main pulmonary artery 
(MPA) and within ascending aorta. By integration of blood flow 
rate over the entire cardiac cycle, stroke volume (SV in ml) of right 
and left ventricles (RV and LV) were obtained and compared. 
Furthermore, in 23 patients (in 18 patients with pulmonary 
hypertension and in 5 cardiac allografts), SV and cardiac output 
(CO = SV x Heart Rate in Vmn) assessed by vMRI within MPA 
were compared with cardiac catheterization (CC) data. 
Results on phantom : the linear regression of vMRI flow as 
function of experimental (Exp) flow was: Flow vMRI = 1.024 
Flow EXIJ - 0.69 cm3/s , r =0.99. In vivo: In HV, RV SV = 1.15 
LV SV - 5.6 ml; r = 0.98. In patients, corellations between CC and 
vMRI were : CC SV (ml) = 0.78 vMRI SV + 16, r = 0.90, SEE = 
12 ml, range 22-128 ml; CC CO = 0.72 vMRI CO + 1.56, r = 
0.86, SEE = 0.9 Vmin, range 2.34-8.8Wmin. 
In conclusion, these data suggest that in both assessment of 
ventricular SV and cardiac output, accurate measurements can be 
obtained using vMRl. This method should be particularly usefull 
for shunt quantitation and for accurately complete ventricular 
function cine MRI studies. 
89A 
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866·81 
Automated Regional Endocarclial Motion Analysis Using Contour Definition 
and Tracking Based on Shape Characteristics Using Gated Magnetic 
Resonance Imaging 
Eliot N. Heller. Albert J. Sinusas. Donald P. Dione. John McEachen. Amit 
Chakraborty. Lawrence H. Staib. Peng-Cheng Shi. R. Todd Constable. QingXin 
Shi. Michael Singer. Dominick Lippolis. James S. Duncan 
Yale University. New Haven. CT 
There are no widely accepted approaches to quantify regional motion analysis. 
We have employed a unique approach for application with high resolution 
imaging which tracks shape properties throughout the cardiac cycle. We tested 
our automated technique in the open chest canine model of myocardial'infarction 
(n=5). ECG-gated MR images were acquired. before and after LAD occlusion. 
using a 1.5 Tesla scanner and gradient echo technique. There were 16 cardiac 
frames per cycle with 10 contiguous short axis slices (5mm thick) from apex to 
base. acquired using 256x256 matrix and pixel resolution of 1.64 mmx 1.64mm. 
The short axis slice at the inferior border of the papillary muscles was selected 
for analysis. Endocardial contours were defined automatically with a program 
that uses shape constraints. gray levels and gray level gradients. We tracked 32 
equally spaced points along the endocardial contours through 16 frames of the 
cardiac cycle using our shaped based approach. The motion vector of each 
contour point was defined from frame to frame. The average infarct size as 
defined by TIC staining was 14±5% of LV. Motion was analyzed before (Base) 
and after MI in normal (NL). infarcted (IN). and horder (B) regions. Derived 
systolic motion parameters were the cumulative systolic path index (CSPI) and 
direct systolic path index (DSPI): (*p<O.OI vs Base) 
~ I2Sfl 
&iil!Il Base MI &iil!Il Base MI 
NL 20.1±4.1 19.6±4.3 NL 18.6±3.9 17 .8±2.5 
B 23.3±1.0 6.5±7.0 * B 24.6±8.0 1O.7±2.0 * 
IN 34.5±9.7 5.9±3.4 * IN 36.0±12.1 8.4±3.3 * 
Both CSPI and DSPI accurately distinguished infarct from normal regions. Under 
baseline conditions the average total path length and average final displacement 
over the entire cardiac cycle were 1O.5±!.3 and !.5±O.5 pixels. respectively. 
This suggests our approach can accurately track displacement temporally over all 
16 frames. 
Thus. this automated shaped based contour analysis approach provides 
quantitative definition of regional wall motion over a dense field of points and 
may pemit the descrimination of viable myocardium. 
866·82 
Impaired Regional Left Ventricular Long Axis Function During 
Dobutamine Stress In Patients With Ischaemic Heart Disease Pre and 
Post Angioplasty 
Stefan P Karwatowski, Nicolas A Chronos, Sandy M Forbat. Raad 
Mohiaddin. Guang Z Yang. David N Firmin. Nigel B Buller. Richard 
Underwood. Donald B Longmore. Royal Brompton National Heart and 
Lung Hospital. London U.K. 
In Ischaemic Heart Disease (lHD) stress may exacerbate resting 
abnormalities of ventricular wall motion and induce new ones. Symptom 
limited dobutamine infusion was used to induce cardiac stress and 
magnetic resonance velocity mapping (MR) used to study regional 
ventricular long axis function. 25 patients with ischaemic heart disease (9 
with prior infarction 6 female age 30-69.20 with effort induced ischaemia) 
and 9 controls were studied.. MR cine velocity information was acquired 
through a basal short axis plane. this was divided into 16 sectors providing 
regional long axis ventricular wall velocity. After a baseline study 
dobutamine was infused at 5, 10 and 151J1kglmin and the study repeated. 
Maximal early diastolic long axis wall motion was measured and 
standardised to the baseline value allowing comparison between stages of 
stress. Controls showed a percentage increase over baseline in peak mean 
long axis velocity at time of peak of 27% ±19 (p=O.OO6) and a decreased 
time to peak velocity (p=O.OO36) at the first level of stress. The velocity 
increase was not uniform. the lateral wall had the greatest increase and the 
inferior wall the least. Stress velocity profiles in controls were ranked and 
a regional reduction of 30% from base line was defined as abnormal. 5 
patient studies were unusable due to motion artefact. Patients without 
effort angina did not develop stress induced reductions in long axis 
velocity. Of IS patients with effort angina 8 developed reductions in mean 
peak long axis velocity during stress. 2 more developed abnormal regional 
reductions. I patient developed improved wall motion in an area abnormal 
at rest. Four patients who did not develop any abnormality had ischaemia 
in the inferior wall. Following angioplasty. 8 patients had a repeat study. 4 
patients with improved exercise tolerance. did not develop impairment of 
wall motion during stress. the others showed no change. MR velocity 
mapping with dobutatnine stress is a useful technique for detecting the 
effects of ischaemia on regional and global ventricular function. it was 
most sensitive to anterior ischaemia and least sensitive for inferior 
ischaemia. 
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866·83 
Quantitation of Myocardial Perfusion in Normal Subjects and 
Patients Using Subsecond Magnetic Resonance Imaging. 
Albert C. van Rossum, J. Tonnis Keijer. Machiel 1. van Eenige. 
Mark B.M. Hofman. Michel A. Galjee. Jaap Valk. Cees A. Visser. 
Free University Hospital Amsterdam and ICIN. The Netherlands. 
Myocardial perfusion can be studied by imaging the first-pass of a 
contrast agent through the myocardium using subsecond magnetic reso•
nance imaging (MRI). According to indicator-dilution theory. flow 
indices can be derived from signal-intensity (SI) versus time curves. 
Thus. mean transit time (Tm) and time to peak signal intensity (Tp) 
were measured in one preselected imaging plane in 3 volunteers and 14 
patients with I-vessel coronary artery disease or a single perfusion 
defect on Thallium-20l scintigraphy. The contrast agent Gadolinium•
DTP A was injected as a compact central bolus (0.04 mM/kg) through an 
ECG-guided intravenous catheter. To detect hypoperfusion. 
measurements were also made after hyperemia induced by 0.56mglkg 
Dipyridamole (Dipy). For analysis of the flow-indices. the myocardium 
was divided in 8 contiguous regions of interest. Based on the 
angiographic and scintigraphic fmdings regions were classified as 
presumed normal (N) and hypoperfused (H). Results: Adequate analysis 
was obtained in 87 (64%) regions before and 115 (85%) after Dipy. 
REST DIPY 
N H P N H P 
Tm (5) 12.6 15.0 0.007 9.6 10.8 0.04 
Tp (5) 6.8 8.4 0.01 5.0 5.8 0.05 
CONCLUSION:Tm and Tp were longer in hypoperfused areas than in 
normal areas before and after Dipy. However. ratios of Tm before and 
after Dipy showed no significant difference between both areas. 
Straightforward interpretation of shown values will not be possible 
unless deconvolution of the left ventricular input function is 
performed. Together with multi-slice imaging and use of intravascular 
contrast agents this should improve sensitivity for detection of individual 
perfusion defects. 
866·84 
AccUl1lcy of Bipllne Long Axil Cine MRI VoIulII8I In Patients WIth 
Regional and Global Left Ventrlcullr Dysfunction 
Mark A. Lawson. Gerald G. Blackwell. louis J. dell·ltalla. Nancy O. Davis. 
Gerald M. Pohost. Unlverslty of Alabama Medical Center. BirmIngham. 
Alabama. 
Left ventricular (LV) volumes and ejection fraction (EF) can be obtained 
usIng a serial short axJs (SA) cine MRI method besed on Slmpson's Rule. 
A simpler method of detennlnlng LV volumes using the areaolength equation 
Is widely accepted and requires less time to acquIre. Its accuracy. however. 
Is questionable In deformed or esymmetrically contractIng ventricles. 
Accordingly. the purpose of this study was to compare biplane long axJs (LA) 
to serial SA LV volumes In two distInct patient populations: 1) patIents w~h 
global LV dysfunction. i.e. dUated cardiomyopathy (OCM) and 2) patients with 
segmental LV dysfunction. i.e. coronary artery disease (CAD). 
Twenty-six studies In patients with CAD and 15 In patients with OCM were 
performed using both serial SA and biplane LA cine MRI methods on a 1.5T 
Philips ACS system. The LV end systolic (ESV) and end diastolic (EOV) 
volumes were calculated. The rasuils (mean ± SEM) compared by paired 
t-tests and correlation (p<.OOO1) for each group and are shown In Table 1. 
TABLE 1 
Dillted Cardiomyopathy Coronary Artery Di_se 
LA SA r LA SA r 
EDV(ml) 254± 23 257± 22 .96 150±9 156± 9 .89 
ESV(ml) 194+22 194± 19 .96 90±9 90±9 .97 
EF (%) 25± 2 26±2 .92 43± 3 44±3 .94 
In this study group. biplane LA computed LV volumes and EF do not differ 
significantly from serial SA computed volumes either in patients with severe 
global LV dysfunction or patients with segmental LV dysfunction. 
Therefore. biplane LA and serial SA detennined LV volumes are slmlar In 
patients with CAD or DCM. In the critically HI patient unable to complete a 
comprehensive MRI exam, the biplane LA derived volumes are adequate. 
lACC February 1994:1A-484A 
866·85 
Quantification of tbe Absolute V oIumetrk: Coronary Flow witb Dual•
Energy Digital Subtraction Angiograpby 
*Sabee Molloi, Atila Ersahin, Yao J. Qian, James W. Hicks, James B. 
Wallis, University of California, Irvine, CA 
We have previously reported on an in-vitro validation of an absolute 
volumetric blood flow measurement tecbnique using a motion immune 
dual-energy (DE) subuaction tecbnique, wbere the low and high x-ray 
energy and filtration are switched at 30 Hz between 60 kVp and 120 kVp + 
2.5 mm Cu. For in-vivo studies five anesthetized pigs (40-50 kg) were 
instrumented with an uluasonic transit-time flow (USF) probe capable of 
measuring volume flow rate and an ocduder producing stenosis in the lef! 
anterior descending (LAD) coronary artery. A bolus of non-ionic contrast 
medium was injected into the left main coronary artery (5-10 mI at 2-4 mU 
sec) while DE images were being acquired. The low- and high-energy 
images were corrected for x-ray scatter and veiling glare before subuac-
tion. Tissue suppressed 120,-----------....".., 
energy subuacted " 
images were used to ~ 100 
generate time density $ 80 
curves (TDC). iJ 
Instantaneous volumetric ~ 60 
blood flow measure- ;., I 
N=19 
R= 0.95 
ments were made using ~ 40 
the TDC and the fact rf 20 
that blood was momen- ~ 
tarily replaced with Q 0 -f-l,-T"""-...... ,...,--r~-r--I 
contrast medium during 0 20 40 60 80 100 120 
!be contrast injection. UItrMOund Flow (mllmin) 
In nineteen comparisons, the mean DE flow averaged over two hean cycles 
correlated extremely well with the mean USF probe data (1'= 0.95), with no 
significant deviation from identity (y=1.01 x - 1.63 mIlmin, SEE = 5.31).ln 
~ these data suggest thaI it may be possible to measure absolute 
volumetric coronary blood flow during routine coronary angiography using 
the motion immune DE subuaction technique. 
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867·71 
Catecholamlnes Facilitate the Reverse Use-Dependence 01 
D,l·Sotalolln Humans_ 
John C.L. Yu, Michael R. lauer, Charlie Young, Anand Munsil, L. Bing 
Liem, Ruey J. Sung. Stanford Univers~y, Stanford, CA. 
Isoproterenol (ISO) can reverse the antiarrhythmic effects ofa variety of 
Na+ channel blocking agents which display use-dependence. Racemic 
(D,l-) sotalol (S) Is a K+ channel blocking agent ~h 'lI-adrenoceptor 
blocking effects which may exhibH reverse use-dependence (RUD). We 
examined the effect 01 ISO on the RUD of S in 4 patients undergoing 
electrophysiology-guided drug therapy lor ventricular tachycardia (VT). The 
monophasic action potential duration at 50% repolarization (MAP50) was 
recorded in the presence and absence of ISO (to increase sinus rate 20%) 
before and after the administration 01 oral S using various drive cycle 
lengths (Cl) (350 to 700 ms). Our results show that in the absence 01 ISO, 
S (320 mg/d x 5 d) caused a fixed increase in the MAP50 at all drive Cl 
(Figure). The slope 01 the best-frt line representing MAP50 vs drive Cl 
was unchanged after S compared to control (0.17 vs 0.17), indicating an 
absence 01 RUD at this S dose. With the addition of ISO, S had less of an 
increase in MAP50 at short drive Cl then at long drive Cl, and the slope 01 
the besllit line representing MAP50 vs drive Cl dramatically increased 
from 0.14 In the control state to 350 
0.24 after S, indicating ISO in-
duced facilitation of RUD. We 'U 300 
conclude that S at a dose 320 ~ 
mgld exhib~s no RUD and cat- - 250 
echolamines facil~ate RUD of ~ 
S by reversing 'lI-adrenocep- < 
tor blockade or by enhancing :E 200 
repolarizing currents. There•
S&150 
-~ 
-~ 
fore, S may be less effective 
in suppressing VT during high 
catecholamine states. 
150 +---'---,.--or--.., 
300 400 500 100 700 
Drive Cycle Length (msec) 
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867·72 
Safety and Efficacy of Intravenous Adenosine Therapy for 
Supraventrlcutar Tachycardia During Pregnancy • Results of a 
National Survey 
Uri Elkayam, T. Murphy Goodwin, USC School 01 Medicine, los 
Angeles, CA 
Adenosi ne is the drug 01 choice lor acute treatment 01 supraventricular 
tachycardia (Svn. The reported experience w~h the use 01 this drug 
during pregnancy is anecdotal only. To investigate the safety and 
efficacy of Adenosine in pregnancy, we conducted a national survey 
among 1302 members 01 the Society 01 Perinatal Obstetricians and 113 
members of the Society 01 Obstetric Medicine. The survey identified 23 
arrhythmic episodes in 20 pts treated with adenosine. Indication lor 
therapy was matemal SVT in 22 cases and atrial Ilutter in 1 case. 
Therapy was given in the 1 st trimester In 2 pts, 2nd trimester in 4 pts 
and 3rd trimester in 14 pts. Adenosine dose ranged between 6-18 mg, 
therapy was successlul in 20 episodes and unsuccesslul in 3 (2 SVT 
and 1 flutter) requiring use of other drugs or DC cardioversion. Uterine 
contract ion and maternal brachycardia was developed in 1 pt w~h 
spontaneous resolution. Two newborns had an Apgar 015 at 5 minutes 
due to letal distress but uncomplicated course thereafter. These 
complication s did not seem drug-related. There were no other matemal 
or fetal complication s. Gestational age at delivery was 35-40 weeks. 
Mode of delivery was abdominal in 5 cases and vaginally in 15. All 
pregnancies resulted in live birlh w~h newborn weight 012640-4050 gm. 
No complication s or congenital anomalies were reported in the 
newborns. 
Conclusions: The use 01 Adenosine lor the treatment of SVT seems 
safe and effective during the second and third trimesters 01 pregnancy. 
More inlormation is needed regarding the salety of this therapy during 
the lirst gestational trimester. 
867·73 
Flecainide Versus Propafenone in the Prevention of Paroxysmat Atrial 
Fibrillation_ A Long-Term, Randomised, Multicenter Study 
·Marcello Chimienti, *Gianluigi Casadei for the FAPIS (FIecainide And 
Propafenone Italian Study) group. 
Centro Cardiovascolare E. Malan, Osp. Clinicizzato S. Donato, Milano, Italy. 
In order to compare the safety and efficacy of flecainide (F) and propafenone 
(P) in the long-term (12 months) treatment of pts with paroxysmal atrial 
fibrillation (PAF), 200 pts were entered into a randomised, open label, group 
comparative, multicenter study. Only pts with at least 2 documented attacks of 
P AF in the four months prior to the study were included. PIs with ejection 
fraction S 35% or clinically significant hean disease were excluded. 
Ninety-seven (48.5%) pts were randomised to F 200 mg/day and 103 pts (51.5%) 
to P 450 mg/day. Dosages were adjusted to a maximum of F 300 mg/day or P 
900 mg/day in case of inadequate efficacy (dermed as ~ 2 recU1Tences). Follow•
up clinical evaluations were conducted at days 15, 30, 90, 180, 270 and 360. 
At baseline, the two groups were comparable as to demographic and clinical 
characteristics. During the follow-up, 16 cardiac adverse events (AE) (F=9, P=7) 
were reported. Only I proanilythmic AE (ventricular tachycardia) was observed 
in the P group. Eight pts, 3 on F (3.1%) and 5 on P (4.9%) withdrew due to 
cardiac AE. Among 27 non-cardiac AE (F=12, P=15), gastro-intestinal AE were 
more common in pts on P (12 vs. 4) while central and peripheral nervous system 
AE resulted more common on F (13 vs. 8). Withdrawal due to non-cardiac AE 
was reported in 4 F (4.1%) and 5 P (4.9%) pts. 
P induced increases in PR interval and QRS duration significantly greater than F; 
only minor changes were induced in QTc interval by both drugs. 
The per-protocol analysis of efficacy, carried out in 159 evaluable pts using life•
table method, showed the following probabilities of therapeutic success: 
15 
0.93 
0.84 
30 
0.93 
0.79 
90 
0.86 
0.70 
180 
0.84 
0.69 
270 
0.79 
0.67 
360 
0.79 
0.63 
The difference between F and P was statistically signifICant (p <0.02). 
Conclusion: F was safe and highly tolerated in the long-term treatmentofPAF as 
compared with P; particularly, no proarrbythmic events were reported. F resulted 
significantly more effective than P in preventing P AF recU1Tences. 
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867·74 
Electrocardiographic Effects of Oral MK.499, a New Class m 
Antiarrhythmic Agent in Patients with Coronary Disease. 
Bramah N. Singh, Kenneth A. Ellenbogen, Robert G. Zoble, 
Micheal G. Kienzle, Roy M. John, Steven F. Schaal, Steven N. 
Singh, George H. Klinger and Virginia Frame. Wadsworth V A 
Medical Center, Los Angeles, California. 
MK-499 is a new Class m antiarrhythmic agent which suppresses 
both cardiac arrhythmias and the repolarizing potassium current Ikr 
in animals. We report a rising dose study in patients with stable 
coronary artery disease. MK-499 doses of 0.5, }, 2 or 4mg or 
placebo were given orally to 25 patients with ejection fraction (EF) 
~35% and 3 patients with EF <35% received 2mg or placebo. 
Plasma levels peaked 2.5 hours post dosing and, apart from QT 
changes, there were no changes in heart rate. blood pressure, or PR 
or QRS intervals. There were no serious adverse events in either the 
high or low EF groups. Peak QT increased after the 2mg and 4mg 
doses by 9.8% and 12.5%, respectively (* p < 0.06 vs. placebo). 
The table shows the QT interval in msec. 
Ejection Fraction ~ 35% EF<35% 
DOSING Pllu:ebo O.5mg Img 2mg 4mg Pllu:ebo 2mg 
BaseliDeQT 403 410 423 413 417 400 388 
PeakQT 408 428 436 452* 466* 424 444 
%changt 1.2% 4.4% 3.1% 9.S% 12.5% 6.0% 14.4% 
Subjects 3 S S 8 4 1 1 
Conclusion: MK-499 oral doses of 2mg to 4mg produce 10% to 
12% QT prolongations without adverse vital sign or ECG effects and 
warrants further evaluation for the treatment of cardiac arrhythmias. 
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867·76 
Estimation of the Serum Digitalis Concentration 
Using Saliva 
*Yoshiki Eguchi. Toshihiro Ryu. Kazuyo Yoshida. Tohru 
Ogata, Shinsuke Tsuji. Takashi Tokushima, Toshinori 
Utsunomiya, Shuzo Matsuo Cardiology Division, 
Dpt. Int. Med., Saga Medical School, Saga, Japan 
Monitoring of serum Digitalis (Dg) concentration (Conc) is 
useful for treatment in pts with heart disease. However, fre•
quent venipuncture is painful and has a risk of transblood 
infection--i.e., AIDS. We evaluated the method for estimating 
serum Dg Conc using saliva. Saliva can be taken without pain 
or risk of infection. ~ Thirteen normal volunteer and 
seventeen pts with various heart disease taking Dg. 
Method: I) In normal subjects, blood and saliva sampling was 
performed at 30. 60. 90 and 120 min after Dg intravenous 
injection. 2) In pts with heart disease, sampling was perfor•
,med at early morning in daily Dg administration. 3) Serum 
and saliva Dg Conc was measured using FPIA method. Blood 
chemistry was also measured. ~ I) In normal subjects 
(52 samples), saliva Dg Conc was significantly correlated with 
serum Dg Conc with r= .83 (p< .05). Saliva and serum Dg Conc 
(SIP) ratio was .89±.37. Fourteen samples (27%) had error of 
estimate out of ±SD (standard deviation). 2) In seventeen pts, 
saliva Dg Conc was significantly correlated with serum Dg 
Conc with r= .90 (p< .OI). SIP ratio was .92*.46. Percent error 
of estimate was -8.0%, on average. 3) Serum protein, electro•
lides, BUN and creatinine had no significant differences 
between pts with SIP ratio within *SD and out of *SD. 4) Five 
patients (29%) had error of estimate over than +SD. Three pts 
were simultaneously taking calcium-antagonist (verapamil, 
nicardipine). Conclusion' Serum Dg Cone can be estimated 
using saliva. Estimation using saliva was not affected by 
renal function, serum protein or serum electrolides. However, 
SIP ratio was high in pts taking calcium-antagonist. These 
drugs may enahnce Dg secretion from serum to saliva. 
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868·121 
HamodyDamIc ~ DurllIg Dobatamlne Sn. Ec:hoaadIogzapb 
_ AI1gmemed III CardIac 'l'zuspIanI RaciplenIlL 
Bethany L. Denlinger, Kwame O. Akosah, Daniel IG:chberg, John T. Funal, 
Pramod 1(. Mohanty. Mec\ Coil orVA and McGuire VAMC, Richmond, VA 
Coronary artery disease (CAD) is the major cause or \imitation to long 
tenn allograft IIII1"rival. Despite the popularity or Dobutamine Stress 
Echocardiography (DSE) as a reliable test for non-transp1ant CAD, the 
hemodynamic effects or increasing doses or c10butamine have not been 
systematically examined in cardiac transp1ant (CT) recipients. Thus, we 
assessed the heart rate (HR) and arterial pr.aure responses 
(mean=MAP, systolic=SAP, diastoUc=DAP, pu\se=PAP) to dobutamine 
in 76 (mean age 80±8 yrs) CT patients and compared them with T1 non 
CT patients (mean age 63±S yrs) during DSE. Results (Mean±SD): 
Baseline HR (bImIn) 
Peak HR (bImIn) 
MAP base (mmHg) 
MAP @ peak (mmHg) 
Baseline SAP (mmHg) 
Peak SAP (mmHg) 
Baseline DAP (mmHg) 
Peak DAP (mmHg) 
Change In DAP (%) 
PAP @ base (mmHg) 
PAP @ peak (mmHg) 
RPP (bImln X mmHg) 
Peak Dob dose 
(mcg/kg/mIn) 
Nqa-C'J'(p-m ~ p ftlue 
69±10 86±13 0.001 
122±23 147±21 0.001 
97±14 loo±18 0.310, NS 
loo±17 97±16 0.230, NS 
14O±23 13O±17 0.026 
163±25 150±24 0.016 
78±12 86±10 0.001 
68±14 73±13 0.020 
-II.5%± 11 -13.4%± 11 0.030 
59±17 44±14 0.001 
94±24 69±22 0.001 
20046±4443 3311 0±5061 0.050 
36±7 36±7 0.826, NS 
Despite similar peak c10butamine dose between CT and non·CT controls, 
CT pts attained & higher peak HR, rate pr.aure product (RPP) and 
greater decrease in DAP compared to non-CT patients. The augmented 
responses in HR, RPP, and decrease in DAP with peale c10butamine close 
has to be talcen into consideration In the Interpntation or the results or 
DSE in patients with allograft coronary vascuJopathy. 
lACC February 1994:IA-484A 
868·122 
Effects of High Frequency Cardiac Sympathetic Nerve Stimulation 
on Cardiovascular Function and Vagal Inotropic Effects. 
Nicholaos P. Xenopoulos, David R. Crosslin, Robert J. Applegate, 
The Bowman Gray School of Medicine, Winston-Salem, NC. 
High frequency stimulation of the ansae subclaviae (HFAS) releases 
neuropeptide Y (NPy) along with norepinephrine. Co-released NPY 
attenuates chronotropic vagal responses, however, its effect on the 
arterial system, LV contractility, and the modulation of vagal inotropic 
effects are not known. Accordingly, we evaluated the effects of 
endogenously released NPY during HF AS using end-systolic pressure 
volume relations (ESPVR) in 6 anesthetized dogs instrumented to 
measure LV P and V. Both ansae subclaviae and the vagi were 
transected. Hemodynamic data were obtained at steady state and during 
transient vena cava occlusion. 5 min after HFAS, (15 Hz, 10 V, 1 ms, 
3 min duration) HR and the slope of the ESPVR (Ees) were not 
significantly different from baseline (131±13 vs 145±13 bpm; and 
4.8±1.6 vs 5.7±2.5 mmHglml; both p=NS), while arterial elastance <Ea) 
increased Significantly 11.8±5.3 vs 14.1±5.8 mmHglmI; p<O.05). 
Moreover, EeslEa decreased (-24.7±18.2%; p<0.05). Vagal stimulation 
(VS) (2 Hz, 5 V, 5 ms, 3 min duration) was applied before,S min, and 
30 min after HFAS. The bradycardic effect of VS was attenuated 5 min 
after HFAS (~HR -36±8 vs -22±12 bpm; p<0.05) as was the decrease 
in Ees observed during VS (.<lEes -52±25 vS-32±21 %, p<0.05). The 
chronotropic and inotropic effects of VS returned to baseline 30 min 
after HFAS. 
Conclusion: Endogenously released NPY lacks any direct chronotropic 
or inotropic effect However endogenously released NPY causes arterial 
vasoconstriction, adversely affects ventricular-arterial coupling, and 
attenuates both the chronotropic and inotropic effects of vagal 
stimulation. 
868·123 
Relationship of Regional Myocardial Function to 
Intracoronary Doppler Guldewlre Derived Diastolic to 
Systolic Flow Velocity Ratio 
Yuri A. Deychak, Allan M. Ross. Jerome Segal, Horace Brown, 
David Alyono 
The George Washington University Medical Center, Washington 
DC 
Myocardial contraction reduces forward systolic epicardial flow due 
to a relative Increase In Intramyocardial Impedance. We 
hypothesized that changes In regional myocardial function would 
contribute to changes In systolic intramyocardial Impedance and 
thus would Influence the diastolic to systolic flow velocity ratio 
(DSVR) In the corresponding normal coronary artery. In an open 
chest porcine model (n=7) we measured LAD mid to distal coronary 
artery spectral flow velocity using a Doppler guidewlre, and 
simultaneous corresponding regional myocardial function, 
expressed as % wall thickening (%WT) using an epicardial 
Doppler crystal focused at the subendocardium. The regional 
myocardium was temporarily stunned with Intracoronary 2% 
lidocaine or brief sub-total coronary constriction. Simultaneous 
DSVR and %WT measurements were obtained during stunning 
and recovery. A linear relationship (r=.83, P<O.OO1) between 
normalized (to pre·stunnlng baseline) %WT and DSVR was 
demonstrated. In this model, DSVR was not dependent on heart 
rate, left ventricular systolic or end-dlastolic pressures, or average 
J)88k coronar}' flow velocity. ,., 
Conclusion: Depression r-_83 ". :1.~ 
and recovery 01 regional .• p<o.ool .' : 
myocardial function in the .• 
distribution of a normal ~ .7 
epicardial coronary artery " .. 
resutts in a parallel change ... 
In DSVR, a Doppler .. 
guidewire derived index 01 .. 
diastolic coronary flow .• 
predominance. .. ..... , ~ .. "-=-' .• --'-.. - .• '""' ............ ,........... --.-• ...-"......-+,., 
""'" 
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868·124 
Age, bFGF and Coronary Adaptations to Left Ventricular 
Pressure Overload Hypertrophy 
Michael F. Flanagan, Teruhiko Aoyagi, Lucy Arnold, Toshiyuki 
Takahashi, Joseph Currier, Henry Warren, Seigo Izumo. 
Dartmouth Medical School, Hanover NH and Harvard Medical 
SchOOl, Boston MA. 
The effect 01 age on coronary conductance, capillary density and 
levels of the angiogenic factor bFGF were assessed In young 10-
week old lambs (V-LVH) and adult 2-year old sheep (A-LVH) with 
ascending aortic bands of 6 weeks duration and age-matched sham 
controls (V-SHAM, A-SHAM). The V-LVH and A-LVH had 
comparable significant Increases In LV pressure and mass. 
Capillary density was decreased In A-LVH In the LV and unchanged 
in the RV vs A-SHAM. In Y-LVH LV capillary number increased 
mainlaining capillary denSity. Maximum coronary conductance in 
the LV measured while conscious with adenosine using the 
microsphere technique was similar In Y-SHAM, A-SHAM and V•
LVH and diminished in A-LVH. Maximum RV coronary conductance 
in A-LVH was also decreased, implying an effect of hypertenSion 
independent of hypertrophy. 
V-LVH lambs had bFGF RNA level. 65±10% of V-SHAM by slot 
blot and densitometry while A-SHAM sheep were 62±10% and A· 
LVH 4S±7% of V-SHAM lambs. The effects of age, aortic stenosis 
and their interaction were significant (2-way ANOVA). The 
localization of bFGF protein In the LV was assessed by 
immunohistochemistry. All groups showed similar Intense 
staining of the coronary artery media. There was relatively 
lighler diffuse staining of LV myocytes which on blinded 
semiquantitative reading (scale 0-3+) was diminished in A-LVH 
wilh aortic stenosis of 6 weeks duration (score: 0.3±O.2) and A•
SHAM (0.7±0.2) compared wilh Y-LVH lambs at 6 wks (1.3±O.3) 
and Y-SHAM (1.4±O.2). 
Young age confers advantages in the coronary adaptation to LV 
pressure overload hypertrophy including angiogenesis maintaining 
LV capillary denSity. These age-related changes are paralleled by 
changes in bFGF. 
868·125 
Aspirin and the Protective Effect of Platelets in the 
Isolated Perfused Rat Heart Subjected to Ischemia· 
Reperfusion 
D. James Kazakis, Baichun Yang, Jawahar L. Mehta, University of 
FL and VA Medical Center, Gainesville, FL. 
Platelets have been shown to protect the isolated buffer-perfused 
rat heart from reperfusion injury. To determine if platelet 
cyclooxygenase inhibition blocks the protective effects of platelets in 
hearts subjected to ischemia-reperfusion, a group of rats was fed 
aspirin-rich chow while other rats from the same batch were given 
standard Purinanf rat chow. Rat hearts were isolated and perfused 
with buffer-alone, or with platelets from control (untreated) rats, or 
with platelets that were harvested from rats fed aspirin-rich chow. 
Platelet aggregation was markedly inhibited in platelets from aspirin•
fed rats. Force of cardiac contraction (FCC), coronary perfusion 
pressure (CPP) and coronary effluent CK were measured in all three 
groups of hearts during 40 min of ischemia and 30 min of reperfusion. 
The parameters at 30 min of reperfusion ~vere: 
Perfusate 
Buffer alone 
Untreated platelets 
Aspirin-treated 
platelets 
aFCC(%) 
-94±3 
-4S±18* 
-47±12* 
aCPP (%) 
+37±13 
+8±4* 
+2.6±3* 
aCK (%) 
+758 
+106* 
+129* 
All values expressed as percent cbange from pre-ischemia values, mean±SE. 
·P<O.OI vs Group 1. 
These data indicate that platelets protect isolated rat hearts from 
ischemia-reperfusion injury. Furthermore, inhibition of rat platelet 
cyclooxygenase with aspirin does not modulate the cardioprotective 
effects of platelet against ischemia-reperfusion injury. 
93A 
94A ABSTRACTS 
868·126 
Do Changes In Calcium Transport During Changes In 
Contractility Affect Cardiac Energetics? 
Donald J. Grandist, Pedro J. DeINido, and Alan P. Koretsky 
tMedical Coilege of Pennsylvania/Allegheny Campus and Pittsburgh 
NMR Center for Biomedical Research, Pittsburgh, PA. 
~ To evaluate the roie of calcium transport (CaTr) on cardiac 
energy consumption during changes in inotropic state. ~ Left 
ventricular developed pressure (systolic - diastoiic pressure, DP, 
mmHg) was altered in Langendorff-perfused rat hearts by either 
EMD 57033 (EMD; n-ll), a calcium sensitizing agent which 
increases DP without changing CaTr, dobutamine (DOB; na 9) which 
increases both DP and CaTr, BAPTA (BAP; n-ll) an intracellular 
calcium chelator which decreases DP without changing CaTr, and 
verapamil (VER; n-9) which lowers both CaTr and DP. Myocardial 
oxygen consumption (MVOz, Ilmoles/min/gm dry weight), 
concentrations of high energy phosphates (by 31 P NMR), and DP 
were measured simultaneously. All hearts were paced at 5Hz. 
~ Data shown as means ± s.d. The figure shows that compared 
to control, for a 4C196 Increase in DP with DOB and EMD, MVOZ 
increased significantiy with DOB but not EMD. With a 6C196 decrease 
in DP by BAP and VER from controi, MVOZ decreased more with VER 
than BAP. (*:p<0.05 versus controi DP; #:p<0.05 versus control 
MVOZ). High energy phosphate concentrations and lactate production 
60 DCB were unchanged by each agent; 
., i.e. metaboiism was in a steady 
40 state. Intracellular pH and 
EMD· [MgZ+] (by 31 P NMR) were 
unchanged from controi by each 
agent. Conclysion; The 
differences in MVOZ between the 
different inotropic agents may 
be caused by the differences in 
10 -i-.:::;:........,..--....... -.--
868·127 
40 60 80 100 
DP 
energy used by CaTr or changes 
in force/ATP by myOSin/actin. 
The Modulating Action of an Atrial Natriuretic Peptide (ANP) Receptor 
Inhibitor Upon the Natriuretic Effects of Exogenous and Endogenous 
ANP 
Tracy L. Stevens, Chi·Ming Wei, Masahiko Kinoshita" YUZUlU 
MatsudaS, Lawrence Aahrus, Denise M. Heublein, and 10hn C. Burnett 
lr. Mayo Clinic, Rochester, MN; Shiga Univ. ofMed. Sci, Ohtsu, 
lapan,; Tokyo Res. Lab., Kyowa Hakko Kogyo Co., Tokyo, Japan S 
Atrial natriuretic peptide is an imPOltant peptide hormone of cardiac 
origin which functions to regulate cardiac preload via the regulation of 
sodium excretion. This natriuretic action occurs through activation of 
the guanylyl cyclase linked·A receptor, the NPR·A receptor. HS-142-1 
(HS) is a newly discovered inhibitor of the NPR-A receptor permitting 
for the first time insight into the functional role of ANP in cardiorenal 
homeostasis. The first objective of the current study was to define for 
the first time the intrarenal action of HS on exogenous ANP- mediated 
natriuresis in normal dogs: Group I (n=6), intravenous ANP infusion 
ar 100 ng/kg/m, followed by an intrarenal HS (O.S mg/kg) bolus. The 
second objective was to determine if endogenous ANP participates in 
the basal regulation of sodiurn excretion: Group n (n=4), intrarenal HS 
alone. ·P<.OS vs baseline; tP<.OS vs ANP. 
Group I Baseline ANP HS ± ANP 
UNaV (j.LEq/m) 40 ± 9 230 ± 32* 8St 16 t 
FENa (%) I.S ± .42 S.6 ± .97* 2.S ± .24 t 
PcGMP (pmol/mI) S ± I 34 ± 7* 24 ± S t 
UcGMP (pmol/m) 10S1 ± 241 S445 ± 869· 3748 ± 890 t 
DFNaR(%) 9S±2 8S±2* 89±5 
UNaV, urine sodium excretion; FEN .. fractional excretion of 1IOdiwn; PcOMP, 
plume cOMP; UcOMP, urine cOMP; DFNaR, distal fractionalllOdium reabsorption. 
In Group I, no significant change was noted in renal blood flow (RBF), 
glomerular filtration rare (GFR) or proximal fractional sodium 
reabsorption. In Group n, HS decreased UNaV from baseline (BL) 
(BL: 68±27, HS: 37±24 uEqlmin; p<.OS) with no significant change in 
RBF or GFR. These studies demonstrate that HS markedly artenuates 
exogenous ANP- mediated natriuresis via inhibition of distal tubular 
reabsorption, a site rich in NPR-A receptors. Secondly, the current 
studies suppolt a functional role for endogenous ANP in the basal 
regulation of sodium excretion. 
JACC February 1994:1A-484A 
868·128 
INFLUENCEOFINSn'UINTRINSIC CARDIAC NEURONAL ACTIVATION 
~HBRADYKD«NONTHEDETERNDNANTSOFCORONARYBLOOD 
FLOW IN ANES11IETIZED DOGS. 
Joim G. Kinpna Jr., J.A. Armour, Denis Simard, Jacques R. Rouleau. 
Laval University, Sre-Foy, Quebec, CANADA. 
EndogCllOUS bndykiniD (BK) prodoced dming ischemia may be cardiopoleCtive. 
Tbesc S1Udies were uncIcnateo to investigarc Ibe effects of: I) BK (SO III in saline) 
injected into iIIlilM amine cardiac DeUI"OIIS, and 2) bolus i. v. BK on end-systolic 
elaslance (Ees; mm Hg/ml). Changes in diastolic IOnic pressure (APd; mm Hg), 
Iystcmic ~ product (RPP=HR x LVPs; mm HgIminIHl",), myocardial 
bloodflow(MBF;mI/minIlOOg)andoxygenconsumption(MV°2;mVmin/IOOg)and 
cuonary vascular conductance (evc; mVmin/IOOg/mm Hg) were assessed during 
Slimulalion of BK-sensitiw DeUI"OIIS; conlrols (CON) received saline. LV volume 
(mJ) and L VPs (mm Hg) were measured using conductance and Millar catheters. Data 
are mean±SEM (nsS dogs); 'pSO.05 vs CON. 
APd RPP MBF MV02 
CON 104±7 18±2 116± 17 6± 1 
BK SS±7' 16±1 263±72' ISH' 
CoaclusiODs: 
I) IICIivalion oCBK-sensitive 
cardiac DeUI"OIIS augments MV02 
independent of RPP and in 
rdalioo to Ees (cC. Fig.); 
2) the bigher MV02 is malChed 
by adjUSllllents in evc as MBF 
increased and APd was reduced 
clming ill situ IICIivation of 
inlrinsic cardiac DeUI"OIIS. 
l 
! 
J 
~ 
evc Ees 
1.2 ± 0.2 2.8 ± 0.8 
4.7 ± 1.1' S.5 ± 1.4· 
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869-64 
Two-dimeuslonal Doppler Ecbocardlography lIS the initial DiBgllostic 
Tool ror Acute PulmODIIl")' EmboUsm. 
Narayanswami Sreenun, Emile C.Oleriex, Yvonne Eussen, 
Frans A.Pietel'S, Hein IJ.WeUens. Department of Cardiology, Academic 
Hospital Maastricbt, The Netherlands. 
The purpose of !be study was to assess two-dimensional Doppler 
echocardiograpbic (2D-DE) indices of acute right ventricular (RV) volume 
or pressure overload and their relation to pulmonary embolism (PE). In 60 
consecutive patienlS (35 M. 25 F; age range 44-86 years) wilb acute 
symptoms suggestive of PE, 2D-DE was used as the initial diagnostic tool. 
Diagnostic confmnation was obtained by high-probability ventilation•
perfusion scan (36 pIS), angiography (18 pIS), at surgery (5 pIS) or autopsy 
(5 pIS). Acute RV volume or pressure overload was diagnosed from: (1) 
RV end-diastolic diameter of >27mm (56 patienlS), and diastoliC leftward 
bulging of the ventricular septum (56 patients); (2) a peak velocity of 
tricuspid regurgitation (I'R) on continuous wave Doppler echocardiography 
of >2.6m/scc (56 patienlS). Of Ibe remaining 4 patients, 3 bad asystole (aU 
witb visible intracaroiac tbrombi) and were undergoing resuscitation at Ibe 
time of W-DE; (3) a collapse index of the inferior vena cava (defined as 
the percentage cbange in diameter between inspiration and forced 
expiration), of <40% indicating an elevated mean right atrial pressure of 
>8 mm Hg (49 patienlS). Right atrial, right ventricular or pulmonary 
arterial thrombi were visualized in 10 patients. Of 14 patients with severe 
hemodynamic impairment in wbom heparin or tbrombolytic therapy was 
given based on 2D-DE findings alone, 4 recovered while 10 died. PE was 
conf1l1lled in 4 of 5 patients in wbom an autopsy was performed. The 5th 
patient bad right atrial tbrombus on WE, but no lung emboli were 
detected at autopsy. 
Conclusions: In patienlS wilb acute onset of symptoms, W-DE indices 
of RV pressure and volume overload are sensitive initial diagnostic signs 
of PE. For patienlS in cardiogenic shock, W-DE can direct Ibe Iberapeutic 
approach. 
869-65 
Dose Ranging Trial of Intraarterial r•
prourokinase (A-74187) for Thromllolysis of 
Total peripheral Arterial Occlusions_ 
Joseph R_ Hartmann, Elaine L_ Enger, Esther M. 
Villiard, Arthur A. Sasahara. Midwest Heart 
Research Foundation, Lombard, Illinois. 
This study evaluated the efficacy and safety 
of 3 doses of a recombinant glycosylated 
prourokinase (r-proUK) in reestablishing blood 
flow in 35 patients (pts) presenting with a 
total peripheral arterial occlusion (PAO) 
(mean duration 5 months). All pts received 
a directed, coaxial infusion of r-proUK (12 
pts-3 mg/hr, 9 pts-6 mg/hr, 14 pts-12 mg/hr) 
until 95% of the clot burden (mean clot length 
19.0 cm ± 10.7) was lysed or for a minimum of 
6 hours (hrs). Successful thrombolysis was 
aChieved in 92% of pts at 3 mg/hr within a 
mean duration of 6.6 hrs + 3.7 and in 100% of 
pts in both the higher dose ranges within a 
mean duration of 5.4 hrs ± 1.8 and 3.9 hrs ± 
1.5. Mean fibrinogen/plasminogen values are 
plotted below with 1 pt per group experiencing 
bleeding requiring transfusion. One month 
follow-up revealed a 97% patenc rate. 
Conclusion: 
Low dose, 
intraarterial 
r-proUK is a 
safe, rapid 
and effective 
method of 
recanalizing 
PAO. 
-~  -
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869-66 
New Infusioo Removable Inferior Vena Caval Filter Catheter ( Fibrd RF 
02 ) for Protected Thrombolytic Trealmeal in Deep Venous Thrombosis ( 
DVT ) and PuImoaary Embolism ( PE ): Results of an Intemational 
Multicentric Study. 
.Dievart F., "·Lefebvre I.M., "Fowrier lL, ·Everaere 5., Quilliet 1., 
Caslrucci M., El Allaf D., Emaouelli G." CJiDique Villette, Duokerque•
France, ""'Clinique la Louviere, Lille-Fmnce. 
Purpose: The lim of Ibis study was to evaluate boIh efficacy of protected 
tbrombolytic therapy in recent DVT and PE, using an infusion removable 
caval filter catheter, and toIenmce and 1JI8D8BC- of the device in 14 
centers in 3 different european COUDlries. 
Material and methods: From 03107/90 to 31107/92, 69 pts, age 18-
87 yn;, wilb recent DVT, in whom proximal extension was ciemoustrated 
by iIio-cavography and/or u\Jrasound ( US ) for all pis, 8Dd associated PE 
confirmed by pu\mODary angiographyand/or perfusion lung sciDt. for 47 
pts, were included in Ibis study to receive thrombolytic IreaImrat. The 
cboice of tluombolytic treatment was free ( 29 uroL, 26 streptok., 16 rt-PA 
) as well as the site of infusion. The device is a .... iDfusioa catheter ( 3 
Frmch ) supplied by a removable filter 011 its tips. IDInlmctioo site of the 
device was free: brachial~ vein ( 0=26 ), ;.guIar (0=31 ), fr:moraI ( 
n=4 ) or subclavian vein ( ""'1). After tbromboIytic treatment the sysIem 
was teIIIOVeei after US and pblebocavogtabic CODImI tbrougb the system. 
ResullS: Thrombolytic treatment arted 011 avenge 81,5 DID after the filter 
m-tiOD and was proIooged 011 avenge 3,56 days. DVT was cleared or 
improved in 79 % of cases and PE in 84 % of cases. In 14 cases, the second 
cavograplly showed tlmJmbi trapped into !be filter. The incidence of 
compIicatioos was low: 1 stroke, 21 hematomas at the puncture site ( II 
after jugular approacb ), 7 vein tJogosis, 7 ca.s of bypaUmias cured with 
antibiotic therapy. Removal of the sylllem was complicated only in 3 cases 
( I PE 8Dd 2 twists). 16 permaneoI filters were placecl 
ConclusiODS: !be efficacy of this new device wiIh combined infusioo 
catheter and removable vena caval filter was dea::tGllliIIed by Ibis study in 
the treatment of DVT with or without usocialed lIE. The possibility of 
Incbial approocb .-.Its in boIh _y management and 1DIeraoce. Further 
randomized tria1s 011 removable filters are uodertakeo to determine the 
interest of the new device in the treatment of the thromboembolism 
disease. 
869-67 
Treabnent of Severe Deep Venous Thrombosis by means of a High Speed 
Rotational Catheter ( Angiocor TbromboIizer ): Experieoce of MecbanicaI 
Thrombolysis in PeripberaI Veins in Human Beings. 
.Dievart F., "Fourrier lL, "Lefebvre I.M., ·Everaere S., Quilliet 1., 
Gomez J., *Clinique Villette, Dunkerque- Fmnce, *'"C1inique Ia LooviCl'e, 
Lille-France. 
The Angiocor Rotatiooa! TbromboIizer ( ART ), a new device already 
successfully tested in animals, was used in 20 patieDIs with a _t deep 
venous thrombosis with or without pu\mODary embolism ( PE ). 
The ART is a 5 Freocb teflon catheter whose distaI tip is split into fuur 15 
mm bends. It is positiomed via a 8 Frencb piding catheter over a f1e)tible 
guide wire. The high roIalion ( 100 000 rpm ) II8CS the effect of ceaIrifugal 
force to open the distal strips, and form a 10ft deJtible spiral able to pulverize 
receot clots into microscopic putic\es in a few 1CCODds. 
All patients ~ a rectIItlJllilatenl i\iac or femoral venous ocelllSion 
( doclllDlmled by pIJIebocavograpby ) with or without puIm<Bwy embolism. 
The procedutre was performed in pati_ C<lIIIniDJicated to chemical 
thrombolysis ..-after DiIure of thrombolysis agents. 
In all pts, a removable vaJa cava filter was introduced ( brachial, jugular 
or CCIIlrolateraI way ) into the inferior veaa cava. ART can be easily 
positionneci into all the occluded veins ( iliac and/or femoral ) 8Dd a bigh 
speed roIatioo was obtained without any paiD felt by the pmieDt. Angiography 
was performed during the ART advIIncemeat cbrougb the clot. In all cases, a 
partial or total clot lysis was doclllJleDted. 
No complication occured ( DO perfuntioo and DO death ) for 19 patieDIs. 
In 1 case, death occured after the procedure following a pandoxal cerebral 
embolism wtbat occured just before the procedure. In 6 cases, thrombi were 
observed into the filter by aogiognIpby ..- eumiDatioo after removal. 
Perlll8Dtatt filters were placed in 8 patieots: coatJaiDdicatio to oral 
anticoegulatioo in 3 cases, RClII'reIICC of deep veaous tlmJmbosis in 4 cases, 
recurreoce of PE 2 days after removal of the filter in J case. Recurreoce of 
deep veaous thrombosis occured III8eIIlialJy wilen there was a lack in 
antiCOAgulatioo in the ~y days after the procedure. 
This lIIKIy &bowed both efficiency 8Dd aafety of ART in severe pati_, 
all with post-operating thrombosis or caocer, and with deep venous 
thrombosis above popliteal level It &bowed great iDtonst to combine this new 
procedure of Ibis DeW device with a removable or a ~ VCDII cava filter 
in this type of pUnts. A ..-m anticoegulatioo after the procedure appeared 
to be easeotialto preveut teCIII'I'aX:es. 
95A 
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869·68 
bAd Artelrl' st._U.n9 for Cont.rol of Congest.i"e .eart 
Failure 
Jeffrey W. Olin, Robert A. Graor, J. Michael 
Bacharach, Cleveland Clinic Foundat.ion, Cleveland, OH 
Indications for intervention for atherosclerotic 
renal artery stenosis (RAS) include preservation of 
renal function or failure to control blood pressure. 
We report 6 patients who underwent renal artery 
st.enting for control of decompensated congestive heart 
failure (CHF). These patients were unable to tolerate 
angiotensin converting enzyme inhibitors because of 
azotemia. All patients had multiple episodes of flash 
pulmonary edema and were severely limited by CHF. 
Bilateral RAS was present in 2 patients and RAS to a 
solitary functioning kidney in 4 patients. The mean 
age was 66.8 years (50-85 year.). The mean American 
Heart Association functional class 6 months prior to 
intervention was 2.5 ( range, 1-3) and was .66 (range, 
0-2) at latest follow up. The mean number of 
hospitalizations was 2.33 (range 1-5) before 
intervention and was .16 (range 0-1) at latest follow 
up. Angiotensin converting enzyme inhibitors were 
tolerated in 5 of 6 patient. after intervention. CHF 
was improved in all 6 patient. and flash pulmonary 
edema did not occur in any patient with a mean follow 
up of 10.6 monthB (range, 2-14 months). Renal artery 
stenting decreased the severity of CHF, the frequency 
of flash pulmonary edema and the need for 
hOBpitalization in all 6 patients in whom this 
modality waB employed. In a large part, thiB was due 
to the ability to UBe angiotensin converting enzyme 
inhibitors without the development of azotemia. 
869·69 
Prevention of RecurreDt Pulmonary Embolism Following Thrombolysis by 
Pen:utaDeoullosertion of Ioferior Vena Caval FUter 
Gian Luigi Morgagni, Claudio Simoni, Enrico POmarici, Alberto Bandini, "Guido 
Rusticali, "Augusto Ruggeri, "Alberico Borghi, "Raffaele Bugiardini. Opt of 
Cardiology, Forli and "lost. ofPatologia Medica, University of Bologna, Italy 
The present study was undertaken to prospectively evaluate the role of 
percutaneous inferior vena cavaI filtration (FUter) in pts presenting pulmonary 
embolism (PE) treated with tbrombolysis (1'). 
From 1988 to 1993, 44 pts (mean age S2 years) ~re admitted to our CCV's for 
acute PE; diagnosis was done by clinical presentation, nonimaging modalities and 
echocardiography (echo) in 12 pts, by lung scanning in 20 and by pulmonary 
angiography (Aogio) in 12. PIS were treated by IV T (ttoPA I mg/kg over 2 hrs) 
followed by IV bcparin (at Ieast 3 days; PTT > I.S times the control level) and/or 
warfarin. Clinical improvement became evident in the wbole population witbin 6 
hrs following T and was associated with a marked rise in arterial POl' A 
significant decrease in pulmonary artery pressure was documented' by 
hemodynamic monitoring and/or echo in 22 pts in whicb pre-therapy data were 
available. Then, pts were randomly selected to FUter (Group I ~ 16 pts) or 
conservative treatment (Group 2 = 28 pts); the magnitude of PE, as well as the 
percentage of pts with deep venous tbrombosis (by duplex scanning of leg veins), 
was similar in both Groups. Clinical course of the pts in Group I was uneventful; 
conversely 5128 pts (17%) in Group 2 underwent acute (within 96 hrs) life•
threatcning recurrency of PE with clinical and hemodynamic deterioration, 
hypoxemia and increase in right ventricular afterlnad. PIS with recurrent PE 
unden\'cnt emergency Angio, selective T (tt·PA 0.3 mglkg, tbrough the 
pulmonary artery catheter) then Filter implant. No further in·bospital rccurrcncy 
of PE was detected in all pts. PIS ~re discharged on anticoagulants, with arterial 
P02 as well as pulmonary artery pressure witbin normal values. No Filter·related 
complications ~re detected at a mean follow·up of 12 months. 
We conclude that: (I) recurrcncy ofPE after IV T is not a rare event; (2) these 
episodes, quite often lifc-tbreatening, should be managed on an emergency basis; 
(3) percutaneous insertion of FUter was found a reliable, safe and effective 
procedure to prevent recurrent PE. 
JACC February 1994:1A-484A 
869·70 
Peripberal Vascular Angioplasty Performed by Ioterventional 
Cardiologists: Initial Experience in an Academic Center 
Jose A. Perez, Hany R. Phillips, Alyson 1. Breisch, Ricbard S. Stack, Gary 
Stiles, Duke University Medical Center, Durham, NC 
A peripheral vascular (PV) interventional service was established in our 
cardiology division as a component of an institutional multidisciplinary PV 
program staffed by radiologists, vascular surgeons and interventiooa1 
cardiologists. We report the initial results of PV interventions performed by 
cardiologists with training and expertise in this area as defined by the ACC 
guidelines. Between 1/92 and 8/93 119 patients (pts) (70% male; mean age = 
63 yrs; 162 lesions) had PV interventions: 
Demographics Renal Indication Limb Indication 
(total pts) (n=33 pts) (n=86 pis) 
Coronary Disease: 82% Hypertension! Claudication>100m: 19"10 
Hypertension: 74% Renal Failure: 24% Claudication<IOOm: 66% 
Cholesterol ~200: 61% Hypertension: 67% Rest Pain: 10% 
Smoking: 76% Hypertension! Subclavian Steal: 5% 
Diabetes: 17"10 Heart failure: 9% Ankle/Arm Index: .6±.l % 
PV interventions included (134/162) 83% balloon angioplasty, (211162) 13% 
stent delivery and (71162) 4% atherectomy. All patients were premedicated with 
oral aspirin and intravenous benadryl. Full therapeutic anticoagulation was 
achieved (peak activated clotting time = 443 ± 100 sec) by giving an 
intravenous heparin dose of 11,581 ± 2,876 units. 
The acute procedural success rate was 99% (160/162) with a reduction in 
mean luminal narrowing from 84 ± 13% to 23 ± 12%. The two unsuccessful 
procedures resulted from failure to cross chronic total occlusions. Major 
complications occurred in 2/119 (2%) due to a large hematoma and 
pseudoanewysm at arterial access sites. There was no incidence of emergent 
surgery, myocardial infarction, stroke, renal failure, thrombosis, amputation or 
death. 
With appropriate training and a multidisciplinary team approach, 
interventional cardiologists can safely and efficaciously perform PV 
interventions. 
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870·130 
mgh-Energy Pboshate Metabolism or the Diseased Human Heart. 
J. Oono van Dobbenburgh. Nicolaas de Jonge, Corinne KU)pping. Jaap R. Labpor, 
Stcpben R. WooUey, Willem J. van der Laarse', Cees J.A. van Echteld. IClN, 
Heart Lung Institute, University Hospital, Utrecbt, and 'Laboratory for 
Physiology, ICaR-VU, Free University Amsterdam, The Netherlands. 
The impairment in functional performance of the failing human heart may be 
related to its energy metabolism. To characterize the high-energy phosphate 
metabolism of the diseased buman heart, patieDlS waiting for heart transplantation 
(all NYHA class IV) with iscbemic beart disease (nID) (n=3) and dilated 
cardiomyopathy (OCM) (n=3) were examined by means of3lP magnetic resonance 
spectroscopy (MRS). However, since these hearts showed extmnely severe 
dilatation in vivo, accurate detemlination and quantification of 3Ip heart spectra 
was impossible due to substantial contamination by signals from either cbest wall 
muscle or blood from the left ventricle. Therefore, in this study the ex vivo energy 
metabolism was assessed by means of 3Ip MRS in excised DCM (n=9), llID 
(n= 10), and bealthy human donor (00) hearts (n=22) at the time of heart 
transpIantation procedures. In addition, to further investigate undetlying metabolic 
wclJanisms which may influence myocardial energy metabolism, biopsy 
specimens were obtained from DCM and llID hearts to assess total creatine (TCr) 
content by means of high performance liquid cbromatographic analysis (HPLC). 
3Ip measurements of DO were perfouned immediately after arrival in the bospital 
and took 160s or 3205. All DO were succesfully transplanted and used as a control 
group. llID and DCM were studied after cold cardioplegia. To allow for direct 
comparison of the hearts, the ratio of phosphocreatine (pcr) + inorganic phosphate 
(Pi)1 adcnosinetriphosphate (ATP) was detennined from each 3Ip spectrum and 
used as an index for cardiac energy state. The 3Ip spectra were quantified by 
means of a time domain fitting routine. All data arc presented as mean ± SD. 
Mean (PCr+Pi)/ATP of DO, DCM and llID amounted to 1.78 ± 0.32, 1.47 ± 
0.17, and 1.56 ± 0.17, respectively. The mean (pcr+Pi)/ATP of DCM is 
significantly different from the mean (PCr+Pi)/ATP of DO (p<0.05 (Student's 
t test»). In addition, there is no significant difference in average (PCr+Pi)/ATP 
between either DO and llID (p=0.06) or DCM and llID (p=0.29). Furthermore, 
a decrease in TCr content in both DCM and llID was observed (78.5 ± 19.7 and 
89.4 ± 20.8, respectively, vs a reponed 125 ± 28 ,.moUg protein in DO). 
In conclusion, the reduced (pcr+Pi)/ATP ratios in DCM and llID appear to be 
related to decreased Ter levels. 
JACC February 1994:1A-484A 
870·131 
Force.Frequency Relatlo... During Heart Failure In the Pig 
Gregory P. Eising, Gregory A. Helmer, H. Kirk Hammond, John Ross Jr., 
University of California San Diego, La JolJa, CA 
The positive inoIropic effect of the force-fn:quency relation (FFR) has recently 
been shown to be markedly enhanced (increased slope) by exercise or adrenergic 
stimulation in dogs. The FFR is often negative in isolated cardlac muscle from 
patients with severe beart failure (Hf), but its basal characteristics and response to 
adrenergic stimulation bave not been studied in !be intact failing bear!. Severe HF 
was produced in pigs (11=6) by continuous rapid left venlricuJar (LV) pacing (225 
bpm) for 14-28 days. In !be conscious state, bigb fidelity LV pressure and LV 
dP/dtmax were obtained during aIriaI pacing (100-225 bpm) before and after HF. 
Before HF, LV dP/dt max did not cbange with beart rate, but there was a lII3rlcedly 
increased slope of the HR vs. LV dP/dt max relation (FFR) during dobutamioe 
infusion, 611glkg/min ~ (pdlO3). After HF, the FFR was depressed 
(p<.OOI); the FFR slope was s1igbtly but significantly positive (p<.OOI), but it 
was not significantly affected by dobutamioe (rigbt figure). 
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After 1 mgikg UL-FS 49 (a specific sinus node inbibitor) in HF pigs, mean HR 
fell from 156 to 95 bpm and LVdP/dt max dCcreased (1656±219 vs. 1402±382 
mmHgls; mean±SD, p<.OO2), despite a trend to bigber L VEDP (32 to 39 mmHg, 
ns), indicating that the LV was not operating on a negative FFR (wbich would 
produce increasing contractility with decreasing frequency). These responses to 
UL-FS 49 were directionally similar to those observed before HF. 
In conclusion, the basal FFR of !be LV in conscious pigs with severe HF is not 
negative (in contrast to that in isolated muscle), but normal adrenergic 
augmenration of the FFR is absent Loss of adrenergic stimulation of FFR as HR 
increases, likely due to impaired ea2+ availability, could play an impor1aDt role in 
!be impaired cardiac response to exercise in patients with HF. 
870·132 
Elevation of the Extracellular Magnesium Concentration Restores the 
Force-Frequency-Relationship in the Failing Human Myocardium. 
Robert H.G. Schwinger, Michael Nabauer, Michael BOhm, Jochen 
MOller-Ehmsen, Ulrich Schmidt, Erland Erdmann. Medizinische 
Klinik III, Universitat zu KOln, S0924 KOln, Germany 
Probably as a result of an increased intracellular Ca2 + -availability an 
increase in frequency of stimulation is accompanied by a reduced force 
of contraction (FOC' in the failing human myocardium. Tne present 
study aimed at investigating the effect of elevation of extracellular 
Mg2+ (1-3 mM, and Ca2+ (l.B, 2.4 mM, on the force-frequency•
relationship (FFR, in electrically driven left ventricular papillary muscle 
strips (PAP, and on the Ca2+ inward-current (lc.' in isolated human 
myocytes from failing (NYHA IV, heart transplants, n = 10' and non•
failing (NF, donor hearts, n=3' human myocardium. Mg2+ was 
effective to reduce the frequency-dependent decrease in FOC in NYHA 
IV (p<O.OS' in a concentration-dependent manner. The FFR was even 
positive in NYHA IV in the presence of 3 mM Mg2 +. Elevation of Ca2 + 
aggravated the frequency-dependent decrease in FOC in NYHA IV, and 
resulted in a negative FFR in NF. Mg2+ was effective to antagonize 
these Ca2+-mediated effects on the FFR. Mg2+ reduced Ie. in a 
concentration-dependent manner in isolated human left ventricular 
myocytes of the same hearts. 
It is concluded that Mg2 + restores a positive FFR in NYHA IV 
probably by its effects on the intracellular Ca2 + -availability. The 
actions of Mg2 + on the force-frequency-relationship may be of special 
importance in patients with heart failure and already enhanced heart 
rates. 
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870·133 
A Thyroid HormODe AoaIocue Used IS • Sdectlw baotropk A&ent til TmIt 
Heart Fa1Inre la Rabbits. 
Kenneth W. Mahaffey, GregOI}' D_ Pennock, Thomas E. Raya.. Tucson 
Veterans Administration Medical Center, Tucson, AZ. 
Previously, our laboratory bas shown that 3,S-diiodopropaoic acid 
(Ditpa), a thyroid hormone anaIogue, bad selective inotropic effects in rats 
with heart failure. One medlanism of Ditpa action is thru gene controlled 
alteration of myosin isoform elq>ression which, in part, reguIatrs myocardial 
contractility. However, rats have a predominance of bigh-ATPase-activity V1 
myosin isoenzyme compared to humans that have low activity V3 isoform. 
1be goal of this project was to hemodynamically and bistologicaJly ddine a 
post-infarct congestive heart failure model in the rabbit, a V3 predominant 
anlmaI, and record IXlIISCious hemodynamic and YeIltricular morphometric 
cbanges after treatment with Ditpa. 
1be conscious hemodynamics are shown below. Morphological analyses 
demonstrated statistically significant increases in left YeIltricular (LV) lcPgth 
and diameter and increases in lWII thickness indicative of YeIltricular 
remodeling in infarcted versus sbam~ted animals. Dltpa decreases LV 
dilation and lWII thidaless in treated animals. 
~ 
Sham (n-16) 
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(., p<o.o5 compared to sbam. Sham-Sham operated, M1-Post 
myocardial infarction, HR-Heart rate, EDP-Eod-Giastolic Pressure, 
dP/dt-Rate of LV pressure development, T-Relaxation time) 
These data define a clinically rclmmt animal model of LV dysfunction 
post-myocardial infarction with increases in EDP and T and a decrease in 
dP 1 dt in infarcted animals compared to controls. Hemodynamic improvement 
following treatment with a thyroid hormooe analogue is demonstrated without 
an increase in heart rate. Ditpa bas potential as a useful inotropic agent for 
the treatment of congestive heart failure. 
870·134 
Epidermal Growth Factor (EGF) Limits Left Ventricular 
Hypertrophy in Uremic Rats Independent of Blood 
Pressure Response 
Glenn E. Davison, Christopher S. Hall, lames G. Miller, David W. 
Moskowitz and Samuel A. Wickline, Washington and St Louis 
Universities, St Louis, MO 
To elucidate the cardiovascular effects of EGF in chronic renal failure, 
Sprague Dawley rats underwent a "516 nephrectomy" (NX) procedure 
and were treated with EGF. The "No Treannent" group received 
vehicle only (n=6). The "Early EGF' group (n=4) were given 19.1 
jlglday of EGF starting at the time of NX. The "Late EGF' group 
(n=8) received identical treannent 3 weeks post-NX. BP was 
measured 4 times a week. Hearts were excised at 6-7 weeks, and LV 
wall thickness (LVWT), myofiber diameter, LV mass, collagen 
content, blood urea nitrogen (BUN), inulin clearance (IC), and urinary 
protein were measured. (.p< 0.005 versus No Treannent) 
No Treatment Early BOF Late EGF 
L VWT (mm/gm body mass) .010 ±.001 .006± .0004" .010 ±.001 
LV (gmLV/gmbodymass) .28±.02 .21±.01" .27±.01 
Collagen content (mglgm LV) 31.6±.9 30.4 ±.3 31.9 ±.8 
Mean BPat 5 weeks (mmHg) 189±8 187±8 177±6 
Myofiber diameter (J.I.ID) 9.6 ±.2 9.3 ±.1 9.7 ±.3 
BUN (mgldl) 58 ± 8 79± 14 93± 53 
IC (j.Ll/min x l00gm) l00±28 118±34 122±56 
Urinary protein (mgl24 hr) 15.3 ± 4.1 18.6 ± 3.5 23.3 ± 4.5 
There was no significant difference in BUN, IC, urinary protein, BP, 
collagen content and myofiber diameter among the three groups. Early 
EGF resulted in a significantly lower LVWT (-34%) and LV mass 
(-23%), compared to "No Treatment" and "Late EGF" groups. 
Treannent with EGF may have an anti-hypertrophic effect in uremic 
cardiomyopathy that does not depend on alteration in BP or LV wall 
stress. EGF downregulates the growth response in uremic heans. 
proportionately reducing both myocyte and matrix components. 
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870·135 
Autocrine/Paracrine Trophic Function of Acidic 
Fibroblast Growth Factor for Cardiac Myocytes 
"Holger Rennollet, Doris Westernacher, Rene 
Zimmermann, Wolfgang Schaper, Max-Planck-Institute, 
Bad Nauheim, F.R.G. 
Acidic fibroblast growth factor (aFGF) plays an 
important role in fetal and neonatal myocyte 
proliferation and angiogenesis and is re-expressed 
in failing human hearts. Adult cardiac myocytes 
(AM) do also contain aFGF-mRNA and -peptide, but 
the functional role of this mitogenic factor for 
the post-mitotic AM is unclear. To test the 
hypothesis that aFGF works as an autocrine/ 
paracrine trophic factor on AM we blocked aFGF•
expression by exposing serum-free short-term and 
serum-containing long-term cultures of rat AM (10 
preparations of 5 animals each) to a 15mer 
phosphooligonucleotide (Pto) complementary to the 
translation initiation region of aFGF (pto I) for 
48 hours. Cultures exposed to a random oligo with 
the same GC- content (Pto II) and untreated 
cultures served as controls. Pto I significantly 
decreased long term survival and the protein 
content per dish in both culture models whereas Pto 
II had no significant effect compared to control. 
The effect of Pto I could be specifically blocked 
by the addition of an oligo complementary to Pto I 
(pto III). We conclude that blocking aFGF gene 
expression by a specific Pto has anti trophic 
effects on AM. These results suggest that the 
physiological role of this mitogen in terminally 
differentiated adult myocytes is a trophic one. 
870·136 
aeduction of lIa,It-ATPase in the pailing 
Myocardium i. Limited to the a3 I.ofor. 
Tai-Hwang M. Fan, Chee H. Kim, Paul F. Kelly, 
Chi-Ling Hang, Yoshihiro Himura, Bernardo 
Nadal-Ginard, Chang-seng Liang. Univ. Rochester 
and Boston Children's Hospital, Rochester, NY 
Digitalis increases cardiac contractility via 
inhibi tion of myocardial Na, K-ATPase, a 
heterodimer enzyme consisting of an a and P 
subunit. The a subunit contains the digitalis 
binding site; 3 different a isoforms each 
encoded by a separate gene have been identi•
fied. To investigate the status of the 3 a 
isoforms in congestive heart failure (CRF), we 
induced CRF in 13 dogs by ventricular pacing at 
225 bpm for 8 weeks and measured the total 
number of Na,K-ATPase by [~Jouabain binding 
assay and the protein content of each isoform 
by western blot analysis using isoform-specific 
monoclonal antibodies. Fifteen dogs paced at 
100 bpm served as control. Western blot showed 
al and a3 isoforms in the canine cardiac 
tissue, but no a2 was detected. Compared to 
the control dogs, the CRF dogs had fewer 
ouabain binding sites (S.2S±0.30 [mean±SE) vs. 
7.86±0.37 pmol/mg protein, p<O.OOOI) and a much 
lower a3 protein content (00 1.0±0.13 vs. 
2.71±0.30, p<O.OOOl). Accompanying these 
changes was a significant decrease in the 
steady state level of a3 mRNA measured by 
Northern blot analysis (00 1.14±0 .18 vs 
1.69±0.15, p=0.03). In contrast, the a1 
protein was unaffected. ThusJ we conclude that 
the reduction of myocardial Na,K-ATPase 
produced by CRF is specific to the a3 isoform. 
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870·137 
Aoc'D"·ticm of Interstitial OOllagaD in tM 
I'ailiDq Left vetricular JIyQcardim 18 M80ciatad 
With IDcnUed AIIMrObic IIetaboliaa 1D:IIIq Affected 
~
Hi.sashi ~, Rani N. Sal:i:lah, victor G. Slarov, 
Jane OXic, Midlael Lesch, Sidney Goldstein. Henry 
Ford Heart and Vascular Institute, Detroit, HI 
Olrcnic heart failure (HF) is often associated with 
.increased acx:nnll1atiat of CXlllagen in the cardiac 
interstitium (reactive interstitial fibrosis, RIF). 
'!be effects of RIF at the ~ viability of the 
CXlllagen encircled. myocyt:es is not Jcnawn. In the 
present study \ole examined whether RIF is associated 
with a shift toward .increased anaerobic metabolism in 
regiats of the failin:j LV that manifest severe RIF. 
Lactate dehydrogenase (Im) activity, an indicator of 
anaerobic metabolism, was evaluated histologically in 
eatstituent myocyt:es of LV myocardium of 8 dogs with 
HF produced by lILlltiple sequential intraoaronary 
microembolizatiats (LV ejectiat fractiat 25±1 %). 
Serial histologic sectiats 10Iere prepared fran fresh, 
rapidly frozen tissue. LV regiatS of severe RIF 10Iere 
identified. by tridlrane stainin;. 'lhree fields 
manifestin:j severe RIF and 3 fields with no evidence 
of RIF 10Iere selected for analysis fran eadt 
histologic sectiat. '!be intensity of Im reactiat was 
quantitated in 10 ran:ianly selected myocyt:es of eadt 
field usin:j gray level video-densit:anetry. '!be 
intensity of the Im reaction was significantly 
higher in eatstituent myocyt:es of regiatS of severe 
RIF CX'IIp8red to myocyt:es of regiats withart: RIF 
(201±6 vs. 112 ± 4) (P<0.001). Cc:n:lusiatS: In dogs 
with dlratic HF, .increased anaerobic metabolism 
occurs am::rq eatstituent myocyt:es of LV regiats that 
manifest severe RIF. 'lbese findin:Js suggest that RIF 
may prao:Jte localized i.schemi.a ard/or hypoxia. 
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871·98 
Oxidized LDL Stimulates Collagen Production in Cultured 
Arterial Smooth Muscle Cells (SMCs) 
"Shiro Jimi, Keijiro Saku, Noriyuki Sakata, Shigeo 
Takebayashi, Kikuo Arakawa. Dept. of Pathology and 
Internal Medicine, Fukuoka University, Fukuoka, Japan 
This is the first report to demonstrate the stimulatory effect of 
oxidized (ox)LDL on collagen production in cultured SMCs. 
Porcine aortic SMCs in DMEM were incubated with 5O-200J.lg 
proteinJml of human LDL with/without 5J.1M Cu2+ for 24 hours. 
Collagen production was assayed by a successive salt 
precipitation method at acid and neutral pH after a pepsin 
digestion of 3H-proline-labeled collagenous protein. Oxida· 
tions were checked by either electrophoresis or by the level of 
thiobarbituric acid reactive substances (TSARS). In the 
presence of ascorbic acid, no differences were noted in 
collagen production between nLDL and LDL+Cu2+, although 
negative charge and TBARS were slightly increased with 
LDL+Cu2+. Without ascorbic acid, collagen production in up 
to 150 J.lg/ml oxLDL increased dose-dependently (5 fold) 
together with an increase in both negative charge and the 
TSARS level (15 fold), while no effects were noted at any 
dose of nLDL By the addition of butylated hydroxytoluene to 
LDL +Cu2+, collagen production was significantly reduced. 
DNA and total protein synthesis, as reflected by the uptake of 
3H·thymidin and 3H-proline, gradually decreased as the 
amount of oxLDL increased. These results indicate that 
oxLDL stimulates collagen production in SMCs. Therefore, 
oxLDL in the arterial intima could playa direct role in 
stimulating collagen production in SMCs, which could lead to 
collagenosis in atherosclerosis. 
JACC February 1994:1A-484A 
871-99 
Can apo A-IV Gene Polymorphism Explain the Differences 
Between the Effects of Diet in Oriental and Western 
Populations? 
*Huai Bai, Keijiro Saku, Rui Liu, Kikuo Arakawa. Dept. of 
Internal Medicine, Fukuoka University, Fukuoka, Japan 
Human apolipoprotein (apo) A-IV is a polymorphic plasma 
protein. Apo A-IV acts as a cofactor for lecithin-cholesteryl•
acyltransferase. Recent studies suggest that apo A-IV 
regulates food intake and obesity. We surveyed normal 
Japanese subjects by DNA sequencing and an RFLP study 
with PCR, and the following apo A-IV gene mutations were 
observed;1) codon 9 (A->G, synonymous) allele 2=.397 
(n=600) (tallele 2=.032) , 2) codon 347 (A->T, 
nonsynonymous) allele 2=0 (n=900) (tallele 2=.216),3) 
codon 360 (T->G, nonsynonymous) allele 2=0 (n=800) 
(tallele 2=.086), 4) VNTR exon 3 [(CTGT)3 and (CTGT)41 
(CTGT)3=O.36 (n=100) It(CTGT)3=.607]. From among these 
900 subjects we found one ACT to ACG synonymous 
mutation at codon 347 (a first report in the world), which does 
not change the primary structure of apo A-IV. Two other family 
members showed the same point mutation at codon 347 
without affecting lipoprotein levels. Conclusions: 1) Apo A-IV 
gene polymorphism in a distinctly Japanese population has 
been established, and 2) the frequencies of both synonymous 
and nonsynonymous polymorphic sites of the apo A-IV gene 
in Japanese are completely different than those in a Western 
population, which may help to explain the lower prevalence of 
CAD in Orientals via the effects of the apo A-IV gene. (t: data 
reported in Western populations by Boerwinkle et al. and v. 
Eckardstein et al.). 
871-100 
Participation In a Heart Disease Reversal Progrsm 
Decreases SuSceptibility to Oxidation of Low Density 
Lipoprotein (LOLl Particles from Patients with Coronary 
Atherosclerosis (CAl 
Elizabelh J. Parks, B.S., Tissa C. Kappagoda, M.D.,Ph.D., 
John C. Rutledge, M.D., Paul A. Davis, Ph.D., and 
Barbara O. Schneeman, Ph.D., Departments of Nutrition and 
Internal Medicine, OMs ions of Cardiovascular Medicine and 
Clinical Nutrition, University of Camomia, Davis 
Oxidative modnication of LDL may contribute to Hs atherogenicity. 
The oxidizable susceptibility (OS) of LDL in vitro has been shown to 
be influenced by particle antioxidant content. The goal of the present 
study was to Investigate the effed of three months participation in a coronary 
atherosclerosiS (CA) reversal program on the OS of LDL from patients wnh 
documented CA. The program consisted of the consumption of a 10% fat, 
vegetarian diet, exercise four timeslweek and stress redudion therapy. 
Total plasma cholesterol (TC), LDL cholesterol (LDLc), and particle 
antioxidant vitamin content were measured. Copper-catalyzed OS was 
assessed by head-space gas chromatography. LDLc decreased 12% over 
the three month period (p .0.048). Serum concentrations of the fat soluble 
micronutrients, alpha-tocopherol and B-carotene, did not change despne 
three months consumption of a low-fat diet. Total volatile fatty acid oxidation 
by-prodUdS produced in vitro decreased 17% at three months compared to 
baseline (p - 0.0065). Using ape B content to normalize for particle number, 
the produdion of oxidation by-produdS was Inversely correlated wHh the 
molar content of vnamin E (r2 = 0.52, p = 0.01) at baseline. At three months, 
this correlation remained statistically signnicanl (r2 = 0.75, p = 0.001). 
These resuhs Indicate that consumption of a 10% fat, vegetarian diet was 
associated wnh a signnicant decrease in LDLc wHhout a decrease in fat•
soluble antioxidant micronutrient status. LDL alpha-tocopherol content 
has previously been shown to be a good predictor of in vitro particle OS 
in heahhy aduHs. To our knowledge, this is the first demonstration of a 
decrease in the in vitro OS of LDL particles from patients participating in a 
program designed to produce regression of atheroscleroSis. Thus, our 
resu~s support the hypothesis that the mechanism by which atherosclerosis 
regression occurs includes a decrease in oxidative susceptibility of low 
density lipoprotein particles. 
ABSTRACTS 
871·101 
Relationships Between Fatty Acid Patterns and HDLJTotal 
Cholesterol In Subjects PartiCipating in the Framingham 
Offspring Heart Study Cycle 4 
*Edward N. Siguel, Robert H. Lerman. Boston University 
Medical Center Hospital, Boston, MA. 
Peter W. F. Wilson, Framingham Heart Study. 
We evaluated the hypothesis that essential fatty acids 
are a major predictor of HDLJTotal Cholesterol levels. 
Background. Some reports suggested a link between plasma 
lipids and fatty acid (FA) levels. Methods. We analyzed 
fasting plasma from approximately 500 randomly selected 
subjects, about 250 men and 250 women participating in the 
Framingham Offspring Study. Results. Cholesterol, 
HDL/total cholesterol and triglycerides correlate with different 
types of FAs (p < 0.01). Plasma polyunsaturated FAs are 
highly associated with HDL/total cholesterol (p < 0.01, age-sex 
adjusted), better than saturated or monounsaturated FAs. 
Subjects with elevated lipids had relative Essential FA (EFA) 
insufficiency, a plasma FA pattern similar to the one found in 
EFA deficient patients (i.e., elevated 20:3w9/20:4w6 ratios, p < 
0.01) but with normal to elevated plasma concentrations of 
EFAs, a condition we attribute to inefficient EFA transport. We 
hypothesize that this condition is caused by excessive intake of 
saturated in relation to polyunsaturated FAs and it is 
associated with coronary artery disease and hyperlipidemia. 
Conclusions. Our data indicate that reduced levels of EFAs 
are positively correlated with elevated lipid levels. We propose 
that abnormal FA metabolism is fundamentally associated with 
acquired hyperlipidemia and cardiovascular disease. We 
suggest that subjects at risk for cardiovascular disease be 
tested for lipid and FA profiles and treated to bring their profiles 
within ideal levels. 
871·102 
Hypercholesterolemia and AIberosderosis Despite Suppnssion or BMG-CoA 
Reductase in Lean and 0be!Ie Pigs Fed High Cholt'Slerol From Birth to Two 
Months. 
Anne M. Hackman, Wilsoo G. Pond, Hany 1. Mersmann, William W. Wong, 
Lemwt Krook. Dept of Pediatrics, Baylor CoUege of Medicine, Houston, TX 
Purpose: Data suggest !bat exposure to cholesterol (C) in infancy is necessary to 
develop IJ'propriate regulatory mechanisms for maintaining a normal C level as 
an adult. This study examined the effects of a high C (HC) vs. no C (NC) diet 
on Yorkshire x Duree pigs selectively bred for low (lean) or high (obese) back 
fat thickness during the first 2 months of life. Method: Sever! lean and 7 obese 
pigs were assigned within genetic group to receive either NC or HC (I % C by 
weight) diet from birth. Serum C and triglyceride (TG) were measured 
dl,dl5,d35 and 1155. Hepatic 3-hydroxy-3-methylglutaryl coeozyme A reductase 
(HMG-CoA red) activity, the enzyme !bat catalyzes the rate-limiting step in C 
synthesis, was assayed at sacrifice (mean age 65 days) using radiochemical 
assay. The intact aorta was examined under light microscopy for atherosclerotic 
plaques. Results: 
um ro 
in Aorta 
·VaJues are means with (standard dev). 
Conclusion: I) Despile IJ'Propriale suppression of bepalic C synthesis, • HC 
diet in infancy produced hypercholesterolemia and aortic plaques in 2 genetically 
distinct groups of pigs at a very young age. 2) There are genetic differences 
between these lean and obese pigs with respect to their serum C and propensity 
to develop aortic plaques in response to a HC diet. 3) These pigs are an 
IJ'propriate model to study the effects of C exposure vs. deprivation in infancy 
lin C metabolism and atherosclerosis in adulthood. 
99A 
100A ABSTRACTS 
871-103 
ContraatiDs Effects of ApoprotelJll A-I md A-U on Coronary Artery 
DiIeaae ClwIge in Men durin& 2.S JUrI iii Llpid-lcM'erIng Therapy 
Vincent M.G. Maher, B. Greg Brown, Xue-Qjao Zhao, Marian Cheung 
Santica M. Marcovtna, John J. Albers, Univ. of WA, Seattle, WA 
High-density lipoprotein cholesterol (HDLc) levels are inversely 
related to coronary heart disease in man. HDL has two fractions, HDL2 
and HDL3 each containing two major apoproteins, apo A-I and apo A-II. 
Apo A-I is thought to confer HDL's anti-atherogenic effect. Recently, a 
pro-atherogenic effect was shown for apo A-II in transgenic mice. We 
therefore ewnined the influence of these two apoproteins on change in 
angiographically quantified coronary artery disease (CAD) over 25 
years among 120 men with CAD, age S 62, and with apolipoprotein B 
(apo B) levels ~125 mg/ dl. LIpids were analyzed at base line and during 
therapy with diet plus lovastatin (20 mg bid) and coIestipol (10 g tid) 
(L+C) or with niacin (1 g qid) and colestipol (N+C) or with conventional 
therapy (placebo only, or poSSibly colestipol) (Conv). CAD severity per 
patient was estimated as the mean percent diameter stenosis in a1l 
coronary segments; its change over 2.5 years was defined as 4%5. 
Results: HDL2 HDL3 apo A-I apo A-II 
Therapy: Base %A Base 'J,4 Base %A Base $A 
N+C (36) 4±4 280!:215§1 38:t1 12±2()§ 133±12 14±16§¥ 3Ot5 -4±25 
L+C (38) 3±2 139±1~ 35±5 2±12 129±11 7±13" 29±5 nt16 
Conv(46) 4±4 @±98 35±Z om 132±18 -1±15 W 2;1:18 
Base z Base-Iine values (mg/d\), %4 .. % ~ from Base-line 
V5 Conv: §p<o.ooI,tp<O.OI,"p<O.os, vs L+C: 'p<O.OI,\Ip<O.05 
Apo A-I levels during treatment correlated inversely with 4%5 (r= ~.26, 
p=0.OO5). Conversely, apo A-II levels correlated positively (r=O.21, 
p=O.()2). Their ratio, apo A-II A-II was the best predictor of 4%5 
(r- ~.42, p<O.oool). Disease change correlated with HDL2 levels during 
treatment (r- ~.25, p<0.0l) but not with HDL3. The significant 
independent predictors of 4%5 are in the multivariate expression 
[0.17 apo A-II + 0.1)3 apo B - 0.07 apoA-I + 1.25) (r=O.45, p<O.DOOl). 
This data confirms the anti-atherogenicity of apo A-I and shows for the 
first time that apo A-II is pro-atherogenic in man. 
872 Cardiac Disease in the Elderly 
Monday, March 14, 1994 3:00-5:00 PM 
Georgia World Congress Center, Hall H 
Presenting Hour: 4:00 PM 
872-104 
Clinical Outcome. In Elderly Patient. Tr .. ted lor 
IndUCible Monomorphic Suatalned Ventricular 
rachvclfdla. 
Alexander G. Vtgh. Denise L Janosik. Preben Bjerregaard, Susan E. 
Wittry. Teny D. Greenwalt. St. Louis University Hospital. St. 
Louis. MO 
We evaluated the clinical course of 55 patients age ;t 70 years (70-
85 yrs.) with inducible sustained monomorphic ventricular 
tachycardia on electrophysiologlc (EP) testing. Clinical 
presentation was cardiac arrest in 21 pts. sustained monomorphic 
ventricular tachycardia in 17 pta. and syncope in 17 pts. The 
majority of pts were male (84%) and had coronary artery disease 
(820/0). Treatment (Tx) was non-randomized and included 
Implantable cardioverter defibrillator (ICD) In 30 pts. EP guided 
drug therapy 16 pis. and empiric amiodarone In 9 pts. There were 
no significant differences between the three treatment groups in 
terms of age, left ventricular function. or clinical presentation. 
Patients were followed retrospectively with sudden cardiac death 
(SCD) and total mortality (TM) as end points. The mean follow-up 
period was 26 months. Kaplan-Melr survival analysis was used for 
assessment of outcome. 
Sudden Deaths 
Total Mortality 
Amio ICD . EP Drug 
n.9 
3(33%)*t 
7(630/0)*0 
1 (3%) 
6(200/0) 
n~16 
1(6%) 
6(38%) 
• I>< 01 vs ICD Tx. t 1><.05 vs EP guided Tx. 0 p..06 vs EP guided Tx 
Conclusions: In elderly pts with inducible sustained monomorphic 
ventricular tachycardia on EP testing. ICD therapy and EP guided 
drug therapy appeared to significandy reduce SCD and TM compared 
to empiric amiodarone therapy. 
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872-105 
There is an Increased Morbidity and Mortality 
Incidence with Digoxin Use in the Elderly. 
Results of the Bronx Longitudinal Aging study 
Robert T. Eberhardt, *William H. Frishman, Andre 
Landau, Dawn Hershman, Paul Simonoff, Marco 
Gentilucci, Miriam Aronson, The Albert Einstein 
College of Medicine, Bronx, New York. 
We analyzed the effects of digoxin (D) use on 
morbidity and mortality rates in an old old 
community-dwelling elderly popUlation (n=488, 
mean age 79 yrs) free from terminal disease. 
Subjects were followed for 10 yrs in a non•
interventional prospective cohort study designed 
to assess risk factors for the development of 
cardiac and dementing illness. No patient had 
a history of clinical congestive heart failure 
at study onset. The use of D was reported in 
13% of the cohort. The all-cause mortality 
rates were 10.2/100 person yrs for patients 
receiving D, compared to 5.2/100 patient yrs for 
patients not receiving the drug (p<O.OOl). The 
cumUlative all-cause mortality was higher among 
those subjects receiving D throughout the study. 
The use of D remained a significant predictor 
of mortality after adjusting for differences in 
baseline characteristics of subjects using 
multiple logistic regression analysis. The use 
of D was not associated with an increased inci•
dence of nonfatal cardiovascular events, though 
it was associated with a 4-fold increase in the 
incidence of both multi-infarct and mixed-type 
dementias. Our findings suggest that D use in 
an old old community-based population is an 
independent predictor of mortality. 
872·106 
Important Correlates or Echocardiographic LV Mass in the Elderly Include 
Gender. Weight. Systolic Blood Pressure. Pulse Pressure, Prevalent Disease 
and ECG Abnonnalities: The Cardiovascular Health Study 
Julius M. Gardin, Richard Kronmal, Vivienne-Elizabetb Smitb, Linda Fried, 
Sidney Klopfenstein, and Teri A. Manolio, for the Cardiovascular Health Study 
(CHS) Research Group, University of California Irvine, Orange, CA 
Left ventricular (LV) mass, as estimated from M-mode ecbocardiography 
(echo), has previously been shown to be an independent predictor of incident 
cardiovascular disease (CVO) morbidity and mortality. We evaluated tbe 
relationship at baseline of echo LV mass to relevant CVD risk factors and other 
potential covariates in the Cardiovascular Health Study (CHS), a large NHLBI•
sponsored multicenter study of men and women aged ~ 65 years (mean 71). 
M·mode (2·0 directed) echo LV mass measurements were obtained in 1360 
men and 2048 women. Multiple linear regression analyses of the relationship 
of echo LV mass to demograpbic risk factors, echo-Doppler LV function, ECG, 
and prevalent disease variables produced a linear model which explained 34% 
of the variance: LV mass = 92.8 + 0.44 (weight in kg) + 16.6 (x 1 for male 
gender) + 0.33 (systolic BP in mmHg) - 0.36 (diastolic BP) - 0.08 (bio 
resistance measure of fatness) - 0.06 (factor VII) + 18.8 (CHF) + 16.4 (MI) + 
18.4 (major ECG abnormality) + 9.5 (minor ECG abnonnality) + 5.3 (x 1 for 
hypertensive medication). Of interest, although height and weight were both 
related to LV mass in healthy subjects and those with clinical CHD, height 
added nothing additional once weight was entered in the multivariate model 
Furthermore, in the multiple regression mode~ diastolic BP was inversely, and 
systolic BP positively related to LV mass, with similar magnitudes for their 
coefficients, suggesting that pulse pressure was a positive predictor of LV mass. 
Various covariates importantly related to LV mass in bivariate analyses -- e.g., 
fasting blood sugar, body mass index, serum hematq,crit, LV wall stress, uric 
acid, LV segmental wall motion abnormalities (all positively related), and HDL 
cholesterol and Doppler peak flow velocity in early diastole (both inversely 
related) .. were not independently related to LV mass in multivariate models. 
We conclude that body weight, male gender, systolic BP, pulse pressure, the 
presence of CHF, MI, major and minor ECG abnormalities, and treatment for 
hypertension are independently and positively related to echo LV mass, wbile 
diastolic BP and factor VII are inversely related to LV mass in this population 
of older adults . 
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872·107 
Rest TI·10llStress Tc·99m Sestamibi Separate Acquisition Dual 
Isotope Myocardial Perfusion SPECT: Diagnostic Efficacy in 
Detection of Coronary Artery Disease Among Octogenarians. 
Fan Ping Wang. Hosen Kiat. Jason Greenspan. Siva Arunasa1am. John D. 
Freidman, Daniel S. Bennan. Cedars-Sinai Medical Center. L.A., CA 
Coronary artery disease (CAD) is often occult in the very elderly. who also 
generally have less coronary hyperemic response to stress. To evaluate the diagnostic 
efficacy of stress myocardial perfusion imaging in these pts, we studied 49 
consecutive octogenarians with no mown CAD (83±3yrs. range 80-91) referred for 
evaluation with separate acquisition rest 11-20l/stress Tc-99m sestamibi dual 
isotope myocardial perfusion SPECT (DIMPS). PIS with prior MI. CABG or PTCA 
were excluded, as weU as 3 with patient motion on SPEer. Coronary angiography 
was peIfonned within 6 months. DIMPS used 3 mCi rest 11-201 SPECT foUowed 
by stress and 25mCi sestamibi injection. Sestamibi SPEer was peIformed IS min 
after exercise (Ex) (nzI6. age 83:±2yrs) or I hr after pharmacologic stress (Pharm) 
with adenosine(14Oug/kg/min for 6 mms. n=25. age:83±3yrs) or dipyridamole(.I42 
mg/kg/min for 4 mins n=5 age: 84±3yrs ). SPECT used high resolution collimator 
and continuous acqusition for 15 mins. SCintigraphic data were read by 2 blinded 
experts using 20 SPECT segment analysis and each segment was scored using S 
point scoring system (O=nl. 4=absent uptake). A SPECT study was considered 
abnormal if ~2 segments had a stress score of ~2 or > 1 segment had a score of~. A 
vascular territory needed 2:1 segment with a stress score of 2:2 to be considered 
abnormal. The sensitivity (Sn) and specificity (Sp) results for detection of pts with 
angiographic CAD (2:70% stenosis) and disease in individual coronary aneries were: 
OVERALL CAD LAD LCX RCA 
TOTAL Sn 37/38 (97%) 20/24 (83%) 15/20 (75%) 23/25 (92%) 
Sp 6/8 (75%) 14/22 (63%) 22/26 (85%) 13/21 (62%) 
Phann Sn 25/25 (100%) 13115 (87%) 
Sp 4/5 (80%) 9115 (60%) 
11/13 (85%) 
13/17 (76%) 
ISI15 (100%) 
9!1S (60%) 
EX Sn 12/13 (92%) 7/9 (78%) 4/7 (57%) 8/10 (80%) 
Sp 2!3 (67%) S/7 (71%) 9/9 (100%) 4/6 (67%) 
Sn and Sp were 100%(22/22) and 75%(3/4) in asymptomatic or nonanginal pts. and 
94% (15116) and 75% (3/4) in pts wilh typical or atypical angina 
In conclusion. phannacologic or exercise stress DIMPS were equally effective among 
octogenarians for assessment of CAD. irrespective of presenting symptoms. 
872·108 
Clinical and Echocardiograpbic Predictors of Exercise-Induced 
Supraventricular Arrhythmias in Healthy Volunteers 
Jerome L. Fleg, Ronaldo Mayuga, Charles T. Arrington, Frances 
O'Connor. Gerontology Research Center, NIAlNlll, Baltimore, MD 
21224 
Although supraventricular aniJythmias (SV A) are commonly seen 
during treadmill exercise, their etiology is poorly understood. To 
determine the relative importance of clinical, exercise and cardiac 
anatomic variables in the occurrence of exercise-induced SV A 
(ElSVA), we analyzed the results of 288 healthy volunteers ages 20 
to 90 years from the Baltimore Longitudinal Study of Aging who 
underwent both M-mode echocardiography and maximal treadmill 
exercise testing within one biennial visit. Simple EISV A were 
observed in 52 subjects (18%) and frequent or repetitive (Le., 
complex) EISVA in 20 (7%). By univariate analysis, older age (p 
< .000 1), lower peak heart rate (p < .00(1), higher left ventricular 
(LV) mass index (p < .004), and shorter exercise duration (p < 
.01) predicted the development of EISVA. By multiple logistic 
regression analysis, only older age (p < .(01) independently 
predicted EISV A. Significant univariate predictors of complex 
EISVA were older age (p < .00(1), lower peak heart rate (p < 
.(02) and shorter exercise duration (p < .01). However, only age 
(p < .01) independently predicted complex EISVA by multiple 
logistic regression. Thus, reduced exercise capacity, blunted 
chronotropic response and greater LV mass are associated with 
EISV A but do not independently predict the development of EISV A 
once the powerful effect of age is considered. 
ABSTRACTS lOlA 
872-109 
Aging caUI8I Plrallel Remodeling of DllCelldlng Thoracic AOI'II Ind 
carotid Artery 
James W. Peterson. Rulqiang Guo. Peter Gray. David A. Orsineill. Anthony 
C. Pearson. The Ohio State University. Coiumbus. Ohio 
Aging Is associated with Increased aortic Intima/-medial thickness (IMT). 
diameter and stiffness. However. the effect 01 aging on carotid 
morphology and stiffness and the raiatlonshlp between carotid and aortic 
remodeling with aging Is unknown. In order to Investigate these 
reiatlonshlps, we examined 119 patients ages 19 to 84 yeara (mean. 55 
years) undergoing transesophageal echocardiography (TEE) for clinical 
Indications. Measurements 01 aortic IMT and diameter were made from 
TEE guided M-mode recordings 01 the descending thoracic aorta. and 
carotid IMT and diameter was measured from B-mode recordings using a 
7.5 MHz linear vascular probe. Peterson's elastic modulus was calculated 
using simultaneously measured pulse pressure. 
Age was highly reiated to both aortic and carotid IMT (r=O.82. p=O.OOOI. 
and r=O.77. p=O.OOOI. respectlveiy). to aortic and carotid diameter 
(r=O.67, p=O.OOOI. and r=O.48. p=O.OOOI. respectively), and to carotid but 
not aortic relative wall thickness (r=O.46. p.O.OOO1. and r=O.OS. p=O.52. 
respectlveiy). A weak. but significant association was seen between age 
and carotid elastic modulus (r=O.3D. p=O.OOO8). Carotid IMT was highly 
correlated wtth aortic IMT and carotid diameter was slgnHlcantly related to 
aortic diameter (r=O.59. p=O.OOOI. and r=O.S2. p=O.OOOI, respectlveiy). 
Carotid stiffness was signHicantly related to aortic stiffness (r=O.49, 
p=O.OOOI). We conclude that thickening of the carotid artery and 
descending thoracic aorta are highly reiated. Aging Is associated wnh 
dilatation and Intima/-medial thickening 01 both the aorta and the carotid 
artery. There Is a parallel decrease In the dlstenslbHIty of the aorta and 
carotid artery. If confirmed In a larger series of patients. carotid artery 
geometry could serve as a surrogate marker for age associated changes 
In the descending thoracic aorta. 
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873·110 
Automated Computer Algorithms Measuring Length and Area 
Parameters for Echo Images are Unaffected by 15:1 JPEG Compression 
ShaJabh Chandra. Tom H. Karson, Steven E. Nissen and James D. Thomas 
The Cleveland Clinic Foundation. Cleveland. Ohio 
Ready access for computer analysis is one of the many imponant advantages of 
digital archiving of echocardiographic images. We have previously shown that 
image compression has negligible impact on manual echo measurements; 
however. measurements done by automated computer algorithms might fail 
because of artifacts introduced by compression. 
Metbods: To address this concern. standard M-mode and spectral Doppler 
tracings were digitaUy acquired and compressed using the baseline JPEG (Joint 
Photographic Experts Group) algorithm. Five quantization tables were used 
resulting in compression ratios (CR) ranging from 4:1 to 26:1. All original and 
compressed images (150 total) were processed using programs written in 
LabView· and Khoros. A region of interest was exuacted, appropriate image 
enhancements peIformed. and automated edge detection and measurements 
were made. Image enhancements included algorithms for speckle noise 
reduction. texture feature analysis, and thresholding. An optimal filter based on 
both a one step and multi-edge model was used for automated edge detection. 
Results: The following automated measurements were made: a) M·mode: 
diameter of aorta. LA. and LV (systole and diastole); LV waU thickness; mitral 
CR %errMM 
4:1 0.50 
7:1 0.00 
12:1 0.50 
22:1 1.04 
26:1 1.04 
%errD 
0.3 
0.3 
0.8 
1.2 
1.5 
valve (MV) excursion and velocity; and b) 
spectral Doppler: aortic peak and integrated 
velocity and MY slope and deceleration time. 
The table shows average compression ratios 
and mean absolute error for aU M-mode (MM) 
and spectral Doppler (D) measurements, using 
the uncompressed images as a gold standard. 
Conclusions: These results show that I) the accuracy of automated measure•
ments does not change significantly even with 26:1 compression; and 2) 
whatever artifact which may have been introduced by compression does not 
significantly alter the measured values. 1berefore. this study further supports 
the potential for JPEG compression 10 be used in the digital storage of 
echocardiograrns. 
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873-111 
New Irrevenlble Compression TechDlques 
for Archlylol Anllocardlolraphk Static Imaaes 
Luisa Portoni. Carlo Combi. Marco Negn:tto. Fraacesco PinciroIi. Giweppe Pozzi 
aad Giorgio Invemizzi. Dipartimento di Bioingegneria - PoIitecoico di Milaao. 
Centro di Teoria dei Sistemi - CNR. Milano. Italy aad Divisione di Cardiologia. 
Ospedali RiUDiti di Bergamo. Bergamo. Italy. 
We defined. implemented aad experimented on aDgiocardiographic static images 
three new irreversible compn:ssion techniques: Brightness Fzror limitation (BEL) 
method. Pseudo-gradient Adaptive Brightness &ror limitation (pABEL) method. 
Pseudo-gradient Adaptive Brightness and Contrast Enor limitation (PABCEL) 
method. Basic principle of all these techniques is to limit maximum difference of 
brightness between <DTCSpODding pixds of the original image aad the recoostructed 
one. Our compression techoiques are based in image scanning according to the 
Peano-Hilbert plane filling curve. 
We applied our compression IeChoiques to lOme 168 ltatiC images selected from 
aagiocardiograpbic 35mm films: images were acquired during aagiocardiographic 
exams performed at the Haemodynamic Labs of the Cardiology Division of the 
Ospedali Riuniti. Bergamo. Italy. aDd are related to 14 different PTCA 
(percutaneous Transluminal Coronary artery Angioplasty) patients. Each method 
was applied with four different threshold values. 
Some cardiologists of the OspedaIi Riuniti di Bergamo compared obtained results 
with those achieved applying to the same images the sequential compression 
modality defined by the standard JPEG. Considering threshold values limited to 
maintain all significaat clinical informations present in the original image. we 
achieved best compression results applying PABCEL method: we obtained a mean 
compression ratio of about 8:1. 1/3 higher than which reached applying JPEG. 
Consulted cardiologists did not find significant diagnostic differences between 
original images aDd reconstructed ones. In order to highlight for every pixel 
brightness differences introduced by compression methods. we displayed diff ereuce 
images among original aad reconstructed images. To have a quaatitative evaluation 
of differences anong ooginaI aad reconstructed images where coosuIted cardiologists 
did oot recognize significaat differences. we built up the histograms of grey level 
differences between consecutive pixds on the Peaao-Hilbert scaa path. 
Our new irreversible IeChoiques are now collected in a software package named 
IT ACA (Irreversible Threshold-based Aogiocardiographic images Compressor and 
Archiver). BEL. PABEL aad PABCEL methods were implemented using Microsoft 
MS-DOS C compiler. 
873-112 
Compression of Two-dImensional Echocardlographlc Images: How Far Can 
We Go? 
Nipun K. Agarwal BS. liri Sklenar PhD. 10hn M. Dent MD. Sang Son PhD. 
Sanjiv Kaul MD. FACC. 
University of Virginia. Charlotte!ville. Virginia 
We sought to e!tabli!h the highe!t compre!sion levels at which two•
dimen!ional echocardlographic (2DE) data do not suffer from loss of image 
quality. Accordingly. 269 cardiac cycle! were randomly !elected from 2DE 
clinical !tudies performed using 3 !Cp8rate ultrasound system! by an 'observer 
not familiar with clinical echocardiography. The!e cycle! were digitized using 
a Macintosh Quadra 950 workstation. The data were compressed using the 
IPEG (loint Photographic Experts Group) protocol at compre!sion ratios ranging 
from I: I to 9: I independent of the image quality. Two experienced 
echocardiographers blinded to the level of compre!!ion independently graded the 
image quality of the digitized data viewed in cine-loop format using a 5-point 
scale (I - poor. 5 - excellent). The Kappa statistic wa! used as an objective 
measure of inter-observer variability. 
There was no difference in the average image score usigned by the 
ob!ervers for the 3 ultra!ound !ystems (P - 0.16). A weak albeit !tati!tically 
!ignificant correlation (r=-o.20. P -O.OOOS) was observed between the level of 
compre!sion and the image score. with the image score declining at higher level~ 
of compression. Multivariate regression analysi! revealed the level of 
compre!sion to be the best predictor of the average image score (P -0.0004). 
Although the Inter-observer agreement wu good for the image score (kappa = 
0.70) when all images were analyzed, it decreased with increa!ing levels of 
compre!!ion and poor agreement wu noted beyond compre!sion levels of> 1 :7. 
Compre!!ion ratio 
Agreement (Kappa) 
1:1 1.5:\ 3:1 5:1 7:1 9:1 
0.8\ 0.67 0.73 0.71 0.6\ 0.36 
We conclude that observer agreement regarding 2DE image quality de•
crea!eS with increasing levels of compression with poor agreement noted above 
compre!sion levels of7: I. The!e results have bearing on the compression levels 
used for storing and di!playing 2DE data. Whether this decrease in observer 
agreement regarding image quality at high compressIon levels of ha! any 
influence on the clinical interpretation of 2DE data remains to be determined. 
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720-1 
Impact of Stent Size and Indicadon for Stendng on 
Immediate Outcome and Restenosis 
4:00 
David R, Holmes Jr .• Kirlt N. Garratt, Peter B. Berger. John F. 
Bresnahan. Malcolm R. Bell. Robert S_ Schwartz, Mayo Clinic. 
Rochester. MN 
Reported risks of acute closure (AC) of a stent or stent restenosis (Res) 
vary widely. This variability may relate to the stent size used and the 
initial indication for stent placement To study this. 184 stenlS (Cook 
Flexstent and Medtronic Wiktor) implanted at Mayo Oinic were 
evaluated_ Indication for stenting was treatment of dissection or abrupt 
closure (DisIC) after PI'CA in 109 pIS. and elective (Elec) stent 
placement for high risk lesion. treaunent of restenosis or recoil in 75 
pIS. Stent sizes used were 2.0 mm (2 pIS). 2_5 mm (22 pIS). 3.0 mm 
(102 pIS). 3.5 mm (41 pIS) and 4_0 mm (18 pIS). Overall Res for Elec 
placement was 15% vs 38% for DiS/C placement p=O.OOO6 
Treatment of Djssection orOosUl'e 
Stent size (mm) 
N 
2.0 2.5 3.0 3_5 4.0 
o 18 66 19 6 
% event 
Persistent in lab AC 
AC out of lab 
CABG 
Restenosis 
Stent size (mm) 
N 
% event 
Persistent in lab AC 
AC out of lab 
CABG 
Restenosis 
2.0 
2 
o 
o 
o 
o 
o 6.1 0 
o 6.1 0 
o 15_5 5.3 
62_5 32.4 36.4 
Electiye Placement 
2.5 3.0 3.5 
4 36 22 
o 
o 
o 
o 
o 
2.7 
2.7 
19.4 
o 
o 
o 
13.6 
o 
33.2 
o 
25.0 
4.0 
12 
o 
o 
o 
8.3 
Conclusion: The variability in outcome of stent placement relates to 
indication for stenting and stent size. Smaller stenlS placed for Dis/C 
have increased incidence of AC and significantly increased restenosis 
while larger stenlS placed Elec have a low incidence of both. 
720-2 4:15 
Complications Related to Intracoronary Stents Placed for 
Moderate and Severe Dissections: Cook FlexStent Registry 
Report 
Kirk N. Garratt, William D. Voorhees m. Malcolm R. Bell. Peter B. 
Berger. Albert E. Raimer. Gary S. Roubin. David R. Holmes. Jr. 
Mayo Clinic. Rochester. MN 
The relationship between intimal dissection severity and complications 
related to intracoronary stent (ICS) placement is poorly defmed. 
Placement of stenlS for angiographically moderate dissections would 
be of greatest value if associated with a low frequency of complications_ 
We reviewed data from the Cook FlexStent Registry regarding pIS who 
received ICS for dissections which narrowed the coronary lumen by 
<50% (moderate dissection. n = 237. Gr 1) or by ~50% (severe 
dissection. n = 455. Gr 2). The two groups were similar with respect 
to patient age and gender distribution. number of diseased vessels. 
prior coronary artery bypass surgery (CABG). prior Q-wave 
myocardial infarction (QMI).left ventricular function. presenting 
symptoms. and vessel receiving the ICS. Pre-stent and post-stent 
lesion severities and 30 day rest-stent complication rates were: 
Gr Gd p 
Pre-ICS stenosis 34.7f12.2 66.7i13.6 ~O_05 
Post-ICS stenosis 10.9±12.7 13.4iI3.8 NS 
QMI 6 (2_5%) 13 (2_9%) NS 
CABG 13 (5.5%) 26 (5.8%) NS 
RepeatPI'CA 5 (2.1%) 13 (2.9%) NS 
Death 6 (2.4%b 10 (2_2%= NS 
tn-hospital bleeding reqwnngUston occ m 41 (17.3%) Gr 1 
and 59 (13%) Gr 2 pIS (p=NS). 
We conclude that the inclClence of complications occurring within 30 
days of ICS placement is the same for dissections causing < or ~ 
luminal nam>wing. 1bese data suggest that complications of this stent 
may not be directly related to the angiographic severity of the treated 
dissection_ ICS should be placed for angiographically moderate 
dissections only when the risk of complications without stent 
placement is perceived to be high or a restenosis benefit is anticipated. 
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720·3 4:30 
Short Term Evolution of non Occlullve DilHctlon After Succ:ealul 
PTeA. 
* Alberto Margonato, Alberto Cappelletti, Sergio L Chlerchia. Istituto 
Sclentlfico H San Raffaele, MIano, Italy. 
Blckground: stentlng is commonty used for the treatment 0/ acute 
dissection after PTCA. but its use Implies longer hospital admission times, 
higher costs and relatively frequent complications. 
Aim of the Itudy: to 8118iuate the short term evolution 0/ untreated non 
occlusive dissection after PTCA 
Pltlentl: we studied 52 consecutive pts (45 men, mean age 53.± 11 years) 
who underwent repeat coronary angiography 24 hours after PTCA (33 LAD-
25 CX.s RCA). For each lesion we 8118iuated residual stenosis and the 
presence 0/ dissection greded 1 to 3 on an arbitrary scale. 
RIIUHI: coronary stenosis (85.±10%) was reduced by PTCA to 3O.±11% 
(p<O.OOI); flow was TIMI grade 3 In all pts. Dissection was seen in 26/613 
lesions (39%), and graded 1 In 17,2 In 7 and 3 in 2. At 24 hours, the severity 
of residual stenosis was 25.±9% (pNS), and dissection was evident In 21/613 
lesions (32%). Dissection severity was grade I, 2 and 3 respectiveiy In 13, 6 
and 2 lesions, With an Improvement In 8/26 lesions (31 'lEo). Worsening of 
dissection <2 1 grade) was found In only 5 (19%) lesions, but worsening of 
distal flow was never observed. No acute events or recurrence of angina 
were seen on the one month follow-up. 
In conclullon, non occlusive dissection at the site of dHatation Is frequently 
present after successful PTCA. However, In the majority 0/ cases this 
finding Is unchanged or Improved after 24 hours, without unfavourable 
clinical evolution on one month follow-up. Therefore, In the presence of 
good distal flow and In the absence of ischaemia, this complication does 
not require any further Intervention. 
720·4 4:45 
Perfusion Balloon versus Stent for Acute or Threatened Closure: 
equal Efficaclcy but significantly higher Costs after Stenting 
Ebo D. de Muinck, Hans L. Hillege, Rene B. van Dijk, Peter den Heijer, 
Kong I. Lie, University Hospital, Groningen, The Netheriands 
Treatment of acute or threatened closure during PTCA with a Stack 
perfusion balloon (PB) or Palmaz-5chatz stent (5) was compared 
regarding: success (stenosis < 50%, T.I.M.1. 3 flow and no in-hospital 
reclosure or restenosis), 3 months angiographic restenosis (> 50%), and 
cost of the intervention based on the total duration of hospitalization, and 
the number of repeat interventions in hospital and during 3 months 
fotlow-up. During 2596 PTCA procedures 6' patients were treated with a 
PB and 36 received a S for acute or threatened closure. There were no 
statistically significant differences regarding: baseline clinical characte•
ristics, lesion morphology pre-PTCA and lesion morphology before PB or 
S. Costs are: 500 US Dollars for , day in hospital, 400 for coronary 
angiography, 4790 for PTCA, 9,60 for bypass surgery. Three patients 
died after S (P < 0.05). In·hospital reclosure occurred " times in 8 pa•
tients after S only (P < 0.0002). The PB was successful in 42 (69%) 
patients and the S in 25 (69%). There was restenosis in '3 (30%) 
patients after PB and in 3 (12%) after S. 
Days in hospital 
(median;range) 
Repeat angiogram 
within 3 months (n) 
Repeat PTCA (n) 
Bypass surgery (n) 
Cost (median;range) 
PB (n=6') 
4 (2-22)" 
7 (12%)t 
3 (5%):t 
,7 (28%) 
6790 (5790·22450)§ 
, P < 0.002; t P < 0.05; :t P < 0.05; § P < 0.005. 
S (n=36) 
13.5 (2-49)' 
'6 (44%)t 
'2 (33%):t 
5 ('4%) 
'1790 (579D-374'5)§ 
Thus, PB and 5 were equally successful for the treatment of acute or 
threatened closure, with no signfficant difference in 3 months restenosis. 
Treatment with a S was significantly more expensive due to longer 
hospitalization and more repeat angiography and PTCA for reclosure. 
ABSTRACTS 
720·5 5:00 
Emergency Temporary Stenting Should be Preferred to 
Permanent Stenting for Abrupt Closure During Coronary 
Angioplasty 
·Philippe E. Gaspard, Bruno P. Didier, Yves A. Lienhart, Didier H. 
Champagnac, Jean-Philippe Frieh, Marc R. Vigneron, GCV, Lyon, 
France 
Coronary stenting has been reported to reduce emergency (Em) 
bypass surgery and to stabilise obstructive flap following PTCA. 
However pennanent stenting (Palmaz Schatz) is associated with 
significant thrombotic complications. We developed in 1988 a 
temporary removable vascular stent (Flow Support Catheter) in order 
to minimise this risk and to avoid the need for strong and prolonged 
anticoagulation. 
From 1989 to 1992, 64 patients underwent Em stenling for post 
PTCA coronary dissection: 26 with temporary stenting (TS) and 38 
with pennanent stenting (PS). All baseline variables were similar 
between the 2 groups except the incidence of multi vessel disease, 
which was significantly higher in the group with TS (50%) than in the 
group with PS (21%, P < 0.05). 
Ei~l mQnlb ~aull~ .IS (n =26) fS. (n=38) p 
death 0 2 ( 5%) os 
Q-MI 2 (8%) 5 (13%) ns 
EmCABG 0 1 (3%) ns 
elective CABG 3 (12%) 1 (3%) ns 
AD~iQ~rlIIlbi~ fQI!QW-lI11 20 (77%) 25 (66%) ns 
mean FU (months) 6.1 ±6.6 3.0 ± 1.5 <0.05 
restenosis 5 (25%) 10 (40%) <0.10 
Thus, emergency temporary stenting seems to reduce the risk of 
thrombotic complications and restenosis, and appear to be a better 
initial alternative than pennanent stenting. Further studies are necessary 
to confinn this statement. 
720·6 5:15 
Development of the Heat Activated Recoverable Temporary Stent (HARTS) 
with 8 Slotted. Tube DesigD for Coronary Application 
Ken N. Mahrer, ·Neal L. Eigler, Mehran J. Kborsandi, Michael C. Fishbein, 
James S. Forrester, Joel Kupfer, ·Frank Litvack, Cedars-Sinai Medical 
Center, Los Angeles, CA 
A coronary stent which is removable hours to days after implantation may 
eliminate recoil and the tendency for subacute thrombosis. The prototype 
HARTS device utilized the thermal elastic properties of oitinol to 
demonstrate the feasibility of percutaneous deployment and recovery up to 
1 week. Our goal is to develop a clinical version of the HARTS device. 
Stents are now constructed as a single piece, articulated, slotted-tube design, 
14.5 mm and 21 mm in length. The stents can be balloon expanded from 1.5 
mm to 4.5 mm in diameter. Recovery is accomplished by coaxially placing 
a 4F catheter with mUltiple side holes through the stent. Injection of ~ ml 
of warmed isotonic crystalloid is sufficient to transiently heat the device 
above its phase transition temperature (53DC when expanded to 3.0 mm and 
57"C at 4.0 mm). The stent recovers to its predeployment configuration 
within 0.2 seconds, grasping the catheter. SteDts (n=8) were successfully 
deployed in the LAD aDd CX of anesthetized dogs with a Dominal 3.5 mm 
balloon at 6 atm. All were percutaneously removed 30 min to 72 hours Ir~er. 
Quantitative angiography revealed: 
expanded expanded percent recovered 
balloon stent stent stent 
diameter diameter recoil diameter on catheter 
3.4±0.2 mm 3.1±0.1 mm 8.8±2.7% 1.9±0.1 mm 
Scanning EM of 72 hour expiaDted stents had scant focal fibrin deposition 
adherent to the struts without platelets. In 2 dogs, bolus injections of 
sol\ltion heated to 80DC (5ml x 3) were performed in 4 coronary arteries. No 
histologic evidence of vascular or myocardial damage were seen at 4 weeks. 
Conclusion: The new generation HARTS device has characteristics similar 
to other slotted-tube stents and can be successfully removed with a simple 
percutaneous procedure. The thermal bolus recovery process does not by 
itself cause a healing response to injury. 
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721·1 4:00 
Duration of Complete Heart Block After Congenital Heart Disease 
Surgery 
Steven N. Welrldllng, J. Philip Saul, Walter J. Gamble, John E. Mayer, Jr., 
Edward P. Walsh; ChUdren's Hospital; Boston, MA 
Introduction .. Methode Post-operatlve (post-op) complete heart block 
(CHB) Is an Infrequent, but Important complication of congenital heart 
disease surgery. Optimum timing of permanent pacemaker (PM) 
implantation Is not clear, since post-op CHB Is often transient. We 
prospectively followed all pts with new post-op CHB since 1/91 to 
determine the time of recovery of atria-ventricular conduction (AYC). 
Temporary or permanent PMs were transiently inhibited to assess retum 
of AYC. 
Results From 1/91 untU 7/93, 46 of 1752 (2.6%) open heart operations 
performed at our institution by 5 surgeons, were complicated by CHB 
lasting > 4 hours. Three pts died of hemodynamic problems, still with 
CHB, 1 each on post-op day (POD) 1, II, & 24. One pt was discharged 
on POD 7 In CHB, with a permanent PM, and is lost to follOW-Up. Forty•
three pts were followed for > 3 weeks for status of AYC. In 28 of 43 
(65.1 %) AYC returned according to the time course shown In the figure. 
Of those who regained AYC, the majority (92.8%) did so by POD 8. Only 
2 pts regained AYC beyond POD 8 (on POD 9 and 21). Permanent PMs 
were implanted In 23 pts (on POD 4.1 ± 5.9). AYC retumed In 8 pts after 
permanent PM Implantation (average POD of AYC recovery = 8.6 ± 4.9). 
Conclusion Recovery 'oo 
from post-op CHB may be 
anticipated In up to 65% 
of pts, and usually occurs 
by POD 8. Delaying 
permanent PM 
Implantation beyond this 
time may be of limited 
benefit. 
721·2 
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4:15 
Risk Factors for Atrial Tachydysrbythmias After Fonlan Operation 
Mark Gelatt, Robert M. Hamilton, Brian W. McCrindle, Robert M. Gow, 
William G. Williams, Robert M. Freedom, The Hospital for Sick 
Cbildren, Toronto, Canada. 
Atrial tachydysrbythmias (AT) are a significant cause of morbidity and 
mortality in patients who have undergone the Fontan operation. To 
determine risk factors for such dysrbythmias, we reviewed an unselected case 
series of 269 consecutive patients who underwent Fontan operation between 
January 1982 and May 1992. The mean age at Fontan operation was 
7.1±4.3 years with 88 (33") patients having tricuspid atresia, 64 (24") 
double inlet LV and 117 (43") baving other types of lesions. The 
morpholoiY of the dominant ventricle was left in 73", right in 26" and 
indeterminate in 1 ". AT were evident in 15 (6") patients before Fontan 
operation. Fontan repair was accomplished using a direct atriopulmonary 
connection (APC) in 142 (53") patients, total cavopulmonary connection 
Oateral tunnel-TCPC) in 89 (33"), and with RA-RV connections (RVCON) 
in 38 (14"). There were 33 deaths in the operative period. Acute AT were 
seen in the post-operative period in 57 (21") operative survivors. The only 
significant risk factor for acute AT was the presence of AT pre-operatively. 
Long-term follow-up was achieved for 201 survivors at a mean interval of 
3.8±2.2 years, There were an additional 15 deaths noted during follow-up. 
AT were present during follow-up in 44 (28") patients, with late AT noted 
in 30" of patients who had APC, 17" in TCPC and 11" in RVCON 
(p < 0.01). Other significant risk factors in univariate analysis for late AT 
included right ventricular morphology, increased pre-operative pulmonary 
pressures, heavier patients, and a longer follow-up interval. However, the 
only two risk factors significant in multiple logistic regression analysis were 
Fontan connection type (Odds Ratio 0.37 for TCPC relative to APC, 
p< 0.05; OR 0.33 for RVCON relative to APC, P < 0.05) and longer follow•
up interval (OR 1.31 for each consecutive year, p<O.OO2). Thus, APC is 
a significant risk factor for late AT even after controlling for the non•
concurrence of the time intervals for these different operative procedures. 
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721·3 
Predicton of Atrial tlutter Following the Fontan Operatioo 
Steveo B. Fishbereer, Gil Wernovsky, Thomas L. GeoUes, 
Kimberlee Gauvreau, 10hn E. Mayer 1r, Edward P. Walsh. 
Children's Hospital, Boston, MA. 
4:30 
Atrial flutter(AF) is • frequent, poteDtially fatal complication of • Fontan 
opention(op), but risk facton for its development are ill defined. We evaluated 
278 patieots after • Fontan operation performed betWeen April, 1973 through 
1uly, 1991 (mean ± SO foUowup[f/ul= 5.1 ± 3.9 yrs). Modifications of the 
Fontan operation included extracardilC conduit (n=39; age@op=11.7 ± 6.4 
yrs; flu = 10.7 ± 4.3 yn), atriopu1monary anastomosis (0=90; ap@op=8.7 
± 6.8 yrs; f/u=6.5 ± 3.3 yrs), and total cavopuimonary anastomosis (n= 149; 
ap @op=5.5 ± S.O yn; f/u=2.8 ± 1.6 yn). Evaluation included electrocar•
diograpby and chart review (n=278), and Holter monitor recording (n= 166). 
Age at operation, anatomic diagnoses, prior palliative procedures, and type of 
Fontan repair were analyzed with respect to the development of AF. 
AF was ideotified in 48 patieots (17"), 20 of whom bad associated sinus 
node dysfunction. The mean time to preseotation of AF was 4.8 ± 4.6 yn (0-
19.7 yn) foUowing surgery. Anatomic diagnoses, previous atrial septectomy, 
and prior cavopulmonary shunts were not risk facton associated with an 
increased incidence of AF. By univariant analysis, patieots who developed AF 
were older at the time of Fontan surgery (13.5 ± 7.8 yn vs. 6.1 ± 5.0 yn, 
p < .001), and bad longer leogtb of foUow up (7.9 ± 4.3 yrs vs. 4.5 ± 3.6 
yn, p <.00 I) than those without AF. Those repaired with an extracanlilC 
conduit were most likely to develop AF (38"), compared with those who bad 
an atriopulmonary (28"), or a total cavopulmonary anastomosis (5"), (p 
< .001). There is • higb correlation betWeen type of repair, age at op, and 
leogtb of follow up. While it is difficult to separate the effects of these 
interrelated variables, multi variant analysis indicates that age at operation is an 
independent risk fictor for the development of AF (p < .001). 
AF continues to develop with time after the Fontan operation despite recent 
modifications. Earlier AIle at repair is associated with a decreased incidence of 
AF. Further follow up is oecessary to determine whether • total cavopulmonary 
anastomosis reduces the incideoce of AF follOWing a Fontan operation over the 
loog term. 
721·4 
Ebatain'. and Arrhythmia.: The Outcome After Surgical Repair 
Timothy M. Cordes, Co-bum J. Porter, Gordon K. Danielson 
Mayo Clinic, Rochester, MN 
4:45 
An early review of our experience suggested that patients with 
Ebstein's anomaly had fewer atrial arrhythmias after surgical repair. A 
ratrospective study was performed looking at all of our patients with 
Ebstein's who have undergone surgical correction to determine the 
Incidence and type of arrhythmias present preoperatively, and early" late 
postoperatively. 
Data were obtained by chart review and a follow-up survey. There were 
a total of 188 patients (102 female and 88 male). The median age at 
operation was 16 years (range 0.9 - 64 years). One or more documented 
arrhythmias wera prasent preoperatively in 115 patients (87 had SYT or 
AFIFI, 24 had unspecified tachycardia, 4 had YT or VF. and 7 had 
conduction abnormalities). Evidence of an accessory pathway was found 
in 25 patients. There were a total of 12 early deaths. Tachyarrhythmias 
were associated with 8 of these early deaths. Of 38 patients with Intra or 
early post-operative YT or VF, 6 (16'11.) died early of ventricular 
arrhythmias. Follow up data were available on 167 of 176 early survivors. 
Average length of follow up was 6.6 yrs (range 0.1 to 21 years). There 
were 15 late deaths, 7 of which were sudden. Of 160 patients with late 
arrhythmia data, 71 (44%) had significant arrhythmias (42 had SYT or 
AFIFI, 23 had unspecified tachycardia, 6 had YT or VF, 12 had 
conduction abnormalities). All 25 patients with accessory pathways had 
successful ablation at the time of operation with no late complete heart 
block. Of the 53 patients with paroxysmal SYT or AFIFI and no accessory 
pathway preoperatively, 26 (49'11.) had late postoperative 
tachyarrhythmias. 
In summary, we found praoperative arrhythmias common in Ebstein's 
anomaly, occurring In 61%. Atrial arrhythmias (SYT or AFIFI) were 
prasent in 46% of patients preoperatively. Postoperatively, overall 
arrhythmias decreased to 44%, and atrial arrhythmias decreased to 26%. 
Intra- or early postoperative ventricular arrhythmia was associated with an 
Increased risk of early sudden death. Documented late YT or VF was 
uncommon. 
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Hemodynamic Effects of Adjustable ASD Closure in Fontall Patients 
·Micheal A. Kuhn, Lester C. Permut, Hillel Laks, Josephine IsabeI·Jones, 
Alvaro Galindo, Jay M. Jarmakani, UCLA 
5:00 
A snared adjustable interatrial communication (ASD) has been used with the 
Lateral Tunnel Fontan operation to blunt the postoperative effects of increased 
pulmonary vascular resistance (PVR), and low cardiac output. This study 
examines the effect of ASD closure up to 13 months (mean=5.98) in two groups 
of patients based on their Pre·Fontan catheterization data: high risk (group I) 
with mean pulmonary artel)' pressure> 15 mmHg, transpulmonary gradient >= 8 
mmHg, PVR> 2 wood units, ventricular end-diastolic pressure> 12 mmHg, or 
ejection fraction < 550/0, arrhythmias, ventricular outflow obstruction, and/or A V 
valve regurgitation; low risk (group 2) with none of the above. All patients had a 
postoperative cardiac catheterization. O""ygen saturations, pressures, and cardiac 
outputs were obtained with the adjustable ASD open and with balloon occlusion. 
ASD closure caused: an increase in aortic saturation from 87 +/. 7 to 95 +/. 3%, 
P=.002; an increase in right atrial pressure from 9 +/- 3 to 12 +/-3 mmHg , 
P=.02; a decrease in cardiac index from 4.45 +/-.82 to 3.25 +/- .5711minlm2, 
P<.OOI; a decrease in oxygen delivery from 768 +/- 125 to 599 +/- 81 mlIminlm2, 
P<.OO I. High risk patients had a significantly lower mean cardiac index with the 
ASD open (3.96 +/- .47 vs. 5.07 +/- .79, P=.02), and closed (2.93 +/-.37 vs. 3.59 
+/- .56, P=.04) when compared to low risk patients. Balloon occlusion caused a 
similar decrease in cardiac index between the two groups (1.03 +/- .38 vs. 1.41 
+/-.86, P=.35). With the ASD open, oxygen delivery in the low risk group was 
significantly greater than in the high risk group (846 +/- 107 vs. 703 +/- 106, 
P=.05). However, the values were similar (608+/- 60 vs. 592 +/- 100, P=.76) 
after ASD occlusion. The patients were also divided into two groups based on 
increase in aortic saturation. Patients with an increase >= 8% had an initially 
higher cardiac index (5.21 +/-.66 vs. 4.01 +/- .55, P =.05). With occlusion, there 
was no significant difference between the two groups (3.53 +/- .54 vs. 3.09 +/•
.56, P=.24). The decrease in cardiac index was greater in patients with a large 
increase in saturation (1.68 +/- .71 vs. 0.92 +/- .43, P=.01). These data indicate 
that for patients with preoperative risk factors complete closure of the adjustable 
ASD might be detrimental at least in the intermediate postoperative period. All 
such patients have higher o""ygen delivery with a patent atrial communication. 
Patients with initial low saturations might benefit from partial closure followed by 
complete closure at a later date. 
721-6 5:15 
Early Cbanges In Ventricular Septal Defect Size In Tbe Single Ventricle 
After Volume Unloading Surgery 
Mary T. Donofrio, Marshall L. Jacobs, William I. Norwood. Jack Rychik. 
The Children's Hospital a/Philadelphia, Philadelphia, PA 
Aortic outflow obstruction has been noted to occur in some patients with single 
left ventricle (SL V) after placement of a pulmonary artery band (p AB). Some 
have theorized that obstruction occurs as the VSD or bulboventricular foramen 
decreases in size due to ventricular muscular hypertrophy secondary to increased 
afterload by the PAB. Alternatively. we hypothesize that decrease in VSD size is 
due to decreased cavil) dimension and increased wall thickness related to acute 
volume unloading of the ventricle. and not due to chronic hypertrophy. Changes 
in VSD size and ventricular dimension hence should be evident early after any 
form of volume reduction surgery such as PAB, primary Fonlan, or Hemi-Fontan. 
We retrospectively reviewed the pre- and post-operative echocardiograms of 16 
patients with SLY who underwent PAB (0=5) or FontanlHemi-Footan (n=lI) 
surgery. All measurements were made at end-diastole. The VSD was measured in 
the subcostal frontal and sagittal views, and the area was calculated using the 
formula of an ellipse. Interventricular septum (IVS), posterior wall (PW). and left 
ventricular diameter (L VEDD) were measured in the subcostal sagittal view. 
Ventricular length (L VEDL) was measured in the apical four chamber view. The 
age at surgery was 16.3±23.9 months. The post-operative study was performed 
6±4 days after surgery. 
The mean VSD area in all diminished by 38±24% (1.I4±1.03cm2 to 
0.7I±O.66cm2. p<O.OOS). Interestingly, a greater diminution in VSD area was 
noted in the FontanlHemi-Fontan group versus P AB group (40±20% v 26±3 1%. 
p=O.28). The mean IVS thickness in all increased by 15±22% (O.6±O.23cm to 
0.68±O.24cm, p<O.OS) as did PW thickness by 13±18% (O.62±O.22cm to 
0.70±O.26cm. p<O.02). LVEDD diminished by 12±IS% (2.7S±1.09cm to 
2.41±O.9Icm. p<O.02). while LVEDL diminished by 6±9% (4.19±1.28cm to 
3.87±O.94cm, p<O.05). As a reflection of mass to volume ratio change the 
IVSILVEDD and PWILVEDD ratios increased significantl)· (O.23±O.06 to 
0.3±O.I, and O.23±O.04 to O.3I±O.II, respectively. p<O.O I). 
Conclusions: In SL V. diminution in VSD size occurs early and is a consequence 
of the acute alteration in ventricular geometry which accompanies any operation 
that entails a decrease in ventricular volume. VSD diminution was greatest 
following maximal volume unloading of the ventricle after FontanlHemi-Fontan. 
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722·1 4:00 
Adjuvant IDtrecoroDary Urokinase WorseDS the Procedural 
Outcome for PTCA of Complex LesioDs In UDstable ADgina: 
Results of the Thrombolysis aDd ADgloplasty In UDstable 
AngiDa (TAUSA) trial. 
Sabino R. Torre, John A. Ambrose, Samin K. Sharma, Jooathan D. Marmor, 
Douglas H.Israel, Thomas P. Cocke, Richard K. Myler, William J. Unterecker, 
Craig Monsen, Melvin B. Weiss, Jeffrey W. Moses, Andrew M. Grunwald, 
Jeffrey S. Garren. Michael J. Cowley, Azam Anwar, John Sobolsld, Orlandino 
Almeida, Denise Ramer. Mount Sinai Medical Cen~, New YO!k, NY 
PrCA has gained widespread acceptance in the treatment of unstable 
angina (UA), however, acute complications are higher. i!l1llI:Oronary thrombus 
(ICT) detected angiographically pre-PTCA has been associated with iqcreased 
complications po!It-PrCA. We hypothesized that intracoronary nroIdnase (UK) 
given routinely at the time of PrCA would lower the acute complication rate, 
particularly when dilating complex, "thrombus associated" lesions in UA. In the 
multicenter TAUSA trial, 469 patients were randomized to receive either 
250,OOOU or 500,OOOU UK vs. placebo at the time of their culprit lesion 
angioplasty. Cineangiognuns were obtained in two orthogonal views pre- and 
post-PTCA and blindly analyzed. Complex lesions had irregular borders, over•
hanging edges, or obvious ICI'. Tbe primary end-points included post-PrCA 
ICI' acute closure, or ischemia Results tabu1ated below:(·J>«}.05 UK vs. PL) 
Post-PTCA Simple Lesion Complex Lesion 
En~int UK(n=9S) PL(n=ll11 UK(n=I23i PL(n=1l7) 
ICf 11.6% 12.6% 20.3% 26.5% 
acute closure 3.2% 0.9% 10.6%· 2.7% 
ischemia 4.2% J 2.7% 9.8%· 2.7% 
UK had no significant effect on the outcome of sunple lesion PrCA m UA. In 
contrast, UK reduced the incidence of ICI' following complex lesion PrCA in 
UA, however, the incidence of acute closure and post-PTCA ischemia were both 
significantly increased. In a subgroup of 71 lesions with discrete proximal or 
dista1 ICI' pre-PrCA, high-dose UK prevented post-PrCA ICI' (p=O.06) but did 
not prevent the other post-PTCA complications. 
Thus, UK prevents ICI' post-PrCA in complex lesions, bowever, the 
incidence of acute closure and po!It-PrCA ischemia is increased. Possible 
explanations include prevention of intimal sealing, worsening of intimal 
dissections, and thrombosis due 10 pro-coagulant effects or increased platelet 
activity. These findings suggest that UK should not be given routinely during 
PTCA in UA due to its lack of efficacy and significant adverse potential. 
722-2 4:15 
Profound Platelet Inhibition Does Not lDcrease Emergency Bypass Surgery 
Complications: The EPIC EKperience 
James D. Boebrer, Dean Kereiakes, Fnnk I. Navetta, Robert M. Califf, 
Eric I.Topol, for the EPIC Investigators 
105A 
Therapy with potent platelet receptor llblIlla antagonists prevents ischemic 
complicalions in the setting of high risk angioplasty (PTCA). Increased 
bleeding appean; to be the major cbawback to therapy with u.- agents. Of 
particular concern in the setting of higb risk PTCA is the potential need for 
emergency bypass surgery (CABO) in the face of profound platelet inhibition. 
The EPIC trial (Evaluation of c7E3 in the Prevention of Ischemic 
Complicalions) included 2099 patients undergoing angioplasty who were 
randomized to receive placebo or cbimeric monoclonal antibody c7E3 as a bolus 
or a bolus plus infusion. SS patients required urgent CABO, and 33 of these had 
received c7E3. By extrapolation from pilot studies with c7E3 at similar dosing, 
_gery was performed at a time when adenosine diphosphate induced platelet 
aggregation was less than 20" and bleeding time was greater than 25 minutes. 
Placebo Bolus Bolus + infusion P 
N (Total) 696 695 708 
N (CABG) 25 16 17 
ICU stay (days) S.6 ± 16 5.1 ± 4.7 6.1 ± 6.3 0.62 
Major Blood Loss ('JI,) IS (72) 14 (100) 13 (76.5) 0.10 
Minor Blood Loss ('JI,) I (4) 0 (0) 2 (11.8) 1.00 
DC Tl"IImf'usion ('JI,) 16 (64) 12 (85.7) IS (88.2) 0.16 
Platelet Tl"IImf'usion ('JI,) 14 (56) 11 (78.6) 13 (76.3) 0.22 
Platelets < 100,000 ('JI,) IS (60) 4 (28.6) 4 (23.5) 0.04 
Death ('JI,) 2 (8) 1(7.1) 3 (29.4) 0.11 
Infardion ('JI,) 5 (20) 1 (7.1) I (5.9) 0.39 
No significant difference in major clinical events or mortality was detected for 
subjects receiving c7E3 compared to placebo. Of note, the patients who 
received placebo bad a significantly higher incidence of thrombocytopenia 
perioperatively. The experience with these 58 patients suggests that CABO may 
be safely performed after the administration of c7E3 with blood loss and surgical 
mortality similar to patients treated with conventional theraPY· 
106A ABSTRACTS 
722·3 4:30 
Bleeding Associated With Use of a Platelet Glycoprotein DbIDIa Inhibitor 
During Routine Coronary Angioplasty: Is Too Much Heparin the Culprit? 
Robert A. Harrington. Kandice Marchant. Neal S. Kleiman, Jeffrey D. 
Leimberger. James E. Tcheng. KrisTina N. Sigmon. Debolah D. Smith. 
·Michael Kin. Eric J. Topol. Robert M. Califf f~ the IMPACT Investigators. 
Duke University Medical Center. Durham. NC. 
Profound platelet inhibition reduces the ischemic complications of coronary 
angioplasty (PTCA) but bleeding may limit the clinical utility. Integrelin (1). a 
synthetic cyclic heptapeptide. inhibits > 80% of ADP-induced platelet 
aggregation within 15 minutes of administration. Patients undergoing routine 
PTCA were randomized to receive bolus and infusion (4 or 12 hours) of I 
(n=IOI) or placebo (P. 0=49). All patients received standard. non-weight 
adjusted PTCA doses of heparin and ASA (325 mg per day). Bleeding was 
classified as mild. moderate (tranSfusion but no hemodynamic compromise) or 
severe (tranSfusion + hemodynamic compromise). A bleeding index was used 
to quantify blood loss (BI",AHCT/3 + PRBC tranSfused). Bleeding occured in 
45% on patients and 22% of P patients though the majority of bleeding was 
mild and occurred at the cath access site. There were 18 patients with 
moderate or severe bleeding (1=13. P=5). These patients weighed less than 
those without bleeding (74±,16 kg vs. 86±16 kg). The total in-lab heparin dose 
was similar between groups but the patients with bleeding received more 
heparin per kg (176±88 units/kg vs. 137j:47 units/kg). The nadir RCT in the 
bleeding group was 28±6 compared to 37±5 in the nonbleeding group. 61% of 
the patients with bleeding received PRBC tranSfusions. The median BI was 5.8 
(3.0.10.1) in the bleeding patients and 1.3 (0.67.2.0) in the others. 
Conclusions: Most bleeding after I administration is mild and at the cath 
access site. Patients who experience more severe bleeding are lighter and 
receive more heparin than those without bleeding. These results suggest that a 
clinically important interaction exists between this potent antiplatelet agent and 
heparin. In combination with I. lower doses of heparin may be sufficient to 
provide adequate antithrombotic protection during PTCA. 
722·4 4:45 
Immediate. Reversible Platelet Aggregation Inhibition in Patients 
Undergoing Coronary Angioplasly_ 
Robert A. Harrington. Kandice Marchant. Neal S. Kleiman, KrisTina N. Sigmon. 
Diane Joseph. Judith Parker. Gaddiel Rios. James E. Tcheng. ·Michael Kin. 
Robert M. Califf and Eric J. Topol. Duke Coordinating Center. Durham. NC. 
Integrelin (1). a synthetic cyclic heptapeptide that inhibits the platelet 
glycoprotein IIb/Illa receptor. recently was shown in pre1imiftary studies to 
reduce the ischemic complications of IDISIable angina and routine coronary 
angioplasty (PTCA). We sought to determine the biologic effectiveness of I. as 
determined by the extent of platelet inhibition. during PTCA. I or placebo (P) 
was given. in a double blind fashion. in 3 dosing schemes (A: 180 l1g/kg b;olus. I 
Ilg/kg-min infusion: B: 135llg/kg. 0.5 jl.g/kg-min; C: 90 jI.g/kg. 0.75 jl.g/kg-min; 
1=14. P=7) to patients undergoing routine PTCA. All patients received I or P for 
18 to 24 hours. heparin (goal ACT 300-350 seconds) and aspirin (325 mg daily). 
Platelet aggregations were measured in response to 20 11M ADP. Bleeding times 
were prolonged during the infusions (A: 22 min. B: 12 min. C: 18 min) but 
returned towards a normal rate within 1 hour of terminating the infusion. 
%PlI 'I~  egg 
o min 15 30 tiO 1211 End 2hr 4hr 
min min min min pm ..... 1 
TIme_boNa 
1 is a very rapidly acting. potent inhibitor of platelet function. These data 
document the ability of I to achieve and maintain complete platelet inhibition for 
the duration of the infusion. These potent antiplatelet effects of I are readily 
reversible following drug termination. This immediate and rapidly reversible 
platelet inhibitor holds promise for reducing the ischemic complications of PTCA 
while also minimizing bleeding; these concepts will be tested in large scale trials. 
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722·5 5:00 
Activated Clotting Time is Increased During Coronary Interventions 
With Platelet 1Ib11l1a Antagonism: Results From the EPIC Trial 
David J. MoJitemo. Robert M. Califf. Keaven Anderson. Kristina N. Sigmon. 
Frank Aguirre. Harlan F. Weisman. Eric J. Topo~ and EPIC Study Investigators 
The Cleveland Clinic Foundation. Cleveland, OH 
The activated clotting time (ACD bas been used during percutaneous transluminal 
coronary angioplasty (PTCA) to monitor the extent of thrombin inhibition and 
anticoagulation in an attempt to minimize untoward thrombotic events. Witb the 
introduction of potent platelet inhibitors. sucb as chimeric monoclonal antibody 
e7E3 Fab. the utility of measuring and regulating ACT during PTCA bas not been 
examined. To this point, an effect of c7E3 on ACT was not known or suspected. 
To investigate tbe possible influence of platelet IIbIIIIa antagonism on procedural 
ACT. we reviewed data from the EPIC (Evaluation of e7E3 Fab in tbe Prevention 
of Ischemic Complications) Trial. In EPIC. 2099 subjects undergoing PTCA were 
randomized to receive placebo (n=696) or IIblllia antagonist, e7E3 Fab (n=1403). 
Despite receiving a similar amount of heparin and fewer patients receiving very 
bigb beparin doses (>14.000 units) compared to the placebo group. those receiving 
c7E3 bad a significantly higher (p<O.OOI) ACT wben corrected for bodyweigbt. 
Procedural Heparin Placebo Subjects (%) c7E3 Fab Subjects (%) 
< 10.000 units or infusion only 
10.000 units 
10.000-14.000 units 
> 14,000 units 
500 
t:; 
c 
~ 
E .00 ~ 350 
J ... 300 
I!! 
Q. 
250 
112 (16) 
220 (32) 
141 (21) 
209 (31) 
265 (19) 
497 (36) 
298 (22) 
316 (23) 
7E3 
~ 00 00 ~ _ 
Weight (kg) 
In conclusion. tbe activated clotting time is increased 35-40 seconds by the 
platelet IlbllIIa antagonist, c7E3 Fab. This bas important implications for dosing 
conjunctive beparin tberapy and performing coronary artery interventions in tbe 
setting of IIbIlIIa-directed tberapy. 
722·6 
A Randomlud SlDdy of the Femostop Compression Device To Prevent 
Vascular CompticatiOllS After Coronary ADgioplasly 
5:15 
Chester Clark. Jeffrey J. Popma. Theresa A. Bucher, Donna Hunn. Angela 
Roth. Lisa Sokolowicz. Steven Hoefer. Bamara Braffman. Kristina CIaR: and 
Martin B. Leon. Washington Hospital Center. Washington DC. 
Major vascular complications occur after 6% of coronary angioplasty 
procedures. New compression devices may reduce the risk of vascular 
complications after sheath removal following coronary angioplasty. To 
determine whether Femostop. a novel manometer-controUed pneumatic 
compression device. reduces vascular complications. 200 patients were 
randomly assigned to Femostop or standard manual compression. In patients 
randomized to Femostop after sheath removal. the device was applied at 
systolic pressure for 10 minutes. diastolic pressure for 10 minutes. followed 
by sandbag pressure for 6 hours. Manual compression for 20 minutes 
followed by a sandbag applied for 6 hours was used in patients assigned to 
standard therapy. Both groups were comparable for age. blood pressure. 
sheath size and duration. anticoagulation. peripheral vascular disease and 
procedural complications. To enhance detection of vascular complications. 
patients were also randomly assigned to either clinical surveil1ance (N=93) or 
vascular ultrasound (N",107) (2 x 2 factorial design). Major vascular 
complications included pseudoaneurysm (pseudo) or arteria-venous (AV) 
fIStulae foonation. retroperitoneal hemotoma (Retro) or vascular repair. 
Femostop 
N=85(%) 
Manual Compression 
N",1l5 (%) 
Sheath/Heparin Duration (hours) 15m 15/29 
Any VascuJar Complication 7 (8.2) 9(7.8) 
Pseudo 2(2.3) 4 (3.5) 
AVFistoia 3 (3.5) 1 (0.9) 
Retro!Surgical Repair 014 (4.7) 0/1 (0.9) 
Severe Pain/Limb Ischemia 6f2.4 3.5/1.8 
AHematocrit 5.5 5.5 
HOSPital CharRes ($) 22741 20892 
We conclude that Femostop compression is safe and easy to apply. 
However. the incidence of major and minor vascular complications was not 
significantly reduced. nor were totaI hospital charges lessened by its use. 
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723-1 4:00 
Determination of Regional Myocardial Perfusion by 
3D-Reconatruction of Biplane Coronary Angiogram. 
Giuseppe Vassalli, Zhihua Jiang, Joerg Grimm, Otto M. Hess, 
Cardiology, University Hospital, Zurich, Switzerland. 
Determination ot regional (endo-/epicardial) myocardial perfusion 
was performed by 3D-reconstruction of biplane coronary 
angiograms in 5 controls (C) and 10 patients with coronary artery 
disease (CAD). Perfusion images were reconstructed from biplane 
densograms of one end-diastolic frame of 8 to 10 cardiac cycles 
using the "a priori" knowledge of ventricular geometry and a ·cosr 
analysis for image optimization. Eight outer (- epicardial) and 8 
inner (- endocardial) regions were used for determination of 
regional perfUSion. Endo/epi flow ratios were calculated at rest (R), 
after 0.2 mg ic. nicardipine (Nic), during bicycle exercise (Ex) and 
after 1.6 mg sl. nitroglycerin (NTG). 
EXERCISE anterior 
epl 
A reconstructed perfusion image during the 2nd cardiac cycle aher 
contrast injection is shown at rest (ieft) and during exercise 
(right). Endo/epi flow ratios were as follow (" p<0.05; 6 p<0.05 vs 
R,ANOVA): 
n R Nic Ex NTG 
C 40 r 1.1 rl.O rl.O rO.8 
CAD non-stenosed 38 *L1.21 t1.561 L.1.561 L.1.4, 
CADslenosed 42 07J 10 41 09.i 08; 
Conclusions: Regional myocardial perfusion can be determined by 
3D-reconstruction of biplane coronary angiograms. The endo/epi 
flow ratio is significantly lower at rest and during exercise in 
perfusion zones supplied by a stenotic artery when compared to non•
stenosed perfuSion zones in the patients with coronary artery disease. 
723-2 4:15 
Vasoconstriction of Coronary Stenoses from Exposure to 
Environmental Tobacco Smoke. 
Ronald E. Brown, Philip J. Nahser, James D. Rossen, 
Michael D. Winniford. University of Iowa, Iowa City, IA 
Exposure to environmental tobacco smoke (ETS) is 
associated with an increased risk of ischemic heart disease. 
We have previously reported that ETS exposure causes 
modest constriction of non-stenotic coronary segments. The 
present study was performed to assess the effect of ETS 
exposure in stenotic coronary arterial segments. We 
measured the coronary artery diameter at the site of a 
stenosis (>50% diameter reduction) in 6 patients (2 LAD, 4 
LCx) before and after exposure to ETS. Sidestream tobacco 
smoke was vented into a chamber placed over the patient's 
head, maintaining an average carbon monoxide level of 30 
ppm. In 3 control subjects, room air without tobacco smoke 
was used. Quantitative coronary angiography was performed 
at baseline and after 15 minutes of ETS or room air exposure. 
Blood pressure, heart rate and serum carboxyhemoglobin 
(CO) were recorded at each point. 
~ Minimum coronary stenosis diameter fell 13% from 
1.6±0.4 mm (mean±SD) at baseline to 1.4±O.4 mm after ETS 
(p<0.05). This corresponds to a 24% reduction in minimum 
cross-sectional area of a circular stenosis. After exposure to 
ETS, CO increased from 0.63 to 0.83 ppm, (p=0.058) while 
HR and BP were unchanged. In the 3 control subjects, there 
was no significant change in coronary diameter, HR or BP. 
Conclusion: Exposure to environmental tobacco smoke 
causes vasoconstriction at the site of coronary stenoses. 
This may contribute to the adverse cardiovascular effects of 
passive smoke exposure. 
ABSTRACTS l07A 
723-3 4:30 
Coronary Flow-Mediated Dilation is Preserved in Hypertensive 
Patien~ 
William D. Anderson, 1. Larry Klein, Steven V. Manoukian, R. 
Wayne Alexander, Charles B. Treasure. Emory University, Atlanta, 
GA. 
The coronary endothelium mediates vasodilation to both 
receptor- (RM) and flow-mediated (FM) stimuli through the release 
of nitric oxide. Abnormal RM and FM responses have been 
demonstrated in several conditions, including atherosclerosis. 
Hypertension similarly impairs RM responses but its effects on FM 
responses have not been reported. To determine whether 
hypertension impairs coronary flow-mediated dilation, seven patients 
with hypertension (HTN, mean BP 153/84) and ten without (Control, 
mean BP 132n7) were studied. All patients had smooth coronary 
angiograms without luminal irregularity and both groups had similar 
risk factors for atherosclerosis (1.9±O.2 (Control) versus 2.l±O.5 
(HTN) mean number of risk factors, p=NS). Quantitative 
angiography and doppler velocities (recorded from an intracoronary 
flow guide wire) were used to assess changes in epicardial coronary 
diameter and coronary blood flow following intracoronary infusion 
of adenosine (2.2 mglmin). FM dilation was determined from 
analysis of proximal coronary segments exposed only to increased 
flow. 
Control 
HTN 
Coronary Flow Distal Dilation FM Dilation 
316±45% 18.9±5.7% 12.1±3.3% 
293±48%* 20.2±5.6%* 11.3±2.0%* 
* (p=NS for Control versus H1N) 
Both the Control and HTN groups responded to adenosine with 
similar increases in coronary flow, distal epicardial dilation, and FM 
dilation. Thus, HTN does not adversely affect FM dilation in the 
human coronary artery. Vascular injury resulting from HTN appears 
to selectively alter responses mediated by the coronary 
endothelium. 
723-4 4:45 
Aminophylline Attenuates Dipyridamole- but no. 
Adenosine-Induced Coronary Hyperemia: Challenging 
Clinically Accepted Drug-Receptor Mechanisms 
Richard G. Bach, Morton 1. Kern, Thomas 1. Donohue, Bassam Al•
loundi, and Eugene Caracciolo. D. Douglas Miller; St. Louis 
University Medical Center, St. Louis, Missouri. 
Both dipyridamole (dipy) and adenosine (adeno) are used clinically 
to produce coronary hyperemia for myocardial perfusion imaging, 
presumably via actions on microvascular adcno receptors. 
Aminophylline (amino) has been employed to reverse these effects. 
putatively by blockade of these adeno receptors. To directly evaluate 
the effects of amino on dipy- and adeno-induced coronary hyperemia, 
intracoronary flow velocity responses were assessed using a 0.018" 
Doppler guidewire in 14 patients with normal left coronary arteries at 
cardiac catheterization. Quantitative spectral flow velocity was 
measured at baseline and following sequential administration of adeno 
(12 mcg IC), dipy (0.56 mglkg IV over 4 min) and amino (125-250 
mg IV). IC adeno was re-administered 2.5±2.2 min after amino. The 
avemge peak velocity (cmls. mean±SP> res.ponses are shown: 
~l ~ AminQ AlknQ.l 
Basal 24±8 24±8 29±9 
Drug effect 61±13* 62±21* 29±9t 61±21* 
*p< ()()()l Vs basal: t p< 01 Vs pre-adenQl & dipy basal flQws 
Peak hyperemia achieved with IV dipy was equivalent to maximal 
hyperemia using IC adeno (peakibasal. 2.6±.5 vs 2.6±.4 respectively, 
p=ns). While IV amino rapidly reversed 88±10% of the dipy-induced 
flow increase, immediate re-challenge with IC adeno again achieved 
100% maximal hyperemia (p=ns vs adeno!). These results suggest 
that the mechanism of aminophylline reversal of dipy-induced 
coronary vasodilatation in patients does not involve simple blockade of 
adenosine receptors. 
108A ABSTRACTS 
723·5 5:00 
Functional evaluation 01 the Internal Mammary Artery bypus graft In the 
early and late postoperative period. 
Olivier Gume. Palrick 0Ie0u. Yves Louagie. Michel Buche. Jean-Paul Haxbe. 
&win Scbroeder. Univ. of Louvain. Moot·Godinoe Hospital. Yvoir. Belgium 
The internal mammlW)' a'tery graft (IMA) is now considered as the graft 
ri choice because of its bigb loog·tenn patency rate. However. little is known 
about the ability of Ibis graft to provide adequate flow II periods of increased 
myocardial demand. as well as its capacity to restore a normal COIOOIU)' flow 
reserve. For Ibll purpose. 22 patiEllts wilb an IMA anastomosed 00 the left 
anterior descending ~ery (LAD) were studied in Ibe early postoperative period 
(_Iy IMA. n .. 12. 8±2 days after surgery) and late after surgery (late IMA. n = 
10. 24±19 monlbs after -Sery) by I'antitative angiography and selective 
intravascular doppler analysis <Flomap • C.-diometrics) II basal, chaing alrial 
pacing (l30/min) and after injectioo of 12 mg papaverine and 2 mg Isosorbide 
Dinitrate (ISDN) into the graft. 8 patients wilb normal LAD served as cootrols. 
At basal. mean graft diameter and bypass flow was similar in early and 
late IMA : 2.29±0.40 vs 2.49±0.52 nun and 37±26 vs 32±12 ml/min (NS). Graft 
diameter increased during pacing in late (+5.0±3.4 %. p=O.OI) but not in _Iy 
IMA. A significant and simil.- vasodilation was observed in both _Iy and late 
IMA. as well as in normal LAD after papavetine (+6.8±5.0 %. +8.2±5.4 % and 
+ 11.4±6.6 % respectively. p<O.OI vs basal) and after ISDN injectioo (+ 16.0±6.4 
%. +14.4±10.0 % and +15.8±4.4 %. p<0.01 vs basal). 
Bypass flow velocity. as expressed by the Peak-to-Rest velocity ratio 
inaeased significantly less in _Iy IMA Iban in late IMA or in normal LAD after 
dye. papavetine and ISDN injection (* : p<0.01 vs late IMA and normal LAD) : 
EarlylMA 
LatelMA 
Normal LAD 
Pacing Dye injectioo ISDN * Papaverine 
1.22...+0.13 1.66±O.28 1.86±O.59 2.40±0.50* 
1.17±O.08 2.10±0.33 2.37±0.36 2.89±O.41 
1.34±O.20 2.18±O.18 2.43±O.32 2.96±0.35 
In ronclusioo. an increased in myoc.-dial blood flow induced by pacing 
results in vasodilation (normal EIIdothelilDD functioo) of the late IMA but not in 
early IMA. Significant vasodilatioo after papavetine and ISDN (not endothelium•
dependent) is observed in both early and late IMA. and was similar to native 
LAD. However. bypass flow reserve is significantly reduced in the early 
postoperative period. probably related to an injury to the microvascu1ature during 
surgery. but normalizes over time. 
723·6 5:15 
Coronary and Limb Vascular Vasoronstriction after Successful Single 
Angioplasty of the Left Anterior Descending Coronary Artery. 
Roberto Ceravolo. Ciro Indolfi. Federico Piscione. Amelia Focaccio. 
AntonGiuJio Maione. Nicolino Esposito. Massimo Chiariello. Division of 
Cardiology. University Federico II. Naples. ITALY. 
Spontaneous coronary artery vasoconstriction after angioplasty (PTCA) 
occurs routinely distal to a balloon dilation. The mecnanisms of this 
vasoconstriction are not known. but are 
likely multifactorial and may include the 60 
release of vasoactive substances fom a so 
aggregating platelets. increased ~ 40 
sympathetic activity or myogenic ~ 
vasoconstriction. To assess the effect of Iii 30 
PTCA on coronary and limb vasomotion m 20 
we prospectively studied 10 .. a.ients 10 
with a single left anterior descending 5 
coronary artery stenosis. Quantitative _ 
coronary angiography and calibrated i 
venous occlusion plethysmography were 
perfonned in the control state and rfter!eli 3 
balloon inflation O. 5 and 15 minutes. ~ 
respectively). After PTCA foreann i 
blood flow (FBF) decreased whereas -
foreann resistances increased. The basal 
dist.! coronary diameter was :".'>±O.5 
* 
* it ............... 
i" 
* pc:O.05 
.. 
.... * * * ................ 
Base 1 min 5 "*' 15 min 
mm before PTCA 2.l±<J.3 mm and 2.1±<J.3 mm 5 and 15 minutes after 
PTCA. respectively (p<0.05 vs Baseline by ANOYA). Thus. after 
successful single PTCA. in addition to a coronary vasoconstriction distal 
to the site of balloon dilatation, a significant foreann vasoconstriction 
occurs. Therefore. a neural and honnonal mechanism may participate to 
the vasoconstriction after a successful coronary angioplasty. 
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724·1 4:00 
Impact of the Shape of the Proximal Flow Convergence Region on the 
Accuracy of Flow Rate Calculation 
Chunguang Chen. Helge Simon. Ehud Schwammenthal. J Luis Guerrero. 
A"hur E. Weyman. Robe" A. Levine. Massachusetts General Hospital, 
Boston. MA. Hartford Hospital. Hartford. CT. 
Proximal flow convergent (PFCI isovelocity shells are hemispheric 
(Fig. 1-AI at an ideal distance from a regurgitant orifice (ROI. The 
isovelocity shells close to or far away from the RO have flat or elongated 
shapes. resulting in under· or overestimation of the actual RO flow (Fig. 
1-B. CI. To assess the effect of different shapes of proximal isovelocity 
FIgure 2 
100 . ... -
•. -..r... • ...,i. .... ' •. : .' 
. -:. 
~--~'A~-'~A~-~~.~~~.~~ •.~'--.~A 
DIr ...... 
shells on the accuracy of 
estimating RO flow. a canine 
model of mitral regurgitation 
(MRI was created using a 
fixed grommet and true RO 
flow measured. The shape of 
the isovelocity shell was 
assessed by the Dfr ratio (Fig. 
11 from color Doppler flow 
mapping. Shape of the 
isovelocity shell was altered 
by changing aliasing velocity 
(Val at each experimental 
stage. PFC flow rate was 
calculated by isovelocity 
surface area (217T21 x Va. 
RESULTS: Difference between 
true R 0 flow and PFC flow 
rate was significantly related 
to Dfr ratio with a curvilinear 
fashion (Fig. 21. For Dfr between 1.5 - 1.9. PFC flow (79.9.±.37.1 mllsl 
was not significantly different from true RO flow (75.3.±.29.9 mils. p 
= NSI. CONCLUSION: The shape of the isovelocity shell significantly 
affects the accuracy of estimating severity of MR by the PFC method. 
Incorporating assessment of isovelocity shape may help in choosing 
appropriate aliasing velocities for accurate PFC flow calculation. 
724·2 4:15 
In·Vltro Experiments for Visualization and Ueasurement of 
Flow Convergence. Using a New Calibrated Two· 
Dimensional Soap Film Tunnel 
Dorian LiepmaM. Mary Gharib. Masoud Baizaie. David J. Sahn. Oregon 
Health Sciences University. Portland. Or. 
Clinical methods using color Doppler imaging of the flow convergence 
(Fe) proximal to regurgHant orifices can estimate regurgitant flow (RF) rate 
but resu~s often overestimete the RF and controversies exist over the 
effect of adjacent surfaces and the most appropriate FC geometries to 
use for computation. Little direct flow visualization data exists to clarify tha 
assumptions in these methods. Soap film flow visualization provides an 
accurate means of identifying isovelocity lines because the local thickness 
and reflected color 0/ the film is proportional to the local velocity field and 
streamlines mey be visualized. We have studied visualized Fe flows in 
soap films. through orifices 0/ 3.5 mm to 6.7 nvn (diameter) at flow rates of 
0.5 to 3.2 mls. The 
quantifiable flow 
streamlines in the 
acceleration flow field 
are perpendicular to the 
isovelocily surfaces 
related to FC. The 
imaged patterns are 
directly COI11l8rable with 
our color Doppler 
studies for these same 
orifices. but boundary 
effects. surface ad· 
herence. and vorticity 
not well visualized on 
color Doppler images can be defined and understood. Further. the soap 
film can be 'seeded' with particles and ks velocity zones can be calibrated 
by laser Doppler velocimetry and digital video particle tracking. This new 
dynamic high resolution velocimetry technique aids understanding 0/ the 
effects of orifica size and shape. distance from the orifice. and the effects 
of boundary layers on the geometry of the FC region and should aid 
application of FC methods to deal with diverse clinical condkions. 
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724·3 4:30 
Automated Doppler Analysis Allows On·Une Quantification 01 
Velocities, Velocity nme Integrals, Pressure Gradients, and 
Acceleration nmes: An AdVance In Quantitative Echoeardlography 
Jean-Claude Tardll, Monica Freire, Heidi Pollard, Steven Schwartz and 
Natesa Pandian. Tutts-New England Medical Center, Boston, Mass. 
Analysis 01 Doppler data In pts wtth cardiac llow abnormalities currently 
requires tedious oil-line manual dlgitizatlon of Doppler profiles. Recently a 
new approach has been developed tor automated on-line analysis of 
Doppler data (Automated Doppler Analysis, ADA). This automated quanti•
fication 01 pulsed or CW Doppler signals Involves thresholding signal to 
noise ratiO, calculation of Instantaneous values for muHiple FFT samples 
and automated plotting on the spectral display. From thiS, the lollowlng 
variables are derived on-line and displayed on the monitor beat-to-beat: 
Peak velocity (PV), mean velOCity (MV), velocity time Integral (VTI), peak pr 
gradient (PG), mean pr gradient (MG) and acceleration time (AT). We 
examined the reliability of this new method by comparing the ADA data to 
that derived by manual dlgitization and oll-Une analysis (Manual Doppler 
Analysis, MDA) of 57 llow jets In 30 pts. The abnormalities Included: aortic 
stenosis 13, mitral regurgitation 12, MS 9, AR 4, TR 2, PR 2, and HOCM 1 
VSD 3, NL aortiC nows 6, NL pulmonic llows 4, and NL mitral now 1: 
Results (MDA Is x and ADA Is y In equations): PV (m's) ranged lrom .7 to 
5.2 by MDA and .7 to 4.S by ADA. Correlation: y- .95x + .016, r-.99, 
p<.OOOI. PG (mmHg) ranged from 2 to 106 by MDA and 2 to 93 by ADA' 
Correlation: y- .S9x + 1.42, r- .97, p<.OOOI. Mean values lor PV and PG 
were almost identical by both methods. MV (m's) ranged from .5 to 3.9 by 
MDA and .1 to 3.3 by ADA; Correlation: y- .506x -.OSS, r-.S2, p<.0001. MG 
(mmHg) ranged Irom 1 to 73 by MDA and 1 to 43 by ADA; Correlation: y•
.221x + .24, r- .63, p<.0001. VTI (cm) ranged from.OS to 3.0 by MDA and 
.07 to 3 by ADA; Correlation: y-.995x + .019, r_ .97, p<.OOOI. AT (msec) 
ranged from 60 to 215 by MDA and 60 to 200 by ADA; Correlation: y •. 912x 
+ 7.264, r-.96, p<.OOOI. Mean values lor VTI and AT were identical by bolh 
methods. Examination 01 causes for discrepancy between MDA and ADA 
after unblindlng the study followtng prospective data analysis indicated that 
the lollowing lactors allected the accuracy of ADA: inappropriate Doppler 
gain setting, incorrect wallfiher and wrong choice of Doppler proceSSing 
algorithms. We conclude that, when technical controls are appropriately 
set, automated Doppler analysis yields reliable on-line quantification and 
depiction of valuable hemodynamic variables in various disease states. 
724·4 4:45 
Real·tlme 3·Dlmenslonal Echocardiography and Innovative 
Image Segmentation Provide Views Unavailable from 2·0 Echo 
and Permit Transthoracic In Vivo Assessment 01 the Dynamic 
Surgical Anatomy of Ventricular Septal Defects 
Michael Vogel, Gerald Marx, Natesa Pandian, David Fulton and 
Konrad BDhlmeyer. German Heart Center, Munich, Germany and 
Tufts - New England Medical Center, Boston, Massachusetts. 
2-~ echo and angiography, while very valuable in demonstrating, 
ventricular septal defects (VSD), do not allow precise delineation of 
the defects (VSD). To explore the utility of 3-D echocardiography 
(3DE) in examining the dynamic surgical anatomy of VSDs, we used 
a tomographic ultrasound probe on the chest of Infants and children 
(n= 22), acquired parallel images of the heart at 1 mm intervals with 
ECG and respiration gating, performed 3D reconstructions and 
displayed in a dynamic (4-0) mode. Results: 3DE cutplanes in 2DE 
orientations such as 4-chamber view allowed appraisal of VSDs with 
a global spatial perspective. In addition to slicing the 3-D imalle in 
the usual 20E planes, we also ·sectioned" the heart to derive views 
that simulate intraoperative visualization of VSDs. Such windowing 
in multiple lesion-specilic views allowed "direct" observation of the 
VSDs in many new projections and angles (from above and below, 
and l!Ilso seeing them en face from RV and LV cavities). The many 
localions of VSDs (perimembranous, muscular, infundibular, and 
doubly committed subarterial VSDs), their size, shape (circular oval 
and irregular) and dynamic geometry could all be well-defined'. The 
functional morphology of the structures adjacent to VSDs was dis•
played in selective cuts. In 5 cases of perimembranous VSD with 
partial closure by septal TV leaflet, and in 2 pts with a subarterial 
VSO partially closed by right aortic cusp, the dynamics of the partial 
~Iosure of VSD by adjacent structures could be portrayed in real•
time. In 4 pts, 3-D images of residual VSD after partial dehiscence of 
VSO patch clearly displayed the underlying mechanisms, facilitating 
reoperations. In other pts, coexistent lesions such as ASOs; and PA 
bands were well seen. We conclude dynamic 3DE provides visuali•
zation .of VSOs in views unavailable fro.m .other conventional imaging 
modalities; 30E allows excellent descrlplion of the surgical anatomy 
and geometry of VSDs, coexisting lesions and associated structures 
and has a vast clinical potential. 
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724·5 5:00 
Quantitative and Qualitative Thr .. Olmenslonal Echocardlographlc 
Evaluation of Ventricular Size, Shape and Function In Patients With 
Singular Ventricular Morphology: In Vitro Validation and Clinical 
Application 
Monica Freire, Gerald Marx, ~i-Ling Cao, Heidi Pollard, Lissa Sugeng, 
Steven Schwartz, Natesa Pandlan. Tufts-N. E. Med Center, Boston, MA. 
The size, shape and function of the ventricle In patients wHh single 
ventricle (SV) morphology have Important pathophysiologic, clinical and 
prognostic Implicalions. AHhough various imaging techniques are used In 
the evaluation of the size and function, quantHative problems remain due to 
distorted and heterogeneous ventricular shapes. Recently a method lor 
performing 3-dimensional echocardlographic (3DE) reconstructions and 
volume determination of the LV has been done from 3-6 equidistant apical 
2-D echo views; this technique has been validated In pts with normal 
ventricles.To determine II 3DE could be applied to patients with SV 
morphology, we assessed Its quantitative ability In vitro, and then applied 
this approach in 17 pts, age 20 days-40 yrs. 13 animal hearts underwent 
experimental alteration and fixation to simulate the size and shape of SV. 
Using a multiplane imaging probe, echo Images of the SV every 30 
degrees were obtained from apical orientation. Borders of SV were semi•
automalically extracted by excluding papillary muscles, but Included outlet 
chambers when present. Using a dedicated system, 3DE reconstruction 
was then performed. From this, SV volumes were obtained and co~ared 
to actual volumes of the anatomiC SV. The pt population consisted of 12 
single LV, 4 tricuspid or pulmonic atreSia with RV hypoplasia, 1 mitral 
atresia and LV hypoplasia. In clinical studies, a multiplane transducer was 
placed at the cardiac apex and Images collected every 30 degrees. Data 
analysis was the same as lor the in vitro studies. Results (MeantSD): In 
~ SV volume (ml) in 3DE was 40±SS while the actual volume was 
41±63 (range 3.5·205): ro< .92: y-.92x + 2.63, SEE- .02: p<.OOOI. ~: 
The SV diastolic volume (ml) was 66±40: systolic volume was 3S±26: EF 
was 46±10%: cardiac output was 2.5 ±1.1. In addHion to yielding 
quantitalive data, dynamic 3DE also portrayed the varied shapes of the 
ventricle in these pts with a wide spectrum of abnormalities. Conclusion: 
3DE is accurate in the measurement of ventricular volume In abnormally 
shaped ventricles such as those present with SV. 3DE is also useful to 
analyse their dynamic geometry. Application 01 3DE to measure volumes 
and EF can be performed clinically in a variety 01 clinical scenarios. This 
technique may be useful in decision making In pts with SV morphology. 
724·6 5:15 
NEW INFORMATION ON THE MORPHOLOGY OF 
SUBVALVAR LEFT VENTRICULAR OUTFLOW TRACT 
OBSTRUCTION BY REAL·TIME 3·0IMENSIONAL 
ECHOCARDIOGRAPHY 
Michael Vogel, Konrad BOhlmeyer 
Dep. Pediatrics, Deutsches Herzzentrum MOnchen, Germany 
In order to evaluate, whether three-dimensional 
echocardiography (30 echo) yields additional information on 
morphology of subvalvar LV outllow over 2D echo, we examined 
21 patients with 3D echo. 17 had concordant connections and 
subaortic stenosis (SAS); 4 had transposition and subpulmonary 
stenosis (SPS). Patient age ranged from newborn to 12 years. 
Transthoracic imaging with a transducer in an external frame 
holder was performed to acquire 3D echo. With respiration and 
ECG gating the transducer is moving in steps of .5mm along the 
chest over a 4.5 cm distance. About SO-90 slices of the heart 
were recorded. Conventional 2D imaging planes like a parasternal 
long axis and lour chamber view were 30 reconstructed as well as 
new views like the one obtained at surgical aortomy through the 
aortic valve or a view from LV apex towards the LV outllow. 
Mechanisms of SAS included fibrous tissue (n=7), hypertrophic 
obstructive cardiomyopathy (n=2), fibromuscular tunnel (n c 3) 
and accessory AV valve tissue (n=5), SPS was due to fibrous 
tissue (n=2) and accessory mitral valve tissue (n=2). New 
information not available by 2D echo was found in 2/7 cases of 
accessory AV valve tissue, one in a patient with partial AVSD and 
double orifice mitral valve and one in a patient with transposition 
VSD, and SPS. In 3 cases of SAS attachment of the obstructing 
tissue to the anterior mitral valve was not appreciated by 2D 
echo. In addition multiple attachments 01 the obstructive tissue to 
the mitral valve could be seen in 2 patients with severe SAS. 3D 
echo findings could be confirmed at surgery in all cases. We 
conclude that transthoracic 3D echo yields additional information 
over transthoracic 20 echo and thus is helpful in better 
describing the anatomy of subvalvar LV outflow obstruction. 
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725·1 
Risk Stratification of Asymptomatic Patients with 
Hypertrophic Cardiomyopathy 
Walter L. Atiga, Dorothea McAreavey, Neal O. Epstein and 
Lameh Fananapazir, NIH, Bethesda, MO 
4:00 
Sudden death (SO) in hypertrophic cardiomyopathy (HCM) is 
often unheralded by symptoms. There is therefore a need for 
improved risk stratification in this group. We examined the 
prognostic significance of 31 clinical, Holter, hemodynamic and 
electrophysiologic (EP) variables in 104 HeM pts (75 males, age 
35 ± 17 yrs) without symptoms of impaired consciousness. Ninety•
one (88 %) pts had one or more of the follOwing risk factors for 
SO: age <30 yrs (n=49), strong family history of SD (n=19), 
ventricular tachycardia (VT) on Holter (n=42), markedly 
thickened LV (>30 mm, n=16). LV outflow obstruction was 
present in 53 pts. At EP study, mild sinus node disease was 
present in 10 pts, and AV node and/or distal conduction system 
disease in 31 pts. Sustained VT was induced with 2 extra-stimuli 
(ES) in 14 (13%) pts and with 3 ES in 12 (12%) pts. Pts in 
whom VT was not induced with ~ ES were not treated with 
antiarrhythmics except for atrial arrhythmias. Four pts had cardiac 
events (3 SO and I syncope associated with an implantable 
defibrillator discharge) during a 3.5±2 yr (max. 9.9 yrs) follow· 
up. All 4 had VT induced with 2 extra-stimuli but only one had 
VT on Holter. The cardiac-event rate at 3 yrs was 29% in pts with 
induced VT with 2 ES versus 0% in pts in whom VT was not 
induced or induced with 3 ES (p<O.OOOI). 
Conclllsio1U: This study extends previous observations. VT is 
induced with 2 ES in a minority of HCM pts without symptoms of 
altered consciousness, but identifies a subgroup at high risk for 
SO. It is unneccessary to perform a more aggressive stimulation 
protocol in these pts. A negative EP study suggests an excellent 
prognosis. Other factors traditionally regarded as indicating high 
risk for SO, including VT on Holter, are not valuable in 
identifying pts who subsequently have cardiac events. 
725·2 4:15 
Importance of the Collagen Matrix in Young Patients 
with Hypertrophic Cardiomyopathy and Sudden Death 
Jamshid Shirani, Ruth Pick, Marc A. Silver, William C. 
Roberts, Barry J. Maron, NHLBI, Bethesda, HD 
Recently, substantial interest has focused on 
mutations in cardiac myosin as the cause of 
hypertrophic cardiomyopathy (HCM). However, in HCM, 
many abnormal structural features appear to be 
unrelated to myosin, including those involving 
connective tissue elements, e.g. replacement scarring, 
mitral valve enlargement, and abnormal small coronary 
arteries. Therefore, to extend our observations 
regarding the distribution of collagen in hearts of pts 
with HCM, we analyzed extent and distribution of 
interstitial (matrix) collagen in ventricular septum of 
16 pts with HCM (aged 11-34; mean 18), selected . 
specifically because they were young, had died suddenly 
without prior symptoms and were free of myocardial 
replacement scarring. Each had marked septal 
thickening (17-40 mm' mean 26). Large transmural 
sections (5.2±2.0 cm~) were stained with Sirius Red 
and the amount of collagen assessed with video•
denSitometry. Pts with HCM had 8-fold greater amount 
of matrix interstitial fibrous tissue (14.1±9% of 
tissue section; range 5-28) compared to 16 normal 
controls (1.8±1%; range 0.6±3.6 p<O.OOOl); no 
difference was evident between the 2 groups in 
perivascular collagen (2.6±1 vs. 2.1%±1; NS), showing 
matrix collagen was increased selectively. In 
conclusion, the collagen matrix in pts with HCM and 
sudden death, is: 1) extensive and substantially larger 
than normal; 2) responsible, in part, for increased 
septal thickness; 3) represents another structural 
abnormality characteristic of HCM, supporting the view 
that HCM involves considerable alteration in connective 
tissue elements in addition to contractile proteins. 
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725·3 4:30 
Lack of Ejection Fraction Increase With Exercise Predicts the 
Progression to Left Ventricular Systolic Dysfunction in 
Hypertrophic: Cardiomyopathy 
Francesco Pelliccia, Cinzia Cianfrocca, Stefano De Castto, Francesco 
Pizzuto, and Giuseppe Critelli. University "La Sapienza", Rome, Italy 
Although LV ejec:tion fraction is usually normal or supernormal 
in hypertrophic cardiomyopathy (HC), some pts may develop 
impaired systolic function. It remains unclear, however, how this 
evolution could be predicted. Accordingly, we attempted to sort out 
which factors could be associated with the progression to LV 
systolic dysfunction in 30 HC pts (mean age: 43±,13 yrs) with 
normal LV ejection fraction (range: 60-85%) and no significant 
mitral regurgitation. At referral, all pts underwent clinical evaluation, 
48-hr Holter monitoring, resting and supine bicycle stress 
echocardiography, and cardiac catheterization. Serial 
echocardiographic studies were performed in all pts over as-year 
period. After a mean follow-up of 3±1 yrs, LV ejection fraction 
became<5O% (mean: 3S±7%) in 6/30 (Gr.A), but was substantially 
unchanged (mean: 67±8%) in the remaining 24/30 pts (Gr.B).At 
referral, clinical and ECG features, as well as LV dimension, wall 
thickness, mass, filling pressures and ejec:tion fraction were similar in 
Gr.A and Gr.B. Conversely, Gr.A pts had a lower cardiac index 
(2.5±O.4 vs 2.9±0.4 l/min/m2, p<O.04), and a lower exercise-induced 
change in ejection fraction (-6±3% vs +5±7%, p<O.OOI), as 
compared with Gr.B pts. No difference between the two groups was 
found in the prevalence of LV gradient at referral, or in medical 
treatment during follow-up. Multivariate analysis showed that the 
behavior at stress echocardiography was the only independent 
predictor of LV dysfunction (p=O.OOl). Noteworthy, an ejection 
fraction response to exercise$()% was detected in all Gr.A pts 
(sensitivity: 100%), but only in 3/24 Gr.B pts (specificity: 87%). We 
conclude that in HC: (I) lack of exercise-induced increase in 
ejection fraction predicts the progression to LV systolic 
dysfunction; (2) LV morphologic features or resting functional 
indices do not play any prognostic role; (3) bicycle stress 
echocardiography is a valuable tool to precociously identify the 
subset of pts with impaired myocardial functional reserve who are 
prone to develop LV systolic dysfunction. 
725·4 4:45 
Morphologic Expression of HypertrophiC Cardiomyopathy 
Differs in North American and European Patients 
Barry J. Maron, Andrea Schiffers, Heinrich G. Rlues, 
University Hospital, RWTH, Aachen, Germany; NHLBI, 
Bethesda, HD; Minneapolis Heart Institute Foundation, 
Minneapolis, HN 
While hypertrophiC cardiomyopathy (HCM) occurs 
throughout the world, the extent to which the 
morphologic expression of the disease differs amongst 
different racial and ethnic groups is not known. Prior 
studies have suggested that the morphology of HCM in 
Japanese pts may differ from Western pts. To extend 
these observations, we compared clinical and 
echocardiographic features of HCM in 420 American and 
100 German adult pts from 2 tertiary referral centers. 
American and German pts had similar age (49±14 vs. 
50±16 yrs) and symptoms (functional class III: 21 vs. 
22%). Maximal left ventricular (LV) wall thickness was 
similar in the 2 groups (21.6±5 vs. 21.8±4mm), but 
patterns of LV hypertrophy were: 1) more diffuse in 
American pts (involving both ventricular septum and 
free wall and often predominantly in distal LV) (134 
pts, 32% vs. 20 pts, 20%; p<0.05) and 2) more often 
localized in distribution in German pts (i.e., confined 
to 1 LV segment and often predominantly in proximal LV) 
(44 pts, 44% vs. 120 pts, 29%; p<O.OOl). Also, mitral 
valve systoliC anterior motion was more severe in 
American pts (mitral-septal contact: 147 pts, 35% vs. 
24 pts, 24%; p<0.05). Conclusions: 1) expression of 
HCM differed amongst American and German pts; 2) it is 
unresolved whether these differences were due to pt 
selection or racial/genetic factors; 3) regardless of 
origin, awareness of such variability in the 
morphologic expression of HCM is relevant to 
interpretation of HCM studies from different regions of 
the world. 
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725·5 5:00 
Comparison of the Echocardlographlc and Clinical Findings In 
"HOCM-Ilke" and "Typical" Cardiac Amyloidosis 
Marvin R. Allen and David A. Foley 
Mayo Clinic and Mayo Foundation, Rochester, MN 
We previously described 27 patients with biopsy proven amyloidosis 
and echocardiographic evidence of cardiac amyloidosis who also 
had echocardiographic findings suggesting hypertrophic cardiomy•
opathy (HOCM). These findings included an intracavitary LV gradi•
ent on Doppler examination (52%), syst06c anterior motion of the 
mitral valve (52%), or LV syst06c cavity obliteration or an ejection 
fraction greater than 80% (33%). We compared echocardiographic 
and c6nical findings in these patients with a randomly selected group 
of 29 patients having "typical" cardiac amyloidosis (i.e., none of the 
features noted above) to determine an etiology for the LV obstruction 
and hyperdynamic function in the "HOCM-tike" subset of patients. 
Echocardiographic measurements were made retrospectively from 
videotaped images accorcing to American Society of Echocardiogra•
phy guidelines. The clinical records of each patient at the time of the 
index echocardiographic study were also reviewed. The ventricular 
septal ciastoHc thickness was greater (18.0 vs 15.3 mm, p < 0.01) 
and the LV cavity ciastolic ciameter was smaller (39.4 vs. 43.7 mm, 
p < 0.01) in the "HOCM-Hke" patients. There were no significant cif•
ferenees in posterior wall thickness, right ventricular wall thickness, 
systoliC or ciastotic blood pressure, clinical symptoms or syndromes 
(heart failure, dyspnea, angina, nephropathy, neuropathy), or med•
ications between the two groups. 
Conclusions: Carciac amyloidosis may mimic hypertrophic car•
ciomyopathy with the presence of dynamic LV intracavitary obstruc•
tion and hyperdynamic LV function. Patients with "HOCM-like" fea•
tures have a greater septal thickness (but similar posterior thickness) 
and smaller LV cavities than patients with "typical" cardiac amyloido•
sis. This suggests that lower LV wall stress may be responsible for 
the "HOCM-fike" features in these patients. 
725-6 5:15 
Potential Diagnostic Role of Circumferential Thallium Washout 
Analysis In Patlants With Hypertrophic Cardiomyopathy 
*Hiromi Seo, James Sneddon, Philip J Keeling, Aris Anastasakis, Alistair 
Slade, William J McKenna, St George's Hospital Med Schl, London, UK. 
Interpretetion of thalHum (TO perfusion is problematiC in the presence of 
asymmetric LVH. Assessment of TI washout provides a quantitative 
measurement of regional myocardial perfusion. To assess the diagnostic 
role of circumferential analysis of TI washout, 41 pts; 27 pts wnh HCM and 
14 individuals with EcG abnormalities and a positive family history but 
normal echocardiograms in whom the diagnosis was uncertain, 
underwent dipyridamole etress thallium SPECT. Circumferential washout 
analysis was performed at mid-ventricular level, and mean washout rate 
(WR), minimum WR and the incidence of reduced WR area (WR < 30% ; 
the mean - 2S0 in previously established controls) were assessed. 
Table: Indices of TI washout. 
meanWR(%) 
minimum WR (%) 
reduced WR area 
controls abnormal ECG HCM 
Four of 14 wHh abnormal EcG had a WR < 30%. Eleven (55%) of 20 
HCM pts had a WR < 30% In a non-hypertrophied segment. Thirteen 
(48%) HeM showed minimum WR in a non-hypertrophied segment. HCM 
pts wHh minimum WR in a non-hypertrophied segment had higher 
incidence of syncope or presyncope (62% vs 21%, p<0.05) and 
ventricular arrhythmia (couplets I NSVT In 24-hr Holter, 60% vs 9%, 
p<0.02) than in pts with minimum WR in a hypertrophied segment. 
These findings reveal abnormel TI washout in HCM is present in 
hypertrophied and non-hypertrophied sagments, associated with adverse 
clinical features, and provides a marker of abnormal myocardium in HCM 
gene carriers. Measurement of TI washout may aid in diagnosis of familial 
HCM particularly in the young who have not yet developed L VH. 
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Complications Following Implantation 01 Non-Thoracotomy Lead System 
CMdioverter-Delibriliators 
4:00 
Gregory K. Jones, G. las Doiack, Peter J. Kudenchuk, Jeanne E. Poole, Merritt Raitt, Jill 
Anderson, Charles Troutman, Gust H. BatdI. University at Washington, SeatUe, WA 
The pu!pOSe of this study was to review major COI11liications in 148 patients with 
Medtronic (72178) non thoracotomy lead (NTL) system illllientable cardOY8l1er defi~ 
rillators (ICD). NTL lCD's have provided excellent protection against death in our patients 
resuscitated from cardac arresI ( 98% one year intention-to-Inlat survival) while also 
raciJcing hospital costs and I1ICO'I8IY period as COf11lI1red to open thoracotomy epicarcial 
lead systems. There are, however, uniq.JEI concerns and COI"fllIicalions related to 
iIIllIantation and foliow t4> at NTL ICDs. 
In our series, there have bsen no perioperative deaths but major COI"fllIicalions have 
occurred in 22 of 148 patients (15%). Corr(Jiications included 12 lead dslodgments (8%) 
which ~red adcitional surgery for repositioning. Ths majority of these dslodgments 
occurred earty in our experience before we initiated dolbIe sleeve anchoring. Seven lead 
dslodgments occurred in patients with a coronary sinus lead. Other dslodgements 
included one Sl4l8rior vena cava lead, three RV leads, and one chest patch lead that 
migrated causing mechanical ilTitation and immobility of the left shoulder. Seven lead 
fractures have occurred in six patients (4%): two occurred in 8 coronary sinus lead just 
under \he anchoring sleeve, one occurred in an RV lead between \he clavicle and \he first 
rib, four occurred in chest patch leads with three fractures noted at the costal rib margin 
and one at the site of the pulse generator. One of the chest patch fractures occurred in a 
patient who ded suddenly when the device failed dJring ventricular fibrillation. Pocket 
infection has occurred in two patients (2%) requiring ICD expiantation and ~t 
reilTlliantation on the right side. Other COI"fllIications included one right ventricular 
perforation which required pericardiocentesis, one bleed in the chest patch pocket 
requiring blood transfusion, one 'twidcle' indJced torsion of the leads requiring surgical 
revision, and one femoralthrornbo-errllolisrn requiring embolectomy in a patient with 
chronic atrial fibrillation who had to have his anticoagulation stewed for illlliantation. 
Use of NTl lCD's has risk but excellent survival is feasible ~ COI"fllIications are prtlIT4ltly 
adaessed. Ths majority of complications in our series have bsen related to lead 
dslodgments or lead fractures and highlights the need for routine X~ examination. 
Future single lead unipolar lCD's may significantly reduce the COI"fllIication rate while 
maintaining high survival rates. 
726-2 4:15 
Tbe SQ Array: A New Non-Tboracotomy Implantable Cardioverter 
Defibrillator Lead That Reduces tbe Defibrillation Tbreshold 
James H. Baker IT , Andrew E. Epstein, 'Lynnett Voshage, and the 
ENDOT AKJPRx Investigator Group, University of Alabama at 
Birmingbam, Binningham, AL 
The efficacy of the SQ ArraylM, a new non-thoracotomy lead (NTL) 
system, was evaluated in a clinical trial of 267 pts receiving a 
programmable, tiered-therapy implantable cardioverter-defibrillator (ICO) 
that delivers monopbasic pulses (CPI PRx). Pts were randomized to 
receive I of 3 non-thoracotomy lead systems: a single-pass endocardial 
lead (CPI EndotaklM) with two spring electrodes for defibrillation, 
cardioversion, and pacing (L); an L with a subcutaneous (sc)1 
submuscular (sm) patch with a surface area of 28 cm2 (P); or an L with a 
scism SQ Array that bas 3 spring electrodes and a composite surface area 
of 51 cm2 (A). In pts randomized to receive a scism electrode, 
defibrillation thresbolds (DFfs) were detemlined for both L alone and the 
scism electrode with L. The 2 spring electrodes on L were linked in 
various combinations to the scism lead to provide 4 possible anode/cathode 
combinations. Among pts randomized to receive only an L, additional 
OFf testing was perfonned with a scism electrode if the OFf was >25 
joules 0). The indication for ICO implantation was ventricular fibrillation 
or polymorphic ventricular tachycardia (Vf) in 29.2% , monomorphic VT 
in 70.4%, and others in 0.4% ofpts. 81.6 % were male and 18.4% were 
female. The mean age was 63 ± II yrs, and mean left ventricular ejection 
fraction 0.33 ± 0.13. OFfs were measured in 84 pts with A, 166 pts with 
P, and 252 pts with L. The mean DFf was 14.9 ± 5.6 j with A, 16.9 ± 5.5 
j with P, and 17.5 ± 4.9 j with L (A vs. P, p=0.007; A vs. L, p=O.OOOI; P 
vs. L, p=O.25). Among 10 pts in whom all 3 lead systems were tested, the 
OFf was lowest using A in 5 pts, P in 3 pts, and the L alone in 1 pI. In 
1 additional pI, the DFf was the same using the A and Lalone. 
Conclusion: The SQ Array significantly reduces the OFf compared to 
conventional NTLs, even for an ICD that delivers monopbasic shocks. 
111A 
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726·3 4:30 
Rise In Defibrillation Thresbold Early After implantation of Non•
Thoracotomy Defibrillation Lead Systems: IDddence and Predlcton. 
David SchwartzmaD, Christopher Mallavarapu, David J. Callans, Mark W. 
Preminger, Steven J. Neirenberg, Charles D. Gottlieb, Harold R Kay, Francis 
E. Marcblinski. Philadelpbia Heart Institute, Philadelphia, PA. 
A defibrillation threshold was obtained at implant (I), prior to discharge 
(D)(mean 4:1:2 days) and at initial followup (F)(mean 4S±l3 days) in S7 
patients who UDderwent cardioverter-defibrillator implaDtation utilizing non•
thorscotomy lead systems and monophasic sbocks (Medtronic Transvene"', 
N~2; CPI Endotak"', N-IS), Forty-three pts (75%) had coronary artery 
disease. Fifty-three patients (93%) had a subcutaneous patch implaDted. 
Defibrillation threshold was defined by moving up or down by 2 or 3 joule steps 
to the lowest first shock energy which termil\8ted ventricular fibrillation. A 
'significant' rise in defibrillation threshold from I was defined as > 2 energy 
steps (greater than or equal to S joules). RESULTS: From I to D, 21(37%) 
patients had a significant rise in defibrillation thresbold. From I to F 21(37%) 
patients had a significant rise in defibrillation thresbold. Three patients had a 
significant defibrillation thresbold rise at F without having had one at D, and 
in 3 patients the defibrillation threshold returned to the baseline value at F. In 8 
patients, the defibrillation threshold at D or F came within S joules of the 
maximum output of the device, A multivariable analysis was performed to 
assess for predictors of significant defibrillation threshold rise after implant. 
Variables included demogrsphic, electrophysiologic and LV function data, body 
surface area, thorscic dimensions, antiarrhythmic drugs, manufacturer. 
implantation procedure durstion or number of shocks, patch location, cathode 
location, current pathway and defibrillation lead impedence. No variable was 
belpful in predicting significant postoperstive defibrillation threshold rise. 
CONCLUSION: A significant defibrillation threshold rise from I is common, 
The increase may be seen at discharge testing and usually persists at follo\\lIp. 
It could not be predicted by the variables described. Predischarge and followup 
defibrillation threshold testing should be performed routinely to ensure an 
adequate energy safety margin. 
726·4 4:45 
Implantation of Nonthoracotomy Cardioverter·Defibrillaton in 
Patients With Hypertrophic Cardiomyopathy 
Fran~is Philippon, Andrew E. Epstein, *Lynnett Voshage, for the 
Endotak Investigators. University of Alabama at Birmingham, 
Birmingham, AL 
Patients (pts) with hypertrophic cardiomyopathy (HCM) and 
life-threatening ventricular arrhythmias may benefit from an 
implantable cardioverter-defibrillator (lCD). However, implantation 
may be more difficult due to underlying cardiac structure and higher 
defibrillation thresholds (OFTs). Thus, the feasibility of implanting 
a transvenous ICD system, with or without a subcutaneous patch, 
was retrospectively studied in pts who participated in the 
transvenous Endotak (CPI) clinical trial. Of the 1389 pts implanted. 
9 (3 males, 6 females; mean age 46.7 ± 14.1 yrs) had HCM, 
Indications for leD implantation were monomorphic ventricular 
tachycardia (MVT) in I pt, MVT and ventricular fibrillation (VF) in 
3 pts, polymorphic VT (PVT) in I pt, PVT and VF in I pt , VF in 2 
pts, and syncope in 1 pI. The mean left ventricular ejection fraction 
was 0.54 ± 0.15, and NYHA class J.3 ± 0.5. The single-pass 
Endotak lead was implanted alone in 4 pts, and was combined with 
a subcutaneouslsubmuscular patch (28 cm2) in 5 pts. The mean 
DFT for the entire Endotak trial population was 16.4 ± 5.0 joules, 
and 16.7 ± 4.3 joules for those with HCM (p=0.98). 8/9 pts had a 
DFT !:: 20 joules. No pt with HCM could not be implanted with 
this system due to anatomical constraints. The mean follow-up for 
the HCM popUlation was 11.2 ± 7.7 months. 5 pts received a 
shock, and no pt died during follow-up. 
Conclusion' Implantation of a transvenous ICD system in patients 
with HCM is feasible. The DFT is not significantly higher in pts 
with HCM compared to more usual pts receiving an ICD. 
lACC February 1994:1A-484A 
726·5 5:00 
Initial IIxperience with a ~rana ... enoua IllPlutable 
C&rdio .... rt.r Defibrillator Srat .. Uaillg a Biphaaic Shock 
"Mark D. Carlson, "Lee A. Biblo, the U.S. P2/Endotak 
Investigators, Ca.e western Reserve University/univ.rsity 
Hospital. of Cleveland, Cl.v.land, OH 
Tranevenous (TV) implantable cardiov.rter d.fibrilla•
tors (ICCs) with a monophasic shock can be implanted in 
up to 88% of patients (PTS). We attempted to implant a 
TV/ICD with a biphasic ahock (CPI Ventak P2/Endotak) with 
or without a aubcutaneous (SO) patch in 209 PTS at 32 
centers. Defibrillation thr.shold testing waa randomized 
to step down to failure, 2 succ.ss •• at 20 joul.s (J), or 
3 aucc •• s.s at 25 J. ICD defibrillation waa t.sted at im•
plant, prior to, and 1-2 months after hospital diacharge. 
The PTS included 158 males (75%), 51 f.males (25%), ware 
62±13 years old, had a left ventricular .j.ction fraction 
of 0.32±.13 and had coronary artery dis.ase (157, 75'), 
nonisch.mic cardiomyopathy (32, 15') , or oth.r heart 
disease (20, 10%). The primary arrhythmia waa monomorphic 
ventricular tachycardia (VT) in 125 PTS (60\), polymor•
phic VT or v.ntricular fibrillation (vr) in 60 PTS (29'), 
and both VT and VF in 24 PTS (11\). Th. P2/Endotak wa. 
implanted in 207 of the 209 PTS (99.0\). The vr conver•
sion rates for the P2/Endotak at the implant, predia•
charge, and follow-up tests were 
IliI EPISOPES 1st SHOCK 2nd SHOCK 3rd SHOCK EXTERNAL 
Implant 215 204(95%) 10(4.5\) 1(0.5\) 
Predischarge 221 202(91%) 15(7%) 3(1.5%) 1(0.5\) 
Follow-up 140 127(91%) 11(8%) 1(0.5\) 1(0.5\) 
Operative mortality and morbidity were 2.0% and 2.9\, re•
spectively. The P2/Endotak system sensed and converted 
all 22 episodes of VF and all 113 episodes of VT during 
the follow-up period (4.7±2.9 months). Life table Burvi•
val estimates of PTS free from sudden cardiac death and 
all-cause death at 12 months were 98.5\ and 96.6% reapec•
tively. COncluaiona: The P2/Endotak system was implanted 
in 99.5\ of PTS, converted 99.5\ of vr during testing and 
converted 100\ of spontaneous VT or vr during follow-up. 
The P2/Endotak system was associated with low morbidity 
and mortality. These results compare favorably with 
reports of a monophasic shock TV/ICD or a biphasic shock 
ICD with epicardial patch leads. 
726·6 5:15 
Chronic Changes In Defibrillation Parameters With A Transvenous 
Lead System 
Rangarao V. Tummala, David W. Riggio. Daniel Weiss. Zenaida 
Feliciano. Stephen R. Shorofsky. Michael R. Gold. University of 
Maryland, Baltimore, MD 
Although defibrillation thresholds (DFfs) are stable over time for 
implantable cardioverter-defibrillators (ICD) using epicardial patch 
systems, the same may not be true for transvenous ICD lead systems 
(TV). To investigate this. we undertook chronic defibrillation testing in 
19 patients with a TV that utilized a right atrial coil. DFfs were 
determined in the operating room at the time of implant and at least 6 
months later (289±33 days), using similar step-down protocols. The 
mean DFf at implantation was 12.4 ±O.7 J. and defibrillation impedance 
was 36±2 n.· Chronically. the mean DFf was unchanged (14.S±1.3 1). 
while the impedance rose (46 ± 2 n .p<.ClOl). 
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Although there was no statistically significant change in the group DFf. 
the DFfs increased significantly in some patients requiring 
reprogramming or system modification. This was unrelated to 
antiarrhythmic drug use. Combined with the rise in chronic impedance. 
this raises concern about the long-term efficacy of TV especially when 
used with fixed pulse width devices. These results indicate that routine 
chronic defibrillation testing is warranted to ensure successful therapy. 
JACC February 1994:1A-484A 
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Complications of Warfarin Therapy Monitored by the 
International Normalized Ratio versus the Prothrombin 
Time 
Thomas C. Andrews. Dennis Doeppenschmidt. Paul J. LaVeau. 
Michael J. Lucca, Joseph A. Deering. San Antonio. TX 
To detennine whether utilization of the International Normalized 
Ratio (INR) instead of the prothrombin time (PT) results in fewer 
hemorraghic complications in monitoring anticoagulant therapy. 
we analyzed data from a large coumadin clinic with over 650 
active patients. Until recently. the PT was the test most 
commonly used to monitor oral anticoagulation therapy with 
warfarin in the United States. Because of marked variation in 
reference thromboplastin reagents in responsiveness to the 
anticoagulant effects of warfarin. recommendations have been 
made to utilize the International Normalized Ratio (INR) instead 
of the PT in monitoring therapy. At Wilford Hall Medical Center. 
patients are monitored no less frequently than every 6 weeks with 
laboratory tests and telephone contact, and potential complications 
of therapy or recurrent thromboembolic events are investigated. 
Hemorrhagic complications were compiled for March thru August 
1992 when therapy was monitored with the PT using established 
guidelines for intensity of anticoagulation. Similar data were 
compiled for March thm August 1993 when therapy was 
monitored with the INR using published guidelines for intensity 
of anticoagulation. Anticoagulant therapy monitored with the PT 
test resulted in 12.8% hemorrhagic complications per patient-year 
of therapy (1.6% major complications). Therapy monitored with 
the INR test resulted in 4.5% complications per patient-year 
(p<O.OI) with no major complications and no clinical recurrence 
of thromboembolism. Oral anticoagulant therapy monitored with 
the INR test results in lower bleeding complications than such 
therapy monitored with the PT. and therapy monitored with the 
INR results in a low rate of recurrent thromboembolic events. 
727·2 4:15 
Effects of a combination of Intravenous Isosorbide Dinitrate and 
N-Acetylcysteine on Platelet Aggregation in Unstable Angina 
Pectoris. 
Frederic Girard, Raphael Adda, Elias Garcia, Kader Touiza, 
Isabelle Jolivet Landreau, Raphael Bejuit, Simon Weber. Yvette 
Sultan, Depts of Cardiology an Hematology. Rene Descartes 
University. Paris, France. 
To assess in vivo a possible potentiation by the reduced thiol N•
Acetylcysteine (NAG of the inhibitory effect of Isosorbide 
Dinitrate (ISDN) on platelet aggregation, we studied 20 patients 
(pIS) with unstable angina and a documented ischemic episode 
within 12 hours of the onset of the study. All pts were free of 
medication and received a 2mg intravenous injection of ISDN 
followed by a 4mg per hour maintenance infusion during W. PIs 
were randomly subdivised in two groups. Group I (n = 10) 
received 30' after the beginning of ISDN infusion 150mglkg 
body weight intravenous NAC over 30' while group II (n = 10) 
received a matching placebo. Platelet aggregation was studied, at 
bedside, on whole blood. wtih an impedance aggregometel" 
before (TO) and 60' after (T6O) the onset of ISDN. Platelet 
aggregation was assessed by the dose response relation of 
electrical impedance to increasing doses of ADP. Platelet 
aggregation markedly and significantly decreased from TO to T60 
in group I (ISDN and NAG but remained unchanged in group II 
(ISDN and placebo). For example at the 7J1mole ADP dose level 
electrical impedance decreased from 9.2±1.8 to 5.4±1.70 
(p<O.02) in group I and remained unchanged (6.0±1.5 vs, 
7.0±1.80 NS) in group II. We conclude that the combination of 
ISDN and NAC inhibits platelet aggregation in unstable angina. 
The clinical relevance of these findings in pts receiving the usual 
antithrombotic treatment of unstable angina (Heparin and/or 
Aspirin) deserves further studies. 
ABSTRACTS 
727·3 4:30 
Effects of Captopril on Endogenoul Fibrinolysil in Patients With 
Recant Myocardillinfarction - A Double Blind Randomised Placebo 
Controlled Crollover Study 
Robert A. Wright, Andrew D. Flapan, Catriona C. Simpson, Frances 
Stenhouse, Fiona Oliver, Christopher A. Ludlam, Keith A.A. Fox, 
Cardiovascular Research Unit and Department of Haematology, 
University of Edinburgh, UK 
113A 
Traatment with ACE Inhibitors reduces the incidence of unstable angina 
and racurrent myocardial infarction (MI) in patients with mild left ventricular 
dysfunction following MI. Increased levels of tissue plasminogen activator 
antigen (t·PA Ag) are associated with a greater risk of Mlln normal 
subjects and in patients with angina. The effect of captopril on fibl1nolytic 
function was investigated in 16 men (mean age 63 years) with 
uncomplicated MI. All ware taking aspirin and beta blocker and none had 
heart failure (mean LVEF 39%). 12 weeks after MI they received 4 weeks 
captopril and 4 weeks placebo in a double blind, randomised crossover 
study. T·PA Ag, plasminogen activator inhibitor·l antigen (PAI-l Ag) and 
plasminogen activator inhibitor· 1 activity (pAI·l Act) were measured at the 
end of each treatment period and values compared with 12 normal controls 
(mean age 56 years). 
Controls MI-Placebo MI-Captopril 
t-PAAg (ng/ml) 9.S- IS.8 10.4** 
(S.3 -17.8) (9.0 - 34.S) (4.0·21.8) 
PAI·l Ag (ng/ml) 8.6 16.8 8.3 
(3.8· 24.S) (3.3· 36.S) (2.S - 28.3) 
PAI-l Act (AU/ml) 6.3 II.S 9.1· 
(1.9 -19.0) (4.0 - 21.9) (2.6·29.8) 
median (range) .p = 0.06 vs MI·Placebo, **p = 0.001 vs MI-Placabo 
After uncomplicated MI there is abnormal activation of the endogenous 
fibrinolytic system. Captopril modifies this and in particular is aSSOciated 
with a highly significant fall in t·PA. This may help to explain the reduction 
in risk of coronary thrombosis associated with the use of ACE inhibitors. 
727-4 4:45 
~ Di9Cldn ~ Actvw.. Effeat CD arvi-.-. of 
~al IDfuct.iCD? n. IIiplricIcIa of Digadn n:.. 
JCDII.than x-r, Ori Goldbaurt, Babat.h Rabino.dtz, 
El i __ Kapl iDldty, Solcacm Baber, cd the SI?RINl' 
study Qrcup, Neufeld Cardiac Raaearc:b IDstitute, 
Tel 1Itii!Ib=-, Israel 
'DIe ~iatiCD t.t- digaltin cd incraua:I. 
KJrtaHty in pati_ts (pta) after acute ~ial 
iDfarctioo (AlII) ia ocntrovarsial. '1b test the hype>•
U-ia that digaltin end pest AlII KJrtaI i ty have doI!Ie 
~- :Ie .. t relatiCDlhip _ ClCIIIP8J"8d in the SI?RINl' study 
41 ~ive .urvi'VlOlnl of AlII (Gr 1) praacribaci 11.5 
~/ __ with 112 c:umterparts (Or 2) gi'I8D )1.5119/ __ • 
Or 1 pta __ CUllpU"8ble to Gr 2 pta in ~ to age, 
gander, hiIrtary of pa-wviCUI III, diabet:ea, hypartamicn 
cd prior lID!liDa. 'It-. _ lID signifiCIIDt diff-.::e in 
the incidance of in-boIIpi tal OCIIplicatiOlll!l such lIS ?l', 
VF, pest III lID!liDa or re III ~ groups. 
tb (t) C&' 1tF AVB* Diure- Ifcl* Antiarr-
tic ~ic 
Or 1 (n-41) 25(61) 17(41) 40(0) 34(83) 24(58) 21(51) 
Or 2 (n-112) 52(46) 34(30) 10(9) 81(12) 41(31) 36(32) 
* p<O.05 
CkIe year lIOIrtality _ aignifiCIIDtly laar ~ Or 1 
pta [1 of 41 (It) J than Gr 2 pta [19 of 112(19t) ;p<0.02J. 
Btapti_ logistic ~icn _lysis, adjusted. for ega 
end potImtial clinical pradict:anl of post III death 
ideDtifiad doI!Ie )1.5 ~/ __ of digaltin lIB i,",,-alent 
variable ~iated with first. year death (relative odds 
13.2; 90t amf idance iDUrrval 2.2-'11.2). Q:IIII::lasioo: QJr 
data ~ that digcatin .ay ~ a cIcae:lo4 """"t 
delet.riCUI effect ~ .urvival of AlII pta. 
114A ABSTRACTS 
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Reduction of Exerclse-Ioduc:ecl SepoeotaI Wall Motion AbnormaHties by 
Long·Term Pharmacologic Treatment of Patients wltb Chronic Stable 
AngIna 
David T. Kawaoishi, Raul Weiss, Young M. Park, Becky Lopez, Shahbudio 
H. Rahimtoola, lAC + USC Medical Center, Los Angeles, CA 
We analyzed upright rest and bicycle exercise 2D echo (2DE) studies in 16 
pts enrolled in a 3-montb trial of pharmacologic treatment of chronic stable 
angina in order to measure tbe effect of treatment on exercise inducible wall 
motion abnormalities (WMA), U/16 pts bad MI. Eight pts bad l-vesse~ 6 
bad 2-vesse~ and 2 bad 3-vessel disease. Pts were randomized to oifedipine 
GITS or propranolollA witb double-blind titration to maximally tolerated 
doses. There were UM/4F, age 56.6± 7.9 (mean±SD) yrs. The parasternal 
long axis, parasternal short axis, apical 4-chamber and apical 2-chamber 
views at rest and at peak EX, were used and a total of 22 segments (SGMS) 
scored for WMA as follows: normal = 1, hypokioetic = 2, akinetic = 3, 
dyskioetic=4. All readings were blinded for status of drug tberapy. 
Results: 
Rest Exercise 
Baseline Treatment Baseline· Treatment 
Total Score 6.6±8.4 8.1±9.4 U.8±10.4 10.8±10.5 
II Abn SGMS 3.1±3.7 3.5±4.0 5.H 4.1 4.4± 3.9 
The location of tbe WMA correlated witb tbe site of stenosis. The incidence 
of an exercise-inducible WMA decreased from 10/15=67% to 4/15=27% 
(p = .03) of pts after 3 mos of pharmacologic treatment; 1 pt developed a 
new inducible WMA not present at baseline. 
Conclusions: 1. An exercise-induced WMA on upright bicycle exercise 
occurs in a majority of pts witb chronic stable angina; 2. The incidence of 
induced WMA is significantly reduced after 3 mos of pharmacologic anti•
anginal treatment and may be an additional measure of anti-ischemic 
efficacy. 
727·6 5:15 
Enoximone in Siable Angina: a New AntiaoginaJ Drug? 
Augusto Ruggeri. Gian L. Morgagni. Guido RusticaJi. Maria L. Loricchio. 
Loredana Caccamo. Raffaele Bugiardini. Inst. of Patologia Medica. Vmversity of 
Bologna. Italy. 
Drugs that dilate atherosclerotic narrowings in the epicardial coronary vessels 
may bave powerful antianginal properties. This study was undertaken to assess 
the effects of Enoximone (E). a phosphodiesterase m inhibitor. in 20 pts with 
stable angina and documented coronary anery disease. Data were compared to 
those obtained witb Isosorbide Dinitrate (ISDN). Pts with congestive heart failure 
were excluded from the study. Bicycle ergometer testing (25 W increments every 
2 min) was performed off-drugs and 15 min following E (0.75 mglkg iv over 10 
min) or ISDN (10 mg s.L) at I day interval using a single bliud. randomized. 
cross-over protocoL Results were similar whether E or ISDN was used: exercise 
duration increased. respectively. from 478±56 to 528±SS sec (p<.ool) and from 
4SI±54 to 543±S6 sec (p<.ool): time to 0.1 mV sn increased from 350±52 to 
496±S6 sec (p<.ool) with E and from 362±52 to 503±95 sec (p<ool) with ISDN. 
The occurrence of angina was prevented in 9120 pts with E and in 7/20 with 
ISDN. These benefits were obtained despite a significant (P<.ool) increase in rate 
pressure product at 0.1 mV sn (253±1.7 Vs IS.3±I.S V·JOl with E and 
23.4±2.6 Vs IS.4±I.S V'103 \\ith ISDN) During coronary angiography. 10/20 pts 
were found to bave a significant stenosis of the LAD aner)'. In these pts. we 
measured changes on coronary diameter (CD: 2 orthogonal views) and great 
cardiac velD flow (GCVF: thermodilution technique) before and 15 min follo\\ing 
E OveralL 90 smooth segments and 16 severe (>70%) stenotic segments were 
quanutatively analysed. After E infusion. mean CD increased from 1.69±O.S3 to 
20l±OS5 mm (p<ool) and stenosis minimal luminal diameter increased from 
0.39±O.I1 to 0.S2±O.32 mm (p<.ool): GCVF increased from 94±14 to I30±22 
m1·min (p<.ool) and anterior coronary resistances decreased from 0.95±O.IS to 
0.6 7±O .13 mmHglmI'min (p<. 00 I). None of the pts developed arrhythmias during 
E infusion. We conclude that: (I) E i.\". administration dilate epicardial vessels 
and atherosclerotic narro\\ings. thus increasing oxygen supply and exercise 
capacil) in pts \\ith effort angina: (2) the e,,1ent of benefits in exercise capacil)· 
are similar to those observed follo"ing s.l ISDN: (3) there may be scope for 
development of oral formulations which could assess the therapeutic potential of E 
in stable angina. 
lACC February 1994:1A-484A 
728 Heart in Hypertension 
Monday, March 14, 1994 4:00-5:30 PM 
Georgia World Congress Center, Room 368W 
728·1 
OVer-reliance on Diastolic Blood Pressure: 
Fraainqhaa study 
4:00 
William B. Kannel, Albert J. Belanqer, Boston 
University, Boston, MA 
Clinical decisions and controlled trials 
regarding hypertension have too long em•
phasized the diastolic blood pressure. The 
cardiovascular hazards of isolated systolic 
(SBP>160 and DBP<90), isolated diastolic 
(SBP<160 and DBP~90), and combined hypertension 
(SBP~160) and DBP~90) are compared in subjects 
aged 35-94 years over 36 years of follow-up. 
The prevalence of IDH tended to decline with 
advancing age, whereas ISH prevalence increased 
steeply. combined hypertension rose with age 
and peaked in prevalence at age 55-64 and then 
declined. Beyond age 65 years in women and age 
75 years in men ISH prevalence exceeds IDH oc•
currence by 2-7 fold. 
In men above and below age 65 risk of CHD, 
stroke, cardiac failure and peripheral ar•
terial disease was substantially greater for 
ISH than IDH. Also in persons with diastolic 
pressures never exceeding 90 mmHg risk of CVD 
tended to increase progressively with systolic 
blood pressure_ In persons with systolic blood 
pressure elevation knowledge of the accompany•
ing diastolic blood pressure was not helpful in 
assessing cardiovascular risk. Combined systol•
ic and diastolic hypertension carried little 
greater risk than ISH. Each standard deviation 
increment in systolic pressure increased CVD 
risk in men 41-51% depending on age, while for 
diastolic pressure the incre~ent was 23-43%. 
728·2 4:15 
Radial Artery Xaaa ia Determined by the Level 
of Arterial Preaaure and Correlated With Left 
Ventricular Xaaa. 
Xavier Copie, Xavier Girerd, Jean-Jacques Mourad, 
Eric Abergel, Michel Slama, Christophe Acar, Guy 
Amah, Michel Safar, Stephane Laurent. 
Broussais Hospital and INSERM U337, Paris, France. 
Left ventricular and vascular hypertrophy are 
observed during the course of hypertension. A high 
resolution echotracking device (Nius-02) allows non•
invasive measurement of diameter and wall thickness 
of the radial artery, a medium sized muscular artery. 
'I\olenty-seven hypertensive patients were included in 
this study to determine the relationship between 
radial artery mass (RAM) and left ventricular mass 
(LVM). RAM was validated in vitro by comparing weight 
of arterial segments to ultrasonographic 
measurement. RAM was determined as RAM =p(nRe2-nRi2) 
where p is the arterial wall density (1.06 g/cm3 ) ,and 
Re and Ri are values of internal and external radii, 
respectively. Repetability coefficient (Rc2=SDi2/n) 
was 1.3 mg. Left ventricular mass (LVM) was measured 
by echography according to ASE convention. Blood 
pressure was (mean±SD) 147±20/86±16 rnrnHg, radial 
arterial diameter was 2440±4l5 ~, radial wall 
thickness was 326±60 ~, RAM was 29.7±7.4 mg (range 
13-43 mg) and LVM was 176±47 g (range 98-283 g). In 
an univariate regression, RAM was positively 
correlated to LVM (r=O.465, p<O.02), SBP (p<O.Ol), 
Body mass index (p<0.05) and sex (M>F, p<O.Ol). In a 
multivariate regression analysis, there was a trend 
towards a correlation between RAM and LVM adjusted 
for SBP. These results indicate that in hypertension 
vascular mass of a medium sized muscular artery is 
correlated with LVM. However, SBP which is the 
principal factor contributing to these changes is not 
the only determinant of these structural adaptative 
process. 
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Depressed Hidwall Left Ventricular Performance Predicts 
Cardiac Death in Arterial Hypertension. 
Giovanni de Simone, Richard B. Devereux, Michael J. 
Koren, Paul N. Casale, John H. Laragh. Cornell Medical 
Center, New York, N.Y. 
Decreased LV function predicts adverse outcome in 
coronary and valvular heart disease but it is unknown 
whether the low midwall LV function recently identified 
in a substantial subgroup of hypertensive patients is 
related to prognosis. Accordingly, both echocardio•
graphic endocardial (e) and midwall (m) LV fractional 
shortening (FS) were analyzed in 280 hypertensive 
patients, of whom 40 suffered cardiovascular morbid 
events during a mean follow-up period of 10 years. 
These patients had initially lower mFS than event-free 
survivors as either absolute value or % of predicted 
from meridional end-systolic stress (p<0.004) , but eFS 
did not differ between groups (p-0.06). mFS, but not 
eFS, was inversely related to LV mass index (g/m2•7) 
(r--0.49, p<O.OOOl). Logistic analysis showed that 
increasing age and the interaction between LV mass 
index and mFS were independent predictors of both 
cardio-vascular events (p<O.OOOl and 0.04) and death 
(p<O.OOl and 0.04); increased LV mass index was an 
additional independent predictor of cardiovascular 
morbidity (p<0.004) , whereas low mFS strongly predicted 
cardiac death (p<O.OOOS). Consistent with logistic 
analysis, low mFS did not statistically increase the 
probability of follow-up cardiovascular events after 
controlling for age, cholesterol, sex, systolic and 
diastolic BP and mFS-LV mass interaction (Cox 
analysis), whereas it strongly increased risk of 
cardiac death. Thus, mFS is an independent predictor 
of adverse outcome, most notably of cardiac death. 
728·4 4:45 
Activation of the Cardiac Renin-Angiotensin System in Response to 
Sodium Restriction 
Michael R. Muellerleile, Mary M. Lunzer. Dianne Judd, F10rdeliza 
D. Dizon. Margaret B. Jones. Alan T. Hirsch. University of 
Minnesota Medical School, Minneapolis. MN 55455 
Dietary sodium is a powerful regulator of the circulating renin•
angiotensin system (RAS). Sodium restriction is a standard 
treatment in congestive heart failure and hypertension. Activation of 
the circulating RAS is common to both disease states. However, the 
relative activation of the tissue (cardiac & renal) RAS to sodium 
restriction (SR) has not been charactelized. Therefore. we examined 
the temporal.changes of these tissue and plasma RAS in 42 Sprague•
Dawley rats In response to normal (0.4%) or low (0.04%) sodium 
diets. Plasma and tissue RAS activities were evaluated after 2. 7. 
10. and 14 days on a SR diet. and compared to a time-control 
normal sodium cohort. Plasma and tissue renin activities and AIl 
concentrations (pAIl) were determined by modified radio•
immunoassays and ACE activities by a tluorometric assay. In 
response to SR. both PRC and pAIl levels increased by day 7 and 
remained devated through day 14. During SR. there were 
progressive increases in both cardiac renin-like activity (2-fold and 
6-fold) and cardiac tissue All concentrations (by 60% and 40%) at 
days 7 and 14 (both p< 0.(1). Additionally, renal All levels also 
doubled (p<O.OI). Whereas PRC and plasma All correlated directly 
(r=O.83, p<O.OI), plasma RAS activities did not predict tissue All 
concenu·ations. SR did not alter plasma ACE nor tissue ACE levds. 
In conclusion. dietary SR elicits a sustained increase in cardiac and 
renal. as well as circulating RAS activities, with concomitant 
increased tissue AIl concentrations. Tissue angiotensin II may thus 
subserve local homeostatic responses to SR. 
ABSTRACTS 
728·5 5:00 
Effect or Long Term Calciom Channel Blocker ADtihypel1eulve Therapy 
on Coronary Phyliology 
Joseph A. Diamond, Josef Machac, Milena J. HeozIova, Kevin Martio, 
Lawreoce R Krakoff, Maria Ardeljan, Arlene Travis, Robert A. Phillips, 
Mount Sinai Medical Center, New York, NY. 
The determinaots of change io oorolllllY physiology after long term tn:aUDent 
with antihypertensive therapy are DOt known. We examioed the role or blood 
pressure (BP) reductioo, left ventricular (LV) mass regression and baseline LV 
function on oorolllllY physiology io 17 moderate to severely hypertensive 
patients (10 meo, 7 women) tn:ated for 6 mouths with either oifedipioe-GITS or 
verapamil SR LV mass and ejection fraction (EF) were measured by 2-0 
directed M-mode echocardiography. CorDIIIIIY flow reserve (CFR) was 
quantified by split-dose thallium-201 perfusion imaging, a method which we 
have validated io dogs. The ratio or anterior wall counts during maximum 
oorolllllY vasodilatation by i.v. adenosine (l7Omcg/kg/mio) divided by baseline 
counts defined CPR. A OOWIIIIIY resistance ratio (CRR) was calculated to 
account for the effect or the changing BP during adenosine infusion on the 
measurement of CPR. CRR was defined: resistance ratio = stress mean arterial 
pressurel(rest mean arterial pressure x CPR ratio). A decrease in the CRR 
indicates a lowering of oorolllllY resistance. Groups were oompared using a 
student's T -test. 
Over 6 months, systolic BP was reduced by 23±4.3 mm Hg and diastolic BP by 
l6±2.3 DIm Hg (mean:iSE). LV mass was reduced by l8±4.5 gmlm2. EF did 
not change significantly. Neither the degree of LV mass regression nor BP 
reduction relahld to changes in CFR or CRR However, those subjects (N=6) 
with an abnormal baseline EF «55%) had an iocrease io CRR (-tQ.07±O.04) 
whereas those with a baseline EF ~5% (N=ll) had a decrease io CRR (~.ll± 
0.03) (p<O.OI for the difference). Although the group with an abnormal resting 
EF had a decrease io CPR (~.05±O.I), and the group with a normal resting EF 
had an iocrease io CPR (-tQ.09±O.06); the difference was DOt significant. Both 
normal and low EF subjects had equivalent reduction of LV mass and BP. 
Thus the treatmeot of arteriaJ hypertension that results io LV mass regression 
may have an adverse effect on OOWIIIIIY physiology io patients with baseline 
abnormal LV systolic function. Lower EF may imply an irriversible change io 
ooronary physiology that preveots re-estab1ishmeot of normal CPR. 
728·6 5:15 
Coronary Pressure-Flow Diagrams During Maximal Vasodilation 
as Assessed by Transesophageal Doppler of Len Coronary Artery: 
U5A 
A New Tool for Evaluation of Absolute Coronary Flow Reserve. 
Carlo Palombo, Michaela Koz8kova, Cristina Vassalle, Alessandro Distante, 
Amonio L'AbbaJe, CNR lnstituJe of Clinical Physiology, Piss, Italy. 
The estimation of corolllllY flow reserve (CFR) as the ratio between blood flow 
during maximal coronary vasodilation and basal flow (i.e., "relative" CPR) is 
affecred by some major limits like the dependence of maximal vasodilatory flow on 
the level of coronary perfusion pressure. Aim of this study was to set-up a 
non-invasive meJhod for the assessment of absolute CFR by TEE-Doppler of LAD. 
~: Five nonnoJensive subjects (NT) and five patients with HBP and LV 
hypertrophy, all with angiographica11y nonnal coronary arteries, underwent 
simultaneous measurement of cowlIIIIY flow velocity (CFV) in the proximal LAD 
by TEE-Doppler (HP Sonos 15(0) and sysJemic BP (Finapres, Ohmeda) in basal 
condition and during Dipyridamole iofusion (0.84 mg/Kg!8min i.v.), immediaJely 
followed by i.v. infusion of AngioJensin 11 (Hypertensin Ciba) at sJepwise doses 
(from 2 to 20 ng/Kg/min io 5 min). From the CFV spectrum io LAD, peak and 
mean diastolic and systolic velocity as well as mean tota1 velocity at baseline, after 
Dipyridamole and during Angiotensin were measured. Coronary pressure-flow 
relationships at maximal vasodilation were estimated through the linear regression 
analysis of mean diastolic and systolic CFV versus increasing mean BP during 
AngioJensin infusion. &m: Dipyridamole/Basal CFV ratio for Mean Total CFV 
was 3.12±O.21 in NT and 1.91±O.3 in HBP (p<.OI); similar results were found for 
diastolic and systolic CFV. MBP in NT and HBP was 98±12 and 125±6 mmHg at 
baseline (p<.OI), did not change after Dipyridamole, and increased by a similar 
amount (+37±IO and +39±4 mmHg) during Angiolensin. The r values for 
Pressure-Flow relationships during Angiotensin ranged between +0.85 and + 1.0 (p 
always <.(01) in all subjects. Slopes of CFV vs increasing MBP in NT and HBP 
were 1.03±O.17 vs 0.33±O.IS cm/sec/mmHg (p<.001) for diastolic mean CFV, and 
0.6S±O.09 vs 0.4S±O.14 cm/sec/mmHg (p<.05) for systolic mean CFV. 
Corresponding intercepts values for NT were 4.97±IO.9 and 12.0±17.7 mmHg, but 
Wldetennined (due 10 negative values) in HBP. Conclusions: TEE-Doppler of LAD 
combined with adequate pharmacologic interventions provides a noninvasive tool 
for the assessment, through the coronary pressure-flow relationships during 
maximal vasodilation. of absolute CFR in patients without significant stenosis of 
epicardial coronary arteries. 
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729·1 4:00 
Comparison of Normalized Uptake Index, Hyperemic Blood Flow, 
Flow Reserve, and Minimal Coronary Resistance for Predicting 
Stenosis Severity in Chronic CAD Patients 
Marcelo Di Carli. JohaMes Czernin. Carl K. Hoh. Victor Gerbaudo. Todd 
Sherman. Jan Tillisch. Michael Phelps. Heinrich R. Schelbert. UCLA 
School of Medicine. Los Angeles. California. 
To determine a noninvasive index that identifies best stenosis severity. we 
obtained the normalized uptake index (NUl). myocardial blood flow 
(MBF. mlIg1min) and myocardial flow reserve (MFR) with N-B ammonia 
and PET in 18 CAD patients (61±9 years) at rest and during iv 
dipyridamole hyperemia (0.56 mg/kg. DIP). The NUl was determined by 
normalizing the myocardial N- t3 concentration to the injected N- t3 
ammonia dose and to body weight. MBF was calculated with a 2 
compartment model. Percent stenosis was obtained by quantitative 
angiography. The severity of 41 coronary stenoses was compared to 
regional NUl and MBF in the dependent myocardial territories: 
<50% 50%-70% 70%-90% >90% 
NUl t.3±O.3* t.2±O.2 1.l±0.2 0.9±O.3 
DIP-MBF 2.3±O.6* t.9±O.4§ t.2±0.4 0.9±O.3 
MFR 2.4±O.4* 2.3±O.4§ t.8±O.5 t.4±O.4 
Resistance 45±9* 53±JO§ 84±28 )25±'~2¥ 
*<50 vs >90. p <0.0); § 50-70 vs 70-90. p< 0.05; ¥ 70-90 vs >90. p<0.05. 
NUl identitled stenosis> 90% only. DlP-MBF and MFR similarly 
identitkd > 90% stenosis. but also distinguished between 50 to 70% and 
70 to 90% coronary stenoses. "Minimal coronary resistance" (mmHg.ml· 
I.min.g) as the ratio of mean blood pressure and hyperemic MBF 
performed similarly to DlP-MBF and MFR. but. in addition. dis(;riminated 
between 70-900/c and >90% stenosis. Thus. NUl identities the most severe 
coronary stenosis only while hyperemic MDF's and MFR identify stenosis 
in the intermediate range. Because the "minimal coronary resistance" 
relates hyperemic MBF to the coronary driving pressure and is less 
variable than dipyridamole MDF. it distinguished best between different 
degwes of stenosis severity. 
729·2 4:15 
Myocardial Blood Flow Response to Increasing Oxygen 
Consumption and to Pharmacologic Vasodilation is 
Globally Impaired in Patients With Single Vessel 
Coronary Artery Disease. 
Gianmario Sambuceti. Oberdan Parodi. Paolo Marzullo. Assuero 
Giorgetti. Alessandro Riva, Nicola Nista. Antonio L'Abbate. CNR 
Institute of Clinical Physiology. Pisa. Ita! y 
It has been demonstrated that coronary artery disease (CAD) is 
associated with a global dysfunction of coronary microvasculature. 
However. the effects of this abnormality on myocardial blood flow 
(MBF) regulation have not been fully defined. This study evaluates 
MBF response to increasing oxygen consumption and to 
pharmacologic vasodilation in myocardial regions supplied by non 
stenotic vessels of patients with CAD. To this purpose, MBF was 
assessed at rest. during atrial pacing tachycardia and after 
dipyridamole (0.56 mglKg over 4 min). in 8 normals and in 19 
patients with ischemia on effort, no myocardial infarction and isolated 
left anterior descending (n=12) or left circumflex (n=7) coronary 
artery stenosis (~50% diameter narrowing). MBF was measured off•
therapy. using positron emission tomography and N·13 ammonia. in 
perfusion areas of both stenotic (S) and normal (N) artery. Normal 
subjects and CAD patients showed similar rate-pressure products at 
rest (8433±1949 vs 8903±1855 bpm*mmHg. ns). during pacing 
(16675±2081 vs 17774±2834 bpm*mmHg. ns) and after 
dipyridamole (l1107±2674 vs 12629±2533 bpm*mmHg. ns). In 
CAD patients. resting MBF was similar in S and in N (O.70±0.l5 vs 
0.78±O.l8 mllmin/g. respectively. ns). however. both values were 
lower than MBF of normals (0.94±O.09 ml/min/g. p<0.05 vs both S 
and N). During pacing. MBF increased to a lesser extent in S than in 
N (0.94±O.32 vs 1.24±O.40 ml!min/g. p<0.05); both values were 
lower than normal MBF (2.l6±O.75 mllmin/g. p<O.Ol vs both S and 
N). Following dipyridamole. MBF was lower in S than in N 
(1.21±O.37 vs 1.83±O.75 ml!min/g. p<O.OI); again. both values 
were reduced with respect to normals (3.60±0.76 ml/min/g. p<O.OI 
vs both S and N). Thus. in patients with CAD. further factors may 
affect MBF regulation besides the severity of epicardial stenosis. 
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Residual Coronary Reserve Identifies Regional Viability in Man 
Paolo Marzullo. Oberdan Parodi, Gianmario Sambuceti. Assuero 
Giorgetti, Alessia Gimelli, Piero Salvadori, A. L'Abbate. CNR 
Institute of Clinical Physiology, Pisa, Italy. 
Preliminary experimental and clinical data suggest that viable 
myocardium may exibit a maintained coronary reserve. To 
determine if the persistence of an efficient coronary reserve could 
identify viable segments. 14 patients with single vessel disease and 
previous myocardial infarction underwent baseline positron 
emission viability imaging by means of N13-ammonia and F18· 
deoxyglucose. In addition. regional blood flow was evaluated in all 
patients following dipyridamole (0.56 mglKg over 4 min). 
Of a total of 252 segments, 133 were dyssynergic at rest. Sixty 
segments showed moderate reduction of myocardial blood flow at 
rest and normal metabolic activity (group I). Of 73 hypoperfused 
segments, 2S showed metabolic activity (group 2) and 48 were 
necrotic (group 3). Despite similar resting hypoperfusion • segments 
of group 2 showed a preserved coronary reserve when compared to 
necrotic segments (2.6±1.3 vs l.3±.S. p<.OS). This value was similar 
to coronary reserve observed in segments of group I (2.5±1.6. 
p=NS). Beyond coronary reserve, viable segments also showed a 
lower incidence of coronary occlusion and a more efficient collateral 
circulation. In conclusion, a maintained coronary reserve 
characterizes viable myocardial segments. Viability imaging by 
positron emission tomography appears feasible using quantitative 
analysis of baseline/dipyridamole coronary blood flow. This 
information might integrate the more complex and expensive 
"static" viability information obtained by standard metabolic/flow 
studies and reduce the incidence offalse negative and false positive 
results. 
729-4 4:45 
Superiority of Estimate, of Myocardial Oxidative 
Metabolism Compared to Mea,uramants of Flow In 
Predicting Functional Racovery aftar Coronary 
Reva,cularlzatlon. 
Dong S. Lee, John F. Walsh, Pilar Herrero, Kenneth B. Schechtman, 
Edward M. GeHman, Victor G. Davila-Roman, Steven R. Bergmann. 
Robert J. Gropter, Washington University. St. LouiS. MO. 
The assessment of oxidative metabotism (OM) with PET using C·11 
acetate, myocardial blood flow (MBF) or the perfusible tissue Index 
(PTI) measured with 0-15 water. have been proposed for use in 
predicting functional recovery in response to coronary 
revascularizatlon. We compared these Indices In 17 patients before 
revascularization referenced to changes in systolic function In 
response to revascularization. Receiver operating characteristiC 
(ROC) curves for predicting functional recovery based on the values 
for OM. MBF (in mUg/min). and PTI were generated for all 
dysfunctional segments (left; n=49) and those segments exhibiting 
severe dysfunction initially (right; n-28). 
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In both groups of dysfunctional myocardium, the OM·ROC curve is 
shifted upward and to the left colT1lared with the MBF and PTI ROC 
curves. These resuHs suggest that assessment of OM Is superior to 
quantification of MBF or PTI in predicting functional recovery after 
coronary revascularization regardless of the level of dysfunction 
present initially. 
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729-5 5:00 
Myocardial Viability Assessed by Combined Nuclear Imaging Using 
Myocardial Scintigraphy and Positron Emission Tomography: Impact 
on Treatment and Functional Outcome FollOwing Revascularlzatlon 
Juergen vom Dahl, Carsten Altehoefer, Florence H. Sheehan*, Ilja 
Beilin, Rainer Uebis, Udalrich Buell, Brune Messmer, Peter Hanrath. 
Univ. of Aachen, Germany, Univ. ofWashington*, Seattle, WA 
To evaluate the clinical impact of a combined imaging approach for as•
sessment of myocardial viability using SPECT with Tc-99m isonitriles 
(MffiI) and PET with F-18 deoxyglucose (FOG) 193 consecutive pa•
tients (pts) were followed prospectively over l7±7 months after nu•
clear imaging. Myocardial viability was defined by semiquantitative 
comparison of SPECT and PET data with normalization to the region 
with highest MmI uptake. MffiI uptake below 2 SD of a normal refer•
ence population indicated a perfusion defect In the presence of a MmI 
defect FDG uptake <50% was defined as scar, of 51-70% as mild 
matched defect, and >70% as mismatch. 92 pts were subsequently 
treated medically and 2 underwent heart transplantation. Of 99 pts with 
coronary revascularization 4 pts died postoperatively. In 25 pts inva•
sive follow-up was not indicated or they refused. 70 pts (62 male, 
57±8 years, 84% previous myocardial infarction, baseline EF 
46±12%) were restudied by angiography 6±2 months after revascular•
ization (37 PTCA, 33 CABG; 2.3±.9 vessels/pt revascularized). 
Regional wall motion (RWM) of paired left ventricular angiograms 
was assessed by the centerline method and results are expressed in SD 
of a reference population with negative values indicating hypokinesis. 
EF ~pr~ved slightl~ to SO±II % at follow-up (p<.05). RWM impro•
ved m mismatch regIOns from -l.8±.8 to -O.7±.5 SD (p<.OOI) with a 
predictive value of improvement >.5 SD of 77%. Regions with a mild 
match (-l.6±.8 and -l.6±.7) or scar (-l.7±.9 and -l.9±.8) did not 
change. Prediction of missing recovery for scar regions was correct in 
88%. Functional improvement in mismatch regions was dependent on 
the angiographic success of revascularization, since in the presence of 
restenosis or graft closure there was no change at follow-up (-l.6±.7 
and -1.5±.6). Thus, combined imaging by MIBI SPECT and FDG 
PET for myocardial tissue characterization provides clinically valuable 
information in pts undergoing coronary revascularization. 
729-6 5:15 
Effects of Dobutamlne Stimulation on Myocardial Blood Flow, 
Glucose Metabolism and Wall Motion In PET Mismatch Regions 
Karl Sun, Johannes Czernin, Janine Krivokapich, Tao Duong, Carl Fung, 
Yuk-Kong Lau, Morgan Chen. Gerold Maurer. Heinrich R. Schelbert. 
UCLA School of Medicine and Cedars Sinai Medical Center, Los 
Angeles.CA 
We previously demonstrated a loss of myocardial blood flow (MBF) 
reserve (with IV dipyridamole) In myocardium with PET MBF•
metabolism matches (M) and mismatches (MM). However. dObutarnine 
has been reported to improve wall motion in dysfunctional mismatch 
regions. To examine the relationship between contractile function, MBF 
and glucose metabolism (MRGlc) during dobutamine stress in 
dysfunctional myocardium. we studied 13 male CAD patients (64±1O 
years) and 4 normal volunteers (3S±21 years) with N-13 ammonia. F-IS 
deoxyglucose (glucose loaded) and dynamic PET and with 2D-echo at 
baseline and during IV dobutamine (S-IO mg/kg/min). Wall motion was 
scored as 3=normal to O=akinesisJdyskinesis. A total of 10 normal (N). 
7 MM and II M regions was analyzed. Dobutamine increased MBF in 
N from O.7S±O.20 to 1.28±O.31 mlfg/min (p<O.OI). in MM from 
0.54±O.22 to O.7S±O.33 mllg/min (p<O.OS) but not in M (O.29±O.09 to 
O.39±O.19 mllg/min; NS). Further. MRGlc declined in N (0.49±O.17 vs. 
O.34±O.IS Ilmolfg/min. p=O.05) but increased in MM (0.46±O.12 vs. 
O.63±O.IS Ilmolfg/min. p=O.OS) and M (O.16±O.OS vs. O.2S±O.14 
Ilmollg/min. pdl.OS). Accordingly. extraction of glucose decreased in N 
from O.72±O.39 to O.26±O.08 Ilmolfml (p<fl.()J). but remained 
unchanged in MM (O.98±O.49 vs. O.91±0.46 Ilmolfml. NS) or M 
(O.S7±O.29 vs. O.72±O.57 IJmolfml. NS). Wall motion improved in MM 
(1.6±0.5 vs. 2.S±O.4. p<O.OOI) but not in M regions (O.6±O.6 vs. 
ll.7±O.7. NS). Thus. inotropic stimulation of normal myocardium 
increases MBF and decreases glucose utilization probably due to 
preferential fatty acid oxidation. In MM myocardium, however. 
preferential glucose utilization persists during dobutamine stimulation 
despite an increase in wall motion and MBF. suggesting abnormal 
substrate regulation and/or induction of ischemia. The dObutamine 
induced MBF increase in MM regions suggests that the previously noted 
loss in MDF reserve might have been due to a dipyridamole related 
"coronary steal". Therefore. PET blood flow metabolism mismatches 
may not consistently be associated with a lixed downregulation of MDF 
as postulated for hibernating myocardium. 
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730-1 
Palmaz-Schatz Coronary Stent Restenosls 
: Pattern and Management 
-Hiroyoshi Yokol, Takeshl Kimura, Masaklyo Nobuyoshi, 
Kokura Memorial Hospital, Kitakyushu. 802,Japan 
Oesp~e the well-recognized incidence of stent restenosls(SR). the 
pattern and management for SR have not been thoroughly 
8:30 
defined. Between June 1990 and March 1993,foliow-up(FU) quantitative 
angiography (OCA) (3-6month) was available in 268 patients who had 
successful stent placement at the Kokura Memorial Hospital. 
The SR , defined as ~50% diameter stenosis (OS) at FU. was observed 
In 39 patients (15%). 
Based on anglographlc charecteristlcs. location and length of SR. 
There groups of SR were Identified: diffuse In stent (lesion length 
>1 Omm)(group1,n=13). focal stent border (group2, n=10). focal In 
stent (group3 .n=16 ; articulation =13 ,body=3). 
Two symptomatic patients (5%) undewent bypass surgery. Medical 
therapy was selected in 9 asymptomatic patients(23%) with a 59±5% 
OS. Stented segments showed no progression at 1Y FUQCA : 
MLO 1.38±O.33 mm(3-6M) ,1.55 to.39 mm(1 V). 
Repeat dilaltatlon was performed In 28 patlents(72%) w~h a 73±15% 
OS. uniformly successful without complication. In 23 patients (FU rate 
82%) .FUQCA was obtained aiter 3months or earlier when Indicated by 
symptoms. 
Group1 Group2 Group3 P value 
(n=8) (n=5) (n=10) 
Ro (mm) 3.18±0.64 2.98±O.39 3.17±O.61 NS 
MLopre 0.75±O.28 0.82±O.35 1.02±O.44 NS 
MLDpost 2.69±0.44 2.40±0.35 2.74±O.46 NS 
MLoatFU 0.76±O.69 1.85±O.95 2.23±O.80 0.009 
Reste.(%) 88 20 10 0.006 
Overall recurrent restenosis ( %DS~50)was present in 9 patients (39%). 
Conclusion: 1 )Three types of SR can be Identified by angiographic 
characteristics. 2)Redilatation of SR is a safe and effective 
management. but has a higher recurrent restenosis rate than a primary 
stent placement. especially in patients with diffuse SR. 
730-2 8:45 
Medtronic Wiktortm Stent Implantation and FoUow-Up: 
Results From The Core Laboratory 
Walter E. Mashman, Sara Gatlin, Spencer B. King Ill, J. Larry 
Klein, for The Wiktortrn Stent Group. Emory University School of 
Medicine, Atlanta, Georgia 
The Medtronic Wiktortrn Stent is undergoing clinical investigation 
in the USA for the indications of acute and threatened closure, 
suboptimal result after PTCA, and in restenosis. As the core 
quantitative coronary angiography (QCA) lab, we have evaluated 
327 stents implanted in either native (n=242) or grafted (n=85) 
vessels. To date, 135 subjects have had angiographic follow-up 
either at 6 months (n=99) or earlier as indicated clinically (n=36). 
The cine images were analyzed using QCA. The average size of the 
implanted vessels was 3.03±O.S8 mm. The average percent diameter 
stenosis at implantation prior to intervention was 66±16%. 
Following balloon angioplasty, before stent implantation, the 
stenoses were reduced to 39±19%. Immediately following stent 
placement the final mean diameter stenosis was 16 ± 13%. Thirty•
six patients underwent angiography due to recurrent symptoms 
earlier than the scheduled 6 month follow-up. Of the 36, eight were 
in the first month following implantation and included 5 complete 
occlusions. Twenty-eight patients were studied early between one 
and five months. The range of stenoses was from -3 to 100% with 
an average of 54±32%. Restenosis, defined as grea~er than fifty 
percent diameter stenosis, was seen in 15 of these subjects, or 54%. 
At the scheduled 6 month follow-up. 99 additional subjects were 
evaluated. The range in this group was -22 to 100% diameter 
stenosis with an average of 43±27%. Of the 99 patients studied at 
six months, 42 had restenosis (42%). The total restenosis rate for 
subjects studied more than one month after implantation is 57 of 
127, or 45%. These data show that The Wiktorlm Stent was effective 
in resolving the remaining post angioplasty stenosis. The restenosis 
rate was comparable to other modalities in this selected population. 
117A 
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730·3 9:00 
Results or Coronary Stenting lor Restenosis 
Antonio Colombo, Yaron Almagor, Luigi Maiello, Patrick 
Hall, Steven L. Goldberg, Renato Ginarossi, Butros Khlat, 
Leo Finci. Columbus, Milan, Italy 
We analyzed a group of 97 consecutive pts (90 males, age 
56±9 years) that had Palmaz·Schatz stents implanted for 
restenosis. First restenosis was present in 86 pts and 
second restenosis in 11 pts. Risk factor ditribution was: 
smoking in 48 pts, family history in 46, hypenension in 
34, high cholesterol in 28, and diabetes in 7 pts. The mean 
EF was 57±9 %. A total of 146 stents (83 standard, 58 shon, 
4 biliary, and 1 renal) were implanted in 101 lesions. 
Mean stenosis was 76 ± 11%, mean lesion length 10.3 ± 
6mm and vessel reference diameter was 3.2mm (range 
1.9-5.1). Angiographic success was achieved in 95 pts (99 
lesions). Single stents were implanted in 67 lesions, 
multiple stents in 32 lesions. The mean post $lent stenosis 
was 3.6 ± 13%. There were 7 complications in 6 pts: 1 
emergency CABG, I MI, 1 death, 2 subacute occlusions 
(2%) and 2 vascular complications. Angiographic follow•
up was completed in 63 of 74 elegible lesions (85%) at a 
mean of 6 ± 3 months. Restenosis was found in 12 lesions 
(19%). Restenosis did not correlate with proximal 
reference vessel diameter, post stent minimal lumen 
diameter, final balloon size and final inflation pressure. 
Clinical follow-up was acomplished in all pts at a mean of 
17±11 months: there were 56 pts free of angina, 8 pts had 
new angioplasty, 5 pts had CABG, 2 pts died, and 10 pts 
were mildely symptomatic. Conclusion: results of 
coronary stenting for restenosis are favorable with a 
high primary success, a subacute occlusion rate of 2% 
and angiographic restenosis rate of 19%. The 
achievement of a low post stent residual stenosis may 
contribute to the decreased restenosis rate. 
730·4 9:15 
Steal Placemea' lor tile TlUtmea' 01 Aorto-Ostlal Sapbeaous 
Vela Graft Lesloas. 
S. Chiu Wong, Mun K. Hong, Jeffrey J. Popma, Kenneth M. Kent, Augusto D. 
Pichard, Lowell F. Satler, Nancy Morris, Richanl A. Schatz, Paul S. Teirstein, Ya 
Chien Chuang, Kathi Donovan, Martin B. Leon. Washington Hospital Center, 
Washington DC, and Scripps Clinic and Research Center, La JoUa, CA 
Pa1maz-Schatz stents (PSS) may be the prefemd therapy for lesions in the shaft 
portion of saphenous vein grafts (SVG) due to improved procedural results and 
reduced late recurrence. To determine the early and late efficacy of PSS 
implantation in the aorkHlstial location (s 3mm from aorta) of SVG, we 
evaluated 104 pts who underwent elective PSS placement usinB the "coronary" 
desiJD (53 pts) and more recently the Jarser "biliary" desiJD (5Ipts). Avent8c pt 
age was 64±9 yesrs, 81 % were male, 31 % bad diabetes, 93% had unstable anJina 
and 36% of lesions treated were restenotic. The avemge SVG was 89±SS months. 
Cm!nary vs. biliary PSS angiographic findinBs are as foUows: 
Coronary Biliary Pvalue 
PSS PSS 
Reference diameter (mm) 3.2:tO.7 3.S1O.6 0.01 
Minimal lumen diameter (mm): Pre 0.71O.S 1.210.7 <0.001 
Fmal 3.110.7 3.410.7 0.06 
% Diameter stenosis: Pre 79±14 67±20 0.001 
Fmal 8±20 Stl8 NS 
The overall procedural success « SO% stenosis and no death, MI, CABG) was 
97% and major early clinical events were infrequent (2%; I death and I urgent 
CABG). Angiographic follow-up was obtained in 70% of eligible coronary PSS 
pts; restenosis (>50% diameter stenosis) was 62%. The majority of biJiary PSS 
pts are presenUy not eligible for late angiographic study. 
. We coaelude: I) PSS implantation in aono-ostial SVG lesions is 
associated with high procedural success, few early complications, and excellent 
angiographic results (average final % stenosis. 6%). 2) However, despite these 
favorable early results, preliminary analysis of coronary PSS at follow-up 
indicates a high frequency of recurrence. Whether improved radial sttength 
characteristics and sreater lumen dimensions achieved by the biliary PSS will 
favorably impact restenosis is now being evaluated. 
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730-5 9:30 
Does Stent Implantation in Ostial Saphenous Vein Graft Lesions Reduce 
Restenosis ? 
Sarah Fenton, David Fischman, Michael Savage, Martin Leon, Richard 
Schatz, Randal Rake, Sheldon Goldberg, Jefferson Medical College, 
Philadelphia, PA 
Balloon angioplasty of ostial saphenous vein graft (SVG) lesions is 
associated with a high restenosis rate. The goal of this study was to 
determine if elective placement of single Palmaz-Schatz stents in ostial 
SVG lesions reduces restenosis. Long-term (7.0 ± 4.6mo) angiographic 
follow-up was obtained in 123 pts. with quantitative analysis performed 
by a core laboratory. Twenty pts. with target lesions within 5 mm of the 
aorto-graft ostium comprised Group I, and the remaining 103 pts. with non•
ostial lesions comprised Group 11. There were no differences between 
groups in baseline demographics (age, sex, hypertension, diabetes, 
hypercholesterolemia, smoking, or angina class). The two groups had a 
similar incidence of prior !'TCA (50% vs. 42%, p=ns) and SVG age (115±62 
vs. 99±40mo., p=ns). Baseline angiographic features of the two groups 
were comparable as to ACCI AHA lesion type, presence of thrombus, 
complex ulcerated morphology, and lesion length. Reference vessel 
diameter was greater in Group 1(3.77±.S5 vs. 3.19±.57mm, p=.OOl). 
Restenosis (diameter stenosis ~ 50%) occurred in 12/20 (60%) ostial lesions 
vs. 30/103 (29%) non-ostial lesions, p=.OOS. Quantitative analysis 
revealed: 
Group Pre-% Post% FlU Acute Late loss 
stenosis stenosis %stenosis gain(%) (%) 
I SD±12 17±15 59±30 63±17 44±31 
II 75±14 21±11 44±26 53±17 21±25 
P l'6 l'6 .02 .03 .001 
Although a greater acute procedural gain was observed in ostial lesions 
than in non-ostial lesions, the significantly greater late loss resulted in a 
less favorable net gain and a higher restenosis rate for ostial SVG lesions. 
Thus, while Palmaz-Schatz stents confer an overall low restenosis rate in 
SVG, the long-term outcome of stents is suboptimal for ostial lesions. 
730-6 9:45 
Rational use of Coronary Stentlng to Prevent 
Restenosls: A Randomized Study In LeSions With 
Early Minimal Luminal Diameter Loss After PTCA 
Alfredo Rodriguez, Omar Santaera, Miguel Larribau, 
Mario Fernandez, Miguel RiCCitelli, Nestor Perez Balif'lo, 
Igor F. Palacios, Gary S. Roubin·. Anchorena Hospital, 
Buenos Aires, Argentina; Massachusetts General Hospital, 
Boston, MA; University of Alabama, Birmingham, AL. 
Early loss (> 0.3 mm) of minimal luminal diameter (MLD) 
after successful PTCA is associated with a higher incidence of 
late restenosis. Therefore, 66 patients (66 lesions) with> 0.3 
mm MLD loss at 24 hours post successful PTCA angiography 
(determined by quantitative coronary angiography) were 
randomized into two groups: I: Gjantyrco-Rpybjn Stent (n=33), 
II: ~, medical therapy only (n=33). All lesions were 
suitable for stenting. Baseline demographic, clinical, and 
angiographic characteristics were similar in both groups 
(100% of the lesions were ACC/AHA lesion type B or C). 
Restenosis (~ 50 % stenosis) occurred in 32166 (48.4 %) at 
4 ± 2 months follow-up angiography. 
Reference Diameter 
pre-PTCA MLD 
post-PTCA MLD 
24 h post-PTCA MLD 
post-STENT MLD 
Follow up MLD 
8esteoQsis 
• P < 0.001 
Stent (33) 
3.22±0.25 
0.85±0.35 
2.57 ±0.37 
1.83±0.44 
3.16 ± 0.28 
2.46±0.82 
7/33 (21.2 %) 
Control (33) 
3.14 ± 0.25 
0.74±0.46 
2.54±0.24 
1.76±0.32 
1.15 ± 0.66· 
25133 (75.7 %). 
Thus, the Gianturco Roubin stent reduces late restenosis in . 
lesions with early MLD loss (> 0.3 mm) after successful PTCA 
detected at 24 hours coronary angiography. 
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731·1 8:30 
'!he Couses 01 Death In Grown-UP Congenital Heart PatIents: 
Avoidable and Unavoidable 
Jane Somerville and Susan Stone, GUCH Unit, Royal Brompton & 
National Heart Hospital, London, England 
The mortality from congenital heart disease in 'grown-up' 
congenital heart (GUCH) patients now exceeds that in infants 
(Office of Population Censuses and Surveys). From the Unit's 
database of 4CXXl patients this retrospective study Investigates the 
events and management of 341 GUCH deaths by scrutiny of all 
data from hospital, general practitioners, and pathologists by 2 
independent assessors. The predisposing factor was identified and 
deSignated "medical" or 'surgical' (cardiac). Deaths that were 
un preventable were designated Unayoidable (U) and occurred in 
246 pts (72%) aged 12-68 yrs (m = 23) and when due to 
Inappropriate management, misdiagnosis etc. were deSignated 
Avoidable (A) and occurred in 71 (21%) aged 12-47 yrs (m = 25). 
The cause was uncertain in 24 (7%). Prior to death 54% A had 
Ability Index 1-2 (well) cf 39% U. The deaths were examined in 
relation to disease categories. Commonest anomaly was 
pulmonary atresia + VSD in A 21% and U 19%, reflecting interest of 
Unit, with aortic valve disease 13% A and 7% U, and Eisenmenger 
13% U, 4% A. Deaths were related to reaperation (A = 49%, U = 
30%), 'sudden' (A = 14%, U = 27%), 1st cardiac operation (A = 13%, 
U = 16%), chronic heart failure (A = 3%, U = 16%), extracardiac 
surgery (A = 6%, U = 0.8%), as well as pregnancy, endocarditis 
and injudicious medication. Medical errors in A occurred from late 
referral, therapy, arrhythmia management, missed lesions and 
poor cardiac care with extracardiac illness. Avoidable 'surgical" 
errors mostly related to suboptimal past-operative core. 
Cyanosed patients, particularly with Eisenmenger, were at special 
risk as were all patients with complex basic anomalies having 
reoperation. To prolong and improve the life of the GUCH there is 
an urgent need for the medical profession to recognize that 
GUCH patients require specialized expertise. 
731·2 8:45 
The Fontan Procedure in Adults: Operative and Late 
Results With 121 Patients (pts.) 
Douglas D. Mair, Gordon K. Danielson, Hartzell V. 
Schaff, Francisco J. Puga, Mayo Clinic, Rochester, 
Minnesota 
From 1973 through 1992, 121 pts. age ~ 18 years had 
the Fontan procedure performed at the Mayo Clinic. 
This included 34 pts. with tricuspid atresia, 38 pts. 
with double inlet left ventricle, and 49 pts_ with 
"complex" malformations such as double inlet right 
ventricle, cor biloculare associated with polysplenia 
and asplenia syndromes, etc. Operative and overall 
mortality from the early, mid, and most recent time 
periods were as follows: 
Year of Pt.' Deaths Deaths% 
Operation Oper Late Oper Overall 
1973-80 24 6 3 25% 33% 
1981-87 66 3 3 5% 9% 
1988-92 31 3 0 10% 10% 
Total 121 12 6 lOS 15% 
Operative and overall mortality for the same 
time periods for 718 Mayo Clinic pts. age s17 years at 
the time of Fontan procedure were as follows: 
Year of Pt.' Deaths Deaths% 
Ope rat i on Oper Late Oper Overall 
1973-80 109 27 16 25% 39% 
1981-87 359 54 32 15% 24% 
1988-92 250 17 8 7% 10% 
Total 718 98 56 14% 211 
Operative and late results in adults who satisfy 
established preoperative criteria involving pulmonary 
arteriolar resistance, pulmonary artery size and lack 
of distortion, and ventricular function equal those of 
pts. operated upon during childhood and the great 
majority of such patients are leading high-quality 
lives up to 18 years following operation. 
ABSTRACTS 119A 
731·3 9:00 
Serial Follow up or Ventricular Function and Death in Adult Patients 
with Repaired Tetralogy or Fallot 
Peter P Liu, Lingde Yang, Bette Rose, Sohail Waien, Gary Webb, Peter 
R. Mclaughlin, Toronto General Hospital, Univ of Toronto, Toronto, 
Ontario, Canada 
To evaluate the long term outcome of adults with repaired Tetralogy of 
Fallot, 205 patients(pts) with a mean age of 35 ± IO yrs(mean ± SO), of 
whom I I I were male, were followed in our Adult Congenital Cardiac Clinic. 
The mean age at the time of repair was 14 ± 10 yrs and these pts are now 
15 ± 6 yrs post repair. Series radionuclide angiography(RNA) were performed 
at regular 3 year intervals during a mean of 4.5 ± 4 yrs follow up. Of these 
205 pts, 88 had 2 sets of RNA done to date. The right and left ventricular 
ejection fraction(RVEF, LVEF) al resteR) and during exercise(EX) for 
baseline(l) and 3 year laler(2) were listed as follows: (mean ± SO, n=88 
* = P<0.05 when compared with baseline) 
RVEFRI 36.67 ± 9.27 RVEFEXI 38.00 ± 11.28 
RVEFR2 36.70 ± 10.19 RVEFEX2 39.08 ± 11.77 
LVEFRI 56.50 ± 9.86 LVEFEXI 62.01 ± 12.87 
LVEFR2 55.87 ± 11.06 *LVEFEX2 59.20 ± 11.37 
Of these 88 pts, 50 had 3 sets of RNA measurements for baseline, 3 year and 
6 year intervals. Same trends in ejection fraction changes were observed. 
During follow up, 9 of 205 pts died, corresponding to a mortality of 0.01 I 
pt.lyr. Causes of death include: 
I) Severe right sided heart failure in 2 pts. 2) Fatal arrhythmia (Atrial 
tachycardia in 2pl, ventricular tachycardia and sinus pause in one pt). 3) 
Bleeding (profuse upper oesophageal vessels bleeding in one pt, pulmonary 
haemorrhage as a result of pulmonary hypertension in one pt). 4) Myocardial 
infarction in one pt. 5) Car accident in one pI. 
Conclusion: In repaired adult Tetralogy of Fallot pts, peak exercise LVEF 
may decrease with time. Bul overall right and left ventricular function were 
relative stable on long term follow up. Mortality is low, however right heart 
failure and atrial ventricular arrythmia may be still the major causes of death. 
731·4 9:15 
...... su..rtic: ........ DIIdnE NabInI ... U ....... 1IiItarJ 
-Josepb D. 0rIe, Lee B. Beenuaa, JDH A. EttedguI, DoDaId R. FIscher, Sang 
C. Park, WIlliam H. Neches. Division or PedIatric: CanlloIOJIY, CbUdren's 
Hospital, UDiversity or PlttlllIurP, PA. 
Discrete subaortic stenosis (DSS) bas been IdeatUied slaee 1960 Ia llO 
patieats either as lID Isolated lIDomaIy Ia 76 patients, or usoclated with 
_tric:ular ""pta! defect (VSD) ... 44. 11Ie meaa .. or rec:opItioa or DSS 
was 6.0±3.9 (1'IlIIp 0.1-17'%),an. 11Ie type or steaosls was a discrete 
memnae Ia 67'1>, a aaembraae plus local muscular Iaypertropby Ia 15'1>, 8 
deviated septum Ia 8'1>, a IDaaei Ia 2 ~ ad • comblaatioa ... 8%. SerIal 
obsenatioa5 areater tbaa 1 )'eIII' were available Ia 66 uaoperated patients. 
An Iacrease Ia the aortic .... dlent or 20 torr or areatel' ocewnd Ia oaly 
29'1>, ad this was aot alrected by a usoclated VSD. FurtbenaOft, only 
21~ bad JII'OIP'e5sloa or aoI1Ic: ft&lU'lltatioa (AR). Although this small 
subset or patients had JII'OIP'e5sloe disease, there was ao correIatioa between 
the aortic aradleat ad the AR. Mild or moderate AR was more CODlIDoa 
Ia patients with a VSD tbaa Ia those with a Isolated defect (SK VI 11'1>, 
p=O.04). SUJ1IicaI resectloa or the membraae, with or without a 
myotomy/myomectomy was performed Ia 57 patients. Postoperatloe follow•
up areater tbaa 6 moaths was available Ia 45 patients ranging from 0.7 to 
14 (m=6.7±5.8),an. 1berewere 2 early deaths aad 1 late c:anUac related 
deaths ( endocarditis ad beart failure). Left buadle braach block OCCUlTed 
Ia 6 patients ad complete beart block Ia 2. Residual steaosls with a 
.... dIent of 20 torr or lftllter, or a murmur louder tbaa .... de II, OCCUlTed 
Ia 51'1>, bowever oaly 16~ required reoperatlon. At last follow-up, 89'lI> had 
either ao AR or trivial AR by doppler aloae (34~), or mild AR (55~). 
Moderate AR was present preoperatively Ia 1 patients ad Improved Ia both 
poStoperatively. However, 5 patients (11~) no had ao or mild AR 
preoperatively, developed moderate AR following operatloa. Ia summary, 
the 1III\I0rity or patients with DSS have oaly a modest procressloa Ia their 
aortic .... dleat. AR may be JII'OIP'e5slve Ia a amaH subset or uaoperated 
patients ad tllis II Dot related to the degree of steaosls. SurgIc:aI 
.......... ent Is eJrectIve Ia most patieats, but some degree of residual 
steaosl5 Is aot uncommon. 
120A ABSTRACTS 
731·5 9:30 
lIechanis. of Relressed Aneurys. in ~a'Wasaki 
disease : SqDiricance or Inti.at Thickeninl at 
Diseased Sites. 
AlSuko Suzuki. Masakazu Yamagishi. Tetsuro Kamiya, Yasuo Ono. 
Kouji Kimura 
National Cardiovascular Center. Suita, Osaka, JAPAN 
The long term follow·up studies of coronary arterial lesion due to 
Kawasaki disease(KD) have demonstrated appearance of progressive 
localized stenosis even after regression of aneurysms. The exact 
mechanism of the regression of aneurysms and of the decrease of their 
size remains to be unclear. We examined coronary lesions in the late 
phase by intravascular ultrasound (lVUS). The material included 9 
pts who had been followed with serial coronary arteriography (CAG) 
(3.9±1.0 times) for 12.1±3.8 yrs after the onset of KD. All pIS were 
noted to have aneurysms on the first CAG. IVUS (30 MHz. 4.3 Fr. 
1800 rpm) were done at the time of the last CAG. The age of pIS at 
the study was IS.2± 2.8 yrs. Aneurysms in 5 pIS (8 branches) were 
noted to have regressed and appeared to be completely normal on 
CAG. persisting aneurysms were seen in 7 pts (8 branches) • and the 
other 4 branches which were considered to be normal on the first CAG 
were also examined by IVUS. Remarkable intimal thickening 
(0.79±O.29 mm) of the 8 branches with regressed aneurysms was 
demonstrated. and at 2 areas it resulted in significant stenoses. In the 
8 aneurysms which had decreased in the size. intimal thickening of 
their wall (0.42±O.13 mm) andlor calcification were shown. Three· 
layered appearance was observed even in apparently normal coronary 
arteries (0.23±O.OS mm). These results suggested that regression of 
aneurysms does not indicate "healing" and that even normal appearing 
coronary arteries might be involved with intimal thickening. 
731·6 9:45 
Late Cardiotoxicity Following Childhood Malignancy: 
The Effects of Gender and Doxorubicin Dose. 
S.E. Lipshultz. S. Lipsitz. S.M. Mone. A.M. Goorin. S.E. 
Sallan. S.P. Sanders. S.D. Colan. Children's Hospital. Boston. 
MA. 
Little is known regarding risk factors for late doxorubicin 
cardiotoxicity in survivors of childhood malignancy. We examined 
echos from 120 pts treated with a cumulative doxorubicin dose of 
244·550 mg/m2 (median. 393) for childhood ALL or osteogenic 
sarcoma. The median interval between the end of treatment & the 
cardiac evaluation was 8.1 yr. 62 pts (52%) were girls. All echo 
parameters were abnormal at follow·up. Sex stratification revealed 
that depressed contractility was due exclusively to abnormalities in 
girls. In a multivariate analysis. female gender & higher 
cumulative dose were associated with depressed LV contractility 
(P=.044). A higher individual dose (ie .• more mg/m2/dose) was a 
risk factor for elevated LV afterload (P=.OOI). A high cumulative 
dose was associated with depressed LV fractional shonening (FS) 
(P=.022). Late elevation of LV afterload was associated with a 
younger age at ALL diagnosis (P<.OO I) as was increased LV 
dimension & reduced LV mass. wall thickness. & FS. However. 
longer post·treatment follow·up was associated with elevated LV 
afterload & reduced LV wall thickness. Conclusion: Female 
gender & higher individual doxorubicin dose constituted 
independent risk factors for abnormalities of LV mechanics after 
childhood doxorubicin treatment. in addition to the previously 
documented risk factors of cumulative dose & age at treatment. 
Prevalence & severity of abnormalities of LV growth & mechanics 
were found to increase with longer follow·up. The risk factors for 
abnormal contractility were different from those for reduced wall 
thickness & mass, & elevated afterload, suggesting separate 
mechanisms for these two forms of cardiotoxicity. 
JACC February 1994:1A-484A 
732 Stress Echocardiography 
Tuesday, March 15, 1994 8:30-10:00 AM 
Georgia World Congress Center, Room 261 W 
732·1 8:30 
Arbutamlne EctMx:.dlography: Sensitivity and Specificity with a New 
Stre .. Agent Dellv'" by a Computwlzecl Closed-Loop System 
"Jerald L. Cohen. VAMC, East Orange, NJ, "Kwan Chan, Ottawa Heart 
Instftute, Ottawa, canada. "Wybren Jaarsma. 51. Antonius Hospftal, 
Nieuwegein, The Netherlands, "Marie R. Star1lng and "William F. Armstrong, 
Univ. 01 Michigan, Ann Arbor MI for the Intematlonal Arbutamine Study Group 
This study evaluated the sensftlvlty and specHlcfty 01 stress echocardlography 
(Echo) with arbutamlne (Arb), a new agent with poIent beta·agonlst effects, 
for diagnosing coronary artery disease (CAD) and Induclng Ischemia. Arb 
was administered by a computerized, closed-loop (Cl) system which 
measures heart rate (HR) and adjusts Arb Infusion to achieve a predefined 
rate of HR rise and target HR. Sensitivity was evaluated in patlent8 (Group 
I, ".146) with quantlatlve coronary anglographlc evidence (~ stenosis 
of any major artery) of CAD within ±14 weeks of stress; 109 (75%) of these 
patients also per10rmed exelQlse (Ex) Echo. SpecHlcfty was determined In 
patients (Group 2, n-63) with a ~8% likelihood of 5·year 8urvlval according 
to a standard exelQlse nomogram. Stress was stopped when intolerable 
symptoms, Ischemia, target HR or plateau of HR response occurred. Stress 
induced ischemia was defined by Echo as new or worsening wall motion 
abnormalfty (WMA) In at least two adjacent segments of the posterior/inferior 
wall or at least one segment 01 the anterior wall. CAD was defined by Echo 
as resting WMA or development 01 stress Induced Ischemia. Echo and 
anglographic data were analyzed by blinded Core Laboratory observers. 
~: In Group I, the maximum HR change from baseline was 53 bpm 
wfth Arb and 59 bpm with Ex. Sensftlvfty for inducing ischemia and detecting 
CAD by Arb/Echo was 76% and 84%, respectively. Of the Group 1 patients 
who were able to exelQise, senslllvfty for Inducing ischemia was 79% wfth 
Arb/Echo and n% with ExlEcho; Arb and Ex resub agreed in 74% of the 
patients. In Group 2. \he specHicfty of Arb/Echo was 96%. 
The most frequent adverse events were tremor (13%). headache (10%). 
arrhythmia (8%), hypotension (7%) and dizziness (6%). In general, the events 
were well tolerated and resolved with the discontinuation 01 Arb. 
Conclusjon' Arbutamlne, administered by the unique closed·loop system, 
provides a reliable and accurate stress echocardlographic method for 
detecting CAD and inducing myocardial Ischemia. 
732·2 
Che.t P.iD De.pite ADgiogr.phic.llJ IIoraa1 COron.rJ 
Arterie. - Perfu.ion Defect.. on ~echDet.iUII Se.t.. 
KIBI SPBCT .re DOt A •• oci.t.ed Wit.h Abnoraa1 St.re •• 
Bcboc.rdiogr .... 
Richard Cooke, John Chambers, Paul Ryan, Michael 
Maisey, Paul CUrry. Guy'. Hospital, London, UK. 
DefectB on nuclear perfu.ion imaging are reported in 
up to 85' of patients with syndrome X (typical cheat 
pain, al:>normal stress electrocardiogram, and 
angiographically normal coronary arteries) but their 
significance is uncertain. If they represented 
myocardial ischaemia, they would be expected to be 
aSBociated with wall motion al:>normalities on 
echocardiography. We therefore studied 16 patients 
(age 55 years;14 female) with syndrome X; 15 with 
atypical pain, normal electrocardiogram and 
angiographically normal coronary arteries (age 50 
years; 5 female); and 15 with angiographically 
significant coronary artery disease (age 59 years; 
6 female). All had Bruce protocol treadmill teating 
with stress echocardiography and injection of 
Technetium Sesta MIBI. SPECT was performed 1 hour 
later and repeated (with reinjection) in 24 hours if 
al:>normal. Receiver operating curve analysis was used 
for interpretation of images. On SPECT there were 
definite al:>normalities in only 3 (10') patients with 
normal coronary arteries (1 syndrome X, 2 atypical 
pain). However minor perfusion defects occurred in 
a further 15 (48'). By comparison, on stress 
echocardiography there were no abnormalities. The 
sensitivity. specificity and accuracy of SPECT and 
stress echocardiography for the recognition of 
coronary artery disease were 67' vs 73' (NS), 90\ vs 
100\ (NS) and 83\ vs 91' (NS). 
In conclusion, (1) perfusion defects in patients 
with angiographically normal coronary arteries are 
less common than previously reported if strict 
criteria are applied, and (2) are not associated 
with wall motion al:>ormalities on stress 
echocardiography. 
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Tile Link Between Coronary Lesion Morpbology and 
Dipyridamole Stress Ecboc:ardiography Results 
Chunzeng Lu, Eugenio Picano, Mario Marzilli, Daniele Rovai, AnlOnio 
L'Abbate, Alessandro Distante. CNR, Institute of Clinical Physiology, Pisa, 
I18Iy. 
The likelihood of a positive response with dipyridamole stress echocaJdiogmphy 
(DSE) is directly related 10 the extent and severity of angiographicaJly assessed 
coronary anery disease. Wbcther coronary lesion morphology - a known predictor 
of adverse cardiac events - may also modulate stress echo results remains 
1riaIown. In order 10 assess the relationship between stenosis lesion morphology 
and stress echocardiogmphic results, we analyzed high dose (up 10 0.84 mglkg 
over 10') DSE and coronary angiogmphic data of 74 in-hospi18l patients with 
single vessel disease, no occluded vessel at angiography and no previous 
myocardial infarction. DSE was performed in all pts within 3 days of coronary 
angiogmphy. An angiogmphic lesion was considered complex when irregular 
borders and/or intraluminallucencies, suggestive of ulcer and/or thrombus, were 
p-esent. According 10 angiogmphic lesion morphology 2 Groups were identified: 
Group I, with complex, non-occluded coronary lesions; Group II, with simple, 
non-occluded coronary lesions. The 2 Groups were matChed for number of pIS 
(n=37 in each group), age (l=6I±9 vs 11= 59+9 years, p=ns), and coronary artery 
stenosis severity (l=89±3 vs 1I=89±3%, p=ns). The sensitivity of DSE was higher 
in pts of Group I when compared with Group II (94 vs 54%, p<O.05). Among 
positive DSE, the low dose (0.56 mg/kg over 4') positivity was more frequent in 
Group I than in Group II pts (79 vs 25%, p<.OI). In conclusion, in pts with 
single vessel disease, without coronary occlusion or previous myocardial 
infarction, a coronary lesion morphology of the complex type, characterized by 
irregular horders and/or intraluminal lucencies, is associated with a higher DSE 
sensitivity, and with a greater prevalence of low dose positive responses. The 
plaque morphology, not only the plaque geometry, is important in modulating 
different pharmacological stress echo responses in the presence of angiographically 
assessed coronary artery disease 
732·4 9:15 
Optimal Duration of the Stages In 
Dobutamlne Stress Echocardlography 
Neil J Weissman, Stefan M Nidorf, Arthur E Weyman, Michael 
H Picard. Massachusetts General Hospital, Boston, HA 
Dobutamine stress echocardiography (DSE) is currently 
performed in 3 or 5 minute (min) stages. To determine if 
th~re is incremental benefit of 5 min stages over 3 min, 
nins! standard DSE's were performed in 7 instrumented 
dogs. The stage duration for the initial DSE was randomly 
allocated and all hemodynamic and echo variables returned 
to baseline prior to the second DSE. At each stage, heart 
rate (HR, beats/min) and systolic blood pressure' (SBP, 
mmHg) were recorded. Mean coronary blood flow (CBF, 
m1/min) was ~easured by a flow probe around the LAD artery 
and wall thlckening (WI) was determined by sonomicro•
meters. Mid-ventricular short axis areas of the LV cavity 
at end-diastole and end-systole were measured by echo and 
the % area change (%AC) calculated. Cavity obliteration 
served as the DSE endpoint. RESULTS: For the 5 min 
protocols, the DSE endpoint was acheived at a lower 
dobutamine dose (p-0.03). At baseline and 5 mcg/kg/min, no 
difference was detected between the 3 or 5 minute proto•
cols in HR, SBP, HR x SBP, CBF, WI, or %AC. 
meg/kg/min 
o 5 10 
HRxSBP 300in 14,30l:t2757 16,546±3761 19,348±6426 
5Ioin 14,907±3950 16,549±4582 24,642±5916' 
rBF 300in 20.0 ± 7.9 22.9 ± 6.4 32.4 ± 10.5. 
SIIin 20.4 ± 9.0 23.7 ± 8.4 47.4 ± 11.6 
%AC 300in 68.2 ± 9.0% 71.1 ± 16.0% 82.0 ± 24.9% 
5Ioin 66.0 ± 13.9% 77.9 ± 10.8% 94.8 ± 4.9% 
#-p<O.05 *-p<O.OOI 
CONCLUSION: In this canine model, a longer stage produced 
a greater hemodynamic effect at a lower dose. Thus, 
extending stage duration in clinical DSE may achieve 
equivalent physiologic stress at lower doses. 
ABSTRACTS I2IA 
732-5 9:30 
Response of left Ventricular Regional Wall Thickening to Dobutamine 
Infusion is Critically Dependent on the Balance Between Regional 
Coronary Flow and Oxygen Consumption 
Chunguang Chen, Jose A Pradial, Minhui Chen, Syed A. Abbas, A"hur E. 
Weyman. linda Gillam. Hartford Hospital, Hartford, CT & Massachusetts 
General Hospital, Boston. MA 
Improvement in regional left ventricular wall thickening during low dose 
dobutamine IDOB) infusion has been used to identify hibernating 
mvocardium. However, it would be expected that the ability to increase 
myocardial thickening would be critically dependent on blood flow and 
oxvgen consumption. To test this hypothesis, a model of coronary a"ery 
stenosis ICAS) was created in 7 pigs who received graded DOB infusion 
12.5 - 15 pg/kg/min). Regional coronary flow IRCFI was measured by 
flowmeter and expressed as mllmin/g myocardium. Wall thickening was 
monitored by sonomicrometers and two-dimensional echocardiography. 
The product of hea" rate and systolic a"erial pressure IHRP) was used as 
an index of myocardial oxygen consumption. The balance between 
oxygen consumption and coronary perfusion was expressed as ratio of 
HRP/RCF. At each of 13 grades of coronary stenosis, all parameters were 
measured before and at each stage of DOB infusion. Results: For each 
coronary stenosis 110 - 65% reduction in baseline RCF), regional wall 
thickening measured prior to DOB infusion decreased from baseline 
136±8% to 15±5%; p<O.01). With low dose DOB, regional wall 
thickening increased in 9 of 13 stenoses 116±6% to 25±5%; p<O.05). 
In these stenoses. the HRP/RCF decreased from 13165 ± 2362 to 
11176 ± 3289 mmHg.beat/mlimin'/g myocardium. In 4/13 stenoses, wall 
thickening following low dose DOB infusion did not improve 114±4% to 
12 ± 5%; p ;NS), in which the HRP/RCF increased from 12089±3458 to 
14645 ± 2539 mmHg.beat/ml/min'/g myocardium Ip<O.05). Following 
release of CAS and termination of DOB. wall thickening in all animals 
returned to baseline, confirming that the myocardium had been 
hibernating. Conclusions: In the presence of coronary stenosis, the ability 
of low dose dobutmaine to improve regional wall thickening is critically 
dependent on the balance between regional coronary flow and oxygen 
consumption. The clinical use of dobutamine echocardiographv to identify 
hibernating myocardium should take these factors into account. 
732-6 9:45 
Optimal Dobutamlne Dose for the Assessment of Myocardial 
Hibernation With Dobutamine Echocardlography: Implications for 
Digital Quad-Screen Image Display 
Imran Afridi, Neal S. Kielman, Albert E. Ralzner, WUllam A. Zoghbl, Baylor 
College of Medicine. Houston, Texas 
In patients with myocardial hibernation, a blphaslc response of the 
dysfunctional myocardium to dobutamine (improvement at low dose and 
worsening at high dose) has been shown to predict viability. However, the 
optimal low dose that induces improvement has not been previously 
determined. Accordingly, we performed dobutamine echo (DE) studies In 
14 patients (mean age 60 ± 12 yrs) wtth stable coronary disease and 
regionallV dysfunction prior to, and 6 wks after angioplasty. Dobutamine 
was given at Incremental doses of 2.5, 5, 7.5. 10, 20. 30 and 40 
mcg/kg/min every 3 minutes. Digital Images of all 8 stages were displayed 
simultaneously (2 quad screens/side by side) and Interpreted using a 16 
segment LV model end a wall motion score Index. During DE. a blphaslc 
wall motion response was seen In 21 of 85 abnormal segments. Other 
responses observed were sustained Improvement in wall motion (n; 19), 
graduai worsening (n= 17) and no change (n=28). Recovery of resting 
function at 6 wks was seen In 30 of the 85 segments. The highest 
predictive value for recovery of function was associated with a biphasic 
response to DE (71%) while the lowest was seen wtth sustained 
Improvement (16%). In segments with a biphasic response, the minimum 
dose at which wall motion improved during DE ranged between 2.5 and 10 
mcg/kg/min but was most prevalent at the 5 mcg (57%) and 7.5 meg 
(33%) doses. The optimal low dose, defined as the lowest dose at which 
maximum improvement In wall motion occurred, ranged between 5 and 10 
meg/kg/min and was 5 mcg in 48% of segments and 7.5 meg In 43%. Wall 
motion started to worsen usually above 20 mcg (86%) but was seen as 
eariy as wkh the 7.5 meg dose. Display of both the 5 and 7.5 meg images 
in addttion to the maximal dose allowed detection of the biphasie response 
in 20 of the 21 segments (9S%). Thus, for the assessment of myocardial 
hibernation, dobutamine eeho should include a 5 and a 7.5 meg/kg/min 
dose in addition to higher doses. For the quad screen format display, 
resting images along with those of 5, 7.5 meg/kg/min and maximal 
dobutamine dose are suggested for optimum interpretation. 
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Ventricular Geometry Is Altered by Aalte Chaoges 10 
lDotroplc State 10 Falllog but not Normal Hearts 
David J. Esposito, Clarence H. OweD, James W. Davis, aDd 
Donald D. Glower, Duke University. Durham. NC 
8:30 
Acute chaoges in inotropic state have been shown to have no effect on 
diastolic left ventricular (LV) geometry in the normal heart, but their effect 
in failing hearts is UDclear. Dynamic LV ~ume aDd transmural pressure 
(P) were measured in 10 conscious dogs using SODomicrometry aDd micro•
maoometry UDder control conditions aDd during heart failure induced by 3 
weeks of rapid right ventricular (R V) paciog at 240 beats/minute. Data 
were obtained during RV pacing at 150 beats/minute after autonomic 
blockade. lDotropic state was acutely increased from baseline (B) using io•
travenous infusion of calcium chloride. Slope (~) aDd x-intercept (V,,) of 
the lincar stroke work versus cnd-diastolic volume relationship (PRSW) 
and the slope (E.,) of the end-systolic pressure-volume relationship 
(ESPVR) were derived from data obtained during rapid vena caval occlu•
sion. All data were mean± S.D. (*p< .05 for Calcium vs. B) 
Control-B 
Calcium 
Failure-B 
Calcium 
ESPVR 
E .. (mmHg/ml) 
2.3± 13 
3.7±1.0* 
1.9±0.7 
2.4±0.7* 
PRSW 
~(Kerg/ml) V.,(ml) 
8S±22 5l±15 
137± 29' 54± 13 
7l± 18 74± 17 
9l±23* 65t 17* 
Calcium infusion acutely increased inotropic state as demonstrated by 
increased ~ and E .. under all conditions. During failure. calcium infu•
sion acutely changed unstressed LV geometry as evidenced by the fall in V" 
from 74±17 to 65t17 ml (p<0.05). while calcium did not affect V., UDder 
control conditions. Therefore. UDstressed LV geometry is sensitive to acute 
chaoges in inotropic state io failing but not normal hearts. This fiodiog may 
contribute to the 1asting benefit from transient inotropic support in failing 
hearts. 
733·2 8:45 
Age Related Changes in Hemodynamic Response to Exercise in Patients 
with Chronic Congestive heart Failure 
Scott W. Mabee, Marco Metra, Douglas E. Reed, Livio Dei Cas, Robert J. 
Cody, The Ohio State University and University of Brescia, Columbus OH 
We have previously shown an age-dependent increase of systemic 
vascular resistance(SVR) in chronic congestive heart failure patients(CHF 
pIS), under resting conditions. In the current study, we addressed the 
hypothesis that age-dependent differences in hemodynamic profile would 
contribute to decreased exercise peJiorrnance in elderly CHF pIS. Eighty•
nine patients with chronic CHF: NYHA 2-4, and age range 29-n years, 
underwent seated ergometric exercise with right heart catheterization and 
brachial artery pressure determination. None of the patients were 
receiving vasodilators at the time of the study. Resting hemodynamic 
characterization included: cardiac index(CI) 2.3±O.7 Vmirv'm2, rest 
-pulmonary wedge pressure(PWP) 18±10 mmHg, and rest SVR 17B2±794 
-d's/cmS. All pts exercised to exhaustion. Hemodynamics at exhaustion 
were: Heart rate 137±26bpm, MAP 104±19 mm Hg, PWP 37±12 mmHg, 
RAP 13±9 mm Hg, SVR 1037j:613 d's/cmS, PVR 158±154d's/cmS and 
maxV0214±5.6mVmirv'kg. Univariate analysis revealed age-dependent 
changes in the following maximum exercise parameters: HR, stroke volume 
index, stroke work index, CI, SVR, PVR, maxV02, pulmonic gradient and 
resistance ratio(all p<O.05). To assign relative importance of these age•
dependent effects these hemodynamic data were entered into a stepwise 
muHivariate regression analysis. Age-dependent decrease of CI, and age•
dependent increase of SVR were selected by the model. The functional 
signnicance of this relationship was demonstrated by a close correlation of 
exercise CI with maxV02(r=O.869, p<.OOO1). This data indicate that elderly 
CHF pts demonstrate an age-dependent reduction of cardiac pertorrnance 
and hence increase of SVR at maximum exercise, compared with patients 
of lesser age. These age-dependent hemodynamic changes are of 
functional signnicance, as maxV02 is dependent upon cardiac output, and 
the ability to increase this with exercise. 
lACC February 1994:1A-484A 
733·3 9:00 
Systemic Hypotension is a Determinant of Functional Exercise Status in 
Chronic Congestive Heart Failure. 
Scott w. Mabee, Marco Metra, Douglas E. Reed, Livio Dei Cas, Robert J. 
Cody, The Ohio State University and University of Brescia, Columbus OH 
Utilizing the resistance ratio(RR, pvrlsvr), we have demonstrated that 
relative pulmonary vasoconstriction in congestive heart failure patients(CHF 
pts) predicted increased mortality. Following formula reduction, the RR is the 
pulmonary pressure gradient(PPG,mmHg) divided by the systemic pressure 
gradient(SPG): PAP-PWPIMAP-RAP mmHg. As increased RR may limit 
oxygenation, we hypothesized that pts with the highest exercise RR would 
have the lowest maximum oxygen consumption (maxV02, mVkglmin) and 
Weber class(class E). Ninety CHF pts underwent seated ergometric 
exercise after right heart catheterization, and brachial artery pressure 
determination. Pis were of a wide CHF range: 29 to n years of age(54± 11), 
NYHA class 2-4(2.8±O.6), with resting hemodynamics consisting of cardiac 
index 2.26±0.7 Vminlm2, PWP 18±10 mmHg, SVR 17B2±794 d's/cms. 
None were receiving vasodilators at the time of study. Statistics for class 
strat~ication were ANOVA. Hemodynamics at exhaustion were: heart rate 
137±26 bpm, MAP 104:t19, PWP 37±12, RAP 13:t9, SVR 1037±613, PVR 
158±154, RR O.15±.11, and maxV02 14±5.6. Weberciass was determined 
from maxV02, and pts were strat~ied to evaluate RR. The RR increased 
progressively for Weber class A(.08±.03), B(.13±.10), C(.14±.09), 
D(.2(l±.09), E(.27±.22), (A vs E, p<.OO1). However, increased RR was due 
to progressive decrease in SPG: A(117±16), B(96±22), C(90±22), 
D(82±20), E(68±26), (A vs E, p<.OO01), with only a small increase in PPG. 
Further analysis revealed the progressive decrease in SPG was due to 
progressively lower MAP: A(124±15), B(108±21), C(104±17), D(100±14), 
E(83:t21), (A vs E, p<.OOO1). RAP was unchanged. Thus, RR increased 
with progressive reduction of exercise capacity in CHF. However, this was 
due to progressive hypotension, not increased pulmonary hypertension. 
Systemic hypotension contributing to hypopeJiusion of exerCising muscle 
therefore represents a limiting factor for exercise capacity. 
733·4 9:15 
The Force-Frequency-Relationship is Different in Human 
Atrial and Ventricular Myocardium 
Robert H.G. Schwinger, Michael Bohm, Andrea Koch, 
Erland Erdmann. Medizinische Klinik III, Universitat zu 
Koln, 50924 Koln, Germany. 
In the failing human myocardium an increase in 
frequency of stimulation is followed by a reduced force 
of contraction (FOC) in vivo and in vitro. The present 
study aimed to investigate whether the origin of the 
myocardial sample influences the force-frequency•
relationship (FFR). Force of contraction (FOe in mN) was 
studied in left ventricular papillary muscle strips (PAP) 
and in right atrial trabeculae (AUT) from failing 
(NYHA IV, heart transplants, n = 10) and nonfailing (NF, 
donor hearts. n = 3) human myocardium at different 
frequency of stimulation (1-3 Hz). The effectiveness and 
the potency to increase FOe following an increase in 
frequency of stimulation was significantly higher in atrial 
than in ventricular myocardium in NF and NYHA IV 
(p<O.05). In PAP and AUT of NYHA IV was the 
maximal increase in FOe following an increase in 
frequency of stimulation smaller than in NF (p<O.05). 
The present study provides evidence for functionally 
relevant differences in the electromechanical coupling 
between the atrial and ventricular myocardium in man. 
The positive FFR in AUT of NYHA IV may support 
ventricular filling even in diseased human hearts. 
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733·5 9:30 
Inhibition of Coronary Nitric Oxide Release Decreases 
Left Ventricular Contractility in Dogs 
David 1. Lefer. David M. Flynn. Timothy 1. McMahon. Alan N. 
Tenaglia, Philip J. Kadowitz. and Andrew J. Buda 
Cardiology Section and Dept. Of Phannacology. Tulane University 
School of Medicine. New Orleans. LA 
Although previous studies have demonstrated that basal 
release of nitric oxide (NO) from the coronary endothelium is 
critical for the maintenance of coronary vascular homeostasis. the 
effects of NO on myocardial contractility in vivo are largely 
unknown. We investigated the effects of infusion of the NO 
synthase inhibitor, N(I)·nitro-L-arginine methyl ester (L-NAME, 3 
mg/kg), into the left circumflex coronary artery (LCx) on release 
of NO, LCx blood flow, and regional myocardial contractility in 
nine anesthetized, open-chest dogs. Injections of the endothelium•
dependent vasodilators, acetylcholine (ACh, 0.3 j.lg) and 
substance P (SP, 3.0 pmol), significantly (p<O.05) increased LCx 
blood flow by 178 ± 16% and 158 ± 20% respectively under 
baseline conditions. In contrast, administration of L-NAME 
significantly (p<O.OI) attenuated the increase in LCx blood flow 
elicited by ACh and SP thus confinning that basal NO production 
was inhibited. L-NAME administration significantly (p<0.05) 
reduced +dP/dt from 1995 ± 144 to 1675 ± 121 mmHg/s. 
Furthermore, regional myocardial segment shortening in the LCx 
region was depressed by L-NAME from 14.1 ± 1.8 % to 10.4 ± 
1.0%. (p<O.05). L-NAME infusion reduced LCx blood flow 
from 52 ± 5 to 45 ± 5 ml/min (p=NS). Thus, the L-NAME 
induced decrease in myocardial contractility was disproportionate 
to the decrease in LCx blood flow. These data strongly suggest 
that basal release of NO by the coronary circulation may playa 
direct role in the maintenance of normal myocardial contractile 
function. 
733·6 9:45 
Impaired Vagal Control 01 Heart Rate In Dogs with Developing Left Ventricular 
Dysfunction and Heart Failure 
Toru Kinugawa and Mark E. Dibner.!)unlap. Department of Veterans Affairs Medical 
Center and Case Western Reserve University, Cleveland, Ohio. 
Background: Autonomic control is impaired in heart failure (HF). This study 
determined H decreased vagal influences are apparent in conscious dogs wfth 
developing left ventricular dysfunction (LVD) due to rapid pacing. We also studied 
the relative contributions of sympathetic and parasylT4lathetic tone to heart rate in 
HF. Methods: Mean RR interval (RR) and standard deviation of RR (STD, an 
index of central vagal outflow) were measured before and aiter muscarinic receptor 
blockade wfth atropine (100 ITl!)'kg), JHllockade wfth propranolol (0.2 mg/kg), or 
both. Studies were repeated at 4, 7, and 11 days of pacing and at HF (in sinus 
rhythm). The difference between baseline and post-atropine RR was used as an 
index of 'resting vagal tone.' Results: see Table (mean±SE; all measurements in 
msec, 'p<O.05 vs. day 0). 
day 0 
RR (baseline) 597:t25 
STD 113±19 
~RR (post-atropine) 335:t28 
~RR (post-propranolol) 232±84 
RR (double blockade) 353±13 
~ 
476±18 
47±6' 
143±17' 
l...Q§Y§. 
524±31 
62±15 
198±32' 
11 days 
464±36 
4O±10' 
169±31 , 
HF 
385±14' 
13:t2' 
11±6' 
69±24' 
441±10' 
Conclusions: 1) central vagal outflow, and the contribution of vagal tone to heart 
rate are reduced vel)' early in developing LVD; 2) the SYlT4lathetic contribution to 
heart rate is less in fully developed HF (colT4lared to pre-pacing), possibly due to 
down-regulation of p-receptors; and 3) intrinsic heart rate is slower in HF. These 
findings suggest that impaired vagal tone contributes to derangements in neural 
control early in the development of the HF syndrome. Assessment of vagal control 
via measurement of RR interval before and aiter cholinergic blockade can be used 
as a marker for autonomic dysfunction in LVD, and could be used as a marker in 
patients wfth LVD who are at risk for developing HF. 
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Quantitative Growth Factor and Cytokine Profile in Human Primary Atheroma 
and Restenosis Tissue 
Conor F. Lundergan, Terence Phillips, Joanna J. Chmielinska, EDen 
Eisenhower. Richard J. Katz. George Washington University. Washington. 
D.C. 
Vascular smooth muscle ceD (VSMC) proliferation is common to primary 
atheroma and restenosis tissue post PTCA There is a paucity of ill vivo 
quantitative data documenting growth factor or cytokine presence in human 
atherosclerotic tissue. We obtained tissue samples from 20 patients by 
directional coronary atherectomy. Group I consisted of 12 samples from 
primary atheromas. Group II consisted of 8 samples of restenotic tissue 
obtained 4-6 months post PTCA Normal human internal mammary arteries, 
N =4, were used as control tissue. Quantitative tissue content of bFGF, PDGF, 
IGF-l, TGF-p, lNFa. IFN-y and IL-l and 1L-2 were determined in Group I 
and Group II and compared to control. Tissue growth factors and cytokines 
were quantified by indirect ELISA of solubilized tissue extracts using human 
monoclonal antibodies. Results are expressed as pglug of extracted protein. 
Values are mean ± SEM. 
Control 
Group I 
GroupII 
Control 
Group I 
Group II 
PDGF 
15±3.3 38±9.7 
784±152* 862±144* 
1045±87* 1238±3S* 
TGF-B IGF-l 
49±3.7 33±6.3 
509±116 349±84 
792±141* 847 ± 205" 
25±4.5 
724±156* 
lOl2±131* 
IFN-y 
2l±2.3 
495±117 
918±102'* 
TNF-a 
47±6.6 
627±168 
1080±199* 
1L-2 
23±4.0 
552±176 
560±155 
._----------------------------------------------------------------
* =p<0.05 vs. control; 4=p<0.05 Group II vs. Group I 
Conclusions: These results are the first demonstration in human coronary 
material of potent growth factors in atheromata and restenosis lesions. 
Moreover, the high concentrations of the inflammatory cytokines IL-l, lNF-a 
and IFN-y in restenotis samples suggests a macrophage mediated mechanism 
for this unique phenomena. 
734·2 8:45 
Increased Exp",sslon of Cbemokine - Beta Proteins In Human Restenotlc 
Coronary Artery Lesions Following Angioplasty 
Ramanath S. Rao, Stephen M. Factor, Mark A. Menegus, E. Scott Monrad, 
Barbara Sherry, Mark A. Greenberg. Joan W. Berman. Albert Einstein 
College of Medicine, Montefiore Medical Center, Bronx, NY and the Picower 
Institute for Medical Research, Manhasset, NY 
A role for monocyte-macrophages (Mo) in atherosclerotic plaque 
development is established. Recently Mo were identified in human coronary 
artery (HCA) restenotic lesions. To assess Mo recruitment in vessels prone to 
restenosis, chemokine beta proteins: monocyte chemotactic protein-1 (MCP-1) 
and macrophage inflammatory proteins (MIP) - 1a and 1B were examined in 
HCA biopsies obtained by directional coronary atherectomy. 20 Primary (PR) 
and 10 Restenotic (RE) specimens from 30 patients were compared for 
expression of MCP-1, MIP-1a and 1B by immunocytochemistry and degree of 
ceUularity on histopathology. Sections were scored, based on number of 
positively stained ceUs per HPF, by a "blinded" observer as NEGATIVE, 
MILD 1-2 (M), MODERATE 3-4 (MOD) or HIGH 5-6 (H) reactivity. Nine 
of 10 RE (90%) specimens showed reactivity for MCP-1, MIP-1a and 1B (3/9 
Hand 6/9 MOD) while only 4 of 20 PR (20%) were 2/20 MOD and 2/20 M 
positive (p<0.OO5). All specimens reactive for MCP-1 were also reactive for 
both MIP-la and lB. None of the 16 PR specimens negative for MCP-1 were 
reactive for MIP-1a or lB. The 9 RE specimens reactive for the 3 chemokines 
also had marked ceUularity (foam, spindle and stellate ceUs) on histologic 
examination, while 4 positive PR specimens contained only minimal cellularity. 
In conclusion, restenotic HCA lesions express significant amounts of the 
chemokine-beta proteins MCP-1, MIP-1a and lB. These chemokines may play 
a role in the recruitment of Mo into damaged sites of HCA and the 
subsequent development of coronary restenosis. 
124A ABSTRACfS 
734-3 9:00 
Local Release of Endothelin In Human Coronary Arteries 
In Response to Balloon Angioplasty. 
Amir Lennan, David R. Holmes Ir, Kirk N. Garratt, Guy S. Reeder, 
Malcolm R. Bell, Iohn C. Burnen Ir., Mayo Clinic, Rochester, MN 
Endothelin (ET) is a potent coronary vasoconstrictor peptide of 
endothelial cell origin which is released in response to both chemical 
and mechanical factors in vitro. Previous studies documented that 
percutaneous coronary balloon angioplasty (PrCA) is associated with 
coronary vasoconstriction by mechanisms which are undefmed. To 
date, the effect of direct mechanical stress on local ET release from the 
coronary vascular wall in vivo is not defined. The current study was 
designed to test the hypothesis that direct mechanical stress on the 
coronary vascular wall induced by PrCA will result in local ET release 
into the coronary circulation. In order to test this hypothesis coronary 
ET was detennined locally proximal and distal to coronary lesion pre 
(Pre) and post (Post) PrCA in 20 patients and correlated with the 
pressure and duration of balloon inflation. 
PrePrCA 
PostPrCA 
A Change 
Proximal ET (pglml) 
9.5±1.0 
9.6±1.5 
0.2±0.8 
Distal ET (pglml) 
8.4±O.9 
16.4±2.0* 
9.0±1.l t 
A change=(ET post PrCA-ET pre PrCA), *p<o.05 vs. pre PrCA, 
tp<O.05 vs. proximal. The correlation between the increase in 
coronary endothelin and the degree of mechanical stress (pressure of 
inflation x duration of inflation) was r=D.71, p<o.Ol. 
This study demonstrates that mechanical stimulation of the coronary 
vascular wall in humans in vivo is a mechanism for local ET release. 
This study also suggests a role for ET in the coronary vascular 
response following PrCA. 
734-4 9:15 
Immunohistologic Features In CAVEAT Biopsies from Directional 
Atherectomy prone to Restenoses 
Peter Gonschior, Andreas Nerlich2, Brigitte Mack, Michael Fleuchaus, 
Berthold Holling; Med. Deptartment I; 2lnst. Pathology, University Munich; 
Germany' 
Elective directional coronary atherectomy (DCA) was compared to 
balloon angioplasty in 61 patients. To determine differences in DCA 
biopsies prone to restenoses immunhistochemical staining was performed. 
Analysis included various monoclonal and polyclonal anti-bodies (MIB 
detecting KI-67; a-SMC actin; desmin; CD 68 as macrophage marker, 
collagen III, IV). Immunohistochemistry was performed using cryosections 
(2-4l!m) of biopsies obtained by directional coronary atherectomy (60 
samples from 31 patients). Analysis ilcluded 15 patients that developed 
restenosis (RPL). Histomorphometry was used for quan@cation. More 
than 200/cells per 0.6mm2 was defined as cell·rich compartments. A 
relational database system that files all relevant clinical, histological. and 
irrvnunohistological data acquisHed by analyzation of tissue specimen was 
used (4th Dimension, ACIUS; Paris, France). All data are given as percent 
of all present cells. The lesions consisted quantHatively of 78.8% intima 
(restenoses prone lesions; RPL: 86.7%) and 8.6% media (RPL: 10%). 
51.1% (RPL: 50%) of the intimal area was comprised of low cellularity and 
41.2% (RPL: 43.4%) of high cellularity and foam-cells. 34.9% of cells were 
posHive for macrophage marker (RPL: 9.35%, p< 0.001) 79.5% expressed 
a·SMC actin (RPL: 64.4%, p< 0.001) and 47% desmin (RPL: 4.1%), 
typical foam cells were negative for a·actin. Collagen III and IV were found 
in 70.5% and 69% of all cells (RPL: 60% and 57%). MIB posHive cells were 
found in 4.8% of biopsies (RPL: 33.3%, p< 0.001). 
In human arteriosclerotic lesions prone to restenoses we found a signHicant 
reduction of extracellular matrix, basement membrane, contractile 
filaments and macrophages. This indicates cellular activation which is 
confirmed by enhanced cellular prolHeration. This data imply the need and 
potential benefHs of a selective antiprol~erative therapy for restenoses 
prophylaxis. ('supported by Sander Stiftung grant no. 90.026.2) 
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734·5 9:30 
Detection of PDGF mRNA In Human Relltenotic Plaque Tissue 
by In Situ Hybrldlzation: ImpUcation for Novel Therapeutic 
Approaches 
Gerhard Baurtedel, Petra Heidemann, JiiIgen Heimerl, Reinhard 
Kandolf. Berthold HOfllng, Dept. of Internal Medicine L University 
of Munich, FRG 
AnImal studies have shown that expression of platelet dertved 
growth factor (PDGF) indicates pathogenetic sIgn1fl.cance for 
vartous Inflammatory processes. Therefore, the detection of PDGF 
mRNA may be of Importance for the fonnatlon of vascular wall 
lesions in man. To detect directly the expression of PDGF·A 
transcrtpts in human artertoscierotic lestons. in situ hybrtdlzatlon 
was penonned with a spec1lJc cDNA·probe for PDGF·A mRNA. 
Tissue samples excised from percutaneously and intraoperativeiy 
reconstructed 8 target lesions (femoral. cororuuy and carotid 
artertes) were stud1ed. In sertal vascular sections of 2/2 intlmal 
lesions with hlgh cellularity. autorad1ograph1c stiver grains were 
detected, whereas no signals were found In Intlmal areas with 
sparse cellulartty and In medtal regions. Add1tlonal studies with 
smooth muscle cells (SMCs) cultivated from human plaque tissue 
showed that PDGF Induced a concentration·dependent stlmulatlon 
of SMC proliferative activity (half·maxlmal effect: 2-4 ng PDGF /ml). 
In SMCs stimulated by 10 ng PDGF/ml. monoclonal anti·PDGF 
(50 ~/ml), decreased SMC proliferation to 16% as compared to 
untreated controls (=100%). The PDGF receptor antagonist 
Suramin (100 mg/ml) blocked replication of serum-stimulated 
SMCs to 58% (p<O.OI: n=8 expertments). 
By In situ hybrtdlzation. PDGF mRNA was detected In cell·rtch 
intimal areas of target lesions from symptomatic patients. The 
expression of PDGF·A mRNA implICates stimulatory effects on SMC 
proliferation in vivo. Therefore, both PDGF antibodies as well as 
PDGF receptor antagoniSts may be effective therapeutic prinCiples 
to suppress neolntlmal fonnation In patients. 
734·6 9:45 
Restenosis Following Directional Coronary Atberectomy is 
Associated witb Innammation and Increased Fibronectin 
Nadine Clausell, Valter C. Lima, Silvana Molossi, Eva Turley, 
A vrum Gotlieb, Marlene Rabinovitch, Peter Liu, Allan Adelman. 
The Toronto Hospital and The Hospital for Sick Children, 
University of Toronto, Toronto, Canada 
Restenosis following coronary intervention remains a challenging 
problem. While the mechanical injury appears to stimulate the 
restenotic process associated with increased cellularity and matrix 
production, the pathobiologic mechanisms involved are poorly 
understood. We demonstrated experimentally that coronary graft 
arteriopathy (GA) is related to increased expression of cytokines, 
interleukin (IL)-lB and tumor necrosis factor (TNF).a, leading to 
accumulation of fibronectin (FN) in the matrix and smooth muscle 
cells in the subendothelium. Also, neutralization of TNF·a activity 
reduced IL-lB and FN, as well as the number and severity of GA 
lesions. Therefore, we hypothesized that a similar process might 
result from the initial mechanical injury associated with directional 
coronary atherectomy (DCA). We studied tissue recovered from a 
selective group of nine patients who had DCA perfonned for 
primary atherosclerotic lesion (P) followed by a repeat DCA for 
restenosis (R) within 5.5 ± 1.06 months. Immunohistochemistry 
was perfonned in both P and R specimens using monoclonal 
antibodies (Ab) to FN, T cells, macrophages and polyclonal Ab to 
JL-lB and to the receptor for hyaluronan mediated motility 
(RHAMM), a surface molecule characteristic of migrating cells. In 
the R compared to the P lesions, we observed increased immune•
staining for macrophages (42% of patients), T cells (57%), IL-IB 
(44%), FN (62%), and RHAMM (55%). This suggests that the 
pathophysiology of restenosis involves an inflammatory process 
similar to GA, associated with production of fibronectin and the 
induction of migrating smooth muscle cells. It might therefore be 
proposed that locally delivered anti-cytokine agents may modulate 
these changes and interfere with the development of Iestenosis. 
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735-1 8:30 
T .. __ AIriII Delllrillltion In Two Canine Models of AIriII Fibrllation 
Jose Ortiz, Shinichi Niw.no, H.ruhiko Abe, X.vier Gonz.lez, 'Gregory M. Ayers, 
Albert L. W.ldo, c .... W.stern R .... rv. University, Cleveland, OH 
Pr.vious ltUdi.s of atrial defibrill.tion (ADF) in sheep have shown the fe.sibility 
of. transvcnous .pproacb to convert atrial fibrill.tion (AFib). We studied 8 dogs 
to determine ADF thresholds (ADFTs) and to ev.luate the importance of electrode 
length and loc.tion. Four steril. pericarditis and four ~-methacboline AFib dogs 
were studied. The same electrode catheter was used to deliver the ADF shocks from 
either the distal three cm or six cm of the c.theter tip. We compar.d ADFTs for 
shocks delivered with each electrode length from an electrode catheter placed in the 
right atrium (RA) [either in the right atri.lappendage (RAA) or in the posterior RA 
(PRA)), and.n electrode catheter in the c.rdi.c venous system [either.t the obtuse 
margin (OM) or under the left atri.1 .ppendage (LAA)]. After AFib induction, 
ADFTs were determined starting.t SOY, incre.sing the intensity by lOY Isbock until 
AFib w.s termin.ted. AFib was reinitiated and 20 shocks were delivered at this 
l.tter intensity to determine the % success. If > 10% and <90% successful, this 
shock intensity w.s considered the ADFT Data shown are mean: SEM 
ADFT LAA-PRA OM-PRA LAA-RAA OM-RAA 
Vol .... (V) 163: 8.8 162 ± 8.9 109: 8.8 107: 8.8 
bell!Y (J) 1.08: 0.11 1.10: 0.11 0.46: 0.11 0.45: 0.11 
Left-Rill'" 3em-3em 3em-6em 6em-3em 6em-6cm 
Vol .... (V) 146: 8.0 141: 10.3 13S: 9.4 117:9.4 
bem (J) 0.93: 0.10 0.80: 0.12 0.77:0.11 0.58 : 0.11 
Vectors that included the RAA location had. significantly lower ADFT compared 
to vectors that included PRA (p<O.OOI), while there was no difference between 
eith.r left side location (p>O.S). Th. ADFTs w.re significantly lower using six cm 
rath.r than three cm long .I.ctrodes in both atria (p<O.OS). Short runs of ventricular 
arrhythmias « 10 beats) were only observed after shocks were delivered with a 
preceding RR interval < 4S0 msec. CONCLUSIONS: In these dog models of AFib, 
ADF can be successfully achieved with energies :s; IJ. The best electrode locations 
for ADF are RAA with either cardiac venous site (OM or LAA). Six cm electrodes 
had lower energy r.quir.m.nts than three cm electrodes. 
735-2 8:45 
R1aht Atrial Electrode Location for TransvenoUl Atrial Denbrillation 
Gregory M. Ayers. Marina L nina, Darrell O. Wagner. William A. 
Sirokman. Jerry C. Griffin, and Clif A. Alfemess. InControl. Inc .• 
Redmond, WA 
Previous studies of transvenous atriaJ defibrillalion have shown that right 
to left shock vectors m superior. We compared atrial defibrillation 
thresholds (ADFI') for &bocks delivered between a calbeter electrode in 
either the great cardiac vein (GCV) or in the coronary sinus with its tip at 
the obtuse margin (OM) and in three locations in the right atrium; right 
atrial appendage (RAA). lareral right atrium with tip in the IIlIero-lateral 
A-V groove (ALRA). J-lead with electrode located in the superior right 
atrium (RAJ). All electrodes were 6 em long coils on a 6 Fr. mapping 
catheter. 
In 9 aduh sheep (62 :i: 9 kg). ADPT were determined for It least 3 of the 
location combinations. Following Induction of atrial fibrillation (AF) with 
rapid atrial pacing. ADPT were determined starting at BOV. incrementing 
the intensity by 10V until AF was terminated. Twenty shocks were 
delivered at this intensity to determine the percent success. If greater than 
10% success was not achieved. the shock intensity was incremented by 
lOY. The intensity that achieved greater than 10% success was the ADPT. 
Shown m the mean and standard deviations. 
Location N Voltage (V) Energy (J) 
GCV·RAA 9 132.0:i: 27.7 0.68 ± 0.26 
GCV-ALRA 9 135.5± 27.9 0.73±0.28 
OM·RAA 8 147.5:i:37.7 0.92:i:0.48 
OM-ALRA 9 138.8:i:28.9 0.n:i:0.31 
GCV-RAJ 5 176.0:i: 39.1 1.25 ± 0.52 
The RAJ site had • significantly higher ADFT than any of the other four 
combinations tested (p<O.OO9). None of the other combinations were 
significantly different from each other (p>O.l). Overall average percent 
success at threshold was '1%21%. Conclusions' 1) ADFI's from right 
atrial electrode positions in the mid-low right atrium were similar. 2) The 
OM location resulted in ADFT comparable to the GCV location. 3) The 
RAJ position resulted in higher thresholds. 
ABSTRACTS 
735·3 
Clinical Efficacy and Safety of Atrial Defibrillation Using Current 
Nonthoracotomy Endocardial Lead Configurations: A Prospective 
Randomized Study 
9:00 
·Sanjeev Saksena, ·Luc Mongeon, Ryszard Krol, Sankar Varanasi, 
Theofilos Kolettis, Philip Mathew, ·Paul DeGroot, 'Rahul Mehra. 
Eastern Heart Institute, Passaic & UMD-NJ Medical School, Newark, NJ 
The feasibility of intracavitary atrial defibrillation [AD] has been 
demonstrated but the clinical efficacy, pt safety or tolerance & OPtimal 
lead configuration for this therapy in symptomatic pts with atrial 
fibrillation [AFI is not known. We evaluated the efficacy of AD using 
biphasic waveform endocardial shocks and currently available 
nonthoracotomy lead systems in a prospective randomized study. 10 
pts with symptomatic AF, mean age 70.±.9 yrs, mean LA diameter 
4.5.±.0.6 cm, mean LV ejection fraction 39.±.17%, underwent insertion 
of 2 transvenous Medtronic model 10285 leads with a cutaneous 
thoracic patch electrode. Lead configurations randomly evaluated in 
each pt were RV-RA, RV-SVC & RA-patch. AF was present or induced 
& a preselected shock protocol (1-20J) initiated to determine 
defibrillation threshold [OFT) for each lead configuration. R wave 
synchronous shocks starting with 1 J were delivered without 
anaesthesia to determine pt tolerance. ~: 2 pts had inducible 
atrial flutter. 26 episodes of AF (5 spontaneous; 21 induced) were 
tested for OFT in 8 pts & 124 endocardial shocks (mean 151pt) 
delivered. Mean DFT(J) OFT current(amps) Impedance(ohms) 
RV-SVC 10.8+6 5.8+1.8 70+15 
RV-RA 10.4:±:11.2 6.7:±:5 57:±:18 
RA-patch 17.5.±.9.7 6.2.±.2.8 87.±.13·,·· 
.p .::;..02 vs RV-SVC; •• p < .01 vs RV-RA 
8/10 pts perceived .::;.2J shocks as uncomfortable but not painful. 
Shocks did not produce ventricular tachyarrhythmias in any pt. 
Conclusions: 1) Catheter AD is feasible & safe with nonthoracotomy 
lead configurations presently used for ventricular defibrillation at 
energies within the capability of current defibrillator pulse generators. 
2) Intermittent low or intermediate energy shocks are an acceptable 
therapy for paroxysmal AF in symptomatic pts. 
735·4 9:15 
Successful Atrial Defibrillation Using Temporary Pericardial Electrodes 
Jose Ortiz, Mary C. Sokoloski, Shinichi Niwano, Harubiko Abc. X.vi.r Gonzal.z, 
'Gregory M. Ayers, 'elif A. Alferness, Albert L. Waldo, CWRU, Cleveland, OH 
The occurr.nc. of atrial fibrillation (AFib) after open-beart surg.ry il a significant 
problem for many pati.nts regardless of the pr.operativ. arrbythmia history. Using 
a customiz.d software program and insulated temporary wire .Iectrodes bared for 
six cm at the tip, we t.sted the bypoth.sis that atrial defibrillation (ADF) could be 
satisfactorily achi.ved with .n.rgy discharg.s below IJ. Six AFib steril. pericarditis 
model dogs (m.an body w.ight 28.4 : 6 kg) with .I.ctrode. ov.rlying both atrial 
free walls w.r. studied. On postoperative day 2, AFib was induc.d with rapid atri.1 
pacing. ADF thresholds (ADFTs) were obtain.d using the pericardial electrodes with 
the chest clo ... d and th.n with the ch.st open. ADFTs were also obtain.d using six 
cm .I.ctrode cath.ters, on. placed in the right atrial appendage and the oth.r in the 
great cardiac vein (under the left atrial appendage). ADFTs were determined starting 
at SOY, increm.nting the intensity by 10V/shock until AFib was terminated. AFib 
was reinitiated and 20 shocks w.re deliv.red at this intensity to determine the % 
succ.ss. If > I 0% and <9O"Ao successful, this shock intensity was considered the 
ADFT. RESULTS: In 6/6 dogs, induc.d AFib was terminated by ADF. Data shown 
are mean: SEM 
GrtJlID. Vol""e IV) be"", (.1\ Impeduce (0) 
Chelt ao ... d 103.3 : S.88 0.36: 0.04 62.0: 1.48 
Chelt Oocn 103.3 : S.9O 0.37: 0.04 6S.1 : 1.48 
Clilheten 90.0: S.80 0.30: 0.04 5S.0: 1.40 
Ther. was no difference in voltage or .n.rgy between the three groups (p>O.I),and 
no diff.rence in impedance betw.en chest closed and cbest open (p>O.I). Tbere was 
a significant difference in impedance betw •• n pericardial electrodes and catheters 
(p< 0.01). The mean % success at the ADFT was 42.8 : 18, with no differ.nce 
betw •• n the three groups. No clinicallh.modynamic complication was observed 
.ith.r during electrode plac.ment or shock deliv.ry, and no ventricular arrhythmia 
was induced during the ADF sbocks. CONCLUSIONS: Tb. en.rgy required using 
temporary pericardial electrodes for ADF is below 0.5J. There is no difference in 
voltag. or energy betw.en pericardialand catheter electrodes. ADF using penc.rdial 
.Iectrodes may be a sar. and effective treatment of AFib aft.r open heart surgery. 
125A 
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735-5 9:30 
Transvenous low-energy cardioversion of short-duration 
atrial fibrillation in humans 
Francis D. Murgatroyd, Alistair K. B. Slade, Dympna M. O'Farrell, Edward 
Rowland, David E. Ward, A. John Camm. St George's Hosp~al Medical 
School, london, UK 
Background: In animal models of atrial fibrillation (AF), very low energy 
thresholds for cardioversion have been obtained using shocks delivered 
between transvenous catheters in the coronary sinus and the right atrium. 
We report use of this technique in humans with AF of short duration. 
Methods: Cardioversion was attempted in 11 patients (2 female) 
undergoing eleclrophysiologic study, with AF sustained for between 10 
minutes and 24 hours. Ages ranged from 34 to n years, and left atrial 
diameters from 2.8cm to 4.2cm. In each patient, 3ms+3ms biphasic 
truncated exponential shocks, synchronised with the R wave, were 
delivered between catheters in the coronary sinus and the anterior right 
atrium or ~ appendage, using a purpose-built extemal device. After a test 
shock of 20V «0.1J), repeated shocks at approximately 2 minute intervals 
were given, with 40V increments, up to a maximum of 340V, or until AF 
was terminated. No general anaesthesia was given; after each shock, 
patients were asked to report sensation and were offered sedation. 
Results: Atrial fibrillation spontaneously ceased in the interval between 
shocks in two patients. In 8 out of the remaining 9 patients, atrial 
fibrillation was terminated by shocks of less than 340V. In one of these, a 
junctional tachycardia (his clinical diagnosis) ensued, which was 
terminated by premature stimuli. In one patient, shocks of up to 340V 
(4.5J) were ineffective. The mean charge of successful shocks was 240V 
(SO 48V, range 140-300V), and the mean energy was 2.2J (SO O.8J, range 
0.7-3.4Jl. In general, shocks below 1J were well tolerated, but shocks 
above this level required sedation. No ventricular arrhythmias were 
induced, and no other complications were observed. 
COnclusions: low energy biphasic shocks delivered between the 
coronary sinus and right atrium are effective and safe for terminating AF of 
short duration, with and do not require general anaesthesia. This method 
can be used for AF occurring during electrophysiologic studies, and 
Indicates the possibility of atrial defibrillation by implanted devices. 
735-6, 9:45 
Stability: An ICD Detection Criteria Useful In Discriminating 
Atrial FibriUation from Ventricular Tachycardia 
Steven L. Higgins, Robert S. Lee, Chad E. Farmer, Scot A. Brewster, 
Regional Cardiac Arrhythmia Center, Scripps Memorial Hospital, 
LaJolla,CA 
The stability feature of the CPI Ventak PRx tiered therapy 
I~D . w.as ~Iinically inve~tigate~ t~ confirm its efficacy in 
discnmmatmg between atnal fibnllauon (A fib) and ventricular 
tachycardia (VT). Without this additional detection criterion, patients 
have received unnecessary shocks for rapid A fib mistaken for VT 
when rate alone is the sole criterion for therapy delivery. 
Population/Methods: Thirty-three rhythms were studied in 19 
patients divided into two groups: 11 with A fib (9 males, 2 female; 
6S.4 ± S.5 years of age) and S with VT below 220 bpm (7 males, I 
female; 71.1 ± 9.0 years). In each A fib patient, two Isoproterenol 
accelerated rates were evaluated: lOS.3 ± 9.6 bpm and 153.3 ± 19.3 
bp~. Eleven different VTs (176.5 ± 29.9 bpm) were studied in S 
patients. All rhythms and marker channels were stored on optical disk 
~or later retrieval ~d analysis. Each rhythm was analyzed for 700 
m~rvals whe~ poSSIble, 100 for each of the 7 programmable stability 
wmdows available (S, 16,23, 31, 39, 47 or 55 msec). The stability 
algorithm declares a single interval (R-R) as stable or unstable by 
keeping a running average of the previous 4 cycle lengths ± the 
programmed stability window. The rhythm is declared stable if 80% 
or more of the intervals are classified as stable. 
Results: For the A fib group, the device appropriately classified the 
rhythm as unstable for HIO% of the rhythms analyzed at 8-47 msec 
but only 91 % (20 of 22 rhythms) at the widest 55 msec window. For 
VT, 100% of the rhythms were appropriately classified for all seven 
stability windows, even including the narrowest 8 msec window. 
Conclusion: The stability feature is highly effective in discriminating 
between A fib and VT. If an arbitrary value such as 23 msec is 
programmed safely, individual testing does not appear necessary. We 
recommend the use of the stability feature at the 23 msec window for 
all patients with this ICD who are at risk for rapid atrial fibrillation. 
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736"1 8:30 
Safety of Early IV Dipyridamole Tc-89m Sestamibi SPECT 
Myocardial Perlmon I:mafinl After First Myocardial Infarction 
Gary V. Heller, Kenneth A. Brown, Ronald J. Landin, Stephen B. Haber 
and the IV Dipyridamole Post·MI Study Group. Memorial Hospital 
Brown Uni~ersity, ~vidence,. RI, University of Vermont, Burlin~n, 
VT, NorthSIde Carcbology, IndIanapolis, IN, The DuPont Merck 
Pharmaceutical Company, Billerica, MA. 
To evaluate the safety of early (2-4 days, mean 3.2 ± 0.7 days) 
intravenous dipyridamole (DP) stress Tc-99m Sestamibi (MIBI) SPECT 
imaging, 305 patients (pts) with first myocardial infarction (MI) were 
randomized (3:1) to DP or Control (no procedure). Demographics are 
shown with mean ± 1 SD. 
DP Control P-Value 
Age, years 57.5± 12.5 57.7 ± 12.3 NS 
Numberpts 229 76 
Male 75% 62% NS 
Creatinine kinase peak 1954 ± 1807 1819 ± 1699 NS 
Thrombolytic Therapy 58% 57% NS 
Q Wave Infarction 62% 61% NS 
ECG Location: Anterior 35% 33% NS 
One hundred ninety-two pts underwent the DP test with MIBI imaging 
with the following consequences: no symptoms (31%), chest pain (26%) 
ST abnonnalities (14%), minor complaints (55%). ' 
Aminophylline was given to reverse conditions in 86 (45%) and no pt 
suffered prolonged chest pain (CP), ECG changes, MI or death as a direct 
resul~ of the procedure. During the 24 hours after dOSing, 3 DP pts 
expenenced CP requiring catheterization and 1 pt suffered recurrent MI. 
In the group not receiving DP, 6 pts experienced CP requiring 
catheterization and 1 pt suffered recurrent myocardial infarction during 
the correspondind period 3.2 + 1 day post MI. 
CONCLUSIONS: IV dipyridamole administered early after first MI in 
192 Pt~ resul~d in no increased adverse complications during or 24 
hours Immediately after the procedure when compared with a control 
group. Therefore, IV dipyridamole is relatively safe to use as a 
pharmacologic vasodilator for myocardial perfusion imaging soon after 
myocardial infarction. 
736-2 8:45 
Arbutamlne Stress U.lng 8 Computerized Cloled-loop Delivery 
System: A Multicenter Trial of Dlagno.tlc Accuracy with Thalllum-201 
SPECT 
"Hosen Kist, Cedars Sinai Medical Center, "Jeffrey A. leppo, "Abdulmassih 
S. Iskandrian, "Mark R. Starling, and "Daniel S. Berman forlhe Intematlonal 
Arbutamine Study Group. 
Arbutamine (Arb), a potent beta-agonist, was evaluated as a phermacologic 
stress agent with thallium-201 SPECT (TI-SPECT) In a mutticenter trial. Arb 
was administered by a novel, computerized, closed-loop (Cl) system which 
measures h~art rate (HR) and adjusts Arb infusion 10 achieve 8 predefined 
rate of HR nse and target HR. SensHivity for coronary artery disease (CAD) 
was. evalu~ted .In patients (Group 1, n-125) with quantkative coronary 
anglOgraplllc eVidence of CAD (~50% stenosis of any major artery) within 
:1:14 ~e.eks of stress; 73 (58%) of these patients also exercised (Ex). 
S~ecHICHY fo~ ~sence of CAD was determined in patients (Group 2, na63) 
wHh ~98% tikehhood of 5-year survival according to the Duke exercise 
~omog~am. Endpoints for stopping stress were intolerable symptoms, ECG 
ISCheml8 (~mm ST deviation), target HR or plateau of HR response. TI· 
SPECT and angiographic data were analyzed by blinded COre Laboratory 
observers using previously validated methods for analysis. 
SensHiv~y (Group 1): Total Performing Arb and Ex 
Am Jl:.. Am flI n.: 
All Evaluable TI·SPECT 87% 112 94% 97% 63 
No History of Infarction 79% 57 91% 94% 32 
SpecHicHy: In Group 2, Arbm·SPECT specHicfty was 90%. 
Adverse events In Arb patients: The most frequent events were tremor 
(22%), heada~e (10%), flushing.(10%), dizziness (8%), paraesthesia (8%) 
and hypotenSIOn (6%). Arrhytlvnl8s (7.5%) Included premature ventricular 
complexes. (2.8%), junctional rhythm (1.4%), nonsustained VT (0.9%), 
supraventrICular tachycardia (0.9%) and atrial fibrillation (O.9%).,There were 
no deaths, myocardial infarction, sustained VT or VF associated wHh Arb. In 
general, events were well tolerated and resolved w~h discontinuation of Arb 
Conclysion: Arbutamlne, administered by the Cl system, is an effectiv~ 
attemative pharmacologic stress method for detecting CAD by TI·SPECT due 
to fts high sensftivfty and specHic~y for CAD, concordance wfth the resuHs of 
ExlTI·SPECT and acceptable safety profile. 
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736·3 9:00 
High Dose Dipyridamole Compared with Standard infusion Falls to 
Further Augment Coronary Hyperemia In Patients 
Richard G. Bach. Bassam Al-Joundi. Monon J. Kern. Thomas J. 
Donohue. Eugene Caracciolo. Frank V. Aguirre. Thomas Wolford and 
D. Douglas Miller; St Louis University Medical Center. St Louis. MO. 
High dose dipyridamole has been proposed as a means to increase 
myocardial blood flow heterogeneity and improve perfusion imaging 
defect detection over that achieved by standard dose dipyridamole 
(DIPY) infusion. To determine the relative coronary flow and peripheral 
hemodynamic effect profiles of high versus high versus standard dose 
DIPY infusion. intracoronary (IC) blood flow velocity (average peak 
velocity. APV. cm/s) was measured continuously using a O.OlS" 
Doppler guidewire in normal left anterior descending arteries of 7 
patients at cardiac catheterization before and during hyperemic stress 
with standard dose (0.56 mg/kg. IV) then high dose (0.84 mg/kg. IV) 
D1PY. Maximal hyperemia and coronary flow reserve (CPR. 
hyperemiC/basal APV) for comparison were obtained using IC adenosine 
(12 11g). High dose DIPY hyperemia reversal by aminophylline (2SOmg. 
IV) was also compared to reversal of standard dose DIPY in 10 similarly 
studied patients. Results (mean±SD; HR=hean rate. MAP=mean arterial 
pressyre): 
awl Adenosine Standard D1PY 
APV 19±4 56±to 55±19 
a=R 3.0±.7 2.9±1 
HR 76±S 96±13· 
MAP 9O±12 83±12 
.p= (Xl! xs Basal: to= 04 ys Standard: all other p=NS 
High DIPY 
54±16 
2.S±.8 
98±21· 
75±13t 
There was no difference in maximal hyperemic flow velocity or CPR 
induced by adenosine. standard dose DIPY or high dose DIPY. 
Hyperemic CPR and the % change in either HR (r2 = .03) or MAP (r2 = 
.23) were not significantly correlated. After IV aminophylline. high dose 
DIPY peak hyperemic flow was only 20±48% reversed. compared with 
9O±12% reversal of standard dose peak hyperemic flow (p<.OOI). 
We conclude that there is no incremental coronary hyperemia or CPR 
augmentation using high dose DIPY compared with standard DIPY 
infusion. Funhermore. coronary hyperemia reversal by aminophylline is 
attenuated following high dose DIPY. 
736·4 9:15 
Effects of Modified Pharmacologic Stress Approaches 
on Hyperemic Myocardial Blood Flow 
lohannes Czemin. Martin Auerbach. Victor Dominquez. Karl Sun. 
Egbert Nitzsche. Marcelo DiCarli, Michael Phelps. Heinrich 
Schelbert. UCLA School of Medicine, Los Angeles. CA 
Higher doses of IV dipyridamole or addition of isometric handgrip 
have been proposed for increasing hyperemic myocardial blood 
flows (MBF) in order to improve the accuracy of CAD detection 
with pharmacologic stress/nuclear imaging. The effects of such 
interventions on hyperemic MBF were examined in 8 healthy males 
(age 24±6 years) during regular dose dipyridamole (IV 0.56 
mg/kg). high dose dipyridamole (IV 0.80 mg/kg) and regular dose 
dipyridamole combined with the isometric handgrip using N-l3 
ammonia and PET (2 compartment model). Heart rate. mean aortic 
blood pressure and rate pressure products remained unchanged from 
regular to high dose dipyridamole (93±7 vs 98±8 blmin, 90±8 vs 
84±1O mm Hg, 11525±1198 vs l2015±l536; p=NS) but increased 
to 103±6 b/min, 104±ll mm Hg and 1477o±l41O during isometric 
hand grip (p<O.05). MBF averaged 2.liO.3 mUg/min during regular 
dose dipyridamole. 2.0±0.2 during high dose dipyridamole but 
declined with isometric hand grip (1.75±O.3 mUg/min; 1'<11.05 vs 
low dose and high dose). Coronary resistance was similar during 
regular and high dose dipyridamole (43.9±6.3 vs 42.4±5.4 mm 
Hg/mUmin/g but increased during isometric handgrip (60.4±13 mm 
Hg/mllg/min; p<O.OOI). The results indicate that dipyridamole 
exerts its maximal vasodilatory response already with regular dose 
schedule. Addition of isometric handgrip increases coronary driving 
pressure but reduces rather than increases the vasodilatory response 
to IV dipyridamole probably because of higher extravascular 
compressive forces. We conclude that high dose dipyridamole or 
addition of isometric handgrip are unlikely to enhance the sensitivity 
of non-invasive stress testing for the detection of coronary artery 
disease. 
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736-5 9:30 
WRC-470 (2-cycJohexylmethylhydrazinoadenosine): A New Selective 
Adenosine A" Receptor Agonist with Potential for Pharmacologic Stress 
Imaging 
David K. Glover, Mirta Ruiz. Bruce A. Koplan. Teny R. Allen. Vladimir 
Kryzhanovski, William Smith, Denny D. Watson. Richard J. Barrett, 'George A. 
Beller. Univ of Virginia, Charlottesville, VA and Whitby Research. Richmond, VA 
WRC-470 (WRC) is a potent, short-acting and selective (I4,()()()'fold vs. AI 
receptors) adenosine (ADO) A" receptor agonist. Studies were conducted in two 
groups of open-chest, anesthetized dogs to determine the effect of WRC on LAD 
and LCX coronary flows and systemic hemodynamics. and to assess its potential 
as a pharmacologic stress agent during Tl-201 (TI) imaging. Ten min i.v. 
infusions of WRC (0.1-3 Ilglkglmin) in 5 dogs produced dose-related increments 
(up to 5-fold) in LAD and LCX flows, but no significant changes in arterial 
pressure (AP) or heart rate (HR). ADO-induced coronary dilation was always 
associated with systemic hypotension. To determine the potential use of WRC as 
a pharmacologic stress agent for imaging, we compared the hemodynamic response 
of WRC (0.6Ilglkglmin x 10 min) with ADO (250 Ilglkglmin) in 5 additional dogs 
with critical LAD stenoses. Microspheres were used to measure regional blood 
flow at rest and at peak ADO or WRC stress. Tl (1.0 mCi) was administered with 
WRC stress. After each experiment, quantitative planar imaging of heart slices 
and gamma well counting was performed. Infusion of ADO or WRC had no 
effect on HR, left atrial pressure, or LV dP/dt, but caused the following changes 
in AP, LAD and LCX flows. and in the transmural LADILCX microsphere flow 
ratio (mean±SE, *pg).02 vs rest, +p=(J.02 vs ADO): 
Restl ADO Rest2 WRC 
AP (mmHg) 97±4 73±4* 92±4 S7±5 
LAD (mllmin) 21±3 19±3 l8±2 21±3 
LCX (mllmin) 29±3 79±JO' 26±1 1l3±24* 
Flow ratio 0.9±O.06 0.5±O.OS· 1.0±0.04 0.4±O.OS*+ 
The TI LADILCX activity ratio (0.53±O.OSI slightly underestimated the WRC flow 
disparity (0.4) (p=O.OI), due to the plateau in tracer extraction. On slice images, 
antero-septal defects wcre readily apparent in all dogs. The mean defect ratio 
(LADILCX) of O.6I±O.09 was similar to that produced by ADO stress in our 
previous studies. Thus, these data indicate that WRC-470 is a potent, short-acting, 
dose-responsive adenosine Au. receptor-selective agonist with potential utility as 
a pharmacologic stress agent during non-invasive imaging. 
736·6 9:45 
Dobutamlne Alterl Flow end Functional Relarve In a Region 
Remote to a Critical Coronary Stenolll: Impllcatlonl for 
Dobutamlne Stre.. Imaging 
Albert J. Sinusas, Edouard Daher. Mitchell T. Saltzberg. QingXln Shi. 
Donald P. Dione, Michael J. Singer, Frans J. Th. Wackers. Barry L. Zaret, 
Lawrence Young. Yale University. New Haven. CT 
Dobutamine (DB) perfusion scintigraphy and 2D-echocardiography have 
been used for evaluation of flow (FL) and functional (FX) reserve for 
assessment of ischemia and viability. The effects of DB on FL and FX in the 
region remote to a critical stenosis (STEN) remain undefined. We 
evaluated regional FL and FX reserve In 12 open chested dogs during 
graded DB stress (S and 10 I1g1kglmin). We evaluated CONTROL dogs 
without a stenoSis (n = 6) and dogs with a LAD STENOSIS (n = 6). In which 
reactive hyperemia was ablated. Myocardial thickening fraction (% TF) in the 
stenotic LAD and control L.CX region was measured at baseline and during 
DB stress wHh sonomlcrometers. FL was assessed wHh radiolabeled 
microspheres. Measured parameters were: heart rate (HR). FLOW and 
%TF. FLOW and %TF were expressed as a % baseline. 
HR(bpm) 
LAD FLOW 
%TF 
LCX FLOW 
%TF 
CONTROL (n = 6) STENOSIS (n " 6) 
DBS DB10 STEN DBS DB10 
118±6* 134±7* 117±6 144±12 IS4±7* 
136±16 IS3±20* 87±17 149±20* 133±23 
18H39* 221±49 101±4 11S±18 137±24 
13S±40 IS8±S4* 84±9 173±22* 129±22 
12S±IS* 13S±21* 91±4 114±17 111±20 
r p < 0.05 vs baseIfle) 
As expected. in CONTROL dogs graded DB produced progressive 
increases in FL and FX in LAD and LCX regions. In dogs with a critical LAD 
STENOSIS, DB (S I1g1kglmin) increased LAD and LCX FL atthough FX 
reserve was impaired. At higher doses of DB (10 I1g1kglmin). FL and FX 
reserve were reduced in remote LeX tenitory as well as the stenotic LAD 
tenitory. 
Thus. DB has graded effects on both FL and FX reserve. In the presance 
of a critical stenoSis. DB aHers FL and FX reserve in areas remote to the 
stenosis. This effect may reduce DB induced heterogeneity of FL and FX. 
potentially reducing the ability 01 DB stress imaging to identify ischemia. 
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Red Cells and Plasma Proteins are Required tor 
Echocardioeraphlc Contrast Formation In Human Blood 
Diane Fatkin, Thanasis Loupas, Joyce Low, Michael Feneley. 
St Vincent's Hospital, and Division of Radiophysics, CSIRO, 
Sydney, Australia 
Spontaneous echo contrast (SEC) has been attributed to 
increased ultrasonic backscatter from aggregates of cellular 
components of blood at low shear rates, but the cause of this 
phenomenon remains controversial. The role of red cell and 
platelet aggregation was evaluated using human blood in an in•
vitro model simulating atrial flow conditions. Venous blood 
from 6 healthy volunteers was centrifuged to obtain separate 
fractions of red cells (RC), platelet·rich plasma (PRP) and 
platelet-poor plasma (PPP) , which were studied in various 
combinations in a cylindrical chamber in which non-laminar 
flow was generated by a magnetically-driven rotating device. 
Echocardiographic images of the chamber, obtained with a 
transesophageal echocardiographic probe (5MHz), were digitised 
on a graded gray scale (O=black, 255=white) for video•
densitometric (VD) analysis. VD scores at high, low, and zero 
flow velocities were: 
Blood component Velocity (cmlsec) 
25 5 0 
Whole blood(WB) 9.5± 1.5 21.3 ± 5.8 52.6 ± 9.2 
WB + ADP 9.6 ± 1.2 20.4± 6.9 53.1 ± 10.9 
RC + PPP 9.6 ± 1.6 19.0 ± 4.1 54.4 ± 15.4 
RC + saline 11.5 ± 1.9 9.3 ± 1.9 8.0 ± 1.6 
PRP 4.6 ± 3.1 2.7 ± 1.2 2.7± 1.0 
Echogenicity in WB increased with decreasing blood flow 
velocities and stasis. Both the absence of platelets (RC + PPP) 
and the induction of platelet aggregates by ADP had no effect on 
WB echogenicity. Neither PRP nor RC suspended in saline 
showed flow-dependent echogenicity. These results demonstrate 
that both RC and plasma proteins are required for velocity•
dependent echogenicity in human blood. 
737·2 8:45 
Left Atrial Spontaneous Contrast in DC-Cardioversion for 
Nonrheumatic Atrial Fibrillation Without Anticoagulation 
Patick MJ. Verhorst, Otto Karnp, Freek W.A. Verheugt, Cees A. 
Visser, Free University Hospital, Amsterdam, The Netherlands 
Recent studies using transesophageal echocardiography (TEE) 
suggested that when TEE excludes the presence of a left atrial 
(LA) thrombus, subsequent cardioversion (CV) in patients with 
atrial fibrillation (AP) without oral anticoagulation (OAC) can be 
performed safely. The significance of LA spontaneous contrast 
(LASC) in this setting is not well known yet. 
We therefore studied 27 consecutive patients with nonrheumatic 
AF lasting more than 48 hours, without OAC, who underwent 
TEE to evaluate the presence or absence of LA thrombus and 
LASC, and to also measure LA appendage peak flow velocities. If 
no LA appendage thrombus was observed subsequent direct 
current (DC) CV was performed. 
LA thrombus 
Forward peak flow 
velocity (m/sec) 
Backward peak flow 
velocity (m/sec) 
Successful DC-CV 
Thromboembolism 
LASC + 
(n= 9) 
0 
0.18 ± 0,07 
0.19 ± 0.06 
7 (78%) 
2 (22%) 
LASC -
(n=18) 
0 
0.34 ± 0.09 
0.37 ± 0.11 
14 (78%) 
0(0%) 
p 
ns 
<0.001 
< 0.001 
ns 
<0.01 
LASC in nonrheumatic AF is associated with low LA appendage 
flow velocities, is of no influence on DC-CV success and carries 
a thromboembolic risk when DC-CV is performed without OAC. 
JACC February 1994:IA-484A 
737-3 9:00 
Cost Effectiveness or TEE-Guided Cardlovenion With Anticoagulation 
Compared to Conventional Therapy In Patients with Atrial Flbrillation 
Allan L. Klein, Ricbard A. Grimm, Ian W. Black, David A. Orsinelli, 
Warren J. Manning, Marcus F. Stoddard, Marion Piedmonte, for the 
ACUTE Investigators, Cleveland Clinic Foundation, Cleveland, Obio 
In this era of cost containment, it is important to show that a procedure is 
cost effective. Transesophageal ecbo-guided cardioversion (TGC) bas 
several advantages over conventional therapy (er) in patients undergoing 
cardioversion (OCC), including a decreased embolic risk, guiding anti•
coagulation (AC) therapy, convenience, decreasing duration of 
anticoagulation, and earlier DCC. To assess the potential cost 
effectiveness of TGC, we modeled the estimated costs of CT compared to 
TGC. Stroke after cardioversion using CT (7 weeks of AC before and 
after DCC) bas an estimated prevalence of 1.6%. Stroke has an enormous 
economic impact with direct (hospitalization, rehabilitation; $44,000 and 
indirect Oost productivity; $20,(00) costs, equaling $64,000. Assuming 
a lowered stroke rate of 0.1 % with TGC, an equal number of in- and out•
patients, and 52% Medicare and 48% non-Medicare patients, the cost of 
CT is equal to ($297, fixed costs (FC) x 0.5, In-patient) + ($297, FC x 
0.5, out-patient) + ($64,000 x 0.016, rate) = $1,321.00. In contrast, 
the cost of TGC with AC is equal to [($444 ,FC,TEE x 0.52, Medicare) 
+ ($1,056, FC, TEE x 0.48 non-Medicare)] x 0.5, out-patients + 
[($453,FC,TEE x 0.52, Medicare) + ($1058,FC,TEE x 0.48, non•
Medicare)] x 0.5, in-patients + ($64,000 x 0.001, rate)] = $804. 
Conyentional TEE guided 
Average Cost Per Pt $ 1,321.0 $ 804.00 
For 100 Pts $132,100.00 $80,400.00 
Net Savings=$S1.700.00j Percent Savings ($1321 -$804)/$1321 =~ 
If TGC lowered the stroke rate from only 1.6% to 0.9%, the costs would 
be equal to the CT group. 
Conclusion: TEE guided cardioversion can be expected to reduce costs 
by 39 % compared to conventional therapy. A large multicenter study is 
underway to evaluate the actual cost effectiveness of this approach. 
737-4 9:15 
Is Spontaneous Echocardiographic Contrast in the Aorta a 
Marker for Embolic Events? 
Robert S. Finkelhor, William E. Lamont, Sam K. Ramanavarapu, 
Robert C. Bahler. MetroHealth Medical Center, Case Western 
Reserve University, Cleveland, Ohio. 
Spontaneous echocardiographic contrast (SEC) is associated with 
embolic events when it appears in the left atrium, however, little is 
known about its appearance and significance in the aorta. Since 
transesophageal echocardiography (TEE) superbly visualizes the 
thoracic aorta this was retrospectively studied in 202 TEE patients 
without evidence of aneurysms or dissections. SEC was defIned as 
a pulsatile, swirling echodensity different from background as 
determined by two independent observers. SEC in the aorta was 
found in 25 patients (12.4 % ). In all of them it was seen only in the 
distal arch or descending aorta. It was seen in older patients 
(64.7±10.2 years versus 53.9±l5.9 years, p<O.OOOI), those with 
slightly larger aortic diameters (2.47±0.39 cm versus 2.17±0.30 
cm, p=O.OOI), more often with complex aortic atherosclerosis 
(16.0% versus 6.2%, p=O.06) and in males ( 64.0% versus 
45.5%, p=0.07). It was not associated with SEC in the left atrium 
or with a reduced left ventricular ejection fraction. Of the 67 
patients referred to fInd a cardiac source of embolus (43 CVAs, 18 
TlAs, 6 peripheral emboli) SEC was observed in the aorta of 12 
(17.9%) while it was seen in 13 (9.6%) of 135 controls (P=0.06). 
It remained an independent predictor of embolic events (p==0.04) 
when considered with SEC in the left atrium, atrial septal 
aneurysm, PFO and complex aortic atherosclerosis. Thus, SEC in 
the aorta is not an uncommon fmding on TEE and may be another 
independent marker for embolic events. 
JACC February 1994:IA-484A 
737·5 9:30 
VALVB STRABDS ARB STRONGLY ASSOCIATBD WITH 
SYSTBKIC BKBOLIZATION: A TRABSBSOPRAGBAL STUDY 
Gregory Goodkin, Robin Freedberg, John Perez, 
Paul A. Tunick, Itzhak Kronzon, New York 
University, New York, NY. 
Fine thread-like strands, seen on native and 
prosthetic valves, have been implicated in 
systemic embolic events. In 1559 pts studied 
by transesophageal echocardiography (TEE), 86 
(5.5%) had strands: 60 on mitral valves, 23 
on aortic valves, 3 on both. 597/1559 (38%) 
pts had a stroke, transient ischemic attack, 
or peripheral embolus. strands were far more 
common in pts with emboli: 63/597 pts with 
emboli (10.6%) had strands vs. 23/962 pts 
without emboli (2.3%) had strands (p=OOOl; 
odds ratio 4.8; 95% CI 3.0-7.9). 
Of the 86 strand pts, 41 pts had no other 
source of emboli (i.e. atrial fibrillation, 
intracardiac clot or smoke, aortic atheroma, 
carotid disease). These 41 pts were randomly 
matched for age, sex, hypertension and smoking 
to 41 other TEE pts without strands who also 
had no other identifiable source of emboli 
(controls) . There was no significant 
difference between the 2 groups with respect 
to presence of prosthetic valve (4 strand pts 
vs. 7 controls), or the use of anticoagulant 
or antiplatelet therapy (22 vs. 22). Of the 
41 strand pts, 33 (83%) had emboli, and of the 
41 controls, only 12 (32%) had emboli 
(p=.OOOOl: odds ratio 10.0: 95% CI 3.6-27.8). 
CONCLUSION: Valve strands identified by TEE 
are very strongly associated with systemic 
embolic events. 
737·6 9:45 
Rare Occurence of Fibrin Strands Attached to 
Mechanical Valve Prosthesis After the Initial 
Post Operative Period. A Transesophageal 
Echocardiographic Study with 320 Prosthesis. 
Frederic Robert. Raymond Roudaut. Thierry Labbe. 
Christophe Pepin. Jacques Bonnet. H6pital Cardiologique. 
CHU de Bordeaux. Pessac. France. 
The presence of strands on Mitral Mechanical Protheses 
(MMP) has been described recently. although their 
significance has yet to be established. The aim of this 
study was to determine the incidence and clinical 
implications of "strands" on MMP in late follow-up by a 
retrospective analysis of 320 consecutive patients (pts) 
who had undergone a transesophageal 
echocardiographic (TEE) examination under standardized 
conditions 7 ±. 6 years after mitral surgery. Twenty pts 
(6.25%) with "strands". defined as highly mobile linear 
echogenic densities. were identified. This group was 
compared with a control group of 38 pts. matched for age. 
sex and interval between surgery and TEE study. selected 
at random from this population. Type of prosthesis. 
echographic characteristics (left atrial diameter. 
spontaneous echo contrast. ejection fraction) and 
anticoagulant status were not found to bear any 
relationship to the presence of strands. However. the 
prevalence of previous embolic events was significantly 
higher in the "strand" group (10/20 = 50%) than in the 
control group (7/38 = 18.4%) p < 0.05). The "strand" group 
also contained more pts with a prior history of mitral 
prosthesis thrombosis (7/20 = 35% vs 1/30 = 2.6%) p < 
0.05). However. long term follow-up (I to 4 years) was 
uneventful. These results suggest that : I) in late follow•
up. strands are rare in pts with MMP (6%) ; 2) strands 
were related to previous thromboembolic episodes. but did 
not appear to confer an enhanced thromboembolic risk. 
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Incidence and Baseline Predictors of Left Ventricular 
Enlargement Post Myocardial Infarction: Survival and 
Ventricular Enlargement (SAVE) Trial. 
Martin St.John Sutton, Marc A. Pfeffer. Ted Plappert, 
Steven Goldman. Oavid F. Gordon. Victoria Bernstein. 
Patricia M. McEwan, Francis J. Menapace. Gervasio A. 
Lamas. Eugene Braunwald. Brigham and Women's Hospital, 
Boston MA. 
L V enlargement (L VE) post-MI has a poor prognosis, yet 
the proportion of pts in whom LYE occurs is unknown. To 
assess the incidence of high risk pts who develop LYE, and 
the baseline demographics that predict LVE post-MI. we 
recorded 20 echoes in 457 SAVE pts (EF<40%) at baseline 
(mean II days) and at follow-up from 3 months to 2 years. 
Each echo required at least 3 of 5 technically satisfactory 
views including both LV long and short axis images. LV 
size was assessed as end-diastolic (OA) and end-systolic (SA) 
cavity areas. L VE was defined as an increase of more than 
1.96 x the standard deviation of reproducibility for diastolic 
and systolic cavity areas. At follow-up echo, regardless of 
treatment assignment to placebo or captopril. 35.4% had 
developed LVE in diastole and 38.6% in systole. To identify 
predictors of L VE, we assessed the relationships between 
L VE, baseline demographics, LV size (OA and SA) by echo, 
history of hypertension (HTN) or diabetes (OM), use of 
thrombolysis. beta blockers. CABVG and PTCA. Lower 
baseline EF. prior MI, higher resting heart rate, clinical 
angina and diuretic use were all strongly associated with 
L VE (all p<0.02). In contrast, important factors such as age, 
sex, baseline LV size by echo. blood pressure, history of 
HTN or OM, use of thrombolysis, beta blockers. PTCA or 
CABVG did not predict pts who developed LYE. We conclude 
that more than one third of post-MI pts (EF<40%) develop 
late L VE; the baseline demographics that predict L VE and 
thereby identify the high risk pts post-MI are low EF, prior 
MI. resting tachycardia, angina and the use of diuretics. 
738·2 8:45 
Left Ventricular Function after Successful Coronary Thrombolysis: 
Impact of Reocclusion 
AJbert Meijer, Machiel J. van Eenige, Christ J.PJ. Werter, 
Freek W.A. Verheugt. Free University, Amsterdam. The Netherlands 
Recently we reported from the APRICOT-trial that at 3 months after 
angiographically successful thrombolysis reocclusion (R) is observed in 
30% of patients (pts). We also analyzed the effects of R on regional and 
global ventricular function (L VF) in pIS with a fust infarction (MI) with 
a left anterior descending (ANT) or right coronary (INF) infarct related 
artery. They underwent both acute and 3 months contrast 
ventriculography in the 30° right anterior projection. Regional L VF was 
analyzed by the Stanford radial method. A total of 135 pIS (ANT 73, 
INF 62), were studied, of whom 39 (ANT 24. INF 15) had R. Only 6 
pts had a re-MI. There were no base-line differences. but LV ejection 
fraction (EF) increased without. but not with R. Importantly, increase of 
EF correlated inversely with baseline EF without (r -0.5;p<O.OOOOI), but 
not with R (r -O.2;p=ns). The recovery of central (CIA) and entire 
infarct area (EIA) wall motion (±sem) was significantly impaired by R. 
both for ANT-MI and INF-MI 
R P no R p 
·EF % -0.1+1.8 ns +3.8+1.1 0.0001 
·CIA-ANT % 5.8+2.0 0.01 13.7+1.9 0.0001 
·EIA-ANT % 2.4+1.3 ns 8.8+1.4 0.0001 
.CIA-INF % 2.7+3.6 ns 3.6+1.7 0.02 
.EIA-INF % 0.6+3.2 ns 3.7+1.5 0.04 
We conclude that R I) is a frequent phenomenon. 2) often occurs 
without reinfarction and 3) impairs regional and global ventricular 
recovery. also at low baseline values. and 4) thus may adversely affect 
long-term prognosis after thrombolysis. 
130A ABSTRACTS 
738-3 9:00 
EIred ofProlOllpCl N"drate Therapy .... LeftVeJltrialbrBypeJ1rophy ud 
."ocIeliB8 after Cuiae Aade ~ IafudioB 
-Bodh I. Jugdutt, Mohammad L Khan. University of Alberta, Edmonton. 
Alberta, Canada. 
The effect of prolonged nitrate therapy. during healing postinfarction. on 
left ventricular (LV) mass, remodeling and function (serial two•
dimensional echocardiograms). hemodynamics, postmortem topograpby 
and infarct collagen .... studied in 64 instrumented dogs that were 
randomized two day. after left anterior descending coronary artery 
Iiption to nitrate therapy (n=32) over the first 2 weeks (subgroup 1: 2% 
transdermal nitroglycerin at 8 am and 4 pm. n =6; subgroup 2: 2% 
transdermal nitroglycerin plus 2 mg oral nitroglycerin SR at 8 am. 3 pm 
and 10 pm. n = 5; subgroup 3: oral isosorbide dinitrate, 30 mg at 8 am and 
4 pm. n=l1) or 6 weeks (subgroup 4: isosorbide dinitrate, n=10). and 
matching controls (n=32). Postmortem sear mass (planimetry) and 
collagen content (hydroxyproline) were similar in control and nitrate 
groups but remodeling (geometric maps; radiographs) was less witb 
nitrates. Changes in LV remodeling between 2 days and 6 weeks post•
ligation in the control group were: increased asyuergic segment, expansion 
index. normal wall thickness, volumes, aneurysms and mass; decreased 
asyuergic wall thickness and thinning ratio; and lillie change in ejection 
fraction. In contrast, changes with nitrates were: decreased asyuergic 
segment, expansion index. volumes. thinning ratio, aneurysms and mass; 
increased asynergic wall thickness and improved ejection fraction; ~nd 
little change in normal wall thickness. The beneficial effect on remodeling 
and function wa. seen in all nitrate subgroups. although the benefit was 
greater witb therapy over 6 weeks (subgroup 4) than that confined to tbe 
first 2 weeks (subgroups 1. 2 and 3). The decrease in LV mass "itb 
nitrate ... s detectable by 1 week and was even greater at 6 weeks. 
Thus, prolonged nitrate therapy effectively limits LV bypertrophy 
and remodeling and preserves function during healing postinfarctioD. 
More important, benefit i. greater with therapy over 6 weeks than the first 
2 weeks. 
738-4 9:15 
Gender Differences in Post-Infarction Left Ventricular 
Remodeling and Function 
Sbeldon E. Litwin. SaIab E. KaIz. Daniel E. Fonnan. James P. Morgan. David 
Tmbay. Pamela S. Douglas. The Harvard-TbOOldike LaboIatoI)' of Beth Israel 
Hospital. Boston. MA. 
Clinical studies suggest that women have a worse prognosis after myocardial 
infarction (MI) dian men. To examine possible differences in LV remodeling that 
could explain Ibis phenomenon, we performed serial transtbOIacic eclIo-Doppler 
studies in age-maICbed male (11=17) and female (n=16) rats before. 1 and 6 weeks 
after large anterior MI or sham smgezy (Sh). High fidelity LV pressure . 
measurements showed comparable elevalions of LV end-diasU>lic pressure in 
males and females (26±3vs 21±4 mmHg). Histologic infarct size was not 
different between males and females (45±1 vs 48±1 % LV). Results are at6 
weeks and are mean±SEM. PW = posterior wall thickness (mm); LVDD = LV 
diastolic dimension (mm); RWT = rela!ive wall thickness (2xPW/LVDD); FS = 
fractional shortening (%); %PWT = PW thickening; EtA = ratio of early to late 
diastolic filling velocities; Decel = decelmuion slope of early filling wave 
(m/s"2). * p < 0.05 vs sham (same gender); § p < 0.05 MI female vs MI male. 
PW LVDD RWT FS (%) %PWT EtA Decel 
Sh M 1.5±.1 8.5±.4 .36±.02 36±2 75±10 2.2±.2 10±1 
Sh F 1.5±.1 7.l±.2 .42±.02 45±2 76±8 2.l±2 12±1 
MI M 1.7±.1* 10.4±.3* .33±.02 1l±2* 45±7* 17±3* 26±3' 
MI F 1.4±.1 10.3±.3' .27+.02' 14±2' 45±9* 7±2* § 17±3 § 
Summary: I. Large MI resulted in comparable elevalion of LV filling pres•
sures. LV dilatation. and impaired systolic fWlCtioo (global and regional) in male 
and female rats. 2. 10 coolraSt, females developed less hypertrophy of the 
noninIiut:ted myocardium n:suIting in decreased relative wall thickness. 
3. Diastolic filling abnormalities ("resttictive" pattern) were also less pronoUllced 
in female rats. Coudusions. There are gender differences in post MI LV 
remodeling and function. Increased mata1ity after MI in females may be related to 
inadequale reactive hypertrophy of the surviving myocardium. which could 
exacetbale palhoIogical remodeling and afterIoad mismatch. 
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738-5 9:30 
Does Residual Exertionallschemia Innuence Left Ventricular 
Remodeling After Anterior Myocardial Infarction? 
Pantaleo Gian~uzzi, Pier L.Temporelli, Ugo Corr~, Alessandro 
Imp~to, Mannella Ga1!one, Riccardo Campini, Michele Galli, 
ClaudiO Marcassa, Amengo Giordano. Luigi Tavazzi. Clinica del 
Lavoro Foundation,lRCCS, Cardiology Depanment, Veruno. Italy. 
The role of residual ischemia on left ventricular (LV) size and 
re~odeling following myocadial infarction (MI) was investigated. 
Nmety-one pts (51±9 yrs) were studied 4-8 weeks after a first 
uncomplicated anterior Q-wave myocardial infarction (MI) and 6 
mont~s late.r by .2D-ECHO at rest and upright symptom-limited 
exercise ~snng With 99mTc-S~stamibi SPET images. The severity of 
the perfuSIOn defect was quantified at SPET polar maps by integrating 
the area wi~h tr~cer uptake falling >2.5 SD below mean reference 
values obta~ned 10 50 no~al subjects. A computerized system was 
used to denve the followmg ECHO variables: global endocardial 
surface area (ESA), volumes. EF, the extent of abnormal wall motion 
(%A ":'M). of regional dilatation (%RD) and the distortion index 
(DISTI). Based. o.n. the pres~nce and severity of reversible perfUSion 
dt:fects on the Im~al exerCise testing, pts were classified as having 
~1d/UJ?derate reSidual exertional ischemia (M ISCH - 45 pts), severe 
Ischemia (S ISCH - 26 pts) or no ischemia (NO ISCH - 20 pts). At 
entry~ ESA, ~n~-diastolic volume (EDV), EF, %WMA, % RD and 
DISTI were slnlliar and they did not change after 6 months in all three 
gr~ups. However. pts with ~40% EF and exertional ischemia, either 
mild/moderate or severe, showed significant (p<O.Ol) and similar LV 
enlargement (p<O.Ol) over time (EDV ml/m2: 75+ 13 to 80+ 10 in M 
ISCH, 72±11 to 81±19 in S ISCH; %RD: 42+16 to 52.+h in M 
IS~, 38±~8 to ~6±27 in S ISCH). In contrast,global and regional 
LV dimen~lOns did not change in pts with ~40% EF and NO ISCH, 
as well as 10 all pts with >40% EF. 
In conclusion: pts with poor LV function soon after anterior MI are 
prone ~o further gl.obal and regional dilatation; residual exertional 
~scht:lIDa may contribute to the increasing late ventricular deterioration 
10 thiS subsel of pts. 
738-6 9:45 
Regional Curvature of the Left Ventricle, an Index of Regional Wall 
Tension, Predicts Progressive Ventricular Dilatation Better Than an 
Index of Global Wall Tension: 1 Year FOllOW-UP of a Randomized 
Study of Enalaprll After First Anterior Myocardial Infarction 
Mani Vannan, Steven Schwartz, Jean-Claude TardH. Donald Miller Natesa 
Pandian. TuftS-New England Medical Center. Boston, Mass. • 
Dispropo~ionate changes in left ventricular (LV) volume and global mass 
resuhlng In Increased global wall tension (GWT) has been suggested as a 
cause o! progressive ventricular dilatation (PVD) after myocardial infarction 
(MI!. II.IS however ~ssible that alterations in regional shape of the LV 
cavity Increases regional wall tension (RWT) that promotes hypertrophy 
and PVD~ independent of ~WT. We studied the time-dependent changes in 
left ven~ncular chamber Size, mass and regional shape and the effect of 
enalapnl therapy in 64 patients with first antr. MI. who were randomized to 
enalapril (E) or placebo (P) therapy for 1 year. All patients received SK. LV 
end·diastolic volume index (EDVI). LV mass index (LVMI) and regional 
curvature (ORCA-quantttative regional curvature analysis) of the infarct 
segment in the apical long-axis view (aplax) were measured from serial 2D 
echo. The ratiO of EDVI and LVMI (V I M) was taken as an index of GWT. 
OR<?A was measur~d i.n e~d-systole in the aplax view. increasing value in 
the Infarct segment Indicating greater systOlic bulging. Results: mean:!:SD. 
·p<O.OS 
n B d7-d1Q 1m 8m 12m 
EDVI P 22 S2.9±lS S7.3±lS· 71.S±23· n.S±2S· SO.7±2S· 
E 42 S2.4±18 sO.s±ls· SS.7±lS· 54.9±lS· Sl.6±17· 
LVMI P 68.7±9 72.1±11 73.3±11 8S.S±14· S9.S±12· 
E 68±14 70±11 68.2±11 65.6±14 66±11 
V IMP 0.92 0.93 0.98 0.89 0.90 
E 0.91 0.S7· 0.84· 0.84· 0.7S· 
ORCA P 9.S±O.3 11.3±0.4· 11.S±0.4· 10.1±O.3· 9.S±0.3 
E 9.9±O.4 9.7±O.3 9.0±O.4· S.6±0.4· 8.S±0.4· 
Thus, inthe P grp.,l) GWT does not show significant change due to 
parallel mcrease In LV volume and LVMI, 2) Regional curvature, a 
determmant of RWT. increases up to Sm after which time curvature 
differences ar~ neutralized by the increasing spherecity of Ihe LV. Within 
limits, sphereclty of the LV may be an adaptation to redistribute abnonnal 
RWT due to dissimilarities in regional curvature. and hence reduce GWT. E 
therapy reduces acute and chroniC disparities in regional curvature and 
thereby attenuates PVD and spherecity of LV. and also reduces GWT. 
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739-1 8:30 
The Adverse Effect of Upopro~In(a) on CoronaJy Atherosclerosis and 
ClInical Evenllia l!limina~d by Sllbstantlally Lowering LDL cholesterol 
Vincent MG Maher, B. Greg Brown, Santica M. Marcovina, Dianne Sacco, 
Jiin-T. Un. Lynn A. Hillger and John J. Albers, Univ. of WA, Seattle, WA 
Upoprotein (a) [l.p(a») is associated with cardiovascu1ar disease; the 
mechanisms and therapelltic implications of this relationship are 
unclear. III association with angiographically quantified coronary artery 
disease (CAD) was examined among 146 men with CAD, age S 62, and 
with apolipoprotein B (apoB) levels ~125mg/dJ. These were randomized 
to a conventional or to one of two intensive lipid-lowering regimens. 
Upids were measured before and during therapy. The lipid-lowering 
response was called "minimal" if non(a)-LDLc [LDL-dlolesterol minus 
that in Lp(a» fell by less than 10% from base line (mean 4±9%) and 
"substantial" if by 10% or more (mean - 4O±15%). ApoB minus that in 
Lp(a) was called non(a)-apoB. Angiograms were repeated at 25 years in 
120 who completed the study. CAD severity, per patient was estimated 
as the mean percent diameter stenosis in nine proximal coronary segments 
(%Sprox); its increase over 25 years quantified progression. 
In univariate and in a multivariate analysis including 8 key risk 
variables, the dominant correlates of base-line %Sprox were Lp(a) 
(r=O.3O; p<O.OOl) and the ratio Lp(a)/HOL cholesterol (HOLc) (r=O.34; 
p<O.OOOl). Similarly, for 37 patients with minimal lipid-lowering 
response, progression during treatment correlated only with levels of 
Lp(a) (r=0.37) and with Lp(a)/HDLc (r=O.45). Conversely, for 83 
patients with substantial responses, proximal disease usually regressed, 
and Lp(a) and l.p(a)/HOLc no longer influenced disease change (r= .{l.03 
and .{l.0l); instead levels of non(a)..LDLc (r=O.24) or non(a)-apoB (r=0.3O) 
determined change. Among 42 patients with Lp(a) levels >90th 
percentile, clinical events (revascularization for unstable ischemia, 
infarction, death) were frequent (42%) if treatment response was minimal 
but were few (4%) if it was substantial. 
Thus in men with raised apoB, Lp(a) levels and the Lp(a)/HOLc ratio 
are dominant correlates of base-line disease severity and of progression 
and clinical event rate over 2.5 years when lipid-lowering response is 
minimal. However, Lp(a)'s dominant influence on disease progression 
and c1inical events is eliminated by substantially lowering LDLe. 
739-2 8:45 
Pravastatin Limitation of Atherosclerosis in the Coronary 
Aneries (PLAC I) 
*Bertram Pitt. G.B. John Mancini. Stephen G. Ellis, Howard S. 
Rosman. and **Mark E. McGovern for the PLAC I 
Investigators. *University of Michigan Medical Center, Ann 
Arbor. MI and **BristoI-Myers Squibb. Princeton. NJ. 
Prava.statin Limitation of Atherosclerosis in the Coronary 
Artenes (PLAC I) was a 3-year, multicenter, randomized. 
placebo-co~trolled study of the effects of pravastatin in 408 
pauents wIth documented coronary artery disease (CAD). 
Entry cri teria were the presence of one or more coronary 
stenoses ::::SO% and mean serum low-density lipoprotein 
cholesterol (LDL-C) after diet ~130 and <190 mg/dL. The 
primary end point. the rate of progression of mean diameter 
averaged over 10 predefined coronary artery segments, is 
pendIng and Will be presented. In addition to lipid and 
anglOwaphlc assessments. predefined clinical end points 
occumng after 90 days on treatment were analyzed, including 
fatal plus nonfatal myocardial infarction (MD. nonfatal MI plus 
CAD death. and nonfatal MI plus all death. Long tenn lipid 
results Included 18% and 26% reductions in serum total 
cholesterol and LDL-C. respectively. and an 8% increase in 
high-density lipoprotein cholesterol. Events after 90 days on 
treatment included S MIs in the pravastatin group and 17 in the 
placebo group (logrank p = O.OOS). For the combined end 
points of nonfatal MI plus death and nonfatal MI plus CAD 
death there were 8 and 7 in the pravastatin group versus 19 and 
18 in the placebo grouP. respectively (logrank p =0.017 and 
0.014. respectively). Results of the analyses of events from the 
date of randomization were consistent with the above findings. 
Thus. in a patient population with moderately-elevated LDL-C 
and manifest CAD. treatment with pravastatin as monotherapy 
was associated with a significant reduction in cardiovascular 
morbidity. 
ABSTRACTS 
739-3 9:00 
'\'he Veilial Hypercholesterolaemia Regression Study 
(FHR~) 
Gilbert R. Tk,mpson on behalf of the FHRS Investigators 
at Hammersmith Hospital, London, Llandough and 
University of Wales Hospitals, Cardiff, University of 
Edinburgh Medical School, UK and Thorax-Cent!"Ulll, 
Rotterdam, Netherlands. 
The FHRS is a randomized angiographic comparison of 
LDL apheresis vs lipid-lowering drugs. FE heterozygotes 
with CAD were randomized to colestipol 20 9 (C) plus 
simvastatin 40 mg daily (S) or LDL apheresis bi-weekly 
(LA) pl·.l3 S for 2.1 years (mean). Lipid and quantitative 
coronary angiographic (QCA) changes were: 
Mean change Patients ('to) 
LDL-C HDL-C Lp(a) Prog- Stable Reg-
C ... 5 \n~13) 
LA+S (n~20) 
p < 0.0001* 
% % Widl 
-44.0 5.8 7.7* 
-49.9 4.8 -12.2* 
ression 
21 
10 
58 
65 
ression 
21 
25 
There were no significant differences between the treat•
lIlent Jroup. on ~atient- or lesion-based QCA analysis, 
nor in Lp(a) levels between progressors and regressors. 
Retrospective comparison with publi3hed data shows that 
f""ourdble angiographic change occurred significantly 
more often than in ~rl subjects on diet ± cholestyramine 
(p~0.012). Exercise tests (Bruce) showed improved per•
fm'llance "t 6, 12, 13 ""j 24 Il'Onths in 14, IB, 32 and 
36% of c+s treated patients versus 25, 35, 25 and 20% 
of thobe on 18 ... S (p>0.2). These results show that C+S 
was as effective as LA+S in FH and suggest that 
perGistence of raised Lp(a) did not adversely influence 
CAD outcome. We conclude that lowering LDL not Lp(a) is 
the main therapeutic aim; apheresis should be reserved 
for FH homozygotes anj drug-resistant heterozygotes. 
739-4 9:15 
Pravachol Decreases Platelet Thrombus Formation in 
Hypercholesterolemic Coronary Patients in Conjunction With 
Improvements in Serum Lipids 
Lucie L.-Lacoste, Jules Y.T. Lam, Joseph Hung, David Waters, 
Montreal, Canada 
Patients with hypercholesterolemia have hyper-reactive platelets 
reflecting a prothrombotic tendency. To assess whether lipid lowering 
is associated with a decreased thrombotic risk, platelet-thrombus 
deposition (PO) was measured in stable coronary patients on aspirin. 
325 mg/day (baseline-AS A, n=10) or without ASA (n=8) (baseline) 
before and after pravachol (Prav) therapy (40 mg/day for 2-3 months), 
(Prav/ASA or pravachol groups respectively). Thrombus fonnation 
(PD) was assessed ~y exposing porcine aortic media (simulating type 
3 arterial injury or plaque rupture) to the patient's flowing venous 
blood for 3 min at shear rates of 2546 and 754 sec" at 37°C. Serum 
lipids and quantitative morphometric PO {j.Im2/mm) before and after 
pravachol treatment are: 
Baseline Pravachol Baseline-ASA 
PO: 2546 sec" S.H 1.1 1.5±0.4* 3.0±0.6 
754 sec" 3.4±0.8 0.9±0.3* 2.7±0.6 
Cholesterol: Total 7.1±0.5 5.6±0.S* 6.6±0.4 
LDL 4.9±0.4 3.5±0.5* 4.5±0.4 
*p<O.OS vs baseline, tp<0.05 vs baseline-AS A 
There were no significant changes in HOL or triglycerides. 
Prav/ASA 
1.1±0.4t 
O.5±O.lt 
4.8±0.2t 
3.0±0.2t 
Thus, pravachol decreased serum total and LDL cholesterol. and 
inhibited platelet-thrombus formation at high and low shear rates. This 
decreased thrombotic risk may explain in pan the benefits observed 
in clinical and regression trials with HMG-CoA reductase inhibitors. 
131A 
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739-5 9:30 
Remodelling of Coronary Artery Lesions: Regression to the 
Mean or Effect of Cholesterol-lowering Therapy? 
Ad J. van Boven, J. Wouter Jukema, Egbert T. Bal, Jollan H.C. Reiber 
and Albert V.G. Bruschke on behalf of the REGRESS study group. 
Interunivers~y Cardiology Instistute, Utrecht, The Netherlands. 
'REGRESS' is a placebo controlled multicenter study to detennine the 
effects of 2 years administration of 40 mg pravastatin on pro- and 
regression of angiographically documented coronlll)' artery disease in 
885 symptomatic men w~h a serum cholesterol level between 4 and 8 
mmoVl. Complementary to automated quant~tive analysis (OCA), visual 
assessment (VA) of the arteriograms is perfonned by at least two inde•
pendent cardiologists, who are blinded to therapy mode. Visual assess•
ment of lesion stenosis percentage is made in 39 coronary segments per 
petient. The use of an electronic caliper is allowed. End resuhs are 
expected by March '94. 
In 173 patients (mean age 54.5 yrs, cholesterol 6.07 mmoVI) who 
recieved solely medical therapy throughout the study, VA and aCA were 
perfonned in a total of 2080 segments. In the stratum of diameter steno•
sis <20%, VA found progression, confinned by a decreasing mean 
diameter on aCA. In stenoses ~O%, both VA and aCA found regressi•
on, by aCA also in percentage narrowing and absolute minimal lumen 
diameter. In stenoses ;a20 and <50%, in which the means changed over 
no more than 1%, changes in VA and aCA were not identical. 
Conclusion. 
By USing this method of stratification the serial angiograms showed a 
remodelling of the coronary artery lesions. This observations could be 
due to a regression to the mean, but also may be typical for cholesterol•
lowering management. 
739-6 9:45 
Treatment of Severe Hypercholesterolemia and Coronary 
Heart Disease by Simvastatin and LDL Apheresis (HELP): 
Effects on Coronary Lesions 
Gunnar K. Lund, Benjamin Pfalzer, Ute Beisiegel, Ulrich Beil, 
Heiner Greten, Christian W. Hamm, University Hospital Hamburg, 
Gennany 
Progression of coronary heart disease (CHD) in patients with 
hypercholesterolemia can be reduced by lipid lowering therapy. In 
severe hypercholesterolemia maximal reduction of plasma cholest•
erol can be achieved by additional LDL apheresis. To investigate 
the effect a combined regimen of diet, simvastatin and intermittent 
LDL apheresis (HELP) 10 patients (6 males, mean age 45 yrs) with 
primary hypercholesterolemia (plasma cholesterol 437±69 mg/dJ) 
and severe CHD were treated for 2 years. Efficacy of lipid lowering 
therapy was documeted by repeated blood analyses and progression 
of CHD was monitored by quantitative coronary angiography 
(QCA). 
~ Plasma LDL cholesterol was reduced from 362±58 
mg/dJ at baseline to 138±30 mg/dJ after 2 years. (LDL cholesterol 
range: 88±21 mg/dJ direct after and 187±35 mg/dl before next LDL 
apheresis). HDL cholesterol increased from 46±10 mg/dJ to 55±14 
mg/dl and Lp(a) was reduced from 147±74 mg/dJ to 99±33 mg/dl. 
~ At baseline 72 stenoses (percent stenosis >20%) were found. 
11 stenoses showed regression (15%),56 stayed unchanged (78%) 
and 5 (7%) showed progression. Proximal and minimal stenosis di•
ameter increased significant (proximal: 3.0±1.3 to 3.3±1.3 mm, 
p<O.OO2; minimal: 2.0±1.1 to 2.2±1.l mm, p<O.OOl), but mean per•
cent stenosis stayed unchanged (baseline: 34±14%, after: 33±15%). 
No adverse events occured during therapy. 
Conclusion: Treatment of primary hypercholesterolemia with 
diet, simvastatin und LDL apheresis reduced LDL cholesterol and 
increased HDL cholesterol. QCA showed a significant increase in 
proximal and mimimallumen diameter. 
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740-1 8:30 
Incidence but not Duration of Silent Myocardial Ischemia 
Correlates With Severity of Coronary Artery Disease. 
Ad J. van Boven, J. Wouter Jukema, Kong I. Ue and Albert V.G. 
Bruschke lor the Regress Study Group. Interuniversity Cardiology 
Institute, Utrecht, The Netherlands. 
Silent Myocardial Ischemia (SMI) is assosciated with a negative 
prognosis in patients with ischemic heart disease. We investiga•
ted whether incidence and activity 01 SMI, found on a 48 hour 
ambulatory ECG monitoring, were related to the extent 01 coro•
nary artery disease in 384 patients (mean age 54.5 yrs.) with 
stable angina. Coronary arteriograms were analyzed using both 
quantitative and visual (panel and caliper) methods. Lesions with 
2:50% diameter stenosis were considered significant. 
1 VD 2 VD 
N(pts.) 162 112 
SMI (pts.)(%) 34(21) 28(25) 
Episodes, Nlpt. 5±1 5±1 
Mean duration (min) 6.SS±.85 4.95±.71 
Totallschemic S8.57±18.S8 61.30±17.85 
Burden(mm.min) 
3 VD 
110 
38(35)' 
5±1 
4.3S±.3S· 
56.04±19.S6 
Values are ±SEM, ') p<0.05 ANOVA, VD=vessel disease. Age 
and medication were evenly distributed in all groups. 
An increased incidence of SMI was found in patients with 
multivessel coronary artery disease. Duration of SMI was longer 
in patients with one vessel disease. The presence 01 silent myo•
cardial ischemia, but not its expression on a ambulatory ECG, is 
01 value to predict the extent 01 coronary artery diesease in 
patients with stable angina pectoris. 
740-2 8:45 
Patients With Asymptomatic Cardiac lscbemla Hav. Severe and Complex 
Coronary Artery Disease 
Barry L. Sbaraf, Nicholas J. Miele, David O. Williams, Robert P. McMahon, 
Peter H. Stone, Joan Barry, Proben Bjenegard, Richard F. Davies, A. David 
Goldberg, Michael Parks, Carl J. Pepine, George Sopko, C. Richard Conti, For 
the ACIP Investigators. Rbode Island Hospital, Brown University, Providence, 
Rhode Island 
Little is known about \be corooary anatomy of patienlS (PIS) with asymptanatic 
cardiac iscbemia (ACI). The coronary anatomy of 500 consecutive pts with a 
positive exen:ise lest, angiograpbically documented coronary disease (CAD) 
and ~I episode of ACI during 48-hr monitoring was compared with 43 pts with 
no ACI but with a positive exercise test and documented CAD. TIle mean ages 
were 61.4 ± 8.5 yrs (mean ± S. D.) and 59.1 ± 8.2 yrs (p=.I0), and a similar 
percent were male (84.2'110 vs. 81.4%, p=.63) for pIS with and without ACI 
respectively. 
ACl HI!..ACl II 
Major arteries with 1 24% 26% 
Sleoosis ~% 2 38 47 .43 
3 37 28 
Number of lesions 1 18% 21% 
with stenosis ~O% 2 23 35 .15 
~3 59 44 
Defmite complex plaque 34% 21% .07 
(ulcer, thrombus) 
Possible complex plaque 50% 28% .005 
Proximal vessel (LAD, 64% 42% .005 
LCX, RCA) with ~O% 
Sleoosis 
Proximal vessel (LAD, 39% 21% .02 
LCX, RCA) with ~70% 
sleoosis 
We conclude that pIS with ACI have more severe and more complex CAD than 
pIS without ACI. 
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740-3 9:00 
Relatioosbip Between Anglograpbic Severity of Conmary Disease and Left 
Ventricular Dysfundion and Frequency of Ambulatory Ischemia in the 
Asymptomatic: Cardia/: Iscbemia Pilot (ACIP) Study. 
Peter H. Stooe, Barry Sharaf, Thomas C. Andrews, Robert P. McMahon, Carl I. 
Pepine, David O. Williams, Martial Cl. Bouraasa, Cleor,e Sopko, C. Richard Conti. 
Brigham and Women's Hospital, Boston, MA 
The relationship between _erity of coronary di_ (CAD) and ambulatory cardiac 
ischemia (ACI) durin, daily activities is unclear in patients with slable CAD. This 
study inveati,ated the relationship between the severity of CAD and left ventricular 
(LV) dy.function and the severity of ACI in 500 slable patients (pts) with ~ 1 
epiaode of ACI, • potIitive exercise _, anaioanphically documented CAD and no 
prior coronary artery bypass sur,ery. All pts underwent 48-bour ambulatory ECG 
off anti-iacbemic therapy or on low dose beta- or calcium cbannel-blocker. Average 
time between angiography and ambulatory ECCl was 82.5 days. Amon, those with 
ACI there was a sisnificant relationabip between CAD severity and the frequency 
of ACI episodes. 
Angjogmphic Variables 
1/ complete occlusions/pt: 
f!§ Mean 1/ episodes AeJ/48-hrs p value 
o 
1 
~2 
o 
1 
~2 
132 3.4 <0.001 
311 2.1 ~ 
1/ ste.noses ~9S%/pt: 
1/ stenoses ~50%/pt: 
LV Ejection Fraction: 
1 
2 
~3 
>60% 
40-60% 
<40% 
51 3.3 
204 1.9 ~ 
193 2.9 
89 3.0 
<0.01 
89 1.9 ~ 
111 2.5 
294 2.9 
<0.01 
266 2.5 ~ 
196 2.1 
16 4.1 
0.09 
Ip conclusion, among pIS with ACI, episodes of ACI are more freqUellt in pIS with 
more severe and extensive CAD, and may be more frequent in pts with low ejection 
fraction. 
740-4 9:15 
Patients With Exercise-Induced Painful Ischemia Have Greater Amount 
of Myocardium at Risk of Ischemia Than Those With Silent Ischemia 
During Exercise Testing 
Prakash C. Deedwania, Enrique V. Carbajal. VAMC. Fresno/UCSF School 
of Medicine. San Francisco. CA 
Although it has been suggested that patients with silent ischemia may 
have lesser amount of myocardium at risk of ischemia. little evidence is 
available to support this hypothesis. Accordingly. we evaluated the 
findings on exercise (Ex) thallium'O! (TI) scintigraphy and various Ex test 
parameters including Ex-time (T. minutes). T to 1 mm SH, peak heart 
rate (HR) and peak systolic blood pressure (BP) to compare the extent 
of myocardium at risk of ischemia in patients with Ex-induced silent 
versus painful ischemia. Fifty-four patients with coronary artery disease. 
stable angina. and ischemia during treadmill exercise testing using Bruce 
protocol were evaluated. All patients had reversible defect on thallium'O! 
scintigraphy. Thallium images were scored on a scale of 0 (normal) to 4 
(severe defect) by calculating the difference in thallium20! uptake 
between the immediate post-exercise period and delayed (4 hr post-Ex) 
scintigraphy. Twenty-eight (Grl) patients developed Ex-induced angina 
with ischemia and 26 (Gr2) had painless ischemia during Ex testing. 
Results: The average values, exercise test parameters and thallium'O! 
scintigraphic findings for the two groups are shown: 
ll:I T-l mmSH Peak-HR Peak-BP 
Gr 1 6.2 4.3 117 161 
Gr 2 6.5 4.2 127 174 
(·p<.05 compared to Gr 2) 
TI score 
6.1' 
4.2 
Although exercise duration, time to 1 mm ST j , peak heart rate and peak 
systolic blood pressure were similar in patients with exercise-induced 
angina and ischemia versus those with silent ischemia, we found a 
significant difference in the extent of reversible defects on thallium'O! 
scintigraphy. Compared to patients with silent ischemia those with 
painful ischemia had significantly higher scores for reversible thallium'O! 
scintigraphic defects indicating a greater extent of myocardium at risk 
of ischemia in patients with painful ischemia. 
ABSTRACTS 
740-5 9:30 
Prognostic Significance of Effort·lnduced Silent Myocardial 
Ischemia in Patients with Coronary Artery Disease. 
Giuseppe M.C. Rosano, Eugenio Martuscelli, Bruno Bonfigli, Fabio 
De Luca, Francesco Romeo. University of Rome and Catania, Italy. 
National Heart & Lung Institute, London, United Kingdom. 
It has been suggested that the presence of silent myocardial 
ischemia (SI) in pts with proven coronary artery disease is associated 
with an unfavourable prognosis. The aim of the present study was 
to evaluate the long·tenn (8 year) prognostic significance of efFort· 
induced SI in 97 pts (group A) without cardiac symptoms during 
exercise test and in 309 pts with angina during effort (group B). Pts 
with SI more frequently were diabetic (27.7% vs 15.8%, p<O.04) 
and had a positive exercise test at low workload (50.5% vs 41.7%, 
p<0.05). The 2 groups had similar male/female distribution, degree 
of coronary artery disease and left ventricular function. During I 8 
year follow-up cumulative mortality was 8.2% in group A and 9.7010 
in group B, p=NS. Mortality due to major cardiac events/year was 
0.8% in group A and 1.1% in group B, p=NS. The incidence of 
sudden death during follow-up was 3.1 % in pts of group A and 
3.2% in group B. Multivariate analysis showed inpaired left 
ventricular function (p<O.OOOI). previous myocardial infarction 
(p<O.OOOI) and multivessel disease (p<O.OOI) as independent 
predictors of unfavourable prognosis. 
In conclusion pts with effort-induced SI are more frequently 
diabetics and have a positive exercise test at low workload. Their 
long-tenn prognosis, however, is similar to that of pts with angina 
during exercise. 
740-6 9:45 
Effort-Induced Silent Myocardial Ischemia is a Better Predictor 
of Prognosis than Silent Ischemia Detected During Daily Life. 
Francesco Romeo, Giuseppe M.C. Rosano, Eugenio Martuscelli, 
Antonio Valente. University of Rome and Catania, Italy. National 
Heart & Lung Institute, london, United Kingdom. 
Although exercise-induced myocardial ischemia associated 
with angina is a better predictor of poor prognosis than myocardial 
ischemia detected during ambulatory electrocardiographic 
monitoring (AEM) in patients with coronary artery disease, it is still 
under debate whether effort-induced silent ischemia (SI) has a better 
prognostic value than SI detected during AEM. To this end we 
studied 406 pts with effort-induced SI and documented coronary 
artery disease. All pts had a positive exercise test (> I mm ST 
depression) but 97 pts had effort-induced SI. AEM was perfonned 
in all pts using a FM system. Episodes of ST segment depression 
during AEM were detected in 312 pts of these 63 had only silent 
episodes and 249 had both silent and symptomatic episodes. 
Cumulative mortality during follow-up (mean 63±18 months) was 
7.8% while cardiac mortality/year was 9.8%. A multivariate analysis 
was perfonned in order to evaluate the electrocardiographic 
variables associated with an unfavourable outcome. A positive 
exercise test at low workload (p<O.OOOI), ST segment depression 
> 1.5 mm (p<O.OOI) and the duration of myocardial ischemia during 
AEM >60 min/day (p<O.OOI) were the independent variables found 
to be associated with a poor prognosis (death and major cardiac 
events) in all pts and in the subgroup of pts with effort-induced SI. 
In the latter subgroup exercise·induced SI was also a predictor of 
prognosis (p<O.OOI). SI during AEM was not found to be an 
independent predictor of unfavourable outcome. In conclusion, 
although SI during AEM is a frequent occurrence in pts with 
coronary artery disease, its presence does not add any prognostic 
infonnation in those pts with effort·induced SI. 
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874·26 
V--.. OapIiAtiww "'~ ~ sa-tiDc: 
I'redidon, ME laeat ud 0uIaIme. 
Mauro Moscucci, Kathleeo Mansour, Richard Kuntz, Craig Kent, Cynthia 
S<IIerchia, DooaId Baim, Josepb Canoua. Beth Israel Hospital, Bos1oo, MA. 
The agereuive auticoagulatiOll that prevents early &IeIIt thrombosis contributes to 
• ruab ilK:ideoce of vascular complicatioas. Predisposing factors, the role of 
different auticoagulation protocols, as well as the mauaaement and long term 
outcome of vascular complicatioas, remain to be defined. We thus examined the 
c1inical coune of 3SS patients who underwent Palmaz-Scbatz (P-S) _ling of 426 
vucular .. aments during 376 procedures. Post-procedure heparin aud sheath 
removal (DC) were mauaged according to 3 different protocols (P): PI) Sheath 
DC lIext day, heparin resumed in 2b (n~31); P2) Sbeaths DC same day with 
beparin off 4 b, resumed in 2 b (n=68); P3) Sbeaths DC same day when ACT 
< 180, beparin resumed in 2 h (n=277). In all cases, post procedure 
auticoaeulation was continued without interruption. During the study period, there 
were only 2 (O.S") sub-acute sleDt thrombosis. Major vascular complications 
(vascular injury requiring surgical repair (SR), A-V fistula, pseudoaueurysm, 
femoral neuropathy, relroperitoDeal hematoma or bleedinll requirinll trausfusiOD). 
however, occurred in 63 (16.7") procedures, including SR in 38 (10.191). SR 
was performed without complications ...... rally (94 91) under local auestbesia. 
Kaplau-Meier survival &Dalysis showed DO adverse effect of SR on long term 
survival. P3 had the lowest incideDce of complications (12.6". with SR in 7.6"). 
Multivariate predictors of vascular complications included: 
Odds Ratio ~ 
P (Sbeatb Protocol 1/2)· 2.5 1.61-3.84 
Hypertension 2.68 1.43-5.01 
Nadir Platelet count 1.11 1.04-1.19 
p value 
<0.001 
0.002 
0.002 
0.050 Age> 70 1.90 1.00-3.62 
~ngest independent predictor. 
Conclusion: I) Same day ACT guided sheath removal significautly reduces 
complications following p·s steoting, although (at 12.6") they remain more 
common tbau after other interventional therapies. 2) Vascular complications cau 
he mauaged without interrupting auticoagulation, or compromising the 0 .5 91) stent 
thrombosis rate. 3) When needed . SR cau be performed under local anesthesia. 
without adversely influencing subsequent survival. 
874·27 
Do Indications Influence Lonq T8nl Clinical OUt~ 
Aftar Pal ... -SChatz COronary stenting ? 
Jean F.jadet. Olivier Bar. Chrietian Jordan. 
J •• n-Baptiete Caillard. Bernard Caeeagneau. Gabriel 
Robert. J.an-Pierre Laurent. J.an Marco. Clinique 
P •• teur, Toulou •• , Prance 
Sub.cute thrombosis (SAT) and reetenoais (R) rates 
have been reported to be lower in de novo (ON) 
l.eione. reet.notic (RS) leeione and auboptimal PTCA 
reaulta (SO) than in bail-out (80) atenting. To 
evaluate the influence of theae indications on long 
term clinic.l outcome we analy~ed the three year 
clinical follow-up (29_2U4 month.. range 0_1 to 49 
month.) of 329 consecutive pati.nt. who underwent 
Palmaz-Schatz etent implantation for ON (41'). R(27'). 
so (23') and BO (9'). Survival analyeee. defined as 
free from cardiac death. myocardial infarction. CABG 
.nd repeat PTCA were as follows 
Indic.tione 
ON 
SO 
R 
80 
6 Month 
Survival (') 
78.sH.7 ] 
78.US_1 
72.5:5.0 ]P<O.Dl 
53.6:9.4 
3 Year 
Survival (') 
77 .OU.O ] 
75.3:6.1 
70.415.4 ] p<O_Ol 
53.319.4 
COnclusion 1/ Three year clinical outcome after 
Palmaz-Schatz coronary stenting is favourable and 
remarkably aimilar for ON. R and SO indications. 
2/ Bail-OUt stenting is followed by an initial 
critical period within the firat .ix months_ However 
later follow-up seems similar to other eubgroups with 
a low incidence of new cardiac events. 
JACC February 1994:1A-484A 
874·28 
Residual Stenosis and MLD Following Coronary Stenting 
Do Not Predict Restenosis in the Strecker Stent 
Jerome Segal, Jonathan S. Reiner. Mark A. Thompson. Jeffrey A. 
Brinker. Richard R. Heuser, Bonnie H. Weiner, Allan M. Ross. for 
the Strecker Stent Investigators. The George Washington University 
Quantitative Analysis Core Laboratory. Washington, DC. 
Lower restenosis rates following coronary interventions have 
been shown to correlate with smaller residual stenosis and larger 
diameter at procedural completion, i.e. "bigger is better". We 
analyzed 54 Strecker stents in 51 patients by automated edge 
detection at procedural completion, and at six month follow·up (FlU) 
in 32 pts, then grouped patients by presence (shaded bars) or absence 
(open bars) of angiographic restenosis (> 50% stenosis) at flu. 
Results (+I-SE): Procedural parameters such as pre-PTCA %DS. 
post-stent %DS, pre and post-PTCA MLD. and post-stent MLD 
failed to correlate with restenosis at follow-up. Overall restenosis rate 
was 45% with mean MLD of 1.52 mm at follow-up.Mean Acute 
Gain (AG) was similar for both groups (2.2 vs. 2.1mm).However. 
patients with restenosis at FlU had greater Late Loss (LL) (2.0mm) 
than those without restenosis (0.9mm). 
0 <50% 
• >50% 
NL PRE POST STENT FlU AG LL 
Conclusion: Large residual lumen and small residual diameter 
stenosis following Strecker coronary stent implantation did 1101 
correlate with restenosis in this group of patients. Factors other than 
angiographically-detennined success clearly contribute to the process 
ofrestenosis and remain to be fully elucidated. 
874·29 
Three Year Clinical Follow-up After Pa~.-Scbatz 
COrozuuy Stant :t.Iplantation 
Olivier Bar. Jean F.jadet. J.an-Baptiate C&illard. 
Christian Jordan. Luis Diaz. Bernard Caesagneau. 
Gabriel Robert. Je.n-Pi.rre L.ur.nt. Jean Marco, 
Cl~nique P.eteur. Toulou ••• France 
If short-term outcome after Palmaz-Schatz coronary 
.tenting h.s been well atudi.d. long-term follow-up 
(l'U) .till remains impreciee_ Therefore we analy~ed 
the long term clinical outcome of 329 coneecutive 
p.tiente (pte) who underwent Palmaz-Schat~ coronary 
atenting between 03/89 .nd 01/91. Clinical information 
W&8 obtained in 303 patienta (92') 29.2 114 months 
(0.1 to 49 months) .fter atent implantation. 
Eighty-five per cent were male •• with mean age 59 :9_2 
yeara. 68' had elective stenting and 17' had multiple 
etents_ Survival .naly.... defin.d .a free from 
cardiac death (CD). myocardial infarction (MI). bypass 
aurgery (CABG) and repeat angioplasty (PTCA) of the 
.ame lee ion were .s follow. 
Free of I 6 Month 
Surviv.l (') 
3 Year 
survival (') 
----------------------------------------------------
CD 
CD.MI 
CD.MI.CABG 
CO.MI.CABG.PTCA 
94.611. 3 
94.211.4 
85_612_1 
74.412.5 
93.211_8 
92.511.9 
84_0:1:2.4 
72.812.8 
Conclusion : After the initial period following etent 
implantation. the long-term outcome for patients 
r.ceiving a Palmaz-schatz coronary stent i8 
.atiafactory with a low rate of new major cardiac 
events. 
lACC February 1994:1A-484A 
874·30 
Quantitative AngIograpbic Analysis of a New Ultrasound-Guided SteJlt 
Imputation Tecbnique 
Jeffrey J. Popma, Antonio Colombo. Varon Almagor. S. Chiu Wong. Gary S. 
Mintz, Augusto D. Pichard. Kenneth M. Kent. Lowell F. Saller. Christine J. 
Dittano. Luella T. Lewis. and Martin B. Leon. Centro Cuore Columbus. 
Mi1an.ltaly and Washington Hospital Center. Washington. DC 
Elective coronary stent placement has been limited by vascular/bleeding 
complications and subacute stent thrombosis. To test the hypothesis that 
optimal stent implantation may reduce complications and the need for 
prolonged systemic anticoagulation. a new technique was devised (by 
Antonio Columbo) incorporating inttavascular ulttasound (IVUS) guidance 
and "over-expansion" of tubular slotted stents using shon. oversized. high 
pressure balloons for post-stent dilatation after initial stent deployment. 
IVUS criteria for optimal stent implantation included flush stent-vessel wall 
apposition. symmetric appearance. and stent cross-sectional area > distal 
reference lumen cross-sectional area. To evaluate the angiographic impact of 
IVUS-guided stent implantation in native coronaries. 77 consecutive lesions 
b'eated by IVUS-guided stent over·expansion (final balloon:artery ratio 
[BAR) .. 1.31tO.20) were compared with 83 consecutive lesions treated using 
routine stent implantation techniques (final BAR = 1.06±0.32. P < 0.001) 
using quantitative angiographic (edge detection) methods. 
Reference Diameter (mm) 
Pre / Final MLD (mm) 
Pre / Final % Stenosis 
% StreICh / Recoil 
Any Dissection / Staining (%) 
Distal Vasospasm (%) 
IVUS Guided Routine 
2.79 2.90 
1.02 / 2.95 0.78/2.56 
63/-4 73/11 
83/11 66/6 
7.8 / 2.6 8.4 / 1.2 
9.9 0 
P Value 
0.47 
.004/<.001 
<.001/<.001 
<.00 I / <.00 I 
NS 
0.005 
MID .. minimum lumen diameter 
In conclusion: IVUS·guided stent implantation using short over·sized. high· 
pressure balloons. compared with routine stent deployment. results in I) a 
marlted improvement in fma1lumen diameter and residual stenosis (averaging 
-4%) and 2) similar low dissection frequency but more frequent ttansient 
distal vessel spasm. The impact of these favorable angiographic results after 
lVUS·guided stent overexpansion on the need for prolonged anticoagUlation. 
subacute thrombosis. and late angiographic restenosis is currently being 
evaluated. 
874-31 
Coronary Stentinll 
Complications and 
witb Multiple 
AnlliOllrapbic 
Stents: 
Follow-Up 
Luigi Maiello, Antonio Colombo. Varon Almagor, Renato 
Gianrossi, Giovanni Manini, Massimo Borrione, Patrick 
Hall, Leo Finei. Centro Cuore Columbus, Milan. Italy 
Previous results reponed a bigh incidence of subacute 
thrombosis and restenosis after multiple coronary 
Palmaz-Scbatz stent implantation. We analyzed 120 
consecutive pts (120 vessels) who bad implantation of 180 
standard and 193 shon stents (mean 3,1 stents/vessel). 
The vessel distribution was: S3 LADs, 34 RCA, 21 LCXs, and 
12 grafts. Angiographic success was 97%, and 
complications occurred in 7 pts (S.8%): emergency CABG 
in S pts. death in 3 pts, and MI in 2 pts. Subacute 
thrombosis occurred in 2 pts (1.6%). Angiographic 
follow-up was completed in 82 of 107 elegible pts (77%) at 
a mean of S ± 3 months. The table shows the results for 
different stent indications: elective (E). restenosis (R), 
and dissection (D). 
Group E R D 
Number of pts 66 18 37 
Angiograpic Success % 98 100 89 
Major Complications % 3 (2 pts) 0 13 (S pts) 
• MI % 0 0 S.4 (2 pts) 
- CABG % 3.(2 pts) 0 8 (3 pts) 
- death % l.S (1 pts) 0 S.4 (2 pts) 
Subacute thrombosis % I.S S.S 0 
Rcstenosjs % 20 28 46 
There was not statistically significant difference between 
the groups except for stenting for dissection. Multiple 
stent implantation bad acute results and restenosis rates 
comparable to what reponed with single stents except 
when the indication for stenting was dissection. 
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Relation of Clinical Presentation and Lesion Morpbology to tbe 
Procedural Results of Palmaz-Scbatz Stent Placement: A New 
Approacbes to Coronary Intervention (NACI) Registry Report 
Sabino R. Torre. Sue M. Lai. Richard A. Schatz for the NACI Investigators. 
Scripps Clinic and Research Foundation. La Jolla. CA. 
The purpose of this study was to determine the relation of patient 
characteristics and lesion morphology to procedural outcome with Palmaz·Scahtz 
stent (PSS) placement. PSS were implanted within 682 lesions in 623 patients in 
the NACI Registty. Clinical characteristics included a mean age=62. 80% were 
male. 66% had unstable angina. 63% had prior PTCA. 44% had prior CABG. 57% 
had multivessel disease. and the mean EF=57%. Lesion characteristics included 
74% discrete. 67% eccenbic. S% calcified. 4% total occlusion. and the mean 
reference vessel size was 3.3mm. Device success (ItlO% & residual stenosis <50% 
after PSS alone) occurred in 83% of lesions. Lesion success (1tl0% & residual 
stenosis < 50% after all devices) occurred in 99% of lesions. Procedural success 
(1tl0% & <50% residual stenosis without Q·MI. emergency CABG. or death) 
occurred in 96% of patients. We then performed a multiple logistic regression 
analysis of those variables that had a P<O.IO in the univariate analysis to 
determine their influence on~ural outcome. Results:irelative risk & 95%CI : 
Supplies Collaterals 
Total Occlusion 
Severe Tortuosity 
M.051 
P=0.021 
P=0.027 
M.OI3 
M.002 
F;:;;~::;I..,.".j~_..........j 
- PriorCABG i ~ Left Main Stenosis ~50% 
~~ 0 o - o o o 
Thus. no clinical or leSIOn varIables appear to mfluence leSion success 
due to the low incidence of lesion failure. However. lesion characteristics such as 
the presence of coUaterai run·off significantly favor PSS device success. while the 
presence of severe lortuosity or total occlusion significantly favors PSS device 
failure. The clinical characteristic of prior CABG surgery significantly favors PSS 
procedural success. while Ihe angiographic fmding of left main stenosis ~50% 
significantly favors PSS procedural failure. These fmdings should prove useful in 
guiding future palient and lesion selection for PSS placement. 
874-33 
Autologous Vein Graft Coating Applied to Vaacular Stents: the 
Ideal Coated Stent? 
Christodoulos Stefanadis, Charalambos VIachopoulos, Ioannis 
KaIlikazaros, Panagiotis Karayannakos, Costas Stratos, Eleftherios 
Tsiamis, Costas Toutouzas, Eva Papadosiorgaki, Vassilis 
Galanopoulos, Pavlos Toutouzas, Athens UniverSIty, Atbens. Greece 
Metal stents are thrombogenic and do not seem to eliminate 
restenosis. A new approacb for addressing these problems is the use 
of coated stents. We developed an endoprosthesis (EN) consisting of 
a stent coated with an autologous vein graft (AVG) and we repon 
the results of its experimental testing in vivo. 
Methods: An A VG of appropriate size -ifi".ed after careful 
preparation as a lining for a Palmaz-Schatz stent. The A VG 
covered completely both the exterior and interior surface of the stent 
and the whole EN formed a continuous cylinder that could be 
mounted on an angioplasty balloon. Twenty anaestbetized pigs 
(weight 19-30 kg) underwent under fluoroscopic imaging trans•
catheter placement of 20 EN.&f different size (iliac, renal and 
coronary type of PaImaz·Schatz stent) via a carotid or a femoral 
artery. Eis.t!t EN were placed in the abdominal aona, 8 in the 
common iliac artery and 4 in tbe femoral artery. After stent 
placement the animals did not receive anticoagulation or antiplatelet 
treatment. Animals were followed-up angiographically and sacrificed 
after a period ranging from 1 weelC to 3 months. Stented segments 
were examined histologically. 
Results: 1) Coating of the metal stent with an AVG was a 
feasible procedure. 2) All EN could be easily deployed and stabilized 
in the lumen of the anery. 3) All EN were in place and patent with 
no luminal stenosis during the follow-up. 4) Scanning electron 
microscopy disclosed incorporation of the EN in the artery by 
neointima coverage and absence of thrombi on the smooth surface 
of the EN. 
Conclusion: The A VG coated stent can easily be prepared and 
deployed. It appears to be nonthrombogenic and was not coml?licated 
by restenosis during the follow-up. A VG is a biological coatmg that 
may prove useful in reducing the thrombosis and restenosis rates of 
conventional stents. 
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874·34 
IIItravucallr tJltrBNDd ~t 01 "Biliary" Stellt haplutatloa ill 
Sapbeaoas Vela Grill Lesioas 
Jack A. Painter. Gary S. Mintz. S. Chiu Wong. Augusto D. Picbard. Kenneth M. 
Kent. LoweD F. Saller. Jeffrey J. Popma. KaIhi M. Donovan. Tamara Weaver. 
Antonio Colombo. Martin B. Leon. Washington Hospital Center. Washington. DC 
Previous intravascu1ar uIIrasound (lVUS) studies have suggested Ihal angiography 
underestimates die adequacy of stent implantation in native coronaries. To 
determine wbelher similar incomplete deployment may be ~t after aaphellOUS 
vein graft ltent placement. we compared IVUS and quantitative angiography 
(QCA) in '" consecutive vein graft lesions in 42 pts after placement of "biliary" 
tubular-slotted stents. IVUS assessment included (1) minimum ltent cross•
sectional -. (2) die smallest (proximal or dislal) reference lumen cross-sectional 
area. (3) ... area ltenosis (minimum stent areII/smaUest reference lumen area). (4) 
die ratio of die minimum/maximum stent diameters. and (S) ltent-vein graft wall 
·tion. Com 'son of A and rvus findin s are as fODows 
QCA minimum lumen diameter 3.3l±O.SSmm 
QCA ... diameter Blenosis 3.M 12.6'" 
Minimum steIIt croas-sectional area 905±4.6mm2 
Smallest reference vein graft lumen cross-sectional area 12.W.6mm2 
,( ... ) wltII SteIItarea -nest rel'ereace lumea area 5 (9"') 
... area stenosis 21.1±18.M> 
Minimum/maximum Blent diameter 0.82±O.10 
• ( ... ) wltII mlnimumlmuimum SteIIt diameter >.7 46 (8S"') 
• ... wltII ClIIII Jete mDt-vein rt WIIIIB itioo 34 63 ... 
Posl stenl QCA '*'diameter stenosis ranged from ·26.7'" to 37.1 ... and was <20% 
in 47/S4 (91"'). However. rvus "'area stenosis did not correlate with QCA ... DS 
(r=.018. p=NS). rvus parameters for optimal stent implantation were defmed as 
(1) ezp.IIsiDII=minimum stent &rea>smallest reference lumen area. (2) 
SJllllIIttr1"minimum/maximum stent diameter>.7. and (3) IIpposiIiDn=flush axial 
and circumferential Blent·vein graft wall contacL Importantly. using these criteria. 
only I stenl (1.9"') mel all 3 criteria, 32 (S9.3"') met 2 criteria. 18 (33.3"') met I 
criteria. and 3 (S.6%) met no criteria. We conclude: Although angiography 
indicated successful vein graft stent implantation with low residual stenosis. NUS 
frequently detected focsl regions of suboptimal deployment due to incomplete stent 
expansion. stent asymmetry. and/or inadequate stent-vein graft wall apposition. 
These data indicate dlat die use of rvus guidance and more aggressive post-stent 
baJloon dilatation may be necessary to optimize vein graft Blent implantation. 
874·35 
Intrava.cular Ultra.ound Guided Coronary 
St.nting of Anglographic Small V •••• I. «3.0 mm) 
Patrick Hail. Antonio Colombo. Yaron Almagor. luigi Maiello. 
Antonio Gaglione. Shlgeru Nakamura. Leo Find. "Steven L. 
Goldberg. "Jonathan Tobls. Centro Columbus. Milan. Italy and 
"UCI Medical Center. Orange. CA 
Intravascular ultrasound (IVUS) guided coronary stentlng was 
performed In 50 pIS (52 lesions) with a proximal anglographic 
reference vessel diameter of <3.0 mm. The vessel distribution 
was: 38 LAD (73%). 9 CirclOM (17%). 3 RCA (6%). and 2 
Ramus Intermediate (4%). Stents were successfully deployed In 
49 pIS (98%). One pt (2%) had an emergency bypass operation. 
Indications for stentlng were 63% elective. 16% restenosls. 
16% suboptimal PTCA result. 6% post-opening a chronic total 
occlusion. A total of 71 stents were deployed. Multiple stents 
were deployed In 20 pts (39%). Optimal IVUS guided stent 
expansion (according to predefined criteria) was achieved In all 
49 pts that had successful primary stenting. Mean proximal 
anglographic reference lumen diameter was 2.7 ± 0.19 mm. 
minimum lesion diameter was 0.8 ± 0.4 mm.. and pre·stent 
mean percent stenosis was 68 ± 19%. Final stent diameter was 
3.3 mm ± 0.45 with a final mean percent stenosis of minus 20 ± 
14 %. Mean final balloon size (IVUS guided) was 3.75 mm. The 
49 pts with successful IVUS guided stent expansion did nol 
receive any additional heparin or coumadin after the completion 
of Ihe procedure and were maintained on ticlopidlne 250 mg bid 
for 2 months. AI a mean follow·up of 83 days (range 42 to 145 
days). there have been no acute or subacute thrombosis and no 
vascular or bleeding complications. Anglographic follow·up is 
scheduled In all patients at five months. Conclusions: IVUS 
guidance allows for safe stenting of vessels tradionally nol 
considered ideal for slentlng. When optimal stent expansion is 
achieved subsequent antICOagulation may nol be necessary. 
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874·36 
Treatment of Failed PTCA with Perfusion BalIoon Versus 
Intracoronary Stent: a Short·term FolIow·up 
Paolo Barberis. Federica Marsico. Stefano De Servi. Ezio Bramucci. 
Luigi Angoli. Jacek Kubica. Annamaria Costante. Diego Ardissino. 
Giuseppe Specchia. Division of Cardiology. IRCCS Policlinico S. 
Matteo University of Pavia. Pavia. Italy 
Perfusion balloons (PB) and intracoronary stents (S) have recently 
been used for the tteatment of failed PTCA defmed as persistence of> 
70% residual lesion or presence of occlusive complications (acute 
dissection or thrombosis). Failed PTCA OCCUlTed in 73 out of 646 
procedures (11 %). The initial treatment was PB in 36 cases and S 
(Palmaz·Schatz) in 37. The vessel involved. the frequency of 
dissection and time (mean and range) of PB inflations were: 
LAD RCA LCX Graft Dissection Time (minutes) 
PB 25 8 3 0 12(33%) 13.7 (4·25) 
S 20 10 5 2 18(49%) 
An immediate success (<50% residual stenosis) was observed in 
26/36 (72%) PB and 35/37 (95%) S • In the 10 cases of unsuccessful 
PB. S was implanted with immediate success in 9. The l·month 
follow·up of pts with PB. S. and S after PB is reported in the table: 
N.ofprocedures 
Acute/subacute thrombosis* 
AMI 
Death 
UrgentCABG 
(* overall S thrombosis= 13%) 
PB S S after PB 
26 37 10 
4 2 
2 1 
1 
1 
Thus. prolonged inflations with PB for treatment of failed PTCA have 
a relatively low success rate but are not followed by complications. S 
implantation has a very high immediate success rate. but is associated 
with a rather high incidence of thrombosis in the short·term. 
874·37 
Vaeular C_plkatlolll FoIIcnriDa DIrec:tIoul CCII'CIIW1 Atberectca1111' 
l'IIImaz-8cbatx StelldD& 
Kathleen A. Mansour. Mauro Moacuccl. CIlIa Kent, Cynthia Seoc:n:hia, Margaret 
FlaIlcy. RichardE. Kuatz. Donald S. Baim, Joseph P. Carrozza. BeIh IsmeI 
Hospital. Bostoo. MA 
The hospital course ol688 pts IreIted willi direcIionaI coronary 8IberecIomy (DCA) 
or PaImaz-Scbatx Stenling (S) in 75 I procedures (DCA: 375. S: 376) was evaluated 
for vascular complications. All DCA', were performed usinJ 10 or II FradI 
IbcaIhs. while 9 Freach sbcaIbs were uaed ill Stent pts. S pts were treated with 
aspirin. dipyridamole and heparin post-prtJQedure untillbe potbrombin time was 
lbcrapeutica11y prolonged by warfariJL 0vaaI1 major vascular complicatioa rate 
was 11.7'" (deemed as surgical repair [7.6"'I.11'8IISfusion alone for >10 point 
bcmaIocrit drop (1.1"'] or medically managed AV fiSIUla, pseudoaneurysm. 
retroperitoncal hematoma or femoral neuropadIy [3.1"')) and was less for DCA 
(6.8"') dian for S (16.7 .... pcO.OOI». ill particular.vascu1ar IIJIiIII'Y was less 
common in DCA pts VI S pts (S.I'" v. 10.1 .... p<0.020). At 1IJIiIII'Y.1here were 10 
(105"') AV fJStulae. 9M> ol whicb were due to cannulation ol superfICial femoral 
.-tery (SFA) or profunda femoral artery (PFA). 'Ibeie were 33 (4.4"') 
pseudoanclll)'sms. 52 ... of wbicb were due to cannulation at or below die common 
femoral artery bifw'calion (CFAB). Independent predictors by mu1tivariable 
logistic regression ol major vascular complicalions for all procedures (S + DCA) 
were determined from selected demopaphic. procedural and laboratory daIa. 
Coyariates Odd. Ratio 95" Cmfu!ence Intmal p yalue 
Stent (vs DCA) 2.30 1.37 - 3.86 0.002 
Age> 70 years 2.27 1.36·3.81 0.002 
Sex (F) 1.84 1.07 - 3.17 0.028 
Multiple procedures' 1.85 1.12 - 3.06 0.017 
Hypeztension 2.23 1.35 - 3.70 0.002 
Nadirplate1etCOUllt 1.09 UI4 -US <0.002 
, Multiple c:alheterization pI'OI:edures during index hospitalization. 
Coodgsiogs· I) Despiae smaUer sheadI sizes. S pts had significantly more 
vascular complications compared to DCA pts, probably reOecting aggressive 
lllticoagulation. 2) Women and elderly pts. and diose who had multiple 
caIheterization during die index bospita1izalions were at increased risk for 
vascular complications. 3) The bigh incidence of vascular entry at or below die 
CFAB among pts undergoing vascular repair suggestS Ihal greater 8llelltion to 
puncture technique might belp reduce major vascular complications. 
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875-38 
Relationship Between Coronary Artery Cyclic Flow Variations After 
Coronary Angioplasty In Humans And RecwTeIlt Iscbemic Events: Initial 
Obsenations 
H. Vernon Anderson, Richard IGrkeeide, Nabil Baradhi, Louise Jooes, Ashok 
Krishnaswami, Harlan Weisman, JIUIIOS Willenon. University of Texas Health 
Science Center and HertDlllll Hospital, Houston, Texas. 
Coronary artery cyclic flow vuiatioas (CFV s), due to accumulation and 
dislodgement of platelet aggregates at sites of coronary stenosis with endothelial 
injury, bave been shown to be related to neointimaJ proliferation in canine 
models. To test the hypothesis that CFVs may be related to future adverse events 
after coronary angioplasty (PTCA) in humans, we studied 27 patients undergoing 
routine elective PTCA. There were 20 men and 7 women, mean age S8 ± II 
years, and 17 (63 %) had unstable angina. The treated coronary artery was the 
left anterior descending in 13 cases, the left circumflex in 6 cases, and the rigbt 
in 8 cases. Coronary arterial flow was monitored for 30 minutes after PTCA, 
using 0.018-incb Doppler guidewires. In S patients (19%), CFVs were detected, 
despite administration of aspirin, beparin, nitrates, and calcium cbannel 
antagonists. Stenosis severity was the same in both groups, although those with 
CFVs had longer lesions (19 ± 8 vs 13 ± 6 mm, p<O.OS). Four patients with 
CFVs were treated with a monoclonal antiplatelet antibody (7E3) whicb 
abolished CFV. and inhibited ADP-induced platelet aggregation for 48 hours, 
and I patient was treated with additional dilatations only. All 27 patients had 
successful procedures and Were discbarged without complications. After mean 
fonow-up of 17 ± 4 months (range 9-24 months), adverse clinical events (death, 
myocardial infarction, bypass surgery, or repeat PTCA) had occurred in 9/27 
(33 %) of the patients. Clinical events occurred in 4/5 (80 %) of patients with 
CFVs detected after PTCA, but in only 5/22 (23%) of patients without CFVs 
detected (p=0.03 by Fisher exact test). 
These data suggest that recurrent platelet aggregation at angioplasty sites 
immediately following PTCA, manifested by CFVs, might be predictive of 
future clinical events, and that prolonged rather than short-term therapies to limit 
this process may be required to be protective. 
875-39 
Relationship of Post-Procedural Distal Coronary Flow Dynamics 
With Restenosis After Coronary Angioplasty: Results of A 
Multicenter Pilot Study 
Morton J. Kern, H. Vernon Anderson, J. David Talley. Eugene A. 
Caracciolo, Richard G. Bach, Thomas J. Donohue, Frank V. 
Aguirre, Joseph A. Moore, Michael S. Flynn, Jerome Segal, Carol 
J. Mechem, Marilyn Cauley, Mio Stikovac, St. Louis University, 
St. Louis, MO 
In experimental animal models of restenosis, higher arterial flow 
velocity has been associated with reduced proliferative responses. 
Quantitative distal arterial flow velocity after PI'CA using a 
Doppler-tipped angioplasty guidewire (FloWire) can now be easily 
measured in patients. To assess whether these data are associated 
with restenosis, mean velocity (MV,cm/sec), maximal peak velocity 
(MAX,cm/sec), diastolic flow velocity integral (DVi,units) and 
coronary vasodilatory reserve (CVR = hyperemia/baseline MY) were 
reviewed in 121 pts with ~6 month follow-up after PI'CA. 25 pts 
had clinical restenosis defined as repeat PI'CA or CABG. There 
were no differences in age, gender, LVEF, pre-PI'CA stenosis 
(78±13%, 80± 13%), post-stenosis (18±14%,22±12%) or arteries 
dilated between groups with and without restenosis. Hyperemia was 
induced with 8-18mcg adenosine Results (meao± 1SD). 
Baseline H}lIeremia 
MV MAX DVi MV MAX DVi 
No resten 28±16 45±22 18±12 49±27 64±24 26±19 
Resten 34± 15 53±25 24± 15 62±23 87±37 37±25 
p value NS NS NS NS .02 NS 
Although hyperemic maximal velocity was higher in the restenosis 
group, post-procedural CVR was the same in both groups (l.8± 
0.65). Resting flow velocity parameters immediately after PI'CA 
do not appear to predict restenosis in patients. 
ABSTRACTS 
875-40 
Late Luminal Loss is Linearly Related to Tangential Wall Tension 
Following Coronary Intervention: Why Loss and Gain are Proportional. 
Panos Papageorgiou, Donald S. Baim, Richard E. Kuntz. Cardiovascular 
Division, Harvard Medical School, Beth Israel Hospital, Boston, MA 
In a variety of experimental models, medial hypertrophy (MH) of the arterial 
wall is related to tangential wall tension (IT), whicb is a function of luminal 
radius (r), blood pressure (P), and wall thickness (h). We tested the hypothesis 
that the amount of late luminal loss (LL) (due largely to MH and neointimaJ 
proliferation) is related to the TT differential (~TT) between before and 
immediately after balloon angioplasty (PTCA, n=288), directional coronary 
atherectomy (DCA, n= 134), or Palmaz-Scbatz stent (n= 102). TT was 
determined before and immediately after the intervention according to Laplace's 
Law: TT=P*(rih). Estimates of b were based upon previously described 
equations (after S. Glagov) and geometric formulas that accounted for both 
dilatation and atheroma excision (mean 16.5 mg of tissue) with DCA. Values 
are expressed as means: 
PTCA DCA STENT 
Reference diameter [mm) 2.84 3.03 3.26 
Pre-procedure diameter [mm) 0.76 0.67 0.73 
Pre-procedure TT [mN/mm2) 1.07 0.93 1.07 
Post-procedure diameter [mm) 1.90 2.88 3.40 
Post-procedure TT [mN/mm2) 3.07 4.80 6.00 
PostTT - PreTT (~TT) [mN/mm2) 2.00 3.87 4.93 
Acute gain (AG) [mml 1.14 2.21 2.67 
Late Loss [mm) 0.50 1.05 1.22 
Ralio ofU:~TT [mm3/mNl 0.25 0.27 0.25 
Conclusions: I) Differences in LL seen after PTCA, DCA or stent can be 
explained as a linear function of the immediate post-procedure IT differential, 
reflected in the constant ratio of LL to ~IT. This suggests that a positive 
change in IT by one mN/mm2 may account for approximately 0.25 mm of MH 
following a procedure. 2) The previously described relationship between LL and 
AG may be explained mechanicaJly by this linear relationship between the 
change in tangential wall tension imparted by a coronary intervenllon, and 
subsequent medial hypertrophy. 
875-41 
The Need for Late Target Lesion RevlISCularization After Rotational 
Coronary Atberectomy is Lower in Women and in Patients witb a Larger 
Acute Angiographic Result 
JeffreyJ. Popma. David K. Roberts. Lowell F. Saller. AugustoD. Pichard. Kenneth 
M. Kent, Ya Chien Chuang,Gary S. Mintz. Luela T. Lewis, Teraza Y. Conway. 
and Manin B. Leon. Washington Hospital Center, Washington, DC. 
To identify the clinical andangiographic predictors of late outcome after rotational 
atherectomy, we followed the clinical course of 6lOpatients undergoing successful 
atherectomy « 50% final diameter stenosis and no death. Q-wave MI, CABG or 
repeat PTCA < 14 days). AIl procedural cineangiograrns were reviewed using 
quantitative angiographic (edge detection) methods. Adjunct balloon PICA was 
performed after rotational atherectomy in 506 (71 %) patients either to optimize 
angiographic results or treat complications. Clinical follow-up was obtained late 
_ 50 (1 year) after rotational athrerectomy 
~ 1_ Men I in 579 (95%) patients (731 lesions). 
'" 40 _ Women Hierarchical late events occurred in 
~ 162 (28%) patients and included death 
! 30 17% (1.6%), Q-wave MI (1.2%), CABG 
'5 (8.6%) and repeatPTCA (16.6%). Tar· 
~ 10 getJesion revascul·arization (1LR) was 
~ performed in 178 (24%) lesions(CABG 1 10 [9.9%) and repeat PTCA [17.5%]). 
Multivariahle correlates of TIR in· 
~~-'1"'0-~--1O.,..L.-4O""""""60 eluded male gender (OR = 1.82. P < 
0.(05), recent MI(OR = 1.92.p<0.05) 
and fmal % diameter stenosis (OR = 
1.27. P < 0.(05). Vessel size and the use of adjunct PTCA (to optimize results) 
were not predictive of lLR. A predictive model was constructed based upon the 
fmal % diameter stenosis and gender (Figure). We conclude tbat: I) the 
probability of repeat TI.R is reduced by obtaining a low residual % diameter 
stenosis with rotational atherectomy alone. or in conjunction with adjunct PICA. 
2) In addition to the effect of fInal % diameter stenosis on late TIR. women had 
a lower incidence of lLR. likely due to either reduced renarrowing of the target 
lesion site. reduced symptoms. or reduced referral for repeat revascularization. 
Ftnal % Diomeler Stenosis 
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875-42 
Geometric Remodeling Is the Predominant Mechanism or Clinical 
RestellOlis After Coronary Angiop1asty 
Gary S. Mintz, Julie A. Kovach, Augusto D. Pichard, Kenneth M. Kent, Lowen 
F. Satler, Jeffrey J. Popma. Jack A. Painter, Kathleen Morgan, Martin B. Leon. 
Washington Hospital Center, Washington, DC. 
To evaluate mechanisms of restenosis (~ diameter Slenosis by quantitative 
angiography @ follow-up), we performed serial qlUJntitative intravascular 
ultrasound (motorized transducer pullback @ 0.5mm/sec) in 107 pts (79% 
males, ages S7± I 0) following transcatheter therapy (TCT: 24 PTCA, 48 
directional and 14 rotational atherectomy, 21 excimer laser angioplasty). Post•
TCr and FlU (4.6:1:2.9 mos) measurements of lumen, external elastic membrane 
(EEM), and plaque aoss-sectionaI areas (mm2) were used 10 calculate % cross•
sectional narrowing (%CSN=P!aque areaJEEM area), late lumen loss (Alumen), 
eometric remodelin2 lAEEMl. and tissue 2IOwth l&Plaaue). 
Restenosis IN=6S) No Restenosis 1N=42) 
Post-TCr Follow-uo Post-TCT Follow-un 
EEM 21.2±7.0 18.8±6.2* 19.5±6.0 19.3±7.0 
Lumen S.5±2.2 1.8±l.l* 7.0±2.2* 6.0±4.S 
Plaque IS.7±S.9 16.9±6.3t 12.6±S.0§ 13.3±4.81§ 
%CSN 73.6±7.3 63.1±IO.l* 
Late lumen loss 3.7±4.8 1.0±4.1t 
Remodeling 2.4±2.6 0.2±4.8§ 
Tissue J!I'Owth 1.0±2.8 0.7±2.4 
*p<.OOI, tp<.01, ,p<.l vs post-TCr; tp<.OOI, §p<.Olvs No RestenoslS 
Both remodeling (r=O.839, p<.OOOI) and tissue growth (£=0.423, p=<.OOOI) 
were independent predictors of late lumen loss. However, remodeling accounted 
for 65% of late lumen loss in pts with restenosis (vs 20% in pts without 
restenosis, p<O.OOOI). Remodeling correlated with post-TCT plaque area 
(r=.346, p=.OOI3) and %CSN (r=.244, p=.OIIS), but was independent of plaque 
morphology (including lesion calcium), acute expansion (t.EEM) during TCT, 
vessel size, and specific device use. We conclude: Serial intravascular 
ultrasound after TCr procedures indicates: (1) both restenotic and non-restenotic 
lesions exhibit similar tissue growth patterns (ie., intimal hyperplasia): (2) 
remodeling (late decrease in EEM) accounts for 65% of late lumen loss in 
restenosis and may he related 10 residual plaque burden, and (3) remodeling and 
tissue growth are, thus far, independent of the therapeutic device employed. 
Thus, optimal treatment 10 prevent restenosis should emphasize achieving the 
largest post -TCr lumen area and minimizing late remodeling. 
875-43 
Veuel Remodeling After Angioplasty: Comparative Anatomic Studies 
Brigitta C.Brott, Marino Labinaz, Stephen C. Culp, James P. Zidar, Donald F. 
Fortin, Renu Virmani, Harry R. Pbillips, Richard S. Stack 
Duke Univerisity, Durham, NC and AFIP, Washington DC 
Vessel remodeling after balloon angioplasty may contribute 10 restenosis. 
Pigs have frequently been used as a model of restenosis because dogs are 
putatively resistent to lesion induction. In order 10 determine the differences 
between these two animal models, oversized balloon injury (1.3-1.5:1) was 
performed in 22 sites Oeft circumflex and anterior descending in II animals - 5 
dogs and 6 pigs). DietS were not supplemented with cholesterol. 28 days after 
initial angioplasty, angiography was performed and the hearts were perfusion 
fixed for histologic and morphometric analysis. 
The baseline arterial diameters by quantitative angiography of the pigs 
and dogs were similar. However, the minimal 1umina1 diameters (MLD) 
immediately after angioplasty were larger in the dog than pig. Repeat 
angiography at 28 days revealed that the MLDs were significantly smaller in the 
pig than the dog. By histologic morphometry, the mean neointimal areas (smooth 
muscle cell-rich by a-actin staining) were similar between the two groups; 
however, the mean arteria1 lumen area was significantly smaller in the pig than 
the dog. This was also associated with a decrease in area within the external 
elastic Iatnina (EEL) in the pig. There was no significant difference in percent of 
internal elasitic Iatnina disrupted, indicaliDg similar degrees of balloon injury 
(43% vs 35%, p"'NS). 
PIG DOG P Value 
Baseline MLD (mm) 1.8 ± 0.3 2.0 ±.0.3 NS 
Immediate post MLD (mm) 1.9 ± 0.2 2.4 ± 0.5 < 0.01 
28d Follow-up MLD (mm) 1.7 ± 0.5 2.4 ± 0.4 < 0.01 
Neointimal area (mrn2) 1.16 ± 0.48 1.76 ± 2.40 NS 
Lumen Area (mrn2) 1.84±0.97 4.19±2.15 <0.05 
EEL Area (mrn2) 4.21 ± 1.32 7.56 ± 3.64 < 0.05 
Conclusions: In this model of repeated oversized balloon injury, pigs and dogs 
develop a comparable degree of neointimal response. The greater degree of 
angiographic stenosis seen in the pig is associated with an overall reduction in 
arterial dimensions in the stenotic segment. The remodeling of vessel geometry 
found in the pig may provide insights into late restenosis that occurs in humans. 
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875-94 
Balloon Overstretcb Injury Correlates Witb Neointimal Forma•
tion and Not witb Vascular Remodeling in tbe Pig Coronary 
Restenosis Model 
Ron Waksman, Keith A. Robinson, Steven R. Sigman, Gustavo D. 
Opolla. Spencer B. King, m. Emory University School of Medicine, 
Division of Cardiology, Atlanta, GA. 
Formation of neointima and vascular mnodeling (changes in vessel 
size) have been suggested as a cause ofrestenosis. The purpose of this 
study was to determine the contribution of these two mechanisms in 
overstretch balloon injury in porcine coronary artery. Twenty-four pigs 
underwent oversized balloon dilatation of the left anterior descending 
and the circumflex arteries and were killed two weeks later. Using a 
computerized morphometry system: Internal elastic lamina fracture 
length (Fl.), intimal area (IA), vessel area (VA), and vessel perimeter 
(VP) were measured in all injured segments (3-6 per vessel). Linear 
regression analysis has shown a high correlation between the amount of 
injury (Fl.) and intimal proliferation (IA) (R2:.805) and no correlation 
between FL with VP and FL with VA (R2::0.100). 
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We conclude that early restenosis in the pig coronary model is due to 
neointimal formation rather than vascular remodeling. Longer tenn 
follow-up and other models will be studied for any effect of vascular 
remodeling. 
875-95 
The Impact of Arterial Remodeling on the Chronic Lumen Size After 
Angioplasty in the Atherosclerotic P,abbit 
Tsunekazu Kakuta, Jesse W. Currier, Jonathan D. Bier, 
David P. Faxon. Boston University Medical Center, Boston, MA 
Efforts to prevent restenasis after angloplasty (A) by targeting intimal 
proliferation have been largely unsuccessful. The purpose of this study 
was to determine the impad of arterial remodeling and neointimal 
formation on the late lumen size In the atheroSClerotic rabbit model of A. 
Iliac arteries (n=51) from New Zealand White rabbits underwent A of 
>50% stenoses, followed by sacrifice and perfusion fixation at • week. 
Lumen area (LA), area circumscribed by intemal elastic lamina (lELA) 
and extemal elastic lamina (EELA) for both the most stenotic sedion and 
reference sedlon were digitized and measured using a computer aided 
morphometric analysis program. Lumen area for reference (LAR), and 
leSion Site (LAl), difference In plaque area between lesion and reference 
site (dPA), and differen"'t-JILr:;z:Ji..&...IlmYi!1lan..me...re:tlmUlCl~IlCl.lasilln, 
(dEELA) were analyzed. lumen area 
There was no correlation dPA<median 0.37:1: .31 
between LAl. and dPA . dPA>median 0.38 :I: .35 
When the data were P value ns <0.001 
divided into two groups by median dPA, there was no difference In 
lesion lumen area between the two groups because vessel enlargement 
accommodated the mar1tedly different plaque areas. LAl. is related to 
LAR by [LAl-LAR - dPA + dEELAJ. Since % stenosis =1 - LALIlAR, % 
stenosls=dPAlLAR - dEELAlLAR. Thus, % stenosis is determined by 2 
fadors: a neointimal formation fador dPAlLAR and a remodelin~ fador 
dEELAlLAR . The relation 
between these two fadors Is 
shown: 
These data suggest that although 
balloon injury results in increased 
PA, arterial remodeling 
limits the effed of neointimal 
formation on LA. 
6 
4 
d EELIlA 
y=O.96x-O.59 ..0.97 
SEE=O.28 
2 .-~'" :..' 
·1.5. ;;~- 1.5 3 4.5 
dPMA 
6 
lACC February 1994:1A-484A 
875·96 
Arterial Remodeling: Importance in Primary Versus Restenotic Lesions 
Jonathan D Bier. Tsunekazu Kakuta. Jesse W Currier. Sunit MukjuJjee. 
Glenn N Levine. Andrew P Chodos. Thomas J Ryan. David P Faxon. Boston 
University Medical Center, Boston. MA 
Compensatory arterial enlargement offsets the encroachment of plaque on 
luminal narrowing in th novo atherosclerotic lesions. Experimentally. we 
bave shown that remodelina after angioplasty may also limit the effect of 
plaque formation on restenosis. and that failure of this remodeling is more 
important than plaque formation in determining ultimate lumen size. To 
examine if failure of remodeling contributes to restenosis in humans. we 
measured total vessel area (TV A,mm,) lumen area (LA,mm,) and plaque 
area (PA,mm,) in primary (n=13) and restenotic lesions (n=15) using 
intracoronary ultrasound. A totaI of 100 non-occlusive sites were analyzed. 
The site adjacent to the lesion with the smallest plaque area was defined as 
the reference site. The LA lesion will be decreased from the LA reference 
by an increase in plaque area (. PA) and increased by an increase in total 
vessel area (. TV A), yielding the equation: 
LA Lesion = LA Reference· .PA + • TVA 
Solving for percent LA stenosis (I - LA lesion/LA reference): 
%LAStenosis = .PAILA reference - .TVAILAreference 
Therefore. percent LA stenosis is determined by a remodeling factor 
(. TV A/LA reference) and a plaque formation factor (. PAlLA reference). 
The relative contributions of these two factors are shown: 
de novo Lesion Bestenosis Lesion L 
Reference Lumen Area 8±2 9±4 NS 
Reference Total Vessel Area 16±4 16±6 NS 
Lesion Lumen Area 6±3 5±3 NS 
Lesion Total Vessel Area 19±6 16±6 0.05 
% Lumen Area Stenosis 0.33±0.3 0.37 ±0.3 NS 
• P A/LA Reference 0.60±0.4 0.48±0.4 NS 
• TV A/LA Reference 0.28±0.3 0.11 ±0.3 0.02 
Thus. despite similar reference areas, restenosis lesions bad smaller total 
vessel area and less remodeling, as defmed by the cbange in total vessel 
area/lumen area reference. compared witb primary lesions. In restenosis 
lesions, the percent stenosis may be determined more by arterial remodeling 
than by plaque formation. 
875·97 
CbnJaic Compensatory Arterial Dilatation Following Coronary Angioplasty: 
An Intravascular Ultrasound Study 
Gary S. Mintz, Fadi A. Matar. Kenneth M Kent, Augusto D. Pichard. Lowell F. 
Saller, Margaret Harvey. Christine J. Ditrano. Nina Prunka. Jeffrey J. Popma. 
Martin B. Leon. Washington Hospital Center, Washington. OC 
Conventional angiography cannot assess interactions between intimal hyperplasia 
and geomettic remodeling after angioplasty procedures. To evaluate precise 
mechanisms of arterial remodeling fOllowing transcatheter therapy (TCT). we 
perfonned serial quantitative intravascular ultrasound (motorized transducer 
pullback @ O.Smm/sec) in 107 pts (79% males. ages 57±10; 24 PTCA. 48 
directional coronary atherectomy. 14 rotational atherectomy. 21 excimer laser 
angioplasty). Pre-TCT, post-TCT and follow-up measurements of external elastic 
membrane (EEM). lumen. and plaque+media cross-sectional areas were used to 
calculate acute (pre-TCT vs post-TCT) and chronic (post-TCT vs follow-up) 
AEEM. &umen. and Aplaque areas. At follow-up (4.6±2.9 months post-TCT), we 
identified a subgroup of 23 pts that bad late arterial dilatation. ie. a chronic 
I . EEM ross sectional area ncrease In C -
Arterial di1aIation No arterial di1aIation 
(AEEM < 0) (0=23) (AEEM ~ 0) (0=84) P 
Acute Aplaque(mm2) -3.4±1.9 -2.S±2.S .176 
Post-TCT plaque (mm2) 12.S±4.6 15.0±5.9 .062 
Arc of lesion calcium 71±79° 94±92° .271 
Chronic &umen (mm2) 0.1±5.2 3.3±2.2 <.0001 
Chronic Aplaque (mm2) 3.0±2.3 0.9±2.1 <.0001 
Restenosis 8/23 (35%~ 83/84 (99%) <.0001 . . .. A chronic increase In EEM area correlated With a chronic mcrease In plaque area 
(r=.424. p<.00(1). Nine of 23 pts (39%) who had a chronic increase i,n EEM area 
a1 follow-up also bad a chronic increase in lumen area Importantly. In this small 
cohort, a chronic increase in EEM was independent ofTCT device. 
We conclude: Serial intravascular ultrasound following TCT shows that 
(I) there is a subgroup of patients with late arterial dilatation (increasing EEM), 
(2) the association between increased plaque mass and arterial dilatation suggestl! a 
compensatory response to intimal hyperplasia. (3) this compensatory artenal 
dilatation results in less late lumen loss. occasional late lumen enlargement. and 
reduced clinical restenosis. (4) compensatory arterial di1atation appears to be 
device independent, and (5) factors that may favor compensatory arterial di1aIation 
are more plaque removal during TCT. a reduced final plaque mass post-TCT. and 
less lesion associated calcium. 
ABSTRACfS 
875·98 
Does local thrombus formation increase long term luminal 
renarrowing following PTCA? A quantitative angIograpbic analysis 
Andonis G Violaris. Jean Paul R "Herrman, Rein Melkert, Davtd P 
Foley, David Keane. Patrick W Serruys. The Thoraxcentre. Rotterdam. 
The Netherlands 
We examined whether the presence and subsequent organisation of local 
thrombus may influence long term lwninal renarrowing following PTCA 
in the 3.066 patients (3,S29 lesions) who were prospectively emoled into 
4 major restenosis trials (MERCATOR, MARCATOR, CARPORT, 
PARK), and who had quantitative angiographic (QCA) follow up (89% 
QCA follow up). As the tested compounds demonstrated no 
angiographic or clinical benefit. data from the active and placebo groups 
were pooled. The study population included IS9 lesions (Gp 1) with. 
and 3370 lesions without. thrombus during PTCA (Gp 2). 
The angiographic restenosis rate (RR) was significantly higher in Gp I 
(42.8%. (68/1S9) vs 32.8% Gp 2 (1104/3370). p<O.OOI), Relative risk 
1.021. CI 1.004-1.037) using the categorical approach (>SO% Diameter 
Stenosis at follow up). Using the continuous. relative loss. (RL), 
approach no significant difference between the two groups was noted 
(RL (mean±sd) O.l61±0.2SS. n=159 Gp I vs 0.123±0.208. n=3370, 
Gp 2, p=ns). The higher RR in Gp 1 was primarily due to an increased 
incidence of re-occlusions in this group (13.8% (22/159 lesions) vs 
5.3% (180/3370 lesions) in Gp 2, p<O.OOl). When these were 
excluded the RR was similar in the two groups using both the categorical 
approach (34%. Gp 1 vs 29%. Gp 2. p=ns, Relative risk 1.159. CI 
0.910-1.476) and the continuous relative loss approach, RL 
0.082±0.171 Gp I. vs 0.091±0.162 Gp 2, p=ns). 
Our results indicate that the presence o( thrombus at PTCA is associated 
with a higher restenosis rate using the categorical (> 50 % OS at fup) 
approach. This reflects an increased risk of occlusion rather than long 
term luminal renarrowing. suggesting that although local thrombus 
formation may be of importance in occlusion it is unlikely to play an 
important role in long term intimal hyperplasia after PTCA. 
875·99 
Predictive Model or Target-Lesion Revascularization After Balloon and 
New Device Saphenous Vein Graft Angiopiasty 
Mun K. Hong. Jeffrey J Popma. Ya Chien Chuang, Lowell F. Saller, Kenneth 
M. Kent. Augusto D. Pichard, Gary S. Mintz. Luela T. Lewis, Robert A. 
DeFalco and Martin B. Leon. Washington Hospital Center, Washington. DC. 
The effect of the immediate angiographic result on late clinical outcome has been 
demonstrated in native coronary arteries. bUI the importance of the final minimal 
lumen diameter on late outcome after new device saphenous vein graft (SVG) 
angioplasty has been less well studied. To address this issue, we reviewed the 
clinical course of 396 patients (550 lesions) undergoing SVG angioplasty using 
balloon angioplasty (N=154), directional (N=6I) and extraction (N=I04) 
atherectomy. and intragraft stenting (N=231). Cineangiograms were analyzed 
using quantitative methods (automated edge detection). ProcedUIal success « 
70 50% final diameter stenosis and no in-hospital death. Q-wave 
60 
10 
myocardial infarction [Mil, or CABG) was 
obtained in 362 (91 %) patients. 
Late (1 year) clinical outcome was 
obtained in 306 (90%) patients . 
Major late clinical events (hierar-
chical outcome) included cardio•
vascular death (3.6%). Q-waveMI 
(2.0%),CABG(7.8%).andrepeat 
PTCA (14.4%). Target lesion 
revascularization (TLR) was per•
fonned in 95 (22%) lesions. By 
o +-~,-,-,-I~r->-"-........ """"--' multivariate logistic regression, 
o 2 3 4 5 6 TLR was related to ostial lesion 
Final MLD (mm) location (odds ratio [OR] = 3.58. 
P < 0.(01) and the final minimal 
lumen diameter (MLD) (OR = 0.59. P < 0.(05) bUI independent of the SVG size or 
the device used. A predictive model was constructed to estimate the probability 
of TLR (Figure). We conclude thaI I ) late clinical outcome after S VG new device 
angioplasty is related to the location of the lesion and the final angiographic resull 
and 2) appears independent of the device used. 
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876-1 
Is Transmyocardlal Norepinephrine Release a Marker of 
Reinnervation of Denervated Cardiac Transplant Recipients? 
Teresa De Marco, Michael Oae, Shantha Kumar, Krishnankutty Sudhir, 
Thomas M. Amidon, Celia RHkin, Cindy Klinski, Fraser Keith, Kanu 
Chatterjee. Cardiovascular Research Institute, University of CalHornia, 
San Francisco, CA. 
Recent studies have suggested that cardiac sympathetic reinnervation 
may occur in patients after orthotopic heart transplantation (OHT) despite 
cardiac denervation during transplantation. Myocardial localization of 1-
123 meta iodobenzylguanidine (MIBG) has been shown to be a 
technique to identHy cardiac reinnervation following denervation. 
Myocardial norepinephrine release assessed by simu~aneously obtaining 
norepinephrine concentrations from aorta and coronary sinus blood 
samples was determined in 7 cardiac transplant recipients who also had 
MIBG scintigraphy at 2 years (6 patients) and 1 year (2 patients) after 
transplantation. In 5 of the 7 patients with positive MIBG uptake, 
transmyocardial norepinephrine release was present and in 2 remaining 
patients with absent myocardial MIBG uptake, there was no 
transmyocardial norepinephrine release. 
Patient TMNER 
1 +104 
2 + 42 
3 
4 
5 
6 
7 
+43 
+128 
+112 
- 26 
-172 
positive 
positive 
positive 
positive 
positive 
negative 
negative 
Thus the positive predictive accuracy of transmyocardial norepinephrine 
release compared to MIBG scintigraphy in detecting cardiac sympathetjc 
reinnervation is 100%. These findings suggest that cardiac reinnervation 
can be identified accurately by assessing transmyocardial 
norepinephrine release in cardiac transplant recipients. 
876-2 
Rejection After Cardiac Transplantation is Accompanied 
by Increased Myocardial cAMP Content • Implications for 
a Rejection Marker ? 
Heiko von der Leyen, Andreas Miigge, Andreas Hecht, Bernd 
Heublein, Wilhelm Schmitz#, Hasse ScholZ#, Axel Haverich, Paul R. 
Lichtlen. Medizinische Hochschule, Hannover, and, #Universitats•
Krankenhaus Eppendorf, Universitat Hamburg, Hamburg, Germany 
Cyclic AMP (cAMP) is involved not only in regulating cardiac 
contractility, but also in mediating pathways of several mitogenic 
factors. To evaluate a possible link between rejection and myocardial 
cAMP content we determined myocardial cAMP levels in 33 patients 
(pts) after cardiac transplantation (Ix). During routine follow-up ~ter 
Tx right ventricular biopsies were taken for morphological evaluatton 
and biochemical assay. Acute cellular rejection grading (Hannover 
classification) was done by an experienced pathologist 10 pts had 
angiographic evidence of transplant coronary vasculopathy (ICV). 
cAMP content was determined by radioimmunoassay. Pts investigated 
showed no differences regarding major clinical variables including 
catecholamine levels. Cyclic AMP levels (pmoVmg wet weight) were 
as follows (mean ± SEM): 
Cellular reject jon TCY n cAMP level 
no no 9 1.41 ± 0.12 
noyes 6 2.24 ± 0.60 
yes no 14 2.25 ± 0.29** 
yes yes 4 5.96 ± 1.62**1+++ 
** P < 0.01 vs. "no rejection", +++ p < 0.001 vs. "no TCV" 
Pts with cellular rejection had significantly higher cAMP levels 
compared to pts without evidence of cellular rejection. Pts with both 
vascular and cellular rejection had the highest cAMP levels. Possible 
as yet speculative explanations for the increased cAMP levels in p~ 
with rejection include changes in activity of the coupling G protem 
(eg. increase in Gs), alterations in the breakdown of cAMP (decreased 
activity of cAMP POE), or stimulation of a specific isoform of 
adenylate cyclase by mitogenic mediators (eg. growth factors) 
involved in the process of rejection. 
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876-3 
Neutralization of Tumor Necrosis Factor·a Reduces Expression 
of Vascular Adhesion Molecules and Associated Intimal 
Thickening in Rabbit Cardiac Allografts 
Silvana Molossi, Nadine Clausell, Suvro Sen and Marlene 
Rabinovitch, Division of Cardiovascular Research, The Hospital 
For Sick Children, Toronto, Canada 
Expression of adhesion molecules, i.e .. vascular cell adhesion 
molecule-l (VCAM-I) and intercellular adhesion molecule-I 
(lCAM·l), occurs in myocardium and coronary arteries (CA) of 
cardiac allografts. Their presence on an activated endothelium 
promote adhesion and transendothelial migration of inflammatory 
cells. Tumor necrosis factor (TNF)-a increases the expression of 
these molecules, but the influence of cyclosporine A (esA) 
remains controversial. We thus compared, in cholesterol-fed 
rabbits after heterotopic cardiac transplantation, the effects of 
neutralizing TNF·a using TNF·Q soluble receptor (sr) and the 
influence of CsA on the expression of VCAM·l and ICAM-I in 
the CA. We also investigated the effect of TNFsr on the 
expression of TNF·a itself. The immunohistochemical studies 
were performed using monoclonal antibodies. The animals were 
fed a cholesterol-rich diet and received CsA (n=5), saline (n=5), or 
TNFsr (n=6). The rabbits were sacrificed at 9 or 10 days after 
cardiac transplantation. All donor hearts showed grade III 
rejection, except the CsA group which showed only grade I. All 
host vessels were negative for all molecules. In the saline-treated 
group, donor vessels showed intense positivity for ICAM-l, 
VCAM-l and TNF-a. But, in donor vessels from both CsA- and 
TNFsr-treated groups, there was minimal endothelial expression of 
those molecules and of T cells and reduced intimal thickening. 
Thus, TNFsr appears to interfere selectively with the immune•
inflammatory reaction and expression of adhesion molecules and 
TNF-a, decreasing the vascular changes associated with graft 
arteriopathy. CsA, however, causes generalized suppression of the 
immune-inflammatory response and this includes the development 
of arterial lesions within this experimental time frame. 
876-4 
Persistent Elevation of Neurohormones Despite Correction of 
Systolic Heart Failure by Cardiac Transplantation 
Rebecca Quigg, Domenic Sica, Livia Griffith, Peggy Roberge, JealUle Salyer, 
Todd Gehr and Roger Quint. Medical College of Virginia, Richmond, Virginia. 
Plasma norepinephrine (NE), atrial natriuretic peptide (ANP) and plasma renin 
activity (PRA) are elevated in patients with severe heart failure. It is unknown 
whether these neurohormonal abnormalities COlTect following cardiac 
transplantation (Tx) or if they contribute to abnormal post-Tx peak exercise 
VO, (VO",) by causing alterations in vascular tone and/or fluid balance. 
Therefore, we measured resting NE, PRA, ANP and VO,p in 54 pts who were 
between I mo to 7 yrs post-Tx: Gr I, <3 mos (n=19); Gr 2, 3 mos-2 yrs 
(n= 13); and Gr 3, > 2 yrs (n=22), and compared values to those of 18 normal 
subjects (NI). The relationships between neurohormone levels and V02p, mean 
arterial pressure (MAP), serum creatinine (Cr), cyclosporine dose and level, 
and number of rejections were evaluated by multivariant analysis. Data are 
expressed as mean ± SEM; 'p<O.OS vs NI. 
QLl 
NE (pJlml) 388.0±63.6 
ANP (fmolclml) 17.7±1.9' 
PRA (nalmilbr) 6.S ± 1. 7' 
VO", (mltq/min) 20.4±0.9' 
MAP (mmH.) 107.3±2.9' 
!kl 
437.9±73.9 
19.1±3.6' 
S.5±1.9 
22.S±2.6' 
1l0.2±2.7' 
QL1 , 
446.8±S7.1 
22.S±3.8' 
3.8±1.2 
23.6±1.1' 
112.9±2.S' 
N! 
231.0±30.8 
S.S±0.8 
1.2±0.2 
4S.3±2.4 
92.8±1.9 
Plasma levels of NE, ANP and PRA were all elevated post-Tx. NE and ANP 
appeared to increase over time while PRA decreased. Plasma NE level. were 
significantly colTelated with serum Cr (r=0.57; p=O.OOI) and PRA (r=0.36; 
p=O.OO7). ANP was highly COlTelated with the number of rejections (r=0.43; 
p=O.OOI). There was a negative colTelation between PRA.nd MAP (r=-O.33; 
p=0.02). No relationship was observed between VO", and NE, PRA or ANP. 
These data suggest that elevated NE post-Tx may be related to cyclosporine•
induced renal insufficiency and that progressive elevation of ANP post-Tx is 
related to reculTent rejection. However, these neurohormonal aberrations do not 
appear to be contributing factors to low exercise VO", in post-Tx pts. 
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876·6 
Nitric Oxide and Pulmonary Vascular Assessment Prior to Heart 
Transplantation 
Ian Adatia, Stanton Perry. Phillip Moore. Michael Landzberg. 
David L. Wessel 
Children's Hospital, Harvard Medical School, Boston, MA 
The eligibility of patients under consideration for heart transplantation is 
influenced by the preoperative assessment of pulmonary vascular reactivity. 
Diagnostic use of intravenous pulmonary vasodilatOR is limited by systemic 
hypotension increased intrapulmonary shunt (Qs/Qt) and secondary changes 
in cardiac index (CI). We have investigated the use of inhaled nitri~ oxide 
(NO) at 80 ppm for 1 S minutes during cardiac catheterization in S patients 
(median age 9 yn) with severe ventricular failure who had been denied 
heart transplantation because of increased PVRI. Two patients had acquired 
disease and 3 had congenital heart disease. 
PAp BP LAp Cl PVRI SVRI Qs/Qt 
mmHg mmHg mmHg lImin/m' U'm' U·m' % 
Baseline 70±IS 73±2 23:1:3 2.8:tO.2 16±4 22±2 17±4 
NO S7±13" 76±6 28~ 3.l:tO.S 8±2' 22±3 13±2 
• p < O.OS 
NO produced selective pulmonary vasodilation in all patients. Two of three 
patients who responded to NO with a reduction of PVRI < S.S U·m' have 
undergone heart transplantation with low PVRI postoperatively. One is 
awaiting heart transplantation. Of 2 patients whose PVRI did not fall 
below 8 U'm', I underwent heart and lung transplantation and I died while 
waiting for a donor. In conclusion, NO is an effective pulmonary 
vasodilator without advene systemic effects which may prove valuable in 
the assessment of candidates for a heart or combined heart and lung 
transplantation. 
ABSTRACTS 141A 
876·7 
Intrarenal Angiotensin II Antagonism Restores the Natriuretic 
Response to Acute Volume Expansion in Cyclosporine Treated 
Dogs 
Sharon M. Sandberg, Martha Grogan, Cheol H. Kim, Terry J. 
Opgenorth*, and Brooks S. Edwards, Abbott Labs*. Abbott Park, IL 
and Mayo Clinic, Rochester,MN. 
Chronic administration of cyclosporine (CYCLO) results in an 
impaired natriuretic response (UNaV) to acute volume expansion and 
activation of the renin-angiotensin-aldosterone system. We have 
previously reported that systemic inhibition of angiotensin D (All) in 
CYCLO treated dogs diminishes both the rise in ANF associated 
with acute volume expansion and the increase in UNaV. We 
hypothesized that intrarenal inhibition of AD would restore UNaV to 
acute volume expansion in CYCLO (2Omglkgld) treated dogs. The 
response to acute volume expansion in CYCLO treated dogs 
receiving intrarenal administration of the All antagonist A81988 
(O.OOO8Smglkglmin x 9Omin, Gr.l) was compared to CYCLO and 
systemic AD blockade (O.lmglkg/d p.o.,Gr.2l and CYCLO 
alone,(Gr.3). The effects at peak volume expansion are reported 
below. 
Urine Row UNaV 
(mllmin) (1JEq/min) 
Gr. 1 7.8±1.2* 983±140* 
Gr. 2 4.0±1.O 467±108 
Gr. 3 6.8±1.6 804±206 
(*p<O.OS Gr. 1 vs Gr. 2, tp<O.OS Gr. 1 vs Gr. 3) 
ANF 
(pglml) 
332±109*t 
48±12 
109±20 
In cyclo treated dogs despite similar mean arterial pressure, intrarenal 
but not systemic inhibition of AD normalized the natriuretic response 
to acute volume expansion. This data suggests that cyclosporine 
promotes sodium retention by stimulating intrarenal angiotensin D. 
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877·9 
~ cI DobIl1amIII8 sn. ~ ID. NOII'JmuIn 
Enluatkm cI CazdIao AIIognft Vucn1Jop&thy. 
Xwame O. Akosah, John T. Funal, Anthony J. Minisi, Chauncey W. 
Crandall, Pramod It Mohanty, Med Coll of VA and McGuire VA Med CII', 
Richmond, VA 
Coronary artery disease (CAD) Is the leading cause of mortality aIIer 
cardiac transplantation (CT). Although, coronary angiography (anglo) is 
considered the gold standard for diagnoais of CAD, It tends to under 
estimate the utent of allograft CAD. We prospectively studied 41 CT 
patienta (pta) by dobutamine stresa echocardiography (DSE:) to determine 
If the praence of CAD could be predicted. DSE was conducted 
according to a BIandard protocol (dob: S, 10, 20, 30 and 40 mcg/kg/min 
at 5 min stages) and compared to anglo perfonned within 48 hours of 
each other. Positive DSE: was delined as a new or worsening LV regional 
wall motion abnormality (RWMA). A positive anglo was ddnecI 
according to Gao'. criteria. Both DSE: and anglo Interpratem were 
blinded. The IM8n dUl8.tion Bince transplantation was 58.±12 months. 
Results: 
ANGlO (+) ANGlO (.) 
DSE: (+) n=20 n= 9 
DSE: (-) n= I n=ll 
Of 21 (51%) pta with CAD by anglo, 20 had positive DSE with a 98% 
positive concordance. Of 12 pta with negative DSE. anglo was negative 
in 11 with a negative concordance of 92%. If CAD Is defined only by a 
positive DSE:, the prevalence of CAD In CT pta Is 71 %. However, If CAD 
Is defined by a positive anglo, the prevalence Ia S I % which may be due 
to poor aensilivity 01 anglo to detect dIlfuae Inl&ll Y88SOl disease. 
Conclusion: (I) DSE Is a reliable non·lnvaatve test to detect 
physiologically significant allograft CAD. (2) A negative DSE In CT 
reclpienta is strongly predictive of abaence of detectable CAD by anglo. 
We speculate that DSE may allow detection of post transplant 
vuculopathy not apparent by anglo. 
142A ABSTRACTS 
877·10 
The Addition 01 Adenosine to Dobutamlne Increua the Sensitivity 01 
Detectllll WaD Motion Abnormalities In tbe Ischemic Canine Model. 
Sandeep Khurana, Petar Prcevski, Steven Laviae. Wayae State 
Uaiversity /Harper Hospital. Detroit. MI 
Pbarmacologic stress ecbocardiography witb dobutamine bas 
demoastrated seasitivity approaching 90% for multivessel coronary artery 
disease; bowever. its seasitivity for siagle-vessel disease is oaly 60%. Adenosiae 
is anotber agent tbat bas been used for pharmacologic stress ecbocardiograpby 
and is believed to produce ischemia via coronary "steal". We sought to test the 
bypotbesis tbat these two agents used in combination may evoke a greater 
degree of ischemia by nOi oaly increasing myocardial oxygen demand but also 
decreasing supply. In live open-chest dogs. a pbysiologically sigailicant stenosis 
was created in tbe proximal circumflex artery. such that reactive byperemia to 
tbree consecutive 15-second occlusioas was abolisbed. Tbe stenosis was 
conflJ'Dled by coronary angiograpby to be > 80% in diameter reduction, and no 
echocardiograpbic wall mOlion abnormality was induced. Coronary flows in tbe 
left anterior descending (LAD) and circumflex artery (Cx) distal to the stenosis, 
along with bemodyaamics, were continuously recorded. Pbarmacologic stress 
ecbocardiography was performed witb increasing doses of dobutamine. after 
whicb adenosine (150 meg/kg/min) was added and ecbocardiograms repeated. 
Regional wall tbickening and endocardial motion were analyzed on digitized left 
ventricular short-axis views at the mid·papillary level using tbe centerline 
method. Compared witb dobutamine alone (at IOmeg/kg/min). tbe addition of 
adenosine resulted in sigaificant (> 2 standard deviatioas of normal) worsening 
in wall thickeaing and endocardial motion in tbe ex distribution in eacb dog. 
A concomitant decrease in mean aortic pressure from 118 to 85 mm Hg was 
observed and the Cx flow decreased from 49 to 46 mlfmin while the lAD flow 
increased from 37 to 51 ml/min. Thus, the ex/LAD flow ratio decreased in 
each dog. 
In conclusion. the addition of adenosine to relatively low doses of 
dobutamine increases the sensitivity of detecting wall motion abnormalities 
during pharmacologic stress echocardiography in a model simulating single· 
vessel coronary artery disease by inducing coronary steal. 
877·11 
Dobutamine Stress Ecbocardiograpby in Patients witb 
Severe Aortic Stenosis and Low Transvalvular Gradients. 
Christopher R. deFilippi. DuWayne L. Willett. M. Elizabeth 
Brickner, 1. Fernando Triana, Eric 1. Eichhorn. Paul A. Graybum. 
UT Soutbwestern & VA Medical Centers, Dallas, TX. 
Patients (pts) with severe aortic stenosis (AS) and a low transvalvular 
mean pressure gradient (MG) are at high risk for aortic valve 
replacement. Some such pts have anatomically severe AS with 
reversible LV dysfunction. Others may have a small effective aortic 
valve area (A V A) due to severe LV dysfunction and low tranSValvuJar 
flow, sucb that an increase in flow could significantly increase 
calculated A VA. This study was undertaken to detennine if low dose 
dobutamine stress echocardiography (DSE) could distinguish these 
hemodynamic subsets. We studied 12 pts (mean age 68 ± 8) with 
severe AS (A V A 0.8 ± 0.2 cm2). low MG (22 ± 6 mmHg). and poor 
LV function (EF 31 ± 4). Eight pts had coronary artery disease with 
prior myocardial infarction. Regional wall motion. MG, and A VA 
were assessed echocardiographically at baseline and during DSE. 
Contractile reserve was defined as ~ 20% improvement in wall 
motion score and enhanced wall thickening in at least 2 adjacent 
segments. Three hemodynamic subsets were identified. Group I 
consisted of 6 pts with contractile reserve in whom MG increased 
from 10-30 mmHg with no change in AVA. fmdings consistent with 
severe AS and viable myocardium. Group II was comprised of 2 pts 
with contractile reserve in whom A VA increased from 0.8 to 1.1 cm2 
with no change in MG. suggesting decreased effective A VA without 
anatomically severe AS. Group 1lI included 4 pts without contractile 
reserve and no change in MG or A VA. findings consistent with non•
viable myocardium. 
Conclusions: DSE may be valuable in assessing the hemodynamic 
profile of patients with severe aortic stenosis and low transvalvular 
gradients. These hemodynamic subsets may prove to be clinically 
useful in predicting wbich patients are likely to benefit from aortic 
valve replacement. 
lACC February 1994:1A-484A 
877·12 
Tbe Usefulness of Dobutamlne Stress Echocardlograpby for 
Detecting Restenosis after PTCA 
*Masaaki Takeuchi. Hidekazu Nandate. Yasushi Miura. Yasuhide 
Nakashima. Akio Kuroiwa 
The 2nd Dept. of Internal Medicine. University of Occupational and 
Environmental Health. Kitakyushu. lapan. 
The noninvasive detection of restenosis is c1inicaIly important in the 
management of patients who had perfonned PI'CA. The aim of this 
study was to examine the usefulness of dobutamine stress 
echocardiography (DSE) for detecting restenosis after PI'CA. Forty· 
five consecutive patients referred for the evaluation of possible 
restenosis or scheduled for follow-up study underwent DSE mean 7.8 
months after angiographicaIly successful PI'CA. Forty patients had 
perfonned single-vessel PI'CA (34:single lesion. 6: multi-lesion in 
the same vessel) and the other 5 patients multi-vessel PI'CA. Thirty•
four patients had a history of previous MI. All patients were studied 
while receiving their antianginai medication. Dobutamine was infused 
incrementally (5-30 mcg/kg/min) under 2-D echocardiographic 
imaging. The LV was divided into 16 segment model and grouped 3 
coronary vascular teritorries. To analyze of wall motion. rest and peak 
images were digitized for quad screen fonnal. The positive findings 
for restenosis was defined as new or worsened wa:lI motion 
abnonnality at previously dilatated site. Stress TI SPECT (SPECT) 
and quantitative CAG was perfonned following DSE. Restenosis was 
defined ~ 50% diameter stenosis at the dilated vessel. Restenosis was 
angiographicaIly demonstrated in 26 (58%) patients and in 30 (60%) 
vessels. The sensitivity of DSE and SPECT for detecting patients 
with restenosis was 77% and 80%. specificity was 84% and 68%. and 
accuracy was 80% and 75% respectively. In total 50 vascular regions. 
DSE had a 73% sensitivity and 85% specificity for detecting 
indivudial restenosis. In 6 patients who had false negative results of 
DSE. 2 had a branch restenosis and the other 2 had mild stenosis 
«70%). It is concluded that DSE has a comparable accuracy to 
SPEer for detecting restenosis in patients after PI'CA. 
877·13 
Chest Pain In Association Witb Dynamic Left Ventricular Outflow 
Obstruction During Dobutamine Stress Testing 
Herman Movsowitz. Craig Lampert. Alfred loli. Larry E. Jacobs. Morris N. 
Kotler. Albert Einstein Medical Center. Pbiladelphia. PA. 
120 consecutive patients with IlUSpeCted coronary artery disease underwent 
continuous wave and pulsed wave Doppler evaluation of left ventricular 
outflow velocity during incremental dobutamine infusion (S - 40 I'I'ftIkg/min). 
Regional wall motion abnormalities (RWMA) were assessed by two•
dimensional ecbocardiograpby in the panstemaJ and apical views. Standard 
electrocardiographic (ECG) criteria for iscbemia were employed. All patients 
bad normal outflow velocities at rest « 1. 7m/s). No patients bad asymmetric 
septal bypertropby. No patients bad systolic anterior motion (SAM) of the 
mitral valve at rest. 30 of the 120 patients developed anginal type cbeIIt .,.m 
during dobutamine stress testing. Two subgroups of patients with cbeIIt .,.m 
were identified: GROUP A developed early peaking outflow velocity paIIerDI 
and GROUP B developed late peaking ·daeger-sbaped· outflow velocity 
patterns. The groups were similar for " expected heart rate achieved. doubIe 
product and peok dobutamiae dose. 
GROUP A GROUP B PVAL 
no. of patients 20 10 
ischemic EeG changes 10 (SO") 0(0") 0.01 
inducible RWMA 15(75") 0(0") <0.001 
peok outflow velocity 1.9" 05 3.9 " 1.0 <0.001 
inducible SAM 0(0") 4 (40") 0.01 
I : 
1) Dunng meremental dobutamiae infusion. chest pain may occur without 
iscbemic BCG changes or inducible regional wall motion abnormalities. 
2) Chest pain in some patients is statistically associated with late peaking high 
velocity outflow patterns and SAM. 3) The mechanism of chest pain in these 
patients appears to be due to dynamic outflow obstruction. 
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877·14 
exercise and Dobutamlne Stress Echocardlography In 
Patients with Left Ventricular Hypertrophy and 
Suspected Coronary Artery Disease. 
Adel S. Yaacoub, Stephen P. Wlet, Rajesh Sehgal, Charles J. 
Davidson. Robert O. Bonow. Carl L. Tommaso. Farooq A. 
Chaudhry Northwestern University and VA Lakeside Medical 
Center, Chicago, IL. 
The usefulness of exercise and dobutamine echocardiography 
(ExSEJDSE) in the diagnosis of coronary disease (CAD) in 
patients (pts) with left ventricular hypertrophy (LVH) is unknown. 
We performed ExSE/DSE in 63 pts with LVH by echo and 
compared them to 34 age matched pts (mean age 63 ± 8 yrs) 
without LVH. All pts underwent ExSE/DSE because of suspected 
CAD and all had coronary arteriography within 30 days. 
Significant CAD was determined quantitatively (Artrek) as the 
presence of ~ 50% stenosis in .. 1 coronary artery. Positive 
ExSE/DSE was the development of new or worsening 01 
preexisting segmental wall motion abnormalities. CAD was 
present in 87% of LVH pts and 78% in pts without LVH (p=ns). 
Positive ExSE/DSE was present in 78% and 65% respectively. 
Sensitivity (SN), specificity (SP) and predictive value (PV) are: 
Group 
LVH 
No LVH 
p value 
§Ii. 
84% 
88% 
NS 
SP 
75% 
100% 
NS 
PI! 
84% 
91% 
NS 
Thus, LVH does not influence sensitivity of ExSE/DSE. 
However, these data support the concept that the specificity and 
the predictive value of ExSE/DSE may be decreased in the 
setting of LVH. 
877-15 
Dobutamlnt Stress Echocardlography In the Presence of Left 
Bundle Branch Block: Clinical Utility. 
Raffi Krikorian, Stewart Jones, Sal SisiJo, James L. Vacek, Thomas L. 
Rosamond. Mid America Heart Institute and Saint Luke's Hospital of 
Kansas City, Missouri. 
The clinical utility of dobutamine stress echocardiography (DSE) in the 
presence of left bundle branch block (LBBB), has not been adequately 
described. Other imaging modalities sucb as myocardial scintigraphy 
in patients with LBBB have proven to be problematic, particularly using 
stress protocols associated with an increase in heart rate (exercise 
stress). In order to determine the usefulness of DSE and assessment of 
induced regional wall motion abnormalities in this setting. we 
retrospectively studied 32 of 626 consecutive studies performed in the 
presence of !BBB (5.1% incidence). The mean age in patients with 
LBBB was 75.7 ± 9 years significantly older than the unselected DSE 
population. 65 ± 12 years. Maximum heart rate attained (115 ± 19 
bpm), percent maximum heart rate achieved (SO ± 13%), and peaJc 
infusion rate (35 ± 8 mcglkgtmin.) were not significantly different than 
the unselected popUlation. The mean resting ejection fraction for 
patients with LBBB was 39 ± 19% (vs 54 ± 10% for all pts). LBBB 
patients were followed for a mean of 19.6 ± 14 months. In patients 
with cardiac catheterization within six months of the study (60%), the 
sensitivity was 100%, specificity 67%, accuracy 89% for coronary 
artery disease. In patients followed without caths, a negative study was 
not associated with adverse cardiovascular outcomes. There were no 
adverse clinical outcomes induced by DSE in these patients. 
SUMMARY: DSE in the presence of LBBB is an acceptably accurate 
test but suffers from a relatively low specificity. Patients submitted to 
DSE with LBBB tend to be older than unselected patients, with a trend 
toward lower ejection fractions. 
ABSTRACTS 
877·16 
Muhlstage Dobutamine Echocardiography Identifies High Risk 
Patients alter Acute Myocardial Infarction Treated whh Thrombolysis 
Maarten J. Cramer, Wybren Jaarsma. Cees A. Visser. Eugene M. Buys, 
Maarten J. Suttorp, Carl A.P.L. Ascoop. St. Antonius Hospital. 
Nieuwegein. The Netherlands 
Purpose of the study: risk stratification alter acute myocardial infarction 
(AMI) traated wtth thrombolysis. Methods: 53 pts underwent multistage 
dobutamine (0) echocardiography and cardiac catherization 7 .. 2 days 
after AMI. At low-dose 0 (5-10 mcg/kg/mln) Infusion attention was paid 
to identify contractile reserve (viabiltty) In the infarct zone. High dose 0 
(30-40 mcg/kg/min) infusion was performed to detect worsening or new 
wail motion (WM) abnormaltties. indicating Ischemia. 
Results: improvement of WM in the Infarct zone at low-dose was present 
In 31 pts (58%). indicating viabiltty. At high-dose. WM worsening Indicat•
ing Ischemia. was detected In 28 pts (53%). If viability In the Infarct zone 
was present. accuracy of WM worsening to predict residual stenosis 
(> 70%) was 88% (22 of 25 pts). In the absence of viability. however. the 
accuracy of WM worsening for detection of residual stenosis was 50% (5 
of 10 pts). Remote asynergy after hlgh-dose O. correctty predicted 
multivessel disease In 9 of 10 pts. all 3 vessel disease pts (5) were 
correctly identified. New ischemic events occurred In 25 pts (47%) after a 
mean follow-up of 9 months. Events occurred in 20 (71 %) wtth WM 
worsening at high-dose and in 5 (20%) of 25 pts wtthout WM worsening. 
Only 1 of 12 pts who had no improvement of WM at low-dose and no 
WM worsening at high-dose in the infarct and/or remote zone had an 
event. 
Conclusion: 1) worsening of WM at high-dose 0 especially In combina•
tion wtth improvement of WM at low-dose 0 Is highly Indicative for a 
significant residual stenosis in the infarct related artery. 2) induced 
remote asynergy at high-dose 0 is predictive of multivessel disease. 3) 
multistage dobutamine echocardiography identifies pts who are at high 
and at low risk for new ischemic events following myocardial infarction 
treated wtth thrombolysis. 
877·17 
Left Ventricular Oudlow Obstruction IIDd H)'IIOWIslw Response J)urIq 
Dobutamlne Stress Edloeardiography: Is There a RdaUonship? 
Sheila K. Heinle, Frank D. Tice, Joseph KissIo. 
Duke University Medical Center, Dwbam, NC. 
To test the hypothesis that a hypotenSive response during 
dobutamine stress echocardiography (DSE) is not related to the 
development of left ventricular outflow tract (L VOT) obstruction, 95 
consecutive patients had pulsed- and continuous-wave Doppler examinations 
of the left ventricular outflow Il1Ict at resr and at peak dose during DSE. A 
hypotensive response was defined as a drop in systolic blood pressure (SBP) 
of ~ 15 mm Hg from baseline.. Left ventricular outflow Il1Ict obstructioIi was 
defined IS the development of a late peaking left ventricular outflow tract 
velocity which increased by ~ 1 m/St:K: from baseline.. 
.:l.SBf ~ ~ 
(n-19) (n-76) 
Age (years) 64±11 62 ± 14 0.6 
Sex (%men) 4291> 45% 0.9 
LVOT 0bstructI00 16% 13% 0.9 
Peak LVOT Velocity(m/St:K:) 2.0:1:0,6 l.9:tO.8 0,6 
Left Ventricular Hypertrophy 21% 29% 0,6 
Peak Dose (meg/kg/min) 3S:I: 7.JJ 37 ±S 0.1 
Baseline SBP (mm Hg) 156 :t 22 138:t 25 0J)()6 
Ischemia by DSE 32% 34% 0.9 
These dala demonstrate that a hypotensive response is.llll1 related 
to the development of left ventricular out1low tract obstruetion during 
dobutamine stress echocardiograpby. Rather, there is a significant 
association between higher baseline SBP and a hypotensive response during 
dobutamine infusion. 
143A 
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877·52 
Systolic Anterior Motion of the Mitral Valve During Dobutamine 
Stress Echocardiography in Normal Subjects Versus Patients 
Gabriela M. Hecht, John S. Gottdiener, Suzanne L. Vargot, Stephen 
R. Kraus, Bernadette B. Falcon, Georgetown University Medical 
Center, Washington, DC 
Inotropic drugs have been reported to elicit systolic anterior motion 
of the mitral valve (SAM) in the absence of hypertrophic 
cardiomyopathy. To determine whether dobutamine induces SAM 
and LV outflow obstruction during dobutamine stress 
echocardiography (DSE), we assessed the presence and degree of 
SAM, LV outflow peak velocity (Vpk) , LV end-diastolic volume 
and ejection fraction during our usual DSE protocol in 47 subjects: 
13 normal men (age 35 ± 5 yrs) and 34 clinical\y referred patients 
(age 62 ± 14 yrs, 59% male). Patients with SAM at baseline or 
prosthetic valves were excluded. At peak dose of dobutamine (30 
mcg/kg/min), 18 (38%) subjects had SAM; 14 without and 4 with 
(3 brief; 1 prolonged) mitral-septal contact. Vpk at peak dose of 
dobutamine was higher in subjects with SAM (2.3 ± 0.6 m/sec) 
than in subjects without SAM (1.8 ± 0.5 m/sec; p = 0.05). The 
maximum LV outflow gradient during DSE was 49 mmHg and 
occurred in 1 normal subject with prolonged mitral-septal contact at 
peak dose. Subjects with and without SAM did not differ in LV 
end-diastolic volume or ejection fraction at baseline or peak dose. 
SAM was more frequent in normal subjects (69%) than in clinical\y 
referred patients (26%; p=0.OO7). Potential\y adverse effects 
(arrhythmia, hypotension) were not more frequent in subjects with 
SAM. Conclusions: 1) While SAM commonly occurs during DSE 
at peak dose, particularly in normal subjects, it is rarely severe or 
accompanied by important LV outflow obstruction; 2) dobutamine•
induced SAM appears to pose no additional risk during DSE. 
877·53 
Comparison of Dobutamine and Dipyridamole Stress 
Echocardiography in Patients With Single and Multivessel 
Disease Undergoing PTCA 
Ursula M. Wilken shoff, Klaus SchrOder, Heinz Voller, Riidiger 
Dissmann, Hanso Dingerkus, Thomas Underer, Rolf SchrOder. 
Dept of Cardiology, Klinikum Steglitz, FU Berlin, Germany. 
To compare the validity of Dobutamine echocardiography test 
(DOT) and Dipyridamole echocardio~phy test (DIT) both stress tests 
were performed in 62 pIs with smgle (SVD) and 18 pts with 
multivessel disease (MVD) one day before and 2 days after successful 
PTCA. Results of DOT (10, 20, 30,40 j!g/kglmin in 3 min stages) 
and DIT (up to 0.84 mg/kg over 10 min) were interpreted by 2 blinded 
reviewers. The regions of stress induced wall motion abnormalities 
(WMA) were related to the location of coronary artery lesions. 
Results: Before PTCA DOT was positive in 47 pts (76%) out of 62 
pts with SVD while DIT was positive in 51 pts (82 %) resp. Both DOT 
and DIT could correctly identify the ischemia related single vessel in 
45 pts (73%). Non-conforming WMA were seen in DIT in 5 pts (8%) 
and in DOT in only 1 pt (2%). After successful revascularizatJon of all 
62 single vessels stress induced WMA were no longer detected in 60 
pts (97%) with DOT and 61 pts (98%) with DIT. 
In 18 pts with MVD 41 vessels showed angiographically 
significant stenosis. WMA were provoked in the corresponding 
regions of 28 (68%) vessels in DOT and of 24 (59%) in DIT 
respectively. In all but one pt both tests before PTCA were positive 
(94%). After successful PTCA of 20 affected vessels no stress 
induced WMA were seen in the corresponding regions with both DOT 
andDIT. 
Conclusion: DOT and DIT are equally sensitive methods in 
detecting a coronary artery disease. Concordance of stenotic vessels 
and ischemia induced WMA was better with both methods in SVD 
than in MVD and DOT seems to be slightly more reliable in MVD. 
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877·54 
Efficacy of Dobutllmlna Stlmulltlon In an Animal Modal of 
Hibernating Myocardium 
HoISI Mertes, Douglas S. Segar, Michael Johnson, Stephen G. Sawada, 
Thomas Ryan, Harvey Feigenbaum. Krannert Institute 01 Cardiology, 
Indiana University School 01 Medicine, Indianapolis, IN 
Dobutemlne (DOB) Infusion has been proposed as a method to detect 
hilemating myocardium (HM). However, studies have been hindered by 
the lack 01 an animal model 01 HM. We developed a canine model 01 HM 
and used the model to evaluate the response 01 HM to DOB stimulation. 
Our hypothesis was thai HM would demonstrate an increase In 
myocardial wall thickening during low dose DOB infusion. Under sterile 
condftions a limHed thoracotomy wae performed In 10 animals and a 
myocardial infarction (MI) created by selective coronary artery ligation. The 
animals were allowed to recover end studied at 3 days, 1, 2 and 4 weeks 
aIIer the MI at which time incrementel DOB Infusion was performed. Two•
dimensional echocardiographic views 01 the infarcted and nonlnfarcted 
areas were obtained prior to the MI and during each stage 01 the DOB 
infusion. The percent systolic wall thickening (%WT) was calculated at 
each time poin\. At the end 01 lour weeks the chest was reopened and a 
carotid artery to coronary artery bypass (CB) was placed distal to the 
ligation. Repeat measures 01 %WT were perfonned up to 1 hour alter CB. 
The transmural extent 01 the MI was determined by planlmetry of TIC 
stained slices of myocardium. 
. % Wall Thickening 
Base MI p!II·CB Post-CB %Transmural 
G!p 1 (11=7) 2H3 ·15±10 1±5 17±5 20-70 
Grp 2 (n=3) 20±3 -18±7 -9±3 -3±2 100 
During DOB infusion (5i!lVkglmin) the % WT increased to 151,116,117 and 
139 % 01 baseline at 3 days and 1,2,4 weeks respectively in Grp 1. In 
contrast there was no Improvement in %WT at any time in Grp 2. W. 
conclude: Improved %WT In Grp 1 myocardium alter CB demonstrated 
that such myocardium had reversl:>le dysfunction, and was therefore 
hibemating, thus validating an animal model 01 HM. Improvement In %WT 
during DOB Inlusion differentiated hibernating from irreversibly 
dysfunctional myocardium. 
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878·55 
Atherosclerotic Disease of the Aortic Arch and the Risk of 
Ischemic Stroke : Preliminary Results of a Case Control 
Stl;ldy, Frenc~ Study of Aortic Plaques In Stroke (FAPS). 
Ar~el Coh~n. PJel:re A.marenc~ on behalf of the F APS investigators, 
Samt Antome Umverslty Hospital and Medical School, Paris, France. 
": previous autopsy study in Stroke patienlS (Pts) has demonstrated 
a hIgh prevalence of ulcerated plaques in the aortic arch. To evaluate 
~e rela.tive risk of aorti~ plaques (AP) in patients aged ~ 60 yrs, with 
IschemIC stroke, we carned out a prospective multicenter case-control 
~tudy t.hat included consCt:utiwly 233 PIS (74.6±8 yrs) with cerebral 
l~farcl1on and 201 control PIS (72±8 yrs). A complete monoplane or 
bIplane Tl'ansesophageal Echocardiography (TEE) examination of the 
aorta \P, proximal aortic arch. Desc., descending, and Asc., 
ascendmg aorta) was performed without significant complications. 
The mam results are summaJized in the tahle. 
Patients Controls 
2<AP Asc + P Arch< 2.9mm 50 25 
3<AP Asc + PArch <3.9mm 33 13 
AP Desc. ~ 4mm 69 31 
AP Asc. + PArch <:4mm 19 2 
OR(CJ) 
l.2 (0.7-2.1) 
2.4 (1.2-4.7) 
2.3 (l.4-3.7) 
8.8 (20-38\ 
We found annOl'malthickening (>Omm) of the aortic arch in 27% of 
controls and 61'70 of Pts (Odds Ratio, OR = 4.4. 95% Confidence 
Interval. CI : 2.9-6:6, p<O.OOI). Atherosclerotic plaques (AP) ~ 4 
mm w\:re present In the ascending and aortic arch, in 2.5% of 
controls, 14.6'k of Pts (OR = 6.7,95% CI : 2.6-17.5), in 25% of 76 
Pts with stroke of unknown cause (OR = 13.1,95% CI: 4.7-36.5) 
and in 9.5% of 157 Pts with a known or uncertain cause or a 
presumed lacunar cause of stroke. There was no correlation with the 
prese~ce of internal carotid artt:ry stenosis, as assessed by duplex 
scanmng. 
In conclusion. atheroscleroti.c dise~se .of the aortic arch. detected by 
TEE. represents a strong l1sk t actor tor Ischemic stroke. 
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878·56 
Aortic Arch Atheromas as a Risk Factor for Cryptogenic Stroke 
Marco Di Tullio, Ralph Sacco, Douglas Kargman, Giuseppe Li Mandri, 
Derek Santiago, Renee Weslow, George Shapiro, David Leibowitz, 
Shunichi Homma. Columbia University, New Yorl<, NY. 
Aortic arch atheromas (AA) detected by transesophageal 
echocardiography (TE) have been recently proposed as a possible cause 
of unexplained (cryptogenic) stroke in elderly patients. However, the 
prevalence of AA in younger stroke patients, as well as in the general 
population, has not been investigated. We performed biplane TE in 63 
consecutive patients of all ages with acute ischemic stroke (26 M, 37 F, 
mean age 67.0 ± 13.0 years) and in 63 controls (40 M, 23 F, mean age 
66.7 ± 12.9 years) undergoing TE for reasons unrelated to stroke. Using 
NIH Stroke Data Bank criteria, 38 patients were classified as determined 
ischemic strokes (DIS) and 25 as cryptogenic ischemic strokes (CIS). The 
prevalence of large (~ 0.5 cm) or ulcerated andlor mobile AA was 
compared in the three groups according to patient age: 
CIS DIS Controls Pvalue 
All ages 
~0.5cm 6/25 (24%) 8/38(21%) 5/63 (8%) n.s. 
Ulc., mobile 4/25 (16%) 1/38 (3%) 4/63(6%) n.s. 
60+ years 
~0.5cm 6/17 (35%) 8/33 (24%) 5/50 (10%) <.05 CIS vs.Ctris 
Ulc., mobile 4/17 (24%) 1/33 (3%) 4/50 (8%) <.05 CIS vs.DIS 
No patient younger than 60 years had large or ulcerated/mobile AA. 
Conclusions: 1) Large AA by TE are more frequent in stroke patients 
than in controls, especially in patients aged 60 years or older. 2) Ulcerated, 
mobile AA appear to be associated with CIS in the elderly. 
878·57 
Reproducibility of Atherosclerotic Plaque Area 
Measurements in the Descending Aorta by Transesophageal 
Echocardiography. 
Zahi Khoury, Choni Rinat, Andre Keren, Jesaia Benhorin, 
Sh1omo Stern. Bikur Cho1im Hospital, Jerusalem, Israel. 
Atherosclerosis of the descending aorta is common in 
pts with coronary artery disease. We describe a new 
method for measuring mean area of the atherosclerotic 
plaque (P) and lumen in the descending aorta by 
transesophageal echocardiography (TEE) and its 
reproducibility were assessed. 256 transverse aortic 
segments, in 21 consecutive pts with angiographically 
proven coronary artery disease were assessed. 
Results: each pt underwent two TEE examinations by 
different sonographers. The descending aorta was 
divided into 15 segments in the transverse view, each 
segment 1 em apart from the other, starting 25 ems 
below the incisor teeth. The P and lumen area were 
measured in that half of the aorta which is distal from 
the probe. Intersonographer reproducibility was asses•
sed by a second TEE study performed immedhtely after 
the first study, using the same probe whl1e in the 
esophagus by a second blinded sonographer, intereader 
reproducibl1ity was assessed as well. The correlation 
coefficient (r) between the first and second study 
(intersonographer reproducibl1ity) was 0.98. The mean 
absolute difference between exams equal to 0.03 cm2 or 
9%. The r between the two readers was 0.83 with a mean 
absolute difference of 0.34 cm2 or 8.4%. 
Conclusion: We describe a new method for quantitative 
measurement of atherosc 1 erot i c aort i c plaque are with 
high i ntersonographer and i ntereader reproduci bl11ty. 
This method can be used to evaluate progression 
regression of aortic atherosclerosis. 
ABSTRACfS 
878·58 
Measurement of Thoracic Aortic Wall Thickness by 
Transesophageal Echocardiography: an in Vitro 
Validation. 
Michel A. Slama, Paul Fornes. Didier Heudes, Benoit 
Diebold. Jean-Yves Fagon. Michel Safar. H6pital Broussais, 
Paris. France. 
The aim of this in vitro study was to assess the thickness 
of descending thoracic aonic wall using transesophageal 
transducer. Autopsy segments of human descending 
thoracic aona were fixed and analyzed with a standardized 
protocol including the comparison between histological 
(H) data and echographic (Echo) measurements of intima•
media thickness (lMT). To obtain Echo cross-sectional 
images. a S mm interval separates the transducer (SMHz) 
from the specimens. Histomorphometric parameters were 
measured using an automatic image analyzer. For each of 
the 17 specimens. the mean values of 5 consecutive Echo 
measurements of IMT were compared to the H data. A 
correlation coefficient was calculated using a least 
squares regression analysis. Bias and precision were 
calculated for Echo vs H methods using the technique of 
Bland & Altman. The mean aonic IMT evaluated by Echo 
(l.72±O.25mm) was larger than the mean IMT measured by H 
(1.63±O.23)(p<O.02). There was a significant linear 
correlation between the measurements obtained with the two 
methods (r=0.94; p .. 0.0004; Echo=1.08H-0.04). Accuracy was 
excellent (biasc -O.09mm), while precision was acceptable (2x 
sda O.19mm). This study indicates that evaluation of aortic IMT 
using TET is highly correlated with H measurements. 
878·59 
145A 
Frequency and Distribution of Atherosclerosis in the 
Thoracic Aorta tn Patients With Coronary Artery Disease 
Zahi Khoury, Andre Keren, Shmuel Gottlieb, Shlomo Stern 
Bikur Cholim Hospital, Jerusalem, Israel. 
We prospectively studied with transesophageal 
echocardiography (TEE) 120 consecutive pts admitted for 
coronary angiography for suspected coronary artery or 
valvular disease, for detection of atherosclerotic 
plaques (P), their severity and distribution in the 
thoracic aorta. Normal or mild intimal irregularity 
were Grade I; increased echo density of the intima with 
well-defined atheroma extending <3mm in the aortic 
lumen were Grade II, atheroma >3mm Grade 111 and 
protruding mobile or pedunculated plaques were Grade 
IV. Grades II-IV were considered as thoracic aortic 
atherosclerosis. 
CAD (n-83) 
No CAD (n-37) 
P value 
Age AHT 
65 37% 
59 28% 
0.06 NS 
Cholt 
38% 
25% 
NS 
smoking 
32% 
15% 
<0.05 
PM aortic p 
15% 92% 
5% 20% 
NS <0.0001 
Results: TEE detected atherosclerotic P in 92% of pts 
with CAD in the descending (des) aorta, 67% in the arch 
and 38% in the ascending (asc) aorta. Only 20% of pts 
without CAD had atherosclerotic P in the des aorta and 
arch. Atherosclerotic P were stronger predictors for 
CAD than conventional risk factors. In CAD pts, 
atherosclerotic plaques were predominantly complex 
(Grade Ill, IV) in the des aorta and arch and all were 
simple in the asc aorta. The presence of 
atherosclerotic P in the des aorta had a sensitivity 
and specificity of 92% and 90%, respectively, for CAD. 
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878·60 
Value of Combined Transesophageal Ec:hoeardiography and 
Acoustic Quantl .... cation for the Early Detection of Abnormal 
Elastic Properties of the Aorta in Patients With MUd Madan 
Syndrome 
Andreas Franke, Heinrich G. K1ues, Eberhard G. MiIhler", Katja Peters, 
Wolfgang Lepper, GOIZ von Bernuth", Peter Hanrath, Medical Clinic I 
and Pediatric CardiOlogy", RWTH Aachen, Germany 
Prognosis in Marfan syndrome (MAS) is strongly influenced by compli•
cations due to diseases of the aorta. Evaluation of the elastic properties 
(EP) allows early detection of these abnormalities even in morphologically 
normal vessels without significant dilatation. 
In 10/17 patients (pts) with MAS (mean 31 years) and in a control group 
of 12 normal pts (mean 27 years, p = n.s.) transesophageal 
ecbocardiography was performed. Descending aorta (AOD) was visualized 
in a short axis view, acoustic quantification (AQ) was used for the on-line 
evaluation of maximal area changes of AOD over time (dA/dt). Maximal 
and minimal diameter (d",.., d,.;" in cm) were also obtained from 2D stop 
frame images. Following parameters were calculated using noninvasively 
measured blood pressure: compliance (C; Wcm2ciyn·I), distensibility (D; 
cm2ciyn·l) and stiffness index (S1). There were highly significant 
differences between the two groups in all parameters (* = p < 0.05, 
•• = P < 0.01, ••• P < 0.005; all values mean ± standard 
deviation). 
d... d.,. dAldt C D SI 
Normal !.8±O.t U±O.t ?.2±2.2 U±J.S 5.6±2.2 fi.5±l.3 
•• •• ••• * •• • •• 
MAS 2.3±O.4 2.2±O.4 S.8±2.0 4.9±t.? 3.2±l.O IO.S±3.3 
Conclusion: In MAS, even in absence of vessel dilatation EP of the AOD 
are significantly different from normal controls. On-line assessment of 
maximal dA/dt by AQ correlates well with standard measurements of C, 
D and SI, allows differentiation from normals and represents a new, safe 
and less time consuming method for the evaluation of this disease. 
878·77 
Atheromatous Plaques In the Thoracic Aorta are Aasoclated 
With Decreased AortiC Dlatenslblllty Evaluated With 
Tranaoesophageal Echocardlography and Automatic 
Boundaries Detection 
George Athanassopoulos, Cristopher OIympios, Stefanos Foussas, Dennis 
V. Cokkinos. Echocardiography Laboratory, Cardiology Department, 
Onassio cardiac Surgery Center, Athens Greece. 
We investigated whether the presence of atheromatous plaques in the 
aortiC wall as assessed by transeosophageal echocardiography (TEE) was 
aSSOCiated by decreased aortic distensibility. For the evaluation of aortic 
distensibility real time automatic detection and tracking of aortic wall 
boundaries (ABO) was applied to TEE conventional imaging. Twenty two 
consecutive patients (pts) with various pathologies were prospectively 
studied. Nine were found to have atheromatous plaques in the thoraCIC 
aorta(Ao) (group Ath), where the other 13 had no evidence of wall 
pathology (group N). the 2 groups had similar age, gender distribution and 
thoracic Ao diameter. 
To evaluate aortic distensibility Peterson's pressure strain modulus 
Ep was estimated using the ABO derived area changes (dAtA) of des•
cending thoracic Ao during cardiac cycle and the pulse pressure (PP) from 
Simul·taneous brachial artery blood pressure measurements: Ep:PP.AldA 
(dyn·cm·2). 
Group Ath showed evidence of decreased distensibility having 
smaller dAtA changes of descending Ao during cardiac cycle (%: 9.2±4.7 
VS 14.6:1:7.8, p<O.05) and increased Ep (dyn·cm-2.1Q6: 1.20:1: 0.81 vs 
0.46:tO.47 p<O.01). In group Ath 319 pts wHh plaques only in descending 
Ao had similar Ep with the other 6pts having plaques both in the arch and 
descending Ao (1.12:10.76 vs 1.26:1:0.88). 
In conclUSion, the presence of atheromatous plaques in the aortic 
wall was strongly related to decreased aortic distenSibiiny as clinically 
expected. ABO of the aortic wall with TEE is feasible and provides an new 
sensitive means for evaluation of aortic distensibility in vivo. 
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878·78 
Prognostic Significance of Thrombo - Occluded Aortic Dissection 
Diagnosed by Transesophageal Ecbocardiography 
Makoto Matsumura, Elina Yamada, Sousuke Kimura, Shunei Kyo, 
Yuji Yokote, Ryozo Omoto. Saitama Medical School, Saitama, Japan. 
To analyze relations between prognosis and transesophageal 
echocardiographic (TEE) findings in patients with aortic dissection 
who has absent flow in the false lumen, we studied 52 pts (16 
Stanford type A and 36 type B) treated conservatively in acute 
phase. Aortic dilatation (dimension ~ 4cm), presence of ulcer-like 
echo (ULE) in thrombosed false lumen and echo intensity . of 
thrombus in the false lumen were evaluated by TEE within 3 hours 
to 3 days and cineangiogram within 2 weeks after onset of dissection. 
All were followed up for 2 days to 8 years. 
Total ~ AOD(cm) ULE Soft Th. 
A B 4~ 4< + +-
Event % 31 56 19 57 13 42 19 60 23 
Mortality % 6 12 3 10 3 12 0 20 2 
TEE showed aortic dilatation in 21 pts, ULE in 26 and soft thrombus 
in 10. Cardiovascular event (shock, heart failure, back pain) occurred 
in 16 pts (31%) after initiation of medical therapy. Surgical operation 
was necessary in 9 patients (17%) becase of progressive dilatation 
and dissection, re-dissection, pericardia! tamponade and aortic 
rupture. Three pts died from aortic rupture and pericardia! 
tamponade in acute phase, and one had a sudden death after 6 
months follow-up (mortality:6%). Occurrence ratio of cardiovascular 
event and mortality were higher in patients who had Stanford type A. 
aortic dilatation, ULE or soft thrombus. In conclusion, patients with 
thrombo-occJuded type aortic dissection in whom TEE reveals 
aortic dilatation, ULE and/or soft thrombus should be kept under 
close medical observation considering early surgical operation in 
acute phase to prevent the aortic rupture and pericardia! tamponade. 
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879·100 
Coronary Stenosis Angiographic Findings Before and 
After Acute Myocardial Infarction in Patients with 
Angina Pectoris 
Diminis TousouIis, Tom Crake, Stuart Rosen, Neal Uren. Agha W. 
Haider, Graham Davies. Cardiology Unit, Royal Postgraduate Medical 
School, Hammersmith Hospital, London. UK. 
Previous studies in patients (pts) with coronary artery disease have 
demonstrated that assessment of the severily of coronary stenosis may be 
inadequate for accurate prediction of the time or location of subsequent 
coronary occlusion that will produce a myocardial infarction (MI). It is not 
known wbether coronary stenoses which progress to MI have similar 
angiograpbic chatacteristics 10 the 'stable' lesions in the same pts. 
The severity and morphology of coronary stenosis in both the infarct related 
artery (IRA) and the DOn-IRA was assessed by computerized edge detection, 
in 32 consecutive pts (27 male. 5 female; mean age 54±10), of wbom 30 
gave a history of angina, in coronary angiograms oblained 16.3±3 (range 1-
63) months before MI and repeated immediately after spontaneous MI. 
Progression in stenosis was defmed as an further reduction in luminal 
diameter of ~%. Morphology was classified as concentric (symmetrical 
stenosis with smooth borders), eccentric (asymmetrical sleDosis with 
smooth borders and a broad neck) or irregular (asymmetrical with a rough 
cootour and overllanging edges). 
In the IRA before MI 16 stenoses were >50%, 9 were 30-50%, 1 was <30% 
and 6 vessels bad no stenosis. After MI all stenoses in the IRA were >SO% 
(p<O.OOI). Furtbennore 18 pIS (61%) bad 2 or 3 vessels disease, and in 11 
of these the most severe steDOsis was in the DOn-IRA. In the non-IRA 
before MI, 25 stenoses were S50% and 21>50% (PONS). After MI, 27 were 
SSO% and 29:>50% (P=NS) (10 new stenoses bad developed. 4 stenoses bad 
progressed). In the IRA (n=26) the perceDlage of stenoses before MI which 
were concentric, eccentric and itTegular were 12%, 15%, and 73% 
respectively, and in the DOn IRA (11=46) 43%, 37% and 20% respectively. 
This difference in distribution of motpbology between the groups was 
significant (p<O.OI). 
In conclusion, in patients with a history of angina the pteoi:xisting lesion 
underlying the coronary occlusion is usually of irregular morpbology, but 
often not the site of greateSt stenosis. 
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879·101 
Survival and Clinical Events Three Years After Thrombolysis 
as a Function of Infarct·Related Artery Patency 
Judith Hsia. Neal Kleiman. Frank Aguirre. Allan M. Ross. George 
Washington University. Washington. DC. Baylor University. 
Houston, TX. and 51. Louis University, 51. Louis, MO 
Despite enrollment of over 100.000 acute myocardial infarction 
(MI) patients into thrombolytic trials. the relationship between long 
term survival and infarct-related artery (IRA) patency has rarely 
been evaluated. We have previously reported results from the 
Heparin Aspirin Reperfusion Trial. a randomized comparison of 
aspirin and intravenous heparin as adjuncts to recombinant tissue 
plasminogen activator in acute MI with IRA patency assessed at 
18 h (mean) and at 7 days. We now report on 131 (out of 199. 
65%) study participants whose vital status is known 3 years later. 
The last known IRA patency of 3 year survivors is compared with 
that of patients who died in-hospital (n=6. 3%) + those who died 
after discharge (n=7. 5%): 
Last known IRA status n 
Occluded 51 
Patent 81 
No angiogram 5 
Alive Dead 
44 7 (14%) 
78 3 (4%) p=.03 
2 3 
Clinical cardiac events occurred in 9 long term survivors (7%), 
including reinfarction in 4 (1 occluded and 3 patent at discharge). 
recurrent hospitalization for angina in 1 (occluded). angioplasty in 
1 (open at discharge) and symptomatic arrhythmias in 3. 
Conclusion: Following thrombolysis for acute MI, 3 year survival 
was excellent (95%) and Clinical cardiac events infrequent (7%). 
IRA patency conferred a long term mortality benefit. 
879·102 
Dynamic Changes of Culprit Lesion Morphology and Severity 
after Successful Thrombolysis for Acute Myocardial Infarction: 
An Angiographic Follow·up Study 
Gerrit Veen. Albert Meijer. Christ 1.P.1. Werter. Hans de Swart. 
Freek W.A. Verheugt. Free University Hospital. Amsterdam and 
Interuniversity Cardiology Institute. the Netherlands 
In the APRICOT-study we performed coronary angiography 
within 48 hours after thrombolysis for acute myocardial infarction. 
When the infarct related artery was open. a follow-up angiography 
was performed after three months. To study changes in morphology 
and severity of the culprit lesion we analyzed the lesions that were 
patent at second angiography (n=I77). Morphology was classified 
as complex or smooth and severity was scored as <50%. 50-90% 
or >90% stenosis. 
MORPHOLOGY CHANGE 
ANGlO 1 
complex 84 
smooth 93 
ANGlO 2 
smooth 
38 (45%) 
90 (97%) 
complex 
46 (55%) 
3 (3%) 
SEVERITY CHANGE severity 
ANGlO 1 ANGlO 2 increase no change decrease 
complex .... complex 46 4 (9%) 39 (85%) 3 ( 7%) 
complex .... smooth 38 3 (8%) 18 (47%) 17 (45%) 
The results show that 45% of the complex lesions changed to 
smooth. Smooth lesions did not change significantly. When com•
plex lesions changed to smooth. they became significantly less 
severe compared to lesions that remained complex (p<O.OOO5). 
In conclusion. nearly half of the CUlprit lesions. that are com•
plex early after successful thrombolysis. change to smooth in the 
following three months. When changing to smooth, they become 
significantly less severe. These data suggest ongoing resolution of 
thrombotic material and plaque repair after successful thrombolysis. 
ABSTRACTS 147A 
879·103 
Does Late Thrombolysis Improve Prognosis in Patients with ST 
Depression? 
Shaun G. Goodman, Anatoly Langer. Eric J. Topol, Andrew Charlesworth 
Allan M. Skene. Robert G. Wilcox, Paul W. Annstrong, for the LATE 
Study Investigators. St. Michael's Hospital, University of Toronto 
Toronto, Canada • 
The benefit of late thrombolysis is now established' however its applica~ility to my~cardial infarction (Ml) pts presenting ~ithout sT t is 
uncertam. Accordingly, we evaluated the impact of thrombolysis in 
patients with STI (0!:2 mm as per study protocol) on the admission ECG 
who were part of Late Administration of Thrombolysis (LATE) a 
rando~zed. double blind, placebo controlled study in pts with acute MI 
presentIng 6·24 hrs after chest pain onset. 
Amo~ 4759 pts with conflrmed MI, there were 550 pts with ST I on the 
adrrusslOn ECG of whom 291 received placebo and 259 tPA. Discharge 
ECG demonstrated non·Q MI in 51.9% of placebo and 49.4% of tPA pts. 
The table shows mortality and reinfarction at 35 days and 1 year 
(*p < 0.05 vs. placebo): 
35 day mortality 
1 year mortality 
Q (n=271) Non.Q (n=279) 
~ ~ ~ ~ 
13.6% 13.0% 18.5% 7.8%" 
21.4% 20.0% 32.4% 15.7%* 
35 day reinfarction 6.1 % 6.5% 
8.6% 
5.7% 
15.9% 
3.3% 
9.2% 1 year reinfarction 8.2% 
The survival benefit offered by tPA was evident early and prior to 
hospital discharge. Further. there was a trend for less reinfarction at 1 
year in tPA treated pts (p=0.08). 
Conclusion: The prognosis in the 50% of pts who present with ST I and 
develop non·Q MI may be substantially improved by the administration 
of thrombolytic therapy. The mechanism for this survival benefit may be 
myocard,al salvage and subsequent reduction in reinfarction and deserves 
further investigation. 
879·104 
Absence of Morning Increase in Transient Ischemia in Survivors of Acute 
Myocardial Infarction 
Prakash C. Deedwania. Carl Pepine. Peter Cohn. Ron Marks. Aileen 
Handberg for the ASIST Study Group. VAMC/UCSF. Fresno. CA 
Although acute myocardial infarction (Mil and sudden cardiac death 
have a circadian pattern with a peak in the morning hours. there is little 
available information regarding the circadian pattern of transient 
ischemic episodes !TIEsI in survivors of MI. In this prospective study of 
1368 patients with evidence of CAD and ischemia during exercise 
testing we evaluated the prevalence and pattern of TIEs during 4B-hour 
ambulatory ECG monitoring (AEMI performed when patients were off all 
antianginal drugs including beta blockers. A total of 306 pts had '" 2 
TIEs or '" 5 minutes of silent ischemia during AEM. 114 pts had prior 
(>3 mol MI (MI + I. whereas 192 pts had no evidence of prior MI (MI-I. 
The time series analysis of the average number and duration of TIEs per 
hour during the 24·hour period for MI + verus MI- patients is shown: 
The above graph shows that although the MI- patients have the morning 
surge in TIEs the MI + patients did not show the usual morning peak. 
The largest number of TIEs in MI + patients were observed around 4 PM. 
The MI positive also had shoner average duration of ischemialhour 
throughout the day. This altered circadian pattern of TIEs was noted 
despite the fact that all patients were off beta-blockers. The altered 
circadian pattern of TIEs is consistent with the prior repons of secondary 
evening peak observed for recurrent Mis in patients with prior MI. 
148A ABSTRACTS 
879-105 
An Open Infarct-Related Artery Influences Baroreflex 
Sensitivity, a Marker of Autonomic Balance. 
Andrea Mortara, Maria Teresa La Rovere, Giuseppe Specchia, 
J Thomas Bigger Jr, Frank I Marcus, Peter J Schwartz on behalf of 
the ATRAMI Investigators. Division of Cardiology, Fondazione 
Clinica del Lavoro, IRCCS, Montescano (pavia), Italy. 
The patency of infarct-related artery (IRA) improves electrical 
stability of the myocardium, even though the operating mechanisms 
are not well defined. We have tested the hypothesis that a patent IRA 
may influence the sympathetic-parasympathetic imbalance that often 
follows myocardial infarction (MI). Autonomic balance was assessed 
by detennining baroreflex sensitivity (BRS). Out of 950 patients (pts) 
~nrolled so far in A 110MI (an ongoin~ multicenter prospective study 
In post-MI pts assessmg the prognostic value of several autonomic 
measures) more than 300 coronary angiographies were performed 
with analysis completed for 143; 1,2,3 vessel disease were present 
in 49, 40 and 54 pts respectively, with a mean BRS of 9.7±6.3, 
8.l±4.7 and 7.5±4.4 msec/mmHg. Patency of IRA was observed in 
76 pts (53%) (Group 1) while in the remaining 67 IRA was occluded 
or suboccluded (Group 2). The two groups were similar in respect of 
age, site of infarction, coronary disease distribution, time elapsed 
from MI to BRS analysis and medical therapy. However, both BRS 
and mean ejection fraction were more depressed in Group 2 compared 
to Group I (7.3±4.9 vs 9.5±6.l msec/mmHg, p=O.02 and 47±14 vs 
53±11 %, p=O.OI respectively). At multiregression analysis BRS 
resulted significantly related to patent or occluded IRA (p=O.03) but 
not to left ventricular mean ejection fraction. 
Thus, the presence of open infarct-related artery may improve 
baroreflex sensitivity, a marker of autonomic balance inversely related 
to post-MI mortality. These data provide new insights on the 
mechanisms by which coronary artery patency affects cardiac 
electrical stability and survival. 
879-106 
Dispersion of Ventricular Repolarization and Sudden 
Cardiac Death in Ischemic Heart Disease 
Wojciech Zareba, Arthur 1. Moss, Saskia Ie Cessie. University of 
Rochester Medical Center, Rochester, NY 
In a recent prospective study of myocardial ischemia, sudden cardiac 
death (SCD) occurred in 17 of 936 pts (2%) followed for a mean 2 
years after acute myocardial infarction or unstable angina. 
Dispersion of ventricular repolarization was evaluated on the 12-lead 
ECG at enrollment (mean 2.7 months after index event) in 17 SCD 
pts and 51 survivors, matched for age, gender, type of acute event, 
prior myocardial infarction, and follow-up time. The aim of the 
study was: 1 )to evaluate which of various measures of dispersion of 
repolarization is the best univariate predictor of SCD, and 2) to 
determine if dispersion of repolarization makes an independent 
contribution to the risk of SCD. Mean QRS duration (QRS-m), as a 
measure of ventricular depolarization, and ventricular repolarization 
parameters QT and IT (IT=QT-QRS), quantitated in terms of mean 
(m), max-min dispersion (d), standard deviation (sd), and 
coefficient of variation (cv) were detennined. Conditional logistic 
regression analyses revealed that three standard ECG parameters: 
QRS-m, QT-m, QTc-m; and three dispersion variables: IT-d, IT-sd, 
and ITc-d were the best univariate predictors of SCD (p<O.02). The 
most significant multivariate model (Chi2=25.1) involving 
electrocardiographic parameters for identifying the risk of SCD 
included QRS-m (p=O.OO9) and IT -d (p=0.OO7). Both of these 
parameters, unrelated to the heart rate, made an independent 
contribution to the model. 
Conclusions: Dispersion of IT, but not of QT, is a strong 
independent predictor of SCD. Concomitant evaluation of QRS 
duration together with the IT dispersion provides a clinically useful 
tool to stratify a risk of SCD in ischemic patients. 
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879-107 
Baroreceptor Reflex Sensitivity but not Heart Rate 
Variability is Reduced in Patients liith Clinical Life•
Threatening Ventricular Arrhythmias 
Gaet~no M De Ferrari, Maurizio Lando1ina, Massimo 
Mantlca, Ruggero Manfredini, Massimo Ar10tti Peter J 
Schwartz, Antonio Lotto. Dept of Cardi~l IRCCS 
Policlinico Milan, and Dept of Med, Univ of Pavia, IT. 
Depressed baroreceptor reflex sensitivity (BRS) and 
~eart 7ate variability (HRV) soon after myocardial 
1nfarct1on (MI) correlate with increased mortality. On 
the other h?nd, very limite~ dat:a exist: concerning BRS 
and HRV 1n patients w1th sustained ventricular 
t:achycardia or fibrillation (VTfVF) in the absence of a 
recent MI. This study test:ed the hypotheSis that vagal 
tone and reflexes in patients with VTfVF > 1 year after 
MI (n-12, age 66 ± 8), eject:ion fraction (EF) 35 + 11% 
would be lower than in a control group wi th comp-;;rabl~ 
age and EF, without VT (NO VT, n-10). All the 
me~surements were obtained within 1 week form the 
ep1sode of VT/VF. HRV was derived from 15 min recordings 
in rest condit:ions. The results are (*- p-O.02): 
mean RR STd MSSD LF/HF BRS(msec/mmHg) 
VTfVF 850±l49 25±l5 l2±8 3.6±2.9 3.8±1.7* 
NO VT 887±l05 27±ll 18±l2 2.5±l.7 6.9±4.2 
STd and MSSD - standard deviation and mean square 
successiv.e difference of RR cycle (msec); LF/HF - ratio 
of 10.w/h1gh frequency areas of power spectrum. Thus, 
relatlvely to controls with comparable ischemic heart 
disease, patient~ wi~h clinical VTfVF have similar vagal 
tone but have 1mpa1red vagal reflexes. A persistent 
depression of vagal reflexes may play a role in the 
occurrence ?f. V.T/VF long term post-MI and baroreceptor 
reflex senslt1 Vlty may be useful for the identification 
of high risk patients. 
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880-18 
Dilated CardiOOlyopatby: Correlation Between Myocardial Cateebolamine, 
Hemodynamics and Long Time Survival 
Petar M. Seferovic, Stepan Stepanovic, lovan Vasiljevic, Miodrag Ostojic, 
Drag8lla Seferovic, Ruzica Maksimovic, Jelena Marinkovic, Slavko Simeunovic, 
Dragan Simic, Vesoa Dangubic, Arseo Ristic, Institute for Cardiovascular 
Diseases of the Univen;ity Medical Center, Belgrade, Yugoslavia 
To assess the hemodynamic and prognostic implications of myocardial 
catecholamine concentration measuremenlS (M CC) in pIS with idiopathic dilated 
cardiomyopathy (lDC), we correlated myocardial norepinephrine (MNEC), 
epinephrine (MEC) and dopamine concentrations with left ventricular (LV) 
function parameters and long-term survival of these pis. 
A group 002 pis (87.5% males. mean age 42.7+1-13.4 years); mean symptom 
duration 10 months, range 1-37, LV ejection fraction 34.9% +1-8.3% was 
prospectively fonowed for mean period of 36 months (range 12~ months). 
Initial assessment included cardiac catheterization and EMB, while MCC were 
measured in EMB samples utilizing catechol-O-metbyl transferase radioenzymatic 
method. Fonow-up was completed for 31 pis (96.8%); 12/31 pis (38.7%) died 
and 1 was transplanted. MNEC correlated well with heart rate (r=0.78, 
p<O.OI), LV dp/dt max (r=0.87, p<O.OI), LV ejection fraction (r=0.89, 
p<O.OI) and mean arterial pressure (r=0.75, p<0.05). Furthermore, a 
correlations betw .... MEC and hean rate (r=0.8, p<O.OI), LV ejection fraction 
(r=O.86, p<O.OI) and LVEDP (r=-<l.75, p<O.OI) were also demonstrated. 
By univariate lD&Iysis, MNEC (Chi'= 14.8. p=O.OOOI) and MEC (Chi'= 14.3, 
p=O.OOO2) predicted survival independently, while dopamine did not. By 
multivariate lD&Iysis (Cox's proportional hazard model) both MNEC and MEC 
predicted survival and their low concentrations were associated with increased 
mortality. Survival was significantly better in IDC pis with bigher MNEC 
(411.8+/-43.4 ng x g" fresh tissue {ft} survivors vs 278.5+1-75.7 ng x g" ft. 
dead) and MEC (55.3+/-4.5 ng x g-I ft survivors vs 39.2+1-9.3 og x g" ft 
dead). 
In conclusion, MNEC and MEC correlated wen with LV function parameters 
and were shown to be independent predictors of the long term (5 years) survival 
in IDC. Low MNEC and MEC were associated with increased mortality and 
should be considered as prognostic marke ... 
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880·19 
Magnetic Resonance Imaging Determines the Extent of 
Fibrosis In Patients With Endomyocardlal Fibrosis 
Antonio C. P. Barretto, Roberto Kalil, JoAo A.C. MagalhAes, 
Fausto Hironaka, Sergio A. Oliveira, Protasio l. da Luz, 
Giovanni Bellotti, Fulvio Pileggi. Heart Institute and 
Radiology-HCFMUSP, sao Paulo, Brazil and Johns Hopkins 
Hospital, Baltimore. 
Surgical resection of fibrous tissue in patients with 
endomyocardial fibrosis (EMF) improves prognosis. We 
investigated whether the extent and topographical distribution 
of fibrosis in 6 patients with EMF could be better 
characterized by magnetic resonance imaging (MRI) versus 
angiography, the current standard. Six patients, aged 25 to 
75 years, 5 men, underwent spin echo and cine MRI and 
contrast angiography. The extent and localization of fibrous 
tissue visualized by MRI and angiography were compared 
with intraoperative examination. MRI delineated the extent of 
fibrosis which involved only the left ventricle in 3 patients, and 
both ventricles in the remaining 3 patients. Most importantly, 
angiography did not detect the extent of involvement of 
fibrosis. MRI showed that the fibrotic tissue compromised 86 
±8% of the left ventricular wall thickness. Thus, MRI is 
superior to angiography in determining the transmural extent 
and location of fibrosis in EMF and should be the method of 
choice to guide surgery in patients with this condition. 
880·20 
Dobutamine Echocardiography To Distinguish Ischemic: From Non•
Ischemic Dilated Cardiomyopathy. 
Car10 Vigna, Vincenzo De Rito, Pompeo Lanna, Tommaso Langialonga, 
Mauro Salvatori, Gian Piero Pema, Marco Testa, Aldo Russo, *Antonella 
Lombardo, Raffaele Fanelli. *Francesco Loperfido. IRCCS S.Giovanni 
Rotondo (FG) and *Catholic University, Rome (Italy). 
Differentiation between ischemic (I) and non-ischemic (NI) dilated 
cardiomyopathy (DCM) may be difficult even after sophisticated 
diagnostic approaches. We utilized dobutamine echocardiography (DE) to 
differentiate I from NI aetiologies in 30 pts with DCM. 22 male and 8 
female, aged 60:!:8 years. All pts were in NYHA class ~ II. Ejection fraction 
was 0.30:!:0.08. No pt had previous myocardial infarction; 12 pts had a 
history of chest pain and 10 left bundle branch block. According to 
coronary angiography, 10 pts had I DCM e70% reduction in diameter in 
at least 1 major vessel) and 20 NI DCM. Among I DCM. " pts had 2- and 6 
3-vessel disease. DE was performed following a protocol with increasing 
doses up to 4cry/Kg/min. Ischemia, target heart rate (HR). hypotenSion and 
arrhythmias were other end points. A 16-region model with 4-point scale 
(1 =normal to 4=dyskinesia) was utilized for analysis of regional wall 
motion. A wall motion score index (WMSI) was calculated. New wall 
motion abnormalities C#MA) or worsening of basal WMA of ~2 points 
during DE were considered to be indicative of ischemia. 
Results: DE was tolerated by all pts and no severe untoward effects were 
observed. The mean dobutamine dose was 29:!:12'y/Kg/min. Findings of 
DE rtd'Tbl are repol e In a e. 
IDClnl0l NI DC ln20l 0 
DE chest pain 4(40%) 6(30%) NS 
Basal HR 85+15 83+13 NS 
DEHR 120+11 123+15 NS 
BasalWMA 5(50%) 12 (60%) NS 
DEWMA 8 (80% 2l10%l <0.001 
BasalWMSI 1.9+0.3 2.2+0.2 NS 
DEWMSI 2.0+0.5 1.6+0.3* <0.01 
·p<O.OI vs basal. 
Conclusions: 1) In pts with NI DCM, global wall motion improves during 
DE; 2) New or worsened WMA during DE are sensitive and specific for I 
DCM. 
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880·21 
Detection of Enteroviral RNA by Polymera.e 
Chain Reaction (PCR) In Patients with 
Myocardltla (Me) and Dilated Cardiomyopathy 
(DCM) 
Matthias Pauschinger, Guido Meissner, Sven Preis, Uwe 
Kuehl, 'Anne Canu, 'Reinhard Kandolf, Heinz-P. 
SchultheiB, Bodo-E. Strauer. Dept. of Cardiology, 
Heinrich-Heine-University of Duesseldorf ; D-W-4022S 
Duesseldorf, ·Dept. of Pathology, D-W·72076 Tuebingen, 
Germany 
The pathogenesis of Me or OeM is thought to be caused 
by a persistent enteroviral infection. We examined 41 
patients with disturbed left ventricular function and 
suspected MC in the past. Heart muscle biopsies were 
examined histologically and immunhistologically. In 
addition, we tested for enteroviral RNA using PCR. Both 
primers used for amplification were located near the 5" 
end of the enterovirus sequence. peR products were then 
further analyzed by southern blot using 32P-labelled 
internal oligonucleotides. This method allowed us to 
detect enterOViral RNA at a very sensitive level. 21 
patients showed histological and immunhistological 
lymphocytic infiltrates and an increased HLA II expression 
indicating a chronic inflammatory process (chronic MC). 
20 patients who were histological and immunhistological 
negative were diagnosed to have DCM. Enteroviral RNA 
was detected in 67% (n=14) of the chronic MC patients 
whereas only 25% (n=S) of the patients with DCM showed 
positive results. 
Conclusion: These results indicate that viral persistance 
might be a trigger mechanism for chronic inflammatory 
processes in the myocardium. 
880·22 
The SlaDdard ECG • Sereenlng Te.t for Hypertrophic Cardiomyopathy! 
Mark P. Ryan, John GF. Cleland. Julie A. French, Jayshree Joshi. Lubna 
Choudhury, Lidia Chojnowska. Eva Michalak, Sabar Al-Mahdawi, Petros 
Nihoyannopoulos, Celia M. Oakley. 
Department of Medicine, Cardiology Unit. Hanunersmith Hospital. RPMS, 
London, United Kingdom and Institute of Cardiology, Warsaw, Poland 
Phenotypic heterogeneity is well reported in Hypertrophic Cardiomyopathy 
(HCM) which makes definitive diagnosis difficult partiCUlarly during family 
screening. Access to skilled echocardiography and its cost can limit its utility as 
8 screening tool. We studied the electrocardiogram 8S a potential initial screening 
test in patients with HCM. 
Using accepted diagnostic criteria we examined the ECGs and echocardiograms 
of ISO patients (mean age 46.8 years, range 3 - 88) with a confmned clinical or 
genetic diagnosis ofHCM. All bad been referred as index cases or were assessed 
during family screening. 144 patients (96%) showed an abnormal ECG while only 
136 (91%) showed abnormal echo. Of the former, 10 patients (7%) bad normal 
echocardiograms and had been diagnosed on the basis of identification of a 
mutation in the myosin heavy cbain gene (n = 9) or obligate carrier status (n = 
I). They ranged in age from 10 - 79 years (mean age 42.7) with only one patient 
under age 20, by which time hypertrophy is nonnany expressed on 
echocardiogram. Their ECGs showed left ventricular hypertrophy (n = 3), Q 
waves (n = 6) or STrr wave abnormalities (n = 8). 
The remaining 6 patients (4%) without ECG abnormality consisted of 2 cases 
where the echocardiogram was clearly diagnostic of HCM and 4 clinically normal 
cases (aged 13,24,29 and 33 y.ars, mean 25.1) with normal echocardiograms 
who had been diagnosed by mutation identification (n = 3) or obligate carrier 
status (n = I). Thus only these latter 4 cases (3%), who were significantly 
yOunger. would not bave been diagnosed as HCM using a combination of 
abnormal ECG and I or abnormal echocardiogram. 
While echocardiography aids specificity in the diagnosis of HCM, the ECG within 
the context of a ramily with a proven case of HCM is a sensitive marker of 
disease. It is therefore both cost effective and useful for screening to select those 
to proceed to echocardiography. It is more sensitive than echocardiography in 
detecting HCM as it probably detects microscopic myocardial disarray and does 
not rely on the presence of macroscopic disease. 
150A ABSTRACTS 
880·23 
Initial Results of Combined Mitral Leaflet Extension and 
Myotomy-myectomy In Patients with Hypertrophic Car•
diomyopathy. 
Folkert J. TenCate, Marcel J. Kofflard, Lex A. van Herwerden. 
Thoraxcenter,Unlverslty Hospital, Rotterdam, The Netherlands. 
Mitral valve replacement (MVR) alone or In combination with 
myotomy-myectomy is performed In selected patients with 
hypertrophic cardiomyopathy (HeM). 
A novel alternative to MVR Is anterior mitral leaflet extension, In 
which a glutaraldehyde-preserved auto- logous perlcardlal patch is 
used to enlarge the mitral valve along Its horizontal axis. We per•
formed combined leaflet extension and myotomy-myectomy In five 
patients with HeM. The Immediate and short-term (up to 2 years) 
follow-up is shown In the Table: 
pts NYHA MI SAM LVOTgrad 
1 III/I 3+/0 ++/0 92/5mmHg 
2 III/I 3+/1+ ++/+ 58/25 mmHg 
3 111/1 3+/0 + +/0 74/9mmHg 
4 III/I 2+/1+ + +/0 112/36 mmHg 
5 II/I 0/0 +/0 100/9 mmHg 
MI:Mlnsufficiency, 0: absent. Numbers before and after vertical 
bars represent pre/post operative data. 
Conclusion:Anterlor mitral valve leaflet extension Is a new 
promising technique which can be used as alternative to MVR In 
selected patients with HeM. 
880·24 
Echocardiography Abnormalities in Chronic Cocaine Users. 
Olivia Adair. Sue Rainquet. Tara Pearson. Jane Mallet. Edward 
Havranek. and Koonlawee Nademanee. Denver General Hospital. 
Denver. CO. 
Cocaine use (COK) increases norepinephrine (NOR) and epinephrine 
levels mimicking pheochromocytoma. Persistent COK use could 
adversely affect the myocardium in the same way as elevated 
catecholamine. especially NOR. affects heart i.e. cardiomyopathy. 
myocardial hypertrophy (L VH) and small vessel coronary artery 
disease. Thus. we hypothesized that chronic COK use adversely 
affects myocardial function which could be detected by echo•
cardiography (ECHO). We studied 60 patients (47M; 13F. mean 
ages 36) admitted to the hospital for chest pain associated with 
recent cocaine use as well as 24 age-matched controls. We 
obtained resting echocardiograms. EKGs. En and cardiac enzymes 
during admission. All patients had used cocaine for > 6 months 
and were ruled out for MI; we found striking ECHO abnormalities in 
a majority of the COK users whereas none of the controls had wall 
motion abnormality (WMA). LVH. right sided chamber enlargement 
(RE). EF <50%. or diastolic dysfunction (DO). 
ECHO WMA LVH RE EF <50% DO 
COK Users 33155%, 18130%, 9(15%' 8(13%' 3(5%1 
Two blinded observers concurred on 31 of the 32 studies con•
firming accuracy of the above ECHO interpretation. Our results 
suggest that COK use causes myocardial damage similar to chronic 
high dose NOR infusion. This subclinical change may in turn lead 
to overt cardiomyopathy. This observation emphasized the need to 
identify an effective regiment to prevent cocaine-induced myocardial 
damage. 
lACC February 1994:1A-484A 
880·25 
Regional Cardiac Magnetic Resonance Imaging for the 
Assessment of Innamarnatory Process in Chronic Chagas 
Heart Disease. 
Roberto Kalil, Robert Weiss. Laercio Rosemberg. Edimar A. 
Bocchi. Alvaro A.C. Magalhaes. Fernando Bacal. Charles Mady. 
Antonio C.P. Barreto. Giovanni Bellotti. Fulvio Pileggi, Incor and 
Radiology - HCFMUSP. Sao Paulo. Brazil and lohns Hopkins 
Hospital. Baltimore Md. 
Endomyocardial right ventricular septal biopsy has limited 
sensitivity for studying the recognized heterogeneous inflammatory 
process of Chagas heart disease. observed in necropsy studies. We 
tested the hypothesis that magnetic resonance imaging can 
characterize the inflammatory process in patients with Chagas 
disease (CD). Single short-axis slice. transverse spin echo. EKG 
gated images were acquired on a Sigma 1.5T system (TE; 25mg. 
TR= R-Rx2. slice thickness 8mm) in 25 patients with CD (mean 
age 41.±-8. 16 males). Cardiac signal intensity (51) from septal and 
free wall myocardial regions was compared with that from skeletal 
muscle before and after a bolus injection of 0.1 mmo1!Kg 
Gadolinium (0) Increased relative SI was observed in the left 
ventricular free wall (before 0 .89 ± .04. after G 1.66 ± .39. p< 
.033). and in the septum (before G .89 ± .04. after G. 1.28 ± .33. 
p<0.03). The difference between free wall and septum was also 
significant (p< .03). These findings showed that magnetic 
resonance imaging can non-invasively detect the presence. 
localization and heterogeneous distribution of inflammatory 
process in Chagas' heart disease. 
880·44 
Length of Disease Correlates With Increased Left Ventricular Mass 
and Impaired Early Diastolic Function in Patients with Sclerodenna 
Stefan P Karwatowski. Nicolas A Chronos, Hilary Sinclaire. Carole 
Black. Martin St John Sutton. Richard Underwood, Donald B Longmore. 
Royal Brompton National Heart and Lung Hospital and Royal Free 
Hospital, London, UK 
Cardiac complications are an important cause of morbidity and mona1ity 
in patients with long standing scleroderma. We studied fifteen patients 
with scleroderma (4 male, age 28-60 mean 48 none with valvular heart 
disease). Using magnetic resonance imaging. multiple contiguous lOmm 
spin echo images were obtained through the left ventricle to lICClIfately 
measure left ventricular (LV) mass. Magnetic resonance velocity 
mapping was used to measure peak early diastolic long axis velocity as a 
marker of diastolic function. (diastolic vel). Pulmonary involvement was 
assessed by gas transfer. (KCO). We documented close correlations 
between desease duration with LV mass and diastolic vel. KCO corelated 
closely with diastolic function but not LVmass. Correlation coefficients 
were as follows: 
LV Mass diastolic vel 
Disease r =0.81. r= -0.63 
Duration p <0.01 p<0.05 
KCO r==-.0.28 r -0.71 
p=NS p<O.05 
The hallmark of cardiac Scleroderma is infiltration of the myocardium 
with fibrosis tissue. This increase in the the non myocite compartment 
will increase LV mass and make it less compliant. In this study duration 
of disease correlated closely with magnetic resonance measures of LV 
mass and diastolic function. Early diastolic function and pulmonary 
function. both affected by fibrosis were also correlated. Magnetic 
resonance imaging is a useful technique for detecting functional cardiac 
involvement in scleroderma and may be useful in following disease 
progression. 
JACC February 1994:1A-484A 
880·45 
"In vivo " Detection of Trypanosoma Cruzl In Hearts of 
Patients With Chronic Chagas' Disease 
Giovanni Bellotti, Alvaro Moraes, Edimar Bocchi, Miguel 
Barbero·Marcial, Maria Lourdes Higuchi, Eduardo Sosa, 
Antonio Esteves·Filho, Roberto Kalil, Adib Jatene, Fulvio 
Pileggi. Heart Institute, Sao Paulo University, Brasil 
The "in vivo" presence of Trypanosoma cruz; (T. cruz; ) in 
hearts of pts with Chagas' heart disease has never been 
reported. In this investigation we analyzed myocardial biopsy 
specimens (by avidin·biotin peroxidase technique using 
policlonal serum against T. cruz; antigens) in order to detect 
the T. cruz; presence in pts with chronic Chagas' 
cardiomyopathy. We studied 5 pts ( 4 male, mean age 46±7 
years), 3 with recurrent episodes of sustained ventricular 
tachycardia (VT) and 2 with congestive heart failure. All pts 
were submitted to heart magnetic resonance with Gadolinium 
to localize the maximal intensity of the inflammatory process 
and to guide the biopsies. Myocardial specimens were 
obtained through left ventricular endomyocardial biopsy in 2 
pts and during surgical procedure for VT correction in 3 pts. In 
4 out 5 pts we detected the presence of the T. cruz; in the 
interstitium with intense myocarditis surrounding it. Thus, 
these findings show that T. cruz; can be detected in hearts of 
pts with Chagas' heart disease. In contrast to accepted 
immunopathogenic concepts, its presence may have an 
important role in the pathogenesis of Chagas' 
cardiomyopathy. 
880·46 
Transmyocardial Laser Revascularization 
John R, Crew, Marilyn Thuener, Reinold 
Jones, Colman Ryan, Catherine Chimenti, John 
C. Fisher. San Francisco Heart Institute, 
Seton Medical Center, Daly City, CA 
Transmyocardial Revascularization (TMR) is 
an investigational technique utilizing a 
1000 Watt C02 laser synchronized with a 
beating heart to revascularize inoperable 
myocardium through a left thoracotomy. 15 
PTS were identified with severe myocardial 
ischemia documented with delayed thallium 
reperfusion studies. Average age was 62, 12 
were male, and all except one had failed 
previous attempts at coronary angioplasty or 
bypass surgery. All PTS had temporary 
symptom relief following TMR. One PT had an 
intraoperative myocardial infarction. There 
were no deaths in hospital or at 30 days. 
One PT was returned to surgery for bleeding 
of the thoracotomy wound. At 12 month 
followup, one death had occurred 7 weeks 
post TMR. TWo PTS required repeat TMR, one 
for inadequate initial therapy and the other 
because of an occlusion in the last re•
maining graft. These preliminary results 
suggest that TMR may provide an alternative 
method for establishing myocardial perfusion 
in selected PTS who have failed traditional 
therapy. 
ABSTRACTS 
880·47 
Autonomic: Dysfunction Evidenced by Hean Rate VarlabHity 
Abnormalities in Latent or Indeterminate Ph .. e of ChlDls' Diselse. 
Jos6 G loyo, Juan J Puigb6, Vicente P6rez D. Federico Moleiro. 
Roger Barroyeta, lise Braun. Angela Ruggiero. Servicio de 
Cardiologla, Hospital Universitario de Caracas and Caltedr. de 
Cardiologla, Escuela de Medicina 'luis Razzetti·. Universidad 
Central de Venezuela, Caracas. Venezuela. 
Chagas' Disease affects approximately 16-20 million people in 
Central and South America. Controversies exist regarding al if 
autonomic dysfunction occurs prior to left ventricular dysfunction 
and dilatation, and bl the autonomic division to be affected first. 
~: To determine time and frequency domain analysis of 
hean rate variability in patients with Chagas' Disease in latent or 
indeterminate phase. MIlI!Ml: 23 patients with positive serology 
for L£nW infestation and 1 S healthy controls matched by age and 
gender were studied. All subjects were asymptomatic. and had Ill! 
clinical, electrocardiographic or echocardiographic abnormalities. 
Bul!!li: Chlg.s' Control p value 
lVDD (cm/m21 2.7±0.3 2.6±0.3 NS 
EF(%1 63.4±7.7 62.3±6.5 NS 
rMSSD (msegl 25.7±13.5 45.2±32.0 <0.02 
HF (NUl 25.0 ± 12.S 44.S ± 15.1 <0.001 
IF (NUl 37.4 ± S.4 29.7 ± 12.2 O.OS 
VLF (NUl 37.7±11.1 26.3±13.4 <0.05 
mean ± SO. alpha =0.05 . lVDD:left ventricular diastolic diameter. 
EF: ejection fraction. rMSSD:root of square mean of standard 
deviation. HF:high frequency. LF: low frequency. VlF: very low 
frequency. NU: normalized units. ConClusions: In these patients we 
found that: al there was evidence of autonomic imbalance 
characterized by decrease of parasympathetic activity (HF and 
rMSSDI. hI autonomic dysfunction was present without left 
ventricular systolic dysfunction , dilatation or apical aneurysm and 
cl there was an increase of the VlF component, the role of which 
in sudden death (the most important cause of monality in this stage 
of the diseasel needs to be clarified by further studies. 
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881·88 
The Profile of Basic Life Support (BLS) Course Trainees: Should 
Course Design be Restructured! 
Nisba C. Chandra, Larry D. Newell, Pamela Myirski, Cynthia Siu for the 
BLS Profile Study Investigators, Johns Hopkins Med Inst, Baltimore, MD 
Most BLS course material have been written at an 8th grade reading level, 
but retention of CPR courses is known to be poor. Also, many victims of 
cardiac arrest do DOt get bystander CPR. These issues may relate to course 
design andlor adequacy of reaching bigh risk populations and families. We 
surveyed persons taking American Red Cross courses nationwide to better 
define the demograpbic profile and motivation of persons taking BLS 
courses. The survey was pre-course. 
Of 1414 persons surveyed, 17.7% were <20 yrs, 27.4% 21-30 yrs, 28.7% 
31-40 yrs, 17.4% 41-50 yrs, 7.2% SI-6O yes. and 1.6% >70 yes of age. 
S3.8% were male. Only 10.1 % bad grade 9 or less education, S8.8% bad 
> 1 + yrs of college. The predominant reason for taking the course was job 
requirement (81.6%), though several persons gave multiple reasons. 3.3% 
had a higb risk family member and 14.8% just wanted to take the course. 
7% had actually performed CPR previously and 19% had witnessed a 
cardiac arrest. 96.3% stlted that they would do chest compressions on a 
stranger in cardiac arrest. Whereas 89.3% would or would "perhaps" do 
mouth-to-mouth ventilation. Willingness to do chest compression or mouth•
to-mouth ventilation was highly related to younger age (p .03 and .OO()J, 
resp), but not to education level, reason for taking the course, previously 
baving seen or performed CPR, or to gender thougb women expressed a 
greater willingness to do mouth-to-mouth ventilation than men (90.8 % vs 
88%. p=.09). Mean age for those willing to do chest compression was 
32.9 years vs 36.1 years (for those not willing). Similarly, for mouth-to•
mouth ventilation 31.6 yrs vs 38.2 yrs. 
These dati suggest that most persons taking BLS CPR courses do so as a job 
requirement, have > high scbool education, are < 40 years of age, and 
mostly have little fear of disease transmission during CPR. These dati 
should prompt re-examination of program designs and a need to develop 
strategies for reaching bigb risk populations that are presently not serviced 
by formal CPR courses. 
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881·89 
Short term predictability of epiwdial potential field. in VF 
Philip V. Bayly, Erie E. Johnson, Patrick D. Wolf, William M. Smith , Ray•
mond E. Ideker, Basic Arrhythmia Lab, Duke University, Durham, NC 
The predictability of epicardial potential fields during ventricular fibrillation 
(VF), and its changes over time, were investigated. Linear autoregressive 
(AR) modeling was used to extrapolate 3/4 sec of past data 1/4 sec into the 
future. Mean square errors (MSE) were used to evaluate prediction accuracy. 
METHODS: VF "as initiated by premature stimulation in 5 pig. (25-27kg) . 
Unipolar , extracellular potentiall "ere simultaneously recorded from a 22 x23 
array of electrod .. "ith 1.12 mm spacing. Data were lampled at 2000 Hz and 
.tored in 1.024-sec block. at various times after the initiation of VF. Data 
from the first 0.768 sec of each block were used as "past" observations; data 
from the last 0.256 sec "ere used to compare to predictions. The Karhunen•
Loeve (KL) decomposition was used to approximate the potential field at 
each past time by the weighted sum of 5 principal orthogonal patterns. The 
o series of weigbting coefficients for tbe past data were fitted by AR models 
and extrapolated. Predicted potential fields were regenerated from the 5 
extrapolated time series and tbeir corresponding KL patterns. 
RESULTS: The mean MSE (±STD) of predictions, and the mean MSE of 
KL approximations are tabulated below for 5 times after initiation of VF. 
[J". '. [j;" . ~. . . . :. ' . ;, "' " 
ACT 128 ms PRED ACT 192 ms PRED ACT 256 ms PRED 
881·90 
Aminophylline Does not Improve the Outcome of Resusci•
tation Prom Prolonged Ventricular Fibrillation in Dogs 
Laszlo Littmann , Peter T. Ashline, William J . Hayes, Pal 
Kempler, Robert H, Svenson, Jan R. Tuntelder, George P. 
Tatsis, Carolinas Medical Center, Charlotte, NC 
Theoretical considerations and uncontrolled clinical 
trials suggest that the adenosine antagonist aminophyl•
line (AMINO), by reversing electromechanical dissocia•
tion (EMD), might improve the outcome of CPR from 
prolonged ventricular fibrillation (VF) , Two placebo•
controlled, randomized, blinded experimental studies 
(EXP) were undertaken to test this hypothesis . In EXP #1 
(n-20), unsupported VF was maintained for 7~ min; dogs 
received 1 mg epinephrine (EPI) followed by 250 mg AMINO 
or placebo 60 sec prior co cardloverslon . In EXP #2 
(n-20) , dogs were cardioverted to EHD after 5 min of VF; 
60 sec inca stable EHD all received 1 mg EPI followed by 
250 mg AMINO or placebo . Ventilation and external 
cardiac massage without additional pharmacologic support 
was continued until return of spontaneous circulation, 
Results : Number of survivors to 1 hour per total: 
AlIINO PlACEBO 
EXP /11 4/10 7/10 
P 
NS 
95% eI FOR 
FAVORABLE OUTCOME 
DUE TO AMINO 
-0.716 - +0,116 
EXP (12 5/10 6/10 NS -0 . 534 - +0.334 
Pretreatment with AMINO increased the number of cardio•
versions required to convert VF from 3. 8t2 . 3 to 6,2t3 . 3. 
Concludon.: AMINO fails to reverse EHD following 
prolonged VF in this animal modeL If given prior to 
cardioversion, AMINO might even worsen the outcome of 
CPR, The rationale of conducting clinical trials with 
AMINO during CPR remains questionable. 
JACe February 1994:1A-484A 
881·91 
Treatment of Rupture of Left Ventricular Free wan with 
Fibrin-eIue: Experimental Study and Clinical Experience 
Shunei Kyo, Masanori Oeiwara, Naomasa Miyamoto, Takeshi 
Motoyama, Makoto Matsumura, Yutaka Dohi, Ryozo Omoto. Saitama 
Medical School, Saitama, Japan 
To enmine the effectiveness of fibrin-glue (FG) in fatal LV free 
wall rupture (L VFWR), acute myocardial infarction (AMI) in LV 
anterior wall was produced in 18 mongrel dogs (weighted 
1,0-lUkg) by coronary ligation under geDlml1 anesthesia. A 
punched-out hole was made in the center of AMI area using 
aortic-punch (E,D,:S,Smm) and it was closed immediately by a 
3-0 polypropylene stitch with a heating electrode. Hemodynamic 
stability was obtained within 30 minutes after closure of the 
pericardium and thoracotomy, then the stitch was cut by heating the 
electrode with an electric power of 0,.(5 Watt and LVFWR was 
induced. Hemodynamic parameters were assessed until cardiac 
arrest in 12 dogs (Control), however, FG therapy was performed on 
6 dogs at 20 min, after the rupture with pericardial centesis and 
drainage, and infusion of 1 unit of FG into the pericardia! space, All 
dogs of control group died with in 40 min" however, 4 of 6 dogs of 
FG . d ( OS) Th han . blood (mmHg) group SUl'Vlve p<O, ec ~ges m pressure 
were as follows; Left Ventricular Free Wall Rupture 
I Group I Pre 20min 40min 80min 
I Control 1108 ± 28 48 j: 41 no SUl'Vlvor no sUl'Vlvor 
FG 110 + 21 FG therapy 93 + 12 90 ± 15 
Forty mne year-old male With cardiogeruc shock due to L VFWR 
was treated with FG therapy, The patient survived after pericardia! 
centesis, drainage of 370 ml of pure blood (Hb: 12,2g!dl) and infusion 
of 4 units of FG. In conclusion, FG therapy can be a promising 
therapy of L VFWR instead of surgical repair that has a extremely 
high mortality rate, 
881·92 
Cardiac Resuacltatlon: Role of N2 and 02 
'SMary Osbakken. 'Hans Van Beek, and 'Oanning Zhang 
'Univers~y of Pennsylvania, Philadelphia, PA and 
$Bristol·Myers Squibb, Princeton, NJ 
Myocardial damage during cardiac arresllresuscltation, either post 
cardiac surgery or after cardio-pulmonary arrest resu~ing from sudden 
death 01 any etiology are not completely understood. Because of this, 
the most optimal methods 01 resusc"alion have not been developed. 
The present study was dOne to explore the role of N2 and 02 in the 
resuscitation process and to investigale the use 01 N2/CD2 (95%/5%) 
ahernating with 02/C02 (95%/5%) in resuscitation of isolated perfused 
rat heMs made hypoxiC/ischemic to rigor. Fibrillation and arrest were 
induced by exposure to N2/C02 and pacing at 6 Hz (15-25 min), after 
which non-beating hearts were perfused with hypoxic buffer for 30 min, 
Tissue 02 monitored with a near infra-red RUN MAN unit (NIM, PhiIa, 
PAl was decreased 80% from baseline. Coronary flow (CF) monitored 
with a Transonics flow probe andlor volumetric measurement of 
coronary effluent was decreased Irom 15 to 5 cC/min. Baseline left 
ventricular pressure (LVP) measured with an intracardiac balloon was 
80/10, going to 45/45 mm Hg al rigor. Heart rate (before and alter 
arrest) was maintained at 4·7 HZ with a Grass stimulator. Hearts were 
resuscitated either with perfusate bubbled only with 02/C02 or with 
N2/C02 alternating with 02/C02 . Hearts perfused with the N2/C02 
plus 02/C02 regimen recovered mechanical function with l VP retuming 
to baseline, while thOse resuscitated with 02/C02 did not recover 
baseline mechanical function. In conclusion, hypoxic rather than 
normoxic or hyperoxic resuscitation may be beneficial in preserving 
ventricular function after cardiac arrest. 
JACC February 1994:1A-484A 
881·93 
Bystander Initiated CPR Maintains Ventricular 
Fibrillation and Triples Survival After Witnessed out 
of Hospital Cardiac Arrest 
lohan Herlitz, Lars Ekstrom, Stig Holmberg, Division of Car•
diology, Sahlgren's Hospital, Goteborg, Sweden. 
Aim: To describe the proportion of patients who were dis•
charged from hospital after witnessed out of hospital cardiac arrest 
in relation to bystander initiated cardiopulmonary resuscitation 
(CPR). 
Patients: All patients with witnessed out of hospital cardiac 
arrest prior to arrival of the ambulance and where CPR efforts were 
attempted by the emergency medical system (EMS) in Goteborg 
during 1980-1992. 
Results: Bystander CPR was initiated in 18% of 1.660 cases. In 
this group, 69% had ventricular fibrillation at first recording as 
compared with 51% in the remaining patients (p<O.OOl). Among 
patients with bystander CPR, 25% were discharged alive versus 8% 
in the rest (p<O.OOl). Independent predictors of survival were in 
order of significance: 1) Initi.al arrhythmia (p<O.OOl); 2) Interval 
between cardiac arrest and arrival of first ambulance (p<O.OOl); 3) 
Bystander initiated CPR (p<O.OOl); 4) Age (p<O.OOl). 
Conclusion: Bystander initiated CPR maintains ventricular 
fibrillation and triples the chance of survival after out of hospital 
cardiac arrest. 
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882·48 
Catheter Ablation of Mahaim Fibers Complicated by Atrial Fib•
rillation 
Riccardo Cappato, Michael SchlUter, Christian Weiss, Karl H. Kuck. 
University Hospital Eppendorf, Hamburg, Gennany 
Eleven pts underwent radiofrequency current (RFC) catheter ablation 
of a right-sided accessory pathway (AP) with slow and decremental 
antegrade conduction (so-called Mahaim fibers). Six of these pts de· 
veloped recurrent episodes of atrial fibrillation (ARb) spontaneously 
or induced by programmed stimulation or mechanical catheter ma•
nipulation. To establish stable conditions for localizing the atrial in•
sertion of the AP (via the recording of an AP potential or stimulus•
to-QRS interval mapping during atrial pacing along the tricuspid an•
nulus), the first 4/6 pts required 4 ± 2 DC cardioversions because of 
recurrent AFib. During mapping in sinus rhythm, "mechanical" con•
duction block at the subannular level of the atrial input to the AP was 
easily and repeatedly induced by catheter manipulation in all 4 pts. 
Therefore, in the last 2 pts in whom AFib recurred during the proce•
dure, no attempt at cardioversion was made. In both pts, mechanical 
block in the right posterolateral region was induced within 10 min•
utes of mapping during AFib. With the catheter left in place, RFC 
was delivered after AP conduction and AFib had resumed. In all 6 
pts, the AP was abolished with a median of 6 RFC applications. 
Conclllsions:The so-called Mahaim fibers are amenable to continued 
mapping during AFib. Catheter-induced mechanical block of ante•
grade AP conduction can easily be provoked and provides a reliable 
marker of localization of their atrial insertion. RFC pulses applied to 
the site of mechanical block after resumption of antegrade conduc•
tion can efficaciously ablate these pathways. 
ABSTRACTS 
882·49 
Precise ldentificatioo of Target Sites by Subthreshold Stimu1atioo During 
Catheter Ablatioo of Coocealed Accessory Pathway: Unipolar vs. Bipolar 
Mode 
Xu. Chen, Mchammad Sheoasa, Gemard Hindricks, Hans Kottkamp, 
SUphan Willems, Wilhelm Haverkamp, Brigitte Rotman, Martin 
8orggrefe, GUnter Breithardt, Dept. of Cardiol and Inst. for Res. in 
Arteriosclerosis, University Hospital Minister, Gennany 
We have recently shown that bipolar direct CIIITSIt (DC) subthreshold 
stimulatioo (STS) is helpful for precise localizatioo of CXXIcealed acx:essory 
pathway (AP) during radiofrequency (RF) ablatioo. The purpose of the 
present prospective study was to assess whelher unipolar STS can further 
improve the predictive value of STS. RF ablatioo was performed in 23 
ccnsec:utive pts with 1eft-sided CXXIcealed APs. Before delivery of RF 
energy, unipolar and bipolar STS was applied at each target site. Unipolar 
STS was applied between the tip electrode of the ablatioo catheter and the 
external plate electrode, and bipolar STS was applied between the distaI 
pair ofelectrodes of the ablatioo catheter. STS was defined as effective if 
terminatioo of orthodromic tachycardia and/or c:oocealed capture of the 
AP occurred (capture of the atrium without capture of the 10cal Vllltricle 
with the catheter underneath the valve annulus at the veutricular insertion 
of the AP). If there was DO effect following more than 5 RF pulses, the 
ablatioo catheter was placed at the atrial side guided by electrogram 
criteria. Results: 20123 (87%) APs were successfully ablated It the 
veotricular insertioos of APs with a median of 2 RF pulse. Bipolar STS 
was effective in 14/20 (70%) and unipolar STS was effective in 18120 
(90%) sites. In three patients, in whom It DO target site the STS was 
effective, the APs could ooIy be successfully ablated It their atrial 
insertioos . 
C<Delusions: DC unipolar STS is a more reliable guide for precise 
Iocalizatioo of CXXIcealed AP and allows successful ablatioo of the APs 
with a median of 2 RF pulses. At sites where STS is not effective, the 
ablatioo should be attempted It atrial sites. 
882·50 
Radiofrequency Ablatioo of Accessory Pathway During Atrial FibriUatioo 
vs. Sinus Rhythm 
Xu Chen, Gerhard Hindricks, Stephan Willems, Wilhelm Haverkamp, Hans 
Kottkamp, Brigite Rotman, Antarie Martinez-Rubio, Mobammad Shenasa, 
Martin 8orggrefe, Gunter Breithardt, Dept. of Cardiol.! Angio\. and Inst. for 
Res. in Arteriosclerosis, University Hospital, MUnster, Gennany 
Atrial fibriUatioo (AF) is frequently initiated during radiofrequency (RF) 
catheter ablatioo of accessory pathways (AP). h has been generally believed 
that initiati<D of AF may ~licate the localizatioo of AP. Therefore, most 
centers c:unmtly perform cardioversioo in order to CXJDtinue the ablatioo 
sessioo. The purpose of this study was to assess the feasibility of ablatioo of 
manifest AP during AF. RF ablatioo was performed in 87 coosecutive pts 
with left -sided IllIIIlifest APs during AF (group 1, n= 16) or during sinus 
rhythm (group IT, n=71). The criteria for 1ocaIizati<D of AP during AF were 
recording of stable AP potentials, local veutricular activaticn preceding the 
ooset of the intrinsic det1ection of the unipolar e1ectrogram and a QS pattern 
of the unipolar electrogram. Overall, the APs were successfully interrupted 
in 85/87 pts (98%). During the first ablatioo procedure, abolishing of APs 
was achieved in 15/16 pts (94%) during AF compared to 64nI pts (90%) 
during sinus Ihythm (n.s.). 
group I group II P value 
RF pulses 3±3 5±4 n.s. 
procedure time (min.) 96±91 156%128 p<0.05 
fluorotime (min.) 31%24 41%26 p<0.05 
Thus, it is feasible and very effective to perform RF ablatioo of the manifest 
APs during AF. Precise Iocalizatioo of AP during AF seems evil! easier 
than during sinus Ihythm as indicated by shorter procedure and fluoro times 
in the AF group. 
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882·51 
Radiofrequency Ablation Therapy in Atypical or Multiple 
Atrioventricular Node Reentry Tachycardias 
San-Jou Yeh, Chun-Chieh Wang, Ming-Shien Wen, Fun-Chung Lin, 
Delon Wu, Chang Gung Medical College, Tao-Yuan, Taiwan 
The efficacy and safety of radio frequency ablation were tested in 23 
patients (pts), 8 with atypical and 15 with multiple atrioventricular 
node reentry tachycardias. Dual pathways with both anterograde fast 
and slow pathway conductions were demonstrated in 16 pts. Studies 
on retrograde conduction revealed the presence of 3 different 
pathways, including a fast pathway (15 pts), an intermediate pathway 
(17 pts), and a slow pathway (16 pts). The radiofrequency current was 
applied using the inferior approach. It resulted in selective ablation of 
both retrograde intermediate and slow pathway conductions in 20 pts. 
In 2 pts, retrograde fast pathway conduction was also modified. 
Complete heart block occurred in the remaining pt. Sixteen pts had no 
induction of tachycardia or echo, 4 had induction of a single echo, and 
2 had induction of slow-fast tachycardia. One of the latter 2 pts 
underwent a second trial and was successful. A median application of 
2 was delivered at a power of 25 ± 5 W and a duration of 18 ± 4 s. 
The total fluoroscopic time was 25 ± 21 min. The anterograde fast 
pathway conduction was unaffected and the shortest atrial paced cycle 
length that sustained I: I fast pathway conduction was 329 ± 65 and 
330 ± 68 ms before and after ablation, respectively. A follow-up study 
was performed in 14 pts 62 ± 14 days after ablation. Nine had no 
induction of tachycardia or echo, and 5 had induction of < 3 echoes. 
Thus, radiofrequency ablation using the inferior approach is effective 
and safe in atypical or mUltiple atrioventricular node reentry 
tachycardias. It resulted in selective ablation of the slow pathway and 
retrograde intermediate pathway conduction with preserved 
atrioventricular conduction. 
882-86 
Fast Pathway Properties Before and After Slow Pathway 
Ablation in Patients With A V Node Reentrant Tachycardia 
Win K. Shen, Stephen C. Hammill, Douglas L. Packer, Mayo Clinic, 
Rochester, MN 
Variable effects on fast pathway (FP) properties after 
radiofrequency ablation (RFA) of slow pathway (SP) in patients with 
A V node reentrant tachycardia (A VNRT) have been reported. These 
observations have been attributed to the fluctuating autonomic tone 
or a direct effect of SP RFA (abolishment of SP-FP interaction). To 
assess the effects due to SP ablation, we evaluated anterograde and 
retrograde effective refractory period (ERP) and shortest 1: 1 
conduction via the FP at baseline study with and without 
isoproterenol (Iso) both before and after successful SP RFA in 41 
consecutive pts (FIM=30/11, mean age±SD--48±18 yrs). FP 
properties (in msee) were: 
AnterQgrade 
PreRFA 
PostRFA 
Retrograde 
PreRFA 
PostRFA 
ERP Shortest I: I 
Baseline Iso Baseline Iso 
338±68 257±45 399±64 312±45 
327±64 246±32 405±72 316±42 
315±62 
321±57 
233±15 381±90 
24000 385±85 
281±40 
305±33 
Anterograde and retrograde ERP and shortest I: I conduction of the 
FP were not significantly changed (p=NS) by RFA of SP. Effects of 
Iso on FP properties were not altered by RFA of SP. Of the total, II 
patients (27%) had persistent dual A VN physiology without 
inducible A VNRT after SP RF A. ERP of the FP was not 
significantly different before and after SP RFA in patients with 
(348±45 and 326±43 msec) and without (330±69 and 318±63 msec) 
persistent dual A VN physiology. We conclude: RF A of SP has little 
effect on residual FP properties under baseline and enhanced 
adrenergic conditions. FP conduction properties were not 
significantly different in patients with or without persistent dual A V 
node physiology after SP RFA. 
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882-87 
Specific Signals From The Fast Pathway in A V Nodal Reentrant 
Tachycardias Confirmed by Radiofrequency Catheter Ablation 
Peter Weismiiller, Jielin Pu, Georg GroBmann, Johannes Wiecha, Frank 
Bogun, Martin HOher, Matthias Kochs, Vinzenz Hombach, University of 
Ulm, Ulm, Germany 
It was the purpose of this study to evaluate signals from fast and slow 
conducting pathways in patients with A V nodal reentrant tachycardias 
(A VNRT) by means of catheter ablation with radiofrequency energy. 
Methods: 11 patients with A VNRT were investigated (mean age 38 
years, 16-54 y), 9 patients with typical, 2 with atypical A VNRT. Energy 
was applied at the site where an additional late atrial signal was recorded 
during sinus rtIythm. Energy applications 7 times (2-12 times), duration 
26 s (20-30 s); amount of energy 26 W (19-30 W). 
Results: The V A V, 
procedure was '-------v- II -----.J "---
succ.:ssful in 9/11 I 
patients. In 5 CS 
patients the slow CS ~ :1 
pathway ,was r HBE 
IDtelTUpted, In the H l 
other 4 patients HBE ------.,' • ~ 
~~ f~~~r:p~~ ., I CS ---;:1:. MAP~ 
The distance from !~. ! ' l I I 
the site of MAP-. "::~ ~ ~ 
successful energy I I MAP~r.V~ ~\t--
application to the ... I HBE 
SHe of the His fig.! fig.2 ... fig.3 
bundle was larger when the slow pathway was interrupted compared to 
the distance when the fast pathway was interrupted. During sinus rtIythm, 
prior to fast pathway ablation a distinct signaf could be recorded before 
the His bundle signal (fig. I , fig.2), showing other characteristics than the 
slow pathway signal (fig.3). The mean ratio of the pathway signal to the 
atrial signal at the site of successful ablation of the slow pathway was 
11.1, at the site of successful ablation of the fast pathway 0.42. Two pa•
tients shOwed a recurrence of the tachycardia during a mean follow-up 
period of 9 month. 
Conclusions: From fast conducting A V nodal pathways specific atrial 
signals can be recorded as from slow conducting pathways. Signals from 
the fast pathways show different characteristics compared to those from 
slow conducting pathways. This has to be confirmed in more patients. 
882-88 
Residual Slow Pathway Conduction After Successful Slow 
Pathway Ablation Does Not P,.dic:t RecuMnc:e of AVNRT 
H. Andrew Hazillt, James H. McClelland, Karen J. Beckman, 
Xunzhang Wang, Lawrence E. WIdman, Mauricio Arruda, Micheal P. 
Rome, Ismaile Abdalla, Reed Sweidan, Ananljit Singn, Bemard 
TnibauH, Marlo 0 Gonzalez, Hiroshi Nakagawa, Ralph Lazzara, 
Warren M. Jackman, university of Oklahoma, Oklahoma City, OK 
AV nodal reentrant tachycardia (A VNRT) can be cured by 
radiofrequenc:y catheter ablation of slow AV nodal pathway conduction 
at the posterior septum. Tnis may be accomplished by either complete 
elimination of all slow pathway conduction or by attenuatlon of slow 
pathway conduction so that A VNRT can no longer be induced. We 
examined the hypothesis that persistence of some degree of slow 
pathway conduction after ablation predicts recurrence of A VNRT. 139 
pts underwent radiotrequenc:y catneter ablation for typical "siow-tast" 
A VNRT. Potentials representing activation of the atrial end at \he slow 
pathway were used to select a site tor slow pathway ablation. 
Procedure endpoint was defined as the Inability to induce more than 
single AV nodal reentrant echo complexes during aggressive atrial and 
ventricular stimulation with and without isoproterenol infusion. 1-
33(median at 1) applications of radiofrequency current (usualy 
delivered between the coronary sinus ostium and tricuspid annulus) 
were required to eliminate A VNRT in all 139 pts. All evidence at slow 
pathway conduction was eliminated in only 32(23%) at the 139 pts 
(Group 1) Single complexes of antegrade slow pathway conduction 
were induced by programed atrial stimulation in 107 (77%) at the 139 
pts (Group 2). During a mean follow-up ot20.4(±1S,1)mos, AVNRT 
recurred In 0 of 32 in group 1 and 1 at 107 in group 2 (P"NS). Follow•
up electrophysiologic studies were obtained in 43 pts(4.7±4.4mos) with 
no pts exhibiting inducible A VNRT. We conclude that total elimination 
of slow pathway conduction is not necessary tor successful ablation for 
AVNRT. 
lACC February 1994:1A-484A 
882·89 
Sinus Node Modification for Inappropriate Sinus Tachycardia 
Randall J Lee, Harlan R Grogin, Adam P Fitzpatrick, Laurence M 
Epstein, Michael 0 Lesh, Melvin M Scheinman. University of 
California, CVRI, San Francisco, CA 
Five female patients, mean age 40 ± 13 yrs, with disabling incessant 
inappropriate sinus tachycardia (1ST) underwent attempted 
radiofrequency (RF) catheter modification of the sinus node. Patients 
were refractory to an average of 3.8 ± 0.7 drugs, including high doses of 
beta-blockers. One patient had a previous A VJ ablation with 
subsequent DOD pacemaker. All patients had baseline excercise stress 
testing (EST) and Holter monitoring which revealed chronic or episodic 
sinus tachycardia at rest and an inappropriate chronotropic response to 
a light work load (mean HR was 134 + 28 beats/min during stage I). 1ST 
was defined as : 1) P wave axis and morphology during tachycardia 
which resemble baseline EKG; 2) Lack of initiation or termination of 
the tachycardia by a critically timed atrial premature stimulus; 3) 
Initiation of tachycardia with isuprel or aminophylline. Successful 
radiofrequency catheter modification of the sinus node was defined as 
elimination of the sinus tachycardia at baseline and following isuprel 
infusion. 
Results: RF modification of the sinus node utilizing a 10 mm tip 
catheter was successful in 5 of 5 patients. Earliest endocardial 
activation mapping was not indicative of the successful site of ablation. 
Successful site of ablation was found to be anatomically located at the 
lateral junction of the superior vena cava and the right atrium at the 
level of the cristi terminales. Successful ablation was characterized by 
immediate termination of the tachycardia with either atrial ectopic 
bradycardia or junctional escape pacemaker rhythm at a mean rate of 
48 ± 13 beats/min. EST post-ablation revealed appropriate 
chronotropic response without evidence of taChycardia. Within 1 week 
all patients had recovered a sinus rhythm. after a mean follow-up of 5 
± 1 month, 2 patients subsequently required permanent pacing because of 
symptomatic pauses and 1ST recurred in 1 patient. 
Conclusion: Sinus node modification (or ablation) is feasible in human 
and may prove to be the therapy of choice for patients with disabling 
1ST. However, risk of need for permanent p~cing is high. 
882·90 
Adenosine/Verapamii Sensitive Atrial Tachycardia: 
Endocardial Mapping And Radiofrequency Catheter 
Ablation 
Anand N Munsif, L Bing Liem, Charlie Young, Michael R Lauer, 
John CL Yu, Ruey J Sung. Stanford University Hospital, Stanford, 
CA 
Over a period of 1 year, 5 patients (pts) age 45 ± 23 (mean ± 
standard deviation) years, all female, with adenosine/verapamil 
sensitive atrial tachycardia (AT) underwent electrophysiologic 
studies and catheter mapping. 2 / 5 had underlying structural heart 
disease. . 
RESULTS : (1) Mapping utilized earliest atrial endocardial 
activation, pacing atrium from tip of mapping catheter to reproduce 
atrial activation sequence during tachycardia and pace mapping with 
high gain 'P' wave. Origin of tachycardia was localized to foramen 
ovale / interatrial septum (N = 3) and low medial right atrium (N = 
2). (2) Ablation was successful in 4/4 patients in Whom it was 
attempted. (3) No complications occurred from ablation. (4) There 
was no recurrence of AT which had been ablated. (5) 3 1 5 pts 
additionally had other ATs which were non - adenosine/verapamil 
sensitive. (6) Pts were discharged on no therapy (N = 2) and with 
therapy (N = 3). (7) During the followup of 5 ± 1.3 months, of 
these latter three, two pts underwent ablation of atrioventricular 
junction and permanent pacemaker implantation due to non 
-adenosine/veraparniJ sensitive AT. 
CONCLUSIONS: (1) AT sensitive to adenosine/verapamil is 
located on the medial aspect of right atrium. (2) Radiofrequency 
ablation is safe and effective in this type of AT. (3) Unfortunately, 
other types of AT may be present and patients may need additional 
medical or other therapy. 
ABSTRACTS 
882·91 
FuciculoveDtric:u\ar Acceuol')' Patllway. CoesItIiDg with Atriovelltric:u\ar 
AccellOl')' Pathways 
155A 
Hirosbi Nakagawa, Karen J. Beckman, James H. McClelland, Xtmzbang Wang, 
Mauricio Arruda, Bernard Thibault, Gerald V. Naccardli, Ralpb Lazzara, Warren 
M Jackman, University of OIdaboma Health SciCIICCS Center OIdaboma City, OK 
Fasciculoventricular Mabaim fibers (FV·AP) c:onnect the His bundle or bundle 
brancb to the ventricle. These fibers do DOt produce a reentraDt tacbyardia due to 
the absence of a region for conduction delay. However, in patients (pis) with 
atrioventricular 8I:CeSSOry pathways (A V -AP), the coexilleDCe of preexcitation from 
a FV-AP may confuse the results of mapping and ablation of the AV-AP. Of S4S 
pts undergoing radiofrequency catheter ablation of AV.APs, FV·APs were also 
present in 3 pts (0.6%). Prior to ablation, ventricular preexcitation was dominated 
by the AV-AP, whicb was Iocatcd at right lateral region in 2 pts and left lateral 
region in I pt. After ablation of the AV-AP, preexcitation over the FV-AP was 
present with short H-V interval (22-30 msec) and QRS duration of 104-116 msec. 
Antegrade block in FV-AP occumd spontaneously (intermittent conduction) in I 
pi, and was produced by atrial stimulation in I pi, increasing H.V interval by IS·20 
msec with normalization ofQRS complex. Prolongation of A-H interval and 
Wenckebacb A V nodal block produced by atrial stimulation or adenosine 
administration were associated with afixed H-V interval and QRS morphology, 
indicating the proximal end ofFV-AP was located diltal to the AV node. His 
bundle pacing was performed in 2 pis and produced S-V interval identical to the 
preexcited H-V interval, and an identical preexcited QRS complex, suggesting the 
proximal end ofFV-AP was located diltal to the His bundle. FV-AP produced a 
sbort, negative delta wave in V I in I pi, with earliest ventricular activation adjacent 
to the proximal right bundle brancb (REB), I em from the His bundle. Intentional 
catheter trauma of the proximal RBB in this pt normalized the H-V interval and 
initial forces of the QRS complex, suggesting FV -AP originates from the RBB in 
this pt. In the other 2 pIS, FV·AP produced positive delta wave in leads VI and n, 
suggesting FV-AP may originate from the left bundle brancb. In all 3 pts after 
ablation of the AV-AP, retrograde conduction occumd only over the AV node, and 
a reentrant tachycardia could not be induced. There was no attempt to ablate the 
FV-AP. During follow-up of2S ± 19 months, there have been no tachyarrbytbmias. 
CONCLUSIONS: FV-AP: I) is present in 0.6% pts with AV·AP; 2) produces a 
unique form ofpreexcitation withfixedH-V interval during A-H prolongation; and 
3) is not arrhythmogenic and does not require ablation. 
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883·79 
Nonlinearity of Heart Rate Response to Minute Ventilation in 
Normals 
Luc P. Soucie, Anthony S.L. Tang, Sankaranarayanan Raman, University 
of Ottawa Heart Institute, Ottawa, Ontario, Canada 
To allow better programming of rate responsive minute ventilation 
pacemakers, it is important to know the relationship of heart rate and 
minute ventilation (VE) during exercise. Maximal cardiopulmonarY 
exercise treadmill tests were performed on 32 normal volunteers (10 
women, 22 men) ranging in age from 26 to 76. During a ramp treadmill 
exercise test in which the work load increases linearily with time, BP, 
HR, VE, 02 consumption (V02) and e02 production (VC02) were 
collected breath-by-breath. In each subject, the HR vs VE plot was not 
linear but could be estimated by 2 straight lines having two distinct 
slopes (SI) and (S2). The inflection point and SI, S2 were determined 
by a change point analysis. Similarly the inflection points for Ve02 vs 
V02 and VE vs V02 curves were determined. S I (1.46± 0.30) was 
significantly higher than S2 (0.55± 0.20, P<D.OOI). The HR vs VE 
inflection point correlated better with the VE vs V02 inflection point 
(R=O.77) than with the Ve02 vs V02 inflection point (R=O.65). 
Although S I was significantly higher in female than male, it correlated 
best with body surface area (R= 0.75)(p<0.002). 
Cootlusion: HR increases in a non-linear fashion with respect to 
minute ventilation, having an initial sharper slope (SI) and an inflection 
point which correlated with the VE vs V02 inflection point. This study 
suggests that the linear increase of HR with VE of current minute 
ventilation rate responsive pacemaker is inappropriate and can be 
improved with a non-linear algorithm. 
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883·80 
Heart Rate and Ventilation During Exercise and Recovery: 
Relevance for Minute· Ventilation Controlled Pacemakers 
Thorsten Lewalter, Werner Jung, Dean MacCarter, Torsten Bauer, Rainer 
Schimpf, Thomas Korte, Matthias Manz, Hermann Funke-, Berndt Liideritz. 
University of Bonn, Departments of Cardiology and Cardiovascular Surgery" 
It has been demonstraled thai the heart rate to minute-ventilation (HR/VE) 
relationship determined during the early phase of the "Low-Intensity Treadmill 
Exercise" (LITE) protocol represents the same HR/VE slope from resl to anaerobic 
threshold throughout peak exercise. The LITE J.lfO!OCOI therefore allows appropriate 
HR/VE slope programming of minute-venulation controlled pacemakers with 
minimal patient effort and serial testing. However, the HR/VE relationship during 
the POSI~ercise recovery phase performing the LITE protocol and its relevance for 
the pacemakers rate adaptive algorithms has not yet thoroughly been investigated. 
The stress tests were performed on a treadmill using the 35 watlS/min LITE 
protocol and a modified "Chronolropic Assessment Exercise ProIOCOI" (CAEP). 
Gas exchange was collected breath-by-breath on a CPX/D system (Medical 
Graphics). The HR/VE slope was determined using linear regression analysis 
during the early, dynamic exercise phase and the dynamic recovery phase 
performing the LITE protocol and below the anaerobic threshold throughout the 
CAEP. The study group consisted of 41 healthy subjects (22 men: 46 +/- 2 yrs and 
19 women 51 +/- 3 yrs). 1. LITE: The HR/VE slope determined during the early, 
dynamic exercise phase was 1.58 +/- 0.17 bealS/liter for the entire study group. 
The heart rate exhibited an increase of 4.2 +/- 0.45 bealS per 10 s exercise duration, 
whereas the VE slope was 12.67 +/- 1.77 I/min. The HR/VE slope determined 
during the recovery phase was 1.56 +/- 0.13 beats/liter indicating no significant 
difference as compared to the dynamic exercise phase (p=O.63). The heart rate 
decrease throughout the dynamic recovery phase was 2.6 +/- 0.24 bealS per 10 s 
resting time and the VE slope was 7.34 +/- 0.47 I/min, both indicating 
significantly slower kinetics during recovery as compared to exercise (p<O.OO5). 2. 
CAEP: The HR/VE slope from rest to AT was 1.54 +/- 0.15 beats/liter 
demonstrating no difference to that slope obtained from the early LITE protocol 
phase (p=O.79). 1. The LITE protocol can not only be used as a substitute for peak 
exercise to determine the correct HR/VE relationShip below the anaerobic 
threshold, but also allows to evaluate the HR/VE slope during recovery. 2. Heart 
rate and minute-venti1ation time kinetics during low-intensity exercise and recovery 
demonstrated a significant difference, whereas the heart rate to minute-ventilation 
relationship remained unchanged. 3. These findings demonstrate Ihat 
minute-ventilation conlrolled pacemakers, when appropriately programmed do not 
require different rate response factor programming during exercise and recovery. 
883·81 
Heart Rate to Work Rate Relationship Throughout Peak Exercise 
in Normals: an Objective of Rate Adaptive Slope Programming. 
Thorsten Lewalter. Werner Jung. Dean MacCarter. Torsten Bauer. Rainer 
Schimpf. Thomas Korte. Matthias Manz. Hermann Funke-. Berndt Liideritz. 
University of Bonn. Departments of Cardiology and Cardiovascular Surgery* 
Recent studies using spiroergometry emphasized the importance of appropriate 
rate adaptive slope programming of rate variable pacemaker systems to generate 
an appropriate matching of heart rate. oxygen uptake and effCl1 at different levels 
of work rate intensities. Gas exchange measurements. however are a highly 
sophisticated technique and only limited avalaible. we therefore evaluated the 
correct physiological heart rate to work rate (HRIWR) slope throughout peak 
exercise as an objective of rate adaptive slope programming. which can be 
measured rather simply. Methods: The slress tests were performed on a 
treadmill using a symptom-limited linearized "Chronotropic Assessment Exercise 
Protocol". The heart rate (HR) response and the work rate (WR) increment was 
collected on a CPX/D system from Medical Graphics. The HRtWR slope was 
determined using linear regression analysis from rest up to peak exercise. The 
study group consisted of 41 subjects (22 men: 46 +/- 2 yrs and 19 women 51 +/-
3 yrs) without evidence of cardiopulmonary disease. Results: Heart rate at rest 
was 78.7 +/- 13.2 bpm. HR at peak exercise 164.2 +/- 14.7 bpm. The HRtWR 
slope for the entire study group was 0.48 +/- 0.15. that means there is an 
increase of approximately 5 beats per increase of 10 walts. Men generated a 
HR/WR slope of 0.39 +/- 0.13 beats/watt, women 0.55 +/- 0.18 beats/watt, 
indicating a sex-related significant difference in the HR/WR slope (p<0.OO5). 
Conclusions: The heart rate to work rate slope throughout peak exercise can 
easily be determined using a linear regression analysis. To achieve an appropriate 
matching of heart rate with patient effort rate adaptive pacemakers should 
generate an increase of approximately 5 beats per increase of 10 watts performing 
peak exercise testing. Additionally. female pacemaker patients should be 
programmed to a greater HRtWR slope as compared to men. 
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883·82 
Quantification of Atrial Arrhythmias under VVI and VVI·R 
Pacing: A Prospective Evaluation in 100 Patients with Sick 
Sinus Syndrome or Higher Degree A V· Block Monitored by 
Holter·ECG 
R. Schrepf MD. J. Pache MD, B. Zrenner MD. M. Hofmann MD. 
L GoedeJ·Meinen MD, W. Rudolph MD. German Heart Center Munich 
Up to now an increased incidence of atrial arrhythmias in patients with 
VVI or VVI·R pacemakers has only been documented by retrospective 
,studies. Therefore we started a prospective study with 100 (64 VVI and 
36 VVI·R paced) patients concerning atrial arrhythmias sc~ned by 
Holter·ECG monitoring. After routine pacemaker follow·up we sup•
plied every ventricular paced patient with either sick sinus syndrome or 
higher degree A V ·block with a 24 hour Holter-ECG (2448 + S2 by EtA 
Medical·).We analysed all tapes in a beat by beat review on Elatec 3.01 
Rev B software by ELA Medical·. At the actual state of evaluation we 
have 50% sick sinus syndrome. 42% higher degree A V ·block and 8% 
binodal disease patients. The mean follow·up post implant lies at 127 ± 
81 months. 
Before implant none of the patients suffered from permanent atrial fibril•
lation. whereas intermittent atrial arrhythmias were documented in 17%. 
In Holter-ECG we registered sinus rhythm without higher degree atrial 
arrhythmias in 28%. intermittent higher degree atrial arrhythmias in 37% 
and permanent atrial fibrillation in 35% of the patients. 
Compared to the group without rate responsive pacing, we identfied a 
significantly higher rate of patients with permanent atrial fibrillation in 
the VVI·R group (19 patients vs 16 in the VVI group). 
In conclusion: We found in more than 70% of ventricular paced patients 
higher degree atrial arrhythmias and permanent atrial fibrillation; this 
figure is considerably higher than the incidence published by retrospec· 
tive studies so far. reporting an incidence between 25 and 45%. 
883·83 
Improved Hemodynamics Adlieved with Biventricular Pacing 
Andrew H. Foster, Joseph S. McLaughlin, Michael L. Fisher, 
Michael R. Gold, University of Maryland School of Medicine, 
Baltimore, Md 
Conventional A V sequential pacing using right ventricular 
(RV) endocardial leads results in asynchronous ventricular 
activation that may be hemodynamically detrimentaL The 
hypothesis that simultaneous biventricular (BiV) pacing is 
hemodynamically superior to single ventricular (LV or RV) 
pacing was tested with epicardial pacing leads in the paraseptal 
anterior LV and RV 8-36 hours following elective coronary anery 
revascularization_ Hemodynamic measurements including cardiac 
output (CO), mean arterial (MAP) and pulmonary artery diastolic 
pressure (PAD) and calculated systemic resistance (SVR) were 
made in 18 pts (mean age 64 ± 13 yrs; preoperative LV ejection 
fraction >40% in 15 of 18 pts). Data were acquired after 10 
minutes of pacing in each of 4 modes (fixed rate 90-105 bpm): 
AAI and DDD using RV, LV or BiV leads (150 msec AV delay). 
Funher testing of BiV pacing by varying A V intervals (75, 100, 
125, 150, 175 msec) did not significantly alter CO in 5 pts. 
Conclusion: A V sequential pacing using biventricular leads 
increases CO and lowers SVR compared to pacing using standard 
single ventricular leads or to intrinsic conduction. These 
hemodynamic data suggest that biventricular pacing is a more 
effective pacing modality. 
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883·84 
Should Cost Play a More Important Role in the Selection 
of Non-Steruidal Permanent Pacing Leads? 
"Thomas P. Gumbrielle, John P. Bourke, Peerapong Kitipawong, 
Ronald G. Gold. Freeman Hospital, Newcastle, United Kingdom. 
The commercial market supports many non-steroidal permanent 
endocardial pacing leads of varying construction and cost. To 
identify superior performance of one type, we compared the long 
term p~cing. pr~perties. of three representative lead types by 
random.lsed tTlal ~n 99 ~allents und~rgomg a first VVI implant. Thirty 
one pallents receIved slntered plallnum leads, 36 activated pyrolytic 
carbon and 32 vitreous carbon leads. Sensing parameters were R 
wave amplitude and ST segment elevation measured from the 
endocardial elecb'ogram. All generators were capable of non-invasive 
~hres~old tt:sting (vario capability). Voltage thresholds were non•
mvaslvely measured at 0.25 and 0.5ms pulse widths at implantation, 
48 hours, 1, 3, and 6 months and yearly for 5 years. 
~ There .v.:e.re no significant differences between pacing or 
sensmg capabllllles of the three leads at implantation. All 
demonstrated similar rises in threshold in the first 3 months which 
plateaued at 1 year and did not vary thereafter. Over the following 
fIve years there was no significant difference between pacing 
thresholds (F ratio - 0.25ms = 0.795, 0.5ms = 1.78). 
Yoltaee Thresholds 
Pulse width 0.25 ms. Pulse width O.S ms. 
Month S I 00" S80** 423S# S 100" S80"* 423S# 
() 0.62 0.65 0.66 0.56 0.49 0.47 
3 1.65 1.72 1.83 1.17 1.22 1.33 
60 1.16 1.33 1.09 0.98 0.93 1.13 
.. - pyrolytic carbon. "* -platinum iridium. # - vitreous carbon. 
Conclusions: (i) These three lead types perform equally well and 
safely dunng long tern) folllow up (ii) none offers any cost effective 
or clinical advantage over another (iii) cost should playa more 
imponant role in the selection of non-steroidal leads. 
883-85 
Time Course of Sinus Node Dysfunction and A V 
Conduction Disturbance after Cardiac Transplantation 
Chakrav~y Raghavan, Junichi Nit~, Richard W. Lowry, Cynthia 
D. Kirkpatnck, Duar S. Khoury, WelXI Zhu, Carlos Rize-Patron 
James B. Young, H.David Short, George P Noon, James D: 
Maloney. Baylor College of Medicine, Houston, Texas 
To clarify the time course of sinus node dysfunction (SND) 
and atnoventncular conductIOn disturbance (A VD) after cardiac 
transplantation and to distinguish between transient and persistent 
SND and/or A VD, 16 cardiac transplant recipients requiring 
permanent pacmg underwent long-term (53 to 2550 days) evaluation 
after transplantation. Pacemakers (PM) were inserted an average of 
140 days after transplantation (range 14 to 1336 days); 13/16(81%) 
within 3 mos (early group) and 3/16 (19%) more than 3 mos after 
transplantation (late group). Indications for PM implantation in the 
early group included SND alone in 11 pts and advanced 
atrioventricular block in 2 pts. In the late group, 2 pts had SND and 
1 pt had both SND and A YD. 
. In the early group, 7111 (64%) pts with SND became 
mdependent of pacmg 3 mos after implantation, and the remaining 4 
pts with SND and the 2 pts WIth advanced A VD were still dependent 
on Jl8cmg. Mean heart rate m 7 pts who became independent of 
pacmg was 72 beats/min at PM implantation and increased to 106 
beats/min 3 mos after implantation. 3/4 pts who remained pacing•
dependent at 3 mos had sinus arrest at implantation. There were no 
si~nifical1t differences in operative ischemic time and/or episodes of 
rejectIOn among transient SND, persistent SND, and persistent A YD 
groups. In the late group,. there was no symptomatic bradycardia 
episode early after operatIOn and no specific history including 
rejection or ischemia during follow-up. 
Conclusions: 1) Pts with mild SND requiring PM early after 
the operation tend to become pacing-independent within 3 months, 2) 
A YD or severe SND is less likely to recover, 3) Pts without 
bradycardia early after the operation can suffer from SND at long•
term follow-up without rejection or ischemia. 
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ABSTRACTS 157A 
Prognostic Value of Adenosine SPECT Thallium Imagina in 
Medically Treated Patienta with Angiographic Evidence of 
Coronary Artery Di •• a •• 
Abdalia Mostafa Kamal, Suii: Pancholy, Alia Abdel Fattah, 
Seidy Aksut, Virginia Cave, Jaekyeong Heo, Abdulmassih S. 
Iskandrian, Philadelphia Heart Institute, Presbyterian 
Medical Center, Philadelphia, PA 
This atudy examined the prognostic value of adenosine 
SPECT thallium imaging in medically treated patients 
(pts) with angiographic evidence of coronary artery 
disease (CAD). There were 177 pts aged 64 ~ 11 years; 74 
had one-vessel, 57 had two-vessel, and 46 had three•
vessel CAD (;t 50' diameter stenosis). During a mean 
follow-up of 22 ~ 13 months, there were 14 events 
(cardiac death or nonfatal myocardial infarction). Cox 
survival analysis using important clinical (age, gender, 
history of infarction, and coronary risk factors), 
catheterization data (number of disealled vessels), and 
scintigraphic data (abnormal images, reversible defects, 
size of perfUSion abnormality, multivessel thallium 
abnormality, lung thallium uptake, LV dilatation, and ST 
depression) identified the following variables to be 
important predictors of events; size of perfusion 
abnormality (X'·9), and lung thallium uptake (X'·3). 
Lifetable analysis show that pts with perfusion 
defects ;t 15, of myocardium had worse prognosis than pts 
with no or smaller defects (Mantel-Cox statistic· 13, P 
<0.001) . The extent of CAD by angiography did not 
contribute independent information. In 190 additional 
pts with CAD who underwent early coronary 
revascularization, the extent of CAD by angiography, and 
the thallium abnormalities Were more severe (P < 0.001, 
each) than the medically treated pts. Thus, adenosine 
SPECT thallium imaging provides important prognostic data 
in medically treated pts with CAD. The extent thallium 
abnormality is the most important predictor of events. 
884-75 
Prognostic Implications of Normal Exerciae SPECT Thallium 
Images in Patients with Angiographic Evidence of Coronary 
Artery Disease 
Alia Abdel Fattah, Samir Pancholy, Abdalia Mostafa Kamal, 
Massroor Ghods, David Cassel, Valerie Wasserleben, 
Jaekyeong Heo, Abdulmassih S. Iskandrian, Philadelphia 
Heart Institute, Presbyterian Medical Center, 
Philadelphia, PA 
Previous studies show benign prognosis of patients (pts) 
with chest pain syndromes who have normal exercise 
thallium images (event rate <1\ per year), however, it is 
not clear that how many of these pts had coronary artery 
disease (CAD) by angiography. The purpose of this study 
was to examine the prognostic implications of normal 
exercise SPECT thallium images in medically treated pts 
with angiographic evidence of CAD. 
There were 97 pts aged 60 ~ 10 years; 52 had one-, 30 
two-, and 15 had three-vessel CAD (;t 50\ diameter 
stenosis). The exercise test was submaximal in 51 pts 
(53%), ST-segment depression during exercise occurred in 
20 pts (21'), and angina during exercise in 23 pts (24'). 
Most pts (81') were receiving antianginal therapy. 
During a mean follow-up of 32 months, only three pts 
(aged 52, 57, and 70 years) had cardiac events; two died 
of a cardiac cause, and one had nonfatal myocardial 
infarction (event rate of 1.1\ per year). The CAD 
involved one vessel in one pt, two vessels in one pt, and 
three vessels in one pt; none had ST depression during 
exercise. 
Thus, medically treated pts with CAD (including those 
with multivessel CAD) have a benign prognosis at 32 
months of follow up in the presence of normal exercise 
SPECT thallium images. These results have important 
implications in pts managements and cost of health 
delivery. 
1S8A ABSTRACTS 
884-76 
Long Term Prognistic Significance of Nonnal or Abnormal 
Exercise TI-201 Myocardial Scintigraphy in Patients With or 
Without Significant Coronary Stenosis. 
Michel Doat, Valerio Podio, Dominique Pavin, Wilhelm 
Rutishauser, Albeno Righetti. Cardiology Center, University 
Hospital, Geneva, Switzerland. 
In order to detennine the prognostic value of a normal result of 
exercise Tl-201 myocardial scintigraphy (Tl-201), we compared 
the clinical evolution of 258 patients (pts) with suspected or 
confirmed coronary artery disease (CAD). They were subdivided 
into 3 groups (01, G2 and G3), according to the results of their 
Tl-201 and coronarography. Gl included the pts with normal 
Tl-201 and with no CAD (stenosis ~30%); G2, the pts with 
normal Tl-201 but with significant CAD (~70%), and G3, the pts 
with ischemic TI-201 and significant CAD (~70%). After a mean 
follow-up of 64±2l months, we obseved the following cardiac 
events: cardiac death (CD), myocardial infarction (MI), unstable 
angina (Ang), cardiac failure (CF), and severe arythmia (Aryth). 
TI·201 
CAD 
CD 
Ml 
Ang 
CF 
Aryth 
Gl (n=101) G2 (n=52) G3 (n=105) 
normal normal ischemic 
~O% ~70% ~70% 
2 
1 
1 
1 
1 
ns 
ns 
ns 
ns 
ns 
o 
2 
o 
1 
1 
p<O.05 
p<O.01 
p<o.OOI 
ns 
ns 
12 
24 
29 
10 
2 
(ns=not significant) 
These data suggest that patients with proven significant CAD 
(stenosis ~70%) who had showed a normal exercise TI-201 
myocardial scintigraphy have as favorable a prognosis at 5 years 
as patients with no CAD (stenosis ~30%). Patients with 
significant CAD and ischemic Tl-20! have a poor prognosis. 
884·130 
Preoperative Dipyridamole Thallium Imaging and Holter Monitoring 
as a Predictor of Perioperatlve Cardiac Events and Long Term 
Outcome 
Lee A fleisher. Stanley H Rosenbaum. Ann H Nelson. Diwakar Jain. 
Frans J Th Wackers. Barry L Zaret. Yale University. New Haven CT. 
Johns Hopkins Medical Instirutions. Baltimore. MD 
If preoperative testing is to be used 10 determine optimal perioperative 
management. then both the perioperative and long-tenn predictive 
value must be detennined. We prospectively perfonned Holter 
monitoring (HM) for silent ischemia detection in patients referred for 
dipyridamole thallium imaging (On) prior to non-cardiac surgery. ST 
segment depression ~I mm or elevation >2mm lasting for at least 60 
seconds was considered signilicant. A poSitive on test was defined 
qualitatively by reversibility. High risk on was determined 
quantitatively by a large zone of redistribution and/or Increased lung 
uptake.(nMI-III criteria) Cardiac death. myocardial infarction or 
symptomatic ischemia with transient ECG changes were defined as 
cardiac events. Patients were followed for an average of 16 months 
(range 3-32 months). A total of 180 pts underwent on of whom 8 did 
not undergo surgery based at least partially upon the result of positive 
On. Of the remaining 172 pIS. 63 (37%) did not undergo HM for 
technical and logistical reasons. 10 perioperative cardiac events 
occurred in the 109 pts who underwent both tests. The odds ratios for 
perioperative cardiac morbidity were similar between the tests. 2.96 
(1.41.6.2095% C.I.) for high risk on scans and 2.60 (1.31. 5.14. 95% 
C.Ll for HM in the group who underwent both tests. Kaplan-Meier 
cardiovascular death·fr~c survival curves were constructed for the 109 
patients who underwent both studies with a Jog-rank statistic of equality 
with p< 0.05 signilicant. Preoperative silent ischemia on HM was not a 
signiJicant predictor of long·term cardiac death. Despite the fact that 
some patients were selected to undergo preoperative coronary 
revascularization based upon a positive test. a positive on was a 
signilicant predictor of death. In conclusion. both tests demonstrate a 
similar predictive value for perioperative cardiac morbidity; however. 
DTI would appear to provide the most infonnation for long-term 
predictions for the high risk patient undergoing noncardiac surgery. 
JACe February 1994:1A-484A 
884·131 
Exercise Tc·99m Sestamlbl Myocardial Perlasloa SPECT: 
Comparative Prognostic Valae In Males and Females. 
Daniel S. Bennan. Hosen Kia!, Jshac Cohen. 1. Arthur C8bico. Jolm D. Friedman. 
Fan Ping Wang. George A. Diamond. Cedars-Sinai Medical Center. L.A.. CA 
The relative prognostic power of exercise Tc-99m sestamibi (Tc-MIBI) SPECT in 
males (M) and females (F) is unknown. Accordingly. we followed 1541 pIS (S98 F. 
943 M) (142 with prior MI) for >1 year (19.l;t4.7mos) after separate acquisition rest 
TI-201rrc-MIBI dual isotope myocardial perfusion SPECT (DIMPS). Pre-scan 
Bayesian likelihood (U) of ischemia, a known prognostic variable, was calcuJated 
from all clinical and exercise daIa. DIMPS was visually evaluated in 20 segments 
with a S point score (o-nJ to 4mabsent uptake). Summed scores (S) were calcuJated 
by adding stress S (SSS .. summed stress score) and stress minus rest S 
(SRS .. summed reversibility score).Tc-MlBI was categorized by size of SSS. 
Prognostic accuracy was assessed by ROC area. Cardiac events included 23 
myocardial infarctions and 13 cardiac deaths. F were older (64 vs 60 yrs. p<.01) and 
had lower U (.3S vs .39. p<.04). Results: SRS did not add significantly to SSS for 
events in M or F. 
~--.!..,--, lU1r.~ r·~ ! .75.71 .7'7 
< .64 
~u 
CIiI 
• _ LK sss 10111 
Conclusions: I)Exercise Tc-MIBI is a strong predictor of cardiac events and provides 
incremental infonnation over pre-scan U in both M and F. 2) For M and F. a 
normal or equivocal scan (SSS 0-3) implies an excellent prognosis. 3) A severely 
abnormal scan in F is strongly predictive of adverse outcome. 
884·132 
COmparllOn of Seltamlbl PerfU8lon Def8ctI and LungJHean RatIo 
During Exerclle With Known Indlc8l of Adv ..... Prognoals In 
Patients With COronary Artery DI .... 
Peter T. Katsiyiannls. Nader Dakak. Arshed A. Quyyumi. Elizabeth Elliot. 
Achilles Neria. Vasken Dilslzlan. NHLBI. Bethesda. Maryland 
Abnormal rest and exercise left ventricular (LV) ejection fraction (EF) and 
increased lung uptake of thallium during exercise identify coronary artery 
disease (CAD) pts at high riSk for future cardiac events. To determine 
whether technetium-99m sestamibi (SM) lung/heart (UH) ratio during 
exercise and the extent of exercise-induced SM perfusion defects also 
correlate with known Indices of adverse prognosis. 12 pts with chronic 
CAD underwent both same-day rest-exerclSe SM SPECT and rest and 
exercise radionuclide angiography (RNA) studies within a mean of 8 
days. Prior to SM exercise studies. Swan-Ganz catheters were placed In 
all pts. Pulmonary capillary wedge pressure (PCWP) measured at 
baSeline ranged from 7 to 43 mm Hg (mean 19 mm Hg) and at peak 
exercise ranged from 7 to 47 mm Hg (mean 27mm Hg). Images were 
acquired within a mean of 25 minutes from the time of SM Injection 
during treadmill exercise. Quantitative SM UH ratios were calculated 
from the anterior projections and baSed on previously published data, UH 
ratio >0.42 was considered abnormal. Mean LVEF at rest was 29% 
(range 10"10 to 50"10) and decreased to 25"10 during exercISe (range 6"10 to 
44"10). The number of exercise-induced SM defects per patient (mean 
2.331pt) correlated significantly with their respective exercise PCWP 
measurements (r-0.59. p<0.04). While PCWP was inversely correlated 
with LVEF both at rest (r--O.73. p<o.o1) and during exercise (r--O.87, 
p<0.01), there was no correlation between PCWP and SM UH ratio 
(r.O.42, p.NS). These data suggest that unlike increased UH ratio of 
thallium. SM UH ratios during exerCise may not be useful In identifying 
CAD pts at high risk for future cardiac events. 
lACC February 1994:1A-484A 
884-133 
Clinical Significance of Lett Ventricular Cavity Dilatation with 
Dipyridamole Tc-88m S.atamlbl SPECT Imaging 
Steven D. Hennan, Carol Ewing Gamer, James G. Gallagher, Joseph R. 
McClellan, Marl< I. Travin, John I. Baron, Donna J. Cloutier, Gary V. Heller. 
Memorial and Roger Williams Hospitals, Brown University, Providence, RI 
The clinical significance of e~her fixed or transient left ventricular cavity 
dilatetion following intravenous dipyridamole Tc-99m sestamibi SPECT 
imaging was assessed in 473 consecutive patients (pts)(59% female). 
Prospective qualitative analysis identified 71 pts with transient dilatation 
(TO), 74 with fixed dilatation (FD), and 328 with normal cavity size (NC). 
Myocardial perfusion defects were evaluated for extent (number of 
vascular territories) and normalization (partial or total = ischemia). All pts 
were followed for the occurrence of cardiac events. During a mean follow•
up period of 6 months, 27 pts suffered cardiac events; cardiac death in 15 
and nonfatal myocardial infarction in 12. An additional 36 pts were 
hospitalized for unstable angina and 17 for congestive heart failure. 
Mukiple territories 
Ischemic defects 
Unstable angina 
Heart failure 
Cardiac events 
CaylySjze 
NarreI (%) FIXed (%) 
6 46* 
31 50* 
5 9 
2 12* 
2 12* 
(*p < 0.01 vs Normal, "p < 0.Q1 vs FIXed) 
Trensient (%) 
56* 
94*0 
23*0 
SO 
15* 
Both FD and TO were more frequently associated with cardiac events 
and ischemic perfusion defects involving mukiple vascular territories than 
studies with NC. However, ischemic defects and unstable angina were 
more common with TO than with FD, while congestive heart failure was 
more common with FD. 
Conclusions: Left ventricular cavity dilatation, both transient and fixed, 
with dipyridamole Tc-99m sestamibi SPECT imaging is associated with 
extensive perfusion defects and an adverse short-term prognosis. These 
data suggest that the poor outcome may be due to acute ischemic events 
in patients with transient cavity dilatation and ischemic cardiomyopathy in 
patients with fixed cavity dilatation. 
884·134 
The TI-201-Tc-99m Difference Bullseye - An Objective Method to 
Identify Perfusion Abnormalities and Attenuation Artifacts In 
Dual TI-201 Rest Tc-99m Stress Perfusion Scans JR Lucas. NW 
Ratzlaff. JW O·Connell. LM Numerow. RS Hanner. MW Dae. EH 
Botvinick, University of California. San Francisco 
To determine whether the relative distribution of regional activity 
derived from perfusion agents with differing energies would reflect 
and differentiate between true perfusion abnormalities(p A) and 
attenuation artifacts(AA). relative regional radioactivity in Tl-201 
rest and Tc-99m stress sestamibi studies were similarly processed. 
normalized to peak values. plotted and compared in anatomic and 
coronary regions. in a single polar map of relative differences. the TI-
201 • Tc-99m Difference Bullseye(DB). Eleven patients(pts) with 
angiographically confirmed coronary disease(CAD) and 30 pts a 
low clinical likelihood of CAD and visually normal images were 
studied. 
Among normal studies. differential radioactivity was well matched. 
with often extensive areas of slight Tc-99m excess. Regions of Tl-
201 excess were limited in extent and maximum counts difference. 
3.6 % ± 1.1 (mean ± SE).A region of Tc-99m excess was evident in 
the anterior wall of 6/13(46%) females and in the inferior wall of 
most males (14/17, 82%). while Tc-99m excess was significantly 
greater in the right coronary distribution of males (8.2 ± 1.6%) 
compared to females (1.5 ± 3.0%). p<o.05. suggesting AA. Among 
pts with CAD. Tl-201 excess significantly exceeded normal values 
(p<O.OO5) in 17/21(81 %) of involved areas. exceeding the per vessel 
sensitivity of visual analysis(63%). p<0.05 and conventional bullseye 
analysis (76%) p = NS. based on the normal distribution of a single 
radionuclide. Per vessel specificity was 67%(8/12). 
The Tl-201 - Tc-99m DB permits objective separation of defects due 
to AA and those related to true PA. Permitted by the dual 
radionuclide method. analysis of such relative count differences 
provides accurate and objective identification of perfusion 
abnormalities based on normal values related to physical principles. 
ABSTRACTS 159A 
884·135 
A Comparison of Myocardial "Risk Area" as Detennined by Stress 
Imaging and by Intracoronary Tc·99m-$estamlbi Injection 
Jeffrey I. Leavitt, Nathan Better, Chanh Syravanh. Martha Nyldel. Joseph 
A. Vita, Donald E. Tow, Thomas P. Rocco. Harvard Medical School, 
Boston, MA. 
The extent of segmental perfusion abnormality during exercise stress is 
a prognostic determinant in patients with coronary artery disease. We 
examined the relationship between non-invasive (exercise testing with Tc-
99m-sestamibi tomography) and invasive (subs elective intracoronary OC) 
TC-99m-sestamibi injection at the site of epicardial stenosis via an infusion 
catheter) measures of myocardium at risk (*risk areaj in 10 patientS with 
sing ie-vessel coronary disease and no prior myocardial infarction. Stress 
perfusion defect extent and IC risk area were determined quantitatively by 
circumferential profile analysiS (dividing 3 short axis sflces Into 6° sectors) 
USing a threshold value of 75% of peak counts/sUce. A stress-lC ratio was 
calculated by dividing the number of abnormal stress sectors within the 
boundaries determined by IC injection by the total number of IC sectors. 
Stenosis severity was determined by angiography using digital calipers. 
We found a strong direct correlation between stress-IC ratio and stenosis 
severity, as shown (r=0.86, p=0.001). Patients with angiographic 
cOliaterals had higher stress-IC ratios than those without coUaterals 
(p=0.02). A relationship was also Observed between stress defect extent 
(uncorrected for IC risk area) and stenosis severity (r=0.81. p=O.004). 
We conclude that the relationship between stress and invasive risk area 
assessment is determined by coronary stenosis severity. Although stress 
imaging may underestimate the size of 
the perfusion bed distal to a non-critical 
coronary stenosis, stress defects 
approximate IC risk area size as 
stenosis severity increases. In addition 
to precise definition of "risk area," IC Tc-
99m-sestamibi administration may 
provide additional insight regarding the 
functional significance of a coronary 
stenosis. 
884·136 
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Sinus Node Deceleration During Dobutamine Stress Perfusion 
Scintigraphy as a Marker of Inferior Ischemia 
Mona R. Hopfenspirger. Todd D. Miller, Timothy F. Christian. 
Raymond 1. Gibbons. Mayo Clinic. Rochester. MN 
Sinus node deceleration (SND) during exercise testing has been 
reported as a marker of right coronary artery disease. To test if SND 
is a marker of inferior ischemia during pharmacologic inotropic 
stress testing, 58 patients with suspected coronary artery disease 
underwent dobutarnine stress perfusion scintigraphy. Dobutarnine 
was titrated in dosages of 5-10 mcg/kglmin over 3 minute intervals 
beginning at 10 meg to a maximum dose of 50 mcg (median=40). 
Systolic blood pressure (SBP) and heart rate were measured at each 
infusion interval. At peak dobutarnine infusion patients were 
injected with either Tl-201 (n=35) or Tc-99m-sestarnibi (n=23). 
Tomographic perfusion images were interpreted by two observers. 
SND was defined as a decrease in heart rate from the maximal heart 
rate obtained during the infusion to the heart rate present at the peak 
dobutarnine dose. The 10 patients (17%) with SND had a decrease 
of 12 ± 9 bpm (range 4-33 bpm). A1110 patients with SND 
demonstrated inferior perfusion defects (9 reversible. I fixed). 
Inferior ischemia 
SBP,!. during infusion 
SND Present SND Absent P 
..in::.l.QL ...!n:ill.. ~ 
9 (90%) 19 (40%) 0.01 
8 (80%) 23 (48%) 0.13 
Conclusion: (I) SND was observed in 17% of patients during 
dobutarnine stress perfusion scintigraphy. (2) SND occurs despite 
a decrease in BP which would be expected to provoke a reflex 
increase in heart rate. (3) In this small series of patients. SND was 
always associated with inferior perfusion abnormalities. 
160A ABSTRACTS 
884-137 
Fe. for NonInvuIve Stteu T .... ReprMelll only a Small Palt of 
the Tolal Coal of Teating to ActHve a favorable Oulcome In 
Coronary DINaN: Coal..ar.otlvenMa of Nuclear T .... 
R.E. PIm8I8on MD, R.t. Ellner PhD, CaI1yIe Fraser Heart CerUr, 
Emo!y: Crawford Long HospItal, Depa/tJnaIU d Medicine (cardiology) 
nI RadIology, Emo!y IJnIverIay School d MedIcine, AIIarta, GA. 
In !hi CUI8I1t hNIth care cIImata, .... with higher feel 
~ juaIIIcaIIon. The JUPC* d thII IIUdy W8I to oompare 3 
IlCIIV1YI8Ive ..... In I8nnI d !hi coati d t8IIIIng I8QIked to achieve 
a clinical ~ UIIng ....... VIIIueI nI a maIhernatlcaI model 
we pubIiIhed prNouaIy. Ow ~ W8I Ita total COllIS to 
achieve a clinical 0IAC0mI would be lower I t8SII were more 
accurate, nI Ita the te8lfee would rapr __ only allTl8ll part d the 
cost d .... accurate tesIS. The model 8SIUITI8d thai coronary anglo 
was performed for positive or non-diagnostic rasu/ls d whichever 
noninvasive te8I waal.-cl (1Ira8I ECG. SPECT or PEl). The model 
lISIImaIed Ita accural8 dlagnosil and tr8IIIIIlIII1t d CAD led to better 
OUIcomea, Le., more Y8lllS d liIe at full quality (.QAI.. y) CNer 10 years. 
The table IhowI variabIeI and results for patienIa with clinical 
probability (P) CAD - 0.2 or 0.5. COllI .. upressed per outcome, 
e.g., .QAI.. Y added by cIiagncIsjs II1d Ir8IiIJTlert. 
~ §fEQI fEI 
SensIIMIy .68.84.115 
SpecitMty .n .87 .115 
Non Oiagnolllc .18.08.02 
Fee ($) $330 $1,200 $1,800 
pCAD@.2 ~COIIt/.QAl..y) .04 .18 .31 
pCAD @ .5 (JeelCOIIt/.QAI.. y) .07 .30 .48 
In conclusion, the tesI with the highest lee (PEl) generateS the lowest 
total cost to achieve a favorable clinical outcome. The fee for PET 
reprwerU a larger traction d the total cost per outcome, because the 
higher accuracy requires leBa frequent cIarIIk:allon by angiography. 
Despite having the IoweIIt ... 8K8I'CIIIe ECG generates more costs 
than the nucIeII' tesIS. 
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885-67 
Coronary Flow Reserve Measurement Allow. Differentiation 
of Hypertrophic Cardiomyopathy From the Athlete's Heart 
Lubna Cboudbury, ·Johannes Radvan. ·Desmond J Sheridan, Celia M 
Oakley and Paolo G Camici. MRC Cyclotron Unit and RPMS. 
Hammersmith Hospital. and ·Deparunent of Academic Cardiology, St 
Mary's Hospital Medical School, London. UK. 
OccUlt hypertrophic cardiomyopathy (HCM) is the commonest 
cause of sudden death in athleteS. However making a conclusive diagnosis of 
HCM on morphological grounds alone may be difficult in the athlete witb 
physiological left venrricular hypertrophy (L VH). Coronary now reserve 
(CFR) is reduced in HCM Independent of the degree of L VH and despite 
angioglllJlhically normal coronary arteries. The JlIUPOse of this study was 
thus to determine whether the two types of hypertrophy could be 
differentiated by measurement of CFR using positron emission tomography 
(PEn. We investigated 7 male patients with HCM. (aged 29 ±4 years), and 
7 elite male athletes with physiological L VH, (aged 23 ±4 years). The 
thickness of the left venrricular posterior wall (PWT) and intervenrricular 
septum (IVS) was documented by echocardiography in each case. All 
subjects underwent PET using \50 labelled water to measure myocardial 
blood now (MBF) at baseline and following i.v. dipyridamole (0.56 mg/kg 
over 4 mius). CFR was expressed as dipyridamole MBFlbaseline MBF. All 
results are given as mean ± SD. 
H.CM AI.IIIW p 
IVS (mm) 19±5 13±1 <0.01 
PWT(mm) 13±2 B±l ns 
Baseline MBF (m1IminIg) 0.89±O.14 0.75±O.l8 ns 
Dipyridamole MBF (mIImin1g) 2.06±O.80 2.99 ±1.23 ns 
Coronary now reserve 2.06±O.80 3.88±1.l1 <0.01 
Conclusions: 1) Coronary now reserve is significantly reduced in HCM 
compared to atbletes with L VH. 2) Non-invasive measurement of coronary 
now reserve by PET may be used to distinguish hypertrophic 
cardiomyopathy from the athlete's heart. 
JACC February 1994:1A-484A 
885-68 
Adults with Cyanotic Congenital Heart Disease Have Impaired 
Coronary Flow Reserve 
Richard C. Brunken, Johannes Cumin, Joseph K. Perlo!f, John S. 
Child, Susan E. Purcell· Tornai, Pamela Miner, Heinrich R. 
Schelben, UCLA School of Medicine, Los Angeles, CA 
In cyanotic congenital heart disease (CCHO) the myocardium is 
perfused by viscous erythrocytotic blood with low 02 content. To 
detennine if coronary flow reserve (RES) is impaired in CCHO pts 
with erythrocytosis, rest (R) and dipyridamole (0) N-l3 ammonia 
PET perfusion studies were performed in 5 adult CCHO pts (37±4 
yrs, 02 sat 87±5%, Hgb 21.5±2.2 gm/dl, Hct 64±8%) and 7 age•
matched normals (37±4 yrs). Myocardial blood flow (MBF, 
ml/min/g) was calculated from regions of interest (ROI's) drawn on 
3 shon axis images using a two compartment N·l3 ammonia 
model. Although hyperemic heart rates were higher in pts than in 
controls (l10±1O vs 89±14, p=O.02), mean arterial pressures did 
not differ (88±10 vs 92±13 \DID Hg). Results (mean ± SD): 
RMBF 
DMBF 
RES 
Controls (21 ROI's) 
LY &JI1WD 
O.54:W.10 O.51:W.10 
2.00:W.39 I.93:W.57 
3.84±1.15 4.03±I.75 
Patients (15 ROl's) 
LY &JI1WD BY t 
O.6I±O.17 O.55:W.16 O.49:W.13 
155:W.63* I.37±O.69* I.29:W.68t 
2.74±I.56* 2.59±1.12* 2.57:W.97t 
*p<O.025 versus control; tp=NS vs patients' LV, Septum 
Conclusion: Coronary flow reserve is decreased in CCHO and this 
may reflect an impaired vasodilatory response and/or the viscous 
propenies of erythrocytosis. Significantly lower RES cannot result 
from differences in heart rate or mean arterial pressures. RV 
MBF's are similar to septal and LV MBF's, and RES is comparable 
in all three regions. The decrease in RES may adversely affect 
myocardial function in CCHD pts in response to physiologic or 
operative stress. 
885-69 
Early Impalrmant of Coronary Mlcrovalcular Funcllon 
Dilitad Clrdlomyop.thy 
Oanilo Neglia. Oberdan Parodi. Gianmario Sambucetl. Assuero Giorgelti. 
Sonia Oi Sacco, Giacomo Puccini. Michela Galoppin. Antonio L'Abbate. CNR 
Institute of Clinical Physiology. Pisa. Italy. 
Myocardial blood flow (MBF) abnormalities have been documented in 
advanced Dilated Cardiomyopathy (OCM). To determine whether these 
abnormalities are dependent on the severity of the disease. absolute 
regional MBF per unit mass (mL' min-I. g.l) was measured by Positron 
Emission Tomography and 13N-Ammonia as a flow tracer. at I'88t. during 
pacing tachycardia (150 bpm or to the Wenckebach point) and after Lv. 
dipyridamole (0.56 rng/Kg in 4') in 24 OCM patients (pts) (M:F. 2:4:1. 
age 48±11 yrs) without oven hean failure (NYHA class I-II) and In 13 
normal controls. OCM pts had all been submitted to hean catheterization 
showing normal coronary angiography. variably depressed left 
ventricular ejection fraction (LV EF 36±8%. range 21-48) and normal 
or moderately increased end·diastolic pressure (LV EOP 8.9±5.5 mmHg, 
range 0-20). Anerial pressure, heart rate and rate pressure products 
were not different between pts and controls in the three conditions. 
Relative to controls. OCM pts showed lower MBF at rest (0.8±.2 vs 
1.1±.2. p<.OI). during pacing (1.1±.6 vs 1.9±.7. p<.OI) and after 
dipyridamole (1.9±.7 vs 3.8±.9. p<.OOI). In addition. MBF was 
correlated to LV EOP both at rest (r=-.53. p<.OI) and during pacing (ra•
.67. p<.OOI) but not after dipyridamole (r=-.17. pa.45). The 13 pIS with 
LV EOP<10 mmHg showed resting and pacing MBF not different from 
controls and. with respect to the remaining OCM pts. higher EF (39±7% 
vs 31 ±7%. p<.OI), higher MBF at rest (O.9±.2 vs O.6±.2. p<.OOI) and 
during pacing (1.4±.6 vs O.7±.4. p<.OI) but similarly depressed 
dipyridamole MBF (2.1±.8 vs 1.6±.6. ns). 
Conclusions. In OCM pts without oven hean failure, MBF per unit mass 
was preserved both at rest and during tachycardia unless LV EOP was 
increased suggesting. in this case. a possible role of extravascular 
resistance; by contrast, maximal coronary vasodilatory response to 
dipyridamole was blunted undependently from the severity of LV 
functional impairment documenting an early alteration of microvascular 
funcflon. 
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885·70 
Assessment 0/ Myocardial Per/usioll alld Oxidative Metabolism 
Using ISO and Positron Emission Tomography ill Cardiomyopathy 
Denis Agostini. Hidehiro lilla. Akira Takahashi. Yoshikazu Tamura. Yukihiko Ona. 
Research Institute/or Brain and Blood Vessels. Akita. Japan. 
Background. In cardiomyopathy (CM). positron emission tomography (PET) 
metabolic studies have investigated the pathways involved in fatly acid. glucose and 
oxidative metabolisms and the alterations which occur in the diseased myocardium 
but none could provide absolute quantitation of metabolic variables. Recently. 
quantitative measurements of metabolic rate of <>2 (MMR<>2) and oxygen extraction 
fraction (OEF) using 0-15 labeled oxygen gas have been validated in animals and 
normal volunteers (NY) studies. In this study. myocardial MMR02. OEF and 
myocardial blood flow (MBF) were measured using ISO and PET and were related to 
hemodynamic and echocardiographic parameters of left ventricular oxygen demand in 
patients with CM and NV. 
Methods and Results. We selected 25 subjects: 16 [(10 ischemic (lCM) and 6 
idiopathic dilated (DCMl] pts and 9 NV. L VEF was evaluated by 2D-Echo [(L VEF: 
35±9 (CM) vs 65±8% (NV). p<.OI)]. PET protocol consisted of transmission. 
CI50 static. H2150 slow infusion dynamic. 1502 gas inhalation steady state 
scans. A whole myocardial region of interest was drawn so as to encompass the 
entire LV myocardium on one midventricuJar slice in each subject Results of PET 
data were as follows: (°p<.05 vs NV .1/p<.05 vs ICM. Student t test). 
ICM 
DCM 
NV 
MBF (ml/min/g) OEF MMR02 (ml/min/g) 
.587±.124· .661±.193 .065±.023· 
.666±.136· .492±.156·# .061±.021· 
.813±.111 .765±.088 .108±.024 
MMR02 and MBF correlated Significantly with the rate-pressure-product for all 
subjects (r =.53. p=.OOOI. r =.63. p=.OOOI). Significant correlations were also 
observed between L VEF and MMR02 (r=.81.p=.OOOI). MBF (r=.58. p=.OOOI) and 
OEF (r=.65. p=.OOOI). In DCM. reduced contractile function is associated with a 
reduced flow - 02 consumption and low OEF (vs NV,ICM, p<.05). In contrast, in 
ICM reduced contractile function is associated with a reduced flow - <>2 consumption 
and normal OEF (vs NV. p=NS). 
Conclusions. These data demonstrated that quantification of metabolic rate of <>2 
by means of 1502 and PET provides direct evaluation of myocardial 02 
consumption reflecting determinants of myocardial 02 demand in patients with 
impaired LV function. The 150 method also shows promise for the characterization 
of flow and oxidative metabolism in both entities of cardiomyopathy. 
885·71 
Myocardial Perfusion Dynamics and Heart Rate Variability in 
Syndrome X: Evidence for Autonomic and Endothelial Dysfunction, 
Joan G Meeder, Paul K Blanksma, Rutger L Anthonio, Antoon TM 
Willemsem, Eng S Tan, Jan Pruim, Wim Vaalburg, Kong I Lie. 
Thoraxcenter & PET center, University Hospital Groningen, The 
Netherlands. 
AIM: To test the hypothesis that autonomic dysregulation and lor 
endothelial dysfunction is associated with Syndrome X (angina pectoris 
and ischaemic-like changes in the exercise ECG, despite angiographi•
cally normal coronary arteries). 
METHODS: In 12 patients (SX) and 18 healthy volunteers (HV), myo•
cardial perfusion (MP), at rest (Rl, during endothelium-related cold 
pressor test (CPT) and endothelium-unrelated dipyridamole stress test 
(DST) were studied, using N-13 ammonia parametric Positron Emission 
Tomography imaging. Autonomic function was explored by time and 
frequency domain parameters of Heart Rate Variability (HRVl, using 
24 h Holter ECG monitoring. 
RESULTS: MP in SX deviated from HV on the following ways: a) het•
erogeneous resting MP (58% vs 11%, p<0.05); b) high resting MP 
(954± 174 vs 1341 ± 192 ml/min/kg, p<0.05), and c) low CPTIR ratio 
(1.22±0.19 vs 0.86±0.13, p<0.05). HRV analysis in SX with hetero•
geneous MP showed significantly lower sd of normal intervals (192 vs 
132; p < 0.05), sd of mean of normal intervals in 5 minutes segments 
(169 vs 117; p<O.05), mean of sd normal intervals in 5 minute 
segments (88 vs 52;p < 0.05) and a trend towards lower values of other 
HRV-parameters. HRV analysis in SX with abnormal high resting MP 
and abnormal response to CPT showed a trend towards lower values of 
HRV-parameters. 
CONCLUSION: The results suggest that both autonomic dysfunction 
expressed by increased heterogeneity of myocardial perfusion and de•
creased HRV-parameters, and endothelial dysfunction expressed by 
abnormal perfusion reserve during cold pressor test, play a role in 
syndrome X. 
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885·72 
Serial Changes in PET Coronary Flow Reserve in Asymptomatic Patients 
Following Coronary Angioplasty: Implications for Late Restenosis. 
Andrew Van Tosh, Dahlia Garza, Roberto R. Roberti, Mitchell A. 
Baruchin, Barbara Ventura, Jennifer Pompliano, Steven F. Horowitz. 
Beth Israel Medical Center, New York, New York. 
Clinical restenosis (RESI following PTCA has been ascribed to either 
abrupt coronary thrombosis, recoil, or progressive coronary narrowing. 
We hypothesized that if gradual coronary narrowing is a more important 
cause of late RES (> 1 month post-PTCAI, onset of RES should be 
preceded by evidence of abnormal coronary flow reserve (CFRI in the 
distribution of the PTCA vessel on dipyridamole perfusion imaging with 
rubidium-82 positron tomography (PET\. We performed PET in 45 pts 
at 1 and 3 mos. after successful single vessel PTCA. All pts were 
asymptomatic at the time of the initial PET study. Only pts who 
remained free of symptoms had 3 mos. PET, Rest Istress PET images 
were graded for perfusion on a 0-3 scale (0 = severely reduced, 3 = nil in 
the distribution of the PTCA vessel. Abnl CFR was defined as a 
decrease of~ 1 grade from rest to stress in a vascular bed. Pts were 
followed for 6 mos. post-PTCA. RES was defined as >50% stenosis of 
the PTCA vessel on cath andlor recurrent angina. w.ulli: 15 pts 
had abnl and 30 pts nl CFR in the distribution of the PTCA vessel on 1 
mo. PET. 5 pts with abnl CFR and 0 pts with nl CFR developed RES 
between 1 and 3 mos. A total of 30 pts underwent 3 mo. PET (10 
aymptomatic pts with nl CFR at 1 mo. refused; 5 pts with RES were 
excludedl. 15 pts had abnl CFR on 3 mo. PET (7 pts with abnl CFR and 
8 pts with nl CFR on 1 month PET). Of these 15 pts, 8 developed RES 
between 3 and 6 mos. post PTCA. 15 pts had nl CFR on 3 mo. PET (13 
pts with nl CFR and 2 pts with abnl CFR at 1 mo). Of these 15 pts with 
nl CFR, 0 pts developed RES between 3 and 6 mos. A total of 14/45 
pts (31 %) developed RES within 6 months post-PTCA. Abnl CFR in the 
distribution of the PTCA vessel precedes the onset of RES in most pts 
(13/14,93%). 1 pt who developed RES 5 mos. post-PTCA had nl CFR 
at 1 mo. but refused PET at 3 mos. Nl CFR is associated with no RES in 
30/31 pts (97%). CONCLUSIQN:These data suggest that gradual, 
progressive coronary narrowing is the more important cause of late RES 
and can be detected with PET prior to onset of symptoms. 
885·73 
Coronary Revascularization Improves the Extent of 
Heterogeniety of Blood Flow in Dysfunctional 
Myocardium 
Patricia 1. Rubin, Deborah A. Garrison, Pilar Herrero, Edward M. 
Geltman, Steven R. Bergmann, Robert J. Gropler, Washington 
University, SI. Louis, MO. 
Although coronary revascularization can improve resting 
myocardial blood flow (MBF), its impact on the degree of 
heterogeniety of MBF is unknown. We have shown recently that 
the perfusible tissue index (PTI) reflects both the level of blood 
flow and its heterogeniety in myocardium. Accordingly, MBF 
(mljg/minl and PTI were quantified by PET and 0-15 water before 
and after coronary revascularization in 10 patients with severe left 
ventricular dysfunction. These parameters were referenced to 
changes in oxidative metabolism measured by PET and C-l1 
acetate [(kl) min-I] and systolic function. Before revascuJarization 
both MBF (O.50±O.2S) and PTI (O.69±O.21) were lower in 
dysfunctional segments (n=34), than in segments with normal 
function (n=6; MBF=O.67±O.OS and PTI=O.S2±O.12) 
demonstrating that MBF was both reduced and heterogeneous in 
these segments. Coronary revascularization to dysfunctional 
segments resulted in a slight increase in MBF (O.57±o.26) but a 
marked increase in PTI (O.SI±O.35, p<O.05 when compared to 
values obtained before revascularization). Both oxidative 
metabolism and systolic function improved in the dysfunctional 
segments (O.043±O.OI2 before revascularization compared with 
O.052±O.OI2 after revascularization, and wall motion score index 
of 2.59±0.59 before revascularization compared with 1.96±o.S3 
after revascularization, p<O.OOO2 for both). In conclusion, even 
when successful coronary revascularization does not alter 
myocardial blood flow appreciably, it does markedly reduce its 
heterogeneity which is associated with improved oxidative 
metabolism and systolic function. 
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886·121 
TGF-& Promotes Proliferation of Cultured SMC Via Both 
PDGF-AA-Dependent and PDGF-AA-Independent Mechanisms 
George A. Stouffer', Gary K. Owens'" ' 
Departments of Medicine' and Molecular PhysIology and Cellular B,o•
physics', University of Virginia School of MedICIne, CharlotteSVIlle, VA 
Transforming growth factor-B 1 (TGF-B 1) has been implicated in 
mediating smooth muscle cell (SMC) growth following vascular InJu.ry. 
Studies examining TGF-B-induced growth of cultured SMC have IdentIfIed 
only modest mitogenic effects which are largely dependent on autocrlne 
production of platelet-derived growth factor-AA (PDGF-AA). Recent 
studies have suggested, however, that TGF-B also may have delayed 
growth effects independent of PDGF-AA. The aims of the present studIes 
were to examine the effects of TGF-B on chronic, as well as acute, growth 
responses of cultured SMC. Results demonstrated that TG~-B elIcIted a 
delayed growth response (24-fold increase in 3H-thymldlne incorporatIon 
measured 48-72 hours after treatment) and enhanced SMC productIon of 
PDGF-AA (S-fold increase over control at 24 hours). Neutralizing 
antibodies to PDGF-AA, however, inhibited only 10 - 40% of delayed TGF•
B-induced growth. Co-treatment with TGF-I!. transiently delayed epIdermal 
growth factor- (EGFl. basic fibroblast growth factor- (bFGF) or PDGF-BB•
induced entry into S phase but enhanced the delayed growth responses 
to these growth factors by 16.0-, 5.8- or 4.2-fold, respectively. Further 
studies demonstrated that: 1) neutralizing antibodies to PDGF-AA had no 
effect on these synergistic responses; 2) exogenous PDGF-AA dId not 
increase growth responses to EGF, bFGF or PDGF-BB; and 3) TGF~B 
enhanced growth responses to EGF in a SMC line in which PDGF~AA did 
not elicit any growth response. Results demonstrated that TGF-I3-tnduces 
marked delayed growth responses with EGF, bFGF or PDGF-BB that are 
largely independent of PDGF-AA. 
886·122 
Beatoration of Endothelial Function in Monkeys With 
Atherogenic LDL Levels Through Prevention of In Vivo 
LDL Osidation and Membrane Lipid Bilayer Stabilization 
by Aalodipine 
Dieter M. Kramsch. Chao-Ran Liu. Ramesh C. Sharma. 
Ci-Hua Liu, Alex Sevanian, Gail Izumi, Pengxuan Liu. 
University of Southern California, Los Angeles, CA 
We tested the lipophilic ca++-antagonist, amlodipine 
(A), with known in vitro antioxidant and membrane 
stabilizing properties for its capacity to restore 
endothelium-derived relaxing factor (EDRF) activity in 
nonhuman primates with apparent atherogenic levels of 
circulating LDL-cholesterol (LDL-Ch). EDRF activity 
was assessed in abdominal aorta of 26 male cynomolgus 
monkeys using B-mode ultrasound following infusion of 
acetylcholine (Ach) and glyceryl trinitrate (GTN): 10 
monkeys fed an atherogenic diet (AD), 11 AD monkeys 
treated with A (ADA: A=2 mg/Kg BW) and 5 animals on 
control diet (C). All diets were fed for 24 months. 
Both AD groups showed comparable rises in mean (mg/dl) 
plasma Ch & LDL-Ch: AD - 487 & 308; ADA - 403 & 286. 
Plasma oxidized LDL-Ch (LDL-), fasting insulin and 
triglycerides also rose significantly while plasma 
y-tocopherol fell significantly in AD but not in ADA 
monkeys. Ultrasound assessment of abdominal aortic 
diameter after 24 months revealed: in C monkeys normal 
dose-dependent relaxation of the vessel wall after 
ACH- and GTN-infusion; in AD monkeys dose-dependent 
paradoxical contraction after ACH with dilatation only 
after GTN; by contrast, in ADA monkeys vessel 
dilatation occurred again after ACH-infusion indicating 
restoration of EDRF activity. Thus, amlodipine appears 
to restore endothelial function through prevention of 
LDL oxidation, preservation of vitamin E and possibly 
endothelial cell membrane stabilization in spite of 
circulating atherogenic LDL-Ch concentrations. 
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886·123 
Abnormal Endothelial/Erythrocyte Adherence in Acute Ischemic 
Syndromes 
Joan L. Thomas, John A. Gillespie, Brian D. Smith, University of 
Rochester, Highland Hospital, Rochester, NY. 
While it is clear that platelets and possibly certain leukocytes are 
involved in acute myocardial injury, red blood cells as yet have not 
been implicated. Adhesion of red blood cells to endothelium may 
also playa significant role in some patients with myocardial ischemia 
and infarction. We quantitated the magnitude of erythrocyte 
adherence to endothelium in twenty patients with either acute 
myocardial infarction or unstable angina and compared them with 
twenty sex-matched controls. Endothelial monolayers were grown in 
culture from human umbilical cord veins. Red blood cells from both 
patients and controls were unsuspended in buffer, allowed to settle 
on the endothelial monolayers and then, under direct microscopic 
observation, were exposed to cal ibrated shear forces through a 
micropipette which were gradually increased until separation of the 
red blood cells from the monolayer occurred_ The range of sbear 
forces applied were I to 55 dynes/cm' and selected to mimic the 
microvascular forces present in vivo in venules, capillaries and 
arterioles. The results indicated significant abnormal erythrocyte•
endothelial adherence in the presence of pbysiologic shear forces in 
13 of 20 patients versus only I of 20 controls (p < .00006). 
F:eqcently the abnormally adherent red blood cells from the patients 
would briefly separate from the endothelial monolayer but 
immediately reattach to adjacent endothelial cells. 
Identification of the membrane adherence molecules and plasma 
factors responsible for this interaction are currently being pursued. 
Thus abnormal erythrocyte-endothelial adherence may contribute to 
the pathophysiology occurring in the microcirculation of some 
patients with myocardial ischemia or infarction_ 
886·124 
Activation of DNA Replication by an FGF-Induced 
Intracrine PDGF A Loop in 'Injured Human Smooth Muscle 
Cell s (SHe) 
Sean Ameli, Anna Hultgardh-Nilsson, Federico Calara, 
Bojan Cercek, James Forrester, Jan Ni 1 sson, Cedars•
Sinai Medical Center, los Angeles, CA 
Activation of SMC in response to tissue damage is 
regarded as an important factor in development of 
restenos is. To study thi s process, serum starved 
confl uent cultures of human SMC were injured by 
inflation of a 4.0 mm angioplasty catheter. 
Following 24 hr pulses of 3H-thymidine, in serum-free 
med i a, the fo 11 owi ng fract ions of rep 1 i cat i ng cells 
were observed in 3 different regions: 
Wound Border Uninjured 
Day 1 15.0(±1.7}% 6.3(±0.6)% 0.3(±0.2}% 
Day 2 72.7(±4.0}% 18.7(±8.5}% 0.5(±0.1}% 
The replicative activity in uninjured nonconfluent 
cultures was below 4%, demonstrating that this 
activation was not due to loss of contact inhibition. 
Injury was associated with increased PDGF A mRNA 
levels and PDGF A immunoreactivity was found in cells 
in and bordering the wound. Addition of PDGF A anti•
sense oligonucleotide to the cells 3 hrs before the 
injury inhibited DNA repl ication by 84% (p<0.005), 
while the corresponding sense oligonucleotide was 
without effect. Pretreatment with blocking antibody 
(ab) against PDGF A did not affect DNA synthesiS, 
suggest i ng i nvol vement of an i ntracri ne PDGF loop. 
In contrast, FGF ab inhibited injury induced activa•
tion of DNA synthesis by 75% (p<0.005). Conclusion: 
Our findings suggest SHC DNA synthesis in response to 
injury may occur as a result of FGF-Activated 
intracrine PDGF-AA loop. 
JACC February 1994:lA-484A 
886·125 
Association Between Glycosylated Hemoglobin and Levels of 
Fibrinogen in Patients With Type 1 Diabetes Mellitus 
Otavio C.E. Gebara, carol McKenna. Joanne Keough, Ping Xu, lzabella 
Llpinska, Murray Mittleman. LarryWelnrauch, John D'EIia, Geoffrey H. lofler. 
Institute for Prevention of Cardiovascular Disease, Deaconess Hospital and 
Joslin Diabetes Center, Harvard Medical School, Boston, MA 
Tight metabolic control has recently been shown to reduce complications 
of diabetes mellitus, although the mechanism is not well understood. Since 
elevated levels of fibrinogen that may predispose to thrombosis have been 
described in diabetes, we determined the relation between levels of 
fibrinogen (Clauss method) and glycosylated hemoglobin (HgA 1c) In 18 
subjects with type 1 diabetes mellitus (13 male and 5 female, mean age 
38.±.8 years). The mean level of fibrinogen was 455.±.29 mg/dl and of HgA 1c 
was 8.9.±.2.0. The relation between the 2 variables is shown in the figure. 
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Fibrinogen showed a significant positive correlation with HgA 1 c (Pearson's 
correlation coefficient=O.56, p=O.OO6). For each 1 untt Increase in levels of 
HgA1c there was a 35 mg/dl (95% confidence Interval: 8 to 62, p=O.01) 
Increase in levels of fibrinogen. 
This association between HgA 1 C and fibrinogen levels suggests that close 
metabolic control in patients with diabetes may reduce their risk of 
cardiovascular events by reducing their prothrombotic state. 
886·126 
Effects Of Gender on Coronary Microvascular Responses 
To Endothelin 
Theressa J. Cole and Kathryn G. Lamping, Department of 
Internal Medicine, University of Iowa, Iowa City, IA 
Epidemiological studies suggest that estrogens 
protect women from coronary artery disease. We tested 
the hypothesis that estrogens modify the response of 
small coronary arteries to the endogenous 
vasoconstrictor endothelin in vivo. Female dogs (n-5) 
were ovariectomized and supplemented With 17-1l 
estradiol pellets (35 mg) two weeks prior to study. 
Responses of microvessels on the left ventricle of 
females were compared to males (n - 4) using 
stroboscopic epi-illumination synchronized with the 
heart cycle and a microscope-video system. 
Endothelin-l (ET, 1nM and 5nM) was suffused topically 
and diameters measured at steady state. Mean arterial 
pressure was maintained at control levels throughout 
the study (males: 82 ± 4; females: 76 ± 1 mmHg). 
Estradiol levels were greater in females (females: 50-
100 pg/ml; males: < 1 pg/ml). Results are % change 
from control diameter (CD): 
% 11 CD 
n QL!.J!ml E1 1nM E1 5nM 
Male 6 130 ± 11 -29 ± 13 -70 ± 8 
Female 8 151 ± 17 -14 ± 4 -45 + 8* 
(n - number of vessels; mean ± SEM; * p<.OS vs-males) 
Thus, constriction to endothelin is greater in males 
compared to females with stable levels of estradiol. 
Estrogens may protect the coronary circulation in 
premenopausal women by attenuating microvascular 
responses to endogenous vasoconstrictors such as 
endothelin. 
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886·127 
Plasma Homocysteine Levels Rise Following Cardiac 
Transplantation. 
Peter B. Berger, James D. Jones, Lyle J. Olson, Brooks S. 
Edwards, Robert P. Frantz, Richard J. Rodeheffer, Bruce A. Kottke, 
Richard C. Daly, Kenneth B. Margulies, Debbie Jensen, and 
Christopher G. A. McGregor, MD. Mayo Clinic & Foundation, 
Rochester, MN. 
.Pts who ~ve undergon:e cardiac transplantation (en develop a 
diffuse, rapidly progressive form of coronary atherosclerosis, the 
major cause of long-term morbidity and mortality following cr. To 
detennine whether homocysteine (H), an amino acid in the blood that 
is an important risk factor for atherosclerosis, is elevated in such pts, 
we studied total plasma H concentration in 44 consecutive pts who 
underwent cr at Mayo Clinic. H levels were determined by 
automated fluorescence high pressure liquid chromatography. The 
mean age at cr was 50 yrs (range, 10 to 64); 90% were male; native 
ischemic cardiomyopathy was present in 33%. The mean pre-cr H 
concentration was 12.5±O.61J.I11011L (normal, 5 to 171J.I110l/L); 3 mos 
following cr, the mean H concentration had risen 69% to 21.1±2.5 
1J.II10l/L (p<O.OO2), and was elevated (> 171J.I1101lL) in 65% of pts. 
The mean H concentration remained elevated 6 and 12 mos following 
cr (20.4±1.4 and 22.7±2.0 1J.II10l/L, respectively). Plasma folate 
and vitamin Bl2, co-factors in H metabolism, decreased 25% and 
52% respectively within 3 mos following cr (11.6;t4.61lg/L to 
9.3±4.5 Ilg/L, p= 0.04, and 584±395 ng/L to 295±97 ng/L, p= 
om, respectively). Glomerular filtration decreased 25% during this 
same time interval (81±20 mlImin to 61±17 mlImin, p=O.OOOl). 
However, linear regression analysis failed to identify correlates of the 
increase in H. 
We conclude that H concentration rises 69% within 3 mos of cr to 
abnormal levels in most pts, and remains elevated for at least 1 yr. 
This study demonstrates for the first time significant and potentially 
deleterious abnormalities in H metabolism in pts following cr. 
Further investigation into the mechanism of the rise in homocysteine 
and the relationship between elevated H and coronary atherosclerosis 
following cr is warranted. 
886·128 
Insulin Resistance Syndrome in Patients with Angina 
Jonathan W Swan, Christopher Walton, Belinda Lees, Ian F 
Godsland, David Crook, John C Stevenson. 
Wynn Institute, National Heart and Lung Institute, London, UK. 
The purpose of this study was to examine insulin resistance and 
associated metabolic risk markers (insulin resistance syndrome) in 
patients with angina referred for angiography. Three groups of 
men were investigated. Group 1 (n = 39) had chest pain and 
angiographically proven coronary artery disease (CAD), group 2 
(n = 38) had chest pain with normal angiography and group 3 (n 
= 40) were asymptomatic, healthy volunteers, without 
angiography. The groups were of similar mean age and body mass 
index. Insulin sensitivity was calculated from an intravenous 
glucose tolerance test using the minimal model method. Serum 
lipids and lipoproteins were assayed and body fat distribution 
measured by dual energy X-ray absorptiometry. 
There were no Significant differences between groups 1 and 2 
except for android/gynoid fat ratio which showed a significant 
trend through all the groups, increasing from group 3 to 1 
(p<0.05). Both angina groups had 26-28% lower insulin 
sensitivity compared to normal men (p<0.05), 57-68% higher 
triglycerides (p<0.01), 17-18% lower HDL (p<0.01) and 7-8% 
higher systolic blood pressure (p<0.05). There were no 
differences in total or LDL cholesterol. Insulin sensitivity was 
positively related to HDL cholesterol and negatively related to 
triglycendes, android/gynoid fat ratio and systolic blood pressure. 
This study provides further evidence for the role of the insulin 
resistance syndrome in the development of CAD. However, both 
angina groups had similarly disturbed metabolic risk markers 
regardless of angiographic appearance, suggesting a common 
etiology or underlying pathology. 
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886-129 
I'IaImlnogGl Adiv ..... lDhibu.-lllemoval by Aphemia aIDe 
DextrUl Sulphate ColUDlllS 
Vincent MG Maher, FeHdta Andreotti, Yuri Kitano, Clare Neuwirth, 
Graham I)jaYies and Gilbert Thompson Hammersmith Hosp.London,U.K. 
Patients with high plasminogen activator inhibitor-l (P AI-1) antigen 
levels are prone to develop thrombosis. We examined the influence on 
plasma P AI-I levels of apheresis using dextran sulphate (OS) columns in 
12 patients (pts) (9male, 3 female, 49±lOyrs) with heterozygous familia) 
hypercholesterolemia and coronary artery disease. One plasma volume 
equivalent (2.3-4 L) was treated per apheresis at flow rates of 
23±2ml/min. Lipids and PAI-l antigen concentrations were measured in 
plasma before and after 19 aphereses (xl in 7pts, x2 in 3pts, x3 in 2pts). 
These measures were also made at 3 and 7 days post apheresis in 7 
patients and in the OS column eluates of 8 patients. 
DS-Apheresis reduced Total Cholesterol (Te) (50±8%), Triglyceride 
(TG) (45±27%), Apolipoprotein B (apo BXS9±lO%) and PAI-l from 
IO.03±1.14 to 6.4±0.8 ng/ml (p<o.o2). P AI-I changes were independent of 
drcadian variation. The quantity of PAI-l removed (3.51±1,(l3 ng/ml 
filtered plasmaXrange 2.29-S.03ng/ml) did not correlate with the TC,TG 
or apo B removed by the columns suggesting an independent OS binding 
(or PAl-I. In some patients, plasma PAI-l levels were unchanged or 
higher post-apheresis despite PAI-I removal. Consequently, the 
difference in the expected (based on P AI-I removed in column eluates) 
and actual plasma PAI-I level immediately post-apheresis was thought 
to reflect either synthesis or secretion of PAl-I. (No dilution of the 
plasma immediately post-apheresis was noted). This synthesis or 
secretion correlated Inversely with the pre-apheresis PAI-I level 
(r-O.95, p<O.oo1). PAI-I levels returned towards base-line 7 days post•
apheresis. 
This study demonstrates that P AI-I antigen is removed by Dextran 
Sulphate-columns, possibly, independent of lipoprotein removal. As a 
result, enhanced synthesis or secretion 01 P AI-I may occur but this is less 
marked if basal PAI-I levels are high. Since PAI-I levels take one week 
to recover, one treatment option (or those with high P AI-I levels and 
thrombotic dia5se may be selective extra-rorporeal removal of PAl-I. 
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887-8 
In VIvo Load Independence of Left Atrial Ellstance 
Abe DeAnda Jr., Marc R. Moon, Masashi Komeda, Cynthia E. Handen, 
Terrence Tye, George T. Daughters, NeD B. Ingels, D. Craig MOler, Srdjan D. 
Nikolic. Stanford University School of Medicine, Stanford, CA and Research 
Institute, Palo Alto Medical FOUndation, Palo Alto, CA. 
To characterize left atrial (LA) contraction, we tested the load-lnclependence 
of maximal elastance (Emax) of the Intact LA. Six dogs underwent complete 
right heart bypass with retum of oxygenated blood to a reservoir. Two large 
pulmonary veins (PV) were cannulated and connected to the reservoir, with 
all remaining PV's tied off. LA preload, and consequently cardiac output 
(CO), was controlled by varying the height of the reservoir (steady·state) and 
transiently occluding the output from the reservoir. LA inflow (equal to CO) 
was measured with an ultrasoniC flowprobe. Two pairs of sonomlcrometers 
were placed on the LA to measure transverse (01) and horizontal (02) 
diameters. LA and LV pressures (LAP,LVP) were measured with micro· 
manometer-tipped catheters. Hemodynamic data were recorded during 
various steady·state and transient occlusion conditions. LA-E was calcu· 
lated from post·atrial contraction LAP and LA volumes (VO~ (01)2*02) 
using an Iterative technique. Representative pressure-volume plots (LA 
contraction phase) during Inflow occlusion: 
LAP 
(mm~~ 
4~~--______ ~ __ ~ ____ -+ ____ _ 
~ ~ ~ ~ ~ ~ 
Relative LA volume (ml) 
ANCOVA with Dog II as a dummy variable demonstrated no correlation 
between LA·E and heart rate (p = .70), LA Inflow rate (p = .89) or LA pre· 
contraction prersure (p = .79). Conclusion: LA end-systolic elastance does 
not appear to be dependent on LA "filling" pressure. 
lACC February 1994:1A-484A 
887-61 
Single Beal Milral Oc:clullon in Ihe in yivo Ejecting Hearl: Ihe Trisection of 
Myocardial Meebanie. 
Christopher A Caldarone, Irvin B Krukenkamp, Paul G Bums, Glenn R Gaudette, 
Truls Myrmel, Sidney Levitsky. New England Deaconess Hospital, Harvard Medical 
School, Boston MA 
To fully describe myocardial function, assessment of systolic mechanics, .ctive 
diastolic relaxation, and the passive properties of the myocardium is requisite. Using 
a novel technique which preserve. mitral function but allow. rapid inflow occlusion, 
volume clamping of the swine left ventricle (n=8) on ri!!.ht heart bypass allowed 
complete control of diastolic filling within a single beat time frame. By halting 
diastolic filling during selected beats and monitoring equilibrium LV epicardial 
volume and intracavitary pressure, active and passive diaslolic mechanics as well 
as single-be.t and ste.dy-state volume loading indices of c:ontraclility were 
quantified. D.ta:mean+I-SD. 
The x·intercept of the linearized passive pressure-volume relationship represents the 
LV equilibrium volume (Ve). Ve (92+/'{; mI) was outside the operating range of 
the LV (end systolic volume 96+1-7 ml, p=O.16 vs Ve) during fully occluded (zero 
filling) beats. Negative diastolic pressures were not generated; equilibrium pressures 
were 2.3+/-1.3 mmHg. Diastolic suction does not occur in this model because the 
ventricle fails to contract to volumes below Ve. 
Active diastolic relaxation was estImated with the constant of isovolumic pressure 
decay (\au) during fully occluded beau:. Three methods were compared: a measured 
pressure asymptote, anflssumed zero pressure asymptote, and 8 calculated -floating•
asymplote. Tau(measured) was shorter than tau(zero) (25.9+/·2.1 vs 28.3+/·2.5ms, 
p<O.OI). The "noating" method (tau:42.9+/.{;.1 mS,calculaledasymptole:-15.6+/.{;.2 
rrunHS) overestimated tau(musured) (p<O.O I) and the measured asymptote (p<O.O I). 
Contractility was assessed with single perturbed beals (SPB's) and during steady· 
state volume loading using the preload recruitable stroke work relationship (pRS',),'). 
Contraclility in SPB's w.s higher than during steady·state volume loading (121 +/·22 
vs 99+/-13 mJ/mllbeat, p<O.05). Because this single beal contractile response occurs 
within a time frame too fast for second messengers, this model may allow direct 
assessment of myofilament length-tension behavior in an inlact, ejecting heart. 
This model uniquely allows comprehensive assessment of diastolic (passive/active) 
and syslolic mechanics in the ejecting heart within single beat and steady state time 
frames. 
887-62 
Redefining Regional Myocardial Function 
Paul G. Bums, Jryjn B. Krukenkamp, Christopher A. Caldarone, Glenn R 
Gaudette, Sidney Levitsky, New England Deaconess Hospital, Harvard 
Medical School, Boston, MA 
Present experimental assessment of regional myocardial function is limited by 
reliance on intracavitary LV pressure (PLV). To better define i!l!!:i!!iil< regional 
mechanical and chemomechanical function, a needle-tipped wall pressure 
micromanometer (PIM) and 2 onhogonal pairs of LAD bed dimension transducers 
were placed in the midmyocardium of 14 porcine hearts SIIpponed by CPB. PLv, 
PIM, regional area, LAD blood flow (ultrasonic flow probe), and both arteria1 and 
interventricular venous emuent oxygen content were measured in the vented 
(PLV =0) and working (modified right heart bypass) heart under control conditions 
and during CaCll infusion (0.04meq/kgimin). Working regional stroke wolk vs 
end diastolic regional area relationships (RSWA) were derived utilizing PIM 
during incremental volume loading. Vented regional stroke wolk (using PIM) and 
the average rate ofPIM decay (Ravg) were calculated. Heart rate remained con•
stant (155+/- 5 beatS/min), as did vented aortic pressure [15+1-5 rrunHg). 
Workin~ (N-14) Vented (N-9) 
RSWASlope SvstolicP ... Stroke Wolk Ravg MVO 
Control 79.20 67.1 52.00 0.39 0.031 
(12.17) (6.6) (11.35) (0.03) (0.002) 
CaCI2 105.24 109.5 148.95 0.66 0.047 
(14.22)* 02.5)# (27.69)# (0.06)# (0.005)· 
Data: mean(SEM); RSWA slope: rrunHgmm2/mml; systohc PIM: rrunHg; wolk 
area: mmHgmml; Ravg: mmHgimscc; MV02: mUmin/IOOg LAD bedlbeat; 
*p<0.05 vs control; #p<0.01 vs control; statistics (ANOVA). 
The PIM-regional area work loop relationship provides a sensitive regional measure 
of mechanical function in the working heart. In addition, this methodology a\lows 
direct measurement of regional systolic, diastolic and energetic penurbations that 
occur in the maximally unloaded heart. where myocardial work has traditionally 
been defined to be zero. Regional stroke work in the vented heart is, therefore, 
nonzero and quantifiable with this technique. 
JACC February 1994:IA-484A 
887·63 
Evaluation of Systemic Arterial Mechanical Properties During Septic 
Shock in the Absence of Volume Resuscitation 
Bernard Cholley, David Miller, Didier Payen, Sanjeev Shroff, University 
of Chicago, Chicago, IL and Lariboisi6re Hospital, Paris, France 
The purpose of this study was to provide a detailed description of 
systemic arterial mechanical properties during septic shock in the 
absence of volume resuscitation. We studied 9 anesthetized, open•
chest rabbits instrumented with a double micromanometer pressure 
catheter (one sensor located in the ascending aorta and the other 15 
cm distally) and one flow transducer (ascending aorta). Data were 
acquired sequentially during nitroprusside infusion (NP 1 0~20 I' 
glkg/min), post-NP control (C), and 3 hours following IV injection of 
endotoxin 600 I'g/kg (LPS, n=6) or placebo (n=3). NP was used in 
this protocol to assess the independent effects of pressure drop on 
arterial properties. Total peripheral resistance (TPR, mmHg·s/cc) was 
used to characterize arteriolar tone. Large artery elastic properties 
were quantified in terms of characteristic impedance (Zc, mmHg·s/ccl. 
computed from the input impedance spectrum, and pulse wave velocity 
(PWV, m/s), calculated from the two pressure measurements. The 
placebo group remained unchanged over the observation period, except 
during NP administration. Data are presented for the sepsis group oniy 
(mean ± SEM; MAoP: mean AoP, mmHg; CO: cardiac output, cc/min; 
·:p<0.05 vs. measurement of preceding time-point; +: p<0.05 vs. 
placebo group at the same time-point) 
MAoP CO TPR Zc PWV 
NP 68±6 212±24 20±2 0.99±O.08 3.4±O.1 
C 87±6· 252±21· 21±2 0.88±O.08 4.1±O.1· 
LPS 67t7·+ 129t16"+ 32±3"+ 1.56±O.19"+ 4.3±O.1 
Conclusions: (1) The classically observed fall in TPR and increase in CO 
during septic shock were not observed in the absence of volume 
resuscitation. This is consistent with previous studies using 
unresucitated animal models of sepsis. (2) The increase in Zc in 
conjunction with unchanged PWV reflects a stiffening of the large 
arteries during septic shock. These effects were not present during 
similar hypotension induced by NP, suggesting septic shock-specific 
alteration of arterial wall properties. 
887·64 
Time Constants of Isovolumic Pressure Fall: Determinants on 
LV Pressure - Volume Relation in Situ Heart 
Teruhiro Tamura, Toshiji Iwasaka, Koji Tamura, Shuji Kitashiro, 
Toshio Izuoka, Tetsuro Sugiura, Mitsuo lnada, Kansai Medical 
University, Osaka, Japan 
As time constant of isovolumetric pressure fall (T) has a 
hyperbolic relation with contractility and depends on after load, 
we hypothesized that T would be determined by end-systolic 
elastance (Ees) and effective arterial elastance (Ea) yielded by 
left ventricular (LV) pressure - volume relation. To examine 
this hypothesis, the influence of Ees and Ea on T was studied 
in 15 open-chest canine hearts. LV volume was measured by 
conductance catheter and LV pressure by a manometer tipped 
catheter. Heart rate was kept at 120 bpm by atrial pacini(. 
Ees was obtained by inferior vena caval occlusion and Twas 
computed by the method of Weisse. After baseline measurements, 
Propranolol (hng/kg) and E-I020 (30 /.Ig/kg), PDE inhibitor, 
were administrated to change Ees and Ea. At baseline, Twas 
directly related to Ea (r = 0.40, p < 0.05) and to I/Ees (r = 0.65, 
p < 0.02), and consequently to Ea/Ees (r = 0.80, p < 0.002). 
This direct relation between T and Ea/Ees was also observed 
after administration of Propranolol and E - 1020 (r = 0.79, 
p < 0.01 and r = 0.89, p < 0.002, respectively) : Propranolol 
decreased Ees and increased Ea and T, shifting the relation 
right and upward, whereas E-I020 increased Ees and decrease 
Ea and T, shifting the relation left and downward. Thus, T 
was determined by Ees and Ea, and the direct relation between 
T and Ea/Ees was kept when contractility and after load were 
changed. Conclusion: T reflects not only the rate of isovolumetric 
relaxation but also the efficiency of ventriculoarterial coupling 
(Ea/Ees). 
ABSTRACTS 
887·65 
CORONARY MICROEMBOUZATION MODEL OF REVERSmLE 
REGIONAL MYOCARDIAL DYSFUNCTION 
Koji Todaka, Howard R. Levin, Anguo Gu, Shu-Ming Zhu, Giuseppe Li 
Mandri, Sergei Savin, Shunichi Homma, Milton Packer, Daniel Burkhoff. 
Columbia Univ., College of Physicians & Surgeons, New York City, NY 
165A 
Availability of a reliable animal model of reversible regional dysfunction 
would facilitate development of techniques to differentiate akinetic yet 
viable myocardium from akinetic irifarcted myocardium. We studied the 
effects of infusing microspheres (S0-70/Lm) via a percutaneously placed 
catheter into either the proximal left anterior descending or circumflex 
artery on regional and global LV function by echocard iography over - 30 
day period in 8 mongrel dogs. LV pressure was 138±18/12±4 mmHg 
at baseline. Microspheres were infused until EDP increased to between 
20 and 30 mmHg with final pressures of ll8±21/2S±4 mmHg. In every 
case an akinetic or severely hypokinetic region was observed on the 
echocardiogram during the fll'st week post embolization which improved 
significantly over the ensuing 3 weeks. This is demonstrated objectively 
in the graph showing the impact of the embolization on area ejection 
fraction (EF) measured from cross-sectional views at the mid papillary 
muscle level which indicates near total recovery of global function 
(*p < O.OS compared with control by ANOVA and Duncan test). Thus, 
selective coronary infusion of microspheres causes severe regional wall 
motion abnormalities and decreases in area EF that recover significantly 
within - 30 days. While the mechanism of the recovery remains to be 
clarified, we propose that this is a 60 
reliable model of producing ~ 
reversible myocardial dysfunction'~ 
that may be useful for studying b 40 
techniques designed to identify 2 
akinetic yet viable myocardium. 4' 
887·66 
Control 2-7 8-1415-.34 
Days Post Embolization 
Calibration of Conductance Catheter Ventricular Volume for Parallel 
Conductance by Dual-frequency Technique. 
Enno T van der Velde, Paul Steendijk, Jan &an. University Hospital Lciden, 
The Netherlands. 
The conductance catheter (CC) technique to measure left ventricular (LV) 
volume is a powerful tool to study LV function, and is in use as such in a 
number of centers. To calibrate CC volume, emmation of parallel 
conductance, 0' (of tissues surroundinll the left ventricular cavity) is 
necessary. Routinely, this is accomplished by injection of a Imall amount of 
hypertonic saline into the pulmonary artery, and recordinl the temporary 
change in measured conductance (0). However, the fact that the electrical 
conductivity of the myocardium is frequency dependent in a different ranae 
than that of blood, can be used to estimate 0' continuously. This also malcea 
it possible to estimate the variation in 0' with volume chanles (e.g. durin, 
the heart-cycle or with loading interventions): a possible volume-depeodency 
of 0' has been recentiy debated. 
In 8 anaesthetized dogs, a CC was inserted in the LV and usinll a 
modification of the existing equipment, conductances (0 .... and 0 ... .,) w;;re 
simultaneously and continuously measured at low (4 or 10 kHz) and high (40 
kHz) frequencies. Variation in 0' was quantified by the slope (S) of the 
relation 0 .... vS G .... : if QP is constant, this slope is I. Furthermore, QP can 
be obtained from (G ••• -G,,,,)/(k-l), where k is obtained as the ratio of two 
saline-injection derived G"s (G' .... /O' .... ). Volume was altered by partially 
occludinll the descending aorta or vena cava inferior, and by dobutamine or 
propranolol. 
HLS was not significantly different from 1 (S ranging from 0.90-1.02) in 7 
of the 8 experiments. In 1 experiment a sizeable volume effect on 0' was 
found (S: 0.86±0.02). Variation in factor k with volume interventions was 
< S% in all dogs. 
In conclusion, the dual-frequency technique can be used to estimate 0, 
continuously. Furthermore, in these experiments, the effect of volume on 0, 
was in most cases not significant. 
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888-48 
Patient Satisfaction witb Healtb Care is lDsensitive to Variations in Care 
Received and Quality of Life: U.s. - Canada GUSTO Substudy Results 
Daniel B. Mark, C. David Naylor, Mark A. Hlatky, Eric J. Topol. J. David Knight. 
Nancy Clapp-Channing. Charlotte L. Nelson. Robert M. Califf, Christopher B. 
Granger, Paul A. Armstrong Duke University Medical Center. Durham, NC 
To srudy differences in the treatment and outcomes of acute myocardial infarction 
(MI) patients in Canada and the U.S .. we randomly selected 3000 NOM American 
pts. enrolled in the GUSTO megatrial. Each Canadian (n=400) and U.S. (n=2600) 
pI. had 3 structured follow-up interviews (30 days. 6 mos. 1 yr.) 10 assess medical 
resource consumption, quality of life, and pt satisfaction. 
Selected 1 Year Measures: ~ ll.S. ~ 
a) Medical Resource Consumption 
Cumularive cardiac cath rate 
Cumularive angioplasty rate 
Cumulative CABG rate 
Oulpt. MD visit last 6 wks 
b) Quality of Life (QOL) 
No/mild health limits 
Duke Activity Status Index (0-58)' 
Any chest pain last 6 wks. 
Working full/part time 
QOL rating scale (0-100)* 
c) Pt. Satisfaction scores (all 0.1(0)* 
49% 
20% 
12% 
2±4 
64% 
30 
36% 
37% 
71±20 
83% 
38% 
21% 
1±2 
74% 
35 
22% 
41% 
77 ± 19 
<.001 
<.001 
<.01 
<.001 
<.01 
<.001 
<.001 
<.01 
< .001 
Ability to see family MD 97 ± 13 92 ± 18 < .001 
Ability 10 see specialist 81 ± 27 91 ± 20 < .001 
Ability to get emergency care 95 ± 15 96 ± 13 < .05 
Skill, caring, concern of MD 93 ± 18 94 ± 16 > .05 
Overall s3lisfaction with qUality of care 94 ± 13 94 ± 14 > .05 
• Higher score = more favorable. MD = physician 
DraInatic differences exist between Canada and the U.S. in the use of invasive 
cardiac care after MI along with substantial differences in associated I year QOL 
outcomes. Canadians were more satisfied with access 10 family MDs while U.S. 
pts. were happier with specialty and emergency access. However, there wa. equal 
satisfaction with overall quality of care. These results suggest that pI. satisfaction 
is insensitive to important variations in quantity of care and quality of life. 
888-49 
Is Coronary Angiography Underused Among Vomen? 
Marianne Laouri, William J. French, Richard L. Kravitz, 
Steven J. Borowsky, Robert H. Brook. RAND, Santa 
Monica, CA; UCLA and Harbor-UCLA Los Angeles, CA 
Prior studies showed that women undergo fewer cardiac 
catheterizations and noninvasive cardiac tests than men. 
Whether women receive needed cardiac procedures had not 
been studied. The purpose of the study was to determine 
whether coronary angiography is underused among women 
compared to men. Explici t clinical indications for 
coronary angiography were established by a national 
multispecialty panel of physicians. Underuse was 
defined as failure to receive indicated coronary 
angiography within 3 months following a positive 
exercise stress test (ETT). Subjects were identified 
from among 6350 patients who underwent an ETT between 
1/1/90 and 6/30/91 at 4 academic medical centers (3 
public, 1 private). After chart review 376 patients 
with a positive ETT met indications for coronary 
angiography. Women were 12% less likely than men to 
undergo indicated coronary angiography. Among wOllen 
unstable angina and acute myocardial infarction were 
significantly associated with receipt of coronary 
angiography. The same did not hold for men. Among 
patients with chronic stable and atypical angina, women 
were 19.4% less likely than men to undergo indicated 
coronary angiography (p<. 002). After adjustment for 
symptoms, number of cardiac risk factors, age, ethnicity 
and hospital where the ETT was performed, women were 
still significantly less likely than men to undergo 
coronary angiography, adjusted odds ratio and 95% CI: 
.60, (.37, .98), p<.005. Conclusion: This study 
demonstrates for the first time that coronary 
angiography is underused among women with various 
clinical presentations. 
JACC February 1994:1A-484A 
888-50 
Soc:lo-EeClllOlllle Dete~ altbt 'llmI ElIpIe4BetwNa tbt 0Dut aI 
~ _BoIpltalAdallal .. III"'~IItfarcd_ 
-C_ A.Belziti,Arbro M.Cqide,Andret 1zajpJirTe,R\HI ICmxtiIll,laicp! 
FlirmIn,lOcll'do perez de I. ~_ Roaario,BlIII80ifer,Hemm DonI. 
CONAREC Group. Buenos Airel kpItUa 
1be ~ of e.-iy CCU -minion ofpta OIIIOina AMI needa net be 
IIrened. ConnquertIy, idertification of!be det.errninna that may prolq the 
time ellplCCi between !be CXIIet or ~ or AMI IIICllapital -minion 
J!I'O'idellmicp! IIICl enertial informltion rer health pro£eniona1a. DIU frclm 
300 pta witb AMI CCCIIeCItiftly duitted to 10 diCferem.. CCUI wa-e collected 
proIpeCtive\y to cIetennine : 1. 1be time ellplCCi &em !be 0IIIet oC ~
up to the fint medical comet (OB-Me) either penonal or by pbaoe-,1.!be time 
pMItd &em MC to emqency room arriftl (MC-Ell); 3.!be time &em 
emqencyroom trriwI to CCU -minion(ER.-cctJ) 1Ild4.!berellticmhip 
between 1,1,3 1IICl16 ..nlblea (ap,~on.c1inical pidlre, 8OCio-economica 
condition, etc). 1be time-perioda wa-e aprened u!be medillllllCl!beir 
rapectift percemilea15 and 75%. Wu1tiftriate IIII\yaiI of !be 16 predefined 
mlblel were teated with !be time-perioda or 1,11nd 3111in1!be propcxtiona1 
buwd Cox rqrenion anaiywillllCl aprened u!be perceID&e of each time•
period prolonptiOlll. Raulta: time-period 08-MC:90 min (30.360); MC-ER 
87.5min (30-120) IIldER-CCU 45 mill(1O-120) . .Auocilled ..nlbl" (pcO.05) 
rellted to inc:re_ 03-MC time wa-e: .. (1.2% per older)'ell' of ap), 
ecb:aciona1lewl:3.5% increue every 1_11_1 (UniftI'Iity,hiah 
ach001,eleDlelDry IIld illitency), medical c:.-e l)'Item.i.e. rorpenaioner 3'7%; 
preaence of prmOUlIll8ina24%: lanel_lIt!be CXIIet of ~:34%; beina 
It home 16.9% IIICl pain na.ity 9.6% every lower Itep or imenlity (for. 1 to 
10 ujetlft ae). 1be time-period MC-Ell increue 34% in plltiera no havina 
• c... 1be ER-CCU time _ imeneiy propcxtional to pain irterwity: IO.1every 
lower Itep in the pain ae. 
Conc1uaiOlll: Theae data cle.-ly indiciltel that dell)ll in CCU -minion £orpta 
with AMI In dOlely rellted to lIOcioeconomic IIld c:u1tJn1 determinII!Ia. nul 
information IIJJIt ruch health Cft Pftl'l to elaborate conmmity e<b:acional 
propnmel. 
888-51 
Determinants or Cost for Acute Myocardial Inrarction: A Report 
From the Myocardiallnrarction Cost Study (MICS) 
The Myocardial Infarction Cost Study Group. Emory University 
School of Medicine, Atlanta Georgia 
There is a pauCity of data on tbe cost of myocardial infarction (MI) 
outside of randomized clinical trials. The Myocardial Infarction Cost 
Study (MICS) is a 16 site group created to study the cost of acute 
Mrs. Hospital charges were assessed in 291 patients completing tbeir 
hospitalization from initial presentation to discharge at tbe index 
hospital. The mean age was 63± 13,65% were men, 27% bad i prior 
MI, 24% had diabetes, 50% hypertension, 38% received thrombolysis, 
67% underwent catheterization, 36% coronary angioplasty (PTCA), 
and 11.5 % coronary surgery (CABG). 22% had ventricular 
tachycardia, 2.8% a stroke and 8.6% died. The mean hospital charge 
was 529,600±25,400 compared to tbe 1993 estimate 511,107 for DRG 
acute Ml. The most powerful covariates of charges were length of stay 
(charges increased from 518,700±22,200 stay :s:6 days to 
553,700±34,900 stay > 12 days, see figure), CABG (charges 
525,600±21,OOO witbout CABG, $60,600±35,300 witb CABG, 
p< .00(1) and PTCA (charges 528,800±22,600 without PTCA, 
538,400±45,700 with PTCA, p=.OO2). Length fSla (D ) 
CABG added $4025 and PTCA 53456 to 0 y ays 
average MI charges. Multiple regression 60 <6 7-9 10-12 > 12 
yielded an r value of .75; covariates SO 
predicted 57% of charge variability. ~~~ 
While tbese data are limited with charges 40 
as a proxy for costs and unavailability of 30 p < .0001 
professional billings, charges for MI's are 
substantial and tberapy to prevent MI's or 20 
control resource use for patients with Mis 10 
may be more cost effective than 
previousl y realized. 0 -'--'-....1....1. ........ ..1-.......... -'--' 
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888·86 
Effect of Informed Consent on Patient Anxiety Levels 
Jeffrey Goldberger, Jane Kruse, Sheila Doyle, Ann Barrett, John Bulke, 
Jeffrey Smith, You-Ho Kim, Alan Kadish 
Northwestern University Medical School, Chicago, n.... 
The effect of 2 types of infonned consent (IC) were studied in 49 patients 
(mean age S6±18 years; 36 males) undergoing electrophysiology studies 
(BPS). Patients were randomly assigned to either lei that did not mention 
specific risks but noted a small risk of complications (all questions 
regarding risks were answered completely) or 1C2 that quoted all reported 
statistical risks of the BPS. The patient's anxiety state (at the time of the 
interview) and anxiety trait (intrinsic character property) were evaluated 
using SpeUberger's State-Trait Anxiety Inventory (higher scores indicate 
increased anxiety). The Inventory was perfonned prior to obtaining 
consent ('1), following consent but before EPS ('2), and following 
discussion of BPS results with the patient ('3). Versed was administered 
during BPS as needed, detennined by staff blinded to the type of IC the 
atient received. Results: Data are re rted as means. 
STATE TRAlT 
y mu tt- actor WI repeate measures, nel er e type 0 
infonned consent received nor the indication (nonsustained ventricular 
tachycardia [VT], syncope, wide complex tachycardia, or cardiac arrest) 
for BPS impacted significantly on the anxiety state or trait. Patients with 
inducible VT had an increase in anxiety state post-EPS (p=O.OOOI vs 
noninducible patients). Mean versed usage was 2.4±O.5 (SE) mg in ICI 
and 3.6±0.8 in 1C2. There were no significant differences in the number of 
patients in each consent group who felt that the infonned consent prepared 
them for the procedure (85%). Conclusions: 1) The extent to which the 
risks of EPS are discussed with a patient does not impact on the patient'S 
anxiety state, need for anxiolytics during EPS, or subjective sense of 
preparedness for EPS. 2) The results of EPS impact strongly on the 
patient's anxiety state. From a patient care viewpoint, comprehensive 
review of statistical information on procedural risks does not offer 
advantages or disadvantages. 
888·87 
Patient Mobilisation At 1 Bonr Following Cardiac 
Catheterisation Using a Biodegradable Collagen Haemostat 
JohD P. Foran, Dipti Patel, John Brookes, Ray J. WaiDwright. 
Brook Cardiac UDit, London, UK. 
Day-case cardiac catheterisation is now commoDplace, but 
proloDged patient immobilisation is required following femoral 
artery cannulatioD to control local bleeding complicatioDs. A 
novel biodegradable collagen-based haemostat has beeD developed 
to facilitate rapid haemostasis followiDg pUDcture of the femoral 
artery. We conducted a prospective study to investigate the 
poteDtial of this device to allow early mobilisatioD iD a series of 46 
consecutive patieDts, mean age (±SD) 59.9±11.Iy, undergoing 
diagDostic cardiac catheterisation. Twenty-seveD (59%) patients 
were taking low-dose aspiriD aDd 5 (II %) were fully 
anticoagulated. Successful placemeDt of the device was achieved 
iD 40 of 46 patieDts (87%). Six (13%) patients did Dot receive the 
haemostat because of femoral artery perforatioD by the tissue 
dilator (n::3), inability to compress the femoral artery proximal to 
the site of delivery (D=I), pre-existiDg haematoma (n= I), or 
patieDt withdrawal from the study (n=1). Uncomplicated 
mobilisation within two hours of iDvestigatioD was possible in 
38/40 (95%) patients. A sigDificant haematoma (>5x5 cm) 
prevented early mobilisation in the remaiDiDg two patieDts. 
Mobilisation was uncomplicated in 25126 (96%) patients 
mobilised at two hours and 11112 (92%) patients at one hour 
(p=NS). Sheath size, arterial pressure, the use of aspirin, heparin 
or warfarin, and body mass index did not influence patieDt 
outcome. 
We conclude that the biodegradable collagen haemostat is a 
relatively safe and effective device which allows far earlier patient 
mobilisation than cODventioDal pressure haemostasis after 
diagDostic cardiac catheterisatioD involving a percutaneous 
femoral artery approach. These results have important 
implications for patients undergoing investigatioD in mobile X-ray 
laboratories or iD hospital based day-case units. 
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889·108 
Can New ECG Diagnostic Algorithms Detect Atrial 
Fibrillation during VVI Pacing? 
Jelena Gataric, Caroline Foote, Paul J. Wang, Antonis S. Manolis, 
N.A. Mark Estes m. Janet Slocum. New England Medical Center, 
Boston, MA and Tufts University College of Engineering, Medford, 
MA. 
Current automated computerized ECG algorithms use the 
irregularity of the ventricular rate in the absence of discrete P waves 
to make the diagnosis of atrial fibrillation. Thus, these algorithms 
are not capable of diagnosing atrial fibrillation during regularized 
ventricular rhythms such as pacing. The purpose of this study was 
to determine whether the atrial power spectrum differed in patients 
with atrial fibrillation or sinus rhythm during ventricular pacing. 
Therefore. we studied 20 patients while they were 100% paced at 
55-120 bpm. Nine were in atrial fibrillation and 11 were in sinus 
rhythm. Ten seconds ofECG were digitized at 1000 Hz with a gain 
of 2000 on a 16 bit NO convener. The mean ventricular beat was 
subtraeted from the ECG. resulting in a remainder ECG which was 
reduced to 250 Hz and the 4096 point power spectrum was 
calculated. The ratio of the power of the peak in the fibrillatory 
band 5-9Hz to the power in the rest of the power spectrum was 
calculated. This ratio expressed as a percentage was 37.54± 15.70 
and 24.4713.93 for the patients with atrial fibrillation and sinus 
rhythm, respectively (p=O.015). 
Thus, the atrial power spectrum may be an important tool in 
the cmnputerized diagnosis of atrial fibrillation. This method has the 
advantage of not utilizing the regularity of the ventricular response in 
its algorithm, a requiremeDt of clinically used systems. 
Incorporating this algorithm into Dew automated ECG systems will 
likely improve their sensitivity for the detection of atrial fibrillation. 
889·109 
167A 
Computer Package for the ADalYlil of Episodes of ParoSYlIDaI Atrial 
Fibrillation Recorded in Long-Term ElectrocardiogramL 
Francis Murgatroyd, Katerina Hnatkova, Bayen Xie. Marek Malik. St. George's 
Hospital Medical School, London, United Kingdom. 
We have developed a software package of several algorithms aimed at the 
analysis of atrial fibrillatioD (AF) episodes recorded in Holter tapes of patients with 
paroxysmal AF. Each recording is initially subjected to computerised analysis and 
manual editiDg on a Marquette Laser Holter system. The precise timing of each 
episode of AF is determined by visual inspection, and these data are combined with 
the computerised analysis to produce a file listiDg the type of the rhythm and the R•
R interval duration for every beat in the recording. This enables. for instance. to 
analyse RR intervals preceding AF episodes. 
One part of the package is devoted to the calculation of the mean values of RR 
intervals in the specified intervals (e.g. lOs or 30s) prior to AF and prior to 
sustained AF longer than 30s. We can compare each of these values with the mean 
value ofRR intervals of all the sinus rhythm in the recording. We can also compare 
the mean value of RR intervals in lOs preceding AF with the mean value in 30s 
before that. It is possible to construct histograms of the lenghts of intervals 
mentioned above. Another part of the package evaluates the length and number of 
AF episodes in dependence on the time of occurrence during 24 hours of recording. 
A count of episodes of AF starting in each hour is provided, as well as the Dumber 
of episodes of sustained AF and the number of minutes of the AF rhythm and 
sustained AF rhythm in each hour of the recordiDg. 
A different section of the package provides a symbolic classification of the 
sequences of the last RR intervals (e.g. three cycles) before AF. By compariDg the 
length of each cycle with the mean value of the last IS intervals preceding the AF 
episode. the cycles are classified as short (5. e.g. < &0% of mean), nonna! (N, e.g. 
·&0-120% of mean). and long (L, e.g. >120% of mean). The frequency of individual 
symbolic clusters of the alphabet {S,N,L} is subsequently provided. In a similar 
way, a histogram is computed of the lengths of the last RR intervals T I'" T D 
preceding AF episode and the leDgth of interval To duriDg that sinus rhythm 
changed to AF episode. 
The package is constructed in an open way and enables inclusion of special 
algorithms developed according demands of particular investigations. Results 
provided by the package have already been used in large number of special studies 
performed in our department. 
168A 
889·110 
ABSTRACTS 
Normal Subjects ECG·and.Resplratlon 
Reference Databues on CD-ROM 
Francesco Pinciroli, Ruggero Rossi, DipllrtimeDto di Bioingegaeria, Politecnico di 
Milano and Callro di Tcoria dei Sistemi, CNR, Milano, Italy. 
A number of DeW quantifim recently suggested for the clinical practice and already 
provided by some mooitoring inslrUments have to be CODsidered insufficiently tested 
still on the normal population. The CD-ROM based technology allows the 
constrUCtion of easy-to-use dynamic archives of biosigaals and bioimages. They can 
give a truly positive contribution to the needed better testing procedures. This 
situation refm for example to the validation of computer algorithms for ECG 
analysis. 
We built the Politecnico Biosigaals Archives on CD-ROM, where two biosigaal 
databases from young normal subjects are stored. The first database is the 
Politecnico Ca Granda VCG/ECG Database on Young Normal Subjects. It was 
developed !o investigate unevident ECG variability. It CODsists of 23 recordings 
about 30 trunutes long, from 23 young normal subjects. Recordings consist of the 
three orthogonal ECG leads com:cted according to Frank. A big effort was made to 
ensure the maximum fidelit~ of recordings. Main technical features are: sampling 
frequency of 500Hz. resolubon of 2.4}lV lunit on 12 bits. 
The second database is the PoIi/Medlav Database on ECG-and-Respiration. It was 
developed to investigate interaction among cardiac and respiratory system. It 
consists of 20 recordings. about 23 minutes long, from 20 young normal subjects. 
Recordiug consist of three ECG leads (the three orthogonal leads corrected according 
to Frank), and two resplTatory traces: the respired airflow and the body volume 
variations, both measured with a plethysmographic chamber. Main technical 
features are sampling frequency of 500Hz, ECG resolution of 2.4}lV /unit, 
respiration resolution of about O.I25m1/s/unit, both on 12 bits. 
Data format respects the practical standards used for similar applications in recent 
years. This makes the Politecoico Biosigaals Archives on CD-ROM a validation 
tool suitable for many experimentations. 
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992·1 
A Databa .. for MultImedia Computer Assisted Instruction 
Robert A. Waugh, Duke University, Durham, N.C .. Gordon Ewy, Joel 
FeIner, Ira Gessner, Joan Mayer, Robert Safford, Stuart Rich, Barry S. 
Ilsenberg 
Over the last decade, The University of Miami Medical Training and 
Simulation Laboratory has developed Multimedia Computer Assisted 
In'truction (CAl) programs with cardiologists, educators and engineers 
from Arizona, Duke, Emory, Florida, Illinois and Mayo. A new database 
system will permit analYSis of program usage and performance for 
multiple learner populations. 
The CAl programs operate in 2 Modes: Self-Learning for single or small 
groups and Instructor for teaching in a lecture hall. Each may be used 
alone or with "Harvey", the Cardiology Patient Simulator. Five programs 
(normal and 4 valve lessons) have undergone a multicenter evaluation. 
Five are being developed (Angina, Acute Anterior and Inferior 
Infarctions, Cardiomyopathy and Hypertension), All are patient-centered 
and problem-based, and include the history, bedside findings, laboratory 
data, therapy and pathology. 
Earlier versions of the database system collected data from the usage 
and performance of 341 senior medical students, including scores and 
time per program. The system has been expanded to evaluate other 
students, house officers, fellows and multiple categories of practicing 
phYSicians. A performance summary includes the history, bedside 
examination, laboratory, diagnosis and treatment, and CME credit is 
provided. An analysis of learner performance compared to others in 
their professional category is based on data collected at multiple Sites. 
The system provides these data to Instructors for professional categories 
and for individualS. Individuals receive printouts that summarize their 
performance, compares them to their peers, advise them how to 
improve their performance and provide documentation of CME credit. 
The database identifies program and learner weaknesses. Population•
specific refinements may then be made. 
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992·2 
comput ... ·B .. ed T .. chlng Program In Nuclear C .. dlology 
Lucy S. Gooclenday and Karol Cios. Medical College of Ohio, Toledo, Ohio. 
Because of the need for a modHiable teaching tool for cardiology 
trainees, we decided to construct an Interactive computer-besed textbook 
capable of displaying dynamic radlonuclide Images from different computer 
sources. 
The textbook was desi~ed on a Macintosh llei networked to the 
existing cardiovascular nuclear medicine computers. Software tools used 
Include HyperCard, Quick Ttrne, MovieMaker, Image Workbench and DeHa 
Manager. InHial sections describe the pertinent anatomy, physiology, and 
technical aspects 01 nuclear cardiology. A chapter on "approach to 
interpretation" gives Interactive guidelines to the user on how to read 
radionuclide studies. The final and major block is a compilation of examples. 
Each radionuclide case study example consists of (1) history (including 
exercise data when pertinent), (2) Images, and (3) official interpretation and 
discussion. 
Some special features of the textbook Include an unusual display of 
SPECT myocardial perfusion images. All three views of both postexercise 
and rest mages are shown on one card. As the user tums to that card, each 
view sequentially cuts dynamically through all frames, then stops on the 
frame of particular interest. The user can then continue to play through the 
frames stopping on whatever frame is desired. All 3 views of both stress and 
rest studies are displayed simuHaneously; the dynamic format allows images 
to be large enough to view comfortably. Each case study requires 
approximately 7 MB. Images may be easily added from clinical cases 
acquired on a planar or SPECT camera. 
Another special feature allows the user to view the original images 
automatically upon exHing the interpretation section. The interpretation 
section utilizes icons rapresentative of the perfusion image so the user can 
see where to look for a perfusion defect. When the user is through reading 
the interpretation, he clicks on the icon, which fades into the original image, 
reinforcing the teaching point. 
The eventual goal is to have 50 case studies in the textbook, 25 for 
teaching and 25 for seH-testing. It will be possible to rotate these, and to add 
or subtract cases. Cases may be stored on a portable extemal drive or 
optical disk so that any Mac II or later model computer can be used. 
992·3 
Supraventricular Dysrhythmiu: Diagnosis 10: Therapy 
Interactive Instructional Computer Leaming 
'Stephen F. Olmstead, "James E. Thiele, and "Christopher L. Fellows 
Supraventricular dysrhythmias (SVD) are the most common rhythm 
disorders encountered by clinicians. Interactive computer assisted 
learning offers physicians an affordable self-directed educational 
environment. We have developed an interactive instructional computer 
program designed to teach the prompt recognition and treatment of SVD 
in a variety of clinical contexts. TIle program utilizes HyperCard as the 
development platform with color and QuickTime support. Graphic 
ele~ents, including actual ECG's, were imported into the HyperTalk 
scrIpted program. There are 5 distinct "patients" which are randomly 
matched with 4 common SVD's to give a total of 20 possible clinical 
scenarios. The player initially encounters a rhythm strip and chief 
complaint, and is asked for the correct diagnosis and urgent treatment of 
the SVD. He/she must then elicit the patient's history and physical 
findings which may contain information crucial to the selection of the 
correct diagnosis and therapy. The player may then review the complete 
12 lead ECG. A moving rhythm strip can be examined to aid in the 
diagnosis. When the correct answer is selected, the player is able to 
review the clinical features, surface ECG characteristics, and 
mechanisms of the SVD, before selecting the appropriate therapy. The 
correct treatment is context sensitive; determined by the diagnosis and 
the patient's history and physical findings. The player receives 
feedback on any incorrect answers. The player can review dosage, 
indications, and pharmacokinetics of the appropriate agent. The 
program incorporates a unique system to track the player's progress and 
performance consisting of a poker game played simultaneously with the 
instructional program. This feature monitors contingencies and encourages 
the player to make diagnostic and therapeutic choices in a thorough, 
methodical manner. Correct decisions are rewarded with a better hand 
while incorrect choices cause the program to "deal off the bottom of the 
deck". An added benefit is enhanced player enjoyment and participation. 
The modular design of program allows for expansion into a comprehensive 
tutorial on the diagnosis and treatment of cardiac rhythm disorders. 
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741-1 10:30 
Superiority of Rotational Scan Reconstruction Strategies 
for TrlOsthoraclc 3-Dlmenslonal Rill-Time Echocardlo•
graphic Studies In Pediatric Patients with CHD. 
Achi Ludomirsky. Michael Siiberbach, Antoinette Kenny, Takahiro 
Shiota, Mary J. Rice, Berthold KIas, Brad Krauzowicz, Peter Klein, Rick 
Dennan, David J. Sahn. C.S. Mott Children's Hospital, Ann Arbor 
Michigan, Oregon Heatth Sciences University, Portland, Oregon. 
Preliminary studies have demonstrated promising transthoracic 3· 
dimensional image reconstructions in young infants with CHD using 
transesophageal systems employing a 'breadloaf' or parallel slice 
technique on images acquired after pullbecks across the precordium. 
The purpose of our study WIS to combine the experience of two centers 
in using a high resolution Interspec ultrasound system optimized for 
pediatric application interfaced with a Torntec computer with new higher 
speed reconstruction algorithms and to evaluate the utility of parallel slice 
vs rotational transthoracic acquisitions. We studied 16 patients, 3 months 
to 5 years in age, with congenital heart disease, including HLH, Tric Atr, 
atrial and ventricular septal defects, aortic or pulmonic stenosis, AV canal 
or aortic coarctation. All chiidren below 4 years of age were sedated. 
Parallel slice or rotational acquisition steps with a probe holder controlled 
by the computer were programmed to match heart cycle length and 
respiratory phase. All 16 of the children had rotational scans (14 apical, 
14 subcostal, 6 parastemal, end 2 right subclavicular, and 6 children also 
had pracordial parallel siica scans. Acquisition times, depending on heart 
rate and patient mobility, were IS short IS 4.5 minutes. All but 2 studies 
rasutted in successful diagnostic quality reconstructions which could be 
formatted, reviewed and rendered into 3-dimensional moving images 
within 15 minutlS 01 acquisition. The rotational views allowed fOCllSing a 
larger number of steps for reconstruction of specific areas and the pre•
selection of optimal single point windows; and they facilitated 
demonstration of aortic arch anatomy, VSD anatomy or semilunar or 
atrioventricular valve anatomy with better surface rendering, and higher 
rasoiution than the parallel slice pullbacks. The ability to focus on areas of 
specific diagnostic importance through the unique rotational windows 
available on young pediatric patients, IS well IS the ease of transthoracic 
acquisition with this new combined system should bring 3-dimensional 
reconstruction closer to clinical application for detailing the complex 
spatial anatomical relationships present in CHD. 
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741·2 10:45 
Delineation of COngenital Malformationa of MHral Valve Apparatus by 
Dynamic Thr.Dlmenslonal EchOCardlography and Unique Image 
Segmentation USing a Tomographic Transthoracic Approach 
Michael Vogel, Gerald Marx, Natesa Pandian, Konrad Buhlmeyer, David 
Fulton, and ai-Ling Cao. Gennan Heart Center, Munich, Germany and 
Tufts-New England Medical Center, Boston, Massachusetts. 
We have previously demonstrated the clinical feasibiiHy of dynamic three•
dimensional echocardiography (3DE) using a tomographic probe via trans•
thoracic windOWS in infants and chiidren. In this study, we explored the 
clinical utility of 3DE in the assessment of congenital disorders of mHral 
valve apparatus (MY). In 34 pediatric pts (age 2 days - 16 yrs with a variety 
of MV abnonnalHies), we employed a 5 MHz tomographic ultrasound probe 
on the parastemal or subcostal region, collected parallel 2-D echo images 
at 1 mm intervals (1 cardiac cycle each mm, gated to EKG and respiration) 
by computer-controlled, prescribed transducer movement and performed 
volume-rendered dynamic 3DE reconstructions. Distance shading, gray•
level gradient shading or a combination of processing techniques were 
applied. Use of various forms of image segmentation and cutting ptanes 
allowed us to depict the MV apparatus in a multitude of orientations, not 
only seeing the MV in 3D along conventional 2DE pianes but also In many 
newer projections (from above, from below from LV body and outflow, and 
in sagittal and coronal orientations). Pathology of MV delineated in 3D 
included stenotic MV, parachute valve, prolapsingniaii leaflets, fenestration 
in the valve, double outlet MV, cleft MV, abnormal MV aSSOCiated with 
ischemic LV due to ALCAPA, and faiied repair of congenHal MV disease. 
The specific lesions, and abnonnalities in shape and motion of MV were 
well displayed in various 3DE projections. Goal-oriented 2DE images 
derived from 3DE further aided in studying the functional morphology of 
diseased MV. Associated lesions such as ventricular septal defects, 
subaortic stenoses, supramitral membrane, and aortic coarctation were 
delineated as well. In 3 pts with prosthetic valves for MV disease, the 
pos~ion and function of the valves could be assessed. When compared to 
conventional 20 echo analysis, 3DE enhanced the diagnostic appraisal and 
decreased ambiguity in interpretation. We conclude that dynamic 3D 
echocardiography using a transthoracic tomographic approach yields a 
number of new image projections in multiple dimensions, displays the 
surgical anatomy and functional morphology of MV apparatus in infants and 
children, and provides infonnation of diagnostic and therapeutic value. 
741·3 11:00 
Mechanisms of Regurgitation in Congenital Mitral Insufficiency -
Echocardiographic Study on 66 Surgical Patients 
"Serban Mihaileanu, Anna Lamberti, Sylvain Chauvaud, Daniel Sidi, 
Christophe Acar, Alain Deloche, Jean Noel Fabiani, Gilles Dreyfus, 
Patrick Perier and Alain Carpentier, H6pital Broussais - Paris, France 
Reconstructive surgery is today the prefered treatment in congenital 
mitral insufficiency (MI). The surgical result depends on a correct 
evaluation of the mechanisms of dysfunction; the aim was to determine 
how they correlate to mitral valve (MV) anomalies. Sixty six surgical 
patients (mean age 9,43) were selected since 1985. Excluded were: genetic 
syndromes, A V canal and double discordance. The functional analysis of 
leaflet motion ciassified the patients into 3 groups: I. Normal motion; n. 
leaflet prolapse (free margin of the leaflet ciosing at the level or 
overiding the plane of the MV annulus); In. restricted leaflet motion 
(incomplete systolic closure). Leaflet dysfunctions were correlated to 
subvalvuJar responsible anomalies The results were as follows: 
Leaflet motion ~ n, Prolapse IILSystolir 
restriction 
AML 15 (22,7%) 45 (68,2%) 6 (9,1%) 
PML 16 (24,2%) 3 (4,5%) 47 (71,2%) 
AML = anterior mitral leaflet; PML = posterior mitral leaflet. 
The lesions responsible for AML prolapse are indicated below: 
~ ~ C with high LongAPM ~ 
marginal C wall orjgin 
22/45pts 17/45pts 10/45pts 15/45pts 6/45pts 
C = chordae; APM = anterior papillary muscle; PPM = posterior 
papillary muscie; pis = patients 
The lesions responsible for PML restriction are indicated bellow: 
~ Short C (LY Short PPM ~ Short APM 
wall origin) 
45/47pts 24/47pts 9/47pts 12/47pts 2/47pts 
Two prominent mechanisms of dysfunction were responsible for the MI: 
AML prolapse and PML systOlic restriction. Despite very different 
anatomic forms of congenital MI, functional analysis provides a simple 
but necessary approach for reconstructive surgery. 
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741·4 11:15 
Volume Estimation of Sin&le Ventricles U.ina Multiplane 
Tr8DIesopbaaeal Ecbocardiovapby and 3-Dimensional 
RetoDItrUdion: V llidation in Human Patbolopcal Specimens 
Acbi Ludomirsky, Thomas R Lloyd, Robert H. Beelanan, Natesa 
Pandian, Gerald A. Serwer, Roger P. Vermilion. C.S. Matt Children's 
Hospital, University ofMicbigan, Ann Arbor, MI 
Spatial geometry of single vcatricles varies between patients and volume 
calculation can be diflicuh from 2·Dimensional imaging. The purpose of 
this study was to assess the accuracy of 3-Dimensional volume 
reconstruction of single ventricles from multiplane ttansesophageal image 
acquisition. The left ventricular cavities of 12 human cardiac specimens 
with tticuspid atresia were filled with a gelatin solution. After the solution 
bad congealed, the specimens were fixed in a water bath and imaged by a 
tomographic Jllultiplane ttansesophageal probe (VingJIIed). hnages were 
acquired at IS· rotational intervals from 0-180· and 3-Dimensioual 
reconstruction was perfonned. Veotricular voIUJIIC was calculated from 
the volumes of the sequl2ltial tomographic slices using the lIIOdified 
Silnpson equation. The vcatricuIar volume measured from the 3· 
Dimensioual reconstruction was compared to a true cavity volume 
detennined from the gelatin cast removed from the specimen after image 
acquisition. Data were coIIected indepeodentJy and blindly. 
Results: 3-Dimensional reconstruction of the lingle ventricle was 
possible in all hearts. Mean left vartricuIar volume by 3·Dimensioual 
reconstruction was 50.4 ± 46.3 (range 3.S • 130.4 nUl and the mean 
volUJIIC of the gelatin casts measured 49.9 ± 4S.0 (range 3.35 • 128.2 nUl. 
Volumes derived by both methods were highly correlated (r2=o. 98, 
P<O.ooo I), and the regression line was not different from the line of 
identity (gelatin voIUJIIC = .97 • [3D volUJIIC] + 1.15 nUl. 
Conclusion: 3·DimensionaI reconstruction from multiplane 
transesophageal ec:hocardiograp imaging provides precise and accurate 
JllCRSurements of the volume of single left ventticles. Clinical application 
of this quantitative technique appears warranted. 
741·5 
Pediatric Biplane TransesophageaJ Echocardiography: Preliminary 
Experience. 
11:30 
Thomas L Gentles, Howard M Rosenfeld, Peler CLaussen, Redmond P Burke, 
Stephen P Sanders, Mary E van der Velde. Children's Hospital, Boston, MA. 
Because of technical constraints, transesophageal echocardiographic (TEE) 
imaging in infants and younger children has generally been limited to the 
horizontal plane. To assess the information added by vertical plane imaging in 
this age group, a prototype pediatric biplane TEE probe (gastroscope diameter 
7mm, probe tip width 9.lmm) with color and Doppler capability, was used 
intra-operativelyon 46 patients (pts) aged 4 days to 13 years undergoing cardiac 
surgery. Weight ranged from 2.9 to 32kg (median Skg). Diagnoses included 
ventricular septal defect (VSD) in 12, tetralogy of Fallot (S), transposition of 
the great arteries in 6 (3 with VSD), atrioventricular cana1 defect (5), single 
ventricle (9), isolated supra· or subaortic sleDosis (3), and other in 3. Imaging 
was performed before and after cardiopulmonary bypass. Lesions were 
categorized as i) detected only in the vertical plane, ii) detected in both planes 
with additional information from the vertical plane and iii) no additional 
information gained from the vertical plane. 
Probe insertion was successful in all pts but imaging was discontinued in one 
neonate because of possible airway compression by the probe. The vertical 
plane added information over that obtained from the horizontal plane in 36/45 
pts (SO !Ii). It was especially useful in obtaining long axis views of both the left 
and right ventricular outflow tracts, providing additional information in 32146 
abnormalities in these~. In particular, vertical plane imaging identified the 
site of obstruction in 7/8 pts with subaortic obstruction, and was the only useful 
imaging plane in all 3 pts with supravalvar aortic sleDosis and in 7117 pts with 
right ventricular outflow tract obstruction. Although vertical plane imaging 
aided in the assessment of 9/24 cotloventricular septal defects, it did not aid in 
the assessment of the 12 defects in the muscular and atrioventricular canal 
septum, and added information over that obtained by horizontal plane imaging 
in only 3/18 abnormalities of the atrioventricular valves. 
In conclusion, the addition of vertical plane imaging added little to the 
evaluation of the atrioventricular valves and VSDs outside the CODoventricular 
septum, but markedly imprOVed assessment of abnormalities of both ventricular 
outflow tracts and the outflow septum. 
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741·6 11:45 
In Utero Pulmonary Artery Growth and Progression of 
Pulmonic Outflow Obstruction in Tetralogy of Fallot. 
Lisa K. Hornberger, Stephen P. Sanders, David ]. Sahn, Mary ]0 Rice, 
Philip ]. Spevak, Steven D. Colan. Children's Hospital. Boston. MA; 
Oregon Health Sci. Univ., Portland, OR. 
We reviewed 27 prenatal and 14 postnatal echocardiognuns of 14 
fetuses with tetralogy of Fallot (fOF) to describe the potential for in utero 
pulmonary artery (PA) growth and progression of BV outflow 
obstruction. Gestational age at the initial study was 24 ± 6 weeks with a 
mean followup interval of 8 weeks. Main (MPA) and branch PAs 
(LPA/RPA) and ascending aortic (AO) di3Jlleters were measured and Z•
scores were calculated based on 120 measurements from 47 nonnal fetuses 
(NL). Fetuses were divided retrospectively into mild and severe TOF 
groups according to postnatal outcomes; 9 with mild or no cyanosis were 
considered to have mild TOF. and 5 with severe pulmonic stenosis or 
valvar (PV) atresia were ductal dependent at birth. From the initial studies, 
Z·scores and their standard deviations were calculated: (* p < .05) 
Severe 
Mild 
MPA· 
-3.5 ± 2.0 
-1.5 ±.77 
AD 
1.76 ± 1.4 
.73 ± .83 
RPA 
-10.5 ± 16.0 
.44±S.1 
LPA 
.23± .08 
.38 ± .65 
Only the initial MPA Z-score was significantly different between the 
groups. The change in Z-scores from serial measurements was calculated 
to detemJine the deviations in growth from NL for each group: (NL = 0) 
MPA AD BPA· LPA· 
Severe -.26 ± .42 .16±.37 
.08± .15 
-2.4 ± .78 -.47 ± .16 
Mild ·.12±.1O -.44 ±.48 -.18±.I6 
Branch PA Z-scores significantly decreased over time in the severe TOF 
group versus the milder group. suggesting a slower rate of growth. Two 
fetuses with PV atresia postnatally, had antegrade MPA flow on the initial 
midlrimester eX3JII. One showed retograde flow in the ductus arteriosus 
on a subsequent prenatal eX3JII. Severity of postnatal RV outflow 
obstruction in TOF is correlated with in utero branch PA growth and the 
initial MPA diameter. PV atresia appears to develop in utero in some 
fetuses. 
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Intracoronary Angioscopy Impacts Clinical Decision Making 
in Patients With Acute Coronary Syndromes 
Francis I. Mirecki, Barry L. Sharaf, David O. Williaros 
Rhode Island Hospital, Brown University, Providence, RI 
The clinical role of percutaneous intracoronary angioscopy 
remains undefmed. In an attempt to correlate angiographic and 
angioscopic fmdings and determine the procedure's impact on 
clinical decision making, 12 consecutive cases having combined 
coronary angiography and angioscopy were reviewed. The mean 
age for the group was 66±13 yrs with 8 (67%) males, 7 (58%) 
presented with unstable angina. 4(33%) presented with 
myocardial infarction, and 5 (42%) received thrombolytic therapy 
(111. The culprit artery was a native vessel in 5 (42%) and a 
saphenous vein graft in 7 (58%). The procedure was successful in 
12 (100%) and there were no complications. 
Angioscopy was performed pre intervention in 9 (75%), post 
intervention in 9 (75%), and pre and post in 6 (50%). 
Angiographic features of intracoronary thrombus were present in 
9 pts (75%). Angioscopy conf1lll1ed the angiographic suggested 
thrombus in only I (8%), but identified a protruding intimal flap 
rather than thrombus in 8 (67%). Angioscopy revealed thrombus 
without angiographic evidence in 1 (8%). The overall correlation 
between angiography and angioscopy for the diagnosis of 
intracoronary thrombus was poor (r=.26, p=.41). Angioscopic 
results changed management in 9 (75%), obviating the need for 
IT in 6 (50%), obviating the need for a mechanical intervention in 
2 (17%), and altering the mechanical intervention chosen in 3 
(25%). 
We conclude that the angiogram may be misleading in the 
diagnosis of intimal flap vs thrombus and accordingly results of 
angioscopy iInpact on patient management. 
JACC February 1994:1A-484A 
742-2 10:45 
A Preliminary Study of Lesion-Specific Strategy 
According to Anglograpblc Findings In Acute Myocardial 
Infarction (AMI). 
Shigeru Saito, Hidekazu Arai, Kunikane Kim, Naoto Aoki, Tai 
Sakurabayashi, Shogo Miyake. Shonan Kamakura Hospital, 
Kamakura, Japan 
Background: The clinical effectiveness of thrombolytic therapy (Ibr-
1) for AMI has been established; however, it accompanies serious 
bleeding complication or recurrent ischemic attacks, and its reperfusion 
rate (rep-rate) is about 80 percent. On the other hand, primary 
balloon coronary angioplasty (p-PTCA) is associated with rep-rate 
exceeding 90 percent with low bleeding complication rate. However, 
even in p-PTCA the reocclusion rate is reported to be 10 percent. 
We tested the hypothesis that the clinical results of a reperfusion 
therapy depends on lesion specificity which is predictable from 
angiographic findings. Method: The results in 200 patients (pts) 
of AMI during phase-l (1989 to 1992) when p-PTCA was the 
first-choice therapy for all patients, were compared with the results 
in 43 pts during phase-2 (January to May, 1993), during which 
period the culprit lesions were divided into group 0 (no or less 
thrombi) and T (rich in thrombi) according to angiographic fmdings, 
and p-PTCA or primary directional coronary atherectomy (p-DCA) 
were chosen in group 0, and intravenous heparin (iv-H) or Tbr-T 
in group T. Results: Successful recanalization rates were 92.5% 
and 97.6%, re-occlusion rate 2.5% and 0%, and in-hospital mortality 
10.0% and 7.1 % in phase-l and phase-2 respectively. Conclusiolls: 
These preliminary data show that the lesion-specific approach in the 
reperfusion therapy in AMI according to the angiographic findings 
of the CUlprit lesion is promising, and should be further evaluated. 
742-3 11:00 
Acute Myocardial Infarction and Normal Coronary Artery - A 
Study of Percutaneous Angioscopy 
Kiyoshi Inoue, Keiichi Kuwaki and Hidenobu Ochiai. 
Cardiovascular Disease Center, Tokyo Metropolitan Police Hospital, 
TOKYO. 
The accepted hypothesis used to explain total occlusion and 
subsequent patency of the infarct related artery (IRA) seen in patients 
with acute myocardial infarction (AMI) is that temporary IRA blockage 
is caused by spasm and/or thrombosis at the site of mild endothelial 
damage or plaque formation invisible to routine diagnostic coronary 
arteriogram (CAO). 
To verify this hypothesis, we examined 7 IRA sites in AMI patients in 
whom CAGs have unequivocally demonstrated both occlusion before, 
and normal or mildly stenotic lesions at the same IRA site after 
thrombolysis. In addition, drug induced spasms were observed in 5 
out of 7 IRA sites. Thrombus obliterating the lumen was 
angioscopically witnessed in all IRA sites before thrombolysis. 
Nitroglycerin alone in 2 patients and combined nitroglycerin with t-PA 
in the remaining patients produced total recanalization in terms of 
angiography. 
Vestiges of withered plaque with fatty streaks in surrounding areas 
were witnessed in 5 IRA sites, while small fibro-fatty plaques with both 
frayed surface and mural thrombus were seen in the other two cases. 
These results indicate that the temporary IRA occlusion in AMI 
patients occurring in spite of angioscopically near-normal coronary 
artery following thrombolysis is produced by thrombus. This 
thrombus is initiated by both reduction in flow due to spasm, and the 
thrombogenitic stimulus of endothelial injury. 
In conclusion, a rapid evolution of rupture prone plaque with large lipid 
core and its sudden rupture or repetitive superficial injury trigger 
spasm and subsequent thrombotic coronary obstruction. 
ABSTRACTS I71A 
742-4 11:15 
A Comparaison of Plaque Morphology by Intravascular Ultrasound and 
Clinical Presentation in Coronary Artery Disease 
Marie-J. AlibelIi-Chemarin, Jacques Puel, Bernard Assoun,Michel Galinier, 
Fadi EI Khoury, Jean-P. Bounhoure. Cardiology department, Rangueil 
Hospital, Toulouse-France 
Atheroma plaque composition and morphology may affect the clinical 
presentation between stable and unstable angina. To test this hypotheSis, 
Intravascular Ultrasound (IVUS) imaging was performed in 80 pts 
undergoing single balloon angioplasty (n~26), directional coronary 
atherectomy (n=40) or stent implantation (n=14). The clinical conditions 
were Stable Angina (SA) in 21 pis, Unstable Angina (UA) in 9 pis and post 
thrombolysis after acute Myocardial Infarction (MI ) in 50 pts. IVUS 
images of culprit lesion were divided into Thrombus (fH) - speckled 
reflection pattern moving with blood flow, Mixed Plaque (MP) -varying 
echogenicity, and Dense Plaque (DP) - intense echoreflection ± Calcium 
(CA)-bright echoes with shadowing. The clinical presentation was 
compared to the IVUS findings: (each lesion could have more than one 
morphology) 
Pla!jue Coml1osition 
Lesions (N) TH MP DP±CA 
MI 50 51% 81% 47% 
UA 9 75% 87% 62% 
SA 21 0 31% 69% 
TH alone (8 pts)or with MP (15 pts)or DP± CA (10 pis) is seen in acute 
myocardial infarctions as well as unstable angina. Stable angina did nol 
demonstrate TH and is composed predominantly of DP±CA.These results 
correia led closely with histologic studies of tissue specimens removed by 
atherectomy. 
Conclusion: IVUS provides in vivo differentiation of lesion composition 
that may have important implications regarding mechanisms of acute 
coronary syndromes. 
742·5 11:30 
As shown in Ihe diagram, angios:qJy deIecII:d a higher incidence eX ulcetaIim and 
dmnbus in diabeIX:s. We found ulcaaIed paque in 16{17(94%) diabeIic pabents vmus 
23/38(60%) IXXHIiabetics (~l.Ol). In1racMlnaly dmnbi were seen in 1&'17(94%) 
diabetic pabents vezsus 21/38(55%) IDI-iIiabeIi;s (p;O.OO4). 
The resuI~ oflheangioocqlic examinaIioo in mdisIUIbed lesioos mw thatdiabelics wiIh 
WlSlabIe angina have a higher incidence of plaque ulcetaIim and inIra:aalaty dmnbus 
fonnalim than 1Dl-diabctics. This increased ~ ofaxnplex lesioo nnrAlOIogy ~ 
coosisIent wiIh Ihe dispropMionaIeIy higher risk fa developmem of 8CUIe caonary 
syndromes in Ihese patients. 
I72A ABSTRACTS 
742·6 11:45 
Coronary Artery Morphology in Sudden Death Due to 
Atherosclerosis 
Andrew Farb, Laura Sessums, Anita L. Tang, Allen P. Burke, John 
Smialek, Renu Virmani. Armed Forces Institute of Pathology, Washington, 
DC and the Office of the Chief Medical Examiner, Baltimore, MD. 
The frequency of coronary artery thrombosis and plaque fissure in victims 
of sudden death (SO) due to coronary atherosclerosis remains 
controversial. Oavies found occlusive or non-occlusive thrombi in 73.3% 
of cases, plaque fissures with intra-intimal thrombus in 7.7%, and no acute 
coronary lesion in 19% (Eur Heart J 1989; 10: 203). Roberts found 
coronary thrombi in only 19% of SO hearts (Am J Cardiol 1984; 54: 1206). 
Methods: We performed post-mortem angiography and detailed coronary 
artery and myocardial histologic examination in 26 cases of SO. 
Individuals were in stable health prior to expiration and died within 6 hours 
after the onset of symptoms. In all cases, there was ~75% atherosclerotic 
narrowing of at least I major coronary artery. 
Results: There were 21 men and 5 women; the mean age was 51±13 years. 
A healed myocardial infarction (HMI) was found in 9 hearts, acute 
myocardial infarction (AMI) in 2, both HMI and AMI in 3, and no 
myocardial infarction (No MI) in 12. The extent of coronary disease was 
similar in patients with and without MI (I vessel=54%, 2 vessel=27%, 3 
vessel=15%, and 4 vessel=4%). 
MI 
NoMI 
Total SO 
~ 
64% 
33% 
50% 
Plaque MOlllholo&y 
Or&aoized Th £E ~ Th or £E Absent 
21% 64%* 93%* 15%* 
0% 17%* 17%* 67%* 
12% 42% 58% 38% 
*p<O.02 "p<O.OOI "p<O.OI 
MI=HMI and/or AMI; Th=Thrombus; PF=Plaque Fissure; 
HP=Hemorrhage into Plaque 
Coronary plaque hemorrhage occupying >25% of total plaque area was 
present in 8 hearts with evidence of MI and in I heart without MI (p<O.02). 
Conclusion: Coronary thrombosis was present in 33% of cases with SO in 
the absence of histologic evidence of acute or healed MI. In contrast, the 
incidence of acute or organized thrombus was 85% in patients with acute 
or healed myocardial infarction (p<O.OI). These results indicate that acute 
coronary thrombus and plaque fissure playa role in a minority of cases of 
SO secondary to atherosclerosis without myocardial infarction. 
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Bar1y 'DIEIIpy With BDalapril or 1I8topro101 Prwvalta 
tbI ftognSsiClll of Left V8ll1:ricular ~ in 
Dag8 with Jlcld£ata a.ut hilure 
Bani N. saliJah, Hi.sash.i Shim::1yama, Howard Rosman, T. 
Barry laVine, sidney Goldstein. Hern:y Ford Heart ani 
Vascular Institute, Detroit, HI 
'Dle effects of 1aq-term JIQ'ttherapy with enal.april 
(JlNA) ani met:oprolol (MEr) en the ptogressien of left 
ventricular (LV) dilatatien was examined in 21 dogs 
with reduced LV ejectien fracticns (EF) • LV 
dysfllrK::tioo was produced by 1IIJltiple sequential. 
intracaralaly mi.c:roembolizaticns. Embolizaticns were 
di.scx:ntin.Ied Wen LV EF was betl.Ieen 30t ani 4ot. 'lbree 
weeks after adlievin;J this target EF, dogs were 
ran:lani.zed to 3 JDa1ths therapy with JlNA (10 Dg BID, 
J"F7), MEl' (25 Dg BID,J"F7) or to no therapy 
(CXNIR:lL,J"F7). LV erD-systolic volume (~ ani LV 
eni-di.astolic volume (EDIT) were measured fran 
ventriculograDB ci:Itained before initiatien of therapy 
eFEEI am after 3 Jmths of therapy emsrl. 
ESV (ml) 28;t3 4l;t4* 28;t3 28;t2 29±2 
FDV (ml) 44;t4 56;t5** 43;t4 46;t4 45.±2 
[*=P<:.OO3j **=p<:.OOlj PRE vs. msrl 
29±2 
49±3 
% /). ESV 47;t6 -1;t4 (P<.001) 3±7 (p<.OOl) 
% /). FDV 26;t5 10;t6 (p<.06) 9;t6 (p<.04) 
rP=yalue relative to snmpLl 
No differences were present lIlIDY,J the 3 stu:iy groJpS 
at PRE therapy. In OCIltrol dogs, as expected, ESV am 
FDV inc:reased progressively durirq the follow-up 
period. In ocntrast, bath JlNA am MEl' prevented the 
progressive increase in ESV am FDV. Ccrx:lusioo: Early 
therapy with JlNA or MEl' limits progressive LV 
dilatatioo in dogs with unclerlyirq LV dysfunc:tioo. 
JACC February 1994:1A-484A 
743·2 10:45 
Changes in Plasma Levels of Endothelin Renect the Long. 
term Clinical and Hemodynamic Effects of Beta·Blockade 
in Patients with Chronic Heart Failure 
Henry Krum, Anguo Gu. MlcheUe Wilshire-Clement, Myron Miller. Nonna 
Medina, Madeline Yushak, Milton Packer. Columbia Vniv .• College of 
Physicians & Surgeons and Mt Sinai School of Medicine, New York, NY 
Plasma levels of eodothelin-I (E'I) are elevated in patients with chronic 
heart failure (CHF), but it is unknown whether levels of ET change in 
parallel with the clinical course of the disease. To investigate this possib•
ility, we measured ET levels in addition to various clinical and hemodynamic 
variables in IS pts with CHF enrolled in a double·blind. placebo-controlled 
study of the beta·blocker. carvedilol (CRy). Pts were randomized (2:1) to 
either CRY (25 mg BID, n =1O) or placebo (PBQ, n = 5) for 14 weeks. and 
all variables were measured before and after long-term therapy. 
When compared with PBQ. CRY improved symptoms and submaximal 
exercise tolerance (both P < 0.05) and increased stroke volume and LV 
ejection fraction and decreased pulmonary wedge and right atrial pressures 
and heart rate (all P < 0.05). These changes were paralleled by a significant 
decline InETlevels withCRV (-1.6 pglmI onCRV vs +2.5 pglmI onPBQ). 
P < 0.05 between the 2 groups. Changes in ET were strongly correlated 
with changes in all functional variables. including symptom severity 
(r=O.73), NYHA class (r=O.70), maximal oxygen consumption (r=-O.84) 
and 6-min walk distance (r:O-{).84). P < 0.05}. Changes in ET were also 
strongly correlated with changes in most hemodynamic variables. Including 
stroke volume index (r=-O.73). pulmonary wedge pressure (r=O.88), right 
atrial pressure (r=0.90), heart rate (r=O.77) and LV ejection fraction 
(r=-O.57). By stepwise regression analysis, the change in ET was the most 
powerful predictor of the clinical and hemodynamic response to CRV. 
These findings indicate that changes in plasma levels of ET accurately 
reflect the magnitude and direction of the functional and hemodynamic 
responses to therapy in pts with CHF treated with beta-blOCkers. Further 
work is needed to determine if changes in plasma levels of ET parallel the 
effects of other classes of therapeutic agents in this disorder. 
743·3 11:00 
Elevated Endogenous Endothelin Mediates Systemic 
Vasoconstriction in Experimental Chronic Congestive Failure 
Alfredo L. Clavell. R. Scott Wright. Matthew R. Thomas. Roland R. 
Brandt, "Terry 1. Opgenorth, John C. Burnett, Jr., Mayo Clinic and 
Foundation, Rochester, MN and "Abbott Laboratories, Abbott Park, IL 
Endothelin (ET) is a potent vasoconstrictor peptide which 
circulates at low picomolar concentrations and its elevation in plasma 
is a hallmark of severe congestive heart failure (CHF). The 
endothelin-A (ET-A) receptor subtype has been shown to mediate the 
potent vasoconstrictor actions of ET. To date, the functional 
significance of ET elevation in CHF via its interaction with the ET-A 
receptor remains undefmed. The current study was designed to 
defme the functional significance of elevated circulating ET in an 
experimental model of CHF produced by chronic thoracic inferior 
vena caval constriction (TIVCC) which results in systemic and renal 
vasoconstriction, elevated circulating ET (TIVCC = 13; Normal 
Control = 9 pglml) and chronic reductions in cardiac output. 
Experiments were conducted in conscious dogs (n=5) after seven 
days of TIVCC. After baseline hemodynamic measurements 
intravenous (FR139317), a selective ET-A receptor antagonist, was 
infused at 5 j.Ig/kglmin for 45 minutes and then 10 j!g/kglmin. The 
results are outlined below 
Haseline !ll!g 10~ 
MAP (mmHg) 116±6 104±6* 95±9* 
co (Umin) 2.14±o.27 2.l2±D.30 2.2I±o.29 
SVR (rom HglUmin) 57±7 51±5 43±3* 
RVR (rom Hg,tml/min) 1.02±O.1O 1.08±o.l5 1.I0i0.21 
Values are mean ± SE. MAP, mean artenal pressure; CO, cardiac output, SVR. 
systemic vascular resistance; RVR, renal vascular resistance. • p<O.05 vs Baseline. 
The current studies demonstrate that., in an experimental model of 
congestive failure with elevated endogenous ET, selective ET-A 
receptor antagonism results in systemic but not renal vasodilatation. 
Thus, the present investigations support a functionally important role 
for endogenous circulating ET in the maintenance of arterial pressure 
by contributing to the increase in systemic vascular resistance which 
characterizes severe CHF. 
JACC February 1994:IA-484A 
743·4 11:15 
Chronic Oiuretic Treatment Mediates a Renal Resistance 
to the Natriuretic Actions of Atrial Natriuretic 
Peptide in Experimental Mild Heart Failure. 
MR Thomas,RS Wright,LL Aarhus,AL Clavell,OH Heublein,RR 
Brandt, JC Burnett Jr. Mayo Clinic, Rochester, MN USA 
Chronic heart failure (CHF) is associated with sodium 
retention and a renal resistance to the actions of 
atrial natriuretic peptide (ANP) mediated in part by an 
activated renin-angiotensin system (RAS). Studies 
suggest that an intact natriuretic response to ANP 
occurs in MHF in which the RAS is not activated. This 
study tested the hypothesis that diuretic therapy 
during the evolution of MHF would activate the RAS and 
mediate a renal resistance to the natriuretic action of 
ANP. The natriuretic response to exogenous ANP 
(lOug/kg iv) was assessed before and during the 
evolution of MHF produced by 10 days of rapid 
ventricular pacing (n-12) in two groups of conscious 
dogs: Group F (Furosemide, 40 mg bid daily) and Group 
NF (Control without Furosemide) . 
're-MHF MHF 
r NT r NT 
CO (L/min) 4.2tO.2 4.7tO.3 2.6tO.3* 2.7tO.l* 
ANP (pg/ml) 24t4 60t20 36t20' 169t34* 
PRA (ng/ml/hr) l±0 4t2 19±4*' 2±1 
dUNaV(~q/min) 214±54t 97±30t 9±9* 105±45t 
ADRNa I%l -6tH -4+3+ +4+3 -3+lt 
Oata are Mean±SEH. .. p <0.05 V8 Pre-MHF respectively, 
• p<0.05 vs NF, t P <0.05 va pre-ANP bol"s. Abbreviations: 
cardiae output (CO), plasma ANP value. (ANP), and plasma renin 
acvtivity (PAA), change in urinary lodium excretion to ANP 
bolus (dUNaV), change in distal sodium reabsorption to ANP 
bolus (dORNa). 
A greater sodium excretion over nine days of evolving 
CHF was observed in the F group vs NF group (450±66 vs 
295±3l mEq, p<.05). 
This study demonstrates that diuretic therapy reduces 
plasma ANP, activates the RAS and mediates at the level 
of the distal nephron a renal resistance to the 
natriuretic actions of exogenous ANP in MHF. 
743·5 11:30 
Hemodynamic and Neuroendocrine Eft'ects of Chronic Vesnarinone 
Administration in Heart Failure: A Placebo-Controlled Trial. 
Edward M. Gilben. Dale G. Renlund. Stephanie L. Olsen. Lisa 
Reynolds, Patrice C. Mealey. Pani Larrabee, Michael R. Bristow. 
University of Utah Health Sciences Center, Salt Lake City, UT. 
Vesnarinone improves morbidity. monality and quality of life in 
patients with heart failure, but the mechanisms for these beneficial 
effects are unknown. Therefore, we measured the hemodynamic and 
neuroendocrine effects of vesnarinone in a substudy of the multi•
centered vesnarinone morbidity/monality trial. Twenty-one patients 
with L VEF < 30% and symptomatic heart failure were randomized 
(double-blind) to receive vesnarinone 60 mg/day or placebo fpr six 
months. Measurements included right heart hemodynamics, arterial 
(ART), coronary sinus (CS), and central venous (RA) norepinephrine 
(NE), RA plasma renin activity (PRA) and RA atrial natriuretic factor 
(ANF). One vesnarinone and one placebo patient died during the 
study and one vesnarinone patient was withdrawn because of 
neutropenia. 
Results (mean ± SEM): 
Vesnarlnone (n=7) Placebo (n=l1) 
~ ~ III.Wl1h ~ ~ III.Wl1h 
SAP (mm Hg): 77±2 78±3 86±4 78±5 
RAP (mm Hg): 6±1 S±I 7±2 5±1 
PAP (mm Hg): 31±3 30±4 31±5 20±3 
WP (mm Hg): 17±4 l4±3 16±3 15±3 
heart rate (b/min): 94±6 87±4 84±4 83±3 
o (llmin/m2): 2.4±.2 2.2±.1 2.0±.1 2.1±.1 
ART NE (pg/ml): 406±105 421±113 379±73 426±103 
CS NE (pg/ml): 814±114 1004±318 647±167 824±249 
RA NE (pg/ml): 554±102 S40±199 502±88 444±l03 
PRA (ng/ml/hr): 16±5 36±15 15±5 65±23 
ANF (pg/ml): 143±66 204±81 250±69 212±34 
SAP= systemic anery pressure, RAP=right atrial pressure, PAP= 
pulmonary artery pressure WP=wedge pressure. O=cardiac index. 
Conclusions: The chronic administration of vesnarinone to patients 
with hean failure does not appear to significantly change 
neurohormonal markers and therefore this agent probably does not act 
by decreasing neurohormonal activation. 
ABSTRACfS 173A 
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Errects or Ibopamine on Plasma Neuro-Hormones and Symptoms in 
Heart Failure Patients Treated With Angiotensin Converting Enzyme 
Inhibitors 
Michel F. Rousseau, Marvin A. Konstam, Julian Donckier, Laurence 
Galanti, Sylvie Ahn, Debra Kinan, Hubert Pouleur, University of 
Louvain, Brussels, Belgium and Tufts University, Boston, MA. 
To assess the effects of dopaminergic DAI and DA2 receptors 
stimulation in patients with CHF remaining symptomatic despite ACE 
inhibitor therapy, 20 patients (pts) were enrolled in a double-blind, 
parallel group, placebo (PLA) controlled, pilot study. The pts were in 
NYHA functional class III despite therapy which included enalapril 
(n= 19) or Iisinopril (n= I) at a mean daily dose of 20 mg. After baseline 
measurements incl ud ing rad ionucl ide angiography, plasma neurohormones 
and visual analog scale r:v AS) for dyspnea and fatigue, the pts received 
PLA or ibopamine (lBO) at a dose producing primarily DAI and DA2 
agonism (100 mg t.i.d.). The measurements were repeated after 4 to 
6 weeks. The changes in heart rate. arterial pressure and in LV ejection 
fraction (PLA: 20±5 to 20±6%; IBO: 22±5 to 23±5%) were 
insignificant in both groups. The changes in plasma renin activity, 
angiotensin II, arginine vasopressin and atrial natriuretic peptide were 
also not significantly different between IBO and PLA. With lBO, 
however, plasma norepinephrine fell from 516 ± 241 to 391 ± 208 pg/ml*§ 
while it continued to rise with PLA (426±249 to 571 ±318 pg/ml*). 
With lBO, there was also a significant reduction in symptoms of dyspnea 
and fatigue (-18%*§ in VAS) and cardiac index and systemic vascular 
resistance tended to improve. Thus, in CHF pts treated with ACE 
inhibitors, dopaminergic stimulation was well tolerated and further 
reduced sympathetic tone, suggesting that this could be an alternative 
approach to Il-blockade in CHF. *p<O.05 vs baseline; §p<O.05 IBO vs 
PLA. 
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Can Intravascular Ultrasound Yield Accurate Measures of 
Vascular Anatomy? Documentation of the Critical Importance of 
Uniform Rotational Velocity 
Bruce J. Kimura, Valmik Bhargava, Wulf Palinski. Kirk L. Peterson. 
Anthony N. DeMaria; UCSD Medical Center and VA Medical 
Center. San Diego. CA 
Although intravascular ultrasound(IVUS) can provide unique 
information about arterial lumen and vessel wall, anatomically 
accurate images require assumptions regarding transducer orientation 
and rotational velocity. Few data exist regarding the validity of these 
assumptions, or of the influence of non-uniform rotational velocity 
upon IVUS images. We examined IVUS images obtained from 6 
commercially available catheter probes (4 mechanical type A,l 
mechanical type B, and I array) insened through an SF guiding 
catheter in a model simulating the natural curve and orientation of the 
aona. A 5.5 mm diameter rubber ring marked by 8 metal wires 
equispaced at 450 was an arterial phantom. Detailed analysis was 
performed in the 4 type A probes. Images derived with the catheter 
concentrically located demonstrated uneven spacing of wire markers 
manifested by a range of angles from 10.20 to 73.90 corresponding to 
an average angular velocity of 47.50/msec to 6.60/msec (uniform 
velocity 1O.80 /msec). Eccentric catheter positioning resulted in 
marked deformation yielding oval. flattened, even kidney shapes. This 
deformation resulted in an average change in area of ±20% from an 
actual average area of 25.6 mm2 to a minimal average of 20.5 mm2 or 
maximal average of 30.7 mm2. Mathematical modeling of eccentric 
probe location and nonuniform velocity yielded distortions of size and 
shape similar to those observed. Similar changes were not seen with 
the array probe, and were less marked with the Type B mechanical 
probe. Thus, these data demonstrate substantial non-uniform 
rotational velocity of IVUS probes. This non-uniformity produces 
marlced distonion of vessel size, shape, and target location. Accurate 
quantitation of vascular anatomy by IVUS is possible only if 
rotational velocity at catheter tip is uniform or precisely known. 
174A ABSTRACTS 
744·2 10:45 
Detection of Coronary Atheroma by Quantilltlve Anglogl'lphy: Insight. 
Gllned from Inll'lcoronary Ulll'llOund Imaging. 
Javier Escaned. Jose Baptista. Carlo dl Marlo. Yukio Ozaki. Jos R.T.C. 
Roelandt. Patrick W. Serruys. Plm J. de Feyter. Thoraxcenter. Erasmus 
University Rotterdam. The Netherlands. 
Automated stenosis analysis (ASA) Is a common feature of quantitative 
coronary angiography systems (OCA) allowing the Identification of the 
boundaries of the stenosis. Interpolated reference dimensions and plaque 
size. However. tts ultimate meaning as to the degree of underlying 
atherosclerotic disease (AD) remains unclear. Using Intracoronary ultrasound 
(ICUS). we Investigated the characteristics of coronary sites defined by ASA 
(CMS II system) as the start of the stenosis (STARn and maximal luminal 
obstruction (MAX). ~: In 40 coronary stenoses ASA was used for 
automated Identffication of START and MAX sttes using curvature analysis of 
the diameter function. Plaque size was measured using ICUS at both 
locations. with an addttionallCUS measurement proximal to START (PROX). 
Crescent~lke distribution of AD. Indicating an arc of the arterial wall free of 
AD. was recorded. 
~: 
Plaque size (mm') 7.79:!:2.91 9.43:!:3.46 13.29:!:4.22 0.0001 
% area stenosis (%) 4O±15 5O±11 83:!:9 0.0001 
Crescent~ike plaque (n) 28(70%) 5(12%) 0 0.0001 
Plaque area estimated wtth ASA at MAX was significantly lower than 
measured wtth ICUS (6.37 ± 3.18 mm' versus 13.29 ± 4.22 respectively, 
p=O.OOOI). 
Conclusions: 1) ASA did not detect AD at START and PROX. 2) ASA 
underscored plaque size at MAX. 3) The degree of AD at START was 50%. 
wtth a signfficant change from crescent to all-around distribution. The latter 
findings suggest that START as defined by ASA represents the point where 
compensatory vessel enlargement falls to preserve luminal dimensions. a 
phenomenon presumably related to the observed loss of a remnant arc of 
normal vessel wall. 
744·3 11:00 
3D Intravascular Ultrasound Imaging With Automated Border Detection 
Using 2.9 F Catheters 
Dirk Hausmann, Guy Friedrich, Krishnankutty sudhir, ·William L. Mullen, 
·Bobby Soni, ·Peter J. Fitzgerald, ·Paul G. Yock. University of California, 
San Francisco, CA. 
Assessment of luminal dimensions by intravascular ultrasound (NUS) is 
currently based on vessel border detection by visual analysis. We tested a 
new off-line, automated border detection system based on acoustic 
quantification (AQ) of blood backscatter and vessel wall. For NUS Image 
aquisition, a newly developed 2.9 F NUS catheter was used. In this system, 
a single lumen is sequentially shared between guidewire and imaging core 
allowing 360' imaging without guidewire artifact. In 10 normal New 
Zealand rabbits, 29 aortic segments were imaged in vivo using a 1 mm/ sec 
motorized pullback; 150 NUS images (8.5/mm) were acquired per 
segment, reconstructed in 3D, and the vessel wall delineated by AQ 
(processing time: 3 min for 150 images). Lumen dimensions at 1 mm 
increments were assessed by AQ, visual border detection (vISUAL) and 
quantitative angiography (ANGlO). AQ reproducibility was determined by 
repeated pullbacks. Results: Of the 551 images, 86 (16%) could not be 
analyzed by AQ due to unclear image in some region, in 385 (70%) border 
delineationby AQ was accurate, in 54 (10%) AQ overestimated and in 26 
(5%) AQ underestimated the lumen. Inaccurate AQ occurred in 19 (5%) 
images with centered and 30 (38%; p< .001) images with non-centered 
NUS catheter. Correlations (r) and percent differences (mean ± 1 50) 
between the techniques were: 
LumenareIJ Lumen diRmeter 
Correlation Difference Correlation Difference 
IAQvs.AQ r=0.97 I 1 + 10% r= 0.98 I 0+5% 
IAQ vs. VISUAL r=0.97 I -2;tl0% r=0.89 I 3;t9% 
IAQ vs. ANGlO r = 0.93 I 7 + 14 % r= 0.95 I 4+7% 
Conclusions: AQ allows rapid, accurate and reproducible measurement of 
lumen dimensions during NUS; errors are due to weak wall signal and 
non-centered catheter position. 
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744·4 11:15 
Comparison of IntraIesional Doppler Flow Velocity and Quanti•
tative Angiography for Determination of Transleslonal Pressure 
Gradients in Patients 
Morton 1. Kern, Frank V. Aguirre, Richard G. Bach, Eugene A. 
Caracciolo, Thomas 1. Donohue, 10seph A. Moore, Michael S. 
Flynn, Carol 1. Mechem, Marilyn Cauley, Arthur 1. Labovitz, St. 
Louis University, St. Louis, MO 
Intracoronary flow velocity is correlated to lesion dimensions using 
the continuity equation. However, unlike quantitative coronary 
angiography (QCA), intralesional velocity (jet, V) has not been 
correlated to translesional pressure loss using the Bemouilli (4 \?) 
pressure-velocity equation. Translesional pressure gradients (2.2F 
Tracker) and spectral flow velocity (O.OIS" Doppler angioplasty 
FloWire) were measured in 20 pts with lesions of 6O±17% (range 
32-91 %) diameter narrowed by QCA. Doppler minimal cross· 
sectional stenosis area (D.CSA) was calculated from the continuity 
equation as [area of reference artery·reference velocity/stenosis 
VJ. Reference artery diameter was 3.01±0.61mm, gradient mean 
was 21 t 15mmH~ Cran~e 0-50mmH~). 
Correlations vs Measured Gradient R Slwe F test p ya!ue 
D.CSA (mml) 0.652 -4.52 11.09 0.0046 
QCA diameter (mm) 0.36 ·29.3 2.63 0.122 
QCA area (mm2) 0.33 -O.IS 2.20 0.156 
Bernouilli gradient (mmHg) 0.366 0.126 2.79 Q.ll.L 
D.CSA vs OCA area lmm2) 0,489 ·2.97 4.70 0.05 
There was no correlation among absolute VJ' reference/Vj ratio, 
angiography or gradients. Vj cannot be used independently to assess 
translesional pressure loss. Despite limitations (e.g., underestima•
tion of V), Doppler-derived indices show better correlations than 
QCA for hemodynamic significance of coronary lesions. 
744·5 11:30 
Importance Of Reference Segment Evaluation For 
Determination Of Post·Interventlonal Stenosis 
Charles 1. Davidson, *William L. Mullen, Bruce A. Bergelson, 
Robert F. Fishman, Michele A. Parker, Andi Schaechter, Sheridan 
N. Meyers, Carl L. Tommaso for the GUIDE IT Investigators, 
Northwestern University, Chicago, IT.. 
To detennine whether the severity of reference segment disease 
affects the angiographic assessment of post-interventional coronary 
stenosis, the database from the ongoing Phase IT of the Guide Trial 
(Guidance by Ultrasound Imaging for Decision Endpoints) was 
utilized. Intracoronary ultrasound (ICUS) was perfonned in 
conjunction with quantitative angiography. To date, 35 patients were 
analyzed at the post-interventional lesion site and within the adjacent 
reference segment. 
Vessel area, lumen area, plaque area and % area stenosis were 
detennined by ICUS at both the reference and interventional sites. 
Quantitative angiographic stenosis was evaluated in the worst view 
with a semiautomated edge detection algorithm. 
ICUS 
Reference < 20 
Segment 20 - 40 
(% Area Stenosis) > 40 
n 
8 
18 
9 
Lesion Segment 
(% Area Stenosis) 
KllS AJlaiJ! 
64±14 4S±22 
70±12 39±20 
77±6 35±10 
~ 
.03 
.0001 
.0001 
(p<.OS for ICUS VS. angio <20 vs. >40) 
The mean lumen cross sectional area at the lesion site was similar 
by ICUS and angiography (4.7 mm2 vs. 4.7 mm2). Reference 
segment vessel area by ICUS was 16.1 ±4.8 mm2 and contained a 
plaque area of 5.3±3.2 mm2. 
Thus, the degree of reference segment disease has a major impact 
on the accuracy of angiography for assessing lesion stenosis after 
interventions. In patients with severe reference segment disease, 
quantitative angiography markedly underestimates lesion severity and 
therefore may be an inaccurate measure of procedural success. 
JACC February 1994:1A-484A 
744·6 11:45 
Variability of Remodeling in Early Coronary Atherosclerosis: An 
Intravascular Ultrasound Study 
Dirk Hausmann, 'William L. Mullen, Guy J. Friedrich, 'Peter J. Fitzgerald, 
'Paul G. Yock. University of California, San Francisco, CA 
Pathologic studies suggest that remodeling of diseased coronary segments 
maintains lumen area until approximately 40% of internal elastic lamina 
(IEL) area is occupied by plaque (PL). Using intracoronary ultrasound (4.3F, 
30 MHz), this process was studied in 80 coronary segments (26 LM, 54 prox. 
LAD) in 61 pIS. without prior intervention. In non-branching segments, 5-15 
sites (median 9) were analyzed quantitatively. To validate prior pathologic 
studies, in a per segment analysis PL and IEL areas in the most diseased site 
of each segment were compared. Per 1 mm2 PL increase, IEL increased 0.98 
(LM) and 0.99 mm2 (LAD). In lesions with <40% stenosis, IEL increased 
1.34 (LM) and 1.72 mm2 (LAD), consistent with "overcompensation". Remo•
deling was also analyzed within each segment (unlike prior pathologic 
studies) by comparing each site to the least diseased site of each segment 
083 LM, 603 LAD). There was wide variabiliy in IEL change (AIEL) as a 
20 over- •••• function of PL change (.1PL) 
compensation ••• •• (Fig.). Using a remodeling index 
'.' •••• artial (R.I.; AIEL/ .1PL) overcompensa-
•• ··:,.,.:pensation tion (R.I. >1), partial compensa-
./ tion (R.I. 0-1) or failure of com-
. ••••• pensation (R.1. <0) occurred in 
:. ' .. :: .;./ 45%,35% and 21% of the sites. 
... :,.::' :. R.1. weakly correlated with PL 
·i .. } ... i!.:.~: '.' area (r=-0.18; n.s.) but was 
..... , . . unrelated to PL eccentricity, 
. ::.' :' :no .' 10 PL area (mm2) 20 extent of PL-free wall, PL 
compensation calcification or any patient•
related factors. 
Conclusions: Comparing different patients confirms that coronary artery 
remodeling occurs and in general is more extensive in smaller plaques. 
However, analysis within segments suggests that there is a wide range of 
compensatory response with no clear predictability based on clinical 
variables or detectable features of plaque morphology. 
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745·1 10:30 
Dynamic Three·Dimensional Imaging of Mitral Valve 
Pathologies using Echo-CT. . . 
*Thomas Binder, Harald Gabnel, Sebastian Globlts, Jeanette 
Koller, Massoud Zangeneh, Wilfried Rothy, Dietmar Glogar, 
Dept of Cardiology, University VieMa, Austria 
Three dimensional representation of the mitral valve could 
potentially be of value in the assessment of mitr~l va~ve 
pathologies. With echo - CT a novel transesophageal unagmg 
device which uses parallel slices of the heart to reconstruct 
dynamic three dimensional images has now beco!De avail~ble. 
In a prospective study echo - CT was performed 10 36 pan~nts 
with various diseases of the mitral valve including mitral 
stenosis (MS, n = 9), mitral valve prolaps (MVP, n = 9) flail 
mitral valve leaflet (FL, n = 16) and mitral valve endocarditis (n 
= 2). 10 patients with normal mitral valve morphology were 
used as controls. The reconstructed studies were then compared 
to both transthoracic and multiplane transesophageal 
echocardiography. Adequate image quality could be achieved 
in all but one patient. Our experience shows tha~ three 
dimensional reconstruction of the mitral valve from different 
view points is feasible and offers correct diagnosis of the 
underlying pathomorphology. In addition relevant information 
such as diastolic mitral valve area in MS, morphology of 
vegetations, exact definition of the involved leaflet scallops in 
MVP and FL and visualisation of the systolic closure defect in 
mitral regurgitation can be obtained. In conclusion our re~u1ts 
show that three-dimensional imaging could lead to a refmed 
diagnosis and a better functional and morphologic 
understanding of mitral valve pathologies. This could be of 
value in medical decision making and preoperative planing. 
ABSTRACTS 
745·2 10:45 
Quantification of Valvular Regurgitation Using a Proximal 
Isovelocity Contours Method and MR Data 
Frederique SA Guenet, Peter G. Walker, Mark W. Doyle, Ajit P. 
Yoganathan, Gerald M_ Pohost Georgia Institute of Technology, 
Atlanta, Ga and University Alabama at Binningham, AI. 
The proximal isovelocity surface area (PISA) method is a promising 
approach for the quantification of valvular regurgitation. Assuming 
hemispherical isovels, the flow rate can be obtained by multiplying the 
radius of a isovel by its velocity. Unfortunately, factors change the 
shape of the isovels making the calculated flow rate false. It is 
postulated, however, that at a certain distance from the orifice the 
iosvels remain hemispherical and can be used to calculate an accurate 
flow rate. To test this hypothesis, Magnetic resonance (MR) was used 
to measure, in-vitro, the velocity proximal to a Simple regurgitant 
orifice. Using MR, allowed the velocity, V, to be measured along a 
line perpendicular to the orifice and is therefore superior to Doppler, 
which measures the velocity at only one location. At each position r 
along this line the flow rate, q, was calculated by the formula, q = 
2n:r2V. The figure shows how q varied with r, distance from the 
orifice. Close to the orifice the flow is underestimated. Like Doppler, 
MR aliases close to the orifice resulting in a false velocity 
measurement. Far from the orifice the flow is overestimated because 
140 of the confinement effects of the 
120 
100 
o 
745·3 
phantom. Conclusions: It is seen 
that at around r = 10 mm, there is a 
plateaux in the flow rate curve 
matching the true flow rate. It was 
found that at this position the 
isovels were hemispherical. For 
larger flow rates, however, 
confinement effects became 
dominant and the flat section of the 
10 20 30 40 curve overestimated the true flow 
Distance from plate [mml rate. 
11:00 
A Study of Normal and Stenotic Mechanical Heart Valves 
Using Magnetic Resonance (MR) 
Peter G. Walker, Erik M. Pedersen, Lecci Flepp, Russell Heinrich, 
Arnold Fontaine and Ajit P. Yoganathan. Georgia Tech, Atlanta, GA, 
USA. and Aarhus University Hospital, Aarhus, Denmark. 
Analysis of prosthetic heart valve function after cardiac surgery is 
necessary, in order to study the operation success. Currently, Doppler 
ultrasound can provide a simple calculation of the pressure drop. But 
is not as successful at visualizing flow. We have used MR to measure 
the velocity downstreanl of normal and stenotic Bjork-Shiley and St 
Jude Medical heart valves in the belief that this method provides an 
improved analysis of the valve function. The accuracy of the MR was 
tested using laser Doppler. Results: Using the FACE MR sequence it 
was possible to measure the axial flow profile downstream of stenotic 
valves even with jets of over 4 mls. Calculation of the pressure drop 
through the Bernoulli equation is therefore possible. In addition the 
visualization of the axial flow through MR, can be used to investigate 
the location of thrombi. This potentially provides an early warning 
mechanism as small thrombi, which may not necessarily show up as a 
significant pressure drop can be seen on the axial flow proflle as an 
abnormal region of stasis. Tracing the growth of such an unusual area 
of stasis over time will provide information as to the size and rate of 
increase of the thrombus which can then be dealt with before 
significant problems arise. Comparing the MR velocity to the accurate 
LOA data it was found that the MR velocity was very accurate in all 
regions except in those with large turbulent levels. Using a second 
MR flow sequence, it was possible to visualize all three velocity 
components downstream of the valve. This gave an excellent 
visualization of the flow and could identify possible regions of blood 
hemolysis. Conclusion: MR can be used to measure the flow 
downstreanl of normal and stenotic mechanical heart valves. The data 
provides not only the pressure drop but also valuable information 
about the location of the thrombus and may lead to earlier 
identification of thrombus formation. 
175A 
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745·4 11:15 
The Impact of Driving Pressure on Effective Repflltaut Orifiee Area 
In Incomplete Mitral Valve Clormre 
Ehud Schwammenthal, Shengqiu He, Anhur E Weyman, Ajit P Yoganathan, 
Raben A Levine, Arnold A Fontaine. Mass. General Hospital, Boston, MA and 
Georgia Institule of Technology, Atlanta, GA 
LV dilatation causing apical displacement of the papillary muscles frequently 
results in incomplete mitral valve closure. According to the Gorlin Formula 
regurgitant now rale should increase in proportion 10 the square root of the pressure 
gradient, if the orifice were constant. On the other hand, the transmitral gradient 
determines the force pressing the mitral leanets together, thus potentially 
contributing to valvular competence. We hypothesized that when increased leanet 
lension prevents comolele valve closure the lransmitral pressure gradient will 
jm[)Tove leaflet coaptation reduce effective regurgitant orifice size and thus 
outwei&h its effect on regurgitant now rate accordjng 10 the Oorljn Fonnula. This 
was tested in a model of the left heart incorporating complete unfixed porcine 
mitral apparatus. For each degree of apical displacement lransmitral pressure was 
varied and regurgitant now rate measured. Results: A) shows the expected 
increase in regurgitant now rate with driving pressure assuming a constant orifice 
for a given degree of displacement. B) Observed now rate, which was higher with 
severe displacement (arrow), decreased with increasing driving pressure at any level 
of displacement; becauSe C) effective regurgitant orifice area decreased in response 
10 increasing pressure. 
I 
.!5 
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1, 
I. 
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Conduslon: When apical displacement of the papillary muscles results in 
incomplele mitral valve closure. the resulting regurgitant orifice will be smaller. 
the higher the transmitra1 pressure difference. because the lanerdetermines the force 
pressing the mitra1leaflets together. A comparable beneficial efTect of increased LV 
pressure without increased volume. as produced in this model, could be achieved in 
vivo by an increase in contractility. 
745·5 11:30 
Mitral Regurgitant Jet Momentum QulDtitation Tbrough Digital Auscultation: 
An In Vitro Study 
Arnold A. Fontaine, Robert A. Levine, Mark Menendez, Kim Williams, 
"William F. Reeves, ·Stan W. Pawlukiewicz, "lames Kassel, Ajit P. 
Yoganathan. The Georgia Institute of Technology, Atlanta, GA, Massachusetts 
General Hospital, Boston, MA and MCG International, New Haven CT. 
Typical mitral regurgitant (MR) jets range in velocity up to 5-6 mls with effective 
orifice diameters up to 6mm. These tuJbulent jets produce characteristic sounds 
distinguishable ftom normal heart sounds. Cardiologists have used auscultation 
and Doppler tecbniques to diagnose and assess the presence and severity of MR. 
However, current non-invasive tools are either StIbjective (auscultation), or time 
coDStlDling and relatively costly (Doppler). Recent technical developments in 
digital auscultation may enable the cardiologist to quantitate heart sounds. To 
evaluate the potential of digital auscultation in the quantitation of MR, an in•
vitro study was conducted to correlate the acoustic signature of physiologic 
regurgitant jets with jet flow characteristics: flow rate, velocity and momentum. 
Methods: Steady flow free jets were driven through 4 and 6mm orifices at flow 
rates of 0.6-8.5 llmin. The jets entered an 88mm diameter cylindrical receiving 
chamber 120mm long. Unique, polymer based, displacement sensitive, acoustic 
sensors were used to passively measure the jet noise preSStll'e spectrum and 
acoustic intensity (AI), the integral of acoustic power spectral density over 
ftequency, at several locations in the receiving chamber. Materials of differing 
acoustic impedance were used to evaluate the effect of attenuation characteristics 
on AI correlations. Rellllts: The acoustic intensity of physiologic jets correlated, 
:; I~ D log/linearly, with the jet area 
'; momentum flux (VoQ). The 
! momentum flux is a basic measure of 
'l the force imparted by tbe jet. 
~ Changing impedance mismatch, by i using surfaces of different sound 
_i 4.& "" •• ""'... characteristics, reduced AI levels while 
o •.• "" """''''' maintaining the logilinear correlation. 
~ 10-' D 
, ,.\c, -;;'::.,--;:o.,;---;.~. -;;;"--:',, 
n:;UR[' ltOWM1JNnux yO 1'114/51 
Conclusions: Passively measured jet 
AI is correlated with the jet momentum 
flux. This suggests that MR jet 
momentum flux and severity may be 
quantified by passively measured AI. 
Furthermore, this technique, combined with Doppler velocities, may be used to 
estimate flow rate and effective orifice diameter ftom momentum flux. 
JACC February 1994:1A-484A 
745·6 11:45 
A new Quantitative Method for Valvular Regurgitation: A 
Control Volume Technique and Magnetic Resonance 
Frederique Guenet, Sten A, Oyre, Kim Houlind, Erik M Pedersen, 
Peter G. Walker, Ajit P. Yoganathan. Aarhus University Hospital, 
Denmark and Georgia Institute of Technology, Atlanta., Ga. 
The purpose of this study was to develop a truly quantitative method 
to estimate regurgitant flow. The PISA method cannot do this as the 
hemispherical isovelocity assumption is not valid in aU but the 
simplest flow cases. The method presented here does not assume any 
velocity contour shape and is potentially better. The technique 
consists of measuring all three components of the flow proximal to 
the orifice with magnetic resonance (MR). The flow rate is then 
calculated by integrating the velocities through an imaginary box 
encompassing the orifice. By continuity, the flow through the box 
equals the flow through the orifice. Note, the box is not an isovelocity 
contour, no assumptions are made about its shape or the velocity 
distribution. The method was tested using an in vitro model which 
provided steady flow through circular orifices of 6 and 12 mm 
diameter, flow rates; 41, 77 and 125mVs. Results: MR,like Doppler 
has an aliasing velocity. Using a small box produced a poor result 
because aliased velocities were included in the integration. By using a 
box just larger than the aliasing, an accurate measurement of the 
velocity was obtained. r = 0.994. Conclusions: The box integration 
technique is a simple application of the principle of mass conservation 
Noonal Velocity and is not dependent 
upon assumptions about 
the proximal flow field . 
Provided the correct size 
of box is used, an 
accurate measurement of 
the flow rate can be 
obtained. This technique 
therefore provides a 
potential method for 
quantifying regurgitation. 
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746·1 10:30 
Augmentation of Synthesis of Plasminogen Activator 
Inhibitor Type·1 in Arterial Endothelial Cells by High 
Concentrations of Glucose and its Clinical Implications 
Thomas K. Nordt, Kevin J. Klassen, David J. Schneider, 
Burton E, Sobel, Washington University School of 
Medicine, St. Louis, MO 
Accelerated vascular disease in non-insulin-dependent 
diabetes mellitus (NIDDM) is associated with attenuated 
plasma fibrinolytic activity secondary to increased 
plasminogen activator inhibitor type-I (PAl-I). To 
identify factors that may contribute to attenuation of 
fibrinolysis locally as well as systemically, porCine 
aortic endothelial cells were grown to confluence in 
primary culture, serum-starved, and exposed to selected 
concentrations of glucose (2.8, 5.6, 11.1, or 22.2 mM) 
and insulin (0,01, 0.1, 1.0, 10 nM) within ranges seen 
in NIDDM. PAI-I activity in conditioned media after 24 
hr incubations increased from 17 ± 0.8 to 29 ± 2.0 arbi•
trary units (AU)!ml (mean ± SE, P = 0,001) with increas•
ing concentrations of glucose. T~e effect was specific, 
as shown by results of assay of S-methionine labeled, 
newly synthesized total protein in cell lysates and in 
conditioned media. It was not attributable to osmotic 
effects as shown by studies with sorbitol substituted 
for glucose. Increases occurred consistently regardless 
of the concentration of insulin. IncreaSing concentra•
tions of glucose augmented PAI-I mRNA (Northern blots) 
from 159 ± 10 to 280 ± 12 CPM (p • 0.001) without con•
comitant changes in levels of 18S rRNA or DNA, Thus, 
endothelial cell PAI-I activity is augmented by glucose 
in concentrations seen in NIDDM as a result of increased 
synthesis mediated at the level of PAI-I gene expres•
sion. This phenomenon may contribute locally to the 
accelerated vascular disease typical of that seen in 
NIDDM and thought to be exacerbated by systemic changes 
in plasma PAI-l as well. 
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746·2 10:45 
Cardiovucular Geoe Thenpy Using Adenoviral Vecton: DillaDt 
Transductloa Following Local Delivery Ulinll a P01"Olll Balloon Catheter 
Keith L. March, Innina Gradus-Pizlo, Robert L. Wilensky, Soonpin Yei, Bruce 
C. Trapnell. KIannert Institute of Cardiology and RL Roudebush V AMC, 
Indpls, IN; and Genetic Therapy, Inc., Gaithersburg. MD 
Smooth muscle cell proliferation plays a major role in I'CItcllOlis following 
angiopJasty or vascular injury. One strategy to modulate the vascular response 
is the local introduction of genetic material into vascular cells. AdenoviraJ 
vectors, which bold particular promise due to their high titer and efficient gene 
transfer, have previously been delivered using techniques which incorporate 
doublc-balloon or surgical isolation of a vascular segment, allowing 
maintenance of a locally high concentration of vector. Porous balloon c:atbeters 
(PBC) represent an alternative single-balloon delivery system. We evaluated 
the use of a PBC to deliver AvlLacZ4, an adcnoviral vector expressing a 
nuclear-targetcd a-galactosidase gene, into rabbit femoral arteries (n=6{ Two 
ml of viral suspension were infused unilaterally (4 ATM, 2-SxlO 0 pfu) 
following bilateral angioplasty (10 ATM). Three days later, vector 
transduction of vascular tissues and multiple organs were evaluated by nuclear 
X.gal staining and polymerase chain reaction amplification of vector DNA 
sequences. Although transduction of the vascular endothelium and media at 
the site of infusion was demonstrated, evidence for viral DNA and gene 
transduction was also noted in numerous tissues. These included the lung, 
heart. thoracic skeletal muscle, and aorta. The observed pulmonary 
transduction displayed a predominantly alveolar pattern, with occasional 
transduction of airway epithelium noted. In many areas, the transduction 
frequency of pulmonary parenchyma per cross-sectional area was higher than 
that of vascular cells at the site of infusion. These observations contrast with 
the previously demonstrated ability of these PBC to localize 10 11m 
microparticles with minirnaI systemic delivery. This difference may be due to 
increased permeation of tissues by the 80 nm-oiameter virions, and loss into the 
systemic circulation at a rate more rapid than the virus-ceU binding interaction. 
This suggests that efficient, local delivery of adenoviral vectors with a PBC will 
likely require approaches which alter kinetics of binding or help to maintain 
high pericellular concentrations of vector at the site of infusion. 
746·3 11:00 
Comparative Effects of Basic Fibroblast Growth Factor and 
Vascular Endothelial Growth Factor on Coronary Collateral 
Development and the Arterial Response to Injury 
Daisy F. Lazarous, Matie Shou, Mickey Scheinowitz, 
Stephen E. Epstein, Ellis F. Unger, NHLBI, Bethesda, MD 
Angiogenic peptides have the potential to induce neovascuIarization 
of ischemic tissues; however, as mitogenic agents, they also have 
the potential to modulate the proliferative response to vascular 
injury. We developed a canine model in which both of these 
processes could be assessed concurrently, and examined the effects 
of basic fibroblast growth factor (bFGF) and vascular endothelial 
growth factor (VEGF). Dogs were subjected to progressive 
ameroid-induced occlusion of the left circumflex coronary artery, 
and to balloon injury of the ilio-femoral artery. Beginning 10 days 
after ameroid placement, the animals were randomized to receive 
systemic bFGF 1.74 mg (n=9), VEGF 0.72 mg (n=9), or saline 
(n = 10) as a daily intra-atrial bolus for 7 days. Treatment with 
bFGF was associated with a 68 % increase in maximal collateral 
flow at the conclusion of treatment (day 17, p<O.Ol), and a 46% 
increase at the end of the study (day 38, p<O.Ol). Collateral flow 
in VEGF-treated dogs was similar to controls (p=NS). Neointimal 
proliferation was observed within injured ilio-femoral arteries in all 
3 groups, with percent luminal stenoses of25±13%, 56±32%, and 
24±13% in bFGF, VEGF, and control dogs, respectively (p<0.05, 
VEGF vs. control). Thus, bFGF markedly enhanced coronary 
collateral blood flow, with no effect on neointimal proliferation. 
VEGF exacerbated the proliferative response to vascular injury, but 
at the dose and treatment interval used in this study, did not 
improve collateral flow. Thus, bFGF may have important 
therapeutic potential in patients with ischemic heart disease. 
ABSTRACTS 
746·4 11:15 
Increased Frequency ofthe Angiotensin Converting Enzyme DID Genotype 
in Patients with Severe Pulmonary HypertenSion 
William T. Abrabam, Mary V. Raynolds, Michael R. Bristow, David B. Badesch, 
Bertron M. Groves, Brian D. Lowes, Kristine M. Wynne, Norbert F. Voelkel, M. 
Benjamin Perryman, University of Colorado Health Sciences Center, Denver, 
Colorado 
A polymorphic marker within the angiotensin converting enzyme (ACE) gene 
has been found to correlate with circulating and tissue ACE activities, the 
incidence of myocardial infarction, and end-stage cardiomyopathy. As ACE is 
Involved in blood pressure regulation, the role of variants in the ACE gene in 
pulmonary hypertension was explored by delennining the ACE genotypes of 22 
patients with severe pulmonary hypertension and 89 normal controls. Genomic 
DNA extracted from peripheral leukocytes was amplified using the polymerase 
chain reaction to detect the polymorphic markers. Pulmonary hypertension 
patients had either primary pulmonary hypertension (n = 15) or precapillary 
secondary pulmonary hypertension. The pulmonary capillary wedge pressure 
was normal in all patients. Mean (± SEM) pulmonary artery (PA) pressures in 
the patients were: PA systolic, 84 ± 6 mmHg; PA diastolic, 36 ± 3 mmHg; mean 
PA pressure, 55 ± 4 mmHg. The mean pulmonary vascular resistance was 16.5 ± 
2.6 Wood units, and was significantly higher in non-DID vs. DID patients (24.5 
± 3.0 vs. 10.8 ± 2.1 Wood units, p<O.OO5). The results of the ACE genotype 
analyses are shown below ('p < om vs. normals): 
ACE eenotype 
111 
lID 
DID 
~ 
1n.ilill 
II (12) 
58 (65) 
20(23) 
Pulmonary H)l!!'I1ension 
1n.ilill 
S (23) 
6 (27) 
11 (50)' 
Conclusion: The ACE DID genotype frequency is significantly increased in 
patients with severe pulmonary hypertension compared with individuals with 
normally functioning hearts. This observation suggests that certain individuals 
may be predisposed to developing pulmonary hypertension by virtue of 
genetically determined alterations in the circulating or tissue-based renin•
angiotensin system. 
746-5 11:30 
The Actions of Natriuretic Peptides on Isolated Human Saphenous 
Veins and Internal Mammary Arteries 
Chi-Ming Wei, Lawrence L. Aarhus, Virginia M. Miller, Hartzell 
V. Schaff, and John C. Burnett Jr, Mayo Clinic, Rochester, MN. 
C-type natriuretic peptide (CNP) is a newly identified peptide of 
endothelial cell origin which shares structurally homology with 
atrial natriretuic peptide (ANP) which is of cardiac origin. Both 
structurally similar peptides are genetically distinct and function via 
separate particulate guanylyl cyclase receptors. Both peptides are 
vasoactive and antimitogenic and may serve as vasodilators and 
inhibitors of vascular smooth muscle proliferation. We have 
recently reponed that CNP and ANP may have differential actions 
on peripheral canine arteries and veins suggesting differential 
receptor localization and physiologic functions, Specifically, CNP 
is a potent endothelium-independent dilator of peripheral isolated 
canine veins. In contrast, ANP has vasodilator actions in peripheral 
canine arteries. To date, the relaxing action of CNP and ANP in 
human isolated saphenous veins (SV) and internal mammary 
arteries (IMA) remains unclear. Rings of human SV and IMA with 
and without endothelium (EC) were suspended for measurement of 
isometric force in an organ chamber (n=6). Maximal % relaxation 
to CNP and ANP is reported below: There no difference in CNP 
and ANP caused relaxation between with and without endothelinm 
in SV and IMA. 
SY IMA 
with EC without EC with EC without EC 
ANP (%) 0.7±O.5 1.9±1.3 lOO±Ot lOO±Ot 
CNP (%) 64±2* 62±7* 59±10* 63±12* 
*<0.05 vs ANP group; tp<O.05 vs SV group. 
These results demonstrate that: I) ANP is a potent relaxing factor of 
isolated human internal mammary arteries and has no effect on 
isolated human saphenous veins. 2) CNP produces potent 
vasorelaxation in saphenous veins as well as in internal mammary 
arteries. These findings suppon distinct biological and potential 
therapuetic roles for ANP and CNP in the regulation of vascular 
tone. 
I77A 
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746·6 11:45 
Increased Expression of VCAM·l and ICAM-l in Early Cardiac 
Allograft Arteriopathy in the Dog 
Christie M. Ballantyne, Fred J. Clubb, Jerry L. Perrard, Branislov 
Radovencovic, Keith A. Youker, C. Wayne Smith, Mark L. Entman, 
Hal K. Hawkins, O. Howard Frazier, James T. Willerson Baylor 
College of Medicine, Texas Heart Institute, and University of Texas 
Houston, TX 
Increased adhesion of monoctyes with subsequent attachment, 
migration and foam cell formation is considered to be the initiating 
event in native and transplant arteriosclerosis. The hypothesis we are 
presently examining is that increased expression of vascular cell 
adhesion molecule-l (VCAM-l) and intercellular adhesion molecule-l 
aCAM-l) occurs in the allograft early after transplantation and may 
lead to increased monocyte attachment and subendothelial migration. 
Heterotopic cardiac allografts were placed into the necks of beagles 
and 8 animals were treated with cycIosporine (2Smg/kg/ d) and 
prednisone (0.3 mg/kg/ d) postoperatively ranging from 33 to 54 days. 
Routine histology showed neointimaI proliferation in varying amounts 
in the allograft, but not in the native heart. Northern blot analysis was 
performed using canine cDNA probes for VCAM-l and lCAM-l which 
showed increases in mRNA levels for ICAM-l and VCAM-l in the 
allograft. Levels of both adhesion molecules were higher in the 
allograft than the native heart, but the relative increase varied from 
animal to animal. In situ hybridization using digoxygenin labeled 
riboprobe showed intense staining for VCAM-l in endothelial cells 
with lesser staining in infiltrating mononuclear cells and smooth 
muscle cells which was specific for the allograft. 
Immunohistochemistry for ICAM-l showed increased expression in 
the endothelium and smooth muscle cells of the allograft. Increased 
expression of both VCAM-l and lCAM-l is present early after heart 
transplantation and this alteration in endothelial and smooth muscle 
phenotype may be important in the pathogenesis of the accelerated 
coronary arteriopathy which occurs after heart transplantation. 
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747·1 10:30 
Sbort and Long Term Reproducibility or QT. QTc, and QT Dispenion 
Measurement in Healthy Subjects 
JosefKautzner, Gang Yi, A John Camm, Marek MaIik 
St. George's Hospital Medical School, London, United Kingdom 
The studY investigated interobserver and intrasubject reproducibility of QT interval 
duration and dispersion measured in standard l2-lead electrocardiograms (ECG) 
recorded at 25mm1s. 
28 healthy volunteers were studied. Each underwent 4 ECG recordings 
performed I, 7 and 30 days apart. Two independent observers analysed each ECG 
record. In eacb lead with a distinguishable T wave pattern, the RR interval, Q - peak 
of T interval, and Q - end of T interval were measured using a digitising board with 
a 0.1 mm resolution. From each recording the following measures were derived: the 
maximum, minimum, and mean QT interval, maximum, minimum, and mean heart 
rate corrected QT interval (QTc), QT and QTc dispersion (the difference between 
the maximum and minimum QT interval among the 12 leads), and adjusted QT and 
QTc dispersion (dispersion divided by the square root of the number or leads 
measured). The interobserver and short- (1 day) and long-term (I week and I 
month) reproducibility of individual indices was assessed by computing the relative 
errors and comparing them by a standard sign test. In addition, the distributions of 
maximum and minimum QTc values among electrocardiographic leads, and the 
differences between QT -end and QT -peak based measurements were investigated. 
The results showed that: (a) The measurement of the QT interval from standard 
EeG recordings is feasible and not very operator dependent (interobserver relative 
error < 4%); (b) The duration of the QT interval in healthy volunteers is stable and 
its short- and long-term reproducibility is high (intrasubject relative error < 6%); (e) 
Parameters which characterise dispeISion of the QT interval in the 12 lead 
electrocardiogram are highly non·reproducible, both between subsequent recording 
(relative error of 25-35%) and between observers (relative error 28-33%), the 
reproducibility of QT dispersion is significantly lower than that of QT duration (p < 
0.01); 
Our data seem to support the view that interlead variability in the QT interval is 
a consequence of different orientation of individual leads to a single repolarisation 
vector and of inaccuracies in the QT interval measurement. The low reproducibility 
of QT dispersion assessed from standard ECG recordings may reduce the 
applicability of such an assessment for risk stratification studies. 
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747-2 10:45 
Value of Exercise I:aduced Q1'c Dispersion in the 
Inte%pretation of stress Electrocardiogram 
Liset N Stoletniy, Ramdas G Pai, VA Med Centre and Lerna 
Linda University, Lerna Linda, CA 
c;[T interval is a measure of the duration of 
ventricular repolarization and is sensitive to myocardial 
ischemia. It is known that drug induced heterogeneity in 
the duration of repolarization gives rise to increased 
inter-lead difference in the c;[T intezval which is referred 
as c;[T dispersion. We hypothesized that exercise induced 
myocardial ischemia would affect ~al repolarization 
regionally in the area of ischemia and may give rise to 
increased c;[T dispersion in the 12 lead electrocardiogram. 
This hypothesis was tested in 56 patients with symptcrn 
limited-treadmill tests: 23 had normal exercise stress 
test and low probability of coronary artery disease 
(normal group, NL); 26 had positive treadmills with 1 lim 
or !\"Ore sr segment depression and abnormal coronary 
~iogram defined as !\"Ore than 50%- stenosis of a major 
ep~cardial coronary artery (true positive, TP); and 7 
patients had poSitive treadmills (5 with reversible 
thallium defects) and non-significant coronary artery 
disease (false positive, FP). The c;[T intezval was measured 
in all 12 leads (at baseline and I(e<lk exercise) and was 
corrected (c;[Tc) for heart rate us~ Bazett's equation. 
c;[Tc dispersion was measured as the difference between the 
longest and the shortest c;[Tc for a given heart rate. 
ResUlts: c;[Tc dispersion at baseline was: 40±.14 msec for 
NL, 56±.13 msec for FP, and 68±20 msec for TP (P<0.05). 
c;[Tc dispersions at peak exercise was 47±.19 for NL, 63±26 
for FP, 102±.23 tor TP (p<O. 05) and catl)ared to 
baseline,only TP showed a marked prolongation of. c;[Tc with 
exercise (P <0.01). Exercise induced c;[Tc dispersion of 60 
msec or less identified 4 of the 7 patients with FP 
treadmill or thallium results increasing the predictive 
accuracy of the stress test. 
CancluSl.an: c;[Tc dispersion is increased during exercise in 
patients with coronary disease and its measurement is a 
useful adjunct to the interpretation of exercise 
electrocardiogram and may reduce the incidence of false 
positive results. 
747·3 11:00 
The Predictive Value of QT versus JT Dispersion After 
Thrombolysis for Acute Myocardial Infarction 
Fidela LI. Moreno, Jeffrey L. Anderson, for the TEAM-2 Study 
Investigators, University of Utah, LOS Hospital, Salt Lake City, UT 
OT dispersion (OTd = OT max minus OT min) has been shown to 
reflect regional variations in ventricular repolarization and is 
significantly greater in patients (pts) with than without arrhythmic 
events. The OT interval is dependent on ventricular conduction time 
and ventricular repolarization. To determine whether one or both of 
these variables contribute to OTd, we studied 155 pts (131 males, 
age 57±10 yrs) with acute myocardial infarction (AMI) Who were 
treated with streptokinase (n=70) or anistreplase (n=85) within 2.4 ± 
0.9 hrs of symptom onset. Angiograms at 2.4±1 hrs after 
thrombolysis showed reperfusion (TIMI grade ~ 2) in 115 pts (74%). 
ORS and OT were measured in 9 ± 2 leads on ECGs at 10 ± 5 days 
post-AMI using a computerized analyzer/digitizer. OTd, ORSd, JT 
(OT minus ORS) and JT dispersion (JTd = JT max minus JT min) 
were computer-derived. RESULTS: Group means ± SO were 
419±43, 93±12 and 339±42 ms for OT, ORS and JT, and 63±30, 
25±10 and 68±33 ms for OTd, ORSd and JTd. There were significant 
differences in OTd (94±32. 88±25. 60 ±22. 52±19 ms, p=0.OOO1) and 
in JTd (95±30, 91±36, 62±24, 59± 30 ms, p=0.0001), but not for 
ORSd (26±11, 21±7, 28±8, 24±10 ms, p=0.24), among perfusion 
grades 0, 1, 2 and 3 respectively. Similar results were obtained 
comparing TIMI grade 0/1 vs 213, and 0,1,2 vs 3. Pts with LAD vs 
RCA/LCX occlusion showed a significant increase in OTd (70±30 vs 
59±29, p=0.003) and a slight increase in JTd (74± 36 vs 64±30, 
p=0.06). Pts with anterior vs inferiorllateral AMI showed slight 
increases in OTd (68±30 vs 59±30 ms, p=0.06) and JTd (74±36 vs 
64±30, p=0.07). Results did not change when Bazett's OTc was 
substituted for OT, nor when analYSis of variance included 
adjustments for age, gender, drug assignment, infarct size, infarct 
vessel and the number of measureable leads. The relationship of 
OTd or JTd and perfusion grade was not influenced by heart rate on 
analysis of covariance. CONCLUSION: Successful thrombolysis is 
associated with less OTd and JTd in post-AMI pts. The results were 
equally significant, whether OT or JT was used in the analysis. Our 
data support the hypothesis that changes in repolarization are 
responsible for OTd noted in our pts. 
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747-4 11:15 
Reduction in Precordial OT Interval Dispersion Following Coronary 
Angioplasty 
Asim Yunus MD, Anne M. Gillis MD, Mouhieddin Traboulsi MD, 
L. Brent Mitchell MD, Henry J. Duff MD, D. George Wyse MD, 
PhD, FACC, MerrU L. Knudtson MD. 
OTc interval dispersion has been reponed to be a marker for 
ischemia. The effects of coronary anery revascularization on OTc 
dispersion have not been previously reponed. We studied 53 
patients with a mean age of 53 years (range 36-75) with single vessel 
coronary anery disease who underwent successful, uncomplicated 
coronary angioplasty (PTCA). We analysed 12-lead ECGs recorded 
before, 1 day after the PTCA. and a median of 27 (range 5-119) 
weeks after the PTCA. Precordial OT intervals were measured by 
an observer who was blinded to the time the ECG was recorded, and 
to all other clinical information. OT intervals were corrected using 
Bazett's formula. OTc interval dispersion was calculated as the 
difference between the maximum and minimum of the 6 precordial 
OTc intervals. Differences in precordial OTc interval dispersion 
measured before, 1 day after PTCA and later after PTCA were 
compared by 2-way analysis of variance (mean ± SO). 
OTc INTERVAL DISPERSION (msec) 
Before PTCA 1 day after PTCA Late after PTCA 
62±28 23±U· 20±8· 
• p<O.OI versus before PTCA 
Conclusion: 
Successful revascularization by PTCA results in a significant 
reduction in precordial OTc interval dispersion which persists over 
time. Whether this measurement would predict restenosis in such 
patients requires funher study. 
747-5 11:30 
Effects of Amiodarone and Quinidine on Depolarization, JT Interval 
and Dispersion in Patients with Intraventricular Conduction Delay 
Guanggen Cui, Philip T. Sager, Brarnah N. Singh, Luyi Sen, V AMCILA & 
UCLA, School of Medicine, Los Angeles, CA 
The conventional QT interval encompas •. '8 the overall duration of the 
ventricular depolarization (VD, QRS) and repolarization (VR, JT). To evaluate 
the relative contributions of the changes in VD and the VR times to prolonged 
QT as well as JT intervals and their dIspersions (D) in patients with 
intraventricular conduction delay (IVCD), we compared the QRS, QT and JT 
intervals and their D in patients with IVCD before (b) and after treatment with 
amiodarone (A), or quinidine (Q). The A group included 60 subjects, 39 patients 
presenting witb nonspecific intraventricular block (NSIVB), 9 patients presenting 
with complete right bundle branch block (CRBBB) and 12 patients presenting 
witb complete left bundle brancb block (CLBBB). The Q group comprised 60 
subjects; it included 29 NSIVB, 12 CRBBB and 19 CLBBB. The QRS, QT and 
IT (IT=QT-QRS) intervals, QTc and lTc were calculated for each complex. 
Mean values of eacb parameter were calculated for eacb lead. The QT and JT 
disp~rsions w~re defined as the differences between the mimmum and maximum 
QT or JT values in any of tbe 12 leads respectively: 
QRS QT QTC JT JTc QT-D QTc-D JT-D JTc-D 
'" '" '" '" "' ...... '" b 126±14 403±50 430±60 277±50 293±47 90±17 99±23 88±19 97±24 
A 129± 15 459±47 477±31 328±45 341 ±45 54± 13 56± 15 59± 14 61 ± 15 
'" '" "' ... '" "'II' '" '" b 130±18 403±41 442±33 273±27 299±27 80±14 88±16 81±16 89±17 
Q 139±25 427±45 477±38 287±35 321±35 94±19105±2695±19107±25 
• P < 0.001 
Thoso «suits domonstratt: tbat: a) botb A & Q prolong QT & QTc, JT & JTc; 
A d~rc:ast:s and Q increast:s their D. These opposing effects are consistent With 
low inCIdence of torsade de pointos wltb A, higher with Q; b) in patients witb 
lVCD recoivmg QRS and QT prolonging medications, such as Q, JT intorval and 
D accurately reflect cbanges in repolarization and may permit the detection of tbe 
heterogeneity in cardiac refractoriness. 
ABSTRACTS 
747-6 
The ST Interval In Children with Long QT Syndrome 
Charles I. Berul, Tammy L Sweeten, A/lIIe M. Dubin, Maully J. Shah, 
Victoria L Veller 
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 
cu at UStD2 the ormula STI RR. 
control LOTS QTc>.45, OTc5.45, STc~.36, 
n 1000 22 13122 9/22 19122 
OTc .41±.01 .48±.06* .5I±.06* .43±.02 
STc .32±.01 .39±.06* .41±.06* 
*-- p<0.001 vs. control 
11:45 
STc<.36s 
3122 
.33±.01 
None of the control group bad a QTc>.45s or STc>.36s [2SD > mean]. The 
standard criteria of QTc >.45s yielded a 59% sensitivity and 100% specificity in 
identifying LQTS. Using an STc cutoff of .36s increased the sensitivity to 86%, 
with a 100% specificity. The 5Tc excludes inherent variability in ventricular 
depolarization time. It is a more precise measurement of repolarization and 
appears to be a useful noninvasive marker in patients with LQTS wbo bave a 
normal QTc on resting ECG. 
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748-1 10:30 
179A 
Probability of Multivessel coronary Artery Disease in 531 
Patients Based upon Ultrafast cr (OFCT) coronary calcifi•
cation: A Multicenter study 
Demetrios Georgiou, Jolm M. Kennedy, Alan S. Brody, Roger 
J. Lewis, Christopher Wolfkiel, Arthur S. Agatston, Warren 
R. Jana.ritz, William Stanford, Paul Shields, Bruce H. 
Brurdage 
Multi vessel coronary artel:y disease confers a high risk 
for coronary events. coronary calcification (CC) is 
asso:iated with coronary atherosclerosis in both synpto•
matic an::i asynptomatic populations. '!hus, it is difficult 
to predict which patients with CC are at risk. '!he 
p.rrp::>Se of this analysis was to determine which patients 
with CC on UFCT have a high probability for multivessel 
disease. 531 patients underwent both a UFCT scan an::i 
iID3iography. '!he majority of coronary iID3iograms were 
done for clinical irrlications. Luminal diameter stenosis 
> 50% was deemed significant. '!he calcium score was 
corrq:JlIted usirg 1Igatston's method. 
Fraction with Multivessel Disease (MVD) 
lex; 
CALCI~ < 40 
sa:RE n = 38 
- 1/24(4%) 
0-1 2/4 (50%) 
1-2 2/5(40%) 
2-3 3/5(60%) 
> 3 
P VAll£; O. 004 
40-49 
n = 136 
2/48 (4%) 
2/18(11%) 
18/41 (44%) 
19/28(68%) 
1/1(100%) 
6x10.10 
Age 
50-59 
n = 143 
1/32 (3%) 
1/16 (6%) 
4/17 (23%) 
26/63 (41%) 
13/15(87%) 
4x10·9 
60-69 
n = 136 
1/18 (6%) 
1/9 (11%) 
5/26(19%) 
35/69(51%) 
10/14 (71%) 
lxlO'5 
~ 70 
n = 78 
0/3 (0%) 
5/14 (36%) 
25/47 (53%) 
11/14(79%) 
0.032 
The probability of MVD is strongly deperrlent upon the log 
of the calcium score. When no CC is present (log calcium 
score = -«», the risk of MVD is small. '!he log of the 
calcium score can be used to determine the risk of 
multivessel coronary artery disease regardless of age. 
180A ABSTRACTS 
748-2 10:45 
Calcium Estimation by Intravasc:ular Ultrasound and U1traCast Computed 
Tomography 
Dan E. Gutfinger, Bavani Maheswaran, Shigeru Nakamura, Robert Detrano, 
Xingping Kang, Weiyi Tang, Jonathan M. Tobis, University of California, Irvine 
and Saint John's Cardiovascular Research Center, Torrance, California 
Calcium in arterial lesions can be detected by both intravascu1ar ultrasound 
(IVUS) and ultrafast computed tomography (UFCT). Validation of total 
calcium estimation has been demonstrated only for UFCT. To examine the 
utility of JVUS in estimating total calcium, 10 human arteries (9 coronaries and 
1 iliac) were obtained at autopsy from 8 patients aged 41 to 83 years. Seven of 
the arteries were diseased, while 3 appeared normal. The arteries were 
pressure perfused with saline at 100 mmHg, and imaged using a 25 MHz IVUS 
catheter driven by a mechanical pull-back unit at 0.25 mm/sec to capture cross 
sectional images on videotape. Total calcium estimates were obtained using 
computer aided tracing of the calcified cross sectional areas (CSAs) at 0.5 mm 
intervals and application of Simpson's rule. Degrees of arc for the calcified 
CSA was also determined. Following fixation in 10% formalin, the arteries 
were placed in a phantom of the human chest and imaged with a UFCT 
scanner with a slice thickness of 3 mm. The UFCT images were analyzed by 
computer aided tracing of the calcified regions, followed by volume and mass 
estimation based on the outlined CSAs and densitometric data. The arteries 
were reduced to ash at 700' F, and the weight of the ashes was used to 
determine total calcium. 
~: There was a close correlation between maximum calcium arc length by 
IVUS and UFCT (r = .81). However, the correlation between total calcium 
volume by IVUS and UFCT (r = .70) or between total calcium volume by 
IVUS and ash weight (r = .41) was dependent on the assumptions made when 
tracing the calcified CSAs in the IVUS images. In one artery which showed 
evidence of atheroma by IVUS there was no evidence of disease by UFCT, and 
in one artery which showed evidence of fibrous plaque by IVUS (no shadowing 
effect) there was significant evidence of calcium by UFCT. 
Conclusion: Modifications in criteria used to identify calcium by IVUS are 
necessary before estimates of total calcium by IVUS will be reliable. IVUS 
shows greater sensitivity in detecting non calcified lesions than UFCT. 
748-3 
Morphological Evaluation of Coronary Artery 
Calcification Using Ultrafast CT Can Improve the 
Validity for the Prediction of Coronary 
Atherosclerosis: Site-by-Site Comparative Study. 
Kouji Kajinami. Noboru Takekoshi, 
Kanazawa Cardiovascular Hospital. Kanazawa, Japan. 
11:00 
To investigate the morphological correlation between coronary 
artery (CA) calcification and CA disease, serial 179 patients were 
studied by both ultrafast CT and elective CA angiography, and 
site-by-site lesion comparison was perfonned in each CA 
segment (segment 1,2,3,5,6,7,9, 11, 12, and 13 in AHA 
classifica-tion). CA calcifications were classified into 5 groups, 
N (none), S (spotty), L (long), W (wide), and D (diffuse), 
based on the comparison of their length and width to CA diameter 
of the calcified site. 
CA calcifications were observed in 445 of total 1757 segments 
(25.3%), ant their positive predictive value (pPV) for the 
existence of significant CA disease (>50% diameter or 
>75% densitometric narrowing on angiography) at that site was 
34%. PPV was 3% in group N (n=1312), 14% in group S (180), 
34% in group L (91), 40% in group W (40), and 59% in group D 
(134). These differences of PPV among these 5 groups were 
statistically significant (p=O.OOI) and also observed in 3 age 
subgroups (50-59, 60-69, and 70-). Furthennore, two thirds of 
angiographically eccentric lesions were classified into either 
group LorD, and majority of severe diffuse lesions (82%) were 
group D. 
These results indicate that the morphological evaluation of CA 
calcification using ultrafast CT can improve the validity for the 
prediction of CA disease at just calcified site, and also provide the 
information concerning the angiographic lesion morphology. 
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748-4 11:15 
Coronary Calcium Predicts Coronary Heart 
Disease in High Risk Asymptomatic Adults 
Robert Detrano, Nathan Wong, Weiyi Tang, 
William French, Demetrios Georgiou, Oleh 
Brezden, Kenneth Narahara, Terence Doherty, 
Bruce Brundage. Saint John's Cardiovascular 
Research Ctr, Torrance, CA. 
Coronary calcium (CC) is almost always 
associated with atherosclerosis. This 
prospective cohort study in the L.A. 
suburbs included 1304 asymptomatic subjects 
with a risk of > 6% of a coronary heart 
disease (CHD) event in 6 years. All 
underwent digital fluoroscopy for CC. 
Angina pectoris (AP), documented infarction 
(MI), revascularization (revas) and CHD 
death were determined after 1 year. The 
prevalence of CC was high (58.6%). Follow•
up examination was completed in 99.6% of 
SUbjects. Six subjects had died from CHD, 7 
had suffered non-fatal MI, 13 had undergone 
revas, and 33 reported AP after 12.0 +/-
1.01 months. One or more events occurred 
in 33 with, and in 10 without CC (Relative 
risk = 2.3, p=O.Ol). Multivariable logistic 
regression including standard risk factors 
showed that CC was independently associated 
with new coronary events (p=0.05). We 
conclude that the prevalence of CC is 
elevated in high risk asymptomatic adults 
and that it independently predicts CHD 
events. However, the absence of CC does not 
exclude clinically important coronary 
atherosclerosis. 
748-5 
Ethnic Differences in Coronary Calcium 
Prevalence 
11:30 
Weiyi Tang, Robert Detrano, Oleh Brezden, 
Demetrios Georgiou, William French, Nathan 
Wong, Terence Doherty, Bruce Brundage. 
Saint John's Cardiovascular Research Ctr, 
Torrance, CA, University of California, 
Irvine, CA. 
Coronary disease incidence and 
atherosclerosis vary with ethnicity. The 
prevalence of radiographically detectable 
coronary calcium (CC) was determined in 
1304 high-risk, asymptomatic adults in the 
South Bay suburbs of L.A. Although no 
subject had a history or ECG evidence of 
prior myocardial infarction, the prevalence 
of CC by digital subtraction fluoroscopy 
was high (58%). Significant ethnic 
differences in prevalence were noted: 36% 
(25/69) of Black subjects, 60% (615/1032) 
of White subjects and 64% (42/66) of Asian 
subjects had definite radiographic evidence 
of CC. The difference in prevalence between 
Black and White subjects was significant (p 
= .001). These differences persisted after 
controlling for age, gender, other risk 
factors, and Framingham risk of coronary 
heart disease events using logistic 
regression analysis. Blacks have a 
significantly lower prevalence of CC than 
Whites and this is independent of age and 
risk factors. Given the higher rate of 
coronary heart disease in Blacks, further 
research is necessary to determine factors 
explaining their lower prevalence of CC. 
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748·6 11:45 
Non-lnva.ive A ..... ment of Intracoronary Stent Patency 
U.ing Ultrafa.t Computed Tomography: Early R •• ult. 
W. Jay Eldredge, Edward C. Santolan, Marc A. Taylor, Richard 
Kovach, Michael Wappel and Charles A. Dennis, Deborah Heart 
and Lung Center, Browns Mills, NJ 
Intracoronary stents provide an effective method for restoring 
vessel flow fOllowing acute or threatened closure complicating 
PTCA. Acute thromboSiS or subacute closure of the stents remain 
significant potential complications. Currently, no non-invasive 
method exists which can accurately detennlne stent p~tency. Six 
patients age range 44 - 84 years with no clinical evidence 
suggesting stent closure underwent evaluation using Ultrafast 
Computed Tomography 6 - 26 days after stent placement (LAD = 
4, Circumflex = 1, RCA = 1). A 20 level, EKG triggered, non•
contrast volume sequence using 3 mm slice thickness with 2mm 
couch Incrementation was performed in each patient to localize the 
site of the stent. The patient's position within the scanner was 
adjusted so that the proximal coronary artery, stent and distal 
vessel were within the scan volume. A second 20 level, diastolic 
triggered volume study was then performed during the peripheral 
injection of 60-aOml of non-ionic contrast medium. The resulting 
images were placed on an off-line 3 dimensional workstation for 
analysis. The stent was considered patent when contrast was 
visualized within the coronary artery distal to the stent. 
Bu.utll; The localization of the coronary stent was readily defined 
on 100% of the patients and corresponded to the angiogram 
performed during stent placement. Flow into the coronary artery 
distal to the stent was delineated in 100% of the cases. No 
comment could be made regarding possible intraluminal pathology. 
Conclusion: This preliminary study suggests that localization and 
patency of intracoronary stents can be rapidly and accurately 
determined non-invasively using contrast enhanced Ultrafast 
Computed Tomography. 
749 Innovative Uses of Computers in Clinical 
Cardiology 
Tuesday, March 15, 1994 10:30 AM-Noon 
Georgia World Congress Center, Room 369W 
749·1 10:30 
A New 3 (+1) - Dimensional Interactive Computer 
Based Model for Reconstruction and Interpretation 
of Cardiac Ultrasound Investigations Using the 
Coneepta of Virtual Reality (CoCard) 
Dierk A. Redel, Winfrid ROtz, *Gemoth Grunst, *Thorsten Fox, 
"Klaus-JOrgen Quast for the University of Bonn, Bonn and the 
"GMD, St.Augustin, Germany 
Special expertise is required for the spatial and temporal 
reconstruction and interpretation of cardiac ultrasound 
images. This is especially important in pediatric heart 
disease, in multiplane transesophageal echocardiography 
and in intraluminal ultrasound. 
We have developed a totally interactive computer-based 3-
dimensional model of the heart and the great vessels in the 
time domaine (+1) derived from cineangiocardiograms stored 
as digital cardiac images (dci) using the concepts of virtual 
reality (CoCard). The computer system used for development 
was Iris Indigo, Silicon Graphics. In this environment 
representative cross-sectional images can be obtained from 
any possible poSition and in any plain outside or inside the 
heart and the great vessels. Even the cross-sectional effect of 
sweeps and rotations can be experienced. Pseudo•
interactive clones of CoCard can be transferred to personal 
computers. 
Preliminary results suggest that such a 3(+1)dimensional 
cardiovascular model has a considerable enabling power for 
diagnostic orientation in complex heart disease and 
interpretation of cardiovascular findings using new ultrasound 
techniques. 
ABSTRACTS 18lA 
749-2 10:45 
3D Shape Based Tracking of Left Ventricular Wall Motion: Exper•
imental Validation 
James S. Duncan, Albert J. Sinusas, R.Todd Constable, Lawrence H.Staib, 
Donald Dione, QingXin Shi, Pengcheng Shi, Amir A. Amini, Elliot Heller, 
Thomas McCauley, Michael Singer, Amit Chakraborty and John C. Gore, 
Yale University, New Haven, Ct. 
An approach aimed at more accurately and objectively determining and 
quantifying the regional and global function of the left ventricle (LV) of the 
heart under both normal and ischemic conditions has been developed. The 
methodology utilizes non-invasive, three-dimensional (3D), cardiae (gradient•
echo) Magnetic Resonance imaging sequences (i.e. four-dimensional (4D) 
data) and relies on a new and unique approach to following the shape prop•
erties of the endocardial and epicardial surfaces of the LV over the entire 
cardiac cycle, based on tracking the differential geometric properties (mean 
and Gaussian curvature) of local surface patches and employing a mathemat· 
ical optimization reasoning strategy. This approach permits the evaluation of 
a spatially dense set of both endocardial and epicardial points in 4D. To val•
idate this automated, shape-based 4D methodology, we compared calculated 
motion trajectories with motion determined by manually tracking 4 pairs of 
implanted endocardial and epicardial markers in 5 open chested dogs, before 
and after acute myocardial infarction. We implanted a small, bullet- shaped 
copper plug (1.5mm x 3.0mm) through the myocardium, creating a signal 
void. This "void" marker was loosely tethered to the endocardial surface 
by an elastic string. The string attached to each endocardial marker passes 
through the myocardium and is secured to a Gd-DTPA· filled marker sutured 
onto the epicardial surface. The "bright" epicardial markers are small, plas· 
tic encasings (inner volume 73.81mm3) filled with a solution of Gd·OTPA 
and saline (200:1). Preliminary results show that the path lengths of the 
algorithm· derived trajectories agree with the gold standard (marker- based) 
trajectories. Thus, we conclude that we can now more confidently study the 
40 trajectories of a spatially dense set of points that sample the LV wall's 
surfaces over many temporally averaged frames within a cardiac cycle. This 
automated approach may permit the reliable 30 assessment of LV function 
and viability post· myocardial infarction. 
749-3 11:00 
A Physiology-Based Program to Assist in Diagnosing Heart Disease 
William J. Long, Shapur Naimi, M. G. Criscitiello. M.I.T. Lab for Computer 
Science, Cambridge, MA and Tufts·New England Medical Center, Boston, 
MA 
Over the past several years we have been developing a program (HOP) 
to assist the physician in the diagnosis of heart disease, its mechanism, and 
complications. The HOP uses a causal physiologic knowledge base with 40 
primary diagnoses, 200 physiologic state nodes, and more than 600 possible 
findings. The input, including history, physical exam, and lab data, is entered 
by the physician using menus. The HOP analyzes whatever data is available. 
The nodes are connected by physiologic relations expressing the probability, 
severity constraints, and temporal constraints of one state causing another or 
causing a finding. The reasoning mechanism is based on Bayesian networks, 
although heuristics are used to enforce the additional constraints and to handle 
forward cycles. This heuristic mechanism generates a differential diagnosis 
from the input findings. 
The hypotheses in the differential are presented to the user as diagrams, 
displaying the physiologic mechanisms from primary cause through interme•
diate state nodes accounting for each finding. The use of explicit causal mech· 
anisms allows HDP t.o discard inconsistent hypotheses, provides justification 
for coneiusions, and serVeS as a basis for reasoning about refinement of the 
diagnosis and management. The HDP also summarizes these diagrams to 
emphasize the essential conclusions and to show the differences between al· 
ternative hypotheses in the differential. 
Five cardiologists independently evaluated the diagnostic accuracy of the 
program. The admission data (prior to new ultrasound or hemodynamic data) 
of 2.6 Cases gathered from discharge sUllllJlaries was entered in the HDP and 
the differentials were reviewed by two cardiologists each. Because of the com· 
plexity of the differentials, there were about 11 progranl generated stat.ements 
to be evaluated per case. Only 4% of these were considered wrong by both 
evaluators, but most raised issues at some level of detail by one or both eval· 
uators. The issues raised were analyzed and attributed to controversies 30%, 
misunderstanding 30%, program error 35%, and reviewer error 5%. 
182A ABSTRACTS 
749·4 11:15 
Neural Network Performance in Recognizing 
Echocardiographic Pixel Luminance Patterns 
George R. Kuntz, Daniel M. Shindler, Lawrence D. Frenkel, 
Norman Sissman, John B. Kostis. Robert Wood Johnson 
Medical School, New Brunswick, N.J. 
Neural networks (NN) can be trained to classify 
complex patterns. The classic backpropagation (BP) is the 
standard to which newer NN such as cascade correlation 
(CC) are compared. We compared CC to BP in their 
handling of echocardiographic data. Gray scale pixel 
luminance pattern arrays from digitized M-mode 
echocardiograms of the interventricular septum of pediatric 
AIDS patients and non AIDS controls were used to train and 
test the two NN. Each NN had 32 pixel luminance inputs and 
one output (normal or diseased). BP had 12 hidden layers. A 
total of 143 patterns were used for training. A different set of 
60 was used for testing. Overall accuracy was not significantly 
different: BP identified 60% of the test patterns correctly. CC 
identified 73% (p=O.I). However, CC was much faster in 
training and testing than BP (31 vs 222 minutes). We have 
made both NN programs and source code available as 
freeware. They are written in the C language by the same 
programmer (GRK) using comparable style to yield similar 
program execution. Yet, cascade correlation learns 
echocardiographic patterns faster than backpropagation. 
749·5 11:30 
Measurement or Left Ventricular Ejec:tion Fnction by 'Artific:ial 
Vision-Neural Network' 
Domenico Cianflone, Sandra Ponti, Fabio Bonelli, Anna Ponti, 
Andrew T. Porter, Filippo Crea, Atti1io Maseri. Cardiology Institute, 
Catholic University, Rome, Italy 
Neural networks are successfully used for pattern recognition and 
class discrimination. This study was aimed at investigating the ability 
of neural networks to evaluate left ventricular (LV) function and 
designing a C-language based application that follows the 'artificial 
vision-neural network' paradigm. Digital pictures of end-systolic and 
end-diastolic frames of ventricular angiograms were acquired by 
means of a video-capture board on an i486-based personal computer. 
The 307200 pixe~ grayscale images were then scaled into 3072 square 
tile pictures. The new end-systolic frame was hence subtracted from 
the end-diastolic frame, resulting in single frame images of 
angiographic area changes. The neural network is a software 
simulated, three-Iayered network: an input (retinal) layer, a hidden 
(corpus genicolatum) layer and an output-response (cortical) layer. 
Digital subtraction frames 'fed' the 3072 neurons of the retinal layer 
with the values of gray levels for each tile. The output layer was 
composed by a single neuron providing the estimated ejection fraction 
(EF). Output values were trained against a QCA evaluation ( 30"RAO 
- Stanford Model) of LV EF for the relevant angiogram. The back 
propagation network was trained through 4300 iterations and 
eventually reached 100010 recognition of training images with a 0.05 
tolerance. The network was then tested with a set of 16 different LV 
angiograms. EF estimation by the network was within the :10"10 of the 
values obtained by QCA in 11116 (68.7%) cases and within the :5% in 
3116 (18.7%) cases. This study provides a starting point for a novel, 
shape and contour independent approach for the evaluation of 
angiographic LV function. 
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749-6 11:45 
.e. 'riDciple for LoDg-7era Cardiac output 
.easur .. eDt 
Rudiger 8illon, Rainer Pospiech, Gunhild 
Herraann, Bernd Wille, Joachi. Zerbst 
University Hosp~tal, Xiel, Geraany 
A new pul.onary catheter and lIonitor syste. fOJ 
autollated continuous long-term .easure.ents of 
cardiac output (CO) was tested in 32 pts under•
going coronary angioplasty. A special SWAN•
GANZ-TYPE catheter was placed in the pulllonary 
artery that provides short heat pulses in 
pseudo random sequence from a 10 em lonq heat 
filament on its body. The resulting blood te.•
perature change. are sampled by a standard 
thermistor incorporated at the catheter tip 
and CO is derived by fast cross correlation 
(FCC) with the heat pulse sequence. For co.•
parison CO .easu-
ra.ants "ara per-co r;:..:I1::.:-==-________ --:::1 
formed using the II _'CIoU .. COIflI .... _.. • 
standard thermo- 10 
dilution technique 
(TD). A total of • 
58 sillultaneos • • easure.ents over 
a wide range of 
different hello•
dyna.ic condition. 
reve.led the 1 I • • • • , • • • ft • • 
correlation given flIf11-.1 
in the fiqure. 
We conclude that CO can be .ssessed continuous•
ly over long tille and with SUfficient accuracy 
using this new principle. Since no injections 
are needed, it lIay be of particular benefit in 
leu or ceu patients. 
750 Agents That Cause or Suppress 
Arrhythmias 
Tuesday, March 15, 1994 10:30 AM-Noon 
Georgia World Congress Center, Room 364W 
750·1 
NOIIIIIdatiag ADIIbIstamIDes Block PouaIum CJwmek 
Clulrles I. Bel'lll, Tammy L Swtttell, Victoria L. Vener, Manin Morad 
10:30 
University of PeMSYlvaflio School of MediciM aNi The Children's Hospital of 
Philadelphill, PhilDdelphill, PtMsylwulilJ 
The actiOllS of terfeuadine (TERF) IIIId ISIaDizoIe (ASn 011 polaSsium cbaDoeIs 
were iDvestillalCd iD sinllie cardiac myocytes 10 delCmline die cellular 
decIropbysiologk:aJ basis of !be drII,s' proarrIIyIIunjc effecls. AST IIIId TERF are 
widely-prescribed -.edaIiD. alillistamiDes wbich bave recently been 
UIOCiIIed wi!b QT iDlerVBI proIonpIiaII. sync.opci, and ventricuJar arrbytbmias 
Including tonades de poiDles. The wboIe-ceU pBIdI-damp ltdInique was used 10 
.lUdy K+ _IS in isoIaIed bUIIWI aIriaI and 1'81 and pioea pill venaicuJar 
myocyleS. Boeb TERF and AST (O.J-l~) suppressed !be iDwani-rectlf'1Cr K+ 
c:baDDe1 (Itt> from 33.1%8.4 pA/pF 10 23.4±S.9 pA/pF (p<O.OOS, n-22). 1be 
bloc:t 0CCIII'Ied iD a voitage-depeJldcnt JII8IIIIer, wi!b a 17% block at -100mv, 
iDa'easiD1l1O a 31 % illbibitiOD 81-1S1DV. The tnDSleDt outward K+ cbaDoeI (110) 
was reversibly bIocUd by 16% from 17,2:t4 pAIpF 10 13.8:1:2 pA/pF (pcO.OS, 
n-9). TERF, but DOl AST. also suppressed !be delayed-rectifier (It> X+ c:baDDe1 
by 9% (p<O.OS, 0-11). 
! ... ~ ~, 
~---"'*"-----t-
... 
... 
... ~Control 
 1,;;.. 
These fiDdiDgs sugllest tbaI \be rare proarrbytbmic action of Ibese suucturally 
unrelated but functionally similar antibistamioes appears 10 be secondary 10 
polaSsium cbannel blockade, leading 10 delayed repolarization, QT iDtervai 
prolonllation, and enbanced susceptibility to premature depolarizations, 
particuJarly iD !be PurltiDje fibers. These medicatiOlls sbould be avoided in 
palients woo bave inbereDt aboormalities of venlricular repoIarization. suc:b as !be 
10Dg QT syndrome, and in patients liking Class III-type antiarrbytbmic 
mediC.'8liOllS or otber QT iDterVal prolongiDll drIIgs. 
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Mechanism Of Pro-Arrhythmic Action Of F1ecainide In The Post Infarction 
Canine Heart. High Resolution Determination of Conduction and Refractory 
Properties of Normal and Ischemic Tissue. 
Mark Restivo, Hong Yin, Edward B. Caref, Gjin Ndrepepa, Mahshid Assadi, 
Nidallsber, Archana Patel, NOOil EI-Sherif. SUNY Health Science Center at 
Brooklyn and VA Medical Center, Brooklyn, NY 
The increased incidence of sudden death in CAST patients receiving 
tlecainide (FLEC) has been attributed to electrical causes though the mechanism 
remains W1clear. Using a high resolution (500 ~ spacing) cross electrode array 
(128 sites, 32 sites/direction) , we measured conduction velocities (CV) 
longitudinal (L) and transverse (T) to the long axis of epicardial fibers and 
effective refractory periods (ERP) in normal (NZ) and ischemic zones (lZ) of dog 
hearts (n=14), 4 days post Infarction, at cycle lengths (Cl) of 250-600 msec. The 
data were compared with whole heart activation maps of reentry (R) and arcs of 
l.' ~ block (ARC) induced by premature stimulation. 
After FLEC, at CL=500, inducibility ofR and g~3 ARCs was similar to control. At CL = 300, the 
J
---" ARC was also similar to control but R was more 
f 
common and susIained VT was Induced in 5 dogs. 
As shown in the table FLEe has not effect on ERP. 
0.9 • n Control Flecainide p 
:::~:::~~ RP room 63 190.0",15.3 192.3 ± 20.7 NS 
-~NZ-" RP,oom 58 180.7",10.2 182.3 ± 12.4 NS 
RP roolZ 91 246.6",20.1 243.4",20.6 NS 
RP,oolZ 88 224.6",19.9 '226.4 ± 20.2 NS 
!IOO 400 500 600 
CV was measured by linear regression of 
activation times of 10-16 sites during unipolar 
stimulation at center of cross. The fractional 
reduction of L & T conduction (normalized (0 
Cl=6oo) shown to the left indicates that FLEC selectively depressed conduction 
in the IZ and the effect sbowed more use dependence in the 1Z. We conclude that 
tlecainide caused no change in the line of block due to its lack of effect on 
refractoriness but facilitated reentry and venuicuiar tachycardia due to a selective 
rate dependent depression of conduction velocity in the slow common pathway of 
potential reentrant circuits. 
750·3 11:00 
Electrophysiologic effects of the new class III antiarrhythmic 
Almokalant in postinfarction porcine model. 
Y,S,Tuininga, C.D.J.de Langen, H.J.G.M.Crtjns, A.C.P.Wiesfeld, 
T.J.M.Tobe, K.I.Ue. 
Univ.Hosp.Groningen, depts. of Cardiology and Clinical 
Pharmacology, Groningen, The Netherlands. 
Almokalant is a new class III antiarrhythmic drug which blocks the 
delayed rectifier potassium current. In general, class III drugs are 
most effective at longer cycle lengths. To Investigate the 
antiarrhythmic and use-dependent effects of almokalant, we 
studied 11 pigs who had a myocardial infarction 2 weeks before 
the administration of the drug. 
Results: The venlricular effective refractory period (ERP) 
increased in all paced cycle lengths after infusion of almokalant. 
In a rate-adaptation model, this effect was confirmed. The 
monophasic action potential duration at 90 % repolarization level 
(APD~) also Increased after almokalant. The ERP/ADP ratiO did 
not change. 
bcl Baseline Almokalant 
ERP 500ms 292±22 308±12 
ERP 400ms 249±18 261±15 
ERP 300ms 209±17 219±17 
APD 500ms 285±17 312±9 
APD 400ms 254±18 267±13 
APD 300ms 214±23 232±17 
ERP/APD 1.02 0.99 
VT Inducible 2 1 
bcl=basic cycle length; VT = sustained ventricular tachycardia 
Conclusions: After myocardial infarction, almokalant significantly 
prolonged the refractory periods in all cycle lengths, indicating that 
almokalant does not have reverse use-dependent properties. 
ABSTRACTS 183A 
750·4 11:15 
Alpbaj'AtlreDoceptor lDtiuence on the incidence of Arrbythmlas DurIDg 
Coronary Occlusion and Reperfuslon In AnestheUzed Dogs 
J. ChrIstoph GaUer and Michael B.. Rosen, Columhla Unlverstty, New York, 
NY 
Alpbaj'adrenoreceptors (AR) bave hll8ll reported to modulate 
arrhytlmlogenesis dlll'lDg corolW'J' occlusion and reperfuslon Independently 
of changes In corolW'J' or QStemlc hemodJllllll1cs. Thus we studied the 
incidence of ventricular tachycardia and IlbrlUaUon (VTIVF) and DOD' 
maUgnant arrbyt1unlas (ventricular premature dep01arlzatlous (VP8) and 
DOusustalDed VT (NSVT)) In chloralose-anesthetized docs subjected to 3D 
mID LAD occlusioD and repertuslOIL Study groups (u-IO) were CODtrol (Co~ 
propranolol (Prop, 1 mg/kg IV). the all AR·subtype blocker WB4101 (WB, 0.5 
mg/kg IV) and the a l• blocker chloroetbylclonldlne (CEC 1.9 mg/kg IV). At 
the start of the 8lperlments heart rate and blood pl'tl88llre were 
comparable &CroSS groups (p > 0.05). DlII'IDg occJusIOD VT and VF incidence 
did not differ among Co, Prop, WB or CEC (Z.3.2 and 2 for VF and 0.1,2 and 
o for VT). Tbe number of VPB In doCS uot bavlDg VF or VT was as foUows: 
control-213±32, Prop-54±13 (p <O.O5). WB-22±4 (p < 0.05). CEC-95±16 
(p < 0.05). In these dogs, WB also reduced the incidence of NSVT (OliO, 
P < 0.05) compared to Co (9/12). Prop (7/9) and CEC (7/12) bad no sIgu1llcant 
effect on NSVT. During reperfusloll, the incidence of VTIVF, NSVT and VPB 
did not differ among groups. In conclusion, a,. AR blockade with WB 
algullicantly reduces VPB and NSVT, and fJ blockade reduces VPB dlll'lDg 
acute ischemia. No intervention motllfled the incidence of occlusion VTIVF 
or was effective during reperfuslon. Tbese resulte suggest efflcacy of a, 
AR subtype blockade In the treatment of certain uOD·mallguant 
arrhythmias, and suggest, as welL that In this model VT and VF are Dot 
Importantly dependent on ", receptor modulation. 
750-5 11:30 
UL-FS 49, a rather Selective Blocker or the Pacemaker Current I, 
has no Errect on Automatic Ventricular Arrhythmias occurring 24 
hours after Inrarction. 
Marc A. Vos, Jet D. Leunissen, Jolanda van der Zande, Hein 1. Wel•
lens. Department of Cardiology, Academic Hospital Maastricht, Maas•
tricht, The Netherlands. 
In dogs with chronic AV-block, we have recently subdivided the 
automatic ventricular tachycardias (VTs) which occur 24 hours after 
LAD-occlusion in two subgroups: those VTs that are temporarily sup•
pressed by prolonged (2 min) pacing. and those VTs which show no 
response to pacing (Circ. 1992; 85: 747-755). The first group could be 
terminated by 0.3 mg/kg lidocaine and by 0.5 mg/kg verapamil, while 
the rate of the latter VTs could only be slowed by verapamil. To gain 
more insight in the ionic currents responsible for the generation of 
the~e VTs. we tested I) the effect of OJ mg/kg UL-FS 49 on the cycle 
length of the idioventricular rhythm, and 2) its possible anti-arrhythmic 
effect on the two subgroups of automatic VT. In this dose UL-FS 49 
selectively blocks the pacemaker current It in an use dependent man•
ner. In dogs it has been reported that UL-FS 49 decreases the sinus 
rate with ± 30%. 
Results: UL-FS 49 doubled the cycle length of the idioventricular 
rhythm: 1485±310 to 3415±775 ms (P.s. 0,05) at 30 min after the 
start of the bolus. Independent of the subgroup of the automatic VT, 
we did not observe an effect on the cycle length of the VT (365± 70 
vs. 385±60 ms), nor did UL-FS 49 terminate the VTs during the 30 
min observation period. 
Therefore, UL-FS 49 I) dramatically increases the idioventricular rate, 
and 2) has no effect on automatic VT. Based on the lack of any anti•
arrhythmic effect of UL-FS 49, we conclude that there is no significant 
contrihution of the pacemaker current It for the generation of either 
suhgroup of automatic VTs occurring 24 hours after infarction. 
184A ABSTRACTS 
750·6 11:45 
Bretyllam Causes a Use-depeDdeDt IDcreue ID Refnletor1De8S DarIq 
VeDtricalar F1brlDatioD 
Russell E. Hillsley, Kurt D. Bollacker, Sharon B. Melnick, Dennis L. 
RolliN, Patrick D. Wolf, Raymond E. Ideker, Duke University Medical 
Center, Durham, NC 
We tested the hypothesis that bretylium increuea refractoriness in a we•
dependent manner during ventric:ular fibrillation (VF). A plaque of S06 (22 
l[ 23) electrodes 1mm apart was sewn to the RV. After a control VF 
episode, in 6 pigs bretylium (10 mglkg) was given, and VF was reinduced 
30, 60, 90, and 120 min later. In 6 additional pigs saline was nm.d 
illltead of bretylium to test if refractoriness increuea with repeated VF 
inductions. The effective refractory period (ERP) during pacing at CJde 
length 300 ms was assessed at an epicardial site prior to each VF episode. 
The ERP prior to the control VF episode (245:!:12 ms) was aot 
significantly different from the ERP 30 min (2SO:!:9 ms), 60 min (252:!:8 
ms), 90 min (247:!:15 ms), or 120 min (248:!:15 ms) after bretylium. VF 
was induced by an extrastimulus, and unipolar electrograms were recorded 
for 2 5 at 15, 155, and 30s after VF onset. Activations at each electrode 
during VF were identified by animating the first derivative of !be 
potentials (dV/dt). The activation rate per electrode per second during VF 
was then calc:ulated by an automated analysis. The VF activation rate per 
electrode during the control episode (7.7:!:0.9 activations/s) was 
significantly greater than the VF activation rate 30 min (7.0:1:0.8 
activations/s), 60 min (6.7:!:0.8 activations/s), 90 min (6.8:!:0.9 
activations/s), and 120 min (6.5:!:0.9 activations/s) after bretylium (P < 
0.05). In the 6 saline pigs the ERP and the VF activation rate 30, 60, 90, 
and 120 min after saline were not significantly different from the conIrol 
ERP and VF activation rate. Thus, the decrease in VF activation rate .r 
bretylium was not due to repeated VF inductions. Bretylium decreased 
the VF activation rate consistent with increased refractoriness but did IIOt 
change the ERP during pacing at a cycle length of 300 ms. This we•
dependent effect of bretylium on refractoriness may result from increased 
activity of the delayed rectifier channel (Ik) at higher activation rates _ in 
VF. Thus, bretylium causes a use-dependent increase in refractoriaess 
during VF. 
890 Coronary Artery AngiopJasty (PTCA) and 
Thrombosis 
Tuesday, March 15, 1994 Noon-2:00 PM 
Georgia World Congress Center, Hall H 
Presenting Hour: Noon 
890·38 
~hroabogoDieitr of .u.aD Artoriel Woll. XaplicatioD. 
for Va.eular XDtor9WDtioDa. 
Antonio l'ernlndez-Ortiz, Juan Badimon, Erling l'alk, 
Valentin ruster, James Chesebro, Lina Badimon. Cardiac 
Unit. Maaaachuaetta General Bospital, Boaton, MA. 
Balloon coronary angioplasty diarupts plaques ar 
the internal elastic lamina expoaing atherosclerotic 
tissuo, media or both to flowing blood. OCcaaionally, 
los ion a undergoing directional coronary atherectcmy may 
even expose adventitia. To inveatigate whether the 
vascular layer exposed after injury influences 
aubsequent thrombotic reaponae, different vascular 
surtaces obtained from human aortas at necropsy (normal 
intima, lipid-rich core, media and adventitia) were 
placed in a tubular flow chamber and perfused with 
heparinized porcine blood (aPTT ratio 1.5tO.04) for 5 
min under flow conditions mimicking mild to moderate 
coronary atenosis (shear rate 1690s-1). Thrombu. 
formation was measured by Indiunt-platelet deposition 
(PO) and by morphometric analysis (thrombus area [TAl 
and percentage of surface covered by thrombus [Tel). 
Re.ults were as follow (meantSEM): 
________________ ~P~O~I~x~106L£m2l~~2L£m2l~ TCI'l 
Intima (n=20) 32±6& 0.4±0.1& 16t5' 
Lipid core(n=31) 65B±95* 6.0±1.0* 62±4 
lIedia (n~32) 122±l6 3.0±O.4 9l±4# 
A4ventitialn-20l 269t49 3.0±0.5 Bl±7 
(P<0.05 ANOVA, * lipid core vs all others, , intima v. 
all others, and # media vs lipid core). 
(~ r-O.B, p=O.OOOl) 
Thua, exp08ure of lipid-rich core results in higher 
platelet deposition and larger thrombus growth than 
expoaure of media or adventitia. Bowever, thrombus 
apreading on injured surface may be larger when tunica 
_dia 1& expoaed. ThiB finding .. y help to explain 
differonce. in acute thrombosis and late restenosi. 
after different degr_. of vaacular injury cau.ed by 
angioplaaty. 
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890·39 
ActIvated Clottlal time PredlcU Bleeding ComplicatloDs From AIIg1oplasty. 
William B. Hillegass. Craig R. Narins. Brigitta C. Brott, Eric B. Haura, Harry R. 
Phillips. Richard S. Stack, Robert M. CaIi1I Duke Hospital. Durham, NC. 
Vigorous anticoagulatioD is maintained and monitored with activated clotting 
times (ACTs) during angioplasty to reduce ischemic complications. The 
relationship between proc:edural ACTs and bleeding, however, is unknown. In 
438 patients (mean age = 60.1. 33% female) undergoing elective or urgent 
angioplasty, blood loss was determined from pre-procedural hematocrit (Hct) 
compared with the lowest hematocrit obtained within 72 hours post.procedure. 
adjusted for interval ttansfusions. Patients were prospectively followed (blinded 
to in·lab ACTs) for 72 hours post-procedure for clinic:aJ bleeding complications 
including large hematomas (n=4I), CT-docwuented retroperitoneal bleeds (n=2). 
gastrointestinal (n=3), other bleeds (ne 2). or Hct dec;line without localized 
bleeding requiring ttansfusion (n-3). tn·lab ACTs. measured with a Hemochron 
device. were 382±81s.d. before initial balloon inflation and a maximum in-lab 
ACT of 401±73s.d. Maximum in-lab ACT had a univariate association with 
blood loss (p=O.037) and bleeding 
complications (p=O.OO3). In 
multivariate analysis. maximum 
in-lab ACT (p=O.OO4) was a 
significant, independent predictor 
of bleeding complications as were 
patient age and gender. The 
predicted probability of a bleeding 
complication as a function of 
maximum in-lab ACT is depicted 
for a 60 year old female and male 
in the figure. While 8 (17%) of 
the patients experiencing bleeding 
complications required transfus· 
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ions. there were no other significant sequelae. We compared the patient's risks 
and outcomes of ischemic versus bleeding complications at any given level of 
ACT using risk.-benefit analysis. This outcomes analysis suggests an optimum 
target ACT range of 425 to 525 seconds. 
890·40 
Intracoronary Thrombus: Still a Risk for PTCA Failure? 
Guy S. Reeder. Sandra Bryant, Vera Suman. David R. Holmes Jr. 
Mayo Clinic and Foundation, Rochester, MN 
Angiographic evidence of intracoronary thrombus is associated with a 
higher incidence of acute PrCA failure. Whether thrombus is an 
independent risk factor for acute failure. and whether this relationship 
has changed over time, is uncertain. Therefore, we identified 2.699 
patients who had single lesion PI'CA (rom January 1984 through 
December 1991; detennined univariate variables associated with acute 
failure, and applied logistic regression modeling methods to identify 
multivariate risk factors for acute failure. Acute failure was defined as 
myocardial infarction within 24 hours post procedure, death or 
emergency bypass within the hospital stay, or a pre-post lesion 
diameter change of <40%. PIS presenting with acute infarction or total 
occlusions were not excluded. To examine effect of time on acute 
failure. the study period was subdivided into 3 time periods; 1184 to 
12186. 1187 to 12189 and 1190 to 12191. Using time as a variable, the 
existing logistic model was again evaluated. 
Results: Of 2.699 pts. 1121 (42%) had thrombus identified. PI'CA 
was successful in 915 (81.6%) of pts with thrombus and in 1386 
(88.2%) of those without thrombus. Univariate analysis of 33 
variables demonstrated that thrombus was strongly associated with 
acute failure (p<.OOOI. Fischer's exact test). Multivariate logistic 
modeling with IS variables demonstrated that thrombus remained 
strongly associated with acute failure (p=.OO IS) with important 
interactions with presence of congestive failure and number of 
diseased (>70%) vessels. Using time variables in the logistic model 
demonstrated that the effect of throm bus on acute failure did not 
change as a function of time over the study period. 
Conclusions: Thrombus remains an independent and important risk 
factor for acute PI'CA failure, despite improvements in angioplasty 
methods and ancillary therapies which have occurred over this time 
period. 
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890·41 
The Association between Heparin Concentration and 
Measured Anticoagulant Effect by Four Commercially 
Available ACT Assays 
Bonnie H. Weiner, Richard C. Becker, Russell P. Tracy. Edwin G. 
Bovill, Elaine Cornell, Steven P. Ball. University of Massachusetts 
Medical School, Worcester, MA 
Activated Cloning Time (ACT) has become the standard technique for 
assessing heparin administration during interventional procedures. A 
value of 300 seconds has been empirically chosen as being therapeutic. 
This has not been correlated with heparin concentrations or activity. In 
order to evaluate these relationships, simultaneous samples were 
obtained for ACT measurement using the 4 commercially available 
assays: "low range Hemochron"; "high range Hemochron"; "low range 
Hemotech"; and "high range Hemotech" as well as for factor Xa and 
Ila assays from 38 patients undergoing routine interventional 
procedures prior to and 10 minutes following intravenous bolus 
heparin administration. Commercial heparin was administered in all 
patients. There was a significant correlation between both of the 
Hemochron ACT assays (r=.68,p<O.OOOI and r=.66,p<O.OOI 
respectively) and factor Xa levels. The correlation between Xa levels 
and the Hemotech ACT assays were less strong but remained 
signiticant. (r=.58,p<O.OOOI and r=.53,p<O.OOOI). Similar 
correlations were found with factor Ila levels; Hemochron low range 
r=.66, p<O.OOOI; Hemochron high range r=.68,p<O.OOOI; Hemotech 
low range r=.56,p<O.OOOI;and Hemotech high range r=.52,p<O.OOOI. 
Our findings show that measured systemic anticoagulant effect and 
serum heparin concentrations correlate closely in each of the 4 
commercially available ACT assays tested. The low and high range 
Hemochron assays, however may be preferred during interventional 
procedures. Heparin titration nomograms can be developed that predict 
anticoagulant response with considerable accuracy. 
890·42 
Bolus versus Prolonged Intracoronary Urokinase Inrusion: 
A Theraptrutic Quagmire? 
Daniel J. Evans, 'red Pacheco, David Grambow and Joseph M. Sutton 
Cleveland Clinic Foundation, Cleveland, Ohio and University of 
Michigan, Ann Arbor, Michigan 
The outcome of bolus versus prolonged (PR) strategies of intracoronary 
(UK) with PTCA for angiographic thrombus was analyzed. Although 
the PR strategy was more frequentl¥ selected in patients with a larger 
clot burden, t1iere was no further anglOgraphic benefit in the PR strategy 
compared to the bolus group. Clot burden was __ graded (1-4; 0 = no 
thrombus; 1 = TIMl ur, <50% stenosis; 2 = TIMI III, ~50%-99% 
stenosis; 3 = TIMI lor II, haziness or loss of two TIMI grades during 
the procedure; 4 = TIMI 0, total obstruction with persistent haziness or 
staining. 
Bolus (n=17l) PR (n=41) P 
Initial Clot Grade 2.8 ± 1.0 3.0± 1.0 0.05 
Total UK Dose 0.7±0.5 2.4± 1.9 0.001 
Infusion Time (hrs) 0.7±0.3 13.3± 11.7 0.001 
Final Clot Grade 1.9± 1.1 2.3±1.2 0.04 
Improvement Clot Grade 0.9± 1.1 O.S± 1.2 NS 
Event Weighted Score 
Bleedin~ .4 4 (2%) 1 (2%) NS 
Units ransfused 0.7±1.8 2.6±9.4 0.02 
Non-Q MI .6 5 (3%) 7 (17%) 0.0004 
Q-Wave MI .7 8 (5%) 3 (3%) NS 
Stroke (major) .9 0(0%) \ (2%) 0.04 
Death 1.0 10 (6%) 6 (\5%) 0.05 
Peak Event Score 0.2±0.4 0.5±0.3 0.003 
Although the improvement in clot grade was similar in both groups, 
adverse events were more frequent in the prolonged cohort. By 
logistical regression modelling, only theraH for acute occlusion was 
predictive of increased adverse events.(UR= 1.6;CI= 1.2-2.3) The 
observed reduction in clot burden in the PR strategy was at the expense 
of a higher incidence of bleeding, non-Q MI, and -death. Thus, given 
the higher complication rate, the PR strategy may be best tailored to 
patients with overwhelming clot burden. 
ABSTRACTS 
890·43 
Activated Clotting Times and Wbole Blood Activated Partial 
Tbromboplastln Times During Coronary Intervention 
185A 
Andrew J. Carter, Roger S. Blumenthal, Sean T. Gloth, Jyostna N. Dalal, Vicki 1. 
Coombs, Jon R. Resar, Jeffrey A. Brinker. The Johns Hopkins University, 
Baltimore, MD. 
The activated clotting time is routinely used to monitor anticoagulation during 
coronary intervention while the hospital laboratory (In.) Am' guides pre and post 
procedure heparin therapy. We studied the relationships of the bedside monitored 
whole blood (WB) Am' and ACT (Hemocbron 801) and the m.. Am' in 122 
patients undergoing coronary intervention, of which 54 (44%) came to the cath lab 
with a heparin infusion. At baseline, the whole blood Am' had good correlation 
within the range of the m.. Am' (20.7-80 sec) (r=.72) while the ACI' and m.. 
Am' had only a fair correlation (r =.46). The total heparin bolus required to 
achieve an ACT >300 sec was 11,055±2,824 units. At this level of 
anticoagulation the mean WB Am' was 569±230 sec and the ACI' was 367±97 
sec. 
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The WB Am' demonstrated a strong correlation with the ACI' throughout the 
range of heparin therapy for intervention (r =.77). At the time of femoral anery 
sheath removal, the WB Am' had good correlation with the m.. AP'IT (r =.66). 
The ACI' and m.. Am' relationship was only fair (r =.33). 
Conclusion: The whole blood Am' obtained by bedside monitoring provides a 
rapid and accurate assessment of anticoagulation throughout a broad range of 
heparin dosing associated with coronary interventions. This test may be 
particularly useful because it is also applicable to monitOring lower levels of 
anticoagulation before or after the procedure. 
890·44 
Clinical Outcomes 01 Percutaneous RevllSCUlarization for Lesions in the 
Proximal Left Anterior Desaudi", Artery 
Allan O. Adelman, Eric A. Cohell and Brian P. Kimball for the CCAT 
Investigators Mount Sinai Hospital and University of Toronto, Toronto, 
Ontario, Canada 
In the Cauadian CoI'Oll8t)' Atherectomy Trial (CCAT), experienced 
interventiooa1ists from 9 COIIten rwIomized 274 patients (pis) with lesioos in the 
proximal left IIDterior desceruling artery (LAD) - 138 to directiODa! IIberectomy 
(DCA) and 136 to balloon IIDeioplasty (PTCA) - and found no significant 
differeuce in the acute or late (6 month) clinical OIltoomes of the 2 procedures. 
The mean age was 56.3 and 83 % were male. The majority (95 %) had good left 
veotricular function (ejection fnctiOD >35%), sinille vessel disease (77%), no 
prior myocardial infarction (MI) (74%) and stahle IIDlJina (57%). There was I 
(0.4%) Q wave MI and 8 pts (2.9%) required coronary artery bypass ""fling 
(CABO) durina the index bospitalization. Two pis (0.7%) UDderweot """'t 
implantation. Other complications included 10 (3.6%) non Q wave MI's, 13 
(4.7%) abrupt occlusions and 6 (2.2%) vascular injuries. Ninety-one percent 
of pis were free of an in-bospital adverse evellt (AE). During the first 6 
months of follow-up, there was 1 (0.4%) death, 2 (0.7%) Q wave MI's and 
CABO or repeat percutaneous revascularization (PR) was carried out in 13 
(4.7%) and 68 (24.8%) pis respectively. The overall major AE rate was 
< 10% (death 0.4%, Qwave MIl.l % and CABO 7.6%). In the remaining 180 
pts (66% of the total), wbo did Dot have an AE or repeal PR, 70% had Class 
III/IV Canadian Cardiovascular Society (CCS) angina at baseline; at 6 month 
follow-up, 76% were asymptomatic or bad Class I, 18% had Class n, and 6% 
Class IIIIIV angina. Eigbty-six percent of these 180 pis improved by at least 1 
angina Class with 9311i of those with severe angina (Class III/IV) at baseline 
improving to Class 1m. Of the original 274 pts, 50% and 62% were in Class 
I or 1m respectively, and 56 % improved by at least 1 angina Class following • 
single PRo Thus, PR was a safe therapeutic sltategy whicb resulted in clinical 
improvement in the majority of patients with deoovo lesions in the proximal 
LAD in CCA T. A one year follow up, whicb will be completed by Dec/93 , 
should provide additional information on the long term clinical efficacy of PR 
in this pt population. 
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891·26 
Intramural Delivery of'H-Heparin With a New Sit&-Specific Drug Delivery 
System - The D' Cadleter 
Daniel B. Fram, Joseph F. Mitchel, Adel M. Eldin, David D. Waters, 
Frederick W. Norenberg, Raymond G. McKay 
Hartford Hospital, University of Connecticut, Hartford, CT 
Current catheter·based, local drug delivery techniques are limited by the 
occurrence of vessel trauma, excessive drug loss via side branches or 
coronary ischemia. This study was designed to assess the efficacy of the D" 
catheter· a new over-the-wire, non..<Jilatation, site specific delivery device 
that allows for prolonged intramural delivery of therapeutic agents 
following balloon angioplasty. The catheter consists of a POC~, helical 
inflation coil which spirals around a tubular urethane sheath. When inflated, 
the coils abut the vessel wall and, in conjunction with the inner sheath, 
create a series of compartments that are isolated from the bloodstream. 
Drug is infused into these spaces via a separate infusion port and bathes the 
vessel wall. The expanded inner tubular sheath allows for normal antegrade 
bloodflow. The ability of this catheter to deliver 'H-heparin was assessed 
in-vivo in 12 normal porcine coronary arteries. Following dilatation with 
a conventional ballnon catheter, the D' catheter was inflated to 6 atm at the 
angioplasty site and 'H-heparin (5 /LCi/cc) was infused at O.5cc/min for 
either 60 seconds (n=3) or 15 minutes (n=5). Five to 90 minutes (min) 
following drug delivery, arteries were surgically isolated and scintillation 
counting performed. Four control arteries did not recieve heparin. 
RESULTS: In all cases, prolonged heparin delivery was possible without 
compromise of blood flow. Intramural delivery of 'H, in counts per minute, 
were: Control-300±88, I min infusion487±210, 15 min infusion-
20,932±23,595 (range-7,620~2,320). Among the 15 min specimens, 1.3% 
of the delivered heparin was present in the vessel wall 5 minutes following 
delivery and 0.2 % at 90 minutes following delivery. This represents an 
85% washout of heparin over this time period. 
CONCLUSION: Prolonged local delivery of 'H-heparin is possible with the 
D3 catheter. Washout of heparin from the vessel wall appears to be rapid 
over a 90 minute period following delivery. 
891·27 
Amphiphilic Polyurethane Coating of 
Intracoronary Stents decreases Mortality due 
to Subacute Thrombosis in a Porcine Coronary 
Model 
Ivan K. De Scheerder, Kristof Wilczek, Eric 
Verbeken, Joke Van Dorpe, Phan N. Lan, Etienne 
H. Schacht, Jan H. Piessens, Hilaire De Geest, 
U.H. Hospital Gasthuisberg, Leuven, Belgium 
Subacute thrombosis (ST) remains a significant 
complication after coronary stent placement. 
In attempt to decrease ST we studied 
amphiphilic polyurethane coated stainless 
steel slotted tube balloon expandable stents 
implanted in porcine coronary arteries. 
Fourteen stents (8 coated, 6 non-coated) were 
implanted in the LAD of 14 domestic pigs using 
a 3.0 rom balloon inflated to 6 atm. 
In the pigs with a coated stent implanted no 
acute thrombotic occlusion leading to sudden 
death occurred. In the non-coated stent group 
three pigs (50%) died respectively after 3, 4, 
and 20 hours after stent implantation due to a 
documented thrombotic occlusion. 
All remaining animals survived until the 
termination of the study, 5-6 weeks after 
stent implantation. Control angiography 
revealed patent stents in all controlled 
animals. Histopathologic examination showed 
comparable mild fibromuscular hyperplasia. 
These preliminary data suggests that 
amphiphilic polyurethane coating decreases 
acute thrombotic occlusions in a porcine 
oversized coronary stent model. 
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891·28 
Initial. Cl.tn1cal ~ of IJXal ~ Del.1wry via a R:nlE 
1Slla:n~ Qnmry 
D C Ct.rrberland, J ClrJn, D Ts:!ka::ler1s, S Arafa, A Ahsan. 
Northam Generallbsp1tal, s-effield, ~. 
lrn Transj:xrt con:mry arg1q:>lasty catreter (Caroio-Vaso.I1.ar Dynanics) 
has an 1nrer ~lasty ballcx:n and an ruter ~ ballcx:n with 
sep3!'ate 1nf1at1cn channel. lrn ruter ballcx:n has lll.Iltiple p:>reS 
~ which agent can be 1nfused locally eitrer before, ~ or 
after angicplasty with tre 1nrer ballcx:n. It 15 0.014" !!1Jl.dew1re 
c:aq:atlble, with distal. start d1aIeter 2.7F. Infus1cn flo.' rates are 
typ1Cal1y 2.5 - 6.0 ml per mlrute at 1nfus1cn pressures of 1-3 Alln. 
We mve used this catreter for arg1q:>lasty of 12 con:mry lesicns 1n 
9 pat1a1ts (8 nele, near! age 59 years), 8 with class IV~. 
Vessels involved were 6 RCA, 5 U\D and 1 lateral ve1tr1a.Uar. M;an % 
sten::s15 d1aIeters were 79 {t-/- 2O)pre, 14 ~/- 17)past. In 6les1a1s 
with angicwaph1c features of thrortlotic a:JJp:rlE!!1t, t1.s.s>.E pJ.asnin::@Fn 
activator was locally 1nfused Via tre p::>rcU'3 ballcx:n at 1 ng per ml 
per m1rute, 2 ng 1n 3 les1a1s and 5 ng 1n 3. In 3 lesims 1nfusicn 
was before, and 1n 3 after angicplasty. Systan1c a::Ei@..Ilaticn factors 
were nmsured at basel1ne, 20 mlrutes and at 1, 2 and 4 1nJrs: 
F1bt'1IX:ge1 and pJ.asnin::@Fn did rot ~ si811f'1cantly 1n arry 
patient. Arute closure CJCCl.lITed at 30 DIlWtes 1n me patient, 
prdJably due to spasn, successfully treated by repeat cx:nvent1cnal 
angicplasty. lrnre were ro otrer c:arplicat1a1s; ro evidence of 
t:hn::ntlcs15, EIItJolisn or d1ssect1cn; ro II\V(JCaI"d1al 1nfarct1cn, 
aJErgerJCy surgery or taem:lnilag1c c:arplicat1a1s. 
Local ~ delivery C01b1m::l with con:mry ang1cplasty 1n ale catreter 
15 trerefore feasible and, 1n tre IJBITler deScr1bed, awears safe. 
This approach has potential for local t:hro!toJ.ys15 1n arute con:mry 
1sc:h3an1.a, the local applicat1cn of agents 1n treatnalt or preventicn 
of arute closure, and, eventually, resten::s15. 
891·29 
Potential Role or Therapeutic Ultrasound in Coronary 
Angioplasty (ruSCA) 
J Gunn, D C Cumberland, R J Siegel, C Wales, R K Myler, 
A Ahsan, D Tsikaderis, R Bowes, S Campbell, D Oakley. 
Northern General Hospital, Sheffield, England. 
Low frequency (20 kHz) ultrasound energy (US) increases 
arterial compliance, causes vaso-relaxation and 
dissolves thrombus with little or no damage to normal 
vessel wall. During percutaneous coronary angioplasty 
in 23 patients, US was delivered for mean 493 (138-890) 
seconds by a 4.6F US catheter (Baxter) with 1.7 mm ball 
tip over 0.014" wire, followed by balloon d1latation in 
every case. The mean pressure needed for full balloon 
inflation (stenosis resolution pressure - SRP) was 2.7 
atmospheres (Atm); in the last 5 cases the mean SRP was 
1.8 Atm. Two patients had had previous failed PTCA 
because of resistant stenoses - dissection had occurred 
at 10 Atm in one, and inadequate result was achieved 
after 15 Atm in the other; after US, SRP was 5.5 Atm 
and 3 Atm respectively. In one patient severe spasm 
did not respond to 700 ug intra-coronary nitrate but 
was completely relieved by 30 seconds US. One patient 
had fresh thrombus proximal to a chronic severe 
stenosis; complete patency was achieved after 10 minutes 
US exposure followed by balloon dilatation at 1.5 Atm. 
Conclusions 
This experience suggests that TUSCA will be useful in: 
a) increasing arterial compliance, with implications for 
pressure-resistant stenoses and possibly other so 
called adverse lesions; b) relieVing otherwise 
refractory coronary spasm during interventional 
procedures; and c) dissolving thrombus. 
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891·30 
Prevention orStent Subacute Thrombosis by Segmented Polyurethaneurea•
Polyethylene Oxide - Heparin Coating in Ibe Rabbit Carotid 
Sushi! Sheth, Ki Dong Park, Vishva Dev, Harvey Jacobs, Sung Wan Kim, 
Tom Lambert, James S. Forrester, Frank Utvack, Neal Eigler. Cedars-Sinai 
Medical Center, Los Angeles, CA and the University of Utah, Salt Lake 
City, UT 
Our goals were to develop a rabbit model of stent subacute thrombosis and 
to evaluate tbe efficacy of a polymer stent coating witb covalently bound 
heparin, for prevention. Bare metal oitinol stents were implanted by 
expansion with a 3.0 mm PTCA balloon in the carotid artery of 10 NZW 
rabbits. Systemic antiplatelet and ant4hrombotic tberapy was withheld. 
Animals were sacrificed at 24, 72 and 96 hours. Only tbe 96 hour group 
consistently developed occlusive or subocclusive thrombosis. Nitinol stents 
were coated with heparin (0.28 mcg/em') linked onto the surface of soluble 
polymer chains of segmented polyurethaneurea (SPUU) by polyethylene 
oxide (PEO) as a bydrophilic spacer group. Nitinol stenls coated with 
SPUU-PEO-Heparin (n=4) and bare metal oitinol stents (n=4) were 
implanted in tbe carotid arteries of 8 NZW rabbits. At 96 bours, both 
carotids were exposed, resting blood flow was measured by a transit time 
perivascular flow probe and tbe vessels were excised. The amount of 
tbrombus present was assessed by a semiquantitative grading scale: I, 
minimal tbrombus not encroacbing on tbe lumen; II, lumen encroachm~nt; 
1Il, subocclusive tbrombus; IV, occlusive thrombus. Thrombosis was "lso 
quantified by tbe dry weight of the thrombus on eacb stent. Results: 
Carotid Thrombus Thrombu-s --
Flow Grade Weight 
(ml/min) lIlorlV (mg) 
Bare Stent 7.5±8.8* 3/4 24.5+ 10.1 
Heparin Stent 12.5±1O.8 0/4 7.8+5.3 
p-value •. 025 vs control .07 .025 
Conclusion: The 96 hour rabbit carotid model yields a high frequency of 
occlusive and subocclusive subacute thrombosis. Nitinol stents coated with 
SPUU-PEO-Heparin accumulate less thrombus and tend to bave better 
patency in a rabbit model of subacute thrombosis. 
891-31 
TbermallPerfusion Balloon Angioplasty: Lower Temper.tore Efficacy in 
an In-Vivo Atherosclerotic Rabbit Model 
Brigitta C. Brott, Stepben C. Culp, James P. Zidar, Marino Labinaz, William 
B. Hillegass, Michael H. Sketch, Jr., .Harry R. Phillips, ·Richard S. Stack, 
Duke Uoiversity, Durham, NC 
Elastic recoil plays a significant role in early abrupt closure and 
restenosis. Radiofrequency therma1Iperl'usion balloon angiop1asty (TPBA) 
allows prolonged, controlled temperature inflations. Previous studies have 
demonstrated that TPBA at 6O·C and 80·C produces less elastic recoil than 
nonthermal (NT) control, without additional benefit found with temperature 
elevation to 80·C. To assess the lower temperature limit of efficacy, TPBA was 
performed at 50·C for I, 5, and 10 minutes in atherosclerotic rabbit iliac 
arteries (n=6 at each time interval, total n=18). This was compared with NT 
controls (total n=18) and rabbits treated with 6O·C TPBA (total n=21) at the 
same time intervals. Quantitative angiography was performed on angiograrns 
taken before, during, and after intervention to determine the degree of elastic 
recoil (inflated balloon size minus post minimallumina1 diameter). 
The application of 50· was a significant predictor of a reduction in 
elastic recoil in a multivariate regression analysis (p<O.OOI). Increasing the 
temperature to 6O·C did not provide any additional benefit. Time and the 
presence of angiographic dissections were not significant predictors of 
reduction in elastic recoil. 
Temperature 
I Minute 
1.07 ± 0.17 
0.76 ±0.32 
0.58± 0.26 
ELASTIC RECOIL 
(mm±S.D.) 
Time Interval 
5 Minutes 
1.13 ± 0.32 
0.67 ±0.16 
0.77 ± 0.20 
10 Minutes 
1.00 ± 0.49 
0.65 ±0.34 
0.64 ±0.34 
Conclusion: Temperature rather than duration of inflation appears to 
be the most important factor in reducing elastic recoil. Inflation to 50·C is as 
effective as 60·C. 
ABSTRACTS 
891·32 
In ·Vivo Local Delivery of Heparin to Coronary Arteries with. 
Microporous Infusion Catheter. 
Clifford N. Thomas, Keith A. Robinson, Gustavo D, Cipolla, 
*Melissa Jones, Spencer B. King III, Neal A. Scott. Division of 
Cardiology, Emory University School of Medicine, Atlanta, GA. 
187A 
Arterial thrombosis has been implicated as a major complication 
associated with PTCA. Data from experimental models have 
shown that extremely high doses of heparin can prevent thrombus 
formation, however, the potential for hemorrhagic complications 
may be prohibitive. Local delivery of heparin to an arterial site 
could potentially provide high local concentrations without 
systemic side effects. To determine the feasibility of local delivery 
of heparin with a microporous infusion balloon catheter (Mlq, 3H_ 
heparin was dissolved in a cold heparin solution (1,<XXJ U/mI) 
(Specific Activity: 77O,<XXJ cpm/mI). The MIC was placed in either 
the left anterior descending or circumflex coronary arteries of 
anesthetized pigs (n = 10). One mI of heparin solution was infused 
at a balloon pressure of 5 ATM (balloon/artery ratio = 1.37:! 0.04: 
1.0). The animal was killed within 60 minutes and the treated 
coronary segment was dissected and counted. The right coronary 
artery was used as a control The arteries treated with the MIC 
had an average of 0.6 ± 0.2 % of the infused heparin dose. Control 
arteries had 0.Q1 % of the infused heparin. When arteries were 
sampled at time points less than 60 minutes (0-10 min, 10-20 min or 
20-60 min) there was no Significant difference from the one hour 
value. We conclude that local delivery of heparin to coronary 
arteries can be performed with the MIC. The efficiency of transfer 
of the heparin to a coronary artery in vivo is less than 1 %. Heparin 
persists for up to 1 hour after delivery. 
891·33 
Intramural Delivery of Marker Agent in Ex Vivo and In Vivo 
Models Using A Novel Drug Delivery Sleeve. 
*Aaron V. Kaplan, James Kermode, Gordon Grant, Enrique Klein, 
James Vetter, Tomoaki Hinohara, John B. Simpson. Localmed, Inc, 
Sunnyvale, CA and Sequoia Hospital, Redwood City, CA. 
The Localmed Infusion Sleeve (IS) is a multi-lumen array with distal 
micro perforations designed to deliver agent into the anerial wall at 
the site of PTCA injury. Prior to the procedure, the IS is loaded onto 
a standard dilatation catheter (DC). Following lesion dilatation, the 
IS is tracked over the DC, aligning the micro perforations with the 
balloon. The balloon is reinflated bringing the array into contact 
with the anerial wall. Drug delivery is performed by a computer 
driven pump. Delivery of Horseradish Peroxidase (HRP) was 
studied in a freshly explanted porcine hean model. The left anterior 
descending is isolated and perfused at physiologic pressures. The 
anerial diameter is measured with intravascular ultrasound. Mock 
PTCA is performed (- \0% over-stretch). The IS is aligned with the 
balloon and reinflated to the same pressure. HRP (2.5 m1) was 
delivered at specific pressures. The aneries are fixed and evaluated 
using standard histologic technique. Sequential anerial segments 
were evaluated in blinded fashion, results are reponed as percent of 
cross sectional area stained: 
Proximal Pressure (psi) 50 100 150 200 
n 10 24 8 5 
% ±SE 0.7±O.5 4.2±O.9 10.9±4.0 36.7±8.7 
P (compared to 50) 0.01 0.04 0.01 
The IS was then evaluated in an in vivo canine coronary model. 
With an IS loaded onto a standard DC through a 9 Fr guide, mock 
PTCA was performed after which FlTC Heparin (tHEP) was 
delivered. Animals were sacrificed 2 hrs after delivery and the 
aneries harvested. Compared to control, tHEP treated segments 
demonstrated high activity colocaIizing with SMC nuclei as well as 
less activity in the interstitium. We Conclude: 1) Agent delivery via 
the IS IS pressure dependent, 2) The IS is compatible with standard 
PTCA equipment. 3) Evidence offHEP delivery persists at least 2 
hrs after delivery. 
188A ABSTRACfS 
891·34 
Feasabllity of Local Drug Applikation with a new Catheter 
Peter Gonschior, Stefan Dei!, Georg R. Maier, 'Marc Dellian,+Alwin 
E. Goetz, Berthold Hofling; Med. Dept.!, Klinikum GroBhadem;' Inst. 
for Surg. Research;+Depl. of Anesthesia, Univers~y of Munich, 
FRG 
A new local drug delivery (lDD) device, a 4.3F flexible catheter ~h 
six 25011 (31 gal needles, which can be extended laterally into 
vascular tissue for drug depos~ion, is described. In five pigs, nine 
carotid arteries were injected with a fluorescent indicator (Photofrin 
lIT" , [QlT Inc., Vancouver],lto 4.5 mg) for two minutes. local con•
centrations in shock frozen segments were compared using semi•
quant~ative measurement of fluorescence, referring to a standard 
representing the fluorescence reached by systemic dosage of 2.5 
mg/kg bodyweighl. The vessels were expianted 15, 30 and 60 
minutes after lDD. Depos~s in periadventnial tissue showed en•
hancement in the lamina elastica extema ~h subsequent diffusion 
in media structures, wnh max. fluorescence after 30 minutes. Auto•
fluorescence was subtracted 
TissuefTime 15min 30 min 60 min 
Intima [1] 1,04 + 0,45 3,22 + 1,10 0,38 ±O,06 
Media [2) 1,48+1,3 1,08 ± 0,23 0,55 ±O,23 
Lamina elastica externa [3) 2,09 ± 1,5 5,07±1,37 4,68±O,91 
Percent. of fluoresc. area [4) 35%±9% 44%±1% 31%±5% 
Fluorescence of this area [5] 1,75±0,33 2,19±0,34 1,75 ± 0,17 
All values computed as averaged medians and, except [4] as ratIO 
of true greyvalue/standard. P< 0.05 for a) [1) vs [2], [2) vs [3] in 
30min group; b) [1] and [2] vs [3] in 60 min group; c) 15 min vs 30 
and 60 min, 30 min vs 60 min in group [1] 
These experiments demonstrate that high-dose lDD is feasible and 
allows to apply toxic agents or gene designed drugs selectively into 
or around the vessel wall ~hout systemic side effects. 
891·35 
The Porous Balloon Catheter Deposits Gold Microparticle Suspension 
Primarily at the Site of Medial Fracture in Balloon-dilated Pie 
Coronary Arteries 
Keith A. Robinson, Ron Waksman, Clifford Thomas, Steven R. Sigman, 
Gustavo D. Cipolla, Barbara Britt, Edward C. Santoian, Norman 
T~Spencer B. King III, Emory University School of Medicine, 
Atlanta, GA, and Deborah Heart and Lung Center, Browns Mills, NJ 
Local delivery of drugs intended to inhibit the restenosis·like response to 
arterial injury in animal models, using the porous balloon (PB) catheter, 
bas been limited due in part to inefficient acute transfer, as well as 
inadequate long-term retention, of active substances as aqueous solutions. 
Infusion of compounds in microparticle fonn, or bound to inert 
microparticle carriers, bas potential to increase efficiency and provide 
sustained release. We previously examined the acute deposition pattern of 
colloidal gold microparticles (30 run) in oonna1 swine coronary arteries 
using the PB. In this study we analyzed transfer of microparticles to sites 
of balloon catheter overstretch injury in swine coronaries. In 7 pigs, 
balloon overstretch was perfonned in the LAD and LCX arteries, 
followed by infusion of 2 mI colloidal gold suspension at 4·5 atms driving 
pressure using the PB (USCI Inc.). Samples were fixed 5·15 min post by 
perfusion with buffered fonna1in at 110 mm Hg pressure. 
Analysis of arterial cross sections by light microscopy, using silver 
enhancement to visualize gold deposits, revealed accumulation primarily 
at the dissected ends of the tunica media, dissection planes between the 
media and adventitia, and in the adventitia and perivascular space 
adjacent to the injury. Irregular distribution at the luminal surface was 
also seen. 
Conclusions: PB infusion of gold microparticu1ate suspension at the site 
of balloon injury in swine coronaries resUlts in deposition at and near the 
medial fracture. Since these are the areas of cellular migratory and 
proliferative response, adsorption of active substances to the 
microparticles may prove an effective local delivery strategy. 
JACC February 1994:1A-484A 
891·36 
Does High Intensity, Low Frequency Catheter Delivered 
mtrasound Induce Vasodilation In Vivo! 
-Wolfgang Steffen, Huai Luo, Peter Gaines, David C. Cumberland, Gerald 
Maurer, Henry Nita,Michael C. Fishbein, ·Robert J Siegel, Cedars Sinai 
Medical Center, Los Angeles, CA 
High intensity, low frequency ultrasound (19.5 kHz) bas been shown to 
induce vasodilation in whole mounted rabbit aortas in vitro. To evaluate the 
vasomotor behavior after ultrasound in vivo, we studied the vasomotor 
behavior after ultrasound exposure in a) 8 angiographicalJy oonna1 human 
femoropoplitcal arterial sites proximal to stenoses or occlusions in 8 
patients undergoing ultrasound angioplasty for peripheral vascular disease, 
b) 8 oonna1 canine coronary arteries after ultrasound exposure and c) 8 
oonna1 canine coronary arteries which served as controls and were only 
exposed to multiple angiograms. Ultrasound energy of 25 wattslcm2 
measured at the transducer was administered via a 7 F peripheral 
ultrasound catheter (length 88 em) in the human cases and with a 4.6F 
coronary ultrasound catheter (length 145 cm) in the canine coronary cases. 
Pre- and postprocedural arterial diameter was analyzed by two observers 
using a computer edge detection program. Analysis of vessel segment 
diameter revealed a high intra- (p < 0.0 I) and interobserver (p<O. 0 I) 
agreement. After ultrasound mean vessel diameter increased by 14.3 % (p< 
0.01) in the human femoropolitcal arteries and by 20.5 % in the canine 
coronaries (p < 0.01). 
site pre·USD (mm) post·USD (mm) o/orl:hange 
human 3.2 ± 0.3 3.6 ± 0.5 14.3 ± 2.9 
canine 2.3 ± 0.3 2.8 ± 0.3 20.5 ± 2.3 
control 2.4 ± 0.3 2.5 ± 0.5 4.2 ± 0.2 
Histology of the canine coronary arteries revealed no ultrasound mediated, 
arterial injury.Condusion:Intravascular therapeutic ultrasound induces 
vasodilation in peripheral and coronary arteries in vivo. This effect is 
unique as most angioplasty devices have the potential to cause vasospasm. 
891·37 
Receptor-aulllted IIpoIome uptake Into vaacular IIIIOCIIh ...... OIIIL 
A simple effective drug delivery canf&r. 
Roxanne Male, Melna Ren, Thomal Lamber, Peter Blndh, CeIHomIa 
Institute of Technology, Pasadena and Cedar-Slnal Medical Center, Loa 
Angeles, CA. 
Use of Dposomes al carrllII1I In local vascular delivery ayatema II 
Hmlted by their Ilow and minimal uptake by YBlCular amooth mUlCle 
cella (VSMC). Hypothesll: addHion of amlnomannose to the llposomes 
eurface may Induce receptor interaction and thereby enhance uptake. 
Methods: dlatearoylph08phatldylchollne (DSPC):choI8IttIRI1 (2:1 mole 
mlo) Ilposomes(L) and DSPC: cholesterol:amlnomannose{2:0.98:0.04) 
(AM) radiolabeled wHh 5 uCI 3H-cholesterylhaxadecyl ether ... 
prepared and labeled with the fluorescent probe octadecyl rhodamine. 
Confluent nd aortic VSMC were Incubated with L or AM llposomes for 
5, 30 and 60 minutes et 37oC. The uptake of IIpOIOmes W8I m.auracI 
by scintillation counting and reported below aa cpm per meg cell 
protein. Florescence mlcroacopy and autoradiography were performed 
to qualitatively detect the alaoclatlon of the llposomes with the VSMC. 
ResuHs: (n=3) uptake of labeled llposomes by VSMC In cpm/mcg 
protein 
0' 5' 30' 60' 
L 1.35 3.83 4.22 6.51 
AM 1.22 25.17 40.35 52.53 
Fluorescence microscopy conflnned binding of the AM to the VSMC 
and autoradiography confirmed the Intracellular localization of the 
llposome lipid within the VSMC. Conclullon: The addition of 
amlnomannose to the llposome lurface greatly enhanced llpoaome 
uptake by VSMC posalbly by Interaction with Insulin-like growth factor· 
2 receptora. We propose that thll ayatem might be useful al a canter In 
dellvertng drugllocally Into VSMC. 
JACC February 1994:1A-484A 
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892-1 
The Effect of Internal Mammary Artery Grafting on Basal Blood Flow 
In the Left Anterior Descending Coronary Artery 
Antoinette Kenny, Leonard M. Shapiro, Papworth Hospital, Cambridge, 
UK. 
Studies have shown that flow in intemal mammary artery (IMA) grafts 
may be transiently reduced post-operatively but the effect on flow in the 
recipient LAD has not been studied. The distal LAD may be imaged and 
blood flow veloc~ies recorded by transthoracic Doppler u~rasound. This 
technique was used to determine the time course and magn~ude of 
improvement in besal recipient LAD flow following IMA grafting. 
Six male patients, mean age 63 years (57 to 66), undergoing 
elective IMA grafting to the LAD were studied the day before, and at 5 
days and 18 months post-operatively. LAD diameter and flow veloc~ies 
were recorded and total flow calculated from: cross sectional area x 
velocity time integral x heart rate. 
Blood flow patterns in the recipient LAD were diastolic 
predominant and directed towards the apex. A signnicant increase in 
heart rate reflecting w~hdrawal of B blockers was observed post•
operatively. Total LAD flow was signnicantly increased 18 months 
following grafting, p<0.05, but was not a~ered in the early post-operative 
period. LAD diameter and diastolic velocities were unchanged but the 
LAD systolic flow co~nent was increased at 18 months. 
Heart rate 
LAD flow mVmin 
Peak systolic veloc~ cmls 
Mean systolic velocity cmls 
Peak diastolic veloc~ cmls 
Mean diastolic velocity cmls 
LAD diameter mm 
fu 
59±7 
55±6 
28±7 
23±6 
78±9 
54±9 
1.8± 0.1 
~ 
86±5t 
52±6 
26± 10 
21±7 
71± 10 
50±8 
1.8±0.1 
18 months 
85±4t 
74± 6' 
40±6' 
32 ± 10' 
n±10 
49±7 
1.8 ± 0.07 
t p<O.Q1 'p<O.05 
These data suggest thatlMA grafting may not increase basal LAD 
flow in the early post-operative period, but improvements occur w~h time 
which reflected an increase in the systolic flow component. This may 
relate to 'growth' of the IMA. The noninvasive techniques described 
should find application in the follow-up of IMA grafts. 
892-2 
Graft AngIoplasty Versus Multiple Reoperatlve Aoriocoronary 
8ypa!18 
Tej K. Kaul, Barry L. Fields, David A. Wyatt, Christopher R. Jones, 
Donald R. Kahn for Princeton·Baptist Medical Center, Birmingham, AL 
Results of saphenous vein graft. angioplasty (graft PTCA) VB. multiple 
CABG reoperation for recurrent lesions after 1st CABG reoperation were 
retrospectively analyzed. During last 6 yean 125 patients (Pta) had 150 
graft PTCA and 90 Pta had 96 2nd or 3rd reop CABG. PTCA group 
differed from CABG group in number of Pta z.70 years (40 VB 23, NS), 
anatable angina (69 VB. 33, p<0.02), a LVEF;5.30'l. (42 VB. 18 NS), interval 
from 1st reoperation (3.9..=.0.2 VB. 10.±.0.05 years, P < 0.001) & vessels 
revaacularized (1.±.0.6 VB. 3.±.0.3, p< 0.001). 
~ GRAFT PTCA 2ND OR 3RD REOP Il.:5.. 
Hospital death5 nil 4(4.4%) 0.03 
Emergency CABG 14(11%) nil 0.001 
Early PTCA 8(6.5%) 1(1.15) 0.01 
Late CABO 21(17%) 5(5.5%) 0.02 
Late PTCA 17(14%) 2(2.2%) 0.02 
(Early ;5. 1 month, l2.te Z. 1 month) 
Actuarial 6 year survival and cardiac events (death,myocardial 
infarction,PTCA.CABG) free survival after ~ PTCA were 73% & 45% 
versus 76'l. & 48% after reoperative CABG (NS). CONCLUSIONS: Graft 
PTCA is a useful technique in IIl8DIIging selected high risk. patients with 
less severe, more localized and more recent recurrent graft. stenosis. In 
lOme cases it may allow an optimal timing for high risk. 2nd or 3rd reop 
CABG. 
ABSTRACTS 
892-3 
The Use of the Internal Thoracic Artery In Patients with Aortic 
Stenosis and Hypertrophied Hearts 
Sary F. Aranki, Francesco Santini, Robert J. Rizzo, David H. 
Adams, *Gregory S. Couper, *John J. Collins, Jr., Nancy M. 
IGnchla, *Lawrence H. Cohn, Brigham and Women's Hospital, 
Boston, MA 
The use of the ITA in patients with hypertrophied hearts is 
not routinely practiced because of the concerns about its flow 
adequacy for such hearts. To determine the impact of ITA use on 
survival in patients with aortic stenosis (AS) and coronary artery 
disease (CAD) we retrospectively analyzed 296 patients who 
underwent aortic valve replacement and myocardial 
revascularization (A VR & CABG) over a 7 year period. In group 
I, (n=188) only vein grafts were used. In group n, (n=108) the 
ITA was used with or without vein grafts. Mean age for group I 
was 77.5 vs 76.6 years for group n (p=O.l). There were 80 
females in group 1(42%) vs 44 (40%) for group n, and 69 (37%) 
patients in NYHA FeIV in group I vs 27 (25%) in group n 
(p=0.025). There was no significant difference in the extent of 
CAD, ejection fraction, valve gradient, valve area, preoperative 
arrhythmias, number of grafts, ischemia time, or bypass time. 
There was no difference in early survival between the two groups. 
Multivariate logistic regression analysis identified bypass time 
(odds ratio =1.12, p=0.012, for every 10 minutes) as the only 
predictor of operative death. Five year survival was 82 % ± 4 for 
group I vs 79% ± 8 for group n (p=0.86). 
The use of the ITA in patients with AS does not seem to 
have a negative impact on early or 5-year survival, suggesting that 
the ITA flow is as adequate as vein grafts to meet the demands of 
hypertrophied hearts. 
892-4 
Gender ha. no Btteet on Cour.e or outeo.e 
ot Patient. Requiring Baergeney surgery tor 
Failed PTCA, 
Jyotsna Dalal, WUllam Baumgartner, VIcki Coombs, Jon Reser, Jeffrey 
Brinker 
Johns Hopkins Medical InstitutIons, Baltimore, Maryland 
In order to determine whether gender differenca Influences the 
outcome of patients requIring emergency CAB (ECAB) for faDed 
PTCA. we compared the hospital course and subsequent foIlowup 
(mean 22± 12 months) 01 52 consecutive patients requiring ECAB 
after faRed PTCA encountered from 7/89-12/92 (1.6% of total 3304 
PTCA's). 
WQmlln (N:22l Mm! !t::I:a!!l .e 
Age 61 55 NS 
IASP 3 (14%) 9 (30%) NS 
Reperfuslon cath 7 (32%) 11 (37%) NS 
IMA use 15 (68%) 19 (63%) NS 
Vessels compromised 
LAD 9(41%) 18 (60%) NS 
RCA 9 (41%) 6 (20%) NS 
LeX 4 (18%) 6 (20%) NS 
Number of grafts 2.18 2.3 NS 
MI 6 (27%) 9 (30%) NS 
Mortal~ (hosp.) 1 (5%) 2 (7%) NS 
Event free survival 17/21 (81%) 24/28 (86%) NS 
(no death, MI, re-PTCA, or re-CAB) 
Emergency surgery Is required In less than 2% of all patients under 
going coronary Intervention; multiple grafts and a high use of IMA are 
common and event free survival rates are high for both men and 
women. Gender does not influence the clinical course ()( outcome of 
patients recaMng ECAB. 
189A 
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892·5 
Overestimation or the Risk or Mortality {onowing Coronary Artery 
Bypass Surgery May Result in Inappropriate Denial of 
Revascularization in Patients Older tban 70. 
Joel Kupfer, Sharon Nessim, Jack Matloff, and Steve Khan. Cedars-Sinai 
Medical Center Los Angeles 
Metbods for evaluating and predicting outcomes following coronary 
bypass surgery are increasingly being used to assess the benefits of this 
costly procedure. Limiting access to procedures in high risk patients is 
one way to reduce health care costs. In one recent model (Parsonnet V., 
et.a1 Circ. 1989, 79:suppl 1:3-11), preoperative risk factors are assigned a 
weighted score. However, the performance of this model in predicting 
mortality for elderly patients is unknown. We therefore, evaluated the 
performance of this model in /8/8 consecutive patients over the age of 
70, undergoing isolated CABG at our institution between 1982 and 1992. 
Study patients were then grouped according to the calculated Parsonnet 
score (0-4,5-9,\o-14,15-19,~20), and in-hospital mortality rates calculated 
and compared to those reported by Parsonnet, et.a1. Risk factors, not 
recorded in our database contributed no points, reducing the estimated 
risk of some patients. This would be expected to result in higher observed 
mortality rates (M) for these subgroups than would be predicted by the 
Parsonnet model. 
Score N M. Predicted· M. Observed S.E. 95%CI 
5-9 251 5.0% 0.4% 0.4 0-1.2% 
10-14 694 9.0% 2.6% 0.6 1.4-3.8% 
15-19 455 17.0% 7.9% 1.3 5.4-10.4% 
>20 418 31.0% 9.6% 1.4 6.7-12.3% 
F;;-r each subgroup, the Parsonnet model" significantly overestimated the 
risk of early mortality. Moreover, at least 52% of patients had mortality 
rates below 3%. The widespread application of the Parsonnet model may 
result in many elderly patients being advised against coronary 
revascularization. 
892·6 
Long-Tenn Effects of Single Lung Transplantation on Right 
Ventricular Remodeling 
Liem Du, John H. Calhoon, Steven R. Bailey, Theresa A. Cronin, 
J. Kent Trinkle, Miguel Zabalgoitia. The University of Texas 
Health Science Center, San Antonio, TX 
Long-term transthoracic echocardiographic (echo) results of 
single lung transplantation (SL T) on right ventricular (RV) 
structure and function haVe been hampered because of the limited 
number of SLT series with 2.12·month follow-up and also because 
of the limited good-quality echo pre- and post-SLT. Of the 46 
SLT pts who have completed 2.12 months (mos) follow-up in our 
institution, 28 (61 %) had satisfactory serial echo studies for 
analysis. Echo data included: RV area at end-diastole (RVAd) 
and at end-systole (RVAs), RV fractional area change (RVFAc), 
RV freewall thickness (RVTh), and interventricular septal motion. 
Although all standard precordial views were attempted in all pts, 
data were obtained from the apical and subcostal windows; 
parasternal short and long axes were satisfactory in 5 (18 %) of 
these pts. Comparisons were pre-SLT, 3-6 mos, and 2.12 mos 
post-SLT. (* p <0.001 vs preop) 
RVAd(cm') RVAs(cm') RVFAc(%) RVTh(mm) 
Pre·SLT 21.3±6.0 14.3±4.4 33±3 92±6 
3-6 mos 16.1±5.1* 9.2±2.9* 43±6* 89±7 
> 12 mos 16.0±4.7* 8.1±2.2* 49±6* 69±7* 
Paradoxical interventricular septal motion was noted in 5 pts pre•
SLT and in none ~.12 mos. Thus, long-term SLT alters RV 
remodeling toward normality by a) decreasing RV areas, b) 
decreasing RV hypertrophy and c) normalizing interventricular 
septal motion. Successful SLT results in significant improvement 
in RV systolic function which persists for at least I yr follow-up. 
lACC February 1994:1A-484A 
892·7 
Results of the Maze Procedure in Patients Undergoing Mitral 
Valve Surgery. 
Francesco Alessandrini. Pietro Santarelli, Faustino Pennestri, 
Antonio M. Calafiore, Nicola Maddestra, Francesco Loperfido, 
Antonella Lombardo, Fulvio BelloOO, Cecilia Marchetti, Sandro 
Bartoccioni, Gianfederico Possati, Depts. of Cardiology and 
Cardiac Surgery, Catholic University, Rome and University of 
Chieti. Italy 
After mitral (M) valve (V) surgery (5), restoration of sinus 
rhythm in patients (pts) with chronic atrial (AI fibrillation (fib) is 
desirable but often impossible. The Maze procedure (MP) has 
been successfully used to eliminate Afib and preserve A 
contraction in pts with nearly normal A dimensions. Its role in pts 
with chronic Afib and dilated atria secondary to MV disease is not 
known. The antiarrhythmic efficacy and the effects on A 
contraction of the MP were studied in 12 pts (8 males, mean age: 
51:!:7 years) with chronic Afib (duration: 1 to 4 years) undergoing 
MVS. Doppler transesophageal echocardiography was performed 
in all pts before MVS and at follow-up (mean: 3.1:!:0.2 months). 
Preoperative left A volume was 129;!:42 ml. Doppler parameters 
obtained at follow-up included: 1) MV and tricuspid (T) V a·wave 
flow velocity (VEL); 2) right and left A filling fraction (FF) (a-wave 
time velOCity integral/diastolic time velocity integral); 3) pulmonary 
vein and hepatic vein A systole-related reversal flow. 
Results: At follow up, 8 pts (67%) were in sinus rhythm (1 had an 
episode ot paroxysmal Afib) and 4 in Afib or flutter (all with 
preoperative left A volume >140 ml). All 8 pts in sinus rhythm 
showed good Doppler representation ot A contraction (mean MV A 
VEL: 57;!:33 em/sec and TV A VEL: 48;!:39 cm/sec; mean right and 
left AFF: 48% and 27% respectively; clear evidence of hepatiC and 
pulmonary vein A systole-related reversal flow). 
Conclusions: in pts undergoing MVS, the MP may be effective in 
restoring sinus rhythm and atrial contraction. Failures might be 
expected in pts with markedly dilated atria. 
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893·8 
Pericerdial Tube Unlfocalization in Patients with Pulrnonlry Atre.iI. 
Ventricullr Septal Defect II1d Multiple Aortopulmonlry Collateral. 
Alon S. Aharon, Hillelllks, Lester Pennut, Alvaro Galindo, Josephine 
Isabel-Jones, Peter Grant, Davis Drinkwater, Jay Jarmakani, 
UCLA Medical Center LA CA. 
Unifocalization of multiple aortopulmonary collaterals may allow 
biventricular repair for patients with pulmonary Itresia and ventricular 
septal defect. Previous techniques with synthetic grafts for multiple 
collaterals were not always .uccessful. We have used autologous 
pericardium to create a tube with anastomosis of multiple collateral 
vessels in 18 patients. A total of 21 pericardial tube unlfocalizations 
were performed with a mean of 2.7 vessels unifocalized per operative 
procedure. There were 12 unilateral and 3 bilateral pericardial tube 
unifocalizations. Three patients underwent unifocalization with a large 
Gortex conduit on the contralateral side. Mean ages were 6.9 years 
lrange; 0.8-26.5) for the first unifocalization and 12.1 years lrange; 
5.4-26.9) for the second unifocalization. There was no early mortality, 
late mortality was 1118 l6%), and there was 1 postoperative 
anastomotic stenosis lmean follow up 2.6 years). To date 6 patients 
lmean age 15 years, range, 4.2-27.2 years) have undergone definitive 
repair. The mean RV/LV pressure ratio measured intraoperatively 
following complete repair was 0.45 lrange; 0.33-0.52). There was 1 
early death l17%), no late deaths, and 1 patient underwent heart-lung 
transplantation 3.3 years after definitive repair. Conclusion; 
Pericardial tube unifocalization facilitates anastomosis of multiple 
collaterals to a single adult sized conduit allowing biventricular repair in 
selected patients. 
lACC February 1994:1A-484A 
893·61 
Bidirectional Glenn Procedure In PatientJ Under Four Months Of Age 
Richard D. Mainwaring, 10hn I. Lamberti, Thomas L. Caner, Cbildn:n's 
Hospital, San Diego, CA 
The bidirectional Glenn Procedure (BG) is utilized in the 
management of patients with single ventricle congenital heart defects. It bas 
yet to be determined what the lower age limits will be for this procedure. The 
present study SIIIDIII3rizes our experience with the BG in patients under the 
age of 4 months. 
In the past five years, we have performed a BG in 13 patients less 
than 4 months old (range 7-IS weeks). Five of the 13 patients bad undergone 
a previous palliative procedure (2 shunts, 3 PA bands). Concomitant 
procedures were performed in 10 of the 13 patients [Norwood (n=3), Damus 
(n=2), Bilateral SVC connection (n=3), VSD enlargement (n=I), LPA repair 
(n=I»). 
Results: There were DO operative deaths in this series. One patient bad 
excessive hypoxemia and required takedown of the BG and insertion of a 
shunt. 10 patients (77%) are alive and well with an average follow-up of 12 
months, and 3 have undergone completion Fontan. There were 3 late deaths 
[pneumonia (n=I), cardiomyopathy (n=I), operative death at Fontan (n=I») 
all of which were unrelated to BG. 
The present study indicates that the BG is applicable to selected 
patients under the age of 4 months. Possible advantages of this approach 
include the early elimination of pressure and volume overload and the 
reduction in number of surgical procedures required to achieve Fontan 
physiology. 
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893·63 
An'bytlllll1a. 1D Infant. IUl4 ChU4raD After FOIltan 
Operation 
Sandra K Tice, Kyung J Chung, Stuart W Jamieson, 
John J Lamberti; 
University of California and Childrens Hospital, 
San Diego, California 
From Nov. 1979 to Oct. 1992, 81 pts underwent 
modified Fontan operation with diagnoses: tricuspid 
atresia (34), pulmonary atresia with intact VS (13), 
single RV (7), double outlet RV (B) and miscellaneous 
category (19). Ages ranged from 0.9 to 18.8 yrs (mean 
4.2). Eight pts were <2 yrs, 46 were 2 to 4 yrs and 27 
were >4 yrs. Surgical techniques were direct right 
atrium (RA) to pulmonary artery {PAl connection (C) in 
28 (8 had cavo-p C), RA to PA C with intra-atrial 
baffle in 36 (22 had cavo-p C), RA to RV C in 5, 
fenestrated Fontan in 4 and extracardiac conduit in B. 
Early postop arrhythmia (A) occurred in 44 (57%) of 
77 pts who were in sinus rhythm (NSR) preop. Junc•
tional tachycardia was present in 20 of 44 pts and 
was fatal in 4. Accelerated J rhythm occurred in 17 
and was well tolerated. Supraventricular tachycardia 
(SVT) occurred in 5: 2 converted to NSR spontaneously, 
2 required procainamide and I had cardioversion. One 
with 2° heart block (HB) converted to NSR and 1 with 3° 
HB required permanent pacemaker. At discharge, 18% 
had arrhythmias. Follow up data was available in 71 pts 
(mean 3.1 yrs, range 1 month to 12.8 yrs). Late A (>30 
days) occurred in 24 (34%): Sick sinus syndrome was in 
18 (25%), 12 of which required permanent pacemaker. 
Five had SVT. Multiple regression revealed time of 
follow up (p=0.002) and presence of A at time of 
discharge (p=0.003) to be correlated with late A. 
Conclusions: Postop arrhythmias are common after 
the Fontan operation with preop variables unpre•
dictive of outcome. Refractory junctional tachycardia 
is associated with early death. Late arrhythmias 
increase in frequency as follow up time increases with 
sick sinus syndrome being most frequent requiring 
permanent pacemaker. 
893·64 
The AP or The TCPC Font8ll: Which is better? 
M Rosenthal, J Deanfie\d, A Bush, A Redington. 
Royal Brompton and Great Ormond Street Hospitals, London, England. 
We have previously demonstrated a close relationship between respiratory 
motion and pulmonary blood flow after total cavopu1monary anastomosis 
(British Heart Journal 1991;65:213-7). In this study we have compared 
the resting, submaximal (Submax) and maximal (max) exercise 
pulmonary haemodynamics of 23 atriopulmonary (AP) Fontan cbildren, 
20 with Total cavopulmonary connection (TCPC) and lOS bealthy cbild 
controls. AU underwent a graded workload protocol with respiratory mass 
spectrometry to measure metabolic gas exchange and pulmonary blood 
flow was _ured with an automated acetylene rebreatbing technique 
during exercise. 
There was no difference in maximal exercise perfonnance in the Fontan 
groups. Effective pulmonary blood flow was equal but low at rest in both 
Fontan groups but relatively declined in the AP group (p<O.OS) and 
re1atively improved in TCPC group during submax exercise, compared to 
controls. As chronotropic incompetence was equaI in both Fontan groups, 
blood flow improvement in the TCPC was due to increased stroke volume 
(p<O.OS). There was a significant1y greater respiratory rate at the same 
minute volume in this TCPC group (p<0.05), compared with AP and 
control groups. In order to compensate for their poorer cardiac output 
AP's had a greater A-V oxygen difference at maximal exercise than the 
TCPC group. (p>O.05). 
Although similar at max exercise, submax exercise baemodynamics are 
superior in the TCPC patients compared with the AP group. Exercise 
tachypnoea in the TCPC group may be an adaptive response to increase 
pulmonary blood flow after this operation. 
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893·65 
Ma!lagement or Atrial F1utter Arter the Fontan Procedure. 
-Seshadri Balaji, Thomas B. Johnson, Robert M. Side, Christopher L. Case, Paul 
C. Gillette for the South Carolina Children's Heart Center, Medical University of 
South Carolina, Charleston, SC. 
Atrial flutter (AFL) is common after the Fontan procedure (FP), is often 
medically intractable, and potentially lethal. Management is therefore critical. 
Between 1984 and 1992, 18 patients (aged 1.75 to 20 years, median 9) had AFL 
con:unencing < I day to 16 years (mean 3.7 yrs) after FP. All patients were 
treated with digoxin. Other drugs were used (0-7 drugs, mean 2.7/pt) but no 
patient responded to drugs alone. The most useful drugs were digoxin, 
amiodarone, flecainide and propafenone. Atrial antitachycardia pacing (ATP) 
(Intertacb 2, Intenncdics) was used in 16 (epicardial in 2, endocardial in 14) and, 
with drugs, belped terminate AFL episodes in 8 (50%). Other methods tried 
were: surgical right atriectomy (n = 3, with 2 successes and I death due to 
infectious complications); His bundle ablation (n=I, success); radiofrequency 
ablation of AFL circuit (n=3, with I partial success). Sudden death occurred in 
2 patients. One patient was found dead in a swimming pool shower room. Her 
A TP bad not been activated. Another died at home. One other patient died of 
complications after an elective pacemaker revision. One patient had beart 
transplantation for protein-losing enteropathy. 
Conclusion: AFL after FP is hard to control and can cause sudden death. 
Aggressive mulli-faceted management approaches are indicated 10 prevent 
morbidity and mortality. 
893·66 
Where Is Sinus Node in Hearts With Isomeric Appendages? 
Hideki Uemura, Toshikatsu Yagihara, Fumio Yamamoto, 
Kyoichi Nishigaki, Osamu Matsuki, Fumitaka Iaobe, 
Yasunaru Kawashima, Robert H. Anderson# 
National Cardiovascular Center, Suita, Osaka, Japan 
National Heart and Lung Institute, London, U.K.# 
The sinus node(SN) is known to be duplicated in hearts 
with bilaterally right appendages, but its site is 
uncertain when both appendages are of morphologically 
left pattern("polysplenia"). We have investigated the 
site of the node clinically. 
Patients & Methods. Epicardial mapping was performed 
during operation in 44 patients with isomeric right 
appendages (IR) and in 21 with isomerism of the left 
appendages (IL), so as to determine the earliest site of 
activation of the atrium(EA) which is taken to represent 
the location of the SN. 
Results: Marked variation was found in the site of 
earliest activation(Table). "Superior" SN are located 
at the junction of atrium and the superior caval vein; 
"inferior" at the junction of atrium and the inferior 
caval or hepatic veins. 
total r superior 1 r inferio% 1 others 
IR 20 (45') 14 (32%) 2 (5') 3 (7%) 5 (11%) 
IL 2(10%) 2( 9%) 8(38') 5(24%) 4(19%) 
of IR(14%) and 2 of IL(lO%) , additional EA was 
observed when the dominant SN was suppressed. The site 
of EA was scrupulously avoided at both the initial 
atriotomy and subsequent surgery for intraatrial 
rerouting. After the surgery, no patients showed 
evidence of SN dysfunction. 
Summary: Ectopic and/or multiple position of the SN 
in hearts with isomeric appendages was revealed by 
epicardial mapping. The. information permitted the 
surgeons to avoid postoperative arrhythmias. 
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894·9 
Mitral Valvular ReSistance To Inertiance Ratio Determination by 
Doppler Echocardiography 
S8ndor J. Kovacs, Andrew F. Hall, Cardiovascular Biophysics Laboratory, Jewish 
Hospital at Washington University Medical Center, SL Louis, MO 
Mitral valve resistance (R) is dermed as the ratio of the atrio-ventricu1ar pressure 
gradient in mm Hg to the volumetric flow (mVsec) across the valve in diastole. 
The mitTal valvular inertiance (M) is defined as the ratio of the atrio-ventricular 
pressure gradient to the volumetric flow acceleration (mVsec2). Individually, these 
are cardiac catheterization detennined physiologic parameters. We show that 
quantitative determination of the mitral resistance to inertiance ratio RIM baving 
units of (I/see), is possible when the clinical transmitTal E wave, i.e. the diastolic 
Doppler velOCity proftle (DVP) is analyzed using the parametrized diastolic filling 
(pDF) fonnalism. We have previously characterized the E and A waves of the 
OVP in kinematic tenns via the PDF fonnalism and have shown thac a) the PDF 
model can solve the 'inverse problem' of diastole by uniquely determining model 
parameters from the E wave of the OVP, and b) the transmitTal flow velocity 
contours generated by the PDF model when compared to the clinical DVP show 
exceilent agreement. Tenn by tenn comparison of the PDF equation of motion 
with the equation of motion of an existing physiologic model for transmitTal flow 
proposed by Yellin's group yields a relationship between the mitral valvular 
resistance to inertiance ratio of the physiologic model (RIM) and the damping 
constant (per gram) c of our PDF kinematic model, given by c=R/M. An 
analysis of the E waves of DVPs, recorded simultaneously with right and left hean 
catheterization using micromanometric catheters in IS patients, with (n=2) and 
without (n=13) mitral stenosis (MS) was perfonncd. Ail patients had nonnal 
ejection fractions and no significant coronary disease. The results show significant 
differences in the Doppler detennined mitral valvular resistance to ineniance 
ratio among groups. We conclude that: I) a primary physiologic meaning of 
the PDF parameter c is equivalent to the mitral valvular resistance to inertiance 
ratio and is related to the 'effective' MY area, 2) solution of the 'inverse 
problem' of diastole, not obtainable by any other 
of DVP analysis can be achieved by the PDF 
fonnalism, and 3) physiologic infonnation 
previously req uiring cardiac catheterization 
is extractable from transmitTal Doppler data 
analvtical or descri tive method 
IZJ"OUO n c=R/M 
nlMY 13 38±7.2 
MS 2 55±7.1* 
using the PDF method. ·p<O.OI vs nl 
894·10 
What is the Pro~nosis of Trace Aortic Regurgitation? 
Maria T. Vivaldi, Robert P. Giugliano, Alex Sagie, Luis Padial, 
Arthur E. Weyman, Robert A. Levine, Ehud Schwammenthal. 
Massachusetts General Hospital, Boston, MA 
Color Doppler echocardiograph~ can detect reverse flow in the left 
ventricular outflow tract (LVOn after aortic valve closure in the 
absence of an audible murmur and even without angiographically 
apparent regurgitation. This has left many patients, who would 
otherwise be regarded as normal, with an uncertain prognosis. We 
therefore investigated whether trace Aortic Regurgitation (AR) 
progresses in patients with normal (NM) and those with abnorinal 
valve motphology (AM). AR was graded by the ratio of proximal jet 
height to LVOT diameter. AM was defined as echocardiographic 
evidence of multiple leaflet thickening or calcification without 
stenosis. Twenty seven patients with trace AR (8 NM, 19 AM), who 
were initially examined between 1987 and 1990 had a follow-up 
study up to 5 years (at least 3 years) later. All patients with NM 
remained unchanged. Of the 19 patients with AM, 13 progressed to 
mild AR, and 4 to moderate AR; only two patients remained 
unchanged (p < 0.00(1). 
so"' ~ AM 1dAR LVOT NM 
1st study 2nd 
Conclusion: In the presence of abnonnal valve morphology, trace AR 
frequently progresses to more severe lesions. In contrast it appeanI to 
remain stable over the observation period if the valve is 
motphologically normal. Consideration of valve motphology should 
therefore be useful determining prognosis and frequency of follow•
up. 
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894·11 
CIIJI1ea1 and Ecboeardlograpbk FlDcIJD&s III PadeDII With Dyuande Left 
Veotrkular M1d-eavlty Obstrucdon 
JIetM C. ADap08. Ruuen F. ICony. Jeffrey S. Soble. AIeUDder N-=, 
Pbilip Jl. Liobloa, JOIeph E. Parrillo. RuIb Medical Colle., OIiQlO. D 
A dyumic LV aystoIic mid_vity pdieat (MCXJ) baa "'- reportecI in 
patiema (pta) with LVH. particularly hyperlropbic cardiomyopathy. but DOt 
in pili without LVH. We llUdiocl31 coueeutive hospitalized pta who bad _ 
I)'ItOlicMCXJ (Iate-peakiDg flowve1ocity ~ 1.5 mI-.aDd p-eaterdwl aortic 
velocity.loca1ized 10 the LV mid_vity by puIaed wave Doppler). Oflheae, 
21 (68~) did DOt have LVH. We compared echo dwacteri8tica of the pia 
without LVH 10 the 10 patiellll with LVH: 
NoLVH LVH P 
Number of pta 21 10 
MeG velocity 2.3±0.7 mI-. 2.6±0.8 mlaec NS 
LV_index 82 ± 10 pnIAf- 130±28 JIIII'W <0.001 
LV eDd-diaalolic 20.8 24.2 <0.01 
dimeaaion index ±2.5 aunJM' ±3.9 mmIM' 
Thickness/radius 0.67±0.14 0.73±0.15 NS 
Fractioaal 49±6~ 52±5~ NS 
&harteDing 
Clinical characleristica of the pta without L VH ilIcluded: _,., 71 ± 12 yean: 
68" female: history of I)'IICOIIC or cIizziMas in 38~: infection in 43": 
clinical hypovolemia in 29": vasodilator use in 48". aDd diuretic use in 
43~. 
Conclusions: 1) Unlib previous reports, we found _ dynamic LV aystolic 
MeG 10 occur more frequently in hospita1ized pta without L VH. 2) PIs with 
MeG have hyperdynamic Iystolic function aDd _ marbdly increuocl 
thicmeu/radius ratio: in pta without L VH the latter is due 10 _ smaller LV 
cavity. 3) A MeG without L VH commonly occurs in elderly female pili with 
clinical characleristica associated with intravascular volume depletion. 
894·12 
Aortic Valve Resistance in Surgical Aortic Stenosis: A Doppler 
Echocardiographic Study of 422 Patients 
Veronique L. Roger, Jae K. Oh, Charles 1. Mullany, James B. 
Seward. Mayo Clinic, Rochester, MN 
Valvular resistance defmed as the pressure gradient/flow rate 
ratio has been the object of renewed interest to quantify 
hemodynamic impairment in aortic stenosis (AS). We examined the 
results of Doppler-derived maximum aortic valve resistance (R 
max) in 422 patients (piS) with AS who underwent aortic valve 
replacement between 1990 and 1992. Mean R max was 375 ± 150 
dynes-s-cm5 (lIS to 107S) and mean AVA was 0.71 ± O.IS cm2 
(0.3 to 1.45). R max was closely correlated to A V A (p < 0.000 I). 
Thirteen pts were felt to have milder AS at surgical inspection. 
comparison of their Doppler hemodynamic data to those of the 
remainder of the pts showed: 
Severe AS Milder AS 
Mean gradient 53 ± 19 32 ± 12 
(nunHg) 
EF(%) 55± 15 
AVA (cm2) 0.71 ±O.lS 
Rmax 37S± 149 
( dynes-s-cm5) 
50± 17 
0.S4±0.26 
267± 104 
P 
0.006 
0.21 
0.OS6 
0.006 
A paired standardized comparison between R max and A V A 
showed that R max had a significantly stronger correlation with 
surgical findings than A V A (p < 0.005). Multivariate analysis of all 
Doppler variables demonstrated that the mean gradient was the best 
predictor of severe AS at surgery, (p < 0.05). but that R max was a 
better indicator of severe AS than A VA. The results were similar 
when the analysis was confmed to pts with a mean gradient less 
than 50 mmHg. The sensitivity and specificity of R max < 300 
dynes-s-cm5 to predict milder AS was 62 and 6S% respectively. 
Thus, in this large series of surgical AS. R max is an index of 
the severity of AS but its clinical use appears limited by the overlap 
of its values; it should be viewed as an adjunct and not a substitute 
to other conventional Doppler indices. 
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894·13 
continuous Wave Doppler OVerestimates Maximal 
Regurgitant Velocity Through Mechanical Valve 
Prostheses 
Frank A. Flachskampf , Wolfgang Lepper, IJ osef 
Kohler, Peter Hanrath. Med. Klinik I and IBiofluid 
Mechanics Lab, Aerodynamics Institute, RWTH 
Aachen, FRG 
We have previously shown that continuous 
wave echo Doppler (CWO) overestimates maximal 
flow velocity through small «10 mm2) orifices in 
vitro independently of probe type. It has also 
been shown that mechanical valve prostheses 
(MVR) have inbuilt normal regurgitant leaks of 
such magnitude. 6 mechanical valves (3 st. Jude 
Medical, 2 Medtronic-Hall, 1 Bjork-Shiley) were 
investigated in a steady flow model with 
pressure drops (Ap) of 30,60, 75, and 98 mmHg. 
Maximal flow velocities were measured with a 
dedicated 1.9 MHz CWO transducer (voopp); 4 
measurements were averaged per valve and 
pressure drop. Predicted maximal velocities 
(VB~) were calculated by the modified Bernoulli 
equation (Ap=0.5Qv2). RESULTS: 96 voopp 
measurements were made; correlation between voopp 
and VB~ was very good (r>0.95 in all 
prostheses), but mean voopp for a given valve and 
pressure drop was higher than VB~ in all valves 
and pressure drops. Mean overestimation 
(averaged for all values measured in a given 
valve) ranged 6.3%-13.7%. CONCLUSION: CWO 
overestimates maximal regurgitant velocity 
across the normal leakage orifices of mechanical 
valve prostheses. This may lead to errors in 
vivo when calculating pressure gradients or 
derived parameters from such regurgitant 
velocities. 
894·14 
Is the Bernoul!i Pressure· Velocity Relationship Correct for St. 
Jude Valves? 
Steven Khan. Lawrence Czer. Helmut Baumgartner. Michele DeRobertis. 
Aurelio Chaux. Jack Matloff. Cedars-Sinai Medical Center. Los Angeles. 
CA 
Purpose: Prior studies have shown that Doppler may overestimate the 
net gradient (P) across SI. Jude bileaflet valves when the modified 
Bernoulli equation is used due to the phenomenon of localized gradients 
and pressure recovery. However, the uue relationship between Doppler 
velocity (V) and the net catheter P remains unknown. 
Methods and Results: The pressure-velocity (PV) relationship was 
modeled as: P=K x VE• Taking the log of both sides yields: log P = log 
K + E log V so that the exponent (E) is the slope of log P vs log V. The 
simplified Bernoulli (S8) equation (P=4 x y2) predicts £=2. Nonnal 19 
mm and 2 I mm SI. Jude valves were studied in vitro using a pulsatile 
flow system and water-glycerol solution with a viscosity of 3.5 cpo Peak 
recovered gradients were dctennined by catheter and peak V measured 
using continuous wave Doppler. Multiple measurements were made at 
flow rates ranging from 68-244 cc/Sec. 
19 mm (n=8) 21 mm (n=7) 
Peak V <±. SO) 3.5 ±. 1.0 1.8 ± 0.5 
Peak P <±. SO) 28 ± 16 18 ±. 10.3 
PV Exponent (E ± SERR) 2.2 ± 0.06 2.3 ± 0.15 
Since E was about 2. we detennined K assuming the SB equation: 
P=K x V'. K was 2.2 + 0.09 for the 19mm data and 2.3 + 0.02 for the 
2 I mm data suggesting that P=2.2Vl gives a reasonable i'stimate of the 
lower bounds of the net gradient. 
Condusion: The experimentally detennined E was about 2 indicating the 
basic BemouUi relationship between V2 and P is correct for the SI. Jude 
valve. However the constant K differed from the Bernoulli value of 4 
and was about 2.2. These results suggest that the actual gradient across 
the SI. Jude valve can be estimated as between P=2.2V2 and P=4V2. 
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894·15 
Echocardiographic Correlates of Only Temporary 
Improvement After Mitral Balloon Commissurotomy 
Itzhak Kronzon, James Slater, Michael J. Attubato, 
Frederick Feit, Mary Mickel, for the NHLBI Balloon 
Valvuloplasty Registry, NY, NY, and Seattle, WA. 
Of 646 pts who underwent balloon mitral commissurotomy 
(BMC), 76 (12%) did not improve clinically. Of the 570 pts 
who were improved at 30 days, 413 (72%) sustained 
improvement for 2 years (Group 1). There were 157 pts 
(28%) (Group 2) who either returned to pre-BMC clinical 
status or had an adverse event (death, mitral valve 
surgery, or repeat BMC). The table compares 
echocardiographic parameters of the 2 groups. 
Group 1 Group 2 p Value 
N=413 N=157 
Pre-BMC 
Echo Score 7.5±2.1 8.4± 2.6 0.001 
Left Atrial Size (em) 5.1 ± 0.8 5.3±0.9 0.05 
Immediate (24-72 hrs) Post-BMC 
Mean Gradient 4.9± 2.2 5.8± 2.6 <0.001 
Fall in Gradient 5.0±4.3 3.0± 2.9 <0.0001 
Valve Area (em» 1.8± 0.5 1.7± 0.5 <om 
Increase in Area 0.8± 0.5 0.5± 0.4 <0.0001 
Left Atrial Size (em) 4.8± 1.0 5.2± 1.0 <0.001 
Thus, higher echo score and larger left atrial size pre•
BMC as well as higher gradient, smaller mitral valve 
area, and less change in mitral valve gradient and area 
immediately post-BMC, were associated with only 
temporary clinical improvement following BMC. 
894·16 
Can Transthoracic or Transesophageal Echocardlography 
Predict Successful Inoue Balloon Mitral Commissurotomy? 
Frank D. lice, J. Kevin Harrison, Steven E. Heame, John S. Wilson, Sheila 
K. Heinle, Katherine B. Kisslo, Joseph Kisslo, and Thomas M. Bashore, 
Duke University Medical Center, Durham, NC 
To evaluate the relative ability of transthoracic (TIE) and 
transesophageal (TEE) echocardiography to predict successful Inoue 
balloon mitral commissurotomy, 78 consecutive patients with rheumatic 
mitral stenosis were studied with both teChniques. Mitral valve leaflet 
mobility, thickening, calcification, and subvalvular thickening were each 
aSsigned a score of 0-4, denoting progressive severity of involvement, as 
conventionally described. Mitral valve area (MVA) was calculated before 
and after balloon commissurotomy by the pressure haH-time teChnique 
using transthoracic Doppler echocardiography. The relationShip between 
TIE and TEE mitral valve scores and the increase in MVA achieved with 
balloon commissurotomy are illustrated below. 
N' 4 D N'4 " E E 
~ 3 iii ~3 D 
c( 
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These data demonstrate that the conventional echocardiographic scoring 
system using either TIE or TEE failed to predict successful mitral 
commissurotomy using the Inoue bailoon catheter system. New 
echocardiographic descriptors, such as commissural morphology and 
calcification, are needed to improve selection of patients for Inoue balloon 
mitral commissurotomy. 
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894·17 
Doppler Pressure Balf-Tiae in Mitral Stenosis: 
Inaccurate in the Elderly? 
Vivian M. Abascal, Pedro R. Moreno, Leonardo Rodriguez, 
Victor M. Monterroso, Igor F. Palacios, Ann Dempsey, 
Arthur E. lIeyman, Ravin Davidoff. Boston University 
Medical Center and Massachusetts General Hospital, 
Boston, MA. 
Doppler pressure half-time (PBT) is a reliable method 
to estimate mitral valve area (HVA) when net left 
ventricular and left atrial compliance remain stable. 
Early myocardial relaxation and LV compliance tend to 
decrease with age and are adversely affected by 
conditions that are common in the elderly. The accuracy 
of PHT derived MVA in this group is unknown. lie studied 
80 pts wi th significant mi tral steno.~is (65 women, 15 
man, age 56~14 yrs) by cardiac cath and echo. MVA was 
calculated by the Gorlin formula (G) and by PHT. Pts 
were stratified into those age )65(E) n~23, and those 
<65(Y), n~57. The difference between PHT and G MVA 
(PHT-G) was assessed and related to sex, age, NYHA 
class, HV gradient, LA pressure, PA pressure, severity 
of HR, echoscore, presence of coronary artery disease 
and aortic disease. PHT-G was greater in group E vs Y 
(0.34~0.30 vs 0.15~0.27cm', p:0.009) but group E had 
smaller HVA by G (O.72~0.18 vs 0.89~0.32 cm', p:0.02) 
and lower cardiac output. To compare PBT and G for 
similar valve areas, pts were matched for HVA < 1 
cm'(0.72~0.17 in E, n~23 vs 0.73~0.17 cm' in Y-n~41, 
p=ns). PHT-G remained greater in-E (O.32~.30 vs 
O.19~.22 cm2, p=O.04). By multivariate analysis of 
previously listed variables age >65 remained the most 
significant predictor for the discrepancy between PHT 
and G derived HVA. Conclusion: Vhen compared to Gorlin 
derived HVA, PHT overestimates MVA in older patients. 
PHT should be used with caution in the elderly. 
894·52 
Proximal Isovelocity Surface Area (PISA) Measurement ofthe 
Effective Regurgitant Orifice of Mitral Regurgitation: Clinical 
Accuracy and Limitations. 
*Maurice E. Sarano, Fletcher A. Miller, James B. Seward, A. Jamil 
Tajik, Mayo Clinic, Rochester, MN 
The proximal isovelocity surface area (PISA) method allows the 
calculation of the instantaneous effective regurgitant orifice (ERO) of 
mitral regurgitation as 
PISA-ERO = Regurgitant FlowlRegurgitant Velocity, with 
Regurgitant Flow = 2n(R)2xVr where R and Vr are the radius and 
the aliasing velocity of the flow convergence region. 
The clinical accuracy and limitations of the PISA-ERO as a 
representation of the overall quantitation of regurgitation have not 
been established. Thus, we prospectively compared the PISA-ERO to 
the ERO obtained by quantitative 2-D Doppler calculated as : 
Doppler ERO = Regurgitant VolumelRegurgitant Time Velocity 
Integral, where regurgitant volume is calculated as the difference 
between mitral and aortic stroke volume as obtained by Doppler 
echocardiography. 
In 114 patients (54 prolapse, 60 nonprolapse), the PISA-ERO and 
Doppler-ERO were simultaneously obtained and their correlation was 
excellent (R=O.92, p<O.OOOl), but with a tendency to overestimation 
by PISA (PISA-ERO=39±40 vs. Doppler ER0=36±33 mm2; p=O.05; 
y= 1.1 x + 1). The overestimation was noted only in patients with 
prolapse (PISA-ER0:66±43 vs. Doppler-ERO=60±34 mm2; p=O.03), 
but was confined to patients with a measured flow convergence of 
non-spherical shape or non-synchronous to the maximum velocity of 
regurgitation (n=7, PISA-ERO=137±35 vs. Doppler-ER0=84±34 
mm2; p=O.OO2l). 
We conclude that I) limitations of the PISA method are represented 
by measured flow convergence of inadequate shape or timing leading 
to overestimation of the ERO, but 2) adequate measurements can be 
obtained in large numbers of patients in whom 3) the PISA-ERO 
represents an accurate quantitation method of mitral regurgitation, and 
thus can be clinically applied. 
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894·53 
Early 'l'bIIrIpJ With EDal.april or HIt:q1rolol Pr8vaDts 
Prograaaive 1roraaDiJJq of I'Imcticmal Mitral 
a.qutgitatiaD in ~ With Itldarate Heart I'ailure 
Hisashi Shllnoyama, Hani N. Sal:i:lah, Howard Rosman, 
Tatsuji Xl:n;), It:bsin Alam, Sidney Goldstein. Henry 
Ford Heart ani Vaswl.ar Institute, Detroit, MI 
'!he effects of early therapy with enalapril (ENA) 
ani metqJrolol (MEr) 00 the severity of functialal 
mitral regurgitatioo (MR.) was examined in 21 dogs with 
IIXlderate heart failure (LV ejectioo fractioo 30-40\) 
produced by IIIlltiple 00I'CI'liIry mic:roembolizatioos. Dogs 
were rIIl'KkIni.zed to 3 JJa1ths therapy with ENA (10 ng 
BID, n=7), MEl' (25 ng BID, n=7) or to no therapy 
(<XNlR:lL, n=7) • left ventriallograms, oolor flew 
Dq:pler (ooP) stuties ani 2-D echocardiograms were 
performed before initiati.n;1 therapy (PRE) ani at the 
exmpletioo of therapy (FOST). '!he severity of MR was 
calallated fran DOP as the ratio of the regurgitant 
jet area to left atrial area. Factors known to 
influence the severity of MR were also measured 
namely, LV shape (~icity) basel 00 the ratio of 
the major-to-minor axis at ern-systole (ESR); LV 
ern-systolic volume (ESV) ani mitral annular diameter 
(MAD) measured at mid-systole. 
CXNIroL ENA MEl' 
PRE FOST PRE FOST PRE FOSl' 
MR (%) 14 22 # 9 11 10 8 
ESR 1.56 1.42* 1.50 1.45 1.62 1.58 
MAD (em) 3.2 3.4 ** 3.3 3.3 3.2 3.2 
FS'J (ml) 28 41 t 28 28 29 29 
[*=P<.05; **=p<.02; #=P<.01; +=0<.001; PRE vs. POST] 
ENA ani MEl' prevented the progressive warsen.in;J of 
functiooal MR seen in cootrol (untreated) dogs. 'Ihi.s 
beneficial effect of ENA ani MEl' was mcst likely 
achieved by preventi.n;1 progressive inc::reases in LV 
~icity, LV size ani MAD. 
894·54 
Is Mitral Regurgitation After Myocardial Infarction Primarily Caused by 
Papillary Muscle Dysfunction or Left VentriculariMitral Annular 
Remodeling? 
linda Gillam, Daniel Fram, Steven Goldblatt, Raymond McKay, Francis 
Kiernan, Jeffrey Hirst, Charles Primiano, Deborah Hall, Nancy Krupowies, 
lisa Carl, Joseph Mikan, David Waters, Chunguang Chen , Hartford 
Hospital, Hartford CT. 
Mitral regurgitation (MRI frequently accompanies myocardial 
infarction and may influence therapy. Its mechanism is controversial. 
Proposed etiologies include primary papillary muscle dysfunction which 
would be expected to be of immediate onset, and ventricular and/or 
mitral annular remodeling, which occurs later. To address this issue, we 
performed echocardiographic imaging and Doppler evaluation of the LV 
and mitral valve in 50 pts undergoing coronary angioplasty during 
balloon inflation (RCA = 22, LCX = 13, LAD = 15), Inflation times ranged 
from 45 seconds to 3 minutes (mean = 1.8 min). Left ventricular 
regional function was monitored using apical and parasternal views and 
MR was Quantitated by color Doppler criteria using apical and/or 
parasternal long-axis windows. No pt had more than 1 + MR at baseline. 
RESULTS: In 42 pts, new wall motion abnormalities (WMAI in the 
territory of the occluded vessel, including variable degrees of papillary 
muscle dysfunction, were produced within seconds of balloon inflation. 
In 28 of these pts and in all 8 with no new WMA, there was no 
associated change in the severity of MR. In 11, there was a modest 
increase in MR from trace to mild occurring immediately after the onset 
of the WMA. Moderate MR was elicited in only 2 patients: 1 with a 
proximal LAD lesion and large WMA and 1 with a proximal LCX lesion 
and large WMA including papillary muscle akinesis. In this pt dilatation 
at a more distal site did not elicit MR. CONCLUSIONS: Despite the 
frequent development of WMA including involvement of the papillary 
muscles during PTCA, significant MR develops less frequently than 
would be expected based on its incidence in the setting of myocardial 
infarction. This suggests that papillary muscle dysfunction alone may not 
be the primary mechanism for post-infarction MR but that LV/ annular 
remodeling may be a more important factor. These data have important 
implications for the surgical repair of post-infarction MR. 
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895·77 
Abnormal Q Waves are Common Early in AMI and Do Not Predict 
Decreased Myocardial Salvage With Thrombolytic Therapy 
Merritt H Raitt, Charles Maynard, Manuel D Cerqueira, Galen S Wagner, Ron H 
Selvester, W Douglas Weaver. University of Washington, Seattle W A, Duke 
University, Durham NC, Memorial Medical Center, Long Beach, CA. 
195A 
Abnormal Q waves in the distribution of ST elevation in patients with AMI are 
considered to be a marker for patients less likely to benefit from tbrombolytic 
therapy. We compared myocardial salvage in patients with and without such Q 
waves on the initial ECG prior to enrollment in the Myocardial Infarction Triage 
and Intervention (MITI) trial. The Aldrich score, an acute measure of infarct 
size based on ST elevation, was calculated from the initial 12 lead ECG as a 
measure of the % myocardium at risk. Final infarct size was estimated 6±6 
weeks later by quantitative thallium tomography. Salvage was defined as the 
difference between % myocardium at risk and the fina1 thallium infarct size. 
Results: Data were available for 187 (93%) of 202 patients with no previous 
AMI. 73 patients had anterior AMI and 114 had inferior AMI. Patients were 
treated with rtPA a mean of 98.5 minutes after the onset of symptoms. An 
abnormal Q wave was evident in a least one lead with ST elevation in 40% of 
patients prior to treatment (anterior=67%, inferior=22%, P<O.OOI). There was 
no correlation between the presence of abnormal Q waves in leads with ST 
elevation and the duration of symptoms prior to treatment. Myocardium at risk 
an all d b b AMI I h d salvage for I patients an su sets oy ocaUon IS s own: 
Qwaves no Q Waves p value 
Myocardium af risk 
all patients 19.8% 17.0% 0.001 
anterior AMI 22.8% 18.9% 0.019 
inferior AMI 17.9% 16.2% 0.25 
Sa/vaf(e 
all patients 12.7% 12.7% ns 
anterior AMI 12.4% 12.7% ns 
inferior AMI 12.9% 12.8% ns 
ConclUSIOn: Abnormal Q waves m leads With ST elevauon are a common 
finding early in the course of first myocardial infarction. The presence of such Q 
waves does not predict duration of the infarct nor decreased efficacy of 
thrombolytic therapy as measured by the salvage of myocardium at risk. 
895·78 
Diff ... entiation of "Benign Mirror m.ge" from High Risk ReciprOClli ST 
Depression using Continuous 12-1 .. d ST .. egment recovery ."alvsis 
Akbar Shah, Cynthia loGreen. Kathleen M. Trollinger, Nancy M. 
Wilderman, Robert M.Califf. James E.Pope. Mitchell W.Krucoff. Duke 
University Medical Center. Durham. NC. 
Controversy persista as to whether reciprocal ST -depression during 
Acute Myocardial InfarctionlAMIl represents benign "mirror image" 
changes or a high risk group. While on a single ECG such changes 
probably represent both. continuous behaviour of reciprocal ST 
depression has never been examined. Continuous 12-lead ECG 
recordings of > 6 hrs for 175 pts treated with Iytics for AMI. were 
prospectively classified into 2 groups: Control pattern ICTRL) and high 
risk pattern (RISK). RISK pattern was defined as reciprocal ST depression 
that persisted despite ST elevation recovery. CTRL pts were sub-grouped 
as no ST depression at any time ICTRL A) and reciprocal ST depression 
at peak ST elevation that resolved prior to ST elevation recovery ICTRl 
B). All pts had pre-discharge angiography for It of vessels with coronary 
disease (CAD) and ejection fraction (EFx), given as median (25th. 75th 
%ile). Non-ECG outcome endpoints were: in hospital death, heart failure 
ICHF). angina (CP), recurrent MHRe-MIl. 
ItPTS Qu1h Re-MI Q:!E ~ ~ lli 
CTRL A 40 0% 3% 30% 8% 1 (1.2) 55(44,61) 
CTRL B 113 1 % 2% 31 % 11 % 1(1,2) 52(46,60) 
CTRL 153 1%002% 31% 10% 1(1,2)053(45,60) 
RISK 22 14%000% 45% 14% 2(1,3)052(44,62) 
00 p_ <0.001, Chi Square; 0 p-O.034, logistic regression 
Other differences between CTRL and RISK were NS. Peak ST elevation 
was comparable in all groups. Thus: 1) Reciprocal ST depression that 
recovers prior to recovery of primary ST elevation identifies pts with 
benign outcomes, similar to pts with no reciprocal changes, and probably 
rapresants I "mirror image" ECG change and 2) Reciprocal ST depression 
that persists despite recovery of ST elevation identifies I high risk group 
196A ABSTRACTS 
895·79 
The ECG IS I Predictor of Outcome In Acute Coronary Syndromes 
Result, of the TIMI III Registry ECG Ancillary Study 
Christopher P. Cannon, Peter H. Stone, William J. Rogers, Carolyn McCabe, 
Mark Schactman, Daniel J. Olver, Catherine M. Kells, Marcus WUllams, Ted 
Feldman, Marvin Kronenberg, Douglas J. Pearce, Robert S. Gibson, James 
T. WUlerson, Eugene Braunwald. Brigham and Women's Hospital, Boston MA 
WhOe the ECG Is the most widely used test for evaluating patients (pis) with 
acute coronary syndromes, little prospective Information is avaUabie on Its 
value In predicting outcome In the current era of aggressive medical and 
Int8lVentionai therapy. ECG's with the qualifying episode 01 angina and 
clinical Information were collected from 1,120 prospectively identified, 
consecutive pts with unstable angina and non.Q wave MI at 7 hospitals 
(hosp). Pts with new ST deviation (dev) ~ 0.1 mV In 2 leads were older (70.3 
vs. 62.2 years, p<0.001), and were receMng nitrates more often (53.0% vs. 
40.8%, P<0.01), but rNer 40 other baseline characteristics were slmlar, 
Including gender, race, pattem 01 angina, prior history of angina or prior 
revascularlzatlon. Intravenous nitroglycerin was prescribed more often In pts 
with ST deY (43.5% vs. 32.7%, p=O.OO7); catheterization was performed at 
similar rates (61 % vs 59%) 
No. In-hospital: 6 weeks: 
PIs. O,MI,I (%) PTCA/CABG(%) O,MI (%) O,MI,I (%) 
STdev 168 21.4 39.3 9.1 33.5 
No STdev 847 10.6 28.9 4.8 17.9 
P value <0.001 0.008 0.03 <0.001 
(O=death; I=rest ISChemia with ECG changes In-hosp or requiring rehosp) 
Thus, pts with ST deY had a higher rate 01 revascularlzation In-hosp, but at 
six weeks had a higher rate 01 D,MI. Pts with new, Isolated T wave Inversion 
had simler outcomes to pts with no ECG changes: PTCA/CABG (31% vs. 
28%), In-hosp O,MI (2.4% vs. 2.3%) and 6 week D,MI (4.9% VS. 4.8%), all 
p=NS. Of the 1120 pts, 105 (9.4%) had LBBB (not in table); their 6 week 
incidence of D,MI was 6.6%. 
Conclusions: 1) New ST deviation denotes a high risk group of pts with 
acute coronary syndromes. 2) New T wave inversion, while a definite 'ECG 
change', adds little to the clinical history in predicting outcome. 
895·80 
Utility or the Signal Averaged Electrocardiogram to Identiry 
Circumnex Coronary Inrarctions 
Pieter Doevendans, Adri van den Dool, Barend van de Bijl, Frits W. 
Bar, Hein J. Wellens. Department of Cardiology, Academic Hospital 
Maastricht, the Netherlands 
Inferior wall myocardial infarction (lMI) may be due to either right 
coronary artery (RCA) or circumflex branch (RCX) occlusion. The 
latter perfuses also !be posterolateral part of the left ventricle, which 
is activated late. This suggests that following MI due to occlusion of 
the RCX late potentials will be more frequently observed than 
following occlusion of RCA. 
Methods: Cardiac catheterization and signal averaging (SAE) were 
performed in 103 consecutive cases with IMI within 24 hours after 
admission. We used !be Marquette computer a1gorhythm to determine 
the duration of !be QRS (QRSd) complex, terminal Root Mean Square 
Voltage (RMSV) and the duration of the High Frequency Low 
Amplitude (HFLA) signals. Patients with bundle branch block, atrial 
fibrillation, previous CA bypass grafting and left main CA disease 
were excluded. 
Results: Mean age was 59 (sd 7.5). 14 patients were female. 73 
patients received thrombolytic therapy. The culprit lesion was seen in 
the CX in 29 patients. In 74 patients the RCA was diseased. 
QRSd RMSV HFLA 
mean sd mean sd mean sd 
CX 111.2 II 44.9 18.6 83.3 11 
RCA 106.7 6 42.4 19.5 81.3 8.4 
p* <0.05 ns os 
* one way analysis of variance 
Conclusion: A significant prolongation of the QRS duration, measured 
with the SAE, is seen after a CX occlusion. 
JACC February 1994:1A-484A 
895·81 
Myourdlal Viability May A~~ount for Late Potentials Deteellon 
Early After A~ute Myourdial Infardlon 
Maria-Aurora Morales, Antonio FaziO, Ezio M. Ferdeghini·, Marcello Piacenti, 
Celio GremigniO, Leandro Chiodio, Gualtiero Pelosi, Rossano Vergassolao, 
Alessandro Oislante·, Antonio L'Abbate· CNR Clinical Physiology Insl., 
Aorence and ·Pisa, Cardiac Unit", SM Annunziata Hospital, Aorence, haly 
Lale potentials (LP) detection early after acute myocardial infarction (MI) can 
identify patients (pts) at risk of subsequenl ventricular tachyarrhythmias. Since 
two-dimensional echocardiography (2-D echo) during low-dose dobutamine (DOB) 
infusion permits to detecl myocardial viability in pts with recenl MI, aim of this 
study was to assess whether the presence of viable myocardium can accounl for LP 
recording early after the acute event. Tbiny-five patients, 29 males, 6 females, mean 
age 61±9 years, underwent a DOB echo test 12B days after a first acute MI. 
Immediately before the tesl a signal averaged ECG was recorded; it was considered 
abnormal when at least two of the following criteria were fulfilled: QRS duration 
~115 ms, RMS40 s25 JAV, LAS4~ 38 ms at 40 Hz high pass bidirectional 
filtering and noise < 0.7 JAV. Intravenous DOB infusion was performed under 
continuous ECG and 2-D echo monitoring at 5 and 10 JAglKg/min, each dose during 
5'. Optimal echo recordings were obtained in 31135 pts. Quantilative analysis of the 
left ventricle, divided in 24 segments, was performed off line on digitized images; 
percenl area changes (<Jt AC) from peak systolic and peak diaslolic area were 
calculated for each segment by centerline 'fixed' system. Of 744 segments, HiO 
were judged asynergic showing a 'it AC <30% in basal conditions. A segment was 
considered viable when DOB infusion increased 'it AC by>35'it from basal values. 
Thirteen pts showed viable myocardium ('it AC from 23±7 to 47±9) - Group I. In 
18 pts- Group II - no increase in contractility in the basal asynergic regions was 
found (% AC 30± 7 to :!8±9). No differences as far as type, site and extension of 
MI, basal ejection fraction, thrombolytic procedure and time of recording from acute 
MI were found in the two groups. Abnormal signal averaged ECG was found in 
11113 Group I pIS (mean QRS 119 ± 7 ms, mean RMS40 lOB JAV, mean LAS40 
49.7 ± 12 ms) and in 1118 Group II pts (p<.0l). Thus, in pts with recent MI, 
viable myocardium in the infarct zone may account for the presence of LP. Non 
contract"e but viable myofibrils within a necrotic area could be the anatomic 
substrate of a slow and desynchronised myocardial conduction at the basis of 
reentrant ventricular arriIythmias. 
895·82 
Heart Rate Variability is Depressed in Patients With Unstable 
Angina 
Jian Huang, Edward Leatham, Simon Redwood, Gang Yi, Lijia 
Chen, Juan Carlos Kaski, Marek Malik. St. Georges Hospital 
Medical School, London, UK 
Reduced hean rate variability (HRV) is a risk marker for 
developing sudden death following acute myocardial infarction 
(AMI). Unstable angina (UA) may evolve towards AMI. 
Whether autonomic nervous dysfunction occurs in UA in not 
well known. 
We carried out 24 hour continuous ECG monitoring starting 
within 24 hours of chest pain in 39 patients presenting with VA 
(associated with transient ST segment shifts), in 26 post 
infarction patients and in 28 age matched normal controls(NC). 
Time-domain HRV was computed from each of the 24 hour 
ECGs. Results: 
mNN SDANN SDNN SDNNi rMSSD 
NC 819:!: 169 107:!:42 131:!:38 66:!:25 38:!:20 
UA 877:!:17984:!:40· 98:!:43·· 46:!:21·· 27±13· 
MI 824:!:178 70:!:23·· 70:!:26" 36:!:14·· 23±8·· 
pNN50 
16:!: 15 
6±7"" 
5:!:4·· 
JilNN=mean of coupling intervals of normal R-R; SONN/SOANN=standard 
deviation of R-R intervals/5-minute mean RR intervals(ms); SONNi = mean of 
all 5-minute standard deviation of RRs; rMSSO = root mean square of the 
difference between adjacent normal RR intervals; pNN50= proportion of 
adjacent RR intervals differing by 5Oms; ·=p<0.05; ··=p<O.Ol compared 
with normal controls. 
HRV was significant reduced in patients with VA and MI 
compared to NC. No significant differences were observed 
between VA and MI patients regarding in SDANN, SDNN, 
SDNNi, rMSSD, and pNN50. 
These data su~est that patients with VA have an abnormal 
autonomic activJty which IS of comparable magnitude to that of 
patients with MI. Automatic dysfunction, as assessed by HRV 
analysis, may have prognostic implications in UA. 
JACC February 1994:1A-484A 
895·83 
Prognostic Value of Heart Rate Variability in Unstable Angina 
Maria L. Loricchio, Domenico Di Clemente. Vincenza Saccone, Paola VenNri. 
Alberico Borghi, Raffaele Bugiardini. lnst. of Patologia Medica, University of 
Bologna, Italy 
Decreased heart rate variability (HRV) correlates with increased sympathetic or 
decreased vagal tone. This could contribute to increase local coronary 
hyperreactivity caused by atherosclerotic plaque disruption. thus facilitating 
progression from unstable angina (VA) to acute myocardial infarction (AMI). To 
test this hypothesis we studied 92 pts admitted to CCU for episodes of chest pain 
at rest associated with transient ST shifts (;~O.15mV). PIs who developed AMI in 
the first 24 hours, as well as those with pmious AMI, concomitant valvular or 
myocardial diseases or diabetes mellirus were not enrolled in the study. At 
admission all pts underwent 24 hr Holter monitoring (HM) during full medical 
treatment (including beta-blockers, heparin and aspirin). Angiography was 
performed within I week in 88 of the 92 pts. During I month follow up. 26 pts 
(Gr. I) had a major coronary event (6 deaths. 7 non fatal AMI and 13 urgent 
revascularization). The remaining 66 pts (Gr.2) had a good clinical outcome. 
ECG recordings during ST shifts were excluded by HM analysis. Time domain 
measurements of HRV predicted mortality and total events. The most powerful 
predictor was the mean of the standard de>iations of the 5 min R·R intervals 
(SDNN index). which was significantly (p<O.OOI) lower in Gr.! than Gr.2 
(57±IS vs 97±30). The relative risk of subsequent coronary events was IS times 
higher in UA pts with SDNN index ,;70ms. All pts showed significant (stenosis 
~50%) coronary anery disease. Morphologic analysis of angiograms revealed the 
presence of plaque disruption. i.e. a complex morphology (CM eccentric stenosis 
with overhanging edges and/or irregular borders) in 21 of 22 pts in Gr. I and ID 
31 of 66 pts in Gr.2. Only 2 of the 31 Gr.2 pts with CM showed SDNN index 
,;70ms. Conversely 20 of the 21 Gr. I pts with CM had SDNN index ';?Oms. 
Association of CM with SDNN index ,;70ms was highly predictive of subsequent 
coronary events (positive and negative predictive value 91 and 97%. compared to 
absence of I or both findings. We conclnded that in UA: (I) in the majority of 
instances. pts \\ith a sympatho-vagal balance shifted towards sympathetic 
predominance (SDNN ,;70ms) and CM are likely to have an adverse outcome: (3) 
the clinical syndrome that ultimately develops after plaque disruption depends on 
the net result of all factors that influence the balance between corollluy blood 
supply and myocardial oxygen demand. 
895·84 
Prognostic Significance of Silent or Symptomatic Myocardial 
Ischemia Detected by Maximal Symptom.Llmited Exercise Stress 
Testlnl after Myocardial Infarction in 6,296 Patients Treated 
wltb Tbrombolytic Agents 
Aldo P Maggioni, Alessandro Villella, Amerigo Giordano, Massimo Villella, 
Maria G Franzosi, Fabio Turazza, Francesco Scapellato, Luigi Santoro, Luigi 
Tavazzi, on behalf of GISSI·2 Investigators, Italy. 
Aim of the study was to evaluate if siienl or symptomatic ischemia deleCled by 
exercise IeSting (ET) provides differenl prognostic information. Of 10219 pIS 
randomized in GISSI·2 slDdy discharged alive with confirmed myocardial 
infarction (MI), 6296 performed maximal symptom.limiled ET 1 month after 
MI. In the remaining 3923 pIS ET was not performed for cardiac or non-caidiac 
contraindications. All pIS were given thrombolytic therapy in the IICUIe phase of 
MI. The independent prognostic value of the resuilS of ET was assessed by Cox 
model.Thc ET results were negative in 2381 pIS (38,." Group 1). A positive ET 
was deleCted in 1626 pts: 1089 (17,." Group 2) for asymptomatic ST depression 
~. I m V, 537 (9,." Group 3) for angina with or without concomitam ST 
depression. In 2244 (36,.,) pIS, withoul ECG signs or symptoms of ttansiem 
myocardial ischemia, the 85,., of maximum predicled hean rale for age was not 
reached. Six-month total mortality (M,.,) and noo-fatal reinfarction (reMI,.,) raIeS 
of the 3 Groups of pts are reporled in the Table: 
Group I 
Group 2 
Group 3 
pIS M,., RR 
2381 0.9 1 
1089 1.3 1.54 
537 2.6 2.56 
95,.,CI reMl,., RR 95,.,CI 
1.9 1 
0.77-3.08 1.7 0.69 0.38-1.24 
1.28-5.12 4.6 1.97 1.13-3.41 
The myocardial revascularization rates during the 6-month follow·up were 3% in 
Group I, 8,., in Group 2 and 18% in Group 3. 
In conclusion, in pts with MI trealed with thrombolysis, only symptomatic 
ischemia detecled by ET performed 1 month afler index MI is an independent 
predictor of 6-month mortalily and non· fatal reM!. The opportunity of further 
diagnostic and therapeutic invasive procedures in pIS with silent ischemia detected 
by ET afler Ml should be carefully considered in Ibis low·risk caleg~ of pIS. 
ABSTRACfS 
895·85 
Prognostic Significance of Maximal Symptom.Limited 
Exercise Stress Testing after Acute Myocardial Infarction 
in 10,219 Patients Treated with Thrombolytic Agents 
Massimo Villella. Amerigo Giordano, Aldo P Maggioni, Alessandro 
Villella, Maria G Franzosi, Fabio Turazza, Eugenio Santoro, Simona 
Barlera, Luigi Tavazzi on behalf of GISSI·2 Investigators, Italy 
The prognostic value of exercise testing (ET) in patients (pts) treated 
with thrombolytic agents remains controversial. To detennine the 
prognostic significance of maximal symptom·limited ET perfonned I 
month after AMI, we evaluated (Cox model) the GISSI·2 database 
on 10219 thrombolyzed pts discharged alive after confmned AMI. In 
3923 (38%) pts ET was not performed for cardiac (10%) or non•
cardiac (28%) contraindications. In the remaining 6296 pts, ET was 
negative in 2381 (38%) (Group 1), positive for angina and/or ST 
depression ~O.1mV in 1626 pts: 747 pts (12%) had a maximal (~85 
of maximum predicted heart rate for age) positive ET (Group 2), 879 
pts (14%) had a submaximal positive ET (Group 3). In 2244 pts 
(36%), without ECG signs or symptoms of transient myocardial 
ischemia, a peak heart rate ~85% was not reached_ Total 6-month 
mortality of pts with ET contraindication was significantly higher 
than that of pts who performed the test (7.1% vs 1.3%,RRCox 
2.90,95%CI 2.19·3.83). Mortality (M%) and reinfarction (reMI") 
rates of the different Groups of pts are reported in the Table: 
pts M% RR 95%CI reMI% RR 95%CI 
Group 1 2381 0.9 1 1.9 1 
Group 2 747 1.5 1.58 0.76·3.29 2.7 1.18 0.68·2.07 
Group 3 879 1.9 2.30 1.18·4.50 2.6 1.00 0.57·1.74 
The myocardial revascularization rates during the 6-month follow·up 
were 3% in Group 1,9% in Group 2 and 14% in Group 3. 
In pts with AMI treated with thrombolysis: 1) the strongest 
independent predictor of death at 6-month follow·up was 
contraindication to ET; 2) among pts performing ET only a 
submaximal positive result was independently associated with a 
higher risk of 6·month mortality and 3) ET had no predictive 
significance for reinfarction. 
895·130 
Acute Effects of Captopril Administration on Baroreflex 
Sensitivity in Patients With Acute Myocardial Infarction 
Stelios A. Marakas, Michael K. Kyriakidis, Anastasia N. Vourlioti, 
Panaghiotis N. Petropoulakis, Pavlos K. Toutouzas. Department of 
Cardiology, Hippokration Hospital, University of Athens, Athens, 
Greece 
Depressed baroreflex sensitivity (BRS) early after acute myocardial 
infarction (AMI) reflects decreased vagal and/or increased 
sympathetic tone and is associated with poor prognosis. The aim of 
the study was to assess the acute effect of angiotensin converting 
enzyme inhibitors (ACEI) on BRS after AMI. We studied 27 patients,. 
mean age 57±9 years, on the 5th day after the onset of a first Q-wave 
AMI who had no clinical evidence of heart failure and no history of 
arterial hypertension or diabetes mellitus. In all patients the 
electrocardiogram and blood pressure (through an arterial line) were 
continuously recorded during the intravenous administration of 3 
successive boluses of phenylephrine. This procedure was perfonned 
at baseline and I hour after a single oral dose of 50 mg captopril. BRS 
was taken as the mean slope of the linear regression lines of RR 
intervals over systolic blood pressure (SBP). Qr interval was also 
measured on the electrocardiogram and corrected according to 
Bazett's fonnula (QTc). 
BRS increased from 5.97±2.97 ms/mmHg at baseline to 9.34±3.85 
ms/mmHg one hour after captopril administration (p<.OOOI); Qrc 
also increased from 414±46 to 425±46 ms (p<.OOOI). SBP measured 
before phenylephrine administration had decreased from 125± 19 at 
baseline to 115±15 mmHg I hour after captopril (p<.OOI), while heart 
rate did not change significantly. Baseline BRS was correlated only 
with age (r=·O.73, p<.OOI). Data are mean values ± SO. 
These data suggest that captopril immediately improves BRS in 
the early phase of AMI. This effect and the observed QTc 
prolongation, also known to be under autonomic control, imply 
a favorable influence of captopril on autonomic nervous system 
and may partly explain the benefit of ACEI administration to patients 
with AMI. 
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896-121 
Comparison of Perfluorochemical Emulsions in Experimental Myocardial 
Infarction and Reperfusion: Neither Fluoso" Nor OxyJeo~ Reduce Infarct 
Size or Improve LV Function 
Gary L. Schaer. Tony L. Hwsey. Kami1Ia 1. Blldden:leier. 1_ N. Moy. 
Russell F. Kelly. Joel C. Olmer. Rosbni B. Patel. Khairwmissa S. Rajwani. 
Joseph E. Parrillo. RWlh Medical College. Chicago. n-
The oxyaen-<:arryins perfluorochemical emulsion Fluosole (Alpha Thenpeutic 
Corp.) has been shown to reduce myocardial reperfus.ion (RP) injury (possibly 
via neutrophil inhibition) and is undergoing clinical trials. Becauae Fluosol 
treatment requires a Iaree volume load. we tested the benefits of. more con•
centrated perfluorooctylbromide emulsion (Oxygen~. Alliance Pharm.) in closed 
chest dogs undergoing 90 min LAD occlusion (PTCA balloon) and 72 hr ofRP. 
Dogs were randomized to receive treatment 15 min before RP: Oxygent (6 
mllkg iv over 15 min. n= 11). Fluosol (15 mllkg iv over 30 min. n-11). or 
Control (saline 6 mllkg iv over 15 min. n= 13). Area at risk (AR) and infarct 
size (1) were determined at 72 hr ofRP by post-mortem dual perfusion using blue 
dye and TIC. LV ejection fraction (EF. contrast ventriculography) was measured 
pre-<lCClusion. and at 72 hr of RP. Transmural collateral blood flow was 
measured using colored microspheres injected durina coronary occlusion. To 
evaluate the effect of the perfluorochemicals on neutrophil function. t!JC vi ..... 
neutrophil chemotaxis. and PMA-stimulated superoxide anion (SOA) reIease. 
were performed pre-infarction. at 1 and 72 hr of RP. 
Results: liAR ARlLV EF-72hr Collateral Blood Flow 
Control n=13 29±5% 31±3% 43±2.8% .19±.04 ml/min/e 
Fluosol n=11 30±4% 27±2% 36±2.2% .22±.04m1/min/g 
Oxygent n=11 24±S% 24±2IIIi 36±2.a .20±.05 ml/minI& 
[Data are mean ± SEM; p = NS by ANOVA for comparisons among sroups] 
Hemodynamic parameters were similar among groups during coronary occlusion. 
To control for variability in collateral blood flow. infarct size was plotted against 
collateral blood flow. but demonstrated no differences among the sroups (p=NS 
by ANCOVA). No significant differences in neutrophil chemotaxis or SOA 
release were seen for either perfluorochemical emulsion compared to control. 
Conclw;ions: 1. At the doses employed in this study. administration of Oxygent 
or Fluosol immediately before RP did not reduce infarct size or improve LV 
function in this canine model of myocardia! infarction. 2. Neither drug resulted 
in significant inhibition of neutrophil function. 3. These data question previous 
data supporting a role for perfluorochemicals to reduce reperfusion injury. 
896·122 
Neutrophil Function is Altered by Rheo~ Injection (poloxamer 
188), 8 Hemorheologic: Agent Shown To Reduce Reperrusion Injury 
Gary L. Schaer. James N. Moy, Tony L. Hursey, Khainmnissa S. 
Rajwani. Venkat Thota. Joseph E. Parrillo. Rush Medical College. 
Chicago. IL 
RheothRx Injection (poloxamer 188. Burroughs Wellcome Co.) is a non•
ionic surface active agent currently in clinical trials as adjunctive therapy 
for patients with myocardial infarction. We have previously shown that 
a 48 hr iv infusion of RheothRx produced a 42 % reduction in infarct size 
and superior LV function in a canine model of 90 min of LAD occlusion 
and 72 hr reperfusion. Because neutrophil-mediated injury may be an 
imponant mechanism of reperfusion injury, we studied the effects of 
RheothRx on canine neutrophil (PMN) function. During PMN incubation 
in RheothRx (0. 1 and 3 mg/ml) for 30 min at 37°C. superoxide anion 
(SOA) release was measured by the superoxide dismutase inhibitable 
reduction of ferricytochrome C. Following incubation in RheothRx. 
PMNs were stimulated with PMA (phorbol myristate acetate, 20 ng/ml) 
and SOA release was measured. PMN chemotaxis was assessed by using 
a Boyden chamber with 5 % zymosan activated serum as the chemoattract•
ant. PMNs were incubated for 35 minutes in wells containing RheothRx. 
Results: [Data are mean± SEM; • p < .05 vs RheothRx concentration =0] 
RheothRx SOA Release PMA-stimulated Chemotaxis 
Cone. (n=6) SOA Release (n=6) (n=8) 
(mg/ml) (nmol/lO'PMNs) (nmoIlIO'PMNs) (% or control) 
o 0 43.5±4.3 lOO±O% 
1.0 I 1.2± 1.9* 37.2±6.5 55±7.8%* 
3.0 17.7±1.1* 25.1±5.5* 45±5.l%* 
Conclusions: I) RheothRx produces dose dependent ~ of canine 
PMNs as shown by release of SOA. 2) Following activation by 
RheothRx. canine PMNs release less SOA in response to PMA. and 
demonstrate impaired chemotaxis. 3) RheothRx-induced PMN dysfunc•
tion may be an imponant mechanism of benefit after myocardial infarction 
and reperfusion. 
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896·123 
Nitric Oxide Release from tbe Heart Contributes to the 
Cardioprotective Effects of Platelets Against Ischemia and 
Reperfusion-Induced Injury in tbe Isolated Rat Heart. 
Baichun Yang, lawahar L. Mehta. University of Florida and VA 
Medical Center, Gainesville. FL 
Platelets protect against ischemia-reperfusion-induced myocardial 
dysfunction and injury in isolated perfused rat hearts partially via 
release of nitric oxide. To investigate the relative role of platelet•
derived nitric oxide vs cardiac tissue nitric oxide in the cardioprotective 
effects of platelets from ischemia-reperfusion injury. isolated rat hearts 
were subjected to 40 min of global ischemia followed by 30 min of 
reperfusion. In hearts perfused with buffer alone (n=12). ischemia•
reperfusion resulted in a decrease in force of cardiac contraction 
(6 FCC. -48±4%) and an increase in coronary perfusion pressure 
(6CPP. +26±4%). Creatine kinase (CK) was released in the coronary 
effluents (0.061±0.013 IU/mL) while myocardial CK fell (182±4 vs 
230±12 IU/g tissue). Perfusion of hearts with washed rat platelets 
(n=13) protected hearts from ischemia-reperfusion injury (6FCC: 
-3±5%; 6CPP: -4±1 %; coronary effluent CK: 0.033±0.03 IU/mL; 
myocardial CK: 199±4 !u/g tissue; all P<O.OI compared with buffer•
perfused hearts). Preincubation of platelets with nitric oxide synthesis 
inhibitors N"'-L-arginine (5xI0" M, n=4) or Nm-L-arginine methyl 
ester (5xlO-4 M, n=4) did not affect the platelet-mediated 
cardioprotection from ischemia-reperfusion injury (6FCC: +2±7; 
6CPP: 0±5%; coronary effluent CK: 0.04±0.007 IU/mL; all P=NS 
compared to platelet-alone perfused hearts). However. when platelets 
were perfused in the isolated hearts along with the nitric oxide 
synthesis inhibitor (n=5). the beneficial effects of platelets on cardiac 
dysfunction were attenuated (6FCC: -32±3%; 6CPP: +15±3%; both 
P<O.05 vs platelets alone-perfused hearts). These results suggest that 
nitric oxide released from the heart during interaction between platelets 
and endothelium. and not the platelet-derived nitric oxide, contributes 
to the platelet-mediated protective effects against ischemia-reperfusion. 
896-124 
ARE CHRONICALLY INFARCTED. NON FAILING RAT HEARTS MORE 
SUSCEPTIBLE TO SUBSEQUENT ISCHEMIA-REPERFUSION INJURY? 
Franz R. Eberll. Soeun Ngoy. Ravin Davidoff. Ann Dempsey. Carl S. 
Apsteln. Boston University. Boston. MA 
Hearts with pressure overload hypertrophy are known to be more 
susceptible to ischemic systolic and diastolic dysfunction. Alter a 
myocardial infarction (MI) the non-infarcted myocardium develops 
compensatory hypertrophy. Such remodeled myocardium may be exposed 
to subsequent ischemic events. We hypothesized that non-failing hearts 
with compensatory hypertrophy following MI may also show an Increased 
susceptl)lllty to Ischemia - reperfuslon Injury. 
We studied lsovolumlc bIood-perfused hearts from shalTHlperated c:oiItrols 
(Sham;n-8) and infarcted rat hearts (MI;n-9). who had no signs of 
congestive heart failure (no Increase in lung and Over edema i.e. weight 
and welldry weight ratio) eight weeks after infarction. In MI hearts scar 
tissue comprised 31±3% of the left venfricle (LV). which showed hyper•
trophy (LV to body weight ratio 1.95±.07 vs. 2.3&±.14 glkg in Sham vs. MI: 
p<O.05) and dilatation (LV volume at LV end-dlastolic pressure (LVEDP) of 
10 mmHg 0.4±.02 vs. 0.52±.14 mlln Sham vs. MI; p<0.05). After baseline 
perfusion at a constanf coronary blood flow (CBF) of 2 ""g LV weight. 30 
min low-flow ischemia (Isch) was imposed by reducing CBF to to% of 
Inftial CBF follOWed by 30 min of reperfuslon (R) at Initial CBF. 
LV deveioped pressure (LV dev P) was similar during baseline (110±8 vs. 
105±5 mmHg Sham vs MI). as well as during Isch and R. Recovery of LV 
dev P was ldenflcal in both groups (73% of baseline). In contrast. during 
Isch Sham showed greater diastolic dysfunction. LVEDP increased by 
42±7 mmHg In Sham vs. 24±5 mmHg in MI (p<0.01). At the end of R 
LVEDP had recovered similarly In both groups (23±4 vs 18±3 mm Hg in 
Sham vs MI;ns). Lactate production as an index of glycolytic activity was 
similar In both groups (20±3 vs 24±4I1'11OVg wet wt; Sham vs MI; ns). 
COnclusion: 1)ln contrast to hearts with pressure overload hypertrophy 
hearts with compensatory hypertrophy following a MI show better diastolic 
function during ischemia than controlS. 2) AI. identical CBF and baseline 
preload conditions chronically infarcted non faUing hearts tolerate ischemia 
and reperfusion similarly to control hearts. indicating the successful 
adaptation of remodeled myocardium. 
lACC February 1994:1A-484A 
896·125 
The calcium Channel BIoc:kar Felocllplne Protects Agaln8llachemla· 
Reperfualon InJury By a Mechenlam Other Than ABducing Oz 
Demand. 
Eugene A. Bernstein, Franz R. Ebertl, Adam M. Silverman, Gary L. 
Horowitz, Cart S. ApSleln, Boston University, Boston, MA 
Calcium channel blockers can reduce Ischemic Injury by bradycardlc and 
negative Inotropic actions by decreasing myocardial oxygen demand, 
when administered prior to the onset 01 ischemia. In the current study we 
Investigated the effects when felodlplne was supplied after the onset of 
/ow-flow ischemia and did not decrease myocardial 02 demand. Isolated 
lsovolumlc (baHon-In-L V), blood-perfused rabbit hearts, paced at constant 
heart rate were subjected to 90 min of low-flow Ischemia at a coronary 
perfusion pressure of 10 mrnHg which reduced coronary flow to 25% of 
baseline. AI 15 min of Ischemia hearts received 2xl0-6 M felodipine (F; 
n-ll) or no drug (controt-C; n.7). Felodlpine was given until 15 minutes 
of reperfuslon. During ischemia both groups of hearts had identical 
coronary blood flow (CBF), heart rate, LV developed pressure. +dP/dI, 
-dP/dI, lactate production, and 02 consumption. However, felodipine 
markedly protected against ischemic diastolic dysfunction: at the end of 
Ischemia, LV end-diastolic pressure (LVEDP) had increased from 10±1 to 
28±5 mmHg in F YS 48±8 mmHg in C, p<0.05. During 30 min reperfuslon, 
felodipine had a beneficial effect on coronary vasomotion (initial 
postischemic hyperemia 245±38% YS 124±18% of baseline CBF in F vs 
C, p<o.ol). Felodlpine markedly improved recovery of contractile function 
(LV developed pressure 75±6vs 34±10 mmHg In F vs C p<0.01), diastolic 
function (LVEDP 25±4 in F YS 61±10 mmHg In C P<O.05), and ATP levels 
(8.5±1.4 IlM/g d.w. in F YS. 3.9±1.4 j1MIg d.w. In C, p<0.05), all measured 
after 30 minutes of reperfuslon. 
Conclyslon: Felodlplne Infusion after the onset of low-flow ischemia 
protects the myocardium during Ischemia and reperfuslon. Felodiplne 
decreases myocardial ischemia-repertuslon injury by a mechanism other 
than by reducing oxygen demand. Possible mechanisms include reduction 
of myocyte calcium overload, protection against endothelial and vascular 
Injury, and lor Improved transmural distribution of the low levels of 
ischemic CBF. 
896·126 
Effect of adelloaine on infarct aize following 
iach.ua-reperfuaion when lidocaine ia given only 
before reperfuaion 
Doron Zahger, Juliana Yano, William Ganz. Cedars-Sinai 
Medical Center and the University of California, Los 
Angeles, California. 
Prior studies found a reduction in infarct size by 
adenosine and lidocaine and attributed it to 
attenuation of reperfusion injury. However, in some of 
these studies drugs were given prior to coronary 
occlusion as well as prior to reperfusion. To rule out 
that the effect was due to reduced i.cm..1c dulage 
rather than reperfusion injury, in this study, using a 
single-heart canine model of ischemia-reperfusion, 
lidocaine was given only be~o~ ~pedu.ion. A 2.SF 
catheter was placed midway between the last diagonal 
branch of the left anterior descending coronary artery 
(LAD) and the apex. The LAD was then occluded proximal 
to that diagonal branch for 90 min and reperfused for 
60 min. Two min before reperfusion lidocaine, 2mg/kg, 
was given IV in 1 min and a 62 min infusion of 
adenosine, 3.4 mg/min, begun selectively, via the 
catheter, into the distal bed. Thus, only the distal 
bed was pretreated with adenosine and lidocaine prior 
to reperfusion. Before euthanasia the LAD was occluded 
at the tip of the catheter and Monastral blue infused 
into the left atrium to delineate the boundary between 
the treated and the untreated region. The heart was 
then removed, cut parallel to the LAD and placed in 
triphenyltetrazolium chloride to determine the 
transmurality of necrosis in the treated and the 
untreated region. 
lIa.ult. (N=9): ''1'ranmaurality or _ero.i. in the 
t~.ted and untre.ted ~ion was 49.3±22.7% and 44.5± 
20.1%, respectively, of wall thickness (mean±S.D.; 
p=0.2l by paired t-test, NS). 
Conclu.ion: When adenosine and lidocaine were given 
only prior to and during reperfusion rather than before 
coronary occlusion, they did not reduce infarct size in 
this model of ischemia-reperfusion, ruling out an 
effect on reperfusion injury. 
ABSTRACTS 
896·127 
The Effect of Induced Tolerance to Bacterial Lipopolysacdwide on 
Myocardial Waret Size in Rats 
Gregory P. Eising, Lan Mao, Geert W. Schmid-Schonbein, Robert Engler, John 
Ross Jr., Univenity of California San Diego, and VAMC, La JoUa, CA 
Polymorphonuclear neutrophil (PMN) activation and Idhesion appear 10 be 
key faclon in the development of reperfusion injury in the heart. Induced 
Iolerance 10 bacterial lipopolysaccharide (LPS) by repeated LPS pretreatment 
with sublethal doses has been shown 10 maricedly downregulate tumor nec:roois 
faclor (TNF) activity and 10 reduce the activation of circulating PMNs, III weU 
as PMN adhesion 10 endothelial ceUs in response 10 subsequent stimuli. To test 
the role of inflammatory activation in reperfusion injury, we tested LPS 
desensitization in a coronary occlusion/reperfusion model. In a randomized 
design LPS Iolerance was achieved in rats by daily intraperitoneal LPS injections 
in increasing doses (0.15 10 0.60 "g/kg) for 10 days; control rats were given 
equal volumes of saline. At day 7 nontransmuraJ infarction was produced by 
a 45 min occlusion of the left coronary artery foUowed by 3 days of reperfusion. 
The percent of circulating PMN activation was assessed by the nitroblue 
tetrazolium test at days 7 and 10. Infarct size was determined in serial 
transverse histologic sections (H & E stained) in each heart, and risk area was 
measured in adjacent sections by • fluorescent microsphere technique. 
A. control 
(n=12) 
B. LPS 
(n=14) 
Infarct 
Size 
54 ± 1% 
34 ± 2% 
Risk 
~ 
60 ± 9% 
51 ± 2% 
% activated PMNs 
l!!U day 10 
6.9 ± 4.8% 11.4 ± 7.2% 
4.2 ± 1.5% 2.9 ± 1.6% 
A vs. B p<O.OO2 NS NS p<O.OO5 
199A 
Data are mean ± SD. Infarct size i. expressed as " of the risk zone. Risk 
zone is expressed as % of the left ventricular myocardial mass. 
We conclude that inhibition of PMN activation/adhesion/migration (or 
downregulation of TNF) by induced LPS tolerance in rats produces a sustained 
reduction in myocardial infarct size at 3 days following coronary occlusion with 
reperfusion. The molecular mechani.m of the LPS effect is under investigation. 
896·128 
Attenuation of Myocardial Stunning by the ACE·Inhibitor Ramiprilat 
Through a Signal Cascade of Bradykinin and Prostaglandins, but not NO 
Thomas Ehring, Dietrich Baumgart, Mladen Krajcar, Melanie Hiimmelgen, 
Stefanie Kompa, Gerd Heusch, Dept. of Pathophysiology, University of 
Essen, FRG 
We have recently demonstrated that ramiprilat increases the recovery of stun•
ned myocardium (SM) through prevention of bradykinin degradation. Brady•
kinin, in turn, may act via enhanced formation and release of nitric oxide 
(NO) or prostaglandins. Experiments were performed to distinguish these two 
signal pathways. Twenty-four dogs were subjected to 15 min LCX-occlusion 
and 4 h reperfusion. They were randomized to four groups, receiving either 
the NO-synthase inhibitor L-NAME (LN; 20 mg/kg Lv.) or the cyclooxyge•
nase inhibitor indomethacin (IN; 10 mglkg Lv.), without or with the ACE· 
inhibitor ramiprilat (RA; 20 ,.g/kg Lv.). All drugs were given prior to 
ischemia. Posterior systolic wall thickening (sonomicrometry) and regional 
myocardial blood flow (colored microspheres) were measured under control 
conditions after drug administration, at 10 min LCX-QccJusion, and at 4 h 
reperfusion. Mean aortic pressure was kept constant with an intra-aortic bal•
loon, and heart rate did not change. Data are mean ± SO, 2-way ANOVA, 
p<O.05: * vs. Control; + vs. LN: 
Control Occlusion Reperfusion 
Posterior ~~J!'_':~L ___ 14.9±2.2 -2.4± 1.7* -1.6±6.0* 
systolic wall --------- ----------- ------------IN+RA (n=6) 13.9±5.0 -2.6±1.8* -a.S±3.3* 
thickening 
!:!"J~.=:~L __ 14.4±3.9 -3.3±2.2* -2.3±2.7* [%) --------- ----------- ------------LN+RA(n=6) 14.4±3.4 -4.3± 1.8* 8.5±4.7*,+ 
Posterior IN 1.29±O.23 O.20±O.OS* O.S9±O.12* 
transmural ------------- --------- ----------- ------------
blood flow 
IN+RA 1.33±O.13 O.26±O.O3* O.95±O.lS* 
[ml/(min*g)) LN 1~~:!=2~!~ _~:1_"-;P~~: ~}-"-;P~!~:---------------
LN+RA 1.13±O.15 O.12±O.09* O.S2±O.20· 
In the presence of IN, RA did not improve the functional recovery of SM. In 
the presence of LN, there was significant functional recovery of SM. Thus, 
the attenuation of stunning by the ACE-inhibitor RA involves the prevention 
of bradykinin degradation and a subsequently enhan.:ed formation of 
prostaglandins. 
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897·18 
Segmental Constrictor and Dilator Responses to Intracoronary 
Acetylcholine in Patients with Coronary Artery Disease. 
Hassan El-Tamimi, Michael Mansour, Thomas J. Wargovlch, Henry 
1. Chen, James A. Hill, Richard A. Kerensky, C. Richard Conti, Carl 
1. Pepine. University of Florida, Gainesville, FL. 
It has been suggested that in patients with angiographically 
detectable atherosclerosis or in those with coronary risk factors, 
intracoronary acetylcholine (ACh) causes constriction instead of 
endothelium mediated dilation. This hypothesis was investigated 
during coronary angiography in 52 patients with. stable. angina, 
positive exercise tests and known coronary artery dISease, 111 whom 
aU anti·anginal therapy had been withheld. After baseline (~) 
angiography, ACh was infused into the left coronary artery (lmllmm 
for 2 min) at concentrations 10- 6, 10-5 ,1O-4M with immediate 
angiography after each dose. Changes in diameter(mm) of non•
stenotic proximal, middle and distal left anterior descending (L~D) 
and circumflex (CX) segments were measured by computerized 
quantitative angiography (mean ±SEM). Two p~ttems of response to 
maximal ACh dose were observed. In 38 patIents (group 1) only 
constriction was observed in all LAD and CX segments studied 
(l4±2%, 18±2%, and 27±S% respectively, p<0.02 vs. B). In 12 other 
patients (group 2) both constriction and dilation occurred in ~d~ace~t 
segments of the same vessel; in the LAD, ACh caused constrIctIOn In 
19 segments by 31±6%, p<O.01 vs. B and dilation in 17 other 
segments by 26±S% p<O.01 vs. B, While in the CX, this do~e c.au~d 
constriction in 20 segments by 26±4%, p<O.OI vs. B and dilatIon In 
19 segments by 31±4%, p<O.OI vs. B. . 
Conclusion: In approximately 25% of patients with coronary 
atherosclerosis, the endothelium is not diffusely dysfunctional as 
currently believed but rather show marked segmental heterogeneity in 
the response to acetylcholine. 
897·19 
Use or Exogenous and Endogenous Nitric Oxide Help Identify Degrees 
or EndotheUaI DysfUnction In Patients with Coronary Arlery Disease 
Hassan EI-Tamimi, Michael Mansour, Thomas J. Wargovich, Henry Chen, 
Roger M. Mills, Richard A. Kerensky, James A. Hill, Carl J. Pepine. 
University of Florida, Gainesville, fL. 
Exogenous nitrates and endothellum-derived nitric oxide mediate 
coronary vasodilation through a common final pathway. Nitroglycerin 
(NTG) could enhance endothellum-dependent dilatory response to 
acetylchollne (ACh) in patients (pts) with atherosclerotic coronary artery 
disease. Accordingly, we Investigated responses of nonstenotic coronary 
segments to ACh and NTG In 86 segments of 12 pts with stable angina, 
multiple risk factors, positive exercise tests, and coronary artery disease, In 
whom all anti-anginal therapy had been withheld. After baseJine(B) 
angiography, three sequential 2 min infusions of ACh (I mVmin, 10.6,10.5 
and 1()-4M) were given into the left coronary artery, followed by 200 IIg IC 
NTG. Angiography was repeated after each Infusion. Dlameters(mm) of 
proximal, middle and distal left anterior descending and circumflex 
segments were measured by computerized quantitative angiography 
(mean±SEM). Four segmental patterns in response to maximal ACh dose 
and NTG were observed. In group I (34 segments) coronary diameter 
decreased by 35±4% after ACh (p<O.OI vs. B) and increased by 42±3% 
after NTG (p<0.001 vs. ACh). In group 2 (17 segments) there were no 
significant change in response to ACh, coronary diameter decreased by 
3±2% ~ns vs. B) and increased by 15±O.8% after NTG (p<O.OI vs. ACh). 
In group 3 (17 segments) coronary diameter Increased by 37±5% after ACh 
(p<O.OI vs. B) with further increase of 20±2% after NTG (p«).02 vs. ACh). 
In group 4 (IS segments) coronary diameter increased by 30±4% after ACh 
(p<0.01 vs. B) with a further increase of 2±O.S% after NTG (p=ns vs. 
ACh). 
Conclusion: Our data demonstrate marked coronary segmental 
heterogeneity in response to ACh and NTG. These findings suggest local 
variations In nitric oxide release in response to ACh. Segments dilating with 
ACh with no further dilation to NTG presumably demonstrate a maximal 
capacity of the endothelium to release endogenous nitric oxide, whereas at 
the other end of the spectrum, segments constricting after ACh and dilating 
after NTG have Intact vasomotor function but defective endogenous nitric 
oxide release. The responses to ACh and NTG permit a functional 
assessment of the endothelial Integrity. 
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897·20 
Effects or Nitric Oxide on Coronary Artery Stenoses 
in Patients with Stable Angina 
Dimitris TousouJis, Costas Tentolouris, Tom Crake, Theodoros 
Apostolopoulos, Filipppos Triposkiadis, Graham Davies, Pavlos 
Toutouzas. Cardiology Unit Athens University Medical School 
GR. 
Modulation of vasomotor tone by endothelium appears to be 
important in the control of the coronary circulation. The effects of 
nitric oxide on coronary artery stenoses in patients with chronic 
stable angina is not known. The effects of an intracoronary (i.c) 
infusion of NG·monomethyl·L-arginine (LNMMA, an inhibitor 
of nitric oxide synthesis), ~ollmin for 4 min, was studied in 5 
patients (mean age SSy. 4 male) with chronic stable angina and 
angiographically documented coronary artery disease. Only 
vessels with non·severe coronary stenoses «50% luminal 
diameter reduction) were studied. In all patients a cold pressor 
(CP) test was performed during normal saline (NS) and during 
the LNMMA infusion. Angiograms were recorded during 
infusions, CP, and after i.c nitrate (N). The hean rate and blood 
pressure remained unchanged during the LNMMA infusion. 
Coronary stenosis (St) and reference segment (RS) diameters 
were measured by quantitative angiography. The mean diameters 
(mm) and % changes were: 
BaseI;ne NStCP LNMMA LNMMAtCP N 
SI J.68±O.2 1.57±O.2 1.62±O.2 1.53±O.2 2.04±O.2 
(-6:tl.7%) (.4:1:2%) (-100%)* (25:tl0%) + 
RS 2.42±0.3 2.49±0.3 2.53±O.3 2.43±O.3 2.77±O.3 
(l.4±3%) (3:1:2.7%) (l±3%) (l4:t4%)+ 
*p=O.06. +p<O.05 
The results of this study suggest that nitric oxide production at 
the site of stenosis is partially preserved and its inhibition by 
LNMMA decreases the threshold to a-adrenergic vasoconstrictor 
stimuli. 
897·21 
A.aoci.tion of D.cr •••• d Endoth.lium-D.p.nd.nt 
•• lax.tion with Pr ••• rv.d Coronary Flow •••• rv. 
c.u... Ex.rci •• -Induc.d I.cheai. in p.ti.nta 
with Ch •• t pain, ADqioqr.phic.lly Morlllal 
coronary Art.ri •• 
*Yasuhiro Fujino, Atsushi Mikuniya, Hiroyuki 
Hanada, Masahisa Takahashi, Mitsuru Sato, 
Yasuhiro Mori, Katsuo Wada, Koqo Onodera, 
and Yasaburo Oike. Hirosaki University and 
Reillleikyo Rehabilitation Hospital, Hirosaki, 
Japan 
A subset of patients (pts) with chest pain and 
normal coronary angiograllls (CPNCA) are believed 
to have coronary lIIicrovascular dysfunction which 
causes ischelllia during exercise. To test the 
hypothesis that coronary steal phenolllenon in 
lIIicrovascular vessels induces ischelllia, we 
studied coronary responses to dipyridalllole (DPM) 
and acetylcholine (ACh) infusion lIIeasuring CS02 
-Sat dynamics in 12 CPNCA pts and 10 normal 
subjects. Chest pain and ischemic ECG ST 
depression (~1 mm) were reproduced with DPM in 
5 of 12 CPNCA pts (DPM-positive), whereas not in 
other 7 CPNCA pts (DPM-negative) nor 10 normal 
subjects. Changes in coronary diallleter to DPM 
and ACh were silllilar alllong 3 groups (*p<0.05 vs 
normal subjects, area:tillle integral of CS~-Sat, 
mean±SD) • 
area DPM-I DPM-NI NS 
DPM(%sec) 7214±716 4051±1499* 7653±1153 
ACh(\sec) 1847±342* 1175±512* 2698±634 
ACh/DPM(%) 25±7* 30±12 36±12 
These data suggest that association of impaired 
microvascular endothelium-dependent relaxation 
with preserved coronary flow reserve induces 
coronary steal phenomenon in lIIicrovasculature, 
resulting in myocardial ischemia during exercise. 
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897-22 
The Improved Myocardial Perfusion By L-arginine in 
Patients with Vasospastic Angina 
·Hideki Fujita, Hiroshi Yamabe, Takashi Yano, Susik Kim, 
Masanori Iwahashi, Kazumi Maeda, Mitsuhiro Yokoyama. Kobe 
University School of Med., Kobe, Japan. 
To elucidate the influence of L-arginine(ARG), a precursor of 
endothelium-derived relaxing factor(EDRF), on exercise-induced 
myocardial perfusion abnormality in patients with vasospastic 
angina and normal coronary arteriogram, 12 patients underwent 
two exercise :IlTI-SPECfs, i.e., control(C-T!) and after 
intravenous administration of 2.5 mmol,lkg of ARG for 30 
minutes(ARG-T!). 
Rate presure products at peak exercise(RPP) and an exercise 
time(ET) increased after ARG. Quantitative analysis of :I"T!_ 
SPECf ~~~~aslT}lseC;dS) ES(%) SS(%) mWR(%) 
C-EX 25±4 55S±1l3 SS±17 S0±26 31±1O 
ARG-EX 27±3 609±96 4O±19 31±18 40±8 
P value sO.ool <0 OS sO OS sO OS sO.OO5 
ES; extent score, SS; severity score, mWR; mean washout rate. 
The increase in m WR significantly correlated with the incidence of 
coronary risk factors(psO.05). The serum level of L-citrulline, 
which was a measurable product derived from EDRF synthesis, 
increased from 4.6± 0.7 to 5.1± 0.8 I1moVdl after exercise, 
suggesting that a part of ARG was converted into EDRF. The 
regions of improved myocardial perfusion by ARG were 
independent of epicardial coronary spasm induced by acetylcholine. 
We conclude that ARG improves the exercise-induced myocardial 
perfusion abnormality in patients with vasospastic angina and 
normal coronary arteriogram, and that this effect of ARG partly 
relates to the abnormal endothelium-dependent vasoactivity in both 
the epicardial coronary arteries and the angiographically non-visible 
arteries. 
897-23 
The Effect of Intravenously Administrated L-arginine 
on Myocardial Perfusion Abnormality in Patients with 
Microvascular Angina 
·Hideki Fujita, Hiroshi Yamabe, Takashi Yano, Susik Kim, 
Masanori Iwahashi, Kazumi Maeda, Mitsuhiro Yokoyama. Kobe 
University School of Med., Kobe, Japan. 
Previous studies have shown that the defective endothelium•
dependent vasodilation contributes to abnormal coronary flow 
reserve in patients(pts) with microvascular angina. The purpose of 
this study was to determine whether L-arginine(ARG), a precursor 
of endothelium-derived relaxing factor(EDRF), could improve 
exercise-induced myocardial perfusion abnormality. The entry 
criteria of 10 pts included in this study were previous chest pain, 
exercise-induced ST depression, normal coronary arteriogram, 
negative provocation of vasospasm ¥t! positive reversible 
purfusion defect(Rd) on control exercise TI-SPECf(C-T!). We 
compared symptom-limited exercise :IlTI-SPECf after intravenous 
administration of 2.5 mmol,lkg of ARG for 30 minutes(ARG-T!) 
with CoT!. 
Rate pressure products at peak exercise were similar, but an 
exercise time prolonged after ARG(482± 98 vs S4O± 85 sec, 
psO.05). Prevalence of Rd and qantitative analysis of :IlIT!-SPECf 
were as follows(· p<O OS ys C-TIl· 
Rd(cases) Extent(%) Seyerjty(%) Washout Rate(%) 
C-T! 10 35±19 26±22 39±lS 
ARG-T! 5 28±18 19±18 45±!0· 
We measured serum levels of L-citru1line, which was a product 
derived from EDRF synthesis, before and after exercise. The % 
changes in L-citrulline of 5 pts, whose Rd disappeared and whose 
extent and severity scores improved after ARG, were significantly 
larger than those of the other 5 pts(l8± 8.2 vs 0.9± 1.5%, 
p<O.OOS). 
In conclusion, ARG improves myocardial perfusion abnormality in 
the half of pts with microvascular angina, and this effect is 
probably due to increased EDRF production. 
ABSTRACTS 
897-24 
Neither Coronary Nor Forearm Flow Reserve Predict 
Exercise ST Depression or Symptoms in Patients with 
Chest Pain and Normal Coronary Arteries 
Donald C. Thompson, George C. Haidet, Alan J. Bank, Marcus J. 
Mianulli, Cheryl L. Iacarella, Robert F. Wilson. University of 
Minnesota, Minneapolis, MN 
20lA 
Although a reduction in coronary flow reserve has been considered 
evidence of microvascular insufficiency, its utility in identifying patients 
with microvascular angina is undefined. To determine the relationship 
between coronary flow reserve (CPR), symptoms, exercise-induced ST 
depression (Ex SID), and forearm reactive hyperemic response (FRH), 
we studied 32 patients with a chest pain syndrome and a normal 
coronary arteriogram (NCA). CPR (peak/resting velocity ratio) was 
measured with a coronary Doppler catheter and adenosine at a paced 
heart rate of 100 beats/min. FRH was measured with impedance 
plethysmography and transient (5 min) forearm occlusion (reactive 
hyperemia). A symptom-limited modified Bruce exercise 
electrocardiogram was evaluated for ST depression ~.l m V, 80 msec 
after J point) by two blinded observers. The presence and severity of 
chest pain at follow-up after angiography was assessed by standardized 
interview. Patients with abnormal LV function or hypertrophy by 
echocardiography were excluded. 
Results: Chest pain symptoms were related significantly to the 
development of ~.l m V Ex SID (r=.55) and maximal Ex SID 
(r=.61), but not to FRH or CPR. Furthermore, CPR and FRH were 
unrelated to each other (r=.03) and did not predict Ex SID. 
CER (peaklrestin~) FRH CmVrnjnllOO mil 
Ex SID + (n=20) 2.4±.2 31±3 
Ex SID - (n=12) 2.4±.2 26±5 
Conclusions: These data suggest that CPR and FRH have limited 
value in differentiating patients with microvascular angina from those 
with chest pain due to other causes. Furthermore, since CPR and FRH 
were unrelated to each other, most patients with chest pain and NCA did 
not have a generalized smooth-muscle disorder detectable by vasodilator 
reserve testing. Functional tests of the coronary circulation may provide 
a better means to detect clinically important microvascular angina 
897-25 
Impaired Flow Mediated Vasodilation of the Brachial 
Artery is a Reliable Indicator of Obstructive Coronary 
Artery Disease 
Thomas Neunteufl. -Reinhold Katzenschlager, Ursula lOaar, 
All Hassan, Severin Schwarzacher, -Herbert Ehringer, Dietmar 
Glogar, Franz Weidinger; Departments of Cardiology and of 
-Vascular Medicine, UnlverSity of Vletma , Vienna, Austria 
Flow mediated vasodilation of the brachial artery has been 
shown to be correlated with several cardiovascular risk 
factors. This study was performed to test the hypothesis that 
noninvasive detection of endothelial dysfunction in peripheral 
arteries correlates with anglographlcally significant coronary 
artery disease. 
Three groups of individuals were studied: Patients (pts) with 
anglographically documented obstructive coronary artery 
disease (CAD; n=29. age 32 to 70 y); patients with smooth 
coronary arteries who underwent coronary anglographle 
because of atypical chest pain (n=6) or other reasons (sudden 
death sUIVlvor. myocarditis; non CAD; n=9, age 21 to 69 y) 
and healthy volunteers (NLS; n=10, age 17 to 36 y). In all 
partiCipants suprasystolic compression (250 mmHg, 4.5 min 
duration) of the right brachial artery was performed. Flow•
mediated vasodilation (FMD) following reactive hyperemia was 
assessed In a fixed position of the ann by measuring the 
resting diameter and the maximum relaxation diameter of the 
brachial artery using high resolution ultrasound (5 MHz. 
Acuson 128 XP/lO; FMD = % change In diameter compared to 
baseline.). 
Results: CAD pts showed a markedly impaired FMD compared 
to NLS (5.8 ± 5 vs 16.3 ± 3 ; p< 0.01) as well as to non CAD 
pts (5.8 ± 5 vs 12.8 ± 5: p< 0.05). There was a tendency 
towards Impaired FMD values In non CAD patients compared 
to controls (NS ). 
ConclUSion: The impairment of flow-mediated vasodilation in 
the brachial artery may seIVe as a noninvasive predictor of 
obstructive coronary artery disease. 
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898·130 
How Useful is Electrophysiologic Testing in Patients 
Resuscitated From Ventricular Fibrillation? 
Huagui G. Li, Ranjan K. Thakur, Raymond Yee, George J. Klein, 
Department of Medicine, University of Westem Ontario, 
London, Ontario, Canada 
ElectrophysioloQiC testing is performed in patients 
resuscitated from ventncular fibrillation (VF) on the assumption 
that sustained monomorphic ventricular tachycardia VT may be a 
precursor to VF, with the former amenable to assessment by 
serial druQ testing. We assessed the usefulness of this strategy 
by analYZing the clinical and electrophysiology study results of 
42 (29 men, 13 women, mean age 54 ± 14 years) survivors of VF 
unrelated to acute myocardial infarction. All patients had VF 
documented and required defibrillation. Underlying heart diseases 
included coronary disease in 28, dilated cardiomyopathy in 3, 
arrhythmogenic right ventricular dysplasia in 1 and no apparent 
heart disease in 10 patients. Only 2 (4.7%) patients had history 
of sustained monomorphic VT. Electrophysiology study was 
performed 1 week to 3 months aiter VF. Right ventricular 
stimulation using 2 drive cycle lengths and up to 3 extrastimuli 
induced sustained monomorphic VT in 4 (9.5%), nonsustained 
monomorphic VT in 1 (2.3%), nonsustained polymorphic VT in 5 
(11.9%) and VF in 13 (30.9%) patients. Two patients with 
cfinical VT and coronary disease had sustained monomorphic VT 
induced during electrophysiology study. Sustained monomorphic 
VT was induced in 53 of 61 (86.9%) age and sex matched 
patients with clinical sustained monomorphic VT using the same 
stimulation protocol. Twenty·five (59.5%) patients received 
implantable defibrillators (ICD) and 11 (26.2%) patients received 
amiodarone therapy. 
Conclusion: Induction of sustained monomorphic VT amenable to 
serial drug testing in VF survivors is uncommon. It may be more 
cost effective to proceed directly to ICD in these patients. 
898·131 
Left Ventricular Catheter Endocardial Mapping During SinUI Rbytbm in 
Chronic Myocardial Infarction: Correlation of Electrograml with 
Electrical Impedance. 
David Schwartzman, Isaac Chang, Mark S. Mirotznik, Charles D. Gottlieb, 
Kenneth R Foster, Francis E. Marchlinski. Philadelphia Heart IDStititute and 
The University of Pennsylvania. Philadelphia, P A. 
Left ventricular endocardial sinus rhythm mapping was performed in three 
normal male sheep and in three sheep that had undergone left anterior 
descending oorooary artery ligation greater than six weeks prior. A 7 French 
catheter with a 0.25 mm length distal electrode and a 2 mm length proximal 
ring electrode (interelectrode spacing of 5 mm) was used for all mapping. Pre•
designated endocardial areas were mapped using a standardized system. 
Bipolar electrograrns were recorded from each site using both fixed (ImV/cm) 
and variable gain amplification, filtered at 40-500 Hz, and recorded at a paper 
speed of 100 mmlsec. Electrographic amplitude (A), duration (0), and 
amplitude/duration ratio (AID) were measured for each electrogram. The 
normal values for A, D, and AID were established using the three normal sheep 
(n=41 LV endocardial sites): A 7.5±2.9 mV; D 36i6 msec; AID 0.217±O.092. 
An "abnormal" electrogram was then defined separately for A, D, and AID as 
that which exceeded two standard deviations above (0)48 msec) or below 
(A<1.7 mV, AID<O.033 mVlmsec) the norm. Additionally, at eacb LV 
endocardial site in the chronically infarcted animals, electrical impedance was 
measured via the distal electrode of the catheter at 550 kHz in unipolar 
oonfiguration using a dispersive ground plate applied over the right anterior 
thorax. RESULTS (figure): Impedances were oompared at normal versus 
abnormal electrogram sites as defined by A 
(n=18 abnormal sites, n=45 normal sites), D 
(n=20 abnormal sites, n=43 normal sites), or 
AID (n=14 abnormal sites, 0=49 normaI sites). 
•• o.om CONCLUSION: Abnormalities in bipolar 
AIO endocardial electrograrns are associated with 
significantly lower electrical impedances. Since abnormal electrograrns have 
been previously associated with sites of infarction, it is possible that the 
electrical impedance may also distinguish infarcted from normaI endocardial 
sites. 
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898·132 
Radiofreqency Ablation in Chronic Infarction: An In Vitro Investigation of 
Endocardial Lesion Formation and Tinue Electrical Characteristics 
David Schwartzman, Isaac Chang, Mark S. Mirotznik, Charles D. Gotllieb, 
Kenneth R Foster, Francis E. Marchlinski. Philadelphia Heart Institute and The 
University of Pennsylvania, Philadelphia, P A. 
Six ovine hearts were excised> 6 weeks after left anterior descending ooronary 
artery ligation. Left ventricles were dissected free, opened, and mounted in a 
pulsatile flow tank, circulating a pbysiologic crystalloid solution at 4 Umin, 37· 
C. Using a 9 French, 0.25 mm length electrode oontaining a thermistor, 
endocardial impedance was measured at S50 kHz in normal (N)(n=82), densely 
infarcted (I)(n=48), and infarct border (B, defined visually)(n=67) sites. Lesions 
were then applied to each site at 550 kHz for 30 sees at a oonstant temperature of 
80·C. For each energy application, power and impedance were sampled at 33 
points/sec. For zones N and B, resulting lesion widths, depths, and volumes 
were measured after tetrazolium staining. RESULTS (Figures are oomposite 
representations.): At baseline, endocardial impedance in N (347±32) was greater 
than in I (263±32) (p<O.OOI). At B, the impedance was 276±42, lower than N 
(p<O.OOI) but not different from I (p=O.l89). During early energy application, 
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tissue impedance fell linearly 
with temperature rise (R>O.9 
for N,B, and l)(Fig I). The 
slope of the impedance versus 
temperature relationship was 
different for N vs. B vs. I (All 
p<O.OOI), as was steady state 
impedance at 80·C (All 
p<O.OOI). Peak and steady state power required to achieve and maintain 80·C 
were different (N vs. lor B, p<O.OOI; I vs. B, p=(J.006). Lesion depths (B:3.5± 
0.6 mm; N:3.5±O.5 mm), widths (B:2.4±O.4 mm; N:2.3±O.3 mm), and volumes 
(B:32±8mm3; N:31±8 mm3) were not significantly different. CONCLUSION: 
Significant electrical differences exist between N, B and I, both at baseline and 
with application of radiofrequency energy. More power (32%) is required at 
steady state in B vs. N to achieve equivalent lesion volumes. These findings have 
implications for catheter ablation of ventricular tachycardia in the setting of 
chronic myocardial infarction. 
898·133 
Utility of Electrophyslologlc Evaluation for Syncope In 
Women 
Kevin T. Cragun, Stephen C. Hammill, Douglas L. Packer, Mayo 
Foundation, Rochester, MN. 
To characterize the utility of electrophysiologic (EPS) and head•
up! isoproterenol ti~ (HUT) testing for the evaluation of syncope in 
women, EPS findings and long-term follow-up from 146 women and 
234 men were compared. Women had higher syncope frequency 
and LVEF (59 v. 51%, p<0.0001), shorter ORS duration (112 v. 
124 ms, p<O.0001) and lower incidence of bundle branch block 
(BBB) (16 v. 25%, p&039) and organic heart disease (OHD) (23 
v. 43%, p<O.0001) than their male counterparts. Positive findings 
with invasive ventricular tachycardia and conduction disease testing 
(VT/CD), carotid sinus massage (CSM) and HUT were as follows 
(*p<0.02): 
~ ~ H1.II ~ 
Women 18/120 (15%) 281 99 (28%) 27/112 (24%) 561146 (38%) 
Men 56/208 (27%)" 61/175 (35%) 271150 (18%) 119/234 (51%)' 
Testing for VT/CD was one-half as likely to be diagnostic in women 
while CSM and HUT testing were of similar utility in both groups. 
Univariate predictors of +VT/CD in both groups were BBB, OHD, 
and LVEF. NYHA class and age were predictive in men but not 
women. The strongest multivariate predictors were BBB/OHD in 
women and LVEF/age in men. Absence of BBB/OHD had a 
negative predictive value of 92% for +VT/CD. During follow-up (25 
± 8 mol, women had more recurrent syncope (44 v. 29%, pcO.013) 
and were more likely to require medical evaluation (36 v. 20%, 
p<0.001) than men. Rates of syncope-related injury, hospitalization 
and overall mortality were similar for both women and men. 01 the 
53 women with recurrent syncope, 36 (68%) had a negative 
syncope evaluation while 17 (32%) had at least one positive test 
with therapy directed at +VT/CD in 4, +CSM in 6 and +HUT in 10. 
From this we concfude: 1) invasive testin!il is less helpful in women 
than men, 2) absence of BBB/OHD predicts -VT/CD in women, 3) 
factors predictive of positive tests are different for women and men, 
and 4) recurrent syncope is common in women deSpite EPS-guided 
therapy. This suggests that in the absence of BBB/OHD, the risk 
and cost of invasive testing in women may not be justifiable. 
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898·134 
Eledrophysiologlc Effects of High Dose Oral Amlodarone Load in 
Heart Failure Patients 
David W. Riggio, Robert W. Peters, Stephen S. Gottlieb, 
Michael R. Gold, University of Maryland, Baltimore, MD 
Amiodarone(Amio) is an effective drug in the management of life•
threatening ventricular anbythmias(V A). Due to peculiar 
pharmacokinetics, its electrophysiologic(EP) effects have traditionally 
been evaluated after a ~10 day loading period, necessitating prolonged 
cardiac monitoring. We assessed the EP effects of an abbreviated high 
dose oral load (50 mg/kg over 2 days, mean 6.9±.4, range 3.5-9.9gms) 
in 13 high risk patients( class 3 or 4 congestive heart failure) being 
treated for VA. 
In I patient, 2 doses were omitted because of bradycardia. In 2 other 
patients, a single dose was omitted because of nausea. Proanbythmia 
was not seen despite marked QT prolongation. 
CONCLUSION: Acute high dose Amio oral loading causes marked 
and diffuse EP effects which are consistent with Class I and Class 3 
actions in addition to anti adrenergic and calcium channel blocking 
effects. Our data suggest that the standard Amio loading period may 
be considerably shortened, decreasing the need for prolonged cardiac 
monitoring. 
898·135 
Im:idence Of Cliniall. M:ri:mrll.e lkanch Reentrant 
Ventricular 'nIdJ.ycardia. After Right amI.e Ablatioo. 
FbI: amI.e Brar¥::b Reentrant Ventricular 'nIdJ.ycardia. 
Galen G. Van Wyhe, steve J. Bailin, Tan E. Edel, w. 
Ben Johnson, Imran K. Niazi, Iowa Heart Center, Des 
Moines, IA, and Arrhythmia Center for Southern WI, 
Milwaukee, WI 
Patients undergoing right bundle ablation for bundle 
branch reentrant ventricular ventricular (BBRVT) often 
have nonBBRVT, the prognostic significance of INhich 
is undefined. Sixteen patients with syncope and/or 
documented ventricular tachycardia (usually by single 
lead rhythm strip) unden.>ent electrophysiologic testing 
with demonstration of BBRVT INhich was then eliminated 
with right bundle ablation. Four had no inducible 
nonBBRVT during the follow-up post ablative evaluation 
and never experienced subsequent arrhythmic events. 
'fue other patients had inducible nonE!8RVT and were 
treated with Jlmiodarone (two, with no subsequent 
arrhythmic event), or ~lantable 
cardioverter/defibrillators (nine, three of which later 
experienced ICD discharges, one of which was clearly 
documented due to ventricular tachycardia by Holter 
techniques). Ole patient experienced in hospital sudjen 
death due to intractable ventricular tachycardia while 
awaiting cardiac transplantation. Average follow-up 
23±13 1lO. 
o::>nclusion: Roughly a quarter of patients with inducible 
nonE!8RVT (post right bundle ablation for BBRVT) will 
experience subsequent arrhythmic events due to the 
nonBBRVT. 
ABSTRACTS 
898-136 
To What Depth is Cryothermal Mapping Effective? 
David Melnick., N. A. Mark Estes m, Antonis S. Manolis, 
*Paul 1. Wang. New England Medical Center, Boston, MA 
Reversible cooling at the "site of tachycaIdia mgin" may be an ideal 
method of predicting the site of effective ablation. However, it is 
not known to what depth myocardium may be reversibly cooled. 
Thus, we achieved a surface temperature(TEMP) of 5 degrees Cor 
less in a 1cm diameter endocardial region of excised ovine right 
ventricular tissue in circulating saline at 37°C at a flow of 2 L /min. 
Using fluoroptic probes, we mapped the TEMP at depths of 0 mm, 
2.5 mm, and 5 mm for 90 sec during cooling and 90 sec after 
cooling ceased. The average minimum TEMP for 14 trials at depths 
of 0 mm, 2.5 mm, and 5.0 mm were O°C, goC, and 16°C 
respectively(p<O.OO1 Omm vs. 2 5mm, p<O.OOl Omm vs 5 Omm). 
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We.conclude that reversible cooling at the endocardial surface may 
result in significant cooling at depths up to 2.5mm but that cooling 
at depths 5mm or more is not as great Thus, cryothermal mapping 
may be extremely effective in identifying subendocardial arrl1ythmia 
foci but may not be effective for tachycardias at deeper sites. 
898-137 
Long Term Prognosis of Arrbytbmogenlc Right Ventricular Disease 
: Follow-up of 74 Patients. 
Claude Daubert, Martine Vauthier, Philippe Mabo, Marcel 
Laurent, Christian De Place, Jean-Luc Foulgoc. Department of 
Cardiology, University Hospital, Rennes, France. 
Long tenn prognosis (LTP) and optimal treatment (T) of 
arrhythmogenic right ventricular disease (ARVD) remain 
controversial. This series reports the follow-up (FU) ~ I year; mean 
= 68 :I: 45 months) of 74 consecutive pts, 51 males and 23 females, 
referred to the same institution between 1981 and 1992. Mean age 
was 35:1: 12.5 years at symptom onset and 44.3:1: 13.S yrs at the time 
of diagnosis. 62 pts (84 %) were highly symptomatic with 
palpitations (75 %), presyncope (52 %) or syncope (30 %). 2 pts 
experienced aborted sudden death due to documented VF. All pts 
had ventricular arrhythmias with LBBB morphology: sustained (s) 
VT : n = 33 ; non sustained (ns) VT : n = 20 ; high grade PVC's: n = 
21. 
T was guided by history and by drug testing, using programmed 
ventricular stimulation in pts with inducible sVT, and 24 hr ECG 
recording and exercise testing in others. The drugs used (one drug in 
SO pts and two drugs in 20 ; S pts were not treated) were : - beta•
blockers in 50 pts (67 %) including sotalol in 20 - class IC in 23 - class 
IA in 7 - amiodarone in 7. ICD was implanted in one VF pt. 
Catheter ablation (CA) or surgery (S) were perfonned respectively in 
3 and 2 drug-refractory pts. 2 early deaths (2.7 %) occured, directly 
related to therapy (I after S and I due to pro-arrhythmic drug 
effect). 
During FU, any other pt died. Total cumulative survival rate was 
97.3 y,. 55 pts (76.4 y,) were free of symptoms with unmodified 
medical therapy. 17 pts remained or became unstable with recurrent 
or newly occured (n = 4) sVT. Finally, arrhythmia control could be 
achieved by modifying medical therapy (n = 14) or by CA (n = 3). 
In conclusion, a large majority of ARVD pts have a good LTP 
under medical therapy, and especially under beta-blockers. 
Indications for non phannacological methods (CA, S, ICD) have to 
be reserved to few carefully selected pts. 
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899-67 
Initial Experience With 71 Patients Undergoing Non•
Thoracotomy Defibrillator System Implantation Using 
the New Subcutaneous Array 
Anand N Munsif, L Bing Liem, Michael R Lauer, Charlie Young, 
John CL Yu, Jan Peterson, Linda K Ottoboni, Ruey J Sung. 
Stanford University, Stanford, CA & The US Ventak: PRxlEndotak: 
Investigator Group 
A total of 71 patients (pts) underwent implantation of non•
thoracotomy defibrillator system using the new subcutaneous coil 
(Endotak: SQ array, CPI) as an alternative to a subcutaneous patch, 
paired with transvenous lead (Endotak C lead, CPI) and third•
generation implantable cardiovener-defibrillator (Ventak: PRx, CPI) 
at 36 centers. Array consists of three electrically common coils 
joined by insulated cable for morphology-sensing and 
cardioversion-defibrillation. Pts were 67 males and 4 females; age 
64 ± 9 years (mean ± SO); ejection fraction 34 ± 16%; NYHA 
Functional Class I = 26, n = 26, m = 6, IV = 2 and not reponed = 
II. Implants were for monomorphic ventricular tachycardia (VT, 46 
pts), ventricular fibrillation (VF, 16 pts), VTNF (6 pts), 
polymorphic VT (2 pts) and other (1 pt). Implant defibrillation 
threshold (Off) was 17 ± 5 joules (range 5 - 25). Final polarity 
configuration was distal and proximal coils negative and array 
positive (2 pts) and distal coil negative and proximal coil and array 
positive (69 pts). A total of nine complications with the combined 
array + lead system were: Overlapping of array coils (1 pt); 
subsequent Off increase (2 pts : requiring lead repositioning in I 
and use of biphasic pulse in I); lead dislodgment (l pt); high lead 
pacing threshold (l pt); inappropriate lead sensing (2 pts); axillary 
vein thrombosis (1 pt); pulse generator pocket infection (l pt). Pts 
were followed for 3 ± 1.5 months. 
CON C L US ION S : Early experience indicates that non•
thoracotomy defibrillator system using the array has excellent 
implant OFfs and minimal problems related specifically to the array. 
Long-term stability and performance remains unknown. 
899-68 
Morni1g Peak in Ventricular ArrhyIhmiIs Detected by T ..... 01 Implantable 
C.n:liovertllr-Defilllilator Therapy 
Otavio C.E. Gebera, Murray Mittleman, Carl Rasmussen, Ferdinand J. 
Venditti, James E. Muller, Geoffrey H. Toller for the CPI VENTAK PRx 
Investigators. Institute for Prevention of Cardiovascular Disease, Deaconess 
Hospital, Harvard Medical School, and Lahey Clinic, Boston, MA 
Identification of the triggers of sudden cardiac death (SCD) has been 
lmited by the difficulty in exact timing of occurrence of the event llinca many 
SCD are unwitnessed. The recant availability of Implantable cardioverter•
defibrillators {ICD) that record the tima of ventricular arrhythmias requiring 
either pacing or shock provides a unique opportunity to clarify the timing of 
onset of SCD. We studied 483 patients (406 men, mean age 63;!:12 years) 
in whom an ICD (CPI VENTAK PRx) was Implanted. Patients were followed 
for an average duration of 345;!:176 days, during which 12,820 episodes of 
ventricular arrhythmia (ventricular tachycardia or fibrillation) were recorded. 
The figure shows the 24-hour distribution of episodes with a harmonic 
regression curve fitted to the data. 
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A prominent peak of episodes occurred between 9 and 11 AM. Chi-square 
goodness-of-fit test showed that the 24-hour distribution of episodes wes not 
uniform (p<0.0001). 
This analysis indicates a moming peak of ventricular arrhythmias 
identified by objective data end not subject to bias due to inaccurate timing 
of events. Further studies with ICDs will enable a greater understanding of 
the timing and activities triggering SCD and facilitate the development of 
improved preventive measures. 
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899-69 
Clreadlan Pattern of Ventricular Tachyarrhythmlas In Patients 
With Implantable Cardloverter Defibrillators 
Mark A. Wood, Pippa M. Simpson, Wendy B. London, BNce S. 
Stambler, John M. Herre, Robert C. Bernstein, Kenneth A. 
Ellenbogen, Medical COllege of Virginia and McGuire Veterans 
Administration Medical Center, Richmond, VA and Sentara Norfolk 
General Hospital, Norfolk, VA 
Cardiac events such as myocardial infarction and sudden death follow 
circadian patterns. We tested the hypotheSiS that ventricular 
tachyarrhythmias (VT) detected by implantable cardioverter 
defibrillators (ICO) also follow a circadian distribution. The data logs 
from 43 patients (pt) with Telectronics 4210 or CPI PRx lC~'s 
provided the time (hr-min or hr-min-sec) and date of 830 VT episodes. 
No pt was taking beta blockers or had incomplete data logs or ICO 
detections from causes other than VT. Thirty-five pt had coronary 
artery disease, 8 pt had cardiomyopathy and the average follow-up 
was 226±179 days. The fitted sine curve distribution model assumed 
a 24 hour periodicity with 1 peak and 1 trough. The cumulative 
weighted hourly VT frequency for all 43 pt fit the model (p<0.05) with 
a peak at 3 PM and trough at 3 am. The frequency distribution for VT 
episodes receiving ICO therapy (42 pt), spontaneously terminating 
episodes (23 pt) and episodes from patients taking no antiarrhythmic 
dNgS (AAO) during fOllow-up (22 pt) fit the sine curve model, all with 
peaks between 2-3 PM (p<0.05). The frequency distribution of 
episodes from 15 pts receiving AAO continuously throughout follow-up 
did not fit the model (p>0.05). Conclusion: 1) Ventricular 
tachyarrhythmias detected by lC~'s show a circadian distribution with 
peak occurrence around 3 PM and 2) AAO therapy aKers this 
circadian pattern. 
899-70 
COnical Outcome of htlenta With Refractory Ventricular 
TachycardlalFlbri1tetion Treated With Implantable CerdIoverter 
DefibriUator and No Concomitant Antiarrhythmic Drug Therapy 
Abiodun G. Olatidoye, Diana Aarons, Juan Juanteguy, Enrico P. 
Veltri, Sinai Hospital, Baltimore, MD 
We assessed the clinical outcome and determinants of outcome in 
122 patients (pts) with refractory vantricular tachycardia 
(VT)lfibrillation (VF) treated with the Implantable Cardioverter 
Defibrillator (lCD) and discharged from the hospital on no 
antiarrhythmic drugs. Thare were 90 males and 32 females, age 62 
± 11 year.; cardiac disease: coronary 82, cardiomyopathy 23, other 
17. Ejection fraction (EF) was 37 ± 16%. Forty..,ight percent 
presented with sudden cardiac death (SCD). At 33 ± 25 months 
followup, 81 pts (66%) had received ICD discharges, with 53 pts 
(43%1 receiving symptomatic discharges. Thare were 22 deaths 
(18%) including 6 sudden cardiac, 9 nonsudden cardiac, and 8 
noncardiac deaths. Actuarial incidence of SCD at 1, 2, and 3 years 
was 1 %,6% and 7% respectively. Of 122 pts, 36 (30%, group n 
eventually received antiarrhythmic drug tharapy at 11 ± 1 0 months 
followup, while 86 pts (70%, group II) remained drug-free. 
Comparative analysis between groups I and II revealed no significant 
difference in sex, age, presenting arrhythmia, previous SCD episodes, 
baseline EF, inducibility of VT on electrophysiology study (EP) or 
incidence of nonsustained VT on baseline Holter or exercise stress 
test. Group I failed more drugs on EP-guided therapy (3.1 ± 1.7 vs 
1.8 ± 1.5; P <0.01). There was no difference in time to first ICD 
discharge, however group I had more symptomatic shocks prior to 
drug initiation (2.0 ± 1.9 vs 0.6 ± 2.5; P < 0.01) as well as more 
total shocks (10.3 ± 11.9 vs 3.5 ± 6.1; P < 0.001). Ufe table 
analysis revealed no difference in sudden, cardiac or total deaths 
between tha groups. 
Conclusion: ICD recipients discharged off antiarrhythmic drugs 
demonstrate a low incidence of SCD. Thirty percent eventually 
require drugs at approximately 3 year followup. Although, need for 
drug use is not predictable from baseline demographic and clinical 
variables in thase select patients, greater EP-guided drug feilures and 
more frequent ICD discharges correlate to future antiarrhythmic drug 
use. 
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899·71 
Occurrence of Spontaneous Shocks in Patients with 
Implantable Cardioverter Defibrillator Without any Shocks 
Before Generator Replacement for Battery Depletion 
Wolfram Grimm*, and Francis E. Marchlinski, Philadelphia Heart 
Institute, PA, *Philipps-University Marburg, Germany. 
The incidence of spontaneous shocks was analyzed in 26 
consecutive patients (pts, 56±15 y, EF: 38±15 %, coronary 
disease: 66 %, cardiac arrest: 76 %) with implantable cardioverter•
defibrillator (leO) who did not receive any spontaneous shocks 
before first generator replacement for battery depletion (29 ± 9 
months after initial lCD-implantation). 
R.sults: During 21 ± 19 months of follow-up after first generator 
replacement for battery depletion, 13 of the 26 study pts (50 %) 
received one or more spontaneous lCD-shocks. The actuarial 
incidence (Kaplan-Meier) of spontaneous shocks after generator 
replacement in pts who had remained frae of any shocks before 
generator replacement was 22 % and 42 % at 1 and 3 years after 
generator replacement for battery depletion respectively. 
Nine of the 26 study pts (35 %) received one or more shocks 
preceded by presyncope or syncope ("appropriate" shocks) upto 66 
mos after first generator replacement for battery depletion (up to 87 
mos after initialleD-implantation). ECG-documentation of VT or VF 
(Holter or telemetry monitoring or stored ECGs by the device) 
preceding spontaneous shocks was available in 4 of 26 pts (15 %). 
Conclusions: The first "appropriate" ICD shock may occur more 
then 5 years after generator replacement because of battery 
depletion and more than 7 years after initial leo implant 
respectively. The high incidence of spontaneous shocks and 
"appropriate" shocks after generator replacement for battery 
depletion in pts who had remained shock-free with the initial device 
warrants generator replacement in all patients, unless there is a 
contraindication to do so. 
899·72 
Sarety and Efficacy or Implantation or Cardioverter Defibrillators 
witb Non-Tboracotomy Lead Systems by Electropbysiologists 
S. Adam Strickberger, John D. Hummel, Emile Daoud, Brian D. Williamson, K. 
Ching Man, Carol S. Hasse, Alice Schmittou, Steven J. Kalbfleisch. Jonathan J. 
Langberg. Fred Morady, University of Micbigan, Ann Arbor, MI 
Traditional lead systems for implantable defibrillators (lCD's) require a 
thoracotomy for placement Non-thoracotomy lead systems (NTL's) are available 
and are usually implanted by an electtophysiologist and a surgeon. This study's 
pmpose was to prospectively evaluate the safety and efficacy of ICD implantation 
with a N11- by electrophysiologists. A consecutive series of 95 patients (mean 
age 60±t3 years) underwent N11- implantation while intubated and under general 
anesthesia. 74 patients had coronary artery disease, 13 bad idiopathic 
cardiomyopathy. and 8 bad miscellaneous heart disease. Mean ejection fraction 
(EF) was 29±t3%. 64 patients bad suffered a cardiac arrest and 31 had bad 
ventricular tachycardia or syncope. All patients except 10 underwent 
electrophysiologic testing and bad failed I±I drug trials prior to leo implantation. 
Of the 3 types of N11-'s used, 2 types could be implanted transvenously 
(Medtronic; CPI) with or without a subcutaneous patch (SCP; n=81) and 1 type 
required a SCP (lntermedics) as pan of the system (n=14). The NTL with an leo 
was successfuUy implanted in 92 patients (97%). Of the unsuccessful implants, I 
patient did not have venous access, the passive flX8tion lead in I patient would not 
remain lodged, and I patient had elevated DITs. The average defibrillation 
threshold (OFT) was 17±6 joules and correlated negatively with EF (r=O.2; 
p=O.03). Average procedure duration was 163±58 minutes and was 56% longer 
(p<.OOI) when a SQP was required (n=56). Patients were in hospital4.5±4 days 
post-implant, with no procedure-related deaths. Acute complications occurred in 9 
patients, 3 patients had lead dislodgements, 1 patient with previous abdominal 
surgery had his abdominal cavity entered without other complications while 
making the leo pocket. 1 patient had postoperative heart failure, 1 patient 
developed a large hematoma when anticoagulation therapy was initiated, and 3 
patients required reintubation due to excessive anesthesia. During 5±3 months of 
follow-up, 3 patients developed lead fractures. Conclusions: (1) implantation of a 
NTL leo can be performed safely and efficaciol!Sly by electrophysiologists; (2) 
utilization of a SQP correlates with longer procedure durations; (3) special 
precautions should be i2ken in patients with previous abdominal surgery; (4) 
although patients with lower ejection fractions tend to bave higher DFrs, NTL's 
nevertheless can usually be successfully implanted. 
ABSTRACTS 
899·73 
Classification of Shocks by History Versus Classification 
by Stored Electrograms in Patients With Implantable 
Defibrillators 
"Richard N. Fogoros, James J. Elson, Christopher A. 
Bonnet, lohn G. Chenarides, Allegheny General Hospital, 
Pittsburgh, PA 
The use of apparent appropriate shocks (APS) to 
estimate the efficacy of implantable defibrillators (lCD) 
has been said to overestimate the true incidence of 
appropriate ICD therapy. In 33 patients (pts) with lCD's 
which store intracardiac electrograms (IECG), we 
compared the incidence of apparent APS to the incidence 
of APS as tabulated by examining stored IECG. All 
unmonitored shock episodes were classified by history as 
being either APS (shocks which terminated episodes of 
syncope or presyncope), or as indeterminate shocks 
(lNDS). Later, all shock episodes were re-classified as 
either APS or inappropriate shocks (INAS) by examining 
the IECG. RESULTS: Seventeen pts experienced 38 
shock episodes. By history, 9/38 episodes (24%) were 
classified as APS and 29 as INDS. By IECG, 28/38 
episodes (74%) were APS, and 10 were INAS. All 
episodes classified by history as APS were confirmed as 
APS by IECG. Of 28 episodes of APS, 26 (93%) consisted 
of a single shock; shocks/episode = l.l±O.6. Only 1 of 10 
episodes of INAS (10%) consisted of a single shock; 
shocks/episode = 6.1±7.0 (p<O.OOI). Of 20 episodes of 
INDS consisting of a Single shock; 19 (95%) were 
re-classified as APS by IECG. CONCLUSION: 1) A strict 
clinical classification of ICD shocks underestimates rather 
than overestimates APS. 2) INAS are significantly more 
likely to occur as multiple shocks than are APS. 3) Single 
ICD shocks preceded by minimal symptoms are usually 
APS. 
899·74 
Is Antitachycardia Pacing Really an Advantage 
in Patients With cardioverter Defibrillators? 
*Hans-Joachim Trappe, Helmut Klein. 
University Hospital Hannover, Germany 
Third generation cardioverter-defibrillator 
devices (ICD) seem to represent real progress 
in ICD therapy because of anti tachycardia 
pacing (ATP) capability. It is, however, 
unproven if patients (pts) with ATP-ICD 
devices will have longt~rm benefit from 
sophisticated ATP programming. We analyzed 
the follow-up of 68 pts, mean age 57±11 years 
who received 3rd generation ICDs for re•
current inducible ventricular tachycardia 
(VT). All pts had inherent VT rates of <200 
bpm and underwent thorough pre-, intra- and 
postoperative electrophysiologic studies in 
order to define the most effective ATP mode. 
Results: Follow-up time was 12±8 months. 
Altogether 974 arrhythmia episodes (AE) 
occurred in 45 pts (68%). ATP was used in 840 
AE (86%) and terminated successfully 744 AE 
(89%). DC shOCks without initial ATP was 
necessary in 134 AE (14%). Disregarding the 
number of AE but counting only the number of 
pts with or without ATP success we found that 
only 4/45 pts (9%) had experienced ATP alone, 
ATP and leo shocks occurred in 36 pts (80%) 
and 5 pts (11%) had only ICD shocks. 
Conclusion: Although ATP is able to terminate 
many AE it remains an unreliable tool since 
the majority of pts with ATP ICD devices 
still need DC shocks_ Percentage of pts who 
benefit from ATP alone is astonishingly 
smalL 
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899-75 
Implantable Cardioverter Defibrillators (lCDs): Should 
Patients be Allowed to Drive? 
Anne B. Curtis, Jamie B. Conti, Roberta E. Reilly, Kelly J. Tucker 
University of Florida, Gainesville, FL 
ICDs are implanted frequently in patients at high risk for sudden 
death. Driving safety after implant is undefined. To date, no 
national consensus exists to guide physicians' recommendations. 
This study was undertaken to define the risk ICD patients pose to 
themselves and others while driving. In addition, current 
recommendation practices were examined. 
Methods: All US cardiologists involved in ICD implantations were 
identified and surveyed by mail. Frequency of motor vehicle 
accidents (MV As), as well as fatal and nonfatal injuries to patients, 
their passengers or bystanders, were compared to similar data 
derived from the US Bureau of Census. 
Results: 418 of 781 (54%) physicians surveyed responded, 
representing 48 states and DC. These respondents represent the 
majority of the approximately 35,000 patients who have had ICD 
implants in the US. The mean implant experience was 5.7 years 
(range:I-13 years). 87 of 418 (21 %) physicians advised complete 
driving restriction. The remaining 328 physicians advised either no 
restriction or a 1-24 month (mean=7.1±3.3 mo) shock free interval 
before resuming driving. 
The frequency of MVAs was low; 29 of 418 (7%) implanting 
cardiologists reported a total of 31 MV As, in which 8 fatal injuries 
and 23 nonfatal injuries occurred. This represents a minimum fatality 
and injury rate of 22.9/100,000 and 65.8/100,000 respectively 
compared to 19.2/100,000 and 4624/100,000 (p<O.OI) among all 
US citizens. All the fatalities occurred among patients with lCDs 
who were driving. Of the nonfatal injuries, there were 17 patients, 4 
passengers, and 3 bystanders involved. 
Conclusions: Recommendations for driving for lCD patients vary 
widely among cardiologists in the US. MVAs among lCD recipients 
occur at a rate comparable to the general population. However, 
fatalities may be more common among lCD recipients who drive. 
The need for a national policy is evident. 
899-76 
Improving Cost Effectiveness of the Transvenous Implantable 
Cardioverter Defibrillator. 
Patricia Guerrero, Andrew Hogan, Joseph Gardiner. E. David Mellits, 
Rosemary A. Baumgardner, David Rovner. Margaret Holmes-Rovner, 
Annette Mclane, Joseph levine, Sanjeev Saksena. lawrence Griffith, 
Joel Kupersmith. Departments of Medicine, Michigan State and John 
Hopkins UniversitieS and UMDNJ-The New Jersey Medical School 
Cost effectiveness (C/E) will be an important consideration in use of 
the transvenous (TV) implantable cardioverter defibrillator (ICD) for 
primary prevention of sudden death. We determined the incremental 
C/E of the TV ICD vs electrophysiology test (EP) guided drug therapy 
using: Michigan Medicare (1989-92), local physician visit, test and ICD 
charges; resource utilization from literature and expert opinion; 
effectiveness from 218 previously published ICD patients in whom time 
of 1 st event (1 st appropriate shock or death) was assumed to 
represent "control" (i.e., EP-drug) mortality; 1991$; 5% discount; 4 yr 
generator life; Markov decision model. We examined a number of 
assumptions related to improved C/E of the device. 
Results: C/E of TV ICD was $19,8001life yr compared to $27,000 for 
the transthoracic (TT) ICD. C/E's of the TV-ICD with various 
assumptions were: 
Assumption TV ICD ($lIife yr) 
Index CIE 19,800 
TV ICD with IT needed in 21% 23,500 
78% 1 st shock = death 22,500 
22% 1st shock = death 18,600 
± SE of charge for 1st hospitalization 25,500/14,100 
Eliminating preceding EP 12,000 
Ejection Fraction (EF) s 0.25 26,900 
Ejection Fraction> 0.25 18,300 
Conclusion: Thus, C/E's of TV ICD an be highly favorable under a 
variety of assumptions. These include patients with EF > 0.25. when 
preceding EP is eliminated and if device development permits higher 
rate of successful TV implant as is achievable with biphasic shock 
generators. 
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900-104 
Termination of CIrCUI Movement Atrial Flutter by the New Type-Ill•
Agent Dofetillde: Differential Effeell on the Componenll of the 
Reentrant Pathway 
Wolfgang Schoels, Bertram Offner, Kirsten D. Freigang, laurence D. 5tems, 
Alexander Bauer, Julia C. Senges, Wolfgang Kuebler, Johannes Brachmann, 
Division of Cardiology, University Medical Hospital, Heidelberg, Germany 
In the sterile pericarditis model, reentrant circuits are functionally deter•
mined and contain areas of normal (NZ) and slow (5Z) conduction. Termi•
nation of reentrant atrial flutter (AF) by type I agents is due to preferential 
depression of conduction in the SZ of the circuit. This study determines the 
effects of Dofetilide (0) on the components of the reentrant pathway. 
In 8 dogs with sterile pericarditis and inducible sustained AF, the total 
epicardial surface was mapped with a special electrode array containing 127 
bipolar electrodes. Activation patterns and local refractory periods (ERP) at 
16± 7 and 9±4 randomly selected sites in the NZ and 5Z, respectively, were 
determined before and after application of D (5j.lg/kg/min iV.). 
AF was due to single loop reentry around arcs of functional conduction 
block, often (n=5) adjoining one of the caval veins. An area of slow con•
duction, bounded by the central obstacle and the AV-ring, was integral part 
of each circuit D terminated AF in all dogs within 94±16 sec, preceded by a 
slight increase in cycle-length (143±12 vs. 157±11 msec, p<O.05). Termination 
was always due to conduction block in the 5Z. D primarily resulted in 
complete conduction block in the 5Z in 5 dogs. In 3 dogs, initially only 
partial conduction block occurred. Consecutive changes in the conduction 
path resulted in oscillations of cycle-length prior to termination. 
Termination finally resulted from complete block in the 5Z. D prolonged 
local ERPs in both, the NZ (132±10 vs. 154±1O, p<O.05) and the 5Z (135±8 vs. 
176±12, p<O.05). However, the relative increase in ERP in the 5Z exceeded 
that in the NZ significantly (31±11 % VS. 17±6%, p<O.05). At termination, 
ERPs in the 5Z had been prolonged beyond the revolution time of the 
circulating impulse. 
Conclusion' Termination of reentrant AF by D is due to conduction 
block in the 5Z of the circuit, resulting from a significant increase in local 
ERPs which exceede the increase in cycle length. The 5Z of the circuit seems 
to be the primary target for the action of D. 
900-105 
An Animal Model or Propafenone-lnduced Atrial ProarrhytJunia 
Moshen Nayebpour, Mario Talajic, Christine Villemaire, Stanley Nattel, 
Montreal, Canada 
Class Ic drugs such as propafenone (Pi) and flecainide can cause 
paradoxical acceleration of the ventricular response to atrial fibrillation 
(AF): sO-i:a1led "atrial proarrhythmia". To assess the mechanism of this 
phenomenon, we used bilateral vagal stimulation (0.1 ms duration, SV, 
4.8±0.S Hz) to induce sustained AF with a ventricular response of 60-
IOO/min in 4 morphine-i:hloralose anesthetized dogs. AV conduction 
properties during atrial pacing, and the atrial (A-A) interval histogram 
(AAH) and the ventricular (V-V) interval histogram (VVH) during AF 
were obtained under control conditions, and after the administration of 
loading doses (dose I, 0.5 mg/kg; dose 2, 1 mg/kg) and maintenance 
infusions of Pf. Pf did not alter AV nodal function, e.g. Wenckebach 
cycle length 24S±9 (SE) ms control vs 2S0± 11 ms (dose I), 2S2±8 ms 
(dose 2). The AAH was shifted to longer AA intervals by Pf (fig.), 
consistent with atrial conduction slowing, while the VVH was shifted to 
shorter intervals, indicating an accelerated ventricular response. 
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The median VV interval was reduced from 738± 122 ms (control) to 
666± 133* ms (dose I, "p<O.OS vs control) and 643±87 ms* (dose 2). 
Pf decreased the zone of concealment (difference between atrial and A V 
node effective refractory period (ERP» by increasing atrial ERP, and 
reduced the standard deviation of the VVH, reflecting decreased 
concealed conduction. 
Conclusions: I) Pf consistently accelerates the ventricular response to AF 
without altering AV node function; 2) in this model, atrial proarrbythmia 
is caused by Pfs action to reduce concealed conduction. 
JACC February 1994:1A-484A 
900·106 
Arrhythmo&enic Effects of Myocardial Stretch in Chronically Dilated 
and Failin& Ventricles 
Zifa Wang, L. Katherine Taylor, William D. Denney, David E. Hansen, 
Vanderbilt University, Nashville, TN 
Stretch-activated channels have been implicated in the genesis of 
arrhythmias induced by transient diastolic stretch in nonnal canine 
ventircles. Since clinically important ventricular arrhythmias arise most 
commonly in failing and dilated ventricles, we hypothesized that the 
arrhythmogenic effect of transient diastolic stretch would be enhanced in 
chronically dilated, failing canine hearts. Heart failure was induced in 7 
dogs by right ventricular pacing at 250 beats/min for 20.2 ± 1.6 days. The 
mean left ventricular (LV) short axis area ejection fraction decreased by 
62.4% (P < 0.001), as end-diastolic and end-systolic diameters increased by 
25.3% and 33.5%, respectively (P < 0.001). LV mass was unchanged. LV 
contractility, quantitated as the slope of the peak isovolumic pressure•
volume relation, was lower (1.6 ± 0.7 vs. 2.8 ± 0.3 mm Hglml, P < 0.01) in 
the heart failure group than in a control group comprised of IS nonnal 
hearts. SlAs were induced by a computerized ventricular volume servo 
pump that transiently increased LV volume by precise amounts (6 V) in 
early diastole. Pre-stretch volume (Vi) was selected to yield an end•
diastolic pressure of approximately 6 mm Hg in all hearts. The fractional 
increase in 6 V that produced SlAs 50% of the time (6 V 5oNi) was lower in 
the heart failure group (1.07 ± 0.34 vs. 0.78 ± 0.11, P < 0.01), indicating 
an increased sensitivity to SIAs as compared with nonnal ventricles. Thus, 
altered mechanical properties (i.e., higher levels of wall stress) and/or 
changes in the properties of stretch-activated channels predispose the 
chronically dilated and failing left ventricle to the arrhythmogenic effects of 
transient diastolic stretch. 
900·107 
Effects of a Combination of Hypoxia, Acidosis and GIacose-DepIetioa on tbe 
Transient Outward Current In Human Atrial Myocytes. 
Johannes Wiecha, Joachim Strcble, Andreas Hannekum"; Anita Ruepp, Vmc:ent 
Hombacb; Dept.ofCardiology,"Dept.ofCardiac Surgery, University ofUlm, 
Germany. 
The clIeets of a combination of factors, which are of importance during mycardial 
ischemia, w= studied on the transient outward current 0(10» in human atrial 
myocytes by means of the patch..cJamp tecImique (whole«il recording). 
The perfusion of the cardiomyocytes witb a hypoxic <POl- 4S mmHg), glucose-free 
and acid (pH=6.8) modified Tyrode solution caused a decrease in the 1(10).' After 
1 1/2 lDlDute of artificial perfusion, voltage..cJamp protocols from a holdliig 
potential of - 70 mY 10 test poIentia\s of - 40 10 + 90 mY (5IepS: 10 my) resulted 
in a significant reduCtion in the peak of ~IO) (Fig. A: comroi/Fig. B: artificial 
solution; examples of the voltage..cJamp protocol in one cell). When currenIs w= 
normalized, the I-V relation revealed a significant di1ference of 1(10) at +4Om V 10 
+90 mY (p<O.OI, 11"14, Fig. C: data IqRSeDt mean values).Comparing 
steady-state inactivation Or~lO) showed DC) marked changes between comrol and 
artificial conditions. 
We conclude tbat the transient outward cumnt in human atrial oel\s is sensitive 10 
the basic fadors of myocardial ischemia. In addition, it seems highly improbable, 
tbat 1(10) conmbutes 10 the weU-1tnow ceUular IC" loss in the early phase of 
myocardial iscbemia llnAl 
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900·108 
Mechanism of Termination of Circus Reentry in Ventricular 
Fibrillation 
Yong-Mei Cha, Ulrika Birgersdotter-Green, Paul L. Wolf, Barry B. 
Peters, Peng-Sheng Chen. UCSD and VA Medical Centers, San Diego 
and Cedars-Sinai Medical Center, Los Angeles, California 
It is known that circus reentry (CR) in ventricular fibrillation has a life 
span of only a few seconds. The mechanisms by which CR tenninates 
are unknown. In 6 open-chest dogs we perfonned computerized 
mapping studies on RV epicardium with an electrode array containing 
56 (7x8) bipolar electrodes separated by 3mm. Baseline pacing (SI) of 
10 rnA was given to 8 pacing sites on right edge of epicardium to 
create parallel activation wave fronts. A premature 50 V shock was 
given to a bar electrode on the upper edge to induce CR. A total of 
117 counterclockwise CR were induced; only 18 had more than 10 
rotations. In 47 episodes, CR drifted outside of the mapped region and 
the mode of tennination was not mapped. The CR in the other 52 
episodes tenninated after an average of 4.0 ± 2.0 rotations. The CR 
cycle length was 119±21 ms' The mechanism ofCR termination was 
due to conduction block when (a) reentrant wave fronts shortcutted 
through the core of CR (N = 23) or (b) an extrinsic wave front invaded 
the CR pathway (N=29). When block occurred, the leading edge of 
the wave front encountered tissue that had been excited within the past 
58± 12 rns (28-77 rns), corresponding to 47± 12% of the preceding 
ventricular fibrillation cycle length. In comparison, the recovery 
period in the same region that had allowed conduction averaged 91 ± 19 
rns (48-137 rns), corresponding to 72± 18% of the preceding 
ventricular fibrillation cycle length (p<O.OOI). Conclusion: (a) In 
intact ventricles the CR is unstable; it often drifts away from original 
site, or has a short life span. (b) The fibrillating ventricular cells have 
a refractory period between 48 and 77 rns. (c) Because the refractory 
period is much shorter than the ventricular fibrillation cycle length, a 
large excitable gap is present. (d) The large excitable gap contributes 
to CR tennination. 
900·109 
Role of Geometry and Timing in the Definition of Dual 
Atrioventricular Nodal Pathways 
Todor Mazgalev, Wanzhen Zeng, Patrick Tchou, Jose Jalife, University of 
Pittsburgh, Pittsburgh, PA and SUNY Health Science Center, Syracuse, NY 
Recenl studies suggested that slow (SPW) and fast pathway (FPW) 
electrophysiology is reflected in the atrioventricular nodal (A VN) conduction 
curves (CC) provided the site of atrial stimulation is appropriately chosen. We 
evaluated the hypothesis thai the variety of CC depend on the space-and-time 
properties of wave fronts initiated at the major A VN inputs. 
MnIwlIi: A) In 18 superfused intact rabbit heart preparations, using an 
A I-A2-A3 stimulation protocol, A3H3 vs A2A3 CC were generated with 
stimulation applied close to the crista tenninaUs (CrT) or interatrial septum (lAS). 
B) 9 preparations were modified by an incision through the base of the coronary 
sinus to fully disconnect the CrT insertion into the proximal A VN. CC were then 
generated by programmed stimulation at each of the A VN inputs and at both 
inputs with variable delays between them. C) An ionic model was developed 
incorporating SPW, FPW and a common pathway branches built of N-type cells 
as well as a distal region built ofNH-type cells. CC were generaled while varying 
the length, width or shape of the components of the model, the distal recovery 
properties and the phase difference between the inputs. 
~ In the intact A VN preparations, CC featuring transition between dual 
pathways were obtained when the stimulating site was the lAS. Mostly smooth 
CC were generated with the CrT stimulation. A VN preparations with separated 
inputs yielded families of CC reflecting the individual conduction properties of 
each input as well as the timing between them. Thus, combined stimulation of 
CrT and lAS resulted in either an improved conduction ("summation") or in a 
block ("cancellation"). An asymmetric Y -shaped model best reproduced the 
experimental results, which confinned the functional role of geometry and timing 
and suggested possible cellular mecbanisms involved in the interaction of the 
wavefronts. 
Conclusions' Dual pathway A VN electrophysiology requires functionally 
divided SPW and FPW which, in general, are activated asynchronously. The 
collision of wavefronts is phase dependent, can take place at different levels and 
produce phenomena of either improved or depressed conduction through the 
AVN. 
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900·110 
Comparison of Monophasic and Blphlslc Shocks In Csrdloverslon of 
Ventricular TachYClrdla In the Canine Infarct Model 
Richard L Callihan, Gregory P. Walcott, William M. Smtth, Raymond E. 
ldaker, Duke Universtty Medical Center, Durham, NC 
experimental and clinical experience demonstrates that blphaslc 
shocks are more efficacious than monophasic shocks for defibrillation. 
Clinically, more implantable cardloverter-defibrillator shocks are given for 
ventricular tachycardia (VT) than for ventricular fibrillation. We 
Investigated the effects of monophasic and blphasic shocks on the 
cardloversion of ventricular tachycardia. Alteen anesthetized dogs 
undeMent programmed electrical stimulation 4-6 days post·thoracotomy 
and proximal LAD ligation. A defibrillation catheter placed In the right 
ventricular apex served as the cathode, and a subcutaneous 3-lead 
electrode Introduced Into the left anterolateral chest wall was deSignated 
as the anode. A 6 ms monophasic and 6/6 ms blphaslc (single capacHor) 
waveform were delivered synchronized to the QRS of surface lead " 
during VT. A paired up-down cardioverslon prOtocol was utilized, 
beginning at 25% of the defibrillation threshOld. 
RESULTS: 8 of 15 dogs produced 286 episodes of sustained 
monomorphic VT wHh an average cycle length of 226:23 ms. Shock 
strength was "1 joule in 80% of episodes. Chi square analysis of shock 
outcome (succeedlfall) versus waveform used, revealed no sign~icant 
difference between waveform efficacy. Following failed shocks, the 
Incidence of post-Shock anhythmlas for monophasic versus biphasic was 
as follows: Identical VT by ECG (73%,61%); different VT (3%,11%); VF 
(24%,28%); AF (3%,1%); SVT (5%,3%). 
CONCLUSION: At very low energies, blphaslc shocks appear to be no 
more effICacious than monophasic shocks for cardloverslon of VT. 
Ventricular fibrillation did occur after failed cardloversion attempts 
emphasizing the need for dafibrillation backup. The mechanism(s) by 
which biphasic shocks are more effective than monophasic shocks for 
defibrillation do not appear to apply for low energy cardioversion of VT, 
and in fact may be entirely dffferent. 
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901·45 
New Ultrafast Computed Tomography Algorithm 
Can Accurately Predict Mass of Calcium in 
Diseased Coronary Arteries 
Robert Detrano, Weiyi Tang, Xingping Kang, 
Paiboon Mahaisavariya, Mike McCrae, Dan 
Garner, Shi Peng, Tina Meecham, Sabee Molloi, 
Dan Gutsinger, Jonathan Tobis, Sharon 
Nickerson, Bruce Brundage. Saint John's 
Cardiovascular Research Ctr, Torrance, CA. UC 
Irvine College of Medicine, Irvine, CA. 
The reliability and validity of currently 
used ultrafast computed tomographic (CT) 
coronary calcium scoring systems have been 
called into question. We derived a simple 
calibrated subtraction algorithm which 
estimates the actual mass of calcium 
phosphate (CaP) in diseased arteries. We 
tested it using diseased human coronary 
arteries embedded in an anthropomorphic chest 
phantom. This was imaged using a coronary 
screening protocol and the arteries were then 
incinerated and the actual mass of CaP 
determined. The algorithm was applied to the 
images to compute the CT 
mass estimates (see figure) . 
The linear fit was 
excellent, (y = 1.2x+8.5; 
r=0.99). This new algorithm 
was applied to 20 clinical 
cases by two independent and 
blinded observers. 
Interobserver agreement was 
good (r=0.97). This new 
method may be preferable to 
''''[2]' i: " .. ~, ~'" . . j,oo .' 
o 100 200 
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presently used scoring systems. 
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901·46 
CaD the Predlc:thoe Accunaq or Fast CT Detected Corollllry Calc:Ulc:atiOD 
be Improved by ModifyID& the Scoring Protocol? 
James A Fallavollita, Alan S. Brody and John M. Canty, Jr., University 
at Buffalo, Buffalo New York 
Although calcification detected by fast cr has been used to predict the 
presence of coronary artery disease, there is controversy regarding the 
number of voxels required to define a positive study and the extent of the 
coronary arteries that needs to be evaluated. Accordingly, we assessed 
the effects of varying these parameters on the sensitivity and specificity 
of fast CT in 106 patients having had coronary angiography. Significant 
disease was defined as ~SO% diameter stenosis. Twenty contiguous 3 
mm diastolic tomograms of the proximal coronary arteries were obtained 
during a single breath hold beginning 1 cm caudad to the carina. 
Significant calcification was defined as a density > 130 Hounsfield units 
in 1 (0.25 mm2) to 4 (1.0 mm2) contiguous voxels. We also compared the 
analysis of all 20 tomograms (20 Tomo) to the 10 tomograms (10 Tomo) 
that began with the most superior visualization of the coronary arteries. 
Sensitivity and specificity using these modifications are compared below: 
Sensitivity (%) Specificity (%) 
10 Tomo 20 Tomo 10 Tomo ~ 
~4 Voxels 
~3 VOllels 
~2 Voxels 
~1 Voxels 
83 
86 
88 
92 
85 
86 
88 
93 
55 
51 
45 
36 
45 
43 
36 
17 
Reducing the number of voxels required to define a positive study 
modestly improved sensitivity however, there was a marked reduction in 
the already compromised specificity. Restricting the evaluation to the 
first 10 tomographic levels improved specificity with little change in 
sensitivity. We conclude that the highest predictive accuracy of fast CT 
(71 %) occurs when using either 3 or 4 voxels to define a positive study 
and limiting the analysis to the proximal coronary arteries (10 tomograms 
or 3 cm). 
901·47 
'!be Value of Receiver cperat:illg O:Iaracteristic (ROC) 
Curve AIIalysis to Detect 00ra:Iary Artery Disease 
Detennine1 by 00ra:Iary Calcific:at:.i.cn em. tJltxafast cr 
(UPCr): A Illl tic:elltar SbJd:y 
Matthew BJdoff, Demetrios GeoIgiru, Alan S. Brcdy, 
Cllristcpher Wolfkiel, Arthur S. Agatstc:n, Warren R. 
Janowitz, William Stanford, Paul Shields, RdJert C. 
Detrano, Bruce H. Brun:lage 
Coralary calcificaticn (ex::) is associated with 
coronary atherosclerosis. UFCI' is sensitive in 
detecting ex::. o::ntroversy exist regarding the 
absolute coronary calciun score to be used. 'lbe 
p.upose of this study was to cg>l Y ROC analysis to 
determine the discriminatory power of UFCI' for 
angiographic disease. 531 patients were analyzed. 
Significant disease was defined as > sot luminal 
diarreter stenosis. 'lbe calciun score was cx:rrp.1ted 
using Agatstc:n's method. ROC analysis is depicted 
helCM. '!he false positive rate represents 1-
specificity. '!he area 
uOOer the ROC curve 
represents the ability 
of UFCI' to detect 
patients with S ••• 'tlvlly 
angiographic disease. 
This analysis inticates 
that UFCT can 
discriminate patients 
with significant 
disease regardless of 
the calciun score used. 
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e.. . ... " .... . 
1.7- .. . 
u c ....... . ..... . 
:~t... . .. ... . ... ": .. ' . 
........ -.,~+-.Q2 . 
....... u ....... o..o:, ...... 1 
FalSe poanlYe Rat. 
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901·48 
Variability in Quantitative Coronary Angiography: 
Higher Precision by Analysis in Consecutive Frames. 
Peter Lippolt, Katja Ehrhardt, Matthias Riedel, Wolf Rafflenbeul, 
Paul R. Lichtlen. Medical School Hannover, Germany 
Intrinsic variability limits the precision of quantitative coronary 
angiography. To evaluate the gain in precision we measured mean 
coronary segment diameters in consecutive frames of routine 
angiograms. 
In 144 randomly selected coronary segments with optimal 
contrast filling over more than two cycles, the mean vessel 
diameter was measured in 6 frames using the CMS analysis 
system (MEDIS, pixel size .099 ± .002 mm): (1) in 3 
consecutive frames (enddiastolic frame of one cycle, one frame 
before and one frame after), and (2) in the 3 corresponding 
frames of the next cycle. Assuming that there is no change in 
vasomotor tone between (1) and (2), all differences in the 
measurements represent errors introduced by the chain of image 
acquisition and analysis. 
~ Comparing the diameters measured in the enddiastolic 
frames (single), the mean value of 2 (double) and 3 (triple) 
consecutive frames, we found the following differences [mmJ 
between (1) and (2): 
SD mean min max 
single .112 .015 ·.43 .88 
double .095 .009 -.41 .69 p< .03 vs single 
triple .085 .011 -.38 .59 p< .001 vs single 
Conclusion' By analysis of 3 consecutive frames the intrinsic 
variability of image acquisition and analysis can be reduced 
significantly (p< .(01) down to the physical pixel size (.099 mm). 
This increased precision might improve the statistical power of 
quantitative studies analysing differences in vessel mean 
diameters. 
901-49 
Me .... rement of Absolute Coronary Flow by Tbree-Dimensional 
Reconstruction of tbe Coronary Arterial Bed: Experimental Results. 
Joseph B. Muhlestein, Qian Zhang, Daniel J. Parker, Taylor D. Boone, Dennis L. 
Parker, Jeffrey L. Anderson, University ofUtah, LOS Hospital, Salt Lake City, 
Utah 
A computerized system has been developed capable of reconstructing 
quantitative three-dimensional (3D) digital coronary images from multiple 
two-dimensional (2D) angiographic views. Through these measurements, a 
system for calculating the absolute blood flow of dynamic coronary arteries has 
been developed. Flow is obtained by measuring the transit time of the leading 
edge of contrast as it passes through a known volume of the arterial bed. the 
volume beiog detennined from three-dimensional reconstruction. 
To determine the feasibility and accwacy of such flow measurements, branching 
3D coronary flow phantoms, constructed of plastic tubing of diameters ranging 
from 2.0 mm - 6.0 mrn, were imaged io multiple 2D views and 3D reconstructed. 
Angiographic images of the leading edge of contrast were obtained duriog power 
coronary injections at flow rates ranging from 1-10 cclsecond. Absolute coronary 
flow within the phantom was calculated from transit time measwements along the 
siogle primary coronary branch or from the summation of transit times of all 
distal branches, and compared to true flow. Results are shown below. 
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Conclusions: Absolute coronary flow may be measured. using 3D reconstruction 
techniques, to a reasonable degree of accuracy io this experimental phantom 
model. Estimations of total flow obtained from the summation of all distal 
branches appear to be the most accurate. 
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901·50 
I. Impaired Exerclae-Induced Coronary Vaaomotlon In 
Hypercholesterolemic Patlenta Due to Microvascular Dysfunction? 
Christian Seiler, Otto Hess. Giuseppe Vassalli. Hans Peter Krayenbuehl. 
University Hospital, Zurich, Switzerland 
There have been only preliminary data on the relation betWeen serum 
cholesterol and exercise-induced coronary vasomotion in normal coronary 
arteries of patients (pts) without angiographic evidence of CAD. The aim of 
the present study was (1) to assess the influence of serum cholesterol 
levels on exercise-induced coronary vasomotor response in pts without 
CAD and (2) to determine ~ hypercholesterolemia and impaired exercise•
induced vasomotion might be associated in the presence of microvascular 
angina (MVA. coronary flow reserve, CFR < 2). Vasomotion of normal 
coronary arteries was evaluated in 22 pts without CAD at rest and during 
bicycle exercise. Luminal area change during exercise (Aex, % change 
compared to rest = 100%) was measured by biplane quantitative coronary 
angiography in two groups (gr) of pts undergoing diagnostic cardiac 
catheteriZation: gr1 14 pts (age 45 yrs) without CAD and With normal CFR. 
and gr2 8 pts (age 43 yrs) without CAD and with reduced CFR. The two 
groups did not differ with regard to Clinical parameters. frequency of 
coronary risk factors other than hypercholesterolemia and exercise 
workload. There was an inverse relation between the serum cholesterol 
level and Aex in the entire study group (figure). 
I 60' '9 Entire Study Gr 60', 
t 40~ 4().c, t v V '9 V v ~20~ 20 
~ . 
Il. Qr 1: Controls 
: .. Gr 2: MVA 
a • 
• o· _.Sx 
.20 r-O.50, p-O.OO5 • .20------"--
3 4 5 6 3 .. 5 e 7 
Cholesterol. mmoiA ChIlI •• ro!, mmoiA 
Conclusions: (1) In pts without angiographic evidence of CAD. exercise•
induced coronary vasomotion of the epicardial vessels is inversely related 
to the level of serum cholesterol. (2) Impaired exercise-induced coronary 
vasomotion in hypercholesterolemic pts occurs more often in pts with 
microvascular angina than in pts with normal CFR. (3) Thus, impaired 
vasomtion of epicardial coronary arteries probably results from a disturbed 
endothelial function of coronary resistance vessels due to an adverse 
effect of hypercholesterolemia. 
901-51 
Coronary Vasomotion and Serum Cholesterol In Anglographlcally 
Normal V ...... of Patient. with and without Coronary Artery Dlaease 
Christian Seiler, Otto Hess. Giuseppe Vassalli, Hans Peter Krayanbuehl. 
University Hospital, Zurich. SWitzerland 
The purpose of the present study was to test the hypothesis that 
coronary vasomotor response to exercise as a function of the serum 
cholesterol level is blunted in angiogarphically 'normal' vessels of patients 
(pts) with CAD compared to that in normal vessels of pts without CAD. 
Vasomotion of angiographically normal coronary arteries in 22 
control pts, age 44 yrs (gr1) and in 48 CAD pts, age 52 yrs (gr2: "normal" 
vessels; gr3: stenosed vessel segments) was evaluated at rest and during 
bicycle exercise. Luminal area change during exercise (MX in percent 
compared to rest = 100%) was assessed by quantitative coronary 
angiography in three serum cholesterol-groups: normal cholesterol (C1: 
<5.2mmolll). slightly elevated C (C2: 5.2-6.5mmolll) and markedly elevated 
C (C3: >6.5mmolll). Except for the frequency of myocardial infarction and 
NYHA-{;Iassification. the three groups did not differ with regard to Clinical 
variables, coronary risk factors and exercise c:~acity. 
Group Aex p 
C1 (<5.2mmolll) C2 (5.2-S.5mmolll) C3 (>6.5mmolll) 
gr1 +23% +20% +13% <0.01" 
gr2 -+37% +15% +2% <0.01 
gr3 -5% -13% -12% NS 
0 <0.01" <0.01" <001 
• :NSbetween C1 andC2 (by AN )VA) . ": NS between gr1 and gr2 (by ANUvA) 
Conclusions: (1) Coronary artery vasomotor response to exercise is 
inversely related to the degree of hypercholesterolemia in angiographicaliy 
normal vessels of pts with and without CAD but it is not related to serum 
cholesterol in stenosed vessel segments. (2) Exercise-induced coronary 
vasomotion of the normal vessel is dependent on the degree of 
hypercholeterolemia and is blunted in pts with CAD compared to those 
without CAD. (3) Thus. in hyperchOlesterolemic pts with CAD coronary 
vasomotion of angiographically normal vessels is impaired probably due to a 
direct effect of cholesterol on the endothelial function and/or due to 
undetected early atherosclerosis. 
210A ABSTRACTS 
901-92 
Relationship of Left Main Coronary Dimension to Branch 
Vessel Size: A New Index for Detection of LMCA Disease 
John Elliott. E. Murat Tuzcu. Skip Guyer. Jeff Lefkovits. Anthony C. 
De Franco and Steven E. Nissen. Cleveland Clinic. Cleveland OH. 
Objectives: The severity of disease in the left main coronary artery 
(LMCA) is often underestimated by percent stenosis measurement 
because of the absence of a normal reference segment within its short 
length. We sought to use angiography and intravascular ultrasound to 
determine the relationship of normal LMCA size to branch vessel size. 
Methods: We measured LMCA diameter by quantitative angiography 
(QCA) and intravascular ultrasound (IVUS) in 25 consecutive recent 
transplantation recipients «12 months post-transplant) in whom 
ultrasound confirmed the absence of significant intimal thickening 
(mean intimal thickness <0.25 mm.) The ratio of LMCA diameter to 
the sum of LAD plus LCx diameters was computed for both IVUS and 
QCA. Values were compared by T-test and regression. 
Results LMCA LAD L.Cx diameter area 
diameter diameter diameter ratio ratio 
QCA 4.95 4.00 3.70 0.65 0.83 
± 0.68 ±O.68 ±0.70 ±O.04 ±.11 
IVUS 4.78 3.56 3.70 0.68 0.90 
±O.71 ±O.70 ±.55 ±.08 ±.13 
P value NS NS NS NS NS 
RegreSSIOn analYSIS revealed a close relationship between 
angiographic and IVUS ratios of LMCA to LAD and LCx. This 
relationship was unchanged in early atherosclerosis (normal 
angiograms with intimal thickening by IVUS). 
Conclusions: We conclude that normal LMCA dimensions can be 
reliably calculated using the diameter of branch vessels measured by 
QCA or IVUS. Routine use of predicted diameter could yield amore 
accurate assessment of LMCA disease in patients with difficult to 
interpret angiograms. 
901-93 
Follow-up of Asymptomatic Individuals witb High Coronary 
Calcium Scores on UFCf Scans 
'tBruce H. Brundage, 'tStuart Rich, 'William Rassrnan, tChristopher 
Wolfkiel, tDemetrios Georgiou. 'Bruce Friedman. tSharon Nickerson, 
tHarbor·UCLA Med. Ctr., Torrance,CA; tUniversity of Illinois. 
Chicago, IL. 
Coronary calcium (CAC) is nearly always associated with coronary 
atherosclerosis. Published evidence suggests that the greater the amount 
of CAC the greater tbe severity of atherosclerosis. To test this 
hypothesis, 100 consecutive completely asymptomatic males with 
unusually high CAC scores on UFCT scan (Agatston method. ~ mean -
·2 S.E.M. for CAD patients) were surveyed to determine their clinical 
status. 65 subjects responded. The average interval from scan to 
follow·up was approximately 6 months. Two experienced myocardial 
infarcts (3%) and 5 additional patients had angioplasty or bypass surgery 
(8%). 8/38 individuals had a positive ECG and/or radioisotope stress 
test (21%). 
12 patients had coronary angiography and II (92%) demonstrated 
coronary narrowing. 8112 (75%) had a stress test prior to angiography 
and it was positive in 5 (63%). Patients with clinical events (11%) had 
CAC in all 3 coronary vessels. 
These findings support the hypothesis that very high CAC scores, even 
in completely asymptomatic individuals, are associated with a high 
incidence of clinically significant coronary disease. Cost efficient clinical 
algorithms need to be developed to identify the 10·20% of asymptomatic 
individuals with high CAC scores who have significant disease. 
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902-86 
Changing Patterns of Pharmacological Treatment after 
Myocardial Infarction. The GISSI Experience. 
Roberto Latini, Fausto Avanzini. Giulio Zuanetti, Aldo P. Maggioni, 
Maria G. Franzosi, Eugenio Santoro. Gianni Tognoni on behalf of 
GISSI Investigators, Italy 
Pharmacological treatment of post-myocardial infarction (MI) 
patients has been the focus of several clinical trials. It is not known 
how these data are transferred into clinical practice. We evaluated 
drug prescription at discharge in a total of almost 40.000 patients 
enrolled in the different GISSI studies. from 1984 up to July 1992. 
The table shows prescriptions at discharge for several major classes 
of cardiovascular drugs. 
GISSI-l GISSI-2 GISSI-3pilot GISSI-3 
Randomized pts 11806 
Start-end 2/84-6/85 
Beta-blockers 10.3% 
Ca++-antagonists 51.1 % 
Digitalis 19.3% 
Antiarrhythmics 11.9% 
Diuretics 13.9% 
·preliminary analysis 
12490 
2/88-7/89 
25.0% 
36.5% 
9.0% 
10.7% 
18.7% 
1526 
1/91-3f)I 
25.3% 
24.4% 
7.5% 
8.0% 
18.3% 
11,564* 
6f)I-8/92 
31.1% 
19.9% 
5.8% 
6.2% 
16.1% 
Drug prescription was mantained in the majority of patients at 6 
months of follow-up. Specific subgroups of patients showed 
different trends of use. 
These data indicate that use of beta-blockers at discharge after MI 
consistently increased over 10 yrs; conversely use of calcium•
antagonists, digitalis and antiarrhythmics progressively decreased. 
The changing pattern of pharmacological treatment post-MI might 
have contributed to the overall decrease in mortality. 
902-87 
Prescription of Calcium Antagonists after Myocardial 
Infarction. The GISSI Experience. 
Giulio Zuanetti. Roberto Latini, Fausto Avanzini. Enrico Nicolis. 
Fabio Colombo, Aldo P. Maggioni. Maria G. Franzosi. Gianni 
Tognoni. on behalf of GISSI Investigators, Italy 
Calcium antagonists are widely used in post-MI patients; however. 
results obtained in clinical trials with these drugs have been mixed. It 
is not known how these data are transferred into clinical practice. We 
evaluated drug prescription of calcium antagonists (CA) at discharge 
in a total of almost 40.000 patients enrolled in the different GISSI 
studies, from 1984 up to July 1993. The table indicates percent 
number of prescriptions for CA at discharge, as well as data for the 
three major drugs: diltiazem, nifedipine and veraparnil. 
GISSI-l GISSI-2 GISSI-3pilot GISSI-3 
Randomized pts 11806 12490 1526 11.564· 
Start-end 2/84-6185 2/88-7/89 If)I-3/91 6/91-8/92 
Total CA (%) 51.1% 36.5% 24.4% 19.9% 
DiItiazem (%) 13.6% 13.7% 9.4% 6.9% 
Nifedipine (%) 30.3% 16.7% 8.7% 6.3% 
Veraparnil (%) 8.9% 4.1% 1.7% 1.4% 
·prelirninary analysis 
Drug prescription was mantained in the majority of patients at 6 
months of follow-up. Specific subgroups of patients (non-Q MI. 
post-infarction angina etc) showed different trends of use. 
These data indicate that (a)use of CA at discharge after MI 
consistently decreased over 10 years (b) trend of use shows wide 
difference among major compounds (c) negative results in clinical 
trials with nifedipine have strongly favoured the declining use of 
other calcium antagonists despite mixed (MDPIT. diltiazem) or 
positive (DAVIT-II, verapamil) results in some subgroups of post•
MI patients. 
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902·113 
S1d. Btteets ot BDalaprll 111 raUats vith Lett 
Vatrioular DysruoUon 
John B. lostis, Lawrenoe Crull, Park W. Wlllis, William 
B. Hood Jr., Jettrey L. Probsttield tor the SOLVD 
Investigators. DMDHJ-Robert Wood Jobnaon Medioal 
Sahool, Rew Bl'IIIl81fiok, Hew Jersey 
Angiotensin oonverUng enzyme 1IIh1bitors relieve 
sympto_ and iaprove hemodynamio ruotion ad prognosis 
ot paUats with lett ventrioular dystunotion (LVD). 
However, there are oonoerna that adveree eftects may 
lilll1t the generalized use ot these agents. 
In the Studies ot Lett Ventrioular DystunoUon (SOLVD), 
enalaprll 2.5 to 20 IllS daily or utoh1ng plaoebo was 
adIII1Distered in a double blind teshion to 6769 patients 
vith ejection traotion ~0.35. During 40 months 
average tollow-up, patients reported side eftects (S8) 
and side ettects resulting in disoontinuation (Diso) as 
tollows. Plaoebo lnalaprll 
(n=3387) (n=3382) 
S8' Diso' S8' Diso' 
ADy Side Eftect. 16.2 8.8 28.5 15.5 
Symptomatio B7potension. 4.9 1.5 10.8 3.6 
Skin Besh 1.2 1.0 1.5 1.2 
uotemia· 1.4 0.7 3.3 1.8 
Dizziness/Fainting· 3.8 1.5 7.3 3.3 
Fatigue· 3.7 1.7 5.2 2.6 
lause. 1.3 0.7 1.7 1.1 
Cough. 1.7 1.2 11.11 2.8 
Other S1de Eftects 8.7 11.7 12.9 6.6 
.p<0.05 between enalapril and plaoebo 
Thus, enalaprll 18 well tolerated by patients with LVD; 
however, hypotension, azotemia, oough, tatigue, and 
other side ettects result in disoontinuation of therapy 
in 15.5' of the paUents oomparad to 8.8' of those 
receiving plaoebo. 
902·114 
Role of Calcium Channel and a·Adrenoceptor Antagonism 
In Estrogen·lnduced Vasodilation In Coronary 
Conductance and Resistance Arteries. 
Krishnankutly Sudhir, Tony M. Chou, William l. Mullen, Peter 
Collins, Paul G. Yock, Kanu Chatte~ee. University of Califomia, 
San Francisco, CA. 
We have previously reported that acute estrogen administration 
induces vasodilation in canine coronary conductance and 
resistance arteries. To further examine the mechanisms of its 
action, we studied the interaction between (i) calcium channels 
and (Ii) a-adrenoceptors, and estrogen-Induced vasodilation 
(111M, intracoronary) In epicardial and resistance coronary arteries 
In vivo In 6 dogs. Changes in coronary flow velocity were 
assessed using a 0.014" Doppler guldewlre (Cardiometrlcs). and 
epicardial cross-sectional area (CSA) was measured using a 
4.3F. 30 MHz ultrasound imaging catheter (CVIS). Interaction 
with calcium channels was studied by measuring estrogen· 
induced vasodilation before and after intracoronary verapamil 
(0.1I1M). Effects on a-adrenoceptor function were examined by 
obtaining concentration-response curves to intracoronary 
phenylephrine (0.1 nM to 0.1I1M). pre- and post-estrogen. 
Estrogen (111M) induced a significant increase in both CSA 
(7.4±1.4%) and flow velOCity (23.8±3%, p<0.01). Pre-treatment 
with verapamil decreased estrogen induced epicardial 
vasodilation from 7.4±1.4% to 4.3±O.4% (p<O.01), but had no 
effect on percent dilation in resistance arteries. Estrogen had no 
effect on a p'henylephrine dose-response curve in the coronary 
arteries, With a maximal vasoconstrictor response (0.1I1M 
phenylephrine) of 4.5±O.8% pre-estrogen and 4.4±O.9% post•
estrogen in the epicardial arteries, and 20.3±2.6% pre- and 
21.6±4.3% post-estrogen in the microcirculation. We conclude 
that acute estrogen-induced epicardial vasodilation may in part 
be via a calcium antagonist effect, and that estrogen does not 
acutely influence a-adrenoceptor mediated sympathetiC 
vasoconstriction in either large or small coronary arteries. 
ABSTRACTS 
902·115 
Anti· Anginal Effects of S.Nitroso.Captopril to Coronary 
Artery and on Platelets 
Masayuki Takahashi.lchiro Nakae, Motoya Amano, Masahiko 
Kinoshita, 1st Department of Medicine, Shiga University of Medical 
Science, Seta, Ohtsu, Shiga, Japan 
Beneficial effects of captopril for patients with acute myocardial 
infarction are established. We explored anti-anginal effects of S•
nitroso-captopril (S-NO-Cap), which is synthesized from exogenous 
captopril and intrinsic EDRF or exogenous organic nitrates. S-NO•
Cap is a hybrid compound of angiotensin converting enzyme 
inhibitor (ACEI) and s-nitrosothiol or EDRF and was synthesized 
chemically from captopril in our laboratory. Anti-platelet effects of 
S-NO-Cap were explored with ADP induced aggregation in human 
platelet rich plasma and with thrombin induced calcium mobilization 
in Fura-210aded washed platelets. S-NO-Cap inhibited ADP 
induced platelet aggregation in a dose dependent manner with IC50 
value of 2.5 ~, which is equipotent as sodium nitroprusside and S•
NO-albumin. In addition, S-NO-Cap (\O~) inhibited cytosolic 
calcium mobilization significantly and markedly by 90.0%. 
Nitroglycerin exhibited same effects with much smaller potency. 
Vasodilatory effects of S-NO-Cap were explored with pentobarbital 
anesthetized dogs. S-NO-Cap (50 I'g, bolusly, i. v.) induced a 7 % 
increase of coronary artery diameter, a \0 % decrease in mean blood 
pressure, a 63 % increase in coronary blood flow, a 26 % increase in 
heart rate and a 50 % decrease in coronary vascular resistance. 
These responses are different from those of captopril but were quite 
similar to those of nitroglycerin.These results demonstrated that anti•
anginal effects of S-NO-Cap are mainly due to EDRF like functions. 
902·116 
211A 
DissocIation of Coronary VucuIar Tolerance and Neurohormonal 
Adjustments During Long-Term Nitroglycerin Infusion in Patients with 
Coronary Artery Disease. 
Thomas Miinzel, Sabine Kurz, Thomas HellZer, Qemens Luhmann, Hanjorg 
Just, Medizinische Klinlk III, Freiburg, Germany 
Prolonged nitroglycerin (NTG) therapy is associated with increased plasma 
renin activity (pHA), aldosterone (AIDO) levels, and a decrease in hemato•
crit (HCT) secondary to salt and water retention. It is assumed that NTG 
tolerance is in part due to these neurohormonal adjusanents. We sought to 
examine this hypothesis and to determine If the loss of vascular effects on 
large epicardial arteries parallel temporally these neurohormonal adjust· 
ments. Three groups were studied. Group I (n= 10), no prior NTG therapy, 
Group II (n= 10) and Group III (n=8) 24 and 72 hr chronic NTG infusion 
respectively. As an index of NTG tolerance, we used the capacity of 
infusions oflarge concentrations of nitroglycerin superimposed on ongoing 
NTG ueattnent to cause further vasodilatation. We reasoned that additional 
higher concentrations of NTG would be unable to vasodilate vessels max· 
Imally dilated by NTG, while vessels in whom NTG effect was lost because 
of tolerance would be dilated by these larger amounts of the drug. In group 
I, increasing concentrations of NTG (0.05. 0.15, 0.5 !£S'kgImin i.v. and 0.2 
mg i.c.) caused a dose dependent dilation of the mldporton of the left 
anterior descending (lAD) by 23±3%. In group II, (n=lO, 0.5 I'-glkg/min) , 
additional i.v. and i.c. NTG challenges did not cause further dilation of the 
LAD indicating that this vessel is maximally dilated. At the same time PHA 
and AIDO increased while HCf fell significantly below baseline values. In 
conuast, the diameter changes observed in patients having received NTG for 
a 72·hr period (group III) did not differ from those of the conuol group 
(maximally +20±3%). This indicates that under ongoing NTG infusion the 
diameter of the LAD had returned to preinfusion values. Now. PHA and 
AIDO of group III did not differ from preinfusion values. Considered 
together, the dissociation between neurohormonal adjusanents and vascular 
tolerance in coronary arteries suggests that during the early phase of l\iTG 
infusion, neurohormonal activation rather than a desensitization of the 
vascular smooth muscle to NTG is the predominant tolerance mechanism. 
Within 3 days of continuous NTG treatment, however, tolerance develops 
in epicardial arteries which, In the absence of further neurohormonal 
activation, may be related at least In part to an Inuacellular tolerance step. 
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902·117 
Proof for Piroximone's Inotropic Effects; Does this Make 
it a Therapeutic Risk in Coronary Artery Disease? 
'Jochen Thormann, Jorg Neuzner, Hans A Dieterich, Martin 
Schlepper, Kerckhoff-Klinik der Max·Planck-Geselischaft, 
Bad Nauheim, Germany 
Improved contractility after applying piroximone (P), the 
new phosphodiesterase·1II inhibitor drug, is difficult to prove 
clinically. However, augmented contractility could increase 
the risk of myocardial ischemia when used in CAD. Analysis 
of the end·systolic pressure-volume relationship (EPVR) as a 
load·independent parameter of the contractile left ventricular 
(LV-) function allows for differentiation of P's effects: 
contractility versus unloading. We, therefore analysed EPVR 
and LV-function in 16 CAD-patients before and after P, 
0.7Smg/kg i.v .. Emax (conductance technique) increased by 
39% and loops of the EPVR moved leftward, indicating 
improved contractility. The delta % changes P versus control 
demonstrated augmentation of LV·function via unloading: LV•
volumes decreased (end-systolic volume by 37%, end•
diastolic by 19%), LV·filiing pressure by 34%, and systemic 
vascular resistance by 19%; dP/dtmax increased by 28%, LV•
efficiency by 24%, cardiac index by 21% and ejection fraction 
by 13%. Pacing-induced anginal threshold increased by 47% 
after P while ischemic post-pacing LV·filiing pressure and ST•
segment changes tended to normalise under the drug's 
influence. Thus, P improved LV-function both, by unloading 
and by positive inotropy. Lack of P-induced angina and an 
increased anginal threshold indicate that the drug can be 
used without inducing ischemia in CAD-patients. 
902·118 
Acute Camitine Administration Improves Left VentriaJlar Ejec. 
tion Fraction in Type I Diabetics Without Cardiac Ischemic Di· 
sease. 
Roldano Scognamiglio. -Romano Nosadini. -Angelo Avogaro. Giuseppe Fasoli. 
Stefano Nistti. Monica PaIisi and -Gaetano Crepaldi. 
Dpml of Canlioiogy and -Institute of Clinical Medicine. Padua University. Padua. 
Italy. 
The risk of cardiac failure is 3-5 fold higher in Type I diabetic than in oon-diabe•
tic subjects and is notfully explained by ischemic heart disease. Itbas been sugge•
sted tbatimpaiml Krebs cycle activity secondary lOexcessivedelivery ofllpids 10 
heart leads k> ~ availability of A TP.lA:ami1ire ha; been shown 10 imjmve Krebs 
cysle activity, possibly incJesing Co-A availability. 
The aim of the present study was 10 investigate as 10 whether acute L-eamitine (I 
g110 Kg body weight).e.v. administration. improves cardiac performance in Type 
I diabetics with disease duration longer (group A: 5). or shorter (group B: 8) than 
10 years. without ischemic heart disease • and with comjllll1lble metabolic control 
(HbAlc%: Group A :9.3±O.9 vs Group B: 8.S±O.6, p:: NS). LV performance was 
evaluated during handgrip and exercise stress tests by 2D ecbocardiographic 
monitoring. In Group A, L VEF increased significantly from S9.2±61O 6S.2±S% 
during handgrip. and from 5S.6±5 k> 71.2±6% during dynamic exercise, p<O.OS for 
botb.aftercamitine.whereasadecreaseand/ortheabsenceofasignificant increa•
se wa<l obuved during placebo. Neither camiline or placebo dlanged L VFF in Group 
B. In Group A. the improvement in L VEF during the dynamic exercise after carni•
lire. wa<l ESOCiaIed with gmIter decreaie in Nood keIme body (KB) than afelrplacebo 
(-140±23 uM/l vs43±12, p<O.OI). 
In conclusion. LV dysfunction induced by exercise characterizes Type I diabetics 
with a more than 10 years durntion of the disease. without ischemic heart disease 
and it is reversed by acute L-earnitine administration possibly through a better 
utilization of KB by LV myocardium. 
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902·119 
Coronary Microvascular Response to Intracoronary 
Administration of Nicorandil in Humans: Comparison with 
Intracoronary Papaverine 
Hongo M, Takenaka H, Uchikawa S, Nakatsuka T, 
Watanabe N, Shimojo T, Yamada H, Okubo S, Sekiguchi M. 
Shinshu University, Matsumoto, Japan 
Nicorandil (N) is an antianginal drug with potent coronary 
vasodilating properties of both epicardial and resistance 
vessels. However, the microvascular dilatory capacity of this 
drug has not yet been evaluated in humans. To assess the 
dose-response kinetics of bolus injections of intravenous N 
(0.1-1.5mg) and to compare the vasodilatory response to N 
with that ~f intracoronary papaverine (P), coronary blood 
~ow velOCity was measured in 30 patients using a 3F 
Intravascular Doppler catheter. Continuous intravenous 
nitroglycerin 6·8lJg/min was infused to achieve maximal" 
vasodilation of the epicardial vessels. Intracoronary N 
caused a dose·dependent increase in coronary blood flow 
and a decrease in coronary resistance. Maximal 
vasodilating effects equivalent to those obtained with P were 
~nduce~ with N 1.5 mg in the left coronary artery and 1.0mg 
In the nght coronary artery. The duration of hyperemia was 
significantly shorter after each dose of N than after P. N 
caused no clinical symptoms or significant changes in 
systemic hemodynamics and electrocardiographic variables, 
whereas P produced a significant reduction in mean aortic 
pressure and a prolongation of aT interval. 
These results indicate that bolus injection of intracoronary 
N can s~fely, quickly, and reliably induce maximal coronary 
hyperemia comparable to that achieved with P in humans. 
902·120 
Intracoronary Injection of Thromboxane (TX) A2 Synthetase 
Inhibitor is Effective to Relieve Coronary Spasm Induced 
by Acetylcholine. 
Shozo Sueda, Naoto Ochi, Yutaka Hayashi, Tadao Uraoka, 
Haruhisa Hashimoto*, Kita Ishikai Hospital, Ozu 
and *Yoshida General Hospital, Yoshida, Japan 
To determine the effects of '!'X A2 synthetase inhibitor 
on coronary spasms induced by either acetylcholine (ACh) 
or ergonovine maleate (EM), we injected Ozagrel Na (X), 
a (Xlstent TXA2 synthetase inhibitor, into 34 coronary 
arteries from 25 patients with vasospastic angina (mean 
age:63 years, range:45-78 years, 21 men and 4 women). 
24 vessels were provoked by ACh and 10 were by EM. 
X was injected bolously at doses of 20mg dissolved in 
5ml saline when coronary spasms were disclosed. The 
efficacy of intracoronary injection of X was 
significantly higher in spasms induced by ACh than in 
spasms induced by EM (21/24(88%) vs 2/10(20%) p<O.Ol). 
In contrast, the need of intracoronary administration 
of nitroglycerine was remarkably higher after EM test 
than after ACh test (8/10(80%) vs 0/24(0%) pKO.01). 
In some cases, the degree of vasodilatation after X was 
same as nitroglycerine. In conclusion, intracoronary 
~njection of X is highly effective on coronary spasm 
l.nduced by ACh, but not on those induced by EM. The 
difference may be due to endothelium dependent and 
vascular srrooth muscle dependent mechanisms involved in 
vasospasm in patients with vasospastic angina. 
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903-94 
Adverse Effect of Aspirin on Water Metabolism In Severe 
Heart Failure Treated with Enalaprll 
Donald Hall, Werner Rudolph. 
German Heart Center, Munich, Germany 
The systemic vasodilation of angiotensin-converting enzyme (ACE) 
inhibition in heart failure can be counteracted by aspirin which is 
frequently used concomitantly. To determine if the prostaglandin 
synthesis inhibition of aspirin also affects free water clearance, serum 
sodium and plasma osmolality were monitored from baseline to the 
end of a S-day study in which 18 patients with severe heart failure 
(mean ejection fraction 23.9%; mean pulmonary artery pressure 34.9 
mmHg; mean cardiac output 3.6 IImin) received double placebo, 
enalapril (10 mg) plus placebo and enalapril plus aspirin (350 mg) 
according to a randomized, double-blind, crossover protocol. 
Thus, in severe HF, a standard dose of aspirin can not only offset 
direct hemodynamic benefits of ACE inhibition but also impose a 
further burden on circulatory homeostasis by increasing total body 
water. Presumably mediated through forfeit of the inhibitory action of 
prostaglandins on arginine vasopressin, the Changes in fluid volume 
and composition were of sufficient magnitude to result in significant 
decreases in plasma osmolality and serum sodium concentration, in 
some patients, approaching and into the hyponatremic range. In part, 
the adverse effect on water metabolism, as well, could contribute to 
the consistently less favorable outcome of treatment reported in the 
major heart failure studies with ACE inhibitors in patients taking 
aspirin. 
903-95 
The Effect of Low-Dose Aspirin on the Acute Hemodynamic 
Response to Enalaprilat in a Canine Model of Heart Failure. 
Mark A. Evans, Lawrence L. Aarhus, John C. Burnett, Margaret 
M. Redfield, FACC, Mayo Clinic, Rochester, MN 
Angiotensin converting enzyme inhibitor (ACEI) therapy for 
congestive heart failure (CHF) is indicated in many patients with 
coronary artery disease. in whom therapy with low-dose aspirin 
(AS A) is of proven benefit. While a recent study reported that 
325 mg ASA blunts the acute hemodynamic response to ACEI in 
humans with CHF, this finding has not been confirmed. The 
current study examined the acute response to Enalaprilat . (0.625 
mg iv) in the absence (n=6) and presence (n=5) of chronic low•
dose ASA (325 mg/day x 4 days) in chloralose-anesthetized dogs 
with severe, chronic CHF due to rapid ventricular pacing (250 
bpm x 12-14 days). Both groups were characterized by similar 
baseline activation of renin (CHF: 4.6±1.2, CHF+ASA: 5.6±1.5 
nglmllhr), aldosterone (CHF: 1l0±40, CHF+ASA: 64±32ngldl) 
and atrial natriuretic peptide (CHF: 238±60, CHF+ASA: 243±52 
pg/ml). Below are hemodynamics at Baseline and at 15 and 60 
minutes after iv Enalaprilat: 
Baseline 
MAP CHF 114±6 
(mmHg) CHF+ASA 110±7 
PCWP CHF 26±2 
(mmHg) CHF+ASA 26±2 
SVR CHF 5561±908 
(dyne·sec· CHF+ASA 4500±537 
cm-5) *=p<0.05 vs. Baseline 
15 min 
95±6* 
96±8* 
22±2* 
22±2* 
4205±707* 
3664±515* 
60 min 
104±9* 
109±8 
22±2* 
24±2 
5378±517 
4415±781 
Hemodynamics were not different between CHF and CHF+ASA 
at Baseline or following Enalaprilat. 
Conclusion: Chronic low-dose ASA did not alter the baseline 
hemodynamic or neurohumoral profile in experimental severe 
CHF. Furthermore, although there was a trend towards a 
shortened reponse, low-dose ASA does not attenuate the acute 
hemodynamic response to ACEI in experimental severe CHF. 
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903·96 
Angiotensin Converting Enzyme Inhibition In Combination with Low 
Dose Salicylate In Heart Failure Patients: Effects on Renal Function 
Leo H.B. Baur. Johan J. 5chipperheyn. Volkert Manger Cats. Johan 
H.M. 50uverijn. Albert V.G. Bruschke. University Hospital. Leiden. 
The Netherlands. 
Nonsteroid antiinflammatory drugs (N5AID) and angiotensin 
converting enzyme inhibitors (ACE!) both reduce glomerular filtra•
tion in patients with congestive heart failure (CHF). Combined use 
is often discouraged. because the potential hazard of renal failure. 
Additionally. N5AIDs are believed to reduce the unloading effect of 
ACEls in all patients. To study acute and chronic effects on renal 
function of enalapril IE) with and without low dose salicylate (5). 
20 patients with congestive heart failure and left ventricular 
ejection fraction (LVEF) 26 ± 10% were given 10 mg E o.d. on 
day 1 and 10 mg E + 300 mg 5 o.d. on day 2; followed by 4 wks 
E and 4 wks E + 5. in the same dose. All pts were on a 
moderately sodium-restricted diet. At base-line. creatinine clear•
ance (CC in mllmin/m2 B5A) showed a normal circadian variation. 
114 ± 72 in the morning and 59 ± 29 during the night. The first 
two days. morning CC was 80 ± 63 (p<0.05) after E. and 79 ± 
60 (p<0.05) after E + 5; nighttime CC values were not different 
from baseline. After 4 wks on E nighttime CC was increased to 
above baseline values (87 ± 88 after E. and 81 ± 42 after E + 5). 
Circadian variation of CC flattened or even reversed. Regression 
analysis showed a relationship between CC and LVEF (r=0.67; 
p<0.0011. but none between CC and blood pressure. plasma an•
giotensin " or plasma norepinephrine levels. 
Conclusion: Glomerular filtration in pts with CHF is mainly related 
to heart function. 10 mg enalapril causes a 30% reduction of CC 
during the day. that is partly compensated. after a few weeks. by 
a rise of nighttime CC. Adding 5 100 mg o.d. had no additional 
depressing effect on CC. 
903·97 
Chronic Opioid aeceptor Blockade Improved 
Myocardial Mechanical FUnction aDd II-Adrenergic 
aesponsivenesa in Congestive Heart Failure 
Akito Yatani, Naoaki Imai, Masakuni Suematsu, 
Yoshihiro Himura, Chang-seng Liang, University 
of Rochester, Rochester, NY 
We have previously shown that acute opioid 
receptor inhibition improves hemodynamics and 
myocardial contractility in dogs with right•
sided heart failure (CHF) produced by tricuspid 
avulsion and progressive pulmonary constric•
tion. To study whether similar changes occur 
after chronic opioid inhibition in CHF, we 
administered naltrexone (NALT, 200 mg/day), a 
long-acting orally active opioid receptor 
blocking agent, to CHF and sham-operated 
animals for 6 weeks. CHF was characterized by 
low mean aortic pressure (mAP, mmHg), elevated 
right atrial pressure (RAP, mmHg), reduced 
right ventricular (RV) dP/dt at rest, and an 
impaired response of RV dP/dt to isoproterenol 
(dP/dt-i). Chamber-specific reduction in P•
adrenoceptor density (PAR, fmol/mg protein) was 
also observed in failing RV. NALT had no 
hemodynamic effects in sham dogs. Effects of 
N~LT (mean±SE) in CHF animals were: 
Sham 
CHF 
NALT 
mAP RAP RV dP/dt dP/dt-i PAR 
ll3±3 5±.5 689± 43 983±lOl l08±6 
l03±3* l5±l* 470± 40* 687± 38* 63±5* 
il2±6 l3±2* 7l7±109t 98l±llOt 43±3*t 
*p<O.05 vs Sham; tp<O.05 vs CHF 
Thus, despite the same RAP, NALT improved RV 
dP/dt and dP/dt-i in CHF. Since PAR density 
did not increase, the preserved p-adrenergic 
responses with chronic opioid blockade probably 
is related to a post-receptor mechanism. 
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903·98 
Early Impairment of Natriuretic Respanse to High Salt Intake in 
PaHents with Mild Heart Failure 
Massimo Volpe. Cristina Trltto. Marla AE,Rao. Rosarla Russo. 
Paolo deCampora. Pasquale Balestrieri. Bruno Trimarco, 
Dept,of Internal Medicine, "Federico Ii" University. Naples, 
This study was designed to assess the ability to 
excrete Ingested sodium In patients with mild heart 
failure, For this purpose dally sodium Intake was 
elevated from 100 to 250 mEq for 6 days In 10 untreated 
patients with dilated cardiomyopathy and mild 
non-congestive heart failure (NYHA class 1-11; ejection 
fraction <50%) (HF) and in 10 matched normal subjects 
(N), under strictly balanced metabolic conditions, N 
achieved neutral sodium balance within 3 days on high 
salt diet. while HF continued to retain sodium 
throughout the high salt diet period. so that cumulative 
sodium balance was significantly different In the two 
study groups (two way ANOVA F=3, 1 O. p<0,05); plasma 
renin activity and aldosterone concentrations were 
suppressed to a comparable degree by high salt diet 
in the two groups, In contrast. high salt diet was 
associated with an increase of the plasma ANF levels 
(pg/ml)/Hematocrit (%) ratio In N (from 0,24±0,05 to 
0,35±0,07. F=3,51. p<0,05) but not in HF (from 0,78±0,2 to 
0, 7±0, 15. n,s,), These results demonstrate that patients 
with mild heart failure and no signs or symptoms of 
congestion exhibit an early impairment of sodium 
handling. as Indicated by the higher cumulative sodium 
balance and by the lack of appropriate plasma ANF 
increase observed during high sodium intake, 
903·99 
Does the NaIK Ratio Reflect the Extent of Aldosterone Activity in 
Congestive Heart Failure? 
Bruce J, Kowalski, Robert J. Cody, The Ohio State University, Columbus OH 
In addHion to the sodium retentive properties of aldosterone(aldo), recent 
data suggest additional importance for aldo. This includes possible aldo 
"escape" from ACE inhib"or suppression in congestive heart failure(CHF), 
which could increase hypokalemia, hypomagnesemia, and subsequent 
mortality from ventricular arrhythmias. A direct role for aIdo in collagen matrix 
development in the myocardium has also been suggested. W"h difficutties 
in measurement of aldo in routine clinical trials, the urinary sodiUrrVpotassium 
ratio (NalK), fett to represent relative changes in aldo secretion, has been 
suggested. and one preliminary report indicates that abnormal suppression 
of NaIK in CHF can be reversed with ACE inhibition. The current study 
assessed whether the NaIK is an adequate reflection of aldo secretion in 
CHF. To achieve this goal, patients were assessed with only digoxin and 
diuretic therapy(none on the day of collection). Ninety·seven consecutive 
patients with these cmeria were studied, ranging in NYHA class from 2-4, and 
from 32·78 years of age. Simuhaneous hemodynamic profiling, 24 hour 
urine collections for Na, K, aldosterone secretion, creatinine, and plasma 
renin ectivity and plasma aldo were obtained. Hemodynamics were: HR 
82±15bpm, MAP 83;t12 mmHg, PWP 24±9 mmHg, CI1.75±.53 Uminlm2, 
SVR 1935±655 d's/emS. Urinary Na was 52±58 meql24hr and urinary K was 
72±43 meql24hr. The NaIK was 0.73;tO.79(range 0.1-3.99). Plasma renin 
activity 14.5±17,8n!¥mlihr (range 0.17-80), plasma aldo 3O.9±34nglml 
(range 1.2-170), and urinary aldo excretion 20.8±21 .6n!¥24hr (range 1.2-
108). Stepwise regression analysis was performed to determine the primary 
factors affecting the NaIK, including hemodynamic, neurohormonal and 
renal excretory factors(excluding the Na and K secretion themselves). This 
revealed that urinary aldo, plasma aldo, and plasma renin activity were the 
primary determinants of the ratio, as the mathematical model rejected other 
variables. Thus, urinary Na/k clinically reflects the extent of aldo activity in 
CHF. In diuretic treated patients, the ratio is reduced to less. than 1.0 in 75 of 
the 97 CHF patients, ahhough a wide range was evident. The effects of 
ACE inhib"ors on NaIK must be assessed, and the response to 
spironolactone suppression of aldo is under assessment in the RALES Trial. 
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903·100 
Levels of Soluble Interleukin·2 Receptor in Dilated 
Cardiomyopathy: Clinicsl and Histological Correlates. 
Philip J. Keeling, David Gordon, Alida L.P, Caforlo +, Jonathan H, 
Goldman, Michael J, Davies, David W. Holt, William J. McKenna. St 
George's Hospital Medical School, London, UK, and University of 
Padua, Padua, Italy +. 
Levels of soluble Interleukln-2 receptor (slL2R) are elevated in 
dilated cardiomyopathy (DCM) and are believed to be a marker of T•
cell activation, However, the clinical significance of raised slL2R 
levels, and the Influence of heart failure per se In DCM are unknown. 
In this study we assessed slL2R levels (normal rang&<919 Ulml) in 
62 patients with DCM (WHO criteria), 36 age-matched healthy 
controls, and 66 patients with ischemic heart failure (IHD), Patients 
with DCM (mean age 43 ± 14, 49 male) had been symptomatic for 36 
±47 months, 33 were in NYHA functional Class 1111,29 in Class IIII1V, 
and 42 had endomyocardial fibrosis. The level of slL2R was 888 
±582 Ulmlln patients with DCM, 762 ±755 Ulml in IHD, and 563 ±31 0 
Ulml in healthy matched controls: this was abnormal in 23 (37%), 11 
(17%) and 5 (14%), respectively. Raised levels of slL2R were more 
common In patients with DCM compared to matched controls (14, 
39% vs 5, 14%; p=O,03) and patients with IHD (p=0.02), but was 
similar in patients with IHD and controls, Soluble IL2R was higher in 
DCM patients with normal histology compared to those with 
myocardial fibrosis (1164 ±818 vs 736 ±423; p=O,008), No 
association was seen between slL2R level and symptom duration or 
clinical severity of heart failure, The finding of raised levels of slL2R in 
DCM supports a role for activated T -cells in the pathogenesis of the 
condition. The association of raised slL2R levels and normal 
endomyocardial histology identifies patients who may benefit from 
aggressive Immunosuppression. 
903·101 
Attenuation of Processing of cGMP on Hemodynamic 
Regulation of Endogenous ANP In Chronic Severe Heart 
Failure 
Yukiharu Maeda, Atsuyuki Wada, Toshiyuki Kanamori, Takayoshi Tsutamoto, 
Masahiko Kinoshha, Shiga Univershy of Medical Science, OIsu, Japan. 
10 examine whether endogenous atrial natriuretic peptide (ANP) exerts a 
vasodilative action independently 01 the duration of a high concentration 01 
plasma ANP, we administered HS-142-1 (HS), a apecHic antagonist lor the ANP 
guanylate cyclase(GC) coupled receptor, to three groups 01 dogs with 
congestive heartlailure (CHF) induced by rapid right ventricular pacing 1) early 
(E, n-S, 7days), 2) early wHh acute saline volume expansion (SVE, n-S) and 
3) advanced CHF (A, n-S, 22days), SVE in dogs with early CHF induced the 
same magnttude 01 hemodynamic severity as advanced CHF. 
E E+HS SVE SVE+HS A A+HS 
ANP (pg/ml) 160 283 236 218 376 508 
cGMP(pmolIml) 23.3 11.31 21.5 8,7/1 35,6 11,1' 
PCWP(mmHg) 11.5 14.70 14.8 17,0' 18.4 20.0 
MAP (mmHg) 94.5 95.8 111.3 114.2 85.6 90.6 
RAP (mmHg) 4.1 5.2 0 4.4 5.9 , 7.8 8.4 
PRA (nglmllhr) 2.3 2.1 1.4 0.5 6.5 13,6' 
NE (pgImQ 315 358 569 583 544 12270 
o p.:O.05, 'p.:O.Ol by ANaVA + H S; after 3.Omg.1(g HS administration 
PCWP; pulmonary capillary wedge pressure, MAP; mean arterial pressure, 
RAP: right atrial pressure, cGMP; cyclic GMP, PRA; plasma renin activity, 
NE; norepinephrine 
In both stages 01 CHF, the plasma cGMP level was signHicantly suppressed by 
HS, however, PCWP and RAP signHicantly increased only in the early CHF 
despite the lack of increment 01 the plasma pressor hormones. We lound a 
signHicant posHive correlation between plasma ANP and cGMP levels in the 
early CHF (r.O.n, p.0.002) but not in advanced CHF (r.O.ll, paO.71). We 
conclude that the hemodynamic regulation 01 endogenous ANP is attenuated 
through the intracellular processing including Hs GC coupled receptor level in 
advanced CHF. 
JACC February 1994:1A-484A 
903·102 
~ Sources of Procb:tJ.on of Atr1al. mxI Brain 
Ilatrluret1c Peptide axe Different in HeBrt Failure 
Goroon W. MJe, Etienne A. Grima, Robert J. Howard, 
Paul W. AImstrong, St Michael's Hospital, University 
of Toronto, Toronto, canada 
we previously reported elevated plasma atrial am 
brain natriuretic peptide (ANP am BNP) levels in a 
canine heart failure (HF) m:x1e1. However, the source 
for the increased plasma BNP levels am the possibi•
l1ty of a cardiac origin have not been explo:rec:l. 'lbere•
fore, we examined tissue iJmunoreactive ANP am BNP of 
the lA, RA, LV an::I RV in 5 nonnal control dogs (C), 21 
dogs with early HF (HFe) after 1 week of RV pacing 
(250 beats/min) am 10 dogs with severe HF (HFs) after 
3 weeks of pacing. Data (x, pooled SO fran ANJVA) for 
ANP am BNP levels In lA, RA, LV am RV (ng/mg) am 
plasma (P) levels (pg/ml) are shown. * p<0.01 vs C. 
ANP BNP 
lA RA LV RV P lA RA LV RV P 
C 22 11 0.03 0.04 45 0.2 0.2 0.01 0.02 13 
HFe 2* 2* 0.03 0.03 502* 0.3 0.2 0.01 0.01 45* 
HFs ...1!.. ..1!.... Q&L 0.02* 454* Q,] 0.2 0.01 0.02 ~ 
SO 3 2 .01 .008 70 I .1 .1 .005 .008 10 
In all dogs, tissue ANP & BNP were higher in the 
atrium than in ventricle, but the atrial/ventricular 
ratio was nuch lower for BNP. With HF, ANP was reduced 
in lA, RA & RV, accarpanied by elevated plasma ANP. 
Unlike ANP, there was no change in BNP in the atrium 
or ventricle with HF, despite a 3 fold increase in 
plasma BNP. These data suggest that the atrium is the 
ma jor cardiac source for ANP & BNP, but relative to 
ANP, the ventricle may also be an iJItlortant source for 
BNP. '!he lack of change in cardiac BNP levels despite 
increased plasma levels in HF suggest that there is 
likely an extracardiac origin of BNP production in HF. 
903·103 
Effect of Exercise on Plasma Lewl of Brain Natriul'etic 
Peptide in Congestive Heart J<'ailure With and Without 
Left Ventriculai' Dysfunction 
Akihiro Matsumoto, Yasunobu Hirata, Shin-ichi Momomura, Etsu 
SU7.uki, Ikuo Yokoyama, Masataka Sata, Yoshi Ohtani, Takashi 
Serizawa,The Second Department of Internal Medicine, Faculty 01 
Medicine, University of Tokyo, Tokyo, Japan. 
This study was designed to see if plasma BNP increases in 
response to exercise in patients with congestive heart failure, and to 
show what kind of hemodynamic abnormalities induce increased 
secretion of BNP during exercise. 
Plasma levels of atrial natriuretic peptide (ANP) and BNP and 
hemodynamic parameters were measured during upright bicycle 
exercise tests in seven patients with dilated cardiomyopathy and nine 
with mitral stenosis. At rest, there were JlO intergroup differences in 
cardiac output or pulmonary capillary wedge pressure, however. the 
dilated cardiomyopathy group had higher left ventricular 
end-diastolic pressures and lower left ventricular ejection fractions 
than the mitral stenosis group. Plasma ANP were comparable 
betweeuthe dilated cardiomyopathy group (170 ± 77 (SE) pglml) 
and the mitral stenosis group (l06 ± .~3 pglml, p = NS). whereas 
BNP was significantly higher in the dilaled cardiomyopathy group 
(211 ± RO pglml) than the mitral stenosis group (37 ± 10 pg/ml. p 
<0.05). Plasma concentratiun of BNP, but not ANP. significantly 
correlated with left ventricular end-diastolic pressure and volullle. 
Exercise increased plasma ANP and BNP in the two groups. The 
dilated cardiomyopathy group had a larger increment in BNP (+ 
157 ± 79 pglml) than the mitral stenosis group (+ 17 ± 5 pglml. p 
<0.05), although the increase in pulmonary capillary wedge 
pressure was greater in the mitral stenosis group. 
Thus, exercise increases plasma levels of BNP. and impaired left 
ventricular function may be a main factor of the greater increment in 
BNP during exercise in patients wilh congestive heart failure. 
ABSTRACTS 
903-111 
Angiotensin D Selectively Iucreases Cardiae Adrenergic Activity in Patients 
With Heart Failure 
William T. Abraham, Brian D. Lowes, Colin P. Rose, Patti Larrabee, Michael R. 
Bristow, University of Colorado Health Sciences Center, Denver, Colorado 
In experimental models, angiotensin II (Ang II) appears to facilitate neuronal 
norepinephrine (NE) release at the presynaptic level. The decreases in systemic 
and coronary sinus (CS) NE levels associated with angiotensin converting 
enzyme (ACE) inhibition in heart failure are consistent with such a 
neuromodulatory effect of Ang II. However, the effect of Ang II on cardiac 
adrenergic activity in patients with beart failure has not been previously 
examined. Therefore, we evaluated the acute effects of pressor doses of Ang II 
(4-8 nglkglmin) on arterial and CS NE and on cardiac neuronal NE release and 
uptake determined using the intracoronary triple isotope technique in 5 patients 
with advanced NYHA class III-IV beart failure. ACE inhibitors and other 
vasoactive medications were discontinued at least I day prior to study. Ang II 
was titrated to increase mean arterial pressure by J 0 mmHg within 30 minutes of 
the start of the infusion. Compared to baseline conditions, transmyocardial (CS•
arterial) NE increased in all 5 patients and the fraction ofNE added to the 
circulation across the beart (CS-arterial NElarteriai NE) increased from 0.94 ± 
0.46 at baseline to 2.70 ± 0.59 pglml during Ang II (p < 0.05). In these patients, 
arterial NE tended to decrease and CS NE tended to increase, eacb contributing 
to the observed increases in transmyocardial NE. Unidirectional cardiac neuronal 
PHINE uptake was unaffected by the infusion of Ang II so that the increase in 
transmyocardial NE was attributable to increased cardiac neuronal NE release. 
Conclusion: Ang II enhances cardiac neuronal NE release in patients with beart 
failure, thus increasing cardiac adrenergic drive. This effect is likely mediated 
via cardiac adrenergic presynaptic Ang II receptors. 
903·112 
Digitalis Augments ('ardiupulmonarJ Barorenex Control of 
Muscle S) mpalhelir 'en e ,\rlh'ity in Hearl Failure 
>tTOYO·\lli Yua,a. Shigen Tak:II.1. ~aoki Sugimolo, Yukio Nakamura. Kazuo 
t: ... udu. Koichlro :\o"-i. At.;,uhiid ShimaJ..ura. Mt){uhiro Yamada. Makolo 
KOIlWIlI, Kl'n-ichl Koha)a ... hi. I'il .. i Dt?'pm1ll1cnl of Intern:.tl Medicine. 
Kan,uav. a l"ni\'t..'p~ity. KJnazav. j. Japan 
Digiluli!o. glycoside produ'-.:I.· ... llwrked sympalhoinhibilOry action in patients 
with heart failure. but the L'\acl IIIL\.:hani~rn for thi ... action is uncenain, To 
determine "he-Ih~r digiwli:-. :IU~Tjl.'I1I' cardiopulmonary baroreflexes in heart 
railure or not. "" c.,amilll'd Ihe dr~·(1S of digiluli, (Cedilanid O.4mg) on 
eff~lC'nt ,ympathetic nl~r\i..' r.: ... poll~.(' ... to Invtcr body negative pressure(LB~P) at 
-10 and -20 mlllllg in 8 patient... ".ilh heart failure. Muscle sympathetic nerve 
~i(ti\'it~ (\1S:\i\) W\.'fl" rt.'(:oHlt'll from a Inu"cle n~rve f.1.. .. cicle in the peroneal 
n('r\'t'. Digil:Jl, .... ignitkailtl) d~UI..·,l"'t,.'d h~an rate tj'om63±B to 61 ±14 bpm 
~ p <" OJ)) ), a1rJ hUfst in;:idl'IH:l' (111 j fmlll 5'l±1h LO 51 ±2J bursts / 100 
Ix:.HS ( P < OJ):'! ). Dulin(:!. LB'\iP, !hCfl' W'P~ no ~igniticant change in heart rate 
or mean art('rial pr~!o. ... ure bt'foll' ~lIld ~lner digitali~. The UeCTea ... e~ in l'entral 
Vl'1l0U'" rr~~,urt" I{'VP} V..l'" I.imilar hch)fe and after digitalb. Increased in RI 
during LRNP at -~(lllllTIl-Ig v.a ... ~:±h bur"'I~/I()otwall.; after digit::ilis. whkh 
"as .. ignifi('allll~ grealt'l I hall thai ht:fore digitalil.; (11 ±7, p<O.05). The ~Illpe 
of Ihe legre"ion line relalin~ ch:tnge in BI and evp during LBNP "3.' II.O± 
6.2 bu",s/iOObealS/mmHg.which "as significallll> sleerer Ihan Ihal hefore 
digilali, (1.2±4.1. p<O.()S II )i)'"alr- did nol afkellhe MSNA responses 10 
hand-grip ('>.cn.:i"ic (3OCIt MVC for jmin. \. 
These It'~ult ... ",ull!le~t thilt dif.il.!li ... glycoside improvt'd l':.udiopulmonary 
harun.~nt:'xc ... ill hl,.'arl faihllt'. ',·,:hic:h may be r~",plln ... ible for sympathoil1hibilor~ 
aClion of digitalis. 
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904·55 
Inhibition of Atherogenesis In Apolipoproteln(a) Mice 
by the Addition of Apolipoproteln AI Transgene 
Alexander C. Liu1, Judy G. Verstuyft2, Edward M. Rubin2, and 
Richard M. Lawn 1. 1 Division of Cardiovascular Medicine, Stanford, 
CA and 2Division 01 Cell and Molecular Biology, Lawrence Berkeley 
Laboratory, Berkeley, CA 
The transgenic mouse model has been a useful tool in 
studying the complex, polygenic nature of atherosclerosis 
development. Our groups have previously shown that transgenic 
mice expressing Apolipoprotein(a) [Apo(a)), the distinguishing 
component of Lipoprotein(a), develop atherosclerosis on a high fat 
diet [Nature 360:670·672). Conversely, transgenic mice 
overexpressing Apolipoproteln AI [Apo AI) are protected from 
atherogenesis [Nature 353:265-267). To test the hypothesis that 
Apo AI could protect against the atherogenicity of Apo(a), we mated 
strains of both groups and assessed degree of atherosclerosis by 
quantifying the area of lipid staining fatty streak lesions formed in 
the mouse aorta after exposure to an atherogenic diet. 
~bl:Dl!ll£lIl! AI![IIS; 1.I!IIlID SS;I![I! 
control 1534 ± 351 
Apo(a) 8499 ± 1724 
ApoAI 419 ± 419 
Apo(a)/Apo AI 381 ± 198 
p values: Apo(a) vs. control p<0.0003; Apo(a) vs. Apo AI 
p<0.0006; Apo(a) vs. Apo(a)/Apo AI p<0.0005 
These results show that the overexpression of Apo AI results 
in complete protection against the atherogenicity of Apo(a). This 
suggests that the availability of cholesterol may play a key role in 
the development of atherogenesis due to Lipoprotein(a). This study 
supports human epidemiological data that show that elevated levels 
of total cholesterol and LDL have a potentiating effect on the 
atherogenicity of Lipoprotein(a). 
904·56 
An Enzyme Linked Immunosorbent Assay of Autoantibodies to 
Oxidized Low·Density Lipoprotein as a Predictor of Coronary 
Artery Disease 
Michael N. Sack, Paul Katz, Rosemary McCown, Jeffrey A. 
Breall, Charles E. Rackley. Georgetown University, Washington 
DC 
The titres of autoantibodies to oxidized LDL correlate with 
progression of carotid atherosclerosis. We measured the titres to 
CuCI2 oxidized LDL in 30 age matched subjects assessing the 
predictive value of autoantibodies to the presence of 
angiographically defm..d coronary artery disease (CAD). 12 
subjects with insignificant anatomical coronary athero· 
sclerosis(group I)(stenosis <25%) were compared to 18 subjects 
with 3 vessel CAD (group II)(stenosis >50 %). Group I was then 
subdivided into 7 subjects with clean coronary arteries (IA) 
compared to 5 subjects with minimal luminal irregularity (lB). 
Using an enzyme linked immunosorbent assay technique, the value 
of Ig-G antibodies were expressed as optical density, and the fmal 
autoantibody titre was calculated by subtracting binding from 
native LDL from binding to oxidized LDL. Total cholesterol was 
similar in groups I and II (l97±35 vs 195±51 mg/dl) with similar 
lipid profiles. Data=mean±SD. 
Group I (.413±.2) vs Group II (.694±.42) p=.02 
Group IA (.328±.18) vs Group IB (.457±.24) p=.057 
Conclusions: 1) A reproducible assay for quantitation of 
autoantibodies to oxidized LDL has been developed. 2) A 
significant autoantibody difference between age matched subjects 
with and without hemodynamically significant CAD was found. 3) 
Minimal angiographic luminal irregularities was associated with 
higher autoantibodies than absolutely clean coronary arteries. 
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904·57 
Influence of Llpldl and F1brlnoge on PI .. me and Blood Vllcollty 
Robert S. Roeeneon, Rush Medical College. Chicago. IL 
Hyperlipidemial hive been a .. ociated with elevationa in levels of 
fibrinogen Ind piasml viscosity; however the Influence of lipids on 
whole blood viacosity or plasma viacosity independent of fibrinogen 
remain. undefined. The impact of lipids and fibrinogen on blood and 
piasma viacoslty was eXlmined. 
Methoda: Dynamic viacosity was measured on SImples of whole 
blood Ind plasme It ahear rates ranging from 2.4-10 IIC·' (Iowahear 
rates I and 10-100 laC·, (high ahear retesl with the Mettler Contrives 
LS-40 microviacorneter. Whole blood viacoslty WIS normalized to a 
hematocrit of 45% (W8V.I. 
Allulta: Forty·four SImples were analyzed on 41 aubjacts. The mean 
(± S. D.I levels for total cholesterol (TCI were 234 ± 81 mg/dL 
(range: 109-4861. total triglyceridea ITGI 369 :t 425 mg/dL (range: 
51-19861. HOL cholesterol (HOL137 :t 13 mg/dL (rlnge: 10-681. and 
fibrinogen 344 :t 96 mg/dL (range: 195-6601. 
Step-wise multivariate anlly ... ahowed significant correlations for the 
following: (11 plaama viacosity at both low and high shear rates with 
TC (R-0.56. p-O.OOO6 Ind R-0.53. p z O.OOl respectivelyl; with 
fibrinogen (R-0.66. p=0.0002 and R-0.64. p-0.0003 
respectivelyl; Ind with TG (R-0.71. p=O.OOOl Ind R-0.71. 
p .0.0001 respectivelyl; Ind (21 WBV. at high &hear rates with 
fibrinogen only (R-0.43. p=O.Oll. 
Conclusion: Elevationa in blood lipids independently influence plasma 
viscosity over I broad rlnge of shear rates even Ifter adjusting for 
fibrinogen. For WBV •• the Influence of fibrinogen predominates over 
lipoproteins. Elevated blood viacoaity may play a role in the 
pathogenesis of atharothrombosis aSlociated with elevated lipids and 
fibrinogen. 
904·58 
Increased In Vivo Production of BDL and 
ApoA-I Under the Treablent With IDIG-CoA 
Reductase Inhibitor Pravastatin. 
Juergen R. Schaefer, Armin 
Horst Schweer, Henning Stracke, 
seyberth, Hans Kaffarnik: 
Hospital, 35033 Marburg, Germany. 
Steinmetz, 
HannsjOrg 
University 
HMG-CoA reductase inhibitors such as 
Pravastatin (sPrava) lower cholesterol 
(=chol) and LDL-chol. In addition they 
increase HDL-chol and ApoA-I. The metabolic 
basis of the HDL increase is not clear. In 
order to determine the changes of the HDL 
in vivo metabolism, we studied the apoA-I 
kinetics in 7 healthy men utilizing stable 
i.sotope tracer techniques (3D-Leucine and 
l'c6Phenylalanin) . Before and after six 
weeks of Prava treatment ( 40mg/d) protein 
turn over studies were performed. Prava 
decreased the mean chol (-21%) and LDL-chol 
(-39%) leveL In 6 out of 7 probands the 
mean HDL-chol (+13%) and ApoA-I (+12%) 
increased. The in vivo data demonstrate 
that Prava increases the fractional 
synthetic rates (mean: O.28/d versus 
0.25/d) and production rates (mean: 
12.7mgjkg-d,SD+/-6% vs 10mg/kg-d,SD+/-11%) 
£or apoA-I in men. The one subject without 
apoA-I increase had unchanged A-I kinetics 
- and a family history of arteriosclerosis. 
We conclude: 1.) HMG-CoA reductase 
inhibition elevates HDL by increasing the 
apoA-I production. 2.) this regulation can 
be missing, which might be of clinical 
importance. 
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904·59 
Modulation of Coronary Heart Disease Risk by 
Apolipoprotein E Genotype 
Mark N. Payne, *Elaine K Green, "Matthew R. Walker, 
*Alan F. Jones, R. Gordon Murray, James M Beattie. 
Departments of Cardiology and *Clinical Chemistry, 
Birmingham Heartlands Hospital, Birmingham, England, UK 
Apolipoprotein (apo) E polymorphism may modulate 
susceptibility to coronary heart disease (CHD) through effects 
on plasma lipids. To investigate this hypothesis we studied 
apo E genotypes and plasma lipid profiles in 75 CHD patients 
(55 men, mean age 55 years) undergoing coronary 
angioplasty. 89 blood donors served as controls. Genotyping 
was performed using an allele-specific oligonucleotide primed 
PCR assay. Apo E allele frequencies were e4 0.12, e3 0.84, 
and e2 0.04 in the CHD group, and 0.10,0.81, and 0.09, 
respectively in the controls. The e2 allele was Significantly 
less frequent in patients (p=O.038) despite comparable lipid 
profiles. Carriers of e4 were younger than those with the 
Wild-type E313 genotype (mean 50 vs 56 years, p=O.034) and 
also presented earlier with ischaemic symptoms (mean 48 vs 
54 years, p=O.04). In the 25 patients aged 50 or less the 
frequency of the e4 allele was increased compared to controls 
(0.20 vs 0.10, p=0.04). This was predominantly due to the 
high e4 frequency in female patients aged 50 or less compared 
with older females (0.33 vs 0.04, p=0.014). 
In conclusion, inheritance of e2 seems to be protective 
against CHD, whereas e4 confers risk of premature CHD, 
particularly in younger females. 
904·60 
Susceptibility of Plasma Lipoprotein Lipids to Peroxidation: 
Correlation with Atherosclerotic Risk 
*Eric T. Fossel. Christine Zanella. Beth Israel Hospital. Boston. 
MA 
Uptake of peroxidized LOL by macrocyte macrophages within 
the intima of the artery is a central event in plaque formation. 
The ease of peroxidation of LOL varies from individual to 
individual. Knowing the relationship between LOL peroxidation 
and plaque formation. we sought to test the hypothesis that 
the susceptibility of plasma lipoprotein lipids to peroxidation 
correlates with atherosclerotic risk. Our protocol calls for 
introduction of a quantitative oxidative challenge to whole 
plasma by addition of 0.3 units xanthine oxidase. 120 nmole 
xanthine and 0.5 pm ole of ferrous sulfate to 0.6 ml plasma. C-
13 NMR spectra were obtained before addition and 24 hr after 
addition of reagents. The reduction of area of the olefinic 
resonances in the 125-130 ppm region of the spectra is the 
measure of the extent of peroxidation of unsaturated fatty 
acids in lipoprotein lipids. In a group of 10 individuals we have 
demonstrated that the reduction of unsaturation in whole 
plasma closely reflects that of purified LOL from the same 
donor (r = 0.89). We then studied a group of 104 CABG 
patients (age 67 yr ± 0.9 yr). and 103 age and sex matched 
controls (age 65 ± 0.8 yr). There was a decrease in 
unsaturation of 21 ± 8% in the CABG group versus a decrease 
of 5.5 ± 3.6% in the control group. In the control group. the 
reduction of area was < 15% in 97 of the 103. and was> 
15 % in 99 of the 104 CABG patients. We conclude that the 
susceptibility of lipoprotein lipids to peroxidation deserves 
further evaluation as a potential risk factor for atherosclerosis. 
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905·88 
Feasibility of Applying Karhunen-Loeve Procedure to 
Transesophageal Echocardiographic Images 
Richard Everson, David Shennan, Marco Di Tullio, Shunichi 
Homma, Lawrence Sirovich, Columbia University and Rockefeller 
University. New York, N.Y. 
The Karhunen-Loeve procedure (K.L.) decomposes the 
images into a natural and intrinsic set of orthogonal modes known as 
empirical eigenfunctions. The full record can then be regarded as a 
temporal superposition of all of the modes. As a result, artifacts 
such as images movements from respiration, probe migration, and 
other unwanted movements may be removed from the record in 
order to enhance diagnostic image quality. Therefore, K.L. may be 
suited for echocardiographic image analysis. To our knowledge, 
however, K.L. has not been applied to echocardiographic images. 
Therefore, we applied K.L. to transesophageal echocardiographic 
studies obtained from 6 patients. Each time, series of images were 
digitized on a Abekas, with all subsequent computations and 
analyses carried out on a SGI Indigo 4000. The contribution from 
empirical eigenfunctions resulting from artifactual movements were 
removed and the resulting images reconstituted using the Abekas for 
diagnostic enhancement. Excellent images were obtained after K.L. 
in all patients. 
Conclusion • K.L. is feasible for echocardiographic images, 
and may prove useful in image enhancement by eliminating 
unwanted motions from the images. 
905·89 
High Wall Filter Imaging Stabilize. Color Doppler Jet Area and 
Reduces Chamber Size Dependence: Computer Model Stuelle. 
Edward G. Cape, M. Bradley Plecs, Albert C. Lardo, Shiro Yamachlka, 
Cheryl L Reid, Julius M. Gardin, Chldren's Hospital - University of 
Pittsburgh, PA and University of CalHornla Irvine Medical Center, Orange, 
CA 
Despite studies showing marked variabUlty In color Doppler jet area (CJA) 
for a given regurgitant now (REG), CJA remains a primary clinical marker 
of the severity of REG. Although CJA Is commonly normalized to receMng 
chamber (RC) size, It Is desirable to stabilize CJA to detect REG 
Independent of RC size, which may vary with slmnar degrees of REG, e.g., 
In acute VB chronic REG or with different body size. We' previously 
evaluated a high wall liter (HWF) approach to Imaging CJA which reduced 
variabDIty due to other Instrument factors and heart rate. This study uses 
a computer model which evolved from that work to address the hypothesis 
that HWF Imaging redYces CJA variabDIty In the face of slgnHicant changes 
In RC size. and thys more directly represents REG severity for norma! or 
I!!!A!!..BQ. CJA's were generated for 9 RC depths (3-7 em), 15 WF (480-
3840 Hz), 9 orifice velocities (V=1-5 m/s), and 3 orifice sizes (1-5 mm) 
(n=3645 expts). Re.ults: For a conventional WF of 480 Hz, Increasing 
chamber depth from 3 to 7 cm for a mitral regurgitant jet caused CJA to 
Increase by a factor of 2.87 (V = 5 m/s) for constant REG; HWF weighted 
at 3840 Hz reduced this factor by 38% for a large orifice (5 mm) and 
virtually eliminated the observed Increase for a small orifice size (1 mm), 
because of a lesser effect of RC constraint on CJA. For low V tricuspid jets, 
variability was eliminated for all orifice sizes by using moderately elevated 
WF (2880 Hz). Conclusion.: Small RC sizes tend to constrain the size of 
CJA displayed using low WF. HWF decreases CJA variability by shifting the 
boundary Inward to more stable portions of the jet. These results are most 
relevant to evaluating pts with acute mitral regurgitation with "normal' atrial 
sizes and the pediatric population with small atria and high heart rates. 
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905·90 
Alignment Software to. Facilitate the. Accur~te 
Registration of Myocardial Images Obtamed with 
Different Imaging Techniques 
Kondapuram Sampathkumaran and Robert J. Gropler, Washington 
University, St. Louis, MO. 
Integration of measu~ment~ of regional my~ardial perfusion, 
metabolism and systolic funCtlon frequently requ~e the ~~ce 
of multiple imaging methods .tha~ each produce ~ages ~n di~ferent 
planes. This increases the likelihood of errors an. regtstranon of 
regions between the different methods. Accordangly, we have 
developed an image-alignment software package that has been 
applied initially to positron emission tomograp~c (PET) im~ges ~d 
echocardiographic images, but that can be applied for other lmagmg 
modalities This software has been implemented on a 24bit color 
display DEC 5000 workstation with a 32 Mbyte of memory, ~78 
Mbyte FUnTSU Winchester disc ~ves and Ultr~ operatang 
system. This software was.de,:eloped an C I?,:<>~ng lan¥Ua~e 
with an X windows graphics anterface. BIlinear anterpolanon IS 
used to match pixel resolution of echocardiographic .images with 
PET images. Initial alignment of the correspondIng !?ET ~d 
echocardiographic images is pert:ormed with the echocardio~phlc 
images displayed in the first 8 display ~lanes ~d the PET Imag~s 
displayed in the next 8 display planes. VIS~al alIgnment proceeds 10 
multiple time points throughout the R-~ Interval .. Su.bseq~entIy, 
regions of interest are placed on v~ous read~ly I~ent~fiable 
structures such as papillary muscle and Image regts.tratIon IS then 
completed by aligning these regi~ns of interest ~th a .standard 
nonlinear least-square search algonthm, performed iteratively. In 
conclusion, the image-alignment software package. ~e have 
developed is fast and user friendly and sh?uld f~clllt~te the 
integration of physiologic measurements obtaIned WIth different 
imaging modalities. 
905·91 
Clinical Application of Echocardiographic Automatic 
Myocardial Contour Detection. 
Rajesh Sehgal, Edwin L Dove, Reena Sinha, Michael J. 
Vonesh, Bonnie J. Kane, Rodney Greene, Sanford I. Roth, 
Krishnan B. Chandran, David D. McPherson, Farooq A 
Chaudhry, Northwestern University, Chicago, IL; University of 
Iowa, Iowa City IA 
To assess ventricular cavity and wall boundaries with 
echocardiography (EC), manual tracing is required. ~is is 
labor intensive and limits clinical applicability. We prevIOusly 
developed an al~orith,? for cine c?mputed tom~graphic ~mage 
boundary definitIOn USIng two new Image processIng techniques; 
a Fuzzy Hough Transform (FHT) for objects whose shape 
cannot be pre-determined and a graph searching technique for 
closed contours. To assess utility of the FHT technique with 
EC, algorithm accuracy was validated in vitro and in vivo in 3 
mongrel dogs (9 slices). Subsequently, 24 patients were 
evaluated (12 with normal systolic function, 12 with wall motion 
abnormalities). _ 
Patient Results: (X.±.SD) (cm2): Epicardial Boundary Area 
(EPBA); Endocardial Boundary Area (ENBA); n=levels 
EPBA 
ENBA 
Automatic.Ml!n!!.ru ...L. ~ 
51 +4.8 50.±.5.3 0.87 75 
li±:4.2 13.±.4.4 0.95 70 
Histogram equalization was required for endocardial but not 
epicardial border detection. In images where epicardium and 
endocardium could be visualized, the algorithm was extremely 
accurate. These contour algorithms may allow better 
quantification of cardiac wall motion and volumes using 
echocardiographic image data. 
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993·1 
A Cardiology Database Integrated with tha VAXC 
Decentralized Hospital Computer Program with Imaga 
Capture and Display 
Ro.s D. rletcher, Ruth Dayhoff, Kevin Crawford, Ronald 
Jone., Veteran. Affair. and aeorgetown University 
Xedical Centers, Wa.hington, D.C. 
The VA Decentrali.ed Hospital Computer Program 
installed 164 hospitals in a database containing all 
admission., and pharmacy data. Cardiology procedure. 
include. cardiac catheterizations, echocardiograms, 
exercise tolerance te.t, Holters, BCa, 
electrophysiological te.ting, nuclear cardiology, 
pacemaker implantations and follow-up. Other medical 
procedures include aI and pulmonary endoscopy, 
pulmonary function and bone marrow. The cardiology 
database automatically enters BCa and Holter data from 
commercial systems. An estimated surgical riek ie 
calculated from historical and catheterization data. 
LV mese i. calculated by ASB and Penn criteria. A 
summary option liste all procedures for a patient from 
which the complete reports are selected. The database 
contains 3,175 catheterizations, 4,579 Holters, 12,307 
BCGs, 9,661 Bcho., 4,818 BTTs, and 566 BPs at the 
Washington DC VAMC. 
Image capture automatically link. to apecific patients 
and procedures. A 12 image composite picture menu is 
displayed on a single screen. rull screen images 
appear with each report. They include echocardiograma, 
coronary arteriograma, ventriculograma, KUQA, thallium 
studie., x·rays BCG and cardiology images as well as 
bone marrow, GI and pulmonary endoscopy, microscopic 
pathology, gross operative and dermatological images. 
Th. system can operate a. a PC workstation with a VAX 
connected through Bthernet but gains efficiency in a 
complete PC environment. 
993·2 
Use of an Interactive Database to Compare DHferent 
Scoring Systems ofRevascularization Appropria~m:ss 
Michael A. Lauer, Robert A. Vogel, Andrew A. Zlskind. 
University of Maryland, Baltimore, MD 
Several scoring algorithms currently exist to evaluate 
the appropriateness of coronary angioplasty and bypass 
surgery. However, such systems are frequently limited 
by the need for complex data entry and manipulation. 
Using 4th Dimension, we developed a program that 
allows comparison of different scoring systems of 
revascularization appropriateness based on a variety of 
patient variables. ..... 
Entry of clinical and anglOgraphlc mformatIon IS 
performed on a Macintosh using a user-friendly multi•
page system with lists and default options to speed entry. 
The program automatically determines the clinical 
scenario and appropriateness ratings from RAND panel 
ratings and the Revascularization Appropriateness 
Score. To allow real-time feedback on scoring 
assignments, they are made at the ti~e. of data entl! 
and continuously displayed as addItIonal data IS 
entered. Algorithms for the scoring systems can be 
modified and new algorithms added without affecting 
the patient data. In this mann~~,. future sc.or~ng 
systems can be easily evaluated utIlIzmg the eXIStmg 
clinical data. 
Conclusion: This Macintosh-based system permits 
rapid analysis of patient variab~es to deter?li~e 
revascularization appropriateness usmg RAND Criteria 
and the Revascularization Appropriateness Score. It 
promises to be a useful tool for the evaluation of new 
algorithms for assessing appropriateness of coronary 
intervention. 
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993·3 
INTEGRATION OF PALM·TOP AND DESK·TOP COMPUTERS 
IMPROVES CARE OF CARDIAC PATIENTS 
Yzhar Charuzi, M.D., F.A.C.C. and Arie Shefer, M.D. 
Cedars·Sinai Medical Center, Los Angeles, California 
We have used a commercially available palmtop computer (PIM), 
equipped with XT type processor, MS·DOS 5.0 system, 1Mb RAM 
memory and 2Mb PCMCIA 2.0 RAM caro.. Data was acquired into 
general purpose data base management system (DBMS) to assure 
standard format and complete data set for each patient (pt). The 
PIM is backed by a desk top computer (PC) via a null modem 
serial interface. 
The pt record can be selectively printed, using pre-defined report 
layouts and immediately placed in the chart as a formal history 
and physical (H&P), daily notes or a discharge summRlj', thus 
obviating frequently illegible handwritten notes. The data base 
can be remotely accessed via modem. The information can be 
integrated with the out patient file to form a master record for 
this patient. The DBMS enables us to search and retrieve specific 
information and to highlight trends of selected data. Our 828 
hospital files and the 979 outpatient files, previously collE !ted 
using a non DOS PIM could be incorporated into the new DBMS 
only by manual data entry. 
Advantages of this integrated system are: 1) Standardization of 
data entry and data integrity; 2) Access to pt data independent 
of the chart; 3) Ability to retrieve and report selected 
information; 4) Rapid, concise and accurate formulation of H&P, 
daily notes and discharge summRlj' with immediate printout; 5) 
Updated office file; 6) Instantaneous recall of information of 
readmitted pts; 7) Accurate billing information; 8) Queries 
derived from the integrated hospital and office data base assist in 
clinical decision making and improve the quality of care of 
individual as well as subsets of cardiac pts. 
993·4 
Management of Cardiology Patients During Fellowship Using 
8 Notebook Computer 
Iqbal!, Omarali M.D .. Kart T. Weber M.D. FACP. University of Missouri 
School of Medicine, Columbia, Missouri 
The management of patient information utilizing a database program 
structured specifically for cardiac evaluation on the Apple Macintosh 
Powerbook during the fellowship program at a University Hospital is 
described. Since commencing the fellowship, all information concerning 
patient management -including phone calls. conservation with physicians, 
chart reView, and history and physical exam (at the bedside) were put 
directly into a notebook computer. utilizing the hard drive as a near•
unlimited source of data storage and totally bypassing the use of notes on 
scraps of paper. On average 57 patients were admitted over four week 
block cardiology roatations. The admission note was printed and placed 
within minutes of leaVing the patient's bed-side in the patient's chart. 
Important daily information concerning the management of the patient was 
inserted into the computer. Daily notes, if required, were hand written as 
they were usually brief and short. The information continuously updated 
proVided a source for letters to referring physicians and discharge 
summaries. 
A template was for the database program. Panorama, was created to 
allowed easy and quick access of screens to insert data, WYSIWYG display 
of letters and notes (as opposed to ·merger" with word-processing and 
database programs), and enhanced battery life. It allows for fast and 
accurate management of patients, with the benefit of data storage for future 
patient-related interaction (ie. telephone calls, pharmacy, visits), and 
storage of patient information for future research and analysis. 
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751·1 2:00 
Directional Coronary Atherectomy for Patients 
with Recent Myocardial Infarction 
*Gregory C. Robertson, Tomoaki Hinohara, James W. Vetter, 
*Matthew R. Selmon, Dennis J. Sheehan, Bruce J. McAuley, 
Donald E. Saunders III, *Ussa J. Braden, *John B. Simpson, 
Sequoia Hospital and the Pacific Foundation for 
Cardiovascular Research, Redwood City, CA 
The purpose of this study was to evaluate the safety and 
efficacy of directional coronary atherectomy (DCA) for the 
treatment of recent myocardial infarction (MI) patients 
(pts). Sixty two pts who had a recent MI (1-14 days) 
underwent DCA for lesions in the infarct related artery. Of 
these, 25 pts (43%) were treated with a thrombolytic agent 
during acute MI. The results were compared with non MI 
pts. 
Ml Non MI p value 
n:62 n:393 
DCA success 92% 93% ns 
Major ischemic complications 9.7% 2.6% 0.01 
CABG 6.5% 1.8% 0.08 
In hospital occlu~ion 4.8% 0.8% 0.05 
Distal embolism 6.5% 1.8% 0.08 
The relationship between days from MI and DCA outcome 
were as follows: 
Days from Ml 
n 
DCA success 
Ischemic complication 
]-4 days 
19 
90% 
11% 
4-7 days 
24 
96% 
8% 
8-14 days 
19 
90% 
11% 
In conclusion, for pts with recent MI, DCA could be 
performed effectively and safely in selected cases, however 
there was a trend for higher ischemic complications 
compared with non MI pts. Timing of the DCA procedure did 
not effect the outcome of DCA. 
751·2 2:15 
MorphoiOllic aDd QuaUtatm PredIcton f1I Aaate 0.'- With New 
Dmces iD Sapbeaou VelD Gnfts 
Michael H. Sketch, Jr~ Charles J. Davidson, Jeffrey Popma, ·Richard A 
Schatz, Tomoaki Hinobara, °FraDk Utvac:k, TlDlotby Sanborn, W8DIin Yeb, 
Katherine Delre, William W. O'Neill, Donald S. Baim, Duke UDMrsity, 
Durham, N.C. 
To determine the relatioDsbip of steDosis morphology to procedural success of 
new devices in saphenous vein grafts, 667 \esions in 638 c:onscc:utive patients 
within the NACI Registry were evaluated morpbologica\ly and quantitatively 
with coronary angiography. These devices include: Atbcrocatb (DCA), 
TransIuminaI Extraction Catheter (TEe), PaImaz-Scbatz stcnt (PSS), AIS and 
Spectranetics (SPE) \ascrs. 
DCA TEe PSS AIS SPE 
LESION CHARACIERISTICS 
Total # of vein graft lesions 165 152 243 60 47 
Ecccntricity(%) 82 70 70 S7* 73 
Thrombus (%) 22 51- 14 23 19 
Total occlusion (%) 4 10 2* 15 6 
Mean vessel size (mm) 3.8 3.7 3.5 3.3 3.2* 
Mean lumen pre-procedure (mm) !n- .72 :n .60 .55 
Mean lesion length (mm) 6.1 10.2- 6.8 8.1 7.7 
OUTCOME 
Angiograpbic success-lesion (%) 96 83 99 94 91 
Clinical Success (%) 78 71 92* 74 83 
Complications: 
Dcatb/Q-Wave MIjEmcrgcncy 
CABG 1 9* 2 2 2 
- p < 0.05 for comparison among new devices 
c.dusloa: Acute outcome of new devices for \ICin grafts is often associated 
with lesion desaiptors. The lowcr success and bigbcr complication rate of the 
TEC appears to be related to lesion \cngth and the presence of thrombus. 
This anaIysis of stenosis morphology may provide a framework to perform 
randomized tria1s assessing the efficacy of new devices in vein grafts. 
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751·3 2:30 
Angiographic Determinants of Risk and Outcome of Coronary Embolus 
And Myocardial Infarction (MI) With The TransluminaJ Extraction 
Catheter (TEC): A Report From The New Approaches To Coronary 
Intervention (NACI) Registry 
Jeffrey W. Moses, Paul S. Tierstein, Michael H. Sketch Jr., Robert M. Siegel, 
Wanlin Yeh, Katherine M. Delre, Alexander Sbaknovich, Robert Safian, Ray 
Matthews, Edward M. Kreps, for the NACIlnvestigators, Lenox Hill Hospital, 
New York, NY. 
TEC atherectomy employs a UDique method of continuous suction timing 
atherectomy. It bas been proposed that this mechanism can reduce the incidence 
of coronary embolus (CE) and subsequent MI, especially in treating degenerated 
saphenous vein grafts and thrombotic coronary lesions. In order to assess the 
frequency and determinants of risk for CE and MI with TEC, 210 pts with 239 
lesions with planned TEC as the sole therapy from the NACI registry were 
analyzed. 51% ofthepts were:;;5 years old, 70.5% were male, 31.4% had prior 
PTCA and 61.9% had a prior MI. Results: 127 pts had at least one SVG treated, 
and 83 had only native coronaries treated. 89% had adjunctive PTCA. There 
were II pts with CE and II with MI (5.2% incidence). 10 of II pts had both CE 
and MI. All CE occurred immediately post TEe. 100% ofpts with CE and 81% 
MI pts had a SVG treated vs 63% without CE and 63.7% without MI (p<O.OOI 
for pts with CE vs without CE). Total occlusion before procedure was present 
in 33.3% with CE vs 8.4% without CE (p<O.05). There were no significant 
differences in graft age or presence of recent MI in cases with or without CE 
and with and without MI. CE occurred 15.4% of SVG with thrombus before 
procedure vs 0% without thrombus (p=O.OOO3) and 0% of native coronaries 
with thrombus (p<O.OOO4 vs SVG with thrombus.) 17.4% oflesions with 
prel'rocedure total occlusions suffered CEo CABG was required 27.3 % in pts 
with MI vs 1% in pts without MI (p<O.OOI.) Mortality inpts with CE was 36.4% 
vs 3.5% without CE (p<0.001). MnItivariate predictors of CE were thrombus, 
total occlusion and EF <50%. Multivariate predictors of MI were family history 
of CAD, thrombus and moderate or severe target vessel tortuosity. 
Conclusions: I) Coronary embolus and MI occur in 5.2% ofpts with planned 
TEC. 2) MI in TEC is almost invariably associated with coronary embolus. 
3) Thrombotic SVGs, including total occlusions, are at high risk for coronary 
embolus and MI. 4) Coronary embolus and MI are associated with markedly 
increased adverse outcomes. 
751·4 2:45 
Translumlnal Extraction Catheter Atherectomy In Bypass Grafts 
vs Native Vessels: Are There Significant Differences? 
-Jeffrey B. Gitlin. Joseph M. Sunon. Paul N. Casale. Patrick L. Whitlow. 
Stephen G. Ellis. and Eric 1. Topol for the US Coronary Transluminal Extraction 
Catheter (TEC) Investigators. Cleveland Clinic Foundation. Oeveland. Ohio 
The lEC catheter was initially developed to target complex coronary anatomy 
and vein graft disease and has been recently approved for use in both nati ve and 
graft vessels. To define differences in complication rates between native and 
graft vessels. outcome among 1141 pts from the multicenter lEC registry 605 
(53)% native; 536 (47%) grafts was analyzed. Major complications. defined as 
acute MI. CABG or death were more common in native vessels (11 %) vs grafts 
(S%; p=O.04). By univariate analysis. there were no differences in lesion 
eccentricity or the use of adjunctive PTCA. Significant differences included: 
MajorComp 
MI 
CABG 
Death 
Calcification 
Restenotic 
Muttivessel 
Thrombus 
Ulcerated 
Diffuse dz 
Total Occlusion 
Lesion Length 
Largest TEe (F) 
Native (%) Graft (%) p 
68 (11) 41 (8) 0.04 
31 (5) 18 (3) NS 
23 (3) 3 (0.5) 0.002 
8 (1) 17 (3) 0.03 
141 (23) 44 (8) 0.0001 
215 (36) 117 (22) 0.0001 
315 (52) 74 (14) 0.0001 
484 (80) 342 (64) 0.0001 
561 (93) 460 (86) 0.0001 
82 (14) 126 (24) 0.0001 
38 (6) 63 (12) 0.001 
11 ±7 14 ±17 0.0002 
6+1 6±2 0.05 
By logistical regression. complications in native vessels were predicted by 
acute MI setting (odds ratio (OR)=2.3; 95%CI=1.8-3.1). and multi vessel 
disease (OR=1.4; CI=l.l-I.S). When targeting grafts. complications were 
asSOCiated with acute setting (OR=2.5; CI= I.S-3.6) and lEe without adjunc•
tive PTCA (OR=2.9; CI= 1.1-7 .4). Thus. complications with lEC appear more 
common when targeting native vessels. especially in the acute MI setting. 
Native arteries were approached more often when treating problematic restenosis. 
however the observed complication rate suggests the device should be used 
with caution in native vessels. 
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751·5 3:00 
su.an P8rcutaaaou.e ~a.y u.iDq the JIew 
IIydrolyaer C&tbater • PreliJUDary ..... It. in SapbeDou. 
Vein Graft. 
Jean Fajadet, Olivier Bar, Chri.tian Jordan, Gabriel 
Robert, Jean-Pierre Laurent, Jean-Baptiste Caillard, 
Bernard Cassagneau, Jean Marco, Clinique Pasteur, 
Toulouse, France 
Percutaneous thrombectomy in bypass grafts (SVG) was 
performed in seven consecutive patients. The device 
(Hydrodynamic Thrombectomy catheter or Hydrolyser 
Catheter) consists of a 7F double lumen drainage 
catheter based on the Venturi effect created by a high 
pressure jet. The seven patients (mean age = 67 years) 
who each had previous coronary bypass surgery (mean 
age of SVG : 8.4 years) had unstable angina and 
presented with eight high grade angiographic stenoses 
with intraluminal filling defects on .even SVGs. The 
Mean graft diameter was 3.9 DIll and mean thrombus 
length was 15 DIll. Thrombus was removed successfully in 
all cases and adjunctive balloon angioplasty was 
needed in six lesions. During the Hydrolyser procedure 
the patients did not experience chest pain or 
myocardial ischemia ; two transient AV blocks 
occurred. After the procedure, angiographic evaluation 
did not show graft dissection or distal embolization. 
No major cardiac events occurred during 
hospitalization. 
Conclusion : 1/ The new hydrolyser catheter is able to 
remove thrombus from SVG percutaneously. 
2/ Further investigations are needed to confirm the 
effectiveness and safety of this new device. 
3/ Future improvements to the hydrolyser catheter, 
particularly in regard to size, probably will allow 
percutaneous thrombectomy of native coronary arteries. 
751·6 3:15 
Tnnscatbeter Device Synergy: Use ~ AdjUIICt Directional Atberectomy after 
RotatioaaJ Atherectomy or Exdmer Laser Angioplasty 
Kenneth D. Henson. Roy flood, Salurnino P. Javier. Jeffrey J. Popma, Gary S. 
Mintz. Christine J. Ditrano. Robert A. DeFalco. Lowell F. Satter. Augusto D. 
Pichard, Martin B.Leon. Washington Hospilal Center. Washington. DC 
Rotational ~tomy (RA) and excimer 1aser angioplasty (ELCA) may ablate 
fibroca1cific plaque but small catbeter size often results in significant residual 
stenose~ Initial ablation with RA or ELCA may facilitate further lumen 
enlargement by directional atherectomy (DCA) in fibrocalcific lesions where iniIial 
DCA may be unsuccessful. We evaluated our experience with the sequential use 
of RA or ELCA followed by DCA in 70 patients (49 ELCA+DCA and 21 
RA+DCA) with fibrocalcific lesions in large vessels. Angiograms were analyzed 
using quantitative angiography and standard qualitative morphologic criteria. 
Intravascular ultrasound was used to measure vessel. lumen. and plaque cross 
sectional areas and the arc of ta lIet lesion calcium. 
pe- post- RA pre- post- ELCA 
RA RA +DCA ELCA ELCA +DCA 
AngiCJl!l1lphy 
MLD(mm) .84 I.5S 2.66· .76 1.41 2.59* 
Diameter stenosis 72% 47% 14%· 76% S4% 13%* 
Ultrasound 
Vessel area (mm2 21.2 22.1 23.3- 18.2 19.1 2O.S* 
Lumen (mm2) 2.2 4.0 6.9" 1.9 3.4 6.3* 
Plaque (mm2) 19.1 IS.I 16.S- 16.1 lS.8 14.~: 
Arc of calcium 164° 139° 98°- 126° 126° 93° 
• ANOVA. p<.!lOOl RA; iANOVA. p<.OOOI ELCA 
The mechanisms of RA vs ELCA differ; RA ablates plaque and removes calcium. 
whereas ELCA elicits minimal tissue or calcium removal. but ·shatters" the 
fibrocalcific plaque matrix. Both facilitate subsequent DCA which results in 
additive tissue and calcium resection. 
In Conclusion: The use of synergistic device modalities (either RA or 
ELCA and adjunctive DCA) to treat fibrocalcific lesions in large vessels (I) is 
associated with excellent angiographic results (average fmal diameter stenosis of 
13%) and (2) the high procedural success is dependent upon both initial ablation or 
modification of plaque calcium (by RA or ELCA) followed by further boIk tissue 
removal of residual hard and soft plaque elements (by DCA). Thus. appropriate 
use of multiple sequential devices are needed to achieve optimal angiographic 
results in specific complex lesion subsets. 
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752-1 2:00 
Does Iscbemic Pnconditiooiug Alter Risk Area Size?: A Study Using 
Myoau'dia1 Contrast Echocardiograpby 
Flordeliza S. Villanueva, Declan McCabe, Edward J. Ncmet, Martin Fallon, 
University of PittsburJb, Pittsburgh, PA 
Althouah repeated brief episodes of reversible iJchemia, or iJchemic 
preconditionina (PC), limit myocardial infarct size after austained ischemia, its 
mechanisms are incompletely UDdentood. Because risk area size is an 
important determinant of the extent of necrosis, we tested the hypothesis that 
ischemic PC alters risk area in an OpcD-<:hcsted canine model using serial 
myocardial contrast echocardiography (MCE). Seven dogs were 
preconditioned with a 5 min left anterior descending (LAD) coronary. artery 
occlusion (OCC) followed by 5 min reperfusion repeated 4 times prior to SO 
min OCC, while 6 control dogs underwent a single SO min LAD OCC. MCE 
was performed during each PC OCC and 5 min into the SO min OCC in the 
PC dogs, and 5 and 45 min after sustained OCC in the control dogs. Blood 
flow to the risk bed was measured using radiolabeled microspheres and 
normalized to left circumflex flow. Risk area was defined as the contrast•
deficient region on digitally subtracted MCE images and expressed as a percent 
of the left ventricular short-axis slicc. 
During PC, at equivalent hemodynamics, there was temporal variability to 
risk area size during intermittent OCC, with a net 31 % ±20 % decrease (range 
13% to 69%) in risk bed size between the first PC OCC (34%±1l %) and 5 
min into the SO min OCC (23%±10%,p<O.OI). There was a corresponding 
32%±24% increase (range 4% to 71 %) in normalized LAD bed flow 
(O.29±.12 vs O.37±O.15, p=O.03) at these 2 stages, which appeared 
predominantly due to a rise in collateral flow at the lateral borders of the risk 
zone. In dogs not undergoing PC, however, there was no significant 
differencc between risk area size 5 min (30%±5%) and 45 min (31 %±5%, 
p=O.44), after the single OCC. Correspondingly, there was no significant 
change in normalized LAD flow (O.23±O.15 vs O.26±16, p=O.41). 
We conclude that in this canine model, PC by intermittent coronary OCC 
over 45 min, as compared to sustained 45 min OCC, reduces risk area size, 
likely due to increasing flow at the 1ateraI borders of the risk bed. MCE may 
be useful in assessing dynamic changes in collateral blood flow during 
ischemic PC. 
752-2 2:15 
Echocardiographic Fourier Phase and Amplitude Imaging 
for Objective Quantification of Ischemic Regional Wan 
Asynergy: An Experimental Study in Dogs. 
Helmut F. Kuecherer, Wolfgang Schoels. Bertram Offner, Kirsten 
Freigang. Gaspar da Silva, Johannes Brachmann. 
University of Heidelberg, Dep. of Cardiology, Heidelberg, Germany 
To investigate whether echocardiographic Fourier phase and 
amplitude imaging can be used to quantitate ischemia related regional 
wall asynergy, we obtained echocardiographic left ventricular long 
and short axis views in 6 anesthetized dogs undergoing microemboli•
zation of LAD and LCX coronary arteries. Cine loops of two-dimen•
sional echocardiographic four chamber and short axis views were 
digitized at baseline and 1,5,10,20 and 30 min. after microemboli•
zation. Cine loops were mathematically transformed using a first 
harmonic Fourier analysis algorithm to obtain parametric images 
displaying sequence and magnitude of pixel intensity changes by 
color-encoded phase angles and intensity-coded amplitudes. Mean 
phase angles and amplitudes were measured in standard endocardial 
segments and compared to planimetrically obtained segmental frac•
tional shonening and to segmental systolic wall stress. At baseline. 
contraction was synergic (range of phase angles 1.25 ± 3.0°) with 
uniform high amplitudes (105 ±30). Microembolization caused 
contraction asynergy within Imin, significantly (p«.l.()OJ) delaying 
phase angles (range of phase angles 94± 46°) and lowering ampli•
tudes (60± 35) in segments with reduced fractional shortening (67±9 
vs. 10 ± 6 %) and elevated wall stress (35±15 vs. 94±30 glcm2). 
Shifts in phase angles correlated better with dynamic changes in 
segmental fractional shortening than did shifts in amplitudes 
(r= - 0.75 vs. r=O.43, p<:(UlOI) during partial recovery of segmental 
wall motion 5-30 min post microembolization. 
Conclusion: Echocardiographic Fourier phase imaging. and less 
reliably amplitude imaging, can be used to quantitate ischemia related 
regional wall asynergy. displaying contraction sequence and 
magnitude in a simple, objective format. 
ABSTRACTS 
752-3 2:30 
Mitral Inflow Affects Aortic Regurgitation Jet Area: 
An In Vitro Study 
Russell S. Heinrich, Kim M. Williams, Randall Y. Grimes, 
Roben A. Levine, Ajit P. Yoganathan. Georgia Institute of 
Technology, Atlanta, GA, Massachusetts General Hospital, 
Boston, MA. 
Introduction: Despite its limitations, color Doppler jet area is 
employed clinically to measure the severity of valvular 
regurgitation. For jets entering a stationary flow field, previous 
research has shown that jet area is a function of jet momentum 
alone and thus is an indication of degree of regurgitation: In 
aortic insufficiency (AI), the jet enters the left ventricle as it is 
simultaneously being filled by the atrium. This departure from 
the ideal case was studied in an in vitro model to determine the 
isolated effects of mitral inflow (MI) on AI jet area (JA) 
measurements. Methods: In a 15 cm wide square chamber, 
steady flow was driven through 0.07-0.17 cm2 circular orifices 
at velocities of 2-4 m/s. MI was simulated by steady flow 
through a 5.06 cm2 orifice and directed at varying angles at 
velocities of 10 to 80 cm/s. Five JA measurements were 
averaged for each experimental condition. Results: When 
compared to the free jet, the simulated MI altered the measured 
jet area. The area was found to decrease with increasing mitral 
inflow velocity. This effect was reduced as the momentum of 
the Al jet increased. JA was reduced by 25% at peak MI for a 
jet velocity of 2 mis, while it only decreased by 7% when the jet 
velocity was 4 m/s. Conclusions: Coflowing fields 
comparable to MI can substantially decrease the size of the color 
Doppler area of regurgitant jets. These results imply that in the 
presence of mitral stenosis AI jet area will be significantly 
underestimated. which obviously has profound implications. 
752-4 2:45 
Detcrmlaants of Functional Tricuspid Regu.,ptatlon In Incomplete TrIcuspid 
Valve eloson: Doppler Color Flow Study of 110 Patients 
Alex Sagie. Luis R Padial, Ebud Schwammenthal, Arthur E Weyman, Robert 
A Levine, Massachusetts General Hospital, Boston, MA 
The incomplete tricuspid valve closure (ITVC) pattern has been described by 
2D echo. To date, however, whether tricuspid regurgitation ITR) is universally 
associated with thjs pattern and the determinants of TR severity in its presence 
have not been studied by DQPplcr color mapping (OeM). We therefore 
identified 110 consecutive pts (age 62 • 17 yrs) with ITVC (~ 6 mm apical 
displacement (DIS) of the coaptation point) studied by DCM over 3 years 
without organic TV disease (54 with cardiomyopathy, 30 with left-sided valve 
diseasc,15 with pulmonary hypertension and 11 with congenital disease). In the 
4-<:hamber view of pts and 15 normals we measured linear apical DIS of 
coaptation from the tricuspid annulus (T A); are.1 of DIS between leaflets and 
TA; TA dimensions; and RV, RA and TR jet areas. RESULTS: 1) TR was 
present in all pts with ITVC, and was moderate to severe in 85% GetfRA area 
2604% to 52016%).2) RV systolic pressure (RVSP) did not correlate with TR 
severity. 3) Area of DIS more strongly predicted TR severity than linear DIS. 
4) RY diastoUc area (RYDAl was nonna! in 32% of pis; in contrast, the TA 
was dilated in all pts in systole, with parallel RA dilation. 
'P <005 Normal Mild TR Mod TR Sev TR 
DIS (linear, em) 0.16 0.96 1.02 1.2' 
nT~ 
, __ 2, n.,., 1 R .,,. ., . 
RVOA (Mn\ 1/;">. ,.!/;~ ,~.! ">.II" 
TA .... (Mn\ 1 ~ ">.1 ">.">. ">.,,' 
TA ,,;. (,.".\ 7~ ">.0 47 4~' 
RVSP (mm He:) 57.2 52.3 48.2 
CONCLUSIONS: 1) TR is universally associated with the ITVC pattern and is 
moderate to severe in the majority of pts. 2) Impaired coaptation is be.t 
reflected by DIS area between leaflets and annulus. incorporating linear DIS 
and annular dilation. 3) Neither pulmonary hypertension nor RV dilation is a 
prerequisite for functional TR. Annular dilation. which can impair coaptation, 
is the most consistent finding and occun in pis with TR and normal RV size. 
221A 
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752-5 3:00 
Regurgitant Orifice Area in Tricuspid Incompetence: Clinical 
Follow-up Study 
J Miguel Rivera, James D Thomas. Cleveland Clinic Foundation, 
Cleveland, OH 
Analysis of the flow convergence zone proximal to a regurgitant 
orifice permits noninvasive quantitative measurement of clinically 
useful parameters of valvular insufficiency. However, indices such 
as regurgitant flow rate (Q..) and regurgitant stroke volume (RV) 
reflect not only the size of the regurgitant lesion but also 
hemodynamic loading conditions. The effective regurgitant orifice 
area (ROA) is a more fundamental parameter, more reflective of 
real changes in the geometry of the valve. To test the consistency of 
these measurements ROA was calculated in 22 patients with 
tricuspid insufficiency (I'R) and repeated at a mean follow-up of 2 
months. Its variability was then compared with that of 0.. and RV. 
METHODS: From a Doppler flow map, peak regurgitant flow rate 
Qo was calculated by identifying a contour velocity v, at a radius r 
from the orifice as Qo= 2m, X (vofvo-V.) X (a/180) where Vo is the 
peak TR orifice velocity from continous-wave Doppler (CW) and a 
is the angle subtended by the tricuspid leaflets. RV was calculated 
as Qox S vIvo, where S v is the time-velocity integral of TR orifice 
velocity from CWo RV was then multiplied by heart rate to yield 
0... Effective regurgitant orifice area (ROA) was calculated as 
Qjvo. RESULTS: In the second study ROA ranged from 7 mm2 to 
85 mm2 (33±24 mm2), RV (7 to 87 cm3/beat) and Qm (580 to 8710 
cm3/min). The % variation in ROA (study 2 - study I) was 
1.8±15%. The variation in RV and Qm was 5±20.6% and 
5.2±35.7%. CONCLUSIONS: ROA is an excellent parameter to 
follow in the serial assessment of valvular insufficiency, less 
dependent on hemodynamic conditions than RV and 0... 
752-6 3:15 
Tricuspid Regurgitation Jet Area. Pbysical Factors Influencing 
its Display in the Clinical Environment 
J Miguel Rivera, Pieter Vandervoort, Tom Karson, MAres, 
Eleanor Morris, James D Thomas. Cleveland Clinic Foundation, 
Cleveland, OH and Massachusetts General Hospital, Boston, MA 
It is commonly held that color jet area closely corresponds to the 
severity of the lesion in tricuspid regurgitation (I'R). To investigate 
whether other recently clinical avilable physical parameters affect 
the displayed jet, we analyzed data from 40 TR patients. All were 
in in sinus rhythm and were divided into those with free jets (pJ, 
Group 1, n=16) and those with impinging wall jets (IJ, Group 2, 
n=24). Jet measurements included mean jet area (MIA) (average of 
four chamber, right ventricular inflow and short axis areas) and 
MJA/MRA where MRA is the mean of the right atrial areas. These 
were correlated with the following factors: 1) Peak flow rate (00) 
determined by identifying a proximal contour velocity v, at a radius 
r from the regurgitant orifice as Qo= 2m, X (vofvo-v.) X (a/180) 
where Vo is the peak TR orifice velocity from CW; 2) effective 
regurgitant orifice area (ROA) given by Qjvo; 3) momentum (M) 
given by Qovo ;and 4) regurgitant fraction (RF), assessed by pulsed 
Doppler tricuspid and pulmonary forward flow. RESULTS: In 
Group 1, MJA correlated best with M and Qo (r=0.94, p< 0.001), 
followed by ROA (r=0.92, p<O.OOI), and RF (r= 0.81, 
p<O.OOI). MJA/MRA showed also very good with Qo (r= 0.92, 
p<O.OOI), M (r=0.91, p<O.OOI), ROA (r=0.91, p< O.OOI),and 
RF (r= 0.85, p<O.OOI). In Group 2, r<0.6O was observed for all 
correlations. CONCLUSIONS: 1) New clinically available 
parameters as Qo, ROA and M influence the size of tricuspid 
regurgitant jets more than RF. 2) Better correlation is obtained 
without normalizing by RA size. 
lACC February 1994:1A-484A 
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Aa&loanphJc DetermlDutl III Acute Outcome After CenIur)' Aa&lopJasty: 
• ......pectlve Quutlt.cbe CenIur)' Aa&loanplak Stud1 III 3679 
Procedura 
Eric Van Belle, Christophe Bauters, Jean-Marc LabIancbc, Eugene P. Me 
FaddeD, Philippe 0uaudaIIc, Michel E. Bertrand. University of Li1Ie, France 
Pucutancous corouary angioptasty (PTCA) is a widely used tcclmie of 
myocardial rcvascu1arizati0ll with primary S1ICCCS6 rates greater than 90 
percent. The modified AHA/ ACC d ... if"",tion is useful in the prediction of 
acute outCOllle after PTCA. However it does DOt take into IIIXOIIDl the results 
of quantitatPe corooary angiography (OCA). The aim of this study was to 
anaIyzc the potential usefulness of OCA in the prediction of acute outcome 
after PTCA in a series of c:oasec:utiYc patients from • singk: institution. 
From January 1988 to December 1991, 3161 paticnt.s uncIcrwcnt PTCA 011 
41571csioas in our institutiOlL Elrdudiog angioptasty 011 ocdusioos, grafts and 
left main stem Iesioas, 3679 1csioas were diIaIed. For each 1esioa 7 qua1itatiYc 
parameters were prospectively measured and DOted: location, irregularity, 
eccentricity, leogth > 10 mm, thrombus, anguIation>4sO, calcification and 
bifurcatiOll. Quantitative ana1ysis of lesiOll &CVCrity before and after 
angioptasty was performed with a COIIlputerized ccIge-detcaion quantitative 
angiography system (CAESAR). UDivariate and multivariate analyses were 
performed with the SAS System. 
Acute closure oa:urcd at 201 1csioas (5.5%). In multivariate ana1ysis 3 
parameters were usociated with acute c:lo6ure: the &e~rity of the 
prcproccdural stenosis measured by OCA (p<O.oool), left coronary artery 
location (p<0.003) and dilation of an anguIated segment (p<O.o5). 
AIIgioptasty was usociated with • reduction in mean percent stenosis &cvcrity 
from 69.4+ /-12.1% to 32.6+ /-14.8%. In multivariate ana1ysis 4 parameters 
were usociated with the &CVCrity of residual stenosis: &e~rity of the 
preproccdural stenosis measured by OCA (p<O.OOOl), irregularity 
(p<O.OOOl), diJatiOll of an anguIated segment (p<O.OO5) and calcification 
(p < 0.(02). 
Percent stenosis &cvcrity, determined by quantitatiYc corouary angiography 
was the most powerful determinant of acute outcome after coronary 
angioptasty. This parameter, which is not taken into account in the modified 
ACC/ AHA classificatiOll for corooary angioptasty, may be useful in the 
prediction of the acute outCOllle after coroaary angioptasty. 
753-2 2:15 
Lesion Morphological Determinants or Coronary Balloon Angioplasty 
Success and Complications: TIme For a Reappraisal 
Kim H. Tan, Neil Sulke, Nick Taub, Elizabeth Watts and Edgar Sowton. 
Guy's Hospital, London, United Kingdom. 
The applicability of the ACCI AHA lesion morphology (LM) classification 
scheme has been put into question in view of the recent advances in 
angioplasty (PTCA) technology. We evaluated the specific LM 
determinants of success and complications in 729 consecutive patients 
(994 vessels, 1248 lesions) who underwent PTCA between 1990-3. 
Procedural success was achieved in 657 patients (90.1 %), 888 vessels 
(89.3%), and 1132 lesions (91 %). 3 patients (0.4%) died,S (0.7%) 
suffered a myocardial infarction and 15 (2.1 %) underwent emergency 
bypass grafting. An abrupt occlusion occurred in 24 vessels (2.4%) and 
38 lesions (3.0%). Success was achieved in 96%, 93%, and 80% of type 
A, B, and C lesions, respectively (p<O.OOI). The incidence of abrupt 
closure did not differ significantly between the LM types (type A 2.1 % '. 
type B 2.6% and type C 5.0%, p=O.i). SUbtyping of type B lesions (BI 
and B2) showed a significant difference in the success (95% versus(vs) 
91 %, p=0.02) and abrupt closure rate (1.1 % vs 4.0%, p=O.OI). 
SUbtyping of type C lesions (C I and C2) only showed a difference in the 
abrupt closure rate (4.2% vs 14%, p=O.04). Multiple stepwise logistic 
regression analysis of specific LM features identified longer lesions 
(2Omm=78%, 10-2Omm=85% and < IOmm=95%, p<O.OOI), lesions 
containing calcium (74% vs 94%, p<O.OOI), and lesions containing 
thrombus (74% vs 93%, p<O.OOI) as independent predictors of 
procedural failure. Longer lesions (>2Omm=16%, 10-2Omm=1I%, and 
< IOmm= 1.5%, p<O.OOI), highly angulated lesions (>900 =13%, 45-
90°=8.8%, and <45°=2.2%, p=O.OO6), and lesions containing calcium 
(14% vs 2.5%, p<O.OOI) emerged as independent predictors of an 
abrupt closure. Conclusion: Procedural success and complications can be 
predicted from easily identifiable LM features. This is more useful than a 
classification scheme and allows better patient stratification and selection. 
JACC February 1994:1A-484A 
753·3 2:30 
Five·Year Event Rates After Multivessel PI'CA When Complete 
Revascularization is not Possible or not Intended 
Martial G. Bourassa, Wanlin Yeh, Katherine M. Detre, for the 
NHLBI PTCA Investigators, Montreal, Canada and Pittsburgh, PA 
Complete revascularization (CR) is often not achievable or not 
intended in pts with multi vessel coronary disease undergoing PTCA. 
To examine whether long-term outcome is affected by the degree of 
revascularization in these pts, we studied the 5-year event rates of 618 
pts with significant disease (~50% luminal diameter narrowing) in 
multiple vessels in the 1985-86 NHLBI PTCA Registry. During data 
collection, the operator was asked to describe the treatment plan prior 
to the procedure and outcome for each procedure. CR was achieved 
in 19% of pts; it was attempted but failed in 9%, intended but not 
attempted in 6 %, and not intended or not possible in 66 %. Five-year 
mortality and myocardial infarction (MI) rates were similar for pts 
with or without CR following PTCA [9.4 vs 12.6%, adjusted risk 
(AR)=1.2, 95% confidence interval (CI) (0.6, 2.3), and 7.7 vs 
15.2%, AR=1.4, 95% CI (0.6, 3.0), respectively]. However, the 
rates of coronary bypass surgery (CABG) were much lower [7.7 vs 
25.2%, AR=3.0, 95% CI (1.5, 6.1)], and the combined rates of 
deathlMIICABG were also lower [21.4 vs 39.9%, AR=1.7, 95% CI 
(1.1, 2.7)] in pts with than without CR. The risk for CABG or the 
combined endpoint of deathlMIICABG was increased approximately 
2-fold when CR was attempted and failed or was not planned, and 5-
to 9-fold when CR was planned but not attempted usually because of 
procedural complications. Thus pts with multivessel disease in whom 
CR is planned and achieved at PTCA have a more favorable overall 
long-term outcome than those in whom CR is not planned or not 
possible. Most of the benefit, however, is due to a reduction of the 
need for CABG. 
753·4 2:45 
In-hospital Costs Comparison of Excimer Laser Angioplasty, Rotational 
Atherectomy (Rotablator) and Balloon Angioplasty for Complex Coronary 
Lesions: A Randomized Trial (ERBAC). 
*Michel Vandormael, Nicolaus Reifart, Wolfgang Preusler, *Hans Storger, 
Franz Schwarz, Manfred Hofmann, Johann W Klapper, Stefan Muller, Red 
Cross Hospital, Frankfurt/Main, Germany 
ERBAC is a single center randomized study comparing results of Excimer Laser 
Angioplasty (ELCA), Rotational Atherectomy (PTRA) and Balloon Angioplasty 
(PTCA) in 700 PTS with native de novo type B or type C lesions suitable to all 3 
techniques. The primary endpoint is procedural success (PS) defined as a residual 
stenosis < 50 % and the absence of death, Q wave MI and Em.CABG during 
hospital stay. Secondary objectives are assessment of sustained angiographic 
(absence of restenosis ;;, 50 %) and clinical success at 4'{; months FUP and 
evaluation of economic outcomes. To calculate and to compare treatment costs 
for PTS treated with ELCA, PTRA and PTCA, in-hospital and cumulative 6 
months direct and indirect costs data are prospectively collected for the three 
groups. In-hospital costs are currently available for 367 PTS. Demographics and 
baseline lesion characteristics are similar in all groups: 
PI'RA ELCA PTCA P 
No. of patients 132 104 131 
PS intention to treat (%) 93* 89 83* 0.04* 
Death, QMI, EmCABG (%) 1.5* 5.7 7.0* 0.02* 
RePTCA,recath,El.CABG(%) 8.3 5.9 8.2 n.s. 
Length of stay (days) 3.5* 3.7 4.2* < 0.05* 
Procedural time (min) 46 47* 42* < 0.05* 
Total(#)in-hosp. costs (OM) 11827* 13932* 9605* < 0.05* 
Incremental cost to PTCA (%) 23 45 0 
(#)includes procedural, hospital and reintervention costs; OM: Deutsche Mark. 
Conclusions: PTRA was both more expensive and more effective than PTCA. 
ELCA was more expensive but not more effective than PTCA. Complete 6 
months cost data analysis will be presented. 
ABSTRACTS 
753·5 3:00 
PI'CA With and Without Inhospital Surgical Standby in 
12965 Patients 
Tassilo Bonze!, Karl-Ludwig Neuhaus, Albrecht Vogt, Enz•
Rudiger von Leitner, Dietrich Harmjanz for the Multicenter 
Quality Control Project of the ALKI< Study Group, Germany 
We compared PTCA results of 5504 pts from 12 centers with 
(group 0 and of 7461 pts from 38 centers without (group IT) 
surgical standby in the same hospital. All PTCAs from each 
center were registered on a Intention-to-treat basis. Each center 
was controlled-by monitoring visits. 
Clinical characteristics were not significantly different (ns) in 
both groups for age, male gender, single, double and triple vessel 
disease, for normal, moaerately and severely impaired LV 
function, for previous CABG, previous PTCA and re-l'TCA, for 
complete occlusions, for the number of dilated lesions per 
sesSIOn, i.e. one lesion, two lesions, three or more lesions. ~ean 
Inhospital time was 4.7 days In group I and 5.6 days in group n. 
There were significant differences In the main Indications (l vs 
m stable angina (68.44 vs 57.5%") and unstable angina (17 vs 
22.8%·). In goup I, more severe lesions were dilated than in 
group II : type A lesionsl3.1 vs 24.6%·, type Bl lesions 30.8 vs 
31.9% (ns), type B2lesions 36.4 V5 29.6%·, type Cllesions 11.1 vs 
8.2%· and type C2 lesions 8.6 vs 5.7%". 
Success rates, i.e. <50% residual stenosis, were similar In each 
group for dilatation of stenoses (92.9 vs 90.5%, ns), and for 
recanalisation of complete occlusions (65.3 vs 67.3%, ns). 
There was no difference In acute vessel occlusion In group I and 
IT (ns). Acute occlusions were treated with standard-balloons in 
19 vs 27%, with perfusion balloons in 16.4 vs 21.1%, with stents 
In 15.5 vs 12.4% and with emergency CABG in 20.7 vs 15.7% (ns 
each). PICA related Mis and mean CKmax values and PTCA 
related death rates were also similar in both groups (ns each). 
Conclusions: Overall PICA success and complication rates are 
not si~nificant1y different in pts treated with or without 
in hospital surgical standby. Hospitals with inhouse surgical 
standby show a tendency to accept a higher rate of complicated 
stenoses. (.= p<.ooo 1) 
753·6 3:15 
Acijusted Influence of Age and Gender on PTCA Outcomes and Hospital 
Resource Conswnption 
223A 
Steven Burstein, Guo-Wen Sun, Jeffrey S. Hammer, Jennifer D. MtIlID, Lucille 
N. Junio. Andrew C. Eisenhauer, Ray V. Matthews, Thomas L. Shook The 
Heart Institute, the Hospital of the Good Samaritan, Los Angeles, California 
Advanced age and female gender have been shown to adversely affect PTCA 
outcome. To adjust for their influence on PTCA outcomes (emergency CABG 
/ CABG < 24 hours and hospital mortality for all causes) and hospital resoun:e 
consumption (adjusted direct hospital costs and 1ength-of-stay), data were 
reviewed for 1732 consecutive PTCAs between March 1, 1991 and February 
28. 1993 at a single non-profit hospital. Females were siplificant older than 
males (mean age 68.1 vs. 63.5, p<O.ool). Females comprised 31" of 
patients with the proportion of females increasing with age from 16.9% 
(age<50), 25.5% (age 50'{;9) to 43.1" (agel!:70, p<O.OOI). Stepwise 
logistic regression was used to investigate the dependence of PTCA outcomes 
on age and gender adjusting for influence of procedure urgeucy and experience 
of procedure operators. In addition, effects on hospital resource consumption 
and length-of-stay were examined by multivariate 8lepwise linear regression. 
Ale Grouli! gSl~er 
Outcomes & Costs <50 50.{;9 ;;,70 pI F M p' 
Number of PTCAs 172 938 622 536 1196 
CABG (%) 4.65 3.52 2.09 (os) 2.99 3.18 (os) 
Mortality (%) 0.71 1.29 3.61 .003 2.38 \.94 (os) 
Length-of-Stay (Day) 3.35 4.05 5.27 .001 5.09 4.11 .001 
Hospital Costs ($) 6643 7881 8561 .001 8506 7767 .048 
t Adjusted for urgency and operator volume; (os)=not significant (p>O.IS). 
Conclusions: 1) Advanced age but nol gender is siplificantJy associated with 
increased hospital mortality. 2) Neither advanced age nor lender predict 
emergency surgery following PTCA. 3) Advanced age and female gender 
adversely affect length-of-stay and hospital resource consumption. 
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Coronary Sinus Anatomy and Anomalies In Patients with 
PolteroMptal AccallOry Path_y Requiring Ablation 
Within a VanoUi Branch of the Coronary Sinus 
2:00 
Mauricio S. Anuda, Karen J. Beckman, James H. MCClelland, 
Xunzhang Wang, Hiroshi Nakagawa, Lawrence E. Widman. H. Andrew 
Hazlitl, Ralph Lazzara, Warren M. Jackman, University of Oklahoma 
Health Sciences Center. Oklahoma City, OK 
Posteroseptal accessory AV pathways CAP) may be associated 
with venous anomalies (such as coronary sinus diverticulum) or may be 
epicardial In locetion requiring ablation from a ventric:ular venous branch of 
the coronary sinus (CS). The purpose of this study was to identify the types 
and frequency of venous anomalies in patients (pis) with AP requiring 
ablation from a venous branch of CS. 
RESULTS: Of 157 pis with posteroseptal APs undergoing radiofrequency 
(RF) catheter ablation, 37 pis (24%) required RF application In a venous 
branch or anomaly of the CS to eliminate AP conduction (27 pis) or 
eliminate one component of the AP (10 pis). This Includes 23 of the 57 pis 
(40%) referred after an unsuccessful ablation procedure compared to 14 of 
the 100 pis (14%) without a prior unSU<lC8ssful ablation. Coronary sinus 
angiography demonstrated the various anomalies Illustrated below. The 
numbers Indicate \he distribution of successful ablation sIIes In the 37 pis. 
CONCLUSIONS: 1) A variety of venous anomalies are associated with 
posteroseptal accessory pathways; 2) These anomalies often account for 
ablation failure at the tricuspid and mitral anuli; and 3) Coronary sinus 
angiography is useful in Identifying successful ablation sIIes. 
754·2 2:15 
Localization or Accessory Pathways in Relation to Coronary 
Venous Morphology 
Dietrich Pfeiffer, Jiirgen Tebbenjohanns, Burghard Schumacher, 
Werner Jung, Matthias Manz, Berndt liideritz. 
Department of Cardiology, University of Bonn, Germany 
Anatomic landmarks are used during catheter ablation (RFA) 
of posteroseptal and left·sided accessory pathways (AP) for 
finding a catheter position near the annulus. No signs for preci· 
se localization of AP arround the annulus are known. The aim 
of the study was detection of anatomic findings, which have a 
correlation to AP location. 
Methods: Retrograde coronary venous phlebography in RAO 
and LAO oblique diameters was performed in 32 patients (pts) 
with left·sided or posteroseptal AP before and after successful 
RF A in comparison to 24 pts with A V nodal reentrant tachycar· 
dia. 
Results: The AP were ablated in the neck of a coronary sinus 
diverticulum (CSD) in 4 pts. No CSD was found without AP. 26 
out of the remaining 28 pts with AP had a ventricular vein close 
to the successful ablation site of AP (retrograde left ventricular 
approach in 18, retrograde left atrial approach in 6, in the CS in 
further 4 pts). 
Conclusions: (1.) Coronary venous morphology predicts localiza· 
tion of AP in 4/32 pts (13%). (2.) A close correlation between 
ventricular veins and AP localization was found in 26/28 pts 
(93%). (3.) In only 2 pts (6%) coronary veinous phlebography 
was not helpful for detection of AP. (4.) Coronary veinous 
angiography should be performed in all left·sided and postero•
septal AP. 
lACC February 1994:1A-484A 
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Negative Delta Wave In Lead II Identifies PosteroMptal 
Acceuory Pathways Requiring AblatIon In Venous 
Branehes of the Coronary Sinus 
Mauricio S. AmKla, Xunzhang Wang, James H. McClelland, Karen 
J. Beckman, Hiroshi Nakagawa, Lawrence E. Widman, H. Andrew 
Hazlitt, Ralph Lazzara, Warren M. Jackman, University of Oklahoma 
Health Sciences Center, Oklahoma City, OK 
Some posteroseptalaccessory AV pathways (APs) are 
associated with venous anomalies or are epicardial In location. 
Successful radiofrequenc:y (RF) catheter ablation requires the 
application of RF current within venous anomalies or ventricular 
venous branches of the coronary sinus (CS). This two phased study 
was designed to assess the value of the electrocardiogram (ECG) 
in predicting the requirement for ablation within venous branches of 
the CS. 
RESULTS: Phase 1 • Out of 135 patients (pts) with a single 
antegrade conducting AP, 10 pts (7.3%) required RF catheter 
ablation in the middle cardiac vein (MCV) or other venous branches 
of CS. Retrospective ECG analysis showed a striking negative 
delta wave in lead II in all 10 pts. After excluding patients with left 
free.wall APs (isoelectric or negative delta wave in lead I, or R > S 
in V1 ), a negative delte wave in lead II was found in only 2 other 
pts (false positive). 
Pha .. 2 • The ECG pattem was prospectively tested in 120 
consecutive pts. It successfully predicted the ablation site in the 
venous system in all 14 pts (MCV • 3 pts, diverticulum of the MCV ·3 
pts, and CS diverticulum • 8 pts). There were no fal .. positives in 
this prospective phase. There was one failed ablation procedure in 
a pt who also exhibited the typical ECG pattem. 
CONCLUSION: A negative delta wave in lead II identifies APs that 
may require RFCA in branches or anomalies of the CS. 
754·4 2:45 
Lessons Learned Fro. Surgery for Failed Rad10frequency 
Catheter Ablation of Accessory Pathways 
James L. Cox, T. Bruce Ferguson Jr, Bruce D. Lindsay, 
Kathy M. Kater, Joseph M. Smith, Michael E. Cain, 
Washington University, St. Louis, MO 
Radiofrequency catheter ablation (RFCA) has supplanted 
surgical therapy for patients with accessory pathways 
(AP). Since January 1990, 15 patients from multiple 
centers were referred for surgery because of failed 
attempts at RFCA. Surgical observations were reviewed to 
determine factors that contribute to failed RFCA. AP 
locations included 5 left-free wall, 9 posterior septal, 
3 right-free wall, and 2 anteroseptal. Eighteen of the 19 
APs were correctly localized at the time of RFCA. Eleven 
(73%) patients had at least one anatomic feature that 
would effect RFCA. These attributes included Ebstein's 
Anomaly (4), anomalous coronary sinus (3), persistent 
left superior vena cava (1), iatrogenic perforation of 
the right ventricle (1), and a small heart due to patient 
age (1). In 2 patients, an anomalous coronary sinus was 
completely enveloped by a II11n thick layer of muscle that 
extended onto the floor of the posterior septum as a 6-8 
IIIn band connecting the atrium to the ventricle. Findings 
at surgery resulting from RFCA ranged from insignificant 
scarring (10 patients), to significant scarring that 
hampered the surgical dissection (4 patients), to 
prohibitive scarring that precluded any surgical 
dissection (1 patient). The conclusions of this study 
are: (1) the majority of failed RFCA procedures do not 
result from inaccurate localization of the AP; (2) 
failure to ablate an AP is often the result of an 
anatomic abnormality and; (3) excessive applications of 
RF lesions can result in permanent damage that interferes 
with or precludes surgical cure. 
JACC February 1994:1A-484A 
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Complications of Radiofrequency Catheter Modification of the 
Atrioventricular Node • Results of the Multicentre European 
Radiofrequency Survey. 
Gerhard Hindricks on behalf of the Multicentre European 
Radiofrequency Survey (MERFS) Investigators 
The incidence of procedure related complication was retrospectively 
analysed in 4398 patients who had undergone radiofrequency catheter 
ablation in 68 European institutions between 1987 and 1992. From 
these 4398 pts., 815 pts. underwent modification of the AV-node in 
A V -nodal reentrant tachycardia. The total incidence of complications 
in these patients was 8.0% (65/815). The most common complication 
was the unintended induction of complete atrioventricular block 
(41/815, 5%). Complete atrioventricular block occurred significantly 
more often in pts. that underwent ablation of the "fast" pathway 
(6.2%) or attempted ablation of the "slow" and "fast" pathway after 
failure of the initial site (16.7%) when compared to "slow" pathway 
ablation (2.0%, p<o.05). In addition, irrespective of the ablation site, 
complete atrioventricular block occurred more often in centres that 
had a limited experience in radiofrequency modification of the A V•
node (less than 30 pts. treated) when compared to centres that had 
treated more than 30 pts. (6.4% vs. 3.0%; p<O.05). Perforation or 
clinically significant pericardial effusion occurred in 5/815 pts.(0.6%), 
thromboembolic complications in 12/815 pts. (1.5%). No death 
related to the ablation procedure was reported. 
Conclusions: Radiofrequency catheter modification of the A V -node 
carries an risk of approximately 5% of complete atrioventricular 
block. The incidence of complete A V -block is significantly higher in 
patients that underwent fast pathway ablation when compared to slow 
pathway ablation. There seems to be a clear learning curve with 
respect to the risk of complete atrioventricular block. 
754·6 3:15 
Quality of Life After lladiofrequency(llF) Catheter Ablation for 
Supraventricular Arrhythmias 
Michael D. Lesh", Cynthia M. Tracy, 'Linda Cooperman, Jonathan J. 
Langberg for the EP Technology Investigators. "University of 
California, San Francisco, CA 
We prospectively evaluated quality of life in 360 patients(pts) before 
and after curative RF ablation for A V node reentry(A VN) or accessory 
pathway tachycardia(AP), or His ablation and pacing for refractory 
atrial arrhythmias(HIS) during a multicenter trial of a new ablation 
system. Pts were carefully questioned before and 1,3, 6, 12, 18, and 24 
mo. after ablation rating overall health, physical condition, whether 
work, exercise and driving were limited due to a cardiac condition, and 
whether pt felt better since ablation. llesults (% of pts): 
... ......•.....• \ .• " ...... ................. ;':p.>;;.:.,'./. "Pie · .... Plm.ii 'SiiiV :MiD: 
AVN 
(N=113) 
AP 
(N=196) 
HIS 
(N=51) 
Health excellent or very good 39 
Can't work due to heart 8 
Can't drive due to heart 17 
Can't exercise due to heart 25 
Feel better since ablation 
Health excellent or very good 49 
Can't work due to heart 5 
Can't drive due to heart 6 
Can't exercise due to heart 37 
Feel better since ablation 
Health excellent or very good 20 
Can't work due to heart 20 
Can't drive due to heart 25 
Can't exercise due to heart 
Feel better since ablation 
SO 
64' 
3 
2' 
lit 
82 
76" 
2 
1.2 
5" 
91 
SOt 
21 
17 
19t 
91 
66' 76' 
5 2 
3' 3' 
4·· 0·· 
91 92 
80" 81" 
3 1 
0.7t 0.7t 
2"· 4·· 
95 96 
SSt 
11 
16 
19t 
87 
SSt 
lit 
16 
16t 
85 
"p<O.OOOI, ·p<O.OOl, tp<O.OI vs Pre. No change occurred beyond 6 mos. 
Conclusions After successful RF ablation: l)regardless of substrate, sense 
of health improves; 2)there is a dramatic improvement in ability to 
exercise, especially for those with A VN or AP; 3)more pts can drive, 
and there is a trend towards return to work. Using these measures, qual•
ity of life improves substantially after ablation. 
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What is the Optimal Treatment for Thrombolytic Ineligible AMI? 
Preliminary Results or the Study of Medicine vs Angioplasty 
Reperfusion Trial (SMART) 
George R. McKendall, Thomas M. Drew, Sheryl F. Kelsey, Mary Jane 
McDonald, Barry L. Sharaf, Edward S. Thomas, David O. Williams, 
Rhode Island Hospita1, Brown University, Providence, Rhode Island 
225A 
Although thrombolytic therapy ('IT) improves outcome in AMI. a 
substantial proportion of patients are not eligible to receive 17. PTCA 
has been proposed as an alternative method of reperfusion in such pts 
although its value has not been measured. We randomly assigned SO pts 
to receive either immediate catheterization and PTCA, when feasible, or 
optimal medical therapy without routine PTCA Pts underwent pre· 
discharge catheterization to assess infarct artery status and were followed 
for clinical outcome. Fifteen of 25 pts (60%) assigned to immediate 
catheterization had anatomy suitable for PTCA which was successful in 
each. Results according to treatment assignment were: 
Invasive Medical 
D=25 D=25 II 
Discharge stenosis severity 37%± 19% 77%±14% .0001 
Infarct artery patency at discharge 88% 77% .37 
Discharge left ventricular EF 57%± 15 51%±14 .24 
Left ventricular EF < .40 14% 18% .73 
Re-infarction 0% 12% .07 
Severe ischemia 12% 36% .04 
Congestive heart failure 36% 36% 1.00 
Death 0% 4% .31 
DeathlRe-infarctionl 
SI::t!.a:l: i~l:bs:miilLflE:!> ~ 52~ 6.4~ 32 
Thus, in AMI pts who are ineligible for 17, PTCA can be performed 
successfully in pts with suitable anatomy. Compared to optimal medical 
therapy, PTCA is associated with a lower incidence of severe ischemia 
and recurrent infarction with favorable trends for other endpoints. From 
these pilot data, we conclude that emergency catheterization and PICA 
appears to be superior to optimal medical therapy for pts ineligible for 
thrombolysis and may become the standard of care. 
755·2 2:15 
Jlescue Yl'CA In the TIMI 4 Trial 
C. Micbael Gibson, Christopber P. Canoon, Robert N. Piana, Robert M. 
Greene, Raphael F. Sequiera, Raymond D. Margorien, Ferdinand Leya, Vicki 
Davis, Donald S. Baim, and Eugene Braunwald for the T1MI 4 Investigators. 
Beth Israel and Brigham and Women's Hospitals, Boston, MA 
While rescue PTCA has been used to improve early reperfusion rates 
achieved by thrombolysis alone, high rates of early and late complications 
have left its overall cIinical benefit in question. The goal of this study was to 
determine the incidence and predictors of adverse outcomes (AO) within 6 
weeks of rescue PTCA in tbe TIMI 4 trial. Of the 367 patients (pts) with 
acute MI enroUed in the TIMI 4 triaI, wbo had received eitber front-loaded 
t-PA, APSAC, or APSAC + t-PA along with ASA and IV heparin, 91 had 
T1MI 0 or 1 flow at 90 minutes, and of these 57 pis underwent rescue PTCA . 
Adverse Outcome Yl'CA Suc:eess Yl'CA FaUure No PTCA 
(n=5O) (n=7) (n=310) 
Deatb 10.0% 28.5%" 4.5% 
Recurrent MI 8.0% 0.0% 6.8% 
New CHF/Shock 4.0% 42.8%" 3.2% 
Discbarse EF <40% 14.0% 42.8%t 15.0% 
T1MI 0/1 flow 18-36b 4.0% N/A 6.1% 
Any A.O. 34.0% 71.4%t 303% 
"p < 0.005, tp < 0.05, comparing PTCA failure to no PTCA 
As a group, 38.6% of pts undergoing attempted rescue PTCA experienced 
any AO, which was oot different from 30.3% for tbe No PTCA group. The 
predictors of clinical failure (CF, i.e. any AO, immediate procedural failure, 
or need for subsequent revascularization) after rescue PTCA were the 
presence of anterior MI (863% vs 343%, p<O.OOl), and age (61.2±8.6 yrs 
in CF vs 53.8± 103, p=O.OO5). There was no difference in tbe incidence of 
CF among the three thrombolytic regimens, by gender, previous MI, time to 
thrombolysis, the presence of multivessel disease, or the angiographic 
presence of thrombus. Coocluslon: Rescue PTCA was performed in 15.5% 
of pis, witb an 88% acute success rate. PIS. witb failed rescue PTCA were at 
high risk for adverse outcomes, while those with successful rescue PTCA had 
outcomes similar to patients treated with thrombolysis alone, suggesting that 
the cIinical outcome of patients undergoing rescue PTCA appears to be 
related to establisbing early patency of tbe infarct related artery. Our findings 
support tbe use of an aggressive strategy of early reperfusion with 
thrombolysis foUowed by rescue PTCA if early patency is not restored. 
226A ABSTRACTS 
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A Prospective Study of Transluminal Extraction Atherectomy 
In High Risk Patients With Acute Myocardial Infarction 
TlUlothy J. Larkin, William W. O'Neill, Robert D. Safian, Theodore 
1.. Schreiber, Melissa A May, Sam Kazziha, Paulette R. Niemyski, 
Michele A Parker, Barty 1.. Kramer, Cindy 1.. Grines, William 
Beaumont Hospital, Royal Oak, Michigan 
The optimal reperfusion strategy for MI pta who have failed or are 
ineligible to receive thrombolytics is unknown. Transluminal c:maction 
atherectomy (TEC) has the ability to aspirate thrombus and excise 
atheroma, thus may be uniquely suited for reperfusion of the high risk 
cardiac pt TEC atherectomy was used to revascularize 76 pta (age 
61:1: 12 yn) with acute myocardial infarction (AMI), including 8 pta in 
cardiogenic shock. TEC was performed as the primary reperfusion 
strategy in 36 pta not eligible for thrombolytics, in 39 pta after failed 
thrombolysis and in 15 pts with post infarction angina and a 
thrombotic coronary lesion. The target lesion was located in a native 
coronary artery in 58 pts (76%) and a saphenous vein graft in 18 pts 
(24%). Angiographic evidence of thrombus was present in 55 p~ 
(72%) and baseline antegrade flow was graded as TIMI 0 or 1 ID 44 
pts (58%). After TEC, TIMI 2 or 3 flow was present in 68 pta (S?%), 
including 37 of the 44 pts with baseline TIMI 0 or 1 flo~. Followmg. 
TEC and adjunctive PTCA, 71 pts (94%) had a final residual stenosIS 
less than 50% and TIMI 2 or 3 flow. Clinical complications included 
no reflow in 5 pts (6.7%), blood transfusion in 17 pts (22%), but no 
pts required emergency CABO. In-hospital death occurred in 7 pts 
(9%) including 3 pts who presented in cardiogenic shock. Continued 
patency of the infarct related artery was present in 25 of 28 pta (88%) 
who underwent pre-discharge angiography. Follow-up catheterization 
is being performed at 6 months to determine angiographic reocclusion 
and restenosis rates. Conclusion: TEC atherectomy in high risk AMI 
pts resulted in a high procedural success rate with a favorable clinical 
outcome. Whether mechanical aspiration of thrombus results in 
sustained patency of the infarct artery will be determined. 
755-4 2:45 
~ of QJnmuy ~ in Plati_t. With Acute 
~al IDfarct:icm lbIpitali.ci in c.atcw With and 
Without QJnmuy AllqiCl!ll"llllbY hciliti_ in Illnel 
Sol~ 8abar, Gabriel BIIrbash, far the Israeli 
'l'brc:Kolytic SUnwy Orcup, Neufeld cardiac Raaearch 
InIItitute, Sbabllllldical Omter, Tel 1IIIIdx.ar, Israel 
During a tNo _th period in 1992, 1014 ~i-ve 
patialta (pta) "ith acute lIYOCU"dial infarction were 
t.::.pitalizad in the 25 aD's operating in Isr_l (16 
bcspitals "ith on-site CICIr"CDUy angiograpilic facilities 
- grcup A and 8 calters "ithcut theae facilities -
grcup B). BcIIpital and 1 ~ .artality ___ oaIPl%"8d 
brt_ grcup A (n-785) and grcup B (n-229). 'lbraabo•
lytic t~~t _ edainist.ared EIl"8 frequently in 
grcup A pta (48t) than in pta frc::a grcup B (41'-; poNS)_ 
DElspite si.iler t.aeliDe c::baracteristics in the 2 
grcupa, caraaary angiCl!ll"llllbY _ parf~ in K1re pta 
(196-~) initially edaitted to bcspitals "ith on-tSite 
caraaary angiCl!ll"llllbY/anqicplasty (grcup A) than in 
thcae (16-7.-; p<0_OO01) edaitted to hcIIpitals "ithcut 
theae faciliti_ (grcup B). 'DIe availability of 
CICIr"CDUy catbsterizaticm laboratori_ ~lted in 
grM.tar __ of caraaary angicplasty and CXZ'ODIU"Y bypass 
III.lrgBry (1~ in grcup A _. ~ in grcup B; p<0_0005). 
DElspite early «72 bra) aartality advantage in grcup A 
_. grcup B (~ __ ~ nllJplCtivaly; p<0_009), no 
signifiCllllt diffar&lC8B ___ '*-t vel in hcIIpital or 1 
year ac:rtality (10.- and 17'- in grcup A _. 1~ and 1S. 
in grcup B nllJplCtivaly; poNS)_ 
Q:lacb_icm: Availability of on-eite CICIr"CDUy angio•
graphy faciliti_ ~lted in ..... use of CICIr"CDUy 
procadures. 'lhis iDClwaaed use of iDvasiva procedures 
_ DOt· ",enied "i th ICMar boapi tal or 1 ~ 
Klrtality. 
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Cardiogemc Shock: Changing Therapies and Prognosis 
Ramon Raneses, Usha Kodali, Cindy 1.. Grines, Joel K. Kahn, Gerald 
C. TinlIDis, William W. O'Neill, William Beaumont Hospital, Royal Oak, 
Michigan 
The impact of a more aggressive approach of cardiogenic shock (CS) 
has not been validated. Since 1988, we have employed interventional 
management of pts with CS. This report analyzes the impact of this 
strategy on hospital survival. We have treated 175 pta with CS from 
1986-92. The pts were divided into 2 groups: pts treated more 
conservatively from 1986-88 (Group 1) and those admitted in 1989-92 
treated frequently with interventional techniques (Group 2). CS was 
defined as systolic BP<8Omm Hg without inotropes,<9Omm Hg with 
inotropes, evidence of MI by ECG or elevation of CPK-MB. Group 1 
had 35 pts and Group 2 had 140 pts. There were no differences between 
these groups in gender, age, hypertension, tobacco use, diabetes, 
hyperlipidemia, family history, history of angina, past MI, prior PTCA, 
or prior CABO. Overall, survival was greater for pts treated with PTCA 
or CABO (55%) VB medical therapy (20%) p=<O.OOl. Usage patterns 
for these interventions differed in the two eras: 
Group 1 Group 2 p value 
(1986-1988) (1989-1992) 
CABO 3/35 (9%) 18/140 (13%) .68 
PTCA 3/35 (9%) 70/140 (50%) .0001 
PTCAorCABO 6/35 (17%) 88/140 (63%) .0001 
MsQical Rx° 29LJ5 (83%) 52£140 (37%) .0001 
(OMedical Rx includes conservative management and lytic therapy). 
Hospital survival was 17% in Group 1 and 44% in Group 2 (p=.OO6). 
In conclusion, these data suggest that the increased use of aggressive 
mechanical revascularization in cardiogenic shock pts may improve in•
hospital survival. 
755-6 3:15 
Adverse catheterization Laboratory Events after Prllllllry PTCA vs. 
PTCA Following Thrombolytic Therapy - A Report from the Primary 
Angloplasty In Myocarcllallnfarctlon (PAMI) Trial 
·Gregg W. Stone, Cindy l. Grines, Kevin F. Browne, Jean Marco, 
Donald Rothbaum, James O'Keefe, ·Geoffrey O. Hartzler, Paul Overlie, 
Brian Donohue, Noah Chelliah, Sylvia Puchrowicz, ·William W. O'Neill. 
EI Camino Hospital, Mountain View, CA and William Beaumont 
Hospital, Royal Oak, MI 
Concern has been expressed that PTCA during acute myocardial 
infarction (MI) may be deleterious, especially PTCA of the RCA. In the 
PAMI Trial, 395 pts within 12 hours onset of MI were prospectively 
randomized to treatment with t-PA followed by PTCA only for failed 
thrombolysis or recurrent ischemia (n=200) vs. primary PTCA without 
antecedent thrombolysis (n=195). To examine the frequency and clinical 
implications of adverse events occurring in the cardiac cath lab (CCl), 
the CCl course of the 175 pts in the PTCA arm who actually underwent 
PTCA was coq>ared to the 72 pts who received t-PA followed by PTCA 
for either failed thrombolysis (n=14), recurrent ischemia (n..sO), or other 
(n=8). 
Major CCl events (bradyarrhythmia requiring pacer, 
tachyarrhylhmia requiring defibrillation, sustained hypotenSion requiring 
pressors or balloon pump, intubation, CPR or death) occurred in 25 
(10.1%) patients, and were more common aller RCA PTCA than LAD or 
lCX PTCA (14.8% vs. 5.6%, p=.017). Major CCl events frequently 
occurred before rather than after reperfuslon (64% vs. 36%). In-hospital 
mortality was 24% in pts with major CCl events vs. 5% in pts without 
CCl evenfs (p..0004). Major CCl events occurred in 13 (7.4%) of 175 
primary PTCA pts, 1 of whom died within 24 hours. In contrast, major 
CCl events occurred in 12 (16.7%) of 72 pts undergoing PTCA after t· 
PA (p<.03 vs. primary PTCA), 3 of whom died within 24 hours. In the t· 
PA/PTCA patients, major CCl events occurred in 6 (43%) pts after 
rescue PTCA vs. 6 (12%) pts after PTCA for recurrent ischemia 
(p:009). 
In conclusion: Major adverse events during PTCA in acute MI 
occur most commonly in pts with RCA occlusion, olten develop prior to 
reperfusion, and are aSSOCiated with increased in-hospital mortality. The 
incidence of major CCl events is reduced in pts undergoing primary 
PTCA compared to PTCA after thrombolysis. 
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756·1 2:00 
Efficacy of AImobJant 01\ Temainalion IIId lDductkm of P_xyamaI. 
Supraventricular Tachycardia 
BiiJje Darpa and "Nils Edvardsson, Div. of Cardiology, Sahlgrenska 
Hospital, Giiteborg. Sweden, for the Alrnokalant PSVf Study Group 
In a Scandinavian multi-<entre, placebo-controJ\ed, trial the anti•
arrhythmic efficacy of a1mokalant, a selective Ik blocker, was investigated 
in patients with paroxysmal, supraventricular tachycardia (PSVf). 
87 patients (pts), mean age of 54±14 years, with reciprocating tachycardia 
(Rn due either to wpw syndrome (n=58) or AV nodal reentry (n=29) 
were studied using transesophagea1 atrial stimulation. After reproducible 
induction of RT, a1mokalant was given by i.v. infusion aiming at pseudo 
equilibrium plasma concentrations of 20, SO, 100 and ISO nmol/l. Each pt 
was studied at two levels. 39 pts were randomly assigned to either placebo 
+ 20 nmol/l or 20 + SO nmol/I of almokalanl26 pts were studied at 
SO + 100 nmol/l and 22 pts at 100 + ISO nmol/l. The ability to terminate 
induced, on-going RT and to suppress the induction of RT was assessed: 
~: 
Concentration: Iennjnation of RT: $ywression of induction: 
(nmoIfI) (n) (%) (n) (%) 
placebo 3/20 15 0/20 0 
20 7/36 19 10/36 28 
SO 10/36 28 11 /36 31 
100 13/34 38 17/39 44 
ISO 4/9 44 12/18 67 
Compared to placebo there was a significant increase in the ability to 
suppress induction of RT already at 20 nmol/I, and a Significant increase 
in the ability to terminate induced RT at 100 nmol/l and above. There was 
'a significant trend (Cochran-Armitage trend test) towards increasing 
antiarrhythmic efficacy with increasing dosage. One pt developed 
torsades de pointes tachycardia on the highest dose given. 
A1rnokalant exhibited a significant, dose-dependent antiarrhythmic 
efficacy both in terminating RT and suppressing its induction. The drug 
gave rise to a serious proaIThythmic event in one pt, but was otherwise 
weD tolerated. 
756·2 2:15 
Differential Electropbysio/ogical Effects of Intravenous 
Acetylcholine and Adenosine. 
Raymond F Stainback. Fernando Costa. Frank A Fish. Rose M 
Robertson. Italo Biaggioni. Vanderbilt University. Nashville. TN 
Exogenous acetylcholine (ACh) and adenosine (Ado) produce 
similar electrophysiological (EP) effects in vitro--SA node slowing 
and A V node inhibition. However. it is unclear which of these 
negative dromotropic effects predominates in humans after IV 
administration of ACh or Ado. Methods: 15 normal volunteers 
(vols) received IV ACh. and 9 of these also received IV Ado. Both 
drugs were given by rapid «2 sec) bolus injection into the right 
antecubital vein in a constant volume of 4 ml while recording 
surface ECG. Doses were titrated to an endpoint of:l!: 25% increase 
in sinus cycle length (SCL = PP interval). AV block (:l!: 25% PR or 
non-conducted P wave) or a max dose of 40 mg ACh or 18 mg 
Ado. Results: Mter IV Ado. AV block occurred in 4 (44%) vols 
at 21 ± 6 sec post injection (threshold dose = 12 ± 2 mg). In 2 a 
trend towards SCL increase occurred just prior to Ado-induced A V 
block. In the remaining 5 vols SCL shortened after Ado without 
A V block at the max dose. In contrast ACh significantly prolonged 
SCL transiently (from 964 ± 219 ms to 2166 ± 892 ms. n=7) at the 
threshold dose (30 ± IO mg) without A V block in any case. Time 
to max SCL post ACh was 8 ± 2 sec. In 7 vols no SCL increase or 
A V block occurred at the max ACh dose and in 2 transient atrial 
flutter (<15 sec) or junctional rhythm limited ACh dose. These EP 
findings were supported by His bundle recordings in 3 pts who 
received IV ACh and Ado post radiofrequency ablation of bypass 
tracts. However. 2 of these pts developed self-terminating atrial 
fibrillation post IV ACh. Conclusions: The predominant EP effect 
of IV ACh is rapid-onset sinus cycle lengthening at the threshold 
dose without significant change in PR interval. In contrast. the 
predominant effect of adenosine is relatively delayed A V block 
without significant SCL prolongation. With careful titration and 
hemodynamic monitoring. IV ACh is generally safe. although atrial 
fibrillation or flutter may occur in predisposed individuals. 
ABSTRACTS 
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Conversion of Atrial Fibrillation and Flutter by Intrsvenous Ibutllida: 
A MultIcenter Dose Response Study 
Kenneth A. Ellenbogen, Mark A. Wood. Bruce S. 5tambler. "Linda K. 
Wakefield. and "James T. VanderLugt, Medical College of Virginia, 
McGuire VA Medical Center, Richmond VA and The Upjohn CorT1'8ny, 
Kalamazoo MI for The Ibutilide in Atrial AlThythmias Dose Response Study 
Group 
Ibutilide is an investigational class III antiarrhythmic agent with a unique 
ionic mechanism of action. The efficacy and safety of ibutilide were 
studied in 98 patients with atrial fibrillation of up to 90 days duration and 
99 patients with atrial flutter. Patients were randomized to receive a single 
intravenous dose of placebo, 0.005. 0.010. 0.Q15 or 0.025 m!ikg over 10 
minutes. Conversion was defined as tennination of the atrial arrhythmia 
within 60 minutes after the infusion. Percent conversion by dose is shown 
in the figure. Mean time to conversion was 18 minutes after the start of 
the drug infusion. Median arrhythmia duration in patients that converted 
was 6 days for flutter and 12.9 days for fibrillation. Mean aTc interval of 
429 msec at baseline increased to 483 msec at 50 minutes after the 
infusion in the high dose group. There was no change in aRS duration. 
Six patients 
developed 
polymorphic 
ventricular 
tachycardia; four 
required DC 
cardioversion and two 
resolved 
spontaneously. 
These data 
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ibutilide is able to 
safely and rapidly 
tenninate atrial flutter 
and fibrillation. 
756·4 2:45 
Plasma FIbrin D-Dlmer Levels In Patients with Atrlat FIbrillation 
and Left Ventricular Aneurysms: Effects of Introducing Warfarin 
Therapy on Thrombogenesis 
Gregory YH Up:Ann Rumley, Francis G Dunn:GordonO 0 0 Lowe 
Department of Cardiology, Stobhill Hospital, Glasgow; and "University 
Department of Medicine, Royal Infinnary, Glasgow, Scotland, U.K. 
To determine whether or not the introduction of wartarin therapy alters 
plasma levels of fibrin D-dimer (~O) [a mart<er of intravascular fibrin turnover 
and thrombus fonnation] we perfonned a prospective study to determine 
sequential DO levels (EUSA; AGEN) in 30 patients in whom warfarin therapy 
was initiated: 20 patients hed chronic atrial fibrillation (Group I), and 10 had 
Iell ventricular aneurysm (Group II). DO levels were measured pre-warfarin, 
and at Days 3, 5, 7 and 2 months following the introduction of warfarin. In 
Group I, there was a substantial reduction in median plasma DO levels by 2 
months following the introduction of warfarin (181 ng/ml vs 80 ng/ml; paired 
Wilcoxon test, p<O.OO1). In Group II, there was also a simHar large redUdion 
in median plasma DO levels by 2 months following the introduction of warlarin 
(115ng/m1 vs 61ng/m1; p:O.01). H patients from both groups with a high initial 
DO level of >1 00ngim1 [> 75th percentile of the range for population values of 
DO] are selected (23 patients), there is a reduction of DO by Day 7 (200 ngl 
ml vs 175 ng/ml; p:O.02), and a highly significant reduction by 2 months post•
warfarin (200 ng/ml vs 68 ng/ml; p<O.OOOI). At 2 months post-warfarin, there 
was a median reduction of plasma DO by 49% (95% confidence interval 36% 
to 72%). These results confirm a progressive reduction of plasma DO 
following the introduction of warlarin therapy, suggesting a beneficial reduction 
of fibrin turnover and intravascular thrombogenesis. This is consistent with 
the prophylactic effect of warfarin therapy against thromboembolic risk, and 
suggests that DO meastnrnent may be useful as a m!l1<er of thrombogenesis. 
227A 
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756-5 3:00 
Flunarizine as a Pharmacologic Probe to Identiry Triggered Activity in 
Patients with Cardiac Arrhythmias 
Jacques T. Metzger, Marc A. Vos, Barbara Dijkman, Joep L.R.M. Smeets, 
Anton P.M. Gorgels, Hein J.J. Wellens. Department of Cardiology. 
Academic Hospital Maastricht. The Netherlands. 
Reentry is considered to be the mechanism responsible for most 
arrhythmias in patients with structural beart disease. Experimentally other 
arrhythmogenic mechanisms bave been described which may be relevant to 
patients with ventricular tachycardia (VT) and apparently DOrmal bearts. In 
animal experiments, we bave demonstrated that the action of FlulUlTizine 
on VT is mechanism-specific for triggered activity (fA). The purpose of 
this study was twofold: I) To confirm the inability of Flu1UlTi4ine to 
suppress reentrant VT in bumans, and 2) to identify the incidence of TA 
in idiopathic VT. 
Two groups were studied: A) 6 patients with sustained monomorphic VT 
after myocardial infarction (5 males, mean age 66 ± 21 yr, 5 inferior 
infarction, 1 anterior infarction) an arrbythmia based on reentry, and B) 14 
patients with VT without structural beart disease (mean age 42 ± 16 yr, 10 
males). Nine had sustained and 5 had repetitive monomorphic VT of which 
10 had left (L) and 4 had right (R) bundle branch block-like (BBB) confi•
guration. Flunarizine (lmg/kg/5 minutes) was injected intravenously during 
a spontaneous or a pacing induced VT. Effectiveness of FlulUlTizine was 
defined as follows: complete effect: termination of VT or reduction of the 
ectopic activity by:,a75 %. Partial effect: prolongation ofVT cycle length 
by :,a25 % or a reduction in the ectopic activity between 25 % and 75 %. 
In group A, none of the VT's were affected by Flunarizine. In group B, 4 
VT's responded to FlulUlTizine: (3 complete effect, 1 partial effect) 1 RBBB 
and 3 LBBB VT. No adverse effects from the drug were observed. 
From these results we conclude that in humans: 1) Flunarizine does DOt 
affect arrhythmias based on reentry 2) TA appears to be the underlying 
arrhythmogenic mechanism in a subset of patients with idiopathic VT. 
756-6 3:15 
Efficacy of Low Doae Aaiodarone in Byaptoaatic 
Buatainacl, Drug Rafractory Atrial Fibrillation-Flutter 
Randy Pritza, Nazih N. Kadri, Tom T. Hee, Dan 
Hilleman, James N. larnegis, Syed M. Mohiuddin, 
Creighton Univeraity, Omaha, HE 
Longterm efficacy, aafety, and effect on functional 
capacity of low dose Amioclarone (LOA) in patienta 
(pta) with drug refractory atrail fibrillation (Fib) 
flutter (Fl) ha. not been adequately documented. LDA 
was given aa a loading doae of 10 grama (1-2 weeks) 
and daily maintenance doae of 268.6 ± 93.7 mg (ateady 
atate Deaethyl Am level 1.34 ± 0.64 and Am 1.22 ± 0.93 
mcg/ml) to 20 pta with a follow-up 16.6 ± 8.4 mo. All 
pt. had drug refractory (documented failure of 3.2 ± 
1.4 drugs) aymptomatic, suatained atrial Fib-Flo pts' 
characteristic.: Age 68.5 ± 8.4 years, .F 43.4' ± 
18.3, and MYRA Claa. (MYRA-C) 2.85 ± 0.95. pts were 
monitored for all known aide effect. of Am. Follow-up 
included atrict quidelines for monitoring of 
hematologic, hepatic, renal, pulmonary, ophthal•
mologic, and endocrine organ ayatam function. MYRA-C 
was estimated by uaing objective data and/or pts 
lifeatyles. 
RESULTS: 17/20 pta (85\) maintained ainua mechanism. 
Remaining 3 pta had controlled ventricular response 
(CVR) to atrial Fib. Pta MYRA-C improved from a 
baseline of 2.85 ± 0.95 to 1.85 ± 0.63 (P<.001). 3 
pta had hypothyroidism corrected by thyroid 
replacement therapy. Am was tolerated well in 19/20 
pts. In 1 pt, it waa diacontinued because of 
psychosis. No other aignificant aide effects neces•
aitated discontinuation of the drug. 3 pta had died 
due to non-Am related cauaes (refractory CHF-l pt, 
pulmonary embolus-l pt, and perforated viacu8-1 pt). 
CONCLUSIONS: In pts with drug refractory, symptomatic 
atrial Fib-Fl, long term (16.6 ± 8.4 mol LOA ia well 
tolerated with infrequent major side effecta requiring 
termination of the drug in only 5' (1/20) aa well as 
effective in CVR to atrial Fib (3/3) and maintaining 
Ainus mechanism (17/20). In this pt population, MYRA-C 
improved by maintaining Ainus mechanism and/or CVR to 
atrial Fib. 
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bcICJIeIIOUS Nitric: Odde Selectively EaIIaace& Left Vealrielll8r RelualioB. 
Richard M. Grocott·Mason, ~ B. Anning, Malcolm J. Lewis and Ajay M. 
Shah. Cardiovascular Sciences Research Group, University of Wales College of 
Medicine, CanIiff, U.K. 
Impaired myocardial relaxation may contribute to diastolic heart failure. 
Recent reports indicate that nitric oxide (NO) selectively hastens relaxation in 
isolated myocardial preparations, via elevation of cyclic GMP (cGMP). We 
examined the effects of exogenous and endogenous NO in isolated ejecting 
guinea-pig hearts (constant loading and heart rate; Krebs buffer; 37°C). We 
studied (i) the NO-donor sodium nitroprusside (SNP); (ii) bradykinin (BK) and 
substance P (SP), two agents known to release NO from guinea-pig cororuuy 
vascular endothelium,and (iii) the cGMP.independent vasodilator nicardipine 
(Nic). Left ventricular pressure (LVP) was measured by a 2F Millar catheler in 
the LV cavity. L VP fall was biphasic and could be characterized by two 
monoexponential time constants; one for early relaxation (TE), and another for 
late relaxation (TL). SNP, SP and BK induced faster early relaxation without 
effecting dP/dt, peak L VP, end-diastolic L VP or TL. Nic bad no effect on TE, 
although it increased coronary flow (CF) similar to the other agents. There was 
no correlation between the increase in CF and the effects on relaxation. 
% Change Control SNP 1jIM SPO.ljIM BK 1nM BK 100nM Nit 100M 
CF 1.9±1.4 23.9±1.0*" 19.9±2.2"" 42.4±7.3"" 63±3.l"" 3S.8±l.S"" 
TE at S '().4±l.S -16.3±l.S"· -13.4±2.l·"-S.2±J.J" -12.7±1.9"" -S.3±3.6 
min 
"p<O.OS,""p<O.Ol c.f. control; ~; 
In the presence of haemoglobin (Hb 1j1M), which inactivates NO, the effects of 
SP and BK on relaxation were abolished (%change 1.3±3.4 and .().6±4.6 with SP 
and BK lOOnM respectively; 0=6; p<O.OS c.f. SP or BK alone). Hb abolished the 
SP-induced rise in CF (O.7±O.7;p<O.0I c.f. SP alone), and reduced but did not 
abolish the vasodilator activity ofBK (peak: %increase +37.6±6.S with 100nM), 
consistent with previous studies. In conclusion (i) these data Show that 
endogenous NO has a novel selective effect on relaxation in the intact ejecting 
left ventricle, with no effect on the contraction phase, (ii) this action is not due to 
the mechanical or metabolic effects of increased CF, but appears to be due to a 
direct action of NO on myocytes, (iii) luch an intervention wbich selectively 
enhances relaxation without compromising systolic perfonnance could be 
benefICial in diastolic heart failure. 
757-2 2:15 
Moderate Potassium Depletion Impairs Diastolic Function. 
T. Narain Srivastava, David B. Young. University of Mississippi 
Medical Center and the Veteran's Administration Medical Center, 
Jackson, MS 39216. 
Recently we found that moderate K depletion of 5 days duration 
impaired left ventricular contractile and relaxation responses to 
epinephrine and preload in dogs (JACC 1991;18:105-11). The 
greatest effect was on the maximal filling rate index. In the present 
study we analyzed the effects of K depletion on cardiac function in 8 
normal male and female human volunteers. Cardiac function was 
assessed by Doppler and M-mode ecbocardiography after a 7 day 
period of K depletion (1.25 mg/kg/day cblortbalidone plus 1.25 
mM/kg/day NaCI), and during a 7 day period of K repletion (96 
mM/day KCI supplement). In the analyses, measurements were made 
during: a) control period; b) during i. v. infusion of the beta adrenergic 
agonist dobutarnine (DBT) at rates of 10 and 15 ug/kg/min. K 
concentration was 3.91 ±.11 mM during K repletion and 3.08 ± .17 
mM following K depletion. The maximal early filling rate was 
estimated from the initial peak flow velocity through the mitral valve 
(MVE). MVE data (cm/sec) are presented in the table: 
Control 10ug/kg/m 15 uglkg/m 
K repletion 93.6±8.3 118.0±8.3 126.5±9.1 
K depletion 76.6±6.6 100.3±8.9 116.0±7.3 
p< .01 .01 .02 
Ejection fraction was 77.8 ± 1.8 % and 76.8 ± 2.5 with no DBT in the 
replete and deplete conditions respectively (n.s.) and increased during 
15 ug/kg/min DBT infusion to 88.0 ± 1.2% and 89.2 ± 2.2 % (n.s.) 
during repletion and depletion respectively. No other measurement of 
cardiac function was affected significantly by K depletion. We 
conclude that moderate K depletion significantly impairs active 
relaxation of the myocardiwn resulting in a reduction in maximal early 
filling rate of the left ventricle. The negative effect on mechanical 
function may be even more prominent in patients with existing 
myocardial dysfunction. 
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757-3 2:30 
Altered Effects of Load on Rate of Pressure Fall in the Stunned Left 
Ventricle: Impaired Relaxation or Decreased Contractility? 
Adelino F. Leite-Moreira and Thierry C. Gillebert 
University of Antwerp, Antwerp, Belgium 
The effect of a given increase in systolic left ventricular pressure (L VP, 
load) on rate ofLVP fall shows an important inter-animal variability. Test 
beats with systolic LVP increases of 12±1 mmHg, produced by partial 
aortic obstruction before aortic valve opening, were com pared to preceding 
control beats in open-chest dogs. The change in time constant t (dt, % 
test vs control) was related to the peak iso(volu)metric LVP increase 
produced by total aortic obstruction (mmHg), in baseline conditions (n=20) 
and repeated after stunning (n=7). Stunning was induced by a 15 min 
occlusion and 30 min repcrfusion of the LAD coronary artery. 
At baseline, the linear relation 40 !IT .1"(0) 
between dt and isometric LVP '. ~ ..• 
increase (8 and 95% tolerance . ~~ .. 
ellipse: dashed lines, r=-0.96) 20 ". ~""" 
showed that the change in t 0 • , • . '. 
induced by 12 mmHg systolic LVP 1 3ir·. .,.. '60 
increases was closely related to the . • 
peak isometric LVP increase. ·20 Isomelric LV? increase (mmHg) 
After stunning, changes in t induced by a 12 mmHg LVP increase were 
larger in comparison to baseline. They were superimposed on the graph as 
0, and connected to corresponding baseline changes by solid lines. 
Stunning induced a deterioration of contractility, hence of isometric L VP 
increase. The relation between change in t and isometric L VP increase 
remained however unchanged. 
Conclusion: In the stunned LV, slower L VP fall in response to increased 
systolic load could therefore be accounted for by a smaller peak isometric 
L VP increase and by working conditions closer to isometric, rather than 
by a primary relaxation disturbance. 
757-4 2:45 
DiastolIC DyafunCtion In Demand Ischemia: Relative Rolea of 
Myocyte ca" OVerload and High Energy Phosphate Depletion 
Niraj Varma, Franz R Eberti, Cart S Apstein, Boston University, Boston, 
MA 
Exercise-Induced angina (demand ischemia (01)) causes an acute 
Increase in LV diastolic chamber stiffness (DCS) via a mechanism 
favoured to be due to myocyte Ca++ overload, but possibly related to 
ATP depletion. We Investigated the pathophysiology of 01 In isolated 
isovolumlc (balloon-in-L V) red-<:ell pertused rabbit hearts by altering 
Ca++ availability and glycolytic ATP. 01 was reproduced by reducing 
coronary perfusion Pressure from 80 to 20 mmHg (decreasing coronary 
blood flow by 70%) and Increasing pacing rate from 3 to 7Hz 
(tachycardla:T). When Isovoklmlc LVEDP had risen by 7 to 8 mmHg, 
indicating Impaired relaxation and increased DCS (mean 14±2 min of 
01) Twas tenninated, and followed by a 1 min Intra-coronary Infusion of 
saline (S:n-7) or high ca++ (n-7) to test the heart's capacity to handle a 
deliberate Ca++ load. Function was similar in S and Ca" groups during 
low-flow ischemia before T (systolic pressure (SP)ILVEDP mmHg in 
S.67118 vs Ca" 61/16,NS) and immediately after tachycardia (S-38/25 
vs Ca++.39/23, NS). 5mM Ca" Increased SP to 81±4 mmHg (indicating 
increased cytosollc Ca++ in systole) vs 57±3mrnHg in S (p<O.OOI). 
However no increase In DCS occurred during high Ca" Infusion 
(LVEDP Ca".22 vs S.25 mmHg, NS), suggesting DCS was insens~ive 
to Increased Ca++' Similarly decreasing Ca" availability by a 1 min 
Infusion of 8mM EGTA 90s after T (0=6) decreased SP by 30% (SE60 
vs EGTA.42mmHg, p<O.001) with no change in DCS (LVEDP 
5-EGT A- 26mmHg). To Increase glycolytic ATP Twas Iollowed by a 5 
min Infusion of gklcose 25mM and insulin 400 j.lUlml (G+I,n=6). S and 
<2+1 were similar during low flow Ischemia before T (SPIL VEDP S.67118 
vs G+I.65/17 mmHg. NS). and Immediately post-T (S.38/25 vs 
G+I.46125, NS). 5 min after T LVEDP in G+I was lower cf S (G+I.22 vs 
5-27 mmHg, P<O.OOI). Mannitol equiosmotlc 10 G+I (n.6) infused for 5 
min post-T did. not Influence DCS. Similar to prior results with pure 
supply ischemia, In the current study Increased DCS in demand 
Ischenia is insensitive to an Increase or decrease of Ca" availability (ie 
Ca++ clearance mechanisms remain competent and even able 10 handle 
an eddMlonalload), but alleviated by Increased G+I, implying glycolytic 
ATP depletion and not Ca" overload In pathogenesis. 
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757-5 3:00 
Effects of Collagen Disruption on Left Ventricular Properties In Rat Hearts 
Koji Todaka, Shu·Ming Zhu, Anguo Gu, Eyal Herzog, Judith S. Hochman, 
Milton Packer, Daniel Burkhoff. Columbia Univ., College of Phys. & 
Surg., New York, NY 
While the collagen matrix is believed to play an important .role in proper 
functioning of the left ventricle ILVI, the effects of disrupting the matrix 
are unknown. We therefore studied the effects of acute collagen matrix 
disruption on LV performance in isovolumic, Langendorf perfused rat 
hearts. The collagen matrix was disrupted in 5 hearts by perfusion with 
1mM 5,5'-dithioI2-nitrobenzoic acid) IDTNB) added to Krebs-Henseleit 
solution IKH) for 1 hour followed by 2-hour perfusion with normal KH at 
a fixed coronary flow; this procedure has been reported to induce 
endogenous collagenolytic activity. 5 control hearts ICNTRl) were 
perfused with normal KH for 3 hours. Collagen content In &4), quantified 
by hydroxyproline assay, was 2.95 ± .3% of total protein in CNTRl 
compared with 1.75±.1% in DTNB Ip=0.04), indicating a 40% 
reduction of collagen by DTN8. Scanning electron micrographs In = 6, up 
to 5000xl revealed the delicate collagen network connecting adjacent 
muscle fibers in CNTRL but these were totally absent in the DTNB 
hearts. This suggested that the collagen remaining after DTNB exposure 
was not serving in a capacity to provide mechanical coupling between 
muscle bundles. Prior to administration of DTNB, with end-diastolic 
pressure IEDP) set at 5mmHg, LV developed pressure lOP) was 
91 ±21mmHg in CNTRL compared with 100±10mmHg in DTNB 
IP =0.45). After 3 hours perfusion, DP was 92 ± 11 % of the baseline in 
CNTRl compared with only 74 ± 7% in DTNB IP =0.02). EDP rose to 
13 ± 6mmHg in CNTRL compared with 23 ± 15mmHg in DTNB IP =0.20). 
In addition, 5 DTNB hearts Inot included in the analysis above) had 
ventricular fibrillation (YF) after 1 hour DTNB which could not be 
converted to sinus rhythm, whereas none of the control hearts had VF. 
These data show that following acute disruption of collagenous 
connections between muscles, lV contractile state is depressed by about 
20%. This is not due to loss of diastolic tone since EDP tended to 
increase in the DTNB group. Collagen disruption caused hearts to be 
susceptible to VF suggesting a role of the collagen matrix in normal 
electrical activation in rat hearts. 
757-6 3:15 
Diastolic Creep Causes Depressed Right Ventricular Free Wall 
Systolic Shortening Following Pressure Overload 
229A 
Clifford Greyson, Jorge Garcia, Gregory G. Schwartz 
VA Medical Center and the University of California, San Francisco, CA 
This study detennined whether acute right ventricular (RV) pressure 
overload causes persistent RV mechanical dysfunction following' 
restoration of control loading conditions. Seven autonomically-blcx:ked, 
open-chest pigs were instrumented with a micromanometer in the RV, 
sonomicrometry crystals in the RV free wall, and a pulmonary artery 
(PA) cx:cluder. Pressure-segment length loops were recorded at control, 
after I hr of PA constriction (PAC), and 50 min after release of PAC 
(Recovery) during 8 s IVC constrictions. The level of PAC used was 
previously detennined not to cause ischemia. The area of a pressure•
segment length loop is a regional analog to stroke work; thus, tre loop 
area vs. end-diastolic segment length relation (Area-v-EDL) is a 
regional analog to the Frank-Starling relation. Area-v-EDL slope is an 
index ofregional contractility, while the length-axis intercept (Len-Int) 
corresponds to unstressed segment length. *p<.05 vs. control. 
Control 
PAC 
Reco\exy 
RVBP, mnHg S·rnJV. PJrlD$ Areaw.EDL RelaIi::n 
syst:>li:: diastlfl: S~g Seg.l..ength Skp: Len-Itt 
34±1 4±1 100% 100% 100% 100% 
56±2* 9±1* 64±13* 107±1* 130±20 110±2* 
37±2 6±1 74±9 * 103±1* 124±16 108±3* 
During recovery, RV pressures were similar to control, but systolic 
shonening fell by 26±9%, despite increased end-diastolic segment 
length. This was not due to depressed contraCtility, since the Area-",EDL 
slope did not decrease. Unstressed segment length (Len-Int) increased 
(diastolic creep), shifting the Area-v-EDL relationShip to the right. 
These findings may be explained by the Maxwell muscle model: 
Increased Len-Int is due to creep in the passive elastic elements; if creep 
in the series elastic element is greater than creep in the parallel elastic 
element, unstressed segment length will increase but end-diastolic 
contractile unit length will decrease under any given set of loading 
conditions, resulting in a decline in systolic shortening without a change 
in contractility. 
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Timing of Detection and Prognosis After Appearance of Coronary 
Artery Disease in Heart Transplant Recipients 
Shao·Zhou Gao, Sharon A. Hunt, John S. Schroeder, Edwin L. 
Alderman, Irene Hill, Edward B. Stinson, 
Stanford University, School of Medicine, Stanford, CA 
We analyzed data on 139 Stanford cardiac transplant patients (fx pts.) 
who developed any angiograpbic evidence of accelerated cororuuy anery 
disease (fxCAD). 115 pts. (83%) had initial appearance ofTx CAD:$; 5 
yrs. post-Tx and 25 (17%) developed it later (actuarial %). 
Freedom from initial appearance of TxCAD post· Tx 
y~ 0 1 2 3 4 5 
% 100 79.1 63.3 43.9 30.2 17.3 
No. at risk 139 111 89 63 43 25 
When TxCAD was initially detected. 33% of pts showed a :<: 50% lesion. 
By 2 yrs after initial detection. an additional 17% ofpts had developed 
:<:50% lesion. Ischemic events (myocardial infarction. congestive heart 
failure. sudden death. and reTx) occurred in 48% of pts within 4 years of 
initial TxCAD detection. 
Freedom from ischemic events (yr after initial onset of TxCAD) 
y~ 0 1 2 3 4 5 
% 100 77.0 67.6 57.5 52.2 47.3 
~at~ IB ~ ~ ~ " U 
There were no strongly correlated clinical or laboratory predictors of 
ischemic events. Pts. were subdivided by earty ( :$; 2 yrs.) vs.late (> 2 
yrs) initial onset of TxCAD. The early group (N=64. onset 0.7 - 2.0 yrs .• 
mean 1.5 yrs) had roore rapid progression to ischemic events by 5 yrs 
after detection than did the late group (N=75. onset 2 - 17 yrs; roean 4.9 
years). 
Freedom from ischemic events (actuarial percent) by year after 
initial onset of TxCAD. (Mantel·Haenszel: p=O.06) 
GrouplYr 0 I 2 3 4 5 
Early 100 75.0 64.8 53.7 44.1 44.1 
No.at risk 64 49 37 29 24 23 
Late 100 79.7 72.6 67.7 67.7 62.8 
No.al risk 75 60 47 37 30 24 
We conclude that: (I) Early appearance ofTx CAD is a mmerof 
intrinsically more aggressive disease.(2) There are no strong predictors 
of the development of ischemic complications of TxCAD. 
758·2 2:15 
Benefit of Steroid Weaning Late After Cardiac Transplant: 
Relationship to Transplant Coronary Artery Disease 
Jon A. Kobashigawa, Michael P. Gleeson, lynne W. 
Stevenson, Erica Brownfield, Jaime D. Moriguchi, Nobuyuki 
Kawata, Antoine Hage, Michele A. Hamilton, Davis 
Drinkwater, Hillel Laks. UCLA Medical Center, Los 
Angeles, CA. 
lhe benefit of steroid weaning late (> 6 Alos) after 
cardiac transplant has not been established. To inves•
tigate risk factors and transplant coronary artery 
disease (lCAD) incidence, steroid weaning over a 4 AlO 
peri od was attempted ina 11 pts at 1 east 6 IIOS from 
transplant who had no rejection in the previous 3 mos. 67 
pts were successfully weaned off steroids (OFF) while IS 
pts failed steroid weaning and were left on Prednisone 5 
AIg daily. Pts in the OFF steroid group had an average 
cholesterol decrease of 14 Alg/dl and an average weight 
loss of 3 lbs over I yr compared to the 15 pts left on 
steroids who had an average cholesterol increase of 20 
Alg/dl and an average weight gain of 4 lbs over the same 
period (p<.002). lCAD incidence at 1-4 years was lower in 
the OFF steroid group compared to another 140 pts 
maintained on chronic steroid therapy (SlER) at least 1 
yr from transplant (p<.OS). 
Incidence of lCAD post transplant 
JL ll:..l lr..l lr..1 :tr...! 
OFF 67 0% 0% 5~ 8% 
SlER 140 7~ 1~ 21' 34' 
Conclusion: Steroid free illl1lunosuppresslon does not 
appear to increase lCAD and Alay actually be associated 
with lower lCAD incidence due to selection of pts at 
lower lCAD risk and reduction of lCAD risk factors. 
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758·3 2:30 
I'I-ogresslw DeterIoration 01 Coronary Raene After Heart Traasplaot: A 
1lme-dependeDt ObsenatIon 
JamiJ N. Bitar. James B. Youag. SaDdeep VardaD, W. Carter GriDstead, Jolm 
Farmer, Betb CocaDougher, Albert Raimer. aDd Neal KJeimlD, The Methodist 
H05pitaiaDd Baylor CoUege of MediciDe. HoustoD, TX 
AUograft arteriopathy may illpair coraDar)' reserve (CR) aDd decrease graft 
survival after beart transp1aat (HT). To evaluate CR. 40 patients transplaDted 
1986 to 1993 (1986=4; 1988=7; 1989=6; 1990=5; 1991=4; 1992=9; 1993=5) 
uaderwent iIItracoroDar)' Doppler flow study. Vessels evaluated were left 
aDterior descendiDg (N=36). circumflex (N=14). aDd right coroaary (N=15). 
ADgiograms were performed aad iIIterpreted as: 1) normal, 2) focal disease 
(discrete stenosis 2. 50%), aDd 3) diffuse disease (lumen diameter diffusely 
narrowed versus baseliDe). Spectral flow velocities, obtaiDed witb Doppler 
tipped flewire were measured ill the proximal aDd distal vessel at baseliDe (base) 
aDd after max byperemia (by) iIIduced witb 45 meg iIItracorooary adenasiDe. 
Velocity spectrum was digitized to compute PVI (illtegral peak velocity ill one 
cycle) aDd APV (average peak velocity) which is derived from PVI. CR = by 
APV /base APV. Coroaary Reserve 
GROUPS N CR p 
TransplaDt between 1993 aDd 90 24 2.82+0.63 
TraDSplaDl between 1986 aDd 89 16 2.23+055 
.005 
Transplant in 1993 6 3.00+0.40 
TransplaDt between 1986 and 92 34 2.50+0.67 
.028 
ADgiograpbically normal vessels 65 2.76+0.63 
Vessels witb focal.Al!l! diffuse disease 21 1.95+0.30 
<0.001 
... CR post HT IS max dunng year one. dimlD1ShiDg significantly thereafter 
(p = 0.005). Though it is reduced in vessels with discrete stenosis or diffuse 
narrowing (P<O.OOI). it appears tbat CR reduction also is seen ill patients witb 
normal angiograms as a function of time alone. This technique may be the best 
pbysiologic assessment of consequences of allograft arteriopathy. 
758·4 2:45 
Progression of Intimal Thickening after Cardiac 
Transplantation: Is it influenced by preexistent Donor 
Coronary Disease? 
Javier Botas. Fausto J. Pinto. Adrian Chenzbraun. Peter 
Rickenbacker. Edwin L. Aldennan. Stephen N. Oesterle. *Alan C. 
Yeung. *Richard L. Popp. Div of Cardiovasc Med. Stanford, CA 
Progressively older donors with a higher likelihood of coronary artery 
disease (CAD) are being accepted for heart transplantation (HTx) due 
to the scarcity of organs. The effect of donor CAD on the 
development and progression of subsequent HTx-CAD is not known. 
We studied 24 coronary sites (11 patients) after HTx before initial 
hospital discharge. and at 1 and 2 years by intracoronary ultrasound 
(ICUS). ICUS catheter location in subsequent studies was verified 
angiographically in relation to branch vessels. Mean intimal thickness 
(MIT) and an index of intimal thickening (II; ratio of the plaque area 
to the area within the media layer) were obtained for each site. Tbe 
severity of the disease was graded from 0 to 4 according to the degree 
of MIT and circumferential involvement. Significant (Class 3 or 4) 
CAD present at the predischarge study. assumed to represent donor 
disease. was observed in 7 sites (Gr. A). Nonsignificant (Class 0-2) 
disease was present in 17 sites (Gr. B). The rate of progression of 
CAD as expressed by the change (~) in MIT. II and Class was 
calculated for each group for the 1 and 2 year follow-up. CAD at the 
end of follow-up was more severe in group A (II 0.3 ± 0.06 vs 0.15 
± 0.04; Class 3.43 ± 0.2 vs 2 ± 0.34; p<O.05) reflecting the greater 
degree of CAD at baseline (II 0.3 ± 0.Q3 vs 0.07 ± 0.02; Class 3 ± 0 
vs 0.94 ± 0.2. p<O.05) but sites with preexisting intimal thickening 
did not progress more than sites initially free of disease: 
AMIT (rom) AD (rom) AClass 
Year 1 2 1 2 I 2 
Gr A 0.02±O.08 0.05±O.11 0.02±O.06 0.00I±O.07 0.29±O.42 0.43±O.20 
Or B 0 08±O 04 0 13±p 05 0 05±p 04 0 08±p 04 I to 34 1 06±p 42 
Conclusion: The development of intimal thickening. probably an 
immune-related process. is not accelerated by the presence of donor 
coronary disease. 
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758-5 3:00 
Prevention or Transplant Accelerated Coronary Vascular Disease 
with Diltiazem 
*John S. Schroeder;"shao-Zhou Gao. Edwin L. Aldennan. Sharon Hunt. 
Irene Hill. Edward B. Stinson. Cardiovascular Medicine and 
Cardiolhoracic Surgery Depanment, Stanford University. Stanford CA 
Randomization of patients (pis) to diltiazem or no calcium blocker 
treatment immediately after heart transplantation (Tx) was initiated Sept. 
1986. Prior results of quantitative arteriography in 75 pts who had both 
early post-Tx and follow-up (F-U) angiography showed that diltiazem 
inhibited Tx coronary disease (CAD). most prominently during the first 
post-Tx yr. By June. 1992. 193 pts were randomized and tolerated 
assigned treatment for ~ days (diltiazem-95; no calcium blocker-98) of 
whom 152 pts completed at least one F-U anglo (diltiazem-71; no calcium 
blocker-81). All pts received triple immunosuppression. ASA and 
dipyridamole. Hypertension was treated with ACE inhibitors. diuretics 
and hydralazine. Allograft survival (alive and free of roTx for CAD) at 1 
yr was 85% for all randomized diltiazem pts (14 events) vs. 85% for no 
calcium blockerpts (15 events; NS). Of the 152 pts who survived one yr 
and had F-U anglo. allograft survival at 5 yrs post-Tx was 90% for 
diltiazem pts (4 events) vs. 72% for no calcium blockerpts (14 events; 
p=O.03). For these same pts. allograft survival iIlIl1 any angiographically 
visible CAD at3 yrs post-Tx was 82% ofdiltiazem pts vs. 62% of no 
calcium blocker pts(p=O.OI). At 5 years. freedom from these combined 
events was 56% in diltiazem pts vs. 30% in no calcium blocker pts 
(p=O.OO4). Univariate correlates of all events were no calcium blocker 
group (p=O.OO2). higher prednisone dose (p=O.OO6). more rejection 
episodes (p=O.03) and elevated triglycerides (p=O.OO8) with low HDL•
cholesterol (p=O.06) during study. Predictors of all events by multivariate 
analysis were no calcium blocker group (p=O.OO6). older recipient age 
(p=O.02). positive donor CMV titer (0.04) and lower average cyclosporine 
dose (p=O.05). The triglyceride and HDL associations with outcome 
events were accounted for by their correlation with cyclosporine dose and 
older recipient age. We conclude that diltiazem is an effective inhibitor of 
TxCAD and substantially improves donor heart survival beyond the first 
post-transplantation year. 
758-6 3:15 
Induction of Addie Fibroblast Growth Factor (aFGF) and Its Receptor 
(FGFR-l) in Bwnan Cardiac Allografts: Role in Pathogenesis of Cardiae 
Allograft Atherosclerosis 
Xiao-Ming Zhao. Tiong-Keat Yeoh. William H Frist. Geraldine G Miller. 
Vanderbilt UDiversity School of Medicine. Nashville. TN 37232 
Cardiac allognft atherosclerosis (CAA) poses a major limit in long•
term success for heart traDsplantation. The diffuse hyperplasia of vascular intima 
characteristic of CAA suggests that growth factors may play a role in the 
development of this disease. To investigate whether traDsplantation resulted in 
upregulation of growth factors in cardiac allografts. 61 allograft myocardial 
biopsies (Bx) from 37 recipients were analyzed for expression of aFGF and its 
receptor (FGFR-I). Myocardium from seven normal hearts was studied in 
parallel. In vitro study was also performed by using cultured human endothelial 
cells to explore possible mechanisms underling regulation of growth factors in 
cardiac allografts. aFGF gene expression was detected by polymerase chain 
reaction (PCR) in S4 of 61 allograft biopsies but not found in any of 7 normal 
hearts. This transcript was induced shortly after traDsplantation (within one 
month) and was consistently present afterwards. Comparable to aFGF. 
expression of an extracellular form of FGF receptor 1 (FGFR-IA. likely 
involving aFGF secretion) was 3S fold increased in allografts. Quantitative PCR 
analysis demonstrated that FGFR-IAiGAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) ratio was 2.4i±2.02 in allografts vs. 0.07 ±0.04 in normal 
hearts (p<O.OOI). In contrast to FGFR-IA. expression oftransmembrane form 
of FGF receptor 1 (FGFR-IB. containing tyrosine kinase domains) was 
associated with allograft rejection. FGFR-IB was detected in S of 6 rejecting Bx 
and was not present in any of non-rejecting Bx (p<O.OOI). In vitro studies 
demonstrated that alternative expression of FGFR-l was regulated by aFGF. 
TGF-tl. and IL-6. Conclusion: Expression of aFGF and its receptor was 
significantly increased in cardiac allografts and was modulated during rejection. 
Their presence is concordant with the incidence of allograft atherosclerosis. 
suggesting aFGF may play a important role in the development of CAA. 
Induction of this potent mitogen for smooth muscle/endothelial cells and its 
receptor in cardiac allografts may result from complex interaction between 
cytokines and growth factors. 
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2:00 
Cardioprotective Effects of Estradiol-17~ in the Isolated 
Working Female Rat Heart 
Andrew Farb. Lisa Triemstra, Frank D. Kolodgie. Ajay Verma. Renu 
Virmani. Anned Forces Institute of Pathology. Washington. DC. 
While estrogen replacement in women is associated with a reduction in 
cardiovascular morbidity and mortality. the effect of estrogen in 
myocardial ischemia and reperfusion has not been fully explored. 
Methods: Female Sprague-Dawley rats (200-300g) underwent ovariectomy 
followed by estrogen replacement (n=9) or placebo (n=9) via placement of 
a subcutaneous estradiol-17~ (0.1 mglpellet) or placebo pellet. After 14 
days. isolated rat hearts were perfused with oxygenated Krebs buffer 
(37°C) and studied in a working heart model of global ischemia .. Hearts 
were paced at 31S beats/minute. Cardiac output (CO). left ventricular 
dP/dT. stroke volume (SV). and coronary flow (CF) were assessed after 20 
min stabilization (Baseline) and after 20 min reperfusion (REP) following 
IS min global ischemia. Percent recovery (=CO at 20 min REP/CO at 
Baseline) was measured. 
Results: The serum estrogen level was 20.6±1.9 pglml in estradiol-treated 
rats and 6.6±1.I pglml in placebo rats (p=O.OOO2). 
Hemodynamics (Mean ±SEM): 
Estrogen Group 
~~
dP/dT 4586±289 4306±237* 
SV (mI) 0.19±O.02 O.l4±O.02* 
CO (mllmin) S9.9±5.S 43.8±6.0* 
CF (mllmin) l6.1±1.3 14.2±1.4* 
Recovery (%) 70.4±6.1· 
Placebo Group 
~~ 
42611398 2739±647· 
0.22±O.02 0.09±0.02* 
67.7±5.6 27.7±6.9* 
17.9±I.S II.S±2.2* 
40.9±9.9* 
0.04* 
0.09* 
0.10* 
0.32· 
0.02* 
Baseline hemodynamics and the severity of ischemia as measured by post•
ischemic release of lactate. lactate dehydrogenase. and creatine kinase 
were similar in both groups. Percent recovery and dP/dT were 
significantly improved post-ischemia in rats treated with estradiol-17~. 
Trends toward enhanced CO and SV were seen in the estradiol group. 
Conclusion: Estrogen replacement has a beneficial effect on myocardial 
hemodynamics following ischemia/reperfusion. Since coronary flow was 
similar in the two groups. these results suggest an increased resistance of 
myocytes to ischemic injury in estradiol-17~-treated animals. 
759-2 2:15 
Does Gender Influence Myocardial Injury and Dysfunction Following 
Experimental Myocardial Ischemia/Reperfusionf 
Karin Przyklenk, Michel Ovize, Barbara Bauer and Robert A. Kloner. Heart 
Institute, Hospital of the Good Samaritan & University of Southern 
Califomia, los Angeles CA. 
Recent clinical interest has focused on possible gender-related differences 
in morbidity and mortality following myocardial infarction. However, the 
effect of gender on the basic pathophysiology of coronary occlusion/ 
reperfusion (CO /Rl is virtually unknown. We addressed this issue in the 
experimental laboratory by performing a retrospective analysis of data from 
5 previous protocols in which adult dogs underwent 1 h of CO and ~ 4h of 
R. We first compared the incidence of lethal ventricular fibrillation (VF) in 
the 14 males vs 46 females randomized into the control groups and then, 
for survivors, compared: subendocardial blood flow during CO (by injection 
of radioactive microspheres); infarct size (assessed by tetrazolium staining 
and expressed as a % of the myocardium at risk); and segment shortening 
in the ischemic/ reperfused region both during CO and postR (measured by 
sonomicrometry and expressed as a % of baseline preCO values): 
Males Females p-value 
lethal VF: 3/14 (21%) 8/46 (17%) ns 
Endocardial Flow (ml/min/g): 0.06+0.02 0.07+0.01 ns 
Infarct Size (% of risk region): 17+6% 18+3% ns 
.Segment Shortening during CO: -22+6% ·26+7% ns 
Segment Shortening 2h PostR: 10+12% 5+9% ns 
Ihere was no enoer-relateo OInerence In me InCloence 01 lell g al Vt. tor 
survivors, both the severity of ischemia and subsequent infarct size was 
similar in males and females. In addition, males and females were equally 
dyskinetic during occlusion and equally hypokinetic following reflow. Thus, 
in the canine model, the fundamental pathophysiology of ischemia/ 
reperfusion is not influenced by gender. 
232A ABSTRACTS 
759-3 2:30 
The 8radycardic Agent ULJ1S.49 Preservt'S Regional Myocardial 
Function and ReduCt'S Infarct Size In the Anesthetized Swine 
Rainer Schulz, Jochen Rose, Andreas Skyschally, Claus Martin, Gerd 
Heusch, Dept. of Pathophysiology, University of Essen, FRG 
The prt'Sent study util ized a porcine model of 90 minutt'S ischemia with 2 
bours subsequent reperfusion and tt'S~ the effects of beart rate reduction 
by ULFS-49 on regional myocardial function and Infarct size (IS). In 13 
Giittinger miniswine, the left anterior dt'Scending coronary artery was 
cannulated and hypoperfused at constant inflow to initially reduce anterior 
systolic wall thickening (AWT, sonomicrometry) by 85%. Seven swine 
served as a placebo group, while in six swine ULFS-49 (0.6 mglkg Lv.) 
was given after 10 minutes ischemia. Heart rate (HR), left ventricular end 
diastolic (L VEDP) and peak (L VPP) pressure, subendocardial blood flow 
(ENDO, microspheres) and AWT were measured under control conditions 
(C), at 10 (110) and 90 (190) minutes ischemia. In the ULFS-49-treated 
swine additional measurements were performed 5 minutt'S after the 
administration of ULFS-49 (115). After 2 bours reperfusion, IS (% area at 
risk) was determined using TIC-staining. 
CliO 115 190 
HR PLACEBO 111±IO 113±11 113±10 117±lS 
(beatImin) ULFS49 112±9 I1S±15 S0±12"a S2±12"a 
AWT PLACEBO 42.3±10.2 6.3±S.S* 4.0±3.9* 4.9±2.4* 
(%) ULFS49 37.1 ±7.9 7.4±7.4* 17.S±7.3* 21.S±12.Sa 
ENDO PLACEBO .71 ±.()6 .09±.OS* .09±.07* 
(m1/min/g) ULFS49 .6S±.13 .OS±.OS* .13±.09* .13±.OS* 
Mean±SD; *:p<O.OS vs. C; a:p<O.OS vs. placebo group; 2-way ANOVA 
L VEDP and L VPP were not different among the two groups and 
did not significantly change during ischemia. With the reduction in HR by 
ULFS-49, ENDO tended to increase at an unchanged transmural myocar•
dial blood flow. Furthermore, A WT was enhanced and IS was significantly 
reduced (4.9±4.7%) when compared to the placebo group (I1.9±8.7%). 
Since IS was reduced at any given ENDO, additional protective effects of 
ULFS-49 apart from increased ENDO are suggested. 
759-4 2:45 
Limitation of Infarct Size in Rabbit Hearts by Adenosine 
Deaminase Inhibition is not Mediated via Adenosine Receptors 
Sarah Freeman, Kevin Mullane, Jim Appleman, Mark Young, 
Gensla, Inc. San Diego, CA 
Inhibition of adenosine deaminase with 2-deoxycoformycin (DC F) 
reduces myocardial infarct size. The role of adenosine In this 
protection is implied, but has not been tested. We studied the effect 
of DCF on Infarct size in Langendorff, buffer-perfused rabbit hearts, 
and whether adenosine receptor blockade with 8SPT reversed the 
protection seen with DCF. Adenosine (ADO) was used as a 
positive control in the absence and presence of BSPT. Hearts were 
paced at 220 btslmin and underwent a 30 min coronary artery 
occlusion followed by 2 hrs reperfusion. DCF (111M) was infused 
30 min prior to ischemia through 60 min reperfusion. ADO (101lM) 
was administered as a 5 min infUSion, beginning 15 min prior to 
occlusion. BSPT was infused continuously 35 min prior to ischemia 
through 60 min of reperfusion. BSPT abolished adenosine-induced 
bradycardia in a separate group of 6 hearts. Risk area and infarct 
size were determined by fluorescent particles and TIC staining, 
respectively. Results were: mean±sem. 'P<0.05 vs control. 
Risk Area Infarct Area 
Treatment n !% of L~ !% of Riskl 
Control 12 50± 3 28± 3 
DCF 6 56± 5 16±4' 
DCF+8SPT 6 48± 3 13 ± 3' 
ADO 6 46± 6 15 ± 5' 
ADO+8SPT 6 42± 3 38±8 
8SPT 4 53± 7 31 ± 7 
Both DCF and ADO significantly reduced infarct size. The effect of 
ADO, but not DCF, was prevented by adenosine receptor blockade. 
These results suggest that the protective effect of DCF is not 
mediated by extracellular adenosine receptors. 
JACC February 1994:1A-484A 
759-5 3:00 
Intramyocardial Injection of Adenosine and Saline Stimulate a 
Cardioprotective Effect in Rats 
Peter Whittaker, Yuwei li, Robert A. K/oner, Heart Institute, Hospital of 
the Good Samaritan '" University of Southern California, Los Angeles, C4 
Adenosine has been implicated in the protection provided by ischemic 
preconditioning. However, attempts to demonstrate protection via 
adenosine infusion have been inconclusive, perhaps due to its short half•
life. We speculated that injection of adenosine directly into myocardial 
tissue might provide a more effective means of delivery. To test this 
concept, 40 rats were randomized to either; control: 60 minutes of 
coronary occlusion followed by 5 hours of reperfusion; ~: four 
0.15 ml adenosine injections (5mg/ml) I minute apart were made into the 
left ventricular wall immediately before occlusion; saline: four 0.15 ml 
saline injections before occlusion; needle: four "sham" (no fluid) 
injections. We measured ectopic beats (total number and duration) and 
also calculated the area at risk (AR) and the area of necrosis (ANI AR) in 
each heart. Data are shown as mean ± SEM. 
1* p<O.OI, + p<0.05 versus control, t p<O.OS versus adenosine]. 
[Ectopic beats: Number Duration (s)] AR(%) AN/AR (%) 
control 288±42 887±50 53±3 52±5 
adenosine 37±11* 519±160 42±5 29±6+ 
saline 296±97 1279± 159t 51 ±5 29± 7+ 
needle 169±21 1044±122t 53±4 38±4 
Adenosine reduced the number of ectopic beats versus both control and 
saline groups, and also reduced the duration of arrhythmia versus both 
saline and needle groups. In addition to being smaller than the confluent 
control infarcts, infarcts in the saline and adenosine groups were patchy 
with areas of necrosis separated by areas of viable tissue. Our results 
confirm the known anti-arrhythmic properties of adenosine, but suggest 
that the observed reduction in infarct size was due to the fluid injection 
alone. In conclusion intramyocardial fluid injection appears to 
"precondition" the heart against subsequent coronary artery occlusion. 
759-6 3:15 
Exposure to Environmental Tobacco Smoke Increases Myocardial 
Infarct Size In Rats 
Bo-qing Zhu, Vi-ping Sun, Richard E Sievers, Stanton A Glantz. William 
W Parmley, Christopher L WoHe, UniversHyof California, San Francisco. 
San Francisco. CalHomia 
To evaluate the effects of exposure to environmental tobacco smoke 
(ETS) on myocardial infarct size, rats exposed to ETS in an exposure 
chamber (4 cigaretteS/15 min. 6 hours/day. 5 dayslweek) for 3 days 
(n-24), 3 weeks (n=21). and 6 weeks (n=12) were subjected to 35 min 
LAD occlusion and 120 min reperfusion. The interior volume of the 
exposure chamber approximates that of a Mazda 626 sedan (3.7 m3). 
During ETS-exposure, average air nicotine, carbon monoxide and total 
particulate concentrations were 1103 I1g/m3, 92 ppm and 60 mg/m3 . 
respectively. Plasma carboxyhemoglobin (COHb). nicotine (NIC), and 
cotinine (COT) increased significantly in the ETS rats. Infarct size 
(infarct mass/risk area x 100%) increased signHicantly in the ETS groups 
compared with the control groups in a dose-dependent manner, with 
larger exposure aSSOCiated with larger infarct size. Average bleeding 
times(BT) in the ETS·exposed rats were significantly shortened 
co"1lared to their respective control groups. 
~ ~ ~ 1lI1!:«oglwll !:<CI([]Q/wll ~ 
Control·3d 35±4 0.5±O.06 0.46±0.04 4.3±O.4 B1±5 
ETS-3days 37±6 4.0±O.14 21.1±2.1 254±23 57±3 
Control·3w 34±5 1.7±O.15 0.40±0.10 4.2±0.8 83±6 
ETS·3wks 43±5 7.5±O.33 49.0±5.9 325±29 56±3 
Control·6W 34±3 1.7±O.29 0.45±0.10 4.5±O.5 102±9 
ETS·6wks 61±5 B.9±O.22 61.4±7.1 484±43 64±5 
p value 0.023 0.001 0.001 0.001 0.215 
Values are Means±SEM. (p values from regression model analysis) 
There were posHive correlations between infarct size and air nicotine. 
CO and total particulate concentrations. as well as plasma COHb. 
nicotine and cotinine levels (1'>0.4. p<0.01). There was no evidence of 
left coronary artery atherosclerosiS in both control (n-3) and 6 weeks 
ETS-exposed rats (n-3). ETS·6 weeks in rats nearfy doubled infarct 
size and this Increase of Infarct size exhibited a dose·response 
relationship. These resuHs are consistant wHh epidemiological studies 
demonstrating that ETS increases the risk of heart death. 
JACC February 1994:1A-484A 
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906-26 
Stimulation of Vascular Smooth Muscle Cell Migration by 
Thrombin and Its Requirement for Protein Synthesis 
Hiroko Noda-Heiny and Burton E. Sobel, Washington 
University School of Medicine, St. louis, MO 
Thrombin, present 1n thrombi and generated juxtaposed 
to atherosclerotic plaques at sites of vascular injury, 
is mitogenic. To determine whether it is also a chemo•
attractant for vascul ar smooth muscle cell s we character•
ized bovine aortic smooth muscle cells in Transwell sys•
tems (modified Boyden chambers). a-Thrombin, 10 and 20 
NIH U/ml, increased smooth muscle cell migration 1.2 to 
3 fold and 2 to 7 fold compared with control cells tncu•
bated in Oulbecco's Modified Eagle's medium nutrient 
mi xture/F -12 HAM N- [2-hydroxylethyl ]pi perazi neoN' [2-eth•
anesulfonic acid] (OME/F-12 with HE PES buffer), pH 7.4 
and 2.5% fetal bovine serum without a-thrombin (n • 16, 
P < 0.001). Transforming growth factor-" (TGF-,,) (1 
ng/ml, n • 4, P < 0.05) and platelet-derived growth fac•
tor (POGF) (1.5 and 10 ng/ml n • 10, p < 0.001) but not 
TGF-" at 5 ng/ml exerted 50 to 130% increases in smooth 
muscle cell migration. By contrast, neither equimolar y•
thrombin nor a-thrombin inactivated with O-phenylalanyl•
L-pro1yl-L-arginine chloromethyl ketone (PPACK) increased 
migration. Simultaneous exposure of smooth muscle cells 
to cycloheximide (2 "g/ml) and a-thrombin to inhibit 
protein synthesis obviated the chemotactic effect of a•
thrombin. Thus, a-thrombin in concentrations thought to 
be present at si tes of vascular injury can st imul ate 
migration of vascular smooth muscle cells by a mechanism 
requiring protein synthesis. 
906-27 
The Potential Influence of Intramural Expression of 
Plasminogen Activator Inhibitor Type-l on Restenosis 
Hirofumi Sawa, Craig H. Lundgren, Burton E. Sobel, 
Satoshi Fujii, Washington University, St. Louis, MO 
Restenosis after angioplasty is characterized by lumi•
nal narrowing with neointima rich in extracellular matrix 
(ECM) containing considerable amounts of plasminogen. 
Accordingly, increased local expression of plasminogen 
activator inhibitor type-I (PAl-I) may exacerbate resten•
osis by attenuating plasmin dependent proteolysis of ECM. 
To define the time course of potential changes in PAI-l 
expression by vascular smooth muscle cells (SMC), endo•
thelial cells (EC), or both after vascular injury, we 
subjected 23 rabbits to carotid artery angiop1asty. 
Plasma PAI-l activity and intramural PAI-l gene expres•
sion were quantified over 4 weeks. Plasma PAI-l in•
creased from 6.0 ± 1.4 (SO) AU/m1 to 14.4 ± 6.3 in 3 hr 
and to 9.5 ± 5.1 in 6 hr after angiop1asty and returned 
to baseline in 24 hr. PAI-l mRNA (3.2 kb) in the injured 
vessel wall increased, peaking 6-fo1d in 3 hr (Northern 
blots) with no changes seen in contralateral, uninjured 
control vessels. Increased expression of PAI-l mRNA was 
evident in the adventitia 3-6 hr after injury and in the 
media and adventitia 24 hr after injury paralleled by co•
localized PAI-l protein as judged from results of in situ 
hybridization and immunocytochemistry. Sustained in•
creases in PAI-l mRNA were evident in the injured vessel 
wall over 4 weeks in neointima1 SMC and EC, during which 
time a substantial neointima1 thickening occurred. Be•
cause the intramural expression of PAI-l in SMC and EC 
precedes neointima1 thickening and may provide an anti•
fibrinolytic activity that may result in initiation or 
propagat i on of thrombos i sand expansi on of ECM, pharmaco•
logic modulation of PAI-l expression may attenuate the 
evolution of restenosis. 
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906-28 
Kinin 82 Receptor Antagonism Reverses Angiotensin 
Converting Enzyme Inhibition of Post-Angioplasty 
Vascular Neointimal Proliferation 
Bouyella H. Reddy, Melody A. Farrar, Daniel S. Yip, Qyniece M. 
Breland, D. Douglas Miller, Saint Louis University Health Sciences 
Center, SL Louis, Missouri. 
The experimental anti-proliferative effects of angiotensin converting 
enzyme inhibitors (ACEI) are thought to be primarily due to 
attenuation of angiotensin U-mediated effects on vascular smooth 
muscle cell (VSMC) growth. ACE! also exen differential effects on 
the kininase-(brady)kinin system. To examine whether reduced kinin 
degradation by ACEI kininase inhibition and kinin receptor blockade 
co-modulate the vascular response to aggressive balloon injury, 20 
atherogenic rabbits had iliac angioplasty (6 ATM x 60 sec x 2) without 
treatment (controls; n=5), after ACEI with Ramipril (RAM=O.3-3 
mglkg/day p.o.; n=10) or after RAM + a kinin B2 receptor antagonist 
(HOE 140=50 J..lglkg/day s.c.; n=5) administered for 3 days before 
and 7 days after angioplasty. Quantitative histomorphometry of 4 wk 
post-angioplasty % cross-sectional area (%CSA) reduction, neointimal 
VSMC density (per 104J..l2) and % collagen-specific picro-sirius red 
staining are given below (*=p<O.05): 
J.CSA YS.MC % Collaun 
Control r 81± 19.., 30± 11 23±4.., 
* * * 
RAM L 42± 16=1 3S±23 7±5 =1 
* * RAM+HOE 140 61 ± 15 .J 24 ± 8 24 ± 1l.J 
We conclude that kinin B2 receptor antagonism attenuates the anti•
proliferative effect of the ACEI Ramipril following experimental 
angioplasty, principally by increasing neointimal collagen synthetic 
activity. These data indicate that kinins may modulate the in vivo anti•
proliferative action of ACEI following angioplasty, and the agents 
which inhibit vascular kinin B2 receptor binding may promote post•
angioplasty restenosis. 
906-29 
Recombinant Human Apolipoprotein AI-Milano Reduces 
Injury Induced Neointimal Thickening in 
Hypercholesterolemic Rabbits 
Sean Ameli, Anna Hultgardh-Nil sson, Ju1 hna Yano, 
Bojan Cercek, Prediman K. Shah, Jan Nilsson, Cedars•
Sinai Medical Center, Los Angeles, CA 
The inverse relationship between HOL-cholestero1 and 
atherosclerosis has been attributed to promotion of 
reverse cholesterol transport by its Apo Al 
component. An inverse relationship between HOL 
levels and restenosis rate following PTCA has also 
been shown. To determine whether Apo Al has a direct 
effect on intimal thickening following balloon 
injury, we evaluated the effect of recombinant Apo-AI 
Mil ano (a human mutant with enhanced abi 1 i ty for 
cholesterol extraction), comp1exed to 1iposomes, 
whi ch was injected every other day X 10 days in 
hypercho1 estero1 emi c (HC) rabbits who underwent 
balloon injury of iliac arteries 5 days following the 
first injection. Eight HC rabbits receiving only 
1 iposomes and 4 receiving no treatment served as 
controls. Following sacrifice at 6 weeks 
morphometric analysis of injured vessels revealed: 
Apo AI-M Liposome 
Intimal area 0.49±0.29:mm2 1. 14±0.38mm2 
Intima/media 0.74±0.27 1.56±0.5 
=p<0.002 Apo AI-M vs. 1iposome (Results-M±SO) 
Intimal area and intima/media ratio in the control 
group of He rabbits which received no treatment was 
similar to 1iposome treated group (1.69±.38 and 
2.ll±0.1 respectively). Conclusion: Human 
recombinant Apo AI-M reduces intimal thickening 
following balloon injury in HC rabbits. 
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906·30 
pn_ III AJcIoIIenM lID the VucuIar Respoue tAl l1li111)' 
Eric Van Belle, Ouistopbe Bauters, N"1COIas Wernert, Martia1 Hamon, 
Bernard Dupui&, Jean-Marc LabIaacbc, Michel Bertrand. UnMnity 01 LiIle, 
France 
Rcstenosis after perc::utaDeous traosIwniDa1 coronary ugiopIasty is 
characterized by DCOiutimai byperpIasia clue to smooth muscle cell proliferation 
and to the synthesis 01 CIIra-cellular matrix. Angiotensin n and ACE inhibitors 
Ium: been investigated but DOt a potcatiaI role 01 aldosterone. Recently, 
aldosterone has been implicated in the &yDIbcsis 01 ema cellular matrix and 
subsequent fibrosis in myocardium. We designed this study to aoalyze the 
influence 01 aldosterone and 01 the aldo&tcrone-antagODist spirooolactone on 
intimal thickening after baIIooa denudation in rabbit arteries. 
Male New ZeIand white rabbits (n=18) underwent aortic and iliac balloon 
denudation and were randomized to implantation 01 aldosterone (7 Jlg/100 
gJday) or ~ solution by continuous subcutanous infusion for 28 days. 
Eighteen other rabbits were randomized to receive a daily subcutaneous 
injec:tion 01 spirooolac:tone (S mg/1OO gJday) or YChicle for 7 days before aortic 
and iliac denudation. Treatment was continued fOl' 28 days after the procedure. 
AU animals were sacificed 28 days after the injury; ~1s were faed under 
pressure and used fOl' histological analysis. Mean values 01 neointimaI area and 
01 neointimaI area/medial area and neointimal area/total ~I area ratios 
were obtained for each animal. Plasma renin activity and arterial pressure were 
measured at the time 01 sac:rifice. 
Treatment with aldosterone was asociated with an inhibition 01 renin activity, a 
DOn-significant increase in arterial pressure and with an increase in DCOiutimai 
thickening that was more marked in the iliac artery (0.42+ /~.07 \OS 0.24+ /~.03 
mm2, p<O.OS) than in the aorta (0.63+ /~.08 \OS 0.59+ /~.11 mm2, ns). These 
effects were confirmed on the intimal standardized ratios. 
Spironolactone induced an increase in renin activity, a decrease in arterial 
pressure and • ryUdion in intimal area in the iliac artery (Om + / ~.02 \OS 
0.29+ /~.012 mm , p<O.oool) and in the aorta (0.31 + /~.03 \OS 0.59+ /~.(Y, 
mm2, p<O.llOOS). These effects were confirmed on the intimal IlaDdardized 
ratios. 
In summary, this study demoostrates that aldosterone eahanc:es neointimal 
hyperplasia after injury and that the a1do&terone-antagonist spironoladone is a 
potent inhibitor 01 neointimaI thickening in our model 
906·31 
Diff.r.ut a.apona. to Balloon Angioplaaty of 
Carotid and Coronary Arteriea. Acut. Platelet 
Dapoaition and Intimal Thick.ning 
Juan Badimon, Antonio Fernandez-Ortiz, Beat Meyer, 
Alessandra Mailhac, James H Chesebro, *Robert McBane 
*Nancy Hassinger, Erling Fa1k, John Fallon, Valentin 
Fuster, Lina Badimon.* Mayo Clinic MN and Cardiac 
Unit. Massachusetts General Hospital, Boston MA 
PTCA is seriously hampered by a 30-50% incidence of 
late restenosis. Several animal models (including 
rodents, pigs and primates) as well as different 
arterial beds (carotid, coronary and iliac arteries) 
have been used to study restenosis. We studied acute 
platelet deposition (PD) and intimal thickening (IT) 
of carotid (elastic) and coronary (muscu1ar)arteries 
following vascular injury in a pig model of balloon 
angiop1asty. Injury was performed at ba11oon:vesse1 
ratio of 2: 1 in both arteries. Deep injury was 
histologically defined as disruption of the internal 
elastic lamina. PD (x 10 6 p1ate1ets/cm2 ) and IT (% 
stenosis) was studied at 1 hour and 4 weeks post•
angiop1asty, respectively. Results are expressed as 
XiSEM (n). (* p<0.05 vs carotids). 
Artery IIUsZ i.;g.jllD: 121112 igjYD! 
fC IitiiUlQ~jlii fC itenS:Uiiii 
Carotid 4±1 (8) 2±1(4) 62±18 (6) 8±2 (4) 
Coronary 15±5*(7) 1±1(4) 160±63 (8) 57±3* (6) 
Deep injury in coronary arteries was associated with 
a greater PD and IT than in the carotids. Our 
results strongly emphasize the importance of the 
arterial bed, degree of injury and acute PD on cell 
proliferation post-PTCA. Differences in local 
rheological conditions and exposure of structural 
wall components may account for the different 
response observed upon similar degree of injury. 
lACC February 1994:1A-484A 
906·32 
Pretreatment with Antagonists to Thromboune A" Serotonin and 
ADP Reduces Neointimal Proliferation in Canine Coronary Arteries 
after Endothelial Injury 
James T. Willerson, Janice McNatt, Sheng-Kun Yao, Kexin Cui, H. 
Vernon Anderson, Fred De Clerck, Jean-Pierre Maffiand, L. Maximilian 
Buja, UT Medical School and Texas Heart Institute, Houston, TX; 
Jannsen Phannaceutica, Belgium; Sanofi Recherche, France 
We have previously reported that after endothelial injury in canine 
coronary arteries, treatment with antagonists to the platelet-derived 
factors, thromboxane A, (TXAJ and serotonin, attenuates but does not 
prevent neointimal proliferation. In this study, we evaluated the effect 
of pretreating dogs with antagonists to platelet-derived factors 15-30 
days before endothelial injury. Thirty-two chronically instrumented dogs 
with mechanically injured endothelium were studied in three groups. 
In Group I, II dogs served as controls. In Group n, 8 dogs received 
ridogrel, a combined TXA, synthetase inhibitor and receptor antagonist, 
and ketanserin, a serotonin (SHT ,) receptor antagonist. In Group ill, 13 
dogs received ridogrel, kctanserin, and clopidogrel, a potent inhibitor of 
ADP-induced platelet aggregation. Blood flow velocity in the 
endothelium-injured coronary arteries was continuously monitored and 
showed cyclic reductions only in Group I dogs. Cyclic flow reductions 
were not observed in dogs in Groups II and ill. The ex vivo platelet 
aggregation induced by TXA, mimetic (046619), serotonin, and ADP 
was significantly inhibited in Groups II and ill. On day 21 after 
endothelial injury, the animals were sacrificed. Histologic study of the 
endothelium-injured coronary arteries demonstrated neointimal 
proliferation-associated stenoses of S9± II % in Group I animals, 14±S% 
in Group II animals, and 10±3% in Group ill animals (p<0.00 I). Thus, 
pretreatment with antagonists to the platelet derived factors TXA" 
serotonir., and ADP before endothelial injury significantly reduces, but 
does not completely prevent, neointimal proliferation after endothelial 
injury in canine coronary arteries in this model. 
906·33 
Intracoronary Activation of Granulocytes During 
Balloon Angioplasty 
IIka Ou, Franz-Josef Neumann, Meinrad Gawaz, Kathrin 
Gloth, Albert Schtimig, I. Medizinische Klinik, Tecbnische 
Universitllt MUnchen, Germany 
After PTCA a transcardiac granulocyte (PMN) acti-
vation has been verified by arterial and coronary sinus 
blood sampling. It is not known, wbether these changes in 
PMN function occur at the site of the plaque or further 
downstream due to ischemia-induced cellular interactions. 
Purpose of the study was to investigate the expression of 
activation-dependent surface receptors on PMNs sampled 
at the downstream vicinity of a dilated coronary artery 
plaque. In 12 patients undergoing elective PTCA of a 
proximal coronary artery stenosis blood samples were ob•
tained simultaneously through the balloon catheter (0.018' 
inner lumen) and through the guiding catheter. Expres•
sion of Mac-I, FcyRIII, and L-selectin was assessed by flow 
cytometry using anti-COllb, -COI6, and -MEL14 monoclonal 
antibodies. Surface receptor expressions on PMNs sampled 
from the proximal vicinity of the plaque before dilatation 
showed no appreCiable difference from those in samples 
from tbe guiding catheter. In contrast, COllb expression 
on PMNs obtained from downstream vicinity of the plaque 
after dilatation was slightly but significantly higher than 
in simultaneous samples from guiding catheter (median 
relative increase: 8%, quartiles 3%, 18%, p<O.OS). A similar 
trend was found for C016 expression (median relative in•
crease distal to the dilated stenosis compared to the guiding 
catheter: 9%, quartiles 7%, 14%, p=0.13), but there was no 
decrease in L-selectin. 
In conclusion, the analysis of PMN surface receptors 
reveals an intracoronary PMN activation distal to the di•
lated plaque. Quantitatively, the observed changes do not 
appear to be sufficient to fully account for the transcar•
diac changes in PMN function after PTCA. 
lACC February 1994:1A-484A 
906·34 
Site lpecinclty of adenovirus·mediated gene transfer by hydrogel•
coated balloon. A histochemical and PCR analysis. 
Laurent J. Feldman. P. Gabriel Steg. Jean-Yves Scoazec. Ouafae Tahlil. 
Samia Boulechfar. Jeffrey M. Isner·. Jim Barry". Thierry Ragot···. 
Michel Perricaudet .. •. Facultc! Bichat. Paris. FR; • SI. Elizabeth·s 
Hospital. Boston. MA; ··Boston Scientific CoIJl .• Boston. MA; ···UA 
1301 CNRS. Villejuif. FR 
Site specificity of percutanous arterial gene delivery is a crucial 
safety issue if this technique is to be applied to the treatment of coronary 
artery disease and restenosis. The hydrogel balloon catheter (HBC) is an 
efficient method for arterial gene transfer. We screened arterial segments 
adjacent to the treated site. and remote tissues (liver. kidney. lung. heart, 
testis. skeletal muscle) for B-galactosidase (B-gal) activity after local 
delivery of the nuclear specific B-gal reponer gene to the rabbit iliac 
arteries (n",15) using a HBC and the adenoviral vector Ad.RSVBgal. 
Histochemistry (X-gal staining) of all samples did not disclose any 
nuclear-specific B-gal activity except at the infected site. either at gross or 
at light microscopic examinations. Since histochemical analysis may not 
detect rare infected cells. we further adressed the issue of site-specificity 
by PCR. Oligodeoxynucleotide primers complementary to DNA sequences 
located in the lacZ gene and the p9 adenoviral protein were used. Thiny•
five cycles of amplification with the Taq polymerase were performed. This 
sensitive method. showed no presence of the reporter gene at sites remote 
from the infection site. Positive controls were obtained after intra-aortic 
injection of 2.1010 pfu which led to massive X-Gal staining and a positive 
PCR. 
In conclusion. after local gene delivery using HBC. transgene 
expression is strictly localized to the infected site. Gene delivery from the 
HBC may reduce the risk of systemic viral distribution and thus facilitate 
clinical application of these techniques. 
906·35 
Smooth Muscle Proliferation During Neointimal Development After 
PTCA in Swine: Identification of Site and Sequence USing 
Proliferating Cell Nuclear Antigen Staining 
John H. Windsor. Edward C. Santoian. Norman Tarazona, Keith A. 
RObinson. Jiang Gu. Charles A. Dennis and Spencer B. King III. Deborah 
Heart and Lung Center & Research Institute. Browns Mills, NJ & Emory 
University School of Medicine, Atlanta. GA 
The purpose of this study was to determine the site and sequence of 
neointimat(NEO) smooth muscle ceU(SMC) proliferation USing immuno•
histochemical staining for proliferating cell nuclear antigen(PCNA). a 
marker of mitosis. following PTCA in swine. 25 swine underwent 
overstretch balloon injury using a 3.5mm balloon in normal coronary 
arteries inducing medial fracture. Vessels were harvested on Days 
0(n=2). 2(n=2). 3(n = 1). 7(n=4), 14(n=9) and 28(n=6) post-injury and were 
perfusion fixed. Sections were stained for PCNA and elastin, and 
underwent quantitative analysis to determine the proliferative index 
(proliferating cells/total number of cellslHPF). Morphometr1c analysis 
measured the maximal intimal thickness(MIT) and the residual lumen 
(RL=lumen area/neointimal area + lumen area). PCNA was located 
mainly at the fractured medial ends early(Day 2-7) and in the NEO 
late(Day 7-14). 
mean!.SD 
Day(n) 
0(n=3) 
2(n=3) 
3(n=1) 
7(n=6) 
14(n=12) 
28(n=9) 
Proliferative IndexlHPF 
Ends NEO Media 
0 0 0 
.27+.16 .16+.14 .009+.011 
.32+0 .31+0 .01+0 
.031+.03 .35+.19 .003+.002 
.001+.003 .015+.036 .003+.003 
.0003+.001 .0006+ .0006 0 
Morphometry 
RL MIT(rrm) 
1 0 
.99+.02 .04+.06 
.83+0 .01+0 
.88+.05 . 29+.14 
.75+.08 .57+.12 
.79+.07 .65+.17 
Conclusions: Peak SMC proliferation occurs at Day 3-7 at the fractured 
medial ends and tapers by Day 14, the pOint of complete NEO 
development. By Day 28, PCNA staining was absent. These data 
suggest that following peak proliferation, the continued formation of the 
neointima occurs through other mechanisms. 
ABSTRACTS 
906·36 
Early Infiltration of Arterial Intima By Activated 'Y/~ TCR 
Bearing Dendritic T Lymphocytes In Ligated Human Arteries 
*Ming K. Heng, Madalene C. Y. Heng. Rolando Rollandelli, 
Moon K. Song. Sepulveda VA Medical Center. UCLA School 
of Medicine. Los Angeles. CA. 
Infiltration of anerial walls by lymphocytes has been reported 
in both chronic atherosclerosis and after acute vascular injury. 
Because acute arterial injury produces an inflammatory 
response which may lead to intimal hyperplasia and luminal 
narrowing, defining the pathogenetic role of T cells may be 
extremely important. Accordingly, the sequential pattern. 
specific subset, and activation of the T cells infiltrating 
anerial walls after acute ischemic injury were studied. 35 
branches of the gastroduodenal. superior or inferior mesenteric 
arteries resected from 8 men who had gastric or colonic 
surgery were examined. 22 arteries had ligatures applied 30 
millS to 4 hrs before surgical resection. while 13 did not. The 
arteries were processed for electron microscopy and 
immunocytochemistry: 22 under the ligature, 22 within 5 mm 
immediately distal to the ligature, and 13 without ligatures. 
Electron microscopy showed intimal infiltration by a dendritic 
T lymphocyte subset in all the immediately-distal and ligated 
specimens. but not in the non-ligated specimens. These cells 
were phenotypically CD3+, CD4- and CD8-. and 'Yla TCR (T 
cell receptor)-bearing. Their activation status is suggested by 
strong HLA-DR positivity and by the presence of interleukin-
2 receptors and increased expression of lymphocyte function 
antigen-I. Infiltration of arterial walls by dendritic T cells 
preceded that of macrophages. The endothelial cells in the 
immediately-distal and ligated arteries expressed HLA-DR and 
intercellular adhesion molecule-l antigens, indicating the 
presence of interferon-'Y. providing further evidence of T cell 
activation. Conclusion: These findings suggest that an early 
immune mechanism initiated by an activated 'Y/o dendritic T 
cell subset may play a pivotal role in the inflammatory 
response after acute arterial injury. 
906·37 
235A 
Collagen Elaboration Following Balloon Angioplasty • Evidence for 
Rapid Expression and Deposition 
J. Geoffrey Pickering. Carol M. Ford. Richard J. Novick. University 
Hospital and Robarts Research Institute. London. Canada 
Collagen deposition following balloon angioplasty may significantly 
influence coronary restenosis but the extent and time course of collagen 
elaboration post-angiop!asty has not been defined. We evaluated collagen 
gene expression in activated human vascular smooth muscle cells (SMCs) 
and quantified collagen deposition in the balloon-injured rat carotid artery 
("",8) and in human primary (0=6) and restenosis (n"'5) coronary lesions 
retrieved from patients by directional atberectomy. 
Using Northem blot analysis. we observed that human SMCs stimulated 
to proliferate in culture expressed abundant mRNA for the al chains of 
collagen types I. III. and XI. The latter chain has not previously been 
identified as a human SMC product We subsequently evaluated collagen 
content and fiber organization using circu1ar polarization video microscopy, 
a highly sensitive and specific collagen detection technique. In the rat 
neointima. fine collagen fibers were first identified 9 days post-injury with 
a diffuse network evident by 8 weeks. An extensive network of fme fibers 
was detected in all human restenosis lesions, including one retrieved 5 
weeks post-angioplasty. This pattem contrasted with the dense. highly 
birefringent collagen bands present in all primary lesions. Collagen content 
of restenosis lesions was 31±14%.lower (p<O.OOI) than that of the primary 
lesions (84±16%). but significantly higher (p<O.05) than that of rat 
neointima 8 weeks post-balloon injury (16±6%) . 
Conclusions: I) Proliferating human SMCs have the capacity to express 
multiple collagen types and the al (XI) collagen chain may be a "new 
player" in restenosis. 2) Collagen deposition is a relatively early response 
to balloon angioplasty and yields a diffuse network that comprises 
approximately 1/3 of human restenotic tissue. Acute deposition of collagen 
should therefore be considered when devising therapeutic strategies to 
prevent restenosis. 
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907·1 
CIIrdlovalCUlI, Aapectl ot Non-Immune Hydrops Felan. 
Jeanine M. Swenson, Steven A. Laifer, DebbIe L Fiotta, Frederick S. 
Sherman Magee-Womens HospItal, University 01 Pittsburgh, Pittsburgh, PA 
Several mechanisms have been proposed as physiologic causes 01 non•
Immune hydrops fetalis (NHF). In order to study cardiac causes 01 NHF, 
we prospectively studied 29 fetuses between AprI 1989 and March 1993 
with serial echocardlography. In each Instance there was abnormal fluld 
collection In at least two body cavities. Fourteen were found to have 
anatomic heart disease (CHD). 01 these, 5 were fait to have a cardiac 
causes for NHF since they had I8YerII tricuspid regurgitation with 
significant atrial dlatatlon. The cardiac lesions _e hypenrophlc 
cardiomyopathy, atrIaIlsomertsm, Ebsteln's anomaly 01 the tricuspid valve, 
and severe aortic stenosis with hypoplastic left ventricle. Doppler derived 
forward cardiac !low remained normal to high In all 01 these fetuses. The 
remaining 9 fetuses wtth CHD had normal cardiac function and chamber 
slzas wtth normal aortic and/OI pUmon&ry lIows. There was no cardiac 
cause for fluid accumWltlon In these fetuses. Eight other fetuses had 
arrhythmias; 3 had supra·ventrlcUar tachycardia (SVT) and 5 had complete 
heart block. None 01 the fetuses with SVT had CHD, but 2 with heart block 
had complex CHD. In all 01 these the atria were very dlated and the 
ventricles were hypertrophied. Cardiac output remained normal despite 
heart rates which ranged from 39 to 240 beats per minute. In conclusion, 
Increased venous pressure Is the contributing cardiovascWir mechanism 
for NHF. POOl cardiac output, II present at all, Is most likely a pre-termlnal 
finding. When NHF Is secondary to fetal arrhythmias, thare Is ventricular 
and atrial dlatation Indicating Increased venous pressure. CHD wtthout 
tricuspid regurgitation wli no! produce fluid accumulation. 
907·2 
Elfects IIlsc:bemlc PrecoIIdltioniDg OD Myocardial IntraceUular pH, Na and 
Ca in Newborn Rabbit Hearts 
H. Liu, S.E. Anderson, and P.M. CaIa. Univemty of California, Davis, CA 
In adult hearts, ischemic preconditioning (PC) has been shown to decrease 
changes in intracellular pH (pHj) and Ca (Cai) and prevent cell damage during 
and after ischemia We tested the hypolhesis that PC decreases changes in pHj, Naj 
and Caj in ischemic newborn bean using 31 P, 23Na and 19p NMR to measure 
(PHi), (Nail, (Cai) and ATP in newborn (4·7 days) rabbit beans Langendorff•
perfused at a constant rate with Krebs-Henseleit solution adjusted to pH 7.4±O.5 at 
37'C after equilibration with 95%O:zIS~. Control beans were perfused for 
30min hefore initiating 40 min of global ischemia fOllowed by 40 min of 
reperfusion. PC hearts were treated with four S min intervals of ischemia each 
followed by 10 min of reperfusion before 40 min global ischemia and 40 min 
reperfusion. Data are mean±SEM *1)<0.05 usinl! Anova. 
Group(n) Baseline End Ischemia End Reperfusion 
pHj control (4) 7.04±O.01 6.48±O.02 7.05±O.01 
PC (4) 7.05±O.01 6.64±O.03* 7.04±O.0l 
Caj (nM/L) control (4) 279±39 1l06±86 737±49 
PC (4) 322±4S 690±163* 420±68* 
Naj control (4) 12±O.9 114±16 55±12 
(mEq/kg/dry) PC (4) 1l±2.1 62±9* 25±6.8* 
Perfusion control (3) 73 ±1.7 0 95±7.6 
Pressure(mmHg) PC (4) 700.5 0 76±5.S* 
The data show that PC decreases changes in pH~ Nai. and Cai during ischemia and 
decreases Naj, Cai. and coronary resistance during reperfusion. A TP depletion is 
faster in control hearts than in PC hearts. It was also noted from our experiments 
that 3 of the control hearts but none of the PC hearts developed anbylhmia during 
reperfusion. We conclude that the results support the hypothesis that ischemic 
preconditioning pnevents the increases of Hj, Naj, and Cai during ischemia and 
prevents the increases of Naj, Caj during reperfusion and preserves myocardial 
function better than that without preconditioning. This could be of particular 
benefit for ischemic myocardial protection in pediatric open·heart surgery and 
heart transplantation. 
JACC February 1994:1A-484A 
907·3 
The New Atrial Natrluretie Peptide Antagonist HS·142-1 Reverses 
the Natriuresis and Diuresis of Chronic Fetal Anemia 
Michael SlIberbach, Lowell E. Davis, Takahlro Shlota, Lori L. Woods, 
Michael Chinkets, Yuzuru Matsuda, Oregon Health Sciences University, 
Portland OR, Kyowa Hakke Kogyo Co., Ltd., Tokyo Japan. 
Chronic fetal anemia causes fetal hydrops and polyhydramnios and is 
sssociated with Increased fetal urine flow and natriuresis. To study the 
role of atrial natriuretic peptide In the renal response to fetal anemia, we 
administered the ANP antagonist HS·142·1 to 4 chronically Instrumented 
unanesthetized sheep fetuses made chronically anemic by Isovolemic 
hemorrhage. Over 7 days, hematocrit decreased from 33 ± 2 to 13 ± I % 
(p<O.OOI), and femoral arterial oxygen COllle~ decreased from 6.9± 0.3 to 
1.3 ± 0.1 mVdl (p<O.OOI)_ ANP Increased from 259 ± 65 to 508 ± 84 
pg/m1 (p=O.005). Fetal urine flow rate (UFR) Increased from 0.42 mVmin 
by 207% (p < 0.(01) and urinary sodium excretion (UNaV) Inaeased 
from 35 lleQ/m1n by 251% (p < 0.(01). On the eighth day, UFR, 
glomerular filtration rate , urinary sodium (UNa V), and urinary excretion 
of cGMP were measured In triplicate and averaged before and immediatly 
after a single IV bolus of HS·142-1 (2 mglkg). 
UFR(mVmin) 
UNaV ijI.eqImin) 
GFR(mVmin) 
cGMP (pmVmin) 
Pre-US-H2.1 
0.84±.34 
9O±1O 
3.13±0_30 
3.U 1.1 
Post·US·142·1 
0.38±0.39 • 
26±24 • 
2.2 ±O.l1· 
1.2±0.4t 
Values are mean± SD, • p< 0.05, t p=O.1 compared to Pre·HS·142·l 
WhIle urine flow and sodium exaction Increased significantly during 
isovolemic hemorrhage over 1 days, ANP blockade immediately returned 
UFR, GFR and UNaV to values which were not different from normal 
healthy fetuses. These data suggest that ANP may, in part. mediate the 
increase in urine flow and sodium exaetion In chronic fetal anemia. 
907·4 
Cerebral Hypoperfuslon Following Low Flow Cardiopulmonary BypUl and 
Hypothermic Cimalatory Arrest 
Craig K Mezrow, Peter S Midulla, Ali M Sadegbi, Alejandro Gandsas, Howard 
H Shiang, Randall B Griepp 
Mount Sinai Medical Center, New YolI< NY 
Hypothermic cin:uIatory arrest (HCA) and low flow cardiopulmonary bypass 
(LFCPB), are commonly employc(\ during surgical repair of congenital cardiac 
anomalies. However, the potential for cerdlral injury continues to be of concern, 
Forty-eigbt puppies llllderwent varying durations (45, 60, 90 min) and 
temperatores (13, lSC) ofHCA and LFCPB. Measurements ofcerdlral blood 
flow (CBF) , vascu1ar resistance (CVR) and cerdlral metabolism of oxygen were 
obtained at baseline 37C (prior to CPB) and 4 and S hrs following HCA and 
LFCPB. 
Four hrs after HCA aDd LFCPB CBF was decreased in all animal groups during 
aD interval of increased CVR and metabolism maintained at baseline values. 
Less pronounced cbanges were observed following LFCPB. By eight hrs, CBF 
returned to baseline levels in all anima1 groups (See table). 
CBF (m11I00g/min) Baseline 
(37 C) 
4hrs 
PostHCA 
orLFCPB 
4S min: HCA (13C) 7l:tS 37:t2 • 
LFcpB mc> 57:tS 46%3 
60 min: HCA (lSC) 69%7 39:t8 * 
LFCPB ClSC) 69%7 47:t6 • 
90 min: HCA (lSC) 65:t6 28:t2 • 
LFCPB CIS£) 76%6 38:t3 * 
• p < 0.05 vs Baseline (37C), values:t standard error 
Shrs 
PostHCA 
orLFcpB 
63:t5 
98:t12 • 
61:t4 
77:t9 
54:t9 
8O:t7 
These data document that following either HCA or LFCPB there is an interval of 
cerebral hypoperfusion and increased CVR during which cerebral metabolic rates 
are maintained. The data suggest that this is potentially a period of increased 
risk for cerebral injury. 
JACC February 1994:1A-484A 
907·5 
Multidose Cardioplegia is Safe and Effective in Newborn Hearts. 
Eliot R. Rosenkranz, Milorad Milovanovic, Christine S. Moravec. 
Cleveland Clinic Foundation, Cleveland, Ohio. 
It has been suggested that cardioplegic solutions and delivery strategies 
that are clinically effective in adults may be less effective or even damaging 
in newborn hearts. This study compares the efficacy of single -vs- multidose 
cardioplegia for preserving pre-ischemic ventricular function in newborn 
rabbit hearts. 
~ Langendorff perfused newborn NZ rabbit hearts (10.1 ± O.4d) 
underwent 2 hours of ischemia at 28·C. Six received a single 3 minute dose 
of 28·C Krebs-Henseleit buffer (KH), 6 received a single 3 minute dose of 
10·C St. Thomas' cardioplegia (SSt) and 7 received multiple 3 minute doses 
of 10·C st. Thomas' cardioplegia delivered every 20 minutes (MSt) during 
ischemia. Recovery (% pre-ischemia) of heart rate (HR), coronary flow 
(CF), LV pressure (LVP), +dp/dt and -dp/dt were measured 
isovolumetrically 15 and 60 minutes after 39·C reperfusion. Wet/dry weight 
was determined at 60 minutes. 
~ 
KH SSt MSt 
15' 60" 15" 60" 15" 60' 
HR 91±9 88±7 73±1O 77±S 102±S+ 92±11 
CF 82±9 7t±4 49±6* S7±S* 9S±4+ 67±4+ 
LVP 4S±S SS±4 31±7 64±4 87±4+ 83±3+ 
+dp/dt 47±8 48±3 33±10 63±8 86±6+ 70±4 
-dp/dt 40±6 48±3 21±7* 41±6 87±8+ 73±S+ 
wet/dry S.4±0.2 S.7±O.1 S.6±O.1 
*p<O.OS -vs- KH, +p<O.OS -vs- SSt; Repeated measures ANOVA 
Conclusions' 28·C KH provided poor protection during 2 hours of 
ischemia. LV function improved over time with single dose 1O·C 
cardioplegia (SSt), but was still significantly depressed compared to pre•
ischemia due to poorer compliance (-dp/dt) after reperfusion. In contrast, 
multidose 1O·C cardioplegia (MSt) provided immediate, complete recovery 
of LV function by preserving pre-ischemic contractility and compliance. 
Multidose cardioplegia is a safe and effective method of protecting the 
immature heart during global ischemia. 
907·6 
Additive Effect of L-arginine Infusion and Leukoc)1e Depletion on Recovery 
After Hypothermic Cardioplegic Ischemia in Neonatal Lamb Heart 
Takeshi Hiramatsu, Joseph M. Forbess, Takuya Miura, John E. Mayer, Jr. 
Department of Cardiovascular Surgery, Children's Hospital, Boston, MA 
Prior experiments on hypothermic ischemialreperfusion(HIJR) have shown that 
I) leukocytes have an imponant role in the injury resulting from HIIR, and 2) 
endothelial dysfunction with reduced release of nitric oxide(NO) occurs after 
H1fR. L·arginine(L-ARG) is a NO precursor which also has anti·leukocyte 
adhesion effects. To examine the interactions between the endothelial 
dysfunction and leukocyte mediated injury, 32 isolated, blood perfused neonatal 
lamb hearts were subjected to 2 brs of ISC cardioplegic ischemia. Group L·ARG 
received 3 roM L-ARG during the first 20 min ofreperfusion(Rep). Leukocytes 
were removed(Sepacell filtration) prior to Rep in group LD, Group ARGILD 
received both L·ARG and LD. Controls(C) had no Rep intervention. At 30 min 
of Rep, LV max developed pressure(DP), mdpldt, ·mdpldt, coronary blood flow 
(CBF), myocardial oX'Ygen consumption(MV02) were measured. Endothelial 
function was assessed by the coronary vascular resistance(CVR) response to 
10-7M acetylcholine(ACh) and 3xlO·SM nitroglycerin(NTG). Results are given 
as % recovery of pre ischemic values. (*,#,$=p<.05 vs C, LD, L·ARG by Student•
Newman·Keuls test) 
Group n 
C 8 
L-ARG 8 
ARGILD 8 
LD 8 
DP mdp/dt -mdp/dl 
7S,S 68.3 60.7 
94,S*# 88.8*# 74.1* 
9S.4*# 100.6·#$ 88.8·#$ 
83.0· 79.3· 69.4 
CBF MV02 
133.0 76.1 
203.2*# 96.8 
222.0·# 110.1· 
IS6.3 94.4 
CVR response 
ACh NTG 
39,2 42.4 
61.0· 36.4 
53,S* 37.7 
57,9. 36.S. 
These results show thai Rep with LD blood and L-ARG infusion during Rep 
have additive effects on the recovery of neonatal lamb hearts and suggest that 
the beneficial effects ofL·ARG invol\'e mechanisms beyond leukocyte 
inhibition, most likely increased endothelial NO production. 
ABSTRACTS 
907·7 
Fatty Acid Oxidation and Mechanical Function During 
and After Anoxia in Newborn Rabbit Myocardium 
Alan H. Friedman, Chin K. Ng, John T. Fahey, Robert Soufer. 
Yale University· VA P.E-T. Center, West Haven, CT 
Newborn rabbit myocardium acquires the ability to utilize 
fatty acids during the first week of life. To determine the 
effect of anoxia and subsequent reoxygenation on fatty acid 
utilization in newborn rabbit myocardium, isolated working 
hearts from 14 day-old rabbits were perfused with 5 mM 
glucose, 0.3 mM palmitate and 10 mU/mi insulin, under 
varying oxygen conditions. Five hearts were perfused at 10 
em H20 preload and 50 em H20 afterioad with the following 
sequence: 20 min normoxia (95% 02, 5% C02); 10 min anoxia 
(95% N2, 5% C02); 30 min reoxygenation (95% 02, 5% C02). 
Steady state rates of exogenous palmitate utilization were 
determined by measuring the production of 14C02. Heart 
rate and cardiac output were measured to assess mechanical 
function. Palmitate oxidation and cardiac output are 
corrected for cardiac dry weight expressed in grams. 
Palmitate oxidation 
(nmol/min/gm) 
Heart Rate 
(beats/min) 
Cardiac Output 
(ml/min/gm) 
Normoxia ~ Reoxvgenatjon 
132 ± 10 84 ± 5 *# 132 ± 12 
200 ± 5 154 ± 6*# 176 ± 4* 
37 ± 3 1 I ± 2* 11 ± 1 * 
* = significantly different from normoxia at p<.05 
# = significantly different from reoxygenation at p<.05 
These data demonstrate that the 14 day·old rabbit heart can 
utilize exogenous fatty acids during anoxia, although at a 
slower rate than during normoxia. With reoxygenation, 
palmitate oxidation returns to baseline despite impairment of 
mechanical function. These results may have important 
implications for the metabolic changes during recovery 
from acute anoxia in the newborn myocardium. 
907·8 
Fetal AIrIo-VlI1IrIcullr Block: Pnnatal DlIgno.ia, Management Ind 
Longterm Follow-up. 
EdwIn W. van de Beek, Joep M. Lsutenachutz, a.tes S. 1OeInman, 
Joshua A. Capel, Joel I. Brenner, PhIlp Stoutenbeek, Erik J. Mellboom, 
Departments of Obstetrics and Pediatric Cardiology of the Unlveraly of 
Utrecht, the NetheIIanda, Yale University School of Medicine, New 
Haven. CO. and University of Maryland School of Medicine, BIIItImore, 
MD. 
To determine --.lUll treatment options of pta with fatal AV-bIock 
(AYB) a group aI 40 pta was IIlUdIed from prenatal dlagnoel8 (14-39 
wks, median 24 gestational age)(GA), upto 15 y aI age (median 7,5 vI. 
Average heartraIe at detection was 58 BPM (45-72 BPM). Isolated AYB 
occurred In 28 pta (all anti SS-A poeItIve), 12 had associated 8IrUcturaI 
heart disease (ASHD). Fetal hydrops was present In 13 pta (5 i80Iated 
AYB, 8 ASHO). 4 pta died In utero, 3 In the neonatal period, II had 
ASHO and fetal hydrops, One filius with i80Iated AYB died In utero, 
having hydrops, 10/17 pta with i80Iated AYB and 5/8 with ASHO_ 
delivered by caesarian eectIon. 
Six pta were diagnosed wille \ItII having a 2nd degree heart block, 4 
with i80Iated AYB, \III progressing to total AYB, Median age at onset of 
development Into i80Iated AYB was 28 wka GA (20-39). 
Pacemaker implantation was required In SO% (17/35) of the IUNivtng 
pta, whether ASHO was present or not Median age at ImpIanIatIon was 
2.3 Y (1 day-11 vI, 
Conclusion: Perinatal mortality aI fatal ~ block 0CCUI8 
mainly In hydropic faluaua with asaociaIed atructural heart disease. In 
i80Iated AV-block prenatally a period exists In which 2nd degree AYB 
d8Yeiops Into 3rd degree block, this period might be the opIimaI time 
gap for --.tuaI treatment with anII-InIIammato therapy. 
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907-61 
Reverse Shunting Across the Ductus Arteriosus or Atrial 
Septum In Utero Signifies Severe Congenital Heart Disease 
Richard A. Bemlng, Norman H. Silvennan, Gerard R. Martin, David J. 
Sahn, Maria D. Villegas, and Mary J. Rice; University of Califomia. 
San Francisco, CA; Children's National Medical Center; Washington, 
DC; and Oregon Health Sciances University, Portland, OR 
Reverse shunting (ie. left-te-right) across the ductus arteriosus or 
atrial septum In utero can be readily identified by 2-D Doppler color 
flow mapping, complemented by pulsed and continuous-wave 
Doppler. To detennine the signlflcance of reverse shunting, we 
reviewed data from 1988 to 1993 from 53 fetuses of gestational age 
18 weeks to tenn with this prenatal findlng. Diagnoses were 
confinned by postnatal echocardiography, surgery,or by autopsy. 
Notably, we found that reverse shunting was consistently 
associated with severe heart disease. Reverse ductal arteriosus 
shunting was found with severe right heart obstructive lesions (Left 
Table). Reverse atrial shunting was found with severe left heart 
obstructive lesions or left ventricular dysfunction (Right Table). In 
both groups associated lesions were common. Only 4 of 11 infants 
who were delivered alive from the reverse ductus arteriosus shunt 
group, and 5 of 14 infants from the reverse atrial shunt group, still 
survive (3 after cardiac transplantation). 
Raverst Ductat Shunt (n:26) River" Atrial Shunt (n:27) 
Pulmonary Atresia 9 Hypoplastic Lalt Heart Syndrome 1 9 
Tricuspid Atresia or Dysplasia 6 Critical Aortic Stenosis 3 
Severe Tetralogy of Fallot 5 Double-Outlet Right Ventricle 2 
Ebstain's Anomaly 4 Interrupted Aortic Arch 1 
Single Ventricle Atrioventricular Septal Defect 1 
... with Pulmonic Stenosis 2 Dilated Cardiomyopathy 1 
Reverse shunting across the ductus arteriosus or atrial septum in 
utero as defined by echocardiography is conSistently associated 
with severe congentital heart disease, which has a very poor 
prognosis. 
907-62 
The Type of Neural Crest Ablation Determines tbe Severity and Timing of 
Ventricular Dyllfunetion in tbe Neural Crest Model of Beart Defeets 
Linda Leatberimry. Jennifer Davis. Donna K. Rhoden, David M. Connock 
Medical College of Georgia. Augusta. GA 
Ablation of premigratory cardiac neural crest produces structural heart 
defects such as truncus arteriosus and aortic arch anomalies. Cardiac neural 
crest ablations also produce abnormal hemodynamic variables in early 
cardiovascular development. 
We hypothesize that ablation oftbe complete cardiac neural crest (destined 
for arches 3. 4 and 6) will cause more severely depressed indices of conttactility 
than the partial cardiac neural crest (destined for arches 3 and 4). Using 100 
frames/sec cinephotographic film. end-diastolic and end-systolic dimensions of 
the primitive ventricle were digitized in chick embryos. Shortening fraction 
(ShFx). Ejection fraction (EjFx). and Cardiac Output (CO) are presented as 
Mean ± SEM (p<O.OS ·Control versus Complete. +Partial versus Complete. 
#Control versus Partia1). 
Control Partia1 Complete 
Stage 16: N 19 17 17 
ShFx(%) 76 ± 2.6· 71 ± 1.7+ 64 ± 2.8·+ 
EjFx(%) 96 ± 0.8· 96 ± 0.6+ 91 ± 1.3.+ 
CO(mm3/min) 19.0 ± 1.7 21.9 ± 1.3 20.6 ± 1.7 
Stage 18: N 13 18 18 
ShFx(%) 65 ± 2.5·# 38 ± 3.8# 37 ± 1.8· 
EjFx(%) 93 ± 1.2·# 71 ± 3.8# 71 ± 2.1· 
CO(mm3/min) 42.8 ± 3.1 40.8 ± 3.7 38.1 ± 2.5 
There is a significant effect by stage across all variables and a significant 
interaction between stage and group for ShFx and EjFx. 
Thus; complete neural crest ablation causes depressed ventricular conttactility 
earlier (stage 16) than the partial ablation (stage 18). Both complete and 
partial neural crest-ablated embryos maintain cardiac output by compensatory 
ventricular dilation. Earlier ventricular dilation and incomplete looping of tbe 
cardiac tube correlate with more outflow ttact maIalignment defects 
(dextroposition of the truncus or aorta) after complete neural crest ablation. 
The severity and timing of ventricular dysfunction in early cardiogenesis will 
predict the mature phenotype of tbe cardiovascular system after neural crest 
ablation. 
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907-63 
Transcatheter ASD Creation in Infants with Left Heart 
Obstruction 
R. Mark Grady. Charles E. Canter, Nancy D. Bridges Washington 
University School of Medicine. Department of Pediatrics. SI. 
Louis. MO 
Creation of an ASD by transseptal puncture and balloon dilation 
of the atrial septum pennits more controlled sizing of the ASD and 
may be safer than other methods. especially in small patients with 
left atrial (LA) hypoplasia andlor a thickened. intact atrial septum 
(lAS). We used this technique in 5 consecutive infants. age 2 days 
to 9 months. weight range 3-7.6 kg. mean LA diameter 16mm 02-
22). Two patients (pt) had hypoplastic left heart syndrome (HLHS) 
and a severely restrictive PFO: 3 pts had mitral atresia (MA) or 
mitral stenosis (MS) with lAS. After ASD creation (maximum 
balioon size 8-12mm). the mean LA pressure fell from 24 (16-30) 
to 14 (11-20) mmHg and the mean transatrial gradient fell from 16 
(8-24) to 7 (0-14) mmHg. No serious complications occurred: 
echocardiography was used to assist with creation and evaluation 
of the ASD in 415 pts. Pts with HLHS had an immediate rise in 
arterial 02 saturation (Sa02) from <60% to >80%: neither 
required further intervention until successfully transplanted 8 and 
30 days I:lter respectively. One pt with MAlI AS weaned from 
ECMO but died 3 three days later from lung disease: a pt with 
MS/IAS and systemic PA pressures (PAP) had a patent ASD and 
nonnal PAP 6 months later; another pt with MS/IAS and elevated 
PAP had an initial rise in Sa02 from 68% to 80%. 2 months later 
the ASD was patent. the Sa02 was 75%. however the PAP had 
risen to pre-ASD levels. ASD creation by septal puncture and 
balloon dilation can provide safe. effective palliation in infants with 
LA hypertension due to MA or MS. 
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908-9 
Safety and Efficacy of mgh Dose (55ug) 
Dobutamlnel Atropine Stress Echo 
William J. Bommer. Frank Arena. William Lewis, Barbara 
Boylan, Mary Beth Cishek. Hassan Hussain, Gary Dabb, and 
Chuck Angelo. for the University of California, Davis, CA 
Dobutaminc: stress echo at currently rc:commended doses (30-
4Oug/kg/min(ug» often does not achieve 85% of maximum 
predicted heart rate (MPHR) or a rate-pressure: product (RPP) 
comparable to maximum exerciSe: trc:admill testing. To assess the 
safety and efficacy of high dose dobutaminc:/atropine in achieving 
a higher heart rate am RPP, we examined 100 patients on a high 
dose protocol. Dobutamine was begun at 5ug am increased by 
5ug every 3 minutes. If at 55ug. the heart rate was < 85%, then 
atropine (max dose I mg) was added until a HR > 85 % was 
achieved. The test was stopped prematurely for a) new or 
worsening wall motion abnormalities, b) sustained arrhythmias, 
or c) severe hypertension or hypotension. Results showed that 
all patients achieved 85% MPHR with a high RPP (mean 
21,939) or a premature endpoint. Complications were low (2 
atrial fib with spontaneous conversion, I asymptomatic VT with 
spontaneous conversion at 60 seconds). No serious or residual 
side effects were seen am no treatment other than monitoring 
was required. 1be only symptoms were of nausea and/or anxiety 
at peak dose in several patients. 
In conclusion, high dose dobutamine/atropine, if administered 
gradually am carefully, can be used to safely obtain a MPHR 
am RPP comparable to maximum exercise testing. This 
protocol may enhance the: sensitivity of this test and provide: 
additional prognostic information, eliminating the low MPHR 
and RPP patients often associated with false-negative results. 
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908·10 
left Ventricular Mass Measurement by Echocardiographic Area-length 
Method: Should Papnlary Muscles be Included or Not? 
A Comparison with Magnetic Resonance Imaging. 
Johan C. Chin.lman Padmos. 'Babette M. Pluim. 'Hans-MarcJ. Siebelink. 
'Albert V.G. Bruschke. 'Ernst E. Van der Wall. Centre for Heart and Lung 
Rehabilitation. Rijnlands Zeehospitium Katwijk. and 'University Hospital 
Leiden. The Netherlands. 
In this study. left ventricular mass (LVMI was measured by two different 
area-length (ALI methods. First. we considered the papillary muscles to 
be part of the LV cavity as is recommended by the American Society of 
Echocardiography lASE-ALI. Second. we considered the papillary muscle 
to be part of the LV wall as is recommended by Reichek et al.(R-ALI. 
These methods were used to calculate L VM in 33 subjects including 12 
elite cyclists. 11 weightlifters and 10 control subjects. The measurements 
were compared with magnetic resonance imaging (MRII calculations of 
LVM using the Simpson method. 
Mean LVM(gl MRI ASE-AL R-AL 
All hearts 199.0±38.6 201.6±37.2 238.0±48.7 
Controls 169.2± 19.0 173.1 ±21.8 202.6±29.4 
Cyclists 242.1 ±19.6 242.8±20.0 292.7±25.3 
Weightlifters 179.1 ±21.8 182.5± 17.8 210.4±20.7 
The correlations (r-valuesl between MRI and ASE-AL and between MRI 
and R-AL in the athletes are noted below. 
ASE-AL R-AL 
Controls rzO.95 r=0.96 
Cyclists r&0.94 r=0.79 
Weightlifters r=0.90 r=0.84 
Conclusions: 11 compared to MRI measurements. the echocardiographic 
R-AL method overestimates L VM in all subjects. 21 when using 2-0 echo•
cardiography for measuring L VM in athletes. the best results are achieved 
when the papillary muscles are considered as being part of the LV cavity. 
as is recommended by the American Society of Echocardiography. 
908·11 
A New Method for Determining Pulsatile Volume Flow Rate by 
Surface Integration of Velocity Vectors from Biplane Doppler 
Echocardiograrns 
Yjn~ Sun, Per Ask, Birgitta lanerot Sjoberg, Lars Eidenvall, Dan 
Loyd, and Bengl Wranne. University of Rhode Island, Kingston, RI 
and University of Linkoping, Linkoping, Sweden 
A new method has been developed to determine volume flow rate by 
using 2-0 Doppler echocardiograms obtained from two orthogonal 
planes. Time sequences of color-flow images are acquired before 
and after a 9O-degree rotation about the long axis of the ultrasound 
probe. Image acquisition is synchronized and progressively delayed 
from a trigger pulse to cover the systolic period with a time 
resolution of 10 ms. At a given time, volume flow rate is 
determined by the method of surface integration of velocity vectors 
(SIVV) described as follows: Data from the two orthogonal views 
are combined to form a spherical surface of velocity vectors at a 
fixed distance from the probe. The spherical surface is equally 
separated into four quadrants; the normal component of the velocity 
is assumed to be uniformly distributed for each quadrant Then, the 
volume flow rate through the spherical surface is determined by the 
sum of velocity-area products over the four quadrants. An in-vitro 
experiment was conducted to provide a quantitative evaluation of 
this method. A hydraulic model that simulates a circulatory system 
with a critical aortic stenosis was built with plexiglass. The system 
was filled with corn-starch-suspended water and driven by a 
pulsatile pump. Accurate measurements of the stroke volume were 
obtained at a region between 1.3 and I.S cm proximal to the orifice, 
just before the region of prestenotic acceleration; the standard 
deviations of the measurements were within 10%. By using the 
Bernoulli's equation, the estimated time·varying flow was used to 
generate the pressure gradient waveform across the orifice, which 
showed an excellent agreement with the measured pressure gradient 
The SIVV method should be useful for quantitative assessment of 
the severity of aortic stenosis by Doppler echocardiography and for 
non·invasive measurement of pulsatile flow in general. 
ABSTRACTS 
908·12 
Comparison B.tween Automatic Border Detection and 
Planlmetry of Right V.ntrlcular Size and Function Following 
Surgical Tr.atm.nt of Thrombo.mbollc Pulmonary 
Hypertension 
Charles Rasmussen, Daniel Oyar, Karen Wheeler, linda Donaghey, 
Howard C Dittrich University of California San Diego 
Automatic Border Detection (ABO) has been proposed as a method to 
quantny ventricular size and function by echocardiography. Previous 
studies have compared ABO to manually drawn ventricular areas with mixed 
results. No study has examined the ability of this technique to quantHy 
changes in ventricular function following an intervention. We therefore 
examined the utility of ABO to quantitate right ventricular function before 
and after pulmonary thromboendarterectomy to relieve severe pulmonary 
hypertension. We imaged 20 patients before and after (mean 11 ± 8 days) 
surgery using a Hewlett Packard Sonos 1500. Manual planimetry of right 
ventricular areas at end-diastole (ED) and end-systole were compared with 
ABO-derived results. 
Surgery resulted in a marked improvement In right-sided cardiac 
hemodynamics as determined by a decrease In Doppler peak tricuspid 
regurgitatant velocities (4.3 ± 0.5 Mis pre to 2.9 ± 0.7 Mis postoperatively, 
p< 0.001). Both manually derived and ABO methods were able to IdentHy 
significant changes in tha chamber areas at ED following surgery (table). 
Pre-op 
Post-op 
ED Marual ED ABO FAC Manual FAC ABO 
34.1±9.0 31.9±6.1 .24±.10 .19±.05 
24.3 ± 7.1 26.0 ± 8.6 .31 ± .11 .32 ± .15 
0.001 0.01 0.05 0.001 
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Fractional area of contraction (FAC), of the right ventricle an 
echocardiographic equivalent of ejection fraction, was found by both 
techniques to increase significantly following surgery. Results by these 
two methods are similar. However, the correlation coefficients for the two 
techniques for individual values are marginal, reaching significance only for 
areas postoperatively ( ED r - 0.56; p<0.02; ES r - 0.55; p<0.02). We 
conclude that right ventricular size and function determined by ABO can 
adequately follow changes after an intervention which Improves function. 
However, measurement variability may prevent direct comparison of the 
individual values when using these two techniques. 
908·13 
Quantification of Flow Rate Through Restrictive Orifice. U.'ng the 
Proximal Flow Conv.rgenc. Region: Development of a new 
Algorithm Using Hemispherical lsoveloclty Surfacas Guided by a 
CenterliRl VelocltylDlstance Function in an In Vitro Study 
Shuping Ge, Takahiro Shiota, You-Bin Deng, Robin Shandes, David J 
Sahn. Oregon Health Sciences University, Portland, OR 
Although Doppler color flow mapping of the proximal flow convergence 
region has been shown promising for calculating the flow rate through 
regurgitant orifices, the widely used assumption of hemispherical (HS) 
isovelocity surfaces is often an oversimplification and subject to 
estimation errors. The purpose of the present study was to investigate to 
what extent the HS model can be used if an algorithm for guiding 
selection of optimal aliasing velocity for the HS method could be 
developed. A steady flow model mimicking valve insufficiency was 
designed with a proximal chamber, a distal chember and an orifice 
between the chambers. Three different flow rates (1.7, 3.5 and 6.5 
Vmin) mimicking mild, moderate and severe regurgitation were studied 
with ten circular, rectangular and ovoid orifices of different sizes (0.031 
to 0.785 cm2). Digital measurements of velocity at discrete positions 
along the canterline for flow towards the orifice (distance increment of 
0.384 mm and time increment of 5 msec) to yield complete centerline 
velocityldistance profiles were obtained using Color Doppler MQ mode 
recordings through the axis of the orifice with a Vingmed scanner 
interfaced to a microcomputer to allow velocity analysis in a digital 
format. Multiple velocity (V)ldistance (D) samples from the digital 
Doppler data were used to calculate 'flow rates' Q. using a 
hemispherical model; Q = 2 on 0 0 2 0 V which were plotted against V. 
On the family of curves derived; the actual flow rate was located around 
the inflection points and oplimal V (OV) thresholds could be identified 
beyond which overestimation and underestimation would occur. Also, 
statistical analysis showed that the OV was correlaled to flow rate 
.(r .. 0.80) and a power function coefficient 'a' (r=0.94) which describes 
the VID relationship (V = a 0 Db). Using this approech an average of 10 
flow rates derived from velocities along the OV portion of each VID 
function correlated well to the actual flow rates (r = 0.84, SEE=0.75 
LJmin) and were consistent regardless of orifice size and shape. 
Optimal velocity for using the hemispherical model for estimation of flow 
rates can be derived from centerline VID profiles and may provide a 
consistently accurate method for estimation of regurgitant flows. 
240A ABSTRACTS 
908·14 
The Chlnging Shipe of the Flow Convergence Region as a Function of 
Orifice Size: Color Doppler, Lllser Induced Fluorescent Pllrticle Studies 
end SOllp·Film Observations in lin In·Vitro Model 
Takahiro Shiota, Robin Shandas, Valdir Moises, Taher Elkadi, Paulo 
Golebiovski, Bruce Mrosko, David J. Sahn. Oregon Health Sciences Univ, 
Portland, OR 
Color Doppler (CD) flow convergence (FC) methods can accurately 
estimate flow rates (FRs) across restrictive orifices IORs), but changes 
in the slope relationships between actual and calculated (CALC) FR for 
different sized ORs at different Nyquist limits (NLs), suggest that FC 
geometry varies at different distances from the OR. We used CD for FC 
CALC, and compared results to FC geometries demonstrated by a new 
2 dimensional soap film based flow visualization method, and laser 
induced fluorescent particle (LFP) tracking of visualized flow for steady 
flow (1.5-4.5 IImin) through 5, 10, & 15mm' ORs. When imaged at 
27cm/sec NL, FC calculations by CD for the 15mm' OR showed a 
significantly lower slope for the relationship between hemispheric FC 
formula CALC FR's vs actual FR with significantly more underestimation 
than for the 5 mm' OR (p=0.05). The 
mean streamline angle for LFP 
trajectories and streamlines on soap film 
visualization approaching the ORs at 
1 em distance was 62' to the surface for 
the 5mm', 42' for 10mm' and 36' for 
the 15mm' OR (all p<O.Ol). As OR size 
increases our images of velocity-vector 
trajectories converged at more obtuse 
angles to the direction of forward flow 
,. rt\IrI' 
especially at closer distances indicating a more hemi-elliptical isovelocity 
surface area in this region. The isovelocity surfaces perpendicular to the 
streamline velocity vectors we imaged in our study provide explanations 
for our CD results and flow geometries which can be used to correct CD 
FC equations for different sized ORs. 
908·15 
lafluence of Variable Loading Conditions on Pulsed Doppler 
Indices of Left Ventricular Ejection Dynamics 
C. Lu, G. L. Nicolosi, C. Burelli, M. Cassin, F. Zardo, M. Brieda, E. Cervesato, 
D. Zanuttini, Ospedale Civile, Pordenone, Italy 
It has been suggested that peak aortic flow velocity (PV) and mean acceleration, 
(MA), derived from Doppler echocardiography, are indicators of Ihe inotropic state 
of left ventricle (LV) and more ~ndy, considelllbie effort has been also directed 
toward the application of these Doppler indices for evaluating LV systolic 
function or diagnosing coronary artery disease during stress interventions. To 
investigate the influence of changes in loading conditions on Doppler 
determination ofPV and MA, puIsed Doppler was perfonned on 20 patients from 
apical 5-chamber view. Doppler aortic flow velocity curves and hemodynamic 
values (LV end diastolic pressure, LV systolic pressure, wedge pressure and 
cardiac output) and fllSt derivative of LV pressure (dP/dI) by tip-transducer catheter 
were simultaneously recorded during baseline 1 and intravenous infusion of 
nitroglycerin, baseline 2 and immediately foHowing left ventriculograpby. During 
nitroglycerin infusion, the hemodynamic values were reduced and peak dP/dt 
remained constant, Doppler PV and MA decreased significantly compared with 
baseline 1 (0.87+-0.11 vs 1.01+-0.14 I'I'/sec and 8.86+-\.68 vs 10.17+-1.88 
m/sec2 respectively, both p < 0.(01). After ventriculoglllphy, the hemodynamic 
values increased and peak dP/dt was still constant, Doppler PV and MA increased 
significandy compared with baseline 2 (1.\5+-0.17 vs 0.98+-0.16 m/sec and 
11.44+-2.06 vs 9.79+-1.88 m/sec2 respectively, both p < 0.(01). 
In conclUSion, Doppler indices of LV ejection dynamics are modified by mild 
changes in loading conditions. Therefore, when evaluating seria11y the inotropic 
state of the LV by interpretation of Doppler PV and MA, the potential influence 
of loading conditions should be taken into account 
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908·16 
Noninvuive Estimation of Pulmonary Wed&e Pressure with Doppler 
Transmitrallnflow in Patients witb Heart Disease 
lean L. Vanoverschelde, Annie Robert, Alain Gerbaux, Xavier Michel, 
Claude Hanet, William Wijns. University of Louvain, Brussels, Belgium 
Pulmonary capiUary wedge pressure (pCWP) is an important marker of 
cardiac function. Regrettably, it requires catheterization. A noninvasive 
method of estimating PCWP would thus be helpful. Recent studies have 
indicated that the Doppler transmittal inflow pattern was strongly dependent 
on preload and could provide an estimate of PCWP. Therefore, we 
prospectively evaluated the relationship between Doppler transmitral inflow 
and measured PCWP in 91 patients (Group 1, age 57:1: 13 yrs) with ischemic 
heart disease (n=36), dilated (n=34), or hypertrophic cardiomyopathy (n=4), 
or aortic stenosis (n= \7). Multiple regression analysis was used to derive an 
equation for estimation of PCWP that was subsequently tested in a separate 
group of 33 patients (Group 2, age 58:1: 12 yrs) with similar cardiac 
conditions. PCWP ranged from 4 to 48 mmHg in Group 1 and from 7 to 40 
mmHg in Group 2. In Group 1, PCWP correlated (r) with FlA ratio (0.95), 
atrial filling fraction (-0.80), peak E velocity (0.79), isovolumic relaxation 
period (-0.75), and deceleration time (0.61). The best model derived from 
Group I data is shown in the figure. All Group 2 data points were within the 
pc\w(_ 95% confidence interval of predictions for 
.. ,~"" •• " _~. this model and PCWP could be predicted 
... T ___ '.",,<-;'; within 3 nunHg of the measured value in 
.. /:~-' 24/33 patients. In 7 additional patients with 
10 .,():/;/ ischemic left ventricular dysfunction, the 
'" '. ,/ M=::'-:::'=- model acurately predicted the changes in 
~:~~+I7.J ·"x PCWP induced by volume loading or 
• intravenous nitrates (r=O.97). Our data thus 
VA ..... suggest that, in patients with overt heart 
disease, Doppler transmitral inflow can predict PCWP with a clinically 
meaningful degree of accuracy. 
908·17 
Can Quantitative WaD Motion Analysis (Centerline Method) Improve !be 
Sensitivity alld Specificity or Exercise Ec:bocardiograpby for !be Detectioll 
or Coronary Artery Disease? 
Gong-Yuan Xie, Mart: A. Lawton. Peter M. Sapin, Mikel D. Smith. 
University of Kentucky, Lexington, KY 
The centerline method is a quantitative appoach for waII motion analysis in 
stress echocardiOglllPhy. However. no study has compared the centerline 
method (QUANI') to the standard qualitative (QUAL) method in evaluating 
sensitivity and specificity for detecting coronary artery disease (CAD). 
Therefore, using QUANT and QUAL methods we analyzed treadmill stress 
echos in 45 patients without known CAD undergoing cardiac catheterization for 
chest pain. Results from 8 age-matched patients with no angiographic CAD 
were used to establish normal QUANT values. QUANT analysis was done 
using digitized cine loops and an off-line computer system. Systolic and 
diastolic endocardial borders from apical 4- and 2-chamber views were traced 
and divided into 100 chords. Endocardial excursion was detennined and 
indexed to the diastolic perimeter. This IlItio was termed "severity". Each view 
was divided into 6 regions; and Ihe severity of each region was determined by 
averaging its chords. A change of regional severity with stress less than (mean 
- 2 standard deviations) from Ihe 8 patients without CAD was considered 
abnormal. QUAL analysis consisted of classification of wall motion as normal, 
hypokinetic, akinetic, or dyskinetic. A stress-induced worsening of waII 
motion by I gIlIde was considered abnormal. Both analyses were perfonned in 
a blinded fashion. 
Results: 37 of 45 patients had angiographic CAD (> 50% luminal diameter 
reduction): 4 patients with 3 vessel disease, 12 with 2 vessel disease and 21 
with 1 vessel disease. 
~ 
QUANT: 89%" 
QUAL: 65% 
"= p< 0.05 • QUANT vs QUAL 
~ 
75% 
100% 
Predictiye value 
94% 
100% 
Conclusions: Quantitative waII motion analysis using the centerline method 
significantly improves the sensitivity of exercise echo for the detection of CAD. 
Although the specificity of Ihe quantitative method is reduced, its positive 
predictive value is still very high. Further studies are needed to fully delineate 
the role of quantitative wall motion analysis. 
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909-52 
Intravascular Coronary U1truound Imallinll. Is It Useful? 
Du-Yi Lee, Neal Eigler, Huai Luo, Wolfgang Steffen, Steven Tabak, 
Robert J. Siegel. Cedars-Sinai Medical Center, Los Angeles, CA. 
Studies have shown that intravascular ultrasound (IVUS) imaging 
provides valid infonnation on arterial dimension and morphology, but 
is it clinically useful? Initially developed catheters were relative laIge, 
inflexible and only deployable in the laJger proximal coronary arteries. 
Recent technological advances have resulted in smaller catheters with 
better image quality and greater flexibility. We have reviewed our 4-
year experience with intracoronary IVUS to assess if there has been a 
change from its use solely as a research tool to one with clinical 
application. 
From 1989 to 1992, we used 4.3F catheters and from 1993 to the 
prescnt, we used S; 3.SF catheters. Coronary interventional decisions 
based in the IVUS findings increased from 42% (8/19) (for the years 
1989-1992) to 78% (29/37) in 1993. In S6 cases IVUS detected 9 
unsuspected coronary dissections,I6/39 inadequate PTCAs, 6/16 
inadequate stent deployments, altered 417 laser angioplasties or 
atherectomies, identified significant stenoses in 8/8 patients with ab•
nonnal stress tests but "nonnal" angiograms and excluded significant 
stenoses in 4 of 4 patients with ambiguous angiograpbic findings. The 
identification or exclusion of coronary ostial lesions was found to be 
useful in 8/14 cases. In 2 additional cases unsuspected thrombus was 
detected and therapy accordingly altered. 
Conclusion: IVUS provides important information for decision 
making in the coronary interventional laboratory. Miniaturization and 
improved image quality have transformed this technology from a 
research tool to a clinically useful device which is superior to 
angiography in the identification or exclusion of I) dissection, 2) 
adequacy of PTCA, 3) stent deployment, 4) depth of tissue removal, 
and S) severity of stenoses especially at ostial sites. Additional 
catheter miniaturization and improvements in image resolution will 
further enhance the application of this technology. 
909-53 
A New Low Cost, Versatile Intravascular Imaging System 
Provides High Quality Studies with Substantially Reduced 
Cost of Catheter. for the Patient 
David J. Sahn, Takahiro Shiota, Mary J. Rice, Mark D. Reiler, Curt 
DeGroff, Paul Droukas, Ryozo Omoto, Shunei Kyo, Makoto Matsumura 
George Pant ely, Andrew Arai. Oregon HeaHh Sciences Univers~y: 
Portland, Oregon and Sa~ama Medical Unive~, Japan. 
While intravascular uHrasound (IVUS) systems have been optimized for 
cor<~nary ~isualization up to :w mHz, lower frequency easily used 
deVICes with deeper penetratIOn for larger vessels and intracardiac 
structures have not been stressed. We have tested a new, low cost 
IVUS scanner, the Aloka SSD550 which has low instrument cost (less 
than $30,000) and a unique configuration with a disposable 
polyethylene catheter which costs $30/patient and a mechanical 
spinning core transducer assembly which costs $500, but is still 
reusable after more than 10 cold ges sterilizations and has no patient or 
blood contact since it is sealed inside the sheath. Six French 20 mHz 
catheters which fit through a six French long Muilen sheaih and 8 
Fren.ch .15 mHz devices are also available. Twenty-three patients, 
ranging In age from 1 month to 20 years of age, were studied and a wide 
range ~f imaging ~ilities were shown with very high image qual~. 
These Included evaluation of the structure of coarctations extending to 
mural detail, and post balloon changes, but also ~h deeper extension 
of imaging to visualize the origin and pos~ion of para-aortic collaterals. 
Evaluations of anomalous pulmonary veins draining into the superior 
vena cava, Fontan baffles, and peripheral pulmonary arteries were easily 
accomplished and unique detailed views of intimal proliferation, mural 
and leaflet calcifICation in RV -PA condu~s could be obtained. The ductal 
lu":!en, neoaortic, pulmonary and coronary anastomoses after arterial 
s~ch, VSD patches and normal and abnormal semilunar valves could 
also be visualized. Intracardiac detail of both right and left ventricles 
appeared excellent encompassing up to 4.5 cm of depth with high detail 
of wall structure, and contractility. This new IVUS system is reliable, 
co~, and .easy to use. It should facil~e comprehensive intravascular 
and Intracardl8c studies for larger vessels in children with congential 
heart disease and aduH patients and its low cost catheters should 
facilitate more wide spread application of intravascular scanning. 
ABSTRACTS 
909-54 
Pathologic Correlates of Intra-Vascular Ultrasound 
Scott M. Lieberman, Cenap Undemir, Volkan N. Adsay, Alexander 
Shaknovich, Edward M. Kreps, Janet E. Strain, James McCrossan, Jill E. 
Higgins, Nancy T. Cohen, Jeffrey W. Moses, Lenox Hill Hospital, New 
Yolk, NY. 
Intra-Vascular Ultrasound (IVUS) has been used to assess the composition of 
vascular wall and has been employed as an aid in device selection for 
interventional therapy in coronary artery disease. To further examine the 
relationship between ultrasound image and pathologic histology, we 
perfonned lVUS prior to directional coronary atherectomy in 14 pts. NUS 
was perfonned using 3.9F Intetpret catheters (C.V.l.S., Sunnyvale, CAl. 13 
pts. were male, avg. age was 57 years. 10/14 were de novo lesions. Vein grafts 
were treated in 4 pts, 12 pts had unstable angina. Tissue retrieved by 
directional atherectomy was examined by light microscopy (P A'IH), by a 
pathologist blinded from NUS results, and graded semi-quantitatively for 
presence of thrombus (1HROM), calcium (CALC), intimal collagen, foam 
cells, cholesterol clefts & proliferntive changes. NUS imaging was good to 
excellent in all 14 pts. and was graded semi-quantitatively for soft and fibrous 
plaque, calcium and thrombus. RESULTS: CALC was seen in 10/14pts. 
(71%) by lVUS, & found on PATH in 6114 pts. (43%). NUS was 100% 
sensitive and 50% specific for CALC. TIIROM was imaged by NUS in 7/14 
pts. (50%) & fOWid on PATH in 8114 pts. (57%). lVUS had sensitivity & 
specificity of 50% for TIIROM. Significant fibrous plaque was seen bv lVUS 
in 10114 pts. (71%) and intimal collagen was seen by PATH in 13/14 <,13%). 
lVUS was 100% sensitive with a specificity of 77% for the detection of the 
fibrous components (lC) of plaque. Foam cells were seen in 4114 pts. (29%), 
cholesterol clefts were seen in 1O/14pts. (71%), andproliferntive changes 
were seen in 4/14 pts. (29%) by PATH. CONCLUSION: NUS is highly 
sensitive for detection of CALC and intimal collagen, but insensitive for 
detection of thrombus. Lower specificity was most likely related to sampling: 
lVUS interrogates the entire lesion, whereas PATH only examines the 
component of plaquelvessel wall tissue removed from the vessel. NUS 
accurately detennines components of atherosclerotic plaque and may be 
useful in guiding interventional device selection. NUS is of limited utility in 
detecting thrombus; and other imaging modalities such as coronary 
angioscopy may prove more useful. 
909-55 
Changes In Wall Morphology and Stiffness of Saphenous Vein 
Grafts One Year After Aonocoronary Bypass Surgery: Serial Intra•
vascular Ultrasound Assessment In Vivo. 
Takeshi Hozumi, Junichi Yoshikawa, Kiyoshi Yoshida, Takashi Akasaka, 
Yasuko Yamaura, Kenji Maeda, Kobe General HospHal, Kobe, Japan 
Previous pathologic studies have demonstrated that saphenous 
vein grafts develop morphologic transformations of the vessel wall after 
aortocoronary bypass surgery. However, It was difficult to evaluate 
morphologic changes and stiffness of grafts wall In vivo. Since introduc•
tion of intravasucular uHrasound (IV US) have provided the accurate mea•
surement of luminal dimensions of vessels and visualization of wall mor•
phology, we evaluated changes in wall morphology and stiffness of 
shaphenous vein grafts one year after implantation. Eight vein grafts in 
seven patients who underwent aortocoronary bypass surgery were exam•
ined with IVUS (30M Hz, 4.3F) early (one month) after operation and at 
follow-up (12 months). Angiography showed no abnormalities in all 
cases. IVUS images were analyzed for maximal and minimal luminal di•
ameters (Omax, Omin) calculated from maximal and minimal luminal ar•
eas. Wall thickness was also measured from IV US images. The pressure•
independent smfness index B was calculated by the following equation: 
B=ln(Ps/Pd)/{(Omax-Dmin)/Ominj. where Ps-systolic aortic pressure, 
Pd=diastolic aortiC pressure. 
Results. 1) IV US images revealed a thin-walled graft with small thick•
ness early after operation (0.34 ±O.09 mm). The wall thickenss of grafts 
significantly increased to 0.66±0.10 mm at follow-up study (p<0.01). 
2) Stiffness index of grafts was significantly increased from 10.3 ±2.0 
early after operation to 18.7 ±6.0 at follow-up (p<0.01). 
COnclusion, IVUS revealed that saphenous vein grafts one year ailer 
implantation had both increased wall thickenss and stiffness compared 
with those at one month after implantation. 
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909-56 
I'arddoxical Vessel Wall Shrinlutge as an Important Mechanism of Femoral 
Artery Stenosis: an Intravascular Ultrasound Study. 
Gerard Pasterkamp, Peter J.W. Wensing, Mark J. Post, Berend Hillen, WiUem 
P.T.M. Mali. Cornclius Borst. Heart Lung Institute, Department of Radiology 
and Department of Functional Anatomy, Utrecbt U Diversity Hospital, Utrecht, 
The Netherlands. 
To determine the mechanisms contributing to luminal narrowing in atheroscle•
rotic human femoral arteries, intravascular ultrasound (IVUS) was used to 
study diseased femoral arteries in 14 patients. 
IVUS-images were obtained cvery 0.5 em over an arterial segment length of 10 
cm. In each cross-section we measured the free lumen area (FLA) and the 
area encompassed by tbe echolucent media, i.e. the media bounded area 
(MBA). In each arterial segmelll, the cross-section which contained the least 
amount of plaque was chosen as reference site. For each cross-section, the 
FLA stenosis was expressed as % of the FLA in the reference site. SimiIarly, 
the MBA was expressed as % of the MBA in the reference site (relative 
MBA). Results: A significant negative correlation was found between the 
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relative MBA and the FLA stenosis percen•
'.age (r=-0.67, p<O.OOI) (Figure). 
y-·05x+113.8 Thus. the higher the percentage stenosis, the 
r--O.67 smaller the outer cross-sectional :}fca 
of the entire vessel. In addition, the 
greatest compensatory enlargement of the 
entire vessel was associated with luminal 
enlargement. These findings cannot be 
explained by the vessel tapering because tbe 
. MBA mcasured in the most proximal and 
25 50 75 100 the most distal cross-sections hardly differed 
FLA slenosis (%) 
(31.5:t 13.4 rum2 and 3O.4:t 11.4 rum2, 
respectively) (mean:tsd). 
Conclusion: Wall shrinkage is an important mechanism that contributes to 
luminal narrowing of the atherosclerotic human femoral artery. Wall shrinkage 
is the opposite of compensatory enlargement in response to plaque formation. 
Hence, it i~ paradoxical. 
909-57 
Dynamic Expansion of Coronary Arteries: 
Implications for Intravascular Ultrasound Measurements 
Neil J. Weissman, Igor F. Palacios, Arthur E Weyman. 
Massachusetts General Hospital, Boston, MA 
The majority of coronary artery blood flow occurs in 
diastole however systolic epicardial coronary artery 
expansion has been described in animal studies. The 
purpose of this study was to determine the presence, 
timing and extent of dynamic expansion of the coronary 
arteries in vivo and assess its implication for 
intravascular ultrasound (IVUS) measurements. IVUS 
images were obtained with simultaneous ECG monitoring in 
55 coronary artery segments and 20 saphenous vein graph 
(SVG) segments in 12 patients. The presence of 
significant plaque (>5~ cross-sectional area) or calcium 
(>30% of the circumference) was determined. Arterial 
cross-sectional area (defined by the external border of 
the media) and luminal area were measured at end-diastole 
and end-systole. RESULTS: Coronary luminal area 
increased 5.~ during systole while neither SVG cross•
sect i ona 1 area nor 1 umi na 1 area changed duri ng the 
cardiac cycle. In coronary arteries without significant 
plaque or calCium, there was a systolic incre~se in both 
the arterial area (17.52±7.06 to 17.9B±7.17 mm , p=0.004) 
and luminal area (11.31±4.94 to 11.73±4.B5 mm2, p=0.02). 
In coronary arteries with Significant plaque (n~B) or 
calcium (n=lO), there was no change in arterial area with 
a trend toward a 3.6-5.7% increase in luminal area 
(p-0.09). 
CONCLUSION: In coronary arteries without significant 
intimal disease, there is significant systolic expansion 
of the artery and lumen. Therefore, all precise IVUS 
measurements of these vessels should be ECG-gated. 
JACC February 1994:1A-484A 
909-58 
Can Intravascular V1tnsound Predict The Clinical Outcome FoUowiug 
Pen:utaneous Tramlwninal Angioplasty ? 
Salem H.K. The, Elma J. Gussenhoven, Marco van Strijen, Lukas C. van Dijk. 
Aad van der Lugt, Hero van Urk, Nicolaas Bom, Herman Pieterman. University 
Hospital Dijkzigt, Erasmus University Rotterdam and ICIN, The Netherlands. 
Background: 10 spite of angiographic success following percutaneous translumioal 
angioplasty (PTA), the incidence of restenosis is high; the reason for this restenosis 
is speculative. This aim of this study was to determine the potential role of 
intravascular ultrasound (NUS; 30 MHz) to predict the clinical outcome after PTA. 
Methods: 23 patienls (Pis) (16 mI7 f; mean age 69 ± 8 years) were studied. The 
narrowest segment seen on IVUS after PTA was selected and compared with the 
corresponding NUS site seen prior to PTA. Qualilalive analysis: Before PTA, 
lesion morphology (softlbard) and geometry (eccentric/concentric) were scored. 
After PTA, the presence of dissection (0), plaque rupture (PR) and internal elastic 
lamma rupture (IELR) was assessed. Quanlilalive analysis: Mean free lumen 
diameter (FLO), free lumen area (FLA), media-bounded area (MBA) and 
percentage area stenosis (%S) were determined. The IVUS data were compared 
with quantitative angiograpby post PTA and the clinical data obtained in the follow•
!'P' . 
Results: Overall eumulati"e success rate of PTA at one month was 91 ± 6 %, at 
six months, 72 ± 10% and at one year, 62 ± 11 % (mean follow-up term: 12.3 ± 
7.1 months). PTA was successfully performed in 13 pis (57%: Group I), 
reintervention was needed in 10 pis (43%: Group II). 
Qualilalively, coneemiog lesion morpbologyand geometry, no difference was found 
between the 2 groups. Dissection, seen on NUS, was present more frequently in 
Group I than in Group II (n=7, 58% vs. n=5, 42%). PR and IELR were found 
in Group I only (n = 3). 
Quantilalively: 
FLO (rum) 
FLA(mru') 
MBA (rum') 
%S(%) 
GROup J In-B) 
4.0 ± 0.7 
12.9 ± 4.5 
31.3 ± 8.1 
60 ± 14 
GROUP D In-10) 
3.6 ± 1.0 
10.5 ± 5.1 
41.9 ± 14.2 
74 ± 8 
After PTA angiography evidenced a diameter stenosis of < 50 % in all 23 pis, in 
contrast IVUS showed an area stenosis of 60 ± 14% in group I and 74 ± 8 % in 
group II. 
Conclusion: 10 this retrospective study, the presence of 0, PR and IELR foUowing 
PTA may be important features to gain maximal positive effect in the clinical 
outcome of tbe pis in the follow-up. The difterences in the quantitative data 
between the 2 groups were marginal. Future studies with larger popUlations are 
necessary to detemune a sensitive, quantitative demarcation. .. 
Thus, IVUS can be used as an objectIve method m provldmg addItional information 
to assess the clinical outcome of the patient. 
909-59 
",ssessm.nt of Coronary Arterial Wall Elasticity Using 
Int'.~.lcular Ulareeound: Alteration Inducad by Slibl:ngual 
NltllCllp'na In HUnIS" 
Katwiuml Mizushige, Mark Reisman', Maurice Buchbinder', Hirohi1e 
Malsuo. Anthon), N. DeMana'. Kagawa Medical S('hocl, Japan:University 
of California, San Oitgo. CA 
Altnough alterial wall elasticity is an important factor regulating coronary 
circulation, few data exist regarding the effect of nifedipine (NiF) upon 
coronary elasticity in man. Since intravaSQJlar uHrascund (IVUS) is a feasible 
method for an in vivo measurement of vessel elasticity. we performed 
aimulianeous coronary IVUS with a 3.S F. 30 MHz probe and ostia! pressure 
(P) measurements before and 10 minules after 10mg sublingual NIF In 20 
pts. IV US images of Ihe vessel wal! at each of 37 coronary sites ware 
subdivided into normal wal! (N) (intima ~0.3mm) , soft atheroma (S) • and 
hard (H) plaque ( identifiaj by high intersity .choe~ with shadowing) to 
yield 53 circ;umferential segments for analysis. Measurements included 
vessel cr05:;-se::'ional area (.'!,). segment Itlng~h (ll and prass:Jre(P) from 
which cyclic variation ""-A/!.,P (mm'/mmHg) and ",,-Ll~P (mIl'JmmHg) 
betweiln ertd-diaztole and peak systole were computed NIl" decreased 
arterial P (13::S179 to 120173 mmHp) and increased HR (79 to 821min). 
Fcllowing NIF. cyclic variation of A~/~P increased from 8.Set 1 0.2x 10' to 
16.5±~4.4Xl0' at 20 N sites (p=0.0049) but was unchanged at 17 
atherosclerotic sites (6.6±7.0Xl 0' 106.7 ±7.1 XI 0'). NIF increased ~LI 
",,-P in N segments (4.::S±7.4Xl0· to !l.4±1.6Xl0·. p=0.0044) but 
produced nC' change in segments w~h H or S plaque (-1.1 ±0.3X1 0" 10 
1.4±1.6Xl0· and S.6..t3.3x1».J to 4.7:t5.9Xl0·, respectively). Thus, 
data uniquely available from IV US establish that NIF increases arterial 
elasticity at normal coronary artery sites but nol Ihose conla:ning 
a!herosclerosis. This increased elasticity is confined to normal 
circumferential wall segments. and likely plays role in the alterations in 
coronary flow induced by n~edipine. 
lACC February 1994:1A-484A 
909-60 
Does the VasocIllatory Response to Nitroglycerin Over TIme Affect 
Quantitative Assessment of Coronary Anery Lesion Dimensions 
Using Intravascular Ultrasound ? 
Jeffrey G. Carr, Jay A. Johnson, Jon A. Kobashigawa, Jeffrey B. Sack, 
Lawrence A. Yeatman, UCLA Medical Center, Los Angeles, CA. 
Intravascular uHrasound (IVUS) can be used to directly image and 
measure coronary artery lesion response to pharmacologic or mechanical 
interventions. Using IVUS to assess endpoints relies on the assumption 
that measured lesion dimensions are not sHered over time in response to 
vasoactive substances routinely used during IVUS studies. 
Methods: To detemine the effects of bolus doses of nitroglycerin (NTG) 
on vessel (lumen + plaque) and lumen dimensions, plaque (intima) area, 
maxirrum intimal thickness (IT) and intimal index (II) (intima arealintima + 
lumen area), 33 patients 1 to 26 months after cardiac transplantation 
underwent seriallVUS imaging (4.3 F, 30 MHz) at a specific site in the 
proximal left anterior descending coronary artery. IVUS images were 
analyzed by planimetry at baseUne (PRE), 5.25 ± 0.5 minutes (POST) and 
13.5 ± 3.2 minutes (FINAL) after administration of NTG 0.4 rng.sublingual 
and 100 or 200 meg. intracoronary. 
Results: Twenty-four patients (73%) had measurable intimal thickening 
with mean IT ~ 0.35 mm, of which 20 were eccentric. Mean lumen area 
increased 20% from PRE to POST (13.7±4.6 mm2 to 16.4±3.8 mm2, 
p<0.001) and by 4 % from POSTto FINAL (16.4±3.8 mm2to 17.1±4.0 
mm2, p = 0.02). Similarly, mean vessel area increased 17% from PRE to 
POST (17.2 ±4.9 mm2 to 20.2±4.4 mm2, p < 0.001) and by 3% from POST 
to FINAL (20.2±4.4 mm2to 20.8±4.4 mm2, p = 0.04). There was a direct 
tinear relationship between changes in vessel and lumen areas for 
conditions PRE to POST and POST to FINAL (r: 0.97, slope= 1.1 and 
r=0.96, slope: 1.0, respectively). Mean plaque area increased from PRE 
to POST (3.4±2.3 mm2 10 3.7±2.7 mm2, p:0.03) but was not different 
POST 10 FINAL (3.7±2.7 mm2lo 3.7±2.3 mm2). Mean IT did nol change. 
Mean II decreased by 10 % from PRE to POST (0.20±0.12to 0.18±O.I', 
p< 0.01) but was similar from POST to FINAL (0.18±O.1110 0.18±O.09). 
Conclusion: Ouantitation of plaque area and intimal index are influenced 
by the vasodilatory response to bolus NTG within the first 5 minutes. 
Despite variability in vessel and lumen area, consistent measurements of 
lesions (plaque area, intimal thickness and intimal index) can be obtained 
between 5 and 13 minutes. 
909-77 
Detection of a Regional Myopathic Process in Pacing•
Induced Heart Failure Using Ultrasonic Integrated 
Backscatter 
Shiro Nozaki, Anthony N. DeMaria, H. Kirk Hammond. University 
of California, San Diego, CA 
Although cyclic variation of ultrasonic integrated backscatter (mS) 
has proved useful in detecting myocardial changes such as those 
accompanying ischemia or cardiac allograft rejection, few data exist 
regarding serial changes of IBS in cardiomyopathic processes. 
Therefore, we studied 6 pigs during rapid ventricular pacing (225 
bpm) of the lateral wall (LW) as a means to induce regional 
dysfunction. A newly developed two-dimensional format IBS 
imaging system was used. Sixty frames from concecutive cardiac 
cycles (short axis, papillary muscle level) were displayed and captured 
in digital format before and every 24 hours after pacing (pacer off). 
Measurements of regional ms were derived by placing a 11 x 11 
pixel region of interest in the mid-Wall of septum (SEP) and LW. The 
magnitude of cyclic variation of ms (dB) was determined as the 
difference between minimal and maximal peak. Functional studies 
included measurement of regional wall thickning (% WTh) in SEP and 
LW. Results (Mean ± SD.,*p<O.05 versus control by ANOVA): 
CONI 24HR 48HR 72HR 96HR 
SEP(%) 683+171 527±165 603±92 622+117 473+185 
SEP(dB) 6 I±I 4 59±1 1 66+1 7 6 6±1 3 62±1 I 
LW(%) 58 3±8 6 47 0±14 7 32 5±9 2* 30 5±1O 3* 27+126* 
LW(dB) 7 1+1 3 5 5±1 0* 4 5±O 8* 4.I±O 4* 3 2±0 6* 
Rapid LV pacing resulted in significant reduction in % WTh in the L W 
(P=O.OOO5) but not in the SEP. Cyclic variation of ms gradually 
decreased in the L W after pacing. In contrast. changes in cyclic 
variation were not observed in the SEP. These data suggest that the 
regional myopathic process induced by chronic rapid ventricular 
pacing is accompanied by an alteration in the acoustic properties of 
myocardium detectable by serial measurements of the magnitude of 
the cyclic variation in ms. 
ABSTRACTS 
909-78 
Ultrasonic Tissue Characterization Defines Abnormal 
Vessel Wall Architecture in Aortic Aneurysms 
243A 
Dino Recchia, Angela M. Sharkey, Nicholas T. Kouchoukos and 
Samuel A. Wickline 
Washington University, SL Louis, Missouri 
Aortic aneurysms are felt to be related to abnormalities in the 
composition and organization of the vessel waIl. To determine 
whether these abnormalities in vessel wall architecture can be 
delineated with ultrasonic tissue characterization, aortic tissue was 
obtained from 8 patients who underwent surgical repair of aortic 
aneurysms. Normal human aortic tissue (n=8) was obtained at 
autopsy or at coronary artery bypass surgery from patients without 
evidence of aortic disease. Integrated backscatter (ffi) was measured 
from the media at more than 500 independent arteriaJ sites from both 
tissue types with a 50 MHz acoustic microscope. The directional 
dependence of ultrasonic backscatter, or anisotropy, was also 
determined for both tissue types to provide a measure of tissue 
organization. Aneurysmal aorta demonstrated 5-fold less back•
scatter than that from normal aorta (-39.9 ± 3.3 vs -32.7 ± 2.3 dB. 
P < .00(1). Aneurysmal tissue also manifested 9-fold less 
ultrasonic anisotropy than did normal aortas ( 24.3 ± 3.0 dB for 
normal vs 14.8 ± 3.5 dB for aneurysm, p < .00(1). 
Hydroxyproline assay was performed for both tissue types and 
revealed no difference in collagen content (238.3 ± 21.8 mg 
collagen/gm tissue for normal vs 249.5 ± 51.2 mg collagen/gm 
tissue for aneurysm, p=NS). Histologic analysis of tissues revealed 
a significant overall decrease, disorganization, and fragmentation of 
elastin fibers in aneurysm tissue as compared with highly ordered 
and well-aligned matrix component in normal aortic specimens. 
These data show that quantitative ultrasonic tissue characterization 
with integrated backscatter sensitively defmes abnormalities in the 
structure of aortic aneurysm tissue. The difference in ultrasonic 
scattering between normal and aneurysmal tissue does not appear to 
be due to differences in overall collagen content but is closely 
correlated with the disruption of the normal vessel wall architecture. 
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910-38 
Distal Coronary Flow Velocity and Physiology During Direct 
Angioplasty for Acute Myocardial Infarction in Patients 
Joseph A. Moore, Morton J. Kern, Thomas J. Donohue, Richard 
G. Bach, Eugene A. Caracciolo, Frank V. Aguirre, Michael S. 
Flynn, St. Louis University Medical Center, St, Louis, MO 
Acute thrombotic occlusion often results in zero distal flow and myocar•
dial infarction unless flow is restored. Quantitative measurement of distal 
coronary flow velocity has not been previously reported during angioplas•
ty for acute infarction in patients. Using a Doppler-tipped angioplasty 
guidewire as the primary crossing wire, maximum peak velocity (MPV), 
average peak velocity (APV) and diastolic peak velocity integral (DPVi) 
were recorded during and after successful direct angioplasty in 15 acute 
infarct patients (9 LAD, I CFX, 5 RCA) presenting within 8 hrs of symp•
tom onset. Proximal and distal coronary flow velocities and coronary 
vasodilatory reserve (CVR) were recorded before and after direct angio•
plasty (residual stenosis.:: 40%). Following angioplasty, responses to 
direct vasodilation with 8-181'g IC adenosine demonstrated distal CYR 
(maximal hyperemic f10wlbaseline flow) was only l.S±O.6 (n=7,p=NS 
ys basel inel 
Pre-PTCA 
Post-PTCA 
APV (em/sec) MPV (em/sec> DPVj (unjts) 
..fmL ...lli§L fm.. ..Ilm..Jm....Ilm. 
16±14 S±7' 32±27 9±l4' 9±8 2±4' 
33±l6 26±IS 62±31 46±21 17±10 13t9 
P value NS 0.0001 NS 0.0001 NS 0.001 
1><0.01 vs proximal 
lilm 
98±8 
30±10 
0.0001 
Proximal flow velocity did not change following successful angioplasty. 
Residual angiographic stenosis did not correlate with post-angioplasty flow 
measures (APV: r·=O.OO7; DPVi: r·=O.068; MPV: r·=O.OOS). TIMI 
flow class also did not correlate with post-angioplasty flow measures. We 
conclude: 1) distal flow is dependent on the status of the microcirculation 
and not conductance vessel angiographic caliber following successful 
angioplasly; 2) distal flow following successful angioplasty increases to 
match proximal flow; and 3) post-angioplasty CYR is markedly abnormal 
in the immediate post-angioplasty period. 
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910·39 
Predictors of In.Hospltal and 6-Month Outcome after Myocardial 
Infarction In the Reperfuslon Era • A Report from the Primary 
Angloplasty In Myocardl8llntarctlon (PAMI) Trial 
"Gregg W. Stone, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald 
Rothbaum, James O'Keefe, "Geoffrey o. Hartzler, Paul Overlie, Brian 
Donohue, Noah Chelliah, Nancy Corbell, Sylvia Puchrowicz, "William W. 
O'Neill. EI Camino Hospital, Mountain View, CA and William Beaumont 
Hospital, Royal Oak, MI 
To determine the safety and efficacy of different reperfusion strategies In 
rnyocardiallnfarclion (MI), 395 pIS presenting within 12 hours of acute MI at 
12 centers were prospectively randomized to treatment with t-PA followed 
by intervention only for spontaneous or inducible ischemia (n=200) or 
primary PTCA wRhout antecedent thrombolysis (n~195). Univariate (UV) 
and multivariate (MV) analysis was performed on 16 clinical variables to 
identHy predictors 01 in-hospital and 6 month outcome. 
The correlates of in-hospital survival are seen in the followin Table: 
Died Survived UVp MVp 
Mean age (years) 72.7 59.3 .0001 .0001 
RandomiZed to t·PA 6.5% 93.5% .06 .039 
Randomized to PTCA 2.SOh. 97.4% 
Male 2.S% 97.2% .005 .25 
Female 9.3% 90.7% 
Diabetes 10.0% 90.0% .048 .31 
No diabetes 3.S% 96.2% 
Similarly, the only factors Independently correlated With the 
combined endpoint 01 in-hospital death or reinfarction were advanced age, 
and treatment by t-PA rather than PTCA (12.0% vs. 5.1%, p=.02). The 
reduction in in-hospRal death or reinfarction after PTCA compared to t-PA 
was particularly marked in patients ~65 years 01 age (S.SOh. vs. 20.0%, 
p...048). Furthermore, treatment by PTCA was the strongest independent 
predictor ollreedom from recurrent Ischemia (10.3% vs. 2S.0%, p:.0001). 
The beneficial effect 01 PTCA on infarct-free survival was maintained at 6 
months follow-up. 
Conclusions: After reperfusion therapy lor acute MI, the adverse 
prognosis present in women and patients with OM is largely attributable to 
advanced age. Compared to t-PA, primary PTCA results in improved 
survival and freedom lrom recurrent ischemia and reinfarction, independent 
of comorbid baseline leatures. 
910·40 
Does Antecedent Angina Predict Whether ReperlusioD by Thrombolysis or 
Primary Angioplasty will be Most Beneficial? 
Stephen T. Bernard, Cindy L. Grines, Kevin Browne, Jean Marco, Donald 
Rothbaum, Gregg Stone, James O'Keefe, Paul Overlie, Bryan Donohue, Noah 
Chelliah, Sylvia Puchrowicz-Ochock~ Gerald C. Timmis, William W. O'Neil~ 
William Beaumont Hospital, Royal Oak, MI 
Previous studies have shown that patients who infarct without antecedent 
angina are more likely to have a thrombotic coronary occlusion, thus may be 
more likely to benefit from thrombolysis. To determine the role of 
thrombolysis verses mechanical reperfusion with PTCA in patients with and 
without antecedent angina, we evaluated the outcome in 395 patients enrolled 
in thr PAMI study. Prior chest pain, antecedent or de novo, was reported in 
33.8% of the PTCA group and 36% of the tPA group (p = NS). 
Table 1. De novo or no angina: 
PTCA (n=158) tPA (n=I66) p value 
Death 5 (3.2%) 13 (7.8%) 0.1 
Recurrent MI 3 (1.9%) 4 (11.8%) 0.2 
Recurrent ischemia 17 (10.7%) 48 (29%) 0.0001 
Death or recurrent 
ischemia 21 (13.3%) 57 (34.4%) 0.0001 
Table 2. Antecedent angina: 
PTCA (n-37) tPA (n-34) p value 
Death 0(0%) 0(0%) 1.0 
Recurrent MI 2 (5.4%) 4 (11.8%) 0.6 
Recurrent ischemia 3 (8.1%) 8 (23.5%) 0.1 
Death or recurrent 
ischemia 3 (8.1 %) 8 (23.5%) 0.1 
Conclusions: Despite the pos,ibility of a larger thrombus burden in MI patients 
with de novo angina, clinical outcome was better when the patient was 
reperfused with YfCA compared to tPA. These data suggest that regardless 
of the atheresclerotic or thrombotic burden most infarct vessels respond well to 
primary PTCA. 
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910·41 
Randomized Evaluation of Coronary Angioplasty for Early TIMI 1 Flow After 
Thrombolytic Therapy for Acute MyOW'dial lnI'an:tion 
Stephen G. Ellis, A. Michael Lincoff, Barry S. George, Dean 1. Kereiakes, 
Mitchell W. Krucoff, E. Magnus Ohman for the T AMI Investigators. Cleveland 
Clinic Foundation. Cleveland, Ohio. 
Patienls (Pis) with "closed" (TIMI 0-1 flow) arteries 90-120 min after thrombolytie 
therapy have been demonstrated to benefit from rescue angioplasty (PTCA), 
whereas pis with "patent" (TIMI 2-3 flow) arteries do not. However, online ECG 
data suggests that TIMI 2 flow is associated with ischemia no different from TIMI 
0-1 flow in at least 20 % of pis, and clinical outcome is decidedly inferior to that 
with TIMI 3 flow, raising the question as to whether PTCA might be beneficial for 
pis with TIMI 2 flow. This issue bas never been addressed, except in th.e TAMI 
1 study where patienls with TIMI 2 and TIMI 3 flow were not separated. 
Therefore, we analyzed clinical and ejection fraction (L VEF) from that study for 
pis with initial TIMI 2 flow. 
Early PICA (P-49) EarlyMedicalThenmy(n-S9l 
Age (yrs) SHI0 S6±l1 
Male gender (%) 86 76 
Time chest pain-ocath (min) 
Anterior Ml (%) 
Multivessel disease (%) 
In-hospital 
26S±7I 26S±81 
41 42 
42 41 
Death (%) 6.1 1.7 
Heart failure (%) IS.4 23.7 
"Acute-odiscbarge LVEF (%) 2.4±7.9 -.7±7.7* 
"p=0.06. but p=0.02 for patienls with cath :s;S hrs from chest pain onset 
Thus, rescue PICA cannot be routinely advocated for these pis. However, the 
modest L VEF benefit suggests a possible benefit in selected pis. A trial of PICA 
or adjunctive antithrombin or antiplatelet therapy in pis with TIMI 2 flow and 
ongoing ischemia may be warranted. 
910·42 
Resolution of Coronary Thrombus Over Time: A Report from the 
GUSTO Angiographic Trial 
Stephen L. Kopecky. Guy S. Reeder. lonathan S. Reiner, Conor F. 
Lundergan, Ali Razavi. Daniel McConnick, Karin S. Coyne, Roben 
lesse. Allan M. Ross for the GUSTO Investigators, Rochester, MN, 
George Washington University. Washington. DC 
Prior studies have suggested continued resolution of coronary aMery 
thrombus (T) over several days following thrombolytic therapy. In the 
GUSTO Angiographic Trial, a large coho" of patients (pts) undergoing 
90 minute post-lytic and 5-7 day late angiography is available in which 
to interrogate this observation. Angiograms were analyzed with respect 
to presence (n = 367) or absence (n = 245) of visible T at 90 minutes, 
mean luminal diameter (MLD), % diameter stenosis (%DS) and % area 
stenosis (%AS). at 90 minute and 5-7 day angiography. Only patients 
without intervening angioplasty or bypass surgery were included. 
90 min 
5-7day 
Thrombus 
MLP (mm ±SOl %PS(±SOl 
0.86 ± .53 71 ± 14 
1.0 ± .52* 65 ± 16* 
(*p < 0.00(1) 
No Thrombus 
MLP (mm ±SOl %DS(±SOl 
90 min 0.74 ± .32 72 ± 13 
5-7 day 0.82 ± .36" 69 ± 12" 
("p < 0.01; * p= 0.04) 
%AS(±SP 
90± 11 
85 ± 13* 
%AS(±SOl 
90±9.6 
89 ± 9.6.< 
MLD was significantly larger at 90 min in pts with T compared to those 
without T (p=0.003). At 5-7 days the coronary lumen was less 
obstructed by all measures in pIS with originally visualized T compared 
to those without T at 90 min, p < 0.001. 
Conclusion: Statistically significant and clinically relevant thrombus 
resolution occurs between 90 min and 5-7 days post thrombolysis in pts 
with Visible thrombus at early angio. In absence of total occlUSion. 
mechanical intervention may be delayed or avoided in many such pIS. 
and "routine" early angiography may overestimate late vessel stenosis 
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910·43 
Platelet·Inhibitory Products Resulting From Direct 
Interactions of Urokinase with Fibrinogen 
Sheryl R. Torr·Brown, Paul R. Eisenberg, Burton E. Sobel, 
Washington University, St. Louis, MO 
Urokinase (UK) has been associated with a low inci•
dence of early, thrombotic reocclusion after coronary 
thrombolysis. To determine whether products of its ac•
tion on fibrinogen, independent of plasmin, may contrib•
ute to this salutary property by affecting platelet ag•
gregation. We characterized platelet aggregation in 
vitro under conditions with and without direct cleavage 
products of fibrinogen exposed to cells. Fibrinogen (1 
mg/ml) was rotated with UK adsorbed to cyanogen bromide 
activated sepharose 4B in a TRIS-NaCl buffer, pH B.5 with 
aprotinin (400 KIU/ml) for 180 min at 37'C; the beads re•
moved by centrifugation; and, the supernatant fraction 
(SN, SO ~l) or urokinase (UK, 3000 U/ml) incubated with 
platelet rich plasma (PRP) from citrated whole blood. 
After 5 min incubation, platelets were stimulated with 
co11 agen (1 ~g/m1), adenos i ne diphosphate (10 ~) or 
thrombin (0.03 U/m1). The SN inhibited aggregation to 
all agonists. UK itself did not. Ultracentrifugation of 
SN showed that the inhibitory fragment had a molecular 
weight> 5000. Plasmin was verified to be absent from 
all samples. 
Collagen 
ADP 
Thrombin 
% Aggregation of Control 
SN UK 
5.6 96.0 
12.5 94.5 
4.9 90.9 
n 
3 
2 
2 
Thus, urokinase digests fibrinogen independently of plas•
min, to yield a fragment of approximately 5000 kilo•
dalton, that inhibits platelet aggregation to diverse 
agoni sts. The i nhi bit i on may exp 1 a i n the pauci ty of 
early reocc1usion seen with UK in clinical studies. 
910·100 
Relationship Between Extent of Thrombin Inhibition and Mode of 
Heparin Administration in Patients Treated With Streptokinase 
Marcello Galvani, Dana R. Abendscbein #, Donatella Ferrini, Filippo 
Ottani, Franco Rusticali, Paul R. Eisenberg #. Div. Cardiol. and Fondazione 
Sacco, Forti', Italy, #Washington University, St. Louis, MO 
The role of heparin therapy in pts treated with streptokinase (SK) for 
acute myocardial infarction (AMn is controversial, in part because the effi•
cacy of different conjunctive heparin regimens in inhibiting early increases 
of thrombin activity is not known. Accordingly, this study was designed to 
characterize the extent of inhibition of thrombin activity achieved with con•
junctive intravenous heparin (iv-Hep, 5,000 U bolus followed by 1,000 UIbr 
infusion) compared with subcutaneous calcium heparin (sc-Hep, 12,500 U 
every 12 hr delayed until 4 hr after SK ). Twenty-eigbt pts treated with 
1,500,000 U of SK and 165 mg of ASA for AMI were randomized to sc•
Hep (n"'14) and iv-Hep (n=14). Anticoagulation was assessed with serial 
measurements offibrinopeptide A (FPA), a marker of thrombin activity, and 
aPIT. Plasma concentrations of MM isofonns were measured over 3 hr to 
determine recana1ization (increase in activity >O.17o/oImin). Recana1ization 
occurred in 27%, 60%, and 79% of sc-Hep vs 43%, 71%, and 86% of iv•
Hep pts respectively at I <FO.2), 2, and 3 hr. Concentrations of FPA at I 
hr were higher in pts without (n=5) than in those with (n=23) MM isoform 
criteria for recana1ization (76.4±25.7 vs 25.2±5.2 oM; po:O.003), and at I, 
2, and 3 hr were significantly lower with iv-Hep (l8.4±4.8 vs 46.7±10.2 oM 
at I hr; po:O. 004) than without heparin. After sc-Hep at 4 hr, FP A was 
similar in both groups, despite lower aPITs in sc-Hep pts. However, FPA 
was not consistently suppressed in either group: 8.7±1.8 (sc-Hep) vs 
I i.8±S.2 (iv-Hep) at 48 hr (p--ns).Thus, iv-Hep attenuates increaBeS in FPA 
early after SK and appears associated with greater patency at 1 hr. 
Subsequently iv- and sc-Hep are similar, but relatively ineffective in 
suppressing t1l1'ombin activity, suggesting a role for more potent an•
titlll'ombin agents during coronary thrombolysis with SK. 
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Relation Between Stability of Reperf.mon and Activation of Haemostatic 
Mechanisms Following Streptokinase in Acute Myocardial Infarction 
John L Morris, Azfar G Zaman, Margaret A Orehard', J Campbell Cowan, Colin 
RM Prentice', J Andrew Davies'. Dept of Cardiology, r.-Is General Infirmary 
and 'School of Medicine, r.-Is University, r.-Is, UK. 
Infarct related artery patency is a major determinant of outcome following MI. 
Thrombolytic therapy bas improved prognosis after MI but there remains a 
proportion of patients in whom patency is not achieved or in whom ear'·' 
reocclusion occurs. Coronary thrombosis and thrombolytic therapy lead to 
considerable activation of the haemostatic mechanisms which may contribute to the 
failure rate of therapy. We studied 8-Thromboglobulin (8TG), thrombin•
antithrombin III complex (TAT), fibrinopeptide A (FPA) and D-Dimer (DD) 
levels in 29 patients receiving streptokinase, 1.5MU and aspirin, 300mg, for acute 
MI. Samples were taken immediately before and after thrombolytic therapy, after 
3 hours and after 18-24 hours. Infarct artery patency was assessed using 
continuous 12-lead ST-segment monitoring. 
Platelet, thrombin and fibrinolytic activity were significantly increased following 
MI and streptokinase therapy. Patients were divided into 3 groups according to the 
pattern of ST resolution. Group I (n= 12) showed rapid ST resolution with no 
evidence of re-elevation. Group 2 (n'" 13) showed ST resolution with at least one 
episode of re-elevation. Group 3 (n=4) showed persistent ST elevation. 
Results for samples taken immediately after thrombolysis are presented below 
(Median & Interquartile Range) 
Normal 
Gp I 
Gp2 
Gp 3 
P 
8TG (IU/mI) TAT (}tg/l) 
10-40 1.0-4.1 
53 (38-69) 19 (16-23) 
60 (38-292) 34 (19-120) 
122 (100-160) 33 (23-52) 
< 0.01 Ivs3 < 0.05 Ivs2 
< 0.05 Ivs3 
FPA (ng/ml) 
<3 
38 (19-50) 
50 (32-120) 
43 (29-50) 
NS 
DD(mg/l) 
<0.25 
1.4 (1.0-1.6) 
1.9 (1.4·2.2) 
1.7 (1.4-2.3) 
NS 
Patients with unstable reperfusion, as assessed by changes in ST elevation, show 
a greater degree of thrombin generation than those with stable reperfusion, 
suggesting a need for more aggressive anti-thrombotic and fibrinolytic therapy in 
this group. 
910-102 
Use of Thrombolytic Therapy - How Much Impact Have We 
Made? 
·W. Douglas Weaver Paul E. Litwin, Jenny S. Martin, Alfred P. 
Hallstrom, for the MITI Project Investigators, University of 
Washington, Seattle, WA. 
We evaluated the usage of thrombolytic drug treatment for 
acute myocardial infarction in over 7,000 consecutive patients 
(pts) in the MITI Registry over the past four years. 
The proportions of pts treated increased from 18% to 23% 
(p<0.001), with the greatest increase in pts ~75 yrs of age (from 
4% to 9%). The use of primary PTCA has not changed - it is used 
in 8% of all pts and 3% of pts aged ~75 yrs. 
The median delay from symptom onset to hospital admission 
was unchanged over the four year period, 120 vs. 128 minutes; 
although hospital admission to treatment times have been 
shortened in younger (71±62 to 50:1:54 minutes) but not older pts 
(75:1:42 vs. 83:1:64 minutes). 
Despite both considerable layperson and health provider 
education, the current use of thrombolytic therapy has increased 
minimally in the past four years. There have also been no 
detectable changes in pt delays. Hospital treatment times have 
shortened, but still remain an impediment to early treatment of 
myocardial infarction. 
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Does Primary Coronary Angioplasty for Myoeardial 
Infarction Reduce Mortality: A Metaanalysis 
Paul T Vaitlrus, University of Vennont, Burlington, VT 
Primary angioplasty (PTCA) for myocardial infarction (MI) has 
been demonstrated to improve outcome over thrombolysis (T), but a 
mortality benefit has not been demonstrated because of the small 
sample size of the trials. We perfonned a metaanalysis of 
randomized clinical trials of PTCA vs T to determine whether a 
survival benefit exists. Pooling of data was perfonned by: 1) 
Mantel-Haenszel Odds Ratio with a Robins, Greenland, and 
Breslow variance and 2) Dersimonian and Laird event rate 
difference. 
Odds Rali. I1Id1 En.' aate Dlfl'e".~e 
Ii O'NolII ~;::I~!lr .e. Ribeiro 
Grille. 
395 Orl.n 
1 U ZIJIII.. Zijllt •• 
181 Glbb... GI ••••• 
101 POOLED POOLED 
0.001 0 1 ·15·10·$ 0 5 10 1.5 
PTCA PTCA n.o.~oly.1I 
better better Hiler ktter 
The 95% confidence intervals for each of the individual studies 
includes the possibility that PTCA reduces mortality. The trend in 
favor of PTCA failed to reach statistical significance. To achieve 
80% certainty of detecting a significant difference (p<.05), the 
pooled analysis would need 1576 pts. We conclude that additional 
data is necessary to detennine if PTCA of MI is associated with a 
reduction in mortality as compared to thrombolysis. 
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911·18 
Sources and Characteristics of Patients Suitable for 
Randomized Coronary Artery Disease Trials: An ACIP Data 
Base Study 
Eileen Handberg, Ann Baker, Joan Barry, Glenda Duke, Sheila 
Byers, Laurel Dvorak, June Elstob, Marilyn Francis, Robert Kolb, 
Gail MacCallum, Susan Townsend, Lucette Whittom, Kathleen 
Hemingway, Sandra Forman, Carl J. Pepine, C.Richard Conti, for 
the ACIP Investigators. University of Florida, Gainesville, FL 
Randomized clinical trials which evaluate mechanisms and 
treatment of CAD must identify sources that yield subjects 
representative of the CAD population. Eleven academic centers, 
made aware of data bias associated with previous Nlfi.BI CAD 
trials (eg. lack of women, elderly, etc) screened available sources 
for suitable CAD pts; angio labs (AL), treadmill exercise labs 
(TE), nuclear labs (NL), and by chart review (CR). Using the 
Asymptomatic Cardiac Ischemia Pilot (ACIP) as a model, 1953 pts 
who had evidence of revascularizable CAD and/or ischemia on TE 
were identified as potential study pts. Of potential pts, 26% were 
from the TE labs, 39% from the AL, 14% NL, 15% from CR and 
direct M.D. referral, and 6% from other sources. Ambulatory 
ECG's (AECG) were performed on all 1953 pts. Asymptomatic 
Cardiac Ischemia (ACI) was present in 914 (45%) pts. Pts with 
revascularizable CAD and ACI were elderly (62 yrs old), male 
(85%), married (77%), retired (44%), current or former service 
industry or blue collar worker (64%) with angina (59%). A family 
history for CAD was present in 41 %, hypercholesterolemia in 43%, 
and smoking in 65%. Associated diagnoses included MI (41 %), 
diabetes (16%) and hypenension (37%). The highest yield ofpts 
screened and eventually randomized (77%), came from pts who 
were M.D. referred. 
Conclusions: Screening, even when a priori data is at hand, yields 
a population of potential study candidates composed predominantly 
of elderly symptomatic, smoking men. The two "best" sources 
were the angio and treadmill labs. Direct M.D. referral appears to 
offer the highest yield source of randomizable pts with CAD for 
clinical trials. 
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911·19 
Predictive ACCUI'tICf fII NoDiD".I"e Jnftldptlon for the DetedloD fIITotaIIy 
Silent Myourdlallldaemia 
Giuseppe Di Pasquale, Stefano UrbiIl8li, *Carlo MageUi, Anna Maria Lusa, 
GiaDcarlo Carini, Graziana LabaDti, Paola PassareUi, Giuseppe PineUi, and 
°BIUlIO Magnani 
Division of Cardiology, BeUaria Hospital, and °Instimte of Cardiology. 
University of Bologna. Bologna, Italy 
The detectioo of silent myoc:anlial iscbemia in totally asymplOtJlatic subjects 
(Cohn type 1) is limited by the high prevalence of false positive results of 
exercise ECG testiDg (FEI} and exercise lballium myocardial imaging (TMI). 
In a program of saeening of silent myocardial ischemia in totally asymplOlDalic 
populatioo, 10 far 27 subjects (26 M, IF) aged 45-70 years (mean 58.4) with 
positive treadmill EET and exercise 'lM1 underwent coronary angiography. AD 
analysis bas heeD made of EET and TMI variables 10 fmd out possible 
discriminant parameters between true and fa\se positive results of noninvasive 
testiDg. Coronary angiography showed signiftalDt Iesioos in 14 cases (52%; 1-
vessel in 6, 2-vessel in 6, and 3-vessel or left main in 2) and oormaI coronary 
arteries in 13. No differences were fouod between pts with or without coronary 
artel)' disease (CAD) as far as age, coronary risk facIcrs, ST-T aboormalities at 
resting ECG, and cbaracteristics of ~ ST at EET (magnitude, type, time of onset) 
are concerned. PIS with CAD bad a lower double product at I-mm ~ ST 
(19.5±2.9 vs 23.5±4.3, p=O.Ol), a longer recovery time of ischemia at EET 
(9.00.7 vs 4.1±3.9 min p=O.03), a higher number of perfusioo defects at 'lMI 
(2.610.9 vs 1.910.8 segments, p=O.04). The absence of CAD was predicted by a 
recovery time of ischemia at EET SI min (p<O.OI), Imd by !be presence of ooIy 1 
perfusioo defect at TMI (p<O.OI). 
In order 10 improve !be predictive value for CAD of !be oooiDvasive protocol of 
investigation, pts were submiued a110 to 48-br Holter mooitoriDg (liM) and 
dipyridamole-ecbocardiograpby test (DEl). CAD was present at angiograpby in 7 
out of 8 pts (87%) with abnormal DET and evideoce of ischemia at lIM, in 6 out 
of 10 pts (60%) with DET or lIM abnormal. and fmally ooIy in 1 out of 8 pts 
(13%) with boIb DET and lIM oormaI. 
In cooclusioo, according to our data: 1) in !be screening of silent myocardial 
ischemia in totally asymptomatic SUbjects up to 50% of fa\se positive results of 
EET and TMI sbouJd be expected; 2) Ibe analysis of !be recovery phase at EET 
and !be extension of perfusioo defects at TMI select pts with higher probability 
of CAD; 3) fmally, !be sequential employement of lIM and DET significanUy 
improve !be predictive accuracy for CAD of the oooiDvasive investigation. 
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911-21 
Impired Perceptive Function of High Level Central Nervous System as a 
Cause of Silent Myocardial Ischemia 
Nagaharu Fukuma, Hiroshi Kishida, Masato Tomimura, Aya Hanashi, 
Yayoi Tetsuou, Yoshiko Yamazaki, Yumiko Tada, Junko Sano, 
Tsutomu Saitoh, Hirokazu Hayakawa 
The lst Dept. of Internal Medicine, Nippon Medical School, Tokyo, 
JAPAN 
To clarify the mechanism of high pain threshold in silent myocardial 
ischemia (SMI), we investigated the functions of both peripheral nervous 
system and central nervous system using somato·sensory evoked 
potential (SSEP). 25 stable effort angina pts (56 ± 6yrs) were 
divided into 2 groups by the occurrence of symptom during ischemic ST 
depression(;;Umm); 15 symptom(+) pts (APpts) and 10 symptom(-) pts 
(SMlpts). Cerebral evoked potentials with 2 different latencies after 
electrical stimulation on radial nerve were measured by SSEP. Short 
latency SSEP (latency 30msec) means the function of peripheral nervous 
conduction and late latency SSEP (latency 200-300msec) indicates the 
function of high level central nervous system related to recognition of 
pain. 
Results:(I)The pain thresholds for electrical stimulation were higher in 
SMlpts (2.0±0.3mA) than in APpts (1.7±0.3mA). (p<0.05) (2)ln short•
SSEP, the conduction times from stimulation to cerebral cortex were 
similar between 2 groups. (2)ln late-SSEP, the amplitudes of evoked 
cerebral potentials were less in SMlpts (5.3± 1.3 It V) than in APpts(7.0 
± 2.0 It V). (P<0.05) 
Conciusions:These results suggested that the response of high level 
central nervous system to electrical stimulation is less sensitive in SMlpts 
than in APpts. It is considered that the impaired perceptive function of 
high level central nervous system may playas an important role in SMI. 
911-22 
Mental Stress Induced Silent Myocardial Ischemia Detected 
During Ambulatory Ventricular Function Monitoring 
loannis Vassiliadis, Alexandros Fountos, Christos Venetis, 
Athanasios Papadimitriou, Evangelos Sbonias, Georgios Protopapas, 
Cardiac and Nuclear Medicine Dpts Athens Navy Hospital, Greece 
Transient ischemic episodes in pts with coronary artery disease 
(CAD) have been attributed to mental stress (MS). Means to 
monitor and record hemodynamic related changes due to MS are 
now available by utilizing the nuclear VEST. Accordingly, 8 pts with 
angiographically documented CAD and 8 normal volunteers, 
underwent a 3 hour session of continuous monitoring and recording 
of the left ventricular function, electrocardiogram, and blood 
pressure during exercise test (EX) and MS (i.e. computer video game 
psychomotor task). In the group of normals, all showed the expected 
normal response (increased EF) to EX, with concomitant increase 
of the heart rate and blood pressure. During MS, 3 (38%) showed 
transient episodes of EF decrease, that was not associated with chest 
pain, ST changes, or significant changes in blood pressure. In the 
group of CAD pts, 5 (60%) had an ischemic EF response to EX with 
evidence of chest pain in 3 (38%) of them, and ST depression in all 
of them. All of these pts during MS revealed transient episodes of 
decrease of the EF>5% of the baseline lasting more than 1 min 
(ischemic response). All these episodes were painless and only 2 
(12%) pts had associated ST changes. The rest of the CAD pts that 
were identified as non-ischemic according to the negative EX had a 
normal variation of the EF during MS. In all pts blood pressure and 
heart rate changes were unremarkable. 
Conclusions: The results provide evidence that there is marked 
disparity in the incidence of chest pain and ST changes despite the 
similar ischemic response of the EF, between EX and MS. This is 
indicative of the major role of MS in provocing silent ischemia. Such 
ischemia occurs at a relatively low heart rate elevation and is 
indepented from loading conditions. Heterogenous responses during 
MS are expected in normals. 
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Do Coavenlioaal Measures 01 eoro..ary Artery DUeue Severity PredIct 
Mental Streu-Iaduced M,....,.....uaJ bcbemla! 
Michael R. Freeman, SIl7JlDDe E. Legault, Anatoly Langer, Ung de Yang. 
Paul W. Armstrong. University of Toronto, Toronto, Ontario CANADA 
To investigate potential predictors of mental stress-induced myocardial 
ischemia, we studied 47 ooronary artery disease(CAD) pts 12 50% stenosis 
or prior myocardial infarction with reversible thallium defect (REV D» with 
the nuclear vest during speech(SP) and exercise(EX) with NIH protoool to 
oompare oontinuous changes in LV ejection fraction(EF), relative end•
diastolic volume(EDV), and end-systolic volume(ESV). 
There was no difference in age, prior MI, medical therapy, angiographic 
jeopardy soore or REV D between the 23 pts with a fall of EF 2. 5% during 
SP (SP +) as oompared to the 24 pIS with a normal response (SP -). 
Although, pis with SP + had more frequent angina during EX (17/23 vs 7{24, 
p < 0.01), there was no difference in Ex duration (11:1:4 mins vs 12:1:5, 
p=0.3). The peak changes from oontrol during SP and EX are shown in the 
table: SPEECH TASK NIB EXERCISE 
SP (-) SP (+) SP (.) SP (+) 
HR 7.9:1:7.2 6.7:1:6.5 49.1:1:23.4 36.4:1:10.9·· 
SBP 25.0:1:15.8 24.4:1:14.5 44.7:1:17.7 32.4:1:19.4" 
DBP 15.3:1:13.5 19.5:1:10.1 14.1:1:8.2 14.3:1:8.2 
EF 0.5:1:4.8 -11.1:1:5.7· 5.6:1:9.4 1.5:1:10.6 
EDV 6.2:1:6.6 0.7:1:6.6· 21.6:1:12.4 17.4:1:6.5 
ESV 3.2:1:3.9 10.0:1:6.3· 3.9:1:12.0 6.9:1:11.6 
.p ,S..01 and •• p <0.03 vs SP(-) 
Multivariate analysis of oonventional indices of CAD severity and EX 
performance did not identify predictors of speech-induced ischemia. Given 
the similar jeopardy soore and REV D oombined with a reduced HR and SBP 
during exercise, mental stress ischemia may be provoked in CAD patients due 
to a greater susceptibility to ooronary vasooonstriction rather than more 
severe fIXed ooronary artery disease. 
911-24 
Mental Stress·Induced Regional LV Dysfunction in Coronary Artery 
Disease: Relation to Ischemia During Sedentary Activity 
John S. Gottdiener, David S. Krantz, Robert H. Howell, Gabriela M. 
Hecht, Jennifer Falconer, Alan Rozanski, Georgetown University Medical 
Center, Washington, DC and Uniformed Services University of the 
Health Sciences, Bethesda, MD. 
While myocardial ischemia is readily induced by exercise, most triggers 
of ischemia during daily activities occur while relatively sedentary. It has 
been postulated that ischemia during sedentary activity may be triggered 
by mental/emotional arousal. To determine the relationship between 
mental stress-induced ischemia in the laboratory and triggers of ischemia 
during daily activity, we studied 60 men with CAD (av age 59 ± 9 years) 
utilizing 48 hr Holter for ST segment analysis, and quantitation of 
physical and mental activity with a special structured diary. These data 
were cross tabulated with regional wall motion abnormality (RWMA) on 
2D echo during mental arithmetic and with a speech exercise. New 
RWMA (group I) was found in 21 pts (35%) with arithmetic, 21 pts 
(35%) with speech and 30 pts (50%) with either mental stressor. In 19 pts 
(32 %), 72 ischemic episodes occurred on Holter. In 628 diary entries 
while sedentary there were 32 (5.1 %) ischemic events, of which 21 
(3.3%) occurred in Group I patients while 11 (1.9%) occurred in pts with 
negative mental stress echo (group II, p = .01). Of 150 diary entries at 
high mental arousal while sedentary, there were 7 ischemic events of 
which 6 occurred in group I pts and I in a group II pt (p = .03). Group 
I pts had greater increase in wall motion score (0.45 ± .04 SEM) with 
bicycle exercise than group II pts (0.21 ± .03, p = .004). Hostility 
score was greater in group 1(23.1 ± 1.1) than group II pts (17.8 ± 0.7, 
p = .02). Conclusions: New regional left ventricular dysfunction with 
mental stress testing is associated with; I) increased ischemia while 
sedentary, 2) ischemia with high levels of mental/emotional arousal, 3) 
greater ischemic severity, and 4) high level of trait hostility. Mental 
stress testing with echo may be useful in predicting triggers of ischemia 
during daily activity. 
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911-25 
Pediatric Silent Ischemia 
Marc Ovadia, George C McNeill, Walter H Williams. University of 
Arizona, Tucson, Arizona. 
Myocardial ischemia is rarely recognized in children except in 
coronary artery disease (CAD): e.g. Kawasaki disease (KD) or 
anomalous left coronary (ALCA). In an autopsy study of children we 
have previously documented extensive myocardial infarction often 
without CAD and generally unsuspected prior to autopsy. This was 
observed in the context of other significant congenital heart disease or 
cardiomyopathy. To address whether ischemia occurs and can be 
detected prior to infarction, we reviewed our experience with 
myocardial perfusion imaging in children. Fifteen (1S) serial patients 
age 1 to 11 years had stress perfusion imaging for variant chest 
discomfort-4, abnortnal ECG-4,asymptomatic CAD-4, dyspnea-2 or 
presyncope-l. Patients were of 2 groups: .cAll e.g. KD or ALCA, 
and pediatric heart disease with no CAD (congenital disease or 
cardiomyopathy). No test was performed for angina or abnormal 
stress test Tc-99m-MIBI or 11-201 was injected at peak hean rate 
(treadmill or dipyridamole). SPECT imaging was done with standard 
protocol with rest images in all cases of abnormal stress images. 
Analysis was by standard criteria requiring 2 views with redistribution 
to diagnose ischemia. Perfusion abnormalities were found in S/8 of 
the patients with CAD and 6n with non-CAD. The majority of 
abnormalities were fixed defects. However, reversible defects 
indicative of ischemia were present in only 1/8 of the group with 
CAD, but in sn with noncoronary disease (p<O.OS). Of these, 1 had 
D-transposition, 1 truncus arteriosus and 3 cardiomyopathy (1 
hypertrophic cardiomyopathy, 2 dilated cardiomyopathy). 
We conclude (1) ischemia occurs in the pediatric age group in 
noncoronary disease. (2) Ischemia may be unsuspected in congenital 
hean disease clinics. Silent ischemia exists in the pediatric age group. 
A high index of suspicion for ischemia is necessary for proper 
workup of a variety of syndromes in children with heart disease. 
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A Comparison or Failure Modes or Glutaraldehyde-treated versus 
Antibiotic-preserved MItral Valve AUografts Implanted in Sbeep 
Koichi Tamura, Michael Jones, Izumi Yamada, Victor J. Ferrans. 
NHLBI, NIH, Bethesda, MD 
The changes that developed in mitral valve allografts (MY A) after 
implantation in sheep permitted a comparison of the two most commonly used 
methods for preservation of tissue replacement heart valves. Hemodynamic 
studies, quantitative ealcium analyses, and light and electron microscopic 
observations were made on MV A from 12 juvenile sheep (used as animal 
models of accelerated ealcification) surviving 12-24 weeks after mitral valve 
replacement. Before implantation, the MVA were treated with 0.625% 
glutaraldehyde (Group I, n=4) or with cold antibiotic solution (Group II, n=8). 
All Group 1 animals died 12-19 weeks after implantation due to dysfunction of 
intrinsieally ealcified valves. One Group II animal died with MV A 
regurgitation; the valves of the other 7 (including 3 with regurgitation) were 
explanted at 19-24 weeks. Three Group II valves had mild ealcification. 
Perforations occurred in I Group 1 valve (related to ealcific deposits) and in 3 
Group II valves (due to connective tissue deterioration). Chordal rupture was 
found in all Group 1 valves and in 4 Group II valves. inflammatory reaction 
(lymphocytes, plasma cells and macrophages) was moderate or severe in all 
Group II valves, but was absent or minimal in all Group 1 valves. These cells 
were mainly loealized in fibrous sheath of leaflets and cbordae, and in the 
spongiosa and fibrosa of distal 1/3 of the leaflets. Fibrous sheaths were thicker 
in Group II than in Group I. in both Groups of MV A, endothelial cells were 
observed only on the surfaces of fibrous sheath. Other changes (not found in 
unimplanted MY A) included a spiraling substructure in many collagen fibrils, 
primarily in Group II MV A. Calcium analyses showed values (mg Ca/g dry 
tissue weight ± SEM) of 249±83, 88±56 and lOO±32 in anterior leaflet, 
posterior leaflet and chordae, respectively, in Group I, vs. 1.4±0.3, 3.0± l.l 
and 11.7±6.4 in Group II. In Group 1 valves, the ealcification was diffuse and 
involved collagen, elastic fibers, and connective tissue cells and matrix; in 
Group II valves, it was loealized mainly in mitochondria of fibroblasts. Thus, 
glutaraldehyde-treated MV A fail because of extensive ealcification; whereas, 
antibiotic-preserved MV A undergo deterioration of connective tissue of 
structural components in association with infiltration of inflammatory cells. 
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912-45 
Hypertrophy and Heart Failure in Chronic Experimental Mitral 
Regurgitation 
Norman M. Magid, Donald C. Wallerson, Stephen 1. Bent, leffrey S. Borer, 
Cornell Medieal Center. New York, NY 
Using a rabbit model, we previously showed that chronic experimental aortic 
regurgitation(AR) caused left ventricular dilatation, eccentric hypertrophy which 
followed a 3-pbase growtb curve, and, ultimately, beart failure. However, 
studies of eardiac mechanics reveal important differences between AR and mitral 
regurgitation(MR). Therefore, to defme the pattern and time course of structural 
and functional responses to MR and compare them with AR. a new rabbit model 
was created by damaging the mitral valve with SF endocardial biopsy forceps 
in S New Zealand White rabbits (2.9±0.3 kg). Doppler-«ho was performed to 
guide the biopsy forceps, quantify MR, and measure left ventricular internal 
dimension at end-iliastole(L VIDd) and end-systole(L VIDs), posterior wall 
tbiclcness(PW), left ventricular mass(L VM) and fractional shortening(FS) prior 
to and for 3 months serially following operation. The initial MR regurgitant 
fraction was 41±14%.l..cft ventricular structural alterations, evident at I week 
following operation, appeared to progress nearly linearly during the first month 
prior to attaining plateau values, following a 2-pbase pattern. One animal died 
with pathologic evidence of biventricular failure at 3 months (pulmonary 
congestion, ascites, pleural and pericardial effusions); FS was normal (34%) in 
this rabbit I week prior to death. *=p<O.OI, **=p<O.OOI vs. preop. values: 
L\1Ddlcml LVIDsIC!Dl fMcml J.YM!&l FSI%l 
Preop 1.4±0.2 0.9±0.2 0.2±0.04 3.7±1.l 35+6 
3 mo 1.9±0.3** 1.3±0.1* 0.20±0.03 5.4±1.4* 31 +S 
Thus, induction of MR in rabbits rapidly produces left ventricular dilatation 
and eccentric hypertrophy with increases in L VIDd of 36 % and L VM of 46 % 
during a 3-month period. As in AR, systolic function is initially preserved and 
congestive heart failure may ultimately develop in a subset of animals with MR, 
though the pattern, time course and degree of left ventricular hypertrophy in MR 
appears to differ from that in AR. 
912-46 
Mechanism of Intravascular Hemolysis After Mitral Valve 
Repair: Assessment by Transesophageal Echocardio•
graphy 
Yasuko Yamaura, Junichi Yoshikawa, Kiyoshi Yoshida, 
Takashi Akasaka, Masahiro Shakudo, Takeshi Hozumi, 
Yukikatsu Okada, Toyo Shomura. 
Kobe General Hospital, Kobe, Japan. 
Intravascular hemolysis (IVH) rarely occurs after mitral 
valve (MV) repair. To assess the mechanism of intravascular 
hemolysis (IVH) after MV repair, we studied 90 consecutive 
patients after MV repair by transesophageal echocardio•
graphy (TEE). 
Results: No IVH occurred in 74 patients with trivial or no 
mitral regurgitation (MR), or without a prosthetic ring. The 
remaining 16 patients had both more than mild MR and 
prosthetic rings. There was no difference in MR jet area by 
TEE between 5 patients with IVH and 11 without IVH (4.4 ± 
1.2 vs. 4.5 ± 2.7 cm2). All 5 patients with IVH had impinging 
MR jets on a prosthetic ring. 
The 11 patients --------M-R-J.-e-t ----
without IVH had 
non impinging 
MR jet. At reope-
ration, no endo•
thelialization of IVH 
the ring was seen No IVH 
Impinging 
on a ring 
5· 
o 
Non impinging 
on a ring 
o 
11·· 
at the site of im- -·,....-p<-0-. ..,..0-1 -v-s..,..N,....0~I::-V:-:-H:-;-:-•• :--p<-:0::-.-:-07"1-v-s-::IV-::H:-:•
pact of a MR jet. 
Conclusion: IVH after mitral valve repair occurs in pts with 
MR impinging on a prosthetic ring. 
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912·47 
Quantification of Regurgitation by the ProximallBovelodty Surface Area 
(PISA) Technique: Detailed Validation by Laser Doppler Anemometry 
Joame Hopmeyer. Serena Yang. Arnold A. Footaine, Ebud Schwammentba1. 
Robert A. Levine. Ajit P. YoglID8Iban. Georgia InstibJte ofTecbnoJogy. At1an1a, 
GAo Massacbusetts General Hospital, Boston, MA. 
The proximal isovelocity surface area (PISA) method bas shown potential for 
quantifying mittal regurgitation. While the proximal convergence region bas been 
sbJdied computatiooalJy. it bas DOt been mapped in an actua1 model with the detail 
possible with laser Doppler aoemometrY (IDA) to determine whether and at wbat 
point the PISA calculation (assuming hemispherical surface) is accurate. We 
therefore mapped Ibis region at 0.3 mm resolution by LDA for regurgitant flow (36 
mIls. jet veIocity=4.6 mls) driven througb a 3.2 mm orifice. Axial and radial 
velocity measurements were measured iD a plane througb the ceottal axis of flow 
up to I em from the orifice. At eacb location along the centerline of flow. 
regurgitant flow rate (Q) was calculated by Q=21U2V (V=magnitude of flow 
vector). and plotted agaiDst distanee from the orifice (pISA radius). The shape of 
Ibis curve was compared to computational studies (finite element Navier Stokes 
solution) at a similar flow rate and geometry. RESULTS: Close to the 
regurgitant orifice. Q was underestimated and approached the true flow rate at a 
distance of approximately I orifice diameter from the orifice. In the plot of 
.. ,,--
912·48 
calculated Q versus distance. a plateau 
was observed wbicb closely estimated 
true flow rate, similar to that observed in 
the computational studies . 
CONCLUSIONS: Laser Doppler 
anemometry measurements permit the 
detailed mapping of the flow convergence 
region by an engineering standard. The 
bigb spatial sampling allows us ID locate 
the plateau of calculated flow rate versus 
PISA radiUs. providing a validation of the 
PISA method for quantification of 
valvular regurgitation and demonstrating 
its woe of greatest accuracy. 
Significant Tricuspid Regurgitation Does Not Substantially Resolve After 
PercutaDeous Balloon Mitral Valvulotomy 
Alex Sagie, Ehud Schwammentha1, Igor F Palacios, Mary Etta E King, 
Arthur E Weyman, Robert A Levine, Massachusetts General Hospital, 
Boston, MA 
Despite adequaIe correction of mitral stenosis (MS), tricuspid regurgitation 
(TR) can persist and contribute to increased morbidity and mortality. 
Objective: to examine whether TR resolves or persists foUowing baUoon 
mitral valvulotomy (PMV). From 318 consecutive patients (pts) who 
underwent PMV and had pre-PMV echocardiography, 97 (31%) had 
sigoiIicant TR. Of those, 32 pts (age ~ • 15 yrs; 15 moderate, 17 severe) 
had echocardiography both 24 hr post PMV and at follow-up (mean of 18 
• 13 months). Sucoessful PMV (post-PMV mltraI valve area :> 15 cm2 or 
~ 50% increase without restenosis) was achieved in '}IJ /32 pts. TR 
decreased by one grade (from severe to moderat,,) in only 4 pts in the 
group with successful PMV and in none of the other U pts. Thus TR did 
not improve in 88% of aU pts studied. On average there was no significant 
change in the ratio of jet area/RA area 24 hr after PMV and at late 
foUow-up (37% vs 33% vs 34%) or in any of the right beart and annular 
dimeDSions even in the pts with successful PMV. RV systolic pressure also 
did not change significantly in the entire group (46.14 vs 42d4 vs 48tl8 
mmHg). RV dimensions did not decrease and TR did not resolve even in 
the 5 pts in whom RV pressure feU by more than 10 mmHg. Conclusions: 
SignifiCant TR is frequently a.~ociated with MS (31%) in pts undergoing 
PMV and does not substantially jmprove in the majority of pts at late 
~ This may be related to persistent pulmonary hypertension, 
irreversible annular dilatation or organic valvular changes. These findings 
support the current practice of correcting significant TR during mitral 
surgery and suggest that surgery, aUowing simultaneous tricuspid valve 
repair, should be considered when significant TR accompanies MS. 
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ABSTRACTS 
A New Proposal for CIiUlflcatIon of Uncommon AIrioventrlcuter Nodal 
Reentrant Tachycardll 
*Michael Biehl, Mita Sheth, Abd~ Wase, Sanjay Deshpande, Mansour 
Moghaddam. AsrNer DhaIa. Brenda Banks, JasbIr Sra, Thomas BroIhIer, 
Masood Akhtar, Mohammad Jazayerl, Sinai Samaritan Medical Center, 
Milwaukee, WI 
The uncommon form d atrtoventrIcuIar nodal fMIlIrant tachycardia 
(A VNRn utDlzes 8 retrograde atrioventricular nodal pathway with relatively 
alowly conductIng properties. Two forms d uncommon AVNRT with 
differing ratio d atrio-His (AH) to HA have been described, known as A) 
fast-slow, and B) alow-slow. However, no clear cut criteria exists for 
separation d these forms d AVNRT. 
In 265 consecutive patients with sustalnad AVNRT undergoing catheter 
ablation, sustalnad unconvnon AVNRT was Induced in 28 (10%). There 
were 18 women and 10 men with a mean age d 43 :I: 18 (range 14·70 ). 
Three forms d unconvnon AVNRT were lcIentified. AI fast-slow form with 
the AH Interval s 100 msec and shorter than the HA InteIvaI (15 patIents). 
B) a slow-slow form with both AH and HA Intervals > 100 msec (10 
patients), and C) a variant form with the HA Interval s 90 msec and 
spontaneous change in the AH:HA ratio occurring during each episode d 
tachycardia (3 patients). 
During endocardial mapping. the eerllest retrograde atrial activation 
was localized in the posteroseptal or mldseptal regions in 27 patlenla. In 
1 patient with the form B, the earliest retrograde activation was recorded 
adjacent to the His bundle site. Successful abIat10n d a slow pathway 
(retrograde or antegrade) was accomplished in all patients at the 
posteroseptal (19 patients) or mldseptal (9 patients) site. 
ConclUSion: 1. Based on this new classification, three distinct forms 
d uncommon AVNRT can be identified. 2. Use d a retrograde slow 
pathway located In the posteroseptal or mldseptal regions of the tricuspid 
annulus Is a common feature d all three forms. 3. RadJofrequency 
catheter ablation can successfully abolish each form d uncommon AVNRT 
by targeting a retrograde or antegrade slow pathway. 
913·114 
Silent Cerebral Infarction in Patients 
with Asymptomatic and symptomatic 
Paroxysmal Atrial Fibrillation 
*Ivan Mendoza, Federico Moleiro,Moises 
Muniz, Juan Marques, Moises Pulido, 
Baudilio Valecillos,Alvaro Matheus, Ana 
Rodriguez and The PLAFA Investigators. 
Experimental Cardiology Laboratory. 
Central University of Venezuela. Cara•
cas.Venezuela. 
BACKGROUND: 1.-Patients with nonvalvular 
atrial fibrillation(AF) are at risk for 
silent cerebral infarction(SCI). 2.•
Patients with paroxysmal AF(PAF) have 
frequent asymptomatic arrhythmias. 
OBJECTIVE:To evaluate the prevalence of 
SCI in pts with asymptomatic and sympto•
matic PAF. PATIENTS: 50 consecutive Pts 
with a history of nonvalvular PAF 
previously documented(28 female, Av age 
66.4 X+/- 14.3) METHODS AND RESULTS: 
Each Pt underwent clinical evaluation, 
ECG,2D and M Mode Echocardiography, 
Doppler Ultrasound, three 24-hour con•
tinuous ambulatory ECGs, stress test, 
brain magnetic resonance imaging and CT 
scan. There were 71 episodes o.f asympto•
matic PAF and 35 symptomatic PAF. SCI 
was detected in 25 pts(SO%) including 11 
Pts with only asymptomatic PAF. 
CONCLUSION: SCI is common in Pts with 
asymptomatic and symptomatic PAF. 
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913·115 
Do Infants Have Medically Refractory Supraventricular 
Tachycardia? 
Wayne H. Franklin, Barbara J. Deal, Janette F. Strasburger, D. 
Woodrow Benson, Jr., Children's Memorial Hospital, 
Northwestern University Medical School, Chicago, TIlinois; 
Children's Hospital, Ohio State University, Columbus, OH 
"Refractory to medical therapy" is often listed as an indication for 
radio-frequency catheter ablation of supraventricu1ar tachycardia 
(SVT), but there has not been general agreement on a definition of 
"refractory." In an attempt to define "medically refractory" SVT in 
infants < 12 months old, we reviewed our experience with 65 
infants referred to our institution from 1987-1992. Prior medical 
treatment with 1-4 medications was unsuccessful in 25 infants 
(38%). All infants presented with SVT < 3 months of age. SVT 
was present in utero in 27 of 65 infants (42%). SVT was associated 
with congestive heart failure or shock in 25 of 65 infants (38%) and 
with hydrops in 10 infants. Pre-excitation was manifest in 24 
infants (37%). SVT mechanism as defined at transesophageal 
pacing study involved an accessory atrioventricular connection in 64 
infants, and atrioventricular nodal reentry tachycardia in 1 infant. 
During the fll"St year of life, 23 different regimens of 9 
antiarrhythmic drugs were used for control of SVT. SVT was 
effectively controlled in 97% of patients with S 2 medications; 2 
infants required 3 medications for SVT control. "No medical 
therapy" was recommended for 27 pts (42%); it was successful in 
20 of 27 infants (74%). Medical management was simple in 53 
(82%) infants who were controlled on the initial regimen or required 
one change in regimen, but 12 (18%) patients required 3 to 6 
changes in their medical regimens to achieve control. Incessant SVT 
at a slower rate developed in 1 pt. receiving amiodarone and 1 pI. 
receiving flecainide. No patient required surgery or catheter ablation 
within the first year of life for control of SVT. Medical management 
of infant SVT is usually simple, but management may be 
challenging in some infants. However, we encountered no cases of 
medically refractory of SVT in infants. 
913-116 
site of origin of Ectopic Atrial Tachycardia 
Predicts Its aesponse to Adenosine. 
Hossein Shenasa, Randolph AS cooper, Joyce 
Pressley, Robert A Sorrentino, Ruth A 
Greenfield, James J Merrill, J Marcus Wharton, 
Duke University Medical center, Durham, NC. 
Ectopic atrial tachycardias (EAT) may arise from 
any site in the atria and are often terminated 
with adenosine. To determine if the site of 
origin affects the probability of termination of 
EAT with adenosine, 43 pts aged 6-80 years with 
44 discrete foci of EAT were given 6 and/or 12 
mg of adenosine via a central or femoral vein 
during EAT at the time of electrophysiologic 
study. Of these 44 foci, 3 (7%) originated in 
the left atrium, 4 (9%) in right atrial 
appendage, and 37 (84%) originated from the 
sinus nodal (SA) to the AV nodal region along 
the crista terminalis (CT) as follows: 11(25%) 
in the SA node region, 11(25%) in the AV 
junction and 15(34%) between the SA and the AV 
nodal regions. Adenosine terminated most (95%) 
of EATs arising from the region of the CT but 
only 29% of those arising elsewhere (p<O. 02) . 
When foci from the SA node region and the AV 
junction were excluded, the likelihood of 
termination with adenosine was still higher in 
foci frOm the CT. (93% vs 29%, p<0.005). Pts 
with EAT originating in the CT had less 
structural heart disease (22% vs 86%, p<0.02), 
but had similar EFs (5 5±8 vs 4 6±1 7) and age 
(49±17 vs 33±23 yrs). Conclusion: there appears 
to be a site specific interaction between 
adenosine and EATs arising in the CT which are 
more likely to be terminated by adenosine. The 
nature of this interaction is unclear. 
JACC February 1994:1A-484A 
913·117 
P Wave Morphology Durlug Automatic Atrial Tacbycardia lu 
Man 
Chris W Tang. Melvin M Scheinrnan. George F Van Hare. Laurence M 
Epstein. Adam P Fitzpatrick. Randy J Lee. Michael 0 Lesh. University of 
California. CVRI. San Francisco. CA 
A total of 16 consecutive patients with automatic atrial tachycardia (AA T) 
underwent detailed atrial endocardial mapping and successful radiofrequency 
(RF) catheter ablation of a single AAT focus. P wave morphology was 
analyzed from 12 lead ECGs during tachycardia. either during spontaneous or 
phannacologically induced A V block. P waves inscribed above the isoelectric 
line (T.p interval) were labeled as positive (+). below as negative (.). above and 
below as biphasic (+.). and Oat P waves as isoelectric (0). In 8 patients the 
tachycardia was located in the right atrium (RA): RA appendage (4). lateral wall 
(3). and coronary sinus os (I). In 8 patients. AAT was located in the left atrium 
(LA): mouth of right (3) or left (4) superior pulmonary veins. and base of LA 
appendage (I). 
Results: There were no significant differences in P wave vectors between sites 
at the right atrial lateral wall versus right atrial appendage. or between sites at 
the mouth of right versus left superior pulmonary veins. However. analysis of 
the P wave morphology showed that leads a VL and V I were helpful in 
distinguishing RA from LA·AAT. 
Criteria 
aVL=(+) 
aVL=(·) 
or (0) 
V 1=(·) 
or (+.) 
Vl=(+) 
Prediction Prediction Results Sensitivity 
RA "1P:7/8; ''IN:8/8 88% 
LA TP: 8/8; IN: 7/8 100% 
RA 1P: 7/8; IN: 7/8 88% 
LA 1P: 7/8; IN: 7/8 88% 
"TP= true positive; "1N= true negative 
Predictive 
Specificity ~
100% 94% 
88% 94% 
88% 
88% 
88% 
88% 
Cone/usion: I) Analyses of surface P wave morphology proved excellent in 
differentiating RA from LA tachycardia foci and may be used to expedite 
endocardial mapping studies for catheter ablation candidates. 2) P wave 
morphology was not helpful in distinguishing specific sites within an atrium. 
913-118 
Long-Term Effect of Cardioverslon on Peak Oxygen Consumption 
In ChronIc Atrial Fibrillation: A 2 Years Follow-up 
A.T. Marcel Gosselink. E. Sabs Bijlsma. Martin LJ. Landsman. Harry 
J.G.M. Crijns, Kong I. Lie. Thoraxcenter. University Hospital 
Groningen, The Netherlands. 
To determine the Iong·term effect of electrical cardioversion 
(CV) on peak oxygen consumption (peak VOJ, 39 patients with 
chronic atrial fibrillation (AF) underwent exercise testing before CV. 
and 1 month and 2 years thereafter. Seventeen patients had SR both 
at 1 month and 2 years after CV (Group I); Elevl'" patients had SR 1 
month after CV but had a relapse between 1 \month and 2 years 
(Group II). Eleven patients were in AF both 1 month and 2 years after 
CV (Group III). Before cardioversion, patients groups were 
comparable with respect to clinical characteristics. Resuhs are shown 
in the Figure (*p<O.05):. 
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Peak VO. improved 1 
month after successful CV 
(Group I and Group II), and 
continued to improve after 
1 month when SR was 
maintained (Group I). In 
contrast, in patients in 
whom AF maintained. peak 
VO. decreased significantly 
after 2 years of follow·up 
(Group III). 
In conclusion, these data indicate that restoration and Iong·term 
maintenance of sinus rhythm improve functional capacity in atrial 
fibrillation. Probably even more important, h demonstrates that 
functional capacity may deteriorate when atrial fibrillation persists. 
Therefore, the present study suggests that aggressive attempts to 
restore and maintain SR seem warranted in AF. 
JACC February 1994:1A-484A 
913-119 
Intennittent Atrial Fibrillation (AF) - Factors Which Predict 
Maintenance of Sinus Rhythm 
Greg C. Flaker, Kristin A. Fletcher, and Rob Rothbart, for the 
Stroke Prevention in Atrial Fibrillation (SP AF) Investigators, 
University of Missouri-Columbia, Seattle WA, Greensboro NC. 
Certain patients with intermittent AF remain in sinus rhythm for 
a prolonged time while other patients have recurrent AF. We 
identified 487 patients with intermittent AF enrolled in the SP AF I 
and II studies. These patients had ECG documented AF within I 
year prior to enrollment, and subsequent ECG evidence of sinus 
rhythm at baseline, I or 3 months follow-ups. Patients electrically 
or chemically cardioverted at any time during follow-up (n=I04) 
and patients with no follow-up ECG's (n=42) were excluded. 
During a mean follow-up period of 26 months (8 ± 5 ECG'slpt), 
173 patients (group A) had only sinus rhythm on ECG and 169 
patients (group B) had AF (127 with sinus rhythm on at least one 
follow-up, 42 in AF at every follow-up). 
Clinical Parameters QrQJ.!ll,.A 
Mean age 64±15 
Heart failure 8% 
Previous MI 5 % 
Antiarrhythmic drugs 24 % 
Echo Parameters 
Mean left atrial size 
Left atrial size > 5 cm 
Moderate-severe 
4.0±.6cm 
4% 
~ 
68±12 
17% 
15% 
25% 
4.4±.6 cm 
13% 
~ 
.013 
.007 
.003 
NS 
<.001 
.004 
LV dysfunction 3% 12% .001 
Clinical and echo parameters identify patients with intermittent AF 
likely to maintain sinus rhythm. 
913-120 
Blunted Sinoatrial Node Response to Exercise in 
Patients After Cardiac Surgery with the Maze Procedure 
Jun Tarnai, Yoshio Kosakai, Takao Yoshioka, 
Etsuko Ohnishi, Katsuro Shimomura, Yasunaru Kawashima. 
National Cardiovascular Center, Suita, Osaka, JAPAN 
We determined whether addition of the Maze procedure in 
cardiac surgery was beneficial for exercise performance 
of the patients with heart disease and atrial 
fibrillation (Af). The Maze procedure was performed in 
15 patients (37-70years) during mitral valve surgery 
(11 patients) or atrial septal defect closure (4 
patients). Cardiopulmonary exercise test using ramp 
incremental protocol (15watt/min) was performed before, 
one month after and 6 months after surgery. 
RESULTS: Af was successfully treated in 14 of 15 
patients. However, sinoatrial (SA) node response to 
exercise was blunted one month after surgery: mean 
heart rate (HR) was 83+13/min at rest, 94+13/min at 
60watt and l08+21/min at-peak exercise. Increase in HR 
was only O.27±O.15beats/watt. Peak oxygen uptake (PV02) 
was unchanged at this period (Before:17.3+4.9, One 
month after: 17 • 3+4. 8ml/min/kg) • SA node response was 
partially restored 6 months after surgery: mean HR was 
81+13/min at rest, l03+15/min at 60watt and 129+24/min 
at-peak exercise (P<O.Ol vs. One month). Increase in HR 
was O.47±O.18beats/watt (P<O.Ol). PV02 also improved at 
this period (20.0±4.7ml/min/kg, P<O.Ol). Increase in 
PV02 from one to 6 months after surgery was correlated 
witli the increase in peak HR (Y=O.71X+3.5, R=O.82). 
CONCLUSION: Af associated with cardiac disease was 
successfully treated with the Maze procedure. However, 
SA node response to exercise was blunted early after 
the surgery. Thus, the improvement of exercise capacity 
was obtained late after the surgery, which was related 
to the restoration of SA node response to exercise. 
ABSTRACTS 
913-121 
Functionally Distinct Dual Inputs Into the Human AV Node 
Kenneth M Stein, Neal Lippman, Erica D Engelstein, Bruce B Lerman. 
The New York Hosp~al· Cornell Medical Center, New York, NY. 
Animal studies demonstrate dual AV nodal inputs that run in the interatrial 
septum (AS) and from the crista terminalis in the posteroseptal region 
(PS). To test the hypothesis that functionally distinct dual atrionodal 
inputs also exist in humans, we evaluated three groups of pts. 
Group I: We compared AV nodal conduction properties during AS and 
PS pacing in 25 pts and evaluated the shortest atrial paced cycle length 
that resuhed in 1:1 anterograde AV nodal conduction (AVN·1:1) and the 
anterograde effective refractory period of the AV node (AVN·ERP). AVN· 
1:1 occurred at significantly longer paced cycle lengths during 
anteroseptal pacing than during posteroseptal pacing (AVN· 
1:1 PS=0.94xAVN-1 :1AS+16.5). The slope of this line was significantly 
less than one (p<0.05). 
Group II: 8 pts who did not have residual dual pathway conduction 
underwent detailed follow-up electrophysiologic testing within 1 week 
following radiofrequency ablation of the slow AV nodal pathway for AV 
nodal reentrant tachycardia (AVNRT). The effective refractory period 01 
the fast pathway (FP·ERP) was signfficantly increased late following RF 
w~h a trend toward an increase in AVN-1:1: 
pre-RF post-RF 
FP-ERP (msec) 326±65 362± 87 (p=.02) 
AVN-1:1 (msec) 339+55 429±107 (p=.08) 
Group III: We examined AV conduction in 8 pts after RF of a right PS 
accessory pathway (from105 consecutive accessory pathway ablations). 
All pts exhibited normal AV conduction before ablation. Following RF (l! 
2cm from the compact AV node). 3 pts exhibited impaired AV conduction: 
2:1 AV nodal block (1 pt), and anterograde AV nodal Wenckebach at 
cycle lengths l!450ms (2 pts). There were no significant differences in the 
number of RF applications between pts who developed impaired AV 
conduction and those who did not. 
Conclusion: These observations suggest the presence of distinct 
atrionodal inputs in humans, with a lower safety factor for impulse 
propagation over the anterior input, which may be related to nonuniform 
anisotropy. 
913-122 
A RaDdamiaed, Pl.cebo-CODtrolled Tri.l of PropafacoD. 
iD the Prophylazia of P.rozy ... l Supr.~tricul.r 
T.cby.rrhythmi •• 
*S.M.Cobbe 
UK Propafenone Study Group, Department of Medical 
Cardiology, Royal Infirmary, Glasgow, Scotland 
A double-blind, placebo-controlled cro.sover trial of 
the prophylactic efficacy of propafenone (P) was 
performed in patients with paroxyamal 
supraventricular tachycardia (PSVT n-SO) or atri.l 
fibrillation (PAr n-48). Mean age of patients was 58 
(range 20-77) years. Prior to entry, all patients 
had 3 or more ECG documented episodes of PSVT or PAr, 
including 2 within the 3 month run-in period. 
Patients were randomized to a low-dose cros.over 
phase (P 600 mg/d vs placebo), followed by a high•
dose crossover comparison (P 900 mg/d va placebo). 
Recurrences were determined symptomatically and by 
transtelephonic ECG starting 1 week after onset of 
treatment to allow steady-state plaama 
concentrations. The ratio of mean (% 95' CI) 
recurrence-free intervals on low-dose P va placebo 
was 5.1 (2.6-11.0) for symptomatic and 4.5 (2.3-9.7) 
for ECG documented recurrences. Comparable figures in 
the high-dose phase were 9.0 (3.2-35) and 7.0 (2.4-
27). Direct comparison of recurrence-free ratios 
between the low and high dose phases revealed no 
significant difference. There were no significant 
differences between the effect of P on PSVT and PAr, 
although a trend towards greater efficacy against 
PSVT than PAr was evident at higher dosage. 
CODcl_ioD. Or.l propafaDODa 18 .ffacti .. iD the 
prophylazi. of paroxy ... l .upr.~tricul.r 
t.cbyarrhythm1 ••. 
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914·94 
Left Ventricular Diastolic Dysfunction in Asymptomatic Pati•
ents with ST Segment-T Wave Abnormalities in the Resting 
ECG 
Angelos G. Economou. Christos A. Venetis. George T. 
Karatassakis. Department of Cardiology. 7th Hospital of Social 
Security Foundation. Athens. Greece 
The finding of ST segment·T wave abnormalities (STTA) in routine 
ECGs of asymptomatic and apparently healthy people are by no means 
uncommon and presents a difficult medical problem. 
The aim of the present study was to asses the left ventricular (LV) 
diastolic function in asymptomatic Pts with sn A in the resting ECG. Two 
groups of cases were prospectively compared: Group A consisted of 20 
asymptomatic pts with STIA (10 men and 10 women, aged 50±5 yrs); 
overt heart disease was ruled out by history. physical examination, chest 
X-rays, echo-studies (internal diameters. waH thickness and fractional 
shortening) and fuUy maximum negative exercise test with normalisation 
of repolarization. Group B consisted of 20 healthy subjects serving as 
controls. matched to A for age and sex, with normal rest ECG The 
comparative study comprised echophonocardiographic evaluation of the 
diastolic function of LV using measurements of isovolumic relaxation time 
(IVRT) and of rapid ventricular filling time (RVFT) as well as the 
calculated maximal (max) and mean (m) diastolic slope of the posterior 
LV wall (OSPW). Systolic function was assessed by isovolumic systolic 
time (IVST). 
Results: 
Group A Group B P 
IVRT(msec) 95.6± 9.7 72.5±10.5 <0.001 
RVFT (msec) 120.0±19.0 96.0±14.9 <0.01 
maxOSPW (mm/sec) 104.B±27.9 138.3±40.5 <0.01 
mOSPW (mmlsec) 48.6± 9.6 60.4±15.0 <0.01 
IVST (msec) 30.7±14.5 32.5± 9.0 NS 
These findings suggest that asymptomatic pts with STT A in the resting 
ECG without overt heart disease have LV diastolic dysfunction. 
914·95 
Autonomic Influeute and Paroxysmal Atrial Fibrillation: Results of l4-Bour 
Power Spectral Analysis. 
Alessandro Capucci FACC. Andrea Santarelli. Giuseppe Boriani. Mauro Biffi, 
Leonardo Spedicato. Bruno Magnani. Institute of Cardiology, University of 
Bologna, Ilaly. 
Twelve patients (pis) (mean age SO ± \3 years) with daily episodes of n:current 
lone paroxysmal atrial fibrillation (p AF) were submitted to 24·bour Holter 
recording during spontaneous daily activity and macthed with a control population 
of 12 pts (mean age 48 ± 23). Holter recordings were evaluated by a Heart Rate 
Variability program (spectral analysis by Fast Fourier Transform). Power of RR 
spontaneous fluctuations were analysed in bourly samples by defining: low 
frequency fluctuations (LF = 0.04 - 0.15Hz) as index of sympathetic activity and 
bigh frequency fluctuations (BF = 0.15 • 40 Hz) as index of parasympathetic 
activity. PIS with PAF had 30 episodes but only periods of sinus rythm were 
considered for spectral analysis. The comparison of the two groups (I = pts with 
PAF episodes, 2 = control population) was evaluated on the whole 24-bours 
recording and on diurnal (6am-IOpm; Sam·lpm) and nocturna1 (lOpm.oam; 
12pm-5am) time·intervals. Subsequently, we have compared the analysis of LF 
and HF over 2 minutes of 10 minutes immediately before the onset of P AF 
-episodes with samples of 10 minutes not preceding arrbythmias but selected in the 
same time interval and with the same mean beart rate Results' 
Inten'als LFI (ms) LF2(ms) BF I (ms) BF2(ms) 
24b 30 ± 15 28 ± IS 17 ± 8 17 ± II 
6am-IOom 27 ± 10 27 ± IS 14 ± 5 16 ± II 
8am- 10m 27 ± II 27 ± 14 13 ± 5 16 ± 11 
100m -6am 37 ± 21 30 ± 14" 22 ± 11 20 ± 11 
120m-Sam 40 ± 22 28 ± 13° 24 ± 12 20 ± II 
*p< 0.02; 0p< 0.002; 
The analysis of the 2 minutes preceding P AF episodes onset did show either 
bigber LF (29 ± 12 vs 23 ± 10) (p< O.os) and HF (18 ± 8 vs 15 ± 6) (p< 0.04) 
compared to controls. 
Conclusions: I) An increased sympathetic tone can be detected during night-time 
in pts with PAF episodes; 2) A sympathetic-vagal activation unbalance is present 
just before P AF onset. 
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914·96 
ImmecIaIa and Short ...... ~ of 1he P..,lIVe Signel-Averaged 
~1Iogram. 
Jonathan S. Steinberg. Frederick A. Ehlert and Edith Menchavez-Tan. St. 
Luke's-Roosevelt Hospital Center and Columbia UniverSity. New York, NY 
Recently. the P-wave signal-averaged ISA) ECG has been reported to 
predict the development of atrial fibrillation. In this study, we report the 
immediate and short-term reproducibility of the P-wave SAECG. The 
SAECG was recorded from 3 orthogonal leads to a low noise endpoint. 
Acquisition was QRS·triggered; P·wave matching via template recognition 
ensured P-wave alignment during averaging. The averaged output was 
analyzed as a total P-wave duration from the least squares fit filtered 
vector combination of the 3 orthogonal leads. A SAECG was defined as 
abnormal if P-wave duration was> 140ms. Immediate reproducibility was 
examined on the basis of 2 consecutively recorded SAECG's in 10 random 
patients and short-term reproducibility was examined on the basis of 2 
recordings made 3-7 days apart in a separate group of 10 patients. 
Results: 
Immediate 
Short-term 
P-wave Duration Ims) 
Recording 1 Recording 2 
144.±. 21 144.±. 17 
140.±. 16 135.±. 13 
P-wave SAECG results were highly correlated for both immediate 11=0.98, 
p <0.0001) and short-term Ir =0.92, p =0.0002) comparisons. There were 
no changes in the frequency of abnormal results 160%) in the 2 immediate 
reproducibility recordings, and there were 2 patients in the short-term 
reproducibility group in whom minor P-wave differences resulted in 
changes in SAECG classification. CONCLUSION: This new application of 
signal-averaging methodology demonstrates excellent reproducibility. The 
P-wave duration on the SAECG appears stable over short-term periods. 
914·97 
Predictora of Early Mortality In Patients Treated Surgically for 
Infective endocarditis, Vishwantha S. Nadig, Bruce E. Lewis. Diane 
E. Wallis,Ronald R. Schreiber, Douglas E. Kopp, Mark Stout, ROQue 
Piffare. Loyola University Medical Center, Maywood, IL 
Twenty-nine patients Ipts) with bacterial endocarditis referred for 
aortic valve replacement were reviewed to assess predictor. of early 
hospital mortality 130 days post surgery). QRS widening seen on EKG 
ILBBB. RBBB, IVCO), NYHA Class, LV function, age, aex and valve 
type were analyzed for impact on hospital mortality. Transthoracic 
endocardiography was evaluated for its correlation with the praaence 
of surgically identified annular abscess. Operative descriptions were 
reviewed to established presence of annular abscess. 
RESULTS: The mean pt Ige was 53.7 139-841. 16 pta had native 
valve endocarditis. 13 pts had prosthetic valve endocarditis. 11 pta 
were Class III-IV, 18 pts were Class HI. 11 pts were found to have 
QRS widening, 18 Pts did not have ORS widening. Pts who 
developed ORS widening on their EKG had the highest 30 day 
mortality 81 % 19/11 Pta) vs. 11 % 12/18 pts) mortality for pta without 
ORS widening Ip<0.05). Surgical deSCription of annular abscess was 
identified in 9/11 181 %) pts with ORS widening. None of the 18 pts 
with normal ORS width had annular destruction. None of the 9 pts 
with surgically identified annular abscess were detected with preop 
transthoracic echocardiography. 7/15 pts > 50 years old died vs. 
3/14 pts <50 years old who died Ip<0.05). Sex, LV function and 
valve type did not influence mortality in this series. 
CONCLUSION: ORS widening on EKG carries a poor prognosis in pts 
with valvular endocarditis. The poor prognosis in pts with ORS 
widening can be explained by the frequent identification of annular 
abscess at surgery. QRS widening on EKG was more predictive of 
annular abscess than transthoracic echocardiography. 
lACC February 1994:1A-484A 
914·98 
Improved ischemia Detection With a Microprocessor Driveu U.lead 
Portable Real1lme ECG Monitor: A Comparison With Holter Monitoring. 
Gary E. Lane, Randall C. Thompson, David C. Mackey, Joseph L. 
Blackshear, Timothy S. Shine, Kathy Ebener, Robert E. Safford; 
Mayo Clinic, I acksonviUe, f1... 
Patients with unstable angina (USA) and patients with coronary artery 
disease (CAD) undergoing surgery are at increased risk of cardiac events 
when Holter ST segment monitoring reveals silent ischemia. Online 
detection of ischemia can .now early therapeutic intervention in these 
patients. We utilized a microprocessor driven real time U·lead ECG 
monitoring device in a comparison with Holter monitoring for ischemia 
detection in 100 patients. The group with CAD included 48 patients with 
USA and 28 patients with stable CAD undergoing surgical procedures. A 
group of 24 normal controls without CAD were also srudied. The patients 
were moDitored for a mean of 13.3 hours. All patients were moDitored at 
hedrest or while undergoing surgery. 
In the group with CAD more ischemic events as manifested by ST segment 
shift were detected by the U·lead device compared with Holter (42 vs. 16, 
p=.028). Total ischemic time was also greater (856 vs. 273 min., p=.05) with 
the 12·lead device. Ischemia was detected by both techniques in 6 patients, 
by the U·lead device alone in 10 patients, and by Holter alone in 1 patient 
(p= .OU). Neither device reported ischemia in the controls without CAD. 
The U·lead device had an advantage in deteetiug inferior ischemia and 
identified an additional 13 USA patients with changes in T wave polarity 
who did not exhibit ST shift. The U·lead device has an alarm function to 
monitor ST shift which was triggered in 79% of the ischemic events. There 
were 0.13 false aIarms/hour, usually from motion artifact. 
Conclusions: The 12·lead real time ECG monitoring device is superior to 
Holter monitoring in detecting and .nowing online identification of 
myocardial ischemia in patients with unstable angina and in CAD patients 
undergoing surgery. 
914·99 
Quantitative Relationship Between Efferent Vagal Stimulation and 
Heart Rate Variability. 
John R. Bailey, David M. Fitzgerald, Robert J. Applegate, The Bowman 
Gray School of Medicine, Winston-Salem, NC. 
Changes in parasympathetic tone alter heart rate variability (HR V). 
However, the quantitative relationship between efferent vagal 
stimulation and HRV is not known. Accordingly, we assessed HRV in 5 
anesthetized dogs with both the ansae subclaviae and the vagi 
decentralized. HRV was assessed for 2 min at S levels of electrical 
stimulation of the vagi. HR decreased from 107±10 at baseline to 
S2;t20 bpm, p<O.OS, during maximal vagal stimulation (VS). The time 
domain parameters of the standard deviation, (4.O;t3.0 to 4S±3S), 
percentage of R·R intervals varying by ~ SO msec from the prior R-R, 
or PNNSO (0.2±0.4 to 21.6±14.8), and coefficient of variance (0.7±0.S 
to 4.1±4.2) all increased (p<O.OS) in a linear relationship with the 
change in the R-R interval during VS. The power spectral density 
(natural log of power) increased exponentially with incremental VS in 
the very low frequency band (0-0.09 Hz), 3.S±1.7 to 8.6±S.5 msec2; 
low frequency band (0.09·0.1S Hz), 2.8±2.0 to 7.3±1.7 msec2; and high 
frequency band (0.IS·0.40 Hz), 4.0±2.0 to 8.0;t1.6 msec2, all p<O.OS. 
Qualitatively similar changes in HRV during VS were seen with 
increased (ansae subclaviae stimulation) and decrease~ (beta blockade) 
sympathetic tone. 
Conclusion: Alterations of efferent parasympathetic nerve activity in 
the anesthetized, denervated dog resulted in time domain measures of 
HRV which were linearly related, and frequency domain measures which 
were exponentially related, to changes in the R·R interval. These data 
provide a quantitative basis for assessment of changes in 
parasympathetic tone and heart rate variability in clinical studies. 
ABSTRACTS 
914·109 
Coaraea.aa of IOD-Rb.U8&~Lc A~rLal 'LbrLlla~LoDI AD 
ADalraLa of '" Pa~L.D~a Followed for 1.3 Y.ara 
Joeeph L. Blackshear, Rober~ E. Safford, tesly A. 
Pearce on Behalf of ~he sPar InveatLgatora, Kayo 
Clinic Jacksonvill. and the Statistica and 
Epidemiology Reaearch Corporation, Jackaonville, FL, 
and Seattle, WA. 
'-wave amplitude varie. from coarae to flat-line in 
atrial fibrillation (Ar) patients and the 
aignificance of the degree of coar.ene.e hae long 
been a aubject of apeculation. Ba.ed on prior 
atudies which included patient. with rheumatic heart 
dieeaae, , amplitude may be related to left atrial 
(LA) .ize, hypertrophy, or to ~he duration of Ar. We 
analyzed the maximum F-wave (Pmax) amplitude in EOG 
lead v, in 464 Ar patienta without rheumatic heart 
diaeaae assigned to receive placebo in the Stroke 
Prevention in Atrial Fibrillation (SPar I) Study. 
At atudy entry, Pmax waa not related to a history of 
hypertenaion, .yatolic blood preasure, abnormal 
echocardiographic left ventricular (LV) function, LV 
maaa, or LA diameter. Patients with intermittent (n 
• 123) Ar had smaller Pmax than conatant (n - 327) Ar 
patfents (mean t SEE - 0.73 t 0.04 veraua 0.88 t 0.03 
mY' , p - 0.001), were younger (63 VB 69 yearB, p < 
0.001), and had a lower frequency of LA enlargement 
(28\ vs 48\, P < 0.001). No aignificant relationship 
waa detected for Pmax versus duration of Ar, defined 
as < 3, 3-12, or > 12 montha. 
In the sPar I study, 37 patients assigned to placebo 
had iachemic stroke or syatemic embolism over 1.3 
years of follow-up. Pmax waa neither protective of 
nor associated with total embolic eventa, or with 
thoae aubclaBsified to be cardioembolic. 
Conclusion: Pmax in non-rheumatic atrial 
fibrillation is amaller in patienta with intermittent 
veraus constant Ar. It is not aasociated with LA 
aize, increaaed LV mass or LV dyafunction, 
hypertenBion, or increased risk of embolism. 
914·110 
253A 
Use or P Wave Morphology to Predict Site or Origin or Retrograde 
Atrial Activation: Validation with Atrial Pacing at the AV Annulus 
David M. Fitzgerald. Harry R. Hawthorne. George H. Crossley. Wesley K. 
Haisty, Jr .. Tony W. Simmons. The Bowman Gray School of Medicine, Wake 
Forest University. Winston· Salem. North Carolina 
Different patterns of atrial activation are manifested by changes in the 
morphology of the surface P wave. For concealed accessory pathways. 
morphology of the surface P wave during orthodromic reciprocating tachycardia 
might aid in localizing the atrial insertion site. We attempted to characterize the 
morphology of the surface P wave during atrial pacing at different sites along the 
AV groove. In twelve patients undergoing electrophysiologic testing. a 12 lead 
surface electrocardiogram (EKG) was recorded during bipolar atrial pacing (2 
mm interelectrode spacing) using a multipolar electrode catheter in the coronary 
sinus vein or a deflectable electrode catheter along the tricuspid annulus. 
Catheter positions were confmned with biplanar flouroscopy. P wave morphology 
at each pacing site was evaluated for each EKG lead and graded as 
predominantly positive. predominantly negative.or isoelectric. Each patient was 
paced at 4-6 sites (median =S) along the mitral annulus and 4·9 sites (median 
=8) along the tricuspid annulus. Overall, 61 recordings of pacing along the 
mitral annulus and 86 recordings of pacing along the tricuspid annulus were 
evaluated. Results: 
1. A negative or isoelecbic P wave in lead I was seen during left atrial pacing at 
59/61 left atrial sites and at 2/86 right atrial sites (predictive value = 96 %). Both 
right atrial sites were along the right posterior septum. Pacing at 84/86 right 
abial sites resulted in a positive P wave in lead I. 
2. A negative or isoelecbic P wave in lead V I was seen during right atrial 
pacing at 51/57 right free wall pacing sites (predictive value = 91 %). while a 
positive P wave in V 1 identified septal pacing in 23{29 sites. 
3. Negative P waves in leads 11. Ill, and aVF indicated a posterior site of atrial 
pacing in 60/65 posterior sites (predictive value = 76 %). 
Conclusions: P wave morphology can accurately localize abial activation 
emanating from the A V groove to a quadrant of the heart. This can be used to 
predict the location of concealed accessory pathways prior to invasive studies and 
to differentiate A V nodal reentry from orthodromic reciprocating tachycardia. 
254A ABSTRACTS 
914-111 
Late Potentials are of No Prognostic Value and Signal Averaged ECG is of 
Little Use in Patients with Coronary Artery Disease in the Absence of a 
Myocardiallnfardion 
·Udbo Tbadani, Lianmin Ma, John Turner, Oklahoma City, OK 
The usefulness of late potentials (LP's) detected by signal averaged 
electrocardiogram (SAECG) in identifying high risk patients with CAD in the 
absence of a myocardial infarction is unknoWD. We prospectively obtained 
SAECG on 89 patients undergoing coronary angiography for evaluation of chest 
pain. None bad history of myocardial infarction, ventricular arrhythmias or 
conditions knoWD to influence SAECG. All recordings were made to a noise 
level < 0.5 p.v with a 40 HZ bidirectional highpass filter. Twenty one bad no 
CAD, 11 bad minimal CAD «50% narrowing) and 57 patients bad severe CAD 
(>50% narrowing of one or more vessels; median 95%, maximum 100%). 
Number and percentage of patients meeting the LP criteria in the three groups 
were: 
LP Criteria 
QRSD> 114 ms 
RMS40 ( < 20 p.v) 
LAS (>38 ms) 
No CAD 
2(9%) 
5(24%) 
4(19%) 
Minimal CAD 
1(9%) 
1(9%) 
1(9%) 
Severe CAD 
5(9%) 
20(35%) 
25(44%) 
At one year follow-up only 1 patient bad myocardial infarction and 1 patient died 
from septic shock; both bad no LP's. Worsening of angina symptoms was 
reported by 8 % of patients with LP's and by 9 % without LP's. Abnormalities 
of QRS duration (p=O.266), RMS40 (p=0.880), or LAS (p=O.630) were not 
predictive of adverse cardiovascular events. Conclusion: 1) presence of LP's in 
CAD patients in the absence of a myocardial infarction is not indicative of 
adversesbort-term clinical outcome. 2) SAECG is of little value for predicting 
cardiovascular events in patients with CAD who never bad a myocardial 
infarction. 
914-112 
Abnormal Signal-Averaged Electrocardiogram in 
Patients With Non-Ischemic Dilated Cardiomyopathy: 
Correlation With Ventricular Tachyarrhythmias? 
Burghard Schumacher, liirgen Tebbenjohanns, Thomas Korte, 
Werner lung, Matlhias Manz, Berndt Liideritz. Dept. of 
Cardiology, University of Bonn, Germany 
Late potentials (LP) are a predictor of risk in patients (pts) 
wilh coronary artery disease. The role of LP in non-ischemic 
dilated cardiomyopathy has not been defined yet. We started 
a prospective investigation to evaluate lhe prognostic impact 
of an abnormal signal-averaged electrocardiogram (SAECG) in 
pts wilh non-ischemic dilated cardiomyopalhy. After coronary 
angiography and left ventriculography 43 pts were enrolled in 
our study. Programmed right ventricular stimulation was 
performed in case of previous syncope or ventricular 
tachyarrhythmias (VTNF). All SAECG recordings were 
analyzed by time domain analysis (TD) as well as by 
spectrotemporal mapping (STM). Results: 
TD EF Vf/VF Vf/VF STM EF Vf/VF VfVF 
(%) sponl. induc. (%) sponl. induc. 
pos 29±13 14/23(61%)6/10(60% pos 29±87 12121(57%) 6/10(60%) 
neg 30±1O 6/20(30%) 4/12(33% neg 29±50 8/22(36%) 5/12(45%) 
n.S. p<0.05 p<O.05 n.s. n.S. n.s. 
Pts wilh positive LP had more pontanous or inducible VTNF 
lhan pts wilhout LP. Sensitivity was 61 %, specificity 70%. In 
pts with VTNF lhe mean QRS- and LAS-duration was 
significantly increased and the mean RMS-voltage was 
significantly decreased. The predictive value of TD-analysis 
exceeded that of STM. Conclusion: In pts wilh non-ischemic 
dilated cardiomyopalhy an abnormal SAECG is also associated 
wilh an increased risk of ventricular tachyarrhylhrnic events. 
Thus SAECG contribute to lhe evaluation of lhese pts. 
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915-49 
Technetium-99m Tetrorosmin Perfusion Imaging: Analysis or 
Heart, Lung and Liver Kinetics arter Dipyridamole and at Rest 
Nasser M. Lakkis, Imran I. Afiidi, John J. Mahmarian, Gerald W. 
Guidry and Mario S. Verani, Baylor College of Medicine, Houston, 
Texas 
Tc-99m tetrofosmin is a new, prolDlsmg agent for 
myocardial perfusion imaging. In this investigation, we assessed lhe 
myocardial, lung and liver activities over time, after an injection of 
5-8mCi of rc-99m tetrofosmin during dipyridamole administration, 
followed 4 hours later by a rest injection of 15-24mCi of rc-99m 
tetrofosmin. Planar and SPECr imaging was performed in 16 
volunteers, (9 males 7 females, mean age 54±11 years). Planar 
images were obtained 10 minutes after administration of Tc-99m 
tetrofosmin and repeated 45 minutes later. SPECT images were 
acquired beginning at 15 minutes post tracer injection. T c-99m 
tetrofosmin activity was assessed on regions of interest on the heart, 
lung and liver. Lung/heart and liverlheart ratios, as well as heart, 
lung and liver clearance were calculated. Low lung/heart ratios 
(0.33 and 0.25) and high liverlheart ratios (1.78 and 1.58) occurred 
10 min after dipyridamole and after rest injection, respectively. 
Significant decreases occurred in lunglheart (p=.OOOI) and 
Iiverlheart (p=.OOOI) ratios from 10 to 45 min after dipyridamole. 
Tc-tetrofosmin activity in the heart, lung, and liver, from 10 to 45 
min after tracer injection, decreased by 9"10, 17% and 41 % after 
dipyridamole and by 12%, 29"10 and 35% at rest, respectively. 
Planar and SPECr images were all of good to excellent quality. 
Thus, low lung and moderate liver uptakes and a mild heart 
clearance allow imaging to be initiated as early as 10 min after T c-
99m tetrofosmin rest injection, although best image contrast occurs 
at 45 min after tracer injection during dipyridamole imaging. 
915-50 
Exercise Thallium-20t Single Pboton Emission Computed 
Tomognpby: An Effective Tool to Detect Late Coronary Artery 
Bypass Gnft Stenosis 
Nasser M. Lakkis, Imran I. Afiidi, John 1. Mahmarian, Mario S. 
Verani, Baylor College of Medicine, Houston, TX 
Tha11ium-201 (T1-201) tomography (SPECr) is superior to 
planar imaging for localizing native coronary stenoses. As yet, the 
value of this test for assessment of late graft patency in pts wilh 
prior coronary artery bypass graft surgery (CABG) is not known. 
Accordingly, we studied 50 pts (40 males, mean age 58±!) years) 
who presented for evaluation of angina (30 pts), atypical chest pains 
(11 pts) and other symptoms (9 pts), at a mean of51.6±47 months 
after CABG. Patients with prior myocardial infarction were 
excluded. All pts underwent symptom limited exercise T1-201 
SPECr and coronary angiography within 3 weeks. The mean 
ejection fraction was 58±17%. There were 119 grafts of which 48 
had >50% stenosis by angiography. The sensitivity and accuracy for 
detecting graft stenosis were higher by rl-201 SPECT than by 
exercise ECG (83% vs 23% p=O.OOOl; and 85% vs 48% p=O.OOOl, 
respectively). The sensitivity of rl-201 SPECT to detect pts with 
~l graft stenosis compared to exercise ECG was 80% vs 50% 
(p=O.OOOl) in pts with angina and 81% vs 23% (p=O.OOOl) in pts 
without angina (atypical chest pain and other symptoms combined). 
The sensitivity for correct anatomical localization of graft stenosis by 
SPEcr was 82% for the left anterior descending artery, 83% for the 
right coronary and 63% for the circumflex coronary artery. 
In conclusion, exercise T1-201 SPEcr is an excellent tool to 
detect and localize graft stenosis late after CABG and it is far 
superior to exercise ECG alone, both in pts with and without 
recurrent angina:. 
JACC February 1994:1A-484A 
915·51 
SPECT Tc-99m Tetrofo.min Imaging During Dipyridamole 
Induced Coronery Hyperemia 
Joseph Powers, Stam Lerakis, Seydi Aksut, Virginia Cave, 
David Cassel, Jaekyeong Heo, Abdulmassih S. Iskandrian, 
Philadelphia Heart Institute, Presbyterian Kedical 
Center, Philadelphia, PA 
Technetium-99m tetrofosmin is a lipophilic cationic 
perfusion imaging agent which in Phase III trials 
provided comparable results to thallium-201 in detecting 
coronary artery disease (CAD) using exercise testing. 
This study examined the results of dipyridamole 
tetrofosmin SPECT imaging in 25 patients (pts) who also 
hsd coronary angiography. A one-day stress/rest protocol 
was used; the dose of tetrofosmin in the stress stUdy was 
8 mCi, and during the rest study 24 mCi. Tetrofosmin was 
injected three minutes after completion of dipyridamole 
infusion (0.142 mg/kg/min over four minutes). SPECT 
images were obtained 15 to 30 minutes after the tracer 
injection. All images were of good quality. The heart 
rate increased from 69 ± 10 to 82 ± 12 bpm (P <0.001), 
and systolic blood pressure decreased slightly (149 ± 31 
to 146 ± 28 mmHg (P:NS). Image was abnormal in 19 of 21 
pts with CAD (sensitivity - 90%), and normal in 4 of 4 
pts with no CAD (specificity - 100%). The perfusion 
defects were reversible in 7 pts, fixed in 6 pts, and 
both fixed and reversible in 6 pts. ST depression 
occurred in 2 pts with CAD. Of the 43 diseased arteries 
with ~ 50% stenosis (left anterior descending: 18, left 
circumflex: II, right coronary artery: 14), 31 vessels 
(72%) were correctly identified. Of the 28 diseased 
arteries with ~ 70% stenosis, 86% were identified. Thus, 
SPECT one-day dipyridamole-rest tetrofosmin imaging is 
useful for the detection of CAD. The image quality is 
high, and results are comparable to historic results 
obtained with dipyridamole thallium imaging. 
915·86 
Co.pariaon of Tc-99a Q12 and Tl-20l Iaaging for 
Detection of Angiographic Coronary Artery Disease 
Myron C, Gerson, Jennifer Lukes, "Edward Deutsch, Danuta 
Biniakiewicz, Charlotte Fortaan. Lee C. Washburn, 
Richard A, Walsh, Univ. of Cincinnati, Cincinnati, OH 
and Mallinckrodt Medical, Inc., St. Louis, MO 
In 20 patients (11 aen, 9 woaen) with angiographic 
coronary artery disease, in 2 patients with noraal 
coronary arteriograas, and in 8 healthy volunteers, 
exercise testing was perforaed with toaographic (toao) 
Tc-99a Q12 (prepared by a two-step batch procedure) and 
with toao Tl-201 iaaging. At rest. 7 aCi of Q12 was 
injected followed after 15 ainutes by iaaging; 
ia.ediately afterward 23 aCi of Q12 was injected at peak 
exercise followed after 15 ain by iaaging. Two weeks 
earlier or later Tl-201 toao was perforaed 15 ain 
following exercise to the saae peak heart rate, and 
followed at 4 hours by redistribution or reinjection 
iaaging. Iaages were interpreted in blinded fashion by 
2 readers. Coronary arteriograas showed a 150% stenosis 
in 3 vessels (V) in 3 patients, in 2 V in 4 pts, and in 
1 V in 13 pts. Sensitivity and noraalcy rate (NR) for 
overall coronary disease detection (CAD), left anterior 
descending (LAD), left circuaflex (LeX), and right 
coronary artery (RCA) disease were: 
Tl SENSITIVITY/NR Q12 SENSITIVITY/NR f 
CAD 90%/90% 85%/80% NS 
LAD 80%/85% 80%/85% NS 
LCX 90%/75% 80%/75% NS 
RCA 70%/85% 60%/90% NS 
Conclusions: 1) Tc-99a Q12 and Tl-201 have coaparable 
sensitivity and NR for detection of CAD and individual 
coronary stenoses, 2) Tc-99a Q12 rest-stress iaaging 
aay be coapleted within 100 ain without apparent loss 
of diagnostic accuracy for coronary disease detection. 
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915·87 
Myocardial Teboroxime Clearance Derived From Canine Scans 
Differentiates Mild and Severe Row-Restrictions Following Dipyridamole 
Gerald Johnson III, Kiem N. Nguven and Robert D. Okada. W. K. Warren 
Medical Research Institute of the University of Oklahoma Health 
Sciences Center and Cardiology of Tulsa, Tulsa. OK 
Previous studies using teboroxime (tebo) following dipyridamole (DP) 
have demonstrated delayed clearance from flow-restricted mvocardium. 
However. these studies have not attempted to differerentiate mild from 
severe stenoses. The primary purpose of this study was to determine 
whether tebo clearance calculated from canine scans could differentiate 
mild from severe flow-restricted myocardium following DP. A secondary 
aim was to compare single zone (posterior wall tebo activity over time) 
and dual zone (posterior/anterior wall tebo ratio over time) methods of 
clearance analysis. 
Methods: Eighteen dogs received either mild (n = 8) or severe stenoses 
(n=101 of the left circumflex coronary artery. A control group (n=3) 
received no stenosis. Tebo and microspheres were injected following DP 
and serial planar images were obtained over sixty minutes. 
Results: Excellent quality images demonstrated initial defects with 
significant qualitative and quantitative differential tebo clearance. 86% 
(617; 1 had no defect) of defects in the mild group had filled-in by 20 
minutes. contrasted with only 30% (311 0) in the severe group. Dual 
zone analysis allowed differentiation of mild and severe stenoses from 
2 min onward. Single zone analvsis allowed differentiation of mild and 
severe from control by 10 min and from each other at 60 min. 
Correlation coefficients were calculated for microsphere-determined 
flows at the time of tebo administration with regional tebo clearance 
quantitated from serial planar scans (r=0.74. p<O.OOOO. n=42) and 
flow ratios with tebo pixel count ratios (r=0.81. p<O.OOOO, n=21). 
Conclusions: Following DP. tebo myocardial clearance calculated from 
canine scans differentiates mild and severe stenoses from two min 
onward. Single zone and dual zone analysis can both differeentiate mild 
from severe stenoses. although dual zone analysis can make this 
differentiation earlier. 
915·88 
Rapid Di.gno.i. of CoroD.ry Di..... V.ing 
Dipyridaaol. .Dd Teboroxiae Wa.bout Iaaging 
Dean J. Phillip., Roberta A. Hennaman, Michael E. 
Kerhige, State University of NY at Buffalo, Buffalo, NY 
COronary di.ea.e (CD) detection with nuclear imaging 
require •• eparate .tre.s and rest .tudi... Since myo•
cardial washout of Teboroxime (TEB) is delayed in post 
atenotic viable zones, we hypothesized that early/late 
phase imaging with Qna injection of TEB during coronary 
hyperemia would permit accurate diagnoBi. of CD. 
Accordingly, we performed dipyridamole SPECT imaging 
and a separate rest (R) Btudy using TEB in a triple 
cryatal camera in 102 patientB. Five, 2 min. image. 
were acquired over 360·, 5 min. after DP infusion 
(0.14mg/kg/min. x 4 min.), 1 min. after TEB injection. 
The first 2, and last 3 .cans were aummed to create 
early (S) and late (W/O) images. S, W/o and R images 
were compared and defect intenSity waB quantified and 
then normalized to peak myocardial counts, uaing 
computer assiated region. of intereat. 
Of 22 patients with .trea. induced defect., 21 had 
high quality W/O atudies. Stre •• induced defect a were 
rever.ible at rest imaging in 24/38 .egment. and fixed 
in 14. Washout imaging correctly predicted 
reversibility in 19/24 .egment. with no further 
improvement at R imaging. 
pefect Iptep.ity (\ PEAK) 
Str... 0.69 ± 0.12 } P < 0.001 
W/O 0.81 ± 0.10 
a •• t 0.84 ± 0.14 } P - N.S. 
No fixed defects improved at W/O. Five reversible 
defects did not improve at W/O. 
CONCLUSION' CD can be diagnosed with a Bingle 10 min. 
image when defect reversibility occura uaing washout 
imaging. If no improvement occurs at waahout, however, 
a aeparate resting .tudy i. neceasary. 
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915-89 
Val1datiOll of a ~b ... tlIo4 of .. aauriDg CorOllarY 
Blood Fl_ ........ A Split Do .. 'l'bal.li_-20l ... t/su ••• 
r.agiDg 
Jo •• f Machac. Jo •• ph A. Diamond. Shank.r V.llabbajo.ul •• 
lIIil.n. J. R.nslova. It.vin Martin. III. lta",1 Ali. Ali 
S.d.ghi. Arl.n. Tr.vi.. er.ig It. 1II •• row. Al.jandro 
Gand •••• Rob.rt A. Phillip •• Mount Sin.i lII.dical Cant.r. 
N.w York. NY 
Imp.ir.d coron.ry blood flow r •• erv. (carR) baa b •• n 
docum.nt.d in v.riou. hyp.rtrophic .t.t... but i. 
difficult to .... ur. noninva.iv.ly. Routin. .tr ••• 
myocardial p.rfu.ion imaging d.t.ct. r.gional d.f.ct. in 
carR. but not globally r.duc.d carR. W. d.v.lop.d and 
t •• t.d a quantitativa noninva.iv. method of .. aauring 
carR uaing Thallium-201 p.rfuaion imagin;. S.v.n 
an •• th.tiz.d dogs war. inj.ct.d .imultan.ou.ly at r •• t 
with 1.5 mCi Tl-201 i.v. and Sn-113 micro.ph.r •• via th. 
l.ft atrium. SPBCT imag.. w.r. obtain.d. A ;rad.d 
ad.no.in. infu.ion wa. th.n start.d and at p.ak .tr •••• 
••• cond 1.5 mCi Tl-201 do •• wa. inj.ct.d .imu1tan.ou.ly 
with Sc··1S microBph.r ••• SPBCT imag •• w.r. th.n r.psat.d. 
Th. h.art wa. ramev.d ••• ction.d and count.d. along with 
artarial blood sampl ••• Blood flow wa. calculat.d at re.t 
and .tr •••• rrom SPBCT imag ••• p.ak r •• ting count. in 
four r.gion. in aach of thr.e slic •• war •• ubtracted from 
str •• a value. and .tress/r.at TL-201 count ratio. (CrR) 
ware calculated and corr.lated with the corr.sponding 
microaph.r. flow ratio •• 
R.gion 
Anterior 
Septum 
Inf.rior 
Lateral 
All 
R coeff 
0.86 
0.82 
0.82 
0.93 
0.83 
l! 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
Th. caFR rang.d from 0.7 to 5.3. Thu8. th. noninv •• ivaly 
.. a.ured carR with Tl-201 imaging and ad.no.ine .treBS 
correlat •• well with microsph.r.-meaaured carR over 8 
wide range of coronary flow.. and .hould b. us.ful in 
clinical .tudi •• of coronary flow re.erve impairment. 
915-90 
Comparison of TI-201 and Tc-99m· Tetrofosmin Imaging 
in Patients With Coronary Artery Disease Using 
Quantitative Circumferential Profile Analysis 
Diwakar Jain, Frans J Th Wackers, Michael McMahon, Barry L 
Zaret for the Tetrofosmin Multicenter Study Group. Yale University 
School of Medicine, New Haven. 
Tetrofosmin (TF) is a new Tc-99 labeled myocardial perfusion 
imaging (MP!) agent with biokinetics suitable for high quality clinical 
imaging, that provides results comparable to standard 11-201 imaging 
for qualitative visual detection of myocardial perfusion abnormalities. 
No data are available concerning the quantification of TF perfusion 
defects and their relationship to TI-20l defects. However, 
quantitative analysis enhances capability for detecting abnormalities 
on MPI and is essential for both clinical and investigative studies. 
Therefore, we compared standard exercise(Ex)-redistribution (RD) 
TI-201 and Ex-rest (R) TF images from 44 patients (pts) with 
coronary artery disease and abnormal images on both studies. 11-201 
and TF 3 view planar images were compared quantitatively using 
circumferential profiles derived frQm individual normal data bases for 
each agent. The defect integrals (J) (defect area below lower limit of 
normal) on E.x IIIJd RD/R images and % reversibility ( % difference 
of Exl-RD/RJ/ExJ ) of the TF and 11-201 images were compared. 11-
201 and TF studies were performed within 2 weeks of each other at 
comparable work load, heart rate and double product. Results of 
quantitative analysis are as follows: 
TI-201 TF P 
Ex Defecd 13.7±15.4 12.5±14.1 0.16 
RD/R Defect J 8.8±11.5 9.l±11.9 0.34 
% Reversibility 36.2±36.8 34.3±36.3 0.37 
Thus, MPI with 11-201 and TF provide comparable quantitative 
results with respect to the myocardial perfusion defect size and 
reversibility. These data further support the use of TF imaging for 
detection of ischemia in Pts with coronary artery disease. 
JACC February 1994:1A-484A 
915-91 
Symptom Limited A.... Exerci.. Incr..... D.tection of 
Iscb.mia During Dipyridamol. SPECT ~halliua Str ••• 
T.stiDg 
Leon Stein. Robert Burt, Bernard Oppenheim, Donald 
Schauwecker. Naomi Fineberg. Indiana University Medical 
Center. Indianapolis, IN 
Exercise combined with IV dipyridamole (Di) thallium 
(Th) stress testing in patients (Pt) with coronary 
disease (CD) increases the frequency of angina and 
ischemic (Is) ST changes in the electrocardiogram. 
Evidence for an increase in Th abnormalities (Abn) has 
been inconclusive. We examined prospectively 54 
consecutive Pt who underwent coronary angiography and 
SPECT Th with Di (0.57 mg/kg) alone and combined with 
symptom limited dynamic arm exercise (AEx). Most Pt 
presented with a history of chest pain and 49 Pt had 
angiographic evidence of Significant coronary stenosis 
(Z50%). Thallium Abn were scored blindly by consensus. 
Number (N) of segments. total and Is. and indices of 
left ventricular (LV) dysfunction such as increased lung 
uptake (LU) or Is dilation (Is Oil) were compared in the 
49 Pt with CD. Peak stress responses and Th Abn results 
were as follows: 
Nor t ;t SO Di Di + AEx p< 
Heart Rate (HR) (b/min) 81!15 107+19 0.001 
Blood Pressure (BP) (mm Hg) 123.119 141+28 0.001 
BPxHR (b/min mm Hg") 9.9;t2.2 15.1;3.9 0.001 
Angina II 22 0.01 
ST Changes > 1 mm 3 11 0.008 
N Pt With Abn Segments 42 47 0.07 
N Pt With Is Segments 30 39 0.001 
N Abn Segments/Pt 3.7;t3.5 5.4.t3.3 0.001 
N°ls Segments/Pt 1.3;!:l.5 2.5;t2.2 0.001 
Severity Score 6.4+4.5 9.9!6.6 0.001 
N Pt With LU -5 16 0.001 
N Pt With Is Oil 4 10 0.03 
Thus Pt who had AEx showed increased Th evidence of 
extent and severity of Is and more frequent indices of 
LV dysfunction such as LU and IS Oil. Conclusion: 
Symptom limited AEx increases the Is burden during DiTh 
and improves Th detection of extent and severity of Is 
in Pt with CD. 
915-92 
'False Positive' Stress Myocardial Perfusion Tomographic 
Studle. Are Significantly Reduced by Comparison to 
Physiologic Post· Stenotic Coronary Flow Re.erve, Not 
Anatomic Quantltatlv. Stenosis Severity 
D. Douglas Miller, Thomas J. Donorue, Eugene A. Caracciolo, Richard G. 
Bach, Thomas WoHord, Morton J. Kem. Saint Louis University Health 
Sciences Center, St. louis, Missouri. 
The diagnostic accuracy of stress myocardial perfusiOn Imaging has 
previously been defined In comparison to quantitative coronary 
angiographic (OCA) lesion severity. To determine H a physiologic 
measurements of stenosis severity made directly at the time of OCA would 
correlate better with myocardial perfusion Imaging than OCA percent 
diameter stenosis ('I'. DS<60, ~%), baseline and hyperemic intracoronary 
Doppler flow veloclties were measured distal to stenoses (range. 30-94 
%DS) In 59 patients (LA0a31, RCA.15, CFX .. 13) to derive coronary flOw 
reserve (CFR). CFR and OCA %DS were correlated with pharmacologic 
(n-33) or exercise (n-26) stress tomography (SPECl) reversible perfusion 
abnormalities In posl-stenotlc myocardial regions subtended by each 
Doppler-interrogated artery: 
specr defect vs 
Distal CFR (>2.0) 
OCA %DS, (>60%) 
.0001 
.820 
0.7 
02 
Distal CFR and post·stenotlc SPECT perfusion defects were better 
correlated in exercise versus pharmacologic stress studies (Kappa=0.76 vs. 
0.63). The number of post-stenotic reversible myocardial SPECT defects 
correlated with distal CFR (r.0.6; p<0.001). ·False positive· SPEcr 
studies were significantly reduced from 18134 (53%) as compared to OCA 
%08<60%, to only 6134 (180/0) when compared to distal normal CFR >2.0 
(p<o.oS). 
We conclude that the comparison of two physiologiC measures of 
coronary stenosis severity, post-stenotic CFR and myocardial SPECT, 
significantly reduces "false positive· Imaging rates aSSOCiated with usual 
comparisons to anatomic OCA percent diameter slenosis. 
JACC February 1994:1A-484A 
915·93 
Differentiation of False Positive Scintigraphy by Intracorooary 
Ultrasound and Doppler 
Raimund Ertlel, Junbo Ge, DOrr Schiimann, Hans J. Rupprecht, 
Giioter GOrge, A. Bockiscb*, K. Hahn*, Jiirgen Meyer"'. Dept. of 
cardiology, University Essen and *University Clioic Mainz, Germany 
The aim of our study was to analyze the morphology and blood 
flow in patients with normal angiograms but with suspected coronary 
artery disease using intracoronary ultrasound (lCUS) and Doppler 
(ICD) in comparison with the results to single photon emission 
computed tomography (SPECf). For ICUS, a 20 MHz side saddle 
3.5F or 4.8F catheter and for ICD a 20 MHz 3F over the wire 
catheter were used. Twenty-nine consecutive patients with chest pain 
but normal coronary angiograms were examined with ICUS, lCD, and 
SPEer. According to lCUS and lCD findings, patients were 
classified into 4 groups: presence (lIl, IV) or absence (I, IT) of 
plaques and normal (I, Ill) or abnormal (II, IV) coronary flow reserve 
(CFR). CFR was obtained by calculating the ratio of maxima1 mean 
(after intracoronary administration of 10 mg papaverin) to basal mean 
flow velocity. SPECf( +) implies a positive scan in the distribution of 
the artery examined with IVUS and Doppler. 
I(N=lO) IT(N=4) ll1(N=S) IV(N=7) 
ICUS - - + + 
ICD 5.2±1.9 2.2±0.4 4.3±0.S 2.3±0.6 
SPECf(+) 1110 3/4 7/S 717 
l..oonclUSlOn: SPECf resu ts prevlousl1 are often regarded as fj y ruse 
positive in patients with normal coronary angiograms. In reality they 
are true positive studies as coronary flow reserve was reduced and 
signs of atherosclerosis detected in a majority of patients. 
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916·79 
Effects of Dynamic Exercise and Calcium Channel Blocker on 
Alteration of Plasma Endothelin-l in Coronary Vasculature 
*Yasuto Nishinaka, Toshikazu Sobue. Mitsunori Iwase, Masahiko 
Ukai, Mitsuhiro Yokota, Hidehiko Saito, Departments of Internal 
Medicine I and Clinical Laboratory Medicine, Nagoya University 
School of Medicine, Nagoya 466, Japan, 
The aim of the present study was to evaluate the alteration of 
endothelin-l, a newly discovered potent vasoconsttictive peptide 
secreted by endothelial cells, in coronary vasculature induced by 
dynamic exercise and Ca channel blocker. Eleven patients with 
stable effort angina pectoris underwent angina-limited supine 
bicycle ergometer exercise testings, and dynamic exercise-induced 
hemodynamic alterations and plasma levels of endothelin-I 
obtained simultaneously from coronary sinus and brachial artery 
were measured at resting period and peak exercise period, 
respectively. Coronary sinus blood flows were also measured to 
evaluate the net release of endothelin-I in coronary vasculature. 
After the control exercise test, five patients received a single oral 
dose of Ca channel blocker pranidipine and then underwent the 
second exercise test for the same duration. During the control 
exercise, arteriocoronary difference of plasma endothelin-I 
increased (from 0.33 ± 0.14 to 0.56 ± 0.17 pg/ml, p < 0.05), while 
this difference was diminished after pranidipine administration 
(0.09 ± 0.16 pg/ml at resting period and 0.04 ± 0.13 pg/ml at peak 
exercise period). Furtermore, an enormous decrease in coronary 
endothelin-I release was induced by control dynamic exercise 
(from -26 ± 14 to -91 ± 27 pg/min, p < 0.01) according with a 
significant increase in coronary sinus blood flow. However, this 
decrease in coronary endothelin-l release was diminished after 
pranidipine administration (from -8 ± 13 to 4 ± 22 pg/min, NS). 
These results suggest that dynamic exercise and Ca channel blocker 
affected the secretion of plasma endothelin-l in coronary vascular 
beds and that endothelin-l is involved in the regulation of coronary 
circulation induced by dynamic exercise. 
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916·80 
Is Improvement in Exercise Chronotropic Response Late After 
Cardiac Transplantation Due to Supernormal Exercise Plasma 
Norepinephrine Levels? 
Rebecca Quigg, Domenic Sica, Peggy Roberge, JeIlDIIe Salyer, Uvia Griffith, 
and Roger Quint. Medical College of Virginia, Richmond, Virginia. 
Cardiac denervation following transplantation (Tx) results in chronotropic 
incompetence during exercise and abnormal exercise capacity. However, we 
have previously sbown that the chronotropic response improves late following 
Tx, whicb we bypothesized could be due to increased circulating norepinephrine 
(NE) levels during exercise. Therefore, we measured HR and plasma NE at rest 
(HRr &. NEr) and peak exercise (HRp &. NEp) during maximal treadmill 
exercise in 52 Tx pts who were between I mo to 7 yrs post-Tx: Gr I, < 3 mos 
(n= 17), Or 2, 3 mos-2 yrs (n= 13) and Gr 3, > 2 yrs (n=22), and compared 
these results to those of 18 similarly aged normal subjects (NI). To determine 
the relationship between NE and HR at various time. post·Tx, the change in HR 
(AHR), change in NE (AN E) and the ratio of AHRiANE during exercise Were 
calculated. nata are expressed as mean ± SEM; p<O.05, • vs Gr I, + vs Or 
2, 'vs Gr 3. 
QrJ. Qr.l QU HI 
HRr (bpm) 90±3 104±4· I02±2· SO±3+' 
HRp (bpm) 120±3 140±6· IS6±4·+ 183±3·+I 
AHR (bpm) 30±2 36±4 S4±4·+ I03±3·+I 
NEr (pgIml) 411±69 438±74 447±S7 23\±31' 
NEp (pg/ml) 2945±304 3263±496 2245±337 2722±371 
ANE (pg/ml) 2534±283 2825±463 1798±304 2491±375 
AHRIANE O.015±O.OO2 O.OI9±O.OO5 O.OSHO.OIO·+ O.066±O.OIO·+ 
These results indicate that both NEp and ANE are not elevated late post-Tx and 
therefore do not account for improved HRp. In addition, we found that HRp did 
not correlate with NEp. The ratio of AHRIANE is abnormally low in patients 
< 2 yrs post-Tx and later becomes similar to that of normally innervated 
controls. These data suggest that late post-Tx patients develop either an increase 
in sinus node responsiveness to circulating NE, andlor panial sympathetic 
reinnervation to explain their improved chronotropic response to exercise. 
916·81 
DlSCOrdanc. 8.tw .. n Mlnut. V.ntllatlon (Ve) and C02 Production 
(VC~ In Heart Failure: Not Cometed by Heart Transplantation 
Ileana L. Pilla, Noah Levy, Edwin Sinnamon, Rajash Iyer, Thomas 
Alexander, Ezra Deutsch, James A. Burke, William G. Combs, Alfred A•
Bove, Vallwan Jeevanandam. Temple University School of Medicine, 
Philadelphia, PA. 
Controversy exists whather the discordance of Va and VC~ in heart 
failure patients is reversed after orthotopic cardiac transplantation (OHn. 
Wa compared V. and VC02 in 12 patients pra and post OHT who 
underwent both right heart catheterization and cardiopulmonary exercise 
(CPX) testing within 1±O.2 month post OHT. Ten normal, age and 
weight·matched SltJjects also underwent CPX. Peak V~ in the nonnals 
was 37.66 ± 11.99 ccJkglmin; in CHF pis. pre OHT 16.1±4.04 cclkglmin 
vs 15.213.23 cclkglmin post OHT. Hemodynamics _nonraIpOEfOHT. 
~'-----------------~n 
20 
15~_...,._,.,...T""""""""""'......j 
0.4 0.6 0.8 1.2 
VC02 (lhnln) 
y = 35.02x + 5.33 
I. P,.OHT 
lID Post OHT 1 
I. Nonnals 
(Pre- vs Posl·OHT: P = NS; Normals vs Pre- and Post-OHT: p <0.05) 
Conclusion: The ventilatory abnonnalilies in CHF are not related to 
central hemodynamics, but may be related to peripheral muscle changes 
(i.e., decondilioning) which have not been aIIered immediately post-OHT. 
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916·82 
Digitalization Increases CardIac Potassium Exposure During Pbysical 
Activity 
Thomas A. Schmidt, Henning Bundgaard, Hanne L Olesen, Niels H. 
Secher, Keld Kjeldsen 
Departments of Cardiothoradc Surgery RT, Anaesthesia AN and 
Cardiology B, Rigshospitalet, University of Copenhagen, Denmark 
Skeletal muscle Na,K·ATPase plays an important role in regulating 
plasma K. and also serves as a major distribution volume for digoxin. 
The aim of the present study was to assess whether the inlubition of 
skeletal muscle Na,K-A TPase resulting from clinical digitalization 
alters extrarenal K handling in heart failure patients. While closely 
monitored 10 patients with ischemic heart disease and congestive heart 
failure (NYHA 2·3) exercised at 40% of maximum work capacity for 
8 min on a cycle ergometer before and following 2 days of complete 
digitalization. Catheters were inserted into both femoral vesse1.s and 
blood samples were drawn every 30-60 sec during exercise to allow 
measurements of plasma K. At steady state following 5 min of exercise, 
cardiac output (CO) measurements were performed by determining 
Cardiogreen dilution. To determine occupancy of skeletal n.uscle 
Na,K·A TPase with digoxin, muscle biopsies were taken and 3H-ouabain 
binding was performed before and after wash in digoxin antibody. Net 
muscle K leak was calculated as the AV difference in piaslna K 
mUltiplied by CO. Occupancy of skeletal muscle Na,K·ATPasc with 
digoxin was 10%. Following digitalization net muscle leak of K 
increased from (means :to SEM) 1.1 :to 0.2 to 2.4 :to 0.4 mmolJmin (A% 
= 118, P < 0.05). Thus, physical activity combined with digoxin 
treatment imposes an increased K exposure of the heart, which may 
be potentially arrhythmogenic. This may be of importance uuring 
cardiac rehabilitation programs which include physical conditir,ning, 
because training earlier has been found to improve extrart.oal K 
homeostasis. 
916·83 
Effect of Thermal Vasodilation on Coronary Blood Flow and 
Myocardial Metabolism. 
Chuwa Tei, Yoshifumi Toyama*, Yutaka Horikiri, Nobuyuki Tanaka, 
Yoshifumi Toyama, Shinichi Minagoe*, Kagoshima University and 
Nanpu Hospitai*, Japan 
Although we have reported that thermal vasodilation therapy improve 
the acute and chronic hemodynamics in patients with congestive heart 
failure, it has not been demonstrated the effect of thermal vasodilation 
on the heart itself. In order to clarify the effects, we analyzed 
coronary hemodynamics and myocardial metabolism during sauna 
bathing in 9 patients with idiopathic dilated cardiomyopathy, mean 
age 62 years old (33-75 years), 7 males and 2 females. After placing 
Swan-Ganz catheter in pulmonary artery and Webster multitherrnister 
catheter in coronary sinus, we measured heart rate, blood pressure, 
mean pulmonary capillary wedge pressure (mPCWP) cardiac output 
(c.o.), coronary sinus blood flow (CSF), coronary resistence (CR) and 
myocardial lactate uptake (MLU) before, during, and 30 minutes after 
sauna bath. Sauna bath was performed for 15 minutes at 60' C. The 
data are as follows: 
HR 
SystBP 
mPCWP 
(mmHg) 
CO (Jlmin) 
CSF (mllmin) 
CR 
(mmHglmJlmin) 
MV02 
(mJI100g.min) 
Rest 
79±7 
12o±19 
17±1O 
4.4±1.1 
115±23 
0.73±.{).lS 
12.6±2.4 
MLU (%) 48±15 
*p<:O.O 1 vs control 
During 
92±5* 
12o±lS 
14±7 
6.2±1.2* 
160±32* 
0.51±'{).ll * 
16.6±3.7* 
55±13* 
30 Min After 
86±14* 
117±lS 
13±8* 
5.6±1.0* 
157±27* 
0.5O±.Q.ll * 
lS.4±3.7 
59±16* 
In conclusion, thermal vasodilation by sauna bath improve coronary 
hemodynamics and myocardial metabolism in dilated cardiomyopathy 
and may account for clinical improvement in these patients. 
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916·84 
Effect of Placebo and Naloxone on Exercise Perfonnance 
Clifton R. Lacy, Sebastian T. Palmeri, John B. Kostis, Joseph 
A. Barone, Lori Acculto, Robert Burke, Jeffrey Danetz, Gregory 
Cuozzo, Antonio Madrid, Bryon Quick, Ronald Cody. UMDNJ•
Robert Wood Johnson Medical School, New Brunswick, NJ 
In this randomized, double-blind study of placebo effect on 
exercise performance, ten healthy volunteers (age 22±1.5 yrs) 
underwent maximal exercise treadmill testing (En). Each 
subject had two baseline Ens, and then four Ens preceded 
by IV injections (in random order) of naloxone 10 mg or saline 
which were identified to the volunteer as either "catheter flush 
solution" or "performanClH!nhancing medication" (control, 
control plus naloxone, placebo, and placebo plus naloxone 
stUdies). En following "performanClH!nhancing medication" 
demonstrated Significantly longer total exercise time. Naloxone 
did not shorten exercise time when administered as "catheter 
flush solution" or "performance-enhancing medication". 
pre-En Injection ETT Time 
Saline as "catheter flush solution" 997 sec 
Naloxone as "catheter flush solution" 1003 sec 
Saline as "performanClH!nhancing medication" 1 055 sec 
Naloxone as "performance-enhancing medication" 1050 sec 
(p<0.02 by AN OVA; p<0.05 by Duncan's Multiple Range Test 
for "catheter flush" vs. "performance-enhancing medication") 
Thus, placebo effect results in significantly longer exercise time 
on treadmill which is not blunted by administration of naloxone. 
Factors other than endogenous opioids may play the major role 
in mediating placebo effect on exercise performance. 
916·85 
WIut IJmIs EIaen:Be ToIInhce in ....... SIenDsis 1 
Jean F. Aupetit, Alain Cohen-Sola~ laurence Marco, Rene 
Ecochard, Marc Femnl, Bernard Ritz, Jean Boutarin. 5t-Joseph 
Hospital, Lyon, France. 
The reasons why patients (pts) with mitral stenosiS (MS) 
stop exeTCislng remain unclear. Accordingly we studied 
mUltiple exercise parameters in 4t pts with pure MS (mitral 
valve area = 0,9+ '-0,04 cm2), nonnal left ventricular and 
pulmonary function who undeIWent left and right heart 
catheterization (at rest in each case and at exercise in 16 pts) 
and maximal cardiopulmonary exercise tests (CPX). In 10 pts 
CPX were repeated two months after mitral valve (MV) 
replacement. 15 pts were in sinus rhythm (SR) and 26 in atrial 
hbriIJation (AP). 
~ : peak oxygen uptake (V02) did not correlate 
neither With rest or exerdse atrial pressures, nor With MV 
area but only conelated with exerciSe cardiac output (r = 0,64 P 
< 0,05) and pulmonary vascular resiStances (PVR) at rest (r = 
0,55 P < 0,05) and during exercise (r = 0,60 P < 0,05). 
Ventilatory threshold did not correlate With any 
hemodynamic parameter, Peak V02 was lower In pts with AF 
but correlated With chronotropiC reserve either in 5R or AF. 
Ouring exerciSe an excessive hyperventilation was observed 
which clid not correlate With any hemodynamic parameter 
and appeared to be a limiting factor (peak ventilation = 97 % 
of maximal voluntary ventilation). Two months after MV 
replacement there was no Significant change of peak V02 or 
ventilatory threshold but a Significant decrease of exercise 
hyperventilation, 
Conclusions: In pts with MS exercise tolerance appears to 
be mainly detennined by pulmonaty (PVR, breathing reserve) 
and peripheral factors as weD as exercise cardiac output. 
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917-64 
Mechanisms of Lidocaine Induced Elevation In D.fibrUlation Threshold 
Michael R. Ujhelyi, Pharm.D., Michael Schur, BS, Thomas Frede, RN, 
Majorie Gabel, Michael B. Bottorff, Pharm.D., Michael L. Markel, M.D. 
Colleges of Pharmacy and Medicine, Univ of Cincinnati, Cincinnati, Ohio. 
A reduction in ventricular conduction velocity (VCV) or action potential 
duration (APO) may explain how lidocaine (L) increases ventricular 
defibrillation threshold (OFT). Using specific probes, we studied the 
effect of VCV and APO on OFT in 39 swine (20-30 kg) who had endo•
cardial pacing and action potential catheters placed in the right ventricle. 
Pacing was used to induced sustained ventricular fibrillation (S-S s) 
which was followed by defibrillation via epicardial electrodes. A step up· 
step down method was used to calculate OFT. OFTs were obtained at 
baseline (b), treatment phase I (PI) and treatment phase II (Pill. Each pig 
was randomly assigned to receive L In = 21) 20mglkg load, 20mglkgihr 
infusion or OSW (OS) (n = IS) in PI followed by OS, hypertonic saline 
(HS) S mmollkg load, 2.0-3.0 mmollkgihr infusion to reverse slowing of 
VCV or cesium chloride (CE) 1 mmollkgihr infusion to increase APO in 
PII. Mean ± SO of OFT values (Joules) predicting SO% success are 
presented below, where column titles represent treatment received 
during PI/PII phases. 
OS/OS OS!!-!S OS/CE LIDS L!!-!S LICe 
B 9.02±4 S.7S±3 S.7S±3 9.7S±4 S.S9±3 S.2S±2 
PI 9.9S±S 9.S2±3 7.10±3 IS.7±S· 14.7±S· lS.7±3· 
PII 11.4±S 9.SS±S 4.1S±2· lS.S±7 lS.1 ±4 7.SS±3· 
(. =p<O.OS vs previous treatment phase). OFT increased from B SO-
90% and S-10% in the Land OSW groups, respectively (p<O.01). The 
OFT change from PI to PII was lower in OSW/Ce vs OS/OS and OS/HS 
(-2.9S±1.S vs 1.S±1.3 and 0.03±2.9, respectively, p=O.Ol). OFT 
change from PI to PII was lower in liCe vs L/05 and LIHS (-S.19 ± 3.S 
vs -0.lS±2.4 and 1.4±3.0, respectively, p<O.01). 
Conclusion: Cesium, possibly through K' blockade and increased 
APO, reverses lidocaine's effect on OFT, whereas the potential of HS to 
reverse Na' channel blockade and increase VCV did not alter 
lidocaine's effect on OFT. Thus, decreased repolarization time may be 
the major mechanism of lidocaine induced elevation in OFT. 
917-65 
Effects of Early '1'barIIpy With EDal.april., 1fetqIro1ol 
aDd Diqc:ad.n em IIyIxlIU:di.al Pibrosis in Dogs with 
~te BaIIrt I'ailure 
victor G. Sharov, Rani N. sabbah, Abbas S_ Ali, 
Hisashi ShlJIDyama, T. Barry IBvine, Michael Iesdl, 
Sidney GolcJstejn. Henry Ford Heart and Vascular 
Institute, Detroit, MI 
We have previously shewn that early, lcn;J-term 
therapy with enalapril (ENA), metcprolol (MEI') or 
Digoxin (DIG) prevents the pr:cgressive decline in LV 
ejection fraction (EF) in dogs with moderate heart 
failure. To determine if this beneficial effect is 
associated with reduced LV replacelnent fibrosis 
(FIB) , stu:iies were perfOI1Ded in 28 dogs in ...rum LV 
dysfunction (LV EF 30-40%) was produced I:¥ lIIlltiple 
oormary microembolizations. '1hree weeks later 
ac:hievin:J this target EF, dogs were rardanized to 3 
Dalths therapy with ENA (10 Dg BID, n=7), ME:!' (25 Dg 
BID, n=7), DIG (0.25 Dg cP, n=7) or to no therapy 
(erN!', n=7). 'lhe percent surface area cxx:upied I:¥ FIB 
was measured I:¥ pl.aniJDetry fran serial, tric:hrane 
stained, LV sections. In erN!' dogs, EF declined fran 
36±1% before to 26±1% after therapy (p<.OOl); whereas 
ENA, ME:!' and DIG preserved or iDproved LV EF _ '!he 
total volume of mic::rtJSIileres (MIC) administered and 
LV weight were similar in all 4 study groops. 
cx:m mA ME:!' DIG 
MIC Volume (ml) 11±1 10±2 10±2 13±4 
LV Weight (gm) 109±8 115±5 116±7 113±4 
LV FIB (t) 21±1 13±1* 16±2 17±2 
[*=PS0.009 relative to erN!'J 
In cxmparison to erN!', the extent of LV FIB was lower 
in dogs treated with ENA but not in dogs treated with 
ME:!' or DIG_ Unlike ME:!' or DIG, the salutary effects 
of ENA on the progression of LV dysfunction may be 
partly due to limitation of 0IYJ0in;J myocardia.l FIB. 
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917-66 
Mechanisms of Relaxations of Coronary Arteries to a Unique Chimeric 
of the Natriuretic Peptides: Vasonatrin Peptide (VNP) 
Chi-Ming Wei, Shiling Hu·, Tracy L. Stevens, Cheol H. Kim, 
Masahiko Kinoshitat, Yuzuru MatSuda~, Virginia M. Miller, and John 
C. Burnett Jr. Mayo Clinic, Rochester, MN; Res. Div. CIBA-GEIGY 
Cmp., Summit, NJ·; Shiga Univ. of Med. Sci., Ohtsu, Japant; Tokyo 
Res. Lab., Kyowa Hakim Kogyo Co., Tokyo, Japan, 
The present study was designed to compare the relaxing actions of 
vasonatrin peptide (VNP) with C-type natriuretic (CNP) and atrial 
natriuretic (ANP) peptides in isolated canine coronary arteries and to 
detennine their mechanisms of action (n=5-9). VNP, which we have 
recently synthesized (Mayo Protein Core Facility), is a chimera ·of CNP 
and ANP and caused concentration-dependent relaxation in coronary 
arteries contracted to prostaglandin F2alpha (2xI0-6M) with a maximal 
relaxation (10-6M) of 90% which was greater (p<.05) than either CNP 
or ANP which each relaxed coronary rings 60%. Relaxations to VNP, 
CNP and ANP were significantly attenuated by HS-142-1, a specifiC 
particulate guanylyl cyclase inhibitor. Relaxations to VNP, CNP and 
ANP were not altered by removal of the endothelium, L-NMMA (10-
6M), methylene blue (lO-6M), indomethacin (1o-5M) or C-ANF (10-
6M) and thus were independent of the endothelium, nitric oxide, soluble 
guanylyl cyclase, cyelo-oxygenase products and the natriuretic peptide 
clearance receptor. Relaxations to VNP, CNP and ANP were 
significantly attenuated when the vessel was contracted with KCl (40 
mM). Thus, to identify possible ionic mechanisms, membrane potential 
and K+ currents were measured in enzymatically dissociated smooth 
muscle cells from porcine coronary arteries with patch-clamp 
techniques in a whole-cell mode (n=5). VNP, CNP and ANP caused K+ 
channel activation and membrane hyperpolarization in a dose•
dependent manner with VNP being the most potenl These studies 
demonstrate for the first time that VNP is a potent coronary artery 
vasodilator. These studies also establish that VNP, CNP and ANP 
mediate relaxation of coronary arterial smooth muscle through 
activation ofreceptors associated with particulate guanylyl cyclase and 
by hyperpolarization of smooth muscle through K+ channel stimulation. 
917-67 
The Nitric Oxide Inhibitor, L-NMMA, Ahers E-C Coupling 
in the Heart 
Carmine V. Oddis, Brack G. Hattler, Geoffrey Moorer, Richard 
L. Simmons, and Mitchell S. Finkel, University of Pittsburgh 
Medical Center, Pittsburgh, Pennsylvania 
We and others have implicated pro-inflammatory cytokines and 
nitric oxide (NO) as possible mediators contributing to revers•
ible myocardial dysfunction. We have also reported an imme•
diate effect of cytokines on myocardial contractility that was 
blocked by an arginine analogue, ~-monomethyl-L-arginine, L•
NMMA (known inhibitor of NO synthesis). We now provide 
evidence for an immediate effect of L-NMMA on myocardial E•
C coupling. 
L-NMMA (l(tsM) significantly altered the negative force-fre•
quency reiationship (negative staircase effect) in isolated hamster 
papillary muscles from negative to positive (p < .01;•
ANOVA;N=6). The addition of the NO donor, sodium nitro•
prusside (l(t3M), to L-NMMA reversed the positive inotropic 
effect of L-NMMA on staircase (p < .01 ;ANOV A;N =6). 
Methylene Blue (l(tsM)(known inhibitor of cGMP) mimicked 
the effect of L-NMMA on staircase (p < .01 ;ANOVA;N =6). 
L-NMMA (lO·sM) also significantly blunted the negative ino•
tropic effect of ryanodine (known regulator of the SR calcium 
. release channel) (p < .01;ANOVA;N=6). The positive inotro•
pic effect of Bay K 8644 (sarcolemmal, L-type calcium channel 
regulator) was not affected by L-NMMA (p = NS;ANOVA;N•
=6). L-NMMA (1(t7-1(t3M) had no effect on either [3H] ryano•
dine or PH] PN200-110 binding to cardiac membranes (p = 
NS;ANOVA;N=6). These findings support a cGMP~ependent 
role for endogenous NO in myocardial E-C coupling. 
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917·68 
Effect of Low Molecular Weight Dermatan Sulfate on Blood 
Coagulation, Clot·bound Thrombin and Platelet Deposition at 
Low and High Shear Rates 
Giovanni Melandri, Franco Semprini, Vittorio Cervi, Stefano 
Boschi, Nicoletta Candiotti, Angelo Branzi, Bruno Magnani. 
Institute of Cardiology, University of Bologna, Italy 
Low molecular weight dermatan sulfate (LOS) has been shown to 
be effective in the treatment of venous thrombosis. To evaluate its 
possible role in the treatment of arterial thrombosis we compared 
different concentrations of LOS and heparin (H) as to the capacity 
to inhibit clot·bound (Cl) and fluid.phase (FT) thrombin. The 
release of fibrinopeptide A was measured in citrated plasma after 
incubation with human thrombin(0.4 nM)(FT) or plasma-derived 
fibrin cJots(Cl). At comparable APTT ratio (H:2.0+/·0.3; 
LOS:1.8+/-O.2; p=NS)the residual Fr activity was similar (11+/·2 
vs 8+/·1 %; p=NS) but the residual cr was much higher for H than 
for IDS (S2+/.S vs 22+/·3 %; p<0.00(1). Of interest, the APTT 
ratio in plasma rich in activated platelets (collagen) decreased to 
1.1+/·0.1 for H (p<O.OOOI vs baseline) but was unchanged for LOS 
(1.8+/-0.3; p=NS). Ill·In·labelled platelet deposition (POx10'/c~ 
was quantified on mild or deep arterial injury on porcine arterial 
segments. Blood anticoagulated with H or LOS was exposed for S 
min to the arterial segJDents in cylindrical (Badimon) flow chambers 
under low (212 sec .1) and high (1690 sec· I ) shear rate at 3 re. 
Results are presented below as mean (SEM): 
LOS B P 
Mild injury 
(low shear) 0.9(0.2) 2.2(2.0) 0.021 
Mild injury 
(high shear) 3.2(3.6) 4.5(4.1) 0.048 
Deep injury 
(high shear) 1.8(2.0) 13.8(3.1) 0.018 
This study shows for the first time that LOS is considerably more 
active than H against cr and in presence of activated platelets, 
particularly at high shear rate and in presence of deep arterial injury. 
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918·69 
Expression of Polymorphonuclear Leukocyte Adhesion Molecules in Human 
Myocardial Ischemia-Repetfusion : A Study in Patients Treated With PTCA 
*Teruo Inoue. Yoshihiko Sakai, Shigenori Morooka, Kan Takayanagi. Yutaka 
Takabatake. Dept. ofC31diology, Koshigaya Hospital Dokkyo University, 
Sailama. Toshiyasu Miyazaki, Otsuka Tokyo Assay Laboratories, Tokyo, Japan. 
Recently, it has been shown that cell-adhesion molecules on both neutrophils 
and capillary endothelial cells play an important role when inflammations are 
formed by neuttophil infiltration. Moreover, several experimental studies suggest 
that they are involved in myocardial reperfusion injury. The neuttophil adhesion 
molecules include LFA-I (COlla!COI8), Mac-I (COllb/C018), and p150,95 
(COl 1 c/CDl 8). The purpose of our study is to evaluate these roles in human 
myocardial ischemia-reperfusion models. Twenty patients, who underwent PTCA 
with 3 to 8 times ballon inflation, were enrolled in our study. Peripheral blood was 
sampled before PTCA and immediately, 12hrs, 24hrs, 48hrs and l44hrs after 
PTCA, and the expression ofCDIS, CO lla, CDllb and COllc on the surface of 
polymorphonuclear leukocytes wa.< ex:unined by 110w cytometty, using the 
monoclonal antibody. Extent of the expression was measured by mean 
fluorescence intenSity (MFI). The MFI increased 48hrs after PTCA in both COl8 
and CDllb, whereas it did not change in COllaand COlle, as shown below. 
before just after 12hrs 24hrs 48hrs l44hrs 
COl8 62±16 63±17 60±17 57±14 69±23*' 66±26 
CUlla 56±Y 58±1l 55±i2 55±.1l 58±17 58±16 
COllb 630±415 556±462 642±523 681 ±519 lOO2t750" 816±661 
COlle 80±49 72±40 73±39 76±32 77±37 74±52 
P< 0.01 (vs before) 
P< 0.05 (vs before) 
Our data suggest that even repeated shon term ischemia-reperfusion cycles induce 
an incroase in the expr~ssion of the neutrophil adhesion molecule, Mac-I. in 
human. Activated neuttophils by the adhesion molecules may cause endotherial 
cell injury after PTCA, and also relate to human myocardial reperfusion injury. 
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918·70 
Time Coone of Alterations in the Expr~ion of Adhesion Molecules 
on the Surface of Neutrophlls Exposed to Hydrogen Peroxide 
Aureliano Fraticelli, Carlos V. Serrano, Jr., Bruce S. Bochner, Maurizio 
C. Capogrossi. Jay L. Zweier. The Johns Hopkins Medical Institutions, 
Baltimore, MD. 
Adhesion of circulating neuttophils (PMNs) to the coronary endoIhelium 
following myocardial ischemia and reperfusion is believed to be related to 
alterations in the surface expression of PMN adhesion molecules which, in 
turn, occurs after exposure to reactive oxygen species. However, relatively 
little is known about the kinetics underlying this chemotactic role of 
reactive oxygen species. Therefore, we examined the time course of the 
alterations of surface expression of the adhesion molecules,' Mac-I 
(CDlIb/CDI8) and L-selectin. on PMNs exposed to H2~' Aliquots 
(N=4) of isolated human PMNs were incubated at 370(; in buffer with 
SmM H202 for up to 60 minutes. The effects on adhesion molecule 
expression were assessed by flow cytometric measurements of CD 18 (_), 
CDllb (e), and L-selectin (A) USing appropriate monoclonal antibodies 
foc labeling. Results are shown in the Figure below (*p SO.OS): 
=-~ 200 
'1> ISO 
~ i 100 
~ 50 
~ 
i 10 20 30 40 50 6 Minute. 
These data demonstrate that H202 Induces a time-dependent activation of 
PMNs by rapidly causing the rapid shedding of L-selectin, within the first 
minute, which is then followed by Mac-I up-regulation on the cell surface. 
918·71 
EXPRESSION OF HSP71 DURING ISCHEMIC PRECONDITIONING 
INRASSITS. 
John G. Kingma Jr., Denis Simard, ·Jacques R. Rouleau, R. 
William Currie. Laval University. Ste-Foy, Qc and Dalhousie 
University. Halifax. NS, CANADA. 
Short periods of ischemia that precondition and mediate 
cardioprotection also induce increased expression of heat shock 
genes. We tested this hypothesis in rabbit hearts subjected to 
0,1,6 or 12 cycles of 5 min ischemia (ISC) and 5 min of 
reperfusion (REP) followed by 0.2,6 or 24 h of REP. At the end of 
each experiment, hearts were extirpated and retrogradely 
perfused with Ringer's lactate via the aorta; the risk area (AR) 
was defined using Monastryl blue after re-occlusion of the 
coronary artery. Hearts were sliced into 3 transverse sections and 
frozen at -70"C. For in situ analysis, 1411 frozen sections were 
fixed in 4% paraformaldehyde and probed with an (l~FSldATP 
end-labeled 30 base oligonucleotide specific to HSP71 
transcripts. Light diffuse labeling was evident throughout control 
hearts (0 cycles of ISC-REP and 0 h REP). Increased labeling 
was evident in the AR after 1 cycle of ISC-REP followed by 2 h of 
REP; however. with 0 h REP labeling of the AR was only evident 
after 12 cycles of ISC-REP. In fact, labeling was coincident with 
the AR. After 6 or 12 cycles of ISC-REP and 2 h of REP the 
labeling intensity was further increased in the AR compared to 1 
cycle of ISC-REP. After 1,6 or 12 cycles of ISC-REP and 6 or 24 
h of REP, labeling was less, punctate, and not localized to the AR 
compared to ISC-REP hearts after 2 h of REP, 
Conclusions: Five minutes of coronary occlusion is sufficient to 
induce increased expression of HSP71 mRNA during 2 h of REP. 
Less intense labeling of the AR at 6 and 24 h of REP suggests 
that most of the mRNA for HSP71 is degraded, but the punctate 
labeling suggests the presence of focal areas of persistent 
metabolic distress. 
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918·72 
Characterization of a heart-specific and 
developmentally regulated promoter in 
transgenic mice i'Wolfgang-Michael Franz, 
iHugo A. Katus, §Gottfried Brem, 'Reinhard 
Kandolf,'Max-Planck-Institute for Biochemistry, 
Martinsried, §Institut f. Molek. Tierzucht, 
LMU, Munchen, iDept.of Cardiology,University of 
Heidelberg, D-69115 Heidelberg, Germany. 
To investigate the etiology of cardiomyopathies, 
an in vivo model for selective targeting of 
genes to the heart of transgenic mice has been 
developed. Based on in situ and slot blot 
hybridization studies of the endogenous myosin•
light-chain-2 (MLC-2) gene during cardiac deve•
lopment, the 2.1 kb promoter of the rat cardiac 
MLC-2 gene was fused to the firefly luciferase 
reporter gene and introduced into fertilized 
mouse oocytes. In four independent transgenic 
mouse lines, the expression of the MLC-2 
luciferase fusiongene was found exclusively in 
heart muscle. In contrast to the endogenous MLC-
2 gene, which is coexpressed in slow twitch 
skeletal muscle, two properties of the 2.1 kb 
MLC-2 promoter were observed: (i) cardiac-muscle 
restricted activity during the entire 
development with no coexpression in any other 
tissues and (ii) 10-fold upregulated expression 
activity during the embryonal period of 
ventricular loop and septum formation. These 
data suggest, that the 2.1 kb DNA fragment of 
the cardiac MLC-2 gene contains most, if not 
all, of the regulatory elements required for 
specific gene expression in cardiomyocytes from 
early embryogenesis. The transgenic model 
developed should provide an important system to 
elucidate the role of pathogenic gene products 
in myocardial diseases such as cardiomyopathies. 
918·73 
Microdeletion o~ Chromosome 22 is a Cause o~ isolated 
D-Trasposition o~ Great Arteries. 
Maria C.Digilio, Bruno Marino, Rita Mingarelli, Salvato•
re Melchionda, Giuseppe Novelli, Bruno Dallapiccola. 
Ospedale Bambino Gesu - ROIII8, Universita Tor Vergata -
Roona, Ospedale C.S.S. - San Giovanni Rotondo, Italy. 
It is well established that deletion o~ chromosome 22ql1 
(del22qll) is the cause o~ conotruncal anomalies in the 
setting o~ Di George (005) and Vel~ardio-Facial syndro•
mes (VCFS) and in ~ami1ial congenital heart disease. This 
deletion was detected also in isolated non syndromic cono•
truncal de~ecta including Tetralogy o~ Fallot (TF), Truncus 
Arteriosus (TA) and Interruption o~ the Aortic Arch (1M), 
but was never reported in association with Trasposi tion o~ 
Great Arteries (TGA). Moreover TGA is very rare in OOS and 
VCFS and ~ter experillelltal neural crest ablation in Chi.ck 
embryo. Ita ellbryology is supposed to be di~~erent ~rom 
other conotruncal de~ects. We analyzed the DNA ~rom 14 no~ 
syndromic pstients with TGA: 7 with D-TGA and Uitact ven•
tricular septum crVS), 5 with D-TGA and ventricular septal 
de~ect (VSD) and 2 with L-TGA. We used the IID7k probe (P.J. 
Scambler) and densitometric analysis. De122q1l was detec•
ted in 2 patienta both with D-TGA, JVS. The present resu.! 
ts, showing del22qll as the cause o~ TGA in 14. 3% o~ our 
patients, indicate that the ~requency o~ TGA related to 
hemizygosity o~ chrOll108ome 22 is siJIIilar to that current-
17 ~ound in other isolated conotruncal de~ecta as TF, TA 
and 1M. 
(Work supported in part by a grant ~rom CEE, Programme 
Genane Analyzes 3-5 Biomed 1). 
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918·74 
Aagmented Arterial Pressure Responses to CycIosporJne In Spontaneoasly 
Hypertensive Rats: InDuenl:e or Renal Family 3A Cytochrome P-450. 
Ashish K. Basu, Siddhartha S. Ghosh, Lora B. Kramer, Pramod K. 
Mohanty, Charles O. Watlington. Medical College of Virginia, Richmond, 
Virginia 
Cyclosporine (Cs) is known to cause an increase in arterial blood pressure 
(ABP) in spontaneously hypertensive rats (SHR) and in hean transplant 
recipients receiving Cs immunosuppression. However, the exact underlying 
mechanism(s) for hypertension remains unknown. We hypothesized that 
increased renal3A P-45O (corticosterone 68.Qhase activity) may contnbute 
to ABP elevation. Accordingly, we assessed the effects of administration 
of troJeandomycin (fAO), a 3A cytochrome P-450 inlubitor is SHR Cs 
(Sm!r/kg/day) ± TAO (4mg/l00g/day) was given S.c. in ll·week SHR ABP 
increased 25±3 mmHg by day 6 and this increase was reversed by TAO 
treatment Results (mean±SEM) of a 6 day protocol with simultaneous 
CsA and TAO are summarized below: 
ABP Control(9l ~ CS;j;TAO TAO(7l 
ill 
NoRx lS0±1.68 14B±1.38 lS4±2.08 153±3.15 
Rx 151±2.08 177±2.18· 139±1.52· 127±2,41' 
P <.wl) 
In these experiments Cs increased renal (60%) but decreased hepatic 
(25%) family 3A P-450 activity. These data suggest a significant role of 
renal 3A cytochrome P-450 in Cs induced ABP augmentation in SHR 
Although, exact mechanism(s) as to how Cs increases renal family 3A· 
cytochrome P-450 remains to be defined, these results add a new dimension 
to our understanding of the pathogenetic mechanisms of Cs induced 
hypertension. 
918·75 
Antiviral Effects of Human Recombinant Interferons a·2a. (J. 
and ')' in Persistently Coxsackievirus B3 Infected Human 
Myocardial Fibroblasts· a Comparative Study in Vitro 
Albert Heim, Michael Stille-Siegener, Claudia Brehm, Thomas 
Meyer, Hans R. Figulla, for the Dept. of Cardiology, University 
Gottingen, Germany 
Treatment of enterovirus myocarditis and dilated cardiomyopathy 
may require the application of antiviral agents such as interferons 
(IFNs). We studied comparatively the antiviral activity of human 
recombinant interferons a-2a (IFN'a, Roche), {3 (lPN-{3, Bio•
feron), and 'Y (lPN·,)" Bioferon) as single agents in cultured human 
myocardial fibroblasts to determine the feasibility of these IFNs for 
clinical testing. 
Seven days before starting application of IFNs, cell cultures were 
persistently infected with the enterovirus coxsackie B3 (CVB3). 
IFNs were administered to culture media at concentrations of 10, 
50, 250, and 1250 IU/mL over a period of 7 days. Virus repli•
cation was quantitatively determined by plaque assays. Antiviral 
effects of IFN sa, {3, and 'Y were observed with concentrations as 
low as 10 IU/mL and as early as day I after starting application of 
IFNs. On day 7 virus yields were reduced by 33.6% with 10 IU 
IFN-almL, 98.7% with 10 IU IFN-{3lmL, and 99.1 % with 10 IU 
IFN·'Y/mL. Antiviral effects of IFN-a, -fJ, and -'Y were signifi•
cantly concentration·dependent (p < 0.01, correlation coefficient 
of regression line). The calculated IFN concentration resulting in a 
90% reduction of virus yields (EC90) was 317 IU/mL for IFN·a. 
EC90s of IFN-fJ and IFN·'Y were both < 10 IU/mL. 
Conclusion: IFN-fJ and IFN, demonstrate a remarkably higher 
antiviral activity than IFN-a in cultured human myocardial fibro•
blasts. However, besides data on antiviral activity, additional data 
on pharmacokinetics must be considered for the selection of IFNs 
for clinical testing. For example, IFN·fJ and IFN·'Y require intra•
venous application, whereas effective concentrations in plasma are 
easily attained with subcutaneous injection of IFN-a. 
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918·76 
Myotonic Dystrophy Kinase mRNA Isoform Expression in Heart 
Mary V. Raynolds, David Friedman, Cathy S. Taft, Erik Bush, M. Benjamin 
Perryman, University of Colorado Health Sciences Center, Denver, CO 
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by 
an extremely variable clinical phenotype. The mutation responsible for 
producing DM is the expansion of an unstable triplet repeat in the 3' untranslated 
region of a gene encoding a unique protein kinase. Since some of the more 
serious consequences of DM in adults involve the heart, we examined the DM 
kinase (DMK) mRNA isoform expression in adult human myocardial tissue. The 
human gene has been cloned, and alternatively spliced mRNA isoforms have 
been detected by reverse transcription PCR (RTPCR) of RNA from several 
human tissues, including heart and skeletal muscle. Despite the detection of . 
mUltiple mRNA isoforms, only one protein isoform has heen found in human 
tissues using antisera prepared to synthetic polypeptides deduced from the cDNA 
sequence of the DM kinase. Using two different single-stranded riboprohes 
transcribed from the full-length DM kinase cDNA and designed to span all 
reported alternative splice sites, we examined DM kinase rnRNA isoform 
distribution from left ventricle, right ventricle, papillary muscle and Purkinje 
fibers of adult human hearts, as well as in human brain and skeletal muscle by 
nuclease protection assay. We detected a single mRNA isoform in all human 
heart samples as well as in skeletal muscle. We verified these results by reverse 
transcription-PCR of total RNA from left ventricle and skeletal muscle using 
PCR primers spanning previously reported alternative splice sites. We found a 
single alternatively spliced mRNA isoform in myocardium and skeletal muscle 
within the 5' untranslated region of DMK mRNA, which would not affect the 
size of the translated protein. Western blot analysis of adult human heart and 
skeletal muscle also detected a single polypeptide with an apparent molecular 
weight of 56,000. These data suggest that the primary mRNA isoform present in 
adult human heart and skeletal muscle is the full-length 3.2-kb transcript 
translating to a protein of 56,000 molecular weight. Therefore, the variability in 
clinical symptoms is not due to expression of alternate DMK mRNA isoforms or 
proteins. 
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919·123 
Identification of Cardiac Myosin.Specific T Cell 
Populations in Rats with Myosin.Induced Autoimmune 
Myocarditis. 
Chandrasekar Basu, Nichet Newton, Sheri E. Belland, Howard J. 
Eisen, University of Pennsylvania, and Temple University, 
Philadelphia, PA 
We have previously developed a model of autoimmune myocarditis 
in Lewis rats by immunization with cardiac myosin and Complete 
Freund's Adjuvant (CFA). This myocarditis is transferable to naive 
syngeneic rats with purified lymphocytes, but not antibodies. Peak 
myocardial inflammation occurs on day 21, with resolution by day 
28. To determine if cardiac myosin-specific T-cel1 populations are 
present in rats with autoimmune myocarditis and the time of peak 
activity of these populations, 9 Lewis rats underwent immunization 
with 1 mg porcine cardiac myosin in CFA on days 0 and 7. Three 
rats each were sacrificed on days 14,21, or 29 and lymphocytes 
were isolated from lymph nodes. Lymphocytes were cultured in the 
presence of Concanavlin A (Con A-positive control), ovalbumin 
(OA-negative control), media alone (background), cardiac myosin 
(CM, 25ug) or skeletal myosin (SM). Proliferation in response to 
antigens was expressed as the Stimulation Index which was the ratio 
of incorporated 3H-Thymidine in cells exposed to antigen to cells 
exposed to media alone. The results were: 
Day 14 
Day 21 
Day 29 
CM SM OA ConA 
3.0 * 0.9 ± 0.2 0.8 8.3 ± 0.5 
2.2 ± 0.2* 0.8 ± 0.2 0.9 ± 0.1 20.0±6.0 
(*p<O.OOI vs. all SM,OA and Day 29 CM) 
1.4 ± 0.0 0.9 1.0 ± 0.1 l3.6±9.0 
We conclude that T-cell populations specific for cardiac myosin are 
present in rats with myosin-induced myocarditis with peak activity 
on days 14 and 21 after immunization. Skeletal myosin fails to elicit 
significant proliferative T-cell responses at these time points. 
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919·124 
Enterovirus in Dilated Cardiomyopathic hearts: 
Molecular Evidence Using PCR and Nucleotide 
Sequencing of the Amplified Product. 
Cornell Badorff, Philip J Keeling, Stephen Jeffery, Jonathan H. 
Goldman, Alida L.P. Caforio, James C. Booth, Michael J. Davies, 
William J. McKenna. St George's Hospital Medical School, 
London, UK.. 
The polymerase chain reaction (PCR) has recently been applied to 
detect enteroviral RNA within the myocardium of patients with 
idiopathic dilated cardiomyopathy (DCM). These studies have 
provided conflicting results due to; inadequate control data, failure 
to confirm the presence of sufficient extracted RNA within the 
clinical sample and erroneous contamination of clinical samples. In 
this study we applied an established PeR technique to myocardium 
taken from 63 patients with DCM and 87 control tissues (57 patients 
with other cardiac diseases and 30 victims of sudden death within 
the community). In order to verify the presence of sufficient target 
RNA the constitutionally expressed cellular gene ~-actin was co•
amplified in each assay. Enteroviral genome was detected in 6 
(10%) patients with DCM and 15 (17%) of the controls (p=NS). 
The presence of enteroviral genome within the myocardium of 
patients with DCM was not associated with any clinical or 
histological feature or the presence of Coxsackie B virus-specific 
IgM. Within the control group enteroviral RNA was equally 
common in patients with cardiac disease and in victims of sudden 
death (3, 5% and 12, 40%, respectively; p=NS). Direct nucleotide 
sequencing of the amplified product confirmed that positive PeRs 
were not due to accidental contamination of clinical samples. 
MUltiple sequence bands were identified in 5/6 dilated 
cardiomyopathic hearts and suggested the presence of multiple 
enteroviral infection within these hearts. These results indicate that 
persistent enteroviral infection does not playa major pathogenic role 
in DCM. However the fmding of multiple sequence bands within 
PeR positive dilated cardiomyopathic hearts warrants further study. 
919·125 
Intracellular Calcium Transients in Postextrasystolic Beats - Mechanical 
Altemans Associated With Intracellular Calcium Excess 
Shoji Kojima, Shao T Wu, Joan Wikman-Coffelt, William W Parmley, 
University of calHomia San Francisco, San Francisco, CA 
Postextrasystolic potentiation (PESP) is mediated by increased intra•
cellular calcium ([Ca2+)i) transients and potentiation gradually retums to the 
control condition in an exponential manner. We evaluated 1) whether the 
maximal attainable PESP was determined by [Ca2+)i and 2) factors affecting 
the exponential contractile decay w~h a surface fluorometry technique in 
Indo-1IAM-loaded AV-blocked isolated isovolumic perfused rat hearts 
(n=6). After control beats with a 400 msec interval, 1. 2, 5, 10, 15, .20. or 25 
extrasystoles (EXs) were interposed with a 140 msec interval followed by 
30 postextrasystolic beats with a 400 msec interval. Perfusate Ca2 + 
([Ca2+)o) of 0.8, 1.5, and 3 mM were used. Left ventricular developed 
pressure (DevP) of the first postextrasystolic beat increased with an in•
crease in the number of EXs reaching the maximum (DevPmax) that was the 
same for all [Ca2+)o and was followed by a slight decline. DevPmax was ob•
tained with a smaller number of EXs with increased [Ca2+)o. On the other 
hand, the amplitude of [Ca2+)i transients (Amp) increased with an in•
creased number of EXs without reaching the plateau in all [Ca2+)o. The re•
lationship between a ratio of DevP to DevPmax (DevPlDevPmax) and a ratio 
of Amp to Amp at DevPmax (Amp/Amp-DevPmax) is plotted in the figure. 
Until DevPmax was obtained, the relationship was linear, and then it peaked 
and decreased slightly. The decay of DevP and Amp were best fit to a mo-
noexponential function. 
1 
1;\ 0.9 
~ 0.8 
., 0.7 
~ 0.6 
> 0.5 
~ 0.4 
. . 
0.301-.5-.-:.0 ...... 6-0 ...... 7-0 ...... 8-0 ...... 9-..... 1 -1.1 
Amp/Amp-DevPmax ([Ca2+Ji) 
However, the exponential de•
cay was preceded by transient 
(3-5 beats) mechanical alter•
nans with Amp/Amp-DevPmax 
> 1. 
Conclusions: 1) The maximal 
PESP was determined by re•
sponsiveness of the sarcom•
eres to [Ca2+)i. 2) Excessive 
Ca2+ release at the poslex•
trasystolic beat caused tran-
sient mechanical attemans. 
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919·126 
Sarcoplasmic: ReticaI_ c.Jci_ Ovelioad: A JoIce ........ For c.1r'IICtiIe 
Dyaluctioll .. Heart Failure 
M A Denvir, N G MacFarlane, S M Cobbe & D ] Miller. Department of Medical 
Cardiology & Instirute of Physiology, Glasgow Univezsity Scotland ,UK. 
The lDIderlying cellullar mechanisms responsible for contractile dysfunction in 
bean failure remain unclear. We have compared myofilament force production, 
Ca2+-scnsitvity and sarcoplasmic reticuImn (SR) Ca"-handling properties in a 
rabbit coronary artery ligation model (LIG, n=15) with sham operated controls 
(SH.n=12) using saponin and Triton-treated ventricular trabeculae. Hean failure 
was usessed by echocardiography and invasive measurements of venl1"icuIar 
pressures and cardiac output (CO). 
LIG anima1s had increased LVEDD compared with SH (1.76±O.21 vs 
1.46±O.13cm, mean±SD, p<O.05) and lower ejection fraction (41.9±9.5 vs 
68.3:1:3.9%, p<O.OOI). LIG animals had a lower resting CO (275.2:1:63.1 vs 
354.3:1:32.9m1/kg/min, p<0.01) and a diminished response to a standardised fluid 
challenge (21.1:1:13.2 vs 35.1:1:8.7%, p<O.OI). In isolated trabeculae maximmn 
force per unit cross sectional area (c".,.) was similar in LIG vs SH (6.22:1:3.85 vs 
7.13:1:4.30 g.wt./mm'). MyofIlament Ca"-sensitivity was not different (pCa,o 
5.52:1:0.02 vs 5.49:1:0.02). Loading the SR for a constant period of time and at a 
controlled [Ca,'] resulted in a greater tension response to application of 10mM 
caffeine (which releases Ca" from the SR) in the LIG group. e.g. 2 minute 
loading 81250nM Ca" produced 63.0:1:22.0% vs 31.5:1:17.8c".,., p<0.02. The LIG 
group tended to generate tension at shorter loading times compared with SH. e.g. 
A1150nM [Ca,'] tension responses were produced after 30secs in 71 % of LIG vs 
33% of SH, p<O.OI. This enhanced SR loading was associ8led with a gre8ler 
predispoSition to SR Ca"-overload revealed as spontaneous Ca" release (tension 
oscillations). For arbitrary loading conditions of [Ca"] and time the probability 
(X') of oscillations was over 40 times greater in LIG animals. 
These results suggest th8l increased tendency to SR calcimn overload in bean 
failure increases the probability of spontaneous calcimn release which will 
deplete the SR calcimn pool thereby reducing the calcimn available for a 
subsequent contraction. This mechanism could contribute to contractile 
dysfunction in hean failure. 
919-127 
L-Arginine Deteriorates Contractile Function In 
Repetitively Occluded - Reperfused Myocardium_ 
*Nobuyuki Morishima, Hideo Matsuura, Nobuo Shiode, 
Koichi Shinohara, Shinji Karakawa, Togo Yamagata, Goro 
Kajiyama, Hiroshima University, Hiroshima, Japan 
Although recent studies have demonstrated that infusion of 
L-arginine (L-Arg) reduces necrotic area in prolonged 
ischemia , its influence on reversible postischemic 
dysfunction (stun) is unknown. We investigated the effect of 
L-Arg on systolic function after multiple brief coronary 
occlusions (Occ). In pentobarbital anesthetized dogs, the left 
anterior descending coronary artery was occluded for 5min, 
followed by a 5min of reperfusion (Rep), repeated 4times 
with a final 60min Rep. Saline vehicle (Veh), L-Arg 
(10mglkg/min) or its antiomer D-arginine (D-Arg) was infused 
via the left atrium starting 5 min before the first Occ and 
continued throughout 5min of the final Rep. LAD flow, heart 
rate, blood pressure and other hemodynamic variables 
during Occ and throughout Rep were not different among 
the groups. Myocardial segment shortening (% baseline) 
was measured by piezoelectric crystals. 
Occl Reol 0cc4 Rep15' Rep30' RepeO' 
Veh (n=6) -45±10 71±12 -37±9 49±10 57±7 61±5 
L-Arg(n=5) -57±11 84±21 -60±13 30±10 24±9* 20±11* 
D-Arg(n=5) -53±12 86±12 -50±14 53±5 47±4 49±10 
mean ± SEM *p < 0.05 vs Veh 
L-Arg markedly worsened the recovery of %SS compared 
with Veh and D-Arg. These data indicate that increased NO 
production may have an unfavorable effect in stunned 
myocardium. 
ABSTRACTS 
919-128 
Expression of an Inducible NO Synthase in Heart Tissue from 
Patients with Inflammatory Heart Disease. 
Adam de Belder, Marek Radomski, Howard Why, Peter 
Richardson, lohn Martin, Salvador Moncada. 
263A 
Nitric Oxide (NO) is generated from L-arginine by the NO 
synthases. One is Ca2+ -dependent and constitutive, and the other is 
cytokine-inducible and Ca2+ -independent. Induction of NO synthase 
within the myocardium is likely to explain, at least in part, the 
negative inotropism associated with endotoxaemia. We have 
investigated the hypothesis that NO generation by the Ca2+•
independent enzyme may playa role in the impaired cardiac 
function seen in other inflammatory heart disorders. Using the 
citrulline assay, we have measured Ca2+-dependent and Ca2+•
independent NO synthases in myocardial tissue obtained from 
patients with similarly dilated hearts,as measured by 
echocardiography and ventriculography, but of different aetiology -
ischaemic heart disorder (llID)(n=4), aortic regurgitation 
(AR)(n=4), focal healing myocarditis (FHMx)(n=4), and dilated 
(DCM)(n=6). 
IHD AR FHMx DCM 
Ca2+ -dependent 11±2.6 14±3.5 O.5±O.2 O.9±O.6 
citrulline/mg/min 
Ca2+- O.5±O.2 1±O.25 17±3.25 16.6±3.5 
independent 
citrullinelmg/min 
These data support the concept of NO production by the inducible 
Ca2+-independent NO synthase within the myocardium of patients 
with inflammatory heart muscle disorder. 
919·129 
Improvement or Post-Ischemic Functional Recovery by Increasing 
Glycogen Content in the Isolated Working Rat Heart 
Christophe Depre, Louis Hue, University of Louvain Medical School, 
Brussels, Belgium 
The protective role of glycogen on the ischemic heart and its implication 
on functional post-ischemic recovery were investigated. Isolated working 
rat hearts were perfused during 30 min with oxygenated Krebs-Henseleit 
buffer containing 11 mM glucose as sole substrate (controls). In some 
hearts, glycogen content was increased by the addition to the perfusate of 
3.S "M insulin or S mM sodium lactate. At the end of this 30 min 
perfusion, glycogen content was 6S±4"mol glu eq./g DW (mean±SEM) 
in controls, and 9S±4 and 92±5 "mollg DW in insulin and lactate 
groups, respectively (p<O.OS vs controls). After removal of insulin or 
lactate, each heart was submitted to 10 min of global no-flow ischemia and 
reperfused during IS min with 11 mM glucose alone. During reperfusion, 
the recovery of the cardiac hydraulic power was 7S ± 3 % (mean ± SEM) 
of pre-ischemic values in controls, and 90±3% and 92±3% in insulin and 
lactate groups respectively (p<O.OS vs control). Glycogen brealcdown 
during ischemia was 3±0.3 ,.mol glu eq.lg DW per min in controls and 
lactate group, and only 0.SiO.03 "mol glu eq.lg DW per min in insulin 
group (p < O.OS vs other groups). Addition to the perfusate before ischemia 
of I"M BAY 01240 (BAY), an inhibitor of 1,6-amyloglucosidase, 
inhibited glycogen brealcdown in the 3 groups and decreased the post•
ischemic functional recovery to SO±4% and 7S±4% of pre-ischemic 
values in controls and lactate group, respectively (p < O.OS vs same groups 
without BAY), but did not affect the recovery in the insulin group 
(85±4%, P=NS vs same group without BAY). We conclude that 
increased glycogen stores effectively improve post-ischemic functional 
recovery in the isolated working rat heart but other factors are involved, 
especially when insulin is present. 
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920-130 
Predictors or Future Coronary Events in Asymptomatic Siblings of 
People with Premature Coronary Artery Disease 
Roger S. Blumenthal, Diane M. Becker, Taryn F. Moy, Lora B. 
Wilder, Lewis C. Becker, The Johns Hopkins Medical Institutions, 
Baltimore, MD 
To determine which modifiable risk factors are most predictive of 
future coronary events in a high risk population we measured blood 
pressure, lipid profile, body mass index, glucose, and determined 
smoking status in 263 asymptomatic 27 to 59 year old siblings (SmS) 
of people with documented coronary artery disease (CAD) ~59 years 
of age. SIBS were followed for a mean of 6.2±2.3 years (range 1-10). 
Of the 24 (9 %) who experienced a coronary event, 1 had sudden 
cardiac death, 11 had documented myocardial infarctions, 3 had a new 
positive exercise stress test with anginal symptoms, and 10 developed 
unstable angina with a worse or new positive exercise test. Of SIBS 
with events, 22/24 (92%) were male and 20 (83%) were 2.45 years of 
age. In men 2.45 years of age at the time of the initial screening, 19/89 
(21 %) developed a coronary event. 
Among traditional CAD risk factors including hypertension, low 
HDL cholesterol, high triglyceride levels, current cigarette smoking, 
elevated body mass index, and hyperglycemia, only LDL cholesterol 
2.160 mgldl was significantly more prevalent in those with events, 52 % 
versus 31 % (p=.05). Multiple logistic regression analysis including all 
traditional risk factors showed that only baseline age (p=.004), male 
sex (p=.Ol), and LDL cholesterol 2.160 mgldl (p=.Ol) were 
predictive of CAD events. These data demonstrate a relatively high 
incidence of future coronary events in asymptomatic male SIBS 2.45 
years of age at the time of initial screening. Aggressive treatment of 
elevated LDL cholesterol prior to a CAD event may decrease morbidity 
in this high risk group. 
920-131 
Lack of Anti-Ath.roscl.rotic Eff.ct of Fi.h Oil In Pati.nts with Coronary 
Di .... a: A Controll.d Quantitativ. Coronary Anglographic Trial 
Frank M. Sacks, Peter H. Stone, C. Michael Gibson, David I. Silverman, 
Bernard Rosner, Richard C. Pasternak, for the 'HARP Research Group, 
Brigham & Women's and Bath Israel Hospitals, Boston, MA 
Epidemiologic studies of populations with high fatty fish intake, and one 
trial of fish intake for prevention of recurrent coronary heart disease 
(CHO) support the hypothesis that fish oil is anti-atherogenic. 
Accordingly, we conducted a controlled trial in normocholesterolemic 
patients with clinical CHO confirmed by angiography. The patients were 
randomized to receive 12 glday of fish oil, containing 6g n-3 fatty acids 
(N=311. or olive oil placebo (N=28). After a mean of 28 months of 
treatment, the patients underwent repeat coronary catheterization. 
Coronary atharosclerosis was quantified by computer-assisted image 
analysis. Baseline mean age was 62.±.7 years, and plasma lipid levels 
(mg/dll were total cholesterol 191.±.34, LOL-C 121.±.28, HDL-C 41.±.10, 
and triglycerides 132.±. 70. Compliance was assessed by fat biopsy at 
the end of the trial showing significantly higher eicosapentaenoic acid 
(EPAllevels in the fish oil compared with the control group, 0.91 % vs 
0.20% of total adipose tissue fatty acids, p < 0.0001. During treatment, 
plasma triglycerides decreased by 30% in the fish oil group compared to 
the control group (p =0.007). whereas LDL-C or HDL-C did not 
significantly change. At base line, the mean minimum diameter of 
coronary arterial lesions was 1 . 64.±.0. 76mm, and mean percentage 
narrowing was 48.±.14. The mean minimum diameter decreased in both 
groups by 0.11mm (p <0.001), and percentage stenosis increased by 2-
3% (p<0.05). The 95% confidence intervals ofthe difference between 
the groups in the changes in minimum diameter or stenosis excluded 
beneficial effects of >0.14mm or >2.5%. The proportion of patients 
or lesions that showed either progression or regression of disease was 
similar in the fish oil and control groups. There were no significant 
effects on rates of total occlusion, new lesions, or clinical cardiovascular 
disease events. We conclude that fish oil does not appear to promote 
favorable changes in atherosclerotic coronary arteries in 
normocholesterolemic patients with CHD. 
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920-132 
National Survey of Sudden Adult Death 
Timothy J Bowker, John DK Burton, Nat RB Cary, Douglas 
R Chambers, Michael J Davies & David A Wood. National 
Heart & Lung Institute and 8t George's Hospital and 
Pap"'orth Hospital, London and Cambridge, England. 
To measure the occurrence & circumstances of sudden 
adult death, a random sample of 12 of the 133 Coroners 
in England was drawn. Each coroner identified a quota 
(weighted by jurisdiction population) of consecutive 
cases, using the following criteria:- Caucasian, 16 to 64 
yrs old, no history of IHD, last seen alive within 12 hrs 
of death and whose post-mortem revealed either a 
cardiac or no identifiable cause of death. 50 males (mean 
age 52.5, range 25.1 - 64.2 yrs) and 13 females (57.5; 
37.3 - 64.8 yrs) were ascertained in a median surve,' 
duration of 102 days. The median time of death was 4:25 
p.m. Death ,,'as witnessed in 59%, with 13% being 
"instantaneous". The median time from symptom onset to 
death was 30 min (range 0-210). In unwitnessed deaths, 
the median time since last being seen alive was 53 
minutes. 72% of all deaths were attended - by a relative 
in 35%, passer-by (9%), ambulance ere'" (31%), nurse 
(13%), doctor (37%), and police (11%). In 63% CPR was 
attempted. 63% had been taken ill at home, 13% at work, 
13% in a public place, and 11% elsewhere. 42% died at 
home, 2% at work, 2% in a public place, .\% in an 
ambulance and 44% reached hospital before death was 
pronounced. In 88% the certified cause of death was IHD. 
In the remainder it was hypertensive heart disease (5%), 
HOCM (3%), arrhythmia only (2%) and "cardiomegaly" 
(2%). The estimated national annual sudden death rate in 
apparently healthy adults of employment age was 1 per 
10000. In 7% coronary thrombosis &/01' myocardial damage 
was absent, in "'hom death must have been either purely 
arrhythmic or due to a sudden adult death syndrome. 
920-133 
Natural History of Early Repolarizalion on EKG: 
A Prospective Study 
Matthews K. Hurley, John Thomas, Ronald J. Visco, 
Thomas A. Peanon 
Mary Imogene Bassett Hospital, Cooperstown, NY 
MebarTy Mediral CoUeae, Nashville, TN 
The electrocardiographic (EKG) rIDding or Early RepoIarization (ER) 
(i.e., J point SoT Sepaeat elnalion of at 1east 1 DUD in two or more leads, 
taIl T waves and couaten:lockwise rotalion or preconlialleads) is thought 
to represent a DOrmal variant, commoaly found in young black males. 
However, the 101lll-term EKG natural history or ER bas DOt been 
adequately studied. We investigated the natural history or ER 1Eina EKes 
derived from the Mebarry Cohort Study, a group 0I4U healthy mediral 
school graduates from the years 1958-1%5, who bad U-Lead EKes at 
baseline and from the 1970's through the 1990's. We investigated whether 
ER found at baseline lasted throlllh the 25 years 01 foUow-up and, 
through examination or the Minnesota Codes, whether it was usociated 
with the development or EKG abDOnnalilies (left ventricular hypertrophy 
(L VH), right bundle branch block (RBBB), and left bundle branch block 
(LBBB». or the 4U baseline EKGs, 27!) bad follow-up EKes (68%) 
(mean or 25 ±. 3.6 years or roUow-up), and 23,. bad typical ER at 
baseline. or those with baseline ER, oaly24/5' (40%) bad ER nmaining, 
with lOIS!) (Ui.!)%) baving typiral ER and 14/5!) (23.7%) having an 
atypiral form of ER. RBBB and LBBB were DOt usociated with having 
baseline ER. The 25 year iacidenre or L VB in penoDS with typiral ER at 
baseline was high (31.3%) versus those with atypiral ER (20.3%) or DO ER 
(18.2%) (p = .03). These difl"er'eIICes in LVB iacideoce could DOt be 
explained by differ'ellCes in development or hypertension in these groups. 
Therefore, on long-tenD foUow-up, typiral ER disappeared in 60% and 
changed in morphology in another 23.7". Moreover, persons with typiral 
ER bave a 1.12 rold risk of the development of L VB. This rIDding 
suggests that ER, detected in youth, may identify those who are at 
iac:reased risk ror developing LVH in middle age. 
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920·134 
Circumstances Surrounding Out-or·Hospital Cardiac Arrest in the 
Maastricht Area 
Jacqueline J.M. de Vreede, Willy I. Arbouw, Lyset T. Mombarg, Anton 
P.M. Gorgels, Hein J.J. Wellens. Depanment of Cardiology, Academic 
Hospital Maastricht, Maastricht, The Netherlands. 
Although there are many reports on the outcome of out-of·hospital sudden 
cardiac arrest (SCA), little is published about circumstances surrounding 
and complaints preceding this event. 
During a period of 18 months (1 January 1991 - 30 June 1992) we 
prospectively included all cases of out-of-hospital non-traumatic SCA 
between the age of 20 and 7S in the Maastricht area (180.000 inhabitants). 
Unwitnessed death were included if patients were alive 24 hours earlier. 
Excluded were patients in whom the primary cause of SCA was not cardiac 
as shown by autopsy. Autopsy was done in 33 % of the patients. Circum•
stances at the moment ofSCA included: location of the victim and physical 
activity at the moment of SCA and complaints within 24 hours before the 
event. Information was collected by interviewing the patients family. 
Results: A total of 129 cases were included (101 men (78%),28 women 
(22%), mean age 61.4 ± 10.4 years, of whom 78 (60.5%) had a clinical 
cardiac history. Family of 941129 (73%) patients could be interviewed. 
~: at home 67/94 (71 %), on the street 14/94 (15%), public places 
10/94 (11 %), waiting room of the general practitioner 2/94 (2 %), at work 
1/94 (1 %). 
Physical activity: lying/sitting/sleeping 57/94 (61 %), walking/standing 
25/94 (27%), working 7/94 (7%), on the toilet 3/94 (3%), sporting 2/94 
(2%). 
Complaints within 24 hours before SCA were present in 74/94 (79%) 
patients: chestpain 21n4 (28%), nausea 19n4 (26%), dyspnea 15n4 
(20%), dizziness 7n4 (9%), pain between shoulders 6n4 (8%), pain in 
arms 4n4 (5%), atypical complaints 17n4 (23%). 
Conclusion: SCA most frequently occurs at home while in rest and is 
frequently preceded by complaints within 24 hours. This suggests that SCA 
might not be as sudden as generally accepted. 
920·135 
Is the Decline in Coronary Heart Disease Mortality Due to 
Decreased Incidence? A Study of Atherosclerosis Among Patients 
with Valvular Heart Disease 
*Maurice E. Sarano, Kirk N. Garratt, Steven J. Jacobsen, Mayo 
Clinic, Rochester, MN 
The decline in coronary heart disease mortality through the 1980s has 
been well documented. Because coronary angiography is not 
routinely performed in the absence of symptoms, however, it is not 
certain that it is due to a decrease in coronary atherosclerosis. To 
address this issue, the extent of coronary disease was determined by 
angiography in 383 patients with isolated, severe mitral regurgitation 
of organic etiology (confmned by surgery) between 1980-89. The 
percentage of patients with at least one coronary artery stenosed, with 
multivessel stenoses, and the mean obstruction per coronary artery 
d I sel(IIlent demonstrate no secu ar trend: 
80-81 82-83 184-85 86-87 88-89 p.tor 
n=51 n=61 n=72 n=9S n=I04 Trend 
% WIth CAD 143 13!! 38 42 37 1 u.:li 
% with 133 19 23 124 26 0.b9 
Multivessel 
Mean 14 9 13 12 13 0.86 
Obstruction (%) 
% Male 1 b9 57 100 61 b9 0.81 
Mean Age Ib6 64 168 166 65 0."/2 
Further, there was no significant trend in prevalence of coronary 
atherosclerotic lesions when restricted to males or patients in 
functional class m-IV. We conclude that 1) In this population of 
organic valvular disease there was no trend for decrease in coronary 
atherosclerosis and 2) If generalizable, these data suggest that the 
decline of coronary mortality during this time period in the general 
population was not due to secular changes in the occurrence or 
severity of coronary atherosclerotic lesions. 
ABSTRACTS 
920·136 
CIInkalandAngiographicvariablesAlIec:liDiProgreMlon ofCoroJwy 
Artery l>iaede DetermJned by Quantitative ADgiognphy 
AbralwnJoseph, J. DavId TaIley, Andrew Shih, Tracy Crum, Robert Vogel, 
Joel Kupersmitb, CarcIiovascu1ar DlvIslon, University of louisville, 
LoulsvIJle, KY 
To assess the .ignJftcance of c:IlnlcaJ and aogIograpblc w.rIables 
associated with progression of coronary artery disease (CAD), serial 
aogIograms on 74 patients (age 59 :t 8 yn) ~ ana1yzed by computer 
assuted quantitative aogIograpby UIlng visual ed8c detection. 99 dlaeased 
segments ~ analyzed Cor progression (absolute reduction of 20% in 
lumlnal cross-sectional area). The mean dU1':ldon between aogIograms 
was 31 :!: 2S months. A prdlmlnary correlation codIIclent was calculated 
for each of the clinical and anglOgrapblc variables to detect any aasodatlon 
with progression, and the odds ratio determined. 
The presence of any c:IlnlcaJ dak &ctor (dlabetes, hypertension, serum 
cholesterol, cIgaretIc smoking, and fiunIly history of CAD) did not predict 
progression. The use of bet!. blacken was 3 times leu likely to be 
associated with progression (odds ratio 0.33). The presence of distal 
disease was associated WIth progression of a more pradmalleslon (odds 
ratio 2.4). Eccentricity, branch point location, lesion length, calclftcu:lon, 
thrombus, or the presence of collateraIs did not Influence progression in 
an lndMdual segment. 
Conclusions: 1) The presence of cl2sslcal clinical risk mctors did not 
predict progression of CAD as determined by ICtIal quantitative 
angiography. 2) The use of bet!. blockers and the absence of cocdstent 
distal disease was assodated WIth less progression in an indMdual 
cororwy segment. This may be related to changes in W2ll stress which 
alter the integrity and permeability of the vascular endothelium to lipids. 
920·137 
265A 
Prevalence or Syndrome X Amongst 189 Consecutive Patients with 
Angina and Normal CoroIUll')' Arteries 
Giuseppe M.C. Rosano, Philip A. Poole-Wilson, Peter Collins, ·Juan 
Carlos Kaslci. ·St George's Hospital Medical School, National Heart & 
Lung Institute, London, UK 
Nearly 20% of patients (pts) who undergo cardiac catheterisation for 
investigation of chest pain are found to have angiographically normal 
coronary arteries (ANCA). However, available data refer to selected 
populations and selection bias may therefore occur. We assessed the 
prevalence of syndrome X (SX) pts amongst 189 consecutive pts with 
anginal chest pain who underwent cardiac catbeterisation in our laboratory 
and were found to have ANCA. SX was defined as angina pectoris, 
positive exercise test and normal coronary arteriograms. Amongst the 189 
pts, 42 had negative exercise tests, 9 had abnormal resting ECGs that 
would mislead the evaluation of the exercise tests, 47 were hypertensive, 
37 had valvar heart disease or cardiomyopathy (2 pts), 9 were unable to 
exercise and 17 refused to undergo further examinations. Twenty-six 
(14 %) pts met the criteria for SX and subsequently underwent extensive 
clinical characterisation. Two of the 26 pts were found to have coronary 
artery spasm. A diagnosis of SX was therefore made in the remaining 24 
pts (16 women, 8 men, mean age 54±4). All SX pts showed ST 
depression (> 1.5 mm) on the exercise electrocardiogram and had a normal 
echocardiogram. Possible transient myocardial ischemia was documented 
objectively by means of Thallium scintigraphy in 4 Pts' Episodes of ST 
segment depression >0.1 mV on the 24 hour ambulatory 
electrocardiogram were detected in 16 pts (66%). 
In conclusion, although a sizeable proportion ofpts with anginal symptoms 
have ANCA, those with true SX represent only a minority. Amongst these 
pts only few show evidence of myocardial ischemia. 
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921·104 
Predicting the Effects of Therapy in Cardiovascular Disease 
Shapur Naimi, William J. Long, M. G. Criscitiello. M.I.T. Lab for 
Computer Science, Cambridge, MA and Tufts-New England Medical 
Center, Boston, MA 
To assist the physician in the diagnosis and management of pa•
tients with heart failure, we have developed a model to predict the 
effect of cardiovascular therapies given the pathophysiologic state of 
the patient. It consists of 40 equations describing the relationships be•
tween the various parameters of the cardiovascular system. Some of 
these reflect well-understood principles of physiology, ie the flow, pres•
sure, and resistance relationship. Others are simplifications of complex 
partially-understood mechanisms such as those involving sympathetic 
response to blood pressure changes. The equations are used to look at 
the changes between steady-states of the model before and after ther•
apy. The solution is achieved using an approach based on signal-How 
analysis. To handle the non-linearity of the model, iteration is used to 
approach the solution. The method highlights pathways through the 
model having the largest influence on the solution and shows parame•
ters with the greatest contribution to the predicted response. 
To test this model, we used data from five published papers in 
which patients with specific diseases showed changes in hemodynamic 
variables in response to pharmacologic therapy or exercise. These in•
cluded mitral stenosis (MS) with exercise and plOpranolol, MS with ex•
ercise and nitroglycerin, aortic stenosis (AS) with exercise, AS with hy•
dralazine, and aortic insufficiency with exercise and hydralazine. When 
the hemodynamic data are fairly complete, the initial values of the 
model parameters can be computed or estimated and the model can 
simulate the patient. Initially, estimates of direct effects were deter•
mined for the interventions the patients experienced. Then the pre•
dicted effects were computed. The model proved sufficient to account 
for the average behavior reported in each of the five papers studied. 
With a few minor exceptions, the predictions were within the errors of 
the mean reported for all of the modeled parameters. 
921·105 
Optimalization of Criteria to Differentiate VT from SVT in 
Wide·QRS Tachycardia using Neural Network Techniques. 
Willem R. Dassen. Rob G. Mulleneers. Karel den Dulk. Jan Tal•
mon, Dept. of Card .• Univ. of Limburg. Maastricht. Netherlands. 
Recently. criteria were proposed in the literature to make the 
diagnosis VT or SVT based on a sequential analysis of: the 
maximal RS interval (RS-Intl. the presence of AV dissociation 
(AV-Oisl. and morphology criteria for leads V1 (Mor·V11 and V6 
(Mor-V61. In these criteria a measured RS-Int greater than 100 
ms was considered diagnostic for VT irrespective of AV-Dis. 
Mor-V1 and Mor-V6. USing 120 ECGs originally used to evalua•
te these criteria. and exactly the same 4 input variables an 
artificial neural network was trained and a non-linear represen•
tation obtained. Subsequently for all 8 different combinations of 
AV-Ois. Mor-V1 and Mor-V6 the RS-Int was varied and the 
diagnosis VT/SVT was calculated. depending on the requested 
sensitivity and specificity. Based on these findings the previous•
ly suggested universal borderline of 100 ms for RS-Int. conside•
red diagnostic for VT in all situations could be adjusted slightly 
depending on MorN1 and Mor-V6. In tachycardias without AV•
Dis and with a negative Mor-V1. the minimal RS-Int for VT 
could be shortened slightly to 95ms. In cases with a negative 
AV-Dis and Mor-V6 and a positive Mor-V1 the minimal RS-Int 
could be shortened to 79 ms. After this refinement original and 
adjusted criteria were compared. using an other independent 
test set of 120 ECGs. The number of VTs misdiagnosed after 
adjustment was reduced from 9 to 4. Due to the high percenta•
ge of already correctly diagnosed tachycardias using the old 
criteria the number of test ECGs was not large enough to obtain 
statistically significant differences, but the results strongly 
suggest. that further optimalization of criteria is possible. 
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921·106 
Computer·Based Classification from Left Ventricular 
Early Filling Patterns in Color M·mode Doppler Images 
of Normals and Coronary Artery Disease 
Marie Stugaard, Arvid Lundervold, Medical Department B, 
Rikshospitalet and Norwegian Computing Center, Oslo, Norway 
Patient selection and image acquisition. We recorded color M•
mode Doppler images (CFM 700, Vingmed Sound, Horten, 
Norway) of the left ventricular inflow in two groups; NOR: 9 healthy 
volunteers without clinical and echocardiograpbical signs of cardiac 
disease or hypertension, CAD: 9 patients with angiograpbica1ly 
verified coronary artery disease with regional wall motion 
abnonnality and ejection fraction less than 50%. Color M-mode 
Doppler data comprising 46 early filling phases (E-phases) in NOR 
and 44 E-phases in CAD were transferred to a Unix workstation for 
off-line image analysis. 
E-phase segmentation was perfonned manually after median 
filtering and percentile thresholding of flow data such that the inter•
and intra- observer variation of this step was negligible. Feature 
extraction was performed automatically by superimposing a 4 x 3 
grid on the segmented E-phase, deriving 3 nonnalized grid features 
to represent each E-phase recording. Pattern classification was 
perfonned by the non-parametric k -nearest-neighbour rule (k = 5) 
and a majority voting among the classified E-phases from each 
individual. Classifier evaluation was done by the leaving-one-out 
validation method. The resulting sample confusion matrix is given 
below (single E-phase classification results in brackets) together with 
empirical sensitivity and specificity. 
Group Predicted NOR Predjcted CAP Classifier perjor1T1!lnce 
True NOR 8 (40) 1 (6) Sensitivity: 77.8% (72.2%) 
True CAD 2 ()2) 7 (32) Specificity- 88 9% (87 0%) 
We conclude the possibility to quantitatively discriminate between 
nonnals and CAD patients from left ventricular filling patterns in 
color M-mode Doppler recordings using image analysis and pattern 
recognition techniques with minor user interaction. 
921·107 
Computer Package for Numerical Processing of Loreatz Plots 01 RR mte",als. 
Katerina Hnatkova, Anne Staunton, A. John Carom, Marek Malik, St. George's 
Hospital Medical School, London, United Kingdom. 
The so-called Lorentz plots are scatter diagrams showing the RR interval as a 
function of the preceding RR intervals. Repeatedly, it has been proposed that these 
plots might be used for visua\ising the variability of heart rate and that the 
assessment of heart rate variability (HRV) from these plots might be superior to 
conventional measures of HRV. However, a precise numerical evaluation of the 
images of Lorentz plots has never been suggested. 
In order to classify the images of Lorentz plots, we developed a computer 
package that measures their density. For each rectangular area of the plot, the 
relative number of RI1R2 samples in that area is established and a function is 
created which assigns the maximum relative number of samples (i.e. the maximum 
density) to each size of an area of the plot. The plots which are very compact result 
in a sharply falling density function whilst plots which are more diffuse lead to a 
flat density function. The distinction between such density functions is expressed by 
a lOgarithmic integral of the density function in order to express the 'compactness' 
of the plot numerically. As the computational demands of this approach are 
intensive, the package also includes an approximate method which restricts the 
measurement of the density to the areas of the plot including the maximum number 
of points at the same location. The results of this approximate method are strongly 
correlating with the results of the full method (r > 0.99) and the measurement of 
one plot with the approximate method requires, on average, less than 2 minutes. 
The approximate method has been applied to a set of 24-hour Holter records 
obtained from 637 survivors of acute myocardial infarction. For each record, the 
SPNN and SDANN values were also calculated as conventional measures of HRV. 
Both the density of the Lorentz plots and the conventional measures of HR V were 
used to investigate the differences among 48 patients who suffered an arrbythmic 
event (sudden death or sustained symptomatic ventricular tachycardia) during a 
follow-up of 2 years, and the remaining 589 patients without arrhythmic post 
infarction complications. At sensitivity of 30%, the Lorentz plot density 
distinguished the patients with events with a positive predictive accuracy (PPA) of 
580/0, while the SPNN and SPANN lead to PPA of only 23% and 180/0, 
respectively. 
Thus the package provides a detailed analysis of Lorentz plots which is feasible 
and potentially more clinically useful than the conventional measures ofHRV. 
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921·108 
Comparison of COhen-C1ass Time-Frequency 
Distributions of Intracardiac aeart Sounds in Man 
Joe M. Moody, Bernard J. Rubal, Theodore E. Posch, 
and James R. Bulgrin. Brooke Army Medical Center, 
Fort Sam Houston, TX and Hughes Aircraft Corp., 
Fullerton, CA 
During the past thirty years there have been 
few advances in the development of automated 
auscultation devices, in part due to the inability 
of conventional (Fourier based) spectral analysis 
techniques to adequately describe the 
multicomponent and nonstationary characteristics 
of phonocardiograms. This study examines the 
time-varying nature of high-fidelity intracardiac 
phonocardiograms (ICP) using Cohen-class time•
frequency distributions (TFDs). rcps were 
obtained at rest, exercise and during physiologic 
maneuvers in 6 patients (age ~ 44±11 yrs) using 
catheter-mounted piezoelectric transducers. rcps 
were bandpass filtered (50-500 Hz) and digitized 
at 4 KHz. The Cohen-class distributions employed 
in this study included: the binomial, Zhao-Atlas•
Marks and minimum cross-entropy distributions. 
Results were compared with the time-frequency 
distributions from the short-time Fourier 
transform. All Cohen class distributions provided 
improved temporal and spectral resolution. These 
findings suggest that recently developed TFDs may 
prove useful in the design of automated 
auscultation systems. 
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760·1 4:00 
Efficacy and Safety of Extended Release Nisoldipine as 
Monotherapy for Chronic Stable Angina Pectoris 
* S. Glasser,*S. Ripa,*E.P. Mac Car thy for the 
Nisoldipine CC Multicenter Study Group 
The effectiveness and safety of mono therapy with an 
extended release calcium antagonist (Nisoldipine Coat•
Core-NIS ee) was studied in 312 patients (PTS) with 
chronic stable angina pectoris. A parallel, randomized, 
2 week double-blind, placebo (P) controlled dose ranging 
(20, 40, 60mg qd) study used modified Bruce exercise 
test (ETr) total exercise time (rET) as the primary 
efficacy variable. For qualification, PTS demonstrated 
ETT reproducibility and a positive ST segment response 
with angina (occurring within 3-7 minutes), or had other 
evidence of coronary artery disease. All treatment 
groups were similar at baseline. 
Two hundred eighty-four patients were valid for analysis 
of "efficacy. NIS ee increased mean TET significantly at 
both peak and trough and there was little difference in 
the placebo-subtracted mean trough TET responses for the 
20mg and 60mg dose groups (34 sec. and 37 sec., 
respectively). NIS CC also produced similar 
improvements in time to onset of angina and time to Imm 
ST segment depression. No clear dose response was 
observed for the 3 main efficacy parameters. NIS ec was 
well tolerated and there were no withdrawals due to 
adverse events in the 20mg dose group. Headache and 
peripheral edema, the most common adverse events, were 
dose related. Angina pectoris occurred as an adverse 
event in 1.3% of P and 4.7% of all NIS ee PTS (3.8% in 
the NIS ce 20mg group). 
In summary, NIS ee (2Omg) is a safe and effective once 
daily dihydropyridine calcium antagonist for PTS with 
chronic stable angina pectoris and one of few such 
agents in its class to prove effective as monotherapy. 
ABSTRACTS 267A 
760.2 4:15 
Evaluation of AntianginaI and Anti·ischemic Efficacy of Nicorandil: Results 
of a Multicenter Study 
"Udbo Thadani. William Strauss, Stephen P. Glasser, William Frishman, Andrew 
J. Burger, Paula K. Locker, J. Scott Mohrland, for the Nicorandil Study Group, 
Oklahoma City, OK 
Nicorandil (NIC) is. nitro vasodilator with potassium channel agonist activity. 
Unlike nitrates, however, long-term use of mc is not associated with 
development of pharmacologic tolerance and therapy with 10 to 20 mg mc twice 
a dsy has been claimed to be efficacious. We evaluated the antianginal and anti•
ischemic efficacy of mc monotherapy in 83 patients with reproducible exercise 
(EX) induced angiDs on the treadmill. After 1 weelc of single-blind placebo 
therapy patients were randomly assigned to either mc 10 mg or double-blind 
placebo (DBPL) B.l.D. groups. After 1 weelc the dose of the medications was 
doubled (NIC 20 mg B.l.D. or DBPL B.l.D.) and one weelc later symptom 
limited exercise tests were repeated before and I, 4, and 8 houn after the 
morning dose of the medications. Changes in EX variables in seconds (S) from 
baseline values after 2 weeks of double-blind therapy were: 
Total EX time (S) Time to Imm sn (S) 
DBPL NIC DBPL mc 
Pre-Dose 39 42 33 20 
IH Post-Dose 57 59 35 41 
4H Post-Dose 54 43 34 30 
8H Post-Dose 38 46 24 20 
Angina attack rate doring dsily activities was similar during DBPL and mc 
therapy. Thus, compared to double-blind placebo, NIC therapy neither improved 
exercise performance nor increased time to ischemia in patients with stable angina 
pectoris. Ths study fails to demonstrate previously claimed efficacy of mc as 
monotherapy in angiDs pectoris. 
760·3 4:30 
Effect of Metoprolol During TWo Years After 
Coronary Artery Bypass Grafting on Cardiac 
Events 
Johan Herlitz, Division of Cardiology, 
Sahlgrenska Hospital, Goteborg, Sweden 
Purpose: To evaluate whether long-term treat•
ment with metoprolol after coronary artery by•
pass grafting (CABG) might favourably affect 
the outcome. 
Methods: All patients in western Sweden in whom 
CABG was performed between June 1988 and June 
1991 were evaluated for inclusion during the 
first week after CABG. Major exclusion criteria 
were age >75 years, simultaneous valve surgery, 
traditional contraindications to betablockers 
and unwillingness to participate. Patients were 
randomized to metoprolol/placebo 100 mg daily 
for two weeks and thereafter 200 mg daily for 
two years. 
Results: In total 2,365 patients were operated 
of which 967 were randomzed to either metoprol-
01 (n=4BO) or placebo (n=4B7). Of all patients 
randomized to metoprolol 31% withdrew blind 
treatment prematurely vs 42% for placebo. Pri•
mary end-pOints, defined as any of the follow•
ing: death, non-fatal myocardial infarction, 
unstable angina pectoriS, requirement of CABG 
or PTCA, were reached by 44 patients in the me•
toprolol group (9.2%), as compared with 36 pa•
tients in the placebo group (7.4%) (p=0.30). 
Conclusion: Prophylactic treatment with meto•
prolol during two years after CABG did not 
reduce the development of ischemiC events 
"defined as death, development of non-fatal 
myocardial infarction or unstable angina 
pectoris or requirement of CABG or PTCA". 
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760·4 4:45 
Is Modulation of Myocardial Metabolism as Effective as ~·Blockade in 
Exercise-Induced Angina ? 
Michel F. Rousseau, Frans G. Visser, Jeroen J. Bax, Marl< I.M. Noble, Simon 
Dubrey, Giuseppe Cocco, WiJlem H. Pasteuning, Gordon Williams, Paul Dodds, 
Hubert Pouleur, for the Ranolazine Study Group, University of Louvain, 
Brussels, Belgium, Free University Amsterdam, Amsterdam, The Netherlands 
and University of London, London, United Kingdom 
In·vitro and in·vivo, ranoJazine (RAN) has no direct bemodynamic effects but 
exhibits anti·ischemic properties and shifts myocardial substrate utilization from 
fatty acids to glucose (action on the pyruvate dehydrogenase complex 1). To test 
the clinical relevance of this metabolic modulation, 158 pts with angina pectoris 
(AP) and ~ 0.1 mV ST depression (Sn) during exercise were enrolled in a 
double·blind, cross-ever study comparing atenolol (ATE, 100 mg o.d.), RAN 
(400 mg t.i.d.) and placebo (PLA). "p<0.05;"" p<O.OOI VB PLA. 
PLA ATE RAN ATEvs 
RAN 
Exercise 405 ± 6 418 ± 6 440 ± 6"" p= 0.003 
duration (s) 
Time to AP(s) 347 ± 7 384 ± 7"" 398 ± 7"" p= 0.11 
Time to STI 322 ± 8 374 ± 8"" 376 ± S"" p= 0.84 
Max PRP 24378 ± 346 17544 ± 349"" 25196 ± 350" p= 0.04 
mmHg.bpm 
After I week of therapy, both drugs significantly improVed the times to AP and 
to ST I and similarly reduced the incidence of anginal attacks. However, RAN 
also increased exercise duration and the maximal pressure rate product (PRP) 
whereas ATE decreased PRP as expected and only had slight effects on exercise 
duration. Further, RAN decreased the integrated ST I despite an increase in 
exercice duration, confirming the reduction in ischemic burden over the whole 
period of exercise. Thus, a clinical improvement in exercise·induced ischemia 
at least as large as with a (j·blocker can be obtained by modulating myocardial 
metabolism. 
760·5 5:00 
Randomized Trial of Surgery, Angloplnty or Medical 
Therapy for Single Vessel Proximal Left Anterior 
Descending Artery Stenosis. Results of Long 
Term Follow-up 
Whady A. Hueb, Siguemituzo Ari~, S~rgio Almeida Oliveira, 
Giovanni Bellotti, Adib Jatene, FOMe Pileggi. Heart Institute•
University of sao Paulo-Brazil 
We compared the effects of angioplasty (PTCA) 
with those of mammary bypass (IMA) and medical therapy (MT) 
in 154 patients with single vessel severe stenosis (>80%) of the 
left anterior descending artery. At baseline all patients had: 
stable angina, absence of previous myocardial infarction and 
normal ejection fraction. The optimum drug regimen included: 
beta-blOCkers, aspirin and calcium channel blockers. Alter two 
years follaw-up, the main end points were: myocardial infarction 
(MI) status of angina, treatment failure (TF) sudden death (SO) 
or progression of coronary atherosclerosis through of second 
catheterization. 
Cross-Over Progression 
N2 AF* TF MI SO PTCA IMA 2VO % 3VO % 
PTCA 52 38 14 5 1 8 37 13 
MT 52 18 6 2 2 2 30 10 
IMA 50 48 1 1 15 17 
-Angina free, 2VO = double vessel disease, 3VO = triple vessel 
disease 
There was a 32% incidence of angiographically significant 
restenosis in the PTCA group. 
Conclusion: The best results after two years of follaw-up were 
obtained with IMA. In this series, PTCA was only superior to 
medical therapy in relation to the status of angina. On the other 
hand, progression of coronary atherosclerosis occurred in the 
three groups of patients studied. 
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760·6 5:15 
!!,urgery Versus ,!.ngioplasty for Proxiaal !teft 
,!.nterior ~escending(LAD) Coronary Artery 
Stenosis (SALAD). A prospective Randoaized 
Trial. 
Jean.J. Goy, E. Eeckhout, P. Vogt, Jean C. Stauffer, M. 
Hurn1, P. Ruchat, F. Stumpe, H. Sadeghi, L. 
Ka~penberger. university Hospital, Lausanne, 
SW1tzerland. 
At present, we are conducting a prospective randomized 
study comparing surgery (S) (implantation of the left 
internal mammary artery) and angioplasty (A) in 
patients (ptS) with normal left ventricular function 
and isolated proximal or mid LAD stenosis. We are 
presenting the interim results of the first 100 pts. 
Fifty-two pts were randomized to A and 48 to S. Risk 
factors and demographic data were similar for the 2 
groups. S was performed in 46 pts, 1 pt had a 
myocardial infarction (MI) before the intervention. S 
was successful in 45 pts (98%) (1 pt had a small 
perioperative MI). A was technically feasible in all 
pts but acute closure occured in 4 pts (1 case during A 
for a restenotic lesion). Closure was treated by 
emergency S in 3 pts and stenting in 1. Except for the 
pts suffering from restenosis in the A-group, there was 
no difference in performance status at stress test and 
angina functional class at 6 months, 1 and 2 years, 
dur1ng a mean follow-up period of 26 months. 
Reangiography and reintervention were significantly 
more frequent in the A group (23 versus 4) and mainly 
due to restenosis noted in 16 pts (31%). Three pts died 
during follow-up (2 in the A group and 1 in the S 
group) with only 1 death from cardiac origin. MI 
occured in 6 pts during follow-up (4 in the A group and 
2 in the S group). Cross over from A to S for a first 
or second restenosis was 7 and from S to A was 2. 
It is concluded that equally revascularization can be 
achieved with A and S in pts with proximal LAD stenosis 
provided reintervention is accepted as part of the A 
treatment. 
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Early Administration of EnaJapril Improves Short and Long Term 
Left Ventricular Function in Patients not Reperfused After 
Thrombolysis 
"Giuseppe M.C. Rosano, Francesco Romeo, "Eugenio Martuscelli, Cesare 
Bianco, Michele Comito, Michele Miceli, Francesco Miceli, Biagio 
Milano, Nicola Cardona, Corrado Colistra, Vito Rosano. Dept of 
Cardiology Vibo Valentia Hospital "GJazzolino", ""University of Catania, 
·University of Roma. Italy 
Early administration of ACE·inhibitors improves left ventricular function 
in pts with acute myocardial infarction not reperfused after thrombolysis. 
To evaluate whether the long term effect of ACE-inhibitors is influenced by 
the timing of initiation of therapy 89 pts who were previously randomly 
assigned to treatment with Enalapril (group A: 46 pts) or placebo (group B: 
43 pts) soon after thrombolysis were started on chronic Ena1april therapy 
(10 mg) at discharge. All pts received similar antianginal therapy and were 
followed at 3 month intervals in order to assess the clinical status and the 
LV function. Two pts of group A and 8 pts of group B underwent coronary 
artery surgery early after hospitalization. At discharge the mean fractional 
shortening was 0.29±0.03 in group A pts and 0.2I±O.04 in group B pts, 
p<O.OOI. Group A pts bad a significantly better regional wall motion 
compared with group B pts. At one year follow up all discharged patients 
were alive, regional and global left ventricular function were more impaired 
in group B, the mean shortening fraction improved in group A 0.32:1:0.03 
while remained unchanged in group B O.20±0.06. In group A pts a 
significant improvement in regional and global LV function was observed. 
In conclusion: ACE-inhibitor therapy improves short and long term left 
ventricular function in pts with myocardial infarction not reperfused after 
thrombolysis. The beneficial effect of chronic ACE-inhibitor therapy in 
these pts is improved by an early initiation of the treatment. 
JACC February 1994:1A-484A 
761·2 4:15 
Effeds of Enalapril on Mitral Flow Profile After Myocardial 
Infarction 
Kenneth Caidahl, Vernon V.s. Bonarjee, Dennis W.T. Nilsen, Steen 
Carstensen, Jens Bemlng, Anneli Ambring, Kaj Lindvall, Ronny Wikh, 
Magnus Edner, for the CONSENSUS II Multi·Echo Trial, Hospitals of 
Gothenburg and Stockholm, Sweden, Stavanger, Norway, and Hillered 
and Copenhagen, Denmark 
To determine the effects of enalaprll (E) on diastolic LV function 
after AMI, we investigated 411 patients randomized within the double 
blind placebo (P) controlled multicenter trial CONSENSUS II. Doppler•
Echocardiography was performed, 2-5 days, 1 month and 6 months after 
an AMI, irrespective of infarct type and ejection fraction. Digital frames 
of pulsed wave mitral Doppler (PWMD) curves were acquired from 
video recordings and the flow profiles were traced by one investigator 
blinded to treatment group. 
Heart rate decreased from 68 to 61 bpm (p<O.OOOI) in both E and P 
groups during the initial 6 months after AM!. Deceleration time and E•
wave velocity half time increased concomitantly in E and P (all 
p<O.OOOI). The E-height, A-height and E/ A ratio were unchanged. The 
E-wave velocity time integral (VTI) increased in E and P (p<O.OO5), 
while the A-wave VTI increased only in E (p<O.OOI). The VTI of the first 
third of diastole in relation to total diastolic VTI did not change. 
Extensive wall motion abnormalities caused a shorter deceleration time 
in both E and P groups (p<O.OI), while a large left ventricle was 
associated with a higher E/ A ratio in P only (r=O.30, p<O.OOI). In the 
small subgroup with previous CHF the ejection fraction was lower 
(p<O.OI), E/ A ratio higher (p<O.OI), and deceleration time shorter 
(p<O.01) in the P group as compared to E treated patients. 
Thus, after an AMI there is an ongoing change in the PWMD 
profile towards a less restrictive filling pattern. Changes may in part be 
secondary to a decreased heart ra teo E may have beneficial effects on 
diastolic function in patients with pronounced CHF. However, in spite 
of previously shown significantly less LV volume expansion in the E 
group (p<O.02), we found no obvious effects of E upon the PWMD 
profile among unselected AMI patients. 
761·3 4:30 
~ CUaga m RqiouI ad GlobaIl.eft Veatricalar DilatioD 
DariDg .1IIOIIeIiJq: Post·M~ IIIfardioa 
.Bodh L Jugdutt, Mohammad L Dau, Brad J. Johnston, S. Joanne 
Jugdutt, Gordon E. Blinston, University of Alberta, Edmonton, Canada. 
Outcome post-infarction is largely inouenced hy mfarct size and LV 
remodeling. Cbanges in regional and glohal LV dilation as well as 
dysfunction can be quantified bytwo-climensionalechocardiograpby (2DE). 
Estimation of infarct size from LV dysfunction by 2DE sum mates 
circumferential extents on diastolic short-axis images without attention to 
regional bulging. Four sbape algorithms (rocket, bullet, grenade, 
spaceship) were systematically applied for calculating LV endocardial 
surface a ..... area of LV asynergy (akinesis + dyskinesis) and volumes 
from 4 sbort-axis and one base-tooapox images in over 800 post-infarction 
patients witb serial lDE studies (1980-1988), with special attention to 
regional bulging. Analyses were done by 2 blinded observers. Areas and 
volumes by tbe 4 algorithms differed by <6% and 11%, respectively. 
Results from the first 2DE in 43 patients (28 anterior, 15 inferior) witb 
creatine kinase (CK) infarct size data and 11 normal controls were: 
Anterior Inferior Control 
CK-Infurct size (g-Eq) 45 44 0 
Mean LV surface area 133t 94 111 
lIfean LV Volume 155t 92 124 
Mean LV asynergy (% area) 31 37 0 
t p<O.OOI, auterior vs inferior (ANOVA) 
Despite similar infarct size and asynergy on the initial lDE post•
infarction, surface areas and volumes were greater in auterior than 
inferior groups indicating marked remodeling in the anterior but 1I0t the 
inferior group. Serial lDE revealed a progressive decrease in tbe hulge 
as global LV dilation develops. 
ABSTRACTS 269A 
761·4 4:45 
Lack of Ventricular Remodeling in Non-Q Wave Myocardial 
Infarction 
Anand M. Irirnpen, Alan N. Tenaglia, David J. Shin, Andrew J. 
Buda, Tulane University, New Orleans, LA 
Left ventricular (LV) remodeling is known to occur following Q 
wave myocardial infarction (MI); however, whether remodeling 
occurs in non-Q wave MI is uncertain. Accordingly, the purpose of 
this study was to examine the hypothesis that ventricular remodeling 
is determined by the extent and degree of myocardial necrosis. As 
non-Q wave MI generally results in less myocardial necrosis than Q 
wave MI, we hypothesized that ventricular remodeling may be 
modified or eliminated in non-Q wave MI. In this study, we 
examined 50 MI patients with serial tw<Hiimensional 
echocardiography (2DE) to measure left ventricular end-diastolic 
volume index (L VEDVI). All Q wave and non-Q wave MI patients 
had 2DE within one week and then at 6 weeks post-MI. Nine 
patients with stable coronary disease served as controls and had 
serial 2DE over the same intelVal. LVEDVI was measured using the 
modified Simpson's rule algorithm from orthogonal apical long axis 
projections. The results are outlined below: 
LVEDVUmVm2 ) 
Control 
Qwave 
Non-Qwave 
~ 
65±8 
57±3 
60±4 
~ 
64±7 
83±4 
60±3 
~ 
NS 
<0.0001 
NS 
Peak creatine kinase (CK) was greater in Q wave MI compared to 
non-Q wave MI (2430±305 versus 567±94 IV, p<O.OOOl). Thus, 
although left ventricular remodeling occurs following Q wave MI 
our data indicate that LV remodeling does not occur following non•
Q wave MI. The lack of LV remodeling following non-Q wave MI 
may relate to the limited extent of necrosis as reflected by peak CK 
levels and/or differences in mechanisms of healing and subsequent 
topographic defonnation. 
761-5 5:00 
Collateral Developing After Myocardial Infarction 
Prevents Subsequent Dilatation of Left Ventricle 
* Atsushi Hirayama, Akihiko Sakai, Naoyuki Misaki, 
Yasuhiko Sakata, Shinji Hasegawa, Takayoshi Adachi, 
Kazuhisa Kodama. Cardiovascular Division, Osaka Police 
Hospital, Osaka, Japan. 
To examine whether collateral (Col) developing after acute 
myocardial infarction (AMI) is enough to prevent the 
subsequent dilatation of left ventricle (LV), LV volumes and 
functions at 1 month and 2±1 years after onset were studied 
in 27 patients of first anterior AMI with total occlusion of 
infarct-related artery (IRA) and poor collaterals during 
acute stage. Of these patients, whose IRA was totally 
occluded, Col developments were observed in 17 patients 
(Group C) and not in 10 patients (Group N) during study 
period. Defect volume (DV) was determined by TI-201 SPECT 
at rest, LV volumes were measure by area-length method 
and regional wall motion (RWM) was determined by 
centerline method using LV grams. Results were as follows: 
Group C (n= 17) N (n= 10) 
1M 2Y 1M 2Y 
1688±21O 1429±li8# 1662±240 1721±289 
37±4 39±2 43±S 40±4 
DV 
EF(%) 
RWM 
(SD/Chord) -4.1±0.3 -3.9±OA -4.2±0.4 -4.0±O.3 
EDVI(mllm2) 61±3* 60±-It 68±4 7S±6# 
ESVl(mllm2) 40±3 38±St 41±S 46±S# 
(#:p<O.OS vs. 2Y, *:p<o.OS vs. Group N at 1M, t:p<O.OS vs. Group 
Nat 2Y») 
These results indicated that Col, even which developed after 
AMI, prevented the progressive left ventricular dilatation 
and remodeling after myocardial infarction independent of 
infarct size reduction. 
270A ABSTRACfS 
761·6 5:15 
Hemodynamic Correlates of Left Ventricular Relaxation and 
Filling in Patients Early after Acute Myocardial Infarction 
Jean L. Vanoverschelde, Annie Robert, Alain Gerbaux, Jean Renkin, 
Jean Etienne, William Wijns. University of Louvain, Brussels, 
Belgium. 
Doppler ·derived left ventricular (LV) filling pattern is widely used to 
evaluate LV diastolic function after acute myocardial infarction (AMI). 
In an effort to determine which hemodynamic parameters influence the 
most LV filling dynamics and relaxation in patients with AMI, we 
measured right (fluid·filIed) and left (LV, hifi) ventricular pressures, 
LV volumes (contrast angiography) and transmitral flow (Doppler) in 
33 AMI patients (27 men, age S8 ± 10 yrs), within 24 hours of the 
acute event. Measurements included LV end·diastolic (ED) and end•
systolic (ES) volumes (V), ejection fraction (EF), peak (+) and (-) 
dP/dt, the time constant of isovolumic relaxation (Tau), LYED 
pressure (L YEDP), and stiffuess (Stiff), LV mass, L YES stress (ESS), 
pulmonary wedge pressure (pWP), peak early (E) and late (A) 
transmitral filling velocities and their ratio. Table shows the correlation 
coefficients for E wave, EI A ratio and Tau: 
ESV EF Tau Stiff PWP Peak CK 
E wave ·0.37· 0.34 0.01 0.S9** 0.66·· 0.29 
EtA ratio ·0.l4 ·0.l4 -0.l0 0.S9** 0.73·· 0.33 
Tau 0.44" 0.38· 0.24 0.36 O.SI" 
• p<O.OS •• p<O.OI CK = creatine kinase 
Multivariate analysis identified PWP (p<0.001) and age (p=O.004) as 
independent correlates of early diastolic filling and peak CK release 
(p=O.0.2S) and ESV (p=O.OS) as independent correlates of Tau. The 
data thus indicate that, in patients with AMI, LV filling is related to 
left atrial pressure and chamber stiffuess, while isovolumic relaxation 
more closely depends on infarct size and end-systolic dimensions. 
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762·1 4:00 
PTCA IN HIGH RISK PATIENTS: COMPARISON OF 
ELECTIVE INTRA-AORTIC BALLOON PUMP AND PERCU•
TANEOUS CARDIOPULMONARY BYPASS SUPPORT - A 
RANDOMISED STUDY. 
Upendra Kaul, Vinay K Bahl, Harbans S Wasir 
All India Institute of Medical Sciences,New Delhi-
110029 ,INDIA 
Forty patients undergoing PTCA with LV ejection 
fraction It! 30% were randomised between prophylactic 
intra-aortic balloon pump support (lABP) (N=20) 
and percutaneous cardiopulmonary bypass support 
(PCPB) (N=20). The indications in both the 
groups were LV dysfunction and a large area 
of viable myocardium (~50%) being perfused 
by the target vessel. 
The IABP " PCPB supported groups were 
comparble in LVEF (20±6. 4% vs 22. 8±8.1%) ,mean 
PA pressure (46.5±lO.5mmHg vs 42.6±12.6mmHg), 
avo no. of vessels dilated (1.4 vs 1.3) ,mean 
inflation time (2. 8±0. 3 vs 3 .1±0. 5min) , and 
hospital stay after PTCA (5.6±1.2 vs 5.2±1.4 days). 
The primary success rate (95% vs 95%) " hospital 
mortality (5% vs 5%) were also similar in the 
two groups. Two patients required surgical 
exploration of the femoral artery " 8 patients 
required blood transfusion in the PCPB group • IABP 
group patients had no vascular complication 
and did not require blood transfusion. 
High risk PTCA using prophylactic IABP and PCPB 
support are equally effective methods. PCPB support 
however has a higher rate of vascular complications 
.. need for blood transfusions. IABP has the 
additional advantage of ease of insertion " the 
support can be used for longer period after 
PTCA if required. 
JACC February 1994:1A-484A 
762·2 4:15 
.. ft ... trieulu UDloa4i.Jag DU'iq Ii,h liat COroury 
~oplutJ - First Uae of Percutaa_ ..."... 
larl a.Scholz, Baas I.rigulla, rraat Scbweda, 
licbard V.Saalling, Gerbar4 ae11ig., aeinrich 
tr.uzer, Vali4 Aboul-aosn, lichar4 I.Weapler. 
uniYerai ty of G6tting.n, Geraany, aa4 lancho 
Cor4ova, Cl 
1 a." ainiaturize4 aeaopup 4evice b .. been 4e•
sion.4 for percutaneous insertion (pBP). The aJllt .. 
ia b ... 4 on a aiz.4 flow rotary pup an4 i. capable 
of flow rat •• of 1.5 to 2.2 L/ain. In 6 patienta, 
pBP w.. u.ed 4uring high riat coronuy angioplasty 
because of h .. odyneaic coaproai.. 4uring balloon in•
flation_ aeaopup aupport 1.4 to heaodyneaic ,tabi•
lization with an incre .. e in aean aortic pressure 
froa 571:10 to 76:1:9 aIIg during iacheaia. SiauUa•
n.oully, a aionificant 4.cr.... in a .. n pulaoury 
capillary we4ge pressure (froa 25 to 12 aIIg) w .. 
observe4, 411110natrating aute4 left ventriCUlar 
unloa4iDg 4uriDg iaeheaia. ID all patieDts, PTCl w.s 
aucce.,ful. 
With aeaopup operation period, of 122:1:21 ainutes, 
we observed DO vascular or eabolic coaplieations. 
ODe patieDt required blood transfusion because of 
IIlee4iq ill the area of the introduc.r aheath. III 
aU patieDta, only a aiDor iDer.ue in botb pl .. a. 
free heaoglohin an4 lac tat. 'ehy4rogenase l.v.l. 
were Doted. 
OUr prelimuy aperiellce. .uggest that the pereu•
tan.ous aeaop\lJlp ia safe and ettecti ve and My be a 
powerful alterllative to other devices use4 for 
aupport.4 an,iopluty. 
762·3 4:30 
Intravascular Ultrasoubd \'5 Qaaatitative Coroaary ADgiograpby: A 
Statistical Comparisoa or 1106 Coasecutlve Target Lesioas 
Gary S. Mintz, Jeffrey J. Popma, AuguslO D. Pichard. Kenneth M. Kent, Jack 
A. Painter. Regina Deible. Angela Roth. CIuistine J. Dittano. Lowell F. Satler. 
Martin B. Leon. Washington Hospital Center. Washington, DC 
We compared intravascular ultrasound (IVUS) 10 quantitative coronary 
angiogtaphy in 1106 consecutive lesions evaluated for transcatheter therapies 
(TCr: 199 no TCr; 174 PTCA; 275 directional. 166 rotational • and 16 
extraction atherectomy; 124 stents; and 152 excimer 1aser angiop1asty I and 
imaged with intravascular ultrasound. NUS assessment included an; of 
calcium. eccentricity (maximumltninimum pJaque+media thickness >3.0), 
lesion length (using motorized transducer pullback @ 0.5mm/sec). minimal 
lumen diameter IMLD). and the me nee of """t-TCr dissections. 
NUS OCA r P 
Calcium(%) 64.9% 29.4% <.0001 
Eccentricity (%) 42.6% 61.3% .0034 
Lesion length (mm) 7.W.4 8.3±S.8 0.58 <.0001 
MLD Oesion~S catheter) 
Pre-TCf(mm) 1.66±O.S7 1.71±O.59 0.69 <.0001 
Post-TCr (mm) 2.42±0.57 2.33±0.67 0.59 <.0001 
Post-TCr dissections 69.1% 22.3% <.0001 
(1) In general. IVUS vs quantitative anglOgraphlc correlations of both 
morphologic characteristics and quantitative assessment of vessel dimensions 
were better in vein grafts than in native coronary arteries. (2) Pre-TCr. the 
cme1ation between NUS and angiographic-measured MLD was influenced by 
the presence of >2 quadrants of target lesion calcium (r=2.7. p=NS) and by a 
lesion length> IOmm (r=.40). This com:1ation was not influenced by vessel 
tortuousity. lesion eccentricity, or lesion location including bend points and 
bifurcations. (3) Post-TCr, the cme1ation between NUS and angiographic•
measured MLD was better after adjunct PTCA than after primary device 
therapy (r=.20); better for stents (r=.65) than PTCA, directional or rotational 
atherectomy. or excimer 1aser angiopJasty; worse in the presence of >2 
quadrants of lesion calcium (r=.48); and not influenced by eccentricity. 
dissections, or lesion length. We coodbde: There are significant, but 
predictable differences between NUS and quantitative angiography in the 
assessment of target lesion severity and morphology before and after TCT; 
these differences have important implications in selecting appropriate 
revascu1arization strategies and in assessing their n:sults. 
lACC February 1994:1A-484A 
762·4 4:45 
Intravascular Ultrasound Evidence of Atherosclerosis 
at "Normal" Reference Sites Predicts Adverse Clinical 
Outcomes Following Percutaneous Coronary Interventions 
Steven E. Nissen, E. Murat TUleu, Anthony C. De Franco, Irving 
Franco, Russell E. Raymond, John Elliot, Jeffrey Leikovits, Patrick 
L. Whitlow, and Stephen O. Ellis Cleveland Clinic, Cleveland OH. 
Objectives: Previous attempts to predict adverse outcomes following 
revascularization have focused on angiographic lesion measurements. 
We hypothesized that plaque burden at "normal" reference sites 
adjacent to target lesions might also influence restenosis. 
Methods: We examined 228 "normal" reference sites by intravascular 
ultrasound for 110 interventions in 105 patients, including 35 
directional atherectomies, 27 rotablations, and 48 PTCA. Ultrasound 
measurements of plaque burden at reference sites included lumen 
diameter (LD-min and LD-mean), maximum plaque thickness (P•
max), and the ratio of P-max to LD-mean_ Patients were followed by 
phone, chart review and contact with primary physician. Adverse 
endpoints included recurrent angina, positive stress ~st~ repeat 
catheterization with restenosis, and target vessel revascularizatton. 
Results: At follow up 3 to 12 months following intervention, adverse 
endpoints were reached in 36% of patients. Favorable and adverse 
outcome groups had similar minmum and mean diameters at ref~rence 
sites. However, there was more plaque burden (P-max) m the 
unfavorable outcome group and the ratio of plaque thickness to mean 
diameter was also significantly higher in the adverse outcome group. 
Clinical LD-min LD-mean P-max P-max/ 
Outcome (mm) (mm) (mm) LD-mean 
Favorable 2.86 3.1 .86 0.29 
Adverse 2.66 2.9 1.26 0.44 
P value NS NS <0.01 <0.01 
Conclusions: Plaque burden at SItes remote ~rom the ~nteryen~on 
strongly influences clinical outcome. These fmdmgs have lffiphcatl?ns 
for understanding the genesis of poor long term results followmg 
coronary interventions and strategies for effective prevention. 
762-5 5:00 
Can Angioscopic Findings Predict the Early Outcome of PTCA? 
Fabrice S. Larrazet, Patrick J. Dupouy, Jean-Luc Dubois Rande, Akira 
Hirosaka, Herben J. Geschwind. University Hospital Henri-Mondor, 
University of Paris XIl, INSERM U2, Creteil, F. 
The predictive factors of failure or early reocclusion « 24 hrs) following 
PTCA have not been well established. We studied the possible influence of 
thrombi, dissections, white or yellow plaques and subintimal hemorrhage in 
the immediate and early results obtained after PTCA as assessed by 
angioscopy. Angioscopy was performed without complications in 60 patients 
(pts) aged 54±8 years before and after PTCA, using a 4.5 F Imagecath 
system. The site of lesion was the left anterior descending anery (n=33), the 
right coronary anery (n= 18) or the left circumflex artery (n=9). There were 4 
type A, 13 type B I, 29 type B2 and 14 type C lesions. Forty eight pts (group 
I) had successful PTCA without early complications. Twelve pts (group 2) 
had a complicated outcome after PTCA corresponding to early reocclusion 
(n=6), restenosis (n=3) or failure to recanalize the obstructed anery (n=3). 
Ten of these pts had successful repeat PTCA. Thrombus was defined as a 
white or red globular mass within the lumen or adhering to the arterial wall 
that persisted despite flUShing with saline. Dissection was defined as a large 
protuberant thic.k flap encroaching the lumen or separ~ting it into two 
channels. Subintimal hemorrhage was defined as a large diffuse red plaque 
not protubing into the lumen. White and yellow plaques were defined as white 
or yenow flat protrusion which may indicate fibrous cap or extruded lipoid 
material respectively. 
Results: 
PTCA 
White thrombus 
Red Thrombus 
Dissection 
Subintimal hemorrhage 
White plaque 
Yellow plaque 
Group I 
n=48 
II (23%) 
6 (13%) 
9(19%) 
14 (29%) 
30 (63%) 
19 (40%) 
Group 2 
n= 12 
5 (42%) 
3 (25%) 
4 (33%) 
2 (17%) 
11 (92%) 
3 (25%) 
Conclusions: 11 Thrombi and dissections were slightly more frequently 
observed in the complicated outcome group. 2/ White plaque was the most 
common angioscopic finding. 3/ No angioscopic predictor of complication 
could be determined. 
ABSTRACTS 271A 
762·6 5:15 
Extent or Plaque Fracture Explains Discrepancy Between Aoglographlc and 
Intravascular Ultrasound Measurements After PTCA 
Shigeru Nakamura, Donald J. Mahon, Bavani Maheswaran, Dan E. Gutfinger, 
Jonathan M. Tobis, University of California, Irvine 
Previous studies have shown a poor correlation between angiographic and 
intravascular ultrasound (IVUS) measurements after PTCA. To understand the 
reasons for this observation, 91 lesions in 84 patients were studied by IVUS 
after successful balloon angioplasty. Plaque morphology on JVUS was classified 
as demonstrating superficial injury if there was either no fracture or only a 
small tear which did not extend to the media, versus a deep injury defined as 
the presence of a plaque fracture which reached the media. Measurem~nts of 
minimum lumen diameter and lumen cross sectional area (CSA) were 
compared between angiography and JVUS. Forty-rour lesions were classified 
as having superficial injury and 47 lesions demonstrated deep injury. There 
were no statistical differences in baseline characteristics of risk factors, vessel 
distribution, percent diameter stenosis, or lesion length. In the superficial injury 
group, there was a good correlation between angiography and JVUS for 
minimum lumen diameter (r ; .67) and lumen CSA (r = .69), P ; 0.001, but 
in the deep injury group there were poor correlations for minimum lumen 
diameter (r ; 0.23) and lumen CSA (r ; 0.28), p = ns. Angiographic 
appearance after successful PTCA showed dissection in 39%, hazy appearance 
in 23%, and a normal contour in 34%. Sixty-five percent of lesions with a 
normal or hazy angiographic appearance were in the superficial injury group, 
whereas 77% of paticnts with angiographic dissection were in the deep injury 
group (p < 0.0(1). 
Conclusions: After successful PTCA, 48% of lesions demonstrate superficial 
injury by IVUS. In these lesions, there is a good correlation between 
angiography and IVUS measurements. There is a poor correlation between 
angiography and IVUS when there is deep injury due to a large plaque fracture. 
When the angiographic appearance shows a normal or hazy contour, there is a 
low probabililY of plaque fracture. When angiography reveals a dissection, there 
is a high probability that IVUS will demonstrate a large plaque fracture 
extending to the media. 
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Flow-Mediated Vasodilatation is Impaired in 
Congestive Heart Failure 
Herbert Hirsch, Laura A. Demopoulos, Rachel 
Bijou, Danny Woo, Margaret Jones, Thierry H. 
LeJemtel, The Albert Einstein College of 
Medicine, Bronx, New York. 
The vascular response to a direct vasodilator 
initially involves vascular smooth muscle 
relaxation. The resulting increase in blood 
flow augments endothelium shear stress, which 
in turn further enhances flow via cGMP produc•
tion. We have previously shown that at low 
dose, Le. 10-9M, nitroglycerin (NTG) does not 
exert hemodynamic effect but amplifies endo•
thelium-dependent vasodilatation. Accordingly, 
the vascular responses to brachial artery 
administration of a direct non-cGMP-mediated 
vasodilator,~hentolamine (P), and simUltaneous 
P and NTG 10-M, were assessed in the forearm of 
5 patients with congestive heart failure (CHF) 
and 4 age-matched normals (N) by plethysmog•
raphy. Results were as follows (P doses 
expressed in mg/ml): 
2.5 x 
pre NTG 
post NTG 
* p= <.05 
10-4 
CHF/N 
2.5/2.3 
2.5/2.7 
P+NTG vs P 
10-3 
CHF/N 
2.8/2.7 
2.7/3.3 
10-2 
CHF/N 
4.1/4.2 
4.4/5.2* 
In summary, while 10-9M of NTG substantially 
increased vasodilatory response to P in normals, 
it did not in patients with CHF_ Therefore, 
flow-mediated vasodilatation appears impaired 
in CHF. 
272A ABSTRACTS 
763·2 4:15 
Venous Endothelial Function In Experimental Chronic Heart Failure. 
S. Gabrielle Horne. Israel Belenkie. Dante E. Manyan, John V. Tyberg. 
Eldon R. Smith. University of Calgary. Calgary. Canada. 
Preload reduction witb venodilators acting on the endotbelium is an important 
treatment strategy in CHF; however. little is known about venous endotbelial 
function in this state. We hypothesised that venous endothelial production 
of nitric oxide is abnormal in CHF. To test this. we instrumented 5 
splenectomized dogs with LV and RV micromanometers. and a portal 
pneumatic constrictor with a portal pressure catbeter upstream. After 
recovery. we used radionuclide equilibrium blood-pool scintigraphy and graded 
portal constriction to examine tbe effect of infusion of a nitric oxide 
synthetase inhibitor. L-NAME, and then the precursor of nitric oxide. L•
arginine. on the portal pressure - abdominal blood volume relation (PVR). in 
the unsedated state. A lead square under the anterior abdominal wall was used 
to detennine the proportion of the total counts attributable to the splanchnic 
circulation (SP% TC). Pacing was initiated at 240 bpm with repeat 
measurements after CHF developed (4-7 weeks). 
CHF was characterized by increased L VEDP (9±4 to 32±S mmHg), 
RVEDP (7±5 to 16±3 mmHg). and heart rate (95±12 to 1l1±S). (all 
p<.05). A dose of L-NAME sufficient to raise LV peak systolic pressure from 
136±27 to 146±25 mmHg in the control state did not shift tbe PVR, but 
during CHF there was a lefrward shift (venoconstriction). L-arginine (7.5 g) 
shifted the PVR to the right (venodilation) in control. but in CHF it did not 
reverse the L-NAME induced venoconstriction. In all cases there was no 
significant change in the SP% TC or the slope of the PVR. 
Abdominal blood volume at portal pressure of 20 mmHg. as % baseline is 
given in tbe Table: 
baseline L-NAME L-argInine 
CONTROL 100 1l0±i3 130±12' 
CHF 100 77±IS' 9O±S 
, denotes p< .05 cf baseline 
These results are consistent with increased basal venous endothelial 
production of nitric oxide in CHF. but an inability to augment production in 
the presence of excess precursor. 
763·3 4:30 
Resting and Exercise·Induced Release of Endothelium-Derived 
Nitric Oxide is Impaired in Patients with Heart Failure 
Stuan D. Katz. Henry Krwn. Milton Packer 
Columbia University College of Physicians and Surgeons. New York. 
New York 
Endothelium-dependent vasodilation in response to muscarinic 
stimulation with acetylcholine is impaired in the peripheral 
circulation of patients with congestive hean failure (CHF). Whether 
release of endothelium-derived nitric oxide in the resting state and in 
response to exercise is also impaired complimentary in patients with 
CHF is unknown. Accordingly. forearm blood flow (mVminllOO ml) 
was measured with venous occlusion strain gauge plethysmography at 
rest and during rhythmic handgrip exercise at 15%. 30% and 45% of 
maximum voluntary contraction (MVC) in 9 men with chronic. stable 
NYHA class 11 and III CHF (mean age 57 years. mean left ventricular 
ejection fraction 23%) before and after administration of an inhibitor 
of nitric oxide synthase. L.NG·monomethylarginine (L-NMMA. 4 
XlO-s M) in the brachial artery. Results as follows (means±s.d.): 
Before L·NMMA 
AfterL·NMMA 
Rest 
2.9±1.6 
3.0±1.2 
Foreanu Blood Flow 
15% MVC 30% MVC 
8.7±4.3 10.4±4.3 
8.0±2.6 1O.1±4.7 
.S%MVC 
14.6±7.5 
15.l±6.2 
In contrast. administration ofL·NMMA in the normal forearm 
circulation decreased resting forearm blood flow by 39% and 
decreased forearm blood flow during handgrip exercise by 15-17%. 
Mean arterial pressure did not char.ge after administration of L•
NMMA. In conclusion. the absence of a dccrease in forearm blood 
flow after administration of L-NMMA suggests that physiologic 
synthesis and/or release of nitric oxide at rest and during exercise is 
impaired in patients with CHF. The current data extends the findings 
of previous studies in animal models of hean failure to the clinical 
setting and provide additional evidence that endothelial cell 
dysfunction contributes to increased peripheral vasomotor tone in 
patients with CHF. 
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763·4 4:45 
Contributions of Nitric Oxide to Basal Vasomotor Tone in Patients 
with Heart Failure 
Spencer H. Kubo. Thomas S. Rector. Leopoldo Raij. Alan 1. Bank. 
Mark D. Kraemer. Peter Tadros. Michael Beardslee. Michael D. 
Garr, University of Minnesota. Minneapolis. MN 
Nitric oxide has a tonic influence regulating basal vasomotor 
tone in normal subjects (NL). Other studies have demonstrated 
attenuated endothelium-dependent vasodilation in patients with heart 
failure (HF) in response to stimulated release with muscarinic 
agonists. We addressed the hypothesis that basal activity of nitric 
oxide was attenuated in heart failure and that this abnormality could 
contribute to the high resting vascular tone characteristic of this 
clinical syndrome. A subsystemic dose range ofL-monomethyl•
arginine (L-NMMA 1.4.8 and 16 ~mol/min), a competitive 
antagonist of nitric oxide synthase. was infused into the brachial 
artery of 10 HF patients and 18 NL and changes in forearm blood 
flow (FBF; mVminllOO ml FAV) and venous nitrate levels. as an 
estimate of basal nitric oxide production, were measured. L-NMMA 
resulted in a significant dose dependent decrease in FBF in NL from 
a baseline of 3.6 to 3.3. 2.6. 2.3 and 2.3 mVminllOO ml FAV with 
the 1,4,8 and 16 ~mole doses respectively. In HF. L-NMMA 
decreased FBF from a baseline of 2.5 to 2.0.2.0.1.5 and 1.4 
mVminlIOO ml FA V respectively. There were no significant 
differences in the L-NMMA responses between the groups when 
measured as absolute or percent changes in FBF or with analysis of 
covariance to adjust for different baselines. Baseline venous nitrate 
levels (l06±36 vs 152±31) and the reduction with L-NMMA (-13 
vs '22) were similar between NL and HF. The present study 
demonstrated that the reduction in resting FBF in response to the 
intra-arterial administration of L-NMMA was similar between NL 
and HF. We conclude that, in contrast to reduced stimulated 
responses, basal activity of nitric oxide is maintained in heart failure. 
This pathway is unlikely to be a major component of heightened 
vasomotor tone in this syndrome. 
763·5 5:00 
Endothelium-Dependent Vasodilation of Small Arteries Is 
Impaired in Rats With Chronic Heart Failure. Effect of 
Angiotensin Converting Enzyme Inhibition. 
Paul Mulder, Lahcen Elfertak, Patricia Compagnon. Vincent 
Richard. Elizabeth Scalbert. Pierre Desche. Christian Thuillez. 
Department of Pharmacology, VACOMED, IFRMP, Rouen 
University Medical School, Rouen. France. 
Chronic heart failure (CHF) impairs endothelium-dependent 
vasodilation of large conductance arteries. We investigated 
whether a similar reduction afso Occurs in small arteries, and 
whether such a reduction can be prevented by the angiotensin 
converting enzyme inhibitor perindopril (P) in a rat model of CHF 
(left coronary artery figation). After 12 months treatment with 
placebo or P (2 mglkgfday), rats were anesthetized. and mean 
arterial pressure (MAP, mmHg), left ventricular (LV) end diastolic 
pressure (LVEDP, mmHg), and central venous pressure (CVP. 
mmHg) were measured (micromanometer). Segments of aorta, 
mesenteric (MA. 304:1:6 11m) and femoral (FA, 2D4±S 11m) arteries 
were then isolated, cannulated and perfused at constant pressure 
using an arteriograph. Responses to increasing concentrations of 
acetylcholine (Ach) and nitroprusside were studied after 
preconstriction by phenylephrine. Responses to nitroprusside were 
not affected by CHF or P. Table shows the effects of CHF and P 
on infarct size (IS. % of LV). hemodynamiCS and maximal 
responses (%) to Ach (* p<O.OS vs sham; § p<O.OS vs CHF) 
n IS MAP LVEDP CVP Ach 
Aorta MA FA 
Sham 22 139±4 9± 2 6±1 46±S 61±S Sa±6 
CHF 11 S1±3 134±S 19±3* 16±2* 31±S 41:1:6* 26±S* 
CHF+P a 54±3 97±S*§ 10±2§ 7±2§ 33±6 S2±B 54±9§ 
Thus. CHF induces a decreased endothelium-dependent response 
to Ach which is heterogenous, and mainly affects small muscular 
arteries. ACE inhibition is able to prevent this impairement in 
territories which are the most affected by CHF. 
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763·6 5:15 
Long Term Angiotensin Converting Ezyme·Inhibition Improves 
Vascular Function in Patients with Chronic Heart Failure by a 
Cyclooxygenase.Dependent Mechanism 
M. Jeserich, L Pape, Th. Miinzel, M. Kupfer, H. Drexler, H. 
Just. Medizinische Klinik III, Universitiit Freiburg, Germany 
Recent data suggest that cyclooxlooxygenase-dependent 
vasoconstrictor factors contribute to vascular dysfunction in 
patients (pts) with chronic heart failure (CHF). We 
lDvestigated the effect of lont! term ACE-inhibition (ACE-I) on 
vascular function in 15 pts WIth CHF (11 men, 4 women; mean 
age 59 yrs, NYHA III, no pretreatment with ACE-inhibitors). 7 
of 15 pts received concomittant cyclooxygenase inhibition with 
aspirin (group I), whereas 8 pts did not (group II). Changes in 
radial artery diameter (RAD) lind blood flow (BF) to 
increasing dosages of intraarterial nitroprusside (SNP) 
(0.3/3/10 p.g/min) were determined before and 3 months after 
therapy with the ACE-Inhibitor perindopril (4 mg daily). RAD 
was measured by a novel A-mode ultrasound deVIce (using a 10 
MHz transducer) with a precision of 2,5 urn. BF was calculated 
from blood flow velocity (8 MHz Doppler) and cross sectional 
area. (* p< 0.05 vs pre ACE-I). 
diameter (mm) blood flow (ml/min) 
group I group II group I group II 
ACE-I pre post pre post pre POst pre post 
saline 2.77 2.80 2.52 2.73' 23.6 20.9 15.6 20.1 
~U~ ~ ~ ~ ill ~ W ill 
SNP 3 3.10 3.22 2.94 3.19* 35.2 30.5 22.6 32.5' 
SNP 10 333 336 29& 3.28* 46.7 40.5 22.9 40.2' 
Thus, concomittant aspirin therapy blunts the benefical 
vascular effect of ACE·inhibitors, suggesting that longterm 
ACE-inhibition improves vascular function by a 
cyclooxygenase-dependent mechanism. 
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764·1 4:00 
EDRF·Mediated Control or Coronary VIISCUIar Tone is Associated 
with Local Platelet eGMP Accumulation. 
J.E.B. Burchenal, John F. Keaney, Jr., Joseph Loscalzo, and Joseph A. 
Vita, Harvard Medical School, Boston, MA. 
Endothelium-derived relaxing factor (EDRF) is important in the 
local control of coronary vascular tone. EDRF influences vascular tone 
and platelet function through the activation of guanylyl cyclase and local 
production of 3 ',5'-guanosine monophosphate (cGMP). Direct assay of 
coronary vascular EDRF production is problematic due to its short half•
life III vivo. We hypothesized that local production of platelet cGMP in 
the coronary vasculature would serve as an iodex of EDRF production. 
We determined the coronary production of platelet cGMP by measuring 
aortic and coronary sinus platelet cGMP levels in 5 patients with varying 
degrees of atherosclerosis at basel ine and during left main infusion of the 
EDRF-dependent dilator substance P (S - 80 pmollmin for 2 min). We 
also measured coronary blood flow by coronary sinus thermodilution, 
epicardial coronary diameter using digital calipers, and coronary vascular 
resistance (CVR), and correlated these indices of EDRF action with the 
accumulation of platelet cGMP across the coronary circulation (.acGMP). 
Correlation R p value 
Coronary flow vs ... cGMP 0.47 .01 
Epicardial diameter vs .. cGMP 0.38 .05 
CVR vs AcGMP .{l.SI .006 
Thus, the prOduction of platelet coMP across the coronary 
circulation correlates with physiologic indices of EDRF action. These 
data suggest that the coronary production of cGMP is an accurate marker 
for coronary EDRF action and support the role of EDRF in the 
modulation of coronary vascular resistance and conductance vessel tone. 
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764·2 4:15 
Meet or Estradiol·17" on Forearm Blood Flow In Menopausal 
Women. A Double BUnd Randomized Study 
Maurizio Volterrani, Giuseppe M.C. Rosano, Andrew Coats, Peter 
Collins. National Heart &. Lung Institute, London, UK 
Women are protected until the menopause from cardiovascular events and 
the incidence of cardiovascular disease appears to rise sharply with the 
decrease in ovarian hormones. Estradiol-17" has recently been shown to 
improve exercise-ioduced myocardial ischemia in menopausal patients with 
coronary artery disease and to normalise peripheral blood flow in female 
patients with syndrome X. 
The aim of the present study was to assess the effect of sublingual 
estradiol-l7" (Img, SLO) or sublingual placebo (SP) upon forearm blood 
flow (FBF) and vascular resistance (VR) in 10 menopausal normal 
volunteers (mean age S4±4.2 years). FBF and VR were measured by 
venous occlusion plethysmography before, and 40 minutes after either SLO 
or SP. Estradiol-I 7 " plasma levels were greater after SLO when 
compared to SP (mean±SD; 3472± 1381 vs 57.6±2S.5, P<O.OO6). FBF 
and VR were similar before either SLO or SP (3.8±1.3 vs 3.5±2.1 
m1/minllOOml forearm tissue, and 30.4±1S.3 vs 32.6± 15.3 units 
(P= NS), respectively. FBF was higher and vascular resistances lower 
after SLO when compared to SP (4.4± 1.3 vs 2.3± 1.3 m1/minllOOm\ 
forearm tissue (P<0.03) and 21.2±10.9 vs 47.8±21.3 units (P<O.OOS), 
respectively). 
In conclusion estradiol-17 P increases FBF and reduces VR in menopausal 
women. The beneficial effect of estradio1-l7" observed upon exercise•
induced myocardial ischemia may be partially due to the effect of this 
hormone on afterload. 
764-3 4:30 
Acetylcholine Infusion Stimulates EDRF Release From Saphenous Vein 
Grafts 
Jeffrey I. Leavitt. William L. Daley. John F. Keaney. Jr .• Joseph A. 
Vita. Harvard Medical School. Boston. MA 
Saphenous vein grafts demonstrate endothelium-dependent 
relaxation in vitro. The endothelium-dependent response of saphenous 
vein grafts and their subtended vessels in vivo remains to be defined. 
We infused acetylcholine (ACH; 10" to 1~ MI into saphenous vein 
grafts in 6 patients and 
examined percent change in 
diameter using angiography and 
digital calipers. Native vessel 
and graft responses were 
examined by paired infusions at 
the distal and then proximal 
anastomoses of the saphenous 
vein grafts. Dose response 
curves for each infusion are 
displayed. Distal ACH infusion 
produced dose-dependent 
constriction of the native 
coronary artery. reflecting 
impaired endothelial function. In 
contrast. proximal ACH infusion 
produced dose-dependent 
dilation of the native vessel 
(p<O.OI. proximal vs. distall. 
but had no effect on the 
30 -.- DislllllnlUsion -e- PrClCimallnlUsion 
20 l 
t 10 .-i-........ I 0 ........ 
is --"""',---'-........ 
<1-
10 
'" 
#. -20 " 
-30 p < 0.01 by ANOVA , 
CTR·9 -8 -7 -6 
AceIyIcholine (Log M) 
diameter of the saphenous vein grafts. These results are consistent 
with ACH-mediated EDRF release from saphenous vein grafts. 
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ABSTRACTS 
Chronic Cocaine Use Impairs 
Endothelium-Dependent Vasorelaxation 
4:45 
Edward Havranek, Melvin Harris, Koonlawee Nadamanee, 
Denver General Hospital and the University of Colorado Health 
Sciences Center, Denver, CO 
Chronic cocaine use has been associated with vasospastic 
ischemic events and premature atherosclerosis; damage to 
vascular endothelium may explain the genesis of both 
phenomena. We assessed vasomotion in 10 chronic cocaine 
users (B male, 2 female; mean age 39), and S normal controls 
(3 male, 2 female; mean age 32), using forearm 
plethysmography. Flow rates are in cc(blood)1 
100cc(tissue)/min ± standard deviation, drug doses are in 11 
g/min. 
Acetylcholine (ACh) was used to assess endothelium•
dependent vasorelaxation: 
baseline ACh 7.5 ACh 1S ACh 30 
control 3.B±0.B S.3±1.6 7.1±2.1 10.1±3.4 
cocaine 3.S±0.7 3.4±0.6 4.6±2.4 6.1±4.1 
p NS <O.OS <0.01 <0.01 
NSisp>O.OS 
Nitroprusside (Npr) was used to assess endothelium-
independent relaxation: 
baseline Nor 0.3 ~ Nor 10 
control 3.B±0.B 6.9±0.6 14.o±1.B lB.6±2.7 
cocaine 3.S±0.7 S.4±l.S 10.o±2.B 12.B±4.1 
p NS NS NS <O.OS 
The data demonstrate an impaired response to ACh, and 
an impaired response to Npr only at quite high doses, implying 
a defect in endothelium-dependent vasorelaxation in chronic 
cocaine users. 
764·5 5:00 
Impaired Endothelium-Dependent Vasodilation in Patients With 
Essential Hypertension: Evidence for a Generalized Endothelial 
Abnormality 
Julio A. Panza, Carlos E. Garcia, Crescence M. Kilcoyne, Arshed A. 
Quyyumi, Richard O. Cannon III. NHLBI, Bethesda, MD 
Patients with essential hypertension have impaired endothelium•
mediated vasodilation to acetylcholine (Ach) and substance P. 
However, because both agents act through the same Gi protein•
dependent signal transduction pathway, it is not known whether those 
abnormal responses are due to a specific defect of this pathway or to 
a more generalized abnormality of the vascular endothelium. To 
address this issue, we studied the forearm vascular responses to Ach 
(7.5, 15, and 30 Jlg/min); the direct smooth muscle dilator sodium 
nitroprusside (SNP; 0.8, 1.6, 3.2 Jlg/min); and bradykinin (BK; 100, 
200, and 400 ng/min), an endothelium-mediated vasodilator which 
acts through a different (Gq protein-dependent) signal transduction 
pathway, in 10 hypertensive patients (5 men; age 48±9 years) and 12 
normal controls (6 men; 48±7 years). Drugs were infused into the 
brachial artery and blood flow was measured by plethysmography. 
Maximum blood flow (mlImin11oo ml of forearm) was as follows: 
Ach 
BK 
SNP 
Normal controls Hypertensive patients 
16.6±8 7.5±2 p<O.005 
15.8±6 8.7±2 p<O.005 
8.6±2 8.6H p= NS 
Compared to normal controls, hypertensive patients had blunted 
vasodilation to both Ach and BK. The endothelium-independent 
response to SNP was similar between the two groups. Thus, the 
impaired endothelium-mediated vasodilation of patients with esseutial 
hypertension is not due to a defect of a single signal transduction 
pathway. Instead, these findings suggest a more generalized 
endothelial abnormality due to either involvement of several signal 
transduction pathways or a specific defect in the fina1 common 
pathway that governs the endothelial regulation of vascular tone. 
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764·6 5:15 
Contribution of Nitric Oxide Release to Metabolic Vasodilation 
in the Human Heart 
Arshed A. Quyyumi, Nader Dakak, Sanjeev Arora, David M. 
Gilligan, Julio A. Panza, Neil P. Andrews, Richard O. Cannon, 
III, Cardiology Branch, NHLBl, Bethesda, MD 
We have previously shown that pts with depressed coronary blood 
flow (CBF) response to acetylcholine (ACH) had reduced dilation 
with atrial pacing, suggesting that the endothelium contributes to 
metabolic coronary vasodilation. To examine whether nitric oxide 
(NO) release contributes to vasodilation during conditions of 
increased CBF, we studied the effect of inhibition of NO synthesis 
by L-NGmonomethyl arginine (L-NMMA) at rest and after atrial 
pacing. CBF was derived from Doppler flow velocity and 
quantitative angiography in \0 patients with normal coronary 
arteries. CBF and diameter changes during atrial pacing (150 
bpm) and sodium nitroprusside (SNP, 40~g/min) infusion were 
compared before and after intracoronary L-NMMA 64~M/min. 
%Change in: Pacing Pacing + L-NMMA 
Resistance -14±19 13±3 p<O.Ol 
Flow 33H8 9±4 p=0.05 
Diameter 9±5 -14± II p=O.03 
L-NMMA increased coronary vascular resistance by 22 ± 7 % at 
rest (p<O.Ol). Both epicardial and microvascular vasodilation 
observed during baseline atrial pacing were inhibited by L•
NMMA. However, endothelium-independent dilation with SNP 
was not suppressed; change in resistance -44±8% before and 
-44±19% after L-NMMA. Thus, NO release from human 
coronary epicardial and microvasculature contributes to the 
dilation during atrial pacing. Endothelial dysfunction may 
therefore reduce coronary vasodilation in response to metabolic 
stimuli due to reduced flow-mediated release of NO. 
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765·1 4:00 
Percutaneous Balloon Pericardiotomy for the Treatment of Effusive 
Pericardi~1 Disease - 104 Patient Follow·up 
Andrew A. Ziskind. Samuel. Rodriguez. Cynthia C. Lemmon, Steven 
Burstein, Sarah A. Johnson, Ted Feldman, Lawrence W. Gimple. Igor 
F. Palacios on behalf of the PBP Registry Investigators. University of 
Maryland, Baltimore. Maryland 
Percutaneous balloon pericardiotomy (PBP) offers a non-surgical 
alternative for the management of pericardial effusion. particularly 
for patients with advanced malignancy and limited survival. This is a 
long tenn follow-up report of pts treated with PBP in the multicenter 
registry. 
Between July 1987 and August 1993. 104 patients (mean age 
58±13 years) underwent PBP using a 20 mm x 3 cm dilating balloon 
(Mansfield) introduced over a guidewire via a percutaneous 
subxiphoid approach. Serial chest x-rays and echocardiograms were 
obtained during a mean follow-up of 4.8 ± 5.8 months. Seventy•
three pts presented with pericardial tamponade, 31 had large effusions 
felt to be at risk for the development of tamponade. Fifty-seven had 
undergone prior pericardiocentesis. Eightly-eight had a history of 
malignancy. 
PBP was successful in 92 pts (88%). Three pts were considered 
failures due to pericardial bleeding and underwent surgical 
windowing. Nine pts had recurrence of pericardial effusion (mean 
time to recurrence 54±65 days). Nine underwent surgical windowing. 
but 4 again recurred. Minor complications occurred in II (II %). the 
most frequent being fever. No patient had documented bacteremia or 
positive pericardial fluid cultures. Following PBP, thoracentesis or 
chest tube placement was required in 15% of pts with pre-existing 
pleural effusions vs. 9% of pts without pre-existing pleural effusions. 
Sixty-eight of the 88 pts with a history of malignancy died compared 
with 2 of 16 with nonmalignant disease. The mean survival for pts 
with a history of malignancy was 3.8±3.3 months. No procedure•
related variables were found to influence either survival or freedom 
from recurrence (e.g. # of sites dilated. visualization of free fluid exit, 
duration of catheter placement). 
Conclusion: Percutaneous balloon pericardiotomy successfully 
treats effusive pericardial disease. This is a particular advantage for 
patients with advanced malignancy and limited survival. 
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765-2 4:15 
Feasibility and Utility of Percutaneous Pericardial Biopsy as an 
Adjunct to Pericardiocentesis or Balloon Pericardiotomy for the 
Diagnosis and Treatment of Pericardial Disease 
Samuel Rodriguez, Cynthia C. Lemmon, Steven Burstein, Andrew 
A. Ziskind. University of Maryland, Baltimore, MD 
Limitations of percutaneous nonsurgical treatment of effusive 
pericardial disease (pericardiocentesis or percutaneous balloon 
pericardiotomy) include the inability to obtain tissue for 
pathological analysis. We report the feasibility and utility of 
adjunctive percutaneous pericardial biopsy as an aid in the 
diagnosis of pericardial disease. 
Twenty-seven patients with effusive pericardial disease treated 
with a percutaneous approach (15 percutaneous balloon 
pericardiotomy, 12 pericardiocentesis) underwent percutaneous 
pericardial biopsy. The mean age was 58±16 years. Sixty-three 
percent were male. Forty-eight percent had a history of malignant 
disease. To perform percutaneous biopsy, the pericardialspace was 
entered via a subxiphoid approach and a serrated jaw bioptome 
(Mansfield) was introduced through an 8F vascular introducer. 
Under fluoroscopic guidance, multiple samples were obtained from 
the posterolateral parietal pericardium. Pericardial fluid was sent 
for traditional analysis. 
Tissue suitable for pathologic evaluation was obtained in all 
biopsies. In six patients (25%), a specific pathological diagnosis not 
suggested by other conventional testing was made (4 cancer, 1 
tuberculosis, 1 radiation pericarditis). Serious complications were 
infrequent (one small pneumothorax, one death due to respiratory 
failure or bleeding, . ) 
Summary of Diagnostic Yield 
Diagnostic History of No History 
Strategy Malignancy of Malignan~ 
Biopsy Alone 38% 28% 
Cytology Alone 46% 7% 
Combined Stratel!Y 62% 28% . , 
ConclUSIOn: Percutaneous pencardlal bIOpsy may be a clinically 
useful tool in the percutaneous management of pericardial disease. 
765-3 4:30 
Adenosine Deaminase and Carci.ooembryonic Antigen in Pericardia! 
Effusion Diaposis : Especially in Suspected Tuberculous Pericarditis 
*Kwaog Koo Koh, Euog Jin Kim, Min Joon Choi, Sang Kyoon Cho, Chul 
Ho Cho, Sam Soo Kim, Chul Ju Lee, Sung Hoon Chin, Joon Mcc Kim, 
Hyeon Seok Nam, Joha University, Soognam, Korea 
Backgf"Ollnd. Adenosine dcaminasc(ADA) and carcinocmbryonic 
anligcn(CEA) ha\e been measured in plcucal fluid to help distinguish 
malignant from bcni811 illusions cspcciaII) in lubccculous picuris) . 
Method. We performed dignostic and therapeutic pericardiostomy with 
drainage and biopsy. We measured ADA and CEA levels in the pericardia! 
fluid in 26 patients(pls) with mode13le to large pcricardiaI effusion(PE) and 19 
coD1rol pis. PIs wen: included in a prospective protocol from ~'lISl. 1991 to 
A\Jb'llSl, 1993. PIs were grouped as follows: Group I - 9 pis with TP confirmed 
by bacteciologic cul!uce or histology of pericardia! biopsy: Group II - 5 pis with 
clinically strongly suspected: Group III - 12 pis with malignancy(S) and acute 
pericarditi,s(4): Group IV - 19 COD1rol pIS without pericardia! disease. We 
treated pis with TP with isoniazid, rifampin, streptomycin or ethambutol for 12 
months and pyrazinamide for 2 months. We observed any symptom and sil,'lI of 
recurrem pericarditis or constrictive pericarditis on follow-up. 
RClIIIU.. 1) In group I. the ADA activity was significantly biger (101 ± 14 
UlL) than ingroup III (22 ± 5 UlL) or that in group IV (J 7 ± 2 UlL).( P<0.05 ) 
2) There was no signifu:anl d.iffi:rence between ADA activit)' in group I (IOJ ± 
14 U/L) and that in group II (JOO ± 26 U/L). 3) If the cut-off value of ADA 
activity is 40 UlL. the sensiiNity is 93% and the specifici~' is 97% in the 
diagnosis of TP. 4) In benign disease, the CEA level was significamIy 
Iower(1.0 ± 0.3 ng/ml) than that in malignam disease(135.1 ± 79.7 
nglml).(p<O.05) 5) If cut-off value of CEA level is 5 nglml, the sensitivity is 
75% and the specificity is 100";' in the diagnosis of malignam pericarditis. 6) 
Follow-up study(mean 12.9, 19.8, 11.8 months in each group 1, II, and HI) 
showed 110 symptom and sign of constrictive pericarditis except one patient 
CoacluJion. Pericardia! fluid ADA and CEA arc useful for the diJIcrcmiaJ 
diagnosis of pericardia! illusion of various causes. They also have peal value 
in the carl) diagnosis or TP. particularl) when lhe results or other clinical and 
IaboraloI) 1CSlS arc negalil e. 
ABSTRACTS 
765-4 4:45 
Pericardia! Effusion in Patients With Cancer: Natural History and 
Management Strategies. Roger J. Laham, David J. Cohen, Michael Simons, 
Harvard-Thorndike Laboratory, Cardiovascular Division, Harvard Medical 
School, Belb Israel Hospital, Boslon, MA. 
Pericardial effusions occur in 5 % to 15 % of patienls wilb malignancy 
and contribute importantly to lbeir morbidity and mortality. The natural bistory 
and the optimal management strategy for this group are not resolved. All 
patients (PIs) at lbe Beth Israel Hospital with a diagnosis of cancer who bad an 
echocardiogram (echo) positive for a pericardia! effusion ~ I em, between 
1986 and 1992 inclusively were identified (n=50). Their clinical bistories, 
physical examinations, echo findings, and management strategies were 
reviewed. RESULTS: The mean age was 53.±. 17 years (13 men) and lbe 
median cancer stage was 4 (mean=3.6 .±.0.5). 37 PIs (74%) were symptomatic 
(66% had dyspnea and 30% bad chest pain). Echo sbowed rigbt atrial collapse 
in 37 Pts (74 %). The average duration of follow up was 10.3 .±. 13 months. 
The mortality was 72 % and was secondary to the pericardia! effusion in only 
one patient (2 %). The mean time to death was 4.7 .±. 5.7 months (median=2 
months). Of tbe 50 Pts, 29 underwent immediate pericardiocentesis, one bad a 
pericardial window placement, and the remaining 20 Pis were managed 
conservatively. Pts in tbe conservative group were less symptomatic at 
presentation than tbe other two groups (55% vs 87%, p=0.012). 4 Pts in the 
conservative group progressed to clinical pericardia! tamponade within 41 .±. 33 
days and underwent pericardiocentesis. In the pericardiocentesis group, the 
mean pericardial pressure was 14.7 .±. 4.3 mmHg and the mean rigbt atrial 
pressure was 15.4 .±. 4.9 mmHg; cytology was positive for malignancy in 15 
Pts (51.7 %). In 18 of these Pts (62.1 %) the pericardia! effusion recurred 
within 45 .±. 70 days and was treated witb a surgical pericardial window in 16 
Pts (55.2 %) and witb a repeat pericardiocenlesis in 2 Pts. Of the 17 Pis wbo 
bad a pericardial window, only one bad a recurrence. There was no statistically 
significant difference in the clinical course or mortality between the three 
groups. CONCLUSION: Patients with a significant pericardia! effusion and 
cancer bave a bigh mortality. Pericardiocentesis bas a bigb failure rate as a 
definitive procedure for these patients. Surgical or alternatively percutaneous 
pericardial window placement may be the procedure of cboice in these patients 
if intervention is needed. In patients without clinical pericardial tamponade, 
observation is recommended. 
765-5 5:00 
Does Echocardiography Accurately Reflect the Severity of 
Hemodynamics in Cardiac Tamponade 
S. Chandra Bose Reddy, Galal M. Ziady, S. Muralidhar Rao, p, 
Sudhaker Reddy, University of Pittsburgh, Pittsburgh, PA 
Cardiac tamponade is 21 clinical diagnosis. Echocardiography (20E) is 
useful to confirm it. The 20E signs of right atrial collapse (RAC), right 
ventricular collapse (RVCI and absence of inferior vena cava collapse 
on inspiration I-IVCC) are sensitive, but cannot correctly predict the 
severity of cardiac tamponade and hence not useful in the timing of 
intervention. Accordingly, we reviewed the 2DE signs in 33 patients, 
in whom a diagnostic cardiac catheterization and pericardiocentesis 
were performed within a few hours of 20E. Hemodynamically, patients 
were divided into 3 groups depending upon the initial rise in intra•
pericardial pressure (lPPI and its equilibration either with mean right 
atrial pressure (RAI or with mean pulmonary capillary wedge pressure 
(PCWP). Group I: IPP < RA and PCWP; Group II: IPP = RA but < 
PCWP; Group Ill: IPP = to RA and PCWP. The results of correlation of 
20E signs with the different hemodynamic groups ere shown in the 
following Table. 
# Pts IPP RA PCWP RAC 
Grp I 13 7 ± 6 11 ± 7' 15 ± 7. 46% 
Grp II 10 10±5 10±5 15±6. BO% 
Grp III 10 17± 5 17±4 17±4 80% 
• p<0.05 IPP vs RA • p<0.05 IPP vs PCWP 
RVC 
31% 
70% 
80% 
-Ivce 
8% 
80% 
80% 
RAC, RVC, .IVCC = percentage of pts in each group with a positive 
sign 
Conclusions: Presence of RAC. RVC in all three groups, implies that 
these findings are highly sensitive, but not specific especially it fails to 
predict the severity of hemodynamic changes. Whereas when 
combined with the absence of IVCC. it helps separating Grps II and III 
from Grp I pts. and thus aids in distinguishing a group of patients with 
severe hemodynamic changes requiring urgent intervention. 
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765·6 5:15 
Tamponade In The Cardiac Surgery Patient: A Clinical· 
Echo Diagnosis 
William J. Bommer. David Follette. John Iguidbashian. and 
Herbert Berkoff, for the University of California, Davis, CA 
Current echocardiography criteria for cardiac tamponade have 
not been tested in the post·operative cardiac patient. We 
evaluated tIx echocardiograms in 10 patients with post-operative 
cardiac tamponade from a group of 479 post·operative patients. 
The tamponade was documented by a significant improvement in 
cardiac output and blood pressure following removal of 
pericardial fluid or clot. The echoes were examined for current 
echo-tamponade criteria (right atrial (RAJ collapse, right 
ventricular (RV) collapse, exaggerated phasic chamber or 
Doppler velocity changes) or tIx presence of > I em pericardia! 
fluid/clot in the presence of hemodynamic or clinical instability. 
Results: 
Echo criteria 
RA collapse 
RV collapse 
Exaggerated Phasic Velocity 
> I em fluid + lrmodyniclin 
Sensitivity 
5/10 
6iI0 
5/10 
10/10 
Thus. tIx sensitivity of current echo criteria for tamponade 
including RA and RV collapse and exaggerated phasic changes 
is significantly reduoed in tIx post-operative cardiac patient. 
However tIx presence of > I em fluid/clot with hemodynamic or 
clinical instability carries a high sensitivity. Patients presenting 
with these clinical-echo findings warrant re-operation or 
pericardiocentesis for cardiac tamponade. 
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766·1 
Radio Frequency Ablation of Atrial Tissues: 
Power Requirements 
4:00 
Boaz Avilall, John Hare, David Krum, Eve Silverstein, Andrea Natale, Sanjay 
Oeshpande, Anwer Ohela. Sinai Samaritan Medical Center, Milwaukee, 1M. 
As redio frequency (RF) ablation proC4ldures for atrial arrhythmias becorna 
more common, power requirements for effective and safe ablation of atrial 
tissuas using the standard 4mm lip electrode should be establshed. In 12 
dogs, RF power was appled to the epicardial surfece of the atrium with a 
Mansfield 4 mm tip electrode deftectable catheter while maintaining constent 
electrode-tisaue contact. The open chest cavtty was filled with saline which 
was stirred by the movement of the lungs. RF power of 1, 5, 10, 15, 20 and 
30 watts were appied randomly to different areas of the right end left atria for 
30 seconds. The hearts were removed end the diameter and dapth (ex•
prassad as a percentage of transmural lesions) of each lesion was measured. 
pow.r (walll> 1 5 10 15 20 30 
Diam.t .. (mm) 0 4.9± 1.1· 5.2± 0.'" 6.4± 1.0 6.7± 0.7 7.5± 12 
D'pth " 0 33 25 75 100 100 
• pc 0.02 VB 15,20 and 30. 
Thirty watts of RF power rasulted in an explosion and tissue tearing in 7 of 12 
dogs at 23± 8 seconds with a lesion size no different than that generated by 
20 watts of power. 
Conclullonl: 1. RF power application to atrial tissue results In transmural 
lesions when power levels are more than 15 watts applied for 30 seconds, 
2. A power level of 30 watts may lead to tissue tearing and explosions and 
3. Twenty watts results in the sarna lesion size as 30 watts without tissue 
tearing. 
JACC February 1994:1A-484A 
766·2 4:15 
Sit. D.plndlnt variability of Sl.ctrod. TIIIIP.ratur. 
During Radio£requlnCY Cath.t.r Ablation Procedur •• 
Hugh G. Calkins, Eric N. prystowsky, Mark D. Carlson, 
Lawrence S. Klein, L. Bing Liem, Stephen Huang, Marcus 
Wharton, Paul Gillette, Ronald Berger, Atakr 
Investigators Group, Johns Hopkins, Baltimore, Me 
The electrode temperature (temp) during 
radiofrequency (RP) ablation procedures may be 
influenced by catheter stability and blood flow. These 
factors may vary with the ablation target. Tne purpose 
of this study was to determine the relationship between 
temp, the ability to achieve the targeted temp (isOC), 
and the ablation target. The study group consisted of 
~ 75 patients who underwent successful RF catheter 
ablation of AVNRT (58 pts), the AV junction (AVJ, 27 
pts), or an accessory pathway (AP, 90 pta). Forty-two 
APa were left free wall (LFW), 30 were septal, and ~8 
were right free wall (RFW). Radiofrequency power (~ to 
50 Watts) was varied to achieve a targeted temperature 
of 70 to 85 degrees using closed loop control. The 
temp and ability to achieve the targeted temp at ~341 
ablation sites were evaluated. 
Results: 
A'El.. AVNRT LFW RFW SEPTAL f 
Electrode 70i~ 59i~ 67i~ 56i1 64i~ <0.001 
Temp °c 
% Sites within 56\ 25% SU 16% 43% <0.001 
5°C Target Temp 
conclusion: The temp and ability to achieve the 
targeted temp are dependent on the ablation target. 
The temp at ablation sites is higher, and the ability 
to achieve the targeted temp is greater during ablation 
of the AVJ and of LFW and septal APs than during 
ablation of RFW APs and AVNRT. 
766·3 4:30 
Ablation of Atrial Fibrillation In 8 Dog Model 
Boaz Avitall, John Hare, Kashef Mughal, Eve Silverstein, David Krum, 
Andrea Natale, Sanjay Oeshpande, lvTwer Ohala, Masood Akhtar. 
Sinai Samaritan Medical Center, Milwaukee, IMsconsin. 
Atrial fibrillation (AFlB) presents the most challenging arrhythmia yet to be 
treated by ablation techniquas. In 13 dogs, Increased suscaptiblity to AFlB 
was created by sterile pericarditis, vegal stimulation and laupral infusion (3 
IIQramtmin). To modify AFlB, continuous epicardial transmural redlo fre•
quency (RF) lesions were created connecting the superior (SVC) end inferior 
(NC) vena cava posterolaterelly. and betwMII the SVC and the tricuspid ring 
anteriorly. The conduction lime of atrial depolarization was evaluated at a 
cycle length of 350 msac with pacing/recording electrodes pIacad anteriorly 
end posteriorly along the lateral free wall of the right atrium. AFlB was 
Induced at least 10 consacutive limes before end after RF lesions, uaing 60 
Hz alternating currentappUed to the left atrial appendllllefor5saconds. Plior 
to the ablation, the AFlB was sustained (> 3 min) in 7 dogs and in 6 dogs the 
AFlB lasted 40± 41 seconds. The length of the lesions between the SVC and 
IVC and the SIIC and tricuspid ring were 5.7± 1.1 and 3.8± 0.9 cm In length 
respectively. After RF appUcalion, AFlB lasted only 9± 14 saconds In the 
sustained group and 12± 18 seconds (pc 0.0001 VB pre-RF) in the remaining 
6 dogs. Conduction lime betwMII the eIectrodas Increased from 33± 5 to 
76± 14 msac (pc 0.0001). In 4 dogs with sustained AFlB, a 1 cm gap was 
not ablated at the mid-point between the SVC end 1\Ie to _ whether 
continuous uninterrupted lesions are required to suppress the AFlB. Three 
dogs still had sustained AFlB end the conduction time Increased ittIe from 
l4± 6 to 40± 11 msecs. 
Conclullonl: 1. RF lesions between the SVC and IVC posterolaterally and 
the SIIC and the tricuspid ring enteriOrly, result in effective suppression of 
AFIB in this dog model. 2. Unless the RF lesion was continuous end trans•
mural, there was lttIe effect on AFlB end conduction lime. 
lACC February 1994:1A-484A 
766·4 4:45 
Right·Sided Accessory Pathway Ablation Using an Anatomically 
Conforming Long Vascular Sheath Design 
·John F. Swanz, Martin E. Bacon, Westby G. FIsher, and Gregory P. 
Fazio. Uniformed Services University and National Naval Medical 
Center, Bethesda, MD 
Radiofrequency (RF) ablation of right free·wall accessory pathway 
(AP) atrial insertion sites is more difficult and less successful than 
left-sided AP ablation, probably due to atrial redundancy along the 
tricuspid annulus (T A) and resultant catheter instability. Further, 
ablation catheter to TA orientation, which depends on the exact AP 
location targeted, is highly variable, making systematic TA mapping 
more difficult than mitral annular mapping. We sought to simplify 
right free-wall AP ablation by using long vascular sheathes designed 
to conform to the atrial aspect of the T A, thereby stabilizing the 
ablation catheter to TA orientation regardless of the AP location. 
Ten consecutive patients with right free·wall AP (3 anterolateral, 4 
lateral, 3 posterolateral) were successfully ablated with 1-7 RF 
applications using the new vascular sheath design. Parallel ablation 
catheter to T A orientation was maintained in all cases, permitting 
successful vector mapping of the AP insertion. Ablation procedure 
time was 2.2±O.9 hours (1.2±O.3 hour reduction compared to an 
historical control group, p<Q.O 1) and required 35.2±1O.2 minutes of 
fluoroscopy (12.4±6.5 minute reduction, p<O.02). 
We conclude that RF right-free wall AP atrial insertion ablation is 
safely and effectively performed using the new anatomically 
conforming long vascular sheath design. The stable parallel ablation 
catheter to tricuspid annulus orientation produced by the conformal 
sheath permits accurate vector localization of AP insertion. Finally, 
significant reduction of both procedure and fluoroscopy time results 
from use of the new sheath design. 
766·5 5:00 
Radiofrequency Current Ablation at the Tricuspid Annulus of 
So-Called Mahaim Fibers Guided by Catheter·Induced Mechan· 
ical Conduction Block 
Riccardo Cappato, Michael Schliiter, Christian WeiB, Karl H. Kuck. 
University Hospital Eppendorf, Hamburg, Germany 
Evidence has been given for decrementally conducting antegrade 
accessory pathways (APs) originating at the tricuspid annulus (T A) 
in pts with the "nodoventricular AP (Mahaim) syndrome". To devise 
a reliable and reproducible strategy of radiofrequency current (RFC) 
ablation in right-sided decrementally conducting antegrade APs, 11 
pts with preexcited tachycardia involving such an AP underwent 
electrophysiologic study and subsequent ablation. Three techniques 
were used to localize the atrial AP insertion: 1) atrial pacemapping; 
2) endo- and epicardial recording of an AP potential during sinus 
rhythm; 3) catheter-induced mechanical conduction block in the AP. 
Nine APs were successfully divided in 1.9 ± 0.9 sessions per pt with 
a median of 5 (range, 1·26) RFC pulses. The site of ablation along 
the TA was anterolateral in I, lateral in 3, and posterolateral in 5 pts. 
Induction of mechanical block at the subannular level of the TA 
proved to be the most reliable means to identify the AP; it was indu•
ced in 9/9 pts. After resumption of preexcitation, RFC delivery to the 
same site eliminated AP conduction. Recurrence within 12 hours was 
exposed by atrial pacing in 5 pts, necessitating 2 eventually 
successful repeat sessions in 4 pts and I in the other. Repeat sessions 
were performed within 24 h!'S by using just the ablation catheter in 
addition to the atrial pacing catheter. During a follow-up of 8.5 ± 2.4 
months, preexcitation recurred in 1 pt. Conclusions. 1) Mechanical 
conduction block induced by catheter manipulation at the TA provi•
des an optimal maIker to guide RFC delivery in right-sided deere•
mentally conducting antegrade APs. 2) To expose early recurrence of 
preexcitation, intermittent atrial pacing after ablation is advisable; in 
cases of recurrence, a repeat procedure can readily be performed with 
just the ablation catheter advanced to the TA. 
ABSTRACTS 277 A 
766·6 5:15 
Use of Natural Magnetic Electrode Catheters for Catheter 
Mapping and Ablation 
Melvin M. Scheinman, "Thomas F. Kordis, Michael 
Chin. University of California and Cardiovascular 
Research Institute, San Francisco, CA 
Two bipolar electrode Neodymium tipped catheters 
with electrode size of 3 rom diameter and 10 rom length 
were mounted on 7 French steerable catheters. The 
Neodymium allows for magnetic interaction between 
catheters. In 5 dogs a target magnetic catheter was inserted 
into the coronary sinus (CS) and a rove magnetic catheter 
was inserted transseptal into the left atrium. When the 
rove catheter was manipulated to within 2-3 em of the 
target catheter, magnetiC interaction pulled the rove 
catheter against the target catheter. The rove catheter 
could be gently pulled over a length of 3-4 em as the 
target catheter was advanced or retracted in the CS. 
When the rove catheter was passed retrogradely across 
the aortic valve and positioned under the mitral annulus 
in close proximity to the target catheter, good attraction 
was obtained in onlyl of 5 dogs. In 4 dogs, rove and target 
magnetic catheterswere placed above and below the 
tricuspid valve ring. Excellent attraction was achieved 
between catheters in 3 of 4 dogs with the rove catheter 
held tightly to the tricuspid annulus. Electrograms 
recorded from these catheters were of excellent quality. 
Conclusions: High strength magnetic materials may be 
used for fixation of exploring catheters near target sites 
and hence may greatly expedite catheter ablative 
procedures. Video demonstration of catheter interactions 
will be demonstrated. 
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767·1 4:00 
Anterior Leaflet Procedures During Kitral Repair Do Not 
Adversely Influence Long-Term Outcome 
Eugene A. Grossi, Aubrey C. Galloway, Hartin LeSoutillier 
III, Bryan Steinberg, Julie Delianides, Frank C. Spencer, 
Stephen S. Colvin, New York University Ked. Ctr., NY, NY 
It has been suggested that mitral valve disease involving 
the anterior leaflet adversely affects the long-term 
outcome of mitral valve repair. Our policy has been to 
aggreSSively repair such anterior leaflets, including 
triangular resection in some cases. This study was done to 
assess the effects of anterior mitral leaflet procedures 
on late valve repair failure rates. From 6/79 through 
12/92 516 Carpentier-type mitral valve repairs were 
performed. The anterior mitral leaflet and chordae were 
repaired in 141 patients (mean age 58 yrs): 71 (50.3%) had 
anterior chordal shortening, 40 (28.4%) had resuspension 
of the anterior leaflet to the secondary chordae, 36 
(25.5%) had anterior leaflet resections, and 26 (18.4%) 
had anterior chordal transpOSition. Sixty five pts. (46%) 
had concomitant cardiac procedures. Operative mortality 
was 4.3% (6/141) overall and 2.6% (2/16) for isolated 
mitral valve repairs. Long term follow-up revealed a mean 
NYHA Class of 1.4 compared to 3.1 preop. Reoperation was 
necessary in 8.5% (12/141) of pts. with anterior leaflet 
procedures compared to 6. U (23/374) with other mitral 
valve procedures (p-NS). Freedom from reoperation at 5 
and 10 yrs was 90.2 and 84.2% for all pts., 89.9 and 81.4% 
for pts. with anterior leaflet procedures, and 93.2 and 
90.0% for non· rheumatic pts. Logistic regression showed 
that only age and rheumatic etiology (odds ratio-l.73) , 
but not anterior leaflet repair, increased the risk for 
reoperation. These results demonstrate that aggressive use 
of surgical repair procedures to treat anterior leaflet 
pathology is justified and does not adversely affect long· 
term results. 
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767·2 4:15 
Valve Replacement In Pta With Severe Left Ventricular 
Dysfunction. 
Frederick A. Dressler, Robert W. Amlbruster, William Collis, Jeanette 
A. SI. Vrain, Andrew C. Fiore, George C. KaIser, Arthur J. Labovitz 
Saint louis University Health Sciences Center, SI. louis, Missouri 
In order to assess the outcome of valve replacement (VR) 
associated with severe pre-operative (Pre·Op) left ventricular (LV) 
dysfunction, 223 pts were studied. Clinical and echocardiographic 
examinations were performed immediately before and 1 year after 
VR. Exercise treadmill testing (En) was also performed at 1 year. 
The PIS were divided into 2 groups according to Pre·Op LV ejection 
fraction (EF): Group I .. LVEF <40"10; Group II,. LVEF >40"10. Pre· 
operatively, these groups were similar In regards to: age (6H1l vs 
57±14); sex (Female .. 47"10 vs 42"10); CHF class (III or IV = 77% vs 
62%); coronary artery disease (21% vs 21%); aortic valve 
dysfunction (regurgitation .. 28% vs 40%; stenosis .. 77% vs 
60%); and VR site (aortic .. 71% vs 56%; mitral .. 21% vs 36%; 
aortic and mitral .. 8% vs 8%). Comparison of the Pre·Op and 1 
year results are shown in the table. 
MpnaIly 1lI Mus LVEE% Hear ETT 
GIIllIII .EIIb£ 1.111 flI:QQ l.:YIaI: fI:tilR.1:Yut ~ MEIS 
I (n-38) 7 (18%) 5 (13%) 161±49131±47 33:t6 48±15 4{14%) 6.S±3. 
II (n.l85) 8 (4%) 21 (11%) 133±51 118±37 55±8 53±9 14{100/0) 6.8±2.9 
P 0.002 NS 0.009 0.2 0.0001 0.03 0.5 0.7 
Early (<60 day) mortality was greater in Group I, however, late 
mortality was similar In both groups. LV mass, pre·operatively 
greater In Group I, decreased In both groups following VR and was 
not significantly different at 1 year. Importantly, Group I showed 
marked improvement in LVEF after VR while Group II had no 
significant changes. In addition, no significant differences in CHF 
class or functional capacity were seen at 1 year. We conclude that, 
although poor Pre-Op LVEF is associated with high early mortality 
following VR, late mortality, and 1 year CHF class and functional 
capacity are slmilar to pis with normal Pre-Op LVEF. This functional 
improvement may be due in part to Increased LV Inotropy and/or 
regression of hypertrophy. 
767·3 4:30 
Predictors and Outcome of Small Abnormal Prosthetic 
Echoes in TransesophageaI Echocardiography After Mitral 
Valve Replacement. 
Bernard lung, Bertrand Cormier, Eric Dadez, Mohamed F.Drissi, 
Raphael Tsezana, *Michel Samama, Alec VahaDian, Jean Acar -
Tenon Hospital and *H6tel-Dieu, Paris,France. 
Small abnormal prosthetic echoes (SAPE) are frequently 
observed on transesophageal echocardiography (TEE) after mitral 
valve replacement (MVR) with a mechanical prosthesis. SAPE 
might be thrombotic filaments, but their predictive factors and 
their clinil=8l consequences are not well established. 
Ninety-nine patients (pts) underwent MVR with a bileaflet 
prosthesis and had standardized anticoagulant therapy. At the end 
of cardiopulmonary bypass (CPB), heparin (H) was neutralized 
by protamin sulphate. Intravenous H was started 4 to 8 hrs after 
CPB, and was replaced after 24 to 72 hours by subcutaneous H. 
Oral anticoagulation with a vitamin K blocker was started after 7 
to 10 days. 
On TEE performed 15±8 days after surgery, SAPE were 
observed in 44 pts (44%). In multivariate analysis, the only 
patient-related predictor of SAPE was left atrium spontaneous 
contrast (LA SC) on TEE (Odds-Ratio=4.2 p<O.Ol). As regards 
treatment related predictors, the presence of SAPE was associated 
with a higher ratio of ProtaminIH during CPB (1.8±.8 vs 
1.2±.2 p< .05) and with a lower percentage of H levels >0.2 U 
(37±21% vs 5O±17% p<.03). There was no significant 
difference for the following factors: use of aprotinin during CPB, 
hematocrit, platelet count, fibrinogen level and efficacy of oral 
anticoagulation (INR). 
The presence of SAPE was related to early thrombo-embolic 
events: 23% in pts with SAPE vs 5.5% (p< .03). 
In conclusion 1) The frequency of SAPE after MVR is related to 
LA SC and to early post-operative anticoagulation, which 
supports a thrombotic mechanism; 2) The presence of SAPE is a 
marker of an increased throm~bolic risk after MVR. 
JACC February 1994:1A-484A 
767·4 4:45 
Pulmonary Autograft Replacement 01 the AortiC Valve and 
Root: Results In 30 Patients Assessed by MRI 
Gerald G. BlackweU, Albert D. Pacifico, James K. Kirklin, David McGillin, 
Maryann Roney, Greg Matter, Louis J. Dell'ltalia and Gerald M. Pohost. 
University of Alabama aI BIrmingham. BIrmingham. AL 
A pulmonary autograft was used to replace the aortic valve as a 
mini-root in 10 and as a full root in 29 patients between July I, 1992 and 
June 30, 1993. It was the first cardiac operation in 24, 2nd in 9, 3rd in S 
and 4th in 1. ASSOCiated procedures included repair 01 subaortic 
stenosis in 1, VSD in I, CABG in 1, replacemenl of ascending aneurysm 
in 2, ascending and arch aneurysm in 2, remodeling of the ascending 
aorta in 2 and enlargemenl of the aortic aMulus in 2. Ages ranged 
between 14 and 62 years. There was one hospital death. 
The 3-D capability of MRI was used to assess post surgical 
anatomy of both outflow tracts, biventricular function and valve 
competency. Diagnostic quality, anatomic and functional images were 
obtained in 30 patients early postoperatively using a I.ST Philips ACS 
Instrument. There was no evidence of anastomotic stenOSis, 
colT1lression or leakage. Mean LVEF was 53 ± 9.8%; LVEDV 130 ± 43 
ml; LVESV 62 ± 29 mi. Mild autograft incompetence (AI) was noted in 
29 and moderate in 1. Pulmonary valve homograft incompetence (Pi) 
was absenl in 11 and mild in 19. Initial fOllow-up studieS ~ 3 monlhs 
postoperative have been perlormed on 7 patienls with no progression 
of AI or PI. 
These resufts suggest mild AI is a common finding after pulmonary 
autograft replacemenl of the aortic valve and root. The uftimate role of 
this procedure will be determined by the long·term integrity of both the 
autograft in the aortiC position and the homograft in the pulmonary 
position. The accuracy of serial MRI derived volumes Is ideally suited to 
provide this long-term follow-up. 
767·5 5:00 
Marked Diastolic Dysfunction I-.ediately After Aortic 
Valve Replaca.ent for Aortic Stenosis 
Patrice A McKenney, Carl S Apstein, Lisa A Mendes, 
Gilbert P Connelly, Deanna Mahoney, Gabriel S Aldea, 
Richard J Shemin, Ravin Davidoff. Boston University 
Medical Center, Boston, MA. 
Since aortic stenosis with LVH may be a risk factor 
for diastolic dysfunction, we compared LV diastolic 
compliance after CABG and after aortic valve 
replacement (AVR). LV end diastolic areas (EDAREA) at 
the mid-papillary level were measured by 
transesophageal echocardiography before and immediately 
after surgery. Volume ~pulation was used to generate 
LV pressure-area curves. The magnitude of change in 
compliance was assessed by comparing EDAREA pre and 
post surgery at a constant preload (wedge pressure). LV 
wall thickness was measured preoperatively. 
N PreBDAREA(c.") PostBDAREA(c.2 ) ABDAREA 
CABG 20 17.6+3.6 14.9+3.5* 2.8+1.8 
AVR 9 18.3+7.3 12.3+5.5* 6.0+3.21 
*p=O.OOOl preop vs, postop Ip=O.019, AVR vs. CABG 
Vorsening of diastolic function and LV compliance, a~ 
evidenced by a leftward shift in the pressure-area 
curve, occurred in all pts. At a constant preload, 
EDAREA fell by 16% postCABG and 33% postAVR. This 
effect was not attributable to tachycardia. In the 
entire surgical group, the degree of diastolic 
dysfunction correlated with wall thickness (r=0.66, 
p=O.OOOl). Systolic function was not changed after 
surgery in either group. 
Conclusions: After cardiac surgery, diastolic 
dysfunction is very common. Diastolic dysfunction was 
more prominent in AVR than CABG pts, and correlated 
with increasing LVH. This may be an important 
consideration in postoperative management of these pts. 
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767·6 5:15 
Repair of Mitral Regurgitation From Myxomatous 
Degeneration and Heavily Caleified Posterior Annulus 
-Lawrence H. Cohn, David H. Adams, Sary F. Aranki, Robert J. 
Rizzo, Brigham and Women's Hospital, Boston, MA 
In a series of 250 mitral valve repairs for myxomatous 
degeneration, 14 patients had a severely calcified posterior mitral 
annulus. Operative techniques included complete resection of the 
posterior calcified annulus, resection of portions of the posterior 
leaflet with leaflet advancement, and placement of an 
annuloplasty ring. There were 13 males, 1 female, 61·81, (69 
years), 12114 functional class 3 or 4, and 5 required associated 
coronary bypass. 
There were no operative deaths and all patients had echo· 
cardiographic confirmation of relief of mitral regurgitation. 
During a mean follow.up time of 24 months (2 mos-84 mos). 
There have been no late valve reoperations and only one late 
death, 6 years postoperatively, from a thromboembolism in a 
patient with atrial defibrillation. 
These data indicate that even in the presence of severely calcified 
posterior annulus, mitral valve repair for myxomatous 
degeneration is possible at a low operative risk and with 
satisfactory long term results. 
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768·1 4:00 
Predidive VUIe 01 ComblDed Holter MODitoriD& (HM) and 
EIedrophysiolo&ic: TatiDI (EP) in the ESVEM Study 
Micbael Reiter, David Mann, James Reiffel, Elizabeth Hahn, 
Vernon Hartz, and the ESVEM Investigators. University of 
Colorado, DelIver, CO, Columbia University, New York, NY, 
University of Arizooa, Tucson, AZ. 
In the ESVEM study, no sianificant difference in outcome was 
obsetved in patients (pts) witb susIained ventricular anbythmias 
(VAs) in whom drug efficacy was defined by suppression of 
spontaneous VAs (by 11M) vs. suppression of inducible VAs (by 
FP). To eumine wbetber use of both techniques results in an 
improved prediction of drug efficacy, 24 br HMs were performed 
in pts randomized to the EP limb of the ESVEM study at the time 
of 1st drug triaI (1st 11M) and at the time of effective (by EP) drug 
triaI (effllM). First HMs were available in 65" (1461226) pts 
who had at least 1 EP test and eff HMs were available in 91 " 
(98/108) pts. 'lbele were no clinical differences between pts who 
bad HMs and those who did not. Concordance and discordance at 
the time of 1st HM are shown (McNemar p <0.0001): 
EP Noninducible 
Yes No 
HM Sgwression Yes 33 64 
No 15 34 
In 98 EP noninducible pts, 67" also had HM suppression in the 
eff HM. The ratio of ooncordanceIdiscordance was not influenced 
by the antiardlythmic agent being evaluated. There was no 
significant (p = 0.98) outcome difference in pts with concordant (n 
= 66) compared to those with discordant (n = 32) tests. In 
addition, comparison of pts with concordant tests to pts in whom 
efficacy was guided by HM only (n = 188), revealed no outcome 
differences (p = 0.48). 
We conclude that 1) thece is a significant discordance between 
assessment by EP and HM criteria, 2) requirement of HM and EP 
concordance reduces the number of pts with an efficacy prediction 
from 45" to 29", and 3) ~on of both spontaneous and 
inducible VA does not identify a group with better outcome. 
ABSTRACTS 279A 
768·2 4:15 
Tonade de PoIDles with SotaJol: RelatiODsblp of Geuder to Risk 
Donald G. Archibald, Barry Ouart, Sterling Hardy, Daniel J. MacNeil, 
Michael H. Lehmann, Bristol-Myers Sqwbb Pharm. Res. lost., Wallingford, 
cr, and Sinai Hospital, Detroit, MI. 
In the ESVEM triaI d,1-Sotalol produced the highest response rate and the 
best safely profile for the treatment of sustained ventricular tachyarrhythmias 
(SusVf); however, torsade de pointes (TdP) can occur with ~otaIol an.d 
therefore identification of factors related to increased risk of this 
proarrhythmia is needed to optimize patient care. We ~yzed. a 
c:omputerized database c:oosisting of c:ontemporary arrhythmia studies 
c:onducted with Sotalol. The incidence of TdP in 3135 pts (median foDow-up 
171 days) was 2.5% overall, but 4.1 % in 799 women vs 1.9% in 2336 men 
(p< .(01). The foDowing other variables were found to correlate with the risk 
of T dP: dose, baseline arrbythmia type (Sus VT vs. other), history of eHF, 
cardiomegaly, cardiomyopathy, MI, CAD, NYHA class, baseline OTe, and 
serum creatinine (er). There was no important relationship of height, weight, 
or beart rate to TdP; age was borderline. In a step-wise logistic regression: 
Gender (p < .lXXll), arrbythmia type (p < .!XXll), dose (p < .(01), history of 
CHF (p < .(01) and serum creatinine (p < .05) bad the strongest association 
with T dP; once these variables were in the mode~ no other baseline 
characteristics were significantly associated. Although mean er was similar 
in women and men, Cr was an important factor for predicting TdP in females 
but only a modest predictor in males. For patients with neither eHF nor Cr 
> 1.4 mg% (59% of men and 76% of women), TdP occurred in 2.9% of 
women and 0.7 % of men. The incidence of TdP at each dose level was 
higher for women than men even after adjusting for weight. In u:n patients 
taking Sotalol for SusVT incidence of TdP was 4.5% (10.9% in 201 women 
and 3.3% in 1076 men). In c:onclusion, women may face a higher risk vs men 
of T dP with Sotalo~ but attention to dose, cardiac and renal function sbould 
help to minimize risk of T dP in both sexes. 
768·3 4:30 
A Comparison of Holter Suppression Criteria for o.clar•
ing Drug Efficacy in Patients with Sustsined Ventricular 
Tachyarrhythmias in the ESVEM Trial. James Reiffel, 
David Mann, Michael Reiter, Roger Freedman, S.K. Stephen 
Huang, Elizabeth Hahn, Vernon Hartz, and the ESVEM In•
vestigators. Columbia Univ., NYC, NY; Univ. of Colorado, 
Denver CO; Univ. of Utah, Salt Lake City, UT; Univ. of 
Mass., Worcester, MA; Univ. of Arizona, Tucson, AZ 
Holter Monitor (HM) criteria for declaring drug efficacy 
(DE) in the Electrophysiologic Study (EPS) vs Electro•
cardiographic Monitoring (ESVEM) trial [reduction of 
total PVC by 70%, pairs by 80%, unsustained ventricular 
tachycardia (VT) runs of 3-15 beats by 90%, and runs of 
VT >15 beats by 100%] were different from criteria used 
in some previous trials. Changes in criteria may affect 
predictive accuracy of HM. Accordingly, we compared the 
predictive accuracy of EPS VB HM using 2 sets of "more 
rigid" lIM criteria for declaring DE: reduction of total 
PVC by 70%, pairs by 80%, and all VT ()3 beats) by 100% -
set 1; and total PVC by 80%, pairs by 90%, and all VT 
(;3 beats) by 100% -set 2. The incidence of DE was 45% 
(108/242 patients)by EPS and 77% (188/244) by our orig•
inal lIM criteria. DE was 59% (144/244) by set 1 and 50% 
(122/244) by set 2. Cumulative arrhythmia recurrence 
with up to 6 yrs of follow up was no different for set 1 
(p=0.78) or set 2 (p=0.84) as compared to patients with 
DE declared by noninducibility at EPS. Additionally, 
frequency of unsustained VI events/day prior to drug the•
rapy [infrequent (1-5) vs more frequent ()5)] did not 
predict arrhythmia recurrence on drug. We conclude: eff•
icacy criteria requiring a greater degree of ectopy sup•
pression than was used in the original ESVEM analysis do 
not improve predictive accuracy of HM. 
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768·4 4:45 
Endpoints of Drug Therapy: Is Tachycardia Slowing Enough? 
Stan J. Wasilewski, Kevin J. Ferrick, James A Roth, Soo G. Kim, 
John D. Fisher. Montefiore Medical Center, Bronx, NY 
Although electrophysiologic (EP) testing is effective in 
assessing drug therapy in pts with VT, the optimal endpoint of 
drug testing is controversial. Thus, we prospectively studied 174 
pts with clinical sustained VT or VF and inducible monomorphic 
VT, to determine the effect on survival of different EP endpoints 
during drug therapy. Group mean age was 62.±14 yrs, 139 pts 
were male. 148 pts had CAD, group mean EF was 37.± 16%. 
Definitions: 1) Noninducible: .510 ventricular complexes (50 pts), 
2) Partial Response: Drug slowed VT to rate < 150 bpm with BP 
~90mmHg (43 pts), 3) Failure: Induction of > 10 complexes of 
VT at rates> 150 bpm (81 pts). 
Results: Actuarial survival rates are as shown. 
12 Months 24 Months 36 Months 
.sJl Ikl!1h ill Ikl!1h ill Ikl!1h 
Noninducible 98% 88% 98%* 81% 98%* 72% 
Partial Response 98% 95%* 98o/c* 95%* 94% 91%* 
Failure 88% 77% 86% 71% 86% 65% 
(S.D. = Sudden Death. * = p < .05 compared with failure) 
In 11 pts, VT induction during therapy was significantly more 
difficult (i.e. second pacing rate + 2/3 extrastimuli); none of these 
pts died during follow-up. 
Conclusions: 1) Pts meeting partial response criteria have a good 
prognosis, survival was comparable to pts in whom VT was not 
inducible. 2) Pts in whom VT induction requires more aggressive 
stimulation also have a favorable prognosis. 
768·5 5:00 
Induction of Ventricular Fibrillation. but not of Sustained Monomorphic 
Ventricular Tachycardia Predicts Sudden Death in Patients on Amiodarone 
Because of Ventricular Tachyarrhythmias After Myocardial Infarction. 
Luz-Maria Rodriguez. Eduardo 8 Sternick. Joep LRM Smeets. 
Carl Timmermans. Jacques Metzger. Eduardo Medina. Arnd Weide. 
Giuseppe Dreto. Hein JJ Wellens. Academic Hospital, Maastricht The 
Netherlands. 
We examined the value of programmed stimulation of the heart in 
predicting sudden death (SDI in patients receiving amiodarone because 
of ventricular tachyarrhythmias after myocardial infarction. 106 pts with 
clinically documented sustained monomorphic ventricular tachycardia 
(SMVT) or ventricular fibrillation (VF) were studied. All pts had been on 
amiodarone for at least 1 month. Endpoints of stimulation (3 basic pacing 
rates. maximum of 3 extrastimulil were: induction of SMVT. VF or 
completion of the protocol. 80/1 06 ptS had either VF (15) or SMVT (65 
pts) induced. After a complete follow-up of 50.±.40 months (1-1441. 13 
patients had SD. Actuarial curves for sudden death are shown. 
J.40NTHS FO! LOW ·up 
Conclusion:ln ptS receiving amiod3rone because of life-threatening 
ventricular arrhythmias after myocardial infarction. inducibility of VF. but 
not of SMVT predicts SO. 
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768-6 5:15 
Early Hospital Discharge After Initiation of Amiodarone Tberapy: 
Mortality and Cost 
Karl C. Stajdubar, Blair D. Halperin, Charles G. Walance, John H. 
McAnulty, Jack Kron, Karen Griffith, Ronald P. Oliver, Oregon Health 
Sciences University, Portland, OR 
Recent studies support a wider role for empiric arniodarone (AMIO) 
therapy for ventricular tachycardia or fibrillation (Vf or VF), though the 
optimal hospital stay after initiation of AMIO is uncertain. Most agree that 
4 days of monitoring is required, and that longer than 10 days is probably 
unnecessary. This study examined 10 day mortality and costs associated 
with a strategy of early hospital discharge after starting AMIO. 162 
consecutive patients enrolled in an electrophysiologic study (EPS) data base 
(1980-93) who underwent EPS for vr or VF and were started on AMIO 
were reviewed to determine hospital stay, 10 day mortality, and mode of 
death. 
RESULTS: Clinical characteristics of the 162 patients include: Male 87%, 
age 72 ± 9 years, coronary artery disease 79%, ejection fraction 34 ± 15%, 
vr 67%, VF 33%, AMIO combined with other antiarrhythrnics 56%, and 
AMIO combined with defibrillator 11%. Three patients (1.9%) died within 
10 days of starting AMIO - 2 patients on day 2 (ischemia; and sudden), and 
I patient on day 10 (sudden). The mean hospital stay after AMIO was 
initiated was 3.8 ± 4 days. The mean AMIO loading dose was 1242 ± 593 
mglday and total in-hospital AMIO dose was 3347 ± 2268 mg. Room and 
telemetry charges are approximately $841/day. Compared to hospitalization 
for 10 days, the savings associated with patient discharge at day 4 after 
starting AMIO was $807,360. 
CONCLUSION: Early mortality after initiating AMIO for vr or VF was 
observed at less than 4 days, when patients are routinely monitored, or at 10 
or more days, after patients are routinely discharged. After starting AMIO 
for vr or VF, patients may be safely discharged after 4 days of cardiac 
monitoring with potentially significant cost savings. 
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Loading and cardiac Mechanical Deterwinants of Left 
Atrial Appendage Doppler Flow Velocities 
Brian D. Hoit, Vanfu Shao, Marjorie Gabel, University 
of Cincinnati, CinCinnati, OH 
To identify the hemodynamic and meChanical 
determinants of left atrial appendage (LAA) flow 
velocities (vel), ve performed transesophagea1 echo in 
8 atrial1y paced anesthetized dogs instrumented vith 
sonomicrometers on the lAA and the left ventricular 
(LV) minor axis, and LA and LV micromanometers. lAA 
emptying ve1s (e and a), and lAA filling ve1s (d and 
s) corresponding to early and late ventricular 
diastole respectively, vere compared at three levels 
of LA pressure (mmHg) produced by volume infUSion: 
LOW (S±l) MID (11±1) HIGH (lS±l) 
e vel 39.4 ± 11.6 31.0 ± 11.4 27.1 ± 16.7* 
a vel 46.1 ± 22.5 56.2 ± 24.5 56.3 ± 24.3 
e/a 0.85 ± 0.24 0.57 ± 0.14* 0.46 ± 0.17* 
d vel 37.7 ± 16.9 37.0 ± 15.8 29.1 ± 24.2 
s vel 38.0 ± 10.0 44.6 ± 9.7 41.5 ± 16.5 
d/s 0.80 ± 0.5 0.70 ± 0.40 0.40 ± 0.20* 
*p<0.05 vs. low, ANaVA; vel, in em/s 
Afterload vas also altered by phenylephrine infusion. 
The independent determinants of each flow vave vere 
identified using multiple regression analysiS. iLY!l: 
time constant of LV relaxation, LV end systolic 
dimension, and aortic pressure (r=.75, p<.001); ~: 
LV dP/dt and shortening fraction (r=.74, p<.001); d 
vel: LAA shortening fraction (r=.45, p:.01) and ~: 
LAA lengthening rate and LV fractional shortening 
(r=.56, p<.01). We conclude: 1) both the Magnitude 
and pattern of LAA emptying and filling velOCities are 
dependent on loading conditions and 2) lAA velocities 
are influenced to a greater extent by changes in LV 
than LA appendage function. These findings may have 
implications for the pathogenesis of lAA thrombi. 
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769·2 4:15 
The Effect. of LoIdlng Condition. on Tran.mitral and Pulmonary 
VIIIIOUI Flow In Severe Congestive Heert Failure 
Michael J. Malkowski. Anthony C. Pearson. DavId A Orsineili. Robert J. 
CodY. The Ohio State University. Columbus. Ohio 
Previous studies have demonstrated a significant relationship between 
pulmonary capillary wedge pressure (PCWP) and mtJtipie parameters 
derived from transmltral ftow (TMF) and pulmonary venous ftow (PVF). 
Such a relationship has not been adequately assessed In patients with 
severe congestive heart faHure (CHF). Thus. we analyzed the relationship 
between TMF. PVF and PC:WP In 12 consecutive patients (mean age 64±8 
years) with severe CHF (ejection fraction 20±7% and PCWP=27±7 mm 
Hg). Pulsed Doppler was recorded from the apical 4-chamber view. From 
the TMF deceleration time (DT). lsovolumlc relaxation time (IVAT). peak 
early (PE) and peak atrial (PA) velocities were measured. From the PVF 
systolic velocity Integral (PVSI) and % systolic Integral (% PVSI) were 
measured. Following a period of ",12 hours off oral medications. TMF and 
PVF parameters were recorded simultaneously with PC:WP In each patient. 
before and aiter administration of intravenous mnrinone or nitroglycerin 
sufficient to decrease PC:WP ~5%. resulting in a maximum of 24 
measurements. In a univariate analysis of TMF and PVF parameters. PA 
(r=0.76. p=0.OO3). E/A ratio (r=0.70. p=O.OO7). DT (r=0.76. p=0.OO7). 
PVSI (r=O.44. p=O.038) and % PVSI (r=O.46. p=0.03) significantly 
correlated with PC:WP. In multivariate analysis only DT was found to be an 
Independent predictor of PC:WP (r= 0.67. p=0.023). In the presence of 
significant (~+) mitral regurgitation (MR) the relationship between PVSI 
and % PVSI and PCWP was not significant. 
Significant MR (n=15) Nonsignificant MR (n=9) 
DT r=0.51. p=0.05 r=0.75. p=0.02 
E/A ratio r=O.88. p=0.02 r=O.68. p=O.06 
PVSI r=0.28. p=NS r=O.64. p=0.07 
% PVSI r=0.13. p=NS r=0.71. p=O.03 
CONCLUSION: PVF parameters are not Independent predictors of PCWP 
In patients with severe CHF. By blunting antegrade systolic flow. the 
presence of significant MR may confound the relationship between PVF 
and PCWP that has been previously reported. 
769·3 4:30 
The Doppler PuJmClllUY Venous Flow Pattei'll has Cliaical Relevance in 
Constrictive Pericarditis 
Huub WJ Meijbur~, 'Cees A VISSer. Pieter W Westerhof. UDiversity 
Hospital Utrecht, Free UDiversity Hospital Amsterdam, the Netherlands 
The Doppler derived pulmonary venous (PV) flow pattern is a readily available 
measure of left atrial inflow and recent studies have indicated its significance 
in the evaluation of diastolic left ventricular function. We therefore assessed 
the diagnostic value of PV flow characteristics in constrictive pericarditis (CP). 
PV flow velocities and their respiratory variation were measured in 10 pis with 
CP and in 15 normal subjects (Contr), using transesophageal Doppler 
echocardiography ('IDE). From the systolic, early and Iste (reversed) diastolic 
flow waves both peak velocity (S, D and R, em/s) and velocity time integral 
(VI'IS' VTID and VTIR' em) were obtained. Measurements were made 
L irrespective Of the re8plr8tory cycle and obtained as the average of 5 consecutive 
carciac cycles (N); 2. at begin inspiration (I); and 3. at begin expiration (E). 
Values for I and E were obtained as the average of 5 measurements at consecutive 
respiratory cycles and were expressed as % difference with those for N. 
Results CP Coutr 
N lEN I E 
S 38±15+ -6% ·2% 57±15 -3% 0% 
D 28±12il -20%+ +19%+ 6l±16 -9% +4% 
R 23±7 -10% +1% 16±6 -1% -1% 
VTIS 5.4±2.5+ -4% +2% 1l.7±4.9 -5% +6% 
VTID 3.2±1.6# -22% +34%+ 9.8 ± 4.0 -12% +8% 
VTIR 1.7:t0.8 -5% +4% 1.3±0.7 -1% +1% 
#p < 0.001 VI Contr 
+ p < 0.01 vs Contr 
Conclusions: 
Antegrade PV flow velocities as assessed by TDE are significantly lower 
in pts with cp than in normal subjects. 
PIs with CP show an exaggerated respiratory variation in D and VTID • significantly larger than in normal subjects. 
ABS1RACTS 
769·4 4:45 
Left Atrial AppeDdage Function In Atrial fibrillation aDd Flutter as a 
Predictor of Outcome Following Cardloverslon; 
A Transesopbageal Echo Doppler Study With One Year Follow-up 
Riehard A. Grimm. Allan L. Klein. William 1. Stewart, Gregory A. 
Kidwell. Lon W. Castle. Ian W. Black. Donald A. Underwood. James D. 
Thomas. The Cleveland CliDie Foundation. Cleveland, Ohio 
281A 
Previous attempts to Jredict recurrence of atrial fibrillation (AF) after 
cardioversion (CV) have focused on return ofieft atrial (LA) function post 
CV. with equivocal results. A pre CV assessment of LA function however. 
would be II10re useful. Utilizing transesophageal echo Doppler (lEE). left 
atrial appendage (LM) function can be evaluated in AF and atrial flutter 
(AFL). To determine whether LM function pre CV Is associated with 
outcome we evaluated LAA function by TEE before CV in 56 pts wiih AF 
(n=42) and AFL (0=14) and followed pts for recurrence of their arrhythmia 
for one year. We measured LAA emptying velocities (LM vel). LM 
mechanical cycle lengths (CL). LM area (cm2) and calculated an LM 
function index (CL x Vel) reJresenting a composite of frequency and 
strength of LM function. Age. etiology and arrhythmia duration. LA size 
and LV function were also assessed. Recurrence was defined by ECG 
criteria or by recurrence of symptoms. Results: Sinus rhythm was main•
tained (SRM) in only 18 (32%) pts while recurrence (R) of AF or AFL 
occurred in 38 (68%) of 56 pts at 1 year. 
LM vel lew) LM CI Ims) CL x yel Index 
R (n=38) 30±17 155±38 3.7±0.6 Oog transform) 
SRM (n=18) 38±18 176;t43 4.I±O.5 Oog transform) 
p=0.1O p=0.08 p=O.02 
Arrhythmia duration tended to be greater in the group with recurrence at I 
year (21±31 vs 6±6 months. p=O.(6). Logistic regression analysis. using 
duration and the LM function index as independent variables showed that 
the LAA function Index had an independent impact on recurrence of AF 
and AFL at one year (p = 0.036. odds ratio = 3.46). No significant differ•
ences were detected between groups for LA size. age. etiology of AF. LM 
area. or LV function. Conclusions: I) Left atrial appendage velocities 
tended to be lower and cycle lengths shorter in patients with recurrent AF 
postcardioversion. 2) The left atrial appendage function index (CL 11 vel) 
measured precardioversion in AF and AFL is useful in predicting which 
pts are likel y to have recurrence of their arrhythmia following CV. 
769·5 5:00 
Left Atrial Function Estimated By Biplane TEE 
When Is Big - Too Big? 
David S. Blondheim, Lubov Tsvik, Alon Marmor. 
Dept. of Cardiology, Rebecca Sieff Hospital, 
Safed, ISRAEL. 
We studied the relation between left atrial 
(LA) function and size. LA volumes were 
estimated by biplane TEE in 63 consecutive 
patients in sinus rhythm (mitral stenosis 
excluded). Volumes at end systole (ESV) and 
end diastole were estimated as the product of 
lateral-medial (LM), superior-inferior (SI) 
and anterior-posterior (AP) dimensions. Atrial 
stroke volume (SV), ejection fraction (EF) and 
the fractional shortening (FS) of each 
dimension were calculated. 
RESULTS: Patients are grouped by ESV; averages 
±SD for SV, EF and FS (%) are presented. 
ESV(ml) N= 
25-49 13 
50-74 18 
75-99 17 
>100 15 
SV(ml) 
22~ 7 
37±10 
43±13 
47±19+ 
EF(%) FS-LX FS-SI FS-AP 
54±15 26~14 24± 8 21±14 
56±13 31± 8 23±11 17±14 
50±16 28±11 21111 14± 7 
34±14* 17±10* 14± 9* 8±4* 
+P<O.OOl vs groups 1,2. 
*P<0.05 vs groups 1-3. 
Although SV does not demonstrate a descending 
limb in relation to ESV, LA performance is 
reduced in patients with volumes >100ml as 
reflected by a decrease in EF. This may be due 
to a decrease in FS in all 3 dimensions when 
LA is "overstretched". 
CONCLUSIONS: 1. LA function can be assessed by 
biplane TEE. 2. EF and FS decrease in patients 
with LA volumes >100 mI. 
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769-6 5:15 
Left Atrial Appendage Function In Atrial Fibrillation: A_alllllnt 
With TranHaophageal Echocardlogrephlc On-Line Automated 
B~r~lonSy~em 
Stacey E. Rosen. Lawrence Baruch. David A. Vorchheimer. Edward A. 
Fisher. Jacqueline Budd. Oma David. Mark Rosenthal. Martin E. 
Goldman. Mount Sinai Medical Center. New York. NY 
The normal left atrium (LA) is a contractile chamber. In patients with 
atrial fibrillation (AF) the LA is dilated and hypocontractile; the resuhing 
stasis of blood may predispose to spontaneous echogenic contrast 
(SEC) and thrombus formation. Most thrombi occur in the left atrial 
appendage (LAA). However. LAA function in pis with sinus rhythm (SR) 
and AF is not well characterized. To determine the relationship between 
cardiac rhythm and parameters of LAA siZe and function. 75 consecutive 
pts (58 pts SR. 17 pts AF) undergoing transesophag~al 
echocardiography were evaluated. We measured LA and LAA size 
(cm2). LAA peak Doppler velocity (pk. cmfs). presence of LAA SEC 
(SEC+) and LAA function as fractional area change (FAC%) using an 
automated on-line computerized border detection system (AUTO). 
AUTO system generated filling curve showed peak LAA ejection to 
immediately follow the ECG p or fibrillatory waves. ("= Ps.OOO1) 
..a. 
SR 58 
AF 17 
J.AWn2} 
20.4" 
33.1 
.L.AA..Wn2 } 
4.2" 
7.4 
LMRk 
78.6" 
22.1 
~ 
73" 
27 
~ 
3" 
11 
PIs with AF had larger LA and LAA siZe. lower lAApk and FAC%. and 
were more likely to have SEC+. The 14 patients with SEC+ had lower 
FAC% (27 vs 73). lower LAApk (23 vs 78) and larger LAA (7.8 vs 4.1). 
(all p S .0001). In all pis. AUTO FAC% correlated directly with LAApk. 
(r=.69 p<.OOOI). but inversely with LA size (r=.61. p:.OO27). LAA size 
(r=.67. p=.OOOI) and SEC presence (p = .0001). AUTO FAC% 
demonstrates that the LAA is an actively contracting chamber whose size 
and function are related to cardiac rhythm. Thus in AF. LA dilatation is 
accompanied by LAA enlargement and dysfunction. which may 
predispose to the presence of SEC. a herbinger of thrombus formation. 
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Acute Amiodarone Terminates Ventricular Fibrillation by Improving 
Intracellular Calcium Homeostasis in Isolated Pelfused Rat Hearts 
Shoji KOjima. Shao T Wu. Joan Wikman-Coffelt. William W Parmley. 
University of Cal~omia San Francisco. San Francisco. CA 
Intravenous amiodarone (AMIO) has acute antiarrhythmic ef•
fects despite a delayed onset of prolongation of the action potential 
and ventricular refractoriness. Effects on intracellular calcium ([Ca2+]i) 
homeostasis have been hypothesized to be an acute antiarrhythmic 
mechanism. We evaluated the acute effects of AMIO on [Ca2+]i in ven•
tricular fibrillation (VF) with sulface fluorometry in Indo-l/AM-loaded 
isolated pelfused rat hearts. [Ca2+)i was expressed as a percentage of 
the control amplitude of the Indo-l fluorescence ratio. Two minutes af•
ter VF induction by rapid pacing. hearts were pelfused with 10 J.lglml 
AMIO for 5 minutes followed by 1 J.lg/ml. simulating the acute phase 
pharmacokinetic profile of a bolus intravenous injection of 400 mg 
AMIO in man. Eleven out of 12 fibrillating hearts treated with AMIO de•
fibrillated during a 30-minute observation period. whereas sponta•
neous defibrillation was noted in only 2 out of 12 control nontreated 
hearts (p<O.OI). In control hearts without recovery (n=10). [Ca2+)i 
(mean value) increased continuously and significantly from 206±44 % 
after induction to 529±138 % at 30 minutes of VF (p<0.05). 
Spontaneously defibrillated hearts (n=2) showed less increase (p<0.05 
vs. no recovery). In hearts that recovered with AMIO (n=11). [Ca2+]i 
decreased significantly from 273±55 % before AMID to 122±94 % prior 
to defibrillation (p<0.05). As rapid [Ca2+)i recycling may be a mecha•
nism for [Ca2+)i overload in VF. we evaluated the power spectrum anal•
ysis of digitally recorded [Ca2+)i and ECG signals. [Ca2+)i responded to 
every 1 or 2 ECG signals during VF. The highest observable [Ca2+)i 
frequency was 19 Hz. AMID did not change this response pattem. 
Conclusions; 1) Acute AMID attenuated [Ca2+)i overload in VF. This 
suggested that improved [Ca2+)i homeostasis was the acute defibrillat•
ing mechanism of AMID. 2) [Ca2+)i responded rapidly to the ECG in a 
1:1 or 2:1 fashion during VF. AMID did not change this response pat•
tern. 
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Ryanodine Prevents Early Afterdepolarizations dependent Torsade 
de Pointes Arrhythmias in the Intact Heart. 
Marc A. Vos. Anton P. Gorgels, S. Cora Verduyn, Jet D. Leunissen. 
lolanda van der Zande, Hein l. Wellens, Department of Cardiology. 
Academic Hospital Maastricht, The Netherlands. 
It is known that ryanodine, a specific blocker of the Ca'· release 
channel of the sarcoplasmic reticulum, suppresses delayed afterdepola•
rizations dependent arrhythmias. In vitro, controversy exists about its 
effect against early afterdepolarizations (EAD): no effect was reported 
for cesium induced EADs, while isoprenaline induced EADs were 
suppressed. In anaesthetised dogs with chronic AV-block, we tested 
the preventive effect of ryanodine (10 /-Ig/kg/in 10 min.) on EAD•
dependent Torsade de Pointes arrhythmias (TdP). In a selected group 
of dogs, TdP were reproducibly <2.. 3 times) induced by the combina•
tion of bradycardia (AV-block), d-sotalol (2 mg/kg) and pacing. 
Results: After d-sotalol, TdP was induced at a cycle length of the idio•
ventricular rhythm of 2015.±345 ms and a QT -duration of 540.±90 ms 
(QT,: 385.±75 ms). Ryanodine prevented induction of TdP in 4/5 
experiments by shortening the cycle length to 1620.±220 ms and QT c 
415.±20 ms (QT, 320.±20 ms, all <0.05). Prevention of VT was also 
seen by shortening of QT -duration after ryanodine when a paced 
rhythm was used to correct for the decrease in cycle length. In one 
experiment, spontaneous induction of TdP occurred during injection of 
ryanodine, confirming that the antagonistic effect is preceded by an 
agonistic action that is proarrhythmic. 
Conclusion: Blockade of the Ca'· -release channel of the sarcoplasmic 
reticulum by ryanodine prevents induction of EAD-dependent acquired 
TdP-arrhythmias. 
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770-4 4:45 
Regional Capture 01 Fibrillating Right Ventricular Myocardium: Evidence or 
an Excitable Gap in VF Using High Resolution Cardiac Mapping 
Bruce H. KenKnight, Philip V. Bayly, Ronald J. Gerstle, Dennis L. RoUins, 
Patrick D. Wolf, Xiaobong Zhou, William M. Smith and Raymond E. !deker; 
Duke University Medical Center, Durham, NC 
Previous investigations suggest that during ventricular fibrillation (VF) pacing 
stimuli (STIM) are incapable of evoking propagated ventricular activations. To 
determine whether local myocardial capture (CAP) could be achieved during rapid 
pacing in YF, extlllceUular unipolar potentials (V) were sampled (2 kHz) and re•
corded from S06 electrodes (Ag-AgO, 125 JIIII dial embedded in a plaque (22x23, 
1.1 mrn spacing) overlying two pacing electrodes in the epicardium of the antero•
basaI RV in pentobarbilal-anesthetized pigs (n=6, 25-30 kg). During YF, two 
bursts of 40 STIM (lO rna, 2 ms) were applied 10 the pacing electrodes in a bipolar 
mode. Evidence of local CAP was determined by animating dV/dt (2 ftameslms) 
and by constructing Poincare maps relating inteJbeat intervals (l,,) 10 the previous 
interval (I •. !) for a recording electrode at the plaque border. 
In all 6 pigs, CAP was observed when STIM feU late in the local intrinsic acti•
vation interval of tissue immediately adjacent 10 the pacing electrodes. In S/6 pigs, 
sustained CAP (>S consecutive beats) was observed (25/108 attempts) when STIM 
cycle length was 8O-lI5% of the intrinsic activation rate. The spatial extent of 
CAP was influenced by pacing cycle length; longer cycle lengths increased the area 
of CAP compared 10 shorter cycle lengths. 
A representative Poincare section (see right 
panel) shows that during YF I n vary for pac- 160 
ing without CAP (X, IIS±8 ms, mean ± SO) 
and afrerpacing ends (+, 126±16ms), but are 140 
tightly clustered on the line of identity at the 
pacing cycle length (1IS ms) during CAP .E 120 
(C,lIS±1 ms). We conclude that activation 
can be,synchronized over a significant por•
tion (~ cm2) of RV epicardium during YF 
by delivering STIM at (I' near the local in•
trinsic activation rate. These dalB demon•
strate the existence of an excilBble gap in 
fibrillating right ventricular myocardium. 
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£1IIc:ts of Rllpid Pacing on Componants of a Stable, Func:tionIIly DeIermi1ed 
Reenlrant Circul 
Shinichi Niwano, Jose Ortiz, Haruhilco Abe, Xavier Gonzalez, Albert L. Waldo, 
Case Western Reserve University, Cleveland, OH 
The effects of rapid pacing (RP) on individual components of functionally 
determined reentrant circuits are not well understood. To test the bypothesis that 
both the direction of the activation wave front and the pacing rate can significantly 
affect the areas of slow conduction and the central area of block, RP was performed 
from selected atrial sites during stable atrial flutter (AFL) in the canine pericarditis 
model. Melho.: During 24 AFL episodes in 6 clogs, and while using a mUltiplexing 
system to record 190 unipolar elcctrograms from the right atrial free wall, RP from 
selected sites for periods of Up to 2 seconds was performed at cycle lengths 
decremented by 2 IDS from the AFL cycle length until RP interrupted AFL. RP was 
performed at 2 sites distant from the reentrant circuit (distant sites), and at 2 sites 
within the reentrant circuit (RC sites). Activation maps during RP from eacb site at 
eacb cycle length were drawn, and the areas of slow conduction and central area of 
block were compared during RP from eacb pacing site. Relllia: RP both from 
distant and RC sites interrupted AFL by causing block of the orthodromic wa.,e 
front in an area of slow conduction. The mean RP cycle length which interrupted 
AFL was 111±5 ms for distant sites and 111±6 ms for RC sites (NS). RP from 
distant sites was associated with disappearance or change in location of an area of 
slow conduction in 7112 AFL episodes, and was associated with a marked change 
in the direction of the activation wave front in the reentrant circuit caused by RP. 
RP from RC sites was not associated with a change in direction of the activation 
wave front nor with disappearance or change in location of an area of slow 
conduction. Progressive prolongation in conduction time in an area of slow 
<:onduction developed during RP from all sites with an increase in the RP rate. Tbe 
length of the functional center of block decreased in 4/12 AFL episodes with RP 
from distant sites, but only at the RP rate whicb interrupted AFL, and was 
associated with a change in the direction of the activation wave front. This did not 
bappen with RP from RC sites. CO.., .... ;ODl: In this functionally determined AFL 
reentrant circuit: I) the area of slow conduction is affected both by the direction of 
the activation wave front and the pacing rate; and 2) the central area of functional 
block may be affected by the direction of the activation wave front, but only at RP 
just prior to AFL interruption. 
ABSTRACTS 283A 
770·6 5:15 
Selective Effect of the Oass III Agent Dofetilide on Potassium Currents 
in Guinea Pig Cardiomyocytes 
Johann Siara, Palloma Villena, Thorsten Beyer, Wolfgang Kuebler, 
Johannes Brachmann, Division of Cardiology, University Medical 
Hospital, Heidelberg, Gennany 
Jon currents in guinea pig left venbicular cardiomyocytes were 
measured with the whole-ceU patch-clamp technique. Cells were isolated 
by using the Langendorff perfusion technique. The electrophysiological 
effects of the new cIass ill drug dofetiJide (UK 68 798) were investigated 
on the follOWing currents: 
1. Delayed rectifier potassium current with its fast component Ikr and its 
slow component Iks. 2. Inward rectifier potassium current Ik1 3. Fast 
sodium current. 4. Calcium current. 
Dofetilide in a concentration of 10-5 M reduced the amplitude of the fast 
component of the delayed rectifier potassium current to 41±8% (n=6) of 
control currents, measured by using 200 ms testpuIses and analyzing the 
deactivating tail currents of Ikr. The slow component of the delayed 
rectifier potassium current exhibited no significant amplitude change, 
(113±18% of control, n=7), but time constants of deactivation became 2.7 
times slower, measured by using 2000 ms testpulses and analyzing the 
deactivating tail currents of Iks. At lower concentrations of dofetilide these 
effects were minimized. 
Rapid application of dofetilide to the isolated cells showed that Ikr was 
reduced within the first minute to 60% of control. For complete current 
reduction at least 3 minutes were necessary. The depressive action of 
dofetilide on Ikr was not reversed during washout of 10 minutes. 
No effect of dofetilide was observed on the inward rectifier potassium 
currents. Also amplitudes and Hodgkin-Huxley parameters of the sodium 
currents as well as the calcium currents were not affected by dofetilide. 
This results indicate that dofetilide is not only a highly selective inhibitor 
of the fast component of the delayed rectifier potassium current, it also 
delays deactivation of its slow component. This effect may be of particular 
significance for the clinical action of dofetilide and its antiarrhythmic 
potential. 
771 Socio·Economic Implications in Clinical 
Practice 
Tuesday, March 15, 1994 4:00-5:30 PM 
Georgia World Congress Center, Room 362W 
771-1 4:00 
Pre and Post Procedure Correlates or In·Hospital Costs or PI'CA 
William S. Weintraub, Patrick Mauldin, Susan Gilbert, Fara Hicks, 
Debbie Canup. Division of Cardiology, Emory School of Medicine, 
AtiantaGA 
In·hospital costs of 2392 patients undergoing PTCA between 4/1191 
and 9/30/92 were examined. Patient Profile: Age: 62tH, Male: 
73%, Diabetes: 23%, Hypertension: 50%, Congestive Failure: 7.1 %, 
Class m-IV Angina: 76% , Prior MI: 44.3%, Prior PTCA: 39%, 
Prior Coronary Surgery (CABG): 26%, Multivessel Disease: 54%, 
Ejection Fraction: 56tll, Angiographic Success: 94%, Mortality: 
0.8%, Q wave MI: 1.1 %, Emergency CABG: 2.3%, Length of Stay 
(LOS) 3±4 days, Professional Charges: $3960±2323, Hospital 
Charges: $11563±14010. Correlates of charges (proxy for costs) 
were predicted with multiple regression. The pre-procedure correlates 
of increased cost were female gender, prior CABG, emergent PTCA, 
class m·IV angina, congestive failure, and reduced ejection fraction, 
r=.19, r sq=.04. Pre and post·procedure correlates were female 
gender, diabetes, congestive failure, death, q wave MI, emergency 
CABG, and LOS, r= .90, r sq= .81. With LOS out of the model r fell 
to .4S, r sq to .20, with emergent CABG the most powerful correlate. 
LOS alone had an r of .81, r sq .15 
Oine in figure). An exponential 100000 -r-------, 
model of the form 90000 Cost $ 
cost=a+b*exp(c*LOS) had an r of = 
.90, r sq of .82 (curve in figure). 60000 
Pre-procedures clinical 50000 
characteristics cannot accuratel y 40000 
predict cost of PTCA. 82 % of the 30000 
variation in cost can be predicted by 18888 
LOS. LOS is a reasonable first 0 -4!!!;!...;-.;....;...,~~~'" 
order approximation of resource 
uti! ization. o 3 6 9 1215182 U42730 
284A ABSTRACTS 
771·2 4:15 
Economic Outcomes FoUowiDg Coronary Angioplasty Venus Coronary 
Atherectomy: Results from the CA VEA T Randomized Trial 
Daniel B. Mark. J. David Talley, Lai Choi Lam, Lisa G. Berdan, Linda Davidson•
Ray, Roben M. Califf, Eric J. Topol Duke Medical Center, Durham, NC 
The CA YEA T multicenter randomized trial has recently reponed that coronary 
lIIherectomy (DCA) provided a larger luminal diameter and a small reduction in 6 
month angiographic restenosis compared with coronary angioplasty (PTCA), but 
was associated with a higher acute phase complication rate. To determine the 
economic consequences of these clinical differences, we performed a prospective 
economic substudy in 19 of the 32 participating U.S. sites. Hospital costs (not 
charges) and resource use were counted out to the 6 month fonow-up contact 
Baseline and 6 month summary data are shown: 
DCA PTCA 
~ !n..:.221l f 
Baseline hospital costs $11,904 $10,637 .006 
Baseline length of stay 5.7 days 5.8 days n.s. 
Fonow-up hospitalization 28% 28% n.s. 
FoUow-up hospital costs $3034 $2926 n.s. 
FoUow-up length of stay 1.6 days 1.6 days n.S. 
The baseline hospital costs for an uncomplicated PTCA pI. averaged $9090. In 
multi variable linear regression analysis, the factors signiflC3lltly (p < .05) 
increasing costs over this baseline value were: 
~ Adj Effect on Baseline Hosp Cost 
Hx of Ml 13% increase 
Hx of PTCA 24% increase 
Multivessel coronary disease 16% increase 
Abrupt closure 51 % increase 
Need for additional procedures in ICC lab 21 % increase 
Emergency bypass surgery 104% increase 
Assigned to DCA group 9% increase 
Thus, DCA was slightly more expensive to perform than PTCA (cath lab costs 
$700 higher) but the dominant forces making the DCA treatment strategy 
significantly more expensive were the higher rate of abrupt closure (7% vs 3% for 
!'TCA) and the greater need for emergency CABG (3% vs 2% for !'TCA). In 
addition, there was no evidence that the small reduction with DCA in 6 month 
restenosis caused any reduction in foUow-up medical costs. 
771·3 4:30 
Projections of the Cost IDd Benefits of EnalapriJ Treatment in Patients 
With Symptomatic Heart Fmure 
Hewy Glick, ·JoIm Cook, Martial Bourassa, Bertram Pitt, Hubert Pouleur, 
Bruce Kinosian, Andre-Pierre Contandriopoulos, *william Gerth for the 
SOL VD Investigators. University of Pennsylvania, Pbiladelphia, PA; 
Merck Research Labs, Blue Bell, P A; Montreal Heart Institute, Montreal, 
Canada; University of Michigan Medical Center, Ann Arbor, MI; 
University of Louvain, Brussels, Belgium; University of Montreal, 
Montreal, Canada; Merck & Co, Whitehouse Station, NJ 
~: Assess the clinical and economic benefits of adding enaiapril to 
usual care in symptomatic heart failure patients based OIl the Study of Left 
Ventricular DysfimctiOll (SOLVD) treatment trial. SOLVD was a 
prospective randomized double-blind placebo-controlled clinical trial of 
2,569 patients. 
Methods: Life expectancy is estimated using a parametric accelerated 
failure time model. Monthly hospitaJizatiOll rates and drug dosages are from 
trial data. Hospitali7.atiOll and enaiapril costs are based OIl the weighted 
average of estimated costs in the three SOL VD countries (Belgium, Canada 
and the U.S.). 
Results: Within trial • Patients receiving enaiaprillived an additional 1.9 
undiscounted months, primarily spent while in NYHA class I and II. The 
expected per patient cost with enaiapril was $750 less than for patients 
receiving placebo. Lifetime • Patients receiving enaiapril are expected to 
live an additional 4.8 undiscounted months, with 4.68 of these months spent 
in NYHA class I and II. The savings in the lifetime cost of care with 
enaiapril are expected to equal $355. 
Conclusions: Use of enaiapril in symptomatic beart failure patients 
increases life expectancy. Unlike many other medical interventions that are 
cost additive, enaiaprillowers the cost of care. 
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Combined Use of Education and Cost·Based Feedback 
Strategies to Successfully Reduce the Use of Low Osmolality 
Contrast Agents in the Cath Lab 
John Portelli, Samuel Rodriguez, J. Lawrence Stafford, William R. 
Herzog, Jeffrey G. Knox, Andrew A. Ziskind. University of 
Maryland, Baltimore, MD 
In recent years, the use of low osmolality contrast agents 
(LOCA) in the cardiac catheterization laboratory has increased 
significantly resulting in large costs to the health care system. The 
cost-benefit ratio may not justify their routine use for low-risk 
patients undergoing catheterization or coronary angioplasty. We 
reviewed pharmacy charges for radiographiC contrast on 2463 
patients before and after instituting a program designed to reduce 
utilization of LOCA by attending physicians. 
The initial strategy consisted of an educational program which 
reviewed current data and suggested guidelines for utilization of 
LOCA. The program was repeated 12 months later. As a second 
strategy, cost-based feedback was provided to individual 
physicians which compared their contrast use to that of other 
physicians. Contrast expenses decreased from $235 per case 
(99% LOCA use) to $214 per case (85% LOCA use) following the 
first educational program and to $167 after the second (66% 
LOCA use). After institution of cost-based feedback, expenses 
further decreased to $92 per case (40% LOCA use) with a 
sustained savings (p<0.02 between all groups). 
Conclusion: Physician education on cost-benefit can reduce the 
utilization of low osmolality contrast agents. Significant 
additional savings were obtained with the addition of individual 
cost-based feedback with peer comparison. This combined 
strategy resulted in a 60% reduction in contrast expenses 
corresponding to a $260,000 annual savings for the laboratory. 
771·5 5:00 
Clinical Efficacy and Cost Effectiveness of Rapid Emergency 
Department Rule Out Myocardial Infarction and Noninvasive 
Cardiac Evaluation in Patients with Acute Chest Pain 
Samuel Rodriguez, Joyce P. Cowler, Deanna J. Lyston, Robert 
Doherty, Debra McCarron, Georgina Groleau, Robert A. Vogel, Robert 
A. Barish, University of Maryland Medical System, Baltimore, MD 
We investigated the clinical utility and cost effectiveness of an 
outpatient chest pain evaluation center (CPEC) for low and medium risk 
pts presenting to the Emergency Department (ED) with acute chest pain 
over a four month period. Eligible pts (CPEC group, 11=108) had chest 
pain consistent with myocardial ischemia, risk factors for CAD, and 
nondiagnostic EKG on presentation to the ED. The CPEC pts 
underwent a 9 hour rule out MI observation period in a specialized ED 
unit followed by cardiac consultation, echocardiography and stress 
testing as appropiate. For coJ'lllarison, a patient cohort admitted to the 
hospital for traditional rule out MI (INPT, n=37 pts) over the same four 
month period was analyzed to determine hospital resource utilization, 
length of stay and hospital charges. The INPT group was selected on 
the basis of DRG criteria (DRG 143: Chest pain with MI ruled out) to 
ensure that the acuity of CPEC and INPT groups was comparably low. 
The mean age in the CPEC group was 50.4 years, with 64% females 
and 36% males. Most CPEC pts were discharged from the ED, but 29% 
required admission for further evaluation. Only one CPEC patient 
developed MI. In the INPT group, the mean age was 51 years, with 
53% men and 47% females. Hospital resource utilization and charges 
for both groups are presented below(ECHO=echocardiogram;STRESS= 
exercise treadmill test;CATH",cardiac catheterization;LOS",length of 
stay, in hours(h) ordavs d);COST",mean hospital charae): 
ECHO STRESS CA TH J LOS I COST I 
CPEC I 59% 47% I 3% I 16.8h I $1246 I 
INPT I 33% 33% 6% 2.2d $2810 
In conclusion: 1) The outpatient CPEe strategy provides an efficient 
evaluation of low and medium risk ED pts with acute chest pain; 2) For 
these pts, CPEC evaluation is more expedient and cost effective than 
inpatient admission, and allows a higher utilization of diagnostic tests at 
a lower overall cost. 
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771·6 5:15 
Cost-Effectiveness of Medical Versus Interventional Therapy in 
Patients With Chronic Stable Angina and Preserved Left 
Ventricular Function 
Sylvie Ahn, Thierry Bouvy, Frederic ChapeIle, Michel F. 
Rousseau, Hubert Pouleur, University of Louvain, Brussels, 
Belgium. 
To assess the cost-benefit of medical versus interventional (CABG 
and/or PTCA) therapy in patients (pts) with chronic stable angina 
and preserved LV function, 29 pts were interviewed and their fIles 
were reviewed. The selection criteria were: stable angina with ~ 
3 years of follow-up; presence of coronary stenosis technically 
suitable for surgery but no left main disease; ejection fraction 
~ 40%; a clinically and electrically positive exercise test at the 
time of the interview, after wash-out of antianginal drugs. 
Seventeen pts (Group A age : 62 ± 8 years; follow-up 6.7 ± 
3.1 years) had been medically treated and 12 pts (Group B age 60 
± 9 years; follow-up 8.5 ± 4.5 years) had had CABG (n=4), 
PTCA (n=5) or both (n=3), but were also all on antianginal 
drugs. The quality of life score showed comparable, mild to 
moderate reductions in quality of life in both groups (0.97 ± 0.86 
vs 1.17 ± 0.75; NS) but there was a trend for more pts in group 
A than in group B to have preserved intact their financial income 
(87 vs 58%; NS). Further, the total number of hospitalizations per 
patient was significantly less in group A than in B (1.06 ± 0.6 vs 
2.92 ± 1.38; p<O.OI), which caused a 200 to 300% increase in 
total cost in group B during follow-up; this difference was mainly 
related to elective hospitalizations, as the rate of hospitalization for 
complication was low and comparable in both groups (0.18 and 
0.33; NS). Thus, in this selected population, the cost of 
interventions is not compensated by a better clinical status or 
financial income. 
772 Rotational Atherectomy 
Wednesday, March 16, 1994 8:30-10:00 AM 
Georgia World Congress Center, Room 261W 
772·1 8:30 
Coronary Rotational Atherectomy for Calcified and Non 
Calcified Lesions: Final Registry Analysis. 
Andrew I. Macisaac, 'Patrick L. Whitlow, Michael J. Cowley and 
'Maurice Buchbinder. The Cleveland Clinic Foundation, 
Cleveland, OH. 
PTCA and DCA of calcified lesions are associated with reduced 
procedural success and increased complications. Data from the 
completed multicenter registry on 2161 rotational atherectomies to 
single lesions was analyzed to determine the relative efficacy of 
rotational atherectomy for calcified (n= 1078) and non calcified 
(n= 1083) lesions. Patients with calcified (CA) lesions were older 
(mean age 65.9 yrs vs 60.5 yrs, p = 0.001), more frequently had 
de novo lesions (75% vs 64%, P =0.0001) and unstable angina 
(45% vs 39%, P = 0.0001) than those with non calcified (NCA) 
lesions. CA lesions were more frequently tortuous (27% vs 22%, 
P = 0.02), eccentric (75% vs 64%, P = 0.0001), long (32% vs 27%, 
~ 10 mm in length, p = 0.01), ACC/AHA type C (26% vs 11%, p = 
0.0001) and located in the LAD (51% vs 44%, P = 0.001). 
Procedural outcomes: 
LeSIOns Success' 
CalCified 1016 
(94%) 
Non Calcified 1031 
(95%) 
Death 
14 (1.3%) 
5 (0.5%) 
CAM 
24 
(2.2%) 
26 
(2.4%) 
aMI 
6 
(0.6%) 
5 
(0.5%) 
p ns 0.04 ns ns 
'Success = <50% reSidual stenosIs Without major comphcabon. 
Non Q MI occurred in 61 (5.7%) CA and 51 (4.1%) NCA lesions. 
Success AHA/ACC type: A l00%CA vs 96%NCA, B 95%CA vs 
97%NCA, C 91%CA vs 91%NCA, (all p = ns). Mean post 
procedure residual stenosis of 21.6% in CA lesions and 23.3% in 
NCA lesions (p = ns). There was no difference in restenosis rate 
(54% CA vs 50% NCA) in the 72% of patients who have had 
angiographic follow up 
Conclysion: The sucess rate of rotational atherectomy is not 
reduced by calcification, despite the more frequent complex 
nature of the calcifed lesions. 
ABSTRACTS 
772·2 8:45 
Rotational coronary atbereetomy witb "adjunctive" balloon 
angiopIuty : wbicb is the primary and wbich is the adjunctive 
tecbnique? 
Marco Zimarino, Thierry Corcos, Xavier Favereau, Nathalie Elbaz, 
Sylvie Brossais, Corrado Tamburino, Marcel Toussaint, Yves 
Guerin, Charles Eilerman, Michel Barthelemy, Gerard Souffiant. 
CMC Parly-Grand Cbesnay, Le Chesnay, France. 
When angioplasty devices are used in combination, it may be 
difficult to determine which is the primary device, i.e. which 
technique contributes primarily to vessel lumen enlargement. 
Therefore, serial measurements were made by quantitative coronary 
angiography in SO lesions before rotational atberectomy (RA), after 
RA, after balloon angioplasty (PTCA) and 24 bours later (by 
protoco~ PTCA was systematically performed after RA). Mean burr 
size was 1.87 ± 0.23 mm (burr/refD ratio was 0.66 ± 0.13). 
RefD(mm) 
MLD(mm) 
DS ("I.) 
MLA(mm') 
AS ("I.) 
AMLA(IIIIII') 
Before RA After RA After PTCA At 14 H 
2.90 ± 0.61 2.75 ± 0.58 2.90 ± 0.60 2.93 ± 0.58 
0.91 ± 0.35 1.49 ± 0.27· 2.36 ± 0.52· 2.25 ± 0.53 
68 ± 8 45 ± 10· 19 ± 8· 23 ± S· 
O.SO ± 0.61 1.82 ± 0.63· 4.59 ± 1.97· 4.22 ± 2.11 
89± 5 70 ±17· 31± 23· 3S± 17 
1.0U 0.67 2.77 :H.7." ~.37 ±1.40· 
RefD = reference diameter; MID = minimal lumen diameter; 
DS = percentage diameter stenosis; MLA = minimal lumen area; 
AS = percentage area stenosis; .1.MLA = absolute gain in MLA 
when compared with previous measurement ; 
·p<0.02 vs previous measurement. 
Conclusion : PTCA, when used in combination with RA, is not the 
"adjunctive" but the primary technique since it provides most of the 
gain in lumen area. 
772-3 
Limitations of Rotational Atherectomy in Angulated 
Coronary Lesions 
9:00 
Bernard Chevalier, Philippe Commeau, Xavier Favereau, Yves 
Guerin, Bernard Lancelin, Thierry Corcos, Bruno Huret, Philippe 
Breno!, Marco Zimarino, Eric Lamy . C.C. Marie Lannelongue, Le 
Plessis-Robinson, France 
285A 
In order to assess the effectiveness and the limitations of rotational 
atherectomy (RA) in anguIated stenoses (AS), we selected among 861 
lesions treated with RA in 4 centers, 123 AS with a diastolic 
angulation> 45° . These 111 pts were 61 +-10 y. old and 37 were 
women. Forty-eight % had multivessel disease . Clinical indication 
was: stable angina 60% unstable angina 32% post-M1 ischemia 8% . 
Target lesions were located on the left coronary artery in 85 and on the 
right in 38; mean length was 10+-7 mm . Modified ACCIAHA 
distribution was BI 2,5%, B2 27%, >B2 44% ,C 26,5% .There 
were 12 failures of guidewire placement among which 4 successfully 
treated with balloon angiopIasty (BA). A single burr was used in 75 
% of cases; burr diameter was 1,7+-O,2mm (burr/artery=O,64+-O,I). 
An adjunctive angioplasty was performed in 97% with a 2,8+-0,36 
mm balloon at 4,3+-2,4 aim .. Diameter stenosis decreased from 75+•
II % to 47+-17% after RA and to 24+-16% after BA. Results were 
compared with those of the remaining non-severely angulated lesions 
(n=738); angiographic parameters, except angulation, were similar in 
both groups, particularly the rate of type C lesion. 
AS non-AS 
Success rate 86% 94% 
Visible dissection rate 36% 16% 
Death 2,7% 0,3% 
Major cardiac event= 5,4% 1,3% 
P 
<0,001 
<0,05 
<0,05 
0,01 
cardiac death/Q MIlemergency CABG. 
We also noted in AS group: non-Q MI 5,4%, bail-{)ut stenting 2%, 
acute closure 8 % . 
Thus, RA in AS is associated with a lower success rate and a higher 
severe complication rate than in other complex lesions. 
286A ABSTRACTS 
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Rotational Ablation with Adjunctive Balloon Angioplasty 
Versus Conventional PTCA In Type 82 Coronary Lesions: 
Immediate and Mid-tenn Results of a Randomized Study. 
Yves Guerin, Christian Spaulding, Michel Desnos, Saliha Rahal, 
Francois Funck, Francisco Femandez, Antoine Py, Alain 
Hagege, Claude Guerot. Boucicaut and eachin Hospital, Rene 
Descartes University, Paris, France. 
Conventional PTCA of type 82 stenoses is associated with 
low procedural success and high complications rates. Initial 
results of rotational ablation (RA) in such lesions appear 
promising. We therefore perfonned a randomized pilot study 
comparing (1) conventional PTCA (PTCA group) at the lowest 
inflation pressure (LIP) and (2) RA using a medium sized burr 
(50-70% burr:artery ratio) with systematic adjunctive ballon 
PTCA at the LIP (RA group) in stenoses with at least 2 of these 
characteristics: angulation! 45°, length! 1Omm, calcifications 
and/or eccentricity. Fifty six pts (28 per group) were included. 
Pre-procedure data were comparable in both groups. 
A ngiooraohic follow-uo was oerforrned in 94% of the pts. 
Results: RA group PTCAgro~ 
Technical failure en) 1 1 
O-wave MI In) 1 0 
Emergency CABG (n) 0 2 
"Bailout" stenting en) 0 2 
Mean LIP (atml 3.9+1.2 p<0.05 6.5+2.8 
Primary success*{%) 92.8 NS 82.1 
Restenosis rate (%) 37.5 NS 40.9 
(*= reSidual stenosIs <50% wlo major complications or stenting) 
Conclusion: RA with a medium sized burr and systematic 
adjunctive balloon angioplasty seems safer and more efficient at 
lower inflation pressure than conventional PTCA in type B2 
lesions. However, restenosis rates remain comparable. 
772-5 9:30 
Clinical and AngIograpblc Features of the No-Reftow Phenomenon 
Katherine M. Abbo, Sam Kazziha, David Byrd, Mark Dooris, Cindy L. Grines, 
William W. O'Neill, Roben D. Safian. William Beaumom Hospital, Royal Oak, 
MI. 
The clinical impact of no-reflow (NR) following coronary intervention is 
unknown. NR is characterized by an acute reduction in flow not explained by 
abrupt closure (dissection or thrombosis) of the target lesion. Although NR was 
reported in 116/10,676 consecutive patients at our institution (1988-93), review of 
clinical and angiographic data confirmed NR in 66 patients (0.6%, mean age 64 
yrs), whereas the remaining 50 patients actually had abrupt closure. The incidence 
of NR was 30/9431(0.3%) for PTCA, 19/469(4.1 %) for extraction atherectomy, 
8/104(8 %) for Rotablator, 7/355(2%)fordirectionai atherectomy, and 11317(0.3%) 
for excimcr laser. No-reflow was associated with death in 15 % and resulted in 
acute myocardial infarction (AMI) in 12/39 patients (30%) who did not present 
with AMI. The following characteristics were important determinants of in-hospital 
mortality· 
Incidence Mortality p-value 
( +) AMI at presentation 27 (41 %) 30% 0.006 
(-) AMI at presentation 39 (59%) 5% 
Final TIMI flow = 3 19 (29%) 0 0.Q3 
Final TIMI flow :s 2 47 (71%) 21% 
Calcified lesion 20 (30%) 30% 0.Q3 
Noncalcified 46 (70%) 9% 
lectlon fractlon < 40 %, muItlvcsscl disease and vem graft mterventlon were not 
determinants of mortality. 
Conclusions: I. No reflow is uncommon (0.6%), frequently misdiagnosed and 
clinically important because of the high incidence of death (15%) and MI (30%); 
2) The incidence of no-rcflow is higher in the AMI setting and with the use of new 
devices; 3) Failure to normalize flow, particularly in the setting of AMI, is 
associated with a poor outcome. 
JACC February 1994:1A-484A 
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The Hemostatic Puncture Closure Device Causes Similar 
Changes In Femoral Artery Flow as a Conventional Pressure 
Bandage: Results of a Randomized Study 
Hans de Swart. Lidwien Dijkman. Vincent van Ommen. Frits 
Bar and Hein J Wellens. Department of Cardiology. 
Academic Hospital Maastricht. Maastricht. The Netherlands. 
Recently the Hemostatic Puncture Closure Device 
(HPCD. Kensey Nash Co.) has been introduced to seal 
arterial puncture sites after catheterization (Cath). The 
device. anchoring behind the inner side of the arterial wall. 
might cause changes in the arterial flow pattern. To 
investigate the effect of the anchor on arterial flow a 
randomized study was started. Patients undergoing a Cath 
were randomized to HPCD insertion or to manual pressure 
followed by a pressure dressing (MP). Ultrasound studies 
were made before the Cath and after 1. 4 and 10 weeks. 
Changes in flow pattern were recorded. 
Bw!.!n: Me HPCD 
Number of patients 35 36 
Weeks 1 4 10 1 4 10 
Change in flow % 71 50 19 85 20 6 
Unchanged flow % 29 50 81 15 80 94 
Intimal flap % 3 3 0 
Anchor visible % 61 20 12 
Conclusions: 1 )The HPCD causes no more changes in flow 
pattern than MP. 2)After 10 weeks the flow patterns are 
similar as before the Cath. 3)Changes in flow pattern are 
caused by the Cath -puncture- procedure and not by the 
anchor of the HPCD. 4)1n the majority of patients the anchor 
is absorbed after 4 weeks. 
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Abnormalities In Lympbocyte Populations In Infants With Neunl Crest 
Cardiovascular Defects 
Donna K Rhoden, Linda Leatherbury, Sandra Heiman, Mary Gaffney, Margaret 
F Guill Medical College of Georgia, Augusta, Georgia 
The DiGeorge sequence has been associated with various inlmune deficits. 
Embryologically, defects of the neural crest are associated with conotruncal and 
aortic arch abnormalities. The neural crest also contributes to the thymus, thyroid, 
parathyroid and periorbital tissues of the face; the regions affected in DiGeorge 
sequence. 
We hypothesize that children with neural crest congenital heart defects 
truncus arteriosus (TA), interrupted aortic arch (lAA), double outlet right ventricle 
(DORY), single ventricle (SY), tetralogy of Fallot (TOF), have subtle but 
significant inlmune deficiencies. A purpose of our research is to identify factors 
that can predict those children most likely to be compromised inlmunologically. 
Seventeen children with neural crest cardiovascular defects were enrolled 
in the study from October 1988 to July 1993. The cardiovascular lesions were TA 
3, IAA 9, PANSD 3, TOF I, PAIlVS I. There was a 53% mortality (9117). 
Immunological studies were performed with standard techniques using 
monoclonal antibodies. Both, survivors and nonsurvivors had normal white blood 
cell counts. The nonsurvivors had a significant decrease in percentages of their 
T cell subsets cm (total T cell marker), CD4 (helper/inducer) and CD8 
(cytotoxic/suppressor) as compared to the survivors (P<.OS). The marker for 
humoral inlmunity or B cell subset (CD20) percentages were also markedly 
reduced in the nonsurvivors (P<.OS). The most significant difference was found 
in the marker for the Natural Killer cells CD 16 (P<.O I). These data demonstrate 
that abnormalities in specific lymphocyte populations and their subsets may be 
predictors of infants at greatest risk for inlmunodeficient complications. These 
children succumbed in spite of being treated as if inlmune deficient 
(administration of filtered and irradiated blood products, infection control 
measures). Therefore, children with neural crest cardiovascular defects need 
evaluation of lymphocyte subsets at birth to prevent potential graft versus host 
disease from transfusion of blood products; and to be aware of the potential 
propensity towards infection. 
JACC February 1994:1A-484A 
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Homeometric Autoregulation in tbe Newborn Heart. 
Robert 1M. Klautz, David F. Teitel, Paul Steendijk, Frank van Bel, 
Jan Baan. Cardiac Physiology Laboratory, Department Cardiology, 
University Hospital Leiden, The Netherlands. 
Maintaining stroke volume against higher afterload, by 
increasing contractility, has been shown to be present in the adult 
heart as well as in isolated muscle fibers. Because the newborn hean 
has a limited contractile reserve, we questioned the existence of 
homeometric autoregulation in the newborn heart. We studied the 
influence of afterload on stroke volume and several indices of 
contractility in 7 anesthetized newborn lambs. Via percutaneously 
placed sheaths, we advanced micromanometric and conductance 
catheters into the left ventricle (LV) and balloon occlusion catheters 
into the upper inferior vena cava (IYC) and mid-thoracic aorta. To 
assess stroke volume and contractility at different afterloads, we 
generated LV pressure-volume loops during IYC occlusion at 
control pressures and in 4-5 steady state increments in afterload 
generated by graded aortic occlusion. We calculated the end-systolic 
pressure-volume relationship (ESPVR) and stroke volume, stroke 
work, and dP/dtmax at matched preload (LV end-diastolic volume). 
By analysis of variance, we found that stroke volume at constant 
preload, but at different afterloads was not significantly different 
Also, each index of contractility increased with increasing afterload. 
The ESPVR became steeper (from 4.4 ± 0.7 at control to 6.7 ± 0.7 
kPa/rnl at highest afterload) and shifted to the left (LV volume at 14 
kPa decreasing from 3.3 ± 0.4 to J.1 ± 0.4 rnl); both stroke work 
(from 17.7 ± 2.9 to 28.4 ± 3.1 kPa.rnl) and dP/dtmax (from 402 ± 
36 to 538 ± 38 kPa/sec) at matched preload were greater at higher 
afterloads. We conclude that despite the limited contractile reserve 
homeometric autoregulation is present in the newborn heart. 
Moreover, the concept of afterload independence of contractility 
(and thus indices of contractility) is not valid in the newborn hean -
these determinants of LV performance are closely linked 
773-3 9:00 
Tilt Table Evaluation for Control Pediatric Patients: Comparison to 
SymptomaticPatients 
"JeffB. Berkowitz. Debbie Auld, J. Edward Hulse, Robert M. Campbell, 
Children's Heart Center, Egleston Children's Hospital of Emory University, 
AtJanta,Georgia 
Despite the widespread use of bead up tilt (HUT) for neurocardiogenic 
syncope evaluatiOll. limited pediatric control (C) data exists. We have 
recently studied pediatric C patients (pts) with HUT and compared this to 
results from symptomatic (S) pediatric pts. 23 C pts (13 F, 10 M; 17-18 
yrs; m=II.9±3.1 yrs) were tested. Using continuous EKG and noninvasive 
BP monitoring, C pts underwent baseline drug-free HUTI, a second drug•
free HUn, and finally HUT3 with Isuprel infusion - each 80° tilt for 30 
minutes (min) or until positive (pos). 12123 pts (52%) bad a pos response 
(6 vasodepressor, 6 mixed) with syncopeIpresyncope during HUT I at a 
mean of 18.4±7.7 min (8-30 min). During HUn, 5/23 pts were pos at 
13.4±S.7 min; all 5 pts bad previously tested pos for HUT 1. Two pts, each 
pos for HUT I and HUT2, refused HUT3. The only pt (1121) testing pos in 
HUT3 was pos for HUTI and negative for HUn. In comparison, 43/66 
(65%) S pts (41 F, 25 M; 7-18 yrs; m=13±2.6 yrs) have tested pos during 
drug-free HUT at a mean of 11.4 ±6.6 min. 20123 underwent Isuprel HUT, 
with 8120 then testing pos. Thus, a total of 5 1166 S pts (77%) were called 
true pos. Uncorrected chi-square analysis for comparison of 30 min drug•
free HUT (43/66 pos S pts) vs HUTI (12123 pos C pts) yielded no 
significant difference (p > 0.05). However, analysis of the same data at 
only 20 min till duration showed 38/66 S pts pos vs 7123 C pts pos (p < 
0.05). In summary: 1. pediatric HUT is relatively nonspecific in a C 
population (52% fulse pos); 2. concordance between HUTI and HUn is 
low; 3. lsuprel does not increase overall pos response rate for pediatric C 
pts; 4. an 80° till protocol, limiting HlTf to 20 min duration may help 
differentiate between fulse and true pos responses. 
ABSTRACTS 
773-4 9:15 
ThR Fiscal I_pact Df an E.~ditRd RRCDYRry Plan 
*J. Terrance Davis, Hugh D. Allen, Daniel M. Cohen 
*The Ohio State University and Coluabus Children's 
Hospital, Coluabus, Ohio 
A physician-driven prospective change in practice 
patterns was developed to consciously decr.ase lengths 
of stay, testing, and therefore, hospital charges for 
the surgical and postoperative aanag.aent of patients 
with uncoaplicahd congenital heart dehch. The 
expedit.d recovery plan (EAP) consistRd of 'aae day 
operation, iaaediate .xtubation and truncated, y.t 
appropriate, postoperative laboratory studies. 
To test the hypotheSiS that an ERP changes 
practice patterns without adversely effecting patient 
care, 6S consecutive atrial septal defect (ASD) 
patients were evaluated. lengths of stay (lOS) in the 
intensive care unit (ICU), hospital (TlOS), and total 
hospital charges (S) were coapared for the 1/2 year 
before and for the 4 1/2 years after institution of 
the ERP. Data were coapared by ANOVA with p<.0S 
considered significant. 
ICULOS decreased by S4.5~ froa aean 2.2 to 1.0 
days (P(.05), TlOS by 6S~ froa aean 10.0 to 3.S days 
(p(.0S), and S were reduced by 32~ froa aean S31,042 
to S21,127 tp(.0S). There was no increase in 
aorbidity (1 transient arrhythaia and 2 
pneuaothoraces), and no aortality. Parent acceptance 
was universal and no untoward events occurred after 
discharge. 
This study deaonstrates that an ERP has a positive 
effect on lOS and hospital costs with no deaonstrable 
negative effect on the patient or his/her care. 
773-5 9:30 
Arterial Switch Operation at a Consortium of University 
Hospitak 
Howard P. Gutgesell, Thomas A. Massaro, Irvin& L. Kron 
University of Virginia Health Sciences Center 
CbarIottesriIIe, Virginia 
To study facton affecting operative mortality for the 
arteria1 switch operation (ASO) for transposition of the great 
arteries, we utilized the data base of the University Hospital 
Consortium, a coalition of 62 university hospitals. From 
January, 1989 through June, 1992, the ASO was performed on 
330 patients at 19 member institutions. Data analyzed included 
age, additional cardiovascular procedures, and outcome 
(discharged, transferred, or expired). 
The overall mortality was 14.8%· Operative mortality was 
unaffected by patient age ( < 30 days vs older), date of surgery 
(initial 100 patients vs last 1 (0), the need to repair a 
ventricular septal defect, or the prior performance of Rashkind 
balloon atriaJ septostomy. However, mortality in the 7 
hospitals performing > 20 operations in the study period 
(median 8 caseslyear) was significantly lower than those 
performing <20 (median 1.7 caseslyear) (10% vs 27.5%, 
p<O.Ol). We conclude that (1) the ASO can be performed 
with a mortality similar to that of other complex procedures for 
congenital heart disease, (2) ventricular septal defect and 
balloon septostomy do not appear to alter risk, and (3) better 
results are achieved in institutions performing a larger number 
of operations. 
287A 
288A ABSTRACTS 
773·6 9:45 
Work·based Relative Value Weights for Congenital Heart Surgery: 
Correlation with Clinical Outcome and Resource Use 
Kathy J. Jenkins, Jane W. Newburger, Ludmila Kyn, James E. Lock, Usa 
I. lezzonl, John E. Mayer, Children's and Beth Israel Hosp~als, Boston, MA 
Cardiac surgeons (N=34) were surveyed to estimate work-based 
relative value weights (RVW) for surgical care for congen~1 heart defects. 
RVW's are used by Medicare for physician reimbursement for adult 
procedures, but were not previously available for pediatric cardiac surgery. 
Cases considered to be technically more difficult and to Involve more 
Intensive pre- and post-operative care received higher RVW's. . 
To determine the relation between these newly derived RVW's and 
past clinical outcomes and resource use, we used hosp~1 discharge 
abstract data from Calffornla (1988) and Massachusetts (1989). Of 2833 
congenital heart operations ldentHied using ICD-9-CM procedure codes, 
we matched 1814 (64.0%) to RVW's, which are based on Current 
Procedural Terminology (CPT) codes. Cases had Independently been 
grouped empirically Into 4 "complexity categories", based on mortality risk, 
using ICO-9-CM codes. 
RVW was signnicantly correlated with length of hosp~1 stay 
(Spearman correlation coefficient 0.43, p=.OOOI) and with total hospital 
charges (0.49, p= .0001). Mean RVW was higher among patients who died 
(25.7 + /- 5.8) than among hospital survivors (23.9 + /- 5.8) (p=.OOt). 
Large institutions had higher RVW's than smaller centers (p=.OOOI). The 
mean RVW was 25.6 + /- 5.8 for procedures performed at centers with 
>300 cases per year and 19.6 +/- 4.5 at centers with <10 cases. 
Slgnnlcant differences in RVW were present among the empiric complexity 
categories for mortality risk (p<.OOOI). Mean RVW was 18.8 +/- 2.2 in 
Category 1 patients and 31.0 + /- 5.0 in Category 4 patients. However, 
patients In Category 2 had higher mean RVW (27.6 + /- 3.6) than Category 
3 (26.9 + /- 26.9) patients. 
Work-based RVW's for congenital heart surgery show good 
correlation with other measures of resource consumption, case complexity 
and In-hospital mortality. These results validate the process by which these 
RVW's were obtained, and suggest that ~ is appropriate to base 
reimbursement for congenital heart surgery, at least In part, on RVW's. 
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Differences In Practice Patterns Between USA and Canada for 
Managemant of Unstable Angina and Acute Non-Q Wave Infarction. 
Robert S. Gibson, Bruce W. Thompson, Ralph S. Buckley, Peter H. 
Stone, Christopher P. Cannon, Margaret F. Frederick, Wayne Warnica, 
Carolyn H. McCabe, James T. Willerson, and Eugene Braunwald for the 
TlMI-3R Investigators, Univ of Virginia, Charlottesville, VA. 
Previous studies of pts with acute Q-wave MI have shown greater use 
of cardiac catheterization Icath) and revascularization procedures in the 
USA vs. Canada (C). To determine If resource use and outcome 
differences exist in pts with unstable angina or non Q-wave MI, data 
from the 18 T3R centers were prospectively evaluated. Because of the 
low representation of blacks in C, only non-black pts in both countries 
were assessed. A total of 1437 consecutive pts were enrolled; 462 
from C, 975 from tha USA. Comparisons wera age and gender adjusted 
using the Mantel-Henzel procedura. C pts were more likely to receive 
heparin IOdds Ratio [ORJ=2.43, p<.001), IV nitroglycerin IOR=I.63, 
p<.001), beta blockers (OR=2.71, p<.001). and calcium antagonists 
lOR = 1.64, P < .001) than USA pts. Exercise ECG testing lET) and cath 
were performed with equal frequency. Among pts who had cath, the 
prevalence of 0,1,2,3 VD or LMCA was similar. The aggregate rate of 
revascularlzatlon (CABG & PTCA) in the two groups was the same, 
though there was a trend favoring more PTCA in C pts lOR = 1.35, 
P = .027). There were no significant differences in the incidence of 
death, MI, and recurrent angina with ECG changes during hospitalization 
IOR=0.78, p=.16). Between discharge and 6 weeks, death and MI 
occurred with equal frequency, but angina was more common in C pts 
IOR=1.58, p<.OOl). 
Conclusions: Canadian pts with unstable CAD received more aggressive 
antianginal and anticoagulant therapy during hospitalization, and they 
were as likely to have ET, cath and a revascularizatlon procedure. 
Surprisingly, there was a trend to perform more PTeA In Canada than in 
the USA. Despite these differences In clinical practice, there was no 
major difference in outcomes. These observations appear to challenge 
the notion that USA physicians use more resources in the treatment of 
unstable CAD than their Canadian counterparts. 
lACC February 1994:1A-484A 
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Clinical Characteristics and Outcomes of Patients with Unstable Angina 
Undergoing Percutaneous Coronary Intervention in CA VEA T_ 
Robert A. Harrington, David R. Hobnes, Lisa G. Berdan, Gordon P. Keeler, 
Robert M. Califf and Eric 1. Topol for the CAVEAT Investigators. Duke 
Coordinating Center, Durham, NC 
Unstable angina (UA) enCOOlpasses a broad spectrum of clinical presentations; 
its optimal management may differ across subgroups and is currently uncertain. 
We compared the clinical characteristics and outcomes (clinical and 
angiographic) of patients with two categories of UA and patients without UA 
enroUed in CA YEA T, a multicenter biaI comparing standard balloon 
angioplasty (PTCA) to directional atherectomy (DCA). 
Outcomes 
(In Hosp; 6 mo) 
MI 
QwaveMI 
CABG 
RepeatPTCA 
Death (6mo) 
MI (6mo) 
CABG(6mo) 
Repeal PTCA (6 
mol 
No UA Accelerating Pain 
DCA 
11=174 
6.3% 
1.1 
1.7 
2.9 
1.1 
6.9 
3.4 
2.5 
PTCA 
n=149 
3.3% 
1.3 
1.3 
4.7 
0.7 
4.0 
4.0 
27.5 
DCA 
n=111 
4.5% 
2.7 
0.9 
4.5 
0.9 
6.3 
9.0 
26.0 
PTCA 
11=223 
2.4% 
1.6 
0.8 
2.4 
0.0 
3.2 
7.2 
32.0 
Rest Pain, Post 
MI, ECG Changes 
DCA PTCA 
n=223 n=223 
9.0% 3.6% 
2.7 0.0 
6.7 3.6 
4.5 3.1 
2.2 0.9 
10.8 4.9 
11.7 9.0 
34.1 31.8 
Restenosis rate 49.6% 53.8% 38.0% 48.0% 52.9% 59.6% 
In a logistic regression model ooly rest pain and/or ischemic ECG changes 
were predictors of either adverse outcomes. Patients with ECG changes had a 
greater acute gain in minimallwninal diameter (MLD), more lale loss in MLD 
and a higher restenosis rate (>50% stenosis) than patients without such changes 
(66.7% vs. 51.0%, p=O.0061). Patients with rest pain were more likely to 
experience an adverse clinical event within 6 months than those without rest 
pain (52.2% vs. 44.2%, p=O.0215). Conclusions: For risk stratification of 
patients with UA undergoing intervention, only rest pain and ECG changes 
predict restenosis and adverse clinical outcomes. In these very unstable 
patients, DCA is associated with worse outcomes than ?TCA. 
774·3 9:00 
The Paradoxical Effect of Thrombolytic Therapy for Unstable Angina: 
Mela-Analysis 
David J. Molitemo, Shelly K. Sapp, and Eric J. Topol 
The Cleveland Clinic Foundation, Cleveland, OH 
Acute coronary syndromes are a diagnostic and pathophysiologic 
continuum, and can be classified into three clinical entities --unstable 
(preinfarction) angina, non-Q-wave myocardial infarction (MI), and Q•
wave infarction. While extensive studies have shown a marked benefit of 
thrombolytic therapy in the settjng of Mis, the benefit of thrombolysis in 
subjects with unstable angina has been inconsistently reported. For this 
reason, we reviewed the medical literature of all randomized, placebo•
controlled trials of thrombolytic agents in the setting of unstable angina to 
determine if a clinical benefit were present. Specifically, a meta-analysis 
was performed comparing major, in-hospital clinical events (death or 
myocardial infarction) for 2,368 subjects enrolled in 12 trials. Studies 
were shown to be homogeneous by the Breslow-Day test, which insured 
the data could be combined, and a meta-analysis was performed using the 
Mantel-Haenszel test as below: 
Study/Author Thrombolytic Control 
n MI Death n MI Death 
Ardissino 11 I 0 12 2 1 
Bar 80 29 3 79 21 1 
Charbonnier 25 5 0 25 2 1 
Freeman 35 2 1 35 1 1 
Gold 12 0 0 12 I 0 
Karlsson 100 6 I 105 7 2 
Neri Seneri 20 0 I 19 0 0 
Nicklas 20 2 2 20 2 0 
Saran 24 2 0 24 8 0 
Schreiber 96 8 0 53 2 0 
TIMI-llm 740 42 18 733 38 18 
WiUiams 45 3 0 23 I 0 
Pooled (%) 1208 98 (8.1) 26 (2.2) 1140 79 (6.9) 24 (2.11 
In conclusion, no benefit was noted in the rate of myocardial infarction 
(thrombolytic 8.1 %, control 6.9%; p=0.39) or death (thrombolytic 2.2%, 
control 2.1%; p=0.79) for subjects with unstable angina receiving 
thrombolytic therapy. 
JACC February 1994:1A-484A 
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Unstable Angina: a Multicenter Comparative Study of Linsidomine 
and lsosorbide Dinitrate. 
·Thierry Giraud, Paris, France, for the French Multicentric Group in 
Unstable Angina. 
We conducted a randomized, parallel group study comparing the 
efficacy and tolerability of a continuous intravenous infusion of 
Iinsidomine [L] (a direct NO donor) with isosorbide dinitrate [ISDN]. 
From November 90 to October 92, 48 centres enrolled 281 [L] and 287 
[ISDN] patients (pts) presenting angina at rest with recent EeG changes 
(ST· segment depression or T·wave inversion). Patients with evolving 
myocardial infarction or ST·segment elevation were not eligible. The 
duration of infusion of L (I mg/hour with a maximum of 1.6 mg/hour) 
and ISDN (2.5 mg/hour with a maximum of 5.5 mg/hour) was 3 days. 
All patients received concomitantly oral aspirin (250 mg/d), intravenous 
heparin, beta· blockers and/or calcium channel blockers. Evaluation 
criteria were the occurrence of pain, ischemic and arrhythmic episodes 
on continuous Holter EeG monitoring (interpreted by an independent 
reader blinded to treatment allocation), and complications. 
During the whole duration of the study, 24.6% [L] vs 25.8% [ISDN] of 
the patients presented chest pain (p = 0.74) and 34% in both groups had 
ischemic episodes on Holter recordings (intention· to-treat analysis). 
During the third day of therapy, chest pain occurred in 10.3% [L] and 
10.0% [ISDN] of the patients (p = 0.82), while angina with altered EeG 
and ischemic episodes on Holter recordings were more frequent in the L 
group (8.2% [L] vs 2.9% [ISDN] p = om and 24.6% [L] vs 16.9% 
[ISDN] p = 0.04, respectively). Severe arrhythmia (Lown scale ~ 4) 
occurred in 45.0% [L] vs 49.6% [ISDN] of the patients (p = 0.28). 
Major events occurred in 4.9% of the patients as follows: 
Oinical events within 72 hours Linsidomjne Isosorbide Dinitrate 
Death 0 (0%) 3 (1.0%) 
Myocardial Infarction 8 (2.8%) 12 (4.2%) 
Emergency Revascularization 2 (0.7%) 3 (1.0%) 
Total IO (3.5%) 18 (6.2%) P = 0.19 
Tolerability was similar with headaches occurring in 32.4% [L] vs 29.6% 
[ISDN] and hypotension in 4.3% [L] vs 3.5% [ISDN] of the patients. 
Intravenous linsidomine at the dose of Img/hour appears equally 
effective to isosorbide dinitrate to stabilize unstable angina. 
774·5 9:30 
Characterization of Patient Management and Outcome in the TIp-n-1IIA 
Trial. Daniel J. Diver, B. Greg Brown, Jeffrey A. Breall, Clifford Berger, 
Susan Dwm, Bruce Thompson, Carolyn H. McCabe, Eugene Braunwald, and the 
TIMI-IlIA Study Group, Beth Israel Hospital and Harvard Medical School, 
Boston, MA. 
The TIMI-IIIA Trial is a study of the effect of thrombolytic therapy on 
the culprit lesion in pts with unstable anginaJNQMI. Pt management following 
angiography was physician directed. We assessed revascularization strategy in 
306 pts with ischemic rest pain and documented coronary stenosis who received 
TIM I-IlIA study drug (lPA or placebo) and underwent baseline and follow-up 
angiography. Selected results by pt management (p<0.01 significant):· 
Medical PTCA CABG p-value 
(N=56) (N=178) (N=72) 
Age 59 58 62 0.02 
ST and T-Wave Changes 
on presentation 55% 74% 71% 0.03 
Current Smoker 46% 40% 24% 0.02 
Multivessel CAD 46% 49% 82% <0.001 
Death, MI, or Ischemia 16% 38% 53% <0.001 
Culprit Lesion 
Averclge Stenosis 83% 84% 85% NS 
TIMI Flow Grade 2.0 2.2 2.0 NS 
Thrombus Grade 0.8 1.2 1.0 NS 
Pts with unstable angina and NQMI did Dot differ with respect to ischemic 
complications by six weeks (39 vs. 34%, p=NS); median length of stay (follow•
up angiogram to hospital discharge: 6 vs 7 days, p=NS); or use of mechanical 
revascularization (PCTA or CABG: 83 vs 78%, p=0.05). 
Conclusions: I) Management of pts with unstable angina or NQMI is related to 
clinical features and presence of multivessel CAD. 2) Age and multi vessel CAD 
may identify pts more likely to undergo CABG and to bave ischemic 
complications by six weeks. 3) Culprit lesion severity, flow, and thrombus grade 
do not appear to affect revascularization strategy. 4) Pts with unstable angina 
and NQMI have similar rates of ischemic complications and mechanical 
revascularization by six weeks. 
ABSTRACTS 
774·6 9:45 
Increasing Angina Instability Predicts An Unfavorable Outcome After 
New Device Angioplasty 
Va Chien Chuang, Jeffrey J. Popma. Lowell F. Sader, Augusto D. Pichard, 
Kenneth M. Kent, Gary S. Mintz. TberesaA. Bucher, Alan J. MelTitt, and Martin 
B. Leon. Washington Hospital Center, Washington, DC 
Unstable angina (VA) is associated with an unfavorable outcome after PTCA, 
although its broad inclusion criteria renders the population with UA marlcedly 
heterogeneous. To determine wbether the panern of UA is associated with 
subsequent clinical events, we examined the early and late clinical outcome in 
2170 patients undergoing new device angioplasty. Patients were classified into 
3 groups based upon the presenting angina pattern: ~: Stable angina; 
_100 
~90 
~ 80 
= 
'" 70 ~60 
= ~50 
~: accelerated or exertional 
post-MIanginaor~: restpain 
or pain associated with electrocardio•
graphic (EKG) changes. Clinical suc•
cess « 50% fmal diameter stenosis 
and no death, Q-wave MI, CABG or 
PTCA < 14 days) was reduced with 
increasingly instability of USA. It 
was 91.3% in Group 1. 87.4% in 
Group 2 and 83.8% in Group 3 (p < 
o 100 200 300 400 ~~;~~:u:n:sn~~~~~::~ 
Follow-up (in days) MI, CABG) increased with the de-
gree of angina instability: they occwred in 1.9% of Group I, 5.1 % in Group 2. 
and 7.5% in Group 3 (p < 0.001 for linear trend). Linear trends were noted with 
increasing angina instability for female gender (p = 0.00 I). diabetes mellitus (p 
.< 0.001). thrombus (p = 0.009), non-Q-wave infarction (p < 0.(01), recurrent 
ischemia (p < 0.(01) and repeat PTCA (p = 0.03). One year event free survival 
(freedom from death. Q-wave MI. CABG or repeat PTCA) was highest (73.2%) 
in Group I patients. lower (66.4%) in Group 2 patients and lowest (62.8%) in 
Group 3 patients (p < O.OOI)(Figure). We conclude the pattern of angina 
instability has important prognostic implications and should be characterized in 
prospective clinical studies which evaluate early and late outcome after coronary 
angioplasty . 
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775·1 8:30 
Time Course of Intimal Thickening Development after 
Heart Transplantation 
Javier Botas, Fausto J. Pinto, Adrian Chenzbraun, Edwin L. 
Alderman, Stephen N. Oesterle, *A1an C. Yeung, *Richard L. Popp. 
Div of Cardiovasc Med, Stanford, CA 
Coron~ artery disease (CAD) is the main cause of morbidity and 
mortaht~ bey.ond one year after heart transplantation (HTx). 
Interv~ntJons auned to reduce CAD would be most effective if applied 
early, Ideally, at the time of most rapid progression of the disease. In 
order to assess the time course of intimal proliferation after HTx 67 
~oronary sit~s (34 patients) were studied three times (one year 
mtervals) by mtracoronary ultrasound (ICUS). ICUS catheter location 
in serial studi~s was verified angiographically in relation to branch 
vessels. Lununal area (LA) and area of lumen plus intima (IL) were 
measured at each site. Mean intimal thickness (IT) and an index of 
intimal thickness (II) were calculated (IL-LAIIL). Our four Class 
system, based on IT and vessel circumference involved was used to 
grade lesion severity. The change (M in IT, II and Class was 
calculated for every site in relation to the time to the operation (134 
paired one year interval observations) for years 1 2 3-4 and >4 after 
HTx. " , 
Results: 
Year N AlI (mm) All (mm) AClass * 
1 24 0.06±O.04 0.04±O.03 0.79±O.28 * 
2 41 0.04±O.02 0.01±O.02 0.22±O.18 
3-4 38 O.OI±O.03 -0.0I±O.02 0.03±O.1l 
>4 31 0.04±Q 04 0.02±Q.02 0.26±O 15 
All values mean±SE, * p<0.05 for 1 vs 2 and 1 vs 3-4 
Co~c1usions: CAD rate of progression appears to be maximal 
dunng the first year after HTx, and may increase again beyond 4 
years after HTx. The i,ncrease in CAD progression late after HTx may 
be secondary to clasSIC coronary atherosclerosis rather than immune 
mediated HTx-CAp. ~terventions aimed to impact the development 
of CAD should be msUtuted early after the operation. 
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775-2 8:45 
Quantification of Coronary Luminal Area by Intracoronary 
UHrasound both Pre and Post PTCA. 
Yuklo Ozaki, Jurgen Haase, Carto dl Mario, David Keane, Jose Baptista, 
Peter de Jaegere, Pim de Feyter, Jos R.T.C. Roeland!, Patrick W. Serruys. 
Thoraxcenter, Erasmus University, Rotterdam, The Nethertands. 
While Intracoronary ultrasound (lCUS) may provide novel tomographic 
information on coronary arteries, Its value in the quantifICation of luminal area 
remains to be estabiished. Sixty patients who underwent successful PTCA 
were examined by ICUS and by quantitative angiography - QCA (eMS II) 
using the minimal iuminal diameter from two angiographic projections to 
calculate the minimal cross sectional area (MCSA). Differences' between 
MCSA obtained from iCUS and QCA were compared pre and post-PTCA in 
60 patients, of whom 35 patients were excluded from pre-PTCA analysis due 
to wedging of the ICUS catheters. 
,-0.63 y-2.15+0.76x 
o~--------------~ o • • OCA (111m2) 10 
10 MCSA ( post PTCA, "-60 ) 
--"/,,,-{ 
N 
~ . 
,-0.43' y-3.77+0.35x 
o~--------------~ 
o • • QCA,(mm2) 10 
MCSA obtained by ICUS is significantly larger than MCSA measured by OCA 
both before and after PTCA (p < .00 1), with considerabie deterioration In 
correlation after PTCA. ICUS has been previously shown to be more sensitive 
than QCA in the detection of plaque disruption. Plaque ruptures not filied by 
contrast medium (stagnant biood or thrombus) may contribute to 
overestimation of luminal area by ICUS. Additionally, echo !all-out due to 
guide wire artifact and elliptical angulation of the ultrasound catheter within 
the longitudinal axis of the vessel may augment the overestimation of cross 
sections. Technological improvement will be required before ICUS can be 
recommended as a reliabie tool for luminal quantification. 
775-3 9:00 
Intracorooary Ultrasound Imaging of Angiograpbically 
Unidentified Left Main Coronary Artery Atherosclerosis 
Raimund Erbel, Junbo Ge, Michael Haude, Giinter GOrge, Hans J. 
Rupprecht*, Jiirgen Meyer*. Dept. of Cardiology, University Essen 
and *11. Medical Clinic, University Mainz, Germany 
Patients with left main coronary artery (LMCA) atherosclerosis 
have a poor prognosis compared with lesions in the other coronaries. 
Because of the methodological problems, LMCA atherosclerotic 
lesions are frequentely not detected by coronary angiography. The 
purpose of the study was to evaluate the existence of LMCA disease 
in patients with normal coronary arteries using intravascular 
ultrasound imaging. Ninety-seven patients with angiographically 
normal coronary arteries were examined with a 3.5 For 4.8 F, 20 
MHz intravascular ultrasound catheter. The vessel area, lumen area 
and plaque area were determined and percent area and diameter 
stenosis were calculated. Plaque formation with or without calcific 
deposits identified by ultrasound accoustic shadowing were regarded 
as signs of atherosclerosis. 
Results: Atherosclerosis was detected in 36/97 (37%) patients. 83% 
of the plaques were eccentric and 17 % were found with calcific 
deposits. The cross-sectional area of the plaques was 6.3 ± 3.3 mm1 
( 1.8 to 16.7 mml). Vessel area was 20.2 ± 7.2 mml. Area stenosis 
was 31.6 ± 12.1 % ( 12% to 57.2%). Diameter stenosis was 19.3 + 
7_2% ( 8.7% to 34.6%). -
Conclusion: LMCA atherosclerosis is present in more than 113 of 
patients with angiographically normal coronary arteries. The negative 
results of angiography may be explained by the compensatory 
enlargement of the coronary arteries which may mask the early signs 
of lumen narrOwing caused atherosclerosis. 
lACC February 1994:1A-484A 
775-4 9:15 
Intravascular Ultrasound Guided Rotational 
Atherectomy of Flbro-Calciflc Plaque Prior to 
Intracoronary Deployment of Palmaz-Schatz Stents 
·Steven L. Goldberg, Patrick Hall, Yaron Almagor. luigi Maiello. 
Leo Fincl •• Jonathon Tobis and Antonio Colombo. Centro Cuore 
Columbus. Milan. Italy and ·UC Irvine. Orange. California 
Flbro-calclflc plaque (FCP) can limit optimal stent expansion. 
Rotational atherectomy (RTB) can be used to modify the libro•
calcifiC region and potentially Improve stent expansion. 
Intravascular ultrasound (IVUS) was used prior to Intracoronary 
Implantation of Palmaz-Schatz stents In 43 pts without 
calcification on angiography to identify flbrocalcific plaque, FCP 
of more than 90· was identified in 20 pts who had subsaquent 
rotational ablation. Successful stent Implantation was achieved In 
42 of the 43 pts (97.7%). The pt with an unsuccessful procedure 
raqulred urgent CABG. There were no other complications, After 
stent deployment, all pts had round. symmetric. well-expanded 
stents on IVUS. The angiographic reference vessel diameters were 
3.1 mm with baseline percent stenosis of 67% for each group 
(MLD 0,910.5 mm in RTB group vs 1.010.4 mm. p= ns). The 
mean pre-stent lumen cross-sectional area by IVUS was 2.9±1.1 
mm2 for the pts receiving RTB vs 3.8±1.8 mm2 In the non RTB 
group (p=0.05). Mean burr size was 1.7510.23 mm. The mean 
angiographlc final percent stenosis was -5±15% In the RTB 
treated pts and -10±14% In the non-RTB pts (p-ns). reflecting 
acceptable stent expansion. The IVUS lumen cross-sectional area 
remained significantly lower, however. for the pts receiving 
RTB. 7.53±1.8 vs 9.01±2.0 mm2 (p<0.05). This difference 
likely represents the effect of FCP on stent expansion. despite 
attempts at plaque modification with RTB. Conclusion: IVUS 
identifies a subgroup of patients with FCP which are not detected 
by angiography. Lesions with FCP are associated with lesser 
degrees of stent expansion. probably due to FCP compression of 
the stent. IVUS followed by RTB when fibro-calciflc plaque is 
seen Is feasible and associated with effective stent deployment. 
775-5 9:30 
Atherosclerotic Burden Detected by Intravascular Ultrasound in Familial 
Hyperlipidemia Relates Inversely to High-Density Upoproteins. 
Dirk Hausmann, Jay A. Johnson, Krishnankutty Sudhir, 'WilIiam L. 
Mullen, Thomas A. Ports, john P. Kane, Mary j. Malloy, ·Peter j. 
Fitzgerald, 'Paul G. Yock. University of California, San Francisco, CA. 
Since angiography (ANGlO) only detects luminal narrowing, this 
teehnique is limited in assessing early atherosclerotic plaque. We studied 
left main, proximal left anterior descending (LAD) and common iliac 
arteries in 48 asymptomatic patients (32 m, 16 f; age 47±12 yrs.) with 
familial hypercholesterolemia or familial combined hyperlipidemia using 
ANGlO and intravascular ultrasound (NUS; 4.3 F, 30 MHz). Intima (INT) 
index (ratio !NT lINT +Iumen area) and plaque surface area (% of total wall 
surface) were measured during timed IVUS pullback (1 mm/sec). Extent 
of plaque was higher in the LAD (mean INT index 0.25±O.14, plaque 
surface 56±34%) than in the left main artery (0.09±0.16; 28±38%) or in the 
iliac artery (O.02±O.04; 5±16%). Compared to ANGlO, NUS was more 
sensitive in detecting plaque in the LAD (89% vs. 26%), left main (44% vs. 
6%) and iliac artery (33% vs. 27%). In all coronary segments, ANGlO detee-
100 ted only advanced disease (max. 
40 
!NT index > 0.4 by IVUS). 
Severity of coronary athero•
sclerosis (max. INT index) in•
versely correlated to HDL 
cholesterol (r=-O.70; p<O.OOl). In 
a multiple regression analysis 
including demographic, lipid 
and other risk factor data, HDL 
• .---....,..--'T.--....... --r-. --"---" cholesterol was the most 
0.0 0.2 0.4 0.6 powerful predictor of severity of 
!NT index (max.) atherosclerosis (p<O.OOI). 
Conclusions: (t) Despite extensive coronary atherosclerosis in asympto•
matic patients with familial hyperlipidemia, most changes remain angio•
graphically silent. (2) HDL cholesterol has a strong inverse relationship to 
the severity of angiographically silent coronal)' atherosclerosis. 
JACC February 1994:1A-484A 
775-6 9:45 
Initial In Vivo Studies Using a New Forward-Viewing 
Intravascular Ultrasound Catheter 
Stephen P. Wiet, Kok-Hwee Ng, Michael J. Yonesh~i11iam N. 
Aldrich~Yue-Teh Jang~Paul G. Yock, Bonnie J. Kane, Rodney 
Greene, Sheridan N. Meyers, Sanford 1. Roth, David D. 
McPherson, Northwestern University Medical School, Chicago, 
IL; Cardiovascular Imaging Systems, Sunnyvale, CA 
We have previously shown that a prototype forward-viewing 
intravascular ultrasound (FY-IVUS) catheter can obtain images 
with good structural resolution in vitro. To evaluate in VIVO 
utility, 14 arterial segments from 4 animals (3 calves, 1 dog; X 
weight 43 kg) were studied. Following abdominal dissection, the 
14 French FY-IVUS catheter was introduced into the proximal 
abdominal aorta. Antegrade images of the aorta, iliac and 
caudal arteries and their bifurcations were obtained. Following 
imaging, the arterial segments were removed, perfusion-fixed 
and histologically compared to ultrasound images. 
Results: In vivo images were obtained up to 2 em forward from 
the catheter tip with little acoustic interference from blood. 
Detailed resolution was obtained without having to enter the 
arterial branches. Very good correlation between histologic and 
FY-lVUS lumen diameter (LO) measurements was obtained. 
Mean FY-IVUS LD = 8.5 ±. 3.8 mm; Mean Histo LD = 7.4 ±. 
2.9 mm. FY-IVUS LO = 1.3(Histo LO) - 1.0; r = 0.95, n = 17. 
Conclusion: These in-vivo data support the use of this forward•
viewing intravascular ultrasound catheter for evaluating 
intravascular arterial geometry. 
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776-1 8:30 
The Severity of Mitral Regurgitation and the Prognosis in Mitral 
Valve Prolapse 
'Seungbum Kim. Toshio Kuroda. Masanori Nishinaga. Masanori Yamasawa. 
Shintaroh Watanabe. Kazuyuki Shimada. Jichi Medical School. Tochigi. Japan 
To investigate the relationship between the severity of mitral regurgitation (MR) 
and incidence of complications and cardiac events in patients (pts) with mitral valve 
prolapse (MVP). a follow-up study was conducted on 200 MY? pis (MJF= 92/108; 
mean age. SO.8± 1.3 yrs). We determined the leaflet of prolapse and grade of MR 
using 2-D/Doppler echocardiography. The degree of MR was classified as trivial. 
mild. moderate or severe. ~: Of the MY? pts. 61% had prolapse of the 
anterior mitral leaflet (AML). 27% of the posterior mitral leaflet (PML) and 12% of 
both leaflets. Of the 187 pts with MR. trivial. mild. moderate and severe MR were 
20%. 39%. 25% and 16% respectively. The rate of pts with moderate and severe 
MR was greater in the ?ML (59%) than in the AML group (28%). Of pIS with 
trivial. mild. moderate and severe MR. the incidence of complications. such as atrial 
fibrillation. congestive hean failure and chordal rupture. was 7.9. 29.2. 60.0 and 
84.4% respectively. We also compared left atrial dimension (LAO) in pts with 
progressive MR (n=22) to pis without progressive MR (n=20) during a follow-up 
period (median 6 yrs). The increase of LAD in pts with progressive MR was 
significantly higher than that in pts without progressive MR (4.1± 1.0 vs 0.2± O. 
8mm. !KO.OI). Furthermore. the percentage of?ML prolapse was higher in pts 
with progressive MR (68%) than in pis without progressive MR (40%). The 
relationship between the initial severity of MR and the incidence of cardiac events 
(MY replacement-16. death-3. infective endocarditis-I. cerebral embolism-I) during 
the follow-up period (76 months) is described below. 
1001 -------- trivial (n=38) 
Cumulative c::: mild (n=73) 
cardiac evcnl80 moderate 
~~~ ~~ 
60 L..- severe (n=30) 
b 20 40 60 80 (months) 
Conclusion: The severity of MR was related to the incidence of complications 
and cardiac events in pts with MY? ax\ affected the prognosis. 
ABSTRACTS 
776-2 
Incidence and Determinants of Mitral Regurgitation in 
Acute Myocardial Infarction. 
8:45 
Jan M. Van Dantzig, Ben J. Delemarre, Hans Bot, Cees 
A. Visser, Department of Cardiology, Academic Medical 
Center, Amsterdam, The Netherlands 
We studied by echo 175 myocardial infarct pts without 
papillary muscle rupture within 24 hrs of admission. 
Mitral regurgitation (MR) was classified as trivial (0 to 
2+) or severe (3 to 4+) using color-flow. Wall motion 
score index (WMSI) was obtained (1=normo- to 4=dyski•
nesis). Parameters evaluated: mean score of individual 
LV segments, enddiastolic volume (EDVOL), systolic RV 
pressure (RVS) by tricuspid regurgitation velocity and 
CK - MB (N < 4 U /1). In 122 first infarcts, severe MR was 
found in 9% (11 pts), and in 53 recurrent infarcts, 
severe MR was found in 27% (14 pts) (p<O.OI). 
MR 3-4+ (n=25) MR 0-2+ (n=150) 
WMSI 1.98±0.47 1.70±0.42(p=0.002) 
EDVOL(ml) 122±38 91±29 (p<O.OOOI) 
RVS(mmHg) 37±12 27±8 (p=0.0003) 
CK-MBmax(U/I) 107±61 99±77 (p=NS) 
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In first infarcts, none of these were significant, except 
RVS (33±6 vs. 26±8, p=0.04). Motion of infero-posterior 
mid- and basal segments was worse in severe MR than in 
trivial MR (2.36±0.57 vs. 1.72±0.71, p<O.OOOI) and this 
was significant in first infarcts also (p=0.0002). CK-MB 
of infero-posterior infarcts with severe MR was 117±68, 
with trivial MR 76±51 U II (p=O. 01). Thus, severe MR 
occurs more frequently in recurrent infarction, in 
association with LV dilatation. Echographic and enzymatic 
extent of inferoposterior wall damage is the other 
determinant of severe MR we identified. 
776-3 9:00 
Radiographic Detection and Successful Prophylactic Explantation 
of Single Leg Separation in Patients With Bjuk-Shiley Convexo•
Concave Prosthetic Mitral Valve 
Richard E. Gordon, Mark D. Castellani, Donovan M. BakaJyar, Karen 
C. Beatty, R. Thomas Catlin, Iames G. Chandler, William W. O'Neill, 
William Beaumont Hospital, Royal Oak, Michigan 
Outlet strut fracture (OSF) with disc embolization and sudden valvular 
incompetence is a known risk of Bj irk-Shiley Convexo-Concave (BSCC) 
prosthetic valves. No current techniques exist for identification of 
implanted valves with structural weakness that might lead to OSF. 
Previous analysis of valves explanted after valve failure with OSF 
revealed that one leg of the outlet strut had a fresh separation and the 
second leg had a chronic separation. We hypothesized that defective 
valves with single leg separation (SLS), might be detected by 
cineradiography prior to OSF and valve failure. We plan to follow 300 
patients with BSCe mitral prosthetic valves known to be at increased 
risk of OSF because of valve size, weld date or patient age at implant 
All 300 patients have been screened using visual assessment of 
radiographic images. Images were graded as suboptimal (0), apparently 
normal (1), minimally suspicious (2), suspicious (3), probable SLS (4) or 
definite SLS (5). The distnbution of most recent grades were: 0: 3 
valves, 1: 262 valves, 2: 23 valves, 3: 2 valves, 4: 5 valves, 5: 5 valves. All 
patients given a Grade 5 had explantation and documented SLS. Of the 
patients given 8 Grade 4, two patients had explantation and documented 
SLS, one patient had an intact valve at explantation, and the results are 
pending on two patients. Repeat radiographic imaging at 6 months and 
long-term foJlow-up is in process. We conclude that BSee valves with 
SLS can be identified using this technique. Sensitivity, specificity and 
predictive accuracy determinations will await long-term follow-up. 
Identification of definite SLS can assist in decisions for prophylactic 
explantation of this valve. 
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776·4 9:15 
Evaluation of Mitral IlegurJitation Murmurs Using a New Digital Heart 
Sound RemrdiDg Method with Real Time Spectral Analysis: Studies ill an 
AnimaI Model with QuantUaable MitralllegurJitation 
Tokahiro ShiOia. Dag Teiea. Michlel lones. Izumi Yamada, Pamela Fry, 
Amaldo Passafini, David 1. Sahn; Oregon IDth Sci Univ; Portland, OR; 
LAMS, NHLBI, Bethesda, MD 
This lludy tested a new diJital heart IIOUIld recording ad analysis system 
(Spectra 3000 MCG HOC) for evaluation of mitral regurgitation (MR) in an 
aaima1 model willi qll8lltifiable chronic MR. Six sheep willi MR previously 
created by cIIordaJ damage were re-operated 4-5 months IaIer after reoperation 
for insertion of mitral and aortic electromagnetic f10wmeters balanced against 
each other for net forward flow to yield true regurgitant volume and 
regurgitant fi1Iction (RF). Three to five stable hemodynamic states were 
obtained pharmacologically in each aaima1 (20 hemodynamic states). Sound 
data were spectrally anaIyz;od 
and displayed in a color 3D 
matrix (x axis: time (sec) [8 
msec sampling], y axis: sound 
frequency (Hz), z axis: sound 
intensity (dB» and a two•
dimensional topographical map 
'i\ \.i rIAl Hi' ~(~ .. t ~l-I ~. " 0 
o --/, __ i:i,.il·~ 
displaying 3D infOrmatiOD in which sound intensity was demonstrated by 
differeDt colors: bright colors showing high intensity and dark colors showing 
low intensity (lIIe Figure demonstrates only grey acales) for visual review and 
analysis. These new visual presentations could provide, to some extent, lIIe 
characteristic of the different degrees of MR murmurs. Mild MR cWsified by 
EM (RF<20!li) was associated with early systolic, high freq\IeDCy/low 
intensity profiles whereas severe MR (RF > 4O!Ii) showed holo-systolic low 
frequency lmoderate intensity profiles. Maximal sound intensity demonstrated 
on lIIese presentations correlated well willi maximal CW Doppler MR jet 
velocity (r = 0.89, p< 0.001). Contributions from!!2!!! modaJ peak 
frequency (MF, Figure) ad frequency vs intensity relationship visuaJiZAld by 
lIIese Dew records could be used to distinguish severity of MR in this study. 
These reproducilbiJe digital sound studies of regurgitant murmurs could be 
useful for following-up clinical patieuls willi a low cost approach. 
776·5 
Early tnd Leta Valve Replacement After In_ Balloon Mitral 
Valvotomy 
9:30 
-Ted Feldman, Howard C. Herrmann, John D. Carroll, Thoma. M. 
Bashore, Gerald Dortos, Patrick L. Whitlow, Jonathan M. Tobia, 
Stefan R. Kiesz, Gregory S. Pavlides and the North American Inoue 
Investigators, University of Chicago, Chicago IL 
The need for mitral valve replacement (MYR) Ifter balloon mitral 
vllvotomy (BMYI remlins poorly chlrlcterized. W. reviewed 770 
J)ltients over the 3 years Ifter Inoue BMY. MYR was necessary in 
4.6% within 30 dava (early) .rid in 6.1 % between 30 days Ind 3 
year. (late) poat BMV. Early MYR was done on the day of BMY in 
1.2%, Ind Ifter the day of BMY but prior to discharge in 1.6%. 
Age 
Echo Score 
MYA pre 
MYA poat 
MR pre (scale 0-4) 
MR post 
Total Early MYR Leta MYR 
53±14 52±14 57±12-
7.3±2.6 7.4±2.2 8.4±2.7--
1 ±.3 1 ±.3 1 ±.3 
1.8±.6 1.6±.6 1.4±.5--
.5±.6 .8±.9-- .8±.8--
1.1 ±.1 3±1.1-- 1.7±1·-
- - p < .05, -- .. p < .01 vs Total 
Early MYR was usually performed for severe mitral regurgitation 
(MR), while lat. MYR was for mitral atenosi. (MS) in 16%, MR in 
45%, or mixed MSIMR in 39%. 
Conclualon: MYR is needed in 10.7% of patients during the 3 year 
post-BMY period. Early MYR is IlmOat entirely for MR complicating 
the procedure could not be predicted from pre-BMY morphologic 
characteristics. Late MVR il for a combination of persistent atenosis, 
restenosis, and increesed regurgitation, and is a more frequent 
occurrence in older patients with more severe valve deformity. 
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776·6 9:45 
The Anatomically Unfavorable Rheumatic Mitral Valve: Improved 
Results of Balloon Mitral Commissurotomy Using the Inoue Balloon 
Technique 
John S. Wilson, Steven E. Hearne, J. Kevin Harrison, Frank D. Tice, 
Katherine B. Kisslo, Charles J. Davidson, Thomas M. Basbore 
Duke University Medical Center, Durbam, NC 
Mitral valve morpbology, determined using ecbocardiograpby, has 
been used to select patients for balloon commissurotomy. Patients witb 
rbeumatic mitral stenosis (MS) and valve echo scores> 8 bave been 
considered poor candidates for BMC based on previous suboptimal 
results with tbe double balloon tecbnique. Tbe effect of balloon 
commissurotomy using tbe Inoue balloon catbeter in pts witb MS and 
ecbo scores> 8 is not known. Of 164 consecutive patients undergoing 
BMC, 42 patients had a total chest wall echo score >8. Of these, 32 
were treated with Inoue balloons and 10 were treated with either single 
(n=4) or double (n=6) (non-Inoue) balloons. Acute changes in mitral 
valve area (MVA) are shown below: 
RESULTS: (mean ± SD) 
~ Non-Inoue ~ 
Cath MVA 
Pre(cm2~ 1.1 ± 0.2 
Post(cm ) 1.8 ± 0.5 
Change in MVA(cm2) 0.8 ± 0.5 
Change in MR ~ 2+ 1 pt 
0.9 ± 0.3 
1.4 ± 0.5 
0.4 ± 0.3 
I pt 
NS 
0.017 
0.048 
The Inoue balloon method results in a larger final MVA and a greater 
absolute change in MVA than non-Inoue techniques in patients with 
high mitral valve echocardiographic scores. This may in part be related 
to the ability of the Inoue balloon to "seat" itself with the mitral valve 
annulus, even in the presence of a stiff, moderately calcified valve. 
These acute bemodynamic results suggest that use of the Inoue balloon 
technique for percutaneous mitral commissurotomy should be extended 
to patients with higher echo scores than has been the custom using non•
Inoue balloon methods. 
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The Effects of Lidocaine on the Vulnerable Period 
During VentricuIar Fibrillation 
8:30 
Yong-Mel Cha, Barry B. Peters, Peng-Sheng Chen. UCSD and VA 
Medical Centers, San Diego, California 
It was postulated that a subthreshold defibrillation shock fails to halt 
ventricular fibrillation because the shock itself reinitiates ventricular 
fibrillation by falling into the vulnerable period of the fibrillating wave 
fronts. This hypothesis was proposed partly because previous studies 
showed that, at the site of the earliest postshock activation after an 
unsuccessful shock, the preshock intervals were not randomly 
distributed. Rather, they clustered in a narrow range, indicating the 
presence of a vulnerable period. However, whether or not the timing 
of this vulnerable period is determined by the ventricular fibrillation 
cycle length is unknown. Methods: We determined the patterns of 
epicardial activation in IO dogs with 56 bipolar electrodes (7 columns 
and Brows) 5 mm apart on the right ventricular epicardium by 
computerized mapping techniques during unsuccessful defibrillation. 
Lidocaine was then given to prolong the ventricular fibrillation cycle 
length, and the computerized mapping studies were repeated. Results: 
The mean lidocaine concentration was 11.7 ±O. 7 JLg/ml, which 
increased the ventricular fibrillation cycle length from 1l0± 13 ms to 
156±15 ms (p<O.OOI). Among 55 episodes of unsuccessful 
defibrillation, the site of the earliest postshock activation occurred in 
the center of the mapped tissue 12 times at baseline and 14 times 
during lidocaine infusion. At electrodes that registered as postshock 
early sites, the preshock intervals did not distribute randomly. Rather. 
they clustered within a narrow range both before (5B± 14 ms) and 
during (IOHIB ms, p<O.OOl) lidocaine infusion. The correlation 
between the preshock intervals and the ventricular fibrillation cycle 
length was significant for these 26 sites (r==0.B7, p<O.OOl). 
Conclusion: (I) A vulnerable period is present during ventricular 
fibrillation. (2) The timing of the vulnerable period is determined by 
the ventricular fibrillation cycle length. 
JACC February 1994:1A-484A 
777·2 8:45 
Rapid Pacing Moves the Upper Umit of Vulnerability Higher on the 
Defibrillation Probability of Success Curve 
Robert G. Walker. Salim f. Idriss. Robert A. Malkin. and Raymond E. 
Ideker. Duke University Medical Center. Durham. NC 
The upper limit of vulnerability (ULV) hypothesis for defibrillation (Of) 
predicts that the shock strength at the UL V should have a high probability 
for successful OF. However. some studies have reported the UL V to be 
lower than the Of threshold. We tested the hypothesis that while rapidly 
pacing the heart. to try to mimic the electrical and mechanical events dur•
ing Vf. the measured ULV corresponds to a point high on the Of probabil•
ity of success curve. Using an RV catheter/(SVC catheter + external patch) 
lead system in 8 closed-chest dogs. we determined 15 ULVs while pacing 
at 80% of the intrinsic R-R interval (NORMAL). and 15 ULVs using a 
rapid pacing protocol (RAPID). RAPID was achieved by successively 
decrementing the S 1 interval in lOms steps until a target rate (range 
165-200ms) was reached which produced a loss of peripheral pressure for 
16 beats while maintaining complete electrical capture. ULVs were deter•
mined by scanning the T-wave in lOms intervals with 6/6ms biphasic 
shocks. An up/down protocol was followed for ULV test shocks using a 40 
volt step size. A similar protocol was used for OF test shocks delivered 
when Vf was induced during ULV testing. Probability curves were con•
structed for NORMAL and RAPID ULVs as well as for OF. The 50% 
probability points for Of. NORMAL. and RAPID were compared. 
RAPID50 (437±111V) was significantly (p<.01) greater than NORMAL50 
(333±73V) and OF50 (344±79V) while NORMAL50 was not significantly 
different from OFSO. RAPI050 voltage corresponded to the 86±17% point 
on the OF curve whereas the NORMAL50 voltage corresponded to the 
42±15% point. 
Conclusions: Rapid pacing moves the ULV high on the OF probability 
curve. as predicted by the ULV hypothesis for OF. Furthermore. for this 
clinically used lead configuration. a rapid pacing protocol for ULV testing 
yields a better estimate of the shock strength required for defibrillation than 
ULVs tested during pacing at a normal rate. 
777·3 9:00 
Relationship of Upper Limit of VulnerabiUty to DefibriUation 
Threshold for Monophasic and Biphaslc Waveform Human 
NODthoracotomy DeflbriUatioD 
10hn F. Swartz. Pamela E. Karasik. Martin E. Bacon, and Ross O. 
Fletcher. Uniformed Services University. Bethesda, MD and 
Veterans AffairslGeorgetown Medical Centers, Washington. O.C. 
Upper limit of vulnerability (UL V) correlates with defibrillation 
threshold (OF!) for human epicardial defibrillation. and has been 
proposed as a suitable surrogate for OFf testing. The purpose of this 
study was to test whether UL V may substitute for monophasic (M) 
and biphasic (BI) OFf testing during nonthoracotomy lead (NTI..) 
defibrillator implantation in humans. Paired UL V and OFf data were 
obtained for both M and BI shocks (65% overall tilt) in 12 patients. 
ULV was determined during sinus rhythm by scanning a 120 msec 
window beginning at 50% repolarization of a right ventricular apex 
monophasic action potential recording. OFf and ULV were 
determined in 25% increments of delivered energy. The results were: 
ULV 
OFf 
Monophwdc Biphwdc 
11.9±S.4 J 5.8±1.9 J. 
l2.3±3.7 J 4.9±1.4 J. 
• = p<O.(X)1 versus M 
ULV and OFf values were within 5 1 for 10112 patients using M 
shocks and 12112 patients with Bl shocks. The ULV-OFf 
relationship was linear. as described by the equation OFf= 
2.6+{).7·ULV (R=O.748, p<O.OOl), and was waveform independent. 
These results suggest that sinus rhythm ULV is a highly accurate 
predictor of OFf for NTI.. defibrillation in humans. particularly for 
BI waveforms. Use of ULV testing for human NIL defibrillator 
implants may be an acceptable alternative to DFf determination and 
will reduce the need for ventricular fibrillation induction. 
ABSTRACTS 293A 
777·4 9:15 
Upper Limit of Vulnerability Tested on or Before the Peak of T wave 
Predicts DefibriUation Threshold in Dogs 
·Wei Fan. Masarnichi Gotoh, Peng-Sheng Chen, Cedars-Sinai Med Ctr, 
Los Angeles. CA 
The purpose of this study is to test the hypothesis that the upper limit of 
vulnerability (UL V) determined without scanning the entire T wave can be 
used to accurately predict defibrillation threshold (OFT), and that the 
correlation between UL V and OFT is not affected by the site of baseline 
pacing (S,), the defibrillation electrode configuration and the lengthening 
of the QT interval by procainamide (PA). In 6 open chest dogs we 
determined the shock strength associated with 50 % probability of reaching 
UL V (UL V",) and the shock strength associated with 50 % probability of 
successful defibrillation (OFT",) by up-down algorithm when S, was at 
RA, LV apex or LV base. Monophasic shocks (6ros) were given to 
epicardial patches at 20 and 40ms before the peak of T wave to bracket the 
mid-upslope. In an additional 6 c1osed-chest dogs, we determined ULV", 
and OFT", with CPI Endotak leads and an 8ros biphasic waveform when 
S, pacing was from either the RA or from the sensing electrode on RV 
apex. Shocks were given on, or 20 and 40ms before. the peak of T wave. 
The same test was repeated after intravenous PA 2mgIKg load, 2mg/min 
maintenance. Results: In the first 6 dogs, the UL V", when paced from 
LV apex. LV base and RA was 4.2±1.7J, 4.4±2.U. and 3.9±1.5J, not 
significantly different from the OFT", of 4.8±1.9J. 4.S±1.9J and 
4.2± 1.3J, respectively. In the latter 6 dogs. PA infusion increased the S,•
T peak interval by 28±2Oms. According to S, sites. ULV", vs OFT", were 
13.5±5.2J vs 18.2±6.2J (RVapex); 12.8±6.0J vs lS.4±6.0J (RA) at 
baseline; 14.6±4.6J vs 19.5±6.7J (RV apex) and 14.3±5.5J vs 
18.7±6.4J (RA) during PA infusion (p=NS for all). The r value between 
ULV", and OFT", was 0.94 (p<O.OOl). Conclusions: When tested with 
2-3 shocks on or before the peak of T wave, ULV", can be used to 
estimate OFT", with either patch-patch or transvenous lead system. 
Different shock electrode combinations, S, sites. or QT intervals do not 
affect the results. Scanning the entire T wave is not necessary to test ULV. 
777·5 9:30 
Asymmetric Injury at the Ends of Ventricular Cells Induced by 
Strong Electric Field Stimulation 
Stephen B Knisley. Augustus 0 Grant, Duke University. Durham. NC 
Strong defibrillation-type electric field stimulation injures cells when 
transmembrane potentials during the pulse exceed the threshold for 
membrane electroporation. Large transmembrane potentials at the 
ends of cells aligned with the field have been reported. however 
whether injury Is localized at the ends of cells is not known. We 
studied injury induced by rectangular electric field stimulation (St) 
with duration=20 ms and strength=50-400 V/cm in rabbit ventricular 
myocytes bathed in Tyrode's solutions. Video images of cells were 
recorded at a magnification of 2000x and cellular injury was 
indicated by contracture. RESULTS: St of 100-150 V/cm produced 
injury in cells oriented parallel to the St field and no injury in cells 
perpendicular to the field. Injury consisted of pulsatile contractions, 
irreversible shortening, widening and darkening that were localized 
at a cell end. Injury resulted from calcium influx as evident from the 
absence of viSible effects of St as high as 400 V/cm in 5 of 5 cells 
with [Ca2+)=0 and [EGTA)=1 mM. In 17 of 17 cells with [K+)=4.5 mM 
and [Ca2+]=1.5 mM. injury was asymmetric. occurred at the cell end 
facing the St anode and propagated to the other end in 5 to 30 
seconds. The St voltage required between cell ends to produce 
injury. determined from a receiver operating analysis for 25 cells, 
was 1.1 V (p<0.05). This indicates a threshold transmembrane 
potential for injury at a cell end of about -0.5 V (half of the voltage 
between cell ends). Asymmetry was not due to intrinsic negative 
transmembrane potential since injury at the cell end facing the St 
anode occurred also in 18 of 18 cells that received St during the 
action potential plateau, 13 of 13 cells with (K+) increased to 20 mM 
and 16 of 18 cells with [K+] increased to 125 mM. Thus injury 1) 
depends on cell orientation, 2) occurs at a transmembrane potential 
of about -0.5 V and 3) is asymmetric occurring first at the cell end 
facing the anode (hyperpolarized end). The results indicate that 
hyperpolarized membrane is more easily injured than depolarized 
membrane. which may be important for defibrillation polarity. 
294A ABSTRACTS 
777·6 9:45 
Membrane Time Constant of Myocardial Cella During a Shock 
Xlaohong Zhou, Adam Cates, Dennis L Rollins, William M. Smith, 
Raymond E. ldeker, Duke University Medical Center, Durham NC 
While much is known about the membrane time constant (MTC) 
during Intracellular stimulation, to understand defibrillation the MTC 
should be studied during field stimulation. MTC was measured In 9 
guinea pig papillary muscles. Papillary muscles were perfused with 
Tyrode's solution and transmembrane potentials were recorded by a 
double-barrel microelectrode with 1 barrel In and the other just 
outside a single cell. The short distance (15-30 .... m) between the 2 
tips cancelled the shock artifact so that the membrane pOtential 
could be recorded during the shock. Following 10 81 stimuli, an 82 
field from a 10 ms square wave was given with a 30 ms S182 
coupling Interval. Four levels of shock potential gradient (PG) for 
both shock polarities were delivered during the plateau of the last 
81 action potential. Transmembrane potentials were recorded from 
the same impalement for all shocks. 82 shocks were delivered 
during the plateau so that transmembrane potentials during the 
shock would not be obscured by a new action potential. MTC was 
calculated by fitting the recorded data during each shock to an 
exponential curve. Results: shocks which Induced depolarization 
(D) with 1 polarity Induced hyperpolarization (H) with the other 
polarity and vice versa. 
PGJY!cm~ 1.7:t:0.1 2.9:t:O.2 6.1:t:0.6 8.8:t:0.9 ~<.05 
MTC-D~m~ 3.3:t:1.6" 2.7:t:1.3" 1.8:t:1.0" 1.4:t:0.7* ...2.<.05 
MTC-Htms) 6.0:t:2.8 6.9:t:2.9 4.0:t:2.7 3.2:!:2.1 ...2.<.05 
p<.05 among 4 PG groups, ": p<.05 between MTC-D and MTC-H 
MTC is longer when the shock Induces hyperpolarization (MTC-H) 
than when it induces depolarization (MTC·D) at the same level of 
PG. MTC becomes shorter as shock PG Is Increased. Thus, MTC 
varies with shock polarity and strength, suggesting active as well as 
passive components In response to the shock. 
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Angiotensin II Regulatu Expression of lnauUn-Uke Growth 
Factor Binding Proteins in Vascular Smooth MlI8de CelJs. 
Asif Anwar, Li Ku, Patrick Delafontaine, Division of Cardiology, Emory 
University, Atlanta, GA 
In addition to its effects on volume homeostasis the vasoactive 
peptide angiotensin II (ang II) is an imponam mitogen for vascular 
smooth muscle cells (VSMC) in vitro and in vivo. We have recently 
shown that ang II transcriptionally activates the Insulin-Uke Growth 
Factor I (lGF I) gene in VSMC and that secreted IGF I is essential for 
ang II-induced mitOj!erle5is y. BiDl Cbem. 1993; 268:16866-16870). 
Availability and interactions of IGF I with its receptor ace regulated 
by a family ofIGF I binding proteins (lGFBPs) that include IGFBP-3, 
the main circulating carrier of IGF I, and IGFBP-4, an inhibitory 
IGFBP. To characterize potential effects of ang II on IGFBPs, 
cultured Cllt aonic smooth muscle cells (RASM) were secum-depcived 
for 48 hr and incubated in the absence or presence of ang II, 100 
nM, for 3, 6 and 24 hr. ConcemCllted RASM conditioned medium 
was subjected to non-reducing SDS-polyacrylamide gel 
electrophoresis and transferred to nitrocellulose prior to Western 
ligand blotting using 'Z5I·IGF I. The data indicated that ang II 
markedly decreased levels of the non-glycosyiated (24 kDa) and 
glycosylated (28 kDa) forms of IGFBP-4 and of the 38-42 kDa IGFBP-
3 doublet (81% and 86% at 24 hr, respectively). The decrease in 
secreted IGFBP-4 coccelated with a progressive decrease in IGFBP-4 
mRNA levels (6596 and 8396 at 6 hr and 24 hr, respectively), as 
determined by Nonhero analysis. Thus ang II, in contrast to other 
mitogens such as platelet-decived growth factor and fibroblast growth 
factor, markedly downregulates IGFBP-4 expression and IGFBP-3/BP-
4 secretion from VSMC. The striking ang II-induced inhibition of 
IGFBP-4 likely serves the key function to increase avallability of free 
IGF I. These findings strongly suppon the concept of an autocrine 
vascular IGF I system that mediates ang II-Induced growth responses. 
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Augmented Expression of the Receptor for Urokinase-Type 
Plasminogen Activator in Human Atherosclerotic Vessels 
Hiroko Noda-Heiny and Burton E. Sobel, Washington 
University School of Medicine, St. Louis, MO 
Mechanisms underlying migration and proliferation of 
vascular smooth muscle cells involved in atherogenesis 
and restenosis have not yet been fully elucidated. Howev· 
er, activation of plasminogen in the extracellular matrix 
is closely linked to migration of carcinoma cells with 
metastatic tendencies. Thus, Del Vecchio showed that 
human urokinase receptor (uPA-R) in particular, is found 
in breast carcinoma cells in five-fold greater amounts 
than that found in cells from benign breast lesions. To 
determine whether cells in the neointima of atheroscle•
rotiC lesions express uPA-R potentiating plasminogen 
activation, and hence migration as well, we characterized 
10 atherosclerotic lesions from human carotid arteries 
and tibial arteries obtained at surgery by immunohisto•
chemistry with anti·human uPA·R monoclonal antibody 
(MoAb3936, ADI). Intense signals (peroxidase 1 abel ing 
with avidin·biotin complex) localized large amounts of 
uPA·R in the neointima of the atherosclerotic lesions. No 
staining was evident in the normal (nonatherosc1erotic) 
vessels. Serial frozen sections were immunostained with 
monoclonal antibodies to Factor VIII related proteins, •. 
smooth muscle actin, and CD68 for identification of endo•
thelial cells, smooth muscle cells, and macrophages. Neo•
intima was richly endowed with smooth muscle cells. In 
lesions with amorphous thrombus present, both uPA-R and 
macrophages were abundant. Thus, smooth muscle cells and 
macrophages, abundant in human neointima, express the 
urokinase receptor which is likely to facilitate activa•
tion of plasminogen by cell surface bound urokinase with•
in the vessel wall. 
778·3 9:00 
In Vivo Evidence that Vascular Endothelial Growth Factor 
Stimulates Collateral Formation by Inducing Arterial Cell 
Proliferation In a Rabbit Ischemic Hindlimb 
Satoshi Takeshita. Marianne Kearney, Carrie Loushin, Edi Brogi, Lu 
P Zheng, Jeffrey Horowitz, Napoleone Ferrara, James F Symes, 
Jeffrey MIsner, St Elizabeth's Medical Center, Tufts University, 
Boston, MA. and Genentech Inc., South San Francisco, CA 
Vascular endothelial growth factor (VEGF) is an endothelial cell (EC) 
specific mitogen that stimulates angiogenesis in vivo. We previously 
demonstrated that a single intra-arterial bolus of the 165·amino acid 
monomer of recombinant VEGF could enhance coUateral. formation in 
a rabbit model of unilateral hindlimb ischemia. In this stUdy, we 
evaluated the proliferative activity of arterial cells after VEGF•
injection. Ten days following induction of ischemia (ligation of the 
external iliac and excision of the common and superficial femoral. 
arteries) in one limb of rabbits, VEGF (500 j.lg) was administered as a 
bolus via infusion catheter into the internal iliac artery of the ischemic 
limb. To evaluate the proliferative activity of arterial cells, 
bromodeoxyuridine (BrdU) was subcutaneously delivered using an 
osmotic pump beginning 24 hours before sacrifice in animals which 
were sacrificed at 0 (baseline), 3, 5, and 7 days post-VEGF. 
Proliferative activity of ECs in internal iliac artery increased and 
reached peak at day 3, and returned to the baseline level by day 7. 
Proliferative activity of ECs in the distal (midzone) collateral. arteries 
reached peak at day 5, and again returned to the baseline level by day 
7. Increase in proliferative activity of medial cells was also observed 
in both the stem (i.e. internal iliac) and midzone collateral arteries. 
Angiographically, neovessel formation became evident at day 7 with a 
statistically significant amelioration of the hemodynamic deficit 
evaluated by lower limb blood pressure ratio (ischemic/normal limb). 
These data thus suggest that (1) active growth process of collateral. 
arteries post -VEGF 1reabnent begins with EC proliferation of the stem 
artery within 3 days, and ends before day 7 with evidence of 
neovessel formation and reduced hemodynamic deficit; and (2) during 
the process of neovessel formation post-VEGF, proliferation of medial 
cells is also induced by as yet undetermined mechanism(s). 
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178·Estradlol Atteaaatu EDdothellal DrdDDetloD 
ID Male SpoDt&lleOllllr Brperteashe aatt. 
K. KaUIltl' and O.M. Rubanyi 
BerJex Biosciences. Richmond. California 
9:15 
Tbe mecbanism of tbe weJl documented vllculoprotective 
(antiatherosclerotic) action of estrogen is UDkDown but action on 
endothelial function bas been postulated. Previous studiel in our 
laboratory demonltrated that aortic ringl isolated from female 
SHRs bave lignificantly greater basal EORF/NO production and 
acetylcboline (ACb)·induced endotbelium.dependent relaxation 
compared to male SHRa (FASEB J. 7:A77S. 1993). In the present 
study we examined the effect of chronic 17kltradiol treatment on 
the endothelial function in aortal ilolated from castrated male 
SHRs. 11 week old male SHRI (36 rats) were divided into three 
croups. Two croups were lonadectomized and the third SHAM 
operated. One week later the animals were treated (0.2 mVday IC. 
injection) with 17l1-estradiol (1 ILl/day) or vebicle (benzylbenzoat 
ricinuloil) for two weeks. After sacrificing the animals, the 
thoracic aortae were isolated and mounted in orean cbambers for 
recording of isometric tension. Balli release of endothelium· 
dependent reluing facton (EORFs) was determined by measuring 
the ability of intact endothelium to luppress phenylephrine (10' 
9.l0,SM) contraction in aortic rings. Two weeks treatment of the 
gonadectomized male rats with eltrogen lignificantly enhanced the 
endotbelial suppression of PE·induced vasoconstriction as 
compared to intact male SHRs. Stimulated release of EORFs was 
examined by measuring ACb·induced (10·9.10·4M) endotbelium· 
dependeDt reluation of the intact male SHRs. Both basal and ACb. 
induced EORF/NP production in 178·estradiol treated males 
reacbed the level observed in intact female SHRs. These results 
luggest that the vasculoprotective effects of estrogens may be 
associated with the protection of endothelial function. 
778·5 9:30 
Coronary Endothelin Durin~ Acetylcholine Induced 
Coronary Vasoconstriction In Humans. 
Amir Lerman. Malcolm R. Bell. David R. Holmes Jr. Roben L. 
Frye, Richard J. Rodeheffer, John C. Burnett Jr, Mayo Clinic. 
Rochester, MN 
Coronary atherosclerosis (CA) is characterized by a coronary 
vasoconstrictive response to the endothelial-dependent vasodilator 
acetylcholine (Ach) by mechanisms which remain undifmed. 
Endothelin (ET) is an endothelial-derived vasoconstrictive peptide 
which is enhanced in human atherosclerosis. The current study was 
designed to test the hypothesis that Ach·mediated coronary 
vasoconstriction is associated with elevated coronary ET. Eight 
subjects with mild CA were studied. Increasing concentration of Ach 
(10.6.10-4 M) were infused into the left anterior descending artery 
and ET was determined in the coronary sinus blood at baseline and at 
peak Ach infusion. Ach induced coronary vasoconstriction 
(Response) was observed in 5 subjects and no response (Non 
Response) was observed in three. Change in coronary diameter (CD) 
was detemined by quantitative angiography. 
Response (n=5) Non Response (n-3) 
Baseline ET pg/ml 14±2* 6.1±O.6 
Ach ET pg/ml 22± 3*t 6.6±O.2 
%ACD ·74±11 * 3±4 
* p<0.05 vs. Non Response, t p<o.05 vs. Baseline. The correlation 
between peak ET and maximum coronary constriction was (r=O.8. 
p<O.05). This study demonstrates that coronary sinus ET is elev~ted 
in subjects with a coronary vasoconstrictive response to Ach. ThlS 
study suggests a role for ET as a marker and/or participant in the 
altrared coronary endothelial function associated with coronary 
atherosclerosis. 
ABSTRACTS 295A 
778·6 9:45 
Enhanced Expression of TNF·a and ICAM·I in Primary 
and Restenotic Coronary Atberec:tomy Tissue 
Roben G. Wilkins, Alan N. Tenaglia, David J. Lefer, Daniel E. 
Friedman, Michael P. Choi, Richard Harlan. and Andrew I. Buda 
Cardiology Section. Tulane University School of Medicine. New 
Orleans, LA 
Tumor necrosis factor·alpha (TNF-a) is an important mediator of 
inflammation which induces endothelial cell expression of intercellular 
adhesion molecule-l (lCAM·l), thus resulting in enhanced leukocyte 
adhesion. Since these mechanisms may be important in the genesis of 
coronary atherosclerosis. we hypothesized that TNF·a and lCAM·I 
expression may be increased in coronary lesions. We utilized 
immunohistochemical staining techniques to investigate the relative 
expression of TNF'a and lCAM·l in atherectomy specimens from 
patients undergoing directional coronary atherectomy for primary 
lesions or restenosis lesions. The anti· TNF·a monoclonal antibody 
(MAb), B·C7, and the anti·ICAM·l MAb, RR 1/1, were used as the 
primary antibodies for the study. Internal mammary artery (lMA) and 
saphenous vein (SV) obtained during coronary bypass surgery served 
as controls. Both primary and restenotic atherectomy tissue exhibited 
very prominent immunostaining for TNF-a, whereas TNF'a 
immunostaining was absent in the lMA and SV. Sparse ICAM·l 
expression was observed in the endothelium of the IMA and SV 
tissue as expected given its known constitutive expression in normal 
endothelium. However, markedly enhanced cellular expression of 
lCAM·1 was evident in primary and restenotic atherectomy tissue. 
TNF'a and lCAM·1 immunoreactivity in the atherectomy tissue was 
most prominent in the fibrointimal plaque and the restenotic 
neointima. In addition. leukocyte accumulation was observed in the 
primary and restenotic atherectomy tissue but not in the IMA or SV. 
These results suggest that increased expression ofTNF-a and lCAM· 
I may play a role in the development of primary coronary artery 
lesions as well as in the process of coronary artery restenosis 
following coronary angioplasty. 
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The Firat Major CardlovalCU .... Evant Following Myocardial Infarction 
In the SAVE Study 
*Marc A. PfeIfer. L.emueI A. Moy6. Jean-Luclen Rouleau, J. Malcolm O. 
Arnold, Edward J. Brown, Jr .• Thomas E. Cuddy, Greg C. Aaker, Edward 
M. Gellman. Steven Goldman. Gervasio A. Lamas, Milton Packer, John O. 
Rutherforc/, and Eugene Blaunwald for the SAVE Investigators. Harvard 
Medical School. Brigham and Women's HospItal, Boston. MA. 
SurvIvors of myocardial Infan:tIon are at heightened risk for major 
llUblequent cardlovaacUar (ev) everu. such as 01 death. the development 
at symptomatic heart falure (CHF). or recurrent myocardial infarction (MI). 
The Survival and Ventricular Enlargement (SAVE) etudy followed the clinical 
courae at 2.231 IIUNIvora at acute MI for an average of 3.5 years. PatIents 
had EF < 4O'lI., but _e excluded from ervoI1menl for 8ymptomatlc CHF 
requiring - vaaodUalor therapy. As anticipated, the development of 
aub8equent CHF W8I a common occurrence In that 456 at 2231 (20.4%) 
patients manifested a clinical deterioration requiring either ACE inhibition or 
hospitalization for the management of CHF. h Is Important to note, 
however, that despite the lIludy'8 aeIectIon for LV dysfunction (median 
baselIne EF-31"), the first major cardlovaacUar event wa.'esa often CHF 
(369) than 01 death or an MI (438). In fact, the maJorfty of the 01 deaths 
(~. 248 0/ 422) occurred In patients who did not man118IIl symptomatic 
CHF. RancIomIzatIon to CAP reduced the number of patients that 
deVeloped CHF (required hospitalization, Wb reduction; P.0.019, or ACE 
inhibition. 37% reduction; P < 0.001). However, the clinical benefits of CAP 
extended beyond this modification of both the expression of CHF and the 
8Ubaequent deaths following CHF. ImpoItantIy, CAP therapy also reduced 
the incidence of 01 death or MI. IIY8I1 In the absence of CHF (22% 
reduction; 95% CI: 6-35%). These resUta indicate that mechanisms 0/ 
benefit In addition to the pr8Y8I'dIon of CHF are ope!8t1ve with long·term 
CAP therapy. These data provtde a IIlrong rationale for the early and 
IUiIlalned initiation 0/ ACE inhibitor therapy to survivors of MI with 
asymptomatic LV dysfunction. 
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779·2 8:45 
Ventricular Arrhythmias and Mortality Arter Myocardial 
Inrarctlon: A Follow·up Study or 14,534 Patients In the CAST 
Holter Reslstry 
Morrison Hodges. Pablo Denes. Mary Morris and Alfred P. Hallstrom for 
the CAST Jnvestigau>rs. Hennepin County and St. Paul Ramsey Medical 
Centers and the University of Minnesota Medical SchooL Minneapolis. MN 
We examined the prevalence and prognostic significance of ventticular eremature depolarizations (VPDs) and nonsustaincd vcruricular tachycardia 
(NSVT) in 14,534 patients enrolled in the Cardiac Arrhythmia Suppression 
Trial (CAST) Holter Registry. Patients (pts) with a CAST -qualifying 
myocardialinCarction (MI) were screened with a Holter recording. and the 
presence or absence ofVPD and NSVT. as well as the average number of 
VP~ were recorded. DemognqQc and clinical data on all patients and left 
ventricular ejection fraction (EF; 0=9.021) were also entered into the data 
base. Vital status was obtained through the National Death Index. Time 
between Holter and MI was < 14 days in 53.5%.15·92 days in 33.1%. and 
> 92 days in 13.6%. There were 1,547 (10.6%) deaths reported. VPDsJhr 
were grouped on a logaritlunic (base = 3) basis. 
~~~3.:n..s.un:..m4IhI.~~l:n...IuD:.. 
Nooe 3.763 25.9% 92% 11~27 1,52:; 10.5% 82% 
1 3.133 21.5% 90% 28-81 1.347 9.3% 79% 
2-3 1.511 10.4% 87% >81 1,593 11.0% 78% 
4-9 1.664 11.4% 85% NSVT 1.593 11.0% 75% 
Survival was analyzed using the Cox proportional hazards model. Three-year 
survival with and without VPDs was 85% and 92%. respectively (p<CJ.001). 
Mortality increased in a log-linear fashion with increasing VPDS/hr 
(p<O.OOO I). After adjusting for EF. age. gender. time from MI to Holter. 
history of> 1 MI. history of congestive heart failure. and history of diabetes. 
there was still a significant (p<O.OOOI) relationship between the log of VPD 
(lnVPD) and mortality. An average of even I VPD/hr was significantly 
associated with increased mortality (p<O.03). NSVT also predicted increased 
mortality (p<O.OOOI). even when adjusted for the clinical variables. EF. and 
In VPD (p=O.035). Conclusions: In this large data base of post-MI patients. 
even one VPD per hour predicted mortality. Mortality increased with ~D 
frequency in a log-linear manner. Furthermore. NSVT predicted mortality 
independently ofEF and InVPD. 
779·3 9:00 
Pnldlctcn of Mortality at Ho.pltal Dlacharge and at One V .. r for 
Patients Prnentlng to Tertiary care Ho.pltall WIth Myocal'lll.llntarctlon 
Mark A. Lawson. W. Ross Davis. SheBa L Burgard. WHllam J. Rogers. for the 
Alabama Registry 01 Myocardial Ischemia Investigators. University 01 
Alabama Medical Center, Blnnlngham. AL 
Umlted data are avalable on risk factors for early and late death among 
patients with acute myocardial infarction (AMI) presenting to tertiary care 
hospitals In the thrombolytic era. Therefore, we assessed historical and 
clinical predictors 01 death from a registry 01 1170 consecutive patients 
enrolled between 1990-1992 with > 30 minutes 0/ chest pain beginning within 
12 hours 0/ presentation to hospitals with laclltles lor Immediate PTCA and 
thrombolysiS. 01 those enrolled. 825 (70.5%) had AMI defined as either ST•
segment elevation 01 >0.1 mV In 2 contiguous leads or a two-fold rise In CK 
01 these AMI patients, 38% received thrombolytic therapy. 82% underwent 
angiography, 50% had angloplasty. and 15% had by-pass surgery. 
MottaIlty wes 7.6% at hospital discharge, and 18% at l-year for the 
patients followed-up to date. Hospital mortality wes significantly (p <0.0001) 
higher lor those with rales (30 va. 6%), pulmonary edema on x-ray (17 va. 
3%). a systolic blood pressure <100 mmHg (33 va. 8%), female gender (54 
va. 29%). and an age > 75 years (27 va. 10%). Similarly, one year mortality 
was predicted by age and hemodynamic sequelae but also by a prelnlarct 
history 01 angina (60 va. 41%). diabetes (34 va. 18%). or peripheral vascular 
disease (18 va. 7%). Multlvarlant analysis identified rales. hypotension, 
female gender. atrial arrhythmia. ST elevation. and delay In evaluation as 
Independent, significant (p<O.05) predictors 01 hospital mortality. Predictors 
0/ mortality at one year were slmlar to In-hospltal predictors with the add~ion 
0/ age. a prelnlarct history o/anglna. diabetes or peripheral vascuiar disease. 
Thus. In the thrombolytic era. even In centers with the availability 01 
Immediate arteriography and Interventional technology. both hospital and 
one year mortality are stUI predicted by simple clinlcel parameters avaUabie 
on emergency department presentation Including evidence for left ventrlcuar 
dysfunction, hemodynamic compromise, ST elevation, female gender. atrial 
arrhythmias, and delay In evaluation. At one year, mortality Is dependent on 
the hemodynamic variables as well as advanced age. diabetes, and evidence 
of advanced atherosclerotic coronary or vascular disease. 01 these factors. 
only the delay In evaluation Is a target lor modification. 
lACC February 1994:IA-484A 
779.4 9:15 
Prognostic Slgnlftcance of Right Ventricular Dysfunction In Patients 
with Acute Inferior Myocardial Infarction and Right Ventricular 
Involvement 
Carlos V. Serrano. Jr .• Josi! A. Ramires. Lulz A. C~ar. Jay L. Zweier. 
Miguel Rati. Pr0t4sio da Luz. FUlvio Pileggi. Heart Institute. School of 
Medicine, University of SAo Paulo. Braz.il. and The Johns Hopkins 
Medical Institutions. Baltimore. MD. 
It is known that impaired left venllicular function is a major detenninant of 
prognosis in patients survlvng from an acute myocardial infarction (MI). 
However. little and controversial infonnation is available on the 
relationship between right venllicular (RV) dysfunction and mortality. 
Therefore. 99 consecutive patients (mean age=56.6:±3.4 years) with RV 
involvement during acute inferior MI were followed for a 12-month period 
to clarify the influence of acute RV dysfunction on shon- and long-term 
survival. Fony-one patients (41.4%) with acute inferior MI evolved with 
severe arterial hypotension due to RV dysfunction, while 58 patients 
(58.6%) had no hemodynamic impainnent due to the RV involvement 
Basal hemodynanlic data (mean±SD) for patients with RV dysfunction 
was: blood pressure (BP)=92159±22120 mmHg, systemic vascular 
resistance (SVR)=2314±,252 dynes.s.cm-5• and cardiac index 
(CI)=1.3±O.3 UnlinIM2. Patients without RV dysfunction demonstrated 
DP=I13n4±,20116 mmHg*, SVR=1324±354 dynes.s.cm-5t, and 
CI=2.6±O.5 UminIM2". Angiographic differences noticed were that 
hemodynamically compromised patients showed lower RV ejection 
fractions (O.27±O.OS) than patients without hemodynamic disturbance 
(O.41±O.1l*); however. left ventricular ejection fractions were O.4S±O.1O 
and O.52±0.12. respectively. Shon- and long-term mortality rates were 
assessed during the follow-up period. Patients with hemodynamic 
impainnent due to RV infarction had a higher monality rate for the first 
month and eleven suhsequent months post-MI, than patients without 
hemodynamiC impainuent, 24.4% vs 6.9% and 14.6%" vs 3.%*, 
respectively. These data suggest that decreased RV ejection fraction is 
possibly linked with significantly reduced short- and long-term survival in 
patients with RV involvement during acute inferior MI. 
(P: "sO.05; tsO.OI.) 
779·5 9:30 
Immediate No-Reflow Predicts Lel't Ventricular Dysfunction and Culprit 
Vessel Patency at One Month Post Myocardial Infarction: An Acute and 
One Month Follow-Up Contrast Echocardiography Application 
Micbael Kenner. Edward Zajac. George Kondos. Ravi Dave. Peter KODdos. 
Maitreya Thakkar. Alex Laucevocius, Egidijus Berukstis. Alex Kybarskis. 
Arvydas Urbonas. Steven B. FeiDstein; Univ. of m.at Chicago. Chicago. IL. 
Vilnius University Hospital. Vilnius. Lithuania 
Despite successful angiographic patency in an infarct related vessel during 
an acute M.I .• a subset of patients fail to recover ventricular function in the 
infarct lODe. Recent evidence suggests that tissue reperfusion is not recovered 
despite epicardial patency. 
12 patients with an acute myocardial infarction were treated with urgent 
PTCA. I.C. and/or I. V. streptokinase. Angiography and myocardial contrast 
echo (MCE) were perfonned using injections in the LM and RCA ostia both 
before and after patency was established. at one day. and ODe month follow-up. 
Regional wall motion. myocardial contrast enhancement. and angiograpbic 
results were graded by three observers. 
RESULTS-I) After opening the culprit vessel. there was a spectrum of flow 
patterns identified including DOrmal. partial. and no reflow. 2) At ODe month 
follow-up. wall motion normalized in 13 of 13 segments in whicb complete re•
flow occurred. Wall motion in .... gions wbicb regained partial flow or no-reflow 
became normal in 3 of 17 segments. bypokinetic in 10 of 17, and akinetic in 
4 of 17. 3) Wall motion recovery was more pronounced at one month than 
immediately after opening the culprit vessel or one day follow-up. 4) 50% of 
vessels associated with no-reflew were re-occluded at one month follOW-Up. 
D ..... O' .... WaU ..... ,. ... ., 
__ It ... , ... .. 
i:~L • _ 
"._1 "'~ AU.ie I • .,..,.. ........... " ....... , 
CONCLUSIONS-I) Long term 
recovery of regional wall motion 
in the infarct zone is related to 
the degree of early flow as 
measured by contrast 
echocardiography. 2) No reflow, 
may identify a subgroup of 
patients at bigb risk for restenosis 
at one month follow-up. 
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779"6 9:45 
Dobutamine Stress Echocardiography for Risk Stratification Following 
Acute Myocardial Infarction 
Michael E. Carios. Steven C. Smart. Thomas C. Stoiber. Anne Toy. lOran B. 
Sagar. Medical College of Wisconsin. Milwaukee. WI 
Since dobutamlne stress echocardiography (oSE) provides assessment of 
left ventricular function and ischemia at a distance. the major determinants 
of prognosis after acute myocardial infarction (AMI). we undertook this 
study to determine the role of oSE for risk stratffication post AMI. Coronary 
angiography and graded a oSE (5 to 40 JIg/kg/min in 5 minute stages) 
were performed in 140 patients (age 57±13 years. mean ± SO) 2-7 days 
after AMI. Follow-up data regarding major cardiac events was obtained by 
telephone or chart review. Mean follow-up duration was 325 ± 179 days 
post AMI. Peak heart rate and systolic blood pressure were 111 ±20/min 
and 135 ± 28 mmHg. respectively. Adverse cardiac events occurred in 
50/140 patients. There were 5 cardiac deaths. 8 patients with nonfatal AMI. 
3 with sustained or symptomatic ventricular arrhythmia. 15 with congestive 
heart failure and 19 with unstable angina. Significant predictors of adverse 
outcome by univariate analysis were anterior infarction (p = .0008), 
multivessel coronary artery disease (p= .02). global resting left ventricular 
wall motion score index> 1.71 (p=.002). central infarction lone akinesis 
unresponsive to low dose dobutamine (p= .0008) and resting or inducible 
noninfarction lone wall motion abnormalities (p= .0003). Multivariate 
analysis of clinical. angiographic and oSE variables revealed that the only 
Independent predictors of adverse outcome were noninfarction zone wall 
motion abnormalities (p=O.OOOI) and central Infarction zone akinesis 
unresponsive to low dose dobutamine (p= .007). An algorithm of the two 
multivariate predictors had a sensitivity of 82% (41/50). specificity of 55% 
(49/90). positive predictive value of 50% (41/82) and a negative predictive 
value of 85% (49/58) for adverse outcome. The algorithm identified 15 of 
the 16 patients with cardiac death. nonfatal MI or ventricular arrhythmias. 
No adverse events occurred during o5E. 
In conclusion. o5E Is superior to clinical and angiographic data for 
predicting adverse outcome. o5E can predict adverse outcomes after AMI. 
780 Magnetic Resonance Imaging-Coronary 
ArterieslMyocardium 
Wednesday, March 16, 1994 8:30-10:00 AM 
Georgia World Congress Center, Room 364W 
780·1 8:30 
Two- and Three- Dimensional High Raolution Coronary Angiograms 
(Spatial Raolution > 70 I'm) of the Isolated Perfused Rat Heart obtained by 
NMR Microscopic Imaging 
Wolfgang R Bauer. *Fridtjof Roder. KarI·Heinz Hiller. Philipp P~I • Ilene 
Lutz, Stefan Neubauer. * Axel Haase • Georg Ern. 
Medizinische Klinik, * Biophysikalisches Institut , Wiirzburg University, Germany 
Until recently NMR angiography of the <:oro1l8Jy system bas mainly focused on 
imaging of macroscopic vessels. Experimental study of microcirculation by 
radioactive microspheres and in vivo mic:roscopy is bampered by many technical 
problems. Our aim was, therefore, to obtain 2· and 3·D microscopic perfusion•
weighted high resolution images of <:oro1l8Jy arteries in the isolated <:ODStant 
pressure perfused beating rat heart with parallel measurements of hemodynamics. 
With this technique we investigated the vasoactive effect of nitroglycerine infusion 
(0.5 mg/min) in <:oro1l8Jy microvessels (n=4 hearts). The 3·D imaging technique 
was tested in <:ontrol hearts (n=4) and hearts in which an anterior wall infarction 
was induced by LAD occlusion (n=3) before NMR imaging. Coro1l8Jy flow was 
measured by an ultrasonic flowmeter. left ventricular pressure by a left ventricular 
balloon. NMR.imaging (AMX 500 Broker. 11.75 Tesla) was triggered by peak left 
ventricular pressure in diastole. Two-dimensional gradient echo sequences (TR=I 
heart cycle, TE=1.6 ms) were used to obtain tomograms parallel and perpendicular 
to heart axis. Three-dimensional gradient echo sequences (TR= I heart cycle, 
TE=2.4 ms) registered a (128)3 3·D image. Results: Due to triggering diastolic 
images were obtained. Saturation of stationary spins resulted in reduced signal 
intensity of extravascular myocardial tissue. Water protons from the buffer entering 
the <:oro1l8Jy arteries were not saturated, thus causing enhanced signal intensity of 
the <:oroDar}' artery tree. In the 2·D images mic;roscopic epicardial and intramural 
vessels (diameter >100 JIIIl) were visible. Nitroglycerine caused a 19.6±3.l% 
increase of global <:oro1l8Jy flow. Small vessels « 210 JIIIl) showed an increase of 
cross section by 47±3.2 % • larger vessels (> 210 JIIIl) were affected by < IS % in 
this model. In the 3·D images, the aorta with its valve and the left and right 
coro1l8Jy artery from their origins up to branches of 200 JIIIl can be clearly 
identified. No artificial interruptions of the <:oro1l8Jy aneries are seen. Due to 3·D 
pulse sequences, a 3·0 image of the whole <:oronary artery tree can be visualized 
from each spatial direction. In the infarcted hearts only the perfused part of the left 
<:oro1l8Jy artery is visible. Both, the 2· and 3·D imaging techniques we developed, 
can be <:ombincd with phase sensitive pulse sequences which will allow to measure 
spatially resolved flow in microvessels. 
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780·2 8:45 
Non-Invasive Assessment of Coronary Artery Graft Patency 
and Flow Rate by Magnetic Resonance Imaging. 
Michel A. Galjee. Albert C. van Rossum. Teddo Doesburg. Cees A. 
Visser. Deparunent of Cardiology. Free University Hospital 
Amsterdam and Interuniversity Cardiology Institute. the Nether· 
lands. 
Magnetic resonance imaging offers the potential to asses coron· 
ary artery bypass graft (graft) patency and flow. The aim of this 
study was to asses the feasibility of magnetic resonance (MR) 
imaging to detennine graft patency as well as flow_ 
In 21 consecutive patients with 44 saphenous grafts MR spin 
echo (SE) imaging and phase velocity mapping was perfonned 
before angiography. In·plane resolution was 1.5 x 1.1 mm2_ Veloc· 
ity maps were obtained at consecutive steps of 50 msec throughout 
the cardiac cycle. Graft patency on MR imaging was judged by 3 
independent investigators. unaware of the angiographic fmdings. 
Volume flow was. calculated by integrating average velocity x graft 
area over the cardiac cycle. 
The sensitivity and specifity for graft patency of SE imaging 
was 97% (34/35) and 78% (719). respectively. Overall accuracy was 
93% (41/44). Adequate flow measurements were obtained in 80% 
(28/35) of the patent grafts. Graft flow was characterized by a 
biphasic pattem with one peak during systole and a second peak 
during diastole. No significant differences were found between the 
flow rate in the left anterior descending grafts (88 ± 53 mVrnin. 
n=15). circumflex grafts (55 ± 34, n=11) and right coronary grafts 
(58 ± 32. n=2). respectively. 
It is concluded that MR imaging is an accurate method for non· 
invasive assessment of graft patency and capable of quantifying the 
flow rate in 80% of patent grafts. 
780·3 9:00 
Tagged Cine MR Imaging During Low-dose Dobutamine Infusion To 
Identify Viable Myocardium 
Arzu A. Cubukcu. U. Mohan Sivananthan. +John P. Ridgway, Andrew 
N.S. Deaner. Gordon J. Williams. Michael R. Rees, lip-Bun Tan, 
Killingbeck Hospital. + St. James' Hospital, Leeds, U.K. 
The prospect of this study is identification of viable but not-contractile, 
"hibernating". myocardium in post-infarct patients with the use of tagged 
cine MR imaging during pharmacological stress. 
Seven patients (7 men. aged 40-601 who previously had a transmural MI 
(6 months to 3 yearsl are investigated due to presence of angina. All 
patients underwent either a dab uta mine (n = 61 or exercise (n = 11 stress 
thallium study followed by a dobutamine tagged cine MRI. 
Tagged cine MR images are obtained on a 1.0 Tesla (Magnetom SP. 
Siemens systeml with the use of FISP sequence. Two tagging 1.3.3.1 
binomial pulses are applied at end-diastole resulting in superposition of an 
orthogonal grid pattern. Imaging is performed in both long-axis and 
selected short-axis directions. Following rest images, dObutamine is 
infused at 5 and 10 mcgikg/min and tagged imaging is repeated. 
The left ventricle is divided into the segments (five in long. four in short 
axis. and to endocardial and epicardial layers when it is possible I and 
tagged images are assessed both visually and quantitatively. An in-house 
image analysis is used for quantification. The distance in between grids 
in each myocardial region is measured for each frame and percentage 
segmental shortening (%51 is calculated in both short and long-axis 
images. Radial displacement of each segment from a fixed centre point is 
also measured and % radial displacement is calculated. 
The %5 in infarcted regions are found to be reduced (9.8 + 1·4% versus 
28.2 + 1- 6%, p< 0.01 I. The %5 in these regions increased from 9.6% to 
14.1 % in five regions (p<0.051. Thallium studies showed partially 
reperfusing defects in 4 of these 5 regions. %S remained unchanged 
(10.0% to 10.2 %)in the other 2 regions which thallium studies showed 
only fixed defects in all of these regions. 
Low-dose dobutamine infusion combined with tagged cine MR imaging 
provides improved assessment of myocardial function. and allows to 
identify viable myocardium. 
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780·4 9:15 
Dobutamlne Cine Magnetic Resonance Imaging for Datection and 
Localization of Coronary Artery Disease Using Quantitative Analysis 
F.Paul van Rugge. Ernst E. van der Wall. Albert de Roos. Sander 
Spanjersberg. Albert V.G. Bruschke. ICIN and Department of 
Cardiology. Laiden. The Netherlands 
To determine the clinical value of cine magnetic resonance imaging 
(MRII for detection and localization of myocardial ischemia in 
patients with coronary artery disease (CAD) a modification of the 
centerline method was used for quantification of MRI wall 
thickening dynamics. 
Thirty-nine patients with significant coronary artery stenosis 
(> 50% diameter stenosis) and 10 normal volunteers underwent 
cine MRI at control state and during peak dobutamine stress 
(maximal infusion rate 20 pglkg/min). Both at control state and 
during peak dobutamine stress. cine MRI tomograms were obtained 
at 4 consecutive short-axis levels. An adapted centerline method 
was used for measurements of wall thickness and percent wall 
thickening (%WTh). Segmental %WTh related to the distribution 
of the coronary arteries in the short-axis plane was compared with 
the coronary arteriographic findings. Dobutamine-MRI was 
considered positive for CAD when segmental %WTh was <2 SO 
below the values from the normal volunteers. 
The overall sensitivity of dobutamine MRI for the detection of 
Significant coronary artery disease (diameter stenosis Ol: 50%) was 
91 % (30 of 33); specificity was 80% (5 of 6) and accuracy 90% 
(35 of 39). The sensitivity for identifying one-vessel disease was 
88% (15 of 17). 91 % (10 of 11) for two-vessel disease. and 
100% (5 of 5) for three-vessel disease. The sensitivity for 
detection of individual coronary artery lesions was 75% for the left 
anterior descending coronary artery. 87% for the right coronary 
artery. and 63% for the left circumflex coronary artery. 
We conclude that dobutamine cine MRI using the centerline method 
is an accurate method for detection and localization of myocardial 
ischemia in pts with CAD. 
780·5 
The Evaluation of Mitral Stenosis With Velocity 
Encoded Cine Magnetic Resonance. 
9:30 
Paul A. Heidenreich, Johann Steffens, Naoya Fujita, 
Margaret O'Sullivan, Gary R Caputo, 8yse Foster, Charles B. 
Higgins. Univ of CA, San Francisco, CA. 
Introduction: Velocity encoded cine-magnetic resonance 
(VEC-MR) is a new method of blood flow evaluation with the 
potential to measure high velocity jets from stenotic valves. 
Purpose: To evaluate the ability of VEC-MR to measure 
trans-mitral velocity in patients with mitral stenosis(MS). 
Methods: Sixteen patients with known MS were recruited. 
Velocity encoded MR images were obtained in the LV short 
axis plane. Doppler echocardiography was performed on 
every patient within 2 hrs. of MR imaging. Peak and mean 
velocities, velocity time integral(VTI),and peak and mean 
gradients, were determined for both VEC-MR and Doppler 
studies. Results: There were strong correlations between 
Doppler and VEC-MR for the peak (r=O.92) (fig.), and mean 
(r=O.90)velocities, the mean pressure gradient (r=O.95) and 
VTI (r=O.89). 
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Conclusion: VEC-MR has the ability to measure trans•
mitral blood velocity in mitral stenosis. 
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780·6 
Magnetic Resonance Angiography of Coronary Arteries: 
a 2-Dimensional Versus 3·Dimensional Approach. 
9:45 
Mark B.M. Hofman, Albert C. van Rossum, 'Cynthia B. Paschal, 
'Debiao Li, 'Mark Haacke, Michiel Sprenger, Cees A. Visser. Free 
University Hospital Amsterdam, The Netherlands, 'University Hospitals 
of Cleveland, and 'Vanderbilt University Medical Center, Nashville. 
Recently, magnetic resonance angiographic (MRA) techniques have 
been developed enabling Don-invasive imaging of coronary arteries in 
humans. Both two-dimensional (2D) and 3-dimensional (3D) approaches 
can be used. With 2D methods a single ECG-gated image is obtained 
within a breath-hold. This must be repeated in multiple oblique planes 
in order to cover all the coronary arteries. 3D methods image a larger 
volume which contains the coronary artery tree. This acquisition requi•
res a longer time and must therefore be gated to the respiration. The 
goal of this study was to compare the feasibility of both approaches of 
magnetic resonance coronary angiography. Eleven healthy volunteers 
(age 19-24) were studied in prone position using a surface coil. Spatial 
resolutions for 2D and 3D techniques were 1.2x2.1 x4 mm' and 
1.2x2.3x2.1 mm' respectively. With the 3D technique respiratory gating 
was obtained by simultaneous imaging of the position of the diafragm. 
Results: 2D 3D 
LM LAD CX RCA LM LAD CX RCA 
visibility 11 11 9 11 9 10 8 II 
length mm 8 40 18 53 7 34 15 46 
diameter mm 3.5 2.8 2.8 2.8 4.1 2.8 2.9 3 
best quality 10 9 7 7 0 2 2 
The overall imaging time for the 2D method was 40 minutes, for the 3D 
method 15 minutes. The 3D method is less operator dependent, requires 
less cooperation of the patient, but needs more time for post-processing. 
Conclusion: Both 2D and 3D MRA methods are feasible for imaging of 
proximal coronary arteries, presently with higher image quality for 2D. 
The lesser image quality of the 3D method is probably due to motion 
artifacts, but is expected to improve with new technical developments. 
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781·1 
Do Women with Coronary Disease Truly 
Get Treated Differently than Men? 
8:30 
Eric D. Peterson, Unda K.Shaw, Elizabeth R.Delong, Julie K Fetters, Daniel 
B. Mark, David B. Pryor, Duke University Medical Center, Durham, NC. 
It is unclear whether reported gender variation in coronary angioplasty 
(PTCA) and bypass surgery (CABG) use are due to casemix differences. 
We examined initial revascularization rates in 12,402 consecutive patients 
with significant coronary disease ~75% stenosis) seen at Duke from 3/84-
12192.28.3% of the cohort was female. Compared to males, females were 
older, more likely to be black, have diabetes and unstable angina. At 
catheterization, females had significantly more single vessel disease and 
higher ejection fractions. Unadjusted rates of revascularization within 60 
days of catheterization were lower in females than males, unadjusted 
femalelmale odds ratio (FIM OR) 0.83 (95%CI 0.76-0.90). Unadjusted 
revascularization rates for males and females by number of significantly 
stenosed coronary vessels are displayed: 
Mal./Female .evalcukulzotlon lat •• by Coronary Anatomy 
---- Mole-CABG 
---0-- femo_.CA8G 
--MOle·PTeA 
- Female·PTCA 
After adjusting for age, race, cardiac risk factors, anginal pattems, history 
of previous myocardial infarctions, coronary anatomy, and ejection fraction, 
gender differences in overall revascularization rates were no longer 
significant, adjusted FIM OR 0.94 (95%CI 0.85-1.03). Females underwent 
significantly less CABG, adjusted FIM OR 0.77 (95%CI 0.69-0.85), but 
significantly more PTCA, adjusted FIM OR 1.20 (95%CI1.08-1.33). 
Conclusion: Much of the variation In overall revascularization rates 
between males and females can be explained by casemix differences. 
Interventional strategies do, however, show gender differences. PTCA is 
"CPIosen more often as an initial interventional procedure in females w~h 
significant disease, whereas, males are more likely to undergo CABG. 
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Are Coronary Angioplasty and Bypass Surgery Underused 
Among African Americans, Women and Poor and Uninsured 
Patients? 
Marianne Laouri, Richard L. Kravitz, William J. French, 
Jeffrey Milliken, Robert H. Brook. RAND, Santa Monica, 
CA; UCLA and Harbor·UCLA, Los Angeles, CA. 
The purpose of the study was to determine whether 
coronary angiop1asty (PTCA) and bypass surgery (CASG) 
were underused among groups of patients with documented 
lower rates of cardiac procedures. Explicit clinical 
indications for PTCA and CASG were established by a 
national multispecialty panel of physicians. Underuse 
was defined as failure to receive indicated PTCA or 
CABG. Subjects were identified from among 9100 patients 
with coronary artery disease who had coronary 
angiography between 1/1/90 and 9/30/91 at 6 academic 
medical centers (4 public, 2 private). After chart 
review, 674 patients met indications for PTCA or CASG. 
32% were women, 67% poor and uninsured, 55% white, 13% 
African American and 20% Latino. Left main or 3-vesse1 
disease was present in 67%; 21% had a recent MI, 41% 
unstable angina and 37% chronic stable angina. Overall 
25% of patients did not receive indicated PTCA or CASG. 
After controlling for clinical and demographic factors, 
hospital where the coronary angiography was performed 
and age, African Americans were less likely to undergo 
indicated PTCA and CASG; respective adjusted odds ratios 
.14 (p<.05) and .50 (p-.05). No differences were found 
between men and women. While not statistically 
significant, poor and uninsured patients were less 
likely to undergo PTCA or CASG than insured patients who 
underwent coronary angiography at a private hospital. 
Conclusion: Underuse of cardiac procedures was found at 
6 academic medical centers, and was more pronounced 
among African Americans. 
781·3 9:00 
toby do wanen Have !iJre Severe An;Jina than Men t>Ilen they 
Urx:lergo cardiac catheterization? 
John M. crean, Edith Flaster, an:i Ridlarc1 M. stein:}art. 
Health Scien:leS Center SUNY stalyBrook an:i wi.nthrc:p•
university Hospital, Mineola, NY. 
wanen have nme severe ~ina than men at the time of 
cardiac catheterization (CA'IH). '1his advaroed clinical 
disease is strorgly associated with poorer prooedural 
0lt0c:Jne for ~ic:plasty an:i CAOO. To better I.IOOerstan:i 
the process that leads to CMll, we studied 58 wanen who 
were referred for thallium exercise testiIg (Ela'L) by 22 
different c:kx:tors (MO). '!heir oo.n:se was cxmpared with 
that of 58 men hav~ Elcr'L, matched for age (60j;B yrs), 
test date, clinical status, likelihood of CAD, presence 
or absence of isdlemia, an:i referriIg MD. pts were 
foll~ for 37+20 l!I011ths after the Elcr'L. None of the 
44 men or waner! with nonnal Elcr'L, bIt 19/36 men an:i 
15/36 waren with i.sdlemic Elcr'L were advised to have CA'lH 
by their MD (NS wanen vs men). Multivariate analysis 
showed that ~2 areas of ischemia (crl:is ratio 8:1) an:i 
the severity of ischemia (odds ratio 22:1) were 
associated with a reccmnen:lation for CA'IH. '!he pt's sex 
was not predictive of the MD t"E!CCIIIIlE!Ition (odds ratio 
wanen:rren 1.3:1). '!he subsequent clinical oo.n:se of rren 
an:i wanen did differ. Foor wanen advised to have CA'IH 
refused; all rren agreed (p<0.02 waren vs men). Of pts 
agree~ to CA'IH, time to CA'IH was lorger for wanen 
(median 20 days for wanen vs 12 days for men, p=O.044). 
By the errl of follOliMlp, a total of 22 wanen an:i 22 men 
had CA'IH (NS); wo~ synptans lead to late CA'IH. 
Time to arrj CA'IH was again lOl'tJer for wanen (median 62 
days for waren, 15 days for men, p=O.04). 'lhus the ex•
tent an:i severity of ischemia, not pt sex or clinical 
status were predictive of an early CA'IH referral. wanen 
were lIOre synptanatic at CMll because lICre refused early 
CA'IH after Elcr'L, rut had CA'IH due to worsenin;J synptcms. 
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Severity of Coronary Artery niaeaae in Black and White 
Veterana and Likelihood of &evaacularization 
Reginald L. Peniston, David Y. Lu, Vasilios 
Pspsdemetriou, Ross D. Fletcher, VA, Howard and 
Georgetown Medical Centera, Washington, D.C. 
Coronary angiograms were reviewed in 1,460 individual 
veterans with chest pain syndromes or other ischemic 
events. These 734 white (W) and 726 African American 
(AA) males had identical mean ages (61 yrs ± 10). 
Although AA pts had significantly (P<.05) greater 
prevalence of diabetes and history of hypertension, W 
pts had significantly greater proportions with typical 
angina, myocardial infarctions, and lipid 
abnormalities. AA pts also had a larger proportion 
without significant coronary artery disease (CAD) (no 
vessel with ~50' stenosis; AA 36%, W 18.9% p<.05). 
Severity of disease was scored using a standardized 
technique (27 anatomic segments and six levels of 
stenosis). Severity scores and referral for 
revascularization (angioplasty or bypass surgery) were 
compared while controlling for ethnicity and number of 
diseased vessels. 
% Referred Severity Score 
AA W P value AA W P value 
Single 33 44 <.05 48±17 53±19 <.05 
Double 53 65 <.05 67±23 72±26 <.05 
Triple 69 77 NS 96±32 96±35 NS 
Left Main 95 93 NS 90±3l 115149 <.05 
Logistic regression analysis indicated that the number 
of diseased vessels, proximal LAD disease, typical 
angina, and ethnicity were independent predictors for 
revascularization referral. In male veterans having 
coronary angiography, AA have less frequent CAD and 
less severe disease as partial but important 
explanations for differences in revascularization 
referral rates. 
781·5 9:30 
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Serum Cholesterol Levels After Coronary Angioplasty in 
Men and Women 
Kevin H. Silver, Bonnie H.Weiner, Marie L. Borbone, Louis 1. 
Heller, Michael N. lolie, U Mass Medical Center, Worcester, MA 
Elevated serum cholesterol (TC) is a risk factor for progression of 
coronary atherosclerosis and may contribute to late restenosis after 
coronary angioplasty (PTCA). To assess whether 
hypercholesterolemia is managed according to NCEP guidelines, we 
obtained follow-up (FlU) in 579 patients at 6,12, and 24 months 
post-procedure. By 24 months, FlU TC had been measured in only 
36 of 167 (W)omen and in only 101 of 412 (M)en (22% v 25%. 
p=NS). Results are shown below: 
TC @ PICA TC @ FlU AYULU. ~ 
All 222±43 213±48 JO±8 mo 0.02 
M 216±38 204±39 11±8 mo <0.01 
W 239±53 240±61 9±8 mo NS 
M and W were treated with lipid lowering drugs at equal frequencies 
(50%). Based on these findings we conclude: I) Seventy five percent 
of our patients did not have cholesterol levels measured within two 
years after angioplasty; 2) Only 50% of patients with TC>200 are 
treated; 3) Among those with FlU, women had higher cholesterol 
levels than men at PTCA; 4) Additionally. among those patients with 
FlU, post-PTCA TC decreased in men but not in women, suggesting 
a less aggressive approach to therapy. 
300A ABSTRACTS 
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EDUCATION LEVEL HORE THAN GENDER OR IlACE PREDICTS 
PATIENTS' ATTITUDES TOWARD HANAGEHENT IN THE CORONARY 
CAll! UNIT. 
Alison D. Schecter, Glenda McKee, Donna Hoffeld, 
Roseann Velez, Mary Myers, Theresa Drayer, Christine 
Szych, Nisha C. Chandra, Pascal J. Goldschmidt•
Clermont, Daniel E. Ford, The Johns Hopkins 
University, Baltimore, Maryland 
Numerous studies have demonstrated that women 
and minority patients with heart disease are less 
likely to undergo cardiac catheterizations and 
revascularization procedures. Patients were 
interviewed at the time of admission to two coronary 
care units (CCU) to ascertain their attitude towards 
cardiac catheterization or revascularization 
procedures. Of the 195 patients interviewed (median 
age 62). 58% were male, 25% were African·American, 56% 
had <high school diploma, 44% had a family income 
between $10,000 and $30,000. Patients were asked to 
rate on a 5-point scale (I-agree to 5-disagree) their 
level of agreement with the recommendation for a 
cardiac catheterization or angioplasty. The mean 
value was 2.3. In univariate analyses, education 
level (p-.004) was positively associated with agreeing 
to catheterization. Mean values were 2.47 for <high 
school, 2.45 for high school graduates, and 2.0 for 
education >high school. Gender, race, age, and 
household income were not significantly associated 
with agreeing to catheterization. A linear regression 
model including all socioeconomic variables confirmed 
that only educational level was associated with 
agreeing to catheterization (p<.Ol). Thus, at the 
time of admission to a CCU, educational level has a 
major effect on a patient's attitude toward undergoing 
cardiac catheterization and angioplasty. 
922 New Device AngiopJasty 
Wednesday, March 16, 1994 9:00-11:00 AM 
Georgia World Congress Center, Hall H 
Presenting Hour: 10:00 AM 
922-26 
Late Deaths in the CA VEA T Study: Statistical or Clinical 
Significance? 
John M Elliott, Robert M Califf. Lisa G Berdan. Gordon P Keeler. 
Marianne Kearney. Eric J Topol for the CAVEAT Study Investigators. 
The Cleveland Clinic. Cleveland. OH and Duke Medical Center. 
Durham. NC. 
Initial analysis of the CAVEAT study suggested an excess of both acute 
complications and 6 month cardiac events in those randomized 10 directional 
atherecoomy (DCA) compared with balloon angioplasty (PTCA). We present a 
detailed analysis of the 14 patients who have died in the fast year after 
randomization. Their mean age aI intervention was 65 years; tbere were no other 
important differences in baseline variables compared with survivors. 
DCA PTCA F lp 
Total dealbsffotal group 111512 3/500 4.4 0.06 
In hospital 0 2 1.7 0.24 
Out of hospital Il 1 8.6 0.01 
-<:mdiac 8 0 8.4 O.oJ 
-vascular 3 0 25 0.25 
-noncanliovascular 0 I 1.0 0.49 
Of the II late deaths fonowing DCA, five died suddenly. 3 died of cardiogenic 
shock. I of pulmonary emboli (femoral hematoma). I of an intracerebral bleed 
after redo PTCA. and I fonowing vascular surgery. The !WO in hospital deaths 
fonowing PTCA were related 10 acute closure, and Ihe late dealh was due 10 cancer. 
AulOpsy was performed in 3 of the DCA group. Thrombus was present at the 
target site in I and severe stenosis with dissection aI the target site in another . 
The third patient had progression of disease with infarction in a nontarget artery 
distribution. Five DCA patients had dissections on the post-procedure angiogram 
wilh distal ectasia before and after DCA in I. Mean residual diameter stenosis by 
QCA was 25% (range 7 10 42%). Media was resected in 5 patients; DO adventitia 
was demonstrnted. 
Mortality was lower than expected in Ihe PTCA group. There is no evidence Ihal 
the small excess of deaths in the DCA group is linked 10 perforation. ectasia or 
deep resection. Althougb there have been few deaths in the fmt year of the 
CAVEAT study. there is a statistically significant difference be!Ween the two 
groups which is nOi explained by differences in baseline variables. 
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922-27 
:Comparison of an Experimental Restenosis Model with Human Arterial 
Vessels after Directional Peripheral Athereclomy 
Peter Gonschior. Florian Gerheuser. Brigitte Mack. Andreas Nerlich2; 
Berthold Hofling; Med. Department I, Klinikum GroBhadem; 21nsthut for 
Pathology; University of Munich. Germany 
Arterial vessels segments treated by directional peripheral atherectomy 
(DA) and from domestic porcine arterial vessels after 'directional 
arteriotomy" were compared. 125 carotid and femoral porcine arteries 
were excised 2 hours to 21 days after DA. 4 peripheral human vessels 
were obtained <24 hours after DA from autopsie, due to lethal events. 
The tissue was adequately fixed and processed for light-microscopy. 
immunohistochemistry or uHrastructural analysis. 
At the sHe of mechanical tissue ablation. minor thrombus aggregation was 
found. A marked. transient infiHration of polymorphonuclear leukocytes 
(PMN) occurred starting in the first few hours (maximum at 10 hours) 
followed by the transfonnation of contractile myocytes into a synthetic 
subtype. Monocytes and macrophages were seen beginning with 2 days. 
Experimental and human myocytes showed striKing uHrastructural 
similarity: The cells revealed abundant perinuclear organelles and 
restricted myofilaments. Numerous myocytes had apparently lost all the 
actin filaments (mean volume fraction <9%) The nucleolus of these 
myocytes was hypodense and the nuclear envelope had i1cklsions. 
indicating an activated status. An intense myoproliferative response was 
found in cases of media and adventHia injury. that peaked at 7 days 
(+400% versus contrOl). WHh deep adventHia laceration occluding 90% of 
the vessel circumference. 
The presented data provide evidence that cellular alteration of the 
atherectomized vessel begins immediately after atherectomy and is not 
predicted by the amount or incidence of thrombus. FollOWIng an inHial 
temporary PMN infiltration an already very early activation of local 
myocytes appears. These effects and particularly a myoproliferative 
response was found after deep vessel laceration. indicatIng a clear 
correlation of injury depth and corresponding myoproliferative response. 
The experimental and the human vessel aHerations demonstrated striking 
simiiarHy. supporting the validity 01 the experimental restenosis model. 
• (supported by Sanderstiftung grant 90.026.2 and DFG grant1076/1-2) 
922-28 
Len Main Coronary Artery Disease In the New Device Era: 
Impact or Excimer Laser and Directional Atherectomy 
Kirk N. Oarratt, Robert D. Simari, Robert S. Schwartz, Malcolm R. 
Bell, Peter Berger, David R. Holmes, Ir. Mayo Clinic, Rochester, MN 
New devices (NO = directional atherectomy and excimer laser 
angiopiasty) may improve results of treatment of coronary lesions at 
high risk of complications with balloon angioplasty (PTCA). To assess 
utilization and impact of ND on treatment of left main coronary lesions, 
we compared the outcome of all pts with left main lesions treated with 
PTCA (n = 15, Or 1) during the 45 months prior to ND aVailability 
(U8S through 9/88) and all pts with left main lesions treated with any 
percutaneous device (n = 34, Or 2) during the fmt 52 months of ND 
aVailability (10/88 through 1/93). ND were used in 18 (53%) Or 2 pts 
(atherectomy used in 2,Iaser in II, and both in 5 pts). Pt age, gender, 
prior bypass surgery (CABO), prior Q-wave myocardial infarction 
(QMI), and left ventricular function were similar in the two groups. 
Pts receiving stents were excluded. Results: 
Or 1 Gd p 
Left mam lesions treated! 1511645 34/2982 
total interventional cases (0.9%) (1.1 %) NS 
Shock before therapy I (7%) 4 (12%) 0.086 
Success· 10 (67%) 24 (71 %) NS 
Shock after therapy 0 0 NS 
In-hospital QMI 0 0 NS 
In-hospital death 3 (20%) 6 (18%) NS 
CABO <24 hrs 1 (7% 0 NS 
(*<5 resl u stenosIs. no death. M or AB). ean ollow·up 
periods were 4.6±0.5 years for Or 1 and 1.5±1.0 years for Or 2. At 
one year, 80% of Or I and 94% of Or 2 pts discharged alive were free 
of death, QMI and CABO; by Kaplan-Meier analysis, the difference 
between event rates for these groups was not significant over the 
follow.up period. We conclude that the frequency of left main 
treatment has increased in proportion to total interventional case 
volume. not availability ofND. Acute and intennediate outcomes have 
not been significantly improved with the availability of ND. 
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922·29 
Comparison or DCA and Rotablatlon by Intravascular 
Ultrasound: Mechanism and Extent or Plaque Removal 
E. Murat TulCu. Patrick L. Whitlow. Anthony C. De Franco. Russell 
E. Raymond. John Elliot. Jeffrey Lefkovits. Skip Guyer. Irving 
Franco. Stephen G. Ellis and Steven E. Nissen Cleveland Clinic. OH. 
Objectives: Although directional atherectomy (DCA) and rotablation 
(ROT A) have been approved. few data exist comparing their 
mechanism of benefit, lumen enlargement, and plaque removal. 
Methods: We examined 62 procedures in 59 patients. 35 DCA and 
27 ROTA. For each lesion. 10 ultrasound measurements were 
performed at lesion and reference sites including minimum. maximum. 
and mean lumen diameter (LD·min, LD-max, LD-mean). maximum 
plaque thickness (P-max). plaque and lumen area (CSA). and presence 
of calcification. Ultrasound stenosis was calculated from plaque vs. 
lumen CSA and plaque removal from pre vs. post plaque CSA. 
Results Lesion Reference Plaque Ultrasound 
PRE LD-mln LD-mean eSA % plaque 
Procedure (mm) (mm) (mm2) Stenosis 
DCA 1.55 3.38 13.6 81.6 
ROTA 1.38 2.85 9.3 81.3 
P value NS <0.0001 NS NS 
Calcium was present at 24% of DCA and 84% ROTA Sites. (p<OOO1). 
Results Lesion LeSion Plaque Plaque Ultrasound 
POST LD-mean P-max eSA removal % plaque 
Procedure (mm) (mm) (mm2) (mm2) Stenosis 
DCA 3.04 1.59 9.S 4.1 51.9 
ROTA 2.06 1.34 6.2 3.1 58.1 
P value <0.0001 <0.0001 <.OS NS NS 
Conclusions: DCA and ROTA remove comparable quantities of 
plaque and yield similar residual percent stenosis. ROTA effectively 
removes plaque in small. calcified vessels. while DCA yields a larger 
overall lumen in bigger vessels. These fmdings may enable application 
of intravascular ultrasound to optimize device selection. 
922·30 
Incidence. Angiograpbic Predictors, and Clinieal Signirlcance of 
Coronary Perforation Occurring Arter New Device Angioplasty 
Roy D. Flood. Jeffrey J. Popma. Ya Chien Chuang. Lowell F. Salter. Augusto 
D. Pichard. Kenneth M. Kent. Gary S. Mintz. Lisa Sokolowicz. Tereza Y. 
Conway and Martin B. Leon. Washington Hospital Center. Washington DC. 
Whereas coronary perforation is infrequent after standard balloon angioplasty. 
it may occur more often after coronary angioplasty using new coronary 
devices which ablate or excise atherosclerotic plaque. To determine the 
incidence. predictors and clinical significance of coronary perforation after 
balloon and new device angioplasty. we reviewed the cineangiograms of 2426 
patients using qualitative morphologic and quantitative angiographic 
methods. Coronary perforation occurred after 19 (0.7%) procedures. 
including balloon angioplasty. I (0.6%. N .. 166). directional. 2 (0.3%. N = 
602). rotational. 3 (0.4%. N = 862). and extraction. 0 (0%. N = 137) 
atherectomy. stenting. I (0.2%. N .. 499). and excimer laser angioplasty. 12 
(1.7%. N = 619). Clinical and angiographic predictors of perforation 
included: 
Perforation No Perforation 
N=19 (%) N = 2407(%) P Value 
Female Gender/Prior CABG 42/ 12 26/37 .18/.02 
Laser Use/Length ~ 10 rnm 63 / 47 25/28 .00 I / .006 
Bend ~ 45°/Concenttic 37/63 I7 /39 .03 / .04 
De Novo/Proximal Tortuosity 94 / 21 66 / 4 .0 I / .006 
Total Occlusion/Right Coronary 26/47 8/26 .02/.16 
Procedural Success 47 91 < .001 
DeathlCABG/MI 5.9/33/5.6 1/3.2/.9 < .001 
Coronary perforation resolved with prolonged balloon angioplasty in 10 
patients (including 5 with residual staining or aneurysms). Hemodynamic 
compromise developed in 9 patients. including 2 requiring pericardiocentesis 
and 6 requiring emergency CABG. We conclude tbat I) coronary 
perforation occurs most often after new device angioplasty using the excimer 
laser catheter (1.7%). 2) is related to a number of preprocedural angiographic 
factors and 3) is associated with major complications and hemodynamic 
compromise in nearly 50% of patients. 
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922·31 
Do Exclmar L .. ara and Atharactomy Davlcaa ·Facllltata" 
tha Raaulta of aaUoon Analoplaaty: Report from the 
HACI Realatry 
Robert D. Safian. Elizabeth D. Kannard. ·Michael H. Skatch Jr. ·Frank 
Lltvack. ·Tlmothy A. Sanborn. ·Maurice Buchbinder. Katherine Detre. 
Donald S. Bairn. William Beaumont Hospital. Royal Oak, MI. 
Excimer lasers and atherectomy devicea are frequently used u 
pratreatment before conventional balloon anglopluty (PTCA). but 
whe ther u.e devices facilitate the results of aubMquant PTCA 18 
unknown. The results of angiographically aucceuful Interventions were 
entered Into the New Approaches to Coronary Intervention (NACI) 
Registry. including PTCA alone (n-211). Rotabiator (MRA, n-215). 
extraction atherectomy (TEC. n-116). AIS laser (AIS. n-327). and 
Spectranetica laser (SPEC. n.99). Adjunctive PTCA was used after 
73% of MM. 84% of TEC. 95% of AIS. and 85% of SPEC lesiona. 
Angiographic results using on .. "e digital caliperl included reference 
artery diameter (A). final lumen diameter (FLO). and final diameter 
stenosis (FDS). The balloon/artery ratio (BlA) wu calculated for all 
lesions to _ure adequate balloon aizing. and FlO was normalized for 
balloon aize (FlOlB) to correct for differences in balloon size: 
Device(s) A (mm) FLO (mm) FDS !%) B/A FLD/B 
PTCA alone 2.54 2.05 21 1.04 0.81 
MRAIPTCA 2.92 2.22 24 0.95 0.83 
TECIPTCA 3.43 2.68 21 1.1 0.76 
AIS/PTCA 2.79 2.17 23 1.05 0.77 
SPEc/PTCA 3.02 2.59 16 1.05 0.83 
Conclualon: 1) Pretreatment With axcimer lasers and atheractomy 
devices before PTCA had variable Impact on lumen enlargement; 2) Final 
diameter 8tenosis was 21 % after PTCA alone. but 16-24% after 
pretreatment With a new device; 3) When normalizing final lumen 
diameter for balloon alze. 81 % (FLDIB-O.81) of the Inflated balloon 
diameter wu retained u lumen enlargement after PTCA alone. whereas 
76-83% of the inflated balloon diameter wu retained after 
pretreatment with a new devica. 3) Further atudias are needed to 
identify lesion subsets In which devices facilitate aubsequent PTCA. 
922-32 
Do Racial Differences Affect Outcome Arter New Device Angioplasty? 
Ya Chien Chuang. Alan J. Merritt. Jeffrey J. Popma. Theresa A. Bucher. 
Roy D. Flood. Lowell F. Satler. Kenneth M. Kent. Gary S. Mintz. Luela T. 
Lewis. and Martin B. Leon. Washington Hospital Center. Washington DC. 
Preliminary reports indieate worsening procedural outcome in specirlc racial 
groups after conventional PTCA. To determine whether racial differences 
affect outcome after new d/!Vice angiopia5ty. we reviewed our experience 
with 2238 patients undergoing directional (N=532). rotational (N=676). or 
extraction (N= \08) atherectomy. stenting (N=402) or excimer laser 
angioplasty (N=520). Procedural success « 50% final diameter stenosis and 
no in-hospital death. Q-wave MI. or CABG) was obtained in 2030 (91 %) 
patients. Hospital complications were identified by chart audit: 
cineangiograms were reviewed using quantitative methods; late outcome was 
assessed by prospective follow-up. Late (1 year) events included death. Q•
wave MI. CABG or rePTCA. 
Race This StudYI 
Regional Population 
AfricanAmerican 
N=I69(%) 
13/27 
Caucasians 
N= 1955(%) 
87/66 
p 
value 
<.001 
Age (years)/Female 59/39 63/26 <.001 / <.001 
Hypertension/Diabetes 74/39 54 / 26 <.001/<.001 
Smoking/Recent MI 37/18 30/13 .08 /.06 
Final % Stenosis 2O±18 21±18 NS 
Procedure Success 91.7 90.8 0.15 
Death/MllCABG 4.1/1.2/2.4 0.6/0.9/3.4 <.001 /NS /NS 
Late Death/MI 1.5 / .8 1.6/ 1.4 NS / NS 
LateCABG{rePTCA 9/21 8/18 NS/NS 
No significant racial differences in pre- or post procedural lesion 
morphology were noted. In-hospital repeat PTCA was required more often 
in African Americans (6% versus 3% in Caucasians; p = 0.03). We 
conclude that Mrican Americans are I) under-represented in patients 
undergoing new device angioplasty. 2) had more co-morbid diseases. 
potentially accounting for higher procedural death rates and 3) have a 
favorable late clinical outcome after new device angioplasty. 
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922·33 
Is the Relationship Between Luminal Increase and Subsequent Renarrowlng 
Uriear or Non-Unear in Patients Undergoing Coronary InterventJons? 
David P Foley, Rein Melkert, Victor A Urnans, Peter P de Jaegere, Pim J de 
Feyter, Patrick W Serruys. Thoraxcentre, Erasmus University, Roterdam, NL 
A linear relationship has been demonstrated between acute luminal gain and 
subsequent iate loss, in patients undergoing various translumlnal coronary 
interventions. This concurs with experimental evidence 0/ a proportional 
relationship I!etween vessel wall injury and neolntlmaJ response. Recent dllta 
from the CA YEA T trial chalienge these reports by suggesting non-Ilnearlty of 
the loss/gain relationship. In the present study, we evaluate the possibility of 
a non..Jlnear relationship between luminal gain (G) and loss (l), In native 
coronary lesions undergoing balloon angloplasty (n ~ 1452, mean G ~O. 75mm, 
l=0.287mm), directional atherectomy (n=123, G=I.25mm, l=O.65mm), or 
Implantation of a Wallstent (n=111, G~1.39mm, l~O.67mm) or Wiktor stent 
(n=101, G=1.31mm, L=0.72mm). Addition of a square and/or cubic term 
failed to exert any statistically significant effect on the linear model, considering 
the entire group as a whole, or each group separately, in univariate and 
multivariate analysis and whether l and G were consider9!:lln absolute terms, 
or adjusted for vessel size (ie relative loss/relative gain (Rl/RG», (all p> .2). 
Use of spline modelling to investigate local non-llnear relationships between l 
and G throughout the range, under the same varied conditions, also did not 
demonstrate any evidence of non..Jinearity (all p > .2). Furthermore, comparison 
of line slopes, for l/G and RL/RG, on each side of cut-points for G from 0.7-
1.3mm, at .2mm increments, and RG from 0.25'{).40, in Increments of 0.05, 
·failed to demonstrate any slgnfficant change, whether a univariate or 
multivariate model was used (all p>.1). These findings also applied when the 
same procedures were repeated after totally occluded lesions pre and at follow 
up were excluded (aI/ p>.1). Conclusion: In contrast with the CAVEAT report, 
.comprehenslve interrogation of the relationship between luminal increase at 
'intervention and subsequent renarrowing, in these patient groups 
representative of European experience, failed to reveal any evidence to. 
indicate non-linearlty. Accordingly, this study must conclude that Increasing 
degrees of renarrowing can be anticipated with a policy 0/ maximizing luminal 
gain. in mind of the clinical consequences, this contentious issue needs to be 
.resolved by further study in larger patient groups treated by different devices. 
922·34 
AllglOIII'aphic SDd Clinical Outcomes in Saphenous Vein Graft (SVG) 
Versus Native Coronary AoJ1o.OstiaI Lesions. 
S. Chiu Wong. Jeffrey J. Popma. MD. Ya Chien Chuang. Lowell F. Sader. MD. 
Kenneth M. Kent. MD. Augusto D. Pichard. MD. Gary S. Mintz. Teraza Y. 
Conway. and Martin B. Leon. WashinglOn Hospital Center. WashinglOn. DC. 
Reduced procedure success. increased complications. and frequent late restenosis 
after PTCA of aorto-ostial lesions has prompted the expanded use of new 
angioplasty devices in this lesion subset. To determine the angioglllphic and 
clinical outcomes of patients undergoing new device angioplasty of aorto-ostiaI 
tesions. we analyzed the ~suIlS in 239 pIS with 262 lesions involving the ostium 
of saphenous vein grafts (SVG. N=I34) or native (right[N=lOS] or left [Nz20]) 
CMlllary arteries trested wilh directional (N=S2). mlalionaJ (N=62). or extraction 
(N=24) atherectomy. stents (N=S4) or excimer laser angiopJasty (N=70). 
Cineangiograms were ~viewed using quantitative methods. Procedural success 
;:~11Jl 1,. 
j .. SVG1U .... .. 
... "l-__ ....... __ ~ 
Native SVG 
N.121(~) N_JJ8('4) 
U ..... bleAqiD. 711(59) 96("')1 
0;. ...... 18(") 43(37)1 
ReIleDotic Lesion 18(16) <16(39)1 
Normal Diameter 2.92%0.61 3.~:tO.63t 
FiDal.-. su.o.. n:tl'7 13t.l't • 1" __ _ 
,.. .. ,( .... ,.) 
(<50% diameter stenosis and no in-hospital death. MI. or CABO) was obtained 
in 223 (93.3%) pts. Early clinical events were uncommon and comparable for both 
native and SVGostiailesions(native2.5% vs. SVG 1.7%). However. late clinical 
events occurred mo~often in SVG ostiallesions{37% vs. 21 % in natives;p=O.OJ). 
most often due to target lesion revascularization (TI.R) (32% vs. 2O%;p=O.05. 
Figure). Using multivariate logistic regression analysis. SVG location is the only 
independent JRd'clOr of aorto-ostiaI TLR (odds ratia=1.9. 99% CI=1.02-3.S4. 
P<O.05). We cooclude I) New device angiopJasty in aorto-ostial lesions is 
associated with high (93.3%) procedural success and few early clinical events and 
2) aorto-ostial SVG lesions. despite hetter initial angiographic ~suJts than aorte>•
ostial native lesions. are associated with more frequent late recurrences. 
JACC February 1994:1A-484A 
922·35 
Predkton ell.lra_tar VItraIoaDd EDdpoillts alter DiredIoDaI CoroII8ry 
AtIIerectomy III 170 Patle.ts 
Fadi A. Matar, Gary S. Mintz, Kenneth M. Kent, Ellen Pinnow. Augusto D. 
Pichard, Lowell F. Saller, Katie Kehoe, Brigette Golden, Robert A. DeFalco. 
Jeffrey J. Popma. Martin B. Leon. Washingron Hospital Center. WashinglOn. DC 
Intravascular ultrasound endpoints may be useful in assessing the results of 
transcatheter therapies. Therefore, we used multivariable logistic regression 
analysis to identify clinical, procedural. and pre-intervention quantitative 
angiographic and intravascular ultrasound predictors of directional coronary 
atherectomy (DCA) resullS in 170 pIS (80% males. ages 6O±11; 4 LM. 83LAD. 
19LCX, 57RCA, 7SVG). Post-DCA intravascular uItraaound endpoints included 
(l) lume. crOll-seello.11 Irea; (2) ~ cross·sectional Darrowinll 
I~SN=pIaque+media ateII/extemal elastic membrane areal; and (3) ~plaque 
vol_e removed (%4plaque vol) measured using Simpson's Rule. motorized 
transducer pullback (@O.Smm/sec), and the decrease in plaque area (pre-DCA -
post-DCA) at Imm axiaJ intervals throughout the length of the target lesion. 
Multivariable. independent predictors of post-DCA intravascular ultrasound 
endooints were: 
Lumen area %CSN %Ap~uevol 
P P P 
USA or recent MI 1171170(69%) NS 0.0\ NS 
% 7F device use 129/170 (76%) . 0.009 NS 0.02 
Reference diameter 3.1±2.Smm 0.0001 NS NS 
Lesion length 7.9±4.Smm 0.03 0.02 NS 
Plaque arm pre-DCA 18.3±6.1mm2 NS 0.0001 NS 
Arc: or calcium 70±7S· 0.002 0.0007 0.01 
Lesion calcIum was seen m 63% of treatment Sttes by mtravascular ultrasound. bul 
in only 22% by angioglllphy. Univariable predictors of intravascular ultrasound 
endpoints after DCA included pre-DCA angioglllphic %diameter stenosis, lesion 
irregularity and ulceration. and intravascular ultrasound ~SN and arc of 
superficial calcium. Non-prediClOrs included maximum DCA pressure, II DCA 
cuts. and intravascular uJtrasound lesion eccentricity (maximum/minimum plaque 
thickness), and calcium length. We conclude: The intravascular ultrasound 
IOtaI arc of target lesion calcium was the most powerful predicror of the resuJlS of 
DCA. Even modest amounts of target lesion calcium not seen angiographically, 
but seen on pre-DCA intravascular ultrasound imaging. impacted negatively on the 
results of DCA. In addition, vessel size. lesion length. and device size influenced 
some. but not all. of the intravascular ultrasound endpoints measured. 
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923·61 
Retrograde Crioplegia Does DOt Perfuse the Right Ventricle 
Bradley Allen, Renee Hartz, Jacqueline Winkelmann, Hanafy 
Hanafy, Solomon Aronson, Laurence Segil, David Mayer. Steven 
Feinstein , University of Dlinois at Chicago, Chicago, Dlinois 
Surgeons often rely primarily on retrograde cardioplegia for 
myocardial protection since it has been shown to provide adequate 
perfusion of the LV. Clinically, however, rettograde myocardial 
perfusion of the RV has not been demonstrated. We examined the 
delivery of cardioplegia solution to the RV using contrast 
echocardiography to assess myocardial perfusion. Utilizing 
intraoperative TE echo, fifteen patients bad four cx:'s of sonicated 
lsovue" injected rettograde via a coronary sinus catheter. Visual 
inspection and 
background- RETROGRADE CARDIOPLEGIA DISTRIBUTION 
subtracted 
videodensitometric 
analysis of the RV 
free wall,septum 
and LV free wall 
were perfonned. 
Results: see graph. 
Conclusions: I) Rettograde cardioplegia provides poor myocardial 
perfusion of the RV as assessed by contrast echocardiography. 2) 
The LV appears to be adequately supplied by rettograde 
cardioplegia. 3) Surgeons may not rely solely on retrograde 
cardioplegia for myocardial protection. 4) Future effons should be 
directed at RV preservation during open hean surgery. 
JACC February 1994:1A-484A 
923·62 
Opt1miz1ng Recovery of Ischemic Myocardium by 
Combining Percutaneous Bypass With Coronary Venous 
Ketroperfusion 
Harold L. Lazar, Patrick Treanor, Samuel Rivers, 
Richard l. Shem1n, Boston University Medical Center, 
Boston, MA 
Although Percutaneous Bypass (PB) can support the 
failing myocardium, regional ischemic damage may still 
occur beyond a coronary occlusion because of decreased 
coronary blood now. This study sought to determine 
whether the addition of coronary venous retroperfusion 
using Pressure Controlled Intermittent Coronary Sinus 
Occlusion (PICSO) to PB would result in more optimal 
ealvage of ischemic myocardium. 
In 30 pigs, the 2nd and 3rd diagonal vessels were 
occluded with snares for Ii hours followed by i hour of 
cardioplegic arrest and 3 hours of reperfusion with the 
snares released. During the period of coronary 
occlusion, 10 pigs were placed on PB, 10 pigs received 
PB+PICSO, and 10 pigs received no support 
(UNMODIFIED). Ischemic damage was assessed by Wall 
Motion Scores (WMS) using 2-D echo (4=normal to -
l=dysldnesis), changes in myocardial tissue pH (ApH) 
and the Area of Necrosis/Areaof Rlsk (ANIAK). Results 
are Mean:t SE; *p < .05 from UNMODIFIED 'p < .05 from 
PB. 
WMS 
~pH 
ANIAK (\) 
UNMODIFIED 
1.3 + .3 
.41:; .13 
7313 
PB 
1.4 + .3 
.60:; .10 
4312* 
PB +PICSO 
2.8 + .3*' 
.30:; .08' 
1412*' 
We conclude that coronary venous retroperfusion 
enhances Percutaneous Bypass and results in the most 
optimal recovery of ischemic myocardium. 
923·63 
Wsrm Continuous Retrograde Cardioplegia: The Impol'tlnce of High 
Flow Rates for Myocardial Protection/Patient Outcome. 
Steven R Gundry, MD, Nan Wang, MD, Anees J Razzouk, MD, Arthur C 
Hal, MD, Chartes M ScIoIaro, MD, Glen S Van Arsdell, MD, Leonard L 
BaDey, MD. 
Prompted by antecdoctal success and falure reports on wann 
continuous retrograde cardioplegia (WCRC), we changed from cold, 
Intennlttent RC to WCRC In February 1991, In order to develop methods 
for WCRC which wolMl consistently ensure that myocardial protection was 
adequate. Since that time, we have studied 240 pta using coronary artery 
blood gas sampling as a measure 01 myocardial protection and as a guide 
to WCRC flow rates. Basad upon these reSIAts and clinical outcome, after 
six months, In September 1991, we Increased ftows 01 WCRC from 125-150 
cc/mln to 200-300 cc/mln and employed a coronary sinus audible low 
pressure alann. Compartson 01 tha two groups, Earty Expertence (Feb-Aug) 
and Late ExperIence (Sept-Sept) for adequacy of preservation as JUdged 
by Intre-eortlc balloon pump PAPB), left ventricular assist devtce (LVAO) 
use, and cardiac deeths (CD) appear below. The groups were equally 
matched for age, sex, type 01 operation and election fractions, but twelve 
01 the Late Expertence group had EFs ~ 15%. 
Operation. ~ IAPBI,I%) WADI"%) CP'!#l%l 
Early 
ExperIanca 90 27 (30%) 4 (7%) 3 (3%) 4 (7%) 
ute 
ExperIence 150 76 (51%) 2 (1%) o o 
All IAPB's and LVAO's were In pts with severe LVH and/or redo 
operations; poor outcome was associated with coronary artery pH's <7.20 
and pC0z's >40. No patient with normal coronary blood gases developed 
myocardial dysfunction. 
We conclude that unlike hypothermic, intermittent RC, WCRC cannot 
be tumed on and Ignored. *Hlgh' WCRC ftows, a low pressure alann and 
periodic assessment 01 coronary blood gases can ensure excellent 
myocardial protection ualng WCRC and can prevent varlabllty In 
myocardial protection. 
ABSTRACTS 
923·64 
Increased Systemic Lactate Production During 
Normothermic Bypass· The Caus. Of Elevated Coronary 
Sinus Lactate During Continuous Cardioplegia. 
Steven R. Gundry, MD, David Kim, MD, Anees J. Rszzouk, 
MD. Arthur C. Hill. MD. Leonard L. Bailey. MD. 
Recent studies have reported elevated lactate 0) levels in 
blood taken from the coronary sinus or the aortic vent site 
during or following warm continuous retrograde cardioplegia 
(WCRC) infusion; the implication being that WCRC failed to 
provide sufficient myocardial nutrient flow. However. no 
studies have been performed to measure systemic L levels 
during normothermic bypass (NB). We studied 136 pts 
undergoing NB and receiving WCRC for myocardial 
protection. Blood for serum L was sampled from the 
perfusion circuit and compared with blood simultaneously 
withdrawn from the coronary sinus 1 min follOwing aortic 
cross-clamp removal. Coronary sinus L levels ranged from 
0.3 to 12.5 mMjL (mean 4.0:1: 3) versus systemic L levels of 
1.0 to 13.5 mMjL (mean 5.0:1: 3) (normal 0.5 to 2.0 mMjL). 
Unear regression analysis yielded an R value of 0.96, shOwing 
near unity in correlation between coronary sinus Land 
systemic L levels. 
These results indicate that the elevated lactate levels attributed 
to poor protection by WCRC merely reflect increased systemic 
lactate levels and are not produced by ischemic myocardium. 
Currently the source of the elevated systemic L is not known, 
but may have important implications for the Mure of 
normothermic bypass. 
923·65 
303A 
Altered S·adrenergic and Cyclic AMP Mediated Coronary 
Microvascular Responses After Crystalloid Cardioplegia. 
Steven Y.Wang, Menachem Friedman, Robert O. Johnson, Frank W. 
Sellke. Beth Israel Hospital, Harvard Medical School, Boston, MA 
The purpose of this study was to examine if coronary 6-adrenergic 
vascular relaxation may be affected by cardiopulmonary bypass (CPB) 
and crytalloid cardioplegia (CP). Pigs were placed on CPB and hearts 
were arrested with cold, crystalloid CPo After 1 hour, hearts were 
reperfused for 1 hour. In vivo and in vitro B-adrenergic microvascular 
responses were compared before CPB, and 2 min.and 60 min. after 
crossclamp removal. In vivo coronary responses to left anterior 
descending artery administration of isoproterenol (ISO, 0.02 
~glkg/min) were evaluated during which time LV dP/dt, shortening 
fraction, and heart rate were unchanged. X±Sem. *p<O.05, vs Control. 
tp<O.05, vs 2 min. post CPo 
~ coronilO' blood flow (%1 coroDiIO' resistance (%1 
Control l00±32 - SI±1S 
2min.postCP IS±S* -17±10* 
60 min. post CP 62±14t - 4O±24t 
In vitro coronary arteriolar responses to ISO, the adenylate cyclase 
activator Forskolin and Os-protein activator NaF were studied in a 
pressurized, no-flow state with video-microscopy and electronic 
dimention analysis. Drugs were applied extraluminally. Responses 
are % relaxation of U46619-induced precontaction (30%). 
~ ISO (] 1JM1 FOrsko!in (10 1JM1 NaE (l mM) 
Control 91±3 93±2 64±9 
2 min. post CP 63±6* 66±7* 30±8* 
60 min. post CP 81±4t 9S±1 t 47±5t 
In vivo and in vitro coronary relaxation responses to isoproterenol 
were reduced by cardiopulmonary bypass and cardioplegia. 
However, microvascular relaxations to Forskolin and NaF were also 
decreased. Thus, cardiopulmonary bypass and cardioplegia reduce 
coronary B-adrenergic responses primarily due to reduced adenylate 
cyclase activity which partially recovers after 1 hour of reperfusion. 
304A ABSTRACTS 
923·66 
Comparilon of Left Ventricular Performance Immediately efter Aortic 
Velve Raplacement Uling Cryltllloid or Blood Cardioplegia 
Xu Y. Jin, Stephen J. Brecker, John Carey, Kit Wong, Mario Albertucci, 
Derek G. Gibson, John R. Pepper, Royal Brompton National Heart & Lung 
Hospital, London, UK 
To assess the different effects between crystalloid ICCP) and blood 
IBCP) cardioplegia on very early change of left ventricular IL V) 
coordination and mechanic efficiency after aortic valve replacement 
(AVR), we studied 40 pta, aged 60:1: 12 yrs, 25 males. 30 of which were 
aortic .tenosis and 10 were regurgitation. Pts were randomized to BCP 
In-20) or CCP (n-20). Transesophageal echo combined with high 
fidelity LV pressure and thermodilution cardiac output were recorded 
before and 1, 6, 12, and 20 hrs after AVR. LV minor axis dimension, wall 
thickness and simultaneous LV pressure trace were digitized throughout 
the cardiac cycle. We derived LV +dP/dt, -dP/dt, time integral of systolic 
pressure IPTI) and of circumferential wall stress ISTI), an index of 
myocardial O. consumption. LV stroke work index (SWI) was calculated 
from PTI and stroke volume index, and the LV mechanic efficiency was 
assesses by SWI/STI. LV coordination was assessed from the LV 
pressure-dimension loop as dimension changes during isovolumic periods 
and measured as cycle efficiency (%). Clinical data, operative profiles and 
pre AVR measurements did not differ between the groups, except more 
CCP pts received dopamine (~ 4 uglkg/min, due to CI<2.0 11m2) (14/20 
vs 4/20, p<0.05) after AVR. Results: LV +dP/dt, -dP/dt. SWI were 
maintained with BCP but all fell with CCP ( all p<O.Oll after AVR; 
Mechanic efficiency index (1.17:1: 0.29 vs 0.78:1: 0.411 and cycle 
efficiency (78:1:7 vs 70:1:11, %1 both increased above pre AVR 95% 
confidence interval at 12 hrs and 20 hrs with BCP but neither cycle 
efficiency (73:1: 9 vs 74:1: 7, % 1 nor mechanic efficiency index 
(0.83:1: 0.36 vs 1.10:1: 0.39) improved with CCP. HR, LV end diastolic 
dimension and pressure were unchanged perioperatively. Conclusion: In 
spite of less positive inotropic support being reQuired, blood cardioplegia 
offers better left ventricular function than crystalloid cardioplegia. not only 
maintaining systolic and diastolic function but also improving ventricular 
mechanic efficiency and coordination within first 24 hours after AVR. 
923·67 
Quality of Life in Octogenarians after Open Beart Surgery 
Pankaj Kumar, Kenton J. Zehr, Andrew Chang, Duke E. Cameron, and 
William A. Baumgartner, The Johns Hopkins Medical Institutions, Baltimore, 
MD 
Despite the increase in cardiac operations on octogenarians (OCI), the long•
term benefits of cardiac surgery in the elderly (functional status, independent 
living, and psychological measures of quality of life as measured by established 
scales) are unproven. We studied 2 groups of OCT (Group I; n=) s; mean age 
83.2 yrs; operated on in 1986 and Group 0; n=53; mean age 83.0 yrs;opesated 
on in 1991) to determine operative mortality and late functional results. 
Operations included isolated CABG (1:10. ll:30) and valve replacement 20 
CABG (1:5, n: 23). Group I bad 0"10 hospital mortality and 53% 5 yr actuarial 
swvivaI; Group n bad 9% hospital mortality and 72% 1 yr actuarial swvivaI. 
Follow-up (flu) was available for all pis. Significant improvements over 
preoperative status were observed: 
Group I 
Pre Post 
NYHA Class 3.6±0.5 2.4±O.9t 
Congestive cardiac Failure Class 1.8±O.7 1.3±O.St 
Kamofsky Dependency Category 2.4±O.5 2.0:1:0.5° 
Life Satisfaction Index (1-7) 3.8±0.8 5.3:1:1.0° 
Affect Index (avg 8 bipolar items) 3.520\.1 4.6±O.9° 
Independence Index (1-7) 3.3±J.0 4.6±O.9t 
II of cardiovascu1ar symptoms 5.1201.3 2.3±O.9t 
Group Social Support Index SO 24° 
(% needing support in 6 areas) 
(tp<.05; ° p<. OJ) 
GroupO 
Pre Post 
3.1±O.9 U±O.7° 
I. 7±O.8 1.2±O.4° 
2.0:1:0.4 1.5:1:0.5° 
3.8±1.1 4.9%1.1° 
3.4±1.2 4.3201.5° 
3.5:1.3 4.7±l.4° 
4.2:1.4 1.6±l.3t 
32 26 
At late follow-up, there were significant improvements in positive and negative 
feeling scales. 75% of Group I and 84% of Group II OCT would undergo 
surgery again if necessary. This study demonsJrates subjective and objective 
evidence of improved quality of life after open heart surgery in OCT. 
lAce February 1994:1A-484A 
923·68 
Is Gender an Independent Risk Factor for Octogenarians 
undergoing Coronary Artery Bypass Surgery? 
Tsung'Po Tsai. Steven Khan, Aurelio Claux. Joel Kupfer. Jack 
Matloff. Aurelio Chang, Sharon Nessim. Cedars-Sinai Medical Center. 
Los Angeles, CA 
Purpose: Though multiple studies have shown that women have a 
higher risk of operative death during coronary artery bypass surgery 
(CABS). gender differences for CABS in the very elderly (age over 
80) remain undefined. 
Methods and Results: The in-hospital mortality and long tel1I1 
survival of 303 octogenarians undergoing CABS between 1982 and 
1992 were compared. Of these, 66% were male (n=201) and 34% 
female (n= 102). Risk factors including age. NYHA class, and diabetes 
showed no differences between groups. Women had a higher operative 
mortality rate for CABS than men but the difference was not 
statistically significant (10.8% vs 7.5%, 1'=0.38). The one year, 3 year 
and 5 year survival probabilities were better for women: 84%, 75% • 
and 71% for women and 81%, 68%, and 56% for men respectively, 
but these differences were also not significant (1'=0.46). The 5 year 
survivals post CABS were slightly better than that of female and male 
octogenarians in the general population although the differences were 
not statistically signilicant (67.3% vs 54.5%, P=NS). 
Conclusion: Short and long tenn survival were similar in elderly men 
and women undergoing CABS. Thus. female gender was not an 
independent risk factor for either higher CABS operative mortality or 
lower 5-year survival in octogenarians. 
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924·54 
CIGsed-Loop Temperature-CoatroUed RacIJotreq.-cy Catheter Ablation 
Reduces Impedance RIse In ChlldreD and Adolescents 
Brian K. O·Connor. Christopher L. Case. Seshadri Balaji, J. Pbilip Saul, 
Ronald Kanter. Edward Walsh, ·PauI C. Gillette. The South Carolina 
Children's Heart Center, Charleston. S.C., and The Atakr Investigations Group 
Electrode-tissue temperature IDODitoring may optimize energy delivery and reduce 
impedance rise during radiofrequency catheter ablation (RFA). To evaluate its 
utility in children, Closed-loop temperature-alntrolled (Te) RF A was compared 
to power-i:OllttOlled (PC) RFA in atrioventricular (A V) nodal reentry and AV 
reciprocating tachycardia. Forty-eight children underwent TC RFA and 11 
underwent PC RFA. An additional 7 children underwent TC RFA with crossover 
to PC RF A at investigator discretion. In TC RF A the amount of energy necessary. 
up to 50 watts. to achieve a tip temperature of 70·C was delivered, and a cin:uit 
was present to stop energy delivery at temperatures approacbing 100·C. 
Age. diagnosis, lesion number. outcome and recurrence were DO different 
between groups. Fluoroscopy (f1uoro) and ablation times were lower in TC RFA. 
K.J!l! ~ ~ 
Patient age (yrs) 12 ± 0.8 IS ± 1.3 0.1 
Lesion number 8 ± 1 12.6 ± 3.2 0.086 
Ablation time (min) 64 ± 9.6 128 ± 27 0.009 
Fluoro time (min) 21 ± 5.4 S3 ± 14.6 0.016 
Success 45/48 (94%) 10/11 (91 %) 0.5 
Maximum temperature for TC RFA was 67 ± !.l·C. and maximum 
power for PC RF A was 44 ± 3 watts. Impedance rise occurred in 10 of 18 
children (26 episodes/233 total lesions) during PC RFA and in 1 of 48 children 
(1 episodel 538 total lesions) during TC RFA (p < 0.001). 
These findings suggest that closed-loop temperature-alntrolled RFA is 
safe and equally effective as power-controlled RFA in children. In contrast, 
however. TC RF A has a lower associated incidence of impedance rise and may 
decrease fluoroscopy and ablation time. 
JACC February 1994:1A-484A 
924·55 
Comparison of Long·term Chronic Epicardial and 
Endocardial Pacing Electrode Thresholds In Children 
Gerald A Serwer, Parvin C Dorostkar, Sarah LeRoy, Macdonald 
Dick,n. Univ. of Michigan, Ann Arbor, MI 
As children require pacing for many years, knowledge of electrode 
threshold cha!!ges with time is necessary to pro,:ide optimal genera•
tor programmmg and follow-up care. Changes m chronic long-term 
thresholds were investigated in 104 children - 54 ages 1 day to 20 
yrs at implant who had undergone implantation of 63 epicardial 
electrodes [Medtronic 4951 (n=39) and Medtronic 6917 (n=24)] 
comprised group I, and 50 ages 18 mos to 22 yrs at implant had un•
dergone implantation of 53 endocardial electrodes [passive fixation 
(n=31), active fIXation (n=22)] comprised group n. None were on 
medication except digoxin. Ten in I and 12 in n had no structural 
disease. The remainder had undergone repair of their structural 
disease. All electrodes had been implanted at least 1 'lear prior to 
entry into the study. Thresholds, defined as the minImum pulse 
width producing 100% capture at 2.5 V amplitude, were determined 
each year for each patient. Follow-up was 1-8 yrs in both groups•
median 5.2 yrs in I and 4.3 yrs in n. The mean threshold each year 
post implant for each group was determined. During the study 
period ~O electrodes f~led - 6 fractured and 1 developed exit block 
m I whIle 3 fractured m II. Thresholds + 1 standard deviation were: 
lyr Zyrs 4yrs 6yrs 8yrs 
I .Z5±O.1 .33±0.2 .Z3±o.o9 .2HO.1 .17±0.03 
II .20+0.03 .20+0.05 .19 0.05 .20 0.1 .lZ+0.1 
There were no Significant threshold changes found from 1 to 8 yrs 
post implant in either group, and there was no statistically signifi•
cant difference between groups for any year. No threshold differ•
ences between electrode types within the groups were seen. 
Threshold rises and exit block are rare, yet fractures continue to be 
a problem. Epicardial and endocardial electrodes beyond 1 year 
post implant exhibit low stable similar thresholds allowing SImilar 
generator programming for both electrode types and do not require 
increasing generator output with age. 
924·56 
Experimental Radiofrequency-Heated Balloon Catheter Ablation of 
Ventricular Outflow Tract MUlcle 
Kazuo Neya, Raymond Lee, J. Luis Guerrero, Peter Lang, Gus J. 
Vlahakes. Depts. of Surgery and Pediatrics, Massachusetts General 
Hospital and Harvard Medical School, Boston, MA. 
Outflow tract (aT) obstruction is part of many types of congenital 
heart disease and sometimes requires palliation. We devised an 
experimentel method for aT muscle ablation using a thermal 
balloon cetheter heated by radiofrequency (RF) energy. Fifteen 
lambs weighing 5-10 kg were studied under anesthesia. The 
balloon catheter was advanced into the RVOT, heated to 75 to 
90'C, and applied to the RVOT for 20 to 60 sec. After a 3 hr 
period, lambs were killed and hearts were excised. The depth and 
volume of the region of necrosis was quantiteted using 
triphenyttetrazolium chloride staining and planimetry. 
.oo~----------~ 
A 8 
• 
Myocardial ablation (necrosis) of the outflow tract was achieved; 
the size of the lesion correlated best with the delivered RF energy 
and the balloon temperature-time integral. It did not correlate well 
with maximum balloon temperature. Full thickness ablation could 
be achieved with 40 to 60 sec epplication times. This technology 
may be useful for palliation of dynamic outflow tract obstruction. 
ABSTRACTS 
924·57 
Electrocardiograpby Discriminates Anomalous Left Coronary Artery from 
Myocarditis and Cardiomyopatby in Infants 
Christopher L. Johnsrude, James C. Perry, Richard A. Friedman, Jeffrey A. 
Towbin, Baylor College of Medicine, Houston, Texas 
Anomalous left coronary artery (ALCA) is an important cause of morbidity from 
heart failure (HF) and mortality in infants. Although difficult to discriminate 
from myocarditis and dilated cardiomyopathy (MC/CM) using noninvasive 
studies, this differentiation is critical for proper management. To address this 
problem, we reviewed electrocardiograms from 28 infants with ALCA (age 1.2-
22 mos, mean 6.2 mos) seen from 1970-1993. These were compared with 28 
age-matched infants with MC/CM, resulting in 103 variables including (not 
limited to): Q wave dimension/sbape; QR, QS, and QT patterns; QRS 
duration/axis; and QTc. 
RwlIn Patient number and % for each group (n = 28) with various ECG 
rrodings were analyzed from leads I, aVL, V5-V7 (unless otherwise specified). 
The Fisher exact test was used for comparisons. 
Q wave finding ALCA MClCM P 
Q amplitude ~ 3 mm 28 (100%) 8(29%) <0.0001 
Q width '" 30 ms 28 (100%) 8 (29"10) <0.0001 
QRpattem 28 (100%) 11 (39%) <0.0001 
No Q (II, Ill, aVF) 28 (100%) 6(21%) <0.0001 
To discriminate between patients with overlapping ECG rrodings, stepwise 
logistiC regression analysis was pertonned, yielding the model P (ALCA) = 
(1+e5I +O.2 ... 2.4<1-4.Ss)'1 where w = Q width I, d = Q depth aVL, and s = ST 
segment height aVL. When P (ALCA) > 0.7 for any given patient, the model 
strongly predicts the diagnosis of ALCA (sensitivity 100%, specificity 96%). 
Of 34 infants with dilated HF presenting in the last 6 years, 6 had ALCA and 28 
MC/CM, giving a prevalence for ALCA of 0.18. Application of this prevalence 
with the model gives a positive predictive value of 85% for ALCA. 
Conclusions ALCA may cause dilated HF in infants with otherwise structurally 
nonnal hearts, and has characteristic Q wave features. The above data show that 
these infants can be readily discriminated from those with MC/CM by ECG with 
high sensitivity, specificity, and positive predictive value. 
924-58 
IJDkagoe ADaIyaIs of the J!IastIn Gale Region In P...w.1 
Sapnmohv AortIc StaIoSIs 
AnIl Kumar, "Timothy M. Olson, "Stephen M. Thibodeau, "VirIPnia 
Michels, Margaret R. Wallace, University of Florida, Galnesvlne, PL 
and "Mayo CUnic, Rochester, MN 
Supravalvar aortic stenosis (SVAS) Is an inherited defect causing 
narrowing of ascending aorta with or without pulmonary or other 
systemJc arteries. SVAS may occur sporadlc:ally, aegrepte as an 
autosomal dominant trait, or as part of WIlllams syndrome. A 
~ne for SV AS was rec:cntly local1zed to the elastin gene region 
(7q) by Iinka~ analysis In two famJUes. The eWotln ge .. ~ may 
Itself be a SVAS ~ne, since a balanced translocation interrupting 
this ~ne was reponed to cosegregate with SVAS In another 
family. 
We tested another family with SVAS for linkage to' the elastin 
~ne region. nus 4-generation family has 5 affected members [by 
cUnlca! examination (CE) and echocardiollraphy (E) or cardiac 
catheterization 1 and 9 at risk individuals who do not have signs of 
disease (by CE). We genotyped this family with an elastin g~n., 
Intragenic 2-allele polymorphism as wen as 2 other nearby 
flanking microsatellite markers mfd 50 and mfd 148. Elastin 
polymorphism was not informative. No recombination was 
observed with marker mfd 50, indicating lInka8e of SVAS 
phenotype to this marker. Our findings "dd another family with 
SVAS linked to elastin ~ne region and support the possibility of 
elastin gene being the candidate gene for familial SVAS. 
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924·59 
BPdothelin-l as a Predictor of le8poD8e to IIead""1lP Tilt 
Study in Children with Syncope 
*Mary B. Mehta, Grace S. Wolff, Ming-Lon Young, Madeleen 
S. Mas, Amelia Escobar, Henry Gelband, University of 
Miami, Miami, FL 
The mechanism of neurocardiac syncope is not 
completely understood. With the emerging role of 
Endothelin-1 (E-l) as a modulator of vascular tone, this 
study sought to determine if E-1 could be a 
discriminator of the response to head-up tilt testing 
(HUT) in children with syncope. 
Nineteen children (mean = 13.2 years) referred for the 
evaluation of syncope were included in this study. 
Samples of E-1 were drawn at supine baseline (BL) , 5, 
10, and 30 minutes after tilt to SOO and 15 minutes post 
return to supine. If symptoms occured, a sample was 
drawn as the table returned to the supine position. E-l 
was measured by radioimmunoassay using the Amersham kit. 
There were a total of 13 patients (pts) with a 
positive tilt response (Group A) l S pts with 
cardioinhibitory, 2 with vasodepressor, and 3 with a 
mixed response. Six pts (Group B) had a negative tilt 
response. In group Al E-1 levels were 15.3 + 3.9 (BL) , 
19.1 ! 4.S (5 min or symptoms), and 16.7 ! 5.7 pglml (15 
min post). Group Bl E-1 levels were 21.6 + 3.3 (BL) , 
lS.5+ 6 (5 min), 21.5 + 4.S (10 min), 20.1"' + 5.2 (30 
min)"; 20.1 + 5.2 pg/mi (15 min post). There was s 
statistically significant difference (p<0.003) between 
the baseline E-1 levels between the two groups. The 
baseline E-1 levels were not a discriminator of the 
different subtypes of neurocardiac syncope. There was 
also a significant difference (p<0.03) between the 
baseline and 5 minute E-1 levels in group A. 
These findings suggest that circulating E-1 levels may 
predict tbe response to HUT testing in children and 
therefore may be a marker of the depressed vascular tone 
in pts with neurocardiac syncope. 
924·60 
Low Level of' Myocardial Superoxide Dismutase in 
Patients with Atria-Ventricular Canal .. 
Giuseppe Santoro, *Giuseppe Ambrosio, Roberto Formigari, 
Carlo Marcelletti, *Massimo Chiariello, Bruno Marino. 
Pediatric Cardiology and Cardiac Surgery, Ospedale 
"Bambino Gesu", Rome; *Cardiology. II School of Medicine 
Naples, Italy 
Superoxide Dismutase (SOD) is the most important intra•
cellular scavenger of the oxygen free radicals (OFR) 
physiologically generated during mithocondrial respira•
tion. One of its codifying genes is located on the 
chromosome 21. Based on the high ~requence of atrio•
ventricular (AV) canal in patients with trisomy 21 (Down 
Syndrome), we evaluated the myocardial level of total 
SOD in patients with AV canal (Group I, n:25), either 
with (n:18) or without Down Syndrome (n:7). These data 
were compared with that of control patients without Down 
Syndrome affected by other types of congenital heart de•
fects (Group 2, n=13). The two groups did not significa•
ntly differ with respect of age, weight and gender. 
Myocardial SOD level (mean ,:t sem) was significantly lo•
wer in AV canal patients than in control group (19.8,:t4.5 
vs 122.8,:t59.7 Ul/mg prot., p 0.01). No significant dif•
ference between AV canal Down and non-Down patients was 
found (29.7,:t5.7 vs 9.9,:t3.3 Ul/mg prot •• p=NS). 
Based on these data, we speculate that SOD might be 
involved in endocardial cushions development during 
fetal cardiac morphogenesis. 
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924·77 
Proteln·Loslng Enteropathy (PLE) Following the Fontan 
Operation 
Robert H. Feldt, David J. Driscoll, Jean Perrault, Hartzell V. Schaff, 
Francisco J. Puga, Gordon K. Danielson. Mayo Clinic. Rochester. 
Minnesota 
A retrospective review of patients who had the Fontan operation 
prior to February 1987 was carried out to identify possible factors 
associated with development and severity of postoperative PLE. Of 
428 thirty day survivors, 48 (11 %) developed PLE ranging from two 
months to nine years after Fontan operation (mean 3.8 years). 
Peri operative factors found to be significantly associated with PLE 
included: preoperative pulmonary resistance, ventricular end 
diastolic pressure. right ventricular morphology. total bypass time. 
postoperative left atrial pressure. postoperative renal failure. total 
hospital days. and heterotaxia. Patients with tricuspid atresia were 
significantly less likely to develop PLE. Length of time from 
Fontan to PLE diagnosis was not a factor in severity or survival. 
Five year mortality after PLE diagnosis was 50%. Of all late 
deaths after Fontan, 27 of 96 (28%) had PLE. No perioperative 
factors were associated with survival vs. death within PLE patient 
groups. Twenty-one of 48 patients survive with PLE and represent a 
spectrum of severity from remission to severe disability (New York 
Class ill). Management with steroids was unsuccessful in 3 
patients. One patient had remission following pacemaker 
placement. Reoperation on patients carried 75% mortality (9 of 12). 
Factors associated with late death were similar to those associated 
with the postoperative development of PLE. 
PLE is an important postoperative sequelae of the Fontan 
operation. A retrospective review noted perioperative factors 
associated with PLE which were similar to those found in a group of 
patients who were late deaths. These data reinforce need for careful 
selection of patients for the Fontan operation and recognize the need 
to screen patients postoperatively for PLE. 
924·78 
Supraannular Mitral Valve Replacement in Early Childhood 
Ian Adatia, Richard A. Jonas, Phillip Moore, John F. Keane 
Children's Hospital, Harvard Medical School. Boston. MA 
Mitral valve replacement in a native annulus too small for the 
smallest prosthesis presents a difficult problem which can be 
overcome by replacing the valve in the supraannular position entirely 
within the left atrium (LA). We reviewed the medical records and 
cardiac catheterization data of 13 children (6 girls) median age 10 
months (range 3-45). weight 6.4 kg (range 3.8·9.6) who underwent 
supraannular mitral valve replacement (SMVR). Other cardiac 
lesions were present in 12/13 and 11 required surgical correction. 
The indication for SMVR in II was mitral stenosis (additional 
supravalvar ring in 7) and in 2. mitral regurgitation. All had high 
pulmonary artery pressures (mean PAp 50±18 mmHg). Prostheses 
used were #17 BjOrk·Shiley (6). #16 Carbomedic (3), #19 St. lude (3) 
and #21 St Jude (I). There have been 4 deaths (I surgical). In 2113 
the prosthesis obstructed the inferior pulmonary veins. both died. At 
foIlowup (median 3 yrs. range 0.6-13) 9/13 remain well. In 8/9 
survivors at cardiac catheterization post SMVR (median 28 months. 
range 6·156) mean PAp was 37±9 mmHg. LA mean 20±4. with "a" 
wave 19±4, ·v· wave 32%7 and LVEDP 15%4. Despite tall LA 'v" 
waves, no child had mitral regurgitation on angiogram. 
Conclusion: Following SMVR pulmonary hypertension. tall LA "v· 
waves and an elevated L VEDP were common despite absence of 
significant mitral regurgitation or mitral stenosis. Decreased LA 
compliance and volume and presence of subprosthetic 
"ventricularized" atrium may account for the hemodynamic 
abnormalities. Additional cardiac lesions and pulmonary velD 
obstruction (15%) contributed to an overall mortality of 30%. 
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924·79 
The Role or Tnustbondc EdIocardilJll'llllhy in the Diapo&is or Infectious 
EncIocarditis In Children 
Crail A. Sable, JODaIban J. Rome, Genrd R. Millin, Kantilal M. Patel, Sharon 
S. Karr, Children's Natioaa1 Medical Center, Washington, D.C. 
Past studies have evaluated the seasitivity of tnDsthoracic echocardi0eraPhy 
('ITE) in patieots with knowD infectious eDdocarditis (IE). However the role of 
1TE as a diagnostic tool in childreo for whom the diagnosis of IE is being 
eotertained has DOl been defiDed. We hypothesized that 1TE is ooIy useful in 
children in whom there is a high cJinicalauspicion of IE hued on the presence 
of physical examination (PE) findinlS (a DeW or changing murmur, heart failure, 
or embolic pbenomeDa), or peni&teotly positive blood cultures (BC). 
~: 1TE reports ud medical records of all inpatieots from April, 1990 to 
December, 1992 who had 1TE for suspected IE were reviewed. Potential risk 
factors includina age, koown congenital or acquired heart disease, recent 
procedure, immune defect, ceotralline, prematurity, fever, PE findings, and BC 
results were recorded ud 1TE findings for each patieot were reviewed. Patients 
were arouped by risk factors. Fisher's exact test (two tails) was employed to 
compare 1TE results in subgroups. A logistic regression lDalysis was carried 
out to aulyze multiple potentially important risk factors. 
&iIIll!: Fifty·nine (44%) of the 133 patieots identified had either persistently 
positive BC (N~48), PE findings of IE (N=20), or both (N=9). 1TE was 
positive in 7 (12%) of these patients ud negative in all 74 patients without 
positive PE or BC (p<O.OI). Six of the 20 patients with positive PE findings 
had positive 1TE compared with I of 113 patients without positive PE findings 
(p<O.OOOI). This one patieot had peni&teotly positive blood cultures. Thus, in 
over one half of cues 1TE could have been predicted to add nothing to the 
diagnostic evaluation of IE. Fifty-ooe (38 %) of the 133 patients had either fever 
and a central line (N=47), fever and immune deficiency (N=26), or all three 
(N =22). Children with uy of these potential risk factors alone or in 
combination were not more likely !hID children without these potential risk 
factors to have positive 1TE. 
Conclusions: In the absence of PE or BC evidence supportive of IE, 1TE is a 
low yield study ud is unlikely to aid in diagnosis. The presence of presumptive 
risk factors including fever, central lines, and immune defects are nol indications 
for 1TE. 
925 Echocardiography: Clinical 
Wednesday, March 16, 1994 9:00-11:00 AM 
Georgia World Congress Center, Hall H 
Presenting Hour: 10:00 AM 
925·1 
Prop_tic Value of Pre and Pon Treadlllill Esercile 
EcbocardiOlraphy in W_ 
James E. Usedom, Susan M. Allen, Gail ArendeH, Oscar R. 
Jenkins, Jr., Gary G. Koch, Charles G. Vasey, Asheville 
cardiology Associates, Asheville, NC and University of 
North carolina at Chapel Hill 
'1'0 evaluate the prognostic value of exercise 
eChocardiography (EE) in women, we reviewed clinical and 
EE data in 693 females. Patients were stratified into 
one of four groups based on EE results. Group I had a 
normal EE, group II a normal resting study but abnormal 
stress response, group III had an abnormal rest echo 
with no exercise-induced wall motion abnormalities 
(WMA), and group IV had resting WMA with worsened or 
remote WMA after exercise. Patients were followed for 
an average of 28 months (12-60) for the following 
cardiac events: death, HI, and unstable angina (UA). 
Group n ~ ~ cardiac death 
1 ill 16(6) 6(2) 1(0.4) 
II 50 10(20)° 0(0) 0(0) 
III 246 48(20)~ 15(6)* 12(5)* 
IV 136 33(24)~ 8(6)* 4(3)* 
*p <0.05, 0p <0.01, ~p <0.001 vs group I 
Stepwise proportional hazards regression analysis was 
used to assess the relation between clinical and 
exercise variables and cardiac events. 
relative risk 95% CI -I!... 
exercise duration S5 METS 
rest or stress WMA 
1.7 
4.0 
1.2-2.5 <0.01 
2.4-6.7 <0.001 
An ischemic ST response was not predictive of adverse 
outcome. We conclude that in women referred for EE: 
(1) a normal study suggests a favorable pro~osis, a~d 
(2) the presence of resting or postexerc1Se WMA 1S 
associated with a greater likelihood of subsequent 
cardiac events, and adds prognostic information beyond 
that available from treadmill alone. 
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925·2 
Differentiation of Hemopericardium and Serous Perlcardlal 
Effusion by Acoustic Densitometry 
Marvin R. Allen and David A. Foley 
Mayo Clinic and Mayo Foundation, Rochester, MN 
Suspensions of static red blood cells eisplay significantly greater 
acoustic scattering than serum proteins alone. We therefore pos•
tulated that hemopericareium could be eifferentialed from serous 
pericardial effusion based upon their relative backscatter intensities. 
6 patients were retrospectively identified with hemopericardium as 
defined by either 1) the presence of blood in the pericardial space 
at autopsy, surgery, or pericareiocentesis with evidence of either 
myocardial perforation or active post·surgical bleeding, or 2) the ap•
pearance of a new (as documented by serial echocardiograms) peri· 
cardia.1 effusion following a catheter-based procedure complicated 
by clinical evidence of right ventricular perforation. 13 additional 
patients who had serous pericareial effusions (no red blood cells 
identified by miaoscopy) by ul1rasOund-guided pericarciocentesis 
were identified. Conventional echocardiographic stucies performed 
with various imaging systems demonstrating the pericareial effusion 
were available for each patient. Selected video frames from each 
echocardiographic study best demonstrating the pericareial effusion 
were cigitized with 640 x 480 pixel by 8 bit resolution. Pixel intensities 
were sampled from regions of interest ~awn within the pericardial 
effusion and within an adjacent cardiac chamber. An effort was made 
to take the samples from similar depths relative to the transducer to 
minimize the effects of attenuation and time-gain compensation. The 
average pixel intensity of the pericardial effusion was normalized to 
the average pixel intensity of the blood in the chamber to compensate 
for variations in gain settings. The mean ratio for hemopericardium 
(1.67 ± 0.64) was significantly greater (p < 0.02) than that for the 
serous effusions (1.09 ± 0.19). 
ConclUSions: The acoustic reflectivity of blood within the peri•
cardial space is significantly greater than that of serous fluid alone. 
This difference is readily detected by measuring pixel intensities from 
conventional two-dimensional echocardiographic stucies. 
925·3 
Diagnostic Yield of Echocardiography in Patients With Syncope - Is 
Current Use Justified? 
Sri Dhatreecharan, Peter Azar, Morgan S. Werner, Andrew M. Keller, 
Adel Mohieldin, Derek Santiago, Shunichi Homma, Deborah Hall, 
Chunguang Chen, linda Gillam, New Britain General Hospital, New 
Britain, CT, Danbury Hospital, Danbury, CT, Columbia-Presbyterian 
Medical Center, New York, NY and Hartford Hospital, Hartford, CT 
Although echocardiography is frequently used to evaluate patients with 
syncope, its diagnostic yield in this setting has not been previously 
defined. To address this issue, echocardiographic and inpatient medical 
records at 4 centers were reviewed to identify 383 patients who 
underwent echocardiography as part of their syncope evaluation. 
Patients ranged in age from 23-93 y (mean = 68 y). The echo findings 
were reviewed in the context of clinical data including history, physical 
examination, electrocardiogram, and, when available, Holter monitor 
and/or electrophysiology evaluation. The diagnostic yield of echo testing 
was categorized as: I- identified obstructive abnormality felt to have 
been sole cause of syncope ; II - identified abnormality possibly 
contributing to syncope in patients with co-existent arrhythmia; III -
demonstrated no pertinent abnormality in patients not clinically 
suspected to have cardiac basis of syncope. 
Results: The diagnostic yield was: 1- 8% ; \I - 18%. III - 74%. Echo 
diagnoses in category I included severe aortic stenosis (AS). idiopathic 
hypertrophic subaortic stenosis, critical mitral stenosis (MS) and large 
pericardia I effusion with tamponade. Category II patients included those 
with mild to moderate AS, mild to moderate MS and previously 
unsuspected left ventricular dysfunction in whom ventricular or atrial 
arrhythmia was demonstrated. Category 11\ patients included those with 
classic vasovagal syncope, alcohol intoxication, and seizure disorder. 
Conclusions: In patients with syncope, echocardiography provides useful 
diagnostic information in 26%. In 8% this information is diagnostic. 
These data support a role for echocardiography in the evaluation of 
patients with syncope. However in patients in whom history indicates a 
non-cardiac etiology and physical examination does not suggest 
Obstructive cardiac lesions, the test has limited diagnostic vield and may 
be inappropriate. 
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925-4 
Is DiagnoBIic AonmIcy of EzerdIe EdJoc:anIioBrap Affected 
by AmiaDgiDa1 Apls? 
Toshihiko Nishioka. Hideki Mitani, ADra Kurita, Akimi Uehata, 
Hiroyuki Hikita, Hirokazu Nagayoshi, Bonpei Takase, 
Haruo Nakamura, Shingo Obtonli*, Satosbi Obm" 
National Defense Medical CoDege. Tokorozawa, Saitama, Japan 
Self DefeJlse Forces Central Hospital, Tokyo, Japan" 
To improve tbe diagnostic accuracy of exercise Eoo (E-ECG) in 
iscbenlic beart disease (IHD), it is necessary to discontinue tbe 
administration of antianginal agenls at least for a few days. However 
in some llID patients, ceasing of medication could be dangerous or 
harmfuII. Exercise ecbocardiograpby (E-ECHO) is known to have 
a higher ac:curacy for tbe diagnosis of llID. Therefore we investigated 
whetber E-ECHO couIcJ get tbe accurate diagnosis of HID patients 
even witb taking antianginaI agents and compared tbe diagnostic 
accuracy of E-ECHO witb that of E-ECG. We performed E-ECHO, 
E-Eoo and coronary angiograpby (CAG) for 220 patients within 5 
days. Patients were retrospectively divided into 4 groups ; group 
(gr) NM (n=49): no medication, gr C (n",,31): witb calcium channel 
blod<er, gr CN (0= 106): witb calcium channel blocker and nitrate, 
gr CNB(n""34): witb calcium channel blocker, nitrate, and beta-blocker. 
E-ECHO and £-£00 data were blindly interpreted and compared 
witb CAG (significant stenosis; defined as !75% narrowing). Positive 
£-ECHO was defined as wall motion abnormality at rest or lack 
of waD motion improvement after exercise. Diagnostic values of E-ECHO 
and E-ECG are sbown below. 
grNM gee grCN grCNB total 
E-ECG sensitivity (%) 43 64 53 48 52 
specificity ( %) 70 82 59 65 
E-ECHO sensitivity (%) 85 92 94" 100" 95" 
specificity (%) 81 72 63 100 73" 
"; p<O.OI vs E-ECG 
Conclusion; Diagnostic accuracy of E-ECHO was superior to E-ECG 
amI not affected even by !be combined use of different types of 
antianginal agents. 
925-5 
Propostic Sipificance of Infarcted and Ischemic Myocardiwn in 
Patients with Coronary Disease: Risk Stratification by Exercise Echo 
Kamtbom S. Lee, Thomas Marwick, Brian Haluska, William 1. Stewart, 
James D. Thomas. The Cleveland Clinic Foundation, Cleve1and, Ohio. 
Although exercise ecltocardiography (ExE) may differentiate infarction 
(INF) from ischemia (lSC) in pts witb coronary artel)' disease (CAD), their 
relative prognostic significance at perfusion imaging bas been debated. and is 
unknown at ExE. The purpose of this study was to examine this question by 
follow-up of 172 medically treated pts witb and without ISC or INF at ExE. 
Ex capacity was gauged in estimated METS. INF was defined by resting 
akinesis or dyskinesis, and its extent was quantified using a wall motion score 
index (WMSI). ISC was defined by stress-induced regional left ventricular 
dysfunction. Pts were classified into 4 groups: normal function at rest and 
stress (N), normal at rest witb stress-induced ischemia (ISC), infarction 
without ischemia (INF), and infiuction witb ischemia (BOTH). Pts were 
followed over 29±5 months for ~rrence of nonfatal events (infiuction, 
hospitalization for unstable angina or heart failure) and death· 
Group n Ex Cap WMSI Deatb Nonfatal Events All Events 
IN 79 8.5 I 0(0%) 3 (4%) 3 (4%) 
ISC 23 7.2 1 1(4%) 5 (22%)" 6 (26%)" 
INF 37 7 1.6 3 (8%) 2 (6%)" 5 (14%)" 
~orn 33 6.8 1.6 1(3%) II (33%)"" 12 (36%)"" 
" p< 0.05, •• p< 0.01 compared to normals. 
Logistic regression demonstrated ISC at ExE to be more strongly correlated 
witb cardiac events (p<0.OO05, odds ratio 5.3, 95% confidence intervaI2.l-
13.5) than INF (p= 0.08, odds ratio 2.3). Restriction oflNF to tbose witb 
extensive dysfunction (WMSI > 1.6) showed it to correlate witb death 
(p=O.02) as well as otber events (p=O.04). 
Conclusion: ExE identifies patients at low or high risk (or cardiac events. 
Normal ExE is predictive of a benign prognosis. ISC identified at ExE may 
be a substrate for the occurrence of cardiac events in patients witb CAD. 
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925-6 
The Value of Dipyridamole Echocardiography in Risk 
Stratification Before Vascular Surgery 
Rosa Sicari, Anna Maria Lusa. Alessandro SaluslIi. Nicoletta Mangialardi. 
Gianfranco Del Rosso. Maria Joao Andrade. Mauro Ferrari. Robeno PedrinelJi. 
Eugenio Picano. on behalf of the EPIC (Echo Persantine International 
Cooperative) Slndy - Subproject vascular surgery stllltification. 
Patients undergoing major vascular surgery are at relatively high risk of 
cardiac events, and pharmacological slIess echocardiography is increasingly used 
for perioperative risk stratification. To evaluate in a multicenter, large scale trial, 
the value of dipyridamole-echocardiography test (OET. up 10 0.84 ms/kg over 10') 
in predicting cardiac events. I) 7 candidates to vascular surgery (age 67±6 years) 
were studied by OET in 5 different centers. Of !he 117 patients. 13 were 
subsequently excluded since surgery was either cancelled (n=7) or postponed 
pending cardiac revascuJarization (n=6) for !he presence of a "high·risk" S\ICSS echo 
response (identified a priori as a positive DET with a dipyridamole-time <5 
minutes and/or a peal< wall motion score index >2. scoring each segment from 
I=nonnal to 4=dyskinetic in an II segment model). No major complications 
occurred during OET. Technically adequate images were obtained in all patients; 
however. in 2 patients only the low dipyridamole dose (0.56 mg/kg over 4') was 
given for limiting side effects. Of !he I ()4 patients undergoing surgery, 23 (22%) 
hid a positive test. Perioperative evenL, occurred in 9 patients (991-): 3 deaths. 2 
myocardial infarctions. 4 unstable angina. Sensitivity and specificity of OET for 
predicting cardiac events were 78% and 79% respectively. with a positive 
predictive value of 26% and a negative predictive value of 97%. Neither clinical 
parameters. such as Goldman or Dctsky score, nor baseline echo parameters. such 
as resting wall motion score index or left ventricular mass index. were able to 
separate patients with and without events. which were effectively discriminated by 
OET results. 
In conclusion. OET is safe and well tolerated in patients undergoing major 
vascular surgery. and provides an effective preoperative screening teSI for the risk 
stllltification of these patients. mainly for the extremely high negative predictive 
value. Stress echocardiography provides a better discrimination compared 10 
clinical and rest echocardiographic varia~les. 
925-7 
Doppler In Hydrops fetalls 
Gerald Tulzer, Saemundur Gudmundsson, Dennis Wood, 
Zhi-Yun Tian, Arnold Cohen, Stuart Weiner, James Huhta 
Perinatal Cardiology, Pennsylvania Hospital, Children's 
Hospital of Philadelphia, The Hospital of the University of 
Pennsylvania , Philadelphia, Pennsylvania. 
Fetal ultrasound studies were performed on 24 fetuses 
(mean gestational age 28 weeks) with non-immune 
hydrops and normal karyotype to evaluate 
echocardiographic and cardiovascular Doppler 
parameters that may be useful in assessing hemodynamics 
and in predicting outcome. Fetal echocardiography, M•
mode, and Doppler examinations were performed in all at 
the time of diagnosis of hydrops. 
Mortaliry was 13124 and only the presence of abnormal 
pulsations in the umbilical vein (UV) (p«>.OOl) and 
abnormal inferior vena caval Doppler (p<O.OOl) were 
found to be Significantly different. Sixteen of 24 cases 
had UV, and 12 (7596) of them died. When fetuses with 
pulsatile flow in the umbilical vein were compared With 
fetuses with normal umbilical venous flow, the following 
significant differences were found (p«>.o5): larger 
inferior vena caval diameter, decreased shortening 
fraction of right and left ventricles, lower peak velOcities 
at aortic and pulmonary valves and in the ductus 
arteriosus, and lower peak acceleration rates at the 
pulmonary valve. 
Conclusions: Abnormal venous Doppler correlated with 
poor prognOSis and was a generic sign of fetal heart 
failure. Serial foUowup of prehydropic fetuses should 
include venous Doppler to detect abnormal cardiovascular 
function which may affect the pregnancy and the 
prognosis. 
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925·8 
New Color Doppler Techniques for Demonstrating Free Vortices and 
Radial Vortex Shedding: An In-Vitro Study 
Takahiro Shiota, Robin Shand as, Paulo Golebiovski, David J. Sahn. 
Oregon Health SCiences Univ, Portland, OR 
lower velocity events, free vortices and small swirling backflows occur 
in both the atria and ventricles in patients with valvular disease and While 
they can be delineated with injected echo contrast or imaging of the 
motion of spontaneous contrast targets, they are not well imaged by 
color Doppler. Using a new CDFM system (Hitachi EUB-165) with the 
capability to image flow with high packet size and low pulse repetition 
frequency (500 Hz and below)' yet at high (15-20/secl frame rates 
(achieved by parallel processing on reception to write 2 lines of flow 
information on the returning signal from each ultrasound beam), we 
imaged pulsatile jets (34-100 beats/min) flowing into a compliant 
·ventricular· chamber. Flow rates ranged from 60 ml/min to 900 ml/min 
and jet velocities ranged from 1.5 m/sec to 4.6 m/sec. Four different 
views, 2 orthogonal long axis views of the jet flowing towards the 
transducer and 2 orthogonal ·short axis· transverse views, were 
obtained at Nyquist limits (Nls) from 4 cm/sec to 24 cm/sec. For all jets, 
back swirling flows were observed when the jet encountered the apex of 
the chamber and swirled back along the walls. As peak velocity of the 
jet was increased, free vortices, and on the axial views, radially disp•
ersing vortices around the jet core were visualized. especially when 
imaged at low NLs, and yet swirling could be appreciated in real time and 
at high frame rates. Laser fluorescent dye studies in the same model 
verified that these swirling vortical and radial events existed as portrayed 
on the Hitachi images but two other standard color Doppler scanners 
imaging at low NLs had frame rates toO slow to delineate them. 
Recognition of low velocity flow structures using this new CDFM 
technology has importance relating to understanding mechanisms of jet 
dissipation, fluid entrainment, surface adherence and intracavitary areas 
where pre-thrombotic cvents may occur in patients. This type of imaging 
can also facilitate improved definition of endocardial (blood-cavityl 
borders for more accurate cardiac chamber volume computation. Parallel 
processing facilitates new types of color Doppler flow visualization. 
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926·9 
Three-Dimensional EChoCardlography Using an Omnlplane Trans•
esophageal EchoCardlographlc Probe: Automated Data Collection, 
and Combined Volume and Surface Rendering Allow Qualitative and 
Quantitative Assessment of Cardiac Structures and AbnonnaJltles 
ai-Ling Cao, Darryl Esakof, Mani Vannan, lisa Sugeng, Glen oeLoid, 
Michael Gordon, Steven Schwartz and Natesa Pandian. 
Tufts-New England Medical Center, Boston, Massachusetts. 
The feasibility of 3-D echocardiography (3DE) using a tomographic 
approach has been shown. In this study, we explored the potential of 30E 
using an omniplane (OP) device which could have both transesophageal 
(TEE) and transthoracic (TTE) applications. 16 hearts of various sizes (9 
dog, 2 pig, 2 sheep, 3 can) wRh experimentally created atrial and ventricular 
septal defects, aortic and m~ral valvular stenoses, and LV aneurysm, were 
imaged with an OP transducer In a water-bath. Using an automated, com•
puter-driven logic, calibrated 2DE Images of the heart were acquired at 
every 3 degrees (from 0 to 180) from three different transducer locations: 
(A) From behind the heart (simulating TEE), (8) from the apex (simulating 
TIE apical rotation) and (e) from the front (simulating parasternal rotation). 
The resulting conical volume data set underwent reformatting and segmen•
tation in a dedicated 3D system. Both volume rendering and surface rende•
ring 01 the 3D data In various grades 0/ resolution were then performed. 
From data collected using all 3 transducer locations, we were able to 
accomplish 30E reconstructions. Manipulation of the clipping/cutting pianes 
in x, y and z coordinates allowed us to derive a multfiude of 30E projec•
tions in axial, sagiffal, coronal and desired oblique planes. We were able to 
visualize valvular abnormalHies, septal defects and LV aneurysm in many 
orientations. The lesions corresponded well in location, shape and size to 
the anatomic specimens. Use of shading techniques allowed appraisal of 
the depth and distances which also could be measured. Blinded compa•
rison 01 30E-derived l V volumes (y) and true anatomic (x) volumes (range 
from 8 to 205 ml) yielded an excellent correlation: y •. 98x--0.24, rz.99, 
p<.0001. Volume-rendered 30E displayed the gray-scale and thus tissue•
depiction Images. Surface-rendered 30E aided in better appreciation of 
wail, structure and lesion surfaces, depths, and distances. We conclude 
that (1) 3DE using omnlplane (mul\lplane) probes is feasible, (2) automated 
rotation logic with a stable transducer position has potential for 3DE via 
both TEE and TIE approaches, (3) abilhy to perform both volume and 
surface rendering enhances the versatility of 30E, and (4) this method 
provides unique qualfiative and reliable quanthatilJe data. 
ABSTRACTS 
926·10 
Trajectory Technique In ThtN-Dlmenslonai Echocarclography: 
A Method to Aid In 3·Dlmenslonol Locallzatlon 01 Cardiac Leslons 
and Direct an Approach With PoIenliallmpllcotlons In Planning 
InlervenilOnal and Surglcol Procedures tor Cardiac lesions 
Darryl Esokof, Glen Deloid, Noteso Pandlan, QI-Ung Cao, Michael 
Gordon, Steven Schwartz and Manl Vannon. 
Tutts-New England Medical Center, Boston, Massachusetts. 
309A 
The versatilhy of three-dimensional eChocardiography (3DE) to display 
cardiac pathology In all its dimenSions opens an avenue to newer approa•
ches to evaluate cardiac disorders. We felt that the unique &bUHy of 3DE In 
delineating cardiac lesions could be extended by using trajectory (beacon) 
approaches. In this study we examined the potential of this new trajectory 
method to localize and visualize cardiac lesions. Using an omnlplane TEE 
probe, we obtained 2DE Images at every 3 degrees (Irom 0 to 180) in 14 
animal hearts in a water-bath, and performed volume and surface-rendered 
30E reconstructions. The reconstructed hearts contained a number of 
experimentally created myocardial, septal and valvular abnormalities. 
These lesions were considered as targets for intervention and surgery. To 
map the precise localization of the lesion, the chamber walls, cavities, 
valves, and lesions such as masses in 3DE data cube underwent selective 
contouring process employing a thresholding technique. Using this app•
roach, we were able to display the cavity and solid structures in a semi•
transparent look-through manner. Such processing allowed us to visualize 
intra cardiac structures simply by rotating the intact heart Image in x, y, and 
z coordinates without using cutting/clipping planes. We then efl1)loyed the 
traiectory technique to localize the desired structure or lesion and place the 
trajectory at the required part of the lesion or structure. Using 8 different 
variables, we were able to alter the size, posfiion and orientation of the 
trajectory in various angles in all 3 dimensions, and visualize lesions and 
also the structures interposed between the target and approach path. The 
target lesion also could be seen directly through the trajectory as H one is 
viewing ~ through an angioscope. We were able to do these maneuvers in 
30E 01 all hearts. Using quantitation algorhhms of 3DE, the size of the 
lesion and its depth from the epicardium or any site could be determined. 
This traiectory technique offers a novel approach to delineating cardiac 
structures in three dimensions. It has potential to enhance planning current 
surgical approaches and also may provide a foundation to consider newer 
surgical and interventional approaches for selected cardiac problems. 
926-11 
Calculation of Left Ventricular Vol~ PrcIII its 'l'brae 
Dimansional Recanstruction i8 Indepandant of its GeaDatry 
Rarrdas G Pai, Woravut Jintapakorn, Masato Tanimoto, Qi•
Ling cao, Natesa Pandian, Pravin M Shah. lara Linda 
University & ~C, CA and Tufts-NEMC, Boston, MA. 
calculation of LV volume by single or biplane 
imaging techniques assumes specific geanetry and involves 
extrapolation for nonvisualized walls. We perfonned three 
dimensional (3D) reconstruction of the LV using an echo-CI' 
technique based on serial pull-back ~allel slice imaging 
technique (Tcmtec, Gennany) both m vitro and in vivo 
settings. Fourteen latex balloons with various sizes (30-
235 ml) and shapes (conical, pear-shaped, rotmd, 
elliptical and aneurysms in various locations) filled with 
known volumes of water were ima!;Jed in a water bath. Fran 
the static 3D image, LV long axJ.S was defined and the LV 
was sectioned perpendicular to this axis into 2 mn 
slices. The volume of each slice was calculated blinded to 
the actual volume as the product of the slice thickness 
and the manually traced perimeter of the slice and the LV 
volume as the sum of the volumes of the slices (Sinpson' s 
method). The calculated LV volmne correlated closely with 
the actual volume (r=0.99, calculated volume=-11.3 
.±1.06.real volume, See=9 ml, mean difference 9 ml). Using 
the same system, transesophageal echocardiographic images 
of the LV were obtained in 15 patients gated to 
respiration and ECG. Satisfactory dynamic 3D reconstuction 
of the LV was possible in 12 patients. The 3D LV volumes 
(systolic and diastolic) using Sinpson' s method correlated 
well with those obtained frcm biplane TEE images using the 
area-length method (r=0.84,See=5 ml) which has been 
independently validated in our laboratory. The LV major 
axis diameters fran the 3D images were not significantly 
different from those obtained by biplane or multiplane 
TEE. 
Canclusian: 3D echocardiography of the LV !;Jives adequate 
anatcmic details and ac=ate LV volumes independent of 
geanetry. 
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926·12 
Biologic Color Encoding In Surface Modeling of Three· 
Dimensional Echocardlogram. Enhance. Appraisal of Cardiac 
Anatomy and Spatial Relations of Cardiac Structure. by 
Simulating Natural Groll Anatomy 
Notesa Pondlon. Darryl Esokof. QI·Ung Coo. and Manl 
Vonnan. Tufts·New England Medical Center. Boston. Moss. 
Three-dimensional echocardiography (30E) portrays cardiac 
anatomy in unique projections not possible by 2-D echo. The new 
cutting planes depict the structures not only in the cut plane but also 
farther beyond, and It could be difficult to gauge the depth and 
distances of structures away from the culling planes when displayed 
only as black-and-white gray scale images. In this study we explored 
the potential of biologic color encoding of 30E imafJes. USing a 
multlplane TEE device and an automated data acquisition approach, 
we collected 20 images of 15 intact (pig, sheep and dog) hearts in 
vitro. Each heart was imaged at every 3 degree angles (60 imaging 
planes for each heart). After registra-lion into 3D cubic matrix, 
automatic contouring followed by solid surface modeling was 
accomplished. We then employed 10 to 15 cut planes to display 
intracardiac structures in various projections, first In blacklwhite gray 
scale and then with biologic color enco-ding. For biologic color 
processing, we viewed the cut sections of the animal hearts and 
Introduced biologic color encoding that simulated true colors of 
intracardiac anatomy. With added use of graded degrees of ambient 
light (brightening the structure as desired), diffuse lighting 
(responsible for visual 3D cueing), specular lighting and specular 
power, we were able to derive 3D views that resembled the gross 
cut specimens of the heart, and allowed appraisal of the neamess, 
depth and distance of various structures, the relative sizes and 
shapes of structures and their spatial relationships. As cut planes 
were rotated or windowing modified, the Illumination of structures 
was automatically adjusted without changing the dominant color. 
Even those not well-versed with echocardiography were able to 
identify the structures and spatial relationships. We conclude that 
biologic color encoding is another technical advance in the evolution 
of three-dimensional echocardiography and is helpful in under•
standing and teaching 30E depiction of the cardiac anatomy. 
926·13 
Three-Dimensional Echocardiography: In Vitro 
Validation of Left Ventricular Volumes. 
Riccardo Pini, Giuseppe Giannazzo, Mauro Di Bari, 
Francesca Innocenti, Richard B. Devereux. Institute of 
Gerontology and Geriatrics, University of Firenze, 
Firenze, Italy and Cornell Medical Center, New York, 
New York. 
We have previously described a new echocardiographic 
system that allows accurate 3D visualization of the 
left ventricular (LV) walls and cavity in humans as 
well as volume measurements of variably shaped 
balloons. To evaluate the accuracy of 3D echocardio•
graphic LV volume measurements, we scanned 8 excised 
sheep hearts filled with agarose to obtain the 3D 
reconstruction of the LV. A prototype 3.5 MHz rotating 
transducer acquired 50 standard fan-shaped 2D images at 
3.6 degree increments around its central axis. For 
each heart, the 50 images were digitized in cylindrical 
coordinates and scan converted to reconstruct a 3D cone 
of data in Cartesian coordinates. Up to 50 sequential 
tomographic planes Were displayed (from the LV apex to 
the mitral valve plane), and their borders manually 
traced to obtain the section volume. Section volumes 
were summed to yield LV volume. For the excised 
hearts, the myocardium was incised and carefully peeled 
off the agarose cast; the actual volumes of the LV 
casts, measured by water displacement, ranged from 20 
to 55ml. There was an excellent correlation between 
the measured and the true volumes (Echo-0.94*Actual 
+2.9; r-0.96; p<O.OOl; SEE-3.3 ml). Intra-observer 
variability was 1.1 ml or 2.9% of the mean; inter•
observer variability was 2.3 m1 or 5.5% of the mean. 
Thus, excellent measurement of LV volume without 
geometric assumptions can be obtained from 3D echocard-
lACC February 1994:1A-484A 
926·14 
Endocardial Phase Mapping Improves Detection of 
Regional Wall Motion Abnormalities. 
Paul A. Heidenreich, Jeffrey Bear, Elyse Foster, Manfred 
Seeberger, Edward Chu, Michael Cahalan, Elias Botvinick, 
William O'Connell, Nelson B Schiller. University of 
California, San Francisco, CA. 
Digital phase mapping(DPM) of the endocardium is a new 
method of quantitating wall motion. Visually inapparent 
changes in endocardial motion may be detected by DPM. 
Objective: To determine if DPM can improve upon standard 
visual analysis in the detection of coronary artery 
disease(CAD) in an atrial pacing model of ischemia. 
Methods: Transesophageal echo images were recorded at 
baseline and during atrial pacing at up to ISS bpm in IS 
CABG pts pre-bypass. Off line computer analysis of phase 
changes was performed, and segments were independently 
graded viSUally. Evidence for ischemia(CAD} was defined as 
a wall motion or phase abnormality present at pacing but 
not at baseline. A 70% or greater stenosis in a mid or 
proximal coronary artery was considered significant CAD. 
Results: DPM analysis was interpretable in 96% of the 
cardiac segments. For a given level of specificity DPM had 
markedly improved sensitivity compared to visual analysis. 
Sensitivity of DPM 72% specificity SO% vs. 23% and 70% for 
visual analysis. Conclusions: Endocardial phase mapping 
is more sensitive and accurate than visual analysis in the 
detection of CAD. This new technique may have applications 
to other forms of stress imaging. 
926·15 
Automated Determination of Pulmonary Artery Elastic 
Properties During Transesopbageal Echocardiography 
William E. Hopkins, Micha S. Feinberg, Benieo Barzilai, 
Washington University, St. Louis, MO 
The relationship between the elastic properties of large 
pulmonary arteries (PA) and PA hemodynamics are not well 
defined. To determine this relationship we used echocardiographic 
automatic border detection to measure the cross-sectional area of the 
proximal right PA during multiplane TEE in 16 patients (age: 54 ± 
17 years). Measurements of PA area were recorded on-line 
throughout the cardiac cycle. Pulsatility (P), distensibility (D), and 
stiffness index (SI) were determined for each patient and defined as: 
P = (ESA.EDA)I(EDA) 
D = l(cbange diameter)l[(dlameterdiaslOle)(Pulse pressure)] 
SI = In[PAsysIPAciiastll(clumge diameter)l(dlameferdiaslOle) 
As expected, there was an inverse correlation between pulmonary 
artery 0 (y) and SI (x) (y = 21.9 - 12.6 [log xJ, r = -0.95, P 
<0.0001). P was significantly less (10.9 ± 3.0 (SD) vs 20.5 ± 6.6, p 
<0.01), 0 was significantly less (2.5 ± 0.8 vs 17.0 ± 10.4 cm2/dyne, 
p «>.01), and SI was significantly greater (16.5 ± 4.8 vs 7.9 ± 4.7, P 
<0.01) in patients with severe PA hypertension (n = 6, mean PA 
pressure 67 ± 11 mmHg) compared to the other 10 patients (mean 
PA pressure 27 ± 7 mmHg). Since determination of P does not 
require knowledge of arterial pressure, we compared P to catheter 
derived hemodynamic measurements. There was a highly 
significant inverse correlation between pulmonary artery P (y) and 
both the mean PA pressure (y = 60.9 - 28.1 [log xl, r == -0.88, P 
<0.0001) and pulmonary vascular resistance (y = 23.4 - 10.7 [log xJ, 
r = -0.79, p <0.001). Thus, automatic border detection can be used 
as a noninvasive means of determining PA elasticity and may allow 
for the accurate determination of hemodynamic measurements such 
as P A pressure and resistance. 
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926·16 
On·Llne Left Ventrlcullr Pre .. ure-Volume Relltlona 
During Alterltlona In Prelold: Complrlaon of Trln .. aophlgell 
Echoclrdlogrlphlc Automltld Border Detlctlon with 
Conductlnce Cltheter Technique. 
John Goresan III, Andre Y. Olnault, WIlliam A Mlndarlno, John Lutz, 
Michael R. Pinsky. University of Pittsburgh, Pittsburgh, PA 
Echocardlogrlphlc lutomatld border detection (ABO) can estimate LV 
volume on-line by a modified Simpson's rule. To determine the feasibil•
Ity of real time pressure-volume (p-V) loops by transesophageal ABO, 
data were compared to simultaneous P-V loops using conductance 
catheter (CC) volume. Six Inesthetlzed closed chest dogs were stud•
Ied by single plane transesophageal ABO (4-chamber view), CC vOl•
ume, Ind high fidelity pressure during Ipnelc Inferior vena clval bal•
loon occlusions. Bllt-to-beat measures of end-dlastollc volume (EOV), 
end-systolic volume (ESV) and stroke work from simultaneous ABO and 
CC P-V loops were complred. ABO EOV and ESV from Individual LVs 
werl closely correllted with CC vllues: r-0.97 ±0.02, SEE-2± 1 ml 
and r-0.9t ±O.t, SEE.2±1 ml, respectively. ABO EOV was 4±9 ml' 
< CC EOV, and ABO ESV was 3±9 ml' > CC volume during caval 
occlusions 'p<O.OS. Changes In ABO stroke work were closely corre•
lated with changes In CC stroke work In IndMdual LVs: r.0.93±0.03, 
SEE. 27±16 mJ, but values were B6±90 mJ less by ABO, p<O.OI. 
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Conclusions: Transesophageal ABO can determine changes In LV 
volume and P-V relations Induced by alterations In preload, although 
absolute values differed from CC values. Transesophageal ABO P-V 
relations are a potential on-line means to assess LV performance. 
926-17 
Brockenbrough Transseptal Puncture with Guidance of 
Intracardiac Echocardiography 
Shunei Kyo, Naomasa Miyamoto, Makoto Matsumura, Takeshi 
Motoyama, Hiroshi lmafuku, Yutaka Dohi, Ryozo Ornoto. Saitama 
Medical School, Saitama, Japan 
To examine the clinical feasibility of intracardiac echocardiographic 
(ICE) guidance for catheter interventions, 13 patients were 
perfonned Brockenbrough transseptal puncture with combined 
guidance of ICE and transesophagea1 echocardiography (TEE). Ten 
patients were perfonned percutaneous transvenous mitral 
commissurotomy (PTMC) and three patients were perfonned 
percutaneous left heart bypass (PLHB) support with transseptal 
introduction of LA cannula. There were 5 males and 8 females and 
the average age was 57 years old. ICE system used was Aloka 550 
(prototype) with a 10 MHz of ICE probe <E.D.=8Fr). ICE probe was 
introduced from the femoral vein and the tip was placed at the 
middle level of RA where the fossa ovalis is seen clearly. Both ICE 
and TEE could demonstrate that the interatrial septum pushed up to 
the direction of LA (tent-formation) at the time of transseptal 
puncture when the needle tip was positioned on the correct point of 
the septum to be punctured. The entire excursion of the Brocken•
brough needle in RA could be seen clearly by the longitudinal image 
of TEE, but it could not be seen by the ICE image. However, 
precise adjustment of the needle tip on the point to be punctured 
was earlier by the guidance of ICE than TEE. Transseptal puncture 
was perfonned successfully in all patients. In conclusion, transseptal 
puncture can be perfonned safely with guidance of ICE when the tip 
of the Brockenbrough needle is introduced into RA Thus, trans•
septal LA cannulation is possible for the patient with cardiogenic 
shock even in the intensive care unit without x-ray arrangement. 
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926-52 
SimuitaDeoul BlplaDe TrlUlMlOpbageal Edlocardlograpby IDd 
CoDcomltant Tl'IDSeSOphageal Atrial Pldnc or the Right 
Ventricle Substantiates Right Ventricular Wall Motion 
Abnormalities 
Andreas Kreis. llirgen A. Hug. Bernhard :benner. Willibald 
Maier·Rudolph. llirgen Pache, Werner Rudolph. German Heart 
CeDlcr Munich. Germany. 
To evaluate wall motion abnormalities of the right ventricular 
poSlerior wall (RVPW) at rest and during stress in ischemic beart 
diaease. in a total of 29 patients (PTS) a simultaneous biplane 
transesophageal echoscope (SBTEE) HitachiJPicker EUP/ES 322 
was used in conjunction with atrial pacing electrodes via the same 
SBTEE. SBTEE of the right ventricle was obtained by positioning 
the probe in the gastric fundus and pacing (lOms pulses of 
17±3mA) for 3·minute intervals with a gradually increa&in$ heart 
rate by 30 beats/minute up to the age related maxllDUID. 
Measurements of wall thickness of the thin walled RVPW could be 
performed by orientating an "M·Mode" scan perpendicular to the 
mid·longitudinal RVPW segment using the sunultaneolll 2D 
transVerse and sagittal plane_ 
In 10 normals. mean RVPW percentage of systolic thickening was 
S4±12% and mean RVPW diastolic wall thickness was 
O.SO±O_06cm_ In 8 PTS with significant proximal right coronary 
artery (RCA) stenoses RVPW was akinetic or dyskinetic at rest. 
during pacing and after pacing. In 7 PTS with proximal occlusion 
of the RCA and retrograde filling by angiography. RVPW was 
DOnnal at rest and became akinetic during pacing or immediately 
after pacing. In 4 PTS with significant stenoses of the mid or distal 
RCA. there were no wall motion abnormalities of the RVPW_ 
In conclusion. the SBTEE stress pacing of the right ventricle 
substantiates ischemic wall motiOD ahuotmalitieI of die RVPW in 
pro&imal ai,Dificant RCA IteIIOICI and allows die effect of 
ICUOJrIdc filling of die RCA _ die RVPW at rest and 411riD& 
IUUL 
926·53 
A Newly Developed Method of Quantitative Aasessment of 
Atherosclerosis Using an Acoustic Microscope 
Shoichi Senda, Hisashi Masugata, Toshihiko Kan, Tomohiko Nishiya, 
Kenichi Hirao, Seiji S!l~.amoto, Hisaki Mor~a, Haruhiko Sakamoto, Hirohide 
Matsuo. Kagawa Medical School, Kagawa, Japan . 
To assess the progression of atherosclerosis in the hL<man coronary 
artery (CA), we quant~atlvely evaluated tissue hardness in the intima of CA 
wail by measuring the propagation velocity (Vs) of ultrasound using 
acoustic micrcscopy. Continued efforts to improve evaluation of tissue 
hardening are aimed not just at identifying hardening, but elucidating the 
hardening mechanism. 
We used an acoustic microscope system (HSAM-SOOS) of 450 MHz 
and examined 4-micron thick CA specimens (21 samples). We calculated 
Vs from Vs=Vwi(I·AZids), where Vw=velocny through water, Abfringe 
shift, ds=thickness. Vs in 3 groups classified according to optical 
microscopy findings in the CA intima was as follows: normal (9) ; 1807 ± 
117 mis, earty stages of scierosis (8); IS72 ±69 mis, advanced stage (4) ; 
2083± 157 mls (p<0.01). Vs being faster in harder tissue, CA intima in the 
early stage Shows an initial softening, followed by increasing hardness L., 
the advanced stage, overturned the commonly accepted notion of simple 
progressive hardening. 
We propose a new mElthod to measure both Ks, the bulk modulus of 
the speCimen, and p 5, density, because Vs is given by Vs=; Kst p s, in 
order to evaluate the hardness of a tissue specimen more precisely. The 
intensny of the signal refiected from the interface of specimen and cover 
membrane, made of polycamonate, represents the impedance property 
(Zs) of the specimen. Zs is given by Zs=J p s . Ks. Then, Ks and p s can 
be obtained as follo'll'5 ; Ks =Zs . Vs, p s=Zs/Vs. 
We therefore conclude that we can evaluate the hardness of a 
specimen more precisElly by calculating the bulk modulus (Ks) from 
measurements of Zs and Vs. 
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927·94 
Prognostic Implications of Dlutollc FIlling Patterns Following Acute 
Myocardial Infarction. 
Ken G Gin, Brad Munt, Brett Heilbron, Lisa M Seminiuk, Joel Singer, 
Christopher R Thompson, Cheryl Davies, Hartmut Henning, John Jue. 
Vancouver Genaral Hospital and 51. Pauls Hospital, Vancouver, B.C., 
Canada. 
Background: Echocardiographically derived diastolic filling parameters, 
particularilya restrictive filling pattem, has recently been demonstrated 
to be more predictive of reduced exercise capacity and increased 
mortality in patients with congestive heart failure than ejection fraction 
(EF). A restrictive pattern has also been shown to correlate with 
development of heart failure during admission with acute myocardial 
infarction (AMI). The long tern prognostic implications of a restrictive 
filling pattern in patients with AMI has not bean reported. 
Methods' 96 patients with an AMI had echocardiography (including 
doppler sampling of mitral inflow at the leaflet tips) perfomed tor clinical 
reasons during their hospitalization. They were followed prospectively 
with a mean follow-up of 2 years. All were in sinus rhythm and none had 
more than moderate mitral regurgitation. Based on the diastolic filling 
pattern, patients were categorized into 2 groups: restrictive (ratio of peak 
early filling to peak late filling [ElA~2:1) or nonrestrictive filling (EIA 
<2:1). EF was measured prior to discharge by nuclear angiography or 
contrast ventriculography. Univariate and multivariate analysis was 
performed to assess whether a restrictive filling pattem predicted long•
term mortality. Logistic regression analysis was perlorrned to determine 
the effects of the two variables (diastolic filling pattem, EF) on mortality. 
EF was considered to be a continuous variable. 
BillIJli;..As univariate predictors, both EF and ElA~2 were statistically 
significant predictors of outcome (p=.008 and p=.025, respectively). 
When EF was utilized as the first predictor in the multivariate model, 
ElA~2 still added significantly to the prediction of mortality (p=.038). 
Conclyslon: During hospitalization, an echo Doppler derived left 
ventricular restrictive diastolic filling pattern,' defined as a ElA-a2, is an 
important independent predictor of long term mortality in patients with an 
acute myocardial infarction. 
927·95 
Syncope and Its Significance in Acute Myocardial Infarction 
·W Douglas Weaver, Paul E Litwin for the MITI Project 
Investigators, University of Washington, Seattle, WA 
Syncope occurred in 251 (3%) of 7591 consecutive patients 
(pts) prior to admission for acute myocardial infarction. Patients 
with syncope were older (70 vs. 66 yrs, p<0.0001), more often had 
a history of heart failure (18% vs. 12%) and came to hospital 
sooner after symptom onset (80 min vs. 120 min, medians), but 
syncope was unrelated to age, sex or prior angina or infarction. 
As expected, bradycardia and heart block requiri.ng a 
temporary pacemaker were more common in pts who had 
syncope prior to admission (18% vs. 6%, p<O.0001). SurpriSingly, 
ventricular fibrillation also occurred more often after admission in 
pts with prior syncope (16% vs. 6%, p<O.0001). Mortality was 
24% in pts with syncope compared to 9% in those without this 
finding. The frequency of thrombolytic therapy use was not 
influenced by syncope. 
Although syncope is a relatively infrequent initial finding in pts 
with acute myocardial infarction, its occurrence prior to admission 
portends a high likelihood of subsequent cardiac arrest and 
increased in-hospital mortality. 
The occurrence of syncope designates a high risk group of pts 
for early transfer and intervention at tertiary cardiac hospitals. 
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927·96 
Impact of Age on Survival After Reperfuslon Therapy of 
Cardiogenie Shock 
Ramon C. Raneses, Usba Kodali, Cindy L Grines, Joel K. Kahn, Gerald 
C. TIII1IIIis, William W. O'Neill, William Beaumont Hospital, Royal Oak, 
Michigan 
Cardiogenic shock (CS) develops in 5·10% of pts with acute 
myocardial infarction (MI). Recent data suggest that early 
revascuIarization (RE) improves survival, however, the benefit in elderly 
patients has been controversial We treated 175 pts with CS from 1986-
1992. CS was defined as systolic blood pressure <8Omm Hg without 
inotropes and <9Omm Hg with inotropes. There were 68 survivors 
(39%) and 107 non-survivors. There were no differences (P .. NS) 
between survivors and non·survivors with respect to hypertension, 
gender, diabetes, history of angina, past MI, PTCA or CABG. RE was 
defined as successful PTCA, byp8S$ surgery or lytic therapy with 
angiographic evidence of arterial patency. In 13 pts RE could not be 
assessed. Of the remaining 162 pts, 97 had successful RE (60%). There 
was a survival advantage with successful RE (59%) vs. 15% without RE, 
p=.OOOl). We analyzed survival by age and RE. 
Age % Reperfusion % Survival % Survival Without 
Wilb BeRSlIi~ion &1lSl~iQn 
<65 42/55 (76%) 34/42 (SI%) 3/13 (23%) 
>f.i~ 5~l1!rz (51~) ~l55 (4~~) 7{~2 mpg) 
Survival of pts s65 and >65 years of age was 65% vs. 25% (p=.0001). 
Multivariate analysis revealed that age (p=.027) and RE (p <.0001) 
were independent predictors of survival These data suggest that 
successful reperfusion benefits both younger and older patients with 
cardiogenic shock. However, the continued poor prognosis of elderly pts 
despite reperfusion will require future study. 
927·97 
a...ctarizatIon and Outcome of C.diogellic ShocII due to Acute 
Myocaniallnfarction by EKG AbnonnaIitieII: R.uIts of the Int8mIIIionaI 
Regis1ry. 
Jacques Col, Jean Boland, David Miller, Sonja McKinlay, Thierry 
LeJamtel, Judith S. Hochman, on behalf of SHOCK Ragistry 
Investlgatora. St. Luke'slRoosevelt Hospital Center and Columbia 
Unlvarslty, NY, NY. 
Outcome and response to therapy, Ie thrombolysis, vari .. for 0 wave 
and non 0 wave MI. To characterize the frequency of 0 weve vs non 
o wave MI causing cerdiogenic shock (CSI, and to examine the 
outcome besed on EKG findings, 216 consecutive patients with CS due 
to LV failure prospectively evaluated In an International raglstry of 19 
centers were analyzed. Patients wera localty cI .. slfied .. ST 
elevat/on/O wavelnew LBBB MI 186%, group 1) or as ST 
depresslon/non specific chenges/old LBBB (14%, group 2). Famales 
represented 41% end 43% (NS). Group 1 EKG pts were "gnificantly 
younger then group 2 (66.±.1'.7 vs 71.±.10.7 yrs p .. 0.031). tn group 
" where 90% EKG chang .. were localizable, a .'ngle Mllocation was 
noted in 59%. In tho.e, anterior Involvement waa pr8lent In 58%, and 
inferior Involv.ment In 36%. Of the 31 % (581 with multiple EKG MI 
locations there was enterior Involvement in 74% end 9 had MI patterns 
in multiple I.ads suggesting ~ 2 vasculer distributions. 18(9%1 had 
Indetarmlnate locations. Timing of shock, therapy and outcom. for 
group 1(n .. 1861 VI. group 2(n=301 are:(times are medians and 25· 
75%1 Group 1 Group 2 P Value 
MI .. > CS (hrs) 8(3,24) 1015,36) 0.208 
CS .. > r.vaacularization (hr.) 4(2,151 48(45,54) 0.006 
MI .. > revaacularizatlon (hraI14(6,401 72(48,721 0.030 
Cardiac Cath 52% 29% 0.002 
PTCA 31% 7% 0.004 
CA8G 7% 10% 0.470 
Thrombolytic e1igibl./edmln 71/68% 43/30% 0.030 
Mortality 54% 77% 0.215 
Patl.nts with non 0 MI and cardiog.nic .hock are significantly older, 
less fr.quentiy thrombolysed and .elected for cardiac cath and 
reva.cularizatlon. Based on clinical and pathophysiologic differ.nc.s, 
the .ffect of interv.ntions on CS mortality mu.t be separately a •••• sed 
bes.d on the type of EKG abnormality. 
lACC February 1994:1A-484A 
927·98 
Excess Delays in Treatmeot in High Risk Patieots in the GUSTO Time to 
Treatment Substudy 
Deborah D. Smith. JeDDY S. Martin, Eva K1ine-Rogers. for the GUSTO Trial 
IDvestigators/Study CoordiDators. Duke Coordinating Center. Durham, NC. 
To determine ifpatient characteristics present on admission to the hospital 
conuibute to in·bospital treatment delays in acute myocardial infarction, we 
examined baseline characteristics of 3,325 patients enrolled into the GUSTO 
Time to Treatment SUbstudy. 
Time to Treatmeot (mins) bospital 
arrival to iDitiation of lytic 
Baseline Percentile 
~ha!:!~r:imcs Ii Mortalln:* MediaD 25th 75th n value 
Men 2446 5.5% 66 49 92 p<.ool 
Women 879 11.3% 73 55 103 
Age!: 75 2947 5.1% 67 50 95 
A > 75 378 20.6% 95 57 101 
AnteriorMI 2048 9.9"10 66 49 91 IF·ool 
lDferiorMI 1188 5.0% 70 51 100 
KiUip I 2928 5.1% 68 50 95 IF·01 
Ki11ip II 329 13.8% 67 50 91 
KiUipill 38 31.6% 100 52 120 
KiIli IV 24 57.6% 86 72 114 
·Mortality of group in overall GUSTO Trial (n = 41.021) 
The average time from onset of pain to hospital arrival was 1.73 hours. There 
was no significant difference in time to treatment in patients presenting at 0-2 
hours. >2-4 hours or >4 hours from symptom onset. Although most patients in 
the uial were low risk, patients at highest risk (women, age >75. and KiIlip 
Class ill or IV) bad the longest treatment delays. These data emphasize for the 
first time the worst case scenario of more extensive delays in the highest risk 
patients and the critical need to focus on more rapid treatment of these patients. 
927·99 
Hyperhomocysteinemia in Young Myocardial Infarction 
Patients is Associated with Extent of Coronary Atherosclerosis 
Manien J.F.M. Janssen, Michiel van den Berg, Walter Deville, 
Jean G.F. Bronzwaer, Jan A. Rauwerda, Freek W.A. Verheugt. 
Free University Hospital, Amsterdam, The Netherlands 
Hyperhomocysteinemia after oral methionine loading is due to 
heterozygous cystathionine B-synthase deficiency. It is rare « 1% 
of normals), increases the risk for vascular disease and can be 
treated with pyridoxine and folic acid. 
We analysed the coronary angiograrns of 34 patients presenting 
with myocardial infarction before the age of 50 and assessed the 
accumulation of plasma homocysteine after standard methionine 
loading. Pts were considered to have hyperhomocysteinemia, if 
peak levels of homocysteine measured after methionine loading 
exceeded the mean levels after methionine loading in normals by 
more than 2SD. 
Hyperhomocysteinemia was seen in 9/34 (27%) patients. Of these 
patients 7 (78%) had multivessel disease against 7/25 (28%) of 
the patients without hyperhomocysteinemia (p=O.012). After 
correction for age, smoking, family history for coronary disease, 
hyperlipidemia, diabetes and hypertension by multiple logistic 
regression analysis hyperhomocysteinemia turned out to be a 
significant (p=O.OO9) risk factor for multivessel disease: OR 9.0 
(95% CI 7.5 - 54.3). 
We conclude, that hyperhomocysteinemia after methionine loa•
ding is not uncommon in patients with premature ischemic heart 
disease and, in this limited series, seems to be an independent risk 
factor for multivessel disease. Since hyperhomocysteinemia is 
easily treatable, it needs screening on a larger scale in patients 
with premature coronary artery disease. 
ABSTRACTS 
927·100 
Influence or Killip Class on Mortality in tbe International 
Trial and the GUSTO Trial. 
Eric R. Bates, Neal S. Kleiman. Douglas C. Morris, David R. Holmes. Jr. for 
the GUSTO Investigators. University of Michigan, Ann Arbor, MI. 
Two comparative thrombolytic megatrials for acute myocardial infarction (the 
International trial and the GUSTO trial) have recorded Killip Class at entry. 
Total enrollment in these uials was 20.891 and 41.021 patients, respectively. 
Percentages of patients by Killip Class were 79 and 85 (Class I). 17 and 13 
(Class II). 3 and 1 (Class III). and 2 and 1 (Class IV). Shorter time to 
randomization (3.0 vs 2.0 hours) may explain the increased number of KilIip I 
patients in GUSTO. Mortality rates (%) by KiUip Class were 4.9 and 5.1 
(Class I), 17.7 and 13.6 (Class II), 31.6 and 32.2 (Class III), and 71.5 and 
57.8 (Class IV). respectively. GUSTO used an accelerated, weight adjusted 
tissue plasminogen activator (rt-PA) dose with IV (not SQ) heparin compared 
with the International Trial. Mortality rates (%) for streptokinase (SK) and rt•
PAwere: 
KjHip Class !I II! IY 
International Trial 
SK/ASA 4.7 17.8 29.9 64.9 
rt·PNASA 5.1 17.7 33.3 78.1 
GUSTO 
SK/ASA 5.4 14.4 33.1 56.4 
U-PAIASA 47 123 271 613 
Preliminary results of worst KilIip class by percent in 17.769 SK patients and 
9.157 rt-PA patients in GUSTO were 65.5 and 67.9 (Class I). 24.9 and 23.9 
(Class 11). 4.6 and 4.1 (Class III) and 4.9 and 4.3 (Class IV). respectively. 
Conclusions: I) In Killip Class I-III patients. the accelerated dosing of rt·PA 
and use of IV heparin in GUSTO improved mortality results relative to SK 
compared with the results with 3 hour rt-PA dosing and SQ heparin in the 
International trial. 2) In both trials, SK was associated with lower mortality 
than rt-PA in Killip IV patients. 3) The majority of patients who develop 
pulmonary edema and cardiogenic shock do so after admission to the hospital. 
927·101 
Incidence and Prognostic Value of Paroxysmal Atrial 
Fibrillation in 11,493 Patients with Confirmed Acute 
Myocardial Infarction treated with Thrombolytic Agents 
Antonietta Ledda, Aldo P. Maggioni, Maria O. Franzosi, Simona 
Barlera, on behalf of GISSI-2 Investigators, Italy 
Paroxysmal atrial fibrillation (PAF) is a frequent complication of 
acute myocardial infarction (AMI) and its presence is generally 
associated with an increasing rate of in-hospital and long-term 
monality, even if its independent prognostic value remains still 
controversial. Aim of this study was to evaluate (Cox proportional 
hazard model) the incidence of PAF and its shon- and long-term 
prognostic value in a large sample of patients enrolled in the GISSI-2 
Study and treated with fibrinolytic agents and beta-blockers and 
aspirin, in the absence of specific contraindications. 
PAF occurred in 963 (8.4%) of 11,483 pts with confirmed AMI; its 
incidence was significantly higher in patients over 70 years of age, in 
those suffering heart failure, pericarditis, reinfarction, sustained 
ventricular tachycardia or ventricular fibrillation. Total in-hospital 
monality rate was 9.4%; in pts with PAF monality was 18.0%, 
while in patients not suffering PAF was 8.6% (adjusted RR 1.56, 
95%CI 1.27-1.93). The 6-month monality rate was also higher in 
patients with PAF with respect to those not suffering PAF: 8.2% vs. 
3.1 % (adjusted RR 1.37,95%CI 1.03-1.83). 
In conclusion, 1) PAF occurred in 8.4% of patients with conf1l'11led 
AMI treated with thrombolytic agents and 2) its occurrence was 
independently associated with an increased risk of in-hospital and 6-
month morta1ity. 
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927·102 
Incidence and Prognostic Significance 01 Primary 
Ventricular Tachycardia in 11,483 Patients Treated with 
Reperfusion Therapy after Acute Myocardial Infarction 
in the GISSI·2 Trial. 
Aldo P Maggioni. Claudio Fresco. Luigi Santoro. Luigi Tavazzi. 
Gianni Tognoni. on behalf of OISSI-2 Investigators. Milano. Italy 
To evaluate the acute and long-tenn clinical significance of primary 
ventricular tachycardia (PVT). both non sustained (3 or more 
consecutive premature ventricular beats at a rate > 100 beats/min and 
< 30 sec) (PNSVT). and sustained (PSVT). occUlTing in day 0-1 
from randomization in patients without hemodynamic impainnent 
(Killip class 1). we analyzed the incidence and the prognostic 
significance of PVT. PSVT and PNSVT in 11.483 pts with 
confmned acute myocardial infarction (AMI) randomized in the 
OISSI-2 trial within 6 hours from the onset of symptoms and treated 
with a thrombolytic agent. Incidence rate of PVT was 15.5%; the 
rates of PNSVT and PSVT were respectively 13.7 and 1.8%. In•
hospital mortality rates were 4.9% for the patients without PVT. 
3.4% for those with PNSVT and 19.8% for those with PSVT. 
Multivariate analysis adjusting for the main clinical-epidemiological 
variables confirmed that PSVT was an independent negative 
prognostic factor for in-hospital mortality (RRCox 5.44; 95%CI 
3.67-8.08), while PNSVT was not (RRCox 0.76; 95%CI 0.56-
1.03). Post-discharge to 6 month mortality rates were respectively 
2.3. 2.4 and 3.8% for the patients without PVT. with PNSVT and 
with PSVT. The differences were not statistically significant both in 
univariate and in multivariate analysis. 
In conclusion. patients with PNSVT do not differ from those 
without PVT in their in-hospital and 6-month fatality rate. PSVT 
occurs relatively rarely (1.8%) but is independently associated with 
a higher in-hospital mortality rate. However. post-discharge 
prognosis is not affected by this event and is similar to that of 
uncomplicated AMI. 
927·103 
IDtracoroaary AspiratioD Throabec:toay Predicts ChroDic 
CliDical aDd ADgiographic •• sults in the cases of Acute 
Myocardial Infarction 
*Tatauaki Murakami. Yoshifurni Takahashi, Surnio Mizuno, 
Kazuo Ohsato, Kensho Koniahi, Ikuo Moriuchi, Fukui 
Cardiovascular Center, Fukui, Japan 
Intracoronary thrombolysis (ICT) and percutaneous 
translwninal coronary angioplasty (PTCA) are well 
established as primary strategies for acute myocardial 
infarction (AMI) ,however, chronic results of both 
therapies are still controversial. We developed 
Intracoronary aspiration thrombectomy (ICAT) , designed 
for recanalization therapy , using intracoronary double•
structure catheter to aspirate intracoronary occlusive 
tissues. To elucidate diagnostic value.. of ICAT, we 
investigated histology of aspirated thrombi (AT) and 
serial clinical and coronary angiographic findings in 
40 cases of evolving AMI treated with lCAT. l:Bistology 
of AT was defined as, recent thrombi (R) in 19(48%) 
cases. atheroma (A) in 6(14%) cases, no thrombi (N) in 
12(30%) cases. and organized thrombi in 1 case. 2:In 
cases of (R) unfavorable coronary events such as 
reocc1usion(ro) Or restenosis(rs) occurred less 
frequently than in those of (A) or in those 
of(N),(ro,0/19,1/6,2/12,rs,0/19,2/6,3/12, respectively). 
3: In cases of (R) treated with ICAT alone(n=8), %•
stenosis of target lesion was maintained in the chronic 
phase (51112% after lCAT,41±14% at pre-discharge,34126% 
in mid-term phase). 4:In cases of(R) treated with lCAT 
followed by PTCA( n=11), i-stenosis of target lesion 
reduced in the chronic phase compared with those after 
intervention ,while in cases of (A) or (N), it 
tended to increase (R,53±7%,3418%,24±10%, 
A,42±12%.60±13\,91±6\,N,43±8%,56±9%,78±lS%, 
respectively). These results indicate that 
interventional or spontaneous dethrombosis reduce 
incidence of restenosis in AMI, and lCAT has potential 
as a prognosis-predictor of AMI. 
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928-105 
A New Variant of Tissue Plasminogen Activator with Enhanced Efficacy 
and Lower Incidence of Bleecfmg When Compared to Recombinant 
Human TISSUe Plasminogen Activator (Activase). 
Claude R. Benedict, eanio Refino, Bruce Keyt, Nicholas Paoni, Jerry 
Todd, Cheryl Pater, Julie Badillo, Roger Thomas. William Bennett. U of 
TX Med. School, Hou .• TX and Genentech. Inc. S. San Francisco, CA 
thrombolysiS with tissue plasminogen activator (t-PAl is an established 
method for treating patients with acute myocardial infarction. However, 
the clinical use is restricted due to concerns with potential bleeding 
complications and the need to administer as an N infusion. We 
describe the thrombOlytic properties of a new mutant of t-PA (Tl03N, 
Nl170. KHRR 296-299 AAAA) (TNK) with longer plasma half life, 
greater fibrin specificity and improved resistance to inactivation by 
plasminogen activator inhibitor when compared to t-PA. 
Methods: Partially occlusive thrombus was formed in the rabbit carotid 
arteries by electrical stimulation. After development of 50% occlusion 
of the artery, the current was stopped and the artery allowed to 
occlude spontanaously. 60 min after occlUSion, t-PA (1.5,3.0.6.0 or 
9.0 mg/kg as "front loaded' IV infusion for 120 min) (n=24) or TNK 
(0.38, 0.75. or 1.5 mg/kg as N bolus) (n=3O) was given. Bleeding was 
assessed by weighing the amount of blood absorbed in a preweighed 
sponge, placed in a cut wound that was 5cm long and 0.5 em deep. 
Results: The dose that produced >90% opening rate of the artery was 
9.0mg/kg for t-PA and 1.5 mg/kg for TNK (p<o.oOOl); the time to 
reperfusion was 26.6±7.4min (mean±SEl with t-PA and 11±1.5min 
with TNK (p=O.04); The total duration for which the artery remained 
patent was 65.4±12.9min for t-PA and 107±1.4min forTNK (p=0.012); 
The weight of the residual thrombus was 8.2±0.6mg with t-PA and 
4.5±0.5mg with TNK (p=O.OOll); Blood loss at the cut incision was 
65±4.3mg for t·PA and 52±4.8mg for TNK (p=0.028); the latter value 
was not different from controls (35±6.2mg). 
Conclusion: TNK is more potent than wild type t-PA in inducing a 
more rapid and complete thrombolysis of an occluded artery and is 
associated with lower incidence of bleeding. 
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928·106 
Coronary Reperfusion in Patients with an Acute 
Myocardial Infarction following Intravenous 
Administration of Recombinant Staphylokinase. 
Steven Vanderschueren. *Desire Collen and Frans 
Van de Werf. Department of Molecular and Car•
diovascular research. University of Leuven. 
Belgium. 
Our current clinical experience with recom•
binant staphylokinase (STAR) is described. 
STAR (intravenous bolus of 1 mg followed by 
infusion of 9 mg over 30 min) was given to 10 
pts (mean age: 64 yrs) with acute myocardial 
infarction of ~ 6 hrs duration and with angio•
graphically proven occlusion (TIMI 0) of the 
infarct related vessel (IRV). Adjunctive 
therapy consisted of heparin (5.000 IU bolus 
followed by 1.000 W/hr) and aspirin (160 to 
250 mg). Control angiograms of the IRV were 
repeated at 10 min intervals up to 10 min after 
the end of the infusion of STAR and also at 24 
hrs. 
The incidence of TIMI flow 2 or 3 at the dif•
ferent time points was: 5/10 (10 min) ; 7/10 
(20 min) ; 7/10 (30 min) ; 9/10 (40 min) ; 8/9 
(24 hrs). The infusion of STAR did not induce 
a lytic state: fibrinogen and ~ z-antiplasmin 
levels before and after infusion were 3.1 ± 0.5 
vs 3.0 ± 0.5 giL and 90 ± 13 vs 76 ± 29%. 
respectively (mean ± SD). 
Thus. STAR appears to be a very potent and 
remarkably fibrin-specific agent. Direct com•
parative trials with other agents are needed. 
928·107 
Combined Use or Thrombolysis and Dipyridamole: Its Effect on 
Regional Lert Ventricular Remodeling and Function in Patients With 
Acute Myocardial Inrarction and Single-Vessel Disease 
Wataru Hayashida, Michel F. Rousseau, Christian van Eyll, Liviu 
Stoleru, Christophe Beauloye, Hubert Pouleur, for the APPI group. 
University of Louvain, Brussels, Belgium 
Dipyridamole (DIP) is known to increase endogenous adenosine levels 
and is expected to protect the myocardium during reperfusion. To assess 
the effect of combined use of rtP A and DIP on LV function and early 
remodeling, sixty-four pts with first acute myocardial infarction and 
single-vessel disease undergoing thrombolysis within 6 hours of the onset 
were randomized in a double-blind study. In addition to rtPA (100 mg) 
and heparin, all pts received placebo (pLA, n=31) or DIP (n=33, 400 
mg/day i.v. followed by 300 mg/day orally). After one month, LV 
(+ Millar) and coronary angiography was performed for each patient, and 
LV function was assessed on a regional basis by the area method. None 
of the pts required CABG or angioplasty and was treated with ACE 
inhibitors. As specified in the protocol, a stratification of the data was 
made according to the degree of residual stenosis in the infarct-related 
coronary artery. In pts with residual stenosis 2: SO %, regional ejection 
fraction of the infarct zone was greater (28± 14 vs. 20± 13%, P < 0.01) 
and end-systolic regional area tended to be smaller (440 vs. 507 mm') in 
the DIP group than in the PLA group. Furthermore, in the DIP group, 
regional peak filling rate and regional compliance (pressure-regional area) 
were also better preserved (I.85±0.92 vs. 1.43±0.72 end-diastolic area/s 
and 16.3±7.2 vs. 12.2±7.3 x 10.3 end-diastolic arealmmHg, both 
p <O.OJ). These effects of DIP on the regional function and geometry of 
the infarct zone were particularly significant in pts with anterior infarct, 
in whom the infarct expansion is more common. However, in patients 
with residual stenosis < SO %, no significant effects of DIP were 
observed for the infarct zone. Thus, DIP is expected to exert a 
cardioprotective effect on the infarct myocardium, particularly in case of 
insufficient recanalization after thrombolysis. 
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928·108 
Prophylactic Lidocaine Was Commonly Used in the GUSTO Trial 
Ouistopher Granger, Zygmunt Sadowski, Matthias Pfisterer, Kerry L. Lee, 
Robert M. Califf. for the GUSTO Investigators. GUSTO Coordinating 
Center. Durham. NC 
Based (II small randoolized trials demonstrating no net benefit, the use 
of prophylactic lidocaine for acute Ml has been discouraged. Nevertheless. 
in the GUSTO Trial in which all patients received thrombolytic therapy. 
16% of patients received prophylactic lidocaine. and the use was much 
more canmoo. in the US canpared with non-US countries (25.4% vs 3.9%. 
p<O.OOl). For patients treated with prophylactic lidocaine canpared with 
patients not treated. the major important prognostic baseline characteristics 
were similar. including median age (61.7 vs 60.5 yrs), systolic BP (128 vs 
130 mmHg). heart rate (75 vs 73), Killip class ill or IV (2.1 vs 2.1 %). 
anterior Mllocation (40.3 vs 38.8%), previous Ml (16.5 vs 16.4%). and 
time to treatment (2.7 vs 2.8 hrs). Outcomes were: 
P!q)hylactic Udocajne No pJWhvlactic lidocajne 
30 day mortality 6.4% 7.0% (p=.05) 
Stroke 1.4% 1.5% 
Reinfarction 4.0% 4.0% 
CHF 17.0% 16.1% 
VFib 7.0% 6.6% 
Sustained VT 6.6% 6.1 % 
Asystole 6.4% 5.6% (p:(J.02) 
In cooclusion. prophylactic lidocaine was used in (lie quarter of US 
patients, and rarely outside of the US. Ventricular arrhythmias occurred 
with similar frequency with and without prophylactic lidocaine. and 
asystole was slightly more canmoo. with prophylactic lidocaine. There was 
a trend towards lower 30 day mortality in patients treated with prophylactic 
lidocaine. Because use of prophylactic lidocaine was not randomized, these 
results must be interpreted with caution. and adjustment for baseline patient 
differences will be helpful in determining whether prophylactic lidocaine is 
or is not associated with an effect on mortality. 
928·109 
Menstruatin& Women May Be Safely and Effectively Treated With 
Thrombolytic Therapy: Experience From the GUSTO Trial 
Sharon Karnash, Christopher Granger, Eva Kline-Rogers, Deborah D. Smith, 
Eric J. Topol, Robert M. Califf, for the GUSTO Investigators, GUSTO 
Coordinating Center, Durham, NC 
Although anecdotal case reports have suggested that thrombolytic therapy 
is safe in women during menstruation, the risk of increased bleeding is poorly 
defined. In order to obtain a more reliable estimate of the risk of treating 
menstruating women with thrombolytic therapy, we identified 12 
menstruating women by soliciting infonnation on patients enrolled in the 
GUSTO trial in North America, and we collected additional information via a 
I page form. 
The median age was 45 years (range 24-51); Mllocation was 60% inferior 
and 40% anterior. 73% were cigarette smokers, compared to 43% overall in 
GUSTO. Median time to treatment was 4.3 hours, compared to 2.8 hours 
overall, and the median length of stay was 7 days, compared to 9 days 
overall. 
Of 9 women with angiograms, 1 had 2 vessel disease, 6 had 1 vessel 
disease and 2 had insignificant disease. The median L VEF was 55%. The 
infarct related artery was occluded in 4 and patent in 5. Other outcomes were: 
Death-30 days 
Stroke 
menstruating women overall trial 
(n=12) (n=41,021) 
o 7.0% 
o 1.5% 
Bleeding, severe' 0 0.4% 
moderate •• 25% (213 vaginal) 5.5% 
Nadir Hct (median) 35% 37% 
'hemodynamically significant; "requiring transfusion 
In conclusion, in spite of the apparent increased risk of non-severe vaginal 
bleeding, the GUSTO experience is consistent with the concept that 
thrombolytic therapy is ~afe and effective in menstruating women. 
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928·110 
Women with Acute Myocardial Infarction: Presentation, Treatment and 
Outcome In Potential Candidates for Thrombolysis 
Peter J. Kudenchuk, Charles Maynard, TlIIlOthy Dewhurst, Jenny S. Martin, for 
the Min ProjecIlnvestigators, University of Washington, Seattle, WA 
Recent reports suggest that women with acute myocardial infarction 
(MI) are treated differently and have poorer outoorne than men. We evaluated 
843 consecutive patients under age 76 with acute MI (675 men and 168 women) 
who were deemed potential candidates for prehospilal thrombolysis, based on 
paramedic ~eening for typical inclusion/exclusion criteria. Women were older 
than men (63! 9 vs 58! 10 years, p<.OO1), were more corrvnonty hypertensive 
(45% vs 34%, p<.02), but less likely to have had previous MI (13% vs 27%, 
p<.OO1) or bypass surgery (5% vs 12%, p=.01). Women delayed seeking 
treatment slighUy longer than men (mean 59 vs 50 minutes, p=.08), but on 
presentation had comparable heart rates, blood pressures, and a similar 
incidence of diagnostic ST elevation on their initial ECG (67% vs 65%). 
Women were as likely as men to receive thrombolysis (61% in both), 
angioplasty (33% in both) and/or bypass surgery (14% vs 16%) during 
hospitalization. GI bleeding was a more common complication in women (4% vs 
1%, p=.02): other complications of stroke, shock, heart failure, infarct extension, 
other bleeding problems, need for temporary pacing, and hospital mortality were 
indistinguishable between men and women. 
The treatment and outcome in women with acute MI who are identified 
by paramedics as potential candidates for thrombolysis is largely comparable to 
men. Suet prehospital screening and evaluation appears to minimize 
subsequent treatment bias based on gender and demonstrates the potential to 
achieve similar benefits in women as in men who are eligible for aggressive 
intervention. 
928·111 
Are There Gender-Related Differences in Treatment Allocation for 
Acute Myocardial Infarction? 
Larry R. Handlin, James L. Vacek, Thomas L. Rosamond, Linda J. 
Crouse, Paul H. Kramer, Gary D. Beauchamp, Mid America Heart 
Institute and St. Luke's Hospital, Kansas City, Missouri 
There is concern that gender-related differences in outcome after 
myocardial infarction (MI) may relate to biased treatment allocation. We 
studied 573 patients presenting with acute Q-wave MI and treated within 
6 hrs with reperfusion therapy. 280 (49%) received direct PTCA while 
293 (51%) received thrombolytics followed by PTCA (p=NS). 74% were 
men and 26% women (p=NS for differences in sex distribution between 
the 2 treatment groups). Women were older than men in both groups 
(p<.01). Inferior MI was more common in women (64% of direct PTCA, 
71 % of lytic 1st) than men (51% and 59% respectively)(p<.03). There 
was no gender-related difference in lesion distribution, % of prior MI, % 
of prior bypass surgery, baseline ejection fraction, % of patients with EF 
<40%, # of lesions dilated, or PTCA success. 
OUTCOME: After 2.5 yrs flu, no gender-related differences were seen 
in need for cardiac cath, documented restenosis, MI, CABG. clinical 
expression of ischemia, or death. The patients treated with direct PTCA 
were more likely to undergo CABG (18% vs 12% for lytic, p<.05) or to 
die (18% vs 9%, p<.OI). 
CONCLUSIONS: Women undergoing reperfusion therapy for Q-wave MI 
at our institution are older than men, with a higher % of inferior MI. 
However, no specific gender-related bias in treatment allocation is 
evident. Outcome is similar for men and women in regards to PTCA 
success, clinical endpoints, and survival. Better outcome with initial lytic 
therapy as compared to direct PTCA is seen in women and men, although 
this may relate in part to treatment of higher-risk patients with direct 
PTCA Therefore an aggressive reperfusion strategy appears to benefit 
women as well as men. 
JACe February 1994:1A-484A 
928·112 
Gender Differences in Speed end StllbDity of Coronary Reperfusion 
Following Thrombolytic Therapy for Acute Myocardial infarction. 
Mitchell W. Krucoff. Suzanne W. Crater, Sheron T. Sawchak. Rolf F. 
Veldkamp, Cynthia l. Green, Nancy M. Wildermann, James E. Pope, 
Christopher Granger, Robert M. Califf. Duke Univarsity, Durham, NC. 
Female myocardial infarction patients have been reported to have higher 
mortality than males, but the reason remains unclear and the effect of 
thrombolytic therepy (TTX) is controversial. Gender differences in speed 
and stability of reperfusion following TTX have never been examined. 
Quantification of TTX efficacy using 12·lead continuous ST -segment 
recovary analysis was related to gender in 328 TAMI 7&9 pta tniated 
with "front loaded" tPA regimens. Definitions were: first reperfusion -
first L50% recovery from peak reference ECG (tested with Kaplan 
Meier); reocclusions - L 150uV ST r.-elevation (tested with Chi 
Square); stable reperfusion - no reocclusions for L 4 hrs; late 
reocclusions - occlusions after L 4 hrs of stable reperfusion. 
Results as median (quartile range): 
Males (N - 244) 
symptoms to TTX (min) 160 (115,232) 
TTX to first reperfusion (min) 54 (22, 96) 
TTX to stable reperfusion (min) 89 (46, 188) 
Results as 1(%): 
persistent occlusion 
late reocclusions 
mortality 
10 (4%1 
33 (15%) 
10 (4%1 
Females IN - 84) Il 
182 (136,230) NS 
42 (11,621 0.0008 
75 (41,167) NS 
1 (1%) 
9 (11%) 
3(4%1 
NS 
NS 
NS 
Thus: In this cohort of 328 patients we observed significantly faster first 
evidence of reperfusion, possibly with slightly earlier stable reperfusion, 
in females treated with tPA regimens compared to males. This beneficial 
response to tPA may in part explain the mortality parity between males 
and females observed in our population, unlike previous gender·related 
differences in outcome. 
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929·36 
Diagnosis of Microlnfarctlon in Acute Ischemic Syndromes Is of 
Prognostic Value 
Anthony Y Fung. John Jue. Christopher R Thompson. Cheryl Davies. 
William E Schreiber. Vancouver General Hospital, Vancouver, B.C .• 
Canada. 
Background: Acute coronary syndromes represent a diagnostic 
and therapeutic continuum. The presence of myocardial enzyme elevation 
is frequently required to differentiate non·a wave myocardial infarction (MI) 
from unstable angina. When total creatine kinase (CK) and the isoenzyme 
CK·MB are elevated, the diagnosis of MI is rarely in doubt. Whe total CK is 
within normal range, and yet CK·MB is elevated. the diagnosis of infarction 
as opposed to unstable angina can be questioned. The prognostic value of 
an isolated elevation of CK-MB with a normal total CK is controversial. 
Newer techniques of CK·MB analysis are more sensitive and may be more 
predictive of adverse outcome in patients admitted with chest pains. 
Methods: We evaluated the prognostic value of CK, and CK·MB in 
acute ischemic syndromes. Over a 4 month period, 269 consecutive 
patients admitted to our coronary care unit with chest pain consistent with 
an acute ischemic syndrome were prospectively studied. Serum CK 
(electrophoresis technique) and CK·MB (irrvnunometric assay, mass 
concentration) were measured on admission. 12 hours and 24 hours later. 
Patients were followed up to time of discharge from hospnal. 
B!wIttI n Mortality Reinfarctlon 
~roup 1- elevated total CK and CK 85 11.8%' 1.2% 
MB 
Group 2· normel total CK and 23 13.0%' 8.7%' 
!llevated CK·MB 
Group 3· normal CK and CK·MB 161 0.6% 0% 
p=O.OOOI compared to group 3 
Conclusions: The isolated elevation of CK·MB in pat~nts with acute 
ischemic syndromes suggests an adverse short term prognosis with event 
rates coll1larable to those patients with MI. This emphasizes the 
ilT1>Ortance of diagnosing microinfarction in acute ischemic syndromes. 
JACC February 1994:1A-484A 
929·37 
Hyperacute Visualization of Myocardial Ischemic Injury: Comparison 
of Tc-99m-glucarate, Thallium-201, and Indium·111-antimyosin 
Jagat Narula, Artiom Petrov, Chris Pak, Ban-An Khaw, Northeastem 
University, Boston, MA 
A radiotracer agent for hyperacute diagnosis of myocardial infarction is not 
yet available, Although both indium-111 antimyosin (AM) and To-99m•
pyrophosphate are effective localizing agents, they require 24-48H for 
definitive diagnosis, To-99m-glucarate (Glu), which is similar to 
pyrophosphate but does not accumulate in bones, may fill this role. To test 
this hypothesis, myocardial Infarction was experimentally produced in 7 
open-chested New Zealand White rabbits by occlusion of LAD coronary 
artery. Reperfusion was Instituted in 4 rabbits after 40 minutes. At 60 min 
after occlusion, all animals received -500~Ci of TI-201, followed 30 min 
later by 10-15mCi of Glu and -500~Ci AM. Infarct localization was 
possible at 8, 15, 30 and 30min after the administration of Glu in 
reperfused and at 45min-3H in nonreperfused animals. Mean %dose/g of 
the radiotracers in tissue samples from infarct center, border and normal 
myocardium (as determined by triphenyltetrazolium chloride staining) were 
as follows: 
tracer 
TI-201 
Glu 
AM 
",perfused 
center border normal 
(0=16) (0=14) (0=16) 
O.O2±O.OO3 O.05±O.OO8 O.08±O.OO8 
O.10±0.01 Q.03±O.006 O.OO3±O.OO6 
1.13±O.1S O.25±O.04 Q.OS±O.OO7 
persistently occluded 
center border normal 
CO=12) (0=14) (n=9) 
0.O1±O.OO2 O.04±O.OO8 O.08±O.02 
O.06±0.01 O.05±0.OO7 O.006±0.OO1 
O.16±O.04 O.15±O.02 O.O6±O.OO5 
In tissue samples, the infarct center (28% of TI-201 of normal; n=16)-to•
normal myocardial ratio of Glu was 35:1 (p=0.0001) and AM was 14:1 
(p=0.0001) at 3H of tracer administration in reperfused animals. In animals 
with persistent occlusion, infarct (18% of TI-201 of normal)-to-normal ratio 
with Glu was 11:1 (p=.0001) and AM 3:1 (p=0.03). 
Therefore, Glu appears to be an early marker for delineation of myocardial 
infarct. 
929·38 
BEAT TO BEAT ICaZ+~ TRANSIENTS AND LEFT VENTRICULAR 
FUNCTION DURING BRIEF BOUTS OF ISCHEMIA IN RATS. 
Ferdinand Urthaler. Kevin Harris. Alfred A. Walker. Russell D. 
Spruell. Stan B. Digerness. Russell C. Reeves. Lloyd L. Hefner. 
University of Alabama at Birmingham. Birmingham. AL. 
Aequorin was Injected under the epicardium of the left ventricle 
of 5 isovolumically beating hearts. As shown in Fig 1 the hearts 
_. __ ._were paced (S) at 130 b/min and 
Fig , ,. P 7 • 'e.mn subjected to 2.5 min of ischemie 
initiated and terminated by computer 
!·~=~~==:;:==·flow adjustments. The beat to beat •• IIi'-"_-i_. __ ICaz+l) transients IT) shown in Figs 
, 2.and 3 illustrate the time course of 
changes in individual leaHI) in tha experiment of Fig ,_ 
~~.~::~ , .... --
~ .... ;::. 
Fig 3 Fig 2 
-~.--....... 
~\ ::::= ! .... ~ .. -i '--. _._- . -"- -
Prior to ischemia resting ICaHI; was 330 ± 80 nM and the LVEDP 
6 ± 2 mmHg. Control steady state ICaHI; Twas 1040 ± 155 nM 
and left ventricular pressure (LVP) was 85±8 mmHg. 2.5 min 
into ischemia L VP was 10 ± 3 mmHg without significant changes 
in LVEDP while ICaHI; T rose to 1320 ± 160 nM. In 3 hearts 
diastolic ICaHI; rose by 50±30 nM but was unchenged in the 2 
other hearts. After 1 min of reperfusion ICaz+l; T and pressures 
returned to preischemic values. The results show that a brief bout 
of ischemia causes large increases in ICaH ); T with marked 
decreases in contractility, Both are readily reversible and likely 
due to rapid changes in myofilament responsiveness to Cao.. 
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929-39 
lachemlc Myocardium Recoil Impalra Early Dlaatollc 
FIlling. 
'Guillaume Jondeau and ~Calvin Eng. 'HOpltal Ambroise Pare, 
92104 Boulogne, France. ~Albert Einstein College 01 Medicine, 
Bronx, New York. 
Alter coronary occlusion, the ischemic myocardium "bulges' 
passively during systole. With the onset 01 Isovolumic relaxation 
(IVR), the Ischemic myocardium reCOils (shortening). This study 
was pertormed to determine the extent of Ischemic myocardium 
recoil during the diastolic filling period (OFP), I. e. after mitral 
valve opening (MVO). In 9 dogs, high fidelity pressure 
fIleasurements were made of the aortic (AP), left ventricular 
(LVP). left atrial (LAP) pressures, as well as endocardial segment 
length In the Ischemic (IZSL) and normal (NZSL) lones. Digitally 
acquired data at , msec Intervals were analyzed for crossover of L VP 
and LAP defining (MVO) and closing (end diastole, ED), and DFP. IVR 
was defined as the period from the AP dicrotiC notch to MVO. 
After coronary occlUSion, IZSL shortened during IVR and continued to 
recoil after MVO reaching a minimum length at 38.3,.10.9 msec 
after MVO, i.e. after 27% of OFT. In the last 3/4 of OFT, IZSL 
Increased Indicating a contrlbution to LV filling. The minimum IZSL 
time occurred slightly after LVP minimum, although not 
significantly. In contrast, after coronary occlusion, the NZSL 
lengthening started earlier, prior to IVR representing wasted 
relengthenlng: 31% of total NZSL lengthening occurred before MVO. 
The maximal rate of decrease In LV pressure after MVO, decreased 
from 129:042 during control to 93±36 mmHg/sec during ischemia. 
CONCLUSION: The Ischemic myocardium continues to reCOil, I.e. 
shorten well after MVO. Simultaneously, the normal zone 
lengthening Is starting early (prior to MVO), which would attenuate 
LV "suction· contribution to diastOliC filling. This combination of 
events would tend to significantly compromise LV IIlIlng during 
Ischemia (the rate of decrease In LV pressure In early diastole Is 
decreased) . 
929·40 
Two-Dimensional Finite Element Analysis of Regional 
Deformation and Rigid Body Motion in Acute Anterior 
Myocardial Infarction 
Victor A. Fem.ri, Feng Xie, Susan B. Yeon, Linda P. Calhoun, 
Christopher M. Kramer, Barbara Tallant, Leon Axel, Nathaniel 
Reichek, University of Pennsylvania, Philadelphia. PA 
Unlike unidimensional indices of segmental function such as wall 
thickening, two-dimensional analysis can detect changes in the 
orientation of deformation and rigid body motion in diseased 
myocardium. Therefore, we used magnetic resonance tissue tagging 
to compare 2D myocardial deformation and rigid body motion in 
infarcted (INF), adjacent (ADJ), and remote regions in 10 acute 
canine apical infarctions (MI) to matched regions in 10 controls (C). 
Tr!-an~ular fin.ite elements were used to ~easure the orthogonal 
pnnclpal strams, Al (1 + greatest systolIc elongation). A1 (1 -
greatest systolic shortening), p or angular deviation of Al from the 
radial direction, as well as element translation (1') and rotation (R) in 
the short axis plane. Results (mean ± S.E.): 
Al A2 B (0) T (mm) R (0) 
AD} C 1.I4±O.04 0.7S±O.02 14.7±2.3 S.4±O.4 4.6±0.7 
MI 1.08±O.O2* O.82±O.Ol* 2S.9±4.7* 2.6±O.1* 3.6±l.O 
INF C 1.I4±O.02 O.74±O.02 12.S±2.0 S.8±O.S M±l.S 
MI 1.O6±O.O2* O.93±O.OI*t 47.2±6.S*t 1.2±O.3*t 2.0±0.3* 
* = p<O.05 vs. Control, t = p<O.05 INF vs. AD} 
In MI, At. A1 and T were reduced in both ADJ and INF regions. 
However, changes were more marked in INF than ADJ regions. 
Remote deformation and motion were similar in MI and C. 
Moreover, the orientation of Al (P) and A1 (90°+ P) changed 
markedly in both AD! and INF regions. We conclude that in acute 
MI, 2D analysis detects the graded changes in angular orientation of 
principal strains and rigid body motion found in the INF and ADJ 
regions that may confound unidimensional analyses of segmental 
myocardial function. 
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929·42 
The Effect of Left Ventricular Infarction on Right Ventricular 
Structure and Function 
Kenneth M. McDonald, Cynthia Toher, Todd Parrish, Arthur 
Stillman, Jay N. Cohn, University of Minnesota, Minneapolis, MN 
Right ventricular (R V) function is an important determinant of 
prognosis in heart failure. Little is known, however, regarding the 
early changes in structure and function of this chamber following 
transmural left ventricular (LV) infarction. We have previously 
demonstrated that repetitive transmural DC shock (DCS) iii the dog 
results in localized necrosis of the LV free wall accompanied by 
progressive LV hypertrophy and dilation (magnetic resonance 
imaging [MRI]) and increased LV end-diastolic pressure (JACC 
1992;19:460-67). In order to assess sequential changes in the RV, 
MRI was performed in both RV and LV at 2 and 16 weeks (W) 
following DCS in 7 mongrel dogs (20.4±O.S kg) with calculation of 
change from baseline in mass (mean±SE) (AM), volume (A V) and 
ejection fraction (AEF). Changes in pulmonary artery pressure (AP) 
were also monitored. 
2W l6W 
RV LV RV LV 
AM(gm) 0±2 +8±3* +7±1 * +20±2* 
AV(ml) +1±2 +S±2 +4±3 +1l±2* 
AEF(%) +1±2 +1±4 -6±3 -9±2* 
*p<O OS with haseline. 
The increase in RVM did not correlate with AP (+4±1 mmHg; 
r=O.06, p=O.9). These data indicate that RVM increases without 
any signilicant AV in the early period following LV infarction, that 
this change occurs later than the increase in L VM and does not 
appear to be explained by an increase in pulmonary arterial pressure. 
The mechanism of this RV mass increase remains to be determined. 
lAce February 1994:1A-484A 
929·43 
TIme-CoUfH and Severity of Arrhythmias In Conscious, Untetherad 
Rats During the First 48 Hours After Myocardial Infarction 
Christian F. opnz, Gary F. Mnchell, Marc A. Pfeffer, Janice M. Pfeffer, 
Harvard Medical School, Brigham & Women's HospHal, Boston, MA. 
Arrhythmic death accounts for most of the early mortalHy associated 
with acute myocardial infarction (MI), but the time course 01 arrhythmias in 
the hyperacute phase is not well-defined. Ischemia-associated arrhythmias 
occur in the rat wnh MI, but their incidence and duration during the acute 
period in the continously monHored animal Is not known. We implanted a 
telemetric EKG monnor to count occurrences (OCC) and measure 
duration (OUR, sec) of ventricular tachycardia (VT) and fibrillation (VF) 
during the first 48 hrs post-MI. Data were obtained In conscious, 
untethered animals. Arrhythmia analysis was performed off-line using a 
digHized EKG-recording, containing up to approximately 1.7 million 
conNCutive beats. 
In 23 rats wHh myocardial infarct sizes >30% (46:1:11%) the time 
course of VT and VF had 2 distinct active phases interspersed by 2 
quiescent periods. Deaths occurred only in the active phases. Immediately 
post-MI (active I, 0-50 min), there were peaks of activny at 4 and 24 min 
for VT-OCC and at 20-30 min for VF-OCC. Means were 10-fold greater 
than in the subsequent quiet period and were associated wHh a mortalHy 
rate of 13%. The most severe arrhythmiaS occurred between 1.5 and 9 hrs 
(active II) and had maximal values for OCC of VT and VF between 3 and 6 
hrs post-MI. Means for OCC and OUR were 2- to 4-fold those of active 
phase I. The mortalHv rate was 62% for active phase II. Tbl Mean:l:SDlhr. 
Active I "uie! Active II "uie! 
Timelhr\ 0- 0.8 0.8 - 1.5 1.5 - 9 9 - 48 
VF-OCC 11 .. -.rO 01 .. -53 -20 ';:-23 -0 
VF·DUR 10.7:1: 29.3 0.3:1: 1.3 37.7:1: 42.2 0 
VT-OCC 6.5:1:21.2 0.7:1: 1.5 25.4:1: 33.6 0.3:1: 1.4 
VT·DUR 18.9:1: 55.8 2.1:1: 7.5 60.7:1: 64.4 0.1 :1:0.4 
In the conscIOUS, untethered rat w~h acute MI, 2 active phases of 
malignant arrhythmias occurred, associated wHh mortality whereas in the 
quiet periods, no deaths occurred. Using this approach, Interventions in 
the acute phase of MI can be tested for their impact on arrhythmic deaths. 
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930·18 
Diabetics with Coronary Disease Have Less Severe Ambulatory 
Ischemia and a Similar Prevalence of Asymptomatic Ischemia 
Compared with Nondiabetic Patients: An ACIP Database Study 
Eugene A. Caracciolo, Sandra A. Forman, Peter H. Stone, George 
Sopko, C. Richard Conti, Bernard R. Chaitman, for the ACIP 
Investigators, St. Louis University Health Sciences Center, St. Louis, MO 
Diabetics with coronary disease are reported to have significantly more 
frequent asymptomatic ST segment depression on ambulatory ischemia 
monitoring (AECG) and during exercise treadmill testing (ETT) 
compared with nondiabetic patients (pts). We assessed the incidence of 
ischemia on the qualifying 48 hour AECG and ETT in 618 randomized 
Asymptomatic Cardiac Ischemia Pilot (ACIP) pts; 89 pIS had a history 
of diabetes and were taking oral hypoglycemics or insulin (group I); 
529 pts did not meet these criteria (group 2). Hypertension (56.2% vs 
34.2%, p<O.OOI), peripheral vascular disease (13.5% vs 6.8%, p<0.03), 
and use of ACE inhibitors (20.2% vs 10.6%, p=O.OI) were all reported 
more frequently in group I. At randomization, resting heart rate (72 ± 
II bpm vs 69 ± 12 bpm, p<O.OI) and systolic blood pressure (147 ± 19 
mm Hg vs 137 ± 19 mm Hg, p<O.OOI) were both significantly higher in 
group 1. Multivessel disease (86% vs 74%, p=O.04) was more frequent 
in group 1. After adjustment for baseline clinical variables, the percent 
of pts with only asymptomatic ST segment depression on AECG was 
similar in groups I and 2 (93% vs 89%), respectively. Mean heart rate 
(76 bpm vs 74 bpm) and maximum heart rate (128 bpm vs 131 bpm) 
on AECG were also similar. The mean number of ischemic 
episodes/day (2.1 ± 2.1 vs 2.7 ± 2.8, p=O.02), total ischemic time/day 
(14 ± 21 min. vs 22 ± 30 min., p<O.OI), and the mean depth of the ST 
segment depression (1.8 ± 0.8 vs. 2.1 ± 0.9, p=O.OI) were all 
significantly less in group I. The percent of pts who experienced 
angina during the ETT was similar in groups I and 2 (46% vs 54%), 
respectively. Final stage of exercise achieved was also similar. At the 
time of I mm ST segment depression, the rate pressure product (21,478 
± 4,489 vs 20,264 ± 4,832, p=O.03) was significantly higher in group I. 
In conclusion, diabetic pts similar to those enrolled in ACIP have less 
severe ischemia on AECG and similar exercise capacity on ETT 
compared to nondiabetic pts. Our data do not support earlier literature 
in smaller patient series which have reported a higher prevalence of 
asymptomatic ischemia in diabetics. 
JACC February 1994:1A-484A 
930·19 
Silent Myocardial Ischemia in Coronary Artery Disease: Comparison 
Between Patients With and Without Oiabetes Mellitus. 
Colomba Falcone. Michael Ochan, Carla Auguadro. Margherita Chioffi. 
Luigina Guasti. Luigi Angoli, Carlo Montemartini. University Hospital, 
IRCCS • Pol S Matteo • Pavia, Italy. 
It bas been reported that silent myocardial ischemia is more frequent in 
patients (pts) with diabetes mellitus (OM). 
In this study we compared the clinical, ergometric and angiographic 
features of subjects with and without OM, matched for age and sex, who 
were observed consecutively in our ergometric laboratory to get a 
diagnostic exercise test: only the pts with exercise-induced myocardial 
ischemia and coronary artery disease (CAD) documented by 
angiography were included. Group I (Gl) consisted of 173 consecutive 
pts with non insulin-dependent OM (155M. 58±7years) 
(gJicemia> 140mg1ml for 13±5years) and Group II (GIl) of 173 non 
diabetic control SUbjects. . 
The prevalence of a previous myocardial infarction, anginal pain in 
history and the distribution of CAD did not .4iffer in the two groups. 
During exercise. silent myocardial ischemia was observed in 59% of pts 
in GI and in 60% of pts in GIl. The heart rate·blood pressure product at 
the ischemia threshold (lmm ST depression) and at pain threshold (onset 
of pain) were similar in the pts ofGI and GIl, with and without angina at 
exercise. The subgroups with silent ischemia of GJ and GIl exercised 
longer achieving a higher double product at peack exercise. In this 
population of CAD pts the presence of OM seemed not to affect the 
ergometric results. the appearance of anginal symptoms and the severity 
of CAD. 
In our study the diabetic pts were enrolled among CAD pts referring to 
our exercise laboratory for myocardial ischemia ( history of angina or 
dispnca or syncope or previous myocardial infarction). The higher 
prevalence of silent ischemia in OM subjects found by others may 
account for the recruitment of a subgroup of silent patients. 
930·20 
Mechanisms of Silent Myocardial Ischemia in Diabetic 
Patients 
*Hiroyuki Hikita. Akira Kurita. Bonpei Takase. Akimi Uehata. 
Hirokazu Nagayoshi. Toshihiko Nishioka. Hideki Mitani. Kimio 
Satomura, Kyoichi Mizuno. Haruo Nakamura. National Defense 
Medical College. Tokorozawa, Saitama. Japan 
Previous studies suppon a role of beta-endorphin (ED). pain 
threshold(PT) and cardiac autonomic tone in silent myocardial 
ischemia (SMI). A relationship between an autonomic dysfunction 
and SM! in patients(pts) with diabetes mellitus (OM) has been 
indicated. However, mechanisms of SM! in OM have not been fully 
elucidated. Therefore. we investigated plasma ED levels. PT and 
autonomic function in diabetic pts with SM! and diabetic pts with 
painful myocardial ischemia(pMI). We performed exercise treadmill 
testing(ETT) and 24-hour ambulatory ECG monitoring(AECG) on 
34 diabetic pts (age; S9±S years) with coronary anery disease and 
with well reproducible exercise-induced ischemia. Pts were divided 
into 2 groups according to previous thallium imaging and symptoms 
during previous ETT: Group I (G I); 20 pts with SM!. Group 2 
(G2) ; 14 pts with PMI . At rest (R) and right after ETT(EX). 
plasma ED level was determined with RIA and PT was measured 
with electrical skin stimulation testing on the forearm. In the AECG. 
the mean of the standard deviations of all normal sinus RR intervals 
during successive S-minute recording periods over 24 hours (mSD) 
was analyzed as an index of hean rate variability. The results are 
shown below. The other data from ETT were similar in the 2 groups. 
OM with SM! (on OM with PMICG2) 
EO(RlEX) 7.0±2.l /S.3±2.2 S.l±3.S/S.S±2.2 
PT(RlEX) 1.7±O.3 */2.o± 0.4*# 0.9±O.4/1.0±0.3 
mSO 31±S* 47 ±9 
(Mean ±SO, ED; pg/ml, PT; rnA, mSO; msec, *p<O.OOI G 1 vs G2 
#p<o.OS R vs EX) 
Conclusjons; ED is not related to the pathogenesis of SM! in OM. 
Progression of diabetic neuropathy leads to SM! in diabetic patients. 
ABSTRACTS 319A 
930·21 
Absence of a Morning Peek of Ambulatory Ischemia In Diabetic 
Patients is Related to Autonomic Dysfunction 
SergiO Waxman. Stuart Zarich. Roy Freeman. Patricia M. Hegarty. 
Murray Mittleman. Richard W. Nesto. Institute for Prevention of 
Cardiovascular Disease. Cardiovascular Division. Deaconess 
Hospital. Harvard Medical School. Boston. MA 
Conflicting evidence exists regarding the presence of a 
morning peak of myocardial infarction (MI) in patients with 
diabetes (0 pts). To determina tha possible impact of autonomic 
nervous system (ANS) dysfunction on the circadian pattern of MI. 
we studied the relation of ANS dysfunction to timing of transient 
ischemia. a phenomenon known to parallel MI onset. ANS testing. 
and 48-hour ambulatory ST segment monitoring were performed 
in 25 0 pts with stable angina off anti-anginal medications. 
The incidence of ischemia was greater between 6 am and 
noon (46/133 episodes or 35%) compered to other 6-hour periods 
(p < 0.0006) which is similar to the pattern observed in non•
diabetic populations. The 18 0 pts (72%) without significant ANS 
dysfunction (group I) demonstrated a peak incidence of ischemia 
(102 episodes) between 6 am and noon (p < 0.0003). However. 
the 7 patients with significant ANS dysfunction (group III did not 
demonstrate a morning peak (p = 0.6) (see table). 
.,,..---::;:,--,----r- Conclusions: The presence of a 
morning peak of ischemia varies with 
'o+---I ... ...c.:=...:.=;:-l- the degree of ANS dysfunction in 0 
pts. The variation in sympathovagal 
20+---1"'-11--111- balance due to ANS dysfunction may 
oj---II--IIhlI-Il1-- account for the conflicting findings 
regarding the presence of a circadian 
pattern of onset of MI in patients 
with diabetes when not categorized 
by ANS status. 
930·22 
Heart Rate Variability Is Increased in Patients with SUent 
Myocardial Ischemia. 
James Coromilas, Kathleen Burns, Murray Olusman, David K. 
Blood, John Lee, Columbia University, New York, N.Y. 
The mechanisms responsible for painless or silent myocardial 
ischemia remain unknown. It has been proposed that 
increased vagal affereJ1t activity can inhibit cardiac pain. We 
studied 31 patients with scintigraphic and electrocardiographic 
evidence of myocardial isdiemia during exercise testing. 
Eleven of the patients had silent myocardial ischemia (no 
angina during daily life or during the exercise test) and the 
remaining 20 patients were symptomatic. There was no 
difference between the silent and symptomatic patients in the 
presence of prior MI or CABO and the 2 groups did not differ 
m response to thermal, electrical or ischemic arm pain tests. 
We performed both time domain and frequency domain 
analysis of normal R-R intervals from 24 hour Holter 
recordings. We computed the standard deviation about the 
mean of all normal to normal intervals (SDNN), the 
proportion of adjacent normal to normal intervals more than 
50 msec different and the high frequency power (0.15 • 0.40 
Hz) . (HFP). These are all measures of parasympathetic 
actIVity. 
Silent Symptomatic 
SDNN (ms) 175 + 55 
PNN 50 (%~ 14. I"}: 11 
HFP (In ms )5.1.±. 0.8 
123.±. 30 
6.1.±. 6.4 
4.4.±. 0.9 
p < 0.005 
p < 0.05 
P < 0.05 
In summary, patients with silent myocardial ischemia have 
greater heart rate variability and parasympathetic activity than 
patients with symptomatic myocardial ischemia. this supports 
the hypothesis that increased vagal tone may inhibit cardiac 
pain. 
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930·23 
Autonomic Modulation of Heart Rate Before and During 
Transient Myocardial Ischemia in Daily Life 
Junichiro Hayano. Jiang Wei. Seiji Mukai. Christopher O·Conner. 
Robert Waugh. David Frid. Takao Fujinami. James A. Blumenthal. 
Duke University Medical Center. Durham. NC and Nagoya City 
University. Nagoya. Japan 
To examine the relationships of the autonomic changes 
accompanying transient myocardial ischemia (TMI) and the 
presence of symptom. physical activity and severity of TMI. we 
analyzed the changes in heart rate (HR) and in the amplitude of 
low-frequency (LF) and high-frequency (HF) components of heart 
rate variability (HRV) in 91 TMI episodes observed during 3456 hr 
of Holter monitoring in 28 patients with documented coronary 
artery disease. Sixty (11 symptomatic and 49 asymptomatic) 
episodes occurred during physical activity (A-TMI) and 31 (all 
asymptomatic) occurred at rest (R-TMI). The presence of 
symptoms did not affect the changes in the HR or HRV. While A•
TMI episodes were preceded by an increase in the HR and LF-to-HF 
ratio and by a decrease in the HF amplitude from 7-19 minutes 
before the onset of ST·segment change (all p<O.05). R-TMI 
episodes were preceded by only an increase in the LF-to-HF ratio 
from 3 minutes before (p<O.05)' During both A-TMI and R-TMI 
episodes. the HR increased (p<O.01) without corresponding 
changes in the HF amplitude. but the LF-to-HF ratio increased only 
during R-TMI episodes (p<O.01) and it decreased during A-TMI 
(p<O.01). While the HR and LF-to-HF ratio during R-TMI episodes 
correlated with peak ST-segment depression (f = 0.75 and 0.76. 
both p<O.01). no such relationship was observed in A-TMI. These 
results suggest that the changes in the HR and HRV preceding TMI 
could largely result from accompanying physical activity. and the 
changes in HR and HRV during R-TMI episodes are consistent with 
sympathetic excitation and reflect quantitatively the severity of TM!. 
930·24 
Autonomic Cbanges Before and During Nocturnal Iscbemic 
Episodes in Patients witb Extended Coronary Heart Disease. 
Panagiotis E.Vardas, Emmanouil I. Skalidis, Emmanouil N. Simandi•
rakis, Frangiskos I. Panhenakis, Emmanouil G. Manios, George E. 
Kochiadakis. Cardiology Dpt, Heraklion University Hospital, Crete, 
Greece. 
Spectral analysis of Heart Rate Variability (HRV) was used to estimate 
the autonomic nervous system changes before and during nocturnal 
ischemic episodes in a subset of ischemic patients. 
Fifteen patients (10 men, age 55 ± 8) were STUdied. All had three 
vessel disease on coronary angio,no prior myocardial infarction and 
preserved left ventricular function. Twenty-four hour Holter tape record· 
ings of these patients were analysed and 39 consecutive episodes of 
nocturnal ischemia were detected, defined by ST depression > I mm of 
over 4 min duration. After analysis in the Holter analyzer (Marquette 
8000) spectral characteristics of HRV were computed for 2 min intervals: 
five consecutive intervals just before the onset, one at the start and one at 
the end of each episode. Spectral power was measured at low frequencies 
(LF) 0,04 - 0,15 Hz and high frequencies (HF) 0,15 - 0,40 Hz and the 
ratio (R) LF/HF was calculated. The 7 sets of values were compared 
statistically to determine in which interval modulation of autonomic 
nervous system occured. 
Results: 
I 2 3 4 5 Start End 
LF 3.82.!.,.0.2 3,89±O,3 3,97±O,3 4,14±O,3 4.24±O.3 4.JO±O,3 4,22±O,3 
HF 4,13±0.2 3.98±O,2 3,84±O,2 3,64±0.2 3,42±O,3 3,17±Q,2 3,56± 0,1 
R O,93:!,.0.1 O,99± 0,1 1,06±Q,1 1.17±O,1 1,29±O,1 1,33±O,1 1,17±Q,1 
The statistical analysis of the above values revealed significant 
diference (p<0,05) mainly at HF and HF ILF ratio between the initial 
intervals 1,2,3 vs "start" interval. 
Our data suggest that the mechanisms responsible to nocturnal ischemic 
episodes modulate autonomic nervous system, mainly by gradual 
parasympathetic withdrawal. This modulation precedes the EeG 
demonstration of ischemia. 
JACC February 1994:1A-484A 
930·25 
Heart Rate Variability BeCore, During and Arter Episodes oC Silent 
Myocardial Ischemia. 
Jan Brouwer, Mireille JM Portegies, Jaap Haaksma, Louis LM vd 
Ven, Jan W Viersma, Kong I Lie. Department of Cardiology, Univer•
sity Hospital Groningen, The Netherlands 
To study the role of the autonomic nervous system in the occurrence 
of myocardial ischemia we analyzed Heart Rate Variability (HRV) in 
14 patients with stable angina pectoris. Holter monitoring after 1 week 
placebo medication revealed 42 episodes of ST segment depression, 
33 could be analysed. Non-spectral parameters included coefficient of 
variation (CV) and pNN50. Spectral analysis using a Fourier algo•
rithm resulted in low and high frequency components (LF, 0.04-0.15 
Hz and HF, 0.15-0.40 Hz). 
Time HR CV 
(min) (bpm) (%) 
-30 75 7.7 
(before) -IS 77 8.2 
-05 83 9.3 
pNN50 
(%) 
11.8 
9.6 
6.9 
(during) +00 95 
+05 89 
10.3 4.6 
(after) + 15 81 
+30 78 
8.0 5.2 
7.6 7.4 
7.5 7.4 
LF 
(abs.) 
215 
255 
148 
148 
155 
203 
169 
HF 
(abs.) 
63 
55 
36 
28 
32 
45 
41 
LFIHF 
ratio 
3.4 
4.7 
4.1 
5.2 
4.9 
4.5 
4.1 
Before ST -segment depression pNN50, HF and LF decreased signifi•
cantly; HR, CV and LF/HF ratio increased. LF calculated in normal•
ized units increased whereas HF in normalized units decreased. After 
ischemia opposite changes were observed. After 4 weeks treatment 
with bisoprolol 10 mg once daily the occurrence of ischemia decrea•
sed 81 % (p<O.OI), in the remaining 8 episodes similar HRV changes 
were seen, ischemia however occured at higher LF/HF ratio values. 
These results indicate a shift to sympathetic activation with myocardial 
ischemia during daily life and can in part explain the effectivity of 
betablockers in the treatment of myocardial ischemia. 
930·51 
Silent Isc:bemia and Autonomic: Func:tion Early After Myoc:ardial 
Infarction: A Comparison With Stable Angina 
Bradley Marchant, Robert Stevenson, Sudhir Vaishnav, Kulasegararn 
Ranjadayalan, Adam D Timmis. London Chest Hospital, London, UK 
Little is known about the mechanism of silent myocardial ischemia 
after acute myocardial infarction (AMI). This study has evaluated 48h 
Holter recordings and treadmill testing in 75 patients with ischemic ST 
depression on both tests. 40 patients with recent AMI (group A) were 
compared with 35 patients with stable angina (group B). Although ST 
depression occurred at comparable rate-pressure products and 
workloads, it was less commonly associated with angina in group A 
(40% vs 80%, p<0.005). During Holter monitoring, ST depression was 
associated with a smaller increase in heart rate in group A compared 
with group B (3.7 vs 18.2%, p<0.005), suggesting that supply-driven 
ischemia may be more important in group A patients. Ischemia was 
more commonly silent during Holter monitoring in group A, only two 
of whom experienced angina in association with S T depression. 
Measures of HRV (assessed from Holter recordings) were significantly 
reduced in group A compared with group B. However, patients in 
group B with silent exertional ischemia had significantly reduced HRV 
compared with those who experienced angina (high frequency peak 
17±1 vs 25±2 ms, p<0.005; rMSSD 19±2 vs 28±3 ms, p<0.05). In 
group A this difference was not seen. 
In conclusion, myocardial ischemia following AMI is more 
commonly supply-driven and silent than in stable angina. Silent 
ischemia in patients with stable angina may be related to autonomic 
dysfunction affecting the sensory supply to the heart. However, in the 
early post-infarction period, despite clear evidence of autonomic 
dysfunction, other mechanisms must also be important since there was 
no tendency for the reduction in HR V to be exaggerated in those with 
silent ischemia, 
lACC February 1994:1A-484A 
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931·46 
The Huge LV: Long Term Outcome Following Valve Replacement for 
Severe Aortic Regurgitation 
Elizabeth Klodas, Maurice E. Sarano, Charles J. Mullany, James B. Seward, 
A. Jamil Tajik, Mayo Medical Center, Rochester, MN 
Although severe left ventricular (LV) dilatation (diastolic dimension 
(L VD)~) in the setting of chronic isolated aortic regurgitation has 
been proposed as a marker of poor prognosis in medically treated pts, 
long term outcome following valve replacement surgery in this group is 
unknown. Of 146 pts who were operated upon for severe aortic 
regurgitation and who underwent pre and post operative (op) echo 
evaluations between 1980 and 1989, we identified, and examined long 
term outcome in, 23 pts who had a pre op L VD~ (group 1). 
Compared to pts with L VD<8Omm (group 2), group 1 had a lower mean 
ejection fraction (EF) (41±12 vs 52±1l %; p<0.OO5), and larger mean LV 
systolic dimension (L VS) (65±8 vs 46±8mm; p<O.OOO1) pre op. Because we 
observed gradual changes in LV size and function post op, long term 
outcome was analysed only in those pts with echos ~ months following 
surgery (group 1 n=21; group 2 n=99; average follow up 6±3 years). 
Group 1 displayed lower final EF (47±17 vs 54±12%; p<0.01), and larger 
final LVD (61±12 vs 52±7mm; p<o.05). However, only 2 group 1 pts 
experienced symptoms of heart failure post op, leading to 1 death and 1 
heart transplantation 7 and 10 years after initial valve surgery, 
respectively. Using multivariate analysis, reduced post op LV function 
(EF<50) was predicted only by pre op EF (p<O.OOOI), and persitent post op 
LV dilatation (L VD~) was predicted only by pre op LVS (p<O.OO5). Pre 
op L VD did not contribute any additional prognostic information in either 
analysis. Conclusions: 1) Pts with LVD~ who undergo valve 
replacement surgery for severe aortic regurgitation have worse post op LV 
function and more persistent LV dilatation than patients with 
L VD<8Omm; 2) Pre op EF is a significant predictor of post op EF 
irrespective of pre op L VD; 3) Pre op LVS is a significant predictor of post 
op LV dilatation, irrespective of pre op L VD; and 4) The chance of 
symptom free survival following aortic valve replacement surgery in pts 
with initially huge left ventricles is good. 
931·47 
Prognosis cI Aortic Valve Disease in Chidnln. 
'David A. Danford, M.Megan Knox, John P. Cheatham, Ameeta B. Martin, 
John D. Kugler, University of Nebraska Medical Center and Childrens 
HospIta~ Omaha, NE. 
Progression of aortic valve disease (AVO) has been notoriously difficult 
to predict. Our purpose was to analyze elnical (C) and echocardlographic 
(E) features of AVO and correlate them with prognosis. 339 patients (pis) 
with AVO, a C and E evaluation between 1984 and 1992, and >1 year 
follow-up, not referred within 6 months for surgical or catheter treatment 
(RX) of AVO ware identified by chart review. AI entry, C data (age, sex, 
history of coarctation of the aorta, ventricular septal defect, previous AVO 
RX) and E data (peak ascanding aortic flow velocity (\/MAX), and 
semiquantitative severity of aortic insufficiency, left ventricular hypertrophy 
and dilatation) were recorded. Outcome was expressed In years of 
freedom from RX by Kaplan-Meier plot. 
Free 
from 
RX 
~(~~)1:==~~~)::::~~'---~~~)----~ 0.9511 (100) (II) 
0.9 
0.85 
0.8 
0.75 
0.7 p<O.OOl 
o l' ~ 5 
Follow Up (years) 
VMAXs 2.5 
VMAX> 2.5 
(9) 
Pts with VMAX>2.5 meters/second at entry to the study hed a remarkably 
poorer 9 year prognosis than those ~2.5. Higher VMAX cutoffs within the 
VMAX>2.5 group did not further stratify outcome (p>O.05). No C data, 
Including the age subdivisions of infant and prateen, and no other E data 
at entry correlated significantly with outcome . AVO in children enjoys the 
reputation of frequent, unpredictable, and important progression, but this 
Is daserved only when VMAX>2.5. A large subgroup of children with AVO 
Is Identified with low VMAX and good outlook. While not a direct measure 
of valve area, VMAX, if carefully measured with sound E technique, may 
stratify risk for Mure need of RX in children with AVO. 
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931·48 
Calculation of Pressure Overestimation Due to Subvalvular 
Acceleration and Pressure Recovery in Mild Aortic Stenosis: A 
Computer Simulation 
Joel A. Strom, Jay Meisner, Nelson P. Daboin, Ernest S. 
Monrad, Albert Einstein College of Medicine, Bronx, NY 
The simplified Bernoulli equation overestimates the aortic valve 
pressure gradient (41') compared to cardiac catheterization 
measurements in patients with mild aortic stenosis or prosthetic valves, 
because it fails to account for the subaortic velocity and pressure 
recovery. 41' not only depends on the valve area (AVA) and 
transaortic velocity (Y), but also on the geometry of the LV outflow 
tract (LVOT) and aona (Ao). Failure to account for the effects ofthe 
last two factors can cause overestimation of 41'. To detennine the 
effect of these factors on peak valvular 41', a computer model was 
constructed to provide a more complete idealized estimation of peak 
41' using the Bernoulli and Clark equations: 
41' = (py2/2){[l-(AVNIA'Lvar)]+(2*AVNA...,)[(AVNA...,)-1]} 
where A..vOT and A..., are the areas of LVOT and Ao respectively. 41' 
calculated by the fonnula was compared to that calculated by the 
Bernoulli, the simplified Bernoulli, and Borda equations. L VOT 
diameter varied from 1.6 to 2.6 em, AVA from 0.4 to 1.8 em', Ao 
diameter from 3.0 to 6.0 em, and V from 3.0 to 6.0 m/sec. The 
simplified Bernoulli equation overestimated 41' from 4% to over 100%: 
To detennine when the simplified Bernoulli equation could be 
employed, an empiric index (Ix) was devised: 
Ix = (AVA'/(ALvOT*A...,>1112 
was devised Ix :!O 0.10 predicted an error in 41' :!O 20% when the 
simplified Bernoulli equation for 41' was used compared to the more 
complete equation. We conclude: (1) 41' overestimation is due to both 
subvalvular acceleration and suupravalvular pressure recovery. (2) Ix :!O 
0.10 predicts that 41' calculated by the simplified Bernoulli equation 
will be accurate for clinical use. 
931·49 
Nifedipine Reduces and/or Delays Need for Valve Replacement 
in Asymptomatic Patients With Severe Aortic Regurgitation. 
Roldano Scognamiglio,* Shahbudin Rahimtoola, Giuseppe Fasoli, 
Stefano Nistri, Nicoletta Frigato, and Sergio Dalla-Volta 
Dpmt of Cardiology, Padua University ,Padua, Italy, and*Griffith 
Center and Division of Cardiology,University of Southern Califor•
nia, Los Angeles, CA. 
Vasodilator therapy with nifedi'pine reduces left ventricular volu•
mes and mass and increases ejection fraction in asymptomatic 
patients with severe aortic regurgitation. 
To assess whether vasodilator therapy reduces and/or delays the 
need for valve replacement, 143 asymptomatic patients with isola•
ted severe aortic regurgitation and nonnalleft ventricular systolic 
pump function were randomized to nifedipine 20 mg twice daily 
(n=69) or to digoxin 0,25 mg daily (II= 74). 
By actuarial analysis, at 6 years 34±6% of patients in the digoxin 
group underwent valve replacement vs 15±3% of those in the nife•
dipine group, p<o.OOO1. In the digoxin group, valve replacement 
(20 patients) was perfonned because ofleft ventricular dysfunction 
in 75%, left ventricular dysfunction plus symptoms in 10%, and 
symptoms in 15%. In the nifedipine group all 6 patients underwent 
valve replacement because of development of left ventricular dy· 
sfunction. After aortic valve replacement, 75% of patients in the 
digoxin group with abnonnal pre.operative left ventricular ejection 
fraction had a nonnal ejection fraction post-operatively and all 6 pa•
tients (100%) in the nifedipine group had a nonnal ejection fraction 
post-operatively. 
These data suggest that long-tenn vasodilator therapy with nifedi•
pine reduces and/or delays the need for aortic valve replacement in 
asymptomatic patients with severe aortic regurgitation and nonnal 
left ventricular systolic pump function. 
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931-50 
Conservative Medical Treatment can be Appropriate in the Managl!lllent of 
Perivalvular Abscess: Diganosis and Followup by TJ'IIJISeSOphageal 
Echocardiography 
Kwan L. Chan, Randall A. Sochowski, University of Ottawa Heart Institute, 
Ottawa, Canada 
Peri valvular abscess (ABS) is a serious complication in endocarditis, and is 
usually considered an indicatioo for early surgery. To assess the impact of 
treatment in this clinical setting, the clinical course of 28 patienls (Pis) with ABS 
diagnosed by lransesophageal echocardiography (TEE) was analyzed. Both native 
and prosthetic valves were represeoted. Aortic valves (A) were more prevalent 
than mitral valves (M) (p<O.OOI). 
ABS A M B2l!! Early Surgery 
Native valve (n= 11) 7 3 I 9 
Prosthetic valve (0 = 17) 17 0 0 8 
The infecting organisms were identified in 26 pIS (streptococci in 7, staph aureus 
in 13, and staph epidermidis in 6), and were similarly represeoled in those with 
and without early surgery. Early surgery was not performed in 11 pis (high 
surgical risk in 9, pt refusal in 2). Followup of these 11 pis by TEE showed that 
peri valvular complications such as diverticulum, fistula, or perivalvular leak were 
present in all. Late surgery was performed in 5 pis (4 for increasing valvular 
incompetence and I for expansion of aortic diverticulum). In the 17 pIS with 
early surgery, 10 had perivalvular complications and repeat surgery was necessary 
in 3 pts for prosthetic incompetence. Death occurred in 3 pis who had early 
surgery and 2 pts in the medical group (p=ns). 
In conclusion, in pts with endocarditis ABS predicts a poor prognosis even 
when early valve surgery is performed. Development of perivalvular 
complications and regurgitation are common regardless of the type of 
management. These data suggest that conservative medical treatment can be 
appropriate in some of these pIS. 
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932-69 
Long Term Efficacy and Safety of Electrophysiologic Guided Sotalol 
Therapy for Life Threatening Ventricular Arrhythmias. Randall J Lee, 
Mary Wong, Andreana Sui, Marilynn Wong, Harlan R Grogin, Adam P 
Fitzpatrick, Laurence M Epstein, Melvin M Scheinman, Michael D 
Lesh. University of California, CVRI, San Francisco, CA 
A total of 177 patients with ventricular arrhythmias was initially 
treated with sotaloI. Forty four patients were excluded from the study 
because of nonreproducibility of EP study( 33 patients), serious side 
effects (6 patients with Torsade de pointes, 2 patients with CHF) and 
arrhythmia recurrences (5 patients). A total of 133 patients with 
reproducibly induced baseline VT was studied before and after oral . 
sotalol (481 ± 125 mg/day). The group consisted of patients with 
coranary artery disease (95 patients), cardiomyopathy (30 patients), 
and normal hearts (8 patients) with a mean ejectin fraction of 41 +11 % 
and mean age of 62 ± 13 years. The mean number of ineffective 
antiarrhythmic drugs was 4.0 + 1.2 drugs per patient (range 1-9). 
Programmed electrical stimulation consisted of three extrastimuli at 
two different drive cycle lengths at two ventricular sites. 
Results: Fifty two patients were found to be noninducible after sotalol, 
and were followed for a mean of 36 months (range 1-103 months). 35 of 
52 patients were treated successfully. There were two recurrences of 
tachycardia and 4 patients died suddenly (3 deaths were in the first 
month of therapy). The actuarial incidence of complete sotalol 
efficacy ( assessed on the basis of sudden death, VT recurrences, syncope 
or discontinuation of sotalol due to side effects) was 78% at 6 months, 
76% at 1 year, 72% at 2 years and 52% at 5 years. Side effects were 
severe enough to warrent withdrawal of sotalol in 7 patients (11 %) 
including severe bradycardia requiring permanent pacemaker in 4 
patients (7%) and severe CHF in 2 patients. 
Conclusion: Use of chronic sotalol therapy based on a rigorous EP 
protocol showed that over a mean of 3 years follow-up recurrent 
symptomatic VT was 3.8 % but the incidence of sudden death (7.4%) 
continues to be worrisome. Over half the patients are well controlled 
without side effects after 5 years. 
JACC February 1994:1A-484A 
932-70 
Changing In Autonomic Innuence on The Heart Immediately Before The 
Onset of Spontaneous Idiopathic Ventricular Tachycardia 
Lii Fe~ Deborah J Statters, Alistair K Slade, Marek Malik, A John Camm. 
Department of Cardiological Sciences, St George's Hospital Medical Schoo~ 
London, England 
Background: It has been shown that heart rate variability (HRV) is depressed 
in many clinical settings and that decreased HRV may be associated with a 
propensity to electrical instability and ventricular tachyarrhythmias. The 
present study aims to assess HRV immediately before the onset of episodes of 
spontaneous ventricular tachycardia (VT). 
Methods: Twenty three patients with symptomatic idiopathic VT underwent 2 
channel 24 hour Holter monitoring in a drug free state. Spectral HRV was 
computed as low (LF, 0.04 - 0.15 Hz) and high (HF, 0.15 - 0.40 Hz) frequency 
components at 2 minute intervals over up to a one hour period immediately 
prior to the onset of VT and over the total 24 hour recordings. LF /HF ratio 
was calculated as an index of the autonomic balance of the heart. 
Results: Sixty nine episodes of VT were recorded in 23 patients. There were 
no significant differences in tbe LF and HF for the hour immediately prior to 
the onset of VT compared with the averaged values for the 24 hour period. 
However, the LF /HF ratio was significantly higher prior to the onset of VT 
than for the whole 24 hours (LF24/HF24): 
.... -:I~_""_F_"_"" ___ '_Q_LF_a4t\lH __ F_ ..... _. :.[m_ .. _n_"_B.;::~:...... __ ~ 
o • 10 15 20 U sa sa 40 
TIrrW ~ VT 0....- [min) 
Conclusions: Abnormal autonomic influence on the heart preceding the onset 
of episodes of idiopathic VT may play an important role in the genesis of the 
arrhythmias. 
932-71 
Efficacy of Amiodarone in Patients With 
Ventricular Tachycardia and Chronic Chagasic 
Cardiomyopathy. 
*Angelo A. V. de Paola, J. Anthony Gomes, Igor 
A. Souza, Antonio C. Vattimo, Ney Guiguer Jr, 
Eulogio E. Martinez Fo. Paulista Medical School 
Sao Paulo-Brazil and Mount Sinai Medical Center 
NY, NY. 
The role of Holter Monitoring (HM) relati•
ve to Electrophysiological testing (EP) has not 
be established to assess amiodarone (AM)effica•
cy in patients (pt) with chronic chagasic car•
diomyopathy (CCC) and ventricular tachycardia 
(VT). To study this, 60 pt with CCC and VT un•
derwent clinical and laboratory evaluation in•
cluding left ventricular angiography, HM and EP 
using up 3 extraestimuli in the apex and right 
ventricular outflow tract. Clinical sustained 
VT (VT-S) was present in 36 pt and 24 pt had 
nonsustained VT (NSVT). Mean age was 52 + 10 yr 
and mean ejection fraction was 0.34. AM acute 
loading was 19 po/day for 10 days and 400-600 
mg/day thereafter. Mean follow-up was 26 + 19 
months. Clinical events (CE) defined as vr-s 
recurrence, sudden cardiac death or syncope 
were present in 19/60 (32%) pt. RESULTS: 
!- Efficacy* CE Innefficacy CE 
HM 60 31/60 (52%) 7 (12%) 29/60 (48%) ~l~2~(2~0~%~) 
EP 39 7/39 (18%) 4 (10%) 32/39 (82%) 10(26%) 
P 0.05. *HM: 75% VPB + 100% VT suppression 
EP: VT-S no more inducible after AM 
Conclusions: 1) In pt with CCC and VT efficacy 
of AM was achieved in 52% by HM and in 18% by 
EP criteria. 2) During AM therapy, clinical ef•
ficacy could not be predicted by either method. 
JACC February 1994:1A-484A 
932·72 
Effect of Sotalol on the Circadian Variation of Heart 
Rate and QTc Interval 
Param P. Sharma, Jonnalagedda S.M. Sarma, K. 
Venkataraman, Bramah N. Singh. Wadsworth VA & City of 
Hope Medical Centers, Los Angeles, CA 
We previously showed that chronic amiodarone 
treatment results in the abolition of circadian 
rhythmicity (CR) of QTc, with no effect on CR of 
heart rate (HR). The effect of 
~Eii sotalol on CR of QT and HR has not 
i been reported. Holters from 19 pts 
~ were analyzed before and after 3-7 ~ I~~I days of sotalol treatment. RR and QT 
~ I, intervals were measured by a signal 
: .. 'iI..wJJ," 'I _ ':n:ry processing system. Normalized QT 
o • 12 18 ~ (QTc) intervals were obtained by an 
625 r-----, exponential formula. ANOVA with 
repeated measures was used to test if 
a significant CR exists. 
Z Results (see figures): The HR was 
~ reduced (P<O.OOl) and QTc was 
& prolonged (P<O.OOl) after sotalol. In 
375 contrast to our previous data On 
o ~R1~ ~y ~ amiodarone, the CR of HR was 
abolished after sotalol (p=O.35), but 
the CR of QTc was maintained (p<O.OOl). Conclusions: 
The effects of sotalol on CR of QTc and HR are 
dissociated. They are reverse of that reported for 
amiodarone, and may account for the differences in 
the anti- and pro-arrhythmic effects of these two 
drugs. 
932·73 
Benign Long Term Prognosis of Frequent and Complex Ventricular 
Arrhythmias in Apparently Healthy Subjects, but Evidence over Time of 
Silent Underlying Cardiac Diseases. 
• Franco Naccarella. Massimo Palmieri, Alberto Accorsi, Gaetano BaIbato, 
Ugo De Castro, Pier Camillo Pavesi. Daniele Bracchetti. 
Cardiology Department, Maggiore Hospital, Bologna. Italy. 
To determine Ihe long term prognosis and Ihe clinical outcome. we prospec•
tively analyzed a group of 171 subjects with frequent and complex ventricular 
anbythmias (CV A), defined as > 100 EVBs/hour, frequently repetitive and po•
Iimorphic, wilhout demonstrable heart disease (lID), as assessed by clinical 
and non-invasive evaluations (B echo, treadmill test or myocardial scinti•
graphy), and blood tests. SUbjects have been divided in two groups, accCl'ding 
to age. < 39 years (GROUP A) and > 40 years (GROUP B). They have been 
prospectively followed fa' a mean of 10 ± 4 years. No cardiac and sudden car•
diac dealbs were observed in bolh groups. NSVT or VT were present in 2.6% 
and 5.2% at control, and in 5.3% and 7.2% during follow up, respectively in 
group A and B. Similarly in bolh groups 40n5 (53%) and 52J96 (S4%) develo•
ped various cardiac diseases, such as diffuse primary LV 0 RV cardiomyo•
pathies (DCM), minor heart disease (MHD). or ischemic heart disease (llID), 
or hypertensive cardiomyopathy (HC) with a different prevalence in Ihe two 
groups. • P < 0.05 to left. 
DCM 
MHD 
IHD 
HC 
all subjects 
GROUP A 
12(15 (16%) 
25{15 (33%) 
0{15 (0%) 
3{15 (4%) 
4O{15 (53%) 
GROUPB 
12196 (12.5%) • 
5/96 ( 5.2%) • 
19/96 (19.7%) • 
16/96 (16.6%) • 
52/96 (54.0%) 
In conclusion, frequent and complex ventricular anbythmias in apparently 
healthy subjects have a benign prognosis. Conversely, a large group of these 
subjects develops, over time, signs of different cardiac diseases not recognised, 
with a similar non invasive approach, in the control evaluation. Localized or 
diffuse cardiomyopalhyc evolutive aspects of !he right or the left ventricle or 
bolh are more common in Ihe youngest group, while IHD and HC are more 
frequently observed in Ihe oldest group. 
ABSTRACTS 
932·74 
Should Children Witb Ventricular Ectopic Rbythm and a Normal Heart Have 
an Endomyocardial Biopsy? 
·Sesbadri Balaji, Henry B. Wiles, Mary Ann Sens, Paul C. Gillette for the South 
Carolina Children's Heart Center, Medical University of South Carolina, 
Cbarleston, SC. 
The value of endomyocardial biopsy (EMB) in patients wirh ventricular ectopic 
rhythm (VER) and a strucruraJly normal beart lies in its in., act on therapy. To 
ascenain Ibis, we reviewed 69 cbildren with VER [defined as ventricular ectopics 
(VE) not suppressed by exercise or ventricular tachycardia (VT)) wbo underwent 
EMB between October 1987 and March 1993. Of them, 10 (aged 5-14.8, media~ 
II) had myocarditislborderline myocarditis on hiopsy. StrucruraJ bear! disea! 
was excluded by ecbocardiograpby, cardiac catheterization, and right ventricular 
angiography. 
Of Ihe 10 patients, 8 were treated with steroids (prednisone 2 mglkg/day) for 2 
weeks followed by tapering. Total resolution of VER was seen in 4, improvement 
in 2 and no effect in 2. At follow-up (8-39 months, mean 22), VER did not recur 
in Ihe 4 wilh resolution, and Ihe 2 with no effect were unchanged. VER recurred 
in Ihe 2 wbo showed improvement. Both received azathioprine for 3 & 6 months 
with further improvement, and bave only infrequent YEs on Holter EeG. 
Follow-up EMBs done in 5 patients sbowed resolving myocarditis in 4 and 
borderline myocarditis in I. All those wbo responded (resolved/improved) to 
steroids (n = 6) were symptomatic at presentation while the non responders 
(n=2) were asymptomatic, p<0.05, Fisher's exact test. 
Conclusions: Treatment of EMB proven myocarditislborderlioe myocarditis wilh 
steroids does benefit a significant proportion of cbildren wilh VER and no 
structural bean disease. We therefore recommend a routine EMB in Ibis 
subgroup of patients. 
932·75 
323A 
Ventricular Pacing.Induced Ventricular Tachycardia in Patients 
with Implantable Cardioverter·Defibrillators 
Marc Roelke, Sean S. O'Nunain, Stefan Osswald, Hasan Garan, 
J. Warren Harthome Jeremy N.Ruskin" Massachusetts General 
Hospital, Boston, MA. 
In patients with pacemakers, ventricular tachycardia (VT) may 
develop spontaneously, from competitive pacing, or, rarely, from 
pacemaker malfunction. It is unclear whether noncompetitive pacing 
(appropriate pacing following the programmed escape interval) ever 
plays a role in VT initiation. Implantable cardiovener-defibrillators 
(lCDs) capable of VVI pacing and of storing intracardiac ventricular 
electrograms during arrhythmias provide an opponunity to study the 
occurrence of pacing-induced VT. 
We reviewed 302 stored episodes of ventricular tachycardia in 93 
consecutive patients with the Ventritex Cadence® ICD,programmed to 
store 30 sec of electrograms during an arrhythmic event Five patients 
demonstrated 25 events (1-16/patient) where VT was triggered by a 
noncompetitively and appropriately paced ventricular beat terminating 
a long escape interval (1500 ms). Neither competitive pacing due to 
ventricular undersensing nor lCD malfunction was observed. All 5 
patients had underlying coronary artery disease with previous clinical 
and inducible ventricular arrhythmias. Programmed pacing parameters 
were: VVI @ 4O/min, output 5V, 0.5ms. Anti-taChycardia pacing 
(A 1P) tenninated the pacing-inducedVT in 22 events and in one 
episode ATP accelerated VT, requiring cardioversion. In 2 cases shock 
therapy was aOOned for nonsustained VT. 
We conclude that in patients with ICDs and clinical ventricular 
arrhythmias 1) VVI pacing may induce VT, 2) such VT can occur 
during appropriate ventricular pacing and a long ventricular escape 
interval may playa role in its initiation, and 3) although A 1P or CV ID 
successfully tenninates the tachycardia, such VT may pose a manage•
ment problem due to the deliverance of excessive ICD therapies. 
324A ABSTRACfS 
932·76 
Proarrhythmla or a Class Ic Antiarrhythmic Drug Suppressed by 
Combination With a Potassium Cbannel Blocking Drug In the Dog Late After 
Infarction 
Henry J. Duff, Margaret Stemler, Tom Thannhauser, Sylvie Laganiere, Elaine 
Rude, and Wanda Lester, University of Calgary, Calgary, AB, Canada 
Encainidc treatment is associated witb increased risk of sudden deatb in 
patients fonowing myocardial infarction. This increased risk may relate to 
drug-induced sustained monomorphic ventricular tachycardia (sust VI). The 
purpose of tbis study was to develop a model of aass Ie-induced sust vr and 
to develop treatments to oppose tbis prodysrhytbmia. We studied dogs late 
following infarction which had time-dependent loss of ability to induce sust 
vr in the drug-free state. These dogs then received a series of three 
infusions of O-demethyl encainide (ODME) achieving ooncentrations of 
6O±31, 136±46 and 339±171 ng/mL The end point of tbis study was 
oonversion of the results of programmed stimulation from noninducible to 
inducible sust vr. When ODME infusion allowed induction of sust vr, 
BaCI, infusions were added. BaCI, at ooncentrations of 10-100 11M selectively 
blocks IR' without effect on resting potential or oonduction velocity. 
RESULTS: Of the 10 dogs studied, 9 had monomorphic sust vr induced 
during an ODME treatment. The electrophysiologic oorrelates of the 
prodysrhythmic sust vr was prolongation of oonduction velocity in the peri•
infarct zone. All 9 animals with inducible sust vr on ODME subsequently 
received Baa, infusions. During this oombination therapy, an 9 became 
noninducible. The electrophysiologic correlates of suppression of this 
prodysrhythmia was homogeneous prolongation of refractoriness in the peri•
infarct zone. In conclusion, prolongation of oonduction velocity without 
prolongation in refractoriness was associated with monosust vr while 
prolonged refractoriness reversed ODME-induced prodysrhythmia. 
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933·86 
Acute Hemodynamic Assessment Falls to Identify Hypertrophic 
Cardiomyopathy Patients Responsive to DOD Pacing 
Jay N. Gross, Uri M. Ben-Zur, Mark A. Greenberg, Mark A Menegus, 
Sheldon Breitbart, Richard Charney, and Seymour Furman. Montefiore 
Medical Center, Bronx, NY 
Recent reports suggest DDD pacing is effective in treating hypertrophic 
obstructive cardiomyopathy [HOCM!. Seven HOCM pts with previously 
documented resting gradients and refractory symptoms underwent left heart 
catheterization to assess hemodynamics during NSR, VVI pacing, and atrial 
synchronous ventricular pacing [VDD) (at various A V delays). Pt #3 was 
studied twice; Pt #4 was studied off/on isoproterenol. 
~ 
SR VDD 
PT OG BP OG BP 
1 60 120/60 25 115/60 
2 10 110/69 o 110/SO 
3a 23 110/60 24 110/60 
3b 70 90/60 55 95/55 
4 0 170/60 
4(ls) 40 130/50 35 140/50 
5 40 110/60 34 100/60 
6 No gradient even with isoproterenol 
7 No resting gradient 
OG 
65 
18 
72 
60 
o 
35 
50 
VVJ 
BP 
55/40 
112/68 
42/24 
70/48 
110/50 
90/45 
60/45 
SR = sinus rhythm; VDD = VDD pacing at optimal AV delay; OG = LV 
outflow gradient; BP = femoral arterial blood pressure; Is = Isoproterenol 
All pts had post-PVC gradients at the time of study. In the 4 pts. with 
concomitant right heart catheterization, no significant differences in cardiac 
output or pulmonary pressures were seen when SR and VDD were compared. 
Conclusions: 1) In typical HOCM patients, hemodynamic improvement with 
acute VDD pacing is not routinely demonstrated; 2) Spontaneous lability of 
gradients complicates interpretation of pacing effects; 3) VVI pacing is highly 
deleterious in these pts and VDD pacing at short A V delays may have similar 
effects; 4) Efficacy of chronic DDD pacing in this population is unknown. 
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933·87 
The IrAJence rI SIalic MIII1*iC FIIIIds rI 1.5 Tasla on ImpIartabIe 
Ca'CIac Pacanakars InI ConipoIIIIfD. 
A1exander von Smekal, Stephan Wolke, Klaus C. SeeIos, Jo Hennans, 
Peter David, Maximilian Reiser, Departments rI Radiology, University rI 
Munich and Nuclear Physics, University rI Bonn, Germany 
Also patients with implantable cardiac pacemakers (PM) are restricted for 
Magnetic Resonance (MR) studies, tests reported a paItly tolerance rI 
this diagnostic method with some used aggregates. The goal rI this 
study was to verily the inIluence rI extended exposure to stalk: magnetic 
fields on reed-swltches, telemetric colis and possible changes in softwere 
progranvning. 
Thirty reed-swlches, five «Mer.. telemetric colis, and ten Isolated 
cardiac pacemakers (aD materials Medtronlc Inc.) were exposed for 12 
hours to a 1.5 Tesla en Philips Gyroscan ACS system. Reeck:ontacts 
were measured on an experimental setup including a 0.35 T permanent 
magnet regarding their response thresholds and hysteresis before and 
after exposure to the static magnetic field. Also the inductivity ([LJ=mH) 
of the coils was measured before and after exposure. Various PM in 
different modes were programmed and telemetry was perfonned before 
and after. 
The isolated reed-switches showed no significant change in response 
thresholds or hysteresis (Tab. 1). Also, the Inductivlty of the telemetric 
coils showed no significant changes. All tested pacemakers had no 
malfunction or any deteetable change In preprogrammed softwere. 
Tab. 1 
Reed-awttches before and after exposure to 1.5 T CMII' 12h. 
before after 
Switch on 18.7 mT (3.4 mT) 16.9 mT (3.3 mT) 
Swnch 0/1 12.4 mT (3.1 mT) 13.2 mT (3.0 mT) 
(Mean thresholds 01 reed-8wilches In mT with standard deviation). 
Static magnetic fields with field strength up to 1.5 T produces no 
significant changes In the tested PM components and software. After MR 
studies, malfunction or defects caused by the static magnetic field on PM 
aggregates and the tested components seem unlikely. 
933·88 
Pacemaker Behaviour During Radiofrequency Current DeUveI)' 
Dietrich Pfeiffer, Jiirgen Tebbenjohanns, Burghard Schumacher, 
Werner Jung, Matthias Manz, Berndt Liideritz. 
Department of Cardiology, University of Bonn. Germany 
Selected patients (pts) with pacemakers (PM) are treated with 
radiofrequency current (RFC) for A V nodal or tachycardia 
ablation. The reaction of the devices on RFC differs widely. 
Methods: We treated 17 pts with atrial fibrillation (n=l1),pre· 
excitation syndrome (n = 2) or A V nodal reentrant tachycardia 
(n=4), who had antitachycardia (n=6) or anttbradycardia 
(n=l1) PM using RFC ablation. 
Results: During RFC ablation 2/6 antitachycardia PM started 
with pacing: 1 of them in antitachycardia stimulation mode, 1 in 
magnet mode, all of them with repeated trains during RFC 
delivery. 8/11 antibradycardia PM started pacing in program· 
med or magnet cycle length. Two otherwise intact PM had an 
exit block during RFC whereas stimulation before and immedia· 
tely after RFC delivery was nonnally. These phenomena were 
reproducible during all RFC deliveries in each of the PM with 
or without occuring junctional tachyarrhythmias. An immediate 
reduction of the amplitude of the stimulus artifact was observed, 
which resulted in prolonged failure of capture up to 84 s after 
RFC. No software failure in the PM was observed. 
Conclusions: (1) RFC ablation is feasible in pts with PM with 
caution. (2) Uncontrolled pacing exit block or failure of capture 
during RFC ablation occurs frequently. (3.) Therefore PM have 
to be deactivated during the procedure to avoid induction of ar· 
rhythmias by PM and a ventricular stimulation catheter should 
be in place. (4) The manufacturers should provide informations 
about the reaction of their devices on RFC. 
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933·118 
Outpatient Electrophysiologiesl Assessment 
or Sinoatrial and Atrioventricular Nodal Function is 
Reproducible 
David Newman. Stephen LaHaye. Paul Dorian. Richard Sheahan. 
David Darling. Shirley Wilkie 
St Michael's Hospital. University of Toronto CANADA 
We hypothesized that variations in the serial assessment by 
programmed stimulation of sinoatrial (SAN) and atrioventricular 
(A VN) nodal function can be minimized if studies are performed 
non-invasively. Ten patients (3 with only A VN disease. 2 each on 
~ blocker and amiodarone) with permanent pacemakers and intrinsic 
heart rates ~50 bpm underwent low current (IOms. 0.4±.5 rnA) chest 
wall stimulation while their device was programmed to an atrial 
triggered mode. Measurements were obtained for: A VN block cycle 
length (A VNBCL). A VN effective refractory period (A VNERP) after 
an 8 beat conditioning drive at 800 ms and 600 ms. and the absolute 
and rate corrected (C) SAN recovery time (SNRT) after 30s pacing at 
800 or 600 ms. All studies were repeated 2 weeks apart (TI and T2) 
mean±SE(ms) r2 p 
4lrl-T2j T1 vsT2 
SNRT800 145±45 0.63 :;:;0.01 
CSNRT800 l00±34 0.50 :;:;0.03 
SNRT600 1 64±49 0.50 :;:;0.07 
CSNRT600 227±72 0.19 :;:;0.32 
A VNBCL 60±52 0.98 g)'OOI 
AVNERP800 27±11 0.55 0.12 
AVNERP600 6±3 0.99 :;:;0.001 
A VN function curves did not significantly differ between T1 vs T2 
at either conditioning drive train. 
CONCLUSIONS: Serial noninvasive electtophysiologica1 measures 
of A VN and SAN function are largely reproducible over 2 weeks. 
Serial outpatient evaluations can be performed using tht:se methods 
and data. 
933-119 
Effect of Lack of CenSOring on estimate. of Pacemaker longevity. 
James W. LeHch, Ketth Dear, Peter Curteis. John Hunter HospHal and 
Newcastle Universtty, Newcastle, Australia. 
Some pacemaker (PPM) companies adjust generator survival curves for 
expected patient mortality whereas others do not. We investigated the ellect 
of Ignoring patient mortality and other causes of censoring on estimates of 
device longevity using data from Implants of the Reflex 8220 VVI device. 
We Implanted this PPM In 79 pts wtth a mean followup of 17±9 months 
(total followup 105 years). There were 13 device failures (foss of output) 
with a median lime to failure of 2.8 years. The time to failure closely 
followed a Weibull distribution with coefficients of 0.325 and 3.43. Expected 
pt mortality was high since VVI unHs were reserved for elderly Infirm pts 
with limited life expectancy. Twenty·two pts died (none from PPM failure) 
with <50% pt survival after 3 years. The effect of ignoring this extenSive 
censoring is shown in the figure below. When pt mortality was accounted 
•• 
0.' ~ ., 
"'" .. E ., 
u .. 
I). 
... 
00 
Months 
.. " 
for by censoring 
the data at the 
time of death, 
30 month PPM 
survival was 
54% (lower 
line). When pt 
mortality was 
ignored. PPM 
survival was 
e r ro n e 0 u sly 
estimated at 
78%, p<0.05 
(upper line). 
Modelling the data demonstrated substantial effects from ignoring censoring 
when the ralio of median failure lime to median censoring time exceeded 
0.2. These data demonstrate that failure to account for censoring may 
substantially bias estimates of device longevity, particularly when patient 
mortality is high. 
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933·120 
Neuropeptlde Secretion in Patients with Bradycardia 
••• Effect of Heart Rate Adjustment by Pacemaker 
"'Tohru Ogata, Toshihiro Ryu, Kazuyo Yoshida, Shinji Eguchi. 
Moronari matsunaga, Shinsuke Tsuji, Takashi Tokushima, 
Toshinori Utsunomiya. Shuzo Matsuo Cardiology Division. 
Opt. lnt. Med.. Saga Medical School. Saga, Japan 
Neuropeptides are high in congestive heart failure or cardiac 
dysfunction. However. little data is available on neuropeptides 
Becretion in bradycardia. We evaluated in patients with brady•
cardia before and after pacemaker implantation. 
~ Twelve patients with bradycardia. Six had complete 
atrioventricular block and six had sick sinus syndrome. Three 
men and nine women. Age ranged from 54 to 87 years. 
M..tlb..w1.;, 1) Following neuropeptides were measured before 
and after pacemaker implantation; epinephrine (EP). Norepi•
nephrine (NE), Plasma Renin Activity (PRA). Antidiuretic 
hormone (ADH). Atrial natriuretic peptide (ANP). 2) Echocar•
diography, chest X-ray and Holter 24 hours electrocardiogram 
were recorded before and after pacemaker implantation. 
3) Changes of serum neuropeptides level before and after 
pacemaker implantation were evaluated. 
Rll.ul1.:. 1) Twenty-four hours total heart beats increased from 
64500 to 91200, on average. 2) PRA was higher by 62%, ADH by 
69% and ANP by 33% in bradycardia than in nomal heart rate. 
These changes were seen in both atrioventricular block and 
sick sinus syndrome pts. 3) ANP and ADH had no significant 
correlation with 24 hours total heart beats at before and after 
pacemaker implantation. 4) However. ANP and ADH reversely 
correlated with cardiac output (r= -0.71 and -0.78, p< 0.1). 
Cope I usioo' 1) Neuropeptides secretion were increased in 
patients with bradycardia. 2) ANP and ADH level reversely 
correlated with cardiac output. Low cardiac output may 
induce neuropeptides secretion in patients with bradycardia. 
3) ANP and ADH may decreased by improvement of low cardiac 
output after heart rate adj ustment. 
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934-44 
Cardiac Blood Volume and Geometry Innuence Upper LImit of 
Vulnerability and Its Relationship to Defibrillation Threshold 
Salim F. ldriss, Mark P. Anstadt. George L. Anstadt. James E. Lowe, 
Raymond E. ldeker. Duke University Medical Center. Durham. NC 
The upper limit of vulnerability (UL V) hypothesiS for defibrillation 
predicts that the UL V will exceed the defibrillation threshold (OFT), but 
many have reponed the UL V equal to or lower than the OFT. A change in 
cardiac blood volume and geometry between paced rhythm and VF may 
cause this inconsistency. We tested the hypothesiS that if these factors 
were held constant between rhythms, the UL V would exceed the OFT. 1n 
each of 12 open-chest pigs with an LV -apex patch/SVC catheter electrode 
configuration, 3 ULVs and 3 DFTs were determined with the heart normal 
(HN) and compressed (H C). An Anstadt cup mechanical cardiac assist 
device positioned over both ventricles r-----------, 
was used to perform reproducible bi•
ventricular compression. UL Vs were_ 
determined by scanning the T -wave in ::! 
IOms intervals with shocks after 30 ~ 
paced beats. DFTs were determined ! 
using an up/down protoCOl with shocks 
delivered lOs after the induction of VF I 
with a 60Hz stimulus. All shocks were F 
6/6ms single-capacitor biphasic 
waveforms. TIle bar graph shows the 
UL V and OFT in terms of total 1.-________ --' 
delivered energy for each hean state for 
all animals combined. Both the UL V and the OFT were decreased (p<.02, 
paired analysis) for HC vs HN (ULV: 61±73V. 2.4±2.6J decrease; OFT: 
108±76V, 3.9±2.5J decrease). For HC. the ULV was significantly higher 
than the OFT (p<.05, paired analysis; voltage. current, total energy). For 
HN, there was no significant difference between the UL V and the OFT. 
Conclusions: Cardiac compression during paced rhythm and VF moves 
the UL V higher than the OFT and causes a significant decrease in both. 
These results suppon the UL V hypothesis for defibrillation. Additionally, 
the results suggest that differences in cardiac geometry and/or blood 
volume between paced rhythm and VF can influence the ULV, the OFT, 
and the relationship between them. 
326A ABSTRACTS 
934·45 
Interaction Between Erythromycin and Disopyramide on 
Ventricular Repolarization in Dogs with Chronic 
Atrioventricular Block 
Ichiro Waranabe, Toshiaki Kojima, Akihiro Kanda, Xinchun Yang, Satoshi 
Kunimoto, Kazuhiko Kondo, Junichiro Kajita. Yoshikazu 'IlIkahashi. 
SalOshi SailO. Yukio Ozawa. 
Nihon University. Tokyo. Japan 
The JIIIIPOse of the investigation was to study the interaction between 
disopytaJllide (D) and erythromycin (E) 011 ventricular repo1arization and on the 
incidence of ventricular extrasyslOles(VEs) and torsades de pointes(TdP) 
arrhythmias.In 12 anesthetized dogs with chronic atrioventricular block. we 
measured monophasic action potentials (MAP) from the left (LV) and right 
ventricular (RV) endocardium with contact electrode catheters. RV or LV was paced 
at a cycle length of 750-1()()()msec. Ten minuteS after intravenous administration of 
3mg,1cg of D. 4Orng,1cg of E was injected in 5 minutes. The MAP duration to 90% 
repo1arization (MAPD9o) was measured at baseline and following D and D+E. 
RV MAPPoo (mw LY MAPD90 (msec) 
Control 247±36 263±49 
D 284±39' 296±59' 
D+E 321±57" 351±81" 
(Mean±SEM. ·p<0.00l vs Control. "p<OJlOI vs COIItrol and D) 
Early afterdepo1arizations developed in I dogs after D and in 6 dogs after D+E. 
Frequent YEs occurred in 2 dogs and TdP developed in 2 dogs after D+E. 
Conclusions: I)D prolonged MAPD but no arrhythmia was observed. 2) The 
MAPD was funher prolonged after administration of E in dogs pretreated with 0 
and frequent YEs or TdPs occurred in 30%. Thus. caution is advised in rapid 
injection of E to patients receiving D. 
934·89 
An Animal Model for Studying Oass III·Induced Proarrhybnlas In 
the Halothane-Anesthetized Dog. 
G6ran D. Duker, Gunilla S. Linhardt, Maria Rahmberg. Preclinical 
Research and Development, Astra Hlissle AB, S-431 83 Miilndal, Sweden. 
A major limitation in the understanding of class ill-induced 
proarrtIythmias, i.e. tasades de pointes (TdP), is the lack of clinically 
relevant animal models. 1berefae, we have developed a new experimental 
model for class ill-Induced proarrtIythmias in the anesthetized dog. 
Conscious dogs were pretreated for 5 days with furosemide (60 + 150 
mg/day p.o.) to induce hypokalemia (2.6±0.33 mmoIII, Mean±SD). 
Anesthesia was induced with thiopental sodium and maintained by 
halothane ( .. 1.0 % in room air). A right-sided thoracotomy was performed 
and complete AV block was created by injection of 0.1 mI of 
formaldehyde in the A V nodaI region (idioventricular rhythm • 50 bpm.) 
This experimental model indicated a very high sensitivity, TdP-like 
arrhythmias were induced in 100% of dogs treated with a1mokalant 1.0 
jUDollkg i.v. (0=16) or dofeti1ide 0.1 jUDollkg i.v. (n=5). The 
proar,rhythmia was preceded by a IIIIUIced QT prolongation and was 
initiated in a very consistent way (short-long-short sequence). Overdrive 
ventricular pacing (rate -100 bpm) and, in most cases, infusion of 
isoproterenol effectively suppressed the proarrhythmia. Crucial factors for 
proarrtIythmia induction seem to be reduced heart rate and the use of 
halothane anesthesia, as dogs in sinus rhythm (.120 bpm) or dogs 
anesthetized with pentobarbital had a lower proarrhythmia incidence (114 
and 114, respectively. The furosemide treatment seems to be less 
important, the incidence in dogs not treated with furosemide was 3/4. 
In conclusion, the proarrtIythmia induced in this animal model has a lot 
of features in common with TdP observed in the clinical setting. The high 
sensitivity, which In part seems to be due to the halothane-anesthesia, 
makes the model suitable for comparing proarrhythmogenicity of different 
class ill compounds and for studying the electrophysiology of drug 
induced TdP. 
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934·90 
Mechanism of Surface ECG Polymorphism of MonomorphIc Ventricular 
Tachycardia: Insights from Simultaneous Endocardial and EpIcardial 
Activation Sequence Mapping In I canIne Infarct Model 
Stelan Osswald, David J. Wilber, Jiunn-Lee Lin, Duke Du, Hartley B. Holden, 
Hasan Garan, Jeremy N. Ruskin. Massachusetts General HospHal, Boston 
MA 
This study inVestigates the mechanisms underlying multiple surface ECG 
morphologies during separate episodes of recurrent monomorphic ventricular 
tachycardia (VT). Computerized ECG analysis of the three orthogonal Frank 
leads (X,Y,Z) and simultaneous endocardial and epicardial activation se•
quence mapping with a 64 bipolar electrode array were used to analyze the re•
lation between the sHe 01 VT origin, the ~ activation sequence and the sur•
face ECG morphology 01 separate VT episodes Induced In the same heart. 72 
episodes 01 reproducible VTwere induced in 9/17 dogs wilh experimental in•
larcts (5-13 VTsldog); 46/72 VTs were Induced In drug Iree state and 26/72 
VTs alter iv procainamide administration. 
Pairwise co~arisonsof all VTs indUCed in the same heart revealed that a simi•
lar surface ECG morphology (ECGM) predicted endocardial breakthrough 
sites. (BS) wHhin <10nvn In 46146 (100%) VT pairs in drug Iree state (p 
..:0.0001). However, 43/95 (45%) VT pairs wHhdifferent ECGM also mannest•
ed endocardial BS wHhin <10 mm. lithe 89 VT pairs with endocardial BS ..:10 
mm (46 wilh similar and 43 wilh dnlerent ECGM) were compared, similarendo•
cardial activation maps were lound in 34/46 (74%) VT pairs with similar ECGM 
and in 6143 (14%) VT pairs wilh different ECGM (p <0.001). Pairwise compari•
sons amongst the VT s induced alter administration 01 iv procainamide re•
vealed that a similar ECGM was no longer predictive 01 endocardial BS wilhin 
<1 Omm (9/12 (75%) VT pairs wilh similar ECGM manifested BS wilhin <1 Omm 
compared to 17/35 (45%) VT pairs classHied as different ECGM, p N.S.). 
Conclusions: I) Similar surface ECG morphologies 01 VTs induced in the 
same heart are highly predictive 01 closely spaced endocardial as in drug Iree 
state, but not alter use 01 ivprocainamide. 11) Different surface ECG morpholo•
gies do not predict different siles 01 origin, since almost haH olthe VTs wilh dif•
ferent morphologies originate from very closely spaced endocardial BS sug•
gesting that some 01 them may share a common substrate. Ill) The mecha•
nism underlying different surface ECG morphologies in VTs with closely 
spaced endocardial BS seems to be related to local changes of the endocar•
dial activation spread from the BS in the majority of these cases. 
934·91 
Effect of Phosducin on G Protein ~'Y Subunit 
Activation of Atrial Muscarinic Potassium Channels 
Arshad Jahangir, Mitsuhiko Yamada, Yukio Hosoy&, Yee-Kin 
Ho, Toshiaki Katada, Yoshihiso Kurachi, Mayo Clinic, 
Rochester, MN. 
Phosducin, a phosphoprotein expressed in the retina and pineal 
gland is involved in the regulation of signal transduction. In 
retina it fonns a tight complex with the dissociated Py subunit of 
transducin, thus preventing its interaction with the a subunit 
(T a). Phosducin, may have a similar modulatory role on the 
activation of muscarinic K + (KACh) channels in the atria by 
fonning a complex with ~y subunit of G protein (GfJr»' Using 
the inside-out patch clamp technique, we have examined the 
effect ofphosducin and the GOP-bound fonn of Ta (Ta..(jDP) on 
the GfJr -induced activation of KACh channels in guinea pig atrial 
cell membranes. When bovine brain G Pr (10 nM) was 
preincubated with phosducin (100 nM) or T a-GDP (100 nM), 
KAOI channel activation by the G fJr was significantly disturbed. 
When applied to the KACh channel preactivated by G Pr or by 
GTP (with acetylcholine), Ta-GDP (0.5-3 J.1M) but not phosducin 
(3 j.1M) inhibited the channel activity. These results suggest that 
(1) when preincubated with G Pr, both phosducin and T a-GDP 
can bind with it and prevent GfJr interaction with KACh channels; 
(2) T a-GDP but not phosducin can enter the cell membrane to 
interact with GfJr and inhibit KACh channel activation. 
JACC February 1994:1A-484A 
934·92 
Effect or Sustained Load On Electrophysiologic Parameters 
During Steady·State Pacing and Premature Extrastimulation in 
the Isolated Intact Rabbit Heart 
Martus Zabel, Stuart Ponooy, Michael R. Franz. Div. of CIin. Pbarmacology aDd 
Cardiology, Georgetown Univenity 8IId VA Medical Center, Wasblngtoo, DC 
It is well known tbaI mecbanical stretch can elicit ventricular arrbytbmias in 
experimeotallJllldrJs.lIoviIM:r, previous rquts ckJam:ufa1 SIIeICb-iDcU:ed ~
ooly during pulsaIile stretch of shcrt duratioo • The arrbythmogenic mecbaoism of 
sustained sialic streIdi, implied by cliDical studies, is iDcompletely UDderstood. We 
tberefore IeSII:d die bypotbesis !bat sustained load leads to III iDaease ill dispersim of 
Iq)OlarizaIioo 8IId a cb:reaI!e ill cxmductioo wlocity. A lMex balIooo was placed inside 
die left vetIIricle of 6 isolaIed laDgeudOOf-pt'rliJsed rabbit beans 8IId Iillcd wiIb lml of 
fluid af'ter baseliDe rec:onliDgs. The bean was paced fn:m !be iDlraveutricular septum. 
The followiDg parametaS were studied during steady-Slate pacing witb a cycle length 
(CL) of 500 msec (S I) 8IId during exuastimulalion (S2, base drive of 8 beats): 
Malopbasic actioo poo:otial (MAP) duraIioos at 90% JqJOlari7lIlioo fn:m 5-7 epicadial 
aJDIaCt electrodes locatI:d 011 both veDIricIe&; MAP dispersim (range of MAP dIntioDs 
fn:m all electrodes); eflectiYe ~ period (ERP) aod aaivaIiOD times as a_ 
of cooductiOD velocity (AT, pacing stimulus to MAP upsInh). Statisticalcauparisons 
were done using a paired Student's t-test. The following results were obtained (all in 
msec±SD): 
°p<O.05 o·p<O.OI lliIIIW:d Sustajned Load 
ERP 
MAPD9O% (SI) 
MAPD9O% (S2) 
MAP Dispersion (SI) 
MAP Dispersion (S2) 
AT (SI) 
AT (S2) 
210± 29 
187 ± 15 
178 ± 25 
35 ± 16 
34± 12 
25 ± 4 
33± 5 
193 ± 28· 
176± 18· 
167 ± 30· 
44 ± 20· 
48 ± 22· 
28 ±6· 
46 ± 11·· 
Conclusions: SUSIaiDed load shcrteDs die FRP 8IId die mean MAP dUllllioo, while it 
iDcreases dispeniOD of repolarizatioo aod slows amx:tion. These IindiDgs may povide 
an additional explanation wby patients witb congestive bean failure are prone to 
~triCUJar tadlyan1lytbmias. 
934·93 
Propranolol Decreases Number or Ventricular Fibrillation Activation 
Fronts Detected by S06 Epicardial Electrodes 
Russell E. Hillsley, Kurt D. Bollacker, Michael D. Yarger, Dennis 
L. Rollins, Patrick D. Wolf, Raymond E. Ideker, Duke Medical 
Center, Durham, NC 
A new 528 channel mapping system enabled us for the first time to assess 
the effect of propranolol on ventricular fibrillation (VF). We determined 
whether the increase in effective refractory period (ERP) by propranolol 
decreased the area excited by VF activation fronts by increasing block or 
decreased the number of VF activation fronts by increasing space between 
fronts. A plaque of 506 (22 x 23) electrodes Imm apart was sewn to the 
RV. VF was induced by an extrastimulus. After a control VF episode, in 
6 pigs propranolol (0.25-0.4 mglkg) was given, and VF was reinduced 60 
and 120 min later. To test the effect of repeated VF inductions, in another 
6 pigs saline was infused instead of propranolol, and the protocol was 
repeated. Unipolar electrograms were recorded for 2s at Is, 15s, and 30s 
after VF onset. Activation fronts were identified by computer analysis of 
dV/dt. VF after propranolol or saline was compared with control by 
activations per electrodels (RATE), number of activation frontsls 
(COUNT), mean percentage of mapped area activated per activation 
front, and mean of most negative dV/dt per activation in VIs. ("p<0.05) 
ERP (ms\ RATE COUNT AREM% dV/dt 
Control 220±23 8.4±1.3 21±5 39±54 -3.3±0.7 
Propranolol-6Omin 247±16" 6.6±1.2" 16±4" 40±39 -3.5±1.4 
Propranolol-l2Omin 247+25" 6.2+1.2" 15+4" 41+35 -3.2±1.4 
Saline did not change ERP or VF; thus, changes observed with propranolol 
were not due to repeated VF inductions. As expected, propranolol 
increased the ERP and decreased the activation rate per electrode during 
VF. Rather than reducing the coherence of activation fronts by altering the 
area activated by each front, propranolol reduced the number of activation 
fronts by increasing the space between them. Thus, ERP prolongation and 
decreased VF activation rate with propranolol is associated with fewer 
activation fronts in VF. 
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935·123 
Discrepancy Between Estimated METs and Measured METs on 
Exercise TreadmiU Testing 
Mandeep R. Mehra, Thirupathi R. Reddy, Carl J. Lavie, Hector O. 
Ventura, Richard V. Milani, Ochsner Medical Institutions, New 
Orleans, LA 
Estimated METs are commonly used in clinical practice to 
determine exercise prescriptions for patients with cardiac disease. 
We studied the accuracy of estimated METs calculated using the 
American College of Sports Medicine formula compared with 
measured METs obtained during cardiopulmonary exercise testing 
(CPX) using standard Bruce or ramp protocols. Our study 
population, consisted of 68 patients with cardiac disease (Le., 
coronary artery disease or congestive heart failure) referred to our 
laborato for CPX testin (Bruce, n=19; ram ,n=49). 
Esnmated METs were consistent y overestunated (r v ue = 0.8) 
when compared with measured METs, and differences were highly 
significant in both groups. The standard Bruce protocol 
overestimated METs the greatest while the ramp protocol was 
considerably closer to measured METs. Variables such as age, sex, 
body surface area, and left ventricular function did not independently 
account for these differences. The standard Bruce protocol is limited 
by the large increments in oxygen consumption between stages and 
does not provide a reliable estimate of workload achieved. In 
conclusion, ramping-based protocols are preferable to the standard 
Bruce protocol when exercise testing is performed to provide 
exercise prescription based on estimated workload achieved. 
Current fonnulas for estimating METs may need to be re-evaluated 
in cardiac patients. 
935·124 
Aerobic and Myocardial Demands of Heavy Snow Sboveling: 
Comparability to Maximal Arm and Leg Exercise Testing 
Barry A. Franklin, Pat Hogan, Kim Bonzheim, Donovan Bakalyar, 
Edward Terrien, Seymour Gordon, Gerald C. Timmis, William 
Beaumont Hospital, Royal Oak, M1 
Recent studies suggest that shoveling light snow is safe and 
approximates the work intensity commonly prescribed for aerobic 
exercise training (70-85% of maximal heart rate). However, excess 
cardiac deaths have been primarily associated with heavy snowfalls. 
To assess the physiologic responses to manual (shoveling, S) versus 
automated (electric snow thrower, ES) snow removal in the cold (2° 
C), we studied 10 healthy untrained men (x ± SD age = 32.4 ± 2.1 
yrs) who cleared two 10 cm high tracts of heavy, wet snow, using S 
and ES, in random order, with rest periods between each 10-min work 
bout. Shoveling rates were self-paced (12-20 loads/min), using a 
plastic shovel (1.4 kg), on a concrete drive. Heart rate (HR), systolic 
blood pressure (SBP), oxygen uptake (\,02 ) and perceived exertion 
(PE, 6-20 scale) were measured during S and compared to values 
obtained during ES, arm ergometry (AE), and treadmill testing (TT). 
Peak responses (x + SOl relative to S ("p< 0.05) were: 
HR (bpm) SBP (mmHg) \102 (METs) PE (#) 
S 175 ± 15 198 ± 17 5.7 ± 0.8 16.7 ± 1.7 
ES 124 ± 18" 161 ± 14· 2.4 ± 0.7" 9.9 ± 1.0" 
AE 171 ± 19 152 ± 16* 6.3 ± 1.1 17.7 ± 1.7 
TT 179 ± 17 181 + 25· 9.3 ± 1.8* 17.9 ± 1.5 
Peak HR and PE responses during S, AE and IT were comparable. In 
contrast, S elicited the highest SBP. \102 during S was similar to that 
for AE, but lower than for IT. Cardiorespiratory and PE responses 
during ES were unifonnly reduced. Conclusion: Heavy snow 
shoveling elicits myocardial demands that are tantamount to maximal 
TT. Automated snow removal markedly decreases these demands. 
328A ABSTRACTS 
935·125 
L.ft V.ntricular Function During Incr ••• ntal 
and It.ad, Itat. Bz.rci •• 
Carl Foster, Steven C. Port, Rami Gal, Donald B. 
Schmidt, Milwaukee Beart Institute, Milwaukee, WI 
Despite extensive study of left ventricular (LV) 
function during incremental exercise (GXT), there is 
little known about LV function during steady state 
(SS) exercise associated with exercise training. In 
this study we evaluated LV function during upright 
cycle ergometer exercise using first pass radionuclide 
angiography (RNA). Bealthy volunteers (n=11)(ageD 30-56 
yr) were studied during both GXT and SS. During GXT 
studies were performed at rest, at the anaerobic 
threshold (AT) (x=175W) and at max exercise (x=227W). 
During SS studies were performed at AT after 10, 20 
and 30 min of exercise. LV volumes were calculated 
from a count based RNA technique. 
During GXT (rest,AT,Max). BR (66,149,174 bpm), xBP 
(93,127,132 mmBg), EF (57,67,68 'I, EDV (189, 178, 180 
ml), ESV (80,59,60 ml),SV (109,126,127 ml), CO 
(7.1,17.4,20.7 L), SVR (1102,585,519). 
During SS (10,20,30 min). BR (149,156,161 bpm), xBP 
(127,121,116 mmBg), EF (67,73,73 'I, EDV (178,163,161 
ml), ESV (59,46,44 ml), SV (126,117,116 ml), CO 
(17.4,18.1,18.5 L), SVR (585,545,512). 
The results suggest that indicies of systolic function 
are nearly maximal during submaximal exercise at AT. 
During GXT late increases in CO depend on BR. During 
SS systolic function is very stable, increases in CO 
also dependent on BR. SVR declined progressively 
during both GXT and SS, with the lowest value observed 
after 30 min SS. This finding suggests that some of 
the augmented LV function during both GXT and SS is 
dependent upon afterload reduction with exercise. 
935·126 
Effect of Persisting Left Ventricular Hypertrophy on 
Functional Capacity and Prognosis in Hypertensive 
Patients. 
Maria G. Modena, Gabriella Masciocco, Giorgio 
Mattioli. Cardiology Opt, University of Modena (Italy). 
Reversal of left ventricular hypertrophy (LVH) in 
hypertensive patients (pts) is recognized to be a benign 
phenomenon difficult nevertheless to quantify. 95 
hypertensive pts with LVH received Lisinopril 20 mg for 
12 months. At the end of treatment all showed 
normalized blood pressure, 65 regression of LVH (left 
ventricular mass index from 150 .± 48 to 114 .± 34, P < 
0.001) and 30 persistent LVH. All pts were free from 
symptoms and underwent exercise test for evaluation 
of exercise capacity and maximal oxygen consumption 
(V02 max). Results: 
~ NOLVH P 
Exercise lime 7.5:!:. 1.2 min. 
V02max 15.1:!:. 3.1 ml/min/Kg 
9.5 :!:.2 
18.n 3 
0.05 
0.01 
Cardiopulmonary exercise test reveals depressed V02 
max and reduced exercise capacity independently of 
blood pressure levels in pts with persistent LVH. All pts 
continued therapy and a follow up of 4 years revealed 
in the group of pts with persistent L VH that 2 had fatal 
MI, 3 non fatal MI, 10 severe arrhythmias at Holter 
Monitoring (Lown class 4 A and B). No major events 
were detected in the other group. 
Left ventricular hypertrophy may be considered a 
malignant phenomenon of pseUdo-compensation. 
lACC February 1994:1A-484A 
935·127 
Exercise Induced Structural Remodelin& or Left Ventricle in 
Super Athletes 
B. William Choi, Mamdouh Bally, Brian G. Choi, 
Peter Katsiyannis, Bernard Dennis, Bernard Emonnot, 
Bernard Bertrand, M. Contard, Jacque Machecourt, Michel 
Lewinter. Albertville Hospital, Albertville, University of 
Grenoble, Grenoble France, NHLBI, NIH, Bethesda, MD 
Previous studies have demonstrated that many super athletes may 
develop left ventricular hypertrophy (LYH) or dilatation (LVD) in 
response to strenuous training. To characterize cardiac structural 
changes which occur in super athletes, we investigated 39 (age: 
18-65 yrs) winter olympians and 9 college varsity rowers (age: 
20-21 yrs) with Doppler and echocardiography for the 
measurement of ventricular septum (VS), LV posterior free wall 
(PW), LV diastolic dimensions (LVDd), LV systolic dimension 
(L VOs), fractional shortening (FS) and diastolic filling pattern. 
11139 olympians had LVH (Group A) and 7/39 olympians had 
increased LVD (Group B). However, none of the college varsity 
rowers developed LVH although 2/9 had LVDd of 5.6 cm. 
LVDd LVDs VS PW FS(%) 
A 5.05±0.43 3.33±0.31 I.39±0.11 I.17±0.19 34±4.5 
B 5.72±0.23 3.94±0.27 1.03±0.13 0.95±0.10 31±3.8 
p <0.001 <0.001 <0.001 <0.01 NS 
Age 
32±1I 
22±7 
<0.02 
10111 in Group A had normal EI A ratio (0.94±0.2/0.37±0.1). A 
65 year old ex-olympian had reversed EtA ratio (0.23/0.79) with 
VS of 1.44 cm. There was a significantly negative linear 
correlation between age and LVDd (r:0.6, p<O.OOI) and positive 
exponential correlation between age and LV wall thickness (r:0.6, 
p<0.05). Therefore, LVD in super athletes may represent an 
early structural change. LVH may develop at the later stage. 
935·128 
Clinical Correlates of Exercise-Induced Atrial FIbrillation 
Maarten P. van den Berg. Harry J. Crijns. Wilfred F. Heesen. Jan 
Brouwer. Kong I. Lie. Department of Cardiology. Thoraxcenter. 
University Hospital. Groningen. The Netherlands. 
It has been claimed that sympathetic nervous system activity per 
se may induce atrial fibrillation (AF) in patients with otherwise 
healthy hearts. To address this issue we analyzed the clinical 
correlates of AF induced during routine exercise testing. With use 
of a prospective data base 11730 consecutive exercise test in 
7273 patients were analyzed. AF developed in 23 patients 
(0.3%); 14 patients had onset of AF during exercise and in 9 
patients AF was provoked during the recovery period. Median 
duration was 233 seconds. Mean workload and heart at onset 
were 92 ± 51 Watt and 111 ± 26 bpm. respectively. Mean age 
was 62 years (range 36-76) and most patients were male (87%). 
Coronary artery disease was the most common underlying 
disorder (43%). In 6 patients (26%) no structural heart disease 
was apparent. AF patients did not differ from control subjects. 
matched for age. sex and test indication. with respect to 
underlying heart disease. previous myocardial infarction and 
congestive heart failure. Also. echocardiographic left ventricular 
and left atrial dimensions were similar. However. AF patients 
more often had a history of paroxysmal AF (39% vs 9%. p<0.05) 
and used less beta-blockers (9% vs 43%. p<0.05). Finally. in the 
AF group heart rate at maximal exercise was higher (144 bpm vs 
127 bpm. p<O.OS) and ischemic responses to exercise were 
more common (26% vs 6%. p<0.05). 
In conclusion: patients with exercise-induced AF represent a 
heterogeneous group. Some patients indeed appear "true" 
sympathetic AF. However. most patients have associated 
disorders. foremost ischemic heart disease. 
lACC February 1994:1A-484A 
935-129 
The Comparison of TreadmiII and Ergometer Exercise 
Test for Measurement of Cardiac Pump Reserve 
·Susik Kim, Hiroshi Yamabe, Masanori Iwahashi, Takashi Yano, 
Hideki Fujita, Mitsuhiro Yokoyama, 
Kobe University school of Medicine, Kobe, Japan 
Treadmill exercise test derives a larger aerobic capacity from 
patients with cardiac disease compared to ergometer exercise test. 
However, it has been uncertain whether treadmill exercise test 
induces a larger cardiac output (Q) or not. The purpose of this study 
was to compare treadmill with ergometer exercise tests in relation to 
the exercise-derived cardiac pump performance. Twenty-one patients 
with chronic heart failure underwent invasive cardiopulmonary 
exercise tests using ramp ergometer protocol and one minute 
incremental treadmill protocol to symptomatic maximum tolerance 
(19 or 20 of Borg's scale). 
peakV02 peakQ peakSv peak02ExR peakRPP IlI;tate 
Treadmill 1496 10.2 67.8 77.7 26377 38.5 
Fzgometer 1301 9.5 62.0 72.6 29353 57.8 
P 0.001 0.001 0.001 0.001 ns 0.001 
Our results showed that treadmill exercise test derived a larger 
aerobic capacity (VOl. mVmin), cardiac pump performance (Q, Vmin 
and SV, mI) and oxygen utilization (02ExR, %). However, the 
cardiac work (RPP, mmHg,beats/min) was similar and 1actate 
accumu1ation (mgldl) was smaller in treadmill exercise test than 
ergometer exercise test. These fmdings suggested that the efficacy of 
cardiac work to produce a pump function was decreased in ergometer 
exercise test, and the glycolytic skeletal muscle was much involved 
during ergometer exercise test. These mechanisms were causes of 
decreased aerobic capacity and Q in ergometer exercise test. We 
conclude that treadmill exercise test is superior in measurement of 
cardiac pump performance in patients with chronic heart failure to 
ergometer exercise test. 
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936-130 
Relative Sensitivity of die Canliac Adenosine AI IIIId A2 Recepton 
to Non-specific Adenosine Blockade in Humans 
Barry D. Bertolet, Elizabeth Franco, Richard A. Kerensky, Wilmer 
W. Nichols, Luiz Belardinelli, James A. Hill. University of Florida, 
Gainesville, FL 
Theophylline (THEO) derivatives are often used to attenuate the 
cardiac actions of adenosine (ADO), but the relative efficacy of 
theophylline on the AI v. A, receptor-mediated cardiac effects is 
unknown. These effects and their duration were examined in ten 
patients during continuous intravenous infusion and bolus of ADO 
before and after THEO. 
~: Baseline measurements of the A-H interval (AI effect), 
sinus cycle length (SCL), systolic blood pressure (SBP), and 
coronary blood flow velocity (CBFV) (A2 effect) were made. 
CBFV measurements were made in a normal coronary artery. ADO 
was infused to increase the CBFV by -SO% then an additional 3 mg 
ADO IV bolus was given and measurements repeated. THEO S 
mgikg was infused and the ADO protocol repeated. 
Results: Baseline ADO llIEO 
A-H (msec) I 09±4 1 I68±S7* 98±3S 
CBFV (cm/sec) 6±4 2I±I2* 7±S 
SBP (mmHg) 130±27 I03±2S* I2S±20 
Duration of t A-H (sec) 9±6 
Duration of t CBFV (sec) 23±IO 
ADO+THEO 
I07±44+ 
I9±13+ 
112±24 + 
I±2+ 
IS±6+ 
• p<o.05 compared to baseline,. p<O.05 compared to ADO 
Conclusions: In patients without severe CAD, 1) ADO causes an 
increase in A-H interval and CBFV; 2) the effect of ADO on CBFV 
(A2 effect) is more prolonged than the effect on A-H interval (AI 
effect); and, 3) AI receptor-mediated effects are more readily 
antagonized by THEO than A2 mediated effects. 
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936·131 
Effect of AggressIYe Arousal oa Prec:onlla1 T -waft Aile ...... Mapltucle 
la tbe No ..... aad Iscbemlc Caalae Heart WI .. ud Witboat Betal -
AdreDel'lic Blockade Wltb Metoprolol 
Julie A. Kovacb, Bruce D. Nearinl, Marian Thurnber, Rlcbard L. 
Verrier. Geol'letown Unlvenlty Scbool of Medldne, Wasblnlton DC 
329A 
T -wave alternans In tbe LV ECG bas been sbown to track cardIac 
vulnerability durlnl acute myocardial Ischemia and reperfuslon In 
anesthetized animals. In a 250,000-beat analysis, this parameter has 
previously been stronlly correlated (r2.0.9B, p<O.OI) with the Inddence 
of VT and VF durinl coronary artery occlusion. A linear relationship 
exists between the LV and precordial ECG. The loal of this study was 
to determine whether precordial T -wave alternans could be utilized as 
a noninvasive means for assesslnl the effects of behavioral stress on 
vulnerability before and durinl coronary ocduslon. Six dOIS were 
chronically Instrumented with Doppler flow probes and occluden placed 
arouod tbe LAD coronary artery. At the time of Itudy, allllressive 
arousal was Induced by a standard paradillm of confrontation over 
access to food. Precordial lead V 4 was recorded durinll a 3-min period 
of LAD occlusion. Behavioral confrontation was Induced for 2 min 
starting at 1 min of occlusion prior to and followlnl I.v. metoprolol (1.5 
mll/kll). T -wave alternans mallnltude was quantified by the spectral 
analytical method of complex demodulation. Values are means ± SEM. 
CONCLUSIONS: 
Aggressive arousal 
substantially Increases r---NS----, , .. " .. ..., 
•• 
T -wave alternans In tbe 
normal and Iscbemic 
heart. Tbls Increase in 
vulnerability Is detectable 
noninvaslvely In tbe 
precordial ECG. Tbe 
results also demonstrate a 
cardioprotective effect of 
beta I-blockade during 
CNS arousal, 
Precordial 3 
T-wue 
Alternans 2 
(mY x mil 
N-6 Dogs 
•• p<O.OI 
• p<0.02 ... 
• 
1 
Arousal Arousal 
I t.4~top 
Occlusions 
936-132 
Cbanges Of Left Ventricle Volume During Head.Up Tilt In 
Patients Wltb Vasovagal Syncope: An Ecbocardiograpbic Study 
Yoshio Yamanouchi. Safwan Jaalouk, Abbas A. Shehadeh. Fetnat M. Fouad· 
Tarazi. Cleveland Clinic Fowldation. Oeveiand. Ohio USA 
We tested the hypothesis that patients (PIs) with history of vasovagal syncope 
(VVS) who develop VVS during head-up tilt (HUT) have a greater decline of 
their left ventricle volume (L VV) in response to HUT dian do normal subjects 
(N). Measurments Wele done in the supine position and during graded HUT 81 
30' and 45' (2 min each), and 60' (at 105.10,15 and 20 min) using 2·0 
echocardiography (Simpson's rule). We compared 9 VVS PIS (BM:IF, age 
34±19 yr) to 9 normal volunteers (SM:IF. age 33±3) with normal HUT 
response. At baseline the 2 groups did not differ in regard to BP. HR. EF and 
stroke index (SI). HUT data were analyzed in two ways: a) Baseline vs 
maximum tolerated HUT and b) slopes of the posturaJ stimulus-hemodynamic 
response utilizing all data points during HUT. Results (mean ± SO). 
a) Change from baseline 
N VVS 
BOV(mVm2) ·16.5 ± 4.1 - 21 ± 6.7 
ESV (mVm2) - 8.2 ± 3.8 - 7.7±4 
SI(mVm2) - S.3 ± 3.2 ·13.3± 4.2 
EF(%) 1.1 ± 5.8 -10.7 ± 4.3 
BOV .. end diastolic volume, ESV "' end systolic volume 
b) 
BOV 
ESV 
SI 
EF 
N 
-0.67 ± 0.19 
0.34 ± 0.13 
-0.33 ± 0.13 
0.05 ± 0.19 
VVS 
·2.22 ± 1.4 
-0.86 ± 0.71 
·1.36 ± 0.83 
-0.99 ± 0.51 
P 
N.S. 
N.S. 
0.01 
0.0002 
P 
0.01 
0.059 
0.006 
0.0002 
Conclusion: 1) the rate of reduction of LV BOV during HUT is faster in VVS 
than in N; 2) the rate of reduction rather than the absolute change in LV EOV 
may play a role in triggering the vasovagal response to HUT; 3) the more 
significant reduction of SI and EF during HUT in VVS vs N may be related \0 
the periphellll IrlIns\ocation of blood volume in the venous system during the 
upright position. 
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936·133 
The Role of Medical Therapy Is Uncenaln In Patients With 
Recurrent Syncope and Positive Tilt Table Tests 
Jay H. Curwin, Brian A. McGovem, Hasan Garan, Jeremy N. Ruskin, 
Ross Brooks, Massachusetts General Hospital, Boston, MA 
Many recent studies have evaluated the utility of upright tilt table testing 
(UTI) in guiding drug therapy for patients (pts) with vasodepressor 
syncope (5). While some studies have suggested a favorable outcome 
in patients with recurrent 5 who are treated with beta adrenergic 
blockers and other agents, most studies have not evaluated the 
outcome of pts treated with placebo or pts who received no therapy'. 
Thus, we examined the long-term outcome In 124 pts with recurrent 5 
who had UTT performed on consecutive days. A total of 42 pts had 
either one (n.25) or both (n=13) tests positive for vasodepressor 
responses, with follow-up obtained on 39 pts (93%) at a mean of 2.2 
years. Therapy was not randomized, but was directed by the treating 
physicians. Twenty-one pts were on therapy, while 18 pts were not 
treated. Therapy conSisted of beta blockers (16), disopyramide(5), 
fludrocortisone (2). (Two pts received combination therapy.) 
Recurrence of 5 on or off medical therapy (meds) is shown in the table: 
Meds 9 12 
No meds 3 15 
·p=O.09, two-sided test 
58±20 
45±22 
ELUW. 
2.3±O.8 
2.0±O.5 
~ 
12±22 
7±11 
5ix of 16 (38%) of pts treated with beta-blocking agents had 5 at follow•
up. Further, there was no difference in outcomes between pts with 
either one or both UTT positive. 
Conclysjons· 1. Many pis with recurrent syncope and positive UTI will 
have event-free long-term outcomes even without drug therapy. 2. A 
signnicant number of pis receiving beta-blocking agents or olher 
therapy continue to have symptoms. 3. Additionallrials randomizing 
pts 10 placebo versus active drug are needed to evaluale Ihe efficacy of 
therapy. 
936·134 
Is Venous Function Abnormal in Patients with 
Neurocardiogenic Syncope? AssesSJDeIlt Using 
Radionuclide plethysmography. 
Dante E. Hanyari and Robert S. Sheldon, University 
of Calgary, Calgary, Canada. 
Patients (pts) with neurocardiogenic syncope 
(NCS) have abnormal autonomic control of heart rate 
(HR) and blood pressure (BP) during tilt table test. 
To investigate the autonomic control of venous tone, 
we studied the forearm venous pressure-volume (P-V) 
relationship before, during and after mental 
arithmetic stress (HAS) in 19 pts with NCS and 10 
normal subjects (N), using radionuclide 
plethysmography. All patients with NCS had abnormal 
tilt table tests. During HAS, HR and systolic BP 
increased from 73.11 to 86.16 beats/min. and 127.16 
to 145.21 mmHg (p<0.001) in pts with NCS, and from 
75.15 to 87.17 beats/min. and 126.12 to 152.20 mmHg 
(p<O.OO1) in N (p=NS vs NCS). In each of the 10 N 
subjects, HAS caused a 13.4\ decrease in forearm 
venous volumes (FW) at all venous occluding 
pressures (0, 10,20 & 30 mmHg) , p< 0.001 vs basel ine 
(B). On the other hand, in 10 pts with NCS, HAS 
caused a 2"4\ decrease in FW (p<0.001 vs Band 
p< 0.01 vs N), whereas in the remaining 9 pts, HAS 
induced an increase of 12.3\ in FVV (p<0.001 vs B & 
vs N). Both, venoconstriction and venodilation took 
place by changes of unstressed forearm venous 
volume. Thus, pts with NCS have abnormal autonomic 
control of venous tone, manifested by either 
exaggerated venoconstriction or paradoxical 
venodilation during a mild "pressor stimulus" . 
Profound abnormalites of venous tone may play an 
important role in the pathophysiology of syncope in 
pts with NCS. 
lACC February 1994:1A-484A 
936·135 
Differentiation Of Cells With Conduction System Phenotype 
From Fetal Ventricular Myocytes 
Wenning Qin, Candace G. Woods, Joel A. Schneider, W.T. 
Woods, Jr., Prairie Education and Research Cooperative, 
Southern Illinois University School of Medicine, Springfield, 
Illinois. 
The origin of cells that become the cardiac conduction system is 
poorly understood. This laboratory found that when 12-day old 
rat ventricles were removed from embryos and cultured in oculo, 
pacemaker cells arose de novo at the point of attachment to the 
growth surface. Morphologically, they resembled immature 
conduction system cells. We postulated blood vessels, nerves, 
extracellular matrix, or iris tissue present in that site might be the 
elements that stimulate organization of the new pacemaker. In 
the present study, influences of blood vessels, nerves, and iris 
tissues were eliminated in 80 embryonic rat ventricles by 
explanting them into culture dishes. After fonnation of a 
regularly beating cluster of cells at the site of attachment to the 
culture dish, pacemaker activity appeared and a stable rate of 
firing was achieved. Action potential recordings resembling 
those from mature sinus node confinned this was the pacemaker 
for the entire explant. 
These observations confmn that pacemaker cells arise from fetal 
ventricular explants at the point of attachment to the growth 
surface; nerves, blood vessels, and iris tissue are not required. 
This suggests development of the cardiac conduction system may 
be initiated or dependent upon intercellular contacts fonned 
between fetal myocytes or attachments to their extracellular matrix. 
936-136 
Cardioprotective Effects of Platelets Against Ischemia and 
Reperfusion Injury in the Isolated Rat Heart are Related to 
Platelet Glutathione Redox Cyeie Antioxidants 
Baichun Yang, Wilmer W. Nichols, Jawahar L. Mehta, University of 
Florida and the V A Medical Center, Gainesville, FL 
Platelets have been shown to protect against ischemia-reperfusion 
injury in isolated hearts. To investigate the role of glutathione redox 
cycle in the cardioprotective effects of platelets, isolated rat hearts were 
perfused with Krebs-Henseleit huffer alone, platelet-rich buffer, or 
buffer containing platelets pretreated with glutathione redox cycle 
inhibitors, and subjected to 40 min of ischemia and 30 min of 
reperfusion. 
Global ischemia-reperfusion in buffer-perfused hearts (n=12) 
resulted in a decrease in force of cardiac contraction (AFCC, -48±4%) 
and an increase in coronary perfusion pressure (ACPP, +26±4%) 
(both P<O.OI). Myocardial injury was evident from release of creatine 
kinase (CK) in the coronary effluent (0.061±O.013 IU/mL), loss of 
myocardial CK (l82±4 vs 230±12 IU/g tissue) and superoxide 
dismutase (SOD) activity (1.08±0.06 vs 1.55±0.04 U/mg protein). 
Perfusion of hearts with washed rat platelets (n=13) protected hearts 
from ischemia-reperfusion injury (AFCC, -3±5%; ACPP, -4±1 %; 
coronary effluent CK, 0.033±0.003 IU/mL; myocardial CK, 199±4 
IU/g tissue; myocardial SOD activity, 1.25±0.06 U/mg protein, all 
P<O.OI). The cardioprotective effects of platelets were attenuated 
when platelets were preincubated with glutathione redox cycle 
inhibitors dehydroepiandrosterone (n=5), 1,3-bis (2chloroethyl)-I•
nitrosurea (n=5) or l-chloro-2,4-dinitrobenzene (n=3), as indicated by 
decrease in FCC (-15±3%) and myocardial CK (l75±51U/g tissue), 
and rise in CPP (+9±2%) and coronary effluent CK (0.044±0.04 
lU/mL) after ischemia-reperfusion (all P<O.05 compared with platelet•
rich buffer perfused hearts). 
These results indicate that endogenous platelet glutathione redox 
cycle antioxidants contribute at least in part to the cardioprotective 
effects of platelets from ischemia-reperfusion injury in the isolated rat 
hearts. 
JACC February 1994:1A-484A 
936-137 
Brief Repeat Human Coronary Occlusions do not Induce 
Myocardial Preconditioning. 
Patrick Dupouy, Herbert J Geschwind, Gabriel Pelle, Jean Luc 
Dubois-Rande. University Hospital Henri Mondor, Inserm 
U2,University of Paris XII, Creteil, France. 
Preconditioning has been demonstrated in experimental studies after 
coronary artery occlusions. Balloon angioplasty induces a regional 
myocardial ischemia and alters the contractile and relaxant propenies 
of the myocardium. Whether serial balloon inflations reduce these 
balloon induced alterations is controversial in humans. Ten ischemic 
patients aged 56±9 years without any myocardial infarction 'history 
had a proximal LAD coronary artery balloon angioplasty. There was 
no evidence of collateral circulation on the pre-procedure 
angiography. Three balloon inflations with 5 mn rest between each 
inflation were performed for each procedure. The mean inflation 
pressure was 6±2 atm and the mean duration of each inflation was 
l00±20 sec. Left ventricular (LV) pressure was measured using a 
micro manometer. The peak positive of the first derivative (dP/dt M, 
mmHg/sec), the peak negative of the first derivative dP/dt (dP/dt m, 
mmHg/sec), the relaxation time constant Tau.(ms) and the LV end 
diastolic pressure (EDP, mmHg) were measured at baseline and after 
90 sec of each balloon inflation. 
Results: 
Baseline I st inflation 
dp/dt M 2385±600 2075±639* 
dp/dt m 2270±387 1793±530* 
Tau 44±7 76±12** 
LVEDP 13±7 30±3** 
*p<O.OI, **P<O.OOI vs baseline 
2ndinflation 
2065±528* 
I 790±520* 
70±13** 
31±3** 
3 rd inflation 
2100±400* 
1500±440** 
88±12** 
33±3** 
Conclusions: 1/ Relaxation and systolic parameters are similarly 
altered for each inflation. 2/ Repeat coronary occlusions by balloon 
angioplasty of the proximal LAD induce neither systolic nor diastolic 
myocardial preconditioning. 
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937-80 
Relationship Between Essential Hypert.ension and Coronary 
Heart Disease: Cell Lipid Mechanisms and Drug Correction. 
Marina J. Shafer, Natalia A Anikina, Tatjana L Bazhenova, Ludmila 
L Gapon, Institute of Clinical and Preventive Cardiology, Tjumen, 
Russia. 
The aim of present investigation was to assess the role of erythrocyte 
and platelet membrane lipid alterations in essential h~rtension 
(EH) in the development of coronary heart disease tCHD) and 
possibility of .s:ell membrane lipid disturbances correction by 
different drugs lcalcium antagonists and ACE inhibitors). 
Erythrocyte and platelet membrane cholesterol (CH) content and 
main pbospholipid (PH) fractions (by thin-layer chromatography 
method) were studied in 154 untreated males 20-55 Y!'l! with 
borderline hypertension (BH), labile EH (LEH), stable EH (SEH), EH 
combined with CHD and 39 healthy persons. In 31 pts cell lipid 
parameters were studied before and after three-week isradipme 
treatment (5-10 mg/day at two daily' doses), in 35 pts - before and 
after two-week eaptopril treatment (75-100 mglday at three daily 
doses). 
Tendency to CH content rising was revealed in BH and LEH pts in 
erythrocyte and platelet membranes. In pts with SEH CH content was 
significantly increased (p<.05) in erythrocyte as well as in platelet 
membranes. PH levels were unchanged in EH in both types of cells. 
Membrane lipid disturbances were more expressive in pts with EH 
combined with CHD: CH level was significantly higher (jJ<.01) than in 
EH both in erythrocytes and platelets, main PH fractions 
(phosphatidylserine, sphingomyeline, phosphatidylcholine) were 
dicreased (p<.OOl) in erythrocyte membranes, while in platelet 
membranes they were uncban~ 
Administration of isradipine reduced signifieantly (p<.01 by Wilcoxon 
test) CH content in erythrocytes as well as in platelets in pts with EH 
and EH combined with CRn. CH lowering under cajltopril treatment 
(p<.Ol) was revealed only in erythrocytes. PH fractions were 
unchanged in both groups. 
Conclusion: 1 Excess cell membrane CH may be an important 
mediator in the development of CHD in EH pts. 2. Administration of 
isradipine and captopril normalize cell membrane CH level. that is 
important in the prevention of CHD in EH pts. 
ABSTRACTS 
937·81 
Responses of Internal Mammary Artery Graft Flow to 
Nitroprusside: 8 Duplex Doppler Study in Hyperttasive Hearts. 
Stefano Bosi*, Claudio Guadagni, Marco Pretolani. Guido BalestraA, Giancarlo 
Bellanti, Eugenio Picano·. "Cardiology Division, S. Maria Delle Croci Hospilal, 
Ravenna, "Casa di Cura "Villa Maria Cecilia", Cotignola. °CNR. Instiwte of 
Clinical Physiology. Pisa. Italy. 
Assessment of flow on internal mammary artery (!MA) graft by Duplex 
Doppler echocardiography provides a noninvasive insight on the coronary 
circulation, whose autoregulatory and vasodilatory capabilities are impaired in 
hypenrophic left ventricle. In order to assess the response of IMA flow of 
hypertensive hearts to nitroprusside infusion. 15 pIS were studied with a high 
frequency Duplex Doppler probe from the supraclavicular approach. All pIS had 
undergone a coronary artery bypass surgery with IMA graft on left anterior 
descending artery. The investigated pIS were normotensives (controls. n=5) and 
hypertensive with normal (Group I; n=5) or hypertrophic (Group II; n=5) LV. 
Values of LV mass index (penn Convention) were I02±1l9 g/m2 (mean ±SD)in 
controls; 115±18 in group 1 (p=ns vs controls) and 153±8 in Group II (p<.OI vs 1 
and c(Mllrols). IMA flow volume (FV. calculated from lime velocity integrals and 
vessel area. ml/min) was studied at baseline and continuously during nitroprusside 
infusion. Arterial blood pressure was measured each minute by cuff 
sphygmomanometer. In each patient we considered the peak FV value (% 
increment from baseline) and the FV value at the end-point (lowest tolerated 
diastolic pressure). Nitroprusside induced a comparable FV increment in controls 
(39±27%) and in Group I (24±11 %. p=ns vs controls). Conversely. the FV 
increment was only trivial in Group I (6±6%. p<.OI); tp<.05 vs Group I and 
p<.OI vs controls). At end-point, FV was similar to baseline in controls (with 
diastolic pressure of 67±9 mmHg) and in Group I (diastolic pressure=6I±4 
mmHg; p=ns vs controls), whereas FV declined significantly from baseline 
(-23%) in Group II at perfusion pressures of 79±5 mmHg (p<.OI vs Group I and 
vs controls). In conclusion. hypertenSive pts with normal LV mass exhibit a 
coronary flow behaviour similar to normotensives in response to a nitroprusside 
infusion. Conversely. hypertrophic hypertensives show a blunted 
nitroprusside-induced coronary vasodilator response and are much more vulnerable 
to coronary flow reductions in face of a hypotensive challenge. This dynamic 
assessment of flow patterns can be noninvasively obtained by Duplex Doppler 
monitoring of IMA graft flow. 
937-82 
Increased Heart Rate Variability is Associated 
with Improvement of Silent Ischemia in 
Hypertensive Patients with Coronary Disease. 
Yaga Szlachcic, Susan Ammon, Julio F. Tubau, 
Brian O'Kelly, Radha J. Sarma, Barry M. Massie. 
USC School of Medicine-RLA Los Angeles, VAMC 
and UC San Francisco, California 
Decreased heart rate variability (HRV) 
indicates poor prognosis in patients (PTS) with 
coronary artery disease (CAD) after myocardial 
infarction. To evaluate if antihypertensive 
therapy with a thiazide diuretic HCTZ or a 
calcium blocker nitrendipine (NITR) can affect 
HRV, we studied 10 asymptomatic hypertensive 
men (age 64±10 years) with CAD using a double 
blind cross-over protocol. Holter monitoring 
was obtained after 2 weeks on placebo and 8-12 
weeks of drug therapy. HoI ters were analyzed 
for the duration of silent iSChemia (51) 
defined as >1 mm ST' for >1 minute and 24 hours 
total spectral analysis of HRV and its low 
(0.04-0.15) and high (0.15-0.4) frequency 
components. 
PLACEBO NITR HCTZ 
BP(mmHg) 152±13/98±6 142±19/90±8* 145±16/88±7* 
HR(BPM) 79±11 74±10 81±16 
51-minutes 37±43 5±9* 54±113 
HRV-Total 5.92±.4 6.81±.9* 5.9±.5 
HRV-Low 4.8±.6 5.7±.9* 4.9±.5 
HRV-High 3.4±.5 4.4±.8* 3.3±.5 
*p< 0.05 vs PLACEBO 
Both drugs reduced DBP without changing HR. 
Improvement in 51 with NITR was associated with 
significant increase in total HRV and its both 
components. 
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937·83 
Increa.ed Blood Pre •• ure veriabilitf during 2. Bour 
Blood Pre •• ure Monitoring a. an sarlf lign of 
Autonoaic Df.fwnction in .on-In.alin Dependent 
Diabetic. 
Suaan MCKinlayl, Clare Fosterl , Susan Clark', Fiona 
~emp', Elizabeth Denver>, Andrew JS Coatsl • Rational 
Beart • Lung Institute, Londonl , John Radcliffe, 
Oxford', Whittington Bospital, London3 • 
To evaluate the preaence of early autonomic 
dyafunction in non-insulin dependent diabetica we 
examined 24hour control of blood pre. sure (1/4 
hourly reading. day • 1/2 hourly at night, using TM 
2420) in 20 non-insulin dependent diabetics, 
controlled only on diet or oral hypoglycaemics and 
20 age/sex/blood pressure matched non-diabetics, 
aged 52:t 9 - 53 ± 8. Both groups included 
normotensives and mild hypertensives in equal 
number. but none was on anti-hypertensive treatment. 
The groupa were well matched for daytime .ystolic 
blood pressure(SBP),(132.2 ± 11.4 va 131.2 ± 10.3) 
and diastolic blood pre.sure( DBP), (82 .l±-
8.3va8l.1±7).The diabetics had significantly 
increased heart rate (BR) both day (79.6 ± 9.5 
vs72.3±8.8p -0.015) and sleep (67.7 :t 6.8 VB 62.5 ± 
8.9).There was also an increased blood pressure 
variability in the diabetics during the day (SO SBP 
16.9 ± 6.2 va 13.3 ± 4.7, p<0.05) but the difference 
for diastolic BP variability was not .iqnificant. 
The day-night difference for SBP,DBP,BR and BR 
variability was the Barna in both groups. We conclude 
that in diabetics there waa evidence for an early 
alteration in BP variability(which may reflect 
baroreflex insensitivity)at a atage where there was 
no alteration in day-night rhythms of blood presaure 
or BR.The increased BR both day and night may also 
reflect baroreflex dysfunction and/or aympatho-vagal 
ilnbalance. 
937·84 
Left Ventricular Hypertrophy in Elderly HyperteDsion : 
Relative Importance of Arterial Wall Stiffness IlDd Dietary Salt 
Intake. 
Kam S Woo, Patricia Wilson, Rachael Gatland, Ping Chook, 
Robin M Norris, Michael F. O'Rourke, Green Lane Hospital, 
Auckland, New Zealand and St. Vincent's Hospital, Sydney 
Left ventricular hypertrophy (LVH) is an important prognostic 
factor for cardio\ascular morbidity and mortality. The 
determinants of LVH in 2S patients (aged 60-78 years) with 
essential hypertension (blood pressure ~ 160/95 mniHg after 4 
weeks' placebo washout) were assessed - including measurements 
of arterial wall stiffness for pulse wave velocity (PWV), 
applanation index (AI) and central aortic systolic pressure (aortic 
SBP) by applanation tonometry, and dietary salt mtake (assessed 
by 24 bour urinary sodium excretion). Left ventricular (LV) 
hypertrophy (LV mass index by 2-D guided M-mode 
echocardiograpby ~ 120 g/M2) was present in 16 patients (64~) 
LV Mass Index LV Mass Index ~ 
< 120g/W ~ 120g/W 
AgeW) 64.i±3.9 63.7±4's >0.2 
DuratIOn of 
Hypertension (yr) 14.1±2.1 12.6±1.9 >0.1 
Urine Na + excretion 125.4±55.8 179.9±69.1 <0.05 
(mmOl/dap-) 
Aortic SB (rrunHg) 163.8±2.6 164.8±3.2 >0.5 
Arterial stiffness (PWV) 1622.8±218.2 1692.S±286.7 >0.1 
(cm/sec) (AI) 126.0± 14.6 136.8± 162 >0.1 
Body Mass Index (~) 26.4±3.1 29.3±3.8 >0.05 
Dietary salt intake remains a most important associated factor for 
LVH in elderly hypertensive SUbjects. 
JACC February 1994:1A-484A 
937·85 
Anti-Hypertensive Medication Use by Hypertensives in the Women Take 
Heart Project 
Arfan A1-Hani, Alice Furumoto-Dawson, Cberdkiat Sangkam, Raja Gowda, 
and Ricbard Cerceo. St. James Hospital & Health Centers, Chicago Heigbts, IL 
Current medication usage along with self-reported hypertension (HTN), 
examination blood pressures (BPs), other cardiovascular risk factors and 
demographics were assessed for the 5932 women (W) in !be Women Take 
Heart Project, a community study of cororuuy artery disease (CAD) in Waged 
35 years or older with minimal or no symptoms of CAD. W who reported a 
medical history of HTN during !beir initial 1992 examination or who reported 
in their 1993 follow-up survey ever having received a prescription to treat HTN 
before the 1992 examination were included in these analyses (n=1336). Using 
the ICS pharmaceutical coding schema, anti-HTN drugs were classified into 4 
types: diuretics (all forms, D), calcium channel blockers (Ca), angiotensin 
converting enzyme inhibitors (ACE), beta adrenergic blockers (BB). 
702 W (52.5%) reported using I anti-HTN agent, 203 (15.2%) 2, 30 
(2.2%) 3, and 2 (.1%) 4. Overall, 995 W (74.5%) had uncontrolled HTN, 
(UBP; systolic ~140 or diastolic ~90 mm Hg). Older W tended to use a greater 
number of anti-HTN agents than younger W (1.0 for ~5yrs compared to .6 for 
<45yrs; "/.' sig.=.OOOOI, linearity p<.00001) and more often had UBP ~75yrs: 
90%; 65-74: 82%; <45: 64%, p<.OOI, linearity<.OOOOI). The observed 
prevalence of UBP increased with the number of different anti·HTN agents 
used. However, once age was taken into account, there was no significant 
differences in the prevalences ofUBP between the different groups. 
The effects of anti-HTN agent type on !be prevalence of UBP were 
compared for W taking only I of the 4 anti-HTN agent types (overall, 75.9%). 
With age and multiple comparisons taken into account, none of the 4 anti-HTN 
agents' effects were found to be significantly different. Among W taking I anti•
JITN agent, the estimated effect of D and BB on rate of UBP was 5% and 3% 
less, rei th rail eva! f UBP alive to eove IjJI' enceo 
Total D ACE BB Ca 
I Groupn 610 199 127 136 139 
Obs. Mean age 59.0 59.4 57.& 5&.& 60.0 
I Age-Ad' % UBP - 69.5 79.9 73.2 &1.4 
ConclUSIOn. Poor BP control m women IS high across anll-HTN agent 
categories, especially in older W and those on multiple-drug treatment regimes. 
937-121 
Regre.siOD of ReDal Fibrosis and Damage iD BxperimeDtal 
ReDovascular IIfpertension usiDg aD Angiot."cin Type 1 
Receptor AntagoDist. 
aRodolfo schudeck , Jorge E. Jalil, Carlos Vio, Angel 
Ralli, carlos Cespedes, Roberto Ebensperger. P 
Oniversidad cat61ica de Chile, Departamentos de 
Enfermedades Cardiovasculares y Ciencias Fisiol6gicas, 
santiago, Chile 
In experimental renovascular hypertension aevere 
architectural renal damage is observed with inters~itial 
and perivascular fibrosis. These lesions are reverted 
with angiotensin converting enzyme inhibitors. In this 
atudy the contribution of the angiotensin type 1 
(AT1) receptor on this pathological process has been 
evaluated. Goldblatt rats (2 kidneys 1 clip) 
hypertensive for 8 weeks received the AT1 receptor 
antagonist Losartan (DUPont 753, 3B/mg/Kg) during 8 
weeks (BT + L, n-7); a second group remained untreated 
(BT, n=9) and a third ~~oup were sham operated animals 
(n= 8). At the time of .acrifice systolic blood pressure 
(SBP) and renal size (weight) of the unclipped kidney 
were measured. Renal tissue was stained with picrosirius 
Red and observed under polarizing microscopy. Renal 
collagen was measured by hydroxyproline concentration 
(OB-PRO). Results were (mean ± SEM): 
BT BT+L 
SBP (llIIll Bg) 197 ± 2- 112 ± 5 
OB-PRO (ng/mg) 733 ± 58* 548 ± 14 
kidney (g) 2.2 ± .4* 1.7 ± .2 
* P < 8.81 VS BT+L and C 
sham 
115 ± 7 
568 ± 2~ 
1.9 ± .2 
BT rats showed ext.nse peri tubular and perivascular 
fibrotic lesions. These lesions were significantly 
reduced in BT+L rats. These results underscore the 
pathological role of AT1 receptor stimulation in renal 
fibrosis and damage and the potential therapeutic result 
of its specific antaqonism. 
JACC February 1994:1A-484A 
937·122 
StN .... nduced H.modynamlc and H.mostIItic AcutII Risk F.ctDrI In 
Patients will Hypel18ns1on: Elltct of V.rapaml 
Otavlo C. E. Gabara, Alfredo H. Jlmanez, Carol McKenna, Murray 
Mittleman, Ping Xu, lzebell. Upin.ka, Jamea E. Muller, Geoffrey H. Toller. 
Institute for Pravantlon of Cardiovascular Diaeaae, Cardiovascular DIvision, 
Deaconeas Hospital, Harvard Medical School, Boston MA. 
Although cartaln atreasOI'l appear to Increase the risk of atherosclerotic 
plaque rupture and thrombosis, the mechanisms through which they operate 
are poorly undel'ltood. We Invastlgated the hemodynamic and hemostatic 
responses to 3 potantlal triggel'l of myocardial Infarction (a88umption of 
upright posture, mental 8lra88 and cold pr8880r tast) and avaluated the 
ability of 8ustalned-ralease verapamil to modify these rasponsas 24 hours 
post-<lose. 
In a doubie-bUnd, placabo-conlrolled Cf0880ver trial of 13 subjects with 
mild hypertension, aystoUc arterial pr888ure (SAP) and platelet aggregabllity 
using Bom aggregometry (PA), were determined before and after stre88. 
Lag time to collagan-lnduced aggregation (COL), and the threshold 
concentrations of adenosine diphosphate (ADP) and epinephrine (EPI) 
required to produca >50% eggregatlon were measured. Rasults are 
prasented for the 3 stressors combined. (Mean iSEM) 
fIIW2 ~ 
Basaline Paak BasaOne Peak 
SAP (mmHg) 144i2 167i3 134:t2§ 154i3§ 
COL (sec) 93i3 91i3 111i9 § 111i9§ 
EPI (~) 3.4iO.9 1.5iO.3 3.0i1.0 3.9i1.3§ 
ADP (~) 2.8iO.4 2.0iO.3 2.4iO.1 2.4i0.4 
(* • P <0.05, peak vs baseline; §. p<0.05, verapamil vs placebo) 
During placebo, the strassors Increased SAP and coagulability, as 
indicated by decreased EPI and ADP threshold for platelet aggregation. 
Verapamil therapy reduced SAP and platelet response to collagen 
Oncreased lag time) at both basal and peak-stress timepoints, and blunted 
the stress-induced Increase in platelet response to EPI and ADP. 
These data indicate that stressors produce potentially harmful surges in 
blood pressure and platelet reactivity that are attenuated by verapamil. 
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938·113 
Computer Model for the Hemodynamic Coupling Between the 
Right Heart and the Left Heart 
Xing Sun. Mazen Beshara, Richard J. Lucariello, and Salvatore A. 
Chiaramida. University of Rhode Island, Kingston, RI and 
Our Lady of Mercy Medical Center, Bronx, NY. 
This model study is intended for establishing a theoretical basis for 
the right-left heart coupling. Using the model, right-heart parameters, 
such as pulmonary wedge pressure (PWP) and cardiac output 
determined by thennal dilution, can be used in a more infonnative 
way to assess the functions and degrees of abnormalities of the left 
heart. The right and left heart are each represented by a previously 
developed electrical analog model. The pulmonary circulation is 
characterized by a resistive-capacitive netwoIk. The circuit equations 
are solved numerically to generate hemodynamic waveforms such as 
those shown below. The model has been implemented in the C 
language on a Macintosh computer. In addition to the normal 
physiology, conditions including congestive heart failure, mitral 
stenosis, mitral insufficiency, and LV diastolic dysfunction are 
simulated. The model accurately predicts the hemodynamic 
consequences for the aforementioned conditions. The simulation 
software should be useful for computer assisted education and 
research in cardiovascular dynamics. 
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938·114 
Thr .. ·dlmenalonal Echocardlography: A Method for 
Right Ventricular Volume and Endocardial Surface 
Area Computation In Vivo by Polyhedral Surface 
Reconatructlon. 
Donald L. King, Aaaha S. Gopal, Donald L. King Jr. 
Zhanqlng Shen, Columbia Unlver81ty, New York, NY 
Echocardlographlc maasurernent 01 the right ventricle (RV) Is Important for 
evaluation 01 lung transplant candidates with pulmonary hypertension, as 
well as for patients with right ventricular Infarction, pulmonic stenosis and 
congenital heart disease. The complex shape of the RV does not permit 
use 01 algorithms based on two-dimensional measurements or geometric 
assumptions. Unlike the left ventricle, a single series of short axis or apical 
views Is Inadequate to represent the entire RV. The distal RV outflow tract 
(OT) can not be Imaged In transverse crose-sectlon orthogonal to its axis. 
To overcome this anatomic limitation we have edapted our polyhedral 
surface reconstruction algorithm to compute RV volume and surface area 
by modeling the non-Imagable portion 01 the RVOT as a curved tube of 
varying diameter. The remainder of the RV Is Imaged by a series of cross•
sections beginning at the uppermost imagable portion of the RVOT and 
progre88ing toward the RV apex. Using these cross-sectlons, the surface 
of the RV Is reconstructed by triangular tiling between the traced 
endocardial boundaries and the volume is computed by use of our 
previously described tetrahedron algorithm. The volume and surface area 
of the RVOT curved tube are obtained by traCing its superior and inferior 
margins as shown on its short axis reference image. dividing each curve into 
an equal number of segments. computing the diameters for each segment. 
constructing a circle based on each diameter orthogonal to the ref~rence 
image. and then USing the polyhedral surface reconstruction algonthm to 
compute the volume and surface area defined by the series of circles. 
These values are then combined with the values for the body of the RV to 
yield totals for the entire RV. When using this model a slight 
underestimation of the RVOT volume and surface area will occur because 
typically the more proximal portion of the RVOT is oval with the superior•
inferior dimension being shorter than the antero-posterior dimension. 
Conclusion: Modeling of the RVOT as a segmented curved tube permits 
use of the polyhedral surface reconstruction algorithm for estimation of total 
RV volume and endocardial surface area. 
938-115 
Matrix XCMD on HyperCard is useful for calculating Cosinor-rhythmometry 
*Minoru Shimizu. yo,hihiko Sakai. Shigenori Morooka, Kan Takayanagi, 
Yutaka Takabatake 
Dept. of Cardiology, Koshigaya Hospital Dokkyo University. Saitama, Japan 
Back ground: Cosinor-rhythmometry is a method for evaluating the circadian 
pattern of blood pressure, but it has been difficult to program for three reasons. 
First. to acquire the data. an interface with the ambulatory blood monitoring system 
to the computer is required for a large number of the data. Secondly, group 
estimation needs database like management of its data. Finally, this method 
requires non-linear multiple regression. 
Resolution: The first difficulty was resolved by using serial control XCMDs 
(distributed by Apple Programing Developer's Associates). As the HyperCard itself 
has a database management system environment, the second problem was naturally 
resolved. For a solution of the third difficulty, we developed matrix calculation 
XCMDs(MatCai verl.1b) on HyperCard 2.0 10 calculate multiple regression. 
Clinical application: Our system clarified the different circadian patterns of blood 
pressure between nonnal subjects(NS) and diabetic patients(DP) without autonomic 
nervous system disturbance. as shown below. 
Mesor 
amplitude 
Acrophase 
probability 
SBP DBP HR 
NS vs. DP NS vs. DP NS vs. DP 
131.6 vs. 129.9 78.3 vs. 73.7 73.9 vs. 68.3 
11.0 I'S. nla 7.3 vs. nla 10.2 vs. 7.0 
12:59 vs. nla 13:11 vs. nla 13:23 vs. 13:23 
0.32 vs. 0.17 0.29 vs. 0.17 0.36 vs. 0.31 
p<o.OI p<0.QJ NS. 
Discussion: Our program demonstrate the HyperCard's capability of dealing with 
chronobiological data. such as blood pressure and heart rate. Making a program 
u.ing C or other compiler on the Macintosh requires knowledge of the Macintosh 
Tool Box. Displaying a text on the monitor is needed for at least 1000 lines of the 
program. However, programing is easy because HyperTaik looks like native 
EngliSh, the running speed is lower than an application made by a compiler. As our 
XCMD is resource written by a compiler(pascal), it runs faster than native 
HyperTalk. and can be use on any Stacks to calculate the matrix complex. 
HyperTaik can also draw objecl' on the card and visualizing data is easy. In 
conclusion. MatCai provides a useful environment for the HyperCard on Apple 
Macintosh computers. 
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938·116 
Studaloae, C·LlJllUle Bued ProcrlDl for 5iDcJe ud MeaD COIinor 
ADalysiJ ofTime Seria 
Anna Ponti, Gaetano A. Lama, Sandra Ponti, ADdrcw T. Porter, Helen 
RaisweU, Filippo Crea, Atti1io Maseri, Domeuico CiarJt1ODe. Cardiology 
Institute, Catholic University, Rome, Italy 
The demonstration that many physiologic and pathophysiologic 
cardiovascular phenomeaa have a typical c:irc:adian variation makes 
evaluation of chrooobiological rlJythms useful to clarify their mcchaoisms 
and possibly to guide thcJapy. Time-series analysis by CosiDor method, 
based on fitting to tcmporal data the hannonic cosine fimction flt) = M + 
Acos(Q)t++), where M = Mesor (the riIythnHIetermi average), A = 
Amplitude (half of the difference between the highest and 10west values in 
the cosine fimction fitted to the data)" = acrophase (the time of the highest 
value of the fimction in the cosine curve fitted to the data), offers some 
important advantages over aD other test types. Indeed, it aDows: 1) amIysis 
of series with irregular sampling intervals; 2) calculation of the parameters 
M, A and • to characterize the rhythm; 3) comparison between rhythms. 
Since commercial statistical packages do DOt provide this kind of analysis a 
C·1anguage program to provide cosiDor analysis was developed. It reads 
several temporal series (e.g. mean R·R intervals from Holter tapes) from a 
text file depeoding upon a specified observation cycle (year, month, week, 
day) and a tcmporal measure unit within that cycle (months, days, hours, 
minutes). Sampling intervals are DOt required to be regular: test runs are 
available for equally and IIOIl equally spaced measurements over the cycle. 
For each series the program performs a 'Single CosiDor' test to estimate M, 
A and ., and the best fitting cosine curve. The program then displays or 
prints the 95% or 99"10 elliptical confidence region for the estimated 
parameters. A 'Mean Cosinor' test is computed for groups of subjects and 
the distribution of A and • of each series is plotted on polar coordinates 
together with the elliptical confidence region with a 95% or 99% probability 
of including the actual A and • of the mean population rhythm. FinaUy, it 
aDows to find not ooIy the fundamental best fitting cosine function, but also 
the next harmonic curves, by dividing the observation interval and the data 
series. A file containing aD test results is automaticaDy generated and can be 
printed or exported to other programs. 
938·117 
Computer Simulation Using Nonlinear Dynamics Accurately 
Predicts Action Potential Alternans Following Sudden Rate 
Changa and ~hemia 
Paulus F. Kirchhof, C. Larissa Fabritz, Bettina S. Koller, Michael R. 
Franz. 
Divisions of Cardiology and Clin. Pharmacology, Georgetown University 
and 
VA Medical Center, Washington, DC 
Cycle Iength(CL)-dependent alternans of monophasic action potential 
duration (APD) in ischemic myocardium is an important precursor of 
arrhythmias, but the factors which initiate or peIJlCIWIle API) altemans are 
still poorly understood. We developed a computer model based on 
nonlinear dynamics which on a beat-by-beat basis calculates the APD as 
an integral function of the diastolic interval immediately preceding the 
action potential (=electrical restitution curve; ERC), the steady state APD•
CL relation and the adaptational changa over time of the APD towards 
steady state after a CL change. A downward shift of the ERC was used to 
account foc adaptive ERC changes with different pacing CLs. Simulations 
were run on a Macintosh IIfx computer with numerical and graphical 
display of calculated APD changes. TIlDe constants for the algorithms 
were derived from ventricular monophasic action potential recordings in 
10 rabbit and 5 human hearts and program output was verified by an 
additional 5 rabbit experiments and 3 human studies. The program 
accurately predicted the beat-to-beat time course of APD changes after a 
sudden decrease or increase in CL (8±6% maximal deviation from actual 
data, n=32) with dampened APD alternans occurring after CL shortening. 
lschemia, simulated by a decreased slope of the ERC, resulted in m.mted 
and undampened APD alternans. Single·beat CL shortening ("PVCs") or 
lengthening ("pauses") either accentuated or attenuated APD alternans 
(on/off "triggering" of alternans). Increases in baseline APD, simulating 
class m antiarrhythmic drug effects, aggravated APD altemans under aD 
conditions. We conclude that the algorithms used in this computer 
simulation accurately retlect actual rate-dependent API) changes in nonna) 
and ischemic myocardium and may help predict arrhythmogenic APD 
alternans in clinically relevant scenarios. 
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994·1 
EnhanciDc Uller IDteramoD by Implementinc Graphical Objects, Video 
Imqes ad Sound Memos in a DepartmeDtaI Cardiovucular Network 
Domeuico CiarJt1one. Cardiology Institute, Catholic University, Rome, Italy 
Patient care is based DOl only on the production and exchange of a vast 
amount of paper documents but also on the amIysis of images and the 
sharing of personal verbal impressions among physicians. These 1atest 
groups of information are difficult to be hard-coded and "transmitted" in a 
computerized environment and are, possibly, ODe of the reasons for the slow 
acceptance of computers by cardiologists. In the attempt to improve user 
interaction an audio and video extended graphical operating Cllvironmmt 
was developed. The latter is an additional layer over our recently developed 
large cbaracter-based relational database application for providing data 
support to clinical research and patient care in our cardiological institution. 
This application runs over an Ethernet network made of 60 workstations and 
3 servers (a database-server, a file-server, and an ECG-server UP 
TraceMaster, respectively), together with standard productivity tools for 
office automation, graphics and statistics. This database aDows on-line 
sharing of diagnostic, history, treatment and follow-up data of several 
thousand patients in any of the workstations, accordingly to the relevant 
user-password and access-level. We hence adopted a commercially available 
graphical user interf.lce (Windows 3.1) and a graphical front -end for the 
existing database files and exploited the available possibilities of including 
"foreign object" (sounds and images). Video images are acquired by video 
acquisition boards, installed in the catheter laboratories, while voice is added 
to patiCllt notes with proper audio-digitiz.ers. As a result physicians are 
provided with electronic image-and-data catheter reports right at the end of 
the procedure. Voice memo-files are used for sharing impressions and 
reminders useful also when changing caD-shifts. Electronic patiCllt notes, in 
the cardiological and eev wards, contain these reports and sound memos as 
screen objects activated by a point-and-i:lick facility. No user has ever to 
know where the data and executable files are or how the programs are run 
since aD those procedures are fully automated. We found that these features 
and the overaU ease of a graphical CllvironmCllt really improve user 
interaction and reduce the gap that frequClltJy separates cardiologists from 
computers. 
994·2 
C·TREE: A Graphic Editor for Delineating and Annotating the 
Anatomy of Coronary Arteria 
va\Chara Sun and Ying Sun 
University of Rhode Island, Kingston, RI 
A computer program for reporting the anatomy of coronary arteries 
and the findings of cardiac catheterization has been developed. Using 
a special-purpose graphic editor, coronary arterial trees can be drawn 
quickly and with sufficient details. This is done by specifying the 
center line of a vessel segment with selective points; the vessel lumen 
width can be adjusted at each point A portion of a coronary arterial 
tree is shown below as an example. The center lines and scan lines 
appear during the initial entry and can be removed in the fmal report. 
LM LAD 
.--.-~ 
The diagrams can be saved, retrieved, and modified. Thus, a library 
of templates for frequently-encountered coronary arterial structures 
can be easily created and managed. Each vessel segment is labeled as 
one of the 26 standard branches, collateral, or by-pass graft 
Additional attributes including vessel size, tortuosity, and description 
of stenosis can be specified. The above sample diagram consists of 
69 entries of center line points; the initial creation of the diagram took 
just a few minutes by an experienced user. An automated reporting 
system is also implemented to output a text description of the fmdings 
along with the diagram. The software has been implemented in the C 
language for the Macintosh computer and should be useful for report 
generation in the cardiac catheterization laboratory. 
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994·3 
Coronary Angioscopy: Digital Recording of Real·Tlme, 
Moving Color Images-Technique and Applications. 
Peter den Heijer. Ren~ B. van Dijk. Kong I. Lie. Thoraxcenter. 
University Hospital Groningen. The Netherlands. 
Digital recording of video images has recently become avail•
able for standard Macintosh'" personal computers. High-resolu•
tion images can be recorded at 25-30 frames per second. and at 
24-bit color depth. using QuickTime'" software and supporting 
application programs. We have applied this technology to coro•
nary angioscopy images. Our system is based on Macintosh 
Quadra'" computers. with video capture boards or built-in 
digitizers. and 3.5 inch erasable magneto-optical disk drives. The 
angioscopic images are either directly acquired from the Baxter 
ImageCathThl system. or recorded from Super-VHS videotapes. 
They can be stored in compressed or uncompressed format. 
The following applications have been developed: 
1. A digital atlas of recorded angioscopic images. with descrip•
tion of these images according to the Angioscopy Classifica•
tion of the European Working Group on Coronary Angios•
copy. 
2. An interactive training program for new angioscopy users. 
developed using HyperCardThl software. 
3. A FileMaker ProThl patient database which incorporates 
digital recordings of angioscopic examinations. linked to 
patient registration. and clinical and procedural data. 
All applications share the same digitally stored recordings. The 
advantages of this technology include: a consistent image qual•
ity. easy editing of angioscopic recordings. compact storage. easy 
retrievability. and quick image processing for slides or photo•
graphs. 
994·4 
A Graphical User Interface Database for the Results of 
Cardiac CatheterisatioD 
Rodney H Stables, Nicolas A Chronos, Nigel P Buller. The 
Department ofInvasive Cardiology, The Royal Brompton 
National Heart and Lung Hospital, London, England. 
Traditional databases are often limited by laborious data entry 
procedures and the need for knowledge of a specialised 
nomenclature. We have developed a new database in which all 
data entry is by "point and click" interaction with computer 
graphics and automated drop down menus. This obviates the need 
for keyboard skills and ensures complete uniformity of 
terminology, facilitating accurate searches. It operates on a stand•
alone PC and is written in Microsoft Access utilising the 
Windows graphical user interface. 
Coronary anatomy is represented diagrammatically with the 
operator recording lesions by "point and click". The same 
graphical approach is employed for bypass graft information. A 
diagram of the coronary tree showing the location and luminal 
stenosis (%) of each lesion is printed as part ofa comprehensive 
procedure report. Data on left ventricular function, aortograms and 
pressures are also recorded. 
Artificial intelligence programmes analyse the raw data to ascribe 
indices of quantitative import, for example classes of disease 
severity and the AHA class of individual lesions. 
The system is in full clinical operation and we have demonstrated 
advantages in speed and precision of data entry, the production of 
appropriate reports and its ease of interrogation by structured 
query. Furthermore it has proven to have an audit and teaching 
role introducing a structured approach to reporting. 
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782·1 10:30 
Relultl of Intravalcullr Ultralound Guided Coronary 
Stenting Without Sublequent Anticoagulation 
Antonio Colombo. Patrick Hall. Yaron Almagor. Luigi Maiello. 
Antonio Gaglione. Shigeru Nakemura. Massimo Borrione. 
·Steven L. Goldberg. Leo Finci. ·Jonathan Tobis. Centro Cuore 
Columbus. Milan. Italy and • UCI Medical Center. Orange. CA 
From March 30 to July 20 1993. 191 consecutive pts 
underwent Palmaz-Schatz stentlng. Indications for stenting were: 
elective (62%). restenosls (15%). suboptimal PTCA result 
(14%). dissection or acute closure (3%). and post opening 
chronic total occlusions (6%). A total of 310 stents were 
deployed in 219 lesions (97% In native coronaries). Multiple 
stents were deployed in 43% of lesions. Primary stenting was 
unsuccessful In 7 pts (3.7%). leading to emergency CABG in 5 
pts (2.6%) • elective CABG in 2 pts (1%) and death in 1 pt 
(0.5%). IVUS was performed in all pts with successful stenting 
except in 8 pts when the machine was not operational and in 2 pts 
with an unsuccessful study. Of the 174 pIS with IVUS evaluation. 
additional complications occurred In 5 pts while attempting to 
improve stent expansion and resulted in 4 emergency CABG 
(2%). 3 coronary ruptures (1.6%). 2 myocardial infarctions 
(1%). and 2 deaths (1%). Fifteen pts (8%) received standard 
anticoagulation.(10 pts without IVUS and 5 pts with suboptimal 
stent expansion by IVUS). An optimal IVUS result (according to 
predefined criteria) was achieved In 164 pts (93%). These 164 
patients did not receive heparin or Coumadin after the procedure 
and were maintained on Ticlopidine 250 mg bid for 2 months. 
There have been no acute or subacute thrombosis. and no vascular 
or bleeding complications in the follow up period at a mean of 91 
days (range 41 to 153 days). Angiographic follow-up is 
SCheduled in all patients at 5 months. Conclusions: when IVUS 
guided optimal stent expansion Is achieved. subsequent 
anticoagulation may not be necessary. This strategy is not 
associated with an increase in stent thromboSis. The role of 
ticlopidine will require further evaluation. 
782-2 10:45 
335A 
Coronary Stenting Without Coumadin. Phase II. 
*Marie-C1aude Morice. Claude Bourdonnec. Yves Biron. 
Jean Fajadet. Bernard Glatt. Thierry Royer. Christian 
Descaves. Phil ippe Gaspard. Yves Lienhard. Jean Marco. 
CCN. Saint-Denis; GCV Volney; Le Tonkin. Lyon; C1inique 
Pasteur. Toulouse. France. 
Standard anticoagulation after coronary stenting is 
difficult to adjust. often provides unstable anticoagu•
lation. requires prolonged hospitalization and faces a 
high rate of subacute occlusion (3-32%). To prevent 
theses drawbacks. we prospectively treated III consecu•
tive patients with only 48 h continuous Heparin followed 
by low molecular weight heparin (LMWH) (0.1/10 kg b.i.d) 
associated with aspirin 0.1 glday and tic10pidin 0.25 
glday for one month. 
From December 1992 to September 1993. 111 patients (106 
males mean age 60.7 .! 9) were included. Stenti~g was 
electively performed in 54 (48.6%) pts inc1udlng 23 
(20.7%) cases of bypass grafts. Remaining indication of 
stenting was poor PTCA results in 57 (51.4%) including 
13 (11.7%) cases performed for bail-out situation. The 
124 stents (116 Pa1maz-Schatz. 7 Cook. 1 Wictor) were 
implanted with 2.5 to 4.5111T1 balloons (3.48.! 0.33nm). 
Subacute occlusion during the first month occurred in 
1 pt (0.9%) with a 7.7% rate for the bail-out patients. 
In-hospital complication included 1 (0.9%) non Q myocar•
dial infarction. 1 (0.9%) gastrOintestinal bleeding and 
3 (2.7%) grOin complications requiring blood transfusion 
or surgical repair. 
Conclusion : Post stenting treatment with LMWH. 
ticlopidin and aspirin provides a very low rate (O.g%) 
of subacute occlusion even in bail-out situation and an 
acceptable rate (3.6%) of bleeding complications. Accor•
ding to the results of Phase I. tic10pidin seems to play 
a major role in these results. 
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782·3 11:00 
Coronary Stenting Without Coumadin. 
*Paul T. Barragan, Marc A. Silvestri, Jo~l B. Sainsous, 
Jean L. Bouvier, Bertrand L. Comet, Jean B. Sim~oni. 
Clinique les Alpilles, Marseille, France. 
Subacute thrombotic occlusion still remains the major 
limitation of coronary stenting. Standart anticoagula•
tion faces a high rate of subacute occlusion (3 - 30 %). 
To prevent these complications we treated 275 consecuti•
ve stented patients (pts) with ticlopidine (500mg/day) 
initiated 3 days before PTCA, 20-hour continuous heparin 
followed by 7-day sub-cutaneous heparin started 5 hours 
after sheath removal (PTT = 1 x control) ; pts were dis•
charged at day 8 with ticlopidine for 6 months without 
coumadin. 
From January 1990 to July 1993 , 275 pts (217 males, 
mean age 63 + 10,2 years) with 282 stented coronary ar•
teries were Included. Stenting was electively performed 
in 103 (36,5 %) cases including 65 (23 %) restenosis and 
13 (4,6 %) bypass grafts; remaining indication of sten•
ting was failed PTCA in 179 (63,5 %) cases with 38 (13,5 
%) suboptimal result and 141 (50 %) dissection including 
43 bait-out. The 310 stents (290 Palmaz-Schatz, 17 Stre•
cker, 3 Gianturco-Roubin) were implanted with 2.5 to 5.0 
mm balloons (mean 3,33 + 0,42). Subacute occlusion du•
ring the first month occured in 10 pts (3,6 %) with a 7 
% rate for the 43 bail-out and 3 % for the 232 remaining 
patients (ns). In-hospital major complications included 
4 (1,5 %) deaths,S (1,8 %) MI. Severe femoral hematoma 
occured in 12 (4,4 %) pte. 
Conclusions : Pre and post coronary stenting treatment 
with ticlopidine in association with sub-cutaneous hepa•
rin seems to reduce the incidence of subacute stent 
thrombosis. Under these conditions urgent coronary sten•
ting may be considered as a safe and definitive therapy. 
782·4 11:15 
Thrombin Activity and Platelet Activation FollOwing Cessation of Hepa•
rln In Patients lifter Intracoronary Stenting 
David L. Brown, Sorin J. Brener, Gaddiel D. Rios and Kandace Kottke•
Marchant, Cleveland Clinic Foundation, Cleveland OH 
Intracoronary stents are 1hought to be potent thrombogenic stimUli. Despite 
current anticoagulant regimens, clinically significant stent thrombosis and 
bemonhage remain problematic. We analyzed factor X activity (F1.2 nglmJ), 
thrombin activity (fibrinopeplide A [FPA) nglmJ), plasmin activity (d-dimer 
[D-D) nglml) and platelet activation (platelet factor 4 [PF4) nglmJ) in 20 pts. 
undergoing intracoronary stent placement, in an attempt to examine the 
efficiency of anticoagulation. Methods: Plasma samples were collected after 
placement of intravascular sheaths and beparin bolus (baseline [B 1)),2-6 brs. 
post procedure (82) and daily for 6d (D 1-6). Heparin was discontinued at a 
mean of 108 brs. Specimens were analyzed by ELISA. Statistical analysis was 
performed using the 2-talled t test. Results: fP A increased from 4±4 at B2 to 
9±6 at D4 (p=O.02) and to 11±2 at D6 (p=O.05). FI.2 decreased from .68±.37 
at BI to .29±.27 at D4(p=O.OO3), to .29±.33 at D5 (p=OJlO6) and to .12±.20 at 
D6 (p=O.OOl). PF4 increased from 29±21 at B 1 to 61±39 at D5 (p=O.OO8) and 
to 52±31 at D6 (p=O.04). Finally. D-D increased from 603 at B 1 to 1217 at D6 
(P=NS). Conclusion: Heparin and Warfarin effectively suppressed factor X 
activity mediated thrombin generation throughout the course if this study. 
However, after discontinuation of heparin there was evidence of increased 
thrombin activity accompanied by platelet activation, possibly related to 
release of clot-bound thrombin. Thus. either slow tapering of heparin or more 
potent direct inhibitors of Clot-bound thrombin may improve late outcome 
after stent placement. 
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782·5 
Two-c:enter Experience With the Palmaz-Scbatz BUiIIry SleDt lor 
Treating VelD Graft and Native CorolllJ'y SleDoses 
Donald S. Bairn, Martin B. Leon. Jospeh P. Carrozza, Augusto D. Pichard. 
Aaron D. Kugelmass, Kenneth M Kent, Kalon K.L. Ho, Lowen F. Saller, 
Jeffrey J. Popma, Richard E. Kuntz. Beth Israel Hospital, Boston. and 
Washington Hospital Center, Washington DC 
11:30 
Within the last 18 months, our two centers have implanted 284 
Palmaz-Schatz biliary stents in 252 saphenous vein grafts and 32 native 
coronary lesions. Cineangiograms were reviewed using quantitative 
angiographic (automated edge detection) techniques. Of the vein grafts 
treaJed, 25.8% were degenerated (more than 50% of the graft length with 
Iwninal irregularities or ectasia). while 25.8% of lreated lesions were 
ulcerated and 16.8% had angiographic thrombus. Stenl placement was 
successful in 279 (98.2%) of lesions, with enlargement of the minimal 
lwnen diameter from 1.21±.69 mm to 3.18±.68 mm, representing 4.9% 
residual diameter stenosis relative to a reference diameter of 3.38±.62 rom. 
Although the average lesion length was 9.6.t6.1 mm, 2 to 5 'multiple 
contiguous stents were required in 4.5% of lesions to treat longer diseased 
segments. 
Despite the advanced age (S.8±3.S years) of the treated vein grafts. 
major complications were infrequent (0.9% in-hospital death. 1.4% 
emergency surgery, 0% Q-wave myocardial infarction). CPK elevation 
consistent with non-Q Ml (12.0%), transient "no-reflown requiring 
intraCoronary verapamil (9.9%). and local vascular complications requiring 
surgical repair (12.2%) or transfusion alone (10.3%). were the most 
common other complications. Acute thrombosis occurred in only 1.0%, and 
sub-acute thrombosis in 2.5%. 
Conclusion: I) The approved biliary stent can provide excenent 
acute angiographic results with high procedural success and safety for this 
non-approved indication. when used by investigators experienced in stent 
placement 2) Additional clinical and angiographic fonow-up will be 
required to assess the relevant restenosis rate. 
782-6 11:45 
Survival and Event-free Survival After Stent Impllntltion In Saphenous 
Vein Grafts and CorOllIry Arteries 
Peter P. de Jaegere, Ron van Domburg, Plm J. de Feyter, Patrick W. 
Serruys. Thoraxcen!er, Rotterdam, The Netherlands. 
There is ample evidence that stent Implantation In both saphenous vein grafts 
and coronary arteries may reduce the restenosis rate, but there are scant 
data on long-term outcome. To determine long-term survival and event-free 
survival (freedom from death, AMI. CABG or PTCA) ail pts In whom a stent 
was successfully Implanted In a vein graft (57 pis. group 1) or coronary 
artery (137 pts, group 2) between November '86 and July '93 were reviewed. 
All events, Including acute complications, were prospectively recorded In a 
computer database. Follow-up Information was obtained by Interview during 
out-patient vls~s or by telephone. Information was complete for 169 piS 
(87%). Mean time to FU was 28 ± 17 mths for group 1 and 20 ± 16 mths for 
group 2. There was no difference between the 2 groups, except for a higher 
age In group 1 (64 ± 8 versus 58 :!: 10) and a higher frequency of multi 
vessel disease (94% versus 32%). The estimated 4 yr survival and event-free 
survival (Kaplan-Meier Method) was 81 ± 5.4% and 28 ± 6.6% In group 1 but 
was 96 :!: 1.6% and 44 ± 5.4% In group 2 (Figure). 
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Conclusion: long-term survival Is acceptable after slentlng of vein grafts and 
coronaries. This does not hold for event-free survival, especially In vein 
grafts. These data Indicate that vein graft disease may be considered as an 
end-stage disease In which we can only offer palliation for some period of 
time. 
lACC February 1994:1A-484A 
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783·1 10:30 
A Prospective Study or Cocaine Related Cardiovascular Morbidity and 
Mortality: Cbronic Cocaine Users vs Post-Anaioplasty Patients. 
KoonIawee Nademanee. Olivia Adair. Edward Havranek, TIIJa Pearson, 
William Bailey and Jill Di Pasquale. Dtmver, CO 
Recent statistics show a surge in cocaine related emergency room 
visits and deaths. possibly due to a rising number of chronic cocaine users 
(CU). The precise incidence of cocaine-related cardiovascular mortality and 
morbidity remain unclear. We prospectively studied 143 CU (mean age= 35; 
102 males) p ....... ting withcocaine related cardiovascular symptoms fromJan 
91 to Dec 92. Allpatients were asked to follow up at I, 6 and 12 months. End 
points were major cardiac events (MI. CHF, Iife-threatening anbythmias or 
cardiac arrest). We compared such events to those occurring in 42 post•
angioplasty patients (pAP). 
During the one year period 
35 (2S %) were lost to follow-
up. Of the remaining lOS, 9 
(S%) died, 7 (6%) suffered 
acute MI. 9 (S %) developed 
arrhythmias or cardiac 
arrests, and 7 (6%) 
developed CHF. All7 CU with 
CHF had dilated hearts; 5 
died within 1 year. When we 
compared the long-term 
outcome of these CU to that 
of post-angioplasty patients 
(see Figure). we found that 
eu had a higher incidence 
(lS%) of major cardiac 
events during the first year 
than PAP (4%). Thus, eu 
Cocaine 
•.• ;-. ~":;---::,,,~,:::,,:-:,,,::-~,,,~,,,=--:,,,=--::,,, 
Days 
have a poor prognosis and are likely to develop heart disease at a relatively 
young age with a high mortality rate. eu represent a major health problem; 
further study is required to develop an effective moatment. 
783·2 10:45 
Cellular Immunity is Activated in Young Normal 
Cholesterol Patients with Coronary Artery Disease 
*Toshinori Utsunomiya, Teruo Noguchi, Toshihiro Ryu, 
Kazuyo Yoshida, Tohru Ogata, Shinsuke Tsuji, Takashi 
Tokushima, Shuzo Matsuo Cardiology Division, Department 
of Internal Medicine. Saga Medical School, Saga. Japan 
Some pts have severe coronary artery disease without major 
coronary risk factors. Cellular immunity is postulated to 
cause endotherial cell damage and progress arteriosclerosis 
in coronary artery. We evaluated the relationship between 
cellular immunity and coronary artery disease. ~
Forty-two pts were analyzed. Twenty·eight pts had arterio•
sclerotic coronary artery disease by coronary arteriography. 
Fourteen pts had other heart disease and had no coronary 
artery disease by coronary arteriography. Thirty-one men 
and eleven women. Age ranged from 21 to 79 years. M.e.1h.2.d..; 
1) Peripheral lymphocyte T-cell subset (CD3, CD4, CDS) and 
B-cell (CD20) were calculated using flow cytemeter. Blood 
sampling was performed at rest in chronic phase. 2) Serum 
total chlesterol, triglyceride and HDL cholesterol were also 
measured. 3) These were compared between coronary artery 
disease (CAD) and non coronary artery disease (NonCAD) 
group. Rult.I.l;. 1) In pts with age over 50 years and normal 
serum total choresterol, CD3, CD4, CDS and CD20 bad no 
significant differences between CAD and NonCAD group. 
2) However. in pts with age under 50 years and normal serum 
total cholesterol, CAD group had higher CDS and CD20 than 
NonCAD group (25.9vs22.4, 14.6vsS.2. p<.05). 3) In pts with age 
under 60 years and normal serum lipid (total cholesterol, 
triglyceride, HDL cholesterol), CAD group had significantly 
higher CDS and CD20 than NonCAD group (26.5vs22.4, ILl vs 
S.2, p< .05). Conclusion' Althougb many mechanisms are 
postulated to cause and progress the arteriosclerosis in CAD, 
activated cellular immunity has possibility to cause endo•
thelial cell damage and progress the arteriosclerosis in 
young CAD pts with normal cholesterol level. 
ABSTRACTS 337A 
783·3 11:00 
The Hyperinsullnemla-Flbrlnolytlc Relationship In Man and Ita 
Relationship to Premature Coronary Artery DI.ea.e. 
Richard J. Katz, Robert Ratner, Robert Cohen, Ellen Eisenhower, 
Helena Jacobs, Craig Kessler. George Washington University, 
Washington, D.C. 
It has been hypothesized that hyperinsulinemia predisposes to 
coronary artery disease (CAD) in part by inducing reduced fibrinolytic 
capacity. Pancreatic beta cell secretory products, particularly 
proinsulin, have been shown to stimulate increased plasminogen 
activator inhibitor-1 (PAI-1), an established risk factor for CAD. We 
assessed this relationship in vivo by measuring 9AM fasting PAI-1, 
immunoreactive insulin (IRI), specific insulin (INS) and proinsulin (PI-
11 E) in 33 nondiabetics. All three hormones showed strong 
correlation with PAI-1 levels: 
R value 
P value 
IRI 
0.55 
0.001 
INS 
0.62 
0.0001 
PI-HE 
0.50 
0.0029 
This correlation with PAI-1 was no stronger for proinsulin than the 
other insulin hormones. 
Since both PAI-1 and pancreatic beta cell hormones increase with 
obesity we further assessed the importance of PAI-1 as a risk factor 
for premature CAD when controlling for body mass index (8MI). We 
evaluated 28 nondiabetic patients who underwent cardiac 
catheterization documentation of coronary status. There were 14 
patients with premature CAD «55yo) with 14 normals matched for 
8MI (31.1 vs 31.2 Kg/m~. PAI-1 levels (ng/ml) were similar in the 
CAD and matched normal groups: 44.9±23.9 and 42.7±25.5 
respectively, pNS. 
The hyperinsulinemia-fibrinolytic relationship exists, however, with 
regards risk for atherosclerosis, obesity may be the controlling factor 
prediposing patients to premature CAD. 
783·4 11:15 
Association between Plasma Thrombomodulin Level and 
Angiographically Assessed Coronary Atherosclerosis. 
*Jun Segawa, Yasuhide Nakashima and AIdo Kuroiwa. 
The 2nd Dept. of Internal Medicine, University of Occupational 
and Environmental Health, Kitakyushu, Japan. 
Thrombomodulin (TM) is an endothelial cell membrane 
glycoprotein which neutralizes thrombin clotting activity and 
accelerates thrombin-catalyzedactivation of protein C. To study 
the relation between coronary atherosclerosis and plasma TM, which 
is widely noted as a molecular marker reflecting endothelial injury. 
we measured plasma TM levels in 154 patients underwent diagnostic 
coronary arteriography. Plasma TM levels were detennined by an 
one-step sandwich enzyme immunoassay. Coronary artery disease 
was rated as present or absent and was also represented by a 
quantitative lesion score derived from estimates of stenosis in every 
coronary arteries. Sixty-seven patients had nonnal coronary arteries 
(non-CAD group) and 87 had diseased coronary arteries (defined 
as ~ 75% stenosis; CAD group). A significantly high level of 
plasma TM was found in the CAD group. The mean value of 
plasma TM was 4.1 ± 0.4 ng/ml in the CAD group while 2.9 ± 0.1 
ng/ml in the non-CAD group (P<O.Ol). Plasma TM levels showed 
a signifcant positive com:lation with the coronary lesion score 
(r=O.41. P<O.OOl). Among the CAD group. plasma TM levels 
were significantly higher in patients with previous myocardial 
infarction than in those without infarction (4.3 ± 0.3 ng/ml vs 3.3 
± 0.2 ng/ml. respectively, P<O.05). These results suggest that 
plasma TM level is a significant predictor of the presence and the 
severity of coronary atherosclerosis. and that the increase in plasma 
TM. which indicates the decrease of cellularTM. may contribute to 
the development of myocardial infarction. 
338A ABSTRACTS 
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Is Coronary Artery Disease the Leading Cause of 
Death Among Black Americans 
cynthia Crawford-Green, William Green, 
Christopher Allen 
Howard university, Washington, D.C. 
The leading cause of death among African 
Americans is most often attributed to coronary 
artery disease (CAD); yet, controversy persists 
regarding the extent and severity of CAD in this 
group from previous arteriographic and 
epidemiological studies. To address this issue 
anatomically, we performed a retrospective 
analysis of the 135 consecutive necropsies 
performed in 1990 at our institution which 
serves a mainly black urban population. 40 
infants were excluded which yielded a study 
group of 52 women, mean age 57.3 and 43 males, 
mean age 51.8 yrs. CAD was documented in 40/95 
or 42% of all pts. Mild CAD defined as 50%-70% 
luminal narrowing in at least one major coronary 
artery was found in 8/95 pts.j moderate CAD or 
71-85% stenosis in 9/95 pts. and severe CAD or 
>85% stenosis in 23/95 pts. CAD was the 
proximate cause of death in none with mild 
disease; 2/9 with moderate diseasej 17/23 with 
severe disease and overall in 19/95 or 20% of 
pts. Marked cardiomegaly was noted in all pt. 
groups: among men 20-39 483gj 40-59 552g; >/60 
502gj among women 20-39 408gj 40-59 456g and 
>/60 354g. These data show 1. that in this 
population, cardiomegaly is commonly found 
despite the absence of CAD or hypertension and 
2. anatomically significant CAD is not 
frequently encountered at necropsy. Thus, the 
data suggest that CAD is not the leading cause 
of death among African Americans. 
783-6 11:45 
Mild Hyperbomocysteinemia in Young Myocardial Infarc· 
tion Patients: Prevalence and Treatment with Pyridoxine 
and Folate 
Michiel van den Berg, Martien J.F.M. Janssen, Jan A. Rauwerda, 
Freek W.A. Verheugt. Depts of Vascular Surgery and Cardiology, 
Free University Hospital, Amsterdam, The Netherlands 
Mild hyperhomocysteinemia after methionine loading is due to 
heterozygous cystathionine B-synthase deficiency. It is rare « 1 % 
of normal individuals) and increases the risk for vascular disease. 
We assessed the frequency of excessive homocysteine accumula•
tion after standard methionine loading in 117 patients (pts) pre•
senting with acute myocardial infarction before the age of 50. 
There were no conditions known to disturb methionine metabolism 
such as renal failure, liver cirrhosis, vitamin B6, vitamin B 12 or 
folate deficiency. Pts were considered to have mild hyperhomocys•
teinemia, if peak levels of homocysteine measured after 
methionine loading exceeded the mean levels after loading in 
normal individuals by more than 2SD. 
Mild hyperhomocysteinemia was seen in 17 (14%) pts. These pts 
were subsequently treated for 6 weeks (wks) with pyridoxine (250 
mg daily) and folate (5 mg daily) resulting in a normal methionine 
response in 15 (88%) pts. The other 2 pts had a normal 
. methionine response after 12 wks. 
We conclude, that mild hyperhomocysteinemia is not uncommon 
in pts with premature ischemic heart disease. Pyridoxine and 
folate results in a substantial lowering of homocysteine levels after 
methionine loading. This therapy needs large scale testing in pts 
with premature coronary disease and elevated homocyslf.ine levels 
after methionine loading. 
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784·1 10:30 
Increase In Plasma Beta Endorphins Precedes Vasodepressor 
Syncope 
David R Wallbridge, Halina E MacIntyre, Christina E Gray, Martin A 
Denvir, Keijh G Oldroyd, Alan P Rae and Stuart M Cobbe. Royal 
Infirmary. Glasgow, UK 
Endogenous opioids inhibij the sympathetic response to orthostatic stress 
and may trigger vasodepressor syncope. Frequent blood sarf1)ling was 
performed during tiH testing to identify evidence for plasma ~-endorphin 
release prior to syncope onset. The study group comprised 24 
consecutive patients [mean age 54.5yrs; range 18-77] undergoing head•
up tiH testing (700 for 40 min) for unexplained syncope. Resuks are 
plasma ~-endorphin levels expressed as mean (SO) pmoVI. 
Patients w~h a posijive test [9 vasodepressor syncope; 1 presyncope] 
showed a significant rise in plasma ~-endorphin levels prior to syncope 
[baseline 4.4(1.5) vs syncope onset 8.5(3.t), p<0.002). In contrast. 
patients w~h a negative test showed little change in plasma p-endorphin 
levels [baseline 3.4(1.0) vs end of test 4.5(2.3), NS). Following syncope 
all patients showed a large secondary increase in plasma p-endorphins 
[32.3(18.6)]. The p-endorphin response appeared independent of changes 
in plasma catecholamines, wijh a similar rise in plasma noradrenaline 
levels in the pos~ive [baseline 2.6 vs syncope onset 4.5 11M) and negative 
baseline 2.2 vs end of test 4.6 11M tik.,..:t::::est::::....l2~rou=ps:::. ______ ~ 
TiH test posijive (syncope = time 0) TiH test negative 
{" 
I .. 
,0 10 •• 
n..(MIft) 
Conclusion: An Increase In plasma beta endorphIns prececles 
vasodepressor syncope, supporting a role for endogenous oploid 
mechanisms In the pathophysiology of this condition. 
784·2 10:45 
AngIogenesis IDdDCed ID Vlyo Following Slte.Spedflc AdmlDstl'ation of 
V MeDlar EndotlleUal Growth Factor (VEGF) Is Potentiated by Systemic 
Administration of Heparin 
Takayuka Asabara, SaIOsbi Takeshila, Lu P. 2heng, Cbristopbe BaulerS, Jeffrey 
Horowitz. -Sloan Bunting, -Napoleone Ferram, James Symes, Jeffrey M. ISlICf, 
St. Elizabeth's Hospital, Tufts Medical Scbool, BostOll, MA. -Gcnentccb Inc., 
South San Francisco, CA 
Recent studies performed in our Laboratory have documented in vivo evidence 
of therapeutic angiogenesis in a rabbit model of unilateral bindlimb ischemia 
following a single intra-anerial bolus of vascular codothelial growth factor 
(VEGF). Because in vitro studies reported by Soker et al (J. BioI. Cbem 268: 
7685, 1993) demonstraled!bat VEGF may be inactivated by binding to a1pba-2-
macroglobulin, and !bat sucb binding may be iDbibited by heparin, we investigated 
tbe bypotbesis !bat syslelllic administratioo of beparin may poteDtiaIc angiogenesis 
induced by VEGF in vivo. Unilalcral hindlimb iscbemia was created in twcoty•
three 4-kg New Zealand white rabbits by excising the femoral artery and ligating 
all residual branches. At 10 days post-operatively, an infusion catbeter was used 
to deliver to the internal iliac artery of the ischemic hindlimb a single bolus of 
saline willl no systemic heparin (Coot, 0=7); saline with systemic (800U) heparin 
(Hep, 0=4); VEGF,I()(41g wilb \10 systemic 0.8 • day/O * 
heparin (VEGF, n=4); VEGF, 100 or :day20 ** 
500!tg wilb systemic beparin (Hep+ VEGF, II: 0.6 dDy4I) 
n=8). Ratio of systolic blood pressure in 
ischemic limb VelSUS normal limb was 0.4 
measured for each rabbit at postoQperlltive ] 
day 10 (immediately pre-treatment), day III 0.2 
20 and day 40 as shown on lbe rigbt. Re•
duction in bemodynamic delicit achieved wilb 00 
Hep+ VEGF exceeded that achieved witb . 
VEGF or heparin alone. Serial angiography performed 
on days 10, 20, and 40, and bistoIogy at day 40 docwnented 
corresponding improvement in collateral artery develop•
ment and capillary density respectively. 
Hop+ 
VEGF 
- > VEGF (1'=(>.024) 
> Hop (1'=0.0005) 
•• > Hep (p:{J.(146) 
Conclusion: systemic beparin potentiates therapeutic angiogenesis achieved wilb 
VEGF in Ibis model of lower extremity vascular disease. 
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Endothelin·l Induces Coronary Vasoconstriction via the 
ET·A Receptors. 
Charles R. Cannan, Roland R. Brandt, R. Scott Wright, Wayne L. 
Miller, "'Terry J. Opgenorth, John C. Burnett, Jr! Amir. Lerman. 
Mayo Clinic, Rochester, MN and * Abbott Laboratones, Chicago, IL. 
Endothelin-l (ET-1) is an endothelial-derived peptide which 
produces vasoconstriction. The ET-A receptor, which binds ET~1 
preferentially, is highly expressed in vascular smooth mu.sc~e and IS 
thought to be instrumental in ET-l mediated vasoconstnctton. To 
date, the role of the ET-A receptor sub-type in mediating coronary 
vasoconstriction has not been defined. The current study was 
designed to assess the role of the ET-A receptor in cot<?nary 
vasomotion in response to both endogenous and exogenous ET m the 
anesthetized dog. ET-1 (2 ng/kg/min) was infused into the left 
circumflex coronary artery in Group 1 (n=5) following vehicle and in 
Group 2 following specific ET-A receptor blockade (FR 139317, 
Abbott Lab. IL) at 4 ~g/kg/min. No alterations in systemic 
hemodynamics were observed in either group. Coronary blood flow 
(CBF; Flow probe), coronary vascular resistance (CVR) and 
coronary artery diameter (CAD; Sonomicrometry) were determined at 
baseline, during antagonist or vehicle and ET-l infusion. CBF and 
CAD were not different between groups at baseline. No significant 
change in CBF or CAD was observed during ET-A blockade. 
Changes during the ET -1 infusion are outlined below: 
.QrQwll ~ 
%6 CBF -48±7* -1213 
%6 CYR 105±24* 7±6 
Data are mean±SEM, *p<0.01 vs. GrouJl2 
The decrease in CBF was foHowed by a small but significant 
change in epicardial CAD (-4.6±0.4% in Group 1 vs. -1.0±0.3% in 
Group 2, p<0.05). This study demonstrates in vivo that: 1. ET-I 
induced vasoconstriction is mediated by the ET-A receptor. 2. The 
large decrease in CBF with only modest changes in epicardial 
diameter indicates that ET -1 induced coronary vasoconstriction may 
occur primarily in small resistance rather than epicardial vessels. 3. 
Endogenous ET does not appear to have a significant role in the 
regulation of basal coronary vascular tone via the ET -A receptor. 
784·4 11:15 
Beta ~oreceptor. Participate in C-Type Natriuretic 
Peptide Mediated Coronary Dilatation. 
R.Scott Wright, Roland R. Brandt, Chi-Ming Wei, Cheol 
H. Kim, Lawrence L. Aarhus, Matthew R. Thomas, John C. 
Burnett, Wayne L. Miller. Mayo Clinic. Rochester, MN 
C-type natriuretic peptide (CNP) is an endothelial 
cell derived, endothelial-independent coronary dilator. 
To date, the mechanisms of CNP-mediated coronary 
dilatation are undefined. While it was reported that 
the beta adrenoreceptor (BAR) modulates the activity of 
the natriuretic peptide clearance receptor in vascular 
smooth muscle, a role for the BAR in modulating CNP•
mediated coronary dilatation is undefined. Left 
circumflex coronary blood flow (CBF) and diameter (CD) 
were measured in five dogs utilizing an EMG flow probe 
and sonomicrometry respectively. Under basal 
conditions, an intracoronary bolus (IC) of CNP (100 
ng/kg) increased CBF from 63±16 ml/min to 116124 
(p<O.05). Following administration of IC propranolol 
(1 mg over 30 min), an IC CNP bolus increased CBF from 
60±18 ml/min to 76±18 ml/min (p<0.05). While the 
increases were significant compared to baseline, IC 
propranolol reduced the absolute increases (Basal 6CBF: 
53±17 ml/min, Propranolol 6CBF:l6±3 ml/min p<0.05). IC 
CNP significantly increased CD by 51±8 ~ during the 
basal period (p<0.05) and this effect was not different 
during the propranolol period. In contrast, IC 
propranolol did not attenuate coronary dilatation to 
the endothelial-dependent coronary dilator 
acetylcholine (ACBF basal:62±6 ml/min, 6CBF Propranolol 
Sl±B,p-NS between basal and propranolol) . 
In summary, the current study demonstrates that 
BAR inhibition attenuates CNP-mediated coronary 
dilatation and suggests that this interaction between 
CNP and the BAR occurs predominantly at the resistance 
level of the coronary vasculature. These investigations 
provide for the first time a functional link between 
the natriuretic peptide and beta-adrenergic systems in 
the regulation of coronary blood flow. 
ABSTRACTS 
784·5 11:30 
Effects of Escherichia Coli Endotoxemia on Coronary 
Microvascular Responses to Serotonin and ADP 
Frank W. SeUke, Steven Y. Wang, Thomas J. VanderMeer, 
Mitchell P. Fink. Beth Israel Hospital and Harvard Medical School, 
Boston MA 
Studies examining the effects of E. Coli endotoxin on end<?thelial 
function have found inconsistant results. In order to examme the 
effects of E. Coli endotoxemia on coronary microvascular responses 
to the platelet-derived vasoactive substances serotonin (5-RT) and 
ADP, coronary arterioles were isolated from pigs 3 h~urs after 
administration of E. Coli endotoxin (Endo, 150 ~g/Kg, I.V. over 1 
hour) or Ringer's lactate (control). Coronary arterioles (90-190 ~.m) 
were studied in vitro with video-microscopy. Drug~ were applied 
extraJuminally. Selected experiments were performed m the presence 
of indomethacin (IND. lO~M) or nitro-L-arginine (NitroArg, 
100~M), Responses are % relaxation of acetylcholine-induced 
precontraction. "p<0.05 vs control, tp<0.05 vs Endo, 
SNP=sodium nitroprusside, risem, (-) = additional contraction. 
Groups (n) 5-HT 00 uM) ADPOO uM) SNP 000 uM) 
Control (8) 21±3 74±4 93±2 
Control-IND (8) -3±2* 58±3* 
Control-NitroArg (5) -15±4* 0±1O* 
Endo (6) -7±5'" 83±6 91±3 
Endo-IND (6) 6±3*t 59±5*t -------
Control microvessels denuded of endothelium failed to relax, or 
contracted in response to 5-HT or ADP, while responses to SNP 
were not a'ffected. Thus, both S-HT and ADP cause endothelium•
dependent relaxations of control porcine coronary microvessels 
through the release of endothelium-derived nitric oxide and 
vasodilator prostaglandin products. Following endotoxemia, the 
microvascular response to ADP is not affected, while the relaxation 
response to S-HT is converted to a contraction response, mediated 
by the release of vasoconstrictor prostaglandin products and to the 
diminished release of endothelium-derived nitric oxide. 
784·6 11:45 
Acute Hypoxia and Endogenous Renal Endotbelin In tbe Dog 
Amiram Nir, Alfredo L. Clavell, Lawrence L. Aarhus, Denise M. Heublein, 
John C. Burnett Jr. Mayo Clinic/Mayo Foundation Rochester. MN 
Endothelin (E1) is a potent systemic and renaJ vasocoostricta peptide of 
endothelial cell origin. Studies have suggested a non-vascular paracrine and/or 
autocrine role for E-T in the kidney. such that ET may decrease tubular sodium 
reabsorption. Hypoxia (Hx) has been teport.ed 10 mediate vasoconstriction and 10 
induce ET telease by endothelial cells in vitro, as well as increase plasma ET in 
vivo. To date, the possible activation of renal ET in Hx remains undefined in 
vivo. The current study was designed to elucidate !be renaI ET tesponse to acute 
moderate Hx, as reflected by urinaIy ET excrelOry rate and renal tissue ET 
immunoreactivity and 10 corte1ate these responses 10 the hemodynamic and 
excrelOry changes during Hx. Experiments were conducted in two groups of 
anesthetized dogs: hypoxic group (10% Oz ventilation, pOz_44 mmHg, n=7) 
and time control group (room air (RA) ventilation, pOz-lll mmHg, n=6). A 20 
min baseline period (RA 1) was followed by 60 minutes Hx or room air 
ventilation (RA 2). IGdneys were then harvested and stained 
immunohiSlOChemically for ET. 
Control Group Hypoxic Group 
RA 1 RA 2 RA 1 Hypoxia 
MAP (mmHg) 118±3 116±5 12218 128±8 
Urine flow (ml/min) 0.18±.03 0.17±O.03 0.24±0.05 O.44±O.IO*t¥ 
UNaV ijlEq{min) 37.3±8.9 34.0±9.1 40.8±10.8 84.2±21.9*¥ 
FENa (%) 1.6..+0.4 1.8±0.5 1.5±O.4 2.9±0.9*¥ 
UETV (pglmin) 9.5±2.0 8.7±1.3 9.8±3.2 14.7±2.6*¥ 
MAP=mean anerial pressure; UNa V =Urinary sodium excretion; FENa=Fractional 
Na Excretion; UE1V=Urinary ET excretion; 
*iKO.05 vs RA; tiKO.05 vs Control; ¥p<O.OS for change from RA vs Control. 
Acute moderate Hx was associated with significant increases in urinary ET 
excretion, urine flow, urinary sodium excretion, and fractional excretion of 
sodium (p<:O.05). There was no signiflC8Dt change in glomerular fliustion rate, 
renal blood flow, renaJ vascular tesistance or mean anerial pressure. Renal 
immunohistochemistry for ET revealed increased staining in the proximal and 
distal tubules in the hypoxic group as compared 10 controls. This study 
demonstrates that acute moderate Hx results in increased urinary ET excretion and 
renal tubular ET immunoreactivity, in association with diuresis and natriuresis, 
and suggests a non-vascular role of endogenously produced renaI ET in the 
regulation of sodium homeostasis during Hx. 
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Interstitial Fibrosis as a Substrate or Spontaneous Nonsustained 
Ventricular Tachycardia in Idiopathic Dilated Cardiomyopathy 
Francesco Pelliccia, Giuseppe Critelli, Cinzia Cianfrocca, Giulia 
d'Amati, Paola Bemucci, Pietro GaUo. University of Rome "La 
Sapienza", Rome, Italy 
Various morphologic and functional abnonnalities have been 
invoked to explain the high prevalence of ventricular anbythmias 
in idiopathic dilated cardiomyopathy (IDC), and a mechano•
electrical feedback has been suggested. However, the structural 
substrates of the electrical instability of IDC are not completely 
known. The aim of this study was to identify which LV 
echocardiographic, hemodynamic or histomorphometric featu.res 
could be associated with the spontaneous occurrence of 
nonsustained ventricular tachycardia (VT) in 40 IDC pts (mean 
age: S2±IO yrs) with an ejection fraction of 28±10% (range: IS-
40%). During 48-hour Holter monitoring, 12/40 pts (Gr. A) showed 
I or more episodes of nonsustained VT, whereas no VT was 
detected in the remaining 28/40 pts (Gr.B). The two groups had 
similar LV dimension, walllhickness, mass and wall stress, as well as 
LV end-diastolic pressure and ejection mction, Conversely, cardiac 
index was lower in Gr.A than in Gr.B pts (2.2±D.4 vs 2.6±O.4 
l/min/m2, p<O.OI). Also, Gr.A exhibited greater amounts of 
interstitial fibrosis (l9±10% vs S±3%, p<O.OOl) and endocardial 
fibrosis (l7±9% vs 7±6%, p<O.OOl), as compared with Gr.B. No 
Significant difference in myocellular area, nuclear area and 
myofibril volume mction was detected between the two groups. 
Multivariate analysis identified interstitial fibrosis (p=O.OOI) as the 
only independent factor associated with nonsustained VT. 
Noteworthy, interstitial fibrosi~lO% was found in 11/12 Gr.A pts 
(sensitivity: 92%), but in only 3/28 Gr.B pts (specificity: 89%). We 
conclude that in IDC: (l) interstitial fibrosis may constitute a 
substrate of spontaneous nonsustained VT; (2) LV dimension and 
load are not significantly associated with anbythmogenesis; (3) 
histologic abnormalities of the LV rather than mechano-electrical 
feedback may play an anbythmogenic role in a subset of pts. 
785·2 10:45 
Prognostic Stratification of Patients With Idiopathic Dilated Canlio· 
myopathy by Doppler Ecbocardio&l1Iphy of Left Ventricular FilIin& 
Gerald S. Werner, Jens B. Fuchs, Richard Schulz, Hans R. Figulla, Heinrich 
Kreuzer, Dept. of Cardiology, Georg-August-University, Goettingen, Germany 
Left ventricular diastolic dysfunction is a major determinant of the clinical 
symptoms of heart failure. It may also be related to the clinical course of a di ...... 
Therefore, we studied 57 patients with idiopathic dilated cardiomyopathy (IDC) by 
Doppler echocardiographic evaluation ofleft ventricular diastolic filling at the time 
when the diagnosis was eatsblished by angiocardiography. During follow-up of 29 
± 16 months, 15 patients h.d died, 12 because of progressive congestive heart fail•
ure, and 3 died suddenly; 4 underwent cardiac transplantation (lUX) because of 
heart failure (two-ye.r survival free of death or HTX: 75%). 
Patients who died of congestive heart failure or underwent HTX had a typical 
pattern of the e.rly filling phase with a steep increa .. and decrease of the peak 
velocity a. compared with survivors: the peak early Doppler velocity w.s higher 
(0.84 ± 0.16 vs. 0.65 ± 0.21 mi.; p<0.OO5) and the deceleration time (DT) of the 
early velocity peak was shorter (117 ± 26 vs. 188 ± 62 ms; p<O.OOI). These two 
Doppler parameters were stronger predictors of survival than the ejection fraction 
and the clinic.1 status in a Cox proportional hazards analysis. However, none of the 
systolic or diastolic parameters could discriminate between survivors and patients 
who died of suddon death. Patients with a short DT (S140 ms) had a significantly 
reduced two-year survival rate (52%; confidence interval: 34-71%) as compared 
with patients with. longer DT (94%; CI: 89-98%) (p<O.OO I). Patients could be 
further stratified by combining the left ventricular enddiastolic diameter (LV D) and 
the deceleration time: None of the patients with a LVoS 70mm and a DT> 140ms 
died (n=9), whereas the mortality was highest in patients with a LV D> 70mm and 
a DT SI40ms with 9 of 13 (69%) baving died during follow-up (p<0.01). 
~: There is a relation between the pattern of left ventricular filling and 
survival in patients with !DC. Doppler echocardiographic assessment oflcft ventric•
ul.r filling proved to be a valuable noninvasive tool to detect patients at increased 
risk for death from progressive he.rt failure. 
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785·3 11:00 
Loss or MyolibrilIar Comp'0nents Predicts Left Ventricular 
Remodeling in Idiopathic Dilated Cardiomyopathy 
Francesco Pelliccia, Cinzia Cianfrocca, Giulia d'Amati, Paola 
Bemucci, Stefano De Castro, and Pietro Gallo. University of Rome 
"La Sapienza" , Rome, Italy 
Progressive LV chamber dilatation (remodeling) in idiopathic 
dilated cardiomyopathy (IDC) is generally said to be associated 
with functional deterioration and a poor prognosis. It remains 
unknown, bowever, how this process can be predicted. 
Accordingly, we attempted to identify which clinical or 
histomorphometric features could relate to the shott-tenn 
occurrence of LV remodeling in 3S IDC patients with an ejection 
ftaction>20% but <40% (mean: 31±7%). All patients were treated 
with digoxin, diuretics and ACE-inhibitors at referral and during 
follow·up. After 6 months. echocardiographicaUy·assessed LV 
end-diastolic volume index increased> 10% in 10 patients (Gr. A) 
and remained substantially unchanged in the remaining 2S 
patients (Gr. B). At referral, clinical features, ECG findings, LV 
dimension and shape, as well as ejection fraction were similar 
between the two groups. Conversely, Gr.A patients had higher LV 
end-diastolic pressure (20±S vs 16±5 mm Hg, p<O.OS), and lower 
cardiac index (2.3±0.4 vs 2.7±O.S 1/min/m2, p<O.(4), with respect 
to Gr.B patients. In addition, Gr.A had a higber myocellular area 
(1090±172 vs 9S8±l1l 11m 2, p<O.02), and a lower myofibril 
volume fraction (8S±3 vs 93±3%, p<O.OOI), as compared with 
Gr.B. No significam difference between the two groups was found 
in interstiatial fibrosis and endocardial fibrosis. Multivariate 
analysis selected myofibril volume fraction (p=O.OOI) as the only 
independent predictor of the subsequent increase in LV volume. 
Noteworthy, a myofibril volume fractionS89% (i.e., lower than 2 
standard deviations from the mean of our control group) was 
detected in 9/10 Gr.A patients (sensitivity: 90%) but in only 3/2S 
Gr.B patients (specificity: 88%). We conclude that in IDC: (I) a 
decreased myofibril volume fraction identifies the subset of 
patients prone to further LV dilatation; (2) the loss of 
myofibrillar components seems to constitute a morphologic 
substrate underlying the occurrence of LV remodeling. 
785·4 11:15 
Diastolic Transmitral Flow in Dilated Cardiomyopathy Following 
Long-tenn Beta-blockade Treatment 
Bert Andersson, Kenneth Caidahl, Finn Waagstein. The Wallenberg 
Laboratory for Cardiovascular Research, Divisions of Cardiology and 
Clinical Physiology, Sahlgrenska Sjukhuset, University or Goteborg, 
Goteborg, Sweden. 
Long-term beta-blockade treatment has been shown to improve 
systolic function in idiopathic dilated cardiomyopathy (IDCM). In 
the present study we investigated the effects on diastolic function 
using pulsed transmitral Doppler. The study was a substudy in the 
international 'MetoproIolin Dilated Cardiomyopathy Trial'. Twenty 
patients with symptomatic IDCM and ejection fraction (EF) <40% 
were randomly assigned to placebo (n=7) or metoprolol (n=13) 
treatment. Investigations were performed at baseline and follow•
ing 6 and 12 months of treatment. 
Results: 
HR(bpm) 
EF(%) 
Deceleration time (ms) 
Total diastolic time (ms) 
E-height (cmJs) 
A-height (cmJs) 
VTIElA(%) 
E velocity halftime (ms) 
Placebo (n=7) 
Baseline 12 months 
79 74 
25 31 
210 167 
367 392 
59 65 
63 57 
163 146 
105 84 
• p < 0.05, !;. Placebo vs !;. Metoprolol 
Metoprolol (n=13) 
Baseline 12 months 
88 80 
25 34 
138 196 • 
365 451 
74 54 
42 52 
216 161 
69 98 • 
Conclusion: Although diastolic dysfunction was more pronounced 
in the metoprolol group at baseline, there were trends toward 
restoration of diastolic flow parameters in the metoprolol group 
following long-term beta·blockade treatment. Deceleration time, 
which in recent studies has been shown to be the most powerful 
diastolic predictor of outcome in IDCM, was significantly improved. 
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785·5 11:30 
Is Left Ventricular Enlargement in Relatives of Patients 
With Dilated Cardiomyopathy Early Disease? 
Philip 1. Keeling, Yi Gang, Hiro Seo, Sonia E. Bent, Gill Smith, 
Alida L.P. Caforio, 10nathan H. Goldman, William 1. McKenna. 
St George's Hospital Medical School, London, UK. 
The identification of individuals with dilated cardiomyopathy 
(OCM) early in its natural history remains a major goal. During 
prospective screening of 208 apparently healthy relatives of patients 
with DCM we have 37 (18%) relatives (mean age 35 ±lS years, 23 
male) with mild left ventricular enlargement (L VB) (end-diastolic 
dimension >112% predicted value according to the method of 
Henry). R.elatives With systemic hypertension were excluded from 
the study. In order to determine if L VB represents early DCM these 
relatives have been extensively characterised by clinical examination, 
12-lead electrocardiography, 2-D and doppler echocardiography, 
metabolic exercise testing, 24-hour Holter monitoring, and analysis 
of the signal-averaged ECG. The majority of relatives with LVE 
were asymptomatic, had a normal physical examination, 12-lead 
electrocardiogram. exercise capacity and showed no significant 
ventricular arrhythmic activity. However, a proportion of these 
relatives had an added fourth heart sound (n=4), reduced oxygen 
consumption at peak exercise (n=3), significant ventricular ectopic 
activity (n=2) or episodes of non-sustained supraventricular 
tachycardia (n=4). Moreover, relatives with LVE showed reduced 
fractional shortening compared to relatives considered normal (32 
±4 versus 36 ±7 %; p=O.OO9) and had a higher frequency of late 
potentials within the terminal QRS complex (5, 19% versus 2, 2%; 
p<O.Ol). In addition the frequency of L VE was higher in relatives of 
patients with DCM than in a healthy control population (18% vs 
10%; p=O.02). These fmdings suggest that a proportion of relatives 
with LVE may have early DCM. Prospective follow-up of these 
individuals is currently underway. 
785·6 11:45 
Increased Frequency of Organ-specific Cardiac A nlibodies in 
Asymptomatic Relatives of Patients Witb Familial and Non•
Familial Dilated Cardiomyopatby 
·#Alida L.P. Caforio, ·Philip J. Keeling, 'Luisa Mesuoni, iFulvio 
Camerini, "Elisabeua Zachara, *Gian Franco Bottazzo. ·WilIiam J. 
McKenna. SI Camillo Hospital", Rome, University Hospital§, Trieste, 
#University Hospital. Padua. Italy, kondon &. ·St George's Hospital 
Medical School. Loodon, England 
Familial occurrence is a feature of aUlOimmune disease. Organ- and disease•
specific autoanuDodies are found in patients and in !heir relatives at a higher 
frequency compared 10 normal. may be detected years before disease onset and 
identify asympromatic relatives a1 risk. Organ-specific cardiac antibodies (o-s 
cardiac Abs) are found in patients with dilaled cardiomyopathy (DCM). We 
assessed the frequency of lIIese antibodies among DCM rel&tives. as a 
potential marker of disease susceptibility. We studied 343 asymptomatic 
DCM relatives (170 M. 173 F. aged 31±16 yrs). 178 from 33 families with 
more lhan I affected member (f8lDilial) and 165 from 31 families willi only I 
affec~4 member (non-familial). All relatives were screened with physical 
examination, EeG and 2 dimensional echocardiography. O-s cardiac Abs 
were detecled by immunofluorescence on human heart; all sera were tested 
wilhout knowledge of the clinical diagnosis. The frequency of o-s cardiac Abs 
was low in normals (7(}.OO. 3.5%) and in heart disease not due to DCM 
(21249. 1%). O-s cardiac Abs were more common in DCM relatives !han in 
normals (68/343. 20% vs 7(}.OO, 3.5% p=O.OOOI) and !han in eonuols willi 
cardiae disease (68/343. 20% vs 21249. 1 %, poO.OOOI). The frequency of o-s 
cardiac Abs was higher in relatives of familial DCM patients than in 
relatives of non-familial cases (24% vs 15%, pooO.03). Antibody positive 
relatives were younger !han lIIose who were antibody negative (mean age 
26±IS vs 33 ±17 yrs, p=O.OI). On 2 dimensional echocardiography mean 
left ventricular end-systolic dimension was higher and % fraclional 
shortening was lower in antibody po.;itive relatives compared 10 those who 
were antibody negative (3S±6 vs 32±6. p=O.OI and 31±6 vs 34±6, p=O.OO8 
respectively). 
The finding of cardiac autoantibodies in asymptomatic DCM relati ves 
provides evidence for autoimmunity in lIIis condition. These disease and 
organ-specifIC antibodies may be early markers for asympromatic relatives at 
risk; foUow-up studies are warrented. 
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Radiofrequency Ablation of Atypical Atrial Flutter 
10:30 
1. Marcus Wharton, 1ames 1. Merrill, Brie E. Johnson, 1ay S. 
Simonson, Ruth A Greenfield, Robert A. Sorrentino, Mark Hamer. 
Duke University Medical Center, Durham, NC. 
341A 
Radiofrequency ablation of atypical (atyp) morphologies of atrial 
flutter (AFI) has not previously been reported. In 14 patients with 
atypAFl, typically with upright flutter waves in the inferior 
electrocardiographic leads, the reentrant circuit was mapped in detail 
at the time of electrophysiologic study. Thirteen eases (93%) also 
had typical AFl which was successfully ablated in each case by 
slowly dragging the ablation catheter across the isthmus from the 
tricuspid annulus to the coronary sinus and inferior vena cava ostia. 
In 3 cases of atypAFl, the circuit was simply clockwise reentry in the 
typical AFl circuit which was successful ablated by the typical AFl 
ablation. In 8 cases, fractionated. prolonged diastolic electrograms 
occurred in the posterolateral right atrium (RA) with presystolic 
activation in the upper portion of the crista terminalis. Linear 
ablation across the region of presystolic activation was successful in 
6 (75%) patients. The two patients who remained inducible have 
new medical control of their previously medically refractory AFI. Of 
the 3 remaining episodes of atypAFl, the diastolic segment was 
located in the RA freewall. posterior LA freewa1l, and interatrial 
septum. The RA atypAFl was successfully ablated at the site of 
presystolic activation, but the LA atypAFI could not be easily 
ablated. Ablation of the site in the interatrial septal atypAFI was not 
attempted because of its proximity to the aorta. Thus, ablation was 
successful in 10 (77%) of the 13 patients with atypAFl in whom it 
was attempted. Radiofrequency ablation offers an acceptible 
alternative for treatment of atypical morphologies of AFI. 
786-2 10:45 
Entrainment Mapping and Ablation of Atrial Flutter in Patients 
Facilitated by a 2G-Polar 'Halo' Catheter in the Right Atrium 
Adam P Fitzpatrick Westby G Fisher Laurence M Epstein 
Randall J Lee Melvin M 5cheinman Michael 0 Lesh University 
of California and CVRI 5an Francisco CA 
Use of the surface ECG to confinn manifest or concealed entrainment 
of atrial flutter (AFL) can be difficult. To facilitate entrainment of 
AFL and identification of the critical slow-zone (5Z) in typical and 
atypical AFL, a deflectable 20-polar, 7Fr 'halo' array catheter 
(HAC) was deployed in the right atrium (RA) close to the tricuspid 
annulus in 8 patients (pts.) during catheter ablation. A rove/ ablation 
catheter delivered atrial pacing and radiofrequency (RF) energy. 
Results. The HAC recorded electrograms in an arc from the 
midseptum near the coronary sinus os, over the superior aspect of the 
tricuspid annulus to the posterolateral RA. Typical AFL was present 
on the ECG in 6 pts, with mean cycle length (CL) 274± 14ms. Two pts 
had atypical AFL (both CL 280ms) and biphasic or upright flutter 
waves inferiorly. In all pts. manifest entrainment was demonstrated 
during pacing remote from the posterior right atrium with fusion in 
surface flutter waves confirmed by fusion in endocardial recordings 
from the halo array. In 7 pts. concealed entrainment was 
demonstrated by pacing from the posterior RA with acceleration of 
flutter to the pacing rate, a long stimulus to flutter wave latency, 
(107±58ms), no surface fusion, an exactly matching endocardial 
activation sequence during pacing and spontaneous flutter, and return 
cycle after pacing at the spontaneous CL. The 5Z exit was postero•
medial in 6 pts. with counter-clockwise rotation around the T A, and 
posterolateral in 1 pt., with clockwise rotation. In one patient halo 
recordings showed that reentry was not around the T A, the slow zone 
was not identified and ablation was unsuccessful. In the other 7pts. 
atrial flutter was abolished by ablation in the 5Z. 
Conclusions. A multi-polar annular halo catheter facilitates 
determination of the orientation and direction of wavefront 
propagation, the location and entrance into and exit from the critical 
slow zone in atrial flutter, and RF atrial flutter ablation. 
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786·3 11:00 
Successful Radlorrequency AblatiOD or AtrIal Flutter with Uaear LesloDs 
Larry Chinitz, Neil Berastein, Erminia Guarneri, Taya G101Zer, New York 
University Medical Center, New York, NY 
Radiofrequency (RF) ablation of alrial tissue bas recently been used to prevent 
recurrenc:e& of common type alrial flutter (AFL). The reentrant impulse in 
these patients rotates around the tricuspid annulus (TA) passing through 
isthmuses between the TA and the ostia of both the coronary sinus (CS) and 
inferior veaa cava (IVC). Fractionated electrograms and double potentials 
recorded at these isthmuses and between the CS and IVC suggest large areas 
of conduction block and slow conduction aitical to the reentrant circuit. The 
purpose of this study was to determine the feasibility and efficacy of 
radiofrequency induced linear lesions produced across both isthmuses. 
Methods: Twelve consecutive patients with resistant common type AFL were 
referred for EPS and RF catheter ablation. The typical activation sequence was 
confll1l1ed with fractioaated electrograms and double potentials recorded 
between the IVC and CS ostium and the previously desaibed isthmuses. A 7F 
4mm tip electrode was positioned between the TA and CS during AFL. After 
delivery of 10-20 watts of RF energy for 20 seconds, the electrode was slowly 
drawn back toward the IVC adjacent to the TA without altering the output of 
the RF generator. Energy delivery was continued for 60 seconds regardless of 
AFI. termination unless marked changes in impedance were noted. 
Results: AFL was no longer inducible in 11 of U patients after a mean of 3 
linear RF lesions. Right atrial anatomy in the one unsuccessful patient 
precluded adequate tissue contact by the 4mm electrode assessed by electrogram 
morphology and measured impedance. There were no adverse complications 
with the procedure and a single recurrence at one month during a mean follow•
up of 5 months. 
ConclusIon: Common type AFL can be safely and consistently eliminated by 
a limited number of linear RF lesions produced across anatomically derIDed 
areas of slow conduction critical to the reentrant circuit. 
786·4 11:15 
Rldlofrequency Ablation of Atrlal Flutter after Fonten Procedure 
John K Trledman, J Philip Sa~, Steven Welndllng and Edward P Walsh 
Chldren's Hospital, BosIon, MA 
Introduction: AtrIal ftutter (AFI) Is a common late complication of the 
Fontan procedure, and In many cases Is refractory to pharmacologic 
and/O( pacemaker therapy. SuccessIU interruption of Type I AFI clrcults 
In atructuraily normal hearts has been reported using anatomic application 
of racliofrequency (RF) energy. In Ihls report, 4 patients with modilled 
Fontan physiology and refractory AFI had actlYatlon mapping of the right 
atrium and attempted RF aI:IIatlon of AFI during 5 cathetertzallons. 
R .. ults: Patlents were 7 - 14 YI1I sip Fontan procedure. They had 
been on 4 - 7 antIarrhythmlc medlcatlons and 3 __ pacad (1 DOD, 2 
AAlT). Righi atrlaI pressure ranged from 12 to 18 mmHg, and maximal 
right atrial dimensions ranged from 6.2 to 11.6 em. AFI actlYatlon was 
mapped uslng mlJtiple deftectable decapolar electrode catheters. M'*4lIe 
(2 - 4) AFI circuits were mapped In each patient. corresponding to different 
cllnlcaI ftutter rat8l. 0111 mapped AFIs, 8 occuring In 3 patients appeared 
to inllolve a zone of alaw conduction (zSC), which was anatrxnlcally 
variable In location. In these 3 patients, applications of RF energy between 
the ZSC and the earliest atrial electrogram ~ed In termination of AFIIn 
5 of 8 clrcults. Electrograms obtained during RF ablation suggest that In 
srxne patients this type of AFI may be Interrupted by creation of exit block 
from a reentrant focus, rather than interruption of a macroreentrant clrcull. 
Followup for 3 - 5 months of the 3 patients In whom a successIU ablation 
was perfrxmed reveals ona off medicine with no Induclble 8U8taIned ftutter, 
ona without clinical ftutter on a previously lneIIectlve therapy (quinidine), 
and ona with relapse of AFI reqUiring hospitalization for relnstItutlon of 
antiarrhythmic therapy after a symptom-free lntervalJastIng 2 months. 
Conclusions: RF ablation can be applied to patients with Fontan 
anatrxny end AFI. and may simplify their managemenL M~lple morpholo•
gies of AFI are seen In these patients; some may represent an arrhythmo•
genic mechanlsm mrxe slmlar to ventrlc~r tachycardia after Ischernlc 
Injury than to Type I AFI. Further development of this technique will require 
Improved methods fO( rapid endocardial mapping and manipulation of 
catheters In enlarged rIgtt atria. 
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Ablation of Reentrant Atrial Tachycardia After Atrial Surgezy - The 
Importance of Identifying A I'JOteded Zone of Slow Conduction 
Michael D. Lesh and George F. Van Hare 
University of California San Francisco, CA 
Radiofrequency energy(RFl must create a lesion in a protected zone of 
slow conduction(SCZ) for ablation of ventricular tachycardia and 
atrial flutter. Our purpose was to determine if targeting a SCZ during 
intra-atrial reentrant tachycardia (IART) predicted successful abla•
'ion. 
METHODS: Symptomatic patients(pts) who had failed medications 
had IART diagnosed during EP testing if initiated and tenninated with 
premature atrial beats, and the AV node was not involved. During 
IART, atrial pacing entrained the rhythm. Mapping was perfomed 
near anatomic/surgical defects or scars. Target sites for ablation were 
sought at which activation preceded the onset of the surface P wave 
by>4Orns, and entrainment without fusion (concealed entrainment) was 
demonstrated. Endpoint was non-inducibility without and with isopro•
terenol. 
RESULTS: Seven pts (age 8-36y) had 9 distinct IARTs (mean 
CL=346ms, 270-435). All had had surgery for congenital heart disease 
(atrial septal defect(ASD) repair: 4; Fontan: 2; Mustard: 1). Ablation 
was successful (median 5 RF applications) in 8/9 tachycardias. The 
electrogram at the successful site was fractionated in all and had acti•
vation time 6O±15ms before P wave. Concealed entrainment with la•
tency was demonstrated in all tachycardias. For successful ablation, RF 
was applied in the SCZ delineated by anatomic and / or surgically cre•
ated barriers (between: inferior border of atriotomy and tricuspid annu•
lusIT A) in 4; superior vena cava/RA junction and atriotomy in 1; ASD 
repair and TA in 1; Fontan conduit and TA in 1; atrial baffle and cOro•
nary sinus in 1). Markedly disparate activation times and split poten•
tials were noted on either side of surgical barriers such as atriotomy 
scars. There were no complications. One patient recurred and repeat ab•
lation was successful. 
CONCLUSION: For pts with reentrant atrial tachycardia after atrial 
surgery, successful ablation requires ablation within an isthmus of slow 
conduction constrained by surgical scars and anatomic barriers. 
786·6 11:45 
Does Ablation of Atrial Tissue Prevent Atrial 
Fibrillation in Patients with Recurrent Atrial Flutter ? 
Gilbert Kirkorian, Enrique Moncada, Guillaume Canu, Philippe 
Chevalier, Jean-Philippe Claudel, Christian Bellon, Magdalena 
Defeo, lean-Michel Sommier, Paul Touboul. Hopital 
Cardiologique, Lyon, France. 
Ablation of atrial tissue has been described as a useful method for 
treating patients (pts) with recurrent episodes of atrial flutter. As pts 
may have associated episodes of atrial fibrillation (AF), efficacy of 
ablation to prevent AF has been invoked. We st\ldied 26 pts aged 54 
± 10 yrs who had atrial tissue ablation using either direct current 
countershock (12) or radiofrequency current (14) directed to the 
inferior part of the right atrium. All pts had recurrent episodes of 
atrial flutter despite I to 5 (3 ± I) antiarrhythmic drugs including 
amiodarone in 24. Intermittent AF had been recorded in 8 pts but 
was not the dominant arrhythmia. The ablation procedure was 
uneventful in all pts except in I who had A V block due to high 
energy shock. Atrial flutter could be acutely interrupted in 25 pts. 
During a follow-up of 23 ± 17 months (3 to 60), AF was recorded 
in 10 pts (38%), intermittent in 3 and permanent in 7 pts. AF was 
noted independently of the ablation method, the number of shocks 
or radiofrequency pulses and the recurrences of atrial flutter_ In 2 
pts with intermittent AF and 1 with permanent AF, this arrhythmia 
had never been recorded prior to ablation_ Drug therapy could 
render AF well tolerated so that the clinical situation improved in all 
pts. No embolic complications occurred on anticoagulant therapy. 
In conclusion, these data do not support the idea that atrial tissue 
ablation for flutter may also prevent AF. Conversely the frequency 
of AF in the aftermath of flutter ablation raises the possibility of 
arrhythmogenic effect. 
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Tc·I9m_atamlbl SPECT Under Nitrate Infullon for Detecting 
Viable Hibernating Myocardium In Asynergic Territoriel. 
Gianni Bisl. Roberto Sciagra', ·Giovanni M.Santoro. Vittorio Briganti. 
"Paola Pedenovl, "Pier Filippo Fazzinl. Nuclear Medicine, University of 
Florence; *Division of Cardiology, Careggi Hospital; Florence, Italy. 
Rest Tc-99m-sestamibi underestimates viable hibemating myo•
cardium in asynergic territories. This study was aimed to test whether 
nitrate infusion at the moment of Tc-99m-sestamibi Injection might 
improve the tracer capability of detecting viable myocardium. 
We studied 19 CAD patients with previous myocardial infarction 
and LV dysfunction (lVEF < 50%) scheduled for coronary artery by· 
pass grafting or angioplasty. Pre- and post-revascularization wall 
motion was assessed by echocardiography using a wall motion score 
index (WMSI) for each vascular territory (1: normal, ~ 1 < 1.5: mild and 
~ 1.5 < 2.5: severe hypokinesis, ~ 2.5: akinesis). Tc-99m-sestamibi was 
injected during isosorbide dinitrate infusion (10 mg over 20 min); 
SPECT data of each vessel territory were analyzed quantitatively and 
compared with the results of baseline Tc-99m-sestamibi Imaging 
performed on a separate day. 
Pre-operatively, 45 asynergic territories (WMSI: 2.3 :t 0.5) were 
found; among them, 11 improved after revascularization (group A: 
WMSI 1.6 :t 0.4, P < 0.001 vs. pre-op) and 34 remained unchanged 
(group B, WMSI 2.4 :t 0.6, NS vs. pre-op). The extent of the baseline 
perfusion defect was not significantly different in the two groups (A: 31 
:t 21.4 %; B: 46.8 :t 33.3 %). In the nitrate SPECT, however, a 
significant decrease of the perfusion defect extent was seen in group A 
(21.4:t 19.1, P < 0.02 vs. baseline), but not in group B (46.6:t 33.8, NS 
vs. baseline, p < 0.05 vs A). Of the 11 territories of group A, 10 (91%) 
had an improved Tc-99m-sestamibi uptake, whereas this finding was 
demonstrated in only 4 of the 34 territories of group B (12%, p < 
0.00001). 
In conclUSion, these preliminary results show that nitrate 
infusion may improve rest Tc-99m-sestamibi SPECT capability of 
detecting viable hibemating myocardium. The most reasonable 
mechanism of action could be the transient improvement of coronary 
blood flow during the phase of tracer uptake. 
787·2 10:45 
Effect of Nitroglycerin on Sestamibi Uptake in CAD and 
L V Dysfunction and Assessment of Myocardial Viability 
Enrique A. Flores, Natesa Pandian, Steven Schwartz, Nancie Shea, 
Marvin A. Konstam, Elizabeth Oates, James E. Udelson. Tufts 
University-New England Medical Center, Boston, Mass. 
To assess whether nitroglycerin (NTG) may improve tracer uptake 
and enhance the prediction of improved regional function after 
revascularization (REV), we studied 9 pts with CAD and LV 
dysfunction (LVEF 29±7%). Tc99m-sestamibi (MIBI, 22 mCi) was 
injected at rest, with SPEer imaging I hour later. On a subsequent 
day, 22 mCi MmI was injected during shon-term IV NTG (up to 
200 ~g/min) and SPEer was repeated. Quantitative analysis was 
performed to assess relative regional MIBI uptake; regional function 
was determined by 2D-Echo before and after REV. Among the 30 
segments with severe regional wall motion (WM) abnormalities (A), 
10 ~ad improved WM post-REV: in these segments relative MIBI 
uptake was higher during NTG (7o±lO vs 79±11 % [% of peakl, 
p=O.OO6). Among the 20 segments with no change in WM post•
REV, MIBI uptake was also higher with NTG (57±11 vs 62±S%, 
p<0.05), though the magnitude of increase in relative uptake during 
NTG was slightly greater in regions with improved WM (9±S%) 
than in those without improvement (4±7%, p=O.06). Sensitivity for 
predicting WM improvement in these 30 segments was higher with 
NTG compared to baseline (100 vs SO%) but with a loss of 
specificity (50 vs 65%). Among the 15 segments with severe WMA 
an.d a > 10% increase in MIBI uptake during NTG, only 6 had 
improved WM post-REV; compared to the 9 segments with no 
change in WM, these 6 segments had higher MIBI uptake at baseline 
(68±S vs 48±S%, p=O.OOI) and during NTG (SI±1O vs 5S±S%, 
p=O.OOI). Hence, MIBI injection during NTG may enhance the 
sensitivity for detecting viable myocardium, but with some loss of 
specificity. These preliminary data suggest that an increase in 
regional MIBI content with NTG compared to a resting scan is not 
uniformly associated with reversibility of regional dysfunction. 
ABSTRACTS 343A 
787·3 11:00 
Kinetic Analysis or Technetium-99m Labeled Nitrolmi•
dazole (BMS-181321), a Marker ror Hypoxic Myocardinm 
Chin K. Ng, Albert J. Sinus as, Barry L. Zaret, Roben Soufer, Yale 
University School of Medicine, New Haven, CT and V A Medical 
Center, West Haven, er 
Tc-99m labeled nitroimidazole (BMS·IS1321) is a recently 
devel.oped tracer for imaging hypoxic tissue; its kinetics, however, 
remams undefined. Accordingly, we have evaluated the kinetics of 
BMS-IS1321 in isolated perfused rat heart under hypoxic conditions. 
Hearts were buffer perfused in Langendorff mode without 
recir~~lation at a co~stant flow o~ 10 mLlmin. Four experimental 
condItIOns were studIed under vanous oxygen tension: I). 100% 
(Norm.oxia, n=3); II). 50% (Hypoxia_I, n=2); Ill). 25% 
(Hypoxla_~, n=3); I~. Or. (Anoxia, n=3). MV02 (JIll1ole/min·g dry) 
was deterttuned on·lme WIth a Clark-type 02 probe by cannulating the 
pulmonary mery. A bolus of20 !lCi BMS·lS1321 was administered 
proximally into the aortic root at 30 min post perfusion. Tissue residue 
curves were acquired externally for 20 min with a pair of Nal 
detectors placed on opposite sides of a perfused heart. All residue 
curves were fitted biexponentially (R>O.95): AI*exp(-AI*t)+A2*exp(. 
A2*t).Percent retention oflabel in tissue was estimated by A2*IOO/AI. 
AI (min-I) 1..2 (min· l ) % retention MV02 
Normoxia 2.29±0.30 0.065±0.OI9 l.33±O.31 44.7±S.3 
Hypoxia_1 2.30±0.04 O.044±O.004 2.77±1.40 26.6±2.2 
Hypoxia_2 2.l3±0.23 O.02S±O.OII' 6.4S±1.26 13.3±2.0 
Anoxia 2.33±O.20 O.02S±O.009 S.OS±2.3S 
The clearance rate constant for the fast phase (A I) did not change 
significantly with perfusion oxygen tension, but the clearance rate 
constant for the slow phase (1..2) decreased proportionately with 
decrease in perfusion oxygen tension. Percent retention of label in 
tissue correlated well with measured MV02 (R=0.S9). 
These data suggest that the initial clearance of BMS·IS1321 is 
independent of tissue oxygen level. The retention of BMS-181321 is 
inversely proportional to tissue oxygen level. Thus BMS-ISI321 is a 
potential tracer for imaging hypoxic tissue. 
787·4 11:15 
Left Veetriallar Ejectioa Pndioa Rapoue to Aarla_ JIGlua. 
A OaIIeep Ia enIer to ldea~ PatieIIa witII ___ Ie ~tIIy 
.. d Re¥enlbIe CllroDIe Left Veetric1dar J)yIf'ucdoD 
"N.A.Perez BaIifto; O.Maaoti A.Rodriguez; M Itunia; A. Meretta; D.CnsnoJino. 
S.Perrone, E. Mele, I.Palacios. Sanatorio Aacbonoa - SIutorio Goemea Bueaos 
Aires IDd MuudIuIetta GeaenI HoepitaJ Bost()ll. 
'!'be aim of tbis study was evUuate the "late outcome prosIIOSis value" of left 
YCDIricuJar ejection frIIction (L VEF) IDd ita dIaasea due to iatraveoous 
IdmiaiIIration of amriaoae (Amr), .-.ed tbroush nIdioaucIide qiosrIphy 
prior IDd after CABO in petiaIta with iIcbemic:: c:ardiomiopatby IDd cbronic left 
YCDIricuJar dysfuaction ThiI study iavoMId 44 petiaIta with cbroaic dc:bemic 
cardiomyopathy IDd L VEF < 40"" , in whom IIUIJeIY was feasible. L VEF values 
were obtained prior to CABO 1IIIpf)'. II bueIiDe IWUI ud 20 minutes after 
iatraWlDOUl IdminisIration of 1mw'Jc8 of Amr. The L VEF VIIues were compared 
with those obtained 21 dayI poet CABO. The rwpoDM to Amr was dulified u 
"positive" (PRA) when: L VEF riMa It Jeut 30% over the bueIine VIIue, IDd 
"aegative" (NItA) when not. CIinicII foUow-up was perfbrmed during 26 % 8 
IIIOIIIbs IDd included aoaIyU of deatb, IDd eveaII (ninfIrc:tion, qina, IDd heart 
fiIiJure).RESULTS: (The preImCe of III@ina or heart fiIiIure did not predict 
response to amrinone.) 
LVEF 
After Amrinone 
After CABO 
PRA.-.' NRA.-26 
22.3% 7 31.5% 7 
34.\%9* 34.9%7 
35.5 % 8 * 31.8 % 9 
• p < .01 COlI PUed with bueIine 
p< .06 
p. NS 
pB NS 
JOLLOW UP1 CAIIG •• 44 ... 
Dead 
Events 
AIymptomatic 
Heat TrwpIuIt 
PRA NRA 
11.2 % 34.4 % 
25.0". 52.9 % 
62.5% 17.0% 
6.2% 5.8% 
ActuIriII Survival Curves l' < .00 1 
Cllltdulou. LVEF ~ immediately after CABO, IDd • better IUIViwl rile 
following 1IUIJeIY, was fouDd IIIIOD8 patieata who bid "positive rwpoDM to 
1IIIriDone". TbeIe fiDdinp IUgeII tbIl IIIII'inone bolus iqection coukI identifY 
patieata with CAD IDd revertible cbroaic left YCDIricuJar dysfunction 
344A ABSTRACTS 
787-5 11:30 
Prediction of Improvement of Left Ventricular Function 
After Coronary Revascularizatlon From Alterations in 
Myocardial Metabolic Activity Detected With 1·123 
Phenylpentadecanoic Acid Dynamic SPECT Imaging, 
"'Christopher L. Hansen, Jaekyeong Heo, "'Abdulmassih S. 
Iskandrian; Temple University Hospital and Philadelphia Heart 
Institute, Philadelphia, PA 
The accurate assessment of myocardial viability is crucial for the 
identification of patients (pts) most likely to benefit from coronary 
revascularization (CR). 1·123 phenylpentadecanoic acid (lPPA) is a 
synthetic fatty acid that has been shown to be useful in the evaluation of 
abnonnal metabolic acitivity in pts with CAD. The current study was 
part of a phase IIII trial to assess the ability of IPPA to identify viable 
myocardium in pts with CAD who had been referred for CR. Fourteen 
pts underwent imaging with IPPA before, and radionuclide ventricu•
lography both before and after CR. Pts were injected with 4-6 mCi of 
IPPA and underwent SPEeT imaging at 4,12,20,28, and 36 minutes 
after injection. Images were downloaded into a Macintosh computer, 
reconstructed, and Bullseye plots created using software written in C. 
Special software was developed to analyze metabolic activity by fitting 
to a monoexponential curve. This was done by performing linear 
regression of the log of activity in the Bullseyes. A parametric Bullseye 
plot showing the slopes of the regression was generated. The range of 
the slopes was 0 to -0.023 10g(counts)/min. It was postulated that pts 
most likely to benefit from CR would show intennediate slopes, greater 
than infarcted segments but less than normal segments. The percent 
area of the parametric Bullseye plots corresponding to slopes between 
-0.008 and -0.014 was calculated. The pts showing ~ 5% increase in 
EF after CR had a mean area of 43 ± 4% (mean ± SEM) of the plot vs. 
26 ± 4% for those showing < 5% increase (p<0.0l). There was a 
correlation between Bullseye plot area and change in EF (r=O.56, 
p=O.037); 7/8 pts with area > 30% improved vs. only 116 with an area 
< 30% (sensitivity 88%, specificity 83%). We conclude that 
abnonnalities in myocardial metabolic activity detected with quantitative 
IPP A are useful in predicting which pts will have an improvement of 
EF after CR. 
787·6 11:45 
Myocardial Contractile Response to Dobutamine is Related to the 
Magnitude of Thallium Uptake in Patients With Coronary Artery 
Disease and Chronic Left Ventricular Dysfunction 
Julio A. Panza, Vasken Dilsizian, Joy M. Laurienzo, Peter T. 
Katsiyiannis. NHLBI, Bethesda, MD 
We have demonstrated that, although a relation exists between 
thallium (TI) uptake and the inotropic response to dobutamine (Dob) 
in patients with coronary artery disease (CAD) and chronic systolic 
dysfunction, a number of segments with positive TI uptake do not 
show contractile improvement with Dob. To determine whether the 
response to Dob is related to the magnitude of TI uptake, we studied 
20 patients with CAD (> 70% stenosis in ~ I major vessel) and 
depressed systolic function (resting ejection fraction < 45 % ). Degree 
of TI uptake was assessed after reinjection, in a stress-redistribution•
reinjection protocol, on a five·point scale (from 0= absent to 2= 
normal). Myocardial contractile reserve was measured during 
transesophagea1 echocardiograpby using stepwise increasing doses of 
Dob starting at 2.5 ",glkglmin. TI uptake and segmental contraction 
were assessed by independent observers. Among 312 segments 
assessed with transesophagea1 echocardiography, 203 (65 %) had 
resting wall motion abnorma1ities, of which 107 (53%) showed 
improvement with Dob. There was a significant relationship between 
contractile reserve and magnitude of TI uptake (p < 0.00(1): 
11 uptake score 0 0.5 1 1.5 2 
Segments with 5122 5122 23152 14126 60181 
contraaile reserve (23%) (23%) (44%) (54%) (74%) 
Thus, in patients with CAD and chronic left ventricular dysfunction, 
the inotropic response to Dob is related to the degree of TI uptake, 
such that the proportion of myocardial segments with contractile 
reserve progressively rises with increasing magnitude of TI uptake. 
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A Randomized, Double-Blind, Placebo-Controlled TrIal or Adjunctive 
Therapy with Rheoth~ Injection (poloxamer 188) In Patients 
Receiving Thrombolytic Therapy ror Acute Myocardial Inrarctlon 
Gary L. Schaer, Leo J. Spaccavento, Kevin F. Browne, Karol A. 
Krueger, Raymond J. Gibbons. Rush Medical College, Chicago, n. and 
Mayo Clinic, Rochester, MN 
RheothRx- Injection (Burroughs Wellcome Co. formulation ofpoloxamer 
188, N.F.), a non-ionic surfactant with hemorbeological, anti-thrombotic 
and neutrophil inhibitory properties, produced a 42" reduction in infarct 
size and a 38" improvement in LV function in a canine model of 
myocardial infarction and reperfusion. To assess the safety and benefits 
of this agent in patients receiving thrombolytic therapy for acute MI, 114 
eligible patients (at 12 centers) underwent a 2: I randomization to 
RheothRx injection (a 48 hour i. v. infusion) or matching placebo. Tc· 
99m·sestamibi SPECT was performed acutely to assess myocardium 
(myocard) at risk of infarction, and at discharge to assess infarct size. A 
radionuclide ventriculogram was also performed before hospital discharge. 
No major safety concerns were identified. 
Interim Results [expressed as Median (25%-75%)]: 
RheothRx Placebo 
Ejection Fraction (%) 54 (42-61, n=43) 46 (37-59, n=21) 
Myocard at Risk (% of LV) 34 (19-49, n=35) 32 (I8-53, n= 19) 
Infarct Size (% of LV) 16 (8-31, n=36) 26 (17-38, n=21) 
InrarctlMyocard at Risk .61 (.39-.82, n=32) .87(.81-1.1I,n=19) 
Death, Reinfarct, Shock (%) IS (n=53) 26 (n=27) 
[Data on all 114 patients with statistical analysis will be available at the 
time of presentation) 
Conclusions: I) These preliminary results suggest that in patients 
receiving thrombolytic therapy for acute MI, adjunctive therapy with 
RheothRx Injection has beneficial effects on myocardial infarct size, LV 
function, and the combined clinical endpoint of death, reinfarction and 
shock. 2) This promising agent merits further evaluation in a larger 
clinical trial. 
788·2 10:45 
Initial Experience with Hirudin and Streptokinase in Acute Myocardial 
Infarction: Results of the TIMI6 Trial 
L. Veronica Lee, Carolyn H. McCabe, Elliott M. Antman, Matthew Koch, 
Robert Wilensky, Kathleen Stringer, Judith Hochman, Hiltrud S. Mueller, 
Timothy D. Henry, Neal Kleiman, Richard M. Steingart, Hal Wasserman, 
Douglas Losordo, Phillip Ludbrook, Andrew Doorey, Samuel Rodriguez, 
Patrick Kennedy, William J. Rogers, Marcus L. Williams, Thomas C. 
Smitherman, Robert S. Gibson, James T. Willerson, ·Susan Edwards, 
'Marc Henis, and Eugene Braunwald for the TIMI 6 Investigators, 
Harvard Medical School, Brigham & Women's Hospital, Boston, MA 
Recombinant desulfatohirudin (CGP 39393, hirudin) is a potent, direct and 
specific inhibitor of both free and clot-bound thrombin. Previous reports 
have shown hirudin to be superior to heparin for improving reperfusion 
and reducing reocclusion when given with thrombolytics in acute MI. The 
TIMI 6 Trial was a randomized, open-label, pilot study designed to 
evaluate the safety and tolerability of hirudin versus heparin when given 
with streptokinase and aspirin in 193 acute MI patients Ipts}. Pts received 
a 5 day infusion IINF} of either heparin In = 71} as a 5000 U bolus IB} 
followed by a 1000 U/h IINF} adjusted to an aPTT of 65-90 secs, or a 
constant hirudin INF at 1 of 3 doses Idose 1-n = 55 - 0.15 mg/kg B + 
0.05 mg/kg/h, dose 2-n=31; 0.3 B + 0.1, or dose 3-n=36; 0.6 B + 
0.2}. ~ There was no added risk of major hemorrhage between 
heparin 16%} and any of the hirudin doses (5%, 6%, 6%). A non•
significant trend was seen in the reduction of mortality and serious cardiac 
events Irecurrent MI, new CHF or cardiogenic shock} between hirudin 
dose 1 and both doses 2 and 3119%,10% and 11 %}. The combination 
of hirudin dose 2 and 3 showed a non-significant trend towards a lower 
rate of death and serious cardiac events than heparin (10.4% vs. 18.3%). 
Conclusion; Hirudin appears to be a lafe antithrombotic when given with 
streptokinase and ASA to acute MI pts. In this pilot trial, not 
prospectively designed to detect I difference in efficacy, an encouraging 
trend towards a lower rate of mortality and serious cardiac events was 
observed in the higher dose groups of hirudin compared with heparin. 
TIMI 9 is currently testing these results in a large international Phase 3 
randomized, double-blind trial comparing hirudin to heparin as adjunctive 
therapy to thrombolysis and ASA in acute MI pts. 
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788·3 11:00 
Quantitative Coronary Angiography of the Culprit Coronary 
Artery Lesion Using a Direct Thrombin Inhibitor Versus Heparin 
as Adjunctive Therapy to Streptokinase in Acute Myocardial 
Infarction 
Pierre Theroux, Jacques Lesperance, Raoul Bonan, Rosa-Maria 
Lid6n, Montreal, Canada 
Hirulog (Hi), 0.5 mg/kg/h or heparin (Hep), 1000 U/h were 
randomly administered in a 2 to 1 ratio, with streptokinase, 1.5 
million U in 1 h, in 45 pts with acute myocardial infarction. 
Opacification of the culprit coronary artery lesion was obtained 60, 90 
and 120 min following drug initiation. Hi resulted in cumulative 
TIMI-3 grade flow in 16 of 30 pts (53%) at 60 min, 20 (67%) at 90 
min and 23 (77%) at 120 min. With Hep, TIMI-3 flow was present 
in 5 pts (33%) at 60 min and in one additional pt (40%) at 120 min 
(p < .02 vs Hi). Quantitative coronary angiography of patent culprit 
coronary artery lesions revealed progressive improvement with Hi but 
not with Hep: 
60 min 90 min 120 min PNJVA 
-Minimum Hi .73±.5 .87±.5 .93±.4 <.02 
diameter (mm) Hep .79±.8 .78±.7 .78±.8 NS 
-%diameter Hi 77±17 73±15 70±14 <.02 
stenosis (%) Hep 80±18 80±17 80±19 NS 
- Area of Hi 91.9±7 90.5±7 89.4±7 < .05 
stenosis (mm2) Hep 92.5±7 92.6±7 91.9±9 NS 
The length of stenosis and asymmetry index were unchanged. 
Conclusion: These results document that adjunctive therapy to 
streptokinase with a direct thrombin inhibitor restores blood flow 
earlier and more frequently and also promotes continuous clot lysis. 
788·4 11:15 
Substantial (Three-Fold) Benefit of Accelerated t·PA Over Standard 
Thrombolytic Therapy In Patients with PrIor Bypass Surgery 
and Acute MI: Results of the GUSTO Trial 
Anthony C. De Franco, Bruce Abramowitz, Daniel Krichbaum 
and Eric 1. Topol for the OUSTO Investigators 
The Oeveland Oinic Foundation, OeveIand, Ohio 
little is known about optimal myocardial reperfusion therapy for patients with 
prior coronary artery bypass surgery-lhese patients have oot been entered into 
most thrombolytic trials. In the OUSTO trial of 41.021 patients, 4% had prior 
CABO. These patients were older (63.6 versus 60.7 years) and more likely male 
(83.5 versus 74.2%). They had a higher incidence ofpriorMl (65 versus 14%) 
and had more risk factors than the patients without prior CABO. Major event 
rates weresignlficant\y higher in this group (death IO.6 versus 6.7%. stroke 1.75 
versus 1.43%) and there was a reduced mortality noted for patients receiving 
accelerated t-PA and IV heparin. 
%0( MortaUtyRates Odds Ratio & 95% CI 
PIs SK I t-PA 
No CABO 96% 7.0% 16.1% 
Prior CABO 4% 11.0% 8.3% 
t-~A be~ I SKBeNn 
0.5 1.0 1.5 
Prior coronary artery bypass surgery was an independent risk factor for a fatal 
outcome regardless of the therapy used. Thus. patients with prior CABG 
receiving thrombolytic therapy are athigherriskofmortaIity and appearto derive 
a greater extent of absolute benefit (2.7 versus 0.9%) from the stralegy 
of acceIeraIed t-PA. 
ABSTRACTS 
788·5 
Saruplasej EffICaCY and Safety Data of 2570 Patients 
Frank Vermeer, Frits W. Bar, Jiirgen Windeler, 
11:30 
Gwyn R. Hopkins, Hannes Barth, Department of Cardiology, 
University Hospital Maastricht, The Netherlands 
345A 
Saruplase 80 mg (full length human single chain urokinase type 
plasminogen activator), a new thrombolytic agent that exerts 
fibrin specific properties, was given to 2570 patients with acute 
myocardial infarction within 6 hours of onset. Prior to the 
infusion of saruplase most patients received heparin 5()()(} IV iv 
as a bolus followed by an infusion titrated against (a)P1T. 848 
patients were in 5 randomized trials, 1722 were in 3 non•
randomized trials. 89 centres from 11 countries participated. 
Results: n % 
Number of patients 2570 
Mortality in hospital 135 5.3% 
Stroke hemorrhagic 15 0.6% 
thrombotic 13 0.5 % 
Bleeding complications severe 61 2.4% 
Reinfarction in hospital 120 4.7% 
Other complications seen with saruplase therapy were benign, 
and usually not related to the treatment itself but to the 
myocardial infarction. Acute angiography within 24 hours was 
performed in 22 % of the patients; average 90 minutes patency 
was 75% (2 trials, n=434). 
Conclusion: Saruplase is an effective and safe thrombolytic 
agent. 
788·6 11:45 
Early Patency and Reocclusion in Acute Myocardial Infarc•
tion. A Comparison Between the Thrombolytic Agents Sam· 
plase and Alteplase. Results of the SESAM Trial. 
*The SESAM investigators; University Hospital Maastricht, 
Maastricht the Netherlands. 
There is increasing evidence that the action of several throm•
bolytics differs in speed of reopening of arteries and in persis•
tence of patency. The multicentre randomized double blind 
SESAM trial was conducted in 17 centers in Europe comparing 
saruplase and aJteplase. Inclusion criteria were treatment delay 
< 6 hours; age < 70 years; ST-segment elevation; no contra•
indication for thrombolysis and informed consent. Patency rate 
was investigated at 45m", and 60'''''' after start of the study medi•
cation, and at 90m", in case patency after one hour was inade•
·quate. Thereafter. PTCA was performed if TIMI flow was 0 or 
I. Reocclusion rate was determined between 24-40 hours in 
patients without PTCA. Saruplase was given as a 20 mg iv bolus 
+ 60 mg iv infusion in I hour and alteplase as a 10 mg iv bolus 
+ 90 mg iv infusion in 3 hours. All patients were treated with iv 
heparin and with aspirin. 
Results: 473 myocardial infarction patients were included. 
Baseline data were similar for both study groups. Patency at 
45"'"', 60""" and 90"'''' after saruplase was 74.6%, 79.5% and 
81.7% and 68.9%. 75.7% and 81.5% after alteplase, respective•
ly (p=ns). Reocclusion rates were 1.2% for sarupJase and 2.4% 
for alteplase (p=ns). Complication rates were identical for the 
two treatment allocations. 
Conclusion: These data suggest that saruplase is at least as fast, 
as effective. and as safe as alteplase. 
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Angioplasty Versus Coronary Artery Bypass in Octogenarians 
Tej K Kaul, Barry L. Fields, David A. Wyatt, Christopher R. Jones, 
Donald R. Kahn for Princeton Baptist Medical Center, Birmingham, AL 
We retrospectively analyzed early &0 late results for 2 treatment strategies 
u significant coronary artery disease (CAD) in 301 octogenarians seen in the 
list 10 years. Ninety-six patients 2.80 yrs of age had angioplasty (PTCA) &0 
205 had CABG. PTCA group differed from CABG group in having a greater 
proportion offemales (72% VB 45%, P < 0.001) and fewer patients (pts) with 
UDStable angina (20% vs 31%, p<O.04), acute myocardjaJ infarction (AMI) 
(11% VB 25%, p<0.03), 3-vessel CAD (21% VB 55% p<o.oOOl), LVEF .=;:.30% 
(10% VB 20% p<O.OOl) &0 the number ofvesse1s revBllClllarized (1.2.±.0.7 vs 
3.5.±.0.8, p<O.OOOl). Hospital mortality was 7.3% after PTCA (7/12 failed 
PI'CA), &0 6.8% after CABG (6120 emergent, 6/95 urgent, 2/90 elective). 
Hospital stay was 7,±,0.7 days after PTCA and 14.±.2 days after CABG 
(p< 0.01). By multivariate analysis independent predictors of hospital 
mortality were: failed PTCA &0 AMI, (PTCA group) LVEF.=;:.30% and 
emergency CABG (CABG group). Survivors after CABG showed a significant 
improvement in their NYHA class (3.2.±.0.06 vs 1.5.±.0.7, p<0.0001). 
Actuarial survival at 3 years post PTCA was 86% &0 post CABG 88% (NS) &0 
11110 years post CABG 54%. Cardiac event free survival (deaths, Ml, PTCA, 
CABG) at 3 years post PTCA was 61% and post CABG 75% (p<0.05). 
CONCLUSIONS: In octogenarians PTCA had a greater mortality and failure 
rate than expected. Elective CABG had most favorable results. Morbidity was 
higher after CABG than after PTCA given the nature and the severity of the 
iD:reased risk factors in the CABG group. 
789·2 10:45 
Is CABG Superior to PlCA In Patients on Chronic Renal 
Dialysis? . . . 
*Toshiya Koyanagi, Masahiro Endo, Hiroshi Nishida, Hltoshl 
Koyanagi, Masao Kawaguchi, Nobuhisa Magosaki, letsuya 
Sumiyoshi, Saichi Hosoda 
Tokyo Women's Medical College, Tokyo, Japan 
To study differences in outcome after coronary artery 
bypass grafting(CABG) or percutaneous transluminal coro•
nary angioplasty (PTeA) in patients(ots) on chronic renal 
diarysis, 23 CABG and 20 PTCA pts form December, 1984 
to December, 1992 were compared. CABG pts were not 
significantly different from PlCA pts in mean age(55 vs 57), 
~ender (1 female vs 4 females), presence of unstable angina 74% vs 100%), previous myocardial infarction (MI)(48% vs 5%), previou~ congestive heart failure (~5% ~s 40%),.LV 
ejection fraction (50% vs 53%) and dialYSIS duration 
(years)(4.7 vs 4.2). Mean number of diseased arteries was 
~.7 in CABG and 1.9 in PTCA (p<0.01). Mean follow-up 
periods was 2.2 years in CABG and 2.4 years in PTCA(NS). 
Mean number of distal anastomosis in CABG was 2.2 and 
the grafts use~ w~re left internal artery (ITA); 21! right ITA; 7, 
right gastroepiploIc artery; 7, and saphenous vein; 15. There 
were no hospital deaths. Angiography performed in 22 pts 
one month after the operation revealed that arterial grafts 
were all patent and overall patency rate was 95.8%(46/48). 
There were 4 late deaths (cerebral hemorrhage;3 cardiac;i) 
and 4 cardiac events (prCA;3, MT;1). In PTCA, lesion 
success rate was 76% (29/38) and patients success rate 
was 65% (13/20). There were no hospital deaths and .3 
major complications(emergent CABG;2, MI;1). Restenosls 
rate was 82%(9/11). There were 2 late deaths (cardiac;1, 
pneumonia;1) and 14 cardiac events (re PTCA;10, CABG;3, 
MI;1). Five-years event free rate W?S 70% in CABG and 
18% in PTCA. In conclusion, CABG In patients on chrOniC 
renal dialysis can be accomplished with more excellent early 
and long-term results than PTCA through careful dialysis 
program and extensive usage of arterial grafts. 
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789·3 11:00 
Does Coronary Bypass Surgery Bave Long-term 
Benefit in Women? ADalysis of 1242 Women 
Followed up to 20 Years 
Gerald M. Lawrie, Nan R. Earle, George C. 
Morris, Michael E. DeBakey, Baylor College 
of Medicine, The Methodist Hospital, 
Houston, TX. 
The value of CAB in women (F) vs men 
(M) is still debated. Between 1969 and 
1993, 7,636 pts had CAB , 16.3% (1242) were 
F. Perioperative mortality for isolated CAB 
was 0/A:4.7%, F:6.0%, M:4_4% (P<0.04). 
Although F were older preop: 59.5 ± 10 yrs 
vs 56.5 ± 9 yrs (P<O_OOl), they had better 
EFs: 57_2% ± 15% vs 54.2% ± 15% (P< 0_001) 
fewer preop MI: 49% vs 57% (P<O.OOl) but 
more CHF: 20_7% vs 12.7% (P<O.OOl). All of 
these factors were predictive of periop 
mortality in M and F to a similar degree. 
Emergency surgery , additional procedures 
were associated with increased risk in M , 
F. Overall survival at 10 yrs was M: 60% 
(expected 76%), F: 62% (expected 84%), 15 
yrs M: 38% (expected 62%), F:41% (expected 
74%) and 20 years M:21% (expected 48%) and 
F:28% (expected 61%) (P<0.05). Angina 
relief at 10 yrs was similar in M , F: 88% 
of F were asymptomatic or improved vs 91% of 
M (P=NS). Thus women had a slightly higher 
intrinsic risk of periop mortality separate 
from their different risk factor profile but 
long term had a prognosis similar to M. 
Surgery should be recommended to F with the 
expectation of an overall outcome similar to 
M. 
789·4 11:15 
Women Are at Higher Risk for Early Coronary Artery Bypass 
Graft Closure 
Lucien Campeau, Genell Knatterud, Norma Lynn Fox, Carl White, 
Irvin Goldenberg, Richard Gray, J. Allan Herd, William Stewart, 
Salim Yusuf, and the Post-CABG Clinical Trial Investigators, 
Montreal, Canada 
We evaluated gender difference in early patency (PAT) of coronary 
artery bypass grafts (CABG) placed in 948 men and 98 women who 
were screened for the post-CABG clinical trial. The study was limited 
to pts who had only 1 bypass operation, 1-6 yrs earlier (mean±SD == 
3.8±1.8 for men and 3.4±1.8 for women) and who had grafts with 
a single coronary anastomosis. There were 2061 saphenous vein grafts 
(SVGs) and 695 internal mammary artery grafts (!MAs). Logistic 
regression analyses showed that overall PAT was higher in men than 
in women (odds ratio=!.71; 95% CI=1.23-2.38; p<O.OO2), in !MAs 
than in SVGs (odds ratio=!.69; 95% CI=1.l2-2.56; p<O.OI), and 
also among grafts to the left anterior descending (LAD) than non-LAD 
arteries, including right coronary artery, diagonal, ramus and obtuse 
marginal branches (odds ratio=2.70; 95% CI= 1.84-3.94, P <0.00(1). 
As shown below, PAT is lower in women for SVGs to non-LAD 
arteries. !MA§ ~ 
Men To LAD To non-LAD To LAD To non-LAD 
No. placed 529 99 230 1644 
No. PAT (%) 503(95) 87(88) 214(93) 1345(82) 
Women 
No. placed 55 12 30 157 
No. PAT (%) 52(95) 11(92) 25(83) 113(72) 
Conclusion: In pts having non-clinically driven angiograms, gender, 
type of conduit and insertion site are all independent risk factors for 
early CABG patency, which combine in such a way that lower patency 
is observed in women with SVGs to non-LAD insertion sites. 
JACC February 1994:1A-484A 
789·5 11:30 
Gender Determines Survival From Coronary Bypass Surgery (CABG) 
Kenton J. Zehr, Andrew Chang, Cynthia Siu, Pankaj Kumar, William A. 
Baumgartner, and Nisha C. Cbandra: Johns Hopkins Med Inst, BaIt, MD 
Prior studies have shown bigher mortality in women following CABG. 
However, these studies from the early 1980's, reflected different clinical 
practice and did not examine several clinical or surgical parameters that 
could change mortality. To examine the effects of gender on survival, 618 
patients (389 male, 229 female) who underwent first time CABG in 1992 
were studied. Compared to females, males were younger (M ± SEM) 
(63.2±O.S vs 66.6±O.6 yrs), had a higher incidence ofsmoking (SI.2% vs 
3S%), higher body surface area (BSA) (2±O vs 1.76±O), lower likelibood 
of diabetes (22.2% vs 39.9%) (all p< .00(1) and less class 3-4 angina 
(p= .04). Males more frequently bad > 70% circumflex and left anterior 
descending artery occlusions (both pS .04) and were more likely to have 
worse left ventricular function (LVF) (p= .07). The incidence of 
bypertension, hyperlipidemia, family bistory, number of vessels diseased, 
left main coronary disease, prior myocardial infarction (MI), pre-CABG 
PrCA were similar. BSA and gender were correlated (p=.0001). 
In terms of operative variables, males and females had a similar incidence 
of the internal mammary being used, number of vessels bypassed, bypass 
time (CPB time), aortic cross clamp time and post-CABG complications 
including stroke and MI (all p NS). Acute surgical mortality was 0.5% for 
males vs 0.9% for females (p NS). Hospital mortality however was 0.9% 
vs 4.1 %, respectively (p = .006). A multivariate logistic regression analysis 
incorporating gender, age, diabetes, LVF, CPB time, number of vessels 
bypassed and post-CABG complications confirmed that female gender, post•
CABG complications and longer CPB time were predictors of worse hospital 
mortality (all p< .01). A logistic adjustment analysis of the gender effect 
for each of the variables tested above confirmed that female gender 
continued to be a powerful predictor of worse hospital mortality (p< .01). 
We conclude that at the time of first CABG, women are older, more 
symptomatic, and despite similar operative variables and acute surgical 
outcome, have a greater risk of dying in hospital than men. Further study 
of this phenomenon is warranted. 
789·6 11:45 
Which Postoperative Risk·factors can Predict Mortality and Event 
Rates 15 Years After Venous Coronary Artery Bypass Grafting? 
Ben L. van Brussel. HW. Thijs Plokker. Sjef M.P.G. Emst. Nicolette M. 
Ernst. Paul J. Knaepen. Freddy E.E. Vermeulen. Egbert M. Koomen. 
Adriaan A. Voors. Jan G.P. Tijssen. St Antonius Hospital. Nieuwegeln. The 
Netherlands 
All our 428 pts who underwent venous CABG between April 1976 and 
April 1977 were followed prospectively. 15 year follow-up was 99.8% 
complete and averaged 13.4 years. To evaluate the Influence of those 
risk-factors which were present 5 y postoperatively on the long-term (15y) 
results. we 'censored' for events which had occurred before 5 y. and 
performed multivariate analysis using the Cox regression model 
Event Risk-factor P value Odds ratio 
Cardiac death LV function 0.000 2.8 
3VD 0.01 2.9 
Hypertension at 5 y 0.03 1.6 
Diabetes at 5 y 0.01 2.5 
AMI Obesttyat 5 y 0.001 2.3 
Triglycerldes t at 5 y 0.001 4.0 
Diabetes at 5 y 0.01 6.5 
Smoking at 5 y 0.001 2.1 
Relnterventions Trlglycerides t at 5 y 0.03 2.2 
Smoking at 5 y 0.0001 2.0 
Angina 3VD 0.01 I.B 
We conclude that besides well·known preoperative risk factors such as 
LV function and three vessel-disease. more 'classical' risk factors such as 
(continued) smoking. elevated triglycerldes. obestty. diabetes and hyper•
tenSion determine late results after venous CABG. These data emphasize 
the Importance of risk factor reduction after venous CABG. 
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Role of Endothelium-Derived Nitric Oxide in the Vasodilator 
Response to Bradykinin in Normotensive and Hypertensive 
Humans 
Carlos E. Garda, Crescence M. Kilcoyne, Arshed A. Quyyumi, 
Richard O. Cannon Ill, Julio A. Panza. NHLBI, Bethesda, MD 
We have shown that the endothelium-dependent vasodilation to 
bradykinin (BK) is blunted in patients with essential hypertension. To 
investigate the mechanisms that determine this abnormal response, we 
studied the contribution of endothelium-derived nitric oxide (NO) to 
BK-induced vasodilation in 10 hypertensive patients (5 men; age 
48±9 years) and 12 normal controls (6 men; 48±7 years). The 
forearm vascular responses to BK (100, 200, and 400 ng/min) were 
measured during combined administration of either 5 % dextrose or 
N"-monomethyl-L-arginine (L-NMMA; 4 "moUmin), an inhibitor of 
NO synthesis. During combined infusion of 5% dextrose, the 
vasodilator response to BK was significantly reduced in hypertensive 
patients compared to normal controls (maximum blood flow 8.7 ±2 
vs. 15.8±6 ml/minilOO ml of forearm, respectively; p<O.(05). L•
NMMA significantly blunted the response to BK in normal subjects 
(maximum blood flow decreased from 15.8±6to 10.1 ±2; p<O.(03). 
In contrast, inhibition of NO synthesis did not modify the response to 
BK in hypertensive patients (maximum blood flow 8.7 ±2 and 8.5 ±3 
before and during L-NMMA respectively; p=NS). The response to 
BK after inhibition of NO synthesis was not significantly different 
between normal controls and hypertensive patients (maximum blood 
flow 1O.1±2 vs. 8.5±3, respectively; p=O.2). Thus, endothelium•
derived NO importantly contributes to BK-induced vasodilation in 
normal humans. This mechanism is substantially impaired in essential 
hypertension and is a major determinant of the abnormal endothelium•
dependent vasodilation in patients with this condition. 
790·2 10:45 
Impairment of Cardiac end Endothelial Function is Independent from 
Blood Pressure Increase in Transgenic Rats Expressing the Renin-2 
Gene. 
Yigal M. Pinto. Hendrik Buikema. Wiek H. van Gilst. Egbert Scholtens. 
Peter-Paul van Geel. Pieter A. de Graeff. Harry Wesseling and *Martin 
Paul. Dept. of Clinical Pharmacology. Univ. of Groningen. The 
Netherlands and * Univ. of Heidelberg. Germany. 
The beneficial effects of ACE inhibition mav extend beyond mere blood 
pressure (BPI reduction. leading to the hypothesis that an activated 
local renin-angiotensin system (RASI adds to the progressive loss of 
cardiac and endothelial function in hypertension and heart failure. 
To test this hypothesis we studied cardiac and endothelial function in 
isolated hearts as well as in aortic rings. in three groups of rats. 
Transgenic rats (TGR( mRen2127), express the mouse Ren-2 gene and 
develop sustained hypertension based on the activation of tissue RAS 
(n = 61. They were compared to normal (n = 61 and Spontaneously 
Hypertensive Rats (SHR;n = 71. In transgenics. BP was increased to a 
similar extent as in SHR (Systolic BP 167 ± 18 and 175 ± 18 vs 
138 ± 61. However. left ventricular weight (per gram body weightl was 
much greater in the transgenic rats. as compared to the SHR and 
normal rats (mean:40 ± 3 vs. 31 ± 2 vs. 26 ± 2 respectively), despite 
comparable elevations in BP. Furthermore. although systolic dP/dT was 
significantly decreased in both transgenics and SHR (2811 ±465 and 
3571 ± 272 resp. vs. 4342 ± 1191. diastolic dP/dT was only decreased 
significantly in the transgenics (1927 ± 291 vs. 3412 ± 199 and 
3081 ±251\. Moreover. aortic responses to acetylcholine were 
significantly depressed only in the transgenic rats. These results show 
that. although BP was similar in transgenics and SHR. in transgenics 
there was significantly more cardiac hypertrophy. diastolic dysfunction 
as well as endothelial dysfunction. 
In conclusion. genetic activation of the local RAS. independent from its 
BP increase. induces massive cardiac hypertrophy. and cardiac as well 
as endothelial dysfunction. These findings support the hypothesis that 
an activated local RAS adds to cardiovascular dysfunction. which 
should have important therapeutical implications. 
348A ABSTRACTS 
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Free Cytosolic Calcium and Proliferative Activity of Human Vascular 
Smooth Muscle Cells are Regulated by L-Type Calcium Channel 
Modulators 
Hans J. Kruse, *J(jrgen Heimerl, --oelhard Bauriedel, *Berthold liOfling, 
Peter C. Weber, Inst. Prophylaxe und Epidemiologie der 
Kreislaufkrankheiten and *Dept of Internal Medicine I, University of 
Munich,FRO 
Changes of free cytosolic calcium concentration ([Ca2+]i) by honnooal 
or phannacological agents can nigger cellular responses, gene expression 
and growth. Thus, we studied the effects of the dihydropyridine (DHP) 
receptor agonist BayK 8644 and the DHP-receptor antagonist Nicaidipine 
(Nic) on [Ca2+]i and on proliferation of human arterial smooth muscle cells 
(SMCs). [Ca2+]i was measured in SMCs by fluorescence (Fura-2). Basal 
Ca2+ level and those 20h after application of BayK or Nic were studied. 
[Ca2+]i-All was the value of the sustained phase 5 min after stimulation 
with 10j.UII A-II. SMC proliferative activity was quantified by the 
population doubling rate (PDR) of growth curves (n=6; x±SEM; *=p<O.OS, 
**=p<0.01 as compared to control): 
Substance Concentration [Ca2+]i [Ca2+]i-All PDR 
Control 23S±IS 421±21 0.21±0.OS 
Nicardipine l00nM 191±3*· 29S±IS** 0.16±0.02* 
BayK 8644 10 nM 30Q± 8·* S46±26** O.43±0.04** 
BayK increased [Ca2+]i and potentiated A-II induced Ca2+ transients in 
human SMCs. Nic significantly reduced [Ca2+]i and stimulatory effects of 
A-II. 10 nM BayK in Ca2+-free buffer (0.2 mM EOTA) had no effect ro 
[Ca2+]i. After adding Ca2+ (1 mM) to the buffer, [Ca2+]i increased, 
indicating that BayK induced Ca2+ increase resulted from Ca2+ influx. 
Concordantly, PDR of SMCs was enhanced by BayK and reduced by Nic. 
In conclusion, dihydropyridines modulate growth activity of human 
arterial SMCs and effects of A-II on [Ca2+]i in these cells. Thus, 
compounds decreasing cellular Ca2+ concentrations may blunt structural 
alterations of the vessel wall by reducing stimulatory effects of the 
vasoconstrictor peptide A-II on cell proliferation. 
790·4 11:15 
HyperteJISion Specifically Induces lnsulin·Uke Growth Factor 
IUnding Protein .. Expression in Rat Aorta. 
Asif Anwar, Patrick DeIafontaine, Division of Cardiology, Emory 
University, Atlanta, GA 
We have previously shown that Insulin-Like Growth Factor I (lGF 
I) Is an important tnitogen for vascular smooth muscle cells (VSMC) 
and is induced in the hypertensive aorta following interrenal aonic 
coarctation (lAC) in the rat. Funhermore, we have demonstrated 
that transcriptional activation of the IGF 1 gene is required for 
angiotensin II-Induced tnitogenesis (J. BioI Chern. 1993; 268: 16866-
16870). The effectS of IGF I are modulated by several binding 
proteins (BPs) including IGFBP-3, the prindpal drculating carrier of 
IGF I, and IGFBP-4, an inhibitory BP secreted by VSMC. To 
detenrune whether IGFBPs are regulated in hypertension, male 
Sprague-Dawley rats underwent lAC or a sham procedure. IGFBP 
mRNA levels were detennined by Nonhem analysis at I, 3, 7, and 14 
days in thoradc hypenensive aorta (HA), nonnotenslve abdotninal 
aorta (NA), and in liver (L). Compared with sham there was a rapid 
increase in lGFBP-4 mRNA in HA (82 :!: 21% at 1 day, n=4), that was 
sustained at 14 days (147 :!: 9%, n=3). In contrast, IGFBP-4 mRNA 
levels decreased slightly in NA and in L (20 :!: 5% and 27 :!: 13% at 
14 days, respectively). Funbennore, lAC suppressed IGFBP-.~ 
expresSion in HA and in L (40% and 52% decrease at 14 days, 
respectively). Strung immunostaining for IGFBP-4 was detected in 
the· medial layer of the thoracic aona. Thus, in this high-renin model 
of hypenension there is a sustained and speclfic induction ofIGFBP-
4 mRNA expression only In the hypenensive blood vessel, consistent 
with a hemodynamically-mediated effect. Together with the known 
increase in aortic IGF I mRNA following lAC, these fmdings strongly 
suppon a role for an autocrine vascular IGF I system that panicipates 
in hypertensive vascular remodeling. Pressure-induced increases in 
IGFBP-4 may serve a key regulato"," function in litniting local 
responses to IGF I and angiotensin II. 
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Effects of Hormone Replacement Therapy (HRT) on Blood 
Pressure In Hypertensive Women 
Gregory Up, Michette Beevers, Alan Holmes, David ChUrchiH, Gareth Beevers 
University Department of Medicine, Dudley Aoad Hospital, Birmingham B18 
70H. England, United Kingdom 
There remains anxiety about the use of hormone replacement therapy (HAT) 
in postmenopausal women with hypertension. We therefore conducted a 
prospective open study of sequential changes in blood pressure (BP) in 
women referred" our hypertension ctnc who required HAT for the Im!IioraIion 
of menopausal symptoms. 75 hypertensive women (mean age 50.4 years % 
s.d.5.6) were studied. All patients were postmenopausal on the basis of a 
natural menopause (With documented high levels of FSH and/or LH) or 
surgicaI menopause. All had blood pressures of more than 160J95mm Hg on 
at least 2 previous occasions whilst attending our ctinic. Mean BP in the year 
prior to receiving HRT was 155.2 %21.4/90.1 % 11.3. Mean weight was 73.6 
%16.41<9. and the average medication was 1.1 % 1.0 drugslpatient. Patients 
were followed up for a median of 14 months (lOR 8-32 months), being seen 
(as far as possible) at 3 monthly intervals. Our results are as follows: 
BP results at follow-up (In months) post HAT (m.n): 
mIh 3 6 9 12 15 18 21 24 27 ~ 
-va 152 156 156 162 1W 155 157 140 148 145 
cia 89 92 92 !l3 !l3 90 89 as !l3 92 
wt Tf.Z' 75.7 78.1' 72.2 75.7" 69.9 76.2 79.2 83.5 73.4 
(mth=months; sys=systolic BP, dia~iaslolic BP, w\=WIlight) 
33 36t 
148 156 
89 92 
79.879.7 
There were no significant differences in average medication taken (1.27 % 1.1 
drugslpatient), nor in systolic or diastolic BPs post-HRT when compared to 
BPs pre-HRT(paired t-test,p:NS) at end of the follow-up period for individual 
patients. This is despite an increase in mean weights, which was significant 
at 3,9 and 15 months post-HRT ('P<O.05). This study suggests that HRT is 
safe in hypertensive women but careful supervision is necessary. In view of 
the benefits of HRT in postmenopausal women, those with hypertension 
should not be denied this treatment. 
790·6 11:45 
Effect of Long Acting Oral Felodipine and Nifedipine on Left 
Ventricular Contractility in Patients with Systemic Hypertension: 
Differentiation Between Reflex Sympathetic and Direct Contractile 
Responses. Margaret M. Redfield, F ACC, Alex Neumann, A. Jamil 
Tajik, FACC, James B. Seward, FACC, Kenneth M. Borow, FACC. 
Mayo Clinic, Rochester, MN and Rusb Presbyterian Hospital, Chicago, IL 
It is controversial whether felodipine, a third generation dihydropyridine, is 
devoid of direct negative inotropic effect in humans. This reflects, in part, 
the confounding effects of drug induced afterload reduction and reflex 
sympathetic responses. Using a double blind, randomized, cross over 
design, fifteen hypertensive patients (mean BP= 114± 12 mmHg) were 
studied with Doppler and imaging ecbocardiograpby and calibrated 
subclavian pulse tracings on placebo and after 8 weeks therapy with 
felodipine ER (5-20 mg qd) or nifedipine XL (30-120 mg qd). A 5 week 
washout period separated treatment protocols. LV circumferential end•
systolic wall stress (aes) vs rate corrected velocity of shortening (V cfc) 
relations were generated over a range of loads using nitroprusside. Data 
were acquired before and during esmolol infusion to assess hemodynamic 
responses with the sympathetic nervous system (SNS) functionally intact 
as well as ablated. Contractility was measured relative to placebo and 
esmolol data as !J. V cfc at a common aes with increased and decreased 
contractility defined as !J.Vcfc>O and !J.Vcfc<O, respectively. Mean BP 
decreased equally (p=0.01 vs placebo) for felodipine (99±8 mmHg) and 
nifedipine (I 02±9 mmHg) compared to placebo. With intact SNS, 
contractility was increased for both drugs compared with placebo due to 
reflex sympathetic activation. Ablation of SNS with esmolol unmasked a 
negative inotropic effect for nifedipine XL (p < 0.0 II vs esmolol alone) 
but not felodipine ER (p = 0.36 vs esmolol alone). Thus, with long acting 
oral dihyropyridines, reflex activation of the sympathetic nervous system 
increased LV contractility. When alterations in afterload and reflex 
sympathetic responses were eliminated as confounding variables, 
nifedipine XL but not felodipine ER decreased ventricular contractile state. 
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Mechanism 0' Relle' in Hypertrophic Cardiomyopathy (HCM): 
Characterization 0' Dual Chamher Pacing.lnduced and Septal 
Ahlation·lnduced Left Ventricular (LV) Dyssynchrony Using 
Fourier Phase Analysis 
Marc Ovadia. George C McNeill. Ding-Sheng He. Anthony C Caruso. Waller H 
Williams. University Hean Center. University of Arizona, Tucson. Arizona. 
In obstructive HCM dual-chamber pacing reduces dynamic LV outflow obstruction. 
Pacing is an alternative to surgery. The mechanism is unclear. Paradoxical septal 
motion has been postulated. However. neither desynchronization nor paradox has 
been shown to occur. If desynchrolUzation is the mechanism. then intracardiac 
ablation may produce the same effect as pacing with similar benefit To address the 
questions of the effect of pacing. and of whether ablation produces the same effec~ 
we have develqJed a canine model for analysis of ventricular activation in DOD 
pacing and after intracardiac ablation. relevant to HCM. Permanent transvenous 
dual-chamber pacemakers were placed in 5 dogs with septa of 12± 0.2 mm(m±SD). 
First-transit and glled equilibrium images were acquired afler 25 mCi Tc-99m 
labeled RBC bolus. Radionuclide ventriculography was performed at constant atrial 
rale in two pacing modes prior to ablation: I) normal AV conduction and 2) dual 
chamber pacing. The protocol was repealed after ablation. Fourier phase analysis 
was used to compare phase angle distributions in outflow trac~ apical. mid-body 
and lateral regions of interest in the LV. Ablation involved multiple radiofrequency 
or DC energy applications to the region of the left bundle branch. With normal A V 
conduction. LV activation was nearly synchronous. with 1541 ° phase difference 
between LV regions (28±12°). Modal phase angle difference betwecn outflow tract 
and laleral LV was 1()'37°(19±4.7°). With dua/-cho.mber pacing. there was marked 
desynchronization of the LV with a 50-255° phase range of LV activation (p<0.02 
in comparison 10 nonnaI A V conduction). LV outflow and Ialeral regions differed 
in phase by 40-85° (59± 19°). In all artimals the outflow 111lCt was desynchronized 
relative 10 the body and lateral wall (p<O.05) but was never paradoxical. Septal 
ablation cf the subaortic septum in the region of the left bundle branch appeared to 
produce /lcll/ely a panem of activation vinually identical 10 that of dual chamber 
pacing. characterized by left ventricular desynchrooization in 3/4 (bean bloclc-I/4). 
In conclusion: (I) in the canine dual-chamber pacing induces marked 
desynchronization of LV activation (p<O.02). (2) In all animals the outflow tract 
was desynchrooized relative 10 the body and lateral wall (p<O.05) but never with 
paradoxical septal motion. The mechanism of relief of obstruction in HCM may be 
LV desynchronization. (3) Sepia! ablation induces identical dyssynchrony. Thus. 
ablation may have a role in Ireaunent of obstructive hypenrophic cardiomyopathy. 
If radiofrequency techniques can be refmed limiting injury 10 the left bundle branch. 
then ablation may be the therapy of choice for HCM in infants and children. 
791·2 10:45 
Effect of varying AV Delay on IBCM)lumic Relaxation Time, 
Mitral Flow Pattern IUId Diastolic Filling Period in 
Subjects With Dual Chamber Pa~ 
Sudha M Pai, Rarrdas G Pai, Alan K Jacobson, Linda 
Feenstra, Roy V Jutzy. VAl! and lana Linda Univ, CA. 
The effect of varying AV delay (AVD) on transmitral 
E/A velocity ratio has been studied. However, its effect 
on left ventricular (LV) isovolumic relaxation time 
(IVRT) and diastolic filling period (DFP) are not known 
although these effects have to be considered in assessing 
overall LV filling dynamics and the ecancmy of use of DFP 
which in turn dete:rmines LV e~ection function. 
We studied 12 patients w~th dual chamber pacemakers 
at a paced rate of 70 beats/minute and varied their AVD 
fran 25 to 250 msec (AVD25 to AVD250) in 25 msec 
increments. Transmitral flow waves were recorded at the 
tips of mitral leaflets using pulsed wave Doppler. The 
flow in the LV outflow tract was recorded and stroke 
volume was canputed. E/A velocity ratio, IVRT (in msec) 
and DFP (in msec) were measured. Results: An increase in 
paced AV delay gave rise to significant increases in A 
wave velocity (Avel in an/s) and reductions in E wave 
velocity (Evel in em/s) , E/A ratio and DFP as shown in 
the table. The IVRT showed a bell-shaped. response to 
increasing AVD, being longest at optimum AVD and there 
was a strong positive correlation between IVRT and stroke 
volume in each of the patients (p<. 01 in each patient) . 
There was no significant change in systolic mitral 
regurgitation (MR) at different AVD; trace am:runts of 
diastolic MR were noted at long AVD in 3 of the patients, 
but probably insignificant fran hem:xlynarnic point of 
view. 
~ aIlIllQJ! ~ ~ P 
Avel 44±19 74±22 79±25 91.±30 <.001 
Evel 71.±17 65±13 5S±18 S4±lS <. OS 
E/A 1. 84±. 80 O. 96±.42 O. 74±. 24 O. 63±. 21 <.001 
DFP 487±107 426±81 373±69 329±86 <. 001 
IVRT lSO±74 lSS±3S 160±39 147±4S >.05 
Cgnc:lusiQ!!S: With an increase in AVD, there ~s a 
short~ LV diastolic filling period besides an 
increase ill A wave velocity and reduction in E/A velocity 
ratio. The duration of ~sovolumic relaxation time is 
strongly and positively related to stroke volume. 
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Acute BsmodyDamic .ffect of A-V DBlay in Patient. With 
CoD9B.ti~ ... zt .ailuEe. 
zenaida Feliciano, Michael L. Fisher, Mary C. 
Corretti, Stephen S. Gottlieb, Michael R. Gold, 
University of Maryland, Baltimore, MD 
Changes in atrioventricular delay (AVO) have 
important hemodynamic effects in paced patients (pts) 
with normal systolic function, where a 150 me AVO is 
usually optimal, or hypertrophic cardiomyopathy, where 
very short AVO is optimal. Congestive heart failure 
(CHF) pts often have diffuse conduction system 
abnormalities and it has been reported that short AVO 
(100 ms) may improve functional status, possibly by 
reducing mitral regurgitation (MR). To assess the 
effect of AVO on acute hemodynamics we studied 17 pts 
with NYHA class III-IV CHF despite standard medical 
therapy. Mean age was 65±7 years and ejection fraction 
was 21±6%. On baseline electrocardiogram mean PR 
(215±44 ms) and QRS (134±37 ms) intervals were both 
prolonged. By echocardiogram, 38% of pts had moderate 
to severe MR. The day following permanent pacemaker 
implantation invasive hemodynamic measurements 
including heart rate (HR, bpm) , cardiac index (CI, 
L/min/M2), pulmonary capillary wedge and right atrial 
pressures (PCWP and MAP, mmHg) were obtained during 
intrinsic (INT) rhythm and VOD pacing at up to five 
AVO (IllS) that did not result in s,j,gnificant fusion. 
VI) %NT 100 125 150 175 200 
~ 83±9 83±7 81±7 83±7 82±7 77±1l 
I 12·2±0.8 j£.2±0.9 j£.l±O.8 ~.2±O. 8 ~.3±O. 7 .O±O.7 
IPCWP 17±9 19±9 18±7 17±8 15±5 16±5 
~ 87±13 87±12 86±13 87±14 86±12 83±14 
NO significant differences were found between any of 
these parameters and AVO either in the total 
population or in the MR cohort. In conclusion, 
changing the AVO does not improve acute hemodynamic 
status in chronic CHF. 
791·4 11:15 
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Safety 0' Low Output (l.5/U Volt) Pad ... In Chlldren From 11me of Implant: 
6 Year Experience with Sterold·Elutl ... EIec:trodes 
Nancy A. Goldman, ·Peter P. Karpawich, Cardiology, Children" Hospital of 
Michigan, Wayne State University School of Medicine, Detroit, MI. 
Low output (2.5/1.6 volt (V) pacing is not recommended in children with 
polished or porous-platinized E due to frequent threshold (Th) c:banges and 
electrode (E) exit block. Steroid-eluting (St) E, however, may maintain E·tissue 
interface stability, permitting continuous low output pacing. To evaluate safety of 
initial low output (2.5V I03ms) programming of both filled and rate-variable 
atrial and ventricu1ar pacing from implant. 26 young patients (pts) (age 2 days • 
26 yrs, mean 13.8yrs) with both epicardial (Ep) (Medtronic models l029SA 
(n-S). I029SB (n"'S) and endocardial (En) (models 5023 (nE10). 5024 (n-l), 
4003 (n=3), 4004 (n=I). 4023 (n=I), 4024 (n"'l» St E were followed up to 6 
years. At implant. mean pacing Th (2.5V) was O.13ms (EpE) and O.IOms 
(EnE)(p<.OS); mean impedance 477~EnE). 522Q(EpE) (p=NS).lnitiai output 
of 2.SV /03ms was programmed in 23 pts while 2 pts were re.programmed at 
either 2 wks or 6 mas after implant. 
Stable or improved Th (2.5V) from implant requiring no change in output 
programming for 3 yr (EpE) and 6 
yr (EnE) were seen in 25 pts I~MS:-:::=EC=-------' 
(Figure). Only one pt (EpE) 02 r------, l_lNEINlUJ."_"""" I showed Th increase after 2 wks to 0.15. . 
O.6ms then improved to O.05ms at 4 
wks. Atrial and ventricular E 
performances were comparable. 
Lead impedances remained 
comparable to implant. Four pts 
(EnE) were programmed to 
1.6V I03ms after 3 mas with Th of 
O.05ms and paced from 1 - 5 yr 
o 
without Th change. 
2 
YEARS 
• 
St E permit safe use of iow output (2.5V / 03ms) EnfEp atrial and ventricular 
pacing from implant in children. Expected generator battery life can be doubled 
over longevity estimates at 5V / O.5ms and lessen the need for system revision. 
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791·5 11:30 
Predictors for Long· Term Survival After Pacemaker 
Implantation In the Very Elderly: Role of Conduction System 
Disease 
Win K. Shen, David L. Hayes, Stephen C. Hammill, Kent R. Bailey, 
Bernard J. Gersh, Mayo Clinic, Rochester, MN. 
Long-term survival was estimated in 157 Olmsted County, 
MN, residents ~ 80 yrs (mean 85.2±3.9 yrs) after pacemaker (PM) 
implantation. 81 had AV block (A VB), 12 chronic atrial fibrillation 
with slow ventricular rate (AF), 50 sick sinus syndrome (SSS), and 
14 carotid sinus hypersensitivity or vasovagal syncope (Other). 
Observed survivals (Kaplan-Meier method) for the 4 groups of pts 
were compared to age and sex matched controls (North Central 
White Population 1980) and analyzed as shown (log rank test): 
Pt Observed Expected P 
Group Survival% Survival% (Obs vsExp) 
1 yr 5yr lyr 5yr 
AVB 79 35 89 51 0.0001 
AF 75 29 88 59 0.0058 
SSS 78 42 89 51 0.1491 
Other 94 71 90 52 0.3220 
Mu1tivariable analysis identified CHF, COPD, cancer, syncope, and 
A VB to be independent predictors of increased mortality. In pts with 
SSS, survival was comparable to controls in the absence of heart 
disease (p=O.5). In patients with A VB, survival was less than 
expected both in the presence (P< 0.001) or absence (p=0.02) of 
heart disease. Conclusions: I) The normal relative survival in pts 
with SSS without heart disease or Other indications for pacing in the 
very elderly is reassuring. 2) The very poor prognosis in pts with 
A VB or AF warrants close evaluation of the methods and indications 
of pacing in the very elderly. 3) Careful evaluation of underlying 
comorbid conditions in PM patients is required. 
791·6 11:45 
Quality of Life and Outcomes after Radiofrequency His-bundle 
Catheter Ablation and Permanent Pacemaker Implantation 
Adam P Fitzpatrick Hratch D Kourouyan Andreana Siu 
Michael 0 Lesh Jerry C Griffin Melvin M Scheinman 
University of California and CVRI San Francisco CA 
Between February 1989 and May 1993 107 patients (pts.) (age 62±15 
yrs, 60F), underwent radiofrequency His-bundle catheter ablation 
and permanent pacing (RFHBCA/PPM) for paroxysmal or 
established drug-refractory atrial fibrillation (AF). We assessed 
quality of life (Q-of-L: l=poor, 5=excellent), daily activities (A-of•
L: i.e. moderate and vigourous exercise, climbing stairs, carrying 
groceries, bathing: l=very limited, 3=not limited), medical care 
access (incl. pacer follow-up (FU)§), number of anti-arrhythmiC drug 
trials (AAO's), heart failure episode (CHF) or death, and 
maintenance of dual chamber pacing (DCMode, of 30 pts. so treated), 
before and after RFHBCA/PPM, by telephone survey. 
Results. 82 pts. (62±16 years, 49 female, 2.3±12 yrs FU) gave details, 
9 pts. were lost to FU, and there had been 16 deaths, (2-sudden, 7-
progression of underlying disease, 5-unrelated causes, 2-unknown). 
Before After p-value 
Overall Q-of-L 1.6±O.8 3.6±1.1 <0.001 
Specific A-of-L 2±0.4 2.4±O.3 <0.001 
MD visits/yr 10tH 5.5±7.8§ <0.03 
Hospital Admsns/yr 4.5±16 0.13±O.43 <0.03 
AAO's 6.4±4.3 0.5±1.6 <0.001 
CHF 18 8 <0.05 
DCMode 23/30 
Conclusions. In this large cohort with the longest follow-up reported, 
RF His-bundle catheter ablation and pacing is effective palliative 
therapy for AF, improving quality of life, activity status, and 
consumption of medical care. 70% of patients with 000 pacemakers 
remained in a dual chamber mode. Fewer heart failure episodes may 
be due to reversal of tachycardic cardiomyopathy. Of concern is the 
(<2%) incidence of sudden death. 
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939·35 
Frequency and Long·term Impact of Complete 
Revascularization Following Percutaneous Coronary 
Intervention for Angina Pectoris From 1986 to 1991 
Malcolm R. Bell. Peter B. Berger, Diane E. Grill. Kirk N. Garratt. 
David R. Holmes Jr. Mayo Clinic, Rochester. MN 
The importance of complete revascularization (CR) with PTCA 
remains controversial- previous studies have included patients with 
a variety of clinical presentations and predominantly. reflect 
experiences with older PTCA technology. The purpose of thIS study 
was to detennine recent rates of CR and whether patients with CR 
have a better long-tenn outcome than those with incomplete 
revascularization (lR). Patients undergoing a fllSt revascularization 
procedure with PTCA, atherectomy, excimer laser angioplasty and/or 
stent placement were selected if they had angina pectoris and no 
recent myocardial infarction « 7 days), and had not had coronary 
bypass surgery. Gp I consisted of 821 patients treated during 1986-
88 and Gp II of 964 patients treated during 1989-91. MuItivessel 
disease was present in 65% of Gp I and 69% of Gp II (p = NS); CR 
was achieved in 58% of each group. No attempt to dilate stenoses of 
70-99% accounted for 49% (Gp I) and 52% (Gp II) of IR and 
avoidance of chronic occlusions for 16% (Gp I) and 14% (Gp II) of 
IR (p = NS). Survival was less in patients with IR vs CR in Gp I 
(84% vs 90% at 6 yrs; p = 0.007) and in Gp II (89% vs 97% at 3 
yrs; p <0.001). After adjusting for baseline differences, the overall 
relative risk for mortality for patients with IR was 1.56 (95% CI: 
1.07, 2.28). Among patients followed for at least 5 years, freedom 
from coronary bypass surgery or occurrence of definite angina was 
significantly less among those with IR compared to CR but no 
differences were seen with occurrence of repeat PTCA or Q-wave 
myocardial infarction. 
Conclusion: CR rates have remained unchanged over this 
recent 6 year experience and in patients with angina, successful and 
complete revascularization was associated with significant survival 
benefit during follow-up. 
939·36 
Gender Comparison of Frequency and Consequences of 
Incomplete Revascularization Following Percutaneous 
Coronary Revascularization 
Malcolm R. Bell, Kirk N. Garratt. Peter B. Berger, Diane E. Grill, 
David R. Holmes Ir. Mayo Oinic, Rochester, MN 
The ability to achieve complete revascularization (CR) with 
coronary angioplasty has improved with advances in technology. 
Whether the frequency of CR is currently different in women 
compared to men is unknown but may be important since women 
initially have a higher in-hospital mortality; in addition, the potential 
consequences of incomplete revascularization (IR) for women 
compared to men are unknown. From 1985 to 1991, 1320 men and 
577 women with angina pectoris and no prior coronary artery bypass 
surgery (CABS) underwent revascularization at this Institution with 
either coronary balloon angioplasty, directional atherectomy, excimer 
laser angioplasty and/or stent placement. Multivessel disease was 
present in 69% of men and 64% of women (p = 0.02). Procedural 
success was 90% in men and 88% in women (p = NS) with CR 
achieved overall in 57% and 60%, respectively (p = NS). CR rates in 
men and women with 2-vessel disease were 53% vs 56% and with 3-
vessel disease, 31 % vs 28%, respectively (p = NS). During follow•
up (mean 3.3 years) no significant differences were observed between 
men and women with IR in survival, incidence of Q-wave myocardial 
infarction, repeat procedure or angina recurrence. However, more 
men than women with IR underwent CABS (28% vs 15%, 
respectively, after 5 years; p = 0.01). Event-free outcomes were 
similar for men and women with CR and in general were better than 
with IR. 
Conclusion: CR is achieved with equal frequency in men and 
women. IR does not adversely affect the outcome of women more 
than men but CABS is less likely to be performed in women with IR 
during follow-up. 
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939·37 
Slow Oacillating Ya. Rapid Inflation and Slow ya. 
Rapid Daflation in PTCA 
Alan Ford, Shaldon Hanry, Carolin Frey, Jim 
Blanken.hip. Gei.inger Med. Center, Danville, PA. 
To determine whether balloon inflation (inf) 
or deflation (defl) technique influence. coronary 
di.aection (di •• ) or clinical outcome in PTCA, we 
randomized 162 la.ion. to alow (1 atm/20 aec) 
oacillating (pra.aura range 2-3 atm) infl va. rapid 
(ovar 15 .ec) infl, and alow (over 15 .ec) va. 
rapid defl in a 2X2 factorial deaign. Polyolefin 
copolymer balloona wera u.ad. Pressura required to 
dilate the le.ion wa. recorded. Blinded analysis 
of angiograms waa performed for presence of diss 
and .averity graded by NHLBI types A-F by two 
observers. 
RESULTS: Slow defl was a •• ociated with more severe 
diss(Type C-F) and fewer mild dia. (Type A-B) 
compared to rapid defl (2S' vs. 13', p •• 026). 
The alow infl/slow defl group had more .evere diss 
than the other groups (p •• 004). Thsre were no 
differences in overall di •• , lesion dilatation 
pressure, or angiographic (97') or clinical auccess 
rate (94\). 
Rap infl Slo infl Rap infl Slo infl 
Rap defl Rap defl 510 defl 510 defl 
Il!!is 11 = 37 11 = 4, n = i9 11 = 34 
none 20 (54\) 21 (50\) 24 (49') 16 (47\) 
A-B 13 (35%) 15 (36\) 16 (33\) 5 (lS\) 
C-F 4 (11\) 6 (14') 9 (lS\) 13 (3S%) 
CONCLUSIONS: (1) Slow defl produces more severe 
diss than rapid def1. (2) Slow oscillating infl 
does not reduce the lesion dilatation pressure or 
diss rate compared to rapid infl. (3) Slow 
oscillating infl and slow defl together may 
particularly predispose to severe diss, perhaps by 
converting otherwise mild diss into more severe 
diss. Shear forcea created by balloon slippage or 
rapid/turbulent blood flow around the partially 
inflated balloon may be responsible. 
939·38 
Does Percutaneous Revascularization of Ostial Saphenous Vein Grafts 
Stenoses Carry an Adverse Outcome? Comparison With Proximal Shaft 
Disease. 
Alaa E. Abdelmeguid, Sbelly K. Sapp, Irving Franco, Kbosrow Dorosti, 
Russell E. Raymond, Gan L. Howell, Stephen G. Ellis, Patrick L. Whitlow, 
Conrad Simpfendorfer. The Cleveland ~linic Foundation, Cleveland, OH 
Percutaneous revascularization of ostial native coronaries (OS-NAn carries 
an adverse prognosis. We examined wbether ostial sapbenous graft stenosis 
(OS-SVG) carries similar prognosis. We identified 68 consecutive pis with OS•
SVG & 72 with proximal non OS-SVG wbo bad intervention for de novo 
single lesion between 1986-92. Data were entered prospectively in our 
registry. There was no difference in age, sex, % of conventional angioplasty 
(90 vs 93%), lesion length or % stenosis between the 2 groups. There was 
also no difference in # of inflations, maximum inflation pressure, dissections 
(6 vs 10%), residual stenosis (24 vs 22%) or procedural success (90 vs 89%). 
These findings contrasted markedly with our experience in OS-NAT: we 
identified 68 consecutive pts with OS-NAT & 1082 with proximal DOn OS•
NAT wbo had intervention for de novo single lesion between 1986-92. 
Compared to non OS-NAT, the Os-NAT group was older (62 vs 59 yrs)", 
bad more females (38 vs 27%)', more calcified lesions (9 vs 3%)' and less 
PTCA (74 vs 92%)· ... OS-NAT also had fewer dissections (9 vs 23%)", 
higher residual stenosis (33 vs 24%)' and lower success (81 vs 90%)'. 
At follow up. there was no difference between the 2 SVG groups in incidence 
of angina (47 vs 41 %), bospitalization for chest pain or repeat 
revascularization. In contrast, recurrence of angina was bigher in OS-NAT vs 
non OST-NAT (56 vs 30%)". 
In summarv, unlike OS-NAT, the clinical, procedural and follow up profile 
of OS-SVG is not significantly worse than proximal non ostial disease. This 
may be related to suboptimal results of angioplasty in SVG vs native 
coronaries, &/or unfavorable intrinsic properties of OS-NAT coronaries. r= 
p<0.05; "= p<O.OI; "'= p<O.OOI) 
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939·39 
Percutaneous Transluminal Coronary Angioplasty of Aorta Ostial, 
Non·Aorta Ostial, and Branch Ostial Stenoses 
Kim H. Tan, Neil Sulke, Nick Taub, Sheila Karani and Edgar Sowton. 
Guy's Hospital, London, United Kingdom. 
The limited data regarding the efficacy of coronary angioplasty (PTCA) in 
patients with coronary ostial stenoses have shown disparate results_ 
Although the application of new angioplasty technology has shown 
favourable results, no randomised trials have been reponed. We evaluated 
success rates, complications and long-term outcome of PTCA of aona 
ostial stenoses (ADS), non-aona ostial stenoses (NAOS), and branch ostial 
stenoses (BOS). Between January 1987 and March 1993, 198 consecutive 
patients underwent PTCA of ADS (34), NAOS (48), or BOS (116). 
Procedural success was achieved in 85% of AOS, 90% of NAOS, and 
87 % of BOS (p = NS)_ The procedural success rate achieved for non-ostial 
stenoses that were dilated at the same time was 93% (p=NS)_ A major 
complication occurred in 5.9%, 6.3%, and 6.9% of patients who 
underwent AOS, NAOS, and BOS PTCA, respectively (p=NS). There 
were no procedural deaths. A greater residual stenosis (p=0.OO5) resulted 
from PTCA of AOS despite a higher inflation frequency (p<O.OOI), a 
higher inflation pressure (p<O.OOI), and a longer total inflation duration 
(p<O_OOI). The restenosis rate was higher for AOS (34%) when 
compared to NAOS (28%) and BOS (16%) (p=O.06). The cumulative 
probability of survival was 99 % and 93 % at one and three years, 
respectively. The one and three year cumulative event free survival rates 
were 70% and 58%, respectively. The survival rates did not differ 
between the lesion locations. At census, 57% were asymptomatic, and 
only 9% suffered grade III or IV angina. Conclusion: PTCA of ADS, 
NAOS, and BOS can be carried out with an acceptable success and 
complication rate, and provides good symptomatic relief and favourable 
long-term outcome. Randomized trials to compare new angioplasty 
technology with balloon angioplasty will be necessary to select the best 
device therapy in ostial lesions. 
939·40 
Effect of Gender on Early and Longterm Outcome Mter Multiple Vessel 
Revascularization Witb Coronary Bypass Surgery or Balloon Angioplast) 
Patricia G. Cavero, James H. O'Keefe, Ben D. Me Callister, Vickie Cochran, 
Patricia Eikenberry, Robert W. Ligon, Geoffrey O. Hartzler. Mid America 
Heart Institute, Kansas City, MO. 
Previous studies suggest that women undergoing coronary revascuJarization 
have a higher risk for early and late adverse events compared to men. Matched 
for age and ejection fraction(EF), the outcomes ofwomen(W) undergoing multi 
vessel coronary revascularization with either CABG(n=170) or PTCA(n=170) 
were compared with a concurrent cohort of men(M) having multivessel 
CABG(n=170), orPTCA(n=170) in 1987-1988. The women in both the CABG 
and PTCA groups were more likely to have diabetes(29% vs 19%, P<.OS) and 
unstable angina(38%vs IS%, p<.OS) than the men in either group. Follo\\up 
was obtained on % % of patients with a mean followup of S4±8 months. 
Early in-hospital and longtenn events 
W-CABG W-PTCA M-CABG M-PTCA 
Complete R 89 % 58%* 86% 48%* 
Early death 5.9 % 2.4% 2.4%+ 0.6%+ 
Early infarct 2.9 % 2.4% 2.4% 0.6% 
Survival I yr 89 % 89 % 87% 94% 
4yr 81% 81% 84% 87 % 
No DeathIMIlyr 89 % 85% 87% 93% 
4yr 82 % 80% 84% 87 % 
No Repeat R I yr 99"10 74%* 99% 83%* 
4 yr 99"/. 64%* 99"/. 6S%* 
R = revascularization, *=p<.05(within group CABG vs PTCA, W or M 
+=p<.05(between group W vs M, CABG or PTCA 
In conclusion, women undergoing multivessel CABG and PTCA compared 
with men when matched for age and EF have a higher earl)' in-hospital 
mortality but similar event-free( deathIMI) and longterm survival. Thus gender 
alone does not appear to be an independent predictor oflongterm outcome after 
coronary revascuJarization. 
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939·41 
Duel die VIIIJIIIIP ~ ~ AIheneIJ Meet die Aate ud 
Loaa-termom-IJI~~ 
Joeepb B. Muble&teia, Michael H. SketclI, Jr~ Alaa N. TeIIIIIia. Jamca P. 
ZicIar, Doaa1cI F. Fortin, Taylor D. Booac, Jamea E. TclIcD& Harry R. 
Pbillip&, Richard S. Stack, Duke UDiYenity Mcclical CeaIer, Durham, N.C. 
IDflatioa prcuurea accecIiDg IIOI1IIIl raJI&CI are IODIctimea 
required to dilatc markedly recalcitraDt laioas duriDg coroaary ugiop1aaty 
(PTCA). The de\'Ciopmenl olltrOllF bII100II materials bas DOW made it 
feasible to approach such CIIII, IItbousb ballooD rupture may IIill oa:ur. 
The aeutc ud lcmg-term outcomea of tbcIe procedurea are IIIIbown. 
Over • S-year period, 5,584 PTCA procedurea were pcrt'ormed at 
our iDstitutioD. Muimum iDflatioa preaaurea ol:t 14 atmospbcrea (atm) 
vmc \lied in 58 patients (mcu IF 62, malea - 72%). Procedural Succe&5 (S 
SO% reaiclllll diameter stCllDlia) was prcMDI in 4S (78%), ud diDical 
._ (procedural 5ucce&5 with DO in-hospital Ml, CABO, or cIcatb) in 36 
(62%) caaea. 
BallOOD rupture (mediaD muimum balloOD iDflation preasure - 16 
(rauge: 14-24) atm was preaent in 13 (22%) proc:eclurea IDd was abscDt 
(mediaD maximum balloon inflation preasure - 16 (rauge: 14-23) atm in 45 
(78%). No balloODs ruptured below rated burst preasurea. Clinical Succe&5 
was 73% in patieDls without bII100II rupture, but oa1y 23% in patieDls in 
which balloon rupture occurred (p~O.ooI). Muimum balloon inflation 
prcsaure was DOt predictive of diDical failure (p-0.90). Core mgjosrapbic 
IDaly&is mcaled heavy 1csion calciIic:ation to be predictive ol balloon 
rupture (p=0.01). 
or luccessfully treated patients, '1Jj/37 ('10%) eligible patients 
UDClcrwent repeat catheterization at 6 mOlllbs, with ID ugiograpbic 
reaICDOIis rate ol42%. 
CoIIcIuloa: The need for high balloon iDflatiOD prCSIure during PTCA 
results in 10wcr acute I\ICCCIS rate than reported for normal prcsaure PTCA. 
When iDfIated ~ recommended prCSIurcs, balloon rupture occura more 
frequently in heavily calc:ilied 1eaioIII ud abould be avoided as it appears 
predictive ol procedural failure. Loaa-term rcstcllOlis rates f01IowiDg 
IUCCCIISfuI high pressure PTCA appear similar to ItaDdard PTCA. 
939·42 
Tbe Role 01 Perfusion BaBoon ADgIoplasty In the Management or Sapbenous 
Vein Bypass Grafts 
Marino LabiDaz, Jeao-Francois Tanguay, Joseph A. Puma, E. Magnus Ohman, 
.HaIry Phillips, Michael H. Sketch Jr. Duke Univenity, Durham NC. 
Previous studies have demonstrated the successful use of prolonged 
diJalations with the Psfusion Balloon Catheter (PBC) as a "bai!-out" device for 
failed interventions in native coronary arteries. Its usc as an adjunctive device 
in saphenous vein grafts (SVG) has not been previously reported. 
We examined 33 consecutive patients in which the PBC was used as a 
secondary device following an initial non-PBC intervention between July 1, 1990 
and June 30, 1993 at Duke Univcnity. The mean age of the group was 59 ± 10 
)'Ill, 79% were male, 85% presented with unstable angina and 45% had 
experienced a previous myocardial infarction (MI). The average age of the SVG 
was 73 ± 44 mos and 76% were older than 3)'1l1. Following the initial 
intervention (TEe 9; DCA 7; laser 5; PTCA 12), the angioJ!l1lPhic success rate 
was 67%. Following trcaIJDent with PBC angioJ!l1lPhic success was achieved in 
94% of patients. Clinical success (angioJ!l1lPhic success without in-hospital MI, 
CABG, repeat intervention or death) was 88%. There were no episodes of the 
no-reflow phenomena and no patients required CABG. MI occurred in 2 
patients, both of which were due to acute occlusion following the initial device. 
During the same period of time, the PBC was used as the primary 
device in 29 SVG patients. Baseline characteristics were not signiflC8DtJy 
different from the group in which the PBC was used as a secondary device 
except for a higher incidence of previous MI (83% vs 45%; p=O.OO4). The 
angioJ!l1lPhic success rate was 100% and the clinical success rate was 90%. 
There were no episodes of the no-reflow phenomena and no patients required 
CABG. MI occurred in 2 pts and one patient died. 
ConcluBions: 1) The usc of PBC as an adjunctive device in SVG improves 
angioJ!l1lPhic outcome and has a high clinical success rate. 2) PBC as a 
primary intervention in SVG appears to be safe and efficacious and merits 
further evaluation in prospective trials. 
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939·43 
A Comparilon of Coronary Artery Bypass Surgery and BaUoon 
AngiopIasty in Patient. with Coronary Artery Disease and Severe Left 
Ventricular Dysfunction 
Edward Terrien, Christopher Bajzer, R. Thomas Catlin, Theodore Schreiber, 
Joseph S. Bassett, Robert D. Safian, William W. O'Neill, William Beaumont 
Hospital, Royal Oak, MI 
Although coronary angioplasty (PTCA) results in relief of angina, little is 
known regarding the impact of PTCA on mortality in patients with coronary 
artery disease and severe left ventricular dysfunction (ejection fraction (EF) 
S; 35%). We retrospectively studied the in-hospital and long•
tcnn outcome of 107 pts treated with PTCA (n=62) and bypass 
surgery (CABO, n=45): 
laljegt lognlatiog fiCA n(06) ~ADG n(%) P-Value 
Age (yrs) 64 ± 9 67 ± 10 NS 
# Vessels Diseased 2.5 2.8 NS 
Previous Infarction 56 (90%) 40 (89%) NS 
Left Main Disease 10 (20%) 13 (29%) NS 
Class III & IV Angina 45 (69%) 31 (72%) NS 
Class III & IV Heart Failure 28 (46%) 13 (29%) NS 
Ejection Fraction (%) 26 ± 7 27 ± 7 NS 
Outcomes 
in-hospital Mortality 19% 7% NS 
18 Month Survival 60% 82% om 
18 Month Event Free Survival 37% 75% 0.0002 
Conclusions: Surgically treated patients with multivessel disease and left 
ventricular dysfunction exhibited significantly better total and event free 
survival. Prospective trials are indicated to detennine the treatment of choice 
for this patient population. 
939·94 
Long Term Followup Arter Pl'CA In Patients With Single and 
Multivesse\ Coronary Artery Disease 
William S. Weintraub, John S. Douglas Jr, Douglas C. Morris, Henry 
A. Liberman and Spencer B. King. Emory University School of 
Medicine, Atlanta, GA. 
The I, 5 and 10 year outcome after PTCA was determined in 9962 of 
10783 (92") patients, 7604 with single vessel disease (SVD) and 3199 
with multivessel disease (MVD). Angiographic success was achieved 
in 91.3" with SVD and 87.0" with MVD (p< .00(1). In hospital 
events included coronary surgery (CABG) in 1.7" of SVD vs 3.0" of 
MVD (p < .00(1), Q wave myocardial infarction (MI) in 0.8" of each 
group and death in o.a with SVD vs 0.6" with MVD (p < .00(1). 
At last followup 30" of each group had recurrent angina. Long term 
actuarial freedom from (FF) events: 
1 Year 5 Years 10 Years P Value 
SVD MVD SVD MVD SVD MVD 
Survival 99" 9a 95" 9a 89" 78" <.0001 
FFMI 96" 94" 89" 85" 81 " 75" <.0001 
FFCABG 92" 88" 8a 78" 76" 56" <.0001 
FFPTCA 79" 7n 68" 60% 55% 44% <.0001 
Figure: Ten year survival for 100 
single vessel disease and multiple 
vessel disease. Patients with 95 SVD multivessel disease have higher 
rates of in hospital complicatiorts 90 
after angioplasty (except for MI) Survival MVD 
and higher rates of events long 8S 
term. These higher event rates in p<.OOOl 
multivessel coronary disease 80 
continued for up to 10 years after 
75 Years the original coronary angioplasty 
procedure. 0 2 4 6 8 10 
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939·95 
Non-surgic:al Treatment of Unprotected Left Main Coronary 
Artery Disease in Inoperable Patients: Acute and Long Term 
Results 
"Fayaz A Shawl, Devendra KAmin, Susan B Hoff, Kathryn G 
Dougherty, Washington Adventist Hospital, Takoma Park, Md 
Critical left main coronary artery stenosis is a particularly lethal 
lesion. Although coronary artery bypass grafting (CABG) has 
significantly improved survival, some pts are inoperable due to low 
ejection fraction andlor non-cardiac disease. We reviewed 30 pts 
(17 males, mean age 67±10 years) who underwent percutaneous 
cardiopulmonary bypass (PCPS) supported intervention for 
treatment of their unprotected left main coronary artery disease 
(LMCAD). All pts were deemed inoperable and 1 was in 
cardiogenic shock post cardiac arrest. Treatment included: laser 
angioplasty (3 pts), directional atherectomy (3 pts) and PTCA (24 
pts). A total of 61 vessels were dilated with a success rate of 97 %: 
left main stenosis was decreased from 92±7% to 16±10% with a 
total bypass time of 82±12 minutes. Of the 30 pts, 28 (93%) were 
discharged from the hospital with reduced symptoms. Follow-up 
(mean 19±11 months) showed: 2 pts died in-hospital from multi•
system failure; 2 died suddenly 3 months post-PTCA, 1 died 4 
months post-PTCA after suffering a stroke and one died after 
CABG 12 months post-PTCA. Overall survival is 80% and the 
mean ejection fraction rose from 25±12% to 42±12 % (p<0.05). 
Conclusions: treatment ofLMCAD in nonsurgical candidates can be 
safely performed using PCPS supported interventions and results in 
symptomatic improvement. This improvement is maintained long•
term in most pts. 
939·96 
Reduction in Emergency Bypass Surgery Following PTCA 
Despite An Increase in High Risk Patient Characteristics. 
Peter B. Berger, Kirk N. Garratt, Malcolm R. Bell, David R. Holmes, 
Mayo Clinic and Foundation, Rochester, MN. 
Emergency bypass surgery (ECABG) for PI'CA complicated by 
dissection and abrupt closure is frequently associated with myocardial 
infarction (MI) and death. To determine whether intracoronary stents 
and atherectomy (DCA), which can treat dissection, have reduced the 
need for ECABG, we performed a databank analysis of all pts under· 
going PTCA between 1982 and 1992, inclusively. PIs undergoing 
PI'CA in recent yrs were older (p<O.OOI) and had a greater inci~nce 
of multi vessel disease (p<O.OOI). Also, increasingly difficult lesions 
were accepted for dilation. Despite the increase in these high risk char•
acteristics, angiographic success R20% improvement, fmal stenosis 
<50%) has increased and the ECABG rate has decreased with time. 
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In·hospital Q-wave Ml and death have remained constant during this 
time period. We conclude that the decrease in ECABG following 
PTCA predates the aVailability of these devices, although they appear 
to have helped in maintaining a low ECABG rate during the recent 
increase in high risk pt and lesion characteristics. 
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940·26 
Angiographic Predictors of Outcome of Coronary Rotational 
Atherectomy from the Completed Multicenter Registry 
Andrew I. Macisaac, "Patrick L. Whitlow, Michael J. Cowley and 
"Maurice Buchbinder. The Cleveland Clinic Foundation, 
Cleveland, OH. 
To determine predictors of outcome of coronary rotational 
atherectomy, data from 2976 patients in the completed 
multicenter Rotablator registry were analyzed. Patient 
demographics included: mean age 61 years, 71% male, 65.4% 
multivessel disease, 40.4% prior MI, 18.9% prior CABG, 43% 
unstable angina and 29% restenotic lesions. Success was 
defined as a final percent stenosis of less than 50% with at least a 
20% reduction in the degree of stenosis, uncomplicated by death, 
CABG orQMI. 
Rotational atherectomy was successful in 3512 of the 3717 
lesions attempted (94.5%). Success was more likely in restenotic 
lesions (96.8%) than de novo lesions (93.6%, p= 0.0002), but 
procedural outcome was not predicted by patient, age, gender, 
prior CABG, multivessel disease nor unstable angina. 
Success rates were 96.0% in the 504 ACC/AHA ~pe A lesions, 
95.5% in the 1968 B lesions, 90.2% in the 501 l, lesions (p = 
0.0001, C vs other). Success was more frequent ill lesions::; 10 
mm in length (94.9% vs 93.0%, P = 0.043). The presence of 
tortuosity, eccentricity, calCification, bifurcation lesion and stenosis 
> 90% were not predictive of outcome. 
Conclusion' Rotational atherectomy has a high success rate in 
complex lesions, success is less likely in de novo, long, and 
ACC/AHA C lesions. Many of the traditional adverse lesion 
characteristics are not predictive of outcome with the Rotablator 
940·27 
353A 
Plaque Characteristics Affect Lesion and Vessel Response to Coronary 
Rotational Atherectomy: An Intravascular Ultrasound Study. 
'Peter ). Fitzgerald, Simon H. Stertzer, Benito O. Hidalgo, Richard K. 
Myler, Richard E. Shaw, 'Paul G. Yock. San Francisco Heart Institute 
and University of California, San Francisco, CA 
Lumen size following coronary rotational atherectomy (CRA) is 
dependent on both the extent of plaque removal and degree of vasospasm. 
We used intracoronary ultrasound (lCUS) to assess the effect of plaque 
composition on these parameters in 27 lesions (16 LAD, 7 LCx, 4 RCA) in 
23 patients undergoing CRA. 
Methods: Pullback ICUS images obtained during and post CRA were 
digitized and measured with a custom electronic planimetric system. The 
lumen shape index (LSI), a measure of roundness, was computed as the 
ratio of the minor to major axes. Plaque was characterized as having 
significant calcification if a calcified arc of greater that 90 degrees was 
present on ICUS. Spasm was assessed by conventional angiographic 
appearance. 
~ Predominantly calcified plaque (CP) was seen in 16 lesions and 
soft plaque (SP) in 11 lesions. Quantitative lCUS measurements revealed: 
Kll !Sf! 
Lumen:burrratio' O.89.±.O.17 O.63.±.O.12 
LSl(roundness)·· O.B4.±.O.12 0.52.±.O.13 
Dissection 6% 45% 
IntralesionaI spasm 9% 42% 
Distal spasm 29% 16% 
• P = .009, •• p<.OOI 
lntralesion spasm was more prevalent in eccentric (42% overall) 
compared to concentric 06%) lesions. 
Consiusjon. Rotational atherectomy in calcified lesions results in larger, 
rounder lumens with fewer dissections than in SP. Spasm within the 
lesion is also less prevalent in CP, but spasm distal to the lesion is more 
common than with SP. ICUS may help in selection of appropriate lesions 
for CRA and in monitoring the response of the lesion and the vessel 
segment to the procedure. 
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940-28 
Coronary Perforation During Rotational Ablation: Angiographic 
Determinants and Clinical Outcomes 
'Barry M. Cohen, Vance 1. Weber, Theodore A. Bass, Gerald Dorros, Martin B. 
Leon, Simon H. Stertzer, 'David Warth, 'Patrick L. Whitlow, Nadim M. Zacca, 
'Maurice Buchbinder, Newark Beth Israel Medical Center, Newark, NJ 
Coronary perforation (CP) is a feared complication of new percutaneous 
revascularization techniques. The US Multicenter Rotational Ablation (RA) 
Registry comprising 2953 procedures (proc), 3737 lesions was studied for CPo 
The cohort was divided into 2 groups (G): GI bad no CP (2931 proc, 3695 
lesions) and G2 did have CP (n=22; 0.7% of proc and 0.6% of lesions). The 
groups were compared for vessel treated, lesion characteristics and clinical 
complications. The G2 angiograms were analyzed by a panel of two 
independent reviewers. 
Lesions: Glo=3695 % G2n=22 % 
LAD 1726 47 I p<.OOI 
RCA 1093 30 12 54 p=.02 
Cx 752 20 9 41 p=.03 
LM 124 3 0 0 
Of lesion characteristics, eccentricity G I 68% vs G2 95%, tortuousity G I 24% 
vs G2 50%, and lesion length > IOmm G I 24% vs G2 55% were significant 
predictors (p $ .0 I). There were no significant differences in calcified, 
bifurcation or restenotic lesions. 
Proc Complications: 
GI n=293 1(%) 
G2 n= 22(%) 
death· 
27(0.9) 
2 (9) 
CABG" 
65(2.2) 
9 (41) 
Q-MI 
33(1.1) 
1(4.5) 
non-Q MI" 
170(5.8) 
9 (41) 
·p=.02, "p< .0001 
In G2 two pIS had tamponade. CP may have been 
technical/procedural considerations in 6/22 (27%). 
avoidable based on 
Conclusions: Coronary perforation is a rare and sometimes avoidable 
complication of RA. Angiographic predictors are RCA and Cx arteries; 
eccentricity, tortuousity and lesion length. CP is frequently associated with 
significant clinical sequelae. 
940-29 
Randomized Bxcimer La.er v •• Convential PTCA Therapy: 
Bucce.. in the Acute Pha.e 
Robert M. Siegel, Alvin W. Nuttall, Barbara Barker, Judy 
L. Finney, Richard Gentzler, Kimberly M. Skemp, 
Healthwest Regional Medical Center, Phoenix, AZ 
Excimer laser angioplasty (LASER) has been shown to be 
safe and effective therapy for occlusive coronary 
disease. We report early results of a randomized trial 
designed to directly compare LASER with adjunctive 
balloon therapy vs conventional PTCA. Sl pts have been 
randomized (56 males, 25 females; ave age = 64.9±11.7 
yrs) with 102 lesions (of which 70% are either total 
(T)or subtotal (ST) occlusion andlor C lesions (C)). 
Crossover occurred when a reasonable attempt failed with 
the initial device. There were 10 lesions which crossed 
over from PTCA to LASER (XOVER); all of which were 
either T or ST andlor C lesions. No LASERs required 
cross over to PTCA. Success rates were: LASER=97.9% & 
PTCA=77. S%. The XOVER group had 90% success when 
adjunct LASER treatment was employed. Cost analysis 
indicators included the number of catheters used 
(balloons & lasers) per lesion (C/L), lab time (LT), 
fluoro time (FT), and dye load (DYE) in ST, T, and C 
lesions. 
ST-LASER ST-PTCA T-LASER T-PTCA 
C/L 2.6 2.7 2.9 2.6 
LT SO.O S2.9 99.0 90.3 
FT 23.4 23.9 31.2 36.0 
DYE 211.S 207.0 292.5 293.5 
" significant at p < .05 level 
C-LASER 
2.7 
SO.l 
23.4" 
225.3 
C-PI'CA 
3.0 
102.5 
37.S" 
291.4 
Analysis demonstrated significantly less FT in C lesions 
treated with LASER. There are no other cost differences 
between the groups. Acute and major complications also 
do not differ between the two groups. Conclusion: 1. 
Early data analysis supports the historical LASER 
registry trend that primary LASER treatment is likely to 
be more successful in difficult lesions than is 
conventional PTCA. 2. The majority of PTCA failures may 
successfully be salvaged when adjunct LASER therapy is 
employed. 
JACC February 1994:1A-484A 
940·30 
Treabnent or Left Main Coronary Artery Disease With 
Exelmer Laser Coronary Angioplasty (ELCA), the ELCA 
Registry Experience 
David R. Holmes, Jr., Augusto Pichard for the ELCA Investigators. 
Mayo Clinic, Rochester, MN 
The treatment of left main coronary artery (LMCA) stenoses by 
conventional PTCA remains difficulL With conventional PTCA, initial 
angiographic results have been suboptimal due to elastic recoil, lesion 
rigidity or heavy calcification. In addition, initial complication rates 
have been increased and restenosis rates are high. ELCA, by 
debulking the lesion may improve both immediate early angiographic 
results as well as improve longer tenn outcome. In the ELCA registry, 
158 LMCA stenoses have been treated from 1989 to March 1993. The 
mean pt age was 65 ±8 yrs; 72% were male. Of these patients, 89 
percent had undergone prior coronary bypass surgery. A procedural 
success (dermed as residual stenosis <50%) of the LMCA was 
achieved in 89%. Adjunctive PTCA was required in 89%. Success 
rates were dependent upon the presence of LMCA calcification. With 
no angiographically evident calcium, 94% of procedures were 
successful compared to 85% when calcium was presenL In-hospital 
events included coronary bypass surgery (2.5%), Q wave MI (2.6%) 
and death (1.2%). These initial complications were not different than 
seen in the entire group of 4193 pts undergoing ELCA during the same 
time period. In the entire experience of 4193, 3.9% required surgery, 
Q wave MI developed in 1.9% and death occurred in .5%. During a 
follow up of 5 ±3 months, 26.9% of LMCA patients required a repeat 
intervention, CABO was perfonned in 5.9%, 1.1 % developed QMI 
and 6.5% died. Sixty percent were free of adverse clinical endpoints. 
In conclusion, in selected patients with LMCA stenosis. ELCA is a 
good therapeutic option with low initial complication rates which are 
similar to those in patients undergoing ELCA for other lesions. Lesion 
calcification identifies a group with lower success rates, but even in 
this setting, 85% of procedures were successful. 
940·31 
Utility of Arterial Fluorescence Feedback During EJ::clmer Laser" 
Coronary Angloplasty 
'Lawrence I Deckelbaum.John J Scott,Kate Rohlfs, Sameer Desai, 
Chang Kim.Mlchael W Cleman. VAMC and Yale U, West Haven, cr 
Laser irradiation through a catheter not In contact with arterial 
tissue results In blood ablation and acousto-mechanlcal damage 
to the arterial wall (eg. dissection). We hypotheSized that arterial 
fluorescence feedback could be used to mInlm1ze blood Irradiation 
by documenting catheter-tissue contact and confirming adequate 
hemodilutlon of blood by Intra-arterial saline infUSion. He-Cd 
laser-Induced arterial fluorescence (LlAF) was recorded In v1tro 
through multlflber catheters from 20 arterial specimens In blood 
using a previously developed diagnostic system.Total fluorescence 
Intensity (IT!), defined as the sum of the fluorescence intensities 
at 380 and 440 run. was evaluated as a function of the catheter-to•
tlssue distance (d) over a range of 0 to 400 11. 'IFI was maximal with 
the catheter In contact with the tissue. and markedly decreased 
with distance. ITI was also recorded as a function of hematOCrit 
over a range of 50% to 0% at d=I00. 300. and 500 lL SalIne hemodi•
lution of blood Increased IT! at all distances. To evaluate cl1n1cal 
utility ofTF'! feedback. a fluorescence spectroscopy system was 
coupled to a Spectranetlcs CVX-3oo exclmer laser anglOplasty 
system. LIAF was performed before and during Intra-arterial 
saline Infusion. and alter each laser ablation train In 11 patients 
(lesions: 2 RCA. 1 LeX. 3 LAD. 5 SVG). Catheter-tissue contact 
could be detected In all patients by an Increase In m. Blood had 
no delectable TF'I. whereas arterial tissue had a LlAF TFI ranging 
from 0.15 to 2.60. Reorientation of an eccentric catheter to 
optimize lesion contact by anglographlc alignment with the 
lesion correlated with a ITI Increase. Catheter passage through 
the lesion could be detected by a decrease In ITI. Sallne infusion at 
2cc/sec through the guide catheter resulted In an Increase In m In 
4 of 5 native coronaries. but In only 1 of 3 SVG , consistent with 
better hemodilution In native coronaries. Saline infusion through 
the gUide catheter was superior to Infusion through the laser 
catheter. By confirming catheter-tissue contact and saline 
hemodilution. LIAF feedback should mln1m1ze Inadvertent blood 
Irradiation and enhance safety and efficacy of laser angloplasty. 
lACC February 1994:1A-484A 
940·32 
Can Patients at Risk of Developing In·Hospitai Peripheral Vascular 
Complications after Percutaneous Coronary Intervention he Identified 
from Baseline Characteristics and Treatment Assignment? 
Nowa Omoigui. Robert Califf. Gordon Keeler. Lisa G. Berdan. Karen Pieper 
and Eric J. Topol for the CA VEA Tlnvestigators. OeveJand, OH and Durham. NC 
To determine whether pts at risk of peripheral vascular complications after 
angioplasty and atherectomy can be identified from baseline characteristics 
and treatment assignment, data from the Coronary AngioplastyversusExcisiona! 
AtherectomyTrial (CA VEA T) was examined. Pts were randomized to atherec•
tomy (DCA) or angioplasty (PTCA).in-hospitai peripheral vascular complica•
tion (PVC) was defined as the composite of pulse loss. pseudoaneurysm. groin 
hematoma >4 cm or groin hemorrhage requiring transfusion. A total of 67 out 
of 1012 patients (6.6%) suffered a PVC. of whom 15 (22.4%) had blood 
transfusion. 14(20.9%) underwent vascular repair ( 11) or embolectomy (3) and 
2 (3.0%) died. There were no in-hospital deaths among patients without PVc. 
However. one year death-rate was 7.5% for PVC pts and 1.1 o/r for others. In a 
logistic model to predict PVC. no significant difference was found between 
patients randomized to DCA or PTCA. Age and female gender were indepen•
dently predictive of complications. Hypertension. diabetes. body surface area. 
smOking and prior peripheral vascular disease were not significant: 
Variable Parameter Estimate Wald Xl P value 
intercept -4.4572 31.7143 OJJOOI 
treatment -0.0574 0.0500 0.8231 
age +0.0280 4.8133 0.0282 
female +0.7873 8.5738 0.0034 
Thus PVC was a marker for higher death rates. Older and female patients were 
at high risk for PVC. irrespective of treatment asSignment to DCA or PTCA: 
DCA PTCA Male Female Age 
<50 50-64 ~65 
n 512 500 735 277 476 332 204 
PVC(%) 34(6.6) 33(6.6) 37(5) 30(10.8) 10(4.9) 25(5.2) 32(9.6) 
Importantiy. even with larger sheath size and increased procedural time. DCA 
was not associated with a higher rate of significant in-hospital PVc. 
940·33 
Mechanical Compression (FemostopTM) Alone 
Versus Combined Collagen Application 
(Vasosea(T'M) and FemostopTM for Arterial Puncture 
Site Closure After Coronary Stent Implantation: a 
Randomized Trial. 
Edoardo Camenzind, Marianne Grossholz, Philip Urban, Damien 
Metz, Vincent Hoang, Pascal Chatelain, Dominique Didier, Bemhard 
Meier, Wilhelm Rutishauser, University Hospital,Geneva, Switzerland 
After coronary artery stent implantation through 6 (75%), 7 
(22%) or 8 (3%) French catheters, 32 patients (25 males; 
mean age 59±10 years) were randomly assigned to either 
delayed sheath removal (when activated clotting time 
reached 150-200 sec) and mechanical compression 
(FemostopTM: F) or immediate sheath removal ~nd local 
application of bovine collagen (VasoseaI™: V) combtned With 
the same type of mechanical compression (V+F). All patients 
had a pressure dressing applied for >6hours (h) after 
FemostopTM removal (F: 12±6h vs V+F: 13±7h: NS) and bed 
rest for> 24h. Local status was assessed clinically after 24 
hours and by Duplex sonography during in-hospital stay. 
Criteria of evaluation were: hematoma (presence and 
diameter), and other complications. 
N Hematoma (cm) False Local Neural Transfusion 
o <10 10-20 >20 Aneurysm Infection Complication Surgery 
F 17 
V+F 15 
12'] 5 0 0 2 1 0 0 
5]*8 2 0 0 1 1 0 
• p < 0.05 
Both strategies were very effective for arterial puncture site 
hemostasis. However the addition of local collagen 
application did neither reduce mechanical compressi~n time, 
nor increase efficacy nor reduce the potential nsks of 
prolonged compression. 
ABSTRACTS 355A 
940·34 
The Hemostatic Puncture Closure Device Shortens Time to 
Hemostasis and Ambulation after Arterial Catheterization: 
Results of 8 Randomized Study 
Hans de Swart, Lidwien Dijkman. Vincent van Ommen. Frits 
Bar and Hein J Wellens. Department of Cardiology. Academic 
Hospital Maastricht. Maastricht. The Netherlands. 
The use of a hemostatic puncture closure device (HPCD. 
Kensey-Nash Co) after arterial catheterization is more 
convenient for patients (pts) than a conventional pressure 
dressing. We compared the efficacy and safety of the HPCD 
with a conventional pressure bandage in a randomized trial. 
After the catheterization pts were allocated to treatment with 
manual pressure and pressure dressing (MP) or to an HPCD. In 
pts receiving MP heparin was reversed with protamine. which 
was not the case in the majority of pts with a HPCD. 
~: (numbers are expressed as the mean ± standard deviation) 
MP HPCD 
NUMBER (pts) 54 55 
APTI(sec) 39.3 ± 13.7 158.5 ±129.1 
TIME TO HEMOSTASIS (min) 12.9 ± 5.6 1.2 ± 1.6 
TIME TO MOBILIZATION (hrs) 32.4 ± 10.9 5.9 ± 6.8 
RE-BLEEDING (pts) 3 4 
In 1 pt the HPCD could not be inserted successfully. MP was 
applied. An additional pressure bandage was applied in 4 pts 
with a HPCD because of oozing. after removal of the tamper. 
while they were on heparin. 
Conclusions: 1) Rapid hemostasis can be achieved using a 
HPCD. 2) Pts can be mobilized very early after the procedure. 
in spite of the use of antithrombotic agents. 3) Early 
mobilization was uneventful. 
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941·25 
Monitoring of Ventricular Function after Heart Transplantation 
with an Implantable Wall Motion Sensor 
Johannes Mueller, Onnen Grauhan, Wera Kupetz. Henning Mansfeld, 
Robert Pfitzmann, Roland Hetzer, German Heart Institute Beriin, Beriin. 
Germany 
Besides inducing electrophysiological changes. rejection after heart 
transplantation leads to an early diastolic distortion and to dynamic and 
static changes in left ventricular wall thickness. To measure changes of 
the left ventricular wall thickness dynamically, a wall motion sensor was 
implanted into the wall of 10 heterotopically transplanted canine neck 
hearts. The sensor is based on magnetoresistive elements. ECG and wall 
motion were recorded in parallel. Biopsy histology, amplitude of the intra•
myocardial electrogram, and myocardial tissue impedance served as refer•
ence to monitor rejection. From the recorded wall motion curve 5 different 
parameters were extracted: maximal diastolic relaxation velocity, maximal 
systOliC contraction velocity, amplitude of thickening as difference between 
systolic and diastolic wall thickness, static diastolic wall thickness, and 
relative duration of systole. 
All afore-mentioned parameters showed a behaviour during the postopera•
tive period of two weeks that corresponded to a damage after reperfusion 
(day 0 - 2) and to a recovery from ischemia (day 2 - 5) under sufficient 
immunosuppression with no signs of rejection in biopsy histology. After 
reduction of immunosuppression. to induce rejection, the parameters 
showed changes which corresponded to beginning rejection (grade 1) (day 
7 - 8) and to moderate rejection (grade 3) (day 9 - 12).Therapy of rejection 
led to a normalization of the parameters. However, the magnitude of 
changes of the parameters was significantly different. Whereas in maximal 
diastolic relaxation velocity a deviation from normal level (no rejection) 
amounted to 16% (grade 3 rejection). a deviation of 7%, 9%,11 %. and 8% 
were noticeable in the parameter 2, 3, 4, and 5, respectively. 
The wall motion sensor makes it possible to measure exactly the static 
and dynamic wall thickness changes of transplanted hearts for rejection 
monitoring. The data confirm that beginning rejection leads mainly to a di•
stortion of early diastole while systolic function remains undisturbed. In 
contrast to measured data. which can also be ascertained by echocardio•
graphy. these data are more precise and easier to record. In combination 
with an implantable telemetriC device remote monitOring of rejection will be 
possible. 
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941·44 
Monitored Titration of Medical Therapy Improves Prognostic 
Indicators in Patients Referred for Cardiac Transplantation. 
Rebecca Quigg, Peggy Roberge, Domenic Sica, Livia Griffith and Roaer Quint. 
Medical College of Virginia, Richmond, Virginia. 
Left ventricular ejection fraction (LVEF), peak exercise VO, (VOlP) and 
plasma norepinephrine (NE) levels are predictors of survival in patienta (pta) 
with severe heart failure and are used to decide the need for cardiac 
transplantation (Tx). To determine whether these parameters can improve with 
maximal titration of medical therapy, we measured LVEF, VDlP and NE at 3 
mo intervals in 28 pta referred for Tx (mean follow-up 9.S ± 1.2 mos). Oral 
medical therapy with digoxin, diuretics, ACE inhibitors and antianginals were 
maximized based upon serum levels, edema, NE levels and evidence of 
ischemia, respectively. Pta were divided into 2 groups based upon the etiology 
of their heart failure: ischemic cardiomyopathy (lSCM; n= 14) and 
nonischemic cardiomyopathy (OCM; n= 14). Data are expressed as initial 
values/cbange from initial to final value (mean ± SEM; .p< O.OS, DCM vs 
ISCM). ~ I2£M 
Initial/Change InitialiChange 
LVEF ('It) 17.4±l.S/+0.l±O.8 19.9± 1.61+ 1 l.S H.9· 
VO, (ml/qJmin) 17.9± 1.1/-0.5 ±0.6 22.6±1.9·1+3.2±1.9· 
NE (palmi) 460.4±84.3/+1.4±l04.0 519.l±1l4.51-l20.1±l22.7 
Baseline parameters were similar in the 3 groups except for a slightly higher 
VO,p in pta with DCM which is representative of our referral population. Pta 
with DCM tolerated titration to a significantly higher final ACE inhibitor dose, 
had a greater improvement in LVEF and VOlP, a trend towards a greater 
decrease in NE and were more often removed from the Tx list (5/14 vs 3114) 
compared to pis with ISCM. Pta who deteriorated or died suddenly had a 
significantly higher NE level prior to the event compared to those who were 
either stable or improved (704.1 ±6S.9 vs 366.2±32.3). We conclude that in 
pis referred for Tx, serial monitoring of L VEF, VO,p and NE during 
maximization of therapy can result in an improvement in these parameters, 
especially in DCM, placing pis in an improved prognostic category and 
avoiding the need for Tx. Elevated plasma NE levels may be the best predictor 
of instability while awaiting Tx. 
941·45 
A Randomized Study of Cardiac Rehabilitation in Heart 
Transplant Recipients 
Jon A Kobashigawa, David A Leaf, Michael P. Gleeson, 
Michele A Hamilton, Catherine Chelimsky-Fallick, Jaime D. 
Moriguchi, Nobuyuki Kawata, Christine Skotzito, Elise Herlihy, 
Nancy Lee, Davis Drinkwater, Hillel Laks, Lynne W. Stevenson. 
UCLA Medical Center, Los Angeles, CA. 
Cardiac rehabilitation (CR) in heart transplant recipients has 
not yet been shown to be beneficial in a randomized tria1 and is 
rarely included in routine heart transplant services. We have 
randomized 20 heart transplant recipients to a structured CR 
program (9 pts) or to routine exercise at home (11 pts). The pts 
randomized to CR had an average of 20 sessions which included 
personalized exercise instruction and use of the exercise tread•
milL All pts underwent cardiopulmonary exercise testing within 
4 wks after transplant and 6 mos later. At 6 mos, our results 
revealed a greater improvement in peak oxygen consumption 
(VO.), workload, and ventilatory efficiency as indicated by 
decreasing ventilatory equivalent (VEQ) for co. in the CR group 
compared to the control group (*p < 0.05). 
CbanEe from 1 mo to 6 mos post transplant 
Exercise Peak Vo. Workload 
Time (min) (mg/kg/min) (Watts) YEO co. 
CR +2.6.±2.1 +6.0.±2.6* +39.±27* ·14.±8* 
Control +1.3.± 2.1 +2.4.± 2.0 +12.± 18 -5.± 8 
Conclusions: Exercise capacity increases after the postoperative 
period with either structured CR or routine home exercise; 
however, structured CR leads ~o greater exercise capacity and 
ventilatory efficiency by 6 months. These benefits suggest that 
structured CR be provided routinely after cardiac transplantation. 
JACC February 1994:1A-484A 
941·46 
Wall Stress aDd Geometric Adaptation of the Left Ventricle 
FollowiDg Orthotopic Heart TraDsplaDtation 
Wickii T Vigneswaran, John A Rumberger. Richard J. Rodeheffer, 
Christopher GA McGregor, Mayo Clinic, Rochester, MN 55905 
Adaptation in equatorial wall stress and changes in the global 
and regional geometry of the LV following orthotopic heart 
transplantation has not been previously reported. However, we 
have previously shown that significant remodeling takes place in 
the orthotopically transplanted heart. Ten umelected orthotopic 
heart recipients underwent cine cr examination of the heart at 
one and 12 months following transplantation. Global L VEDV.long 
axis length (L) and global shericity index (51) were quantified. In 
addition based on the local geometry mid-ventricular wall thickness 
(t), ventricular end-diastolic radius of curvature (r) and peak 
systolic orthogonal meridional (am) and circumferential (oc) wall 
stresses were determined. Data are given below (mean ± SEM) 
LVEDV L(c SI" r(em) I(em) Om . ° • c 
(ee)" m) .. .. 
1 mo 94.6 9.1. 0.24. 2.07. 1.29. 119. 306. 
0.2 0.01 0.06 0.06 8 17 
12mo 118.8 8.8. 0.34. 2.27. 1.09. 154. 381. 
0.3 0.02 0.08 0.03 10 21 
• - p < 0.05, •• - p < 0.01 
Conclusion: Significant changes occur in global and local LV 
geometry during the first year following orthotopic heart 
transplantation. Although the LV dilates during this time global 
and regional dimensions and shape normalize by 12 months. 
Significant increases in mid ventricular peak systolic wall stresses 
are observed at 12 months however, they too remain within the 
normal range. 
941-47 
Factors Associated with Sudden Cardiac Death in Patients 
Evaluated for Orthotopic Cardiac Transplantation 
Michael O. Sweeney, Jeremy N. Ruskin, Gus Vlahakes. G. William 
Dec, Massachusetts General Hospital. Boston, MA 
Cardiac death was retrospectively analyzed in 224 consecutive pts 
evaluated for possible cardiac transplantation. Actuarial cardiac 
survival was 71% and 53% al12 months and 24 months, respectively. 
There were 77 (34%) cardiac deaths during followup: 45 (58%) sudden 
deaths (witnessed cardiac arrest or death during sleep) and 32 (42%) 
nonsudden deaths (death due to progressive heart failure while 
hospitalized). Mode of cardiac death was compared across 3 groups: 
history of symptomatic ventricular arrhythmias treated with either 
implantable cardioverter-defibrillators (lCD, N= 39) or antiarrhythmic 
drugs alone (AA. N= 44), or no history of symptomatic ventricular 
arrhythmias (NONE, N= 141). There were no significant differences 
at baseline between these groups for the following clinical variables: 
age, diagnosis, ejection fraction, cardiac index, NYHA class, heart 
failure therapy, or percent listed for transplant. Prior history of cardiac 
arrest (ICD=74%. AA= 20%. NONE= 6%; p<O.OOI) and cardiac 
syncope (ICD= 87%. AA= 42%, NONE= 14%; p<O.OOI) were 
significantly different. During followup there were no significant 
differences in mean time awaiting transplant or propOItion tr.tnsplanted. 
Total cardiac survival was marginally different between groups at 12 
months (lCD= 73%, AA= 56%. NONE= 78%; p=O.ll). Nonsudden 
death rates were not significantly different between groups at 12 
months (ICD= 26%, AA= 21 %, NONE= 14%; p=0.29). However, 
the 12 month sudden death rate was highest in pts treated with AA and 
lowest in pts treated with ICD (ICD= 4%, AA= 38%, NONE= 20%; 
p=O.OI). Stepwise multivariate regression identified ICD as the only 
independent predictor of freedom from sudden death (p=0.05). 
Conclusions: I. Sudden death is frequent in pts evaluated for 
transplantation despite no prior history of cardiac arrest, cardiac 
syncope or symptomatic ventricular an·hythmias. 2. ICD reduces 
sudden death in selected high-risk pts evaluated for transplant. The 
effect on overall survival is less certain. 
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941·48 
Do Heart Fallare Patieats With Low Peak fuygea Coasumption 
Benefit From Beta Blockers While Awaiting Transplant? 
Jill Kalman, CaIhleen Buchholz, Marilyn Steinmetz, Mary Courmey, Alan Gass, 
Steven Lansman, Marrick L. Kukin. Mount Sinai School of Medicine, NY, NY 
Patients with severe bean failure referred to transplant centers an: historically at 
highest risk for death during the first 6 months on a waiting lisL Peak oxygen 
consumption (mV<>2) provides an objective assessment of functional capacity and 
can risk stratify patients with beat! failure. This exercise measurement can then 
help identify tbose patients in whom cardiac transplant should be expedited. We 
investigated wbether those patients with an mVOz <14 mlJkg/min (Low) on 
digoxin, diuretics, and ACEI could benefit from further medical therapy witb beta 
blockade (P-B) while awaiting transplanL We gave 16 patients witb class II-IV 
CHF tbe P-l antagonist metoprolol (M). EF, 6 minute walk (yards), mVOz 
(mlJkg/mio), bean rate (bpm), puJmonary artery systolic pressure (pAS, mmH~), 
pulmonary wedge pressure (PeW, mmHg), stroke volume index (SVI, mVm ), 
and pulmonary vascular resistance index (pVRI, Woods-m2) were measured at 
baseline and after 3 months of continuous tberapy. All pIS received M 6.25 mg 
bid initially and were tittated to a target dose of 50 mg bid. Sbown below are 
measured parameters at baseline (Pre) and after long term (LT) P-B therapy for all 
patients and then for tbe 5 pts with a Low mVOz. • = p < .05 (LT vs. baseline). 
EF Walk m V02 HR PAS PCW SVI PVRI 
All: Pre 13 369 12.4 89 51 24 32.3 4.3 
LT 17· 428* 15.6* 66* 41* 16* 41.4* 3.8 
Low: Pre 15 363 9.2 88 46 19 30.8 4.2 
LT 22* 471* 15.4* 68* 42 15 39.2 3.8 
P-B produced significant clinical and hemodynamic improvement in tbis pre•
transplant population. In pts with baseline m VOz < 14, there was an i EF, 
Walk, and mVOz, with.l. HR. In fact, the mVOz improved to a "mOOl favorable" 
prognostic level. There were no deaths in the low group awaiting transplant while 
I pt witb an mV02 of 16 died suddenly. 
In conclusion, P-B produces significant clinical improvements. P-B can be safely 
used in the sickest hean failure patients and may improve sbon term prognosis in 
these patients awaiting transplanL 
941·49 
Importance of Imaging the Pulmonary Veins After Lung 
Transplantation: a Prospective Transesophageal 
Echocardiographic Study. 
David Leibowitz, Robert Michler, Craig Smith, Mark Ginsburg, 
Lawrence Schulman, Carlton McGregor, Renee Weslow, Marco 
Di Tullio, Shunichi Homma. Columbia University, New York, NY. 
The pulmonary venous anastomoses pose a potential site for 
complications following lung transplantation and isolated cases of 
pulmonary vein thrombosis at the anastomotic site have been 
described. The true incidence of these complications and their 
relationship to outcome remains unknown. To assess the frequency 
of complications involving the pulmonary veins post-lung 
transplant, we performed biplane transesophageal echocardiography 
(TEE) in 18 patients (I IF, 7M, mean age 42.9 ± 13.1years) within 0 
and 33 days post transplantation (mean 7.3 ± 9.9 days). There were 
13 single lung , 4 double lung and one heart-lung transplant 
recipients. 
A total of 54 pulmonary veins were visualized. Pulmonary 
venous thrombosis was noted in 4 patients involving a total of 5 
pulmonary veins (9.3%). Of these 4 patients, 2 (50%) died within 9 
days of surgery . An additional patient, doing poorly clinically, was 
noted on TEE to have external compression of a pulmonary vein and 
rapidly improved following surgical intervention. Of the 13 patients 
with a normal study, I (8%) died 3 months post-transplant. 
Conclusions: I) TEE should be used to evaluate the 
pulmonary veins after lung transplantation. 2) Complications 
involving the pulmonary veins may be associated with poor short•
term outcome. 
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942·1 
Pulmoury \'aIve dilation in TOF with dlminutlft PA's, 
lacqueline Kreutzer, Stanton B Perry, Aldo R Castaneda, 10hn E Mayer, 
Richard A lonas, lames E. Lock. Children's Hospital, Boston MA. 
357A 
Tetralogy of Fallot (TOf) with severe pulmolllll)' steoosis (PS) and diminutive 
pulmolllll)' arteries (PA's) is rare and resembles TOF with pulmolllll)' atresia, 
with a high incidence of aorto-pulmolllll)' coUaterals (APe's), arborization 
abnormalities with stenosis and need for multiple operations. Since combined 
interventional catheterization and surgery in pts with TOF, pulmonary atresia 
and diminutive PA's enhances the chances of a satisfactory repair, we used a 
simi1ar approach in 10 pIS with TOF, severe PS and diminutive PA's; right 
vcntricular(RV) to PA antegrade Oow was increased by balloon dilation(BD) 
of the pulmonary valve (PV) and outflow tract (OT), coil embolization(~) of 
APC's and BD of distal PA stenosis, foHewed by surgical repair. From 6/89 to 
7/93 BD of the PV was attempted in 10 unoperated pIS with TOF, severe PS 
and diminutive PA's aged from 17 d to U yrs(mean l.5y). Three pts had been 
initially diagnosed to have pulmonary atresia. The Nakata index ranged from 
41 to 158 mm2/M2. There were 6 pts with large APe's and I with a PDA. 
BD of the PV was performed I to 11 times in each pt. All pIS had hypoplastic 
PV annulus (A) with mean z- -3.2, which ina-eased to -2.4 post BD (p<0.01). 
The main PA pressure after BD ina-eased in 19% to 125% (mean 62%) in 6 
pIS. There was no change in 2 pts. In the remaining 2 pts the PA pressures 
couldn't be measured before BD. Five pIS underwent successful BD of PA 
branches in the same or subsequent catheterizations. In spite of simultaneous 
CE of APC's, the postBD aortic saturation remained the same or ina-eased in 
all the pIS. In 2 of 3 pIS with a restrictive ventricular septal defect (VSD) the 
RV pressure decreased from suprasystemic to systemic postBD. Significant 
complications were limited to congestive heart failure in One pt. Eight pIS had 
a successful complete surgical repair (VSD closure and transannular patch). 
Only 1 pt required a 2 stage surgical approach, with later closure of the VSD. 
The other pt is scheduled for complete repair. 
Conclusioas: In pIS with TOF, severe PS and diminutive PA's PV baloon 
dilation: I) may avoid the need for multiple surgeries; 2) results in only a 
small immediate ina-ease in PV annular size; 3) provides access for branch 
PA dilation; 4)will ina-ease antegrade Oow, improve oxygen saturation and 
thus, allow simultaneous CE of APC's simplifying their intraoperative and 
postoperative management in most pts. 
942·2 
Balloon Angioplasty Versus Surlical Correction for Aortic Coarctation 
in Infants $ Three Months of Age 
P. Syamasundar Rao, Paramjeet S. Chopra. Patricia A. Smith, Allen D. Wilson, 
University of Wisconsin Medical School. Madison, WI 
Background. There is a controversy with regard to the role of baBoon 
angioplasty in the treatment of aortic coarctation (AC), especially in youog 
Infants. The purpose of this study is to compare safety and efficacy of balloon 
angiopiasty with surgical correction of native AC in tbis age group. 
Metbods and Results. Twenty-nine infants aged S 3 months undergoing 
therapy for AC during the decade ending 1992 were analyzed. Founeen infants 
underwent surgery while IS bad balloon angioplasty. The sale criterion for 
allotment to these two groups is the availability of the interventional 
cardioiogist at time of presentation of tbe infant. The surgical and baBoon 
groups were comparable (p> 0.1) with regard to age (27:1: 35 vs 29:1: 27 days), 
weight (3.S :I: 0.4 vs 3.8 :I: 1.1 kg), prevalence (7 of 14 vs 8 of IS), and type of 
associated defects. Operative mortality (1 of 14 vs I of 15),late mortality (3 
of 13 vs 3 of 14), immediate gradient relief (36:1: 25 to 10:1: 9 vs 41 :I: 14 to 6:1: 
6 mm Hg), and follow-up gradients (27 :I: 27 vs 24 :I: 19 mm Hg) were similar 
(p > 0.1). Infants with gradients> 20 mm Hg at follow-up (6 of 13 vs 7 of 14) 
and need for re-intervention (6 of 13 vs 7 of 14) were also similar (p > 0.1) in 
both groups. Duration of hospitalization during the first Intervention was 
higher (p < 0.05) for the surgical (32 :I: 37 days) than for the balloon (7:1: 6 
days) group. Similarly, tbe duration of mechanical ventilation was longer 
(p<O.OI) in the surgical (12:1: 16 days) than that in the baBoon (2:1: 3 days) 
group. Complications after surgery, nameiy, cardiac arrest, acute renal failure, 
CNS event, tension pneumothorax, septicemia. and paradoxical hypenension in 
two patients each (0.86 events per patient) were higher (p < 0.05) than those 
seen with balloon angioplasty. namely. femoral artery compromise and blood 
loss·requiring transfusion in two infants each (0.27 events per patient). 
Conclusions. The data indicate that the degree of relief of AC and the 
frequency with which re-interyention is needed are similar in botb groups. 
However. the morbidity and complications are lower with baBoon than with 
surgical therapy. These data suggest that baBoon angioplasty may be an 
acceptable alternatiYe to surgery in the treatment of symptomatic AC in 
infants S 3 months of age. 
358A ABSTRACTS 
942·3 
Two·Year Follow·up Results of Transcatbeter Occlusion of Secundum 
Atrial Septal Defects With Buttoned Device 
P. Syamasundar Rao, Allen D. Wilson, Patricia A. Smitb, University of 
Wisconsin Medical Scbool, Madison, WI 
Feasibility, effectiveness and safety of transcatbeter occlusion of secundum 
atrial septal defect (ASD) witb buttoned device bave been demonstrated. The 
purpose of this study is to evaluate tbe follow-up results in an attenpt to furlber 
assess long-term efficacy and safety of this procedure. Successful implantation of 
the device was accomplisbed in 20 of 22 (91%) patients. These 20 patients were 
followed for 24 t 9 months; range 12 to 36 months. Follow-up included clinical 
evaluation, cbest x-ray and ecbo-Doppler studies and were performed 1,6, and 12 
months after occlusion and yearly thereafter. All patients received S-IO mg/kg of 
aspirin per day for 12 weeks following tbe device implantation. Ages and 
weigbts at device implantation respectively were 7 mo to S I years and 3.6 to 105 
kg. These were divided into three groups based on the type of sbunt across tbe 
ASD. In 14 left-to-rigbt sbunt ASD closures, tbe rigbt ventricular size 
diminisbed from 2.3 t 0.6 to 1.7 t 0.38 cm immediately after closure (p <0.01) 
and remained decreased (1.6 t 0.46 cm) at last follow-up. Paradoxical/flat septal 
motion was present in II of 14 (79%) prior to closure wbile sucb an abnormal 
septal motion was not present in any at follow-up. Small to trivialleft-to-rigbt 
shunts across the implanted device were seen in 6 of 14 (43%) patients 
immediately after closure while such residual sbunts were present in 3 of 14 
(21%) at follow-up. Small sbunts became trivial and trivial sbunts disappeared. 
None of the patients bad any clinical signs of ASD and none required surgical 
intervention during follow-up period. 
None of tbe patients with cerebrovascular accident (eV A)/paradoxical 
embolism bad recurrence of eVA. Repeat transesopbageal contrast ecbo study 
with Valsalva revealed minimal rigbt-to-Ieft shunt in 1 of S (20%) patients 
initially, wbicb disappeared at follow-up. The single patient witb eVA 
secondary to atrial right-to-Ieft sbunt following previous tetralogy repair bad 
transient ischemic episode 4 montbs after closure and underwent surgery at tbe 
discretion of the primary cardiologist. There were no wire fractures on follow•
up x-rays. None developed endocarditis. 
These data indicate that effective ASD occlusion can be accomplished in left-to•
right shunt and paradoxical embolism patients. Modification of tbe device to 
inven the device so as to position the square-shaped patcb on tbe rigbt atrial side 
may be necessary to prevent eVA in patients with right-to-Ieft sbunts. 
942·4 
Aortic Valve Regurgitation at Long·Term Follow·Up In Pediatric 
Patients Arter Balloon Aortic Valvotomy 
Roben Justo, Brian W. McCrindle, Jeffrey F. SmaJlhom, Lee N. Benson, 
Robert M. Freedom, The Hospital for Sick Children, Toronto, Canada. 
To determine the incidence and severity of aortic valve regurgitation (A VR) 
after balloon aortic valvotomy (BAV), data were reviewed for 106 
consecutive patients who underwent BAV between July, 1985 and June, 
1993. Previous surgical valvotomy had been performed in 13 patients. 
Median age was 5.7 years (range, I day-17.9 years). Mean balloon:anulus 
ratio was 0.99±0.09. LV to Ao systolic gradient was reduced by 66±27~ 
(p < 0.0001), and LV/Ao pressure ratio was reduced by 24±12~ 
(p<0.0001). AVR at BAV was graded angiographically before dilation as 
none in 69~, trivial in 14~, mild in 15~, and tnoderate in 2%. After BAV 
A VR grade increased in 43 ~ and decreased in I ~, with tnoderate or severe 
AVR evident in 19~. Six patients had avulsed valve leaflets. Subsequent 
procedures performed at a median interval of 2.5 months (range, I day-6.2 
yrs) included AoV repair in 6 patients, repeat BAV in 4, surgical valvotomy 
in 3 and AoV replacement in 9 patients. Two neonates died within 24 hours 
of BA V and 2 patients died at later surgery. Echocardiograms at latest 
follow-up or prior to further procedures were analyzed in 78 patients. The 
median interval was 1.9 yrs (range, I day-7.2 yrs). Peak instantaneous 
Doppler AoV gradients ranged from 12 to 142mmHg (median 44mmHg). 
A VR was detectable in 58 (74~) patients with an A VR jet width to valve 
anulus diameter ratio (JWR) on long-axis views of 32±14~ (range, 10 to 
69~). The jet was centrally located in 36%, eccentric in 53~, and 
peripheral in II ~ on short-axis views. JWR was correlated with immediate 
post-BAY angiographic assessment of AVR (r=0.50; p<O.OOOI), and also 
related to jet location, with mean JWR 26±13% for central, 34±14~ for 
eccentric, and 4O±15~ for peripheral jets (p<0.05). JWR was not related 
to valve morphology or balloon:anulus ratio. Echocardiographic features of 
A VR reflects the mechanisms of valve disruption after BA V. 
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942·5 
Intrava.cular Stent. in coarctation of the Aorta. Barly 
ae.ult. aDd Interaadiate Pollow-Up 
Peter M. Kilbridge, James B. Lock, John F. Keane, 
Stanton B. Perry, Children'. Ho.pital, Boston, KA 
Short and long-term .tudie. have .hown .tents to 
Buccesafuly relieve experimental aortic coarctation; 
the performance of .uch .tent. in patients i. unknown. 
Between 19B9 and 1993, we placed .tent. in 6 patients 
with both complex congenital heart dieease and 
recurrent (na 3) or native (n-3) CoAo who failed balloon 
angioplasty. In addition to CoAo, diagnoeea included. 
corrected TGA, sIp cavopulmonary anaatomosis; complete 
A-V canal, sIp repair and mitral valve replacement; 
Williams syndrome with aupravalvar aortic atenosis; and 
vsntricular septal defect; all had LV dysfunction with 
elevated LVEDPs. PSEG (mm Hg) and minimum aortic 
diameter (mm) before and after .tent placement are 
shown below. 
~ l2§.I 
Age Diam. PSEG Diam. PSEG 
l2yr 2.3 49 5.5 25 
14 9.5 27 12.5 7 
16 10.0 30 24.0 19 
5 3.0 90 9.0 10 
13 10.5 45 15.0 15 
IB 12.9 10 17.0 0 
mean B.O 42 13.B 13 
+I-SD 4.3 27 6.5 9 
One stent migrated into a post-atenotic aneurism and 
was stabilized with a larger balloon with placement of 
a second proximal .tent in the CoAo. Intermediate 
follow-up (1-42 mo, meana 6) demonstrated continued 
gradient reduction in all patients. There has been no 
radiologic evidence of stent. developing fractures, or 
of aortic diasection. Recurrent or complicated native 
CoAo can be managed witb the use of intravascular 
stente, with .ubstantial reduction in preasure gradient 
and prevention of recoarctation for the duration of the 
study. 
942·6 
Balloon Dilation va Stent Implantation in Peripheral 
Pulmonary Branch Stenosis in Congenital Heart Def'ects. 
Jorge Casado, *Ramon Bermudez, **Charles Mullins, Lucia•
no Pasquini, Roberto Formigari, Giuseppe Santoro, Luigi 
Ballerini. 
Pediatric Cardiology, Ospedale Bambino Gesu, Rome, Italy 
*Cardiology Ramon y Cajal, Madrid, Spain. **Cardiology 
Texas Children Hospital, Houston, Texas, U.S.A. 
Stenoses of branch pulmonary arteries (SBPA) are diff~ 
cult to relieve surgically, so that pulmonary angioplasty 
(PAA) is usually used to treat this type of lesion. Beca~ 
se of' poor results of this technique or restenosis, endo•
vascular stent implantation (EST) was introduced. We des•
cribe a serie of' 8 patients (pts) with 12 post-surgical 
stenoses who underwent ESI because of failure of PAA or 
restenosis. Diagnoses were: tetralogy of Fallot (4 pts), 
DORV (2 pts), truncus arteriosus (1 pts), and TGA+VSD+PA 
(1 pts). At PAA age was 5.6!3.7 ys, weight 9.0!1.7 kgs. 
After PAA, RV/Ao decreased from O.9!O.1 to O.7!O.6(p;NS) 
percent of stenis from 74.0!9.3 to 52.0!22.0 (p;NS), MLD 
increased from 3.4!1.5 to 5.0!2.0 mm (p;NS). At ESI age 
was 8.5!2.S ys, weight 28.0!8.4 kgs. After EST, RV/Ao fell 
from O.8!O.3 to O.S!O.2 (peO.OS), percent of stenosis 
from 66.0!9.3 to 3.6!S.O (p<O.001), and MLD increased 
from 4.2!1.3 to 11.8!1.8 mm (p<O.001). EST revealed a si•
gnificant decrease in percent of stenosis with respect to 
PAA (S2.0!22.0 vs 3.6!5.0, p<O.01). In conclusion, in our 
experience, EST is a better therapeutic option than PAA' 
for SBPA in selected patients. 
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942·7 
Improved Safety of Transcatheter Vascular Occlusion 
Utilizing a New Retrievable Coli Device 
·Patrick A. Cambier, Karl C. Stajduhar, Douglas A. Powell, 
Richard R. Gomez, Renu Virmani, Andrew J. Farb, 
John W. Moore 
Madigan Army Medical Center, Tacoma, WA; Children's 
Hospital and Health Center, San Diego, CA; Armed Forces 
Institute of Pathology, Washington, DC 
Transcatheter coil embolization is an established 
technique for therapeutic vascular occlusion. Limitations 
exist however such as inadvertent coil migration or 
difficulty when sizing the device to the vascular lumen. In 
response to these problems, a new integrated retrievable 
coil delivery system was tested in a small ruminant model. 
Deployment precision, retrievability, and histopathologic 
response were evaluated. Eleven newborn animals (S 
lambs, 2 goats, mean weight 5.S .±. 1.1 kg). underwent 
embolization of either a patent ductus arteriosus (n = 5). or 
collateralized peripheral artery (n = 6). < 3.0 mm diameter. 
Using a 6 French Judkins left angioplasty guiding 
catheter, a single stainless steel (.038 inch - 4 cm - 3 mm) 
Cook Retrievable Embolization Coil was inserted into the 
chosen vascular site. Each coil was retracted into the 
guide and subsequently reinserted prior to final 
deployment. Successful delivery was achieved in 11 of 11 
attempts. There were no incidents of acute coil migration 
or vascular complication. Histologic analysis was carried 
out at 1-7 days (n=6), and 60-S0 days (n=5). 
Microscopic examination of the short-term implants 
revealed organized thrombus. Late specimens 
demonstrated endothelialization and fibrous consolidation. 
Conclusion. The retrievable coil occlusion system 
represents a significant improvement regarding the 
precision and safety of transcatheter vascular embolization. 
942·8 
Intra-Aortic Spring Coil Loops; Late ResullS 
·Rajiv Venna, Stanton B. Perry, Phillip Moore, BaIbara G. Lock, 
John F. Keane, James E. Lock. 
·Division ofPediatric Cardiology, New York University Medical Center, New 
York, NY and Department of Cardiology, Children's Hospital, Boston, MA. 
Rcc:cnt studies have focused attention on the use of coil spring occluders [Cook] 
to close small patent ductus arteriosus [PDA]. By necessity, part of the coil 
occluder must protrude into the ductus diverticulum; the late fate of sucb intra•
aortic coil loops is unknown. 
Since we have used a similar approacb to occlude proxirna1ly stenosed aono•
pulmonary collateral's [APC] for over 5 years, we reviewed 234 cine•
angiograms ftom January 1988 to August 1993, and identified 53 patients with 
the coil protruding into the aona. Age at initial coil procedure ranged from 0.5-
203 months [median = 34 months]. Patients were evaluated clinically and cine•
angiograms were reviewed when subsequent cardiac catheterization was 
performed. This study repons data from follow up of patients ranging from 0.5-
61 months [median = 13 months] with a total patient follow up of SO patient 
years. Anti-Q)8gulation and endocarditis prophylaxis were not utilized 
routinely post procedure. 
Coil protrusion occurred on 63 occasions in 53 patients. 4 had PDA's, 59 bad 
APC's. During follow up there were no episodes of stroke, embolic events, 
endocarditis or coil migration. In 33 patients, subsequent cine-angiography 
(performed from 0.5-49 months, median = 10 months], showed no evidence of 
residual APC flow. Angiography also demonstrated separation of the coil and 
aortic contrast column in 35 coils whose proximity to the aona was well 
profiled, suggesting endothelial coverage of the intra-aortic coil loop. 
Conclusion: The presence of an intra-aonic coil loop has not been associated 
with late complications. The closure rate, in this study, of APC's with coils so 
placed was 100% although further studies will be needed to assess late closure 
rates ofPDA's with spring coil occluders. 
ABSTRACTS 
942·61 
Transc:atbeter BaUoon DUadon or Stenosed Systemic Venous Patbways 
Following tbe Mustard Operation: Immediate and FoUow-np Results. 
Narayanswami Sreeram, Venkatesh Dikkala, Mark Jackson, Kevin Walsh, 
Ian Peart, Roben Arnold. Hean Clinic, Royal Liverpool Children's 
Hospital, Uverpool, England. 
This study was performed to assess the immediate and long-term effects 
of percutaneous balloon dilation (BO) of stenoses in the superior (SVP) 
and inferior (lVP) systemic venous pathways following the Mustard 
procedure (M). The study population consisted of 15 patients (17M, 8F) 
who underwent 43 BDs (18 SVP, 15 IVP). The median age at M was 1 
(range 0.3 - 2.9) yr, and at first BD 6.4 (2 - 18) yrs. The diameter of the 
stenosis was averaged from the maximum and minimum diameter of the 
stenotic segment during one cardiac cycle. Gtadients were estimated from 
the mean pressures in the superior and inferior vena cava and the systemic 
venous atrium. 
For 13 initial SVP dilations (median balloon to stenosis (B:S) ratio 
3.15), the gradient across the stenosis decreased from 8 (3 - 21) to 4 (0 -
1) mm Hg (p<O.Ol). The diameter of the stenosis increased from 4.7 (2.7 -
8.6) to 11.1 (7.3 - 17.5) mm (p<O.OI). For 22 initial IVP dilations (B:S of 
2.5) the gradient decreased from 3 (3 - 10) to I (0 - 5) mm Hg (p<0.01). 
The stenosis diameter increased from 6.1 (4.1 - 9) to 10.1 (5.7 - 18) mm 
(p<O.Ol). Over a median follow-up of 3.5 (0.3 - 9.1) yrs, patients were 
evaluated by serial two-dimensional Doppler ecbocardiography (N=25), 
and angiography (N=9). Five patients (20%) have undergone 8 funher BO 
procedures (5 SVP, 3 IVP). The percentage reduction in gradient (59% vs 
69% for SVP and 67% vs 75% for IVP), and increase in stenosis diameter 
(158% vs 130% for SVP and 58% vs 20% for M) were not different 
between first or subsequent BD procedures (p>0.05). Finally 1 patient has 
undergone bame revision for severe recurrent SVP obstruction, despite an 
acute decrease in gradient from 15 to 6 mm Hg at initial BD. There were 
no complications associated witb any procedure. 
Systemic venous pathway stenoses following M respond well to 
transcatheter BD, with excellent long-term results. Multiple procedures are 
required in some patients, but the results of subsequent BDs are 
comparable with those at initial BD. 
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943·9 
359A 
Mechanism of Hemolysis with Mitral Prosthetic Regurgitation: 
A Study Using Transesophageal Echo and Fluid Dynamic Simulation 
Mario 1. Garcia, Pieter Vandervoort, William J. Stewart, Bruce W. Lytle, 
Delos M. Cosgrove, James D. Thomas and Brian P. Griffin. 
The Cleveland Clinic Foundation, Cleveland, Ohio 
Although hemodynamic conditions associated with high shear stress 
(>3000 dynes cm-2) cause traumatic hemolysis in vitro, the precise 
mechanism by which significant hemolysis occurs with prosthetic valvular 
regurgitation in vivo is unknown. To study this, we used transesophageal 
echo (TEE) and fluid dynamic simulation in 16 pts with prior mitral repair 
(n=5) or replacement (n=II), who had severe hemolysis (mean WH of 
2945 ± 442 (SEM) IV) and severe mitral regurgilation (MR). MR was 
central due to flail leaflet in all 5 repairs and in 3 bioprostheses, and was 
paravalvular in 8. Three flow pattems were identified: A) rapid accelera•
tion through leaflet perforation (n=2), B) rapid deceleration (n=11 ) follow•
ing collision with solid object (atrial wall or strut), and C) fragmentation 
of flow by a suture (n=3). These anatomic conditions were simulated at a 
regurgitant flow velocity of 5m1s (F) using computerized finite difference 
analysis. This demonstrated shear stress (a)values of 4500 dynes cm-2 for 
both A and B, and 6000 dynes cm-2 for C (see Figure). 
Conclusion: I )Distinct patterns 
of regurgitant flow recognizable 
by TEE are associated with sig•
nificant hemolysis at mitral pros•
theses 2)Hemolysis results from 
the high shear stress produced 
by each of these flow patterns. 
P--' /Suture ~IL- --P~ ~~~ P:;+ 5 mls 
cr = 6000 dyn-cm-2 
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943·10 
Estimation of Mitral Valve Area by Transthoracic and Transesophageal 
Echocardiography Using Different Techniques 
StuartJ. Hutchison, louis S. Cristol, P. Anthony N. Chandraratna, Susan 
Curry, Tahir Tak, Julio F. Tubau, USC School of Medicine, los Angeles, 
California 
Mitral valve area may be estimated by several techniques using 
echocardiography. To compare the accuracy, reproducibility and 
feasibility of estimation of mitral valve area (MVA) by transthoracic (TIE) 
and transesophageal (TEE) echocardiography using pressure half-time 
(PHT) method, planimetry and color Doppler convergence flow (CDCF) 
imaging (MVA = 2 x " x aliasing radius' x Nyquist velocity/peak 
velocity). we prospectively and blindly assessed the mitral valve area of 
30 patients with mitral stenosis undergoing cardiac catheterization (Fick). 
Patients with valvuloplasty within 3 months, with > 2 + mitral 
insufficiency, > 2 + aortic insufficiency, with > mild aortic stenosis 
were excluded. 
Inter Intra 
~ ~ ~ flliiQi!)!y 
TIE-PHT r=0.88 r=0.68 r=0.85 100% 
TEE-PHT r=0.94 r=0.84 r=0.83 100% 
TIE-CDCF r=0.19 r=0.30 r=0.81 87% 
TEE-CDCF r=0.71 r=0.10 r=0.74 87% 
TIE-Planimetry r=0.83 r=0.51 r=0.85 80% 
TEE-Planimetry 0% 
The pressure half-time method has superior accuracy, reproducibility and 
feasibility by both TIE and TEE for estimation of MVA, and is much 
simpler to perform than the CDCF technique, and is more feasible than 
planimetry. Of note, the poor reproducibility of CDCF severely limits its 
value for routine clinical application. 
943·11 
Coronary Flow Response to Dipyridamole using Transesophagea1 Eeho 
Correlates with Myocardial Blood Flow Measured by Positron Emission 
Tomography 
Johannes Radvan, Thomas Marwick, Neil Uren, John Williams, Daniel 
O'Gonnan, Paolo Camici. St Mary's and Hanunersmith Hasp, London, UK. 
Coronary flow reserve (CFR) in the left anterior descending coronary 
artery (LAD) can be measured using transesophageal echo (TE). However, 
TE-CFR has not been validated against an established method for CFR 
measurement. The purpose of this study was to compare TE-CFR with CFR 
obtained with positron emission tomography (PET) in 13 healthy male. 
volunteers (aged 30±12 years). Subjects underwent TE and PET, in random 
order on different days. TE transverse plane views of the LAD were used to 
measure coronary flow by pulsedwave Doppler before and after dipyridamole 
(0.56mglkg). PET measurements of absolute myocardial blood flow in the 
LAD territory, at rest and after dipyridamole, were made using a standard 
0·15 water technique. To compensate for heterogeneity in resting hemo•
dynamics between the two studies, resting flow and perfusion measurements 
were corrected to a standard cardiac workload. CFR was calculated as the 
ratio between dipyridamole and corrected resting flow. Dipyridamole stress 
induced a greater tachycardia during TE (91±14 vs 73±12 beats/min, 
p<O.OI), with comparable mean arterial pressures (91%20 vs 81±9mmHg, 
_TE-aR 
p=NS). Corrected TE-CFR was 
2.3±O.9, compared with 2.2±0.7 at 
PET. The measurements correlated 
with an R value of 0.87 (p<0.001). 
The mean difference between TE•
and PET·CFR was O.l7±O.4I; 
discrepant results occurred at higher 
flows and in the presence of 
discordant blood pressure responses 
• to stress. Conclusion. TE-CFR 
correlates well with PET -CFR. 
JACC February 1994:1A-484A 
943·12 
MYOCARDIAL VIABll.1TY ASSESSED BY DOBUTAMINE 
ECBOCARDIOGRAPBY SOON AFTER MYOCARDIAL INFARCTION: 
INFLUENCE OF MYOCARDIAL ECBOCONTRAST OPACIFICATION 
OF INFARCTED AREA AND TlMI GRADING OF INFARCTED 
RELATED ARTERY. 
Leonarda Galiuto, Alfredo Marchese, Daniela CavalIari, Antonio 
Amico, Venanzio F. Napoli, Sabino Iliceto, Paolo Rizzon. 
Institute of Cardicvascular Diseases. University of &ri, &ri. Italy. 
To investigate the relationships existing, in patiente (pte) with recent 
myocardial infarction (MI), among infarct related artery (IRA) and 
collateral circulation (CC) patency degree (TIM! grading 0-3 and 1·3 
respectively), myocardial echocontrast (MCE) opacification of left 
ventricular (LV) segmente with impaired post M! function and the 
presence of viability as expressed by low dose (5mcg/kg/min for 5' 
plus lOmcg/kg/m' for 5') dobutamine echocardiography (DE) response, 
19 pte with recent M! « 10 days) were studied. Response to DE was 
defined as "viable" in the presence of an improvement in wall motion 
of at least 2 contiguous M! segmente (improvement from dys- or 
akinesia to at least hypokinesia or from hypokinesia to normokinesia) 
during Dobutamine infusion. MCE was obtained by injecting 
sonicated loxaglate in IRA or in the other coronary if IRA was 
occluded. Pte were classified as having :! 50% or < 50% of M! area 
opacified by MCE. Eleven pte had TIMl 0 or 1 IRA: in 11/11 pte MCE 
was:! 50%, DE showed a viable response and CC had TIM! 2 or 3 
grading. In the 8 pte with TIM! 2 or 3 IRA, MCE was:! 50% in 5 pte 
and a viable DE response was obselVed in 3 pte (all 3 pte had MCE :! 
50%). 
Conclusions: TIM! grading of IRA after M! « 10 days) does not 
predict either myocardial perfusion or viability as respectively shown 
by MCE and DE; MCE :::... 50% is an expression of viability as 
expressed by DE response. In pte with occluded IRA, CC with grading 
TIM! 2 or 3 guarantees :! 50% MCE perfusion and viability as 
expressed by DE response. 
943·13 
Simultaneous TransthoraCiC and Trans .. ophageal 
Dobutamlne Str ... Echocardlography. 
Jason T. Tauke, Stephen P. Wiet, Lynn Y. Shelton-Zolopoulos, 
Stuart Greenfield, Carl L. Tommaso, Robert O. Bonow, Farooq A. 
Chaudhry. lakeside VA Medical Center and Northwestern 
University Medical School, Chicago, IL. 
The ability of dobutamine stress echocardiography (DSE) to 
Identify wall motion abnormalities (WMA) secondary to flow 
Ilmiting coronary stenoses may be limited In up to 10% of 
patients because of poor transthoracic echocardlography (TIE) 
acoustic window. We hypothesized that transesophageal 
echocardiography (TEE) may overcome the acoustic limitations 
associated with TIE and Improve the diagnostiC accuracy of 
DSE. Twenty-two consecutive male VA pts (67 ± 10 yrs) 
underwent simultaneous TIE and TEE using a standard DSE 
protocol without prior TIE screening. Fifteen pts underwent 
quantitative coronary arteriography (OCA) and flow limiting 
lesions were defined as .. 50% stenosis. Twenty-one of 22 pts 
reached an endpoint of either new WMA or target heart rate. No 
complications were noted. TEE adequately visualized 99.3% of 
LV segments vs 75.0% by TIE (p <0.0001). A total of B6 new 
WMA's were Identified by TEE vs 45 by TIE (p <0.0001). 
Sensitivity (SN), specificity (SP), and predictive value (PV) of TIE 
vs TEE to detect WMA's secondary to flow limiting stenoses are: 
TTE 
TEE 
~ §E. PV 
73% 80% 80% 
82% 100% 93% 
Conclusion: DSE with TEE is a feasible, safe, and promising 
new technique for detecting flow limiting coronary stenoses. 
DSE with TEE may be especially useful in patients with poor 
acoustic windows. 
lACC February 1994:1A-484A 
943·14 
The Potential Value of Echocardiographic Fourier Phase 
Imaging of Left Ventricular Contraction Sequence in 
Patients with Coronary Artery Disease. 
Helmut F. Kuecherer, Elias H. Botvinick, J. William O'Connell, 
Joseph A. Abbott, Michael W. Dae, Nelson B. Schiller 
University of Heidelberg, Heidelberg, Germany and 
University ofCalifomia San Francisco, San Francisco, CA 
The purpose of this study was to investigate, whether echocardio•
graphic Fourier phase imaging can be used to detect altered left 
ventricular contraction s.:quence in patients with coronary artery 
disease and regional wall motion abnormalities. Therefore, we studied 
15 patients (11 male,age 61±12years) with angiographically proven 
regional wall motion abnormalities, using intraoperative (n=12) and 
ambulatory (n=3) transesophageal echocardiography. A group of 6 
age matched normal subjects served as a control. To objectively 
identify contraction sequence, we applied a first harmonic Fourier al•
gorithm to digitized cine loops of standard apical and transgastric 
cross-sectional views. Phase angles were color encoded using a cyclic 
color scale. From functional images, phase angles were determined in 
standard wall segments. The range of segmental phase angles within a 
cross-sectional view was calculated as a measure of global contraction 
homogeneity and regional abnormality. We found that in normal 
subjects segmental contraction was homogeneous with uniform phase 
angles. In contrast, in patients, phase angles were delayed in the 
segments with wall motion abnormalities (range of segmental phase 
angles: Normal: 25±15°SD, Hypokinesia (n=lO) 105±20oSD, 
Akinesia (n=2) dropout in phase image, Dyskinesia (n=3) 
175±20oSD. 
Conclusion: Contraction sequence is altered in patients with 
regional wall motion abnormalities. Echocardiographic Fourier phase 
imaging may be a new method to objectively analyze regional wall 
asynergy by displaying contraction sequence as a functional image. 
943·15 
Effectl of Dobutlmln. on the Aft.rlOid Ullmatch of Left 
Atrial Booat.r Pump Function 
Hisanorl SakaI,Kazuhiro Kalayama,Takafumi HI/O,Kohzaburo SekI, 
Yasuhl<o Saekl,HIdekI Kunlchka,Takahilo Yonezawa, Masunorl Matsuzaki 
Dept. of Int. Meet ,Yamaguchi Univ.SchooI of Med.,Ube,Japan 
We have previously demonstrated that In patients with old myocardial 
Infarction, the increase In left ventricular(L V) operational stiffness by acute 
pressure load induced a significant reduction of LV fUling during left 
atrial(LA) contraction, resulting In an alterload mismatch of LA booster 
pump function. To test the hypothesis thai dobuIamine(DOB) aflects LV 
filling during LA contraction, we examined LA afterload mismatch 
pIOcIuced by aortic occkJsIon during acute myocardial infarction(AMI) In 10 
dogs, before and after DOB infusion(3jl glKglmln). Transmitral flow 
(TMF;transesophageal echocardiography), LV pressure (micro· 
manometer) and LV volume (conductance catheter) were recorded. We 
measured elllly(E) and tale ciastoIic(A:cm'sec) peak flow velocllies of TMF 
and LV chamber stilfness(~P/~V:mmHgImI; ~P Is developed pressure 
and ~V Is absolute filling volume during LA contraction). When LV 
chamber stiffness was Increased by aortic occIusion(Aoc) during AMI, A 
was significantly decreased and ElA ratio was Increased, indicating LA 
afterload mismatch. By DOB infUSion during AMI+Aoc, ~P/~V was 
decreased, resulting In Increase of A and decrease of EI A. Diastolic LV 
pressure-volume relation shifted left-downward to the baseline(B) by 
DOB infusion during AMI. There was an Inverse correlation between 
~P/~V and time-velocity Integral of A(r-o.64, p<o.ol). 
A EIA ~(A'J ...... l ~\ J
AMI 30±5 1.0±:0.3 1.1iO.8' _ 
AMI+Aoc 22±8- 1.4iO.8' 3.1±2.1r" • "-
AMI+Aoct[)QB 31t8a 1 0tQ 3t 1 It1 2a .'-.-' 
Mpc1U:pdl5 VlAM~.01.arpc.05V1AM+Aoc 1: .~y ·~o ' 
Thus, cIobutamine improved the afterload mismatch of LA booster pump 
function. This mechanism might be due to a reduction of LV operational 
chamber stiffness, resulting In an Increase of LA forward ejection. 
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943·16 
&timation of Mean Pulmonary Wedge Pressure From 
Transoesophageal Echocardiography. 
Charles C. Gueniche, Michel S. Slama, Sylvie Dinanian, Thierry 
Lherm, Gilbert Mottl! .H6pital Antoine BI!c1ere. Clamart. FRANCE 
We assessed the relationship between mean pulmonary wedge 
pressure (pWP, mmHg) measured by Swan-Ganz catheter (SG) and the 
ratio of systolic to diastolic velOCity time integrals (R) obtained in the 
pulmonary venous flow by transoesophageal echocardiography (TOE). 
Fifty three patients (pts) (33 males), mean age 68 years old, were 
studied in the intensive care unit by SG and simultaneous TOE 
performed for etiologic assessment of hemodynamic failure. W ~ 
excluded pts with mitral regurgitation or atrial arrhythmias. PWP values 
ranged from 3 to 42 mmHg. PWP and R were inversely related 
(r=-O.82, p<O.OOOI). According to an R value < 0.75 (n=24) or 
20.75 (n=29), sensitivity of TOE for the discrimination between PWP 
5: 15 mrnHg (n=28) and > 15 mrnHg (n=25) was 96 %, specificity 
was 100 %, positive and negative predictive accuracy was respectively 
100 % and 97 %. Variability of TOE derived data tested among 15 
unselected pts was 2.5 ± 4 %. 
In conclusion, in our study, TOE allowed in all cases but one to 
identify pts with PWP .:5.. or > 15 mmHg according to R value. This 
study suggests that TOE could avoid a number of catheterizations but 
requires validation in larger series. 
:g; (IMjHg) 
35: '., r. ·0.82 
30; ". 
A. 25; .:, p< 0.0001 ~ 20: Co. 
CL. 15~ .......... \ • • ~ .""'.~ .. --10· '-. , 
5~ •• •• 
o ... Rxl0.2 
o 25 50 75 1 00 1 251 50 175 200 225250 275 
943·17 
Prognostic Implications of Pulmonary Venous Flow Pattern Assessed by 
Transcsophagcal Echocardiography in Dilated Cardiomyopathy. 
Maurizio Turiel, Anna Frisinghelli, Cristina Crema, Sabrina Muzzupappa, 
Stefano DeCastro. Med Int, Osp L. Sacco, Univ Milan; Italy. 
Pulmonary venous flow (PVF) pattern is reponed to be more sensitive in 
detecting LV diastolic pressures than mitral inflow. A recent study confirmed 
that reduced «0.4) systolic fraction (ratio of systolic to the sum of systolic 
and diastolic velocity integral, SF) and prolonged reversal flow exceeding 
mitral A duration might identify patients (pts) with decreased LV 
compliance. Accordingly, we studied 37 dilated cardiomyopathy (DCM) pts 
(27M, 10F, aged 6h2yrs), in sinus rhythm, matched with 20 normal subjects 
(C), by TEE to assess prognostic value of these new parameters related to 
different degrees of diastolic dysfunction. Measurements included early (E), 
atrial (A) mitral velocities, EI A ratio and A duration (Ad); systolic (S), 
diastolic (D), atrial reversal (Ar), SID ratio and Ar duration (Ard), and 
difference Ard-Ad for PVF. 36137 pIS presented mitral regurgitation, severe 
only in 3. Diastolic phase of PVF correlated with mitral inflow (D vs E, 
r=.48, peOI; SID vs B/A, T--.58, peOI). Subsequently, we considered 3 
groups according to E/A ratio: 1 (E/A<l), II (/<E/A<2) and III (E/Al2). 
Results (mean.SD; "pe05; '"peOI): 
C(20) 1(20) 11(7) II1(10) 
S(cm/s) 62±11 53.16 39.23" 2.7>32"" 
D(cm/s) 39: II 34±9 43±20 78±22 
Ar(cm/s) -22 .4 -26±1O -27±9 -31±10" 
SID 1.6:.3 1.7±.7 1.I±.7" 0.1±.4"· 
Ard-Ad(ms) -40.18 -16±26 8.18"" 25±27"" 
A mean follow-up period of 10.5 months showed major complications in 
19/37 (51%): 2 deaths and 17 progressive hean failure. These complications 
were closely related to a reduced SF and a positive Ard-Ad (peOI). In 
conclusion: a) normal PVF pattern is present in DCM with abnormal LV 
relaxation; b) progressive inverted PVF profile (diminished S and increased 
D) with increased Ar characterizes DCM; c) reduction of SF with progressive 
prolonged Ard-Ad is already evident in "pseudonormalized" DCM, but 
always present In restrictive pattern; d) SF and Ard-Ad changes are related 
to LV diastolic dysfunction, providing a prognostic tool for monitoring 
DCM. 
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944·52 
Myocardial Salvage from Recanalization in Patients Treated 
with Heparin and Aspirin Alone for Acute Myocardial 
Infarction 
Timothy F. Christian, Todd D. Miller, Ian P. Clements, David R. 
Holmes, Raymond J. Gibbons. Mayo Clinic, Rochester, MN 
The purpose of this study was to determine the amount of myocar•
dial salvage in patients (pts) who have recanalization of the infarct 
vessel who receive heparin and aspirin alone. A consecutive series 
of 199 pts were injected with Tc-99m-sestamibi during acute 
myocardial infarction (AMI); 26 (13%) were treated with heparin 
and aspirin but no other reperfusion therapy during hospitalization, 
at the discretion of the attending physician. ST elevation was 
present in only 42% of this group. All patients developed enzymatic 
evidence of AMI. Tomographic imaging was performed 1-6 hours 
later to determine myocardium at risk (MAR) and a second injection 
and acquisition was performed at discharge to measure infarct size 
(IS). MAR and IS were determined using a previously described 
quantitative method and expressed as a % of the left ventricle (LV). 
Myocardial salvage was calculated as the difference of MAR and IS 
(MAR-IS) and the salvage index (Salv I) by (MAR-IS)IMAR: (the 
proportion of MAR salvaged). Angiography was performed in 21 of 
26 pts (2.2 ± 3.3 days from admission) with 12 (62%) pts 
undergoing angiography within 24 hours. Pts with a patent artery 
(57%) were compared to those with an occluded artery (43%): 
Patent (o=! 2) occluded (0=9) ...£ 
MAR (%LV) !6± 14 12± 9 NS 
IS (%LV) 7±8 14±7 0.08 
Salvage (%LV) 9 ± 9 -2 ± 7 0.01 
SalvI 0.62±0.37 0.19±0.33 0.01 
Conclusions: I) When infarction is treated with heparin and aspirin 
alone, pts with recanalization salvage more than half the MAR, 
similar to previous values reported in pts treated successfully with 
thrombolysis. 2) Pts without recanalization demonstrate minimal 
salvage. 
944·53 
Pre-hospital Thrombolysis in Rural Emergency Room and 
Subsequent Tranport to a Coronary Care Unit. 
Stefano Coccolini, Gianni Berti, Marco Pretolani, Stefano Bosi, 
Giorgio Tumiotto, *Mario Marzilli for the EMIP Group. 
Cardiology Dpt.- S. Maria Delle Croci Hospital - Ravenna and 
*CNR Pisa - Italy. 
Time delay in thrombolytic therapy administration for acute myocardial 
infarction has a crucial effect on reperfusion efficacy. In order to 
reduce time delay in our area, thrombolytic therapy (APSAC 30 U 
over 5 ') was started on 102 patients (pts) (Group I) with chest pain 
and STi within 6 hours of onset, by the general physician, in 4 rural 
hospital emergency rooms. Diagnosis was confirmed by ECG 
cardiotelephone transmission to the coordanting coronary care unit, 
where pts were immediately transported for further care. A group of 
178 pts (Group II) with the same baseline clinical characteristics 
received APSAC only after reaching the central unit and served as 
control. We compared time delay (TO) to treatment, infarct size- as 
peak CPK, regional LV function- using an echocardiographic wall 
motion abnormality score (WMAS), mortality at 35 days (M-35) and 
I year (M-l yr): 
Results: TD (min) CPK 
Group I 130 ** 1389 ** 
Group II 189 2186 
* p<O.OI ** p<O.OOl 
14.5 ** 
16.6 
Adverse effects were similar in both groups. 
7.5% 
10.7% 
M-I yr 
8.6 * 
19.7% 
We conclude that early pre-hospital coronary thrombolysis in rural 
emergency rooms is feasible and safe, shortens significantly time delay 
and achieves a better LV function preservation, and reduced I year 
mortality. 
lACC February 1994:1A-484A 
944·54 
Intravenous Magnesium Sulfate Infusion At Up To 45 Minutes 
Into An Ac:ute Myocardial Infarction Significantly Reduces 
Infarct Size 
Cart W. Christensen, Nelson E. Gencheff, Michelle A. Rieder. Eve L. 
Silverstein, Donald H. Schmidt, University of Wisconsin Medical 
School, Milwaukee, WI 
Magnesium sulfate (MS) has been suggested to play a beneficial 
role in acute myocardial infarction (AMI). Animal studies have shown 
that dogs deficient in MS in their diels developed larger myocerdial 
infarcts (MI) than did controls. Although MS has been suggested in 
the treatment of AMI, no studies have conclusively shown systemiC: 
administration of MS to be beneficial in reduction of MI. We studied 
three groups of dogs (n=21) for the effects of intravenous MS 
infusion (4 mM bolus with 2 mMlHr x 5) on infarct size (IS) when MS 
was infused at either 15 minutes (15' MS) or 45 minutes (45' MS) into 
an AMI produced by oc:cIusion of the LAD for 90 minutes followed by 
270 minutes of reperfusion. IS to area at risk (IStAR) was 
quantitated by planimetry after triphenyltetrazolium chloride staining 
and collateral coronary blood flow (CBF) measured by radioactive 
microspheres. 
Group IStAR 
Control 58.7±16.7 
15' MS 20.5±11.7* 
45' MS 21.3±6.5* 
*p<O.05 vs. Control 
HR 
113±14 
123±16 
116±13 
SAP 
104±14 
116±11 
124±12* 
HR = heart rate; SAP = systOliC arterial pressure 
CBF 
O.13±O.03 
O.14±O.05 
O.12±D.03 
The data suggest that MS infusion at both 15 and 45 minutes into a 
AMI has beneficial effects in reducing IS in this model. The 
significant reduction in IS does not appear to be related to alterations 
in HR. SAP or CBF. It appears that infusion of MS during an AMI 
may be effective in reducing IS in AMI patients. 
944·55 
Intravenous Nitrate in Acute Myocardial Infarction; Benent in Non Q-wave 
but not Q-wave Infarcts 
John L Monis, Azfar G Zaman, John H Smyllie, J Campbell Cowan. 
Department of Cardiology, The General Infirmary at Leeds, UK. 
Intravenous nitrates are frequently used in the treatment of acute myocardial 
infarction but the possible mechanisms of benefit remain unclear. We undertook 
a double-blind randomised placebo-controlled study of the effect of intravenous 
isosomide dinitrate on infarct size, ST resolution and ventricular function. 
Three hundred and one patients Were studied. Trial infusion was started within 
90 minutes of thrombolytic therapy (n=292) or immediately in patients 
ineligible for thrombolysis (n=9) and was titrated to achieve a 10% reduction 
of systolic BP. The infusion was continued for 24-42 hours. Infarct size was 
assessed by the cumulative release of a-hydroxybutyrate dehydrogenase (Q72). 
ST resolution was assessed using continuous 12-lead ECG monitoring and 
ventricular function was measured echocardiographically 12 hours after 
discontinuation of trial therapy. 
The mean(SEM) BP reduction in the first 3 hours in the nitrate group was 
14(0.9)% compared with 7{1.1)% in the placebo group (p < 0.(01). 
Overall there was no reduction in infarct size in patients treated with nitrate 
compared to placebo (Q72 829(58) vs 830(48». However those patients with 
DOn Q-wave infarction (n=9O) showed a highly significant reduction in infarct 
size (384(65) vs 632(75) p=O.O(6). The rate of ST resolution was similar in 
overall groups, although a trend towards earlier ST resolution was observed 
with nitrates amongst non Q-wave infarcts: After 30 minutes of trial infusion 
ST elevation was 55.8{8.9)% of admission value with nitrate vs 88.1(13.6)% 
with placebo (p = 0.052). There was no significant difference measured in 
ejection fraction on day 3 in the overall group (43.7{1.1)% vs 44.5(1.2)%) or 
the DOn Q-wave group (44.2(1.9)% vs 41.2(2.1)%). 
Non Q-wave infarction suggests early reperfusion or the presence of collateral 
arterial supply to the infarct region. Nitrates may be of benefit in reducing 
myocardial necrosis in these patients leading to better residual LV function and 
an Unproved prognosis. Possible mechanisms of nitrate benefit therefore include 
acceleration of reperfusion, prevention of reocclusion and improvement in 
collateral flow. 
lACC February 1994:1A-484A 
944·56 
rTPA Therapy Changes the Pror.Je of Cause of Death Post·MI. 
·Nisba C. Cbandra, Alan J. Tiefenbrunn, William J. Frencb, Joel M. Gore, 
William J. Rogers, National Registry of Myocardial Infarction (NRMI). 
Johns Hopkins Inst, Bait MD 
Prior studies bave sbown that women bave a bigber mortality than men, 
following myocardial infarction (MI). To determine whether this bigher in•
bospital mortality in women was a consequence of differences in cause(s) of 
death, data from the NRMI for 113,106 patients (Pis), were examined. PIs 
received rTPA therapy (rTPA) or no thrombolytic therapy (TT). Causes of 
death (1-7) by ')Ii incidence of mortality are displayed. 
ABC D 
N=48,919 N=32,734 N=23,027 N=8,426 
PTS tlo IT l!!I!!e No II fel!!!le rTPAmale rTPAfemale 
mortality (\IIi) 11.S 16.7 4.S 8.6 
shock (I) 32.9 33.7 41.2 44.4 
cardiac arrest (2) 29.7 29.8 25.3 23.4 
recurrent MI (3) 7 8.1 7.6 6.0 
arrhythmia (4) IS.S 14.2 18.0 IS.5 
rupturelEMD (S) 6.1 7.4 10.S 13.1 
other cardiac (6) 11.2 11.8 9.3 9.6 
non~rdiac (7) 16.9 IS.0 13.3 14.0 
For mortality, A vs B, C vs 0, A vs C, B vs D, all P < .001. 
For Cause of Death (1-7), A vs B, C vs D, all p - NS except for groups A vs 
B for (3,S,7) p < = O.OS. 
For A vs C, all p < O.OS except for (3,6) p NS; B vs 0, all P < O.OOS except 
(3,4,6,7) NS. 
These data suggest that without thrombolytic therapy females bave a bigber 
incidence of reinfarction, rupture and non-cardiac death as compared to 
males. rTPA therapy obliterates this gender difference in cause of death and 
significantly reduces overall mortality in both males and females. Sudden 
cardiac arrest as a cause of death is re9uced with rTP A therapy wbile 
cardiogenic shock and cardiac rupture occur more frequently. 
944·57 
Recombinant Hirudin for Unstable Angina: A Pilot Multicenter, 
Randomized Angiographic Trial 
James H. Chesebro, Valentin Fuster, Robert M. Califf, Robert A. 
Harrington, Neal S. Kleiman, Dean J. Kereiakes, Marc Cohen, Anthony 
Chapeliis, Herman K. Gold, Phillip Bear, A. Koneti Rao, Darrell 
Debowey, Darryl Schwartz, Marc Henis and Eric J. Topol, 
Massachusetts General Hospital, Boston, Massachusetts 
Coronary artery thrombosis plays an important pathophysiologic role in 
unstable angina and non-Q wave myocardial infarction. To date, heparin 
and thrombolytic therapy have not provided complete or consistent benefit. 
We hypothesIZed that recombinant hirudin, a direct thrombin inhibitor, 
would prevent accumulation of coronary artery thrombus in a manner 
superior to heparin. Patients with rest ischemic pain, abnormal 
electrocardiogram and baseline angiogram indicating a ~ 60% stenosis of 
a culprit coronary artery or saphenous vein graft with visual appearance 
of thrombus, were randomized to one of 2 different doses of beparin (N 
= 50) (either a target aP'IT of 65-90 sec or 90-110 sec) or one of 4 doses 
of hirudin (N = 116) (0.05, 0.10, 0.20~ or 0.30 mg/kg/hr infusion) in a 
dose-escalatins protocol. After 78-1011 hours of study drug, a repeat 
coronary angiogram was obtained and the paired study underwent 
quantitative analysis. The Ilrimary endpoints were changes in culprit 
lesion dimensions and TIMI flow grade. 
Recombinant hirudin led to a dose-dependent elevation of activated partial 
thromboplastin time (aPTT) which appeared to plateau at the 0.2 mg/kg 
dose. A higher proportion of hiruam treated patients had their aP'IT 
within a 40 second range (16% heparin versus 65-74% hirudin, P < 
0.001). The average lesional cross-sectional area improvement (mm') was 
maximal in the 0.20 mg/kg/hr hirudin dose group ana significantly greater 
than with heparin (p = 0.04). Overall, the change in cross-sectional area 
for heparin (0.08 mm') tended to be less than hirudin (0.31 mm2, 
P=0.08). Myocardial infarction was reduced from 8.0% in the heparin 
group to 2.6% in the hirudin group. Recombinant hirudin appears to be 
a promising anti-thrombotic intervention compared with heparin for 
inhibition of coronary artery thrombus. Large scale comparatives trials 
are warranted. 
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944·58 
The Dissociation of Microvascular and Myocardial Stunning After Acute 
Myocardial Infarction 
Neal G. Uren, Tom Crake, John Williams, Ranil de Silva, Petros 
Nihoyannopoulos, Graham J. Davies. Hammersmith Hospital, London, UK 
After successful recanalization for acute myocardial Infarction (MI) 
with thrombolysis, there is a reduction in the coronary vasodilator 
reserve (CVR) associated with reduced wall motion In the infarcted 
region. To investigate the relationship between the residual stenosis 
severity, the extent of viable myocardium, the CVR and wall motion, 19 
patients (mean1SD, age 59112 years) underwent dynamic pOSitron 
emission tomography with 1 SO-water, 713 days after transmural MI (11 
anterior, B inferior). Regional myocardial blood flow (MBF) at basal and 
after Lv. dipyridamole (Dip; 0.5 mg/kg over 4 min) was assessed in the 
infarct region and both the CVR (post·Dip MBF Ibasal MBF) and the amount 
of 1 5-0 water-pefused tissue determined, using the pertusable tissue 
index (PTI) as an index of myocardial viability). In 15 patients with 
successful reperfusion, coronary stenosis severity was measured with 
quantitative angiography and regional left ventricular function assessed 
by ventriculography and/or 2D-echocardiography, early (43142 days) 
and late (19112 months) after MI, with determination of an infarct wall 
motion score (WMS). Mean time to thrombolysis was 2311122 min. 
Residual mininum luminal diameter (MLD) was 0.B310.56 mm (71.4113.4 
%). MBF was 0.B010.21 and 0.9B10.46 ml/min/g at basal and post-Dip 
respectively, giving a CVR of 1.2310.45. Basal MBF and post-Dip MBF 
both correlated with the PTI (R=0.56 and R=O.sB, respectively, both 
p<0.05). PTI correlated inversely with the time to thrombolysis (R=-
0.67, p<O.Os). Infarct WMS correlated inversely with PTi (R=-0.S4, 
p<O.Os) but directly with time to thrombolysis (R=0.59, p<O.OS). 
Comparing patients with and without a recovery in infarct WMS, no 
association was found with MBF, CVR, PTI, or MLD. In conclusion. there 
is a relationship between coronary resistive vessel function and tissue 
viability in infarcted myocardium. Microvascular stunning (or 
vasodilator impairment) after MI is independent of myocardial stunning, 
suggesting that wall motion recovery is independent of resistive vessel 
injury after coronary occlusion/reperfusion. 
944·59 
Diagnostic Value and Safety of Early Adenosine TI 201· 
SPECT to predict severity of coronary atherosclerosis in 
patients with Unstable Angina. 
Jacques Helias, Coralie Cadiou, Jean-Noel Trochu, Jacques-Fran\X>is 
Godin, H6pital Laennec, CHU Nantes, France. 
We have prospectively used early Adenosine TI 201-reinjection 
SPEC[ (ATRS) to assess the extent of coronary artery disease (CAD) 
in patients (pts) recently hospitalized for unstable angina 
Between nov. 92 and aug. 93, we performed ATRS (with 
conventional oral therapy but discontinuation of IV-nitroglycerin, 
coffee and tea) in 69 consecutive pts without prior myocardial 
infarction (50 men, 19 women, mean age 62 ± 8 years) ,3 to 6 days 
after onset of symptoms.Adenosine infusion was perfonned following 
a two steps protocol (70 gamma.kg- 1.min- 1 during 1 min and 
140.gamma.kg- l .min- 1 during 5 min with TI 201 injected 2 min 
before the end).All patients were also investigated by coronary 
angiography (CA) and results obtained by comparison of these 
procedures following a double-blinded protocol. CA showed 40 pts 
with multi vessel disease (MVD), 20 pts with one vessel disease and 9 
pts without any significant coronary stenosis. 
Results :during adenosine infusion, side effects were frequent (85 % 
pts) but always minor and short (34 ± 29 sec). The presence of 
reversible defect (s) allowed correct identification of a significant CAD 
in 58/60 pts leading to a 94 % positive predictive value and a 71 % 
negative predictive value of ATRS for this purpose. ATRS with major 
and/or multiple defect(s) detected 38/40 pts with MVD leading to a 95 
% sensitivity and a 69 % specificity to diagnose severe CAD. 
Reversibility and/or extend of defect(s) identify 46/48 pts needing 
revascularisation and the absence of need for this therapy in 18/21 
leading to 94 % and 90 % positive and negative predictive value 
respectively. 
So, in patients with unstable angina, early A TRS is well tolerated. 
This procedure allows a correct identification of patients with severe 
and/or multi vessel coronary disease, and those who need 
revascularization. 
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944-60 
Coronary Angloscopy In patients with Acute Myocardial Infarction 
undergoing Direct Balloon Angloplasty 
*Hiroaki Hosokawa, Takahiko Suzuki. National Toyohashi Higashi Hospital, 
Toyohashi, JAPAN 
Coronary angioscopy was performed in 20 patients with acute 
myocardial infarction(AMI) undergoing balloon angioplasty(PTCA). PTCA 
was primarily done without thrombolysis. The time from onset to 
angioscopy was 8.0±8.4 (2 to 24) hours. Coronary arteries imaged were 
LAD= 12, RCA = 8. All vessels dilated showed no reocclusion at follow•
uP(FU). A total of 20 vessels were imaged at 47 distinct procedural time 
points including: pre-PTCA=17, post-PTCA=19, at 2 weeks to 1 . 
month(Earty FU)=8, and at 3 month to 5 month(Late FU)=3. Lesion 
morphologies observed included plaque color (yellow or white), surface 
texture of the plaque (smooth, rough, or ulcerative), intraluminal 
thrombus, and color of the thrombus (red, white, or red/white mixed). 
Results: 
Plaque Yellow W!ll1t ~ .Rw!sIb. ~ ~ 
Pre-PTCA 10(59%) 1(6%) 4(24%) 2(12%) 5(29%) 7(42%) 
Post-PTCA 18(95%) 1(5%) 1(5%) 4(21%) 14(74%) 0 
Early FU 7(88%) 1 (13%) 3(38%) 1 (13%) 4(50%) 0 
Late FU 2(67%) 1 (33%) 1 (33%) 0 2(67%) 0 
Thrombus f1:ewll.lW! Wllitt ~ 1lIlknllml 
Pre-PTCA 17(100%) 7(41%) 5(24%) 5(35%) 0 
Post-PTCA 18(95%) 7(37%) 2(11 %) 9(47%) 0 
Early FU 4(50%) 1 (13%) 0 3(38%) 0 
Late FU 1 (33%) 0 0 1 (33%) 0 
In 7{17(42%) pre-PTCA. angioscope was unable to cross the lesion due to 
occlusive plaque or thrombus. The color of thrombi pre-PTCA revealed all 
red/white mixed thrombi were present later than 3 hours from onset, 
while red and white thrombi were mostly present eartier than 3 hours from 
onset 
Conclusions:1) Yellow plaque underties AMI. 2) Ulcerative plaque was 
disclosed by PTCA and lasted long through FU. 3) The presence and color 
of thrombus may represent different types or different stages in AMI. 
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945-18 
Factors Predicting Long-Ter:. OUtcoe in Patients With 
Acute Myocarditis. 
Federico Valles, Manuel Anguita, Jose M. Ariz6n, Jose 
M. Latre, Diego Gimenez, franciSCO Torres, Manuel 
Franco. Hospital Reina Sofia. c6rdoba, spain. 
With the aim to study long-term outcome and clinical 
predictors of prognosis in patients with acute myocar•
ditis (AM), we have prospectively assessed 61 patients 
with AM diagnosed in our hospital in the last 7 years. 
Mean age was 29±14 years; 73\ of patients were male. 
NHYA class III or IV heart failure was present in 60\, 
and severe ventricular arrhythmias in 15\. Left ventri•
cular ejection fraction (LYEF) was 40±18\. Immunosupre•
ssive therapy was not used in any patient. After a mean 
follow-up of 24±18 months (range: 2-70), 8 patients 
(13%) had dead or undergone heart transplantation, 14 
(23%) had chronic dilated cardiomyopathy (CDCM) with 
LYEF <45%, and 39 (64%) had good evolution, with a LYEF 
>45%. LYEF rose at 1 month over 45% in 16 (43\) of the 
37 patients with initial LYEF <45%, while it only 
decreased in 3 (12%) of the 24 patients with initial 
LYEF >45%. Although initial severe heart failure, 
ventricular arrhythnmia and lower initial LYEF were 
significantly (p<O.Ol) associated with poor long-term 
outcome (death, transplant or evolution to CDCM), the 
more powerfull predictors of long-term outcome were 
related to the short-term, 1-month evolution: a lower 
1-month LYEF and a poor 1-month evolution predicted a 
non-favorable long-term outcome (p<O.OOl). Long-term 
outcome was poor in 78\ of patients with poor 1-month 
evolution and in only 5% of those with favorable 1-
month evolution (p<O.OOl). Data from this large and 
prospective series suggest that one-third of patients 
with AM have a poor long-term outcome (death, trans•
plant or CDCM), and that long-term outcome is mainly 
associated with short-term evolution. 
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945-19 
AbDonnai Left Ventricular Diastolic Function ID Symptomatic and 
Asymptomatic: Human ImmllllOdefidency Virus Carriers: Doc:umentatlon by 
Echo-Doppltr and Di&ltIzed M-Mode Measures 
Dominique de Zunere. Nicolas Coudray. Gilles Force. Dominique Cbampetier de 
Ribes. Jcan·Oaude Poumy.lsabc:lIe Antony. Yves Lecarpentier. Deuis ChemIa 
INSERMU251. HOpiIaI Bichat. Paris; INSERM U275. PaIaiswu.Frarre. 
IDlroduc:tIon: Human immunoddiciency virus (HIV) infcctioo (HIVI) at the AIDS 
stage is known to be frequently associated with LV regional or global systolic 
dysfunction. Several studies have shown that diastolic filling abnormalities may 
precede systolic dysfunction in the early stages of other diseases. The aim of the 
present srudy was to determine whether altetalion of left ventriaJIar (LV) diastolic 
function (L VDF) occurs in mv carriers (HIVC) without clinical symptoms of 
cardiac disease. Methods: Fifty-onc mvc were prospectively examined by 20. 
M-mode and DoppIer-echocardiography. and oompared to 2S healthy controls; the 
two groups were similar with respect to age. sex. heart rate, blood pressure levels. 
LV internal cavity dimensions. shortening fraction and indexed mass. The mvc 
group consisted of 28 asymptomatic subjects and 23 patients with ARC or AIDS. 
The pulsed Doppler parameters of L VDF included isovolumic relaxation time 
(lRn and 5 mitral outflow indexes: pc:ak velocity of early (E) and late (A) mitral 
outflow. FJ A ratio. EF deceleration slope (EF slope) and duration of early flow 
velocity wave (DF). We also measured 3 digitized M·mode indexes of LVDF: 
pc:ak rate of LV enlargement in diastole (D+). peak rate of posterior wall thinning 
(PW1). and peak velocity of lengthening of the posterior wall in diastole (PVL). 
Rosults: 
Controls HIVC HIVC /A HIVC/S 
(n=25) (n=51) (n=28) (n=23) 
E (emlo) 73:1:3 6$:t2' 66:t2 64:t2 
A (emlo) 49:t2 4$:tl 46:t2 45:t2 
E/A 1.$4:t0.08 1.$0:t0.0$ 1.$1:t0.07 1.49:t0.07 
IRT (IDS) 83:t3 91:t2' 93:t3' 90:t3 
DF (mo) 134:t$ 156:t4'" 157:t611 I54:t$ 
EF slope (mmls2) $$9:t27 429:t15'" 434:t21'" 423:024 
D+ (eml.) 15.0:t0.7 13.3:t0.$· 13.9:t0.7 12.6:t0.6 
PWT (eml.) 10.6:t0.5 8.9:t0.4" 9.$:t0.$ 8.1:t0.$§ 
PVL (emlo) 12.5:t0.$ 11.0:t0.4· 11. 7:t0.6 10.1:t0.$ 
HIVC/A= asympIomaIic HIVC; HIVC/S= symplOmalic HIVe. • p<O.OS." p<O.OI. , •• 
p<O.OOI: wlrole HIVC group versus c""/rots;, p<O.OS. II p<O.OI. II' p<O.OOI: HIVC/A 
W'rlW COfIIrots; § p<O.OS: HIVC/A versus HNClS. 
Condusion: LV relaxation and early filling dynamics abnorma1ities are present in 
mVl.not only at the ARC and AIDS stages but in symptom·free subjects too. The 
fact that hoth digitized M·mode and Doppler ultrasound were concordant in 
disclosing these LVDF alterations in mvc strengthens the relevance of our results. 
945-20 
Changes of Left Ventricular Systolic Function hy Quantitative Echo•
Doppler from a Prospective Long-term Controlled Study of HIV-Infected 
Patients 
Melvin D. Cheitlin. Laura Kee. Harry Hollander, Gunnard Modin, Carolyn 
Somelofski. Nelson B. Schiller. San Francisco General Hospital & 
University of California. San Francisco (CA) 
This is a prospective long-term study of changes in left ventricular 
function by echo-Doppler (echo) of 4 groups of gay men on entry: 
I =HIV-positive asymptomatic; II = with AIDS-related complex; III =AIDS 
pts; IV =HIV-negative healthy. All were recruited as out-pts. Serial 
exams and echos were done over 4 yrs. Average follow-up duration 
(mo)'1=355±160 11-305±16 111-165±12 IV=400±14 .. .. - -
Baseline (N) 1(58) II (61) III (74) IV (21) 
EDVI (cc/m2i 54.8±9.0 57.1 ±21.1 60.4±16.3 52.7±12.1 
ESVI (cc/m2) 17.7±4.3 21.3±20.5 22.0±12.5 16.5±4.3 
EF O.68±.O4 O.65±.08 0.65±.08 O.69±.O4 
LV mass (g) 186±25 184±34 187±40 183±30 
ESV/LV mass 
(cc/g) O.19±.O5 .022±.12 O.23±.12 O.17±.O4 
Tnere are no SIgnifIcant differences among groups at base Ine for these 
variables nor for variables reflecting diastolic function by Doppler. The 
final echo showed no significant changes in mean values from the initial 
echo by analysis of variance. 14 pts (12%) dropped EF 2. 1 standard 
deviation (SD) but < 2SD and 7 pts (4%) dropped EF by > 2SD. 
By Final Group (N) 1(34) II (29) III (87) IV (17) 
EF drop > 1 SD < 2 SD 2 3 8 1 
EF drop 2. 2 SD 0 1 4 2 
square there were no slgoo Icant lifferences amon rou S By Chi g g p in the 
percentage who dropped EF 2. 1 SD or even 2 SD. 
Summary: The fall in EF in HIV-positive pts is similar at different stages 
of HIV disease and in the HIV-negative gay men. 
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945·21 
Left Ventricular Dilatation in HIV Infection: the Role of Clinical 
Disease Stage and Zidovudine Therapy 
Hans·Michael Steffe"', Ralf MOiler", Bemd Salzberger, 
Gerd Fliitkenheuer, Matthias Schrappe, Reinhard Griebenow" 
Med. Klinik I and 2Med. Klinik II, University of Cologne, Germany 
It has been suggested that zidovudine toxicity may be related to the 
development of dilated cardiomyopathy in HIV infection. We carried 
out an echocardiographic study to assess myocardial structure and 
function in 61 asymptomatic pts (37.8±8.5 yrs) who were sero· 
positive for HIV·1 (WR·stage II: 6, III: 3, IV: 2, V: 25, VI: 25). Using 
digitized M·mode echocardiograms of the LV the following para· 
meters were determined: endsystolic and enddiastolic LV dimension 
(LVESD, LVEDD), fractional shortening (FS), peak normalized rate 
of change of dimension in systole and diastole (VeFs, VeFd), LV 
muscle mass (LVMI, Devereux's method). Pts were stratified 
according to their CD4+·cell count (A: ! 100/~1, n=30; B1: >100/~1 
and no zidovudine therapy, n=18; 82: >100/~1 and on zidovudine 
therapy, n=13). 32 healthy volunteers (34.7±10.6 yrs) served as a 
control group (e). 
A C 81 82 
LVEDD (mm) 51 ± 4 p<.05 49 + 4 49 ± 4 ns 50 ± 5 
LVESD (mm) 33 ± 4 p<.05 30 + 4 30 ± 3 ns 31 ± 4 
FS (%) 36 ± 6 ns 38 ± 6 38 ± 4 ns 38 + 4 
VCFs (cire/s) 2.68 ±.54 ns 2.84 ±.47 2.69 ±.35 ns 2.90 +.48 
veFd (cire/s) 2.97 ±.69 p<.01 3.44 ±.47 3.13 ±.49 ns 3.41 ±.66 
LVMI (g/m2) 173 + 35 ns 164 + 46 177 + 35 ns 173 + 33 
Pericardial effusions were found in- 9 pts (A:8, 81:1) and aCtive 
concomitant diseases in 18 pts (A:15, 81:1, 82:2). 
These data suggest that there is no clinically relevant cardia•
depressive effect of zidovudine. The risk of infective perimyocarditis 
increases with progressive destruction of the immune system, finally 
leading to dilated cardiomyopathy in some cases. 
945·22 
Increased Left Ventricular Mass, Rather Than Atrophy, is a Precursor of 
Cardiomyopathy in AIDS Patients Despite Significant Loss of Body Mass 
Hercules Panayiotou, Keith Ramsey, Mahesh Bikkina, Ahtisham Shakoor, 
Clara V. Massey Department of Medicine, University of South Alabama, 
Mobile, Alabama 
AIDS causes a dilated cardiomyopathy with increase in left ventricular mass 
(L VM). AIDS also causes marked loss in body mass and cachexia, secondary 
to starvation and anorexia nervosa, has been associated with cardiac atrophy 
and significant loss in L VM. The effect of weight loss on L VM in AIDS 
patients has not been previously reported. 
To determine if cardiac atrophy precedes appearance of AIDS 
cardiomyopathy, we measured L VM (M-Mode Penn Convention) and systolic 
function in AIDS patients (21 males, 6 females) with no clinical or echo 
evidence for heart disease or conditions that could affect L VM or LV 
function. rmdings were compared to age, height and pre-morbid weight 
matched controls (13 males, 10 females). Mean weight loss for AIDS males 
was 29.2 Ibs. (13.3Kg.) (18%, p < 0.001) and, for females, 34 Ibs (15.5Kg.) 
(23%, p < 0.0001). 
AIDS CONTROLS Jl..Yrm< 
LV MI (g/m2):males 108.3..±. 24.3 84.3 ..±. lS.l 0.004 
females 97.0..±. 12.2 S1.0 ..±. 11.4 0.019 
% fractional shortening: males 33.S..±. 6.3 38.7 ..±. 4.2 0.019 
females 34.2..±. 5.4 39.1 ..±. 3.4 0.041 
LVlD (em): males 3.5..±. 0.6 3.1 ..±. 0.3 0.033 
females 3.0..±. 0.4 2.9 ..±. 0.3 0.439 
Abbreviations: L VMI = left ventricular mass index, L VlD = LV systolic 
internal dimension. 
There was no significant difference in septal or posterior wall thickness or 
LV diastolic internal dimension. 
Conclusions' (1) AIDS patients with significant loss of weight and no cardiac 
symptoms show increases in LV mass and early depression of LV systolic 
function. (2) Preservation or increase in L VM, rather than cardiac atrophy, 
may be an early indicator of AIDS cardiomyopathy. 
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945·23 
Discordance of Right and Left Ventricular R..adeling in 
Active Myocarditis 
Lisa A. Mendes, Michael H_ Picard, G. Villiam Dec, Igor 
F_ Palacios, Deanna Mahoney, Ravin Davidoff for the 
Myocarditis Treatment Trial Investigators, Boston 
University Medical Center and Massachusetts General 
Hospital, Boston, HA 
Ve have previously shown that in active myocarditis 
(M) remodeling of the LV occurs with development of a 
spherical cavity. The response of the crescent shaped 
RV to M has not been described_ To study this further, 
echocardiograms performed within 5_8±1.0 days of 
initial biopsy in 34 patients with histologically 
proven M were analyzed. The long axis length (lax) and 
the mid-cavity diameter (mid) of the LV and RV were 
measured in cm, and the ratio of mid to lax was used to 
express a sphericity score (SS) with a value of 1 
representing a perfect sphere. Measurements were 
compared to 18 control (C) pts with normal LV and RV 
size and function. 
LV lax LV aid LV-SS RV lax RV aid RV-SS 
C 7.8±.2 4.2±.1 .54±.01 6.0±.1 2":'7±.T .45±.01 
M 8.2±_2 5.3±.1 .65±.01 6.6±.2 2.5±.1 _39±.01 
p 0.2 0.0001 0.0001 0.005 0.2 0.003 
LVEF < 50% was present in all 34 M pts of whom 
30 (88%) had a LV-SS greater than C mean. Conversely, 
RV dysfunction defined as fractional area change < 40% 
was present in 26 of 34 pts (76%), of whom 22 pts (85%) 
had RV-SS less than C mean. 
Conclusion: Ventricular dysfunction in active M is 
associated with increased LV sphericity while the RV 
predominantly elongates. Thus, early but discordant 
remodeling of the LV and RV occurs in M_ 
945·24 
Quantitation of Enteroviral RNA in Endomyocardial 
Biopsy by Competitive Polymerase Chain Reaction. 
Peter Liu, Tami Martino, Linda Penn, Michael J. Sole, c.c. 
Liew, Centre for CV Research, The Toronto Hospital, 
Toronto, Ontario, Canada 
Enteroviruses such as coxsackievirus B3 (CVB3) have 
been implicated in the pathogenesis of myocarditis and 
dilated cardiomyopathy. Reverse transcription polymerase 
chain reaction (RT-PCR) is a powerful dia~nostic technique 
for the detection of enteroviral mfection from 
endomyocardial biopsy. However it does not provide 
quantitative information. 
This study establishes an RT-PCR technique that can be 
used for quantitation of enteroviral RNA in clinical 
specimens. We created a standard RNA which was 
homologous to sequences at the S'-end of CVB3 genome, 
with the exception of a single base pair mutation which 
created a novel internal restriction site. Serial known 
dilutions of this standard template were mixed with a fixed 
concentration of CVB3 RNA, and amplified by RT-PCR. 
Since the templates were both present In a single reaction 
tube and competed for the same I'rimers, the ratio of 
standard and viral products remainea proportional during 
amplification. 
By this approach, a 4·fold difference in viral titre was 
clearly distinguishable. The quantitation was accurate down 
to extreme low levels of virus at 15 TCIDSO' 
We conclude that guantitation of enterovirus by 
competitive RT-PCR with an internal standard is feasible, 
accurate and very sensitive. Its application could prove 
useful in predicting the severity of the myocarditic process, 
patient outcome and the evaluation of efficacy of treatment 
against enteroviral infections. 
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946·62 
Impact Of Atrial Compliance On Pulmonary Vein Flow Reversal 
In Mitral Recurgitation. 
Randall Y. Grimes, Peter G. Wa1k«, Ajit P. YoglII&Ihan, Robert A. Levine. 
Georgia Inst. ofTecimology, Atlanta, GA. Mus. GenenI Hospital, Boston, MA. 
Systolic puImoIImy venous (PV) flow is primarily determined by IIriaI pmue 
events. As the atrium relaxes, IIriaI pressure decreases and creates • favonble 
gradient for forward systolic flow into the atrium. Howev«, the IIdditioul 
volume of regurgitation causes IIriaI JlIII68IIre to increase rapidly aod creates • 
pmue gradient favoring flow out of the atrium (PV flow revena1). Since the 
rise in pressure due to additional volume is determined by IIriaI compliance, -
tested the ~ that the 1I""""R II!d mapl!M!e of flow ImQIl is nqt gg1y 
• ftmctiOQ of I'eJlQitmt yoIume Imt dmmde on atrial rorgpI;8Df& II well. 
Method: A mathematics1 mode1 of an atrium with varying complianoe and PVs 
was developed. The IIriaI preasure-vohune (~1ianoe) Je1atioosbip was modeled 
as an exponential function: initia11y npidly increasing compliance (llrial 
Jelaxation) which then decreued I8I1ria1 volume iD:reued. A simplification of 
the Navi«·Stokes fluid flow equations was used to solve for PV velocities that 
Ie8IIIt from the developed pmue gndient. Using an initialllrial volume of <40 
cc (nonraI), the modeling was performed ov« a range of initialllrial ~1iaDI:es 
(C = 3-10 cclmmHg),with and without the addition of • regurgitant jet. 
Results:The mode1 tealistically IIimuIated the systolic PV waveform in 
magnil!M!e and morphology. As the volume of regurgitation incrrued, peak flow 
velocity decreased, aod evmtually late systolic flow 1 00 with. regurgitant jet 
Jeversal occurred. Howev«, the preseoce aod -;;-
magnil!M!e of flow reversa1 WI8 detamined by e 8 0 
atrial comp1ianoe. As the initialllrial compliance ~ 6 0 
decreased, the msgoitude of flow revena1 increased, ;.-. 
because higher atrial pressures were developed aod .-= 4 0 
promoted flow out of the atrium into the PV s. 15 
Conclusion: PV flow reversal depends onllrial ~ 20 
compliance as well as regurgitant volume. As 
initial atrial compliance decteases (atiffec atria), the ~ 0 .f4-------Ir 
likelihood of flow revena1 increases. As a result, 
flow reversa1 is mon: likely in acute compared to -2 0 +""""-r-""""r-...., 
chronic regurgitatiOll because the atrium is less 0.0.0. , 0 . 2 0 . 3 
compliant. Time (sec) 
946·63 
Qinical Outcome in Pros!betic Valve Fndoclll1litis .. Compared 
With Native Valve Endoclll1litis in !be Era of Transesopblceal 
Echoclll1liography 
Richard Schulz, Gerald S. Werner, Heinrich Kreuzer. Dept. of 
Cardiology, Georg-August-University, Goettingen, Germany 
The aim of this study was to determine the prognosis of the in•
creasing number of patients with prosthetic valve endocarditis (PVE) 
in view of the improved diagnostic accuracy achieved by 
transesophageal echocardiography (TEE). 
We studied a cohort of 78 patients with a diagnosis of PVE (n=22) 
or native valve endocarditis (NVE, n=56) by transthoracic echocar•
diography (TIE) supplemented by TEE. PVE more often occured in 
females (60% vs.37%;p<0.05) who tended to be older (64 vs. 56 
years). The interval between onset of symptoms and hospital admis•
sion was similar, but the hospitalization was longer in PVE (71±50 
vs. 53±39 days; p<0.05). Vegetations were found by TIE in 36 pa•
tients with NVE, but in only I patient with PVE (sensitivity 64% vs. 
5%). TEE yielded a positive result in 82% of patients with NVE, and 
it detected a finding indicative of endocarditis in 73% of patients 
with PVE. In patients with NVE a trend for more embolic events was 
observed (36% vs. 18%), whereas the anticoagulation in PVE seemed 
to have a favorable effect on this complication. Accordingly, TEE 
more often demonstrated large pedunculated vegetations prone to 
embolism in NVE (50% vs. 32%; p<O.05). Nevertheless, in-hospital 
mortality as a whole did not differ between the groups of PVE and 
NVE (14% vs. 18%). This was probably due in part to a better visu•
alization of vegetations by TEE leading to earlier diagnosis and 
appropriate medical therapy. Surgical therapy was required in 71% of 
patients with NVE and in 48% with PVE. 
PVE was not linked to a higher in-hospital mortality when compared 
to NVE as suggested by earlier studies. This improved outcome 
might be attributed in part to the improved diagnostic yield of TEE. 
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946-64 
Left and RIght Ventricular P«fonnanc:e Early and Late After Mitral Vain 
Repair Versus Mitral Valve Replacement for Mitral Reprgltatlon 
Detlef Wencker, Jeffrey S. Borer, Clare Hocbreiter, Phyllis Supino, Richard 
Devereux, Mary Roman, Paul K1igfield, Gtegory CbIouverakis, Cornell Medics1 
Center, New York, NY 
The IIlItUr8I history of right(R) and left(L) ventricu1ar(V) ejection fraction(EF) 
after surgics1 correction of chronic nonischemic mitral regurgitalion(MR), and 
the effects of mitral valve teplacement(MVR) VI MY tepair(r) on early VI late 
post-op RVILV EF, are incompletely defined. nemore, in prospectively 
studied pts with MR who underwent MVR or MYr, we compared LVIRV EF 
81 JeSt and exercise(ex) preop vs < I yr post-op VI 4-7 yn post-op. For all 27 
pIS (21 studied with ex), LVEFJeSt and ex were uncbanged from preop (SI % 
and SI %) to late post-op (SI % and 54%, NS, NS), while RVEFJeSt and ex rose 
(from 37% and 34% 1047% and 46%, p<.OOOI, p<.OOOI). For the 17 pIS 
with both early and late post-op measurements, 
preop < I yr post-op 4-7 yn post-op 
MVR LV ... , SO% p<.OO8 43% NS 44% 
n=11 LV", 48% p<.08 44% NS 48% 
RV ... , 36% p<.02 43% p<.IO 4S% 
RV.. 34% p<.02 44% NS 47% 
MVr LV ... , 51 % NS 51 % NS 53% 
n=6 LV.. 49% NS 45% NS 51 % 
RV.... 40% p=.01 49% NS 47% 
RV.. 33% NS 43% NS 43% 
Thus, RV response is Iimilar early and late post-op for MVR and MVr. 
However, MVr causes more rapid and complete restitution of LVEF to preop 
level than does MVR. 
946·65 
Reduced Need for Subsequent Mitral Valve Replacement FollOwing 
Inoue Balloon Mitral Commissurotomy Compared With Non-Inoue 
Methods Despite Similar Procedural Success 
John S. Wilson, Steven E. Hearne, J. Kevin Harrison, Katherine B. 
Kisslo, Cynthia H. Pierce, Charles J. Davidson, Peter Van Trigt III, 
Thomas M. Bashore, Duke University Medical Center, Durham, NC 
Thus far, no studies have shown a relationship between balloon type 
and need for subsequent mitral valve replacement following balloon 
mitral commissurotomy (BMq. The present study evaluated 164 
consecutive patients undergoing BMC, 101 with the Inoue balloon and 
63 with either single (n=12) or double (n-Sl) balloons. The groups 
were similar in baseline hemodynamics and clinical characteristics. 
Procedural success was defined as either final mitral valve area (MVA) 
> l.Scm2 or a > SO% increase in MVA and no increase in mitral 
regurgitation (MR) of ~ 2 grades. We examined whether balloon type 
affected the need for subsequent mitral valve replacement. Only 
patients who had reached the followup anniversary or underwent mitral 
valve replacement were included. Followup was 99% complete. 
lnl!IlIl IiIlD-lnllus:: JUillIl: 
Acute Success 78/100(78%) SO/62(81%) NS 
Increase MR ~ 2 grades 9/101(9%) 4IS9(7%) NS 
Mitral Valve Replacement 
Emergently 21101(2%) 2/63(3%) NS 
6 Months 4179(5%) 12/63(19%) .009 
1 Year 8IS4(IS%) 16/63(25%) .16 
Although acute procedural success was similar with the two methods, 
the need for MVR within the first 6 months was significantly less using 
the Inoue balloon. This trend persisted at 1 year after BMC. These 
results suggest that additional factors other than acute hemodynamic 
success may be important in predicting long-term outcome following 
percutaneous balloon mitral commissurotomy. 
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946-66 
What can be Done for Symptomatic Restenosls After 
Percutaneous Mitral Commissurotomy? 
Bertrand Connier, Bernard lung, Olivier Nallet, Jean·Marc 
Porte, Joseph Elias, Alec Vahanian, Jean Acar • Cardiology 
Department - Tenon Hospital, Paris, France. 
The results of the different procedures which may be 
performed in patients (pts) with symptomatic restenosis (R) 
after successful percutaneous mitral commissurotomy (PMC) 
were assessed in 28 pts with R after PMC (final valve area 
(VA) 1.9±.3cm2 [1.5-2.7] without mitral regurgitation 
(MR) > 2/4). 
At the time of R, 3 pts were in NYHA class II and 25 in class 
m. After echo examination, pts were divided in 3 groups (Gr): 
2 (7%) had pliable valves and mild chordal thickening (Gr I), 
15 (53 %) pliable valves and extensive subvalvular disease (Gr 
II), and 11 (39%) calcified valves (Gr Ill). V A was 
1.l±.2cm2 [.7-1.3] as assessed by 2D echo, and MR grade 2/4 
was present in 3 pts. 
Treatment of R was performed 31±17 months [6-74] after 
PMC. Valve replacement (VR) was carried out in 16 pts (57%) 
because of valve calcification (10), significant MR (3) or 
subvalvular disease (3). Two post-operative deaths occurred. 
Open-heart commissurotomy was successfully performed in 2 
pts in Gr n. Re-PMC was performed in 10 pts (2 in Gr I, 7 in 
Gr II, and 1 in Gr m). After the procedure, V A increased from 
1±.2 to 1.9±.3cm2 (p<.OOOI) without complication. After a 
mean follow-up of 21 ±19 months [1-63], 9 pts were symptom•
free while 1 pt with calcified valves required operation 63 
months after re-PMC. 
Thus, in pts with symtomatic R after PMC, VR is necessary in 
cases with extensive valve damage, while re-commissurotomy 
mainly percutaneous appears to supply good initial and mid•
term results providing anatomy remains acceptable. 
946-67 
Vasodilator Therapy In Cbronlc AortIc Regurgitation: Enalapril Versus 
Hydralazine 
Mike Lin, Hung·Ting Chiang, Shoa·Un Lin, Benjamine N. Chiang, Melvin D. 
Cbeitlin, Department of Emergency, China Medical CoDege Hospital, Department 
of Medicine and Veterans General Hospital and National Yang.Hing Medical 
CoDege, Taicbung, Taiwan. 
Vasodi1ator therapy in severe aortic regurgitation (AR) deereases LV end 
diastolic (L VEDVI) and end systolic volumes (L VESVI) and increases ejection 
fraction (EF). Angiotensin converting enzyme inhibitors (ACEI), have a 
theoretical advantage over pure vasodilators. 74 Asymptomatic AR patients were 
randomized, 37 to enalapriJ (E) 20 mg BID and 37 to hydralazine (H) 100 mg 
BID. 2-D Echos were done at baseline, 6 months, 1 year. Plasma renin activity 
(PRA) and aldosterone levels (A) were also done. Heart rate was stable. Systolic 
and diastolic BP deere &sed uaU 'bE dH I CQl uy WIt an 
E Base E 1 Year HBase H 1 Year 
LVEDVI (cc/m2) 
++ 
124:t 23 10S:t 22 122:t 25 118:t 24 
L VESVI (cc/m2) 
M 
5O:t 18 39:t 19 49:t 20 44:t 19 
EF(%) 6O:t15 64:t 18 6O:t20 62:t 20 ... 
LV mass 13O:t 24 110:t 23 128:t 20 124:t 25 
(Gm/m2) 
.... # ++++ 
LV wall stress 389:t 38 306:t 29 391 :t 40 317:t 38 
(K·dvne/cm2) 
• + • PRA (mll/ml/br) 1.10:t 0.92 2.00:t 1.54 1.49:t 1.40 4.50:t 7.70 
+++ 
A (ngjdl) 2O.8:t 12.3 16.2:t 8.2 18.1:t 14.6 33.1:t 22.8 
ConclUSIOn: E m the dose used was more effective m redUCing LV volumes than 
H in patients with moderate to severe AR. E limited the rise in PRA and 
aldosterone compared to H whicb may be advantageous in reducing LV mass and 
limiting sodium retention. Sig: + p<O.5; + + p<.Ol; + + + p<.005; + + + + 
p < .001 compared with Base. 
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947·78 
367A 
Penlllrltlon of Atrioventrlcullr Nodal Reentrant Circuit During AtrIal 
Extraatlmulatlon WIthout Rnattlng Tachycardia Cycle Length: Further 
Inslghtllnto the Anatomic Boundary of Reentry 
Mohammad Jazayerl, Mansour Moghaddam, Sanjay Deshpande, AbdIJ 
Wase, Michael Biehl, Brenda Banks, Andrea Natale, ArMer Dhala, JesbIr Sra, 
Masood Akhtar, Sinal SamarItan MedIcal Center, Mlwaukee, WI 
Introduction at a premaIUr8 atrial Impulse (AJ during atrIaventrIctW 
nodal reenII'IIIt tachycardia (AVNRT) may reseI the tachycardia cycle 1ength 
• the A. penalr8tes the ~ cIrcutL The I'IIS8ltlng phellOI1I8IIOn Is 
considered to have 0CCUIT8d • the Interval between the His bundle potential 
(H) corresponding to the A. (HJ and the next tachycardia H Is dllleren! then 
the tachycardia cycle length (H-H). At certain coupling IrUrvela, however, 
the A. may fBI to reseI AVNRT evan though • depolarlzes the pertnocIal 
atrium. ThIs "no resetting' phenomenon (NRP) has been edvocated as the 
most compelling evidence against atrial partlcipatlon In the AVNRT circuit 
We, therefore, hypothesized that • auch an Interpretation was valid, A. 
associated with NRP would not penetrate the AV node. 
FIfteen patIenta (pis) with common AVNRT and constant tachycardia cycle 
length were Included. The mean H-H was 354 :t 51 maec (range 260-460 
maec). Pacing was perfonned from the proximal coronary sInus. A. was 
lnkiaIly lnIrocIuced In late diastole and .. coupling 1nteIV8l (A-AJ was 
progressively decreased by 10 maec l1'1li atrial refractoriness was 
encountered. H-H Intervals 1nvnecI1ate/y preceding A. and those during 2 
cycles 1nvnecIlately after A. (H-H. and H.-H) were analyzed. 
Results: Four patterns at rasettlng (H-HJ.(H-H) were observed: 
Increasing (7 pis), decreasing/increasing (4 pis), decreasing (2 pis), and ftat 
(2 pis). At critical A-A., 1nt8lV8ls. NRP (l.e.,(H-H.) K (H-Hlt was observed In 
8 (53%) pis. However, two obseMIIIons strongly indicated a persistent AV 
nodal penetration despite NRP. I) 5 pis had (H.-H).(H-H) < -5. 2) All 8 pis 
exhibited resumption at resetting or AV nodal block at A. at shorter A-A., 
1nt8lV8ls. 
Conclusion: ~RP may occur when the degree at A. prematurtty Is 
identical to the magnitude at 1.o-H.lengthanIng. This phenomenon does not 
necessaray mean a loss at AV nodal penalr8t1on nor does • exclude atrial 
participation In the A VNRT circuit. 
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947·79 
Does Adenosine Help to Differentiate aet.een 
Retrogrsde AV Node and Retrograde Acceaaory 
Connection Conduction? 
Jane E. Crosson, Chuen Tang, Susan P. Etheridge, 
Peter S. Hesslein, Sim6n Milstein, Ann Dunnigan. 
University of Minnesota and Minneapolis Heart 
Institute, Minneapolis, MN 
This study evaluated the usefulness of 
adenosine to differentiate between retrograde 
conduction over the AV node and accessory AV 
connections (AC) in pediatric patients (pts), age: 
13 ± 5 years (mean ± SD). Nineteen pts with 
electrophysiological1y demonstrated retrograde AV 
nodal conduction and 8 pts with 
electrophysiologically demonstrated retrograde AC 
conduction received adenosine by central intravenous 
administration during ventricular pacing at a cycle 
length 40 msec greater than the shortest cycle 
length supporting 1:1 ventriculoatrial (VA) 
conduction. Pts <50 kg received bolus doses of 50-
250mcg/kg until VA block occurred. Pts >50 kg 
received a 6 mg dose, followed by 12 mq if VA block 
did not occur. 
In 19 pts with retrograde AV nodal conduction, 
adenosine administration resulted in VA block in 15, 
while 4 did not have VA block. In 8 pts with 
retrograde AC conduction, 2 pts had VA block, while 
6 did not. The sensitivity of adenosine to predict 
route of VA conduction was 79%, and the specificity 
was 75%. 
Thus, the presence or absence of VA block with 
adenosine cannot be used as a conclusive test in the 
evaluation of the route of retrograde conduction. 
947·80 
Unusual Features of Intermediate Septal Bypass 
Tracts: Multiple Ventricular Insertions? 
John M. Miller, Steven A. Rothman, Henry H. Hsia, Alfred E. Buxton 
Temple University, Philadelphia, PA 
We have observed several unusual phenomena in patients with 
Wolff·Parklnson·Whlte (WPW) syndrome due to so· called 
"Intennedlate" (located between the coronary sinus os and His) 
septal bypass tracts (IBT), Including 1) sudden prolongation of 
the stimulus-delta Interval of >10 ms over a range of Incremental 
atrial pacing rates, 2) slight changes In delta wave morphology 
associated with the Increase In stlmulus·delta Interval, 3) 
eltherlboth of these chanQ8S occurring also during radiofrequency 
ablation. Among 78 patients undergoing ablation for WPW, 10 
had IBT; all IBT patients had ablation from the atrial side of the 
tricuspid annulus. 
'The increase In the stimulus-delta interval (which ranged from 12· 
59 [mean 34] ms at paced cycle lengths from 600 ms to block in 
bypass tract [380 to 260 msJ) occurred suddenly rather than 
gradually, OCCUlTed with a change in the delta morphology, and 
was not due to varying degrees of fusion with nonnal pathway 
conduction. Two patlents also showed discrete changes in 
retrograde conduction Intervals with rapid ventricular pacing. 
Concfusions: 1) some IBTs have unique properties compared to 
other BTs and 2) these features are best explained by multiple 
branching ventricular Insertions with different conduction 
properties. Although anatomically related to the atrioventricular 
node, the physiology of IBTs is not consistent with an integral 
connection to the node. 
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947·81 
Atrial Fibrillation in tbe Elderly, i. tbe ... e 
~b.r.p.utic Strategy Fea.ible? 
Isabelle C. van Gelder, Harry J.G.M. Crijns, Wilfred 
F. Heeaen, A.T. Marcel Gosselink, Hana Hillege, Kong 
I. Lie. Dept. of cardiology, Thoraxcenter, University 
Hospital Groningen, The Netherlands. 
Due to ageing of the population atrial fibrillation 
(AF) has become an increasing problem. ~he aim of this 
.tudy was to aS8ess difference. in outcome in younger 
« 70 years, n-243) and older (~ 70 years, n-10l) 
patients with chronic atrial fibrillation (AF). All 
patients underwent at least 1 electrical cardioversion 
(CV). After CV antiarrhythmic drugs were initiated 
during sinus rhythm (SR) according to a aerial 
treatment protocol. Follow-up (FU) of all patients was 
42:17 months. More older patients were female 
(P<0.001), suffered from coronary artery disease 
(p<0.001) or hypertension (P<0.05) aa underlying 
disease, and were in a higher N~HA class for exercise 
tolenncl! (P<0.001). Previous duration of AF (33±63 
versus 32±ll months) and left atrial size (46:8 versus 
45±7 mm, long axis view) were not significantly 
different. 
Overall 67\ had successful CV and 30\ maintained SR 
after 8erial treatment. Success of CV was related to 
duration of AF and not to age. Maintenance of SR after 
CV was related to age (p2 0.003), duration of AF 
(p2 0.Ol) and left atrial 8ize (p=0.03, multivariate 
analYSis). Using Kaplan Meier survival curve8 
mortality was significantly higher in the elderly (20\ 
versus 16\), due to progresion of the underlying 
disease and non cardiac causes. Mortality during SR 
and during AF was not statistically different. 
These data indicate a lower maintenance rate of sinus 
rhythm in the elderly accompanied with higher 
mortality rates irrespective of arrhythmia outcome. 
This warrants less aggressive antiarrhythmic 
strategies in the elderly. 
947·82 
IDtraveDoul PropafeDoDe ID ParollYlmal Atrial FlbrillatloD: a 
RaDdomlzed, Placebo CODtrolled, Double Blind, MDltlceDt..., 
Cllalcal Trial 
Alessandro Prodana-. Manuela Miorelli. Alessandro Pavan. Alfredo Via:ntini. 
TWlio MOIgon. Daniela Pavan 00 behaf rL tbc PAFIT·2 investigalcn, 11aIy. 
Aim of Ibis study was to compare intmvalOUS propaC_ (PR). a class Ie anti•
.mythmie &galt, to placebo (PL) in paroxymal aaiaI fibrillalioo (P AF) rL ftlCeDt 
ooset (<72 boon). We llIDdomIy aUocab:d 75 patients. aged 18 to 70. with PAF to 
receive intravenous PR (2 mglkgin 15 miDJta and then I mglkg in two boon) or 
tbc matdIing PI. Patients were f<Jllowed for three hours. ExcIusioo airaia w""': 
clinical heart failure. recent acute myocardial inCarctioo, hypoleoSioo, A V block, 
WPW. anart _ with mti-arythmieagm\S ordigilalis. 
RESULTS. No sign rLheart disease were detected in 74.7% rL the nmdomized 
patients. EdlocmIiografically detcnnined Jc{t Blrium diamcotcr Will simiIarin tbc 
two groups. Coovcrsioo tosinllS rytbmoccum:din2401ttrL 41 patients aIIoa!1ed 
to PR and in 10 out of 34 patients allocated to PL (Odds Ratio 3.2 95% 
Confidence Intervals 13·7.9). The odds of returning to sinus rhythm were 
significantly greater for PR treaIed patients (p<O.OI). For those who RfUmed to 
S)1I1IS dJytbm, tbc delay between the nmckmizaIioo and ooovcrsioo was 34:t29 and 
71:tS5 minutes respectively for PR and PL. Mean heart rate in patients wbo did 
DOl return to sinus rhythm decreased fran 146 beals/minute to 109 beals minute 
for patients treaIaI with PR wmJe tanained uodJaogaIfor PI. 
<X>Na..USIONS.lnllaveDOUS PropaCeoooe is an dfective tbcrapeutie option for 
","loring synllS dJythm in patients with P AF of ftlCeDt onset. Its use is ... sociated 
with bigboo" and quicker mIIOlaIioo rL tbc sims rytbm CXJIIIIHI'd to Placebo. 
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947-83 
Double Potentials Recorded in the Superior Vena Cava During 
Sinus Rhythm: Physiological or Pathological? 
Masashi Inagaki, Tohru Ohe, Yoshio Kosakai, Wataru Shimizu, 
Takashi Kurita, Naohiko Aihara, Shiro Kamakura, Katsuro 
Shimomura, National Cardiovascular Center, Osaka, Japan 
Double potentials (DPs), defined as two deflections separated by an 
isoelectric interval, have been observed in the abnormal conduction 
area and linked to the occurrence of tachyarrhythmias. Recently, we 
found that DPs could be recorded in tbe superior vena cava (SVC) 
during sinus rhythm (SR). The purpose of this study is to investigate 
the incidence and the genesis of DPs recorded in SVC. In 8 patients 
(pts) with atrial arrhythmias and 5 pts without atrial arrhythmias, 
detailed endocardial mapping was performed in SVC and the right 
atrium (RA) during SR using a bipolar electrode catheter with an 
interelectrode distance of lOmm. Electrograms of SVC, the high right 
atrium (HRA), and the coronary sinus(CS) were recorded 
simultaneously during extrastimulus studies from HRA. In 2 other pts 
without atrial arrhythmias, intraoperative epicardial mapping was 
performed during SR, RA appendage pacing, and the left atrium (LA) 
appendage pacing. Results: DPs (labeled the early component as X 
and the late component as Y) were recorded in the lower SVC during 
SR in all pts with and without atrial arrhythmias. The DPs interval (X 
- Y interval) was widened by shortening the coupling interval of 
extrastimulus. The conduction interval curve of X to extrastimulation 
was similar to that of HRA electrograms and the conduction interval 
Curve of Y was similar to that of LA electrograms (recorded in CS). 
In the intraoperative epicardial mapping studies, DPs were recorded 
in the lower posterior part of SVC (between RA and LA). The 
activation time of X was always similar to that of adjacent RA 
electrogram, and the activation time of Y was always similar to that 
of adjacent LA electrogram during SR and pacing studies. 
Conclusions: (1) DPs recorded in the SVC during SR are 
physiological and not related to atrial arrhythmias. (2) The early 
component of DPs represents an adjacent RA potential and the late 
component of DPs represents an adjacent LA potential. 
947-84 
Effect of Adenosine on Atrial ActIvity During Atrial Fibrillation 
Mario D. Gonzalez, H. Andrew Hazlit\, James H. McClelland, Karen J. Beckman, 
Xunzhang Wang, Hiroshi Nakagawa, Lawrence E. Widman, Hein Heidbuchel, 
Ralph Lazzara, Warren M. Jackman, Univ. of Oklahoma, Oklahoma.City, OK 
The mechanism of atrial fibrillation appears to be random reentry of multiple 
wavelets. Adenosine shortens action potential duration in the atrium and could 
therefore modify this arrhythmia. We studied the effect of adenosine on the atrial 
electrical activity during atrial fibrillation. Adenosine (12 mg) was injected as a bolus 
in 8 patients (mean age: 44±15; 7 males) during electrically induced atrial 
fibrillation. All patients had no apparent structural hear1 disease and 5 had 
antegrade conduction through an accessory pathway. Peak atrial adenosine effect 
was observed 20:12 seconds after the injection. The mean cycle length of the atrial 
activity in the right atrial appendage (RAA), His bundle region (HB) and left atrium 
(CS) was measured in 3 second periods before, during, and after adenosine (table 
and figure). Adenosine shortened atrial cycle length in all 3 sites, greatest in the 
RAA. Atrial fibrillation did not terminate in any patient despite abrupt increase in 
atrial cycle length at the end of adenosine effect. 
CONTROL 
RAA·t f j r 
~~ v v v 
ADBNOSINE 200 ml 
RAA-ttT t-H H t t t 
HB 'i' i ~ , ~ . cs
Baseline AdenosIne Recovery 
RAA 159! 10 84+ 6*0 167! 15 
HB 168!20 116! 17' 181 !23 
CS 164! 15 lOB! 16' 169! 9 
'psO.05 VI baseline; ·psO.05 VI other arial siles 
Conclusions: Adenosine accelerates the atrial rate during atrial fibrillation, probably 
by shortening refractory periods. This response is not uniform throughout the atrial 
myocardium. 
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947-85 
Effects of Enhanced Vagal Tone on Fut and Slow Pathway Conduction 
During AV Nodal Reentrant Tachycardia 
Michael K. Betz, Bruce S. Stambler, Mark A. Wood, Kenneth A. Ellenbogen, 
Medical College of Virginia and McGuire VA Medical Center, Richmond, VA 
Seventeen patients with AV nodal reentrant tachycardia, AVNRT, were 
studied to determine the effects of enhanced vagal tone on tachycardia cycle 
length (TCl), and fast and slow pathway conduction. carotid sinus 
stimulation was performed during invasive electrophysiology study with 
maximal neck suction (NS) at ~O mm Hg. We measured TCL, antegrade 
slow pathway conduction - AH interval, and retrograde fast pathway 
conduction - VA interval, immediately before and during epiSodes of neck 
suction. Six patients with typical AVNRT received edrophonium (edro) during 
AVNRT and NS protocol was repeated. Intervals before and during NS 
before and after edro were compared. 
rg,(ms) AH(ms) 
Control (n=l7) 371.4 263.9 
NS (n=l7) 383.4' 276.9' 
edro (n=6) 409.8 321.0 
NS w/edro (n=6) 425.8' 337.2' 
('p<0.01 for control vs. NS and edro vs. NS w/edro) 
~(ms) 
26.5 
26.0 
24.9 
25.3 
AH intervals increased by 13:1:3.5 ms (mean:l:SEM) during baseline NS and 
by 16:1:7 ms compared to baseline after edro (p=0.3). Six of the 155 
applications terminated tachycardia by blocking antegrade slow pathway 
conduction after decremental slowing. The VA interval was not prolonged 
during any of the neck suction applications, before or after edro. There were 
3 episodes of VA block during NS after edro without any decrement in 
conduction preceding block. These data suggest that enhanced vagal tone 
by NS and edro effects antegrade slow pathway conduction in a decremental 
and similar fashion and retrograde fast pathway conduction in a 
nondecremental fashion during AV nodal reentrant tachycardia. This is 
further evidence that the retrograde fast pathway is physiologically dissimilar 
to the antegrade slow pathway. 
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Gender Dift'erences in QRS Dw'atioa ud Voltage: Reiatiomhip to the 
EIec:trocardiograpbic ldentif'acation or Left Veatricular Hypertropby 
Peter M. Olein, Mary 1. Roman, lticlwd B. Devereux, Paul Kli,field. Cornell 
Mediw CeGIer, New York, NY. 
Difl'ermcel in QRS duntiOll IIIId voltage between _ IIIId WOIDaI with UId 
wilbout left ventricular hypertrophy (L VH), IIIId the reIationabip of 1I01101ie< 10 
perfOl'DWl<:e of otandanI EOO criteria for the detection of L VH was .-ed in 
112 _ IIIId 277 _. LVH (iDdeud LV .... > 110 .,.,,;. in _ IIIId 
> 125 ".,,;. in men) was .,.-t in 47 _ IIIId 69 _. Usina two-way 
aalyus of variaDce to mjllll for the pr-.ce or abIence of L VH, Iiaoificant 
differax:eo were fOUDd between _ IIIId women for QRS dunliooi. IIIId voltaaes. 
Amonll subjecta with IIOIDIa! LV IIIISI, men bad 100000er QRS duntioa (94 vs 87 
DIS, p<O.OOl), hillber CoraeU voltage (1,506 vs 1,378 ",V, p<O.OOI) IIIId hi,ber 
12-leod IUID of QRS voltaae (14,833 vs 13,759 ",V, p<O.OOS) than women. 
Similarly, amonll IIlbjecta with L VH, men bad Ionaer QRS duntiOll (108 vs 97 
DIS, p<O.OOI), hillber CoraeU voltage (2,601 vsl,988",V, p<O.OOI) IIIIdbiJIber 
12-leod sum of QRS voll_lIe (20,482 vs 19,002 ",V, p<O.OOS) than women. 
After Idjustment by aalysis of covariance for the JIreaIer LV internal dimension 
in diastole, the ,reater LV wall thickness in diastole, ..... the greater body surface 
uea and body mass index in men than in women, significant differences between 
men IIIId women in QRS duration IIIId the 12-lead sum of QRS vollaJle persisted 
both in normal subjecta without LVH (94 Vs 90 DIS, p<O.Ol; 14,818 vs 13,808 
",V, p<O.OS) ..... in subjects with LVH (108 vs 97 DIS, p<O.OOS; 21,192 VI 
17,959 ",V, p<0.05). Compari8Oll ofareuunderrec:eiver operatin,cbancteristic 
curves cIemonstraIed IUperior performance of QRS duration (0.83 vs 0.78), 
Cornell voltage (0.81 vs 0.72)1IIId the 12-lead sum ofQRS voltage (0.86 vsO.80) 
for the identification ofLVH in meA than in women (each p < O.OS). Thus, .ender 
differences in QRS voltage IIIId duration persist even after Idustment for gender 
differences in body size, obesity, and cardiac dimensions, IIIId ECG criteria for 
LVH have lower accuracy in women even when ,ender differences in partition 
value selection are taken into lCCOunt. 'These findings indicate • need for more 
_te, lIfiIIder-specific ECG criteria for the detection of LVH and lIl,gest that 
factors other than LV dimensions ..... body size play a role in the observed 
differences in QRS voltap; IIIId duration between men ..... women. 
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948·51 
Electrocardiographic Identification or Left Ventriaalar Hypertrophy: 
Relationship or Test PerrOl'llUlllt.e to QRS Duration and Validation or 
the Voltage-Duration Product 
Peter M. Okin. Mary J. Roman. Richard B. Devereux. Paul K1igfield. 
Cornell Medical Center. New York. NY. 
To further assess the contribution of QRS duration to the ECG 
identification of left ventric:ular bypertropby (L VH). 12·lead ECGs and 
echoeardiograpbic LV mass index were compared in 389 patients. L VH. 
defined as indexed LV mass > 110 glm' in women and > 125 glm' in 
men. was present in 116 patients. Voltage4uration products were 
calculated as the product of QRS duration and Cornell voltage (Cornell 
product) and the 12·lead sum of QRS voltage (l2·lead product). In a step•
wise logistic regression model that also induded Cornell voltage. Sokolow•
Lyon voltage. age and gender. QRS duration remained a bighly significant 
predictor of the presence of LVH (x2=26.9. p<O.OOOI). At partitions 
with matched specificity of 96 % • eacb voltage-iluration product 
significantly improved sensitivity for the detection ofL VH wben compared 
with simple voltage criteria alone (Cornell product 37% (43/116) vs 
Cornell voltage 28% (33/116). p < 0.02 and 12-lead product 50% [58/116) 
vs 12-1ead voltage 43% [50/116). p<0.OO5). Sensitivity of both the 
Cornell product and the 12-lead product was significantly greater than the 
27% (31/116) sensitivity of QRS duration alone (p<O.OI to p<O.OOI). 
the 20% (23/116) sensitivity of a Romhilt-Estes point score >4 
(p<O.OOI). and than the 33% (38/116) sensitivity of the best fit logistic 
regression model in this population (p < 0.05). Comparison of receiver 
operating characteristic curves demonstrated that improved performance 
of the voltage-iluration products for the detection of L VH was independent 
of partition value selection. These findings confirm that QRS duration is 
an independent predictor of the presence of L VH and that the simple 
product of either Cornell or 12-lead voltage and QRS duration significantly 
improves the identification of L VH relative to other ECG criteria 
employing QRS duration and voltages in linear combinations. 
948·86 
Total QRS Voltage; Echocardlographlc Evaluation of Its 
Accuracy In Dlagnoalng Left Ventricular Hypertrophy. 
George Athanassopoulos. Athanasse Manolis. Gregoris Mountzouridis. 
Vasilis Laskos. Kostas Barakos. Genovefa Kolovou • Dennis V. Cokkinos. 
Cardiology Dep. Onassio Cardiac Surgery Center, Athens Greece. 
We assessed the contribution of total QRS voltage (TQRS). a recently 
proposed electrocardiographic (EGG) index. which up to now has only been 
evaluated at necropsy to the echocardiographic evaluation of left 
ventricular hypertrophy (LVH). Left ventricular mass (LVm) was estimated 
using the Penn convention in 131 patients (age: 52:1:10, 
malelfemale:105l26. 86 with essential hypertension-HYPo 16 w~h dilated 
cardiomyopathy-DCM. 16 w~ hypertrophic cardiomyopathy-HOCM and 15 
w~h aortic stenosis-AS). Fifty eight pts (all w~ DeM. HOCM, AS and 13/86 
with HYP) had LVH defined by LVm >120g1m2 in men and >104g/m2 in 
women. For each patient the following indices for LVH were measured: 
Sokolow-Lyon (SL). Comell cr~eria (RaVL+SV3) ), Estes'score, ratio of 
RV5IRV6 and TQRS (sum all the leads: from the peak of R wave to the nadir 
'of ~her the Q wave or the S wave whichever was deeper). 
Linear regression analysis between each of the aforementioned indices 
and calculated LVm index showed: total QRS-r=O.54'. SL- r=0.18, Cornell•
r =0.45', Estes' s- r=O.41'. RV5IRV6- r=0.21'. TORS had the best 
sensitiWy (SN) (0.45 vs SL:=O.15. Estes score:=O.22. Comell :=0.33 and 
RV5IRV6<1 :=0.42) with comparable specificity-o.80. SN for pts w~ OCM. 
HOCM and AS pts. SN remained unchanged (=0.47) when the 13 pts with 
HYP were analysed separately. (' p<:O.OS) 
In conclusion. TORS has the best relationship and the highest SN for 
echocardiographically estimated L VH among all the quant~ative criteria 
used with high specific~. SN was comparable to that found up to now at 
necropsy. This simple index may prove helpful in screening for L VH in wide 
scale epidemiological studies. 
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948·87 
Electrocardiographic Evidence of NonunHorrn Ventricular Recovery 
In Patients With idiopathic Ventricular Fibrillation 
Arne SippensGroenewegen, Heidi A.P. Peeters. Marcel C.G. Daniels, 
Richard NW. Hauer, Eric F.D. Wever, Etienne O. Robles de Medina 
Heart-Lung Institute. University Hospital Utrecht. Utrecht. The 
Netherlands 
The arrhythmogenic etiology of ventricular fibrillation occurring in the 
absence of overt heart disease has not yet been established. In order to 
examine the ventricular recovery process in primary electrical disease. 
62-lead body surface QRST integral maps were obtained during sinus 
rhythm in 11 patients (mean age 38:1:12 years) without structural heart 
disease, preexcitation or long QT syndrome who survived out of 
hospital cardiac arrest due to documented ventricular fibrillation. 
Absence of organic cardiac disease was confirmed using 
echocardiography. radionuclide imaging. coronary angiography, left and 
right ventriculography and right ventricular endomyocardial biopsy. 
Coronary spasm could not be provoked by ergonovine testing in any of 
these patients. Cardioverter·defibrillator implantation was subsequently 
carried out in 10 patients. Body surface mapping took place 27:1:23 
months after the initial cardiac arrest episode had occurred. QRST 
integral map analysis was performed visually and focused at 
discriminating dipolar (uniform ventricular recovery) from nondipolar 
(nonuniform ventricular recovery) patterns. 
Resu~s: Dipolar QRST integral patterns were obtained in only 3 of 11 
patients (27%), while nondipolar ORST integral patterns were obtained 
in 8 of 11 patients (73%). 
Conclusions: These data are the first to demonstrate that over two 
thirds of patients with idiopathic ventricular fibrillation demonstrate 
nonuniform ventricular recovery characteristics during sinus rhythm. 
Thus. inhomogeneity in the sequence of ventricular repolarization 
representing a potentially arrhythmogenic condition is present in a 
considerable subset of patients with primary electrical disease. Further 
studies utilizing similar or other electrocardiographic techniques could 
help to unmask the underlying electrophysiologic mechanism that leads 
to the development of ventricular fibrillation in the absence of structural 
heart disease. 
948·88 
Practicality of Time-Domain Measurement or Heart Rate Variability for the 
Allelsment of tbe Risk of Early Deatb Mter Acute Myocardial Infarction 
Marek Malik, Katerina Hnatkova, Angus Turner. Anne Staunton, Ruiping Xia, Jan 
Poloniecki, A John Camm, St. George's Hospital Medical ScOOol, London, England 
The necessity of manual editing of Holter data is a major practical obstacle which 
limits clinical use of bean rate variability (HR V) in survivors of acute myocardial 
infarction (AMI). This study investigated whether some of the HRV time-domain 
methods provide clinically useful information wben applied to unedited Holter data. 
Pre-discbarge Holter tapes form a population of 569 survivors of AMI were 
analysed and three different series of accepted 'normal-ta-normal' RR intervals were 
obtained from each tape: (a) after careful manual editing; (b) without any editing but 
including only RR intervals classified automatically as sinus rbythm intervals, and 
(c) without any editing including all RR intervals. Each RR interval sequence of 
each tape was processed by 7 published methods for HRV assessment: SDNN, 
SDNN index, SDANN, rMSSD, pNNSO, HRV index, and triangular interpolation of 
RR interval histogram (TINN). All patients were foUowed up for a minimum of 18 
months (range 18 months - 6 years). Each set of results was used to stratify the 
patient population and to identify 28, 39, and 56 patients who died during the first 
6, 12, and 24 months, respectively. The receiver operator characteristics and 
maximum positive predictive accuracy (PPA) for each level of sensitivity were 
computed and statistically compared in order to determine which measure of HRV 
performed best with each metbod of generating the RR interval sequence. 
For manually edited Holter data, the best performance was achieved with the 
SDNN, HRV index, and TINN methods (e.g. prediction of 24 month mortality with 
a PPA 3S-44% at 40% sensitivity). The SDANN and SDNN index methods 
performed slightly worse (pPA 2l-2S% at 40"10 sensitivity) whilst the pNNSO and 
rMSSD methods were effectively random in predicting patients at high risk of early 
death. For unedited Holter data, both with and without fully automatic QRS 
classification, the performance of SDNN, SDANN, and SDNN index methods was 
very significantly worse (p < 10-9 for the reduction of PPA at 40% sensitivity) while 
the performance of the HRV index and TINN methods did not differ significantly. 
Clinically relevant assessment of HRV in survivors of AMI can be obtained 
from unedited Holter data which can be easily obtained in standard clinical settings. 
When applied to automatically analysed data, robust geometrical methods (such as 
HR V index and TINN) give results which are comparable with the stratification 
using any recognised time-domaio method using most carefully edited Holter data. 
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948·89 
ST ·Segment Chlnges During Acute Coronary Occlusion in the Presence 
of Pacing Induced Left Bundle Branch Block Pattern. 
Kenichi Fujise, Matt Bach, David Pinnelas. Warren Sherman 
Beth Israel Mecfcal Center, New Yor1t NY 
Background & Method: Right ventricufar pacing (RVP) ruring totaf coronary artety 
occfusion by a percutaneous transfuminal coronary angicpfasty (PTCA) balloon provides an 
unique opportunity to evaluate ischemic ECG changes in the p!esence of left burde branch 
paIIem(LBBB). Accortingly, RVP was perfonned and 12 lead ECGs recorded with and 
without balloon inflation in 25 patients II1dergoing elective PTCAs on the left anterior 
descendng(LAO, N=9), circumllax(LCx, 9), right(RCA, 6) and other(3) coronary arteries. 
Result: Acute myocanial ischemia from balloon occfusion of a coronary srtety pnxiJced 
various degrae of ST segment efevations (LAO, RCA) and depr9ssion (LCx) in native and 
paced ECGs. The location and cirection 01 these ST -segment changes in native ECGs were 
same as those in paced ECGs. Larger ST -segment changes in native ECGs were 
associated with larger ST -segment changes in paced ECGs. When ST -segment changes 
(mm) in native ECGs (X) were plotted against ST -segment changes in paced ECGs M, 
significant correfations were noted in all leads except for aVR. Correlation coefficients (CC) 
for I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5 and V6 were 0.47,0.39,0.53,0.36,0.62, 
0.46, 0.67, 0.72, 0.83, 0.6, 0.6, 0.6, 0.55 ,respectively. (All p<O.01 except for I,ll and aVF 
(p<O.05) and aVR (p<O.1)) The higher correfation was noted in antero-septalleads 0/1,V2 
and V3) COfT"4l8red with inferior or lateral leads (p<O.05). With all leads conilined, CC was 
0.66 (p<O.01) with a linear regression Y(mm) 
line determined as Y=O.952X+O.0732. 
(Figure) Conclusion: Even in the 
presence of LBBB, ST-segment 
changes, especially those in 
anteroseptal leads, indcate the 
presence of acute ischemia. More 
severe ischemia causes more ST•
segment changes in ECGs with LBBB. 
Comparison of ST -segments in current 
ECGs with those in old ones can .. 
provides the clue to ciagnosis of acute 
ischemia in the setting of LBBB. 
948·90 
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Circadian Variation of Ischemic Threshold in Syndrome X. 
Gaetano A. Lanza, Filippo Stazi, Patrizia Pedrotti, Giuseppe Colonna, 
Alessandro Manzoli, Michele Lucente, Attilio Maseri. Cardiology Institute, 
Catholic University, Roma, Italy. 
To evaluate whether the ischemic thneshold has a circadian rhythm (CR) in 
patients with syndrome X (effort angina, positive exercise test and normal 
coronary arteries), we analyzed 90 episodes of ST -segment depnession 
(STd) (II symptomatic), detected on 24·hour Holter monitoring (HM) in 
12 patients (9 women, age 54±8 yrs) with this syndrome. The heart rate 
(HR) at I mm ST d was recorded for each episode. To eliminate differences 
in HR among patients, the modal value of HR in the 24 hours was obtained 
and a normalized HR value at Imm STd (N-HR) for each STd episode (N. 
HR:HR at Imm-STdlmodal HR*IOO) was calculated. Then, mean hourly 
values ofN-HR were obtained by groupping and averaging N-HRs of STd 
episodes detected in each hour of the day. Chronobiologic analysis was 
done by single cosinor method. 
HR had a significant CR (mesor 76 bpm, amplitude 10 bpm, acrophase at 
02:16 PM, p<O.OOI). The number ofSTd episodes (mesor 3. 75, amplitude 
2.9, acrophase at 02:45 PM, p<O.OOI) showed a CR similar to that of HR. 
The circadian distribution of STd episodes showed a double peak, the first 
in the morning and a second in the afternoon. The chronobiologic 
evaluation of N·HR revealed a lower ischemic threshold in the night and 
early morning hours, with a progressive increase until the first afternoon 
hours (mesor 20.5%, amplitude 14.5%, acrophase at 02:55 PM) and a 
subsequent reduction in the evening. 
Thus, I) our data evidence a CR of transient STd episodes in S}lldrome X 
similar to that found in patients ..... ith coronary artery disease; 2) The CR of 
STd episodes is correlated with that of HR, suggesting a significant role of 
the increase in myocardial oxygen demand in the induction of ischemia in 
the syndrome; 3) however, the significant CR of ischemic threshold 
indicates that variations in vasomotor tone have an important role in the 
pathophysiologic mechanisms oftransient ischemia in these patients. 
ABSTRACTS 
948·91 
Changes in Sympatho.Vagal Balance are Associated With 
V sriability of Ventricular Arrhythmia Complexity in Idiopathic 
Dilated Cardiomyopathy 
Francesco Pelliccia, Cinzia Cianfrocca. Stefano De Castro, and 
Giuseppe Critelli. University of Rome "La Sapienza", Rome. 
Italy 
Arrhythmia variability in idiopathic dilated cardiomyopathy 
(IDC) is well-recognized. but the mechanisms of this phenomenon 
remain unclear. We investigated whether changes in sympatho•
vagal balance could be a reason for variability of ventricular 
anbythmia complexity in a subset of 20 IDC patients (aged 54±12 
yrs). All patients underwent 24 hr-Holter monitoring (HM) at 
recruibnent (TI) and 4 to 6 months later (1'2). Treatment included 
digoxin, diuretics and vasodilators either at T1 or T2. At TI, all 
patients exhibited couplets or salvos at HM. At T2, complex 
ventricular anbythmias were detected in 11/20 patients (Gr.A), but 
not in the remaining 9/20 patients (Gr.B). HMs were analyzed and 
4 measures of heart rate variability were assessed: 1) SDANN index 
(standard deviation of the average RR intervals for all S-min 
segments), and 2) SDNN index (mean of the standard deviations of 
RR intervals for all S-min segments), that reflect mixed sympathetic 
and parasympathetic activity, 3) rMSSD (root mean square 
successive RR difference), and 4) pNNSO (percent of differences 
between adjacent RR intervals>SO ms), that are pure vagal signals. 
At n, both Gr.A and Gr.B patients exhibited similar SDANN 
index (62±22 vs 67±18 ms), SDNN index (71±11 vs 76±13 ms), 
rMSSD (13±7 vs 11:t9 ms) and pNN5D (2±4 vs 3±S %). At T2, the 
autonomic profIle was substantially unchanged in Gr.A patients. 
On the contrary, Gr.B patients exhibited an improved sympatho•
vagal balance, as indicated by the significant (p<O.OOI) increase in 
SDANN index (+2S±lS ms), SDNN index (+17±9 ms), rMSSD 
(+8±S ms) and pNN50 (+4±3 %). We conclude that in IDC 
patients: (I) the occurrence of complex ventricular anbythmias is 
associated with time-domain measures of heart rate variability 
reflecting a higher sympathetic drive and a lower vagal output; (2) 
changes in sympatho-vagal balance might be responsible for 
variability of ventricular anbythmia complexity. 
948·92 
371A 
THE FREQUENCY·DEPENDENT EFFECTS OF BETA-ADRENERGIC 
SYMPATHETIC STIMULATION ON VENTRICULAR 
REPOLARIZATION AND CONDUCTION IN HUMANS 
Philip T. Sager, Mahnaz Behboodikhah, Rafique Ahmed, Christopher 
Follmer. West Los Angeles VAMC & UCLA Med Ctrs, LA, CA. 
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Beta-adrenergic sympathetic stimulation is 
arrhythmogenic, but its frequency-dependent 
electrophysiologic effects have not been 
well defined in the human ventricle. We 
examined the monophaSic action potentia 
duration (APOllO)' ORS duration, and RV 
ERP during steady state RV pacing in 22 
drug-free pts before and during isopro•
terenol (ISOP; 35ng/(kgmin)) infusion. 
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Isoproterenol decreased the sinus cycle 
length (from 725ms to 481ms, p<.OOl), the 
APOllO (by 6.4% (p<.OOl)) and RV ERP (by 
10.8% (p<.OOl)) at all paced cycle lengths 
without frequency-dependent effects 
Ventricular conduction, as determined by 
ORS duration, was significantly improved by 
ISOP (4.4%). At longer paced cycle lengths 
ISOP shortened the VERP/APOIlO ratio 
indicating that the reduction in RV ERP was 
not exclusively secondary to decreases in 
, 
the repolarization (ie., APOllO). 
CONCWSION: ISOP decreases the 
APOllO and RV ERP at all paced cycle 
lengths. improves ventricular conduction and 
appears to reduce the RV ERP via time and 
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voltage·dependent processes. These electrophyslologlc actions likely 
play an important role in the arrhythmogenic effects of beta-adrenergic 
sympathetic stimulation. 
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948·93 
Autonomic: Triggers ot Ventric:ular Tac:hyc:ardla In Patients 
with Repetitive Monomorphic: Ventrlc:ular Tac:hyc:ardla 
Kenneth M Stein, labros A Karagounis, Jeffrey L Anderson, Bruce B 
Lerman. Cornell University Medical Center, New Yorn, NY 
We have idenitifed 2 forms of adenosine-sens~ive ventricular tachycardia 
(VT), both ot which occur in pts w~hout structural heart disease and are 
thought to be due to cAMP-mediated triggered activity: a sustained 
paroxysmal form that is exercise-induced and a non-paroxysmal form that 
occurs primarily at rest, is nonsustained (NSVT) and is characterized as 
repetitive monomorphic VT (RMVT). To idenify and characterize the 
potential autonomic triggers of RMVT, we screened 9 piS wnh RMVT and 
30 pts with reentrant VT in whom the diagnoses were confirmed by 
electrophysiologic study. In 3 pts with RMVT and 9 pis ~h reentrant VT 
w~h at least 1 analyzable episode of NSVT (~ 6 consecutive VPCs) during 
ambulatory ECG recording the mean RR interval for all sinus beats 
preceding a sinus beat and tor all sinus beats preceding NSVT, and the 
mean root-mean-square difference (RMSSD, a measure 01 cardiac 
parasympathetic tone) of all windows ot 15 successive RR intervals 
(excluding ectopic beats) preceding a sinus beat, and preceding NSVT 
were measured. Results: There were no differences in mean RR 
preceding sinus beats in the two groups. However, NSVT in RMVT was 
preceded by signifcantly NN Inlerva 
shorter RR intervals than sinus 1000 
b .. " (p.O.oo04'. Th;, ... I h:11 different from the pattern in pts 900 
with reentrant VT (p=0.003), in 800 
whom there was no .such 700 
difference (p=0.36). There 
were no differences in RMSSD 600 
in either goup. Conc:lusion: 500 p:O.OO3 
Heart rate is increased 
preceding episodes of NSVT in 
patients with RMVT although 
parasympathetic tone is 
R·R·(N) 
Reentrant 
R·R·{VT) 
........ RMVT 
unchanged. This pattern is distinct from that observed in patients with 
reentrant VT and suggests that transiently increased sympathetic tone 
plays a role in triggering RMVT, aHhough this arrhythmia occurs at rest. 
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949-109 
Endothelin-I Does Not Selectively Impair Blood Flow to Collateral•
Dependent Myocardium 
Jay H. Traverse, Todd Pavek, Sara Herrlinger, Melanie Crampton, 
Paul Lindstrom, Dianne Judd, Robert J. Bache. 
University of Minnesota, Cardiovascular Div, Minneapolis,MN 
Plasma levels of Endothelin-I (ET-I) rise during ischemic events 
and may impair coronary collateral blood flow since collateral 
vessels show enhanced responsiveness to certain vasoconstrictors. 
To see if this occurs, we studied the effects of increasing doses of 
intracoronary ET-I infusions in normal (NL) and collateral•
dependent myocardium (CaLL) in 8 adult dogs. CaLL was 
generated by fluoroscopic em bolization of the mid-left anterior 
descending ar1ery by a small hollow plug 4-6 wks before the study. 
Myocardial blood flow was assessed by microspheres at the 
completion of each 30 minute left main infusion of ET-I (1,3, 
10. 100 n~min) COLL was 12% of total left venuicular mass 
ET-I Concemtation AD HR Myocardial Blood flow 
Infusion Intracoronary Plasma (mVrninlg) 
(De/miD) (p~/1D1l epe/mll NL em I 
!n'Cline 0 5.8 88 104 O.74±O.O'J O.57±O.04* 
I 14.5 10.0 88 118 O.72±0.05 0.59±O.04* 
3 35.3 8.6 89 120 O.87±0.12 0.6I±O.!l4* 
10 116.0 15.4 94 126 O.94±O.12t O.73±O.07*t 
100 1382 40.0 92 144 0.54±O.06* OAO±O.O'J§ 
*p<0.05 NL vs COI.L. t p<O.05 NL blL'C vs ET-!, tp<O.08 COIL base 
ys ET-I §psO O~ COl L Pase ys ET-! 
Ao was unchanged and HR increased (p<O.05) with increasing 
ET-I. At 10 nglmin, both NL and CaLL were increased compared 
to baseline. However,at the highest dose of ET-l blood !low was 
reduced to both regions. We conclude that acute elevations in ET-l 
within the physiologic range do not impair collateral blood flow. 
These results are consistent with isolated vessel studies that show 
vasodilation rather than vasoconstriction at physiologic doses 
although supra physiologic doses decrease flow in both nonnal and 
collateral regions. 
JACC February 1994:1A-484A 
949-110 
Arterial Endothelium Abrasion Permits Adenovirus-Mediated Gene 
Transfer to Medial Smooth MUIICIe CeDI. 
P. Gabriel Steg, Laurent 1. Feldman, Jean-Yves Scoazec, Ouafae Tahlil, 
Jeffrey M. Isner", Jim Barry.·, Michel Perricaudet···. Facultt Bichat, 
Paris, F; ·St Elizabeth's Hospital, Boston, MA; ··Boston Scientific CoIp., 
Boston, MA; ···UA 1301 CNRS, Villejuif, F 
Gene transfer to medial smooth muscle cells is essential for gene 
therapy of restenosis. 10 test whether the arterial endothelium (End) is a 
barrier when local intraluminal delivery of adenoviral vectors is used, 29 
rabbi IS underwent percutaneous arterial gene delivery to the iliac artery 
without (n = 9) or with (n = 20) endothelium (End) removal by balloon 
abrasion. The adenoviral vector Ad.RSV8gal was used as a carrier for the 
nuclear-specific 8-gaJactOSidase reponer gene. Expression was assessed at 
3 to 7 days by X -gal staining. Local delivery was perfonned by double 
balloon (DB) infusion (n = 15) of 2. 109 pfu of Ad.RSV8gal in 30 min, or 
by hydrogel-coated balloon catheter (HBC) delivery of 2.109 to 2.1010 pfu 
at 6 aOll for 30 min (n = 14). When End was intact, transgene expression 
was strictly confined to the End. After End abrasion, DB infusion resulted 
in infection of sparse superficial medial cells, which were further identified 
as smooth muscle cells by a-actin countel'Staining. However, when HBC 
was used, massive staining was seen in the superficial layers of the media 
and in sparse deeper medial cells. In all cases, the internal elastic lamina 
was intact (orcein staining). Neither intact (n = 18) nor End-abraded (n = 
8) contralateral arteries, used as controls, showed any IDlclear staining. 
In conclusion, End removal and high pressure infusion by the 
HBC permit adenovirus-mediated gene transfer to the media, with an intact 
internal elastic lamina. 
949·1l1 
Effect of insulin infusion on Endothelium-DerIved Vasoactive 
Mediators 
Kees H. Polderman, Coen D.A. Stehouwer, louis J.G, 
Gooren, and Freek W.A. Verheugt. Free University Hospital, 
Amsterdam, The Netherlands. 
Insulin has vasodllating properties, but their mechanism Is 
unknown. 
We assessed the effect of short-term hyperlnsullnemla on 
plasma levels of endothelln (an endotheliwn-derived vasocon•
strictor) and urinary excretion of 6-keto PGFll11 (a measure 
of prostacyclln production), Hyperlnsullnemla was Induced In 
12 healthy subjects (aged 17-38 years) with a 3-step eu•
glycemic clamp, which achieved plasma Insulin levels of 
about 50, 130 and 800 mUll, each for a period of 120 min; 
nonnal saline served as control. In men (n=6) neither insulin 
nor saline affected endothelin levels or 6-keto-PGFll11 ex•
cretion. In women (n=6) endothelln levels decreased (from 
6.4 [sd 2.41 to 4.3 11.81 pg/ml, peO.05 vs saline and vs base•
line) and 6-keto-PGFla excretion Increased (from 80 (20) to 
200 [361 pmol/hr, peO.OS) during Insulin infusion (at insulin 
levels of 50-130 mUIJ) but did not change during saline 
Infusion. 
We conclude that short-term hyperlnsuHnemla affects 
vasoactive endothelial mediators (endothelln and prostacyc•
lin) In women, but not In men. These effects may partly ex•
plain Insulin's vasodllatlng properties, and may account for 
the sex difference In hyperlnsullnemla as a risk factor for 
cardiovascular disease. 
JACC February 1994:1A-484A 
949·112 
MYocardial Adaptation to Acute, Demand Induced Iachemia 
Mark Berman, Frank Marecki, Henry Gewirtz, Rhode Island 
Hospital, Providence, R.I. and Massachusetts General 
Hospital, Boston, MA 
There are only limited data available concerning 
myocardial (MYO) metabolic responses to sustained 
demand induced ischemia with preserved MYO blood flow 
(Q). Thus, this study tests the hypothesis that MYO 
aerobic metabolism will stabilize, not deteriorate, 
during sustained demand induced ischemia. Closed chest 
sedated pigs (n=4) with an 80% stenosis in the left 
anterior descending coronary (LAD) had measurements of 
Q (microspheres; ml/min/g) , hemodynamics, MYO oxygen 
(MV02; ml/min/100g) and lactate consumption data at 
control; 10, 20, and 30 min of ischemia. Atrial pacing 
plus IV norepinephrine caused myocardial ischemia by 
increasing MYO contractility and doubling rate pressure 
product (10562±3321 mmHg/min to 20061±2315, P<.OI). 
Results (Mean±SD): 
Time LAD-ENDO-Q 
Base 0.85±0.32 
10 min 1.20±0.2S 
20 min 1.0S±0.20 
30 min 1.18±0.22 
LAD-EPI-Q 
1. 31±0. 41 
2.06±0.44* 
2.10±0.Sl* 
1. 88±0. 36* 
MV02 02ext(%) AIV pH 
11.5±2.6 8S±4 7.41±0.05 
18.1±3.S* 79±S* 7.38±0.02 
17.9±4.9* 78±6* 7.3S±0.03* 
17.6±1.6* 78±4* 7.37±0.04 
*p<.05 vs Base; AIV=Anterior Interventricular Vein 
ENDC=endocardium; EPI=epicardium; ext=oxygen extraction 
Lactate production (mmoles/min/100g) occurred at 20 
(-.21±.39) and 30 (-.35±.26) min of stress but not at 
control (P<.05). Despite metabolic evidence of MYO 
ischemia, MV02 increased then plateaued. Similarly, AIV 
pH and MYO 02 extraction declined at 10 min of stress 
but then equilibrated. Accordingly, under clinically 
relevant conditions when MYO Q is maintained at or 
above baseline levels, sustained demand induced 
ischemia tends to stabilize and is not associated with 
worsening MYO tissue acidosis nor progressive decline 
in MYO oxygen extraction or consumption. 
949·113 
CHnlc:aI Correlates or Atherosclerosis III ADgIograpblcaUy Normal Coronary 
Artery Reference Segments: An Intravascular Ultrasound Study 
Jack A. Painter, Gary S. Mintz, Augusto D. Pichard, Kenneth M. Kent, Lisa E. 
Sokolowicz, Mary Ellen Hughes, Lowell F. Saller, Jeffrey J. Popma, Martin B. 
Leon. Washington Hospital Center, Washington, DC. 
We used intravascular ultrasound (IVUS) to study angiographically normal 
coronary artery reference segments in 884 pts evaluated for transcatheter therapy 
fIX' symptomatic CAD. IVUS % cross-sectional narrowing (%CSN=plaque+media 
area!extemal elastic membrane area I and arc of reference segment calcium were 
measured at the most normaI-looking intravascular ultrasound cross-section within 
IOmm proximal to the target lesion, but distal to any major side branch. 
Angiographic reference segment diameter measured 2.8:iO.Smm. Only 60/884 
(6.8%) angiographically normal reference segments were normal by lVUS. 
Reference segment %CSN measured 51±13% and correlated with target lesion 
%CSN (85±12%, r=O.I66, p<O.OOOI). Reference segment calcium measured 
4O±7go and correlated with arc of target lesion calcium (113±109°, 1'=0.367, 
1<0.0001). Clinical correlates of reference sellment disease inchJded 
%CSN Arc of calcium 
p p 
Age (6at:12years) 0.0542 <0.0001 
Male gender (77%) 0.0023 0.0155 
Diabetes (25%) <1>.0001 NS 
Smoking history (23%) 0.0041 0.0384 
Hypercholesterolemia (61 %) 0.0263 NS 
Multivessel disease (74%) 0.0010 0.0937 
Prior bypass surgery (15%) NS 0.0025 
Serum creatinine O.2±l.Imllfdll 0.0119 <0.0001 
Race, hypertenSion, unstable angma, recent or remote MI, target leSIOn restenosis, 
reference segment location, or angiographic lesion severity did not correlate with 
reference segment disease. Importantly, reference segment disease noted during 
transcatheter therapies was not an independent predictor of the need for late target 
vessel revascu1arization (foUow-up=6.8±5.4 months). We conclude: rvus shows 
that significant atherosclerosis (I) is ubiquitous in angiographicaIly normal 
coronary artery reference segments, (2) parallels the severity of target lesion 
disease, and (3) is associated with many of the conventional risk factors for clinical 
CAD. Because of its senSitivity in detecting atherosclerosis in angiographically 
normal reference segments, IVUS should enhance the study of risk factors for 
atherosclerosis and the results of therapies to control disease progression. 
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949·114 
localization of MIB 1, TGFbl and bFGF In ArterIoscIerotIInIinaI Biopsies 
From Directional Athereclomy 
Peter Gonschior, 2Andreas Nertich, Brigitte Mack, 21rmgard WIeSt, Berthold 
HOfling; I Med. Dept.!, Klinikum GroBhadem; 2lnst. for Pathology; University 
of Munich, Gennany* 
Basic fibroblast growth factor (bFGF) and transforming growth factorbl 
(TGFbl) are known to be potent growth factors for mesenchymal cells. 
The immunohistochemical distribution of prolHerating cells (MIB), bFGF and 
TGFbl was analyzed, using antibodies (MIB 1, monoclonal, Dianova; 
TGFbl, bFGF, polyclonal, Oncogene ScL) and the avidin-biotin method en 
37 intimal tissue specimen (15 restenoses) obtained by directional 
atherectomy. For further investigation frozen cryocut sections were 
prepared. The specifity of the immunohistochemical-staining had been 
tested using various normal tissues and negative controls. The intimal 
tissue areas were divided into highly cellular (hc;>200cells, x68) and low 
cellular (Ic) fields. Hc restenoses had 10% MIB 1 posttive cells (counted i1 
relation to all present cells) whereas Ie primary stenoses had 0% MIB 1 
poSitive cells (hc primary stenoses: 4.8%). In hc areas we observed an 
extensive positive cell-associated bFGF and TG F bl labelling of 
myofibroblasts in intimal areas (20-30 cells, x68) comprising most cells 
present. bFGF was found in the cytoplasma and extracellular and was 
coexpressed mainly in prolfferative areas. In restenoses, clinical data 
revealed a later onset of TGF bl in biopsies (> 4 weeks). In contrast, in Ie 
areas only very few cells demonstrated a positive staining for bFGF and 
MIB 1 «5 cells, x6S) and an more extensive TGF bl labelling. The resu~s 
thus provide evidence for the presence of enhanced amounts of bFGF and 
in highly cellular, prolHerating intimal tissue areas, thus emphasizing the 
importance of bFGF in the myoprolHerative response of restenotic intimal 
thickening whereas TGFbl seems to be associated with the fibrotic phase. 
* (supported by Sanderstiftung grant 90.026.2) 
949·115 
Ron-Invasive Ultrasound De.onstration of Atheroscler•
osis Progression and its Suppression by the Antioxidant 
Calciua Channel Blocker A.lodiptne 
Ramesh C. Sharma, Dieter M. Kramsch, Chao-Ran Liu, 
Wendy J. Mack, University of Southern California, Los 
Angeles, CA 
We tested the second generation Ca++ antagonist amlo•
dipine (A) with known antioxidant and anti-cell prolif•
erant properties in vitro, for its antiatherogenicity 
in nonhuman primates_ Progression of atherosclerosis 
was assessed in abdominal aorta, aortic bifurcation, 
common carotid and ileofemoral arteries of 26 male 
cynomolgus monkeys at baseline, 6, 12, 18 and 24 months 
using B- and M-mode Doppler: 10 monkeys fed atherogenic 
diet (AD), 11 AD monkeys treated with A (2 mg/Kg body 
weight - ADA), and 5 control animals (C). Both AD 
groups showed comparable rises in mean (mg/dl) plasma 
total cholesterol (Ch) and low-density lipoprotein-Ch 
(LDL-Ch): AD - 487 & 308; ADA - 403 & 286. Plasma 
oxidized LDL (LDL-), fasting insulin and triglycerides 
also rose significantly while plasma y-tocopherol fell 
significantly in AD but not in ADA monkeys. Arterial 
pulse wave velocity, stiffness index e and elasticity 
modulus increased While blood flow arrival time 
decreased in AD monkeys with the changes becoming 
progressively more significant after 12 months, 
indicating atherosclerosis progression. By contrast, 
in ADA the indices were not significantly different 
from C, indicating steady atherosclerosis suppression 
at all sites as confirmed by autopsy. Conclusion: (1) 
amlodipine suppresses atherosclerosis despite athero•
genic LDL-Ch levels; (2) preVention of LDL-oxidation 
and preservation of vitamin E appears to play a major 
part in its antiatherogenic effect, and (3) progression 
and suppression of atherosclerosis can be monitored 
noninvasively by ultrasound. 
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949·116 
Prevention of Thrombus Formation by Local Delivery of 
Antithrombotic Agents. 
Takanobu Tomaro, Fumitaka Nakamura, Atsuko Miwa, 
Yoshiharo Fujimori, Yaeko Murata, Sachio Kawai, 
Ryozo Okada,Masao Ornata, Yasumi Uchida, 
University of Tokyo,and Juntendoh University, Tokyo, Japan. 
Use of antithrombotic agents efficacy may be limited by bleeding 
complication. Then, efficacy of low dose local delivery of either 
heparin (H), antithrombin(argatroban;A) or defibrlnogenating agent 
(batroxobin;Btx) was investigated in dogs. One side of canine iliac 
artery was injured by balloon dilatation under thread constriction using 
a 4 mm PTA balloon catheter inserted through the distal sheath at the 
femoral artery, and the antithrombotic drug diluted in 3 cc of saline 
was infused through the distal sheath with ligation of proximal iliac 
artery. Then, the drug was placed there for 3 minutes(H;25 Ulkg, A; 
0.05 mg/kg, Btx; 0.05 Ulkg). After blood flow was reestablished, 
another side of the iliac artery was also injured similarly. Thrombotic 
obstruction was evaluated by angioscopy and pathological examination 
at 60 minutes after the balloon injury. ~ Angioscopic percent 
area obstruction with thrombus was as follows(mean ± standard 
deviation);n=number of dogs 
Groyp n Local infusion site Control side p valye 
Heparin S 3.6 ± 4.2 44.6 ± 26.7 <O.OS 
Argatroban 6 0.7 ± 1.6 36.7 ± 23.4 <0.05 
Batroxobjn 7 S I#;4 9 48.1 #; 22.0 <0 005 
In locally delivered segments, mean thrombus w ~ht (gram;g) was 
0.001 g with H or A, and 0.002 g with Btx( P<O.OS vs control 
segments respectively;0.047 g with H, 0.037 g with A, 0.028 gwith 
Btx). Adhesion of the FITC-Iabeled drug to the injured site was 
confirmed by fluorescent microscopy even at 3 hours afetr the drug 
infusion, and the drug covered the injured surface where heparan 
sulfate layer was also destroyed. The activated partial thromboplastine 
time prolonged slightly( by less than 20%). Thus, thrombus formation 
can be prevented by local delivery of antithrombotic drug after vascular 
injury without significant influence on coagulability. 
949·117 
Insulln·Receptor Mediated Increase by Glyburlde or Platelet 
High Amnlty Prostacyclln·Receptor Number. 
iAndreas Wolf, *Nigat N. Kahn, *Asru K. Sinha 
iStanford University, Stanford, CA, ·VA Med. Center, Bronx, NY. 
Inhibition of platelet aggregation by prostacyclin (POI2), which is 
believed to be important in the prevention of thrombosis in acute 
ischemic heart disease, has been shown to be mediated through the 
binding of the agonist with the cell surface receptors. Glyburide 
(GLY), an insulin secretagogue, is known to enhance the prosta•
cyclin induced inhibition of platelet aggregation. We investigated 
the effect of GLY on POl2-binding to platelets by using [3H]•
prostaglandin El (POEl) as a stable probe for POIz-receptors. Incu•
bation of platelet rich plasma (PRP) from fasting (l2h) normal vol•
unteers (n=lO) with GLY for Ih at 23'C stimulated POEI-binding in 
a dose-dependent manner with a peak effect at 2.5 jlg/ml, where it 
increased binding from 414*145 (SO) to 553*130 fmol/mg mem•
brane protein (psO.OOO5, n=IO). Scatchard plot showed that the ef•
fect of GLY was due to an increase of high affinity receptor num•
bers without significant change of the affinity (kd 9.2±D.4nM). In•
cubation of PRP with anti-mouse insulin-receptor (lR) antibody 
(lOjlg/ml), which specifically bound to the a-subunit of IR and in•
hibited the activation of IR-tyrosine kinase, blocked the effect of 
GL Y. Normal mouse IgG, which served as control, had no effect 
These results suggest that the increase of platelet POEln2-receptor 
numbers by GL Y was due to the activation of tyrosine kinase of the 
a- subunit of IR. 
JACC February 1994:1A-484A 
949·118 
Laser Thrombolysis for Bypass Graft Thrombosis 
Edward A. Chasteney, P.S. Ravlchandran, Anthony P. Furnary, 
Deborah Tuke Bahlman, Kenton W. Gregory', Oregon Heahh Sciences 
University, Portland Veterans Administration, and the Oregon 
Medical Laser Center, Portland, OR. 
Feasibility of selective laser thrombolySis(L T) has been 
demonstrated with acute myocardial infarction In native coronary 
arteries. Thrombosed coronary bypass grafts are a significant 
clinical problem for which existing therapies are limited. In order 
to assess L T as a treatment for this disorder, common to external 
carotid artery bypasses were formed, stenosed, and thrombosed in 
domestic swine. Vessels were treated with contrast injection 
(control) or pulsed·dye laser therapy(light) by fluid core catheter 
(577nm,2j1S pulse,3Hz). This catheter uses a contrast stream to 
transmit laser light from a fiberoptic source, avoiding the 
complications of bare fiber delivery. Treatment energy was 
94;1:.8mJ per pulse for a fluence of 11.9J/cm2. The wavelength of 
light utilized has ten fold higher absorption by thrombus compared 
to vessel wall. Graft length was 55±..5mm and diameter 
5.0;l:.O.7mm. Ught treated vessels received 1108;1:.320 pulses over 
6±2 minutes. Results are mean±sd. *p<0.001 vs. control 
Light(N=13) Control(N=4) 
Grafts reperfused 10 0 
Perforation 0 0 
Baseline flow(mVmin) 129±37 105±12 
~bb d d 
Post tx flow 42±31 * <5 
TIMI flow Pretx 0 0 
TIMI flow Posllx 2.0±0.8' 0 
Angiographic and direct visual assessment revealed minimal 
thrombus in the light treated vessels. Conclusions: l)LT can 
effectively remove large thrombi in arterial bypass grafts. 
2)Patency is rapidly achieved. 3)Selectivity and fluid core delivery 
avoid perforations despite direct light delivery to vessel wall. 
4)Seleclive L T may be a useful therapy for bypass graft thrombosis. 
949·119 
Value of Intracoronary Venous Electrocardiogram to Detect Regional 
Myocardial Ischemia During Intracoronary Injection of 
Acetylcholine:Comparison With Lactate Metabolism 
Takayoshi adachi, Atsushi Hirayama, Akihiko Sakai, Naoyuki 
Misaki, Sinji Hasegawa, Yasunori Ueda, Kazuhisa Kodama 
Osaka Police Hospital, Osaka, Japan 
Intracoronary ECG is proved to be more sensitive than standard 
ECG(12ECG) in detecting myocardial ischemia during PTCA. It is 
hazardous, however, to insert the guidewire into the coronary artery 
other than during PTCA. Therefore, we developed the method of 
intracoronary venous ECG(icv-ECG). Studied were 24 patients with 
vasopastic angina. Unipolar iv-ECG was recorded from a guidewire 
in the anterior interventricular vein running parallel with LAD. ST 
shift in iv-ECG and 12-ECG during intracoronary injection of 
acetylcholine(ACH) were measured. Aorta-coronary sinus differences 
of lactate extraction ratio(LER) as an index of myocardial ischemia 
were calculated. 
Results: Iv-ECG could be safely recorded. ST shift in iv-ECG 
correlated well with LER. When considered LER<O% as a gold 
standard of ischemia, and the criteria of ST elevation or 
depression>O.lmV for 12-ECG and that of ST elevation>O.lmV or 
ST depression>O.ISmV for iv-ECG were used, the sensitivity and 
specificity were as follows: 
12-ECG icv-ECG 
sens1l1vJty 64%(9/14) 100%(14/14) 
specificity 90%(9/10) 90%(9/10) 
Conclusion: These deta indicate that icv-ECG was safe and superior 
to 12-ECG in detecting regional myocardial ischemia during ACH. 
JACC February 1994:1A-484A 
949·120 
Changes in Hemostatic Function at Times of 
Cyclic Variation in Occupational Stress 
"Aron Frimerman, Hylton I Miller, David Samuel, 
Shlomo Laniado, Gad Keren, Dept of Cardiology, 
Tel-Aviv Medical Center, Tel-Aviv, Israel 
This study examined the possible effect of 
mental stress on coagulation parameters which 
have a role in the pathogenesis of coronary 
disease (CAD). We examined 20 certified 
accountants, volunteers in good health (age 
34.5±9y), who reported subjective feelings of 
stress at a peak work load period just prior to 
the deadline of annual income report submission 
(stress period=SP). The following factors were 
assessed: Coagulation factors VII (F7), VIII 
(F8), Fibrinogen (Fib), platelet aggregation 
(PA), PT, PTT, and thrombocyte count (Thr). 
These parameters were reassessed during a calm 
work period (calm period=CM). 
Results: 
("=p<O.Ol) 
ll!..!.l..! 
668±722 
112±28 
~ FIB(mg/dl)" Thr(x1000)* 
77134 350±58 207±38 
37±18 320129 173±35 
fALll PT( sec. ) PTT( sec. ) 
~ 74±19 11.2±0.4 23±3 
~ 71±17 11.2±0.4 24±2 
Conclusions: There is a significant increase in 
F7, F8, Fibrinogen and ThrOmbocytes during SP 
in comparison to CPo These data suggest that 
in persons under mental stress a hypercoaguable 
state prevailed. This may contribute to the 
pathogenesis of CAD. 
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950·121 
Treatment of Pulmonary Hypertension With Prostacyclin 
Analogue Iloprost 
*A Yazdani Butt, A TUan Oinh-Xuan, Motoshi Takao, George 
Cremona, Tim W Bigenbottam. Papworth Bospital, 
Cambridge, England 
Prostacyclin (PGI,) has been shown to improve well 
being as well as survival in severe pulmonary 
hypertension. PGl1 however is quite unstable and 
expensive. Therefore we have compared the efficacy of 
PGI, with its synthetic analogue Iloprost (ILO). Ten 
patients were included, (5 males and 5 females1 mean age 
36.1 years, range 20 to 54 years)1seven patients had 
primary pulmonary hypertension while three had thrombo•
embolic disease. They were all severely incapacitated 
and were categorised into NYBA grade III to IV. Right 
heart catheterization was performed on all patients 
(mean right atrial pressure 9. 8±!. 7 IIIIIIIIg, mean pulmonary 
artery pressure 71.913.8mmBg, cardiac index 1.6610.12 
litres/minute/m' and mixed venous oxygen saturstion 
58.712.6%). Patients were randomised either to receive 
PGI, or ILO for Phase I and then were crossed over to 
Phase II. An optimum dose required for ILO was less 
than for PGI, (2.68t1.79ng/kg/min for ILO and 
8.9t5.6ng/kg/min for PGI,1mean ±SO). Exercise tolerance 
was measured at baseline and at the end of each phase. 
Comparison was made between distancea(m), rest time(S), 
percent change in oxygen saturation(6saO,) and percent 
increase in heart rate(6BR) during a 12 minute walk. 
The results are as followa: 
** 
* ± 
There was a significant improvement in exercise 
tolerance both with PGI, and Iloprost. Similarly the 
rest periods both with PGI, and Iloprost were 
significantly less than baseline. We conclude that 
continuous Iloprost infusion is comparable to PGI, in 
the treatment of severe pulmonary hypertension. 
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950·122 
Acute Vasodilatory lIesponaiven.a. in S .... re PulJaonary 
Hypertenaion (SPH) and 'l'reat..nt With Continuoua 
Proatacyclin (PGI,) Infusion 
*A Yazdani Butt, George Cremona, Motoshi Takao, Tim W 
Higenbottam. Papworth Bospital, Cambridge, England 
Continuous PGI, infusion has produced sustained 
haemodynamic and symptomatic improvement in SPB. 
Generally vasodilator therapy is recommended for those 
patients showing significant reduction in pulmonary 
vascular resistance (PVR) to acute vasodilator challenge. 
We have questioned the need to perform acute vasodilator 
trial in SPB and report the results from 21 patients 
(mean age 37 .3±!4) with SPB (Mean pulmonary artery 
pressure 60.8t2.6mmBg, cardiac index 1.63±O.07L/min/m', 
right atrial pressure 12. 9il .4mmBg and mixed venous 
oxygen saturation 59.9±2.3'1 mean ± SEM). Majority of 
patients had primary pulmonary hypertension (n-16) while 
others had SPB due to pUlmonary embolism (n-S). 
Baemodynamics were measured at baseline and after 
vasodilator trial with PGI, and patients were grouped 
into responders (R) and non-responders (NR) depending 
upon the degree of fall in PVR, 20% being target value. 
All patients were then commenced on continuous PGI, 
infusion and their exercise tolerance was measured at 
baseline and after PGI, therapy (6 .5±7.3 weeks1mean1S0). 
The results are as follows:-
PVR (Wood , drop 12min walk 
rl.s~ 1.n 
exerC1.se 
Patients units) in PVR (m) tolerance 
lBaseT1.ne PGI, Baseline PGI, 
f21J.1 114:"2" f2"9."9" [31lT ;:~ 'i::% ~ll) t2.9 ±1.6 t2.1\ ±47 117 • 4 l5.3 112.9 1341 I~~~ I;~~, 10) ±1.2 t1.3 :!:l.9' ±44 
mean va. ues :t SE ~ 
Improvement in exercise tolerance with continuous PGI, 
infusion was not predicted from the acute vasodilatory 
responsiveness. Prostacyclin may not act as a 
vasodilator only and might have a role in remodelling of 
the pulmonary vasculature in patients with SPB. 
950·123 
Acute Hemodynamic and NeurohUlllOlllI arec:t. of Intravenous 
Prwtacyc:lln in Primary Pulmonary ~
Srinivas Murall, Tammy R. Tokarczyk, VlshwaJeth B. Bhoopalam, 
Yvonne M. Cannon, Susan Loftus, Barry F. Uratsky. University of 
Pittsburgh Medical Center, Pittsburgh, PA 
Pravious studies have shown that acute Infusions of Intravenous 
prostacyclln (PC) favorably alter hemodynamics, and chronic 
Infusions Improve clinical symptoms, and exercise tolerance in 
patients (pta) with primary pulmonary hypertension (PPH). The 
neurohumoral effects of PC infusion In PPH ara however not known. 
We studied the acute hemodynamic and neurohumoral effects of PC 
infusIon In 9 PPH patients (8 femal_, 1 male; mean age 37±7 yrs) 
with NYHA clats m-l'/aymptoma and normal left ventricular function 
(mean ejection fr.lct:on 5!1±~%). PC InfUsion was given starting at 2 
ng/kg/mln \'Vith Incramerota of 2 ng/kg/mln every 15 min until side 
effecta occurred precluding further Incra .. es In dosage. 
Hemodynamic and neurohumoral data at baseline (B) and 15 min 
after maximal dose of PC (M, 6.6±0.7 ng/kg/mln) ara shown. 
RA PAM CO fllR APM NE PRA ANP 
B 813 57t4 3.6±0.4 13.712.6 9413 557±92 3.6±1.3 135t24 
M 6±3 51±5 4.8±0.6' 8.6±1.4' 77±4' 534±74 9.0±3.8° 142t30 
°p=0.07; 'p<0.05 , ... va B; RA, PAri., APM = me3'·. right atrial, 
pulmonary artery, systemic Iitery plftsures (rmnHg); CO=cardlac 
output (Uml",; PVR=~ulmonati vascular teSlsta',c.! (Wood uniu); 
NE=pI3sm .. llorcp!naphriR9 iXJIm!, normal 110-410); PRA=plasma 
renin Ictivlt'/ lng/mil:" norma! 0.2-2.3); .Il.I\P=plaGr".1 atrial natriuretic 
peptide Ipg/ml, normal ~0-77). !!.oneluslon..; PC infusIon acutely 
improve" hemoo,/namic5 without correcting the naurohumoral 
abnormalities lieen in PPH. 
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950·124 
ACT (Aadv.tod Cloning TIm.) o.t...,,1netIon In V •• _, Sheath.. A,. ACT VaIu •• 
DIff.,ent _ .... An .... , .net V_a s.m ..... Aft., H_rIn FIu.h or H_rIn IoIuI 
Admlnlatrotlon? 
J. Randall Forrer, Joaeph Stein, Richard Friadmen, Darlene Rudzlk, Mercy Hoop~al, 
Sen Diego, CA 
To determine ij ACT mooourement I. affected by hoporin flulh or heparin 
bolus after 3 cc of waste i, removed. Petlents hid In8rial and venoul sheath placed. 
Then bel.line ACT me •• ur.ment. wlr. performed. Both ,heath. Wlr. fluehad with 
heparinized .ellne 1000 cc/500 cc 05W. ACT', we,. drown from both. A haperin 
bolul 13ooo·5000u) WOl given o~her onoriolly levon daye) or venoully (odd doyo). 
After a 10 minute waking period ACT'. wore agein porformed. 
Fourteen pltient. we" given heparin bolus via .rtari.1 ,heath (evln deYI) 
and II pationtl via venouo oheoth lodd davol. 
Aa detailed in the tabl. below. b ••• Une value. pre-heparin IlImpte. v •. 
heparinized 'tush .ampl •• ahowed no .tlti,tical diff.rence in ACT levlls (p V.lul 
< 0.001). ACT valu •• er. not Itatisticilly different between venous and an.rial 
IIImpiel pre-heparin and with heparin flush lamp Ie •• fter 3 cc of wI.te removed. 
ACT me.aurementl after a heparin bolus and tin minute waiting period showed no 
.tati,tical difference between arterial and venous values. 
Conclusion: Our study shows thlt the ACT mealurement is not atatilticallv 
different between ba.eline pre·heplrin valuas Ind post-heparin flush values 81 long 
88 3 cc wllte ramoved. Also after a heparin bolus is given, if I 10 minute waiting 
period il adhered to end 3 cc waite withdrawn, the ACT values ,re not statisticallv 
different. Thi. i. not affoctad bV which route the heparin bolus i. given. 
ACT l.ecI) Pre·Heparin Heparin 
Flush 
125 ± 16 
123 ± 30 
Heperin Bolus 
Arterial 
293 ± 57 
306 ± 64 
Venoul 
An.rial 
ACT 
Venous 
Anerial 
ACT 
Venous 
Arterial 
950·125 
124 ± 27 
t09 ± 27 
Pre· Heparin 
127 ± 17 
114 ± 17 
Heparin 
Flush 
128 ± 20 
131 ± 6 
Heparin Bolus 
Venous 
296 ± 99 
277 ± 69 
Grouped Heparin Venous + Arterial 
125 ± 24 
110 ± 25 
126 ± 16 
125 ± 26 
294 ± 69 
297 ± 65 
Is aPTT the Appropriate Marker for Direct Thrombin Inhibitor Effect? 
A Comparison of Hirudin and HlruJog. 
Jeffrey Lelkovits, Eric J Topol, The Cleveland Clinic. Cleveland. OH. 
The activated partial thromboplastin time (aP'IT) has long been accepted as 
the method of choice for monitoring heparin's in-vivo anticoagulant effect. 
Yet it remains uncertain if this is also true for direct thrombin inhibitors (T.I.). 
recently introduced into the clinical arena. We compared the aP'IT response 
to hirudin. a T.I. with broad thrombin binding site actions. and hirulog. a more 
selective T.I .. to determine dose response relationship with aP'IT in patients 
with a clinical need for an antithrombotic. 
Data were obtained from two recently conducted, multicenter. dose-escalat•
ing, thrombin inhibitor studies comparing hirudin and heparin in unstable 
angina (n=159). andhirulog with heparin during coronary angioplasty (n=29 I ). 
Hirudin was given in 4escalating dosages. with a bolus ofO.15-0.6mglkg. and 
an infusion of O.05-0.3mglkg/hr. Hirulog was given in 5 doses with a bolus of 
O.15-0.55mglkg. and an infusion ofO.6-2.2mglkglhr. The maximum aP'IT or 
aP'IT ratio for each dose was detennined using Ciba-Corning 512 Monitors 
in both studies. 
Hirudin induced a linear increase in aP'IT in the the lower dose range. llUl 
plateaued at O.2mglkglhr. No further increase in aP'IT occurred. even with a 
50% increase in hirudin dose. Hirulog on the other hand. continued to prolong 
aP'IT with each dose increment. but required an approximately sevenfold 
increase in dose to obtain the equivalent aPTf level. 
[ ';:j ~ ~:j ~~:Hi;; 
50 I I I I 2 -'-'TI-....,--.,.....~....,-....,--
0.05 0.1 0.2 OJ 0.6 1.4 1.8 2.2 
mglkglhr mglkg/hr 
The aP'ITresponse to these agent~ is not uniform. and it is not known if the 
plateau effect of aPTf for hirudin. or the different dose response of aP'IT to 
hirulog. translate into differences in clinical antithrombotic etlect. We con· 
c1ude that the aP'IT dose response varies with T.I. agent. and may theretl)re 
not be the most appropriate marker of in-vivo antithromhotic action tilT this 
new drug class. Further attention should he directed in detemlining measures 
that reflect in·vivo antithromhntic effect as opposed to in-vitro 
"anticoagulant"effect. 
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950·126 
DltferiDl Blood Prl!lllll't ud ReDID AaJloteIIIIn S,aIem RespcIII8eII to ACE 
IIIhlbltioD ID Heart FaUure. 
Jain B Squire. Roben 1 MacFadyen. Kennedy R Lees, lobo L Reid, Uni~ty 
Depanment of Medicine and Therapeutics,Western 1Dfirmary. Glaslow Gil 6NT. 
UK. 
BACKGROUND EnaIapriI2,Sml but DOt perindopril2melowen BP acutely in 
patients with CHF despite similar plasma ACE inbibiliOD, The response 10 
subsequent doses is unknown. 
OBJECIJ\IE To examine the response oC the renin-angiolensin ByIlClllID cnaIapriI 
and perindopril and the BP response 10 repeated tIosine, 
McIIIW A double blind, randomiscd, placebo conl1011ed parallel JrOuP study 
CODIparing enala¢l2.Smg (E) and perindopriI2mg (PER) in patients (n-48) with 
ll!able symptomatic (NYHA IT-IV) eHF (24-48 hours diuretic withdrawal), BP, 
plasma ACE. plasma renin activity and angiOlcnsin peptides wm moniured for 48 
hours after randomisation 10 treatment on consec:utive days with: E and E; PER and 
PER; Plac:ebo (PLA) and PLA; ~rindoprilat 0.167mg iv,(PER1) and PER, Patients 
were studied supine after dose 1. BP was monitored semi· automatically; 
ambulatory monitDring was used Cor day 2, 
~ Prestudy mean BP, diuretic dose, serum sodium. NYHA class and plasma 
renin activity (PRA) were comparable between JrOUPS, E produced a JrOtracted fall 
in MAP from 3.5-10 hours post dose (mean maximal fall± ISD,2I±3mm Hg), In 
contrast PER showed a similar response 10 PLA (PER,-16 ±2mmHg; P.-IS±2). 
PERT produced a Call in BP over the infusion (Ihr), there being no difference from 
plac:ebo thereafter, After dose 2, mean holD'ly ambulatory BP was lower for E (79.6 
mmHg) than for other treatments (PER.88.6;PLA,88.o-,PERT ,84.2). Mean 24 hour 
BP after PER in the JrOup receiving PERT on day I was greater than with PER or 
PLA(p<o.ol) and less than with ENA(p<O.OI). Plasma ACE inhibition profiles were 
similar for all three active therapies. However the rise in PRA in response 10 E 
(8.l1±S.12 ng Al/mIIhr) was greater CODIpared 10 other ucaunents (PER,3.49±2.S8; 
PERT,S.I8i2.63; PLA,·1.2S±2,S8. p<O.OS). 
ConclusionsWe have confinned a greater initial BP response with enalapri1 than 
perindopril in eHF which persists with repeated ucatment. Initial exposure 10 
PERT enhanced the haemodynamic response 10 PER. The differing responses of the 
RAS indicated by the change in PRA are not reflected by in vitro plasma ACE 
activity. 
950·127 
Hypoteosion Induced by CaplAlpril in PatieDts witb Primary Autonomic 
Failure Occurs Independently or Plasma Renin Levels ud Sympatbetic 
Nervous Activity 
IS Kooner'. RR Baliga'. WS Peart. CJ Mathias 
'Clinical Cardiology Unit. Royal Postgraduate Medical School, Hammersmith 
Hospital and Department of Cardiovascular Medicine. St Mary's Hospital 
Medical School. London. UK 
We have investigated the haemodynamic and honnonaI responses to 
angiotensin converting enzyme inhibition in 12 patients with primary 
autonomic failure (AF. 5 pure autonomic failure and 7 multiple system 
atrophy) and 7 normal subjects. 
Measurements of blood pressure (BP). heart rate (HR) using an 
automated sphygmomanometer (Senlron), stroke distance (SD) and cardiac 
index (el) using continuous wave Doppler (QuinlDn). forearm blood flow 
using mercury strain guage plethysmography and digital sldn blood flow using 
laser Doppler (Periroed) were made non-invasively. Plasma renin activity 
(PRA) and noradrenaline were measured before and at 30 min intervals after 
50 mg oral captopril. 
Basal mean supine blood pressure was higher in AF compared to 
nonnals (117±6 vs 99±4 mm Hg, p<O.05). After captopril mean BP feU in 
AF (to J03±5 mm Hg. p<O.05) but not in nonnals (to 97±5 mm Hg. ns). HR 
was unchanged after captopri1 in both groups. The depressor response in AF 
was accompanied by a fall in SD (9.6±1.2 to 7.6±.0.7 cm, p<O.05) and in eI 
(676±79 to 536±6S cm/min. p<O.05). SD and CI were unchanged after 
captopril in nonnals (SD, 7.7±1.3 to 7.4±O.6 em; el. 579±117 to 571±69 
em/min. both lIS). There was no reduction in forearm or digital sldn vascular 
resistance after captopril in either group. Basal PRA in AF was similar to 
normals. but did not rise after captopril (691±217 10 68I±221 pg/ml/ht. ns) 
unlike nonnals (813±J03 to 136O±290 pg/ml/h. p<O.05). Noradrenaline was 
unChanged after captopril in both groups. 
We conclude that. captopril lowers blood pressure in AF. unlike 
normals. The depressor response in AF occurs independently of plasma renin 
levels and sympathetic nervous activity suggesting that alternative mechanisms 
such as accumulation of prostaglandins and bradyldnin may be responsible. 
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950·128 
Prevention of v •• ov.gal Re.ction During _ .... 1 of 
Femoral Arterial Sheath 
B. N. Rama, Syed K. Kohiuddin, Aryan N. Kooss, Daniel 
Hilleman, Kay Ryschon, Dan Lucas, The Cardiac center 
of Creighton University, Omaha, Nebraska 
Vasovagal reaction (VVR) ia an abnormal autonomic 
imbalance characterized by lightheadedness, nausea, 
vomiting, diaphoresia and hypotenaion with or without 
bradycardia. It is observed with various medical and 
aurgical procedures. There is no prospective study 
evaluating the efficacy of atropine in prevention of 
VVR in clinical aituations. We conducted a randomized 
prospective, double blind, placebo-controlled study to 
evaluate the efficacy and safety of atropine in 
prevention of VVR during removal of the femoral 
arterial sheaths. 
One hundred sixty five patients undergoing left 
heart catheterization were randomly assigned to 
atropine (n=88) or placebo (n-77) group. Patients 
received 0.5 mg of atropine or placebo, five minutes 
prior to the sheath removal. Incidence of VVR was 
significantly reduced in the atropine group 2/88 
(2.3\) compared to 8/77 (10.4\) in the placebo group 
(p=0.02). In ten patients with VVR, significant 
decrease in systolic blood pressure (35.20%5.81; 
p<0.001) and diastolic blood pressure (12.63±l2.6; 
p=0.002) was noted compared to rest of the group. 
Heart rate did not change (4.315.54; p=0.06\). No 
arrhythmia was seen. Dryness of mouth was the only 
side effect of atropine. 
We conclude that atropine may be useful in the 
prevention of vasovagal response associated with the 
femoral sheath removal and may decrease the morbidity 
and associated costs in patients undergoing left heart 
catheterization. 
950·129 
Paradoxical Effect of Intravenous Diltiazem on Aortic Elastic Properties 
Bernard Cholley, Roberto Lang, Claudia Korcarz, Sanjeev Shroff, 
University of Chicago, Chicago, Illinois 
Since in-vitro data have shown that calcium channel blockers reduce 
smooth muscle tone, these drugs are expected to reduce wall stiffness 
and increase large artery compliance in' vivo. To test this hypothesis, 
we examined the effects of IV diltiazem (0.4 mgikgihl on aortic elastic 
properties using transesophageal echo (TEE) with automated border 
detection (ABD) in 7 closed-chest, anesthetized dogs. We measured 
instantaneous pressure (P) in the initial portion of the descending aorta 
with a micromanometer and the cross-sectional area (A) at the same 
level using 2-D TEE with ABO. Data were recorded over a wide range 
of pressures (6P = 48 ± 3 mmHg, mean ± SEM) generated by inferior 
vena caval balloon inflation. Aortic wall thickness was measured using 
M-mode TEE. Aortic compliance per unit length (C = dA/dP), wall 
stress, and incremental elastic modulus (Einc, a measure of wall 
stiffness) were computed prior to and during diltiazem infusion. 
Diltiazem decreased mean P in all dogs (108 ± 6 to 91 ± 5 mmHg, 
p<0.05). A·P relations were linear (r>O.93) over the range of P 
induced by balloon inflation (left panel). 
1 .70 ,-:.-------;,.----" 
o,~o 100 "'---------' 
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Pr.'35Uf. (mmHg) ')11.S5 (q/cm2) 
In every case, diltiazem increased Einc at any level of wall stress (right 
panel). This can be explained by a greater contribution of passive 
stiffness secondary to a drug-induced reduction of vessel tone. With 
diltiazem, aortic compliance either remained unchanged (n; 4) or 
decreased In; 31. reflecting the combined effects of increased Einc and 
altered vessel caliber. Thus, these in-vivo data demonstrate that a 
reduction in smooth muscle tone is not necessarily associated with 
reduced aortic wall stiffness and increased vessel compliance. 
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951·68 
A Mechanism of Ischemic Preconditioning During Percutaneous Transluminal 
Coronary Angioplasty 
377A 
'Teruo Inoue. Yoshihiko Sakai. Shigenori Morooka. Terumi Hayashi. Kan 
Takayanagi. Yutaka Takabat3ke. Depl. of Cardiology, Koshigaya Hospital Dokkyo 
University, Saitama. Japan. 
The manife~tation of ischemic preconditioning and its mechanisms during 
percutaneous transluminal coronary angioplasty (PTCA) were evaluaxed. Twenty 
one patients (20 men and one woman. aged 55 ± 7 years) with stable angina 
pectoris due to single vessel coronary anery disease of the left anterior descending 
anery without visual collateral circulation. who underwent elective PTCA, were 
enrolled for this study. In all patients. PTCA was perfonned by three times balloon 
inflations for 60 seconds each time under the monitoring of a 12·lead 
electrocardiogram. The great cardiac vein oxygen saturation (GCVSatO,) was 
simultaneously monitored with a fiber-optic catheter insened into the great cardiac 
vein. Moreover. in 10 patients. the intrinsic adenosine concentration of the great 
cardiac vein blood was examined after the first and third balloon inflations. 
Anginal chest pain ocrured in all patiems during the first balloon inflation, but only 
in 8 patients (38%) during the third intlation. In ccmparison with the first inflation. 
the third one produced less ~hifts in the ST junction (0.20 ± 0.14 vs 0.14 ± 0.09m v. 
P<O.01) and peak T (0.35 ±O.27 vs O.23:'::0.14mV. P<O.OI). which were 
measured and averaged by 4 chest leads from V, to V,. llle hean rate- blood 
pressure product during the third inllation was equivalent 10 that during the firsl. 
The GCVSarO, decreased equally during the filst and third inflations (35 ±9 vs 
34 ± 90/c). However. the increasing ratio of GCVSatO, at reactive hyperemia after 
balloon deflation 10 the baseline was 1.49 ±O.38 in the third inflation. and higher 
(P<0.01) than the value 011.36±OJI in the first inflation. The serum adenosine 
was 267 ± J 69pmol/ml after the third inflation. and higher (P< 0.05) than the value 
of 145 ± 110 after the first inflation. These results suggest that repeated (three 
times) coronary anery occlusion during PTCA could cause adaptation to 
myocardial ischemia. so-called ischemic preconditioning, which may not be derived 
from an increase in collateral blood flow. but from mechanisms common to 
accelerated reactive hyperemia. for example, an increased adenosine. 
951·69 
Differential Effects of Estrogen in Postmenopausal Women 
'With Presence or Absence of Vascular Dysfunction 
David M. Gilligan, Diane A. Badar, Arshed A. Quyyumi, Julio 
A. Panza, Richard O. Cannon, III. NHLBI, Bethesda, MD 
We have previously shown that estradiol (E,) potentiates the 
forearm vascular response to the endothelium-dependent 
vasodilator acetylcholine (Ach) in un selected postmenopausal 
women. To assess whether women at risk for vascular dysfunction 
respond differently to E, from healthy subjects, we studied the 
forearm vascular responses using brachial anery infusions and 
strain gauge plethysmography in 38 postmenopausal women; 19 
had 1 or more risk factors for vascular dysfunction (hypenension, 
hypercholesterolemia, diabetes, coronary artery disease). Women 
with risk factors had reduced vasodilator responses to Ach 
(7.5. 15,30)Lg/min)(p=O,04) and to the endothelium-independent 
vasodilator sodium nitroprusside (SNP)(O.8, 1.6,3.2 )Lg/min) 
(p<O.OOJ) compared to healthy subjects. E, infusion, which 
increased forearm venous E, levels from J 6 ± II to 32 J ± J 93 
pg/ml, caused no direct vasodilation, but potentiated the forearm 
vasodilation induced by Ach by J8±44% (p<O.OOI) in women 
with risk factors, and by J4±27% (p=O.06) in healthy women. 
E, also potentiated the forearm vasodilation induced by sodium 
nitroprusside in women with risk factors by 14±2J % (p<O.OOJ). 
but not in healthy women. Thus, E, potentiates both endothelium•
dependent and endothelium-independent vasodilation in 
postmenopausal women with risk factors for and evidence of 
impaired vascular function. A trend towards improvement in 
endothelium-dependent vasodilation was also seen in healthy 
women. These beneficial vascular effects may be partly 
responsible for the long-term benefit of estrogen therapy on 
cardiovascular events in postmenopausal women. 
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951-70 
Estradiol Potentiation of Endothelium-Dependent Vasodilation 
is Dependent on Nitric Oxide Production 
David M. Gilligan, Diane A. Badar, Victor Guetta, Arshed A. 
Quyyumi, Julio A. Panza, Richard O. Cannon, ill, NHLBI, 
Bethesda, MD 
We have previously shown that estradiol potentiates the forearm 
vascular response to the endothelium-dependent vasodilator 
acetylcholine (Ach) in postmenopausal women. To determine 
whether this effect is dependent on nitric oxide production, we 
measured the capacity of estradiol to enhance the Ach response 
before and after NG monomethyl-L-arginine (L-NMMA), an 
inhibitor of nitric oxide synthesis, in 13 postmenopausal women, 
aged 59±8 years (mean±SD). On day 1, the responses to Ach 
(7.5, 15, and 30 I'g/min) were measured during concomitant intra•
arterial infusion of 5 % dextrose (D5W), and subsequently, of 17B•
estradiol (2Ong/min). On day 2, the responses to Ach were 
measured during D5W, during L-NMMA (4I'mol/min) and during 
estradiol + L-NMMA. Forearm blood flow was measured by 
plethysmography and forearm vascular resistance was derived. 
On day 1, estradiol potentiated the mean fall in forearm vascular 
resistance with Ach by 23±24% (p=O.01). On day 2, L-NMMA 
impaired the Ach response due to nitric oxide inhibition: the 
mean Ach resistance was 80±63% higher than during D5W 
(p<O.OOI). Administration of estradiol following nitric oxide 
inhibition potentiated the Ach response by only 9±29%, an effect 
that was not statistically significant. Thus, the potentiation of the 
forearm vasodilator response to Ach by estradiol in postmeno•
pausal women is attenuated by inhibition of nitric oxide synthesis. 
These findings suggest that estradiol potentiates endothelium•
dependent vasodilation primarily by enhancement of the nitric 
oxide pathway. 
951-71 
Increased Splanchnic Vascular Capacity During 
Severe Hemorrhage. 
Steven Y. Wang, Frederick G.P. Welt, David L. Rutlen. Yale 
University School of Medicine, New Haven, CT. Medical 
College of Georgia. Augusta, GA 
Previous studies have shown decreases in sympathetic nerve 
activity, arterial resistance and heart rate (HR) during severe 
hemorrhage. Effects of severe hemorrhage on splanchnic 
vascular capacity have not been determined. In 6 chloralose•
anethetized pigs, the intestinal blood volume (lBY) and portal 
vein pressure (pport) relationship was measured using blood 
pool scintigraphy (99mTc) and by variations of Pport. Moderate 
(M) and severe (S) hemorrhage were induced by removal of 
15% and 25% of total blood volume, respectively. mY, mean 
arterial pressure (MAO), cardiac output (CO) and HR were 
recorded. mean±sem, *p<O.05, M vs control (C) and S vs M. 
~ m.Y.f}hl 
C 0 
M -17±2* 
S -8±4* 
MAf (mmHl:l 
75±6 
60±6* 
36±4* 
CQ(Llmiul 
1.3±O.2 
0.9±O.l* 
O.5±O.l* 
HR<bpm) 
159±10 
18l±18* 
161±11 * 
Moderate hemorrhage shifted pport-my curve to the left with 
a decrease in mY, whereas severe hemorrhage resulted in a 
rightward shift with an increase in my compared to moderate 
hemorrhage. These results show that severe hemorrhage is 
associated with an increase in splanchnic vascular capacity 
~- ro m""""'" """- "I V This paradoxical change in vascular 'iii fi capacity may contribute to further i ,. 
decreases in cardiac output and ! ,. 
arterial pressure by pooling of I . 
blood in the splanchnic circulation." ". c 
!'G-2o-no 1020~U40 
IBV",,) 
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951-72 
Characterization of Vascular Mechanical Properties with Three•
Dimensionallntrlvascular Ultrasound and Finne Element Analysis. 
Michael J. Vonesh. Jack V. Pinto Jr .. Cheol·Hyung Cho, David S. Lee, David 
IvanciC. Sanford I. Roth, Krishnan B. Chandran. David D. McPherson. 
Northwestern University. Chicago, IL; University of Iowa, Iowa City, IA 
Vascular mechanical properties (VMP) of atheromatous arterial tissue 
influence reactivity and response following intervention. A novel approach 
was developed to accurately characterize VMP. Human arterial specimens 
(iliac and femoral, N = 10) were collected at autopsy and perfused wnh 
normal saline (3i'C) at 4 static pressures: 80, 100, 120 and 160 mmHg. At 
each pressure, sequential intravascular ultrasound (IVUS) image data was 
collected at 2.0 mm Increments. IVUS data were used to formulate a three· 
dimensional reconstruction of each vascular segment. Incremental elastic 
modulus (Emod) was determined using finne element analysis (FEA). As a 
measure of tissue stiffness, the slope of Emod vs pressure change (Eslope) 
was calculated. The vascular tissue segments visualized by iVUS were 
histologically evaluated to Identify tissue composition (normal. complex 
[fibrous. fatty, calcifiC) and pure fibrous) and compared to VMPs. 
Results: * p<0.05 vs normal; +p<0.05 vs complex (X,±,SEM) 
N 
Emod(xl0
6dyne/cm2) 
Eslope 
~ ~ Fibrous 
17 12 11 
7.6,±,0.16 2.S,±,0.47* 4.3,±,0.55*+ 
29.9,±,13.40 42.1,±,12.27 54.1,±,IS.16 
Emod and Eslope differentiated alterations in stiffness between normal. 
complex and fibrous plaques. This novel approach may provide a method 
of determining in vivo physiologic vascular mechanical properties and 
Identification of the extent and location of diseased segments. 
951-73 
Rapid Evaluation oC Three-dimensional Ardtitecture oC NonnaI and 
AthenJsclerotic Rabbit Femoral Arteries using Confocal Scanning Laser 
Microscopy 
"-ony K. Nasser, .Kbawar Mebdi, .Irmina Gradus-Pizlo, ·Robert L. 
Wilensky, .Keith L. March, Krannert Institute of Cardiology, Dept. of 
Medicine, IndiIUlll University School of Medicine, IndilUlllpolis, IN 
Vascular responses to a variety of physiologic and pathologic stimuli involve 
both alterations in cellular growth and correlated remodeling of vascular 
structure. Evaluation of three-<Iimeasiona1 architecture at the ceUu1ar level has 
typically required labor-inlellSive protocols involving reconstruction of 
multiple seria\ sections. We have utilized ooofocal scanning laser microscopy 
(CSLM) to examine the liIreoMimeosiona1 relationships of the ceUular and 
extraceUular components in full-tbic\cness (100-200 11) specimens of norma! 
and atherosclerotic rabbit femoral arteries. Arteries were perfusion-washed 
with saline (n=4) or perfusion-fixed with formalin (n=20) and examined 
following dissection with no further preparation, embedding, or sectioning. 
Most were examined for autofluorescence (488 and S68 run excitation) with no 
staining, although BOme were examined at the same wavelengths following 
exposure to either fluorescein or propidium iodide. Elastin autofluorescence, 
excited at 488 run, allowed sharp definition of the elastic laminae as well as a 
fine fibrous meshwork surrounding medial and neointimal cells, which 
exhibited preferential autofluorescence at S68 run. The internal elastic lamina 
was seen to possess elliptical fenestrations generally ranging from S-25 p. in 
diameter, and the extemal elastic lamina to be comprised of a meshwork of 
predominantly longitudinally-arranged fibrils. These bounded the layer of 
circularly-oriented medial smooth muscle cells. Also clearly identified was a 
surface layer with occasional adherent formed elements consistent with 
erythrocytes and platelets, overlying a single intimal cell layer in normal areas, 
and mUltiple layers of longitudinally-oriented neointimal cells in 
atherosclerotic areas. A branching microvascular network containing 
erythrocytes was recognized in the adventitia and periadventitia, with 
adipocytes and nerve fibers seen in the periadveotitia. Although nuclear 
orientation and structure were visible after brief exposure to propidium iodide, 
and fluorescein exposure resulted in general signal enhancement, sequential 
visualization of all layers was routinely ICCOmplished by optical sectioning 
without staining or manipUlation of the specimen. Confocal scanning laser 
microscopy represents a powerful tool for determination of three-dimensional 
vascular structure at the cellular level without fixation or destruction of tissue. 
This will make possible detailed evaluation of vascular structure as well as 
composition in single full-tbic\cness specimens. 
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951·74 
Sodium Nitroprusside and Isoproterenol Augment 
Acetylcholine Induced Vasodilation 
"'Jeffrey S. Todd, Susan M. Deiling, Maureen Rafferty, Robert Zelis, 
Penn State University College of Medicine, Hershey, PA 17033 
It has been suggested that a chronic increase in shear stress can 
augment the vasodilator response to agents that release Endothelium 
Derived Relaxing Factor (EDRFj. The converse may be true for low 
flow states such as heart failure (CHF). We proposed that a short tenn 
increase in blood flow (shear stress) in an isolated human forearm, 
would condition the endothelium and result in an augmented response 
to Acetylcholine (ACh), a known stimulator of EDRF release. Nine 
healthy males were studied by infusing ACh into the brachial artery, 
and measuring the forearm blood flow (FBF) response by venous 
occlusion plethysmography. Sodium nitroprusside (SNP) and at a 
later time, Isoproterenol (ISO) were infused intra-arterially for one 
hour, titrating the dose to maintain a FBF of I OmlIminol 00mI of 
tissue. After FBF returned to baseline, the ACh infusions were 
repeated. 
Mean FBF (mIlminoIOOml) Pre SNP 
Baseline 2.55 
ACh 2J.1g1minoIOOml 5.94 
ACh 4J.1g1minol00ml 11.21 
ACh 8J.1g1mino1 OOml 24.57 
*p<.05, post hoc paired comparisons (Newman-Keuls) 
Post SNP 
3.10 
8.92 
17.84* 
31.07* 
Similar results were obtained when ISO was used instead of SNP. 
These results demonstrate that intra-brachial arterial infusions of SNP 
and ISO result in an augmented forearm blood flow response to ACh, 
which is likely due to a conditioning effect on the endothelium from 
short tenn increases in shear stress. 
951·75 
ATP·K Channel Blockade Improves Coronary Autoregulation 
Brian A. Cason, Robert F. Hickey, Igor Shubayev, from the 
University of California - San Francisco, and San Francisco Veterans 
Affairs Medical Center, San Francisco, California 
Blockade of cardiac A TP-sensitive potassium channels diminishes 
vasodilator response to both hypoxia and to transient occlusion. 
Although ATP-K channel blockade is also reponed to diminish 
microvascular adjustments to flow reductions, the effects on classic 
coronary pressure-flow relationships (autoregulation) have not been 
directly measured. Methods: In 11 swine the LAD coronary artery 
was cannulated, and coronary pressure controlled by a pressurized 
reservoir. At coronary pressures from 60 to 100 mm Hg, we 
measured CBF during i.c. infusion of vehicle and of glibenclarnide 
(G, 50 11M blood concentration). CV 02 sat% was measured. 
Coronary pressure-flow slope provided a measure of autoregulation. 
us ~o............. Results· G infusion 
.......... .., diminished coronary ~ ,... blood flow at all .t~ " ~ levels of pressure, 
f f" f 1 1 decreased coronary .. " pressure-flow slope, 
i "::::::.:::.:.:~ and decreased e .. _ __ coronary venous 02 
-..... - sat% substantially. ·""'"--"-~"--""--"--'~"~125 Myocardial ischemia 
_"""","",'_Oft ,....... was not induced, as 
• = different than vehicle, p < 0.05. indicated by stable 
systolic shortening. 
Conclusion: ATP-K channel blockade reduced CBF and made CBF 
more constant over a range of pressures, thus "autoregulation" was 
improved. G acted as a potent vasoconstrictor. We speculate this 
closer matching of flow to metabolic needs was probably mediated by 
a different mechanism (such as tissue P02), rather than a direct 
enhancement of the efficiency of microvascular adjustments by G. 
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951·76 
Do Coronary Vascular Smooth Muscla Cells Become Dysfunctional 
As Laslon Saverlty Incrtlllts? 
Thomas J. Wargovich, Hassan EJ-Tamimi, Michael Mansour, Henry 
Chen, Carl J. Pepine. Division of Cardiology, University of Florida, 
Gainesville, Florida. 
II is generally thought that endothelial dysfunction (as evidenced by 
vasoconstriction in response to acetylcholine) oorrelates directly with 
severity of atherosclerotic disease such that the degree of dysfunction 
increases with lesion severity. To further investigate the relationship 
between coronary reactivity in response to Ach and lasion severity, 23 
patients with stable angina, pos~ive exercise tests and no anti-anginal 
therapy , were studied using computerized quant~ative ooronary 
angiography. Thirty-five lesions were identified and divided into 3 
groups acoording to severity of disease (% diameter stenosis, %STEN): 
MILD lesions (n=8, ranging in severity 15·39%, MODERATE (MOD) 
included 13 lesions, ranging from 40-59% ; and SEVERE included 14 
lesions, ranging 60-95%). Ach was infused selectively into the left 
ooronary artery (ImVmm for 2 min) at concentrations from 10-6 to 10-4M. 
Mean % STEN in MilLO increased from 31±3% et baseline to 45±4% 
after Ach (p<O.02l; after n~roglycerin (NTGl, lesion severity was 29±4%. 
Mean % STEN in MOD increased slightly from 51 +2% at baseline to 
56+-2% after Ach (p=ns); after NTG, lesion severity was 46+4%. Mean 
% STEN in SEVERE did not change from 67±2% at baseline to 65±2% 
after Ach; after NTG, lesion severity was 32±6%. 
In summary, there exists a dissociation between response to Ach and 
lesion severity. The vasoconstrictor response was greater in MILD than 
in MOD or SEVERE, desp~e similar dilator responses to NTG. This 
suggests e~her greater degree of endothelial dysfunction in MILD, 
developing lesions, or a greater degree of smooth muscle dysfunction in 
more severe lesions possibly involving damage, down-regulation or 
absence of muscarinic receptors. 
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952·130 
Small· Diameter Dacron Grafts Seeded With Omental 
E~dothelial <;ells for C:0ronary Artery Bypass Grafting 
Miralem PasIC, LudWIg von Se$esser, Werner Miiller-Glauser 
Marko Turina, Clinic for Cardiovascular Surgery, Department 
of Surgery, University Hospital Zurich, Zurich, Switzerland 
The patency of synthetic aortocoronary grafts is poor. This 
study was designed to investigate whether endothelial cell 
seeding may improve patency rate of small-diameter Dacron 
grafts useable for coronary artery bypass grafting (CABG). 
In 64 mongrel dogs microvascular cells were enzymatically 
harvested from omentum and seeded onto either 4·mm or 6· 
~·inte11?-al diameter Dacron .prostheses prior to the graft 
unplantatlOn. The grafts were unplanted end-to-end into the 
carotid arteries; each dog received one seeded and one non· 
seeded graft. The prostheses were explanted at 2 weeks (n = 5 
dogs), 5 weeks (n = 31 dogs), 12 weeks (n = 10 dogs), 26 weeks 
(n = 12 dogs) and 52 weeks (n = 6 dogs) after surgery. The 
results were assessed by patency, angiography, light, scanning 
electron microscopy and transmission electron microscopy 
imunochistochemistry and morphometry. ' 
The seeded grafts exhibited significantly better overall short and 
long·term patency rates with significantly higher thrombus-free 
surface areas than the control, non-seeded grafts. The overall 
actuarial patency rates at 1, 5, 12, 26, an 52 weeks were 100% 
98%, 93%, 93%, and 93%, respectively, for seeded Dacro~ 
grafts, and 100%, 91 %,61 %, 54 and 18%, respectively, for non•
seeded grafts. The seeded grafts developed a uniform luminal 
monolayer of endothelial·like cells with minimal platelet or 
cellular deposition and without late neointimal hyperplasia. 
One-stage endothelial cell seeding with omentally derived 
microvascular endothelial cells improved short and long-term 
patency of small·diameter Dacron grafts for CABG. 
380A ABSTRACTS 
952·131 
Physiologic Assessment of Angiogenesis Induced by a 
Single Intra·arterial Bolus of Vascular Endothelial Growth 
Factor in The Rabbit Ischemic Hindlimb 
Christophe Bauters, Takayuki Asahara, Satoshi Takeshita, Lu P. 
Zheng, Jeffrey Horowitz, Stuart Bunting, Napoleone Ferrara, James 
F. Symes, Jeffrey M. Isner, St. Elizabeth's Hospital, Tufts 
University, Boston, MA and Genentech Inc., South San Francisco, 
CA 
Vascular endothelial growth factor (VEGF) is an endothelial cell•
specific mitogen which can stimulate angiogenesis in vivo. Recent 
studies from our laboratory have shown angiographic and necropsy 
evidence of augmented collateral artery development and capillary 
density following a single bolus of intra-arterial VEGF in a rabbit 
model of lower extremity ischemia. To evaluate the physiologic 
response to VEGF, a single dose of 100-500 Ilg of VEGF (n=5) or 
saline (n=S) was selectively injected into the ipsilateral internal iliac 
artery (Int I) via 3F infusion catheter, 10 days (d) following ligation of 
external iliac and excision of common and superficial femoral arteries 
in one limb of New Zealand White rabbits. Limb perfusion was 
evaluated immediately pre-VEGF (I0d) and again at 40d. A O.OIS" 
Doppler wire was advanced to Int I to record flow velocity (FV) at rest 
and maximum FV provoked by intra-arterial injection of papavenne 
(pap) 2 mg. Diameter of Int I (Int I d) was measured by quantitative 
angiography. Rest and maximum flow were calculated assuming a 
circular lumen geometry. Data are presented as percent changes from 
10d to 4Od. 
FV rest FV pap Int I d Flow rest Fiow pap 
VEGF +4O(±12) +23(±4) +15(±3) +S5(±1I) +67(±1O) 
Saline -6{±7) -7(±9) +12(±3) +16(±5) +15(±S) 
p value <0.005 <0.05 NS <0.0001 <0.002 
These physiologic findings complement previous anatomic studies by 
showing that intra-arterial VEGF increases resting and maximum flow 
in the rabbit ischemic hindlimb. This data thus supports the notion that 
therapeutic angiogenesis may represent a viable treatment for certain 
patients with lower extremity ischemia. 
952·132 
Acute Vascular Responses to 171l-Estradiol in Postmenopausal 
Women With and Without Atherosclerosis 
Matthias Riedel, Anke Oeltermann, Wolf Rafflenbeul, Andreas Miigge, 
Paul R. Lichtlen. Hannover Medical School, Hannover, FRG 
We compared the acute vascular responses to 176-estradiol (E) in 
postmenopausal women with (Fontaine class lIB: + PAD; n = 8) and 
without (-PAD; n= 17) peripheral atherosclerotic disease using a 
randomized double-blind crOSS-Qver design. All subjects received I mg 
E and placebo (P) sublingually (sl) on consecutive days in random order. 
Axial diameter and blood flow rate of femoral arteries were calculated 
before and 60-80 min after drug administration using the average of 
multiple (20x for each value) measurements with a quantitative Doppler 
ultrasound technique. AfterwardS, 10 mg Isosorbid-dinitrat (ISDN) was 
given sl and the measurements were repeated after 10-30 min. 
Table: Change in % [mean±SD] of basal values (* p<O.OI vs p) 
Diameter P E ISDN 
-PAD 1±2 6±4* 9±5* 
+ PAD I±I -2±2 7±4* 
BIQQa flQw 
-PAD 12±21 37±30* -22± 18* 
+ PAD 13±12 - 4± 17 -17±21* 
As shown in the table, ISDN application was followed by a vasodilation 
and reduction of blood flow in both groups. In contrast, E induced a 
significant vasodilation and increase of flow in healthy women, but was 
ineffective in those with PAD. 
In conclusion, the acute vascular effects of E but not of ISDN are 
abolished in atherosclerosis. This differential response to E and ISDN in 
atherosclerotic vessels supports the experimental evidences for an 
endothelium-dependent action of 176-estradiol. 
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952·133 
Influence of Prior Heart Disease on Morbidity and Mortality 
After Vascular Smgery: Role of Coronary Artery Bypass Grafting. 
Sumita D. Paul, Gilben J. L'Italien, Roben C. Hendel, Jeffrey A. Leppo, 
Kim A. Eagle. University of Massachusetts Medical Center, Worcester, and 
Massachusetts General Hospital, Boston, MA. 
To determine the prognostic imponance of prior hean disease (HD), for 
vascular surgery, 567 patients undergoing vascular surgery (68 with prior 
coronary anery bypass grafting (CABG»; were stratified by # of HD markers 
(hx of MI, angina, CHF, or Q waves on ECG). In those with no prior CABG 
(NOCABG), risk of postoperative cardiac events (EVENn (non-fatal MI or 
cardiac death), increased (t) significantly from 5 % to 27 %, with t # of markers 
(p<O.OOO3). Although a significantly greater # of CABG patients had > 2 HD 
markers compared to NOCABG (63% vs 22%, p<O.OOOI); CABG patients had 
significantly fewer EVENT: 1(\.5%,95% CI:O,4) vs 45 (9%, 95% CI: 7,12). 
Coronary Revascularization Prior to Vascular Surgery 
no prior CABG (n=499) prior CABG (n=68) 
b)~ 100 100 100 100 oS'- 95 92 96 g,~ 85 76 73 ~!JI §~ 
" .I!l!\ 
, 
t::~ : i i; r 4 ',' ~~ 5 o ~/ 0 -- 0 0 ~:§! 0 1 2 3 4 0 1 2 3 4 
Number of Clinical Markers 
Co1lCbuio1lS: 
1. Despite having a greater number of HD markers. patients with prior CABG 
who underwent vascular surgery had significantly fewer EVENT. 
2. In NOCABG patients, t gradient of risk occurs with t # of markers. 
952·134 
A Siapl. Soorin9 sy.t.. for Preop.rativ. C&r4iao Ri.k 
a. ...... nt iD Va.oular Pati.nt. 
Gilbert J. L'Italien, Jeffrey A. Leppo, SUIlita D. Paul, Robert 
c. Hendel, John B. Newell, Chriatopher Col.ey, Kim A. Eagle, 
Univ. of Mass. Medical Center, Worcester, MA.; Massachusetts 
General Hospital, Boston, MA 
We d.veloped a aethod of perioperative cardiac riBk 
.asessment for vascular surgery patients which cOmbin .. 
elements trOll Bayes Theorem and loqistic reqression yet 
requires no computation beyond simple addition and chart 
transcription. The model vas developed froll a dataset of 567 
vaScular surgical patients aged 64 ± 7 years, and comprised ot 
380 males (6") and 187 females (33t). Weighted scoreB v.re 
derived from a COIIbination of clinical (CLIN) risk factor. 
(prior HI by history or ECG, diabetes, angina, congestive beart 
failure, advanced age), and Dipyridamole Thallium (DTJIAL) teet 
findings (fixed or reversible defects, ST depresBion) 
predictive of MI or cardiac d.ath. 
Individual risk estimates are obtained by first adding 
those weights corresponding to the patient's combination of 
CLIN and/or DTJIAL factors; an associated likelihood ratio(LR) 
is then transcribed graphically, and a posterior probability is 
read from a Bayesaan nomogram using the LR and a user defined 
prior probability. 
Internal validation V&8 obtained by stratifying patients 
according to range. of estimated risk and comparing midvaluea 
of these estimates to observed event rates ( ± 95% CI). The 
results are given belovo 
Estimated Risk: 
Range Mid 
0.00 - 0.05 0.03 
0.05 - 0.10 0.08 
0.10 - 0.15 0.13 
0.15 - 0.20 0.18 
0.20 - 0.35 0.28 
0.35 - 0.52 0.44 
Total: 
Observed Event Rate: 
levent total rate 95t CI 
9 I 342 0.03 0.01 - 0.04 
4 / 75 0.05 0.00 - 0.10 
6 I 45 0.13 0.03 - 0.23 
8 / 38 0.21 0.08 - 0.34 
9 I 38 0.24 0.10 - 0.37 
10 / 29 0.34 0.17 - 0.52 
46 567 0.08 0.06 - 0.10 
Least squares regression of mid range risk estimat.. to 
observed event rates yielded a correlation coefficient of .97. 
We conclude that the method allows the clinician to easily, 
reliably, and quickly assess the 30 day risk of a cardiac event 
... on9 patients who are candidates for vascular surgery. 
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952·135 
Reduced Time (or Femoral Venipuncture by Simple Bedside 
Application o( Valsalva Maneu,'.r: the Poor Cardiologist's Smart 
Needle. 
Tonino Bombardini, Enrico Magagnini, Eugenio Picano. CNR, Inslilule of 
Clinical Physiology Institule, Pisa, Italy 
Femoral venipuncture mighl be made easier by the Valsalva maneuver. which 
distends the femoral vein. Aims of this sludy were: I) to assess the entilY and 
time course of changes in femoral vessels caliber during Valsalva; 2) to evaluate 
whether Valsalva maneuver mighl shorlen the time required for femoral vein 
cannulation. In the fU'Sl pan of the sludy, performed in the echo lab. we evaluated 
10 ptS by transcutaneous Duplex Scan allowing simultaneous imaging of femoral 
artery and vein in the shorl axis seclion. Cross seclional area of both vessels was 
evaluated al reSI and after 5 and 20 seconds of strain phase of Valsalva. The 
increase of femoral vein caliber (resl = 94±50 mm2) was substantial after 5 sec of 
Valsalva (I 98±60 mm2; p<.01 vs resl) and did nol increase furtherly after 20 sec 
(201±80 mm2, p=ns vs 5 sec; p<.OI vs resl) whereas femoral artery size (resl= 
85±25 mm2) was nOI signifieanlly affected by 5 sec (91±27 mm2, p=ns vs resl) 
and only minimally by 20 sec of Valsalva (99±33 mm 2, p<.OI vs resl). 
Therefore, a brief Valsalva maneuver more Ihan doubles the size of femoral vein 
with only a trivial effecl on femoral arlery size. In the second parI of the sludy. 
performed in the calh lab, 76 consecutive pts were randomly assigned 10 2 groups: 
30 pIS underwent cannulation of the femoral vein with the standard approach and 
30 pts with the usual approach and al leasl 5 sec of Valsalva maneuver. The 2 
groups were similar for age, sex, heigh I and body weigh!. A shOrler overall time 
for the completion of the procedure from cutaneous punclure to cannulation was 
recorded with the Valsalva approach (J hI 5 sec) in comparison wilh the standard 
one (32±46 sec, p<.05). We conclude thai a brief Val salva maneuver is a highly 
feasible, very well toleraled way 10 double the "target" size in femoral 
venipuncture and to make the femoral vein cannulation easier and fasler, with no 
additional apparalus rC{)uired. 
952·136 
Beparin Adainistration Via .a.ograa Versus Standard 
Approach in Venous aDd Arterial Disorders 
Michael R. Jaff, Jeffrey W. Olin, Marion Piedmonte, Carol 
Pirzada, Robert A. Oraor, Jess R. Young, Cleveland Clinic 
roundation, Cleveland, Ohio. 
To determine whether heparin administered by a 
continuous intravenous infusion using a nomogram was 
superior to a random d08ing scheme, we performed a 
prospective, randomized, comparative trial in 161 
patient. (ptS). In group I, pte received a 5000 IU bolus 
of heparin followed by heparin administration by a 
previously publhhed nomogram. In group II, pts received 
a 5000 IU bolus of heparin followed by continuous heparin 
with dosage at the discretion of the attending physician. 
Group III received a continuous heparin with dosage at 
the discretion of the attending physician without the 
prior administration of a bolus. Demographics baaeline 
APTT and total heparin do.e were not different among the 
3 group.. The re.ults are shown below. 
~ GroupII ~ 
(N-54) (N-54) (11-53) 
, achieving 
therapeutic APTT 
in 6 hours 35.2 37.0 30.2 
in 24 hours 64.8 64.8 62.9 
in 48 houra 85.2 84.0 91.8 
, remaining in 
therapeutic range 
at 24 hours 46.7 44.0 46.1 
at 48 hours 67.3 74.0 79.3 
There was no statistical difference in efficacy or in 
bleeding complications between the three group •• 
Theee data show that the nomogram wae not more effective 
in achieving a therapeutic APTT more rapidly nor does it 
improve the time a patient remaine in the therapeutic 
range when compared to the methods of administration 
described above. These data also suggeet that we need to 
be more aggressive in heparin dosing 80 as to achieve 
therapeutic APTTS more rapidly and keep the APTT in the 
therapeutic range more conaiatently. 
ABSTRACTS 
952·137 
Circadian and Circannual Rhythm of Pulmonary Embolism In a 
Hospitalized Population 
G.V.R.K. Sharma, James M. Frisbie, Jeffrey I. Leavitt, Mehdi L. 
Sarkarati, Shukri F. Khuri. BrocktonlWest Roxbury VA Medical 
Center and Harvard Medical School, Boston, MA. 
In 89 patients who developed pulmonary embolism (PE) during 
hospitalization the time of onset of PE symptoms could be accurately 
determined. PE was diagnosed by pulmonary angiography in 53, high 
probability via scan in 26 and autopsy in 10 patients. 
40 Circadian Circamual 40 
~~ ~ 
w~ ~ a. 
10 10 
O.J.....J ...... ~----~ ...... L.....J.....-.---.-....-....J.. 0 
Hours of Day Months of Year 
Incidence of PE (see Figure) varied depending on the time of the day 
(circadian) and the time of the year (circannual). It was higher in the 
AM (0-12) hours, compared to the PM (12-24) hours (67/89,76% 
VS. 22189, 24% p < 0.0001). The winter season (months 1-3) in 
Figure) had a higher PE incidence (20/89, 45%) than other seasons 
(p < 0.001). 
The results show that the onset of PE follows a circadian and 
circannual rhythm which may be secondary to increased 
prothrombotic and decreased fibrinolytic mechanisms, Awareness of 
the chronobiological rhythm of PE in the hospitalized population may 
have important diagnostic and therapeutic implications. 
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953·97 
Reduced Bioavailability of Enalapril in 
Patients with Severe Heart Failure 
381A 
Kristin C. Oberg, Vicki L. Just, Jerry L. 
Bauman, Mary Anne Papp, University of Illinois 
and VA West Side Medical Center, Chicago, IL 
Prior studies have shown that elevated right 
atrial pressure (RAP) in severe heart failure 
(HF) is a predictor of poor long-term clinical 
response to angiotensin converting-enzyme 
inhibitors (ACEI). Bioavailability (F) of oral 
enalapril (E) is reported to be unchanged in 
compensated HF, however we questioned the F in 
functional class III-IV HF patients (pts) with 
elevated RAP (systolic RAP~30 mmHg by doppler) 
and hepatomegaly. Pts and normal volunteers 
(V) were given a single dose of 5 mg of E then 
(after washout) 1.25 mg IVenalaprilat (ET). 
Serum for the determination of ET 
concentrations were collected for each dose 
serially over 60 hours, The F in pt8 with 
increased RAP was decreased compared to V, 
31±10 versus 61±6%, respectively (p<O.OOl). 
Time to peak ET concentration was delayed in 
pts versus V, 7.4±2 and 3.5i2 hours, 
respectively (p<O.Ol). Both clearance 
(0.6±0.14 versus 1±0.2 L/hr) and volume of 
distribution (0.liO.03 versus 0.17tO.05 L/kg) 
were decreased in pts with HF (p<0.05). These 
data suggest that 1) pts with severe HF and 
elevated RAP may have a diminished response to 
to oral E therapy because of decreased F 2) 
pts thought to be refractory to ACEI therapy 
may benefit from a trial of IV ET therapy 3) 
the F of other ACEI should be determined for 
HF pts in states of congestion. 
382A ABSTRACTS 
953-98 
Left Ventricular Volumes Predict Development of Heart 
Failure and Potential Clinical Utility of ACE Inhibitors in 
Patients with Asymptomatic Systolic Dysfunction 
Laurence A. Conway, Hubert Pouleur, Marvin W. Kronenberg, 
Michel F. Rousseau, James E. Udelson, Dawn Stewart, Salim Yusuf, 
Debra Kinan, Marvin A. Konstam, for the SOLVO Investigators, 
Tufts University, New England Medical Center, Boston, MA. 
In asymptomatic patients, L VEF ~ 35% is. known to carry a 
substantial incidence (18% in I year) of progreSSIOn to o~en <;HF. In 
this population, ACE inhibitors reduce both further LV dilatanon and 
development of CHF. However, it is not known to .what extent 
additional stratification by LV volumes defines a populanon at greater 
risk, or whether the predictive value is altered by trea~ent. We 
correlated baseline radionuclide L VEF and LV volumes WIth a) onset 
of CHF, b) 1st hospitalization (hosp) for CHF and c) 1st ~ardiac 
hosp in 108 asymptomatic patients ~th L YEP .s 35%, randormzed to 
enalapril or placebo. Below ~ rel!lnve nsks (RR). of event for each 
increment in L VEF, LV end-diastolic (ED) volume index (VI) and LV 
end-systolic (ES)VI for placebo-treated patients. 
Cardiac Hosp CHf Hosp CHF Onset 
Increment RR ~ RR ~ RR ~ 
LVEF 1% 0.849 0.0001 0.882 0.01 0.859 0.005 
LVEDVI ImJ,1M2 1.012 0.008 n.s. n.s. 
LVESVI 1mJ,1M2 1.019 0.0004 1.020 0.04 1.017 0.05 
In patients receiving enalapril, the frequency of adverse clinical events 
was reduced, and correlations between baseline LV volume 
measurements and clinical events were lost. 
Conclusions: In asymptomatic patients with reduced L VEF, ~ 
with ACE inhibitors, the severity of LV dysfunction and dilatation 
predicts clinical progression: hospitalization and onset of ~ .are 
more common with lower EF and larger LV volumes. Similar 
correlations are absent in patients receiving ACE inhibitors, possibly 
due to reduction in both LV dilatation and clinical event rates. These 
data suggest that within a population with L ~F .s. 35%, ~ditional 
stratification by L VEF and LV volumes further Idennfies panents who 
are most likely to benefit from ACE inhibitors. 
953-99 
The Effects of ACE Inhibition on Ventricular Volume and Mass in 
Tachycardia·Induced Cardiomyopathy: Timing Dependence or Therapy 
Michael J. Child, Henry H. Holzgrefe, Susan R. Arthur, and Michael A. 
Thomas. Bristol-Myers Squibb, Princeton, NJ 
ACE inhibition (ACEI) improves left ventricular function and reduces mortality 
in congestive heart failure (CHF). Recent reports have described differential 
effects on ventricular morphology in CHF which were dependent upon Ibe 
timing of ACEI Iberapy, but Ibe course of ACEI time dependence Iw not been 
resolved. Accordingly, we compared Ibe effects of chronic ACEI (fosinopril, 30 
mgikg, BID) initiated before, and after maximal ventricular dilation, in a canine 
model of pacing-induced CHF (216 ±2 bpm for 4 weeks, followed by. 4 week 
recovery at NSR). Eighteen dogs were randomized to 3 treatmeot groups: 
Vehicle (n=6), ACEI·14 (ACEI for 14 days, weeks 3 and 4, D=6), and ACEI-
30 (ACEI for 30 days, weeks 0-4, n=6). Hemodynamic and hormonal profiles, 
and clinical assessment by 2·D echocardiography, were performed weekly for 
eight weeks. Ventricular volumes are expressed as percent of prepacing control. 
(Data are mean ± SEM, -p < 0.05 vs Vehicle) 
Week 
Vehicle 
ACEI-14 
ACEI-30 
Diastolic Volume 
2 
150±7 
164±7 
133±6 
3 4 2 
162±8 165 ±5 327±43 
171 ±9 172±6 322±59 
134±6" 154±6 259±34 
Plasma ANF (fmoi/mil 
Systolic Volume 
3 4 
393±41 422±43 
323±50 354±53 
Z74±33- 345 ±43 
Week 0 1 2 3 4 5 8 
Vehicle 14±1 57±16 59±7 64±14 57±l9 13±1 8±2 
ACEI-14 17±2 54±15 44±6 61±11 67±11 22±4 18±7 
ACEI-30 13±2 25±3 Z6±4" 33±3- 26±3 19±Z" 1l±2 
Systolic and diastolic volumes, and plasma ANF were significantly decreased in 
the ACEI·30 group. Following 4 weeks of recovery the LV masslbody weight 
ratio was reduced in the ACEI-30 group (6.7±0.4, 6.3±0.4, 5.4±0.2- gikg; 
Vehicle, ACEI-14, and ACEI-30, respectively). These data suggest Ibat Ibe 
beneficial effecls of ACEI on ventricular morphology are dependent upon Ibe 
degree of ventricular dilation at the initiation of Iberapy. ACEI, initiated after 
ventricular dilation was maximal, was ineffective in Ibis model of heart failure. 
lACC February 1994:1A-484A 
953-100 
Differencea in Vaaodiletor Reaponaa by Race in Beart 
railure. Wen 
Peter B. Caraon, Gary R. Johnaon, Stave H. Singh, Roa. 
D. rletcher, Jay H. Cohn for the VA Cooperative Study 
Group, Waahington, DC, Kinneapoli., KH 
Converting enzyme inhibitor. (CRI) are le •• effective in 
hypertenaion in black (B) pta than white (W) pt •• rrom 
Wen I • II we _Ulined the hypotheBi. that CBI may be 
le •• effective in B pt. in heart failure by evaluating 
the ba.eline variablea, annual mortality rate (AMa), and 
re.pon.e to therapy with hydralazine-i.~.orbide 
dinitrate (B-I) v. placebo (P) and B-I v. enalapril (B). 
Ba.eline variable. differed below (P<.OS). 
Wen I B(lSO) W(4S0) WerT II B(21S) W(S74) 
Age SIi.3±9 S9.2±1i.9 SS.S±9.0 61.2±S.0 
IIxIITH\ 46.6 37.3 64.9 U.S 
CAD'll 20.S 53.2 2S.4 61.6 
CTRatio SS.Ii±6.3 S2.7±1i.3 S4.4±S.9 S2.2±6.0 
BTN.ax Hyperten.ion CAD_coronary artery diaea.e. 
In WerT II pla ... norepinephine (pg/ml) wa. S13±229 B 
and SS9+367 W (P<.002) while pla.ma renin activity 
(ng/ml/hr) waa 13.S±22.1 B v. 19.6±4S.1 W (P.<.03). 
Va.odilator therapy raaulted in the following (* p<.OS). 
WerT I B-I P P VBen II B-I B P 
B pt. 9.7 17.3 .04* 12.9 U.S .94 
W pta 16.9 18.S.48 14.9 11.0 .02* 
XOrtality for B v. W wa. not different for P in V-Sen I 
(p.0.66). Summary. In VHerT B pta with heart failure 
had larger heart., more often BxBTN, le •• CAD but al.o 
were younger and with le •• neurohormonal .timulation. 
Mortality in B pt. wa. reduced by H-I wherea. W pt. 
re.ponded more favorably to B. Conclusion. ae.pon.e to 
va.odilator therapy appear. to differ by race. Thi. may 
reflect different etiologie. of heart failure and the 
degree of neurohormonal .timulation, 
953-101 
P .... lst.nce 01 Abnormal V.ntrlculOllrterial Coupling Ind Decr .. _ 
ConcluH V .... I Complilnce Desplt. Perlpherel VllOdlletlon with 
Hydralezlne Ind Nitroglycerin In Congestive H .. rt Fillur. 
PhUlp F. Blnldey. Douglas B. VanFossen. Garrle J. Haas, Robert J. Cody, 
Carl V. Leier. The Ohio State University, Columbus, OH 
We have demonstrated that abnormal ventrlculoarterial rJ A) coupling 
and decreased condutt vessel compliance are early and integral 
components of the vascular response to decreased ventricular 
contractHIty and contribute to the increased afterload in congestive heart 
IaOure (CHF). It Is not known whether the vasodUators used in the 
clinical management of CHF rectify these fundamental abnonnaltt1es. We 
tested the Influence of the combination of hydralazine (HYD) and 
nttroglycerln (NTG) on VA coupling in 24 CHF patients in whom aortic 
Input impedance was measured at baseline and at plateau response to 
sequential randomized administration of intravenous HYD and NTG. 
Although peripheral resistance significantly decreased and stroke volume 
increased (p=.OOOl), a persistent decrease in condutt vessel compliance 
was evidenced by an increase in characteristic aortic Impedance (dynes· 
sec/cm") from 97±54 to 116±60 and wave reflection index (dynes· 
sec/cm") from 166±137 to 221 ±185. Efficiency of energy transfer 
significantly (p= .001) decreased as indicated by a significant increase in 
the ratio of pulsatHe to total power output and which was by post test 
comperlson attributable to HYD but not NTG. Therefore, desptte 
peripheral vasodHatlon and augmented stroke volume, the combination 
of HYD and NTG laBs to alter large vessel compliance or rectify 
abnormal ventriculoarterial coupling in CHF with consequent Impairment 
of efficiency of energy transfer. Given the demonstrated influence of 
pulsatile hydraulic load on myocardial energetics. these observations 
have Important Implications regarding the long·term benefit of this 
vasodHator regimen to clinical response. myocardial function. and 
potentialiy mortality in CHF. 
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953·102 
Altered Blood Volume Responses to Nitroglycerin In ExperImental CHF. 
S. Gabrielle Home. Israel Belenkie. Dante E. Manyari, John V. Tyberg, 
Eldon R. Smith, University of Calgary, Calgary, Canada 
In CHF, the distribution of blood volume (a venous property). has received 
little attention. Reasoning that shifts of blood volume between the central and 
peripberal compartments could modulate cardiac preload, we instrumented 7 
splenectomized dogs witb LV and RV micromanometers. and a portal 
pneumatic constrictor witb a portal pressure catbeter upstream. After 
recovery, we used radionuclide equilibrium blood-pool scintigraphy and graded 
portal venous constriction to examine the effect of angiotensin II and 
nitroglycerin on the portal pressure - abdominal blood volume relation 
(PVR). in the control state and during CHF in the unsedated dog. A lead 
square under the anterior abdominal wall allowed determination of the 
proportion of the total counts arising from the splanchnic circulation 
(SP%TC). Total blood volume was determined by labelling packed cells ("Cr) 
and plasma ("'1) (n=6). After control measurements, the dogs were paced at 
240 bpm for 4-7 weeks until CHF developed. The same drug doses were used 
at the 2 time intervals. 
In CHF. blood volume increased from 76::1:15 to 97::1:11 ml/kg 
(p<0.05). fully accounted for by a 38'* increase in plasma volume. The 
SP'ifTC decreased in CHF from 50::1:13 to 16::1:16% (p<0.05). A dose of 
angiotensin II sufficient to raise LV peak systolic pressure from 139::1: 18 to 
180::1:23 mmHg in the control state, resulted in a lefrward sbift of tbe PVR 
(venoconstriction) of similar magnitude in the control and CHF states. 
Abdominal blood volume at a portal pressure of 20 mmHg. as a percentage 
of baseline (ABV",), was 91 ::1:9% and 93::1:8% respectively (p=ns). In contrast. 
with a dose of nitroglycerin sufficient to decrease LV peak systOlic pressure 
from 143::1:15 to 129::1:12 mmHg in the control state. the rightward shift of the 
PVR (venodilatation) was greater during CHF tban in the control state 
(ABV", was 150± 14'* and 120::1:20'* respectively, p<0.05). These results are 
consistent witb venoconstriction of the splanchnic bed in CHF. despite an 
increase in total blood volume. The enhanced venodilatation with nitroglycerin 
in CHF may renect the more vao;oconstricted baseline (representing a small 
absolute volume shift), or an abnormality of venous endothelial nitric oxide 
production in CHF. 
953·103 
Nisoldipine Therapy Improves Resting Abnormalities in Myocardial 
Perfusion in Patients With Severe Ischemic Left Ventricular 
Dysfunction 
Michel F. Rousseau, Jacques Melin, Sylvie Ahn, Claude R. Benedict, 
"Martin Bornemann, University of Louvain, Brussels, Belgium and 
Bayer AG, WuppertaJ, Germany. 
Trials are assessing the benefit of calcium antagonists in CHF but the 
mechanism of action of these drugs in CHF is unclear. Accordingly, the 
effects of this therapy on regional myocardial perfusion and neuro•
hormonal status were assessed in a double-blind, placebo-controlled 
study including 28 patients (pts). All pts had ischemic LV dysfunction, 
with an ejection fraction between 25 % and 35 %; per protocol, they 
were stratified according to concomitant use of ACE inhibitor (n= 14) or 
no (n= 14). After baseline measurements at rest, including single photon 
emission computed tomography (SPECT) with Tc-MIBI, neuro-hormones 
(norepinephrine, renin, arginine vasopressin, atrial natriuretic peptide) 
and echocardiography, the pts were randomized to the dihydropyridine 
derivative, nisoldipine (NlS, 20 mg once daily; n= 14) or placebo 
(n= 14). Measurements were repeated after 8 weeks. SPECT data were 
analyzed quantitatively to derive an index of hypoperfusion representing 
the % of the LV mass with Tc-MIBI activity below normal. At baseline, 
all pts had areas with reduced Tc-MIBI uptake and had significant 
elevation of plasma neuro-hormones. Wall thickness was unchanged in 
both groups while the extent of hypoperfusion was reduced in 8114 pts 
with NIS and in 2/14 pts with placebo (p=O.046, 2 tailed). The benefit 
of NIS was similar with or without ACE inhibitor and none of the neuro•
hormones was significantly modified by NIS. Thus, chronically 
underperfused but viable areas are present at rest in pts with ischemic 
LV dysfunction; NIS improved perfusion in these areas without neuro•
hormonal activation, suggesting a mechanism by which dihydropiridines 
could be useful in ischemic CHF. 
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953·104 
Effects of Amlodipine on Venous Capacttance and Contractility in Acute 
Heart Failure 
Debra L Isaac, Israel Belenkie, Dante E. Manyari, and John V. Tyberg, 
University of Calgary, Calgary, Alberta, Canada 
Amlodipine (AML) improves exercise capacity in patients with congestive 
heart failure (CHF). This may be due to an increase in venous capacttance 
(CAP) leading to lower filling pressures. To test this hypothesis and to 
assess the hemodynamic effects of AML in CHF, incremental doses 01 
intravenous AML were given to 11 anesthetized splenectomized dogs (4 
controls and 7 CHF). Aortic (P.J, LV end-diastolic (LVEDP), and portal 
venous (P .. ) pressures, cardiac output (thermodilution), portal'f1ow (0 ... 
u~rasonic probe), and intestinal blood volume (IBV, ""'c blood-pool 
scintigraphy) were measured. Intestinal vascular conductance (COND = 
Q,J(mean p .. -mean PO')) and CAP were measured before and 15 min 
after each dose 01 AML (150 l1g/kg to a max total dose 011000 l1g/kg). p .. -
IBV curves were obtained by impeding QO' (pneumatic cuff) and I1CAP 
were defined by the I1IBV at P", = 7.5 mmHg. CHF was induced by the 
infusion 01 microspheres into the left coronary artery. AML increased 
COND in both groups; however CAP OQ 0 ....... , 
tended to increase (11=8%, p=.052) as eo • CHF 
COND increased (11=44%, p=.019) in the '0 
controls, whereas CAP did not change 10 
(11=-5%, p= NS) as COND increased 00 
(11=34%, p=.OO1) in the CHF group. 
Changes in stroke work (SW) were dose•
dependant (Figure). LVEDP increased in 
both groups (11=3 mmHg. p<.05). In the 
o 
o 
o o 
o 
controls this was associated wtth an g.o 0 
increase in SW (11=30 g/m. p=.01B), while F-.. i ____ _ 
in the CHF group SW decreased (6=-12 
g/m, p=.OO1) as lVEDP increased, 
suggesting a negative inotropic effect. In 
conclusion, AML increased LVEDP, failed to 
increase CAP, and may have a negative 
inotropic effect in our acute CHF model. 
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Utility or Direct Symptom Assessment in Measuring the 
Efficacy or Therapy in Chronic Heart Failure: Evaluation 
in a Controlled Trial or Beta·Blockade 
Madeline Yushak, Norma Medina. Henry Krum, Jonathan Sackner•
Bernstein, Rochelle L. Goldsmith, Marrick L. Kukin, Brian Schwartz, 
Joshua Penn, Milton Packer. Columbia University College of P & S and 
ML Sinai School of Medicine, New York, NY 
Maximal exercise tests have been used to assess the efficacy of drugs for 
heart failure (CHF) but C3IU\Ot be used to evaluate ~-blockers because they 
attenuate maximal HR. Some have advocated the use of submaximal tests, 
but their clinical utility remains unproven. We developed a brief (7-item) 
CHF symptom questionnaire (HFSQ) that inquires directly about the 
severity of CHF symptoms and closely mimics the usual patient-physician 
dialogue. The responses to the HFSQ are averaged to produce a global 
score ranging from 0 (least symptoms) to 21 (worst symptoms). The HFSQ 
was used prospectively in a double-blind study of the beta-blocker. 
carvedilol (CRV) in 49 CHF pts. PIs received either CRY (0=33) or PBO 
(0=16) [2:1 randomization] for 14 wks, and the HFSQ (and other functional 
variables) were assessed before and after long-term thecapy. 
Before randomization, the HFSQ score ranged from 3 to 17 units and 
did not correlate with NYHA class. 6-minute walk distance (6MW) or 
maximal oxygen consumption (V02max). Following long-term therapy, the 
HFSQ score improved markedly in pts on CRY (11.6 ± 0.8 to 5.5 ± 0.6 
units), but did not change in pts on PBO (10.2 ± 1.2 vs 10.1 ± 1.7 units), 
P < 0.005 between the two groups. CRY also Improved NYHA class and 
6MW but not V02Dlax (both P < 0.(05), but among the variables measured, 
the HFSQ score provided the best disaimination between PBO and CRY. 
The HFSQ score improved by ~ 5 units in 55% of CRY pts but in only 7% 
of PBO pts. Changes in HFSQ score were poorly correlated with changes 
in LV function or VOwax (both r < 0.40) but were significantly correlated 
with changes in NYHA class (r=O.66) & 6MW (r=-O.64), both P < 0.001. 
In conclusion, the direct assessment of CHF symptoms using a 
standardized questionnaire provides clinically relevaru information about the 
effect of drugs and can reliably discriminate between placebo and active 
therapy. Responses to this questionnaire are closely paralleled by changes in 
submaximal but not maximal exercise performance. 
384A ABSTRACTS 
953·106 
Characterization of the 9·minute Self·Powered Treadmill Walk, 
a New Submaximal Exercise Test in Patients with Heart Failure 
Douglas 1. Hart, Stuart D. Katz, Sun HI Lee, Deborah Ahern, Gregory 
Delong, James Whelan, Milton Packer, Rochelle L. Goldsmith. Columbia 
University, College of Pbysicians and Surgeons, New York, NY 
The 6-mlnute corridor walk test has been used to assess submaxlmal 
exercise capacity in heart failure (CHF), but the test is difficult to 
standardize. does not permit close patient monitoring and has DOt been 
useful in evaluating drug efficacy in pIS with mild CHF. The self-powered 
treadmill (SPT) is a stationary motorless device with a conveyor belt which 
is propelled by the force of the patient's stride and permits precise 
measurements of distance as a function of effon. To evaluate the utility of 
the SPT. the distance covered during a 9-min SPT walk was compared with 
that during a 6-min walk in S4 CHF pIS with a wide range of symptoms. In 
the group as a whole, the distances achieved during the two tests were 
closely correlated (r .. 0.80, P = 0.(01), but the increase in heart rates 
produced by the 9-mln SPT were higher (+22 vs +IS bpm, P < 0.(01). The 
correlation between 6-min and 9-min tests was still significant when 
examined in subgroups based on NYHA class, but the slope of the 
regression line in class I-II pIS was different (p < 0.05) from that in class 
III-IV pIS and indicated that the 6-min test was more sensitive in class 111-
IV pIS but the 9-min test was more sensitive in class I-II pts. 
To further characterize the responses to the 9-mln test in mild-to•
moderate CHF (V02max = 20 mVkg/min), we measured oxygen uptake 
(V02) continuously during the 9-min SPT in II CHF pIS. Oxygen uptake 
rose rapidly during the 1st min with little change thereafter. Importantly, 
patients self-selected a pace on the test that produced a V02 that averaged 
84% of V02max (as measured on a motorized treadmill using the 
Naughton protocol) and was • 25% above the anaerobic threshold. This 
self-selected submaximal pace resulted in a distance traversed on the 9-min 
walk that was closely correlated with V02IDax (r:=O.95). 
In conclusion, the 9-min SPT walk test provides continuous 
submaxlmal stress that is more strenuous than the 6-min walk and thus may 
be ideal for the quantitative evaluation of exercise capacity in patients with 
mild-ta-moderate heart failure. 
953·107 
Effects of Digoxin and lbopamine as Monotherapy In Patients with 
Mild Heart Failure. Results of the DIMT Study. 
Dirk J. van Veldhuisen, Jan Brouwer, Arie J. Man in 't Veld, Peter H.J.M. 
Dunselman, Dirk J.A. Lok, K.I. Lie, for the DIMT Study Group. 
Atthough mutt i-drug therapy is often used in chronic heart failure 
(CHF), many patients (pts) w~h mild symptoms will prefer single-drug 
therapy, H possible. Digoxin (D), and the oral dopamine agonist, ibopa. 
mine (I) have been shown useful when added to diuretics, but their 
effects as monotherapy are unknown. In the DIMT, 161 CHF pts under· 
went double·blind Rx w~h D (lx 0.25 mg), I (3x 100 mg) or placebo (P) 
for 6 months. Of these 161 pts. 64 (40%) [age 60i8 years. ejection frac•
tion 0.33±O.08) had no medication at baseline (l:n=19; D:n=21; P:n=16). 
Of the 64 pts. 56 (88%) completed the 6·months study (p=NS 
between groups). Exercise time significantly decreased in P·treated pts 
after 6 months, but not on I and D. both when pts who completed the trial 
were examined and on intention·to·treat analysis 
I langE'S In exerCise lime [sec 
Plasma norepinephrine decreased on I (·24 pglml) and D (·98 
pg/ml), but increased on P (+31 pg/ml; poc 0.05 vs I and D). Aldosterone 
was unaffected. and renin decreased only on D (·5 ng/mVhr; pocO.05). 
These data show that ibopamine and digoxin exert different 
effects on exercise time and neurohumoral activation in mild CHF. 
although both drugs favorably affect these parameters. 
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953·108 
High Dose Oral Amlodarone Loading Exerts 
Important Hemodynamic Actions In Patients 
with Congestive Heart Failure 
Stephen S. Gottlieb, Salvatore Lauria, David W. Riggio, Robert W. 
Peters, Stephen R. Shorofsky, Michelle Cines, Deborah Froman, 
Michael R. Gold. University of Maryland School of Medicine, 
Baltimore, Maryland 
Amiodarone (amio) Is frequently used in patients with heart 
failure, but Its unusual pharmcoklnetics have prevented accurate 
assessment of Its hemodynamic effects. We therefore gave high 
loading doses of amio (100mg/kg in 8 divided doses) for 2 days 
(total: 3.5 • 9.9 g, mean 6.9 ± 0.5) to 16 patients with NYHA 
class III and IV CHF (EF - 11 to 33%, mean 22%). We assessed 
mean arterial, pulmonary capillary wedge & right atrial 
pressures (MAP, PCW & RAP. mmHg), systemic vascular resis' 
tance (SVR, d-s·c), cardiac index (CI, IImin/m2), heart rate 
(HR, min· 1), stroke volume (SV, ml) and CRS, OT, & PR 
intervals (msec) before drug administration (Pre), 3 hours after 
the first dose (for hemodynamic parameters, Hr 3) & after 8 doses 
(Hr 48\ where' - p < 0.05 v. Pre: 
HR CI MAP PCW RAP SVR 9J CR3 or PR 
!Pre 84 1.8 90 19 9 12033 42 160 395 216 
I-ir 3 85 1.9 84' 19 8 1825 44 . 
~r 48 62· 1.6' 89 23· 1 2' 12186 51 ' 163 491 ' r260' 
Acutely, amlodarone lowered MAP, an acllon consistent With Its 
known vasodilation effects. After 48 hours, high loading doses of 
amiodarone caused a marked electrophysiologic effect, with OT and 
PR prologation. The heart rate decreased by 22 beats/min, which, 
despite an increased SV, resulted in a lower CI and elevated PCW 
and RAP. The effects on contractility cannot be assessed. 
We conclude that, although amio acutely vasodilates, after 48 
hrs of treatment its HR effect may have important adverse 
hemodynamic consequences. This action should be remembered 
when considering patients for amiodarone therapy. 
995 Computers in Cardiology and Cardiovascular 
Surgery . 
Wednesday. March 16, 1994 1:30-5:00 PM 
Georgia World Congress Center, Hall G 
995·1 
KNOW YOUR DEFIBRILLATOR: AN INSTRUCTIONAL 
COMPUTER PROGRAM. Porterfield, L., 
Porterfield, J., Eppes, D., Bray, L., McManus, 
C., Smith, B., Kritchevsky, S., Methodist 
Hospital and University of Tennessee, Memphis, 
TN. 
We have developed a computer-assisted 
instructional program to meet the educational 
needs of patients with implanted 
defibrillators. The KNOW YOUR DEFIBRILLATOR 
(KYD) program makes use of: 1) textual 
information, 2) illustrations, 3) sound-bytes, 
and 4) color. These components have been 
assembled into a HyperCard program for use on 
the Macintosh computer. The program has been 
designed to be used by patients without the 
assistance of a physician. It consists of 
modules which review: 1) implantable cardioverter•
defibrillator functions, 2) cardiovascular 
pharmacology, 3) coping skills, 4) nutrition, 
5) cardiac rehabilitation, and 6) human 
sexuali ty. KYD received favorable reviews 
during field testing in 15 patients ages 38 to 
74 years with no computer knowledge. This 
system is an ideal tool for educating patients 
with implantable defibrillators. Utilizing the 
KYD program to educate medical students not 
familiar with implantable defibrillators is 
also being investigated at our institution. 
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995-2 
AlIocadon of Hearts for Tnlnsplant: A Computer Slmuladon Model for 
Redudng Na&nal Disparities In Waldng Times 
John H. Carson, Jobn M. Herre, School of Government and Business 
Administration, The George Washington University, Washington, D.C., 
Eastern Virginia Medical School and Sentara Norfolk General Hospital, 
Norfolk, VA 
Waiting times for bear! transplants vary greatly by geograpbic location. 
Patient movement is not regulated. The resulting distribution of demand, par•
ticularly in localities with national transplant centers, is not matcbed by supply 
because present allocation policy gives localities priority for locally procured 
hearts regardless of medical need in other areas. Additionally, maximum 
iscbemia time limits donor sources for any given transplant center. As a result, 
localities witb national transplant centers experience a relative over-demand 
for bearts and, consequently, greater !ban average waiting times. The present 
bear! allocation system thus fails eqnitably to matcb organ supply and demand. 
We bave simulated a strategy to allocate organs, particularly bearts, 
based on (1) medical need, (2) waiting time, and (3) logistics and cost 
considerations. A national database characterizing the supply and demand for 
bearts bas been developed from bistorical data. Visualization was employed to 
exantine the complex data interrelationsbips present in Ibis problem. Based on 
Ibis analysis, a discrete event simulation, written in C++, was developed and 
used to exantine alternative allocation strategies for bearts. A geograpbic 
information system is used to present resulting dara. 
In tbe model, patient priority for an available beart is set by medical need 
and, among patients with equivalent need, is determined by deviation from the 
national tbiny-day running average waiting time for comparable patients. 
Among patients witb equivalent waiting times. an organ is allocated to the 
patient closest to the donor site in order to minimize iscbemia time and costs 
associated witb organ recovery. 
Conclusions: Data from !be simulation suggest !bat bearts can be allocated 
dynamically to equalize waiting times wbile making reasonable efforts to 
conttol iscbemia time and costs associated witb tbe logistics of organ recovery. 
995-3 
Interactive Computer Program for Training in the Use of 
Extracorporeal Membrane Oxygenation (ECMO) 
Don McCumin and George Sheplock. Wilford Hall USAF Medical 
Center, San Antonio, Texas 
The purpose of this computer program is to provide an interactive 
training module for ECMO. The software uses the Macintosh based 
commercially available LabVIEW (National Instruments, Austin, 
Texas). The trainee is presented with a computer screen which 
includes a graphical representation of the ECMO circuit including 
the pump, membrane lung, pre- and post membrane pressure 
monitors venous pressure monitor and in-line blood gas monitors. 
Also displayed on the screen are the patient's vital signs and 
saturation. Additionally on the screen is an image of the patient with 
the arterial and venous cannulas originating from the patient. The 
mouse is used to change pump flow and ventilator settings. When the 
pump flow is changed or the circuit is clamped the circuit pressures 
and patient's vital signs change accordingly. Additionally the trainee 
can change the FI02, sweep flow and carbogen flow to the membrane 
lung which affect both the patient's ABG and the circuit blood gases. 
ABG's, CXR's and routine laboratory values can be viewed by 
activating a radio button which then displays a "pop-up" window. 
The CXR's are actual digitized images and vary depending on the mean 
airway pressure. Fluid boluses of colloid, PRBC's or platelets can 
be given into the circuit which will affect the circuit pressures, 
patients vital signs and urine output and will be reflected in the 
patient's CBC. The circuit Activated Clotting Time (ACT) is 
displayed and changes based on heparin infusion rate, urine output 
and blood product infusion. There are several problem scenarios 
built into the program which include exercises in adjusting the 
various circuit parameters to obtain an "ideal" ABG. Other 
scenarios include practice in management of abnormal ACT's, air 
embolism in the circuit, and blood leak from the membrane lung. By 
interacting with the program the student gains experience in 
managing the ECMO circuit and patient. 
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A Graphical Interface Data-Bue for Step-by-Step Collection of Data 
Durin& Cardiac Sur&ery 
Helen Raiswell, Claudio Pragliola, Lorenzo Martinelli, Andrew T. Porter, 
Anna Ponti, Sandra Ponti, Filippo Crea, Gianfederico Possati, Domenico 
Cianf)one. Cardiology Institute, Catholic University, Rome, Italy 
Cardiac surgical interventions rely on a continuous flow of infonnation 
between surgeons, 811eSthetists and perfusionists. These data are shared 
verbally and stored in separate paper charts, hence they are difficult to 
integrate, compare and archive. This data base and support application was 
designed to incorporate in a single grapbical-interface "front~" the three 
surgery fulcra by means of a non procedural application development tool 
(DataEase Express for Windows). The database comprises 22 relational 
tables allowing users to browse heterogeneous datasets in a single grapbical 
"document", thanks to available "multiple join" functions. Documents have 
been specially designed for each type of surgical operation: aorto-coronary 
by-pass grafting, valvular, aortic and large vessels, and congenital defect 
surgery. Specific operative, cardiopulmonary bypass and intensive care 
summaries and interest-specific queries are available. All descriptive and 
semiquantitative variables are encoded as drop-down choice-lists to simplify 
input and to maintain data consistency. Numeric values are cross-checked 
against valid ranges. Data selection and input are perfomed directly using 
the mouse, with the exception of numeric values. The application stores and 
charts vital parameters such as pressure and blood gas samples step-by-step 
during the intervention, using the Object Linking and Embedding (OLE) 
functions provided by the user interface. The system runs on a local 
workgroup network allowing "on-line" data input and supports the 
simultaneous use of two workstations for each operating theatre: one for the 
anesthetist and one for the perfilsionist. The application is intrinsically multi•
user and is able to interrogate and integrate remote databases. It runs in a 
DOS-Windows environment but it is easily portable via specific dynamic 
link libraries (DLL) to SQL, OS/2 and UNIX servers. The local network is 
pan of a larger departmental network. 
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792-1 2:00 
Long-tenn FoUow-up of Patients in the New Approaches to 
Coronary Intervention (NACn Registry 
"'Donald S. Bairn, Anne Steenkiste, Katherine Detre for the 
NACI Investigators, Boston, MA 
Prior reports from the NACI registry have concentrated on 
acute (in-hospital) results. With 2741 patients foUowed for 6 
months, and 2413 patients followed for 1 year, it is now possible 
to examine cumulative long-term outcomes: 
~ 2...!nQs WI 
Death 1.6 % 3.8 % 5.8 % 
Q-wave MI 1.8 % 2.4 % 2.9 % 
any MI 7.0 % 9.0 % 10.8 % 
Repeat revasc 7.2 % 25.7 % 33.2 % 
percutaneous 3.9 % 15.5 % 20.4 % 
CABG 3.5 % 8.6 % 10.7 % 
Symptoms 
any angina 28 % 23 % 
same as pre- 30 % 24 % 
less or not limited 80 % 85 % 
In conclusion: I) Late follow-up data suggest that patients 
treated with new interventional devices in the NACI Registry 
have appropriately low cumulative I year death and MI rates, but 
a similar need for late revascularization as seen after conventional 
PTCA; 2) Despite these late events, most patients at 1 year feel 
that their anginal symptoms have improved, and 85 % feel that 
they are less or not limited by their heart condition. 
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792·2 2:15 
Directional Coronary Atherectomy of the Left Main 
Coronary Artery : Acute and Long Term Results 
Steven B. Laster, Barry D. Rutherford, David R. McConahay, 
Lee V. Giorgi, Warren L. Johnson, Thomas M. Shimshak and 
Geoffrey O. Hartzler 
Mid America Heart Institute, Kansas City, MO 
Balloon angioplasty (PTCA) of left main (LM) coronary 
stenoses is limited by high restenosis rates, which commonly 
necessitate repeat revascuJarization procedures. Directional coronary 
atherectomy (DCA) may be an effective alternative to PTCA due its 
success in treating bulky, eccentric atherosclerotic plaques and ostial 
lesions. We analyzed the acute and long term results following 24 
DCA procedures in 22 patients with protected LM lesions. An 
average of an additional 1.3 lesions/procedure were dilated. Two 
patients had undergone previous LM PTCA. Acute success (residual 
stenosis <40%, no major ischemic complications) was 88% overall, 
100% in 13 "stand alone" procedures and 73% in II procedures 
following inadequate PTCA results. Inability to cross the lesion 
accounted for all DCA failures. Mean LM stenosis was reduced from 
86.0 ± 2.2 to 13.2 ± 2.7% (p< 0.01). There were no clinically 
significant dissections, abrupt closures, emergent CABG, deaths or 
peri-procedural non-Q or Q wave MIs attributed to DCA. Late 
followup was available in 18 of 19 patients that underwent 
successful DCA. At 16 ± 3 months, 89% had NYHA Class 0 - I 
angina. Late events included 0 deaths, 0 elective CABG and 2 repeat 
DCA procedures. One patient required a 3rd intervention (LM stent). 
Event free survival (freedom from death, MI, major complications or 
repeat lesion-related interventions) was 89%. We conclude that DCA 
in protected LM lesions 1) can achieve excellent angiographic results 
with low procedural complication rates; 2) may succeed where PTCA 
yields suboptimal results; and 3) may provide favorable late clinical 
outcomes. 
792·3 2:30 
DifTereatial Benefit of Directional Athem:tomy Over Angioplasty for Left 
Anterior Descending in Proximal, NOll-Ost/QI LeslOllS: Results From 
CAVEAT 
James D. Boehrer, Stephen G. Ellis, Gordon P. Keeler, Darrell Debowey, 
Robert M. Califf, Erid.Topol, for the CAVEAT Investigators 
Balloon IDgiopIasty (PTCA) of ostial coronary artery lesions bas been associated 
with • lower proceduraI success rate, • higher rate of complications, IDd a 
higher rate of resteaosi. compared to lDgioplasty of non-ostial stenoses. Thus, 
directional atherectomy (DCA) bas been proposed as ID alternative therapy for 
ostial lesions. While many previous series hove considered aorta-ostial stenoses 
toaethet with left IDterior deacending (LAD) ostial lesions, it may not be 
appropriate to group these together. This analysis of the coronary IDgioplasty 
versus excisional atberectomy trial (CAVEAT) was performed to determine (1) 
if atherectomy is superior to IDgioplasty in the treatment of LAD ostial lesions 
and (2) if ostial LAD stenoses differ from non-ostial LAD stenoses in terms of 
acute success, procedural complications, IDd restenosis. There were no 
signifiClDt differences between the two procedures for the treatment of ostial 
LAD stenoses in initial success, restenosis, or complications. In contrast, 
comparison of the two procedures for non-ostial stenoses (P values shown) 
revealed signifiClDtly higher initial success and lower restenosis for atherectomy. 
In • second analysis, the 73 with ostial LAD lesions were compared to the 487 
with non-ostial LAD lesions. By logistic regression, ostial location was Dot 
associated with a lower rate of initial success, procedural complications (death, 
infarction, emergency bypass surgery (CABG», or restenosis. 
OSTIAL LAD NON-OSTIAL LAD 
DCA PICA DCA PICA P 
Number 40 33 250 237 
Success (%) 86.5 86.7 91.0 78.0 .0003 
Restenosis (%) 48.4 46.2 50.8 65.8 .013 
Death (%) 0 0 0 0.84 NS 
Infarction (%) 7.5 6.1 8.0 3.0 .023 
EmeJ-x CABG (%) 5.0 3.0 1.6 2.1 NS 
In summary, (1) DCA IDd PTCA used to treat ostial LAD lesions yielded 
similar rates of initial success, acute complications, IDd restenosis, and (2) The 
predominant benefit (increased success IDd less restenosis) of atherectomy for 
the left anterior descending artery is for proximal, non-<>stiallesions. 
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792·4 2:45 
Directional Coronary Atheredomy versus Perfusion Balloon Angloplasty in 
the Proximal Left Anterior Descending Artery 
Marino Labioaz, E. Magnus Ohman, Michael Sketch Jr .. Jean-Francois Marquis, 
Don Fortin, Deborab Labinaz, Paul Owens, Heather Dowell, Cindy Green, Nancy 
Wildermann. Robert Califf. Duke University, Durham NC. 
The optimal method of percutaneously revascularizing the proximal left anterior 
descending (LAD) has not been clearly establisbed. The procedural and in-bospital 
outcome of patients undergoing directional coronary atherectomy (DCA) in the 
proximal LAD at Duke University and the University of Ottawa Heart Instirute 
from 111191 10 3/1193 was compared 10 standard dilatation (std. dil.) and 
prolonged dilatation (loog dil.) with the Perfusion Balloon Catheter (pBC). 
Average dilatation time for std. dil was I (1,1) minute and for loog dil. 15 
(15,15.1) minutes. All films were reviewed by an angiograpbic core lab. 
Angiograpbic success rate was defmed as .$. 50% stenosis at the end of the 
procedure. Clinical success was defined as angiographic success without in•
hospital MI, CABG, repeat intervention or death . 
DCA n=1I3 Sid DU n=55 Long Dil n=89 
Age (yrs) 56 (49,64) 56 (51,63) 60 (50,65) 
Males (%) 68 75 72 
Unstable Angina (%) 82 51 57 
Prior MI (%) 42 40 28 
Pre-Stenosis(%) 95 (75,95) 95 (75,95) 95 (75,95) 
Post-Stenosis (%) <25 (<25,25) 25 (<25,25) <25 «25,25) 
Angio Success (%) 96 98 99 
Major Dissections (%) 8 12 I 
Clinical Success (%) 88 87 98 
Although the residual stenosis foUowing DCA was less compared 10 std dil 
(p=O.OOOl), there was no difference compared to prolonged dil. The number of 
major dissections in the long dil. group was also significantly lower compared 10 
DCA (p=O.04). Clinical success was similar with both DCA and std. dil. but 
significantly higher with long di!. compared 10 DCA (p=O.OO8). 
Conclusions: I) Gradual, prolonged dilatations with the PBC in the proximal LAD 
are associated with high angiographic and clinical success. 2) Both DCA and 
prolonged dilatation with the PBC result in a significant improvement in luminal 
stenosis but DCA appears 10 be associated with a lower clinical success raIe and 
a higher incidence of ~or dissections. 
792·5 3:00 
Maximizing Plaque Removal with Directional Coronary Atherectomy: A 
New Method Using Ultrasound Guidance 
RobertP. Bauman, Kenneth G. Morris, Mitchell W. Krucoff, Brian H. Annex, Brigitta 
C. Brotl,"WilIiam L. Mullen,and "Paul G. Yock for the DeparttnentofVeterans Affairs 
Medical Center, Durham, NC and the University of California at San Francisco, CA. 
AHhough intracoronary uHrasound (ICUS) is potentially well suned to help 
guide directional coronary atherectomy (DCA), in practice the orientation of 
cuts based on the images can be challenging. We describe a new method of 
correlating the cutter orientation on fluoroscopy wnh ICUS images based on 
an innial"reference cut·(RC). Pilot studies were completed in seven patients. 
The cross sectional diameter (d) (mm) of the media wnhin the stenosed 
segment was determined by ICUS (Fig.1) to select the DCA device: 2.5-2.9: 
§E, 3.0-4.0:.lE and > 4.0:.1E.a.raft. Wnh the window visualized on fluoroscopy 
(Fig. 2) a RC was made and imaged by ICUS (Fig.3) to map the distribution of 
plaque. Plaque was removed to the border of the media wnhin the hemisphere 
of the RC prior to making any cuts in the opposne hemisphere. This precise 
extraction was directed by ICUS images of residual plaque refer-
enced to the plane of uncut plaque. Inflation pressures (IP) were ~ 
advanced stepwise 7 ... 15 .. 22 ... 30 ... 45 PSi following each DCA --;;;::'Q-;;-
(6-8cuts) IICUS mapping sequence until the hemisphere was free F;g.! 
of plaque (Fig.4). In a similar manner the hemisphere wnhout the ~ 
RC was evacuated of plaque(Fig.5) beginning DCA 180' from the 
original position in Fig.2. RESULTS: There were no cardiovascu· \ \;g;" 
lar complications. Cutter size was upgraded from quantitative 
coronary angiography (OCA) measurements using ICUS in 4 of 7 u", .. ' 
patients before DCA. Minimal luminal diameters (MLD)(mm)(OCA): R .'", 
are given for reference(R) and stenosed (S) vessels pre and post F;g.l 
DCA. MLD-S-post is also expressed as a % of MLD-R. e 
Patients 1 2 3 4 5 6 7 MEAN+SE 
MLD·R 4.24 4.23 2.90 2.78 2.97 4.27 2.40 3.40±.33 U'ME' 
MLD·S-pre 1.91 .79 1.47 .75 1.06 1.26 .94 1.17±.17 F;g.4 
MLD-S-post 3.41 4.27 2.93 2.48 2.72 4.58 3.24 3.38±.32 e 
% of MLD-R 80% 101%101%89% 92% 107% 135% 101±7% UJML' 
Maximum IP 45 22 22 15 7 15 45 
Device 7FG 7FG 7F 7F 7F 7FG 7F F;g.5 
This preliminary experience suggests that systematic, uHrasound-guided 
plaque extraction with DCA following an initial "reference cut" allows safe use 
of large cutters and resuHs in a large final lumen with minimal plaque residual. 
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792·6 
Comparative Effects of Angioplasty and Atherectomy on Human 
Atherosclerotic Plaques Studied hy High Field NMR Imaging 
3:15 
Jean-Fran~ois Toussaint, James F. Southern, Valentin Fuster, Howard L. Kantor. 
Massachusetts General Hospital and Harvard Medical School, Boston, MA. 
We have demonstrated in previous work that high field in vitro NMR imaging of 
human atherosclerosis enables discrimination of the major plaque components 
(collagenous fibers, lipid deposits and calcifications). We have applied this serial 
and non-destructive imaging technology to compare the effects of angioplasty and 
atherectomy on fibro-fatty plaques in the presence or absence of a collagen cap 
(protected vs unprotected plaques). ~: We studied 17 human plaques 
obtained at autopsy, and observed the effects of angioplasty (ANG) on II arteries, 
using a Mansfield balloon inflated for 5min at 6aun. The effects of atherectomy 
(ATC) were studied on 6 arteries using a 6 French DVI system. We also 
examined the effects of the two successive procedures (ANG followed by A TC) on 
3 protected plaques. Images were acquired at 9.4 Tesla and 37OC: spin echo, 
TI w (TR=600ms, TE=3ms) and T2w sequence (TR=2s, TE=50ms); FOV=2cm, 
156x156mm. With a computerized planimetry program, we measured the plaque, 
collagen, lipid and lumen areas before and after each procedure. Imaging results 
were correlated with histology. ~ I. Effects of ANG: In the absence of a 
collagenous cap, plaque area is reduced by 34%*, mostly due to a reduction of the 
lipid pool (38%*), resulting in a net increase of the luminal area by 15%*. In 
the presence of a cap, plaque area is reduced by 6%, without significant change in 
luminal area. 2. Effects of A TC: In the presence of a cap, plaque area is reduced 
by 35%*, with an increase in luminal area of 21 %*, but this is due to a dramatic 
reduction of the collagenous cap by 57%*. 3. Effem of ANG followed by ATC 
on protected lesions: plaque and lumen are not affected by ANG but reduced by 
20%*+ and increased by 8%*+ respectively after ATe. Collagenous caps are also 
preserved by ANG, but greatly reduced after ATC (42%*+). Conclusions: NMR 
imaging can monitor in vitro procedures commonly used in interventional 
cardiology. In our experimental model, ANG reduces the degree of obstruction by 
extruding the lipid pool, but, unlike ATC, it does not alter the collagen 
component. This study emphasizes the importance of developing a biochemical 
imaging technique for in vivo investigations in order to select plaques for the 
appropriate procedure and understand their effects on both parietal and luminal 
sides. * p<O.05 to baseline; + p<0.05 to ANG. 
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793·1 2:00 
A Prospective Randomized Study to Compare Multiplane With Biplane 
TransesophageaJ Echocardiography in Anatomic Visualization and Doppler 
Assessment of Cardiac Structures 
Kenneth J. Yvorchuk, Randall A Sochowski, Kwan L. Chan, University of 
Ottawa Heart Institute, Ottawa, Canada 
To assess whether multiplane (MP) provides additional diagnostic information 
to biplane (BP) transesophageal echocardiograpby, 317 consecutive patients were 
randomised to undergo either MP (n= 162) or BP (n= ISS) examinations. Both 
ambulatory and intubated patients were included. Images of 24 cardiac structures 
and 9 Doppler signals were graded prospectively as follows: 0 = Dot visualised, 
I = suboptimal, 2 = optimal. Referral diagnoses and age were similar in both 
groups, but there were more men in BP than MP (63% versus 46%, p<O.OS). 
Botb MP and BP provided excellent visualization of the 24 structures, but MP 
was superior to BP in both men and women. 
Mean Score 
Overall MID Women 
MP (n= 162) 1.88 1.88 <-p=NS-> 1.89 
BP (n=155) 1.84 1.83 <-p=NS-> 1.85 
p (for X') 0.001 0.001 0.003 
When tbe individual structures were analyzed, tbe following were significantly 
better visualized by MP: mitral valve (p=O.OS), left ventricle (p=0.02), and 
rigbt atrial appendage (p=0.05). The 6 PW signals, attempted in all pts, were 
from right and left pulmonary veins, left atrial appendage, left ventricular 
outflow tract, rigbt ventricular outflow tract, and coronary sinus. The 3 CW 
signals, mitral regurgitation, tricuspid regurgitation and aortic stenosis, were 
attempted only in pts with these valvular abnormalities. While the mean PW 
scores obtained by MP and BP were similar (1.77 vs 1.72, p=NS), the mean 
CW score was higher with MP than BP (1.48 vs 1.23, p=0.(02). All 3 CW 
signals were better assessed by MP (p<0.05). There were 3 failed esopbageal 
intubations (all MP) and 9 complications (7 BP, 2 MP). Duration of examination 
was similar (MP 19.7.±5.8 min, BP 20.3.±6.2 min, p=NS) . 
Both MP and BP allow comprehensive assessment of cardiac anatomy and 
function, but MP demonstrates overall superiority. Although MP is superior to 
BP in obtaining CW signals, both imaging techniques are limited in their ability 
to obtain these CW signals consistently. 
ABSTRACTS 387A 
793.2 2:15 
Assessment of Mitral Regurgitation by Color Flow 
Imaging of the Vena Contracta: Superiority of Multiplane 
over Monoplane Transesophageal Echocardiography. 
Paul A. Graybum, Wolfgang Fehske, Heyder Omran, M. Elizabeth 
Brickner, Berndt Luederitz. University of Texas Southwestern 
Medical Center, Dallas, TX, and University of Bonn, Gennany. 
Transesophageal echocardiography (TEE) is widely used to assess ~ 
severity of mitral regurgitation (MR). However, few dat.a eXist 
regarding objective means of quantitating MR by TEE. MR Jet area 
depends on hemodynamic variables and often extends outsid~ the 
imaging sector. Flow convergence methods have not been Wldely 
accepted clinically. Thus, we prospectively studied the width of the 
MR jet at its vena conttacta by Doppler color flow imaging using both 
monoplane and multiplane TEE. We studied 80 patients (mean age 52 
± 9, range 21 to 76) within 48 hours of catheterization. MR was 
graded angiographically by standard criteria. The width of the vena 
contracta was measured from a monoplane 4-chamber view as the 
narrowest part of the MR jet at the valve plane. Multiplane imaging 
was then specifically aligned to obtain orthogonal 2-chamber .and 
long-axis views. The long-axis view was used to measure the Wldth 
of the vena contracta; whereas the 2-chamber view was used to verify 
that the vena contracta was symmetrical. Monoplane TEE system•
atically overestimated the size of the vena contracta as compared to 
multiplane TEE (5.6 ± 2.6 mm vs 4.8 ± 2.3 mm, p<O.OOOI). A vena 
contracta width ~6 mm was able to separate patients with and without 
severe MR (3-4+). Using this cutoff value, multiplane TEE identified 
20/21 patients with severe MR (sensitivity 95%) and 58/59 without 
severe MR (specificity 98%). Monoplane TEE identified all 21 
patients with severe MR (sensitivity 100%), but was false positive in 
10/59 without severe MR (specificity 83%). . 
Conclusions: Multiplane TEE is superior to monoplane TEE In 
assessing the vena contracta of MR jets. A vena contracta width of ~6 
rom by multiplane TEE accurately describes the severity of MR. 
793·3 2:30 
Feasibility of Aortic Diameter Measurement using Multiplane 
Transesophageal Echocardiography for Presurgical Selection lind 
Preparation of Homograft Aortic Valves 
Lynn Weinert, Roberto Lang, Richard Marcus, Robert Karp, University of 
Chicago, Chicago, lIlinois 
Preoperative knowledge of the aortic annular diameter (AoDI enables 
presurgical selection and preparation of an appropriately sized homograft 
aortic valve. We have previously shown in a retrospective study that 
transthoracic echocardiography (TIEl may be useful in making these 
measurements. However, TIE measurements of the AoD were less 
accurate when (11 studies were technically difficult, (21 the aortic root 
was heavily calcified, and (31 the AoD was larger than 25 mm. In this 
prospective study we hypothesized that preoperative measurement of the 
aortic diameter using multiplane transesophageal echocardiography (TEE) 
would circumvent these limitations. Accordingly, we measured the AoD 
preoperatively in 13 patients undergoin;) primary Ao valve replacement 
using multiplane TEE imaging. AoD was measured from the long axis 
plane as the maximal distance separating the bases of the non-coronary 
and right coronary cusps, measured from their point of insertion into the 
aortic root (A). Multiplane TEE AoD measurements were compared with 
thaoAe obtained during Brg:[Z]::,u.~ing a ~ing s~ei':B .. -
, In';' 
. ;)0 ••• ~;+.~~ . . ~:. !: .. . 
llJl' 2< 2t n ,. n ,. )0 ~ ·,u 1<1 ,M ,XI n ,. :110 
SurgIcal Sile Imml r,,,gIUI Sire {mml 
An excellent correlation between multi plane TEE ADD and surgical 
measurements was noted regardless of AoD size and degree of 
calcification (BI. There was no significant bias between measurements. 
The 95% confidence limits of agreement between methods was narrow 
(-4.9% to + 5.7%1 (CI. Thus, preoperative measurement of AoD using 
multiplane TEE is accurate and clinically feasible. Presurgical knowledge 
of the AoD may be used to select and prepare the Ao homograft 
improving valve availability and reducing ischemic time. 
388A ABSTRACTS 
793-4 2:45 
Assessment of Aortic Valve and Ascending Aorta by 
Transesopbageal Echocardiograpby : Incremental Information of 
Multiplane Over Biplane Imaging 
Dominic Y Leung, Warren F Walsh, Gregory B Cranney. Prince 
Henry Hospital, Sydney, NSW, Australia. 
The assessment of the aortic valve (A V) and the ascending aorta (AO) 
is difficult using biplane transesophageal echocardiography (TEE) 
because of the oblique orientation of the AV and AO. Multiplane TEE, 
with multiple intermediate imaging planes, may enhance the 
visualisation of these oblique structures. We performed multiplane 
TEE on 61 consecutive patients (mean age 59± 17 yrs. 37 males, 24 
females) with suspected pathology of AV (endocarditis 20, bicuspid 
valve 3, stenosis 14, regurgitation 8, prosthetic dysfunction 5, source 
of embolism 3) or AO (dissection 4, atheroma 3, aneurysm I). Forty 
three patients (70%) had a native AV and 18 (30%) had AV 
prosthesis. In all patients, initial comprehensive assessment was 
performed at 0" and 9ff' (equivalent to the horizontal and vertical plane 
respectively) followed by imaging at multiple planes from 0" to 180" 
and these results were compared. Multiplane TEE optimally visualised 
the AV and AO in short and long axis with the imaging plane at 40"-
60" and 120"-140" respectively thereby enhancing diagnostic confidence 
in all patients. Additional diagnostic information was obtained in II 
patients (18%). Multiplane TEE visualised perforation of AV leaflets 
in 2 patients, dehiscence of bioprosthetic AV in 2. previously 
undiagnosed bicuspid A V in 2, prosthetic A V vegetation in I. 
ascending AO aneurysm and bicuspid AV in I, an obstructive 
subaortic membrane in I, a thrombus on an A V leaflet in 1 and 
refuted 1 case of limited proximal dissection diagnosed by monoplane 
TEE. Conclusions: Multiplane TEE enhances diagnostic confidence in 
pts with suspected AV and AO disease and provides valuable 
additional diagnostic information in a significant proportion of patients. 
793-5 3:00 
Transesophageal Multiplane 3-D Volume Calculation in 
Patients With Normal and Aneurysmatic Left Ventricular 
Geometry; Comparison to Angiography 
Heinrich G. Klues, Stefan Steinert, Winfried Krebs, Andreas 
Terstegge, Frank P .Job, Frank A. Flachskampf, Peter Hanrath, 
Medical Clinic I, RWTH Aachen, Germany 
Angiography is at present the golden standard for determi•
nation of LV-volumes and EF's. Precision of this method, 
however, is significantly limited in the presence of LV•
aneurysms and distorted geometries. Based on previous in•
vitro validation (r = 0.98) we used multiplane TEE to obtain 9 
L V-crossections in 20° rotational steps. Echo-images from 
two transducer positions (transgastric-TG and transesopha•
geal-TE) were used to calculate two independent end-diastolic 
volumes from the same patient within a short time frame. 
Results were correlated to biplane angiographic volumes 
utilizing the disc summation method. 
TG echo-volumes (166.±.42 ml) correlated highly with volu•
mes from the TE position (169.±.42 ml; r=0.94) in all pts. 
independent from the presence of LV-aneurysms. Correlation 
with standard angiography was good in normals (r = 0.92, 
n = 10) but significantly less precise in pts. with aneurysms 
(r=0.68, n=15). 
Conclusion: TEE 3-0 LV volume reconstruction from two 
independent transducer positions, utilizing nine cross•
sectional views is a highly reliable method and is superior to 
angiography especially in the presence of aneurysms or 
distorted geometries. 
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793-6 3:15 
Assessment of Left Ventricular Volumes, Ejection Fraction and 
Cardiac OUtput by Quantitative Three-Dimensional Ech0c8rdlography 
From Multlplane Transesophageal Ech0c8rdlographlc Studies: 
Validation and Clinical Application In Various Patient Care Scenarios 
Monica Freire, Qi-Ung Cao, Jose Azevedo, Heidi Pollard, Joanne 
Zachistal, Achi Ludomirski and Natesa Pandian. 
Tufts-New England Medical Center, Boston, Massachusetts. 
We have, in previous studies, validated the quantitative refiabilily of three•
dimensional echocardiographic (30E) reconstruction from transthoracic 
echo in vitro, and in pts by comparing the technique to simuhaneous MUGA 
radionuclide studies. We have now developed an approach to perlorm 30E 
reconstructions from muhiplane TEE (MPTEE). In this study, we explored 
the quantitative ability of 30E from MPTEE in providing LV diastolic and 
systolic volumes, ejection fraction (EF) and cardiac output and its clinical 
applicability. Because simultaneous MUGA or angiography are not possible 
during TEE, we compared the 30E quantitative data to (the already valida•
ted) TIE 30E method in 20 pts. The TIE-30E was performed immediately 
before the MPTEE. The method involves digital collection of 3 equidistant 
views, semiautomatic border extraction and dynamic 3D reconstruction. 
Then we applied the MPTEE 30E technique in 40 pts in a variety of clinical 
scena-rios including operating room and intensive care units. 
~ (Mean±SO, Vol in mI): LV Dlast Vol was122±33 by TEE-30E and 
125±33 by TIE-30E (range 72 to 194); Correlation between TEE-30E (y) 
and TIE-30E was y=.72X+32, r-.73, p<.001; LV Syst Vol was 69±18 by 
TEE-30E and 68±19 by TIE-30E (range 37 to 99); y=.68X+22, r=.70, 
p<.OOl; Stroke volume was 52±19 by TEE-30E and 57±20 by TIE-30E 
(range 35 to 100); y=.77x+8, r-.77, p<.OOl; % EF was 43±6 by TEE-30E 
and 4S±7 by TIE-30E; Yc.62x+1S, rc.70, p<.002. Cardiac output (Um) 
was 4.3±1.62 by TEE-30E and 4.4±1.7 by TIE-30E (range 2 to 8.2); 
y=1.lx+0.74, r-.74, p<.0001. Thus, 30E from MPTEE yielded reliable mea•
sures of LV volumes and function. 30E in clinical MPTEE studies aided in 
identifying altered LV size and function in various clinical states such as 
ischemic and non-ischemic LV dysfunction, hypovolemia, and low & high 
output condi-tions. It allowed serial assessment of LV size and function and 
aided in recognizing the improvement after myocardial revascularization 
procedures thus pointing out stunned and hibemation states. 
Conclysion: This Simple and practical approach of 30E reconstruction from 
MPTEE recordings yieldS reliable quantitative data on LV size and function 
and is easily applicable in various clinical scenarios. 
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794-1 2:00 
Prognostic Value of Right Heart Catheterization Hemodynamic Data in Medically 
Treated Patients With Coronary Artery Disease 
William R Hathaway, Steven E. McNulty, Karen Pieper, Frank E. Harrell, Jr., Daniel B. 
Marl<, Thomas M. Bashore, Robert M. califf, Christopher M. o'Connor Duke University 
Medcal Center, Durham, NC 
Some centers routinely perform right heart catheterization (RHC) in all patienls (Pis) 
referred for evaluation of coronary artery dsease. To determine the value of this practice, 
we investigated the added prognostic content of hemodynamic data obtained from 11 RHC 
variables in 2821 consecutive madcally treated patients (pts) with significant coronary 
artery dsease ~75% stenosis) between 8/6169 and 111180. During this period, RHC was 
performed routinely on all patients undergoing 
low LP was left heart cathelelization (lHC). Fol 
97% ~ete. Univariate RHC pred 
survival included CO, CI, AV~ dff 
systolic pressure, PA systolic, 
dastolic pressures, and PCW? (p 
ctors of 
erence, RV 
mean and 
<0.0001 for 
Aoe VTS (madan\ 52 (18-81) 
Male 82.7% 
EF(median\ 52% (5-60) 
Hxof CHF 10.9% 
Prior MI 48.3% 
LVEDP (madan) each). 
Using a Cox model the 
independent predictive value of 
each variable was analyzed when 
added to a prognostic model 
derived from clinical and LHC 
data. PA mean (PAM) (p=O.ool) 
and CO (p=O.043) added 
independent information to the 
standard clinical and invasive (left 
heart) prognostic factors. 
Addtionally, there was a 
significant interaction be~ EF 
and PAM (p =0.0047) with 
llmmHg 
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increased prognostic power of PAM for lower EF values. 
Conclusion.: Although data from RHC adds statistically significant information to standard 
clinical and LHC measures, the magnitude is small. RHC cannot be justified routinely 
except in patients with severe left ventricular dysfunction. 
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794·2 2:15 
'fime to First Cantu Event in Patients After Coronary 
Artery Bypass Grafting 
Eckart Frantz,Hans· Ulrich Sauer,Peter Pfautscb,Eckart Fleck, Clinic 
ofIntemal Medicino-Cardiology,Gennan Heart Institute,BetIin,FRG 
~i!h growin~ know~ about I~.terrn OOUISe after CABG-surgery 
It IS essential to idenbfy predictors for long event-free-intervaJs 
following the operation. \Ve investigated 497 consecutive patients 
(pts.) re-catIteterim1 because of recUITeDt ischemia 0-209 (m 68.6) 
months after CABG-surgery. Event-free intervals were: (tbJ.l) 
months: I 0 I < 6 I < 12 I < 36 I < 60 I < 120 I > 120 ~ % pts.: 20) 1~.1 12.1 20.1 13.5 12.5 5.4 
FtrSt postoperative cardiac event was myocardial infarction (M.L) in 
~ 1.7%,. ~stable. angina in 13.1 %, recurrent angina (a.p.) in 65.7%, 
lscberma m routine stress test in 7.5 %, and other indications for re•
angiography in 1.8% of pts. Patients with different event-free intc:rvals 
revealed the followin c:baracttristics: (tb1.2) 
free interval: none < 12 * 
entry aiteria: months 
(9) +/- sci) n=157 
met .0 diabetes 
794·3 2:30 
Long Term Clinical Results and Safety of Epidural Spinal 
Stimulation (ESES) for Angina. 
'JE Sanderson, B Ibrahim, D Waterhouse, RBG Palmer. 
Taunton & Somerset Hospital, UK, and Chinese University 
of Hong Kong. Prince of Wales Hospital, Hong Kong. 
ESES is an alternative therapy for patients with 
intractable angina. Although it has been shown to 
produce symptomatic relief and reduce ischaemia, doubts 
remain about its long term safety. We report the 
results of a follow up study over a period of 62 months 
(mean 45 ~ 10) of 23 patients who had these units 
implanted for intractable angina unresponsive to 
standard therapy. SymptomatiC improvement was good and 
persisted in the majority with an mean change of NYHA 
grade from 3.1 ~ 0.8 preoperatively to 2.0 ~ 0.9 
immediately postoperative and 2.1 ~ 1.07 at the latest 
follow up. GTN consumption fell and a symptom 
questionnaire confirmed improvement of angina symptoms 
at rest (2.7 ~ 2.1 to 1.3 ~ 1.3; p<0.05) and on 
exercise (4.8 ~ 0.4 to 2.9 ~ 1.4; p<0.005). Treadmill 
exercise time increased from 407 ~ 92 secs. with 
the stimulator off to 499 ± 92 secs. with the 
stimulator on (p<O.OI). 48 hrs. ST segment monitoring 
in those with bipolar leads showed a reduction of total 
number (28 ± 15 to 19 ± 16) and duration (365 to 232 
secs.) of ischaemic episodes. There were 3 deaths 
none of which were sudden or unexplained and this 
mortality rate is acceptable for such a group of 
patients. Complications related to early lead design 
were frequent. 
This study confirms that ESES is an effective and safe 
form of alternative therapy for the occasional patient 
whose angina is unresponsive to standard therapies. 
ABSTRACTS 389A 
794·4 2:45 
Benefits Are Sustained at 3-Year Follow-up in 
Patients Who Have Been Treated with Enhanced 
External Counterpulsation. 
William E. Lawson, John C. Hui, Zhen Sheng 
Zheng, Zvi oster, Jordan P. Katz, Paul Diggs, 
Lynn Burger, Clifford Cohn, Harry S. Soroff, 
Peter F. Cohn. SUNY Health Sciences Center, 
Stony Brook, NY 
Enhanced external counterpulsation (EECP) 
has been shown to be a safe and effective 
therapy for selected pts with chronic angina, 
'but its long-term results remain unclear. 
Accordingly, we successfully contacted 17 of 
the 18 pts who underwent a 7 week course of 
EECP between 1989-91 for angina symptoms 
refractory to coronary angioplasty, coronary 
surgery and/or medical therapy. Thallium 
stress testing had been performed pre- and 
post-EECP to the same exercise duration. The 
initial evaluation of EECP (reported at this 
meeting in 1992) demonstrated subjective 
improvement in all pts, with reduced perfusion 
defects noted in 14 of 18 and no change in 4. 
At a mean follow-up of 3 yrs, all 17 pts 
reported continued absence of angina. 
Furthermore, on repeat thallium stress 
testing, improvement from the pre-EECP test 
was noted in 6, no change in 4 and worsening 
in only 1. These results indicate that even 
after 3 yrs, one 7 week course of EECP therapy 
continues to have beneficial effects both 
subj ecti vely and obj ecti vely. EECP therapy 
should be seriously considered in suitable pts 
with chronic refractory angina. 
794·5 3:00 
Disease-Free Interval Assessments After Partial Ileal Bypass in Coronary 
Heart Disease Patients 
Henry Buchwald. Christian T. Campos, James R. Boen, Phuong Nguyen. 
Stanley E. Williams. for the POSCH Group, University of Minnesota, 
Minneapolis. MN 
Analyses of the disease-free intervals for clinical endpoints of athero•
sclerosis intervention trials. in particular in lipid/atherosclerosis studies, 
are not generally reported. POSCH has provided definitive affirmation of 
the lipid/atherosclerosis thcory and strong evidence for the beneficial 
effects of lipid modification (35% reduction in coronary heart disease 
(CHD) death or confirmed nonfatal myocardial infarction; p<O.OOOl) in 
post myocardial infarction patients. POSCH was the first study to demon•
strate that sequential changes in coronary arteriograms are significant 
predictors of overall and CHD mortality. We analyzed the POSCH results 
for disease-free intervals. Results for firm clinical endpoints arc: 
Qiseasc-frec Intervals (nearest ~ear) 
Control Surilery Years 
Group Group Gained 
Overall Mortality. 
90'7, survival 7 10 3 
CHD Mortality, 
90'k. survival 10 14 4 
CHD Mortality of Definite 
Myocardial Infarction, 
80% without event 5 9 4 
Peripheral Vascular Disease. 
90% without event 4 8 4 
Coronary Artery Bypass. 
80% without event 5 15 10 
For the clinician and the patient knowledge of an expected diseasc-frL'e 
interval (or specific cardiovascular events is important. and they have the 
right to ask for this in(onnation from the trialist. 
390A ABSTRACTS 
794·6 3:15 
ChroaIc Total Coroury OcduslOll fIl aD boIated Vessel .. 891 PatieDu 
Over 24 Years: b Medical Mallapmat aD Adequate Approadl? 
Joseph A. Puma, Michael H. Sketch, Jr" James E. Tcheug. Laura H. 
Gardner, Charlotte L. Nelson, Harry R. Phil1ips, Richard S. Stack, Robert M. 
Califf, Duke University Medical Center, Durham, N.C. 
When a patient is identified with a total occlusion of a single ~l remote 
from an acute infarction, the standard of care has been medical therapy. 
Concern has been raised about the potential need for rcvascu1arization 
because of the ·open artery hypothesis.' 10 order to understand the long•
term outcomes associated with medical therapy of this condition, we 
evaluated prospcctively-col1eded fo1low-up information from a population of 
51,388 consecutive patients undergoing cardiac catheterization between July 
1969 and June 1993. Of the 14,728 patients with single ~l disease, 891 had 
a single vessel total occlusion without an acute myocardial infarction within 30 
days and without a previous coronary angiop1asty or bypass surgery 
procedure. All patients were contacted annually for the occurrence of death, 
nonfatal infarction, angiop1asty, or bypass surgery. Kaplan-Meier estimates 
of event rates were calcu1ated. 
The population was relatively young (median age 55 yrs), 78% male with a 
symptomatic history of M1 in 60%. L VEF was well-preserved with a median 
of 51% and most were symptomatic at cath with stable angina in 48%, 
progressive angina in 39%, and unstable angina in 13%. 
KAPlAN·MEIER FOlLOW·UP EVENT RATES: 
l.lr Ur .lII..n" .lUr 
Patients (ill) 815 S45 187 61 
Myocardiallnfarction (%) 3 8 11 15 
CABG (%) 4 U 22 34 
PTCA(%) 2 4 8 8 
Death (%) 2 11 2S 33 
A subana1ysis of patients with proDmai left anterior descending coronary 
artery occlusions revealed similar follow-up event rates. 
Conclusion: Although event rates are low in the first year with medical 
management, death, myocardial infarction, and revascu1arization rates are 
substantial over long-term follow-up. Aggressive risk factor modification to 
prevent progression of disease in other ~1s appears to be indicated. 
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795-1 2:00 
Transcatheter Occlusion of Patent Ductus Arteriosus With an Adjustable 
Buttoned Device: International Experience 
P. Syamasundar Rao. Jorge Haddad, Christian Rey. Gerd Hausdorf. Ann Worms, 
Eustaehio Onorato. Ramesb Arora. Rajeev Locban, P. Seshagm Rao, B. S. RaJu. 
0Eleftherios B. Sideris. University of Wisconsin Medical School, Madison, WI 
The purpose of this communication is to present our experience witb an 
adjustable buttoned device in occluding patent ductus .artenosus (PDA) to an 
attempt to assess the feasibility. efficacy and safety of thtS system. Dunng a 32-
month period ending May 1993,35 patients underwent transcatheter closure of 
PDA with an adjustable buttoned device delivered via 117 French sheath under an 
IRB-approved custom made device protocol. . The device is a modified version of 
the buttoned device used for atrial septal defect closure. The pallents were 15 mo 
to 65 yr (median 7 yr) old; all but five were children below .18 years. The PDAs 
measured 2to 8 mm (median 4 mm) attbe narrowest dtameter and were of 
different types: conical, short and tubular. They were occluded with devices 
measuring 15 to 20 mm. All but one (3%) were successfullytmplanted; to tbe 
lone exception, the device was inadvenently dislodged while disconnecung Wtth 
the loading wire but was extracted out of the patient transvenously. In the 
remaining 34 patients the Qp:Qs decreased (p<0.01) from 1.9 ± 0.5 (range 1.3 to 
3.2) to 1.05 ± 0.1 (Ito 1.3). Small residual shunts were present in 12 (35%) 
patients. Continuous murmur disappeared in all but I patient. 
Twenty patients were followed for I to 24 mo (6 ± 7 mol with chest x-ray and 
echo-Doppler studies. The device was intact in all patients and no breakage M the 
wires was noted. No shunts were present in 18 of 20 (90%) patients and mmUle 
residual shunts were seen in two children. No thromboembolism or endocarditis 
was noted. 
It is concluded tbat transeatheter occlusion of PDA with the adjustable buttoned 
device is feasible. effective and safe; can be accomplished via small, '7-Freneh 
sheatbs; a 117-Freneh sheatb is adequate for all ductal sizes; and the adjustable 
length of the loop accommodated all ductal types and lengths. Clinical trials.on 
a larger number of patients are warranted. Furtber improvement In tbe deVice 
may eventually result in extending the procedure to close PDAs ID younger 
babies including neonates and premarure infants. 
JACC February 1994:1A-484A 
795-2 
Retrleveble Colla for Interventionel Treatment of 
Peralatent Ductua Arterlosua: Firat Clinlcel ReaulU. 
Malte B. Nauss, Trong-Phi Le, +James Y. Cae, +Ralph G. Grabitz, 
Dierk A. Redel, Dept. Pediatr. Cardiol., University of Bonn, 
Germany, +Div. Pediatr. Cardiol., University of Alberta, Canada 
2:15 
Since the first interventional treatment of an aortic aneurysm using 
coiled metal wire by C. Moore in 1864, several attempts were made to 
occlude vessels using nonsurgical techniques. But coil occlusion of 
unwanted vascular channels did not gain widespread clinical use until 
the modification of C. Gianturco. These cylindrical shaped coils are 
not repositionable and retrievable, leading to an increased risk of 
peripheral embolization in high-velocity arteriovenous shunts. 
Therefore coil occlusion of the patent ductus arteriosus (PDA) has 
not been perfonned routinely. 
We have developed a new occlusion device with memory shaped 
retrievable coils with the shape of double-disks (DuctOcdud, pfm, 
Cologne, Germany). Its wide variety of length and shape allows optmal 
tldaption to the individual PDA. A snap-in mechanism keeps the coil 
attached to the delivery wire and enables the retrieval of coils ~ 
inadequatly selected or placed. ControUed coil delivery is performed 
with a hand grip using a winding diagram. A safety stop avoids 
unintentional detachment. Depending on coil size (0.018"-o.028"i) 
the device uses alow friction 3F-SF (1.011.7mm) implantation 
catheter with marker rings for exact vessel measurement. 
Animal studies demonstrated the possible access via pulmonary 
tn!ry and aorta as well as its use in very small animals 
(piglets 1.8 kg). Wrth this new device we have now occluded the 
PDA in 31 patients (4 month - 20 years, 4.S - 64 kg). Complete 
occlusion was achieved in 26 cases. The coils were retrieved up to six 
times until final placement. No surgical intervention for coil 
removal was necessary. All complications (n=4) could be managed by 
interventional techniques. 
Our new device using speciaty shaped retrievable coils seems 
to be a safe and effective method for interventional occlusion of 
smallll'ld medilJTl size PDA. 
795·3 2:30 
Stent RediiatioD .. CaDine Models or Pulmonary Artery Stenosis 
and Coarctation or the Aorta 
Alan M. Mendelsohn, Parvin C. Dorostkar, Catherine P. Moorehead, Flavian M. 
Lupinetti, Paul I. Reynolds, Achi Ludominky, Tho~as R .. Lloyd,Kathleen 
Heidelberger, Robert H. Beelanan. C. S. Mon Children s Hospnal. Uruverstty of 
Michigan. Ann Arbor, M1 
To assess the feasibility of steD! rcdilation in growing animals, pulmonary 
artery stenosis (absorbable band, n=8) or coarctation (wedge resection, 0=16) were 
created in 24 puppies. Catheterization and steoling (Pa1maz P308; Johnson & 
Johnson) was performed 2-3 months after surgical preparation. 
Pulmopary Artcry (PA) Slepts: Two puppies acquired LPA atresia. 
Six had LPA hypoplasia with proximal stenosis and were stented. Stents were 
implanted with an 8-IOmm balloon, decreasing the systOlic gradient from 13± I to 
l±lmmHg (mean:!:SE). Stents were rcdilated with a 12mm balloon (4-7 ATM) 
4-6 months later, after the puppies had gained 54±3% in weight Percutaneous 
redilation was not possible in 2 steIIts which protruded into the MP A; these stents 
were redilated post-mortem. Redilation increased the proxima1 stent diameter from 
9±0.4 10 1l.S±O.4mm, the "waist" from 7.4±O.4 to 9.2±O.3mm, and decreased 
stelU length from 27.4tO.9 to 2S.7±O.8mm. The residual gradient decreased from 
4±2 to OmmHg. Gross examination 2·3 months after rcdilation revea1~ an intact 
neoinlima without restenosis, aneurysm or stent fracture; superfiCtai 1-3mm 
aeointimal tears were noted in the acute specimens dilated post-mortem. 
Coarctatiop (COA) Stcpts: Eight puppies did not survive COA surgery. 
The other 8 had a discrete thoracic COA and underwent stent implantation with a 
10-15mm balloon, decreasing the systolic gradient from 36±7 to 2±lmmHg. 
Stents were rcdilated with a 14-ISmm balloon (4-7 ATM) 6-10 months later, 
when the puppies had gained 74±7% in weighL Rcdilation was not technically 
possible in I steI\l which protruded into a dilated post-stenotic aorta. In the other 
7 aortic stents redilation inaeased the proximal stent diameter from 12±O.5 to 
14.S±O.3mm, the 'waist" from 1O±O.6 to 13.5tO.Smm, and decreased stent 
length from 27±O.4 to 24.S±O.Smm. The residual gradient decreased from 7±2 to 
0.4±O.4mmHg. Two animals died immediately from aortic rupture; gross 
examination documented a 2-3mm transmural acruc perforation through each stent 
at the COA sutures. Examination of the other S stents 2-3 months after redilation 
revca1ed an intact aeointima, without restenosis, aneurysm or steIIt fracture. 
COpd".iOps: Rcdilation of PA stents is safe and effective. In contrast, 
rcdilation of aortic SleDts was hazardous in this canine model of COA. This 
experience suggests that aortic stents should be implanted at an adult diameter 
because redilation may be associated with important acruc wall tnwma. 
JACC February 1994:1A-484A 
795·4 2:45 
Intennediate-Tenn FoUowup or BaUoon Valvotomy of 
Congenital Aortic Stenosis. 
Cameron 1.B. Ward, Ronald G. Grifka, Charles E. Mullins, 
Michael R. Nihill, for Texas Children's Hospital, Baylor 
College of Medicine, Houston, TX 
Balloon aortic valvotomy (BA V) has been performed in 106 pts 
since 1984 with initial decrease in aortic pressure gradient 
(APG) from 7l±19 to 26.5±17 (p=0.01) and increase in AR 
by 0.52±0.66 grades (range 0-3). Followup > 3yrs of 32/56 pts 
undergoing BA V revealed 22/32 pts have not required further 
intervention (Group 1). In Group 1 differences in peak Doppler 
APG immediately post-BA V and at recent followup (51 mmHg 
±18 vs 42 mmHg±30, p=0.24) and Doppler AR since BAV 
(p=0.61) were not significant. Aortic valve replacement (A VR) 
was performed on 10/32 pts (31 %) - Group 2 - including 3/3 pts 
undergoing repeat BAV. AVR was performed from 0.07-88 
mths (mean 43±32) post BAV, for significant residual AS 6/10, 
AR 2/10 and combined ASIAR 2110 pts. The APG was 
significantly higher in Group 2 than Group I pre-BA V (80 
mmHg±19 vs 67 mmHg±16, p=0.05) and post-BAY (40 
mmHg±20 vs 21 mmHg±9, p=O.OOI). Between the groups 
differences related to mean age (p=O.5), annulus diameter 
(p=0.9), annulus diameterlBSA (p= I) and increased severity of 
aortic regurgitation post-BAY (p=O.8) were not significant. 
Onel32 pts died undergoing A YR. 
BA V intermediate-term prognosis probably relates to intrinsic 
valvar pathology. The greater the APG pre-BAY and post-BAY, 
the poorer the intermediate-term prognosis. Repeated BA V 
confers little benefit and is a predictor of A YR. 
795·5 3:00 
Serial Intravastular Assessment of Neo-Intimal Coverale of Aortic 
Stents in Dogs 
Acbi Ludomirsky, Raymond T. Fedderly, Alan M. Mendelsohn, Catherine 
P. Moorehead, Satinder Sandhu, Thomas R. Lloyd, Robert H. Beekman. 
C.S. Mott Children's Hospital, University ofMicbigan, Ann Arbor, MI 
The purpose of this study was to describe the course and extent of neD•
intimal coverage of aortic stents in dogs (palmaz P308; stainless steel 
strut). Seven stents were implanted to treat experimental coarctation and 
one was placed in a normal descavling aorta. Stents were redilated (3-4 
mm larger) at a mean of 8 months after implantation. Serial intravascular 
ultrasound imaging was performed with a CVIS system 10 MHz, 10 
French mechanical system at 4 points in time: immediately after stent 
implantation; immediately before and after stent redilation g months later; 
at follow up 2.5 months after redilation. The ultrasound images were 
analyzed independently and b1ind1y and were compared to anatomical 
specimens. 
Results: Stent struts were well·visua1ized in all cases immediately post 
implantation. Neo-intimal proliferation was imaged as a thin layer 
unifonnal1y covering the stent within the first g months, with no excessive 
growth into the lumen in all g stents. The mean lumen diameter at the 
narrowest point was 9.3 ± .5 nun immediately after implantation and did 
not change significantly at 8 months fol1ow up (mean 9.S ± .4 nun). The 
narrowest lumen diameter increased after stent redilation to a mean of 13.1 
± .4 nun and did not change significaDtly 2·3 months later (mean 12.9 ± .5 
nun). All side branches of the thoracic aorta ranained patent and no 
fonnation of thrombi and aneurysm were detected. In two stents 
longitudinal tears (2·2.5 nun) of the aortic wall were seen immediately 
after stent redilation. Ultrasound fiDdings were in complete agreement 
with gross inspection of the specimens. 
Conclusions: I) Neo-intimal coverage of aortic: stent was present by g 
months. 2) No progressive neo-intimal proliferation was observed before 
or in response to stent redilation. 
ABSTRACTS 391A 
795·6 3:15 
Radiofrequency·Powered, Therma1 Balloon Atrial Septostomy: A New 
Technique 
Joseph F. Mitchel, Lisa A. Pearsall, Timothy M. Curley, Michael A. 
Azrin, Adel M. Eldin, David D. Waters, Chunguang Chen, Raymond G. 
McKay 
Hartford Hospital, University of Connecticut, Hartford, CT 
Current techniques of balloon atrial septostomy may be complicated by 
excessive tearing of the interatrial septum, inadequate creation of an 
interatrial communication, and damage to the femoral vessels with the use 
of oversized balloons. In an attempt to overcome these problems, we 
evaluated the feasibility of using a new radiofrequency·powered, thermal 
balloon catheter positioned across the fossa oval is to create atrial septal 
defects (ASD) with thermal remodelling of cardiac tissue. Twenty fresh 
porcine or lamb hearts underwent radiofrequency-powered, thermal balloon 
atrial septostomy (RBAS) with a 10 mm balloon powered with a 10 watt 
radiofrequency generator. In 10 hearts, three serial balloon inflations were 
performed at room temperature, 70'C, and 90'C; all balloon inflations 
were performed at 5 atm for 6Osec. In the remaining 10 hearts, RBAS was 
performed at 9O'C with 5 atrn balloon inflations at 5 sec, 20 sec, 40 sec, 
60 sec, and 120 sec. Following each in-vitro RBAS procedure, ASD size 
was measured using intravascular ultrasound with a 12.s MHz catheter. 
RESULTS: In all cases, RBAS resulted in a discrete atrial septal defect 
with smooth-contoured edges and no gross tears of margins. ASD size 
increa~ed from 0.18 em' at room temperature, to 0.33 cm' at 70'C, to 0.38 
cm' at 90'C. In addition, serial 90'C inflations progressively increased 
ASD size from 0.17 cm' at 5sec, to 0.22 cm' at 20see, to 0.28 cm' at 
4Osec, to 0.33 cm' at 6Osec, to 0.40 cm' at 120 sec. Repetitive inflations 
without an increase in the temperature or duration of heated inflation did 
not demonstrate any progressive increase in ASD size. 
CONCLUSIONS: Radiofrequency-powered, thermal balloon atrial 
septostomy can create discrete, smooth-contoured interatrial 
communications. Larger ASD's are created with increasing temperature and 
with increasing duration of thermal balloon inflation. 
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796·1 2:00 
VT Length is a Better Predictor of Mortality than Frequency 
of VT or VPD in Patients with CHF 
Daniel B. Reese, Michael E. Silverman, Jeffrey c. Brackett, Michael D. 
Pressel, Michael R. Gold, Stephen S. Gottlieb. University of Maryland 
School of Medicine, Baltimore, MD 
An increase in the length of the longest run of ventricular tachycar•
dia (VT length) on Holter monitor recordings was recently shown to be 
the only electrocardiographic predictor of an increased risk of mortality 
in CHF pts given milrinone. However, it is unknown if VT length on a 
baseline Holter recording predicts mortality in CHF pts. We therefore 
evaluated the prognostic importance of VT length, frequency of VT (VT 
Freq), & frequency of ventricular premature depolarizations (VPD Freq) 
in 122 CHF pts with 24 hr Holter monitors obtained between 7/88 and 
6/93. Pts were divided into 2 groups for each Holter parameter according 
to the median value for that parameter. Survival between groups was 
compared by Kaplan-Meier analysis, with pts censored at time of ICD 
implant or cardiac transplant. By NYHA, there were 10 class II, 84 class 
111, & 28 class IV pts. The mean age was S9 ± 13 yrs & the mean EF by 
MUGA was 23 ± 8%. 
Pts with VT length $ 3 beats (i.e. no VT or only triplets) had a better 
survival rate (84% at 1 & 2 yrs) than pts with VT length> 3 beats (76% 
at 1 yr & 54% at 2 yrs, P = 0.03). VT Freq ($ I/day vs. > I/day) and VPD 
Freq ($47 vs. >47 beats/hr) did not predict mortality. The prognostic 
importance of these parameters was then analyzed based upon etiology 
of CHF. For the 71 nonischemic pts, pts with VT length S 3 beats had a 
higher survival rate than pts with VT length >3 (1 yr survival 94% & 
78% respectively, p=0.03). VT length did not predict mortality in the 51 
ischemic pts (1 yr survival 70% & 71% respectively, p=0.60). For both 
ischemic & nonischemic pts, VT Freq did not predict mortality (p=0.21 
for nonischemic & 0.26 for ischemic pts). Similarly, VPD Freq did not 
predict mortality (p=0.22 for nonischemic & 0.79 for ischemic pis). 
We conclude that VT length predicts mortality only in CHF pts 
with nonischemic CHF. In these pts, the absence of VT > 3 beats 
portends a good prognosis. 
392A ABSTRACTS 
796·2 2:15 
Circadian Pattern or Heart Rate Variability in Heart Failure is 
Progressively Disturbed with Increasing Neurohumoral Activation. 
Jan Brouwer, Dirk J van Veldhuisen, Arie J Man in 't Veld, Peter 
HJM Dunselman, Jaap Haaksma, Kong I Lie, for the DIMT Study 
Group, Groningen, The Netherlands. 
In patients with congestive heart failure (CHF) autonomic dysfunc•
tion can be found. Analysis of heart rate variability (HRV) is used to 
provide information about autonomic control. We analyzed 24 Hour 
Holter recordings in 87 patients with mild to moderate CHF (mean 
age 60 ± 8 years, ejection fraction (LVEF) 29±9%). Background 
therapy consisted of furosemide 0-80 mg. HRV analysis included 
standard deviation (SDNN), coefficient of variation (CV) and pNN50. 
Spectral analysis using a Fourier algorithm resulted in total, low and 
high frequency components ([P, LF (0.04-0.15 Hz) and HF (0.15-
0.40 Hz». In multi variant analysis moderate significant negative 
correlations were found between plasma norepinephrine (PNE) and 
SDNN, CV, TP and LF (r = -0.30 to -0.38). In contrast, LVEF 
showed positive correlations with mean NN, SDNN, pNN50, TP and 
HF (r = 0.25 to 0.30). HRV _"'_ 
parameters also showed a1- 8 
tered diurnal distribution with 
increasing neurohumoral acti- s 
vat ion. The graph shows as 
an example the relation be- • 
tween PNE and CV: CV is 
progressively reduced with 2+-'-~~~~~~~~""< 
increasing PNE, the differ- 0 3 I I 12 15 II %1 
ence being especially pro- .... (hoonl 
nounced during daytime hours. 
Quo/1II .. 
alPNE 
We conclude that already in mild to moderate CHF HRV parameters 
are significantly reduced with increasing neurohumoral activation. 
Furthermore the circadian distribution of HRV parameters is progres•
sively disturbed with increasing PNE. 
796·3 2:30 
A Link Between Ventricular Arrhythmias and Autonomic 
Imbalance in Congestive Heart Failure 
Andrea Monara, Maria Teresa La Rovere, Paolo Pantaleo, Massimo 
Pozzoli, Giovanni Forni, Oreste Febo, Franco Cobelli, Luigi Tavazzi. 
Division of Cardiology, Fondazione Clinica del Lavoro, IRCCS, 
Montescano (Pavia), Italy. 
To assess the relationship among ventricular arrhythmias, 
hemodynamic profile and autonomic nervous system 72 pts with 
Congestive Hean Failure (CHF) (mean age 51±1 yrs, EF 22±1 %, 
NYHA class II-IV, stable therapy) underwent 24-hour ECG 
recording, right hean catheterization, baroreflex sensitivity (BRS) 
assessment and heart rate variability (HRV) analysis. Pts were 
grouped according to the absence (29 pts, Group 0) or presence (43 
pts, Group 1) offrequent (VEBs>lOlh) and or complex (couplets, VT) 
ventricular arrhythmias. Therapy, NYHA class and Ejection Fraction 
did not differ between the two Groups. Group 1 showed a 
significantly higher mean pulmonary anery pressure (30±2 vs 23±2 
mmHg, p<O.03), pulmonary capillary pressure (PCP) (22±2 vs 16±2 
mmHg, p<0.03) and right atrial pressure (6.4±1 vs 3.8±O.6 mmHg, 
p<0.04) as compared to Group 0, while BRS (3.1±3 vs 4.3±3 
msec/mmHg) and HRV (root Mean Square Successive Difference, 
rMSSD, 11±8 vs 14±11 msec; Total Power (0.0-0.45 Hz), TP, 
516±720 vs 845±1040 msec2) were not significantly different. When 
patients were stratified according to hemodynamic deterioration (PCP 
~ or < 18 mmHg) it was found that among pts with PCP ~ 18 mmHg 
a markedly depressed BRS (l.7±0.5 vs 3.6±1.2 msec/mmHg, 
p<0.05) and a markedly reduced HRV (rMMSD 11±2 vs 20±5 msec, 
p<0.05; TP 510±199 vs 1281±558 msec2, p<0.05) were observed in 
arrhythmic as compared to non-arrhythmic pts. No differences were 
found in pts with PCP < 18 mmHg (BRS 3.5±3.2 vs 4.9±5.4 
msec/mmHg; rMMSD 13±10 vs 14±1O msec; TP 804±533 vs 
964±1060 msec2). Thus, in CHF, ventricular arrhythmias are largely 
related to hemodynamics; however in the more advanced stages of 
hemodynamic decompensation the autonomic imbalance seems to play 
an additive role in the genesis of cardiac arrhythmias. 
JACC February 1994:1A-484A 
796·4 2:45 
Heart Rate Variability and Its Relation to Ventricular Arrh~1hmias in 
Congestive Heart Failure 
Lii Fei, Philip J Keeling, Jaswinder S Gill, Deborah J Staners, William J 
McKenna, A John Camm. St George's Hospital, London UK. 
Background: It has been sbown that heart rate variability (HRV) is decreased 
in patients witb congestive heart failure (CHF) and that depressed HRV is 
associated with a propensity to ventricular arrhythmias. However, little is 
known about HRV in patients with both CHF and ventricular arrhythmias. 
Methods: Spectral HRV was analysed from 24-hour ambulatory ECGs in 15 
normal subjects (NS), 15 patients with idiopathic non-sustained ventricular 
tacbycardia (NHVT) and 40 patients with CHF secondary to either ischaemic 
heart disease (IHD, n ; 15) or idiopathic dilated cardiomyopathy (DCM, n ; 
25). Of tbe 40 patients with CHF 15 had no significant ventricular arrhythmias 
(ventricular ectopic beats < 10 beats / hour and no salvos) and were taken 
as group IlIa (CHF· VA'). Another 15 CHF patients with non· sustained 
ventricular tachycardia were taken as group IIIb (CHF·NSVT). 
Results: HRV was significantly lower in CHF than NS (total frequency, 23 :!: 
12 vs 43 :!: 13 ms; low frequency, 12 :!: 8 vs 28 :!: 9 ms; high frequency, 8 :!: 5 vs 
14 :!: 7 ms; p < 0.(01). The differences in HRV between NS and NHVT, 
between IHD and DCM, and between CHF·YA· and CHF·NSYT were not 
statistically significant. In CHF, HRV was significantly related to LVEF but not 
associated with ventricular arrh)1hmias. However the frequency of ventricular 
ectopic beats was significantly related to the high frequency component of 
HRV (r ; 0.54, p < 0.05) in NHVT. Stepwise multiple regression analysis 
sbowed that in CHF HRV was predominantly (p < 0.05) related to left 
ventricular ejection fraction. There was no significant difference in HRV 
between survivors (n ; 34) and those who died suddenly (n ; 6) during one 
year of follow·up in CHF. 
Condusions: In patients with CHF HRV is significantly decreased. The 
depressed HRV is principally related to the degree of left ventricular 
impairment and is independent of disc'-1se aeliology and the presence of 
ventricular arrhythmias. The data suggest that analysis of HRV in these 
patients does not help the identification of those at increased risk of sudden 
death. 
796·5 3:00 
QT Dispersion: a Predictor of Sudden, Unexplained Death in 
Congestive Cardiac Failure. 
Craig S Barr, Abdul A Naas, Matthew Freeman, Chim C Lang, Allan D 
Struthers, University Department of Clinical Pharmacology, NineweIls 
Hospital and Medical School, Dundee, DDt 9SY, Scotland, UK. 
QT interlead variability (dispersion) reflects regional variation 
in ventricular repolarisation. This may represent electrophysiologic 
substrate for arrhythmias. We have measured QT dispersion (maximum 
corrected QT interval minus minimum corrected QT interval) on surface 
12 lead ECGs of 40 patients with NYHA m·IV chronic heart failure 
who were subsequently followed for a period of 48 months (range 24-60 
months). During follow up 7 patients died suddenly (SUD) and 12 died 
from progressive heart failure (PHF). There were no significant 
differences in age or electrolytes between each group. Patients who died 
of PHF had lower L YEF. Patients who died had significantly greater 
QTc dispersion but not QTc max compared to those who survived. 
Patients who died a sudden unexpected death had significantly more 
QTc dispersion compared to those who survived or who died from 
progressive beart failure. 
Alive(n=21) PHF(n=12) 
Age 70.0 (1.1) 68.2 (1.7) 
K+ (mmolll) 4.1 (0.1) 4.0 (0.2) 
LVEF (%) 28.0 (2.0) 20.6 (3.0)* 
QTc max(ms) 465 (7.5) 465 (13.0) 
QTc disp(ms) 52.2 (4.8) 61.5 (8 .. 3)* 
Adjusted QTc disp(rns)+ 21.0 (\.9) 25.7 (3.6) 
Results are presented as mean (se mean). 
+ adjusted for number of measurable leads, 
* p < 0.05 vs alive, t p < 0.05 vs PHF 
SUD(n=7) 
68.6 (2.5) 
4.3 (0.2) 
27.0 (2.7) 
471 (13.9) 
98.6 (10.3)*t 
38.7 (3.7)*t 
Conclusion Studies should address the predictive value of QT dispersion 
as a useful technique for distinguishing those patients with chronic heart 
failure who may be at risk of sudden death. 
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796·6 3:15 
Exacerbation of Heart Failure Precedes Sudden Death 
In Patients With and Without Implantable Defibrillators. 
Erica S. Zado, Charles D. Gottlieb, Francis E. Marchlinski, Diane 
M. Butscher, Elizabeth J. Paugh, and Marieli Jessup. 
Philadelphia Heart Institute, Philadelphia, PA. 
The mode of death was evaluated and compared for 230 pts with 
LV dysfunction (EFs40%) referred with either symptomatic 
congestive heart failure (CHF) or ventricular arrhythmias 
requiring defibrillator implantation (ICD) between 1990·'93. 
Death was classified as sudden in the absence of other cardiac 
symptoms (SCD), sudden but in the setting of worsening heart 
failure (SCHF), progressive heart failure (PHF), or non·cardiac. 
There was no difference in mean EF (22 vs 25%), age (62 vs 63 
yrs), or follow·up (433 vs 455 days) in the CHF or ICD groups. 
It..21.f1s. ~ SQ.Q s.miE EI::iE 
CHF 132 37(28%) 5(14%) 10(27%) 13(35%) 
ICD 98 24(25%) 5(21%) 4(17%) 8(33%) 
Actuarial freedom from all cause mortality is shown below: 
.~ 1~~~\ ... '",~. ::::......... ~ 
~ 80 ~.',~ ..... _., 
:l 70 •••••.•.• en ~. . ...... _ .. " 
o 60 ' •• 
~ 50 i 
o 365 Davs 730 1095 
In summary, there is no difference in the mode of death between 
patients with LV dysfunction and symptomatic CHF or malignant 
arrhythmias treated with an ICD. Exacerbation of heart failure 
was associated with the majority of deaths in both groups (62 vs 
50%). Since worsening heart failure oiten precedes the terminal 
event even in patients with a defibrillator, earlier transplantation 
or therapy directed towards correcting cardiac performance may 
be necessary to prolong survival. 
797 New Developments in Ultrasonic Contrast 
Wednesday, March 16, 1994 2:00-3:30 PM 
Georgia World Congress Center, Room 254W 
797·1 2:00 
Dose· Response Characteristics, Time·Course, and Hemodynamic 
Responses to QW3600, an Ultrasonic Contrast Agent Capable of 
Myocardial Opacification by Intravenous Injection 
"'Bruno Cotter, Oi Ling Kwan, Yong Mei Cha, Howard Dittrich, 
Valmik Bhargava, Anthony N. DeMaria; University of California, 
San Diego, CA 
QW3600 is a new ultrasonic contrast agent which undergoes a phase 
shift from liquid to gas at body temperatures and has been observed to 
produce myocardial opacification with intravenous injection. Few 
data exist regarding the dose·response characteristics, time course, 
and hemodynamic effects of this agent. Therefore, we performed 
echocardiograms in the parasternal short axis view at the papillary 
muscle tips in 5 closed chest anesthetized dogs before and after the 
intravenous injection of progressive doses (0.1,0.3,0.5, and 0.7 cclkg) 
of QW3600. Hemodynamic measurements included HR, arterial 
pressure, PA pressure, and cardiac output. Dense reflectances filled 
the entire LV cavity in all dogs at all dose levels and persisted for 30 
to 115 sec. Slight myocardial visualization occurred in 2 animals at 
0.5 cclkg, but 0.7 cclkg produced dense opacification of all segments 
in every animal (mean increase in video·intensity from 23 to 86 and 
19 to 63 gray levels in septum and posterior wall respectively). 
Myocardial opacification was seen 10 to 25 sec after LV, and 
persisted from 5 to 35 minutes. Hemodynamic changes were minimal 
and short lived «30 seconds) at low dose injection. At a dose of 0.7 
cclkg sufficient to produce dense myocardial opacification, systolic 
BP fell from 139±35 (mean±SD) to l1O±29 mmHg and HR increased 
from 121±27 to 129±19, fractional shortening changed from 59 to 
48% and, in 2 dogs, PA pressure increased (25/18 to 45129 mmHg) 
and CO decreased (3.4I;tO.92 to 1.72;tO.6511min). Thus, QW3600 is 
a new echo contrast agent which consistently produces dense 
sustained LV opacification. Although minor myocardial visuali7.ation 
may occur at lower doses, 0.7 cclkg universally produced dense 
myocardial opacification which persists for greater than 5 minutes. 
The hemodynamic changes observed in this study likely represent the 
acute as well as cumulative effect of multiple injections of the agent. 
ABSTRACTS 393A 
797·2 2:15 
Myocardial Perfusion Using New Intravenous Ultrasound 
Contrast Agents: Comparison Between Video and 
Integrated Backscatter Images with a Prototype Program 
"Howard C Dittrich, "Gary L Bales, "Teri Kuvelas, "Alwyn P D'Sa, "Yigal 
Greener University of CalHomia San Diego School of Medicine, Molecular 
Biosystems Inc, San Diego, CA and Hewlett Packard, Andover MA. 
Because of a growing interest In myocardial contrast echocardiography, 
new contrast agents and technology are being developed to optimize 
the detection of myocardial blood flow. We therefore compared 
myocardial time·intensity curves obtained from a Hewlett Packard Sonos 
1500 prototype program. Video and integrated backscetter (IBS) images 
were acquired during myocardial perfusion wHh several new agents 
(Molecular Biosystems, Inc) given Intravenously into 5 closed chest 
dogs. Co~arisons of 18 paired injections for the septal and lateral walls 
were made of peak change in intensity from baseline (PK), time to peak 
intensHy (TP), and peak intensHy change relative to the opacHied left 
ventricular cavity. ECG-gated digHal images were acquired onto the bum· 
in optical disc. Myocardial opacification was visualized and measurable in 
all 18 injections from both video and IBS. The PK for cavity was greater 
by video than by IBS (13.8 ± 5.6 Vs 8.9 ± 3.4 dB, p<0.02) but the PK by 
video and ISS for the septal (4.7 ± 1.3 Vs 4.3 ± 1.7 dB, respectively, NS) 
and lateral (2.7 ± 1.0 Vs 3.2 ± 2.4 dB, respectively, NS) segments were 
similar. TP for cavky by video (4.5 ± 1.2 sec) and ISS (5.1 ± 1.1 sec) were 
shorter than for septal (6.6 ± 0.8 and 6.5 ± 1.3 sec, respectively, both 
peO.Ol) and lateral (6.4 ± 1.1 and 6.1 ± 1.4 sec, respectively, both 
peO.05) segments. The peak changes in intensity for septal and lateral 
segments relative to cavHy were greater by IBS (54 ± 31and 41 ± 33%, 
respectively) than by video (39 ± 20 and 21 ± 10%, respectively) but the 
differences did not reach statistical significance. This easy to use 
prototype for analysis of time·lntensHy curves detects myocardial 
perfusion wHh these new intravenously administered agents. The 
present findings suggest that on·line analysis of video and IBS images of 
myocardial perfusion yield similar quantHative data which may prove 
useful in clinical applications of myocardial contrast echocardiography. 
797·3 2:30 
Evaluation or Mammary Artery Gran Perfusion Using Contrast 
Echocardiography 
Neal D Hillman, Takahiro Ota, Hide Utsunomiya, Rakesh Uppal, David C 
Sabiston, Peter K Smith, Duke University Medical Center, Durham NC. 
Although saphenous vein bypass graft function can be assessed with contrast 
echocardiography, this requires direct injection of contrast material into the graft 
Since this is inappropriate for left internal mammary artery (LIMA) grafts, the 
purpose of this study was to evaluate the feasibility of aortic root contrast injection 
as an alternate sttategy. 
Ten swine underwent LIMA grafting to the occluded LAD. Following 
cardiopulmonary bypass, A1bunex was injected through the cardioplegia catheter 
into the unclamped aortic rool Optimal dose was defined as that dose obtaining 
enhancement of the septum. Septal blood flow was varied by pneumatic occlusion 
of the LIMA graft. Mid·papillary short-axis epicardial echocardiograms 
underwent intensity analysis to generate time intensity curves. The gamma-variate 
function y=Ate· at (where A is a scaling factor, t is time and C1 is an index of curve 
width), was fitted to the time intensity curves. ECG, left atrial, leCt ventricular 
pressures and aortic flow were recorded. Area under the curve (AUC), peak pixel 
intensity (PI), and mean transit time (MTT) were calculated from each time 
intensity curve. Linear regression analysis was used to compared time intensity 
curve parameters to blood flow measured by radioactive microspheres. 
Hemodynamics were compared by Student's paired t·test, P< 0.05 was significant. 
One animal was excluded due to aortic insufficiency. The optimal injection dose 
of Albunex was 10 ce. (4 ce.·14 cc.). No significant hemodynamic changes 
occurred during Albunex injections. Septal perfusion defects were visually 
deteclable by echocardiogram and resolved upon release of the graft occluder. 
There was no correlation between the time intensity parameters and myocardial 
blood now measured by microspheres (AUe vs Perfusion r2 = 0.05, PI vs 
Perfusion r2 = 2.71 E"" M1T vs Perfusion r2 = 0.05 ,C1 vs Perfusion r2 = 0.06). 
Albunex can safely' be injected into the unclamped aortic root with no 
significant changes in hemodynamics. Injection of Albunex into the unclamped 
aortic rOOI is capable of enhancing the myocardium permitting evaluation of the 
myocardial region perfused by the LIMA graft. Aortic root injection also permits 
visual detection of septal perfusion abnormalities secondary to decreased now in 
the LIMA grafl In the swine model, time intensity parameters do not correlate 
with absolute myocardial blood flow. Further studies are required to evaluate 
methods to improve delivery of Albunex to the myocardium and permit 
calculation of myocardial blood now. 
394A ABSTRACTS 
797-4 2:45 
Myocardial Contrast Echocardiography: Assessment of 
Myocardial Perfusion of Dilated Cardiomyopathy Patients With 
Comparison to Thallium Uptake by SPECT 
"Takahiro Ota, Noriyoshi Yamawake, Mitsuhiro Nishizaki, Masataka 
Arita, Yokohama Minami Kyousai Hospital, Yokohama, Japan 
We have reponed using myocardial contrast echocardiography (MCE) 
that the myocardial microcirculation of dilated cardiomyopathy (DCM) 
patients may be impaired. To compare the myocardial perfusion using 
MCE and perfusion scintigram of thaUium-20l SPECT 
imaging(SPECT), we studied 8 patients with DCM. Sonicated 
lopamidol was injected into the left main coronary artery while 2-
dimensional echocardiography was taken to evaluate LV wall motion 
and perfusion contrast effects simultaneously. Regions of interest 
(ROI) were defined in the antero-septal (ROI-l), posterior (ROI-2) and 
lateral wall (ROI-3) of the LV and the quantitative indices such as peak 
pixel intensity (Ip) and washout half decay time (TI!2) were 
determined from time intensity curves. Wall motion (WMS) for each 
ROl was scored from normal(4) to dyskinetic(O). Regional myocardial 
uptake ratio(MUR) was calculated by SPECT correspond to ROI-l to 
ROI-3 re tivel. 
2.8 ±O.4" 2.5±O.5** 
O.91±O.1 O.69±O.7 
*p p < . I vs. 
Despite normal coronary aneriography, contrast effects were not 
uniform in the LV wall. lp was significantly less in the antero-septal 
than in the posterior and lateral wall regions, correlating well in six 
patients with WMS. The results of MCE suggest the microcirculation 
was impaired in regions with akinetic to severe hypokinetic wall motion 
abnormality. However, the lack of correlation between MUR and wall 
motion abnormality and Ip indicates that cellular injury detectable via 
SPECT may be caused by other factors unrelated to microcirculatory 
impairment. Funhermore, the 'spouy' appearance of the SPECT image 
suggests the resolution of SPECT may not be as good as MCE. 
797-5 3:00 
Determination of Regional Renal Blood Flow Changes During Surgery 
With Perfusion Ultrasonography 
S. Aronson. RJ Thistlethwaite. R. Walker. C. Beezhold. SB Feinstein. 
University of Chicago. Chicago. Il 60637 
This study is the first using Albunexs and perfusion ultrasonography 
(USI to evaluate regional renal blood flow. 10 patients were studied 
during renal transplantation. 48 contrast-enhanced ultrasound 
images were recorded on video. EKG. BP. CVP. and urine output 
were monitored throughout surgery. Doppler-derived renal artery 
resistance index (RJ) was measured before injection. immediately 
after. and 24hr. post-op. A renal flow scan was obtained 24hr. 
post-op. Intraoperative renal perfusion was visually scored and 
compared to contrast dose. Following perfusion grading. intrarenal 
verapamil (2mgl was administered. An identical contrast dose was 
reinjected and perfusion was again graded. Videodensitometry (VOl 
was used to determine outer - inner cortical peak pixel intensity (PPJ) 
ratio when possible. Differences in perfusion scores and RI were 
compared with an analysis of variance and Student's t-test with 
P:s 0.05 considered significant. Results:9/10 patients had immediate 
normal graft function. 2/10 patients had evidence of ATN at 24h. 
No acute changes were noted in HR. BP. and CVP during injection. 
RI values before 10.68 ± 0.181. immediately after injection 
(0.72 ± 0.131. and 24h after (0.69 ± 0.111 did not change. VD 
analysis was possible in 6 patients. In 4/4 patients with normal graft 
function. outer to inner PPI ratio was :s 1. whereas in 2/2 patients 
with abnormal graft function. the PPI ratio was > 1. When renal 
perfusion imaging was excellent (score 21, 0.5ml of contrast was 
required 35% of the time and 2.0ml was required 50% of the time. 
A 2.0ml dose always enabled perfusion assessment. whereas 0.5ml 
failed to allow perfusion assessment 30% of the time and provided 
suboptimal enhancement 65% of the time. With verapamil. the avg. 
regional renal perfusion grade increased: 1.4 ± 0.6 before vs 2.1 ± 0.6 
after (P sO.051. implying greater regional blood flow. Conclusion: 
Intraoperative contrast US with Albunex'" appears safe and feasible 
for direct. on-line determination of acute changes in renal blood flow. 
lACC February 1994:IA-484A 
797-6 3:15 
Concentration and Pressure Dependence of Ultrasonic 
Integrated Backscatter of a New Echo Contrast Agent 
Jack G. Mottley,l Richard Johnson,2 Sarah M. Middleton2 Richard 
S. Meltzer 1. 1 University of Rochester, Rochester, NY, and 20elta 
Biotechnology, Ltd., Nottingham, Great Britain. 
A novel albumin-based microbubble contrast agent, prepared 
by a different technique from the sonication method used for other 
albumin based echo contrast agents, has been developed. It has 
microbubbles (I1B) with relatively thick walls that are highly 
pressure-resistant. To investigate the acoustic properties of this 
agent in vitro, we measured ultrasonic integrated backscatter of 3 
aliquots during 10 successive dilutions (6xl07 I1B/cm3 to 
.Olxl07 I1B/cm3 by factors of 2) at atmospheric pressure, and 
of 3 aliquots at different pressures at a single dilution. The batch 
measured had an average diameter of 4.9 11m. Integrated 
backscatter was measured 480 times over 100 sec at each 
dilution or pressure with a speclrum analyzer set to a 1 MHz 
bandwidth, centered at the center frequency (5 MHz) of the 
wideband transducer used (Panametrics V309). The agent was 
contained in a specially designed plastic chamber that allowed 
stirring and was diluted with degassed, deionized water. Results: 
The backscatter increased as a function of concentration up to 
approximately 0.75xl07 I1B/cm3, after which there was 
significant attenuation and the measured backscatter decreased. 
The decay of backscatter with time was very slow. averaging only 
1 dB/hr at atmospheric pressure. and was not significanlly 
increased at 100 mm Hg applied pressure. 
We conclude that this agent yields a stable relation between 
concentration and ultrasonic integrated backscatter up to 
approximately 0.5xl 07 I1B/cm3 • and that its integrated 
backscatter is relatively unaffected by ·physiologic· pressures. 
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798-1 2:00 
Differential Expression and Function of iwo 
Nonmuscle Myosin Isoforms in Human Vascular 
Smooth Muscle Cells 
Sigrid Nikol, Noriko Murakami, Gerhard Bauriedel, Geoffrey 
Pickering, Ralf Koster, Ahmad Boseila, Meinhof VoS, Lawrence 
Weir, Jeffrey M. Isner, Berthold Hofling, Ludwigs-Maximilians•
Universitat, Munchen, Germany 
This investigation was performed to study isoforms A and B of 
nonmuscle myosin II (NMM II), implicated in playing a role in 
vascular restenosis. Cultured vascular smooth muscle cells 
(VSMCs) were investigated using in situ hybridization, 
immunocytochemistry, Western Blot analysis and inhibition by 
antisense oligonucleotides (ONs)_ Gene expression was measured 
using in situ hybridization. Counting silver grains per nucleus a 
significant difference in proliferating vs. quiescent VSMCs was 
found (16.7±8_6 vs. 7.5±8.3, p<O_OI). However, on the protein 
level there was no significant serni-quantitative difference except 
for the presence of a contractile ring, which was consistently 
detected using the NMM lIB antibody for immunofluorescence. 
After treatment with specific ONs prolifemtion and rnigmtion were 
measured. Counting cells, both anti-NMM IIA and anti-NMM IIB 
ONs were found to inhibit prolifemtion of VSMCs compared to 
the missense control (23,095±9,577, 7,238±3,039 and 
58,344±20,661 cells, respectively). However, anti-NMM lIB 
ONs had a 3-fold stronger effect than anti-NMM IIA ONs. In 
contrast, there was no significant difference regarding migration 
velocities using the same antisense ONs_ Thus, NMM lIB seems 
to playa more important role in proliferation of VSMCs than 
NMM IIA, possibly by formation of a contractile ring. NMM IIB 
may therefore represent a suitable target at which to direct efforts 
to inhibit vascular restenosis. 
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798.2 2:15 
ReductiOli of NeoIatImMI IIypapIuIa Willi Per\adopril After Esperimeatal 
W0plaal)' Is AasocIated Willi baIllbitiOli of tile C·JIIII ucI C.fotl Oacoge_ 
.Eric Van Bellc, Christophc Bautcr&, N"1OO1as Wcmcrt, Oaudc Dckayre, 
Christine Piraubc, Benaard Dllpuis, Jcan-Marc LabIanchc, Michcl E. 
Bertrand, Bernard SwyDghcdallW. Ullivenity of Lillc, IDsenn U127 Paris and 
I.R.I.s Courbcvoic, France 
Angiotcnsin CXlII\'Crtiog eDZ)'IDc (ACE) inhibitOR redllce DCOintimal 
hyperplasia aftcr czpcrimcDlal baJJooD injury. II Iaas bcca dcmoastrated that 
nuclear ODCOgCDCS arc iDduccd in the YaSCUIar wall in the boors foUowiDg 
injury. These geDCS arc abo iDduccd in vascular smooth mllScle cells by 
angiotensin n. It has bcca lU(!gested that the effects of ACE inhibitors OD 
DCOiDtimal byperpIasia could be mediated by an iDhibilioo of nuclear proto•
oocogcae iDductioD. 
To tcst this hypothesis, 16 New-Zealand Whitc rabbits werc randomized for 
histologic analysis 10 periDdopril1mgJkgJday (0=7) or placebo (0=9). After 
7 days of treatmeDl aortic: injury was performed. The trcatmeDl was 
continued and the animals were saaificcd 28 days after injury. In ~ 
pcriDdopriJ group, DCOiot.imal cross-sedional arca (0.32+ /.{I.05 mm ) 
(mcan+ /-SEM) r,s signiftcalltly (p<O.05) 1css thaD in the control group 
(0.56 + / .{I.08 mm ),' 43% reduction. 
Six animals without any drug trealJDeDl werc used 10 assess the timc course of 
proto-onCGgcDC ClIprcWOD in the aortic wall aftcr injury. Total aortic RNA 
was hybridized with myc, f06 and jUD probes. Based on the results in these 
animals, the effects of pcriDdopriI were tested in animals ki\led 1 hour after 
injury. 
Twenty-foor animals were raodomizcd to pcriDdopriI 1mgJkgJday (n=8), 
IOmg/kgfday (n E 8) or placebo (n E 8) for 7 days and sacrifaccd 1 boor after 
injury for northern blot analysis. C-myc aprcssioo was Dot altcred by 
prClrcatmcnt. However, periDdopril at 1 mgf'qjday iDduccd a 50% reduction 
in C-jUD and a 45% in C-f06 aprcssioo (p<0.02 \'CrSUS COIIIrol). No additional 
cffect was obtained with 10 mg/kg/ day ( 30% and 47% reductioo \'CrSUS 
CODIrol, respccti\'CIy ). 
The inhibitory effect of periDdopriJ on intimal hyperplasia is associated with a 
reduction in c-fos and c-jUD ClIprcWon. These results suggest that 
prClrealJDcnt may be required 10 maximize a potcDlial cffect of periDdopril 
on restcnosis. 
798-3 2:30 
Inblbltlon of Rabbit and Human Vascular Smooth Musci. C.II 
Prol1fentioo: Efficiency of ProloollCogene M ..... nger RNA TargellDg by 
Antisense OUgonucleoUde Compared to Heparin 
Pierre Voisinc, Guy Leclcrc. Univcrslty of Montreal School of Medicine. 
Notte-Dame Hospital. MontreaJ. PQ. Canada 
Itomediate early proloODcogene (JEP) activation is associated with vascular 
smooth muscle cell (SMC) proliferation. This activation may be essential for 
SMC proliferation. as heparin. a potent inhibitor of SMC growth. interferes 
indirectly (via supression of second messenger palhways) with the iDduction of 
c-myc and c-ros mRNA in SMCs. Antisense oligonucleotides pennit a direct 
intenlCtion with these mRNAs. Accordingly. the purpose of Ibis study was to 
dere:nnine the sequence-specific anliprolifcnllivc cfficiency or oligonucleotides 
targeting the mRNA of two different IEP, c-lUyc and c-fos. in SMC culture 
systems from two species. and to compare tbeir growth inhibitory elJ'JCieDcy to 
that of unfractiODDCd heparin. Pbospborotbioa/e oligonucleotides (15 to 18 mer. 
antisense and sense) specifically targeting tbe traDsla1ion initiation codon 
region of Ibese mRNAs were syDlbesizcd in various sequences and added to 
syncbrooized human and rabbit SMC cultmes at coocenttations of up to 75 liM 
(c-myc) or 100 liM (c-fos) at day O. Conlrols consisted of cells lDIexposcd to 
oligomers. Heparin was added according to a regular schedule to similarly 
synchronized SMCs in concenttations ranging from 1 to 1000 l1g1ml. Percent 
growth inbibitory effect was assessed at day lOin each treatment arm by 
automated cell counting. Sequence-specific growth inhibition was maximaJly 
obtained with a c-myc antisense oligomer in both human (61.4%. at 75 liM. 
with a dose-related increase) and rabbit SMCs (66.7%. at 25 liM. with a 
plateau tbereaftcr). while no toxicity was observed. No Significant effect was 
seen with sense conlrols. Antisense oligomers complementary to c-fos also 
sbowed a lDlI1i:ed inhibitory activity wilb 70.0% (human) and 61.7% (rabbit) 
growth inbibition at 100 liM. which proved. however. to be DOD sequence•
specific (p=NS vs sense CODIroIs). Hcparin also demonstrated a dose-related 
inhibition. ranging from 0% to 37.3% (human) and 0% to 42.2% (rabbit). 
Sequence-specifIC maximaJ growth inhibitory effect with the c-myc antisense 
oligomer was significanUy higher than the maximaJ inhibitory activity seen 
with heparin (p=O.007, buman; p-o.013, rabbit). Conclusions: 1-
Pbospborotbioate antisense oligOlDen complementary to c-myc mRNA inhibit 
human and rabbit SMC proliferation in a sequence-specific manner. 2-The 
strategy of direct interference with c-myc expression by modified antisense 
oligonucleotides appears to be more efficient than unfractionned heparin in 
inhibiting prolifcnllion of both human and rabbit SMCs. 
ABSTRACTS 395A 
798-4 2:45 
Persisleace of Lnciferase GeBe Expressibn FoliowiDg 
Adenovirus-mediated I" VivD Direcl Gene Transfer lBto Porcine 
Coronary Arteries 
Nadir M. Ali, Wojciech Mazur. George P. Rodgers. Daryl G. Scbulz. Robert 
Roberts, Albert E. Raizner. Brent A. French, Baylor College of Medicine, 
Houston. TX 
Restenosis following coronary angioplasty may be amenable to gene therapy 
provided that therapeutic levels of nlCOIIIbinant gene expression can be obtained 
in afflicted vessels over an appropriate period of time. Evidence from animal 
models and human autopsies indicates that the majority of the smooth muscle 
cell migration and proliferation responsible for restenoSis occur dufing the first 
weeks follOwing angioplasty. Thus to be effective, an antiproliferative gene 
therapy would have to provide for at least two weeks of therapeutic gene 
expression. We have previously used recombinant adeooviral vectln to obtain 
high levels of reponer gene expression in porcine coronary arteries 3 days after 
gene transfer; however. little is known about the time course of gene expression 
in vivo following adenoviral infection. The current study was undertaken to 
detennine the duration of recombinant gene expression provided by a replication•
deficient adenoviral vector containing the frrefly luciferase expression cassene 
(Ad5/RSV/GL2) in porcine coronary arteries. Under fluoroscopy. 4 ml of virus 
(4x109 pfu) was infused into each ~ 70·,.------.... :-;;;---....., 
pore ine coronary artery at a ~ 
pressure of 8 aim using perforated ~ 
balloon catheters. Reporter gene .e 
activity was de!ermined at I. 3. 7. ~ 
and 14 days following gene .!:! 
transfer using a luminometric 'g 
assay for luciferase. ResuilS are .J 
shown in the graph where values Day 3 Days 
represent mean level s of luciferase recovered per artery in picograms (pg) ± 
standard deviation and n equals the number of coronary arteries assayed. Reponer 
gene expression was found to persist at significant levels from I to 14 days 
following gene transfer. We conclude that the. duration of gene expression 
provided by adenoviral vectors appears to be suitable for antiproliferative gene 
therapies direc!ed against resteoosis. 
798-5 3:00 
C-myc Antisense Ollgomers Reduce Neolntlma 
Formation In Porcine Coronary Arteries. 
Vi Shi, Ali Fard, Pawan Vermani, Andrew zalewski. 
Thomas Jefferson University, Philadelphia, PA. 
Nuclear proto-oncogenes play an important role in cell proliferation 
functioning as a common final pathway onto which many mitogenic 
signals converge. We have previously shown a significant growth•
inhibitory effect of antisense oligomers directed against the 
translation initiation region of the c-myc proto-oncogene In both 
human and porcine vascular smooth muscle cells in vitro. To 
determine the polential therapeutic role of this approach In the 
prevention of coronary restenosis, placebo (sense or saline) or 15-
mer c-myc antisense ollgomers (1 mg) were delivered via a porous 
balloon Into denuded porcine coronary arteries. OIiQomer delivery 
was associated with no adverse effects. HistologiC injury score 
demonstrated comparable degree of medial injury in both groups. 
The maximal neointimal area (NA max), neointimal thickness (NT 
max) and residual lumen (RL) were determined by morphometry 1 
month after balloon denudation: 
n 
placebo 12 
antisense 13 
p 
NA max (mm2) 
O.8O±O.17 
0.24±O.06 
<0.01 
NT max (mm) 
O.48±O.09 
O.2O±O.04 
<0.01 
RL(%) 
64i£ 
81:t5 
<0.05 
In addition. when maximal neointimal area was analyzed as a linear 
function of histologic injury score, c-myc antisense ollgomers 
significantly reduced neoinlima formation even with more advanced 
grades of Injury (p<O.01 vs. placebo). 
In cooclusion: 1. these results suggest an important role of the c•
myc gene activation in the process of phenotypiC modulation of 
smooth muscle cells in vivo, 2. local transcatheter delivery of c•
myc antisense oligomers reduced the formation of neointima in the 
coronary vasculalure Implying therapeutic potential of this 
approach. 
396A ABSTRACfS 
798-6 3:15 
Inhibition of S.aoth Muscle Cell Proliferation In-Vivo 
Following Local Delivery of Antisense Oligonucleotides 
to C-~b During AngioplaBty. 
Midlael A. Azrin, JClSElil F. Mitchel, carl Pedersen, Ti.JTDthy 
OJrley, Iaurine M. B::w, ~ V.Alberghini, r:avid D. W>ters, RayrraXl 
G. M::Kay,Hartfard HcEpital,Uliversity of o:nnectiOlt,Hartfard,cr 
Oligcrucleotides CXIlP1STBltary to C-m:rb _ inhibit = 
proliferatien in vitro ard !!BY r€duce the proliferative resp::rJSe to 
va!Ollar injury foll~ tallOCll argicplasty. on.;, effect of in•
vivo delivery of antisense C-m:rb oligcrucleotides en this resp:nse 
106S evaluated after local intrarrural delivery in mnral periIiJeral 
p:m:ine arteries usin;J antise1se-ooated hydrcgel J::allcalS. '!he 
ability to deliver 32p -oligcrucleotides IoI6S dsralstrated by 
scinl:illatien cnmtin;J ard by autoradiQ9rali1y after ar>;Jicplasty of 
7 vessels. 'lWelve iliac or carotid vessels fran 7 swine received 
locally delivered 18 tase pair ~oated oligcrucleotides 
in c:xn::entratiCllS =in;J fran 0.025 to 0.300 1ITD1es. '!he 12 
ocntralateral vessels received the CXIlP1STBltary sense stram. All 
arterial segments 1oIeI'e rE!!"(7.fed 5-7 days after argicplasty. Cellular 
proliferatien 106S evaluated by imrurxiJistodlanioal stainin;J with 
PCI0 an anti.J:x:qy to KWI (Proliferatin;J Cell N.Jclear Antigen). 
N.Jclear stainin;J 106S (J.Ialltified usin;J the cell Analysis Systan. 
RBStlLTS: 32p -oligcrucleotides were identified within the mejia by 
autoradiQ9rali1y. QJantitatien of 32p -oligcrucleotide delivery 
dEm:nstrated that ax:prod.rrately 10% of the oligcrucleo-tide en the 
tallOCll surface IoI6S delivered to the arterial 11611 dJrin;J tallOCll 
argicplasty. SllOOEqUent 1IBSh:ut fran the 11611 occurred rapidly, 
alth:ugh SIlBll anrunts (0.5 -1 %) of intrarrura1 oligcrucleotide 
persisted for CNer 24 h:J..Irs after local delivery. In 10/12 vessel 
pairs, proliferatien106S less in antisense treated vessels than in 
ocntrols. In antrol vessels 9.3 ± 5.2% of ruclear area 
daTalstrated stainin;J for KWI. It1ile in antisense treated vessels 
stainin;J 1IBS present in 7.7 ± 4.9%, (p<0.04). Stainin;J with anti•= actin anti.J:x:qy OM) ruggested a = origin of proliferatin;J 
cells. CONCLUSION: IDealized delivery of antisense 
oligcrucleotides dJrin;J talloon ar>;Jicplasty r€duces the 
proliferative resp::rJSe to vascular injury ard !!BY be useful in the 
ra:ilcticn of restemsis by re::lucin;J = proliferaticn. 
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799-1 2:00 
Blockade of Both Adenosine and Alpha Adrenergic Receptors is 
Required to Prevent Hypoxic Preconditioning in Rabbit Hearts. 
Robert S. Walsh, John J.F. Daly, Michael V. Cohen, and James 
M. Downey. University of South Alabama, Mobile, AL. 
The protection of ischemic myocardium induced by 
hypoxia mimics that of ischemic preconditioning. To determine 
whether this hypoxia-related protection is also receptor•
mediated, buffer-perfused rabbit hearts (N = 30) underwent 30 
min regional ischemia and 2 hr reperfusion. Hearts were 
preconditioned by 10 min perfusion with hypoxic buffer 
(pOz =43±2 rnrnHg) and 10 min reperfusion with oxygenated 
buffer before regional ischemia. At the end of reperfusion, 
infarct size was determined by tetrazolium staining. Hearts 
exposed to hypoxia had smaller infarcts compared to controls, 
10±2% of the risk zone vs 29±4%, p!>0.05. This protection could 
not be blocked either by the adenosine receptor antagonist 8-p•
sulfophenyl-theophylline (SPT, 100 ~M) given during hypoxia 
(l3±3%) or by pretreatment with the alpha-adrenergic 
antagonist phenoxybenzamine (PBZ, 10 ~M), 7±2%. When 
pretreatment with PBZ was combined with administration of 
SPT, the hypoxia-induced protection was lost (23±3%, p!>0.05 vs 
hypoxic preconditioned). These data indicate that the protection 
of the ischemic myocardium by hypoxia is initiated by dual 
receptor pathways. Both catecholamines and adenosine are 
released under hypoxic conditions and either can trigger 
protection; thus, blockade of both receptor pathways is required 
to abort this protection. Hence a redundant signalling pathway 
ensures maximal myocardial salvage under ischemic conditions. 
lACC February 1994:1A-484A 
799-2 2:15 
Acetylcholine Acts as a 'Preconditioning-Mimetic' in the Canine Model 
Karin Przyldenk and Robert A. Kloner. Heart Institute, Hospital of the Good 
Samaritan and University of Southem Califomia, Los Angeles CA. 
Brief episodes of antecedent ischemia protect or 'precondition' the heart 
from subsequent sustained coronary occlusion (CO), perhaps by stimulation 
of the adenosine A, receptor coupled to the G, protein. Brief ischemia is 
not, however, a desirable therapeutic means to initiate cardioprotection; 
thus, we assessed whether stimulation of G, by an IV bolus of the vaso•
dilator acetylcholine could mimic the protective effects of ischemic pre· 
conditioning. Four groups of dogs underwent 1 h of sustained CO and 5h 
of reflow. Prior to CO, each dog received: no intervention (controls); four 
5-minute episodes of preconditioning ischemia; IV bolus of acetylcholine 
(0.01 mg); or IV bolus of nitroglycerin (0.05 mg: a dilator which does not act 
on G,). Myocardial blood flow was measured during sustained CO by 
injection of radioactive microspheres, area at risk of infarction (AR) was 
delineated by in vivo dye injection, and infarct size was assessed by 
tetrazolium staining. 
§ P < .05 vs. Control by Endocardial Flow Area at Risk Infarct Size 
ANOVA and ANCOVA (ml/min/g) (% of LV) (%ofAR) 
Control (n:9): 0.06+0.02 18+2% 19+3% 
Preconditioned (n: 8): 0.08+0.02 19+1% 7+2% § 
Acetylcholine (n: 6): 0.05+0.02 22+1% 11+2% § 
Nitroglycerin (n ~ 8): 0.05+0.02 21+1% 17+4% 
III groups were comparaOie wlln respect to COllateral 01000 flOW ana area 
at risk. However, infarct size was Significantly smaller in both 
preconditioned and acetylcholine-treated dogs vs. controls. Importantly, the 
protective effect of acetylcholine was not simply due to acute vasodilation: 
both acetylcholine and nitroglycerin induced similar modest and transient 
changes in arterial pressure and coronary blood flow, yet nitroglycerin did 
not limit infarct size. Thus, IV bolus acetylcholine is an effective and 
therapeutically feasible 'preconditioning-mimetic' in the canine model. 
799-3 2:30 
ai-Adrenergic Agonists Can Precondition Myocardium Through 
Direct Activation of Protein Kinase C 
Akihito Tsuchida, Yongge Liu, Guang Liu, Michael V. Cohen, 
James M. Downey, University of South Alabama, Mobile, AL 
Brief ischemia preconditions myocardium and salvages ischemic tiss•
ue by activation of protein kinase C (PKC) via adenosine (AD) 
receptor stimulation. ai-Adrenergic agonists also protect but there 
is confusion about the role played by AD in this protection. We 
studied interaction between AD and ai-receptor pathways, in 
isolated, buffer-perfused rabbit hearts subjected to 30 min regional 
ischemia (RI) and 2 hr reperfusion. Infarct size was measured with 
tetrazolium. Untreated hearts experienced 31.0± 2.6% infarction of 
the ischemic zone. 5 min of ai-agonist phenylephrine (PE) followed 
by 10 min washout before RI caused only 9.7± 1.3% infarction 
(p<0.05 vs untreated). Neither methoxamine, an Olio-agonist, nor 
PE plus chloroethylc1onidine, a specific alb-blocker, could protect 
implicating participation of only the alb receptor. The alb like the 
AD receptor couples to PKC and, as predicted, a specific PKC 
blocker, polymyxin B blocks PE's protection. Protection persisted 
when the AD blocker 8-(p-sulfophenyl)theophylline (SPT) was given 
along with PE indicating that al-agonists protect by direct activation 
of PKC independently of AD. However, SPT infused during RI 
blocked PE's protection implying endogenous AD is needed to 
reactivate PKC during RI. PE's protection could be restored if PE 
continued to be infused along with SPT during RI since PKC could 
be reactivated through the alb receptors. Thus, if PKC activation 
occurs once prior to RI and again at the onset of RI, then protection 
will occur regardless of the receptor involved. These results 
strongly support the central role of PKC in the protection of 
ischemic preconditioning. 
ACC February 1994:1A-484A 
799·4 2:45 
Protection of Myocardium by Transient, Pre·Iscbemic, 
Alpba,·Adrenoceptor Activation in tbe Rabbit 
Sharon L Hale. Roben A KIoner. The Hean Institute of the Hospilal of the 
Good Samaritan and Depanment of Cardiology. USC. Los Angeles. CA 
Transient ischemia preconditions the myocardium, possibly through 
an adenosine-mediated mechanism. Alphal-adrenoceptor stimulation 
has been shown to augment the release of adenosine by increasing 
5'-nucleotidase activity. We studied whether the a.-adrenoceptor 
agonist, phenylephrine, would confer a cardioproteCtive effect when 
given before an ischemic event. Phenylephrine, 50 )lg/kg, was given 
as a bolus 15 min before coronary anery occlusion in the treated 
group; control rabbits received saline. All rabbits underwent 30 
minutes of coronary artery occlusion and 4 hours reperfusion. Infarct 
size (IS) was determined by tetrazolium staining and risk lOne (RZ) 
by blue dye. Mean systemic pressure increased briefly after 
phenylephrine administration (80±4 to 123±8 mmHg) but returned to 
baseline before occlusion. Hean rate was similar in both groups. 
Regional myocardial blood flow was not altered by the phenylephrine 
bolus, and both groups were equally ischemic during occlusion. 
Group 
Control 
Phenylephrine 
n 
9 
9 
RZ (% LV) 
31±1 
28±2 
IS (% RZ) 
44±5 
23±4* 
* p<.007 versus control 
Infarct size was reduced 48% by phenylephrine pre-treatment. We 
conclude that transient, pre-ischemic, a.-adrenoceptor activation 
renders the myocardium more resistant to necrosis during an ensuing 
ischemic event. 
799·5 
RIt .. of Subltrlte Utilization In Preconditioned Pig H •• rt •. 
3:00 
A. James Uedtke, Britta Renstrom, Stephen H. Nellis, Timothy A. Hacker. 
University of Wisconsin, Section of Cardiology, Madison, WI 
One hypothesis to explain the benefits of preconditioning Is that transient 
Ischemia with reperfusion Imposed before sustained ischemia somehow 
lessens metabolic demand In treated myocardium. This is argued to 
diminish certain adverse consequences of sustained ischemia, i.e., aCidosis 
and the noxious effects of catabolite accumulation. Evidence to support the 
amelioration of acidosis has been confirmed from several laboratories but 
metabolic trends, in particular, direct measurements of substrate utiliZation 
remain outstanding. Such was the purpose of the present report. Intact, 
extracorporeally perfused pig hearts were divided into two groups, infused 
with [U-"C] palmitate and [5-'H] glucose, and studied during 40 min 
intervals of sustained ischemia [-60.10% In anterior descending (LAD) flow] 
and reperfusion. Prior to this in one group (TREAT. n=7), a short cycle of 
transient ischemia (-70.10% in LAD flow for 10 min) with 20 min reflow was 
interposed. As compared with untreated hearts (CONTROL. n= 7) during 
sustained ischemia, TREAT further impaired regional shortening (-7.2" 14. 7% 
vs 22.2" 19.6% of initial values) which did not recover during reperfusion 
(19.3.16.9% vs 69.5.13.7%, p< 0.04). Conversely, metabolic behavior was 
comparable or increased in TREAT hearts. SpecWically, myocardial oxygen 
consumption (MVO,) was equivalent during ischemia between groups (0.62 
• 0.04 and 0.65 • 0.05 mmol hr' g dry wr' for TREAT VS CONTROL, 
respectively, NS) as was exogenous glucose utiliZation (224 " 22 vs 182 • 
36 JJlllol hr' g dry wr" respectively, NS). Fatty acid (FA) oxidation was 
actually increased in TREAT hearts (13.8" 1.2 vs 9.7" 0.9 JJlllol hr' g dry 
wr', p<0.016). During reperfusion, TREAT vs CONTROL data were also 
comparable: MV02: 0.98.0.08 vs 0.95,,0.04 mmol hr' 9 dry wr', NS; 
glucose utiliZation: 32.5 vs 45.9 JJlllol hr' g dry wr', NS; and FA oxidation: 
25.4,,4.7 vs 19.3.1.5 JJlllol hr' g dry wr', NS. Tissue ATP and creatine 
phosphate at end-reperfusion were no different between groups. These 
results do not support the construct of decreased metabolic performance 
as an obligatory component of preconditioning. Rather, aerobic metabolism 
appeared spared in TREAT hearts and the previously reported observations 
of decreased acidosis in part may be explained by the preserved oxidation 
of fatty acids. 
ABSTRACTS 
799·6 
Sodium Kinetics in Interventions that Umit InfarC1 Size: 
Insights into Preconditioning 
Saul Schaefer, Hong Liu, Erik Prussel, Steven Anderson. 
University of California, Davis, Davis, CA 
397A 
3:15 
Myocardial infarct size can be dramatically limited by interventions 
such as ischemic preconditioning (PC) and the use of pyruvate (PYR) 
as a substrate. One potential mechanism is limitation of intracellular 
sodium (Nai) accumulation, either by reduction of intracellular 
acidosis or a primary effect on sodium transport. To test this 
hypo~hesis, isolated ~at hearts (n = 5 each group) were subjected to 
30 minutes of global Ischemia followed by 30 minutes of reperfusion. 
Control hearts used glucose substrate in modified Krebs-Henseleit 
buffer. PC hearts had 4 five minute episodes of total ischemia 
separated by 5 minutes of reperfusion. PYR hearts had 10 minutes 
of substrate-free perfusion and 30 minutes of pyruvate without 
glucose. Nai was measured using the shift reagent dysprosium•
~THA (7 mM) and 23Na magnetic resonance spectroscopy. Infarct 
Size, measured by creatine kinase release in parallel experiments, was 
reduced In both the PC and PYR hearts by greater than 60% 
(p<0.05). Recovery upon reperfusion was improved in the PC and 
PYR hearts compared to control, manifested by lower perfusion 
pressures upon reperfusion (130 ± 11.7 and 141 ± 8 vs 180 ± 9.8 em 
H20, p = 0.01). During the first 5 minutes of ischemia, Nai increased 
by 15.5 mEq/kgdw in the PC hearts, 14.4 mEq/kgdw in the PYR 
hearts, and 5.2 mEq/kdw in control hearts, although only in PC 
hearts was the increase statistically significant (p < 0.05). There was 
no difference in Nai between groups at the end of ischemia. Nai 
declined equally upon reperfusion in all groups, returning to control 
values within 30 minutes. These data suggest that infarct size 
limitation by PC and PYR is less dependent on end-ischemic Nai than 
on alterations in sodium transport during the early phase of ischemia. 
800 Ventricular Arrhythmias, Pharmacologic 
Therapy 
Wednesday, March 16, 1994 2:00-3:30 PM 
Georgia World Congress Center, Room 361W 
800·1 2:00 
Adenosine Sensitivity of VerapamiI-Responsive Ventricular 
Tachycardia: Role of Catecholamines 
Kathy L FLee, Wen-Ter Lai, Yau-Ting Tai, Michael R Lauer 
Charlie Young, L Bing Liem, Ruey J Sung. Stanford University: 
Stanford, CA. 
Adenosine-sensitivity has been proposed to identify cyclic 
adenosine-m~mophosphate (cAMP)-mediated triggered activity as 
the mec~amsm of cenain verapamil-responsive ventricular 
tachycardia (VR VT) because adenosine is known to counteract 
catecholamine-induced increase in cAMP. 31 patients (pts) (age 
39±19 years) with VR VT (cycle length 364±86 ms) were studied. 
27 pts had no oven stru~tural heart disease, I had cardiomyopathy, 
I had coronary artery disease and 2 had hypertension. The QRS 
!D0rphology o~ the :"T w~ left bundle branch block-like (LBBB) 
10 12 (II had Infenor axiS, 1 had superior axis) and right bundle 
branch block-like (RBBB) in 19 (16 had superior axis 3 had 
inferior a.x!s). Tachycardia induction characteristically ~curred 
after a cnucal range of cycle lengths was attained, and overdrive 
pacing was effective in tachycardia termination. In 17 pts, the VT 
was considered catecholamine-dependent (CD) as isoproterenol (1-
5uglmin). was required for initiating and/or sustaining the 
tachy~ardla (9 LBBB-~, 8 ~BBB-VT). Adenosine (up to 12 
mg, 10 18 pts) or adenosme-tnphosphate (up to 30 mg, in 13 pts) 
was administered during sustained episodes of VT to assess its 
efficacy in tachycardia termination: 
LBBB-YT RBBB-YT 
CD Non-CD CD Non-CD 
Adenosine-sensitive 9/9 3/3 3/8 3/11 
Conclusion; Adenosine can terminate VR VT regardless of its 
catech<;>lanune-dependence, thus adenosine-sensitivity may not be 
a speCific marker for cAMP-mediated triggered activity. The 
disparity of adenosine sensitivity between LBBB and RBBB-VT 
(12/12 vs 6/19; 100% vs 32%) suggests that anatomical factor is 
important in determining adenosine sensitivity of VR VT. 
398A ABSTRACTS 
800·2 2:15 
A Prospective Randomized Comparison of Amiodarone and Sotalol 
for tbe Treatment of Ventricular Tacbycardia 
K. Ching Man. Brian D. Williamson. Emile Daoud. Mark Niebauer. Omar Bakr. 
John Jentzer. S. Adam Slrickberger. John D. Hummel. William Kou. Fred 
MOI3dy. University of Michigan. Ann Arbor. M1 
Previous swdies using SOI8101 have suggested that it may be as effective as 
amiodarone in controlling venlricular taehycardia (V1). The purpose of Ibis swdy 
was 10 compare prospectively and in a randomized fashion the efflC8C)' of SOIa101 
and amiodarone. Consecutive patienls with coronary anery disease. left vcnlricular 
ejection fraction (L VEP) >20%. and sustained monomorphic venlricular 
tachycardia inducible by programmed stimulation (PS) were prospectively 
randomized 10 either SOI81ol (n=\3) or amiodaronc (n=IO). Sotalol patients 
received 80mg bid x 4 doses. I60mg bid x 4 doses then 240mg bid x 5 doses. 
Amiodarone patients received 600mg tid x 10 days. In two patients. sotalol was 
discontinued due to heart failure. Repeat PS was performed at the end of the 
loading regimen. Patients were felt to be adequately treated if they were 
noninducible or had relatively slow (cycle length a35Oms) bemodynamically 
stable VT (B~ 9OmmHg). 
Amiodarone (n=10) Sota101 (n=l1) p value 
LVEF O.34±O.06 O.34±O.06 NS 
VT CL (baseline) 275±18 26l±37 NS 
VT CL (on drug) 351±56 305±33 <0.02 
Sinus CL (baseline) 88O±103 796±98 NS 
Sinus CL (on drug) 974±152 1.155±103 <0.01 
Successful 5(50%) 1(9%) <0.05 
CL= cycle length expressed in ms±sd; successful=noninducible VT or stable VT 
In the following electrophysiology test, there was a significant difference in sinus 
cycle length and venlricu1ar tachycardia cycle length. but no significant differences 
in AH. HV. or venlricular effective refraclOry periods between sotalol and 
amiodarone were noted. Conclusion: Amiodarone offers a significant clinical 
advantage over sotalol for the control of VT as assessed by electrophysiologic 
testing. 
800·3 2:30 
Beta Blockade Blunts Diurnal Variations in Ventricular Retractoriness 
*Thomas Q. Kong. Jeffrey J. Goldberger. Alan Kadish 
Nonhwestem University Medical School. Chicago. lL 
We have previously demonstrated significant diurnal variations in 
ventricular effective refractory periods (VERP). To determine if alterations 
in sympathetic tone account for this variation. VERPs were measured 
hourly for 24 hrs using noninvasive programmed stimulation in S subjects 
with no structural heart disease and permanent pacemakers at baseline and 
during complete beta blockade (BB; propranolol 0.25 mg/kg IV bolus; 6 
mgJhr IV for 24 hrs). VERPs were measured in duplicate at pacing cycle 
lengths (PeL) 600 ms and 400 ms by the incremental method at 2 ms steps. 
Mean propranolol levels were 120±13 ng/ml. To confirm the adequacy of 
BB. subjects received isoproterenol. 6 mcg/min for 5 min. after the 24th hr 
of testing during BB; no HR changes occurred. 
RESULIS: The figure compares mean VERPs (normalized to the noon 
value) at baseline versus during BB: g 
.. 1.05 .J1'-__ ---8-ase--, 
.... 
u 
!:. 1.03 
A. 
a: 
~ 1.01 
1 "i 0.99 
E 
o 
.... 
Z 0.97 + ...... ..,....,.....,.....,.. ...... -.-0-,-1 
12 16 20 o 4 8 
n.". of Day 
BB reduced the 
difference between 
shortest and longest 
VERPs from 23 ms at 
baseline to 7 ms at PCL 
600 ms. and from 21 ms 
to 6 ms at PCL 400 ms 
(p<O.OI). At baseline. 
maximum VERP 
shortening per hour was 
between 5 and 9 AM in 
individual patients. This 
morning drop was 
almost completely 
abolished by BB. 
CONCLUSIONS: Diurnal variation in ventricular refractoriness is primarily 
due to alterations in beta adrenergic tone. The reduction in early mOming 
sudden deaths by BB may be due to electrophysiologic in addition to anti•
ischemic effects. 
JACC February 1994:1A-484A 
800·4 2:45 
Differential Effect of d·Sotalol on Normal and Infarcted TilBue in the 
Canine Infarct Model 
Kirsten D. Freigang, Wolfgang Schoels, Laurence D. Stems, Bertram 
Offner, Alex Bauer, Wolfgang Kuebler, Johannes Brachmann, Division 
of Cardiology, Urtiversity Medical Hospital, Heidelberg, Gennany 
Introdyctioo' Despite its documented clirtical efficacy especially in fast 
ventricular tachycardia (V1), the type ill agent d-Sotalol (d-sot) has been 
shown to exert reverse use dependent effects in normal ventricular 
myo-cardium. This discrepancy between clinical and experimental 
findings might be due to differential effects of d-sot on normal and 
infarcted tissue. 
M£lilI:ld.;. Nine Beagle dogs were studied 5 days after left anterior 
descending coronary artery ligation. With a special patch electrode 
covering both normal and infarcted areas, 192 bipolar electrograms (Els) 
were simul-taneously recorded. Epicardial activation maps were 
construc-ted during pacing at 350, 300 and 250 ms. Based on the 
activation map, zones of normal (NZ) and slow conduction (SZ) could 
be identified in normal and infarcted areas, respectively. Local effective 
refractory periods (ERPs) were determined from sites under the patch in 
the SZ and NZ at 350, 300 and 250 ms basic drive cycle lengths before 
and after infusion of d-sot 1.5 mg/kg. 
~ Under control conditions SZ were found in infarcted areas 
only. After d-sot, conduction in the NZ did not change. In the SZ short 
arcs of functional conduction block occurred, especially at faster pacing 
rates forcing a change in the activation pathway. Mean change in ERPs 
after d-sot in percent ± standard deviation are shown in the table below. 
number of Els 350 ms 300 ms 250 ms 
peNS 
Conclysions' As opposed to normal tissue, d-sot does not demonstrate 
reverse use dependence in functionally abnormal tissue. Effects on fast 
VT might be due to prolongation of ERP in SZ beyond the tachycardia 
cycle length thereby producing functional conduction block. 
800·5 3:00 
Left Ventricular Fibromuscular Band is the Substrate for Idiopathic 
Left Ventricular Tachycardia RK Thakur, OJ Klein, M Zardini, HG Li, 
R YeA!. University Hospital, London, Canada. 
A left ventricular fibromuscular band (FMB) has been described in a 
patient with idiopathic left ventricular tachycardia (lL VT) with a 
characteristic right bundle branch, left axis morphology in whom surgical 
resection of the band resulted in cure. This observation raises the 
possibility that the FMB is responsible for the genesis of similar VT in 
others. We prospectively performed transthoracic 2D-cchocardiography 
(TTE) and transesophageal echocardiography (TEE) in 8 patients 
undergoing catheter ablation for IL VT to further define the incidence of a 
fibromuscular band in such patients. Patients consisted of 6 men and 2 
women, mean age 32.4 ± 13.1 years with symptom duration of 15.8 ± 16 
years. The mean VT cycle length was 360 ± 61 ms with right bundle 
branch block, left axis morphology in all patients. Cardiac chamber sizes, 
left ventricular wall thickness and left ventricular wall motion were 
normal in all patients. TTE demonstrated a FMB extending from the 
postero·inferior apical region to the left ventricular septum in all patients. 
TEE was performed in 4 patients and confinned the presence of a 
fibromuscular band. Thickness of the band varied from a fine strand to a 
well defined muscular band. Catheter ablation using radiofrequency 
and/or direct current applied at the postero-inferior apical region resulted 
in a cure in 7 patients during a mean follow-up of 15.5 ± 12.2 months. 
CONCLUSIONS: A fibromuscular band extending from the postcro•
inferior apical region to the septum is a consistent finding in patients with 
IL VT with right bundle, left axis morphology. This band may be 
responsible for VT in these patients. 
lACC February 1994:1A-484A 
800·6 
Ascertainment of Arrhythmogenic Right VentriCular Dysplasia: 
Angiographic Markers. 
Stefan Peters",Bettina Weber,Carl Arthur Hartwig,Gert·Hinrich Reil 
"Med.Fakultiit Magdeburg, Stlldt.K1iniken Oldenburg,Gennany 
In 112 patients with ARVO(n=58),WPW-syndrome(n=3),sarcoido•
sis(n=l),atrial septum defect(n=8),dilated cardiomyopathy(n=8), 
mitral valve disease(n=l7) and missing organic heart disease 
("",17) selective 3O'RA0160'LAO light ventricular angiography 
was perfonned in order to find angiographic markers of ARVO 
in patients with asymptomatic, oligosymptomatic and symp•
tomatic stages of the disease.RV angiograms were analysed 
with regard to RVEoVi,RVEF ,segmental contraction(regional 
RVEF) and some qualitative criteria. 
Results: 
RV-dil. 
segm. 
contr.imp. 
diffuse 
contr.imp. 
deep 
fISSures 
ARVO WPW Boeck ASo OCM MVP nonn 
n=18 n=O n=O n=8 n=3 n=6 n=O 
n=51 n= 2 n= 1 n= 0 n= 0 n= 8 n= 0 
n= 7 n= 0 n= 0 n=O n=3 n=O n=O 
n=25 n=O n= 0 n=O n=O n=9 n=O 
pile d'as- n=41 n= 0 n= 0 n= 5 n= 5 n= 8 n= 5 
siettes 
ED bulges n=58 n= 2" n= 1 n= 0 n= 0 n= 0 N= 0 
-=In 2 pat.with WPW-syndrome asymptomatic ARVO could be 
diagnosed by angiography. 
Enddiastolic bulges with loss of trabecular structure and segmen-
tal contraction impainnent were criteria with the highest value of 
specifrty,sensilivily,predictive value and correctness. 
Conclusion: ARVO can be diagnosed angiographically in all 
stages of the disease - even in asymptomatic fonns with leading 
symptoms of WPW-syndrome - and can be be clearly distinguished 
from predominant or biventricular idiopathic dilated cardiomyopathy. 
Enddiastolic bulges with loss of trabecular structure and segmental 
contraction impainnent are the best angiographic arteria which can 
be explained by morphology and histology with segmental loss of 
RV myocardium. 
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801·1 
3:15 
2:00 
Exercise Training Improves Functional Capacity in 
Patients with Compensated Congestive Heart Failure 
Steven J. Keteyian, Sidney Goldstein, T. Barry Levine, 
Arlene B. Levine, Paul D. Stein, Takeshi Kataoka, John 
R. Schairer and Frank F. Fedel, Henry Ford Heart and 
Vascular Institute, Detroit, HI 
The effects of exercise training on cardiac function and 
exercise performance were studied in a randomized trial 
of 24 NYHA Class II/III patients with compensated heart 
failure. Patients were exercised for 30 min, three 
times/wk after demonstrating stabilization on standard 
therapy including digitalis, angiotensin converting 
enzyme inhibitors and diuretics. Mean age and ejection 
fraction were 55±10 yr and 22±7%, respectively. The 
effects of 12 wk of exercise were: 
Controls 
Pre 12 wk 
Exercise 9.8±3.6 9.8±3.3 
Duration (min) 
Peak V02 
(l'min-1) 1.2±0.3 1. 2±0. 4 
15±5 
9±3 
(ml'kg-1 'min-1) 14±4 
Peak 02 Pulse 
(ml'beat-1) 
Maximal Power 
Output (watts) 
9±2 
83±28 83±26 
Exercise 
Training 
Pre 12 wk 
10.3±2.8 12.5±2.1** 
1. 4±0. 2 
15±4 
10±2 
86±25 
1. 6:t0. 2* 
17±4 * 
11±2 * 
102:t19 * 
Hean±SD; Change for exercise trained subjects 
to change in controls; *p(0.05, **p<O.OI. 
compared 
Exercise training in patients with heart failure results 
in an increase in both functional capacity and cardio•
respiratory fitness. These results were achieved without 
exercise related complications. Exercise therapy should 
be considered as an adjunct to standard medical therapy 
for patients with compensated congestive heart failure. 
ABSTRACTS 399A 
801·2 2:15 
Exercise Training Improves Diastolic: Filling at Rest and During Exercise 
in Patients With Dilated Cardiomyopathy. 
RomuaJdo Belardinelli. *Dernetrios Georgiou, * Rahul Dashi. Augusto Pun:aro 
Lancisi Heart Hospital. Ancona, Italy and * Harbor-UCLA Medical Center 
and Saint John's Cardiovascular Research Center. Torrance, California. 
To detennine whether exercise training (ET) can improve left ventricular 
(LV)diastolic filling in pts with dilated cardiomyopathy(DC). 55 pts (47M. 
8F, mean age 55:t8 years)were studied. PIs were in NYHA Oass II(68%)or 
III(32%)and in sinus rhythm over the last 3 months. Patients were randomized 
in 2 Groups. GT(Training, n=36)and GC(Control. n=19)and matched for 
anatomic and clinical correlates. Training consisted ci endurance exercise 3 
days a week for 8 weeks at 60% ci maximal oxygen uptake(V02max). Before 
and after ET. LV diastolic function was studied at rest with pulsed Doppler 
Echo (DE)and gated blood pool scintigraphy (GBPS)and during exercise 
with only the GBPS. At baseline and at peak exercise GBPS peak filling 
rate(SPFR) was low(13±.6and 1.9:t1 EDV/s. respectively). After training. 
in GT V02max(+IO%;p=O.OO2). resting SPFR(+9%;p=O.02)and peak 
SPFR (+ II %;p=O.OO3)were increased and resting heart rate was reduced 
(-IO%;p«1.05). Ejection fraction was unchanged at rest, with a modest 
increase at peak (+6%;p=O.06)which was associated with a reduction in 
ESVI( -12%;p<O.05). At peak exercise the increase in SPFR was correlated 
with the increase in EF (p<O.05). DE and GBPS compared favorably in 
respect to fractional early filling and atrial systole before and after training. 
No significant changes were observed in Gc. The independent predictors 
ci a greater V02max by multivariate analysis were a higher heart rate at peak 
exercise and a greater resting early peak filling rate. Bivariate analysis 
revealed that a combination of the DE variables of a shortened deceleration 
time and increased early diastolic to atrial filling velocities ratio were 
stronger predictors ci cardiac events. 
In conclusion. these results show that: I) ET enhances early diastolic filling 
at rest and at peak exercise; 2) these adaptations may allow an increase in LV 
systolic indexes and V02max; 3) Doppler LV diastolic filling variables have 
an important prognostic significance in patients with DC. 
801·3 2:30 
Predictors of Outcome In Dilated cardiomyopathy (DCM) 
Frederick A. Dressler, Arthur Stetken, Dennis Anthonis, Leslie W. Miller, 
Ramon Castello, Jeanette A. St. Vrain, Elizabeth O. Ofili. Arthur J. 
Labovitz, Saint Louis University Health Sciences Center, St. Louis, 
Missouri 
Peak exercise oxygen consumption (VOvls commonly used to 
stratify pts with DCM in regards to cardiac transplant. It is thought 
that exercise V02 <14 mg/kg/mln Is associated with Increased 
morbidity and mortality. To assess the accura~ of this measurement, 
62 pts with DCM referred for transplant evaluation were studied. 
Symptom-limited treadmill exercise tests (with rest and exercise 
V02) and exercise echocardiography were performed. Pts were 
followed for a mean of 15±5 months and grouped according to 
outcome: 1) Worse - death or hospitalization for CHF; 2) Stable = 
alive and not hospitalized for CHF. The groups were similar In 
multiple clinical and resting metabolic and echocardiographic 
parameters Including age, etiology of DCM, V02, left ventricular 
ejection fraction, end-diastolic and -systoliC and stroke volumes, and 
ventilation. Although at peak exercise no significant differences in 
echocardiographic parameters between the groups were seen, 
several metabolic differences were found : 
Outcome Peak Peak Peak VO;#a % Pred % Pred ~ 
.......IDL- y;m ~ s1.! ~ ~ ~ ~ ~ 
Worse(37) 4.1±1.2 14.0±3.9 20(74%) 17(490/0) 45±12 15(94%) 22(56%) 0 
Stable(25) 5.1±1.6 17.0±4.6 7(26%) 18(51%) 63±22 1(6%) 17(44%) 7(100%) 
0.002 0.004 0.04 0.0001 0.0001 
The worse outcome group had significantly lower peak exercise 
METS, V~. and % predicted (Pred) V~. Of pis with peak V02 <14 
mVkglmln, 26% remained stable while 49% of pis with V02 > 14 
mVkglmin were ciinlcally worse (predictive accuracy 61%). Of pis 
with % Pred V~ <400/0, only 6% remained stable while in the group 
with values >65%. no pt was worse. Of the pis with % Pred V02 
values from 40 to 65%, 44% were ciinlcally worse. No significant 
dinical, metabolic, or echocardiographic predictors of outcome were 
found in this group. Thus, % Pred V~ is a better predictor of 
outcome in DCM pis than peak V02, and may be useful in stratifying 
these pts for transplant. 
400A ABSTRACTS 
801·4 2:45 
Attenuated Response of Blood Flow Redistribution in Non· 
exen:isinl Orpns in Patients with Heart Failure 
*Osamu Walla, Hidetsugu Asanoi. Kyoko Miyagi. Shinji Ishizaka. 
Tomoki Kameyama. Hiroshi Inoue 
Toyama Medical & Pharmaceutical University. Toyama, Japan 
Patients with congestive heart failure are known to have a relative 
attenuation of sympathetic drive during exercise despite increased 
sympathetic activity in the resting state. To examine whether the reduced 
sympathetic drive could impair blood flow redistribution. we asses~ the 
blood flow distribution to skeletal muscles and kidneys dunng exercise In 
11 patients with chronic heart failure(CHF) and 10 normal subjects(N). 
Whole-body thallium scintigraphy during one-leg ergometer exerCIse was 
performed at rest. at the level of anaerobic threshold(AT). and at peak 
exercise. Blood flow distribution to exercising thigh. non-exercising calf. 
and kidneys was quantified by expressing regional thallium counts as a 
percentage of the whole-body counts. 
boThigh(%) boCalf(%) boKidneys(%) 
AT Peak AT Peak; AT P~ 
~w ~OO 
Changes in Mixed Venous Oxygen Saturation During 
Routine Daily Activities in Heart Failure Patients 
"'David M. Steinhaus, Larry Handlin, Dennis R. Bresnahan, 
Jr., Robert Lemery, Debbie Cardinal, Laura Foley, Kelly 
Moutray, "'Alan Moore, "'George Pool, "'Tom Bennett 
Mid America Heart Institute, Kansas City, Missouri 
The ability to measure mixed venous oxygen saturation 
(Sv02 ) continuously has potential value in patients (pts) 
with congestive heart failure (CHF). We determined Sv02 
responses in 10 CHF pts (mean ejection fraction =13,!4%) 
using an implanted O2 sat sensor and custom pacemaker to 
telemeter Sv02 values. The hermetically sealed sensor was 
a dual wavelength (red/infrared) reflectance oximeter. 
This was positioned 3 cm proximal to the distal tip of a 
transvenous right ventricular (RV) lead. The telemetered 
signal was recorded by a custom radiofrequency 
programmer. The mean recorded Sv02 at implant was 
50.8+13.4% and was similar to simultaneously measured RV 
blood samples 54+13.5%. Sv02 responses to routine daily 
activities were determined at 2 wk intervals in all pts 
during 4-26 wks follow up. Compared with supine controls, 
Sv02 decreased by 3.6:2.9% when pts sat upri~ht (46 
episodes/9 pts; PSO.O!) and 6.5:5.4% with standmg (59 
episodes/9 pts; PSO.Ol). Three min. walks (38 episodes/9 
pts) resulted in decreases of 12.5:12.6% (P<O.OI). In 3 pts 
RV blood samples were obtained 16-22 wks post-implant and 
did not differ significantly from simultaneously telemetered 
values. One pt had an apparent sensor failure 2 wks after 
implant related to malpositioning. In 3 pts, decreases in 
Sv02 ()10%) were early indicators of worsening 
cardiovascular status preceding clinical symptoms. We 
conclude that chronic Sv02 monitoring is feasible and may 
have clinical utility in heart failure patients. 
JACC February 1994:1A-484A 
801·6 3:15 
Improved Risk Stratification of Heart Failure Patients 
Using Exercise V02 and Echocardiographic Indexed Left 
Ventricular Mass 
Arthur M. Stelken, Liwa T. Younis • L. Michele Vaughn, Dennis M. 
Anthonis, Stephen H. Jennison. Thomas Wolford, D. Douglas Miller. 
Leslie W. Miller, Arthur J. Labovitz, Bernard R. Chaitman. Saint 
Louis University Health Sciences Center, St. Louis, Missouri. 
Selected pts with refractory congestive heart failure have significant 
mortality and morbidity which can be reduced by heart transplantation. 
Risk stratification of transplant candidates is mandatory due to donor 
scarcity. To evaluate the relative prognostic value of rest 
echocardiography (ECHO) and cardiopuhnonary exercise testing (EX 
V02) in ambulatory pts with Class II-ill heart failure. 57 pts, age 
49±8 yrs, mean LV ejection fraction 24±8%, cardiac index 
(2.3i{).5), had EX V02 and ECHO. After 12±S months of follow•
up, 18 pts had cardiac events (6 patients died IlI!d 12 patients h~ ~ean 
transplantation due to refractory heart fadure). The cllmcal. 
hemodynamic and angiographic characterstics between pts with 
(n=18) and without events (n=39) were not different. ECHO left 
ventricular mass and percent of maximal predicted oxygen uptake 
achieved (calculated by Wasserman formula) were discriminatory 
predictors of survival. 
LV Mass Index (gm/m2) 
% Predicted V02 max 
V02 max (ml/kg/min) 
~ 
189±59 
43±9 
13.9±3.7 
No EyenlS 
148±43 
52±18 
15.5±4.8 
~ 
.005 
.04 
NS 
Left ventricular mass index> 170g/m2 and V02 <50% of maximum 
identified 15 of 18 pts (82%) who sustained cardiac events during 
follow up. Multivariate regression analysis selected left ventricular 
mass index as the best predictor of cardiac events. Therefore ~e u~e 
of simple measurem.ent of LV ~ass and EX ,v02 may aSSl~t. 10 
objectively stratifymg congestive hean failure pts awaltmg 
transplantation. 
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802·1 
Poor Recovery in Young Women With Coronary 
Heart Disease 
Jill Downing. Andrew B. Uttman. Judith Scheer, 
Massachusetts General Hospital, Boston. MA 
2:00 
A multicenter database was used to evaluate gender 
differences in recovering coronary heart disease (CHD) 
patients. Data was collected on entry and after an average 
10 week cardiac rehabilitation program. Of 776 patients 
(mean age 60). 219 (2896) were female. Events leading to 
referral were similar for both sexes, although referral 
rates were lower for women (W). W entered with 
diminished NYHA functional status and more risk factors 
(RF). Drop out rates were higher for W than men (M) (2396 
vs 1896). All measurable RFs (exercise parameters; EXDUR, 
V02' lipid parameters: TCHOL, lDL, and HDL, TRIG; weight) 
imp;oved significantly except W's improvement in TCHOL, 
lDL, HDL was not significant. Depression (Kellner) and 
well-being and functional status (MOS SF-36) was 
measured. In all age/sex categories (M<60 (n=256); W<60 
(n=61); M>60(n=240); W>60 (n=126», W reponed 
Significantly more symptomatology and functional 
impairment than M upon entry. All groups significantl~ 
improved in all subscale scales except for W <60. At exll 
there was no Significant difference between the scores of 
older M and W, but W<60 demonstrated significantly more 
functional impainnent and psychological distress than all 
other groups. 3196 of W and 2096 of M demonstrated severe 
depressive symptomatology (~9 on a 0-23 scale) and were 
associated with functional impainnent equal to that of 
clinical depression. Multivariate analysis showed 
depression predictive of exit TCHOL, lDL, and HDL; weight; 
and EXDUR, raising the possibility that depression plays a 
role in the increased morbidity and mortality associated 
with W recovery from CHD. 
lACC February 1994:1A-484A 
802·2 2:15 
Gender Does Not Innuence the Morbidity and Mortality Associated 
With Diagnostic and Interventional Cardiac Catheterization 
Procedures 
William O. Combs. Mark D. Rothenberg. James A. Burke. Alfred A. Bove. 
Ezra Deutsch. Temple University School of Medicine. Philadelphia. P A 
The increasing magnitude of morbidity and monality from coronary artery 
disease (CAD) in women has been documented. It has been suggested that 
the morbidity and mortaIity in women undergoing diagnostic and 
interventional catheterization procedures is also increased relative to men. 
This may result in a bias against early diagnosis and invasive evaluation 
and treaunent of CAD in women. To determine whether women (F) are at 
higher risk for complications than men (M). we prospectively examined all 
diagnostic and interventional catheterizations performed at our institution 
from June 1990 to July 1993 to assess the frequency of complications. 
5766 procedures were performed. of which 1388 were percutaneous 
interventions. Data were compared by Chi Square analysis. 
All Catheterization Procedures: 3937 male; 1829 female 
COMPLICATION #M % #F % 
Death 10 0.25% 3 0.16 
Acute MI (MIl 20 0.51 7 0.3 
Major vascular 24 0.61 27 1.5 
Minor vascular 46 1.2 24 1.3 
Neurologic 7 0.2 8 0.4 
Interventional Procedures: 982 male; 406 female 
P value 
NS 
NS 
NS 
NS 
NS 
COMPLICATION #M % #F % P value 
Acute closure 27 2.7% 21 5.2% <0.05 
Emergency CABO 24 2.4 8 2.0 NS 
Unsuccessful PfCA 75 8.5 37 9.7 NS 
Unsuccessful DCA 14 14 6 24 NS 
The incidence of death. acute MI. vascular or neurologic complications 
was similar in men and women. Acute closure within the first 24 hours 
after intervention was significantly higher in women. However. the 
likelihood of emergent CABO due to a failed interventional procedure was 
equivalent. Conclusions: Gender does not influence morbidity and 
mortality associated with diagnostic and therapeutic catherization. and 
should not impact on the decision to undergo invasive treatment . 
802·3 
The Quantity of Coronary Artery Calci_ Predict. Maximum 
Steno.i. Better Than Ri.k Factor. 
Rachel B. Kaufmann, Patricia Peyser Moll, Patrick F. 
Sheedy II, Robert S. Schwartz. University of Michigan, 
Ann Arbor, MI and Mayo Clinic, Rochester, MN 
Coronary artery calcium (CAC) detected by electron beam 
computed tomographic scanning (EBCT) is an accurate 
marker for coronary artery disease (CAD). EBCT was 
performed on 160 patients age 20-59 without previously 
diagnosed CAD undergoing routine angiography for 
clinical indications. The percent diameter stenosis in 
the sample ranged from 0% to 100% (mean=44.5%). CAC was 
defined as presence of any foci> 2 rnrn2 (8 pixels) above 
130 HU within the coronary arteries and quantified as 
the total number of pixels within all such calcified 
areas in the coronary arteries. The quantity of CAC 
ranged from 0 to 2933 pixels (mean=265 pixels). Risk 
factors for CAD studied included age, sex, diagnoses of 
hypertension and diabetes, family history of premature 
CAD, smoking status and pack-years of smoking, and total 
cholesterol, triglycerides, and HDL cholesterol. Only 
age, male sex, and total cholesterol:HDL cholesterol 
were predictive of the maximum stenosis in the heart, 
and these risk factors together accounted for only 25% 
of the variation in maximum stenosis. The same set of 
risk factors was predictive of CAC, accounting for 34% 
of the variation in total calcified pixels in the heart. 
When quantity of CAC was considered as a predictor of 
CAD along with risk factors, it accounted for 55% of the 
variation in maximum stenOSis, and none of the risk 
factors studied contributed any further information in 
the prediction of maximum stenosis. Thus, quantity of 
CAC was a better predictor of severity of CAD than risk 
factors in this sample of younger patients undergoing 
angiography. 
ABSTRACTS 401A 
802·4 2:45 
Defining the Normal Heart in Elite Basketball Players 
Alfred A. Bove, Edward B.winslow, Mark Upton, Ezra Deutsch, Temple 
University, Phila, PA for the National Basketball Assn. Physicians 
Society 
Assessment of cardiac hypertrophy or dilatation in elite basketball 
players is made difficult by the influence of body size and training on the 
heart. Left Ventricular (LV) diameter and wall thickness may appear 
abnormal when compared to usual clinical norms. Recent cardiac deaths 
in elite basketball players point out the difficulty in identifying 
abnonna1ities in these athletes. Cardiac evaluation to prepare for 
professional play is done annually prior to the NBA draft. We examined 
the data from 158 athletes (age 22.o..±.95 years) who were invited to the 
NBA draft over two years. Body Surface Area (BSA) for athletes was 
2.33±O.19M2, hgt was 78.3±3.9 in, wgt was 214±27Ibs, blood pressure was 
125±14/74±9. LV fractional shortening (36.8±4.8%) was normal, however 
absolute LV measurements (table) exceeded clinical norms by 2: 1.5 S.D., 
while indexed values with the exception of LV mass (Penn formula) were 
within 1 S.D. of normals. 
LV Sept LV Post LV Dias 
mn mn mn 
11.1 10.6 56.1 
± 1.5 ±1.4 ±5.3 
9" 9" 47" 
mm/M2 rrrn/M2 mm/M2 
4.8 4.6 24.2 
±o.74 ±O.66 ±l.3 
LV Mass 
t}l\ 
255 
±53 
146" 
mmJM2 
109 
±20 
LA 
mn 
36.2 
±5.2 
29" 
mm/M2 
15.5 
±l.1 
AORoot 
nm 
32.1 
±3.5 
27" 
nm/M2 
13.8 
±1.4 
5" 5" 26" 81" 16" IS" 
data are mean ± SO "nonnal mean values 
While fractional shortening is normal, LV diameter and wall thickness 
in these athletes exceed clinical norms. When indexed to ESA, these 
measurements approximate normal valUes, however LV mass exceeds 
normal values even when indexed to body si'ze. Increased LV mass is 
likely due to conditioning. Cardiac dimensions in elite basketball 
players should be indexed to BSA when evaluating cardiac structure and 
function. 
802·5 3:00 
A Reli~le and Reproducible Echocardioqraphic Method for 
Selectinq High Risk Patients With Left ventricular Dysfunction 
Shortly After Acute HI in Multicentre studies 
*Lars KlZber, Christian Torp-Pedersen, Jan Carlsen, Regitze 
Videb~k, Henrik Egeblad, Svanem011evej 2, Copenhagen, Denmark, 
on behalf of the TRACE Study Group. 
To examine if videotaped 2 dimensional echocardiograms, 
recorded by investigators who had received brief but thorough 
training, then evaluated by echocardioqraphic experts, can 
reproducibly be used to select high risk patients with reduced 
left ventricular function shortly after myocardial infarction 
(MI) in a multi centre study. 
The TRAndolapril Cardiac Evaluation study (TRACE) randomised 
patients with reduced left ventricular function 3-~ days post 
HI to receive the ACE inhibitor trandolapril or placebo. 7,100 
consecuti ve HI patients at 27 Danish centres were screened for 
entry. Local investigators who had received a short but 
thorough training course, recorded a 2 dimensional echocardio•
graphic examination on videotape 2-6 days after HI. Wall 
motion index (WMI) was then determined by 1 of 2 experts 
(examiners). WMI :5 1.2 (corresponding to left ventricular 
ejection fraction :5 35%) determined eligibility. Two other 
expert echocardiographers (controllers) reevaluated 155 
randomly chosen videotapes. 
94% of the videotaped echocardiograms c~uld be assessed. 
The 1 year mortality was inversely related to WMI: 
WMI 
1 year mortality 
WMI was :5 1.2 in 37% of patients. The Pearson correlation 
coefficient was 0.93 between the two examiners and 0.79 
between examiners and controllers. The standard error of 
estimate was 0.25 WMI units between the controllers and the 
examiners. The agreement between the examiners and the 
controllers was 80% with WMI of 1.2 as the discriminative 
value. 
Evaluation of videotaped echocardiograms by expert echocardio•
qraphers recorded by briefly trained investigators is a 
reliable and reproducible method for selectinq hiqh risk 
patients shortly after MI in multicentre studies. 
402A ABSTRACTS 
802·6 3:15 
Life Expecta'lcy in the Marfan Syndrome Revisited 
David I. Silverman, Kevin Burton, Jonathon Gray, Maureen Boxer, 
Matthew Bosner, Nicholas Kouchoukos, Mary J. Roman, Richard B. 
Devereux, Petros Tsipouras. U CONN Health Center, Farmington, CT, 
Ninewells Hospital & Medical School, Dundee, Scotland, Jewish Hos•
pital, Washington University School of Medicine, St Louis MO, New 
York Hospital, Cornell University Medical College, New York, NY, 
In order to examine whether reported advances in the treatment of 
the Marfan syndrome (MFS) have had a beneficial effect upon life 
expectancy, we estimated survival in 400 patients (pts) affected with 
MFS and compared our data to historical data trom Murdoch et al (N 
Engl J Med 1972;286:804-8). Pta dying before 1970 were excluded 
from our analysis. 101 pts had undergone cardiovascular surgery; 19 
died. 169 pts received B adrenergic receptor antagonists; 6 died. 
Mean age at death for pts undergoing cardiovascular surgery was 
36 :t 9 years and for pts receiving B-adrenergic blocking drugs was 
38 :t 6 years. The graph compares cumulative survival probability 
(using the Cutler-
Ederer estimate) for ~ ,., 
1 )the 1993 cohort I , .. t-iiti~_ ...... 
with 2)Murdoch. • .• 
Overall mean age at , 0.1 
death in our cohort ~ ::: 
was 44 ± 21 years c •. 6 
compared with i ... 
32 :t 16 years for •.• 
Murdoch et al (p = ! •. 1 
0.0034). ute ex- ; •. , 
o ,.11 
• ,171 
pectancy was 72 yrs ~ •.• L~_~~~~----'~~-"":"'-:,:-l>-~ 
compared to 48 yrs. ,. I. •• •• 6. I. 7. I. 
In conclusion, AGE .. YEARS 
lite expectancy in MFS over the last two decades appears to have 
increased compared to historical controls. Surgical and medical 
treatment for MFS may have contributed to the increase, although 
their precise effect upon survival remains to be determined. 
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954·26 
Short·term Observation after Elective PTCA: Safety and 
Patient Selection. 
Karel T.Koch. Jan J.Piek. Karla Mulder. Gerard Hoedemaker. 
Bob van Vlies. Ron J.G.Peters. Jacques J.Koolen. George K.David. 
Department of Cardiology. Academic Medical Center. Amsterdam. 
The Netherlands. 
To anticipate on the limited number of in-hospital beds for patients 
referred to our center for PTCA. a short-term observation period after 
PTCA was mandatory. The procedure was performed using heparin 
5000 IV i.v. and the sheaths were removed directly after PTCA. The 
patients were observed during 4 hours a~d returned to the referrin.g 
hospital in a 40 miles area after uncomplicated PTCA. Safety of this 
strategy was evaluated prospectively in 464 pts. (339 male.125 
female, age 60 ±10.2 yrs) who underwent elective PTCA; 43% had 
previous MI, 26% underwent earlier PTCA. One coronary segment 
was treated in 61 % of pts. two or more in 39%. After PTCA , the 
attending interventional cardiologist could decide to prolong the 
observation period. 
Results: 
Success, defined as less than 50% residual stenosis, was obtained in 
86% of pts. Acute re-PTCA was performed in 6 pts within one hour. 
Mortality was 0.4%, CABG within 24 hours was 2.8%. A prolonged 
observation period was considered necessary in 49 pts (10.7%) for 
suboptimal result (4 pts). spasm (2 pts) .. presence of tr?mbus (5 p~s), 
dissection (18 pts). (temporary) occlUSIOn (9 pts). bail-out stenung 
(4pts). elective stenting (lpt), and after acute re-PTCA ~6 pts). 
The prolonged observation period was uncomplicated In 33/49 (67%) 
and complicated in 16/49 pts (33%) by MI (mean CK-MB 4O.3U/l. 
range 12-102). Four hours after PTCA, 86.3% of all pts left the PTCA 
center and remained stable for at least 3 days. 
Conclusion: 
A short-term observation period after elective PTCA appears to be 
safe. Patients eligible for prolonged observation can be selected 
appropriately after PTCA. 
JACC February 1994:1A-484A 
954·27 
ra.n:al VaDOll8 keen Daring ADgiopluty: Jaatified or 
Bot? 
*Scott H. McCallister, James B. Hermiller, Daniel L. 
Lips, Edward T.A. Fry, Ronald J. Landin, Cass A. 
Pinkerton, Thomas J. Linnemeier, Indiana Heart 
Institute, Indianapolis, IN 
Femoral venous line8 are placed prophylactically prior 
to all percutaneous trans luminal coronary angioplasties 
(PrCA) at this institute. To determine whether 
prophylactic femoral venous access during PTCA is 
necessary, we reviewed 2529 consecutive PrCAs performed 
from 3/92 to 3/93. 2315 (92') ware elective and 214 
(8') were during acute myocardial infarction (AMI). 
Temporary pacemakers (TPH) ware required due to hypo•
tension, bradycardia, heart block or asystole in only 
0.4' of the PrCAs (11/2529). Nine ware during AMI and 2 
were during high riek elective PTCA (severe 3VCAD and 
LVO). Eight of the 9 AMI TPHa were during 
recanalization of the infarct related artery (6 RCA, 1 
LAD, 1 LX). All 11 PrCAs were successful following TPM 
placement. No TPMS were required during any routine 
elective PrCA_ Thus, 99.6% (2518/2529) of the time a 
TPM was not required during PTCA and, therefore, femoral 
venous access was not necessary. 
This study suggests that the increased risk and cost of 
prophylactic femoral venous accesa is not justified in 
routine elective PTCAs, but may be justified in high 
risk elective and AMI PTCAs. Based on this study, 
femoral venous access will be performed in the future on 
a selective basis at this institute with an estimated 
savings of over $300,000 annually. 
954·28 
EIIrly Economics of Revascularization - CABe vs PTCA 
Thomas M _ Shimshak, Lee V. Ciorgi, David R. McConahay, 
Warren L. Johnson, Barry D. Rutherford, Kenneth C. 
Huber, Robert Ligon, Ceoffrey O. Hartzler 
Mid America Heart Institute, Kansas City, Missouri 
We compared hospital charges (HC) and length of stay 
(LOS) among a series of consecutive pts who had elective, 
isolated CABC (N=381) or PTCA (N=984) at our institution 
in 1992. Procedural risk included age ~70yrs, EF~40%, 
3-vessel (v) CAD, and unstable angina (UsA). 
<70 (y) 
>70 (y) 
EF> 40% 
EF< 40% 
1v -CAD 
2v CAD 
3v CAD 
(-) UsA 
(+) UsA 
RISK (,) 
N 
381 
256 
125 
266 
104 
20 
128 
233 
234 
147 
CABC PTCA 
HC($) LOS(d} N HC($} LOS(d) 
38,591 11.6 984 17,420 5.7 
36,969 10.9 657 16,455 5.3 
41,913 13.2 327 19,360 6.6 
37,077 11.0 814 16,388 5.4 
42,927 13.3 170 22,367 7.1 
32,704 9.8 358 14,745 5.3 
35,749 11.1 320 18,255 5.8 
40,657 12.1 306 19,678 6.0 
36,962 11.0 617 16,860 5.4 
41,183 12.7 367 18,362 6.1 
o 56 33,359 10.0 272 14,780 4.9 
1 125 35,626 10_4 372 16,248 5.3 
2 129 39,261 11.7 235 20,136 6.6 
3 58 45,178 14.4 92 21,685 6_ 7 
4 13 53,591 16.6 13 26,918 9_6 
This analysis of the economic impact of 2 revascularization 
strategies demonstrates: 
1) Higher risk pts (~ 70yrs, EF~40%, 3v CAD, UsA) had 
higher HC and LOS for both CABC and PTCA. 
Lower HC and LOS for PTCA pts vs CABC. 
Cumulative number of risks results in > HC and LOS 
for all pts, but is < for PTCA pts compared to CABC_ 
2) 
3) 
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954-29 
Does Previous Angioplasty of a Coronary Lesion Influence its Subsequent 
Response to Lipid-lowering Therapy? A CCAIT Sub study 
David Waters, Peter Gladstone, Lyall Higginson, Stephen Boccuzzi, 
Thomas Cook, Jacques Lesperance, for the CCAIT Investigators, 
Montreal, Ottawa and Toronto, Canada, and Hartford, CT 
Based upon a retrospective analysis from one angiographic trial, it has 
been suggested that lesions previously subjected to coronary angioplasty 
are particularly susceptible to regression. This hypothesis was 
prospectively tested in the Canadian Coronary Atherosclerosis Inter•
vention Trial, the primary goal of which was to determine whether 
monotherapy with lovastatin influences the evolution of coronary athero•
sclerosis. In 3 Canadian centers, 331 pts with diffuse coronary disease 
and a fasting serum cholesterol between 220 and 300 mgldl were 
enrolled. Total and LDL-cholesterol decreased by 21 % and 29% 
respectively in lovastatin pts Imean dose 37 mglday) and by < 2% in 
placebo pts. Coronary arteriography was repeated after 2 years in 299 
pts (90%); films were read blindly using Quantitative techniques. At least 
6 months before the first angiogram, 46 pts had undergone coronary 
angioplasty of 50 lesions. Progression and regression were prospectively 
defined as a minimum lumen diameter change 2:0.4 mm. Among 23 
placebo pts, 3 had progression and 2 had regression at a previous 
angioplasty site. Among 23 lovastatin pts, the only change was 
progression in 1 case. The mean change in minimum lumen diameter 
(follow-up minus baseline angiogram) for all angioplasty lesions was 
trivial, -0.025 ± 0.36 mm, with a trend favoring placebo that was not 
statistically significant. Lovastatin slowed progression in the 251 pts 
without previous angioplasty: the mean worsening of minimum lumen 
diameter was reduced from -0.09 ±0.16 to -0.04 ±0.13 mm (p =0.016). 
Overall, progression was seen in 48 of 146 lovastatin pts and 76 of 153 
placebo pts (33% versus 50%, p =0.003). New lesions developed in 231 
lovastatin and 49 placebo pts (16% versus 33%, p =0.001). 
Conclusion: After 6 months, post·angioplasty lesions remain relatively 
stable. They do not appear to be particularly susceptible to regression 
with lovastatin therapy. Lovastatin slows the progression of coronary 
atherosclerosis. 
954-30 
!ffeets of Percutaneous • .."..., Coapare4 With 
lDtraaortic kllOOD Couterp1llsatiOll Dllriag k1lte 
lJoCaraial Ischelia. 
larl H.Scholz, Frank Schweaa, Thoaas SchrOder, 
,anther Hahn, llexander Toro .. ian, Hans R.rigulla, 
Jens P. Hering, Heinrich Ireuzer, Gerhard Hellige. 
University of G6ttingen, Geraany. 
Reduction in outer diueter (lU) enables percu•
taneous Heaopuap in.ertion (pHP) • Heaodynuic and 
aetabolic effect. of pHP and lABP were directly coa•
pared during ayocaraial iseheaia in sheep (n-13; 
b.w. 62-94 kg). Three repetitive balloon-occlusions 
of the proxual LAD 13.5 ain; identical position) 
were perforaed during control, IlBP-, and BP-inter•
vention (randoaized sequence; recovery: 60 ain). 
Kyocardial perfusion (aierospheres), perfusion 
pres.ure (IPP), blood flow (IBr) , oxygen consuaption 
(JfV02) , and arterial coronaryvenous difference in 
lactate (Lae-lCVD; during first ainute of reper•
fusion) were aeasured. 8eeause of ventricular fi•
brillation during occlusion without a •• ilt in 4 
aniaals, eoaplete series are available in n-9 aheep. 
Kean values during occlUlion: 
IPP (aBg) 
IBr (al/ai.*l00g) 
JfV02 (al/ain*100g) 
Lae-lCVD ("01/1) 
10 lasist 
34 
74 
4.25 
-0.37 
DBP 
54 
86 
5.2 
-0.27 
pBP 
48 
79 
4.5 
-0.20 
During beheaia, both pBP- and IlIP-support led to 
ayocardial protective effects as iIIaicated by the 
significant decrease in lactate release in the early 
reperfusioD period_ Coapared with DBP, pBP appears 
to provide superior left ventricular unloading. 
ABSTRACTS 
954-31 
A Comparison of Balloon Pumping (IABP) with 
Cardiopulmonary Support (CPS) for High Risk PTCA 
Usha Kodali, William W. O'Neill, Theodore Schreiber, V. 
Gangadharan, Gregory S. Pavlides, Steven L Almany, Sylvia 
Puchrowicz-Ochocki, Vid;y Savas, Sue Tomaszycki, Vicky 
Hollingsworth, Robert D. Safian, Cindy L Grines, William Beaumont 
Hospital, Royal Oak, MI 
Others have suggested that high risk PTCA in pts with poor 
ventricular function or vessels supplying the majority of myocardium 
can be safely performed using either IABP or CPS. To determine the 
role of both support devices, we reviewed clinical and angiographic 
data on 174 pts (CPS n=60, IABP n=114) who had support devices 
placed prior 10 in ilia lion of PTCA Cardiogenic shock pts were 
excluded. PIS undergoing CPS were more likely to be male, have a 
prior hislory of heart failure (58 vs 30%, p=.OO(3), lower ejection 
fraction (26± 13 vs 30± 11 %, p=.05), and multivesscl disease (98 vs 
84%, p=.04). CPS pts more commonly undeIWent PTCA of mulliple 
vessels (48 vs 24%, p=.OO(3) or of the left main (24 vs 12%, p=.06). 
Longer balloon inflations were performed on CPS (mean 196 vs 151 
sec, p=.06) and PTCA success rates tended to be higher (95 vs 88.6%, 
p=.08). The average duration of CPS was 1 hr and IABP 34 hrs, 
p=.OOOl. Four (3.5%) pts initially treated with IABP required CPS for 
development of shock wilh balloon inflation; 14 (23%) CPS pts 
required IABP during weaning from bypass. Cardiac events including 
recurrent chest pain, reinfarction, need for bypass surgery, slroke and 
death wcre similar between the 2 groups. Need for transfusion (58 vs 
37%. p=.007) and vascular repair (13 vs 3%, p=.OO6) were higher in 
CPS piS. In conclusion, despile an obvious selection of higher risk 
PTCA pts ['or support wilh CPS, major cardiac events wcre similar to 
pts treated with IABP. Beller hemodynamic support with CPS 
allowing longer balloon inflations may be responsible for the trend for 
higher PTCA success rates. 
954·32 
403A 
Elastic Recoil During PleA: Does H Have Any Significance? 
Juerg W. Laltmann, Otto M. Hess, Martin Buechi, Thomas Suter, 
Hans P. Krayenbuehl, Cardiology, University Hospital, ZUrich, Switzerland 
Elastic recoil is defined as the decrease of coronary luminal area 
Invnediately after PTCA in relation to maximal kJminal area wring balloOn 
inflation. In 28 patients wkh coronary artery disease (age 52±S years) elastic 
recoil was calculated immediately after PTCA (.early") and 20±21 months 
following PTCA (.Iate·). Coronary luminal area was determined by 
quantHative coronary angiography. Percent area stenosis was calculated in 
all patients. Elastic recoil amounted to 33±18% and was similar in eccentric 
(35±17%) and concentric lesionS (29±2O%, ns). Patients were divided Into 
two groups depending on the extent of elastic reco~: group 1 ~O% (n-1S) 
and group 2 <30% (n-13). 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
elute neoU l%) 'Mo area .teDosla 
C group 1 
• group 2 
mean± 1 SD 
0.01 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
o 
C group 1 
• group 2 
mean± 1 SD 
early late 
Although elastic recoU was more pronounced in group 2, the early and late 
follow-up resul was not different in the two groups. A significant correlation 
was found between the elastic recoil and the vessel area early after PTCA 
(r-o.59, p.c:0.01). This relationship was lost wring the follow-up (r.0.31, 
ns). 
Conclyslon; The elastic recoil II dependent neither on the severity nor on 
the eccentricity of the stenosiS. Pallents w~h a mild elastic recoU IIhow a 
slightly better initial resu. but a similar % area stenosis late after PTCA when 
compared to patients wkh large recoU. Thus, elastic recon appears to have 
no prognostic signHicance in regard to the outcome after PTCA. 
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954·33 
Evaluation of Elastic Recoil F .. fteen Minutes After Coronary 
Angioplasty: A Quantitative Analysis 
Serge Doucet, Raoul Bonan, Jacques Lesperance, Gilbert Gossain, 
Gilles Hudon, Jean Laurier, Montreal, Canada 
Delayed elastic recoil 4 to 24 h after coronary angioplasty (PTCAl 
has already been reported but not early evaluation in the same 
procedure. In a prospective study evaluating the influence of contrast 
media on thrombus formation during PTCA, 272 stenoses in 206 pts 
were analyzed quantitatively immediately after (lmm-Post) and 15 min 
after PTCA (I5-Post). Intracoronary nitro (0.3 mg) was 'given before 
each angiogram. Seventeen pts, all with immediate success « 50% 
stenosis), had repeated PTCA after the 15 min angiogram because of 
visual recognition of early "restenosis" (;::50%). Also these segments 
showed either dissection or thrombus in 14/17. Minimal lumen 
diameter (MLD) of each dilated stenosis was measured using the 
coronary measurement system (CMS). Results were as follows: 
No. pIS 206 
No. stenoses 
Pre-MLD 
Imm-Post MLD 
15-Post MLD 
272 
0.93±0.33 mm 
1.8H0.46 mm * 
l.7H0.49 mm * p=0.OOO2 
Acute vessel closure at 24 h was only 1.9% in this consecutive 
series. In conclusion, MLD showed a further significant decrease as 
early as 15 min post-PTCA and this secondary elastic recoil cannot be 
prevented by intracoronary nitro. Such an early 15-min angiogram 
post-PTCA may reduce the 24 h acute vessel closure rate. 
954·34 
Prolonged Oilatation z.proves the Results of P'lCA - an 
Intravascular ultrasound and Angiograpbic study. 
Hylton I. Millet, Aron Ftimerman, Uri Rosenschein, 
Shlomo Laniado and Gad Keren. Department of Cardiology, 
Tel-Aviv Medical Center, Israel. 
Recent trials have demonstrated improved short term 
clinical results after prolonged dilatation (PO) in PTCA. 
Accordingly, we compar~ the results of standard dilatat•
ions (SO) and a prolonged dilatation (PO) at the same 
dilatation pressure and balloon-size. In 17 pts, two 2 
minute dilatations were compared with one 10 minute 
dilatation. Quantitative computerized angiography (QCA) 
and intravascular ultrasound (IVUS) analyses after SO and 
PO were performed. Per-cent stenosis and minimal lumen 
size was measured by QCA, and lumen area, arterial area 
(internal elastic lamina) and area of atheroma were 
measured by IVUS. No significant dissection or abrupt 
closure was noted in these 17 patients. 
OCA IVUS 
~ diam (mm) art (mm2, lumln (mm2, 
~ 32t.13 2.1!.0.5 14.8t.3.5.0t.2.O 
~ 22t.10 2.5!.0.6 15.5t.3.5 8.4t.2.1 
~ 0.03 0.004 0.03 <0.001 
atheroma (mm2, 
8.8t.2 . 5 
7.0t.2 .2 
<0.001 
PO results in a larger lumen unrelated to the balloon 
size and inflation pressure used, but related to the 
duration of the inflation. The mechanism of this 
Significant mean luminal area increase is not clear but 
should have a beneficial effect on maximal blood flow. 
Conclusions: PO results in a further significant increase 
in lumen size of the dilated artery after SO. PO may be 
the preferred method for balloon dilatation. 
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954·41 
Mechanism of PTCA in Acute Coronary 
Syndromes Assessed by Intravascular Ultrasound 
*Aron Frimerman, Hylton I Miller, Uri 
Rosenschein, Arie Roth, Shlomo Laniado, Gad 
Keren, Tel Aviv Medical Center, Tel Aviv, 
Israel 
To assess the mechanism of PTCA in acute 
coronary events we have employed intravascular 
ultrasound (IVUS) in 26 pts (age 54±10 y) after 
the procedure (22-LAD, l-LCX, 3-RCA). 18 pts 
were studied 7 days after acute MI and 8 had 
unstable angina (UA). Two types of atheroma 
were defined by IVUS: 1) Soft plaque (SP=low 
echogenecity, composed of cellular elements, 
loose connective tissue and lipids). 2) Hard 
plaque (HP=high echogenecity, composed of 
collagen, elastin and calcium). Four mechanisms 
which explain angiographic improvement after 
PTCA were observed: l)Oissection (0). 
2)Fissures in the plaque (F). 3) Compression of 
atheroma (C). 4) Arterial expansion (E). 
Results: 
....HI. !lA ...Q 1. ...£ J 
~ 15 3 60% 0% 100% 27% 
HP 3 5 100% 62% 75% 25% 
Conclusions: 1) In acute coronary syndromes the 
plaque is composed mainly of "soft" components. 
2) Plaque composition is a major determinant of 
PTCA mechanism in acute MI and unstable angina. 
In soft plaque angiographic improvement post 
PTCA is mainly due to compression and less due 
to dissection. In hard plaque this improvement 
is mainly due to dissection and less due to 
compression. 
954·42 
Impact of Clinical Site on Ischemic Events and Bleedin& Complications: 
Results from the EPIC Trial 
Neal Shadoff, Robert M. Califf for the EPIC Study Group, New Mexico 
Heart Clinic, Albuquerque, NM 
In the EPIC Trial 2099 patients (pts) at high risk of ischemic events 
after PTCA were randomized to receive either placebo, a bolus of chimeric 
7E3 (c7E3), a monoclonal antibody to the glycoprotein llblllla platelet 
receptor, or a bolus and infusion of c7E3. Because the tria\ enrolled a large 
number of pts with a high event rate at multiple institutions, it provides a 
unique opportunity to examine the impact of the clinical site on these 
outcomes. Inclusion criteria defining high risk pts were: unstable angina, 
acute MI or high risk lesion specific morphological criteria characteristics. 
Excluding 6 sites enroI1ing< 9 pts, 50 sites enrolling 2067 pts were 
evaluated. The primary endpoint of the trial was the occurrence of at least 
one ischemic event within 30 days of the initial procedure (death, nonfatal 
MI, and need for urgent intervention including surgery, angioplasty, ba1Joon 
pump or steIlt placement). Transfusion rates were also tabulated. Without 
adjusting for differences in baseline cbaracteristics of pts enrolled, the 
following table ranks the sites by the percentage of pts with an event: 
Lowest 25th o/oile Median 75th %i1e Highest 
1· outcome 0% 6% 9% 15% 26% 
Transfusion 0% 8% 12% 17% 37% 
Even after adjustment for the effects of multiple baseline clinical 
characteristics the effect of the clinical site on the rates of ischemic 
outcomes (p<.005) and transfusions (p<.005) remained highly significant. 
The relative reduction in events attributable to c7E3 was constant across 
sites. These results suggest that in a population of carefully characterized, 
high-risk angioplasty pts the risk of adverse events is dependent upon 
variations in clinical practice, although the beneficial effect of c7E3 is not 
altered by fluctuations in event rates. 
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954-43 
Comparison Between Acute YfCA After Failed Thrombolysis 
and immediate YfCA Without Thrombolysis In Acute 
Myocardial Infarction. 
·Frits W. Bar, Joost Frederiks, Hans de Swart, Vincent G. van 
Ommen Anton P. Gorgels, Chris de Zwaan, Frank Vermeer, Hein 
J. Wellens: University Hospital Maastricht, the Netherlands. 
It has been suggested that acute PTCA after failed thrombolysis ff) 
is less successful than PTCA without pretreatment with thrombolytic 
therapy because failed T might be more common in complex 
lesions. In addition, PTCA without T has been shown to result in a 
better clinical outcome compared to T without further intervention. 
A retrospective analysis of 176 consecutive acute myocardial 
infarction (MI) patients treated with PTCA was carried out. The 
clinical outcome was compared between the 100 patients in whom 
acute PTCA was performed because of failed T and the 76 patients 
in whom PTCA was the primary treatment. The angiographic result 
was judged to be satisfactory in case of residual stenosis < 50% and 
TIMIlII flow. 
Results: Distribution of sex, previous MI, risk factors, NYHA class 
before MI, location of MI, and location of culprit lesion was 
statistically not different. Also time delay from onset of chest pain 
to PTCA was comparable in both groups (Failed T + PTCA: 223"" 
vs PTCA without T: 245"'"'). Patency was reached in 86.0% vs 
85.5% in T+PTCA vs PTCA without T. Procedural complication 
rates were also similar. Clinical outcome during hospital stay was 
not significantly different: death 4.0% vs 6.6%; recurrent MI 6.0% 
vs 4.1%; and recurrent angina 16.0% vs 11.9% in failed T+PTCA 
vs PTCA without T. 
Conclusion: In this retrospective analysis, evidence is found that 
acute PTCA after failed T is angiographically and clinically equally 
successful as immediate PTCA without T. 
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955-35 
Hemodynamic Effect of Percutaneous Hemopump in High Risk 
Coronary Angioplasty Patients 
Jean-Luc. Dubois-Rande, Patrick. Dupouy, Philippe. Deleuze, Jean•
Marc. Pemes, Daniel Y. Loisance, Herben J. Geschwind. Henri•
Mondor University Paris XII, Creteil94010, France. 
The aim of this study was to assess the safety and efficacy of 
a new 14 F hemopump device (HP). Seven high risk angioplasty 
(PTCA) patients (pts)(64±4 yrs) [last remaining patent vessel and/or 
low left ventricular ejection fraction (21±5 %)] underwent PTCA with 
the prophylactic use of the HP. This device was inserted 
percutaneously through the femoral artery using a long 14 F sheath 
and placed into the left ventricle. Hemodynamic parameters 
(pulmonary capillary wedge pressure: PCWP; cardiac output: CO and 
mean aonic pressure: MAP) were recorded before, during and after 
PTCA both when the HP was on and off. Adequate placement of the 
HP was obtained in all cases with moderate temporary rhythm 
instability and PTCA was carried out in all pts. • p<O.05 vs Baseline; 
t p<o.05 vs HP off. 
Baseline 
PTCAHPoff 
PTCAHPon 
PCWP(mmHg) 
15±4 
27±6* 
20±6*t 
COUmin 
4.2±0.6 
3.8±O.8 
4.5±O.9 
MAP (mmHg) 
82±17 
77±14 
83±12 
One pt experienced ventricular fibrillation twice during PTCA which 
was corrected by electrical cardioversion. During this temporary 
cardiac arrest, the aonic blood pressure was maintained at 50 mmHg 
with the HP. For all pts, HP was withdrawn 15 min after the end of 
PTCA and the sheath was removed 4 to 6 hours later without any 
major complications. One pt died from cardiogenic shock in the 
intensive care unit. Other pts were discharged 3 days after the 
procedure. 
In conclusion: These data show: 1/ that the 14 F percutaneous HP is 
safe 2/ allowed to unload the left ventricle during PTCA while 
maintaining MAP and CO. 
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955-36 
CIInIc8I ExpIrIInce WIll 1drIcaroI_, tPA: ...... all IIuIIcInIIr 
Reglltry. 
Thomel A. Carlson Ind Jim .. J. Ferguson, lor TlIIlnlrlcoronary tPA 
Reglltry InvesUgltora, Teu. Heart Institute, at. Luke'. EpIIoopal 
Hospital, Blylor College of Medicine, HOUltOn, TX. 
The role of thrombolytic therapy In lcute myOCIrdlal InIerctIon (MI), 
unatable Inglna, Ind II In IdJunct to PTCA continues to evolve. 
O .. plta the wId ....... d use of lnlrlcoronary tIvombolytic therapy, there 
.... lew pubIIIhIICI dele on the UN of lnlrlcoronary tPA (lc-tPA). A 
multlcerl* I'8IIIItry Wli initiated to dOCUlllll1l the current cllnIcIl 
expMence with Ind use patt.-nslor 1C-tPA. A total of 131 patI8ntI 
flave beln enrolled to dlte, with 144 tOllI OCCIllona of UN (4 pta .... 
treated twice; 2 pta WII'II treated In 2 YIII8II). Th ... W11'11108 men Ind 
30 women; the m .. n Ige WI.II8±12 years (I'IInge 31-81). The m .. n 
dOlI of Ic-tPA WI. 32.±.1e mg (I'IInge 10-100). 1nd1cetl0lll lor use 
included Ibrupt closure (e), lcute MI (eo), pott-PTCA "clIIn-up" (3), 
thrombUi without IdJunctlve PTCA (25), thrombUi with adJunctive PTCA 
(31), Ind unltllble Inglna (I). The m .. n nMI lIow gl'llde prior to 
tr .. tment Wli 1.2±1.1; Iller tnIItment • lncrelsed to 2.4±O.1 
(peO.GOO1). The mesn nMI thrombul gl'llde prior to tnatment Wli 
3.2±O.I; Iller treatment n decreased to 1.8.±.1.3 (peo.GOO1). 
Compllcetlonllncluded bleeding In 18 ptl (4 requiring tranlfuslon); MI 
In 21 ptl (12 with evolving MI, 7 with pre-procedure thrombuI, 1 with 
unltllbl.lnglna, 1 with Ibrupt Clolure); CASG In 13 pta (I with evolving 
MI, 4 with pre-procedure thrombul, 1 with Ibrupt closure); repeat PTCA 
In 2 ptl; ventricular IIbrillltion In 3 pta (III lnoclated with thl opening 
of occluded Irterles); Ind In-hospital d .. th In e pta (5 with Icute MI, 1 
with Ibrupt elolur.). 
emn"""'li Intracoronary tPA II effecllveln improving dlltllillow Ind 
d.creallng thrombul burden; hOWlVII', th ... are some rllkll .. oellted 
with Ita u... Further prolpectlveevalUltion ollc-tPA will be n.c .... ry 
to determine the optimal cllnlcel IltUitiona lor Ita UN, II Will II the 
appropriate dOling I'8IIlm.n. 
955-37 
Extraction Atherectomy For The Treatment Of Recent Totally 
Occluded Saphenous Vien Grafts. 
James R. Margolis. Sameer Mehta. Barry Kramer. Robert Trautwein. 
Jorge Bejarano. Michael Traktman. Miami Heart Institute. Miami 
Beach. FL 
Recently occluded IIphenous vein grafts ISVG) may contain 
abundant thrombus. Conventional balloon angioplasty of such SVG 
often resulu in signifICant distal embolization and myocardial 
necrosis. Since Transluminal Extraction Atherectomy !TEC) 
effectively removes thrombus. we employed this technique to treat 
33 pts. with recent SVG occlusions. All pts had Functional Class 3-4 
angina. OCClusions occurred 3 days-4 weeks Imedian 13 days) prior 
to TEC. SVG were 10±3 years old. SVG insertion sit.s wer.: LAD 
11. lCX 13. RCA 9. All occlusions were > Scm in length and 
revealed TIMI grade zero flow. TEC was performed with catheters of 
sizes 1.S-2.5 mm. Multiple passes were often required to maximally 
debulk the voluminous thrombus. Additional intragraft urokinase. in 
doses of 0.5-1.5 million units. was delivered to additionally lyse 
residual thrombus in 9 pts. Adjunctiva PTCA was required in 28 of 
33 pts: these SVG demonstrated larger luminal diameter I>3mm) 
and PTCA was performed to diminish the residual stenosis. 27 of 33 
procedures IS2%) were successful 1<50% final stenosis). Percent 
stenosis was: 100% prior to TEC. 46% post-TEC and 27% post•
adjunctive PTCA andlor thrombolysis. Distal embolization occurred in 
5 pts 117%): of thesa. 4 pts demonstrated mvocardial infarction. No 
spasm. abrupt occlusion. perforation. emergency surgery or deaths 
were observed in the remaining pts. 
CONCLUSIONS: TEC appears extremely effective for treating recently 
occluded SVG. Complications and rates of distal embolization are 
low. 
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955·38 
In Vivo Evaluation of the Safety to the Vessel wall of the Hydrolyser 
(a Hydrodynamic Thrombectomy Catheter). 
Vincent van Ommen. Erik v.d. Veen. Mat Daemen. Jo Habets. Hein J. 
Wellens. Departments of Cardiology and Pathology. Academic Hospital 
of Maastricht. The Netherlands. 
The Hydrolyser (H) is a recently developed 7F double lumen 
hydrodynamic thrombectomy catheter. Using a conventional contrast 
injector saline is injected (3 ml/sec. 500-600 psi) into a narrow supply 
channel that makes a 1S0' curve at the tip. The high velocity jet (± 
100 mph) is directed over a sidehole into a wide discharge channel. 
Due to the resultant Venturi effect the thrombus is sucked into the 
sidehole. fragmented and removed through the discharge channel. In 
recent animal experiments and 50 clinical cases the efficacy in 
removing intravascular thrombus material of up to 14 days was proven. 
To evaluate the effect of this thrombectomy procedure to the vessel 
wall the passage of a nonfunctioning (NF) H in the proximal part of a 
vessel was compared to that of a functioning (F) H in the distal part of 
the same vessel. Histological evaluation was performed in 3 goats (15 
normal arteries and 14 normal veins) 10 days after treatment. 
Results: 
arteries F 
NF 
veins F 
NF 
endothelial 
damage 
2 
Conclusion: This study shows 
(endotheliol reaction) by the 
Hydrolyser is not different to 
(catheter only). 
955·39 
intimal hyperplasia (cell layers) 
o 1 - 5 >5 
7 S o 
S 6 
10 3 
12 2 o 
that the effect on the vessel wall 
thrombectomy action (jet) of the 
that of the non-functioning system 
A COriDg l)eYice: Intracoronary Rotational beiaion 
B_ Hadley Wilson, Jan Tuntelder, Michelle Thompson, 
Kathy Dezern, Chi Hui Chuang, Kenneth J _ Daignault, 
George P_ Tatsis, Robert H_ Svenson, The Sanger Clinic, 
Carolinas Medical Center, Charlotte, Ne 
We tested a unique atherectomy design incorporating a 
stationary auger wire in 56 procedures in 47 canine 
coronary arteries_ The auger wire is threaded over a 
standard guide wire followed by a flexible, hOllow 
cutting catheter connected to a motor drive unit_ The 
catheter is rotated at approximately 1400 rpm as it is 
advanced and envelopes the material captured within the 
auger wire coils_ 16 procedures utilized a round-wire 
auger and 40 procedures a flat-wire auger with both 
open end (11) and closed end (29) leaf-tip designs_ 5, 
6, or 7F cutting catheters were tracked over a distance 
of 10-40 mm in all cases_ Angiography, gross, and 
histology were examined_ Angiographic results 
demonstrated contrast staining (3) and extravasation 
(1) in the round-wire and nonleafed flat-wire auger 
groups due to auger-guide wire separation, but in no 
case after the adaptation of the leaf-tip design_ 
Transient spasm occurred in 9 vessels and appeared 
related to oversizing the system (2) or lack of 
nitroglycerin (5). The flat-wire auger system also 
appeared to provide more flexibility in tracking with 
placement of the system in tortuous and smaller 
arteries «2 _ 5 mm) _ No total occlusions, dissections 
or hemodynamic compromise appeared in any animal after 
the procedure _ Long vessel segments (10-40 mm) and 
even smaller and more distal anatomy appear safe and 
suitable for the flat-wire leaf-tip auger design in 
this preliminary study of an intracoronary coring 
device. 
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955·40 
Coronary Lellon Morphology by Anglolcopy VI 
Angiography: The Ability of Angiography to Detect 
ThrombI. 
Karen Manzo, Richard Nesto, Michael Sassower, David Leeman, 
Philip Fitzpatrick, Murray Mittleman, Stuart Zarich, George Abela, 
Deaconess HoSpital, Harvard Medical School, Boston, MA. 
In -acute coronary syndromes, identification of red thrombus, 
white thrombus, and plaque may be important In the selection of 
therapy. To test the ability of angiography to identify thrombus, 36 
patients undergoing interventional procedures were studied with a 
4.5 F extendible coronary angioscope. Angiographic and angioscopic 
lesion Interpretation was performed by readers blinded to the 
results of the alternate method. By angiography, lesions were 
categorized as a filling defect, a hazy lesion or a smooth stenosis. By 
angioscopy, red thrombus was defined as gelatinous red material 
protruding Into the lumen; white thrombus with intimal disruption 
as billowing material protruding Into the lumen; plaque only, as 
either flat or elevated pearly white and/or glistening yellow 
material without thrombus. 
ANGIOGRAPHY 
Filling defect 
Hazy lesions 
Smooth stenosis 
ANGIOSCOpy 
Red White Thrombus + Plaaque 
ThrOlJ'i]us Intimal Disru tion nlv 
4 0 0 4 
o 4 1 5 
o 4 23 27 
4 24 36 
If filling detects and hazy lesions are considered to be signs of 
thrombus, the sensitivity of angiography for detecting thrombus was 
67% (S/12) and the specificity was 96% (23/24). The lower 
sensitivity was due to the difficulty in detecting white thrombus 
with Intimal disruption (418), whereas red thrombi were readily 
detected (4/4). Conclysion' A filling defect on angiography suggests 
presence of red thrombus. However, hazy lesions on angiography 
may be white thrombus with intimal disruption or smooth plaque. 
955·98 
Measuring Intraluminal Area: Significant Madline Dependent 
Intravascular Ultrasound (lVUSI Imaging Differences. 
Mark Koenig, Donald A. Conetta, Paul S. Gilmore. Theodore A. Bass. 
Julye A. Nesbitt, Robert F. Percy, University of Florida Health Science 
Center. Jscksonville. FI 
Several multicenter trials of IV US data are being collected to determine 
drug and device protocol effects on coronary atherosclerotic lesions. 
The purpose of this study was to compare measurement accuracy of 
two commercial ultrlsonographs [Hewlett Packard [HP) Diasonics (Dll 
by measuring intraluminallrea in a plexiglass phantom. Comparisons 
were made to determine accuracy of coaxial (C) Ind noncoaxial (NC) 
(parallsl to lumen Igainst wall) transducer positions. A 3.5 Fr 'lVUS 
catheter was immersed in water and stabilized in C or a NC position in 
precision drilled lumens of 5.05.3.51 and 2.51 mm diameters (dl (•
coronary artery lumsn sizel. Recorded images were digitizsd off line for 
area measurement. The mean (MI ± SO (mm'l and diffsrences 
between HP and D lumen areas werlt determined by ANOVA. 
Bul!!lI;. 
CA P HP ('!bEl D ('!bEl '!bC 
20.03 C 19.69±.10(-1.71 IS.12 ± .67(-9.5) 7.S· 
NC 20.66± .11 (+3.1) + 19.67 ± .2S(-1 .S) + 4.9· 
9.68 C 9.65 ± .14(-0.31 S.49±.14(-12.31 12.0· 
NC 10.09± .04( +4.5) + 9.34 ± .16(-3.5) + S.O· 
4.95 C 4.55 ± .01 (-S.11 4.06 ± 0.06(-IS.01 9.9· 
NC 4.94 ± .03(-0.2) + 4.S3 ± 0.02(-2.41 + 2.2· 
CA = calculated area using "( ~ d)', P = Position, '!bE = 'lb difference 
from CA, '!bC = '!b diffsrencs HP vs D, • = p<.05, HP V$ 0, 
+ = p<.05 NC vs C. 
Cone/usions: Both IVUS ultrasooographic systsms underestimated 
intraluminal Irea in C poSition and have increased areas in NC 
poSitions. Greater '!bE occurred in smaller lumens. '!bC between 
machines can be large and must be considsred whsn comparing device 
and drug effects on coronary lesions derived from multipls centsrs. 
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955·99 
Accuracy of Angioscopy in Diagnosing EndoluminaI Lesions 
Barry F. Uretsky, Bart G. Denys, Peter Counihan, Michael Ragosta, P. 
S. Reddy, University of Pittsburgh, Pittsburgh, PA 
Angioscopy (AS) may become the "gold standard" for evaluating 
endoluminallesions. To test the accuracy of AS, we developed a model 
consisting of a 3.S mm diameter thick walled rubber tube with 24 
eccentric "lesions" composed of plastic beads (n=22) (gold, n=2; 
yellow, n=S; green, n=3; red, n=S; white, n=2; silver, n=S) or 
yellow foam rubber (n=2). The beads (2.0 mm diameter, 1.3 mm 
width) were spaced apart between S mm to 43 mm and were randomly 
positioned along the internal circumference of the tube. Ten observers 
used a commercially available angioscopic catheter system advanced over 
a guidewire in a manner similar to clinical use (non-steerable). The 
catheter was also rotated to maximize field of view (steerable). Lesions 
were recognized in 92.0 ± 6.3% by steerable and 73.S ± 19.7% by 
non-steerable method (p=0.037). With the steerable method the most 
frequently missed lesion (7 of 10 observers) was the bead with the 
shonest distance (5 mm) from the previous lesion. Of 18 lesions not 
identified by one or more observers, 13 (72 %) were silver. Lesions with 
colors expected to be seen in the coronary artery were well recognized 
with the steerable approach (accuracy: red 98 %, yellow 98 %, white 
90%, gold 100%), whereas silver was less well seen (74%). In contrast, 
using non-steerable technique there was a decreased accuracy in 
identifying these lesions: red, 76%; yellow, 92%; white, 86%; gold 
90%. The shonest spaced lesion continued to be the most frequently 
missed lesion (9 of 10 observers). 
These data suggest that clinical angioscopy without the ability to steer 
will miss a sizeable proponion of lesions. In addition, closely spaced 
lesions may be overlooked. Thus, technical advances are required to 
allow for more complete surveillance of the endoluminal surface prior to 
acceptance of angioscopy as the "gold standard." 
955·100 
Angioscopic Versus Angiographic Detection of Intimal 
Dissection and Intracoronary Thrombus. 
Peter den Heijer, David P. Foley*, Javier Escaned*, Hans L. 
Hillege, Patrick W. Serruys*, Kong 1. Lie. Dept. of 
Cardiology,University Hospital Groningen,and *Thoraxcenter, 
Rotterdam, The Netherlands. 
To compare angiography (AGr) with coronary angioscopy 
(ASe) for the detection of intimal dissection (D) and intra•
coronary thrombus m, the angiograrns and videotapes of 52 pts 
who had undergone ASc (15 pre-PTCA and 37 post-PTCA) were 
reviewed independently, by 2 blinded observers. Classical 
angiographic definitions for D (filling defects, extravasation, 
linear staining) and T (lucency surrounded by contrast in multi•
ple projections) were used. Angioscopic D was defined as visible 
luminal surface disruption, and T as the presence of red/white 
adherent, and intraluminal, material. 
Results: 
Conclusions: There is a poor correlation between AGr and ASc 
for intimal disruptions after PTCA. AGr failed to detect D in 64% 
of cases, but showed signs of D in 2 pts without angioscopic D. 
AGr and ASc appear to be complementary imaging techniques 
for D. Using ASc as the standard, although the specificity of AGr 
forT was 100%, sensitivity was low at 19%. Thus angiography 
clearly underestimates the presence of T and should no longer 
be used for that purpose. 
ABSTRACTS 
955·101 
The eo.t of Pl'CA WIth aDd WIthout IDtracoroDuy IDtruound 
J. David Talley, Massoud Leesar, MJodrag Stikooac, Claudio Maldoruulo, 
Charles Prince, Abraham Joseph, Prasad VemulapaW, Robert Vogel, 
Craig Zeigler, Catdiovaacular Division, Unmrsuy of LouisYtl1e, 
LouisYtl1e, KY 
The economic Impact of pc:rforming Intracoronary ultrasound (ICUS) 
during PTa Is noc known. To define the COlt of lCUS used with 
PTCA, absolute COlt (noc reimbursement or charge) analysis was 
prospecd\>dy l2bulated In 87 COIlJeCUtM patients (pts) referred for 
PTCA. Costs accrued from the time the pt entered the cath lab until 
hospllal discharge and Included COlt of supplies, equipment, wages and 
fringe benefits of RN/RT, post-PTa care and all procedural related 
complications. Medicare reimbursement was used for physician COlt. 
PTCA was used without ICUS In 37 pIS, with only post.lCUS (post•
PTCA JCUS) In 23 pts, and with both pre and post.JCUS (PreIpost 
leUS) In 27 pts. The total and components of the hospllal COlt were 
analyzed In these 3 categories (mean :I: ISD): 
407A 
PTa • Post-PTCA ICUS • PreIoost lCUS , 
Supplies 
Equipment 
RN/RT 
195:1:206 224:1:177 216:1:168 
Post-PTCA care 
Physician 
TafALCOST 
1287:1:566 • t 1882:1:266 
114:1:61 124:1:57 
1736:1:1045 • 2703:1:1224 
1573:1:146· t 1876:1:152 
4906:1:1175 • t 6809:1:1124 
• p= .0001 PTCA VI Post-PTa lCUS, 
t p=.OOOI PTCA VI Pre/post ICUS. 
2126:1:719 
153:1:74 
2085:1:1223 
1908:1:191 
6489:1:1709 
Conclusion: The total cost of PTCA Is dtamatlca1Jy increased with the 
usc of ICUS. This cost increase Is due to the additional COlt of 
equipment, post-PTa care, and profeSSional fees. For ICUS to be COlt 
efficient, clinical benefit will need to be proven by randomized tt1als. 
955·102 
Optimizing in vivo Performance of Coronary Autoperfusion Balloons: 
A Doppler Flow Study 
Jeffrey W. Moses, Ceuap Undemir, Janet E. Strain, Scott M. Lieberman, 
Alexander Sbaknovich, Edward M. Kreps, Lenox Hill Hospital, New York, NY. 
Coronary autoperfusion balloons mitigate ischemia dming PTCA. There are few 
data quantifying their in vivo performance and optimal flow conditions. 14 pIS. 
undergoing PTCA with 2.5 to 3.5 mm Stack™ or F1owtrack™ autoperfusion 
catheters were studied (mean age=60 (37-81); 76 % male). 0.014" or O.OIS·' 
High Torque Floppy (RTF) wires (Advanced Cardiovascular Systems, Inc., 
Santa Clara, CAl and 7F Or SF guide catheters without side holes were used. 
An 0.018" Doppler Flow Wire (Cardiometrics, Inc., Mountain View, CAl was 
placed as a second "side wire" distal to the tip of the autoperfusion catheter 
for measurement of Average Peak Velocity (APV). DistaJ coronary diameter (D) 
was measured by Quantitative Coronary Angiography with the Artrek system 
(lmageComm Systems, Inc., Swmyvale, CAl. Flow (F) was calculated using 
the fonnula F=(D2)(APV)(23.56) The flow wire remained in a distal position 
throughout the study. Flow was calculated at baseline and dming balloon 
inflation, first with the RTF wire distal, then with the HTF wire withdrawn 
proximally, and finally with the guide catheter withdrawn from the coronary 
ostium. The balloon was inflated at 6 to 12 ATM. for 120 to 900 sec. All 
PTCAs were successful. 
Baseline 
30 
(21 - 47) 
p<O.OOI 
Distal Flow (cclroin; mean/range) 
Inflated Inflated Inflated 
RTF Distal RTF Proximal Guide Withdrawn 
6 18 16 
(0-39) (0-41) (0 -54) 
p<O.OOl p"'NS 
Conclusions: I) Perfusion balloons enhance distal coronary flow dming 
balloon inflations when the guidewire is withdrawn. 2) There is a wide 
variability in absolute flow from pI. to pI. 3) With the wire proximal, guide 
withdrawal does not improve distal flow. 
408A ABSTRACTS 
955·103 
Size and Color of Intracoronary Thrombi In Unstable Coronary 
Syndromes: Relation of Angloscoplc Findings to Clinical 
p,. .. ntatlon. 
Jean-Marc Lablanelle. Martial Hamon. Eugtne P. McFadden. Christophe 
Bauters. Philippe Quandalle. XIvier Escudero. Michel E. Bertrand. 
University of Ulle. F,.nce. 
The lack of efficacy of thrombolytic therapy In unstable angina compared 
with acute myocanlill infarction his been ascribed to a different 
composition of thrombi In the two syndromes. 
Pravlous studies suggest that white thrombus. composed predominantly 
of platelets. predominates In unstable angina. whereas red thronlbus Is 
cha,.cteristlc of acute myocanlillinfarction. 
We prospectively studied "e patients who presented with unstable 
coronary disease. We compared angloscopk: findings In 3 groups of 
patients with unstable coronary disease: patients with accele,.ted angina 
(increasing frequency. no rest pain. n • 11). rest angina (paIn at rest. no 
Infarction. n • e). and patJents with recent (13 +/. 6 days) infarction. (n • 
28) of whom 21 (72%) hed received thrombolytic therapy. Thrombi were 
classified by size as lining thrombi (flat. attached to the vessel wall) or as 
protruding (protruding Into the vessel lumen) thrombi. Color was cilsslfled 
as red. white (cotton-woolllke) or pink (mixed white and rad). 
Thrombi were equally common In patients with racent myocanlial 
infarction (2312e. 78%) and In patJents with rast angina (7Ie. 78%) but 
much less common In accelerated angina (4111. 36%). Large thrombi 
were common In the post MI group (12123. 52% protruding) and In the 
rest angina group ("n. 57% protruding) but not found In the accelerated 
angina group (01" protruding). 
OVerall. red thrombi predominated (221304. 65%). followed by pink thrombi 
(el34. 26%). Purely white thrombi occurred In only 3134 (9%) patients. 
The predominance of red thrombi was equally marked In the unstable 
angina groups (7/11. 64%) and In the post myocanlial Infarction group 
(15123. 85%). 
These findings demonstrate that In patients with differing presentations of 
acute coronary disease. differences In the frequency and size of 
Intracoronary thrombi between groups. detected by angioscopy. are much 
more marked thin dlfferances In the composition of the thrombi. 
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956·1 
Opeu Beart Surgery iu Octogeuariaus: Cau We! Should We! 
Paul Stelzer. John C. McCabe, Valavanur A. Subramanian, 
Leuox Hill Hospital, New Yorl<, N.Y. 
To assess risklbeuefit ratios for cardiac surgical !reatmeut in the elderly, we 
reviewed our surgical data for patieuts 80 years of age and older. Among 
2,425 consecutive patieuts who UDderweut opeu heart operations January 
1989-March 1993, 173 (7.1%) were octogenarians. Principal procedures 
performed were coronary artery bypass grafting (CABG) in 127 (73.4%), 
combined CABG and valve repairlreplacemeut in 24 (13.9), and single valve 
replacemeuts in 17 (9.8%). Five other complex procedures were performed. 
The overall mortality rate of octogenarian patieuts was 9.83%, compared with 
4.97% (PS02) for the UDder-80-year-old cohort. The mortality for CABG•
onlypatieuts was 5.51% for octogenarians and 2.74% (PS2) forpatieuts 
UDder 80 years old. For procedures other thau isolated CABG mortality in 
octogenarians was 21.7% vs. 12.8% (p=NS) WIder 80. C~ pre-op~tive 
risk factors, such as chronic obstructive pulmonary disease, cougestive heart 
failure, and reuaJ failure were more common on a per-patieut basis among the 
octogenarians. Three serious complications were more thau twice as common 
in octogenarians: stroke (6.64% vs. 2.35%, PSOO2), sepsis (5.2% vs. 2.4%, 
pS06) and reual failure (4.6% vs. 1.6%, p=.OI). The average post-operative 
leugth ofhospitaI stay was 15.6 days for octogenarians and 12.6 days for 
patieuts WIder 80. 
CONCLUSION: Isolated CABG cau be performed in octogenarians with 
acceptable mortality. MOIbidity is significautJy higher thau in YOWlger 
patients. More complex procedures, however, carry much higher risk and 
should be offered only to carefully selected patients. 
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956-2 
Predictors of Valve Performance Following Mitral Valve 
Repair in Young Patients With Rheumatic Mitral Disease. 
John Skoularigis, Vania Sinovich, Mohammed R Essop, 
Thomas Wisenbaugh, Pinhas Sareli. Baragwanath Hospital, 
Johannesburg, South Africa 
We followed 251 consecutive patients (mean age 18 ± 9 years) 
who underwent mitral valve repair between 1981 and 1989 for 
symptomatic rheumatic mitral valve disease (72 % pure mitral 
regurgitation and 28 % mixed disease). Mean follow-up period 
was 4.9 ± 3.0 (range }-ll)J,ears. Multivariate analysis to 
determine ~redictors of surviv ,re-operation, valve failure and 
overall major events (valve-related mortality, reoperation, bac•
terial endocarditis and thromboembolism) included 108 vari•
ables. 
Results: 
2 
3 
Independent Predictor 
Sinus Rhythm 
Yariabk 
Long-Term Survival 
Absence of Thromboembolism 
Active Rheumatic Reoperation 
Carditis (by clinical/ Valve Failure 
serological criteria) Future Major Events 
Mixed MV Disease Valve Failure 
Future Major Events 
Patients (n=80) with pure mitral regurgitation, sinus rhythm 
and no active carditis at initial operation had the best overall 5 
year results: 
• Survival 90% (vs 81 % for the rest of the patients) 
• Reoperation-free 78% (vs 75%) 
• Valve failure-free 73% (vs 64%, p = 0.04, logrank test) 
• Event-free 70% (vs 59%, p = 0.02) 
In conclusion, the results of mitral valve repair are doubtful in 
patients with mixed disease and/or in the clinical presence of 
active carditis. 
956-3 
Red 0 He art Val v e Sur g e r y: a 30 • Year Experience 
Miralem Pasic, Thierry Carre~ Manfred Ritter, Rolf Jenny, 
Ludwig von Segesser, Marko Turina, Del>artments of Surgery 
and Medicine, University Hospital Zurich, Zurich, Switzerland 
The study was undertaken to evaluate the risk factors and 
results of redo valvular surgery. 
Five hundred eighty seven consecutive patients (male n=351; 
female n=236; age mean=47.6+ /-13 [SD], range, 18-82 years) 
underwent valve reoperation between 1961 and 1990. Aortic 
valve reoperation was performed in 228 (39%) patients, mitral 
valve re~eration in 248 (42%), and double valve reoperation in 
111 (19%). 
Overall operative mortality was 6.8%. The mortality rate after 
secondary reoperation was significantly higher (p<0.05) as 
compared to the mortality rate after primary reoperation 
(11.3~ vs. 6.2~). The operative mortality for aortic, mitral, and 
combmed aortic and mItral valve reoperation was 5.7%,7.1%, 
and 8.5%, respectively. Multiple logistic regression revealed 
presence of early complicauons (p = 0.00(01), presence of 
endocarditis (p = 0.01), female gender (p = 0.03), additional 
coronary artery bypass graftin$ (p=0.03), and double valve 
replacement (p=0.04) as predictors of early death. Actuarial 
survival of all patients at 10 years was 64%. Actuarial survival at 
10 years was 65% for patients having aortic valve reoperation, 
74% for patients having mitral valve reoperation, and 47% for 
patients having double valve reoperation. 
Inspite of improved methods of myocardial protection and 
postoperative treatment, redo valvular surgery still remains a 
procedure with an increased early and late mortality. 
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956·4 
Reduction of Left Ventricular Afterload after Implantation of 
SL Jude Medlcall9 mm Valve Prosthesis 
Toshiaki Ola, Kazuhiko Iwahashi, Hitoshi Matsuda, Takuro 
Tsukube, Morihito Okada, Keiji Ataka, Masayoshi Okada. 
Kobe University School of Medicine, Kobe, Japan 
To examine whether the use of SL Jude Medical 19 mm valve 
(SJM19) for patients with severe aortic stenosis were pennissible or 
not, postoperative degree of left ventricular (LV) afterload reduction 
was studied in 20 patients (BSA 1.28-1.56 m2, mean age 60 years). 
Patients were divided into two groups according to their BSA; group S 
(BSA< 1.45, n=10) and group L (BS~1.45, n=IO). Preoperative 
pressure gradient (PG) measured by Doppler echocardiography was 
121±26 mmHg in group Sand 112±33 mmHg in group L. From mod•
erate to severe LV hypertrophies were observed in all patients, and no 
significant differences were found in the values of various preopera•
tive parameters between two groups. Postoperative PG at rest was 
30±15mmHg in group S and 25±13 mmHg in group L; values were 
insignificantly different. PG was also measured during dobutarnine 
administration, then significant correlations were found between 
cardiac output (CO) and PG (y=6.lx-10.1, r=O.76). The 40 mmHg of 
PG was estimated when CO was approximately 8 Umin. Echocardi•
ographically calculated effective orifice area was 1.4O±O.09 cm2 in 
group S and 1.42±O.05 cm2 in group L. The reduction of LV hypertro•
phy was achieved not only in patients of group S but also in those 
of group L postoperatively (mean II months); the reduction rates 
[(preoperative value - postoperative value)/preoperative value x 
100%] in group S/L were 16±15%/15±13% in LV wall thickness, 
34±15%/29±14% in LVmass and 27±12%/30±7% in LV cross 
sectional area. These results indicate that the implantation of SJM 19 
obtains apparent LV afterload reduction in patients with smaller BSA, 
like those studied here. However, even in such patients, the limitted 
use is recommended because the increase corresponding to the in•
crease of CO during exercise could not ignore. 
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957·9 
IDgbly·Compressed Digital Archival of Ecbocardiograms Can Replace 
Analog Videotape and Improve Objective Image Quality 
10m H. Karson, Shalabh Chandra, Annitta Morehead, Steven E. Nissen, 
The Cleveland Clinic Foundation, Cleveland, Ohio. 
Objectives: To determine, for echocardiographic images, the effect of JPEG 
image compression on image quality and accuracy in comparison to standard 
analog videotape using objective analysis criteria. 
Background: Digital archiving of echo images offers many potential advantages 
over analog video cassette tape, but requires massive amounts of digital storage. 
Adaptive data compression can reduce these storage require-ment; however, its 
effect 00 subjective and objective image quality have not been well snuiied. 
Methods: Using a standard ultrasound scanner, transthoracic echocardiograms 
were acquired and simultaneously recorded on digital magneto-optical disk and 
standard '/,* analog VHS videotape. Representative frames from each storage 
modality were selected and matched for subsequent analysis. The digitally stored 
images were COIII\Te5Sed using the JPEG algorithm, at various ratios (CR) ranging 
from 4:1 to 40:1. The analog images were digitized from videotape for analysis. 
Analysis: Objective image fidelity criteria were developed, including a pixel•
to-pixel comparison of the stored images with the original digitally stored 
frame. A totaJ of 180 images were analyzed for image quality. Objective 
parameters included signaJ-to-noise ratio (SNR) in decibels and the absolute 
mean (A mean) and standard deviation (A Sm) of the difference image: 
Results: m...s:;.R ~ ~ ~ 
6.9:1 38.81 0.01 1.27 
9.8:1 34.99 0.Q1 1.97 
16.8:1 28.71 0.08 4.05 
29.9:1 23.84 0.59 7.07 
35.6:1 22.93 0.09 7.89 
Video 25.75 0.63 5.28 
Conclusion: Our data shows that digitally compressed images are objectively 
superior in quality to analog videotape, evtlf. at compression ratios exceeding 
20: 1. Therefore, in echocardiography, digital archiving with JPEG compression 
can replace video cassette tape. 
ABSTRACTS 
957·10 
A Real·Tlme, Satelllte·Baaed Telecommunications System 
Providing Live Video Conferenclng and Instantaneous 
Transmission of Echo Doppler Images 
David J. Sahn, Jim Williams, Mary J. Rice, Robert W. McDonald, Brian 
Gross. Oregon Heahh Sciences University, Portland, Oregon 
While trans-telephonic transmission of cine loops of moving uhrasound 
images has been achieved, the rates are, at best, too slow to be 
compatible with actual real·time supervision of achos while they are 
done and high data-rate fiberoptic phone lines do not exist in many rural 
locations and are expensive to lease where they do exist. We have 
utilized a 40 s~e, 15-channel compressed 2-way regional video network 
based on the EDNET educational system which operates on the 
SpaceCom 3 Satellite designed to transmit 786 kbyteslsec of 
compressed videoldig~al signals on a Ku band frequency and modified 
~ to support image teleconferencing. The coverage of Space Com 3 
extends over most of the Westem Un~ed States from the Mississippi 
River west to Washington State and down to Northern Mexico. A special 
real-time system was designed to dig~ize and compress the ultrasound 
images to 480 x 320 x 8 bits at 30 frames/sec using a video V-Tel codec. 
Sending and receiving sites had previously installed the V-SAT 3.4 
meter transmission/reception dishes. The system was tested on 10 
occasions and reliably provided two-way transmission capability for the 
whole range of real-time uhrasonic imaging including color Doppler. 
spectral Doppler, high resolution, real-time aduh, pediatric, and fetal 
cardiac imaging w~h slight visible temporal compression at high heart 
rates, but minimal image degradation. Interactive video pointers allowed 
both sender and distant reviewer to point to and talk about the 
ultrasound image or alternatively look at each other's faces for 
discussion. The PC windows-based codec's we use for data 
compression should be available for between $6-10,000. Air time on 
the system costs $200 for a 30 minute conference. The system should 
be adaptable for fiber optic line transmission once suitable fiber optic 
media are available ~ and can be expanded via military linkages to 
encompass the Eastern, Pacific, and Alaskan regions. Lastly, local 
hospitals may be linked directly to their satell~e network station via local 
cable video lines to develop local or regional networks and perm~ direct 
porting of imaging data even from the patient's bedside. 
957·11 
409A 
A Computerized Method for calculating cardiac Output Based on 
Real Time Color Doppler Images USing the Proximal Flow 
Convergence Technique: Experimental Studies in an Animal Model 
Robin Shandas, Michael Jones, Takahiro Shiota, Izumi Yamada, Dag 
Teien, DaVid J. Sahn. Oregon Hlth Sci Univ; Portland, OR; LAMS•
NHLBI, Bethesda, MD 
Previous in-vitro studies have shown that the flow convergence (FC) 
method is useful In calculating flow through rastrictive orifices and that it 
can be modified for non-restrictive orifices. We tested the applicability of 
a prolate hemispheroidal (PHS) flow convergence equation, which 
requires both axial and transverse radii as Input, for celculating cardiac 
output (CO) In 5 sheep (15 hemodynamiC conditions) instrumented with 
calibrated electromagnetic flow maters (EMF). Color M·mode recordings, 
guided by 20 color Doppler Imaging from an apical 5 chamber view, were 
transferred digitally into a computer and after angle correction. wera used 
to obtain continuous isovelocities along axial radii proximal to the aortic 
(AO) valve; 20 echo wes used to measure the transverse radius (112 
LVOT diameter) proximal to the AO valve. For each condition exial 
isovelocities and radii and the transverse radius wera then used to 
calculate instantaneous flow rates through the AO valve at 60-90 
isovelocities over 12 periods during systole. Calculated results for 
instantaneous flow rates and 
for CO agreed well with EMF 
determinations (mean 
difference=13+4%. SEE=273 
mVmin) over" range of CO 
1.74 to 3.35Umin. This PHS 
Fe model uses multiple axial 
acceleration boundaries and 
20 echo dimensions to yield 
accurate semi-automated 
estimates of flow rate and 
CO through non-restrictive 
AO valves from real time 
color Doppler images. 
----
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957·12 
Colored 2-D Blood Flow Structure on B-mode echography 
Using Two-Dimensional Moving Target Indication 
-Ken Ishihara, Toshiaki Nagskura, 'Kohji Masuda, Takeo 
Okada, Yousuke Ohe, "Shinji Kishimoto, "Kenji Nosaka, 
Tohru Hayashi, Masato Asao, Toshiyuki Furukawa; 
Osaka National Hosp., Osaka-city; 'Osaka Univ.; 
"Hitachi Medical Corp.; JAPAN 
We have developed a new method to visualize two•
dimensional blood flow structure without Doppler 
technique. This method, named two-dimensional moving 
target indication (2D-MTI), extracts color-encoded path 
lines (streamlines in clinical concept) of echoic 
particles in the blood. The principle of the 2D-MTI 
method is a kind of optic flow method, which succes•
sively abstrscts difference between high-frame-rate 
(164/sec) B-mode echograms and superimposes those 
difference upon the last original B-mode image. This 
system elucidates dynamic change of two-dimensional 
distribution of path lines. Vortex flow which is a 
difficult objects for conventional echo-Doppler method 
to evaluate is also elucidated precisely. In 30 
clinical cases, we could visualize not only intra•
cardiac flow with contrast agent (sonicated albumin in 
3 right cardiac cavity) but also intravenous flow with 
spontaneous echoic particle (moyamoya echo in jugular 
vein, 30 examinations including 20 healthy volunteers). 
We conclude that the present color-encoded path lines 
are much more useful to evaluate in vivo blood flow 
compared to conventional color Doppler method. 
957·13 
Color Visualization ot Propagating Contraction trom the 
Focus ot Ventricular Premature Contraction by High•
speed Digital Subtraction Echography 
Ken Ishihara, Toshiaki Nagakura, NKohji Masuda, Takeo 
Okada, Yousuke Ohe, "Shinji Kishimoto, '#Kenji Nosaka, 
Tohru Hayashi, Masato Asao, Toshiyuki Furukawa; 
Osaka National Hosp., Osaka-city; 'Osaka Univ., Suita; 
"Hitachi Med. Corp. Kashiwa,; Japsn 
To visualize the propagation ot myocardial 
contraction from the tocus of a ventricular premature 
contraction (VPC) , we have developed a color-encoded 
high-speed digital subtraction (High-speed DSE) system. 
This system elucidate tine motion smaller than 
ultrasonic wavelength based on subtraction between 
high-trame-rate (164trames/sec) B-mode echograms. We 
have directly demonstrated the electricsily stimulsted 
focus of VPCs caused by an artificial pscemaker in 
mongrel dogs (10 examinations in 3 dogs open-chested). 
Color-encoded contracting zone of the ventricular myo•
cardium has propagated from the stimulated point to the 
surrounding tissue on the original B-mode echograms. 
Substantially the same High-speed DSE images have been 
extracted in a patient with VPCs originated trom a 
talse tendon in the left ventricle. De-synchronization 
of contraction was observed in color information 
immediately after initial contraction in this patient. 
We conclude that the current color-encoded high-speed 
DSE has practical potential to locate the focus of 
arrhythmias in clinical use. 
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957·14 
Different Flow Reserve of Coronary Artery Bypass Grafts Assessed by a 
Doppler Guldewlre;Comparlson Between Internal Mammary Artery 
Grafts and Saphenous Vein Grafts 
Takashi Akasaka, Junichi Yoshikawa, Kiyoshi Yoshida, Takeshi HOlumi, 
Tsutomu Takagi, Shinobu Miyake. Kobe General Hospital, Kobe, Japan 
Abhough decreased coronary flow reserve has been reported in patients 
wUh Intemal mammary artery grafts (IMA) by radioisotope studies. Its mecha· 
nism remains unclear. To investigate the flow dynamics of coronary artery 
bypass grafts (CABG), phasic flow velocHy patterns 01 CABG to the left ante· 
rior descending artery (LAD) and the recipient LAD were analyzed using a 12 
MHz Doppler guidewire in 13 patients (pis) wHh IMA and 14 pts wHh saphe· 
nous vein grafts (SVG). SystoliC and diastolic peak velocities (SPV, DPV) and 
time velocHy integrals (SVI, DVI) of the flow were measured in the mid•
portion of the CABG and the distal LAD. Flow volumes (FV) of the CABG and 
LAD were calculated from SVI+DVI (TVI), heart rates and diameters of the 
vessels. Maximal peak velocHy (MPV) and flow reserve (FR) of the CABG 
were also measured using intravenous dipyridamole administration (0.56 mgt 
kg/min for 4 min). Resutts are shown as mean ±sd (*=!?<.01 vs SVG): 
SPY DPV TVI Diameter FV MPV FR 
(em/s) (emil) (em) (mm) (mVmln) (emilie) 
IMA 27±S' 39±10' 18tS' 2.4±O.3· 58±16 68±23 2.1±O.4· 
SVG 9±4 19±10 9±3 3.5±O.8 63±24 S8t16 3.3±O.9 
In the recipient LAD, SPV (19±5 vs 15±7 cm/s) , DPV (41±10 VB 35±12 cm/s), 
TVI (17±7 vs 16±6 cm). diameter (1.8±O.3 vs 1.6±O.3 mm) and FV (35±12 vs 
30±13 mVmin) were not signHicantly different between IMA pts and SVG pts. 
Atthough TVI of the IMA was significantly greater than that of the SVG, the 
diameter of the IMA was signHicantly smaller than that of the SVG, and con· 
sequently FV was not signHicantly different between both IMA pts and SVG 
pts. Because SPV and DPVof the IMA were significantly greater than those 
of the SVG, and MPV was not signHicantly different between IMA and SVG 
pts, FR of the IMA was signHicantly smaller than that of the SVG. In conclu· 
sion. FR of the IMA is smaller than that of the SVG, which might be related to 
a smaller diameter and higher peak velocHy at rest in the IMA compared wHh 
those in the SVG. 
957·15 
Efficacy of COronary COllateral Circulation detected by 8 Doppler 
guldewlre during Balloon Angloplasty 
*Tsutomu Takagi, Junichi Yoshikawa. Kiyoshi Yoshida, Takashi Akasaka. 
Takeshi HOlumi, Kobe General HospHal, Kobe, Japan 
In order to determine the efficacy of coronary circulation distal to 
the angioplastic Site in reducing myocardial ischemia during balloon 
Inflation. we perfonned flow velocity measurements with a 12MHz 
Doppler guidewire in 14 patients undergoing balloon angioplasty. Alter 
crossing the lesion wHh a Doppler guidewire, spectral Doppler velocity 
data were obtained before and during balloon inflation. COllateral circu•
lation was defined as retrograde or persistent antegrade flow during 
balloon inflation. Myocardial ischemia was assessed by the extent of 
echocardiographic left wall motion abnonnalHy, occurrence 01 ST seg· 
ment deviation and anginal pain during balloon inflation. Regional wall 
motion score was defined as normal (1), hypokinesia (2), akinesia (3) 
and dyskinesia (4). Wall motion score index was calculated as the 
sum of scores in visualized segments divided by number of segments 
visualized. 
Resutts: Doppler velocHy spectrum was obtained in all of the 14 
patients at baseline. During balloon inflation. however, Doppler velocity 
spectrum was obtained in 7 of the 14 patients. In this 7 patients, 
systolic peak velocHy. diastolic peak velocHy and time velocity integral 
during balloon inflation did not change when compared with those 
before balloon inllation (13.2 ± 9.6 vs 12.8 ± 7.9 cm/sec, 16.4 ± 5.1 vs 
18.8 ± 8.4 cm/sec, 9.0 ± 2.4 vs 10.8 ± 5.0 em, respectively). There was 
no signHicant difference in baseline wall motion score index between 
patients wHh and wHhout coronary Circulation during balloon inflation 
(1.1 ± 0.1 vs 1.2 ± 0.2). A reduction in wall motion score index in patients 
wHh collateral circulation (1.1 ± 0.2) versus wHhout collateral circulation 
(1.6 ± 0.3) during balloon inflation was noted (peO.Ol). Occurrence of 
ST segment deviation and anginal pain were less frequent in patients 
with collateral flow during balloon angioplasty (28.6% vs 71.4%, and 
14.3% vs 71.4%, respectively). 
Conclusion: In patients wHh coronary circulation detected by a Doppler 
guidewire distal to a lesion, myocardial ischemia as defined by wall 
motion abnormalHy is reduced during balloon Inflation. and occurrence 
of ischemic change is less frequent. 
JACC February 1994:1A-484A 
957·16 
Echo Phase Analysis of the Sequence of ADular Descent and 
its Value in LocaliziIIg Accessory Pathways 
Rarrdas G Pai, Sudha M Pai, Vilma Torres, Pravin M Shah. VA 
hospital and Lana Linda University, Lana Linda, CA. 
The mitral and the tricuspid anuli descend towards 
the apex during systole and we hypothesized that the 
temporal sequence of descent of di-fferent parts of the 
anuli depends upon the activation and contraction sequence 
of the regional myocardium. This was tested in patients 
with normal and abnormal intraventricular conduction and 
WPW syndrane who have predictable activation and 
contraction sequence of the ventricular walls. M-m:::xie 
echocardiograms were recorded fran the apical window 
through the anterior (A), lateral (L), posterior (P) and 
medial (M) aspects of the mitral anulus and the lateral 
margin of the triCllS.Pid anulus in 19 subjects with normal 
EO:; (NL), 10 with n.ght blmdle branch block (RBBB) and 7 
with left bundle branch block (LBBB). The onset of descent 
of different parts of the anuli were timed in relation to 
the R wave of the EO:;. In all NL, M was the first to start 
descent follCMed sequentially by A (+7 .6±3.1 ms, pc 001 vs 
M), P (+16.6±6 ms, pcOOl vs A) and L (+22.4±6.9 ms, p<.OS 
vs P). Onset of descent of the tricuspid anulus was 
+13. 2±9. 8 ms after M (pc 001 vs A and M), In RBBB, the 
same sequence was maintained for the mitral anulus, but 
descent of tricuspid anulus was markedly delayed 
(+6l.S±lS.B ms, p<O.OOl vs M). In LBBB, T.A was the first 
to descend, followed sequentially by M (+8.6±10.7 ms), P 
(+34.1±26.2 ms), A (+4S±lS ms) and L (+S8.6±28.4 ms). This 
principle was used to localize accessory pathways (AP) in 
various locations in 4 patients with WPW syndrane and 
antegrade conduction before the electrophysiological study 
and ablation. All 4 pathways were accurately localized by 
this method. 
Conclusions: S~ence of descent of parts of mitral and 
tricuspid anul~ reflect activation and contraction 
sequence of the adjoining ventricular walls and may help 
in localizing accessory pathways and possibly origin of 
ventricular premature beats and tachycardia. 
957·17 
Adequacy of Low Stress ArbuWnine Delivered by a Computerized OO&ed 
Loop System to Provoke lllChemia During Edtocardiography 
"David S. Bach and "William F. Armstrong, University of Michigan, 
Ann Arbor, MI for the International Arbutarnine Study Group 
Previous reports on the accuracy of arbutamine (Arb) stress 
echocardiography (Echo) have relied on heart rate (HR) increases 
similar to those seen wi th exercise (Ex). This report describes the 
detection of inducible ischemia at lower HRs than achieved by symptom•
limited stress testing. Arbutamine was administered by a computerized, 
closed loop system which measures HR and adjusts Arb infusion to 
achieve a predefined HR objective. 144 patients with documented 
coronary artery disease ~ 50% stenosis of any major coronary artery by 
quantitative angiography) received Arb. Endpoints for stopping stress 
were intolerable symptoms, ischemia, target HR or plateau of HR 
response. Echocardiography was performed at baseline, low stress (LS, 20 
bpm above baseline) and peak stress (PS, stress endpoint). Detection of 
ischemia was defined as the induction of new or worsening wall motion 
abnormalities with stress. Blinded analysis of digitized images for 
ischemia was available at LS and PS for 120 patients. 92 of these 
patients underwent Ex Echo. Ejection fraction (EF, n=l34) and wall motion 
score index (WMSl, n=l(4) were determined at baseline, LS and PS. 
EE..{!a) ~ A...IDdSl 
Baseline 59±1 N/A N/A 
Low Stress 72± 1 73/120 (61%) 0.18 ± .02 
Peak Stress 72 ± 1 88 1 120 (73%) 0.27 ± .03 
% PS achieved at LS 100% 83% 67% 
Of 92 patients who underwent Ex Echo, 71 had an ischemic response. 
61 of 71 (86%) ischemic responses were detected by Arb Echo at PS, and 50 
(70%) were detected at LS. A further 9 patients without ischemia on Ex 
Echo had an ischemic response with Arb Echo at PS, of which 8 were 
detected at LS. 
We conclude that with Arb, 1) augmentation of EF appears complete 
at LS, and 2) a majority of Echo signs of ischemia are present at LS. 
Establishment of an Arb infusion endpoint using a lower target HR may be 
feasible. 
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957·52 
Assessment of Right Ventricular Volume and Function with 
Intracardiac Ultrasonography: In Vivo Validation 
Jose A Vazquez de Prada, Ming Hui Chen, Luis R Padial, J Luis 
Guerrero, Leng Jiang, Ehud Schwammenthal. Arthur E Weyman, 
Chunguang Chen, Robert A Levine. 
Massachusetts General Hospital, Boston, MA. 
Accurate quantification of right ventricular (RV) size and function, 
although important in clinical practice, remains difficult with 
conventional noninvasive and invasive techniques because of RV 
complexity. Intracardiac ultrasound UCUS) allows direct 
visualization of the RV cavity in serial cross·sections and may be 
ideal for evaluating RV volumes without geometric assumptions in 
patients undergoing RV catheterization. In a canine model, 
instantaneous RV volume was directly measured in 21 
hemodynamic stages by using a high-compliance latex balloon 
connected to an extra-cardiac reservoir. A 10MHz ICUS catheter 
was introduced through the right atrium into the RV apex and 
sequential cross-sectional images recorded at 10 mm intervals 
during a stepwise pullback from apex to base. RV images were 
traced at end-diastole (ED) and end-systole (ES) and RV volumes 
calculated by Simpson's rule integration of all segmental areas 
times height. RESULTS: RV volumes and ejection fraction (EF) by 
ICUS agreed well with actual values: 
Actual vol ICUS vol R Equation SEE r 
RVEDvol(ml) 60.9±17 60.3±18 y=0.95x+2.7 4.0 .97 
RVESvol(ml) 46.6±15 44.3±14 y=0.94x+0.6 3.6.97 
EF (%) 24±5 27±6 y+0.94x+0.l 4.2 .86 
CONCLUSIONS: Despite the irregular crescentic shape of the RV, 
ICUS can visualize its entire extent and accurately evaluate RV size 
and global systolic function. This technique may be particularly 
useful at the time of catheterization, especially in patients with 
congenital and pulmonary vascular lesions. 
957·53 
Intracardiac Echocardiography: Observations in Normal and 
Diseased Hearts Using IO-MHz Catheter Transducer 
Jui-Sung Hung, Morgan Y. Fu, Kou-Ho Yeh, Jong-Jen Wu, 
Chang Gung Memorial Hospital, Taipei, Taiwan 
To investigate the imaging quality of a newly developed 
8F lO-MHz ultrasound catheter (non-over-the-wire), 
intracardiac echocardiography aCE) was performed in 18 pts 
(9 men and 9 women, aged 28 to 63 years). They were 7 
normal subjects and 11 pts with severe mitral stenosis (MS) 
undergoing Inoue-balloon mitral valvuloplasty. The 
normal subjects were those who underwent diagnostic 
coronary angiography for chest pain and were found to 
have normal coronary arteries. The transducer catheter was 
introduced from the right femoral vein and was interfaced 
with a CVIS real-time ultrasound system for imaging of the 
right and left heart (via transseptal catheterization). In all 
pts, there were no complications. High quality, real-time 2-
D echocardiographic imaging was obtained within each 
cardiac chamber, the pulmonary artery and vena cavae. 
Relative chamber size as well as wall motion could be 
assessed in all pts. In addition, in pts with MS, ICE ensured 
that the transseptal needle tip was in good contact with the 
bulged interatrial septum to facilitate safe transseptal 
puncture. Mitral leaflet morphOlogy and motility as well as 
subvalvular disease could be determined. Commissural 
splitting was observed after the balloon valvuloplasty. 
In conclusion, ICE using SF 10-MHz ultrasound catheter 
is useful in evaluating normal as well as diseased cardiac 
structures and guiding/monitoring interventional 
procedure such as balloon mitral valvuloplasty. 
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958·54 
Troponin T in Patients with Acute Chest Pain 
Paula A. Johnson, Maureen P. Albano, David Sacks, E. John Orav, 
Lee Goldman, Thomas H. Lee, Department of Medicine, Brigham 
and Women's Hospital and Harvard Medical School, Boston, Ma. 
Elevated levels of troponin T mm, a cardiac specific enzyme, may 
be a predictor of poor outcomes in patients (PTS) with unstable 
angina (UA). To further evaluate the utility of TnT as a diagnostic 
and prognostic tool in the evaluation and management of PTS with 
ischemic heart disease, we measured TnT in 378 PTS who presented 
to the emergency department (ED) with a chief complaint of acute 
chest pain, unexplained by trauma or chest X ·ray findings, of whom 
316 (84%) were admitted. Of these 316 PTS who constituted the 
study population, 54% were male with a mean age of 61±14 years. 
Thirty-five (11%) and 90 (29%) of the patients had discharge 
diagnoses of myocardial infarction (MI) and UA, respectively. TnT 
was measured every 8 hours for the first 24 hours of admission. 
Physicians were blinded to the results. TnT ranged from 0 to 22 
nglml with a mean of .40 ± 2.0 nglml. The normal range for TnT is 
o to 0.1 ng/ml. The maximum (MAX) TnT level during the first 24 
hours of admission differed significantly among diagnostic groups. 
Patients with MI, UA and non-ischemic chest pain had a mean MAX 
TnT of 3.2 ± S.3 nglml, .09 ± .21 nglml, and .03 ± .14 nglml, 
respectively (p=.0001). Thirty five (100%) of PTS with MI had an 
elevated MAX TnT (>0.1 nglml). Of the remaining 281 PTS, 19 
(21%) PTS with a clinical diagnosis of UA and !O (S%) PTS with 
non-ischemic chest pain had and elevated MAX TnT, 1'='.0001. 
Therefore, an abnormal elevation in the maximum troponin during the 
first 24 hours of admission was 100% sensitive in detecting MI. The 
significantly (p=.0001) higher rate of elevated TnT in patients with 
a clinical diagnosis of UA as compared with non-coronary diagnoses 
suggests that a substantial minority of UA PTS have true myocardial 
necrosis. 
958·55 
Optimal Intensity of Oral Anticoagulant Therapy In 3404 Post•
Myocardial Infarction Patients. 
*Alda J. Azar. Jaap W. Deckers. Frits R. Rosendaal. Ernst Briet. 
Thoraxcentre, University Hospital Dijkzigt, Rotterdam; Dept. of 
Haematology/Clin.Epidemiology University Hospital Leiden; The 
Netherlands. 
The optimal intensity of long-term anticoagulant therapy in post•
myocardial infarction (MI) patients required to prevent the occurrence 
of arterial thromboembolic and bleeding complications is not known. 
Here, incidence rates associated with specific international normalized 
ratio (INR) intervals were calculated for all bleeding and 
thromboembolic complications In 3404 post-MI patients enrolled in the 
ASPECT (Anticoagulants in the Secondary Prevention of Events) trial. 
Total treatment period was 7213 patient-years. Major bleeding occurred 
in 57 (0.8/1 00 patient-years) and thromboembolic complications in 397 
patients (5.6/100 patient-years). Poisson regression analysis was 
performed. Results, after adjustment for confounders (rate ratios and 
95% confidence intervals): 
INR Bleeding Thromboembolic 
<2 1.0 1.0 
2-3 0.2 (0.1;1.3) 0.3 (0.2;0.6) 
3-4 0.6 (0.1;2.4) 0.2 (0.1 ;0.5) 
4-5 1.8 (0.4;7.8) 0.5 (0.2;1.0) 
>5 4.9 (1.1 ;22) 0.2 (0.1 ;0.7) 
Other predictors for bleeding and thromboembolic complications were 
higher levels of systolic blood pressure and age and female sex. 
These results suggest the optimal intensity of long-term anticoagulant 
therapy for poat-MI patients to lie between 3.0 and 4.0 INR. 
JACC February 1994:1A-484A 
958·56 
Continued Left Ventricular Remodeling Beyond One Year 
after Myocardial Infarction. 
Martin St. John Sutton, Marc A. Pfeffer, Ted Plappert, 
Jacques R. Rouleau. Jean L. Rouleau, Marc Klein, Bruce A. 
Sussex, Sandra Lewis, John O. Parker, Gervasio A. Lamas, 
Eugene Braunwald, Brigham and Women's Hospital, Boston, 
MA. 
LV remodeling following acute MI is considered an early 
process that can be modified by angiotensin converting 
enzyme (ACE) inhibitors. To assess whether this process 
continues beyond 1 year after MI and whether ACE 
inhibitors remain effective. serial 2D echoes were obtained 
at baseline (mean 11 days), 1 and 2 years post MI on 373 
Survival and Ventricular Enlargement (SAVE) patients. 
Each echo required at least 3 of 5 technically satisfactory 
views which included both long and short axis images. LV 
size was assessed as total diastolic (DA) and systolic (SA) 
cavity areas. L V enlargement (L VEl was defined as an 
increase of more than 1.96 x the standard deviation of 
reproducibility for diastolic and systolic cavity areas. 
Although this analysis censored the highest risk group 
(non-survivors), the percentage of survivors who 
developed LVE from I to 2 years increased from 30.3% to 
35.4% (p<O.OOI) in diastole and 33.5% to 38.6% (p<O.OOI) in 
systole irrespective of treatment. During this late period, 
absolute DA and SA both increased significantly (p=O.02) 
and (p<O.OOI), respectively. Over the 2 years post-MI, LVE 
occurred in both treatment groups, but the rate of increase 
in DA and SA was slower in the captopril than placebo 
group (p=0.048). We conclude that LV remodeling 
continues even beyond I year post-MI and that captopril 
remains effective in attenuating post MI L VE. These 
results suggest that the pathophysiology of LV remodeling 
is insidious and on-going and that ACE inhibitors should be 
continued long-term post-MI. 
958·57 
Divergent Eflilcts of ACE~nhibition on Hemodynamics and Sear Healing 
After Myocardial Infarction in Spontaneously HyperIensive Rats. 
Tomasz Zdrojewski, Peter Gaudron,"Peter Whittaker, Sulamith PliIzI, Kai Hu, 
Georg Erti. Unlversitlit Wiirzburg, Germany & "Hospital of Good Samaritan, Los 
Angeles, CA. 
Our aim was to examine the long-term effect of ACE-inhibition initiated early 
aIIer myocardial infarction (MI) on hemodynamics and cardiac remodeling in 
the presence of hypertension. MI was produced by permanent coronary artery 
occlusion in spontaneously hypertensive rats (SHR). AI 30 min aIIer oa:Iusion, 
SHR were randomized to receive either quinapril (Q: 6 mgIkgIday per gavage) 
or to no treatment. Nine weeks aIIer infarction, we measured left ventricular 
systolic (L VSP) and end-diastolic (L VEDP) pressure, peak cardiac index (pC1) 
during aarte volume load, and also oIltained passive pressure-vokJrn CUNeS 
for each left ventricle (LV). Structural changes were assessed by calculation of 
LVIbody mass ratio and miaosalpically by measurement of the brightness of 
pia"osirius red stained collagen fibres in the scar viewed with polarized light, 
which will be a function of collagen fiber thickness, packing, and moIeaIIar 
anisotropy and so provided an assessment of scar healing. We divided the 
hearts into those with small to moderate infarels (1044%) and those with IaIge 
. infarcIs (LM1:45-6O%). The table shows only data obtained from hearts with 
IaIge infarels as we obsetved no differences between groups with smaller 
infarels. 
SHRsham 1n=35l SHR:LMI In-7l SHR+Q:LMI 1n=8) 
MI size(%) 53:t2 55±2 
LVSP (mmHg) 179±3 147:t7* 129%7*$ 
LVEDP(mmHg) 4:t1 15:t4' 10:t2"S 
LVIbody mass (mglg) 2.6O:t0.04 3.06:1:0.22" 2.501:0.13$ 
pCl (mVrninlkg) 491:t17 342t2!r 419±28 
Vol at 20 mmHg (ml/kg BW) 0.93±O.04 1.87:t0.13' 1.87:t0.12* 
~hIness 35%9 18:t4$ 
V81ues are mean:tSEM; p<O.OS: 'vs.sham, $ vs.SHR:LMI 
Q reduced LVSP and LVEDP, prevented the ina'ease in LVIbody mass ratio, 
but did not alter the pressure-voIume CUNeS. However, Q did reduce collagen 
fiber brightness suggesting a disruption of the healing process. Thus in IIIge 
infarcls, chronic ACE-inhibitor therapy started early aIIer MI irnptMId 
hemodynamic profile, but did not raduce venbicuIar n!I'IIOdeIing and also 
appeared to impair scar '-ling. 
JACC February 1994:1A-484A 
958·58 
Compeautory Bypenropby III BIIIIWU FoIknriDg EDeaIift Myocanllal 
lIIfamioD II DiKonllDt wltb Clwlpalll Left Veatricalar Volume 
Eve M Gerasimou, Ric:hanI C. RigiiDg, AlIdrew M Keller. DaDbwy Hospital, 
DaDbwy cr, and Columbia UDiversity, New York NY. 
Compcnsatoty left ventricu1ar hypertrophy following myocardial infarction, and 
its cIepcndIma: upon changes in left ventricular volume, was investigated with 
magnetic R&ODaIII:C imaging in IS patients with enzymatic CYidence for large 
myocardial infarctiODS (CPK > 1000 lUlL). LV mass and LV volume was 
measured at I wk, and I, 6, and 12 months following MI. LV mass increased 
between 1 and 6 months (rdlecting compensatory left ventricular bypcrttopby) 
withOllt a pm:edingorpuallel ina'casc in LV volume (see left figure, *, p < 
0.05, n:pcaIcd IIIC8SUIIlS ANOVA) Moreover, the extent of the changes in LV 
mass between I and 6 IIIODtbs in individual patients was not mated to the size of 
the infarct but was invenely mated to the initiallcft ventricular volume ODe 
week following infan:tion (right figwe). 
00 
10 
10 
1 wk 1 mo • mo 12 mo 
• 
~. . .. .-• • 
-'0 L....~~_ ..... ~---'--Oo~ 
20 30 40 sc 107010 
LV Volume at one "Hk (mi/m t) 
It is concluded that 1) compensatoty LV hypertrophy occurs I to 6 months 
following large myocaniiaI infarctioDS in humans, and 2) the extent of 
hypertrophy is not related to infarct size, but is invenely mated to the initial LV 
volume. The discordance between changes in LV mass and volume following MI 
suggests that compensatoty hypertrophy is DOt just an adaptive response to 
ventricular dilatation. 
958·59 
Ia it Safe to ~ibe Digcatin to Pati-m ......... wJ 
P'raI llya:iu'd.ial IDfarctien? ~tiCIIB in Pati-m at 
Iaf IIIId Inter.miate 21_ 
Jcmathan I;aar. Ori Goldbcurt. SolCKID BIIbar. Eli __ 
Kaplil!illky. BIIbeth Rabinc:witz and the SFRINl' study Group. 
Neufeld Cardiac RaIIeII:rcb Institute. Tel ~. Israel 
'lba iDcleaad KJrtality in digoxin (D) tr..ted 
patients (pta) after acute lIlf'IOCBl'dial infarcticn (AMI) 
_ related to high pnrnhmce of edvarae risk factars 
like ___ a::mgIBt;i_ t.art failure (aIF). To en.luate 
the iIIpIICt of ~ibing D after AMI __ lyzed data 
of 1731 AlII pta -=lled in the SFRINl' study in Iilich 
pta "ith ...... aIF __ .:Eluded. At dil!lCbarge fran 
halpital. 175 pta (1ot) ___ taking D. 'it- pta tere 
older IIDd __ i..,."..d a higher prcparticn of _iaus HI 
and in-hcIIpi tal CXIIPlicatiCIIB. First yaar .::a:tali ty _ 
.ignifiClllllt1y higher in pta en D than pta "it.hcut D (1S. 
VB. 4t;p<0.001). In a stepci_ logistic ~ien 
_lyei.. edj~ed fer age. clinical predict.ans of 
IICrlal i ty IIIId errlJytlai_ dstected by prediacharge 24 
bra Iblter .:mitoring. D tbIIrepy retained a statisti•
cally .ignifiClllllt .-ociatien "ith first yaar .::a:tality 
[cdda ratio (ell)-2.9; 90t ccnfidarlce interval (CI) 1.9-
4.5»). Subgrcq:llID&lysis indicated that therapy "ith D 
_ predictor of first yaar death in subgraupB of 468 
pte "ith aIF (ell 2.6; 90t CI 1.4-4.7). as _11 _ IIKD'J 
1259 pta "it.hcut C&' (ell 3.6; 90t CI 1.7-8.0). Furt.Mr 
SIb;rc::q) _lysis indicated that for arty c;ri-a. sut:eet.s 
of pta. i ••• _1_. f_l_. prvvious MI. anterior MI, 
infarct .i_ IIIId typa of errl1ytiaia in Iblter. D ~ 
a::riptien _ .-ociated "ith iJx::reuai risk of 
.:x-t.aHty in the first year after MI. Cka:lwIiCIIB: Pbs 
en D after AlII taperiencwJ i~ KJrtality. 'ftIe 
findiDc;rs frca the SFlUNT study to tam"Ci_ 
OIIUtien .m- pnsribing D in lm"Vivars of AMI. 
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958·60 
The Innuence of Preceding Insulin Dependent Diabetes Mellitus 
and Hypertension OIl Cardiac Deatb After Myocardial Infarction 
Shmuel Gottlieb, Arthur J. Moss, Michael McDennott, Shirley Eberly. 
Bikur Cholim Hospital, Jerusalem, Israel, and Univ. of Rochester, 
Rochester, NY 
The influence of the interrelation between iDSulin dependent diabetes 
mellitus (IDOM) and history of hypertension (lIT) on 2-yr posthospital 
cardiac death (CO) was evaluated in 2095 AMI survivors from two 
multicenter post-infarction studies. 100M was noted in 165 pts (8"), and 
HT in 795 (38"). 
~ PIs with 100M or with HT were more frequently women, had 
significantly higher prevalence of prior MI and NYHA class W prior to the 
indexAMI. Pulmonary congestion (PC) in the CCU, predischarge LVEF, 
heart rate variability (HRV) measured on Holter, medications prescribed, 
and 2-yr CO were: 
~ II:!DM 
NlUIT HI lImM lI!I!UIT ~ 
No.ofpts 1221 709 79 86 
PuImonary congestion 20% 27% 28" 44% <0.0001 
LVEF 46% 47% 41% 43% <0.0001 
HRV (msec) 89 86 75 66 <0.0001 
&-blockers at discharge 43% 51 % 34% 36% <0.0002 
Digitalis at discharge 18% 22% 35% 37" <0.000 I 
2-yrCOrate 8% 15% 18% 26% <0.0001 
After adjustment for best selected pertinent clinical variables, 100M and 
HT were found to have an independent prognostic significance for predicting 
CD; Cox hazard-ratio 1.94 (95% CI 1.29, 2.92,p=O.OOI) for 100M, and 
1.61 (95% CI 1.19, 2.l8,p<0.OO2) forHT. No significant interaction was 
found between 100M and HT, nor did either of these variables interact with 
PC, LVEF <35%, or gender. 
Conclusions: I) 100M and HT contribute independent CO risks after 
AMI (1.94 and 1.61, respectively) with more than Hold risk when both are 
present in the same patient; 2) No interaction effect is present between 
100M and HT, or gender for CO. 
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959·18 
Angiography Poorly Predicts Actual lesion EccentricIty III Severe 
Coronary Stenoses: Confinnation by Intnlcoronary Ultrasound 
Imaging. 
Gregory A. Braden, David M. Herrington, Richard A. Kerensky, Michael A. 
Kutcher, William C. LillIe. The Bowman Gray School of Medicine, Wake 
Forest University, Winston-Salem, NC 
Eccentric coronaty stenoses are associated with higher peri-procedural 
complication rates from PTCA and lesion eccentricity is important in the 
selection of newer catheter based teclmologies for coronaty revascularization. 
However, angiography only defines the path of coronaty lumens and the 
ability to correctly define actual lesion geemetty is limited. Accordingly, we 
compared coronaty angiography with intracoronaty ultrasound (ICUS) 
imaging at the site of 78 severe stenoses prior to PTCA or directional 
athcrectomy. Angiographic eccentricity was detennined by a consensus of 3 
InteIVentional Cardiologist defining an eccentric lesion as one with an 
asymmetric lumen to one side of the inferred midline of the vessel. ICUS 
eccentricity was defined as a r.tio of the thickest to the thinnest wall ~ 2.0 
from the pre-inteIVention ICUS image (ER). Angiographically, 62% of 
lesions were eccentric (ECC), 38% concentric (CON), with similar 
pmportions by ICUS, 65% ECC and 35% CON, however, only 39 of 78 
lesions had concordant angiographic and ICUS assessmenl [Kappa=O.OI, 
(I = perfect concordance and 0 = none) 
p<O.OOII. Angiob'l'8phy is a poor 
predictor of lesion morphology with the 
positive predictive value of an ANGlO 
angiograpbic apparent ECC stenosis of 
only 62.5%, for CON lesions of only 
30.('%. 
JCUS 
~~ 
~ 30 18 
CON 21 9 
Conclusion: Coronaty angiography poorly predicts actual lesion morphology 
of severe coronary stenoses. Since lesion morphology is important in 
selecting new inlervcnlional technolOgies and is a powerful predictfJr of peri. 
procedural complications, then pre-inteIVentional ICUS imaging may 
significantly enhance patient outcomes. 
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959·19 
Failure of Compensatory Enlargement During tbe Development 
of Coronary Artery Disease is Often Responsible for Severe 
Coronary Stenoses 
David D. Gayle, Gregory A. Braden, Section of Cardiology, The 
Bowman Gray School of Medicine, Wake Forest University, 
Winston-Salem, NC 
Early coronary atherosclerosis is marked by an increase in wall 
thickness with compensatory enlargement of the vessel itself while 
luminal encroachment is a late event. However, the transition from 
compensatory enlargement to luminal encroachment is IIQt well 
understood. Therefore, we studied the site of severe stenoses and 
adjacent angiographically normal appearing segments in 10 patients 
undergoing PTCA or DCA. Intracoronary ultrasound (ICUS) 
images were coDected I em proximal and distal to the site of severe 
stenoses as weD as the stenotic site prior to any intervention. Cross•
sectional vessel area (VA) and plaque area (PA) were measured at 
each site. The expected VA and PA at the site of stenosis was 
considered to be the mean of the proximal and distal values and this 
was compared to that actually obtained at the stenosis site. 
Although for the group the expected V A was not different from the 
measured VA: 16.4±1.5 vs 16.0±2.6mm2 (p=.43) (x±SE), in 6 of 
the vessels, the measured V A was substantially smaller (23.7%) than 
the expected VA. In fact, these V A's were smaller than the more 
distal segment. P A at stenoses sites was not different from the mean 
ofproxima1 and distal sites: 13.7±2.7 vs 12.1±1.6, (p=.34) and does 
not substantially account for development of severe stenoses. 
Conclusion: Frequently, severely stenotic coronary lesions are the 
result of inadequate compensatory enlarg,~ment of diseased vessels, 
not merely an increased accumulation of atherosclerotic plaque. 
959·20 
Differential Progression of Complex and Smooth 
Coronary Stenoses Within the Same Coronary Artery Tree 
in Patients with Stable Angina. 
Michael R Chester, Lijia Chen, Dimitris Tousoulis, Juan Carlos 
Kaski. St George's Hospital Medical School, London, UK. 
Complex coronary stenoses are associated with progression to 
acute coronary syndromes and adverse outcome. Whether this is the 
result of predominantly local or systemic factors is controversial. We 
assessed whether, within the same coronary tree, the progression of 
angiographic complex lesions (CL) and smooth lesions (SL) differs in 
clinically stable coronary artery disease. We studied 50 consecutive 
male patients who underwent two angiograms: the 1st one at study 
entry and the 2nd 11±2 months later. All the patients had chronic 
stable angina at presentation and symptoms had remained unchanged 
at 2nd angiogram. All patients had at least 1 CL (uneven or 
overhanging edges, ulceration or thrombus) and 1 SL (the absence of 
any of CL features) >30% diameter reduction in different arteries at 
the first study. Automated edge detection (CAAS) was used to 
determine the change in absolute lumen diameter and % stenosis 
reduction. 
Results (mean ±SD) 
Morphology 
Smooih 
Complex 
% stenosis 
1st angi0l.ram 
49.2 ± .60 
61.1 ± 12.2 
% stenosis 
2ndangiorr 50.5 ± L 
66.8 ± 14.0 
pValue 
NS 
0.006 
These results show that complex lesions progress more rapidly than 
smooth coronary stenoses even in the same coronary tree. This 
observation is consistent with the view that CL morphology 
represents a more active phase of the disease, and that local factors 
may playa major role in progression of complex stenoses. 
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959·21 
The Importance of Criterie Selected to Def."e Pro- end RegreSSion In 
Anglogrephic Intervention Trials. 
J. Wouter Jukema, Ad J. van Boven, Egbert T. Bal, Otto E.H. Sartorius, 
Feikje M. van Rappard, Johan H.C. Reiber, Kong I. Lie, Albert V.G. 
Bruschke on behalf of the REGRESS study group. 
Interuniversity Cardiology Institute, Utrecht, The Netherlands 
REGRESS is a placebo controlled multicenter study to assess the affect 
of 2 yr treatment by pravastatin on pro- and regression of 
angiographically documented coronary artery disease in patients with a 
serum cholesterol between 160 and 310 mgldl (4-8 mmol/ll. Analysis of 
baseline (BI and follow-up (FUI coronary arteriograms is performed 
visually and by quantitative computer analysis (OCA-CMSI. OCA-results 
in 253 patients who received solely medical or PTCA therapy (the PTCA 
segments were excluded for this analysisl are here presented. In 2189 
coronary segments we analyzed the changes in mean segment diameter 
(MSOI vs changes in obstruction diameter (001 in the same segments 
with a diameter·stenosis :!! 20% at B. 
Results: 
For all segments the mean MSO decreased from 2.80 to 2.71 mm and 
the mean 00 decreased from 1.92 to 1.87 mm. An overview of changes 
in MSO vs 00 for the individual segments is presented in the figure 
below. 
i I o .• 1~----t--;-;'-;"-:--
i ~'+-'-'''''' ".', 
• ... l·~·"""-'.':"iL ... ':-"I~-'----1 
I 
0W«lf IN IIENI SEmoIENT OIAMElER (tAl.) 
Conclusion: In general there is good agreement between pro- and 
regression determined by changes in respectively MSO and 00. However, 
in a substantial number of cases the results are divergent. This may 
considerably affect the results of intervention trials. 
959·22 
Determinants of Lumen and Plaque Changes After Balloon 
Angloplasty: A Quantitative Ultrasound Study. 
Jose Baptista. Carlo dl Mario, Yuklo Ozaki. Pim de Feyter, Peter de Jaegere. 
Jos RTC Roelandt, Patrick W. Serruys. Thoraxcenter. Erasmus University, 
Rotterdam, The Netherlands. 
In order to assess the mechanisms of action of balloon angioplasty (PTCA) 
and the determinants of lumen gain. 48 patients were studied with 
Intravascular ultrasound before and after PTCA. Ultrasound was used to 
measure the stenosis minimal lumen cross sectional area (LA) and area 
Inside the extemal elastic membrane (EEMA). Plaque area (PA) was defined 
as the difference between EEMA and LA Plaques were classified as soft 
(predominance of low echogenic material with an arc 01 calcium < 90 
degree) or hard (calcium ~ 90 degree or predominance of highly echogenlc 
material). The presence 01 a relatively dlsease·free wall was defined as a 
minimal wall thickness of stenosis ~ 0.6 mm. 
Results 
LA (mmt) 
EEMA(mmt) 
PA (mm2) 
Pre-PTCA 
1.85 ±0.55 
15.99±4.75 
14.13±4.76 
Post-PTCA 
4.73 ±1.42 
17.31 ±4.83 
12.56±4.38 
p value 
<0.0001 
<0.0001 
<0.005 
The more concentric lesions showed a higher LA gain and PA reduction (LA 
gain of 3.4 ± 1.0 mmt vs 2.0±1.0 mmt for lesions with or without disease•
free wall. respectively, p<0.005; PA reduction: 3.0±4.2mmt vs 0.1 ±2.4mmt, 
p<O.OOl). No differences In LA or PA changes were observed between soft 
and hard plaques. 
Conclusions: LA gain after PTCA Is the combined resUt 01 vessel wall stretch 
and plaque compression. The presence 01 a disease-free wall prevents an 
effective plaque compression during balloon inflation resulting In a lower LA 
gain and plaque reduction. 
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959·23 
Quantitation oC Coronary Collateral Flow Velocity by Anatomic 
Pathway in Patients 
Thomas J. Donohue, Richard G. Bach, Eugene A. Caracciolo, 
Thomas Wolford, Morton J. Kern, Frank V. Aguirre, Marilyn 
Cauley, St. Louis University, St. Louis, MO 
Angiography poorly quantitates and cannot characterize phasic flow 
patterns in collaterally supplied vessels. Collateral flow arising from 
different anatomic pathways has not been compared in patients. To 
quantitate collateral flow based on different anatomic pathways, we 
measured retrograde intracoronary spectral Doppler flow velocity 
(0.018" Doppler guidewire) in 45 patients at PTCA. Pre-PTCA 
collaterals were graded by traditional angiographic criteria (0-3) and 
by anatomic pathway: epicardial (BPI); intramural (IM); septal 
(SEP) or acutely recruitable (AR). Retrograde mean (MY) and peak 
(pY) velocities, and peak velocity integral (pYI) were 
determined: (mean+SDl. ·p<O.Ol vs EPI 
Collateral Pre-PTCA MY PY PYI 
Path (n) % Sten cm/sec cm/sec units 
EPI (6) 89±12 34±12 59±19 25±1O 
1M (11) 89±1l 16±9' 26±14' 8±3' 
SEP (23) 94±12 16±8' 28±12' 9i6' 
AR (5) 84+9 lar 22+6" HZ" 
Additionally, EPI collaterals had predominantly biphasic flow 
patterns (5/6) while 1M, SEP and AR were predominantly mono•
phasic (36/39, p<O.OI). Traditional angiographic collateral grading 
did not correlate with retrograde flow velocity. The anatomic 
pathway was an important determinant with the BPI pathway 
having the highest collateral flow velocities, and typical epicardial 
artery biphasic flow. Differences in collateral flow velocities by 
conduit type may contribute to variations in ischemic thresholds in 
patients with similar angiographically graded collaterals. 
959·24 
Ultrasonographic Assessment of Peripherat Artery Morphology in 
patients with Angina Pectoris. Gender Differencies and Relation to 
Clinical Risk Stratification. 
Claes Held, Inge BjOrkander, Lennart Forslund:Paul Hjemdahl, Nina 
Rehnqvist; Dept of Internal Med, Danderyd Hospital, 'Dept of Clin 
Pharmacology, Karolinska Hospital, Stockholm, Sweden. 
Peripheral arterial wall morphology was assessed with uHrasonography in 
376 patients in an ongoing long term prospective study in patients with 
stable angina pectoris. The carotid and femoral artery on the left side was 
studied with an Accuson (7.S MHz transducer) at the time of inclusion. 
Vessel lumen and intima-medial thickness (IMT) were measured. The 
patients were stratified into low, medium or high risk based on age >60 
years, signs of left ventricular dysfunction and suspected multi-vessel 
disease based on the exercise ECG. Women had smaller lumina in both the 
carotid (S.81.±0.70 vs 6.71±0.88 mm;p<O.05) and femoral (8.6Q±1.11 vs 
10.09±1.48 mm;p<O.OS) arteries. IMT was also significantly lower in the 
carotid (0.77.±<J.24 vs 0.B4.±0.28 mm;p<O.05) and the femoral (1.03.±0.S9 vs 
1.27±0.66 mm;p<0.05) arteries. Patients who were classified into high risk 
had greater IMT than those classified as low risk patients in both the carotid 
(0.87.±0.27 vs 0.76±0.24 mm;p<O.05) and the femoral (l.34.tO.66 vs 
0.99±0.S3 mm;p<O.05) artery. The carotid vessel lumen was also greater in 
the high risk patients (6.56±0.98 vs 6.22±0.B4 mm;p<O.05) than those in the 
low risk group. 
Conclusion: High risk according to a clinical risk stratification was associated 
with increased intima· medial thickness in the carotid and femoral arteries. 
This probably reflects the degree of atherosclerosis. If this finding carries 
prognostic information will be elucidated in the long term follow·up. 
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959·25 
Racial Di.ff.Hnc.. ill l170cardial I.cheaia aDd 
COronary rl_ .... n. in Hypert.naion 
Jan L. Houghton, L • Michael Prisant, Albert A. 
Carr, Nancy C. Flowers, Martin J. Frank, Albany 
Medical college, Albany, NY and Medical COllege of 
Georgia, Augusta 
African Americans (AA) cOlllpared to Caucasian 
Americans (CA) appear to have a higher case 
fatality from coronary heart disease (CHD) but 
lesser amounts of atherosclerosis. This paradox 
may be explainable by intrinsic or acquired racial 
differences in coronary arteriolar vasoreactivity. 
This study investigated racial differences in 
coronary flow reserve (CFR) and thallium test 
(THAL) ischemia in hypertensive left ventricular 
hypertrophy (LVH) among 91 AA and 81 CA without 
significant coronary stenosis. 
-LVH(ECHO) +LVH(ECHO) 
M CA M g 
N 3S* SS* 53* 23* 
LVMI(g/m2) 94+14* 87±lS* 146±42 138+32 
ABN THAL 31\ 38% 59' 39'-
CFR 4.4±2.3* 4.l±2 3. 2±1. 3* 3. 6±1. 5 
N=number, LVMI= indexed left ventricular mass 
calculated using echocardiographic M-mods 
measurements, ASN= abnormal, *p<O.OS 
In AA but not matched CA with LVH, CFR dropped 
significantly (p=O.OOS) associated with a marked 
increase in number of ABN THAL tests. 
Conclusions: Development of LVH in hypertension 
carries greater physiologic morbidity for AA 
compared to CA possibly secondary to differing 
adaptations of the coronary microcirculation. This 
study suggests that non societal factors may 
contribute importantly to excess morbidity in AA 
with CHD. 
959·44 
Effect of Fructose-1,6-diphosphate(FDP) on 
Exercise Performance and Left Ventricular 
Function in Patients with Stable Angina 
Pectoris 
*Yong Li, Rui-hong De.i, Sbou-yi Wang,Zi-XWl 
Hang Huashan Hospi\al; Shanghai, P.R .China 
415A 
The effects of FDP{F) and placebo{P) were 
evaluated in 16 pts with stable pectoriS using 
a double-blind, crossover trial design. After 
\heir angina was stabilized in 1-2 weeks,the 
pts were randomly assigned to sequence group A 
or B. Group A received a P intravenous (iv )in•
fusion 2 times dAlly for 7 days and then F iv 
infusion 2 times daily for 7 days. Group B 
received the same treatment in the reverse 
order. Treadmill exercise test and radionuclide 
angiography(RNA) were performed before and on 
the last day of P or F treatment. Compared with 
baseline (B) and P, F had no effects on resting 
and peak exercise heart rate, systolic blood 
pressure and rate-pressure product but could 
improve exercise duration(51H52(B} ,508:!:,56(P) 
vs 557+61 (F) sec., p~O.01. tiIDe to onset of 
angina-(504±60(B). 509:!:,55(P) vs 557±61{F)sec., 
p'<0.01) time to ST depression exceeding 1mm 
(328:!:,51 (B), 335+48(P) vs 403,:t58{F)sec •• p< 0.05 
and time to iflalUmal ST depression (4E9+41 (B) • 
473!54{P) vs 575±63{F)sec •• p<0.05). respec•
tively. And RNA shown that a higher L'V 
ejection fraction(0.54+O.02(B) , 0.55+O.03(P) vs 
0.58+O.03(1). p,<0.05) as well as peak filling 
rate t2 .18+0.13 (B) 2.12+0.14 (p) vs 2.50+O.19(F) 
EDC/s. -p<C5'.05). These data indicated tli8.t F 
~ould iriip-rove the "exercise perfo):'mahce and _ 
left ventricular function to a certa-in -extent 
1il the pt~ _wJ.th stable angina .pectoris. 
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959·45 
Effeeta of • New Calcium Channel Blocker In Pltlants with Stsble Angina 
Pectoris 
Ad L. Baloc. Ernst E. van der Wall. Shimon Braun. Hakan Emanuelsson. 
Isaac Kobrin. Albert V. Bruschke. on behalf of the trial participants. 
Department of Cardiology. University Hospital Leiden. the Netherlands 
Ro 40-5967 is a new calcium channel blocker. which has a high 
bioavailabity in a once daily dosage and does not induce reflex 
tachycardia or negative inotropy. In a randomized. multicenter placebo•
controlled study 126 patients (pts) with chronic stable angina pectoris 
(AP) were treated with 25. 50. 100 and 150 mg dosages of Ro 40-5967 
to evaluate its effect on exercise dur.tlon. anginal and silent ischemic 
episodes. Prior to study entry. anti-anginal medication was discontinued. 
After a one week placebo run-in period (baseline). pts were randomized 
to two weeks of active treatment or to placebo. In both periods. exercise 
tests and Holter-monitoring were performed. 
The five groups did not differ for gender and age. The differences in 
outcome between week 2 and baseline (BL) were the following: 
Week 2 - BL: placebo 2S mg 50 mg 100 mg 150 mg 
duration (sec)" 40±67 60±78 46±72 83±60+ 94 ±85 + 
time to sn (sec)" 20±68 26±69 72±116 104±100+ 116±94+ 
time to AP (sec)" 36±76 43±76 85±101+ 98±79+ 98±79+ 
silent ischemia (no) 1.5±6.2 0.3±2.4 -1.0±3.4 -3.H3.7 -6.1±7.1 
silent ischemia (min) 29±69 -3±6 -30±59 -23±47 -77±67 
• lineair trend test p~ 0.005; +: p~ 0.05 
A maximal dose related decrease in heart rate to -6.4 ± 10.1 bpm and 
systolic blood pressure to -6.9 ± B.2 mmHg was noticed. The adverse 
events were mild and transient in nature: dizziness (7.1 %) and 1 st degree 
atrioventricular block (7.1 %) were most often reported. 
In conclusion. Ro 40·5967 is a new safe calcium channel blocker in pts 
with chronic stable angina. It prolongs exercise duration in a dose•
dependent fashion. and decreases anginal and silent ischemic episodes. 
959·46 
The Antllschemlc Eff8cts of Perlndoprllat are More Pronounced In 
P.tlenla with Aaymptollllltic LV Dysfunction Than In Tho.. with 
Normal LV Function. 
Louis Bartels, Willem J. Remme, Martin van der Ent, Ad van den Hewel, 
Dick Kruijssen, Sticares Foundation, Rotterdam, The NeIher1ands. 
Recent studies (SOLVO and SAVE), Indicate that ACE-inhibitors sig•
nificantly decIUse ischemic events in pts with LV dysfunction, which 
contrasts with negative findings in patients with exen:ise-induced angina 
and, generally, a normal ventricular function. To _Iuate whelhar base•
Hne LV function mey affect the antiischemic properties of ACE-inhibitors, 
14 untreated, normotensive mele pis with exercise-induced angina wiIh•
cui signs of heart failure undeIwent 2 Identical, incremental pacing stress 
tests, 45 min befOle (T1) and 15 min after (T2) 0.5 mg Intravenous perin•
cIoprilat, while fasting and supine for 2 hrs bafore the study. Seven pts 
had asymptometic LV dysfunction (D) defined as ejection fraction <40%, 
and 7 had normel LV function (N). At baseline, both groups were c0m•
parable as to age, severily of coronary lesions and hemodynamic and 
neurohumoral variables, except for contractility ryce,J, IlIIaxation (Tau) 
and stroke woli< index, which were diminished, and cardiac norepineph•
rine releese, which was increased by 51% in in 0 compared to N. During 
T1, the rate pressure product, coronary flow, ST depression and lactate 
production were similar In both groups. However, meen arterial pressure 
and arterial norepinephrine Increased 57% and 24% more in 0 than in N. 
During T2, following perindoprilat, ST depression was 0.73 and 0.38 mV 
less in 0 and N. resp. Also, in 0, LV end diastolic pressure was signifi•
cantly reduced by 67% but not in N. Furthermore, whereas in N myocar•
dial lactate production was similar in T1 and T2, in 0 lactate production 
during T1 (-1%) was pnavented and had changed to normal extraction 
during T2 (+11%) (p<O.05). Moreover, the increase In arterial norepin•
ephrine during pacing was reduced by 74% In 0 VI 33% in N, whereas 
systemic resistance was 252 d.s.em" less in 0 VI only 39 d.s.em" in N 
during T2, as compared to T1. Thus, the antiischemic effect of perindo•
prilat is more pronounced In pis with asymptomatic LV dysfunction than 
in pis with a normel LV function, which mey relate to more extensive 
neurohormonal activation and systemic vasoconstriction and subsequent 
modulation by perindopriilt in the first as compared to the latter. 
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959·47 
Transmyocardial Laser Revascularization 
M_ Mirhoseini, M.D., D. Sc., F_A.C.C., Mary 
M. Cayton, R.N., B.S.N. & S. Shelgikar, M.D., 
F.A.C.C., Heart & Lung Institute, St. Luke's 
Medical Center, Clement Zablocki VA Center, 
Milwaukee 
An investigational treatment for patients with 
ischemic heart disease is being evaluated. 
C02 laser energy is used to create transventri•
cular channels. Perfusion occurs from the 
blood supply in the ventricular cavity through 
the channels to the ischemic areas. Suitable 
candidates are those with diffuse disease or 
those not candidates for aorto-coronary bypass. 
Exposure is through a left thoracotomy. Screen•
ing includes cineangiogram, nuclear studies, 
and perfusion scans. Viable myocardium must 
be demonstrated. Exclusion criteria include 
ejection fraction less than 15%. overt conges•
tive failure. or inability to withstand thora•
cotomy. Laser pulses are synchronized with 
the EKG and are from 45-60 msec. Penetration 
is verified by transesophageal echocardiogram. 
Post operative evaluation of all parameters 
is done at 3 month intervals and then annually. 
In a group of 20_patients follow_up ranges 
from 1/2 to 9 mos. In all instances angina 
class improved immediately, from class III 
or IV to O. Nuclear & perfusion studies show 
improved wall motion & increased perfusion 
in previously ischemic areas. Preliminary 
conclusions are that this method improves myo•
cardial perfusion. relieves angina and improves 
performance and quality of life in these 
R~ti~n~~~de§~rther studies and long term follow 
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960·48 
Beat-to-Beat Hemodynamics Durlnll Atrial Fibrillation: 
Observations In Normal and Impaired Left Ventricular Function 
Athanase Dritsas, Francesco Ciaramella, Celia M. Oakley. Petros 
Nihoyannopoulos. Dept. of Medicine. Clinical Cardiology, Hammersmith 
Hospital, RPMS. London, UK. 
To examine beat-to-beat changes in left ventricular (LV) stroke volume and 
diastolic filling during atrial fibrillation (AF), we used 2-D and Doppler 
edIocardiography to study 30 patients (pis) (age 63±12 yem) with AF (duration 
>6 months). LV function was normal in 15 pIS and impaired (fractional shonening 
<25%) in 15 pts. Pulsed-wave Doppler recordings of transmitral and LV outflow 
tract velocities were used to calculate LV stroke volume and time-velocity integiai 
of the early filling phase (E) on a beat-to-beat basis. In all parameters measured 
beat-ta-beat variability was expressed as coefficient of variation (standard 
dcviation/mean value-expressed as %, over at least 7 consequtive beats). 
Mean age was similar between pts with normal LV and those with impaired 
LV function (62±13 vs 65±12 years, respectively. p=ns). Left atrium was dilated 
in both groups however, the atrial size was not different between the two groups 
(49±9 vs 48±7 mm, p=ns). LV end-diastolic diameter was greater in pts with 
impaired LV function (59±7 mm) than normal LV function (48±4 mm) (p<O.OI). 
Mean RR interval was not different between the two groups (814±165 vs 744±120 
ms, p=ns) neither was beat-to-beat variability in RR interval (16±6 vs 17±7 %, 
p=ns). Beat-to-beat variability in stroke volume was greater in the group with 
impaired LV function (13±8 %) compared with normal LV function (7±4%) 
(p<O.05). However. beat-to-beat variability in time-velocity integral of E was 
similar between normal and impaired LV function (19±13 vs 23± 12 %. p=ns). 
Beat-to-beat variability in suoke volume did not correlate with beat-to-beat 
variability in the preceding-RR in the normal LV function group (r=O.42, p=ns), 
however in pts with impaired LV function this correlation was significant (1)=0.55, 
p<O.05). 
We conclude that in patients with AF and impaired LV function there is 
greater dependence of suolce volume on the preceding-RR interval compared with 
normal LV function. This finding can not be explained fully by the variation in 
LV filling with different preceding-RR intervals (Frank-Starling mechanism). 
Other faclots like calcium ion handling by the diseased myocardium may be 
responsible for this phenomenon. 
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960·49 
In Older Patients with Normal Ejection Fraction, High Relative 
Wall Thickness is Associated with Reduced Systolic Pump 
Performance and Depressed Myocardial Contractile Function 
Gerard P. Aurigemma. Michael Mclaughlin. Robert McGinn. Roben S. Lind. 
Andrea Sweeney. William H. Gaasch. University of MassachusetlS Medical 
Center and the Medical Center of Central MassachusetlS. Worcester 
Massachusetts. 
Some older patienlS with concentric left ventricular hypertrophy (L VH) develop 
congestive hean failure (CHF) despite normal ejection fraction (EF). presumably 
due to diastolic dysfunction. However the effect of increased relative wall 
thickness (RWT ~ .45). on systolic pump performance and myocardial fiber 
function in older pIS has been less well studied; we therefore detennined LV end 
diastolic and end systolic dimensions (Dd. Ds) and volumes (Yd. Vs). stroke 
volume index (SVI). and cardiac index (CI) in 74 pIS with normal EF. All pIS 
were free of valvular disease and focal wall motion abnormalities. Diastolic RWT 
was defined as the ratio of LV wall thickness to chamber radius. Pump function 
was characterized by SVI. Myocardial fiber function was determined as midwall 
shortening (FSmw-%) using a cylindrical two-shell model which does nOi assume 
uniform wall thickening; shonening was related to systolic circumferential stress 
(ac). In Group I (RWT ~.45. n=47). mean age was 74 ± 5; in Group 2 
(RWT<.45. n=27) mean age was 74±6. FSendo=% endocardial fractional 
shoncning. Dala are mean ± SEM; '=p<O.05 
1M y'd 
Gr I 42±1' 81±4' 
Gr 2 50±1 I 25±6 
.s.Y.l liE Q 
32±1' 68±1 2.6±.2' 
46±3 66±2 3.5±.1 
~~ 
38±1 17±.5' 
37±1 19±.6 
~ 
67±4' 
89±5 
In Gr I the low FSmw. which cannot be attributed to afterload excess. indicates 
decreased myocardial contractile function. RWT was inversely related 10 SVI and 
CI (r=.66. and r=.45. respectively. p<.OOO5 for both). The low SVI. likely due 10 
small chamber size. was not offset by increased heart rate in these older pIS. 
resulting in a low-normal CI; in 33% of Gr.1 pIS. CI was < 2.2 Llmin. These 
data indicate reduced pump performance. A subgroup of 18 Gr I pIS who had 
L VH (elevated LV mass index by Framingham criteria) also had significant 
decreases in SVI. CI. and FSmw compared with the 9 Gr 2 pIS with L VH. Thus 
while increased RWT is commonly associated with diastolic dysfunction in older 
pIS. our data indicate a previously unrecognized abnormality in systolic pump 
performance and myocardial function. despite normal EF. 
960·50 
Effect of Age on Left Atrial Systolic Function, Stroke 
Volume and Work 
*Harisios Boudoulas, Elizabeth Sparks, Kwame Osei, *Charles 
F. Wooley, The Ohio State University, Columbus, Ohio 
The effect of age on left ventricular and aortic dynamics 
have been extenSively studied, but its effect on left atrial (LA) 
energetics has not. 
LA stroke volume (volume at atrial systole • P wave on 
electrocardiogram • minus LA minimal VOlume), ejection 
fraction (LA stroke volume/LA volume at atrial systole), A 
wave velocity, and kinetic energy (LAKE), were measured from 
the biplane area-length method and transmitral flow using 
echo-Doppler techniques in 87 normal subjects with an age 
range from 4 to 71 years. LAKE was obtained from the 
formula 1h myZ, where m=LA stroke volume x 1.06 (blood's 
specific gravity) and v = A wave velocity. 
Correlations were found between age and LA stroke volume 
(r=.61), age and A velocity (r=.58), but not between age and 
LA ejection fraction (r=.03). Thus, LA stroke volume and A 
velocity increased gradually with age, but LA ejection 
performance remained relatively constant in a wide range of 
age. LAKE, index of LA work, increased dramatically with age, 
from 2.0 dyne· em • 103 at age 4, to 30.0 dyne· cm .103 at age 
70 (Figure). The data indicate that, with increasing age, 
- ~ . ., higher LA work is required to maintain 
" .! LA stroke volume and ejection fraction. 
'. Increased LA work with increasing age 
.... may lead to atrial myopathy and atrial 
arrhythmias frequently present in elderly 
population. 
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960·51 
Recovery of Right Ventricular Function Following Lung 
Transplantation and Possible Relationship to Pre-op Diagnosis. 
David Leibowitz, Marco Di Tullio, Larry Schulman, Carlton McGregor. 
Renee Weslow, Mark Ginsburg. Robert Michler, Craig Smith, Shunichi 
Homma. Columbia University, New York, N.Y. 
Single or double lung transplantation (LTx) is increasingly utilized as 
alternative therapy for patients with end-stage lung disease refractory to 
medical therapy. Many centers consider right heart failure a 
contraindication to L Tx, however the effect of LTx on right ventricular 
function (RVFx) as well as the variables that may detennine such effect, 
are not well characterized. From 58 patients who underwent L Tx at our 
institution, we identified II patients (8F, 3M. mean age 32.0± 13.3 yrs.) 
with abnonnal RVFx detected by 20 echocardiography prior to transplant 
and compared those studies with 2D studies perfonned post-transplant 
(mean time 6.5 ± 6.0 mos.). Seven patients had primary pulmonary 
hypertension (PPH), 3 had COPO, and I had idiopathic pulmonary 
fibrosis. Right ventricular end-diastolic area (EDA), end-systolic area 
(ESA), and percent fractional area change (FAC) were measured in the 
apical four chamber view. Results are as follows: 
EDA(cm2) 
ESA (cm2) 
FAC (%) 
En; 
24.1 ± 8.5 
20.3 ± 6.6 
21.9 ± 6.3 
&!S1 
17.9±4.3 
12.3 ± 3.0 
35.9 ± 8.9 
bm 
< 0.02 
< 0.01 
< 0.01 
Patients with PPH exhibited a greater trend towards RVFx 
improvement compared to others (AFAC 21.9% vs. 1.5% ;p=0.09). 
Conclusions' 1. As an overall group, patients with right ventricular 
dysfunction pre-LTx exhibit a significant degree of improvement post•
LTx. 2. The degree of improvement may depend on the patient's 
underlying pulmonary pathology. 
960·86 
Exercise Capacity and Cardiac Performance After Heart 
Transplant: Importance of Chronotropic Incompetence. 
Laurence A. Conway, John J. Smith, James E. Udelson, Debra 
Kinan, Ann Turbett, Lori Kilcoyne, Marvin W. Kronenberg, 
Marvin A. Konstam. Tufts University, New England Medical 
Center, Boston, MA. 
Exercise capacity is known to be limited after orthotopic cardiac 
transplantation (Tx). To detennine the mechanisms responsible, we 
compared radionuclide LV end-diastolic volume (EDV) and end•
systolic (ES) V during rest and maximaJ cycle exercise in 3 groups: 12 
Tx patients [37 ± 22 (SD) months post-Tx]. 31 patients with CHF 
(L VEF 22 ± 7%), and 7 normals_ 
~ (*:p<O.OS; #:p<O.OOOI vs normals): 
HR syst BP EDV ESV stroke V syst BP I 
(min-I) (mmHg) (m1/m2) (m1/m2) (mI/m2) LVESV 
Normals 70±8 119±12 72±16 29±9 43±9 4.S±1.4 
Tx 84±IS* 134±16* 70±11 32±10 38±8 4.6±1.5 
CHF 82±14* 118±2S 162±54# 13Q±S2# 33±10* 1.1±0.5* 
Compared to nonnals, Tx patients had marked reduction in exercise 
time (p<O.OOOI)(nonnals: 22±2; Tx: 9±3; CHF: 8±4 min) and in 
cardiac index response (p<O_OOOI)(normals 3_0 to 8.3; Tx: 3.1 to 4_8; 
CHF: 2.6 to 3.8 Vmin/m2), despite physiologic increase in LV 
systolic function and stroke volume. HR response was markedly 
blunted in Tx patients, as in CHF patients. 
Maximal exercise (*:p<O.OS; #:p<o.OOOI vs normals for l!. from rest): 
l!.HR !J.Syst BP l!.EDV l!.ESV l!.stroke V syst BP/ESV 
Normals t84±11 tS3±14 tS±4 ,S±3 tll±4 8.6±3.8 
Tx t23±16# t43±23 t2:t9 '6±S t8±8 7_6±2.4 
CHF t31±16# t26+17· t3±11 '2±12 tS±lO· l.3±0.S# 
Conclusions: In patients with cardiac Tx, exercise capacity is 
markedly impaired to a degree similar to patients with CHF, despite 
physiologic augmentation in LV contractile function and stroke 
volume. Limitation in cardiac output during exercise is associated with 
severe chronotropic incompetence. 
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960·87 
Right and Len Ventricular Diastolic Function at Rest and 
Exercise in Pulmonary Hypertension 
Mary Seidlitz, Mark Nootens, Christopher Wolfkiel, 
Elizabeth Kaufmann, Stuart Rich, University of Illinois at 
Chicago, Chicago, Illinois 
Biventricular diastolic interactions during exercise in pts with 
RV dysfunction and normal LV has not been characterized. 
We studied 8 pts with primary pulmonary hypertension 
(PPH) with ultrafast cr using contrast enhancement at rest 
and during supine bicycle exercise. LV and RV end-diastolic 
volumes were determined by tracing the endocardial borders 
of each ventricle at every level. Global measures of peak 
filling rate (PFR) in cc/sec, and time to peak filling rate 
(tPFR) in msec were determined from volumetric analysis 
acquired at 17 frames per second. When compared to 
normals, RV·PFR (2.3.±..54) was reduced 21%, and RV•
tPFR (239.±.39) was increased 46%. LV·PFR (1.8.±..6) was 
reduced 45%, and LV-tPFR (145.±.10), was increased 16%. 
LV filling was more impaired than RV filling (p=.04). With 
exercise, RV-PFR increased 18% (2.6.±.1.3), and RV-tPFR 
fell 24% (182.±.44), LV-PFR increased 22% (2.2.±.1.2) and 
LV-tPFR fell 24% (145.±.10). LV filling remained more 
impaired than RV filling (p=.04). We conclude that pure 
RV pressure overload results in biventricular diastolic 
abnormalities which appear to affect LV more than RV, 
both at rest and with exercise. Abnormal interventricular 
septal geometry is presumed to be the primary cause. Some 
symptoms of PPH (orthopnea, dyspnea), may be explained by 
LV diastolic dysfunction. 
960·88 
Enhanced Left Ventricular Function After Long Term Continuous 
Positive Airway Pressure Treatment of Sleep Apnea 
Sven-Olof Strtlmblad, Jan Hedner, Milan Lomsky, BOrje DarptI, Kenneth 
Caidahl, Divisions of Cardiology, Clinical Pharmacology and Clinical 
Physiology, Sahlgren's University Hospital, Gothenburg, Sweden 
As we have observed patients with the obstructive sleep apnea syn•
drome (OSAS) to have LV hypertrophy, and to be symptomatically im•
proved by continuous positive airway pressure (CPAP) treatment, the 
aim of the present study was to investigate whether CPAP improves 
cardiac function in OSAS patients. Thus, we examined the cardiac ef•
fects of 2 years of nightly CP AP treatment in 9 patients (8 men, 1 
woman) with moderate to severe OSAS, but no signs of heart failure. 
Echocardiography and equilibrium radionuclide angiography 
(ERNA) were performed at rest and LV ejection fraction (EF) was also 
obtained during supine exercise (L VEFex). Although only 4 patients 
were hypertensive before CP AP, 7/9 had increased septal thickness and 
LV mass. Long term CP AP reduced daytime and night-time markers of 
sympathetic activity by 3O-S0% (plasma and urinary catecholamines), 
but did not significantly reduce LV hypertrophy. Pre-treatment eleva•
tion of atrial contribution to right ventricular (RV) and LV filling did not 
decrease significantly after CPAP treatment. However, the Doppler 
early (E) LV filling velocity increased as did ERNA LV peak filling rate 
(pFR), see table. L VEF increased within the normal range but LVEFex 
did not change. Systolic RV function remained unchanged. 
l!il~iDl: Atl!:i: CfAf f-nlue 
Doppler E (m/s) O.5OiO.04 0.68±O.18 <0.02 
PFR (LVEDV Is) 2.1±0.2 2.5±{).2 <0.05 
LVEF("Io) 65.3±4.0 72.00.8 <0.02 
LVEFex(%) 74.9±2.S 74.8±2.3 ns 
BYEE(Zol jfj.J+--J a jfj,lWl D~ 
Thus, 2 years CP AP treatment of OSAS seems to enhance systolic LV 
function within the normal range, and to reduce diastolic LV 
dysfunction in spite of remaining LV hypertrophy. 
lACC February 1994:1A-484A 
960-89 
RIGHT VENTRICULAR FUNCTION IN OBSTRUCTIVE SLEEP APNEA. 
*Amanullah Vazir, Greg Schwartz, Jeffrey Nahmias, Monroe 
Karetzky Newark Beth Israel Medical Center Newark, New 
Jersey 
Right ventricular dysfunction (RVO) has been demon•
strated with obstructive sleep apnea (OSA). The purpose 
of this study was to examine the characteristics of RVO 
in patients with OSA and to determine the therapeutic 
efficiency of nasal continuous positive airway pressure 
(nCPAP). The patient population sample was stratified 
into three groups: 1) OSA with RVO (n=51) 2) OSA without 
RVO (n=65) and 3) control (n-10). The patients underwent 
all night polysomnography (PSG). MUGA scans were also 
performed to assess both right and left ventricularfunc•
tion. OSA was defined as an apnea plus hypopnea index 
(AHI) of 10, RVO as right ventricular ejection fraction 
of ~39% and left ventricular dysfunction (LVO) as left 
ventricular ejection fraction (LVEF) 455%. 
A comparsion of patients with OSA with RVO and 
patients with OSA and no RVO revealed that group 1 
patients had significantly lower LVEF (56 vs 63 p~.OOl). 
There were differences in their percentage ideal body 
weight (%IBW), disordered breathing event (DBE) indices, 
age, awake Pa02, PaC02 or spirometry. All but three 
patients with RVO had either awake alveolar hypoeventi•
lation or severe OSA (AHI~40). 
Follow-up of patients with RVO after treatment with 
nCPAP (n=7) for 6 to 24 months revealed improvement in 
their RVEF from 30.4% to 38.9% (p ~.(5) and LVEF from 
58% to 62% (p :7 .(5). No significant change in body 
weight. 
In conclusion, patients with OSA have a greater in•
cidence of RVO than previously suggested and benefit from 
nCPAP with significant improvement in RVO. 
960·90 
Right and Len Ventricular Systolic Interaction at Rest and 
Exercise in Pulmonary Hypertension 
Mark Nootens, Elizabeth Kaufmann, Christopher Wolfkiel. 
Stuart Rich, University of Illinois at Chicago, Chicago, 
Illinois. 
Interventricular systolic interactions during exercise in pts 
with RV dysfunction and normal LV has not been 
characterized. We studied 16 pts with primary pulmonary 
hypertension (PPH) with ultrafast cr using contrast 
enhancement at rest and during supine bicycle exercise. 
Stroke volume (SV in ml) and ejection fraction (EF) were 
computed from differences in end-diastolic volume (EDV) 
and end-systolic volume. Cardiac output (CO in L/min) was 
computed as SV x heart rate. At rest RVEDV was increased 
(215.±. 72) and RVEF was reduced (31%.±. 8) compared to 
normals. LVEDV was reduced (80.±. 31) while LVEF was 
normal (66%.±. 9). RVSV (65 .±. 26) was greater than 
L VSV (54.±. 25) due to tricuspid regurgitation resulting in 
a RV regurgitant fraction (RF) of 17%. With exercise CO 
remained constant (4.0 to 3.9, p=ns). while RVEF fell (26% 
.±. 10, p=.08), and RVRF increased to 33% (p=0.05). 
LVEDV also fell (52.±. 22, p=.OO2), but LVEF remained 
constant (65 .±. 15) in spite of reduced filling. The inability 
of pts with PPH to increase CO with exercise appears due to 
exercise induced RV failure. In contrast, LV contractility 
becomes enhanced but severe underfilling of the LV results 
in a limitation of SV. 
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960-91 
Dlfferenliallmpact of Right Ventricular Pressure.nd Volume Overload 
on Left Ventricular Ejection Fraction 
Eric K louie, Steve S. Un, Sandra I. Reynertson, Bruce H. Brundage, 
Sidney Levttsky, Stuart Rich, Loyola Unlv Med Clr, Maywood, IL & Unlv of 
Illinois, Chicago, IL 
Both RV volume ovel1oad (RWO) and RV pressure overload (RVPO) shift 
the ventr1cular septum leftward distorting LV geometry. In RWO due to 
tricuspid regurgttation, ~ ~ septai shift is associated wtth 
depression in LV ejection fraction (LVEF). This study was performed to 
assess the effects of ~ ~ septal shift due to RVPO on LVEF. 10 
previously reported pts wtth severe TR following tricuspid valvuIectomy for 
isolated tricuspid valve endocardttis were studied as a model 01 isolated 
RWO. 10 pts wtth severe RVPO due to primary pulmonary hypertension 
were compared to the pts wtth RWO to examine the differential Impact of 
isolated RVPO and RWO on LVEF and LV diastolic filling In pts wtthout 
overt LV pathology. LV end diastolic volume (LVEOV) and LVEF were 
measured by biplane modified Simpson's rule applied to echocardiographic 
short axis and four chamber views. Transmttral pulsed Doppler flow 
velocities were recorded to evaluate LV diastolic fdling. Whereas LVEF was 
<50% In 4/10 RWO pIS, it was <50% In only 1/10 RVPO pIS: 
LVEF (%) LVEOV (ml) A/E %A 
RVPO 56.±.5 48.±.26 1.66.±..98 49+16 
RWO 51.±.4 84.±.26 0.56.±..20 24±10 
p <.05 <.01 <.005 <.0005 
Oesptte lower LVEDV in RVPO pts than in RWO pts, LVEF was better 
preserved in RVPO than In RWO. The ratio of the atrial systolic to early 
diastolic (A/E) peak transmitral flow veloctties was greater in RVPO pts than 
in RWO pIS. Similarly the percent of the total transmttral flow veloctty 
Integral attributable to atrial systole (%A) was greater in RVPO pts than in 
RWO pts. Conclusions: Oesptte relative underf~ling of the LV in RVPO pts, 
LVEF Is higher In Isolated RVPO than In RWO. End ~ compression 
of the LV due to leftward ventricular septal shift in RVPO may contribute to 
this preservation in LVEF. ~ ~ compression of the LV in RWO 
may attenuate the atrial systolic component of LV fUling which plays an 
Important compensatory role in LV f~ling in pts wtth RVPO. The differential 
timing of LV geometric distortion In RVPO and RWO may explain, In part, 
the greater preservation of LVEF in RVPO pts compared to RWO pts 
960-92 
Role of Pericardial Constraint for Right Ventricular 
Function at Different Right Ventricular Afterloads. 
Wolfram Burger, Martin Straube, Koppany Sarai, Michael 
Behne, Lothar Eckel, Friedheim Beyersdorf, Martin 
Kaltenbach. Departments of Cardiology, Anesthesiology, and 
Thoracic Surgery, University Hospital, Frankfurt, Germany. 
Pericardial constraint of the right ventricle in man is still 
questioned. Therefore, right ventricular (RV) volumes were 
measured using a new Swan-Ganz thermodilution catheter in 
20 patients, 59±8 years old, during coronary bypass surgery. 
Angiographically determined left ventricular ejection fraction 
was 67±8 %. Right atrial pressure (substituting RV diastolic 
pressure) and RV end-diastolic volume index were used to 
construct RV pressure-volume relations before and after 
pericardiotomy, both before (control) and during increased 
RV systolic pressure (from 25±4 to 39±S mmHg) by partial 
compression of the pulmonary artery (PA compression) 
(Figure). Pericardiotomy by itseH did not significantly change 
the investigated parameters. However, after pericardiotomy 
the RV diastolic pressure-volume relation was shifted signifi· 
cantly rightward 
when PA compres· 
sion was applied 
(Figure). 
i8 
E 
-S7 
..... before ptJricard;otomy 
0-43 after pericardiotomy 
~ n.S. PA compression 
!: P<005[~~.. ]-_ 
:s 4 
o control 
1: ~ ~3~ ~ ~ ~ ~ ~ 
RV end-diastolic volume index (ml m o ,) 
Conclusion: With 
increasing levels of 
RV afterload peri· 
cardial constraint 
significantly in· 
fluences RV dias•
tolic function in 
man. 
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960-93 
Comparison of the Impact of Exercise on Left Ventricular Filling 
in Normal Subjects and Patients With Dilated Cardiomyopathy 
Ian P. Clements, Wayne L. Miller, Mayo Foundation, Rochester, MN 
To assess the effect of exercise on left ventricular (LV) filling in 
dilated cardiomyopathy (DCM), supine exercise radionuclide 
ventriculography was perfonned in 18 nonnal volunteers and 
12 patients with DCM (NYHA Class II-ill) without significant 
coronary artery disease. LV ejection fraction (EF), peak filling rate 
(PFR, end-diastolic volume/sec), end-diastolic volume index 
(EDVI, mlIm2), heart rate (HR, beat/min), and systolic blood 
pressure (SBP, nun Hg) were measured at rest (R) and at a moderate 
exercise (EX) level (Table). 
NORMAL PATIENTS 
R EX R EX 
EF .63±.09 .70±.09 .27±.09* .24±.U* 
PFR 3.5+.85 5.7+1.6 1.7+.49* 2.2±.79* 
EDVI 83±23 92±23 185±98* 194±93* 
HR 79±15 118±12 83±21 107±14t 
SBP 122+15 159±30 124±24 146±21 
METSI - 4.7±1.0 - 2.6±O.6* 
I = Metabolic equivalents of exercise; * p:5 .0002 and t p :5.03, 
nonnal vs DCM 
DCM patients compared to nonnals showed, per MET of 
exercise, significantly reduced increments in EF (-.005 vs .014, 
p=.OO4) and PFR (.16 vs .49, p=.OO4) with similar responses in 
EDVI, HR, and SBP. 
Therefore, these data indicate that the impaired exercise capacity 
of DCM is not only related to LV systolic dysfunction but also to 
restricted diastolic function. 
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961-94 
Tlie Clinical Utility and Limitations of Stored Electrograms in 
Determining the Appropriateness of Implantable Cardioverter•
Defibrillator Therapy 
Marc Roelke, Sean S. O'Nunain, Tom G. Trouton, Stefan Osswald, 
Hasan Garan, Jeremy N. Ruskin, Massachusetts General Hospital, 
Boston,MA. 
The aim of this study is to assess the utility and limitations of 
intracardiac electrograms (ICECGs) stored by Implantable Cardio•
vener-Defibrillators (ICDs) during an arrhythmic event. 
From 9/89 through 12/92, 93 patients received the Ventritex 
Cadence® lCD, which stores intracardiac ventricular ICECGs and de· 
tects arrhythmias by rate criterion. Over a mean of 16 months (range 2-
42),595 electrogram recordings were stored (mean 6/pt, range 0·36). 
Using clinically available data and ICECGs recorded during real time 
telemetry and noninvasive programmed stimulation, it was detennined 
that anti-tachycardia pacing (ATP) or cardioversionldefibrillation 
(CV ID) was appropriately delivered for ventricular tachycardia 1 
fibrillation (VT/VF) in 359 (60%) episodes. CVID was withheld 
appropriately for nonsustained events in 9% of episodes. A total of 
69% of therapy was therefore appropriate. 
Inappropriate therapy included A TP or CV /D for sinus tachycardia 
and atrial fibrillation in 108 episodes (18%). Inappropriate therapy for 
lead noise, non sustained VT, or excessive autogain leading to multiple 
counting occurred in 15 episodes (2%) and was reliably diagnosed only 
with the use of ICECGs. Pseudotennination of VT by ATP (transient 
VT slowing) occurred in 19 events (3%) and could only be diagnosed 
from ICECGs. In 45 cases (8%), the arrhythmia leading to therapy 
could not be detennined with certainty even after review of 
ICECGs. 
Conclusions: I) about 70% of ICD therapy is appropriate, 2) ven· 
tricular ICECGs are valuable in diagnosing the appropriateness ofICD 
therapy, and 3) despite the availability of ventricular ICECGs, 
approximately 8% of arrhythmias remain indetenninate. 
420A ABSTRACTS 
961·95 
"Stored Electrograms" Accuracy in Arrhythmia 
Classification and Clinical Value in Cardioverterl 
Defibrillator Therapy 
·Pitschner H. Friedrich, Neuzner Joerg, Sack Stefan, KOnig 
Stefanie, Schlepper Martin, Kerckhoff·Clinic, Max·Planck•
Society, Bad Nauheim, Germany 
"Stored electrograms" (SEG) of spontaneous arrhythmia 
episodes (SAE) is the most recently introduced data storage 
option in cardioverter/defibrillator (ICD) therapy. The 
accuracy in arrhythmia detection and the clinical value of 
SEG were evaluated in 56 consecutive ICD·patients (pts) 
(mean age: 59±9 years; mean LVEF: 30.7±7%). 
lCD-pulse generators capable of recording SEG via the 
ICD.shocking leads (VENTAK P2IPRX2, CPI) were 
implanted with patch/patch (n=12), and with 
nonthoracotomy (n=44) electrode systems. Detectable p. 
waves and changes in QRS morphology served as. SEG 
criteria to distinguish supraventricular from ventricular 
arrhythmias. . .. . 
During a mean follow-up of 8.4 months 335 SA~ initiating 
electrical therapy were recorded in 27 pts (ICD-dl~charges: 
n=223; antitachycardia pacing: n=112). The analys.ls ~f SEG 
provides an accurate classification of the arrhythmia In each 
case: in 254 SAE (75%) ventricular tachyarrhythmias were 
present; in 83 SAE (25%) i!,adequa~e ICD-thera~y occurred 
due to atrial tachyarrhythmla or device oversenslng (1.8%). 
Reprogramming of the lCD, guided by SEG was done In 
16/27 pts. 
The high accuracy in arrhyt~mia classificati<?n qualifies SEG 
as a valid method to establish the appropriateness of ICD•
therapy. Correct device reprogramming, avoidance of 
unnecessary shocks, and the immediate identification of 
ICD-oversensing are important clinical advantages. 
961·96 
Specificity of Algorithms used by Implantable Devices for 
the Detection of Ventricular Tachycardia 
Francis D. Murgatroyd, Mark H. Anderson, Katerina Hnatkova, Xie Baiyan, 
A. John Camm, Marek Malik, St. George's Hospital, London, UK. 
Atrial fibrillation (AF) is the commonest cause of inappropriate vr 
therapy by modem cardioverter-defibrillators (ICDs). Current vr 
recognition algorithms are based on all or most of a given number of RR 
intervals being less than the "tachycardia detection interval" (TOI). 
To examine the specfficity of these algorithms, we analysed 44 24-hour 
ECG recordings containing spontaneous episodes of AF, and 31 
containing spontaneous episodes of vr. After automated analysis with 
manual editing on a commercial Holter system, files were derived listing 
the rhythm and RR interval of each beat in the recording. 482 episodes of 
AF and 260 episodes of vr, each ~ 24 beats in duration, were identified 
and challenged with algorithms at different settings. At each setting, the 
specificity was calculated at the TDI required for a given sensitivity:-
Specificity at 
99% sensitivity 
-rylj I! 
:~' ~ri!~ 20%1 10%1 
O%B 10 12 14 1B 1B 20 22 
We conclude that: tachycardia detection windows of >20 beats do not 
significantly improve specificity, but that allowing even one interval to 
exceed the TDI results in a significant loss of specificity. 
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961·97 
Errects or Bipbasic Sbocks on Electrogram Amplitudes Using a 
New Integrated Bipolar Transvenous Dual Cbamber Defibrillator 
Electrode System 
Werner lung, Matthias Manz, Peter Accorti, Rainer Moosdorf* Michael Piel, 
Torsten Bauer, Thomas Korte, Berndt Lilderitz. Depts. of Cardiology and 
·Cardiovascular Sur~ery, University of Bonn, Gennany 
There has been concern over the use of integrated bipolar endocardial defibrillation 
electrodes in their ability to adequately sense post shock sinus rhythm and 
ventricular fibrillation (VF). The purpose of this prospective study was to evaluate 
the effects of biphasic shocks on wideband (1.5 - SOO Hz) integrated bipolar 
electrograms using the EnGuard Ph lead system and Guardian 4211 ICD with 
automatic sensitivity tracking (Telectronics Pacing Systems). The lead system 
consists of two integrated bip10ar fixation leads (RV and atrial 1 lead). The RV lead 
has an intra-electrode separation of 23 Mm. Wide band atrial and ventricular 
electrograrns from 22 inductions of VF were recorded and digitized at 2000 
samples/sec. A computer program was used to perform digital high pass filtering 
for each complex. Values (expressed as mean+/-SD) were recorded at baseline sinus 
(BSR) prior to shock application, during initial and redetection of ventricular 
fibrillation, and at sinus rhythm 5, 10,20,30, and 60 s after shock delivery. 
Results: Peak 10 Peak Filtered Slew rate R width 
Amplitude (mY) Amplirude (mV) (dV/dI) (msec) 
BSR: 10.0+/-1.4 5.6+/-1.5 3.5+/-1.1 14.2+/-6.7 
5s: 8.1+/-1.4· 3.6+/-0.8' 1.9+/-0.3· 45.5+/-19.9· 
lOs: 8.9+/-1.9 4.7+/-1.0' 2.2+/-0.6' 35.0+/-18.9· 
20s: 9.3+/-1.7 5.3+/-1.1 2.4+/-0.6· 28.4+/-17.9' 
30s: 9.1+/-1.7 5.2+/-1.3 2.5+/-0.8· 26.3+/-16.4' 
60s: 9.6+/-1.6 5.1+/-1.6 2.7+/-0.8 18.2+/-11.3 
lnitial VF: 7.7+/-2.8 6.7+/-2.6 
RedeL VF: 2.4+/-0.5 2.0+/-0.7 ('p<O.05) 
Conclusions: 1. Minimal post shock R wave attenuation was observed 
immediately after defibrillation shocks. No significant post shock R wave reduction 
was documented after 5 seconds. 2. Care must be taken in inteIpreting electrogram 
amplitudes from high pass filters due to filter reduction of the electrograms. 3. In 
all patients, aulomatic sensitivity tracking successfully detected the arrhythmia with 
no undersensing. 
961·107 
Effects of Defibrillation Shock on Ventricular excitability In Man: Is 
High Output Post-deflbrillation Bradycardia Pacing Clinically 
Necessary? 
John C.L. Yu, Michael Lauer, Hingson M. Chun, Chariie Young, 
L. Bing Liem, Anand Munsi!, Jan Peterson, Linda anoboni, Auey 
J. Sung, Stanford University, Stanford, CA. 
It has been shown from cellular preparations that the 
pacing threshold (PT) and cell membrane action potential 
duration (APD) are Increased post-electrical Shock. Accordingly 
most IlT1llantabiB Cardiovertor Defibrillators (ICD) have post•
shock pacing programmed to high outputs. We studied 11 
consecutive patients (mean age: 59 yrs) undergoing follow-up 
ICD studies. The post-shock PT (at 500 ms cycle length), 
effective refractory period (EAP) and APD as measured using 
Monophasic APD recordings at 50% repolarization (MAPD50) 
and 90 % repolarization (MAPD90) were examined: 1) ERP 
decreased from 260 ±20 to 221 ±25 ms [p<0.01), 2) MAPD50 
decreased from 214 ± 18 to 183 ± 29 ms [p<O.01), 3) MAPD90 
decreased from 316 ± 75 to 231 ± 63 ms [p<0.01), 4) PT at 13 ± 
6 post-shock did not change signfficantly (0.24 ± 0.08 vs. 0.28 ± 
0.13s mAl [p>0.1) wnh pulse width constant at 2.0 ms. Systemic 
levels of epinephrine showing norepinephrine a trend towards 
post-Shock increase were noted. No pts exhibned any clinical 
evidence of ischemia during the study. 
Thus, there are no signfficant changes in the effects of 
electrical shock on ventricular PT in human subjects wnh an 
intact autonomic nervous system. Contrary to vHro studies, therB 
was a decrBased post-shock ERP, which could be partly 
explained by the accollllanying decrease in APD both at the 
plateau (MAPD50) and complete repolarization (MAPD90) 
phases. We conclude that there is no need to use high output 
bradycardia pacing as H may unnecessarily shorten the longevity 
of ICD and may pose increased risk of proarrhythmia post shock 
in this subset group of patients. 
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961·108 
Ventricular Fibrillation Ind Polymorphic Ventricular TlchYCIrdla With 
CrltlCiI Coronary Stenolll: II Bype .. Surgery Enough? 
Andrea Natale, Jasblr Sra, Boaz Avltall, Abdul Wase, Kathl Axtell, Anwer 
Dhala, Sanjay Deshpande, Mohammad Jazayeri, Cheryl Maglio, Masood 
Akhtar, Sinai Samaritan Medical Center, MUwaukee, WI 
Previous studies have suggested that coronary artery bypass surgery 
(CABG) Is sufficient to prevent recurrence 01 sudden death In patients (pts) 
with critical coronary artery stenosis presenting with ventricular flbrUlation 
(VF) or polymorphic ventricular tachycardia (VT). In 58 pis (age 63 ± 
8 years) wtth 1 or more episodes 01 sudden death associated with 
documented VF or polymorphic VT and severe operable coronary artery 
disease, a defibrillator (ICD) was Implanted at the time 01 CABG. Eighteen 
out of 58 patients had no evidence or previous myocardial Infarct and 50 
pts had Inducible sustained ventricular arrhythmia Including ventricular 
fibrillation, monomorphic and polymorphic ventricular tachycardia. Mean 
EF was 37 ± 13% and mean follow-up 4.6 ± 2 years. SUIVivaI curves 
generated Including total death and sudden plus cardiac death were 
compared with the projected survival based upon ICD discharge preceded 
by syncope, presyncope, or ECG documented VT fVF. 
2 years 
3 years 
4 years 
Total Death 
83.6% 
81.5%* 
76.6%* 
*p < .05;t p < .01 
Sudden + Cardiac Death 
92.8%* 
92.8%t 
92.8%t 
Projected Survival 
n.2% 
67.6% 
62.0% 
EF lower than 30% and Induction 01 arrhythmias with S2, S3 versus S4 
were Independent predictors for ICD discharge. None 01 the remaining 
variables Including age, gender, number 01 bypasses, and type of 
arrhythmias Induced were predictive for death and occurrence of shocks. 
Conclusion: a) In pts wtth VF and polymorphic VT CABG does not 
protect from recurrence oIlHe-threatenlng arrhythmias and, b) as In our 
population ICD Implant may have signHicant impact on survival. 
961·109 
Changes in Cerebral Parfusion During ICD Tasting 
"Igor Singer and Harvey Edmonds, Jr., University of Louisville, Louisville, 
KY 
Third generation implantable cardioverter-defibrillators (lCDsl provide 
tiered therapy for ventricular tachycardia (VT) and ventricular fibrillation 
IVFI. Presently, therapy prescription does not take into account the 
hemodynamic consequences of ventricular dysrhythmias. Ouantitative 
EEG (OEEGI, transcranial Doppler (TCD) and transcranial oxymetry (TO) 
were shown previously to provide sensitive and specific measures of 
cerebral perfusion. The time for TCD to return to baseline has been 
shown to correlate with OEEG indices of cerebral ischemia. Cerebro•
vascular reactivity (CVRI was defined as the number of beats for TCD to 
return to baseline. To test the usefulness of these techniques for 
assessment of end-organ perfusion during induced VT and VF 19 con•
scious patients (ages 36-72 years) were tested in the EP laboratory. 4 of 
19 patients were tested in supine and 70° upright tilt. VT was induced 
by using the implanted ICD. Electrocardiographic, continuous arterial 
pressure, OEEG, TCD and TO were recorded simultaneously. 
91 hypotensive episodes (HTEsl were observed, which lasted 2 to 97 
seconds. In 66 HTEs s 15 sec. the immediate CVR was 2 beats, i.e. the 
time required for the TCD to return to the baseline peak velocity. 
However, in 25 HTEs > 15 sec. a delayed CVR response was noted 
which averaged 20 beats. The percent increase in the CVR was signi•
ficantly longer (p< .011 for the delayed vs immediate CVR (58±35% vs 
35 ± 24%1. Loss of alpha power on OEEG occurred in 25 HTEs > 15 sec., 
but not in HTEs s 15 sec. Ischemia did not persist > 30 sec. These 
changes were exaggerated in the erect posture during tilt table testing 
resulting in loss of cerebral autoregulation. A fall in transcranial 
oxyhemoglobin saturation was measured by TO from the mean of 61 % 
at baseline to 57% during VT, and 64% post HTEs. 
These data suggest that TCD, OEEG and TO are sensitive and specific 
indicators of cerebral perfusion. Combined techniques may be used to 
evaluate hemodynamic sensors and to optimize ICD programming for 
future "intelligent" ICDs. 
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961·110 
Relationship Between Right and Left Ventricular Hemodynamics During 
Sustained Ventricular Tachycardia in Humans 
Theofilos Kolettis, "Sanjeev Saksena, Philip Mathew, Ryszard Krol. 
Eastern Heart Institute, Passaic, NJ 
Hemodynamic parameters are being evaluated for automated sensing 
& treatment algorithms in implantable cardioverter-defibrillators but the 
relationship between RV & LV indices is unknown. We examined RV & 
LV systolic & diastolic function during ventricular tachycardia IVT] in 9 
pts, mean LV ejection fraction [LVEF] 24.±.8%, who had peak systolic 
pressure ISP]' end-diastolic pressure IEDP], + dP/dT & -dP/dT 
measured simultaneously during 11 hemodynamically stable or unstable 
induced VT episodes, mean cycle length 283 ms. Mean data for sinus 
rhythm [NSR] was compared to the 10th & 40th VT beats & % mean 
change over the initial 80 beats (VT801 was analyzed. Bnl!!a: 
Parameter ~ VT10 VT40 llilllihl 
LVSP(mmHgl 132+23 51 +9' 52+19' -57 
LVEDP(") 24,±,10 27±9 29±7 +26 
RVSP(") 37.±.6 26 + 8' 26 + 7" -26 
RVEDP("I 9.±.8 17-:;:-9 15-:;:-7 + 74 
LV + dP/dT(mmHg/sl 1063.±.304 450.±.135· 433.±.212· -55 
RV +dP/dT(") 353.±.136 248+ 111 273 + 113 -28 
LV -dP/dT(") 1100.±.315 358-:;:-135' 373-:;:-192' -64 
RV-dP/dT("1 291+175191-:;:-96186-:;:-70 -39 
• p< .005 as compared to NsR. LV -dP/dT was directly related to peak 
LVSP during VT (r = .74; p < .003). LVSP decreased more significantly 
than RVSP during VT with a limited correlation (r=.67; p=.06). This 
relationship was stronger for RV & LV +dP/dT (r=.69;p=.031. LVEF & 
VT morphology did not correlate with RV or LVSP. Regression analysis 
weakly correlated LVSP with RVSP (r =.47) & RV -dP/dT (r = .43) 
during VT. RVEDP in NSR correlated with RV diastolic parameters 
during VT (p< .02). Conclusions: 11 RV & LV systolic pressure & 
function decline with VT onset. 2) Impaired relaxation occurs at VT 
onset & maintains RV & LVEDP. 3) Impact of VT on systolic RV or LV 
function is directionally similar but often unequal. Prediction of L VSP 
from pressure indices alone is difficult. 4) ICD algorithms will need to 
be modified based on hemodynamic sensor location. 
961·111 
Epicardial Mapping Demonstrates a Predictable Arrhythmia 
FoUowiog Unsuccessful Transvenous Defibrillation Near Threshold 
·Patrick D. Wolf, Gregory P. Walcott, William M. Smith, Raymond E. 
Ideker Duke Universiry, Durham, NC 
It has been shown that epicardial activation immediately following 
failed shocks near the defibrillation threshold (OfT) is significantly more 
organized than before the shock. We mapped the epicardium after 
transvenous defibrillation shocks near the DfT to detennine how con•
sistent and predictable these wavefronts were across shocks and animals, 
and to detennine how long the organization lasted. Five 25 kg pigs were 
studied. The heart was exposed and placed in a pericardial cradle. A 510 
electrode sock made with 1.5mm diameter silver beads with approximately 
4mm interelectrode spacing was pulled over the apex of the heart and 
sutured to the pericardium. A defibrillation catheter was placed in the 
RV apex with a second catheter in the SVC. Biphasic, 6/6 ms, defibrilla•
tion shocks were given in accordance with an up/down D fT protocol. 
Activation patterns following 19 (4 each from 4 pigs and 3 from 1 pig) 
failed shocks were recorded and analyzed by animating the first derivative 
of the electrograms. 
In all cases the fitSt three post-shock activations originated from the 
LV apex or posterolateral wall; in general, opposite and inferior to the 
RV catheter. The fitSt beat appeared an average(range) of 72(37-124) ms 
after the shock and spread from apex to base activating the base of the 
RV last. The second beat originated 228(161-363) ms after the shock and 
followed a similar pattern to the fitSt with some regions of block in the 
RV which did not lead to reentry. The third beat emerged 381 (287-
573) ms post-shock and broke into multiple fronts as it encountered refrac•
tory tissue. On the third and successive beats reentry into the early site 
led .to continuous activation of the epicardium and subsequent fibrillation. 
Thus, for unsuccessful transvenous defibrillation shocks near the DfT, 
there is a window of at least 287 ms during which the arrhythmogenic 
region of the heart is stable and predictable. This result suggests the p0s•
sibility that an intervention timed appropriately after the shock could inhi•
bit or block these early activations. 
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961-112 
Refractory Period Extension for Monophasic Versus 
Blphsslc Shocks 
• Robert J. Sweeney •• Robert M. Gill •• Philip R. Reid 
Lilly Research Laboratories. Eli Ully and Company. Indianapolis. IN 
Electrical defibrillation may be related to a shock's ability to 
prolong tissue refractoriness. To better understand the action of 
biphasic waveforms. we compared the refractory period extension 
(RPE) produced by monophasic (M) and biphasic (B) shocks in four 
pentobarbital anesthetized dogs (18.6 ± 3.0 kg). All shocks were 
rectangular current pulses delivered across stainless steel disk 
electrodes on the RV base and LV apex. M shocks were 10 msec long 
and B shocks had a 6 msec first phase followed immediately by a 4 
msec second phase of equal intensity. RPE was measured during 
ventricular pacing (300 msec Bel) by using a series of training 
stimuli and a premature stimulus. The refractory period was first 
measured while a M shock was delivered 10 msec after the last 
training stimulus. The refractory period was then re·measured 
while M or B shocks were given 15. 30 or 45 msec before the end of 
the first refractory period. RPE was the increase in refractory 
period due to the shocks at the 15. 30 or 45 msec timing. Shock 
currents were adjusted to produce voltage gradients of 4. 8 or 12 
~ : Its/cm at the measurement site. RPE results were (mean ± SO 
-15 msec -30 msec -45 msec 
4 V/cm M 19 ± 7 12 ± 13 7±7 
B 14 ± 6 9±6 4±4 
8 V/cm M 45 + 9 26 + 6 15 + 4 
B 29 + 6· 17 + 6· 10 ± 3· 
12 V/cm M 56 ± 13 34 ± 9 22 ± 7 
B 40 ± 17 • 25 ± 7 • 16 ± 4 • 
(. p ~ 0.05 for B * M. paired t-test) 
We conclude that the B shocks consistently produced less RPE than M 
shocks with the same duration. timing and intenSity. This finding 
suggests that the increased defibrillation efficacy of B shocks is not 
due to increased RPE for the B waveforms. 
962 Radionuclide Imaging-New Tracers and 
Viability Assessment 
Wednesday, March 16, 1994 3:00-5:00 PM 
Georgia World Congress Center, Hall H 
Presenting Hour: 4:00 PM 
962-113 
Myocardial Tc-99m 0-12 (TechneCardTM) Clearance il not Affected by 
Ischemia and Reperiusion in an Isolated Perfused Rat Heart Model 
Gerald Johnson III, Kiem N. Nguyen, Iantha L. Alton, J. Michaellauinger 
and Robert D. Okada. W. K. Warren Medical Research Institute of the 
University of Oklahoma Health Sciences Center and Cardiology of Tulsa, 
Tulsa, OK 
Previous studies have shown no difference in Tc-SSm 0-12 myocardial 
clearance in low flow and hypoxic hearts compared to controls. The 
purpose of this study was to determine whether a greater insult 
produced by a noflow-reflow model would result in alterations in 
myocardial Tc-SSm 0-12 clearance. 
~: Following a 1 mCi bolus injection, myocardial clearance was 
monitored for 1 hour using a Nal detector in 13 isolated, perfused rat 
hearts. In S control hearts (C), flow was maintained at 12 ml/min 
throughout uptake and clearance. In 4 hearts (R) 30 min of no flow was 
followed by 65 minutes of reflow. Tc-SSm 0-12 was injected 5 minutes 
post-reperfusion. 
~ Tc-SSm 0-12 myocardial clearance was biphasic in both 
groups. No significant difference in myocardial clearance between the 
groups was observed for the early rapid phase lasting from 1 to 10 
minutes. Fractional clearances during the slow late phase (from 10 to 
60 minutes post-injection of Tc-SSm 0-12) were not found to be 
significantly different between the groups (S.4 ± 1.4% (C) vs. 8.5 ± 1.5% 
(R); p = ns). Electron micrographs of the reperfused hearts revealed 
predominately intact cells and cellular organelles with minimal injury 
evident compared to control hearts. 
Conclusions: Even under the more severe conditions of noflow-reflow, 
Tc-SSm 0-12 myocardial clearance is unaltered and is minimal from 10 
to 60 minutes. Thus, Tc-99m 0-12 should be an excellent imaging 
agent for tomographic imaging and should provide stable images over 
time even in situations of severe transient ischemia. 
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962-114 
BKS181321 Accumulation in Iachemic Myocardium aeflects 
the Severity of Ischemic Insult 
Mark Berman, H.W. Strauss, A. Nunn, Mike Gilson, Dan 
Levine, Henry Gewirtz, Rhode Island Hospital, 
Providence, R.I. and Bristol Myers Squibb Research 
Institute, Princeton, N.J. 
Although, nitroimidazole compounds (NIC) are known 
to accumulate in hypoxic tissue, there are only limited 
data available concerning the extent to which NIC's 
accumulate in ischemic myocardium. This study tests the 
hypothesis that the degree of retention of Tc-99m•
BMS181321 (BMS) , a NIC, in ischemic myocardium relates 
to severity of ischemia. Five pigs (Group (GP)-l) had 
80% stenosis of left anterior descending (LAD) coronary 
artery and moderate ischemia induced by rapid atrial 
pacing plus IV norepinephrine infusion X30 min. BMS 
(30mCi IV) was given at 10 min of ischemia and the pig 
sacrificed 1-2h later. GP-2 (N=3) had balloon occlusion 
(XIO min) and 60-90 min reperfusion of LAD. BMS was 
given IV 40s prior to occlusion. 
In this stenosis model myocardial blood flow 
(ml/min/g) increases vs control in both endocardium 
(ENDO) and epicardium (EPI) during ischemia (ENDO = 
0.85±0.28; [MEAN±SD] to 1.05±0.17; [P=O.ll] and EPI 
1.31±0.36 to 2.10±0.56; P<.Ol). Despite increased flow, 
however, lactate consumption at control (0.21±0.20; 
mmoles/min/l00g) changes to production at both 20 and 
30 min of stress (-0.21+0.39 and -0.35±0.26; both 
P<.05); thereby confirming ischemia. 
Hearts from both groups were breadloaf sliced and 
imaged on the face of a gamma camera.In GP-l(demand is•
chemia) LAD zone BMS activity exceeded that of CX zone 
in 4/5 pigs (LAD:CX count ratio=1.21±0.10; (N=4) 
P<.05) .In GP-2 LAD:CX count ratio (2.87±0.38; (N=3) 
P<.05) was 2X greater than GP-l.Thus, BMS is a sensi•
tive biochemical indicator of myocardial ischemia whose 
cardiac retention reflects severity of ischemic insult. 
962-115 
Quantitative SPECT Tc99m·Sestamibi Provides an 
Accurate Assessment of Infarct Zone Collateral Flow: 
Experimental Validation 
Michael Y. H Shen, QingXin Shi, Donald P. Dione, Michael J. 
Singer, Robert Fettennan, Frans 1. Th. Wackers, Barry L. Zaret, 
Albert J. Sinusas. 
Yale University, New Haven, CI' 
The extent of myocardial injury during acute myocardial infarction 
is critically dependent on collateral flow (CF). Quantitative Tc-99m 
Sestamibi (MIBI) SPECI' imaging has been proposed for noninvasive 
assessment of CF during coronary occlusion. however, the reliability 
and optimal approach for assessment of CF with ~I .SPI?CI' 
remains undefined. We perfonned SPECI' MIBI nnagmg m 7 open 
chest dogs with pennanent LAD occlusion. Imagin~ was initiated 60 
minutes after i. v. injection of MIBI (30 mCi). Radiolabeled 
microspheres were injected for evB;luation of~. Addition.al SPECI' 
imaging was perfonned on the eXCised heart. ClfCumfe~nl1al profiles 
were generated from in vivo short axis slices (10 ± 1 shceslheart, each 
5mm thick) and compared with postmortem (PM) SPECI' images and 
microsphere flow. Defect magnitude was assessed by integrating the 
area of the defect below a 60% threshold. CF was estimated by 
analysis of the SPECI' MIBI defect nadir belo,",: the 60% thre~ho~d. 
Each heart was sectioned for ganuna well countmg for detenrunal10n 
of myocardial MIBI activity and flow. Average infarct size was 
16±5% LV. There was an excellent correlation (r= 0.99) of infarct 
zone collateral blood flow and myocardial MIBI activity by well 
counting using this quantitative approach among aJI.67 slices 
analyzed. In vivo SPECI' defect area correlated With .PM .def~t 
area (r = 0.76) and the flow deficit (r = 0.74). ~alY~ls of m VIVO 
SPECI' defect nadir provided a beller correlauon With measured 
CF (r = 0.87). ., .. .. 
Thus, defect magnitude can be estimated With m VIVO quan1?tallve 
SPECI' MIBI imaging using a simple 60% threshol~. ~alysls of 
SPECI' MIBI defect nadir provides an accurate norunvaslve 
assessment of collateral flow during coronary occlusion. 
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962·116 
IUI_BMIPP as a Marker of Myocardial Hypoperfusion: Comparison 
to 20ITI by Quantitative Dual Tracer Autoradiography 
Christopher P. Reinhardt, Howard Weinstein, Robin Marcel and 
Jeffrey A. Leppo. U Mass Medical Center, Worcester, MA. 
Radiolabeled fatty acids such as p-methyl•
iodophenylpentadecanoic acid (BMIPP) have unique metabolic 
properties of potential use as myocardial perfusion tracers. 
Accordingly, we compared the in vivo pattern of uptake of BMIPP 
and TI in 12 rabbits. Animals were intubated, ventilated and their 
LV pressures monitored. A left thoracotomy was performed. 
BMIPP or BMIPPfTI were injected IV along with I5Nb microspheres 
(LA) after ligation of a major branch of the circumflex artery and 
in a control group. Tracers were allowed to circulate for 10 min 
before sacrifice. TI (12h) and 1251_BMIPP,85Nb (10-21d) 
autoradiographs were produced from 30pm short axis LV slices. 
Co-mounted TI and ' 251 tissue standards were used to convert 
circumferential LV film intensity profiles to true tracer activity. 
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The area of occlusion was 
determined by the segmental 
I5Nb microsphere content of 
5 contiguous slices. BMIPP 
normal-to-defect contrast 
was then compared to TI. 
BMIPP delineated normal 
from low-flow zones as well 
as simultaneously injected TI 
(Figure) and produced 
comparable activity profiles. 
We conclude that BMIPP accurately delineates areas of 
hypo perfusion distal to a coronary occlusion. 
962·117 
Rest-Redistribution "'Thallium Tomography Ideatifies Viable 
Dysfunctional Myocardinm in Patients With Coronary Artery Disease. 
Pasquale Perrone-Filardi, -Leonardo Pace, Mariella Prastaro, Federico 
Piscione, Sandro Belocchi, -Fiorenzo Squame, -Andrea SoriceUi, -IiMarco 
Salvatore, Massimo Chiariello. Divisions of Cardiology and -Nuclear 
Medicine, "Federico II" University, and IIlstituto "Pascale", Naples, Italy. 
Quantitative '·'thallium (TL) tomography after rest injection has been 
proposed for assessing viable myocardium in patients with coronlllY artery 
disease. To verify its accuracy in predicting functional improvement after 
myocardial revascularization (R), 14 patients (age 61±8 years) underwent, 
while off drugs, TL tomography 20 minutes and 4 hours following a 2-3 
mCi TL injection at rest, and 2D-echocardiography within the same day. TL 
tomography and 2D-echocardiography were repeated a mean of 32±6 days 
after R. TL uptake ~80% of maximal activity was defined as a TL defect. 
Wall motion (WM) was scored from I (normal) to 4 (dyskinesia), and WM 
improvement after R defmed as WM change ~I grade. Normal TL uptake, 
TL redistribution at 4 hours or a mild-moderate ~50".4 of maximal activity) 
persistent TL defect were defmed as TL. viability. Severe «50% of maximal 
activity) persistent TL defects were considered as nonviable myocardium. 
Thirty-eight dysfunctional myocardial segments were identified before R. 
TL viability was found in 32(84%) of them. In 25(78%) of these 32 
segments WM improved after R. In particular, WM improved in all 9 
segments with normal TL uptake before R, in 9(75%) of I2 with TL 
redistribution and in 7(64%) of II with a mild-moderate persistent TL 
defect. In contrast, WM after R improved in 2 (33%) of 6 segments with no 
evidence of TL viability. In segments with abnormal TL uptake before R 
and improved WM after R, TL uptake (% of maximal activity) in the initial 
images was significantly higher (68±9%) compared to that of segments 
where WM did not change (55±17%;p<0.01); after R, initial TL uptake 
significantly increased in the former (74±9%;p<0.01) but not in the latter 
segments (56±17%;p=ns). Thus, quantitative TL tomography after rest 
injection is an effective technique for identifying dysfunctional but viable 
myocardium and for predicting recovery of function after R. 
ABSTRACTS 423A 
962·118 
Functional OUtcome of Mlld-IO-Moderate and Severe Irreversible 
Thallium DefICtl After RevacularlUtlon As AstIIII8d by Magnetic 
ReIonance Imaging 
Abhinav Raina, Stephen L. Bacharach. Brenda M. Jan, Jaetae Lee. 
Arshed A. Quyyumi, Vasken Diisizian, NHLBI. Bethesda, Maryland 
When irreversible thallium (TI) defects on conventional 3-to 4-hour 
redistribution Images are subgrouped according to the severity of 
reduction in TI activity. regions with mild-to-moderate reduction in TI 
activity (51 % to 85% of peak activity) demonstrate greater systolic wall 
thickening (SWT) than regions with severe reduction In TI activity «50% 
peak). To determine the functional outcome of such regions after 
revascularization (rev), we studied 160 regions In 5 pIS with chroniC 
stable coronary artery disease who underwent both TI tomographic 
imaging using a reinjaction protocol and gated magnetic resonance 
imaging (MRI). before and after rev. Mean LV ejaction fraction was 28 ± 
6%. From matched TI and MRI transaxial Images. 80 myocardial regions 
were identified to be abnormal on stress-3-to 4-hr redistribution studies. 
of which 40 had mild-to-moderate reduction in TI activity and 40 had 
severe reduction in TI activity. Before rev, SWT in regions with mild-to•
moderate reduction in TI activity was significantly greater than those with 
severely reduced TI activity (3.6 ± 0.7 vs 2.8 ± 0.4mm, p<0.(01). 
Furthermore, of the 40 regions with severely reduced TI activity, SWT did 
not differentiate among regions that became reversible (20 regions, or 
50"/.) from those that remained irreversible after reinjection (2.8 ± 0.7mm 
vs 2.8 ± 0.6mm. p.NS). After rev. 29 of 40 regions (72%) with mild-to•
moderate reduction in TI activity had significant improvement in SWT 
from 3.6 ± 0.7mm before to 4.4 ± 0.3mm after rev (p<0.01), Among the 
40 regions with severe reduction in TI activity, 12 of 20 (60%) regions 
that were reversible after reinjection showed improvement in SWT from 
2.8 ± 0.7mm before to 3.1 ± O.lmm after rev. In contrast, only 3 of 20 
regions (15%) that remained irreversible after reinjection showed such 
improvement after rev (p<0.008). These findings substantiate our 
previous observation with PET that mild-to-moderate irreversible TI 
defects represent predominantly viable myocardium capable of improving 
after revascularization. 
962-119 
Mechanisms and Implications of Redistribution During 
Dynamic Rest SPECT 1-123 IPPA Imaging 
Joseph Powers, Virginia Cave, Valerie Wasserleben, David 
Cassel, Jaekyeong Heo. Abdulmassih S. Iskandrian, 
Philadelphia Heart Institute, Presbyterian Medical 
Center, Philadelphia, PA 
We previously reported that the presence of 
redistribution by 1-123 iodophenylpentadecanoic acid 
(IPPA) predicts improvement of left ventricular (LV) 
function after coronary revascularization. This study 
examined the biokinetics of 1-123 1PPA using rest dynamic 
imaging in 21 patients (pts) with CAD and LV dysfunction. 
Five sets (8 min each) of 180· SPECT images were obtained 
starting at 5 minutes post injection. The regional 
activity in 4 quadrants in short-axis slices were 
measured from sets 1, 2, and 4, and were used to derive 
clearance rates. The uptake was considered normal if 
activity was ~ 80% of normal area, mildly reduced if 50 
to 79%, and severely reduced if < 50%. There were 45 
segments with normal uptake. 20 with .ild decrease, and 
19 with severe decrease in the initial images. Of the 39 
abnormal segments, 21 (54%) showed redistribution in set 
4. Redistribution was seen in 7 of 20 segments with 
mild, and 14 of 19 segments with severe defects (P -
0.02). A differential washout (WO) ratio was measured in 
abnormal segments (WO of abnormal segment/WO of normal 
segment). Differential WO ratio was significantly lower 
in segments with redistribution than in segments without 
redistribution (14 t 57% vs. 68 t 59 •• P <0.007). Thus. 
reversible defects are COJDDlon in pts with CAD and LV 
dysfunction. Slow clearance in abnormal zones is the 
mechanism of redistribution probably due to reduced & 
oxidation. 
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962·120 
A Multimodality Approacb to Myocardial Viability: DobutamiDe Ecbocardio•
Vapby,lOlTballium SPECT liter Nitrates IDd Nuclear Magaetic ResoDIDCe. 
Carlo Trani, • Alessandro Giordano, Antonella Lombardo, "Luigi Natale, 
"Riccardo Manfredi, Maria L. Finocchiaro, Roberto Patrizi, Giampiero Patrizi, 
'Guido Galli, "Pasquale Marano, Gianfederico Possati, Attilio Maseri. 
Opts. Cardiology, 'Nuclear Medicine"'Radiology-Catholic Univ.- Rome -Italy. 
In order to assess the relative value of 3 different approacbes in myocardial 
viability detecting, we performed Dobutamine ECHO (DE), 10ITballium SPECT 
after Nitrates (NSPECT) and NMR in 12 pts (62±9 yrs) with previou.~ AMI, who 
uoderwent successfuII coronary revascularization (3 PTCA and 9 CABG). 
Before revascularization all patients underwent DE (5-IOJlg/Kglmin), NSPECT 
(2"ITballium rest injection at the end of lsosorbide dinitrate 5 mg iv., with 
imaging 4 hours later) and NMR (Spin-Echo and Cine sequences ECG gated at 
0.5 n. The tomographic slices of each procedure were properly tailored in order 
to best fit the standard 16 segment echocardiographic model. We defined as 
viable all segments A-Dyskinetic at basal ECHO presenting: an improvement of 
wall motion at DE from A-lDyskinetic to Hypokinetic/Normal; Thallium uptake 
~50% of max at NSPECT; diastolic wall thickness ~9.5mm and systolic 
thickening ~30% at NMR. To assess contractile recovery, follow-up ECHO was 
perfonned 41±7 days (range 32-55) after revascularization procedure. 
Results: at baseline preoperative ECHO 53/192 segments resulted A-lDyskinetic 
and 19 (36%) of them became Hypokinetic/Nonnal in the postoperative study. 
Segments correctly identified preoperatively were 11/19 by DE. 13/19 by 
NSPECT. 11/19 by diastolic thickness and 15/19 by systolic thickening at NMR. 
DE NSPECT NMR P 
Diastolic thickening 
thickness % 
Sensitivity (%) 58 68 57 78 ns 
Specificity (%) 73 53 42 71 ns 
Positive Predictive Value (%) 55 46 33 58 ns 
Negative Predictive Value(%) 75 74 42 86 ns 
Conclusions: our preliminary data show no significant differences in identifYing 
viable myocardium in pts with previous AMI. among DE. NSPECT and NMR. 
These results could be relevant in evaluating the costlbenefit of these techniques. 
962-121 
Viability or Sympathetic Nerves Versus Myocytes in Ischemic 
and ReperCused Myocardium 
Shiro Iwanaga, Charles Espy. J. William O'Connell. Elias H. 
Botvinick. John P. Huberty. Michael W. Dae. University of 
California at San Francisco. San Francisco, California 
Regional denervation of myocardium following nontransmural 
infarction has been previously demonstrated, suggesting that 
sympathetic nerves may be more susceptible to ischemic damage 
than myocytes. To test this hypothesis. we performed dual isotope 
autoradiography in eight reperfused rabbit hearts using Tc-99m 
sestamibi (MIBI) to assess myocardial perfusion. and 1-125 
metaiodobenzylguanidine (MIBG) to assess sympathetic innervation. 
Following 30 minutes of circumflex coronary artery occlusion and 60 
minutes of reperfusion, we injected a mixture of 15 MCi MIBI. and 
250 uCi 1-125 MIBG. After 10 minutes. the artery was reoccluded 
and monastral blue dye was injected in the LV cavity to determine 
the area at risk (AAR). Twenty micron thick frozen sections were 
cut from each heart. mounted on glass coverslips, and exposed to 
storage phosphor imaging plates and xray film for one hour (Tc 
exposure). removed for three days to allow Tc decay, and reexposed 
for 24 hours to image 1-125 MIBG. Adjacent sections were stained 
in glyoxylic acid for fluorescence microscopy of sympathetic nerves. 
Phosphor imaging plates and xray film were scanned to form 
digitized autoradiographs of MIBI and MIBG. Defect areas were 
measured from autoradiographs and normalized to AAR. 
Defects were primarily subendocardial. The MIBI defect size 
exceeded the MIBG defect in seven of eight hearts (MIBIJAAR = 
0.48 ± 0.16 vs MIBG/AAR = 0.22 ± 0.16, P = .02), while one 
showed no defects. Fluorescence microscopy confIrmed the presence 
of intact sympathetic nerves in ischemic regions showing MIBG 
uptake. MIBG defects corresponded to regions of hemorrhage, 
implying reperfusion injury. These data suggest that the sympathetic 
nerve endings are more ~to ischemic injury than myocytes. 
Mechanisms leading to denervation in the absence of transmural 
necrosis remain to be explained. 
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962-122 
Noninve.ive Imaging of Left Atriel Thrombi with 
Intrevenou. Admini.tretion of Rediolabeled Annexln V 
Timothy A Dewhurst. Jonathan F . Tail. "Sudhakar Kasina, • John M Reno, Manuel 
Cerqueira and John Stratton. Seattte V~, University of Washington, and NeoRx 
Corp., SeatUe WA. 
This study examined the feasibility of gamma camera imaging of atrial IIlrombi 
using a novel imaging agent, annexin V (AnxV), which is a human protein willl marked 
affinity for activated platelets. Left atrial appendage (LAA) IIlrombi were induced in 13 
operK:hested Yorkshire swine (20-27 kg) by crush injury and injection of IIlrombin and 
ricinoleic acid. A sealed cobaH marker was placed on the LAA and imaged for 
reference. AnxV (200-300 J.I9) was radiolabeled with 1-123 by the lodogen method 
(n=8, 2.14!1.39 mCi injected dose) or Tc-99m by lIle N2S2 preformed chelate method 
(n=5, 11.1!3.8 mCi). Labeled AnxV was injected intravenously a! 20-105 minutes 
(median 60) following LAA crush. A non-specific control protein was co-injected (1·125 
ovalbumin). Planar and tomographic imaging were done for 2-3 hours, after which lIle 
animals were sacrificed, and sectioned specimens of IIlrombus well counted. Total 
LAA IIlrombus weighed 0.()9.1.33 gm per animal. Thrombus activity (countslgmlmin) 
was comoared to finat blood activitv usina a IIlrombusiblood ratio. 
THROMBUSI Labeled Control (ovalbumin) p value 
BLOOD RATIO Annexin 
Average 7.4!5.0 1.2!O.3 0.008 
Maximum 13.3+6.5 1.8+0.7 < 0.001 
The table below shows lIle number of animals in which IIlrombus was visually 
detected over lIle number of animals imaged a! lIlat time point The ratio is the 
counts/pixel of lIle LAA region over lIle counts/pixel of a blood pool background 
'&!lion. These ratios were obtained from imaaes 90 minutes after AnxV administration. 
VISUAL ANALYSIS Hour 1 Hour 2 Hour 3 Ratio 
Planar 1-123-AnxV 0/8 217 214 2.37 
Planar Tc-99m-AnxV 415 415 3/3 2.79 
Tomographic Tc-99m-AnxV 415 5/5 212 2.21 
In conclusion, lIlis study demonstrates lila! 1) radiolabelled AnxV is selectively 
taken up by atrial IIlrombi and 2) in-vivo imaging of atrial IIlrombi is possible after 
intravenous injection of radiolabelled AnxV. 
962-123 
Sillultanecus Biplane To-99m sestamibi First Pass 
~ Us:in;J a Scintillaticn camera with 'Dolo 
Pel:perdiaJlar Detectm:s_ 
E. Gordon DePuey, Helen salensky, steven Mel.an=on, 
Kenneth J. Nichols. st. llIke's-Roosevelt Hospital and 
Co1unilia University, New York, NY 
Generally perfonned in a s:in;J1e anterior or right 
anterior cillique (RllD) view, first pass radicnJCl.ide 
angiocardiOCJI'ClPly (FP) is 1imitai due to its inability 
to evaluate septal and posterior wall JllJtion ~ _ A neiI7 
SPEcr camera with two peIJlerXiic:ular high sensitivity 
detectors l'ICIIoi allows s.iJtul.t:anecus planar RllD and' left 
anterior cillique (lAO) FP_ 'lhirty five patients (pts) 
~o:in;J stress/rest sestamibi SPECI' (22nCi/22nCi two•
day protocol) un::len/ent biplane FP at the time of 
rest:in;J injection. '!he stress SPEcr ilnages (acquired 
with the pt at rest) \Were EX:G-gatai to evaluate rest:in;J 
re:Jional myocardial wall tbickerlin] (Wl') _ By this means 
~ assessed by FP was c::arpared to the preseooe of a 
rest:in;J SPEC!' perfusion defect with a localized decrease 
in wr. 
In 16 pts in whan perfusion and wr \Were nonnal, FP 
showed apical hypokinesis in 1 and was normal in 15. In 
the other 19 pts FP ~ abnormalities \Were associatai 
with perfusion defects with decreased wr in the 
follow:in;J re:Jions: 
ANI' INF AP SEPl' POOl' 
n=12 n=13 n=14 n=11 n=8 
RllD FP ~ abncmnal 12 12 14 
lAO FP ~ abnormal 11 10 
FP ~ was abnonnal in 57 of 58 rest:in;J perfusion 
defects with decreased wr (sensitivity = 98%). Septal 
or posterior ~ abnormalities, =:in;J in 17 of these 
19 pts (89%), \Were detected by lAO FP only. 'lhus, 
s.iJtul.t:anecus biplane FP acx:urate1y detects ~ 
abnormalities frequently missed by s:in;J1e plane RllD FP. 
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963·5 
Continuous Nitroglycerine Therapy Abolisbes now Mediated VuodiIation 
Sbanthi Mendis, George s. Koustas, Willialn H. Baker, Paul A. Sobotka. 
Loyola University Medical Center, Maywood IL 
To examine the hypothesis that nitroglycerine tolerance abolishes flow 
mediated vasodilation (FMVD), FMVD was studied in healthy subjects (C, 
D= 13). patients with coronary artery disease (CAD, D= 13), and patients with 
CAD following >48hours of continuous IV nitroglycerine therapy (CAD+N, 
D=13). The brachial artery diameter (D, em). and peak Doppler velocity (V. 
em/s) were obtained at rest, during max.imaI hyperemia following S min of 
blood flow occlusion (FMVD), and following sublingual nitroglycerine, .O.4mg 
(NTG). Measurements were obtained with a S·IOmHz transducer, 3 cm 
above the elbow. during pulse diastole. Serum cholesterol, glucose and 
amoking history were not significantly different between CAD and CAD + 
NTG. There was no significant difference in resting D. V between groups. 
Results: " change from rest (m ± sd). 
C 
CAD 
CAD + NTG 
.. Change Diameter .. Change Velocity 
..EM.Y!2. NTG FMVD NTG 
14.2±4.7 22.7±S.9 18±2S 21 ±24 
4.1±4.1* 12.9±7.6· 14±26 10±12 
O.9±2.3,,* 1.6±2.9,,* S ± 7 23 ±4S 
* p<O.OOOlvs C; ·p<O.OOSvs C; *p<O.OOOlvs CAD. 
An additional 9 suheets with coronary artery disease were studied 
while on continuous nitroglycerine therapy and > 24 hours after cessation of 
nitroglycerine infusion. Results: " change from rest (m ± sd) 
CAD+NTG(n=9) 2.3±3.1 4.6± S.8 
CAD-NTG(n=9) 8.7±6.0* 16.2±11.S* 
*p<O.OI 
Conclusions: 1) Continuous NTG abolishes brachial artery dilation in 
response to sublingual NTG. 2) Continuous NTG abolishes flow mediated 
vasodilation. 3) Both FMVD and response to sublingual NTG are Ittenuated 
in patients with CAD. 4) The effects of nitroglycerine tolerance OD FMVD 
and response to sublingual nitroglycerine in the brachial artery can be 
reversed by nitroglycerine avoidance. This data suggest that flow mediated 
vasodilation and NTG induced vasodilation occur by similar mechanisms; 
continuous NTG exposure can abolish endothelial mediated vasodilation. 
963-6 
Reduced Coronary Flow Reserve during Exercise 
after H.art Transplantation 
Giuseppe Vassall!, Augusto Gallino, Otto M. Hess, Marco Maggiorini, 
Wolfgang Kiowski, Marko Turina. Hans P. Krayenbuehl. 
Cardiology, University Hospital, Zurich, Switzerland 
Pharmacologic coronary flow reserve (CFR) has been reported to 
be normal early after heart transplantation (HTX). However, CFR 
during dynamic exercise has not yet been evaluated in these patients. 
CFR was determined by parametric Imaging in 6 controls (C; age 
4S±6 years) and 12 patients (age 47±10 years) 24±12 months 
after HTX. Coronary flow was measured in the perfusion bed of the 
left anterior descending and circumflex coronary artery at rest (Rl 
and R2), after 10 mg Ic papaverine (PAP) and during bicycle 
exercise (Ex). Workload was similar In HTX and C (93 vs 107 
watts, respectively; NS) but the rate-pressure product was higher 
In HTX than In C (22298 vs 1740S mmHg/min, p<O.OS). CFR was 
calculated as the flow Index (FI; l/sec) after PAP or Ex divided by 
resting flow: 
1.2 ...-----...,...---------~:__-___, 
,........L... *~----. ,..-l- *-.!t....,--., 
7' 0.9 OHTX (0=24) 
u ec (0-12) 
::; 0.6 * p<O.O 1 
LL 0.3 
o.o..l---===--______ ......:::J::I.:.:::-.. ____ --' 
Rl PAP R2 Ex 
Pharmacologic CFR after PAP was normal in HTX (3.6 ± 1.9) when 
comparod to C (3.7 ± 1.0; NS). Physiologic CFR during exercise was 
iower In HTX (2.2 ± O.S) than In C (4.7 ± 1.6; p<O.OOl). 
Conclusions: Coronary flow reserve in patients with HTX Is 
normal after pharmacologic but reduced after physiologic 
vasodilation. This discrepancy could be explained by the occurrence 
of early vascuiopathy or endothelial dysfunction. 
ABSTRACTS 
963·7 
Effect of Beta-Adrenergic Blockade on Blood Flow to Collateral•
Dependent Myocardium During Exercise. 
Jay H. Traverse, John D. Altman, James Kinn, Dirk J. Duncker, 
Robert J. Bache 
University of Minnesota, Cardiovascular Div. Minneapolis, MN 
Beta -adrenergic receptors have recently been identified in isolated 
coronary collateral blood vessels but their functional significance has 
not been demonstrated. This study tested the hypothesis that beta•
receptor mediated vasodilation contributes to the maintainence of 
blood flow to collateral-dependent myocardium (COLL) during 
exercise. We measured myocardial blood flow with microspheres 
to normal (NL) and COLL in 8 chronically instrumented dogs 
trained to run on a u·eadmill before and after propranolol 
(0.2 mglkg iv). COLL was 17% of LV mass and was produced by 
chronic intermittent occlusions. of the left-ameli or descending artery 
followed by permanent occlusion. HR was maintained by constant 
atrial pacing. 
Mean Myocardial 
Ao HR DP/dt Blood Flow 
mmHg h/min mmHg/sec mllmin/gm 
NL COIL 
Control 120 229 27.300 3.14±O.21 L93±O.17* 
Propranolol 124 232 28.800 2.23±O.12t l.SO±O.14*t 
*0< Q ()()J NI ys COil to< Q no; COUlro) vs prnnmnolo) 
At identical levels of exercise, non-selective beta-adren.:rgic 
blockade significantly reduced blood tlow to both NL and COLL 
while improving the Endo/Epi now ratio in both regions 
(p < 0.05) Thus. beta-adrenergic receptors in COLl vessels are 
functionally intact and comribute to the maintainence of blood now 
in collateral-dependent regions during exercise. 
963-8 
The Role of Endothelin Receptors in the Regulation of 
Cardiovascular Function 
David P. Chan. Steven C. Cassidy. Hugh D. Allen, Children's 
Hospital and The Ohio State University. Columbus. OH 
Endothelin (ETl is a potent vasoconstrictor. Exogenous ET, 
when given in pathophysiologic and phannacologic doses causes 
marked vasoconstriction and decreased cardiac output. The 
cardiac and vascular actions of endogenous ET upon ETa receptors 
under non-pathologic conditions is unclear. BQ123 (19.0 ± 1.2 
mcglkg IV). a specific antagonist for ETa receptors, was given to 
3 week old piglets (n=8) that were acutely instrumented to measUre 
vascular and cardiac systolic function. Hean rate (HR), mean 
arterial pressure (MAP), cardiac output (CO), systemic vascular 
resistance (SVR), and end systolic elastance (Ees) were measured 
at baseline and 15 minutes after administration of BQ123. Results 
are expressed as mean ± standard error. Student's t-test was 
applied with p < 0.05 (*) accepted as significant. 
Baseline BQ-123 
HR(bpm) 136±6 140±8 
MAP (mmHg) 77 ± 4 67 ± 3 * 
CO (l/min) 0.32 ± 0.04 0.32 ± 0.04 
SVR 273.9 ± 44.5 244.6 ± 38.1 * 
Ees 24.7 ± 1.8 23.8 ± 2.2 
Antagonism of ETa receptors was not associated with 
chronotropic changes. The absence of significant changes in Ees. 
an estimate of ventricular systolic function that is afterload 
independent, indicates that ET is not involved in the regulation of 
systolic function under non-pathologic conditions. This is further 
substantiated by CO measurements. ETa receptor antagonism was 
also associated with significant decrease in arterial pressure and 
vascular resistance. In sununary, endogenous ET via ETa 
receptors is an important regulator of normal systemic vascular 
tone but not nonnal ventricular systolic function. 
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963·61 
1bSotheJ.1U111-~ Dilat1al in tbo Arteriu of ~tic 
SUbject. R8l.atu to ClaraIal:y R1aIt 1'IIcton IIIId 'Ibtir Interact1a:l. 
[avid Celernajer, Keld Sorensen, Jacqui Fobinsm, o::lette 'Ih:nas, 
John Deanfield. Hospital for Sick Children, London, England. 
Encbthelial dysfunction has been dan:::nstrated in I"D..nrems with 
established atffirosclerosis. We postulated that kIlaoIn oarcoary 
risk factors (such as older age, nale sex, high cholesterol, and 
smoking) might interact to pro:ruce encbthelial dysfunctioo in 
asynptaratic subjects, earlier in the natural history. 
Using high resolution ultrasoond, we ln3aSUI"ed systemic arterial 
dianeter at rest, after reactive l"(tperemia (leading to no.' 
increase; flo.' mediated dilation, FMD, is encbtheliun dependent) 
and after sublingual nitroglycerin (Grn, an encbtheliun-indepenlent 
dilator), in 500 clinically well, non-l"(tpertensive children and 
adults (252 nales and 248 fenales) aged 5-73 (36±15)years, 
incltrling 179 current and former SllOkers. As cptinal vessel size 
for respoose evaluation is 2.0-6.Ornn, the superficial f€!TOral was 
studied in 46 children and the brachial artery in 454 adults. 
There was a wide range of encbthelit.rn-dependent respooses (FMD -1 
to +17%). All arteries dilated in respoose to Grn (17±6%), 
suggesting an ahlornality of encbthelial funetioo in subjects with 
irrpaired FMD. on univariate analysis, reduced FMD was related to 
hypercholesterolemia, SllOking, higher blood pressure, nale gender, 
older age, posidve family history of prerrature vascular disease 
and larger Vessel size (F60 .01 for all). By nultiple stepNise 
regression analysis, reduoed FMD was independently associated with 
cigarette srroking, older age, nale gend2r and larger vessel size 
(p<O .005 for each), rut n::Jt with cholesterol level. A c-arpxite 
risk factor soare was strcngly and independently related to FMD, 
suggesting risk factor interaction. W1en the SllOking/cholEsterol 
interactiC>r! was examined, ch:>lesterol level w:tS significantly 
related to FMD in non-and light SllOkers ooly; in heavy SllOkers, FMD 
was :inraired vmatever tffi cholesterol level. F'Urthernore light and 
moderate snoking was ITere danaging in subj"--t:s in the highest 
CCIlpored to the lo.oest cholesterol gJartile. 
'lhus the same risk factors that predispose to athercsclerosis and 
its cmplications interact to produce loss of endotheliun-deperrlent 
dilatioo in yeung and middle-aged asynptmatic subjects. '!his nay 
be an early manifestatirn of the athercxJenic process. 
963·62 
1bSotheJ.1U111-~ Dilaticc 18 lDpaired in tbo Large Arteriu of 
II8altI:\Y Youcg Adult Type I D1.abat1c. IIIId 18 R8l.atad to tbo ~
of K:I.c:roall:uII. 
Dimitri Georgak!::prulos, [avid Celernajer, o::lette 'Ih:nas, Jacqui 
Robinson, John Bettericge, John Deanfield. Hospital for Sick 
Children, L:Jndon, England. 
Large vessel disease is a o::mton and frequent cmplication of type 
I (insulin-dependent) diabetes nellitus (rM), and an inportant 
cause of prerrature death. As encbthelial dysfunctioo is an early 
event in atherogenesis, we studied endothelit.rn-dependent dilation 
non-invasively in 16 yeung adults (age 13-35 y....rs, nean 24±2; 6 
rren, 10 waren) with type I rM. All were life lco;J non-SllOkers, 
non-lM>ertensi ve and 00 no cardiovasoular medicatict1S. N:Jne had 
synptam or signs of large or snall vessel disease. Vascular 
respooses were CCIlpIlred with those of 32 healtl¥ Oct1trols natched 
for age and sex. 
Using high resolution external ultrasamd, brachial artery diarreter 
was neasured at rest, in response to reactive IM>eremia (RH) (with 
no.' increase leading to encbthelium-dependent dilatioo) and after 
sublingual nitroglycerin (Grn, an encbthelium-independent dilator). 
Each diabetic had fastirr;; cholesterol, glucose, insulin and 
glyoosylated h€!TOglobin ln3aSUI"ed and 14/16 had urine albJrnin 
concentratict1S estinated. Vessel size, l:aseline no.' and degree of 
RH (D:::{:pler estinated) were similar in both gro.JpS. Flo.' mediated 
dilation (FMl) \..as irrpaired in the diabetics (6±1%, range 1-12% VB 
controls 10±1%, range 6-17%, p<0.02). GIN caused dilatioo in all 
subjects (diabetics: 18±1%; Oct1tro1s: 2l±1%; p=NS), suggesting that 
reduced FMD in the diabetics was due to encbthelial dysfunctioo. 
HolD in the diabetics was not related to age, blood pressure, age at 
diagnosis, glyoosylated h€!TOglobin, blood sugar or total 
cholesterol levels. Reduced I'M) .as, ~, related to the 
presence of albJrninuria. N:J1e of 6 diabetics with a nomal 
FMD(>6%) had evidence of microalbJrninuria, rut 5/8 of those with 
i.rrp;ired FMD (S;6%) had urine alb.lmin ~firg!1 (p<0.01). 
Therefore healtl¥ yeung ad.!lts with type I rM have irrpaired 
endothelium-dependent dilatioo, "*rich nay be present even in the 
abeence of microalbJrninuria, a narker of snall vessel disease. 
'!his non-invasive test nay provide a rreans of assessirr;; early large 
vessel al:nornalities in this high risk pcp.llatioo. 
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IbSotheJ.1U111-DIIri wd IIal.axiD; Pactar IIainta1ns lDW l'IllDaIa%y 
Vuc:ul.ar Rui8t:aDce in NaI::IIal 0l1lc!r:an. 
[avid Celernajer, Clare D::>llery, Mike 9..Irch, John Deanfield. 
Hospital for Sick Children, U::t1<kn, England. 
Rest ing vascular tooe is 10.' in the nomal p.!lnonary circulation, 
and exper:inental aninal studies have suggested that this nay be due 
to oontinucus release of the encbtheliun-derived relaxing factor, 
nitric oxide (NJ) . We studied the herodynamic effects of 
N::;-m::ncmetl¥l-L-arginine (L-tM1A) , a specific inhibitor of NJ 
synthesis, and L-arginine, the suJ:strate for NJ syntffisis, on the 
p.!lnonary circulation of 6 children aged 2-17 (nean 9) years with 
congenital heart disease rut noma! p.!lnonary blood no.', pressure 
and resistance (all had isolated left heart cl:structive lesict1S). 
Drugs were infused into a segteJltal branch of the left lo.oer lobe 
p.!lnonary artery via an intra-arterial D:::{:pler catheter, I>ohich 
recorded blood no.' velocity. Diarreter of the segnental artery was 
tooaSured I:¥ quantitative angiography. 
There was a consistent, dose-dependent fall in p.!lnonary blood no.' 
velocity in respoose to 3 increasing doses of L-tM1A (3.5-14 
IJIlOl/nu!l/m2); CCIlpIlred to l:aseline, no.' velocity fell to 76±7 
(range 46-88), 63±8 (35-81) and 40±10% (10-72%) (p<0.01), 
mdicating vasooonstrictioo. With suJ:sequent infusioo of L•
arginine (70 IJIlOl/min/m2), fl"", velocity returned to Oct1trol values 
(l06±8%) within 3 minutes, h:Mever there was 00 further rise in 
nOo' velocity with higher doses of L-arginine (up to 140 
IJIlOl/min/m2). TI1€!reafter acetylcholine (ACh), an endothelium•
depe:1dent dilator, pro:ruced an increase in flo.' velocity (55±13% 
greater than l:aseline). Segnental artery diarreter .as unchanged 
all ing tffise infusions, indicating that the najor effect of each 
agent is to alter vasrular tooe distal to the segrental p.!lnonary 
a..rt:eries. 
In nomal children, encbtheliun Oct1trols p.!lnonary vascular tone, 
via endothelium-derived nitric oxide. '!his systE!T, can be 
stinulated (I:¥ ACh) or inhibited (I:¥ L-tM1A) , with resulting 
increase or decrease of p.!1nonary blood no.'. In children ",'ith 
p.!lnonary endotffilial Wnage, irrpaiment of NJ prod.lction nay 
oontriWte to the elevated p.!lnonary vascular resistance that 
cmplicates sene oases of congenital heart disease. 
963·64 
.. ........ Neurohumoral Ac:tIVIItIon In Primary Pulmonary 
HypertensIon end Isolated Right Ventricular Dpfunc:tion? 
SrinlYas MUI1lIi, Tammy R. Tokarczyk, Vishwajeth B. Bhoopalam, 
Yvonne M. Cannon, Susan Loftus, Barry F. Uretaky. Unlvel1llty of 
Pittsburgh Medical Center, Pittsburgh, PA 
Neurohumoral systems are frequently activated In patients (pta) 
with left ventricular dysfunction (LVD) and predictive of increased 
rnortlility. To detennine If similar activation occurs In Isolated right 
ventricular dysfunction (RVD), 9 pta (8 females, 1 male; mean age 
37 ± 7 yrs) with primary pulmonary hypertension (PPH) and RVD were 
studied. All had n01'l'1111 LV function (nonnal LV size and well·motlon 
on echocardlogl1lphy; mean LV ejection fraction 59±5% on 
I1Idlonuclide angiograph)'; mean pulm:)nllry wedge pressul1l 9±1 
mmHg), NYHA class III·IV symptoms, RVD (dilated diffusely 
hypoklnetic RV on ochocardiogl1lphy; right atrial pressure 8±3 
mmHg) and SIIvel1l PH (mean pulmonary artery pressure 57 ±4 
mmHg; mean pulmonary vascular resistance 13.7±2.6 wood unlta). 
Resulta: Mean plasma levels of nOl1lplnephrine (NE, 557±92 pglml), 
atrial natriuretic peptide (ANP, 135±24 pglml) and plasma renin 
activity (PRA, 3.6±1.3 ng/mUh) were all elevated (nonnal tIE 110-410 
pglml, ANP 20-77 pglml, PRA 0.2·2.3 ng/mUh). Plasma NE levels 
correlated well with right atrial pressure (r=O.77, p<0.05). mean 
pulmonary arterial pressure (r=0.84, p<0.02), pulmonary wedge 
pressUI1l (r=C.86. p<O.03). and cardiac output (r=.Q.84, p<0.04), but 
plasma ANP and PM did not. Conclusions· 1) Neurohumoral 
activation Is p"Osent In pta with PPH and Isolated RVD; and 2) 
Sympathetic nervous system activity may corrolate direc'ly with both 
degree of pulmonar{ hypertel\llion and severity of FtVD. 
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Coronary Vaaodilation a.apona. to Captopril i. 
Xediated by Endoth.lium Derived aelaxing Pactor 
Katharine O. Burleson, and Bruce R. Ito. VAMC and 
UCSD, San Diego, CA. 
Captopril (CP) is believed to be a coronary 
vasodilator, but in-vivo data is limited and the 
mechanism is unclear. To further establish this 
therapeutic potential, we examined the effect of 
intracoronary (IC) CP on coronary blood flow(CBF) in 
open chest pigs (n=6) at constant coronary pressure. 
Contrary to published data, CP produced only minor 
increases in CBF (1%-30%) over a pharmacologic range 
(0-3roM or 17mg/min IC). We hypothesized that 
significant CP vasodilation might only occur during 
enhanced EDRF release. To test this, we stimulated 
EDRF release by l)increasing CBF/shear with constant 
IC adenosine (AD,O.l5mg/min) and 2) IC bradykinin(BK) 
an EDRF dependent di lator. Compared to control, CP 
caused a significant ('=p<.01) dose-dependent increase 
in CBF when given during AD (Table 1). Similarly, the 
CBF response to BK (10-40 nmo1es/min)was augmented 
durlng CP infusion (2-4 x 10 3 roM), Table 2. In both 
cases, the changes in CBF were abolished by inhibition 
of EDRF with n-W nitro-1-arginine (NLA, 2mg/kg iv.). 
Tabl. 1 aCBF (ml/min/g) Table :I aCBF (ml/min/q) 
CPmM i Ctr1. +AD AD=NLA BK Ctrl. +CP CP+NLA 
0.5 I 0.0+.1 0.7+.4 0.0+.1 10 10.4+.2 1.1+.3 0.3+.2 
1.0 10.1+.1 0.9+.4 0.1+.2 20 I 0.5+.3 1.4+.4 0.5+.3 
2.0 I 0 .2+.2 1. 0+.4 0.2+.1 40 ' 0.7+.3 1. 8+.5 0.8+.4 
We conclude that CP is only a minor vasodilator at 
resting CBF. However, CP produces additional 
significant vasodilation in the presence of conditions 
that stimulate increased EDRF release. Thus captopril 
may be able to reduce ischemia when used with other 
EDRF dependent vasodilators. 
963-66 
Cardiac Innervation is not Necessary for the Systemic and 
Coronary Vasoconstrictor Effects of Cocaine 
Richard P. Shannon, Tadashi Ihara, You-Tang Shen 
Cardiovascular Division, Beth Israel Hospital, Harvard Medical 
School, & New England Regional Primate Research Center, 
Southborough,~ 
The effects of cocaine (COC) on cardiac function are complex. 
Controversy exists as to whether central stimulatory effects, 
inhibition of peripheral neuronal reuptake, or membrane 
stabilizing properties predominate. To address this, we compared 
the effects of cocaine (COC 1 mg/kg) in 8 intact conscious dogs 
(CON) and 6 dogs with ventricular denervation (VD) to determine 
if cardiac autonomic innervation is required for the systemic 
(SVR) or coronary (CVR) vasoconstrictor effects ofCOC. Dogs were 
instrumented with LV pressure gauges (LV dP/dt), aortic and 
coronary sinus (CS) catheters and aortic (CO) and left circumflex 
flowmeters. The mean arterial pressure response was greater 
(p<0.05) in the VD dogs (+59:1:4% from 92:1:3 mmHg) compared to 
CON (41:1:3% from 95:1:5 mmHg) as was the peak SVR response 
(CON: 13:1:4%; VD:25:1:4%), while heart rate (CON:+48:1:4% from 
88:1:4 min·1; VD:+32:1:4% from 100:1:4 min·1) and CO (CON:+40:1:5% 
from 2.4:1:0.2 lImin; VD:+27:1:6% from 2.2:1:0.3 lImin) responses 
were less (p<0.05). In contrast, the peak LV dP/dt response (CON: 
+23:1:4%; VD:+45:1:6%) was greater (p<0.05), while the initial 
depression in LV dP/dt was comparable. There was no difference 
in the plasma NE response (CON:+129:1:34 pglml from 170:1:27 
pglml; VD:+107:1:22 pg/ml from 203:1:29 pglml). Despite greater 
(p<0.05) O2 consumption (CON:36:1:4%j VD:52:1:6%),the increase in 
CVR was comparable (CON:24:1:3%; VD:22:1:5%), requiring VD dogs 
to extract greater O. from the CS (CON: 72:1:3%; VD:82±4%, 
p<0.05) to meet metabolic needs. These data suggest that neither 
direct cardiac neural stimulation nor local inhibition of cardiac NE 
reuptake are critical to the cardiovascular effects of COCo 
ABSTRACTS 
963-67 
Differential Effect of Acetylcholine on AtrIal and Ventricular 
Resistance Vessels Isolated from Human Hearts. 
Francis J. Miller, Kevin C. Dellsperger, Richard P. Embrey, 
David D. Gutterman, University of Iowa and VAMC, Iowa City, 
IA 
The direct effect of acetylcholine (ACH) on atrial and 
ventricular human coronary resistance vessels isolated from 
the same heart has not been studied. We dissected coronary 
arterioles (71-350J.LITI passive diameter) from pectinate muscles 
of the right atrial appendage and from the subepicardial 
surface of the left ventricle from four freshly explanted hearts. 
Vessels were mounted onto pipettes in Kreb's buffer under 
conditions of zero flow and constant distending pressure of 60 
mmHg. Drugs were applied extraluminally and changes in 
diameter measured by video microscopy. After constriction 
with endothelin (50% of resting diameter), ACH (10-9 to 10-5 M) 
dilated arterioles (6 vessels, 3 hearts, maximum dilation 79.:!:.4% 
of resting diameter, mean.:!:.SE) isolated from ventricles of 
patients with no or minimal coronary artery disease (CAD). In 
these same 3 hearts, isolated atrial arterioles (5 vessels) 
constricted to ACH (73+8%). All vessels dilated to adenosine 
diphosphate (ADP 10-5" M, 94.:!:.5%) and sodium nitroprusside 
(SNP 10-5 M, 98.:!:.4%). However, in one patient with diffuse 
CAD, ACH dilated ventricular arterioles (2 vessels) at lower 
doses and constricted at higher doses (50% constriction at 
10-5 M) while dilation to ADP was nonnal. We conclude that 
human coronary arterioles from atrial and ventricular tissue 
respond differently to ACH but not to ADP or SNP. These 
findings may have pathophysiological importance in conditions 
such as diabetes or atherosclerosis. 
963-68 
Effect of Inhibition of Nitric Oxide Synthesis in the Human 
Coronary Circulation 
Arshed A. Quyyumi, Nader Dakak, Sanjeev Arora, David M. 
Gilligan, Gregory B. Johnson, Julio A. Panza, Neil P. Andrews, 
Richard O. Cannon, m, NHLBI, Bethesda, MD 
427A 
To determine the contribution of nitric oxide (NO) to human 
coronary (C) vascular tone at rest and with acetylcholine (ACH), 
we studied the effect of NO inhibition with intracoronary 
L-NGmonomethyl arginine (L-NMMA 64 I'M/min) in 15 pts with 
normal C arteries. Blood flow was derived from doppler flow 
velocity and C diameter measurements. At rest, L-NMMA 
produced significant (p<0.01) increases in C vascular resistance 
(CVR)(24±14%), blood pressure (10%), and arterio-venous 
oxygen difference (9%), and a decrease in epicardial C diameter 
(I0±9%). L-NMMA also inhibited the C vascular effects of 
ACH; compared to baseline, CVR and diameter changed by 
-36±25% and 2±12% respectively before, and by -26±24% and 
-12 ±13% after L-NMMA (p<O.OI). However, responses to the 
endothelium-independent dilators, sodium nitroprusside (40 
I'g/min) and adenosine (2.2 I'gimin) were unaffected by L•
NMMA. 8 pts without risk factors for C disease had a greater 
reduction in CVR with ACH (-66±10%) compared to 7 pts with 
risk factors (-44±1O%, p<O.Ol). At rest, L-NMMA produced 
similar increases in CVR in both groups, but the inhibition of 
ACH-induced dilation of epicardial C was greater in pts with 
normal endothelial function (no risk factors). Thus, NO release 
contributes to resting C epicardial and microvascular tone in pts 
with and in those without endothelial dysfunction. However, the 
maximum dilator capacity of the NO system is reduced in pts with 
risk factors for coronary artery disease. 
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964·69 
Cardlomyoplasty: Hemodynamic Effect of latissimus 
Dorsi Muscle Contraction After 6 Months. 
"Guillaume Jondeau, lIRichard Dorent, "Jean·Claude Dib, 
"Frank Chikli, lIValeria Bors, "Olivier Dubourg, 1I1radj 
Gandjbakhch, "Jean-Pierre Bourdarias. "A Pare, 92100 
Boulogne, France; lIPitie Salpetriere, Paris, France. 
We performed right·heart catheterization in 7 patients '" 6 
months after cardiomyoplasty, and compared hemodynamic 
variables obtained while the Latissimus Dorsi muscle was 
stimulated every other systole (on), with those obtained after 
pacing was stopped for 1 min, 5 min and 1 hour. All the 
patients had been subjectively improved by cardiomyoplasty. 
Mean Pulmonary Artery Pressure (mPAP, mmHg), mean 
Pulmonary Capillary Wedge Pressure (Pcwp, mmHg), mean 
Blood Pressure (mBP, mmHg), Heart Rate (HR, b/min), 
Cardiac Index (el, IlminIm2), and Oxygen Venous Saturation 
(02VS, %) were recorded. Results were as follows: 
on off 1 min off 5 min off1h P 
mPAP 21.9:1:8.4 22.6:1:9.1 22.2:1:8.1 20.3:1:7.2 NS 
Pcwp 17.1:1:6.3 17.0:1:7.3 16.6:1:7.7 15.3:1:6.6 NS 
mBP 86.2:1:8.8 89.2:1:12.6 87.0:1:10.3 89.2:1:8.3 N S 
HR 75.7:1:13.2 77.7:1:11.9 77.4:1:15.7 72.3:1:12.6 N S 
C I 2.2:1:0.4 2.3:1:0.4 2.2:1:0.5 2.2:1:0.4 NS 
02VS 66.0:1:6.2 65.2:1:7.1 64.6:1:6.8 66.0:1:2.5 NS 
p: column ·on" versus any other column. 
CONCLUSION: Stopping Latissimus Dorsi muscle 
contraction for 1 hour or less, 6 months after surgery, did not 
modify hemodynamics at rest. This suggests that symptomatic 
improvement reported by the patients is not associated with 
an improvement in rest LV systolic function. 
964·70 
Contractile Reserve in Patients with Peripartum Cardiomyopathy and 
Recovered Left Ventricular Function. 
Mark Lampert, Lynn Weinert, Judy Hibbard, Unda Roberts, Marshall 
Undheimer, Roberto Lang. University of Chicago, Chicago, IL. 
Peripartum Cardiomyopathy (PPCM) is an unusual form of heart disease. 
Although 30% of patients with PPCM recover baseline left ventricular 
(LV) function within 6 months of delivery, the ability of these ventricles 
to respond to hemodynamic stress is unknown. Accordingly, we 
evaluated LV contractile reserve using a dobutamine (OOB) infusion 
challenge test in 7 patients with previously diagnosed PPCM whom by 
echocardiographic criteria had recovered LV dimensions and function and 
comparild them with age, race, and parity 
matched controls, Baseline LV contractility was -I~  
assessed using the load and heart-rate -
independent relation between end· systolic stress ~ --
(ues)·rate corrected velocity of fiber shortening i ~~ I 
relation (Vcfc)' Data were acquired using 2-0 
targeted M'mode echocardiography and 
calibrated subclavian pulse tracings over a wide ........ "".....,. 
"'" '" '''"',,d. '<,,' '",,''''' '" ~SIT~ methoxamine (1 mg/min) infusion. Contractile I ~ .-
reserve was assessed by a OOB challenge (5 -..;; 
pg/kg/min) and quantified as the vertical i c.;; 
deviation ofthe dobutamine ues' VCfc data point 
from the ues' Vcfc baseline contractility line. 
PPCM and matched·controls had similar baseline heart rates, blood 
pressures, and LV dimensions. Despite similar baseline LV function, 
contractile reserve was reduced in pts with recovered PPCM when 
compared to matched controls (,30 ± .12 vs .17 ± .04 circ/sec, p < .03). 
Conclusions: 1) LV contractile reserve in recovered PPCM patients is 
significantly reduced and 2) Although clinical practice usually 
recommends avoiding subsequent pregnancies in recovered PPCM 
patients, this study constitutes the first objective assessment of 
contractile reserve in these patients and demonstrates that these 
ventricles respond suboptimallv to hemodynamic stress. 
JACC February 1994:1A-484A 
964·71 
Measurement of Pulmonary Artery Diastolic Pressure from the 
Right Ventricle 
"Dwight W. Reynolds, "Nick J. Bartelt, "Robert T. Taepke, "Tom D. 
Bennett, University of Oklahoma Health Sciences Center, 
Oklahoma City, OK., and Medtronic, Inc., Minneapolis, MN. 
Pulmonary artery wedge pressure (PAWP) is commonly used to 
estimate left ventricular (LV) filling pressure in patients (pts) with a 
variety of problems induding congestive heart failure patients 
(CHF). PA diastolic pressure (PADP) is commonly used as an 
estimate of PAWP. Hypothesis: Right ventricular (RV) pressure at 
the time of RV dP/dtmax could be a reliable estimate (ePADP) of 
the actual PADP (aPADP), because RV dP/dtmax occurs at the end 
of the isovolumic contraction phase when RV and PA pressures 
equilibrate at the time of pulmonic valve opening. Methods: During 
right heart catheterization, ten Pts had ECG and simultaneous RV 
and PA pressure recordings made using micromanometers. 
Pressures from multiple (25-75) individual cardiac cydes were 
analyzed over 40 seconds to average out respiratory variations. 
Control Results: RV systolic pressure was 35.1:1:12.6 mmHg and 
was not significantly different from the PA after correction for a 
systematic offset (3.5 mmHg) in PA pressure. ePADP (16.1:1:6.8 
mmHg) and aPADP (15.1:1: 7.3 mmHg), were not significantly 
different (P=0.31). RV dP/dtmax occurred n.8±17.9 ms from the 
surface ECG QRS complex. Dynamic Results: Interventions 
intended to affect RV and PA pressures were performed in 9 of 10 
pts: ePADP and aPADP changes were correlated during Valsalya 
maneuvers (r=0.94, n=5); during isometrics (r=0.75, n=8); and 
during i.v. nitroglycerin 3-8uglminlkg (r=0.65, n=1). Conclusion: 
Because ePDP statically and dynamically reflected aPADP, we 
condude that it may be feasible to continuously monitor pts using 
RV pressure measured at RV dP/dtmax as an estimate of actual 
PADP, and thus LV filling pressures. If confirmed by further 
studies, this concept would have important implications for 
development and use of an implantable hemodynamic monitor. 
964·72 
Pulmonary Artery Pressure EstImated from a Right Ventricular Sensor 
Alee Ohlsson MD, Hans AstrOm MD, "Tom Bennett PbD, "Henri Heynen PbD, 
Rolf Nordlan~er MD. FACC, "]oban Ryd~n MS. Lars Ryd~n MD, FACC. 
Karolinska Insutute, Stockholm, Sweden. 
Background: For continuous hemodynamic monitoring of patients with severe 
congestive heart failure (CHF). an implantable monitoring system, designed as a 
cooventional pacemaker with a single right ventricular (RV) lead. might be 
beoeficial. An imponant parameter in such a system is pulmonary artery end 
diastolic pressure (PAD). 
Hypothesis: PAD can be obtained from a sensor positioned in RV. Pulmooary 
valve opening and PAD occur at the time of RV dP/dlmu when the pressures are 
equal. RV pressure measured at dP/dlmu (PAD Index) is therefore a reasoaable 
estimate of PAD. 
Methods: Eight CHF patients. EF 25-57% (range), were catheterised for two hours 
while exposed to hemodynamic stress. RVP and PAP were continuously and 
simultaneously recorded from a MilJar catheter with two pressure senson. The 
distal sensor was positioned in PA·bifurcation. and the proximal in high RV. PAD 
and PAD Index were derived on a beat·by.beat basis and stored in a bedside 
computer. 
Results: Acceptable recordings were obtained in all patients. Linear regressioo of 
PAD Index vs. PAD gave (mean±SD) r2=0.77±O.13, SEE=1.45±O.71, SlopeooO.85± 
0.21 and an intercept of 5.63±3.07. A typical trend plot of a patient is given: 
PAD Index ••••••• PAD ---
'00 30 Supine Exercise 
:c ,Dobutamine Nib'ate 
! 20 \ ••••••••• (. ••••••••• 1 ............ . 
J I:~ __ ~----~---~----~----~----­
o 20 40 60 80 100 120 
Tim. (min) 
Concl.uslon: This study indicates that pulmonary artery end diastolic pressure can 
be esumated from a sensor in the right ventricle, thus eliminating the need for a 
permanent pulmonary arterial lead in an implantable hemodynamiC monitoring 
system. Further studies are needed to verify the correlation on a long term basis. 
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964·130 
Plasma Norepinephrine and AtrIal NatrlIRIic PeptIde lewis Predict 
Prognosis in Patients with Asymptomatic Left Ventricular Dysfulction. 
Claude R Benedict, Brent Shelton, Gary Francis, Jeff Probstfield, David 
Johnstone, Chang-Seng Wang, John Nicklas, Salim Yusuf for SOLVD 
Investigators. University of Texas Medical School, Houston, lX. 
Previous studies have Indicated that In patients with symptoms of 
CHF, the Increased plasma levels of norepinephrine (PNE) and atrial 
natriuretic peptide (ANP) were predictors of mortality. However, it is 
not clear whether the activation of neurohumoral mechanisms In 
patients with asymptomatlc left ventricular dysfunction correlates with 
the development of adverse clinical events in these patients. 
Methods: In 558 patients in the SOLVD Prevention Trial, PNE, ANP, 
vasopressin (AVP) and plasma renin activity (PRA) were measured at 
entry into the study and during follow-up at 4 mos, 1 yr and at 2 yrs. 
The mean duration of follow-up was 3 yrs. We used the Cox 
proportional hazards regression analysis adjusting for the effect of LV 
ejection fraction and treatment with enalapril, to determine whether the 
neurohormonal values measured immediately prior to the development 
of a clinical event [death (0), or hospitalization for symptoms (HOSP)) 
were predictors of occurrence of the event. Excess risks are reported 
for 1 SO increase in PNE (+225pg/ml) or ANP (+69pg/ml). 
Results: 
PNEln-SSn ANPln-245l 
DEATH HOSP DEATH HOSP 
Number of Events 63 316 34 153 
Excess Risk for 1 SO 25% 7% 32% 32% 
P (two-tailed) o.ot 0.24 0.08 0.0003 
Increase in PRA or AVP did not predict 0 or HOSP. 
Conclusion: These data show that increases in the levels of PNE in 
patients with asymptomatic LV dysfunction predict death while an 
increase in the levels of ANP predict subsequent need for 
hospitalization for symptoms. These findings suggest that modulation 
of neurohumoral profile in these patients, may reduce morbidity and 
mortality. 
964·131 
Inclusion or Patients only witb Low Ejection Fraction in Heart 
Fallure Trial Biases the Population Against Women and the Elderly 
Rekba Garg, Salim Yusuf, Richard Gorlin, on behalf of the Digitalis 
Investigation Group, National Heart, Lung and Blood Institute, 
Bethesda, MD 
Most beart failure (HF) trials enroll bighly selected patients with low 
ejection fraction (EF). Consequently, little data exists to support 
extrapolations to patients with relati vely preserved EF. To assess the 
impact of low EF on the representativeness of UP patient population, 
we reviewed the clinical characteristics of 7666 UP patients 
randomized in the Digitalis Investigation Group trial subdivided by EF. 
Clinical Characteristics EF <0.45 
N= 6695 
Percent 
3 or more 
symptoms of UP 89.6 
NYHA Class I-n 67.3 
Etiology 
Iscbemic heart disease 70.8 
Hypertension 8.6 
Women 22.2 
>70 yrs 26.9 
Blacks !J.5 
Ef>0.45 
971 
90.9 
77.9 
56.8 
22.4 
41.3 
37.0 
10.8 
P-value 
NS 
<o.elO! 
<0.001 
<0.001 
<0.001 
NS 
In the DIG trial, the clinical characteristics of patients with low EF 
were similar to the patients in other UP trials. However, patients with 
preserved EF were more likely to be women, elderly, in NYHA class I 
and II and have hypertension as the underlying etiology. Thus, studies 
that have an entry restriction of low EF may underrepresent the above 
subgroups of patients. 
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Lyme Disease is Not a Common Cause of Idiopathic Dilated 
Cardiomyopathy 
Spencer H. Kubo, Susan C. Holmer, Steven W. Sonnesyn, Jesse 
L. Goodman, University of Minnesota, Minneapolis, Minnesota 
A recent report demonstrated that Bon elia burgdoiferi, the agent 
responsible for Lyme disease, could be cultured from an 
endomyocardial biopsy in a patient with idiopathic cardiomyopathy. 
This finding suggested the possibility that Lyme disease might be 
the underlying disease in many patients who are given the diagnosis 
of idiopathic cardiomyopathy. We evaluated 160 consecutive 
patients referred for heart transplantation from the midwestern 
United States which is an endemic region for Lyme disease. There 
were 52 patients (33%) with a history of tick bites but only 2 
patients reported symptoms consistent with Lyme infection. There 
were 14 patients (9%) who were seroreactive by ELISA assay 
whieh was signiticantly greater than 3 of 101 (3%) consecutive 
blood donors to the St. Paul Red Cross (p<O.05). However, 
among the seroreactive patients, there were no differences in ELISA 
tests between patients with idiopathic cardiomyopathy and those 
with ischemic heart disea<;c. Western immunoblots, which are more 
sensitive for Borreli(/ burgdmieri infection, were positive in only 4 
of 14 scroreactive patients. A subset of 4 patients with positive 
ELISA (3 with positive Wcstem immunoblots) were treated with 
intravenous ceftriaxone or I month of doxycycline to test the 
hypothesis that chronic Borrelia burgdoiferi infection was a 
reversible cause of ventricular dysfunction. However, in all cases 
there were no changes in ejection fraction by follow-up gated blood 
pool scan. In summary, positive ELISA tests for Lyme disease are 
common among patients refen-ed for heart transplant from an 
endemic region. However, seroreactivity is not more common 
among patients with idiopathic cardiomyopathy compared to patients 
with ischemic heart disease and treaUnent of Lyme disease does not 
change ventricular function. We conclude that Lyme disease is not a 
common cause of heart failure in patients with idiopathic cardio•
myopathy referred for heart transplantation from an endemic region. 
964·133 
Familial Dilated Cardiomyopathy is not Linked to the B-Myosin Heavy 
Chain Gene. 
Thomas Scheffold. Ekkehard Grilnig. Gorana Hollmann. Andrew 
Remppis. Wolfgang Franz. Erich Kuhn. Hans-Peter Vosberg'. Hugo A. 
Katus. Innere Medizin III. University of Heidelberg. and 'Max-Planck•
Institut Bad Nauheim. Germany 
It is the goal of this ongoing study to investigate the linkage of 
polymorphic DNA-markers within or near known loci of myofibrillar 
proteins with the unknown disease locus of familial dilated 
cardiomyopathy (DeM). 
For this analyses two of 1 5 families with familial DeM were 
selected. In these two families pedigrees were obtained over 4 
generations. A total of 121 members of these 2 families underwent a 
physical examination. echocardiography. and electrocardiography. 
DeM of the index patients was determined by heart catheterisation. In 
family 01 DeM was proven in 3 members by heart catheterisation 
and in one member by autopsy. whereas 5 another members revealed 
a depressed left ventricular function on echocardiography. Two 
members revealed borderline left ventricular ejection fraction and 
septal hypertrophy. In family 02 3 brothers in the age between 25-35 
suffer from DeM as proven by heart catheterisation. Their 58 year old 
mother and two children of the eldest brother in the age of 9 and 11 
revealed a depressed left ventricular function on echocardiography. 
Genomic DNA obtained from blood of these patients was amplified 
by peR using known oligo nucleotide primers. The products were 
seperated by polyacrylamide gelelectrophoresis. First the B-myosin 
heavy chain gene was analysed as a possible candidate gene because 
two patients in family 01 reveal septum hypertrophy. Three 
polymorph isms within the B-myosin heavy chain gene were selected: 
the restriction fragment length polymorphism (RFLPI of BamHl 
located in intron 28 and two small tandem repeats (STR's) located in 
intron 1 and 24. 
By LOD-score analyses for these markers (LOD score fam 01: 
MYO-I -7.6 and BamHl -5.11; fam 02: MYO-I -1.2. MYO-It -6.95 and 
BamH 1 -1.0) it was possible to rule out linkage of the B-myosin heavy 
chain gene to familial DeM in the two families analysed. 
In the future polymorphic DNA-markers located on different 
chromosomes will be tested for linkage with DeM in these families. 
429A 
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964·134 
Assessment or Working Skeletal Mnscle Oxygenation in Patients 
With Chronic Heart Failure. 
'Shinobu Matsui, Nobuki Tamura, Eiji Murakami, Tomoyuki Hirakawa, 
Noboru Takekoshi, Kanazawa Medical University, Ishikawa, Japan 
Patients with chronic heart failure(CHF) are frequently limited by 
muscle fatigue due to impaired skeletal muscle blood flow. Accordingly, 
we assessed working skeletal muscle oxygenation in CHF patients with 
near-infrared spectroscopy(NIS). Methods: Nine normal subjects 
(mean age: 52 years old) and twelve patients with CHF (mean age: 60 
years old) were studied. Using NIS, changes of oxygenated 
hemogiobin(Hb) and myogiobin(Mb) contents foxy Hb/Mbj and deox•
ygenated Hb and Mb [deoxy Hb/Mbl in the vastus lateralis muscle were 
monitored at rest, during warm-up (0 watt, 30 cycle/min for 3 min), 
incremental maximal supine bicycle exercise (ramp protocol, 15 
watt/min, 50 cycle/min), and recovery. Results: I)At peak exercise, 
patients exhibited reduced DR, SBP, V02 (15±3.0 ml/kg/min vs. 32±8.5) 
and workload (99±23.4 watts vs. 183±68.4) as compared with normal 
SUbjects. Respiratory gas exchange ratio was comparable in both group. 
2)Changes of oxy Hb/Mb is shown in figure. 
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The changes of deoxy Hb/Mb and oxy Hb/Mb were inversely propor•
tionate. Conclusions: 1n patients with CHF, oxygen delivery to working 
skeletal muscle is impaired throughout exercise and a reactive hyperemic 
response to strenuous exercise is blunted. 
964·135 
Does Growth Hormone Contribute to Reduced Peak 
Aerobic Capacity in Congestive Heart Failure? 
Laura A. Demopoulos, Danny Woo, Herbert Hirsch, 
Mariell Jessup, Rachel Bijou, Marie Galvao, 
Paola Levato, Harry Shamoon, E. Scott Monrad, 
Thierry H. LeJemtel, The Albert Einstein College 
of Medicine, Bronx, New York. 
The loss of skeletal muscle mass which accom•
panies congestive heart failure (CHF) contrib•
utes to decreased peak aerobic capacity (peak 
vOz' ml/kg/min). Reduced levels of growth 
hormone (GH), an important determinant of 
skeletal muscle mass, have been demonstrated in 
the elderly and in patients with debilitating 
diseases, using insulin-like growth factor (IGF-
1) which is produced and released by the liver 
in response to GH secretion. Accordingly, IGF-
1 levels were measured in 46 patients with CHF 
and symptoms compatible with stable NYHA class 
III and IV and decompensated class IV (0 IV), 
and in 13 age- and sex-matched control (C) 
subjects. Peak vOz was measured by a modified 
Naughton protocol. Results were as follows: 
NYHA Class: C III IV 0 IV 
j/: 13 32 6 8 
Mean IGF-1: 139±46 140±44 l29±42 44±21 
P vs C: NA NS NS <.0001 
IGF-1 and peak vOz correlated weakly (r=.302, 
p=.03) in patients with CHF. Thus, IGF-1 levels 
are only reduced at the very end stage of the 
syndrome of CHF. In addition, the weak correla•
tion between IGF-1 level and peak vOz suggest 
that skeletal muscle mass is not predominantly 
responsible for determining peak aerobic 
~apacity in patients with CHF. 
lACC February 1994:1A-484A 
964·136 
Changes in Autonomic Regulation Induced by Physical 
Training in Patients With Congestive Heart Failure. 
*Rainer Hambrecht, Eduard Fiehn, Josef Niebauer, Klaus 
Hauer, Barbara Kaelberer, and Gerhard Schuler. Med. Uni.•
K1inik Heidelberg and St. Vincentius Hospital Karlsruhe, 
Germany. 
In patients (pts) with congestive heart failure (CHF) elevated 
sympathetic drive contribute to reduced peripheral blood 
flow and exercise tolerance. The purpose of this study was 
to assess the effects of regular physical exercise in pts with 
CHF on oxygen uptake (V°2) , leg blood flow (LBF), leg 
vascular resistance (LVR), and sympathetic activity 
assessed by plasma epinephrine (EPI) and norepinephrine 
(NOR) levels. Pts (n = 12) were randomly assigned to an in•
tervention group (I) with daily exercise training (ET) or to an 
inactive control group (C). Before and after S months pts 
were instrumented with Swan·Ganz catheters and femoral 
venous thermodilution flow catheters. Central hemodyna•
mics, LBF as well as catecholamine levels were measured 
simultaneously at rest and during cycle ergometry. ET leads 
to a Significant increase in oxygen uptake at submaximal 
(sm) (.91 ±.2 vs 1.26 ±.2 I/min, p < .05 vs C) and peak exer· 
cise (pe) (1.S5±.4 vs 2.1 ±.4 I/min, p< .05 vs C) as well as 
LBF (sm: 4.2± 1.5 vs 4.7±.7, pe: 5.4±1.S vs S.4±1.4, p<.05 
vs C), with a significant reduction in LVR. Sympathetic acti•
vity at rest (EPI: .2S±.1 vs .1S±.05 nmol/I, NOR: 1.42±.5 vs 
1.OS±.2 nmol/I) and submaximal exercise (EPI: 0.S2±.3 vs 
0.S5±.2 nmol/I, NOR: S.S5±S vs 5.2±1 nmol/I) was signifi•
cantly reduced by physical training (p<.05 vs C). These re•
sults indicate that in pts with CHF regular physical exercise 
increases oxygen uptake as well as leg blood flow and de•
creases leg vascular resistance, due to an exercise-induced 
reduction in sympathetic drive. 
964·137 
Low Dose Dobutamlne Ecboc:ardioarapby Accurately Identifies 
Hibernating Myocardium In Patleats Wltb Severe Cbronlc 
Iscbemlc Left Ventricular Dysfunction. 
Roxy Senior. Brian Glenville, Sumit Basu, Bangalore S. Sridhara, 
Usha Raval, Edward B. Raftery, Avijit Lahiri, Northwick Park 
Hospital, Harrow, UK 
Myocardial thailium-201 uptake (n-201) bas been shown to be 
an indicator of myocardial viability. However, low dose 
dobutamine (DaB) induced wail thickening on 
echocardiography (Echo) has not been compared to TI-201 for 
detection of viable myocardium. In 34 pts with severe cbronic 
ischemic left ventricular dysfunction (ejection fraction ± SD, 
25±9%) with predominant symptoms of dyspnoea, 74MBq of no. 
201 was injected at rest after sublingual nitroglycerin and 
planar imaging was performed at I and 4 hrs. Low dose (5-
10mcg/kg/min) DOB was infused and wall thickening on Echo 
was assessed. Echo was repeated without DOB in II pts, 3 
months after revascularisation. TI-201 and Echo imaging were 
interpreted blind by two independent observers, using the 13 
segmental model for both modalities. TI-201 uptake was scored 
semiquantitatively from grade 1-4 according to increasing 
uptake with a segmental score of >2 being considered viable. 
Myocardial viability on Echo was considered to be present when 
there was an increase in wall thickening in dysynergic segments. 
TI-20 I (n=207 dysynergic segments) 
Viable Non-viable 
DOB Viable 131 12 
Echo Non-viable 28 36 
Concordance = 81% 
Dob Echo showed improvement in 52 out of the 60 segments 
(86%) which improved after revascularisation; of the 38 
segments which did not improve after revascularisation, Dob 
Echo detected 32 segments as non-viable (84%). Detection of 
viable myocardium by Dob Echo has a high concordance with 
TI-20 I imaging and predicts mechanical improvement of 
dysynergic segments after revascularisation with a high degree 
of accuracy. 
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965-124 
Lipoprolein(a) Levels are relaled 10 Ihe presence/absence or 
angiographic coronary arlery disease : resulls rrom a cohorl or 
800 palienls. 
• Pascal Barraud, Eliane Albuisson. Pierre Jouanel, Jean· Rene Lusson, 
Christian Schandrin, Isabelle Chapel, Dominique Lamaison, Jean Cassagnes. 
Depanment of Cardiology. Faculty of Medicine. University of Clennont· 
Ferrand· France. 
Elevated lipoprOlein(a) [Lp(a)] is associated with an increased risk of coronary 
artery disease (CAD). We studied prospectively 800 consecutive pIS (59.8 ± I I 
years) undergoing coronary angiography from OclOber 9110 June 92. These 
angiograms were evaluated by two cardiologists in blinded manner. 241 pts (30 
%) had nonnal coronary aneries (group CAD (.). 542 plS (68 %) had ~ 50 % 
luminal diameter narrowing of I or more major epicardial coronary aneries or 
severe atheroma without significant lesion detennined by a multicomponent 
score (group CAD (+). 17 plS (2 %) could nOi be classified and were not 
included in the study of predictive faclOrs. A stepwise discriminant analysis was 
used among males and among females in order 10 study the influence of age, 
total cholesterol, Iriglycerides. phospholipids, HDL cholesterol, HDL 
phosphOlipids, LDL cholcsterol, apo-AI, apo·B, Lp(a), Lp·AI on CAD. 
For the 596 males (CAD(+): 443 (74 %), CAD(·): 153 (26 %) Lp(a) was the 
4th factor selccted after age, Apo-B, Apo-AI (p<O.OOOI). For the 187 females 
(CAD(+): 99 (53 %), CAD(·) : 88 (47 %) Lp(a) was the first faclOr selccted 
before age and apo·B (p<O.OOOI). 
Considering Lp(a) alone, we oblain with reference to CAD(+), CAD(.) : 
male 
female 
Trueclassificd ~ ~ 
50.7 % >O.3lg/l 43 % 
60.4 % >O.36g/1 46 % 
.5milkilY 
73 % 
76% 
Lp(a) levels which arc independent of the other previous parameters is an 
important predictive faclOr in CAD, especially for females. 
965-125 
Effect of Vitamins A, C, and E on Oxidative Modification of 
LDL From Hypercbolesterolemic Subjects 
Michael N. Sack, Daniel I. Rader, David M. Gilligan, Victor 
Guetta, Richard O. Cannon, III. Georgetown University, 
Washington, DC; NHLBI, Bethesda, MD 
Elevated LDL is associated with increased risk of atherosclerosis 
and cardiovascular events, and it is believed that oxidative 
modification of LDL may be a key etiologiC factor. Because 
antioxidant vitamins inhibit in vitro peroxidation of LDL from 
normal subjects, we measured the effect of antioxidant vitamins E 
(800 IU), C (1 gm), and B-carotene (30 mg), taken daily for one 
month, on oxidizability of LDL (mg/dl) from 14 hypercholesterol•
emic subjects. LDL oxidation was assessed by measuring the 
formation of conjugated dienes following the addition of CuCI" 
using spectrophotometric absorbance at 234 nm. We measured 
the lag time (minutes) to onset of oxidation and the maximum 
oxidative rate (MO,R, /j, absorbance/hour). Data = mean ±SD. 
Total cholesterol =mg/dl. 
Total Cbolesterol LDL Lag Time MO"R 
Baseline 280±30 178±45 118±42 .668±.11 
One montb 282±5 I 173±59 182±49 .465±.14 
P value N.S. N.S. <0.001 <0.001 
One month of antioxidant vitamins prolonged the onset of LDL 
peroxidation by over an hour, with a significant correlation 
between the vitamin E level and the lag time (r=O.80), and 
reduced the maximum rate of oxidation by 30%. In conclusion, 
oxidative modification of LDL is markedly inhibited in 
hypercholesterolemic patients on antioxidant vitamin therapy. 
Increasing the resistance of LDL to oxidative modification may 
contribute to a reduction in cardiovascular mortality despite no 
significant reduction in elevated cholesterol levels. 
ABSTRACTS 
965-126 
Apollpoproteln(a)-Lowerlng Effect of Hormone Replacement 
Therapy In Postmenopausal Women May be One Mechanism of 
Cardioprotectlve Effect of Estrogen. 
Chee Jeong Kim, Yong Ki Min, Cheil General Hospijal, Seoul, Korea 
High concentration(C) of lipoprolein(a)[Lp(a)] is an independent risk 
factor for atherosclerosis. It is generally accepted that eslrogen 
replacement therapy in postmenopausal women decrease 
cardiovascular morbidity and mortafijy. Modifications of lipid profile and 
vascular tone seem to be mechanisms of cardioprolective effect. Lp(a) C 
is known to be associated with female sex hormones. 
To evaluate Ihe ellect of estrogen wilh/without progesterone on 
apolipoprotein (aHApo(a)], Apo(a) Cs were measured before, 2 monlhs, 
and 12 months after hormone replacement therapy(HRT) in 139 
postmenopausal women, who were divided inlo 4 groups(Gr): Gr 
A(n=42); conjugated equine estrogen(CEE) O.62Smg + 
medroxyprogesterone acetate(MPA) 10mg, Gr B(n=44); CEE 0.62Smg 
+MPA smg, Gr C(n=23); CEE 0.625mg in hyslerectomised cases, and 
Gr D(n=30); control. 
After 2 months of HRT, median Apo(a) Cs were lowered by 26.3% in Gr 
A(27 0 Urdl vs 21.0 Uldl, p=O.0004), 23.2% in Gr B(23.9 Uldl vs 17.1 
Uldl, p=0.0001) and 37.0% in Gr C(22.3 U/dl vs 13.9 U/dl, p=O.0017) 
respectively After 12 months of HRT, there were neither further 
decreases nor increases of Apo(a) Cs in Gr A(21.0 U/dl vs 16.8 U/dl. 
NS), in Gr B(17.1 Uldl vs 17.4 U/dl, NS) and in Gr C(13.9 Uldl vs 9.7 
U/dl, NS) respectively. In Gr D, Apo(a) Cs were nol changed. There were 
no dillerences in Apo(a)·lowering ellects among treated Grs. Total 
cholesterol was decreased in Gr A and B, and not changed in Gr C after 
2 months and 12 months. High densrty lipoprotein cholesterol was not 
Changed in Gr A and Gr B, and increased in Gr C after 2 monlhs. That 
was increased in all treated Grs after 12 monlhs. 
In conclusion, HRT in postmenopausal women lowers the Apo(a) Cs 
and Ihe ellect is maintained at least for 1 year. These results may be 
responsible lor cardioprotective ellect of estrogen in addition to other 
mechanisms. 
965-127 
431A 
Long-Term (5 Year) Cbanges in HDL-Cbolesterol in Cardiac 
Rebabilitation Patients: Do Gender Differences Exist? 
James G. Warner, Ir., Molly E. Rush, Peter H. Brubaker, Ying Zhu, 
Timothy M. Morgan, Paul M. Ribisl, Henry S. Miller, David M. 
Herrington. The Bowman Gray School of Medicine and Wake Forest 
University, Winston-Salem, NC. 
Previous studies demonstrating beneficial effects of exercise on high 
density lipoprotein cholesterol (HDL-C) have been short-term and 
were conducted almost exclusively with men. It is unknown if the 
short-term benefits are equally achieved in both men and women and 
whether the improvements can be maintained with prolonged 
participation in an exercise program. To study this, we compared 
changes in HDL-C in 662 men and women participating in a cardiac 
rehabilitation program for up to 5 years. HDL-C (mg/dl) was 
measured from fasting sera annually among program participants. 
While men showed little or no increase relative to baseline in HDL-C 
(mean±S.E.M.) after 1 year, women continued to achieve increases 
over 5 years (p=0.001 using repeated measures analysis, test for 
linear time trends). 
Xm!: Mm Women 
N !rn!..:C % Increase N HDL-C % Increase 
o SIS 37.0±0.3 147 47.4±0.S 
I 21S 4O.7±0.5 10.0 60 SI.3±0.9 8.2 
2 142 41.0±0.5 10.8 29 S3.8± 1.3 13.5 
3 106 41.2±0.6 11.4 2S 5S.6± 1.4 17.3 
4 87 39.7±0.7 7.3 16 52.0± 1.7 9.7 
S 66 4O.0±0.7 8.1 14 S6.9± 1.8 20.0 
Conclusion: Women with heart disease who participate in a cardiac 
rehabilitation program achieve and sustain even greater increases in 
HDL-C than men. 
432A ABSTRACTS 
965·128 
IIFLUEIICE or aKlLBSTDOL UJIDIIG C. PWIIl IIIIIIBIlII! I.II'Im 11[) cmOlIC 
DAISI'Oi! SYSDIS 
Li jnen P, Celis H, raqard I, staessen J, ft1i js L, and AIery A. Hypertension 
Unit, University of Le1l'len (KULeuven), BelgiUl. 
In order to deteraine whether alterations in Ie!brane lipids affect 
traDSlelbrane cationic transport systelS in erythrocytes and platelets, 
cationic fluxes and intracellular concentrations were JeaSUred in 
bypercholesterolelic patients before and during adlinistration· of a 3' 
bydroxy-3-lethylglutaryl coenzYie ! reductase inhibitor. 
After a 1 IOnth placebo run·in period on a lipid lowering diet, the 
patients were treated double-blind either lith placebo (n' 25) or with 
pravastatin (n • 25) for 6 IODths. Placebo or pravastatin 10 III during the 
first IOnth, 20 III during the second IOntb and 40 III during the additional 
4 IOnths was adlinistered once daily in the evening. 
COipaIed to the placebo group the erythrocyte and platelet Ie!brane 
cholesterol content lIS reduced in the pravastatin·treated patients. !be 
intraerythrocyte and intraplatelet ta+ concentration was reduced during 
pravastatin adlinistration, while the erythrocyte and platelet la+ ,~.puIp 
activity lIS increased. BoVever, the intraerythroctye and intraplatelet ~, 
192+ cytosolic ca2+ concentration and water content as well as the 
ervtbrocYte la+,Li+-countertransport and ta+, K+-cotransport activity and 
the Ja+. and K+'leak were not changed during pravastatin treatEnt. 
our data show that cholesterol lowering in bypercbolesterolealc patients 
IIY result in a significant decrease in erythrocyte and platelet Ie!brane 
cholesterol content. ft1ese changes in lelbrane cholesterol are acco!IpIDied 
by an increase in the la+ ,K+'P~ activity. and by a decrease in 
intraerythrocyte and intraplate let ta concentratlon. 
965·129 
'!!Ie ~.a. _ ~ic: Bignifiaaoe of IalIIL-C, _ Hi. TriglycRidIB JIK:Dg Diat.tic: 0crcIIuy Flati-u. 
&olc:.m BIber, EnD Qraff, Baari.tta Rlticbar-Rlti_, 
IIvnIbea Sbctcl, llic:bal Blmdarly, Va18DtiDa BcIyIrc, Ori 
IJoldbcurt _ the Bazafibrate IDflU"Crt.iCD PravaDtiCD 
(BIP) study CJr'cq), Naufeld cardiac BIIIIaarcb IJBtitute, 
Tal ~, Illreal 
'!!Ie CCiIIbiDatiCD of low BL-C «35 -v/dl), high 
triglycm'idas (>200 -v/dl) IIIlIi diabetas ocartitute the 
"dIIadly triade" (Dl'). It '. freqwmcy IIDd iJIpect. CD 
~i. -=ag ccrCDII!Y pati_ta (pta) i. UIIIaIcMn. 
JIiII::IIg 985 ~i_ ccrCDII!Y pta agad 45-70 yaars frail 
the f_fbi 1 i ty of tha BIP .tudy, the prevaltmca of Dl' 
_ 4t (It iIl.al, 6t ill ~). Pbs with Dl' had the 
__ ~ but higiar rate of hypart_iCD (SOt) than 
trUlterparta witbcut the Dl' (35t). 'DIe lipid profile _ 
.. follCNI: 
Dl' (n-36) 
l'b Dl' (n-953) 
235:t48 
239%40 
165%38 
138%39 
29:t3 
40%10 
Triglyceride 
327:t126 
173:t98 
cardiac .artality aftar a follat-up paried of 3.5 yaars 
_ 14t ill pta with IIDd 4t in tbcae witbcut Dl'. Aftar 
_dUple edj~t iDcludiDg gaJder, 11gB, ~ial 
inflU"Crt.iCD, 8DgiDil IIDd ~iCD in the past the Dl' 
..-gad l1li a .tl"CDJ j" ~iant predictor of ~t 
death (Rltlati_ Rillit 3.2; 95t Ccafidaaoa IDtmvaI 
1.3-7.8) • 
pmgl_iCD: 'DIe Dl' i. a relati_ly rare _tity ..:ng 
ccrCDII!Y ptII. a-var, ~ u- pta lDhibitad a 
four-fold ~ rilllt far death in a:.psriJlCll to 
ccrCDII!Y ptII wltbcut Dl' they cIaaana apacial end 
clClllt acrutiuy duriDg follow-up. 
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966·73 
Validity of Self-Report of Myocardial Infarction in the Elderly 
Christopher J. O'Donnell, Randy Averback, Robert Glynn, Terry 
Field, Gottlieb C. Friesinger, Fran laMotte, Suzanne Satterfield, James 
O. Taylor, Charles H. Hennekens, Brigham and Women's Hospital, 
Boston, MA 
·History of prior myocardial infarction (MI), a risk factor for 
cardiovascular death as well as morbidity, is commonly used to stratify 
risk in patients such as those with unstable coronary syndromes. In a 
general population of the elderly, it is unclear whether self-report is a 
valid measure of prior hospitalization for MI. As part of the National 
Institute on Aging Established Populations for the Epidemiologic Study 
of the Elderly, 3809 residents of East Boston. MA, aged 65 or older 
were followed for 6 years. The self·report of any intercurrent 
hospitalization and MI was recorded in yearly interviews by telephone 
and in·person. Using commonly accepted clinical criteria for MI, we 
sought to confirm the diagnosis by review of hospital records in 22 
participating Boston area hospitals where 489 of the 553 reported 
hospitalizations for MI occurred. Records were obuined for 278 (57%) 
of the patients; for the remaining 211 patients, no record of 
hospitalization could be found at the reported hospital in the specified 
year. Only 41 % (n = 115) of the records reviewed were confirmed 
Mis. Of the 163 hospitalizations that were not for MI. the most 
common reason for admission was cardiac (30 admissions for unstable 
angina, 43 for congestive heart failure, and 18 for arrhythmia), but 
many were not clearly for a cardiac etiology. We also reviewed HCFA 
reports for the 386 patient self·reports which occurred during or after 
1985, when Medicare dau became available. By this source, only 134 
(35%) hospitalizations were for MI. An additional 112 Mis were 
identified by HCFA that were not reported by the participants. In the 
elderly. self-report of MI poorly correlated with hospital diagnosis. 
966·74 
Sigoifi.cm:e of Prebospital <hest Pain, 'IhmIilolytic 'DIerapy, IDI 
M:Jrtality in Elderly alii Yomaer Patients. 
Donald D. Tresch, Tan P. Aufdetheide, Willian Braly, for the Medical 
College of Wisconsin, MilwaJkee, WI. 
2!iJ7 pts evaluated by paranedics for chest pain were studied. Pts 
were divided in three age groups: I) Very Elderly (VE), age 80 or 
older, N • 403; 2) Elderly (E), age 70 or older, N = 1004; and 3) 
Younger (y), age < 70, N = 1503; and clinical characteristics were can•
pared IIlIXlg the groups (pi - Y vs E, p2 _ Y vs VE). Even thrugh ap•
proximately 40% of E and VE had past history of myocardial infarction 
(MI) +/or coronary artery bypass (CABG), the ~ time to seek medical 
assistance fran onset of chest pain was > 5.7 hrs in E and > 7.4 hrs in 
VE. In 70% of VE and 67% of E the chest pain was diagoosed as my0car•
dial ischania, ~ to 49% of Y (pi < O.(XXlI, p2 < 0.0001); appr0x•
imately 25% of each grrup had acute MI (AMI). 26% of Y pts with AMI 
were fsnales, lihereas, fsnales c:x:q>rised 46% of E and 49% of VE pts 
with AMI, pi < 0.0001, p2 < 0.0001. 176 of 346 (51%) Y with AMI re•
ceived thrmbolytic therapy (TI), ~ to only 47/246 (17%) E and 
17/403 0%) VE, pi < 0.0001, p2 < 0.0001. Contrainiications for TI 
were mre camxm in E and VE ~ed to Y (48%, 46%, and 31%, pi < 
0.0001, p2 < 0.01); and E and VE were mre likely to have IJJr1"Q-wave 
MI (67%, 70%, and 49%, pi < 0.0001, p2 < 0.01), 47% of Y and CABG +/or 
Pl'CA, ~ to 32% of E and 21% of VE, pi < 0.001, p2 < 0.001. Of 
AMI pts, 7% of Y died, ~ to 16% of E and 21% of VE, pI < 0.001, 
p2 < 0.00 I. 24% and 35% of deaths in E and VE occurred after 48 hrs of 
hospitalization ~ to only 7% of deaths in Y, pi < 0.001, p2 < 
0.001. TI reduced mrtality in all three groups: Y ~ 10% vs 5%, E = 
17% vs 7%, VE = 22% vs O. 
CXNllJSICN: E and VE pts camonly delay seeking medical assistance 
for chest pain, even thrugh past history of CAD is camxm. fue to this 
delay, the increase contrairxlications, and the increase prevalence of 
IJ:l!t"Q-wave MI, TI is infrequently used in the age groop, and mrtality 
is high. Deaths mre camonl y occur later in hospital course in E and 
VE, canpared to Y, which may partially reflect increase extent of my0-
cardial danage related to decrease utilization of TI and interventional 
therapy in these eUlerly patients. 
JACC February 1994:1A-484A 
966·75 
Repeat Revascularization Following Coronary Artery Bypass Surgery 
and Coronary Angioplasty In Patients Over Age 65 in the United 
States 
James G. JOllis, Judith D. Bebchuk, Eric D. Peterson, Elizabeth R. 
DeLong, Lawrence H. Muhlbaier, Donald F. Fortin, Daniel B. Mark, David 
B. Pryor, Duke University Medical Center, Durham, NC 
The need for repeat procedures is a major limitation of coronary 
revascularization (revase.), particularly coronary angioplasty (PTCA). 
Using the Medicare Provider Analysis and Review (MEDPAR) file from 
1987 - 1990, we examined the rates of repeat coronary artery bypass 
surgery (CABG) or PTCA during the 1st year following initial revase. 
258,172 patients had initial CABG (mean age 71.5,32.6% women, 13.4% 
after acute myocardial infarction) and 155,405 patients had initial PTCA 
(mean age 71.5, 40.7% women, 24.1% after acute myocardial infarction). 
(99% 1 year repeat (99% 
initial 1 year repeat confidence revase. or confidence 
procedure revase. rate intervan death rate interval) 
CABG 1.1% (1.1-1.2%) 12.4 % (12.2-12.5%) 
PTCA 22.6% (22.3-22.8%) 29.3% (29.0-29.5%) 
These repeat revase. rates remained stable over all years studied. Of 
those patients with Initial CABG undergoing repeat procedures, 76% 
underwent PTCA and 24% underwent re-CABG, while following initial 
PTCA, 62% underwent re-PTCA and 38% underwent CABG. The subset 
of patients undergoing Initial revase. following an acute myocardial 
infarction had similar repeat revase. rates to the overall group, but 
significantly higher 1 year mortality. These rates of repeat revase. after 
PTCA are substantially lower than reported angiographie restenosis rates 
of 30-50%. Similarly, the rates of repeat revascularization after CABG 
are also substantially lower than reported angiographie bypass graft 
occlusion rates of 10-18%. While important baseline differences between 
the CABG and PTCA groups prevent direct comparisons, the immense 
number of patients in the MEDPAR file provides stable population based 
estimates conceming the application of revaseularization in the elderly 
U.S. population. 
966·76 
Effect of Propranolol on Mortality in Elderly 
Patients With Heart Disease and Complex 
Ventricular Arrhythmias 
Wilbert S. Aronow, Chul Ahn, Anthony D. Mercando, 
Stanley Epstein, Itzhak Kronzon, Hebrew Hospital Home, 
Mount Sinai School of Medicine, and New York University 
School of MediCine, New York, NY 
A prospective, randomized study compared propranolol 
versus no antiarrhythmic (AA) drug on sudden cardiac 
death (SCD), total cardiac death (TCD), and total death in 252 
pts, mean age 81 ±8 years, with heart disease, complex 
ventricular arrhythmias detected by 24-hour ambulatory 
electrocardiography, and a left ventricular ejection 
fraction <:40%. Of 252 pts, 157 (62%) had prior myocardial 
infarction, and 95 (38%) had nonischemic heart disease. 
Follow-up was 28± 13 months for pts treated with 
propranolol and 26± 13 months for pts treated with no AA 
drug. Propranolol was stopped in 14 of 126 pts (11%) 
because of adverse effects. Data was analyzed by intention 
to treat. At follow-up, SCD occurred in 20 pts (16%) on 
propranolol and in 36 pts (29%) on no AA drug (p=0.015); 
TCD occurred in 37 pts (29%) on propranolol and in 57 pts 
(45%) on no AA drug (p=0.009); total death occurred in 64 
pts (51%) on propranolol and in 77 pts (61%) on no AA drug 
(p=0.099). Kaplan-Meier survival curves showed improved 
survival for SCD in pts treated with propranolol (log-rank 
test: p=0.018), improved survival for TeD in pts treated with 
propranolol (log-rank test: p=0.017), and insignificant 
improved survival for total death in pts treated with 
propranolol (log-rank test: p=0.127). These data show that 
in elderly pts with heart disease, complex ventricular 
arrhythmias, and a left ventricular ejection fraction <:40%, 
propranolol caused a 45% significant decrease in SCD, a 36% 
significant decrease in TCD, and a 16% insignificant 
decrease in total death. 
ABSTRACTS 433A 
966-77 
Elderly Patients Have Reduced Regional Contractile Function and Impaired 
Regional Recovery Despite Successful Early Thrombolysis 
Edward J. Lesnefsky, Conor F. Lundergan, John McB. Hodgson, Ravi Nair, 
Allan M. Ross. Case Western Univ., George Washington Univ. and the 
GUSTO Angiograpbic Core Laboratory, Oeveland, OH and Washington, D.C. 
The mortality of acute myocardial infarction (MI) increases with increasing age. 
Based on experimental animal data, we hypothesized that the elderly (age <!: 
75) have a greater degree of initial regional wall motion dysfunction and 
decreased functional recovery in the territory of the infarct related artery (IRA) 
despite successful early thrombolysis. The GUsro angiograpbic trial enrolled 
546 adult (age < 75) and 78 elderly (age <!: 75) patients who achieved TIMI 2 
or 3 flow 90 minutes post thrombolysis with adequate ventriculograms for 
quantitative analysis. Follow-up ventriculograms (5-7 days) were available in 
414 and 42 of the adult and elderly respectively. Mortality was 17% in the 
elderly and 4% in the < 75 age group (p<O.OOOI). We compared ejection 
fraction (EF), end systolic volume index (ESVI), regional wall motion 
(SD/chord) and MI extent (# chords) in the adult and elderly patients with 
early and sustained IRA patency. 
90 Minutes 
Age < 75 
Age ~ 75 
5-7 Days 
Age < 75 
Age ~ 75 
EF(%) 
6O:t0.6 
57:t2.0 
6O±0.7 
54:t2.5* 
*=p<0.05; **=p<O.OI 
ESVI(CClm') SD/chord 
27±0.6 
29±2.5 
27±0.7 
33±3.1* 
-2.3:t0.l 
-2.8±0.2** 
-1.8±0.1 
-2.5±0.2** 
#chords 
21±0.8 
27±2.1** 
16±0.8 
21±3.1 
Gender, time to treatment, frequency of multivessel disease, and bistory of 
previous MI had no effect on regional wall motion observations. 
Conclusion: The elderly sustain greater regional ventricular injury and reduced 
recovery compared to patients < 75 years of age despite successful early and 
persistent rcperfusion. This may contribute to the significantly greater 
mortality associated with acute MI in the elderly. 
966·78 
Intensive Home-Care Surveillance Reduces the Need 
for Hospitalization in Elderly Patients With Severe 
Congestive Heart Failure 
Ran Kornowsky, Doron Zeeli, Ariel Finkelstein, 
Mordechai Averbuch, Doron Schwartz, Baruch Weinrav, 
Rami Hershkovitz, Dalia Eyal, Michael M11ler, Yoram 
Levo, Amos Pines. 
Dept. of Medicine T, Ichilov Hospital & The Home•
Care Unit, The General Sick Fund, Tel Aviv, ISRAEL. 
Forty two patients aged 78±8 years, sufferin~ from 
grade 3-4 congestive heart failure (CHF) (EF 27±6%), 
were examined at least once a week at home by in•
ternists from the District Hospital and by a trained 
para-medical team. The year prior to entry to the 
Home-Care program was compared to the first year of 
home surveillance. 
The mean total hospitalization O1os) rate was re•
duced from 3.2±1.S to 0.8±1.1 hos/yr and duration 
from 26±14 to 6±7 days/yr ( p < 0.001 for both). 
Cardiovascular admissions decreased from 2.9±1.S to 
0.8±1.1 hos/yr and duration from 23±13 to 4±4.days/ 
yr (p < 0.001). The vital status (the ability to 
perform daily activities, expressed in a 1-4 scale) 
was improved from 1.4±0.9 to 2.3±0.7 (p < 0.001). 
In conclusion, an intensive hOllie-care program was 
associated with a marked decrease in the need for 
hospitalization and improved the functional capacity 
of patients with severe CHF. Such a service also has 
a cost-effective advantage, having a major impact 
on Health expenditure. 
434A ABSTRACTS 
966·79 
Long term Results of PTCA In Patients over 75 Years of Age: 
A Matched Control Study 
Adriaan A. Voors, Jurrien M. ten Berg, HW. Thijs Plokker, Sjef M.P.G. 
Ernst, Egbert T. Bal, Maarten J. Suttorp, E. Gijs Mast. St Antonius Hospi•
tal, Nieuwegein, The Netherlands 
192 consecutive patients (pts) aged 75 or older (75-84/mean n.6) were 
matched w~h 192 control pts aged 40-65 (mean 54.7) who underwent a 
successful PTCA. Groups were matched for gender (42% female, 58% 
male), angina pectoriS (AP) class (50% class IV), acute myocardial infarc•
tion (AMI) prior to PTCA (2.6%), diminished left ventricular function (15%) 
and ,. 2- or 3-vessel disease (resp. 50%, 37% and 13%). The mean 
follow-up time was 40.4 months (0-110). Actuarial analysis after 5 years 
yielded the following results: 
Freedom from events 75+ 40-65 log rank 
Cardiac death 95.3% 97.9% p=O.0490 
Non-cardiac death 93.2% 100% p=O.OOOI 
Myocardial Infarction (MI) 97.9% 96.9% p=0.5549 
Re-PTCA for restenosis 95% 96.4% p=0.1811 
Re-PTCA for any stenosis 91.1% 86.5% p=0.5130 
CABG 97.4% 93.2% p=0.2502 
Re-PTCA, CABG, MI, cardiac death 84.4% 75.5% p=0.4357 
AP 71.9% 76% p=0.0323 
Re-PTCA, CABG, MI, cardiac death, AP 68.2% 68.8% p=O.0891 
Thus, ~ appears that 75 + group had significant poorer cardiac, and 
especially non-cardiac survival. However, the risk of subsequent other 
serious cardiac events such as AMI, re-PTCA and CABG whether con•
sidered separately or in combination is not higher than in younger 
patients. Symptomatic relief is less often observed in the elderly patients. 
When all cardiac events are considered together, (w~h or w~hout AP), we 
found no differences between the groups. We conclude that, w~h regard 
to subsequent cardiac event rates, PTCA can be performed wtth good 
long term results in patients aged over 75. 
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967·80 
Management Patterns and Outcome of Acute Myocardial 
Ischaemia and Infarction in the U.K. 
Timothy J Bowker, Roger M Boyle, Kim M Fox, Jeremy H 
'lurphy and Dayid A ,,'ood, or, behalf of the S.A.M.I.r. 
Studj Group, Department of Clinical Epidemiology, 
:\atioI,al Heart & Lung Institute, London, CK. 
To measure the national frequency, management & 
prognosis of acute myocardial ischaemia (ISCH) & 
infarction (I~F), a random self-weighting sample of 25 of 
the 261 CI\ district general hospitals was dra,,-n. 23 
agreed to identify prospectively 10 consecutive patients 
<70 yrs, being admitted "'ith an initial diagnosis of acute 
myocardial ISCH or INF. Demographic and clinical data 
collected in a standardised format are now available from 
the first 20 hospitals. 146 males and 58 females (mean 
age 58 & 59 yrs, respectively) were ascertained in a 
median survey duration of 10 days. Final diagnosis was 
IKF 10 43.1% (27.9% Q-wave, 15.2% non-Q), ISCH in 48.5% 
and lloncardiac (KCD) in 8.3%. Of Q-.,ave IKF's, 5.3% died 
in-hospital, 3,5% "-ere transferred to regional cardiac 
centres for coronary angiography and 91.2% discharged 
home, Proportions for non-Q INF were 3.3%, 10% & 86.7% 
respectively, for ISCH 0%, 13.1% & 86.9% and for NCD 0%, 
0% 6. 100%. Of the surviving Q-",ave INF's, the future 
management plan on discharge "'as regional cardiac 
referral in 11.1%, local out-patients in 90.7% and no 
follo,,--up in 5.6%. Proportions for surviving non-Q I\'F's 
"'ere 13.8%, 82.8% & 6.9% respectively, for ISCH 32.7%, 
83,7% & 8.1% and for NCD 0%, 58.2% & 35.3%. Except for 
KCD, the more evidence there was of irreversible 
myocardial damage, the less likely ...-as the patient to be 
referred for in"asive management, either as an in-patient 
or later as an out-patient. The C.K. immediate transfer 
rate for invasive management of up to 13.1% compares to 
the 68% & 35% recently reported in the US & in Canada. 
lACC February 1994:1A-484A 
967·81 
Assessing Quality of Life in Patients with Coronary Artery Disease: An 
Alternative Endpoint in Outcome Oriented Clinical Research 
John A. Spertus, Jennifer Winder, Stephan D. Fihn, Timothy A. 
Dewhurst, Richard A. Deyo from the VA Medical Center, Seattle, WA 
The Seattle Angina Ouestionnaire (SAO) is a valid, 19 item, self-ad•
ministered questionnaire for monitoring 5 aspects of coronary artery 
disease (CAD): exertional capacity, anginal stability, anginal frequency, 
treatment satisfaction, and emotional burden. To establish the reliabili•
ty and responsiveness of the SAO, we measured the 3 month change 
in scores among 11 7 patients with stable CAD and 45 patients under•
going successful percutaneous coronary angioplasty (PTCA), Patients 
classified as stable had no change in antianginal medications for 9 
h d h . r d' f 2 h mont san no osplta Izatlons or car lac tests or mont s. 
Ain Ain 
SAO Scale Stable p Value PTCA p Value 
(Range = 0-100) Patients Patients 
Exertional Capacity 1.1 0.48 17.9 <0.0001 
Angina Stability -3.8 0.10 46.3 <0.0001 
Angina Frequency -1 0.56 33.3 <0.0001 
Emotional Burden -0.5 0.77 36 <0.0001 
Treatment Satisfaction -1 0,44 -1.5 0.66 ... 
Among the Initially stable patients, 28 rated their angina as worse, 
73 as unchanged, and 16 as better after the 3 month study period. 
SAO Scale 
Exertional Capacity 
Anginal Stability 
Anginal Frequency 
Emotional Burden 
Treatment Satisfaction 
"pSO.05 ""p~O.Ol 
A in Worse A in Stable A in Better 
Patients 
-6.7"" 
-14.8"" 
-10.4"" 
-9,9"" 
-4.2 
Patients 
2.0 
-4.7 
0.4 
0.5 
-1.2 
Patients 
8.4" 
25"" 
8.8" 
9.4" 
5.6 
The SAQ responds both to the major clinical changes seen after 
PTCA and to the subtler changes seen in relatively stabte patients, Its 
use as an endpoint in clinicat trials would greatly reduce the sample 
sizes necessary to evaluate new therapies for CAD, 
967·82 
Economic Impact or Abrupt Closure Following Percutaneous 
Intervention: The CA VEA T Experience 
Lisa G. Berdan, David R. Holmes. Linda Davidson-Ray. Lai Choi 
Lam. 1. David Talley, Daniel B. Mark for the CAVEAT Investigators. 
Duke University. Durham. NC. 
The economic impact of abrupt closure (AC). which occurs in 
about 5 % of patients after balloon angiq>lasty (PTCA) and directional 
atherectomy (DCA). is not known To detennine the cost associated 
with AC. we prospectively collected economic data on 60% of the 1012 
enrolled pts. Twenty-seven of these 545 pts experienced AC after 
PTCAorDCA. 
Inpatient costs were dramatically higher ($24,042) for the AC 
patients compared with the no AC pts ($11.017) (p<O.OOO1), and the 
length of stay was almost twice as long (9 vs. 5 days, p<O.OOOI). 
Comparison of the components of the hospital costs revealed the 
following mean costs: 
AC(o= 21) ~Q AC (0=5 IS) ~ 
ICU/CCU $4714 $2257 0.0002 
Cath lab/cardiology $5919 $3909 0.0012 
Lab $1357 $505 <0.0001 
Phannacy $1823 $558 0.0002 
OR/anesthesia $2317 $160 <0.0001 
The greater than twofold increase in total costs for the pt with 
AC is due in part to the high incidence of emergency coronary bypass 
surgery (31%) and myocardial infarction (41%) in this group. From 
these data. we conclude that future interventions able to Significantly 
reduce the incidence of AC following percutaneous intervention will 
have a substantial cost-saving potential if other complications are not 
increased. 
lACC February 1994:1A-484A 
967·83 
Echocardiography has a Low Diagnostic Yield in the 
Evaluation of Syncope of Unclear Etiology 
Dino Recchia, M.D. 
Washington University, Sl Louis, Missouri 
The evaluation of patients presenting with syncope of unclear 
etiology frequently involves multiple diagnostic tests. Echo is often 
employed as a means of evaluating cardiac structure and function but 
its role in the evaluation of patients with syncope of unclear etiology 
has not been defmed. A retrospective evaluation was undertaken to 
evaluate the use of echo in patients with syncope admitted to an 
academic medical center. The charts of 35 patients admitted with a 
diagnosis of syncope of unclear etiology were reviewed. The mean 
age was 65.7 ± 18.2 years. The average length of stay was 3.5 ± 
1.6 days and 92% of patients received some form of cardiac 
evaluation during their hospitalization. Echo was performed in 43% 
of patients and failed to reveal the cause of syncope in any patient 
Echo uncovered one case of LV dysfunction not suspected by 
physical examination but this did not lead to a diagnosis. There was 
no relationship between the frequency with which echo was 
obtained and patient age, history of heart disease, presence of 
cardiac abnormalities on physical examination, or choice of other 
diagnostic tests. The use of echo was not statistically different in 
patients with a prior history of syncope compared to those without a 
prior history of syncope (46% vs 41% respectively, p=N.S.). 
Consultation from a cardiologist was obtained in 11 % of patients 
and did not appear to influence the use of echo. These data suggest 
that echos are obtained in a significant number of patients admitted 
to a teaching hospital because of syncope of unclear etiology. The 
presence or absence of objective fmdings on history and physical 
examination did not appear to influence the rate at which echo was 
ordered. The diagnostic yield of echo in this patient population was 
low and added significant expense to the cost of evaluation. These 
data suggest that echo should not be considered part of a routine 
evaluation for syncope when an etiology is not clear from a 
thorough history and physical examination. 
967·84 
Feasibility Of Prehospital Thrombolysis In a Rural Area: The 
Southern Italian Study on Thrombolysis Early In Acute 
Myocardial Infarction 
Vito Rosano, Giuseppe M.e. Rosano, Michele Comito, Michele 
Miceli, Nicola Cardona, Corrado Colistra, Biagio Milano, Francesco 
Miceli, Bruno Lacquaniti, Francesco Romeo for the SISTEMI 
Investigators, ITALY 
The Southern Italian Study on Thrombolysis Early In Myocardial 
Infarction (SISTEMI) has the purpose to treat at home in a rural 
area with thrombolytic therapy patients with suspected acute 
myocardial infarction (AMI) The organization consists of 411 
trained local doctors who administer the rt·PA at home; 12 
cardiologists of the coronary care unit; a system of on-line and 
cellular telephone ECG transmission; and two resuscitating equipped 
ambulances. The rt·PA is administered at home by the trained local 
doctor after transmission of the ECG to the coronary care unit and 
telephone consultation with the cardiologic team. 
Phase I of the project studied the feasibility of prehospital diagnosis 
of AMI for potential thrombolysis, in this phase no thrombolytic 
therapy was given in the field. Fifty-six pts were evaluated, the 
diagnosis of AMI was confirmed in 52 pts in hospital, while the 
remaining 3 pts were found to have unstable angina. 
The average times of intervention were: response time of medical 
team 21 ±5 min; transmission of the ECG and diagnosis l2±6 min; 
insertion of a venous line 5±2 min; preparation and transport 32± J3 
min, 
In conclusion medical selection of pts for initiation of thrombolysis 
at home, in rural areas, is feasible, In these areas prehospital 
intervention may reduce the delays in diagnosis and in the initiation 
of thrombolysis, 
ABSTRACTS 435A 
967·85 
Is Routine Use of Coronary Angiography Justified For Smokers 
Undergoing Lung Transplantation Evaluation? 
David Leibowitz, Andrea Caputo, George Shapiro, Lawrence 
Schulman, Carlton McGregor, Mark Ginsburg, Robert Michler, 
Craig Smith. Marf:o Di Tullio, Shunichi Homma. Columbia 
University, New York, N.Y. 
A large proportion of patients evaluated for lung 
transplantation (L Tx) are smokers who can not exercise because of 
dyspnea, In order to exclude coronary artery disease (CAD) in this 
population, many smokers older than 40 undergo coronary 
angiography. However, the usefulness of this approach remains 
unknown, In order to address this issue, records of 69 smokers older 
than 40 who underwent coronary angiography for L Tx evaluation 
were reviewed, Of these patients, 17 had coronary risk factors 
defined as hypertension, diabetes mellitus, elevated cholesterol, or 
family history of CAD (Group A); 2 had EKG evidence ofM! and 2 
had angina, The rest of the patients were risk factor free, had no 
EKG evidence ofMI and were asymptomatic (Group B), Patients in 
both groups were similar in age (59 vs. 56 yrs.) Significant CAD 
was defined as ~50% stenosis in one of the major coronary arteries. 
Results are as follows: 
~(N=17) 
ilim!Il.B (N=5 2) 
7 (41%) 10 (59%) 
0(0%) 52 (100%) 
P<O.OOOI 
Conclusions' I. Routine use of coronary angiography in all 
smokers undergoing L Tx evaluation is unjustified. 2. The presenct 
of CAD risk factors in addition to smoking identifies a high-ris~ 
subset of patients in whom angiography would be appropriate. 
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968·104 
Abrupt Vessel Closure After Coronary Angloplasty Is 
Associated wIth High IntralumInal Pixel Variance at the 
Post Procedure Angloplasty Site. 
Sean T. Gloth, Mary Jane Flynn, Steven E. Reis, Aravindan 
KoIandaivelu, Jeffery A. Brinker. The Johns HOpkins Hospital, 
Baltimore, MD. 
Abrupt vessel closure, thought to be due to thrombus, is a 
complication of 7% of angioplasty procedures and results in 
death, emergency bypass surgery, or myocardial infarction in 
more than 50% of these patients. Thrombus is 
angiographically detected by the presence of filling defects 
and haziness resulting from platelet aggregation and 
turbulence. We postulated that post image texture could 
quantify these image features and therefore identify unstable 
lesions prone to abrupt closure post angioplasty. The 
variances of intraluminal pixel intensities, a measure of texture, 
obtained from digitized coronary angiograms were compared 
In 7 patients who experienced abrupt closure within twenty· 
four hours of angioplasty and in the same patients after 
successful re-angioplasty without abrupt closure. A high 
variance is associated with a rough texture Q.e. filling defects 
and haziness) whereas a low variance is associated with 
smooth texture. Pixel variance (mean:!:S.D.) in the post 
angioplasty images before abrupt closure was 2.23:!:.74 and 
wes 0.98:!:0.29 following successful angioplasty, p<0.OO2. 
Pixel variance may be a useful quantitative descriptor of post 
procedure angiographic coronary morphology and identify 
unstable lesions at high risk for abrupt closure. 
436A ABSTRACTS 
968-105 
Batt.atiOD of LoIII-'1'_ Mortality of lIyooarcU.al 
IntarotiOD U-1D& leural letvorJca 
William J. loatis, Cb8111 Ii, BvaDgelia 
Micbeli-'1'zanakou, JobD B. loatis. Rutgers University, 
P1aoataway, lev Jersey 
We bave applied neural network algorithms to estimate 
tuture aortal1ty of patients witb aoute ~ocardial 
infarction. 
.l large databue (Myocardial Infarction Data 
.loqu1aition System - MIDAS) inoludilll "9,250 ~ooard1al 
infarctions that ooourred in tbe state of lev Jersey in 
1986 and 1981 vas used. 'l'be following input variables 
vere entered: su, age, diabetes .ellitue, arrbytbm1a, 
oongestive beart failure, stroke, paripberal vuoular 
diseue, bypertenaion, obesity, and ocourrenoe of 
previous myocardial infarction. 
Sinoe intormation sutfioient to allow tbe ezaot 
prediotion of vital statue in all patients witb 100, 
aoouraoy is not usually available, ve developed a 
neural network able to oategorize patients aooording to 
the probability of dying ratber than prediot 
categorioally whetber a given patient will be dead or 
alive at a given tae in tbe tuture. .l new algorithm 
vas developed to aooommodate oues vbere identioal 
input veotors vere usociated witb different outputs 
(vital status). 
Employing tbe above input variables, a tvo bidden layer 
peroeptron vas trained to prediot six aontb IIOrtality 
using the .lLOPBI feedbaok optaization algorithm for 
veight updating. The trained neural network vu 
suooessful in predioting vital statue in unknown ouas 
with 1liJ prediotive aoouraoy. 
Thus, neural netvorks oan be adapted to aooomodate 
oonfl1ot1D& oues and oan be used to predict aortali ty • 
968-106 
Fractal Analysis of Surface Areas of 3-D Objects in 
Echocardiography 
Valerie Desjardins, Thomas Behrenbeck, James F. Greenleaf, 
Marek Belohlavek, Thomas Gerber, David A. Foley, James B. 
Seward; Mayo Clinic, Rochester, MN 
COJ;nputer algorithms for calculating surface area of 3-D objects 
obtam different results depending on the size of the differential area 
patch used to measure area. Three-dimensional ultrasound images 
of car~ac su:uc!Ures hav~ v~ing degrees of roughness depending 
on therr proXlDllty to the unagmg probe and on the ftItering methods 
used in th~ post-processing. Calculations of surface areas of objects 
such as nutral valve leaflets depend on the resolution of the 
reconstructed image and area measurement algorithm. 
We tested the accuracy and precision of surface area measurement 
algorithms (SAM) applied to 3-D objects, reconstructed from 2-D 
echocardiographic data sets. Surface roughness and congruity could 
be varied on a range of simple to complex objects. SAMs that 
calculated surface using total picture element (pixel) areas tended to 
perform worse than SAMs that counted surface volume elements 
(voxels). However, SAMs that fit patches to the surface or which 
measured the area of spines fit to the data tended to perform best. 
The relationship of the size of the smallest surface area to the total 
area of complicated surfaces was somewhat fractal, giving insight to 
methods for solving the problem. We "extrapolated" the fractal 
curve of area vs. measurement patch size to a point of departure 
from fractal (straight line) and found such fractal analysis predicted 
the correct surface area in many examples. 
Conclusion: The relationship of surface area to measurement 
patch size on 3-D rendered images of cardiac structures is fractal and 
thus should be approached using fractal methods. 
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kDa 
with 
Expression and Cellular Localization or 92 
Gelatinase in Coronary Lesions of Patients 
Unstable Angina 
David L. Brown, Margaret S. Hibbs, Marianne Kearney, Eric J . 
Topol, Carrie Loushin and Jeffrey M. Isner, University of 
California, San Diego Medical Center. San Diego CA and St. 
Elizabeth's Hospital, Boston, MA 
The acute ischemic coronary syndromes, myocardial infarction 
and unstable angina, are initiated by rupture of atherosclerotic 
plaque, usually at sites of intense macrophage infiltration. The 
proximate cause of plaque rupture is unknoWD. 
To evaluate the hypothesis that over-expression of matrix•
degrading enzymes by macrophages within atherosclerotic 
lesions contributes to plaque rupture, immunoperoxidase staining 
for 92 kDa gelatinase (G) was performed on directional coronary 
atherectomy specimens obtained from patients with unstable 
angina(UA)(n= 12). Because restenotic lesions exhibited degrees 
of cellularity similar to UA lesions, atherectomy specimens from 
patients with restenosis (R) (n=12) as well as normal left internal 
mammary artery (LIMA)(n=2) specimens obtained at surgery 
were examined as controls. Adjacent section immunostaining 
with cell-specific antibodies to macrophage and smooth muscle 
antigens was used to defme the cellular source of G. 
Immunostaining for G was positive in 10112 UA, 0/12 R and 
012 LIMA specimens. Positive staining localized predominantly 
to macrophage cytoplasm was detected in 9/10 positive UA 
specimens and was observed to a lesser degree in the remaining 
positive UA specimen. Staining was localized predominantly to 
smooth muscle cell cytoplasm in 1110 positive UA specimens but 
was detected to a lesser degree in all 10 positive UA specimens. 
G was detected in the extracellular space in 3/10 UA specimens. 
These results suggest that macrophage or smooth muscle cell 
production of G may, by degradation of extracellular matrix, play 
a role in plaque rupture. 
803-2 4:15 
Regulation of Type-l Plasminogen Activator Inhibitor 
Concentration and Activity in Adipocytes: Implication 
for Obesity as a Risk Factor for Cardiovascular Diseases 
Hirofumi Sawa. Thomas K. Nordt, Burton E. Sobel. Satoshi 
Fujii, Washington University. St. louis. MO 
Obesity is an independent risk factor for atheroscle•
rosis and cardiovascular diseases. and associated with 
attenuated fibrinolysis attributable to increased plasma 
concentrations of type-l plasminogen activator inhibitor 
(PAl-I). the primary physiologic inhibitor of endogenous 
fibrinolysis. In human tissues large amounts of PAI-l 
are detected in lipid-laden smooth muscle cells and foam 
cells. To define potential mechanisms underlying these 
alterations, 3T3-l1 preadipocytes were induced to dif•
ferentiate into adipocytes with isobutylxanthine (0.5 mM) 
and dexamethasone (0.25 ~M) over 7 days and stimulated 
for 24 .hours .with transforming growth factor p (TGF-P), 
a mult1funct10nal peptide present in platelets and re•
leased upon activation. TGF-p increased PAI-I activity 
in conditioned media in a dose dependent fashion (0.8 ± 
0.6 AUlml at baseline, 1.7 ± 0.5 at 0.5 nglml, 9.2 ± 3.0 
at 1 nglml, 11.4 ± 4.3 at 5 nglml, and 10.7 ± 4.7 at 10 
nglml, mean ± SEt n ~ 4) without significantl~ affecting 
cell proliferation. Immunoprecipitation of 5S-labeled 
PAI-I showed that PA1-l antigen in media increased in 
parallel with augmentation in PAI-l activity (6-fold over 
control at 5 ng/ml). Pulse-labeling showed that marked 
elevation in the relative rate of cellular PAI-l synthe•
sis preceded increase in PAI-l activity and antigen in 
the me~ia: These results suggest that (1) TGF-p may 
underl1e 1ncreased plasma PAI-l activity in vivo, espe•
cially in obese patients, in whom the mass of adipose 
~issue can be increased by several fold. (2) elevation 
1n ~lasma PAI-l activity in obese patients is likely to 
be 1nfluenced by synthesis of PAI-l in adipose tissue. 
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~e Lipid-Rich Core ia the Moat ~ro.bogeDic ea.pDD8Dt 
of ._ Atho~8Cle~t1c "-doDa. 
Antonio Fernlndez-Ortiz, Juan Badimon, Brling Falk, 
valentin rueter, Beat Meyer, Aleaaandra Mailhac, Lina 
Badimon. Cardiac Unit. Maasachuaetta General Bospital, 
Boaton, MA. 
Ruptured atheroaclerotic plaques trigger 
thromboai •• Bowever, the relative thrombogenicity of 
different human athero.clerotic plaque components is 
not well established. We investigated platelet 
depo.ition on fatty .treak. (foam cells), .clerotic 
plaque. (collagen-rich matrix), atheromatous plaque. 
(lipid-rich core with abundant choleaterol cryatab) 
and .egment. of normal intima derived from human aorta. 
at necropsy. Specimen. were mounted in a tubular 
perfu.ion chamber and perfu.ed for 5 minutes at high 
.hear rate conditions (1690s- 1 ) with hepariniaed 
porcine blood (ex-vivo, aPTT ratio 1.StO.04) or 
heparinized human blood (in vitro, 2IU/ml). Platelet 
depo.ition, calculated by Indium labeling, was a. 
followa (xl06/cm2, XtSEM)1 
Substrate Ex-yivo 
Normal intima 66t9 (n=4S) 
Fatty .treak 128±35(n=6) 
Sclerotic plaque 108±12(n-24) 
Atheromatous plague 6S8±9Sfn-311* 
In-vitro 
9±2 (n=21) 
lUI (n=19) 
10il (n=15) 
S3±l2 fn=lll* 
Platelet deposition on atheromatous plaques was four•
to aixfold greater than on all other substrate. 
(*p-O.OOOl, K-W test) in both ex-vivo and in-vitro 
ayat~s. Conclusion: The lipid-rich core is the mo.t 
thrombogenic component of human atherosclerotic 
plaque.. Therefore, the increased propensity of 
atheromatous plaques to lead to .cute coronary 
ayndromes may be related not only to their incre •• ed 
yulnerability to rupture but aho to their incre •• ed 
thrambogenicity when the lipid-riCh core i. expoaed to 
flowing blood after plaque rupture. 
803·4 4:45 
Aalodipine Prevents In Vivo LDL-Qxidation, Preserves 
Vitamin E, Inhibits Bypertnsulinemia and Suppresses 
Plaque Growth 
Dieter H. Kramsch, Ramesh C. Sharma, Howard N. Hodis, 
Juliana Hwang, Hei Lai, University of Southern 
California, Los Angeles, CA 
Quantitative coronary angiography in MARS and five 
other lipid-lowering trials showed significant regres•
sion only in advanced fibrous-fatty plaques (>50% 
stenosis) while the younger, presumably more cell 
proliferative lesions «50% stenosis) continued to 
progress, suggesting the need of antiproliferative 
agents for secondary prevention. To test the ~po­
thesis, we investigated a second generation Ca -
antagonist, amlodipine (A) with known in vitro anti•
proliferant and antioxidant properties for its in vivo 
antiatherogenicity in nonhuman primates. We fed 26 
male cynomolgus monkeys for 24 months control diet (C, 
n-5) or atherogenic diet (AD, n-lO) or AD + A (2 mg/Kg 
BW, n-ll). Both AD groups showed comparable rises in 
mean (mg/dl) plasma cholesterol (Ch) & LDL-Ch: AD - 487 
& 308; ADA • 403 & 286. Circulating oxidized 
LDL-cholesterol (LDL-), insulin (I) & triglycerides 
(TG) also rose while y-tocopherol fell significantly 
in AD but not in ADA; blood pressure remained unchanged 
in all 3 groups. At sacrifice all AD monkeys showed 
severe atherosclerosis in aorta and coronary arteries 
(>45% involvement). By contrast, in the 11 ADA monkeys 
lesions were absent in 5, mild in 4 «10%) and severe 
only in 2 animals with significant negative correlation 
to plasma amlodipine concentrations. Conclusion: the 
lipophilic amlodipine ap~ars to stabilize membrane 
lipid bilayers, block Ca movement into cells, prevent 
LDL oxidation, inhibit smooth muscle and macrophage•
foam cell proliferation as well as prevent rises in 
plasma I and TG, thus suppressing atherosclerosis. 
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Chronic ReJection: Gene Transcript Analysis of Cytoklne Activation 
In Rat Cardiac Allografts with Arteriosclerosis 
Mary E. Russell. Nicholas E.S. Slblnga, Africa F. Wallace. 
Lauri R. Wyner, Yukarl Yamashita, David H. Adams, 
Morris J. Kamovsky. Harvard School of PubUc Health and 
Harvard Medical School. Boston, MA 
Heterotopic cardiac transplantation from leWis to F344 rats produces 
allografts With long-term survival that develop arteriosclerotic lesions 
similar to those In human heart vessels. To Identify potentlallnflamma· 
tory mediators Involved In chronic rejection. we compared gene 
expression in rat cardiac allografts (at days 7. 14. and 28) with that in 
paired host hearts (histologically normal but exposed to same 
circulation), syngrafts (LewIs to lewis). and day..Q hearts (harvested but 
not transplanted). Transcript levels were measured by a reverse· 
transcription PCR assay optimized for each gene studied: CD4. CD8. 
MCP-l. IFN·y. and ll..-6. For all five genes. transcript levels increased 
significantly In allografts compared with the other three study groups 
(p<O.OO6). CD8. IPN-y. and ll..·6 levels Increased by day 7 and remained 
elevated, whereas CD4 levels Increased progressively and peaked at day 
28. To determine if this induction was specific to the transplanted heart. 
we compared gene expression in allografts with that in host spleens (at 
days 7 and 28). For the inducible genes IFN-y and MCP-l. high 
transcript levels in allografts were In contrast With low levels in host 
spleens. the major source of inflammatory cells (but without local 
allogeneic stimulation). For the constitutive genes CD4. CD8. and IIA. 
however. allograft levels were mirrored by high transcript levels in host 
spleens. The increase in CD4 and CD8 transcripts documents a time· 
dependent localization of specific T cell and monocyte subsets to the 
allograft. with a correlate increase in ll..-6 I~vels. For IFN·y and MCP-I. 
the localized nature of gene induction is in keeping with the observation 
that chronic rejection occurs only in the donor heart and not in the host. 
These allograft·specific findings strongly support the theory that 
ongoing. local activation of T cells and macrophages. with cytokine 
production. mediates chronic cardiac rejection. 
804·2 4:15 
437A 
Transfer Of human HLA class II alpha chain gene Into cunuracl animal 
cells 
Melna Ren, Lawrence Czar, Ivan AlekSiC, Alfredo Tranto, carlos 
Blanche and Peter Barath, Cedara-Slnal Medical Center, L.oI Angeles, 
CA 
Hypotbeses: 1. Expression Of the raclplent HLA anUgens on the aurface 
of donor organ cells might facilitate the acceptance of both allografts 
and xenografts. 2. Transfer of the recipient's HLA genes leads to 
expression of the anUgens on the surface of the donor cella. Goals: 1. 
To demonstrate the feasibility of the transfer of a human HLA gene Into 
animal cells In vitro. 2. To determine the optimal circumstances of this 
In vitro gene transfer. Methods: Human HLA class II DR alpha gene 
connected with a pVCD VBctor (ATCC) was used for tranlfectlon. The 
DNA wal laolstad and purified with CaCI method and was Incubated 
with lipofectin (Glbco) In different concentration ratios for 10 mlnuteL 
Chicken embryo heart cells were cultured In Medium 199. COS monkey 
cells (ATCC) were culture In DMEM. Transfectlons were performed by 
Incubating the cultures for 4, 8 or 18 hra with DNA:llpofectin complex of 
1:1,1:2,1:4,1:5,1:10 and 1:20 ratios. The cultures were maintained for 
24. 40 or 144 hrs atter ramoval of the DNA:llpOfectin complex. We 
dstected the HLA DR alpha chain antigen production by 
Immunohistochemical staining using a monoclonal antibody. The 
Immunohlstochemlcally positive cell number was expressed In the 
percentage. Results: The Immunohlstochemlcally positive cells 
appeared In the cultures Incubated for 4 houra and were present at 144 
hours after ramoval of the DNA:llpofectln complex. There was no 
significant dlfferance In the percentage Of the positive cells between 
the normal chicken heart and monkey COS tumor cells (2.7 VI. 2.4 %). 
However, the Immunostalnlng was mora Intel11llve In the COS cells. The 
optimal transfaction was achieved with a DNA:llpofectln ratio of 1:4 
with a transfectlon time Of 18 houra. Conclusions: 1. The transfan'ed 
human HLA DR alpha chain gene Is expressed In animal cells. 2. The 
transfactlon time, DNA:llpofectln ratio Influence the level of gene 
exprelsion. 3. To Increase the effiCiency of the gene transfer to the 
level of clinically mesnlngful level other VBctora (viral) are al80 to be 
Investigated. 
438A ABSTRACTS 
804-3 4:30 
Prolonged Expression of Foreign Genes in Cardiac 
Transplants in Rats 
Howard J. Eisen, Sheri E. Belland, Nadine Humen, University of 
Pennsylvania and Temple University, Philadelphia, PA 
We have previously shown that foreign genes can be transfected 
into cardiac transplants in rats with shon-term expression using 
direct intracardiac injection of plasmid DNA. To determine if 
prolonged expression of foreign genes can be accomplished in 
cardiac transplants, we studied 5 Lewis rat recipients of Lewis 
abdominal heterotopic isografts. After anastomosis of the isograft to 
recipient, the transplanted hean apex was injected with lOOug of 
CMV-LUC plasmid DNA containing a reponer gene for luciferase 
under control of a CMV promoterl enhancer. Transplant recipients 
were sacrificed 30 days after transfection and transplantation. 
Transfected transplant hean apexes, nontransfected transplant bases 
and native heans were homogenized, solubilized and cardiac 
luciferase expression was measured by quantifying light generation 
in the presence of appropriate substrates (Iuciferin, ATP). 
Luciferase activity (light units ±SD) in transfected transplant apexes 
was 8,838 ± 7,528 vs 10 ± 20 for nontransfected transplant bases 
(p<O.OI) and vs 3 ± 2 for native heans (p<O.01). We conclude that 
prolonged expression of foreign proteins can be achieved in cardiac 
transplants after transfection with plasmid DNA. This technique 
should allow for prolonged expression of immunologically active 
proteins to alter immune responsiveness to transplanted organs. 
804·4 4:45 
Soluble Interleukin·l Receptor Levels and Allograft 
Vasdopathy: An Intravascular Ultrasound Study 
Hector O. Ventura, Frank W. Smart, Suresh P. Jain, Tracy Toups, 
Tyrone J. Collins, Richard V. Milani, E. Shannon Cooper, Dwight 
D. Stapleton, Christopher J. White, Ochsner Medical Institutions, 
New Orleans, LA 
The pathogenesis of allograft vasculopathy in cardiac transplant 
recipients (CTRs) is likely an immune mediated endothelial injury 
which leads to myointimal proliferation. Thus, elevated soluble 
interleukin-2 receptor (sJL.2R) levels, a marker of T cell activation, 
have been asSOCIated with the development of cardiac allograft 
vasculopathy. To further characterize the relationship between 
allograft vasculopathy and sD..-2R, intimal thickening (IT) and 
percent area stenosis (II> AS) were measured in 3 coronary anery 
segments (proximal, mid, distal) by intravascular ultrasound in 10 
CTRs with normal sD..-2R levels (Group I; sn..-2R=446± 47 U/ml) 
and in 10 CTRs with high sD..-2R levels (Group 2; sD..-2R; 1 139±87 
U/ml). All patients were evaluated at least 1 year after transplant. 
Results are as follows' (mean ± SEM) 
Prurlmal Mid DIsbI 
dlrlR rr "AS rr "AS rr "AS 
f.Jroup I 446:1: 41 0~:l:0.6 9:1:3 19 :1:0.9 1:1:4 0.01:1:0.2 3:1:3 
f.Jroup2 1139 :I: 81" 0.41":1:0.8 20:1:3" 0.41:1:0.1" !D:l:S 0.21:1:0.8 10:1:3 
·In~mal.oolthi k . and f ' h' her· CTR b C erung percent area 0 stenoS1s were 19 ID s 
with high sn..-2R levels. Cardiac transplant recipients in Group 2 
had more diffuse structural changes in all coronary segments by 
intravascular ultrasound than recipients in Group 1 (90% vs 30%, 
p..o.06). This observation supports the hypothesis that cardiac 
allograft vasculopathy is an immunologic phenomenon since CTRs 
with higher levels of sn..-2R demonstrate a higher degree of intimal 
thickening in proximal, mid, and distal segments of the coronary 
anenes by intravascular ultrasound. 
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Tha National Medicare Experlanca: Changing Pattams of 
Myocardial R.vascularlzatlon Utilization and Outcome. 
Eric D. Peterson, James G. Jotlis, S. Robert C'.ollins, Judith D. Bebchuck, 
Elizabeth R. DeLong, Lawrence H. Muhlbaler, Daniel B. Marl<, David B. 
Pryor, Duke University Medical Center, Durham, NC. 
This study examines secular trends in the utilization and outcome of 
coronary angioplasty (PTCA) (N=163,863) and bypass surgery (CABG) 
(N=313,340) in US non-HMO Medicare patients ~ age 65 from 1987-1990. 
The number of initial PTCAs performed Increased by 65%, from 31,242 in 
1987 to 51,576 in 1990. Initial CABGs also increased by 28% from 68,525 
to 87,887 during this period. Increased utilization of PTCA and CABG was 
noted in ail age-groups, but grew fastest In patients age ~80 yrs, whose 
rate nearly doubled over this period. Overall 3D-day and one year mortality 
rates are displayed below: 
.1\1117 
01188 
121 
.1989 1'1~mllJm 0 •• 
PlCADOo,< PICA 1·\1l CJIIG:DO::ti CJIIG 1·\1l 
Overall 3Q-day and one year post-PTCA mortality feil during this time 
period by 48% (95%CI31%-69%) and 10% (95%CI 4%·17%) respectively. 
Overall 3O-day and one year post-GABG mortality also fell by 21% (95% 
CI 15%-28%) and 15% (95% CI 11 %-19%) respectively. 
Conclusion: The last four years have seen dramatic increased use of 
PTCA and CABG in the US Medicare population. This increase in use was 
accompanied by significant improvements in post procedure mortality. The 
reasons for this improvement are not clear, but differences in patient 
selection and technical advances may have contributed. This analysis 
provides population-based national benchmarl< of PTCA and CABG 
mortality. 
805-2 4:15 
Temporal Changes in the Management of Acute Myocardial 
Infarction Between the 19805 and the 19905: 
Are we Getting More Aggressive With the Elderly? 
Sumita D. Paul, Patrick T. O'Gara, Vitasta Bamezai. Adolph M. Hutter, 
Roman W. DeSanctis, Kim A. Eagle. Massachusetts General Hospital, 
Harvard Medical School, Boston. MA. 
Recent studies have suggested a bias in the management of the elderly patient 
with acute myocardial infarction (MO aDd imply that physicians offer less 
aggressive care. This study was done to detennine temporal changes in the 
management of acute MI in the elderly Q7S years) over the past decade, aDd 
to determine if these changes have bad an impact on outcome. 
We studied 154 elderly patients who were admitted between 1981 and 1984, 
and 172 admitted between 1991 and 1992. Both groups of patients were admitted 
with acute MI, 10 the same university teaching hospital. Data for clinical features. 
management, and outcomes were obtained by chart review. 
IimIIIJ;. Elderly patients admitted in the 1980s were more likely to present with 
CHF (40% vs 29%, p<0.05). Pulmonary edema also developed more frequently 
in the 1980s (47% vs 28%, p<O.OOI). There were a significantly greater number 
of smokers among the patients in the 1990s vs 1980s (33% vs 13%, p<O.OOOI). 
However, there were DO significant differences in other cardiac risk factors 
including prior MI, gender, diabetes mellitus, or family history of MJ. 
The utilization of coronary angiograpby in the elderly has increased from 21 % 
in the 1980s to 55% in the 1990s (p<O.OOOJ). The use of PTCA has also 
illl:reased significantly from 0.6% in the 1980s 1019% in the 1990s (p<O.OOOI ). 
However, there has been DO significanl difference in the in·hospital mortality rate 
which continues to be high at 17% in the 1990s vs 12% in the 1980s (p=NS). 
CMrfrrlm': 
I . There has been a striking increase in the use of coronary angiography and 
PTCA after acute myocardial infarction in the elderly over the past decade. 
2. Despite this difference in utilization, there is no difference in mortality rates. 
3, Although we have found that the management of the elderly patient with ,acute 
MI has become more aggressive, the impact of this on patient outcomes IS not 
clear. Prospective studies of much larger numbers of patients are needed to 
examine both costs and outcomes. 
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Marked Benefits or Cardiac Rebabilitation and Exercise 
Training in a Large Elderly Cobort 
Carl J. Lavie, Richard V. Milani, Chris Boykin, Ochsner Medical 
Institutions, New Orleans, LA 
Although cardiac rehabilitation and exercise training are 
associated with reduced coronary morbidity and mortality, elderly 
patients arc often not referred to or vigorously encouraged to 
attend these programs. We compared the benefits of cardiac 
rehabilitation and exercise training in 199 consecutive elderly 
patients ~ 65 years, mean 70±5 years) with those in 259 younger 
patients «65 years, mean 53±6 years). At baseline, the elderly 
patients had lower exercise capacity (-28%, p<O.OOOI), 
triglr.ccrides (-16%, p<.O.OOI), body mass index (-7%, p<.O.OOOI), 
hostility (2.0±3.1 versus 3.W.2 units, p<.O.OOOI), and functional 
scores (34.6±7.3 versus 37.5±8.1 units, p<O.05) and higher 
percentage fat (+5%, p=O.05) and HDL-C (+13%, p<.O.OOOI) than 
the younger patients. After cardiac rehabilitation, elderly patients 
had significant improvements in METs (+43%, p<.O.OOOI), 
percentage fat (-6%, p<.O.OOOI), body mass index (-1%, p<.O.OI), 
HDL-C (+3%, p<.O.OO5), and in nearly all parameters of quality of 
life, but did not significantly improve LDL-C (-3%, p~.08), total 
cholesterol, triglycerides, insulin resistance, or hostility. While the 
improvements in these parameters were statistically similar in 
older and younger patients, after cardiac rehabilitation, elderly 
patients had greater general health (23.8±4.3 versus 22.6±4.5 units, 
p~.09) and mental health (25.6±4.3 versus 23.8±4.3 units, 
p<O.Ol) than younger patients. Conclusions: 1) Following 
cardiac rehabilitation and exercise training, elderly patients 
improve coronary heart disease risk factors, exercise capacity, and 
quality of life to a similar or even greater extent than younger 
patients. 2) These data indicate that elderly patients should be 
routinely referred to and vigorously encouraged to pursue formal 
cardiac rehabilitation and exercise training programs following 
major cardiac events. 
805-4 4:45 
CbaDgiDg Outcome or AogIopiasty In the Elderly 
Randall C. Thompson, David R. Holmes, lr., Diane E. Grill, and Kent R. 
Bailey. Mayo Clinic, lacksonville. FL and Rochester. MN. 
Elderly patients have a higher incidence of procedure related death 
and recurrent angina after FJ'CA. However, receDtly early complication 
rates seem to be imprlM:d. In order to determine whether outcome of 
FJ'CA in the elderly has changed in recent years we compared baseline 
characteristics, hospital results, and late event rates in 982 patients over age 
65 who underwent FJ'CA 1980-1989 (Group A) with 768 patients it 65 
years undergoing FJ'CA 1990-1992 (Group B). Late followup was obtained 
in 100%. 
The more recent elderly cohort was slightly older. Mean Group A 
age 72.4 :I: 5.4 \'5 73.5 :I: 5.7 years Group B (p < .(01). There was also a 
greater incidence of prior myocardial infarction, (46.8% Group A \'Ii 51.6% 
Group B) (p = .05) and prior bypa$s surgery (14.6% \'Ii 21.4%) (p < .(01). 
Slightly fewer vessels were dilated in the more recent cohort (121 
vessels/patient average Group A Vi 1.18 vessels/patient Group B) (p = 
NS). 
The procedural success rate was improved and the acute 
complication rates were significantly lower in the more recent cohort. 
Procedure sucoess rate 88.1% Group A \'Ii 93.5% Group B (p < .(01). 
acute coronary occlusion 6.8% Group A \'Ii 3.3% Group B (p = .(01). 
myocardial infarction 3.9% \'Ii 22% (p = .05). hospital death 3.3% \'Ii 1.4% 
(p < .02). However. late event free survival for hospital survivors was not 
improved in the more recent experience. Group A death/MI rate at six 
months = 4.7% \'Ii 7.1% Group B (p - .05). Combined hospital deathfMI 
+ death/MI in the first six months was essentially equivalent (10.3% Group 
A \'Ii 9.9% Group B) (p - NS). 
Thus, the acute sucoess rate is much improved in the more recent 
experience with FJ'CA in the elderly. This, however. does not translate into 
improved intermediate event free survival. This difference in late results 
may be from changes in the patient population. 
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Inhibition by Gemfibrozil of Induction of Plasminogen 
Activator Inhibitor Type-l by Insulin and its Precursors 
Thomas K. Nordt, Satoshi Fujii, Burton E. Sobel, 
Washington University School of Medicine, St. Louis, MO 
Patients with non-insulin-dependent diabetes mellitus 
(NIOOM) exh ibit accel erated atheroscl erosi s, el evated 
plasminogen activator inhibitor type-l (PAl-I) in plasma, 
and increased insulin (I), proinsulin (Pl, and des(31,-
32)- and des{64,65)proinsulin (d3P and d6P) with fasting. 
We have shown that insulin and its precursors augment 
synthesis of PAI-I in Hep G2 cells (a line derived from 
human liver cells thought to be the major source of cir•
culating PAl-I). To determine whether the increase can 
be suppressed pharmacologically, Hep G2 cells were grown 
to confluence, serum· starved for 16 hr, and exposed to I, 
P, d3P, d6P. (10 nM). or vehicle alone in the presence or 
absence of gemfibrozil for an additional 24 hr. 500 ~ 
gemfibrozil. a concentration that did not inhibit overall 
protein synthesis and one consistent with that seen in 
plasma in vivo after pharmacological administration of 
the agent, decreased basal PAI-l secretion by 18 t 5% (± 
SO) and attenuated the insulin-induced augmentation of 
PAI-I in conditioned media by 52 ± 8% (n = 6 each). 
Inhibition was time- (up to 72 hr) and concentration•
dependent (up to 750 ~M) (n = 3 for each). Gemfibrozil 
attenuated augmentation of PAI·I secretion induced by 
proinsulin (llO t 27%). and the two des products. d3P (80 
± 6%). and d6P (73 ± 17%) as well (n = 3 for each). Re•
sults of Northern blot analyses indicated that the chang•
es reflected modulation of PAI-l gene expression mani•
fested by changes in PAI-I mRNA levels (n = 4). Thus, 
gemfibrozil attenuates the augmentation of ~ynthes~s ?f 
PAI-! by insulin and its precursors. Accord1ngly, 1t 1S 
a promiSing agent for normalizing the impaired fibrinoly•
sis in patients with NIDDM that has been implicated as a 
factor contributing to accelerated atherosclerosis. 
806·2 4:15 
Adenosine Causes Contraction of Human 
Placental Arteries and Veins In Vitro 
Hatim A. Omar, Larry A. Rhodes, Rolando 
Ramirez, Stanley Einzig. West Virginia 
University, Morgantown, West Virginia. 
Adenosine is frequently used for 
termination of supraventricular 
tachycardia. It is often used in pregnant 
females secondary to its short half life. 
In order to determine the effect of 
adenosine on placental vascular tone, we 
used isolated (1-2 mm diameter) placental 
arteries and veins from term uncomplicated 
pregnancies. These vessels, incubated in 
Krebs buffer (Ph 7.4) under 5% 02/ 5% C02 
(balance N2, P02 ~35 torr) were noted to 
undergo contraction of 2.2 ± 0.5 - 3.5 ± 
0.7 gm, (n = 5) when exposed to 1-3 JIM 
adenosine, respectively. This contraction 
lasted 2.5 ± 0.6 - 3.4 ± 0.8 min and was 
observed under basal conditions as well as 
when the placental vessels were 
precontracted with 5-Hydroxytryptamine 
(serotonin) to submaximal level of tone. 
Removal of the endothelium did not alter 
these responses. 
Our data suggest that using adenosine 
for treating pregnant women with SVT may 
cause significant placental vascular 
contraction, which could lead to fetal 
hypoxia. Caution should be observed 
especially when repetitive doses of 
adenosine are used. 
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806·3 4:30 
Inhibition of Na/H Exchange II not the Mechlnllm by Which Amllorlde 
Improves Poatlschemlc Function In Open Cheat Dog. 
Steven C. Smart, JoEl Schultz, Anthony LoCurto, Kiran B. Sagar, David C. 
Warttler, Medical College of Wisconsin, Milwaukee, WI 
Amilorlde (AMl) has been shown to Improve postlschemlc function In 
several models. Amilorlde Inhibtts Na channels, ca channels, Na/H and 
Na/Ca exchange and alpha and beta receptors. Hexamethytene amilorlde 
(HMA) Is a specific Inhlbttor of Na/H exchange which Is 500 times as potent 
as AML To determine K Inhlbttlon of Na/H exchange Is the mechanism by 
which amilorlde improves postlschemlc function, 24 open chest dogs 
undergoing a 15 minute occlusion (OCC) of the proxlmal left anterior 
descending artery (LAD) and three hours of reperfuslon (REP) were 
randomized to three Intracoronary treatment protocols: control (dextrose, 
n=8), HMA (0.06 mg/mln, n=8) and AMl (5 mg/mln, n=8). Infusions Into 
the LAD were started 55 minutes before occlusion and stopped 30 minutes 
after reperfusion (total Infusion time 100 minutes). Regional myocardial 
function and blood flow were measured by sonomicrometry and 
radlolabeled mlcrospheres, respectively. Demand atrial pacing was used 
whenever heart rate decreased below baseline (Bl). Hemodynamics were 
similar In all groups. Blood flow In HMA animals was similar to controls 
throughout the protocol, but amUoride markedly Increased Ischemic zone 
blood flow (p<.01 vs controls) during drug Infusion. During occlusion, 
ischemic zone blood flow In HMA and AMl animals was slmBar to controls 
(0.02±0.01 ml/mln/gm). Systolic shortening (mean ± SEM) was as 
follows: *p<0.01 vs control flg<0.05 vs baseline 
rug 15' 50' 180' 
Bl Treatment OCC REP REP 
Controls 17±1 17±2 17±1 -1 ±2 -2±2 
HMA 15±2 15±2 -8±3 -2±3 -3±2 
AMl 18±2 26±2¢ -8±1 16±2* 10±2* 
Amllorlde markedly Increased blood flow, was posttlvely Inotropic and 
markedly Improved postlschemic systolic shortening. In contrast, HMA did 
not affect regional myocardial blood flow or function and post Ischemic 
function remained dysfunctional throughout reperfuslon. 
In conclusion, Inhlbttion of Na/H exchange Is not the mechanism by which 
amilorlde Improves postischemic function In open chest dogs. 
806·4 4:45 
Monoclonal Antibody to P·selectin (PBl.3) Protects 
Against Loss of Coronary Flow Reserve and Myocardial 
Segmental Dysfunction Following Coronary Artery 
Occlusion and Reperfusion in Dogs. 
Liying Chen, Wilmer W. Nichols, Baichun Yang, James B. 
Hendricks, lawahar L. Mehta, University of Aorida and V A Medical 
Center, Gainesville, FL 
Coronary artery occlusion and reperfusion (O-R) leads to loss of 
flow reserve (CFR), measured as coronary blood flow (CBF) 
response to acetylcholine (ACh) or nitroglycerin (NTG), or reactive 
hyperemia (RH), and reduction in regional shortening fraction (SF). 
Both loss of CFR and SF deterioration after O-R have been attributed 
to neutrophil accumulation in the reperfused regions. To examine the 
effect of PB!.3, a MAb against P-selectin (GMP-140) adhesion 
molecule, open-chest dogs were given PB 1.3 (2mglkg, n=8) or buffer 
(n=8) 50 min into total LAD occlusion. Ten minutes later, the LAD 
was reperfused for I hr. Peak RH (after 20 sec LAD occlusion), A 
CBF in response to ACh (0.5~g) and NTG (25~g), LAD region SF 
and myocardial infarct size (% LV) were measured. 
Results: 
Treatment 
Buffer (n-8) 
PB1.3 (n=8) 
PeakRH 
(Basal 
CBFA%) 
87±17 
196±40* 
·P<O.OI vs buffer group. 
ACBF 
NTG 
(%) 
31±1l 
98±19* 
ACBF 
ACh 
(%) 
55±12 
85±17* 
SF 
(%) 
-2±1 
4±1* 
Infarct 
Area 
(%LV) 
23±1 
10±3* 
Histopathology showed extensive injury and neutrophil accumulation 
in the reperfused regions ofthe buffer-treated dogs. Myeloperoxidase 
activity in the reperfused LAD-supplied regions was also greater Wlan 
in the Cx-supplied regions in these dogs (P<O.OI); this difference in 
myeloperoxidase activity was not observed in the PB 1.3-treated dogs. 
Histopathology also showed marked reduction in injury and neutrophil 
accumulation in the reperfused regions in the PB!.3-treated dogs. 
Thus MAb to P-selectin protects against loss of CFR and SF after 
O-R, and decreases infarct size, probably by reducing neutrophil 
deposition in the reperfused regions. 
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Emel'lency Revasc:ularlzatlon for Refractory Ventricular 
Flbri11ation 
"Fayaz A Shawl, Devendra KAmin, Susan B Hoff, Kathryn G 
Dougherty, Washington Adventist Hospital, Takoma Park, Md 
Refractory ventricular fibrillation (VF) is a uniformly fatal 
arrhythmia. Of 77 pts who required emergency percutaneous 
cardiopulmonary bypass support (PCPS) for hemodynamic collapse 
or cardiac arrest as a result of cardiogenic shock during 
angiography or an interventional procedure, 7 (9%) remained in 
refractory VF even after the institution of PCPS. Of these 7 (4 
males, mean, age 7l±6 years), VF occurred during routine 
angiography in 5 and during complex angioplasty in 2. Mean VF 
time was 39±23 minutes with an average of 4 defibrillation 
attempts. Bypass flow was established within 10 minutes of VF in 
the cath lab in all patients. Mean flow rate was 4.3 Umin. Total 
bypass time was 118±62 minutes and mean blood pressure was 
80±9 mm Hg. Coronary revascu1arization with PTCA (4 pts) and 
CABG (3 pts) was undertaken during persistent VF. All patients 
were successfully defibrillated following revascularization. One 
patient, who suffered recurrent VF, died 10 days post-PTCA. Six 
pts were discharged from the hospital (average length of stay 
18±12 days) without neurological deficit. Conclusion: patients with 
refractory VF can often be successfully defibrillated if they are 
supported hemodynamically through a revascularization procedure. 
These data emphasize the importance of having circulatory support 
available for cath lab emergencies. 
807-2 4:15 
Evaluation of Active Compression. Decompression CPR in 
Victims of Out.of.hospital Cardiopulmonary Arrest 
*Keith G Lurie t, Jeffrey I Shultz t. Michael L Callaham tt, Theresa M 
Schwabtt, Terry Gischttt, Thomas Rectort, Ralph I Frasconettt, 
Linda ALong ttt. University of MiMesota, Minneapolis, Minnesota t; 
University of California, San Francisco, Californiatt; and St. Paul•
Ramsey Emergency Medical Services, St. Paul, Minnesota ttt. 
A prospective, randomized, 10 month pilot study was performed to 
compare standard with active compression-<iecompression (ACD) 
cardiopulmonary resuscitation (CPR) in victims of out-of-hospital 
cardiac arrest in St. Paul, MiMesota. The mean Emergency Medical 
Services (EMS) call-response interval was <3.5 minutes in both 
standard (n=77) and ACD (n",S3) CPR groups. Analysis of all 
patients, independent of the "down time" (time from collapse to arrival 
to scene of EMS personnel), revealed that a higher percentage of ACD 
CPR patients had a return of spontaneous circulation (ROSC), were 
admitted to the intensive care unit (leu), and returned to baseline 
neurologic status versus standard CPR (45% vs 31%, and 40% vs 
26%, and 19% vs 17%, respectively), but these trends were not 
statistically significant (p=O.IO, 0.10, and 0.77 for ROSC, ICU 
admission, and neurologic status, respectively). ROSC, ICU 
admission, and neurologic recovery in both CPR groups were highly 
colTelated with whether arrests were witnessed and with "down time". 
With "down times" <4 minutes, ROSC was 82% with ACD CPR and 
33% with standard CPR (pg).OI) and survival to the ICU was 73% 
with ACD CPR and 32% with standard CPR (pg).05). With "down 
time" of <10 minutes, survival to the ICU was 59% with ACD CPR 
and 33% with standard CPR (pSO.02) and return to baseline 
neurologic function was 30% with ACD CPR and 20% with standard 
CPR (p=0.27). Complication rates were not increased in the ACD 
group. This pilot study demonstrates that ACD CPR resuscitates 
victims in out-of-hospital cardiac arrest with shan "down times" more 
effectively than standard CPR in St. Paul's EMS System. 
Determination of the potential long-term benefits of ACD-CPR will 
J"e{juire further testing. 
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A Randomized Prospective Trial or Active CompresSion -
Decompression Cardiopulmonary Resuscitation during 
Asystole or Electromechanical Dissociation 
·Todd J. Cohen, Bruce G. Goldner, Lisa Lehnert. Paul C. Maccaro, 
Anthony P. Ardito, Salvatore Trazzera. Mitchell B. Cohen, North 
Shore University Hospital-Cornell University Medical College, 
Manhasset, NY 
Recently, improvements in resuscitation, 24 hour survival, and 
neurologic outcome have been demonstated during cardiac arrest with 
use of a modified hand-held suction device (Ambu CardioPumpTM) to 
perform active compression-decompression (ACO) CPR. The 
purpose of this study was to compare ACO to standard CPR during 
asystolic or electromechanical dissociation cardiac arrest (in•
hospital). Pts over 18 yrs of age with witnessed nontraumatic cardiac 
arrest were randomized to ACD or standard CPR. End points 
included initial resuscitation, 24 hr survival, hospital discharge, and 
neurological outcome. CPR was performed at 80-100 
compressions/min, 50% duty cycle with 1.5-2 inch depth. 
Results: 42 pts (21 ACD, 21 standard) were enrolled in the trial. 
57% of ACD arrests were successfully resuscitated vs 24% of 
standard arrests (P < 0.06); 43% of ACD arrests resulted in >24 hour 
survival vs 9% of standard arrests (P<D.04). One of 42 study pts 
survived to discharge (randomized to ACD). Neurologic outcome 
via Glasgow Coma Score was improved with ACD (6.3±1.1) as 
compared to standard CPR (3.1±O.1; P< 0.005). 
Conclusions: Active compression-decompression CPR is a simple 
manual technique which improves outcome following cardiac arrest 
in patients with asystole or electromechanical dissociation. In 
particular, this technique improved 24 hr survival and neurologic 
outcome following cardiac arrest when compared to standard CPR. 
807-4 4:45 
Iyocardial ProtectiYe Iffects of Percutaneous 
Cardiopulaonary Support ill IzperiMatal I1loet 
Iarl B. Scholz, Jens P. Bering. Thollas SchrOder, 
lartus Ferrari. Bani 1. Figu11a, Beinrich (reuzer. 
Gerhard Bellige. University of G6ttingen. laG. 
In cardiogenic shoct, YeDO-arterial bypasl has been 
dis cUlled to induce deleterioul effects to the 
ayocardium becaule of an iDcreale ill after load. 
Thul. effects of percutaneoul cardio-pulaoDary 
support (CPS) 00 ayocardial perfusioD and aetabolisa 
were exuined in differeDt experiaental aodels of 
cardiogenic ahock (sheep, .-18, b.w.: 77-115 kg): 
1.) Tachycardia-iDduced .hoct (bigh frequency 
pacing. 0-9); 2.) Ischeaic .hoct (left coronary 
eabolis. of aicrospherel. 0-9). (KlPeaean aortic 
prellure; IBF .. yocardial blood flow; IV02 .. yocardial 
oxygen consumption; Lac-AVO-arterial coronary-yenous 
difference of lactate; each aean of n-9): 
Pacing-Wet 
I1P (lIIIBg) 
IBY (al/ain*100g) 
IV02 (al/ain*100g) 
Lac-l'ID (801/11 
lachgia 
HlP (IIIIB,) 
IBF (al/ain*100g) 
!!V02 (al/ain*100g) 
Lac-AVD (_111) 
control 
92 
116 
7.1 
0.14 
90 
131 
7.1 
0.07 
shoct 
U 
15 
6.1 
-0.23 
34 
50 
2.6 
-0.68 
.hocHeps 
61 
95 
6.1 
0.01 
61 
fit 
2.7 
-0.38 
In lIoth aodels of Ihoct, heaodynuic and aetabolic 
data luggelt ayocardial protective effectl of cPS. 
Thus. in the beating beart, cPS represents an 
eUective alternatiYe to other assist devicel. 
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Left Atrial SpontaneOus Echo Contrast is a Risk Factor ror Future 
Thromboembo6c Events in Non Valvular Atrial Fibrillation - Results 
or a Prospective Study 
Dominic Y Leung, Ian W Black, Gregory B Cranney, Warren F Walsh. 
Prince Henry Hospital, Sydney, Australia. 
Left atrial spontaneous echo contrast (SEC) seen on transesophageal 
echocardiography (fEE) is associated with a history of previous 
thromboembolism in patients (pts) with non valvular atrial fibrillation 
(NV AF) but the effect of SEC on the prospective thromboembolic risk in 
these pts is unknown. We prospectively followed up a cohort of 233 pts 
(mean age 67 ± 11 yrs, 159 males and 74 females) with NVAF undergoing 
TEE and compared the thromboembolic event rate of pts with and without 
SEC. At baseline, SEC was present in 133 pts (SEC+, 57%) and absent 
in 100 pts (SEC-, 43%). The mean follow up was 17 months (median 18 
months). On follow up, 88 pts in the SEC+ group and 11 in the SEC•
group were on warfarin therapy (p < 0.(01). In the SEC + group, 18 pts 
(13.5 %) had CV AITIA and 2 pts (1.5 % ) had peripheral embolism (overall 
event rate 12%/yr) and in the SEC- group,S pts (5%) had CVA (3%/yr, 
p=O.OI). Compared to the SEC· group, the SEC+ group had 
significantly decreased actuarial survival (p=0.02) and event free survival 
(p=0.007). Multivariate analysis identified only 2 independent predictors 
of subsequent thromboembolic events: presence of SEC at baseline as a 
positive predictor and warfarin therapy on follow up a negative predictor. 
Variable ~ ~ 95%confidence interval 
SEC 0.Q2 3.7 \.2-11.5 
warfarin 0.03 0.25 0.Q7-{)8 
441A 
Age, sex, LV dysfunction, LV hypertrophy, LA size, aortic atheroma, 
mitral annular calcification, previous thromboembolism and aspirin 
therapy were not significant predictors. Conclusions: Presence of SEC 
identifies a subgroup of pts with NV AF who are at higher risk of 
developing future thromboembolic events and in whom warfarin may be 
of most benefit. 
808-2 4:15 
Asymptomatic Stroke in Patients With Chronic Nonrheumatic 
Atrial Fibrillation. 
Michael D. Ezekowitz, Sarkis M. Nazarian, Kenneth E. James, 
for SPINAF Investigators, West Haven, cr. 
The SPINAF study evaluated warfarin for preventing stroke in 
patients with nonrheumatic atrial fibrillation and no clinical 
evidence of previous stroke. To determine the prevalence of 
asymptomatic stroke (AS) and the effect of warfarin among 
these patients, non-enhanced computed tomography (Cf) of the 
brain was performed within one month of randomization and 
after completion of the study. Of 516 neurologically normal 
patients with cr scan at randomization, 78 (15%) had lucencies 
consistent with previous ischemic events; 44/78 (56%) were 
subcortical, 51/78 (65%) were < 4 ern in size and 63/78 (81 %) 
were located in the anterior circulation. Carotid ultrasound was 
performed in 323/516 (63%). Among those with non critical 
disease, <75% occlusion, 42/311 (14%) had asymptomatic 
strokes vs 3/12 (25%) with critical disease. After a mean follow•
up of 2 years, 7 patients had asymptomatic strokes (2 from the 
placebo and 5 from the warfarin groups). 
We conclude that the small number of AS that occurred during 
the study, when patients were under careful neurological 
monitoring, compared to the large numbers reported in other 
studies and found at our baseline, suggest that most of these 
strokes represent undiagnosed rather than asymptomatic strokes. 
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808·3 4:30 
Distribution of Mobile Aortic Masses and Their Relationship to Aortic 
Atherosclerosis: A TransesophageaJ Echocardiographic Study of the Thoracic 
Aorta 
Kenneth J. Yvorchuk, Randall A. Sochowslti, Kwan L. Chan, University of 
Ottawa Heart Institute, Ottawa, Canada 
To evaluate the features of mobile thoracic aortic masses the records of 3300 
patients (pts) who underwent transesophageal echocardiography were reviewed. 
The incidence of mobile masses was 1.5 % with 93 masses in 50 pts (single 
mobile mass (SM) in 31 pts; multiple masses (MM) in 19 pts). Of these 93 
masses, 40 (43%) were present within a 4 cm segment at the lraDsition between 
the arch and descending aorta. This clustering was particularly striking in SM 
pts with 22 of 31 (71 %) masses present in this region. Of the remaining 53 
masses, 1 was located in the ascending aorta and the rest scattered throughout the 
descending thoracic aorta. In 18 SM pts and 12 MM pts (60% of all pts) a 
mobile mass was located at or proximal to an arch vessel. 
The severity of atherosclerosis in 4 segments of the thoracic aorta [ascending 
(A), distal arch (DA), proximal descending (PD) and distal descending (DD») 
was scored: 0= normal; 1 = intimal thickening; 2= plaque protruding < 5 mm; 
3 = plaque protruding > 5 mm. The MM group had a greater overall degree 
of atherosclerosis than the SM group. Atherosclerosis was least in the ascending 
aorta, and involved the other 3 segments to a similar degree but was consistently 
more severe in the MM pts: 
MM 
SM 
P 
Il 
19 
31 
Average Score of Aortic Segments 
Overall A DA PD 
2.40 1.06 2.68 2.84 
1.80 0.77 2.19 2.10 
0.001 0.10 0.08 0.006 
DD 
2.68 
2.27 
0.27 
l V dysfunction was graded (0 = normal, I = mild, 2 = moderate and 3 = 
severe), and was more severe in the MM pts (average grade 1.2) than the SM pts 
(average grade .45, X' = 12.3, P = 0.(08) 
Conclusions: Mobile intraluminal masses tend to cluster within a small 
segment of the aorta, frequently at or proximal to an arch vessel. They appear 
to be a manifestation of atherosclerosis, a diffuse process with a predilection to 
the distal arch and the descending aorta. Multiple masses occur in patients with 
a greater degree of atherosclerosis and more severe left ventricular dysfunction. 
808·4 4:45 
Elevated Plasma Levels of Hemostatic Markers Indicate Ii Prethromhotic 
State in Patients with NODvaivular Atrial Fibrillation. 
Rolf Mitusch, Michael GaJbe, Hans Joachim Siemens, ,nomas Wagner, 
Abdolhamid Sheikhzadeh, Karl Werner Diederich. Cardiology and Medical 
Clinic, University of Luebeck, Germany. 
Nonvalvular atrial fibrillation (AF) holds a risk for systemic embolism. To detect 
an activation of the hemostatic mechanism and a possible reversibility by the use of 
anticoaguIants in AF, plasma levels of hematologic markers were determined in 32 
patients (pts) with AF (group I), 17 pts with AF receiving warfarin or intravenous 
heparin (group 2) and 24 age matched controls. Prothrombin activation fragment 
1+2 (F 1+2), thrombin-antithrombin II1-<Xlmplexes (TAT), fibrin monomers (FM), 
tissue-plasminogen activator (t·PA), plasminogen activator inhibitor (PAl-I) and 
D-dimers were measured by ElISA·technique. Levels are given as mean ± SEM: 
Yrl!!ml; Group 2: Control: D-value: 
Age (years) 74 ± 2 72 ± 2 70 ± 2 NS 
Prothrombin time (sec) 28 ± 0.7 48 ± 4.0 27 ± 0.6 < 0.001 
F 1+2 (nm01l1) 1.2±0.1 0.8±0.1 0.9±0.1 <0.05 
TAT (Ilgll) 8.9±2.0 3.7±0.6 2.3±0.3 <0.001 
FM (nm01l1) 24.2 ± 4.8 19.4 ± 4.8 16.9 ± 4.6 NS 
t-PA (Ilgll) 9.3 ± 0.7 22.2 ± 1.9 7.2 ± 0.5 < 0.001 
PAl-I (Ilgll) 66.5 ± 6.7 78.3 ± 5.6 52.4 ± 5.4 < 0.05 
D-dimers (Ilgll) 791 ± 132 570 ± 134 440 ± 58 < 0.05 
Fibrinogen (gil) 4.6 ± 0.4 4.7 ± 0.5 3.3 ± 0.3 < 0.05 
In AF, levels of F 1+2 and T AT were elevated indicating enhanced prothrombin 
conversion and thrombin formation. FM levels, which demonstrate thrombin ac•
tion on fibrinogen, were only insignificantly elevated in AF, suggesting a sufficient 
inactivation of thrombin by antithrombin III in most of the pts, thus preventing the 
coagulation system from further activation. D-dimer levels were higher in group I 
compared to the other groups indicating plasmin action on fibrin and intravascular 
thrombus formation. In pts receiving anticoagulants, levels of F 1+2 and T AT 
were lower or normalized and fibrinolytic markers (t-PA and PAl-I) were elev•
ated. Fibrinogen levels were higher in both groups with AF. In conclusion, a pre•
thrombotic state is detected in AF, which is reversible by anticoagulant therapy. 
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809·1 4:00 
Myocardial Infarction Q Waves are 
Conduction 
Related to Slow 
Robert J. Hariman, Dayi Hu, Henry S. 
Scanlon, Hines VA Hospital, Hines, 
University Medical Center, Maywood, IL 
Loeb, Patrick J. 
IL and Loyola 
Q waves due to myocardial infarction (MI) have been 
explained, first, by normal contralateral endocardial to 
epicardial depolarization (Wilson'S window theory) or, 
second, by slow epicardial to endocardial depolarization 
adjacent to the MI (vectorial theory). We attempted to 
determine which explanation on the origin of Q waves in 
MI (QM!) is more likely by measuring dV/dt of QM! and by 
comparing it to that of normal Q waves (Q.). If the 
first theory is correct, dV/dt of QM! should not differ 
from dV/dt of QN' If the second theory is correct, dV/dt 
of QM! should be less than dV/dt of QN' because the Q 
vector is due to abnormal slow conduction in the 
infarcted area. Therefore, we measured dV/dt at 10 msec 
(dV/dt,,,,,«) after the onset of the Q waves and at the 
point of maximum dV/dt (dV/dt~) in 19 patients with 
documented Q wave MI (12 inferior wall and 7 
anterolateral wall MI) and 11 normal individuals. 
Results: dV/dt (Mean ~ SD, in V/sec) of Q waves in leads 
II, III, and AVF in inferior wall MI vs normal: 
dV/dtlO~", dV/dt~ 
Normal (N=ll) -7 .1~2. 2 -8. 3~3.1 
MI (N=12) -2.4~1.1· -3.0~1.8· 
dV/dt (V/sec) in I, AVL, VS and 
anterolateral wall MI vs normal: 
dV /dtlomsee 
Normal (N=ll) -4.7~2.4 
MI (N=7) -2.1~O.7·· 
*p<O.Ol, *·p<O.OS, compared to QN" 
dV/dt~ 
-S.1~2.3 
-2.7±O.9** 
V6 in 
Conclusion: The lower values of dV/dt"",., and 
dV/dt~ in QM! compared QN suggest that abnormally 
directed conduction adjacent to the MI is responsible for 
QM!' This study supports the vectorial origin of Q,,!. 
809·2 4:15 
Inherent Variability in Transient Ischemia Ma~' Make Ambulatory ST 
Segment Monitoring Inaccurate in the Assessment of Therapeutic Agents 
De\'en J Patel. David Mulcahy. °John Norrie. Jane Sparrow, Christine Wrighl 
°lan Ford. Kim Fox. Royal Brompton National HeaM and lung Hospital, °The 
Robertson Centre for Biostatistics, Glasgow University. UK 
Introduction: Ambulatory ST monitoring is increasingly used to assess the effect 
of therapeutic agents on the frequency of the total ischemic burden. Tbe 
minimum duration of monitoring recommended to minimise natural variability is 
48 hrs. It is not clear, however. whether inherent variability in ischemic acti\ity 
during serial 48 hr monitoring periods could influence the assessment of the 
effect of therapeutic interventions. 
Ml!thods: We performed 48 hr periods of ST segment monitoring. outside 
hospital. off all routine anti-anginal therapy. for 4 consecutive weeks. in 16 males 
(mean age 58~TS) with proven CAD, stable angina and 3 positive exercise ECG. 
Results: There were a total of 142 episodes of ischemia in 64 periods of 48 hr 
monitoring. 5 pts (31 %) had no ischemia during any nlonitoring period. 
Patient A BCD E F G HI J K 
Visit 1 10 3 0 3 5 3 2 0 8 0 I 
Visit 2 9 8 I I 5 3 I I 3 2 2 
Visit 3 3 6 0 I 4 I 7 0 15 2 5 
Visit 4 5 3 0 I 3 0 7 0 4 I 3 
Estimated number of subjects. based on the results. for 80 % power at the 5 % 
significance leycl for a cross-()\'er study and a parallel group design comparing 
two therapies. are shown below. 
Cross-Oyer Group 
Parallel Group 
30 % Ischemia Reduction 
70 
260 
20 % Ischemia Reduction 
160 
600 
Conclusion: There is marked inherent variability in ischemic activity. making it 
potentially difficult to accurately assess the effects of therapeutic agents on the 
total ischemic burden unless a large number of subjects is studied. The results of 
small sample studies should be interpreted \lith caution when no difference is 
demonstrated between treatments. Multiple period, of monitoring for each 
treatment strateID' would help minimise variability and thus reduce sample size. 
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809·3 4:30 
Silent Ischemia During Ambulatory ECG Monitoring Identifies Multivessel 
CAD Patients Who are at Increased Risk of Cardiac Death 
Prakash C. Deedwania, EnriQue V. Carbajal, James Oakley, VAMC, 
Fresno/UCSF School of Medicine, San Francisco, CA 
Most patients (ptsl with multi vessel CAD are referred for myocardial 
revascularization based on extent of disease revealed by angiographic 
findings. Recent efforts to contain health care costs now make it 
essential for us to identify pts who are most likely to benefit from 
revascularization. Accordingly we compared the prognostic value of 
angiographic findings, clinical variables, exercise (Exl test parameters, 
and ambulant ischemia in 52 pts with stable angina, Ex-induced 
ischemia, and multivessel CAD (~2 vessels, ~ 70% narrowing). Two 
channel Holter monitoring (HMI was performed for 24-48 hours utilizing 
freQuency modulated recorders. Holter tapes were analyzed in a blinded 
fashion by 1 x1 x1 rule. Pts were continued on prescribed antianginal 
drugs and followed at 3-month intervals. Of the 52 pts, 25 (Gr11 had 
silent ischemia and 27 IGr21 had no ischemia during HM. Although both 
groups were comparable in age, angina history, prior MI, coronary risk 
factors, and ECG findings, Gr 1 pts had earlier onset of ischemia during 
Ex (p< .011. Over a mean follow-up of 23 ± 8 months, there were 7 
(28%1 cardiac deaths in Gr 1 compared to only one (4%1 in Gr 2 pts 
Irelative risk 7.0), Kaplan-Meier actuarial survival analysis revealed a 
significantly (p< .021 worse survival for Gr 1 patients. Stepwise 
multivariate Cox regression analysis of 13 variables including 
angiographic findings, exercise parameters, HM results, and LVEF 
revealed ischemia on HM as an independent and the most powerful 
predictor of survival. 
Conclusion: Silent ischemia during daily life is a powerful and 
independent predictor of clinical outcome and survival in patients with 
stable multivessel CAD. Because patients with multivessel CAD without 
ischemia during daily life have an excellent prognosis they may not 
benefit from myocardial revascularization unless it is indicated for control 
of symptoms in presence of drug refractory angina. 
809·4 4:45 
Mechanism of Stress Induced ST Elevation Determined 
by Dobutamine Echocardiography. 
Colleen M. Coughlin, Carlos A. Roldan, 
Michael H. Crawford. University of New Mexico and 
VAMC, Albuquerque, New Mexico 
Although stress induced ST elevation is commonly 
believed to represent dyskinesis in post myocardial 
infarction patients, little direct validation of this 
hypothesis exists. Some investigators have speculated 
that during stress testing, ST elevation is related to 
elevated plasma norepinephrine levels (Eur Heart J 
1988; 9: 359). To clarify the mechanism underlying 
stress induced ST elevation, we studied 27 post 
myocardial infarction patients with dobutamine 
echocardiography. The mean patient age was 63 years 
and ejection fraction range was 25 to 60%. Results: 
Of these 27 patients, 15 demonstrated ST elevation at 
peak dobutamine infusion on a 12 lead EGG. ST 
depression was induced in the remaining 12 patients. 
Of the 15 patients who had ST elevation, 13 had left 
ventricular regional dyskinesis. Whereas, only one 
patient with ST depression had dyskinesis. The 
sensitivity and specificity of ST elevation in 
predicting dyskinesis is shown in the table below. 
Sensitivity 93% 
Specificity 85% 
Positive Predictive Value 87% 
Negative Predictive Value 92% 
We conclude that the underlying mechanism of stress 
induced ST elevation in post myocardial infarction 
patients is left ventricular regional dyskinesis and 
that ST elevation is an accurate marker for 
dyskinesis. 
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Differential Mechanistic Responses of Atrial Tachycardia 
to Adenosine 
Erica D. Engelstein, Kenneth M. Stein, Neal Lippman, Laura Seche, 
Bruce B. Lerman. The New York Hospital-Cornell Medical Center, 
New York, NY. 
Adenosine's antiarhythmic effects on supraventricular tachycardia 
were originally thought to be confined to tachycardia involving the 
A V node. However, recent reports have suggested that adenosine 
also has antiarrhythmic effects in atrial tachycardia. We hypothesized 
that the response of atrial tachycardia to adenosine would be 
mechanism specific and that adenosine would affect atrial 
tachycardias due to sinus node reentry, cAMP mediated triggered 
activity or enhanced automaticity but would be ineffective in 
terminating reentrant atrial tachycardia. This was based on the 
cellular effects of adenosine on supraventricular tissue, which 
include: I) shortening of action potential duration in atrial myocytes 
mediated by the potassium current, IKAdo, 2) shortening of action 
potential duration and hyperpolarization in sinus node cells, and 3) 
anti adrenergic effects due to inhibition of cAMP. To test our 
hypothesis, we administered adenosine, 6-24mg IV, to 19 pts 
(52±21 years, mean±SD) with atrial tachycardia whose mechanism 
was conlinned by eleclrophysiologic study. 
Results: 
Auial tachycardia 
Sinus node reentry 
Nonreentranl 
Reentrant 
Cycle Length 
(ms) 
385±78 
486 ± 73 
293 + 57 
Response to Adenosine 
tenmnated 6/6 
suppressed or terminated 717 
no effect 6/6 
Conclusions: These findings demonstrate that adenosine's effects 
on atrial tachycardia are more complex than previously recognized. 
Adenosine's effects are mechanism specific and can thus be used as 
a diagnostic tool to diferentiate between sinus node reentry, 
nonreentrant atrial tachycardia and reentrant atrial tachycardia. 
810·2 4:15 
Termination and Suppression of Experimental Canine 
Atrial Flutter by Dofetilide: Effects on Dispersion of 
Repolarization and Conduction Velocity 
*Gregory K. Feld, Yong-Mei Cha, Neil Sawhney, University 
of California San Diego, La Jolla, CA 
To study the mechanisms of termination and suppression 
of atrial flutter (AFL) by dofeti1ide (D) in the canine 
right atrial crush-injury (Cl) model, a 56-bipolar 
electrode plaque was placed over the CI in 8 dogs to map 
epicardial activation patterns during and at termination 
of AFL and to measure effective refractory periods (ERP) 
at 56 sites and conduction velocity (CV) parallel to the 
CI, before and after D (25mcg/kg over 10 min, then 9 
mcg/kg/min). Results: Initiation of AFL at baseline was 
dependent on unidirectional block below CI. At baseline, 
ERP was longer below CI than above (118±9 ms vs 113±8 
ms, p<O.OOI) and there was significant overall 
dispersion of ERP (7.2±2.6 msec, p<O.OI). CV was slower 
below CI than above (0.69 m/s vs 0.91 mis, p<O.OOI). AFL 
terminated after 0 in all 8 dogs due to block below CI, 
occurring either abruptly or following premature 
eccentric activation of the reentry circuit. After 0, 
ERP was prolonged significantly overall, the difference 
in ERP above and below CI was eliminated (142±9 ms vs 
141±12 ms, paNS), and overall dispersion of ERP was 
reduced (6.6±3.7 msec, paNS). CV was slightly but 
similarly slowed above and below CI by 0 (0.62 mls vs 
0.87 mis, p<O.OOI). AFL was not inducible after D in any 
dog. Conclusion: 1) Dispersion of ERP and CV appears to 
playa role in the initiation of AFL, 2) Termination and 
suppression of AFL by 0 appears to be related to 
prolongation of ERP and elimination of dispersion of 
ERP, but not due to alterations in CV. 
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The Response to Atrial Pacing as an Aid to the Diagnosis 
of Atypical Atrioventricular Nodal Reentrant Tachycardia 
K. Ching Man. Brian D. Williamson. Emile Daoud. Mark Niebauer. 
John Jentzer. Omar Bakr. John D. Hummel. S. Adam Strickberger. 
Fred Morady. University of Michigan. Ann Arbor. MI 
Long R-P tachycardias may be caused by atypical atrioventricular 
nodal reentrant tachycardia (AA VNRT) or reentry involving an 
accessory pathway which conducts slowly in the retrograde direction. 
Because of retrograde conduction through a proximal common 
pathway during AA VNRT. we hypothesized that the AH interval 
during AA VNRT would be shorter than during atrial pacing at the 
tachycardia cycle length (CL) in the setting of sinus rhythm. In 
contrast, because there is no reentry within the atrioventricular node in 
orthodromic reciprocating tachycardia (ORn. the AH intervals during 
ORT and atrial pacing should be similar. Consecutive patients with 
AA VNRT (n=ll) and ORT (n=16). diagnosed by conventional 
criteria and subsequently successfully ablated with radiofrequency 
energy. were enrolled in the study. The AH intervals were measured 
at the His catheter during the tachycardia and during atrial pacing from 
the high right atrium (HRA) at the tachycardia cycle length in the 
setting of sinus rhythm. 
AAVNRT 
ORT 
Tachycardia AH AH·paced 
(msec) (msec) 
101±41 
128±43 
164±57 
126±412 
Values are expressed as MS ± SO 
Delta AH 
(msec) 
63±30 
2±5 
p value 
<0.001 
NS 
In all the cases of AA VNRT. the AH during tachycardia was ~ 30 ms 
shorter than during pacing. In contrast. in all cases of ORT. the 
change in AH interval during tachycardia was never more than 10 ms 
during pacing. Conclusion: The difference in the AH interval 
between atrial pacing and the tachycardia allows a simple and rapid 
means of differentiating AA VNRT from other types of long R-P 
tachycardia. 
810·4 4:45 
Constant Direction of Multiple Episodes of "Linking" During 
Atrial Fibrillation: Implications for Possible Mechanisms 
Adam T. Schoenwald. Alan V. Sahakian. Haris J. Sih. Steven Swiryn. 
Northwestern University and the Evanston Hospital. Evanston, II... 
We have previously reported ttansient "linking" of atrial endocardial activation 
during atrial fibrillation (AF), during which consecutive electrograms (EO) have 
similar vector directions. Over the few episodes of linking seen during 1 minute, di•
rections apparently repeated. In the present study, we examined AF over 15 minutes 
to see if this constancy of direction is stable. 
Endocardial recordings were made from 5 patients with AF (1 chronic, 4 induced) 
using a catheter with 3 orthogonal bipoles, allOwing measurements in three dimen•
sions. The direction of activation for each EO was calculated using Pipbergei's half•
area method. Pairs of adjacent electrograms with directions within 30 degrees were 
identified, and consecutive strings of 5 or more such pairs were termed as one 
episode of linking. An average direction for each episode of linking was calculated 
and ploued in 2 dimensions using spherical coordinates (a1tirude and azimuth). 
The number of episodes of linking detected for each patient was 3, 17, 50, 52 and 
90. In all cases, the episodes for a given patient clustered closely in direction, 
though episodes may have been separated by several minutes. In conlJ'ast, directions 
measured for the EGs in general filled up the entire available range. An example for 
the patient with chronic AF is shown below. Figure A indicates the average direc•
tion for each of 50 episodes of linking over 15 minutes, while Figure B shows the 
directions of all EGs during the same time period. Note that each dot in Figure A 
represents an average of six or more EGs. 
90 
II 45 
'to 
B 0 := 
< -45 *> 
-90 0 
Fig. A Fig. B 
180 
Azimuth 
360 
90 
II 45 
j 0 
< -45 
-90 
Condusions: A constant direction for many episodes of linking over long 
time periods conflicts with the traditional description of AF as "random". Multiple 
circulating wavelets or a moving rotor constrained by constant anisotropiC properties 
of the atrium, or ectopic foci with fibrillatory conduction are consistent with this 
finding. 
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Computer Modeling of Dual Atrioventricular Nodal Pathways 
Wanzhen Zeng, Todor Mazgalev, Patrick Tchou, Jose Jalife, University of 
Pittsburgh, Pittsburgh, PA and SUNY Health Science Center, Syracuse, NY 
Recent insights into the cellular electrophysiology of the atrioventricular nodal 
(A VN) dual pathways (DPW) suggest a complex time/space interaction between 
wavefronts resulting in a variety of conduction phenomena. The purnose of this 
study was to develop a computer model based on the available experimental data 
which could be used to extend the mechanistic understanding of the DPW. ~ 
1IWlkl, built as a ring-like structure (see figure), contained up to 300 cells forming 
a longer slow (SPW) and a shorter fast pathway (FPW) 
limbs, which met at a junction ( .). A common pathway 
led to a functional "barrier" (thick line). It represented 
the ttansition between the proximal N cells and the distal 
NH-H cells. The simplified ionic model of the former 
consisted of a slow inward calcium, a delayed rectifying 
potassium and a background currents, while sodium 
current was added to the ionic model of the latter. The 
length, width and conduction properties of each limb 
could be arbitrarily adjusted and "dead" zones could be 
created to produce local block in either of the DPW. 
Stimulation ( SI ) was applied as a sequence of basic beats A I followed by 
premature beats A2 and A3. Conduction curves along with cellular action 
potentials for the test beat A3 were constructed as a function of the preceding 
coupling intervals (CI). ~ The model predicted the following four major 
prematurity-dependent patterns of interaction between wavefronts initiated in the 
DPW structure: I) Switch between FPW which was predominant at longer CI, 
and SPW which was predominant at shorter CI, resulting in either smooth or 
interrupted conduction curves. 2) Summation at the junction producing either 
improvement of conduction due to increased proximal driving force or. in 
conlJ'ast, distal block due to earlier arrival of impulse at the barrier. 3) Retrograde 
invasion of the SPW by the FPW wave with collision resulting in annihilation. 
4) Electrotonic inhibition at the junction following parrial depolarization 
produced by the FPW. ConrJusjop; The proposed model provides a mechanistic 
explanation for numerous experimentally observed phenomena and can be used as 
a guide in further detailed experimental studies of the DPW. 
811·2 4:15 
Modulation of the Electrophys101og1c Effects of 
Ambasilide Induced by Beta-adrenergic Stimulation in 
Isolated Ventricular Myocyte. 
Carlo Napolitano, Livia Diehl, Peter J Schwartz, Silvia 
G Priori. Depts of Medicine, University of Milan and 
Pavia, Italy 
There is growing interest for potassium channel 
blockers in the treatment of arrhythmias; however, under 
conditions of increased adrenergic activation their 
elecrophysiologic properties may be substantially 
modified thus reducing the antiarrhythmic efficacy. In 
the present study we evaluated if beta adrenergic 
stimulation alters the electrophysiologic effects of 
ambasilide (Amba) , a new potassium channel blocker. 
Isolated guinea pig ventricular myocytes (n-ll), 
superfused with HEPES buffer (pH 7.3; 37 C), were 
exposed to Amba (10'6M) for 15 minutes and action 
potential duration at-80mV (APD) was measured at steady 
state during pacing at different frequencies (0.5- 2Hz) . 
This allowed to evaluate if Amba presents the "reverse 
use dependency" phenomenon. Isoproterenol 10-% (Iso) was 
added and after 10 minutes the pacing protocol was 
repeated. Amba significantly prolonged APD, but at 
variance with other agents of the same class APD 
prolongation was constant at all cycle lengths. Iso 
blunted APD prolongation by 40% at all pacing 
frequencies. APD changes are shown in the table (*p<O,05 
vs control;**p<0.05 vs Amba): 
0.5Hz 1Hz 1. 5Hz 2Hz 
Control 217+17 221+20* 216+20* 209+18* 
Amba 281+44 291+29* 284+26* 272+26* 
Amba+lso 256+31 259+25** 256±23** 249±22** 
These data suggest that: 1) Amba lacks reverse use 
dependency thus making less likely proarrhythmic events 
mediated by excessive APD prolongation at low pacing 
frequencies; 2) Beta adrenergic stimulation 
substantially attenuates the effects of Amba at all 
cycle lengths implying that the drug may be less 
effective during sympathetic activation. 
lACC February 1994:1A-484A 
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Vagal ModulaUon of Ventricular IlepolarlzaUon and F1brlllaUon In Cats 
LeoDld V. RoseDShtraukh, Peter DlDIlo, Jr., VltaIy\ O. Rybln, Susan F. 
Stelnberr, II1chael I. Rosen, Columbia Unlverslty, New York. NY and the 
CardioloD lleIIearch Center, Moscow 
We studied receptor·effector lIDkagee In the vagal modulaUon of s1Dus 
rbythm and ventrlCDlar ftbrlllaUon (VF) Induced by a 30 mID left anterior 
deecendiDI coronary artery HraUon In chIoralose-anestheUzed normal cats 
and cats "ven pertussIJ to:dD (P1'X) 30 UlIkr IV 60 bom prior to atDdy (to 
ADP'rlbosylate the G, family of G protsIDs~ EJperimental lfOups were: A. 
Controls (n~IO): B, atropine, .1 mglkllV (to Induce mnscarlDlc blockade) 
(D-IO): C, m (n=l3). All cats received bilateral cervical vagal sUmulaUon 
at I, 3 and 5 Hz (2 msec and 5-10 V) for I mID at 10 mID Intervals. Sinus 
rate (i±SE) durtnr control and durin, mulmal va,al sUmulaUon = lSO±8 
and 91±12 blmlD. P < .05 (Grp A~ 19O±8 and 190±8 b/mID (Grp B~ 214±6 and 
157±12 blmlD. P <.05 (Grp C). G·T, Intervals durin, control and mulmal 
vagal sUmulaUou - 394±1l and 331±14, P <.05 (Grp A~ 385±19 and 
386±ZO (Grp B~ 341±6 and 332±9 (Grp C). Comparable effects on 
repolarlzaUon were seen In an addlUonal subgroup of cats subjected to 
atrial pacing and "ven propranolol. .75 mg/kg IV. Rere, the actual Q·T 
(rather than Q·T J was mortened (P <.05) by varal sUmulaUon IndicaUng 
that the effect was not an arUftfact of Q·T, measurement and was not the 
reeDIt of catecholamine release. Tbe \ decreases In s1Dus rate and Q·T 
were Inversely related to the level of S. (r=.,82 and ·.65 respecUvely; both 
p < .05} Coronary occluslon was performed durin, atrial pacing such that 
bean rate In Grp A-B=C. incidence of VF - 10\ (Grp A~ 50' (Grp BF and 
54\ (Grp C) (P < .~ with onset of VF at 2-3 mID In Grp B and C and 22 mID 
In Grp A. Durtnr atrial pacini before coronary occluslon a vagal Index was 
calculated as P·R durin, vagal sUmulaUoDicontrol p.1. Wben vagal Index 
> 20, incidence of VF durtnr occluslon - 15\ Wben vagal Index < 20, VF 
- 55\ (P<.05). Concluslons: (I) vagal sUmulaUon Infiuences Q·T In cats 
via m-dependent G protein .lIDkage, (2) removal of vagal effect durin, 
Iscbemla favors VF, as predicted by the vagal Index prior to occlUSion. 
811·4 4:45 
Ventricular Tachycardia and Sudden Death Associated with Sleep in 
German Shepherd Dogs 
N. Sydney Moise, Paula F. Moon, Dee A. Dugger, Darcy Brittain, 
Beth A. Lewis, William J. Flahive, Robert F. Gilmour, Jr., College 
of Veterinary Medicine, Cornell University, Ithaca, NY 
A colony of Gennan shepherd dogs with inherited VT and sudden 
death has been established. Of 17 dogs that have died suddenly, 4 
died during sleep, 8 were found dead in the morning, 3 died during 
rest after exercise and 2 died during exercise. To determine whether 
VT occurs more often during sleep, 3 dogs with VT were videotaped 
with ECG monitoring for 24 hrs. Activity was classified as excited, 
ambulatory, sitting, lying or rapid eye movement (REM) sleep. VT 
incidence (beats per minute of a given activity) increased during lying 
and sleep (Figure), in association with decreased heart rate (HR), 
whereas PVC incidence was not altered by activity. To further 
investigate the relationship between HR and VT, 2 dogs with VT and 
2 control (C) dogs were anesthetized with etomidate and given 0.1 
mg/kg iv phenylephrine (PE) to decrease HR reflexly. PE was 
repeated with atrial pacing at baseline heart rate or after 0.1 mg/kg iv 
propranolol (PR). VT and C dogs had no VT at baseline (HR=75-
100 bpm). VT but not C dogs developed VT after PE (HR=30-50 
bpm). No VT occurred during PE + pacing. PR did not alter the HR 
response to PE, but abolished VT. Thus, VT induction required 
reduced HR combined with maintained ventricular sympathetic tone, 
a state that may pertain to REM sleep and recovery from exercise. 
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445A 
Magnetic RuolllllICe IlIIIIglng In Petl,nts with Anglllll lnet NOI'IIIIII 
CorOllllry Anglograml. 
*Enrlco Rossetti, Gabriele Fragaseo, Angelo Vanzulll, Renata Mellone, 
Alberto Cappelletti, Ettore Colombo, Alessandro Del Maschlo, Sergio 
Chlerchla. Istltuto SclentHico H San Raffaele, Milano, Italy. 
The significance d anginal episodes (A) that occur In patients (pis) 
with normal coronary arteries (NCA) remains elusive. Recently, abnormal 
myocardial exogenous glucose UIIlzatlon, possibly resulting from 
anaerobic glycolysis, has been observed In a number 01 these pts. The 
paramagnetic contrast agent gadollnlum-DTPA (Gd-DTPA) Is known to 
accumulate In regions 01 myocardial Infarction on magnetic reSonance 
Imaging (MRI). Based on the hypothesis that Gd-DTPA might represent a 
sensitive marker 01 Interstitial edema In Ischaemlc conditions, we submitted 
to MRI a group 01 pis with A. positive exercise test. NCA and no evidence of 
spontaneous or Inducible spasm. In 12 pis (10 women. mean age 57.± 9 
yrs) and 5 age-matched controls (C), five 1 cm thick slices were obtained 
from the short axis view 01 the left ventricle with T1-welghted ECG-gated 
spln-echosequences (TR z 80% RR Interval, TE-20-30 ms) before and soon 
after I.v. Injection 01 Gd-DTPA (0,1 mgjkg). The Images were blindly 
evaluated by 3 independent observers by a qualitative and semlquantlatlve 
analysis. For each slice the signal Intensity wes determined as the contrast 
to noise ratio (CNR) by placing regions of Interest in the enhancing area in 
the non-enhenclng areas and In the background. 
Results: In 9 pis (75%) discrete areas of Gd-DTPA deposition were 
documented. Mean CNR after Gd-DTPA was 14.4 In pts and 0.3 In C (p < 
0.003). Conversely, none of the C exhibited Gd-DTPA enhancement. In a 
subgroup of 6 pts showing Gd-DPTA deposition, MRI was repeated after a 
10 day treatment period with atenoiol (100 mg 00). that resulted In 5 in Im•
proved anginal symptoms and a complete disappearance of Gd-DTPA 
enhancement. These preliminary findings show that pts with A and NCA 
often exhibit Gd-DTPA accumulation In the myocardium possibly because 
01 Interstitial edema. The disappearance of these abnormalities following 
treatment with betablockers suggests the possibility thet they ara caused by 
chronic Ischaemia. 
812·2 4:15 
New Approach witb Gd-DTPA Enbanced MRI to Evaluate Myocardial Tissue 
Cbaracterization witb Cardiac Histology 
Toshio Shimada, Hironori Tsukihasbi • Kouichi Ochiai , Yutaka Ishibashi, Saburou 
Nagaoka, Shigefumi Morioka. Shimane Medical University, Izumo Japan 
The aim of this study is to demonsuate if Gd-DTPA enhanced magnetic resonance 
imaging(Gd-EMRI) can be used to evaluaIC myocardial tissue characterization. We 
perlormed Gd·EMRI in 18 hypertrophic cardiomyopathy(HCM) patients and 6 nor•
ma! controls. Ventricular myocardial biopsy was perlormed in 7 of 18 patients. Gd•
EMRI was obtained every 10 minutes form 5 to 50 minutes after inuavenous Gd-
DTPA(O.2mmol/kg) injection. Signal fig.! SIRiIITilllecoane 
intensity(SI) in hypertrophic region of myocar-
dium was measured from LV short axis image. 13 • 
We standardized the data according to following 
equations. IR(intensity ratio)=SI(myocardium)! 
SI(skeletal muscle) SIR=IR(in time course)! 
IR(before Gd·DTPA injection). SIR in HCM was \J 
delayed in time course compared with that in 
normal controls.{Fig.1) Interstitial fibrosis was 
prominent when PeaIc(SIR)-SIR(50min. after)! 
Peak SIR was small.(Table I) The delayed decay 1J 
of IR in HeM closely related to the grade of inter•
stitial fibrosis rather than the edema of interstitial 
tissue or the myocardial cell diameter. We COll-
--CootroI 
-0- HCM 
• • Pd.t5..c.o1ro1 
clude that the decay analysis wiUt Gd-EMRI is u 0-.--...--,-....,.. ......... ......., 
useful to evaluate myocardial tissue charllcteriza· I II It Jt • It 
tion closely related to myocardial fibrosis in 
comparison with cardiac histology. Time(1IIiII) 
Tablel .... - "birr diana,. ":::" m...udal - .... ,... slR(j>C&li)·SIR(5W CUm} - _. SIR(peak) ,,,,.tD.o ± ± + 0.118 
n.on .• ± ± + O.lSS 
U.,±l.l ± ±-+ .+ 0.026 
Ja.",:!: ... 2 .+ ±-+ ± ± .+ oms 
U.9:b.l ± ±-+ .+ O.03S 
22.':±6 ... ± + ±-+ +-.+ .+ 0.036 
U.:1i.J.l + 0.167 
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Changes In Skeletal Muscle Water Content During Exercise In 
Heart Failure: RelatIon with Blood Flow and Tissue Addosls 
""Daniel Morvan, "Thierry Laperche, "Alain Cohen-Solal, "Val~rie 
Vilgrain, "!jonel Arriv~. "Hlipital Beaujon & ""Cochin, Paris, France. 
This study was designed to evaluate the relationship between skeletal 
muscle transcapiUary water shifts, tissue acidosis and blood flow during 
exercise by means of 31P-Magnetic Resonance (MR) Spectroscopy, IH•
MR Imaging and Doppler in patients (pts) with chronic heart failure 
(CHF). 3lP spectra and lH-T2 images of the leg anterior compartment 
muscles were obtained at rest and during exercise in 27 pts (12 in NYHA 
class II and 15 in lII-IV, same age 55±10 years) and 5 normal subjects. 
This yielded measurements of intracellular pH (pHi), ratio of inorganic 
phosphate to phosphocreatine (only pIS with peak PilPCr > 1 were 
included) and n. Blood flow (BF) was measured in the popliteal artery. 
Changes (%) between maximum variation and rest were compared 
(" p<0.05 vs NYHA II, t p < 0.05 vs controls, £, not tested). 
Controls NYHA II NYHA Ill-IV 
Ejection fraction (%) 
Peak VOl (m1/min/kg) 
Workload (Watts) 0.6±O.3 
Peak Pi/PCr 1.7±O.7 
% pHi (%) -9.7±4.l 
% BF (%) 282±110 
T2 rest (msec) 3O.4±1.0 
% n (%) 2B.2±B.l 
Slope % T2!W (Watts-I) 25.4±5.9 
Slope %T2 I %pHi 
(r-O.65, £,) 
-1.9±O.5 
(r=.{).75, £,) 
3S±lS 19±6" 
21±S 17±3" 
0.5±O.2 0.2±O.1"t 
1.8±O.8 l.5±O.5 
-B.9±3.3 -10.9±2.2 
290±125 26S±175 
30.9±2.4 33.4±3.0"t 
2S.7±7.9 23.B±7.3 
lS.8±6.St 3.2±19.l 
(r=O.S9, p=O.03) (r=O.OS, NS) 
-l.O±O.4t '{).5±0.9 
(r-.{).6S, p-O.02) (r=.{).14, NS) 
Conclusions : In severe CHF, 1) despite equivalent blood supplies, 
intense anaerobic glycolysis is observed at a smaller workload, 
suggesting intrinsic impairment of oxydative metabolism; 2) Water 
content (reflected by n) is higher at rest and increases as in moderate 
CHF during exercise. However, the relation between increase in water 
and acidification is lost. Thus, other factors than tissue osmolaliry 
originating from lactate (reflected by pHi) seem to have an important 
role in the regulation of transcapillary water shifts during exercise. 
812·4 4:45 
Serial Evaluation of PCr/ATP Ratio and Left Ventricular 
Mass and Volumes In Chronic Mitral Regurgitation In 
The Intact Dog 
Louis J. Dell'ltalia, William T. Evanochko, Ingrid Straeter•
Knowlen, Gerald H. Hankes, A. Raymond Dillon, Jan 
den Hollander, Roger Orr, Sanford P. Bishop, Gerald M. 
Pohost. The University of Alabama at Birmingham, 
Birmingham, Alabama, Auburn University School of 
Veterinary Medicine, Auburn, Alabama. 
Pressure overload hypertrophy has been associated with 
a decreased PCr/ATP ratio. However, PCr/ATP ratio has 
not been evaluated serially in mitral regurgitation (MR) 
where left ventricular ejection fraction (L VEF) may be 
normal in the presence of myocyte failure due to ejection 
into the low pressure left atrium. Accordingly, six 
anesthetized dogs were studied with in-vivo, closed-chest 
31p NMR spectroscopy and combined magnetic resonance 
imaging (cine-MR) and high-fidelity pressures at baseline 
and 4-5 months after percutaneous chordal rupture of the 
mitral valve. Simpson's rule LV end-diastolic volume 
increased from 58±13 [SD] to 102 ± 35 ml (p<0.001) as 
did end-systoliC volume (33 ± 10 to 47 ± 18 ml, p <0.001). 
LVEF increased from 44 ± 7 to 55 ± 5% (p < 0.01). Mean 
mitral regurgitant fraction was 41 ± 15%. LV mass 
increasecf in all dogs from 82 ± 22 to 112 ± 25 grams (p 
<0.001). LV diastolic wall stress (29 ± 22 gm/cm2) and 
end-systolic wall stress (91 ± 28 gm/cm2) were elevated. 
Serial PCr/ATP ratio decreased for the group from baseline 
to MR (2.40 ± 0.24 to 2.20 ± 0.25, P < 0.02). We conclude 
that the PCr/ATP ratio decreases in dogs with chronic MR 
having well preserved LVEF but Significant increases in LV 
volumes, mass, and wall stress. 
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813·1 4:00 
What Detennlnes The EDent of Mitral Valve Motion? A Combined 
Hemodynamlc-Echocardlographlc Experimental Study. 
John M. Dent. MD. Ananda R. Jayaweera. PhD. William D. Spotnitz. MD. 
FACC. Stanton P. Nolan. MD. FACC. Sanjiv Kaul. MD. FACC. 
University of Virginia. Charlottesville. Virginia 
There is controversy regarding the factors that determine the extent 
(both opening and closure) of mitral leaflet (ML) motion. We hypothesized that 
the extent of mitral leaflet motion is determined by LV systolic function and not 
by LA pressure. mitral valve flow. or LV end-diastolic size. Accordingly. we 
placed micromanometer-tipped catheters in the LV and LA of 8 open-chest 
anesthetized dogs. An electromagnetic flow probe was placed at the mitral 
annulus during cardiopulmonary bypass after which the dogs were maintained 
on partial bypass in order to control LA pressure via control of systemic volume. 
Using this approach. LA pressure was held constant. LV systolic function was 
randomly changed by decreasing or increasing left main flow through a Gregg 
cannula. The extent of ML opening (distance between anterior ML and 
interventricular 5eptum when ML are maximally open) and the extent of ML 
closure (distance between ML coaptation point and mitral annular plane when 
ML are maximally closed) were measured on 2D echo along with LV end•
systolic and end-diastolic dimensions. 
The extent of both ML opening and closure correlated with measures 
of LV systolic function (r~-0.83 and r--0.87 for LV dP/dt: r=0.89 and 
r=0.88 for LV end-systolic size) independent of LA pressure. since LA 
pressure was held constant. Poor correlations were noted between the extent of 
ML opening and closure and LA pressure (r=0.48 and r-0.51) as well as LV 
end-diastolic size (r =0.51 and r-0.42). A fair correlation was noted between 
ML opening and closure and initial mitral valve flow (from mitral opening to 
maximal flow: r=-O.66 and r~-0.54). On multivariate analysis. only measures 
of LV systolic function correlated with ML kinetics. When these were entered 
into the model. all other variables no longer correlated with ML kinetics. 
We conclude that the extent of mitral leaflet motion (both opening and 
closure) is predominantly influenced by LV systolic function and not mitral valve 
flow, LA pressure, or LV end-diastolic size. These findings explain why the 
measurement of mitral valve kinetics can provide an accurate and simple assess· 
ment of LV systolic function. Furthermore, since they are not influenced by LA 
pressure. mitral valve kinetics may be relatively independent of preload. 
813·2 4:15 
Quantification of Mitral Regurgitation by Doppler 
Backscatter Power 
Andrew I. Macisaac, Ian G. McDonald, Richard L. Kirsner, 
Sandra A Graham and Robert W. Gill. 
The Cleveland Clinic Foundation, Cleveland, OH, and SI. 
Vincent's Hospital, Melbourne, Australia 
The severity of mitral regurgitation can be directly quantified 
by measuring continuous wave Doppler backscatter power. 
The power of a Doppler backscatter Signal, at a given 
frequency, backscatter coefficient and signal attenuation is 
proportional to the volume of moving blood insonated .. This 
power can be estimated from the pixel intensities of the 
spectral display when the mapping of spectral power to pixel 
intensity is known. Computer post-processing was used to 
derive the relative power of the Doppler backscatter signal 
from the intensity of the pixels within the spectral display of 
antegrade aortic and mitral flow. The relative power of these 
Signals is proportional to the ratio of systolic antegrade flow 
across the aortic valve to the diastolic ante grade flow across 
the mitral valve, from which the regurgitant fraction (RF) can 
be calculated. This Doppler RF was compared to RF derived 
from angiographic LV volumes and thermodilution 
measurements 
In 19 patients with pure mitral regurgitation, 11 M, 9 F, mean 
age 61 years, the mean catheterization RF was 0.53 (sd 
0.22), mean Doppler RF was 0.48 (sd 0.20). Correlation 
between invasive RF and Doppler RF was r= 0.89, p < 0.001. 
In 12 normal controls with an expected RF of zero, the mean 
Doppler RF was 0.03 ± 0.05. 
Summary: Doppler backscatter power from mitral inflow and 
aortic outflow provides a new, accurate method for 
quantifying mitral regurgitation. 
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813·3 4:30 
Papillary Musde ischaemia Is Not the Only Caule or Dynamic 
Mitral Regurgitation 
Ricbard A Jones, Navroz D Masani, Alan G Fraser, Roger JC Hall. Department of 
Cardiology, UnivlllSity of Hospillll of Wales, Cardiff, UK. 
During acute ischaemia some patients with coronary artery disease develop 
transient or 'dynamic' mitral regurgitation (MR), wbich bas been attributed to 
papillary muscle dysfunction. lbe posteromedial and anterolateral papillary 
muscles are supplied by the right and left circumflex coronary arteries respectively, 
so transient ischaemia in the territory of either artery may result in papillary 
muscle dysfunction and mitral regurgitation. To investigate this bypothesis we 
studied patients during coronary angioplasty, as a controlled model of acute 
iscbaemia. 37 men (mean age S8 years) were studied by transthoracic 
ecbocardiograpby before and during elective coronary angioplasty. With the patient 
lying supine, imaging was performed and the left atrium was interrogated using 
colour flow mapping. lbe optimal window was Identified and marked on the 
patient's chest, then used throughout the study. The ratio of the area of the mitral 
regurgitant jet (MRJ) to the area of the left atrium (LA) was determined by off-line 
computerised planimetry. Dynamic MR was defined as an increase in the MRJILA 
ratio during ischaemia. Annular diameter and the distance from the mitral leaflet 
coaptation-point to the annular plane were also measured. 
During angioplasty 26 patients developed ischaemia (ST segment 
depression and/or new regional wall motion abnormality). 16 of these (62%) 
developed dynamic MR. Tbe average MRJILA ratio increased from S.6%± 
S.2(mean±SD) to 20.7%±7.0 (p<O.OOI). 64% of patients undergoing angioplasty 
to the LAD developed dynamic MR. wbereas only 33% of patients with RCA 
lesions and 20% of LCX lesions bad increased regurgitation. 11 (30%) of patients 
bad no iscbaemia; DOne developed dynamic MR. The distance between the mitral 
leaflet coaptation point (MLCP) and the annular plane increased with ischaemia 
from 0.S7cm±O.2 to 0.7±O.3 (p=<0.01). Tbere was no change in annular 
diameter before (2.9Scm±O.6) and during (2.92cm±O.9) ischaemia 
These data suggest that dynamic mitral regurgitation is common during 
acute ischaemia and is associated with apical displacement of the coaptation poinL 
It occurs more frequently with LAD territory ischaemia than with ischaemia in the 
territories of the RCA and LCX which supply the papillary muscles. lbus, 
papillary muscle dysfunction is not the only cause of dynamic mitral regurgitation. 
813·4 4:45 
Mitral Valve Repair Preserves LV Function and Lowers LV Mass More 
than Valve Replacement for Mitral Regurgitation 
David S. Hamer, Gregory T. Almony, Brian P. Griffin, James D. Thomas, 
Delos M. Cosgrove, and William J. Stewart 
The Oeveland Oinic Cleveland OH 
The adverse effect of chronic mitral regurgitation(MR) on LV function is 
well known, but the relative effects of mitral repair and replacement on long 
term LV mass and function are poorly defined. We analyzed the 
preoperative and postoperative echocardiograms of ISS patients undergoing 
surgery for MR: 100 with mitral repair(68M132F;60 ± 13 years) and 55 with 
prosthetic replacement(30Ml25F;62±.16 years), with all postoperative 
echos performed between 2 months and 4 years after surgery. Ejection 
Fraction(EF) was measured with the 4 chamber apical single plane area 
length method and LV mass with the Penn formula .. Results: 
MYB~IIIlI[ MY BI:IIIIlg:m~Dl II 
EF(pre) 56.7%±8% 58.5%±9% NS 
EF(post) Sl,4%±11% 47.5%±1l% <.03 
Change In EF ·S.3%±9% ·1l%±9% dlOO2 
LV Mass(pre) 409.5g±1l3,4g 336.3g±1l7.4g d)OOI 
LV Mass(posl) 323.6gtl04.3g 322.5g±93.6g NS 
Change In Mass -8S.9g±10S.9g -13.8g±83.8g <000001 
Conclusion: Mitral valve repair preserves EF and causes a greater reduction 
In LV Mass. than mitral valve replacement in patients with mitral regurgita•
tion. 
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814·1 4:00 
A Comparison of the Incremental Value of Exercise Testing in 
Men and Women for the Diagnosis of Coronary Artery Disease 
Anthony P. Morise, George A. Diamond, Marco Bobbio, Robert 
Detrano, West Virginia University, Morgantown, WV 
Exercise testing is reported to be less accurate in women than in 
men. Therefore, we compared the incremental diagnostic accuracy 
of sequential clinical, exercise ECG, and thallium scintigraphic 
variables in men and women. Using previously derived logistic 
regression algorithms (based on age, sex, symptoms, diabetes, 
smoking, cholesterol, ST segment and heart rate response, and 
thallium defect reversibility or intensity), the probabilities of 
coronary artery disease (21 vessel with a ~50% stenosis) for 
each patient were calculated at each incremental stage (pretest, 
post-exercise ECG, post-thallium). All resting ECG's were 
interpretable. Accuracy was assessed using receiver operating 
characteristic (ROC) curve areas in 952 patients (331 women) with 
a disease prevalence of 57% (women 39% and men 67%). 
Incremental value was the difference in ROC curve areas from one 
incremental stage to the next. RESULTS: The ROC curve area 
results for both men and women are presented in the following 
table. 
Men 
Pretest 
0.7S 
NS 
p<O.OOOI 
Exercise 
ECG 
0.80 
NS 
p<0.02 
Thallium 
0.82 
p=O.OS 
Women 0.77 p<O.OOOI 0.8S p<O.02 0.87 
CONCLUSION: Using logistic prediction algorithms, the 
incremental diagnostic value of both exercise ECG and thallium 
scintigraphy is similar in men and women. 
814·2 4:15 
Hemodynamic and Ischemic Responses During Exercise Testln&: 
Gender Differences. 
A.P. Ignaszewski, MJ. Haykowsky, C.A. Murray, RH. Hann, K.K. Teo, 
D.P. Humen, University of Alberta, Edmonton, Alberta, Canada 
Earlier reports suggest that the rates of silent and symptomatic ischemia may 
be different in men and women. We hypothesized that there is no difference 
in angina during the maximaJ exercise tolerance test (ETT), and that rates of 
silent ischemia (defined as asymptomatic ST depression during ETT) are no 
different between genders. We reviewed the records of 28,366 consecutive 
ETT performed in our laboratory since 1981. Out of SSSI tests with 
significant ST segment depression, 4626 (83%) tests were selected. Excluded 
were atrial fibrillation, paced rhythm, bundle branch block, and resting ST -T 
changes. To exclude the influence of f81se positive tests, patients' likelihood 
of coronary artery disease (CAD) was estimated using Bayes' theorem. 
Results are summarized below as mean±ISD: 
Variable Women Men 
Patients with probability of CAD >8()01o 
Patients with documented CAD 
" p<O.OS vs. women 
32% 
30% 
3700 
S7±IO 
8968±2IS8" 
2SS2S±6837" 
·1.46±O.S" 
86±27" 
27%" 
31% 
31% 
We conclude that women have significantly higher resting double product 
and exercise to more ST depression, reaching higher stress double product. 
The rate of silent ischemia (as defined above) is higher in women but their 
probability of CAD is significantly lower. When this variable is controlled 
the differences in the rates of angina and silent ischemia during EIT do not 
differ between the gender groups. 
447A 
448A ABSTRACfS 
814·3 4:30 
Improved Risk Stratification of Ambulatory Congestive Heart 
Failure Patients Using Aga and Gender Adjusted Percent 
Predicted Peak Exercise Oxygen Uptake 
Arthur M. Steken, Uwa T. Younis, Stephen H. JeMison, Thomas WoHord, 
Leslie W. Miller, D. Douglas Miller, Bernard R. Chait man. Saint louiS 
University Heafth Sciences Center, St. louis, Missouri. 
Peak oxygen Uplake (V02) during exercise (EX) S14 mUkgtmln In pts with 
congestive heart failure (CHF) Is associated with slgnHicant Increased 
mortality rtsk. V02·EX Is also Influenced In part by age and gender. To 
determine H the use of an age and gender corrected percent ("10) predicted 
V02·EX achieved a more accurate rtsk stratHlcatlon 01 CHF pts than peak 
V02 alone,102 pts with class II or III CHF, aged 49±9 yrs, performed 
cardiopulmonary exercise testing wfth measurements 01 V02·EX and "10 
predicted V02·EX computed using the Wasserman formula. After 12±4 
mos of follow-up, 34 pts had a cardiac event (12 piS died and 22 underwent 
heart transplantation lollowlng prolonged refractory heart failure). The "10 
predicted V02·EX achieved was lower In pis who died (37±12 vs. 58±16; 
p<0.009). When cardiac events were analyzed, there were signHlcant 
dll!e!l!!Q!S be!weeo pIS wI!h and wIboy! eyenIS' 
LV ejection fraction ("10) 
Pulmonary capillary wedge pressure (mmHQ) 
Mean arterial pressure(mmHg) 
Peak V02·EX mlnlg/mln 
% predicted V02·EX 
lxO (Xi' =pso 01 
Event 
~ 
23±9 
23±8 
80±9 
13.3±4 
44±13 
No Event 
~
25±9 
23±9 
84±9· 
15.1±5 
51t17·· 
Multivariate regression analysis selected "10 predicted V02·EX achieved 
as the most slgnHicant predictor of death (p<0.02), or cardiac events 
(p<o.o1) In these pts. 
We conclude that the use 01 age and gender corrected "10 predicted V02· 
EX is more accurate in risk SlratHying pts with CHF compared to the use 01 
peak V02·EX alone and should be used to assess the timing and suitability 
01 pts lor cardiac transplantation. 
814·4 4:45 
Is Rate of Anaina and Silent Myocardial Ischemia Durin\: Exercise 
Testin\: Different Between YOUD\:and Elderly Populations? 
A.P. IgnaszewsId, C.A. Murray, MJ. Haykowsky, R.H. Hann, K.K. Teo, 
D.P. Humen. University of AlllCna, Edmonton, A1bena. 
We bypothesized that rates for angina during maxima1 exercise tolerance test 
(ETT), and for silent iscbemia (defined as asymptomatic ST depression) do not 
di1fer between IRJbjects 56S years and >6S years. We reviewed the records of 
28,366 consecutive ETT performed in our laboratory since 1981. Out of 5551 
tests with significant ST segment depression, 4626 tests (83%) fulfilled the 
study criteria. Excluded were atrial fibrillation, paced rbythm, bundle branch 
block, and resting ST· T wave abnormalities. Patients' likelihood of coronary 
artery disease (CAD) was estimated using Bayes' theorem to exclude the 
influence offalse positive tests. Results are summarized below as mean±ISD. 
Variable >6S year old 
n 1044 
Rest Double Product 9181:2219 
Stress Double Product 23674:6154 
Stress ST change (mm) ·1.5±O.5 
Probability of CAD ("10) 84±31 
IDcideace of Symptomatic bcbemia (Angina) 
Overall 31% 
Patients with probability of CAD >80% 32% 
Patients with documented CAD 28% 
, p<O.OS vs. population >65 years old 
565 year old 
3582 
9019±2171' 
26315:6783' 
·1.5±O.6 
81±30' 
26%' 
31% 
28% 
We conclude that the elderly have significantly higher resting double product 
but the young exercise to higher stress double product. The degree of ST 
segment depression is similar between groups. The rates for the occurrence of 
exertionaJ angina are statistically higher in the elderly whicb maybe explained 
by their higher overall probability of CAD. Wben the influence of this variable 
in removed, tbe rates of angina (and silent ischemia as defined above) are 
similar between the young and the elderly during ETT. 
JACC February 1994:1A-484A 
815 Laser Angioplasty-Mechanisms and Results 
Thursday, March 17, 1994 8:30-10:00 AM 
Georgia World Congress Center, Room 265W 
815·1 8:30 
Results or The F1rst 5000 Patients Treated With Exclmer 
Laser Coronary Aqioplasty 
James R. Margolis, Sarneer Mehta, Frank Utvack, William J. 
Untereker, Tsvi Goldenberg and the ELCA Registry 
Investigators. Miami Heart Institute, Miami Beach, Florida 
Between Jul, 1988 and Mar 1993, 5885 lesions in SOOO patients 
were treated with the LAIS 308nm XeCl Excimer laser. Patient 
age was 62±1l; 72" were men; 71" had class 3 or 4 angina. 
Lesions were in LAD 36"; LeX 15", RCA 31", SVG 14", 
LMT 3". Complex morphology was present in 88" and 
included: total occlusions 9.3", calcified lesions 35", lesions 
> IOmm 52", aorto-ostial lesions 14", SVG 14". Laser 
pulse width was > 200 nsee., repetition rate 20 Hz and fluences 
35-65 mJ/mm2. Catheter sizes were 1.3-2.2mm. Procedure 
success, <50" final stenosis (with or without PTCA), was 
achieved in 89" of lesions. Stenoses were 86±12" pre, 
50±22" post·ELCA and 24±17" post·adjunctive PTCA. 
Complications included: transient closure 3.5", spasm 1.3", 
dissection 17", perforation 1.2", Q wave MI 2.0", 
emergency CABO 3.8", death 0.6". Lesion morphology did 
not adversely affect success or complication rates. Six month 
follow·up is complete for 3213 patients· 72" are event-free. 
Late MI occurred in 0.7", late CABG in 3.2%, reintervention 
in 4.2", and late death in 1.9". CONCLUSIONS: ELCA 
favorably treats complex coronary lesions with high success and 
low complication rates, and good long term clinical results. 
815·2 8:45 
Prospective Multicenter Analysis or Exclmer Laser Coronary 
Angioplasty (ELCA) In Stenoses With Complex Morphology. 
Lloyd W. Klein, Frank Litvack:, David Holmes, Frank Cummins, Neal 
Eigler, and Donald Rothbaum, for the AIS Investigators. Rush Heart 
Institute, Chicago, !L. 
To determine the influence of stenosis morphology (sten morph) on the 
outcome of ELCA, 2187 consecutive stenoses from the last 1994 patients 
in the AIS ELCA registry have been characterized prospectively at 35 
centers. The procedural outcomes in 781 sten with complex morpb were 
then compared with 1406 sten with simple morpho ~: In the 
complex morpb group (comprised of sten with morpb defined below), 590 
sten bad at least I complex morpb; 191 had 2 or more. There was 87" 
success in the complex morpb group vS. 90% in the simple sten group 
(p=n.s.) (defined as ,.S.50% residual sten and no major in-hospital 
complications). In the complex group, there were 8 deaths (1.0%), 12 
(1.6%) Q wave infarctions (QMI) and 23 (3.0%) emergency bypass 
(CABG) versus 6 (0.5%) deaths, 22 (1.8%) QMI and 57 (4.6%) CABG 
in the simple group (all p=n.s.). 
Complex Lesions 
> 20mm length 
Chronic total oed 
Total occl < 3mo. 
Friable vein graft 
Thrombus 
>45' angle 
II Success 
426 89% 
172 85% 
107 90% 
60 90% 
127 81% 
106 84% 
Occ! 
8.9% 
4.5% 
2.7% 
10.4% 
11.4% 
9.2% 
QMI CABO Death Emboli 
2.4% 2.6% 1.2% 0.7% 
0.0% 1.1% 1.1% 0.0% 
0.0% 1.8% 0.9% 2.7% 
0.0% 0.0% 4.2% 14.6% 
1.6% 4.9% 0.8% 5.7% 
0.0% 3.7% 0.9% 0.0% 
Perf 
1.2% 
0.0% 
0.9% 
0.0% 
0.8% 
2.8% 
Emboli were more common with friable vein grafts and pre·ELCA 
thrombus (p < .(01); perforations were more common with stens 
containing> 45' angle (p= .05). 
Conclusions: (I) Carefully selected stens in complex morpb subgroups 
have acceptable acute results with ELCA and low complication rates; (2) 
specific complex morphs have predilections for emboli or perforation; and 
(3) the overall outcome in patients with complex sten morph is similar to 
that of simple stens, suggesting that ELCA may be best applied in these 
cases. 
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815·3 9:00 
Mechanisms of LameD EDlargemeDt after Exdmer Laser ADglopbBty aDd 
AdjUDCt BaIIoOD Auplplasty: A SequeDtialIDtravascular UItrasoUDd 
Study 
Julie A. Kovach, Gary S. Mintz, Satumino P. Javier, Kenneth D. Henson, 
Augusto D. Pichard, Kenneth M. Kent, Lowell F. Saller, Jeffrey J. Popma, 
Martin B. Leon. Washington Hospital Center, Washington, DC 
Excimer Juer angioplasty (ELCA) usually requires adjunct PTCA to achieve an 
optimal fmal result To separate the effect of ELCA from adjunct PfCA, we 
used iDtravascular ultrasound and quantitative coronary angiography to study 
104 lesions iD 103 pIS (1 LM, 42 LAD, 22 LCX, 29 RCA, 10 SVG) before 
ELCA, after ELCA, and after adjunct PfCA. Intravascular ultrasound 
measurements included external elastic membrane (EEM), lumen, and plaque 
cross-sectional areas and % cross-sectional narrowiDg (PlaquelEEM); arc of 
lesion calcium; and the presence, location, length, deplh, and circumferential 
extent of dissections. Quantitative angiographic measurements iDcluded 
minimal lumen diameter (MJ Dl and %diameter stenosis. 
!pre-ELCA POSt-ELCA POSI-PfCA ANOVA 
MLD(mm) 0.6±O.S 1.2±O.S 1.9±O.S <.0001 
% diameter stenosis 77±18 SI±16 24±18 <.0001 
EEM area (mml) 19.3±7.0 19.5±7.1 21.1±7.1 <.0001 
Lumen area (mml) 1.4±O.2 2.7±O.7 4.611.1 .0002 
Plaque area (mml) 17.9±7.0 16.8±7.1 16.617.1 NS 
Cross-sectionaI nanowiDg 92±4% 84±8% 76110% <.0001 
Arc of calcium 103±93° 104±93° 103±93° NS 
The post-ELCA lumen area averaged SO% larger than die area of the ELCA 
catheter (p<.0001). Dissections were present iD 4S% lesions post-ELCA and 
iDcreased to 81% post-PTCA (p<.0001). The location of dissection planes after 
ELCA (93% withiD calcified plaque) changed signiflcantly after adjunct PTCA 
(SO% withiD calcifled plaque and SO% at the junction of calcifled and non•
calcified plaque, p=.002) with an increase in the axial, radial, and circumferential 
extent of existing dissections. 
ID coucJusiOD: From sequential intravascular ultrasound studies, we 
hypothesize that lumen en1argement after ELCA is the result of a small, but 
signiflcant amount of tissue ablation (p=.OOOI, post-ELCA plaque area vs pre•
ELCA plaque area) and acoustic shock-wave-induced vessel expansion. Lesion 
calcium appears modified ("shattered"), but not removed after ELCA thereby 
increasing vessel wall compJiance and facilitating additional lumen enlargement 
afterPTCA. 
815·4 9:15 
Does Coronary Exclmer Laser Ablation Reduce Elastic Recoil Following 
Balloon Dilatation? A Quantitative Anglographlc Comparison WIth 
Balloon Angloplasty Alone Based on Matched Laslon, 
Sipke Strikwerda, Eline van Swijndregt. Rein Melkert. Pim J. de Feyter. Patrick 
W. Serruys. Thoraxcenter. Erasmus University. Rotterdam. The Netherlands 
Exclmer laser ablation may modify the elastic properties c:A the vessel wall 
thereby facDitatlng balloon dlatation and Improving the final angiographlc 
outcome of a coronary intervention as compared to balloon angloplasty 
(PTCA) alone. A consecutive series c:A 571eslons In 51 patients successfully 
treated by excimer laser-asslsted balloon angioplasty (EL-BA) (Xea. 308nm. 
200ns pulse width. 20-30 Hz. 45-65 mJ /mm2) were individually matched with 
57 successfully treated PTCA lesions according to vessel location. minimal 
luminal diameter (MLO) and reference diameter (RO) as determined by an 
automated lumen contour detection algorlthm. Matching was considered 
adequate since before EL-BA. MLO and RD (mean±SD) were 0.73±0.44 mm 
and 2.66±0.44 mm. and before PTCA 0.74±0.43 mm and 2.67±0.44 mm. 
respectively. Mean balloon diameter at maximal Inflation was 2.59 ± 0.35 mm 
In the EL-BA group and 2.56±0.40 mm in the PTCA group. resulting in a final 
MLO after Intervention of 1.75±0.35 mm and 1.75±0.34 mm. respectively. 
Extent of laser abiatlon (MLO after laser - MLO pre laser). vessel stretch 
(mean balloon diameter - MLO pre balloon). elastic recoil (mean balloon 
diameter - MLO after balloon) and acute gain (MLO after - MLO pre 
Intervention) were calculated and normalized for vessel size (RD). 
Results' 
Ablation Stretch Recon Gain 
EL-BA 0.22±0.18 0.49±0.16 0.32±0.13 0.39 ± 0.20 
PTCA - 0.69±0.23 0.31±0.13 0.38±0.21 
t-test - p<O.OOOl p>0.05 p>0.05 
Conclusion: In a matched population of successfully treated coronary lesions. 
xea exclmer laser ablation did not reduce elastic recoM or Improve the final 
angiographic outcome after EL-BA In comparison with PTCA alone. 
ABSTRACTS 449A 
815·5 9:30 
OuIntlt8llvl AnglographJc Analylls of Vlln Grift Llliona TnIIIIld wnh 
Exclmar Llser AngJopIlIty: immediate and Follow-Up Rllulta 
Bradley H. Strauss. Madhu K. Netarajan. Wayne B. Batchelor. David E. 
Yardley. Timothy A. Sanbom. John A. Power. Unley E. Watson. Richard 
Moothart. James E. Tcheng. John A. Bittl. Robert J. Chisholm. St. Michaers 
Hosp~al, Toronto. Canada. 
Although percutaneous exclmer laser-assisted angioplasty (PELCA) has 
been proposed for treatment of COfl1)lex saphenous vein graft (SVG) lesions. 
quantltatlve angiographlc assessment has been limited. partiaJlarty by 
incofl1)lete follow-up (FU). Therefore. we used a core quant~ative 
angiographic laboratory (Cardiac Measurement System) to evaluate 
immediate and late follow-up resuHs in 101 high risk SVG lesions (86 
conseaJ!1ve patients) treated with excimer laser (CVX-300"'j (10% stand 
alone). Mean graft age was 96 months (range 2-214). Lesions were located 
at the ostium (21%). body (67%) or distal anastomosis (12%). The mean graft 
reference diameter was 3.24±O.80 mm (±S.D.). Angiographlc procedural 
suooess (~% stenosis) was 61% post-paCA and 92% post-PTCA. The 
overall angiographlc FU rate was 81%. (MLD-rrinlmallurrinal diameter (mm). 
DS=diameter stenosis) 
Pre Post-PELCA Post-PTCA Follow-up 
MLD 1.10±.56 1.63±.68 2.20±.64 1.51±1.22 
OS(%) 66±15 49±20 33±14 58±29 
Restenosis rate (>50% OS at FU) was 51%. Including 23% total occlusions. 
SigMicant predictors of restenosis included: 
MLO pre OS% pre Laser Gain (mm) 
Restenosis 0.91 (p<.02) 70 (p=.05) 0.78 (p=o.o4) 
No Restenosis 1.22 63 0.48 
Laser gain represents the Increase In MLO from pre to post PELCA. 
Procedural gain (change in MLD pre-PELCA to post-PTCA) was not 
predictive of restenosis. The clinical event rate (death. MI. CABG. PTCA) at 
12 months was 37%. Overall mortality rate during follow-up was 9.8%. 
In conclusion. exclmer laser-assisted angioplasty achieves a high success 
rate In SVG lesions. However. the early benefits of PELCA in these high risk 
lesions are limited by restenosis. partiaJlarty total occlusions. Furthennore. 
resutts of this quant~atlve analysis suggest that aggressive debulking wHh 
paCA may adversely affect restenosis. 
815·6 9:45 
Laser Ablation Versus Rotary Abrasion: A Makbed Comparative 
Analysis or Procedural Results and Late Clinical Outcome 
Manin B. Leon, Jeffrey J. Popma. Augusto O. Pichard, Lowell F. Satter, S.Chiu 
Wong. Gary S. Mintz, Kenneth D. Henson, Ya Chien Chuang. Teraza Y. Conway. 
and Kenneth M. Kent. Washington Hospital Center. Washington DC 
Although excimer laser angioplasty (ELCA) and rotational atherectomy (RA) are 
commonly used in overlapping lesion subsets, there are few comparative studies to 
assess their relative benefits and risks. Thus, we established matching criteria for 
lesions equally suited for either ELCA or RA (native coronaries, excluding lesions 
with total occlusion~ 20 mm long, or heavy calcium) and compared clinical 
characteristics, angiographic outcome. major early complications (death, Q-wave 
MI. urgent CABG). procedural success « SO% diameter stenosis and no early 
complications). and late target lesion revascularization (1LR = CABG or repeat 
!'TCA) in 272 ELCA pts (333 lesions) and476RA pts (628 lesions). ELCA pts had 
'00 more frequent unstable angina (74 vs SI%. p 
<.(01) and longer lesion length (8.1 vs6.6mm. 
p< .(01). RAlesions were more often restenotic 
(36% vs 72%, p <.(01) and calcified (67% vs 
42%. P < .(01). Reference vessel diameter was 
smaller in RA pts (2.4 I vs2.52mminELCAplS, 
p < .00 I), although the residual % stenosis was 
higher in ELCA pts (26% vs 24% in RA pIS. p 
"1' =().06). Dissections were more common in I-----,~oo---~,.. ELCA lesions (29% vs 13% in RA lesions. p < 
F .. ""· •• ' .... ,,' 0.(01) as were perforations (1.8% vs 0.3%, P = 
.02). Procedural success was higher in RA pIS (93.7% vs 86%, P < .(01) and in· 
hospital major complications were more frequent in ELCA patients (7.4% vs 3.2%. 
P < .009), especially urgent CABG (6.6% vs 2.1 %, P < 0.(02). Imponantly. TI.R•
free survival (see Figure) was lower in ELCA patients (p = 0.(03); ELCA was the 
only independent predictor for1LR using Cox regression analysis. In conclusion: 
Despite the differences in pt/lesion characteristics and the limitations of matChing 
studies. this comparative analysis of ELCA vs RA indicates I) similar quantitative 
angiographic results (final lumen diameter and % stenosis), but 2) more frequent 
peri-procedural complications (dissectionS/perforations). 3) more frequent in-hospi•
tal complications (esp. urgentCABG).4) lowerprocedural success rates. and 5) more 
frequent lale lLR with ELCA. 
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Identification of Viable Myocardium with Contrast Echo In Patients with 
Myocardial Infarction and Poor Left Ventricular Function. 
Gustavo Camarano. MD. Michael Ragosta. MD. Lawrence W. Gimple. MD. 
FACC. Eric. R. Powers. MD. FACe. Sanjiv Kaul MD. FACC. 
University of Virginia. Charlonesville. Virginia 
Global LV function is the major determinant of outcome in patients with 
myocardial infarction (MI). Hence. those with poor LV function have the 
greatest potential of benefit from revascularization if they have viable 
myocardium. Since the presence of microvascular patency is associated with lack 
of necrosis and since myocardial contrast echocardiography (MCE) defines 
microvascular perfusion. we hypothesized that this technique could be used to 
identify viable myocardium in this group of high-risk patients. Accordingly. we 
studied 39 patients (30 men. 9 women. median age=61 years) with low LV 
ejection fraction <.5,0.40. mean= 0.31). 23 (59%) of whom had multi-vessel 
disease. Thirty patients had a recent « 4 weeks) MI while 18 had a remote 
MI. Wall motion (WM) was assessed in all 12 segments of the LV with 2D echo 
at baseline using a 5-point score (I = normal motion. 5=dyskinesia). MCE was 
performed during coronary angiography followed by revascularization (' 7 angio•
plasty and 10 bypass surgery) if clinically indicated. Each segment was scored 
for contrast effect using a 3-point score (I ~homogeneous: O=none: and. 
0.5 = partial). 20 echo was repeated I month later in all patients for WM 
assessment. 
Four hundred and sixty-eight myocardial segments were analvz~d. The 
predictors of I monlh WM score were baseline WM score (r=0.83). with bener 
baseline WM predicting bener 1 month WM: contrast score (r= 070). with 
bener contrast effecl predicting bener I monlh WM: and. final %stenosis 
(r=0.17). with worse final stenosis predicting worse I month function. On 
multivariate analysis. all 3 were independent predictors of 1 month WM score 
described in the following equation: 1 month WM score = 0.6 baseline WM 
score-I.O contrast score-0.002 final % stenosis + 1.4 (r=0.87. P<O.OOOI). 
We conclude that MCE can define myocardial segments which are 
viable in patients with MI and poor LV systolic function. Revascularization of 
such segments results in improvement in WM. Thus MCE can be used as an 
adjunct to coronary angiography to determine strategies for improving outcome 
in high-risk patients with coronary artery disease. 
816·2 8:45 
A New Phase Shift Echo Contrast Agent: EehoGen®; 
(Sonus Pharmaceutic a's) Becomes a Gas 'n Blood to 
Produce Left Heart and Quantiflab'e Myocardial Contrast 
After Venous 'njeetlon. Stud Ie. In Sheep and Monkeys 
Antoinette Kenny. David J. Sahn. Takahiro Shiota. Arnaldo Passafini. 
George Pantely. Andrew Arai. Michael Jones. Shuping Ge. Isumi 
Yemada. Mark D. Reller. Oregon Health Sciences University. Portland. 
Oregon. LAMS·NHLBI. Bethesda. Maryland 
No contrast agent reported to date produces visually apparent and 
intense myocardial contrast opacification aiter intravenous injection. We 
tested a new colloidal dispersion (EchoGen® Sonus Phannaceuticals) 
of a fluorocartxm compound which changes from liquid-in-liquid droplets 
to 2 micron microbubbles aiter injection upon warming to blood 
temperature. Our aim was to assess the pulmonary transit. left heart end 
myocardial opacification potential of this new agent. Studies were 
accomplished in three juvenile sheep. (24·25 kg) imaged open chest 
aiter premedication with aspirin to prevent prostaglandin mediated 
pulmonary hypertension and three 5.9-7.5 kg aduh rhesus monkeys 
studied closed chest. both spontaneously breathing. and intubated and 
ventilated aiter barbiturate anesthesia. Doses of EchoGen® as low as 
0.05 mVkg produced intense and prolonged leit ventricular contrast in 
both species aiter central venous or even peripheral venous injection. 
Doses greater than 0.2 mVkg produced videodensitometrically 
detectable myocardial opacification aiter venous injection without 
changing systemic or pulmonary ertery pressures in either species. 
Doses from 0.4-0.8 mVkg tested only in the monkeys produced intense 
and prolonged brightening of the myocardium which persisted from 2.5 
to more than 12 minutes aiter chamber washout and was easily 
identiflBbie both to the eye and quantifiable as a change in videodensity 
at 4 quadrants around the myocardium (video levels increasing 10%. 
40" .... and 54% [for 0.2. 0.6 and 0.8 mVkg respectively)). Only the 
highest dose produced ST or other ECG changes and all closes less 
than 0.6 cclkg were accomplished without hemodynamic or wall motion 
changes. While the continued recirculation of agent and persistence of 
the myocardial contrast may preclude its use as a tracer. it is the first off•
the-shelf echo contrast preparation which produces unequivocal. 
quantifiable myocardial opacification eiter even peripheral venous 
injection with small injection volumes and without major adverse 
hemodynamic effect. 
lACC February 1994:1A-484A 
816·3 9:00 
Myoeardial Contrast Echocardiography: Correlation of 
Resting Perfusion Defects in Hurnans to Sestarnibi SPECT 
Mario Meza, Robert Sonnemaker, Stephen R. Ramee, Bret Perry, 
Dagnovar Aristizabal, James V. Connaughton m, Susan Revall, 
Joseph P. Murgo, Jorge Cheirif, Ochsner Medical Institutions, New 
Orleans,LA 
Previous animal studies havc found myocardial contrast 
echocardiography (MCE)-defmed petfusion defects to correlate with 
anatomic areas at risk and with thallium perfusion defects. To 
detennine whether this is also true in humans, we studied 22 patients 
with resting wall motion abnonnalities using MCE (2 cc inttacoronary 
sonicated meglumine) and Tc99m-sestamibi SPECf (SES) (22 lOCi, 
Lv.). Visually perceived perfusion defects (MCE-no contrast, SES•
defect at 30% of maximum counts) were planimetered on all available 
orthogonal midventticular correspondent views. The location of the 
petfusion defects was assigned to one of the three coronary artery 
petfusion territories, Le., LAD, LCX, and RCA. No petfusion 
defects were seen in 15 patients by MCE and in 10 patients by SES. 
Petfusion defects were seen in 7 patients by MCE and in 12 patients 
by SES. Concordance for the absence or presence of a petfusion 
defect was seen in 10 and 6 patients, respectively. The following 
table shows occurrence of petfusion defects by territory. 
I Perfusion Territo¥~~ I 1ft I 1fl I 
A modest but highly significant correlation between the size of 
perfusion defects by both techniques was observed (r=0.64, 
p<O.OOOI). In conclusion, the presence of resting perfusion defects 
by myocardial contrast echocardiography correlates with the presence, 
size, and location of perfusion defects by sestamibi SPECf. 
816·4 9:15 
Estimation of M~'oc8rdIal Blood Vo'ume by Contrast Echocardlography can 
Provide an Assessment of Myocardial Blood Flow. 
Gustavo Camarano. MD. Ananda R. Jayaweera. PhD. Suad Ismail. MD. N. 
Craig Goodman. BS. Danny Skyba. MS. Sanjiv Kaul MD. FACC. 
University of Virginia. Charlonesville. Virginia 
We have previously demonstrated that when myocardial hlood volume 
(MBV) is held constant. the transit rate (el) of albumin microbubbles (mean 
size-4.311) measured during myocardial contrast echocardiography (MCE) cor•
relates with myocardial blood flow (MBF). However in situations such as 
exercise. where MBF increases by increasing MBV. el cannot provide an assess•
ment of MBF. Any measure of MBV will. however. provide an estimate of 
MBF. Since the concentration of microbubble. within the myocardium is 
determined by the MBV. we hypothesized that MCE can be u.ed to assess MBV 
and hence MBF. where the latter increases because of the former. 
Accordingly. 7 open-chest dogs underwent MCE (AO root injection of 
1-5 ml of AlbunexR) at baseline and during increasing doses of phenylephrine 
(0.4-O.8I1g/kg/min) to increase MBF by increasing MBV. Stenoses were 
randomly placed on either the left anterior descending (LAD) or the left 
circumflex (LC) arteries. MBF was measured using radiolabeled I1spheres. 
MBV was calculated by dividing MBF by el obtained from background•
subtracted MCE time-intensity curves (Volume * Flowltransit rate). Mean 
videointensities were measured in the LAD and LC beds in the background· 
subtracted images during maximal contrast disparity in order to estimate the 
relative microbubble concentration within these beds. 
There was a close linear relation between MBF and MBV (y= 1.0x + 
0.32. r=0.84. P<O.OOOI) indicating that MBF increased in this model in 
relation to increase in MBV. The average correlation between MBV ratio and 
mean intensity ratio in the LAD and LC beds in the 7 dogs was r = 0.86 
(p<O.OOI) and the average correlation between MBF ratio and mean intensity 
ratio in the two beds was r=0.82 (P<O.OOI). 
We conclude that: a) MCE can measure relative microbubble concentra•
tion within the myocardium: b) this concentration relates to MBV: and. c) 
measurement of MBV provides an estimation of MBF when MBF increases as 
a result of an increase in MBV. These results indicate that during exercise or 
pharmacologic stress testing with catecholamines. MCE can provide an assess•
ment of relative MBF within myocardial beds. 
JACC February 1994:1A-484A 
816-5 9:30 
Concordance of Myocardial Contrast Echocardiography 
and Dobutamine Stress Echocardiography in Evaluation 
of Myocardial Viability. 
Christopher R. deFilippi, DuWayne L. Willett, I. Fernando Triana, 
Carlos E. Velasco, Eric I. Eichhorn, and Paul A. Grayburn. 
Univ. of Texas Southwestern and VA Medical Centers, Dallas, TX. 
Myocardial viability may be. assessed by demonstrating perfusion of 
segmental wall motion abnormalities or eliciting contractile reserve in 
response to inotropic stimulation. This study was undenaken to 
examine the concordance between perfusion by myocardial contrast 
echocardiography (MCE) and contractile reserve by dobutamine 
stress echocardiography (DSE) in 18 patients with segmental wall 
motion abnormalities due to coronary artery disease. Patients ranged 
in age from 45 to 75 years (mean 63 ± 8). MCE was performed 
using sonicated Renografin selectively injected into the coronary 
arteries during catheterization. DSE was performed within 24 hours 
of catheterization. Regional wall motion was graded using a 16-
segment model wherein 1 is normal or hyperkinetic, 2-hypokinetic, 
3-akinetic, and 4-dyskinetic. Contractile reserve was considered to 
be present if wall motion grade improved at any dose of dobutamine. 
Perfusion was defined as a characteristic echodense myocardial 
blush. MCE and DSE were analyzed separately by a blinded 
observer for contractile reserve and perfusion. MCE and DSE were 
concordant in 106 of 139 abnormal myocardial segments (76%) that 
were adequately visualized by both techniques (p<o.OOO I). Of these, 
86 segments had both perfusion and contractile reserve, whereas 20 
had neither. Perfusion was present in 24 segments (17%) that lacked 
contractile reserve. Only 9 segments (6%) had contractile reserve 
without evidence of perfusion. 
Conclusions: MCE and DSE are concordant in assessing myocardial 
viability. Long term followup is presently underway in the 
discordant patients to determine whether perfusion or contractile 
reserve is the best predictor of recovery of left ventricular function 
after revascularization. 
816-6 9:45 
Innuence of Ultrasonic Contrast Enhancement on the Size 
and Shape or the Flow Convergence Area by Color 
Doppler: An In Vitro Study 
Shiro Nozaki, Robin Shandas, David J. Sahn, Howard C. Dittrich, 
Anthony N. DeMaria. University of California, San Diego, CA 
Although assessment of the flow convergence area proximal to an 
orifice by Color Doppler provides a potential method to quantify 
valvular regurgitation, suboptimal visualization often limits 
measurement accuracy. Therefore, we studied the influence of an 
ultrasound contrast agent upon the size and shape of flow convergence 
(FC) images using a constant flow in vitro model with a circular 
orifice (0.15 cm2l. FC images were obtained with a Toshiba SSH-
140A for Nyquit limits of 8 and 12 cm/sec produced by baseline shift 
After baseline study using 1 % cornstarch, a galactose contrast agent 
(Levovist®) was injected into the chamber proximal to the orifice. We 
measured the maximal distance from the orifice plane to the initial 
aliasing interface (A cm), maximal width of the FC image (B cm) and 
calculated an index of eccentricity (NB: Hemispherical ratio = 0.5) in 
each condition. RESULTS (Mean±S.E.,·p<O.OI versus BASE): 
BASE CONTRAST 
~W 
A B AlB A B NB 
NYQlIist 12cmlse Scm/sec 
BASE 65± 04 1 02± 09 64 80t 05 1 23+ 05 65 
CONI n±ol 142*±Q8 51* 120*+01 237*±04 51* 
Addition of contrast agent significantly increased width and decreased 
eccentricity producing a more hemispherical FC shape. Standard error 
in the measurement of A and B were improved by contrast At these 
low Nyquist limits, contrast improved recognition of low velocity 
events such as in the region at the sides of the FC image. Thus, 
ultrasound contrast produces enhanced visualization of the proximal 
flow convergence area and may improve quantitation of valvular 
regurgitation by color Doppler. 
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Platelet degranulation by Non-ionie Contrast Media in Unstable 
Angina patients. 
Nicolas A Chronos, Deven J Patel, Darren J Wilson, *AJison H 
Goodall·, Ulrich Sigwart, Kim Fox, Nigel P Buller.· Royal Free 
Hospital School of Medicine and Royal Brompton National Heart & 
Lung Hospital, London, UK 
Introduction: Thrombotic coronary occlusion is a recognised 
complication of angiography in patients with unstable angina and has 
been associated with non-ionic contrast media (NICM) angiography. 
We have previously demonstrated that NICM caused platelet 
degranulation in blood from stable angina patients and nonnal 
volunteers. 
Methods: In this study we have investigated the influence of three 
commonly used contrast media, Omnipaque (low osmolar NICM), 
Urografin (high osmolar ionic) and Hexabrix (low osmolar ionic) on 
platelets in whole blood from patients (n=8) with unstable angina. All 
patients were anti coagulated (PIT> 2.5 x control) with heparin and 
receiving standard medical therapy including aspirin, l3-blockers and 
nitrates. Chronic stable angina patients (n=6) were used as controls. 
Blood was incubated \\ith contrast media or saline (control) for I minute 
and analysed for P-selectin and C063 expression , both markers of 
platelet degranulation. 
Results: Omnipaque caused P-selectin expression on 52.2±14.0 % 
(mean±SO) and C063 on 57.6±13.8 % of platelets. Urografin caused 
12.58±554% of platelets to express P-selectin and 30±13.3% C063. 
These were significant (p<O.O I) when compared to control and similar to 
those seen in patients with stable angina and nonnals. Hexabrix caused 
no platelet degranulation. 
Conclusions: NICM induced platelet degranulation may release 
prothrombotic and vasoactive factors which in vivo could promote 
intracoronary thrombus fonnalion and reduc~ coronary flow in an 
already prothrombotic coronal!· environment. 
817-2 8:45 
Blocking Platelet's GPIlb-IIIa Receptor in Unstable 
Angina Patients. 
Pascal J. Goldschmidt-Clermont, Steve P. Schulman, Nisha 
C. Chandra, Kirk R. Dise, Gary Gerstenblith. Johns 
Hopkins University, Baltimore, Maryland. 
We tested the effect of a cyclic heptapeptide, Integrelin 
(INT), on platelet aggregation in patients with unstable 
angina (UA), in a double-blind randomized prospective 
study. INT is a specific inhibitor of fibrinogen binding to 
platelet integrin GPIIb-I1Ia. Two doses of INT (Low: 451lg 
/kg-bolus plus O.5Ilg/kg/min; High: 90llg/kg-bolus plus 
1.0llg/kg/min, for 72 hours of continuous infusion) were 
compared to placebo plus acetylsalicylate (ASA), for their 
ability to block platelet aggregation. All patients also 
received I.V.-heparin. Platelet aggregation was measured 
after addition of201lM ADP, which induced aggregation even 
in the presence of ASA. Both doses of INT were able to 
rapidly inhibit platelet aggregation, in a dose-dependent 
fashion. Reduction of platelet aggregation was significant 
with low-INT (p<O.Ol) and high-INT (p<O.OOl) at 1 and 4 
hours and until the end of infusion. Aggregation returned to 
~O% of baseline within 4 hours after discontinuation of the 
infusion in all three groups, and 4 hours post-infusion data 
were not significantly different. Bleeding time increased by 3 
120 
to 4 minutes at both doses 
and normalized within 15 
minutes of discontinuation of 
infusion. We conclude that 
INT is a potent and rapidly 
reversible platelet inhibitor in 
~= patients with unstable 
001:-7, -7""-End~.:':;2~ .. :-,~1NT angina. 
_Tlmo 
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~ III:tiv.tion ill htlIIIl.e AIIIina. 
Stefono de Servi, Giovonni Ricevuti', Antonino IIozzone', DoIIide 
Posotti', Federico IIorsico, Ezio Brwucci, Giuseppe Specchio 
Div.Cordiol e 1st Pot lied' ,Univ Hosp,PAVIA <Itoly) 
Recent dote suggest thot lyaphocyte octivotion lOy trigger IIOnocyte 
octivotion ond thrOllbus forution in unstoble engine (\lA). Coronery 
sinus (CS) ond oortic (Ao) blood so.ples litre token before coronory 
orteriogrophy in 35 pta (14 ~ith UA, 11 ~ith stoble ongino-SA-, and 
10 ~ithout ische.ic heort diseose-1tO IHD-) The foll~ing .. Isure .. nts 
were .Ide: soluble CDI4(ls index of IIOnocyte function, by 
iuunoenzyaotic .. thod) loctoferrin( os index of grlnulocyte 
function, by iuunoenzyaltic .ethod) Ind the surflce receptor CD71 
(IS indeK of T-ly.phocyte function, by direct iuunofluorescence 
ISsessed ~ith flow cyto.etryl. 
Results ("lntSD) : 
soluble CD14 (ng/.ll Loctoferrin (ug/.ll CD7H .. ln 
chlnnell 
Ao CS Ao CS Ao CS 
UA 4.2±D.4 6.0tO.S· 193t38 420t89" 2.S±D.S 2.710.S 
SA 4.4Z0.S 4.5tO.6 193153 180145 2.910.6 2.810.4 
NO IHD 3.910.4 4.110.4 210138 218140 2.310.5 3.1±D.4 
• p<.OI CS vs Ao; •• p<.OOI CS vs AD 
"onocytes Ind neutrophils but not T-lyaphocytes ore activlted in \lA. 
Such octivltion is not I .yst •• ic phellOll8non but occurs only in the 
coronery tree of pts with \lA. T-lyaphocytes Ire not responsible for 
IIOnocyte octivotion in \lA. 
817·4 9:15 
Acquired Neutropbil Myeloperosydase Deficiency in Unltable Angina and 
Myocardial Infarction: a Possible Marker of Innammation. 
Luigi M. Biasucci, "Giuseppe D'Onofrio, Giovanna Liuzza, "Gina Zini, 
Giuseppina Caligiuri, Antonio G Rebuzzi, "Bruno Bizzi, Attilio Maseri. Institute 
of Cardiology and "Department of Hematology, Catholic University, Rome, Italy. 
Growing evidence suggests that inflammation may play a major role in the 
pathogenesis of Unstable Angina (UA) and Acute Myocardial Infarction (MI). 
Myeloperoxidase (MPO) release from neutrophil azuropbil granules is an early 
and sensitive marker of neutrophil activation. In order to assess if neutrophil 
granulocytes are early activated in UA and MI, we measured the intra-ceUular 
myeloperoxidase index (MPXI, by automated blood cells counter, Bayer H·I 
instr.) ill IS patients (pts) with MI. admitted to Coronary Care Unit (CCU) within 
6 hours from symptoms onset. and in 2S pts with UA. admitted to CCU because of 
symptoms severity within 24 bours from the last ischemic episode. We also 
assessed MPXI in 26 healthy volunteers (N). In all groups a basal blood sample 
was taken at pts entry; in UA further san\ples were taken at 6, 12. 18, 24. 48 
hours and within 2 bours from any ischemic attack; in MI further samples were 
collected at 6. 24 and 48 hours. In aU samples of UA pts and in the samples taken 
on admission in MI pts, serum creatine kinase (CK) and Troponin T were also 
measured to exclude myocardial cell necrosis as a cause of neutrophil activation. 
Results: data are expressed as mean ± SO . On admission no UA or MI pts had 
increased values of CK or Troponin T. On admission, MPXI was significantly 
lower in pts with UA (-5.2 ± 4.2) and AMI (-8.2 ± 7) than in controls (-1.9 ± 3. 
p<O.OI). In MI pts MPXI was slightly. but not significantly, lower at entry than in 
the subsequent samples, suggesting that, in MI. myocardial cell necrosis is nOI 
the major cause of neutrophil degranulation. 
In 18/25 pts with UA. MPXI was also measured before (4-6 hours) and after 
(within 2 hours) an ischemic attack: MPXI was -3.8 ± 4.3 before, and 
significantly decreased to -5.5 ± 3.6 (p<O.OI) after the iSChemic episodc. 
Conclusions: our data indicate that an acute MPO defiCiency. (an early and 
specific index of neutrophil activatioll). occurs during acute ischemia, suggesting 
that neutrophil activation Dlay play an importanl role in the pathogenesis of 
unstable angina and in the very early stage of acute myocardial infarction. 
JACC February 1994:1A-484A 
817-5 9:30 
Increased Macrophage Plaque Infiltration in Patients with 
Acute Coronary Syndromes 
Pedro R Moreno, Valentin Fuster, Igor F. Palacios, John T. 
Fallon, Erling Falk. Cardiac Unit, Massachusetts General 
Hospital, Harvard Medical School. Boston, MA. 
lipid-rich plaque rupture is responsible for acute coronary 
syndromes and macrophage infiltration could induce lysis of 
the plaque cap. Hxpotbesis; Macrophage rich areas are 
higher in unstable angina (UA) and non-Q wave myocardial 
infarction (NQMI) than in stable angina (SA). Methods: 
Immuno-staining with human macrophage lysosome•
membrane monoclonal antibody (PG-Ml) was perfonned 
and quantified using computerized planimetry from 
microscope tissue analysis in 26 consecutive atherectomy 
samples. Eight pts had SA, 8 had UA, and 10 had NQMI. 
Age, sex, and risk factors were similar in the 3 groups. 
RmIl.ts:. ~ JIlUn:.B.1 NOM I (n-1B) It 
TR Imm2 -2) 417 ± 87 6B1 ± 157 499 ± 79 NS 
MRST/TRI") 2.5 ± B.8· 13:t 6.B 12 :t 3.8" B.B58 
MRRMITRI") B.6:t B.3. B.4:t B.2@) 2.7 ± B.9 B.B37 
MRT/TRI") B.B2:t B.B2 B.4 t B. 4 B.6 ± B.6 NS 
MRST+MRRM 
MRT/TR($) 3.14+ 1. J:5.3+5.6 141 +4.6" B.BI8 
TR: Total Rrea. MRST: Macrophage Rich Sclerotic TIssue. 
MRRM: Macrophage Rich Rtheromatous Material. MRT: 
Macrophage Rich Thrombus •• p < B.B 16 between SR and UR, 
• P < B.BI6 between SR and NQMI, @.l P < B.B1 between UR 
and NQMI. Conclusion; Macrophage rich areas were more 
frequently found in atherosclerotic plaques of pts with acute 
coronary syndromes suggesting that macrophages playa role 
in plaque ulceration and rupture. 
817·6 
Differential 8eDsitivity of White aDd Red CoIllllary 
TIu:oEli to Thra.bolytic Therapy 
9:45 
Kyoichi Mizuno, Hirokuni Etsuda. Tomoo Nagai. 
Katsuhiro Kitamura. Hiroyuki Hikita, Koh Arakawa, 
Toshio Shibuya. Kimio Satomura, Akira Kurita. Haruo 
Nakamura, National Defense Medical College. Saitama. 
Japan 
To determine whether or not the effect of 
thrombolytic therapy depends upon the character of 
coronary thrombi. we used percutaneous transluminal 
coronary angioscopy to examine 25 acute myocardial 
infarction and 10 unstable angina patients undergoing 
thrombolytic therapy. Thrombi were classified by 
angioscopy as either red or white. White thrombi were 
observed in 8 of the 10 patients with unstable angina 
but in none of 25 patients with acute myocardial 
infarction. In contrast, red thrombi were observed in 
all patients with acute myocardial infarction but in 
only 2 patients with unstable angina (p<O.Ol). The 
efficacy of thrombolytic therapy evaluated by 
angioscopy and coronary arteriography was less in 
patients with white thrombi than in patients with red 
thrombi (25% vs. 67%. p<0.05j. Conclusion; White 
thrombi are older than red thrombi or are platelet 
rich. while red thrombi are characterized by an 
abundance of fibrin and erythrocytes along with the 
platelets. Differences between white and red thrombi 
with respect to compoSition or age can account for 
the contrasting results of thrombolytiC therapy. This 
difference may explain the lack of clear benefit of 
thrombolytic therapy in patients with unstable 
angina. 
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818·1 8:30 
Erythropoietin In Heart Failure: A. Novel Hormonal Mechanism? 
Massimo Volpe. Cristina Trltto. 'Ugo Testa. Speranza Rubattu. 
lolanda Enea. Angela Mlrante. Sara Canglanlello. 
Alessandro F.Mele. 'Cesare Peschle. Mario Condorelli. 
Dept.of Internal Medicine. "Federico II" University. Naples. and 
'Laboratory of Hematology and Oncology. istltuto Superiore 
di Sanita. Rome. ITALY. 
Previous studies demonstrated that plasma erythropoietin 
levels (EPO) are Increased In congestive heart failure (CHF). 
We measured EPO In lOB patients with CHF. EPO (mU/ml) 
Increased progressively In CHF according to NYHA classes (I: 
n=2B. 1.4iO.2 (mean±SEM); II: n=27. 5.4iO.B; III: n=32. 9.6±2.0; IV: 
n=21, 34±B. F=57.7. p<O.OOl) and was Inversely correlated to 
left ventricular ejection fraction (r=-0.49B. p<O.OOl). In a 
subgroup of 9 patients In NYHA class IV. EPO fell from 43± 14 to 
12±3. p<O.Ol. after effective treatment that significantly 
Increased ejection fraction. Finally. in 9 patients In NYHA closs 
IV with elevated EPO ~1.±9) total red blood cell volume. 
calculated by using the l-albumin method. was significantly 
higher (2.62±0.2 liters) than in 11 normal control subjects 
(2.03iO.l liters). In whom EPO was 2.0i0.7. These results 
demonstrate that (0) blood levels of EPO are progressively 
elevated In CHF and this increase Is related to the severity of 
the disease; (b) conversely. on Improvement of the 
hemodynamic function Is associated with a reduction of EPO 
levels during treatment; (c) finally. erythrocytosis Is associated 
with the Increased Circulating levels of EPO. These results 
suggest that Increased EPO production may participate in the 
hormonal adaptation to the foiling cardiac function. 
818·2 8:45 
Suppression of Tumor Necrosis Factor Synthesis by n·3 Fatty 
Acids In End·stage Congestive Heart Failure 
Richard V. Milani. Stefan Endres. Hector O. Ventura. Carolyn B. 
Daul. Peter C. Weber, Frank Smart, Dwight Stapleton. Carl J. Lavie. 
Wayne Barbee. Joseph P. Murgo. Ochsner Medical Institutions. New 
Orleans. LA 
Elevated levels of the cytokine tumor necrosis factor (TNF) have 
been found in patients with end-stage congestive heart failure (CHF) 
and are thought to contribute to the cardiac cachexia often seen in 
these patients. We assessed the impact of n-3 fatty acids on levels of 
TNF and interleukin-l (lL-l) in a placebo-controlled study of eight 
patients with Class ill-IV CHF. TNF and a-I were measUred by 
radioimmunoassay in vitro after endotoxin stimulation of peripheral•
blood mononuclear cells. Results after IS weeks of treatment with S 
grams daily of either n-3 fatty acids (n=5) or placebo (n=3) are 
shown in the follOwing table: 
PretreatmeDt Po&ttreatmeDt CbaDlle p value 
(Dx/ml) (Dx/ml) ('1» 
D-3 fatty acids: 
TNF 1.21tO.74 0.58±O.70 -52'1> 0.01 
IL-I 3.94±4.58 1.12±I.72 -72'1> 0.06 
Plac:ebo: 
1NF 0.83tO.22 1.08±0.33 +30'1> NS 
ll.-l 0.68tO.58 0.78±O.39 +15% NS 
The n-3 fatty acid-treated patients had 52% and 72% reductions in 
TNF and ll..-l. respectively. compared with 30% and 15% increases 
in the placebo-treated patients. Intergroup differences in response to 
treattnent were significant (TNF, p=O.OI; ll..-l. p=O.07). 
In conclusion: I) The synthesis of TNF and ll..-l can be suppressed 
by dietary supplementation with n-3 fatty acids in severe CHF. 2) 
Supplementation with n-3 fatty acids may be useful for managing 
cardiac cachexia in patients with severe CHF. 
ABSTRACTS 
818-3 
The Endothelin System in Thoracic Inferior Vena Caval 
Constriction 
9:00 
Alfredo L. Clavell. Amiram Nir. R. Scott Wri~t, Denise Heublein. 
John C. Burnett.Ir. Mayo Clinic and Foundanon. Rochester. MN 
Endothelin (En is a potent vasoconstrictor and mitogenic 
peptide of endothelial cell origin which functions as both a 
circulating hormone and as a local autocrine/paracrine factor in 
cardiovascular regulation. Chronic thoracic inferior vena caval 
constriction (TIVCC) is an experimental model of congestive hean 
failure (CHF) characterized by reduced cardiac output. increased 
systemic and renal vascular resistance and elevated circulating ET. 
While circulating and/or local tissue ET may mediate potent 
myocardial and renal actions via well characterized and abundant 
cardiac and renal ET receptors. the activity of the local tissue ET 
system in CHF remains undefmed. The current study was designed 
to investigate the circulating. cardiac and renal ET system in 
TIVCC. Studies were conducted in 5 chronically inStrumented 
conscious dogs on a fixed sodium diet. Daily blood samples for 
ET were obtained and the tissue ET examined at day 7 post•
TIVCC by immunohistochemistry. TIVCC resulted in an increase 
in circulating ET which occurred at day 4 (S.7±O.6 vs 17.0±4.0 
pg/ml. p<O.OS) and remained elevated in association with 
decreases in cardiac output (4.S±O.5 vs 1.9±O.3 l./min, p<O.05). 
increases in systemic vascular resistance (23.S±1.9 vs 5S.6±9.0 
mmHg/l.Jmin. p<O.05) and decreases in sodium excretion 
(2S.0±1.3 vs 4.6±2.7IJ.eC11min. p<O.OS). Immunohistochemical 
staining was markedly positive for ET in myocyles from all cardiac 
chambers while renal cortical and medullary tissue revealed 
marked immunostaining for ET in renal tubular cells. Normal 
cardiac and renal tissue revealed minimal ET staining with no 
positivity detected utilizing non-immune rabbit serum as control. 
These studies demonstrate for the first time local cardiac and renal 
tissue ET activation in association with activation of the circulating 
ET system. We conclude that generalized ET activation may play 
an important role in the cardiac. vascular and renal adaptation 
observed in experimental CHF. 
818·4 9:15 
453A 
Atrial. am Brain Natriuretic Peptide have different 
NSptlISES to JIcute am tlJronic Increases in Heart Rate 
am Atrial. Pressures 
Q>rcIon W. M:le, NoIlll!l1l L. WOng, Etienne A. Grima, 
Robert J. Howard, Paul W. Annstrong, St Michael's 
Hospital, University of Toronto, Toronto, canada 
Atrial aryj brain natriuretic peptide (lINP, IH') 
constitute a dual natriuretic peptide systan which is 
activated in heart failure (HF) • we previously 
reported that the magnitude of increase in plasma BNP 
during evolving HF is less than lINP. Unlike lINP, the 
responses of BNP to both acute & chronic incranents in 
heart rate (HR) aryj atrial pressures have not been 
explored. we therefore studied the effects of acute RV 
pacing in 8 conscious clogs (Acute VP, 250 beats/min, 
Day 1); acute voll.l1lB expansion (Acute VE, Day 2) aryj 
acute VE after 7 days of chronic VP (Repeat VE, Day 
8). Data (x, pooled SO fran ANJ\TA) for (:Ulm:>nary 
capillaxy wedge pressure (PCWP, om Hg), plasma lINP & 
BNP (pg/ml) at baseline (Ba) am after VP (acute am 
chronic) am VE(Day 2 am 8) are shown. <rp<0.05, 
5p<0.01 VB Ba at Day 1 am 2. 
Acute VP Acute VE Repeat VE 
lINP BNP I PCWP lINP IH' I PCWP lINP IH' 
Ba 53 12 Ba 11 38 13 Ba 22 5355 485 
VP ~ ~ VE .4!!.. ~ 11- VE ~ 449 42 
SO 103 7 SO 6 123 5 SO 8 178 18 
BNP resporxied nrx1estly to an acute increase in HR 
(Acute VP), rut not to acute increases in atrial pres•
sure (Acute VE), am mre markedly after chronic VP. 
By contrast, lINP was responsive not only to acute aryj 
chronic VP, rut also acute VE. '1llese data lrxiicate 
that BNP is less sensitive to changes in HR am atrial 
pressure than lINP. '1llese 2 peptides likely play 
different pathophysiologic roles in heart failure. 
454A ABSTRACfS 
818·5 
Insulin Res~nce in Chronic: Heart Failure 
Jonathan W. Swan, Christopher Walton, Ian F. Godsland, 
Andrew J.S. Coats, Michael F. Oliver. 
9:30 
Wynn Institute and National Heart and Lung Institute, London, 
UK. 
The mechanisms responsible for reduced myocardial 
contractility in heart failure remain unclear. Abnonnalities of 
myocardial metabolism, including inadequate substrate supply, 
may play an important part. Carbohydrate metabolis~ may be 
particularly important as glucose becomes the mam energy 
substrate 10 the failing myocardium. We have assessed glucose 
metabolism and insulin resistance in 10 male patients with severe, 
chronic heart failure and in 10 matched control subjects. Glucose, 
insulin and C·peptide concentration profiles were measured 
following a 0.5 g/kg intravenous glucose tolerance test. Insulin 
sensitivity (inversely related to insulin resistance) was estimated 
by minimal modelling analysis of the glucose and insulin profiles. 
Heart failure patients had similar mean fasting plasma 
glucose concentration to controls but a significantly greater mean 
fasting plasma insulin concentration (18.4 vs 4.5 "U/ml; P = 
0.002). Plasma glucose response profile was similar in the two 
groups but the mean incremental plasma insulin response proflle 
of the heart failure group was significantly greater (6620 vs 3327 
min."U/ml; p = 0.004). Incremental plasma C-peptide response 
profile was not significantly greater 10 the heart failure gf!lup. 
Mean insulin sensitivity was 73 % lower in the heart fallure 
patients (0.88 vs 3.29 xlO"' min'!/"U/ml; p = 0.003). 
These findings show that patients with severe chronic heart 
failure are hyperinsulinaemic and insulin resistant compared with 
a matched healthy group. These findings may contribute to the 
progressive ventncular dysfunction seen in heart failure. 
818-6 
Effects of Myocardial Muscarinic: Stimulation 
on Dobutamine Stimulated Inotropic: Responses in the 
Normal and Failing Human Left Ventricle. 
9:45 
John D. Parker, Wilson S. Colucci. Joel S. Landzberg. and Anne 
M. Schofield. Mount Sinai Hospital. Toronto. Ontario. Canada 
and the Brigham and Women's Hospital. Boston. MA 
Muscarinic stimulation with acetylcholine (Ach) causes 
attenuation of dobutamine (Dob) stimulated LV inotropic 
responses in the normal human LV. Patients with congestive 
heart failure (CHF) have evidence of parasympathetic withdrawal 
and this might cause muscarinic post-receptor pathway 
supersensitivity. Such supersensitivity might playa role in ~­
adrenergic receptor pathway dysfunction that is seen in CHF. 
A total of 20 patients were studied; II with CHF secondary to 
dilated cardiomyopathy and 9 with normal LV function. All 
patients had normal coronary angiograms. Using a left main 
coronary infusion technique. peak LV +dP/dt responses (Millar) 
to Dob (20 Ilg/min) and Dob + Ach (111M) were evaluated. 
There was no change in heart rate. systolic blood pressure or 
L VEDP during intracoronary Dob. intracoronary Ach or their 
combination. Intracoronary Ach caused no change in basal LV 
+dP/dt but caused a significant decrease in Dob stimulated +dP/dt 
responses in both the normal and CHF groups (p<O.Ol for both). 
The % suppression of Dob stimulated LV +dP/dt responses was 
greater in the CHF group: 
% decrease in +dP/dt response 
Normals 34±16% 
CHF 74±9%* 
.p={l.03 vs response seen in normals 
The suppression of LV inotropic responses by Ach is greater in 
patients with CHF suggesting muscarinic receptor pathway 
supersensitivity. This abnormality in parasympathetic receptor 
pathway function may play a role in abnormalities of ~­
adrenergic receptor pathway function that exist in this disorder. 
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819-1 8:30 
Complications Following Angioplasty for Failed Thrombolysis in 
GUSTO; Further Evidence for the "Rescue Right" Syndrome 
Jonathan S. Reiner, Conor F. Lundergan, P. Jacob Varghese, Noah 
Israel, Doug Morris. Pamela Walker. Ted Parris. M. Walsh. Lloyd 
Solberg. Eric J. Topol, Allan M. Ross, for the GUSTO Investigators. The 
George Washington University Medical Center, Washington, DC 
Previous small reports of "rescue" PTCA for failed thrombolysis 
have suggested an increased rate of non-fatal major complications in 
patients undergoing right coronary artery (RCA) compared with other 
vessel PTCA. In the GUSTO Angiographic Trial, there were 301 PTCA 
procedures for a TIMI grade 0 or I infarct related artery (IRA) (rescue). 
Rescue of the circwnflex or vein grafts was infrequent and therefore' we 
compared 143 rescues of the RCA to 121 rescues of the left anterior 
descending (LAD). When the RCA group was compared with the LAD 
group there was no difference in mean patient age (60 ± 11 yrs vs. 58 ± 
13 yrs), gender (78% vs. 78% male), mean time to thrombolytic 
treatment (3.3 ± l.4h vs. 3.3 ± 1.8h). previous MI (7.0% vs. 9.9%), prior 
CABG (1.4% vs. 1.7%). or % undergoing rescue within 90 minutes of 
initiation of therapy (53% vs. 57%). There was no difference in success 
rate (defined as restoration of TIMI 2 or 3 flow) in the RCA vs. LAD 
groups (89% vs. 87%). There were only 2 procedure-related deaths. 
Non-fatal major complications defined as sustained ventricular 
tachycardia. bradyarrhythmia, or sustained hypotension. were more 
frequent in the group undergoing RCA compared with LAD rescue 
PTCA (15% vs. 7.4%. P = .05). Within the group with RCA rescue the 
vessel proximal to RV marginal branches was occluded in 72 procedures 
(50%) vs. 71 for the mid and distal vessel. The incidence of the major 
complications listed above was significantly higher when rescue was 
perfonned in the proximal RCA. 22%. compared with the mid and 
distal vessel. 8.5%, p = .02. 
Conclusion: Experience in the GUSTO trial confinns that rescue 
angioplasty of the RCA following failed thrombolysis is associated with 
a significantly increased incidence of major complications compared 
with rescue of the LAD. The risk is greatest when the site of occlusion is 
proximal to RV marginal branches. 
819·2 8:45 
Reperfuslon Rapidly Increases Electrical Stability and Prevents Fatal 
Arrhythmias In Rats With Acute Myocardial Infarction 
Christian F. Opnz, Gary F. Mnchell, Marc A. Pfeffer, Janice M. Pfeffer, 
Harvard Medical School, Brigham & Women's Hospital, Boston, MA. 
One of the underlying mechanisms by which reperlusion (RP) of the 
occluded artery during acute myocardial infarction (MI) reduces mortalfty 
may be the prevention of fatal anttythmias by increased electrical stability. 
To test this hypothesis we compared the anttythmia profile in rats with 
coronary artery occlusion that was permanent (CAO,n=19) with 
reperlusion after 45 (RP45,n=9) or 90 min (RP90.n:ll). We recorded the 
continuous EKG in the untethered rat by a subcutaneous telemetry system 
and counted occurrences (OCC) and measured duration (OUR,sec) of 
ventricular tachycardia (VT) and fibrillation (VF) for up to 48 hrs post-MI. 
The high mortalfty rate of 58% for CAO was reduced to 0% by RP. In 
CAO, 79% of the animals had at least one VF between 90 min and 48 hrs 
post-MI. The number of VF-OCC was, on the average, 17, and OUR, 326 
sec. In contrast, VF occurred in only 18% (RP90) and 33% (RP45) of the 
reperfused groups, w~h mean values <1 for OCC and sa sec for OUR. 
Wfth respect to VT, RP produced a 40-fold reduction in OCC and a 32-fold 
decrease in OU R. 
All animals had moderate·to-large MI (endocardial MI >30%) whose 
mean values were comparable (CAO, 52:1:10%; RP90, 44:1:7%; RP45, 
45:1:9%: P=NS). The reduction of epicardial MI size by RP (means: CAO, 
44:1:14%; RP90, 21:1:14%'; RP45, 23:1:12%'; 'p<0.05 vs CAO) translated 
into a 41% reduction in Mltransmuralfty (TM). 
Table: Mean:l:SO for up to 48 hrs post-RP:P<O.05 vs CAO:ANOVA or f. 
VF-OCC VF-DUR VT-OCC VT-DUR Mortality MI-TM 
CAO 17.3:1:18 326:1:331 240:1:294 544:1:500 58% 85:1:19% 
RP90 0.5:1:1" 5:1:13' 6:1:9' 8:1:14" 0%' 48:t:29%' 
RP45 0.6:1:1" 8:1:20" 6:1:11" 17:1:37" 0%" 5O:t:24%" 
Our data supporl the concept that coronary artery reperfusion 
markedly decreases mortalfty by creating a rapid increase in electrical 
stabilfty, thus protecting against fatal and non-fatal VF and VT. The 
increased continu~y of the epicardium with RP may facilitate a more 
normal ventricular activation. thereby suppressing anttythmogenesis. 
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819·3 9:00 
Coronary Vasodilatory Reserve i, Impaired After Reperfusion 
in Acute Myocardial Infarction 
Masaharu Ishihara, Hikaru Sato, Hironobu Tateishi, Takuji 
Kawagoe, Yuji Yasunobu, Yuji Shimatani, Atsushi Ueda. 
Hiroshima City Hospital, Hiroshima, Japan 
Coronary reperfusion therapy can reestablish coronary 
blood flow to the infarct region, however, reperfusion may 
result in a significant impairment of coronary vasodilatory 
reserve. To assess this issue, we examined coronary flow 
responses to dipyridamole in 8 patients with acute myocardial 
infarction (AMI) who underwent coronary angioplasty (PTCA) 
within 6 hours of symptom and follow up angiography 2 weeks 
after AMI. 9 patients with normal arteriograms served as 
contro\. A coronary Doppler guide wire (FloWire) was positioned 
beyond the infarct related coronary lesion. After stable signals 
of coronary flow velocity were obtained, dipyridamole 
(0.56mg/kg) was administered intravenously over 4 minutes 
and coronary flow velocity was measured for 10 minutes. 
Coronary vasodilatory reserve was calculated as the ratio 
of hyperemic average peak velocity (APV) I resting APV. 
Results: 
After PTCA Follow ul2 Control 
resting APV (cm/s) 28 ± 19 J 25 ± 7 17 ± 5 
hyperemic APV (cm/s) 39 ± 25 * 49 ± 16 J# 51 ± 16J# 
vasodilatory reserve 1.4 ±0.3 2.0 ± 0.2 3.0 ± 0.3 
I I 
* # 
# * p < 0.05, # p < 0.01 
Conclusion: Our data demonstrated that coronary vasodilatory 
reserve was severely impaired immediately after PTCA in 
AMI and the recovary of vasodilatory reserve was insufficient 
2 weeks after AMI. 
819·4 9:15 
Patients Delay SccIdng ~t fa Su.spcctcd Myocardial IDfan:IioD in Spite of 
Prior Experieoce of IacbaImic Heart Disease: A Missed Opportunity fa Rcduciog 
Delays to 1brombolysis. 
Andrew D. Mmnford, Kim V. Wm, Sandra 1. Owen, Alan G. Fraser, Uoiver&ity 
of Wales Col1ege of Medicine, Cardiff, U.K. 
Pre-bospilal delay Is Ibe main component of Ibe interval between ODSet of 
symptoms of acute myocardial infarction (AMI), and Ibe administtation oC 
thrombolysis. This delay, and Ibus tbe effectiveness of early treatment, is 
determined by patients' decisions to seek belp. In order to understand factors 
influencing patients' delays, and to determine possible sttategies Cor acbieving 
earlier self-referral, we prospectively studied 100 patients (65 men: meau age 64, 
range 37-87 years) admitted consecutively to coronary care units in Cardiff, U.K. 
and Vancouver, Canada. The groups were well-matcbed and Ibey are reported 
togetber. AU patients bad severe chest pain and suspected AMI was ronfJIDled in 
47%. We recorded Ibe circumstances, mode of onset and nabJre of symptoms, prior 
cardiac history, knowledge of symptoms of iscbaemic heart disease (IHD), and 
demognIpbic Cacun. 
Amongst 87 patients aniving witbin 24 hours of die onset of symptoms, Ibe meau 
delay before admission was 2S6 minutes. Patients' delays represented 66% of Ibis 
time (meau 170 min, interquartile range 3()"180), and were unrelated to age, sex, 
education, or socioeconomic group. They were independent of perceived severity oC 
symptoms and diagnosis, but were shorter in patients witb crescendo symptoms 
and in tbose later coofmned to have AMI (botb, p <0.05). 
49% of patients bad a history of prior angina, and 63% a Camily history of DID. 
56% knew tbe symptoms of AMI and 56% knew patients witb angina or AMI. 
None of tbese factors was associated witb reduced delays in presenl8tion. Only 
patients witb previous AMI (40%) presented earlier wben experiencing IICW 
symptoms (p<O.05). 
We bave ronf1tDled that patients' delays in seeking belp are tbe main Cactor 
delaying tbrombolysis. These delays were not related to educational or 
socioeronomic status, IlOl' shorter in Ibe substantial proportion of patients witb 
prior angina or knowledge of AMI. Efforts to reduce delays in thrombolysis 
should concenttate on specific education of patients witb angina, previous 
myocardial infarction, or a positive family history. 
ABSTRACTS 455A 
819·5 9:30 
Geuder DiffereDCes in lefusal to Participate in a 
laDdoaized Trial: A leport Fr_ 'l'be Bypasl ADgioplasty 
IevascularizatiOD Investigation (IWU) 
Alice I. Jacobs, Sheryl Kelsey, Joseph Kelvin, Amy 
Rogers, Kark Kacedo, Bernard Chaitaan, David P. Faxon, 
latherine Detre and the BARI Investigatorl, Boston 
University Kedical Center, Boston, KA 
It has been suggested that vomen (V) are referred for 
coronary revascularization less often or later than .en 
(K). Bovever, it is unclear vhether these referral 
decisions are aade for V or by V. As a related issue, 
ve investigated the gender differences in the reasons 
for refusal to participate in a randomized trial of 
revascularization in a lubset of 381 eligible but not 
randoaized (randomizable) patients in BARI of whoa 103 
(27%) vere V. The decision to refuse randomization vas 
aade by the patient in 64% of V and 68% of K and by the 
physician in 36% of V and 32% of K (p-NS). Gender or 
age did not effect treataent selection of CABG or PTCA. 
In another separate cobort of 105 randoaizable patients 
(K.83 , V.22), the cardiologist left the decision to 
participate in BARI to the patient in 50% of V and 57% 
of K. Hovever the spouse left this decision to the 
patient in 41% of V and 71% of K, p<0.05. The aajor 
responsibility for aedical care decisions vas assumed 
by 59% of V and 81% of K, p<0.05. 
Therefore, in this subset of randoaizable patients in 
BAR I , there are no gender differences in either the 
patient's or cardiologist's decision to participate in 
the trial although the spouse influences the decision 
aore often in V. These decision aaking patterns 
suggest that some of the gender differences in baseline 
characteristics in patients presenting for 
revascularization aay not be due to physician bias but 
aay be explained by spousal influences that relate to 
cultural/societal factors. 
819·6 9:45 
Effect of Monotherapy with lin HMG CoA Reductase Inhibitor Upon the 
Progression of Coronary Atherosclerosis in Women: a CCAIT Substudy 
David Waters. Jacques Lesperance. Lyall Higginson. Peter Gladstone, 
Brian Kimball. Michel Le May, Stephen Boccuzzi. and the CCAIT 
Investigators. Montreal, Ottawa and Toronto. Canada, and Hartford. CT 
Although coronary disease is the leading cause of death in women and 
its clinical features differ from those in men, few women have been 
included in angiographic trials of lipid-lowering therapy. The Canadian 
Coronary Atherosclerosis Intervention Trial is a double-blind, randomized, 
placebo-contolled trial to determine whether monotherapy with lovastatin 
ameliorates the evolution of coronary atherosclerosis. In 3 centers 269 
men and 62 women s 70 years old with diffuse coronary disease and a 
fasting serum cholesterol (CI between 220 and 300 mgldl were enrolled. 
Baseline features of the lovastatin and placebo groups were similar. 
Women were older than men (57.6 vs 52.2 years, p<0.0011 and were 
more likely to have angina (95% vs 83%. p=0.0161. hypertension (58% 
vs 33%. p<O.OOll and diabetes (23% vs 12%. p=O.041. Men were 
more Ikely to have smoked (82% vs 68%. p =0.0221 and to have had a 
previous MI (58% vs 39%. p =0.0071. Mean total C was higher at 
baseline in women. 257 vs 248 mgldl (p=O.0631, as was HDL-C, 47.5 
vs 39.8 mg/dl (p<0.0021. All pts received dietary counselling. Lovastatin 
or placebo was begun at 20 mglday and was up-titrated to 40 and 80 
mg during the first 16 weeks to a target LDL -C of 130 mg/dl. The mean 
lovastatin dose in women was 34 mglday and in men was 36 mg/day. 
Total C decreased by 24% in women and 20% in men in the lovastatin 
group; LDL-C fell by 32% and 28% respectively (p = NS)' C changes in 
placebo pts were all <4%. Coronary arteriography was repeated after 2 
years in 54 women and 245 men (90% of ptsl. Films were read blindly 
using Quantitative techniques. Progression. defined as a worsening of 
minimum lumen diameter by :.::0.4 mm of:.:: 1 lesion, was seen in 7 of 25 
lovastatin and 17 of 29 placebo women (28% vs 59%, p = 0.0261. New 
lesions developed in one lovastain and 13 placebo women (4% vs 45%. 
p=O.OO1). Results for women and men were not significantly different, 
in spite of the large differences in baseline features. 
Conclusion: Lovastatin slows the progression of coronary atherosclerosis 
and prevents the development of new coronary lesions in women. 
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Is Multiple Valve Replacement With Bioprostheses Appropriate? 
8:30 
Prasad Krishnan, Thomas A. Orszulak, Hartzell V. Schaff, Gordon K. Danielson, 
James R. Pluth, Francisco J. Puga, Mayo Clinic, Rochester, MN 
To evaluate effectiveness of bioprostheses for muHiple valve replacements. 
Between March 1980 and April 1991, 50 patients (25 men, 25 women) (mean age 
70 years, range 25-85 years) underwent muHiple valve replacement utilizing the 
Carpentier-Edwards (C-E) porcine bioprosthesis. FOrty-two patients received 
aorti: and mitral replacements (A-MVR) and eight patients had n1tral and tricuspid 
replacements (M-TVR). The majority of patients required valve replacement for 
rheumatic heart disease and valvular regurgitation. In-hospttal mortality was 14% 
(7 patients). Preoperative ejection fraction mean was 50%. Twenty-nine patients 
were etther In atrial fibrillation or a paced rhythm preop. Slx1een patients (40%) 
had previous cardiac procedures. Ten patients had concomttant coronary 
bypasses (mean 1.8 grafts/patient) at the time of muHiple valve replacement. 
Follow-up ranged from 1-12 years, mean 3.5 years; total patient years 177.9. 
Five-year survival and freedom from stroke or anticoagulant (AlC) bleed for 
A-MVR was 57%, 77% and 74% respectively. Five-year survival and freedom 
from stroke and AlC bleed for M-TVR was 45%, 100% and 83% respectively. AI 
follow-up, 31 patients were receiving Coumadin anticoagulation. Three patients 
required reoperation for bioprosthetic valve failure a mean of 30 months postop 
(mean age 73 years). Desptte the perceived beneftts with bloprotheses of not 
requiring long-term anticoagulation, the majority of this patient population was 
receiving Coumadin at follow-up. The predominant reason for use of the 
bioprosthesls appears to be advanced patient age and the potential to prevent 
anticoagulant-related bleeding. Wrthin the constraints of a smaD patient population 
of 50 patients, broad recommendations are not valid; yet H would appear that 
cardiac disease affecting muHiple valves is frequently associated wHh atrial 
fibrillation and patients will require long-term AlC therapy and the bioprosthetic risk 
of stroke and AlC bleeding is similar to that with mechanical prostheses. Based 
on this series of patients and the potential for asynchronous valve failure, H would 
be best to consider mechanical prostheses for muHiple valve replacements unless 
there is overwhelming contraindication for Coumadin AlC. 
820·2 8:45 
'I1Ireshoid or Hemodyaamlc BeaeIIt or Aortic Valve Replacement (A VR) In 
AoI1Ic Stenosis With Doppler Pre-ope1'lldve Mean Gradients Leu 1ban SO 
mmHg 
Joseph L. Blackshear, Fletcher A. Miller, Hassan Loutfi, Thomas A. 
0rszuIak, Mayo Clinic:, Jacksonville, FL, Srottsdale, AZ, and Rochester, 
MN. 
The management of patients with moderate to severe aortic stenosis (AS) is 
problematic:, especially in patients with indefinite symptoms, and a low 
mean transaortic gradient. Moreover, patients with mild-moderate AS 
occasionally require urgent coronary bypass surgery, and a decision to 
replace or retain the aortic va1ve must be made. We sought to define 
whether patients with low gradients undergoing aortic va1ve replacement 
benefit hemodynamica1ly, and by how much. 123 patients with a Doppler 
mean pre-operative gradient < SO mm Hg had assessment of pre-and post•
operative peak left ventricu1ar outflow tract to peak aortic va1w1ar velocity 
ratios (VIfV2) and effective orifice areas (EOA, cnh The change in 
VIfV2 was significantly greater for patients receiving aortic homografts (4 
VI/V2 - 0.41 t .05, n .. 12) than non-homograft valves (4 V1fV2 = 0.17 
t 0.01, n = 111, p < 0.0001). Non-homograft prostheses included St. 
Jude's, Carpentier-Edwards, and Medtronic-Hall valves. Marginal 
hemodynamic benefit was seen with pre-op mean gradients s 26 mm Hg, 
and substantial benefit with pre-op gradients> 26 mm Hg (TABLE). 
Pre-QP i gradient· 
~ .2IlU.1:26l 
Pre-op V1fV2 0.30t.02 
Post-op V1fV2 0.41t.02 
4 V1fV2 0.11t.05· 
4 EOA( cm2) 0.51t.20· 
·p<0.05; "p<0.0001 
.llW:lil 
0.25t.01 
0.47t.03 
0.22t.04·· 
Ul8t.13" 
~ 
O.22t.Ol 
0.44t.02 
0.21t.03" 
1.15t.14" 
~ 
0.21:1:.01 
0.41t.01 
0.19t.01" 
O.94t.07·· 
Conclusion: Patients with mean aortic gradients of < SO mm Hg may 
undergo aortic va1ve replacement with anticipation of improved 
hemodynamics. In this series, the mean pre-operative gradients above 
which significant hemodynamic benefit from A VR occurred were 
approximately 25-30 mm Hg. 
lACC February 1994:1A-484A 
820·3 9:00 
Defining Acute Hemodynamic Success Following Balloon 
Mitral Commissurotomy 
J. Kevin Harrison, John S. Wilson, Steven E_ Hearne, 
Frank D. Tice, Karen S. Pieper, Katherine B_ Kisslo, 
Thomas M_ Bashore_ 
Duke University Medical Center, Durham, He 
The definition of a successful balloon mitral 
commissurotomy (BMC) remains controversial and 
inconsistent. Various arbitrary definitions have been 
used including a post-procedural valve area a 1_5 cm2 , an 
increase in valve area of 25%, 35%, or 50% or some 
combination of these parameters_ The purpose of this 
study was to determine which acute measure best predicts 
improved, event-free survival at one year_ 
Of 164 BMC patients, 120 had reached the one year 
endpoint_ Event-free survival was defined as NYHA class 
I or II symptoms in the absence of mitral valve 
replacement (MVR). Measures of acute procedural success 
examined included the absolute mitral valve area after 
BMe (post MVA), the change in mitral valve area (AMVA), 
the percentage change in mitral valve area (%AMVA), and 
the severity of mitral regurgitation (MR) following BMe_ 
Results: AMVA and %AMVA were most strongly related to 
one year event-free survival (P=.OOOl). Analysis by 
hazards ratios revealed a steep increase in the risk of 
a poor one year outcome associated with a gain of less 
than 50% in MVA. While MR a 3+ vas almost uniformly 
associated vith need for MVR, event-free survival with 2+ 
or 1+ MR was excellent, and not different than the event•
free survival with no post procedure MR_ 
Thus, the best acute predictor of one year event-free 
survival after BMe is a 50% or greater increase in MVA in 
the absence of 3+ or greater MR_ These findings should 
help standardize the definition of a successful balloon 
mitral commissurotomy_ 
820·4 9:15 
Relation of Phasic Coronary Blood Flow Velocity Profile to 
Clinical and Hemodynamic Characteristics of Patients with 
Aortic Valve Disease 
Hongo M, Goto T, Watanabe N, Nakatsuka T, Takenaka H, 
Tanaka M, Yamada H, Okubo S, Sekiguchi M. 
Shinshu University, Matsumoto, Japan 
To assess the relation of coronary blood flow velocity (CBFV) 
characteristics to the clinical and hemodynamic manifestations 
in aortic valve disease, we analyzed phasic CBFV pattems of 
the proximal portion of the left anterior descending artery in 30 
patients (pts) with chronic aortic regurgitation (AR), 1S with 
predominant aortic stenosis (AS), and 11 control subjects 
using a 3F Doppler catheter with spectral analysis. The resting 
systolic coronary flow velocity·time integral (VTI) was 
significantly higher and the diastolic VTI was slightly but 
significantly higher In pts with severe AR than in those with 
mild AR (11.8±4.2 VS 4.1 ±1.1 cm, p<.001 ; 18.S±5.B VS 
13.2±3.2cm, p<.OS) and control subjects (4.0±1.0cm, p<.001 
and 13.3±3.6cm, p<.OS). Pts with AS had a slightly lower 
systolic VTI (3.7±1.3cm) and a higher diastolic VTI 
(14.8±3.9cm) than control subjects. Coronary vasodilator 
reserve in pts with AS and angina pectoris with effort was less 
than that in pts with AS without anginal pain (1.6±O.3 vs 
2.2±O.1, p<.01). There was a significant correlation between 
the ratio of the resting systolic to diastolic VTI (SID ratio) and 
the ratio of the aortic systolic to diastolic pressure (r=.7S, 
p<.001) In pts with AR. The SID ratio was inversely correlated 
with left ventricular systolic pressure (r=-.92, p<.OO1) in pts 
with AS. These results suggest that hemodynamic changes 
related to aortic valve disease contribute to alterations in the 
resting phasic CBFV profiles observed in these pts and that 
Impaired coronary vasodilator capacity plays an important role 
in the pathogenesis of myocardial ischemia in pts with AS. 
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820·5 9:30 
Destendin& Aortic Flow Reversal Predicts Ascendin& Aortic 
Re&u!,&itant Fraction in Chronic Aortic Relu!,&itation 
Sharon C. Reimold. Kavita Aggarwal, Stephan E. Maier, Kirsten E. 
Fleischmann, David R. Piwnica-Worms, Ron Kikinis, Richard T. 
Lee, Brigham and Women's Hospital, Boston, MA. 
Quantitation of descending aortic diastolic flow reversal is a 
measure of aortic regurgitant disease severity. To explore the 
relationship between flow reversal in the ascending (AA) and 
descending aorta (DA) in patients with chronic aortic regurgitation, 
QRS-gated cine phase velocity magnetic resonance imaging with 16 
acquisitions/cycle was performed on axial thoracic images. 
Antegrade and retrograde flow and regurgitant fraction were 
measured in the AA and DA. The regurgitant proportion (regurgitant 
f10w/antegrade flow) of 9 sample volumes (diameter 2.Smm) 
equidistantly placed in a crosshair pattern on the end-diastolic image 
of AA and DA studies (n=24) was determined and compared to the 
AA regurgitant fraction. Results. The AA regurgitant fraction was 
directly related to the DA regurgitant fraction (y=0.71x+S, r=0.81, 
p<O.OOI). The 9 DA sample volume regurgitant proportions 
correlated well with the AA regurgitant fraction (r= 0.81-0.96). In 
contrast, only 119 AA sample volumes reliably predicted the AA 
regurgitant fraction. In seven patients who underwent repeat imaging 
6 weeks after the initial study, there was excellent reproducibility 
between AA regurgitant volumes (y=0.98x-0.82, r=0.99) and 
regurgitant fractions (y=0.95x-0.3, r=0.94). Conclusion. The 
regurgitant fraction can be predicted from flow patterns in the 
descending aorta and individual descending aortic sample volumes. 
Ascending aortic sample volume regurgitant proportions do not 
correlate with the regurgitant fraction due to nonuniform velocity 
profiles. 
820-6 
Aortic Stenosis With Severe Left Ventricular 
Dysfunction; Determinants of Operative Mortality 
and Long-Term Survival 
Heidi M Connolly, Jae K Oh, Thomas A Orszulak, Sara L 
Osborn, Veronique L Roger, David 0 Hodge, Kent R Bailey, 
James B Seward, A Jamil Tajik 
Mayo Clinic, Rochester MN 
The outcome of aortic valve replacement in pts with 
severe symptomatic aortic stenosis (AS) and marked 
9:45 
LV dysfunction (EF.s35%) is not well known. Thus we 
reviewed 154 such pts (MI07:F47), mean age 73 yrs, (range 
32-93), who were operated on between 1985-1992 and 
describe their survival. 
Pre-operative echo or cath demonstrated the following 
mean values; LVEF 27±7%, (range 10-35%), AV area 0.63± 
0.22 cm2, mean gradient (MG) 43±18 nunHg, and cardiac 
output (CO) 3.9±1.3 Vmin. Coronary artery disease 
(CAD) requiring bypass was present in 78 pts (51%). 
The in-hospital mortality was 11% (17/154), and 50 pts 
(32%) were dead at follow-up, mean 2.1 yrs (up to 8.2 years). 
Overall five year mortality was 58%. In-hospital mortality 
was significantly associated with lower preop MG (p=.04) 
and CO (p=.03) by univariate analysis. The only predictor of 
overalliongterm mortality was the presence of significant 
CAD (;::.2 vessels or left main). Five year survival with 
significant CAD was 39% vs 69% without signifcant 
CAD (p=0.005). Age, gender, NYHA class, LVH, EF, MG, 
creatinine, urgency of surgery, and prosthesis type or size, 
did not have independent effect on long-term survival. 
CONCLUSION: 1) Operation for AS with reduced 
LV function (EF.s35%) can be performed at an acceptable 
risk. 2) In-hospital mortality is associated with lower preop 
CO and MG. 3) Overall long-term mortality is related to the 
presence of Significant CAD. 
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821·1 8:30 
The First Seventy-Two Hours of Acute Atrial Fibrillation 
are Associated With Significant Thromboembolic Risk 
Gary L. Pauls, Tonda D. Bradshaw, Chandra R. Hart, Patricia M. 
Applegate, Lorna Linda University Medical Center, Loma Linda, CA 
The current "standard of care," in the management of acute atrial 
fibrillation (AF), does not require anticoagulant therapy if 
cardioversion is accomplished within the first 72 hours of AF. These 
recommendations were a result of animal studies performed several 
decades ago. The current investigation collected seventy-five 
consecutive patients with atrial fibrillation between 9-92 anQ 3-93; 
thirty-one were found to have acute AF « 72 hours duration). 
Those with acute AF were examined for evidence of major 
thromboembolic endpoints of: stroke, unexplained altered mental 
status, arterial thromboembolism and unexplained macroscopic 
hematuria. The group of patients with thromboembolism was 
compared to those without thromboembolism, in terms of: gender, 
age, hours of atrial fibrillation duration, left ventricular (LV) ejection 
fraction, left atrial size, LV thrombus, history of (hlo) hypertension, 
hlo previous thromboembolism, hlo CHF, hlo smoking, hlo 
diabetes, prothrombin time, partial thromboplastin time, platelet 
count and medications. Results: The incidence of major 
thromboembolic events was 38.7%; of those with major 
thromboembolism 25.0% had stroke, 41.7% had unexplained altered 
mental status, 16.7% had unexplained macroscopic hematuria and 
16.7% had arterial thromboembolism. A statistically significant 
difference between those patients with thromboembolism and those 
without thromboembolism was found only between: duration of atrial 
fibrillation (43.5 hours versus 25.9 hours, p = 0.02), left ventricular 
ejection fraction (LV EF %: 62% versus 45%, p = 0.03) and hlo 
hypertension (75% versus 26%, p = 0.02). Conclusion: The 
patient population with acute atrial fibrillation is at significant risk 
of suffering a major thomboembolic event. The current 
recommendations for the management of acute AF require 
reexamination. 
821-2 H:45 
Autonomic Nervous System Activity Bdore Onset or Paroxysmal 
Atrial· Fibrillation by Power Spectral ADBlysls or Heart Rate. 
Prateek DalaI, Bengt Herweg, Paul Schweitzer, Beth Israel Medical Center, MI. 
Sinai School of Medicine, New York, NY. 
Onset (0) of Paroxysmal AtriaI Fibrillation (PAP) has been related to autonomic 
modulation in past, both in vivo and in vitro. Power Spectral Analysis (PSA) of 
R-R intervals was performed to examine the influence of sympathetic (S) and para•
sympathetic (P) activity before 0 of PAF. In 16 pis., 24 episodes of PAF were 
detected by 24 hr. Holter monitoring. Sequences of 2S6 sec. of continuous sinus 
rhythm were analyzed 20 min. and S min. before 0 of PAF. Power Spectral 
Density (PSD) was measured in absolute (A) and nonna1ized (N) forms from R-R 
interval trend in frequency bands of 0.IS..o.4 Hz (higb freq. band correspooding to 
Pl. and 0.04..0.12 Hz (low freq. band corresponding to S) using fast Fourier 
analysis. 
Results: In 13 out of 14 samples (II of 12 pis.) with PAF 0 at night (OOam-
6am), there was increase in PSD (by A and N) in high freq. band (HF) during S 
min. sample prior to 0 compared to 20 min prior to O. There was no consistent 
trend in PSD change in low freq. (IF) band while comparing the S min. to 20 
min. samples for 0 at night. Similarly, there was no consistent trend in PSD 
change in both bands while comparing the S min. to 20 min. samples for 0 during 
day. Shown in the table below are PSD measurements in A (msec2) and N, 
reported as MeaD (SD). 
ODset of PAF 
durlDg Dlgbt 
(OOam-hm): 0=14 
20 miD before 0 
A N 
HF: 113(108) 0.09(0.08) 
LF: 449(653) 0.15(0.08) 
Onset of PAF HF: 250(284) 0.19(0.13) 
during day LF: 312(361) 0.25(0.15) 
(bm-Upm): n=IO 
5 mID before 0 
A N 
509(621)11 0.18(0.10)11 
383(553) 0.16(0.09) 
259(371) 0.13(0.11) 
403(460) 0.19(0.13) 
• pdl.02 for chll1ge in A and N (from 20 min. to 5 min. in HF) 
Conciusioas: PIs. with onset of PAF at nighl, often with preceding increase in 
R -R interval, demonstrated HF activity surge which may be vagally induced P AF. 
Interestingly, this was not always associated with decrease in LF. On the ether 
hand, 0 during day was not clearly related to changes in autonomic balance as 
detennine<! by this methnd. PSA of sequences of R-R interval before PAF may 
help to identify the modulating effects of autonomic imbalances on its onset. 
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821-3 9:00 
Modes of Onset of Spontaneously Occurring EpIsodes of 
Atrial Fibrillation 
Francis D. Murgatroyd, Katerina Hnatkova, Xie Baiyan, A. John Camm, 
Marek Malik. St George's Hospital Medical School, London, UK 
BackfTOund: new algorithms are being developed for the prevention of 
atrial fibrillation (AF) by overdrive pacing and the suppression of atrial 
premature complexes and pauses. However, few data exist regarding the 
mode of onset of spontaneously-occurring AF. 
Methods: 78 ambulatory ECG recordings from patients with paroxysmal 
AF were analysed. Each 24-hour recording was subjected to 
computerized analysis and manual editing on a Ma"luetle Laser Holter 
system. The first and last beat of each episode of AF were identified by 
visual inspection, and their precise times were combined with the 
computerized analysiS to produce a file listing the rhythm and R-R interval 
of every beat in each recording. The RR intervals preceding the onset of 
1126 episodes of AF were then analysed. For each episode of AF, the 
mean heart rate in the 105 (HR10) and in the 30s (HR30) prior to AF was 
calculated, along with the mean heart rate of all the sinus rhythm in the 
recording (HRM). Additionally, the RR intervals in each of the three beats 
preceding AF were compared with the mean of the 15 RR intervals 
preceding AF and classified as short (S, <80% of mean), normal (N, 80-
120% of mean), and long (L, >120% of mean). 
Results: HR30 was <50 bpm in 8.7% of episodes, 5O-1oobpm in 82.8% 
of episodes, and >100 bpm in 8.5% of episodes. There was very close 
correlation between HR10 and HR30. However, HR30 was greater than 
HRM in 86.4% of episodes. The commonest modes of initiation were: 
N-N-N (40.9%), N-N-S (11.7%), S-L-S (5.2%), S-L-N (5.1%), L-S-L (4.2%), 
and L-N-S (3.0%). The last or penultimate cycles included S in 38.6% of 
episodes. 
Conclusions: most episodes of atrial fibrillation do not occur at times of 
bradycardia or tachycardia, but do occur at relatively stable heart rates 
which are slightly above average. Although cycle length irregularity 
frequently precedes AF, the commonest mode of onset does not involve a 
pause or a premature beat. 
821-4 9:15 
Action Potential Altemans and Slow Conduction Provoked by 
Overdrive Pacing in the "Substrate" Area in Atrial Flutter 
Michael R. Franz, Hans Moore, Marlrus Zabel, Ross D. Fletcher. Div. of 
Cardiology, VA Medical Center, Washington, DC 
Type I aIrial flutter is considered due to reentry, depending on an area 
of slow conduction in die infero-paiterlor aspect (IP A) of the right atrium. 
The area of slow conduction has ttadionally been localiu:d by measuring 
activation times at different sites within die right atrium. This approach 
identifies sites between which conduction is delayed but usually does not 
pinpoint die site of abnormal electrophysiological property directly. We 
used a new approach which uses a monophasic action potential 
(MAP}-pacing catheter tip electrode to map atrial depolarization and 
repolari7ation in 6 patients with type I aIrial flutter. MAP recordings were 
obtained at 8±2 right atrial sites during spontaneous atrial flutter and 
during e1ecIrical pacing, starting with a cycle length (CL) 10 msec shorter 
than die spontaneous flutter CL and subsequent CL decranents in l(}'msec 
steps. Results: During spontaneous atrial flutter, MAP recordings at all 
sites including IP A exhibited sharp upstrokes and short, but regular 
repolarization contours with no or very short « 1 0 msec) diastolic 
intervals. Decremental pacing resulted in further shortening of MAP 
duration with maintenance of sharp upstrokes, short stimulus response 
latency, and 1:1 conduction, at all sites except IPA. At IPA, decrement:ll 
pacing produced rate-dependent altemans of MAP duration and amplitude, 
progressively increasing stimulus response latency, and finally (at pacing 
<35 msec below die flutter CL) 2: 1 or irregular conduction. In 3/6 cases, 
rapid pacing resulted in an irregular MAP pattern characteristic of atrial 
fibrillation, confmed to the IP A, while the other regions maintained the 
regular pattern of atrial flutter. 
ConcJugODS' In patients with type I aIrial flutter, overdrive pacing causes 
action potential altemans and conduction abnormalities. This abnormal 
response is very similar to that of ischemically damaged myocardium and 
suggests that die substrate of aIrial flutter cmsists of diseased myocardial 
tissue which, for still unknown reasons, happens to be located within the 
anatomical boundaries of the IVC and TP valve. 
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821-5 9:30 
Assessment of Antiarrhythmic Drug Action on Local Atrial 
Refractoriness During Atrial Fibrillation In Hurnans 
Gregory W. Sotteron and Joseph M. Smith 
Washington University, St. Louis, MO 
Lack of objective measures of antiarrhythmic drug (AAD) action on 
atrial tissues during atrial fibrillation (AF) frustrates patient•
specific, electrophysiologically guided therapy. To overcome these 
limitations, we measured the time-varying frequency of local 
activation during AF and exploited the inverse relation between 
activation frequency and local refractory period (RP) in order to 
quantitatively evaluate the effects of antiarrhythmic drugs on atrial 
refractoriness during AF. Ten (10) simultaneous bipolar atrial 
electrograms were recorded from the right atrium (RA) and left 
atrium (LA) in 14 patients experiencing AF while undergoing EP 
study. The local activation frequency (f) during AF was determined 
before and during IV procainamide infusion (15mg/kg over 30 min) 
in 5 pts, and before, during, and after a 1 2 mg intravenous bolus of 
adenosine in 14 pts. Procainamide decreased f in both the RA and LA 
~ r::-~~~ ro. !~.tloo ~"MI ~j 
o 10 MiMes into infusion 20 
153 to 229 ms. Adenosine caused dramatic, transient, and 
inhomogeneous changes in local activation frequency corresponding to 
differential shortening of RP in the RA and LA, with the result being 
~ BPIcootrol1 ~ BP£idmQl. ~ 
RA 6.42 Hz 1 SS.8 msec 12.3 Hz 81.6 msec 29 sec 
LA 6.14Hz 162.7msec 8.7 Hz 11S.6msec 20sec 
a marked, transient non-uniformity in RP duration, thus suggesting 
a mechanism for adenosine's propensity to initiate transient AF. 
Determination of local activation frequency provides a quantitative 
measure of the regional and dynamic effects of antiarrhythmic drugs 
on atrial refractoriness during AF in vivo, and may ultimately enable 
patient-specific selection of AAD therapy for AF. 
821-6 9:45 
Observations from Epicardial Maps on the Termination of Atrial 
Fibrillation in a Swine Model 
Haris J. Sih. Alan V. Sahakian, Carl E. Arentzen, Steven Swiryn. 
Northwestern University and the Evanston Hospital, Evanston, IL. 
The circulating wavelet hypothesis suggests that fibrillation could 
tenninate by either progressive fusion or simultaneous block of all wavelets. Right 
atrial free wall epicardial maps were made during 6 spontaneous terminations of 
induced atrial fibrillation in 4 open-chest swine. 240 unipolar sites. 2.5mm apart. 
mapped the last 45sec prior to tennination. Atrial rate, activation maps. and 
coherence maps of consecutive 4sec segments were analyzed. Over all episodes, 
atrial rates varied from 413BPM to 72IBPM (mean±std.dev.=561±83) during atrial 
fibrillation. Atrial rate decreased modestly but significantly from 45se~ prior 
(570±96BPM) to just prior to tennination (520±85BPM) (p=(l.()()3). Activation 
maps during the last 4sec prior to termination were compared to those from 45sec 
prior to tennination. In all 6 episodes, similar features existed between the earlier 
activation maps and from the activation maps just prior to termination. In 2 of 6 
cases, the activation maps just prior to termination could be distinguished by the 
last I or 2 cycles preCeding tennination. These last cycles tended to be longer in 
duration than the average cycle length. While earlier cycles were associated with 
more complex patterns during atrial fibrillation, these last I or 2 cycles were 
associated with one wavelet that activated the entire region of tissue under the 
electrode array and originated from a region dissimilar to immediately preceding 
wavelets. In the other 4 episodes, activation maps from 45sec prior to tennination 
could not be discriminated from activation maps just prior to tennination. 
Coherence maps show Ihe phase consistency between each recording sile and a 
reference over a 4sec interval. Coherence vs. distance from the reference was 
calculated. Coherence dropped, often precipitously, with distance from the reference 
during atrial fibrillation. Coherence was not significantly different from 45sec prior 
to just prior to tennination for all measured distances. Coherence maps changed 
shape and overall value over time during atrial fibrillation. Changes in coberence 
maps did not correspond to any changes in atrial rate. 
Conclusions: In this animal model, atrial rates have a significant. but 
small decrease prior to tennination of atrial fibrillation. Activation maps suggest 
two ~ mechanisms for tennination of atrial fibrillation: the abrupt fusion of 
wavelets over only I or 2 cycles, and the simultaneous block of wavelets. 
Coherence maps as one measure of organization do not show a progressive increase 
in the organization of atrial fibrillation prior to tennination. but do show changes in 
spatial organization during atrial fibrillation. 
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822·1 8:30 
Risk and Benefit of Combined Maze Procedure for Atrial 
Fibrillation Associated with Valvular Heart Diseases 
Akira T. Kawaguchi. Yoshio Kosakai. Fumitaka Isobe. 
Yoshikado Sasako. Kiyoyuki Eishi. Kiyoharu Nakano. 
Yoshitsugu Kitoh and Yasunaru Kawashima 
National Cardiovascular Center. Osaka. Japan 
Persistent atrial fibrillation (AF) often leaves pa•
tients symptomatic even after a successful valvular 
surgery. To identify merits of a modified Maze pro•
cedure (Maze) combined with valvular surgery. 51 pa•
tients (Gl) undergoing mitral (n=26). aortic (n=2). 
mitral+aortic surgery (n=16) and ASD closure (n=7) each 
combined with Maze for AF were compared with 51 pa•
tients (G2) matched for underlying diseases and pro•
cedures except for Maze in the preceding years. Each 
group had a similar average age (year). duration of AF 
(AF. year). cardiomegaly (CTR. %) and functional class 
(FC). undergoing 31 concomitant tricuspid annuloplasty 
and 12 reoperation. Gl had longer bypass runs (CPB. 
min). longer cardiac arrest (AA. min) and larger blood 
loss (BL. ml) with longer respiratory care (RC. hour). 
but without mortality. No significant differences (NS) 
were found in catecholamine or transfusion requirements 
(TX. ml). cardiac output or ICU stay. Sustained AF was 
much less frequent at any time after surgery (1. 3. 6 
months: 1M, 3M. 6M) in Gl with an average follow-up of 
8.1 months (1 to 18 months). Medication was totally 
discontinued in 6 of 21 patients without mechanical 
valve in G1 as compared to none in G2. 
AGE AF CTR FC CPB AA BL RC TX 
Gl 58 7.7 64 2.4 211 133 1000 37 625 
G2 59 8.9 66 2.4 142 92 695 18 437 
p< NS NS NS NS .01 .01 .05 .05 NS 
1M 3M 
4/51 4/43 
46/51 47/51 
.01 .01 
6M 
3/30 
SO/51 
.01 
Restoration of sinus rhythm with combined Maze made 
worthwhile the increased time and complexity of surgery. 
822·2 8:45 
Intracavitary Repair of Left Ventricular 
Aneurysm: Four Years of Follow-up 
Zvonimir Krajcer, Denton A. Cooley, MacArthur 
Elayda, Lucely Causay, Texas Heart Institute, 
Houston, TX 
Intracavitary repair of left ventricular 
aneu~sm (LVA) nas shown favorable preliminary 
results. Between March of 1989 and June of 
1993, 163 pts underwent intracavitary repair of 
LVA at our institution. This procedure utilizes 
an elliptical intracavitary dacron patch or 
glutaralaehyde treated pericardium to eliminate 
paradoxical contract~le forces allowing 
restoration of normal LV volume and contour. 
To assess the long term benefits of this 
procedure we evaluated operative and late 
mortality, post-operative New York Heart 
Associat~on r'unctional Class (FC) improvement 
(IMPR), and post-operative IMPR in ejection 
fraction (EF) using nuclear angiography. The 
mean duration of fo~low-up was 13 months (Ran~e 
1 to 51 months). Thirty day mortality was 4~. 
Six month and 2 year survival was 90% and 86% 
respectively. 
Preop 
Postop «30 days) 
Postop (> 2 yrs) 
* -pc 0001 
EF% 
* 
* 
IMPR EF 
% of pts 
77 
81 
IMPR FC 
% of pts 
96 
95 
These results indicate that intracavita!y repair 
of LVA offers low operative mortal~ty and 
significant improvement in EF and FC in the 
great majority of pts. This improvement in EF 
and FC continues 2 years postoperatively. 
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822·3 9:00 
Revenibility of Left Ventricular Remodeling after Aneurysmectomy 
for Anterior Postinfarction Aneurysm. 
Marisa Di Donato, Anna Toso, ·Michel Sabatier, Giuseppe Barletta, 
Fabio Fantini, ·Vincent Dor. 
Dpt of Cardiology, University of Florence, Italy; 
·Centre Cardiothoracique de Monaco, Monaco 
The altered left ventricular (LV) topography remote to the infarction 
scar has been described as LV remodeling. We studied the effects of LV 
aneurysmectomy with patch reconstruction (L VR) on regional 
myocardial performance of the non ischemic zone remote to an anterior 
aneurysm (AA). We selected 13 patients (mean age 56 yrs) with non 
diseased right coronary artery who underwent L VR for an AA. The 
analysis of pressure/length (PL) loops for the chords pertaining to the 
inferior regions was performed before and after surgery. Ventricular 
angiography (RAO 30°) was performed with a microtip Pig-Tail Cordis 
catheter at a paced heart rate of 100/min. 
After surgery, systolic and diastolic LV function significantly improved 
(Ejection Fraction from 31±14 to 46±13% p < .001; Maximal Elastance 
from 1.I±.6 to 1.6±.6 p < .002; Peak Filling Rate from 1.8±.7 to 2.7±.9 
p<.OI). Before surgery: 10% of the PL loops was normal; 60% was left 
oriented couterclockwise (CCW), with early shortening, early relaxation 
and reduced systolic shortening; 16% had right orientation, clockwise 
(CW) or CCW, and 14% had left CW orientation. After surgery: systolic 
shortening of the inferior regions significantly improved (centerline 
method) and an almost complete reversal of the inferior wall segmental 
dysfunction was observed: 26% of the loops was normal, and right 
oriented loops were no longer present. 
Thus, the presence of an AA induces abnormalities of the inferior wall 
performance even in the absence of coronary disease (LV remodeling). 
These abnormalities are potentially reversible if the abnormal mechanical 
burden imposed to the wall is relieved. 
822.4 9:15 
Pc:rioperame Mcc::haDkal Support in Cardiac Surgery: EIJect of Taniag 011 
0utaJme 
Lawrence L. Creswell, Nicholas T. Kouchoukos, James L. Cox, Michael 
Rosenbloom, Washington University, St. Louis, MO 
Mortality in patients receiving perioperative support with intraaortic balloon 
pump (IABP) or ventricular assist devices (VAD) remains high. Little 
attention, however, has been devoted to the group of patients receiving both 
of these support measures. Between Jan. 1, 1986 and June 30, 1992, 9,910 
patients underwent cardiac surgical procedures requiring cardiopulmonary 
bypass, including 8,500 adult and 1,410 pediatric patients. Perioperative IABP 
support was required in 10.6% of adult procedures (903/8,500). For 93 adult 
patients who required V AD support in addition to an IABP, the V AD weaning 
rates aDd operative (30-day) mortality, by timing of intervention was: 
Taniag Taniag of VAD 
of JaIra.Op POil-Op 
IABP D "Wcaa "Mort • "Wcaa "Mort 
Pre-Op 5 60.0% 40.0% 17 52.9% 64.7% 
Iatra-Op 36 63.9% 55.6% 22 36.4% n.7% 
POil-Op 1 100.0% 0.0% 12 583% 58.3% 
TOTAL 42 643% 52.4% 51 47.1% 66.7% 
By comparison, the weaning rate and mortality rate for all patients receiving 
only V AD support were 48.8% and 65.0%, respectively. Importantly, in 
patients treated with a V AD after an IABP, delayed usage of the V AD was 
associated with decreased VAD weaning (p<O.05) and increased operative 
mortality. Therefore, these data may support the earlier use of more 
aggressive ventricular support modalities such as the V AD in the perioperative 
setting. 
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822·5 9:30 
Smoking Cessation and the Risk of Acute Myocardial Infarction and 
after Venous Coronary Artery Bypass Grafting: 15 Year Follow·Up. 
Adriaan A. Voors. Ben L van Brussel. H.W.Thijs Plokker, Sjel M.P.G. 
Ernst, Paul G. Knaepen, Egbert M. Koomen, Jan G.P. Tijssen, Freddie 
E.E. Vermeulen. St.Antonius Hospital, Nieuwegein, The Netherlands 
Although It has been well established that smoking has deleterious effects 
on cardiac event rates, the influence of smoking cessation after venous 
coronary artery bypass grafting (CABG) is less well known. 428 patients 
who underwent venous CABG between April 1976 and April 1977 In our 
Instkution were studied prospectively. Fifteen year follow-up was 99.8% 
complete and averaged 13.4 years. We studied the effects of smoking 
cessation after CABG on the occurrence of acute myocardial Infarction 
(AMI). Smoking behaviour at 1 year and AMI-rates 15 years after CABG 
were as follows' 
n % n of AMI '!bAMI 
non-smokers 221 53.3 40 18.1 
quitted since CABG 72 17.3 10 13.9 
non.qultters 95 22.9 27 28.4 
unknown 27 6.5 4 14.8 
Ne erformed univariate anal' SIS USln the I p  y g og ·rank stallstlcs and the 
Kaplan Meyer method for estimating survival probabilkies. Multivariate 
analysis, where smoking behaviour was controlled for the univariate 
Important risk factors, was performed by the Cox proportional hazard 
method. 
This analysis revealed that there was no significant difference between 
the 'quitters' and the 'non-smokers'. However, continued smoking after 
CABG turned out to be an independent significant (p = 0.0194) risk factor 
for the occurrence of AMI. When compared wkh the 'quitters' the risk 
increased 2.4 times. 
These data show that smoking cessation after CABG has Important 
beneficial effects on the occurrence of AMI. 
822·6 9:45 
Angiographic Correlates of Lesion Relevance and Suitability 
for PTCA and CABG In The Bypass Angioplasty 
Revascularlzation Investigation (BARI) 
Javier Bow. Michael L. Stadius. Manial Bourassa. Alan Rosen. Hanzell 
V.Schaff. Oeorge Sopko. David O. Williams. Edwin Alderman and the 
BARl Investigators; Core RadiographiC Laboratory (CRL) Stanford 
University; CA 
BARI randomized 1829 patients to PTCA or CABO. Oinical sites (11=18) 
categorized lesions ~O% diameter stenosis (n=4977) as Clinically 
significant (86%) or not significant (14%). Suitability for lesion 
revascularizatlon was categorized as favorable (PTCA 78%; CABO 91 'II) or 
not favorable (PTCA 22%; CABO 8%). For the subgroup of lesions 99-
100% (n=581). 22% were considered favorable for PTCA and 78% for 
CABO (p<O.Ol). Angiographic features. assessed by CRL. were correlated 
with clinical importance and suitability for PTCA or CABO using lOgistic 
regression analysis (p<O.05 threshold). Positive predictors of clinical 
importance for 50-95% lesions (0=4396) were. in rank order. greater LV 
jeopardy score. greater stenosis severity • larger reference diameter and more 
proximal location; and for 99-100% lesions. lesion age < 3 months. LAD 
involvement, more proximal location. larger reference diameter and less 
proximal tortuosity. Predictors of PTCA suitability for 50-95% lesions 
were greaterTlMI flow. greater LV jeopardy score. less proximal tortuosity. 
more proximal location within the artery. larger reference diameter. and 
lower patient age. but also components of lesion class including shorter 
lesions. and absence of angulation or ostial location. For 99-100% 
ste~s.lower lesion class. lesion age < 3 months. lower patient age. less 
proximal tonuosity and higher TIMI flow were predictive of PTCA 
suitability. Predictors of CABO suitability for lesions 50-95% were greater 
LV jeopardy score. larger reference diameter; and more proximal location. 
and for 99-100% lesions greater LV jeopardy score. lower lesion class. 
more proximal location and higher TlMI flow. Thus. LV jeopardy score. 
stenosis severity. and native vessel size are major angiographic detenninants 
of clinical imponance. Lesion suitability for PTCA depends on lesion 
patency and morphologic characteristics to a greater extent than for CABO. 
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823·1 8:30 
Abnonna1 Signal-avenged Electrocardiogram in Patients with 
Idiopathic Ventricular Fibrillation 
Marcel C.G. Dllllieis. Riccardo ParllDgeli. Arne Sippeos(lroenewegen. 
Richard N.W. Hauer and Etienne O. Robles de Medina 
Heart-Lung lostitute. University Hospital Utrecht. Utrecht. The 
Netherllllds 
The electropbysiologic IUbstrate for idiopa1hic venlricular 
fibrillation (VF) is not known. We lOalyzed the signa1-averaged BCG 
(SAECG) in 8 patients (age 19-59 years. mean 38) characterized by a) 
successful resuscitalion from documented VF • b) absence of detectable 
structural heart disease. long QT - or pre-excitation syndrome at thorough 
cardiologic evaluation, c) a QRS duration < 120 IDS on the surface BCG. 
and d) a drug free state. An internal defibrillator (lCD) was implanted in 
all patients because of DOD-inducibility of venlricular arrhythmias during 
programmed eleclrical stimulation (PES). Five patients with ICD were 
studied 19-48 (mean 31) months after the initial arrhythmic evenl; the 
other 3 were seen within 2 months after cardiac arrest and prior to ICD 
implantation. Nine palients (age 14~2. mean 3S) with AV-nodal reenlry 
tachycardias or concealed accessory atrioventricular connections served as 
control group. 
SAECGs were recorded from three bipolar ortbogonalleads hy an 
ART 1200EPX system wilh bidirectional filtering between 40 and 250 Hz. 
Noise levels were < 0.3 uV after averaging lSO-250 cycles. Criteria for 
abnormality of the SAECG were a filtered QRS duration > 114 IDS. 
RMS40 < 20 uV. and LAS40 > 38 IDS. 
In 4 of the 8 patients with idiopathic VF all three parameters were 
abnormal (including two patients studied before lCD implantalion), while 
in 6 patients two of the three criteria were abnormal. In contnlst, none of 
the control patients had three abnormal parameters and only one patient 
had two abnormal criteria. 
We conclude that the SAECG can be abnormal in patients with 
idiopathic VF. This. combined with non-inducibility at PBS. suggests the 
presence of areas of slow conduction that might be the substrate for 
reentry with a short excitable gap as an explanation for the arrhythmic 
events. 
823·2 8:45 
AlijUllment 01 !be Sipa!-A .... ed EIectrocanIicJp for DiIr.- in 
BMrline QRS Duratioa 
Pel« M. Okia, XameIh M. Stein. Ne8l Uppman. Bruce B. lMmID. Paul 
Klipield. ComeIl Medical c.tec. New York. NY. 
The relatioasbip of QRS duralioa 011 the bueIine 12-1ead BCG and filIered QRS 
(IQRS) dutatioD 011 !be lipI-averqed BCG (SAECG) 10 ~ or the 
SAECG for ideatific:alioa of inducible -.morpbic vealricuIar lKbycardia 
cIurina electropb)'lIiolosicalllUd)' (BPS) - eumined in 144 ---1IlI!iecta and 
in 132 patieats IIUdied by BPS (87 paIimII with -BPS. 4S paIi_ with + BPS). 
PotioaIa with left and ript buadIe hrmch b\oc:b were excluded. The SAECG_ 
couidered positive by otandMl criteria wbea the veclor IQRS duraIioa _ > 114 
_ and either the root _ IqIWe voltap of the terminal 40 DIS of the IQRS 
_ <20,.V or the low amplitude lipol or the IQRS _ >38 JIlL AIDoaJ 
paIimII with EPS. IUbpouped IICCIIIdina 10 • bueIine QRS duraIioa of 108 DIS. 
perfOl1ll&llCC of. + SAECG _ hi,bly depeadenI 011 otandMl QRS dutatioD. with 
both 10wer specificity (44" VI SUi. p<O.OOl) and hiP« IICIIBitivity (83" VI 
44". p<O.OS) fouad for paIimII with biper QRS duratioas. A Dew SAECG 
criterioa for the preeeace of \ate poteIltiaJs _ derived in the 144 DOrmaI 
IUbjecta. hued 011 !be differaa '*- !be loapst IQRS duraIioa in my of the 
ortboaoaalleads and QRS duraIioa WI !be bueIine BCG (QRSdift). which _ 
Ibal adjlllled hy ~ _ylil for !be cIecnuina QRSdiff fouad with 
increuiaa QRS duraIioa. Tbia Dew criterioa _ derived 10 bave Iliabtly higher 
lpOCific:ity (96" VI 92") .... +SAEOO in dIeM aormalllllbjecta. Applied 10 
'the 132 pati_ who UIIIIeowla BPS. specificity of the derived +QRSdiff_ 
lianificaady pater tbaa dial of. +SAECG inpalimll with -BPS (89" VI 79". 
p<O.OS). with nearly ideaticallICIIBitivity in paIieIIU with +EPS (S8" VI 60". 
p-u). In contnlst 10. +SAECG. perfOl1ll&llCC ofa +QRSdiff _ much less 
clCpendcat 011 staDdanI QRS duratioa. with oaty lliahd)' 10wer specific:ity (72" VI 
93". p<O.OS). and IimiIar IICIIBitivity (6'" VI 52". p-u) at QRS durations 
;t lOS DIS. These data cIemoaItnte dial IeIt performance of otandMl SAECG 
criteria is hi,h1y depeadenI 011 bueIine QRS duratioa and dial accuracy of the 
SAECG can be improved by adj\lllina IQRS criteria for bueline QRS duratioo. 
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823·3 9:00 
Natural History of Ventricular Late Potentials Detected from 
Immediately After Acute Myocardial Infarction and the 
Subsequent Six Months and the Influence of Fibrinolytic 
Therapy 
A Cheng, D Shanit, R Greenbaum. Cardiovascular Research Unit, 
Edgware Geneml Hospital, Edgware, Middlesex, UK 
The incidence of venUicular late potentials (VLP) have been shown 
to change over the first few days of acute myocardial infarction, and 
also reduced by fibrinolytic therapy. We prospectively studied the 
natural history of VLP from immediately after acute myocardial 
infarction (AMI) and during the first 6 months of follow-up in 
patients (pts) who received fibrinolytic therapy compared to those 
who did not. 127 pts, 102 (80%) males and 25 (20%) females, mean 
age 60:1:11 yrs, with a diagnosis of AMI underwent signal averaged 
electrocardiography immediately following admission to the Cardiac 
Care Unit, and at 1 week, 1 month and 6 months after AMI. Twelve 
of 23 (52%) patients who did not receive fibrinolytic therapy 
developed VLP compared to 30 of 104 (29%) patients who received 
fibrinolytic therapy (p<0.05). In patients who did not receive 
fibrinolytic therapy, the incidence of VLP detected decreased from 
admission over the subsequent 6 months whereas in patients who 
received fibrinolysis, the incidence did not change significantly. This 
difference in incidence between patients who received fibrinolytic 
therapy and those who did not gradually disappeared over the 
subsequent 6 months (Figure). 
Percent 
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823-4 
Fibrinolytic therapy reduces 
the incidence of VLP 
detected immediately after 
acute myocardial infarction. 
The incidence of VLP 
detected in patients who did 
not receive fibrinolytic 
therapy gradually decreases 
from admission over the first 
6 months after AMI. 
9:15 
Incidence and Prognostic Value of Late Potentials After Acute 
Myocardial Infarction in the Thrombolytic Era: Results of a Stepwise 
Regression Analysis 
Stefan H. Hohnloser, Peter Franck, Thomas Klingenheben, Markus Zabel, 
Hanjorg Just. University Hospital, Freiburg, Germany 
The incidence and the predictive value (PV) of late potentials (LP) after 
myocardial infarction (MI) in the thrombolytic era is not precisely 
determined. Thus, in 173 consecutive pts with MI, signal averaged ecg 
(SAECG), and coronary artery and left ventricular angiography were 
performed 10-20 days post MI in order to determine the incidence of LP 
and their PV for future events. 12 clinical variables including L VEF and 
regional wall motion (RWM; defined as near normal RWM in 107, akine•
sis in 36 and dyskinesis in 30 pts) were evaluated. Results: 411173 pts 
(24 %) exhibited a LP on SAECG. Infarct artery (IA) patency was 
documented in 128 pts (74%). By univariate analysis, LP were more 
frequent (p < 0.01) in pts with an occluded 1A (44% vs. 16% in pts with 
an open IA), in pts with dyskinesis (33% vs. 16% in pts with normal 
RWM), and in pts with a Q-wave MI (85% vs. 15% in non-Q-wave MI). 
Multivariate analysis was performed including as independent variables 
age, sex, infarct location, Q-wave or non-Q-wave MI, RWM, # of 
diseased vessels, thrombolysis or not, and IA patency. The final 
regression model selected RWM (p<O.OOI) and 1A patency (p=0.04) as 
the only independent predictors of the development of LP. During a mean 
follow-up of 12±9 mo, 7 pts died suddenly and 1 developed sustained 
VT. Significant predictors for these events were only an occluded lA, 
EF<45%, and RWM. Sensitivity of LP's in predicting these events was 
44%, specificity 77%, positive PV 10%, negative PV 96%. 
Conclusion: l.The development of LP after MI correlates not only with 
IA patency but also with RWM impairment. 2. There is a remarkably low 
incidence of arrhythmic events during follow-up, particularly of sustained 
VT. 3.The predictive value of LP for future arrhythmic events is low. 
Thus, in the thrombolytic era their role in risk-stratification in pts after MI 
appears to be limited. 
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823-5 9:30 
Prediction of Ventricular Arrhythmias by Ventricular Late 
Potentials in the Short and Long· Term Follow up after 
Coronary Artery Bypass Grafting 
JUrgen FrieIingsdorf, Andreas Gerber, Andreas Laske, Osmund 
Bertel, Cardiology and Cardiovascular Division, Triemli Hospital 
ZUrich and University Hospital ZUrich, Switzerland 
VenUicular late potentials (LPs) have been identified as a prognostic 
factor in the prediction of venUicuiar arrhythmia (VA) in patients after 
myocardial infarction. In this prospective study the possible impact of 
LPs on the prediction of VA in the short and long-tenn follow up after 
coronary artery bypass grafting (CABG) was evaluated. In 188 
patients (165 men, 23 women, age 57±8 years) with chronic coronary 
heart disease there were 48 (26%) patients with LPs before CABG 
whereas after CABG 39 (21 %) patients had LPs (ns). In 16 (33%) of 
the 48 patients with LPs before CABG, LPs were no longer present in 
the short-term follow up (9±6 days). On the other hand, 7 (5%) of the 
140 patients without LPs before CABG developed LPs in the short•
term follow up. Nine (19%) of the 48 patients with LPs before CABG 
had VA in the perioperative phase which had to be treated with 
antiarrhythmic agents. In contrast, only 3 (2%) of the 140 patients 
without LPs before CABG had to be treated because of VA (p<O.OO 1). 
In the long-term follow up of 29±3 months, there were no events in 
the group of 149 patients without LPs after CABG. In the 39 patients 
with LPs after CABG, there were 4 (10%) events: 2 patients with 
syncope due to venUicular tachycardias and 2 patients with exercise•
induced venUicular tachycardias. No events occured in the 16 patients 
whose LPs disappeared after CABG. 
Conclusions: 1) Patients with LPs before CABG have a markedly 
higher risk of developing VA in the perioperative phase than patients 
without LPs. 2) Patients with persistent or new LPs after CABG have 
an elevated risk of developing VA in the long-term follow up. 3) 
Patients without LPs after CABG have a very low risk of VA in the 
long-term fonow up. 
823-6 9:45 
Innuence of Filtering Tecbniques on The Time-Domain Analysis, and Clinical 
Use of Signal Averaged Electrocardiogram 
Katerina Hnatkova, Piotr Kulakowski, Anne Staunton, Phillip Keeling, Gang Yi, A 
John Canun, Marek Malik, SI. George's Hospital Medical School, London, United 
Kingdom 
In order to investigate the effect of different filtering techniques on the time-domain 
analysis of signal averaged electrocardiogram (SAECG), recordings of 606 subjects 
were analysed USing both Butterworth and Del Mar filter, both set at 40-250 Hz high 
and low pass frequencies. The recordings were taken from 2 clinically defined 
groups: (a) survivors of acute myocardial infarction (n = 553) recorded prior 
bospital discharge (on day 5 - 11 after admission), (b) patients reported with 
sustained symptomatic post-infarction ventricular tachycardia (n = 53), were 
recorded free of antiarrhythmic therapy. The pts of the population (a) were followed•
up for at least 9 months (range 9 months - 4 years). During the follow up restricted 
to first 2 years after admission, 32 pts suffered either from sudden death (n=18) or 
from spontaneous symptomatic ventricuIar tachycardia (n=14). 
Both filters provided standard time-domain SAECG indices (i.e. total QRS 
duration, tenninal low amplitude signals duration, and tenninal root-mean square 
voltage). The study investigated differences between the SAECG results reported 
with both filters in 2 individnal aspects: (A) differences in SAECG findings of 
patients with post-infarction ventricuIar tachycardia and pair matched patients with 
uncomplicated follow-up after acute infarction, and (B) the power of SAECG 
findings to predict high risk of arrhythmic complication (sudden death and/or 
sustained ventricular tachycardia) among survivors of acute myocardial infarction. 
Compared with the Butterworth filter, the Del Mar filter (A) was equally 
powerful in distinguishing between the pair matched patients with and without post 
infarction ventricular tachycardia. but (B) was statistically significantly more 
powerful in identifying those survivors of acute infarction who were at high risk of 
arrhythmic complications: positive predictive accuracy of 28% vs 16% at 25% 
sensitivity (p < 0.01), 19"10 vs 13% at 40% sensitivity (p < 0.01), 14% vs \0% at 
50% sensitivity (p < 0.01). 
The use of different filters may produce discordant results of SAECG analysis. 
Normal and abnormal values for various types of SAECG recording and analysis 
have to be established individually for different equipment and different software 
settings. The optimal cut-offs of SAECG variables should also take into account the 
clinical characteristics of patient groups. 
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Intracardiac Ultrasound Provides More Accurate AsseSSEnt 
of left Ventricular VollIIIe as CoIIpared with Biplane 
Angiography: An in Vitro Study 
Ming Hui Chen, Jose A Vazquez de Prada, Luis R Padial, J L 
Guerrero, Ehud Schwal1ll1E!ntha 1, Linda Gill am, Arthur E Weyman, 
Robert A Levine, Chunguang Chen. Massachusetts General Hospital, 
Boston, HA and Hartford Hospital, Hartford, CT 
Intracardiac ultrasound (ICUS) has been shown to estimate left 
ventricular (LV) volume accurately; however, its coq>arative 
accuracy relative to biplane angiography (Angio) is unknown. We 
therefore c~ared ICUS and Angio methods for LV volume in 14 
excised pig and sheep hearts with normal and distorted LVs. A 10 
MHz ICUS catheter obtained serial cross· sectional LV images from 
apex to base by a calibrated pull back: subsequently biplane LV 
Angio was p!!rformed. LV volume was calculated by a Siq>son's 
rule algorlthm for both methods, and c:oq>ared to actual values 
determined by filling the LV with saline. 
RESULTS: Although 
both ICUS and Angi 0 
correlated we 11 
with actual values 
(r=.99, r=.91) , the 
abso 1 ute measure· 
ment error of Angi 0 
(3.9±3.7 ml) was 
hi gher than that of 
IeUS (1.5±1.6 ml, 
p<.025) . 
<n«:LUSII*S : 
m z • ~ ~ _ 0 m m • ~ m -
AlUlIIliIIne(mI) AlUlIIliIIne(ln) 
In this study, LV 
volume measurements by ICUS proved more accurate than Angio for 
both normal and distorted ventricles. ICUS may therefore provide 
an attractive alternative to angiography during catheterization. 
with reduction of contrast injection and decrease in radiation 
exposure. 
824·2 8:45 
Intracarcliographic Echocardiography W'rth a Steerable Un ear 
Array Device Permits High Resolution Imaging of Cardiac 
Chambers and Valves With an Extended Depth of Field and 
thus Left Heart Imaging From the Right Side 
Jean Claude Tardif. Q~Ung Coo. Steven Schwartz, Manl Vannan and 
Notesa Pandian. Tufts-New England Medical Center, Boston, Mass. 
Oesp~e a need for intracardiac echocardiographic (ICE) guidance during 
interventional procedures, an optimal ICE catheter device is not available. 
While ICE catheters bearing 10, 12.5, 15 and 20 MHz transducers are com•
mercial/y available, the depth of field of such catheters does not allow easy 
or complete visualization of the left heart from the right heart. Requirement 
of an expanded aperture and thus a larger catheter size for carrying lower 
frequency transducers has lim~ed the util~y of these mechanical rotational 
devices in aduH patients. The potential of other transducer modal~ies which 
could explo~ the length of the imaging device rather than the circumference 
could potentially solve the problem of aperture size. Intracardiac imaging 
capabil~y of such transducer concepts however has not been explored so 
far. To examine whether an electroniC linear array transducer without 
mechanical rotation could provide adequate images of the left heart from 
the right side, we employed a prototype 7 MHz linear array probe w~h a 
steerable tip, inside 8 animal (pig/sheep/dog) hearts with experimentally 
created atrial and ventricular septal defects (ASO, VSO). The device was 
introduced into the right atrium both via IVC and SVC routes. Excellent 
quality images of the right heart were seen. Using the steerability and rota•
tability of the device, we were able to project the transducer in many direc•
tions. This allowed visualization of aI/ cardiac chambers. PosHioned within 
the RA, the atrial septum, LA and the farther LA wall could be seen in the 
imaging field. The AS Os were seen clearly. In addition, the mitral valve, the 
LV inflow & outflow, and the whole LV body could be easily brought into the 
field. The site and size of VSOs could be well ascertained. From the RA 
location, we could also view the aortiC valve, RV outflow, the pulmonic 
valve and the pulmonary artery. In contrast to the circular imaging field of 
rotating devICes, the linear array portrayed the structures in a rectangular 
filed in front of the transducer thereby always indicating Hs location. We 
conclude that the linear array approach could allow Intracardiac Imaging of 
the left heart from the right side at frequencies less than 8 MHz w~h excel•
lent image qual~y. The rectangular imaging field in front of the transducer 
could potentially aid in guiding interventional procedures as well. 
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Intracardiac Ultrasound Measurement of Left 
Ventricular Wall Thickening - In Vivo Validation with 
Sonomicrometers 
Ming Hui Chen. Jose A Vazquez de Prada. J Luis Guerrero. Luis 
R Padial. Arthur E Weyman. Robert A Levine. Linda Gillam. 
Chunguang Chen. Mass General Hospital. Boston. MA and Hartford 
Hospita 1. Hartford. CT 
The new intracardiac ultrasound (ICUS) catheter with lower 
frequency provides continuous and circumferential imaging of 
the entire left ventricle (LV) with clear epicardial and 
endocardial delineation: this capability makes it ideal for 
monitoring LV wall motion during catheterization. To validate 
ICUS measurements of LV wall thickening (WTh). we 
simultaneously determined LV WTh with ICUS and with 
sonomicrorneters (Sonos) in a pig model. A 10 MHz ICUS 
catheter. with image updating at 30 frames/so obtained cross•
sectional images of the LV at the papillary muscle (tip) 
level: at this level. pai red 
Sonos were embedded in the 
LV epi - and endocardial 
surface. Regional LV WTh was j .... y-1.oax;.2.2 
altered by dobutami ne. SEE- 9.HI, 
partial occlUSion of a ,-0.92 :. 
coronary artery (i schemi a) 'I .. t • 
or total occlusion of an ;1:" 
artery (infarction) ~ 
RESULTS: In all cases ~". n=32 
(n=32). ICUS measurements ~~-=--=---=---=--::,.....-;~ 
carre 1 ated well wi th that of'· .. .. .. .. 
Sonos. ICUS accurately ,,_w .. ..-
identified decreases in WTh 
by ischemia/infarction, and increases in WTh by dobutamine. 
CONCLUSIONS: ICUS accurately quantifies regional WTh and 
identifies its dynamic changes. ICUS may be an ideal tool for 
assessing and monitoring regional LV function. particularly 
during interventional procedures. 
824·4 9:15 
Accuracy of Doppler Ultrasound Assessment of Transvalvular Pres· 
sure Gradients Across Nonnal St. Jude Valve Prostheses in Vitro. 
Pieter M. Vandervoort, Neil L. Greenberg, Min Po, Brian P. Griffm, 
James D. Thomas. Cleveland Clinic Foundation, Cleveland, OH 
Significant overestimation of Doppler gradients has been reported in 
bileaflet heart valve prostheses due to downstream pressure recovery, but 
the basic hydrodynamic etiology and possible corrective approaches 
remain unclear. Since pressure recovery depends on the geometry of the 
outflow diffuser, the net loss of pressure for flow through the central 
orifice of the St Jude valve can be specified by an experimentally 
determined pressure loss coefficient K. K is defined by the change in 
total pressure divided by maximal kinetic energy: K=M'/4v2, where M' 
represents the net pressure gradient and v the maximal velocity. In an In 
vitro flow model, we studied St Jude valves (#19 to #29) under different 
hydrodynamic conditions with flow rates ranging between 215 and 405 
cm3/s. High-fidelity pressure pulI·backs and simultaneous continuous 
wave Doppler velocities were obtained across the valves. Results: The 
calculated pressure loss coefficient, K=O.64±O.04 (mean±SD), was 
independent of valve size. The maximum Doppler gradients (y) 
calculated by the simplified Bernoulli equation correlated closely (r=.99) 
but overestimated the transvalvuIar pressure gradients (x) significantly: 
y=1.73x-O.29, M' (Doppler - cath) = 9.9±9.6 mmHg (mean±SD). 
Incorporating K=O.64 in the Doppler gradient calculations improved the 
accuracy dramatically: 1'=0.99, y=l.llx·O.l9, M' = 1.4±2.l mmHg 
(mean±SD). 
Conclusions: Doppler ultrasound does allow for accurate calculations of 
the transvalvuIar pressure gradients based on central orifice velocity 
measurements in all sizes of St Jude valves. However, a pressure loss 
coefficient K=O.64 should be incorporated in the simplified Bernoulli 
equation to account for pressure fee ,)very occuring in between the 
leaflets of the valve. 
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Calculation of Regurgitant Volwnes from the Proximal Orifice Flowfield 
Using a New Non-Dimensionalized Technique 
Jerry G. Myers. Derek W. Green. Andreas Anayiotos. GilbertJ. Perry. Po Hoey 
Fan. Navin C. Nanda. The University of Alabama at Birmingham. AL. 
Several investigators have proposed quantitating valvular insufficiency 
based on analysis of the orifice proximal flowfield (OPF). We used a finite 
element model (FEM) to analyze the properties of the OPF for steady state flow 
through circular orifices under varying conditions (3.5.7.10 mm orifice diamete 
(D). flow (Q) = 4 and 6 liters/min). The OPF was also analyzed by laser 
Doppler velocimetry (LDV) using an in vitro model of regurgitant flow. There 
was excellent correlation between the LDV and FEM results (Fig. I). Both 
techniques demonstrated that the shapes of the isovelocity surfaces are 
bemielliptical close to the orifice « 2D) and are bemispberical at distances 
(>2D) (Fig. I). However. by normalizing the velocity (V) with the orifice 
velocity (V.). and the distance from the orifice (r.) to D. it was possible to 
predict the shape of the isovelocity surface. regardless of D and Q (Fig.2). 
Further. for this model (circular orifice. steady flow).a single curve describes the 
normalized relation between centerline velocity and distance from the orifice 
(Fig.3). regardless of Q or D. This allows calculation of the orifice diameter and 
regurgitant volume(RV) without geometric assumptions. from measurement of V • 
Vo, and re' 
We conclude: I) Calculation of RV using geometric assumptions about 
the shape of tbe isovelocity surface is prone to error. as these surfac", are not 
hemispherical close to the orifice; 2) It is possible by using non-dimensionalized 
data from the OPF to calculate D and RV without making any geometric 
assumptions. This method overcomes tbe limitations of the aliasing technique 
and provides greater potential for accurate estimation of R V and D from the 
OPF. 
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Instantaneous Left Ventricular Filling Gradients Through Nonstenotic 
Mitral Valves Can be Derived from Color Doppler M-rnode Velocities: 
Intraoperative Clinical Validation 
Neil L. Greenberg. Pieter M. Vandervoort. Brian P. Griffin. William J. 
Stewart. Robert M. Savage. Patrick M. McCarthy. James D. Thomas. 
Cleveland Clinic Foundation. Cleveland. OH 
Noninvasive assessment of the transmitral pressure difference by 
Doppler echocardiography is well validated in stenotic but not in normal 
mitral valves. If the spatiotemporal velocity distribution obtainable with 
color Doppler M-mode echocardiography (CMM) reflected local 
instantaneous pressure gradients throughout the normal LV inflow tract. 
then a more complete assessment of filling dynamics and diastolic function 
would be possible than with either pulsed or continuous wave Dop[!ler. 
Methods: In 6 patients undergoing open heart surgery. high fidelity left 
atrial and left ventricular pressure measurements were obtained with 
simultaneously digitized CMM velocities using transesophogeal 
echocardiography. The diastolic transmittal pressure difference was then 
noninvasively reconstructed at S msec intervals with and without the inertial 
term included in the Bernoulli equation. 
LV v(s) dv (I) 
P(t)=XPV;(I)+[p J--=-ds]= 
LA vp(t) dt 
Convective + IMrtial Terms 
where p is the density of blood and vp is the peak velocity along an M-mode 
column (representing a streamline with velocities v(s». Results: The 
gradient calculated from the simplified Bernoulli equation (including only 
the convective term) showed significant underestimation and time-lag 
compared to the invasive gradient, with only modest correlation (average r 
for all cardiac cycles = O.46iO.IS (mean±S.D.». Adding the inertial term 
improved the temporal alignment and allowed the detection of the short 
gradient reversal in mid-diastole. with significantly better correlation with 
the true gradient (average r=O.84±O.12. p<O.OOOI compared with the 
simplified formula). Conclusion: 1) The inertance of blood passing 
through the normal mitral valve significantly impacts the transmitral 
gradient. 2) Noninvasive estimation of the normal trans mitral pressure 
difference is possible using CMM if the inertial term is included in the 
Bernoulli equation. 3) CMM may therefore be useful in the quantitative 
assessment of ventricular filling dynamics and diastolic function. 
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8:30 
Cellular Cholesterol Modulation Affects the Intracenular Calcium Ion 
Concentration In Cardiomyocyte. Independent of M.mbrllll. fluidity 
E.M. Lars Bastiaanse, Marinette M.C. Kuijpers, Douwe E. Auma, 
Uzet J.M. Van der Valk, Arnoud Van der Laarse, University Hospital. 
Leiden, The Netherlands 
The membranous cholesterol content [CCI of heart cells .ffects the 
fluidity of the membrane and the function of membrane proteins. We 
have found that the CC of cardiomyocytel is increased by high plasma 
cholesterol levels. We investigated whether modulation of CC affects 
intracellular calcium ion concentration llea'+1;1 in cultured neonatal 
cardiomyocyte5, and if so, whether this was medi.ted by • change in 
membrane fluidity. Cardiomyocytes were preincubated for 5 h with 
Cholesterol-rich liposomes [cholesterol/phospholipid [CIPLI .. 21 to increase 
the cellular cholesterol content, with cholesterol-free liposomes [C/PL =01 
to decrease the cholesterol content, or without Jiposomes [controll. In 
another series, we preincubated the myocytes for 15 min with 20 pM 
A.C. which increases membrane fluidity. After these preincubations, we 
measured changes in: L the membranous cholesterol content [CCI. 
1, membrane fluidity using the fluorescent anisotropy probe TMA-DPH, 
and ~ [Ca" I, using the fluorescent calcium indicator Fura-2. All values 
are expressed as % increase [t 1 or % decrease [II vs. control: 
Treatment l1CC 1%1 l1fluidity 1%1 l1[Ca'+I, [%1 
C/PL-2 
C/PL=O 
A,C 
55 ± 5.8t· 
22 ± 4.91· 
8.2 ± 1.21· 
4.2 ± O.4t· 
7.9 ± 0.6t· 
Mean ± SEM, n~5. ·P<O.05 vs. control. 
44 ± 12'-
32 ± 111· 
60 ± 19t· 
The increase in [Ca'+I,. as a result of increased CC, is not mediated by 
the concomitant decrease in membrane fluidity, since treatment with the 
fluidity increasing probe A,C also resulted in an increased [Ca'+ I,. Thus, 
CC is positively related to [Ca'+I,. independent of membrane fluidity. 
Since calcium is involved in numerous cellular processes, such as 
excitation-contraction coupling. energy metabolism, etc., these changes 
in (Ca" I, could have profound effects on myocyte function. 
825-2 8:45 
IanUCDte or PCrfDSlte ClklulD CODteDtl'ltioD 011 OJ:ncu Free IlIdIcII 
GCDcratioo 
Timothy D. Henry, Roland B. loJmston, Stepben L. Arcbcr, E. Keuncth Weir, 
Arthur H. L. From, Hennepin County MedicaJ Center and Minneapolis V AMC, 
Minneapolis, MN 
Increaed myocardial oxygen free mdicaI (OFR) generaIiou and elevation 
of intracellular ealciwn (Ca) COIICCDInIliOll bas been implicaled in !be pathogenesis 
of myocardial SlUDning. SlWIning can be prevented by JqlCIfusioo with low Ca 
perfusate. We evllualed the effects of vuying perfusate Ca 011 myocardial 
cnbanccd cbemilumiDesccace (CL) 10 deItmIine if perfusale Ca Iltaa1ioo cffeclS 
OFR generatiOll during ischemia and reperfusion. CL bas been Ibowo 10 be • 
IeDSitive. cootinuous measure of OFR Jevds. Fifty Langendorf( pafuaed rat beans 
w= lllUdied It bueIine. during IS and 30 min periods of wmn global iscbemia, 
and during 20 min reperfusioo. HCIII1I pafuaed with 1.8 mM Ca throughout were 
compared 10 groups perfused with O_S and 3_S mM Ca througboul, or during 
reperliJsion only. Low Ca perfusate (O.S DIM) during reperfusion only lignificandy 
reduced peak CL compared 10 1.8 mM Ca perfusiOD (306±47 VI. 492±72 
counts/sec:, pooO.OI).1n CODIrast, low Ca perfusiOllIbrougbout did DOt !educe peak 
CL, but it martedIy lltered both !be time coune and paIICIll of OFR generation. 
Perfusion with high Ca (3.5 DIM) throughout was associated with reduced CL 
during baseline (138±12 vs. 203±2S), ischemia (38±4 VI. 8O±16), and reperfusion 
(326:1:29 VI. 492±72, iii counts/sec and p<O.03 vs. 1.8 mM Ca) and the time 10 
peak CL was prolonged. For iii groups. 30 min ischemia yielded similar RSulIS. 
During reperfusion. beans with low Ca bad less frequent and beans with high Ca 
more frequent ventricular fibrillation compared 10 1.8 mM Ca perfused beans 
(both p<O.OS). indicating • relationship between post-ischemic myocardial Ca and 
fibrillation frequency. In cooclusion. the relalionship betwec:n perfusate Ca levels 
and OFR generation is quite complex. While low Ca during only reperfusion 
decreases OFR generation, low Ca throughout changes only the time course and 
paIICIll of OFR generation. In CODIrast, high Ca perfusate lowered OFR duoughout 
as well as during reperfusion only. The frequency of ventricular fibri1lalion was 
mire dependent 011 Ca than OFR levels. 
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825·3 9:00 
Doel GIucoH and/or InlUlln Influence SurvIVal or MyocyteI During 
Simulated Hypoxia? 
Thomas M. Suter, Richard P. Kondo, Franz R. Eberll, Douglas TIllotson, Cart 
S. Apsteln. Boston University, Boston, MA 
In Intact rrr;ocardium glucose (GIu) and insulin (Ins) Is proJective against 
ischemic contracture, bulilis not known which 01 tile Iwo agents Is Important 
for the beneficial effact. To distinguish the effect 01 Giu and Ins under 
conditions 01 metabolic stress, Isolated single rat cardIo myocytes, paced at a 
uniquely high rate 0I3OOImin at 37"C were exposed to 2mM Cyanide (CN). 
The rnyocytes were superperfused with Tyrode solUtIon with addition 01 either 
0, 5.5 or 19 mM Giu with or withoUt 250 mUlml Ins. Survival was defined as 
continued twitching 01 the rnyocytes after 60 min exposure to CN. 
All control cells (I.e. cells not exposed to CN, with or withoUt GIu; ",,141, 5 
hearts) survived 60 min. In contrast 100% 01 myocytes exposed to CN went 
Into contracture when no GIu was added (table). Addition 01 physiologic levels 
of Glu Improved the percentage of surviving cells and addition of 
superphyslologlc levels 01 Giu almost prevented ceO death. Insulin had an 
additional effact In physiologic, but not In SUptrphyslologIcaIleveis 01 Glu. 
Interestingly, In contrast to the percentage 01 surviving cells, the average 
time when "non surviving" cells went Into contracture was Independent 01 the 
addition 01 Giu or Ins and contracture occurred within a narrow range (3-19 
min) In all "non surviving" cells regardless 01 group. All cells withstanding CN 
poisoning tor 19 min survived for another 41 min. 
% cells surviving Avg. time 01 contracture 
o mM Glu (n = 54; 4 hearts) 0 J. 11.0 :t 3.2 min. 
5.5 mM GIu (n=168;10 hearts) 36 :t16 :l, 9.h 3.6 min. 
5.5 mM Glu + Ins (n=96; 6 hearts) 70 :t 26!.o ••• 8.5 :t 3.6 min. 
19 mM Glu (n=66; 5 hearts) 68:t 16 J 9.0:t 1.5 min. 
19 mM Glu + Ins (n=67; 4 hearts) 93:t 9 10.3:t 2.0 min. 
Table shows mean values:t SDV; ••• p<0.OO1 
These data suggest that a high concentration of Giu alone, as well as the ad•
dition 01 Ins to a physiological concentration 01 Glu, presumably via activation 
of glycolysis, can prevent hypoxic myocyte death. However Giu and Ins do not 
Increase time to onsa! of contracture in cells which die and appear 10 represent 
a population 01 non-responders. We speculate that the survival 01 a cell could 
be dependent upon successful activation 01 glycolysis during early Ischemia. 
825·4 9:15 
Contraction Amplitude and Amplitude-Frequency Relationship in 
Single Cardiomyocytes from Goldblatt Hypertensive Guinea-Pills 
Crispin H. Davies, Ruby U. Naqvi, Kenneth T. Macleod, Phillip A. 
Poole-Wilson, Sian E. Harding, Department of Cardiac Medicine, 
National Heart and Lung Institute, London, U.K. 
Using a Goldblatt (2 kidney, I clip) guinea-pig model of 
renovascular hypertension we have investigated the effect of left 
ventricular hypertrophy on the contraction characteristics of isolated 
cardiac myocytes. Unilateral renal artery banding was performed in 
Dunkin·Hartley guinea·pigs (GB) and sham operated controls (SH). 
Mean BP (mmHg) rose significantly at 3 weeks (GB=108 Vs SH=80, 
P<O.OOI) and 7 weeks (125 Vs 85, P<O.OOI) but had returned to 
normal bv II weeks (102 Vs 107, not significant). There was no 
evidence -of cardiac failure. Isolated cardiac myocytes showed 
significant increases in area at 3 weeks (GB=3397I1m', SH=2208I1m', 
P<O.OI), 7 weeks (GB=4250l1m', SH=2830l1m', P<O.OI) and II 
weeks (4391 11m' Vs 3343 11m', P<0.02). There was no increase in 
heartlbody weight ratios. At 32°C and 0.5 Hz the percentage 
shortening in response to a maximally activating extracellular Ca'+ 
was unchanged at 3 and 7 weeks but reduced at II weeks 
(GB=IO.O% Vs SH=6.8%, P<O.OI). Normalised relaxation velocities 
were unchanged as were the times to 50% and 90% relaxation at 3, 
7 and II weeks. Contraction amplitude at 37°C at O.IHz was also 
depressed in GB (3.6%) Vs SH (7.8%) (P<O.OI). Both GB and SH 
showed an initial positive contraction amplitude frequency response. 
The maximum amplitude in GB animals remained depressed even at 
optimum stimulation frequencies (GB at 1.4Hz=5.6%, SH at 
0.5Hz=9.46%, P<0.05). Thus the time courses of contractile 
impairment and hypertrophy do not fully coincide and this 
impairment is not reversible by an increase in stimulation frequency. 
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825·5 9:30 
The Direct Fifeets of Acute Administration of 3,5,3'Triiodo-L-thyronine on 
Isolated Myocyte FlDlction 
·Jennifer D. Walker, Fred A. Crawford, Rupak Mukherjee, Michael R. Zile, 
Francis G. Spinale. Medical University of South Carolina, Charleston, SC 
Chronic T, elevation causes an increase in the ventricular contractile state by 
changing both sarcolemmal and coDttac1iIe proteins. Recent studies have 
suggested that acute T, administration can also increase ventricular performance. 
However, the IPcclJanisms causing these effects of acute T, administration are 
Jess well understood. The purpose of this study was to deteIIDine (I) whether 
T, acts direcdy on the cardiac IPuscle cen (IPyocyte) itself; and (2) whether T, 
acts independently of the IPyocyte ~·adrenergic receptor (~AR). If T, acts 
independently of the ~AR this may have therapeutic utility in patients with heart 
failure who have down regulation of the ~AR systeIP. Accordingly, indices of 
myocyte (MYO) function: initial length, shortening percent (%), shortening 
velocity (VEL), lengthening VEL, and coDttaction duration (DURATION) were 
examined using video·microscopy in porcine MY 0' s (n = 60) in the presence of 
increasing doses of T, (10-500 pM). ("P<O.OS vs baseline) 
BASELINE ~ ~ li!!lJlML 
INITIAL LENGTH v.m) 133.5±0.9 127.3±3.S 131.5±3.2 126.4±3.5 
SHORTENING % 5.3±0.3 6.1±0.3 6.5±0.4' 6.7±0.3' 
SHORTENING VEL {Jtm/s) 49,2±4.3 59.1 ±4.9 63.2±4.4' 66.S±6.I' 
LENGTIiENING VEL {Jtm/s)61.9±S.3 73.8±6.S' 75.8±6.9' 77.9±6.0' 
DURATION (ms) 554.S± 13.6 S62.9± 13.7 S64.5± 12.2 S68.9± 12.3 
To detennine whether T, acts independently of and/or additive to ~AR 
stimulation, the effects of 2S oM isoproterenol (ISO) alone and ISO followed by 
the addition of T, were examined. (+ p<O.OS vs ISO alone) 
SHORTENING % SHORTENING VEL LENGTIiENTNG VEL 
2SoM ISO 9.2±0.S' 97.6±S.7' 87.2±4.9' 
ISO+ 80pM T,11.7±0.S'+ 168.5±10.9'+ 154.6±13.7'+ 
Analysis of variance revealed that this increase with T, was independent of and 
additive to the ~AR. In summary, (I) T, acted direcdy on the myocyte itself 
(2) T, caused a dose dependent increase in the contraCtile state and relaxation 
rate, and (3) the effects of T, upon MYO contractile function were independent 
of and additive to ~-adrenergic receptor stimulation. Thus, acute T, 
administration may provide a novel modality to improve left ventricular 
function independent of the ~-adrenergic receptor system. 
825·6 9:45 
Regional Expression of the Calcium Release Channel 
(Ryanodlne Receptor) In Human Heart Failure 
Loewe O. Go, Steven O. Marx, Billie 8. Fyfe, and Andrew R. MarkS. Mount 
Sinai School of Medicine, New York, NY. 
The ryanodine receptor (RyR) forms the major calcium release channel in 
cardiac and skeletal muscle activated during E·C coupfing. Previous 
studies showing decreased RyR mRNA expression in failing human hearts 
examined left ventricular samples. The purpose of the current study is to 
determine whether RyR mRNA expression is uniform throughout the 
heart. Fresh tissue samples (~2 gm) were obtained prospectively from 
end·stage heart failure patients undergoing cardiac transplantation 
(n=15). Total RNA was isolated from the left and right atria (LA & RA), left 
ventricular free wall and septum (LV & LV8), and right ventricular free wall 
and septum (RV & RV8), and analyzed with northem and slot blots using a 
rabbit cardiac RyR cDNA probe. RyR mRNA levels were quantitated with a 
phosphorimager and normalized to 288 ribosomal RNA levels. RNA 
quality as assessed by ethidium bromide staining was excellent in aU 
samples (Il0090). Northem blot analyses of RNA isolated from each region 
detected a single ~16 kb cardiac RyR mRNA. Relative normalized RyR 
mRNA levels are shown below. 
'p<.05, "p<.01 vs LVIRV 
o Std dey !! 1'~ji ~e ~ 0.5 i .. 
i:! M" • Mean :t ~ 0 ~~~I.~1I.j..1 --tJ1:S~I.;'1I.j..1 ~1~~lflli~1 ~ __ --' 
We conclude that the cardiac RyR mRNA is expressed variably in diHerent 
regions of the failing human heart. This is the first study demonstrating 
significant diHerences in regional expression of a calcium release channel 
involved in E-C coupling in the myocardium. This variable RyR expression 
may contribute to or reflect the divergent hemodynamic stresses 
throughout the cardiomyopathic heart. 
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Hitral Valve Repair in the Elderly 
8:30 
Eugene A. Grossi, Aubrey C. Galloway, Martin LeBoutill1er 
III, Bryan Steinberg, Rick Esposito, Alfred T. Cull1ford, 
Frank C. Spencer, Stephen B. Colvin, New York University 
Medical Center, New York, NY 
Recent favorable experience with mitral valve 
reconstructive techniques has led to an attempt to apply 
these techniques to elderly mitral valve patients in the 
hope of improving ventricular function and freedom from 
complications in this higher risk group. Between 5/80 
and 1/93 146 consecutive mitral valve reconstructions 
were performed on patients ~ 70 years of age (n-126'for 
70· 79, n-20 for ~80). All procedures were for either pure 
mitral regurgitation or mixed stenosis/regurgitation and 
involved placement of an annuloplasty ring. Concomitant 
cardiac procedures were performed in 100 patients 
(68.5\), including bypass grafting (n-64) and other valve 
surgery (n-25). Hospital mortality was 12.3\ (18/146) 
for all patients and 4.4\ (2/46) for those having 
isolated mitral reconstruction. Preoperatively 89.6\ of 
the patients were either NYHA Class 3 or 4 and 
postoperatively 90.1\ were NYHA Class 1 or 2. Inpatients 
with isolated mitral valve disease, cumulative survival 
of freedom from cardiac death and reoperation, including 
hospital mortality was 86.6\ and 74.2% at 3 and 5 years 
respectively. These data demonstrate that the 
encouraging results seen to date in younger patients who 
have undergone mitral valve reconstruction can be 
achieved in elderly patients as well. 
826·2 
Secundum Atrial Septal Defect (ASD): Clinical Prorile and 
Surgical Experience in Septuagenarians and Older 
8:45 
Karl W. Foster-Smith, Joseph G. Murphy, Kent R. Baile~, ClI!.ole A. 
Warnes, Gordon K. Danielson, James B. Seward, A. Jamil TaJik. 
Mayo Clinic, Rochester, MN 
Survival beyond sixth decade is rare in patients (pts) with 
uncorrected ASD. We report the clinical features of 69 pts, aged 70 
yrs or older, diagnosed with ASD by echocardiography (echo). Pts 
with a patent foramen ovale were excluded. The mean age (±S.D.) 
was 76.6 yrs ± 5.0 (median 76, range 70 - 93 yrs). The female:male 
ratio was 20:49. Mean follow up was 3.6 yrs (median 2.7, longest 
12.7 yrs). Forty percent ofpts were not suspected of having an ASD 
prior to echo. New York Heart Association class was as follows (% 
pts): Class I - 41 %, class II - 25%, class ill - 14%, class IV 20%. 
Thirteen pts had angina (6 of these had known coronary artery 
disease). . 
Right axis deviation and right bundle branch block were found m 
30 percent on EKG. Mean left ventricular ejection fraction (±S.D.), 
as determined by echo, was 59.4%±13. PA systolic pressure was 
determined by Doppler or catheterization in 60 pts and was as 
follows: 
Group 1 (25-39 rom Hg) 7 (12%) pts 
Group 2 (40-59 rom Hg) 37 (62%) pts 
Group 3 ~ 60 rom Hg) 16 (27%) pts 
Overall actuarial survival at 1,3,5, and 7 yrs was 81%, 65%, 54%, 
and 48%, respectively. Seventeen pts had surgical repair.with 
1(5.8%) perioperative death. The strongest overall,Predict?rs .of 
survival were functional class (P=O.OOOI), left ventncular eJectJon 
fraction (P=O.OOO5), PA systolic pressure (p=O.06), and the presence 
of atrial fibrillation (p=O.OOO8). Conclusion: ASD in elderly (~ 70 
yrs) is frequently unsuspected because of atypical features. ~he 
principal predictors of survival are functional class, left ventrIcular 
ejection fraction, PA systolic pressure and atrial fibrillation. Surgery 
can be performed at an acceptable risk with gratifying results. 
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Clinical Features of Persistent Ductus Arteriosus in the 7th and 8th 
Decade and Results of Non-Operative Closure with IvaIon"-Plugs 
Rainer Schriider, Gerhard Cieslinski, Martin Kaltenbach, University 
Hospital, Frankfurt am Main, GE 
In patients (P) with persistent ductus arteriosus (PDA) survival 
is rare after age 60 years and surgical closure carries an inc~ 
risk since the ductus may be calcified as well as aneurysmatJcally 
dilated. 
We have performed non-operative PDA-closure in 18 femaIe and 3 
male Paged 61-72 years (mean, 65). All P had cardiac symptoms: 
7 were in NYHA-class n, 9 in class III, and 5 in class IV. 
Concomitant cardiovascular disease was present in 19/21 P 
(myocardial infarction = 2; mitral regurgitation = 6; arterial 
hypertension = 8; atrial fibrillation = 13). Qp/Qs was 1.8 (range, 
1.3-2.5), mean pulmonary artery pressure was 26 mmHg (range, 
12-61), PDA-diameter was 5.2 mm (range, 4-9), and femoral artery 
diameter was 8 mm (range, 5-11) on an average. 
The ductus was successfully closed with an IvaIon"-plug in ail P. 
The femoral artery was surgically exposed in 10/21 P. 
In 1 P the 1st plug was too small and slipped through the ductus. 
It was surgically removed from the femoral vein and subsequently 
closure was performed with a 2nd larger plug. No other 
complications occurred. Mean pulmonary artery pressure decreased 
to 15 mmHg (range, 8-25) after closure. There was no evidence of 
residual ductal flow as assessd by both angiography (n=21) 
and color Doppler (n = 19). 
Follow-up studies were performed in 20/21 patients 1 month to 5 
years (median, 17 months) years after PDA-closure. There were no 
late complications, no mfective endocarditis and no plug 
dislodgements. 19/21 P were improved by at least 1 NYHA-class. 
Conclusion: Heart failure was a regular finding in P with PDA in 
their 7th and 8th decade. Non-operative PDA-closure with Ivalon"•
plugs was performed in ail P without significant complications. 
There was no residual left-to-right shunt following the procedure. 
The long-term clinical benefit for this group of P was high. 
826·4 9:15 
II Hypertrophic Cardiomyopathy In the Elderly a HeteroFDolI1 Diapoll11 
Mark P. Ryan, Julie A. French, Jayshree Joshi, Lubna Choudhury, Petros 
Nihoyannopoulos, Celia M. Oakley. 
Department of Medicine, Cardiology Unit, Hammersmith Hospital, RPMS, 
London. United Kingdom 
Hypertrophic Cardiomyopathy (HCM) is characteristically a disease of 
the young but there are a number of elderly patients who phenotypically have the 
disease but differ clinically, with no family history, a late presentation and a 
better prognosis. Physiologic age related changes such as hypertension, left 
ventricular hypertrophy, angulation of the ventricular septum and diastolic 
dysfunction make a definitive diagnosis ofHCM difficult. To determine whether 
HCM patients seen after age 60 years do represent the true genetic condition as 
in the young rather than a cluster of different diseases, we studied the clinical. 
electrocardiographic and echocardiographic characteristics of elderly HCM 
patients (age> 60 years). 
Comparing only HCM patients over 70 years (n = 19) and a group of age 
matched nonnal controls (n = 60), left atrial size (46.3 ± 8.6mm vs 35.6 ± 
8.2mm; P<.05). septal wall thickness (18.8 ± 4.0 vs 11.0 ± 1.6mm; "".001). 
posterior wan thickness (13.1 ± 1.7 vs 11.0 ± 1.5mm; p<.ool). E/A ratio (0.99 
± 0.56 vs 0.80 ± 0.17; p<.OI) and left ventricular outflow tract (LVOT) velocity 
(2.61 ± 1.88 vs 0.92 ± 0.25 msl) were Significantly greater reflecting the presence 
of left ventricular hypertrophy, diastolic dysfunction and L VOT obstruction (n = 
9, 53% with a gradient >30mmHg) and confirming their variance from the 
nonnals. In 31 elderly HCM patients (>60 years) only septal wall thickness (22.4 
± 5.3 vs 18.7 ± 3.6mm; p<.05) was significantly greater in those presenting at an 
age <60 years (n = 14; 50 ± 8.8 years) compared to those presenting >60 years 
(n = 17; 67 ± 5.8 years) which may reflect their longer disease dWlltion. There 
was no significant difference in clinical, ECG or echo characteristics between 
those with or without either a history of hypertension (n = 8. 26%) or a confirmed 
family history of HCM (n = 7, 23%; mean of 2.9 affected relatives). 
Elderly HCM patients differ from the nonnal elderly popUlation. Age at 
presentation. hypertension or family history do not help to differentiate this group 
by clinical, ECG or echo criteria. Thus elderly HCM patients by virtue of their 
longevity must represent a less malignant spectrum of the condition, perhaps 
lirlked to a more benign genetic mutation. 
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R!ripEml. ArgiqIlasty in 1m EldeI:ly: D:iustxaLim 
of lJIrc:Md PrlDmy au:a:a ali IHBr::Id IaJ;J-'.IB:m 
Bsn!f:i.t 
""lmwir K. B:ljw!, Ib1ald II. SdJnidt, thiversi.ty of 
Wisxrsin MEdical. SChool (MX:), MilwU<ee, WI 
'lhe effi.a:Ic:t ani safety of perjpleral argicpl.asty 
(Pm) in older p:s is rot -U establiSled. 
'lIoo-iudre:i atrl sixty p:s (4aI l.esias, 
fata:crp;;pllteal=300, ~, bel.ai krEe=28) 
InEI:w!nt: Pm at wr irstit:utial a.oer 48 lIrI'lI::lB (lID). 
stu:iy gtt1I) lIEaJ'l a;JE! 1IIBS 74 years (:taJ'1}a 70-63), 200 
nales, 60 fEllBl.es. All 260 p:s ha:l cl.aulicatial (S 2 
bl.l:Jd(s): 32 p:s ha:l rest pUn with :isch!mic uloeI:s. 
c:te-h.n:lI:e:i ani thirty p:s (50%) ha:l asex:i.ata:l. 
a::a:amy artmy disease. ArKle-ilrac:hi. in:lices (Am) 
were cb'e pre ani 6 lID p:st Pm. 
stsJ::sis o:x:lusiat (S5an) o:x:lusiat ~ 
(lF26O) (n=60) (n=S8) 
&xx::ess 99% 
Am Pre 0.5±17 
R:st *O.95;t10 
*p value < 0.001 
95% 
0.47±13 
*O.84±12 
85% 
0.33.±07 
*O.1;t04 
Q:npl.il::atil:: sixteen p:s (6\) ha:l CXJIpl.i.c:ati. 
(dj.........tial=10, hBrat.cmF4, di.sbU ad:ol.izat:icn=. No 
1oItrSIE1JUrg of lilIb is:iBuia res.Il.te:i fmn Pm. At a 
lIEaJ'l fallaor ~ of 28 lID (:taJ'1}a 12-.48), 80\ of all 
s.JXJeSSful. p:s were eitlEr asynp:.aratic or 
sjgni.fi.artly ilIproIIed. In o:n:.li.Edcn: 1) Pm am te 
P=tfuute:l with hiIjl pril!EIIy SIXDE!SS in elderly p:s 
with syuptamtic ~ vas::u1ar disease. 2) 
Q:npl.il::atil: are la.r ani syqt:.atatic benefits are 
m:rintained a.oer ext:En:led p!ricxis of tine. 
826·6 9:45 
Clinical Characteristics Associated with Acute Cardiogenic 
Pulmonary Edema 
Orlando Rodriguez, Bernard J. Ransil, Peter Zimetbaum and Richard P. 
Shannon. Department of Medicine, Harvard Medical School, Beth Israel 
Hospital, Boston, MA 
Acute cardiogenic pulmonary edema(ACPE) is often the cause of 
sudden respiratory failure in the elderly. Diastolic dysfunction has been 
implicated in the pathogenesis. To examine the clinical characteristics 
associated with ACPE, we screened all admissions for "pulmonary 
edema" from January, 1990 through October, 1992(n=242). Selection 
criteria were the sudden o\lSet of severe dyspnea, respiratory rate > 24, 
bilateral rales and radiographic evidence of pulmonary edema. Exclusion 
criteria were dyspnea for > 6hrs or subacute symptoms of congestive 
heart failure(n=60), rapid atrial fibrillation(n=7), renal failure(n=9) or 
lung disease(n= 10). Analysis was performed on 100 pts from 156 
hospital admissions. Results from coronary angiography(n=35) and 
echocardiogratns(n=89) obtained within 6 months were reviewed. 
Women composed 74% of the group(3:1) and were older than men 
(84+8 yrs vs 75+ II yrs, p<O.OI). The proportion of women ~90yrs 
was greater than for men(26% vs 4%). When the data were age adjusted, 
the female to male ratio remained 3: I. Moderate or severe mitral 
regurgitation(72%) and left atrial enlargement(74%) were highly 
prevalent. Wall motion abnormalities(74%) were two times more likely 
to be focal(49% ) than diffuse(24% ). Where left ventricular wall thickness 
was assessed(n=78), 65% showed left ventricular hypertrophy(L VH). 
Coronary artery disease(CAD) was present in 80%(28/35) of pts who 
underwent angiography within one year of admission. 
Thus, the most common characteristics associated with the development 
of ACPE were female gender, advanced age, mitral regurgitation, left 
atrial enlargement, regional wall motion abnormalities, LVH and CAD. 
The predominance of women affected by this syndrome is unexplained 
by age. ACPE is most likely a manifestation of ischemic heart disease 
and the vulnerability of the hypertrophied heart to ischemia. 
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The Diastolic Slope as a Parameter to Demonstrate Delayed AfterdepoIari•
zations and Triggered Arrhythmias in Vivo: Validation With Lidocaine 
s. Marieke de Groot, Marc A. Vas, Anton P. Gorgels, Jet D. Leunissen, Bert 
J. van der Steld, Hein J. Wellens. Department of Cardiology, Cardiovascular 
Research Institute Maastricht, The Netherlands. 
Methodological difficulties hamper the direct visualization of delayed after•
depolarizations (DADs) and triggered anhythmias in vivo. In this study, the 
bypothesis was tested that during pacing, ouabain-induced DADs and triggered 
anhythmias can more easily be detected by an increase in the maximal 
baseline slope (dV Idt) of the diastolic interval of the monophasic action 
potential (MAP) recordings. To exclude artefacts in the MAP registrations, the 
effect of lidocaine (3mg/kg) was also tested. In anaesthetized dogs with 
chronic A V -block, • right ventricular endocardial MAP was recorded during 
I) control (n=I1), 2) 15-45 minutes after ouabain (45±10 "g/kg bolus, 
followed by continuous infusion througbout the experiment, n= 11), 3) the first 
10 minutes after a bolus of lidocaine (n=5) and 4) during the wash-out period 
of this bolus of lidocaine (n=3). Pacing Was performed from the MAP•
catheter with an interstimulus interval of 300 DIS for 4, 10 and 20 seconds. 
Rm!Us During control the slope value was 18±3 mV/s (mean±SEM), the 
incidence of DADs was 6% and their mean amplitude (A DAD) was 0.4±0.5 
mV. There were no (oon-sustained) ventricular tachycardias (NSVTs) in•
ducible. After ouabain all these parameters increased and NSVTs were 
frequently induced. Lidocaine prevented induction of NSVTs by decreasing 
slope, incidence and amplitude of DADs. This reversed after wash-out (table). 
The changes in diastolic slope coincided with the changes seen in incidence, 
DAD amplitude and induction of NSVTs. 
Control Ouabain Lidocaine Wash-Out 
Slooo (mV/s) 18+3 79+8" 4Q±S' 93± ]3' 
DADs 6% 74%' 57%' 77%' 
A nAnlmY 0.4+0.5 1.0+0.1" 0.7+0.1' 11+0.1' 
I NSVT 0% 33%- 0%' 56%' 
ymbols: .: \IS collIrol, .: \IS o/UU am, ~: \IS uaocame, p<u.u:. 
Conclusion: The diastolic slope observed during pacing on MAP recordings in 
ouabain-intoxicated hearts can be used as a marker for DADs and triggered ar•
rhythmias. 
827·2 10:45 
Intracellular Acidification and ADP Enhances NicorandiI. 
but not Pinacidil-Induced ATP·sensitive Potassium 
Channel Current in Ventricular Cardiomyocytes 
Arshad Jahangir, Andre Terzic, Mitsuhiko Yamada, Win K. Shen, 
Yoshihisa Kurachl, Mayo Clinic, Rochester, MN 
Potassium channel openers, have been proposed to be beneficial 
in the treatment of myocardial ischemia and hypertension. While it 
is established that cardiac ATP-sensitive K+ (KATP) channels are 
modulated by intracellular pH (PH;) and nucleoside diphosphates, 
it is not known how these factors affect the phannacological 
modulation of KATP channels. To address this issue, the effects of 
ADP and intracellular acidification on KATP channel activation by 
nicorandil (300 I!M) and pinacidil (tOO I!M) were evaluated in 
guinea·pig single ventricular cardiomyocytes using the whole·cell 
patch clamp technique. Both K +-channel openers induced a time•
independent K + current, which was inhibited by glyburide (6 I!M), 
a selective blocker of KATP channels. Nicorandil, but not pinacidil, 
required the presence of ADP in the pipette to induce the 
glyburide-sensitive whole cell current at pH 7.2. When 
experiments were performed with pH 6.5 pipette solution, 
nicorandil induced a current even in the absence of ADP. The 
pinacidil·induced KATP channel current was not significantly 
affected by this change in pHi. In the absence of K +-channel 
openers, no spontaneous KATP channel current was induced by 
either application of ADP or acidification. Hence, intracellular 
ADP and acidification selectively regulate the nicorandil-induced 
KA TP channel activity, which could be of therapeutic importance in 
states associated with a change in intracellular H+ and nucleotide 
concentrations, such as ischemia. 
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Evidence Against the Existence of Adenosine·lnduced 
Activation of ATP·Sensitive K+ Channels in Guinea Pig 
Cardiac Myocytes 
Yejia Song, luiz Belardinelli. University of Florida, Gainesville, Flo 
Activation of A TP-sensitive K + (KATP) channels hyperpolarizes cardiac 
myocytes and shortens action potential duration (APD). To test the 
hypothesis that stimulation of A,-adenosine(ADO) receptors may 
activate or facilitate the activation of KATP channels, APD or holding 
current was measured in guinea pig isolated cardiac myocytes. The 
effect of ADO was compared with that of pinacidil, a direct KATP 
channel opener. ADO did not alter APD of ventricular cells. In atrial 
cells, ADO-induced shortening of APD and hyperpolarization were 
attenuated by the ADO-receptor antagonist cyclopentyltheophylline 
(CPT) but not by the KATP channel blocker glibenclamide (Glib). In 
contrast, pinacidil shortened APD in both atrial and ventricular cells, 
which was antagonized by Glib but not by CPT. Facilitation by the 
ADO-analogue cyclopentyladenosine (CPA) of activation of KATP 
channels was tested in the presence of either dinitrophenol (DNP) or 
cyanide, inhibitors of oxidative phosphorylation that lower cellular A TP. 
DNP at 0.1 mM shortened APD of ventricular cells from 165 ± 10 to 
123 ± 19 ms (n =4). In the presence of DNP, addition of CPA failed to 
further shorten the APD (126 ± 20 ms). DNP at 0.2 mM reduced the 
APD to 58 ± 22 ms and this action was reversed by Glib. The rate of 
shortening of APD by DNP was not accelerated by CPA (n = 6). 
likewise, holding currents in ventricular cells clamped at -50 mV in the 
presence of DNP or DNP+CPA were not different (1.4±0.2 and 
1.3 ± 0.2 nA, respectively, n = 12). Similar results were obtained using 
CPA and either cyanide or pinacidil. In summary, distinct differences in 
the actions of ADO and KAT!' channel openers were observed and 
provide evidence against the hypothesis that ADO activates KATP 
channels in cardiac myocytes. 
827·4 11:15 
Effect of In Iithmul on AnilOlrOplc Conduction of Atrial Myocardium: A 
POlilble Model of Slow Conduction 
Haruhiko Abe, Jose Ortiz, Shinichi Niwano, Xavier Gonzalez, Albert L. 
Waldo. CWRU / University Hospitals of Cleveland, Cleveland, OH 
Although recent studies suggest that an isthmus and also anisotropic 
conduction play an important role for the area(s) of critically slow con•
duction of reentrant arrhythmias, anatomical-electrophysiological corre•
lations for slow conduction are not well understood. To test the hypo•
thesis that slow conduction across an isthmus (IS) at rapid rates critically 
depends on anisotropy, we studied conduction both parallel and perpen•
dicular to cardiac fibers across an IS, made perpendicular or parallel to 
the sulcus terminalis in 8 dogs using cryosurgical techniques. Two types 
of lesions were created. Lesion #1: length of IS was constant at 5 mm; 
width of IS was 15 mm, then 10 mm; pacing wave front conducted per•
pendicular to cardiac fibers (nK4). Lesion #2: width of IS was constant 
at 10 mm; length of IS was 5 mm, then 10 mm; pacing wave front con•
ducted parallel to cardiac fibers (n=4). During rapid atrial pacing (300, 
400,440,480, 550, 600 bpm), conduction was mapped using a very high 
density electrode array to record from 190 electrodes placed over and 
around the IS. Rapid pacing was performed immediately opposite the IS 
until either refractoriness at the pacing site or conduction block in the 
IS occurred. Results: Prior to creating an IS, parallel conduction velocity 
(CY) did not change significantly at all pacing rates; perpendicular CY 
decreased significantly; no fractionated signals (Fr) were recorded. After 
creation of lesion # I, perpendicular CY decreased significantly when the 
IS was narrower (no lesion vs 15 mm:P-NS, vs 10 mm width:P<O.05). Fr 
were recorded in the IS during pacing rates~440 bpm; conduction block 
occurred in the center of the IS at a rate~550 bpm. After creation of 
lesion #2, parallel CY did not decrease significantly even when the IS 
was longer (no lesion vs S mm or 10 mm length of IS:P=NS); neither Fr 
nor conduction block were recorded at any pacing rate. Conclusions: 
Anisotropic conduction alone did not produce critical slowing of con•
duction at any rate. However, anisotropic conduction plus a critical 
width of IS produced marked slowing of conduction and also conduction 
block in the IS. These data suggest that an IS may play an important role 
for creating slow conduction in reentrant circuits. 
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Differentiation of the Effects of 'Fast' and 'Slow' Pathway Ablation 
on Intra-Atrial VI A·V Nodal Conduction 
Herv~ Poty, Benjamin J. Scherlag, Kenzo Hirao, Hiroshi Nakagawa, 
Ralph Lazzara, University of Oklahoma Health Sciences Center, 
Oklahoma City, OK 
We have developed epicardial approaches for selective atrial 
antero-septal or 'fast' pathway (FP) and posteroseptal or 'slow' 
pathway (SP) radiofrequency ablation in the open-chest, normal dog 
heart. In 10 dogs, respective P-R and A-H intervals increased from 
an average 97 ± 10 and 66 ± 11 msec before to 149 ± 23 and 
115 ± 20 after 'fast' pathway ablation p<0.0001; however, no 
significant change occurred in antegrade Wenckebach cycle length 
(WBCl) from 210±31 to 254±89 msec, p, ns. Subsequent SP 
ablation was successful in 6 dogs since there was a further P-R and 
A-H prolongation (222±33 msec; 192±39 msec, p<0.01) and a 
significant lengthening of the antegrade WBCL to 350 ± 116 msec 
compared to control, p<0.05. After FP ablation, recording and 
pacing from the ablation site in several cases showed splitting of 
the atrial potential indicating that a local intra-atrial delay could 
account for the P-R and A-H prolongation. Also pacing from this 
site showed two distinct stimulus to P wave latencies and different 
A-H intervals depending on stimulus intensity. In addition, 
morphology of the local atrial activation suggested two different 
conduction pathways related to stimulus intensity. In another case, 
after slow pathway ablation second degree V-A block occurred at 
a slower rate than control but V-A intervals showed a Mobitz II 
pattern leading to single or multiple V-A block. Pacing at higher 
rates revealed typical WB cycles at the same heart rate seen prior 
to SP ablation. These data indicate that FP and SP ablation can lead 
to changes previously considered to represent only A-V nodal 
function. Recording and pacing at the ablation sites can thus be 
used to differentiate between A-V nodal and lor intra-atrial 
conduction changes. 
827·6 11:45 
Three Dimensional Mapping of Cesium Chloride Induced Yentric:ular 
Arrhythmias 
Laurence D. Stems, Wolfgang Schoels, Julia C. Senges, Kirsten D. Freigang. 
Alexander Bauer, Wolfgang Kuebler, Johannes Brachrnann, Division of 
Cardiology, University Medical Hospital, Heidelberg. Germany 
Cesium chloride (CsO) has been used to produce early afterdepolarizations 
and triggered activity in vitro and a variety of ventricular tachyarrhythrnias 
in vivo. This study is the first to determine the mechanism of these 
arrhythmias in a canine in vivo model by means of three dimensional (3D) 
mapping. 
~ Following radiofrequency ablation of the AY node, repetetive 
(every 10 minutes) doses (lmmol/kg Lv.) of CsO were administered in 4 
beagle dogs in an effort to induce sustained ventricular tachyarrhythmias 
(VT). The 3D activation pattern during VT was reconstructed from 240 
bipolar electrograms recorded simultaneously from 60 intramyocardial pins 
in the left and right ventricle. The distance between pins ranged from 10-15 
nun; each pin contained 4 electrode pairs with an intereIectrode distance of 
2 nun. 
~ esCI at an average dose of 1.5 mmol/kg produced polytopic pves 
and nonsustained (<3Osec) VT in all 4 dogs. Sustained polymorphic and 
monomorphic VT occurred in 3 dogs. All PVC's were focal in origin, 
starting from various left (37%) or right (63%) ventricular endocardial sites. 
Significant ventricular pauses preceded 80"1. of the PVC's. All episodes of 
VT, irrespective of their duration, were focal in origin. In monomorphic VTs 
(mean cycle length 448±66 msec) a single focus repeatedly fired at variable 
rates. In polymorphic VTs (mean cycle length 383±28 msec), variable foci 
consecutively replaced each other. For all VTs, the total ventricular 
activation time per beat was 74±13 msec versus 41±1O rns for spontaneous 
junctional beats (p<O.05). Areas of slow conduction or conduction block 
were not evident. 
Cpnclusions' Consistent with EADs and triggered activity as the underlying 
etiology, CsCI induced arrhythmias demonstrate a focal activation pattem 
starting endocardially. Individual foci seem to be capable of multiple 
consecutive discharges, resulting in sustained VTs. Moving or static foci 
account for polymorphic or monomorphic VTs, respectively. 
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Quantitation of Left-to-Right Shunts in Secundum 
Atrial Septal Defect: A Clinical Application of Two•
dimensional Contrast Echocardiography with Use of 
Sonicated Albumin 
Hiroyuki Okura, Junichi Yoshikawa, Kiyoshi Yoshida, Takashi 
Akasaka, Yasuhiro Honda, Kobe General Hospital, Kobe, Japan 
Sonicated albumin (SA) has been shown to successfully cross the 
pulmonary vasculature and opacify left ventricular cavity without 
significant hemodynamic changes. The purpose of this study was to 
quantitate the left-to-right (L-R) shunts in secundum atrial septal 
defect (ASD) by two-dimensional contrast echocardiography 
(2DCE) with use of SA. Eight patients (pts) with secundum ASD 
were examined. Two-dimensional echocardiographic images were 
obtained during intravenous injection of SA (O.OI-O.04mL/kg). 
Time-intensity curves were generated from right ventricular cavity. 
They showed an early reap-
pearance of contrast inten- (%) L·R Shunt(%) 
sity which interrupted the 100 
exponential decrease in in- 10 
tensity afier the first peak. 10 0 
Values for the L-R shunt 0 70 
ratio were calculated based ~ 60 
on the dye- dilution theory. i so 
The values obtained by c ~ 0 
2DCE were compared with 8 30 
those obtained by cardiac 20 
catheterization (Cath) us- 10 y.O.78X+14,r.O.95, p<O.OOI 
ing oximetry and the Fick's 0 +-.-....... ..,..., .............. .....,........,.....,......., ....... ........-1 
method. 0 10 20 30 ~ so 60 70 10 10 100 
Result The calculated val- FIcl<'. method (%) 
ues for the L-R shunt ratio by 2DCE showed a high correlation with 
those obtained by Cath . 
Conclusion: 2DCE using SA is an accurate method for the mea•
surement of the L-R shunt ratio in pts with secundum ASD. 
828·2 10:45 
Comparative Value of Myocardial Contrast Ecbocardiograpby, 
Dobutamine Ecbocardiography and Sestamibi SPECT for 
Detecting Myocardial Viability in Patients witb Resting Wall 
Motion Abnormalities 
Mario Meza, Robert Sonnemaker, Christopher J. White, Dagnovar 
Aristizabal, Bret Perry, Susan RevaH, James V. Connaughton ill, 
Jorge Cheirif, Ochsner Medical Instititions, New Orleans, LA 
Previous studies have independently suggested that myocardial 
contrast echocardiography (MCE), dobutamine stress 
echocardiography (DSE), and sestamibi SPECT (SES) are valuable 
techniques for identifying viable but dysfunctional myoca¢ium. 
This prospective study was conducted to identify the relative value 
of these three techniques for assessing the presence or absence of 
myocardial viability in 17 patients with severe resting wall motion 
abnormalities treated with medical therapy (n=4) or revascularization 
(PTCA=7, CABG=6). All patients underwent a baseline two•
dimensional echocardiogram and a follow-up two-dimensional 
echocardiogram 7 to 90 days (mean 51 days) after treatment. An 
improvement in regional wall motion score (·I=hyperkinesis, 
O=normal, l=mild hypokinesis, 2=akinesis, 3=dyskinesis) was 
defined as a change of one or more grades. Presence of myocardial 
viability was defined as presence of contrast effect by MCE, as 
presence of visible counts by SES (30% of maximal counts) and as 
an improvement in contractility by one or more grades by DSE. A 
total of 151 regions were studied, 7S of which showed an 
improvement in wall motion on follow-up. Correct prediction of 
viability was seen in 84% of regions by MCE, in 93% by SES, and in 
39% by DSE. In conclusion, MCE and SES were found to be 
superior to DSE in identifying viable but dysfunctional segments. 
Because DSE would have been expected to improve stunned but not 
necessarily hibernating segments, our data suggest that hibernation 
occurs frequently in the presence of resting wall motion 
abnormalities. 
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Contrast Enhanced Color Doppler Tachnique for Me.suring 
Len Ventricular Ejection Fraction 
Helen von Bibra. Christian Firschke, JOrg Horcher, Hans 
ScMn, Reinhard Schlief R·, Albert ScMmig. 
I. Med.Klinik Technical University, Munich, ·Contrast 
media research section, Schering AG, Berlin, GE 
Poor image quality may impede assessment of LV 
ejection fraction (EF) by 2-d echocardiography (2DE). We 
tested, if a color Doppler technique with contrast 
enhancement (CD) achieves better distinction between 
endocardial borders and blood pool for measurement of LV 
EF. Thus. 22 patients had 2DE and CD examination within 3 
days of radionuclide angiography (EF range 22-79%). 
Patients were not selected based on 2DE and CD image 
quality. Using biplane Simpson's rule, LV enddiastolic and 
end systolic volumes were calculated from manually traced 
4- and 2 chamber views. With CD examination, we used the 
smallest sector encompassing the entire LV and also had 
24cmls as Nyquist limit, so that LV flow was imaged with 
aliased, mosaic color Doppler signals. The border of the 
mosaic color flow area was traced after I.V. injection of 2 
or 3 g SHU 508A. a transpulmonary contrast agent. Inter•
and intraobserver correlations for CD EF were good 
(r~.90). EF obtained with radionuclide angiography had 
a good correlation with EF measured by CD (r=O.90, SEE: 
9%) and a fair correlation with EF measured by 2DE 
(r=0.79, SEE=l1%). This correlation improved in a 
subgroup of 10 patients with good 2DE image quality 
(r=0.88). In this subgroup, LV enddiastolic and endsystolic 
volumes were 105±54 and 54±53 ml and compared well 
with LV volumes obtained with CD (1l3±61 and 57±62 ml). 
Conclusion: Contrast enhanced color Doppler technique 
provides accurate measurement of LV ejection fraction. 
This technique is independent of image quality in 2DE. 
828·4 11:15 
Improved Correlation Betw .... Bcho-Contraat Derived 2nd 
Diaatolic Vol...... and Left Ventriculography U8ing 
IDtravenOu8 Contraat Echo 
Amy Chou, Douglas Netz, Thomas Porter, Feng Xie, Alan 
Kricsfeld; University of Nebraska Medical Center, Omaha, 
Nebraska 
Rest and exercise left ventricular (LV) end•
diastolic volumes are important prognostic indicators in 
ischemic and valvular heart disease. Although the 
correlation (CORR) between echocardiographic and 
angiographic LV volumes have been good, there is 
significant standard error (SEE) of this estimation, 
because echo consistently underestimates angiographic•
derived volume. Since underestimation by echo may be due 
to failure to delineate endocardial borders, ultrasound 
contrast agents which produce LV opacification following 
intravenous (IV) injection may improve this CORR. 
Accordingly, we measured LV end-diastolic (EDV) and end•
systolic (ESV) volume from the apical four chamber 
view (A4CV) using an area-length formula in 18 patients 
(mean age 63±12 years)without echo contrast (EC) , and 
again at maximal LV opacification following the IV 
injection of sonicated dextrose-albumin(SDA). 
Improved resolution of septal, apical and/or lateral 
endocardial borders from the A4CV following IV SDA 
occurred in 15/18(83%) patients. Of these 15 patients, 12 
had angiographic measurements (AM) of EDV and ESV 
performed within 3±3 days of echo measurements. The 
difference (A) between AM and each echo measurement were 
compared. The range of EDV by AM was 82-206 mI. Results 
are shown below (*p<0.005 compared to echo-derived volume 
without SDA): 
Echo withQut SPA Echg with SPA Angiography 
EDV 98±32 ml l23±34 ml 126±23 ml 
ESV 55±29 ml 65±34 ml 63±39 ml 
A (EDV) 27123 mI 2112 ml* 63+39 ml 
The CORR between EC-derived EDV and AM of EDV was 
0.96 with a SEE of only 10 ml, while the CORR for echo•
derived EDV without SDA was only 0.84 with an SEE of 20 
mI. We conclude that IV SDA significantly improves the 
non-invasive determination of end-diastolic volume, and 
should be considered when this clinical parameter is 
needed to assess prognosis. 
JACC February 1994:1A-484A 
828·5 11:30 
Longterm Estrogen Deprivation Alters Cardiovascular 
Structure and Function in Adult Female Rats 
Craig S. Keighley, Sarah E. Katz, James P. Morgan, Pamela S. 
Douglas. The Harvard-Thorndike Laboratory of Beth Israel Hospital, 
Boston,MA. 
Both gender differences in clinical hean disease and the identification 
of myocardial estrogen receptors suggest that the hean may be a target 
organ for gonadal hormones. To examine the longterm 
cardioreguiatory role of endo¥enous estrogens, we used transthoracic 
echoDoppler to evaluate LV SIZe and function in oophorectomized rats 
(OVx; n=10), and female control rats (C; n=5). Gonadectomy was 
perfonned immediately post puberty, and both groups were studied at 
9 months of age. Results are mean ± SEM. L VD = LV dimension, 
diastole, indexed to BW (emlg )( 103); RWT = 2 )( LV posterior wall 
thickness + L VD; L VM = LV mass indexed to BW (mgtg); FS = LV 
fractional shortening; CO = cardiac output indexed to BW (llmin/g); 
E/ A = early/late diastolic filling velocities. 
.·p<O.OO5 vs C; ·p<O.05 vs C. 
LVD RWT LVM FS CO EtA 
C 21.6±2.1 .SSt.03 2.9±0.6 39±2 IS.S±1.2 4.1±2.1 
OVx tS.6±O.S" .42±.02" 1.6±O.t" 42±2 11.6±O.S" 2.3±O.3 
Summary: 1. Post pubertal estrogen deprivation in adult OVx rats is 
associated with reduced RWT, and reduced LV dimension and mass 
when indexed to BW. 2. Although FS is unchanged, reduced CO in 
OVx rats suggests altered hemodynamics. 3. LV diastolic filling 
pattern is not significantly changed. Conclusion: Longterm estrogen 
deprivation results in cardiac atrophy, changes in LV geometry, and 
altered hemodynamics. Thus, estrogen appears to have an important 
influence on the cardiovascular system 
828-6 11:45 
Systolic and Diastolic Dysfunction Among Patients with the Clinical 
Diagnosis of Dilated Cardiomyopathy. 
Charanjit S. Rihal. Liv K. Hatle. Kent R. Bailey, A. Jamil Tajik. Mayo 
Clinic, Rochester, MN 
To determine the relative prognostic value of systolic and diastolic 
function parameters we identified 102 patients (mean age 61, 64 % male) 
with the clinical diagnosis of dilated cardiomyopathy (DCM) who 
underwent complete 2DE and Doppler exams. Patients with NYHA III 
or VI symptoms were characterized by a lower EF (0.18 VS 0.24) greater 
LA and RV dilatation, and "restrictive" LV filling patterns (mean 
deceleration time "DT" 120 vs 200 msec). In multivariate analysis, DT 
(p =0.08), EF (p =0.004) and peak. E velocity (p =0.02) were associated 
with symptom class. Over a mean follow up of 36 months 35 patients 
died (34 of cardiac causes). Kaplan-Meier survival at I, 2 and 4 years 
was 84 %, 73, and 61 %. significantly poorer than the expected 98 %, 
95% and 91 % survival for a matched population (p <0.0001). Subgroups 
stratified according to EF (at 0.25) and DT (at 130 rnsec) had markedly 
different 2 year Kaplan-Meier survival (chi square=22, p<O.OOOI): 
EF DT< 130 DT> 130 
<0.25 35% 72% 
>0.25 100% 95% 
In multivariate analYSIS ower t.F (p-0.0006) and lower systolic BP 
(p =0.006) were independently associated with worse survival, while 
shorter OT and a higher EI A ratio were significant only in univariate 
analysis. 
We conclude that markers of systolic function are most 
important, and that parameters of diastolic dysfunction add important 
hemodynamic and prognostic information in DCM. 
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10:30 
Results From the Emory Angioplasty Vs. Surgery Trial (EAST) 
Compared to the Eligible, Non-Randomized Registry 
Spencer B. King lll. Nicholas J. Lembo, William S. Weintraub and 
the EAST Investigators. Emory U. School of Medicine, Atlanta. Ga. 
The EAST trial is the first completed randomized study of 
angioplasty vs. surgery in multivessel disease. Of 5,118 screened 
patients, 842 (16.5%) were eligible for the trial. Thrae hundred 
ninety two patients agreed to randomization and 450 patients 
declined. Both groups have been followed for 3 years. Baseline 
characteristics of the 2 groups are shown in the table: 
Age 
PriorMI 
Class fllffV Angina 
2 Vessel Disease 
3 Vessel Disease 
Ejection Fraction 
Randomized Registry 
62 Yrs 62 Yrs 
41% 39% 
79% 73% 
60% 60% 
40% 40% 
61% 60% 
In the randomized grouP. equal numbers of 2 and 3 vessel patients 
were treated with angioplasty and surgery. however in the registry 
patients the distribution was uneven. 
Randomized CABG 
Randomized PTCA 
Registry CABG 
Registry PTCA 
2 Vessel 
117 
n 
122 
140 
3 Vessel 
119 
79 
149 
28 
Outcome differences will be examined between the randomized 
cohort and the very similar registry cohort in whom the initial 
treatment depended on physician recommendation. 
829-2 10:45 
Argentine Randomized Trial ofPertutaneous Transluminal Coronary 
Angioplasty versus Coronary Artery Bypass Surgery in Multivessel 
Disease (ERACI): Late Cost and Three Ytars Follow Up Re!ults 
Alfredo Rodriguez, Pablo Ahualli, N~stor perez Balino, Eduardo Mele, 
Qaudia Paviotti, Marfa Sosa Liprandi, *Igor Palacios. Anchorena 
Hospital, Buenos Aires - Argentina. "Massachusetts General Hospital, 
Boston. 
The purpose of the pre!ent study was to compare freedom from 
combined coronary cardiac events (death. myocardial infarction, repeat 
revascularization procedures and angina) and late cost at 1, 3 and S years 
follow up in patients with multiple vessel disease randomized to either 
percutaneous transluminal coronary angioplasty (PTCA) or to coronary 
artery bypass graft surgery (CABG). 
Patients were randomized if the coronary lesions were suitable for 
either form of therapy. One hundred and twentyseven patients with 
multiple vessel disease and need for myocardial revascularization were 
randomized to either CABG (n = 64) or to PTCA (n = 63) at the 
Anchorena Hospital (Buenos Aires, Argentina). In this study we report 
the late cost and three years follow up of one hundred and twenty three 
survival patients (CABG 61 and PTCA 62). 
At three years follow up survival and freedom from AMI were 
similar between both groups. CABG patients were more frequently free 
from angina (80.4%) than patients treated with PTCA (59.7%) (p < 
0.001). Need for new revascualrization procedures were higher in I'tCA 
than CABG patients (37% vs. 3.2%. P < 0.001). 
AJthough the prevalence of angina was higher in PTCA than CABG 
patients. this difference became less marked at the end of the 3th. year 
(11.3% vs. 5% respectively. p NS), Late cost at 3 years follow up 
including the new revascularlZation procedures in both groups was higher 
in CABG than PTCA patients (U$S 828.000 vs. U$S 510.000 
respectively. p < 0.01). 
CONCLUSIONS: patients with multiple vessel CAD treated with 
CABG were more frequentl y free of angina and need for 
revascularization procedures. However incidence of angina at the end 
of the follow up was similar in both groups. Late cost was higher in 
CABG than PTCA patients. 
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829·3 11:00 
Lovastatin Restenosis Trial: Results in Patients With 
Cholesterol Over 200 mgldl 
Lovastatin Restenosis Trial Study Group 
Emory University School of Medicine, Atlanta GA and Merck 
Research Laboratories, Rahway NJ, USA 
The Lovastatin Restenosis Trial (LRT) is an II center randomized, 
double blind placebo controlled trial testing whether lovastatin (Lova), 
40 mg twice daily, begun 7-10 days before elective PTCA in patients 
with tota1 cholesterol between 160 and 300 mg/dl, can decrease 
restenosis. The primary endpoint is a quantitative coronary 
arteriographic comparison between groups at 6 month restudy of 
percent diameter stenosis (% DS) of the first native vessel site 
successfully dilated (index lesion). 404 patients (203 Lova, 201 
placebo) were randomized, and 324 completed the trial. Baseline 
characteristics of the two groups were similar. Of these 404, 202 (108 
Lova, 94 placebo) had serum cholesterol measured at a core laboratory 
of over 200 mg/dl. Of these 202, 168 (90 Lova, 78 placebo) 
underwent angiographic restudy. 
Baseline Cholesterol 
Baseline LDL 
Followup Cholesterol 
FollowupLDL 
%DSPrePTCA 
%DS Post PTCA 
%DS Restudy 
~SO %DS 
Lovastatin 
228±22 
147±29 
IS3±2S 
82±20 
64±IO 
31±12 
46±23 
39% 
Placebo 
229±22 
147±24 
218±32 
141±29 
64±1I 
29±13 
4H23 
38% 
P Value 
NS 
NS 
<.0001 
<.0001 
NS 
NS 
NS 
Lovastatin was shown to have a profound 1 
effect on LDL cholesterol. Despite this 0.8 
effect and the excellent balance between the 0.6 
two treatment arms, there was no effect to 0.4 
. decrease the restenosis process after 
coronary angioplasty, as measured with 0.2 
quantitative coronary arteriography, in 0 -'1''''',-,-,-,'''' 
patients with cholesterol over 200 mgldl. -20 0 20406OS0100 
829·4 11:15 
Restenosis With Chronic Total Occlusion: The 
MARCATOR Randomized Trial Experience 
David R. Holmes Jr., David Faxon, Patrick. W. Serruys, Robert S. 
Schwartz for the Marcator Investigators, Mayo Clinic, Rochester, MN 
Percutaneous transIwninal coronary angioplasty (PI'CA) for chomic 
total occlusions (erO) is known to have a lower initial success rate. 
Although restenosis in this setting is felt to be increased, there is 
limited data in well controlled consecutive patient studies. In the 
Multicenter American Research Trial with Cilazapril after Angiopiasty 
to Prevent Restenosis, 140 patients with successful PI'CA of a CTO 
had by protocol 6 mo follow up quantitative coronary angiography: 
Mean Mean Minimal Mean 
Reference Lumen Diameter 
Y£!iscl SilC (mml Diameter (mml ~ 
PrePI'CA 0 100% 
PostPI'CA 2.SI±O.SS l.SS±O.34 37.6±8.9 
6MonthFU 2.61±O.S7 1.1l±O.63 S7.S±23.6 
Loss ·O.IO±O.33 O.44±O.63 19.9±23.7 
19% of the ero returned to 100% occlusion at follow up. The 
cumulative MLD distribution at follow up was: 
100 
% 
50 
o 
MLD 
mm 
2 
27% had restenosis defmed 
as loss in MLD of ~.72 mm 
while 50% had restenosis 
defmed as DS >50%. 
Conclusion: Restenosis rates after CTO PI'CA depend upon defmition 
used and range from 27% to 50%; when restenosis occurs, it is usually 
a subtotal stenosis. 
JACC February 1994:1A-484A 
829·5 11:30 
Hemodialysis Aa:ess ADg!opIasty: Stent Deploymeat for Suboptimal Balloon 
AngiopJasly Results 
A1varoEscobar.AnmK.Karsan, TyroneJ.Co1lins,0uisI0phezJ. Whire.Jose A. Silva, 
JilIS.Lindberg.JulioE.Figueroa.SrephenR.Ramee.~CIinic.NewOrleans.LA 
PercutaneOUS translwninal angioplasty (PTA) is an accepred rechnique f~ creating 
hemodialysis access insufficiency. In IowcrUoIl'elllity PTA, vascuIlI' srent deployment 
is an imporlant bailout technique. We deployed inlravascular SIeIIIS in 31 hemodialysis 
palients(34lesioos)wilhsuboptimalresultsafterPTA.lndiaWonsf~srentdeployment 
included pcrsisIent angiographic diameI.cr srenoses > SO% after ba1loon angioplasty in 
29 (85%) palientsand flow IimiIing dissecIioos in 5 (15%) patients. SIeIIIS were p1aced 
in 12 ana5IOmOIic (II venous side,l arterial side) and 22 venous drainage lesions. A 
single non-aniculared PaImaz srent was deployed in 12 (35%) lesions and a self· 
Uopanding Wa1lsIent in 22 (65%) lesions. Multiple SIeIIIS were p1aced in 3 patients. No 
anticoagulants were administered after SIeIIt impJanralion. Quantitative angiography 
delennined the mean lesion length 10 be 2A.I ± 21 mm. 
Results: (n=34lesions) Baseline Post Balloon Post Srent 
Luminal Diamerer (mm) 2.1 ± 1.3 3.5 ± 2" 6.9 ± 2.7 t 
Lwninal Slellosis (%) 72 ± 13 51± 19" 8.2 ± 11 t 
"< O.<XXl1 vs Baseline t < O.<XXl1 Baseline and Post balloon 
Residual stenosis was signiftcandy reduced by srellt implantation afree failed PTA. 
S~uI SIeIlt delivery was accomplished in 3O{31 (97%) patients. One complication 
occurred in a patient whele the SIeIIt migrared inlO the pulmonary anery. The remaining 
30 patients derived inunediaJe clinical benefit and were able 10 be dialysed through the 
srenled access sire within 2A homs. Upon clinical foUow-up (mean time = 5.3 ± 5 
monlhs). 27/30(90%) continued dialysis through the srenled access sire. Of the three 
palientsthatdid11Olcontinuedialysis,onepatientWiderwentlridneyuansplantation.and 
two patients required a new access sill: within one monlh due 10 Slellt thrombosis. There 
were no inSWlces of bleeding. infection ~ srent-related death. Three patients expired 
of unrelated causes wilh a functioning access sire. 
Conclusion: Slellt deployment is a safe and effective non-SW'gical ueaunent straJegy 
for failed PTA in hemodialysis access sires while preserving !be access f~ fuwre 
surgery. The lack of anticoagulation and the ability 10 inunedialely dialyse the patient 
makes Slellt implantation an auractive a1remative III ba1100n angioplasty. The resrenosis 
rate will be determined based upon 6 mon!hs angiographic follow-up results. 
829·6 11:45 
Activated Clotting Time Predicts Abrupt Closure Risk During Allgioplasty. 
Craig R. Narins. William B. Hillegass, Charlotte L. Nelson. Robert A. 
Harrington. Harty R. Pbillips. Richard S. Stack, Robert M. Califf. Duke 
University Medical Center. Durham NC. 
Patients undergoing coronaIy angiopiasty are routinely anticoagulated with 
heparin to prevent thrombin-mediated abrupt closure. The relationship 
between the intensity of anticoagulation and abrupt closure risk, however. bas 
not been established. In 1.290 consecutive patients undergoing elective or 
urgent angiopiasty. there were 62 cases of abrupt closure. Compared to a 
control population (n=124) matched on c1inical and angiographic factors, 
patients with abrupt closure bad significantly lower activated clotting times 
(ACT) at the time of initial balloon inOation (3S2±68 vs. 3SS±SI. p<O.002) 
and minimum in-lab ACTs (346±67 vs. 376±79. p<O.009). All inverse linear 
relationship (figure) 
existed between 
procedural ACTs 
and the probability 
of abrupt closure 
(p=O.OIS). Since 
risk of abrupt 
closure declines 
progressively with 
increasing ACT. no 
threshold safe mini•
mum ACT was 
evident. Higher 
ACTs were not 
associated with 
increased bleeding 
requiring transfus•
ions in this selected 
I 
0.2 
0.11 
0.11 
0.14 
0.12 
0.1 
0.01 
0.01 
0.04 
0.02 
ACT va. Probability 01 Abrupt Closure 
with H% Collclence Intervals 
250 SSO 4S0 ISO 
ACT(IKOIIdoI_ MonHoring Device 
popu1ation. CondDJions: In-lab ACTs have a strong association with abrupt 
closure risk. In addition to supporting the role of thrombus formation in the 
genesis of abrupt closure. this study suggests that currendy recommended 
thresholds for ACTs (300 to 350) during angiopiasty are inadequately low. 
JACC February 1994:1A-484A 
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830·1 . 10:30 
Patients with Heart Failure Demonstrate Increased Oxygen 
Consumption and Symptoms following Maximal and Submaximal 
Exercise 
Mark D. Kraemer. Spencer H. Kubo. Linda K.Tschumperlin. 
Thomas S. Rector. Alan J. Bank. University of Minnesota 
Patients with heart failure (HF) are often symptomatic for long 
periods after physical activity. This study examined excess post•
exercise oxygen consumption (EPOC) and its relationship to post•
exercise fatigue. Ten HF patients (NYHA Class ll-IV) and IO age•
and weight-matched normal (NL) subjects were studied after 3 
separate bicycle tests including a symptom-limited maximal (Max) 
ramp test and 8-minute constant-workload tests at 2SW and 80% 
peak V02 (80%P). Subjects graded their perception of shortness 
of breath (SOB) and fatigue (F) from 0 (none at all) to 10 (worst 
possible) during exercise (Ex) and recovery (Rec). EPOC was 
calculated as the Rec portion (%) of the total 02 consumption 
durine Ex and Rec Mean yalues (±SDl for ErOC <%) were-
Mllli 2Si:L 80% P 
HF 26±7* l7±7t l7±7 
NL 19±5 9±2 16±3 
<*p<O os tp<O Q] HF vs NLl 
Mean increases in SOB and F were greater in HF vs NL during 
Rec from Max (SOB: 2.6 vs 1.4*; F: :,,0 vs I.7t) and 80%P (SOB: 
1.6 vs 0.7*; F: 2.5 vs 0.7t). but were not different between HF and 
NL during Ex at these levels. At 2SW. differences in SOB and F 
between HF and NL were greater during Rec than during Ex 
(p<O.05). EPOC was linearly related to F. but not SOB. during 
Rec from 2SW (r=O.71. p<O.OO I), 80%P (r=O.S2, p<O.OS) and Max 
(r=O.58, p<O.OI). These data suggest that EPOC is elevated in HF 
and is associated with increased fatigue after exercise at a fixed 
absolute submaximal workload and after maximal exercise. 
Differences in exertional dyspnea and fatigue between HF and NL 
are more marked during recovery than during exercise. 
Examination of recovery from exercise may be useful in the 
clinical assessment of patienL~ with heart failure. 
830·2 10:45 
Lack of Impaired Muscle Arteriolar Vasodilation During Leg 
Submaximal Exercise in Patients with Congestive Heart Failure. 
Richard Isnard, Philippe Lechat, Michel Komajda, Anna Kalotka, 
Hafida Chikr, Serge Fitoussi*, Yves Grosgogeat, Daniel Thomas, 
Hopital Pitie.SaIpemere and Therapharm*, Paris, France. 
Impaired muscle arteriolar vasodilation might contn'bute to 
exercise intolerance but remains controversial in congestive heart 
failure (CHF). We studied leg arterial blood flow (LBF) in the 
superficial femoral artery using a transcutaneous 7.5 MHz 
2D/doppler transducer system in 30 patients with CHF (pts) and in 
12 age-matched nonna1s (N). Arterial diameter (AD) and flow 
velocity integral were measured at rest and immediately afIer 
increasing levels of submaximal supine bicycle exercise (Ex) 
perfonned till 66 % of a previous upright maxima1 exercise. 
AD was not significantly different at rest and did not change 
significantly during Ex in both groups. At rest, LBF was lower 
(0.29±O.14 vs 0.45±O.14 llmin, p<O.OI) and leg vascular resistance 
(LVR) was higher (407±186 vs 247±7l mmHg/lImin, p<O.Ol) in 
pts than in N. Pts reached a lower suhmaximalload than N (57±18 
vs 118±28 watts, p<O.OOI). Despite a lower increase of LBF 
during Ex (1.9±1 vs 3.9±1.4 llmin, p<O.OOI), the decrease ofL VR 
was higher in pts than in N ( 334±177 vs 216±70 mmHg/lImin, 
p<O.OS). Moreover, even though the ratio of increase in LBF to 
load is identical in both groups (0.031±O.01 vs 0.034±O.01 
llmin1watts), the ratio of decrease in L VR to load is markely higher 
in pts (5.9±3.3 vs 1.9±O.94 mmHg/lIminlwatts, p<O.OOl). In 
addition, a close correlation between rest L VR and L VR decrease 
during Ex was found in pts and N (r=0.96 and 0.98) with an 
identical slope in both groups. Therefore, the higher the L VR is at 
rest, the greater a decrease is observed during exercise. 
These results suggest that leg vasodilation response to submaxima1 
Ex is preserved in pts with eHF and is not a factor limiting 
exercise capacity. 
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830·3 11:00 
The Skeletal Muscle Ergoreceptor Contribution to 
the Ventilatory Response to Exercise Is Enhanced In 
Patients with Chronic Heart Failure 
"#Massimo Piepoli. "Maurizio Volterrani, "Andrew Clark, 
#Peter Sleight, "Andrew JS Coats. "Cardiac Department, 
National Heart & Lung Institute. London, and Cardiovascular 
Medicine, John Radcliffe Hospital, Oxford, UK. 
The ventilatory response to exercise is increased in chronic 
heart failure (CHF). Whether the responses to exercise of 
skeletal muscle ergoreceptors (nerve afferents sensitive to 
skeletal muscle work) are increased is controversial. The 
ergoreflex role in control of ventilation was measured in 12 
CHF patients (59.6i5 yrs, NYHA class 11·111, EF=27%) and 10 
age·matched normal controls during dynamic handgrip 
exercise (40 times/min, 50% of maximal exercise capacity, till 
exhaustion) and during a 3 min period of posthandgrip 
regional circulatory arrest (PH·RCA) (Mark et ai, 1985, Cire. 
Res. 57, 461). We quantified the ergoreflex contribution, as 
the percentage of the exercise ventilatory response which is 
maintained by PH·RCA, compared to recovery without RCA. 
The ergoreflex-dependent component of the ventilatory 
response was greater in CHF patients than controls (45.3±5% 
respect to 25.2i2%, p<0.02). The absolute ventilatory 
response attributable to the muscle ergoreflex was also 
greater in CHF patients (3.3±2 respect to 1.8±1 I/min, p<0.05). 
The difference in the ergoreflex component could not be 
explained by any difference in C02 production, 02 
consumption, arterial blood gases or arterial potassium 
(p=NS, for all comparisons). We conclude that there is an 
enhancement of the muscle ergoreflex role in the ventilatory 
response to exercise in CHF. This may help to explain why 
the muscle abnormalities in CHF could cause both fatigue 
and exaggerated ventilatory response. 
830·4 11:15 
Cardlomyoplasty: Effect of Latissimus DorSi Muscle 
Contraction on Exercise Capacity 
"Guillaume Jondeau, lIRichard Dorent, "Rachid Benzidia, 
lIValeria Bors, "Olivier Dubourg, lIFrederique Jault, 1I1radj 
Gandjbakhch, 'Jean-Pierre Bourdarias. "A Pare, 92100 
Boulogne, France; lIPitie Salpetriere, Paris, France. 
In 7 patients (pts) , we measured oxygen consumption (V02, 
mlhnin), C02 release (VC02), heart rate (HR, bhnin) and 
blood pressure (BP, mmHg), during maximal exercise 
(bicycle, 12.5 Watts 12 min), when the Latissimus Dorsi 
muscle was stimulated every other systole (on), and after 
stimulation had been stopped for at least one hour (off). All the 
pts had been operated on more than 6 months earlier, and 
reported symptomatic improvement. Ventilatory threshold (AT) 
was determined as the time when the ratip V02lventiiation 
started to increase continuously. In addition, respiratory 
exchange ratio (RER), and oxygen pulse m02, mlhnin2) were 
calculated. 
AT on AT oft P peak on .,.akoft P 
sBP 124:t17 126:1:14 NS 134:t30 131:1:28 NS 
HR 119±7 118:1:13 NS 14O:t13 139±21 NS 
Watt 6O:t12 65:i:17 NS 113:1:32 114:t27 NS 
V02 1004:1:204 1049:1:259 NS 1540±479 1576±384 NS 
RER O.93±O.06 O.95:tO.05 NS 1.14:1:0.06 1.16:1:0.09 NS 
n02 8.4:1:2.7 8.9:1:2.3 NS 10.9±2.8 11.3:1:2.4 NS 
P: on versus off, paired t test. 
We conclude that acutely stopping Latissimus Dorsi muscle 
contraction does not modify peak V02. This suggests that 
either systOlic function was not improved by Latissimus Dorsi 
muscle contraction during exercise or exercise was limited by 
an extra cardiac factor, as observed in congestive heart failure 
patients. 
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LcIIq-'l'em 'l'bEapy With ~ allIS ~lol But 
!lot DipiD ~ the Pm;reaSiw DeanUe in the 
PropartiaD of 'l'ype-I 8Uletal JUcl.e I'ilIera in Dogs 
With IIr:IGIa:ate a.rt J'ailure 
Han! N. Satilah, Hisashi Shimyama, Victor G. Sharov, 
Michael Issch, T. Barry Levine, Sidney Goldstein. 
Henry Ford Heart an:i Vascular Institute, Detroit, MI 
Heart failure (HF) is associated with a progressive 
decrease in the prqatia'l of aerobic Type-I skeletal 
DUSCle (91) fibers. In the present study, we exzIIIIine1 
the effects of early therapy with enalapril (ENA), 
IIIIi!t:qlrOlol (MEr) an:i digoxin (DIG) a'I 9f fiber type 
CXIlpC6itia'l in 24 dogs with moderate HF produced bj 
IIIlltiple intracara'lary mic:roE!lllbolizatia'lS (EMS). EMS 
were discx:rltiraled 1I41en LV EF was 30-40\. '1hree weeks 
later, dogs were rankmized to 3 matths therapy with 
ENA (10 JIg BID, n=6), MEl' (25 JIg BID, n=6), DIG (0.25 
JIg cp, n=6) or to no therapy (Centrol, n=6). Triceps 
9f biopsies were obtained at baseline, prior to artj 
EMS an:i repeated before initia~ therapy (PRE) ani 
after 3 matths of therapy (rosT) • 9f fiber types 
(Type-I an:i Type-II) were delineated hist:ochemi.cally 
based a'I ATPase content (pH 9.4). Q\an:Jes in the 
prqxlItia'l (% of total) of 9f Type-I fibers are smrm. 
Baseline PRE=lberapy POST-'Iherapy 
Centrol 
ENA 
33±1 27±3 23±1 * 
33±4 29;±4 33±4 
MEl' 32±1 28±2 3o.±l 
DIG 38+3 3m 26-+4 * 
[*=P<0.02, repeated measure AN'JIlA] 
In untreated dogs ani dogs treated with DIG, the 
prcp:n.-tia'l of 9f Type-I fibers decreased 
progressively; whereas therapy with ENA ani MEl' 
prevented this decline. OJrx:lusion: Early therapy with 
ENA or MEl' rut not DIG maintains 9f fiber type 
CXIlpC6itia'l in dogs with moderate HF. 
830·6 11:45 
Improved Physical Performance in Congestive Heart Failure (CHF) by 
One·leg Endurance Compared to One-leg Strength Training 
Allan Gordon, lennar! Kaijser, Gi Magnusson, Bengt Saltin, Christer 
Sylvan, Karolinska Institute at Dept of Physiology lIT and at Dept of 
Medicine, Huddinge University Hospital, Sweden 
Aims of study: To determine effects of exercise training in patients with 
congestive heart failure with exercise-models which are not limited by 
circulatory capacity. How much is endurance and strength increased after 
one·leg or endurance or strength training? 
~: Twelve patients with CHF (aged 42-69 years, EF 5-45%) were 
randomised to two different training protocols during 8 weeks. . 
~: One leg quadriceps strength training 3-10 contractions at 80% of 
max strength during 4 periods with one min rest intermission. The other 
leg was not trained and used as control. 
~: Knee extension endurance training of one leg during 15 min at 
55-65% of V02 max of one-leg kick. The other leg trained both endurance 
and strength. 
~: The two groups were comparable at start of study. After 8 weeks 
train!ng ~F and maximal oxygen uptake were not changed. Strength 
tralOing Increased strength by 45% (p<0.01) and in the non-trained leg by 
20% (p<o.o2). Endurance was moderately Increased in both legs. Only 
endurance training led to an increase in strength which was lower but not 
significantly different from only strength training. One leg endurance was 
increased 47% (p<0.OO2) and two leg endurance increased 23% (p<0.01). 
When endurance training was combined with strength training no further 
Significant improvement occurred. 
Conclusion: One-leg endurance training appears superior to one-leg 
strength training in patients with CHF. Both types of one-leg training that 
are in most cases not limited by central circulation are at least as efficient 
as former examined training models with 2-leg training. 
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Low Pmm- Red Laser Upt IDhlblts Smooth Muscle Cell ProUferation Following 
Balloon AogloplU1y. 
Nicholas Kipshidze, Hany Sabota, Richard A. Komorowski, Lawrence E. 
Bocrboom, Michael H. Keelan, John E. Baker. Depts. of Cardiology, Pathology 
and Cardiothoracic Surgery, Medical College of WIsconsin, Milwaukee, WI. 
The impact of low power (cold) Helium-Neon laser light (632 nm,1.1 J/cm') 
treatment at the time of balloon angioplasry upon vascular smooth muscle cell 
proliferation was investigated in rabbit abdominal aortas. RabbilS (n-6/group) 
were divided equally among treatments: mnImI-no balloon inflation or laser 
illumination, balloon jnfJatjon-three ~Ies of inflation to 8 atm for 30 sec each 
and one ~le to 8 atm for 90 sec, balloon inflation plus laser illumination•
consisting of balloon inflation followed by transIuminai illumination for 60 min. 
Animals received a diet supplemented with 2% cholesterol for 15, 30 and 60 days 
following treatment. Vessels were fixed in vivo at harvest with 10% fonna!in at 
80 mm Hg, processed and stained with hematoxylin and eosin, Movat's and for 
PCNA. The area in em' of the lumen, intima and media were then detennined 
by computer planimeny on photomicrographs of vessel cross sections. Data shown 
are mean area ± SD at 60 days. 
Control Balloon 
inflation alone 
Lumen 33.9 ± 2.7 
Intima 6.2 ± 0.5 
Media 14.4 ± 2.9 
Intima/Media 0.4 ± 0.02 
a .. p < 0.05, balloon inflation vs control 
b = P < 0.05, balloon plus laser vs balloon 
8.9 ± 0.9' 
26.4 ± 28' 
12.7 ± 3.1 
2.1 ± 0.29' 
Balloon plus 
laser 
35.4 ± 5.4b 
4.2 ± 0.1' 
12.4 ± 2.9 
0.3 ± O.o2b 
In the laser plus balloon group histological examination revealed no evidence 
of intimal smooth muscle cell proliferation using PCNA or inflammatory cell 
infiltration. Medial necrosis in the laser plus balloon group was greater than in 
the balloon group. Elastic fibers in the vessel wall of laser plus balloon group 
were straightened. We conclude low power red laser light inhibited neointimal 
smooth muscle cell proliferation following balloon angioplasty for up to 60 days. 
831·2 10:45 
Low Dose, Sub-ablative Ultraviolet (UV -C) Laser Irradiation from 
a Q-switched, Frequency·quadrupled Nd:YLF Diode Laser Inhibits 
Neointimal Hyperplasia in Balloon.injured Rat Carotid Arteries 
Christopher J. Pastore, *Stephen T. Dejesus, §Robert A. Van Tassel, 
§David R. Ho~es, §R?bert S: Schwartz, *Richard H. Clarke, Jeffrey 
M. I~ner, St. Ehzabeth s Medical C.enter, Thfts University School of 
Medicll;te, Bost~n, MA, §Mayo Cliruc, ROChester, MN, *Angiomedics, 
Inc., Minneapolis, MN 
Previous attempts to employ ultraviolet (UV) laser irradiation (LI) in 
the treatment of vascular disorders have used ablative doses of UV-B 
(290-320nrn) ~l to deb~lk. atherosclerotic plaque, attempting to 
reduce restenoslS by achievmg a more definitive primary result. In 
contrast, the ~nt study extended previous work demonstrating that 
low-(sub-ablative) doses of UV-C «290nrn) LI was cytotoxic to 
cultured vascular smooth muscle (VSM) cells; such LI could be 
applied immediately post-revascularization to preempt VSM cell 
proliferatIOn. Accordingly, immediately following balloon-injury (BI) 
?f the rat common c~otid artery, the Bl-arterial segment was 
uradlated for 5 mm With ultra-sub-ablative (IOmW or 2j!J/pulse x 
5kHz) doses of UV -C (262nrn) light from a Q-switched, frequency•
quadrupled Nd:YLF diode laser, transmitted via a 2001Jlll optical fiber. 
Controls receiv7d BI but no LI. Intimal cross-sectional area (CSA), % 
luminal narrowmg (LN), and intimal:medial area (IIM) were measured 
3 wks post-BI: 
control (n=lQ) laser (n-I]) 
CSA [mm2) O.25±O.02 O.06±O.OI p=O.OOOI 
% LN 64.03±4.35 17.87±3.64 p=O.OOOJ 
11M 2 08+0 20 043#1 II p=0 ()()O! 
Laser irradiation produced extensive medial necrosis in 411 I treated 
animals, and in these cases, CSA (0.05±O.04mm2), % LN 
(l1.32±8.34), and 11M (0.38±0.29) were even more diminutive 
(pSO.OOI vs controls for each). Neither thrombus formation nor 
disruption of the internal elastic membrane was observed. Likewise, 
!he~e was no eviden~e of systemic toxicity. Conclusion: these findings 
mdicate that apphcation of sub-ablative, low dose UV-C LI effectively 
inhibits neointimal hyperplasia in vivo. 
JACC February 1994:IA-484A 
831·3 
Effects of Endovascular Irradiation in a Swine Model of 
Restenosis after Aogioplasty 
11:00 
Ron Waksman, Keith A.Robinson, Ian RCrocker, Robin Smith, 
Gustavo D.Cipolla, Spencer B. King ill, Emory University School of 
Medicine, Atlanta, Georgia 
Ionizing radiation (R) bas been shown to suppress cellular 
proliferation and matrix synthesis in vitro. Accordingly, we studied 
the effect of R on the neointima1 proliferatjve response to vascular 
injury in swine. Eleven swine (20-25 kg) underwent overstretch 
injury with a 3.5 mm angioplasty balloon in the LAD, and LCX or 
right coronary arteries. A high energy Ir source was immediately 
introduced by random assignment into one of the injured arteries in 
each animal and allowed to dwell for a period sufficient to deliver 
100 cGy to a depth of 4 mm. Two weeks later the animals were killed 
and the coronary vasculature perfusion fixed at 110 mm Hg with 
10% buffered fonnalin. Serial sections spanning the injury site were 
stained with H&E or VVG, then evaluated by histopathologic and 
computer-assisted morphometric techniques.The maxirnaI intimal 
thickness (MIT) and intimal area (IA) were measured from each 
section. Arteries showing significant thrombosis (2) were excluded; 
Mann-Whitney rank sum test was used for comparison of groups. 
MIT, rnrn IA, rnrn2 
Control 0.45 0.69 
Irradiated 0.31 0.59 
P <0.001 <0.001 
Conclusions: A significant reduction in both MIT and IA responses 
to balloon injury was associated with R. Additionally, in two 
irradiated arteries isolated zones ofrninimal (1-2 cell layers) 
regrowth over exposed externa11arnina were seen. These results 
suggest an inhibitory effect of localized R on the coronary artery 
response to balloon injury. 
831·4 11:15 
In Situ Photo·polymerized Thin Hydrogel Barriers Applied 
Following Arterial Injury Reduce Intimal Thickening 
·Marvin 1. Slepian, Amar Sawhney, C. P. Pathak, Fred Khosravi, 
Larry Roth, Stephen P. Massia, #Jeffrey A. Hubbell, Univ of 
Arizona-Tucson V A, Tucson, AZ and fUniv of Texas, Austin, TX 
Early interactions between injured arterial sub-intima and blood 
following angioplasty are important steps leading to restenosis. 
We developed a method of in situ formation of photo-polymerized 
hydrogels on the arterial endoluminal surface capable of physically 
limiting arterial surface-blood interactions. In this study we 
examined whether application of hydrogels immediately following 
balloon injury and prior to blood re-exposure, would alter the 
subsequent development of neoinimal hyperplasia at 14 days in the 
rabbit. In 13 rabbits (3-3.8kg.) the common carotid artery was 
isolated, a segment washed free of blood, and balloon abraded (2fr 
Fogarty x3). In 7/13 rabbits blood flow was then immediately 
restored (non-coated controls). In 6113 rabbits a thin layer of 
hydrogel (poly(ethylene glycol)-lactic acid block copolymer) was 
photopolymerized intraluminally on the injured segment, following 
which blood flow was restored. No anti-platelet agents or anti•
coagulants were utilized. At 14 days rabbits were sacrificed, 
carotid arteries pressure fixed and mean intima and media area 
determined. Rl:mJ.ts;.. The mean intima/media area ratio (I/MAR) 
of control balloon abraded arteries was 1.6 ± 1.04. In abraded•
polymer coated arteries IIMAR was 0.56 ±. 0.10 (p<0.05). 
Polymer coating lead to a 63% reduction in the degree on 
neointimal hyperplasia development. There was no significant 
change in media thickness between the groups. ConclusiOn" In 
situ application of photo-polymerized thin hydrogel barrier 
coatings, capable of limiting early arterial subintirna-blood contact, 
reduces the extent of intimal thickening development at 14 days 
post injury in the rabbit. Evolution of this method may lead to a 
non-pharmacologic approach to reduce restenosis post PTCA. 
ABSTRACTS 473A 
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Local Drug Delivery and Photodynamic Therapy (PDT) in an 
ExperinentaI Restenosls Model 
Peter Gonschior, Michael Fleuchaus, Florian Gemeuser, Brigitte Mack, 
Berthold Hofling; Med. Dept.l, Klinikum GroBhadem; UniversHy of MlIlidl, 
Gennany' 
PDT might be able to prevent restenosis as H is known to be an effective 
tumor therapy of superficial cancer. Efficacy of PDT was studied in a 
porcine restenosis model using directional arteriotomy (DA). Photofrin II 
(PF; Ql T, Vancouver, Canada) was used as a photosensHizer, 
selectively endoluminal delivered and activated by adequate 
monochromatic light irradiation. Using DA, a standardized media injury 
was created. 45 arterial segments of pigs (mean weight: 30 kg) were 
studied. 22 vessel segments were removed after 7 and 21days (group 1), 
23 vessel segments received a selective application of Smg PF per 
segment. The pretreated vessel segments (group 2) were exposed to 
monochromatic light (630 nm; 100 J/cm2). 7d and 21d later all vessels were 
explanted and processed for immunohistochemistry and electron 
microscopy. 
In group 1 an intense inflammation wnh infiHration of polymorphonuclear 
leucocytes and increased prol~eration of smooth muscle cells was found. In 
cases of media lesion a myoprol~erative response led to a mean luminal 
narrowing of 50% in group 1. Vessels treated wnh PDT: After media 
lesions and consecutive PDT, no proliferative response occurred. A 
mar1<ed destruction of nuclear membranes and P deposHs in smooth muscle 
cells were seen, dependilg on the extent of lesion. These aHerations were 
only seen in vessel segments that received PDT. 
The proliferative reaction of tissue in these segments was effectively 
reduced and no luminal narrowing was seen. After selective application of 
photosensitzers, PDT led to a mar1<ed reduction of proliferation in a 
porcine restenosis model wHhout adverse effects. 
• (supported by Deutsche Forschungsgemeinschaft grant 1076/1-2) 
831·6 11:45 
Palmaz·Schatz Stent as Treatment for Refractory 
Restenosis :Retrospective Comparison with Repeat 
Balloon Angioplasty 
*Hiroyoshi Yokoi , Takeshi Kimura, Eiji Shinoda , Masakiyo Nobuyoshi 
Kokura Memorial Hospital, Kitakyushu, 802, Japan 
Refractory restenosis is B troublesome problem of balloon angioplasty 
(BA), aHhough repeat BA is generally safe and effective. To assess 
efficacy of Palmaz-Schatz stent in the management of refractory 
restenosis fOllowing BA, angiographic and clinical outcome was 
co~ared with that of repeat BA. 
The stent group consisted of 66 patients who had recurrent lesions'after 
2 or more prior BA treated by a single stent from Jun. 1991 to Sep. 
1992. Between Jan. 1985 to May 1990, 112 patients undewent repeat 
BA for recurrent lesions after 2 prior BA. Angiograms of the repeat BA 
group were reviewed by two experienced angiographers. In 64 patients 
(57°-,», stent implantation was considered to be feasible from the view 
point of vessel size and lesion length (repeat BA group). The major 
endpoints were quantitative coronary angiograms at 3-6 months and 
clinical events at lyear follow-up (FU). Restenosis was defined as 
~50% diameter stenosis at FU. 
(FU rate) 5tent(87%) BA (86%) 
Ref.Dia.(mm) 3.12±0.67 3.01±O.33 
MLD pre 0.B1±O.47 0.B2-+O.33 
MLD post 2.B3±0.36 2.01±O.35 
MLD at FU 1.B5±O.78 1.22±O.56 
Restenosis 29% 55% 
Freedom 
from 
death+MI 
+CABG 
any BA 
angina 
Stent A 
97% 96% 
79% 
87% 
58% 
73% 
P value 
NS 
NS 
0.0001 
0.0001 
0.004 
pvalue 
NS 
<0.001 
<0.001 
Conclusion:Coronary stenting as treatment for restenosis refractory to 
BA is an effective approach associated w~h a lower restenosis rate, less 
repeat BA , and less recurrent symptom. 
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Percutaneous Tl'lnslurnlnal Carotid Angloplalty • Earty Experience 
Gerald Dorms, St Luke's Medical Center, Milwaukee, WI 
Balloon angloplasty was used as a potential technique to revasrularize 
patients wHh a carotid arterial stenosis, 
Sixteen patients (PTS) (mean age 69;t6 years) underwent 21 
percutaneous transiurninal carotid angioplasty (C·PTA) procedure, The 
indications for revasrularization were recurrent, crescendo transient 
ischemic attacks (TIA's) in 8 PTS, and a severe (>90% diameter stenosis) 
clinically silent stenosis in 8 PTS, Of these, 4 lesions (3 PTS) were 
intracranial and surgically lnaccessble, and 4 were restenosed intemal 
carotid lesions (3 PTS) at the site of prior endarterectomy, Lesions were 
located in the Intemal carotid (16), middle cerebral (3), and common carotid 
(2), C-PTA was successfully performed in all PTS with the diameter 
stenoSiS reduced from 84+ 11 % to 23+ 11 %, Intraprocedural complications 
included bradycardia duri~ balloon iiiilation (5 PTS) which were managed 
with temporary pacing, and 1 intimal dissection which resuHed in reduced 
flow (TIMI I) and was managed successfully wHh stent deployment, Post 
procedural neurologic deficits occurred in 3 PTS, 2 TIA's (resolved within 
4 hours) and 1 localized transient upper extremity weakness (resolved in 
36 hours), No patient had a residual neurologic deficit upon discharge, At 
followup (mean time 22 months) 13 PTS remained asymptomatic (3 PTS 
had restenosed as determined by carotid duplex scan with 1 PT having a 
2nd successful C-PTA), 1 PT had a cerebral vasrular accident 16 months 
post C-PTA, presumably from the contralateral side, and 2 PTS had died, 
(1 from an M I 3 months post C-PT A, and 1 from a subarachnoid 
hemorrhage 6 months post C-PTA), 
This pilot study indicates that C-PT A can be performed with exceHent 
initial success and few Immediate serious complications, However, a larger 
study roost assess different C-PTA techniques, the incidence of 
neurological complications and mortality, as well as evaluate C-PTA's 
effectiveness on relieving symptoms, prevention of subsequent ipsilateral 
neurologic events, and survival as compared with surgical endarterectomy, 
832·2 
Treatment of Severe PuImooary Embolism by means of I Higb 
S~ Rotational Catheter ( Angiocor Tbrombolizer ): Fint 
Experience of Mechanical Thrombolysis in Human Beings. 
"Dievart F., .... Foutrier I.L, "·Lefebvre I.M., ·Ev~ S., 
Qui1liet L, Gomez J., *Clinique Villette, Duokerque- France, 
**clinique Ia Louvim'e, Li1Ie-Frmce. 
The Angiocor Rotational Thrombolizer ( ART ), I DeW 
device already successfully IeSted in 1IOimaIs, was UBed in 15 
patients with a severe acute pulmonary embolism ( PE ). 
The ART is I 5 Fnocb teflon catheter wbooe distal tip is split 
into four 15 mm bends. It is positiooned via I 8 Fnocb guiding 
catheter over a flexible guide wire. The high rotation ( 100 000 
rpm ) uses the effect of ceotrifugaI force to open the distal strips, 
.00 form a soft flexible helix spiral able to pulverize _t clots 
into microscopic particles in a few seconds. 
All patients in this study pre&eoIed a life threattning PE with 
acute cor pulmonale and I contraindication to or m inefficiency 
of systemic or local chemical thrombolysis. In aD cases, large 
thrombi were detected in the proximal part of the main pulmonary 
uteries. 
In aD pts, ART WlS easily positiOODed into the pulmonary 
arteries md a bigh speed rotation was obIained without my pain 
felt by the patient Angiography was performed during the ART 
advancement through the clot. In aD ~ a partiaJ or totaI clot 
lysis was documented. 
No complication occured ( DO perforU:ion, no death during or 
after the procedure in the bospita1ization period ). 
13115 patients were clinically improved 6 bours after the 
procedure. For IIlOOI of the patients, pulmooary pressure ( US or 
Swan~ catheter ) decreased near the normal rIDge. In some 
patients, after a rapid decreue of pulmonary pressure, a 1ater 
decreue to normal rIDge was observed only after I or 2 weeks ( 
US ). For aD patients there was a better arterial bypoxemia soon 
after the procedure. 
This preliminary results revealed I possible safe IUd efficient 
way of treating severe pulmonary embolism in buman beings with 
contraindication or inefficiency of cbemical thrombolysis. 
10:45 
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832·3 11:00 
Renal Artery Stent Placement 
Christopher J. White, Stephen R. Ramee, Tyrone J. Collins, Arun K. 
Karsan, Alvaro Escobar, Ochsner Oinie. New Orleans, LA 
A total of 45 balloon expandable. non-articulated, stainless steel 
Palmaz stents were successfully placed in 40renai arteries of32 patients 
(P) undergoing angioplasty for treatment of hypenension (n = 26) or 
chronic renal insufficiency (n = 6). Indications for stent placement 
included de novo ostial lesions (n=3O) or after a suboptimal angioplasty 
rcsult (dissection or residual stenosis> 50%. n=IO). Eight P received 
bilateral renal artery stents. The blood pressure response at a mean 
follow-up of 4.l±2.5 months in the 26 P with hypertension is shown 
below. 
200 
ISO 
100 
.Baseline 0 Follow-up 
SO 
0 ................ -';:'"---'---
Syst Dias Mean 
The minimum diameterforalliesions increased from 1.2 mmiO.63 
to 5.0mmiO.82 (p <0.001) afterstent placement In the 6 Ptreated for 
renal insufficiency the mean creatinine fell from 3.l±3.7 to 2.7±3.l (p 
= 0.09) with improvement in creatinine < 1.5 seen in 2 P (33%). 
Complete angiographic follow-up is scheduled at 6 months for all 
patients. Complications included death (n= 1), abrupt occlusion (n= 1), 
contraSt nephropathy (n=I), bleeding (n=2), and vascular access com•
plications (n=3). 
In conclusion, stent placement is an atttactive percutaneous alterna•
tive to surgical revascularization in patients with ostial renal artery 
stenosis and following suboptimal renal angioplasty. Renal artery 
stenting was an effective treatment for hypenension, while only a 
minority of patients with renal insufficiency improved. 
832·4 
Preliminary Patency Experience with Renal Artery Stents for 
Atherosclerotic Renal Artery Stenoses 
J. Michael Bacharach, Mary Beth Childs, Jeffrey W. Olin, 
Robert A, Graor 
Cleveland CRnie Foundation, Cleveland, OH. 
11:15 
We report our preiminary patency experience and follow-up with renal 
artery stenting for proximal and nstial atherosclerotic lesions. Over a 22-
month period 54 renal artery stents were placed in 47 patients, 
Indications for intervention included preservation of renal function, and/or 
hypertension that could not be adequately controlled with medication, 
Technical success as defined by normalization of angiographic 
appearance of the renal artery and no residual pressure gradient was 
achieved in 52 of 54 stents (96%). Post procedure, patients were 
followed for cinical response including hypertension and serum 
creatinine and were monitored with serial duplex ultrasound, Routine 
angiographic follow-up was performed to assess renal artery patency, 
Angiographic follow-up is available for 22 patients with a range of 2 to 18 
months, Six-month angiographic follow-up is complete for 17 patients, 
comprising 19 renal artery stents. Patency, as defined as luminal 
diameters? to 50% of post placement diameter was observed in 16 of 
19 (84%) stented renal arteries. There was 1 major complication 
secondary to atheroemboli. There were no acute renal artery 
occlusions, major surgeries or deaths. 
Conclusion: Due to the high restenosis rate after renal artery balloon 
angioplasty for proximal and nstial atherosclerotic lesions, and the 
potential morbidity and prolonged recovery period aSSOciated with 
surgical revascularization, renal artary stenting represents an attractive 
altemative in treating patients with atherosclerotic renal artery stenoses, 
Our data shows that renal artery stenting can be achieVed with a high 
degree of technical success and patency at 6 months, 
JACC February 1994:1A-484A 
832·5 11:30 
Limitations of Diae Anlliography in Identifying Hemodynamiea\1y 
Significant Lesions: Comparison of Quantitative Angiography, 
Intravascular Ultrasound and Intra. Arterial Pressure Gradients 
Recorded During Diac Artery Revascnlarlzatlon. 
"Robert SdlaiDfeld, Kenoetb Rosenfield, Ann Pieczek, Jeonifer Kaufman, Jeffrey 
M. IsDer Sl Elizabeth's Mcdieal Center, Boston, MA 
To assess !be adjUDClive role of intravascular ultrasound (IVUS) and intra-arterial 
(IA) pressure monitoring (PM) dming pcreutaneous revascularization (PR), we 
perfonned quantitative angiography (QA), IVUS and IA PM on 78 iliac arteries in 
69 patients uudergoing PR for symptomalic peripheral arterial disease (PAD) 
(Rotherford Class :<! 3). Percent luminal diameter and cross·sectional area (CSA) 
narrowing were measured by QA and IVUS, respectively. Mean transstenotic 
gradient pre- and post·PTA was obtained at baseline BOd following 300mcg. of IA 
NTG. Results are as follows: 
QA (%diameter oanowin ) 
IVUS (CSA, mm~) 
Mean Gradient (mm.Hg.) 
Thigb:BIlIChiaI Index 
Pre 
(M±SEMI 
56.4 ± 2.2 
13.2 ± 1.1 
15.0 ± 1.3 
0.74 ± 0.02 
Post 
(M±SEMI 
17.0 ± 1.8 
30.6 ± 1.5 
3.0 ± 0.5 
0.86 ± 0.03 
1!5 
0.0001 
0.0001 
0.0001 
0.0001 
Despite significant symptoms ~Rutberford Class 3), 38n8 (49'll) of vessels 
appeared <50% narrowed by QA. In cootrast, 38/38 (lOO%) of these same vessels 
demonstrated :<!75% CSA stenosis by lVUS, and 36/38 (95%) exhibited 
significant mean transsteootic gradient at rest (> IOmm.Hg.) or after NTG (> 15% 
augmentation in gradient). Percutaneous revascuJarization (PTA ± SleDt) resulted 
in a Significant increase in lomen CSA by IVUS in 78n8 (lOO%) of vessels, 
including the 38 with <50% stenosis by QA. Likewise, in the 38 patients with 
<50% stenosis by QA, traDSstenotic mean gradient improved from 12 to 3. At 
follow·up to 24 months (M=13 months), ankIe:bracbial indices improved from 
0.62 to 0.80 and 34/38 (89'll) improved to Rutherford Class 0-1. Conclusions: 
(l) In symptomatic patients with PAD, QA may underestimate degree of luminal 
compromise. (2) lVUS and IA PM identify anatomically and hemodynamically 
significant lesions which, though appeared <50% narrowed by angiography, 
improved Clinically and hemodynamically after revascularization. (3) The 
limitations of QA imply a role for IVUS and IA PM as adjunctive modalities for 
evaluation of iliac disease during PRo 
832·6 11:45 
Warfarin Monitoring - Evaluation of the Reproducibility of 
Fingerstick INR Determinations and Comparison with 
Values Obtained with Recombinant Thromboplastins. 
Alan K. Jacobson, Chandra Hart, Morrill T. Moorehead, Carol 
Tocco, J. Thomas Heywood. Loma Linda Veterans 
Administration Medical Center, Loma Linda, CA 
The reliability and reproducibility of the Prothrombin Time (PT) 
and the Intemational Normalized Ratio (INR) by fingerstick 
determination (Ciba·Coming Biotrack 512) has been 
questioned. As a quality assurance project, we evaluated 50 
patients from our anticoagulation clinic to compare fingerstick 
INR values with those obtained by routine laboratory 
determinations utilizing the newer recombinant thromboplastins 
(Dade, Organon, Ortho). Right hand and left hand fingersticks 
were performed and a venipunture sample was obtained with a 
portion of the whole blood sample being evaluated on a 
fingerstick cartridge and the remainder of the sample evaluated 
with routine thromboplastin methodology in the clinical lab. 
Results: We performed comparisons of right hand fingerstick 
(RHF) vs. left hand fingerstick (LHF) INRs, averaged right & left 
hand fingerstick (aR&LF) vs. whole blood (WB) placed on a 
fingerstick cartridge, and the average of all three fingerstick 
cartridge (aF) values vs. the average of three recombinant 
thromboplastins (aRT) run in the laboratory with standard 
methodology. The regression equations were: 
LHF = 0.258 + 0.89 RHF ; R2 = 0.956 
WB = ·0.216 + 1.075 aL&RF; R2 = 0.962 
aRT = ·0.551 + 1.121 aF; R2 = 0.92 
Conclusion: INR values obtained by fingerstick 
methodologies are reproducible and give good correlation with 
INR values obtained by traditional methodologies utilizing the 
newer recombinant thromboplastins. 
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Assessment of Myocardial Viability by Tc·99m Tetrofosmin in a 
Canine Model of Coronary Occlusion and Reperfusion 
David K. Glover, Mirta Ruiz, Terry R. Allen, Bruce A. Kaplan, 
Vladimir Kryzhanovski, William H. Smith, Denny D. Watson, 
*George A. Beller, University of Virginia, Charlottesville, V A 
We have previously shown that Tc-99m Tetrofosmin (fc·T) uptake, 
like Tl-201 (fl), reflects viability in predominantly salvaged 
myocardium when administered 90 min after reperfusion (RP) 
preceded by 60 min of LAD occlusion (OCC). The goal of this study 
was to compare Tc·T with Tl uptake with more prolonged LAD OCC 
(3 hrs) followed by RP (n=6 dogs). After 90 min of RP, Tc·T (10 
mCi) and TI (I mCi) were injected and dogs killed 15 min later. 
Quantitative imaging of heart slices was perfonned and regional blood 
flow (microspheres) and transmural (TM) tracer activities were 
detennined by well counting. Infarct size averaged 29±6% of the 
LAD risk area. TM flow and tracer activity ratios (ischemic(I) 
/nonischemic(NI)) from regions grouped by the severity of endocardial 
OCC flow (* P ~ 0.01) are shown: 
Nonnal(>60%NI) Moderate(30-60%NI) 
Flow 0.98±0.01 1.J±0.07 
Tc·T 0.99±0.02 0.85±0.02* 
TI 0.97±0.01 0.85±0.04* 
Severe( <30%NI) 
1.2±O.l 
0.65±0.05* 
0.68±0.06* 
Within each of the 3 regions, Tc·T and TI activities were comparable 
and were significantly less than RP flow. In addition, there was a 
graded reduction in uptake of both tracers from nonnal to severe 
regions. Defect magnitudes (I/N count ratios) were similar for Tc· T 
(0.61 ±O.l) and TI (0.65±O.l). Thus, these data show that, in this 
model of prolonged OCC with total RP, Tc·T and TI uptake are 
comparable; both tracers reflect myocardial viability and not 
reperfusion flow. 
833·2 10:45 
""'Tc-Teboroxime ScIntigraphy for the Early Diagnosis of Coronary 
Reperfusion During Thrombolytic Therapy for Acute Myocardial 
Infarction 
Jean Gregoire, Felix perez·ViIla, Pierre Theroux, Montreal, Canada 
To try to detect early and noninvasively coronary reperfusion 
following thrombolytic therapy (IT), we studied 21 pts admitted with an 
acute myocardial infarction (AMI) using .... Tc·teboroxime imaging. In 
13 pts, a .... Tc·teboroxime study was perfonned in the emergency room 
(ER) within 30 min of the onset of the IT (mean: 17± 10 min). All pts 
had serial .... Tc·teboroxime scans performed between each dye injection 
of a coronary angiogram obtained between 90 and 120 min after the onset 
of the IT. Planar scintigraphies were acquired 2 min after .... Tc· 
teboroxime injection for 2-3 min each. The incidence was chosen to best 
optimize the perfusion defect based on the infarct site on ECG. All 
scintigraphies were reviewed blinded to all data except for the AMI site 
on the ECG. Uptake in the involved area was determined to be present 
or not and a defect/normal wall count ratio (R) calculated. 
On the initial study in the ER, uptake in the involved myocardial wall 
was present in 5 pts (R= 1.0±0.3) and absent in 8 (R=0.4±0.3, 
p<O.OI). On the last study (TIMI flow ~ 2), the ratio did not change 
in the fonner group (R= 1.0±0.2) but improved significantly in the latter 
(0. 8± 0.5, P < 0.05). The first coronary dye injection showed a TIMI· 3 
flow in II pts, TIMI-2 in 6, TIMI·I in I, and TIMI-O in 3. -rc· 
teboroxime uptake was present in all TIMI-3 flow pts and 4 of 6 TIMI-2 
pts, but absent in all TIMI-O pts with respective R values of 1.01 ±0.34, 
0.56±0.27 (p<0.01), and 0.38±0.36 (p=0.05 vs TIMI-3). 
Thus, .... Tc·teboroxime planar imaging could rapidly detect 
noninvasively coronary recanalization following IT in patients with AMI. 
The more variable results with TIMI-2 are consistent with the less 
predictable outcome of these patients. 
476A ABSTRACTS 
833·3 11:00 
Correlations Between Isonitrile Uptake Defects and 
Myocardial Viability Vary in Myocardial regions: Results 
of a Comparison with Positron Emission Tomography 
Juergen vom Dahl, Carsten Altehoefer, Maik Biedermann, Udalrich 
Buell, Peter Hanrath, University of Aachen, Germany 
Previous studies comparing resting Tl-201 SPECT and PET with F-18 
fluoro-deoxyglucose (FOG) revealed regional differences of the rela•
tionship between both tracers uptake. To study the regional relation•
ship between defects in SPECT at rest with Tc-99m isonitriles (MIBI) 
and FDG uptake by PET, a semiquantitative comparison was perfor•
med in III patients with coronary artery disease (98 male, 58±9 
years, 87% with previous myocardial infarction). Tracer uptake was 
analyzed for 13 left ventricular segments within dermed coronary arte•
ry distribution territories. MIBI and FOG uptake was normalized to the 
segment with highest MmI uptake and expressed as %. FDG uptake 
>70% was defined as preserved myocardial viability. The correlation 
between MmI and FOG uptake and the tissue characterization by FOG 
PET are summarized for the territories of the left anterior descendent 
(LAD), the left circumflex (LCx), and the ri ~t coronary artery (RCA)' 
MIBI uptake % < 3U 31·5U 51·7U > 7U r 
LAD (n) 49 130 222 265 
FDG viable (% of n) 6% 15% 47% 88% 0.69 
LLx (~) I J2 96 204 
FDG viable (% of n) - 19% 59% 94% 0.56 
RCA (!I). 7 32~~** 7~~~* 13J FDG viable (% of n) 29%* 92% 0.49 
* p<U.05, ** p<O.OI vs. L ill territo ry 
In the LAD territory was a moderate correlation between MIBI and 
FDG uptake. In the RCA territory were considerably more segments 
with significantly reduced MmI (:5 50%) uptake but preserved glucose 
metabolism as compared to the LAD territory, whereas higher MmI 
uptake in the RCA and LCx territory correlated to high FDG values. 
This may rather reflect attenuation artifacts for MIBI SPECT than true 
differences in viability between the different regions. These regional 
inhomogeneities have to be considered if using the severity of a MIBI 
defect as indirect marker of tissue viability. 
833·4 11:15 
Technetium·99m Sestamibi Distinguishes Stunned From Infarcted 
Myocardium and Predicts 6 Week Left Ventricular Ejection Fraction After 
Acute Myocardial Infarction. 
Michael J. Gitter, Timothy F. Christian, "Raymond J. Gibbons, Mayo Clinic, 
Rochester, MN 
The ability to predict late ejection fraction (EF) is difficult early after 
myocardial infarction (MI) due to the presence of stunning and 
compensatory hyperkinesia. The purpose of this study was to prospectively 
predict the change in EF between discharge (d/c) and 6 weeks (wks) based 
on pre-discharge technetium-99m sestarnibi defect size using a regression 
equation previously published from our laboratory (Christian, J Am Coll 
Cardiol 16:1632, 1990). We studied 84 consecutive patients (pts) with MI 
who were not induded in our earlier study and had no cardiac events 
between dlc and 6 wk follow-up. Tomographic acquiSition was performed 
prior to dlc using 20 to 30 mO of Tc-99m sestarnibi with quantitation of 
infarct size using a previously published threshold method. Radionudide 
ventriculography was performed at dlc and 6 wks later. 
There was no overall group difference in EF between d I c and 6 wks 
(p=O.54); however 12 pts (14%) had a marked increase in EF (~.08) from 
die to 6 wks, and 14 pts (17%) had a marked decrease (S-O.08). Based on the 
regression equation of infarct size with EF, we identified pts with a die EF 
that was inappropriately low (STUNNED), appropriate (INFARCT), or 
inappropriately high (HYPERKIN) for their die infarct size: 
Group .!!. Infarct Size "EF at 6 £ 
(%LV) weeks dLc vs. 6 wk EF 
STUNNED 21 13±16 i.06±.08 <0.001 
INFARCT 45 13±15 0±.06 NS 
HYPERKIN 15 14±14 ,l..06±.06 <0.001 
CONCLUSION: A disparity between EF and Tc-99m sestamibi infarct size 
at discharge 1) identifies pts with stunning and compensatory hyperkinesia, 
and (2) predicts subsequent changes in EF between die and 6 wks. 
lACC February 1994:1A-484A 
833·5 
Dlpyrid ...... 1e lbaWum·201 ScIDtigrapby ill ucompUcated AMI t .... ted by 
lbrumbolysll : Diagnostic ad I'ropMtlc value. 
11:30 
Maurizio D'Urbono, Francesco Cafiero, ·Fabio CammdIi, Salvatore RonwIo. Divisione 
di Canliologia e • Senizio di McdiciDa Nucleare-Ospcdale di Legnano -Italy 
To ...... the diagnostic IIId propostic value of Dipyridamole ThalIiIDll-201 
acintigraphy (D-Th) in the' thrcBnbolytic era' we studied 110 c:onsec:utive patients (pts) 
younger than 75 recovering from lint UIICOIIIplicated AMI treated by thrombolytic 
agents. Non-Q wave AMI were excluded. All pts IJIIderwent D-Th wilb stBndard dose 
IIId conmary lllSiography before discharge (10-20 days). 96 pts underwent exercise test. 
All pts were followed-up for 22 ,., 9 months. Perfusion abnormalities were classified as 
reversible (totally or partially) defec:ts (RD) or persistent defec:ts (PO) and within or 
outside the infarct zone. S8 pts cieveloped anterior AMI, S2 inferior AMI. Coronary 
lllSiography showed single vessel c:orooary artery disease in 66 pts, multivessel disease 
in 34, nonnal coronary arteries or sub-critical stenosis in 10. 62 pts bad RO at ThallilDll 
scanning (34 within the infarct zone, 21 within IIId outside the infarct zone, 7 outside~, 
38 pts bad PO; 10 pts had nonnal acintigraphic paIIem. The diagnostic value of 
bomozonal perfusion RO for identiJYing a patent infarct-related vessel Wll._ poor 
(sensitivity 69.""" specificity 64.70/.). The diagnostic values of RO improved in 
detecting patent infarct-related artery wilb residual critical stenosis (sensibility 7S.4%, 
specificity 77.3%); in all the false positive cases (RD within the infarct zone and 
occluded infarct-related artery) a good coUateral flow was present. The sensitivity ofRO 
outside the infarct zone in detecting multivessel disease was 64.7% vs 56.3% of exercise 
test; the specificity was 92% vs 64%; the positive predictive value 78.6% vs 44%; the 
negative predictive value 85.3% vs 74.5%. During Ibe follow-up 2 deaths, 7 recurrent 
myocardial infarction , I sustained ventricular lal:hycardia, I heart failure and 13 
recurrence of unstable angina occurred among pts wilb reversible defec:ts (eilber within 
or outside the infarct zone) at Thallium scanning. I recurrent myocardial infarction and 4 
recurrence of unstable angina occurred among pts wilb persistent defec:ts or nonnal 
acintigruphy pall<:m (p<Xl,OOI). Ischemic events occurred wilb simi1ar frequency in pts 
wilb reversible perfusion defec:ts within and outside the infarct zone (41% vs 35.6%). 
CONCLUSIONS: D-Th performed after UIICOIIIplicated myocardial infarction treated by 
thrombolytic agents has good diagnostic value in identiJYing viable jeopardized 
myocardium within Ibe infarct zone perfused by patent but critically JWTOWed vessel; it 
shows better diagnostic 8CCUI8CJ' in detecting multivessel disease than exercise test; it is 
able to identifY. subset of pts at risk for future ischemic events after thrombolysis. 
833·6 11:45 
Dual Thallium • Fatty Acid SPECT and Prediction of Left 
Ventricular Improvement After Revascularization Following a 
Myocardial Infarction. 
Vanzetto G, Machecoun ], Fagret D, Rocca C, Schwebel C, Comet M, 
Denis B. University Hospital- Grenoble - France. 
Improvement of left venaicular (LV) function after a transmural myocardial 
infarction (MI) relies on the presence of residual viability. Fatty acid (FA) 
SPECT has been previously favourably compared to FOG-PET for the 
detection of this viability. The aim of our study was to assess whether dual 
stress-1L I rest-FA SPECT could accurately predict the improvement of left 
ventricular function after revascularization following an acute MI. 
A stress 1L-SPECT (2.5 mCi injected at peak load exercice) followed one 
hour later by a rest FA-SPECT (4 mCi) was perfonned in 28 patients, 7 to 
15 days after a first transmural MI. LV was divided into 9 segments and 
visually analysed. A segment was definied as viable in case of a 1L-FA•
SPECT mismatch (TL defect with FA uptake). A pt was said to be a "viable 
pt" if mismatch occured in at least 50% of the initial 1L defects. 
Improvement of LV function was assessed by quantitative angiography, 
before (I) and 3 months after (2) systematical revascularization, according to 
3 criteria: the global ejection fraction (L VEF), the MI regional EF (M1EF) 
and an asynergic score (AS). 
ReSlIlls : 28 male, mean age 57 ± 9 years, underwent revascularization (10 
CABG, 18 PTCA) 30±20 days after MI. Dual SPECT was perfonned 
l5±10 days after MI, second LV angiogram 108±35 days after 
revascularization. 
n tenns 0 percentage, e Improvement 0 an was 
significanly higher in viable than in non viable pts (respectively + 19 vs -6% 
p=O.OO8 and +126 vs +29% p=0.02) 
Conclusion· L VEF, MlEF and AS improved significantly in "viable" pts 
while they did not significantly change in "non viable" pts. A 1L-FA•
SPECT mismatch is a reliable marker of improvement of LV function after 
revascularization. 
JACC February 1994:1A-484A 
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ACE Inhibition Limit. Dy.functlon In the Non-Infarcted 
Region AdJacent to Antarlor Infarction During Remodeling 
Christopher M. Kramer. Vielor A. Ferrari. Michael L. Nance. Fe Wright. 
Laon Axel. Natheniel Reichek. Medical College 01 Pennsylvania. 
Allegheny Campus. and University 01 Pennsylvania Medical Center 
ACE inhibitora (ACEi) reduce left ventricular dilatation and 
mortality after anterior MI. but their effect on hypertrophy and regional 
function in non-infarcted myocardium during remodeling is not well 
characterized. Therefora. a sheep model (naB) 01 transmural anteroapical 
MI produced by coronary ligation was studied using magnetic resonance 
tissue tagging (MRI) prior to MI (day 0) and at 8 weeks after MI. Four sheep 
received ramipril (10 mg q.d.) beginning day 2 after MI. Trough serum 
ACE levels in the treated sheep fell to 113 that 01 controls (p<O.01). but 
mean blood pressures were unchanged throughout the 8 weeks. LV 
mass (M). end-diastolic volume (V). ejection fraction. and circumferential 
intramyocardial segment shortening (%S) in infarcted myocardium and in 
non-infarcted regions adjacent to and remote from MI were measured 
using MRI. Results for mass and volume were: 
M (s:!ay Q) cikg M (8 wi(! 'ikg V (day Q) mIIkg V (SWk) milk; 
Control 2.1±O.1 2.7±O.2' 1.4±O.1 3.1±O.4' 
ACEI 2.0±0.1 1.8±O.211 2.0±0.3 2.:hO.2* 
'pcO.05 vs. day O. 1Ipc0.05 vs. control. *'>-0.13 vs. control 
Ejection fraction fell from 44±2% at day 0 to 18±4% at 8 weeks post-MI in 
controls (p<O.02) and from 46±4% to 29±5% In the ACEI group (p=0.14). 
In both groups. subendocardial %S fell in the Infarcted region 
from day 0 to 8 weeks after MI (-16±5% controls. -13±2% ACEI. p=NS) 
but was minimally reduced in the non-infarcted remote region (-6±1 % 
controls. -4±3% ACEI. paNS). Subepicardial %S fell to a similar extent in 
both groups in infarcted and remote regions. In contrast. adjacent region 
(adD %S res~ were: 
Adj endo(davOl Adj endo (8w1(! Adj eoi (day Q) Adi epj (SWk) 
Control 23:1:2% 10±1%' 16±2% 512%' 
ACEI 221:2% 17±2%1I 19±2% 10±2M 
'pcO.02 VI. day O. 1Ipc0.02 vs. control. * p=O.14 VS. control. 
ACE inhibition In this model is associated with preserved function 
In the adjacent non-infarcted region 8 weeks after MI and with a limitation 
01 the ventricular dilatation and eccentric hypertrophy that characterize 
left ventricular remodeling. Adjacent region dysfunction may be an 
important detenninant 01 left ventricular remodeling after anterior MI. 
834-2 10:45 
Nipradilol Reduces Left Ventricular Remodeling Following 
Myocardial Infarction in Spontaneously Hypertensive Rats. 
*Hiroyuki Sonoki, Masaki Nakamura, and Akira Takeshitat. 
Tokyo Research Laboratories, Kowa Co. Ltd., Tokyo ,Japan. 
tKyushu University, Fukuoka, Japan. 
The present study was undertaken to determine if 
nipradilol, a new a-blocker, alters favorably ventricu•
lar remodeling following myocardial infarction (MI) pro•
duced by coronary ligation in 749 spontaneously hyper•
tensive rats (SHRs). The effects of the following drugs, 
which were administered orally for 4 weeks, on ventricu•
lar remodeling were evaluated by assessing the left ven•
tricular (LV) end-diastolic volume index (LVEDVI) and 
the passive pressure-volume relations ·of the LV; l)no 
drug (control), 2)nipradilol IOmg/kg/day, 3)propranolol 
5Omg/kg/day, and 4)captopril 3Omg/kg/day. Since LVEDVI 
depends on the infarct size, the drug effects on LVEDVI 
were compared between rats with similar infarct size; 
small <20%, moderate 20-40%, and large >40%. Nipradilol 
as well as captopril reduced LVEDVI irrespective of in•
farct size (right figure) and caused leftward shift of 
the pressure-volume relations of the LV (left figure, in 
the groups with large MI). 
"j ~5- Jlfj f:~ t, 
o , I ) .... 
0"'_ D_' .•.- LYEDVI • 'dl06 •• "~OI 
Conclusion: Nipradilol as well as captopril reduces left 
ventricular remodeling following MI whereas propranolol 
tended to aggravate it. 
ABSTRACTS 477A 
834-3 11:00 
The Comparative Effects of Converting Enzyme Inhibition and 
Angiotensin IT Subtype I Receptor Blockade on Right Ventricular 
Remodeling Following Myocardial Infarction in the Dog 
Kenneth M. McDonald. Todd Parrish. Arthur Stillman. Jay N. 
Cohn. University of Minnesota. Minneapolis. MN 
Right ventricular mass (RVM) increases after localized left 
ventricular (LV) necrosis produced by transmyocardial direct current 
(DC) shock in the dog. The effect and potential mechanism of 
action of converting enzyme inhibition in attenuating this structural 
change was analyzed in 24 mongrel dogs assigned 24 hours after 
DC shock to a control group (C: n=7). to ramipril (R: 10 mg BID. 
n=8) or DUP 532 (15 mg BID. n=9). an angiotensin IT subtype I 
receptor blocker. The pressor response to angiotensin IT confirmed 
the adequacy of receptor blockade. Changes (mean ± SE) in right 
ventricular volume (li V). RVM (liM) and right ventricular ejection 
fraction (liEF) between baseline and 16 weeks following infarction 
were estimated using magnetic resonance imaging. Change in mean 
arterial pressure IAAP) was also measured 
.:mml1 ~ ~ 
C +4±3 +7±1* -6±3 
R -4±7t O±2t -1±2 
DUP +4±7 +7±2* -3±4 
*p<O 05 with baseline: +p<O 05 with C DUP 
AAP(mmH~) 
0±3 
-9±4*t 
-3±4 
These data demonstrate that R can attenuate the increase in RVM and 
decrease in RVEF that occurs in the control group. Therefore. 
similar to LV remodeling. structural changes in the right ventricle 
following LV necrosis can be attenuated by converting enzyme 
inhibitor therapy. Since DUP appeared to be ineffective. the 
mechanism of this inhibitory effect does not appear to be linked to 
blockade of the systemic effect of angiotensin II. 
834-4 11:15 
ra.orable Left ventricular R..adeling Following Large 
MYocardial Infarction by Bserci.e ~rainingl Re.er.al 
of Abnoraal cardiac MYo.1n Gane _spre •• ion. 
Teddi L. Orenstein, Thomas G. Parker, Jagdi.h Butany, 
Fayez Dawood, Wen-Hu Wen, Lily Wee, Tammy Martino 
Peter R.Mclaughlin, Peter Liu, The center for 
Cardiovascular Research, Toronto, Ontario, Canada. 
We tested the hypothesi. that esercise training in a 
healed myocardial infarction - dy.function rat model 
can attenuate the adverse effect. of ventricular 
remodeling including rever.al of abnormal p-myosin 
gene expre •• ion. Five weeks post LAD ligation(N-55) 
or aham operation (N-10), sprague-Dawley rat. were 
randomly assigned to .edentary conditions or 6 weeks 
of graduated .wim training. At 11 weeka all rat. were 
.acrificed and randomly assigned to hemodynamics, 
using a Langendorf preparation and morphometry using 
digital micro.copy or to molecular atudies. To insure 
aevere LV dy.function, infarctions < 45' LV perimeter 
were excluded. 
Compared to infarcted rat. assigned to .adentary 
conditiona(N-5), exercise training in infarction 
rats(N-6) attenuated LV dilation (18.4 ± 6.2mm2 vs 
32.2 ± 14.7mm2,p<0.03) and allowed more hypertrophy of 
the non infarct wall(1.43 ±.05mm vs 1.15 ±.28mm,p<.02) 
reducing wall ten. ion (512 ± 64mmHg'mm vs 898 t 
2SOmmHg·mm,p<.002). Northern blot analysis (N-10) 
ahowed P-Myo.in Heavy Chain expression in infarct 
exerci.e trained rat. .imilar to aham sedentary and 
exerci.e control •• In contrast to the above J groups, 
p-nHC expre.sion in infarct rat. as.igned to sedentary 
condition. wa. markedly increased • 
Bxerci.e training in a healed infarction-dy.function 
mod.l can improve adver.. remodeling process by 
attenuating ventricular dilation and reducing wall 
tension and can favorably alter P-nHC expression. 
478A ABSTRACTS 
834·5 11:30 
Preservation of Left Ventricular Shape And Volume (Remodeling) After 
Reperfusion Improve Hemodynamics Independently to Infarct Size in 
Rats With Chronic Myoc:ardiallnfan:tion 
Peter Gaudron, Kai Hu, Han Hong, Christof PoIoek, Georg ErtI, Medizinische 
Klinik, Universitllt WOrzburg, Gennany 
Due to favourable effects on scar thickness, infarct expansion and 
aneurysm fonnation, coronary reperfusion may be of advantage even 
without salvage of myocardium. The hemodynamic effects of this 
·advantage beyond salvage·, however, are not known. To test this, 94 rats 
were assignad to sham operation (A; n=33), pennanent left coronary artery 
ligation (B; n=26) ligation and reperfusion (C; n=21) and to reperfused rats 
matched to group B for similar Infarct volume (0; n=14). Eight weeks later, 
left ventricular (Lv) end-diastolic pressure (L vedp; mmHg), peak 
developed Lv pressure (DevP; mmHg) during brief aortic occlusion and Lv 
volume (Lv·V; ml) were measured by Millar microlip manometer, and the 
passive Lv pressure-volume relation, respectively. From 8-12 stained and 
digitized transverse Lv sections, circumferential Mi size (Mi-C; %) was 
calculated from Mi circumference and Mi volume (Mi-V; %) from Mi area 
as the percentage of total Lv circumference and Lv wall volume, 
respectively, as well as average transmurality (TM;%) of Mi, Lv diameter 
(Lv-D; mm) and scar thickness (scarT; mm). As expected (table), transmu-
Mi-C MiN 1M Lv-D Sca~ Lv-V" Lvedp DevP 
A 0 0 0 5±1 100:1:12 49t15 5±1 230t25 
B 46±9 18±5 67:1:16 7:1:1" 34:1:19'F 69±23" 11:t1F8 165:1:35" 
C 36:1:14T 11:1:71 33:1:7T 5±1T 88:1:15T 49t17T 5:1:2T 186:1:35T 
D 45:!:9 15±7 33:1:4T 5±1T 9O:I:15T 55±16T 5:l:2T 186:1:36T 
mean:t:sd; §tree Lv wall in sham; "x10-2; #P<0.01 vs A; t p<O.OS vs B. 
ral Mi (group B) caused Lv dilatation (Lv-V), shape distortion (Lv-D, ScarT) 
and dysfunction (Lvedp, DevP) which was reversed by smaller (Mi-C, Mi•
V) and less transmural (TM) infarcts following reperfusion (group C). By 
design, infarct volume (Mi-V) in the matched reperfused group with non•
transmural Mi (group D) was similar as in group B at similar transmurality 
(TM) as in group C. Despite this correction for Mi volume, the beneficial 
effects of reperfusion on Lv shape, volume (remodeling) and function were 
maintained. These data suggest that the advantageous modification of 
remodeling by reperfusion with subsequent reduction of transmurality goes 
beyond and, in part, is independent to salvage of myocardium. 
834·6 11:45 
Potential Role of Increased Myocardial Stiffness in the 
Attenuation of Ventricular Remodeling With Late 
Reperfusion Following Myocardial Infarction 
Roben D. Simari, Malcolm R. Bell, Bernard J. Gersh, Y.C. Pao, 
Erik L. Ritman, Mayo Oinie, Rochester, MN 
The mechanisms by which resumption of arterial patency confers 
improved survival following myocardial infarction (MI) are 
unclear. Experimental models have shown that late reperfusion 
may attenuate ventricular remodeling independent of myocardial 
salvage. To determine the potential mechanisms involved a closed 
chest canine model of late reperfusion following MI was studied: 4 
Control (C) dogs underwent catheterization and observation for 4 
hours, 5 dogs (0) underwent occlusion of the left anterior 
descending artery for 4 hours and 4 dogs (R) underwent occlusion 
for 3 hours followed by 1 hour of reperfusion. Dogs were 
scanned with an ultrafast computed tomographic scanner during 
sequential aortic root and right atrial contrast injections at baseline, 
3 and 4 hours. 
Infarct size (% left ventricle) was 17.9% for R and 18.0% for O. 
Comparing RandO, reperfusion was associated with prolongation 
of global indices of relaxation (relaxation half-time 46 vs 29 ms 
respectively, p< 0.05) and increased end diastolic pressure (13 vs 
9 mm Hg, p<0.05). Pressure-volume loops revealed an upward 
shift of the diastolic pressure-volume relationship suggesting 
decreased ventricular distensibility. Reperfusion was associated 
with increased intrarnyocardial blood volume (8.1% vs 3.4%, 
p<O.05) and increased wall thickness (14.6 vs 9.4 mm, p<o.OO5) 
in the anterior wall. Finite element analysis demonstrated 
increased myocardial stiffness following reperfusion. 
Conclusion: In this in vivo closed chest canine model, late 
reperfusion was associated with global and regional effects 
independent of myocardial salvage. These changes may be 
responsible, at least in part, for the attenuation of ventricular 
remodeling observed with late reperfusion following MI. 
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Dose Ranging Study of N·0861, a New Selective A1 
Receptor Antagonist, In Patients Receiving Adenosine 
Satoru Nagashima, Hans J. Moore, Cynthia M. Tracy, Allen J. 
Solomon, Jan L. Hewett-Meulman, Suzanne M. Cowley, Raymond L. 
Woosley, Jean T. Barbey, Georgetown University, Washington D.C. 
The purpose of this study was to identify the dose range of N-Q861 
(Whitby Research Inc.), a selective A1 adenosine receptor 
antagonist, that could inhibit adenosine (ADO) induced delay in AV 
conduction. Following a normal EP study, 11 patients (pts) received 
increasing doses of N-0861: load of 0.025, 0.05, 0.1, 0.25 
(2pts/dose) and 0.5mg/kg (3pts) over 3 min. followed respectively 
by 0.0022, 0.0044, 0.0088, 0.022 or 0.044mg/kg/min. up to 45 
min. ADO boluses (60 to 140 I!g/kg q. 5min. ) were given before 
and during N-0861. Intracardiac electrocardiogram, ECG and BP 
were continuously recorded. 
N-0861 doses~0.1 mg/kg (load) inhibited ADO induced AH 
prolongation in all pts, the most pronounced effect occurring in pts 
receiving 0.5mg/kg (Pt09,10,11): 
AHCmsec) IlIM!j;!alAxiUlm.!.l<uUlmL-.ClA.uH,--cPo""s",t-",A",D"",O 
Baseline 60 100 140 (I!g/kg) 
Pt09 Control 60 
N-0861 65 
Ptl0 Control 77 
N-0861 69 
Ptl1 Control 63 
N-0861 61 
92 
67 
121 
87 
81 
65 
AVB(134) -
78 
135 161 
113 111 
95 AVB(228) 
77 89 
AVB=AV block, ( )=Max. AH prior to AVB 
Even at effective doses, N-0861 caused no side effects and did not 
alter blood pressure changes induced by ADO, suggesting that its 
effect is highly selective for A1-receptors. In addition N-0861 did 
not increase HR or shorten AH, failing to support the hypothesis that 
ADO plays an important role in the control of cardiac function during 
physiological conditions. We conclude that N-0861 safely and 
selectively inhibits the A1-mediated effects of ADO in man. 
835·2 10:45 
Variable Dose Dependent Coronary Vasomotor 
Responses to Acetylcholine in Patients with Normal 
Coronary Arteries 
Dimitris TouSQulis, Agha W. Haider. Stuart Rosen, Graham Davies, Tom 
Crake. Cardiology Unil, Hammersmith Hospital, London.UK 
The dose dependent vasomotor effects of acetylcboline (Acb) in proximal 
aod distal coronary artery segment were examined in 15 patients (mean age 
48±8 years) with normal coronary arteries, cbest pain and risk factors for 
coronary artery disease. Quantitative angiograpby was used to measure 
minimum lumen diameter of proximal and distal coronary artery segments at 
baseline (BL), dwing inuacoronary infusion of Acb (10-7 to 10-3 M) and 
following intracoronary isosorbide dioittate (ISDN) (2 mg). In respOnse to 
the low concenttation of Acb 20 (61 %) distal and 11 (41 %) proximal 
segments showed <!: 5% dilatation (group 1), wbereas 13 (39%) distal 
segments and 14 (52%) proximal segments showed constriction immediately 
after the Acb infusion (group 2). The mean luminal diameter (in mm) in both 
groups were: 
group 1 group 1 
proximal djstal mmdmal distal 
BL 3.S3±O.2 l.32±O.07 3.1S±O.1 l.S1±O.06 
Acb (10-7) 3.SS±O.2 1.39±O.07 2.94±O.1 1.3S±O.OS 
Acb (10-6) 3.71±O.2 1.48±O.08* 2.9S±O.1 l.36±O.OS 
Acb (lO-S) 3.81±O.2* 1.41±O.08 2.87±O.1 l.28±O.06 
Acb (104 ) 3.67±O.2 1.29±0.08 2.83±O.2 1.26±O.05 
Acb (10-3) 3.60±0.3 l.04±O.J3 2.63±O.2* O.97±0.19* 
ISDN 3.93±O.3 1.62±O.1O 3.S2±O.2 1.68±O.07 
*p<O.OOI vs. BL 
The two different patterns of the vasomotor response coexisted in 10 of the 
15 patients. The magoitude of constriction was greater in distal than at 
proximal segments (group 1: 15.8±8.2% vs. 0.7±2.6%. group 2: 
33.1±11.6% vs. 16.5±3.3% respectively; p<O.OS). In conclusion in patients 
with normal CA and risk factors for coronary artery disease both constriction 
and dilatation occur in proximal and distal segments in response to Acb, 
suggesting local endothelium dysfunction. Tbe magnitude of the 
vasoconstrictor response to acetylcboline was greater in distal than in 
proximal segments. 
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AngioleDsio·n iDdllces dilfereotial mega iD the iDoervated aod 
Deoenated limbs or patieats with oilateral brachial plexus iDjury 
JS KooneI'. RR Baliga'. R Birch. WS Peart. CJ Mathias 
'Clinical Cardiology Unit, Royal Postgraduate Medical School. Hammersmith 
Hospital and Department of Cardiovascular Medicine. St Mary's Hospital 
Medical School. London. UK 
We investigated the contribution of neurogenic and direct vascular 
effects in the pressor action of angio/ellsin·ll (A·ll) in S patients with 
unilateral brachial plUIlS injury (ULBPI) before and after cenlr3l sympathetic 
blockade with clonidine. 
Measurements of blood pressure (BP). heart rate (HR) IlSing an 
automated sphygmomanometer (SenlrOll). stroke distance (SD) and cardiac 
index (CI) llSing ContinUOIlS wave Doppler were made non·invasively. 
SimultanCOllS measurements of digital skin blood flow (DSBF) (laser doppler) 
were made in the innervated and sympathetically denervated limbs of patients 
with ULBPI; A reduction in digital skin blood flow is a sensitive marker of 
sympathetically mediated vasoconstriction (Pickering GW. Heart;16:11S·135. 
1933). A-ll was infused for 6 min at each 4 doses (0.001. 0.002. 0.005 & 
om p/kg/min) before and after clonidine (2 p/kg. iv). There was a dose 
related rise in BP after A-ll. There was no difference in dose response 
curves to A·II before (3±2. 4±3. 8±3 & 15±3% respectively) and after (2±2. 
4±2. 8±2 & 16±2%) c1onidine. The pressor response to A·ll was due to a 
rise in systemic vascular resistance as HR. SD and CI were unchanged. A·ll 
induced digital skin vasoconstriction in the innervated (10±6. 35±8. 61±17 & 
85±l6%. p<1l.05) but not in the denervated limb (1±4. -6±9. ·5±1l & -6%:14 
%. ns). After c1onidine. vasoconstriction did not occur in response to A-II 
in the innervated (-lli. 1±6. 9±9 & 2O±1l %. ns) or the denervated limb (-
6±9. 1±9. 5±1l & IOtll%. ns). 
We conclude that the ability of angiotensin-ll to increase blood 
pressure after cenlr3l sympathetic blockade with clonidine is due to its direct 
vascular effects. Digital skin vasoconstriction. however. is due to a centrally 
induced increase in sympathetic nervous activity as it can be inhibited by 
clonidine and does not occur in the denervated limb. 
835-4 11:15 
Unique vasorelaxing properties with a new cardiotonic 
agent, MCI-lS4, in human diseased heart. 
:Comparison with phosphodiesterase inhibitor 
*Masuki Mori. Motoshi Takeuchi. Hideyuki Takaoka. Katsuya 
Hata. Hideyuki Yamakawa. Mitsuhiro Yokoyama. Kobe 
University. Kobe. Japan 
The positive inotropic action of conventional Ca2+ 
sensitizing agents is mediated through both a sensitization of cardiac 
contractile proteins to Ca2+ and an inhibition of phosphodiesterase. 
with the latter prevailing. We assessed inotropic and vasodilatory 
effects of a new Ca2+ sensitizing inotropic agent. MCI-I54 (MCI). 
on human diseased hearts in comparison with phosphodiesterase 
inhibitor (EI020). Variably loaded left ventricular (LV) pressure•
volume loops were obtained by conductance method in 14 patients 
before and after MCI (16.6 pg/min iv. n = 7) and EI020 (0.3 
pg/kg/min iv. n = 7). LV contractility and afterload were assessed 
with Em.x (the slope of the end-pressure-volume relation) and E. 
(arterial effective elastance). respectively. End-diastolic volume 
index (EDVI) was obtained as the index of the venodilatory action of 
these agents. LV pressure-volume area (PVA) was also assessed as 
the index of the total mechanical energy. MCI produced a 
comparable increase in Emu to that of EI020 (MCI 45.3. DOB 46.3 
%). Ea was decreased with EI020 (3.44 ... 2.72 mmHglmllm2. p < 
0.05). but not with MCI. Both agents decreased EDVI. but the 
decrease in EDVI with MCI was larger than that with EI020 (MCI 
14.6 vs E1020 8.0 %. P < 0.05). PVA decreased with MCI (13170 
.... 10998 mmHg.ml. p < 0.05). but not with EI020. These results 
indicate that Mel -154 had a more pronounced venodilatory action in 
comparison with phosphodiesterase inhibitor despite the comparable 
positive inotropic effect with both agents in human heart. resulting 
in a decrease in LV total mechanical energy. Thus. unique 
vasorelaxing properties with a new Ca2+ sensitizing inotropic agent. 
MCI-I54. may be beneficial in the setting of congestive heart 
failure. 
ABSTRACTS 
835-5 11:30 
Ambulatory pump driveo Prostaglaodio El infllSioo as pbarmacologit 
bridging before beart traosplantation in refrattory beart failure 
Richard Pacher*. Michael Wuue. Sebastian G1obits. Homayoun Daneschvar. 
Rudolf Berger. Suzanne ROdier. Margret Bilhringer. Susanne Schmidt, 
Gottfried Heinz. Brigiue Stanek. Dept of Cardiology. University of Vienna. 
Austria 
Infusion of prostaglandin El (POEl) is currently IlSed to prevent right heart 
failure in patients at risk before and during heart tranSplantation (HTX). A 
study was conducted to investigate safety and efficacy of continuous. i.v. 
long term therapy with PGEI with and without a standardized dobutamine 
(5 mcg/kg/min.) and dopamine (3 mcg/kg/min.) infusion. 25 HTX 
candidates (24 males. I female. mean age 56±8 y) with refractory heart 
failure were treated with increasing dosis of PGEI during hemodynamic 
monitoring until symptoms indicating individual maximum dose (32±8 
ng/kg/min.). Then, 50 % of individual maximal dose (15±5 ng/kg/min.) was 
used for continuous infusion via a subcutaneous. cenual venous line 
connected to a portable pump. Nineteen patients were catecholamine 
dependent before initiation ofPGEl therapy. 
During an observation period of 6 months. 12 patients were transplanted 
after 2-140 days and 9 pts died after 11-71 days (2 from cerebral infarction, 
4 due to progressive heart failure. 3 from sudden death). Four patients were 
stabilized with conservative ueaunem, 3 of them eventually weaned from 
pump driven therapy. 
Out of 12 patients who received HTX. pulmonary vascuiary resistance index 
was> 340 dyn s cm'S m_2 (652±250 dyn s cm-5 m_2) before PGEl therapy. 
which was decreased to < 340 dyn s cm-5 m.2 (262±65 dyn s cm-5 m_2) in 
10 patients with combined cateCholamine-PGEI infusion. In none of the 
patients perioperative right heart failure was observed during PGEI infusion. 
Fourteen of 25 hospitalized HTX candidates could be stabilized by PGEI 
pump driven infusion and ueated for 39-140 days without side effects 
necessitating termination of PGE 1 therapy. 
In conclusion, the continous pump driven infusion of PGE I via a 
subcutaneous. cenual venous catheter has proved its efficacy in 2/3 of 
previously hospitalized outpatients up to 6 months and provides a novel and 
safe bridging before HTX. 
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Maternal and Fetal Effects of Beta-Blockade During Pregnancr 
Marla A Mendelson, Selena L Hariharan, Cheryl L DaVIS. 
Alan M. Peaceman 
Northwestern University Medical School, Chicago, IL 
Reports have suggested that beta-adrenergic blocking 
medications (BB) used during pregnancy for hypertension 
control have been associated with severe growth retardation. 
Their effects, when ~ven to pregnant mothers with other 
cardiovascular conditIOns is unknown. We followed 16 
pregnancies of normotensive women with cardiovascular disease 
on BB and 16 pre¥"ancies in normotensive control women 
without BB. IndicatIOns for beta-blockade included: idiopathic 
hypertrophic subaortic stenosis; Marfan's syndrome; atrial 
arrhythmias; mitral valve prolapse and ventricular tachycardia. 
The mothers were matched for maternal age. gestational age 
and obstetric history. 
There were no differences found in subjects vs controls in: mean 
birth weight; Apgar scores at 1 and 5 minutes; and fetal heart 
rate during labor or delivery. There was no increase in growth 
r-'lardation found in the BB group. Birth weight on BB was 
(X.±.SD) 112.6.±. 30.3; vs Control group 119.5.±. 30 (p=NS). No 
differences in neonatal hypoglycemia, hyperbilirubinemia or 
polycythemia were found between groups. No clinically relevant 
differences were found attributable to BB use during pregnancy. 
These preliminary data suggest that treatment of cardiovascular 
disease with beta-blockers may be continued throughout 
pregnancy with less risk than has been previously reported. 
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Long-Term Results of Catheter Ablation of Ventricular 
Tachycardia in Patients with Coronary Artery Disease 
8ernd-D. Gonska, Kej iang Cao, Anselm Schaumann, Axel Dor•
szewski, Friederike von zur MGhlen, Heinrich Kreuzer, 
Dept. of Cardiology, University of G5ttingen, Germany 
Catheter ablation (CA) was performed in 134 patients with 
angiographically proven coronary artery disease (107 men, 
27 women, mean age 56, LVEF 36 + 9 %). All of them had 
one type of monomorphic sustained VT (mean cycle length 
353 msec). The mapping procedure to detect an adequate 
target site for ablation included pace-mapping during 
sinus rhythm, activation mapping, detection of an area of 
slow conduction, and concealed entrainment. For ablation, 
radiofrequency energy was applied in 71 patients, direct 
current in 63. 
Results: Primary success was achieved in 100 patients 
(75 %). Control stimulation after 1 week revealed non-in•
ducibility of the VT in 96 patients. During a mean fol•
low-up of 24 + 13 (3 - 68) months, 80/96 patients (83 %) 
remained arrhythmia free. 16patients had a recurrence of 
VT, 4 of them died as a result of sudden cardiac death. 
Early recurrences « 3 months after CAl occurred in 9 pa•
tients. In 7 of these patients, the VT could be documented 
and proved to be of the same type as the one that had been 
ablated. In the remaining 7 patients, VT recurred 5 - 17 
months after CA, and in the 3 patients in whom it was do•
cumented it was of another type with respect to rate, 
axis and morphology. 
Conclusion: In a selected group of VT-patients with coro•
nary artery disease, CAshows promising long-term results. 
Nevertheless, the procedure is burdened with a number of 
recurrences especially during the first 3 months. There•
fore strict monitoring of these patients is required on 
an outpatient basis. Late recurrences seem not to be re•
lated to the procedure but seem to be due to the progres•
sion of the underlying heart disease. 
836·2 10:45 
Radiorrequency Energy Delivery Results in Non-Uniform Heating 
Patterns. 
Isaac Chang. Mark S. Mirotznik, David Schwartzman, Charles D. Gottlieb. 
Francis E. Marchlinski, Kenneth R Foster. Philadelphia Heart Institute 
and The University of Pennsylvania. Philadelphia, P A. 
The interface heating patterns generated by delivering radiofrequency 
energy (RF) through two electrodes were evaluated: 7F, 4mm length and 
7F, 8mm length. Electrodes were separately mounted in a chamber 
containing a physiologiC crystalloid solution and RF was pulsed (30 watts 
for SOO ms) at SSO kHz in a unipolar configuration. The resulting maximum 
rate of temperature rise was mapped at 1.0 millimeter intervals with a 
thermistor probe at designated points along the electrode interface (Figure). 
Resolution of this technique is accurate to within O.Smm. The Specific 
Absorption Rate (SAR), which is proportional to the magnitude of 
instantaneous heating at each point, was calculated based upon the rate of 
temperature rise at each point. The results were normalized to the 
maximum point of heating for comparison. RESULTS: The SAR pattern 
of each electrode is highly non-uniform. This is greater with the longer 
electrode. Two distinct heating peaks exist: at the proximal edge of the 
electrode. and at the distal tip. 
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CONCLUSION: Heating peaks occur at points of curvature, due to larger 
current densities at these points. The larger electrode has a more 
hetergeneous heating profile because of a greater surface area with no 
curvature. These findings have implications for RF electrode shape and size 
design, as well as for location of thermistors. 
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ENDOCARDIAL RESECTION FOR VENTRICULAR 
TACHYCARDIA IN 353 PATIENTS. 
W. Clark Hararove m, Mule E. JOIepbson, AideD H. Harken, Jolm M. 
Miller. Pbiladelphia Heart IDstitute, Philadelphia, PA 
Today surpcallhenpy for patients with ma1isnant ventricular anhythmias 
is implantation of an internal cardiovertor defibrillator (lCO) no matter 
what the anhythmia. Nevertheleos endocardial Ihlative procedures offer 
the only chance for cure. Since 1978, 353 patients bave underaone 
electrophysiolopcal (EP) auided IIUbendocardial reoection(SER). All 
patients IwI IUStained DIODOIIIOrphic ventricular lIcbyeardia, most 
secondary 10 coronary artery disease. Mortality (30 day) was 15 'Ai 
(53/353). Risk faclOn increasina operative mortality were: (I) left 
ventricular ejection fnction less than 2S 'Ai. (2) Urgent or emergent 
operation (3) NY Heart Association Class m or IV. Ejection fraction in 
26 'Ai of patients was less than 20 'Ai. Operative mortality in this aroup was 
27 'Ai. In operative survivon 92'Ai bave been free of clinical anhythmias 
or sudden cardiac death. Of operative survivon 67" were DOD inducible 
at postoperative EP testing. In early results patients with anterior aneurysm 
IwI • higher percentage of non-inducibility than those with inferior 
aneurysm. Addition of cryoblation eliminated this difference. Of the 353 
patients, 262 were operated on after the ICD was available. ICD patches 
were placed in 28 patients for various reasons at the initial operation. Only 
6 of these 28 patients IwI the aeneralOr later implanted for inducible 
ventricular tachycardia postoperatively. Subsequently 6 of the initial 
patients IwI both patches and the aenerator placed. Five year actuarial 
survival,includina operative deaths is 65". Conclusions: SER continues 
10 offer excellent long term freedom from anhythmias or sudden cardiac 
death in patients with sustained monomorphic ventricular tachycardia. 
Operative risk is primarily related 10 left ventricular function. ICD patches 
should not be placed at the time of SER operation. 
836·4 11:15 
Presystolic Spikes Are Not a Specific Marker for Idiopathic 
Ventricular Tachycardia with a QRS Pattern of Right Bundle 
Branch Block and Superior AxIs 
Ming-Shien Wen, San-Jou Yeh, Chun-Chieh Wang, Fun-Chung Lin, 
Delon Wu, Chang Gung Medical College, Tao-Yuan, Taiwan 
To detennine whether the sharp spikes that preceded the QRS in 
patients (pts) with idiopathic ventricular tachycardia (lVT) of right 
bundle branch block and superior axis morphology are specific 
marker, 16 pts with this type of VT and 15 control pts with no VT or 
structure heart disease underwent a detail activation mapping study. 
In all 16 pts with IVT, sustained VT was inducible with programmed 
stimulation. The VT was resportsive to verapamil but not to 
adenosine. During VT, entrainment was demortstrable by pacing the 
right ventricular outflow tract in 8 pts. Activation and pace mapping 
studies disclosed that the VT originated from the inferior apical 
septum (12 pts), midseptum (3 pts), or anterior-lateral wall (1 pt) of 
the left ventricle. DUring VT, sharp spikes preceding the local 
ventricular electrogram and occurring 34±S (range 2645) msec 
before the ortset of QRS were noted al the earliest endomyocardial 
activation site or near arround. Radiofrequency current 25±S watts 
for 20±9 sec delivered to this site resulted in successful ablation of 
VT in 13 pIS. However, these sharp spikes were also recordable 
during sinus rhythm and remained recordable after successful ablation 
of VT at the same site. In the 15 control pts without VT or structure 
heart disease, sharp spikes were also recordable along the fascicular 
networks of the left bundle branch system. These spikes merged 
progressively into the local ventricular electrogram as the recording 
catheter was advanced from the proximal left bundle at the base of the 
left ventricular septum toward the distal fascicle at the apex of the 
septum. These findings suggest that the sharp spikes that preceded 
the QRS in NT are not a specific marker for this tachycardia; they 
are likely to reflect fascicular potentials. 
JACC February 1994:1A-484A 
836·5 11:30 
The PatterD or Block or Stimulated Premature Impulses Determines the 
QKS MorpbolOlD' or the initial Beats or Induclble Mooomorphlc 
VeDtricular Tacbycardla 
Bernard Deruyter, James Coromilas, Andrew L. Wit. Columbia University, 
New York, NY 
Several electrocardiographic characteristics occur during the onset of 
sustained monomorphic ventricular tachycardia (SVT) initiated by 
programmed electrical stimulation (PES) in patients with ischemic heart 
disease. One characteristic is that the QRS morphology of the initial beats of 
SVT are identical to the QRS during the sustained phase of the SVT. A 
second characteristic is that SVT begins with a short period of polymorphic 
QRS complexes before monomorphic SVT occurs. Identical modes of SVT 
initiation are fouod in the canine heart with a healing infarct. To determine 
the mechanism for each of these characteristics, we mapped excitation in 
reentrant circuits in tbe epicardial border zone (EBZ) of tbe infarcts witb a 
192 electrode array during initiation of SVT with PES. We fouod that when 
the QRS of the initial beats of SVT were identical to tbe sustained period, 
the initiating premature impulse blocked in a long line transverse to the 
myocardial fiber orientation. Slow activation around botb ends of tbe line of 
block resulting in reexcitation proximal to tbe block, immediately establisbed 
a stable reentrant circuit in the EBZ that persisted unaltered during svr. 
Tbe exit route to the ventricles from the circuit was the same during the 
initial and sustained periods. During the initiation of SVT with an early 
polymorphic phase, a long line of block of the initiating premature impulse 
did not occur. Instead, there were several short lines of block, fragmenting 
the premature impulse into multiple wavefroots, some of which conducted 
intramurally. Unstable reentrant circuits with intramural components 
. resulted, witb changing exit points to the ventricles causing the 
polymorphism. During tbe period of instability, a long line of block 
eventuaUy formed in the EBZ leading to tbe establishment of a stable 
reentrant circuit witb a uniform exit route. Tberefore, the characteristics of 
block of the initiating premature impulse is related to the pattern of tbe 
initial beats of svr; a long line of block is needed to establisb a stable 
reentrant circuit and the monomorphic phase of svr. 
836·6 11:45 
Percutaneous Computerized Electrical Activation Happing 
of the Heart via Multipolar Electrode Catheters in the 
Coronary Arteries and Veins in Dogs 
"Laszlo Littmann, Guanglie Wu, "Omar Amirana, Jan R. 
Tuntelder, Michelle Thompson, Kathy R. Dezern, Pal 
Kempler, George P. Tatsis, Robert H. Svenson, Carolinas 
Heart Institute, Charlotte, NC 
The purpose of this study was to introduce a percuta•
neous technique for rapid multipoint global electrical 
activation mapping of ventricular arrhythmias. Guidewire 
based 21, F 16-polar (8 bipolar) torquable floppy tip 
electrode catheters were designed with 1 mm gold ring 
electrodes, interelectrode spacing of 2 mm and electrode 
pair spacing of 10 mm. In 7 anesthetized dogs, 3-5 of 
these multipolar electrode catheters were advanced 
through guiding catheters, under fluoroscopic guidance, 
to the aortic root and coronary sinus, and were simulta•
neously positioned in major epicardial branches of the 
coronary arterial and venous beds. A 56-channel comput•
erized system was used to display isochronal maps during 
sinus rhythm and a variety of right and left ventricular 
paced rhythms. Bipolar electrogram amplitudes measured 
0.1-1.2 mV; electrogram quality was uniformly excellent. 
In a total of 50 maps, activation sequences were recon•
structed in all. Spacial resolution for identification 
of left ventricular endocardial pacing sites was as low 
as 1. 5 - 2.5 cm. Pos t-procedure coronary arteriograms, 
venograms and pathology showed intact vascular struc•
tures. 
Percutaneous computerized activation mapping via 
multipolar coronary electrode catheters is feasible and 
safe. This technique could prove to be useful for trans•
catheter mapping of ventricular tachycardias in humans. 
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Natural Antioxidant Vitamins Reduce Coronary Artery lAsion 
ProgrfSSion as Asst>ssed by Sequential Coronary Angiography 
Howard N. Hodis, Wendy J. Mack, Laurie LaBree, Linda C. Hemphill, 
Stanley P. Azen, University of Southern California School of Medicine, 
Los Angeles, CA 
The Cbolesterol Lowering Atherosclerosis Study (CLAS) was a 
randomized, placebo-controlled, angiographic trial which demonstrated that 
aggressive lowering of LDL-C with colestipol-niacin therapy reduced 
progression of coronary artery lesions. Baseline and 2-year coronary 
angiogram pairs were obtained on 162 nonsmoking men, 40-59 years old 
with coronary artery bypass grafts. Change in percent diameter stenosis 
(%S) averaged over all evaluable coronary lesions within each subject was 
measured by quantitative coronary angiography. Self reports of vitamin 
supplementation were obtained every 6 months. Average on-trial vitamin 
E and C supplementation was computed and subjects were stratified for 
"high" and "low" supplementation levels. The table below provides 
average change in %S according to treatment group. 
QrQl!1l Sl!lllllmnenl L~vel I! MIliII!(SD) Q2flS Il 
Both Vitamin E >100 47 0.2(5.9) 0.04 
(IU/day) ~IOO 109 2.1(5.9) 
Placebo Vitamin E >100 27 1.2(5.1) 0.26 
(IU/day) ~IOO 51 3.5(6.1) 
Drug Vitamin E >100 20 -1.2(6.8) 0.<Xi 
(IU/day) ~IOO 58 0.8(5.6) 
Both Vitamin C >150 72 0.6(6.3) 0.00 
(mg/day) ~150 84 2.3(5.6) 
Placebo Vitamin C >150 35 1.8(5.5) 0.39 
(mg/day) <150 43 3.4(6.1) 
Drug Vitamin C >150 37 -0.5(6.8) 0.18 
(mg/day) ~150 41 1.0(5.0) 
These data indicate less coronary artery lesion progression with 
supplemental natural antioxidant vitamin intake whether associated with a 
high LDL-C level (mean, 160 mg/dL) in the placebo group or with an 
aggressively lowered LDL-C level (mean, 95 mg/dL) in the drug group. 
Antioxidants may be effective adjunctive therapy to LDL-C reduction in the 
retardation of atherosclerosis progression. 
837-2 
Estrogen Administration Inhibits Oxidative Modification 
of LDL in Postmenopausal Women 
10:45 
Michael N. Sack, Daniel J. Rader, Richard O. Cannon, III. 
Georgetown University, Washington, DC; NHLBI, Bethesda, MD 
Estrogen therapy in postmenopausal women is associated with a 
reduction in cardiovascular events, the mechanisms of which are 
unclear. Because oxidative modification of LDL may contribute 
to atherogenesis, we measured the effect of 176-estradiol (E" 
pg/ml) on the time of onset (lag time, minutes) and maximum rate 
of oxidation (MO,R,.t. absorbance/hr) of LDL (mg/dl) from 18 
postmenopausal women. Conjugated diene formation due to 
peroxidation of LDL following addition of CuCI, was measured by 
spectrophotometric absorbance at 234 mn. There was a weak 
correlation between parameters of LDL peroxidation and serum E, 
level (r=0.46), but not LDL level or age. Women then received 
E, by acute arterial infusion with venous sampling at 20 min. 
Data = mean±SD. *=p<0.05 vs baseline. 
LDL 1h Level Lag Time MO.R 
Baseline 150±51 15±21 134±41 .526±.18 
Acute E, 436±186* 167+36* .438±.16* 
Twelve women then received E, for 3 weeks using a patch 
preparation (.1 mg/day). *=p<O.05, +=p=O.08 vs baseline. 
LDL 1h Level Lag Time MO.R 
Baseline 140±90 16± 17 132±31 .542± 16 
Chronic E, 114±27 126±43* I 78±45 * .455±.11 + 
Acute and chronic E, similarly prolonged the onset and reduced 
the maximum rate of LDL peroxidation by CuCI" despite lower 
chronic E, levels. Thus, acute and chronic E, administration 
reduces oxidizability of LDL, and suggests an antioxidant role of 
E, which may be antiatherogenic and contribute to a reduction of 
cardiovascular events in postmenopausal women. 
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837·3 11:00 
Lplal in Ischemic He.rt Disease. The 0u6bec Cardiovascular Study. 
Bernard Cantin. Sital Moorjani. Jean-Pierre Despr6s. Gilles R. Dagenais 
and Paul·J. Lupien. 
Lipid Research Center. Laval University Medical Center and Faculty of 
Medicine. University of Montreal. Qul!bec. Canada 
In an ongoing ischemic heart disease ((HD) risk factor study. plasma lipid. 
apoprotein IApo} and Lpla} measurements were performed in 2156 men 
aged 45-75 years in 1985-86. The subjects were followed until 
September 1 st 1990. During that period. 116 first IHD events were 
documented 15.4% of the cohort}: 51 men had myocardial infarction 
IMI). 50 angina and 15 an IHD death. Subjects with IHD were older 
159±8 vs 56±7 years; p<O.OOll. had higher systolic blood pressure 
1137±17 vs 130±17 mmHg; p<O.OO1l. had a higher frequency of 
smoking .. 20 cigarenes/day (32 vs 23%. p=0.0271 and had a higher 
prevalence of diabetes 116 vs 4%; p<O.OOII. Plasma levels of 
cholesterol 1235 ± 41 vs 221 ± 39 mg/dl; p < 0.0011. LDL-cholesterol 
(162.0±37 vs 149.5±35.4 mg/dl; p<O.OOI) and Apo 81130.4±31.7 
vs 117.0 mg/dl; p<O.OOII were higher in IHD while HDL-cholesterol was 
lower (37.1 ±9.3 vs 39.9±10.1 mg/dl; p=0.OO41. Lp(allevels were 
higher in IHD 141.0±45.9 vs 32.7±34.9 mg/dl; p=0.0141. There were 
no differences in body mass index. diastolic blood pressure and Apo A-I 
levels. From a stepwise discriminant analysis. the following risk factors 
were found to be significantly related to IHD: Apo B Ip<O.OOII. age 
Ip<O.OO1l. systolic pressure Ip=0.0071. smoking Ip=0.0091 and Lplal 
Ip = 0.051. In order to further ascertain the role of Lplal in IHD. subjects 
were assigned to one of four groups according to Apo Band Lplallevels. 
Group 1: Apo Bs 116 mg/dl and Lpla) s25 mg/dl; Group 2: Apo Bs 116 
mg/dl and Lplal>25 mg/dl; Group 3: Apo B> 116 mg/dl and Lplals25 
mg/dl; Group 4: Apo B> 116 mg/dl and Lp(a} > 25 mg/dl. Risk ratios for 
each group were estimated using Group 1 as a reference. Risk ratios 
were significantly increased in Group 3 12.06. p = .009) and Group 4 
12.74. p=.OO02} but not in Group 211.56. p=0.1701. The findings from 
this prospective study indicate that Lpla} is a risk factor for IHD but its 
importance is increased when Apo B levels are elevated. 
837·4 11:15 
Protection by 8-Blocking Agents Against Oxygen Radical·Induced 
Human Low Density Lipoprotein Peroxidation. 
Claudio Napoli, Giuseppe Ambrosio, Giuseppe Palumbo*, Paola 
Chiariello, Massimo Chiariello. Division of Cardiology and *Dpt. of 
Cellular and Molecular Pathology, Federico IT University, Naples, 
Italy. 
Peroxidation oflow density lipoproteins (LDL) by oxygen radicals 
is a potent atherogenic stimulus. Previous studies in cell membrane 
systems have shown that 8-blockers may effectively inhibit oxygen 
radical-induced lipid peroxidation. In the present study we investigated 
whether 8-blockers may also reduce oxygen radical-mediated 
peroxidation of LDL. Purified human LDL were oxidized by exposure 
to CuSO. (15 ~M for 20 hs at 37°C) after pre-incubation (30 min) with 
different concentrations of acebutolol, metoprolol or propranolol, three 
agents with a different degree of lipopbilicity, as indicated by their log 
octanoVwater partition coefficient (log P). Peroxidation was measured 
from malonyldihaldehyde (MDA) production. Data are expressed as % 
inhibition ofMDA production. (*p<o.05 vs controls). 
W&.J! lJlM ~ ~ 
Acebutolol (1.80) 12.8±2.6* 27.8±3.9* 42.8±6.8* 
Metoprolol (2.15) 16.7±4.6* 41.5±4.2* 61.3±7.5* 
Propranolol (3.65) 25.5±3.1* 57.8±5.6* 89.5±8.3* 
Thus, 8-blockersreduced peroxidation ofLDLin vitro. at concentrations 
similar to those achieved in vivo. The order of potency of this effect 
followed the degree of lipophilicity of the various agents. Our data 
suggest that, although 8-blockers are known to have adverse effects on 
lipid metabolism in vivo, they might also prevent atherogenesis by 
inhibiting LDL peroxidation, the key event in foam-cell formation. 
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837·5 11:30 
Abnormal Replation of the LDL-Receptor Gene in Subjects with the 
"French Canadian" Mutation of the LDL-R Gene Who Fail to 
Respond to HMG CoA Reductase Inhibitors. 
Shiqian& Qiu, Jacques Genest Jr. Clinical Research Institute of 
Montreal, Montreal, Canada. 
100 "French Canadian" mutation of the LDL-Receptor gene 
(> 10kb deletion, 5' end) is the most common cause of 1iunilial 
hypercholesterolemia in Fn:uc:b Canadians and results in a "null" allele. 
We detennined the response to HMG CoA reductase inhibitors in 105 
subjects heterozygous for the 10 Kb deletion and found that 8.6% of the 
patients do not respond to maximal doses of such agents (non-responders, 
defined as <15% decrease in LDL-C). To explain these findings, we 
studied the regulation of the LDL-R and HMG CoA reductase genes in 
cultured skin fibroblasts of subjects with the 10 kb deletion, using the 
following defined culture conditions: complete serum (Cs), lipoprotein 
deficient serum (Ld), lovastatin 10-6M (Lv) and Ld + Lv. Messenger 
RNA (mRNA) was isolated after 16h in defined media and Northern blot 
analysis performed using cloned cDNA probes. In controls (n=3) and in 
subjects with the deletion (n=7), the LDL·R and HMG CoA reductase 
genes were expressed in coordinate regulation. Compared with Ld, 
controls and responders (n=4) had a near two fold increase in LDL-R and 
HMG CoA red. mRNA levels in the presence of Ld+Lv. In non•
responders (n=3), no increase in LDL-R mRNA was observed in Ld+Lv. 
125I_LDL binding assays revealed that the LDL-R is not up-regulated in 
non-responders to the same degree as in responders in the presence of 
Ld+Lv. Our data suggests that the LDL-R and HMG CoA red. genes are 
coordinately regulated even in the presence of a "null" allele mutation and 
that some patients resistant to drug therapy with HMG CoA reductase 
inhibitors may have abnormal regulation of the LDL·R gene. 
837·6 
Do Plasma Antioxidant Levels 
with Endothelial Dysfunction In 
With Kormal Total Cholesterol? 
11:45 
Correlate 
Subjects 
Shigeyuki Nishimura, Kenichi Katoh, Shinichiro 
Yamagami, Toshiyuki Tamaki, Hiroshi Ohta, 
Gouichi Sano. Yokohma Rosai Hospital, Yokohama, 
Japan 
To determine whether coronary endothelial 
dysfunction is correlated with plasma lipids, 
lipoprotein (a) [Lp(a)] and natural 
antioxidants, B-carotene (B-Ca) and vitamin E 
(VE), levels in subjects with angiographically 
normal coronary artery and normal total 
cholesterol levels «210mg/dl), we studied 
acetylcholine (ACh) mediated coronary vasomotor 
response in 26 subjects ( mean age 55 yrs) 
without hypertension and diabetes. The 
vasomotor responses to ACh (0.5, 5. 10, 50mcg) 
were assessed by changes in diameter with 
quantitative angiography. 
Endothelial response 
NOrmal!n=81 abnormal (n=lB1 p 
T-C (mg/dl) lB5±17 1B7±12 ns 
LDL-C (mg/dl) 116±15 120±25 ns 
HDL-C (mg/dl) 57±15 44±16 0.07 
LDL/HDL-C 2.UO.4 3.0±0.B 0.02 
TG (mg/dl) 115±49 l6UB8 0.08 
Apo Al (mg/dl) 131± 19 125±19 ns 
Lp(a) (mg/dl) 13±B 22±20 ns 
B-Ca (~g/dl) 24±12 28±18 ns 
VE (mg/dl) 1.4±0.5 1.6±0.9 ns 
The present study demonstrates that elevated 
LDL/HDL-C ratio but not antioxidant level is 
associated with endothelial dysfunction in 
subjects with normal total cholesterol. 
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838·1 10:30 
The Natural History or Focal Moderate Rejection in Orthotopic 
Heart Transplant Recipients 
Michael P. Gleeson, Jon A Kobashigawa, Lynne W. Stevenson, 
Jaime D. Moriguchi, Nobuyuki Kawata, Michele A Hamilton, 
Antoine Hage, Davis Drinkwater, Hillel Laks. UCLA Medical 
Center, Los Angeles, CA. 
The treatment of endomyocardial biopsy proven focal moderate 
rejection (FMR), ISHLT II, is controversial. As of yet, there is no 
standard protocol for the treatment of such patients, who are 
sometimes administered high dose corticosteroid therapy. 
Between January 1990 and June 1993, we retrospectively 
reviewed 41 episodes of non·treated focal moderate rejection in 
patients on triple drug immunosuppression. The rejection 
episodes were divided into those occurring less than 1 yr (18 
episodes) and those occurring at greater than 1 yr (23 episodes) 
post transplant Endomyocardial biopsy (bx) was repeated within 
2 wks for each episode. If the repeat bx showed worsening 
rejection, the patient was treated with high dose corticosteroid 
therapy. Bxs which appeared unchanged or improved, but not yet 
clear, warranted a second repeat bx within 2 weeks. Focal 
moderate rejection cleared by 4 wks in 89% of patients less than 
1 yr post transplant and in 83% of patients greater than 1 yr post 
transplant. Oeared . Oeared Progressed to 
b.y 2 wks by 4 wks Moderate Rej 
FMR < 1 yr 11/18 = 61% 5/18 = 28% 2/18 = 11% 
FMR> 1 yr 17/23 = 74% 2/23 = 9% 4/23 = 17% 
CONCLUSION: Focal moderate rejection does not progress to 
moderate rejection in the majority of cases. Oose observation 
and repeat biopsy may be warranted to avoid excess 
immunosuppression. 
838·2 10:45 
Prevention of Severe Cardiac Allograft Rejection with Pravastatln: A 
Randomized Trial 
Jon A. Kobashlgawa. Michael P. Gleeson. Lynne W. Stevenson, Jeffrey G. 
Carr. Jaime D. Moriguchi. Nobuyukl Kawata. Michele A. HamUton. Antoine 
Hage, Davis Drinkwater. HUleI Laks. UClA Medical Center. los Angeles. CA. 
Pravastatin (pRV). an HMG CoA reductase Inhibitor lowers cholesterol. but 
has also been suggested to Inhibit natural kUler cell cytotoxicity and antibody 
dependent cellular cytotoxicity. To detennlne the effects on cholesterol and 
reJection. we have thus far randomized 67 cardiac transplant patients on 
triple drug Immunosupresslon to PRY 40 mg qd (33 pts) or to no PRY (34 
pts) at 1-2 wks following cardiac transplant surgery. Both groups were ~mlar 
In mean age, number females. donor ischemic time/sex/age. HLA matches. 
number with previous coronary artery disease. Average cholesterol (mean of 
mos 3.6.9,12) of the PRY group was 182.± 31 vs 278.± 65 mg/dl In the no 
PRY group (p<.OOl) without myositis or rhabdomyolysls occurring. Severe 
rejection leading to hemodynamic compromise and/or death occurred 
significantly more often In the no PRY group compared to the PRY group (10 
pts vs 1 pt. p<0.05). 
ActuariaI Freedom from Severe Rejection 
100% 
50% 
- - - PRV group 
- NoPRV 
group 
Months 6 12 
Conclusion: In addition to lowering cholesterol. Pravastatin when used early 
after transplant in combination with triple drug Immunosuppression appears 
to reduce the development of severe rejection leading to hemodynamic 
compromise and/or death In cardiac transplant patients. This may reflect the 
Importance of early cholesterol reduction for vascular Integrity or a direct 
immunosuppressive effect . 
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838·3 11:00 
Effect of Steroid Withdrawal on Cardiac AUograft FWlCtion and Exercise 
Tolerance 
Maria-Teresa Olivari, Clyde W. Yancy, w. Steves Ring, Brian J. Baldwin, 
Vern P. Hom, Univen;ity of Texas Southwestern Medical Center and St. Paul 
Medical Center, Dallas, TX 
Withdrawal of prednisone (P) in cardiac transplant recipients (erR) leads to 
significant increase in acute ~ection (AR), which might jeopardize long-teIlD 
graft function and exercise tolerance. To test this hypothesis, hemodynamic and 
cardiopulmonary stress test data were compared 1 and 2 y post T in Group I 
(n=32) in which P was stopped 6 months post T and in Group n (n=46), 
continued on P. Both groups received identical doses of azathioprine and 
cyclosporine. One and 2 y survival was similar, AR was higher in Group I, 
54% vs 12%, p < .01. Data are shown as mean ± SD, "p < .05, "p < .01 
between Groups. VO,=oxygen consumption, AT=anaerobic threshold. 
Group I Group II 
ly 2y ly 2y 
EF % 66 ± 8 65 ± 10 63 ± 12 64 ± II 
CIl/min/M' 2.8 ± .5 2.8 ± .5 2.7 ± .5 2.8 ± .5 
PAPmmHg 26 ± 6 21 ± 3 24 ± 5 24 ± 4' 
Wedge mmHg 18 ± 4 15 ± 4 15 ± 5 16 ± 5 
BP mmHg III ± 12 104 ± II 111 ± 15 113 ± 14 
YO, at AT ml/Kg/min 19 ± 5 20 ± 3 15 ± 4' 16 ± 6· 
max va, ml/Kg/min 2i± 6 21 ± 6 19 ± 6 21 ± 6 
Conclusions: in spite of higber AR, erR withdrawn from P, have normal graft 
function, and lower pulmonary and systemic pressures at 2 y. They also bave 
better submaximal exercise capacity than pts on P. These results may be due to 
reduced steroid toxicity including decreased sodium and water retention, steroid•
induced myopathy and osteoporosis. 
838.4 11:15 
Functional Capacity of Murine Cardiac Allograft· 
Infiltrating T·Celis Obtained by In vitro Stimulation 
with IL·2. 
John F. Carlquist, Jane Shelby, Linda Edelman, Shixuan 
Xu, Jeffrey L. Anderson. University of Utah and LOS 
Hospital, Salt Lake City, UT 
The process of cellular allograft rejection is initiated by the 
recognition of graft-expressed alloantigens by the 
reCipients T lymphocytes. This interaction results in the 
activation of these T cells which subsequently express the 
receptor for Interleukin-2 (IL-2) or T-cell growth factor. In 
the present study we obtained large quantities of T cells 
from rejected C3H/HeN grafts, heterotopically transplanted 
to C57BV6 recipients, by culturing disrupted graft tissue with 
160 units/ml exogenous IL-2. The cultures of graft•
infiltrating T lymphocytes (GITL) obtained in this manner 
were 93.4 ± 3.B% (mean±SD) COB positive; 7.2 ± 5.5% 
expressed both CD4 and CDS surface markers. To assess 
the functional capacity of these GITL, cultures derived from 
individual, rejected C3H grafts were adoptively transferred 
to C57BV6 recipients of C3H grafts in quantities from 
1x1 06-1 x1 07 cells/animal (median: 3x106). Animals 
receiving GITL 24 hours post-transplantation (PT) (n=6) 
rejected C3H grafts a mean of 6.2±O.B days PT (median: 6, 
range: 5-7) compared with a mean of S.3±1.6 days PT 
(median: 7.5, range: 7-11) for controls (n=8; p<0.007, Mann•
Whitney). In contrast, adoptive transfer of GITL 48 hours 
pre-transplantation (n=3) did not accelerate graft rejection 
as compared with controls (mean: S.7±0.6 days PT; median: 
9. range: 8-9, p=NS). These findings suggest that GITL 
recovered by this method correspond to in vivo cellular 
mediators of graft rejection which may be used to increase 
our understanding of rejection mechanisms. 
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838·5 11:30 
The Pharmacokinetics of Preo(lfJ'8tive Amiodarone After Cardiac 
Transplantation 
Christopher D. Scott, Derek Buss, Philip A. Routledge, 10hn H Dark, 
lanet M. McComb. Freeman Hospital, Newcastle upon Tyne and 
Llandough Hospital, Cardiff, UK 
Amiodarone (AMID) is a highly effective antiarrhythmic agent with 
little or no negative inotropic effect. h is, therefore, commonly prescribed 
for patients with end-stage heart disease awaiting transplantation. The 
unusually long elimination half life of AMID raises the possibility of 
redistribution of amiodarone taken preoperatively to the transplanted heart. 
This has DOt previously been confirmed by direct measurements of serum 
and tissue drug levels. 
AMID and desethylamiodarone (DesA) levels were measured in 
serum and endomyocardial biopsy samples in six recipients 1,2,3 and 6 
weeks, 3 and 6 months after transplantation. All subjects had taken 200mg 
daily with a mean cumulative dose of 82 ± 72g, none received AMID after 
transplantation. Assays were performed using high performance liquid 
chromatography. 
Results: (mean± lSD, serum levels in mcg/mI, cardiac levels in meg/g) 
Serum AMID 
Serum DesA 
Cardiac AMID 
Week 1 Week 2 Week 3 Week 6 Month 3 Month 6 
1±0.2 1.6 ± 1.4 2.2± 1.4 1.2± 1.6 0.5±0.7 0.1 ±0.3 
2.2±0.7 3.6±2.6 4.3±2.4 1.5±1.7 0.7±0.9 0.1±0.1 
9.B±S.4 6.4±2.2 8.2±7.7 S.9±3.S 3.5±2.4 0.9±1.3 
Cardiac DesA 42±17 42±18 29±l7 31±13 22±lB 7±6 
These data confirm that AMID taken before transplantation is 
redistributed to the transplanted heart. 1 week after transplantation serum 
and cardiae drug levels are directly comparable with those previously 
reponed in subjects taking regular oral therapy. Serum levels increase until 
3 weeks and then decline progressively. Cardiac levels are sustained for 2 
to 3 weeks then fall. Both AMID and DesA remain detectable in 
myocardium in some subjects for up to 6 months after transplantation. 
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838·6 11:45 
Rigbt Ventricular Performance (but Dot Outflow Resistance) is a Major Pre•
Operative Determinant or Rigbt Heart Failure In Patients wltb Chronic 
Heart Failure Who Receive a Left Ventricular Assist Device 
Howard R. Levin, Daniel Burkhoff, Jonathan Chen, Mebmet C. Oz, Milton 
Packer, Eric A. Rose, Columbia University, College of Physicians and 
Surgeons, New York, NY 
Right heart failure (RHF) is a major complication In patients with congestive 
beart failure (CHF) following implantation of a LV assist device (LV AD), but 
previous studies have failed to identify pre-operative predictors of RHF. We 
analyzed the pre-operative characteristics of 92 CHF patients (Pts) who 
underwent implantation of a TCI HeartMate 1000 IP LV AD. RHF was defmed 
as the bemodynamic and clinical requirement for placement of a RV assist 
device. Eighteen of 92 pts (19.6%) developed RHF; of these, 79 pts bad 
hemodynamic data, of whom II had RHF. Analysis was performed using the 
Mann-Whitney U test. Results are shown in the following table: (values are 
means for each group; • = P < 0.05 between the 2 groups): 
RAP PAM RVSW LVSW PVR 
NoRHF 14.5 40.2 11.7 18.6 3.6 
RHF 19.6* 33.6* 6.3* 19.5 2.45 
t' AM - t'Ul monary anery mean pressure KAt' - Klgnt atnat pressure 
RVSW· Right ventricular stroke work LVSW-Left ventricular stroke work 
Pts with RHF post.LV AD had higher RAP and lower PAM pre-operatively than 
pts without RHF, and thus, pre-op RV stroke work was substantially lower in 
pts with RHF (P < 0.001). In contrast, variables reflecting LV function (mean 
aortic pressure (69± II vs 68± 12), pulmonary capillary wedge pressure (29±7 
vs 26±5) and cardiac output (3.6± 1.1 vs 3.4±0.7)) were similar in both 
groups. Importantly, in contrast to the experience in CHF pts undergoing cardiac 
transplantation (CTX), pre·LV AD PVR was not a determinant of post-op RHF. 
In conclusion, RV function (but not PVR) is an important pre-op risk factor for 
post-LV AD RHF. The lack of importance of PVR in LV AD pts (in contrast to 
CTX pts) may be related to the fact that the RV of LV AD pts (hut not the donor 
RV of the CTX pts) has been remodelled to tolerate high resistance to RV 
outflow. 
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930·41 
The RelatioAsbip ~ Coronary Risk Factors and the Augiograpbic 
Chancta'istics of Coronary ArtIly Lesioas 
MicbIeI J. AUubIto, Frederick Fat, James E. Best, IsobeIJa VenIInoIli. Allan 
Rosen, Alice K. J8CObs, Boanie H. WeInec, William J, Rogen ad the Bypus 
AllgiopIasty RevuculuizaIiaa Invatiptioo Core Radiographic Labontory, New 
Yorl< University, New Yark, NY, ad Stanford University, Stanford, CA 
The relalioasbip betweal CDl'OIW)' Jesioo morphology ad the risk fiIc:ton for 
COI'OIW)' uta)' eli-. (CAD) _ ewnined in 2243 pIS with ~ CAD 
emoIIed In the Bypus AIIgiopIasty RaYuculariDtiaa InYelligatiaa (BAlU). . All 
pIS bad a SO" or ..... diMaeter nducQaa in two or more uterieI; 1829 of the 
pis bad -'om)' IUiIlble for nadomiDIion to COI'OIW)' bypuI ~ or 
angiopJasty, wbiJe414 were DOt rudomiud precIomInudydue to IlII8ioppbic 
cooditioas PRdudins ugiopIuty. The angiograpbic .--e of uIcenIioa, 
c:.Jcific:ation, -mcity. thrombus, 0&tiaI JoQ]iaa and __ ..,w.tioa in 
12,732 COI'OIW)' IeIiaas _ comIated with age, geoder. biItocy of diUIetes, 
byporteasioo. hyperc:bolellaul cipreUe use, ad famiIy biItocy of CAD. 
Resulls: U.m, a cueloaaIIoI _)'lis cootroUiDg for the DIUIIber of IeIiaas pel' 
pi, pis with at lout _ uICCAIed lesiaa were more likely to bave a biItocy of 
cigareUo use CCJIIIIIIRd to thole without m uIcenIed Iesioa (10" VI 70". 
p-O.02). Pta with at Ieut _ calcified Iesioa were more commaalyovec 65 years 
old (SI" VI 37", p<O.OI), u were potients with seva-ely apIated IeIiaas 
(S7" VI 39". p<O.OI) ad !hoe with ostia1lcsioas (SI" VI 39". p-O.02). 
Adding a cootrot for age, 0&tiaI1eIiaas were associaIed with a ~ iacicIeace of 
bigh cboIeoteroI (IS" VI 29". p<O.OI). The able coatalns the odds ntiOl for 
the likelibood of a risk fact« In the presence of a Iesioa cbancteristic. 
U1cer Cak SeYAng Ostial Throm Eccen 
Age >65 0.65 1.68* 1.93* I.S2* 1.06 1.02 
Hx Smk 1.7S* 0.95 US 0.72 0.94 1.08 
a.ol >240 I.OS 0.84 0.93 0.47* 1.01 0.90 
*iDdicalellligaificaDce at a 9S" confidence interval 
There were DO ligaificut uaocUtioas of mgiograpbic cbancteristicI with 
geoder, diabetes, hyperteasioa or fami1y bistory of CAD. 
Coadusion: In Ibis cohort of pts with multivessel CAD NqUiriDg 
- -.--.~~ .. ~-- .oL ______ • "':-1.. &-. ___ ... ___ ~ ••• __ .... tIt, .. _i ....... nt 
